PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Mudeppa, DG; Kumar, S; Kokkonda, S; White, J; Rathod, PK				Mudeppa, Devaraja G.; Kumar, Shiva; Kokkonda, Sreekanth; White, John; Rathod, Pradipsinh K.			Topoisomerase II from Human Malaria Parasites EXPRESSION, PURIFICATION, AND SELECTIVE INHIBITION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIHYDROOROTATE DEHYDROGENASE INHIBITORS; C-TERMINAL DOMAIN; PLASMODIUM-FALCIPARUM; DIHYDROFOLATE-REDUCTASE; DNA; FLUOROQUINOLONES; PROTEOMICS; PROTEINS; REVEALS; ASSAY	Historically, type II topoisomerases have yielded clinically useful drugs for the treatment of bacterial infections and cancer, but the corresponding enzymes from malaria parasites remain understudied. This is due to the general challenges of producing malaria proteins in functional forms in heterologous expression systems. Here, we express full-length Plasmodium falciparum topoisomerase II (PfTopoII) in a wheat germ cell-free transcription-translation system. Functional activity of soluble PfTopoII from the translation lysates was confirmed through both a plasmid relaxation and a DNA decatenation activity that was dependent on magnesium and ATP. To facilitate future drug discovery, a convenient and sensitive fluorescence assay was established to follow DNA decatenation, and a stable, truncated PfTopoII was engineered for high level enzyme production. PfTopoII was purified using a DNA affinity column. Existing TopoII inhibitors previously developed for other non-malaria indications inhibited PfTopoII, as well as malaria parasites in culture at submicromolar concentrations. Even before optimization, inhibitors of bacterial gyrase, GSK299423, ciprofloxacin, and etoposide exhibited 15-, 57-, and 3-fold selectivity for the malarial enzyme over human TopoII. Finally, it was possible to use the purified PfTopoII to dissect the different modes by which these varying classes of TopoII inhibitors could trap partially processed DNA. The present biochemical advancements will allow high throughput chemical screening of compound libraries and lead optimization to develop new lines of antimalarials.	[Mudeppa, Devaraja G.; Kumar, Shiva; Kokkonda, Sreekanth; White, John; Rathod, Pradipsinh K.] Univ Washington, Dept Chem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle		rathod@chem.washington.edu	kokkonda, sreekanth/N-4457-2017; Regan, Clinton/E-6250-2012		National Institutes of Health [AI093380, AI099280, AI089688]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099280, U19AI089688, R01AI093380] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI093380, AI099280, and AI089688. The authors declare that they have no conflicts of interest with the contents of this article.	Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Auparakkitanon S, 2000, BIOCHEM BIOPH RES CO, V269, P406, DOI 10.1006/bbrc.2000.2305; Barnabe N, 2001, J CHROMATOGR B, V760, P263, DOI 10.1016/S0378-4347(01)00274-2; Bax BD, 2010, NATURE, V466, P935, DOI 10.1038/nature09197; Berger JM, 1996, NATURE, V379, P225, DOI 10.1038/379225a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARON PR, 1994, MOL CELL BIOL, V14, P3197, DOI 10.1128/MCB.14.5.3197; Chavalitshewinkoon Porntip, 1994, Southeast Asian Journal of Tropical Medicine and Public Health, V25, P32; CHEESMAN S, 1994, NUCLEIC ACIDS RES, V22, P2547, DOI 10.1093/nar/22.13.2547; Cheesman S, 1998, MOL BIOCHEM PARASIT, V92, P39, DOI 10.1016/S0166-6851(97)00223-5; Cheesman SJ, 2000, PARASITOL TODAY, V16, P277, DOI 10.1016/S0169-4758(00)01697-5; Cortazar TM, 2007, EXP PARASITOL, V116, P475, DOI 10.1016/j.exppara.2007.02.018; Coteron JM, 2011, J MED CHEM, V54, P5540, DOI 10.1021/jm200592f; Dahl EL, 2007, ANTIMICROB AGENTS CH, V51, P3485, DOI 10.1128/AAC.00527-07; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Florens L, 2004, MOL BIOCHEM PARASIT, V135, P1, DOI 10.1016/j.molbiopara.2003.12.007; Ganesan K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000214; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Goodman CD, 2007, MOL BIOCHEM PARASIT, V152, P181, DOI 10.1016/j.molbiopara.2007.01.005; Guler JL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003375; HekmatNejad M, 1996, ANTIMICROB AGENTS CH, V40, P1628, DOI 10.1128/AAC.40.7.1628; Jahnz M, 2005, CHEMBIOCHEM, V6, P920, DOI 10.1002/cbic.200400379; Kappe SHI, 2010, SCIENCE, V328, P862, DOI 10.1126/science.1184785; Kelly JM, 2006, P NATL ACAD SCI USA, V103, P6706, DOI 10.1073/pnas.0510363103; Lasonder E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000195; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lindner SE, 2013, MOL CELL PROTEOMICS, V12, P1127, DOI 10.1074/mcp.M112.024505; Mahmoudi N, 2003, ANTIMICROB AGENTS CH, V47, P2636, DOI 10.1128/AAC.47.8.2636-2639.2003; Meczes EL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001754; Mehlin C, 2006, MOL BIOCHEM PARASIT, V148, P144, DOI 10.1016/j.molbiopara.2006.03.011; Miller LH, 2013, NAT MED, V19, P156, DOI 10.1038/nm.3073; Mitscher LA, 2005, CHEM REV, V105, P559, DOI 10.1021/cr030101q; Mudeppa DG, 2007, MOL BIOCHEM PARASIT, V151, P216, DOI 10.1016/j.molbiopara.2006.10.016; Mudeppa DG, 2013, EUKARYOT CELL, V12, P1653, DOI 10.1128/EC.00222-13; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Nenortas E, 2003, ANTIMICROB AGENTS CH, V47, P3015, DOI 10.1128/AAC.47.9.3015-3017.2003; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Oehring SC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r108; Pang CKT, 2009, MOL BIOCHEM PARASIT, V168, P74, DOI 10.1016/j.molbiopara.2009.06.011; Phillips MA, 2008, J MED CHEM, V51, P3649, DOI 10.1021/jm8001026; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Ram EVSR, 2007, MOL BIOCHEM PARASIT, V154, P30, DOI 10.1016/j.molbiopara.2007.04.001; Rathod PK, 1997, P NATL ACAD SCI USA, V94, P9389, DOI 10.1073/pnas.94.17.9389; Romero IC, 2005, J PARASITOL, V91, P1474, DOI 10.1645/GE-3489.1; Roy A, 2011, MOL BIOL INT, V2011; SAHAI BM, 1986, ANAL BIOCHEM, V156, P364, DOI 10.1016/0003-2697(86)90267-8; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schmidt BH, 2012, NAT STRUCT MOL BIOL, V19, P1147, DOI 10.1038/nsmb.2388; Silvestrini F, 2010, MOL CELL PROTEOMICS, V9, P1437, DOI 10.1074/mcp.M900479-MCP200; Singh PK, 2011, PROTEIN EXPRES PURIF, V76, P165, DOI 10.1016/j.pep.2010.08.001; Taylor JA, 2012, METHODS MOL BIOL, V815, P229, DOI 10.1007/978-1-61779-424-7_17; Vedadi M, 2007, MOL BIOCHEM PARASIT, V151, P100, DOI 10.1016/j.molbiopara.2006.10.011; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; Weissig V, 1997, DNA CELL BIOL, V16, P1483, DOI 10.1089/dna.1997.16.1483; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Widdowson K, 2010, FUTURE MED CHEM, V2, P1619, DOI 10.4155/FMC.10.250; Wu CC, 2011, SCIENCE, V333, P459, DOI 10.1126/science.1204117; Zhang K, 2002, SCIENCE, V296, P545, DOI 10.1126/science.1068274	58	15	15	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20313	20324		10.1074/jbc.M115.639039	http://dx.doi.org/10.1074/jbc.M115.639039			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26055707	Green Published, hybrid			2022-12-28	WOS:000359608900030
J	Liu, Y; Batchuluun, B; Ho, L; Zhu, D; Prentice, KJ; Bhattacharjee, A; Zhang, M; Pourasgari, F; Hardy, AB; Taylor, KM; Gaisano, H; Dai, FF; Wheeler, MB				Liu, Ying; Batchuluun, Battsetseg; Ho, Louisa; Zhu, Dan; Prentice, Kacey J.; Bhattacharjee, Alpana; Zhang, Ming; Pourasgari, Farzaneh; Hardy, Alexandre B.; Taylor, Kathryn M.; Gaisano, Herbert; Dai, Feihan F.; Wheeler, Michael B.			Characterization of Zinc Influx Transporters (ZIPs) in Pancreatic beta Cells ROLES IN REGULATING CYTOSOLIC ZINC HOMEOSTASIS AND INSULIN SECRETION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE-HOMEOSTASIS; OXIDATIVE STRESS; SUPEROXIDE-DISMUTASE; DIABETES-MELLITUS; ADAPTIVE RESPONSE; GENE-EXPRESSION; LIV-1 SUBFAMILY; GLP-1 RECEPTOR; CELLULAR ZINC; MICE	Zinc plays an essential role in the regulation of pancreatic beta cell function, affecting important processes including insulin biosynthesis, glucose-stimulated insulin secretion, and cell viability. Mutations in the zinc efflux transport protein ZnT8 have been linked with both type 1 and type 2 diabetes, further supporting an important role for zinc in glucose homeostasis. However, very little is known about how cytosolic zinc is controlled by zinc influx transporters (ZIPs). In this study, we examined the beta cells. Modulation of ZIP6 and ZIP7 expression significantly altered cytosolic zinc influx in pancreatic beta cells, indicating an important role for ZIP6 and ZIP7 in regulating cellular zinc homeostasis. Functionally, this dysregulated cytosolic zinc homeostasis led to impaired insulin secretion. In parallel studies, we identified both ZIP6 and ZIP7 as potential interacting proteins with GLP-1R by a membrane yeast two-hybrid assay. Knock-down of ZIP6 but not ZIP7 in MIN6 beta cells impaired the protective effects of GLP-1 on fatty acid-induced cell apoptosis, possibly via reduced activation of the p-ERK pathway. Therefore, our data suggest that ZIP6 and ZIP7 function as two important zinc influx transporters to regulate cytosolic zinc concentrations and insulin secretion in beta cells. In particular, ZIP6 is also capable of directly interacting with GLP-1R to facilitate the protective effect of GLP-1 on beta cell survival.	[Zhang, Ming; Pourasgari, Farzaneh; Hardy, Alexandre B.; Gaisano, Herbert; Dai, Feihan F.; Wheeler, Michael B.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Taylor, Kathryn M.] Cardiff Univ, Sch Pharm & Pharmaceut Sci, Breast Canc Mol Pharmacol Unit, Cardiff CF10 3NB, S Glam, Wales	University of Toronto; Cardiff University	Dai, FF (corresponding author), 1 Kings Coll Circle, Dept Physiol, Med Sci Bldg,Rm 3352, Toronto, ON M5S 1A8, Canada.	f.dai@utoronto.ca; Michael.wheeler@utoronto.ca	Taylor, Kathryn M/O-3401-2014; Liu, Ying/H-6045-2018	Taylor, Kathryn M/0000-0002-9576-9490; Liu, Ying/0000-0001-7710-0809; Wheeler, Michael B./0000-0002-7480-7267	Ontario Research Funds [19442, 30961]	Ontario Research Funds	We thank the Canadian Foundation for Innovation and Ontario Research Funds (19442 and 30961) for providing the equipment used in our study. We thank Islet Core and Clinical Islet Laboratory (University of Alberta) providing us human islets from review board-approved donors. We thank Judith A. Eversley for contributions to the manuscript. We also thank Kyle W. Sloop for the pcDNA3.1-ZIP6-HA plasmid construct.	Al-Maroof RA, 2006, SAUDI MED J, V27, P344; Anderson RA, 2001, J AM COLL NUTR, V20, P212, DOI 10.1080/07315724.2001.10719034; ATWATER I, 1979, J PHYSIOL-LONDON, V288, P575; Bao B, 2008, TRANSL RES, V152, P67, DOI 10.1016/j.trsl.2008.06.001; Basford CL, 2012, DIABETOLOGIA, V55, P358, DOI 10.1007/s00125-011-2335-x; Bayascas JR, 2002, CELL DEATH DIFFER, V9, P1078, DOI 10.1038/sj.cdd.4401075; Bellomo EA, 2011, J BIOL CHEM, V286, P25778, DOI 10.1074/jbc.M111.246082; Benters J, 1997, BIOCHEM J, V322, P793, DOI 10.1042/bj3220793; Besecker B, 2008, AM J PHYSIOL-LUNG C, V294, pL1127, DOI 10.1152/ajplung.00057.2008; Chimienti F, 2004, DIABETES, V53, P2330, DOI 10.2337/diabetes.53.9.2330; Chowanadisai W, 2008, BRAIN RES, V1199, P10, DOI 10.1016/j.brainres.2008.01.015; COFFMAN FD, 1988, BIOCHEMISTRY-US, V27, P6179, DOI 10.1021/bi00416a053; Craddock TJA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033552; CROUCH RK, 1984, EXP MOL PATHOL, V41, P377, DOI 10.1016/0014-4800(84)90026-1; CUNNINGHAM JJ, 1994, METABOLISM, V43, P1558, DOI 10.1016/0026-0495(94)90016-7; Desouki MM, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-37; Diao J, 2008, P NATL ACAD SCI USA, V105, P12057, DOI 10.1073/pnas.0710434105; Dufner-Beattie J, 2004, J BIOL CHEM, V279, P49082, DOI 10.1074/jbc.M409962200; Dufner-Beattie J, 2007, HUM MOL GENET, V16, P1391, DOI 10.1093/hmg/ddm088; Favaro E, 2012, DIABETOLOGIA, V55, P1058, DOI 10.1007/s00125-011-2423-y; FLATT PR, 1980, BIOCHEM J, V190, P361, DOI 10.1042/bj1900361; FOSTER MC, 1993, BIOPHYS J, V64, P525, DOI 10.1016/S0006-3495(93)81397-3; Foster M, 2010, ANTIOXID REDOX SIGN, V13, P1549, DOI 10.1089/ars.2010.3111; Fukada T, 2011, J BIOL INORG CHEM, V16, P1123, DOI 10.1007/s00775-011-0797-4; Gyulkhandanyan AV, 2006, J BIOL CHEM, V281, P9361, DOI 10.1074/jbc.M508542200; Hardy AB, 2012, AM J PHYSIOL-ENDOC M, V302, pE1084, DOI 10.1152/ajpendo.00448.2011; Hardy AB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119136; Hardy AB, 2009, J BIOL CHEM, V284, P30441, DOI 10.1074/jbc.M109.040659; Hashemi M, 2007, EUR J PHARMACOL, V557, P9, DOI 10.1016/j.ejphar.2006.11.010; Hennigar SR, 2012, BIOL CHEM, V393, P565, DOI 10.1515/hsz-2012-0128; Hogstrand C, 2009, TRENDS MOL MED, V15, P101, DOI 10.1016/j.molmed.2009.01.004; Hogstrand C, 2013, BIOCHEM J, V455, P229, DOI 10.1042/BJ20130483; Huang LP, 2005, J BIOL CHEM, V280, P15456, DOI 10.1074/jbc.M412188200; Huang X, 2013, MOL ENDOCRINOL, V27, P1550, DOI 10.1210/me.2013-1047; Jansen J, 2009, J NUTR BIOCHEM, V20, P399, DOI 10.1016/j.jnutbio.2009.01.009; Kahn SE, 2001, INT J CLIN PRACT, P13; Kambe T, 2004, CELL MOL LIFE SCI, V61, P49, DOI 10.1007/s00018-003-3148-y; Kitamura H, 2006, NAT IMMUNOL, V7, P971, DOI 10.1038/ni1373; Le DA, 2002, P NATL ACAD SCI USA, V99, P15188, DOI 10.1073/pnas.232473399; Lee SC, 2009, J ENDOCRINOL, V203, P33, DOI 10.1677/JOE-09-0117; Lemaire K, 2009, P NATL ACAD SCI USA, V106, P14872, DOI 10.1073/pnas.0906587106; Li YZ, 2003, J BIOL CHEM, V278, P471, DOI 10.1074/jbc.M209423200; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Lu HF, 2010, DIABETES, V59, P448, DOI 10.2337/db09-0129; Luu L, 2013, DIABETOLOGIA, V56, P2010, DOI 10.1007/s00125-013-2946-5; Maclean KH, 2001, BLOOD, V98, P3831, DOI 10.1182/blood.V98.13.3831; Makhov P, 2008, CELL DEATH DIFFER, V15, P1745, DOI 10.1038/cdd.2008.106; Maret W, 2007, MOL MED, V13, P371, DOI 10.2119/2007-00036.Maret; MCNAIR P, 1981, CLIN CHIM ACTA, V112, P343, DOI 10.1016/0009-8981(81)90457-5; Meier JJ, 2012, NAT REV ENDOCRINOL, V8, P728, DOI 10.1038/nrendo.2012.140; Mendivil-Perez M, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/313275; Myers SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079316; Nicolson TJ, 2009, DIABETES, V58, P2070, DOI 10.2337/db09-0551; Nygaard Sanne Bjorn, 2014, BMC Res Notes, V7, P84, DOI 10.1186/1756-0500-7-84; Ohly P, 2000, DIABETOLOGIA, V43, P1020, DOI 10.1007/s001250050009; Oteiza PI, 2012, FREE RADICAL BIO MED, V53, P1748, DOI 10.1016/j.freeradbiomed.2012.08.568; OTEIZA PI, 1995, J NUTR, V125, P823; Plum LM, 2010, INT J ENV RES PUB HE, V7, P1342, DOI 10.3390/ijerph7041342; Pound LD, 2009, BIOCHEM J, V421, P371, DOI 10.1042/BJ20090530; Prentice KJ, 2014, CELL METAB, V19, P653, DOI 10.1016/j.cmet.2014.03.008; QUARTERMAN J, 1966, BIOCHEM BIOPH RES CO, V25, P354, DOI 10.1016/0006-291X(66)90785-6; Quoyer J, 2010, J BIOL CHEM, V285, P1989, DOI 10.1074/jbc.M109.067207; Shuttleworth CW, 2011, TRENDS PHARMACOL SCI, V32, P480, DOI 10.1016/j.tips.2011.04.001; Slepchenko KG, 2012, EXP DIABETES RES, DOI 10.1155/2012/190309; Tamaki M, 2013, J CLIN INVEST, V123, P4513, DOI 10.1172/JCI68807; Taylor KM, 2008, ENDOCRINOLOGY, V149, P4912, DOI 10.1210/en.2008-0351; Taylor KM, 2007, MOL MED, V13, P396, DOI 10.2119/2007-00040.Taylor; Taylor KM, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002585; Taylor KM, 2003, BBA-BIOMEMBRANES, V1611, P16, DOI 10.1016/S0005-2736(03)00048-8; Trzcinska-Daneluti AM, 2009, MOL CELL PROTEOMICS, V8, P780, DOI 10.1074/mcp.M800268-MCP200; Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355; Wichroski MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042609; Wijesekara N, 2010, DIABETOLOGIA, V53, P1656, DOI 10.1007/s00125-010-1733-9; Williams RG, 2006, METHOD ENZYMOL, V414, P364, DOI 10.1016/S0076-6879(06)14021-5; Wolff NA, 2014, FASEB J, V28, P2134, DOI 10.1096/fj.13-240564; Wu CY, 2007, J BIOL CHEM, V282, P2184, DOI 10.1074/jbc.M606639200; Wu CY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007061; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081; Zhang TT, 2006, NANO LETT, V6, P800, DOI 10.1021/nl0603350; Zhao L, 2007, BIOCHEM BIOPH RES CO, V363, P82, DOI 10.1016/j.bbrc.2007.08.127; Zhu D, 2012, CELL METAB, V16, P238, DOI 10.1016/j.cmet.2012.07.001	81	49	49	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18757	18769		10.1074/jbc.M115.640524	http://dx.doi.org/10.1074/jbc.M115.640524			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	25969539	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000358512100043
J	Pandalaneni, S; Karuppiah, V; Saleem, M; Haynes, LP; Burgoyne, RD; Mayans, O; Derrick, JP; Lian, LY				Pandalaneni, Sravan; Karuppiah, Vijaykumar; Saleem, Muhammad; Haynes, Lee P.; Burgoyne, Robert D.; Mayans, Olga; Derrick, Jeremy P.; Lian, Lu-Yun			Neuronal Calcium Sensor-1 Binds the D2 Dopamine Receptor and G-protein-coupled Receptor Kinase 1 (GRK1) Peptides Using Different Modes of Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; RHODOPSIN KINASE; NCS-1; FREQUENIN; PHOSPHORYLATION; CALMODULIN; CHANNELS; 4-KINASE-BETA; LOCALIZATION; PROMISCUITY	Neuronal calcium sensor-1 (NCS-1) is the primordial member of the neuronal calcium sensor family of EF-hand Ca2+-binding proteins. It interacts with both the G-protein-coupled receptor (GPCR) dopamine D2 receptor (D2R), regulating its internalization and surface expression, and the cognate kinases GRK1 and GRK2. Determination of the crystal structures of Ca2+/NCS-1 alone and in complex with peptides derived from D2R and GRK1 reveals that the differential recognition is facilitated by the conformational flexibility of the C-lobe-binding site. We find that two copies of the D2R peptide bind within the hydrophobic crevice on Ca2+/NCS-1, but only one copy of the GRK1 peptide binds. The different binding modes are made possible by the C-lobe-binding site of NCS-1, which adopts alternative conformations in each complex. C-terminal residues Ser-178-Val-190 act in concert with the flexible EF3/EF4 loop region to effectively form different peptide-binding sites. In the Ca2+/NCS-1.D2R peptide complex, the C-terminal region adopts a 3(10) helix-turn-3(10) helix, whereas in the GRK1 peptide complex it forms an alpha-helix. Removal of Ser-178-Val190 generated a C-terminal truncation mutant that formed a dimer, indicating that the NCS-1 C-terminal region prevents NCS-1 oligomerization. We propose that the flexible nature of the C-terminal region is essential to allow it to modulate its protein-binding sites and adapt its conformation to accommodate both ligands. This appears to be driven by the variability of the conformation of the C-lobe-binding site, which has ramifications for the target specificity and diversity of NCS-1.	[Pandalaneni, Sravan; Karuppiah, Vijaykumar; Lian, Lu-Yun] Univ Liverpool, Inst Integrat Biol, NMR Ctr Struct Biol, Liverpool L69 7ZB, Merseyside, England; [Mayans, Olga] Univ Liverpool, Inst Integrat Biol, Liverpool L69 7ZB, Merseyside, England; [Karuppiah, Vijaykumar; Saleem, Muhammad; Derrick, Jeremy P.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Haynes, Lee P.; Burgoyne, Robert D.] Univ Liverpool, Inst Translat Med, Dept Cellular & Mol Physiol, Physiol Lab, Liverpool L37 4BY, Merseyside, England	University of Liverpool; University of Liverpool; University of Manchester; University of Liverpool	Burgoyne, RD (corresponding author), Univ Liverpool, Inst Translat Med, Dept Cellular & Mol Physiol, Physiol Lab, Liverpool L37 4BY, Merseyside, England.	Burgoyne@liverpool.ac.uk; Jeremy.Derrick@manchester.ac.uk; Lu-Yun.Lian@liverpool.ac.uk	Saleem, Muhammad/W-4014-2017; Burgoyne, Robert D/P-6641-2019	Saleem, Muhammad/0000-0002-0994-9701; Burgoyne, Robert D/0000-0002-9219-0387; Derrick, Jeremy/0000-0002-4350-5354; Karuppiah, Vijaykumar/0000-0002-9645-7958; Mayans, Olga/0000-0001-6876-8532	University of Liverpool	University of Liverpool	We acknowledge the University of Liverpool for its support of the NMR Centre for Structural Biology. We thank Diamond Light Source for access (Proposal MX7146) that contributed to the results presented here. We thank Dr. Peter Gimeson, Malvern Instruments Nordic AB, Uppsala, Sweden, for guidance and help with the ITC experiments.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ames JB, 2006, J BIOL CHEM, V281, P37237, DOI 10.1074/jbc.M606913200; Ames JB, 2012, BBA-GEN SUBJECTS, V1820, P1205, DOI 10.1016/j.bbagen.2011.10.003; Ames JB, 2000, BIOCHEMISTRY-US, V39, P12149, DOI 10.1021/bi0012890; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bayburt TH, 2011, J BIOL CHEM, V286, P1420, DOI 10.1074/jbc.M110.151043; Bourne Y, 2001, J BIOL CHEM, V276, P11949, DOI 10.1074/jbc.M009373200; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Burgoyne RD, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-2; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; de Barry J, 2006, J BIOL CHEM, V281, P18098, DOI 10.1074/jbc.M509842200; DECASTRO E, 1995, BIOCHEM BIOPH RES CO, V216, P133, DOI 10.1006/bbrc.1995.2601; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Dragicevic E, 2014, BRAIN, V137, P2287, DOI 10.1093/brain/awu131; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Gomez M, 2001, NEURON, V30, P241, DOI 10.1016/S0896-6273(01)00276-8; Gurevich EV, 2012, PHARMACOL THERAPEUT, V133, P40, DOI 10.1016/j.pharmthera.2011.08.001; Handley MTW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010534; Haynes LP, 2007, TRAFFIC, V8, P1080, DOI 10.1111/j.1600-0854.2007.00594.x; Haynes LP, 2006, PROTEOMICS, V6, P1822, DOI 10.1002/pmic.200500489; Haynes LP, 2005, J BIOL CHEM, V280, P6047, DOI 10.1074/jbc.M413090200; Heidarsson PO, 2012, J MOL BIOL, V417, P51, DOI 10.1016/j.jmb.2011.12.049; Hui H, 2006, J PHYSIOL-LONDON, V572, P165, DOI 10.1113/jphysiol.2005.102889; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; Kabbani N, 2006, NEUROREPORT, V17, P299, DOI 10.1097/01.wnr.0000199460.24412.04; Kabbani N, 2002, J NEUROSCI, V22, P8476; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Koh PO, 2003, P NATL ACAD SCI USA, V100, P313, DOI 10.1073/pnas.232693499; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Lian LY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027779; London N, 2010, STRUCTURE, V18, P188, DOI 10.1016/j.str.2009.11.012; Martin VM, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-39; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McCue HV, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004085; McFerran BW, 1998, J BIOL CHEM, V273, P22768, DOI 10.1074/jbc.273.35.22768; Mikhaylova M, 2011, J NEUROCHEM, V118, P695, DOI 10.1111/j.1471-4159.2011.07372.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura TY, 2006, J CELL BIOL, V172, P1081, DOI 10.1083/jcb.200508156; Pang ZP, 2010, J NEUROSCI, V30, P4132, DOI 10.1523/JNEUROSCI.3129-09.2010; Pioletti M, 2006, NAT STRUCT MOL BIOL, V13, P987, DOI 10.1038/nsmb1164; Piton A, 2008, HUM MOL GENET, V17, P3965, DOI 10.1093/hmg/ddn300; PONGS O, 1993, NEURON, V11, P15, DOI 10.1016/0896-6273(93)90267-U; Saab BJ, 2009, NEURON, V63, P643, DOI 10.1016/j.neuron.2009.08.014; SEEMAN P, 1992, NEUROPSYCHOPHARMACOL, V7, P261; Strahl T, 2007, J BIOL CHEM, V282, P30949, DOI 10.1074/jbc.M705499200; Tidow H, 2013, FEBS J, V280, P5551, DOI 10.1111/febs.12296; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang HY, 2007, NAT NEUROSCI, V10, P32, DOI 10.1038/nn1822; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Zernii EY, 2011, BIOCHEM J, V435, P441, DOI 10.1042/BJ20110013; Zhou W, 2004, NEURON, V41, P573, DOI 10.1016/S0896-6273(04)00045-5	59	22	22	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18744	18756		10.1074/jbc.M114.627059	http://dx.doi.org/10.1074/jbc.M114.627059			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	25979333	Green Published, hybrid			2022-12-28	WOS:000358512100042
J	Beier, EE; Sheu, TJ; Dang, D; Holz, JD; Ubayawardena, R; Babij, P; Puzas, JE				Beier, Eric E.; Sheu, Tzong-jen; Dang, Deborah; Holz, Jonathan D.; Ubayawardena, Resika; Babij, Philip; Puzas, J. Edward			Heavy Metal Ion Regulation of Gene Expression MECHANISMS BY WHICH LEAD INHIBITS OSTEOBLASTIC BONE-FORMING ACTIVITY THROUGH MODULATION OF THE Wnt/beta-CATENIN SIGNALING PATHWAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; ROS 17/2.8; SCLEROSTIN EXPRESSION; GROWTH-FACTOR; LONG-TERM; RAT; DIFFERENTIATION; PHENOTYPE; INCREASES; EXPOSURE	Exposure to lead (Pb) from environmental sources remains an overlooked and serious public health risk. Starting in childhood, Pb in the skeleton can disrupt epiphyseal plate function, constrain the growth of long bones, and prevent attainment of a high peak bone mass, all of which will increase susceptibility to osteoporosis later in life. We hypothesize that the effects of Pb on bone mass, in part, come from depression of Wnt/beta-catenin signaling, a critical anabolic pathway for osteoblastic bone formation. In this study, we show that depression of Wnt signaling by Pb is due to increased sclerostin levels in vitro and in vivo. Downstream activation of the beta-catenin pathway using a pharmacological inhibitor of GSK-3 beta ameliorates the Pb inhibition of Wnt signaling activity in the TOPGAL reporter mouse. The effect of Pb was determined to be dependent on sclerostin expression through use of the SOST gene knock-out mice, which are resistant to Pb-induced trabecular bone loss and maintain their mechanical bone strength. Moreover, isolated bone marrow cells from the sclerostin null mice show improved bone formation potential even after exposure to Pb. Also, our data suggest that the TGF beta canonical signaling pathway is the mechanism by which Pb controls sclerostin production. Taken together these results support our hypothesis that the osteoporotic-like phenotype observed after Pb exposure is, in part, regulated through modulation of the Wnt/beta-catenin pathway.	[Beier, Eric E.; Sheu, Tzong-jen; Dang, Deborah; Holz, Jonathan D.; Ubayawardena, Resika; Puzas, J. Edward] Univ Rochester, Sch Med & Dent, Ctr Musculoskeletal Res, Rochester, NY 14624 USA; [Beier, Eric E.; Holz, Jonathan D.; Puzas, J. Edward] Univ Rochester, Sch Med & Dent, Dept Environm Med, Rochester, NY 14624 USA; [Babij, Philip] Amgen Inc, Dept Metab Disorders, Thousand Oaks, CA 91320 USA	University of Rochester; University of Rochester; Amgen	Puzas, JE (corresponding author), Ctr Musculoskeletal Res, Dept Orthopaed, 601 Elmwood Ave, Rochester, NY 14642 USA.	edward_puzas@urmc.rochester.edu	Regan, Clinton/E-6250-2012	Holz, Jonathan/0000-0003-1486-7230	National Institutes of Health [P30 AR061307]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR053459, P30AR061307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007026, P01ES011854, R01ES012712] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank S. Mack and K. Maltby for assistance with histology, R. Gelein for bone Pb measurements, and M. Thullen for microCT imaging and analysis. Biomechanical testing was performed with assistance from Drs. H. Awad and J. Inzana in the Biomechanics and Multimodal Tissue Imaging Core laboratory, established by National Institutes of Health Grant P30 AR061307.	ANGLE CR, 1990, TOXICOL APPL PHARM, V103, P281, DOI 10.1016/0041-008X(90)90230-R; ARONOW MA, 1990, J CELL PHYSIOL, V143, P213, DOI 10.1002/jcp.1041430203; Beier EE, 2013, ENVIRON HEALTH PERSP, V121, P97, DOI 10.1289/ehp.1205374; Buttery LDK, 2001, TISSUE ENG, V7, P89, DOI 10.1089/107632700300003323; Cain CJ, 2012, J BONE MINER RES, V27, P1451, DOI 10.1002/jbmr.1608; Canalis E, 2002, ANN NY ACAD SCI, V966, P73, DOI 10.1111/j.1749-6632.2002.tb04204.x; Chipuk JE, 2002, J BIOL CHEM, V277, P1240, DOI 10.1074/jbc.M108855200; Chytil A, 2002, GENESIS, V32, P73, DOI 10.1002/gene.10046; Cory-Slechta DA, 2010, TOXICOL SCI, V117, P427, DOI 10.1093/toxsci/kfq221; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Declercq H, 2004, BIOMATERIALS, V25, P757, DOI 10.1016/S0142-9612(03)00580-5; Delgado-Calle J, 2013, MOL CELL ENDOCRINOL, V369, P27, DOI 10.1016/j.mce.2013.02.002; Ferguson CM, 2000, ENDOCRINOLOGY, V141, P4728, DOI 10.1210/en.141.12.4728; Fuhrmann S, 2009, INVEST OPHTH VIS SCI, V50, P432, DOI 10.1167/iovs.08-2270; Gifre L, 2013, BONE, V57, P272, DOI 10.1016/j.bone.2013.08.016; Gruber HE, 1997, MINER ELECTROL METAB, V23, P65; Haider S, 2013, METAB BRAIN DIS, V28, P85, DOI 10.1007/s11011-012-9374-y; Holz JD, 2012, J ORTHOP RES, V30, P1760, DOI 10.1002/jor.22117; Hossain MA, 2000, J BIOL CHEM, V275, P27874; Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564; Ignasiak Z, 2006, ANN HUM BIOL, V33, P401, DOI 10.1080/03014460600730752; Kafourou A, 1997, ARCH ENVIRON HEALTH, V52, P377, DOI 10.1080/00039899709602214; Kerper LE, 1997, J BIOL CHEM, V272, P8346, DOI 10.1074/jbc.272.13.8346; KLEIN RF, 1993, ENDOCRINOLOGY, V132, P2531, DOI 10.1210/en.132.6.2531; Li H, 2006, CELL RES, V16, P169, DOI 10.1038/sj.cr.7310023; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Li XD, 2009, J BONE MINER RES, V24, P578, DOI 10.1359/JBMR.081206; LONG GJ, 1992, CALCIFIED TISSUE INT, V50, P451, DOI 10.1007/BF00296777; Loots GG, 2012, BONE, V50, P663, DOI 10.1016/j.bone.2011.11.016; Ominsky MS, 2010, J BONE MINER RES, V25, P948, DOI 10.1002/jbmr.14; Padhi D, 2011, J BONE MINER RES, V26, P19, DOI 10.1002/jbmr.173; PEIFER M, 1991, DEVELOPMENT, V111, P1029; SAUK JJ, 1992, TOXICOL APPL PHARM, V116, P240, DOI 10.1016/0041-008X(92)90303-A; Sutherland MK, 2004, BONE, V35, P448, DOI 10.1016/j.bone.2004.04.019; Uchiyama Y, 2008, J BONE MINER RES, V23, P1619, DOI 10.1359/JBMR.080502; Vazquez A, 2004, TOXICOL APPL PHARM, V200, P27, DOI 10.1016/j.taap.2004.03.011; Wang L, 2010, HUM EXP TOXICOL, V29, P581, DOI 10.1177/0960327109357270; Wijenayaka AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025900; Yamashita T, 2007, J BIOL CHEM, V282, P18245, DOI 10.1074/jbc.M610701200; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Yu LC, 2011, BONE, V49, P1131, DOI 10.1016/j.bone.2011.08.016	42	20	22	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					18216	18226		10.1074/jbc.M114.629204	http://dx.doi.org/10.1074/jbc.M114.629204			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	25975268	hybrid, Green Published			2022-12-28	WOS:000358511700050
J	Hudson, GM; Watson, PJ; Fairall, L; Jamieson, AG; Schwabe, JWR				Hudson, Gregg M.; Watson, Peter J.; Fairall, Louise; Jamieson, Andrew G.; Schwabe, John W. R.			Insights into the Recruitment of Class IIa Histone Deacetylases (HDACs) to the SMRT/NCoR Transcriptional Repression Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-I; PROTEIN COMPLEXES; STRUCTURAL BASIS; CLASS IIHDACS; REVEALS; DOMAIN; SMRT; PATHWAY; COR; COREPRESSORS	Class IIa histone deacetylases repress transcription of target genes. However, their mechanism of action is poorly understood because they exhibit very low levels of deacetylase activity. The class IIa HDACs are associated with the SMRT/NCoR repression complexes and this may, at least in part, account for their repressive activity. However, the molecular mechanism of recruitment to co-repressor proteins has yet to be established. Here we show that a repeated peptide motif present in both SMRT and NCoR is sufficient to mediate specific interaction, with micromolar affinity, with all the class IIa HDACs (HDACs 4, 5, 7, and 9). Mutations in the consensus motif abrogate binding. Mutational analysis of HDAC4 suggests that the peptide interacts in the vicinity of the active site of the enzyme and requires the "closed" conformation of the zinc-binding loop on the surface of the enzyme. Together these findings represent the first insights into the molecular mechanism of recruitment of class IIa HDACs to the SMRT/NCoR repression complexes.	[Hudson, Gregg M.; Watson, Peter J.; Fairall, Louise; Schwabe, John W. R.] Univ Leicester, Dept Biochem, Henry Wellcome Labs Struct Biol, Leicester LE1 9HN, Leics, England; [Jamieson, Andrew G.] Univ Leicester, Dept Chem, Leicester LE1 7RH, Leics, England	University of Leicester; University of Leicester	Schwabe, JWR (corresponding author), Univ Leicester, Dept Biochem, Henry Wellcome Labs Struct Biol, Leicester LE1 9HN, Leics, England.	john.schwabe@le.ac.uk	Schwabe, John WR/A-9132-2008	Schwabe, John WR/0000-0003-2865-4383; Jamieson, Andrew/0000-0003-1726-7353; Fairall, Louise/0000-0001-9456-3047	Wellcome Trust [WT085408, WT100237]; Royal Society; EPSRC [EP/L018152/1] Funding Source: UKRI; MRC [MC_PC_14117] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/L018152/1] Funding Source: researchfish; Medical Research Council [MC_PC_14117] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by Wellcome Trust Programme and Senior Investigator Awards WT085408 and WT100237. The authors declare that they have no conflicts of interest with the contents of this article.; Royal Society Merit Award Holder.	Agis-Balboa RC, 2013, J ALZHEIMERS DIS, V33, P35, DOI 10.3233/JAD-2012-121009; Ago T, 2008, CELL, V133, P978, DOI 10.1016/j.cell.2008.04.041; Ahmad KF, 2003, MOL CELL, V12, P1551, DOI 10.1016/S1097-2765(03)00454-4; Barneda-Zahonero B, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.594; Bellenguez C, 2012, NAT GENET, V44, P328, DOI 10.1038/ng.1081; Bottomley MJ, 2008, J BIOL CHEM, V283, P26694, DOI 10.1074/jbc.M803514200; Burli RW, 2013, J MED CHEM, V56, P9934, DOI 10.1021/jm4011884; Chan JKL, 2003, J BIOL CHEM, V278, P23515, DOI 10.1074/jbc.M301922200; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Ding ZH, 2003, MOL CELL BIOL, V23, P250, DOI 10.1128/MCB.23.1.250-258.2003; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Fischle W, 2001, J BIOL CHEM, V276, P35826, DOI 10.1074/jbc.M104935200; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Guo L, 2007, P NATL ACAD SCI USA, V104, P4297, DOI 10.1073/pnas.0608041104; Hayakawa T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/129383; Hildmann C, 2007, APPL MICROBIOL BIOT, V75, P487, DOI 10.1007/s00253-007-0911-2; Hu E, 2000, J BIOL CHEM, V275, P15254, DOI 10.1074/jbc.M908988199; Kao HY, 2000, GENE DEV, V14, P55; Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269; Lahm A, 2007, P NATL ACAD SCI USA, V104, P17335, DOI 10.1073/pnas.0706487104; Lechner T, 2000, J BIOL CHEM, V275, P40961, DOI 10.1074/jbc.M005730200; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Matsuoka H, 2007, BIOCHEM PHARMACOL, V74, P465, DOI 10.1016/j.bcp.2007.05.002; Mielcarek M, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001717; Millard CJ, 2013, MOL CELL, V51, P57, DOI 10.1016/j.molcel.2013.05.020; Oberoi J, 2011, NAT STRUCT MOL BIOL, V18, P177, DOI 10.1038/nsmb.1983; Petrie K, 2003, J BIOL CHEM, V278, P16059, DOI 10.1074/jbc.M212935200; Scott FL, 2008, J BIOL CHEM, V283, P19499, DOI 10.1074/jbc.M800331200; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Watson PJ, 2012, NATURE, V481, P335, DOI 10.1038/nature10728; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; Xu HE, 2002, NATURE, V415, P813, DOI 10.1038/415813a; Yang XJ, 2005, MOL CELL BIOL, V25, P2873, DOI 10.1128/MCB.25.8.2873-2884.2005; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924	35	31	31	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					18237	18244		10.1074/jbc.M115.661058	http://dx.doi.org/10.1074/jbc.M115.661058			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26055705	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000358511700052
J	Yordanova, MM; Wu, C; Andreev, DE; Sachs, MS; Atkins, JF				Yordanova, Martina M.; Wu, Cheng; Andreev, Dmitry E.; Sachs, Matthew S.; Atkins, John F.			A Nascent Peptide Signal Responsive to Endogenous Levels of Polyamines Acts to Stimulate Regulatory Frameshifting on Antizyme mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORNITHINE-DECARBOXYLASE ANTIZYME; OPEN READING FRAME; RIBOSOMAL-RNA; MAMMALIAN ANTIZYME; NEUROSPORA-CRASSA; TRANSLATIONAL REGULATION; ESCHERICHIA-COLI; E-SITE; EXPRESSION; SYSTEM	The protein antizyme is a negative regulator of cellular polyamine concentrations from yeast to mammals. Synthesis of functional antizyme requires programmed + 1 ribosomal frameshifting at the 3' end of the first of two partially overlapping ORFs. The frameshift is the sensor and effector in an autoregulatory circuit. Except for Saccharomyces cerevisiae antizyme mRNA, the frameshift site alone only supports low levels of frameshifting. The high levels usually observed depend on the presence of cis-acting stimulatory elements located 5' and 3' of the frameshift site. Antizyme genes from different evolutionary branches have evolved different stimulatory elements. Prior and new multiple alignments of fungal antizyme mRNA sequences from the Agaricomycetes class of Basidiomycota show a distinct pattern of conservation 5' of the frameshift site consistent with a function at the amino acid level. As shown here when tested in Schizosaccharomyces pombe and mammalian HEK293T cells, the 5' part of this conserved sequence acts at the nascent peptide level to stimulate the frameshifting, without involving stalling detectable by toe-printing. However, the peptide is only part of the signal. The 3' part of the stimulator functions largely independently and acts at least mostly at the nucleotide level. When polyamine levels were varied, the stimulatory effect was seen to be especially responsive in the endogenous polyamine concentration range, and this effect may be more general. A conserved RNA secondary structure 3' of the frameshift site has weaker stimulatory and polyamine sensitizing effects on frameshifting.	[Yordanova, Martina M.; Atkins, John F.] Natl Univ Ireland Univ Coll Cork, Sch Biochem & Cell Biol, Cork, Ireland; [Wu, Cheng; Sachs, Matthew S.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [Andreev, Dmitry E.] Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow 119991, Russia; [Atkins, John F.] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA	University College Cork; Texas A&M University System; Texas A&M University College Station; Lomonosov Moscow State University; Utah System of Higher Education; University of Utah	Atkins, JF (corresponding author), Natl Univ Ireland Univ Coll Cork, Sch Biochem & Cell Biol, Cork, Ireland.	j.atkins@ucc.ie	Andreev, Dmitry/I-6346-2012; Regan, Clinton/E-6250-2012	Andreev, Dmitry/0000-0001-5320-3045; Sachs, Matthew/0000-0001-9891-9223; Atkins, John/0000-0001-7933-0165; Yordanova, Martina/0000-0001-9693-3857	Science Foundation Ireland; National Institutes of Health [GM068087]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM068087] Funding Source: NIH RePORTER	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Science Foundation Ireland grant (to J. F. A.). This work was also supported in part by National Institutes of Health Grant GM068087 (to M. M. S). The authors declare that they have no conflicts of interest with the contents of this article.	Anderson JB, 2014, MYCOLOGIA, V106, P642, DOI 10.3852/13-367; Arenz S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4501; Atkins JF, 2010, NUCLEIC ACIDS MOL BI, V24, P1, DOI 10.1007/978-0-387-89382-2; ATKINS JF, 1975, J BIOL CHEM, V250, P5688; AUVINEN M, 1992, NATURE, V360, P355, DOI 10.1038/360355a0; BALASUNDARAM D, 1994, J BACTERIOL, V176, P7126, DOI 10.1128/JB.176.22.7126-7128.1994; Baranov PV, 2002, EMBO REP, V3, P373, DOI 10.1093/embo-reports/kvf065; Cao JH, 1996, MOL CELL BIOL, V16, P7109; Chen J, 2014, NATURE, V512, P328, DOI 10.1038/nature13428; Chen SL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1923; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dmitriev SE, 2003, FEBS LETT, V533, P99, DOI 10.1016/S0014-5793(02)03776-6; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Dyer BW, 2000, ANAL BIOCHEM, V282, P158, DOI 10.1006/abio.2000.4605; Fixsen SM, 2010, J MOL BIOL, V399, P385, DOI 10.1016/j.jmb.2010.04.033; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; FUJITA K, 1982, BIOCHEM J, V204, P647, DOI 10.1042/bj2040647; Gong F, 2002, SCIENCE, V297, P1864, DOI 10.1126/science.1073997; Grentzmann G, 1998, RNA, V4, P479; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; Gupta P, 2013, MOL CELL, V52, P629, DOI 10.1016/j.molcel.2013.10.013; Gurvich OL, 2011, NUCLEIC ACIDS RES, V39, P3079, DOI 10.1093/nar/gkq1272; Gutierrez E, 2013, MOL CELL, V51, P35, DOI 10.1016/j.molcel.2013.04.021; Hayashi S, 1996, TRENDS BIOCHEM SCI, V21, P27, DOI 10.1016/0968-0004(96)80882-6; Howard MT, 2001, GENES CELLS, V6, P931, DOI 10.1046/j.1365-2443.2001.00477.x; Ivanov IP, 2000, P NATL ACAD SCI USA, V97, P4808, DOI 10.1073/pnas.070055897; Ivanov IP, 1998, GENOMICS, V52, P119, DOI 10.1006/geno.1998.5434; Ivanov IP, 2004, J MOL BIOL, V339, P495, DOI 10.1016/j.jmb.2004.03.082; Ivanov IP, 2000, EMBO J, V19, P1907, DOI 10.1093/emboj/19.8.1907; Ivanov IP, 1998, RNA, V4, P1230, DOI 10.1017/S1355838298980864; Ivanov IP, 2008, P NATL ACAD SCI USA, V105, P10079, DOI 10.1073/pnas.0801590105; Ivanov IP, 2007, NUCLEIC ACIDS RES, V35, P1842, DOI 10.1093/nar/gkm035; Ivanov IP, 2010, J MOL EVOL, V70, P289, DOI 10.1007/s00239-010-9331-5; Ivanov IP, 2010, NUCLEIC ACIDS MOL BI, V24, P281, DOI 10.1007/978-0-387-89382-2_13; Kahana C, 2009, ESSAYS BIOCHEM, V46, P47, DOI [10.1042/BSE0460004, 10.1042/bse0460004]; Kramer DL, 2001, CANCER RES, V61, P7754; Kurian L, 2011, NATURE, V477, P490, DOI 10.1038/nature10393; LARSEN B, 1994, J BACTERIOL, V176, P6842, DOI 10.1128/JB.176.22.6842-6851.1994; Leger M, 2007, NUCLEIC ACIDS RES, V35, P5581, DOI 10.1093/nar/gkm578; Li YH, 2014, P NATL ACAD SCI USA, V111, pE2172, DOI 10.1073/pnas.1321930111; Lightfoot HL, 2014, NUCLEIC ACIDS RES, V42, P11275, DOI 10.1093/nar/gku837; Loughran G, 2011, P NATL ACAD SCI USA, V108, pE1111, DOI 10.1073/pnas.1102932108; LUO ZG, 1995, MOL CELL BIOL, V15, P5235; MATSUFUJI S, 1995, CELL, V80, P51, DOI 10.1016/0092-8674(95)90450-6; Matsufuji S, 1996, EMBO J, V15, P1360, DOI 10.1002/j.1460-2075.1996.tb00478.x; Mitrasinovic PM, 2006, J STRUCT BIOL, V153, P207, DOI 10.1016/j.jsb.2005.12.001; Murakami Y, 2014, AMINO ACIDS, V46, P575, DOI 10.1007/s00726-013-1598-6; Pegg AE, 2006, J BIOL CHEM, V281, P14529, DOI 10.1074/jbc.R500031200; Pegg AE, 2011, METHODS MOL BIOL, V720, P3, DOI 10.1007/978-1-61779-034-8_1; POULIN R, 1993, J BIOL CHEM, V268, P4690; Rato C, 2011, NUCLEIC ACIDS RES, V39, P4587, DOI 10.1093/nar/gkq1349; Ray RM, 2014, AMINO ACIDS, V46, P2231, DOI 10.1007/s00726-014-1777-0; Ray RM, 2012, J BIOL CHEM, V287, P3674, DOI 10.1074/jbc.M111.232561; Ruan HJ, 1996, J BIOL CHEM, V271, P29576, DOI 10.1074/jbc.271.47.29576; Sakata K, 2000, BIOCHEM J, V347, P297, DOI 10.1042/0264-6021:3470297; Sanders CL, 2007, RNA, V13, P1483, DOI 10.1261/rna.638707; Seiler N, 2005, J CELL MOL MED, V9, P623, DOI 10.1111/j.1582-4934.2005.tb00493.x; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Tosaka Y, 2000, GENES CELLS, V5, P265, DOI 10.1046/j.1365-2443.2000.00324.x; Vazquez-Laslop N, 2010, EMBO J, V29, P3108, DOI 10.1038/emboj.2010.180; Wang Z, 1997, J BIOL CHEM, V272, P255; Wang Z, 1997, MOL CELL BIOL, V17, P4904, DOI 10.1128/MCB.17.9.4904; Wei JJ, 2012, MOL CELL BIOL, V32, P2396, DOI 10.1128/MCB.00136-12; WEISS RB, 1988, EMBO J, V7, P1503, DOI 10.1002/j.1460-2075.1988.tb02969.x; Wilson DN, 2011, CURR OPIN STRUC BIOL, V21, P274, DOI 10.1016/j.sbi.2011.01.007; Wu C, 2007, METHOD ENZYMOL, V429, P203, DOI 10.1016/S0076-6879(07)29010-X; Wu C, 2012, J MOL BIOL, V416, P518, DOI 10.1016/j.jmb.2011.12.064; Yusupova G, 2014, ANNU REV BIOCHEM, V83, P467, DOI 10.1146/annurev-biochem-060713-035445	69	14	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					17863	17878		10.1074/jbc.M115.647065	http://dx.doi.org/10.1074/jbc.M115.647065			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	25998126	hybrid, Green Published			2022-12-28	WOS:000358511700022
J	Rahaman, MM; Reinders, FG; Koes, D; Nguyen, AT; Mutchler, SM; Sparacino-Watkins, C; Alvarez, RA; Miller, MP; Cheng, DM; Chen, BB; Jackson, EK; Camacho, CJ; Straub, AC				Rahaman, Md. Mizanur; Reinders, Fabio G.; Koes, David; Nguyen, Anh T.; Mutchler, Stephanie M.; Sparacino-Watkins, Courtney; Alvarez, Roger A.; Miller, Megan P.; Cheng, Dongmei; Chen, Bill B.; Jackson, Edwin K.; Camacho, Carlos J.; Straub, Adam C.			Structure Guided Chemical Modifications of Propylthiouracil Reveal Novel Small Molecule Inhibitors of Cytochrome b(5) Reductase 3 That Increase Nitric Oxide Bioavailability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECESSIVE HEREDITARY METHEMOGLOBINEMIA; SMOOTH-MUSCLE-CELLS; ANGIOTENSIN-II; B5; PARTICIPATION; MITOCHONDRIAL; EXPRESSION; CULTURE; PROTEIN; ZINC	NADH cytochrome b(5) reductase 3 (CYB5R3) is critical for reductive reactions such as fatty acid elongation, cholesterol biosynthesis, drug metabolism, and methemoglobin reduction. Although the physiological and metabolic importance of CYB5R3 has been established in hepatocytes and erythrocytes, emerging investigations suggest that CYB5R3 is critical for nitric oxide signaling and vascular function. However, advancement toward fully understanding CYB5R3 function has been limited due to a lack of potent small molecule inhibitors. Because of this restriction, we modeled the binding mode of propylthiouracil, a weak inhibitor of CYB5R3(IC50 = similar to 275 mu M), and used it as a guide to predict thiouracil-biased inhibitors from the set of commercially available compounds in the ZINC database. Using this approach, we validated two new potent derivatives of propylthiouracil, ZINC05626394 (IC50 = 10.81 mu M) and ZINC39395747 (IC50 = 9.14 mu M), both of which inhibit CYB5R3 activity in cultured cells. Moreover, we found that ZINC39395747 significantly increased NO bioavailability in renal vascular cells, augmented renal blood flow, and decreased systemic blood pressure in response to vasoconstrictors in spontaneously hypertensive rats. These compounds will serve as a new tool to examine the biological functions of CYB5R3 in physiology and disease and also as a platform for new drug development.	[Rahaman, Md. Mizanur; Nguyen, Anh T.; Mutchler, Stephanie M.; Sparacino-Watkins, Courtney; Alvarez, Roger A.; Miller, Megan P.; Straub, Adam C.] Univ Pittsburgh, Heart Lung Blood & Vasc Med Inst, Pittsburgh, PA 15213 USA; [Reinders, Fabio G.; Koes, David; Camacho, Carlos J.] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA 15213 USA; [Mutchler, Stephanie M.; Cheng, Dongmei; Jackson, Edwin K.; Straub, Adam C.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; [Alvarez, Roger A.; Chen, Bill B.] Univ Pittsburgh, Pulm Allergy & Crit Care Med, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Straub, AC (corresponding author), Univ Pittsburgh, Sch Med, Heart Lung Blood & Vasc Med Inst, E1254 Biomed Sci Tower,200 Lothrop St, Pittsburgh, PA 15216 USA.	astraub@pitt.edu	Regan, Clinton/E-6250-2012; Alvarez, Roger A./AAZ-3730-2020; Rahaman, Md Mizanur/ABC-7163-2021; Koes, David Ryan/M-4523-2018	Alvarez, Roger A./0000-0001-7819-6486; Rahaman, Md Mizanur/0000-0001-6939-0500; Koes, David Ryan/0000-0002-6892-6614; Straub, Adam/0000-0003-0542-9466; Mutchler, Stephanie/0000-0002-4288-4452; Jackson, Edwin/0000-0002-8101-6009; Sparacino-Watkins, Courtney/0000-0002-2954-9633	National Institutes of Health [R00 HL11290402, R01 HL116472, P30 DK079307, R01 GM097082]; Institute for Transfusion Medicine; Hemophilia Center of Western Pennsylvania (Straub); American Heart Association Postdoctoral Fellowship [14POST20490112]; National Institutes of Health Post Doctoral Fellowship [T32 DK 06129611]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079307, T32DK061296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097082] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Transfusion Medicine; Hemophilia Center of Western Pennsylvania (Straub); American Heart Association Postdoctoral Fellowship(American Heart Association); National Institutes of Health Post Doctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R00 HL11290402 (to A. C. S.), R01 HL116472 (to B. B. C.), P30 DK079307 (to E. K. J.), and R01 GM097082 (to C. J. C.). This work was also supported by the Institute for Transfusion Medicine and the Hemophilia Center of Western Pennsylvania (Straub). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of training support by American Heart Association Postdoctoral Fellowship 14POST20490112.; Recipient of National Institutes of Health Post Doctoral Fellowship T32 DK 06129611.	Altuve A, 2004, BIOCHEM BIOPH RES CO, V314, P602, DOI 10.1016/j.bbrc.2003.12.138; Bando S, 2004, ACTA CRYSTALLOGR D, V60, P1929, DOI 10.1107/S0907444904020645; Deng Z, 1999, NAT STRUCT BIOL, V6, P847; DUBEY RK, 1992, CIRC RES, V71, P1143, DOI 10.1161/01.RES.71.5.1143; Ewenczyk C, 2008, BRAIN, V131, P760, DOI 10.1093/brain/awm337; Fermo E, 2008, BLOOD CELL MOL DIS, V41, P50, DOI 10.1016/j.bcmd.2008.02.002; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Frye CA, 2002, IN VITRO CELL DEV-AN, V38, P208; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Halligan KE, 2009, J BIOL CHEM, V284, P8539, DOI 10.1074/jbc.M808231200; Heberlein KR, 2010, CIRC RES, V106, P1092, DOI 10.1161/CIRCRESAHA.109.215723; HILDEBRANDT A, 1971, ARCH BIOCHEM BIOPHYS, V143, P66, DOI 10.1016/0003-9861(71)90186-X; HULTQUIST DE, 1971, NATURE-NEW BIOL, V229, P252, DOI 10.1038/newbio229252a0; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Isakson BE, 2005, CIRC RES, V97, P44, DOI 10.1161/01.RES.0000173461.36221.2e; KITAO T, 1974, BLOOD, V44, P879, DOI 10.1182/blood.V44.6.879.879; Koes DR, 2013, J CHEM INF MODEL, V53, P1893, DOI 10.1021/ci300604z; Koes DR, 2012, NUCLEIC ACIDS RES, V40, pW409, DOI 10.1093/nar/gks378; LEE E, 1986, FEBS LETT, V209, P49, DOI 10.1016/0014-5793(86)81082-1; MAGLIOLA L, 1990, J PHYSIOL-LONDON, V421, P411, DOI 10.1113/jphysiol.1990.sp017952; Mokkapatti R, 1998, J PHARMACOL EXP THER, V287, P223; OSHINO N, 1971, J BIOCHEM, V69, P155, DOI 10.1093/oxfordjournals.jbchem.a129444; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Parekh N, 1996, AM J PHYSIOL-REG I, V270, pR630, DOI 10.1152/ajpregu.1996.270.3.R630; PASSON PG, 1972, BIOCHIM BIOPHYS ACTA, V275, P62, DOI 10.1016/0005-2728(72)90024-2; Percy MJ, 2008, BRIT J HAEMATOL, V141, P298, DOI 10.1111/j.1365-2141.2008.07017.x; REDDY VVR, 1977, J BIOL CHEM, V252, P2797; Sacco JC, 2010, PHARMACOGENET GENOM, V20, P26, DOI 10.1097/FPC.0b013e3283343296; SHIRABE K, 1989, BIOCHIM BIOPHYS ACTA, V1008, P189, DOI 10.1016/0167-4781(80)90007-X; Siendones E, 2014, ANTIOXID REDOX SIGN, V21, P1708, DOI 10.1089/ars.2013.5479; Sparacino-Watkins CE, 2014, J BIOL CHEM, V289, P10345, DOI 10.1074/jbc.M114.555177; Straub AC, 2012, NATURE, V491, P473, DOI 10.1038/nature11626; STRITTMATTER P, 1957, BIOCHIM BIOPHYS ACTA, V25, P228, DOI 10.1016/0006-3002(57)90462-6; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; TSUNODA R, 1994, J CARDIOVASC PHARM, V24, P87, DOI 10.1097/00005344-199407000-00015	36	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16861	16872		10.1074/jbc.M114.629964	http://dx.doi.org/10.1074/jbc.M114.629964			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	26001785	Green Published, hybrid			2022-12-28	WOS:000357572800031
J	Monteil, A; Chausson, P; Boutourlinsky, K; Mezghrani, A; Huc-Brandt, S; Blesneac, I; Bidaud, I; Lemmers, C; Leresche, N; Lambert, RC; Lory, P				Monteil, Arnaud; Chausson, Patrick; Boutourlinsky, Katia; Mezghrani, Alexandre; Huc-Brandt, Sylvaine; Blesneac, Iulia; Bidaud, Isabelle; Lemmers, Celine; Leresche, Nathalie; Lambert, Regis C.; Lory, Philippe			Inhibition of Cav3.2 T-type Calcium Channels by Its Intracellular I-II Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium channel; neuroblastoma; neuron; patch clamp; Western blot; Cav3; 2; HEK-293T cell line; T-type calcium channels; Sindbis virus; thalamic neurons	PLASMA-MEMBRANE EXPRESSION; CA2+ CHANNELS; SURFACE EXPRESSION; ABSENCE EPILEPSY; NEURONS; MUTATIONS; ALPHA(1G); RAT	Background: Novel strategies are needed to characterize the properties of T-type (Cav3) calcium channel isoforms. Results: The I-II loop of the Cav3.2 protein potently inhibits both recombinant and neuronal Cav3.1 and Cav3.2 channels. Conclusion: This I-II loop region can be used to selectively silence Cav3.1/Cav3.2 channels. Significance: This study reveals a new approach to differentiate among the activity of native Cav3 channels. Voltage-dependent calcium channels (Cav) of the T-type family (Cav3.1, Cav3.2, and Cav3.3) are activated by low threshold membrane depolarization and contribute greatly to neuronal network excitability. Enhanced T-type channel activity, especially Cav3.2, contributes to disease states, including absence epilepsy. Interestingly, the intracellular loop connecting domains I and II (I-II loop) of Cav3.2 channels is implicated in the control of both surface expression and channel gating, indicating that this I-II loop plays an important regulatory role in T-type current. Here we describe that co-expression of this I-II loop or its proximal region (1-Cav3.2; Ser(423)-Pro(542)) together with recombinant full-length Cav3.2 channel inhibited T-type current without affecting channel expression and membrane incorporation. Similar T-type current inhibition was obtained in NG 108-15 neuroblastoma cells that constitutively express Cav3.2 channels. Of interest, 1-Cav3.2 inhibited both Cav3.2 and Cav3.1 but not Cav3.3 currents. Efficacy of 1-Cav3.2 to inhibit native T-type channels was assessed in thalamic neurons using viral transduction. We describe that T-type current was significantly inhibited in the ventrobasal neurons that express Cav3.1, whereas in nucleus reticularis thalami neurons that express Cav3.2 and Cav3.3 channels, only the fast inactivating T-type current (Cav3.2 component) was significantly inhibited. Altogether, these data describe a new strategy to differentially inhibit Cav3 isoforms of the T-type calcium channels.	[Monteil, Arnaud; Mezghrani, Alexandre; Huc-Brandt, Sylvaine; Blesneac, Iulia; Bidaud, Isabelle; Lemmers, Celine; Lory, Philippe] Univ Montpellier, Inst Genom Fonct, Dept Physiol, CNRS,UMR 5203, F-34094 Montpellier, France; [Monteil, Arnaud; Mezghrani, Alexandre; Huc-Brandt, Sylvaine; Blesneac, Iulia; Bidaud, Isabelle; Lemmers, Celine; Lory, Philippe] INSERM, U1191, F-34094 Montpellier, France; [Monteil, Arnaud; Lemmers, Celine] INSERM, US009, CNRS, Plateforme Vectorol,UMS 3426, F-34094 Montpellier, France; [Monteil, Arnaud; Mezghrani, Alexandre; Huc-Brandt, Sylvaine; Blesneac, Iulia; Bidaud, Isabelle; Lemmers, Celine; Lory, Philippe] LabEx Ion Channel Sci & Therapeut, F-34094 Montpellier, France; [Chausson, Patrick; Boutourlinsky, Katia; Leresche, Nathalie; Lambert, Regis C.] Univ Paris 06, Univ Sorbonne, UM 119, NPS, F-75005 Paris, France; [Chausson, Patrick; Boutourlinsky, Katia; Leresche, Nathalie; Lambert, Regis C.] CNRS, UMR 8246, NPS, F-75005 Paris, France; [Chausson, Patrick; Boutourlinsky, Katia; Leresche, Nathalie; Lambert, Regis C.] INSERM, NPS, U1130, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm)	Lory, P (corresponding author), Inst Genom Fonct, 141 Rue Cardonille, F-34094 Montpellier 5, France.	philippe.lory@igf.cnrs.fr	Monteil, Arnaud/G-3113-2012; Brandt, Sylvaine/AAJ-1277-2021	Monteil, Arnaud/0000-0003-1632-7318; Brandt, Sylvaine/0000-0002-5582-4643; BIDAUD, Isabelle/0000-0002-1812-1447; Leresche, Nathalie/0000-0001-6705-9769; LORY, philippe/0000-0002-1638-7604	Agence Nationale de la Recherche [ANR-10-BLAN-1601, ANR-09-MNPS-035]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by Agence Nationale de la Recherche Grants ANR-10-BLAN-1601 (to P. L.) and ANR-09-MNPS-035 grants (to P. L., R. C. L., and N. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Arias-Olguin II, 2008, J BIOL CHEM, V283, P8136, DOI 10.1074/jbc.M708761200; Astori S, 2013, J NEUROSCI, V33, P624, DOI 10.1523/JNEUROSCI.3185-12.2013; Baumgart JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002976; Bidaud I, 2011, BIOCHIMIE, V93, P2080, DOI 10.1016/j.biochi.2011.05.015; Cain SM, 2010, CHANNELS, V4, P475, DOI 10.4161/chan.4.6.14106; Chemin J, 2002, J PHYSIOL-LONDON, V540, P3, DOI 10.1113/jphysiol.2001.013269; Cheong E, 2013, PHYSIOL REV, V93, P961, DOI 10.1152/physrev.00010.2012; Dreyfus FM, 2010, J NEUROSCI, V30, P99, DOI 10.1523/JNEUROSCI.4305-09.2010; Dubel SJ, 2004, J BIOL CHEM, V279, P29263, DOI 10.1074/jbc.M313450200; Ernst WL, 2009, J NEUROSCI, V29, P1615, DOI 10.1523/JNEUROSCI.2081-08.2009; Francois A, 2014, PFLUG ARCH EUR J PHY, V466, P707, DOI 10.1007/s00424-014-1484-4; HUGUENARD JR, 1992, J NEUROSCI, V12, P3804, DOI 10.1523/jneurosci.12-10-03804.1992; Kim D, 2001, NEURON, V31, P35, DOI 10.1016/S0896-6273(01)00343-9; Kim J, 2004, J NEUROSCI METH, V133, P81, DOI 10.1016/j.jneumeth.2003.09.029; Lambert RC, 2014, PFLUG ARCH EUR J PHY, V466, P415, DOI 10.1007/s00424-013-1353-6; Leresche N, 1998, J NEUROSCI, V18, P4842; Mezghrani A, 2008, J NEUROSCI, V28, P4501, DOI 10.1523/JNEUROSCI.2844-07.2008; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Shcheglovitov A, 2008, FEBS LETT, V582, P3765, DOI 10.1016/j.febslet.2008.10.013; Talley EM, 1999, J NEUROSCI, V19, P1895; Vitko I, 2007, J NEUROSCI, V27, P322, DOI 10.1523/JNEUROSCI.1817-06.2007; Zamponi GW, 2010, PFLUG ARCH EUR J PHY, V460, P395, DOI 10.1007/s00424-009-0772-x	22	6	6	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16168	16176		10.1074/jbc.M114.634261	http://dx.doi.org/10.1074/jbc.M114.634261			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25931121	hybrid, Green Published			2022-12-28	WOS:000356930100021
J	Siddiq, MM; Hannila, SS; Carmel, JB; Bryson, JB; Hou, JW; Nikulina, E; Willis, MR; Mellado, W; Richman, EL; Hilaire, M; Hart, RP; Filbin, MT				Siddiq, Mustafa M.; Hannila, Sari S.; Carmel, Jason B.; Bryson, John B.; Hou, Jianwei; Nikulina, Elena; Willis, Matthew R.; Mellado, Wilfredo; Richman, Erica L.; Hilaire, Melissa; Hart, Ronald P.; Filbin, Marie T.			Metallothionein-I/II Promotes Axonal Regeneration in the Central Nervous System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						central nervous system (CNS); cyclic AMP (cAMP); myelin; neurite outgrowth; regeneration; axonal regeneration; metallothionein	MYELIN-ASSOCIATED GLYCOPROTEIN; CHONDROITIN SULFATE PROTEOGLYCANS; RECEPTOR FAMILY-MEMBER; SPINAL-CORD-INJURY; NEURITE OUTGROWTH; NOGO RECEPTOR; CYCLIC-AMP; EXTRACELLULAR METALLOTHIONEINS; INHIBITORY-ACTIVITY; ZINC TOXICITY	Background: MT-I/II are zinc-binding proteins that are also neuro-protective. Results: MT-I/II can overcome myelin-mediated inhibition in vitro and in vivo. MT-I/II-deficient mice have reduced spinal axon regeneration. Conclusion: MT-I/II are required for the conditioning lesion effect and can promote axonal regeneration in the injured CNS. Significance: MT-I/II have therapeutic potential for the treatment of spinal cord injury. The adult CNS does not spontaneously regenerate after injury, due in large part to myelin-associated inhibitors such as myelin-associated glycoprotein (MAG), Nogo-A, and oligodendrocyte-myelin glycoprotein. All three inhibitors can interact with either the Nogo receptor complex or paired immunoglobulin-like receptor B. A conditioning lesion of the sciatic nerve allows the central processes of dorsal root ganglion (DRG) neurons to spontaneously regenerate in vivo after a dorsal column lesion. After a conditioning lesion, DRG neurons are no longer inhibited by myelin, and this effect is cyclic AMP (cAMP)- and transcription-dependent. Using a microarray analysis, we identified several genes that are up-regulated both in adult DRGs after a conditioning lesion and in DRG neurons treated with cAMP analogues. One gene that was up-regulated under both conditions is metallothionein (MT)-I. We show here that treatment with two closely related isoforms of MT (MT-I/II) can overcome the inhibitory effects of both myelin and MAG for cortical, hippocampal, and DRG neurons. Intrathecal delivery of MT-I/II to adult DRGs also promotes neurite outgrowth in the presence of MAG. Adult DRGs from MT-I/II-deficient mice extend significantly shorter processes on MAG compared with wild-type DRG neurons, and regeneration of dorsal column axons does not occur after a conditioning lesion in MT-I/II-deficient mice. Furthermore, a single intravitreal injection of MT-I/II after optic nerve crush promotes axonal regeneration. Mechanistically, MT-I/II ability to overcome MAG-mediated inhibition is transcription-dependent, and MT-I/II can block the proteolytic activity of -secretase and the activation of PKC and Rho in response to soluble MAG.	[Siddiq, Mustafa M.; Hannila, Sari S.; Bryson, John B.; Hou, Jianwei; Nikulina, Elena; Willis, Matthew R.; Mellado, Wilfredo; Richman, Erica L.; Hilaire, Melissa; Filbin, Marie T.] CUNY Hunter Coll, Dept Biol Sci, New York, NY 10065 USA; [Carmel, Jason B.; Hart, Ronald P.] Rutgers State Univ, WM Keck Ctr Collaborat Neurosci, Piscataway, NJ 08854 USA; [Carmel, Jason B.; Hart, Ronald P.] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA	City University of New York (CUNY) System; Hunter College (CUNY); Rutgers State University New Brunswick; Rutgers State University New Brunswick	Siddiq, MM (corresponding author), Mt Sinai Sch Med, Icahn Med Inst Pharmacol & Syst Therapeut 12 52, 1425 Madison Ave, New York, NY 10029 USA.	mustafa.siddiq@mssm.edu	Hart, Ronald P/D-5219-2009; Hart, Ronald P/G-6530-2019	Hart, Ronald P/0000-0003-4836-8712; Hart, Ronald P/0000-0003-4836-8712	National Institutes of Health Shared Instrumentation [1S10RR026639-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026639, G12RR003037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037060, F32NS054511, U54NS041073, K08NS073796] Funding Source: NIH RePORTER	National Institutes of Health Shared Instrumentation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Multiphoton microscopy was performed in the Microscopy CORE at the Icahn School of Medicine at Mount Sinai and was supported with funding from National Institutes of Health Shared Instrumentation Grant 1S10RR026639-01. We thank Saranna Belgrave and Dr. Nagarathnamma Chaudhry for their outstanding technical support and Drs. Rajiv R. Ratan (Burke-Cornell Medical Research Institute, White Plains, NY) and Ravi Iyengar (Mount Sinai School of Medicine, New York) for assistance with this manuscript. We also thank Drs. Larry Benowitz and Barbara Lorber (Harvard University, Cambridge, MA) for providing instruction in the optic nerve crush surgery and the GAP-43 antibody. We also thank Drs. Frank Bradke and Farida Hellal at Axonal Growth and Regeneration, German Center for Neurodegenerative Diseases (Bonn, Germany), for their instruction on performing chemical clearing.	Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; Cai DM, 2002, NEURON, V35, P711, DOI 10.1016/S0896-6273(02)00826-7; Cao ZX, 2006, J NEUROSCI, V26, P5565, DOI 10.1523/JNEUROSCI.0815-06.2006; Carmel JB, 2001, PHYSIOL GENOMICS, V7, P201, DOI 10.1152/physiolgenomics.00074.2001; Carrasco J, 2000, EUR J NEUROSCI, V12, P2311, DOI 10.1046/j.1460-9568.2000.00128.x; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Chung RS, 2008, J BIOL CHEM, V283, P15349, DOI 10.1074/jbc.M708446200; Chung RS, 2003, J NEUROSCI, V23, P3336; Chung RS, 2004, NEUROSCIENCE, V123, P595, DOI 10.1016/j.neuroscience.2003.10.019; Davis SR, 2000, J NUTR, V130, P1085; Deng KW, 2009, J NEUROSCI, V29, P9545, DOI 10.1523/JNEUROSCI.1175-09.2009; Dergham P, 2002, J NEUROSCI, V22, P6570; Domeniconi M, 2005, NEURON, V46, P849, DOI 10.1016/j.neuron.2005.05.029; Erturk A, 2012, NAT MED, V18, P166, DOI 10.1038/nm.2600; Esch F, 1998, J NEUROSCI, V18, P4083; Fehlings MG, 2011, J NEUROTRAUM, V28, P787, DOI 10.1089/neu.2011.1765; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Gao Y, 2004, NEURON, V44, P609, DOI 10.1016/j.neuron.2004.10.030; GILAD GM, 1988, DEV BRAIN RES, V38, P175, DOI 10.1016/0165-3806(88)90042-9; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Hannila SS, 2013, J NEUROSCI, V33, P5138, DOI 10.1523/JNEUROSCI.5321-12.2013; Kelly EJ, 1996, J NUTR, V126, P1782; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; Leon S, 2000, J NEUROSCI, V20, P4615, DOI 10.1523/JNEUROSCI.20-12-04615.2000; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Miyazaki I, 2011, GLIA, V59, P435, DOI 10.1002/glia.21112; Monnier PP, 2003, MOL CELL NEUROSCI, V22, P319, DOI 10.1016/S1044-7431(02)00035-0; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; Niederost B, 2002, J NEUROSCI, V22, P10368; NISHIMURA N, 1989, J HISTOCHEM CYTOCHEM, V37, P1601, DOI 10.1177/37.11.2809172; Noh KM, 1999, J NEUROCHEM, V72, P1609, DOI 10.1046/j.1471-4159.1999.721609.x; Park JB, 2005, NEURON, V45, P345, DOI 10.1016/j.neuron.2004.12.040; Penkowa M, 2001, EXP NEUROL, V170, P1, DOI 10.1006/exnr.2001.7675; Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; RICHARDSON PM, 1984, NATURE, V309, P791, DOI 10.1038/309791a0; Shao ZH, 2005, NEURON, V45, P353, DOI 10.1016/j.neuron.2004.12.050; Siddiq MM, 2004, MOL CELL NEUROSCI, V25, P162, DOI 10.1016/j.mcn.2003.10.007; Sivasankaran R, 2004, NAT NEUROSCI, V7, P261, DOI 10.1038/nn1193; Suzuki Keiji, 1994, Biological Signals, V3, P188; Trendelenburg G, 2002, J NEUROSCI, V22, P5879; UDOM AO, 1980, BIOCHEM J, V187, P329, DOI 10.1042/bj1870329; VALLEE BL, 1991, P NATL ACAD SCI USA, V88, P999, DOI 10.1073/pnas.88.3.999; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; West AK, 2004, REV NEUROSCIENCE, V15, P157; ZENG J, 1991, P NATL ACAD SCI USA, V88, P9984, DOI 10.1073/pnas.88.22.9984	51	17	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16343	16356		10.1074/jbc.M114.630574	http://dx.doi.org/10.1074/jbc.M114.630574			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25947372	Green Published, hybrid			2022-12-28	WOS:000356930100036
J	Lenselink, AM; Rotaru, DC; Li, KW; van Nierop, P; Rao-Ruiz, P; Loos, M; van der Schors, R; Gouwenberg, Y; Wortel, J; Mansvelder, HD; Smit, AB; Spijker, S				Lenselink, A. Mariette; Rotaru, Diana C.; Li, Ka Wan; van Nierop, Pim; Rao-Ruiz, Priyanka; Loos, Maarten; van der Schors, Roel; Gouwenberg, Yvonne; Wortel, Joke; Mansvelder, Huibert D.; Smit, August B.; Spijker, Sabine			Strain Differences in Presynaptic Function: PROTEOMICS, ULTRASTRUCTURE, AND PHYSIOLOGY OF HIPPOCAMPAL SYNAPSES IN DBA/2J AND C57Bl/6J MICE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						electrophysiology; exocytosis; neuroscience; neurotransmitter release; proteomics; synaptic plasticity; RASAL1; iTRAQ; presynaptic	PROTEIN-KINASE-C; GTPASE-ACTIVATING PROTEINS; INBRED MOUSE STRAINS; DEPENDENT DIFFERENCES; SYNAPTIC PLASTICITY; CA2+ OSCILLATIONS; GAP1 FAMILY; WATER MAZE; MEMORY; RAS	Background: The inbred mouse strain DBA/2J shows impaired hippocampal memory formation, which has been attributed to postsynaptic changes. Results: DBA/2J shows reduced expression of exocytosis proteins, paired-pulse facilitation, and number of synaptic vesicles. Conclusion: Proteomic, ultrastructural, and physiological investigations suggest a deficit in presynaptic function in DBA/2J. Significance: This is the first study describing the DBA/2J hippocampal proteome and ultrastructure. The inbred strains C57BL/6J and DBA/2J (DBA) display striking differences in a number of behavioral tasks depending on hippocampal function, such as contextual memory. Historically, this has been explained through differences in postsynaptic protein expression underlying synaptic transmission and plasticity. We measured the synaptic hippocampal protein content (iTRAQ (Isobaric Tags for Relative and Absolute Quantitation) and mass spectrometry), CA1 synapse ultrastructural morphology, and synaptic functioning in adult C57BL/6J and DBA mice. DBA mice showed a prominent decrease in the Ras-GAP calcium-sensing protein RASAL1. Furthermore, expression of several presynaptic markers involved in exocytosis, such as syntaxin (Stx1b), Ras-related proteins (Rab3a/c), and rabphilin (Rph3a), was reduced. Ultrastructural analysis of CA1 hippocampal synapses showed a significantly lower number of synaptic vesicles and presynaptic cluster size in DBA mice, without changes in postsynaptic density or active zone. In line with this compromised presynaptic morphological and molecular phenotype in DBA mice, we found significantly lower paired-pulse facilitation and enhanced short term depression of glutamatergic synapses, indicating a difference in transmitter release and/or refilling mechanisms. Taken together, our data suggest that in addition to strain-specific postsynaptic differences, the change in dynamic properties of presynaptic transmitter release may underlie compromised synaptic processing related to cognitive functioning in DBA mice.	[Lenselink, A. Mariette; Rotaru, Diana C.; Li, Ka Wan; van Nierop, Pim; Rao-Ruiz, Priyanka; Loos, Maarten; van der Schors, Roel; Gouwenberg, Yvonne; Smit, August B.; Spijker, Sabine] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Mol & Cellular Neurobiol, NL-1081 HV Amsterdam, Netherlands; [Rotaru, Diana C.; Mansvelder, Huibert D.] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Integrat Neurophysiol, NL-1081 HV Amsterdam, Netherlands; [Wortel, Joke] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Funct Genom, NL-1081 HV Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Spijker, S (corresponding author), CNCR, Dept Mol & Cellular Neurobiol, De Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands.	s.spijker@vu.nl	Mansvelder, Huibert/N-6138-2018; Rotaru, Diana/AAZ-9058-2020	Mansvelder, Huibert/0000-0003-1365-5340; li, ka wan/0000-0001-6983-5055; Rao-Ruiz, Priyanka/0000-0001-9504-1427; Spijker, Sabine/0000-0002-6814-2019	NeuroBsik grant; Center for Medical Systems Biology; Netherlands Consortium for Systems Biology [050-060-409]; Dutch Medical Research Council [ZonMW 912-04-022, HEALTH-2009-2.1.2-1 EU-FP7 "SynSys", 242167]	NeuroBsik grant; Center for Medical Systems Biology; Netherlands Consortium for Systems Biology; Dutch Medical Research Council(Danish Medical Research Council)	This work was supported by a NeuroBsik grant to the Dutch Mouse Phenomics consortium (to A. B. S., K. W. L., and S. S.), the Center for Medical Systems Biology (to A. B. S., K. W. L., and S. S.), Netherlands Consortium for Systems Biology Grant 050-060-409 (to M. L. and S. S.), Dutch Medical Research Council Grant ZonMW 912-04-022, and HEALTH-2009-2.1.2-1 EU-FP7 "SynSys" Grant 242167 (to A. B. S., K. W. L., and S. S.).	Andre JM, 2012, BEHAV NEUROSCI, V126, P249, DOI 10.1037/a0027048; Andrieux A, 2002, GENE DEV, V16, P2350, DOI 10.1101/gad.223302; Bernardinelli Y, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/232105; BOWERS BJ, 1995, J NEUROCHEM, V64, P2737; Cijsouw T, 2014, J CELL BIOL, V204, P759, DOI 10.1083/jcb.201308026; Counotte DS, 2010, EUR J NEUROSCI, V32, P1452, DOI 10.1111/j.1460-9568.2010.07404.x; Craske H, 1999, P NATL ACAD SCI USA, V96, P4426, DOI 10.1073/pnas.96.8.4426; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Ertunc M, 2007, J NEUROSCI, V27, P341, DOI 10.1523/JNEUROSCI.4051-06.2007; FORDYCE DE, 1995, BRAIN RES, V672, P170, DOI 10.1016/0006-8993(94)01389-Y; Giese KP, 2013, LEARN MEMORY, V20, P540, DOI 10.1101/lm.028449.112; Goudriaan A, 2014, SCHIZOPHRENIA BULL, V40, P925, DOI 10.1093/schbul/sbt109; Holmes A, 2002, GENES BRAIN BEHAV, V1, P55, DOI 10.1046/j.1601-1848.2001.00005.x; Izquierdo I, 2000, BEHAV PHARMACOL, V11, P517, DOI 10.1097/00008877-200011000-00001; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; Jones MW, 2001, HIPPOCAMPUS, V11, P391, DOI 10.1002/hipo.1053.abs; Karp NA, 2010, MOL CELL PROTEOMICS, V9, P1885, DOI 10.1074/mcp.M900628-MCP200; Klemmer P, 2011, J BIOL CHEM, V286, P25495, DOI 10.1074/jbc.M110.210260; Krapivinsky G, 2004, NEURON, V43, P563, DOI 10.1016/j.neuron.2004.08.003; Kupzig S, 2006, J BIOL CHEM, V281, P9891, DOI 10.1074/jbc.M512802200; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li KW, 2007, J PROTEOME RES, V6, P3127, DOI 10.1021/pr070086w; Li KW, 2004, J BIOL CHEM, V279, P987, DOI 10.1074/jbc.M303116200; Liu Q, 2005, J CELL BIOL, V170, P183, DOI 10.1083/jcb.200504167; Lvov A, 2008, PFLUG ARCH EUR J PHY, V456, P1121, DOI 10.1007/s00424-008-0468-7; Menard C, 2004, BRAIN RES, V1010, P134, DOI 10.1016/j.brainres.2004.03.012; Meyer-Arendt K, 2011, J PROTEOME RES, V10, P3060, DOI 10.1021/pr200039p; Nguyen PV, 2000, J NEUROPHYSIOL, V84, P2484, DOI 10.1152/jn.2000.84.5.2484; Nguyen PV, 2000, LEARN MEMORY, V7, P170, DOI 10.1101/lm.7.3.170; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Otto T, 1991, Hippocampus, V1, P181, DOI 10.1002/hipo.450010206; Paylor R, 1996, BEHAV NEUROSCI, V110, P1415, DOI 10.1037/0735-7044.110.6.1415; Rao-Ruiz P, 2015, HIPPOCAMPUS, V25, P1250, DOI 10.1002/hipo.22432; Reiter L, 2009, MOL CELL PROTEOMICS, V8, P2405, DOI 10.1074/mcp.M900317-MCP200; Ruano D, 2010, AM J HUM GENET, V86, P113, DOI 10.1016/j.ajhg.2009.12.006; Rudolf R, 2011, J NEUROCHEM, V116, P177, DOI 10.1111/j.1471-4159.2010.07110.x; Schimanski LA, 2005, BEHAV NEUROSCI, V119, P38, DOI 10.1037/0735-7044.119.1.38; Schimanski LA, 2004, NEUROSCI BIOBEHAV R, V28, P463, DOI 10.1016/j.neubiorev.2004.04.002; Schluter OM, 2004, J NEUROSCI, V24, P6629, DOI 10.1523/JNEUROSCI.1610-04.2004; Sot B, 2013, P NATL ACAD SCI USA, V110, P111, DOI 10.1073/pnas.1201658110; Sudhof T. C., 2011, CSH PERSPECT BIOL, V3, P3, DOI DOI 10.1101/CSHPERSPECT.A005637; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; UPCHURCH M, 1988, BEHAV GENET, V18, P55, DOI 10.1007/BF01067075; Verbich D, 2012, GLIA, V60, P1067, DOI 10.1002/glia.22335; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Walker SA, 2004, EMBO J, V23, P1749, DOI 10.1038/sj.emboj.7600197; WEHNER JM, 1990, BRAIN RES, V523, P181, DOI 10.1016/0006-8993(90)91485-Y; Wollert T, 2011, J BIOL CHEM, V286, P14352, DOI 10.1074/jbc.M110.187286; Yarwood S, 2006, BIOCHEM SOC T, V34, P846, DOI 10.1042/BST0340846; Youn J, 2012, BEHAV BRAIN RES, V226, P397, DOI 10.1016/j.bbr.2011.09.034; Zilles K, 2000, HIPPOCAMPUS, V10, P213, DOI 10.1002/1098-1063(2000)10:3<213::AID-HIPO2>3.0.CO;2-Q	51	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15635	15645		10.1074/jbc.M114.628776	http://dx.doi.org/10.1074/jbc.M114.628776			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25911096	Green Published, hybrid			2022-12-28	WOS:000356527400027
J	Chandrachud, U; Walker, MW; Simas, AM; Heetveld, S; Petcherski, A; Klein, M; Oh, H; Wolf, P; Zhao, WN; Norton, S; Haggarty, SJ; Lloyd-Evans, E; Cotman, SL				Chandrachud, Uma; Walker, Mathew W.; Simas, Alexandra M.; Heetveld, Sasja; Petcherski, Anton; Klein, Madeleine; Oh, Hyejin; Wolf, Pavlina; Zhao, Wen-Ning; Norton, Stephanie; Haggarty, Stephen J.; Lloyd-Evans, Emyr; Cotman, Susan L.			Unbiased Cell-based Screening in a Neuronal Cell Model of Batten Disease Highlights an Interaction between Ca2+ Homeostasis, Autophagy, and CLN3 Protein Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEROID-LIPOFUSCINOSIS; INTRACELLULAR CALCIUM; BIOMETAL HOMEOSTASIS; ENDOCYTIC PATHWAY; BRAIN MICROSOMES; IMAGE-ANALYSIS; LYSOSOMAL PH; MOUSE MODEL; MITOCHONDRIAL; LINK	Abnormal accumulation of undigested macromolecules, often disease-specific, is a major feature of lysosomal and neurodegenerative disease and is frequently attributed to defective autophagy. The mechanistic underpinnings of the autophagy defects are the subject of intense research, which is aided by genetic disease models. To gain an improved understanding of the pathways regulating defective autophagy specifically in juvenile neuronal ceroid lipofuscinosis (JNCL or Batten disease), a neurodegenerative disease of childhood, we developed and piloted a GFP-microtubule-associated protein 1 light chain 3 (GFP-LC3) screening assay to identify, in an unbiased fashion, genotype-sensitive small molecule autophagy modifiers, employing a JNCL neuronal cell model bearing the most common disease mutation in CLN3. Thapsigargin, a sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) Ca2+ pump inhibitor, reproducibly displayed significantly more activity in the mouse JNCL cells, an effect that was also observed in human-induced pluripotent stem cell-derived JNCL neural progenitor cells. The mechanism of thapsigargin sensitivity was Ca2+-mediated, and autophagosome accumulation in JNCL cells could be reversed by Ca2+ chelation. Interrogation of intracellular Ca2+ handling highlighted alterations in endoplasmic reticulum, mitochondrial, and lysosomal Ca2+ pools and in store-operated Ca2+ uptake in JNCL cells. These results further support an important role for the CLN3 protein in intracellular Ca2+ handling and in autophagic pathway flux and establish a powerful new platform for therapeutic screening.	[Chandrachud, Uma; Simas, Alexandra M.; Heetveld, Sasja; Petcherski, Anton; Klein, Madeleine; Oh, Hyejin; Wolf, Pavlina; Zhao, Wen-Ning; Norton, Stephanie; Haggarty, Stephen J.; Cotman, Susan L.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Boston, MA 02114 USA; [Walker, Mathew W.; Lloyd-Evans, Emyr] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales	Harvard University; Harvard Medical School; Massachusetts General Hospital; Cardiff University	Cotman, SL (corresponding author), Ctr Human Genet Res, Dept Neurol, 185 Cambridge St, Boston, MA 02114 USA.	cotman@helix.mgh.harvard.edu	Petcherski, Anton/AAC-2509-2019; Haggarty, Stephen J/M-9495-2016	Petcherski, Anton/0000-0002-3143-3867; Haggarty, Stephen J/0000-0002-7872-168X; Simas, Alexandra/0000-0003-0242-1442	National Institutes of Health from NINDS [R01NS073813]; National Institutes of Health from National Institute of Mental Health [R33MH087896]; Batten Disease Support and Research Association; National Tay-Sachs and Allied Diseases Association, Inc.; Tau Consortium; National Contest for Life Foundation (NCL Stiftung) fellowship; Finnish Foundation for JNCL Research fellowship; Knowledge Economy Skills Scholarship; Research Councils UK Fellowship; Basil O'Connor Starter Scholarship; Royal Society project grant; NATIONAL INSTITUTE OF MENTAL HEALTH [R33MH087896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073813] Funding Source: NIH RePORTER	National Institutes of Health from NINDS; National Institutes of Health from National Institute of Mental Health; Batten Disease Support and Research Association; National Tay-Sachs and Allied Diseases Association, Inc.; Tau Consortium; National Contest for Life Foundation (NCL Stiftung) fellowship; Finnish Foundation for JNCL Research fellowship; Knowledge Economy Skills Scholarship; Research Councils UK Fellowship(UK Research & Innovation (UKRI)); Basil O'Connor Starter Scholarship; Royal Society project grant; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS073813 from NINDS (to S. L. C.) and R33MH087896 from National Institute of Mental Health (to S. J. H.). This work was also supported by the Batten Disease Support and Research Association (to S. L. C.), the National Tay-Sachs and Allied Diseases Association, Inc. (to S. L. C.), the Tau Consortium (to S. J. H.), National Contest for Life Foundation (NCL Stiftung) fellowship (to A. P.), the Finnish Foundation for JNCL Research fellowship (to A. P.), a Knowledge Economy Skills Scholarship (to M. W. W.), a Research Councils UK Fellowship (to E. L. E.), a Basil O'Connor Starter Scholarship (to E. L. E.), and a Royal Society project grant (to E. L. E.) S. L. C. is a member of the Batten Disease Support and Research Association Advisory Board. P. W. is currently an employee of Sanofi.	[Anonymous], 1995, Cell, V82, P949; BUTTLE DJ, 1992, ARCH BIOCHEM BIOPHYS, V299, P377, DOI 10.1016/0003-9861(92)90290-D; Cao Y, 2006, J BIOL CHEM, V281, P20483, DOI 10.1074/jbc.M602180200; Cao Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017118; Chang JW, 2007, HUM MOL GENET, V16, P317, DOI 10.1093/hmg/ddl466; Cotman SL, 2002, HUM MOL GENET, V11, P2709, DOI 10.1093/hmg/11.22.2709; Cotman SL, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0366-z; Cotman SL, 2012, CLIN LIPIDOL, V7, P79, DOI 10.2217/CLP.11.70; Criollo A, 2007, CELL DEATH DIFFER, V14, P1029, DOI 10.1038/sj.cdd.4402099; Cuervo AM, 2000, J CELL SCI, V113, P4441; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; East DA, 2013, AUTOPHAGY, V9, P1710, DOI 10.4161/auto.25367; Engedal N, 2013, AUTOPHAGY, V9, P1475, DOI 10.4161/auto.25900; Fossale E, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-57; Ganley IG, 2011, MOL CELL, V42, P731, DOI 10.1016/j.molcel.2011.04.024; Golabek AA, 2000, MOL GENET METAB, V70, P203, DOI 10.1006/mgme.2000.3006; GORDON PB, 1993, J BIOL CHEM, V268, P26107; Grubman A, 2014, CHEM SCI, V5, P2503, DOI 10.1039/c4sc00316k; Grubman A, 2014, METALLOMICS, V6, P932, DOI 10.1039/c4mt00032c; Haack KA, 2011, BBA-GEN SUBJECTS, V1810, P186, DOI 10.1016/j.bbagen.2010.09.004; Holopainen JM, 2001, EUR J BIOCHEM, V268, P5851, DOI 10.1046/j.0014-2956.2001.02530.x; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Kang S, 2013, NEUROCHEM INT, V62, P931, DOI 10.1016/j.neuint.2013.03.007; Kanninen KM, 2013, BIOL OPEN, V2, P635, DOI 10.1242/bio.20134804; Kim Y, 2003, P NATL ACAD SCI USA, V100, P15458, DOI 10.1073/pnas.2136651100; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kollmann K, 2013, BBA-MOL BASIS DIS, V1832, P1866, DOI 10.1016/j.bbadis.2013.01.019; Kong SMY, 2014, HUM MOL GENET, V23, P2816, DOI 10.1093/hmg/ddu099; Korkotian E, 1999, J BIOL CHEM, V274, P21673, DOI 10.1074/jbc.274.31.21673; Lloyd-Evans E, 2003, BIOCHEM J, V375, P561, DOI 10.1042/BJ20030613; Lloyd-Evans E, 2003, J BIOL CHEM, V278, P23594, DOI 10.1074/jbc.M300212200; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Lojewski X, 2014, HUM MOL GENET, V23, P2005, DOI 10.1093/hmg/ddt596; Luiro K, 2004, HUM MOL GENET, V13, P3017, DOI 10.1093/hmg/ddh321; Luiro K, 2006, J NEUROSCI RES, V84, P1124, DOI 10.1002/jnr.21015; Vidal-Donet JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055526; Metcalf DJ, 2008, TRAFFIC, V9, P1905, DOI 10.1111/j.1600-0854.2008.00807.x; Misquitta CM, 1999, CELL CALCIUM, V25, P277, DOI 10.1054/ceca.1999.0032; Mole S., 2011, NEURONAL CEROID LIPO, DOI DOI 10.1093/MED/9780199590018.003.0018; Park JS, 2014, HUM MOL GENET, V23, P2802, DOI 10.1093/hmg/ddt623; Pearce DA, 1999, MOL GENET METAB, V66, P320, DOI 10.1006/mgme.1999.2819; Pelled D, 2003, J BIOL CHEM, V278, P29496, DOI 10.1074/jbc.M302964200; Persaud-Sawin DA, 2004, PEDIATR RES, V56, P449, DOI 10.1203/01.PDR.0000136152.54638.95; Sano R, 2009, MOL CELL, V36, P500, DOI 10.1016/j.molcel.2009.10.021; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schultz ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096647; Smaili SS, 2013, CURR MOL MED, V13, P252; Tecedor L, 2013, J NEUROSCI, V33, P18065, DOI 10.1523/JNEUROSCI.0498-13.2013; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Tsunemi T, 2014, HUM MOL GENET, V23, P2791, DOI 10.1093/hmg/ddt572; Uusi-Rauva K, 2008, EXP CELL RES, V314, P2895, DOI 10.1016/j.yexcr.2008.06.016; Uusi-Rauva K, 2012, CELL MOL LIFE SCI, V69, P2075, DOI 10.1007/s00018-011-0913-1; Vella F, 2002, IUBMB LIFE, V54, P89, DOI 10.1080/15216540214307; Warnock A, 2013, BIOCHEM BIOPH RES CO, V436, P645, DOI 10.1016/j.bbrc.2013.04.113; Warrier V, 2013, BBA-MOL BASIS DIS, V1832, P1827, DOI 10.1016/j.bbadis.2013.03.017; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79; Wu D, 2014, BIOCHEM BIOPH RES CO, V447, P115, DOI 10.1016/j.bbrc.2014.03.120; Yasuma T, 1998, J MED CHEM, V41, P4301, DOI 10.1021/jm9803065; Zhang LH, 2007, P NATL ACAD SCI USA, V104, P19023, DOI 10.1073/pnas.0709695104; Zhou CH, 2012, AUTOPHAGY, V8, P1215, DOI 10.4161/auto.20284	61	64	66	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14361	14380		10.1074/jbc.M114.621706	http://dx.doi.org/10.1074/jbc.M114.621706			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25878248	Green Published, hybrid			2022-12-28	WOS:000355754600009
J	Huang, SYN; Ghosh, S; Pommier, Y				Huang, Shar-yin Naomi; Ghosh, Sanchari; Pommier, Yves			Topoisomerase I Alone Is Sufficient to Produce Short DNA Deletions and Can Also Reverse Nicks at Ribonucleotide Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACCINIA TOPOISOMERASE; GENOME INTEGRITY; EXCISION-REPAIR; LEADING-STRAND; DUPLEX DNA; COMPLEXES; CLEAVAGE; MECHANISMS; COVALENT; YEAST	Ribonucleotide monophosphates (rNMPs) are among the most frequent form of DNA aberration, as high ratios of ribonucleotide triphosphate: deoxyribonucleotide triphosphate pools result in approximately two misincorporated rNMPs/kb of DNA. The main pathway for the removal of rNMPs is by RNase H2. However, in a RNase H2 knock-out yeast strain, a topoisomerase I (Top1)-dependent mutator effect develops with accumulation of short deletions within tandem repeats. Proposed models for these deletions implicated processing of Top1-generated nicks at rNMP sites and/or sequential Top1 binding, but experimental support has been lacking thus far. Here, we investigated the biochemical mechanism of the Top1-induced short deletions at the rNMP sites by generating nicked DNA substrates bearing 2',3'-cyclic phosphates at the nick sites, mimicking the Top1-induced nicks. We demonstrate that a second Top1 cleavage complex adjacent to the nick and subsequent faulty Top1 religation led to the short deletions. Moreover, when acting on the nicked DNA substrates containing 2',3'-cyclic phosphates, Top1 generated not only the short deletion, but also a full-length religated DNA product. Acatalytically inactive Top1 mutant (Top1-Y723F) also induced the full-length products, indicating that Top1 binding independent of its enzymatic activity promotes the sealing of DNA backbones via nucleophilic attacks by the 5'-hydroxyl on the 2',3'-cyclic phosphate. The resealed DNA would allow renewed attempt for repair by the error-free RNase H2-dependent pathway in vivo. Our results provide direct evidence for the generation of short deletions by sequential Top1 cleavage events and for the promotion of nick religation at rNMP sites by Top1.	[Pommier, Yves] NCI, Dev Therapeut Branch, NIH, Bethesda, MD 20892 USA; NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pommier, Y (corresponding author), NCI, Dev Therapeut Branch, NIH, Bethesda, MD 20892 USA.	pommier@nih.gov			National Institutes of Health from the Center for Cancer Research, NCI [Z01 BC006161]; NATIONAL CANCER INSTITUTE [ZIABC006161] Funding Source: NIH RePORTER	National Institutes of Health from the Center for Cancer Research, NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Intramural Program Grant Z01 BC006161 from the Center for Cancer Research, NCI.	Abaan OD, 2013, CANCER RES, V73, P4372, DOI 10.1158/0008-5472.CAN-12-3342; Antony S, 2007, NUCLEIC ACIDS RES, V35, P4474, DOI 10.1093/nar/gkm463; Chakravarty AK, 2011, J BIOL CHEM, V286, P4117, DOI 10.1074/jbc.M110.196766; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Cho JE, 2013, DNA REPAIR, V12, P205, DOI 10.1016/j.dnarep.2012.12.004; Clausen AR, 2015, NAT STRUCT MOL BIOL, V22, P185, DOI 10.1038/nsmb.2957; Clausen AR, 2013, DNA REPAIR, V12, P121, DOI 10.1016/j.dnarep.2012.11.006; Dexheimer TS, 2008, NAT PROTOC, V3, P1736, DOI 10.1038/nprot.2008.174; HENNINGFELD KA, 1995, BIOCHEMISTRY-US, V34, P6120, DOI 10.1021/bi00018a015; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; Interthal H, 2005, J BIOL CHEM, V280, P36518, DOI 10.1074/jbc.M508898200; Interthal H, 2011, BIOCHEM J, V436, P559, DOI 10.1042/BJ20101841; Kim N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003924; Kim N, 2011, SCIENCE, V332, P1561, DOI 10.1126/science.1205016; Koster DA, 2005, NATURE, V434, P671, DOI 10.1038/nature03395; Lazzaro F, 2012, MOL CELL, V45, P99, DOI 10.1016/j.molcel.2011.12.019; Leppard JB, 2005, CHROMOSOMA, V114, P75, DOI 10.1007/s00412-005-0345-5; McElhinny SAN, 2010, NAT CHEM BIOL, V6, P774, DOI [10.1038/NCHEMBIO.424, 10.1038/nchembio.424]; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; Meng B, 2014, GYNECOL ONCOL, V134, P15, DOI 10.1016/j.ygyno.2014.05.006; Palles C, 2013, NAT GENET, V45, P136, DOI 10.1038/ng.2503; POMMIER Y, 1994, BIOCHEM BIOPH RES CO, V205, P1601, DOI 10.1006/bbrc.1994.2850; Pommier Y, 1998, BBA-GENE STRUCT EXPR, V1400, P83, DOI 10.1016/S0167-4781(98)00129-8; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Potenski CJ, 2014, NUCLEIC ACIDS RES, V42, P10226, DOI 10.1093/nar/gku773; Potenski CJ, 2014, NATURE, V511, P251, DOI 10.1038/nature13292; Pourquier P, 1997, J BIOL CHEM, V272, P26441, DOI 10.1074/jbc.272.42.26441; Pourquier P, 1999, J BIOL CHEM, V274, P8516, DOI 10.1074/jbc.274.13.8516; Redinbo MR, 1998, SCIENCE, V279, P1504, DOI 10.1126/science.279.5356.1504; Reijns MAM, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.011; Sekiguchi J, 1997, MOL CELL, V1, P89, DOI 10.1016/S1097-2765(00)80010-6; Seol Y, 2012, P NATL ACAD SCI USA, V109, P16125, DOI 10.1073/pnas.1206480109; Shen Y, 2012, NAT STRUCT MOL BIOL, V19, P98, DOI 10.1038/nsmb.2176; Shuman S, 1998, MOL CELL, V1, P741, DOI 10.1016/S1097-2765(00)80073-8; SHUMAN S, 1992, J BIOL CHEM, V267, P8620; SHUMAN S, 1993, J BIOL CHEM, V268, P18943; Sousa FG, 2015, DNA REPAIR, V28, P107, DOI 10.1016/j.dnarep.2015.01.011; Sparks J. L., 2015, EMBO J; Sparks JL, 2012, MOL CELL, V47, P980, DOI 10.1016/j.molcel.2012.06.035; Strumberg D, 2000, MOL CELL BIOL, V20, P3977, DOI 10.1128/MCB.20.11.3977-3987.2000; Takahashi T, 2011, P NATL ACAD SCI USA, V108, P692, DOI 10.1073/pnas.1012582108; Tanaka N, 2010, STRUCTURE, V18, P449, DOI 10.1016/j.str.2010.01.016; Tumbale P, 2014, NATURE, V506, P111, DOI 10.1038/nature12824; Vaisman A, 2014, MUTAT RES-FUND MOL M, V761, P21, DOI 10.1016/j.mrfmmm.2014.01.005; Vaisman A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003878; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Williams JS, 2014, DNA REPAIR, V19, P27, DOI 10.1016/j.dnarep.2014.03.029; Williams JS, 2013, MOL CELL, V49, P1010, DOI 10.1016/j.molcel.2012.12.021; Woodfield G, 2000, NUCLEIC ACIDS RES, V28, P3323, DOI 10.1093/nar/28.17.3323; Yang SW, 1996, P NATL ACAD SCI USA, V93, P11534, DOI 10.1073/pnas.93.21.11534	50	44	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					14068	14076		10.1074/jbc.M115.653345	http://dx.doi.org/10.1074/jbc.M115.653345			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25887397	hybrid, Green Published			2022-12-28	WOS:000355313000036
J	Ruelas, DS; Chan, JK; Oh, E; Heidersbach, AJ; Hebbeler, AM; Chavez, L; Verdin, E; Rape, M; Greene, WC				Ruelas, Debbie S.; Chan, Jonathan K.; Oh, Eugene; Heidersbach, Amy J.; Hebbeler, Andrew M.; Chavez, Leonard; Verdin, Eric; Rape, Michael; Greene, Warner C.			MicroRNA-155 Reinforces HIV Latency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B-ALPHA; T-CELLS; CELLULAR MICRORNA; PROTEIN; TRIM32; REPLICATION; RESERVOIR; DOMAIN; UBIQUITINATION; IDENTIFICATION	The presence of a small number of infected but transcriptionally dormant cells currently thwarts a cure for the more than 35 million individuals infected with HIV. Reactivation of these latently infected cells may result in three fates: 1) cell death due to a viral cytopathic effect, 2) cell death due to immune clearance, or 3) a retreat into latency. Uncovering the dynamics of HIV gene expression and silencing in the latent reservoir will be crucial for developing an HIV-1 cure. Here we identify and characterize an intracellular circuit involving TRIM32, an HIV activator, and miR-155, a microRNA that may promote a return to latency in these transiently activated reservoir cells. Notably, we demonstrate that TRIM32, an E3 ubiquitin ligase, promotes reactivation from latency by directly modifying I kappa B alpha, leading to a novel mechanism of NF-kappa B induction not involving I kappa B kinase activation.	[Chavez, Leonard; Verdin, Eric; Greene, Warner C.] Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA; [Ruelas, Debbie S.; Heidersbach, Amy J.; Chavez, Leonard] Univ Calif San Francisco, Program Biomed Sci, San Francisco, CA 94143 USA; [Verdin, Eric; Greene, Warner C.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Verdin, Eric; Greene, Warner C.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Oh, Eugene; Rape, Michael] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Rape, Michael] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Heidersbach, Amy J.] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California San Francisco; The J David Gladstone Institutes	Greene, WC (corresponding author), Gladstone Inst Virol & Immunol, 1650 Owens St, San Francisco, CA 94158 USA.	wgreene@gladstone.ucsf.edu	Verdin, Eric/AAB-7999-2019	Rape, Michael/0000-0003-4849-6343; Verdin, Eric/0000-0003-3703-3183; Chavez, Leonard/0000-0003-3226-0897; Oh, Eugene/0000-0003-1970-8423	Martin Delaney CARE Collaboratory (National Institutes of Health) [NIAID U19 AI096113]; UCSF Microbial Pathogenesis and Host Defense Program (National Institutes of Health) [NIAID 5 T32 AI60537-9]; Jane Coffin Childs Postdoctoral Fellowship; Centers for AIDS Research (CFAR), a National Institutes of Health [P30 AI027763]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, T32AI060537, U19AI096113] Funding Source: NIH RePORTER	Martin Delaney CARE Collaboratory (National Institutes of Health); UCSF Microbial Pathogenesis and Host Defense Program (National Institutes of Health); Jane Coffin Childs Postdoctoral Fellowship; Centers for AIDS Research (CFAR), a National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Martin Delaney CARE Collaboratory (National Institutes of Health Grant NIAID U19 AI096113 to W. C. G.), the UCSF Microbial Pathogenesis and Host Defense Program (National Institutes of Health Grant NIAID 5 T32 AI60537-9 to D. S. R.), and the Jane Coffin Childs Postdoctoral Fellowship (to E. O.). This work was also supported by Centers for AIDS Research (CFAR), a National Institutes of Health-funded program (Grant P30 AI027763 to W. C. G.).	Albor A, 2006, J BIOL CHEM, V281, P25850, DOI 10.1074/jbc.M601655200; Archin NM, 2014, CURR OPIN INFECT DIS, V27, P29, DOI 10.1097/QCO.0000000000000026; Banerjee A, 2010, EUR J IMMUNOL, V40, P225, DOI 10.1002/eji.200939381; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Calvanese V, 2013, VIROLOGY, V446, P283, DOI 10.1016/j.virol.2013.07.037; Chan JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077749; Chiang K, 2012, J VIROL, V86, P3244, DOI 10.1128/JVI.05065-11; CHUN TW, 1995, NAT MED, V1, P1284, DOI 10.1038/nm1295-1284; Colin L, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-111; Descours B, 2012, CLIN INFECT DIS, V54, P1495, DOI 10.1093/cid/cis188; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dornadula G, 1999, JAMA-J AM MED ASSOC, V282, P1627, DOI 10.1001/jama.282.17.1627; FRIDELL RA, 1995, VIROLOGY, V209, P347, DOI 10.1006/viro.1995.1266; Gottwein E, 2007, NATURE, V450, P1096, DOI 10.1038/nature05992; Gottwein E, 2013, CURR TOP MICROBIOL, V371, P201, DOI 10.1007/978-3-642-37765-5_8; Haasch D, 2002, CELL IMMUNOL, V217, P78, DOI 10.1016/S0008-8749(02)00506-3; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Jordan A, 2001, EMBO J, V20, P1726, DOI 10.1093/emboj/20.7.1726; Kwon H, 1998, J BIOL CHEM, V273, P7431, DOI 10.1074/jbc.273.13.7431; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Linnstaedt SD, 2010, J VIROL, V84, P11670, DOI 10.1128/JVI.01248-10; Loeb GB, 2012, MOL CELL, V48, P760, DOI 10.1016/j.molcel.2012.10.002; Lu F, 2008, J VIROL, V82, P10436, DOI 10.1128/JVI.00752-08; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Murugaiyan G, 2011, J IMMUNOL, V187, P2213, DOI 10.4049/jimmunol.1003952; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nathans R, 2009, MOL CELL, V34, P696, DOI 10.1016/j.molcel.2009.06.003; Nettles RE, 2005, JAMA-J AM MED ASSOC, V293, P817, DOI 10.1001/jama.293.7.817; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Ryu YS, 2011, J BIOL CHEM, V286, P25729, DOI 10.1074/jbc.M111.241893; Schwamborn JC, 2009, CELL, V136, P913, DOI 10.1016/j.cell.2008.12.024; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; Skalsky RL, 2007, J VIROL, V81, P12836, DOI 10.1128/JVI.01804-07; So AYL, 2013, IMMUNOL REV, V253, P129, DOI 10.1111/imr.12043; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; Spina CA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003834; Sun SC, 1996, MOL CELL BIOL, V16, P1058; Swaminathan G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002937; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Uchil PD, 2013, J VIROL, V87, P257, DOI 10.1128/JVI.01804-12; Williams SA, 2004, J BIOL CHEM, V279, P42008, DOI 10.1074/jbc.M402124200; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159; Zhang J, 2012, J BIOL CHEM, V287, P28646, DOI 10.1074/jbc.M112.362608	50	49	56	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13736	13748		10.1074/jbc.M115.641837	http://dx.doi.org/10.1074/jbc.M115.641837			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25873391	hybrid, Green Published			2022-12-28	WOS:000355313000010
J	Samelson, BK; Gore, BB; Whiting, JL; Nygren, PJ; Purkey, AM; Colledge, M; Langeberg, LK; Dell'Acqua, ML; Zweifel, LS; Scott, JD				Samelson, Bret K.; Gore, Bryan B.; Whiting, Jennifer L.; Nygren, Patrick J.; Purkey, Alicia M.; Colledge, Marcie; Langeberg, Lorene K.; Dell'Acqua, Mark L.; Zweifel, Larry S.; Scott, John D.			A-kinase Anchoring Protein 79/150 Recruits Protein Kinase C to Phosphorylate Roundabout Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATES SYNAPTIC PLASTICITY; COMMISSURAL AXON GUIDANCE; AKAP79 SIGNALING COMPLEX; NERVE GROWTH CONES; FUNCTIONAL DIVERSITY; DEPENDENT REGULATION; DYNAMIC REGULATION; SCAFFOLD PROTEIN; AMPA RECEPTORS; CAMP SYNTHESIS	Anchoring proteins direct protein kinases and phosphoprotein phosphatases toward selected substrates to control the efficacy, context, and duration of neuronal phosphorylation events. The A-kinase anchoring protein AKAP79/150 interacts with protein kinase A (PKA), protein kinase C (PKC), and protein phosphatase 2B (calcineurin) to modulate second messenger signaling events. In a mass spectrometry-based screen for additional AKAP79/150 binding partners, we have identified the Roundabout axonal guidance receptor Robo2 and its ligands Slit2 and Slit3. Biochemical and cellular approaches confirm that a linear sequence located in the cytoplasmic tail of Robo2 (residues 991-1070) interfaces directly with sites on the anchoring protein. Parallel studies show that AKAP79/150 interacts with the Robo3 receptor in a similar manner. Immunofluorescent staining detects overlapping expression patterns for murine AKAP150, Robo2, and Robo3 in a variety of brain regions, including hippocampal region CA1 and the islands of Calleja. In vitro kinase assays, peptide spot array mapping, and proximity ligation assay staining approaches establish that human AKAP79-anchored PKC selectively phosphorylates the Robo3.1 receptor subtype on serine 1330. These findings imply that anchored PKC locally modulates the phosphorylation status of Robo3.1 in brain regions governing learning and memory and reward.	[Samelson, Bret K.; Whiting, Jennifer L.; Nygren, Patrick J.; Langeberg, Lorene K.; Scott, John D.] Univ Washington, Howard Hughes Med Inst, Dept Pharmacol, Seattle, WA 98195 USA; [Gore, Bryan B.; Zweifel, Larry S.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Gore, Bryan B.; Zweifel, Larry S.] Univ Washington, Dept Psychiat, Seattle, WA 98195 USA; [Purkey, Alicia M.; Dell'Acqua, Mark L.] Univ Colorado, Dept Pharmacol, Aurora, CO 80045 USA; [Colledge, Marcie] Yellow Scope LLC, Portland, OR 97212 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Colorado System; University of Colorado Anschutz Medical Campus	Scott, JD (corresponding author), Univ Washington, Howard Hughes Med Inst, Dept Pharmacol, 1959 NE Pacific St,Box 357280,HSB E-417, Seattle, WA 98195 USA.	scottjdw@uw.edu	Regan, Clinton/E-6250-2012; Zweifel, Larry/O-3284-2017	Zweifel, Larry/0000-0003-3465-5331; Purkey, Alicia/0000-0002-1865-1421	National Institutes of Health [DK105542, DK54441, MH094536, NS40701]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105542, P01DK054441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007635, T32GM007750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040701, R56NS040701] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK105542 and DK54441 (to J. D. S.), MH094536 (to L. S. Z.), and NS40701 (to M. L. D.).	Ba-Charvet KTN, 1999, NEURON, V22, P463, DOI 10.1016/S0896-6273(00)80702-3; Bauman AL, 2006, MOL CELL, V23, P925, DOI 10.1016/j.molcel.2006.07.025; Carlson BR, 2011, J NEUROSCI, V31, P2447, DOI 10.1523/JNEUROSCI.4433-10.2011; Carlson CR, 2006, J BIOL CHEM, V281, P21535, DOI 10.1074/jbc.M603223200; CARR DW, 1992, J BIOL CHEM, V267, P13376; Chalasani SH, 2003, J NEUROSCI, V23, P1360, DOI 10.1523/JNEUROSCI.23-04-01360.2003; Chen Z, 2008, NEURON, V58, P325, DOI 10.1016/j.neuron.2008.02.016; Cheng EP, 2011, CIRC RES, V109, P255, DOI 10.1161/CIRCRESAHA.111.248252; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Dell'Acqua ML, 2006, EUR J CELL BIOL, V85, P627, DOI 10.1016/j.ejcb.2006.01.010; Dell'Acqua ML, 1998, EMBO J, V17, P2246, DOI 10.1093/emboj/17.8.2246; Dessauer CW, 2009, MOL PHARMACOL, V76, P935, DOI 10.1124/mol.109.059345; Dodge-Kafka KL, 2006, CIRC RES, V98, P993, DOI 10.1161/01.RES.0000218273.91741.30; Efendiev R, 2010, J BIOL CHEM, V285, P14450, DOI 10.1074/jbc.M110.109769; Evans TA, 2010, CURR BIOL, V20, P567, DOI 10.1016/j.cub.2010.02.021; Faux MC, 1999, BIOCHEM J, V343, P443, DOI 10.1042/0264-6021:3430443; Fenstermaker V, 2004, J NEUROBIOL, V58, P403, DOI 10.1002/neu.10304; Fraser IDC, 2000, CURR BIOL, V10, P409, DOI 10.1016/S0960-9822(00)00419-X; Fraser IDC, 1999, NEURON, V23, P423, DOI 10.1016/S0896-6273(00)80795-3; Gao TY, 1997, NEURON, V19, P185, DOI 10.1016/S0896-6273(00)80358-X; Gold MG, 2011, P NATL ACAD SCI USA, V108, P6426, DOI 10.1073/pnas.1014400108; Guan CB, 2007, CELL, V129, P385, DOI 10.1016/j.cell.2007.01.051; Guirland C, 2004, NEURON, V42, P51, DOI 10.1016/S0896-6273(04)00157-6; Hinke SA, 2012, EMBO J, V31, P3991, DOI 10.1038/emboj.2012.244; Horn KE, 2013, CELL REP, V3, P173, DOI 10.1016/j.celrep.2012.12.005; Hoshi N, 2003, NAT NEUROSCI, V6, P564, DOI 10.1038/nn1062; Hoshi N, 2005, NAT CELL BIOL, V7, P1066, DOI 10.1038/ncb1315; Hoshi N, 2010, MOL CELL, V37, P541, DOI 10.1016/j.molcel.2010.01.014; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Jaworski A, 2010, J NEUROSCI, V30, P9445, DOI 10.1523/JNEUROSCI.6290-09.2010; Ke RQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069813; Keith DJ, 2012, J NEUROSCI, V32, P7119, DOI 10.1523/JNEUROSCI.0784-12.2012; Kenwrick S, 2000, HUM MOL GENET, V9, P879, DOI 10.1093/hmg/9.6.879; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; Lefkowitz RJ, 2004, TRENDS PHARMACOL SCI, V25, P413, DOI 10.1016/j.tips.2004.06.006; Lester LB, 1996, J BIOL CHEM, V271, P9460, DOI 10.1074/jbc.271.16.9460; Logue JS, 2011, J BIOL CHEM, V286, P22113, DOI 10.1074/jbc.M111.232660; Long H, 2004, NEURON, V42, P213, DOI 10.1016/S0896-6273(04)00179-5; Marillat V, 2002, J COMP NEUROL, V442, P130, DOI 10.1002/cne.10068; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Nishiyama M, 2003, NATURE, V423, P990, DOI 10.1038/nature01751; Nystoriak MA, 2014, CIRC RES, V114, P607, DOI 10.1161/CIRCRESAHA.114.302168; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; Robertson HR, 2009, J NEUROSCI, V29, P7929, DOI 10.1523/JNEUROSCI.6093-08.2009; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; Sanderson JL, 2012, J NEUROSCI, V32, P15036, DOI 10.1523/JNEUROSCI.3326-12.2012; Scott JD, 2013, ANNU REV PHARMACOL, V53, P187, DOI 10.1146/annurev-pharmtox-011112-140204; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Smith FD, 2013, ELIFE, V2, DOI 10.7554/eLife.01319; Snyder EM, 2005, J BIOL CHEM, V280, P16962, DOI 10.1074/jbc.M409693200; Soderling SH, 2007, J NEUROSCI, V27, P355, DOI 10.1523/JNEUROSCI.3209-06.2006; Soderling SH, 2003, P NATL ACAD SCI USA, V100, P1723, DOI 10.1073/pnas.0438033100; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Song HJ, 2001, NAT CELL BIOL, V3, pE81, DOI 10.1038/35060164; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; Tasken KA, 2001, J BIOL CHEM, V276, P21999, DOI 10.1074/jbc.C000911200; Tavalin SJ, 2002, J NEUROSCI, V22, P3044, DOI 10.1523/JNEUROSCI.22-08-03044.2002; Tavalin SJ, 2008, J BIOL CHEM, V283, P11445, DOI 10.1074/jbc.M709253200; Terman JR, 2004, SCIENCE, V303, P1204, DOI 10.1126/science.1092121; Tunquist BJ, 2008, P NATL ACAD SCI USA, V105, P12557, DOI [10.1073/pnas.0805922105, 10.1073/pnas.0B05922105]; Weisenhaus M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010325; Welch EJ, 2010, MOL INTERV, V10, P86, DOI 10.1124/mi.10.2.6; Westphal RS, 2000, EMBO J, V19, P4589, DOI 10.1093/emboj/19.17.4589; Whitford KL, 2002, NEURON, V33, P47, DOI 10.1016/S0896-6273(01)00566-9; Willoughby D, 2010, J BIOL CHEM, V285, P20328, DOI 10.1074/jbc.M110.120725; Ypsilanti AR, 2010, DEVELOPMENT, V137, P1939, DOI 10.1242/dev.044511; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748; Zalatan JG, 2012, SCIENCE, V337, P1218, DOI 10.1126/science.1220683	71	5	5	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					14107	14119		10.1074/jbc.M115.637470	http://dx.doi.org/10.1074/jbc.M115.637470			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25882844	Green Published, hybrid			2022-12-28	WOS:000355313000039
J	Yang, J; Tan, GQ; Zhang, T; White, RH; Lu, JX; Ding, HG				Yang, Jing; Tan, Guoqiang; Zhang, Ting; White, Robert H.; Lu, Jianxin; Ding, Huangen			Deletion of the Proposed Iron Chaperones IscA/SufA Results in Accumulation of a Red Intermediate Cysteine Desulfurase IscS in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFUR CLUSTER BIOSYNTHESIS; SCAFFOLD PROTEIN ISCU; BACTERIAL FRATAXIN; BINDING ACTIVITY; FUNCTIONAL-CHARACTERIZATION; MONOTHIOL GLUTAREDOXINS; 2FE-2S CLUSTERS; BOUND FORMS; BIOGENESIS; CYAY	In Escherichia coli, sulfur in iron-sulfur clusters is primarily derived from L-cysteine via the cysteine desulfurase IscS. However, the iron donor for iron-sulfur cluster assembly remains elusive. Previous studies have shown that, among the iron-sulfur cluster assembly proteins in E. coli, IscA has a unique and strong iron-binding activity and that the iron-bound IscA can efficiently provide iron for iron-sulfur cluster assembly in proteins in vitro, indicating that IscA may act as an iron chaperone for iron-sulfur cluster biogenesis. Here we report that deletion of IscA and its paralog SufA in E. coli cells results in the accumulation of a red-colored cysteine desulfurase IscS under aerobic growth conditions. Depletion of intracellular iron using a membrane-permeable iron chelator, 2,2'-dipyridyl, also leads to the accumulation of red IscS in wild-type E. coli cells, suggesting that the deletion of IscA/SufA may be emulated by depletion of intracellular iron. Purified red IscS has an absorption peak at 528 nm in addition to the peak at 395 nm of pyridoxal 5'-phosphate. When red IscS is oxidized by hydrogen peroxide, the peak at 528 nm is shifted to 510 nm, which is similar to that of alanine-quinonoid intermediate in cysteine desulfurases. Indeed, red IscS can also be produced in vitro by incubating wild-type IscS with excess L-alanine and sulfide. The results led us to propose that deletion of IscA/SufA may disrupt the iron delivery for iron-sulfur cluster biogenesis, therefore impeding sulfur delivery by IscS, and result in the accumulation of red IscS in E. coli cells.	[Yang, Jing; Tan, Guoqiang; Ding, Huangen] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [White, Robert H.] Virginia Polytech Inst & State Univ, Dept Biochem, Blacksburg, VA 24061 USA; [Tan, Guoqiang; Zhang, Ting; Lu, Jianxin] Wenzhou Med Univ, Lab Mol Med, Wenzhou 325035, Zhejiang, Peoples R China	Louisiana State University System; Louisiana State University; Virginia Polytechnic Institute & State University; Wenzhou Medical University	Lu, JX (corresponding author), Wenzhou Med Univ, Lab Mol Med, Wenzhou 325035, Zhejiang, Peoples R China.	jxlu313@163.com; hding@lsu.edu	Regan, Clinton/E-6250-2012; Ding, Huangen/AAJ-8550-2020	Ding, Huangen/0000-0002-4815-7336	National Institutes of Health [GM109399]; American Heart Association [13GRNT16890014]; Chinese National Natural Science Foundation [31228006, 31200587]; Natural Science Foundation of Zhejiang Province [LY12C05003]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM109399] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Award GM109399. This work was also supported by American Heart Association Grant 13GRNT16890014, Chinese National Natural Science Foundation Grants 31228006 and 31200587, and Natural Science Foundation of Zhejiang Province Grant LY12C05003.	Adinolfi S, 2009, NAT STRUCT MOL BIOL, V16, P390, DOI 10.1038/nsmb.1579; An XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051265; Banci L, 2014, P NATL ACAD SCI USA, V111, P6203, DOI 10.1073/pnas.1400102111; Bandyopadhyay S, 2008, BIOCHEM SOC T, V36, P1112, DOI 10.1042/BST0361112; Behshad E, 2009, BIOCHEMISTRY-US, V48, P12014, DOI 10.1021/bi802161u; Bitoun JP, 2008, BIOMETALS, V21, P693, DOI 10.1007/s10534-008-9154-7; Bonomi F, 2011, BIOCHEMISTRY-US, V50, P9641, DOI 10.1021/bi201123z; Bou-Abdallah F, 2004, J MOL BIOL, V341, P605, DOI 10.1016/j.jmb.2004.05.072; Bulteau AL, 2004, SCIENCE, V305, P242, DOI 10.1126/science.1098991; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Chahal HK, 2009, BIOCHEMISTRY-US, V48, P10644, DOI 10.1021/bi901518y; Cupp-Vickery JR, 2003, J MOL BIOL, V330, P1049, DOI 10.1016/S0022-2836(03)00690-9; Desnoyers G, 2009, EMBO J, V28, P1551, DOI 10.1038/emboj.2009.116; Ding BJ, 2005, BIOCHEM J, V389, P797, DOI 10.1042/BJ20050405; Ding HG, 2005, J BIOL CHEM, V280, P30432, DOI 10.1074/jbc.M504638200; Ding HG, 2004, BIOCHEM J, V379, P433, DOI 10.1042/BJ20031702; Ding HG, 2007, J BIOL CHEM, V282, P7997, DOI 10.1074/jbc.M609665200; Duby G, 2002, HUM MOL GENET, V11, P2635, DOI 10.1093/hmg/11.21.2635; FERREIRA GC, 1995, PROTEIN SCI, V4, P1001; Fleischhacker AS, 2012, BIOCHEMISTRY-US, V51, P4453, DOI 10.1021/bi3003204; Gerber J, 2003, EMBO REP, V4, P906, DOI 10.1038/sj.embor.embor918; Gonzalez-Cabo P, 2005, HUM MOL GENET, V14, P2091, DOI 10.1093/hmg/ddi214; Gupta V, 2009, J AM CHEM SOC, V131, P6149, DOI 10.1021/ja807551e; Jensen LT, 2000, MOL CELL BIOL, V20, P3918, DOI 10.1128/MCB.20.11.3918-3927.2000; Johnson DC, 2006, J BACTERIOL, V188, P7551, DOI 10.1128/JB.00596-06; Karsten WE, 2009, BBA-GEN SUBJECTS, V1790, P575, DOI 10.1016/j.bbagen.2009.02.012; Kaut A, 2000, J BIOL CHEM, V275, P15955, DOI 10.1074/jbc.M909502199; Kim JH, 2014, J AM CHEM SOC, V136, P11586, DOI 10.1021/ja5055252; Kim JH, 2014, J AM CHEM SOC, V136, P7933, DOI 10.1021/ja501260h; Kim JH, 2013, J AM CHEM SOC, V135, P8117, DOI 10.1021/ja401950a; Kim JH, 2009, BIOCHEMISTRY-US, V48, P6062, DOI 10.1021/bi9002277; Kurihara T, 2003, BBA-PROTEINS PROTEOM, V1647, P303, DOI 10.1016/S1570-9639(03)00078-5; Landry AP, 2013, DALTON T, V42, P3100, DOI 10.1039/c2dt32000b; Lauhon CT, 2000, J BIOL CHEM, V275, P20096, DOI 10.1074/jbc.M002680200; Layer G, 2006, J BIOL CHEM, V281, P16256, DOI 10.1074/jbc.M513569200; Li DS, 1999, FEBS LETT, V456, P13, DOI 10.1016/S0014-5793(99)00896-0; Li HR, 2012, BIOCHEMISTRY-US, V51, P1687, DOI 10.1021/bi2019089; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Lu JX, 2008, BIOCHEM J, V409, P535, DOI 10.1042/BJ20071166; Lu JX, 2010, BIOCHEM J, V428, P125, DOI 10.1042/BJ20100122; Mapolelo DT, 2013, DALTON T, V42, P3107, DOI 10.1039/c2dt32263c; Mapolelo DT, 2012, BIOCHEMISTRY-US, V51, P8056, DOI 10.1021/bi300664j; Mapolelo DT, 2012, BIOCHEMISTRY-US, V51, P8071, DOI 10.1021/bi3006658; Marinoni EN, 2012, ANGEW CHEM INT EDIT, V51, P5439, DOI 10.1002/anie.201201708; Mettert EL, 2008, J MOL BIOL, V384, P798, DOI 10.1016/j.jmb.2008.09.080; Muhlenhoff U, 2011, J BIOL CHEM, V286, P41205, DOI 10.1074/jbc.M111.296152; Nuth M, 2009, J BIOL INORG CHEM, V14, P829, DOI 10.1007/s00775-009-0495-7; Pandey A, 2013, J BIOL CHEM, V288, P36773, DOI 10.1074/jbc.M113.525857; Pastore C, 2006, STRUCTURE, V14, P857, DOI 10.1016/j.str.2006.02.010; Roche B, 2015, MOL MICROBIOL, V95, P605, DOI 10.1111/mmi.12888; Schwartz CJ, 2000, P NATL ACAD SCI USA, V97, P9009, DOI 10.1073/pnas.160261497; Shakamuri P, 2012, J AM CHEM SOC, V134, P15213, DOI 10.1021/ja306061x; Sheftel AD, 2012, MOL BIOL CELL, V23, P1157, DOI 10.1091/mbc.E11-09-0772; Shi R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000354; SIEGEL LM, 1965, ANAL BIOCHEM, V11, P126, DOI 10.1016/0003-2697(65)90051-5; Smith AD, 2001, J AM CHEM SOC, V123, P11103, DOI 10.1021/ja016757n; Song DS, 2009, J BIOL CHEM, V284, P35297, DOI 10.1074/jbc.M109.040014; Tan GQ, 2014, MOL MICROBIOL, V93, P629, DOI 10.1111/mmi.12676; Tan GQ, 2009, BIOCHEM J, V420, P463, DOI 10.1042/BJ20090206; Vinella D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000497; Vivas E, 2006, J BACTERIOL, V188, P1175, DOI 10.1128/JB.188.3.1175-1179.2006; Wang W, 2010, BIOCHEM J, V432, P429, DOI 10.1042/BJ20101507; Wollers S, 2010, J BIOL CHEM, V285, P23329, DOI 10.1074/jbc.M110.127449; Yan R, 2014, CHEMBIOCHEM, V15, P1681, DOI 10.1002/cbic.201402211; Yan R, 2013, J BIOL CHEM, V288, P24777, DOI 10.1074/jbc.M113.480327; Yang JJ, 2006, J BIOL CHEM, V281, P27956, DOI 10.1074/jbc.M601356200; Yoon T, 2003, J AM CHEM SOC, V125, P6078, DOI 10.1021/ja027967i; Zhang WJ, 2010, J BIOL CHEM, V285, P2302, DOI 10.1074/jbc.M109.082172; ZHENG LM, 1994, BIOCHEMISTRY-US, V33, P4714, DOI 10.1021/bi00181a031; Zheng LM, 1998, J BIOL CHEM, V273, P13264, DOI 10.1074/jbc.273.21.13264	70	5	7	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					14226	14234		10.1074/jbc.M115.654269	http://dx.doi.org/10.1074/jbc.M115.654269			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25907559	Green Published, hybrid			2022-12-28	WOS:000355313000049
J	Zhang, SY; Bryant, DA				Zhang, Shuyi; Bryant, Donald A.			Biochemical Validation of the Glyoxylate Cycle in the Cyanobacterium Chlorogloeopsis fritschii Strain PCC 9212	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRICARBOXYLIC-ACID CYCLE; FLUX BALANCE ANALYSIS; BLUE-GREEN ALGAE; ESCHERICHIA-COLI; CARBON METABOLISM; ISOCITRATE LYASE; ANACYSTIS-NIDULANS; ACETATE; SYNECHOCOCCUS; BACTERIA	Cyanobacteria are important photoautotrophic bacteria with extensive but variable metabolic capacities. The existence of the glyoxylate cycle, a variant of the TCA cycle, is still poorly documented in cyanobacteria. Previous studies reported the activities of isocitrate lyase and malate synthase, the key enzymes of the glyoxylate cycle in some cyanobacteria, but other studies concluded that these enzymes are missing. In this study the genes encoding isocitrate lyase and malate synthase from Chlorogloeopsis fritschii PCC 9212 were identified, and the recombinant enzymes were biochemically characterized. Consistent with the presence of the enzymes of the glyoxylate cycle, C. fritschii could assimilate acetate under both light and dark growth conditions. Transcript abundances for isocitrate lyase and malate synthase increased, and C. fritschii grew faster, when the growth medium was supplemented with acetate. Adding acetate to the growth medium also increased the yield of poly-3-hydroxybutyrate. When the genes encoding isocitrate lyase and malate synthase were expressed in Synechococcus sp. PCC 7002, the acetate assimilation capacity of the resulting strain was greater than that of wild type. Database searches showed that the genes for the glyoxylate cycle exist in only a few other cyanobacteria, all of which are able to fix nitrogen. This study demonstrates that the glyoxylate cycle exists in a few cyanobacteria, and that this pathway plays an important role in the assimilation of acetate for growth in one of those organisms. The glyoxylate cycle might play a role in coordinating carbon and nitrogen metabolism under conditions of nitrogen fixation.	[Zhang, Shuyi; Bryant, Donald A.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Bryant, Donald A.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Montana State University System; Montana State University Bozeman	Bryant, DA (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Althouse Lab 403C, University Pk, PA 16802 USA.	dab14@psu.edu		Zhang, Shuyi/0000-0001-8500-5836	National Science Foundation [MCB-1021725]; Air Force Office of Scientific Research MURI [FA9550-05-1-0365, FA9550-11-1-0148]; Div Of Molecular and Cellular Bioscience [1021725] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Air Force Office of Scientific Research MURI(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)MURI); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grant MCB-1021725 (to D. A. B.) and Air Force Office of Scientific Research MURI Grants FA9550-05-1-0365 and FA9550-11-1-0148 (to D. A. B.).	Bandyopadhyay A, 2011, MBIO, V2, DOI 10.1128/mBio.00214-11; Becker HM, 2005, J BIOL CHEM, V280, P39882, DOI 10.1074/jbc.M503081200; Bedhomme M, 2009, J BIOL CHEM, V284, P36282, DOI 10.1074/jbc.M109.064428; Boyle NR, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-4; BRAUNEGG G, 1978, EUR J APPL MICROBIOL, V6, P29, DOI 10.1007/BF00500854; BROWN TDK, 1977, J GEN MICROBIOL, V102, P327, DOI 10.1099/00221287-102-2-327; Chen ZH, 2000, PLANT CELL PHYSIOL, V41, P960, DOI 10.1093/pcp/pcd021; COMBRES C, 1994, PHYSIOL PLANTARUM, V91, P729, DOI 10.1111/j.1399-3054.1994.tb03012.x; DAVIS WL, 1990, ANAT REC, V227, P271, DOI 10.1002/ar.1092270302; Dunn MF, 2009, MICROBIOL-SGM, V155, P3166, DOI 10.1099/mic.0.030858-0; Eastmond PJ, 2001, TRENDS PLANT SCI, V6, P72, DOI 10.1016/S1360-1385(00)01835-5; ELEY JH, 1988, J PHYCOL, V24, P586, DOI 10.1111/j.1529-8817.1988.tb00111.x; Ensign SA, 2011, SCIENCE, V331, P294, DOI 10.1126/science.1201252; Erb TJ, 2007, P NATL ACAD SCI USA, V104, P10631, DOI 10.1073/pnas.0702791104; Feng XY, 2010, J BIOL CHEM, V285, P39544, DOI 10.1074/jbc.M110.162958; Frigaard NU, 2004, METH MOL B, V274, P325; Gan Fei, 2015, Life-Basel, V5, P4, DOI 10.3390/life5010004; Gan F, 2014, SCIENCE, V345, P1312, DOI 10.1126/science.1256963; GIBBS M, 1986, PLANT PHYSIOL, V82, P160, DOI 10.1104/pp.82.1.160; Gimenez R, 2003, J BACTERIOL, V185, P6448, DOI 10.1128/JB.185.21.6448-6455.2003; Graham IA, 2008, ANNU REV PLANT BIOL, V59, P115, DOI 10.1146/annurev.arplant.59.032607.092938; GUTOWSKI SJ, 1975, BIOCHEM J, V152, P647, DOI 10.1042/bj1520647; HOARE DS, 1967, J GEN MICROBIOL, V49, P351, DOI 10.1099/00221287-49-3-351; IHLENFELDT MJA, 1977, ARCH MICROBIOL, V113, P231, DOI 10.1007/BF00492030; KAY WW, 1971, EUR J BIOCHEM, V18, P274, DOI 10.1111/j.1432-1033.1971.tb01240.x; Khomyakova M, 2011, SCIENCE, V331, P334, DOI 10.1126/science.1196544; Knoop H, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003081; Kondrashov FA, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-31; Kornberg H, 2000, NAT REV MOL CELL BIO, V1, P225, DOI 10.1038/35043073; KORNBERG HL, 1966, BIOCHEM J, V99, P1; KORNBERG HL, 1957, NATURE, V179, P988, DOI 10.1038/179988a0; Korotkova N, 2002, J BACTERIOL, V184, P1750, DOI 10.1128/JB.184.6.1750-1758.2002; Kreth J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067125; Kunze M, 2006, BBA-MOL CELL RES, V1763, P1441, DOI 10.1016/j.bbamcr.2006.09.009; Ludwig M, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00041; Madigan MT, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 4, THIRD EDITION, P951, DOI 10.1007/0-387-30744-3_31; McNeely K, 2011, APPL ENVIRON MICROB, V77, P2435, DOI 10.1128/AEM.02792-10; MILLER JS, 1972, ARCH MIKROBIOL, V86, P1, DOI 10.1007/BF00412395; Nakazawa M, 2011, J EUKARYOT MICROBIOL, V58, P128, DOI 10.1111/j.1550-7408.2011.00534.x; Oh MK, 2002, J BIOL CHEM, V277, P13175, DOI 10.1074/jbc.M110809200; PEARCE J, 1967, J GEN MICROBIOL, V49, P301, DOI 10.1099/00221287-49-2-301; Perez-Garcia O, 2011, WATER RES, V45, P11, DOI 10.1016/j.watres.2010.08.037; PICKETT MW, 1994, PHOTOSYNTH RES, V41, P75, DOI 10.1007/BF02184147; Pinchuk GE, 2011, APPL ENVIRON MICROB, V77, P8234, DOI 10.1128/AEM.05382-11; Plancke C, 2014, PLANT J, V77, P404, DOI 10.1111/tpj.12392; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Shastri AA, 2005, BIOTECHNOL PROGR, V21, P1617, DOI 10.1021/bp050246d; Sirevag R., 1995, ANOXYGENIC PHOTOSYNT, P871; Tang KH, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00165; Tang KH, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-150; Tsang TK, 2013, PHOTOSYNTH RES, V118, P37, DOI 10.1007/s11120-013-9923-1; Wood BJB, 1999, J BIOTECHNOL, V70, P175, DOI 10.1016/S0168-1656(99)00070-X; WRIGHT RT, 1966, ECOLOGY, V47, P447, DOI 10.2307/1932984; Xu Y, 2011, METHODS MOL BIOL, V684, P273, DOI [10.1007/978.1.60761.925.3_21, 10.1007/978-1-60761-925-3_21]; You L, 2014, BIOTECHNOL J, V9, P684, DOI 10.1002/biot.201300477; Zarzycki J, 2011, APPL ENVIRON MICROB, V77, P6181, DOI 10.1128/AEM.00705-11; Zhang S., 2014, PERSPECT PHYCOL, V1, P73, DOI [10.1127/pip/2014/0016, DOI 10.1127/PIP/2014/0016]; Zhang SY, 2011, SCIENCE, V334, P1551, DOI 10.1126/science.1210858	58	48	49	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					14019	14030		10.1074/jbc.M115.648170	http://dx.doi.org/10.1074/jbc.M115.648170			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25869135	Green Published, hybrid			2022-12-28	WOS:000355313000032
J	Ogbe, A; Miao, TZ; Symonds, ALJ; Omodho, B; Singh, R; Bhullar, P; Li, SL; Wang, P				Ogbe, Ane; Miao, Tizong; Symonds, Alistair L. J.; Omodho, Becky; Singh, Randeep; Bhullar, Punamdip; Li, Suling; Wang, Ping			Early Growth Response Genes 2 and 3 Regulate the Expression of Bcl6 and Differentiation of T Follicular Helper Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GERMINAL-CENTER FORMATION; TRANSCRIPTION FACTOR; B-CELLS; LYMPHOCYTE DIFFERENTIATION; INFLAMMATION; INDUCTION; BLIMP-1; EGR-2; STAT1; FH	T follicular helper (Tfh) cells support differentiation of B cells to plasma cells and high affinity antibody production in germinal centers (GCs), and Tfh differentiation requires the function of B cell lymphoma 6 (BCL6). Wehave now discovered that early growth response gene 2 (EGR2) and EGR3 directly regulate the expression of Bcl6 in Tfh cells, which is required for their function in regulation of GC formation. In the absence of EGR2 and -3, the expression of BCL6 in Tfh cells is defective, leading to impaired differentiation of Tfh cells, resulting in a failure to form GCs following virus infection and defects in production of antiviral antibodies. Enforced expression of BCL6 in EGR2/3-deficient CD4 T cells partially restored Tfh differentiation and GC formation in response to virus infection. Our findings demonstrate a novel function of EGR2/3 that is important for Tfh cell development and Tfh cell-mediated B cell immune responses.	[Ogbe, Ane; Omodho, Becky; Singh, Randeep; Bhullar, Punamdip; Li, Suling] Brunel Univ, Dept Life Sci, Div Biosci, Uxbridge UB8 3PH, Middx, England; [Ogbe, Ane; Miao, Tizong; Symonds, Alistair L. J.; Wang, Ping] Queen Mary Univ London, Blizard Inst Cell & Mol Sci, Barts & London Sch Med & Dent, London E1 2AD, England	Brunel University; University of London; Queen Mary University London	Li, SL (corresponding author), Brunel Univ, Dept Life Sci, Div Biosci, Kingston Lane, Uxbridge UB8 3PH, Middx, England.	su-ling.li@brunel.ac.uk; p.wang@qmul.ac.uk		Ogbe, Ane/0000-0001-7774-7215; Wang, Ping/0000-0001-8992-1233; Symonds, Alistair/0000-0002-9461-0816	Arthritis Research UK; Versus Arthritis [20455] Funding Source: researchfish; MRC [MC_PC_13074] Funding Source: UKRI	Arthritis Research UK(Versus Arthritis); Versus Arthritis(Versus Arthritis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Arthritis Research UK. The authors declare that they have no conflicts of interest with the contents of this article.	Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; [Anonymous], 2014, R LANG ENV STAT COMP; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Bollig N, 2012, P NATL ACAD SCI USA, V109, P8664, DOI 10.1073/pnas.1205834109; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Choi YS, 2013, J IMMUNOL, V190, P3049, DOI 10.4049/jimmunol.1203032; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Hao ZY, 2001, J EXP MED, V194, P1151, DOI 10.1084/jem.194.8.1151; Harris JE, 2004, J IMMUNOL, V173, P7331, DOI 10.4049/jimmunol.173.12.7331; Hothorn T, 2008, J STAT SOFTW, V28, P1; Huang CX, 2013, NAT IMMUNOL, V14, P380, DOI 10.1038/ni.2543; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Li SL, 2012, IMMUNITY, V37, P685, DOI 10.1016/j.immuni.2012.08.001; Liu XD, 2014, NATURE, V507, P513, DOI 10.1038/nature12910; Liu XD, 2013, IMMUNOL REV, V252, P139, DOI 10.1111/imr.12040; Ma CS, 2012, BLOOD, V119, P3997, DOI 10.1182/blood-2011-11-392985; Nakayamada S, 2014, J IMMUNOL, V192, P2156, DOI 10.4049/jimmunol.1300675; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Ovcharenko I, 2005, GENOME RES, V15, P184, DOI 10.1101/gr.3007205; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Safford M, 2005, NAT IMMUNOL, V6, P472, DOI 10.1038/ni1193; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Sofra V, 2009, EUR J IMMUNOL, V39, P85, DOI 10.1002/eji.200838443; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Warnes GR, 2014, GPLOTS VARIOUS R PRO; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Zhu B, 2008, J EXP MED, V205, P2295, DOI 10.1084/jem.20080187	36	23	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20455	20465		10.1074/jbc.M114.634816	http://dx.doi.org/10.1074/jbc.M114.634816			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	25979336	Green Published, hybrid			2022-12-28	WOS:000359608900043
J	Tourmente, M; Villar-Moya, P; Rial, E; Roldan, ERS				Tourmente, Maximiliano; Villar-Moya, Pilar; Rial, Eduardo; Roldan, Eduardo R. S.			Differences in ATP Generation Via Glycolysis and Oxidative Phosphorylation and Relationships with Sperm Motility in Mouse Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE-S; LDHC-NULL SPERM; LACTATE-DEHYDROGENASE; FIBROUS SHEATH; TYROSINE PHOSPHORYLATION; SPERMATOGENIC CELLS; MITOCHONDRIAL-DNA; SWIMMING VELOCITY; MALE-FERTILITY; TESTIS	Mouse sperm produce enough ATP to sustain motility by anaerobic glycolysis and respiration. However, previous studies indicated that an active glycolytic pathway is required to achieve normal sperm function and identified glycolysis as the main source of ATP to fuel the motility of mouse sperm. All the available evidence has been gathered from the studies performed using the laboratory mouse. However, comparative studies of closely related mouse species have revealed a wide range of variation in sperm motility and ATP production and that the laboratory mouse has comparatively low values in these traits. In this study, we compared the relative reliance on the usage of glycolysis or oxidative phosphorylation as ATP sources for sperm motility between mouse species that exhibit significantly different sperm performance parameters. We found that the sperm of species with higher oxygen consumption/lactate excretion rate ratios were able to produce higher amounts of ATP, achieving higher swimming velocities. Additionally, we show that the species with higher respiration/glycolysis ratios have a higher degree of dependence upon active oxidative phosphorylation. Moreover, we characterize for the first time two mouse species in which sperm depend on functional oxidative phosphorylation to achieve normal performance. Finally, we discuss that sexual selection could promote adaptations in sperm energetic metabolism tending to increase the usage of a more efficient pathway for the generation of ATP (and faster sperm).	[Tourmente, Maximiliano; Villar-Moya, Pilar; Roldan, Eduardo R. S.] CSIC, Museo Nacl Ciencias Nat, Reprod Ecol & Biol Grp, E-28006 Madrid, Spain; [Rial, Eduardo] CSIC, Ctr Invest Biol, Mitochondrial Bioenerget Res Grp, E-28040 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Roldan, ERS (corresponding author), CSIC, Museo Nacl Ciencias Nat, Reprod Ecol & Biol Grp, C Jose Gutierrez Abascal 2, E-28006 Madrid, Spain.	roldane@mncn.csic.es	Rial, Eduardo/A-4242-2008; Roldan, Eduardo R.S./M-7947-2014; Tourmente, Maximiliano/I-2852-2019	Rial, Eduardo/0000-0001-8634-8902; Roldan, Eduardo R.S./0000-0002-7545-4248; Tourmente, Maximiliano/0000-0002-5833-9117	Spanish Ministry of Economy and Competitiveness; Junta para la Ampliacion de Estudios-Technicians Program (JAE-Tec) training scholarship	Spanish Ministry of Economy and Competitiveness(Spanish Government); Junta para la Ampliacion de Estudios-Technicians Program (JAE-Tec) training scholarship	This work was supported by the Spanish Ministry of Economy and Competitiveness. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a "Juan de la Cierva" postdoctoral fellowship from the Ministry of Economy and Competitiveness.; Recipient of a Junta para la Ampliacion de Estudios-Technicians Program (JAE-Tec) training scholarship.	Amaral A, 2013, REPRODUCTION, V146, pR163, DOI 10.1530/REP-13-0178; Anderson MJ, 2007, AM J PHYS ANTHROPOL, V134, P274, DOI 10.1002/ajpa.20674; BOER PH, 1987, MOL CELL BIOL, V7, P3107, DOI 10.1128/MCB.7.9.3107; BOHNENSACK R, 1986, BIOCHIM BIOPHYS ACTA, V850, P72, DOI 10.1016/0005-2728(86)90010-1; Boussouar F, 2003, BIOL REPROD, V69, P1069, DOI 10.1095/biolreprod.102.010074; Bunch DO, 1998, BIOL REPROD, V58, P834, DOI 10.1095/biolreprod58.3.834; BURGOS C, 1995, BIOL REPROD, V53, P84, DOI 10.1095/biolreprod53.1.84; Cazaux B, 2013, CHROMOSOMA, V122, P209, DOI 10.1007/s00412-013-0402-4; Cummins J, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P185, DOI 10.1016/B978-0-12-372568-4.00005-7; Danshina PV, 2010, BIOL REPROD, V82, P136, DOI 10.1095/biolreprod.109.079699; DEBURGOS NMG, 1994, ARCH BIOCHEM BIOPHYS, V308, P520, DOI 10.1006/abbi.1994.1073; Di Rienzo JA, 2002, J AGRIC BIOL ENVIR S, V7, P129, DOI 10.1198/10857110260141193; Eddy EM, 2003, MICROSC RES TECHNIQ, V61, P103, DOI 10.1002/jemt.10320; Ferramosca A, 2008, INT J ANDROL, V31, P337, DOI 10.1111/j.1365-2605.2007.00775.x; Ford WCL, 2006, HUM REPROD UPDATE, V12, P269, DOI 10.1093/humupd/dmi053; GALLINA FG, 1994, ARCH BIOCHEM BIOPHYS, V308, P515, DOI 10.1006/abbi.1994.1072; GARCIA CK, 1995, J BIOL CHEM, V270, P1843, DOI 10.1074/jbc.270.4.1843; GARDNER DK, 1990, J REPROD FERTIL, V88, P361, DOI 10.1530/jrf.0.0880361; Gawlik V, 2008, MOL MEMBR BIOL, V25, P224, DOI 10.1080/09687680701855405; Montoto LG, 2011, REPRODUCTION, V142, P819, DOI 10.1530/REP-11-0232; Montoto LG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018173; Goodson SG, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102673; GOPALKRISHNAN K, 1995, INT J ANDROL, V18, P67, DOI 10.1111/j.1365-2605.1995.tb00642.x; HAMMERSTEDT RH, 1983, J BIOL CHEM, V258, P8759; Harris SE, 2005, THERIOGENOLOGY, V64, P992, DOI 10.1016/j.theriogenology.2005.01.004; HENNIG B, 1975, EUR J BIOCHEM, V55, P167, DOI 10.1111/j.1432-1033.1975.tb02149.x; Johnson AR, 2010, FASEB J, V24, P2752, DOI 10.1096/fj.09-153718; Krisfalusi M, 2006, BIOL REPROD, V75, P270, DOI 10.1095/biolreprod.105.049684; LI SSL, 1989, BIOL REPROD, V40, P173, DOI 10.1095/biolreprod40.1.173; Luke L, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.115956; Mannowetz N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041030; Miki K, 2004, P NATL ACAD SCI USA, V101, P16501, DOI 10.1073/pnas.0407708101; Miki Kiyoshi, 2007, Soc Reprod Fertil Suppl, V65, P309; Mitra K, 2005, J BIOL CHEM, V280, P25743, DOI 10.1074/jbc.M500310200; MONTAMAT EE, 1988, BIOCHEM J, V255, P1053, DOI 10.1042/bj2551053; Mori C, 1998, MOL REPROD DEV, V49, P374, DOI 10.1002/(SICI)1098-2795(199804)49:4&lt;374::AID-MRD4&gt;3.0.CO;2-K; Mukai C, 2004, BIOL REPROD, V71, P540, DOI 10.1095/biolreprod.103.026054; Mukai C, 2012, REPROD DOMEST ANIM, V47, P164, DOI 10.1111/j.1439-0531.2012.02071.x; Nakamura N, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.107128; Nakamura N, 2010, BIOL REPROD, V82, P504, DOI 10.1095/biolreprod.109.080580; Narisawa S, 2002, MOL CELL BIOL, V22, P5554, DOI 10.1128/MCB.22.15.5554-5562.2002; NEVO AC, 1970, J THEOR BIOL, V26, P11, DOI 10.1016/S0022-5193(70)80027-3; Odet F, 2008, BIOL REPROD, V79, P26, DOI 10.1095/biolreprod.108.068353; Odet F, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.108530; Odet F, 2011, BIOL REPROD, V85, P556, DOI 10.1095/biolreprod.111.091546; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Pasupuleti V, 2007, THESIS KENT STATE U; Ruiz-Pesini E, 2007, CURR TOP DEV BIOL, V77, P3, DOI 10.1016/S0070-2153(06)77001-6; SHI QX, 1995, BIOL REPROD, V52, P540, DOI 10.1095/biolreprod52.3.540; Soulsbury CD, 2010, PLOS ONE, V5, pA152, DOI 10.1371/journal.pone.0009581; Storey BT, 2008, INT J DEV BIOL, V52, P427, DOI 10.1387/ijdb.072522bs; Suzuki H, 2013, HEREDITY, V111, P375, DOI 10.1038/hdy.2013.60; Takao D, 2008, J EXP BIOL, V211, P3594, DOI 10.1242/jeb.021923; Takei GL, 2014, J EXP BIOL, V217, P1876, DOI 10.1242/jeb.090985; Tanaka H, 2004, INT J ANDROL, V27, P172, DOI 10.1111/j.1365-2605.2004.00471.x; Tanaka H, 2003, INT J ANDROL, V26, P52, DOI 10.1046/j.1365-2605.2003.00389.x; Tang HH, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.107011; Terrell KA, 2011, BIOL REPROD, V85, P473, DOI 10.1095/biolreprod.111.092106; Tourmente M, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.114.127621; Tourmente M, 2013, EVOLUTION, V67, P1838, DOI 10.1111/evo.12079; Travis AJ, 2001, J BIOL CHEM, V276, P7630, DOI 10.1074/jbc.M006217200; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Turner RM, 2006, REPROD FERT DEVELOP, V18, P25, DOI 10.1071/RD05120; Urner F, 2001, BIOL REPROD, V64, P1350, DOI 10.1095/biolreprod64.5.1350; VANDOP C, 1977, J BIOL CHEM, V252, P1303; Vemuganti SA, 2007, DEV BIOL, V309, P18, DOI 10.1016/j.ydbio.2007.06.010; Vicens A, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-106; WELCH JE, 1992, BIOL REPROD, V46, P869, DOI 10.1095/biolreprod46.5.869	68	87	87	5	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20613	20626		10.1074/jbc.M115.664813	http://dx.doi.org/10.1074/jbc.M115.664813			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26048989	hybrid, Green Published			2022-12-28	WOS:000359608900056
J	Smith, KD; Gordon, PB; Rivetta, A; Allen, KE; Berbasova, T; Slayman, C; Strobel, SA				Smith, Kathryn D.; Gordon, Patricia B.; Rivetta, Alberto; Allen, Kenneth E.; Berbasova, Tetyana; Slayman, Clifford; Strobel, Scott A.			Yeast Fex1p Is a Constitutively Expressed Fluoride Channel with Functional Asymmetry of Its Two Homologous Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSPORTING P-1B-TYPE ATPASE; SACCHAROMYCES-CEREVISIAE; RESISTANCE PROTEINS; MEMBRANE-PROTEINS; TOPOLOGY; SELECTIVITY; MODEL; NEUROSPORA; ANTIPORTER; MECHANISM	Fluoride is a ubiquitous environmental toxin with which all biological species must cope. A recently discovered family of fluoride export (FEX) proteins protects organisms from fluoride toxicity by removing it from the cell. We show here that FEX proteins in Saccharomyces cerevisiae function as ion channels that are selective for fluoride over chloride and that these proteins are constitutively expressed at the yeast plasma membrane. Continuous expression is in contrast to many other toxin exporters in yeast, and this, along with the fact that two nearly duplicate proteins are encoded in the yeast genome, suggests that the threat posed by fluoride ions is frequent and detrimental. Structurally, eukaryotic FEX proteins consist of two homologous four-transmembrane helix domains folded into an antiparallel dimer, where the orientation of the two domains is fixed by a single transmembrane linker helix. Using phylogenetic sequence conservation as a guide, we have identified several functionally important residues. There is substantial functional asymmetry in the effect of mutation at corresponding sites in the two domains. Specifically, mutations to residues in the C-terminal domain proved significantly more detrimental to function than did similar mutations in the N-terminal domain. Our data suggest particular residues that may be important to anion specificity, most notably the necessity of a positive charge near the end of TMH1 in the C-terminal domain. It is possible that a cationic charge at this location may create an electrostatic well for fluoride ions entering the channel from the cytoplasm.	[Smith, Kathryn D.; Gordon, Patricia B.; Berbasova, Tetyana; Strobel, Scott A.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Rivetta, Alberto; Slayman, Clifford] Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Allen, Kenneth E.] Yale Univ, Dept Genet, New Haven, CT 06520 USA; [Strobel, Scott A.] Yale Univ, Dept Chem, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University	Strobel, SA (corresponding author), Yale Univ, Dept Chem, Dept Mol Biophys & Biochem, POB 208114, New Haven, CT 06520 USA.	scott.strobel@yale.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [GM60696, GM022778]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060696, R01GM054839, P01GM022778] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM60696 (to C. S.) and GM022778 (to S. A. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Adamek Ewa, 2005, Roczniki Pomorskiej Akademii Medycznej w Szczecinie, V51, P69; Adle DJ, 2008, J BIOL CHEM, V283, P31460, DOI 10.1074/jbc.M806054200; Adle DJ, 2007, J BIOL CHEM, V282, P947, DOI 10.1074/jbc.M609535200; Adle DJ, 2009, P NATL ACAD SCI USA, V106, P10189, DOI 10.1073/pnas.0812114106; Agalakova NI, 2012, ISRN CELL BIOL, V2012, P1, DOI DOI 10.5402/2012/403835; ANTEBI A, 1992, MOL BIOL CELL, V3, P633, DOI 10.1091/mbc.3.6.633; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Baker JL, 2012, SCIENCE, V335, P233, DOI 10.1126/science.1215063; Barbier O, 2010, CHEM-BIOL INTERACT, V188, P319, DOI 10.1016/j.cbi.2010.07.011; Barrick JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r239; Bertl A, 1998, PFLUG ARCH EUR J PHY, V436, P999, DOI 10.1007/s004240050735; Bihler H, 1999, FEBS LETT, V447, P115, DOI 10.1016/S0014-5793(99)00281-1; BLATT MR, 1987, J MEMBRANE BIOL, V98, P169, DOI 10.1007/BF01872129; Brachmann CB, 1998, YEAST, V14, P115; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; dos Santos SC, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00180; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; IPCS UNEP ILO WHO, 1984, FLUOR FLUOR; Jagtap S, 2012, CHEM REV, V112, P2454, DOI 10.1021/cr2002855; Javadpour MM, 1999, BIOPHYS J, V77, P1609, DOI 10.1016/S0006-3495(99)77009-8; Ji CH, 2014, J GEN PHYSIOL, V144, P257, DOI 10.1085/jgp.201411243; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kaiser C., 1994, METHODS YEAST GENETI; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KROPF DL, 1986, J CELL BIOL, V102, P1209, DOI 10.1083/jcb.102.4.1209; Kuroda T, 2004, J MEMBRANE BIOL, V198, P177, DOI 10.1007/s00232-004-0671-1; Law CJ, 2009, BIOPHYS J, V97, P1346, DOI 10.1016/j.bpj.2009.06.026; LEBIODA L, 1993, PROTEINS, V16, P219, DOI 10.1002/prot.340160302; Lee H, 2012, BIOCHEM BIOPH RES CO, V427, P780, DOI 10.1016/j.bbrc.2012.09.138; LESHER RJ, 1977, ANTIMICROB AGENTS CH, V12, P339, DOI 10.1128/AAC.12.3.339; Li L, 2003, CRIT REV ORAL BIOL M, V14, P100, DOI 10.1177/154411130301400204; Li SS, 2013, P NATL ACAD SCI USA, V110, P19018, DOI 10.1073/pnas.1310439110; Lloris-Garcera P, 2014, J MOL BIOL, V426, P2246, DOI 10.1016/j.jmb.2014.03.012; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Madrid R, 1998, J BIOL CHEM, V273, P14838, DOI 10.1074/jbc.273.24.14838; Miranda M, 2001, J BIOL CHEM, V276, P22485, DOI 10.1074/jbc.M102332200; Modi N, 2013, BIOCHEMISTRY-US, V52, P5522, DOI 10.1021/bi400522b; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Muth TR, 2000, EMBO J, V19, P234, DOI 10.1093/emboj/19.2.234; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Rapp M, 2006, NAT STRUCT MOL BIOL, V13, P112, DOI 10.1038/nsmb1057; Rivetta A, 2013, EUKARYOT CELL, V12, P684, DOI 10.1128/EC.00017-13; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; SMITH FA, 1978, CRIT REV ENV CONTR, V8, P293; Stefan CP, 2013, EUKARYOT CELL, V12, P204, DOI 10.1128/EC.00299-12; Stockbridge RB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6120; Stockbridge RB, 2013, ELIFE, V2, DOI 10.7554/eLife.01084; Stockbridge RB, 2012, P NATL ACAD SCI USA, V109, P15289, DOI 10.1073/pnas.1210896109; Ubarretxena-Belandia I, 2001, CURR OPIN STRUC BIOL, V11, P370, DOI 10.1016/S0959-440X(00)00217-7; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Weinstein LH, 2004, FLUORIDES ENV EFFECT; WHO, 2006, FLUOR DRINK WAT; World Health Organization, 1970, WHO SWITZ MON SER, V59; Wright MB, 1996, J BACTERIOL, V178, P7197, DOI 10.1128/jb.178.24.7197-7205.1996; Wysocki R, 2010, FEMS MICROBIOL REV, V34, P925, DOI 10.1111/j.1574-6976.2010.00217.x; Yang TT, 2014, SCIENCE, V346, P355, DOI 10.1126/science.1259723; Yerushalmi H, 2000, J BIOL CHEM, V275, P5264, DOI 10.1074/jbc.275.8.5264	60	23	26	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19874	19887		10.1074/jbc.M115.651976	http://dx.doi.org/10.1074/jbc.M115.651976			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26055717	Green Published, hybrid			2022-12-28	WOS:000359364600043
J	Crowder, JJ; Geigges, M; Gibson, RT; Fults, ES; Buchanan, BW; Sachs, N; Schink, A; Kreft, SG; Rubenstein, EM				Crowder, Justin J.; Geigges, Marco; Gibson, Ryan T.; Fults, Eric S.; Buchanan, Bryce W.; Sachs, Nadine; Schink, Andrea; Kreft, Stefan G.; Rubenstein, Eric M.			Rkr1/Ltn1 Ubiquitin Ligase-mediated Degradation of Translationally Stalled Endoplasmic Reticulum Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUALITY-CONTROL PATHWAY; MESSENGER-RNAS LACKING; STRUCTURAL BASIS; SACCHAROMYCES-CEREVISIAE; TRIGGERS DEGRADATION; SHUTTLE VECTORS; HYGROMYCIN-B; STOP CODON; YEAST; RIBOSOME	Aberrant nonstop proteins arise from translation of mRNA molecules beyond the coding sequence into the 3'-untranslated region. If a stop codon is not encountered, translation continues into the poly(A) tail, resulting in C-terminal appendage of a polylysine tract and a terminally stalled ribosome. In Saccharomyces cerevisiae, the ubiquitin ligase Rkr1/Ltn1 has been implicated in the proteasomal degradation of soluble cytosolic nonstop and translationally stalled proteins. Rkr1 is essential for cellular fitness under conditions associated with increased prevalence of nonstop proteins. Mutation of the mammalian homolog causes significant neurological pathology, suggesting broad physiological significance of ribosome-associated quality control. It is not known whether and how soluble or transmembrane nonstop and translationally stalled proteins targeted to the endoplasmic reticulum (ER) are detected and degraded. We generated and characterized model soluble and transmembrane ER-targeted nonstop and translationally stalled proteins. We found that these proteins are indeed subject to proteasomal degradation. We tested three candidate ubiquitin ligases (Rkr1 and ER-associated Doa10 and Hrd1) for roles in regulating abundance of these proteins. Our results indicate that Rkr1 plays the primary role in targeting the tested model ER-targeted nonstop and translationally stalled proteins for degradation. These data expand the catalog of Rkr1 substrates and highlight a previously unappreciated role for this ubiquitin ligase at the ER membrane.	[Crowder, Justin J.; Gibson, Ryan T.; Fults, Eric S.; Buchanan, Bryce W.; Rubenstein, Eric M.] Ball State Univ, Dept Biol, Muncie, IN 47306 USA; [Geigges, Marco; Sachs, Nadine; Schink, Andrea; Kreft, Stefan G.] Univ Konstanz, Dept Biol, D-78457 Constance, Germany	Ball State University; University of Konstanz	Kreft, SG (corresponding author), Univ Konstanz, Dept Biol, D-78457 Constance, Germany.	stefan.kreft@uni-konstanz.de; emrubenstein@bsu.edu	Regan, Clinton/E-6250-2012	Rubenstein, Eric/0000-0003-4983-1430; Geigges, Marco/0000-0001-9071-5162	National Institutes of Health [R15 GM111713]; Ball State University ASPiRE research awards; Indiana Academy of Science; Ball State University Provost's Office; Ball State University Department of Biology; Deutsche Forschungsgemeinschaft [SFB969]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM111713] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ball State University ASPiRE research awards; Indiana Academy of Science; Ball State University Provost's Office; Ball State University Department of Biology; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R15 GM111713 (to E. M. R.). This work was also supported by Ball State University ASPiRE research awards (to J. J. C., E. S. F., and E. M. R.), an Indiana Academy of Science senior research award (to E. M. R.), funds from the Ball State University Provost's Office and Department of Biology (to E. M. R.), and Deutsche Forschungsgemeinschaft Grant SFB969 (to S. G. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Bengtson MH, 2010, NATURE, V467, P470, DOI 10.1038/nature09371; Brachmann CB, 1998, YEAST, V14, P115; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; Braun MA, 2007, MOL CELL BIOL, V27, P2800, DOI 10.1128/MCB.01947-06; Brodersen DE, 2000, CELL, V103, P1143, DOI 10.1016/S0092-8674(00)00216-6; BRODSKY JL, 1995, P NATL ACAD SCI USA, V92, P9643, DOI 10.1073/pnas.92.21.9643; Cacciottolo M, 2011, EUR J HUM GENET, V19, P974, DOI 10.1038/ejhg.2011.70; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Chu J, 2009, P NATL ACAD SCI USA, V106, P2097, DOI 10.1073/pnas.0812819106; Deak PM, 2001, J BIOL CHEM, V276, P10663, DOI 10.1074/jbc.M008608200; Defenouillere Q, 2013, P NATL ACAD SCI USA, V110, P5046, DOI 10.1073/pnas.1221724110; Dimitrova LN, 2009, J BIOL CHEM, V284, P10343, DOI 10.1074/jbc.M808840200; Duttler S, 2013, MOL CELL, V50, P379, DOI 10.1016/j.molcel.2013.03.010; Ganoza MC, 2001, ANTIMICROB AGENTS CH, V45, P2813, DOI 10.1128/AAC.45.10.2813-2819.2001; Gauss R, 2006, EMBO J, V25, P1827, DOI 10.1038/sj.emboj.7601088; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Graille M, 2008, J BIOL CHEM, V283, P7145, DOI 10.1074/jbc.M708224200; GROLLMAN AP, 1966, P NATL ACAD SCI USA, V56, P1867, DOI 10.1073/pnas.56.6.1867; GROLLMAN AP, 1967, J BIOL CHEM, V242, P3226; Guthrie C., 2004, GUIDE YEAST GENETICS, P1; Habeck G, 2015, J CELL BIOL, V209, P261, DOI 10.1083/jcb.201408088; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; HJELM H, 1972, FEBS LETT, V28, P73, DOI 10.1016/0014-5793(72)80680-X; Hrizo SL, 2007, J BIOL CHEM, V282, P32665, DOI 10.1074/jbc.M705216200; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Inada T, 2005, EMBO J, V24, P1584, DOI 10.1038/sj.emboj.7600636; Ito-Harashima S, 2007, GENE DEV, V21, P519, DOI 10.1101/gad.1490207; Izawa T, 2012, CELL REPORTS, V2, P447, DOI 10.1016/j.celrep.2012.08.010; Jackson DD, 1997, J BIOL CHEM, V272, P25928, DOI 10.1074/jbc.272.41.25928; Klucevsek KM, 2012, GENETICS, V191, P1107, DOI 10.1534/genetics.112.141713; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Lee HH, 2007, MOL CELL, V27, P938, DOI 10.1016/j.molcel.2007.07.019; Loayza D, 1998, MOL BIOL CELL, V9, P2767, DOI 10.1091/mbc.9.10.2767; Lu JL, 2008, J MOL BIOL, V384, P73, DOI 10.1016/j.jmb.2008.08.089; Lykke-Andersen J, 2014, J CELL BIOL, V204, P467, DOI 10.1083/jcb.201311103; Lyumkis D, 2014, P NATL ACAD SCI USA, V111, P15981, DOI 10.1073/pnas.1413882111; Matsuda R, 2014, GENES CELLS, V19, P1, DOI 10.1111/gtc.12106; Metzger MB, 2008, J BIOL CHEM, V283, P32302, DOI 10.1074/jbc.M806424200; Mitra K, 2005, NATURE, V438, P318, DOI 10.1038/nature04133; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; OOI CE, 1992, CELL, V71, P87, DOI 10.1016/0092-8674(92)90268-H; Pang SY, 2002, J CLIN ENDOCR METAB, V87, P2556, DOI 10.1210/jc.87.6.2556; Plemper RK, 1999, J CELL SCI, V112, P4123; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; REDDY VA, 1988, J BIOL CHEM, V263, P6978; Rubenstein EM, 2012, J CELL BIOL, V197, P761, DOI 10.1083/jcb.201203061; Sato BK, 2009, MOL CELL, V34, P212, DOI 10.1016/j.molcel.2009.03.010; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Shao SC, 2015, MOL CELL, V57, P433, DOI 10.1016/j.molcel.2014.12.015; Shao SC, 2014, MOL CELL, V55, P880, DOI 10.1016/j.molcel.2014.07.006; Shao S, 2013, MOL CELL, V50, P637, DOI 10.1016/j.molcel.2013.04.015; Shen PS, 2015, SCIENCE, V347, P75, DOI 10.1126/science.1259724; Shoemaker CJ, 2010, SCIENCE, V330, P369, DOI 10.1126/science.1192430; SIKORSKI RS, 1989, GENETICS, V122, P19; STEVENS T, 1982, CELL, V30, P439, DOI 10.1016/0092-8674(82)90241-0; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Taniguchi A, 1998, HUM GENET, V102, P197, DOI 10.1007/s004390050677; Theodoraki MA, 2012, J BIOL CHEM, V287, P23911, DOI 10.1074/jbc.M112.341164; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tsuboi T, 2012, MOL CELL, V46, P518, DOI 10.1016/j.molcel.2012.03.013; Turner GC, 2000, SCIENCE, V289, P2117, DOI 10.1126/science.289.5487.2117; Tyson JR, 2000, EMBO J, V19, P6440, DOI 10.1093/emboj/19.23.6440; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; Verma R, 2013, ELIFE, V2, DOI 10.7554/eLife.00308; von der Malsburg K, 2015, MOL BIOL CELL, V26, P2168, DOI 10.1091/mbc.E15-01-0040; Watts SG, 2015, JOVE-J VIS EXP, DOI 10.3791/52428; Wilhovsky S, 2000, MOL BIOL CELL, V11, P1697, DOI 10.1091/mbc.11.5.1697; Willer M, 2008, J BIOL CHEM, V283, P33883, DOI 10.1074/jbc.M803054200; Wilson MA, 2007, GENETICS, V177, P773, DOI 10.1534/genetics.107.073205; Zattas D, 2015, CRIT REV BIOCHEM MOL, V50, P1, DOI 10.3109/10409238.2014.959889	73	29	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18454	18466		10.1074/jbc.M115.663559	http://dx.doi.org/10.1074/jbc.M115.663559			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26055716	Green Published, hybrid			2022-12-28	WOS:000358512100017
J	Mahajan, S; Saini, A; Chandra, V; Nanduri, R; Kalra, R; Bhagyaraj, E; Khatri, N; Gupta, P				Mahajan, Sahil; Saini, Ankita; Chandra, Vemika; Nanduri, Ravikanth; Kalra, Rashi; Bhagyaraj, Ella; Khatri, Neeraj; Gupta, Pawan			Nuclear Receptor Nr4a2 Promotes Alternative Polarization of Macrophages and Confers Protection in Sepsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVITY; NGFI-B; PHOSPHATIDYLINOSITOL 3-KINASE; INNATE IMMUNITY; PROTEIN-KINASE; ARGINASE 1; T-CELLS; ACTIVATION; NURR1; EXPRESSION	The orphan nuclear receptor Nr4a2 is known to modulate both inflammatory and metabolic processes, but the mechanism by which it regulates innate inflammatory homeostasis has not been adequately addressed. This study shows that exposure to ligands for Toll-like receptors (TLRs) robustly induces Nr4a2 and that this induction is tightly regulated by the PI3K-Akt signaling axis. Interestingly, exogenous expression of Nr4a2 in macrophages leads to their alternative phenotype with induction of genes that are prototypical M2 markers. Moreover, Nr4a2 transcriptionally activates arginase 1 expression by directly binding to its promoter. Adoptive transfer experiments revealed that increased survival of animals in endotoxin-induced sepsis is Nr4a2-dependent. Thus our data identify a previously unknown role for Nr4a2 in the regulation of macrophage polarization.	[Mahajan, Sahil; Saini, Ankita; Chandra, Vemika; Nanduri, Ravikanth; Kalra, Rashi; Bhagyaraj, Ella; Khatri, Neeraj; Gupta, Pawan] CSIR, Inst Microbial Technol, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Gupta, P (corresponding author), CSIR, Inst Microbial Technol, Chandigarh 160036, India.	pawan@imtech.res.in	Ella, Bhagyaraj/X-2823-2019; Chandra, Vemika/AAK-6997-2020; NANDURI, RAVIKANTH/Q-9729-2018	Chandra, Vemika/0000-0001-5360-7875; NANDURI, RAVIKANTH/0000-0002-0031-2333	Department of Biotechnology-India [BT/01/IYBA/2009]; Council of Scientific and Industrial Research 12th Plan Network project [BSC0211, BSC0210]	Department of Biotechnology-India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research 12th Plan Network project	This work was supported by the Department of Biotechnology-India project BT/01/IYBA/2009 and Council of Scientific and Industrial Research 12th Plan Network project Bugs to Drugs and Infectious Disease (Grants BSC0211 and BSC0210) (to P. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Aherne CM, 2009, MOL IMMUNOL, V46, P3345, DOI 10.1016/j.molimm.2009.07.019; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Barish GD, 2005, MOL ENDOCRINOL, V19, P2466, DOI 10.1210/me.2004-0529; Chawla A, 2010, CIRC RES, V106, P1559, DOI 10.1161/CIRCRESAHA.110.216523; Cho DI, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2013.135; Doi Y, 2008, P NATL ACAD SCI USA, V105, P8381, DOI 10.1073/pnas.0803454105; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; Fujiwara Nagatoshi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P281, DOI 10.2174/1568010054022024; Gallardo-Soler A, 2008, MOL ENDOCRINOL, V22, P1394, DOI 10.1210/me.2007-0525; Han YF, 2012, WORLD J GASTROENTERO, V18, P6865, DOI 10.3748/wjg.v18.i47.6865; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Ishii KJ, 2002, J EXP MED, V196, P269, DOI 10.1084/jem.20020773; Kondo T, 2012, TRENDS IMMUNOL, V33, P449, DOI 10.1016/j.it.2012.05.002; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Le WD, 2003, NAT GENET, V33, P85, DOI 10.1038/ng1066; Li X, 2012, BIOCHEM PHARMACOL, V83, P1445, DOI 10.1016/j.bcp.2012.02.021; Liao XD, 2011, J CLIN INVEST, V121, P2736, DOI 10.1172/JCI45444; LoPiccolo J, 2008, DRUG RESIST UPDATE, V11, P32, DOI 10.1016/j.drup.2007.11.003; Mahajan S, 2012, J INFECT DIS, V206, P366, DOI 10.1093/infdis/jis354; Mahajan S, 2012, J IMMUNOL, V188, P5593, DOI 10.4049/jimmunol.1103038; Maira M, 2003, MOL CELL BIOL, V23, P763, DOI 10.1128/MCB.23.3.763-776.2003; Maira M, 1999, MOL CELL BIOL, V19, P7549; Menzies FM, 2010, CLIN EXP IMMUNOL, V160, P369, DOI 10.1111/j.1365-2249.2009.04086.x; Mix KS, 2012, ARTHRITIS RHEUM-US, V64, P2126, DOI 10.1002/art.34399; Monick MM, 2001, J IMMUNOL, V166, P4713, DOI 10.4049/jimmunol.166.7.4713; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Munder M, 2009, BRIT J PHARMACOL, V158, P638, DOI 10.1111/j.1476-5381.2009.00291.x; Murray PJ, 2012, NAT IMMUNOL, V13, P916, DOI 10.1038/ni.2391; O'Kane M, 2008, J INVEST DERMATOL, V128, P300, DOI 10.1038/sj.jid.5701023; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Ojaniemi M, 2003, EUR J IMMUNOL, V33, P597, DOI 10.1002/eji.200323376; Ordentlich P, 2003, J BIOL CHEM, V278, P24791, DOI 10.1074/jbc.M302167200; Park SJ, 2002, CELL BIOL TOXICOL, V18, P121, DOI 10.1023/A:1015384201785; Pauleau AL, 2004, J IMMUNOL, V172, P7565, DOI 10.4049/jimmunol.172.12.7565; Pei LM, 2005, J BIOL CHEM, V280, P29256, DOI 10.1074/jbc.M502606200; PERLMANN T, 1995, GENE DEV, V9, P769, DOI 10.1101/gad.9.7.769; Pirih FQ, 2004, J BIOL CHEM, V279, P53167, DOI 10.1074/jbc.M405677200; Pourcet B, 2011, CIRC RES, V109, P492, DOI 10.1161/CIRCRESAHA.111.241810; Ruse M, 2006, IMMUNOL RES, V34, P33, DOI 10.1385/IR:34:1:33; Sacchetti P, 2006, NUCLEIC ACIDS RES, V34, P5515, DOI 10.1093/nar/gkl712; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Sarkar SN, 2004, NAT STRUCT MOL BIOL, V11, P1060, DOI 10.1038/nsmb847; Sekiya T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1272; Shi YH, 2007, DRUG DISCOV TODAY, V12, P440, DOI 10.1016/j.drudis.2007.04.006; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Tugal D, 2013, ARTERIOSCL THROM VAS, V33, P1135, DOI 10.1161/ATVBAHA.113.301453; Wang ZL, 2003, NATURE, V423, P555, DOI 10.1038/nature01645; Wijnands KAP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086135; Zetterstrom RH, 1996, MOL ENDOCRINOL, V10, P1656, DOI 10.1210/me.10.12.1656	53	46	47	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18304	18314		10.1074/jbc.M115.638064	http://dx.doi.org/10.1074/jbc.M115.638064			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	25953901	Green Published, hybrid			2022-12-28	WOS:000358512100005
J	Stival, C; La Spina, FA; Bar Graf, C; Arcelay, E; Arranz, SE; Ferreira, JJ; Le Grand, S; Dzikunu, VA; Santi, CM; Visconti, PE; Buffone, MG; Krapf, D				Stival, Cintia; La Spina, Florenza A.; Bar Graf, Carolina; Arcelay, Enid; Arranz, Silvia E.; Ferreira, Juan J.; Le Grand, Sibylle; Dzikunu, Victor A.; Santi, Celia M.; Visconti, Pablo E.; Buffone, Mariano G.; Krapf, Dario			Src Kinase Is the Connecting Player between Protein Kinase A (PKA) Activation and Hyperpolarization through SLO3 Potassium Channel Regulation in Mouse Sperm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPACITATING AGENT BICARBONATE; TYROSINE KINASE; ACROSOME REACTION; PLASMA-MEMBRANE; ION CHANNELS; BOAR SPERM; K+ CHANNEL; PHOSPHORYLATION; SPERMATOZOA; DEPHOSPHORYLATION	Plasma membrane hyperpolarization is crucial for mammalian sperm to acquire acrosomal responsiveness during capacitation. Among the signaling events leading to mammalian sperm capacitation, the immediate activation of protein kinase A plays a pivotal role, promoting the subsequent stimulation of protein tyrosine phosphorylation that associates with fertilizing capacity. We have shown previously that mice deficient in the tyrosine kinase cSrc are infertile and exhibit improper cauda epididymis development. It is therefore not clear whether lack of sperm functionality is due to problems in epididymal maturation or to the absence of cSrc in sperm. To further address this problem, we investigated the kinetics of cSrc activation using anti-Tyr(P)-416-cSrc antibodies that only recognize active cSrc. Our results provide evidence that cSrc is activated downstream of PKA and that inhibition of its activity blocks the capacitation-induced hyperpolarization of the sperm plasma membrane without blocking the increase in tyrosine phosphorylation that accompanies capacitation. In addition, we show that cSrc inhibition also blocks the agonist-induced acrosome reaction and that this inhibition is overcome by pharmacological hyperpolarization. Considering that capacitation-induced hyperpolarization is mediated by SLO3, we evaluated the action of cSrc inhibitors on the heterologously expressed SLO3 channel. Our results indicate that, similar to SLO1 K+ channels, cSrc blockers significantly decreased SLO3-mediated currents. Together, these results are consistent with findings showing that hyperpolarization of the sperm plasma membrane is necessary and sufficient to prepare the sperm for the acrosome reaction and suggest that changes in sperm membrane potential are mediated by cSrc activation.	[Stival, Cintia; Bar Graf, Carolina; Arranz, Silvia E.; Krapf, Dario] CONICET UNR, Inst Biol Mol Celular Rosario, RA-2000 Rosario, Sf, Argentina; [Stival, Cintia; Bar Graf, Carolina; Arranz, Silvia E.; Krapf, Dario] UNR, Fac Ciencias Bioquim & Farmaceut, RA-2000 Rosario, Sf, Argentina; [La Spina, Florenza A.; Buffone, Mariano G.] Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt, RA-1033 Buenos Aires, DF, Argentina; [Ferreira, Juan J.; Le Grand, Sibylle; Dzikunu, Victor A.; Santi, Celia M.] Washington Univ, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Arcelay, Enid; Visconti, Pablo E.] Univ Massachusetts, Dept Vet & Anim Sci, Paige Labs, Amherst, MA 01003 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; National University of Rosario; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; Washington University (WUSTL); University of Massachusetts System; University of Massachusetts Amherst	Krapf, D (corresponding author), CONICET UNR, Inst Biol Mol Celular Rosario, RA-2000 Rosario, Sf, Argentina.	krapf@ibr-conicet.gov.ar	Regan, Clinton/E-6250-2012; Ferreira, Juan/GNW-6445-2022	Ferreira, Juan/0000-0001-8175-9067; Baro Graf, Carolina/0000-0003-4490-9083; Krapf, Dario/0000-0001-7607-1954	National Institutes of Health [RO1TW008662, RO1 HD38082, HD440044, RO1 HD069631]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2011-0540, PICT 2014-2702, PICT 2013-1175]; CONICET [PIP 112-201101-00740]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD044044, R01HD038082, R01HD069631] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R01TW008662] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1TW008662 (to M. G. B.), RO1 HD38082 and HD440044 (to P. E. V.), and RO1 HD069631 (to C. M. S.). This work was also supported by Agencia Nacional de Promocion Cientifica y Tecnologica Grants PICT 2011-0540 and PICT 2014-2702 (to D. K.) and PICT 2013-1175 (to M. G. B.) and CONICET Grant PIP 112-201101-00740 (to D. K. and M. G. B.). The authors declare that they have no conflicts of interest with the contents of this article.	AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; AUSTIN CR, 1952, NATURE, V170, P326, DOI 10.1038/170326a0; Baker MA, 2006, J CELL SCI, V119, P3182, DOI 10.1242/jcs.03055; Battistone MA, 2014, MOL HUM REPROD, V20, P1054, DOI 10.1093/molehr/gau073; Bjorge JD, 2000, ONCOGENE, V19, P5620, DOI 10.1038/sj.onc.1203923; Buffone MG, 2014, BBA-MOL BASIS DIS, V1842, P2610, DOI 10.1016/j.bbadis.2014.07.013; CHANG MC, 1951, NATURE, V168, P697, DOI 10.1038/168697b0; Chavez JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060578; Cho CH, 2005, J NEUROSCI, V25, P3712, DOI 10.1523/JNEUROSCI.5389-03.2005; Cornwall GA, 2009, HUM REPROD UPDATE, V15, P213, DOI 10.1093/humupd/dmn055; Davis MJ, 2001, AM J PHYSIOL-HEART C, V281, pH1835, DOI 10.1152/ajpheart.2001.281.5.H1835; Escoffier J, 2012, J CELL SCI, V125, P473, DOI 10.1242/jcs.093344; Gadella BM, 2000, DEVELOPMENT, V127, P2407; Gonzalez-Fernandez L, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.107078; Goupil S, 2011, J ANDROL, V32, P95, DOI 10.2164/jandrol.110.010462; Harrison RAP, 2004, MOL REPROD DEV, V67, P337, DOI 10.1002/mrd.20028; Harrison RAP, 2000, MOL REPROD DEV, V55, P220, DOI 10.1002/(SICI)1098-2795(200002)55:2&lt;220::AID-MRD12&gt;3.0.CO;2-I; Hasuwa H, 2010, EXP ANIM TOKYO, V59, P105, DOI 10.1538/expanim.59.105; Hernandez-Gonzalez EO, 2006, J BIOL CHEM, V281, P5623, DOI 10.1074/jbc.M508172200; Krapf D, 2012, DEV BIOL, V369, P43, DOI 10.1016/j.ydbio.2012.06.017; Krapf D, 2010, J BIOL CHEM, V285, P7977, DOI 10.1074/jbc.M109.085845; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Ling SZ, 2000, J BIOL CHEM, V275, P30683, DOI 10.1074/jbc.M004292200; De La Vega-Beltran JL, 2012, J BIOL CHEM, V287, P44384, DOI 10.1074/jbc.M112.393488; Luo JP, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.093864; Michels S, 2013, CANCER RES, V73, P2518, DOI 10.1158/0008-5472.CAN-12-3023; Morgan DJ, 2008, P NATL ACAD SCI USA, V105, P20740, DOI 10.1073/pnas.0810971105; Nikolic DS, 2011, BLOOD, V118, P4841, DOI 10.1182/blood-2010-09-305417; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; Santi CM, 2010, FEBS LETT, V584, P1041, DOI 10.1016/j.febslet.2010.02.005; Sato K, 1996, J BIOL CHEM, V271, P13250, DOI 10.1074/jbc.271.22.13250; STEELE RE, 1985, NUCLEIC ACIDS RES, V13, P1747, DOI 10.1093/nar/13.5.1747; Visconti PE, 2011, ASIAN J ANDROL, V13, P395, DOI 10.1038/aja.2010.69; Visconti PE, 2009, P NATL ACAD SCI USA, V106, P667, DOI 10.1073/pnas.0811895106; Visconti PE, 1997, DEV BIOL, V192, P351, DOI 10.1006/dbio.1997.8768; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; Wischmeyer E, 1998, J BIOL CHEM, V273, P34063, DOI 10.1074/jbc.273.51.34063; Yuan A, 2000, NAT NEUROSCI, V3, P771, DOI 10.1038/77670; Zeng XH, 2011, P NATL ACAD SCI USA, V108, P5879, DOI 10.1073/pnas.1100240108; Zeng Y, 1996, DEV BIOL, V173, P510, DOI 10.1006/dbio.1996.0044; ZENG Y, 1995, DEV BIOL, V171, P554, DOI 10.1006/dbio.1995.1304	41	32	33	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18855	18864		10.1074/jbc.M115.640326	http://dx.doi.org/10.1074/jbc.M115.640326			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26060254	Green Published, hybrid			2022-12-28	WOS:000358512100051
J	Westman, JS; Benktander, J; Storry, JR; Peyrard, T; Hult, AK; Hellberg, A; Teneberg, S; Olsson, ML				Westman, Julia S.; Benktander, John; Storry, Jill R.; Peyrard, Thierry; Hult, Annika K.; Hellberg, Asa; Teneberg, Susann; Olsson, Martin L.			Identification of the Molecular and Genetic Basis of PX2, a Glycosphingolipid Blood Group Antigen Lacking on Globoside-deficient Erythrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UDP-N-ACETYLGALACTOSAMINE; MASS-SPECTROMETRY; INTERNATIONAL-SOCIETY; EXPRESSION CLONING; SYNTHASE; GLYCOSYLTRANSFERASES; GLYCOLIPIDS; ANTIBODIES; GLYCOPROTEINS; PURIFICATION	The x(2) glycosphingolipid is expressed on erythrocytes from individuals of all common blood group phenotypes and elevated on cells of the rare P/P1/P-k-negative p blood group phenotype. Globoside or P antigen is synthesized by UDP-N-acetylgalactosamine: globotriaosyl-ceramide 3-beta-N-acetylgalactosaminyl-transferase encoded by B3GALNT1. It is the most abundant non-acid glycosphingolipid on erythrocytes and displays the same terminal disaccharide, GalNAc beta 3Gal, as x(2). We encountered a patient with mutations in B3GALNT1 causing the rare P-deficient P-1(k) phenotype and whose pretransfusion plasma was unexpectedly incompatible with p erythrocytes. The same phenomenon was also noted in seven other unrelated P-deficient individuals. Thin-layer chromatography, mass spectrometry, and flow cytometry were used to show that the naturally occurring antibodies made by p individuals recognize x(2) and sialylated forms of x(2), whereas x(2) is lacking on P-deficient erythrocytes. Overexpression of B3GALNT1 resulted in synthesis of both P and x(2). Knockdown experiments with siRNA against B3GALNT1 diminished x(2) levels. We conclude that x(2) fulfills blood group criteria and is synthesized by UDP-N-acetylgalactosamine: globotriaosylceramide 3-beta-N-acetylgalactosaminyltransferase. Based on this linkage, we proposed that x(2) joins P in the GLOB blood group system (ISBT 028) and is renamed PX2 (GLOB2). Thus, in the absence of a functional P synthase, neither P nor PX2 are formed. As a consequence, naturally occurring anti-P and anti-PX2 can be made. Until the clinical significance of anti-PX2 is known, we also recommend that rare P-1(k) or P-2(k) erythrocyte units are preferentially selected for transfusion to P-k patients because p erythrocytes may pose a risk for hemolytic transfusion reactions due to their elevated PX2 levels.	[Westman, Julia S.; Storry, Jill R.; Hult, Annika K.; Hellberg, Asa; Olsson, Martin L.] Lund Univ, Div Hematol & Transfus Med, Dept Lab Med, SE-22184 Lund, Sweden; [Benktander, John; Teneberg, Susann] Univ Gothenburg, Inst Biomed, Sahlgrenska Acad, SE-40530 Gothenburg, Sweden; [Storry, Jill R.; Hult, Annika K.; Hellberg, Asa; Olsson, Martin L.] Off Med Serv, Clin Immunol & Transfus Med, Lab Med, SE-22185 Lund, Sweden; [Peyrard, Thierry] INTS, Dept Ctr Natl Reference Grp Sanguins, F-75015 Paris, France; [Peyrard, Thierry] Lab Excellence GR Ex, F-75015 Paris, France	Lund University; University of Gothenburg	Teneberg, S (corresponding author), Univ Gothenburg, Inst Biomed, Dept Med Biochem & Cell Biol, POB 440, SE-40530 Gothenburg, Sweden.	Susann.Teneberg@medkem.gu.se; Martin_L.Olsson@med.lu.se	Storry, Jill R/AAF-9130-2019	Storry, Jill R/0000-0003-2940-2604; Westman, Julia S./0000-0002-5506-1543; PEYRARD, THIERRY/0000-0002-7715-568X; Olsson, Martin L/0000-0003-1647-9610	Swedish Research Council [342-2004-4434]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	We express our gratitude to Sylvie Poupel in Paris, France for technical assistance with serological investigation and to Ulla Mandel in Copenhagen, Denmark for the generous donation of the monoclonal antibody TH2. We also acknowledge Rut Norda and Jan Safwenberg in Uppsala, Sweden; Birgitta Nilsson Sojka in Umea, Sweden; Marja-Kaisa Auvinen in Kuala Lumpur, Malaysia; and many others involved in the original clinical case that spurred our first interest. The use of the LTQ linear quadrupole ion trap mass spectrometer (obtained by Swedish Research Council Grant 342-2004-4434 to Gunnar Hansson), is gratefully acknowledged.	Amado M, 1998, J BIOL CHEM, V273, P12770, DOI 10.1074/jbc.273.21.12770; ANDO S, 1973, J BIOCHEM-TOKYO, V73, P387; Breton C, 2012, CURR OPIN STRUC BIOL, V22, P540, DOI 10.1016/j.sbi.2012.06.007; Chai WG, 2001, ANAL CHEM, V73, P651, DOI 10.1021/ac0010126; CLAUSEN H, 1989, VOX SANG, V56, P1, DOI 10.1111/j.1423-0410.1989.tb03040.x; Daniels G., 2013, HUMAN BLOOD GROUPS, P162; Daniels GL, 2004, VOX SANG, V87, P304, DOI 10.1111/j.1423-0410.2004.00564.x; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; FLETCHER KS, 1979, J BIOL CHEM, V254, P1196; FOLCH J, 1957, J BIOL CHEM, V226, P497; HANSSON GC, 1983, J BIOL CHEM, V258, P4091; Hellberg A, 2002, J BIOL CHEM, V277, P29455, DOI 10.1074/jbc.M203047200; KANNAGI R, 1982, J BIOL CHEM, V257, P4438; KANNAGI R, 1982, P NATL ACAD SCI-BIOL, V79, P3470, DOI 10.1073/pnas.79.11.3470; Karlsson H, 2010, GLYCOBIOLOGY, V20, P1103, DOI 10.1093/glycob/cwq070; KARLSSON KA, 1987, METHOD ENZYMOL, V138, P212; Keusch JJ, 2000, J BIOL CHEM, V275, P25308, DOI 10.1074/jbc.M002629200; Keusch JJ, 2000, J BIOL CHEM, V275, P25315, DOI 10.1074/jbc.M002630200; KOERNER TAW, 1983, BIOCHEMISTRY-US, V22, P2676, DOI 10.1021/bi00280a014; Kojima Y, 2000, J BIOL CHEM, V275, P15152, DOI 10.1074/jbc.M909620199; KOSCIELAK J, 1978, ARCH IMMUNOL THER EX, V26, P119; Kraft B, 2011, CELL MOL LIFE SCI, V68, P4091, DOI 10.1007/s00018-011-0725-3; KUNDU SK, 1983, J BIOL CHEM, V258, P3857; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; MARCUS DM, 1976, P NATL ACAD SCI USA, V73, P3263, DOI 10.1073/pnas.73.9.3263; Merrill AH, 2011, CHEM REV, V111, P6387, DOI 10.1021/cr2002917; NAIKI M, 1977, J IMMUNOL, V119, P537; Okajima T, 2000, J BIOL CHEM, V275, P40498, DOI 10.1074/jbc.M006902200; Olsson ML, 2011, VOX SANG, V6, P1; Palcic MM, 2011, CURR OPIN CHEM BIOL, V15, P226, DOI 10.1016/j.cbpa.2010.11.022; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; Reid ME., 2012, BLOOD GROUP ANTIGEN, V3th, P135; Robbe C, 2004, RAPID COMMUN MASS SP, V18, P412, DOI 10.1002/rcm.1352; SAMUELSSON BE, 1990, METHOD ENZYMOL, V193, P623, DOI 10.1016/0076-6879(90)93442-N; Steffensen R, 2000, J BIOL CHEM, V275, P16723, DOI 10.1074/jbc.M000728200; Storry JR, 2011, VOX SANG, V101, P77, DOI 10.1111/j.1423-0410.2010.01462.x; Suchanowska A, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.408286; Takematsu H, 2011, J BIOL CHEM, V286, P27214, DOI 10.1074/jbc.M111.234526; TANIGUCHI N, 1984, J BIOL CHEM, V259, P5637; THORN JJ, 1992, BIOCHEMISTRY-US, V31, P6509, DOI 10.1021/bi00143a022; Thuresson B, 2011, BLOOD, V117, P678, DOI 10.1182/blood-2010-08-301333; Toivonen S, 2001, J BIOL CHEM, V276, P37141, DOI 10.1074/jbc.M105715200; TONEGAWA Y, 1977, BIOCHEM BIOPH RES CO, V76, P9, DOI 10.1016/0006-291X(77)91661-8; Varki A., 2009, ESSENTIALS GLYCOBIOL; Waldi D., 1962, DUNNSCHICHT CHROMATO, P496; Westman JS, 2013, TRANSFUSION, V53, P2928, DOI 10.1111/trf.12355; Working Party for Red Cell Immunogenetics and Blood Group Terminology, 2014, C INT SOC BLOOD TRAN; YANG ZT, 1994, J BIOL CHEM, V269, P14620; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440	49	12	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18505	18518		10.1074/jbc.M115.655308	http://dx.doi.org/10.1074/jbc.M115.655308			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26055721	Green Published, hybrid			2022-12-28	WOS:000358512100023
J	Kang, GM; Han, YM; Ko, HW; Kim, J; Oh, BC; Kwon, I; Kim, MS				Kang, Gil Myoung; Han, Yu Mi; Ko, Hyuk Whan; Kim, Joon; Oh, Byung Chul; Kwon, Ijoo; Kim, Min-Seon			Leptin Elongates Hypothalamic Neuronal Cilia via Transcriptional Regulation and Actin Destabilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR RFX3; CILIOGENESIS; INTRAFLAGELLAR; PROTEINS; INHIBITION; ASYMMETRY; OBESITY	Terminally differentiated neurons have a single, primary cilium. The primary cilia of hypothalamic neurons play a critical role in sensing metabolic signals. We recently showed that mice with leptin deficiency or resistance have shorter cilia in the hypothalamic neurons, and leptin treatment elongates cilia in hypothalamic neurons. Here, we investigated the molecular mechanisms by which leptin controls ciliary length in hypothalamic neurons. In N1 hypothalamic neuronal cells, leptin treatment increased the expression of intraflagellar transport proteins. These effects occurred via phosphatase and tensin homolog/glycogen synthase kinase-3 beta-mediated inhibition of the transcriptional factor RFX1. Actin filament dynamics were also involved in leptin-promoted ciliary elongation. Both leptin and cytochalasin-D treatment induced F-actin disruption and cilium elongation in hypothalamic neurons that was completely abrogated by co-treatment with the F-actin polymerizer phalloidin. Our findings suggest that leptin elongates hypothalamic neuronal cilia by stimulating the production of intraflagellar transport proteins and destabilizing actin filaments.	[Kang, Gil Myoung; Han, Yu Mi; Kwon, Ijoo; Kim, Min-Seon] Univ Ulsan, Asan Inst Life Sci, Appetite Regulat Lab, Coll Med, Seoul 138736, South Korea; [Kim, Min-Seon] Univ Ulsan, Coll Med, Asan Med Ctr, Div Endocrinol & Metab, Seoul 138736, South Korea; [Ko, Hyuk Whan] Dongguk Univ, Coll Pharm, Goyangsi 410773, Gyeonggido, South Korea; [Kim, Joon] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Taejon 305338, South Korea; [Oh, Byung Chul] Gachon Univ Med & Sci, Lee Gil Ya Canc & Diabet Inst, Inchon 406840, South Korea	University of Ulsan; University of Ulsan; Asan Medical Center; Dongguk University; Korea Advanced Institute of Science & Technology (KAIST); Gachon University	Kim, MS (corresponding author), Univ Ulsan, Div Endocrinol & Metab, Dept Internal Med, Asan Med Ctr,Coll Med, 88 Olymp Ro 43 Gil, Seoul 138736, South Korea.	mskim@amc.seoul.kr	Kim, Joon/C-1833-2011	KO, HYUK WAN/0000-0003-1753-1900	National Research Foundation of Korea [NRF-2013M3C7A1056024, NRF-2014R1A6A3A01057664]; Asan Institute for Life Sciences [13-326]	National Research Foundation of Korea(National Research Foundation of Korea); Asan Institute for Life Sciences	This work was supported by National Research Foundation of Korea Grants NRF-2013M3C7A1056024 and NRF-2014R1A6A3A01057664 and Asan Institute for Life Sciences Grant 13-326. The authors declare that they have no conflicts of interest with the contents of this article.	Ait-Lounis A, 2007, DIABETES, V56, P950, DOI 10.2337/db06-1187; Ashique AM, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000602; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Bisgrove BW, 2012, DEV BIOL, V363, P166, DOI 10.1016/j.ydbio.2011.12.030; Bonnafe E, 2004, MOL CELL BIOL, V24, P4417, DOI 10.1128/MCB.24.10.4417-4427.2004; Cao JL, 2012, NAT CELL BIOL, V14, P697, DOI 10.1038/ncb2512; Chu JSC, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-130; Chung MI, 2014, ELIFE, V3, DOI 10.7554/eLife.01439; Chung MI, 2012, DEV BIOL, V363, P155, DOI 10.1016/j.ydbio.2011.12.029; Davenport JR, 2007, CURR BIOL, V17, P1586, DOI 10.1016/j.cub.2007.08.034; Frew IJ, 2008, EMBO J, V27, P1747, DOI 10.1038/emboj.2008.96; Fuchs JL, 2004, CELL BIOL INT, V28, P111, DOI 10.1016/j.cellbi.2003.11.008; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Guemez-Gamboa A, 2014, NEURON, V82, P511, DOI 10.1016/j.neuron.2014.04.024; Han YM, 2014, J CLIN INVEST, V124, P2193, DOI 10.1172/JCI69395; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Kim MS, 2006, NAT NEUROSCI, V9, P901, DOI 10.1038/nn1731; Manojlovic Z, 2014, MECH DEVELOP, V132, P28, DOI 10.1016/j.mod.2014.02.001; Marshall WF, 2006, CURR BIOL, V16, pR604, DOI 10.1016/j.cub.2006.07.012; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; Neugebauer JM, 2009, NATURE, V458, P651, DOI 10.1038/nature07753; Ning K, 2006, EMBO J, V25, P2377, DOI 10.1038/sj.emboj.7601118; Ning K, 2009, J BIOL CHEM, V284, P9331, DOI 10.1074/jbc.M806774200; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Ou Y, 2009, EXP CELL RES, V315, P2802, DOI 10.1016/j.yexcr.2009.06.028; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Qin HM, 2007, CURR BIOL, V17, P193, DOI 10.1016/j.cub.2006.12.040; Rahmouni K, 2008, J CLIN INVEST, V118, P1458, DOI 10.1172/JCI32357; Rosenbaum J, 2002, CURR BIOL, V12, pR125, DOI 10.1016/S0960-9822(02)00703-0; Schwartz MW, 1996, J CLIN INVEST, V98, P1101, DOI 10.1172/JCI118891; Sen Gupta P, 2009, J ENDOCRINOL, V203, P327, DOI 10.1677/JOE-09-0116; Seo SJ, 2009, HUM MOL GENET, V18, P1323, DOI 10.1093/hmg/ddp031; Serezani CH, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002448; SOROKIN S, 1962, J CELL BIOL, V15, P363, DOI 10.1083/jcb.15.2.363; Sun T, 2009, DEV GROWTH DIFFER, V51, P735, DOI 10.1111/j.1440-169X.2009.01141.x; Sutherland Calum, 2011, Int J Alzheimers Dis, V2011, P505607, DOI 10.4061/2011/505607; Swoboda P, 2000, MOL CELL, V5, P411, DOI 10.1016/S1097-2765(00)80436-0; Thoma CR, 2007, CELL CYCLE, V6, P1809, DOI 10.4161/cc.6.15.4518; Thomas J, 2010, BIOL CELL, V102, P499, DOI 10.1042/BC20100035; Whitfield JF, 2004, CELL SIGNAL, V16, P763, DOI 10.1016/j.cellsig.2003.12.002; Wilson NF, 2004, EUKARYOT CELL, V3, P1307, DOI 10.1128/EC.3.5.1307-1319.2004; Yan XM, 2013, EXP CELL RES, V319, P147, DOI 10.1016/j.yexcr.2012.08.009	43	25	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					18146	18155		10.1074/jbc.M115.639468	http://dx.doi.org/10.1074/jbc.M115.639468			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26041775	Green Published, hybrid			2022-12-28	WOS:000358511700045
J	Mei, YW; Xu, L; Mowrey, DD; Giraldez, RM; Wang, Y; Pasek, DA; Dokholyan, NV; Meissner, G				Mei, Yingwu; Xu, Le; Mowrey, David D.; Giraldez, Raul Mendez; Wang, Ying; Pasek, Daniel A.; Dokholyan, Nikolay V.; Meissner, Gerhard			Channel Gating Dependence on Pore Lining Helix Glycine Residues in Skeletal Muscle Ryanodine Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-RELEASE CHANNEL; DISCRETE MOLECULAR-DYNAMICS; AMINO-ACID-RESIDUES; SARCOPLASMIC-RETICULUM; POTASSIUM CHANNELS; PROTEIN STABILITY; DISEASE; HINGE; RYR1; CONDUCTANCE	Type 1 ryanodine receptors (RyR1s) release Ca2+ from the sarcoplasmic reticulum to initiate skeletal muscle contraction. The role of RyR1-G4934 and -G4941 in the pore-lining helix in channel gating and ion permeation was probed by replacing them with amino acid residues of increasing side chain volume. RyR1-G4934A, -G4941A, and -G4941V mutant channels exhibited a caffeine-induced Ca2+ release response in HEK293 cells and bound the RyR-specific ligand [H-3] ryanodine. In single channel recordings, significant differences in the number of channel events and mean open and close times were observed between WT and RyR1-G4934A and -G4941A. RyR1-G4934A had reduced K+ conductance and ion selectivity compared with WT. Mutations further increasing the side chain volume at these positions (G4934V and G4941I) resulted in reduced caffeine-induced Ca2+ release in HEK293 cells, low [ 3H] ryanodine binding levels, and channels that were not regulated by Ca2+ and did not conduct Ca2+ in single channel measurements. Computational predictions of the thermodynamic impact of mutations on protein stability indicated that although the G4934A mutation was tolerated, the G4934V mutation decreased protein stability by introducing clashes with neighboring amino acid residues. In similar fashion, the G4941A mutation did not introduce clashes, whereas the G4941I mutation resulted in intersubunit clashes among the mutated isoleucines. Co-expression of RyR1-WT with RyR1-G4934V or -G4941I partially restored the WT phenotype, which suggested lessening of amino acid clashes in heterotetrameric channel complexes. The results indicate that both glycines are important for RyR1 channel function by providing flexibility and minimizing amino acid clashes.	[Mei, Yingwu; Xu, Le; Mowrey, David D.; Giraldez, Raul Mendez; Wang, Ying; Pasek, Daniel A.; Dokholyan, Nikolay V.; Meissner, Gerhard] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Meissner, G (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	meissner@med.unc.edu	Regan, Clinton/E-6250-2012; Xu, Le/HDN-9623-2022; Dokholyan, Nikolay/D-8081-2018	Dokholyan, Nikolay/0000-0002-8225-4025	National Institutes of Health [AR018687]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR018687, R01AR018687] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR018687.	Ding F, 2008, STRUCTURE, V16, P1010, DOI 10.1016/j.str.2008.03.013; Ding F, 2006, PLOS COMPUT BIOL, V2, P725, DOI 10.1371/journal.pcbi.0020085; Ding SH, 2005, J GEN PHYSIOL, V126, P213, DOI 10.1085/jgp.200509287; Dirksen RT, 2002, TRENDS CARDIOVAS MED, V12, P189, DOI 10.1016/S1050-1738(02)00163-9; Dokholyan NV, 1998, FOLD DES, V3, P577, DOI 10.1016/S1359-0278(98)00072-8; Efremov RG, 2015, NATURE, V517, P39, DOI 10.1038/nature13916; Euden J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066542; Euden J, 2013, J BIOL CHEM, V288, P16671, DOI 10.1074/jbc.M113.465310; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699, DOI 10.1152/physrev.1997.77.3.699; Gao L, 2000, BIOPHYS J, V79, P828, DOI 10.1016/S0006-3495(00)76339-9; Gao L, 1997, FEBS LETT, V412, P223, DOI 10.1016/S0014-5793(97)00781-3; Hamilton SL, 2009, J BIOL CHEM, V284, P4047, DOI 10.1074/jbc.R800054200; Hardman RM, 2007, J BIOL CHEM, V282, P31972, DOI 10.1074/jbc.M705835200; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Lanner JT, 2012, ADV EXP MED BIOL, V740, P217, DOI 10.1007/978-94-007-2888-2_9; LIU QY, 1989, BIOPHYS J, V55, P415, DOI 10.1016/S0006-3495(89)82835-8; Ludtke SJ, 2005, STRUCTURE, V13, P1203, DOI 10.1016/j.str.2005.06.005; LYU PC, 1991, P NATL ACAD SCI USA, V88, P5317, DOI 10.1073/pnas.88.12.5317; Magidovich E, 2004, BIOCHEMISTRY-US, V43, P13242, DOI 10.1021/bi048377v; Meissner G, 2002, FRONT BIOSCI, V7, pD2072, DOI 10.2741/meissner; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; RADERMACHER M, 1994, J CELL BIOL, V127, P411, DOI 10.1083/jcb.127.2.411; Ramachandran S, 2013, J BIOL CHEM, V288, P6154, DOI 10.1074/jbc.M112.433789; Rosenhouse-Dantsker A, 2006, BIOPHYS J, V91, P2860, DOI 10.1529/biophysj.105.080242; Samso M, 2009, PLOS BIOL, V7, P980, DOI 10.1371/journal.pbio.1000085; SERYSHEVA II, 1995, NAT STRUCT BIOL, V2, P18, DOI 10.1038/nsb0195-18; Shirvanyants D, 2012, J PHYS CHEM B, V116, P8375, DOI 10.1021/jp2114576; SMITH JS, 1988, J GEN PHYSIOL, V92, P1, DOI 10.1085/jgp.92.1.1; TINKER A, 1992, J GEN PHYSIOL, V100, P479, DOI 10.1085/jgp.100.3.479; Wang RW, 2004, J BIOL CHEM, V279, P3635, DOI 10.1074/jbc.M311367200; Wang Y, 2005, BIOPHYS J, V89, P256, DOI 10.1529/biophysj.104.056002; Wehrens XHT, 2005, ANNU REV PHYSIOL, V67, P69, DOI 10.1146/annurev.physiol.67.040403.114521; Xiao BL, 2002, J BIOL CHEM, V277, P41778, DOI 10.1074/jbc.M208210200; Xu L, 2006, BIOPHYS J, V90, P443, DOI 10.1529/biophysj.105.072538; Xu L, 2008, J BIOL CHEM, V283, P6321, DOI 10.1074/jbc.M707353200; Yan Z, 2015, NATURE, V517, P50, DOI 10.1038/nature14063; Yin S, 2007, STRUCTURE, V15, P1567, DOI 10.1016/j.str.2007.09.024; Yin SY, 2007, NAT METHODS, V4, P466, DOI 10.1038/nmeth0607-466; Zalk R, 2015, NATURE, V517, P44, DOI 10.1038/nature13950; Zhao MC, 1999, J BIOL CHEM, V274, P25971, DOI 10.1074/jbc.274.37.25971	42	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17535	17545		10.1074/jbc.M115.659672	http://dx.doi.org/10.1074/jbc.M115.659672			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	25998124	Green Published, hybrid			2022-12-28	WOS:000357730900044
J	Prasad, JM; Migliorini, M; Galisteo, R; Strickland, DK				Prasad, Joni M.; Migliorini, Mary; Galisteo, Rebeca; Strickland, Dudley K.			Generation of a Potent Low Density Lipoprotein Receptor-related Protein 1 (LRP1) Antagonist by Engineering a Stable Form of the Receptor-associated Protein (RAP) D3 Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOXYL-TERMINAL DOMAIN; ALPHA-2-MACROGLOBULIN RECEPTOR; LIGAND-BINDING; ER RETENTION; CHAPERONE; SITES	The low density lipoprotein receptor-related protein 1 (LRP1) is a member of the low density lipoprotein receptor family and plays important roles in a number of physiological and pathological processes. Expression of LRP1 requires the receptor-associated protein (RAP), a molecular chaperone that binds LRP1 and other low density lipoprotein receptor family members in the endoplasmic reticulum and traffics with them to the Golgi where the acidic environment causes its dissociation. Exogenously added RAP is a potent LRP1 antagonist and binds to LRP1 on the cell surface, preventing ligands from binding. Following endocytosis, RAP dissociates in the acidic endosome, allowing LRP1 to recycle back to the cell surface. The acid-induced dissociation of RAP is mediated by its D3 domain, a relatively unstable three-helical bundle that denatures at pH <6.2 due to protonation of key histidine residues on helices 2 and 3. To develop an LRP1 inhibitor that does not dissociate at low pH, we introduced a disulfide bond between the second and third helices in the RAP D3 domain. By combining this disulfide bond with elimination of key histidine residues, we generated a stable RAP molecule that is resistant to both pH-and heat-induced denaturation. This molecule bound to LRP1 with high affinity at both neutral and acidic pH and proved to be a potent inhibitor of LRP1 function both in vitro and in vivo, suggesting that our stable RAP molecule may be useful in multiple pathological settings where LRP1 blockade has been shown to be effective.	Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Strickland, DK (corresponding author), Ctr Vasc & Inflammatory Dis, 800 W Baltimore St,Rm 219, Baltimore, MD 21201 USA.			Prasad, Joni/0000-0001-5224-6502	National Institutes of Health from the NHLBI [HL114379, HL120388];  [T32 HL007698]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL120388, R01HL114379, T32HL007698] Funding Source: NIH RePORTER	National Institutes of Health from the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL114379 and HL120388 from the NHLBI and by Grant T32 HL007698 (to J. M. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Andersen OM, 2003, BIOCHEMISTRY-US, V42, P9355, DOI 10.1021/bi034475p; BATTEY FD, 1994, J BIOL CHEM, V269, P23268; Bu GJ, 1997, J CELL SCI, V110, P65; BU GJ, 1995, EMBO J, V14, P2269, DOI 10.1002/j.1460-2075.1995.tb07221.x; Bu GJ, 1996, J BIOL CHEM, V271, P22218, DOI 10.1074/jbc.271.36.22218; Dani VS, 2003, PROTEIN ENG, V16, P187, DOI 10.1093/proeng/gzg024; Estrada K, 2008, BIOCHEMISTRY-US, V47, P1532, DOI 10.1021/bi702076y; Fisher C, 2006, MOL CELL, V22, P277, DOI 10.1016/j.molcel.2006.02.021; HERZ J, 1991, J BIOL CHEM, V266, P21232; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Jensen JK, 2009, BIOCHEM J, V421, P273, DOI 10.1042/BJ20090175; Josephson N, 2013, HEMATOL-AM SOC HEMAT, P261, DOI 10.1182/asheducation-2013.1.261; KOUNNAS MZ, 1992, J BIOL CHEM, V267, P21162; Lee D, 2006, MOL CELL, V22, P423, DOI 10.1016/j.molcel.2006.04.011; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Medved LV, 1999, J BIOL CHEM, V274, P717, DOI 10.1074/jbc.274.2.717; Migliorini MM, 2003, J BIOL CHEM, V278, P17986, DOI 10.1074/jbc.M212592200; PERRY LJ, 1984, SCIENCE, V226, P555, DOI 10.1126/science.6387910; Polavarapu R, 2007, BLOOD, V109, P3270, DOI 10.1182/blood-2006-08-043125; Rall SC, 1998, J BIOL CHEM, V273, P24152, DOI 10.1074/jbc.273.37.24152; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; Saenko EL, 1999, J BIOL CHEM, V274, P37685, DOI 10.1074/jbc.274.53.37685; SAUER RT, 1986, BIOCHEMISTRY-US, V25, P5992, DOI 10.1021/bi00368a024; Savonen R, 1999, J BIOL CHEM, V274, P25877, DOI 10.1074/jbc.274.36.25877; STRICKLAND DK, 1991, J BIOL CHEM, V266, P13364; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; Wei Y, 2014, BBA-PROTEINS PROTEOM, V1844, P2331, DOI 10.1016/j.bbapap.2014.10.001; WILLIAMS SE, 1992, J BIOL CHEM, V267, P9035; Willnow TE, 1996, EMBO J, V15, P2632, DOI 10.1002/j.1460-2075.1996.tb00623.x; WILLNOW TE, 1995, P NATL ACAD SCI USA, V92, P4537, DOI 10.1073/pnas.92.10.4537; Yepes M, 2003, J CLIN INVEST, V112, P1533, DOI 10.1172/JCI200319212	31	18	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17262	17268		10.1074/jbc.M115.660084	http://dx.doi.org/10.1074/jbc.M115.660084			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26013822	Green Published, hybrid			2022-12-28	WOS:000357730900022
J	Walliser, C; Tron, K; Clauss, K; Gutman, O; Kobitski, AY; Retlich, M; Schade, A; Rocker, C; Henis, YI; Nienhaus, GU; Gierschik, P				Walliser, Claudia; Tron, Kyrylo; Clauss, Karen; Gutman, Orit; Kobitski, Andrei Yu.; Retlich, Michael; Schade, Anja; Roecker, Carlheinz; Henis, Yoav I.; Nienhaus, G. Ulrich; Gierschik, Peter			Rac-mediated Stimulation of Phospholipase C gamma(2) Amplifies B Cell Receptor-induced Calcium Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRUTONS TYROSINE KINASE; OF-FUNCTION MUTATION; ANTIGEN RECEPTOR; C-GAMMA; INOSITOL 1,4,5-TRISPHOSPHATE; DIFFERENTIAL REGULATION; C-BETA(2) ACTIVITY; CA2+ SIGNALS; T-CELLS; ACTIVATION	The Rho GTPase Rac is crucially involved in controlling multiple B cell functions, including those regulated by the B cell receptor ( BCR) through increased cytosolic Ca2+. The underlying molecular mechanisms and their relevance to the functions of intact B cells have thus far remained unknown. We have previously shown that the activity of phospholipase C gamma(2) ( PLC gamma(2)), a key constituent of the BCR signalosome, is stimulated by activated Rac through direct protein-protein interaction. Here, we use a Rac-resistant mutant of PLC gamma(2) to functionally reconstitute cultured PLC gamma(2)-deficient DT40 B cells and to examine the effects of the Rac-PLC gamma(2) interaction on BCR-mediated changes of intracellular Ca2+ and regulation of Ca2+-regulated and nuclear-factor-of-activated-T-cell-regulated gene transcription at the level of single, intact B cells. The results show that the functional Rac-PLC gamma(2) interaction causes marked increases in the following: ( i) sensitivity of B cells to BCR ligation; ( ii) BCR-mediated Ca2+ release from intracellular stores; ( iii) Ca2+ entry from the extracellular compartment; and ( iv) nuclear translocation of the Ca2+ regulated nuclear factor of activated T cells. Hence, Rac-mediated stimulation of PLC gamma(2) activity serves to amplify B cell receptor-induced Ca2+ signaling.	[Walliser, Claudia; Retlich, Michael; Schade, Anja; Gierschik, Peter] Univ Ulm, Med Ctr, Inst Pharmacol & Toxicol, D-89070 Ulm, Germany; [Tron, Kyrylo; Clauss, Karen; Roecker, Carlheinz] Univ Ulm, Inst Biophys, D-89069 Ulm, Germany; [Gutman, Orit; Henis, Yoav I.] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel; [Kobitski, Andrei Yu.; Nienhaus, G. Ulrich] Karlsruhe Inst Technol, Inst Appl Phys, D-76131 Karlsruhe, Germany; [Kobitski, Andrei Yu.; Nienhaus, G. Ulrich] Karlsruhe Inst Technol, Ctr Funct Nanostruct, D-76131 Karlsruhe, Germany; [Nienhaus, G. Ulrich] Karlsruhe Inst Technol, Inst Toxicol & Genet, D-76344 Eggenstein Leopoldshafen, Germany; [Nienhaus, G. Ulrich] Univ Illinois, Dept Phys, Urbana, IL 61801 USA	Ulm University; Ulm University; Tel Aviv University; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; University of Illinois System; University of Illinois Urbana-Champaign	Gierschik, P (corresponding author), Univ Ulm, Med Ctr, Inst Pharmacol & Toxicol, Albert Einstein Allee 11, D-89081 Ulm, Germany.	peter.gierschik@uni-ulm.de	Nienhaus, Gerd Ulrich/G-8698-2012	Nienhaus, Gerd Ulrich/0000-0002-5027-3192; Henis, Yoav/0000-0002-1408-3877	Deutsche Forschungsgemeinschaft [SFB 497, SFB 1074]; International Graduate School in Molecular Medicine Ulm (IGradU)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); International Graduate School in Molecular Medicine Ulm (IGradU)	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB 497 and SFB 1074 (to the P.G. and the G.U.N. laboratories) and grants within the International Graduate School in Molecular Medicine Ulm (IGradU) to the P. G. laboratory. The authors declare that they have no conflicts of interest with the contents of this article.	Abe K, 2011, ARTHRITIS RHEUM-US, V63, P1301, DOI 10.1002/art.30280; Aki D, 2008, GENES CELLS, V13, P199, DOI 10.1111/j.1365-2443.2007.01159.x; Alkhairy OK, 2015, J ALLERGY CLIN IMMUN, V135, P1380, DOI 10.1016/j.jaci.2014.10.039; Amin RH, 2003, ENDOCRINOLOGY, V144, P4508, DOI 10.1210/en.2003-0106; Arakawa H, 2001, BMC Biotechnol, V1, P7, DOI 10.1186/1472-6750-1-7; Arana E, 2008, IMMUNITY, V28, P88, DOI 10.1016/j.immuni.2007.12.003; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Baba Y, 2011, TRENDS IMMUNOL, V32, P589, DOI 10.1016/j.it.2011.09.004; Bae YS, 1998, J BIOL CHEM, V273, P4465, DOI 10.1074/jbc.273.8.4465; Bai L, 2007, MOL CELL BIOL, V27, P5957, DOI 10.1128/MCB.02273-06; Barrio L, 2013, J IMMUNOL, V191, P3867, DOI 10.4049/jimmunol.1301623; Berridge MJ, 2007, BIOCHEM SOC SYMP, V74, P1, DOI 10.1002/9780470514696.ch1; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; BOURNE HR, 1993, CELL, V72, P65, DOI 10.1016/S0092-8674(05)80029-7; Bunney TD, 2009, MOL CELL, V34, P223, DOI 10.1016/j.molcel.2009.02.023; CAMBIER J, 1988, P NATL ACAD SCI USA, V85, P6493, DOI 10.1073/pnas.85.17.6493; CAMBIER JC, 1990, J IMMUNOL, V145, P13; Carrasco YR, 2004, IMMUNITY, V20, P589, DOI 10.1016/S1074-7613(04)00105-0; Chiang CY, 2012, J BIOL CHEM, V287, P3704, DOI 10.1074/jbc.C111.328559; Croker BA, 2002, J IMMUNOL, V168, P3376, DOI 10.4049/jimmunol.168.7.3376; de Gorter DJJ, 2007, IMMUNITY, V26, P93, DOI 10.1016/j.immuni.2006.11.012; Deckert M, 1996, IMMUNITY, V5, P591, DOI 10.1016/S1074-7613(00)80273-3; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Dupont G, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004226; Efron B, 1993, INTRO BOOTSTRAP, P124; Fu C, 1998, IMMUNITY, V9, P93, DOI 10.1016/S1074-7613(00)80591-9; Fujikawa K, 2003, J EXP MED, V198, P1595, DOI 10.1084/jem.20030874; Guidetti GF, 2009, J THROMB HAEMOST, V7, P1200, DOI 10.1111/j.1538-7836.2009.03444.x; Guinamard R, 1997, SCAND J IMMUNOL, V45, P587, DOI 10.1046/j.1365-3083.1997.d01-447.x; Gutman O, 2010, J BIOL CHEM, V285, P3905, DOI 10.1074/jbc.M109.085100; Gwack Y, 2007, CELL CALCIUM, V42, P145, DOI 10.1016/j.ceca.2007.03.007; Hajnoczky G, 1997, EMBO J, V16, P3533, DOI 10.1093/emboj/16.12.3533; Hao SL, 2003, EMBO J, V22, P4166, DOI 10.1093/emboj/cdg401; Harwood NE, 2010, ANNU REV IMMUNOL, V28, P185, DOI 10.1146/annurev-immunol-030409-101216; Hashimoto A, 2000, J IMMUNOL, V165, P1738, DOI 10.4049/jimmunol.165.4.1738; Hashimoto A, 1998, J EXP MED, V188, P1287, DOI 10.1084/jem.188.7.1287; Henderson RB, 2010, J EXP MED, V207, P837, DOI 10.1084/jem.20091489; Henis YI, 2006, METHODS, V40, P183, DOI 10.1016/j.ymeth.2006.02.003; Hikida M, 2003, J EXP MED, V198, P581, DOI 10.1084/jem.20030280; Hirose K, 1999, SCIENCE, V284, P1527, DOI 10.1126/science.284.5419.1527; Hoffman GR, 1998, J BIOL CHEM, V273, P4392, DOI 10.1074/jbc.273.8.4392; Hogg N, 2003, J CELL SCI, V116, P4695, DOI 10.1242/jcs.00876; HOMMA Y, 1992, J BIOL CHEM, V267, P21844; Illenberger D, 2003, J BIOL CHEM, V278, P8645, DOI 10.1074/jbc.M211971200; Jiang X, 2010, J R SOC INTERFACE, V7, pS5, DOI 10.1098/rsif.2009.0272.focus; Kadamur G, 2013, ANNU REV PHYSIOL, V75, P127, DOI 10.1146/annurev-physiol-030212-183750; Kitajima N, 2011, BIOCHEM BIOPH RES CO, V409, P108, DOI 10.1016/j.bbrc.2011.04.124; Kiyonaka S, 2009, P NATL ACAD SCI USA, V106, P5400, DOI 10.1073/pnas.0808793106; KOPPEL DE, 1976, BIOPHYS J, V16, P1315, DOI 10.1016/S0006-3495(76)85776-1; Kredel S, 2008, CHEM BIOL, V15, P224, DOI 10.1016/j.chembiol.2008.02.008; Kuhne MR, 2000, J BIOL CHEM, V275, P2185, DOI 10.1074/jbc.275.3.2185; Kurosaki T, 2002, NAT REV IMMUNOL, V2, P354, DOI 10.1038/nri801; Li WH, 1998, NATURE, V392, P936, DOI 10.1038/31965; Miyakawa T, 1999, EMBO J, V18, P1303, DOI 10.1093/emboj/18.5.1303; Morita T, 2004, BIOCHEM J, V382, P793, DOI 10.1042/BJ20031970; Nishida M, 2003, EMBO J, V22, P4677, DOI 10.1093/emboj/cdg457; Nishihara H, 2002, BLOOD, V100, P3968, DOI 10.1182/blood-2001-11-0032; Ombrello MJ, 2012, NEW ENGL J MED, V366, P330, DOI 10.1056/NEJMoa1102140; Patterson RL, 2002, CELL, V111, P529, DOI 10.1016/S0092-8674(02)01045-0; Petersen N. O., 1986, HDB EXPT IMMUNOLOGY; Piechulek T, 2005, J BIOL CHEM, V280, P38923, DOI 10.1074/jbc.M509396200; Pleines I, 2009, PFLUG ARCH EUR J PHY, V457, P1173, DOI 10.1007/s00424-008-0573-7; Rawlings DJ, 2012, NAT REV IMMUNOL, V12, P282, DOI 10.1038/nri3190; Rossi AM, 2012, BBA-GEN SUBJECTS, V1820, P1214, DOI 10.1016/j.bbagen.2011.10.004; Salzer U, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4032; Sanchez-Martin L, 2004, J BIOL CHEM, V279, P16194, DOI 10.1074/jbc.M400905200; SCHAEFER BC, 1995, ANAL BIOCHEM, V227, P255, DOI 10.1006/abio.1995.1279; Scharenberg AM, 2007, NAT REV IMMUNOL, V7, P778, DOI 10.1038/nri2172; Spaargaren M, 2003, J EXP MED, V198, P1539, DOI 10.1084/jem.20011866; Spoerner M, 2001, P NATL ACAD SCI USA, V98, P4944, DOI 10.1073/pnas.081441398; Sun Y, 2013, BIOESSAYS, V35, P513, DOI 10.1002/bies.201200171; TAKATA M, 1995, J EXP MED, V182, P907, DOI 10.1084/jem.182.4.907; Tedder TF, 2010, J IMMUNOL, V184, P2231, DOI 10.4049/jimmunol.1090001; Tedford K, 2001, NAT IMMUNOL, V2, P548, DOI 10.1038/88756; Thiel J, 2012, J ALLERGY CLIN IMMUN, V129, P801, DOI 10.1016/j.jaci.2011.09.027; Tomida T, 2003, EMBO J, V22, P3825, DOI 10.1093/emboj/cdg381; Tybulewicz VLJ, 2009, NAT REV IMMUNOL, V9, P630, DOI 10.1038/nri2606; van Zelm MC, 2006, NEW ENGL J MED, V354, P1901, DOI 10.1056/NEJMoa051568; van Zelm MC, 2010, J CLIN INVEST, V120, P1265, DOI 10.1172/JCI39748; Walliser C, 2008, J BIOL CHEM, V283, P30351, DOI 10.1074/jbc.M803316200; Walmsley MJ, 2003, SCIENCE, V302, P459, DOI 10.1126/science.1089709; Wang DM, 2000, IMMUNITY, V13, P25, DOI 10.1016/S1074-7613(00)00005-4; Weber M, 2008, J EXP MED, V205, P853, DOI 10.1084/jem.20072619; Wen RR, 2006, MOL CELL BIOL, V26, P9364, DOI 10.1128/MCB.00839-06; Wienands J, 1998, J EXP MED, V188, P791, DOI 10.1084/jem.188.4.791; Yu P, 2005, IMMUNITY, V22, P451, DOI 10.1016/j.immuni.2005.01.018; Zhou Q, 2012, AM J HUM GENET, V91, P713, DOI 10.1016/j.ajhg.2012.08.006	88	11	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17056	17072		10.1074/jbc.M115.645739	http://dx.doi.org/10.1074/jbc.M115.645739			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	25903139	Green Published, hybrid			2022-12-28	WOS:000357730900002
J	Wang, L; Lee, SJ; Verdine, GL				Wang, Lan; Lee, Seung-Joo; Verdine, Gregory L.			Structural Basis for Avoidance of Promutagenic DNA Repair by MutY Adenine DNA Glycosylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; FREE R-VALUE; ESCHERICHIA-COLI; EXCISION-REPAIR; 8-OXOGUANINE; MUTATIONS; HOMOLOG; PROTEIN; GENE; SPECIFICITY	The highly mutagenic A: oxoG (8-oxoguanine) base pair in DNA most frequently arises by aberrant replication of the primary oxidative lesion C:oxoG. This lesion is particularly insidious because neither of its constituent nucleobases faithfully transmit genetic information from the original C:G base pair. Repair of A: oxoG is initiated by adenine DNA glycosylase, which catalyzes hydrolytic cleavage of the aberrant A nucleobase from the DNA backbone. These enzymes, MutY in bacteria and MUTYH in humans, scrupulously avoid processing of C: oxoG because cleavage of the C residue in C: oxoG would actually promote mutagenic conversion to A: oxoG. Here we analyze the structural basis for rejection of C: oxoG by MutY, using a synthetic crystallography approach to capture the enzyme in the process of inspecting the C: oxoG anti-substrate, with which it ordinarily binds only fleetingly. We find that MutY uses two distinct strategies to avoid presentation of C to the enzyme active site. Firstly, MutY possesses an exo-site that serves as a decoy for C, and secondly, repulsive forces with a key active site residue prevent stable insertion of C into the nucleobase recognition pocket within the enzyme active site.	[Wang, Lan; Lee, Seung-Joo; Verdine, Gregory L.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Verdine, Gregory L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Verdine, Gregory L.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University	Verdine, GL (corresponding author), Harvard Univ, 12 Oxford St, Cambridge, MA 02138 USA.	gregory_verdine@harvard.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [CA100742]; NATIONAL CANCER INSTITUTE [R01CA100742] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by National Institutes of Health Grant CA100742. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828; Barrett TE, 1999, EMBO J, V18, P6599, DOI 10.1093/emboj/18.23.6599; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; BRUNGER AT, 1993, ACTA CRYSTALLOGR D, V49, P24, DOI 10.1107/S0907444992007352; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI 10.1038/hr.2014.17; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fromme JC, 2004, NATURE, V427, P652, DOI 10.1038/nature02306; Gad H, 2014, NATURE, V508, P215, DOI 10.1038/nature13181; Guan Y, 1998, NAT STRUCT BIOL, V5, P1058, DOI 10.1038/4168; Huber KVM, 2014, NATURE, V508, P222, DOI 10.1038/nature13194; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Labahn J, 1996, CELL, V86, P321, DOI 10.1016/S0092-8674(00)80103-8; Lee S, 2009, P NATL ACAD SCI USA, V106, P18497, DOI 10.1073/pnas.0902908106; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lu AL, 1998, J BIOL CHEM, V273, P25098, DOI 10.1074/jbc.273.39.25098; MICHAELS ML, 1992, P NATL ACAD SCI USA, V89, P7022, DOI 10.1073/pnas.89.15.7022; MICHAELS ML, 1992, J BACTERIOL, V174, P6321, DOI 10.1128/JB.174.20.6321-6325.1992; MORIYA M, 1993, MOL GEN GENET, V239, P72, DOI 10.1007/BF00281603; Nash HM, 1996, CURR BIOL, V6, P968, DOI 10.1016/S0960-9822(02)00641-3; NGHIEM Y, 1988, P NATL ACAD SCI USA, V85, P2709, DOI 10.1073/pnas.85.8.2709; Noll DM, 1999, BIOCHEMISTRY-US, V38, P6374, DOI 10.1021/bi990335x; Parikh SS, 2000, P NATL ACAD SCI USA, V97, P5083, DOI 10.1073/pnas.97.10.5083; Parker A, 2000, NUCLEIC ACIDS RES, V28, P3206, DOI 10.1093/nar/28.17.3206; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; Slupska MM, 1996, J BACTERIOL, V178, P3885, DOI 10.1128/jb.178.13.3885-3892.1996; THAYER MM, 1995, EMBO J, V14, P4108, DOI 10.1002/j.1460-2075.1995.tb00083.x; Verdine GL, 2003, ANNU REV BIOCHEM, V72, P337, DOI 10.1146/annurev.biochem.72.121801.161447; Volk DE, 2000, BIOCHEMISTRY-US, V39, P7331, DOI 10.1021/bi000416p; Werner RM, 2000, BIOCHEMISTRY-US, V39, P14054, DOI 10.1021/bi0018178	32	18	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17096	17105		10.1074/jbc.M115.657866	http://dx.doi.org/10.1074/jbc.M115.657866			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	25995449	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000357730900005
J	Cantlon, A; Frigerio, CS; Freir, DB; Boland, B; Jin, M; Walsh, DM				Cantlon, Adam; Frigerio, Carlo Sala; Freir, Darragh B.; Boland, Barry; Jin, Ming; Walsh, Dominic M.			The Familial British Dementia Mutation Promotes Formation of Neurotoxic Cystine Cross-linked Amyloid Bri (ABri) Oligomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; ALZHEIMERS-DISEASE; A-BETA; DANISH DEMENTIA; MEMORY DEFICITS; SYNAPTIC PLASTICITY; PLAQUE-FORMATION; DISULFIDE BONDS; PEPTIDES; PROTEIN	Familial British dementia (FBD) is an inherited neurodegenerative disease believed to result from a mutation in the BRI2 gene. Post-translational processing of wild type BRI2 and FBD-BRI2 result in the production of a 23-residue long Bri peptide and a 34-amino acid long ABri peptide, respectively, and ABri is found deposited in the brains of individuals with FBD. Similarities in the neuropathology and clinical presentation shared by FBD and Alzheimer disease (AD) have led some to suggest that ABri and the AD-associated amyloid beta-protein (A beta) are molecular equivalents that trigger analogous pathogenic cascades. But the sequences and innate properties of ABri and A beta are quite different, notably ABri contains two cysteine residues that can form disulfide bonds. Thus we sought to determine whether ABri was neurotoxic and if this activity was regulated by oxidation and/or aggregation. Crucially, the type of oxidative cross-linking dramatically influenced both ABri aggregation and toxicity. Cyclization of Bri and ABri resulted in production of biologically inert monomers that showed no propensity to assemble, whereas reduced ABri and reduced Bri aggregated forming thioflavin T-positive amyloid fibrils that lacked significant toxic activity. ABri was more prone to form inter-molecular disulfide bonds than Bri and the formation of covalently stabilized ABri oligomers was associated with toxicity. These results suggest that extension of the C-terminal of Bri causes a shift in the type of disulfide bonds formed and that structures built from covalently cross-linked oligomers can interact with neurons and compromise their function and viability.	[Cantlon, Adam; Frigerio, Carlo Sala; Freir, Darragh B.; Boland, Barry] Natl Univ Ireland Univ Coll Dublin, Conway Inst, Sch Biomol & Biomed Sci, Lab Neurodegenerat Res, Dublin 4, Ireland; [Cantlon, Adam; Jin, Ming; Walsh, Dominic M.] Brigham & Womens Hosp, Ann Romney Ctr Neurol Dis, Lab Neurodegenerat Res, Boston, MA 02115 USA; [Cantlon, Adam; Jin, Ming; Walsh, Dominic M.] Harvard Univ, Sch Med, Boston, MA 02115 USA	University College Dublin; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Walsh, DM (corresponding author), Harvard Inst Med, Brigham & Womens Hosp, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	dwalsh3@partners.org	Boland, Barry/D-1235-2010	Boland, Barry/0000-0003-2676-4343; Sala Frigerio, Carlo/0000-0003-4038-6449	Science Foundation Ireland [08/1N.1/B2033]; Cure Alzheimer's Fund; Foundation of Neurological diseases	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Cure Alzheimer's Fund; Foundation of Neurological diseases	This work was supported by Science Foundation Ireland Grant 08/1N.1/B2033, the Cure Alzheimer's Fund, and the Foundation of Neurological diseases (to D.M.W.). The authors declare that they have no conflicts of interest with the contents of this article.	AIKAWA H, 1985, ANN NEUROL, V17, P297, DOI 10.1002/ana.410170313; Akiyama H, 2004, ACTA NEUROPATHOL, V107, P53, DOI 10.1007/s00401-003-0783-1; Andreu D, 1994, Methods Mol Biol, V35, P91; [Anonymous], 2011, NAT NEUROSCI, V14, P399, DOI 10.1038/nn0411-399; Betts V, 2008, NEUROBIOL DIS, V31, P442, DOI 10.1016/j.nbd.2008.06.001; Chen QS, 2000, J NEUROSCI RES, V60, P65, DOI 10.1002/(SICI)1097-4547(20000401)60:1<65::AID-JNR7>3.0.CO;2-Q; Choi SI, 2003, FASEB J, V17, P373, DOI 10.1096/fj.03-0730fje; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; Coomaraswamy J, 2010, P NATL ACAD SCI USA, V107, P7969, DOI 10.1073/pnas.1001056107; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; El-Agnaf O, 2004, PROTEIN PEPTIDE LETT, V11, P207, DOI 10.2174/0929866043407156; El-Agnaf OMA, 2001, J MOL BIOL, V310, P157, DOI 10.1006/jmbi.2001.4743; El-Agnaf OMA, 2001, BIOCHEMISTRY-US, V40, P3449, DOI 10.1021/bi002287i; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Ghiso J, 2006, BRAIN PATHOL, V16, P71; Ghiso JA, 2001, J BIOL CHEM, V276, P43909, DOI 10.1074/jbc.M105956200; Gibson G, 2005, BIOCHEM SOC T, V33, P1111, DOI 10.1042/BST0331111; Giliberto L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007900; Golde TE, 2011, NEURON, V69, P203, DOI 10.1016/j.neuron.2011.01.002; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hedlund Joel, 2009, BMC Res Notes, V2, P180, DOI 10.1186/1756-0500-2-180; Hellstrand E, 2010, ACS CHEM NEUROSCI, V1, P13, DOI 10.1021/cn900015v; Holton JL, 2001, AM J PATHOL, V158, P515, DOI 10.1016/S0002-9440(10)63993-4; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kim SH, 2002, J BIOL CHEM, V277, P1872, DOI 10.1074/jbc.M108739200; Kim SH, 1999, NAT NEUROSCI, V2, P984, DOI 10.1038/14783; Marcora MS, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-5; Matsuda S, 2011, J ALZHEIMERS DIS, V27, P385, DOI 10.3233/JAD-2011-110785; Mead S, 2000, BRAIN, V123, P975, DOI 10.1093/brain/123.5.975; Mesulam NM, 1999, NEURON, V24, P521, DOI 10.1016/S0896-6273(00)81109-5; Minogue AM, 2009, BRAIN RES, V1262, P89, DOI 10.1016/j.brainres.2009.01.008; Morris RGM, 2003, PHILOS T ROY SOC B, V358, P643, DOI 10.1098/rstb.2002.1230; O'Malley TT, 2014, BIOCHEM J, V461, P413, DOI 10.1042/BJ20140219; PLANT GT, 1990, BRAIN, V113, P721, DOI 10.1093/brain/113.3.721; Revesz T, 1999, ACTA NEUROPATHOL, V97, P170, DOI 10.1007/s004010050970; Rostagno A, 2005, CELL MOL LIFE SCI, V62, P1814, DOI 10.1007/s00018-005-5092-5; Rowan MJ, 2003, PHILOS T R SOC B, V358, P821, DOI 10.1098/rstb.2002.1240; Sanchez-Pulido L, 2002, TRENDS BIOCHEM SCI, V27, P329, DOI 10.1016/S0968-0004(02)02134-5; Shankar GM, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-48; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Srinivasan R, 2003, J MOL BIOL, V333, P1003, DOI 10.1016/j.jmb.2003.09.001; Tamayev R, 2012, J NEUROSCI, V32, P5481, DOI 10.1523/JNEUROSCI.5193-11.2012; Tamayev R, 2010, P NATL ACAD SCI USA, V107, P20822, DOI 10.1073/pnas.1011689107; Tamayev R, 2010, J NEUROSCI, V30, P14915, DOI 10.1523/JNEUROSCI.3917-10.2010; Tsachaki M, 2010, NEUROBIOL AGING, V31, P88, DOI 10.1016/j.neurobiolaging.2008.03.004; Vidal R, 2000, P NATL ACAD SCI USA, V97, P4920, DOI 10.1073/pnas.080076097; Vidal R, 1999, NATURE, V399, P776; Vidal R, 2009, BRAIN PATHOL, V19, P58, DOI 10.1111/j.1750-3639.2008.00164.x; Walsh Dominic M., 2003, Current Medicinal Chemistry - Immunology Endocrine & Metabolic Agents, V3, P277, DOI 10.2174/1568013033483311; Walsh DM, 2009, FEBS J, V276, P1266, DOI 10.1111/j.1742-4658.2008.06862.x; Wang QW, 2004, J NEUROSCI, V24, P3370, DOI 10.1523/JNEUROSCI.1633-03.2004; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134	53	5	5	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16502	16516		10.1074/jbc.M115.652263	http://dx.doi.org/10.1074/jbc.M115.652263			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25957407	Green Published, hybrid			2022-12-28	WOS:000357572800004
J	Valencia-Sama, I; Zhao, YL; Lai, D; van Rensburg, HJJ; Hao, YW; Yang, XL				Valencia-Sama, Ivette; Zhao, Yulei; Lai, Dulcie; van Rensburg, Helena J. Janse; Hao, Yawei; Yang, Xiaolong			Hippo Component TAZ Functions as a Co-repressor and Negatively Regulates Delta Np63 Transcription through TEA Domain (TEAD) Transcription Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR; BREAST-CANCER; CELL-PROLIFERATION; SIGNALING PATHWAY; P63 EXPRESSION; TISSUE-GROWTH; SIZE CONTROL; YAP; PROTEIN; COACTIVATOR	Transcriptional co-activator with a PDZ binding domain (TAZ) is a WW domain-containing transcriptional co-activator and a core component of an emerging Hippo signaling pathway that regulates organ size, tumorigenesis, metastasis, and drug resistance. TAZ regulates these biological functions by up-regulating downstream cellular genes through transactivation of transcription factors such as TEAD and TTF1. To understand the molecular mechanisms underlying TAZ-induced tumorigenesis, we have recently performed a gene expression profile analysis by overexpressing TAZ in mammary cells. In addition to the TAZ-up-regulated genes that were confirmed in our previous studies, we identified a large number of cellular genes that were down-regulated by TAZ. In this study, we have confirmed these down-regulated genes (including cytokines, chemokines, and p53 gene family members) as bona fide downstream transcriptional targets of TAZ. By using human breast and lung epithelial cells, we have further characterized Delta Np63, a p53 gene family member, and shown that TAZ suppresses Delta Np63 mRNA, protein expression, and promoter activity through interaction with the transcription factor TEAD. We also show that TEAD can inhibit Delta Np63 promoter activity and that TAZ can directly interact with Delta Np63 promoter-containing TEAD binding sites. Finally, we provide functional evidence that down-regulation of Delta Np63 by TAZ may play a role in regulating cell migration. Altogether, this study provides novel evidence that the Hippo component TAZ can function as a co-repressor and regulate biological functions by negatively regulating downstream cellular genes.	[Valencia-Sama, Ivette; Zhao, Yulei; Lai, Dulcie; van Rensburg, Helena J. Janse; Hao, Yawei; Yang, Xiaolong] Queens Univ, Dept Pathol & Mol Med, Kingston, ON K7L 3N6, Canada	McMaster University; Queens University - Canada	Yang, XL (corresponding author), Queens Univ, Dept Pathol & Mol Med, Richardson Lab 201,88 Stuart St, Kingston, ON K7L 3N6, Canada.	yang@path.queensu.ca	van Rensburg, Helena Janse/AAF-8548-2019; zhao, Yulei/M-8667-2018	Valencia-Sama, Ivette/0000-0003-2706-7435; Janse van Rensburg, Helena/0000-0002-4066-7489	Canadian Institute of Health Research (CIHR) [119325]; Canadian Breast Cancer Foundation, Canada; CIHR/Terry Fox Foundation Training Program in Transdisciplinary Cancer Research; Queen's graduate studentship; Ontario Trillium graduate scholarship	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Breast Cancer Foundation, Canada; CIHR/Terry Fox Foundation Training Program in Transdisciplinary Cancer Research(Canadian Institutes of Health Research (CIHR)); Queen's graduate studentship; Ontario Trillium graduate scholarship	This work was supported in part by Canadian Institute of Health Research (CIHR) Grant 119325 and Canadian Breast Cancer Foundation, Canada (to X. Y.).; Supported by the CIHR/Terry Fox Foundation Training Program in Transdisciplinary Cancer Research and a Queen's graduate studentship.; Supported by an Ontario Trillium graduate scholarship.	Avruch J, 2012, SEMIN CELL DEV BIOL, V23, P770, DOI 10.1016/j.semcdb.2012.07.002; Badouel C, 2011, CELL, V145, P484, DOI 10.1016/j.cell.2011.04.009; Barron DA, 2014, CLIN TRANSL MED, V3, DOI 10.1186/2001-1326-3-25; Bartucci M, 2015, ONCOGENE, V34, P681, DOI 10.1038/onc.2014.5; Basu D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062478; Bergholz J, 2014, ONCOGENE, V33, P212, DOI 10.1038/onc.2012.564; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Chan SW, 2009, J BIOL CHEM, V284, P14347, DOI 10.1074/jbc.M901568200; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; de Cristofaro T, 2011, EUR J CANCER, V47, P926, DOI 10.1016/j.ejca.2010.11.008; DeYoung MP, 2007, ONCOGENE, V26, P5169, DOI 10.1038/sj.onc.1210337; Di Palma T, 2009, EXP CELL RES, V315, P162, DOI 10.1016/j.yexcr.2008.10.016; Diepenbruck M, 2014, J CELL SCI, V127, P1523, DOI 10.1242/jcs.139865; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Gao YJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5629; Gomez M, 2014, CLIN TRANSL MED, V3, DOI 10.1186/2001-1326-3-22; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Hildmann C, 2007, APPL MICROBIOL BIOT, V75, P487, DOI 10.1007/s00253-007-0911-2; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Hong WJ, 2012, SEMIN CELL DEV BIOL, V23, P785, DOI 10.1016/j.semcdb.2012.05.004; Hublitz P, 2009, INT J DEV BIOL, V53, P335, DOI 10.1387/ijdb.082717ph; Jang EJ, 2012, MOL CELL BIOL, V32, P4925, DOI 10.1128/MCB.00392-12; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Koker MM, 2004, AM J SURG PATHOL, V28, P1506, DOI 10.1097/01.pas.0000138183.97366.fd; Koontz LM, 2013, DEV CELL, V25, P388, DOI 10.1016/j.devcel.2013.04.021; Lai D, 2013, CELL SIGNAL, V25, P1720, DOI 10.1016/j.cellsig.2013.05.002; Lai D, 2012, BIOSCIENCE REP, V32, P361, DOI 10.1042/BSR20110125; Lai D, 2011, CANCER RES, V71, P2728, DOI 10.1158/0008-5472.CAN-10-2711; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Lindsay J, 2011, J BIOL CHEM, V286, P3915, DOI 10.1074/jbc.M110.162511; Liu Chenying, 2011, Int J Biochem Mol Biol, V2, P247; Liu H, 2012, PROTEIN CELL, V3, P291, DOI 10.1007/s13238-012-2919-3; Mo JS, 2014, EMBO REP, V15, P642, DOI 10.15252/embr.201438638; Murakami M, 2006, BIOCHEM BIOPH RES CO, V339, P533, DOI 10.1016/j.bbrc.2005.10.214; Murakami M, 2005, P NATL ACAD SCI USA, V102, P18034, DOI 10.1073/pnas.0509109102; Oh H, 2013, CELL REP, V3, P309, DOI 10.1016/j.celrep.2013.01.008; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Qing Y, 2014, ELIFE, V3, DOI 10.7554/eLife.02564; Reis JS, 2003, CANCER CYTOPATHOL, V99, P172, DOI 10.1002/cncr.11061; Skibinski A, 2014, CELL REP, V6, P1059, DOI 10.1016/j.celrep.2014.02.038; Stefanou D, 2004, HISTOL HISTOPATHOL, V19, P465, DOI 10.14670/HH-19.465; Varelas X, 2014, DEVELOPMENT, V141, P1614, DOI 10.1242/dev.102376; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Wang Xiaojuan, 2002, Breast Cancer, V9, P216, DOI 10.1007/BF02967592; Wu J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.239; Xie M, 2012, J THORAC ONCOL, V7, P799, DOI 10.1097/JTO.0b013e318248240b; Xu JX, 2013, GENES CELLS, V18, P1082, DOI 10.1111/gtc.12102; Yang XL, 2011, CELL RES, V21, P715, DOI 10.1038/cr.2011.63; Yuen HF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054211; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Zhang WJ, 2014, CELL RES, V24, P331, DOI 10.1038/cr.2014.10; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhao B, 2009, CANCER RES, V69, P1089, DOI 10.1158/0008-5472.CAN-08-2997; Zhao YL, 2015, INT J CANCER, V137, P2767, DOI 10.1002/ijc.29293; Zhou Z, 2011, ONCOGENE, V30, P2181, DOI 10.1038/onc.2010.606; Zhou Z, 2011, MOL MED REP, V4, P1075, DOI 10.3892/mmr.2011.543	60	30	31	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16906	16917		10.1074/jbc.M115.642363	http://dx.doi.org/10.1074/jbc.M115.642363			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25995450	hybrid, Green Published			2022-12-28	WOS:000357572800035
J	Morales, Y; Nitzel, DV; Price, OM; Gui, SY; Li, J; Qu, J; Hevel, JM				Morales, Yalemi; Nitzel, Damon V.; Price, Owen M.; Gui, Shanying; Li, Jun; Qu, Jun; Hevel, Joan M.			Redox Control of Protein Arginine Methyltransferase 1 (PRMT1) Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASYMMETRICAL DIMETHYLARGININE; RISK-FACTOR; METHYLATION; DISEASE; ADMA; PHOSPHORYLATION; OLIGOMERIZATION; INACTIVATION; SPECIFICITY; DYSFUNCTION	Elevated levels of asymmetric dimethylarginine (ADMA) correlate with risk factors for cardiovascular disease. ADMA is generated by the catabolism of proteins methylated on arginine residues by protein arginine methyltransferases (PRMTs) and is degraded by dimethylarginine dimethylaminohydrolase. Reports have shown that dimethylarginine dimethylaminohydrolase activity is down-regulated and PRMT1 protein expression is up-regulated under oxidative stress conditions, leading many to conclude that ADMA accumulation occurs via increased synthesis by PRMTs and decreased degradation. However, we now report that the methyltransferase activity of PRMT1, the major PRMT isoform in humans, is impaired under oxidative conditions. Oxidized PRMT1 displays decreased activity, which can be rescued by reduction. This oxidation event involves one or more cysteine residues that become oxidized to sulfenic acid (-SOH). We demonstrate a hydrogen peroxide concentration-dependent inhibition of PRMT1 activity that is readily reversed under physiological H2O2 concentrations. Our results challenge the unilateral view that increased PRMT1 expression necessarily results in increased ADMA synthesis and demonstrate that enzymatic activity can be regulated in a redox-sensitive manner.	[Morales, Yalemi; Nitzel, Damon V.; Price, Owen M.; Gui, Shanying; Hevel, Joan M.] Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA; [Li, Jun; Qu, Jun] SUNY Buffalo, Dept Pharmaceut Sci, Buffalo, NY 14260 USA; [Li, Jun; Qu, Jun] New York State Ctr Excellence Bioinformat & Life, Buffalo, NY 14203 USA	Utah System of Higher Education; Utah State University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Hevel, JM (corresponding author), Utah State Univ, Dept Chem & Biochem, 0300 Old Main Hill, Logan, UT 84322 USA.	Joanie.Hevel@usu.edu	Gui, Shanying/AAM-8633-2021; Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; Price, Owen/0000-0001-5894-9022; Morales, Yalemi/0000-0001-9697-099X; Hevel, Joan/0000-0002-9559-4635	Utah State University URCO award; Utah State University Dissertation fellowship; National Science Foundation [0920776, 1412405]	Utah State University URCO award; Utah State University Dissertation fellowship; National Science Foundation(National Science Foundation (NSF))	This work was supported by a Utah State University URCO award (to O. M. P.), a Utah State University Dissertation fellowship (to Y. M.), and National Science Foundation Awards 0920776 and 1412405 (to J. M. H.).	Achan V, 2003, ARTERIOSCL THROM VAS, V23, P1455, DOI 10.1161/01.ATV.0000081742.92006.59; Antoniades C, 2009, EUR HEART J, V30, P1142, DOI 10.1093/eurheartj/ehp061; Atmane N, 2003, J BIOL CHEM, V278, P35086, DOI 10.1074/jbc.M303813200; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; Boger RH, 1998, CIRCULATION, V98, P1842, DOI 10.1161/01.CIR.98.18.1842; Boger RH, 2000, CIRC RES, V87, P99, DOI 10.1161/01.RES.87.2.99; Burgoyne JR, 2012, CIRC RES, V111, P1091, DOI 10.1161/CIRCRESAHA.111.255216; Carter EL, 2014, J INORG BIOCHEM, V133, P92, DOI 10.1016/j.jinorgbio.2014.01.005; Chen X, 2006, BASIC RES CARDIOL, V101, P346, DOI 10.1007/s00395-006-0592-5; Chen YH, 2009, EXP EYE RES, V89, P1028, DOI 10.1016/j.exer.2009.09.004; Cheng Y, 2011, J MOL BIOL, V414, P106, DOI 10.1016/j.jmb.2011.09.040; Chobanyan-Jurgens K, 2011, HYPERTENSION, V58, pE184, DOI 10.1161/HYPERTENSIONAHA.111.180984; Coiner H, 2006, PLANT J, V46, P193, DOI 10.1111/J.1365-313X.2006.02680.x; Cornell KA, 1996, BIOCHEM BIOPH RES CO, V228, P724, DOI 10.1006/bbrc.1996.1723; Di Simplicio P, 2003, AMINO ACIDS, V25, P323, DOI 10.1007/s00726-003-0020-1; Feng Y, 2011, BIOCHEMISTRY-US, V50, P7033, DOI 10.1021/bi200456u; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Gui SY, 2011, J BIOL CHEM, V286, P29118, DOI 10.1074/jbc.M111.224097; Hansen RE, 2009, ANAL BIOCHEM, V394, P147, DOI 10.1016/j.ab.2009.07.051; Higashimoto K, 2007, P NATL ACAD SCI USA, V104, P12318, DOI 10.1073/pnas.0610792104; Huang BW, 2013, FASEB J, V27, P3763, DOI 10.1096/fj.12-226043; Jiang JL, 2006, CARDIOVASC DRUG THER, V20, P281, DOI 10.1007/s10557-006-9065-1; Kielstein JT, 2004, CIRCULATION, V109, P172, DOI 10.1161/01.CIR.0000105764.22626.B1; Kleinschmidt MA, 2008, NUCLEIC ACIDS RES, V36, P3202, DOI 10.1093/nar/gkn166; Kolbel K, 2009, J BIOL CHEM, V284, P8274, DOI 10.1074/jbc.M809547200; Lafleur VN, 2014, MOL BIOL CELL, V25, P925, DOI 10.1091/mbc.E13-07-0423; Lim Y, 2005, BBA-GEN SUBJECTS, V1723, P240, DOI 10.1016/j.bbagen.2005.02.015; Lim Y, 2008, J BIOCHEM, V144, P523, DOI 10.1093/jb/mvn097; Lu TM, 2003, CLIN CARDIOL, V26, P458, DOI 10.1002/clc.4960261006; Luneburg N, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/501612; Nelson KJ, 2010, METHOD ENZYMOL, V473, P95, DOI 10.1016/S0076-6879(10)73004-4; OGAWA T, 1987, BIOCHEM BIOPH RES CO, V148, P671, DOI 10.1016/0006-291X(87)90929-6; Osborne TC, 2007, BIOCHEMISTRY-US, V46, P13370, DOI 10.1021/bi701558t; Sanchez R, 2008, PROTEIN SCI, V17, P473, DOI 10.1110/ps.073252408; STADTMAN ER, 1993, ANNU REV BIOCHEM, V62, P797, DOI 10.1146/annurev.bi.62.070193.004053; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; Suh-Lailam BB, 2010, ANAL BIOCHEM, V398, P218, DOI 10.1016/j.ab.2009.09.005; Sydow K, 2003, ATHEROSCLEROSIS SUPP, V4, P41, DOI 10.1016/S1567-5688(03)00033-3; Tang J, 1998, J BIOL CHEM, V273, P16935, DOI 10.1074/jbc.273.27.16935; Tang J, 2000, J BIOL CHEM, V275, P7723, DOI 10.1074/jbc.275.11.7723; Troffer-Charlier N, 2007, EMBO J, V26, P4391, DOI 10.1038/sj.emboj.7601855; Tyagi N, 2005, AM J PHYSIOL-HEART C, V289, pH2649, DOI 10.1152/ajpheart.00548.2005; Valkonen VP, 2001, LANCET, V358, P2127, DOI 10.1016/S0140-6736(01)07184-7; Vallance P, 2004, ARTERIOSCL THROM VAS, V24, P1023, DOI 10.1161/01.ATV.0000128897.54893.26; Wang R, 2011, MOL BIOSYST, V7, P2970, DOI 10.1039/c1mb05230f; Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472; Weiss VH, 2000, NAT STRUCT BIOL, V7, P1165; Wilcox CS, 2012, HYPERTENSION, V59, P375, DOI 10.1161/HYPERTENSIONAHA.111.187310; Wu YL, 1998, FEBS LETT, V440, P111, DOI 10.1016/S0014-5793(98)01415-X; Yamagata K, 2008, MOL CELL, V32, P221, DOI 10.1016/j.molcel.2008.09.013; Yue WW, 2007, EMBO J, V26, P4402, DOI 10.1038/sj.emboj.7601856; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zoccali C, 2001, LANCET, V358, P2113, DOI 10.1016/S0140-6736(01)07217-8	54	32	32	2	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					14915	14926		10.1074/jbc.M115.651380	http://dx.doi.org/10.1074/jbc.M115.651380			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25911106	Green Published, hybrid			2022-12-28	WOS:000356177300011
J	Spelios, MG; Olsen, JA; Kenna, LA; Akirav, EM				Spelios, Michael G.; Olsen, John A.; Kenna, Lauren A.; Akirav, Eitan M.			Islet Endothelial Cells Induce Glycosylation and Increase Cell-surface Expression of Integrin beta 1 in beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN SECRETORY RESPONSES; IN-VITRO; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; BETA-1-INTEGRIN; RECEPTORS; APOPTOSIS; ADHESION	The co-culturing of insulinoma and islet-derived endothelial cell (iEC) lines results in the spontaneous formation of free-floating pseudoislets (PIs). We previously showed that iEC-induced PIs display improved insulin expression and secretion in response to glucose stimulation. This improvement was associated with a de novo deposition of extracellular matrix (ECM) proteins by iECs in and around the PIs. Here, iEC-induced PIs were used to study the expression and posttranslational modification of the ECM receptor integrin beta 1. A wide array of integrin beta subunits was detected in beta TC3 and NIT-1 insulinomas as well as in primary islets, with integrin beta 1 mRNA and protein detected in all three cell types. Interestingly, the formation of iEC-induced PIs altered the glycosylation patterns of integrin beta 1, resulting in a higher molecular weight form of the receptor. This form was found in native pancreas but was completely absent in monolayer beta-cells. Fluorescence-activated cell sorting analysis of monolayers and PIs revealed a higher expression of integrin beta 1 in PIs. Antibody-mediated blocking of integrin beta 1 led to alterations in beta-cell morphology, reduced insulin gene expression, and enhanced glucose secretion under baseline conditions. These results suggest that iEC-induced PI formation may alter integrin beta 1 expression and posttranslational modification by enhancing glycosylation, thereby providing a more physiological culture system for studying integrin-ECM interactions in beta cells.	[Spelios, Michael G.; Olsen, John A.; Kenna, Lauren A.; Akirav, Eitan M.] Winthrop Univ Hosp, Res Inst, Islet Biol, Mineola, NY 11501 USA; [Akirav, Eitan M.] SUNY Stony Brook, Sch Med, Stony Brook, NY 11794 USA	Winthrop University Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Akirav, EM (corresponding author), 222 Stn Plaza North, Mineola, NY 11501 USA.	eakirav@winthrop.org			Novo Nordisk Diabetes Innovation Award; Winthrop-University Hospital	Novo Nordisk Diabetes Innovation Award; Winthrop-University Hospital	This work was supported by a Novo Nordisk Diabetes Innovation Award, 2012, and Winthrop-University Hospital.	AKIYAMA SK, 1987, J BIOL CHEM, V262, P17536; Bosco D, 2000, DIABETES, V49, P233, DOI 10.2337/diabetes.49.2.233; Castello-Cros R, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-94; Daoud J, 2010, BIOMATERIALS, V31, P1676, DOI 10.1016/j.biomaterials.2009.11.057; Diaferia GR, 2013, DEVELOPMENT, V140, P3360, DOI 10.1242/dev.098533; EFRAT S, 1988, P NATL ACAD SCI USA, V85, P9037, DOI 10.1073/pnas.85.23.9037; Gu JG, 2009, BIOL PHARM BULL, V32, P780, DOI 10.1248/bpb.32.780; Hammar E, 2004, DIABETES, V53, P2034, DOI 10.2337/diabetes.53.8.2034; Hauge-Evans AC, 1999, DIABETES, V48, P1402, DOI 10.2337/diabetes.48.7.1402; HOTCHIN NA, 1992, J BIOL CHEM, V267, P14852; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Jiang FX, 2002, J HISTOCHEM CYTOCHEM, V50, P1625, DOI 10.1177/002215540205001206; Johansson M, 2006, ENDOCRINOLOGY, V147, P2315, DOI 10.1210/en.2005-0997; Kaas A, 2010, CLIN EXP IMMUNOL, V161, P444, DOI 10.1111/j.1365-2249.2010.04193.x; Kaido T, 2004, J BIOL CHEM, V279, P53762, DOI 10.1074/jbc.M411202200; Kaido T, 2004, J BIOL CHEM, V279, P17731, DOI 10.1074/jbc.M308425200; Kaido TJ, 2010, J CELL PHYSIOL, V224, P101, DOI 10.1002/jcp.22101; Kantengwa S, 1997, EXP CELL RES, V237, P394, DOI 10.1006/excr.1997.3803; Krishnamurthy M, 2011, ENDOCRINOLOGY, V152, P424, DOI 10.1210/en.2010-0877; Krishnamurthy M, 2008, J CELL COMMUN SIGNAL, V2, P67, DOI 10.1007/s12079-008-0030-6; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Li TS, 2005, CARDIOVASC RES, V65, P64, DOI 10.1016/j.cardiores.2004.08.019; Luther MJ, 2006, BIOCHEM BIOPH RES CO, V343, P99, DOI 10.1016/j.bbrc.2006.02.003; Luther MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE502, DOI 10.1152/ajpendo.00424.2004; MENDOLA JF, 1994, TRANSPLANTATION, V57, P725, DOI 10.1097/00007890-199403150-00015; Nanji SA, 2006, DIABETES OBES METAB, V8, P15, DOI 10.1111/j.1463-1326.2005.00476.x; Nikolova G, 2006, DEV CELL, V10, P397, DOI 10.1016/j.devcel.2006.01.015; Olsson R, 2006, INT J BIOCHEM CELL B, V38, P492, DOI 10.1016/j.biocel.2005.06.021; Paraskevas S, 2000, PANCREAS, V20, P270, DOI 10.1097/00006676-200004000-00008; Parnaud G, 2006, DIABETES, V55, P1413, DOI 10.2337/db05-1388; PARR EL, 1980, TRANSPLANTATION, V30, P135, DOI 10.1097/00007890-198008000-00012; Rosenberg L, 1999, SURGERY, V126, P393, DOI 10.1067/msy.1999.98783; Saleem S, 2009, J PATHOL, V219, P182, DOI 10.1002/path.2577; Spelios MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072260; Stendahl JC, 2009, CELL TRANSPLANT, V18, P1, DOI 10.3727/096368909788237195; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Wang RN, 2005, DIABETES, V54, P2080, DOI 10.2337/diabetes.54.7.2080; Yashpal NK, 2005, ENDOCRINOLOGY, V146, P1798, DOI 10.1210/en.2004-1292	38	9	9	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15250	15259		10.1074/jbc.M114.628784	http://dx.doi.org/10.1074/jbc.M114.628784			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25911095	hybrid, Green Published			2022-12-28	WOS:000356177300037
J	Tebbi, A; Guittet, O; Tuphile, K; Cabrie, A; Lepoivre, M				Tebbi, Ali; Guittet, Olivier; Tuphile, Karine; Cabrie, Aimeric; Lepoivre, Michel			Caspase-dependent Proteolysis of Human Ribonucleotide Reductase Small Subunits R2 and p53R2 during Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; NITRIC-OXIDE; CARBOXYL-TERMINUS; GENOME INTEGRITY; CELL-DEATH; PROTEIN R1; PATHWAYS; MOUSE; REPAIR; DEGRADATION	Ribonucleotide reductase (RnR) is a key enzyme synthesizing deoxyribonucleotides for DNA replication and repair. In mammals, the R1 catalytic subunit forms an active complex with either one of the two small subunits R2 and p53R2. Expression of R2 is S phase-specific and required for DNA replication. The p53R2 protein is expressed throughout the cell cycle and in quiescent cells where it provides dNTPs for mitochondrial DNA synthesis. Participation of R2 and p53R2 in DNA repair has also been suggested. In this study, we investigated the fate of the RnR subunits during apoptosis. The p53R2 protein was cleaved in a caspase-dependent manner in K-562 cells treated with inhibitors of the Bcr-Abl oncogenic kinase and in HeLa 229 cells incubated with TNF-alpha and cycloheximide. The cleavage site was mapped between Asp(342) and Asn(343). Caspase attack released a C-terminal p53R2 peptide of nine residues containing the conserved heptapeptide essential for R1 binding. As a consequence, the cleaved p53R2 protein was inactive. In vitro, purified caspase-3 and -8 could release the C-terminal tail of p53R2. Knocking down these caspases, but not caspase-2, -7, and -10, also inhibited p53R2 cleavage in cells committed to die via the extrinsic death receptor pathway. The R2 subunit was subjected to caspase-and proteasome-dependent proteolysis, which was prevented by siRNA targeting caspase-8. Knocking down caspase-3 was ineffective. Protein R1 was not subjected to degradation. Adding deoxyribonucleosides to restore dNTP pools transiently protected cells from apoptosis. These data identify RnR activity as a prosurvival function inactivated by proteolysis during apoptosis.	[Tebbi, Ali; Guittet, Olivier; Tuphile, Karine; Cabrie, Aimeric; Lepoivre, Michel] Univ Paris 11, Inst Mol & Cellular Biochem & Biophys, UMR 8619, F-91405 Orsay, France; [Tebbi, Ali; Guittet, Olivier; Tuphile, Karine; Cabrie, Aimeric; Lepoivre, Michel] CNRS, F-91405 Orsay, France; [Tebbi, Ali] Inst Pasteur, Dept Virol, Pathogenesis Hepatitis Virus B, F-75015 Paris, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Lepoivre, M (corresponding author), Univ Paris 11, CNRS, UMR 8619, IBBMC, F-91405 Orsay, France.	michel.lepoivre@u-psud.fr			Groupement des Entreprises Francaises dans la Lutte contre le Cancer Paris Ile-de-France; l'Association pour la Recherche sur le Cancer	Groupement des Entreprises Francaises dans la Lutte contre le Cancer Paris Ile-de-France; l'Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was supported in part by a grant from the Groupement des Entreprises Francaises dans la Lutte contre le Cancer Paris Ile-de-France (to M. L.).; Supported by a fellowship from l'Association pour la Recherche sur le Cancer.	Arntzen MO, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010447; Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040; Chabes AL, 2003, P NATL ACAD SCI USA, V100, P3925, DOI 10.1073/pnas.0330774100; Cooperman BS, 2003, BIOPOLYMERS, V71, P117, DOI 10.1002/bip.10397; D'Angiolella V, 2012, CELL, V149, P1023, DOI 10.1016/j.cell.2012.03.043; Devlin HL, 2008, MOL CANCER RES, V6, P808, DOI 10.1158/1541-7786.MCR-07-2027; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Fairman JW, 2011, NAT STRUCT MOL BIOL, V18, P316, DOI 10.1038/nsmb.2007; FILATOV D, 1992, J BIOL CHEM, V267, P15816; Guittet O, 1998, J BIOL CHEM, V273, P22136, DOI 10.1074/jbc.273.34.22136; Guittet O, 2008, NITRIC OXIDE-BIOL CH, V19, P84, DOI 10.1016/j.niox.2008.04.011; Inoue S, 2009, CELL DEATH DIFFER, V16, P1053, DOI 10.1038/cdd.2009.29; LEPOIVRE M, 1994, J BIOL CHEM, V269, P21891; LYCKSELL PO, 1994, BIOCHEMISTRY-US, V33, P2838, DOI 10.1021/bi00176a013; Mahrus S, 2008, CELL, V134, P866, DOI 10.1016/j.cell.2008.08.012; MANN GJ, 1991, BIOCHEMISTRY-US, V30, P1939, DOI 10.1021/bi00221a030; McStay GP, 2008, CELL DEATH DIFFER, V15, P322, DOI 10.1038/sj.cdd.4402260; Niida H, 2010, CANCER SCI, V101, P2505, DOI 10.1111/j.1349-7006.2010.01719.x; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Nowsheen S., 2012, Experimental Oncology, V34, P243; Pontarin G, 2007, J BIOL CHEM, V282, P16820, DOI 10.1074/jbc.M701310200; Pontarin G, 2012, P NATL ACAD SCI USA, V109, P13302, DOI 10.1073/pnas.1211289109; Prunet C, 2005, J BIOCHEM MOL TOXIC, V19, P311, DOI 10.1002/jbt.20096; Qiu WH, 2006, BIOCHEM BIOPH RES CO, V340, P428, DOI 10.1016/j.bbrc.2005.12.019; SJOBERG BM, 1987, J BIOL CHEM, V262, P9736; Smith P, 2009, BIOCHEMISTRY-US, V48, P11134, DOI 10.1021/bi9001425; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; Tebbi A, 2011, J BIOL CHEM, V286, P7873, DOI 10.1074/jbc.M110.184879; Thelander Lars, 1994, V30, P109; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; UHLIN U, 1994, NATURE, V370, P533, DOI 10.1038/370533a0; Varshavsky A, 1997, GENES CELLS, V2, P13, DOI 10.1046/j.1365-2443.1997.1020301.x; Verspurten J, 2009, TRENDS BIOCHEM SCI, V34, P319, DOI 10.1016/j.tibs.2009.04.001; YANG FD, 1990, FEBS LETT, V272, P61, DOI 10.1016/0014-5793(90)80449-S	34	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					14077	14090		10.1074/jbc.M115.649640	http://dx.doi.org/10.1074/jbc.M115.649640			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25878246	Green Published, hybrid			2022-12-28	WOS:000355313000037
J	Fakhraldeen, SA; Clark, RJ; Roopra, A; Chin, EN; Huang, W; Castorino, J; Wisinski, KB; Kim, T; Spiegelman, VS; Alexander, CM				Fakhraldeen, Saja A.; Clark, Rod J.; Roopra, Avtar; Chin, Emily N.; Huang, Wei; Castorino, John; Wisinski, Kari B.; Kim, TaeWon; Spiegelman, Vladimir S.; Alexander, Caroline M.			Two Isoforms of the RNA Binding Protein, Coding Region Determinant-binding Protein (CRD-BP/IGF2BP1), Are Expressed in Breast Epithelium and Support Clonogenic Growth of Breast Tumor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYC MESSENGER-RNA; CANCER-CELLS; C-MYC; CRD-BP; STEM-CELLS; KH DOMAINS; ZBP1; TRANSLATION; IGF2BP1; IMP1	CRD-BP/IGF2BP1 has been characterized as an "oncofetal" RNA binding protein typically highly expressed in embryonic tissues, suppressed in normal adult tissues, but induced in many tumor types. In this study, we show that adult breast tissues express ubiquitous but low levels of CRD-BP protein and mRNA. Although CRD-BP mRNA expression is induced in breast tumor cells, levels remain similar to 1000-fold lower than in embryonic tissues. Despite low expression levels, CRD-BP is required for clonogenic growth of breast cancer cells. We reveal that because the most common protein isoform in normal adult breast and breast tumors has an N-terminal deletion (lacking two RNA recognition motif (RRM) domains) and is therefore missing antibody epitopes, CRD-BP expression has been under-reported by previous studies. We show that a CRD-BP mutant mouse strain retains expression of the shorter transcript (Delta N-CRD-BP), which originates in intron 2, suggesting that the impact of complete ablation of this gene in mice is not yet known. Either the full-length CRD-BP or the N-terminally truncated version can rescue the clonogenicity of CRD-BP knockdown breast cancer cells, suggesting that clonogenic function is served by either CRD-BP isoform. In summary, although CRD-BP expression levels are low in breast cancer cells, this protein is necessary for clonogenic activity.	[Fakhraldeen, Saja A.; Clark, Rod J.; Chin, Emily N.; Alexander, Caroline M.] Univ Wisconsin, Sch Med & Publ Hlth, McArdle Lab Canc Res, Madison, WI 53705 USA; [Roopra, Avtar] Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurosci, Madison, WI 53705 USA; [Huang, Wei] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pathol & Lab Med, Madison, WI 53705 USA; [Wisinski, Kari B.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Madison, WI 53705 USA; [Kim, TaeWon; Spiegelman, Vladimir S.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Dermatol, Madison, WI 53705 USA; [Castorino, John] Hampshire Coll, Sch Nat Sci, Amherst, MA 01002 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Alexander, CM (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, McArdle Lab Canc Res, 1111 Highland Ave, Madison, WI 53705 USA.	alexander@oncology.wisc.edu		Spiegelman, Vladimir S/0000-0003-4847-155X; Kim, TaeWon/0000-0002-6443-2465; Fakhraldeen, Saja/0000-0003-3919-0270	National Institutes of Health, NCI [T32 CA009135]; Era of Hope Scholars Award [W81XWH-06-1-0491 CDMRP]; Cancer Center Core Support for University of Wisconsin [AR063361, P30 CA014520]; Kuwait Foundation for the Advancement of Sciences [2013-6302-03]; Cancer Center Core Grant [NCI 2P 30CA014520-39]; NATIONAL CANCER INSTITUTE [T32CA009135, P30CA014520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063361] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Era of Hope Scholars Award; Cancer Center Core Support for University of Wisconsin; Kuwait Foundation for the Advancement of Sciences(Kuwait Foundation for the Advancement of Sciences (KFAS)); Cancer Center Core Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health, NCI Grant T32 CA009135 (to S. A. F.), Era of Hope Scholars Award W81XWH-06-1-0491 CDMRP (to C. M. A. and R. J. C.), and Grants AR063361 (to V. S. S. and T. W. K.) and P30 CA014520 from Cancer Center Core Support for University of Wisconsin (to C. M. A. and V. S. S.). This project was also supported in part by the Kuwait Foundation for the Advancement of Sciences under project 2013-6302-03 and by Cancer Center Core Grant, NCI 2P 30CA014520-39 to the Translational Science BioCore Biobank of the University of Wisconsin Carbone Cancer Center.	Badders NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006594; Bell JL, 2013, CELL MOL LIFE SCI, V70, P2657, DOI 10.1007/s00018-012-1186-z; BERNSTEIN PL, 1992, GENE DEV, V6, P642, DOI 10.1101/gad.6.4.642; Boyerinas B, 2008, CANCER RES, V68, P2587, DOI 10.1158/0008-5472.CAN-08-0264; Boyerinas B, 2012, INT J CANCER, V130, P1787, DOI 10.1002/ijc.26190; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Brackett DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058296; Chao JA, 2010, GENE DEV, V24, P148, DOI 10.1101/gad.1862910; Craig EA, 2012, PIGM CELL MELANOMA R, V25, P83, DOI 10.1111/j.1755-148X.2011.00921.x; de Klerk E, 2015, TRENDS GENET, V31, P128, DOI 10.1016/j.tig.2015.01.001; Dimitriadis E, 2007, INT J CANCER, V121, P486, DOI 10.1002/ijc.22716; Doyle GA, 2000, CANCER RES, V60, P2756; Elcheva I, 2008, ONCOGENE, V27, P5069, DOI 10.1038/onc.2008.141; Eyal Y, 1999, BIOTECHNIQUES, V27, P656, DOI 10.2144/99274bm04; Farina KL, 2003, J CELL BIOL, V160, P77, DOI 10.1083/jcb.200206003; Goel S, 2012, J BIOL CHEM, V287, P16454, DOI 10.1074/jbc.M112.362137; Gu W, 2008, MOL CELL BIOL, V28, P4963, DOI 10.1128/MCB.00266-08; Gu W, 2012, J CELL SCI, V125, P81, DOI 10.1242/jcs.086132; Gu W, 2009, J CELL SCI, V122, P1895, DOI 10.1242/jcs.045278; Gutschner T, 2014, HEPATOLOGY, V59, P1900, DOI 10.1002/hep.26997; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hansen TVO, 2004, MOL CELL BIOL, V24, P4448, DOI 10.1128/MCB.24.10.4448-4464.2004; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; Ioannidis P, 2005, J BIOL CHEM, V280, P20086, DOI 10.1074/jbc.M410036200; Ioannidis P, 2003, INT J CANCER, V104, P54, DOI 10.1002/ijc.10794; Jonson L, 2007, MOL CELL PROTEOMICS, V6, P798, DOI 10.1074/mcp.M600346-MCP200; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Le HTT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033140; Lembo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031129; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahaira LG, 2014, STEM CELLS DEV, V23, P2501, DOI 10.1089/scd.2013.0604; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Mongroo PS, 2011, CANCER RES, V71, P2172, DOI 10.1158/0008-5472.CAN-10-3295; Moschner K, 2014, J BIOL CHEM, V289, P16814, DOI 10.1074/jbc.M113.541425; Nielsen FC, 2002, J CELL SCI, V115, P2087; Nielsen J, 2000, MECH DEVELOP, V96, P129, DOI 10.1016/S0925-4773(00)00383-X; Nielsen J, 1999, MOL CELL BIOL, V19, P1262; Nielsen J, 2003, BIOCHEM J, V376, P383, DOI 10.1042/BJ20030943; Nishikawa T, 2000, BIOINFORMATICS, V16, P960, DOI 10.1093/bioinformatics/16.11.960; Nishino J, 2013, ELIFE, V2, DOI 10.7554/eLife.00924; Noubissi FK, 2006, NATURE, V441, P898, DOI 10.1038/nature04839; Noubissi FK, 2014, J INVEST DERMATOL, V134, P1718, DOI 10.1038/jid.2014.17; Noubissi Felicite K, 2010, Genes Cancer, V1, P1074, DOI 10.1177/1947601910395581; Noubissi FK, 2009, CANCER RES, V69, P8572, DOI 10.1158/0008-5472.CAN-09-1500; Rackham O, 2004, EMBO J, V23, P3346, DOI 10.1038/sj.emboj.7600341; Ross AF, 1997, MOL CELL BIOL, V17, P2158, DOI 10.1128/MCB.17.4.2158; Ross J, 2001, ONCOGENE, V20, P6544, DOI 10.1038/sj.onc.1204838; Runge S, 2000, J BIOL CHEM, V275, P29562, DOI 10.1074/jbc.M001156200; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Stohr N, 2012, GENE DEV, V26, P176, DOI 10.1101/gad.177642.111; Tessier CR, 2004, CANCER RES, V64, P209, DOI 10.1158/0008-5472.CAN-03-2927; Vikesaa J, 2006, EMBO J, V25, P1456, DOI 10.1038/sj.emboj.7601039; Yisraeli JK, 2005, BIOL CELL, V97, P87	53	35	36	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13386	13400		10.1074/jbc.M115.655175	http://dx.doi.org/10.1074/jbc.M115.655175			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25861986	Green Published, hybrid			2022-12-28	WOS:000354975700035
J	Schmidt, PJ				Schmidt, Paul J.			Regulation of Iron Metabolism by Hepcidin under Conditions of Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							MESSENGER-RNA EXPRESSION; ANTIMICROBIAL PEPTIDE; MOUSE MODEL; BETA-THALASSEMIA; GENE-EXPRESSION; RECEPTOR ALK3; ANEMIA; MICE; HFE; INDUCTION	Iron is a redox-active metal required as a cofactor in multiple metalloproteins essential for a host of life processes. The metal is highly toxic when present in excess and must be strictly regulated to prevent tissue and organ damage. Hepcidin, a molecule first characterized as an antimicrobial peptide, plays a critical role in the regulation of iron homeostasis. Multiple stimuli positively influence the expression of hepcidin, including iron, inflammation, and infection by pathogens. In this Minireview, I will discuss how inflammation regulates hepcidin transcription, allowing for sufficient concentrations of iron for organismal needs while sequestering the metal from infectious pathogens.	[Schmidt, Paul J.] Boston Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; [Schmidt, Paul J.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Schmidt, PJ (corresponding author), Boston Childrens Hosp, Dept Pathol, Enders Res Bldg,Rm 1110 BCH3108,320 Longwood Ave, Boston, MA 02115 USA.	paul.schmidt@childrens.harvard.edu						Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Adamsky K, 2004, BRIT J HAEMATOL, V124, P123, DOI 10.1046/j.1365-2141.2003.04734.x; Ahmad KA, 2002, BLOOD CELL MOL DIS, V29, P361, DOI 10.1006/bcmd.2002.0575; Anderson DS, 2010, ANAL CHEM, V82, P1551, DOI 10.1021/ac902479p; Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Armitage AE, 2014, P NATL ACAD SCI USA, V111, P12187, DOI 10.1073/pnas.1402351111; Armitage AE, 2011, BLOOD, V118, P4129, DOI 10.1182/blood-2011-04-351957; Artz AS, 2014, BRIT J HAEMATOL, V167, P286, DOI 10.1111/bjh.12984; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Besson-Fournier C, 2012, BLOOD, V120, P431, DOI 10.1182/blood-2012-02-411470; Camaschella C, 2000, NAT GENET, V25, P14, DOI 10.1038/75534; CARTWRIGHT GE, 1946, J CLIN INVEST, V25, P65, DOI 10.1172/JCI101690; Chen W, 2011, BLOOD, V117, P6319, DOI 10.1182/blood-2010-12-327957; Chen Y, 2015, CELL SIGNAL, V27, P168, DOI 10.1016/j.cellsig.2014.11.002; D'Alessio F, 2012, J HEPATOL, V57, P1052, DOI 10.1016/j.jhep.2012.06.015; Deschemin JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061050; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Drakesmith H, 2005, BLOOD, V106, P1092, DOI 10.1182/blood-2005-02-0561; Falzacappa MVV, 2008, J MOL MED, V86, P531, DOI 10.1007/s00109-008-0313-7; Falzacappa MVV, 2007, BLOOD, V109, P353, DOI 10.1182/blood-2006-07-033969; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; FINCH C, 1994, BLOOD, V84, P1697; Fleming MD, 1997, NAT GENET, V16, P383, DOI 10.1038/ng0897-383; Frank KM, 2011, NEW ENGL J MED, V364, P2563, DOI 10.1056/NEJMc1010939; Ganz T, 2008, BLOOD, V112, P4292, DOI 10.1182/blood-2008-02-139915; Gardenghi S, 2014, BLOOD, V123, P1137, DOI 10.1182/blood-2013-08-521625; Gkouvatsos K, 2011, HEPATOLOGY, V54, P1800, DOI 10.1002/hep.24547; Guida C, 2015, BLOOD, V125, P2265, DOI 10.1182/blood-2014-08-595256; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Guo SL, 2013, J CLIN INVEST, V123, P1531, DOI 10.1172/JCI66969; Gutschow P, 2015, HAEMATOLOGICA, V100, P167, DOI 10.3324/haematol.2014.116723; Harris ZL, 1999, P NATL ACAD SCI USA, V96, P10812, DOI 10.1073/pnas.96.19.10812; Howard CT, 2007, AM J TROP MED HYG, V77, P623, DOI 10.4269/ajtmh.2007.77.623; Huang FW, 2005, J CLIN INVEST, V115, P2187, DOI 10.1172/JCI25049; Kartikasari AER, 2008, BBA-PROTEINS PROTEOM, V1784, P2029, DOI 10.1016/j.bbapap.2008.08.004; Kautz L, 2014, BLOOD, V124, P2569, DOI 10.1182/blood-2014-06-584607; Kautz L, 2014, NAT GENET, V46, P678, DOI 10.1038/ng.2996; Kawabata H, 2005, BLOOD, V105, P376, DOI 10.1182/blood-2004-04-1416; Kemna E, 2005, BLOOD, V106, P1864, DOI 10.1182/blood-2005-03-1159; Kim A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093283; Kim A, 2014, BLOOD, V123, P1129, DOI 10.1182/blood-2013-08-521419; Krause A, 2000, FEBS LETT, V480, P147, DOI 10.1016/S0014-5793(00)01920-7; Langdon JM, 2014, AM J HEMATOL, V89, P470, DOI 10.1002/ajh.23670; Lee P, 2005, P NATL ACAD SCI USA, V102, P1906, DOI 10.1073/pnas.0409808102; Lesbordes-Brion JC, 2006, BLOOD, V108, P1402, DOI 10.1182/blood-2006-02-003376; Maccio A, 2015, HAEMATOLOGICA, V100, P124, DOI 10.3324/haematol.2014.112813; Maes K, 2010, BLOOD, V116, P3635, DOI 10.1182/blood-2010-03-274571; Mayeur C, 2014, BLOOD, V123, P2261, DOI 10.1182/blood-2013-02-480095; McCranor BJ, 2013, HAEMATOLOGICA, V98, P1633, DOI 10.3324/haematol.2013.087114; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Millonig G, 2012, J BIOL CHEM, V287, P37472, DOI 10.1074/jbc.M112.358911; Motley ST, 2004, CELL MICROBIOL, V6, P849, DOI 10.1111/j.1462-5822.2004.00407.x; Muckenthaler M, 2003, NAT GENET, V34, P102, DOI 10.1038/ng1152; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nicolas G, 2002, P NATL ACAD SCI USA, V99, P4596, DOI 10.1073/pnas.072632499; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498; Niederkofler V, 2005, J CLIN INVEST, V115, P2180, DOI 10.1172/JCI25683; Oliveira SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006618; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Peyssonnaux C, 2006, BLOOD, V107, P3727, DOI 10.1182/blood-2005-06-2259; Pietrangelo A, 2007, GASTROENTEROLOGY, V132, P294, DOI 10.1053/j.gastro.2006.10.018; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Ramos E, 2012, BLOOD, V120, P3829, DOI 10.1182/blood-2012-07-440743; Rivera S, 2005, BLOOD, V106, P2196, DOI 10.1182/blood-2005-04-1766; Rodriguez R, 2014, INFECT IMMUN, V82, P745, DOI 10.1128/IAI.00983-13; Roy CN, 2007, BLOOD, V109, P4038, DOI 10.1182/blood-2006-10-051755; Roy CN, 2004, NAT GENET, V36, P481, DOI 10.1038/ng1350; Ryan JD, 2012, HEPATOLOGY, V56, P492, DOI 10.1002/hep.25666; Sakamori R, 2010, J GASTROENTEROL, V45, P244, DOI 10.1007/s00535-009-0159-y; Sasu BJ, 2010, BLOOD, V115, P3616, DOI 10.1182/blood-2009-09-245977; Schmidt PJ, 2008, CELL METAB, V7, P205, DOI 10.1016/j.cmet.2007.11.016; Schmidt PJ, 2013, BLOOD, V121, P1200, DOI 10.1182/blood-2012-09-453977; Schmidt PJ, 2012, AM J HEMATOL, V87, P588, DOI 10.1002/ajh.23173; Sharma S, 2008, CLIN CANCER RES, V14, P3262, DOI 10.1158/1078-0432.CCR-07-4153; Shike H, 2002, EUR J BIOCHEM, V269, P2232, DOI 10.1046/j.1432-1033.2002.02881.x; Spottiswoode N, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00125; Steinbicker AU, 2011, BLOOD, V118, P4224, DOI 10.1182/blood-2011-03-339952; Steinbicker AU, 2011, BLOOD, V117, P4915, DOI 10.1182/blood-2010-10-313064; Theurl I, 2008, BLOOD, V111, P2392, DOI 10.1182/blood-2007-05-090019; Theurl I, 2011, BLOOD, V118, P4977, DOI 10.1182/blood-2011-03-345066; Truksa J, 2009, BLOOD, V113, P688, DOI 10.1182/blood-2008-05-160184; Vecchi C, 2009, SCIENCE, V325, P877, DOI 10.1126/science.1176639; Vulpe CD, 1999, NAT GENET, V21, P195, DOI 10.1038/5979; Wallace DF, 2011, BLOOD, V117, P2960, DOI 10.1182/blood-2010-08-303859; Wallace DF, 2009, HEPATOLOGY, V50, P1992, DOI 10.1002/hep.23198; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; Weinstein DA, 2002, BLOOD, V100, P3776, DOI 10.1182/blood-2002-04-1260; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; West AP, 2001, J MOL BIOL, V313, P385, DOI 10.1006/jmbi.2001.5048; Wrighting DM, 2006, BLOOD, V108, P3204, DOI 10.1182/blood-2006-06-027631; Wu XG, 2014, BLOOD, V124, P1335, DOI 10.1182/blood-2014-01-552281; Xia Y, 2008, BLOOD, V111, P5195, DOI 10.1182/blood-2007-09-111567; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040; Zhang SP, 2014, CELL SIGNAL, V26, P2539, DOI 10.1016/j.cellsig.2014.07.029	101	97	103	3	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					18975	18983		10.1074/jbc.R115.650150	http://dx.doi.org/10.1074/jbc.R115.650150			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26055723	Green Published, hybrid			2022-12-28	WOS:000358781100012
J	Yao, JW; Cherian, PT; Frank, MW; Rock, CO				Yao, Jiangwei; Cherian, Philip T.; Frank, Matthew W.; Rock, Charles O.			Chlamydia trachomatis Relies on Autonomous Phospholipid Synthesis for Membrane Biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OBLIGATE INTRACELLULAR PATHOGEN; ENDOCYTIC MULTIVESICULAR BODIES; FATTY-ACID SYNTHESIS; HOST-CELL; DEVELOPMENTAL CYCLE; ENDOPLASMIC-RETICULUM; ESCHERICHIA-COLI; EPITHELIAL-CELLS; LIPID-METABOLISM; BINDING PROTEIN	The obligate intracellular parasite Chlamydia trachomatis has a reduced genome and is thought to rely on its mammalian host cell for nutrients. Although several lines of evidence suggest C. trachomatis utilizes host phospholipids, the bacterium encodes all the genes necessary for fatty acid and phospholipid synthesis found in free living Gram-negative bacteria. Bacterially derived phospholipids significantly increased in infected HeLa cell cultures. These new phospholipids had a distinct molecular species composition consisting of saturated and branched-chain fatty acids. Biochemical analysis established the role of C. trachomatis-encoded acyltransferases in producing the new disaturated molecular species. There was no evidence for the remodeling of host phospholipids and no change in the size or molecular species composition of the phosphatidylcholine pool in infected HeLa cells. Host sphingomyelin was associated with C. trachomatis isolated by detergent extraction, but it may represent contamination with detergent-insoluble host lipids rather than being an integral bacterial membrane component. C. trachomatis assembles its membrane systems from the unique phospholipid molecular species produced by its own fatty acid and phospholipid biosynthetic machinery utilizing glucose, isoleucine, and serine.	[Yao, Jiangwei; Frank, Matthew W.; Rock, Charles O.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Cherian, Philip T.] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Rock, CO (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	charles.rock@stjude.org	Regan, Clinton/E-6250-2012	Yao, Jiangwei/0000-0001-7088-3468; Frank, Matthew/0000-0002-4914-1440; Cherian, Philip/0000-0002-1070-6483	National Institutes of Health [GM034496]; Cancer Center Support Grant [CA21765]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034496, R01GM034496] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM034496 (to C.O.R.). This work was also supported by Cancer Center Support Grant CA21765 and the American Lebanese Syrian Associated Charities. The authors declare that they have no conflicts of interest with the contents of this article.	Al-Zeer MA, 2014, MOL MICROBIOL, V94, P1285, DOI 10.1111/mmi.12829; ALVAREZ JG, 1992, J CHROMATOGR-BIOMED, V577, P142, DOI 10.1016/0378-4347(92)80609-T; Babiychuk EB, 2006, BIOCHEM J, V397, P407, DOI 10.1042/BJ20060056; Bastidas RJ, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010256; Beatty WL, 2008, INFECT IMMUN, V76, P2872, DOI 10.1128/IAI.00129-08; Beatty WL, 2006, J CELL SCI, V119, P350, DOI 10.1242/jcs.02733; BECKER Y, 1978, MICROBIOL REV, V42, P274, DOI 10.1128/MMBR.42.2.274-306.1978; Belland RJ, 2003, P NATL ACAD SCI USA, V100, P8478, DOI 10.1073/pnas.1331135100; BIDAWID S, 1989, A VAN LEEUW J MICROB, V55, P123, DOI 10.1007/BF00404752; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CALDWELL HD, 1981, INFECT IMMUN, V31, P1161, DOI 10.1128/IAI.31.3.1161-1176.1981; Carabeo RA, 2003, P NATL ACAD SCI USA, V100, P6771, DOI 10.1073/pnas.1131289100; Casadei BR, 2014, MOL MEMBR BIOL, V31, P195, DOI 10.3109/09687688.2014.949319; Cocchiaro JL, 2008, P NATL ACAD SCI USA, V105, P9379, DOI 10.1073/pnas.0712241105; COLEMAN J, 1992, MOL GEN GENET, V232, P295, DOI 10.1007/BF00280009; Cox JV, 2012, CELL MICROBIOL, V14, P1497, DOI 10.1111/j.1462-5822.2012.01823.x; Derre I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002092; Dumoux M, 2015, CURR OPIN MICROBIOL, V23, P1, DOI 10.1016/j.mib.2014.09.019; Dumoux M, 2012, TRAFFIC, V13, P1612, DOI 10.1111/tra.12002; Elwell CA, 2012, CELL MICROBIOL, V14, P1010, DOI 10.1111/j.1462-5822.2012.01794.x; Elwell CA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002198; Fagone P, 2013, BBA-MOL CELL BIOL L, V1831, P523, DOI 10.1016/j.bbalip.2012.09.009; Fields KA, 2002, ANNU REV CELL DEV BI, V18, P221, DOI 10.1146/annurev.cellbio.18.012502.105845; Fukuda EY, 2005, INFECT IMMUN, V73, P4017, DOI 10.1128/IAI.73.7.4017-4024.2005; Giles DK, 2008, MICROBES INFECT, V10, P1494, DOI 10.1016/j.micinf.2008.09.001; HACKSTADT T, 1995, P NATL ACAD SCI USA, V92, P4877, DOI 10.1073/pnas.92.11.4877; Hackstadt T, 1996, EMBO J, V15, P964, DOI 10.1002/j.1460-2075.1996.tb00433.x; Hatch GM, 1998, INFECT IMMUN, V66, P3727, DOI 10.1128/IAI.66.8.3727-3735.1998; Heuer D, 2009, NATURE, V457, P731, DOI 10.1038/nature07578; HOWARD L, 1974, APPL MICROBIOL, V27, P102, DOI 10.1128/AEM.27.1.102-106.1974; Ivanova PT, 2007, METHOD ENZYMOL, V432, P21, DOI 10.1016/S0076-6879(07)32002-8; JACKOWSKI S, 1986, J BIOL CHEM, V261, P1328; Koumanov KS, 2004, SUB CELL BIOCHEM, V37, P153; Krank J, 2007, METHOD ENZYMOL, V432, P1, DOI 10.1016/S0076-6879(07)32001-6; Kumar Y, 2006, CURR BIOL, V16, P1646, DOI 10.1016/j.cub.2006.06.060; Lu YH, 2011, J BIOL CHEM, V286, P5506, DOI 10.1074/jbc.M110.199265; MacKenzie A, 2009, J AM OIL CHEM SOC, V86, P757, DOI 10.1007/s11746-009-1403-6; Nans A, 2014, CELL MICROBIOL, V16, P1457, DOI 10.1111/cmi.12310; Nicholson TL, 2003, J BACTERIOL, V185, P3179, DOI 10.1128/JB.185.10.3179-3189.2003; Parsons JB, 2013, PROG LIPID RES, V52, P249, DOI 10.1016/j.plipres.2013.02.002; Parsons JB, 2011, P NATL ACAD SCI USA, V108, P15378, DOI 10.1073/pnas.1109208108; PETERSON EM, 1988, J BACTERIOL, V170, P1389, DOI 10.1128/jb.170.3.1389-1392.1988; Pilhofer M, 2014, ENVIRON MICROBIOL, V16, P417, DOI 10.1111/1462-2920.12299; Robertson DK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000664; Rock C O, 1981, Methods Enzymol, V71 Pt C, P341; ROCK CO, 1979, J BIOL CHEM, V254, P7123; Rockey DD, 1997, MOL MICROBIOL, V24, P217, DOI 10.1046/j.1365-2958.1997.3371700.x; Scidmore Marci A, 2005, Curr Protoc Microbiol, VChapter 11, DOI 10.1002/9780471729259.mc11a01s00; Soupene E, 2015, MICROBIOLOGYOPEN, V4, P235, DOI 10.1002/mbo3.234; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Su H, 2004, J BIOL CHEM, V279, P9409, DOI 10.1074/jbc.M312008200; SWANSON J, 1975, J INFECT DIS, V131, P678, DOI 10.1093/infdis/131.6.678; Turnbull AP, 2001, STRUCTURE, V9, P347, DOI 10.1016/S0969-2126(01)00595-0; Vance JE, 2008, J LIPID RES, V49, P1377, DOI 10.1194/jlr.R700020-JLR200; Vignola MJ, 2010, J BIOL CHEM, V285, P21625, DOI 10.1074/jbc.M110.103010; Vromman F, 2014, CURR OPIN MICROBIOL, V17, P38, DOI 10.1016/j.mib.2013.11.003; Wang GQ, 2007, MICROBIOL-SGM, V153, P1935, DOI 10.1099/mic.0.2006/003491-0; Wylie JL, 1997, J BACTERIOL, V179, P7233, DOI 10.1128/jb.179.23.7233-7242.1997; Yao JW, 2014, J BIOL CHEM, V289, P22365, DOI 10.1074/jbc.M114.584185; Yao JW, 2013, BBA-MOL CELL BIOL L, V1831, P495, DOI 10.1016/j.bbalip.2012.08.018; ZEICHNER SL, 1983, INFECT IMMUN, V40, P956, DOI 10.1128/IAI.40.3.956-966.1983; Zhang L, 1998, INFECT IMMUN, V66, P1167, DOI 10.1128/IAI.66.3.1167-1173.1998; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839	64	32	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					18874	18888		10.1074/jbc.M115.657148	http://dx.doi.org/10.1074/jbc.M115.657148			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	25995447	hybrid, Green Published			2022-12-28	WOS:000358781100001
J	Daniel, B; Pavkov-Keller, T; Steiner, B; Dordic, A; Gutmann, A; Nidetzky, B; Sensen, CW; van der Graaff, E; Wallner, S; Gruber, K; Macheroux, P				Daniel, Bastian; Pavkov-Keller, Tea; Steiner, Barbara; Dordic, Andela; Gutmann, Alexander; Nidetzky, Bernd; Sensen, Christoph W.; van der Graaff, Eric; Wallner, Silvia; Gruber, Karl; Macheroux, Peter			Oxidation of Monolignols by Members of the Berberine Bridge Enzyme Family Suggests a Role in Plant Cell Wall Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COVALENTLY ATTACHED FAD; AUTOMATED DOCKING; CRYSTAL-STRUCTURE; FLEXIBLE LIGANDS; PROTEINS; BIOSYNTHESIS; MECHANISM; OXIDASE; OXIDOREDUCTASE; FLAVINYLATION	Plant genomes contain a large number of genes encoding for berberine bridge enzyme (BBE)-like enzymes. Despite the wide-spread occurrence and abundance of this protein family in the plant kingdom, the biochemical function remains largely unexplored. In this study, we have expressed two members of the BBE-like enzyme family from Arabidopsis thaliana in the host organism Komagataella pastoris. The two proteins, termed AtBBE-like 13 and AtBBE-like 15, were purified, and their catalytic properties were determined. In addition, AtBBE-like 15 was crystallized and structurally characterized by x-ray crystallography. Here, we show that the enzymes catalyze the oxidation of aromatic allylic alcohols, such as coumaryl, sinapyl, and coniferyl alcohol, to the corresponding aldehydes and that AtBBE-like 15 adopts the same fold as vanillyl alcohol oxidase as reported previously for berberine bridge enzyme and other FAD-dependent oxidoreductases. Further analysis of the substrate range identified coniferin, the glycosylated storage form of coniferyl alcohol, as a substrate of the enzymes, whereas other glycosylated monolignols were rather poor substrates. A detailed analysis of the motifs present in the active sites of the BBE-like enzymes in A. thaliana suggested that 14 out of 28 members of the family might catalyze similar reactions. Based on these findings, we propose a novel role of BBE-like enzymes in monolignol metabolism that was previously not recognized for this enzyme family.	[Daniel, Bastian; Steiner, Barbara; Wallner, Silvia; Macheroux, Peter] Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria; [Gutmann, Alexander; Nidetzky, Bernd] Graz Univ Technol, Inst Biotechnol & Biochem Engn, A-8010 Graz, Austria; [Sensen, Christoph W.] Graz Univ Technol, Inst Mol Biotechnol, A-8010 Graz, Austria; [Pavkov-Keller, Tea; Dordic, Andela; Gruber, Karl] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Pavkov-Keller, Tea] ACIB GmbH, A-8010 Graz, Austria; [van der Graaff, Eric] Univ Copenhagen, Sect Crop Sci, DK-2630 Copenhagen, Denmark	Graz University of Technology; Graz University of Technology; Graz University of Technology; University of Graz; Austrian Centre of Industrial Biotechnology; University of Copenhagen	Macheroux, P (corresponding author), Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria.	peter.macheroux@tugraz.at	Macheroux, Peter/AAB-5157-2019; van der Graaff, Eric/F-8198-2014; Pavkov-Keller, Tea/K-9234-2015; Sensen, Christoph W./C-1798-2013; Gruber, Karl/GPP-6706-2022	Macheroux, Peter/0000-0002-0242-454X; van der Graaff, Eric/0000-0002-5265-4239; Pavkov-Keller, Tea/0000-0001-7871-6680; Sensen, Christoph W./0000-0001-9604-8962; Gruber, Karl/0000-0002-3485-9740; Gutmann, Alexander/0000-0003-1693-4599; Daniel, Bastian/0000-0001-9210-7136; Wallner, Silvia/0000-0002-3608-4029; Nidetzky, Bernd/0000-0002-5030-2643	"Fonds zur Forderung der Wissenschaftlichen Forschung" through the Ph.D. Program "Molecular Enzymology"; Austrian Science Fund (FWF) [W 901] Funding Source: researchfish	"Fonds zur Forderung der Wissenschaftlichen Forschung" through the Ph.D. Program "Molecular Enzymology"(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the "Fonds zur Forderung der Wissenschaftlichen Forschung" through the Ph.D. Program "Molecular Enzymology" (to K. G., B. N., and P. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alexeev I, 2007, P NATL ACAD SCI USA, V104, P6170, DOI 10.1073/pnas.0700579104; Attila C, 2008, MICROB BIOTECHNOL, V1, P17, DOI 10.1111/j.1751-7915.2007.00002.x; Carlson JC, 2011, NAT CHEM, V3, P628, DOI [10.1038/NCHEM.1087, 10.1038/nchem.1087]; Carter CJ, 2004, PLANT PHYSIOL, V134, P460, DOI 10.1104/pp.103.027482; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cummings MD, 2006, J BIOMOL SCREEN, V11, P854, DOI 10.1177/1087057106292746; Custers JHHV, 2004, PLANT J, V39, P147, DOI 10.1111/j.1365-313X.2004.02117.x; D'Arcy A, 2007, ACTA CRYSTALLOGR D, V63, P550, DOI 10.1107/S0907444907007652; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Escamilla-Trevino LL, 2006, PHYTOCHEMISTRY, V67, P1651, DOI 10.1016/j.phytochem.2006.05.022; Facchini PJ, 1996, PLANT PHYSIOL, V112, P1669, DOI 10.1104/pp.112.4.1669; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Gonzalez-Candelas L, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-194; Goodsell DS, 1996, J MOL RECOGNIT, V9, P1, DOI 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6; Gosch C, 2010, PLANT SCI, V178, P299, DOI 10.1016/j.plantsci.2009.12.009; Hooper CM, 2014, BIOINFORMATICS, V30, P3356, DOI 10.1093/bioinformatics/btu550; Huang CH, 2005, J BIOL CHEM, V280, P38831, DOI 10.1074/jbc.M506078200; Jamet E, 2006, TRENDS PLANT SCI, V11, P33, DOI 10.1016/j.tplants.2005.11.006; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kantardjieff KA, 2003, PROTEIN SCI, V12, P1865, DOI 10.1110/ps.0350503; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; KUTCHAN TM, 1995, J BIOL CHEM, V270, P24475, DOI 10.1074/jbc.270.41.24475; Liu YC, 2011, NAT CHEM BIOL, V7, P304, DOI 10.1038/nchembio.556; MASSEY V, 1978, BIOCHEMISTRY-US, V17, P9, DOI 10.1021/bi00594a002; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mo XH, 2011, ORG LETT, V13, P2212, DOI 10.1021/ol200447h; Morreel K, 2004, PLANT PHYSIOL, V136, P3537, DOI 10.1104/pp.104.049304; Morris GM, 1996, J COMPUT AID MOL DES, V10, P293, DOI 10.1007/BF00124499; Noinaj N, 2011, J BIOL CHEM, V286, P23533, DOI 10.1074/jbc.M111.247833; Ober D, 2009, PHYTOCHEMISTRY, V70, P1687, DOI 10.1016/j.phytochem.2009.05.017; Pagnussat GC, 2005, DEVELOPMENT, V132, P603, DOI 10.1242/dev.01595; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Schrittwieser JH, 2011, J ORG CHEM, V76, P6703, DOI 10.1021/jo201056f; Shoyama Y, 2012, J MOL BIOL, V423, P96, DOI 10.1016/j.jmb.2012.06.030; Tsuji Y, 2005, PLANTA, V222, P58, DOI 10.1007/s00425-005-1517-5; Wallace IM, 2006, NUCLEIC ACIDS RES, V34, P1692, DOI 10.1093/nar/gkl091; Wallner S., 2013, HDB FLAVOPROTEINS OX, V1; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weis R, 2004, FEMS YEAST RES, V5, P179, DOI 10.1016/j.femsyr.2004.06.016; Winkler A, 2008, NAT CHEM BIOL, V4, P739, DOI 10.1038/nchembio.123; Winkler A, 2007, J BIOL CHEM, V282, P24437, DOI 10.1074/jbc.M703642200; Winkler A, 2006, J BIOL CHEM, V281, P21276, DOI 10.1074/jbc.M603267200; Winkler A, 2009, PHYTOCHEMISTRY, V70, P1092, DOI 10.1016/j.phytochem.2009.06.005; Winkler A, 2009, J BIOL CHEM, V284, P19993, DOI 10.1074/jbc.M109.015727; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Xu ZW, 2004, PLANT MOL BIOL, V55, P343, DOI 10.1007/s11103-004-0790-1; Zafred D, 2015, FEBS J, V282, P3060, DOI 10.1111/febs.13212	50	57	83	4	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18770	18781		10.1074/jbc.M115.659631	http://dx.doi.org/10.1074/jbc.M115.659631			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26037923	Green Published, hybrid			2022-12-28	WOS:000358512100044
J	Nam, YW; Nihira, T; Arakawa, T; Saito, Y; Kitaoka, M; Nakai, H; Fushinobu, S				Nam, Young-Woo; Nihira, Takanori; Arakawa, Takatoshi; Saito, Yuka; Kitaoka, Motomitsu; Nakai, Hiroyuki; Fushinobu, Shinya			Crystal Structure and Substrate Recognition of Cellobionic Acid Phosphorylase, Which Plays a Key Role in Oxidative Cellulose Degradation by Microbes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYTIC POLYSACCHARIDE MONOOXYGENASES; X-RAY-DIFFRACTION; SACCHAROPHAGUS-DEGRADANS; PHANEROCHAETE-CHRYSOSPORIUM; NEUROSPORA-CRASSA; ESCHERICHIA-COLI; DEHYDROGENASE; ENZYMES; HYDROLYSIS; CONVERSION	The microbial oxidative cellulose degradation system is attracting significant research attention after the recent discovery of lytic polysaccharide mono-oxygenases. A primary product of the oxidative and hydrolytic cellulose degradation system is cellobionic acid (CbA), the aldonic acid form of cellobiose. We previously demonstrated that the intracellular enzyme belonging to glycoside hydrolase family 94 from cellulolytic fungus and bacterium is cellobionic acid phosphorylase (CBAP), which catalyzes reversible phosphorolysis of CbA into glucose 1-phosphate and gluconic acid (GlcA). In this report, we describe the biochemical characterization and the three-dimensional structure of CBAP from the marine cellulolytic bacterium Saccharophagus degradans. Structures of ligand-free and complex forms with CbA, GlcA, and a synthetic disaccharide product from glucuronic acid were determined at resolutions of up to 1.6 angstrom. The active site is located near the dimer interface. At subsite + 1, the carboxylate group of GlcA and CbA is recognized by Arg-609 and Lys-613. Additionally, one residue from the neighboring protomer (Gln-190) is involved in the carboxylate recognition of GlcA. A mutational analysis indicated that these residues are critical for the binding and catalysis of the aldonic and uronic acid acceptors GlcA and glucuronic acid. Structural and sequence comparisons with other glycoside hydrolase family 94 phosphorylases revealed that CBAPs have a unique subsite + 1 with a distinct amino acid residue conservation pattern at this site. This study provides molecular insight into the energetically efficient metabolic pathway of oxidized sugars that links the oxidative cellulolytic pathway to the glycolytic and pentose phosphate pathways in cellulolytic microbes.	[Nam, Young-Woo; Arakawa, Takatoshi; Fushinobu, Shinya] Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan; [Nihira, Takanori; Saito, Yuka; Nakai, Hiroyuki] Niigata Univ, Fac Agr, Niigata 9502181, Japan; [Kitaoka, Motomitsu] Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan	University of Tokyo; Niigata University; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan	Fushinobu, S (corresponding author), Univ Tokyo, Dept Biotechnol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	asfushi@mail.ecc.u-tokyo.ac.jp	Arakawa, Takatoshi/K-9739-2013; Fushinobu, Shinya/E-4987-2011; Kitaoka, Motomitsu/R-1536-2019	Arakawa, Takatoshi/0000-0001-6496-5440; Fushinobu, Shinya/0000-0003-1346-6435; Kitaoka, Motomitsu/0000-0002-0083-1838	Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry [25010A]; Platform for Drug Discovery, Informatics, and Structural Life Science - the Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Society for the Promotion of Science KAKENHI [2380053, 15H02443]; Promotion of Environmental Improvement for the Independence of Young Researchers under Special Coordination Funds for Promoting Science and Technology; Grants-in-Aid for Scientific Research [15H02443] Funding Source: KAKEN	Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry; Platform for Drug Discovery, Informatics, and Structural Life Science - the Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Promotion of Environmental Improvement for the Independence of Young Researchers under Special Coordination Funds for Promoting Science and Technology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry (Grant 25010A); in part by the Platform for Drug Discovery, Informatics, and Structural Life Science funded by the Ministry of Education, Culture, Sports, Science and Technology, Japan, by Japan Society for the Promotion of Science KAKENHI (Grants 2380053 and 15H02443 to S. F.); and by the Promotion of Environmental Improvement for the Independence of Young Researchers under the Special Coordination Funds for Promoting Science and Technology. The authors declare that they have no conflicts of interest with the contents of this article.	Bianchetti CM, 2011, ACTA CRYSTALLOGR F, V67, P1345, DOI 10.1107/S1744309111032660; Bornscheuer U, 2014, ANGEW CHEM INT EDIT, V53, P10876, DOI 10.1002/anie.201309953; Cannella D, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-26; DALE MP, 1985, BIOCHEMISTRY-US, V24, P3530, DOI 10.1021/bi00335a022; De Maria L., 2012, COMPUT STRUCT BIOTEC, V2; Desai SH, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0232-6; Ekborg NA, 2005, INT J SYST EVOL MICR, V55, P1545, DOI 10.1099/ijs.0.63627-0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ERIKSSON KEL, 1993, ENZYME MICROB TECH, V15, P1002, DOI 10.1016/0141-0229(93)90046-5; Forsberg Z, 2014, P NATL ACAD SCI USA, V111, P8446, DOI 10.1073/pnas.1402771111; Forsberg Z, 2011, PROTEIN SCI, V20, P1479, DOI 10.1002/pro.689; Fushinobu S., 2011, Journal of Applied Glycoscience, V58, P91, DOI 10.5458/jag.jag.JAG-2010_022; Fushinobu S, 2014, NAT CHEM BIOL, V10, P88, DOI 10.1038/nchembio.1434; Gardner JG, 2014, MOL MICROBIOL, V94, P1121, DOI 10.1111/mmi.12821; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Hemsworth GR, 2013, CURR OPIN STRUC BIOL, V23, P660, DOI 10.1016/j.sbi.2013.05.006; Henriksson G, 2000, J BIOTECHNOL, V78, P93, DOI 10.1016/S0168-1656(00)00206-6; Hidaka M, 2004, STRUCTURE, V12, P937, DOI 10.1016/j.str.2004.03.027; Hidaka M, 2006, BIOCHEM J, V398, P37, DOI 10.1042/BJ20060274; HIGHAM CW, 1994, FEBS LETT, V351, P128, DOI 10.1016/0014-5793(94)00847-7; Hildebrand A, 2015, APPL ENVIRON MICROB, V81, P597, DOI 10.1128/AEM.02885-14; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Horn SJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-45; Igarashi K, 1998, EUR J BIOCHEM, V253, P101, DOI 10.1046/j.1432-1327.1998.2530101.x; Kittl R, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-79; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Langston JA, 2011, APPL ENVIRON MICROB, V77, P7007, DOI 10.1128/AEM.05815-11; Lebedev AA, 2012, ACTA CRYSTALLOGR D, V68, P431, DOI 10.1107/S090744491200251X; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakai H, 2013, CURR OPIN CHEM BIOL, V17, P301, DOI 10.1016/j.cbpa.2013.01.006; Nihira T, 2013, FEBS LETT, V587, P3556, DOI 10.1016/j.febslet.2013.09.014; Nouaille R, 2009, APPL MICROBIOL BIOT, V83, P425, DOI 10.1007/s00253-009-1884-0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; POCKER Y, 1973, J AM CHEM SOC, V95, P113, DOI 10.1021/ja00782a019; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; Southall SM, 2006, J BIOL CHEM, V281, P30650, DOI 10.1074/jbc.M601783200; Suvorov M, 2011, BIOFUELS-UK, V2, P59, DOI 10.4155/BFS.10.79; Taylor LE, 2006, J BACTERIOL, V188, P3849, DOI 10.1128/JB.01348-05; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Van Hoorebeke A, 2010, ACTA CRYSTALLOGR F, V66, P346, DOI 10.1107/S1744309110002642; Vu VV, 2014, J AM CHEM SOC, V136, P562, DOI 10.1021/ja409384b; Watson BJ, 2009, J BACTERIOL, V191, P5697, DOI 10.1128/JB.00481-09; Weiner RM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000087; Zhang HT, 2011, J IND MICROBIOL BIOT, V38, P1117, DOI 10.1007/s10295-011-0945-4	46	18	18	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18281	18292		10.1074/jbc.M115.664664	http://dx.doi.org/10.1074/jbc.M115.664664			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26041776	Green Published, hybrid			2022-12-28	WOS:000358512100003
J	Brennan, MJ; Karcz, J; Vaughn, NR; Woolwine-Cunningham, Y; DePriest, AD; Escalona, Y; Perez-Acle, T; Skerrett, IM				Brennan, Matthew J.; Karcz, Jennifer; Vaughn, Nicholas R.; Woolwine-Cunningham, Yvonne; DePriest, Adam D.; Escalona, Yerko; Perez-Acle, Tomas; Skerrett, I. Martha			Tryptophan Scanning Reveals Dense Packing of Connexin Transmembrane Domains in Gap Junction Channels Composed of Connexin32	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; ACETYLCHOLINE-RECEPTOR; HELIX INTERACTIONS; MUTAGENESIS; MUTATIONS; RESIDUES; IDENTIFICATION; TOPOLOGY; MODEL	Tryptophan was substituted for residues in all four transmembrane domains of connexin32. Function was assayed using dual cell two-electrode voltage clamp after expression in Xenopus oocytes. Tryptophan substitution was poorly tolerated in all domains, with the greatest impact in TM1 and TM4. For instance, in TM1, 15 substitutions were made, six abolished coupling and five others significantly reduced function. Only TM2 and TM3 included a distinct helical face that lacked sensitivity to tryptophan substitution. Results were visualized on a comparative model of Cx32 hemichannel. In this model, aregion midway through the membrane appears highly sensitive to tryptophan substitution and includes residues Arg-32, Ile-33, Met-34, and Val-35. In the modeled channel, pore-facing regions of TM1 and TM2 were highly sensitive to tryptophan substitution, whereas the lipid-facing regions of TM3 and TM4 were variably tolerant. Residues facing a putative intracellular water pocket ( the IC pocket) were also highly sensitive to tryptophan substitution. Although future studies will be required to separate trafficking-defective mutants from those that alter channel function, a subset of interactions important for voltage gating was identified. Interactions important for voltage gating occurred mainly in the mid-region of the channel and focused on TM1. To determine whether results could be extrapolated to other connexins, TM1 of Cx43 was scanned revealing similar but not identical sensitivity to TM1 of Cx32.	[Brennan, Matthew J.; Karcz, Jennifer; Vaughn, Nicholas R.; Skerrett, I. Martha] SUNY Coll Buffalo, Dept Biol, Buffalo, NY 14222 USA; [Woolwine-Cunningham, Yvonne] SUNY Buffalo, Clin & Translat Res Ctr, Buffalo, NY 14214 USA; [DePriest, Adam D.] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA; [Escalona, Yerko; Perez-Acle, Tomas] Fdn Ciencia & Vida, Computat Biol Lab, Santiago 7780344, Chile; [Escalona, Yerko; Perez-Acle, Tomas] Univ Valparaiso, Ctr Interdisciplinario Neurociencias Valparaiso, Valparaiso 2360102, Chile	State University of New York (SUNY) System; Buffalo State College; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Roswell Park Cancer Institute; Universidad de Valparaiso	Skerrett, IM (corresponding author), SUNY Coll Buffalo, Dept Biol, 1300 Elmwood Ave, Buffalo, NY 14222 USA.	skerreim@buffalostate.edu	Perez-Acle, Tomas/F-7176-2012	Perez-Acle, Tomas/0000-0002-3769-390X; Vaughn, Nicholas/0000-0003-0428-2909	American Heart Association National Affiliate Scientist Development grant; State University of New York Buffalo State Incentive Funding Program; Buffalo State Undergraduate Research Fellowship program; Fundacion Ciencia para la Vida [FONDECYT 1130652, ACT1107, PFB16]; ICM-Chilean Ministry of Economy [P09-022-F]	American Heart Association National Affiliate Scientist Development grant(American Heart Association); State University of New York Buffalo State Incentive Funding Program; Buffalo State Undergraduate Research Fellowship program; Fundacion Ciencia para la Vida; ICM-Chilean Ministry of Economy	This work was supported in part by an American Heart Association National Affiliate Scientist Development grant and the State University of New York Buffalo State Incentive Funding Program. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Buffalo State Undergraduate Research Fellowship program.; Supported in part by FONDECYT 1130652, ACT1107, PFB16 Fundacion Ciencia para la Vida, and Centro Interdisciplinario de Neurociencias de Valparaiso Millennium Institute that is funded by ICM-Chilean Ministry of Economy Grant P09-022-F.	Alexopoulos H, 2004, CURR BIOL, V14, pR879, DOI 10.1016/j.cub.2004.09.067; Araya-Secchi R, 2014, BIOPHYS J, V107, P599, DOI 10.1016/j.bpj.2014.05.037; Arora A, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.034108; Balice-Gordon RJ, 1998, J CELL BIOL, V142, P1095, DOI 10.1083/jcb.142.4.1095; BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101; Bruzzone R, 1996, EUR J BIOCHEM, V238, P1, DOI 10.1111/j.1432-1033.1996.0001q.x; Otero-Cruz JD, 2007, J BIOL CHEM, V282, P9162, DOI 10.1074/jbc.M607492200; De Feo CJ, 2010, J MEMBRANE BIOL, V234, P113, DOI 10.1007/s00232-010-9239-4; DePriest A, 2011, BIOPHYS J, V101, P2408, DOI 10.1016/j.bpj.2011.10.004; Goodenough DA, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002576; Guzman GR, 2003, BIOCHEMISTRY-US, V42, P12243, DOI 10.1021/bi034764d; Harris AL, 2001, Q REV BIOPHYS, V34, P325, DOI 10.1017/S0033583501003705; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Ishii TM, 2007, J PHYSIOL-LONDON, V579, P291, DOI 10.1113/jphysiol.2006.124297; Kleopa KA, 2012, BRAIN RES, V1487, P198, DOI 10.1016/j.brainres.2012.03.068; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; Kwon T, 2011, J GEN PHYSIOL, V138, P475, DOI 10.1085/jgp.201110679; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee SP, 2000, NEUROPSYCHOPHARMACOL, V23, pS32, DOI 10.1016/S0893-133X(00)00155-X; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; Mall S, 2000, BIOCHEMISTRY-US, V39, P2071, DOI 10.1021/bi992205u; Matthews EE, 2006, CELL, V127, P447, DOI 10.1016/j.cell.2006.10.016; MILKS LC, 1988, EMBO J, V7, P2967, DOI 10.1002/j.1460-2075.1988.tb03159.x; Oh S, 1997, NEURON, V19, P927, DOI 10.1016/S0896-6273(00)80973-3; Oshima A, 2007, P NATL ACAD SCI USA, V104, P10034, DOI 10.1073/pnas.0703704104; Oshima A, 2013, J BIOL CHEM, V288, P10513, DOI 10.1074/jbc.M112.428383; PERACCHIA C, 1973, J CELL BIOL, V57, P66, DOI 10.1083/jcb.57.1.66; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SHARP LL, 1995, BIOCHEMISTRY-US, V34, P9166, DOI 10.1021/bi00028a028; Shy ME, 2007, NEUROLOGY, V68, P849, DOI 10.1212/01.wnl.0000256709.08271.4d; Skerrett IM, 2004, FASEB J, V18, P860, DOI 10.1096/fj.03-0763fje; Skerrett IM, 2001, METH MOL B, V154, P225; Skerrett IM, 2002, J CELL BIOL, V159, P349, DOI 10.1083/jcb.200207060; Skerrett IM, 2000, CURR TOP MEMBR, V49, P249; Smith TD, 2012, J MEMBRANE BIOL, V245, P221, DOI 10.1007/s00232-012-9443-5; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Subbiah RN, 2005, J PHYSIOL-LONDON, V569, P367, DOI 10.1113/jphysiol.2005.097386; SUCHYNA TM, 1993, NATURE, V365, P847, DOI 10.1038/365847a0; Toloue MM, 2008, CELL COMMUN ADHES, V15, P95, DOI 10.1080/15419060802013463; Ueno S, 2000, BRIT J PHARMACOL, V131, P296, DOI 10.1038/sj.bjp.0703504; Willecke K, 2002, BIOL CHEM, V383, P725, DOI 10.1515/BC.2002.076; Zonta F, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00085	44	2	2	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17074	17084		10.1074/jbc.M115.650747	http://dx.doi.org/10.1074/jbc.M115.650747			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	25969535	hybrid, Green Published			2022-12-28	WOS:000357730900003
J	Bridges, AA; Gladfelter, AS				Bridges, Andrew A.; Gladfelter, Amy S.			Septin Form and Function at the Cell Cortex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							RICE BLAST FUNGUS; MOTHER-BUD NECK; BUDDING YEAST; SACCHAROMYCES-CEREVISIAE; MAMMALIAN SEPTINS; PLASMA-MEMBRANE; FILAMENT FORMATION; DIFFUSION BARRIER; MICROTUBULE ORGANIZATION; ENDOPLASMIC-RETICULUM	Septins are GTP-binding proteins that form filaments and higher-order structures on the cell cortex of eukaryotic cells and associate with actin and microtubule cytoskeletal networks. When assembled, septins coordinate cell division and contribute to cell polarity maintenance and membrane remodeling. These functions manifest themselves via scaffolding of cytosolic proteins and cytoskeletal networks to specific locations on membranes and by forming diffusional barriers that restrict lateral diffusion of proteins embedded in membranes. Notably, many neurodegenerative diseases and cancers have been characterized as having misregulated septins, suggesting that their functions are relevant to diverse diseases. Despite the importance of septins, little is known about what features of the plasma membrane influence septin recruitment and alternatively, how septins influence plasma membrane properties. Septins have been localized to the cell cortex at the base of cilia, the mother-bud neck of yeast, and branch points of filamentous fungi and dendritic spines, in cleavage furrows, and in retracting membrane protrusions in mammalian cells. These sites all possess some degree of curvature and are likely composed of distinct lipid pools. Depending on the context, septins may act alone or in concert with other cytoskeletal elements to influence and sense membrane properties. The degree to which septins react to and/or induce changes in shape and lipid composition are discussed here. As septins are an essential player in basic biology and disease, understanding the interplay between septins and the plasma membrane is critical and may yield new and unexpected functions.	[Bridges, Andrew A.; Gladfelter, Amy S.] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA	Dartmouth College	Gladfelter, AS (corresponding author), Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA.	Amy.Gladfelter@Dartmouth.edu	Bridges, Andrew/U-9907-2019	Bridges, Andrew/0000-0002-8132-751X	National Science Foundation [MCB-507511]; National Institutes of Health [NIGMS T32GM008704]; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008704] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation Grant MCB-507511 (to A. S. G.) and National Institutes of Health Grant NIGMS T32GM008704 (to A. A. B.). This is the fifth article in the Thematic Minireview series "The State of the Cytoskeleton in 2015." The authors declare that they have no conflicts of interest with the contents of this article.	Ageta-Ishihara N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3532; Bai XB, 2013, J CELL BIOL, V203, P895, DOI 10.1083/jcb.201308068; Barral Y, 2000, MOL CELL, V5, P841, DOI 10.1016/S1097-2765(00)80324-X; Baumann S, 2014, EMBO REP, V15, P94, DOI 10.1002/embr.201338037; Bertin A, 2008, P NATL ACAD SCI USA, V105, P8274, DOI 10.1073/pnas.0803330105; Bertin Aurelie, 2012, Commun Integr Biol, V5, P503, DOI 10.4161/cib.21125; Bertin A, 2012, MOL BIOL CELL, V23, P423, DOI 10.1091/mbc.E11-10-0850; Bertin A, 2010, J MOL BIOL, V404, P711, DOI 10.1016/j.jmb.2010.10.002; Bowen JR, 2011, J CELL BIOL, V194, P187, DOI 10.1083/jcb.201102076; Bridges AA, 2014, CURR OPIN MICROBIOL, V20, P42, DOI 10.1016/j.mib.2014.04.004; Bridges AA, 2014, P NATL ACAD SCI USA, V111, P2146, DOI 10.1073/pnas.1314138111; BYERS B, 1976, J CELL BIOL, V69, P717, DOI 10.1083/jcb.69.3.717; Cao LH, 2009, CELL MOL LIFE SCI, V66, P3309, DOI 10.1007/s00018-009-0087-2; Casamayor A, 2003, MOL CELL BIOL, V23, P2762, DOI 10.1128/MCB.23.8.2762-2777.2003; Caudron F, 2009, DEV CELL, V16, P493, DOI 10.1016/j.devcel.2009.04.003; Caviston JP, 2003, MOL BIOL CELL, V14, P4051, DOI 10.1091/mbc.E03-04-0247; Chao JT, 2014, CELL, V158, P620, DOI 10.1016/j.cell.2014.06.033; Cho SJ, 2011, MOL CELLS, V32, P89, DOI 10.1007/s10059-011-1048-9; Clay L, 2014, ELIFE, V3, DOI 10.7554/eLife.01883; Dagdas YF, 2012, SCIENCE, V336, P1590, DOI 10.1126/science.1222934; DeMay BS, 2011, J CELL BIOL, V193, P1065, DOI 10.1083/jcb.201012143; Demay BS, 2009, MOL BIOL CELL, V20, P2311, DOI 10.1091/mbc.E08-12-1169; Dobbelaere J, 2004, SCIENCE, V305, P393, DOI 10.1126/science.1099892; Dolat L, 2014, J CELL BIOL, V207, P225, DOI 10.1083/jcb.201405050; Dolat L, 2014, BIOL CHEM, V395, P123, DOI 10.1515/hsz-2013-0233; El Amine N, 2013, J CELL BIOL, V203, P487, DOI 10.1083/jcb.201305053; Estey MP, 2010, J CELL BIOL, V191, P741, DOI 10.1083/jcb.201006031; Farkasovsky M, 2005, BIOL CHEM, V386, P643, DOI 10.1515/BC.2005.075; Feng ZH, 2015, MOL BIOL CELL, V26, P1211, DOI 10.1091/mbc.E14-09-1363; Frazier JA, 1998, J CELL BIOL, V143, P737, DOI 10.1083/jcb.143.3.737; Ghossoub R, 2013, J CELL SCI, V126, P2583, DOI 10.1242/jcs.111377; Gilden J, 2010, CYTOSKELETON, V67, P477, DOI 10.1002/cm.20461; Gilden JK, 2012, J CELL BIOL, V196, P103, DOI 10.1083/jcb.201105127; Gladfelter AS, 2010, CURR OPIN MICROBIOL, V13, P720, DOI 10.1016/j.mib.2010.09.012; Gladfelter AS, 2001, CURR OPIN MICROBIOL, V4, P681, DOI 10.1016/S1369-5274(01)00269-7; Gladfelter AS, 2002, J CELL BIOL, V156, P315, DOI 10.1083/jcb.200109062; Hagiwara A, 2011, CYTOSKELETON, V68, P512, DOI 10.1002/cm.20528; Hall PA, 2012, J PATHOL, V226, P287, DOI 10.1002/path.3024; HARTWELL LH, 1971, EXP CELL RES, V69, P265, DOI 10.1016/0014-4827(71)90223-0; Hernandez-Rodriguez Y, 2012, CURR OPIN MICROBIOL, V15, P660, DOI 10.1016/j.mib.2012.09.007; Hu JL, 2012, CURR BIOL, V22, P1109, DOI 10.1016/j.cub.2012.04.019; Hu QC, 2010, SCIENCE, V329, P436, DOI 10.1126/science.1191054; Huang YW, 2008, MOL BIOL CELL, V19, P1717, DOI 10.1091/mbc.E07-07-0641; Huijbregts RPH, 2009, MOL BIOL CELL, V20, P270, DOI 10.1091/mbc.E08-07-0754; Iwase M, 2006, MOL BIOL CELL, V17, P1110, DOI 10.1091/mbc.E05-08-0793; John CM, 2007, EMBO J, V26, P3296, DOI 10.1038/sj.emboj.7601775; Joo E, 2007, DEV CELL, V13, P677, DOI 10.1016/j.devcel.2007.09.001; Kechad A, 2012, CURR BIOL, V22, P197, DOI 10.1016/j.cub.2011.11.062; Kim MS, 2011, J CELL BIOL, V195, P815, DOI 10.1083/jcb.201106131; King K, 2013, MOL BIOL CELL, V24, P914, DOI 10.1091/mbc.E12-11-0812; Kinoshita M, 2006, CURR OPIN CELL BIOL, V18, P54, DOI 10.1016/j.ceb.2005.12.005; Kozubowski L, 2005, MOL BIOL CELL, V16, P3455, DOI 10.1091/mbc.E04-09-0764; Kremer BE, 2005, MOL BIOL CELL, V16, P4648, DOI 10.1091/mbc.E05-03-0267; Ladabaum U, 2013, CANCER EPIDEM BIOMAR, V22, P1567, DOI 10.1158/1055-9965.EPI-13-0204; Lewellyn L, 2011, J CELL BIOL, V193, P155, DOI 10.1083/jcb.201008138; Li LF, 2012, EUKARYOT CELL, V11, P1210, DOI 10.1128/EC.00216-12; Luedeke C, 2005, J CELL BIOL, V169, P897, DOI 10.1083/jcb.200412143; Maddox AS, 2007, DEV CELL, V12, P827, DOI 10.1016/j.devcel.2007.02.018; Mavrakis M, 2014, NAT CELL BIOL, V16, P322, DOI 10.1038/ncb2921; McMurray MA, 2008, CURR BIOL, V18, P1203, DOI 10.1016/j.cub.2008.07.020; McMurray MA, 2011, DEV CELL, V20, P540, DOI 10.1016/j.devcel.2011.02.004; McMurray MA, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-18; Merlini L, 2011, BIOL CHEM, V392, P805, DOI 10.1515/BC.2011.090; Meseroll RA, 2013, EUKARYOT CELL, V12, P182, DOI 10.1128/EC.00251-12; Mitchison TJ, 2002, CURR BIOL, V12, pR788, DOI 10.1016/S0960-9822(02)01295-2; Mostowy S, 2014, BIOL CHEM, V395, P119, DOI 10.1515/hsz-2013-0291; Mostowy S, 2012, NAT REV MOL CELL BIO, V13, P183, DOI 10.1038/nrm3284; Mostowy S, 2011, BIOPHYS J, V100, P1949, DOI 10.1016/j.bpj.2011.02.040; Nishihama R, 2011, BIOL CHEM, V392, P681, DOI 10.1515/BC.2011.086; Okada S, 2013, DEV CELL, V26, P148, DOI 10.1016/j.devcel.2013.06.015; Ong K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6698; Potter NT, 2014, CLIN CHEM, V60, P1183, DOI 10.1373/clinchem.2013.221044; Pringle JR, 1995, COLD SPRING HARB SYM, V60, P729, DOI 10.1101/SQB.1995.060.01.079; Renshaw MJ, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.130190; Rodal AA, 2005, MOL BIOL CELL, V16, P372, DOI 10.1091/mbc.e04-08-0734; Rodriguez-Escudero I, 2005, BIOCHEM J, V390, P613, DOI 10.1042/BJ20050574; Roelants FM, 2015, J CELL BIOL, V208, P299, DOI 10.1083/jcb.201410076; Ryder LS, 2013, P NATL ACAD SCI USA, V110, P3179, DOI 10.1073/pnas.1217470110; Sadian Y, 2013, ELIFE, V2, DOI 10.7554/eLife.01085; Sellin ME, 2011, MOL BIOL CELL, V22, P4588, DOI 10.1091/mbc.E11-09-0754; Sellin ME, 2011, MOL BIOL CELL, V22, P3152, DOI 10.1091/mbc.E11-03-0253; Sharma S, 2013, NATURE, V499, P238, DOI 10.1038/nature12229; Sheffield PJ, 2003, J BIOL CHEM, V278, P3483, DOI 10.1074/jbc.M209701200; Sirajuddin M, 2007, NATURE, V449, P311, DOI 10.1038/nature06052; Spiliotis ET, 2012, TRAFFIC, V13, P195, DOI 10.1111/j.1600-0854.2011.01268.x; Spiliotis ET, 2010, CYTOSKELETON, V67, P339, DOI 10.1002/cm.20448; Tada T, 2007, CURR BIOL, V17, P1752, DOI 10.1016/j.cub.2007.09.039; Takizawa PA, 2000, SCIENCE, V290, P341, DOI 10.1126/science.290.5490.341; Tanaka-Takiguchi Y, 2009, CURR BIOL, V19, P140, DOI 10.1016/j.cub.2008.12.030; Tooley AJ, 2009, NAT CELL BIOL, V11, P17, DOI 10.1038/ncb1808; Trimble WS, 2015, J CELL BIOL, V208, P259, DOI 10.1083/jcb.201410071; Versele M, 2004, J CELL BIOL, V164, P701, DOI 10.1083/jcb.200312070; Vrabioiu AM, 2006, NATURE, V443, P466, DOI 10.1038/nature05109; Vrabioiu AM, 2004, J BIOL CHEM, V279, P3111, DOI 10.1074/jbc.M310941200; Weems AD, 2014, GENETICS, V196, P711, DOI 10.1534/genetics.114.161182; Wloka C, 2011, BIOL CHEM, V392, P813, DOI 10.1515/BC.2011.083; Xie YL, 2007, CURR BIOL, V17, P1746, DOI 10.1016/j.cub.2007.08.042; Yamazaki T, 2013, PLANT J, V74, P605, DOI 10.1111/tpj.12147; Zhang JS, 1999, CURR BIOL, V9, P1458, DOI 10.1016/S0960-9822(00)80115-3	99	87	89	5	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17173	17180		10.1074/jbc.R114.634444	http://dx.doi.org/10.1074/jbc.R114.634444			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	25957401	hybrid, Green Published			2022-12-28	WOS:000357730900014
J	Fujimaki, K; Ogihara, T; Morris, DL; Oda, H; Iida, H; Fujitani, Y; Mirmira, RG; Evans-Molina, C; Watada, H				Fujimaki, Kyoko; Ogihara, Takeshi; Morris, David L.; Oda, Hisanobu; Iida, Hitoshi; Fujitani, Yoshio; Mirmira, Raghavendra G.; Evans-Molina, Carmella; Watada, Hirotaka			SET7/9 Enzyme Regulates Cytokine-induced Expression of Inducible Nitric-oxide Synthase through Methylation of Lysine 4 at Histone 3 in the Islet beta Cell	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; SIGNAL-TRANSDUCTION; INSULIN-SECRETION; METHYLTRANSFERASE; ACTIVATION; INTERLEUKIN-1-BETA; TRANSCRIPTION; LANGERHANS; CHROMATIN; INFLAMMATION	SET7/9 is an enzyme that methylates histone 3 at lysine 4 (H3K4) to maintain euchromatin architecture. Although SET7/9 is enriched in islets and contributes to the transactivation of beta cell-specific genes, including Ins1 and Slc2a, SET7/9 has also been reported to bind the p65 subunit of nuclear factor kappa B in non-beta cells and modify its transcriptional activity. Given that inflammation is a central component of beta cell dysfunction in Type 1 and Type 2 diabetes, the aim of this study was to elucidate the role of SET7/9 in proinflammatory cytokine signaling in beta cells. To induce inflammation, beta TC3 insulinoma cells were treated with IL-1 beta, TNF-alpha, and IFN-gamma. Cytokine treatment led to increased expression of inducible nitric-oxide synthase, which was attenuated by the diminution of SET7/9 using RNA interference. Consistent with previous reports, SET7/9 was co-immunoprecipitated with p65 and underwent cytosolic to nuclear translocation in response to cytokines. ChIP analysis demonstrated augmented H3K4 mono-and dimethylation of the proximal Nos2 promoter with cytokine exposure. SET7/9 was found to occupy this same region, whereas SET7/9 knockdown attenuated cytokine-induced histone methylation of the Nos2 gene. To test this relationship further, islets were isolated from SET7/9-deficient and wild-type mice and treated with IL-1 beta, TNF-alpha, and IFN-gamma. Cytokine-induced Nos2 expression was reduced in the islets from SET7/9 knock-out mice. Together, our findings suggest that SET7/9 contributes to Nos2 transcription and proinflammatory cytokine signaling in the pancreatic beta cell through activating histone modifications.	[Fujimaki, Kyoko; Ogihara, Takeshi; Iida, Hitoshi; Fujitani, Yoshio; Watada, Hirotaka] Juntendo Univ, Grad Sch Med, Dept Metab & Endocrinol, Tokyo 1138421, Japan; [Watada, Hirotaka] Juntendo Univ, Grad Sch Med, Ctr Mol Diabetol, Tokyo 1138421, Japan; [Fujitani, Yoshio; Watada, Hirotaka] Juntendo Univ, Grad Sch Med, Ctr Therapeut Innovat Diabet, Tokyo 1138421, Japan; [Fujitani, Yoshio] Juntendo Univ, Grad Sch Med, Japan Sci & Technol Agcy, Core Res Evolutionary Sci & Technol Program, Tokyo 1138421, Japan; [Mirmira, Raghavendra G.; Evans-Molina, Carmella] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Morris, David L.; Mirmira, Raghavendra G.; Evans-Molina, Carmella] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Mirmira, Raghavendra G.; Evans-Molina, Carmella] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA; [Mirmira, Raghavendra G.; Evans-Molina, Carmella] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Oda, Hisanobu] Natl Hosp Org Kyushu Canc Ctr, Dept Gastrointestinal & Med Oncol, Fukuoka 8111395, Japan	Juntendo University; Juntendo University; Juntendo University; Japan Science & Technology Agency (JST); Juntendo University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Kyushu Cancer Center	Ogihara, T (corresponding author), Juntendo Univ, Grad Sch Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	take@juntendo.ac.jp; cevansmo@iu.edu	Mirmira, Raghavendra G/AAD-7592-2020; Regan, Clinton/E-6250-2012	Mirmira, Raghavendra G/0000-0002-5013-6075; Watada, Hirotaka/0000-0001-5961-1816	National Institutes of Health [R01 DK093954, F32 DK091976, K01 DK100515]; Japan Society for the Promotion of Science KAKENHI [23591324, 26461345]; Suzuken Memorial Foundation; Veterans Affairs Merit Award [I01BX001733]; Asteras; Astrazeneca; Boehringer Ingelheim; Daiichi Sankyo Inc.; Eli Lilly and Co.; Kissei Pharmaceutical Co.; Kowa Pharmaceutical Co.; Kyowa Hakko Kirin Co.; Merck Sharp and Dohme; Novartis Pharmaceuticals; Novo Nordisk Pharma; Ono Pharmaceutical Co.; Mitsubishi Tanabe Pharma; Sanofi-Aventis; Sanwakagaku Kenkyusho; Takeda Pharmaceutical Co.; Bristol-Myers Squibb; Dainippon Sumitomo Pharma; Eli Lilly; Johnson and Johnson; Mochida Pharmaceutical Co.; Pfizer; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093954, F32DK091976, R01DK083583, K01DK100515, P30DK097512] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001733] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [26461345] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Suzuken Memorial Foundation; Veterans Affairs Merit Award(US Department of Veterans Affairs); Asteras; Astrazeneca(AstraZeneca); Boehringer Ingelheim(Boehringer Ingelheim); Daiichi Sankyo Inc.(Daiichi Sankyo Company Limited); Eli Lilly and Co.(Eli Lilly); Kissei Pharmaceutical Co.(Kissei Pharmaceutical Co Ltd); Kowa Pharmaceutical Co.; Kyowa Hakko Kirin Co.(Kyowa Kirin Ltd); Merck Sharp and Dohme(Merck & Company); Novartis Pharmaceuticals(Novartis); Novo Nordisk Pharma(Novo Nordisk); Ono Pharmaceutical Co.; Mitsubishi Tanabe Pharma(Mitsubishi Tanabe Pharma Corporation); Sanofi-Aventis(Sanofi-Aventis); Sanwakagaku Kenkyusho; Takeda Pharmaceutical Co.(Takeda Pharmaceutical Company Ltd); Bristol-Myers Squibb(Bristol-Myers Squibb); Dainippon Sumitomo Pharma(Dainippon Sumitomo Pharma Co., Ltd.); Eli Lilly(Eli Lilly); Johnson and Johnson(Johnson & JohnsonJohnson & Johnson USA); Mochida Pharmaceutical Co.; Pfizer(Pfizer); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK093954 (to C. E.-M.) and F32 DK091976 and K01 DK100515 (to D. L. M.). This work was also supported by Japan Society for the Promotion of Science KAKENHI Grants 23591324 and 26461345 and the Suzuken Memorial Foundation (both to T. O.) and Veterans Affairs Merit Award I01BX001733 (to C. E.-M.). H. W. has received lecture fees from Asteras, Astrazeneca, Boehringer Ingelheim, Daiichi Sankyo Inc., Eli Lilly and Co., Kissei Pharmaceutical Co., Kowa Pharmaceutical Co., Kyowa Hakko Kirin Co., Merck Sharp and Dohme, Novartis Pharmaceuticals, Novo Nordisk Pharma, Ono Pharmaceutical Co., Mitsubishi Tanabe Pharma, Sanofi-Aventis, Sanwakagaku Kenkyusho, and Takeda Pharmaceutical Co. and research funds from Asteras, Astrazeneca, Bristol-Myers Squibb, Boehringer Ingelheim, Daiichi Sankyo Inc., Dainippon Sumitomo Pharma, Eli Lilly, Johnson and Johnson, Kissei Pharmaceutical Co., Kowa Pharmaceutical Co., Kyowa Hakko Kirin Co., Merck Sharp and Dohme, Mitsubishi Tanabe Pharma, Mochida Pharmaceutical Co., Novartis Pharmaceuticals, Novo Nordisk Pharma, Pfizer, Sanwakagaku Kenkyusho, Sanofi-Aventis, and Takeda Pharmaceutical Co.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Barsyte-Lovejoy D, 2014, P NATL ACAD SCI USA, V111, P12853, DOI 10.1073/pnas.1407358111; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Black JC, 2012, MOL CELL, V48, P491, DOI 10.1016/j.molcel.2012.11.006; Chakrabarti SK, 2002, J BIOL CHEM, V277, P13286, DOI 10.1074/jbc.M111857200; Chan JY, 2011, DIABETOLOGIA, V54, P1766, DOI 10.1007/s00125-011-2139-z; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; COMENS PG, 1987, DIABETES, V36, P963, DOI 10.2337/diabetes.36.8.963; CORBETT JA, 1992, BIOCHEM J, V287, P229, DOI 10.1042/bj2870229; CORBETT JA, 1993, P NATL ACAD SCI USA, V90, P1731, DOI 10.1073/pnas.90.5.1731; CORBETT JA, 1992, J CLIN INVEST, V90, P2384, DOI 10.1172/JCI116129; CORBETT JA, 1994, AM J PHYSIOL, V267, pC48, DOI 10.1152/ajpcell.1994.267.1.C48; Deering TG, 2009, DIABETES, V58, P185, DOI 10.2337/db08-1150; Donath MY, 2013, CELL METAB, V17, P860, DOI 10.1016/j.cmet.2013.05.001; Ea CK, 2009, P NATL ACAD SCI USA, V106, P18972, DOI 10.1073/pnas.0910439106; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; EIZIRIK DL, 1992, FEBS LETT, V308, P249, DOI 10.1016/0014-5793(92)81285-T; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; EIZIRIK DL, 1989, ENDOCRINOLOGY, V125, P752, DOI 10.1210/endo-125-2-752; Evans-Molina C, 2013, DIABETES OBES METAB, V15, P159, DOI 10.1111/dom.12163; Evans-Molina C, 2009, MOL CELL BIOL, V29, P2053, DOI 10.1128/MCB.01179-08; Francis J, 2005, J BIOL CHEM, V280, P36244, DOI 10.1074/jbc.M505741200; Gysemans C, 2008, BIOCHEM SOC T, V36, P328, DOI 10.1042/BST0360328; Ivanov GS, 2007, MOL CELL BIOL, V27, P6756, DOI 10.1128/MCB.00460-07; Ko S, 2011, MOL ENDOCRINOL, V25, P433, DOI 10.1210/me.2010-0482; Kono T, 2012, MOL ENDOCRINOL, V26, P257, DOI 10.1210/me.2011-1181; Kouskouti A, 2004, MOL CELL, V14, P175, DOI 10.1016/S1097-2765(04)00182-0; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li Y, 2008, J BIOL CHEM, V283, P26771, DOI 10.1074/jbc.M802800200; Maganti AV, 2015, J BIOL CHEM, V290, P9812, DOI 10.1074/jbc.M114.616219; Munro S, 2010, ONCOGENE, V29, P2357, DOI 10.1038/onc.2009.511; Nishioka K, 2002, GENE DEV, V16, P479, DOI 10.1101/gad.967202; Ogihara T, 2009, ISLETS, V1, P269, DOI 10.4161/isl.1.3.9779; Okabe J, 2012, CIRC RES, V110, P1067, DOI 10.1161/CIRCRESAHA.112.266171; Richardson SJ, 2009, DIABETOLOGIA, V52, P1143, DOI 10.1007/s00125-009-1276-0; Roep BO, 2014, NAT REV ENDOCRINOL, V10, P229, DOI 10.1038/nrendo.2014.2; SADOWSKI HB, 1993, SCIENCE, V261, P1739, DOI 10.1126/science.8397445; Shimabukuro M, 1997, J CLIN INVEST, V100, P290, DOI 10.1172/JCI119534; Stassi G, 1997, J EXP MED, V186, P1193, DOI 10.1084/jem.186.8.1193; Stull ND, 2012, JOVE-J VIS EXP, DOI 10.3791/4137; Subramanian K, 2008, MOL CELL, V30, P336, DOI 10.1016/j.molcel.2008.03.022; Xu L, 2008, J BIOL CHEM, V283, P3077, DOI 10.1074/jbc.M705709200; Yang XD, 2009, EMBO J, V28, P1055, DOI 10.1038/emboj.2009.55	45	20	21	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16607	16618		10.1074/jbc.M115.661777	http://dx.doi.org/10.1074/jbc.M115.661777			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25995453	hybrid, Green Published			2022-12-28	WOS:000357572800013
J	Kitchen, P; Day, RE; Taylor, LHJ; Salman, MM; Bill, RM; Conner, MT; Conner, AC				Kitchen, Philip; Day, Rebecca E.; Taylor, Luke H. J.; Salman, Mootaz M.; Bill, Roslyn M.; Conner, Matthew T.; Conner, Alex C.			Identification and Molecular Mechanisms of the Rapid Tonicity-induced Relocalization of the Aquaporin 4 Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WATER PERMEABILITY; COLLECTING DUCT; MEMBRANE TRAFFICKING; PLASMA-MEMBRANE; PHOSPHORYLATION; CALMODULIN; AQP4; TRANSLOCATION; CELLS; INVOLVEMENT	The aquaporin family of integral membrane proteins is composed of channels that mediate cellular water flow. Aquaporin 4 (AQP4) is highly expressed in the glial cells of the central nervous system and facilitates the osmotically driven pathological brain swelling associated with stroke and traumatic brain injury. Here we show that AQP4 cell surface expression can be rapidly and reversibly regulated in response to changes of tonicity in primary cortical rat astrocytes and in transfected HEK293 cells. The translocation mechanism involves PKA activation, influx of extracellular calcium, and activation of calmodulin. We identify five putative PKA phosphorylation sites and use site-directed mutagenesis to show that only phosphorylation at one of these sites, serine 276, is necessary for the translocation response. We discuss our findings in the context of the identification of new therapeutic approaches to treating brain edema.	[Kitchen, Philip; Taylor, Luke H. J.] Univ Warwick, Mol Org & Assembly Cells Doctoral Training Ctr, Coventry CV4 7AL, W Midlands, England; [Day, Rebecca E.; Salman, Mootaz M.; Conner, Matthew T.] Sheffield Hallam Univ, Biomed Res Ctr, Sheffield S1 1WB, S Yorkshire, England; [Bill, Roslyn M.] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Bill, Roslyn M.] Aston Univ, Aston Res Ctr Hlth Ageing, Birmingham B4 7ET, W Midlands, England; [Conner, Alex C.] Univ Birmingham, Sch Clin & Expt Med, Birmingham B15 2TT, W Midlands, England	University of Warwick; Sheffield Hallam University; Aston University; Aston University; University of Birmingham	Bill, RM (corresponding author), Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England.	r.m.bill@aston.ac.uk; m.conner@shu.ac.uk; a.c.conner@bham.ac.uk	Kitchen, Philip/J-6936-2019; Bill, Roslyn M/D-4554-2012; Salman, Mootaz M./J-3111-2019	Kitchen, Philip/0000-0002-1558-4673; Bill, Roslyn M/0000-0003-1331-0852; Salman, Mootaz M./0000-0002-5683-1706	Engineering and Physical Sciences Research Council through the Molecular Organisation and Assembly in Cells Doctoral Training Centre, University of Warwick [EP/F500378/1]; Engineering and Physical Sciences Research Council [1091578] Funding Source: researchfish	Engineering and Physical Sciences Research Council through the Molecular Organisation and Assembly in Cells Doctoral Training Centre, University of Warwick; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Engineering and Physical Sciences Research Council through the Molecular Organisation and Assembly in Cells Doctoral Training Centre, University of Warwick, Grant EP/F500378/1 (to P. K. and L. H. J. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Assentoft M, 2014, AM J PHYSIOL-CELL PH, V307, pC957, DOI 10.1152/ajpcell.00182.2014; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Bustamante M, 2008, J AM SOC NEPHROL, V19, P109, DOI 10.1681/ASN.2007010092; Carmosino M, 2007, BIOL CELL, V99, P25, DOI 10.1042/BC200600068; Conner AC, 2013, MOL MEMBR BIOL, V30, P101, DOI 10.3109/09687688.2012.743194; Conner MT, 2012, J BIOL CHEM, V287, P11516, DOI 10.1074/jbc.M111.329219; Conner MT, 2010, BIOCHEMISTRY-US, V49, P821, DOI 10.1021/bi902068b; De Bellis M, 2014, MOL BIOL CELL, V25, P470, DOI 10.1091/mbc.E13-06-0331; Gouraud S, 2002, J CELL SCI, V115, P3667, DOI 10.1242/jcs.00053; Gunnarson E, 2008, GLIA, V56, P587, DOI 10.1002/glia.20627; Hoffert JD, 2007, J PROTEOME RES, V6, P3501, DOI 10.1021/pr0701153; Huber VJ, 2009, BIOORGAN MED CHEM, V17, P411, DOI 10.1016/j.bmc.2007.12.040; Ishikawa Y, 2002, MOL PHARMACOL, V61, P1423, DOI 10.1124/mol.61.6.1423; JUNG JS, 1994, P NATL ACAD SCI USA, V91, P13052, DOI 10.1073/pnas.91.26.13052; Kalman K, 2008, J BIOL CHEM, V283, P21278, DOI 10.1074/jbc.M801740200; Kato J, 2013, BIOCHEM J, V454, P275, DOI 10.1042/BJ20130046; Katsura T, 1997, Am J Physiol, V272, pF817; Madrid R, 2001, EMBO J, V20, P7008, DOI 10.1093/emboj/20.24.7008; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; MARPLES D, 1995, AM J PHYSIOL-CELL PH, V269, pC655, DOI 10.1152/ajpcell.1995.269.3.C655; Moeller HB, 2009, NEUROSCIENCE, V164, P1674, DOI 10.1016/j.neuroscience.2009.09.072; Nejsum LN, 2005, AM J PHYSIOL-RENAL, V288, pF930, DOI 10.1152/ajprenal.00291.2004; Nicchia GP, 2008, GLIA, V56, P1755, DOI 10.1002/glia.20724; Papadopoulos MC, 2013, NAT REV NEUROSCI, V14, P265, DOI 10.1038/nrn3468; Rabaud NE, 2009, BIOCHEM BIOPH RES CO, V383, P54, DOI 10.1016/j.bbrc.2009.03.128; Rash JE, 2004, NEUROSCIENCE, V129, P915, DOI 10.1016/j.neuroscience.2004.06.076; Reichow SL, 2008, STRUCTURE, V16, P1389, DOI 10.1016/j.str.2008.06.011; Rossi A, 2010, J BIOL CHEM, V285, P4562, DOI 10.1074/jbc.M109.069245; Song YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034936; Tanimura Y, 2009, J STRUCT BIOL, V166, P16, DOI 10.1016/j.jsb.2008.11.010; Varadaraj K, 2005, INVEST OPHTH VIS SCI, V46, P1393, DOI 10.1167/iovs.04-1217; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Wisniewski JR, 2010, J PROTEOME RES, V9, P3280, DOI 10.1021/pr1002214; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Zador Zsolt, 2009, Handb Exp Pharmacol, P159, DOI 10.1007/978-3-540-79885-9_7	35	61	62	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16873	16881		10.1074/jbc.M115.646034	http://dx.doi.org/10.1074/jbc.M115.646034			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	26013827	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000357572800032
J	Loo, TW; Clarke, DM				Loo, Tip W.; Clarke, David M.			The Transmission Interfaces Contribute Asymmetrically to the Assembly and Activity of Human P-glycoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; NUCLEOTIDE-BINDING DOMAINS; CYSTIC-FIBROSIS; DRUG-BINDING; ATPASE ACTIVITY; ABC TRANSPORTERS; DISRUPT INTERACTIONS; CATALYTIC CYCLE; MUTANTS; MUTATIONS	P-glycoprotein (P-gp; ABCB1) is an ABC drug pump that protects us from toxic compounds. It is clinically important because it confers multidrug resistance. The homologous halves of P-gp each contain a transmembrane (TM) domain (TMD) with 6 TM segments followed by a nucleotide-binding domain (NBD). The drug-and ATP-binding sites reside at the interface between the TMDs and NBDs, respectively. Each NBD is connected to the TMDs by a transmission interface involving a pair of intracellular loops (ICLs) that form ball-and-socket joints. P-gp is different from CFTR (ABCC7) in that deleting NBD2 causes misprocessing of only P-gp. Therefore, NBD2 might be critical for stabilizing ICLs 2 and 3 that form a tetrahelix bundle at the NBD2 interface. Here we report that the NBD1 and NBD2 transmission interfaces in P-gp are asymmetric. Point mutations to 25 of 60 ICL2/ICL3 residues at the NBD2 transmission interface severely reduced P-gp assembly while changes to the equivalent residues in ICL1/ICL4 at the NBD1 interface had little effect. The hydrophobic nature at the transmission interfaces was also different. Mutation of Phe-1086 or Tyr-1087 to arginine at the NBD2 socket blocked activity or assembly while the equivalent mutations at the NBD1 socket had only modest effects. The results suggest that the NBD transmission interfaces are asymmetric. In contrast to the ICL2/3-NBD2 interface, the ICL1/4-NBD1 transmission interface is more hydrophilic and insensitive to mutations. Therefore the ICL2/3-NBD2 transmission interface forms a precise hydrophobic connection that acts as a linchpin for assembly and trafficking of P-gp.	[Clarke, David M.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto	Clarke, DM (corresponding author), Univ Toronto, Dept Med, 1 Kings Coll Circle,Rm 7342,Med Sci Bldg, Toronto, ON M5S 1A8, Canada.	david.clarke@utoronto.ca	Clarke, David M./A-1112-2008	Clarke, David M./0000-0003-4335-7184; Loo, Tip W/0000-0003-2108-0188	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Institutes of Health Research (to D. M. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Ambudkar SV, 1997, J BIOL CHEM, V272, P21160, DOI 10.1074/jbc.272.34.21160; Becker JP, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-3; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; CHIFFLET S, 1988, ANAL BIOCHEM, V168, P1, DOI 10.1016/0003-2697(88)90002-4; Cooper RS, 2013, J BIOL CHEM, V288, P20785, DOI 10.1074/jbc.M113.477976; Delannoy S, 2005, BIOCHEMISTRY-US, V44, P14010, DOI 10.1021/bi0512445; DeLano W.L, PYMOL MOL GRAPHICS S; Dey S, 1997, P NATL ACAD SCI USA, V94, P10594, DOI 10.1073/pnas.94.20.10594; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Du K, 2009, MOL BIOL CELL, V20, P1903, DOI 10.1091/mbc.E08-09-0950; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; Kapoor K, 2013, J BIOL CHEM, V288, P32622, DOI 10.1074/jbc.M113.498980; Kluth M, 2015, J BIOL CHEM, V290, P4896, DOI 10.1074/jbc.M114.588566; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Li JZ, 2014, PROTEIN SCI, V23, P34, DOI 10.1002/pro.2387; Loo TW, 2008, J BIOL CHEM, V283, P28190, DOI 10.1074/jbc.M805834200; Loo TW, 2008, ARCH BIOCHEM BIOPHYS, V476, P51, DOI 10.1016/j.abb.2008.02.025; Loo TW, 2007, J BIOL CHEM, V282, P32043, DOI 10.1074/jbc.M706175200; Loo TW, 2014, BIOCHEM PHARMACOL, V92, P558, DOI 10.1016/j.bcp.2014.10.006; Loo TW, 2014, J BIOL CHEM, V289, P229, DOI 10.1074/jbc.M113.527804; Loo TW, 2013, BIOCHEMISTRY-US, V52, P7167, DOI 10.1021/bi401269m; Loo TW, 2013, BIOCHEMISTRY-US, V52, P3194, DOI 10.1021/bi400425k; Loo TW, 2013, J BIOL CHEM, V288, P20326, DOI 10.1074/jbc.M113.484550; Loo TW, 2012, J BIOL CHEM, V287, P26806, DOI 10.1074/jbc.M112.376202; Loo TW, 2012, BIOCHEM PHARMACOL, V83, P345, DOI 10.1016/j.bcp.2011.11.014; Loo TW, 2010, BIOCHEM BIOPH RES CO, V395, P436, DOI 10.1016/j.bbrc.2010.04.057; Loo TW, 2009, J BIOL CHEM, V284, P24074, DOI 10.1074/jbc.M109.023267; Loo TW, 1997, J BIOL CHEM, V272, P709, DOI 10.1074/jbc.272.2.709; Loo TW, 2003, J BIOL CHEM, V278, P39706, DOI 10.1074/jbc.M308559200; Loo TW, 2005, J BIOL CHEM, V280, P2522, DOI 10.1074/jbc.M411483200; Loo TW, 2004, J BIOL CHEM, V279, P38395, DOI 10.1074/jbc.M405623200; Loo TW, 1999, FASEB J, V13, P1724, DOI 10.1096/fasebj.13.13.1724; Loo TW, 1999, J BIOL CHEM, V274, P35388, DOI 10.1074/jbc.274.50.35388; Loo TW, 1999, J BIOL CHEM, V274, P24759, DOI 10.1074/jbc.274.35.24759; LOO TW, 1994, J BIOL CHEM, V269, P7243; Loo TW, 1998, J BIOL CHEM, V273, P14671, DOI 10.1074/jbc.273.24.14671; LOO TW, 1995, J BIOL CHEM, V270, P21449, DOI 10.1074/jbc.270.37.21449; LOO TW, 1995, J BIOL CHEM, V270, P21839, DOI 10.1074/jbc.270.37.21839; LOO TW, 1995, J BIOL CHEM, V270, P22957, DOI 10.1074/jbc.270.39.22957; Lugo MR, 2005, BIOCHEMISTRY-US, V44, P643, DOI 10.1021/bi0485326; Lugo MR, 2005, BIOCHEMISTRY-US, V44, P14020, DOI 10.1021/bi0511179; Nakagawa H, 2011, J PHARM SCI-US, V100, P3602, DOI 10.1002/jps.22615; Okiyoneda T, 2012, J CELL BIOL, V199, P199, DOI 10.1083/jcb.201208083; Omote H, 2002, J BIOL CHEM, V277, P45688, DOI 10.1074/jbc.M206479200; Ostedgaard LS, 1997, BIOCHEMISTRY-US, V36, P1287, DOI 10.1021/bi962174s; Pajeva IK, 2013, CHEMMEDCHEM, V8, P748, DOI 10.1002/cmdc.201200491; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rosenberg MF, 2010, STRUCTURE, V18, P482, DOI 10.1016/j.str.2010.01.017; Sauna ZE, 2007, BIOCHEMISTRY-US, V46, P13787, DOI 10.1021/bi701385t; Siarheyeva A, 2010, J BIOL CHEM, V285, P7575, DOI 10.1074/jbc.M109.047290; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; VANDERBLIEK AM, 1988, GENE, V71, P401, DOI 10.1016/0378-1119(88)90057-1; Wang Y, 2007, MOL PHARMACOL, V71, P751, DOI 10.1124/mol.106.029926; Wise JG, 2012, BIOCHEMISTRY-US, V51, P5125, DOI 10.1021/bi300299z; Zoghbi ME, 2013, J BIOL CHEM, V288, P34259, DOI 10.1074/jbc.M113.500371; Zolnerciks JK, 2014, FASEB J, V28, P4335, DOI 10.1096/fj.13-245639	57	20	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16954	16963		10.1074/jbc.M115.652602	http://dx.doi.org/10.1074/jbc.M115.652602			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25987565	Green Published, hybrid			2022-12-28	WOS:000357572800039
J	Cali, T; Lopreiato, R; Shimony, J; Vineyard, M; Frizzarin, M; Zanni, G; Zanotti, G; Brini, M; Shinawi, M; Carafoli, E				Cali, Tito; Lopreiato, Raffaele; Shimony, Joshua; Vineyard, Marisa; Frizzarin, Martina; Zanni, Ginevra; Zanotti, Giuseppe; Brini, Marisa; Shinawi, Marwan; Carafoli, Ernesto			A Novel Mutation in Isoform 3 of the Plasma Membrane Ca2+ Pump Impairs Cellular Ca2+ Homeostasis in a Patient with Cerebellar Ataxia and Laminin Subunit 1 Mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ataxia; calcium; calcium ATPase; enzyme mutation; laminin	CALCIUM-PUMP; CALMODULIN; CELLS; OVEREXPRESSION; EXPRESSION; ATPASES; PROTEIN; PMCA2; MOUSE; YEAST	Background: Mutations in plasma membrane Ca2+-ATPase (PMCA) isoform 3 and in laminin subunit 1 have previously been linked to ataxic phenotypes. Results: A novel PMCA3 missense mutation co-occurring with a compound heterozygous mutation in laminin subunit 1 impaired cellular Ca2+ homeostasis. Conclusion: The two mutations could work synergistically to generate the disease phenotype. Significance: A digenic mechanism could be responsible for this case of cerebellar ataxia. The particular importance of Ca2+ signaling to neurons demands its precise regulation within their cytoplasm. Isoform 3 of the plasma membrane Ca2+ ATPase (the PMCA3 pump), which is highly expressed in brain and cerebellum, plays an important role in the regulation of neuronal Ca2+. A genetic defect of the PMCA3 pump has been described in one family with X-linked congenital cerebellar ataxia. Here we describe a novel mutation in the ATP2B3 gene in a patient with global developmental delay, generalized hypotonia and cerebellar ataxia. The mutation (a R482H replacement) impairs the Ca2+ ejection function of the pump. It reduces the ability of the pump expressed in model cells to control Ca2+ transients generated by cell stimulation and impairs its Ca2+ extrusion function under conditions of low resting cytosolic Ca2+ as well. In silico analysis of the structural effect of the mutation suggests a reduced stabilization of the portion of the pump surrounding the mutated residue in the Ca2+-bound state. The patient also carries two missense mutations in LAMA1, encoding laminin subunit 1. On the basis of the family pedigree of the patient, the presence of both PMCA3 and laminin subunit 1 mutations appears to be necessary for the development of the disease. Considering the observed defect in cellular Ca2+ homeostasis and the previous finding that PMCAs act as digenic modulators in Ca2+-linked pathologies, the PMCA3 dysfunction along with LAMA1 mutations could act synergistically to cause the neurological phenotype.	[Cali, Tito; Brini, Marisa] Univ Padua, Dept Biol, I-35131 Padua, Italy; [Lopreiato, Raffaele; Frizzarin, Martina; Zanotti, Giuseppe] Univ Padua, Dept Biomed Sci, I-35131 Padua, Italy; [Shimony, Joshua] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA; [Vineyard, Marisa; Shinawi, Marwan] Washington Univ, Sch Med, Dept Pediat, Div Genet & Genom Med, St Louis, MO 63110 USA; [Zanni, Ginevra] Bambino Gesu Pediat Hosp, Dept Neurosci, Unit Mol Med Neuromuscular & Neurodegenerat Disor, IRCCS, I-00165 Rome, Italy; [Carafoli, Ernesto] VIMM, I-35131 Padua, Italy	University of Padua; University of Padua; Washington University (WUSTL); Washington University (WUSTL); IRCCS Bambino Gesu; Veneto Institute Molecular Medicine	Brini, M (corresponding author), Univ Padua, Dept Biol, I-35131 Padua, Italy.	marisa.brini@unipd.it; Shinawi_M@kids.wustl.edu; ernesto.carafoli@unipd.it	Brini, Marisa/K-5189-2016; Carafoli, Ernesto/K-5192-2016; Calì, Tito/K-5064-2016; Zanni, Ginevra/L-2869-2015	Carafoli, Ernesto/0000-0002-7826-0094; Calì, Tito/0000-0002-8901-1659; Zanni, Ginevra/0000-0002-6367-1843; Brini, Marisa/0000-0001-5141-0243; LOPREIATO, RAFFAELE/0000-0003-2368-9384; shinawi, Marwan/0000-0003-1329-4100; Andrews, Marisa/0000-0002-5448-1204	University of Padova; Progetto Giovani [GRIC128SP0]; Progetto di Ateneo [CPDA115047/11]; University of Padova [Giovani GRIC128SP0]	University of Padova; Progetto Giovani; Progetto di Ateneo; University of Padova	This work was supported by the University of Padova (local grants (to M. B.), Progetto Giovani GRIC128SP0 (to T. C.), and Progetto di Ateneo CPDA115047/11 (to R. L.)).; Supported by the University of Padova (Progetto Giovani GRIC128SP0, Bando 2012).	Aldinger KA, 2014, AM J HUM GENET, V95, P227, DOI 10.1016/j.ajhg.2014.07.007; Baekgaard L, 2006, J BIOL CHEM, V281, P1058, DOI 10.1074/jbc.M508299200; Bortolozzi M, 2010, J BIOL CHEM, V285, P37693, DOI 10.1074/jbc.M110.170092; Brini M, 2000, EMBO J, V19, P4926, DOI 10.1093/emboj/19.18.4926; BRINI M, 1995, J BIOL CHEM, V270, P9896, DOI 10.1074/jbc.270.17.9896; Brini M, 2003, J BIOL CHEM, V278, P24500, DOI 10.1074/jbc.M300784200; Brini M, 2014, CELL MOL LIFE SCI, V71, P2787, DOI 10.1007/s00018-013-1550-7; Brini M, 2013, METAL IONS LIFE SCI, V12, P119, DOI 10.1007/978-94-007-5561-1_5; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; Carafoli E, 2007, N COMP BIOC, V41, P3; Chand K. K., 2014, J PHYSL, V593, P245, DOI DOI 10.1113/JPHYSIOL.2014.284133; Cox JS, 1997, MOL BIOL CELL, V8, P1805, DOI 10.1091/mbc.8.9.1805; CUNNINGHAM KW, 1994, J CELL BIOL, V124, P351, DOI 10.1083/jcb.124.3.351; Dumont RA, 2001, J NEUROSCI, V21, P5066, DOI 10.1523/JNEUROSCI.21-14-05066.2001; EAKIN TJ, 1995, MOL BRAIN RES, V29, P71, DOI 10.1016/0169-328X(94)00231-3; Empson RM, 2010, J PHYSIOL-LONDON, V588, P907, DOI 10.1113/jphysiol.2009.182196; ENYEDI A, 1989, J BIOL CHEM, V264, P12313; Ficarella R, 2007, P NATL ACAD SCI USA, V104, P1516, DOI 10.1073/pnas.0609775104; FUJIMOTO T, 1993, J CELL BIOL, V120, P1147, DOI 10.1083/jcb.120.5.1147; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Hammes A, 1998, CIRC RES, V83, P877; Heng C, 2011, CELL ADHES MIGR, V5, P480, DOI 10.4161/cam.5.6.19191; INOUE Y, 1993, NEUROSCI RES, V16, P39, DOI 10.1016/0168-0102(93)90007-D; Lopreiato R, 2014, J BIOL CHEM, V289, P10261, DOI 10.1074/jbc.O114.555565; Mao P, 2013, P NATL ACAD SCI USA, V110, P8644, DOI 10.1073/pnas.1221478110; Powell SK, 1997, INT J BIOCHEM CELL B, V29, P401, DOI 10.1016/S1357-2725(96)00110-0; Rizzuto R, 1995, METHOD ENZYMOL, V260, P417, DOI 10.1016/0076-6879(95)60155-4; Schultz JM, 2005, NEW ENGL J MED, V352, P1557, DOI 10.1056/NEJMoa043899; Ton VK, 2004, AM J PHYSIOL-CELL PH, V287, pC580, DOI 10.1152/ajpcell.00135.2004; VERMA AK, 1994, J BIOL CHEM, V269, P1687; Zanni G, 2012, P NATL ACAD SCI USA, V109, P14514, DOI 10.1073/pnas.1207488109	31	34	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16132	16141		10.1074/jbc.M115.656496	http://dx.doi.org/10.1074/jbc.M115.656496			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25953895	Green Published, hybrid			2022-12-28	WOS:000356930100018
J	Birkholz, AM; Howell, AR; Kronenberg, M				Birkholz, Alysia M.; Howell, Amy R.; Kronenberg, Mitchell			The Alpha and Omega of Galactosylceramides in T Cell Immune Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						ceramide; cytokine; glycolipid structure; immunology; lipid	NKT CELLS; IN-VIVO; RECOGNITION; DISTINCT; BETA; GLYCOLIPIDS; ACTIVATION; RESPONSES; ANTIGENS; LIGAND	Glycosphingolipids are a subgroup of glycolipids that contain an amino alcohol sphingoid base linked to sugars. They are found in the membranes of cells ranging from bacteria to vertebrates. This group of lipids is known to stimulate the immune system through activation of a type of white blood cell known as natural killer T cell (NKT cell). Here we summarize the extensive research that has been done to identify the structures of natural glycolipids that stimulate NKT cells and to determine how these antigens are recognized. We also review studies designed to understand how glycolipid variants, both natural and synthetic, can alter the responses of NKT cells, leading to dramatic changes in the global immune response.	[Birkholz, Alysia M.; Kronenberg, Mitchell] La Jolla Inst Allergy & Immunol, Div Dev Immunol, La Jolla, CA 92037 USA; [Birkholz, Alysia M.; Kronenberg, Mitchell] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92037 USA; [Howell, Amy R.] Univ Connecticut, Dept Chem, Storrs, CT 06269 USA	La Jolla Institute for Immunology; University of California System; University of California San Diego; University of Connecticut	Kronenberg, M (corresponding author), La Jolla Inst Allergy & Immunol, Div Dev Immunol, 9420 Athena Circle, La Jolla, CA 92037 USA.	mitch@lji.org	Kronenberg, Mitchell/AAT-6078-2021	Howell, Amy/0000-0003-1958-6411; Birkholz, Alysia/0000-0002-3794-5636	National Institutes of Health [R37 AI71922, R01 AI105215]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI071922, R01AI105215] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants R37 AI71922 and R01 AI105215 (to M. K.). This is the first article in the Thematic Minireview series "Novel Bioactive Sphingolipids." The authors declare that they have no conflicts of interest with the contents of this article.	An DD, 2014, CELL, V156, P123, DOI 10.1016/j.cell.2013.11.042; Arora P, 2014, IMMUNITY, V40, P105, DOI 10.1016/j.immuni.2013.12.004; Aspeslagh S, 2013, J IMMUNOL, V191, P2916, DOI 10.4049/jimmunol.1203134; Aspeslagh S, 2011, EMBO J, V30, P2294, DOI 10.1038/emboj.2011.145; Blomqvist M, 2009, EUR J IMMUNOL, V39, P1726, DOI 10.1002/eji.200839001; Brennan PJ, 2014, P NATL ACAD SCI USA, V111, P13433, DOI 10.1073/pnas.1415357111; Brennan PJ, 2011, NAT IMMUNOL, V12, P1202, DOI 10.1038/ni.2143; Brown LCW, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001610; Degroote S, 2004, SEMIN CELL DEV BIOL, V15, P375, DOI 10.1016/j.semcdb.2004.03.007; East JE, 2014, MED RES REV, V34, P45, DOI 10.1002/med.21276; Exley M, 1998, J EXP MED, V188, P867, DOI 10.1084/jem.188.5.867; Facciotti F, 2012, NAT IMMUNOL, V13, P474, DOI 10.1038/ni.2245; Fox LM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000228; Girardi E, 2012, IMMUNOL REV, V250, P167, DOI 10.1111/j.1600-065X.2012.01166.x; Girardi E, 2012, NAT IMMUNOL, V13, P851, DOI 10.1038/ni.2371; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Harada K, 2003, LIVER INT, V23, P94, DOI 10.1034/j.1600-0676.2003.00807.x; Ilan Y, 2009, CLIN EXP IMMUNOL, V158, P300, DOI 10.1111/j.1365-2249.2009.04030.x; Issazadeh-Navikas S, 2012, J MOL CELL BIOL, V4, P70, DOI 10.1093/jmcb/mjr035; Jahng A, 2004, J EXP MED, V199, P947, DOI 10.1084/jem.20031389; Kain L, 2014, IMMUNITY, V41, P543, DOI 10.1016/j.immuni.2014.08.017; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Kinjo Y, 2008, CHEM BIOL, V15, P654, DOI 10.1016/j.chembiol.2008.05.012; Koch U, 2011, ANNU REV CELL DEV BI, V27, P539, DOI 10.1146/annurev-cellbio-092910-154008; Lahiri S, 2007, CELL MOL LIFE SCI, V64, P2270, DOI 10.1007/s00018-007-7076-0; Leslie M, 2012, SCIENCE, V335, P1428, DOI 10.1126/science.335.6075.1428; Li XM, 2010, P NATL ACAD SCI USA, V107, P13010, DOI 10.1073/pnas.1006662107; Long XT, 2007, NAT CHEM BIOL, V3, P559, DOI 10.1038/nchembio.2007.19; MACDONALD HR, 1995, J EXP MED, V182, P633, DOI 10.1084/jem.182.3.633; MAKINO Y, 1995, INT IMMUNOL, V7, P1157, DOI 10.1093/intimm/7.7.1157; Mallevaey T, 2011, IMMUNITY, V34, P315, DOI 10.1016/j.immuni.2011.01.013; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; MORITA M, 1995, J MED CHEM, V38, P2176, DOI 10.1021/jm00012a018; NATORI T, 1994, TETRAHEDRON, V50, P2771, DOI 10.1016/S0040-4020(01)86991-X; Oki S, 2004, J CLIN INVEST, V113, P1631, DOI 10.1172/JCI200420862; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Ortaldo JR, 2004, J IMMUNOL, V172, P943, DOI 10.4049/jimmunol.172.2.943; Parekh VV, 2004, J IMMUNOL, V173, P3693, DOI 10.4049/jimmunol.173.6.3693; Pei B, 2011, J IMMUNOL, V186, P1348, DOI 10.4049/jimmunol.1001008; Pellicci DG, 2011, NAT IMMUNOL, V12, P827, DOI 10.1038/ni.2076; PORCELLI S, 1993, J EXP MED, V178, P1, DOI 10.1084/jem.178.1.1; Porubsky S, 2007, P NATL ACAD SCI USA, V104, P5977, DOI 10.1073/pnas.0611139104; Raphael I, 2015, CYTOKINE, V74, P5, DOI 10.1016/j.cyto.2014.09.011; Rossjohn J, 2012, NAT REV IMMUNOL, V12, P845, DOI 10.1038/nri3328; Salio M, 2014, ANNU REV IMMUNOL, V32, P323, DOI 10.1146/annurev-immunol-032713-120243; SCHMIDT RE, 1986, J EXP MED, V164, P351, DOI 10.1084/jem.164.1.351; Schmieg J, 2003, J EXP MED, V198, P1631, DOI 10.1084/jem.20031192; Sidobre S, 2004, P NATL ACAD SCI USA, V101, P12254, DOI 10.1073/pnas.0404632101; Sullivan BA, 2010, J IMMUNOL, V184, P141, DOI 10.4049/jimmunol.0902880; Terabe M, 2014, CANCER IMMUNOL IMMUN, V63, P199, DOI 10.1007/s00262-013-1509-4; Tyznik AJ, 2011, CHEM BIOL, V18, P1620, DOI 10.1016/j.chembiol.2011.10.015; Wei B, 2010, J IMMUNOL, V184, P1218, DOI 10.4049/jimmunol.0902620; Wingender G, 2012, GASTROENTEROLOGY, V143, P418, DOI 10.1053/j.gastro.2012.04.017; Zajonc DM, 2007, CURR OPIN STRUC BIOL, V17, P521, DOI 10.1016/j.sbi.2007.09.010; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440	56	13	13	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15365	15370		10.1074/jbc.R115.647057	http://dx.doi.org/10.1074/jbc.R115.647057			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25947378	Green Published, hybrid			2022-12-28	WOS:000356527400002
J	Calabuig-Navarro, V; Yamauchi, J; Lee, S; Zhang, T; Liu, YZ; Sadlek, K; Coudriet, GM; Piganelli, JD; Jiang, CL; Miller, R; Lowe, M; Harashima, H; Dong, HH				Calabuig-Navarro, Virtu; Yamauchi, Jun; Lee, Sojin; Zhang, Ting; Liu, Yun-Zi; Sadlek, Kelsey; Coudriet, Gina M.; Piganelli, Jon D.; Jiang, Chun-Lei; Miller, Rita; Lowe, Mark; Harashima, Hideyoshi; Dong, H. Henry			Forkhead Box O6 (FoxO6) Depletion Attenuates Hepatic Gluconeogenesis and Protects against Fat-induced Glucose Disorder in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						diabetes; gluconeogenesis; glucose metabolism; liver; obesity; FoxO6; glucose metabolism; mice	TRANSCRIPTION FACTOR FKHR; INSULIN-RESPONSE SEQUENCE; ADIPOSE-TISSUE; GENE-EXPRESSION; VLDL PRODUCTION; IN-VIVO; METABOLISM; PHOSPHORYLATION; OBESITY; LIVER	Background: Excessive endogenous glucose production is a major contributing factor for fasting hyperglycemia in diabetes. Results: FoxO6 deficiency attenuates hepatic gluconeogenesis and protects against fat-induced glucose disorder in mice. Conclusion: FoxO6 plays a significant role in regulating gluconeogenesis in the liver. Significance: FoxO6 is a potential therapeutic target for improving glucose metabolism in diabetes. Excessive endogenous glucose production contributes to fasting hyperglycemia in diabetes. FoxO6 is a distinct member of the FoxO subfamily. To elucidate the role of FoxO6 in hepatic gluconeogenesis and assess its contribution to the pathogenesis of fasting hyperglycemia in diabetes, we generated FoxO6 knock-out (FoxO6-KO) mice followed by determining the effect of FoxO6 loss-of-function on hepatic gluconeogenesis under physiological and pathological conditions. FoxO6 depletion attenuated hepatic gluconeogenesis and lowered fasting glycemia in FoxO6-KO mice. FoxO6-deficient primary hepatocytes were associated with reduced capacities to produce glucose in response to glucagon. When fed a high fat diet, FoxO6-KO mice exhibited significantly enhanced glucose tolerance and reduced blood glucose levels accompanied by improved insulin sensitivity. These effects correlated with attenuated hepatic gluconeogenesis in FoxO6-KO mice. In contrast, wild-type littermates developed fat-induced glucose intolerance with a concomitant induction of fasting hyperinsulinemia and hyperglycemia. Furthermore, FoxO6-KO mice displayed significantly diminished macrophage infiltration into liver and adipose tissues, correlating with the reduction of macrophage expression of C-C chemokine receptor 2 (CCR2), a factor that is critical for regulating macrophage recruitment in peripheral tissues. Our data indicate that FoxO6 depletion protected against diet-induced glucose intolerance and insulin resistance by attenuating hepatic gluconeogenesis and curbing macrophage infiltration in liver and adipose tissues in mice.	[Calabuig-Navarro, Virtu; Yamauchi, Jun; Lee, Sojin; Zhang, Ting; Liu, Yun-Zi; Sadlek, Kelsey; Miller, Rita; Lowe, Mark; Dong, H. Henry] Univ Pittsburgh, Childrens Hosp Pittsburgh, UPMC, Sch Med,Dept Pediat, Pittsburgh, PA 15224 USA; [Yamauchi, Jun; Harashima, Hideyoshi] Hokkaido Univ, Fac Pharmaceut Sci, Lab Mol Design Pharmaceut, Sapporo, Hokkaido 0600812, Japan; [Liu, Yun-Zi; Jiang, Chun-Lei] Second Mil Med Univ, Fac Psychol & Mental Hlth, Lab Stress Med, Shanghai 200433, Peoples R China; [Coudriet, Gina M.; Piganelli, Jon D.] Univ Pittsburgh, Dept Surg, Sch Med, Pittsburgh, PA 15224 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Hokkaido University; Naval Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Dong, HH (corresponding author), UPMC, Childrens Hosp Pittsburgh, Rangos Res Ctr, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	dongh@pitt.edu	Regan, Clinton/E-6250-2012; Zhang, Ting/J-5074-2015; Calabuig, Virtu/AAB-2990-2021	Calabuig, Virtu/0000-0001-6277-7040; Dong, H. Henry/0000-0003-0279-5241	National Institutes of Health [R01 DK087764]; Japan Society for the Promotion of Science [24-3549]; Chinese Natural Science Foundation Fellowship [201306580015]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087764, R01DK098437] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Chinese Natural Science Foundation Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK087764. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of Grant-in-aid scholarship 24-3549 from the Japan Society for the Promotion of Science.; Supported by Chinese Natural Science Foundation Fellowship 201306580015.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Altomonte J, 2003, AM J PHYSIOL-ENDOC M, V285, pE718, DOI 10.1152/ajpendo.00156.2003; Ayala JE, 1999, DIABETES, V48, P1885, DOI 10.2337/diabetes.48.9.1885; Baffy G, 2009, J HEPATOL, V51, P212, DOI 10.1016/j.jhep.2009.03.008; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Barthel A, 2003, AM J PHYSIOL-ENDOC M, V285, pE685, DOI 10.1152/ajpendo.00253.2003; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; Durham SK, 1999, ENDOCRINOLOGY, V140, P3140, DOI 10.1210/en.140.7.3140; Edgerton DS, 2009, DIABETES, V58, P2766, DOI 10.2337/db09-0328; Edgerton DS, 2009, FRONT BIOSCI-LANDMRK, V14, P1169, DOI 10.2741/3301; Ekberg K, 1999, DIABETES, V48, P292, DOI 10.2337/diabetes.48.2.292; Fisher SJ, 2003, J CLIN INVEST, V111, P463, DOI 10.1172/JCI16426; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Furuyama T, 2004, J BIOL CHEM, V279, P34741, DOI 10.1074/jbc.M314214200; Haeusler RA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6190; Huang W, 2010, DIABETES, V59, P347, DOI 10.2337/db09-0016; Jiang GQ, 2003, AM J PHYSIOL-ENDOC M, V284, pE671, DOI 10.1152/ajpendo.00492.2002; Kamagate A, 2008, CELL CYCLE, V7, P3162, DOI 10.4161/cc.7.20.6882; Kamagate A, 2008, J CLIN INVEST, V118, P2347, DOI [10.1172/JCI32914, 10.1172/JC132914]; Kamagate A, 2010, ENDOCRINOLOGY, V151, P3521, DOI 10.1210/en.2009-1306; Kim DH, 2013, J DIABETES, V5, P233, DOI 10.1111/1753-0407.12027; Kim DH, 2011, DIABETES, V60, P2763, DOI 10.2337/db11-0548; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Lee P, 2004, P NATL ACAD SCI USA, V101, P9263, DOI 10.1073/pnas.0403108101; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Lu MJ, 2012, NAT MED, V18, P388, DOI 10.1038/nm.2686; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Marra F, 2014, GASTROENTEROLOGY, V147, P577, DOI 10.1053/j.gastro.2014.06.043; Massillon D, 1995, AM J PHYSIOL-ENDOC M, V269, pE1037, DOI 10.1152/ajpendo.1995.269.6.E1037; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Nakae J, 2000, EMBO J, V19, P989, DOI 10.1093/emboj/19.5.989; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Obstfeld AE, 2010, DIABETES, V59, P916, DOI 10.2337/db09-1403; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Qu S, 2006, ENDOCRINOLOGY, V147, P5641, DOI 10.1210/en.2006-0541; Rodgers JT, 2010, CELL METAB, V11, P23, DOI 10.1016/j.cmet.2009.11.006; Rossetti L, 1997, J BIOL CHEM, V272, P27758, DOI 10.1074/jbc.272.44.27758; Schmoll D, 2000, J BIOL CHEM, V275, P36324, DOI 10.1074/jbc.M003616200; Scott DK, 1998, J BIOL CHEM, V273, P24145, DOI 10.1074/jbc.273.37.24145; Streeper RS, 1997, J BIOL CHEM, V272, P11698, DOI 10.1074/jbc.272.18.11698; Tonelli J, 2005, CURR OPIN CLIN NUTR, V8, P450, DOI 10.1097/01.mco.0000172588.47811.63; Vander Kooi BT, 2003, J BIOL CHEM, V278, P11782, DOI 10.1074/jbc.M212570200; Wahren J, 2007, ANNU REV NUTR, V27, P329, DOI 10.1146/annurev.nutr.27.061406.093806; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang LP, 2005, CELL METAB, V2, P141, DOI 10.1016/j.cmet.2005.07.002; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200; Zhao XS, 2004, BIOCHEM J, V378, P839, DOI 10.1042/BJ20031450	53	34	36	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15581	15594		10.1074/jbc.M115.650994	http://dx.doi.org/10.1074/jbc.M115.650994			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25944898	Green Published, hybrid			2022-12-28	WOS:000356527400023
J	Feng, J; Yang, WS; Xie, ZL; Xiang, F; Cao, ZJ; Li, WX; Hu, HZ; Chen, ZY; Wu, YL				Feng, Jing; Yang, Weishan; Xie, Zili; Xiang, Fang; Cao, Zhijian; Li, Wenxin; Hu, Hongzhen; Chen, Zongyun; Wu, Yingliang			Kv Channel S1-S2 Linker Working as a Binding Site of Human -Defensin 2 for Channel Activation Modulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						defensin; immunology; ligand-binding protein; toxin; voltage-dependent anion channel (VDAC); Kv channel; S1-S2 linker; human beta-defensin 2; electrostatic interaction; gating modifier	GATED POTASSIUM CHANNELS; VOLTAGE-SENSOR; STRUCTURAL BASIS; GATING MODIFIER; RECEPTOR-SITE; K+ CHANNELS; TOXIN; INHIBITOR; CHARYBDOTOXIN; HANATOXIN	Background: The functional role of the Kv channel S1-S2 linker remains unclear. Results: The S1-S2 linker-hBD2 interaction modifies Kv1.3 channel activation through electrostatic repulsion between positively charged hBD2 and the channel S4 segment. Conclusion: The Kv1.3 channel S1-S2 linker is a novel peptide-binding site. Significance: These findings could define the function of S1-S2 linkers in Kv channel gating modification among different Kv channels. Among the three extracellular domains of the tetrameric voltage-gated K+ (Kv) channels consisting of six membrane-spanning helical segments named S1-S6, the functional role of the S1-S2 linker still remains unclear because of the lack of a peptide ligand. In this study, the Kv1.3 channel S1-S2 linker was reported as a novel receptor site for human -defensin 2 (hBD2). hBD2 shifts the conductance-voltage relationship curve of the human Kv1.3 channel in a positive direction by nearly 10.5 mV and increases the activation time constant for the channel. Unlike classical gating modifiers of toxin peptides from animal venoms, which generally bind to the Kv channel S3-S4 linker, hBD2 only targets residues in both the N and C termini of the S1-S2 linker to influence channel gating and inhibit channel currents. The increment and decrement of the basic residue number in a positively charged S4 sensor of Kv1.3 channel yields conductance-voltage relationship curves in the positive direction by approximate to 31.2 mV and 2-4 mV, which suggests that positively charged hBD2 is anchored in the channel S1-S2 linker and is modulating channel activation through electrostatic repulsion with an adjacent S4 helix. Together, these findings reveal a novel peptide ligand that binds with the Kv channel S1-S2 linker to modulate channel activation. These findings also highlight the functional importance of the Kv channel S1-S2 linker in ligand recognition and modification of channel activation.	[Feng, Jing; Yang, Weishan; Xie, Zili; Xiang, Fang; Cao, Zhijian; Li, Wenxin; Chen, Zongyun; Wu, Yingliang] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Cao, Zhijian; Li, Wenxin; Wu, Yingliang] Wuhan Univ, Ctr BioDrug Res, Wuhan 430072, Peoples R China; [Hu, Hongzhen] Washington Univ, Sch Med, Dept Anesthesiol, Pain Ctr,Ctr Study Itch, St Louis, MO 63110 USA	Wuhan University; Wuhan University; Washington University (WUSTL)	Chen, ZY (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	chenzy2005@126.com; ylwu@whu.edu.cn	Feng, Jing/C-1729-2018	Feng, Jing/0000-0001-6726-7912; Hu, Hongzhen/0000-0002-8967-7522	National Natural Sciences Foundation of China [31470812, 31170789]; National Science Fund for Excellent Young Scholars [31422049]; Wuhan University Natural Sciences Foundation [2042015kf0168]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101218] Funding Source: NIH RePORTER	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Excellent Young Scholars; Wuhan University Natural Sciences Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Natural Sciences Foundation of China (Nos. 31470812 and 31170789), National Science Fund for Excellent Young Scholars (No. 31422049), and Wuhan University Natural Sciences Foundation (No. 2042015kf0168).	Banerjee A, 2013, ELIFE, V2, DOI 10.7554/eLife.00594; Bohlen CJ, 2010, CELL, V141, P834, DOI 10.1016/j.cell.2010.03.052; Chen XR, 2010, P NATL ACAD SCI USA, V107, P11352, DOI 10.1073/pnas.1000142107; DeSimone CV, 2011, MOL PHARMACOL, V80, P345, DOI 10.1124/mol.111.072405; DeSimone CV, 2009, MOL PHARMACOL, V76, P125, DOI 10.1124/mol.109.055657; GOLDSTEIN SAN, 1994, NEURON, V12, P1377, DOI 10.1016/0896-6273(94)90452-9; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; Han S, 2008, J BIOL CHEM, V283, P19058, DOI 10.1074/jbc.M802054200; Hou PP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089975; Huang PT, 2007, TOXICON, V49, P285, DOI 10.1016/j.toxicon.2006.09.015; Jensen MO, 2012, SCIENCE, V336, P229, DOI 10.1126/science.1216533; Kanda N, 2011, J LEUKOCYTE BIOL, V89, P935, DOI 10.1189/jlb.0111004; Lee HC, 2003, NEURON, V40, P527, DOI 10.1016/S0896-6273(03)00636-6; Lee SY, 2004, NATURE, V430, P232, DOI 10.1038/nature02632; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; MACKINNON R, 1990, NEURON, V5, P767, DOI 10.1016/0896-6273(90)90335-D; Shiau YS, 2002, J MOL MODEL, V8, P253, DOI 10.1007/s00894-002-0095-8; Swartz KJ, 1997, NEURON, V18, P675, DOI 10.1016/S0896-6273(00)80307-4; Tudor JE, 1996, NAT STRUCT BIOL, V3, P317, DOI 10.1038/nsb0496-317; Wee CL, 2007, BIOPHYS J, V92, pL7, DOI 10.1529/biophysj.106.098681; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yang WS, 2015, CELL MOL LIFE SCI, V72, P845, DOI 10.1007/s00018-014-1715-z; Yin SJ, 2008, J PROTEOME RES, V7, P4890, DOI 10.1021/pr800494a; Yu LP, 2005, BIOCHEMISTRY-US, V44, P15834, DOI 10.1021/bi051656d	25	14	16	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15487	15495		10.1074/jbc.M115.639500	http://dx.doi.org/10.1074/jbc.M115.639500			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25944908	Green Published, hybrid			2022-12-28	WOS:000356527400015
J	Cooper, DE; Grevengoed, TJ; Klett, EL; Coleman, RA				Cooper, Daniel E.; Grevengoed, Trisha J.; Klett, Eric L.; Coleman, Rosalind A.			Glycerol-3-phosphate Acyltransferase Isoform-4 (GPAT4) Limits Oxidation of Exogenous Fatty Acids in Brown Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE-TISSUE; INSULIN-RESISTANCE; MICE; TRIACYLGLYCEROL; IDENTIFICATION; DEFICIENCY; ENZYME; THERMOGENESIS; EXPRESSION; CLEARANCE	Glycerol-3-phosphate acyltransferase-4 (GPAT4) null pups grew poorly during the suckling period and, as adults, were protected from high fat diet-induced obesity. To determine why Gpat4(-/-) mice failed to gain weight during these two periods of high fat feeding, we examined energy metabolism. Compared with controls, the metabolic rate of Gpat4(-/-) mice fed a 45% fat diet was 12% higher. Core body temperature was 1 degrees C higher after high fat feeding. Food intake, fat absorption, and activity were similar in both genotypes. Impaired weight gain in Gpat4(-/-) mice did not result from increased heat loss, because both cold tolerance and response to a beta 3-adrenergic agonist were similar in both genotypes. Because GPAT4 comprises 65% of the total GPAT activity in brown adipose tissue (BAT), we characterized BAT function. A 45% fat diet increased the Gpat4(-/-) BAT expression of peroxisome proliferator-activated receptor alpha (PPAR) target genes, Cpt1 alpha, Pgc1 alpha, and Ucp1, and BAT mitochondria oxidized oleate and pyruvate at higher rates than controls, suggesting that fatty acid signaling and flux through the TCA cycle were enhanced. To assess the role of GPAT4 directly, neonatal BAT preadipocytes were differentiated to adipocytes. Compared with controls, Gpat4(-/-) brown adipocytes incorporated 33% less fatty acid into triacylglycerol and 46% more into the pathway of beta-oxidation. The increased oxidation rate was due solely to an increase in the oxidation of exogenous fatty acids. These data suggest that in the absence of cold exposure, GPAT4 limits excessive fatty acid oxidation and the detrimental induction of a hypermetabolic state.	[Cooper, Daniel E.; Grevengoed, Trisha J.; Klett, Eric L.; Coleman, Rosalind A.] Univ N Carolina, Dept Nutr, Chapel Hill, NC 27599 USA; [Klett, Eric L.] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Coleman, RA (corresponding author), Univ N Carolina, 2301 MHRC,135 Dauer Dr, Chapel Hill, NC 27599 USA.	rcoleman@unc.edu	Regan, Clinton/E-6250-2012; Grevengoed, Trisha/AAA-3980-2021; Ariel, Pablo/AGJ-4118-2022	Klett, Eric/0000-0002-8000-6810; Grevengoed, Trisha/0000-0003-4433-3950	National Institutes of Health [DK56598, K08DK090141, DK56350]; American Heart Association [13PRE16910109]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056598, P30DK056350, K08DK090141] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK56598 (to R. A. C.), K08DK090141 (to E. L. K.), and DK56350 (to the University of North Carolina Nutrition Obesity Research Center), and American Heart Association Predoctoral Grant 13PRE16910109 (to T. J. G.).	Aoki N, 1999, BIOSCI BIOTECH BIOCH, V63, P1749, DOI 10.1271/bbb.63.1749; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Beigneux AP, 2006, J LIPID RES, V47, P734, DOI 10.1194/jlr.M500556-JLR200; Buhman KK, 2002, J BIOL CHEM, V277, P25474, DOI 10.1074/jbc.M202013200; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon B, 2010, INT J OBESITY, V34, pS7, DOI 10.1038/ijo.2010.177; Cao J., 2014, AM J PHYSIOL-ENDOC M, V306, pE1176; Cao JS, 2006, P NATL ACAD SCI USA, V103, P19695, DOI 10.1073/pnas.0609140103; Cattaneo ER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042986; Drover VA, 2005, J CLIN INVEST, V115, P1290, DOI 10.1172/JCI200521514; Ellis JM, 2012, TOXICOL PATHOL, V40, P513, DOI 10.1177/0192623311432298; Ellis JM, 2010, CELL METAB, V12, P53, DOI 10.1016/j.cmet.2010.05.012; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fromme T, 2011, AM J PHYSIOL-REG I, V300, pR1, DOI 10.1152/ajpregu.00411.2010; Hammond LE, 2002, MOL CELL BIOL, V22, P8204, DOI 10.1128/MCB.22.23.8204-8214.2002; Irie Y, 1999, BIOCHEM BIOPH RES CO, V255, P221, DOI 10.1006/bbrc.1998.9999; Khedoe PPSJ, 2015, J LIPID RES, V56, P51, DOI 10.1194/jlr.M052746; Klingenberg M, 1999, INT J OBESITY, V23, pS24, DOI 10.1038/sj.ijo.0800939; Lewin TM, 2004, J BIOL CHEM, V279, P13488, DOI 10.1074/jbc.M314032200; LINDBERG O, 1970, LIPIDS, V5, P204, DOI 10.1007/BF02532470; Matthias A, 2000, J BIOL CHEM, V275, P25073, DOI 10.1074/jbc.M000547200; Mottillo EP, 2012, J BIOL CHEM, V287, P25038, DOI 10.1074/jbc.M112.374041; Nagle CA, 2008, J LIPID RES, V49, P823, DOI 10.1194/jlr.M700592-JLR200; Neschen S, 2005, CELL METAB, V2, P55, DOI 10.1016/j.cmet.2005.06.006; SADDIK M, 1991, J BIOL CHEM, V266, P8162; Vergnes L, 2006, J LIPID RES, V47, P745, DOI 10.1194/jlr.M500553-JLR200; Wendel AA, 2013, J BIOL CHEM, V288, P27299, DOI 10.1074/jbc.M113.485219; Yen CLE, 2009, NAT MED, V15, P442, DOI 10.1038/nm.1937; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018; Zhang CB, 2014, AM J PHYSIOL-ENDOC M, V307, pE305, DOI 10.1152/ajpendo.00034.2014	30	22	22	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15112	15120		10.1074/jbc.M115.649970	http://dx.doi.org/10.1074/jbc.M115.649970			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25918168	hybrid, Green Published			2022-12-28	WOS:000356177300026
J	Long, WT; Panwar, P; Witkowska, K; Wong, K; O'Neill, D; Chen, XZ; Lemieux, MJ; Cheeseman, CI				Long, Wentong; Panwar, Pankaj; Witkowska, Kate; Wong, Kenneth; O'Neill, Debbie; Chen, Xing-Zhen; Lemieux, M. Joanne; Cheeseman, Chris I.			Critical Roles of Two Hydrophobic Residues within Human Glucose Transporter 9 (hSLC2A9) in Substrate Selectivity and Urate Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; URIC-ACID; EXOFACIAL VESTIBULE; KINETIC-PARAMETERS; ESCHERICHIA-COLI; BINDING-SITE; GLUT-FAMILY; MECHANISM; FRUCTOSE; DETERMINANT	High blood urate levels (hyperuricemia) have been found to be a significant risk factor for cardiovascular diseases and inflammatory arthritis, such as hypertension and gout. Human glucose transporter 9 (hSLC2A9) is an essential protein that mainly regulates urate/hexose homeostasis in human kidney and liver. hSLC2A9 is a high affinity-low capacity hexose transporter and a high capacity urate transporter. Our previous studies identified a single hydrophobic residue in trans-membrane domain 7 of class II glucose transporters as a determinant of fructose transport. A mutation of isoleucine 335 to valine (I355V) in hSLC2A9 can reduce fructose transport while not affecting glucose fluxes. This current study demonstrates that the I335V mutant transports urate similarly to the wild type hSLC2A9; however, Ile-335 is necessary for urate/fructose trans-acceleration exchange to occur. Furthermore, Trp-110 is a critical site for urate transport. Two structural models of the class II glucose transporters, hSLC2A9 and hSLC2A5, based on the crystal structure of hSLC2A1 (GLUT1), reveal that Ile-335 (or the homologous Ile-296 in hSLC2A5) is a key component for protein conformational changes when the protein translocates substrates. The hSLC2A9 model also predicted that Trp-110 is a crucial site that could directly interact with urate during transport. Together, these studies confirm that hSLC2A9 transports both urate and fructose, but it interacts with them in different ways. Therefore, this study advances our understanding of how hSLC2A9 mediates urate and fructose transport, providing further information for developing pharmacological agents to treat hyperuricemia and related diseases, such as gout, hypertension, and diabetes.	[Long, Wentong; Wong, Kenneth; O'Neill, Debbie; Chen, Xing-Zhen; Cheeseman, Chris I.] Univ Alberta, Fac Med & Dent, Dept Physiol, Edmonton, AB T6G 2H7, Canada; [Panwar, Pankaj; Lemieux, M. Joanne] Univ Alberta, Fac Med & Dent, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Witkowska, Kate] QMUL, John Vane Sci Ctr, William Harvey Res Ctr, Dept Clin Pharmacol, London EC16BQ, England	University of Alberta; University of Alberta	Cheeseman, CI (corresponding author), Univ Alberta, Fac Med & Dent, Dept Physiol, Edmonton, AB T6G 2H7, Canada.	chris.cheeseman@ualberta.ca		Lemieux, Joanne/0000-0003-4745-9153; Long, Wentong/0000-0003-4650-8064	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Augustin R, 2010, IUBMB LIFE, V62, P315, DOI 10.1002/iub.315; Bibert S, 2009, AM J PHYSIOL-RENAL, V297, pF612, DOI 10.1152/ajprenal.00139.2009; Bo S, 2001, EUR J CLIN INVEST, V31, P318, DOI 10.1046/j.1365-2362.2001.00812.x; CANNON PJ, 1966, NEW ENGL J MED, V275, P457, DOI 10.1056/NEJM196609012750902; Carruthers A, 2009, AM J PHYSIOL-ENDOC M, V297, pE836, DOI 10.1152/ajpendo.00496.2009; Caulfield MJ, 2008, PLOS MED, V5, P1509, DOI 10.1371/journal.pmed.0050197; Cheeseman C, 2009, CURR OPIN NEPHROL HY, V18, P428, DOI 10.1097/MNH.0b013e32832ee3de; Cura AJ, 2012, COMPR PHYSIOL, V2, P863, DOI 10.1002/cphy.c110024; Deng D, 2014, NATURE, V510, P121, DOI 10.1038/nature13306; Dietvorst J, 2010, YEAST, V27, P131, DOI 10.1002/yea.1737; EMMERSON BT, 1974, ANN RHEUM DIS, V33, P276, DOI 10.1136/ard.33.3.276; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Hill WG, 2005, AM J PHYSIOL-RENAL, V289, pF217, DOI 10.1152/ajprenal.00022.2005; Hirai T, 2003, J BACTERIOL, V185, P1712, DOI 10.1128/JB.185.5.1712-1718.2003; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Iancu CV, 2013, P NATL ACAD SCI USA, V110, P17862, DOI 10.1073/pnas.1311485110; Jayaraj V, 2009, BIOINFORMATION, V3, P409, DOI 10.6026/97320630003409; Johnson RJ, 2010, J AM SOC NEPHROL, V21, P2036, DOI 10.1681/ASN.2010050506; Joost HG, 2001, MOL MEMBR BIOL, V18, P247, DOI 10.1080/09687680110090456; KATAGIRI H, 1991, J BIOL CHEM, V266, P7769; KATAGIRI H, 1993, BIOCHEM J, V291, P861, DOI 10.1042/bj2910861; KAYANO T, 1990, J BIOL CHEM, V265, P13276; Kimura T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084996; Komala MG, 2013, CURR OPIN NEPHROL HY, V22, P113, DOI 10.1097/MNH.0b013e32835a17ae; Komoda F, 2004, PEDIATR NEPHROL, V19, P728, DOI 10.1007/s00467-004-1424-1; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Madej MG, 2014, P NATL ACAD SCI USA, V111, pE719, DOI 10.1073/pnas.1400336111; Maher F, 1996, BIOCHEM J, V315, P827, DOI 10.1042/bj3150827; Manolescu A, 2005, J BIOL CHEM, V280, P42978, DOI 10.1074/jbc.M508678200; Manolescu AR, 2007, MOL MEMBR BIOL, V24, P455, DOI 10.1080/09687680701298143; Matsuo H, 2008, AM J HUM GENET, V83, P744, DOI 10.1016/j.ajhg.2008.11.001; Mueckler M, 1997, J BIOL CHEM, V272, P30141, DOI 10.1074/jbc.272.48.30141; Mueckler M, 2013, MOL ASPECTS MED, V34, P121, DOI 10.1016/j.mam.2012.07.001; Onat A, 2006, AM J HYPERTENS, V19, P1055, DOI 10.1016/j.amjhyper.2006.02.014; Phay JE, 2000, GENOMICS, V66, P217, DOI 10.1006/geno.2000.6195; Puig JG, 1999, J HYPERTENS, V17, P869, DOI 10.1097/00004872-199917070-00001; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Salas-Burgos A, 2004, BIOPHYS J, V87, P2990, DOI 10.1529/biophysj.104.047886; Seatter MJ, 1998, BIOCHEMISTRY-US, V37, P1322, DOI 10.1021/bi972322u; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smirnova I, 2011, BIOCHEMISTRY-US, V50, P9684, DOI 10.1021/bi2014294; Stein W. D., 1986, TRANSPORT DIFFUSION, P31; STEIN WD, 1972, ANN NY ACAD SCI, V195, P412, DOI 10.1111/j.1749-6632.1972.tb54823.x; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; Sweet IR, 1997, DIABETOLOGIA, V40, P112, DOI 10.1007/s001250050652; TAYLOR LP, 1981, BIOCHIM BIOPHYS ACTA, V642, P325, DOI 10.1016/0005-2736(81)90449-1; Vollers SS, 2012, J BIOL CHEM, V287, P42533, DOI 10.1074/jbc.M112.369587; Wang Q, 2013, J BIOL CHEM, V288, P264, DOI 10.1074/jbc.M112.396408; WIDDAS WF, 1952, J PHYSIOL-LONDON, V118, P23, DOI 10.1113/jphysiol.1952.sp004770; Witkowska K, 2012, AM J PHYSIOL-RENAL, V303, pF527, DOI 10.1152/ajprenal.00134.2012; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	53	12	14	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15292	15303		10.1074/jbc.M114.611178	http://dx.doi.org/10.1074/jbc.M114.611178			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25922070	Green Published, hybrid			2022-12-28	WOS:000356177300040
J	Weems, JC; Slaughter, BD; Unruh, JR; Hall, SM; McLaird, MB; Gilmore, JM; Washburn, MP; Florens, L; Yasukawa, T; Aso, T; Conaway, JW; Conaway, RC				Weems, Juston C.; Slaughter, Brian D.; Unruh, Jay R.; Hall, Shawn M.; McLaird, Merry B.; Gilmore, Joshua M.; Washburn, Michael P.; Florens, Laurence; Yasukawa, Takashi; Aso, Teijiro; Conaway, Joan W.; Conaway, Ronald C.			Assembly of the Elongin A Ubiquitin Ligase Is Regulated by Genotoxic and Other Stresses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; TRANSCRIPTION FACTOR-SIII; COUPLED DNA-REPAIR; PROTEIN IDENTIFICATION TECHNOLOGY; DAMAGE-INDUCED UBIQUITYLATION; SPECTRAL ABUNDANCE FACTORS; ELONGATION-FACTOR ELONGIN; INDUCED GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; PROTEOMIC ANALYSIS	Elongin A performs dual functions in cells as a component of RNA polymerase II (Pol II) transcription elongation factor Elongin and as the substrate recognition subunit of a Cullin-RING E3 ubiquitin ligase that has been shown to target Pol II stalled at sites of DNA damage. Here we investigate the mechanism(s) governing conversion of the Elongin complex from its elongation factor to its ubiquitin ligase form. We report the discovery that assembly of the Elongin A ubiquitin ligase is a tightly regulated process. In unstressed cells, Elongin A is predominately present as part of Pol II elongation factor Elongin. Assembly of Elongin A into the ubiquitin ligase is strongly induced by genotoxic stress; by transcriptional stresses that lead to accumulation of stalled Pol II; and by other stimuli, including endoplasmic reticulum and nutrient stress and retinoic acid signaling, that activate Elongin A-dependent transcription. Taken together, our findings shed new light on mechanisms that control the Elongin A ubiquitin ligase and suggest that it may play a role in Elongin A-dependent transcription.	[Weems, Juston C.; Slaughter, Brian D.; Unruh, Jay R.; Hall, Shawn M.; McLaird, Merry B.; Gilmore, Joshua M.; Washburn, Michael P.; Florens, Laurence; Conaway, Joan W.; Conaway, Ronald C.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Washburn, Michael P.] Univ Kansas, Dept Pathol & Lab Med, Kansas City, KS 66160 USA; [Conaway, Joan W.; Conaway, Ronald C.] Univ Kansas, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA; [Yasukawa, Takashi; Aso, Teijiro] Kochi Med Sch, Dept Funct Genom, Nankoku, Kochi 7838505, Japan	Stowers Institute for Medical Research; University of Kansas; University of Kansas; Kochi University	Conaway, JW (corresponding author), Stowers Inst Med Res, 1000 50th St, Kansas City, MO 64110 USA.	jlc@stowers.org; rcc@stowers.org	Regan, Clinton/E-6250-2012	Unruh, Jay/0000-0003-3077-4990; Florens, Laurence/0000-0002-9310-6650; Washburn, Michael/0000-0001-7568-2585; Conaway, Joan/0000-0002-2786-0663	National Institutes of Health [GM041628]; Helen Nelson Medical Research Fund at the Greater Kansas City Community Foundation; KAKENHI [24590279, 24590357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041628, R01GM041628] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen Nelson Medical Research Fund at the Greater Kansas City Community Foundation; KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM041628 (to R. C. C. and J. W. C.). This work was also supported by a grant from the Helen Nelson Medical Research Fund at the Greater Kansas City Community Foundation (to the Stowers Institute) and by KAKENHI Grants 24590279 (to T. Y.) and 24590357 (to T. A.).	Anindya R, 2007, MOL CELL, V28, P386, DOI 10.1016/j.molcel.2007.10.008; Aso T, 1996, EMBO J, V15, P5557, DOI 10.1002/j.1460-2075.1996.tb00940.x; ASO T, 1995, SCIENCE, V269, P1439, DOI 10.1126/science.7660129; Banks CAS, 2014, MOL CELL PROTEOMICS, V13, P1510, DOI 10.1074/mcp.M113.033902; Beaudenon SL, 1999, MOL CELL BIOL, V19, P6972; BRADSHER JN, 1993, J BIOL CHEM, V268, P25594; BRADSHER JN, 1993, J BIOL CHEM, V268, P25587; Bregman DB, 1996, P NATL ACAD SCI USA, V93, P11586, DOI 10.1073/pnas.93.21.11586; Bushnell DA, 2002, P NATL ACAD SCI USA, V99, P1218, DOI 10.1073/pnas.251664698; CHAFIN DR, 1995, J BIOL CHEM, V270, P19114, DOI 10.1074/jbc.270.32.19114; Chopra VS, 2009, CURR BIOL, V19, P688, DOI 10.1016/j.cub.2009.02.055; Curtin NJ, 2012, NAT REV CANCER, V12, P801, DOI 10.1038/nrc3399; Deshaies RJ, 2010, SUBCELL BIOCHEM, V54, P41, DOI 10.1007/978-1-4419-6676-6_4; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dinant C, 2007, J CELL SCI, V120, P2731, DOI 10.1242/jcs.004523; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fan AX, 2014, NUCLEIC ACIDS RES, V42, P7625, DOI 10.1093/nar/gku467; Florens L, 2006, METHODS, V40, P303, DOI 10.1016/j.ymeth.2006.07.028; Florens Laurence, 2006, V328, P159; Fong YW, 2013, MOL CELL, V52, P291, DOI 10.1016/j.molcel.2013.10.018; FRASER NW, 1978, NATURE, V272, P590, DOI 10.1038/272590a0; GARRETT KP, 1994, P NATL ACAD SCI USA, V91, P5237, DOI 10.1073/pnas.91.12.5237; GARRETT KP, 1995, P NATL ACAD SCI USA, V92, P7172, DOI 10.1073/pnas.92.16.7172; Gerber M, 2005, J BIOL CHEM, V280, P4017, DOI 10.1074/jbc.C400487200; Gerber M, 2004, MOL CELL BIOL, V24, P9911, DOI 10.1128/MCB.24.22.9911-9919.2004; Golding SE, 2009, MOL CANCER THER, V8, P2894, DOI 10.1158/1535-7163.MCT-09-0519; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Harreman M, 2009, P NATL ACAD SCI USA, V106, P20705, DOI 10.1073/pnas.0907052106; Huibregtse JM, 1997, P NATL ACAD SCI USA, V94, P3656, DOI 10.1073/pnas.94.8.3656; Jonkers I, 2014, ELIFE, V3, DOI 10.7554/eLife.02407; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Ju BG, 2006, CELL CYCLE, V5, P2557, DOI 10.4161/cc.5.22.3497; Jung Y, 2006, J BIOL CHEM, V281, P1361, DOI 10.1074/jbc.M509688200; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Kamura T, 2001, J BIOL CHEM, V276, P29748, DOI 10.1074/jbc.M103093200; Kawauchi J, 2013, J BIOL CHEM, V288, P24302, DOI 10.1074/jbc.M113.496703; Le May N, 2012, MOL CELL, V47, P622, DOI 10.1016/j.molcel.2012.05.050; Le May N, 2010, MOL CELL, V38, P54, DOI 10.1016/j.molcel.2010.03.004; Lee KB, 2002, P NATL ACAD SCI USA, V99, P4239, DOI 10.1073/pnas.072068399; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; Lukas C, 2005, CHROMOSOMA, V114, P146, DOI 10.1007/s00412-005-0011-y; Mancebo HSY, 1997, GENE DEV, V11, P2633, DOI 10.1101/gad.11.20.2633; Nguyen VT, 1996, NUCLEIC ACIDS RES, V24, P2924, DOI 10.1093/nar/24.15.2924; Pankotai T, 2012, NAT STRUCT MOL BIOL, V19, P276, DOI 10.1038/nsmb.2224; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Perillo B, 2008, SCIENCE, V319, P202, DOI 10.1126/science.1147674; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Ratner JN, 1998, J BIOL CHEM, V273, P5184, DOI 10.1074/jbc.273.9.5184; Ribar B, 2007, MOL CELL BIOL, V27, P3211, DOI 10.1128/MCB.00091-07; Ribar B, 2006, MOL CELL BIOL, V26, P3999, DOI 10.1128/MCB.00293-06; Rudd MD, 1996, J BIOL CHEM, V271, P21549, DOI 10.1074/jbc.271.35.21549; Sekar RB, 2003, J CELL BIOL, V160, P629, DOI 10.1083/jcb.200210140; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; Sigurdsson S, 2010, MOL CELL, V38, P202, DOI 10.1016/j.molcel.2010.02.026; Somesh BP, 2005, CELL, V121, P913, DOI 10.1016/j.cell.2005.04.010; Svejstrup JQ, 2002, NAT REV MOL CELL BIO, V3, P21, DOI 10.1038/nrm703; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Titov DV, 2011, NAT CHEM BIOL, V7, P182, DOI [10.1038/nchembio.522, 10.1038/NCHEMBIO.522]; Van Munster EB, 2005, J MICROSC-OXFORD, V218, P253, DOI 10.1111/j.1365-2818.2005.01483.x; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wilson MD, 2013, BBA-GENE REGUL MECH, V1829, P151, DOI 10.1016/j.bbagrm.2012.08.002; Yang LY, 2003, INT J ONCOL, V22, P683; Yasukawa T, 2012, CELL REP, V2, P1129, DOI 10.1016/j.celrep.2012.09.031; Yasukawa T, 2008, EMBO J, V27, P3256, DOI 10.1038/emboj.2008.249; Yumimoto K, 2013, J BIOL CHEM, V288, P32766, DOI 10.1074/jbc.M113.511303; Zhang Y, 2010, ANAL CHEM, V82, P2272, DOI 10.1021/ac9023999; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	72	17	17	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15030	15041		10.1074/jbc.M114.632794	http://dx.doi.org/10.1074/jbc.M114.632794			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25878247	hybrid, Green Published			2022-12-28	WOS:000356177300019
J	Binsker, U; Kohler, TP; Krauel, K; Kohler, S; Schwertz, H; Hammerschmidt, S				Binsker, Ulrike; Kohler, Thomas P.; Krauel, Krystin; Kohler, Sylvia; Schwertz, Hansjoerg; Hammerschmidt, Sven			Pneumococcal Adhesins PavB and PspC Are Important for the Interplay with Human Thrombospondin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR ADHERENCE PROTEIN; HEPARIN-BINDING DOMAIN; STREPTOCOCCUS-PNEUMONIAE; HUMAN PLATELETS; NASOPHARYNGEAL COLONIZATION; EPITHELIAL-CELLS; MESSENGER-RNA; STAPHYLOCOCCUS-AUREUS; MATRIX MOLECULES; INTENSIVE-CARE	The human matricellular glycoprotein thrombospondin-1 (hTSP-1) is released by activated platelets and mediates adhesion of Gram-positive bacteria to various host cells. In staphylococci, the adhesins extracellular adherence protein (Eap) and autolysin (Atl), both surface-exposed proteins containing repeating structures, were shown to be involved in the acquisition of hTSP-1 to the bacterial surface. The interaction partner( s) on the pneumococcal surface was hitherto unknown. Here, we demonstrate for the first time that pneumococcal adherence and virulence factor B (PavB) and pneumococcal surface protein C (PspC) are key players for the interaction of Streptococcus pneumoniae with matricellular hTSP-1. PavB and PspC are pneumococcal surface-exposed adhesins and virulence factors exhibiting repetitive sequences in their core structure. Heterologously expressed fragments of PavB and PspC containing repetitive structures exhibit hTSP-1 binding activity as shown by ELISA and surface plasmon resonance studies. Binding of hTSP-1 is charge-dependent and inhibited by heparin. Importantly, the deficiency in PavB and PspC reduces the recruitment of soluble hTSP-1 by pneumococci and decreases hTSP-1-mediated pneumococcal adherence to human epithelial cells. Platelet activation assays suggested that PavB and PspC are not involved in the activation of purified human platelets by pneumococci. In conclusion, this study indicates a pivotal role of PavB and PspC for pneumococcal recruitment of soluble hTSP-1 to the bacterial surface and binding of pneumococci to host cell-bound hTSP-1 during adhesion.	[Binsker, Ulrike; Kohler, Thomas P.; Kohler, Sylvia; Hammerschmidt, Sven] Ernst Moritz Arndt Univ Greifswald, Dept Genet Microorganisms, Interfac Inst Genet & Funct Genom, Friedrich Ludwig Jahn Str 15a, D-17487 Greifswald, Germany; [Krauel, Krystin; Schwertz, Hansjoerg] Univ Med Greifswald, Inst Immunol & Transfus Med, D-17489 Greifswald, Germany	Ernst Moritz Arndt Universitat Greifswald; Greifswald Medical School	Kohler, TP (corresponding author), Ernst Moritz Arndt Univ Greifswald, Dept Genet Microorganisms, Interfac Inst Genet & Funct Genom, Friedrich Ludwig Jahn Str 15a, D-17487 Greifswald, Germany.	kohlert@uni-greifswald.de	Hammerschmidt, Sven/G-2598-2010	Hammerschmidt, Sven/0000-0002-6382-6681; Krauel, Krystin/0000-0002-2030-1332	Deutsche Forschungsgemeinschaft [SFB TRR 34, DFG HA 3125/4-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB TRR 34, Project C10 (to S. H.) and DFG HA 3125/4-2.	Agarwal V, 2009, J BIOL CHEM, V284, P19427, DOI 10.1074/jbc.M109.003442; ASCH AS, 1986, P NATL ACAD SCI USA, V83, P2904, DOI 10.1073/pnas.83.9.2904; Asmat TM, 2012, MICROBIOL-SGM, V158, P771, DOI 10.1099/mic.0.053603-0; Balachandran P, 2002, INFECT IMMUN, V70, P2526, DOI 10.1128/IAI.70.5.2526-2534.2002; BAUGHMAN RP, 1993, CHEST, V104, P1243, DOI 10.1378/chest.104.4.1243; Bertling A, 2012, ARTERIOSCL THROM VAS, V32, P1979, DOI 10.1161/ATVBAHA.112.246249; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; BORNSTEIN P, 1995, J CELL BIOL, V130, P503, DOI 10.1083/jcb.130.3.503; Bumbaca D, 2004, OMICS, V8, P341, DOI 10.1089/omi.2004.8.341; Byrne MF, 2003, GASTROENTEROLOGY, V124, P1846, DOI 10.1016/S0016-5085(03)00397-4; Calzada MJ, 2003, J BIOL CHEM, V278, P40679, DOI 10.1074/jbc.M302014200; Carlson CB, 2008, CELL MOL LIFE SCI, V65, P672, DOI 10.1007/s00018-007-7484-1; Denis MM, 2005, CELL, V122, P379, DOI 10.1016/j.cell.2005.06.015; Dieudonne-Vatran A, 2009, J IMMUNOL, V182, P7865, DOI 10.4049/jimmunol.0802376; Elm C, 2004, J BIOL CHEM, V279, P6296, DOI 10.1074/jbc.M310528200; Fitzgerald JR, 2006, NAT REV MICROBIOL, V4, P445, DOI 10.1038/nrmicro1425; Fitzgerald JR, 2006, MOL MICROBIOL, V59, P212, DOI 10.1111/j.1365-2958.2005.04922.x; Gamez G, 2012, CURR DRUG TARGETS, V13, P323, DOI 10.2174/138945012799424697; Garenne Michel, 1992, World Health Statistics Quarterly, V45, P180; GRAY BM, 1980, J INFECT DIS, V142, P923, DOI 10.1093/infdis/142.6.923; GWALTNEY JM, 1975, J INFECT DIS, V132, P62, DOI 10.1093/infdis/132.1.62; Hammerschmidt S, 2005, INFECT IMMUN, V73, P4653, DOI 10.1128/IAI.73.8.4653-4667.2005; Hammerschmidt S, 2000, MOL MICROBIOL, V36, P726, DOI 10.1046/j.1365-2958.2000.01897.x; Hammerschmidt S, 2007, J IMMUNOL, V178, P5848, DOI 10.4049/jimmunol.178.9.5848; Hernani MD, 2011, FEMS IMMUNOL MED MIC, V62, P263, DOI 10.1111/j.1574-695X.2011.00809.x; Hussain M, 2005, EPIDEMIOL INFECT, V133, P891, DOI 10.1017/S0950268805004012; Hussain M, 2008, INFECT IMMUN, V76, P5615, DOI 10.1128/IAI.00480-08; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Isenberg JS, 2007, J BIOL CHEM, V282, P15404, DOI 10.1074/jbc.M701638200; JAFFE EA, 1985, BLOOD, V65, P79; Jensch I, 2010, MOL MICROBIOL, V77, P22, DOI 10.1111/j.1365-2958.2010.07189.x; Kerrigan SW, 2002, BLOOD, V100, P509, DOI 10.1182/blood.V100.2.509; Kohler TP, 2014, J BIOL CHEM, V289, P4070, DOI 10.1074/jbc.M113.521229; Levi M, 2004, J THROMB HAEMOST, V2, P2094, DOI 10.1111/j.1538-7836.2004.01004.x; Narizhneva NV, 2005, FASEB J, V19, P1158, DOI 10.1096/fj.04-3310fje; Nelson AL, 2007, INFECT IMMUN, V75, P83, DOI 10.1128/IAI.01475-06; Niemann S, 2009, THROMB HAEMOSTASIS, V102, P735, DOI 10.1160/TH09-01-0049; Ogunniyi AD, 2007, INFECT IMMUN, V75, P1843, DOI 10.1128/IAI.01384-06; Orihuela CJ, 2009, J CLIN INVEST, V119, P1638, DOI 10.1172/JCI36759; Panetti TS, 1999, J BIOL CHEM, V274, P430, DOI 10.1074/jbc.274.1.430; Paterson GK, 2010, MOL MICROBIOL, V77, P1, DOI 10.1111/j.1365-2958.2010.07190.x; PREISSNER KT, 1991, ANNU REV CELL BIOL, V7, P275, DOI 10.1146/annurev.cellbio.7.1.275; RAUGI GJ, 1987, AM J PATHOL, V129, P364; RAUGI GJ, 1982, J CELL BIOL, V95, P351, DOI 10.1083/jcb.95.1.351; Rennemeier C, 2007, FASEB J, V21, P3118, DOI 10.1096/fj.06-7992com; Resovi A, 2014, MATRIX BIOL, V37, P83, DOI 10.1016/j.matbio.2014.01.012; Rondina MT, 2011, J THROMB HAEMOST, V9, P748, DOI 10.1111/j.1538-7836.2011.04208.x; Rosenow C, 1997, MOL MICROBIOL, V25, P819, DOI 10.1111/j.1365-2958.1997.mmi494.x; Rozario T, 2010, DEV BIOL, V341, P126, DOI 10.1016/j.ydbio.2009.10.026; Schaefer L, 2010, CELL TISSUE RES, V339, P237, DOI 10.1007/s00441-009-0821-y; Schwertz H, 2006, J EXP MED, V203, P2433, DOI 10.1084/jem.20061302; Sharma B, 2007, ANAESTH INTENS CARE, V35, P874, DOI 10.1177/0310057X0703500604; Stephan F, 1999, CHEST, V115, P1363, DOI 10.1378/chest.115.5.1363; Tan K, 2008, J BIOL CHEM, V283, P3932, DOI 10.1074/jbc.M705203200; Tan K, 2009, J CELL COMMUN SIGNAL, V3, P177, DOI 10.1007/s12079-009-0074-2; Tang MX, 2011, MOL CELL BIOCHEM, V346, P49, DOI 10.1007/s11010-010-0590-7; Vanderschueren S, 2000, CRIT CARE MED, V28, P1871, DOI 10.1097/00003246-200006000-00031; Vincent JL, 2002, CRIT CARE MED, V30, pS313, DOI 10.1097/00003246-200205001-00022; VOGEL T, 1993, J CELL BIOCHEM, V53, P74, DOI 10.1002/jcb.240530109; Voss S, 2012, MOL ORAL MICROBIOL, V27, P246, DOI 10.1111/j.2041-1014.2012.00654.x; Voss S, 2013, J BIOL CHEM, V288, P15614, DOI 10.1074/jbc.M112.443507; WEISER JN, 1994, INFECT IMMUN, V62, P2582, DOI 10.1128/IAI.62.6.2582-2589.1994; Weyrich AS, 2007, BLOOD, V109, P1975, DOI 10.1182/blood-2006-08-042192; Yu HN, 2000, ARCH BIOCHEM BIOPHYS, V374, P13, DOI 10.1006/abbi.1999.1597	64	25	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14542	14555		10.1074/jbc.M114.623876	http://dx.doi.org/10.1074/jbc.M114.623876			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25897078	Green Published, hybrid			2022-12-28	WOS:000355754600026
J	Habets, RAJ; Groot, AJ; Yahyanejad, S; Tiyanont, K; Blacklow, SC; Vooijs, M				Habets, Roger A. J.; Groot, Arjan J.; Yahyanejad, Sanaz; Tiyanont, Kittichoat; Blacklow, Stephen C.; Vooijs, Marc			Human NOTCH2 Is Resistant to Ligand-independent Activation by Metalloprotease Adam17	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MARGINAL ZONE LYMPHOMA; NEGATIVE REGULATORY REGION; SQUAMOUS-CELL CARCINOMA; PROTEOLYTIC ACTIVATION; T-ALL; CLEAVAGE; MUTATIONS; DOMAIN; DROSOPHILA; RECEPTORS	Cell surface receptors of the NOTCH family of proteins are activated by ligand induced intramembrane proteolysis. Unfolding of the extracellular negative regulatory region (NRR), enabling successive proteolysis by the enzymes Adam10 and gamma-secretase, is rate-limiting in NOTCH activation. Mutations in the NOTCH1 NRR are associated with ligand-independent activation and frequently found in human T-cell malignancies. In mammals four NOTCH receptors and five Delta/Jagged ligands exist, but mutations in the NRR are only rarely reported for receptors other than NOTCH1. Using biochemical and functional assays, we compared the molecular mechanisms of ligand-independent signaling in NOTCH1 and the highly related NOTCH2 receptor. Both murine Notch1 and Notch2 require the metalloprotease protease Adam17, but not Adam10 during ligand-independent activation. Interestingly, the human NOTCH2 receptor is resistant to ligand-independent activation compared with its human homologs or murine orthologs. Taken together, our data reveal subtle but functionally important differences for the NRR among NOTCH paralogs and homologs.	[Habets, Roger A. J.; Groot, Arjan J.; Yahyanejad, Sanaz; Vooijs, Marc] Maastricht Univ, Dept Radiotherapy MaastRO GROW, Sch Dev Biol & Oncol, NL-6200 MD Maastricht, Netherlands; [Tiyanont, Kittichoat; Blacklow, Stephen C.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Blacklow, Stephen C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Maastricht University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Vooijs, M (corresponding author), Maastricht Univ, Dept Radiotherapy MaastRO GROW, Sch Dev Biol & Oncol, Univ Singel 50, NL-6229 ER Maastricht, Netherlands.	marc.vooijs@maastrichtuniversity.nl	Vooijs, Marc/K-3522-2019		European Research Council (ERC) under the European Community Seventh Framework Program (FP7) ERC [208259, 334987]; NATIONAL CANCER INSTITUTE [R01CA092433] Funding Source: NIH RePORTER	European Research Council (ERC) under the European Community Seventh Framework Program (FP7) ERC(European Research Council (ERC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the European Research Council (ERC) under the European Community Seventh Framework Program (FP7/2007-2013) ERC starting Grants 208259 and 334987 (to M. V.).	Aster JC, 1999, BIOCHEMISTRY-US, V38, P4736, DOI 10.1021/bi982713o; Aster JC, 2011, J PATHOL, V223, P262, DOI 10.1002/path.2789; Bozkulak EC, 2009, MOL CELL BIOL, V29, P5679, DOI 10.1128/MCB.00406-09; Bush G, 2001, DEV BIOL, V229, P494, DOI 10.1006/dbio.2000.9992; Chen JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022837; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Dey A, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/17/175101; Dontje W, 2006, BLOOD, V107, P2446, DOI 10.1182/blood-2005-05-2090; Ebsen H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076853; Egloff AM, 2012, CLIN CANCER RES, V18, P5188, DOI 10.1158/1078-0432.CCR-11-2258; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Gordon WR, 2007, NAT STRUCT MOL BIOL, V14, P295, DOI 10.1038/nsmb1227; Gordon WR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006613; Gordon WR, 2009, BLOOD, V113, P4381, DOI 10.1182/blood-2008-08-174748; Gridley T, 2003, HUM MOL GENET, V12, pR9, DOI 10.1093/hmg/ddg052; Groot AJ, 2014, MOL CELL BIOL, V34, P2822, DOI 10.1128/MCB.00206-14; Groot AJ, 2013, J INVEST DERMATOL, V133, P2286, DOI 10.1038/jid.2013.162; Kidd S, 2002, MECH DEVELOP, V115, P41, DOI 10.1016/S0925-4773(02)00120-X; Kiel MJ, 2012, J EXP MED, V209, P1553, DOI 10.1084/jem.20120910; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li K, 2008, J BIOL CHEM, V283, P8046, DOI 10.1074/jbc.M800170200; Liu ZY, 2013, DEV CELL, V25, P585, DOI 10.1016/j.devcel.2013.05.022; Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108; Malecki MJ, 2006, MOL CELL BIOL, V26, P4642, DOI 10.1128/MCB.01655-05; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Pickering CR, 2014, CLIN CANCER RES, V20, P6582, DOI 10.1158/1078-0432.CCR-14-1768; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; Rossi D, 2012, J EXP MED, V209, P1537, DOI 10.1084/jem.20120904; Roti G, 2013, CANCER CELL, V23, P390, DOI 10.1016/j.ccr.2013.01.015; Sanchez-Irizarry C, 2004, MOL CELL BIOL, V24, P9265, DOI 10.1128/MCB.24.21.9265-9273.2004; Shimizu K, 2000, MOL CELL BIOL, V20, P6913, DOI 10.1128/MCB.20.18.6913-6922.2000; Stephenson NL, 2012, P NATL ACAD SCI USA, V109, pE2757, DOI 10.1073/pnas.1205788109; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Sulis ML, 2011, LEUKEMIA, V25, P1564, DOI 10.1038/leu.2011.130; Tiyanont K, 2011, STRUCTURE, V19, P546, DOI 10.1016/j.str.2011.01.016; Troen G, 2008, HAEMATOL-HEMATOL J, V93, P1107, DOI 10.3324/haematol.11635; van Tetering G, 2011, CURR MOL MED, V11, P255, DOI 10.2174/156652411795677972; van Tetering G, 2009, J BIOL CHEM, V284, P31018, DOI 10.1074/jbc.M109.006775; Vardar D, 2003, BIOCHEMISTRY-US, V42, P7061, DOI 10.1021/bi034156y; Vooijs M, 2004, J BIOL CHEM, V279, P50864, DOI 10.1074/jbc.M409430200; Wang NJ, 2011, P NATL ACAD SCI USA, V108, P17761, DOI 10.1073/pnas.1114669108; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160	44	20	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14705	14716		10.1074/jbc.M115.643676	http://dx.doi.org/10.1074/jbc.M115.643676			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25918160	Green Published, hybrid			2022-12-28	WOS:000355754600040
J	Kuznetsov, NA; Kladova, OA; Kuznetsova, AA; Ishchenko, AA; Saparbaev, MK; Zharkov, DO; Fedorova, OS				Kuznetsov, Nikita A.; Kladova, Olga A.; Kuznetsova, Alexandra A.; Ishchenko, Alexander A.; Saparbaev, Murat K.; Zharkov, Dmitry O.; Fedorova, Olga S.			Conformational Dynamics of DNA Repair by Escherichia coli Endonuclease III	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-SPECIFICITY; LESION RECOGNITION; ANALOGS TC; GLYCOSYLASE; DAMAGE; FLUORESCENCE; 8-OXOGUANINE; 2-AMINOPURINE; MECHANISM; EXCISION	Escherichia coli endonuclease III (Endo III or Nth) is a DNA glycosylase with a broad substrate specificity for oxidized or reduced pyrimidine bases. Endo III possesses two types of activities: N-glycosylase (hydrolysis of the N-glycosidic bond) and AP lyase (elimination of the 3'-phosphate of the AP-site). We report a pre-steady-state kinetic analysis of structural rearrangements of the DNA substrates and uncleavable ligands during their interaction with Endo III. Oligonucleotide duplexes containing 5,6-dihydrouracil, a natural abasic site, its tetrahydrofuran analog, and undamaged duplexes carried fluorescent DNA base analogs 2-aminopurine and 1,3-diaza-2-oxophenoxazine as environment-sensitive reporter groups. The results suggest that Endo III induces several fast sequential conformational changes in DNA during binding, lesion recognition, and adjustment to a catalytically competent conformation. A comparison of two fluorophores allowed us to distinguish between the events occurring in the damaged and undamaged DNA strand. Combining our data with the available structures of Endo III, we conclude that this glycosylase uses a multistep mechanism of damage recognition, which likely involves Gln(41) and Leu(81) as DNA lesion sensors.	[Kuznetsov, Nikita A.; Kladova, Olga A.; Kuznetsova, Alexandra A.; Zharkov, Dmitry O.; Fedorova, Olga S.] Inst Chem Biol & Fundamental Med, 8 Lavrentyev Ave, Novosibirsk 630090, Russia; [Kuznetsov, Nikita A.; Kladova, Olga A.; Kuznetsova, Alexandra A.; Zharkov, Dmitry O.; Fedorova, Olga S.] Novosibirsk State Univ, Dept Nat Sci, Novosibirsk 630090, Russia; [Ishchenko, Alexander A.; Saparbaev, Murat K.] Univ Paris 11, Inst Gustave Roussy, Grp Reparat ADN, CNRS UMR8200, F-94805 Villejuif, France	Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Novosibirsk State University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy	Kuznetsov, NA (corresponding author), Inst Chem Biol & Fundamental Med, 8 Lavrentyev Ave, Novosibirsk 630090, Russia.	nikita.kuznetsov@niboch.nsc.ru; fedorova@niboch.nsc.ru	Saparbaev, Murat K/N-3225-2015; Kuznetsov, Nikita/CAA-3889-2022; Kuznetsova, Aleksandra A/G-5119-2013; Kuznetsov, Nikita/AFU-9897-2022; Zharkov, Dmitry/K-2158-2012; Fedorova, Olga/ABE-6637-2020; Kladova, Olga A/J-4564-2018; Fedorova, Olga S./E-1291-2013; Ishchenko, Alexander/D-4133-2013; Saparbaev, Murat/AAC-5478-2020; Kuznetsov, Nikita A/F-3245-2011	Saparbaev, Murat K/0000-0002-4630-1074; Kuznetsov, Nikita/0000-0002-4016-198X; Kuznetsov, Nikita/0000-0002-4016-198X; Zharkov, Dmitry/0000-0001-5013-0194; Fedorova, Olga/0000-0002-4001-7187; Kladova, Olga A/0000-0002-4157-5244; Fedorova, Olga S./0000-0002-4001-7187; Ishchenko, Alexander/0000-0002-0488-8858; Saparbaev, Murat/0000-0002-4630-1074; Kuznetsov, Nikita A/0000-0002-4016-198X; Kuznetsova, Aleksandra/0000-0002-9805-7050	Russian Academy of Sciences "Molecular AMP; Cell Biology" Program [6.11, 6.12]; Russian Foundation for Basic Research [14-04-01879, 13-04-00013, 14-04-31174, 15-04-00467]; Russian Science Foundation [14-14-00063, 14-24-00093]; Russian Ministry of Education and Science [SS-1205.2014.4, SP-4012.2013.4]	Russian Academy of Sciences "Molecular AMP; Cell Biology" Program(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF)); Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation)	This work was supported by Russian Academy of Sciences "Molecular & Cell Biology" Program Grants 6.11 (to O. S. F.) and 6.12 (to D. O. Z.), Russian Foundation for Basic Research Grants 14-04-01879 (to D. O. Z.), 13-04-00013 (to O. S. F.), 14-04-31174 (to A. A. K.), and 15-04-00467 (to N. A. K.), Russian Science Foundation Grants 14-14-00063 (stopped-flow experiments) (to N. A. K.) and 14-24-00093 (structural analysis) (to D. O. Z.), and Russian Ministry of Education and Science Grants SS-1205.2014.4 and SP-4012.2013.4.	Asagoshi K, 2000, BIOCHEMISTRY-US, V39, P11389, DOI 10.1021/bi000422l; ASAHARA H, 1989, BIOCHEMISTRY-US, V28, P4444, DOI 10.1021/bi00436a048; Bandwar RP, 2001, J BIOL CHEM, V276, P14075, DOI 10.1074/jbc.M011289200; Banerjee A, 2006, SCIENCE, V311, P1153, DOI 10.1126/science.1120288; Banerjee A, 2005, NATURE, V434, P612, DOI 10.1038/nature03458; Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; Bowman BR, 2010, J BIOL CHEM, V285, P35783, DOI 10.1074/jbc.M110.155663; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; Crenshaw CM, 2012, J BIOL CHEM, V287, P24916, DOI 10.1074/jbc.M111.316497; Demchenko AP, 2006, FEBS LETT, V580, P2951, DOI 10.1016/j.febslet.2006.03.091; DEMPLE B, 1994, ANNU REV BIOCHEM, V63, P915, DOI 10.1146/annurev.biochem.63.1.915; Denver DR, 2003, MOL BIOL EVOL, V20, P1603, DOI 10.1093/molbev/msg177; Dizdaroglu M, 2000, BIOCHEMISTRY-US, V39, P5586, DOI 10.1021/bi9927787; DIZDAROGLU M, 1993, BIOCHEMISTRY-US, V32, P12105, DOI 10.1021/bi00096a022; DODSON ML, 1994, J BIOL CHEM, V269, P32709; Dunlap CA, 2002, BIOCHEMISTRY-US, V41, P11226, DOI 10.1021/bi025837g; Dziuba D, 2012, J AM CHEM SOC, V134, P10209, DOI 10.1021/ja3030388; Evans MD, 2004, MUTAT RES-REV MUTAT, V567, P1, DOI 10.1016/j.mrrev.2003.11.001; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Fromme JC, 2003, EMBO J, V22, P3461, DOI 10.1093/emboj/cdg311; Fromme JC, 2003, NAT STRUCT BIOL, V10, P204, DOI 10.1038/nsb902; Gros L, 2002, ONCOGENE, V21, P8905, DOI 10.1038/sj.onc.1206005; HATAHET Z, 1994, J BIOL CHEM, V269, P18814; Jacobs AL, 2012, CHROMOSOMA, V121, P1, DOI 10.1007/s00412-011-0347-4; Jurado J, 1998, BIOCHEMISTRY-US, V37, P7757, DOI 10.1021/bi972982z; Katafuchi A, 2004, J BIOL CHEM, V279, P14464, DOI 10.1074/jbc.M400393200; Koval VV, 2010, MUTAT RES-FUND MOL M, V685, P3, DOI 10.1016/j.mrfmmm.2009.08.018; KUO CF, 1992, SCIENCE, V258, P434, DOI 10.1126/science.1411536; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Kuznetsov NA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P118, DOI 10.1134/S0006297911010123; Kuznetsov N. A., 2014, PLOS ONE, V9; Kuznetsov NA, 2005, NUCLEIC ACIDS RES, V33, P3919, DOI 10.1093/nar/gki694; Kuznetsov NA, 2007, J BIOL CHEM, V282, P1029, DOI 10.1074/jbc.M605788200; Kuznetsov NA, 2007, BIOCHEMISTRY-US, V46, P424, DOI 10.1021/bi060787r; Kuznetsov NA, 2015, NUCLEIC ACIDS RES, V43, P272, DOI 10.1093/nar/gku1300; Kuznetsov NA, 2012, DNA REPAIR, V11, P884, DOI 10.1016/j.dnarep.2012.08.004; Kuznetsov NA, 2012, NUCLEIC ACIDS RES, V40, P7384, DOI 10.1093/nar/gks423; Kuznetsov NA, 2009, BIOCHEMISTRY-US, V48, P11335, DOI 10.1021/bi901100b; Kuznetsova AA, 2009, RUSS CHEM REV+, V78, P659, DOI 10.1070/RC2009v078n07ABEH004038; Kuznetsova AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100007; Kuznetsova AA, 2014, BBA-GEN SUBJECTS, V1840, P387, DOI 10.1016/j.bbagen.2013.09.035; Lee AJ, 2014, DNA REPAIR, V20, P23, DOI 10.1016/j.dnarep.2014.01.007; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lukin M, 2006, CHEM REV, V106, P607, DOI 10.1021/cr0404646; Nash HM, 1997, CHEM BIOL, V4, P693, DOI 10.1016/S1074-5521(97)90225-8; Nelson SR, 2014, P NATL ACAD SCI USA, V111, pE2091, DOI 10.1073/pnas.1400386111; Parker JB, 2007, NATURE, V449, P433, DOI 10.1038/nature06131; Qi Y, 2012, P NATL ACAD SCI USA, V109, P1086, DOI 10.1073/pnas.1111237108; Qi Y, 2009, NATURE, V462, P762, DOI 10.1038/nature08561; Sandin P, 2008, NUCLEIC ACIDS RES, V36, P157, DOI 10.1093/nar/gkm1006; Sandin P, 2009, NUCLEIC ACIDS RES, V37, P3924, DOI 10.1093/nar/gkp266; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sowers LC, 2000, BIOCHEMISTRY-US, V39, P7613, DOI 10.1021/bi992388k; SOWERS LC, 1986, P NATL ACAD SCI USA, V83, P5434, DOI 10.1073/pnas.83.15.5434; Stengel G, 2009, ANAL CHEM, V81, P9079, DOI 10.1021/ac9017555; Stengel G, 2009, BIOCHEMISTRY-US, V48, P7547, DOI 10.1021/bi9006995; Stivers JT, 1999, BIOCHEMISTRY-US, V38, P952, DOI 10.1021/bi9818669; Sung RJ, 2013, J BIOL CHEM, V288, P10012, DOI 10.1074/jbc.M112.415612; THAYER MM, 1995, EMBO J, V14, P4108, DOI 10.1002/j.1460-2075.1995.tb00083.x; WARD DC, 1969, J BIOL CHEM, V244, P1228; Wiederholt CJ, 2005, NUCLEIC ACIDS RES, V33, P3331, DOI 10.1093/nar/gki655; Wilhelmsson LM, 2010, Q REV BIOPHYS, V43, P159, DOI 10.1017/S0033583510000090; Wong I, 2002, J BIOL CHEM, V277, P19424, DOI 10.1074/jbc.M201198200; Yang KS, 2008, PHOTOCHEM PHOTOBIOL, V84, P741, DOI 10.1111/j.1751-1097.2007.00251.x; Zang Z, 2005, J BIOL CHEM, V280, P30873, DOI 10.1074/jbc.M505283200	65	35	37	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14338	14349		10.1074/jbc.M114.621128	http://dx.doi.org/10.1074/jbc.M114.621128			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25869130	Green Published, hybrid			2022-12-28	WOS:000355754600007
J	Cai, CX; Lin, PH; Zhu, H; Ko, JK; Hwang, M; Tan, T; Pan, Z; Korichneva, I; Ma, JJ				Cai, Chuanxi; Lin, Peihui; Zhu, Hua; Ko, Jae-Kyun; Hwang, Moonsun; Tan, Tao; Pan, Zui; Korichneva, Irina; Ma, Jianjie			Zinc Binding to MG53 Protein Facilitates Repair of Injury to Cell Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACRODERMATITIS ENTEROPATHICA; HUMAN HEALTH; DEFICIENCY; DYSFERLIN; TRAFFICKING; DISRUPTIONS	Zinc is an essential trace element that participates in a wide range of biological functions, including wound healing. Although Zn2+ deficiency has been linked to compromised wound healing and tissue repair in human diseases, the molecular mechanisms underlying Zn2+-mediated tissue repair remain unknown. Our previous studies established that MG53, a TRIM (tripartite motif) family protein, is an essential component of the cell membrane repair machinery. Domain homology analysis revealed that MG53 contains two Zn2+-binding motifs. Here, we show that Zn2+ binding to MG53 is indispensable to assembly of the cell membrane repair machinery. Live cell imaging illustrated that Zn2+ entry from extracellular space is essential for translocation of MG53-containing vesicles to the acute membrane injury sites for formation of a repair patch. The effect of Zn2+ on membrane repair is abolished in mg53(-/-) muscle fibers, suggesting that MG53 functions as a potential target for Zn2+ during membrane repair. Mutagenesis studies suggested that both RING and B-box motifs of MG53 constitute Zn2+-binding domains that contribute to MG53-mediated membrane repair. Overall, this study establishes a base for Zn2+ interaction with MG53 in protection against injury to the cell membrane.	[Cai, Chuanxi; Lin, Peihui; Zhu, Hua; Ko, Jae-Kyun; Hwang, Moonsun; Ma, Jianjie] Rutgers Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA; [Cai, Chuanxi] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA; [Lin, Peihui; Zhu, Hua; Tan, Tao; Ma, Jianjie] Ohio State Univ, Dept Surg, Columbus, OH 43210 USA; [Pan, Zui] Ohio State Univ, Dept Surg, Davis Heart & Lung Res Inst, Dept Internal Med, Columbus, OH 43210 USA; [Korichneva, Irina] Univ Picardie, Dept Sci, Lab Cellular & Mol Physiol, F-80000 Amiens, France	Rutgers State University New Brunswick; Rutgers State University Medical Center; Albany Medical College; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Picardie Universites; Universite de Picardie Jules Verne (UPJV)	Korichneva, I (corresponding author), Univ Picardie, Dept Sci, Lab Cellular & Mol Physiol, F-80000 Amiens, France.	irina.korichneva@u-picardie.fr; jianjie.ma@osumc.edu	Regan, Clinton/E-6250-2012; Cai, Chuanxi/AAW-1488-2020; Zhu, Hua/G-4409-2010	Pan, Zui/0000-0003-4105-901X; Zhu, Hua/0000-0001-7136-7326	National Institutes of Health [AR061385, HL069000]; American Heart Association; Ohio State University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061385] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Ohio State University(Ohio State University); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR061385 and HL069000 (to J. M.). This work was also supported by the American Heart Association (to C. C. and H. Z.) and an Ohio State University intramural Lockwood Early Career Development Award (to P. L.). J. M. has an equity interest in TRIM-edicine, which develops MG53 for treatment of human diseases. Patents on the use of MG53 are held by the Rutgers Robert Wood Johnson Medical School.	Agren MS, 2006, WOUND REPAIR REGEN, V14, P526, DOI 10.1111/j.1743-6109.2006.00159.x; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bozym RA, 2010, EXP BIOL MED, V235, P741, DOI 10.1258/ebm.2010.009258; BRAUN OH, 1976, EUR J PEDIATR, V121, P247, DOI 10.1007/BF00443018; Brewer GJ, 2013, INT J ALZHEIMERS DIS, V2013; Cai CX, 2009, J BIOL CHEM, V284, P15894, DOI 10.1074/jbc.M109.009589; Cai CX, 2009, J BIOL CHEM, V284, P3314, DOI 10.1074/jbc.M808866200; Cai CX, 2009, NAT CELL BIOL, V11, P56, DOI 10.1038/ncb1812; Cao CM, 2010, CIRCULATION, V121, P2565, DOI 10.1161/CIRCULATIONAHA.110.954628; Chasapis CT, 2012, ARCH TOXICOL, V86, P521, DOI 10.1007/s00204-011-0775-1; Frederickson CJ, 2006, EXP NEUROL, V198, P285, DOI 10.1016/j.expneurol.2005.08.030; Frederickson CJ, 2004, J NEUROSCI METH, V139, P79, DOI 10.1016/j.jneumeth.2004.04.033; Frustaci A, 2012, EUR J HEART FAIL, V14, P202, DOI 10.1093/eurjhf/hfr167; Glover L, 2007, TRAFFIC, V8, P785, DOI 10.1111/j.1600-0854.2007.00573.x; Grommes J, 2011, INT J COLORECTAL DIS, V26, P295, DOI 10.1007/s00384-010-1070-y; Gupta M, 2014, DERMAT RES PRACT, V2014, DOI 10.1155/2014/709152; Haase H, 2014, METALLOMICS, V6, P1175, DOI 10.1039/c3mt00353a; Han R, 2007, J CLIN INVEST, V117, P1805, DOI 10.1172/JCI30848; Herbein G, 2006, BIOGERONTOLOGY, V7, P409, DOI 10.1007/s10522-006-9056-4; Hwang M, 2011, AM J PHYSIOL-CELL PH, V301, pC106, DOI 10.1152/ajpcell.00382.2010; Ikeda K, 2012, ADV EXP MED BIOL, V770, P27; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Ko JK, 2005, AM J PHYSIOL-CELL PH, V288, pC1273, DOI 10.1152/ajpcell.00517.2004; Korichneva I, 2002, J BIOL CHEM, V277, P44327, DOI 10.1074/jbc.M205634200; Korichneva Irina, 2005, Exp Clin Cardiol, V10, P256; Lansdown A. B. G., 1993, International Journal of Cosmetic Science, V15, P83, DOI 10.1111/j.1467-2494.1993.tb00072.x; Lansdown ABG, 2007, WOUND REPAIR REGEN, V15, P2, DOI 10.1111/j.1524-475X.2006.00179.x; Lin PH, 2012, FASEB J, V26, P1875, DOI 10.1096/fj.11-188599; Marger L, 2014, BIOCHEM PHARMACOL, V91, P426, DOI 10.1016/j.bcp.2014.08.002; McNeil PL, 2000, J CELL SCI, V113, P1891; McNeil PL, 2005, NAT REV MOL CELL BIO, V6, P499, DOI 10.1038/nrm1665; Meroni G, 2012, ADV EXP MED BIOL, V770, P1; Micale L, 2012, ADV EXP MED BIOL, V770, P11; MOYNAHAN EJ, 1974, LANCET, V2, P399; MOZZILLO N, 1984, Italian Journal of Surgical Sciences, V14, P229; Park KH, 2014, JOVE-J VIS EXP, DOI 10.3791/50898; Prasad AS, 2013, ADV NUTR, V4, P176, DOI 10.3945/an.112.003210; Sensi SL, 2009, NAT REV NEUROSCI, V10, P780, DOI 10.1038/nrn2734; Shen SS, 2005, J BIOL CHEM, V280, P1652, DOI 10.1074/jbc.M410136200; Song RS, 2013, NATURE, V494, P375, DOI 10.1038/nature11834; STEINHARDT RA, 1994, SCIENCE, V263, P390, DOI 10.1126/science.7904084; Terasaki M, 1997, J CELL BIOL, V139, P63, DOI 10.1083/jcb.139.1.63; Towler MC, 2004, TRAFFIC, V5, P129, DOI 10.1111/j.1600-0854.2003.00164.x; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; van der Meer LT, 2010, LEUKEMIA, V24, P1834, DOI 10.1038/leu.2010.195; Wang C, 2010, PROTEIN SCI, V19, P494, DOI 10.1002/pro.327; Wang XH, 2010, CIRC RES, V107, P76, DOI 10.1161/CIRCRESAHA.109.215822; Weisleder N., 2011, JOVE-J VIS EXP, V52, P2717; Weisleder N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003921; Yi JS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3354; Zhu H, 2011, J BIOL CHEM, V286, P12820, DOI 10.1074/jbc.C111.221440; Zorrilla P, 2006, WOUND REPAIR REGEN, V14, P119, DOI [10.1111/j.1743-6109.2006.00100.x, 10.1111/j.1743-6109.2006.00100.X]	54	26	28	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13830	13839		10.1074/jbc.M114.620690	http://dx.doi.org/10.1074/jbc.M114.620690			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25869134	Green Published, hybrid			2022-12-28	WOS:000355313000017
J	Catici, DAM; Horne, JE; Cooper, GE; Pudney, CR				Catici, Dragana A. M.; Horne, James E.; Cooper, Grace E.; Pudney, Christopher R.			Polyubiquitin Drives the Molecular Interactions of the NF-kappa B Essential Modulator (NEMO) by Allosteric Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN INTRINSIC DISORDER; CONFORMATIONAL SELECTION; UBIQUITIN CHAINS; TRYPTOPHAN FLUORESCENCE; PRESSURE-DEPENDENCE; INDUCED FIT; ACTIVATION; BINDING; IKK; TEMPERATURE	The NF-kappa B essential modulator (NEMO) is the master regulator of NF-kappa B signaling, controlling the immune and nervous systems. NEMO affects the activity of I kappa B kinase-beta (IKK beta), which relieves the inhibition of the NF-kappa B transcriptional regulation machinery. Despite major effort, there is only a very sparse, phenomenological understanding of how NEMO regulates IKK beta and shows specificity in its large range of molecular interactions. We explore the key molecular interactions of NEMO using a molecular biophysics approach, incorporating rapid-mixing stopped-flow, high-pressure, and CD spectroscopies. Our study demonstrates that NEMO has a significant degree of native structural disorder and that molecular flexibility and ligand-induced conformational change are at the heart of the molecular interactions of NEMO. We found that long chain length, unanchored, linear polyubiquitin drives NEMO activity, enhancing the affinity of NEMO for IKK beta and the kinase substrate I kappa B alpha and promoting membrane association. We present evidence that unanchored polyubiquitin achieves this regulation by inducing NEMO conformational change by an allosteric mechanism. We combine our quantitative findings to give a detailed molecular mechanistic model for the activity of NEMO, providing insight into the molecular mechanism of NEMO activity with broad implications for the biological role of free polyubiquitin.	[Catici, Dragana A. M.; Horne, James E.; Cooper, Grace E.; Pudney, Christopher R.] Univ Bath, Dept Biol & Biochem, Fac Sci, Bath BA2 7AY, Avon, England	University of Bath	Pudney, CR (corresponding author), Univ Bath, Dept Biol & Biochem, Fac Sci, Bath BA2 7AY, Avon, England.	c.r.pudney@bath.ac.uk		Pudney, Christopher/0000-0001-6211-0086				AGASHE VR, 1995, NATURE, V377, P754, DOI 10.1038/377754a0; Akasaka K, 2006, CHEM REV, V106, P1814, DOI 10.1021/cr040440z; Brunecky R, 2005, BIOCHEMISTRY-US, V44, P16064, DOI 10.1021/bi051127+; Courtois G, 2011, CURR TOP MICROBIOL, V349, P73, DOI 10.1007/82_2010_98; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Emmerich CH, 2013, P NATL ACAD SCI USA, V110, P15247, DOI 10.1073/pnas.1314715110; ENGELHARD M, 1995, PROTEIN SCI, V4, P1553, DOI 10.1002/pro.5560040813; Fenner BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008799; Ferreon ACM, 2013, NATURE, V498, P390, DOI 10.1038/nature12294; Fontan E, 2007, FEBS J, V274, P2540, DOI 10.1111/j.1742-4658.2007.05788.x; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Hammes GG, 2009, P NATL ACAD SCI USA, V106, P13737, DOI 10.1073/pnas.0907195106; Ivins FJ, 2009, BIOCHEM J, V421, P243, DOI 10.1042/BJ20090427; Kensche T, 2012, J BIOL CHEM, V287, P23626, DOI 10.1074/jbc.M112.347195; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Nakamori Y, 2006, J CELL BIOL, V173, P665, DOI 10.1083/jcb.200601065; Nussinov R, 2014, BIOPHYS CHEM, V186, P22, DOI 10.1016/j.bpc.2013.10.002; Pan CP, 2004, BIOPHYS J, V86, P3828, DOI 10.1529/biophysj.103.038901; Pudney CR, 2007, J AM CHEM SOC, V129, P13949, DOI 10.1021/ja074463h; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Ravindra R, 2003, CHEMPHYSCHEM, V4, P359, DOI 10.1002/cphc.200390062; Schrofelbauer B, 2012, MOL CELL, V47, P111, DOI 10.1016/j.molcel.2012.04.020; Schulenburg C, 2013, TOP CURR CHEM, V337, P41, DOI 10.1007/128_2012_411; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Solt LA, 2009, J BIOL CHEM, V284, P27596, DOI 10.1074/jbc.M109.047563; STRYER LUBERT, 1965, J MOL BIOL, V13, P482; Tantos A, 2012, MOL CELL ENDOCRINOL, V348, P457, DOI 10.1016/j.mce.2011.07.015; Tarantino N, 2014, J CELL BIOL, V204, P231, DOI 10.1083/jcb.201307172; Tognotti D, 2013, BIOPHYS CHEM, V182, P44, DOI 10.1016/j.bpc.2013.06.005; Tsai CJ, 2001, PROTEINS, V44, P418, DOI 10.1002/prot.1107; Uversky VN, 2013, PROTEIN SCI, V22, P693, DOI 10.1002/pro.2261; Uversky VN, 2009, PROTEIN J, V28, P305, DOI 10.1007/s10930-009-9201-4; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Wiedersich J, 2008, P NATL ACAD SCI USA, V105, P5756, DOI 10.1073/pnas.0710409105; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Xu GZ, 2011, NATURE, V472, P325, DOI 10.1038/nature09853; Zhang J., 2014, BIOCHEM J, V461, P531	40	16	16	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					14130	14139		10.1074/jbc.M115.640417	http://dx.doi.org/10.1074/jbc.M115.640417			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25866210	Green Published, hybrid			2022-12-28	WOS:000355313000041
J	Cooper, CDO; Newman, JA; Aitkenhead, H; Allerston, CK; Gileadi, O				Cooper, Christopher D. O.; Newman, Joseph A.; Aitkenhead, Hazel; Allerston, Charles K.; Gileadi, Opher			Structures of the Ets Protein DNA-binding Domains of Transcription Factors Etv1, Etv4, Etv5, and Fev DETERMINANTS OF DNA BINDING AND REDOX REGULATION BY DISULFIDE BOND FORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; HEMATOPOIETIC STEM; MOLECULAR-BIOLOGY; PROSTATE-CANCER; FACTOR ER81; FAMILY; METHYLATION; INSIGHTS; CELLS; RECOGNITION	Ets transcription factors, which share the conserved Ets DNA-binding domain, number nearly 30 members in humans and are particularly involved in developmental processes. Their deregulation following changes in expression, transcriptional activity, or by chromosomal translocation plays a critical role in carcinogenesis. Ets DNA binding, selectivity, and regulation have been extensively studied; however, questions still arise regarding binding specificity outside the core GGA recognition sequence and the mode of action of Ets post-translational modifications. Here, we report the crystal structures of Etv1, Etv4, Etv5, and Fev, alone and in complex with DNA. We identify previously unrecognized features of the protein-DNA interface. Interactions with the DNA backbone account for most of the binding affinity. We describe a highly coordinated network of water molecules acting in base selection upstream of the GGAA core and the structural features that may account for discrimination against methylated cytidine residues. Unexpectedly, all proteins crystallized as disulfide-linked dimers, exhibiting a novel interface (distant to the DNA recognition helix). Homodimers of Etv1, Etv4, and Etv5 could be reduced to monomers, leading to a 40-200-fold increase in DNA binding affinity. Hence, we present the first indication of a redox-dependent regulatory mechanism that may control the activity of this subset of oncogenic Ets transcription factors.	[Cooper, Christopher D. O.; Newman, Joseph A.; Aitkenhead, Hazel; Allerston, Charles K.; Gileadi, Opher] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England	University of Oxford	Gileadi, O (corresponding author), Univ Oxford, Struct Genom Consortium, Old Rd Campus Res Bldg,Roosevelt Dr, Oxford OX3 7DQ, England.	opher.gileadi@sgc.ox.ac.uk	Cooper, Chris/G-9982-2014; Gileadi, Opher/F-1105-2013	Cooper, Chris/0000-0002-9197-8041; newman, Joseph/0000-0003-4488-0516; Gileadi, Opher/0000-0001-6886-898X	SGC [1097737]; AbbVie; Boehringer Ingelheim; Canada Foundation for Innovation; Canadian Institutes for Health Research; Genome Canada; GlaxoSmithKline; Janssen; Lilly Canada; Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer; Takeda; Wellcome Trust [092809/Z/10/Z]; E.P. Abraham Cephalosporin Fund	SGC; AbbVie(AbbVie); Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lilly Canada(Eli Lilly); Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission); E.P. Abraham Cephalosporin Fund	This work was supported by the SGC (the SGC is a registered charity (number 1097737) that receives funds from AbbVie, Boehringer Ingelheim, Canada Foundation for Innovation, Canadian Institutes for Health Research, Genome Canada, GlaxoSmithKline, Janssen, Lilly Canada, Novartis Research Foundation, Ontario Ministry of Economic Development and Innovation, Pfizer, Takeda, and Wellcome Trust Grant 092809/Z/10/Z).; Supported in part by the E.P. Abraham Cephalosporin Fund. Present address: Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, United Kingdom.	Abe H, 2011, P NATL ACAD SCI USA, V108, P12497, DOI 10.1073/pnas.1109940108; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Babayeva ND, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033698; Baena E, 2013, GENE DEV, V27, P683, DOI 10.1101/gad.211011.112; Baert JL, 2002, J BIOL CHEM, V277, P1002, DOI 10.1074/jbc.M107139200; Baillat D, 2009, BIOCHEM BIOPH RES CO, V378, P213, DOI 10.1016/j.bbrc.2008.11.035; BANNISTER AJ, 1991, ONCOGENE, V6, P1243; Barik S, 1996, Methods Mol Biol, V57, P203; Batchelor AH, 1998, SCIENCE, V279, P1037, DOI 10.1126/science.279.5353.1037; Bojovic BB, 2001, J BIOL CHEM, V276, P4509, DOI 10.1074/jbc.M005509200; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Carrere S, 1998, ONCOGENE, V16, P3261, DOI 10.1038/sj.onc.1201868; Charlot C, 2010, METHODS MOL BIOL, V647, P3, DOI 10.1007/978-1-60761-738-9_1; Chi P, 2010, NATURE, V467, P849, DOI 10.1038/nature09409; Chinenov Y, 1998, J BIOL CHEM, V273, P6203, DOI 10.1074/jbc.273.11.6203; Chotteau-Lelievre A, 2003, DEV BIOL, V259, P241, DOI 10.1016/S0012-1606(03)00182-9; Cooper CDO, 2014, BIOCHEM SOC T, V42, P130, DOI 10.1042/BST20130227; Coyne HJ, 2012, J MOL BIOL, V421, P67, DOI 10.1016/j.jmb.2012.05.010; Danciu TE, 2010, J CELL BIOCHEM, V109, P417, DOI 10.1002/jcb.22415; DEGNAN BM, 1993, NUCLEIC ACIDS RES, V21, P3479, DOI 10.1093/nar/21.15.3479; Donaldson LW, 1996, EMBO J, V15, P125, DOI 10.1002/j.1460-2075.1996.tb00340.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erkizan HV, 2009, NAT MED, V15, P750, DOI 10.1038/nm.1983; Evans EL, 2011, NUCLEIC ACIDS RES, V39, P6390, DOI 10.1093/nar/gkr266; FISHER RJ, 1992, J BIOL CHEM, V267, P17957; Gajiwala KS, 2000, CURR OPIN STRUC BIOL, V10, P110, DOI 10.1016/S0959-440X(99)00057-3; Garvie CW, 2002, J BIOL CHEM, V277, P45529, DOI 10.1074/jbc.M206327200; Goel A, 2003, MOL CELL BIOL, V23, P6243, DOI 10.1128/MCB.23.17.6243-6254.2003; Greenall A, 2001, J BIOL CHEM, V276, P16207, DOI 10.1074/jbc.M011582200; Hendricks T, 1999, J NEUROSCI, V19, P10348; Hendricks TJ, 2003, NEURON, V37, P233, DOI 10.1016/S0896-6273(02)01167-4; Hogart A, 2012, GENOME RES, V22, P1407, DOI 10.1101/gr.132878.111; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; Hollenhorst PC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000778; Iwasaki H, 2005, BLOOD, V106, P1590, DOI 10.1182/blood-2005-03-0860; Jane-Valbuena J, 2010, CANCER RES, V70, P2075, DOI 10.1158/0008-5472.CAN-09-3092; Janknecht R, 2005, GENE, V363, P1, DOI 10.1016/j.gene.2005.08.007; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalodimos CG, 2004, SCIENCE, V305, P386, DOI 10.1126/science.1097064; Kodandapani R, 1996, NATURE, V380, P456, DOI 10.1038/380456a0; Laskowski RA, 2009, FEBS LETT, V583, P1692, DOI 10.1016/j.febslet.2009.03.019; Legrand AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055883; Lelievre E, 2001, INT J BIOCHEM CELL B, V33, P391, DOI 10.1016/S1357-2725(01)00025-5; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; LEPRINCE D, 1983, NATURE, V306, P395, DOI 10.1038/306395a0; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; LIANG H, 1994, NAT STRUCT BIOL, V1, P871, DOI 10.1038/nsb1294-871; Lucas ME, 2009, J BIOL CHEM, V284, P14698, DOI 10.1074/jbc.M901104200; Macauley MS, 2006, J BIOL CHEM, V281, P4164, DOI 10.1074/jbc.M510488200; Martin ME, 1996, J BIOL CHEM, V271, P25617, DOI 10.1074/jbc.271.41.25617; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mo Y, 1998, MOL CELL, V2, P201, DOI 10.1016/S1097-2765(00)80130-6; Mo Y, 2000, NAT STRUCT BIOL, V7, P292; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagahara N, 2011, AMINO ACIDS, V41, P59, DOI 10.1007/s00726-010-0508-4; Newman JA, 2015, J BIOL CHEM, V290, P8539, DOI 10.1074/jbc.M114.619270; Nickel J, 1995, NUCLEIC ACIDS RES, V23, P4785, DOI 10.1093/nar/23.23.4785; Oh S, 2012, BBA-REV CANCER, V1826, P1, DOI 10.1016/j.bbcan.2012.02.002; Oikawa T, 2003, GENE, V303, P11, DOI 10.1016/S0378-1119(02)01156-3; Peter M, 1997, ONCOGENE, V14, P1159, DOI 10.1038/sj.onc.1200933; Pio F, 1996, J BIOL CHEM, V271, P23329, DOI 10.1074/jbc.271.38.23329; Polansky JK, 2010, J MOL MED, V88, P1029, DOI 10.1007/s00109-010-0642-1; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; Prinz WA, 1997, J BIOL CHEM, V272, P15661, DOI 10.1074/jbc.272.25.15661; Pufall MA, 2005, SCIENCE, V309, P142, DOI 10.1126/science.1111915; Rahim S., 2011, YK 4 279 INHIBITS ER; Regan MC, 2013, P NATL ACAD SCI USA, V110, P13374, DOI 10.1073/pnas.1301726110; Rooman M, 2002, J MOL BIOL, V319, P67, DOI 10.1016/S0022-2836(02)00263-2; Savitsky P, 2010, J STRUCT BIOL, V172, P3, DOI 10.1016/j.jsb.2010.06.008; Sedy J, 2006, DEV DYNAM, V235, P1081, DOI 10.1002/dvdy.20710; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shin S, 2013, ONCOL REP, V29, P306, DOI 10.3892/or.2012.2079; Shin S, 2009, CANCER RES, V69, P8102, DOI 10.1158/0008-5472.CAN-09-0941; STRAUSS JK, 1994, SCIENCE, V266, P1829, DOI 10.1126/science.7997878; Surh YJ, 2005, J NUTR, V135, p2993S, DOI 10.1093/jn/135.12.2993S; Szymczyna BR, 2000, J BIOL CHEM, V275, P28363, DOI 10.1074/jbc.M004294200; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Toone WM, 2001, ONCOGENE, V20, P2336, DOI 10.1038/sj.onc.1204384; Tron AE, 2002, J BIOL CHEM, V277, P34800, DOI 10.1074/jbc.M203297200; Vageli D, 2009, ONCOL RES, V17, P413, DOI 10.3727/096504009788912507; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Wang H, 2002, J BIOL CHEM, V277, P2225, DOI 10.1074/jbc.M109430200; Wang Y, 2011, PATHOLOG RES INT, V2011; Wang YC, 2010, ENDOCR-RELAT CANCER, V17, P283, DOI 10.1677/ERC-09-0243; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Wintjens R, 2000, J MOL BIOL, V302, P395, DOI 10.1006/jmbi.2000.4040; Wu HT, 2013, CELL REP, V3, P1663, DOI 10.1016/j.celrep.2013.04.020; Wu JM, 2002, J BIOL CHEM, V277, P42669, DOI 10.1074/jbc.M205501200; Yan CH, 2013, BBA-REV CANCER, V1835, P76, DOI 10.1016/j.bbcan.2012.11.002	91	27	29	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13692	13709		10.1074/jbc.M115.646737	http://dx.doi.org/10.1074/jbc.M115.646737			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25866208	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000355313000007
J	Hisaoka-Nakashima, K; Miyano, K; Matsumoto, C; Kajitani, N; Abe, H; Okada-Tsuchioka, M; Yokoyama, A; Uezono, Y; Morioka, N; Nakata, Y; Takebayashi, M				Hisaoka-Nakashima, Kazue; Miyano, Kanako; Matsumoto, Chie; Kajitani, Naoto; Abe, Hiromi; Okada-Tsuchioka, Mami; Yokoyama, Akinobu; Uezono, Yasuhito; Morioka, Norimitsu; Nakata, Yoshihiro; Takebayashi, Minoru			Tricyclic Antidepressant Amitriptyline-induced Glial Cell Line-derived Neurotrophic Factor Production Involves Pertussis Toxin-sensitive G alpha(i/o) Activation in Astroglial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C6 GLIOMA-CELLS; GROWTH-FACTOR RECEPTOR; MAJOR DEPRESSIVE DISORDER; MESSENGER-RNA EXPRESSION; TYROSINE KINASE DOMAIN; PROTEIN ALPHA-SUBUNIT; GTP-BINDING-PROTEIN; SIGNALING PATHWAY; FACTOR GDNF; CYCLIC-AMP	Further elaborating the mechanism of antidepressants, beyond modulation of monoaminergic neurotransmission, this study sought to elucidate the mechanism of amitriptyline-induced production of glial cell line-derived neurotrophic factor (GDNF) in astroglial cells. Previous studies demonstrated that an amitriptyline-evoked matrix metalloproteinase (MMP)/FGF receptor (FGFR)/FGFR substrate 2 alpha (FRS2 alpha)/ERK cascade is crucial for GDNF production, but how amitriptyline triggers this cascade remains unknown. MMP is activated by intracellular mediators such as G proteins, and this study sought to clarify the involvement of G protein signaling in amitriptyline-evoked GDNF production in rat C6 astroglial cells (C6 cells), primary cultured rat astrocytes, and normal human astrocytes. Amitriptyline-evoked GDNF mRNA expression and release were inhibited by pertussis toxin (PTX), a G alpha(i/o) inhibitor, but not by NF449, a G alpha(s) inhibitor, or YM-254890, a G alpha(q) inhibitor. The activation of the GDNF production cascade (FGFR/FRS2 alpha/ERK) was also inhibited by PTX. Deletion of G alpha(o1) and G alpha(i3) by RNAi demonstrated that these G proteins play important roles in amitriptyline signaling. Gprotein activation was directly analyzed by electrical impedance-based biosensors (CellKey (TM) assay), using a label-free (without use of fluorescent proteins/ probes or radioisotopes) and real time approach. Amitriptyline increased impedance, indicating G alpha(i/o) activation that was sup-pressed by PTX treatment. The impedance evoked by amitriptyline was not affected by inhibitors of the GDNF production cascade. Furthermore, FGF2 treatment did not elicit any effect on impedance, indicating that amitriptyline targets PTX-sensitive G alpha(i/o) upstream of the MMP/FGFR/FRS2 alpha/ERK cascade. These results suggest novel targeting for the development of antidepressants.	[Hisaoka-Nakashima, Kazue; Matsumoto, Chie; Kajitani, Naoto; Abe, Hiromi; Morioka, Norimitsu; Nakata, Yoshihiro] Hiroshima Univ, Grad Sch Biomed Sci, Dept Pharmacol, Minami Ku, Hiroshima 7348553, Japan; [Miyano, Kanako; Yokoyama, Akinobu; Uezono, Yasuhito] Natl Canc Ctr, Res Inst, Div Canc Pathophysiol, Chuo Ku, Tokyo 1040045, Japan; [Abe, Hiromi; Okada-Tsuchioka, Mami; Takebayashi, Minoru] Natl Hosp Org, Kure Med Ctr, Inst Clin Res, Div Psychiat & Neurosci, Kure 7370023, Japan; [Takebayashi, Minoru] Natl Hosp Org, Kure Med Ctr, Dept Psychiat, Kure 7370023, Japan; [Takebayashi, Minoru] Chugoku Canc Ctr, Kure 7370023, Japan	Hiroshima University; National Cancer Center - Japan	Hisaoka-Nakashima, K (corresponding author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Pharmacol, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	hisaokak@hiroshima-u.ac.jp; mtakebayashi@kure-nh.go.jp	Morioka, Norimitsu/J-3165-2019	Morioka, Norimitsu/0000-0001-9148-4167; Miyano, Kanako/0000-0003-1673-6074; Kajitani, Naoto/0000-0001-7245-9206	Japan Society for the Promotion of Science [25870461, 23591686]; Takeda Science Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by Grants-in-aid for Young Scientists (B) 25870461 and 23591686 from the Japan Society for the Promotion of Science and the Takeda Science Foundation.	Castillo CA, 2007, NEUROCHEM RES, V32, P1056, DOI 10.1007/s11064-006-9273-x; Allen NJ, 2009, NATURE, V457, P675, DOI 10.1038/457675a; Belcheva MM, 2002, J PHARMACOL EXP THER, V303, P909, DOI 10.1124/jpet.102.038554; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI 10.1038/nrdp.2016.65; Bespalov MM, 2007, TRENDS PHARMACOL SCI, V28, P68, DOI 10.1016/j.tips.2006.12.005; Bohn LM, 2000, J NEUROCHEM, V74, P564, DOI 10.1046/j.1471-4159.2000.740564.x; CHEN JA, 1995, J NEUROCHEM, V64, P724; Davies SL, 2006, AM J PHYSIOL-CELL PH, V290, pC1543, DOI 10.1152/ajpcell.00482.2005; Donati RJ, 2001, MOL PHARMACOL, V59, P1426, DOI 10.1124/mol.59.6.1426; Duncia JV, 1998, BIOORG MED CHEM LETT, V8, P2839, DOI 10.1016/S0960-894X(98)00522-8; FONG HKW, 1988, P NATL ACAD SCI USA, V85, P3066, DOI 10.1073/pnas.85.9.3066; Galeotti N, 2002, NEUROPSYCHOPHARMACOL, V27, P554; GLOTZBACH RK, 1982, PSYCHOPHARMACOLOGY, V78, P25, DOI 10.1007/BF00470582; Graler MH, 2003, J CELL BIOCHEM, V89, P507, DOI 10.1002/jcb.10537; GROBELNY D, 1992, BIOCHEMISTRY-US, V31, P7152, DOI 10.1021/bi00146a017; Hisaoka K, 2001, J NEUROCHEM, V79, P25, DOI 10.1046/j.1471-4159.2001.00531.x; Hisaoka K, 2007, J PHARMACOL EXP THER, V321, P148, DOI 10.1124/jpet.106.116558; Hisaoka K, 2011, J BIOL CHEM, V286, P21118, DOI 10.1074/jbc.M111.224683; Hohenegger M, 1998, P NATL ACAD SCI USA, V95, P346, DOI 10.1073/pnas.95.1.346; Kajitani N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051197; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Kowal D, 2002, BIOCHEM BIOPH RES CO, V294, P655, DOI 10.1016/S0006-291X(02)00535-1; Kurino M, 1996, J NEUROCHEM, V67, P2246; Lagriffoul A, 1996, J BIOL CHEM, V271, P31508, DOI 10.1074/jbc.271.49.31508; LAMB NJC, 1988, J CELL BIOL, V106, P1955, DOI 10.1083/jcb.106.6.1955; Lin YF, 2006, MOL ENDOCRINOL, V20, P2514, DOI 10.1210/me.2005-0347; Luo JS, 2008, MOL PHARMACOL, V74, P338, DOI 10.1124/mol.107.044750; MATSUOKA M, 1988, P NATL ACAD SCI USA, V85, P5384, DOI 10.1073/pnas.85.15.5384; MIYAKE K, 1990, J PHARM SCI, V79, P288, DOI 10.1002/jps.2600790403; Miyano K, 2014, J PHARMACOL SCI, V126, P302, DOI 10.1254/jphs.14R13CP; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; Morioka N, 2014, BRIT J PHARMACOL, V171, P2854, DOI 10.1111/bph.12614; Morioka N, 2010, J PHARMACOL SCI, V113, P234, DOI 10.1254/jphs.10031FP; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; O'Donnell JM, 2011, DRUG THERAPY DEPRESS; Ohta M, 2000, BIOCHEM BIOPH RES CO, V272, P18, DOI 10.1006/bbrc.2000.2732; Onali P, 2010, J PHARMACOL EXP THER, V332, P255, DOI 10.1124/jpet.109.159939; Owens MJ, 1997, J PHARMACOL EXP THER, V283, P1305; PEAKMAN MC, 1994, BRIT J PHARMACOL, V113, P1554, DOI 10.1111/j.1476-5381.1994.tb17173.x; Peters MF, 2007, J BIOMOL SCREEN, V12, P312, DOI 10.1177/1087057106298637; Peters MF, 2010, ASSAY DRUG DEV TECHN, V8, P219, DOI 10.1089/adt.2009.0232; Rajkowska G, 2013, CURR DRUG TARGETS, V14, P1225; Schmidt Heath D, 2008, Drug Discov Today Ther Strateg, V5, P151, DOI 10.1016/j.ddstr.2008.10.003; Scott CW, 2010, DRUG DISCOV TODAY, V15, P704, DOI 10.1016/j.drudis.2010.06.008; Shen JX, 2013, BIOCHEM J, V455, P47, DOI 10.1042/BJ20130359; Skaper SD, 2000, J NEUROCHEM, V75, P1520, DOI 10.1046/j.1471-4159.2000.0751520.x; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Takebayashi M, 2006, INT J NEUROPSYCHOPH, V9, P607, DOI 10.1017/S1461145705006085; Toki S, 1999, J NEUROCHEM, V73, P1114, DOI 10.1046/j.1471-4159.1999.0731114.x; Tran MD, 2006, P NATL ACAD SCI USA, V103, P9321, DOI 10.1073/pnas.0603146103; Tsai LK, 2010, NEUROPSYCHOPHARMACOL, V35, P2225, DOI 10.1038/npp.2010.97; Tsuchioka M, 2008, J NEUROCHEM, V106, P244, DOI 10.1111/j.1471-4159.2008.05357.x; Van Kolen K, 2004, J NEUROCHEM, V89, P442, DOI 10.1111/j.1471-4159.2004.02339.x; VANCORVEN EJ, 1993, P NATL ACAD SCI USA, V90, P1257, DOI 10.1073/pnas.90.4.1257; Wang J, 1997, J BIOL CHEM, V272, P5732, DOI 10.1074/jbc.272.9.5732; Wetzker R, 2003, NAT REV MOL CELL BIO, V4, P651, DOI 10.1038/nrm1173; WILSON KM, 1990, MOL PHARMACOL, V38, P274; YAMAMOTO H, 1992, NEUROSCI LETT, V139, P194, DOI 10.1016/0304-3940(92)90550-Q; Zhang XB, 2008, PROG NEURO-PSYCHOPH, V32, P886, DOI 10.1016/j.pnpbp.2008.01.004; Zhang YY, 2008, DEVELOPMENT, V135, P775, DOI 10.1242/dev.009910; Zysk JR, 2011, SYNAPSE, V65, P64, DOI 10.1002/syn.20817	62	33	35	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13678	13691		10.1074/jbc.M114.622415	http://dx.doi.org/10.1074/jbc.M114.622415			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25869129	Green Published, hybrid			2022-12-28	WOS:000355313000006
J	Kwon, Y; Kim, Y; Eom, S; Kim, M; Park, D; Kim, H; Noh, K; Lee, H; Lee, YS; Choe, J; Kim, YM; Jeoung, D				Kwon, Yoojung; Kim, Youngmi; Eom, Sangkyung; Kim, Misun; Park, Deokbum; Kim, Hyuna; Noh, Kyeonga; Lee, Hansoo; Lee, Yun Sil; Choe, Jongseon; Kim, Young Myeong; Jeoung, Dooil			MicroRNA-26a/-26b-COX-2-MIP-2 Loop Regulates Allergic Inflammation and Allergic Inflammation-promoted Enhanced Tumorigenic and Metastatic Potential of Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSITIVE FEEDBACK RELATIONSHIP; AIRWAY INFLAMMATION; PULMONARY INFLAMMATION; EXPERIMENTAL ASTHMA; LUNG INFLAMMATION; SKIN INFLAMMATION; COX-2 EXPRESSION; TUMOR-METASTASIS; MURINE MODEL; MAST-CELLS	Cyclooxgenase-2 (COX-2) knock-out mouse experiments showed that COX-2 was necessary for in vivo allergic inflammation, such as passive cutaneous anaphylaxis, passive systemic anaphylaxis, and triphasic cutaneous allergic reaction. Target-Scan analysis predicted COX-2 as a target of miR-26a and miR-26b. miR-26a/-26b decreased luciferase activity associated with COX-2-3' -UTR. miR-26a/-26b exerted negative effects on the features of in vitro and in vivo allergic inflammation by targeting COX-2. ChIP assays showed the binding of HDAC3 and SNAIL, but not COX-2, to the promoter sequences of miR-26a and miR-26b. Cytokine array analysis showed that the induction of chemokines, such as MIP-2, in the mouse passive systemic anaphylaxis model occurred in a COX-2-dependent manner. ChIP assays showed the binding of HDAC3 and COX-2 to the promoter sequences of MIP-2. In vitro and in vivo allergic inflammation was accompanied by the increased expression of MIP-2. miR-26a/-26b negatively regulated the expression of MIP-2. Allergic inflammation enhanced the tumorigenic and metastatic potential of cancer cells and induced positive feedback involving cancer cells and stromal cells, such as mast cells, macrophages, and endothelial cells. miR-26a mimic and miR-26b mimic negatively regulated the positive feedback between cancer cells and stromal cells and the positive feedback among stromal cells. miR-26a/-26b negatively regulated the enhanced tumorigenic potential by allergic inflammation. COX-2 was necessary for the enhanced metastatic potential of cancer cells by allergic inflammation. Taken together, our results indicate that the miR26a/-26b-COX-2-MIP-2 loop regulates allergic inflammation and the feedback relationship between allergic inflammation and the enhanced tumorigenic and metastatic potential.	[Kwon, Yoojung; Kim, Youngmi; Eom, Sangkyung; Kim, Misun; Park, Deokbum; Kim, Hyuna; Noh, Kyeonga; Jeoung, Dooil] Kangwon Natl Univ, Dept Biochem, Coll Nat Sci, Chunchon 200701, South Korea; [Lee, Hansoo] Kangwon Natl Univ, Dept Biol Sci, Coll Nat Sci, Chunchon 200701, South Korea; [Choe, Jongseon; Kim, Young Myeong] Kangwon Natl Univ, Grad Sch Med, Coll Nat Sci, Chunchon 200701, South Korea; [Lee, Yun Sil] Ewha Womans Univ, Coll Pharm, Seoul 120750, South Korea	Kangwon National University; Kangwon National University; Kangwon National University; Ewha Womans University	Jeoung, D (corresponding author), Kangwon Natl Univ, Dept Biochem, Coll Nat Sci, Chunchon 200701, South Korea.	jeoungd@kangwon.ac.kr	Lee, Yun-Sil/AAP-1378-2020	Lee, Yun-Sil/0000-0002-7538-8850	National Research Foundation [2014R1A2A2A01002448]; BK21 Plus Program; National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea [1320160]; Kangwon National University	National Research Foundation; BK21 Plus Program; National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea; Kangwon National University	This work was supported by National Research Foundation Grant 2014R1A2A2A01002448; a grant from the BK21 Plus Program; and National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea Grant 1320160. This work was also supported by a grant from Kangwon National University.	Ano S, 2013, J IMMUNOL, V190, P1056, DOI 10.4049/jimmunol.1202386; Aung HT, 2006, FASEB J, V20, P1315, DOI 10.1096/fj.05-5360com; Barrett EG, 1999, AM J PHYSIOL-LUNG C, V276, pL979, DOI 10.1152/ajplung.1999.276.6.L979; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Cao DS, 2007, AM J RESP CELL MOL, V37, P232, DOI 10.1165/rcmb.2006-0449OC; Church RJ, 2012, J IMMUNOL, V188, P4093, DOI 10.4049/jimmunol.1101873; Collison A, 2011, J ALLERGY CLIN IMMUN, V128, P160, DOI 10.1016/j.jaci.2011.04.005; Davaatseren M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102975; De Filippo K, 2013, BLOOD, V121, P4930, DOI 10.1182/blood-2013-02-486217; Dohadwala M, 2006, CANCER RES, V66, P5338, DOI 10.1158/0008-5472.CAN-05-3635; Eom S, 2014, J BIOL CHEM, V289, P29483, DOI 10.1074/jbc.M114.603480; Eom S, 2014, J BIOL CHEM, V289, P12126, DOI 10.1074/jbc.M113.521245; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fogli LK, 2013, J IMMUNOL, V191, P3100, DOI 10.4049/jimmunol.1301360; Hoh BL, 2011, CIRCULATION, V124, P2243, DOI 10.1161/CIRCULATIONAHA.111.036061; Huang WC, 2011, CELL CALCIUM, V50, P27, DOI 10.1016/j.ceca.2011.04.004; Ito W, 2005, AM J RESP CELL MOL, V32, P268, DOI 10.1165/rcmb.2004-0058OC; Jeon CM, 2014, INT IMMUNOPHARMACOL, V22, P414, DOI 10.1016/j.intimp.2014.07.013; Kim Y, 2008, MOL IMMUNOL, V45, P2537, DOI 10.1016/j.molimm.2008.01.008; Kim Y, 2012, J BIOL CHEM, V287, P25844, DOI 10.1074/jbc.M112.348284; Kim Y, 2011, MOL IMMUNOL, V48, P1035, DOI 10.1016/j.molimm.2011.01.013; Kim Y, 2010, MOL IMMUNOL, V47, P1010, DOI 10.1016/j.molimm.2009.11.017; Lappalainen U, 2005, AM J RESP CELL MOL, V32, P311, DOI 10.1165/rcmb.2004-0309OC; Li H, 2013, AM J RESP CRIT CARE, V187, P812, DOI 10.1164/rccm.201211-2073OC; Maeda K, 2010, J IMMUNOL, V185, P4252, DOI 10.4049/jimmunol.1001228; de Lima FM, 2010, PHOTOMED LASER SURG, V28, P763, DOI 10.1089/pho.2009.2638; Mahmutovic-Persson I, 2014, ALLERGY, V69, P348, DOI 10.1111/all.12329; Mattes J, 2009, P NATL ACAD SCI USA, V106, P18704, DOI 10.1073/pnas.0905063106; McKinley L, 2005, CYTOKINE, V32, P178, DOI 10.1016/j.cyto.2005.09.006; Morin C, 2013, CLIN EXP ALLERGY, V43, P1071, DOI 10.1111/cea.12162; Na YR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063451; Nagarkar DR, 2009, J IMMUNOL, V183, P6698, DOI 10.4049/jimmunol.0900298; Olivera A, 2013, IMMUNOL LETT, V150, P89, DOI 10.1016/j.imlet.2013.01.005; Passos GF, 2013, EUR J PHARMACOL, V698, P413, DOI 10.1016/j.ejphar.2012.10.019; Polikepahad S, 2010, J BIOL CHEM, V285, P30139, DOI 10.1074/jbc.M110.145698; Rebane A, 2014, J ALLERGY CLIN IMMUN, V134, P836, DOI 10.1016/j.jaci.2014.05.022; Reuter S, 2012, J IMMUNOL, V188, P5123, DOI 10.4049/jimmunol.1101618; Rose CE, 2010, CELL MOL IMMUNOL, V7, P361, DOI 10.1038/cmi.2010.31; Shi CZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066814; Shiraishi Y, 2008, J IMMUNOL, V180, P541, DOI 10.4049/jimmunol.180.1.541; Starkhammar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104114; Tengroth L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098239; Wang B, 2011, DIABETES, V60, P280, DOI 10.2337/db10-0892; Wang Q, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002070; Wei J, 2014, FREE RADICAL BIO MED, V67, P91, DOI 10.1016/j.freeradbiomed.2013.10.811; Wu F, 2008, GASTROENTEROLOGY, V135, P1624, DOI 10.1053/j.gastro.2008.07.068; Wu ZL, 2014, J IMMUNOL, V192, P5130, DOI 10.4049/jimmunol.1301677; Xiang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098139; Xu KM, 2013, MOL CANCER RES, V11, P875, DOI 10.1158/1541-7786.MCR-12-0706; Yadav UCS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057442; Yadav UCS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006535; Yamada Y, 2014, BIOCHEM BIOPH RES CO, V443, P980, DOI 10.1016/j.bbrc.2013.12.078; Yang M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097537; Yang X, 2014, HEPATOLOGY, V59, P1874, DOI 10.1002/hep.26941	54	49	51	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					14245	14266		10.1074/jbc.M115.645580	http://dx.doi.org/10.1074/jbc.M115.645580			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25907560	Green Published, hybrid			2022-12-28	WOS:000355313000051
J	Wang, JY; Kuryatov, A; Sriram, A; Jin, Z; Kamenecka, TM; Kenny, PJ; Lindstrom, J				Wang, Jingyi; Kuryatov, Alexander; Sriram, Aarati; Jin, Zhuang; Kamenecka, Theodore M.; Kenny, Paul J.; Lindstrom, Jon			An Accessory Agonist Binding Site Promotes Activation of alpha 4 beta 2*Nicotinic Acetylcholine Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSITIVE ALLOSTERIC MODULATOR; BETA 2; NS9283; POTENTIATION; SUBUNIT; STOICHIOMETRY; MECHANISM; INSIGHTS; DOMAIN	Neuronal nicotinic acetylcholine receptors containing alpha 4, beta 2, and sometimes other subunits (alpha 4 beta 2* nAChRs) regulate addictive and other behavioral effects of nicotine. These nAChRs exist in several stoichiometries, typically with two high affinity acetylcholine (ACh) binding sites at the interface of alpha 4 and beta 2 subunits and a fifth accessory subunit. A third low affinity ACh binding site is formed when this accessory subunit is alpha 4 but not if it is beta 2. Agonists selective for the accessory ACh site, such as 3-[3-(3-pyridyl)-1,2,4-oxadiazol-5-yl]benzonitrile (NS9283), cannot alone activate a nAChR but can facilitate more efficient activation in combination with agonists at the canonical alpha 4 beta 2 sites. We therefore suggest categorizing agonists according to their site selectivity. NS9283 binds to the accessory ACh binding site; thus it is termed an accessory site-selective agonist. We expressed (alpha 4 beta 2)(2) concatamers in Xenopus oocytes with free accessory subunits to obtain defined nAChR stoichiometries and alpha 4/accessory subunit interfaces. We show that alpha 2, alpha 3, alpha 4, and alpha 6 accessory subunits can form binding sites for ACh and NS9283 at interfaces with alpha 4 subunits, but beta 2 and beta 4 accessory subunits cannot. To permit selective blockage of the accessory site, alpha 4 threonine 126 located on the minus side of alpha 4 that contributes to the accessory site, but not the alpha 4 beta 2 sites, was mutated to cysteine. Alkylation of this cysteine with a thioreactive reagent blocked activity of ACh and NS9283 at the accessory site. Accessory agonist binding sites are promising drug targets.	[Wang, Jingyi; Kuryatov, Alexander; Sriram, Aarati; Lindstrom, Jon] Univ Penn, Perelman Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; [Jin, Zhuang; Kamenecka, Theodore M.] Scripps Res Inst, Dept Mol Therapeut, Scripps, FL 33458 USA; [Kenny, Paul J.] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA	University of Pennsylvania; Pennsylvania Medicine; Icahn School of Medicine at Mount Sinai	Lindstrom, J (corresponding author), Univ Penn, Perelman Sch Med, Dept Neurosci, 217 Stemmler Hall, Philadelphia, PA 19104 USA.	JSLKK@mail.med.upenn.edu	Regan, Clinton/E-6250-2012; WANG, JINGYI/GSJ-1241-2022; wang, jing/GRS-7509-2022		National Institutes of Health [DA030929]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030929] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant DA030929.	Andersen N, 2013, P NATL ACAD SCI USA, V110, P20819, DOI 10.1073/pnas.1315775110; Campling BG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079653; Eaton JB, 2014, J PHARMACOL EXP THER, V348, P46, DOI 10.1124/jpet.113.208389; Gaimarri A, 2007, BRAIN RES REV, V55, P134, DOI 10.1016/j.brainresrev.2007.02.005; Gerzanich V, 1997, MOL PHARMACOL, V51, P320, DOI 10.1124/mol.51.2.320; Gill JK, 2011, P NATL ACAD SCI USA, V108, P5867, DOI 10.1073/pnas.1017975108; Gill-Thind JK, 2015, J BIOL CHEM, V290, P3552, DOI 10.1074/jbc.M114.619221; Grupe M, 2013, BRIT J PHARMACOL, V168, P2000, DOI 10.1111/bph.12095; Grupe M, 2015, BASIC CLIN PHARMACOL, V116, P187, DOI 10.1111/bcpt.12361; Grupe M, 2014, NEUROPHARMACOLOGY, V79, P444, DOI 10.1016/j.neuropharm.2013.12.008; Grupe M, 2013, BIOCHEM PHARMACOL, V86, P1487, DOI 10.1016/j.bcp.2013.09.005; Han ZY, 2000, EUR J NEUROSCI, V12, P3664, DOI 10.1046/j.1460-9568.2000.00262.x; Harpsoe K, 2011, J NEUROSCI, V31, P10759, DOI 10.1523/JNEUROSCI.1509-11.2011; Hibbs RE, 2009, EMBO J, V28, P3040, DOI 10.1038/emboj.2009.227; Jin Z, 2014, BIOORG MED CHEM LETT, V24, P674, DOI 10.1016/j.bmcl.2013.11.049; Kaitin KI, 2010, CLIN PHARMACOL THER, V87, P356, DOI 10.1038/clpt.2009.293; Kuryatov A, 1997, J NEUROSCI, V17, P9035; Kuryatov A, 2005, MOL PHARMACOL, V68, P1839, DOI 10.1124/mol.105.012419; Kuryatov A, 2011, MOL PHARMACOL, V79, P119, DOI 10.1124/mol.110.066357; Lee CH, 2011, BIOCHEM PHARMACOL, V82, P959, DOI 10.1016/j.bcp.2011.06.044; Li SX, 2011, NAT NEUROSCI, V14, P1253, DOI 10.1038/nn.2908; Marotta CB, 2014, ACS CHEM BIOL, V9, P1153, DOI 10.1021/cb400937d; Mazzaferro S, 2014, J BIOL CHEM, V289, P21795, DOI 10.1074/jbc.M114.555136; Mazzaferro S, 2011, J BIOL CHEM, V286, P31043, DOI 10.1074/jbc.M111.262014; McIntosh JM, 2004, MOL PHARMACOL, V65, P944, DOI 10.1124/mol.65.4.944; Millar NS, 2009, NEUROPHARMACOLOGY, V56, P237, DOI 10.1016/j.neuropharm.2008.07.041; Mohler EG, 2014, PSYCHOPHARMACOLOGY, V231, P67, DOI 10.1007/s00213-013-3207-5; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; Olsen JA, 2014, J BIOL CHEM, V289, P24911, DOI 10.1074/jbc.M114.568097; Olsen JA, 2013, J BIOL CHEM, V288, P35997, DOI 10.1074/jbc.M113.498618; Papke RL, 2011, NEUROPHARMACOLOGY, V60, P159, DOI 10.1016/j.neuropharm.2010.07.014; Papke RL, 2010, METHODS, V51, P121, DOI 10.1016/j.ymeth.2010.01.012; Paradiso K, 2001, J NEUROSCI, V21, P6561, DOI 10.1523/JNEUROSCI.21-17-06561.2001; Rayes D, 2009, J NEUROSCI, V29, P6022, DOI 10.1523/JNEUROSCI.0627-09.2009; Rode F, 2012, BRAIN RES, V1458, P67, DOI 10.1016/j.brainres.2012.03.064; Rudolph U, 2011, NAT REV DRUG DISCOV, V10, P685, DOI 10.1038/nrd3502; Shen HB, 2007, BIOCHEM BIOPH RES CO, V363, P297, DOI 10.1016/j.bbrc.2007.08.140; Sigel E, 2012, J BIOL CHEM, V287, P40224, DOI 10.1074/jbc.R112.386664; Timmermann DB, 2012, BRIT J PHARMACOL, V167, P164, DOI 10.1111/j.1476-5381.2012.01989.x; Turner JR, 2005, J NEUROSCI, V25, P9258, DOI 10.1523/JNEUROSCI.2112-05.2005; Wang F, 1996, J BIOL CHEM, V271, P17656, DOI 10.1074/jbc.271.30.17656; Wang F, 1998, J BIOL CHEM, V273, P28721, DOI 10.1074/jbc.273.44.28721; Wang J, 2015, NEUROPHARMACOLOGY, V96, P194, DOI 10.1016/j.neuropharm.2014.10.009; Williams DK, 2011, BIOCHEM PHARMACOL, V82, P915, DOI 10.1016/j.bcp.2011.05.001; Williams DK, 2011, J GEN PHYSIOL, V137, P369, DOI 10.1085/jgp.201010587; Zhou Y, 2003, J NEUROSCI, V23, P9004; Zhu CZ, 2011, BIOCHEM PHARMACOL, V82, P967, DOI 10.1016/j.bcp.2011.05.007; Zwart R, 1998, MOL PHARMACOL, V54, P1124, DOI 10.1124/mol.54.6.1124	48	33	33	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13907	13918		10.1074/jbc.M115.646786	http://dx.doi.org/10.1074/jbc.M115.646786			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25869137	hybrid, Green Published			2022-12-28	WOS:000355313000023
J	Zhong, WW; Cui, NR; Jin, X; Oginsky, MF; Wu, Y; Zhang, S; Bondy, B; Johnson, CM; Jiang, C				Zhong, Weiwei; Cui, Ningren; Jin, Xin; Oginsky, Max F.; Wu, Yang; Zhang, Shuang; Bondy, Brian; Johnson, Christopher M.; Jiang, Chun			Methyl CpG Binding Protein 2 Gene Disruption Augments Tonic Currents of gamma-Aminobutyric Acid Receptors in Locus Coeruleus Neurons IMPACT ON NEURONAL EXCITABILITY AND BREATHING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRASYNAPTIC GABA(A) RECEPTORS; MOUSE MODEL; CO2 CHEMOSENSITIVITY; RETT-SYNDROME; BRAIN-STEM; WILD-TYPE; INHIBITION; MECP2; MODULATION; MICE	People with Rett syndrome and mouse models show autonomic dysfunction involving the brain stem locus coeruleus (LC). Neurons in the LC of Mecp2-null mice are overly excited, likely resulting from a defect in neuronal intrinsic membrane properties and a deficiency in GABA synaptic inhibition. In addition to the synaptic GABA receptors, there is a group of GABA(A) receptors (GABA(A)Rs) that is located extrasynaptically and mediates tonic inhibition. Here we show evidence for augmentation of the extrasynaptic GABA(A)Rs in Mecp2-null mice. In brain slices, exposure of LC neurons to GABA(A)R agonists increased tonic currents that were blocked by GABA(A)R antagonists. With 10 mu M GABA, the bicuculline-sensitive tonic currents were similar to 4-fold larger in Mecp2-null LC neurons than in the WT. Single-cell PCR analysis showed that the delta subunit, the principal subunit of extrasynaptic GABAARs, was present in LC neurons. Expression levels of the delta subunit were similar to 50% higher in Mecp2-null neurons than in the WT. Also increased in expression in Mecp2-null mice was another extrasynaptic GABAAR subunit, alpha 6, by similar to 4-fold. The delta subunit-selective agonists 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol hydrochloride and 4-chloro-N-[2-(2-thienyl)imidazo[1,2-a]pyridin-3-yl]]benzamide activated the tonic GABAA currents in LC neurons and reduced neuronal excitability to a greater degree in Mecp2-null mice than in the WT. Consistent with these findings, in vivo application of 4,5,6,7-tetrahydroisoxazolo[5,4-c] pyridin-3-ol hydrochloride alleviated breathing abnormalities of conscious Mecp2-null mice. These results suggest that extrasynaptic GABA(A)Rs seem to be augmented with Mecp2 disruption, which may be a compensatory response to the deficiency in GABAergic synaptic inhibition and allows control of neuronal excitability and breathing abnormalities.	[Zhong, Weiwei; Cui, Ningren; Jin, Xin; Oginsky, Max F.; Wu, Yang; Zhang, Shuang; Bondy, Brian; Johnson, Christopher M.; Jiang, Chun] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University	Jiang, C (corresponding author), Georgia State Univ, Dept Biol, 100 Piedmont Ave, Atlanta, GA 30302 USA.	cjiang@gsu.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [R01-NS-073875]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073875] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-NS-073875.	Abdala APL, 2010, P NATL ACAD SCI USA, V107, P18208, DOI 10.1073/pnas.1012104107; BARRY MA, 1992, BIOCHEM BIOPH RES CO, V186, P782, DOI 10.1016/0006-291X(92)90814-2; Belelli D, 2009, J NEUROSCI, V29, P12757, DOI 10.1523/JNEUROSCI.3340-09.2009; Blatt GJ, 2001, J AUTISM DEV DISORD, V31, P537, DOI 10.1023/A:1013238809666; Blue ME, 1999, EXP NEUROL, V156, P345, DOI 10.1006/exnr.1999.7030; Boggio Elena M, 2010, Front Synaptic Neurosci, V2, P28, DOI 10.3389/fnsyn.2010.00028; Brickley SG, 2001, NATURE, V409, P88, DOI 10.1038/35051086; Brickley SG, 2012, NEURON, V73, P23, DOI 10.1016/j.neuron.2011.12.012; Bright DP, 2007, J NEUROSCI, V27, P2560, DOI 10.1523/JNEUROSCI.5100-06.2007; Brown N, 2002, BRIT J PHARMACOL, V136, P965, DOI 10.1038/sj.bjp.0704795; Calfa G, 2015, HIPPOCAMPUS, V25, P159, DOI 10.1002/hipo.22360; Calfa G, 2011, J NEUROPHYSIOL, V105, P1768, DOI 10.1152/jn.00800.2010; Caro AA, 2002, J BIOL CHEM, V277, P104, DOI 10.1074/jbc.M107864200; Carver CM, 2014, J NEUROSCI, V34, P14181, DOI 10.1523/JNEUROSCI.0596-14.2014; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Clarkson AN, 2010, NATURE, V468, P305, DOI 10.1038/nature09511; Cui NR, 2011, J NEUROPHYSIOL, V105, P2791, DOI 10.1152/jn.00759.2010; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Drasbek KR, 2007, J NEUROPHYSIOL, V97, P2293, DOI 10.1152/jn.00651.2006; El-Khoury R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092169; Evers DM, 2010, NAT NEUROSCI, V13, P1199, DOI 10.1038/nn.2624; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Fatemi SH, 2009, J AUTISM DEV DISORD, V39, P223, DOI 10.1007/s10803-008-0646-7; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Ferando I, 2012, EPILEPSIA, V53, P89, DOI 10.1111/epi.12038; Fleming RL, 2007, J NEUROPHYSIOL, V97, P3806, DOI 10.1152/jn.00101.2007; Glykys J, 2006, J NEUROPHYSIOL, V95, P2796, DOI 10.1152/jn.01122.2005; Hamann M, 2002, NEURON, V33, P625, DOI 10.1016/S0896-6273(02)00593-7; Hanchar HJ, 2005, NAT NEUROSCI, V8, P339, DOI 10.1038/nn1398; Ide S, 2005, NEUROSCI LETT, V386, P14, DOI 10.1016/j.neulet.2005.05.056; Jin XT, 2013, AM J PHYSIOL-CELL PH, V305, pC1080, DOI 10.1152/ajpcell.00109.2013; Jin X, 2013, AM J PHYSIOL-CELL PH, V305, pC1151, DOI 10.1152/ajpcell.00195.2013; Jin X, 2013, AM J PHYSIOL-CELL PH, V304, pC844, DOI 10.1152/ajpcell.00399.2012; Lioy DT, 2011, AUTON NEUROSCI-BASIC, V161, P55, DOI 10.1016/j.autneu.2011.01.006; Maguire EP, 2014, J NEUROSCI, V34, P823, DOI 10.1523/JNEUROSCI.3232-13.2014; Maguire J, 2009, J NEUROSCI, V29, P9592, DOI 10.1523/JNEUROSCI.2162-09.2009; Medrihan L, 2008, J NEUROPHYSIOL, V99, P112, DOI 10.1152/jn.00826.2007; Moretti P, 2006, J NEUROSCI, V26, P319, DOI 10.1523/JNEUROSCI.2623-05.2006; Mortensen M, 2010, J PHYSIOL-LONDON, V588, P1251, DOI 10.1113/jphysiol.2009.182444; Na ES, 2011, HORM BEHAV, V59, P364, DOI 10.1016/j.yhbeh.2010.05.014; Oginsky MF, 2014, AM J PHYSIOL-CELL PH, V307, pC508, DOI 10.1152/ajpcell.00035.2014; Patel B, 2014, BRIT J PHARMACOL, V171, P985, DOI 10.1111/bph.12514; Porcello DM, 2003, J NEUROPHYSIOL, V89, P1378, DOI 10.1152/jn.00899.2002; Prenosil GA, 2006, J NEUROPHYSIOL, V96, P846, DOI 10.1152/jn.01199.2006; Robinson L, 2012, BRAIN, V135, P2699, DOI 10.1093/brain/aws096; Roux JC, 2010, J NEUROSCI RES, V88, P1500, DOI 10.1002/jnr.22312; Samaco RC, 2005, HUM MOL GENET, V14, P483, DOI 10.1093/hmg/ddi045; SHIVERS BD, 1989, NEURON, V3, P327, DOI 10.1016/0896-6273(89)90257-2; Sigel E, 2012, J BIOL CHEM, V287, P40224, DOI 10.1074/jbc.R112.386664; Smith SS, 2007, PHARMACOL THERAPEUT, V116, P58, DOI 10.1016/j.pharmthera.2007.03.008; Song IS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1377; Vardya I, 2008, J NEUROPHYSIOL, V100, P526, DOI 10.1152/jn.01224.2007; Viemari JC, 2005, J NEUROSCI, V25, P11521, DOI 10.1523/JNEUROSCI.4373-05.2005; Viemari JC, 2005, EUR J NEUROSCI, V22, P2403, DOI 10.1111/j.1460-9568.2005.04441.x; Voituron N, 2011, RESP PHYSIOL NEUROBI, V177, P56, DOI 10.1016/j.resp.2011.02.002; WHITE SR, 1991, PROG BRAIN RES, V88, P343; Wojtowicz AM, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00188; Yamashita Y, 1998, J NEUROL SCI, V154, P146, DOI 10.1016/S0022-510X(97)00223-2; Ye ZW, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00203; Zhang L, 2008, HIPPOCAMPUS, V18, P294, DOI 10.1002/hipo.20389; Zhang W, 2014, J NEUROSCI, V34, P2754, DOI 10.1523/JNEUROSCI.4900-12.2014; Zhang XL, 2011, AM J PHYSIOL-CELL PH, V301, pC729, DOI 10.1152/ajpcell.00334.2010; Zhang XL, 2010, BIOCHEM BIOPH RES CO, V394, P285, DOI 10.1016/j.bbrc.2010.02.156; Zhang XL, 2010, AM J PHYSIOL-CELL PH, V298, pC635, DOI 10.1152/ajpcell.00442.2009; ZOGHBI HY, 1985, NEW ENGL J MED, V313, P921, DOI 10.1056/NEJM198510103131504	66	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18400	18411		10.1074/jbc.M115.650465	http://dx.doi.org/10.1074/jbc.M115.650465			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	25979331	Green Published, hybrid			2022-12-28	WOS:000358512100013
J	Garcia-Marquez, A; Gijsbers, A; de la Mora, E; Sanchez-Puig, N				Garcia-Marquez, Adrian; Gijsbers, Abril; de la Mora, Eugenio; Sanchez-Puig, Nuria			Defective Guanine Nucleotide Exchange in the Elongation Factor-like 1 (EFL1) GTPase by Mutations in the Shwachman-Diamond Syndrome Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							60S RIBOSOMAL-SUBUNIT; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; TRANSFER-RNA; FACTOR SELB; P-SITE; RELEASE; BINDING; COMPLEX; DOMAIN	Ribosome biogenesis is orchestrated by the action of several accessory factors that provide time and directionality to the process. One such accessory factor is the GTPase EFL1 involved in the cytoplasmic maturation of the ribosomal 60S subunit. EFL1 and SBDS, the protein mutated in the Shwachman-Diamond syndrome (SBDS), release the anti-association factor eIF6 from the surface of the ribosomal subunit 60S. Here we report a kinetic analysis of fluorescent guanine nucleotides binding to EFL1 alone and in the presence of SBDS using fluorescence stopped-flow spectroscopy. Binding kinetics of EFL1 to both GDP and GTP suggests a two-step mechanism with an initial binding event followed by a conformational change of the complex. Furthermore, the same behavior was observed in the presence of the SBDS protein irrespective of the guanine nucleotide evaluated. The affinity of EFL1 for GTP is 10-fold lower than that calculated for GDP. Association of EFL1 to SBDS did not modify the affinity for GTP but dramatically decreased that for GDP by increasing the dissociation rate of the nucleotide. Thus, SBDS acts as a guanine nucleotide exchange factor (GEF) for EFL1 promoting its activation by the release of GDP. Finally, fluorescence anisotropy measurements showed that the S143L mutation present in the Shwachman-Diamond syndrome altered a surface epitope for EFL1 and largely decreased the affinity for it. These results suggest that loss of interaction between these proteins due to mutations in the disease consequently prevents the nucleotide exchange regulation the SBDS exerts on EFL1.	[Garcia-Marquez, Adrian; Gijsbers, Abril; de la Mora, Eugenio; Sanchez-Puig, Nuria] Univ Nacl Autonoma Mexico, Inst Quim, Dept Quim Biomacromol, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Sanchez-Puig, N (corresponding author), Univ Nacl Autonoma Mexico, Inst Quim, Dept Quim Biomacromol, Circuito Exterior S-N, Mexico City 04510, DF, Mexico.	nuriasp@unam.mx		Gijsbers, Abril/0000-0001-6622-3686; de la Mora, Eugenio/0000-0001-6945-7357; Sanchez Puig, Nuria/0000-0002-8945-7001	Universidad Nacional Autonoma de Mexico, Direccion General de Asuntos del Personal Academico; Consejo Nacional de Ciencia y Tecnologia [166472, 167359]	Universidad Nacional Autonoma de Mexico, Direccion General de Asuntos del Personal Academico(Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Supported by a postdoctoral fellowship from Universidad Nacional Autonoma de Mexico, Direccion General de Asuntos del Personal Academico.; Supported by Consejo Nacional de Ciencia y Tecnologia Projects 166472 and 167359.	ARAI KI, 1972, J BIOL CHEM, V247, P7029; Asano N, 2014, BIOCHEM BIOPH RES CO, V443, P1251, DOI 10.1016/j.bbrc.2013.12.143; Boocock GRB, 2003, NAT GENET, V33, P97, DOI 10.1038/ng1062; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Bussiere C, 2012, J CELL BIOL, V197, P747, DOI 10.1083/jcb.201112131; Ceci M, 2003, NATURE, V426, P579, DOI 10.1038/nature02160; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; des Georges A, 2014, NUCLEIC ACIDS RES, V42, P3409, DOI 10.1093/nar/gkt1279; Eccleston JF, 2008, METHOD CELL BIOL, V84, P445, DOI 10.1016/S0091-679X(07)84015; ENGELBORGHS Y, 1987, J BIOL CHEM, V262, P5204; Finch AJ, 2011, GENE DEV, V25, P917, DOI 10.1101/gad.623011; Fischer JJ, 2012, BIOCHIMIE, V94, P1647, DOI 10.1016/j.biochi.2012.04.016; Gijsbers A, 2013, BIOCHEM BIOPH RES CO, V437, P349, DOI 10.1016/j.bbrc.2013.06.077; Graindorge JS, 2005, J MOL BIOL, V352, P355, DOI 10.1016/j.jmb.2005.07.037; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Hauryliuk V, 2006, BIOCHIMIE, V88, P747, DOI 10.1016/j.biochi.2006.06.001; Klinge S, 2011, SCIENCE, V334, P941, DOI 10.1126/science.1211204; Kressler D, 2010, BBA-MOL CELL RES, V1803, P673, DOI 10.1016/j.bbamcr.2009.10.009; Lo KY, 2010, MOL CELL, V39, P196, DOI 10.1016/j.molcel.2010.06.018; McCann KL, 2013, SCIENCE, V341, P849, DOI 10.1126/science.1244156; Menne TF, 2007, NAT GENET, V39, P486, DOI 10.1038/ng1994; Moser C, 1997, P NATL ACAD SCI USA, V94, P11339, DOI 10.1073/pnas.94.21.11339; Nakamura Y, 1996, CELL, V87, P147, DOI 10.1016/S0092-8674(00)81331-8; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Paleskava A, 2012, J BIOL CHEM, V287, P27906, DOI 10.1074/jbc.M112.366120; Paleskava A, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.081380; Pisareva VP, 2006, J BIOL CHEM, V281, P40224, DOI 10.1074/jbc.M607461200; Senger B, 2001, MOL CELL, V8, P1363, DOI 10.1016/S1097-2765(01)00403-8; Shammas C, 2005, J BIOL CHEM, V280, P19221, DOI 10.1074/jbc.M414656200; Teng T, 2013, CURR OPIN GENET DEV, V23, P63, DOI 10.1016/j.gde.2013.02.001; Thomson E, 2013, J CELL SCI, V126, P4815, DOI 10.1242/jcs.111948; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Wilden B, 2006, P NATL ACAD SCI USA, V103, P13670, DOI 10.1073/pnas.0606099103; Wittinghofer A, 2011, ANNU REV BIOCHEM, V80, P943, DOI 10.1146/annurev-biochem-062708-134043; Woolford JL, 2013, GENETICS, V195, P643, DOI 10.1534/genetics.113.153197; Zhou J, 2014, SCIENCE, V345, P1188, DOI 10.1126/science.1255030	38	19	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					17669	17678		10.1074/jbc.M114.626275	http://dx.doi.org/10.1074/jbc.M114.626275			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	25991726	Green Published, hybrid			2022-12-28	WOS:000358511700003
J	Shir-Shapira, H; Sharabany, J; Filderman, M; Ideses, D; Ovadia-Shochat, A; Mannervik, M; Juven-Gershon, T				Shir-Shapira, Hila; Sharabany, Julia; Filderman, Matan; Ideses, Diana; Ovadia-Shochat, Avital; Mannervik, Mattias; Juven-Gershon, Tamar			Structure-Function Analysis of the Drosophila melanogaster Caudal Transcription Factor Provides Insights into Core Promoter-preferential Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREB-BINDING PROTEIN; GAP GENE GIANT; HOX GENE; OVERLAPPING FUNCTIONS; POSTERIOR AXIS; TATA-BOX; EXPRESSION; RNA; CDX2; GRADIENT	Regulation of RNA polymerase II transcription is critical for the proper development, differentiation, and growth of an organism. The RNA polymerase II core promoter is the ultimate target of a multitude of transcription factors that control transcription initiation. Core promoters encompass the RNA start site and consist of functional elements such as the TATA box, initiator, and downstream core promoter element (DPE), which confer specific properties to the core promoter. We have previously discovered that Drosophila Caudal, which is a master regulator of genes involved in development and differentiation, is a DPE-specific transcriptional activator. Here, we show that the mouse Caudal-related homeobox (Cdx) proteins (mCdx1, mCdx2, and mCdx4) are also preferential core promoter transcriptional activators. To elucidate the mechanism that enables Caudal to preferentially activate DPE transcription, we performed structure-function analysis. Using a systematic series of deletion mutants (all containing the intact DNA-binding homeodomain) we discovered that the C-terminal region of Caudal contributes to the preferential activation of the fushi tarazu (ftz) Caudal target gene. Furthermore, the region containing both the homeodomain and the C terminus of Caudal was sufficient to confer core promoter-preferential activation to the heterologous GAL4 DNA-binding domain. Importantly, we discovered that Drosophila CREB-binding protein (dCBP) is a co-activator for Caudal-regulated activation of ftz. Strikingly, dCBP conferred the ability to preferentially activate the DPE-dependent ftz reporter to mini-Caudal proteins that were unable to preferentially activate ftz transcription themselves. Taken together, it is the unique combination of dCBP and Caudal that enables the co-activation of ftz in a core promoter-preferential manner.	[Shir-Shapira, Hila; Sharabany, Julia; Filderman, Matan; Ideses, Diana; Ovadia-Shochat, Avital; Juven-Gershon, Tamar] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel; [Mannervik, Mattias] Stockholm Univ, Dev Biol, Wenner Gren Inst, Arrhenius Labs E3, SE-10691 Stockholm, Sweden	Bar Ilan University; Stockholm University	Juven-Gershon, T (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel.	tamar.gershon@biu.ac.il	Juven-Gershon, Tamar/AAC-7799-2022	Juven-Gershon, Tamar/0000-0003-2607-5476; Mannervik, Mattias/0000-0003-4999-9655	Israel Science Foundation [798/10]; European Union Seventh Framework Programme (Marie Curie International Reintegration Grant) [256491]; United States-Israel Binational Science Foundation [2009428]	Israel Science Foundation(Israel Science Foundation); European Union Seventh Framework Programme (Marie Curie International Reintegration Grant); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation)	This work was supported by Israel Science Foundation Grant 798/10 (to T. J.-G) and the European Union Seventh Framework Programme (Marie Curie International Reintegration Grant 256491 to T. J.-G.). The analysis of the transcriptional activity of Bicoid was supported by United States-Israel Binational Science Foundation Grant 2009428 (to T. J.-G. and James T. Kadonaga). The authors declare that they have no conflicts of interest with the contents of this article.	Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Burke TW, 1996, GENE DEV, V10, P711, DOI 10.1101/gad.10.6.711; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Chalkley GE, 1999, EMBO J, V18, P4835, DOI 10.1093/emboj/18.17.4835; Charite J, 1998, DEVELOPMENT, V125, P4349; Chawengsaksophak K, 2004, P NATL ACAD SCI USA, V101, P7641, DOI 10.1073/pnas.0401654101; Chawengsaksophak K, 1997, NATURE, V386, P84, DOI 10.1038/386084a0; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Copf T, 2004, P NATL ACAD SCI USA, V101, P17711, DOI 10.1073/pnas.0407327102; Davidson AJ, 2003, NATURE, V425, P300, DOI 10.1038/nature01973; Davidson AJ, 2006, DEV BIOL, V292, P506, DOI 10.1016/j.ydbio.2006.01.003; De Guzman RN, 2005, BIOCHEMISTRY-US, V44, P490, DOI 10.1021/bi048161t; DEAROLF CR, 1989, NATURE, V341, P340, DOI 10.1038/341340a0; Dikstein R, 2011, TRANSCR-AUSTIN, V2, P201, DOI 10.4161/trns.2.5.17271; Edgar LG, 2001, DEV BIOL, V229, P71, DOI 10.1006/dbio.2000.9977; ELDON ED, 1991, DEVELOPMENT, V111, P367; EMAMI KH, 1995, MOL CELL BIOL, V15, P5906; Epstein M, 1997, DEVELOPMENT, V124, P3805; Faas L, 2009, DEV DYNAM, V238, P835, DOI 10.1002/dvdy.21901; FitzGerald PC, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r53; Flores MVC, 2008, GASTROENTEROLOGY, V135, P1665, DOI 10.1053/j.gastro.2008.07.024; Fu DC, 2005, NUCLEIC ACIDS RES, V33, P3985, DOI 10.1093/nar/gki691; Fu DC, 2004, J BIOL CHEM, V279, P48725, DOI 10.1074/jbc.M407066200; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Gershenzon NI, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-161; GOLDBERG ML, 1979, THESIS STANFORD U; Grainger S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054757; Grainger S, 2010, DEV BIOL, V339, P155, DOI 10.1016/j.ydbio.2009.12.025; Heintzman ND, 2007, CELL MOL LIFE SCI, V64, P386, DOI 10.1007/s00018-006-6295-0; HOEY T, 1986, P NATL ACAD SCI USA, V83, P4809, DOI 10.1073/pnas.83.13.4809; Holmqvist PH, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002769; Hunter CP, 1996, CELL, V87, P217, DOI 10.1016/S0092-8674(00)81340-9; Hussain MA, 1999, J BIOL CHEM, V274, P28950, DOI 10.1074/jbc.274.41.28950; Juven-Gershon T, 2008, GENE DEV, V22, P2823, DOI 10.1101/gad.1698108; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; Juven-Gershon T, 2010, DEV BIOL, V339, P225, DOI 10.1016/j.ydbio.2009.08.009; Kadonaga JT, 2012, WIRES DEV BIOL, V1, P40, DOI 10.1002/wdev.21; Kedmi A, 2014, GENE DEV, V28, P2163, DOI 10.1101/gad.245670.114; KRAUT R, 1991, DEVELOPMENT, V111, P601; Kutach AK, 2000, MOL CELL BIOL, V20, P4754, DOI 10.1128/MCB.20.13.4754-4764.2000; Lafontaine CA, 2012, BIOCHEMISTRY-US, V51, P9698, DOI 10.1021/bi301241q; Lagha M, 2012, TRENDS GENET, V28, P409, DOI 10.1016/j.tig.2012.03.006; Lenhard B, 2012, NAT REV GENET, V13, P233, DOI 10.1038/nrg3163; LEVINE M, 1985, COLD SPRING HARB SYM, V50, P209, DOI 10.1101/SQB.1985.050.01.027; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Levine M, 2005, P NATL ACAD SCI USA, V102, P4936, DOI 10.1073/pnas.0408031102; Levine M, 2014, CELL, V157, P13, DOI 10.1016/j.cell.2014.02.009; Lim CY, 2004, GENE DEV, V18, P1606, DOI 10.1101/gad.1193404; Lohnes D, 2003, BIOESSAYS, V25, P971, DOI 10.1002/bies.10340; Ludlam WH, 2002, MOL CELL BIOL, V22, P3832, DOI 10.1128/MCB.22.11.3832-3841.2002; MacArthur S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r80; MACDONALD PM, 1986, NATURE, V324, P537, DOI 10.1038/324537a0; Marom K, 1997, MECH DEVELOP, V64, P41, DOI 10.1016/S0925-4773(97)00043-9; MEYER BI, 1993, DEVELOPMENT, V117, P191; MLODZIK M, 1990, DEVELOPMENT, V109, P271; MLODZIK M, 1987, CELL, V48, P465, DOI 10.1016/0092-8674(87)90197-8; MLODZIK M, 1985, EMBO J, V4, P2961, DOI 10.1002/j.1460-2075.1985.tb04030.x; Moreno E, 1999, NATURE, V400, P873, DOI 10.1038/23709; Ohler U., 2002, GENOME BIOL, V3, pRESEARCH0087, DOI [10.1186/gb-2002-3-12-research0087, DOI 10.1186/GB-2002-3-12-RESEARCH0087]; Ohler U, 2010, DEVELOPMENT, V137, P15, DOI 10.1242/dev.035493; Parry TJ, 2010, GENE DEV, V24, P2013, DOI 10.1101/gad.1951110; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Pilon N, 2007, DEVELOPMENT, V134, P2315, DOI 10.1242/dev.001206; Ponjavic J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r78; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Rawat VPS, 2012, BLOOD, V120, P519, DOI 10.1182/blood-2012-02-385898; Reeve JN, 2003, MOL MICROBIOL, V48, P587, DOI 10.1046/j.1365-2958.2003.03439.x; RIVERAPOMAR R, 1995, NATURE, V376, P253, DOI 10.1038/376253a0; Savory JGA, 2011, MECH DEVELOP, V128, P41, DOI 10.1016/j.mod.2010.09.004; Savory JGA, 2009, DEVELOPMENT, V136, P4099, DOI 10.1242/dev.041582; Savory JGA, 2009, DEV BIOL, V330, P114, DOI 10.1016/j.ydbio.2009.03.016; Sikorski TW, 2009, CURR OPIN CELL BIOL, V21, P344, DOI 10.1016/j.ceb.2009.03.006; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Smale ST, 2001, GENE DEV, V15, P2503, DOI 10.1101/gad.937701; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; SUBRAMANIAN V, 1995, CELL, V83, P641, DOI 10.1016/0092-8674(95)90104-3; Tee WW, 2014, DEVELOPMENT, V141, P2376, DOI 10.1242/dev.096982; Theisen JWM, 2010, MOL CELL BIOL, V30, P3471, DOI 10.1128/MCB.00053-10; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; van den Akker E, 2002, DEVELOPMENT, V129, P2181; van Nes J, 2006, DEVELOPMENT, V133, P419, DOI 10.1242/dev.02216; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Wang Y, 2008, P NATL ACAD SCI USA, V105, P7756, DOI 10.1073/pnas.0708951105; Wolff C, 1998, DEVELOPMENT, V125, P3645; Zehavi Y, 2014, J BIOL CHEM, V289, P11993, DOI 10.1074/jbc.M114.550251	88	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17293	17305		10.1074/jbc.M114.632109	http://dx.doi.org/10.1074/jbc.M114.632109			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26018075	Green Published, hybrid			2022-12-28	WOS:000357730900025
J	Nemoto, K; Takemori, N; Seki, M; Shinozaki, K; Sawasaki, T				Nemoto, Keiichirou; Takemori, Nobuaki; Seki, Motoaki; Shinozaki, Kazuo; Sawasaki, Tatsuya			Members of the Plant CRK Superfamily Are Capable of Trans- and Autophosphorylation of Tyrosine Residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; BRI1 RECEPTOR KINASE; BIOCHEMICAL-CHARACTERIZATION; SYNTHESIS SYSTEM; IN-VITRO; SIGNAL-TRANSDUCTION; PHOSPHORYLATION; STRESS; EXPRESSION; GENE	Protein phosphorylation on Tyr residues is a key post-translational modification in mammals. In plants, recent studies have identified Tyr-specific protein phosphatase and Tyr-phosphorylated proteins in Arabidopsis by phosphoproteomic screenings, implying that plants have a Tyr phosphorylation signal pathway. However, little is known about the protein kinases (PKs) involved in Tyr phosphorylation in plants. Here, we demonstrate that Arabidopsis calcium-dependent protein kinase (CDPK/CPK)-related PKs (CRKs) have high Tyr-autophosphorylation activity and that they can phosphorylate Tyr residue(s) on substrate proteins in Arabidopsis. To identify PKs for Tyr phosphorylation, we examined the autophosphorylation activity of 759 PKs using an Arabidopsis protein array based on a wheat cell-free system. In total, we identified 38 PKs with Tyr-autophosphorylation activity. The CRK family was a major protein family identified. A cell-free substrate screening revealed that these CRKs phosphorylate beta-tubulin (TBB) 2, TBB7, and certain transcription factors (TFs) such as ethylene response factor 13 (ERF13). All five CRKs tested showed Tyr-auto/trans-phosphorylation activity and especially two CRKs, CRK2 and CRK3, showed a high ERF13 Tyr-phosphorylation activity. A cell-based transient expression assay revealed that Tyr(16)/Tyr(207) sites in ERF13 were phosphorylated by CRK3 and that Tyr phosphorylation of endogenous TBBs occurs in CRK2 overexpressing cells. Furthermore, crk2 and crk3 mutants showed a decrease in the Tyr phosphorylation level of TBBs. These results suggest that CRKs have Tyr kinase activity, and these might be one of the major PKs responsible for protein Tyr phosphorylation in Arabidopsis plants.	[Nemoto, Keiichirou; Takemori, Nobuaki; Sawasaki, Tatsuya] Ehime Univ, Proteosci Ctr, Matsuyama, Ehime 7908577, Japan; [Seki, Motoaki] RIKEN Ctr Sustainable Resource Sci, Plant Genom Network Res Team, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Shinozaki, Kazuo] RIKEN Ctr Sustainable Resource Sci, Gene Discovery Res Grp, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Seki, Motoaki] Japan Sci & Technol Agcy JST, CREST, Kawaguchi, Saitama 3320012, Japan	Ehime University; RIKEN; RIKEN; Japan Science & Technology Agency (JST)	Sawasaki, T (corresponding author), Ehime Univ, Proteosci Ctr, 3 Bunkyo Cho, Matsuyama, Ehime 7908577, Japan.	sawasaki@ehime-u.ac.jp	Nemoto, Keiichirou/P-2085-2015; Shinozaki, Kazuo/G-4202-2013; Takemori, Nobuaki/O-3990-2014; Seki, Motoaki/I-2854-2012; Shinozaki, Kazuo/AAB-4945-2019	Nemoto, Keiichirou/0000-0002-0344-004X; Shinozaki, Kazuo/0000-0002-6317-9867; Takemori, Nobuaki/0000-0001-6639-854X; Seki, Motoaki/0000-0001-8288-0467; Shinozaki, Kazuo/0000-0002-6317-9867; Sawasaki, Tatsuya/0000-0002-7952-0556	Ministry of Education, Culture, Sports, Science, and Technology in Japan	Ministry of Education, Culture, Sports, Science, and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research (B) (to T. S.) and the Platform for Drug Discovery, Informatics, and Structural Life Science (to T. S.) and a Grant-in-Aid for Scientific Research on Innovative Areas (to T. S.) from the Ministry of Education, Culture, Sports, Science, and Technology in Japan. The authors declare that they have no conflicts of interest with the contents of this article.	ALI N, 1994, J BIOL CHEM, V269, P31626; Blume Y, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-29; Blume Y, 2008, PLANTA, V229, P143, DOI 10.1007/s00425-008-0816-z; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Boudsocq M, 2013, TRENDS PLANT SCI, V18, P30, DOI 10.1016/j.tplants.2012.08.008; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; Das R, 2010, CURR GENOMICS, V11, P2, DOI 10.2174/138920210790217981; Du W, 2005, PLANT SCI, V168, P1181, DOI 10.1016/j.plantsci.2004.12.019; Engelsberger WR, 2012, PLANT J, V69, P978, DOI 10.1111/j.1365-313X.2011.04848.x; Fu XD, 2002, PLANT CELL, V14, P3191, DOI 10.1105/tpc.006197; Ghelis T, 2008, PLANT PHYSIOL, V148, P1668, DOI 10.1104/pp.108.124594; Ghelis T, 2011, PLANT SIGNAL BEHAV, V6, P942, DOI 10.4161/psb.6.7.15261; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Hegeman AD, 2006, PROTEOMICS, V6, P3649, DOI 10.1002/pmic.200500926; Hotta H, 1998, GENE, V213, P47, DOI 10.1016/S0378-1119(98)00207-8; Hrabak EM, 2003, PLANT PHYSIOL, V132, P666, DOI 10.1104/pp.102.011999; Hua W, 2004, J BIOL CHEM, V279, P31483, DOI 10.1074/jbc.M402861200; Hua W, 2004, PLANT SCI, V166, P1253, DOI 10.1016/j.plantsci.2004.01.003; Huang YF, 2000, PLANT PHYSIOL, V122, P1301, DOI 10.1104/pp.122.4.1301; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Kim TW, 2009, NAT CELL BIOL, V11, P1254, DOI 10.1038/ncb1970; Kudoh A, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-9; Kulik A, 2011, OMICS, V15, P859, DOI 10.1089/omi.2011.0091; Leclercq J, 2005, J EXP BOT, V56, P25, DOI 10.1093/jxb/eri003; Lee SJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-277; Li RJ, 2006, BIOCHEM BIOPH RES CO, V342, P119, DOI 10.1016/j.bbrc.2006.01.100; Lin WW, 2014, P NATL ACAD SCI USA, V111, P3632, DOI 10.1073/pnas.1318817111; Liu HT, 2008, PLANT J, V55, P760, DOI 10.1111/j.1365-313X.2008.03544.x; Liu JY, 2014, PLANT GROWTH REGUL, V74, P187, DOI 10.1007/s10725-014-9910-3; Lu YT, 1997, PLANTA, V203, pS91, DOI 10.1007/PL00008121; Ma L, 2004, PLANT PHYSIOL, V135, P1280, DOI 10.1104/pp.104.041970; Madin K, 2000, P NATL ACAD SCI USA, V97, P559, DOI 10.1073/pnas.97.2.559; MANESS PF, 1990, CIBA F SYMP, V150, P57; Masaki T, 2014, J VIROL, V88, P7541, DOI 10.1128/JVI.03170-13; Masaoka T, 2008, FEBS LETT, V582, P1795, DOI 10.1016/j.febslet.2008.04.060; MATTEN WT, 1990, J CELL BIOL, V111, P1959, DOI 10.1083/jcb.111.5.1959; Nakagami H, 2010, PLANT PHYSIOL, V153, P1161, DOI 10.1104/pp.110.157347; Nemoto K, 2011, PHYTOCHEMISTRY, V72, P1136, DOI 10.1016/j.phytochem.2011.02.029; Nozawa A, 2009, BIOSCI BIOTECH BIOCH, V73, P1661, DOI 10.1271/bbb.90026; Oh MH, 2012, FEBS LETT, V586, P4070, DOI 10.1016/j.febslet.2012.09.040; Oh MH, 2012, P NATL ACAD SCI USA, V109, P327, DOI 10.1073/pnas.1108321109; Oh MH, 2009, P NATL ACAD SCI USA, V106, P658, DOI 10.1073/pnas.0810249106; Pandey S, 2002, EUR J BIOCHEM, V269, P3193, DOI 10.1046/j.1432-1033.2002.02994.x; Rigo G, 2013, PLANT CELL, V25, P1592, DOI 10.1105/tpc.113.110452; Ritsema T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006605; Rudrabhatla P, 2006, PLANT MOL BIOL, V60, P293, DOI 10.1007/s11103-005-4109-7; Sangwan V, 2001, PLANT J, V27, P1, DOI 10.1046/j.1365-313x.2001.01052.x; Satoh R, 2004, PLANT CELL PHYSIOL, V45, P309, DOI 10.1093/pcp/pch036; Sawasaki T, 2002, P NATL ACAD SCI USA, V99, P14652, DOI 10.1073/pnas.232580399; Sawasaki T, 2002, FEBS LETT, V514, P102, DOI 10.1016/S0014-5793(02)02329-3; Sawasaki T, 2008, FEBS LETT, V582, P221, DOI 10.1016/j.febslet.2007.12.004; Sheremet YA, 2012, CYTOL GENET+, V46, P263, DOI [10.3103/S0095452712050088, 10.3103/S0095452712010112]; SMITH JA, 1993, MOL CELL BIOCHEM, V128, P51, DOI 10.1007/BF01076757; Sugiyama N, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.32; Swatek KN, 2014, BIOCHEM J, V459, P15, DOI 10.1042/BJ20130035; Takahashi H, 2012, FEBS LETT, V586, P3134, DOI 10.1016/j.febslet.2012.08.014; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; van Bentem SD, 2009, TRENDS PLANT SCI, V14, P71, DOI 10.1016/j.tplants.2008.11.003; van Wijk KJ, 2014, PLANT CELL, V26, P2367, DOI 10.1105/tpc.114.125815; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wang L, 2001, PLANTA, V213, P556, DOI 10.1007/s004250100540; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Wang XL, 2005, DEV CELL, V8, P855, DOI 10.1016/j.devcel.2005.05.001; Wang Y, 2005, CELL RES, V15, P604, DOI 10.1038/sj.cr.7290330; Wang ZX, 2002, BIOCHEM J, V368, P947, DOI 10.1042/BJ20020557; Xu Q, 1998, PLANT CELL, V10, P849, DOI 10.1105/tpc.10.5.849; Yemets A, 2008, CELL BIOL INT, V32, P630, DOI 10.1016/j.cellbi.2008.01.013; Zhang L, 2002, BIOCHEM J, V368, P145, DOI 10.1042/BJ20020780	68	35	36	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16665	16677		10.1074/jbc.M114.617274	http://dx.doi.org/10.1074/jbc.M114.617274			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25969537	hybrid, Green Published			2022-12-28	WOS:000357572800017
J	Pathak, KV; Bellamri, M; Wang, Y; Langouet, S; Turesky, RJ				Pathak, Khyatiben V.; Bellamri, Medjda; Wang, Yi; Langouet, Sophie; Turesky, Robert J.			2-Amino-9H-pyrido[2,3-b]indole (AC) Adducts and Thiol Oxidation of Serum Albumin as Potential Biomarkers of Tobacco Smoke	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carcinogenesis; Cigarette Smoke; DNA Damage; Oxidative Stress; Protein Chemical Modification	HETEROCYCLIC AROMATIC-AMINES; TANDEM MASS-SPECTROMETRY; EXPERIMENTAL CANCER-RESEARCH; PROTEIN ADDUCTS; IN-VITRO; HUMAN HEPATOCYTES; LIVER-MICROSOMES; DNA-ADDUCTS; CARCINOGENIC ARYLAMINES; EPIDEMIOLOGIC EVIDENCE	Background: The reactivity of AC, a tobacco smoke carcinogen, was investigated with DNA and albumin of human hepatocytes. Results: Hepatocytes bioactivate AC to metabolites, which adduct to DNA and albumin. Conclusion: Cys(34) and Met(329) of serum albumin are targets for AC electrophiles. Significance: AC forms macromolecular adducts and induces oxidative stress, which may be contributing factors to liver damage and cancer risk in smokers. 2-Amino-9H-pyrido[2,3-b]indole (AC) is a carcinogenic heterocyclic aromatic amine formed during the combustion of tobacco. AC undergoes bioactivation to form electrophilic N-oxidized metabolites that react with DNA to form adducts, which can lead to mutations. Many genotoxicants and toxic electrophiles react with human serum albumin (albumin); however, the chemistry of reactivity of AC with proteins has not been studied. The genotoxic metabolites, 2-hydroxyamino-9H-pyrido[2,3-b]indole (HONH-AC), 2-nitroso-9H-pyrido[2,3-b]indole (NO-AC), N-acetyloxy-2-amino-9H-pyrido[2,3-b]indole (N-acetoxy-AC), and their [C-13(6)]AC-labeled homologues were reacted with albumin. Sites of adduction of AC to albumin were identified by data-dependent scanning and targeted bottom-up proteomics approaches employing ion trap and Orbitrap MS. AC-albumin adducts were formed at Cys(34), Tyr(140), and Tyr(150) residues when albumin was reacted with HONH-AC or NO-AC. Sulfenamide, sulfinamide, and sulfonamide adduct formation occurred at Cys(34) (AC-Cys(34)). N-Acetoxy-AC also formed an adduct at Tyr(332). Albumin-AC adducts were characterized in human plasma treated with N-oxidized metabolites of AC and human hepatocytes exposed to AC. High levels of N-(deoxyguanosin-8-yl)-AC (dG-C8-AC) DNA adducts were formed in hepatocytes. The Cys(34) was the sole amino acid of albumin to form adducts with AC. Albumin also served as an antioxidant and scavenged reactive oxygen species generated by metabolites of AC in hepatocytes; there was a strong decrease in reduced Cys(34), whereas the levels of Cys(34) sulfinic acid (Cys-SO2H), Cys(34)-sulfonic acid (Cys-SO3H), and Met(329) sulfoxide were greatly increased. Cys(34) adduction products and Cys-SO2H, Cys-SO3H, and Met(329) sulfoxide may be potential biomarkers to assess exposure and oxidative stress associated with AC and other arylamine toxicants present in tobacco smoke.	[Pathak, Khyatiben V.; Wang, Yi; Turesky, Robert J.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Pathak, Khyatiben V.; Wang, Yi; Turesky, Robert J.] Univ Minnesota, Dept Med Chem, Minneapolis, MN 55455 USA; [Bellamri, Medjda; Langouet, Sophie] Univ Rennes 1, INSERM, IRSET, UMR 1085,UMS Biosit 3480, F-35043 Rennes, France	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes	Turesky, RJ (corresponding author), Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA.	rturesky@umn.edu	Langouet, Sophie A/I-2776-2015; Bellamri, Madjda/AAX-9938-2021	Bellamri, Madjda/0000-0002-6477-967X; PATHAK, KHYATIBEN/0000-0002-8050-0747; Langouet, Sophie/0000-0002-0016-5425	National Institutes of Health of the Family Smoking Prevention and Tobacco Control Act [RO1 CA134700, R01CA134700-03S1]; PNREST Anses, Cancer TMOI AVIESAN [2013/1/166]; NATIONAL CANCER INSTITUTE [R01CA134700] Funding Source: NIH RePORTER	National Institutes of Health of the Family Smoking Prevention and Tobacco Control Act; PNREST Anses, Cancer TMOI AVIESAN; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 CA134700 and R01CA134700-03S1 of the Family Smoking Prevention and Tobacco Control Act. This work was also supported by PNREST Anses, Cancer TMOI AVIESAN (2013/1/166). The authors declare that they have no conflicts of interest with the contents of this article.	Aldini G, 2008, J MASS SPECTROM, V43, P1470, DOI 10.1002/jms.1419; Bessette EE, 2010, CHEM RES TOXICOL, V23, P1234, DOI 10.1021/tx100098f; Bruschi M, 2008, J CHROMATOGR B, V864, P29, DOI 10.1016/j.jchromb.2008.01.035; Carballal S, 2003, BIOCHEMISTRY-US, V42, P9906, DOI 10.1021/bi027434m; Colombo G, 2012, ANTIOXID REDOX SIGN, V17, P1515, DOI 10.1089/ars.2012.4702; Colombo G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029930; Colombo G, 2010, ANTIOXID REDOX SIGN, V12, P349, DOI 10.1089/ars.2009.2806; Colzani M, 2013, J PROTEOMICS, V92, P28, DOI 10.1016/j.jprot.2013.03.030; Damsten MC, 2007, DRUG METAB DISPOS, V35, P1408, DOI 10.1124/dmd.106.014233; Eyer P., 1996, CHEM AMINO NITRO SF2, P999; Felton J. S., 2000, Food borne carcinogens: heterocyclic amines., P31; FINCH JW, 1993, ARCH BIOCHEM BIOPHYS, V305, P595, DOI 10.1006/abbi.1993.1466; Frederiksen H, 2004, CARCINOGENESIS, V25, P1525, DOI 10.1093/carcin/bgh156; Giovannucci E, 2001, CANCER EPIDEM BIOMAR, V10, P725; Goodenough AK, 2007, CHEM RES TOXICOL, V20, P263, DOI 10.1021/tx0601713; Grigoryan H, 2012, CHEM RES TOXICOL, V25, P1633, DOI 10.1021/tx300096a; Guillouzo A, 1998, ENVIRON HEALTH PERSP, V106, P511, DOI 10.2307/3433803; Hackett TL, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-180; Hecht SS, 2003, NAT REV CANCER, V3, P733, DOI 10.1038/nrc1190; Hoffmann D, 2001, CHEM RES TOXICOL, V14, P767, DOI 10.1021/tx000260u; International Agency for Research on Cancer, 1986, IARC MON EV CARC RIS, P127; International Agency for Research on Cancer, 2002, IARC MON EV CARC RIS, P1005; John H, 2010, ANAL BIOANAL CHEM, V398, P2677, DOI 10.1007/s00216-010-4076-y; Kang P, 2007, DRUG METAB DISPOS, V35, P1081, DOI 10.1124/dmd.107.014860; Kim DH, 2004, CHEM RES TOXICOL, V17, P529, DOI 10.1021/tx034267y; King RS, 2000, CARCINOGENESIS, V21, P1347, DOI 10.1093/carcin/21.7.1347; KRIEK E, 1992, J CANCER RES CLIN, V118, P481, DOI 10.1007/BF01225261; LANGOUET S, 1995, CANCER RES, V55, P5574; Lemke T. L., 2012, REV ORGANIC FUNCTION, V5th, P85; Li B, 2007, ANAL BIOCHEM, V361, P263, DOI 10.1016/j.ab.2006.11.018; Liebler DC, 2002, ENVIRON HEALTH PERSP, V110, P3, DOI 10.1289/ehp.02110s113; Luchtenborg M, 2007, CANCER EPIDEM BIOMAR, V16, P1341, DOI 10.1158/1055-9965.EPI-06-0519; Majer BJ, 2004, J CHROMATOGR B, V802, P167, DOI 10.1016/j.jchromb.2003.10.042; MILLER JA, 1970, CANCER RES, V30, P559; Murata M, 2011, FRONT BIOSCI-LANDMRK, V16, P1132, DOI 10.2741/3739; Nauwelaers G, 2013, CHEM RES TOXICOL, V26, P1367, DOI 10.1021/tx4002226; Nauwelaers G, 2011, CHEM RES TOXICOL, V24, P913, DOI 10.1021/tx200091y; Neumann HG, 2007, CRIT REV TOXICOL, V37, P211, DOI 10.1080/10408440601028603; NIWA T, 1982, MUTAT RES, V95, P159, DOI 10.1016/0027-5107(82)90254-8; Noort D, 2004, J ANAL TOXICOL, V28, P333, DOI 10.1093/jat/28.5.333; Noort D, 2003, ARCH TOXICOL, V77, P543, DOI 10.1007/s00204-003-0484-5; Noort D, 2009, ARCH TOXICOL, V83, P1031, DOI 10.1007/s00204-009-0456-5; Novak M, 2003, J ORG CHEM, V68, P9875, DOI 10.1021/jo034505u; Novak M, 2000, J AM CHEM SOC, V122, P3606, DOI 10.1021/ja993433e; Okonogi H, 1997, CANCER LETT, V111, P105, DOI 10.1016/S0304-3835(96)04505-3; Peng LJ, 2014, J PROTEOMICS, V103, P267, DOI 10.1016/j.jprot.2014.03.023; Peng LJ, 2013, ANAL CHEM, V85, P1065, DOI 10.1021/ac3028273; Peng LJ, 2012, CHEM RES TOXICOL, V25, P2179, DOI 10.1021/tx300253j; Peng LJ, 2011, CHEM RES TOXICOL, V24, P2004, DOI 10.1021/tx2003504; Rappaport SM, 2012, TOXICOL LETT, V213, P83, DOI 10.1016/j.toxlet.2011.04.002; Raza H, 1996, DRUG METAB DISPOS, V24, P395; REISTAD R, 1994, CARCINOGENESIS, V15, P2547, DOI 10.1093/carcin/15.11.2547; Rubino FM, 2009, MASS SPECTROM REV, V28, P725, DOI 10.1002/mas.20207; SAITO K, 1984, BIOCHEM BIOPH RES CO, V124, P1, DOI 10.1016/0006-291X(84)90907-0; Siraki AG, 2002, DRUG METAB REV, V34, P549, DOI 10.1081/DMR-120005657; SKIPPER PL, 1990, CARCINOGENESIS, V11, P507, DOI 10.1093/carcin/11.4.507; SNYDERWINE EG, 1988, CARCINOGENESIS, V9, P1061, DOI 10.1093/carcin/9.6.1061; Steen H, 2001, J AM SOC MASS SPECTR, V12, P228, DOI 10.1016/S1044-0305(00)00219-1; Sugimura T, 2004, CANCER SCI, V95, P290, DOI 10.1111/j.1349-7006.2004.tb03205.x; Tabb DL, 2007, J PROTEOME RES, V6, P654, DOI 10.1021/pr0604054; Tang YJ, 2013, TOXICOL SCI, V133, P248, DOI 10.1093/toxsci/kft077; Tornqvist M, 2002, J CHROMATOGR B, V778, P279, DOI 10.1016/S1570-0232(02)00172-1; Tsuneoka Y, 2003, J NATL CANCER I, V95, P1227, DOI 10.1093/jnci/djg025; TURESKY RJ, 1987, CARCINOGENESIS, V8, P1537, DOI 10.1093/carcin/8.10.1537; TURESKY RJ, 1992, CHEM RES TOXICOL, V5, P479, DOI 10.1021/tx00028a005; TURESKY RJ, 1994, CHEM RES TOXICOL, V7, P752, DOI 10.1021/tx00042a007; Turesky RJ, 2007, CANCER EPIDEM BIOMAR, V16, P1554, DOI 10.1158/1055-9965.EPI-07-0132; Turesky RJ, 2011, CHEM RES TOXICOL, V24, P1169, DOI 10.1021/tx200135s; Turesky RJ, 2009, CHEM RES TOXICOL, V22, P726, DOI 10.1021/tx800473w; Vineis P, 2004, JNCI-J NATL CANCER I, V96, P99, DOI 10.1093/jnci/djh014; Wang ZH, 2011, CHEM RES TOXICOL, V24, P54, DOI 10.1021/tx1002854; WESTRA JG, 1981, CARCINOGENESIS, V2, P355, DOI 10.1093/carcin/2.4.355; YOSHIDA D, 1980, CANCER LETT, V10, P141, DOI 10.1016/0304-3835(80)90037-3; YOSHIDA D, 1978, BIOCHEM BIOPH RES CO, V83, P915, DOI 10.1016/0006-291X(78)91482-1; Yu MC, 2002, MUTAT RES-FUND MOL M, V506, P21, DOI 10.1016/S0027-5107(02)00148-3; Zhang LQ, 2011, NICOTINE TOB RES, V13, P120, DOI 10.1093/ntr/ntq219; Zhang XB, 1996, CARCINOGENESIS, V17, P2259, DOI 10.1093/carcin/17.10.2259	77	17	17	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16304	16318		10.1074/jbc.M115.646539	http://dx.doi.org/10.1074/jbc.M115.646539			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25953894	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000356930100033
J	Siddique, MM; Li, Y; Chaurasia, B; Kaddai, VA; Summers, SA				Siddique, Monowarul Mobin; Li, Ying; Chaurasia, Bhagirath; Kaddai, Vincent A.; Summers, Scott A.			Dihydroceramides: From Bit Players to Lead Actors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						apoptosis; autophagy; cell signaling; hypoxia; membrane; ceramides; sphingolipids; dihydroceramide; proliferation	NOVO SPHINGOLIPID BIOSYNTHESIS; INDUCED INSULIN-RESISTANCE; DIET-INDUCED OBESITY; CELL-DEATH; CERAMIDE SYNTHESIS; MEMBRANE-STRUCTURE; DESATURASE 1; AKT KINASE; APOPTOSIS; INDUCTION	Sphingolipid synthesis involves a highly conserved biosynthetic pathway that produces fundamental precursors of complex sphingolipids. The final reaction involves the insertion of a double bond into dihydroceramides to generate the more abundant ceramides, which are converted to sphingomyelins and glucosylceramides/gangliosides by the addition of polar head groups. Although ceramides have long been known to mediate cellular stress responses, the dihydroceramides that are transiently produced during de novo sphingolipid synthesis were deemed inert. Evidence published in the last few years suggests that these dihydroceramides accumulate to a far greater extent in tissues than previously thought. Moreover, they have biological functions that are distinct and non-overlapping with those of the more prevalent ceramides. Roles are being uncovered in autophagy, hypoxia, and cellular proliferation, and the lipids are now implicated in the etiology, treatment, and/or diagnosis of diabetes, cancer, ischemia/reperfusion injury, and neurodegenerative diseases. This minireview summarizes recent findings on this emerging class of bioactive lipids.	[Siddique, Monowarul Mobin; Li, Ying; Chaurasia, Bhagirath; Kaddai, Vincent A.; Summers, Scott A.] Baker IDI Heart & Diabet Inst, Melbourne, Vic 3004, Australia	Baker Heart and Diabetes Institute	Summers, SA (corresponding author), Baker IDI Heart & Diabet Inst, 75 Commercial Rd, Melbourne, Vic 3004, Australia.	Scott.summers@bakeridi.edu.au	/AAE-5384-2020	Li, Ying/0000-0002-6859-7208				Apraiz A, 2012, BIOCHEM CELL BIOL, V90, P209, DOI [10.1139/O2012-001, 10.1139/o2012-001]; Azzam R, 2013, DNA CELL BIOL, V32, P310, DOI 10.1089/dna.2013.1993; Bao HF, 2007, AM J PHYSIOL-RENAL, V293, pF1178, DOI 10.1152/ajprenal.00153.2007; Barbarroja N, 2015, DIABETES, V64, P1180, DOI 10.2337/db14-0359; Beauchamp E, 2007, BIOCHIMIE, V89, P1553, DOI 10.1016/j.biochi.2007.07.001; BIELAWSKA A, 1993, J BIOL CHEM, V268, P26226; Bikman BT, 2012, J BIOL CHEM, V287, P17426, DOI 10.1074/jbc.M112.359950; Bikman BT, 2011, J CLIN INVEST, V121, P4222, DOI 10.1172/JCI57144; Breen P, 2013, ANTICANCER RES, V33, P77; Brockman HL, 2004, BIOPHYS J, V87, P1722, DOI 10.1529/biophysj.104.044529; Brodesser S, 2011, J LIPIDS, V2011, DOI 10.1155/2011/724015; Brozinick JT, 2013, INT J OBESITY, V37, P1064, DOI 10.1038/ijo.2012.191; Buist PH, 2004, NAT PROD REP, V21, P249, DOI 10.1039/b302094k; Chavez JA, 2012, CELL METAB, V15, P585, DOI 10.1016/j.cmet.2012.04.002; Chik CL, 1999, ENDOCRINOLOGY, V140, P5682, DOI 10.1210/en.140.12.5682; Colombini Marco, 2013, Handb Exp Pharmacol, P109, DOI 10.1007/978-3-7091-1368-4_6; Colombini M, 2010, BBA-BIOENERGETICS, V1797, P1239, DOI 10.1016/j.bbabio.2010.01.021; Delmas D, 2011, CURR MED CHEM, V18, P1100, DOI 10.2174/092986711795029708; Devlin CM, 2011, J BIOL CHEM, V286, P38069, DOI 10.1074/jbc.M111.297994; Erdreich-Epstein A, 2002, J BIOL CHEM, V277, P49531, DOI 10.1074/jbc.M209962200; Ezanno H, 2012, LIPIDS, V47, P117, DOI 10.1007/s11745-011-3638-x; Fabrias G, 2012, PROG LIPID RES, V51, P82, DOI 10.1016/j.plipres.2011.12.002; Gagliostro V, 2012, INT J BIOCHEM CELL B, V44, P2135, DOI 10.1016/j.biocel.2012.08.025; Geeraert L, 1997, BIOCHEM J, V327, P125, DOI 10.1042/bj3270125; Grassme H, 2002, J IMMUNOL, V168, P298, DOI 10.4049/jimmunol.168.1.298; Grassme H, 2001, BIOCHEM BIOPH RES CO, V284, P1016, DOI 10.1006/bbrc.2001.5045; Grassme H, 2001, J BIOL CHEM, V276, P20589, DOI 10.1074/jbc.M101207200; Hail N, 2006, APOPTOSIS, V11, P1677, DOI 10.1007/s10495-006-9289-3; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378; Hu W, 2011, J BIOL CHEM, V286, P16596, DOI 10.1074/jbc.M110.186916; Idkowiak-Baldys J, 2010, BIOCHEM J, V427, P265, DOI 10.1042/BJ20091589; Kok JW, 1997, J BIOL CHEM, V272, P21128, DOI 10.1074/jbc.272.34.21128; Kraveka JM, 2007, J BIOL CHEM, V282, P16718, DOI 10.1074/jbc.M700647200; Lee H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019783; Lopez X, 2013, J PEDIATR ENDOCR MET, V26, P995, DOI 10.1515/jpem-2012-0407; Mamtani M, 2014, OBESITY, V22, P950, DOI 10.1002/oby.20598; Maurer BJ, 1999, JNCI-J NATL CANCER I, V91, P1138, DOI 10.1093/jnci/91.13.1138; Menuz V, 2009, SCIENCE, V324, P381, DOI 10.1126/science.1168532; Merrill AH, 2002, J BIOL CHEM, V277, P25843, DOI 10.1074/jbc.R200009200; Mitoma J, 1998, J NEUROSCI RES, V51, P712, DOI 10.1002/(SICI)1097-4547(19980315)51:6<712::AID-JNR5>3.3.CO;2-Q; Mukhopadhyay S, 2014, APOPTOSIS, V19, P555, DOI 10.1007/s10495-014-0967-2; Nichols FC, 2006, ORAL MICROBIOL IMMUN, V21, P84, DOI 10.1111/j.1399-302X.2006.00264.x; Nichols FC, 2004, J LIPID RES, V45, P2317, DOI 10.1194/jlr.M400278-JLR200; Nichols FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016771; Nichols FC, 2009, AM J PATHOL, V175, P2430, DOI 10.2353/ajpath.2009.090544; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; Omae F, 2004, BIOCHEM J, V379, P687, DOI 10.1042/BJ20031425; Oridate N, 1997, J NATL CANCER I, V89, P1191, DOI 10.1093/jnci/89.16.1191; Preitner F, 2009, AM J PHYSIOL-ENDOC M, V297, pE1420, DOI 10.1152/ajpendo.00362.2009; Qiang W, 2009, P NATL ACAD SCI USA, V106, P15314, DOI 10.1073/pnas.0907360106; Rahmaniyan M, 2011, J BIOL CHEM, V286, P24754, DOI 10.1074/jbc.M111.250779; Rodriguez-Cuenca S, 2015, BBA-MOL CELL BIOL L, V1851, P40, DOI 10.1016/j.bbalip.2014.09.021; Ruvolo PP, 1999, J BIOL CHEM, V274, P20296, DOI 10.1074/jbc.274.29.20296; Ruvolo PP, 2003, PHARMACOL RES, V47, P383, DOI 10.1016/S1043-6618(03)00050-1; Shen SS, 2012, AUTOPHAGY, V8, P1, DOI 10.4161/auto.8.1.16618; Shimabukuro M, 1998, J BIOL CHEM, V273, P32487, DOI 10.1074/jbc.273.49.32487; Siddique MM, 2013, MOL CELL BIOL, V33, P2353, DOI 10.1128/MCB.00226-13; Siddique MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044042; Signorelli P, 2009, CANCER LETT, V282, P238, DOI 10.1016/j.canlet.2009.03.020; Simon CG, 1998, BIOCHEMISTRY-US, V37, P2059, DOI 10.1021/bi9710636; Sims K, 2010, J BIOL CHEM, V285, P38568, DOI 10.1074/jbc.M110.170621; Siskind LJ, 2002, J BIOL CHEM, V277, P26796, DOI 10.1074/jbc.M200754200; Siskind LJ, 2000, J BIOL CHEM, V275, P38640, DOI 10.1074/jbc.C000587200; Stiban J, 2006, APOPTOSIS, V11, P773, DOI 10.1007/s10495-006-5882-8; Summers SA, 1998, MOL CELL BIOL, V18, P5457, DOI 10.1128/MCB.18.9.5457; Sun SY, 1999, MOL PHARMACOL, V55, P403; Ternes P, 2002, J BIOL CHEM, V277, P25512, DOI 10.1074/jbc.M202947200; Tirodkar T. S., 2012, Experimental Oncology, V34, P231; Ueda N, 1998, KIDNEY INT, V54, P399, DOI 10.1046/j.1523-1755.1998.00008.x; Uyama R, 2005, J VET MED SCI, V67, P1273, DOI 10.1292/jvms.67.1273; van Blitterswijk WJ, 2003, BIOCHEM J, V369, P199, DOI 10.1042/BJ20021528; Vieira CR, 2010, CHEM BIOL, V17, P766, DOI 10.1016/j.chembiol.2010.05.023; Walls SM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003970; Wirawan E, 2012, CELL RES, V22, P43, DOI 10.1038/cr.2011.152; Wu JM, 2001, APOPTOSIS, V6, P377, DOI 10.1023/A:1011342220621; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Young MM, 2013, J LIPID RES, V54, P5, DOI 10.1194/jlr.R031278; Zhang QJ, 2012, DIABETES, V61, P1848, DOI 10.2337/db11-1399; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009; Zhou HL, 1998, J BIOL CHEM, V273, P16568, DOI 10.1074/jbc.273.26.16568	81	91	91	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15371	15379		10.1074/jbc.R115.653204	http://dx.doi.org/10.1074/jbc.R115.653204			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25947377	Green Published, hybrid			2022-12-28	WOS:000356527400003
J	Tholen, M; Wolanski, J; Stolze, B; Chiabudini, M; Gajda, M; Bronsert, P; Stickeler, E; Rospert, S; Reinheckel, T				Tholen, Martina; Wolanski, Julia; Stolze, Britta; Chiabudini, Marco; Gajda, Mieczyslaw; Bronsert, Peter; Stickeler, Elmar; Rospert, Sabine; Reinheckel, Thomas			Stress-resistant Translation of Cathepsin L mRNA in Breast Cancer Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alternative splicing; breast cancer; cysteine protease; metastasis; translation control	INTERNAL RIBOSOME ENTRY; PLASMINOGEN-ACTIVATOR INHIBITOR-1; L SPLICE VARIANTS; L EXPRESSION; ENDOPLASMIC-RETICULUM; DEFICIENT MICE; CELL STRESS; STEFIN-A; HYPOXIA; GENES	Background: Translational regulation might underlie the high expression levels of the protease cathepsin L (CTSL) associated with poor breast cancer prognosis. Results: Translation of CTSL mRNA is highly stress-resistant and promotes metastasis of murine breast cancer. Conclusion: CTSL mRNA circumvents translational shutdown in cancer-associated stress conditions. Significance: High expression of a metastasis promoting protease is maintained by translational regulation. The cysteine protease cathepsin L (CTSL) is often thought to act as a tumor promoter by enhancing tumor progression and metastasis. This goes along with increased CTSL activity in various tumor entities; however, the mechanisms leading to high CTSL levels are incompletely understood. With the help of the polyoma middle T oncogene driven breast cancer mouse model expressing a human CTSL genomic transgene, we show that CTSL indeed promotes breast cancer metastasis to the lung. During tumor formation and progression high expression levels of CTSL are maintained by enduring translation of CTSL mRNA. Interestingly, human breast cancer specimens expressed the same pattern of 5 untranslated region (UTR) splice variants as the transgenic mice and the human cancer cell line MDA-MB 321. By polyribosome profiling of tumor tissues and human breast cancer cells, we observe an intrinsic resistance of CTSL to stress-induced shutdown of translation. This ability can be attributed to all 5 UTR variants of CTSL and is not dependent on a previously described internal ribosomal entry site motif. In conclusion, we provide in vivo functional evidence for overexpressed CTSL as a promoter of lung metastasis, whereas high CTSL levels are maintained during tumor progression due to stress-resistant mRNA translation.	[Tholen, Martina; Wolanski, Julia; Stolze, Britta; Reinheckel, Thomas] Univ Freiburg, Inst Mol Med & Cell Res, D-79104 Freiburg, Germany; [Tholen, Martina] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Chiabudini, Marco; Rospert, Sabine] Univ Freiburg, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; [Chiabudini, Marco; Rospert, Sabine; Reinheckel, Thomas] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany; [Gajda, Mieczyslaw] Univ Jena, Inst Pathol, D-07743 Jena, Germany; [Bronsert, Peter] Univ Med Ctr Freiburg, Inst Pathol, D-79106 Freiburg, Germany; [Bronsert, Peter; Stickeler, Elmar; Reinheckel, Thomas] German Canc Consortium DKTK, Comprehens Canc Center, D-79106 Freiburg, Germany; [Stickeler, Elmar] Univ Med Ctr Freiburg, Clin Gynecol, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Friedrich Schiller University of Jena; University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Freiburg	Reinheckel, T (corresponding author), Inst Mol Med & Cell Res, Stefan Meier Str 17, D-79104 Freiburg, Germany.	thomas.reinheckel@uniklinik-freiburg.de	Stickeler, Elmar/AHE-9022-2022; Reinheckel, Thomas/AAL-9761-2021	Reinheckel, Thomas/0000-0001-9866-9105; Rospert, Sabine/0000-0002-3089-9614	Deutsche Forschungsgemeinschaft [SFB850, RE1584/6-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB850 project B7 and RE1584/6-1 (to T.R.) and SFB850 project C8 (to E. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Abudula A, 2001, BIOL CHEM, V382, P1583, DOI 10.1515/BC.2001.193; Bengsch F, 2014, ONCOGENE, V33, P4474, DOI 10.1038/onc.2013.395; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Caserman S, 2006, BIOL CHEM, V387, P629, DOI 10.1515/BC.2006.080; Chang TH, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S2-S4; Dennemarker J, 2010, BIOL CHEM, V391, P913, DOI 10.1515/BC.2010.097; Esposito A. M., 2010, J VIS EXP, V40, P1948, DOI DOI 10.3791/1948; Foekens JA, 1998, J CLIN ONCOL, V16, P1013, DOI 10.1200/JCO.1998.16.3.1013; Gilbert WV, 2010, J BIOL CHEM, V285, P29033, DOI 10.1074/jbc.R110.150532; Gocheva V, 2006, GENE DEV, V20, P543, DOI 10.1101/gad.1407406; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Harbeck N, 2001, CLIN CANCER RES, V7, P2757; Houseweart MK, 2003, J NEUROBIOL, V56, P315, DOI 10.1002/neu.10253; Ivanov PA, 2003, EXP CELL RES, V290, P227, DOI 10.1016/S0014-4827(03)00290-8; Ivanov P, 2011, GENE DEV, V25, P2119, DOI 10.1101/gad.17838411; Jean D, 2006, ONCOGENE, V25, P1474, DOI 10.1038/sj.onc.1209196; Jean D, 2008, BIOCHEM J, V413, P125, DOI 10.1042/BJ20071255; Kozak M, 2005, NUCLEIC ACIDS RES, V33, P6593, DOI 10.1093/nar/gki958; Levicar N, 2002, CANCER DETECT PREV, V26, P42, DOI 10.1016/S0361-090X(02)00015-6; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Mason SD, 2011, TRENDS CELL BIOL, V21, P228, DOI 10.1016/j.tcb.2010.12.002; Meng XB, 2012, J BIOL CHEM, V287, P4485, DOI 10.1074/jbc.C111.291518; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Mittal S, 2011, BIOL CHEM, V392, P405, DOI 10.1515/BC.2011.039; Miyamoto K, 2011, INT J ONCOL, V39, P1109, DOI 10.3892/ijo.2011.1127; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Noch E, 2011, CANCER BIOL THER, V11, P32, DOI 10.4161/cbt.11.1.13835; Nouh MA, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-1; Piccirillo CA, 2014, NAT IMMUNOL, V15, P503, DOI 10.1038/ni.2891; Rafn B, 2012, MOL CELL, V45, P764, DOI 10.1016/j.molcel.2012.01.029; Reid DW, 2012, J BIOL CHEM, V287, P5518, DOI 10.1074/jbc.M111.312280; Rescheleit DK, 1996, FEBS LETT, V394, P345, DOI 10.1016/0014-5793(96)00986-6; Samaiya M, 2011, J CELL MOL MED, V15, P2189, DOI 10.1111/j.1582-4934.2010.01203.x; Sevenich L, 2006, BIOL CHEM, V387, P885, DOI 10.1515/BC.2006.112; Shatsky IN, 2010, MOL CELLS, V30, P285, DOI 10.1007/s10059-010-0149-1; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Skrzypczak M, 2012, CANCER INVEST, V30, P398, DOI 10.3109/07357907.2012.672608; Spriggs KA, 2008, BIOL CELL, V100, P27, DOI 10.1042/BC20070098; Spriggs KA, 2010, MOL CELL, V40, P228, DOI 10.1016/j.molcel.2010.09.028; Thomssen C, 1995, CLIN CANCER RES, V1, P741; Thoreen CC, 2009, AUTOPHAGY, V5, P725, DOI 10.4161/auto.5.5.8504; Unsworth H, 2010, FASEB J, V24, P3370, DOI 10.1096/fj.09-151142; Vasiljeva O, 2008, ONCOGENE, V27, P4191, DOI 10.1038/onc.2008.59; Wilkinson N, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00176; Young RM, 2008, J BIOL CHEM, V283, P16309, DOI 10.1074/jbc.M710079200; Zajc I, 2002, CANCER LETT, V187, P185, DOI 10.1016/S0304-3835(02)00452-4	47	19	19	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15758	15769		10.1074/jbc.M114.624353	http://dx.doi.org/10.1074/jbc.M114.624353			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25957406	hybrid, Green Published			2022-12-28	WOS:000356527400037
J	DeMartini, DG; Izumi, M; Weaver, AT; Pandolfi, E; Morse, DE				DeMartini, Daniel G.; Izumi, Michi; Weaver, Aaron T.; Pandolfi, Erica; Morse, Daniel E.			Structures, Organization, and Function of Reflectin Proteins in Dynamically Tunable Reflective Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHYSIOLOGICAL COLOR-CHANGE; SQUID IRIDOPHORES; IRIDESCENCE; LIGHT; SKIN; LEUCOPHORES; MECHANISMS; CAMOUFLAGE; MOLLUSCA	The reversible assembly of reflectin proteins drives dynamic iridescence in cephalopods. Squid dynamically tune the intensity and colors of iridescence generated by constructive interference from intracellular Bragg reflectors in specialized skin cells called iridocytes. Analysis of the tissue specificity of reflectin subtypes reveals that tunability is correlated with the presence of one specific reflectin sequence. Differential phosphorylation and dephosphorylation of the reflectins in response to activation by acetylcholine, as well as differences in their tissue-specific and subcellular spatial distributions, further support the suggestion of different roles for the different reflectin subtypes.	[DeMartini, Daniel G.; Morse, Daniel E.] Univ Calif Santa Barbara, Biomol Sci & Engn Program, Santa Barbara, CA 93106 USA; [DeMartini, Daniel G.; Izumi, Michi; Morse, Daniel E.] Univ Calif Santa Barbara, Inst Collaborat Biotechnol, Santa Barbara, CA 93106 USA; [Weaver, Aaron T.; Pandolfi, Erica; Morse, Daniel E.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Morse, DE (corresponding author), Univ Calif Santa Barbara, Biomol Sci & Engn Program, Santa Barbara, CA 93106 USA.	d_morse@lifesci.ucsb.edu	DeMartini, Daniel/D-1264-2017	DeMartini, Daniel/0000-0002-2377-3749	Office of Naval Research via a Multidisciplinary University Research Initiative (MURI) award [N00014-09-1-1053]; Army Research Office [W911NF-10-1-0139]	Office of Naval Research via a Multidisciplinary University Research Initiative (MURI) award; Army Research Office	This work was supported by grants from the Office of Naval Research via a Multidisciplinary University Research Initiative (MURI) award to Duke University (Grant N00014-09-1-1053), and the Army Research Office (Grant W911NF-10-1-0139 to D. E. M.).	Andouche A, 2013, DEV DYNAM, V242, P560, DOI 10.1002/dvdy.23938; ARNOLD JM, 1967, J ULTRA MOL STRUCT R, V20, P410, DOI 10.1016/S0022-5320(67)80109-6; ARNOLD JM, 1974, BIOL BULL, V147, P507, DOI 10.2307/1540736; BARER R, 1954, NATURE, V173, P821, DOI 10.1038/173821b0; Bergersen LH, 2008, NAT PROTOC, V3, P144, DOI 10.1038/nprot.2007.525; Boal JG, 2004, BEHAVIOUR, V141, P837, DOI 10.1163/1568539042265662; BROCCO SL, 1980, CELL TISSUE RES, V205, P167; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; CLONEY RA, 1983, AM ZOOL, V23, P581, DOI 10.1093/icb/23.3.581; COOPER KM, 1990, CELL TISSUE RES, V259, P15, DOI 10.1007/BF00571425; Crookes WJ, 2004, SCIENCE, V303, P235, DOI 10.1126/science.1091288; DeMartini DG, 2013, J EXP BIOL, V216, P3733, DOI 10.1242/jeb.090415; DeMartini DG, 2013, P NATL ACAD SCI USA, V110, P2552, DOI 10.1073/pnas.1217260110; DENTON EJ, 1971, PROC R SOC SER B-BIO, V178, P43, DOI 10.1098/rspb.1971.0051; ELLIS RJ, 1979, TRENDS BIOCHEM SCI, V4, P241, DOI 10.1016/0968-0004(79)90212-3; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; Fudouzi H, 2011, SCI TECHNOL ADV MAT, V12, DOI 10.1088/1468-6996/12/6/064704; Ghoshal A, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0386; Hanlon RT, 2009, PHILOS T R SOC B, V364, P429, DOI 10.1098/rstb.2008.0270; Hanlon R. T., 1996, CEPHALOPOD BEHAV, p[31, 120]; HANLON RT, 1990, CELL TISSUE RES, V259, P3, DOI 10.1007/BF00571424; HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070; Holt AL, 2011, J R SOC INTERFACE, V8, P1386, DOI 10.1098/rsif.2010.0702; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; Izumi M, 2010, J R SOC INTERFACE, V7, P549, DOI 10.1098/rsif.2009.0299; Kramer RM, 2007, NAT MATER, V6, P533, DOI 10.1038/nmat1930; Land M F, 1972, Prog Biophys Mol Biol, V24, P75, DOI 10.1016/0079-6107(72)90004-1; LAND MF, 1992, ANNU REV NEUROSCI, V15, P1, DOI 10.1146/annurev.ne.15.030192.000245; Mathger LM, 2013, ADV FUNCT MATER, V23, P3980, DOI 10.1002/adfm.201203705; Mathger LM, 2003, J EXP BIOL, V206, P3607, DOI 10.1242/jeb.00599; Mathger LM, 2007, CELL TISSUE RES, V329, P179, DOI 10.1007/s00441-007-0384-8; Parker R, 2000, J OPT A-PURE APPL OP, V2, P15; Qin G., 2012, J POLYM SCI B, V51, P254; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Ruby EG, 1996, ANNU REV MICROBIOL, V50, P591, DOI 10.1146/annurev.micro.50.1.591; Seago AE, 2009, J R SOC INTERFACE, V6, pS165, DOI 10.1098/rsif.2008.0354.focus; Tao AR, 2010, BIOMATERIALS, V31, P793, DOI 10.1016/j.biomaterials.2009.10.038; Vigneron JP, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.031907; Walish J., 2009, ADV MATER, V21, P1, DOI DOI 10.1002/ADMA.200990117; Wardill TJ, 2012, P ROY SOC B-BIOL SCI, V279, P4243, DOI 10.1098/rspb.2012.1374; Weiss JL, 2005, BBA-BIOMEMBRANES, V1668, P164, DOI 10.1016/j.bbamem.2004.11.014; Zhao HY, 2011, BIOPHYS J, V100, P2309, DOI 10.1016/j.bpj.2011.03.004	42	35	35	0	66	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15238	15249		10.1074/jbc.M115.638254	http://dx.doi.org/10.1074/jbc.M115.638254			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25918159	Green Published, hybrid			2022-12-28	WOS:000356177300036
J	Nakane, S; Iwamoto, A; Matsuda, Z				Nakane, Shuhei; Iwamoto, Aikichi; Matsuda, Zene			The V4 and V5 Variable Loops of HIV-1 Envelope Glycoprotein Are Tolerant to Insertion of Green Fluorescent Protein and Are Useful Targets for Labeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MEMBRANE-SPANNING DOMAIN; CYTOPLASMIC TAIL; BETA-LACTAMASE; TYPE-1 GP120; FUSION; CLEAVAGE; REGIONS; SURFACE; CELLS	The mature human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein (Env) comprises the non-covalently associated gp120 and gp41 subunits generated from the gp160 precursor. Recent structural analyses have provided quaternary structural models for gp120/gp41 trimers, including the variable loops (V1-V5) of gp120. In these models, the V3 loop is located under V1/V2 at the apical center of the Env trimer, and the V4 and V5 loops project outward from the trimeric protomers. In addition, the V4 and V5 loops are predicted to have less movement upon receptor binding during membrane fusion events. We performed insertional mutagenesis using a GFP variant, GFPOPT, placed into the variable loops of HXB2 gp120. This allowed us to evaluate the current structural models and to simultaneously generate a GFP-tagged HIV-1 Env, which was useful for image analyses. All GFP-inserted mutants showed similar levels of whole-cell expression, although certain mutants, particularly V3 mutants, showed lower levels of cell surface expression. Functional evaluation of their fusogenicities in cell-cell and virus-like particle-cell fusion assays revealed that V3 was the most sensitive to the insertion and that the V1/V2 loops were less sensitive than V3. The V4 and V5 loops were the most tolerant to insertion, and certain tag proteins other than GFPOPT could also be inserted without functional consequences. Our results support the current structural models and provide a GFPOPT-tagged Env construct for imaging studies.	[Nakane, Shuhei; Iwamoto, Aikichi; Matsuda, Zene] Univ Tokyo, Inst Med Sci, Res Ctr Asian Infect Dis, Tokyo 1088639, Japan; [Iwamoto, Aikichi] Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr, Div Infect Dis, Tokyo 1088639, Japan; [Nakane, Shuhei; Matsuda, Zene] Chinese Acad Sci, Inst Biophys, China Japan Joint Lab Struct Virol & Immunol, Beijing 100101, Peoples R China	University of Tokyo; University of Tokyo; Chinese Academy of Sciences; Institute of Biophysics, CAS	Matsuda, Z (corresponding author), Univ Tokyo, Inst Med Sci, Res Ctr Asian Infect Dis, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	zmatsuda@ims.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology for the Program of Japan Initiative for Global Research Network on Infectious Diseases (J-GRID)	Ministry of Education, Culture, Sports, Science and Technology for the Program of Japan Initiative for Global Research Network on Infectious Diseases (J-GRID)	This work was supported by a contract research fund from the Ministry of Education, Culture, Sports, Science and Technology for the Program of Japan Initiative for Global Research Network on Infectious Diseases (J-GRID).	ABACIOGLU YH, 1994, AIDS RES HUM RETROV, V10, P371, DOI 10.1089/aid.1994.10.371; Abrahamyan LG, 2005, J VIROL, V79, P106, DOI 10.1128/JVI.79.1.106-115.2005; Bartesaghi A, 2013, NAT STRUCT MOL BIOL, V20, P1352, DOI 10.1038/nsmb.2711; BOSCH V, 1990, J VIROL, V64, P2337, DOI 10.1128/JVI.64.5.2337-2344.1990; Bultmann A, 2001, J VIROL, V75, P5263, DOI 10.1128/JVI.75.11.5263-5276.2001; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chan WE, 2004, J VIROL, V78, P5157, DOI 10.1128/JVI.78.10.5157-5169.2004; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; CLEMENTS GJ, 1991, AIDS RES HUM RETROV, V7, P3, DOI 10.1089/aid.1991.7.3; Curlin ME, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001228; da Silva ES, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-54; Diaz-Aguilar B, 2013, BIOCHEMISTRY-US, V52, P3552, DOI 10.1021/bi400201h; Doucet N, 2004, J BIOL CHEM, V279, P46295, DOI 10.1074/jbc.M407606200; Du SX, 2008, PROTEIN EXPRES PURIF, V59, P223, DOI 10.1016/j.pep.2008.02.002; Falcon-Perez JM, 2005, J CELL SCI, V118, P5243, DOI 10.1242/jcs.02633; Gallagher JR, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004373; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; HELSETH E, 1991, J VIROL, V65, P2119, DOI 10.1128/JVI.65.4.2119-2123.1991; Ishikawa H, 2012, PROTEIN ENG DES SEL, V25, P813, DOI 10.1093/protein/gzs051; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; Kondo N, 2010, J BIOL CHEM, V285, P14681, DOI 10.1074/jbc.M109.067090; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; Leung K, 2008, CELL HOST MICROBE, V3, P285, DOI 10.1016/j.chom.2008.04.004; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Miyauchi K, 2005, J VIROL, V79, P4720, DOI 10.1128/JVI.79.8.4720-4729.2005; Moore PL, 2006, J VIROL, V80, P2515, DOI 10.1128/JVI.80.5.2515-2528.2006; Moulard M, 2000, BBA-REV BIOMEMBRANES, V1469, P121, DOI 10.1016/S0304-4157(00)00014-9; Munro JB, 2014, SCIENCE, V346, P759, DOI 10.1126/science.1254426; Niwa Y, 1996, EUR J BIOCHEM, V237, P64, DOI 10.1111/j.1432-1033.1996.0064n.x; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pereira CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017016; Postler TS, 2013, J VIROL, V87, P2, DOI 10.1128/JVI.02053-12; Ren XP, 2005, J VIROL, V79, P5616, DOI 10.1128/JVI.79.9.5616-5624.2005; Royant A, 2011, J STRUCT BIOL, V174, P385, DOI 10.1016/j.jsb.2011.02.004; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Tran EEH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002797; Vollenweider F, 1996, BIOCHEM J, V314, P521, DOI 10.1042/bj3140521; Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233; Wallace A, 2009, J VIROL, V83, P7883, DOI 10.1128/JVI.00582-09; Wang H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096790; Wolf MC, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-119; WYATT R, 1993, J VIROL, V67, P4557, DOI 10.1128/JVI.67.8.4557-4565.1993; Yang XZ, 2006, J VIROL, V80, P11404, DOI 10.1128/JVI.01102-06; Yuan TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069789; Zhang MS, 2012, NAT METHODS, V9, P727, DOI [10.1038/NMETH.2021, 10.1038/nmeth.2021]; Zolla-Pazner S, 2010, NAT REV IMMUNOL, V10, P527, DOI 10.1038/nri2801	53	18	18	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15279	15291		10.1074/jbc.M114.628610	http://dx.doi.org/10.1074/jbc.M114.628610			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25911103	hybrid, Green Published			2022-12-28	WOS:000356177300039
J	Teasley, DC; Parajuli, S; Nguyen, M; Moore, HR; Alspach, E; Lock, YJ; Honaker, Y; Saharia, A; Piwnica-Worms, H; Stewart, SA				Teasley, Daniel C.; Parajuli, Shankar; Mai Nguyen; Moore, Hayley R.; Alspach, Elise; Lock, Ying Jie; Honaker, Yuchi; Saharia, Abhishek; Piwnica-Worms, Helen; Stewart, Sheila A.			Flap Endonuclease 1 Limits Telomere Fragility on the Leading Strand	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; REPLICATION FORK PROGRESSION; DNA-REPLICATION; MAMMALIAN TELOMERES; TRANSCRIPTION; BINDING; RECOMBINATION; MAINTENANCE; STABILITY; HELICASE	The existence of redundant replication and repair systems that ensure genome stability underscores the importance of faithful DNA replication. Nowhere is this complexity more evident than in challenging DNA templates, including highly repetitive or transcribed sequences. Here, we demonstrate that flap endonuclease 1 (FEN1), a canonical lagging strand DNA replication protein, is required for normal, complete leading strand replication at telomeres. We find that the loss of FEN1 nuclease activity, but not DNA repair activities, results in leading strand-specific telomere fragility. Furthermore, we show that FEN1 depletion-induced telomere fragility is increased by RNA polymerase II inhibition and is rescued by ectopic RNase H1 expression. These data suggest that FEN1 limits leading strand-specific telomere fragility by processing RNA: DNA hybrid/flap intermediates that arise from co-directional collisions occurring between the replisome and RNA polymerase. Our data reveal the first molecular mechanism for leading strand-specific telomere fragility and the first known role for FEN1 in leading strand DNA replication. Because FEN1 mutations have been identified in human cancers, our findings raise the possibility that unresolved RNA: DNA hybrid structures contribute to the genomic instability associated with cancer.	[Teasley, Daniel C.; Parajuli, Shankar; Mai Nguyen; Moore, Hayley R.; Alspach, Elise; Lock, Ying Jie; Honaker, Yuchi; Saharia, Abhishek; Piwnica-Worms, Helen; Stewart, Sheila A.] Washington Univ, Sch Med, Canc Environm Inst, Depts Cell Biol & Physiol, St Louis, MO 63110 USA; [Piwnica-Worms, Helen; Stewart, Sheila A.] Washington Univ, Sch Med, Canc Environm Inst, Dept Med, St Louis, MO 63110 USA; [Teasley, Daniel C.; Parajuli, Shankar; Mai Nguyen; Moore, Hayley R.; Alspach, Elise; Stewart, Sheila A.] Washington Univ, Sch Med, Canc Environm Inst, Dept Integrating Communicat, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Stewart, SA (corresponding author), Washington Univ, Sch Med, Canc Environm Inst, Depts Cell Biol & Physiol, St Louis, MO 63110 USA.	sheila.stewart@wustl.edu	Regan, Clinton/E-6250-2012	Alspach, Elise/0000-0002-2740-9768	National Institutes of Health [GM95924]; NRSA [GM007067]; Siteman Cancer Center at Barnes-Jewish Hospital; Washington University School of Medicine; NATIONAL CANCER INSTITUTE [T32CA113275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007067, R01GM095924] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Siteman Cancer Center at Barnes-Jewish Hospital; Washington University School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM95924 (to S. A. S.) and Training Grant GM007067 from NRSA (to D. C. T. and E. A.). This work was also supported by the Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine (to S. P. and H. R. M.).	Arora R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6220; Atkinson J, 2011, NUCLEIC ACIDS RES, V39, P1351, DOI 10.1093/nar/gkq975; Azvolinsky A, 2009, MOL CELL, V34, P722, DOI 10.1016/j.molcel.2009.05.022; Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Badie S, 2010, NAT STRUCT MOL BIOL, V17, P1461, DOI 10.1038/nsmb.1943; Bah A, 2012, NUCLEIC ACIDS RES, V40, P2995, DOI 10.1093/nar/gkr1153; Bailey SM, 2001, SCIENCE, V293, P2462, DOI 10.1126/science.1062560; Balk B, 2013, NAT STRUCT MOL BIOL, V20, P1199, DOI 10.1038/nsmb.2662; Bornarth CJ, 1999, BIOCHEMISTRY-US, V38, P13347, DOI 10.1021/bi991321u; Burrow AA, 2010, NUCLEIC ACIDS RES, V38, P2865, DOI 10.1093/nar/gkp1245; Bushnell DA, 2002, P NATL ACAD SCI USA, V99, P1218, DOI 10.1073/pnas.251664698; Chawla R, 2011, EMBO J, V30, P4047, DOI 10.1038/emboj.2011.280; Deng Z, 2009, MOL CELL, V35, P403, DOI 10.1016/j.molcel.2009.06.025; Duxin JP, 2009, MOL CELL BIOL, V29, P4274, DOI 10.1128/MCB.01834-08; Fu YV, 2011, CELL, V146, P930, DOI 10.1016/j.cell.2011.07.045; Gilson E, 2007, NAT REV MOL CELL BIO, V8, P825, DOI 10.1038/nrm2259; Guo ZG, 2008, J MOL BIOL, V377, P679, DOI 10.1016/j.jmb.2007.10.074; Helmrich A, 2011, MOL CELL, V44, P966, DOI 10.1016/j.molcel.2011.10.013; Honaker Y, 2010, ONCOGENE, V29, P3324, DOI 10.1038/onc.2010.96; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; Letessier A, 2011, NATURE, V470, P120, DOI 10.1038/nature09745; LI XY, 1995, J BIOL CHEM, V270, P22109, DOI 10.1074/jbc.270.38.22109; LIU B, 1993, NATURE, V366, P33, DOI 10.1038/366033a0; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Martinez P, 2009, GENE DEV, V23, P2060, DOI 10.1101/gad.543509; McNees CJ, 2010, J CELL BIOL, V188, P639, DOI 10.1083/jcb.200908136; Muftuoglu M, 2006, CANCER RES, V66, P113, DOI 10.1158/0008-5472.CAN-05-2742; Parrish JZ, 2003, EMBO J, V22, P3451, DOI 10.1093/emboj/cdg320; Pomerantz RT, 2008, NATURE, V456, P762, DOI 10.1038/nature07527; Popuri V, 2014, NUCLEIC ACIDS RES, V42, P5671, DOI 10.1093/nar/gku200; Prado F, 2005, EMBO J, V24, P1267, DOI 10.1038/sj.emboj.7600602; Rudd MD, 1996, J BIOL CHEM, V271, P21549, DOI 10.1074/jbc.271.35.21549; Rudolph CJ, 2007, DNA REPAIR, V6, P981, DOI 10.1016/j.dnarep.2007.02.017; Sabouri N, 2012, GENE DEV, V26, P581, DOI 10.1101/gad.184697.111; Saharia A, 2008, CURR BIOL, V18, P496, DOI 10.1016/j.cub.2008.02.071; Saharia A, 2010, J BIOL CHEM, V285, P27057, DOI 10.1074/jbc.M110.112276; SAMBROOK J, 1989, MOL CLONING LABORATO, pCH7; Schoeftner S, 2008, NAT CELL BIOL, V10, P228, DOI 10.1038/ncb1685; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Shen BH, 1996, J BIOL CHEM, V271, P9173, DOI 10.1074/jbc.271.16.9173; Sidorova JM, 2008, DNA REPAIR, V7, P1776, DOI 10.1016/j.dnarep.2008.07.017; Singh DK, 2009, BIOGERONTOLOGY, V10, P235, DOI 10.1007/s10522-008-9205-z; Skourti-Stathaki K, 2014, GENE DEV, V28, P1384, DOI 10.1101/gad.242990.114; Sordet O, 2010, CELL CYCLE, V9, P274, DOI 10.4161/cc.9.2.10506; d'Alcontres MS, 2014, CELL CYCLE, V13, P1463, DOI 10.4161/cc.28419; Stewart JA, 2006, J BIOL CHEM, V281, P38565, DOI 10.1074/jbc.M606884200; Stewart JA, 2012, EMBO J, V31, P3537, DOI 10.1038/emboj.2012.215; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Stewart SA, 2003, NAT GENET, V33, P492, DOI 10.1038/ng1127; Tsutakawa SE, 2011, CELL, V145, P198, DOI 10.1016/j.cell.2011.03.004; Vallabhaneni H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003639; Vannier JB, 2012, CELL, V149, P795, DOI 10.1016/j.cell.2012.03.030; Zheng L, 2005, EMBO REP, V6, P83, DOI 10.1038/sj.embor.7400313	53	20	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15133	15145		10.1074/jbc.M115.647388	http://dx.doi.org/10.1074/jbc.M115.647388			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25922071	hybrid, Green Published			2022-12-28	WOS:000356177300028
J	Antonenkov, VD; Isomursu, A; Mennerich, D; Vapola, MH; Weiher, H; Kietzmann, T; Hiltunen, JK				Antonenkov, Vasily D.; Isomursu, Antti; Mennerich, Daniela; Vapola, Miia H.; Weiher, Hans; Kietzmann, Thomas; Hiltunen, J. Kalervo			The Human Mitochondrial DNA Depletion Syndrome Gene MPV17 Encodes a Non-selective Channel That Modulates Membrane Potential	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; INNER MEMBRANE; CELL-DEATH; AUTOPHAGY; PROTEIN; FUSION; TRANSLOCATION; FISSION; DISEASE; MTDNA	The human MPV17-related mitochondrial DNA depletion syndrome is an inherited autosomal recessive disease caused by mutations in the inner mitochondrial membrane protein MPV17. Although more than 30 MPV17 gene mutations were shown to be associated with mitochondrial DNA depletion syndrome, the function of MPV17 is still unknown. Mice deficient in Mpv17 show signs of premature aging. In the present study, we used electrophysiological measurements with recombinant MPV17 to reveal that this protein forms a non-selective channel with a pore diameter of 1.8 nm and located the channel's selectivity filter. The channel was weakly cation-selective and showed several subconductance states. Voltage-dependent gating of the channel was regulated by redox conditions and pH and was affected also in mutants mimicking a phosphorylated state. Likewise, the mitochondrial membrane potential (Delta psi(m)) and the cellular production of reactive oxygen species were higher in embryonic fibroblasts from Mpv17(-/-) mice. However, despite the elevated Delta psi(m), the Mpv17-deficient mitochondria showed signs of accelerated fission. Together, these observations uncover the role of MPV17 as a Delta psi(m)-modulating channel that apparently contributes to mitochondrial homeostasis under different conditions.	[Antonenkov, Vasily D.; Isomursu, Antti; Mennerich, Daniela; Vapola, Miia H.; Kietzmann, Thomas; Hiltunen, J. Kalervo] Univ Oulu, Bioctr Oulu, Fac Biochem & Mol Med, FI-90014 Oulu, Finland; [Weiher, Hans] Leibniz Inst Expt Virol, Heinrich Pette Inst, D-20251 Hamburg, Germany	University of Oulu; Heinrich Pette Institute	Antonenkov, VD (corresponding author), Univ Oulu, Bioctr Oulu, Fac Biochem & Mol Med, POB 3000, FI-90014 Oulu, Finland.	vasily.antonenkov@oulu.fi; kalervo.hiltunen@oulu.fi		Kietzmann, Thomas/0000-0003-0242-8636; Salo, Miia/0000-0003-2085-7880; Hiltunen, Kalervo/0000-0002-3073-9602	Academy of Finland; Sigrid Juselius Foundation; Biocenter Oulu	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Biocenter Oulu	This work was supported by grants from the Academy of Finland, the Sigrid Juselius Foundation, and Biocenter Oulu.	Antonenkov V. D., 2011, 3 EMBO M B108 VIENN, P115; Antonenkov VD, 2012, BBA-MOL BASIS DIS, V1822, P1374, DOI 10.1016/j.bbadis.2011.12.011; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Binder CJ, 1999, AM J PATHOL, V154, P1067, DOI 10.1016/S0002-9440(10)65359-X; Bolter B, 1999, EMBO J, V18, P5505, DOI 10.1093/emboj/18.20.5505; Bottani E, 2014, MOL THER, V22, P10, DOI 10.1038/mt.2013.230; Casalena G, 2014, AM J PHYSIOL-RENAL, V306, pF1372, DOI 10.1152/ajprenal.00608.2013; Dalla Rosa I, 2014, NUCLEIC ACIDS RES, V42, P8500, DOI 10.1093/nar/gku513; Dallabona C, 2010, HUM MOL GENET, V19, P1098, DOI 10.1093/hmg/ddp581; De Marchi U, 2008, BBA-BIOENERGETICS, V1777, P1438, DOI 10.1016/j.bbabio.2008.08.007; Dishon M, 2011, LANGMUIR, V27, P12977, DOI 10.1021/la202533s; Drin G, 2010, FEBS LETT, V584, P1840, DOI 10.1016/j.febslet.2009.10.022; Edwards JC, 2010, FEBS LETT, V584, P2102, DOI 10.1016/j.febslet.2010.01.037; Ehses S, 2009, J CELL BIOL, V187, P1023, DOI 10.1083/jcb.200906084; El-Hattab A. W., 2012, GENEREVIEWS; El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6; El-Hattab AW, 2010, MOL GENET METAB, V99, P300, DOI 10.1016/j.ymgme.2009.10.003; Fan XY, 2010, FREE RADICAL BIO MED, V49, P1646, DOI 10.1016/j.freeradbiomed.2010.08.024; Fedorowicz MA, 2014, EMBO REP, V15, P86, DOI 10.1002/embr.201337294; Frank M, 2012, BBA-MOL CELL RES, V1823, P2297, DOI 10.1016/j.bbamcr.2012.08.007; Gincel D, 2001, BIOCHEM J, V358, P147, DOI 10.1042/0264-6021:3580147; Gorlach A, 2007, METHOD ENZYMOL, V435, P421, DOI 10.1016/S0076-6879(07)35022-2; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Goo HG, 2013, BBA-MOL CELL RES, V1833, P1866, DOI 10.1016/j.bbamcr.2013.03.016; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; Heinen A, 2007, AM J PHYSIOL-HEART C, V293, pH1400, DOI 10.1152/ajpheart.00198.2007; Hempel SL, 1999, FREE RADICAL BIO MED, V27, P146, DOI 10.1016/S0891-5849(99)00061-1; Jendrach M, 2008, MITOCHONDRION, V8, P293, DOI 10.1016/j.mito.2008.06.001; Kadenbach B, 2010, BBA-GEN SUBJECTS, V1800, P205, DOI 10.1016/j.bbagen.2009.04.019; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; Krick S, 2008, P NATL ACAD SCI USA, V105, P14106, DOI 10.1073/pnas.0801146105; Kunkele KP, 1998, CELL, V93, P1009, DOI 10.1016/S0092-8674(00)81206-4; Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.E02-06-0330; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; Mailloux RJ, 2014, REDOX BIOL, V2, P123, DOI 10.1016/j.redox.2013.12.011; Mailloux RJ, 2011, FREE RADICAL BIO MED, V51, P1106, DOI 10.1016/j.freeradbiomed.2011.06.022; Marks JD, 2005, J NEUROSCI, V25, P6561, DOI 10.1523/JNEUROSCI.1450-05.2005; Matsuzaki K, 1998, BBA-REV BIOMEMBRANES, V1376, P391, DOI 10.1016/S0304-4157(98)00014-8; MORAN O, 1990, J BIOL CHEM, V265, P908; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Navarro-Yepes J, 2014, ANTIOXID REDOX SIGN, V21, P66, DOI 10.1089/ars.2014.5837; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; PETRONILLI V, 1989, FEBS LETT, V259, P137, DOI 10.1016/0014-5793(89)81513-3; Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Reinhold R, 2012, MOL CELL BIOL, V32, P5009, DOI 10.1128/MCB.00843-12; Rokka A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005090; Roux B, 2011, J GEN PHYSIOL, V137, P415, DOI 10.1085/jgp.201010577; Scorrano L, 1997, J BIOL CHEM, V272, P12295, DOI 10.1074/jbc.272.19.12295; Shutt T, 2012, EMBO REP, V13, P909, DOI 10.1038/embor.2012.128; SORGATO MC, 1987, NATURE, V330, P498, DOI 10.1038/330498a0; Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765; Szabo I, 2014, PHYSIOL REV, V94, P519, DOI 10.1152/physrev.00021.2013; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001; Uusimaa J, 2014, EUR J HUM GENET, V22, P184, DOI 10.1038/ejhg.2013.112; Viscomi C, 2009, HUM MOL GENET, V18, P12, DOI 10.1093/hmg/ddn309; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wanagat J, 2010, MECH AGEING DEV, V131, P527, DOI 10.1016/j.mad.2010.06.002; Watanabe T, 2014, EXP CELL RES, V323, P314, DOI 10.1016/j.yexcr.2014.02.027; WEIHER H, 1990, CELL, V62, P425, DOI 10.1016/0092-8674(90)90008-3; Wirth A, 2003, MOL CELL, V12, P261, DOI 10.1016/S1097-2765(03)00283-1; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013	65	42	43	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13840	13861		10.1074/jbc.M114.608083	http://dx.doi.org/10.1074/jbc.M114.608083			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25861990	Green Published, hybrid			2022-12-28	WOS:000355313000018
J	Yuan, FH; Dutta, T; Wang, L; Song, L; Gu, LY; Qian, LY; Benitez, A; Ning, SB; Malhotra, A; Deutscher, MP; Zhang, YB				Yuan, Fenghua; Dutta, Tanmay; Wang, Ling; Song, Lei; Gu, Liya; Qian, Liangyue; Benitez, Anaid; Ning, Shunbin; Malhotra, Arun; Deutscher, Murray P.; Zhang, Yanbin			Human DNA Exonuclease TREX1 Is Also an Exoribonuclease That Acts on Single-stranded RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AICARDI-GOUTIERES-SYNDROME; FAMILIAL CHILBLAIN LUPUS; DEGRADATION ACTIVITY; DOMINANT MUTATIONS; AUTOIMMUNE-DISEASE; CRYSTAL-STRUCTURE; PROTEIN; GENE; SPECIFICITY; EXPRESSION	3' repair exonuclease 1 (TREX1) is a known DNA exonuclease involved in autoimmune disorders and the antiviral response. In this work, we show that TREX1 is also a RNA exonuclease. Purified TREX1 displays robust exoribonuclease activity that degrades single-stranded, but not double-stranded, RNA. TREX1-D200N, an Aicardi-Goutieres syndrome disease-causing mutant, is defective in degrading RNA. TREX1 activity is strongly inhibited by a stretch of pyrimidine residues as is a bacterial homolog, RNase T. Kinetic measurements indicate that the apparent K-m of TREX1 for RNA is higher than that for DNA. Like RNase T, human TREX1 is active in degrading native tRNA substrates. Previously reported TREX1 crystal structures have revealed that the substrate binding sites are open enough to accommodate the extra hydroxyl group in RNA, further supporting our conclusion that TREX1 acts on RNA. These findings indicate that its RNase activity needs to be taken into account when evaluating the physiological role of TREX1.	[Yuan, Fenghua; Dutta, Tanmay; Song, Lei; Qian, Liangyue; Benitez, Anaid; Malhotra, Arun; Deutscher, Murray P.; Zhang, Yanbin] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA; [Wang, Ling; Ning, Shunbin] E Tennessee State Univ, Dept Med, Quillen Coll Med, Ctr Inflammat Infect Dis & Immun, Johnson City, TN 37614 USA; [Gu, Liya] Univ Kentucky, Grad Ctr Toxicol, Coll Med, Lexington, KY 40536 USA	University of Miami; East Tennessee State University; University of Kentucky	Zhang, YB (corresponding author), Gautier Bldg,Rm 311,1011 NW 15th St, Miami, FL 33136 USA.	yzhang4@med.miami.edu	Zhang, Yanbin/F-2998-2011; Regan, Clinton/E-6250-2012; Ning, Shunbin/AAC-6895-2021; Ning, Shunbin/I-3961-2019; Malhotra, Arun/Z-5140-2019	Zhang, Yanbin/0000-0002-7263-5510; Ning, Shunbin/0000-0001-5484-5779; Malhotra, Arun/0000-0001-6656-7841; Benitez, Anaid/0000-0002-5861-588X	National Institutes of Health [HL105631, GM16317]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105631] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM016317, F32GM016317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL105631 (to Y. Z.) and GM16317 (to M. D.).	Bailey SL, 2012, DNA REPAIR, V11, P65, DOI 10.1016/j.dnarep.2011.10.007; Barber GN, 2011, IMMUNOL REV, V243, P99, DOI 10.1111/j.1600-065X.2011.01051.x; Benitez A, 2014, NUCLEIC ACIDS RES, V42, P1671, DOI 10.1093/nar/gkt975; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; de Silva U, 2007, J BIOL CHEM, V282, P10537, DOI 10.1074/jbc.M700039200; DeLano W.L, PYMOL MOL GRAPHICS S; DEUTSCHER MP, 1978, NUCLEIC ACIDS RES, V5, P3821, DOI 10.1093/nar/5.10.3821; Dutta T, 2009, J BIOL CHEM, V284, P15425, DOI 10.1074/jbc.M109.005462; Fye JM, 2011, J BIOL CHEM, V286, P32373, DOI 10.1074/jbc.M111.276287; Geijtenbeek TBH, 2010, NAT IMMUNOL, V11, P979, DOI 10.1038/ni1110-979; Hasan M, 2013, NAT IMMUNOL, V14, P61, DOI 10.1038/ni.2475; Hoss M, 1999, EMBO J, V18, P3868, DOI 10.1093/emboj/18.13.3868; Kavanagh D, 2008, CELL CYCLE, V7, P1718, DOI 10.4161/cc.7.12.6162; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Lee-Kirsch MA, 2007, J MOL MED-JMM, V85, P531, DOI 10.1007/s00109-007-0199-9; Lehtinen DA, 2008, J BIOL CHEM, V283, P31649, DOI 10.1074/jbc.M806155200; Li ZW, 1996, J BIOL CHEM, V271, P1133, DOI 10.1074/jbc.271.2.1133; Mazur DJ, 1999, J BIOL CHEM, V274, P19655, DOI 10.1074/jbc.274.28.19655; Mazur DJ, 2001, J BIOL CHEM, V276, P14718, DOI 10.1074/jbc.M010051200; Mazur DJ, 2001, J BIOL CHEM, V276, P17022, DOI 10.1074/jbc.M100623200; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; O'Driscoll M, 2008, DNA REPAIR, V7, P997, DOI 10.1016/j.dnarep.2008.02.010; Orebaugh CD, 2011, J BIOL CHEM, V286, P40246, DOI 10.1074/jbc.M111.297903; Reijns MAM, 2014, BIOCHEM SOC T, V42, P717, DOI 10.1042/BST20140079; Rice G, 2007, AM J HUM GENET, V80, P811, DOI 10.1086/513443; Richards A, 2007, NAT GENET, V39, P1068, DOI 10.1038/ng2082; Rigby RE, 2008, BIOESSAYS, V30, P833, DOI 10.1002/bies.20808; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941; Zuo YH, 1999, NUCLEIC ACIDS RES, V27, P4077, DOI 10.1093/nar/27.20.4077; Zuo YH, 2002, J BIOL CHEM, V277, P50155, DOI 10.1074/jbc.M207706200; Zuo YH, 2002, J BIOL CHEM, V277, P29654, DOI 10.1074/jbc.M204252200; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017; Zuo YH, 2007, STRUCTURE, V15, P417, DOI 10.1016/j.str.2007.02.004	34	23	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13344	13353		10.1074/jbc.M115.653915	http://dx.doi.org/10.1074/jbc.M115.653915			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25855793	Green Published, hybrid			2022-12-28	WOS:000354975700032
J	Beyriere, F; Sommer, ME; Szczepek, M; Bartl, FJ; Hofmann, KP; Heck, M; Ritter, E				Beyriere, Florent; Sommer, Martha E.; Szczepek, Michal; Bartl, Franz J.; Hofmann, Klaus Peter; Heck, Martin; Ritter, Eglof			Formation and Decay of the Arrestin center dot Rhodopsin Complex in Native Disc Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFORM INFRARED-SPECTROSCOPY; PROTEIN-COUPLED RECEPTOR; METARHODOPSIN-II; CRYSTAL-STRUCTURE; PHOSPHORYLATION SITES; MONOMERIC RHODOPSIN; SECONDARY STRUCTURE; FTIR SPECTROSCOPY; VISUAL ARRESTIN; SIGNALING STATE	In the G protein-coupled receptor rhodopsin, light-induced cis/trans isomerization of the retinal ligand triggers a series of distinct receptor states culminating in the active Metarhodopsin II (Meta II) state, which binds and activates the G protein transducin (G(t)). Long before Meta II decays into the aporeceptor opsin and free all-trans-retinal, its signaling is quenched by receptor phosphorylation and binding of the protein arrestin-1, which blocks further access of G(t) to Meta II. Although recent crystal structures of arrestin indicate how it might look in a pre-complex with the phosphorylated receptor, the transition into the high affinity complex is not understood. Here we applied Fourier transform infrared spectroscopy to monitor the interaction of arrestin-1 and phosphorylated rhodopsin in native disc membranes. By isolating the unique infrared signature of arrestin binding, we directly observed the structural alterations in both reaction partners. In the high affinity complex, rhodopsin adopts a structure similar to G(t)-bound Meta II. In arrestin, a modest loss of beta-sheet structure indicates an increase in flexibility but is inconsistent with a large scale structural change. During Meta II decay, the arrestin-rhodopsin stoichiometry shifts from 1:1 to 1:2. Arrestin stabilizes half of the receptor population in a specific Meta II protein conformation, whereas the other half decays to inactive opsin. Altogether these results illustrate the distinct binding modes used by arrestin to interact with different functional forms of the receptor.	[Beyriere, Florent; Sommer, Martha E.; Szczepek, Michal; Bartl, Franz J.; Hofmann, Klaus Peter; Heck, Martin] Charite, Inst Med Phys & Biophys, D-10117 Berlin, Germany; [Bartl, Franz J.; Hofmann, Klaus Peter] Humboldt Univ, Zentrum Biophys & Bioinformat BPI, D-10115 Berlin, Germany; [Ritter, Eglof] Humboldt Univ, Inst Biol, Expt Biophys, D-10115 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; Humboldt University of Berlin	Ritter, E (corresponding author), Humboldt Univ, Inst Biol, Expt Biophys, D-10115 Berlin, Germany.	eglof.ritter@hu-berlin.de		Sommer, Martha E./0000-0003-0493-8584	Deutsche Forschungsgemeinschaft [SFB 740, SO1037/1-2]; European Research Council; German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung) [05K13KH1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF))	This work was supported by Deutsche Forschungsgemeinschaft Collaborative Research Grant SFB 740 (to K. P. H. and M. H.) and Grant SO1037/1-2 (to M. E. S.), European Research Council Advanced Grant "Towards Understanding the Structure and Dynamics of Receptor Protein" (TUDOR) (to K. P. H.), and German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung) Grant 05K13KH1 (to Peter Hegemann).	Ahuja S, 2009, NAT STRUCT MOL BIOL, V16, P168, DOI 10.1038/nsmb.1549; Allin C, 2001, P NATL ACAD SCI USA, V98, P7754, DOI 10.1073/pnas.131549798; ARNIS S, 1993, P NATL ACAD SCI USA, V90, P7849, DOI 10.1073/pnas.90.16.7849; ARRONDO JLR, 1993, PROG BIOPHYS MOL BIO, V59, P23, DOI 10.1016/0079-6107(93)90006-6; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; BANDEKAR J, 1979, P NATL ACAD SCI USA, V76, P774, DOI 10.1073/pnas.76.2.774; Bartl F, 2000, FEBS LETT, V473, P259, DOI 10.1016/S0014-5793(00)01544-1; Bartl FJ, 2001, J BIOL CHEM, V276, P30161, DOI 10.1074/jbc.M101506200; Bayburt TH, 2011, J BIOL CHEM, V286, P1420, DOI 10.1074/jbc.M110.151043; Cooper E A, 1995, Pharm Biotechnol, V7, P101; Deupi X, 2010, PHYSIOLOGY, V25, P293, DOI 10.1152/physiol.00002.2010; Elgeti M, 2013, J AM CHEM SOC, V135, P12305, DOI 10.1021/ja405133k; Elgeti M, 2011, J AM CHEM SOC, V133, P7159, DOI 10.1021/ja200545n; Elgeti M, 2008, Z PHYS CHEM, V222, P1117, DOI 10.1524/zpch.2008.5392; FAHMY K, 1993, P NATL ACAD SCI USA, V90, P10206, DOI 10.1073/pnas.90.21.10206; Garwin GG, 2000, METHOD ENZYMOL, V316, P313; Gibson SK, 1998, BIOCHEMISTRY-US, V37, P11393, DOI 10.1021/bi980933w; GOORMAGHTIGH E, 1990, EUR J BIOCHEM, V193, P409, DOI 10.1111/j.1432-1033.1990.tb19354.x; Granzin J, 1998, NATURE, V391, P918, DOI 10.1038/36147; Gurevich VV, 2011, PROG RETIN EYE RES, V30, P405, DOI 10.1016/j.preteyeres.2011.07.002; Hanson SM, 2007, P NATL ACAD SCI USA, V104, P3125, DOI 10.1073/pnas.0610886104; HENRY ER, 1992, METHOD ENZYMOL, V210, P129; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Kim M, 2012, P NATL ACAD SCI USA, V109, P18407, DOI 10.1073/pnas.1216304109; Kim YJ, 2013, NATURE, V497, P142, DOI 10.1038/nature12133; Klahn M, 2004, J PHYS CHEM A, V108, P6186, DOI 10.1021/jp048617g; Knierim B, 2007, P NATL ACAD SCI USA, V104, P20290, DOI 10.1073/pnas.0710393104; KRIMM S, 1962, J MOL BIOL, V4, P528; Lefkowitz RJ, 2013, PROG MOL BIOL TRANSL, V118, P3, DOI 10.1016/B978-0-12-394440-5.00001-2; Mahalingam M, 2008, P NATL ACAD SCI USA, V105, P17795, DOI 10.1073/pnas.0804541105; Maurice P, 2011, ADV PHARMACOL, V62, P349, DOI 10.1016/B978-0-12-385952-5.00001-4; Mendez A, 2000, NEURON, V28, P153, DOI 10.1016/S0896-6273(00)00093-3; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Piechnick R, 2011, BIOCHEMISTRY-US, V50, P7168, DOI 10.1021/bi200675y; Ritter E, 2007, J BIOL CHEM, V282, P10720, DOI 10.1074/jbc.M610658200; SCHLEICHER A, 1989, BIOCHEMISTRY-US, V28, P1770, DOI 10.1021/bi00430a052; Schroder K, 2002, J BIOL CHEM, V277, P43987, DOI 10.1074/jbc.M206211200; Shukla AK, 2013, NATURE, V497, P137, DOI 10.1038/nature12120; Siebert F, 1995, ISRAEL J CHEM, V35, P309; SMITH WC, 1994, J BIOL CHEM, V269, P15407; Sommer ME, 2006, VISION RES, V46, P4532, DOI 10.1016/j.visres.2006.08.031; Sommer Martha E, 2014, Handb Exp Pharmacol, V219, P101, DOI 10.1007/978-3-642-41199-1_5; Sommer ME, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2000; Sommer ME, 2011, J BIOL CHEM, V286, P7359, DOI 10.1074/jbc.M110.204941; Sommer ME, 2006, J BIOL CHEM, V281, P9407, DOI 10.1074/jbc.M510037200; Szczepek M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5801; Tsukamoto H, 2010, J MOL BIOL, V399, P501, DOI 10.1016/j.jmb.2010.04.029; Vedantham G, 2000, ANAL BIOCHEM, V285, P33, DOI 10.1006/abio.2000.4744; Vishnivetskiy SA, 2007, J BIOL CHEM, V282, P32075, DOI 10.1074/jbc.M706057200; Vogel R, 2003, BIOCHEMISTRY-US, V42, P9863, DOI 10.1021/bi034684+; Vogel R, 2001, J BIOL CHEM, V276, P38487, DOI 10.1074/jbc.M105423200; Vogel R, 2007, J MOL BIOL, V366, P1580, DOI 10.1016/j.jmb.2006.12.019; Ye SX, 2010, NATURE, V464, P1386, DOI 10.1038/nature08948; Zhang LR, 1997, J BIOL CHEM, V272, P14762, DOI 10.1074/jbc.272.23.14762; Zhuang TD, 2013, P NATL ACAD SCI USA, V110, P942, DOI 10.1073/pnas.1215176110	56	9	9	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12919	12928		10.1074/jbc.M114.620898	http://dx.doi.org/10.1074/jbc.M114.620898			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25847250	Green Published, hybrid			2022-12-28	WOS:000354569000041
J	Deng, GP; Nagai, Y; Xiao, Y; Li, ZY; Dai, SJ; Ohtani, T; Banham, A; Li, B; Wu, SL; Hancock, W; Samanta, A; Zhang, HT; Greene, MI				Deng, Guoping; Nagai, Yasuhiro; Xiao, Yan; Li, Zhiyuan; Dai, Shujia; Ohtani, Takuya; Banham, Alison; Li, Bin; Wu, Shiaw-Lin; Hancock, Wayne; Samanta, Arabinda; Zhang, Hongtao; Greene, Mark I.			Pim-2 Kinase Influences Regulatory T Cell Function and Stability by Mediating Foxp3 Protein N-terminal Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE ACETYLTRANSFERASE; PROMOTER OCCUPANCY; IMMUNE REGULATION; GENE-EXPRESSION; SELF-TOLERANCE; CUTTING EDGE; TGF-BETA; KAPPA-B; TRANSCRIPTION; ACTIVATION	Regulation of the extent of immune responses is a requirement to maintain self-tolerance and limit inflammatory processes. CD4(+)CD25(+)Foxp3(+) regulatory T (Treg) cells play a role in regulation. The Foxp3 transcription factor is considered a dominant regulator for Treg cell development and function. Foxp3 function itself is directly regulated by multiple post-translational modifications that occur in response to various external stimuli. The Foxp3 protein is a component of several dynamic macromolecular regulatory complexes. The complexes change constituents over time and through different signals to regulate the development and function of regulatory T cells. Here we identified a mechanism regulating Foxp3 level and activity that operates through discrete phosphorylation. The Pim-2 kinase can phosphorylate Foxp3, leading to decreased suppressive functions of Treg cells. The amino-terminal domain of Foxp3 is modified at several sites by Pim-2 kinase. This modification leads to altered expression of proteins related to Treg cell functions and increased Treg cell lineage stability. Treg cell suppressive function can be up-regulated by either pharmacologically inhibiting Pim-2 kinase activity or by genetically knocking out Pim-2 in rodent Treg cells. Deficiency of Pim-2 activity increases murine host resistance to dextran sodium sulfate-induced colitis in vivo, and a Pim-2 small molecule kinase inhibitor also modified Treg cell functions. Our studies define a pathway for limiting the regulation of Foxp3 function because the Pim-2 kinase represents a potential therapeutic target for modulating the Treg cell suppressive activities in controlling immune responses.	[Deng, Guoping; Nagai, Yasuhiro; Xiao, Yan; Ohtani, Takuya; Samanta, Arabinda; Zhang, Hongtao; Greene, Mark I.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Li, Zhiyuan; Li, Bin] Chinese Acad Sci, Key Lab Mol Virol & Immunol, Inst Pasteur Shanghai, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Dai, Shujia; Wu, Shiaw-Lin] Northeastern Univ, Barnett Inst Chem & Biol Anal, Dept Chem & Chem Biol, Coll Sci, Boston, MA 02115 USA; [Banham, Alison] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Oxford OX3 9DU, England; [Hancock, Wayne] Childrens Hosp Philadelphia, Div Transplant Immunol, Philadelphia, PA 19104 USA; [Hancock, Wayne] Childrens Hosp Philadelphia, Biesecker Ctr Pediat Liver Dis, Philadelphia, PA 19104 USA	University of Pennsylvania; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Northeastern University; University of Oxford; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Greene, MI (corresponding author), Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	greene@reo.med.upenn.edu	lI, Bin/AAR-4966-2021; Regan, Clinton/E-6250-2012	lI, Bin/0000-0002-7640-8884; Zhang, Hongtao/0000-0001-9173-0049; Banham, Alison/0000-0002-3197-273X	National Institutes of Health [PO1 AI073489-03]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI073489] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported, in whole or in part, by National Institutes of Health Grant PO1 AI073489-03 (to M. I. G.).	Alvarado Y, 2012, EXPERT REV HEMATOL, V5, P81, DOI [10.1586/EHM.11.69, 10.1586/ehm.11.69]; Barnes MJ, 2009, IMMUNITY, V31, P401, DOI 10.1016/j.immuni.2009.08.011; Basu S, 2008, J IMMUNOL, V180, P5794, DOI 10.4049/jimmunol.180.9.5794; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Bettini ML, 2012, IMMUNITY, V36, P717, DOI 10.1016/j.immuni.2012.03.020; BREUER ML, 1989, EMBO J, V8, P743, DOI 10.1002/j.1460-2075.1989.tb03434.x; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Chen CX, 2006, J BIOL CHEM, V281, P36828, DOI 10.1074/jbc.M608848200; Chen XP, 2002, P NATL ACAD SCI USA, V99, P2175, DOI 10.1073/pnas.042035699; Crellin NK, 2007, BLOOD, V109, P2014, DOI 10.1182/blood-2006-07-035279; Darce J, 2012, IMMUNITY, V36, P731, DOI 10.1016/j.immuni.2012.04.007; Deng GP, 2012, EXP MOL PATHOL, V93, P334, DOI 10.1016/j.yexmp.2012.09.013; Du TF, 2013, EXP MOL PATHOL, V95, P38, DOI 10.1016/j.yexmp.2013.04.003; Fox CJ, 2005, J EXP MED, V201, P259, DOI 10.1084/jem.20042020; Hammerman PS, 2005, BLOOD, V105, P4477, DOI 10.1182/blood-2004-09-3706; Hancock WW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007890; Hogan C, 2008, J BIOL CHEM, V283, P18012, DOI 10.1074/jbc.M709695200; Holmes D, 2007, J BIOL CHEM, V282, P15973, DOI 10.1074/jbc.M702051200; Huber S, 2004, J IMMUNOL, V173, P6526, DOI 10.4049/jimmunol.173.11.6526; Isaac M, 2011, DRUG RESIST UPDATE, V14, P203, DOI 10.1016/j.drup.2011.04.002; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Li B, 2007, CELL CYCLE, V6, P1432; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Li ZY, 2014, J BIOL CHEM, V289, P26872, DOI 10.1074/jbc.M114.586651; Lopes JE, 2006, J IMMUNOL, V177, P3133, DOI 10.4049/jimmunol.177.5.3133; Mikkers H, 2004, MOL CELL BIOL, V24, P6104, DOI 10.1128/MCB.24.13.6104-6115.2004; Morawski PA, 2013, J BIOL CHEM, V288, P24494, DOI 10.1074/jbc.M113.467704; Nakahira K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077099; Nie H, 2013, NAT MED, V19, P322, DOI 10.1038/nm.3085; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; QIN SX, 1993, SCIENCE, V259, P974, DOI 10.1126/science.8094901; SAKAGUCHI S, 1985, J EXP MED, V161, P72, DOI 10.1084/jem.161.1.72; Samanta A, 2008, P NATL ACAD SCI USA, V105, P14023, DOI 10.1073/pnas.0806726105; SELTEN G, 1985, EMBO J, V4, P1793, DOI 10.1002/j.1460-2075.1985.tb03852.x; Shevach EM, 2006, NAT REV IMMUNOL, V6, P613, DOI 10.1038/nri1867; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Song XM, 2012, CELL REPORTS, V1, P665, DOI 10.1016/j.celrep.2012.04.012; SUZUKI H, 1995, SCIENCE, V268, P1472, DOI 10.1126/science.7770771; Taylor PA, 2001, J EXP MED, V193, P1311, DOI 10.1084/jem.193.11.1311; van Loosdregt J, 2014, TRENDS IMMUNOL, V35, P368, DOI 10.1016/j.it.2014.06.005; White E, 2003, GENE DEV, V17, P1813, DOI 10.1101/gad.1123103; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Xiao Y, 2014, CELL REP, V7, P1471, DOI 10.1016/j.celrep.2014.04.021; Xiao Y, 2010, CURR OPIN IMMUNOL, V22, P583, DOI 10.1016/j.coi.2010.08.013; Zhang HT, 2012, IMMUNOL CELL BIOL, V90, P95, DOI 10.1038/icb.2011.101	46	55	58	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20211	20220		10.1074/jbc.M115.638221	http://dx.doi.org/10.1074/jbc.M115.638221			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	25987564	Green Published, hybrid			2022-12-28	WOS:000359608900022
J	Koh, EI; Henderson, JP				Koh, Eun-Ik; Henderson, Jeffrey P.			Microbial Copper-binding Siderophores at the Host-Pathogen Interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							UROPATHOGENIC ESCHERICHIA-COLI; IRON TRANSPORT COMPOUNDS; P-TYPE ATPASE; YERSINIA-PESTIS; PSEUDOMONAS-AERUGINOSA; FERRIC ENTEROBACTIN; VIRULENCE FACTOR; SUPEROXIDE-DISMUTASE; METAL SELECTIVITY; SULFUR CLUSTERS	Numerous pathogenic microorganisms secrete small molecule chelators called siderophores defined by their ability to bind extracellular ferric iron, making it bioavailable to microbes. Recently, a siderophore produced by uropathogenic Escherichia coli, yersiniabactin, was found to also bind copper ions during human infections. The ability of yersiniabactin to protect E. coli from copper toxicity and redox-based phagocyte defenses distinguishes it from other E. coli siderophores. Here we compare yersiniabactin to other extracellular copper-binding molecules and review how copper-binding siderophores may confer virulence-associated gains of function during infection pathogenesis.	[Henderson, Jeffrey P.] Washington Univ, Sch Med, Div Infect Dis, Ctr Womens Infect Dis Res, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Henderson, JP (corresponding author), Washington Univ, Sch Med, Div Infect Dis, Ctr Womens Infect Dis Res, St Louis, MO 63110 USA.	jhenderson@DOM.wustl.edu	Henderson, Jeffrey P/D-3337-2015		Burroughs Wellcome Fund; National Institutes of Health through the NIDDK [R01DK099534]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099534] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Institutes of Health through the NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a Career Award for Medical Scientists from the Burroughs Wellcome Fund and National Institutes of Health Grant R01DK099534 (to J. P. H.) through the NIDDK. This is the fourth article in the Thematic Minireview series "Metals at the Host-Pathogen Interface." The authors declare that they have no conflicts of interest with the contents of this article.	Abergel RJ, 2006, J AM CHEM SOC, V128, P8920, DOI 10.1021/ja062046j; Andreini C, 2008, J BIOL INORG CHEM, V13, P1205, DOI 10.1007/s00775-008-0404-5; BAGG A, 1987, BIOCHEMISTRY-US, V26, P5471, DOI 10.1021/bi00391a039; Balasubramanian R, 2011, J BIOL CHEM, V286, P37313, DOI 10.1074/jbc.M111.284984; Balasubramanian R, 2010, NATURE, V465, P115, DOI 10.1038/nature08992; BEAMAN L, 1984, ANNU REV MICROBIOL, V38, P27; Bearden SW, 1997, INFECT IMMUN, V65, P1659, DOI 10.1128/IAI.65.5.1659-1668.1997; Benedek Orsolya, 2007, Acta Microbiologica et Immunologica Hungarica, V54, P89, DOI 10.1556/AMicr.54.2007.2.1; Berger T, 2006, P NATL ACAD SCI USA, V103, P1834, DOI 10.1073/pnas.0510847103; BESWICK PH, 1976, CHEM-BIOL INTERACT, V14, P347, DOI 10.1016/0009-2797(76)90113-7; Brandel J, 2012, DALTON T, V41, P2820, DOI 10.1039/c1dt11804h; Braud A, 2010, ENV MICROBIOL REP, V2, P419, DOI 10.1111/j.1758-2229.2009.00126.x; Brem D, 2001, MICROBIOL-SGM, V147, P1115, DOI 10.1099/00221287-147-5-1115; BRICKMAN TJ, 1992, J BIOL CHEM, V267, P12350; Chaturvedi KS, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00003; Chaturvedi KS, 2014, ACS CHEM BIOL, V9, P551, DOI 10.1021/cb400658k; Chaturvedi KS, 2012, NAT CHEM BIOL, V8, P731, DOI [10.1038/NCHEMBIO.1020, 10.1038/nchembio.1020]; Chillappagari S, 2010, J BACTERIOL, V192, P2512, DOI 10.1128/JB.00058-10; Choi DW, 2008, J INORG BIOCHEM, V102, P1571, DOI 10.1016/j.jinorgbio.2008.02.003; Chu BC, 2010, BIOMETALS, V23, P601, DOI 10.1007/s10534-010-9361-x; CROCKER A, 1992, J NATL MED ASSOC, V84, P697; Djoko KY, 2013, ACS CHEM BIOL, V8, P2217, DOI 10.1021/cb4002443; ECKER DJ, 1983, J BACTERIOL, V155, P616, DOI 10.1128/JB.155.2.616-622.1983; Fetherston JD, 2010, INFECT IMMUN, V78, P2045, DOI 10.1128/IAI.01236-09; Fetherston JD, 1996, MOL MICROBIOL, V22, P315, DOI 10.1046/j.1365-2958.1996.00118.x; Fetherston JD, 1999, MOL MICROBIOL, V32, P289, DOI 10.1046/j.1365-2958.1999.01348.x; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Fu Y, 2014, ACCOUNTS CHEM RES, V47, P3605, DOI 10.1021/ar500300n; Gehring AM, 1998, CHEM BIOL, V5, P573, DOI 10.1016/S1074-5521(98)90115-6; Gleason JE, 2014, P NATL ACAD SCI USA, V111, P5866, DOI 10.1073/pnas.1400137111; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Grass G, 2004, J BACTERIOL, V186, P5826, DOI 10.1128/JB.186.17.5826-5833.2004; Gray LW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038327; HAAG H, 1993, J GEN MICROBIOL, V139, P2159, DOI 10.1099/00221287-139-9-2159; Hagan EC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001187; Hannauer M, 2012, ENVIRON MICROBIOL, V14, P1696, DOI 10.1111/j.1462-2920.2011.02674.x; HARRIS WR, 1979, J AM CHEM SOC, V101, P6097, DOI 10.1021/ja00514a037; HEESEMANN J, 1993, MOL MICROBIOL, V8, P397, DOI 10.1111/j.1365-2958.1993.tb01583.x; Hellman NE, 2002, ANNU REV NUTR, V22, P439, DOI 10.1146/annurev.nutr.22.012502.114457; Hellman NE, 2002, J BIOL CHEM, V277, P46632, DOI 10.1074/jbc.M206246200; Henderson JP, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000305; Hodgkinson V, 2012, J BIOL CHEM, V287, P13549, DOI 10.1074/jbc.R111.316406; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Ilback NG, 2003, BIOL TRACE ELEM RES, V91, P111, DOI 10.1385/BTER:91:2:111; Jozefczak M, 2012, INT J MOL SCI, V13, P3145, DOI 10.3390/ijms13033145; Kenney GE, 2012, ACS CHEM BIOL, V7, pA, DOI 10.1021/cb2003913; Kim B, 2010, J BACTERIOL, V192, P2140, DOI 10.1128/JB.00016-10; Kim HJ, 2004, SCIENCE, V305, P1612, DOI 10.1126/science.1098322; Knapp CW, 2007, P NATL ACAD SCI USA, V104, P12040, DOI 10.1073/pnas.0702879104; Koh EI, 2015, METALLOMICS, V7, P1011, DOI 10.1039/c4mt00341a; Lamont IL, 2002, P NATL ACAD SCI USA, V99, P7072, DOI 10.1073/pnas.092016999; Lukacik P, 2012, P NATL ACAD SCI USA, V109, P9857, DOI 10.1073/pnas.1203472109; Luo MK, 2006, ACS CHEM BIOL, V1, P29, DOI 10.1021/cb0500034; Lv HT, 2014, J PROTEOME RES, V13, P1397, DOI 10.1021/pr4009749; Mabbett AN, 2009, INT J MED MICROBIOL, V299, P53, DOI 10.1016/j.ijmm.2008.06.003; Macomber L, 2007, J BACTERIOL, V189, P1616, DOI 10.1128/JB.01357-06; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; Matousek de Abel de la Cruz A. J., 1993, BIOL TRACE ELEMENT R, V37, P51, DOI DOI 10.1007/BF02789401; Mazur MT, 2003, BIOCHEMISTRY-US, V42, P13393, DOI 10.1021/bi035585z; MESSERSCHMIDT A, 1990, EUR J BIOCHEM, V187, P341, DOI 10.1111/j.1432-1033.1990.tb15311.x; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Miller DA, 2002, CHEM BIOL, V9, P333, DOI 10.1016/S1074-5521(02)00115-1; Miller MC, 2006, J INORG BIOCHEM, V100, P1495, DOI 10.1016/j.jinorgbio.2006.04.007; NEILANDS JB, 1981, ANNU REV BIOCHEM, V50, P715, DOI 10.1146/annurev.bi.50.070181.003435; NEILANDS JB, 1995, J BIOL CHEM, V270, P26723, DOI 10.1074/jbc.270.45.26723; Noinaj N, 2010, ANNU REV MICROBIOL, V64, P43, DOI 10.1146/annurev.micro.112408.134247; Nunes P, 2013, TRAFFIC, V14, P1118, DOI 10.1111/tra.12115; Osman D, 2013, MOL MICROBIOL, V87, P466, DOI 10.1111/mmi.12107; Outten FW, 2001, J BIOL CHEM, V276, P30670, DOI 10.1074/jbc.M104122200; Perry RD, 2011, MICROBES INFECT, V13, P808, DOI 10.1016/j.micinf.2011.04.008; Prentice AM, 2007, J NUTR, V137, P1334, DOI 10.1093/jn/137.5.1334; Raymond KN, 2003, P NATL ACAD SCI USA, V100, P3584, DOI 10.1073/pnas.0630018100; Reigstad CS, 2007, J BIOL CHEM, V282, P21259, DOI 10.1074/jbc.M611502200; Rensing C, 2000, P NATL ACAD SCI USA, V97, P652, DOI 10.1073/pnas.97.2.652; Ridge PG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001378; Rodriguez GM, 2006, J BACTERIOL, V188, P424, DOI 10.1128/JB.188.2.424-430.2006; Schalk IJ, 2008, J INORG BIOCHEM, V102, P1159, DOI 10.1016/j.jinorgbio.2007.11.017; Schwan WR, 2005, INT J MED MICROBIOL, V295, P237, DOI 10.1016/j.ijmm.2005.05.005; Shields-Cutler RR, 2015, J BIOL CHEM, V290, P15949, DOI 10.1074/jbc.M115.645812; Soldati T, 2012, TRAFFIC, V13, P1042, DOI 10.1111/j.1600-0854.2012.01358.x; TUFFT LS, 1988, AVIAN DIS, V32, P779, DOI 10.2307/1590998; Valdebenito M, 2006, INT J MED MICROBIOL, V296, P513, DOI 10.1016/j.ijmm.2006.06.003; Walsh CT, 2012, NAT PROD REP, V29, P37, DOI 10.1039/c1np00072a; Wang JY, 1996, P NATL ACAD SCI USA, V93, P10434, DOI 10.1073/pnas.93.19.10434; White C, 2009, J BIOL CHEM, V284, P33949, DOI 10.1074/jbc.M109.070201; Winterbourn CC, 2006, J BIOL CHEM, V281, P39860, DOI 10.1074/jbc.M605898200; Xu FF, 2012, APPL ENVIRON MICROB, V78, P3614, DOI 10.1128/AEM.07368-11; Zaitseva I, 1996, J BIOL INORG CHEM, V1, P15, DOI 10.1007/s007750050018; Zhang Y, 2011, J BIOL CHEM, V286, P23623, DOI 10.1074/jbc.R110.172833	89	37	37	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					18967	18974		10.1074/jbc.R115.644328	http://dx.doi.org/10.1074/jbc.R115.644328			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26055720	Green Published, hybrid			2022-12-28	WOS:000358781100011
J	Wareham, LK; Poole, RK; Tinajero-Trejo, M				Wareham, Lauren K.; Poole, Robert K.; Tinajero-Trejo, Mariana			CO-releasing Metal Carbonyl Compounds as Antimicrobial Agents in the Post-antibiotic Era	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							UNCOUPLES MITOCHONDRIAL RESPIRATION; BINUCLEAR RHODIUM COMPLEXES; ESCHERICHIA-COLI; HEME OXYGENASE-1; NITRIC-OXIDE; ANTIBACTERIAL ACTIVITY; HYDROGEN-PEROXIDE; FLUORESCENT-PROBE; MONOXIDE RELEASE; AQUEOUS-SOLUTION	The possibility of a "post-antibiotic era" in the 21st century, in which common infections may kill, has prompted research into radically new antimicrobials. CO-releasing molecules (CORMs), mostly metal carbonyl compounds, originally developed for therapeutic CO delivery in animals, are potent antimicrobial agents. Certain CORMs inhibit growth and respiration, reduce viability, and release CO to intracellular hemes, as predicted, but their actions are more complex, as revealed by transcriptomic datasets and modeling. Progress is hindered by difficulties in detecting CO release intracellularly, limited understanding of the biological chemistry of CO reactions with non-heme targets, and the cytotoxicity of some CORMs to mammalian cells.	[Wareham, Lauren K.; Poole, Robert K.; Tinajero-Trejo, Mariana] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Poole, RK (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England.	r.poole@sheffield.ac.uk			Biotechnology and Biological Sciences Research Council; Leverhulme Trust; BBSRC [BB/M022579/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/M022579/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Leverhulme Trust(Leverhulme Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Biotechnology and Biological Sciences Research Council and The Leverhulme Trust (to R. K. P.). This is the eighth article in the Thematic Minireview series "Metals at the Host-Pathogen Interface." The authors declare that they have no conflicts of interest with the contents of this article.	Atkin AJ, 2011, DALTON T, V40, P5755, DOI 10.1039/c0dt01809k; Bang CS, 2014, MICROB PATHOGENESIS, V66, P29, DOI 10.1016/j.micpath.2013.12.003; Bergstraesser C, 2012, FREE RADICAL BIO MED, V52, P794, DOI 10.1016/j.freeradbiomed.2011.11.035; Boczkowski J, 2006, TRENDS BIOCHEM SCI, V31, P614, DOI 10.1016/j.tibs.2006.09.001; Chaves-Ferreira M, 2015, ANGEW CHEM INT EDIT, V54, P1172, DOI 10.1002/anie.201409344; Chin BY, 2009, CURR OPIN PHARMACOL, V9, P490, DOI 10.1016/j.coph.2009.06.025; Chung SW, 2008, J CLIN INVEST, V118, P239, DOI 10.1172/JCI32730; Chung SW, 2009, CELL MICROBIOL, V11, P199, DOI 10.1111/j.1462-5822.2008.01261.x; Clark JE, 2003, CIRC RES, V93, pE2, DOI 10.1161/01.RES.0000084381.86567.08; Crook SH, 2011, DALTON T, V40, P4230, DOI 10.1039/c1dt10125k; D'Amico G, 2006, J CELL SCI, V119, P2291, DOI 10.1242/jcs.02914; Davidge KS, 2009, J BIOL CHEM, V284, P4516, DOI 10.1074/jbc.M808210200; Desmard M, 2012, ANTIOXID REDOX SIGN, V16, P153, DOI 10.1089/ars.2011.3959; Desmard M, 2009, FASEB J, V23, P1023, DOI 10.1096/fj.08-122804; Dordelmann G, 2012, CHEM COMMUN, V48, P11528, DOI 10.1039/c2cc36491c; Esteban J, 2010, ANGEW CHEM INT EDIT, V49, P4934, DOI 10.1002/anie.201001344; FINAZZIAGRO A, 1982, BIOCHEMISTRY-US, V21, P415, DOI 10.1021/bi00531a032; Flatley J, 2005, J BIOL CHEM, V280, P10065, DOI 10.1074/jbc.M410393200; Foresti R, 2004, BRIT J PHARMACOL, V142, P453, DOI 10.1038/sj.bjp.0705825; Fukuto JM, 2012, CHEM RES TOXICOL, V25, P769, DOI 10.1021/tx2005234; Hou SW, 2008, P NATL ACAD SCI USA, V105, P4039, DOI 10.1073/pnas.0800304105; Jesse HE, 2013, BBA-PROTEINS PROTEOM, V1834, P1693, DOI 10.1016/j.bbapap.2013.04.019; Johnson TR, 2007, DALTON T, P1500, DOI 10.1039/b613629j; Keilin D., 1966, HIST CELL RESP CYTOC, P252; Kitagishi H, 2010, ANGEW CHEM INT EDIT, V49, P1312, DOI 10.1002/anie.200906149; Klein M, 2014, J PHYS CHEM A, V118, P5381, DOI 10.1021/jp503407u; Kobeissi S. F., 2014, ARCH CARDIOV D S6 S1, V6, P17, DOI [10.1016/S1878-6480(14)71308-4, DOI 10.1016/S1878-6480(14)71308-4]; Kumar A, 2008, J BIOL CHEM, V283, P18032, DOI 10.1074/jbc.M802274200; Kung Y, 2009, BIOCHEMISTRY-US, V48, P7432, DOI 10.1021/bi900574h; Lam PL, 2014, DALTON T, V43, P3949, DOI 10.1039/c3dt52879k; Lancel S, 2009, J PHARMACOL EXP THER, V329, P641, DOI 10.1124/jpet.108.148049; Lemire JA, 2013, NAT REV MICROBIOL, V11, P371, DOI 10.1038/nrmicro3028; LIGHTHART B, 1973, APPL MICROBIOL, V25, P86, DOI 10.1128/AEM.25.1.86-91.1973; Lo Iacono L, 2011, FREE RADICAL BIO MED, V50, P1556, DOI 10.1016/j.freeradbiomed.2011.02.033; Long R, 2014, BBA-BIOENERGETICS, V1837, P201, DOI 10.1016/j.bbabio.2013.10.002; Lu S, 2004, J AM CHEM SOC, V126, P15332, DOI 10.1021/ja045233v; Luhachack L, 2014, CURR OPIN MICROBIOL, V21, P13, DOI 10.1016/j.mib.2014.06.017; Mann BE, 2010, TOP ORGANOMETAL CHEM, V32, P247, DOI 10.1007/978-3-642-13185-1_10; McLean S, 2013, ANTIOXID REDOX SIGN, V19, P1999, DOI 10.1089/ars.2012.5103; McLean S, 2012, ANAL BIOCHEM, V427, P36, DOI 10.1016/j.ab.2012.04.026; Medeiros CA, 2011, J MED MICROBIOL, V60, P1146, DOI 10.1099/jmm.0.028910-0; Meister K, 2010, ANGEW CHEM INT EDIT, V49, P3310, DOI 10.1002/anie.201000097; Messner KR, 1999, J BIOL CHEM, V274, P10119, DOI 10.1074/jbc.274.15.10119; Michel BW, 2012, J AM CHEM SOC, V134, P15668, DOI 10.1021/ja307017b; Moragues ME, 2011, J AM CHEM SOC, V133, P15762, DOI 10.1021/ja206251r; Morse D, 2009, FREE RADICAL BIO MED, V47, P1, DOI 10.1016/j.freeradbiomed.2009.04.007; Motterlini R, 2007, BIOCHEM SOC T, V35, P1142, DOI 10.1042/BST0351142; Motterlini R, 2005, EXPERT OPIN INV DRUG, V14, P1305, DOI 10.1517/13543784.14.11.1305; Motterlini R, 2002, CIRC RES, V90, pE17, DOI 10.1161/hh0202.104530; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Munasinghe PC, 2014, RSC ADV, V4, P37575, DOI 10.1039/c4ra04696j; Murakawa T., 2007, ANTIMICROBIAL PHARMA, P103; Murray TS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035499; Nagel C, 2014, DALTON T, V43, P9986, DOI 10.1039/c3dt51848e; Navarathna DHMLP, 2010, FREE RADICAL BIO MED, V49, P1561, DOI 10.1016/j.freeradbiomed.2010.08.020; Nobre LS, 2007, ANTIMICROB AGENTS CH, V51, P4303, DOI 10.1128/AAC.00802-07; Nobre LS, 2009, MICROBIOL-SGM, V155, P813, DOI 10.1099/mic.0.023911-0; Onyiah JC, 2014, GUT MICROBES, V5, P220, DOI 10.4161/gmic.27290; Onyiah JC, 2013, GASTROENTEROLOGY, V144, P789, DOI 10.1053/j.gastro.2012.12.025; Otterbein LE, 2005, CELL MOL BIOL, V51, P433, DOI 10.1170/T647; Pai S, 2014, DALTON T, V43, P8664, DOI 10.1039/c4dt00254g; Park SS, 2012, ANAL CHEM, V84, P1792, DOI 10.1021/ac2031628; Pena AC, 2012, ANTIMICROB AGENTS CH, V56, P1281, DOI 10.1128/AAC.05571-11; Pierri AE, 2012, J AM CHEM SOC, V134, P18197, DOI 10.1021/ja3084434; Poh HT, 2014, ORGANOMETALLICS, V33, P959, DOI 10.1021/om401013a; Policar C, 2011, ANGEW CHEM INT EDIT, V50, P860, DOI 10.1002/anie.201003161; Ramamoorthi L, 2009, MEAT SCI, V83, P358, DOI 10.1016/j.meatsci.2009.06.005; Reeder BJ, 2011, BIOCHEM J, V434, P483, DOI 10.1042/BJ20101136; Romanski S, 2013, FREE RADICAL BIO MED, V65, P78, DOI 10.1016/j.freeradbiomed.2013.06.014; Sandouka A, 2005, CELL MOL BIOL, V51, P425, DOI 10.1170/T646; Santos MFA, 2012, J INORG BIOCHEM, V117, P285, DOI 10.1016/j.jinorgbio.2012.06.018; Santos-Silva T, 2011, J AM CHEM SOC, V133, P1192, DOI 10.1021/ja108820s; Schatzschneider U, 2011, INORG CHIM ACTA, V374, P19, DOI 10.1016/j.ica.2011.02.068; Seixas JD, 2013, DALTON T, V42, P5985, DOI 10.1039/c2dt32174b; Sheikh SZ, 2011, J IMMUNOL, V186, P5506, DOI 10.4049/jimmunol.1002433; Shiloh MU, 2008, CELL HOST MICROBE, V3, P323, DOI 10.1016/j.chom.2008.03.007; Silva-Gomes S, 2013, INFECT IMMUN, V81, P2536, DOI 10.1128/IAI.00251-13; Smith H, 2011, IUBMB LIFE, V63, P363, DOI 10.1002/iub.476; Stripp ST, 2009, P NATL ACAD SCI USA, V106, P17331, DOI 10.1073/pnas.0905343106; Tavares AF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083157; Tavares AFN, 2012, FEMS MICROBIOL LETT, V336, P1, DOI 10.1111/j.1574-6968.2012.02633.x; Tavares AFN, 2011, J BIOL CHEM, V286, P26708, DOI 10.1074/jbc.M111.255752; Tinajero-Trejo M, 2014, J BIOL CHEM, V289, P29471, DOI 10.1074/jbc.M114.573444; Tinajero-Trejo Mariana, 2013, F1000Prime Rep, V5, P28, DOI 10.12703/P5-28; Tsoyi K, 2009, MOL PHARMACOL, V76, P173, DOI 10.1124/mol.109.055137; Vareille M, 2008, J IMMUNOL, V180, P5720, DOI 10.4049/jimmunol.180.8.5720; Wang J, 2012, ANGEW CHEM INT EDIT, V51, P9652, DOI 10.1002/anie.201203684; Wang PP, 2014, EUR J MED CHEM, V74, P199, DOI 10.1016/j.ejmech.2013.12.041; Wang SY, 2009, APPL ENVIRON MICROB, V75, P6110, DOI 10.1128/AEM.00914-09; Ward JS, 2014, CHEM-EUR J, V20, P15061, DOI 10.1002/chem.201403305; Wasser IM, 2005, J AM CHEM SOC, V127, P3310, DOI 10.1021/ja0458773; Wegiel B, 2014, J CLIN INVEST, V124, P4926, DOI 10.1172/JCI72853; WEIGEL PH, 1975, J BIOL CHEM, V250, P8536; Wilkinson WJ, 2009, BRIT J PHARMACOL, V158, P862, DOI 10.1111/j.1476-5381.2009.00354.x; Wilkinson WJ, 2011, PURINERG SIGNAL, V7, P57, DOI 10.1007/s11302-010-9213-8; Wilson JL, 2015, ANTIOXID REDOX SIGN, V23, P148, DOI 10.1089/ars.2014.6151; Wilson JL, 2013, ANTIOXID REDOX SIGN, V19, P497, DOI 10.1089/ars.2012.4784; World Health Organization, 2016, ANTIMICROBIAL RESIST; Zacharia VM, 2013, MBIO, V4, DOI 10.1128/mBio.00721-13; Zhu WM, 2000, J BACTERIOL, V182, P6783, DOI 10.1128/JB.182.23.6783-6790.2000; Zobi F, 2013, J MED CHEM, V56, P6719, DOI 10.1021/jm400527k	101	65	66	3	82	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					18999	19007		10.1074/jbc.R115.642926	http://dx.doi.org/10.1074/jbc.R115.642926			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26055702	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000358781100015
J	Takahashi-Niki, K; Kato-Ose, I; Murata, H; Maita, H; Iguchi-Ariga, SMM; Ariga, H				Takahashi-Niki, Kazuko; Kato-Ose, Izumi; Murata, Hiroaki; Maita, Hiroshi; Iguchi-Ariga, Sanae M. M.; Ariga, Hiroyoshi			Epidermal Growth Factor-dependent Activation of the Extracellular Signal-regulated Kinase Pathway by DJ-1 Protein through Its Direct Binding to c-Raf Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL PARKINSONS-DISEASE; OXIDIZED DJ-1; CELL-DEATH; ANTIOXIDATIVE STRESS; PHOSPHORYLATION; IDENTIFICATION; GLYOXALASE; PTEN; TRANSFORMATION; OXIDATION	DJ-1 is an oncogene and also a causative gene for familial Parkinson disease. DJ-1 has various functions, and the oxidative status of cysteine at position 106 (Cys-106) is crucial for determination of the activation level of DJ-1. Although DJ-1 requires activated Ras for its oncogenic activity and although it activates the extracellular signal-regulated kinase (ERK) pathway, a cell growth pathway downstream of Ras, the precise mechanism underlying activation of the ERK pathway by DJ-1 is still not known. In this study, we found that DJ-1 directly bound to the kinase domain of c-Raf but not to Ras and that Cys-106 mutant DJ-1 bound to c-Raf more weakly than did wild-type DJ-1. Co-localization of DJ-1 with c-Raf in the cytoplasm was enhanced in epidermal growth factor (EGF)-treated cells. Knockdown of DJ-1 expression attenuated the phosphorylation level of c-Raf in EGF-treated cells, resulting in reduced activation of MEK and ERK1/2. Although EGF-treated DJ-1 knock-out cells also showed attenuated c-Raf activation, reintroduction of wild-type DJ-1, but not C106S DJ-1, into DJ-1 knock-out cells restored c-Raf activation in a DJ-1 binding activity in a c-Raf-dependent manner. DJ-1 was not responsible for activation of c-Raf in phorbol myristate acetate-treated cells. Furthermore, DJ-1 stimulated self-phosphorylation activity of c-Raf in vitro, but DJ-1 was not a target for Raf kinase. Oxidation of Cys-106 in DJ-1 was not affected by EGF treatment. These findings showed that DJ-1 is a positive regulator of the EGF/Ras/ERK pathway through targeting c-Raf.	[Takahashi-Niki, Kazuko; Kato-Ose, Izumi; Murata, Hiroaki; Maita, Hiroshi; Ariga, Hiroyoshi] Hokkaido Univ, Fac Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Iguchi-Ariga, Sanae M. M.] Hokkaido Univ, Fac Agr, Kita Ku, Sapporo, Hokkaido 0608589, Japan	Hokkaido University; Hokkaido University	Ariga, H (corresponding author), Hokkaido Univ, Fac Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan.	hiro@pharm.hokudai.ac.jp	Maita, Hiroshi/D-5495-2012		Ministry of Education, Culture, Sports, Science and Technology; Grants-in-Aid for Scientific Research [25830071] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology. The authors declare that they have no conflicts of interest with the contents of this article.	Abraham D, 2000, J BIOL CHEM, V275, P22300, DOI 10.1074/jbc.M003259200; Ariga H, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/683920; Bandopadhyay R, 2004, BRAIN, V127, P420, DOI 10.1093/brain/awh054; Barnard D, 1998, ONCOGENE, V17, P1539, DOI 10.1038/sj.onc.1202061; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; BRTVA TR, 1995, J BIOL CHEM, V270, P9809, DOI 10.1074/jbc.270.17.9809; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Chen J, 2010, HUM MOL GENET, V19, P2395, DOI 10.1093/hmg/ddq113; Choi J, 2006, J BIOL CHEM, V281, P10816, DOI 10.1074/jbc.M509079200; Choi MS, 2014, J NEUROSCI, V34, P15123, DOI 10.1523/JNEUROSCI.4751-13.2014; DAUM G, 1994, TRENDS BIOCHEM SCI, V19, P474, DOI 10.1016/0968-0004(94)90133-3; Dhillon AS, 2002, MOL CELL BIOL, V22, P3237, DOI 10.1128/MCB.22.10.3237-3246.2002; Gu L, 2009, BIOCHEM BIOPH RES CO, V383, P469, DOI 10.1016/j.bbrc.2009.04.037; Hasim S, 2014, J BIOL CHEM, V289, P1662, DOI 10.1074/jbc.M113.505784; He XY, 2012, CARCINOGENESIS, V33, P555, DOI 10.1093/carcin/bgs002; Ito G, 2006, BIOCHEM BIOPH RES CO, V339, P667, DOI 10.1016/j.bbrc.2005.11.058; Junn E, 2005, P NATL ACAD SCI USA, V102, P9691, DOI 10.1073/pnas.0409635102; Kahle PJ, 2009, FREE RADICAL BIO MED, V47, P1354, DOI 10.1016/j.freeradbiomed.2009.08.003; Kato I, 2013, MOL CELL BIOL, V33, P340, DOI 10.1128/MCB.01350-12; Kim RH, 2005, CANCER CELL, V7, P263, DOI 10.1016/j.ccr.2005.02.010; Kim YC, 2010, FEBS LETT, V584, P3891, DOI 10.1016/j.febslet.2010.08.010; Kim YC, 2009, INT J ONCOL, V35, P1331, DOI 10.3892/ijo_00000451; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kinoshita E, 2009, NAT PROTOC, V4, P1513, DOI 10.1038/nprot.2009.154; Kinumi T, 2004, BIOCHEM BIOPH RES CO, V317, P722, DOI 10.1016/j.bbrc.2004.03.110; Koide-Yoshida S, 2007, INT J MOL MED, V19, P885; Lee JY, 2012, HUM MOL GENET, V21, P3215, DOI 10.1093/hmg/dds155; Lev N, 2009, J NEURAL TRANSM, V116, P151, DOI 10.1007/s00702-008-0134-4; Maita C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054087; Martinat C, 2004, PLOS BIOL, V2, P1754, DOI 10.1371/journal.pbio.0020327; Mitsugi H, 2013, FEBS LETT, V587, P2493, DOI 10.1016/j.febslet.2013.06.032; Mitsumoto A, 2001, FREE RADICAL RES, V35, P301, DOI 10.1080/10715760100300831; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Oehrl W, 2003, J BIOL CHEM, V278, P17819, DOI 10.1074/jbc.M209951200; Olzmann JA, 2004, J BIOL CHEM, V279, P8506, DOI 10.1074/jbc.M311017200; Rahman-Roblick R, 2008, ONCOGENE, V27, P4854, DOI 10.1038/onc.2008.124; Saito Y, 2014, J NEUROPATH EXP NEUR, V73, P714, DOI 10.1097/NEN.0000000000000087; Saito Y, 2009, NEUROSCI LETT, V465, P1, DOI 10.1016/j.neulet.2009.08.074; Shinbo Y, 2006, CELL DEATH DIFFER, V13, P96, DOI 10.1038/sj.cdd.4401704; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Takahashi K, 2001, J BIOL CHEM, V276, P37556, DOI 10.1074/jbc.M101730200; Takahashi-Niki K, 2004, BIOCHEM BIOPH RES CO, V320, P389, DOI 10.1016/j.bbrc.2004.05.187; Tang J, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/735618; Toyoda Y, 2014, BIOL OPEN, V3, P777, DOI 10.1242/bio.20149399; Waak J, 2009, J BIOL CHEM, V284, P14245, DOI 10.1074/jbc.M806902200; Wilson MA, 2011, ANTIOXID REDOX SIGN, V15, P111, DOI 10.1089/ars.2010.3481; Xuan YT, 2005, CIRCULATION, V112, P1971, DOI 10.1161/CIRCULATIONAHA.105.561522; Zang MW, 2008, J BIOL CHEM, V283, P31429, DOI 10.1074/jbc.M802855200; Zhao QQ, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-86	49	25	25	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					17838	17847		10.1074/jbc.M115.666271	http://dx.doi.org/10.1074/jbc.M115.666271			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26048984	hybrid, Green Published			2022-12-28	WOS:000358511700020
J	Uyama, T; Kawai, K; Kono, N; Watanabe, M; Tsuboi, K; Inoue, T; Araki, N; Arai, H; Ueda, N				Uyama, Toru; Kawai, Katsuhisa; Kono, Nozomu; Watanabe, Masahiro; Tsuboi, Kazuhito; Inoue, Tomohito; Araki, Nobukazu; Arai, Hiroyuki; Ueda, Natsuo			Interaction of Phospholipase A/Acyltransferase-3 with Pex19p A POSSIBLE INVOLVEMENT IN THE DOWN-REGULATION OF PEROXISOMES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEINS; RAS PROTEINS; N-ACYLPHOSPHATIDYLETHANOLAMINE; LIPID-METABOLISM; IMPORT RECEPTOR; CDNA CLONING; BIOGENESIS; GENE; BIOCHEMISTRY; DEGRADATION	Phospholipase A/acyltransferase (PLA/AT)-3 (also known as H-rev107 or AdPLA) was originally isolated as a tumor suppressor and was later shown to have phospholipase A(1)/A(2) activity. We have also found that the overexpression of PLA/AT-3 in mammalian cells results in specific disappearance of peroxisomes. However, its molecular mechanism remained unclear. In the present study, we first established a HEK293 cell line, which stably expresses a fluorescent peroxisome marker protein (DsRed2-Peroxi) and expresses PLA/AT-3 in a tetracycline-dependent manner. The treatment with tetracycline, as expected, caused disappearance of peroxisomes within 24 h, as revealed by diffuse signals of DsRed2-Peroxi and a remarkable decrease in a peroxisomal membrane protein, PMP70. A time-dependent decrease in ether-type lipid levels was also seen. Because the activation of LC3, a marker of autophagy, was not observed, the involvement of autophagy was unlikely. Among various peroxins responsible for peroxisome biogenesis, Pex19p functions as a chaperone protein for the transportation of peroxisomal membrane proteins. Immunoprecipitation analysis showed that PLA/AT-3 binds to Pex19p through its N-terminal proline-rich and C-terminal hydrophobic domains. The protein level and enzyme activity of PLA/AT-3 were increased by its coexpression with Pex19p. Moreover, PLA/AT-3 inhibited the binding of Pex19 to peroxisomal membrane proteins, such as Pex3p and Pex11 beta p. A catalytically inactive point mutant of PLA/AT-3 could bind to Pex19p but did not inhibit the chaperone activity of Pex19p. Altogether, these results suggest a novel regulatory mechanism for peroxisome biogenesis through the interaction between Pex19p and PLA/AT-3.	[Uyama, Toru; Watanabe, Masahiro; Tsuboi, Kazuhito; Inoue, Tomohito; Ueda, Natsuo] Kagawa Univ, Sch Med, Dept Biochem, Miki, Kagawa 7610793, Japan; [Kawai, Katsuhisa; Araki, Nobukazu] Kagawa Univ, Sch Med, Dept Histol & Cell Biol, Miki, Kagawa 7610793, Japan; [Kono, Nozomu; Arai, Hiroyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan; [Watanabe, Masahiro] Kagawa Univ Hosp, Miki, Kagawa 7610793, Japan; [Inoue, Tomohito] Shikoku Med Ctr Children & Adults, Dept Orthoped Surg, Zentsuji, Kagawa 7650001, Japan	Kagawa University; Kagawa University; University of Tokyo; Kagawa University	Ueda, N (corresponding author), 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	nueda@med.kagawa-u.ac.jp	KONO, nozomu/AAM-3178-2020	Araki, Nobukazu/0000-0001-6160-210X	Japan Society for the Promotion of Science [24590355, 25460370]; Fund for Kagawa University Young Scientists; Naito Foundation; Japan Foundation for Applied Enzymology; Grants-in-Aid for Scientific Research [15K08278, 25460370] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Fund for Kagawa University Young Scientists; Naito Foundation(Naito Memorial Foundation); Japan Foundation for Applied Enzymology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (C) 24590355 (to T. U.) and 25460370 (to N. U.) from the Japan Society for the Promotion of Science; the Fund for Kagawa University Young Scientists 2014 (to T. U.); the Naito Foundation (to T. U.); and the Japan Foundation for Applied Enzymology (to N. U.). The authors declare that they have no conflicts of interest with the contents of this article.	Bartz R, 2007, J LIPID RES, V48, P837, DOI 10.1194/jlr.M600413-JLR200; Benjamin DI, 2013, P NATL ACAD SCI USA, V110, P14912, DOI 10.1073/pnas.1310894110; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Duncan RE, 2008, J BIOL CHEM, V283, P25428, DOI 10.1074/jbc.M804146200; Fujiki Y, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00307; Fujiki Y, 2012, BBA-MOL BASIS DIS, V1822, P1337, DOI 10.1016/j.bbadis.2012.06.004; HAJNAL A, 1994, ONCOGENE, V9, P479; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Hara-Kuge S, 2008, EXP CELL RES, V314, P3531, DOI 10.1016/j.yexcr.2008.09.015; Hummasti S, 2008, J LIPID RES, V49, P2535, DOI 10.1194/jlr.M800269-JLR200; Islinger M, 2010, BBA-MOL CELL RES, V1803, P881, DOI 10.1016/j.bbamcr.2010.03.013; Iwata J, 2006, J BIOL CHEM, V281, P4035, DOI 10.1074/jbc.M512283200; Jaworski K, 2009, NAT MED, V15, P159, DOI 10.1038/nm.1904; Jin XH, 2007, J BIOL CHEM, V282, P3614, DOI 10.1074/jbc.M606369200; Jin XH, 2009, BBA-MOL CELL BIOL L, V1791, P32, DOI 10.1016/j.bbalip.2008.09.006; Jones JM, 2004, J CELL BIOL, V164, P57, DOI 10.1083/jcb.200304111; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kurochkin IV, 2007, EMBO J, V26, P835, DOI 10.1038/sj.emboj.7601525; Lodhi IJ, 2014, CELL METAB, V19, P380, DOI 10.1016/j.cmet.2014.01.002; Ma CL, 2011, J CELL BIOL, V193, P7, DOI 10.1083/jcb.201010022; Manjithaya R, 2010, FEBS LETT, V584, P1367, DOI 10.1016/j.febslet.2010.01.019; Martens K, 2012, MOL GENET METAB, V107, P735, DOI 10.1016/j.ymgme.2012.10.015; Matsuzaki T, 2008, J CELL BIOL, V183, P1275, DOI 10.1083/jcb.200806062; Matsuzono Y, 2006, J BIOL CHEM, V281, P36, DOI 10.1074/jbc.M509819200; Matsuzono Y, 1999, P NATL ACAD SCI USA, V96, P2116, DOI 10.1073/pnas.96.5.2116; Matsuzono Y, 2006, J CELL SCI, V119, P3539, DOI 10.1242/jcs.03100; Misaki R, 2010, J CELL BIOL, V191, P23, DOI 10.1083/jcb.200911143; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Morales M, 2014, EMBO MOL MED, V6, P865, DOI 10.15252/emmm.201303675; Nordgren M, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00145; Purdue PE, 2001, ANNU REV CELL DEV BI, V17, P701, DOI 10.1146/annurev.cellbio.17.1.701; Sacksteder KA, 2000, J CELL BIOL, V148, P931, DOI 10.1083/jcb.148.5.931; Shinohara N, 2011, J LIPID RES, V52, P1927, DOI 10.1194/jlr.M015081; Smith JJ, 2013, NAT REV MOL CELL BIO, V14, P803, DOI 10.1038/nrm3700; Steinberg SJ, 2006, BBA-MOL CELL RES, V1763, P1733, DOI 10.1016/j.bbamcr.2006.09.010; Tabak HF, 2013, ANNU REV BIOCHEM, V82, P723, DOI 10.1146/annurev-biochem-081111-125123; Theodoulou FL, 2013, BIOCHEM J, V451, P345, DOI 10.1042/BJ20130078; Ueda N, 2013, FEBS J, V280, P1874, DOI 10.1111/febs.12152; Uyama T, 2013, BBA-MOL CELL BIOL L, V1831, P1690, DOI 10.1016/j.bbalip.2013.08.017; Uyama T, 2012, J BIOL CHEM, V287, P31905, DOI 10.1074/jbc.M112.368712; Uyama T, 2012, J BIOL CHEM, V287, P2706, DOI 10.1074/jbc.M111.267575; Uyama T, 2009, BBA-MOL CELL BIOL L, V1791, P1114, DOI 10.1016/j.bbalip.2009.07.001; Uyama T, 2009, J LIPID RES, V50, P685, DOI 10.1194/jlr.M800453-JLR200; Vaccari CM, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-63; Van Veldhoven PP, 2010, J LIPID RES, V51, P2863, DOI 10.1194/jlr.R005959; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Wang CH, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-36; Weller S, 2003, ANNU REV GENOM HUM G, V4, P165, DOI 10.1146/annurev.genom.4.070802.110424; Xiong SB, 2014, P NATL ACAD SCI USA, V111, P11145, DOI 10.1073/pnas.1404139111; Yao F, 1998, HUM GENE THER, V9, P1939, DOI 10.1089/hum.1998.9.13-1939; Yonekawa S, 2011, P NATL ACAD SCI USA, V108, P12746, DOI 10.1073/pnas.1103283108	53	21	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17520	17534		10.1074/jbc.M114.635433	http://dx.doi.org/10.1074/jbc.M114.635433			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26018079	hybrid, Green Published			2022-12-28	WOS:000357730900043
J	Xu, MX; Cooper, EC				Xu, Mingxuan; Cooper, Edward C.			An Ankyrin-G N-terminal Gate and Protein Kinase CK2 Dually Regulate Binding of Voltage-gated Sodium and KCNQ2/3 Potassium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AXON INITIAL SEGMENT; NEURONAL POLARITY; PYRAMIDAL NEURONS; BIPOLAR DISORDER; ANION-EXCHANGER; MOTIF; ASSOCIATION; SPECTRIN; EPILEPSY; RANVIER	In many mammalian neurons, fidelity and robustness of action potential generation and conduction depends on the colocalization of voltage-gated sodium (Na-v) and KCNQ2/3 potassium channel conductance at the distal axon initial segment (AIS) and nodes of Ranvier in a ratio of similar to 40 to 1. Analogous "anchor" peptides within intracellular domains of vertebrate KCNQ2, KCNQ3, and Na-v channel alpha-subunits bind Ankyrin-G (AnkG), thereby mediating concentration of those channels at AISs and nodes of Ranvier. Here, we show that the channel anchors bind at overlapping but distinct sites near the AnkG N terminus. In pulldown assays, the rank order of AnkG binding strength is Na(v)1.2 >> KCNQ3 > KCNQ2. Phosphorylation of KCNQ2 and KCNQ3 anchor domains by protein kinase CK2 (CK2) augments binding, as previously shown for Na(v)1.2. An AnkG fragment comprising ankyrin repeats 1 through 7 (R1-7) binds phosphorylated Na-v or KCNQ anchors robustly. However, mutational analysis of R1-7 reveals differences in binding mechanisms. A smaller fragment, R1-6, exhibits much-diminished KCNQ3 binding but binds Na(v)1.2 well. Two lysine residues at the tip of repeat 2-3 beta-hairpin (residues 105-106) are critical for Na(v)1.2 but not KCNQ3 channel binding. Another dibasic motif (residues Arg-47, Arg-50) in the repeat 1 front alpha-helix is crucial for KCNQ2/3 but not Na(v)1.2 binding. AnkG's alternatively spliced N terminus selectively gates access to those sites, blocking KCNQ but not Na-v channel binding. These findings suggest that the 40:1 Na-v:KCNQ channel conductance ratio at the distal AIS and nodes arises from the relative strength of binding to AnkG.	[Xu, Mingxuan; Cooper, Edward C.] Baylor Coll Med, Dept Neurol, Mol Neuropharmacol Lab, Houston, TX 77030 USA; [Cooper, Edward C.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Cooper, Edward C.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Xu, MX (corresponding author), Baylor Coll Med, Dept Neurol, 1 Baylor Plaza,MS NB302, Houston, TX 77030 USA.	mingxuax@bcm.edu; ecc1@bcm.edu	Cooper, Edward/X-6659-2019; Regan, Clinton/E-6250-2012	Cooper, Edward/0000-0003-3672-8442; 	National Institutes of Health [RO1 NS049119, T32NS043124]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049119, T32NS043124] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 NS049119 (NINDS; to E. C. C. and M. X.) and T32NS043124 (to M. X.). The authors declare that they have no conflicts of interest with the contents of this article.	Abdi KM, 2006, J BIOL CHEM, V281, P5741, DOI 10.1074/jbc.M506697200; Adler J, 2010, CYTOM PART A, V77A, P733, DOI 10.1002/cyto.a.20896; AULD VJ, 1988, NEURON, V1, P449, DOI 10.1016/0896-6273(88)90176-6; Barlow AL, 2010, MICROSC MICROANAL, V16, P710, DOI 10.1017/S143192761009389X; Barry J, 2014, DEV CELL, V28, P117, DOI 10.1016/j.devcel.2013.11.023; Battefeld A, 2014, J NEUROSCI, V34, P3719, DOI 10.1523/JNEUROSCI.4206-13.2014; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bi C, 2012, HUM MUTAT, V33, P1635, DOI 10.1002/humu.22174; Biervert C, 1998, SCIENCE, V279, P403, DOI 10.1126/science.279.5349.403; Brachet A, 2010, J CELL BIOL, V191, P383, DOI 10.1083/jcb.201003042; Brechet A, 2008, J CELL BIOL, V183, P1101, DOI 10.1083/jcb.200805169; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Cai XJ, 2006, MOL BIOL EVOL, V23, P550, DOI 10.1093/molbev/msj056; Chang KJ, 2014, NAT NEUROSCI, V17, P1673, DOI 10.1038/nn.3858; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cooper EC, 2003, ARCH NEUROL-CHICAGO, V60, P496, DOI 10.1001/archneur.60.4.496; Cunha SR, 2008, J BIOL CHEM, V283, P31968, DOI 10.1074/jbc.M806050200; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; DAVIS JQ, 1990, J BIOL CHEM, V265, P17252; Devaux JJ, 2004, J NEUROSCI, V24, P1236, DOI 10.1523/JNEUROSCI.4512-03.2004; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Galiano MR, 2012, CELL, V149, P1125, DOI 10.1016/j.cell.2012.03.039; Garrido JJ, 2003, SCIENCE, V300, P2091, DOI 10.1126/science.1085167; Gasser A, 2012, J NEUROSCI, V32, P7232, DOI 10.1523/JNEUROSCI.5434-11.2012; Hallermann S, 2012, NAT NEUROSCI, V15, P1007, DOI 10.1038/nn.3132; Hedstrom KL, 2008, J CELL BIOL, V183, P635, DOI 10.1083/jcb.200806112; Hien YE, 2014, FEBS LETT, V588, P3403, DOI 10.1016/j.febslet.2014.07.032; Hill AS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000317; Ho TSY, 2014, NAT NEUROSCI, V17, P1664, DOI 10.1038/nn.3859; Howard RJ, 2007, NEURON, V53, P663, DOI 10.1016/j.neuron.2007.02.010; Kang S, 2014, J BIOL CHEM, V289, P11536, DOI 10.1074/jbc.M113.528497; Kato M, 2013, EPILEPSIA, V54, P1282, DOI 10.1111/epi.12200; Lemaillet G, 2003, J BIOL CHEM, V278, P27333, DOI 10.1074/jbc.M303327200; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; Lowe JS, 2008, J CELL BIOL, V180, P173, DOI 10.1083/jcb.200710107; Michaely P, 1995, J BIOL CHEM, V270, P31298, DOI 10.1074/jbc.270.52.31298; Nakada C, 2003, NAT CELL BIOL, V5, P626, DOI 10.1038/ncb1009; Pagano MA, 2007, CHEMBIOCHEM, V8, P129, DOI 10.1002/cbic.200600293; Pan ZM, 2006, J NEUROSCI, V26, P2599, DOI 10.1523/JNEUROSCI.4314-05.2006; Peters HC, 2005, NAT NEUROSCI, V8, P51, DOI 10.1038/nn1375; Rasband MN, 2010, NAT REV NEUROSCI, V11, P552, DOI 10.1038/nrn2852; ROPER J, 1989, J PHYSIOL-LONDON, V416, P93; Rueckert EH, 2013, MOL PSYCHIATR, V18, P922, DOI 10.1038/mp.2012.104; Sanchez-Ponce D, 2011, MOL CELL NEUROSCI, V46, P222, DOI 10.1016/j.mcn.2010.09.005; Schroeder BC, 1998, NATURE, V396, P687, DOI 10.1038/25367; Schwarz JR, 2006, J PHYSIOL-LONDON, V573, P17, DOI 10.1113/jphysiol.2006.106815; Shah MM, 2008, P NATL ACAD SCI USA, V105, P7869, DOI 10.1073/pnas.0802805105; Wang C, 2014, ELIFE, V3, DOI 10.7554/eLife.04353; Weckhuysen S, 2013, NEUROLOGY, V81, P1697, DOI 10.1212/01.wnl.0000435296.72400.a1; Weckhuysen S, 2012, ANN NEUROL, V71, P15, DOI 10.1002/ana.22644; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251; Zakon HH, 2012, P NATL ACAD SCI USA, V109, P10619, DOI 10.1073/pnas.1201884109; Zhang X, 1998, J CELL BIOL, V142, P1571, DOI 10.1083/jcb.142.6.1571; Zhang X, 1998, J BIOL CHEM, V273, P30785, DOI 10.1074/jbc.273.46.30785; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295	58	40	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16619	16632		10.1074/jbc.M115.638932	http://dx.doi.org/10.1074/jbc.M115.638932			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25998125	Green Published, hybrid			2022-12-28	WOS:000357572800014
J	Yoo, JY; Ko, KS; Seo, HK; Park, S; Fanata, WID; Harmoko, R; Ramasamy, NK; Thulasinathan, T; Mengiste, T; Lim, JM; Lee, SY; Lee, KO				Yoo, Jae Yong; Ko, Ki Seong; Seo, Hyun-Kyeong; Park, Seongha; Fanata, Wahyu Indra Duwi; Harmoko, Rikno; Ramasamy, Nirmal Kumar; Thulasinathan, Thiyagarajan; Mengiste, Tesfaye; Lim, Jae-Min; Lee, Sang Yeol; Lee, Kyun Oh			Limited Addition of the 6-Arm beta 1,2-linked N-Acetylglucosamine (GlcNAc) Residue Facilitates the Formation of the Largest N-Glycan in Plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-MANNOSIDASE-II; CORE ALPHA-1,3-LINKED FUCOSE; ENDOPLASMIC-RETICULUM; ARABIDOPSIS-THALIANA; LINKED OLIGOSACCHARIDES; SECRETORY PATHWAY; MOLECULAR-CLONING; GOLGI-APPARATUS; IN-VIVO; COMPLEX	The most abundant N-glycan in plants is the paucimannosidic N-glycan with core beta 1,2-xylose and alpha 1,3-fucose residues (Man(3)XylFuc(GlcNAc)(2)). Here, we report a mechanism in Arabidopsis thaliana that efficiently produces the largest-N-glycan in plants. Genetic and biochemical evidence indicates that the addition of the 6-arm beta 1,2-GlcNAc residue by N-acetylglucosaminyltransferase II (GnTII) is less effective than additions of the core beta 1,2-xylose and alpha 1,3-fucose residues by XylT, FucTA, and FucTB in Arabidopsis. Furthermore, analysis of gnt2 mutant and 35S:GnTII transgenic plants shows that the addition of the 6-arm non-reducing GlcNAc residue to the common N-glycan acceptor GlcNAcMan(3)(GlcNAc)(2) inhibits additions of the core beta 1,2-xylose and alpha 1,3-fucose residues. Our findings indicate that plants limit the rate of the addition of the 6-arm GlcNAc residue to the common N-glycan acceptor as a mechanism to facilitate formation of the prevalent N-glycans with Man(3)XylFuc(GlcNAc)(2) and (GlcNAc)(2)Man(3)XylFuc(GlcNAc)(2) structures.	[Yoo, Jae Yong; Ko, Ki Seong; Fanata, Wahyu Indra Duwi; Harmoko, Rikno; Ramasamy, Nirmal Kumar; Thulasinathan, Thiyagarajan; Lee, Sang Yeol; Lee, Kyun Oh] Gyeongsang Natl Univ, Div Appl Life Sci, Jinju 660701, South Korea; [Yoo, Jae Yong; Ko, Ki Seong; Fanata, Wahyu Indra Duwi; Harmoko, Rikno; Ramasamy, Nirmal Kumar; Thulasinathan, Thiyagarajan; Lee, Sang Yeol; Lee, Kyun Oh] Gyeongsang Natl Univ, Plant Mol Biol & Biotechnol Res Ctr, Jinju 660701, South Korea; [Seo, Hyun-Kyeong; Park, Seongha; Lim, Jae-Min] Changwon Natl Univ, Dept Chem, Chang Won 641773, South Korea; [Mengiste, Tesfaye] Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA	Gyeongsang National University; Gyeongsang National University; Changwon National University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Lee, KO (corresponding author), Gyeongsang Natl Univ, Div Appl Life Sci, 501 Jinju Daero, Jinju 660701, South Korea.	leeko@gnu.ac.kr	Ramasamy, NirmalKumar/ABG-2032-2020; Harmoko, Rikno/Q-3783-2018; Fanata, Wahyu Indra Duwi/GPK-6251-2022	Harmoko, Rikno/0000-0003-3166-2966; Fanata, Wahyu Indra Duwi/0000-0002-4992-9799; Ramasamy, NirmalKumar/0000-0002-6500-311X; Mengiste, Tesfaye/0000-0001-8865-994X	Next-Generation BioGreen Program [PJ01137901]; Technology Innovation Program - Ministry of Trade, Industry and Energy [10048311]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology, Republic of Korea [2012R1A1A2001074]; Basic Science Research Program through the NRF - Ministry of Education, Science and Technology [NRF 2011-0013961, NRF 2010-0029634]; Priority Research Centers Program through the NRF - Ministry of Education, Science and Technology [NRF 2011-0013961, NRF 2010-0029634]; BK21 program; NRF Postdoctoral Fellowship Program for Foreign Researchers	Next-Generation BioGreen Program; Technology Innovation Program - Ministry of Trade, Industry and Energy; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology, Republic of Korea(National Research Foundation of Korea); Basic Science Research Program through the NRF - Ministry of Education, Science and Technology(National Research Foundation of Korea); Priority Research Centers Program through the NRF - Ministry of Education, Science and Technology(National Research Foundation of Korea); BK21 program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); NRF Postdoctoral Fellowship Program for Foreign Researchers(National Research Foundation of Korea)	This work was supported in part by grants from the Next-Generation BioGreen Program (Grant PJ01137901); the Technology Innovation Program funded by the Ministry of Trade, Industry and Energy (Grant 10048311); the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (Grant 2012R1A1A2001074), Republic of Korea; and the Basic Science Research Program and the Priority Research Centers Program through the NRF funded by the Ministry of Education, Science and Technology (Grants NRF 2011-0013961 and NRF 2010-0029634). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by scholarships from the BK21 program.; Supported by the 2013 NRF Postdoctoral Fellowship Program for Foreign Researchers. Present address: Center for Development of Advanced Science and Technology (CDAST) and Faculty of Agriculture, University of Jember, Jember 68121, Indonesia.	AALBERSE RC, 1981, J ALLERGY CLIN IMMUN, V68, P356, DOI 10.1016/0091-6749(81)90133-0; ALTMANN F, 1995, GLYCOCONJUGATE J, V12, P150, DOI 10.1007/BF00731359; Bione HM, 1998, AUST DENT J, V43, P181, DOI 10.1111/j.1834-7819.1998.tb00162.x; BRETSCHER MS, 1993, SCIENCE, V261, P1280, DOI 10.1126/science.8362242; Castilho A, 2008, PLANT PHYSIOL, V147, P331, DOI 10.1104/pp.108.117572; Castilho A, 2010, J BIOL CHEM, V285, P15923, DOI 10.1074/jbc.M109.088401; Erbayraktar S, 2003, P NATL ACAD SCI USA, V100, P6741, DOI 10.1073/pnas.1031753100; Fanata WID, 2013, PLANT J, V73, P966, DOI 10.1111/tpj.12087; FIEDLER K, 1995, CELL, V81, P309, DOI 10.1016/0092-8674(95)90380-1; Frank J, 2008, PLANT PHYSIOL, V148, P1354, DOI 10.1104/pp.108.127027; Ghaderi D, 2010, NAT BIOTECHNOL, V28, P863, DOI 10.1038/nbt.1651; Gomord V, 1997, PLANT J, V11, P313, DOI 10.1046/j.1365-313X.1997.11020313.x; Gutternigg M, 2007, J BIOL CHEM, V282, P27825, DOI 10.1074/jbc.M704235200; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Henquet M, 2008, PLANT CELL, V20, P1652, DOI 10.1105/tpc.108.060731; IOFFE E, 1994, P NATL ACAD SCI USA, V91, P728, DOI 10.1073/pnas.91.2.728; Kajiura H, 2012, J BIOSCI BIOENG, V113, P48, DOI 10.1016/j.jbiosc.2011.09.011; Kang JS, 2008, P NATL ACAD SCI USA, V105, P5933, DOI 10.1073/pnas.0800237105; Kaulfurst-Soboll H, 2011, J BIOL CHEM, V286, P22955, DOI 10.1074/jbc.M110.196097; Liebminger E, 2011, J BIOL CHEM, V286, P10793, DOI 10.1074/jbc.M110.178020; Manduzio H, 2012, PLANT BIOTECHNOL J, V10, P184, DOI 10.1111/j.1467-7652.2011.00654.x; Martina JA, 2000, NEUROCHEM RES, V25, P725, DOI 10.1023/A:1007527523734; Molinari M, 1999, NATURE, V402, P90, DOI 10.1038/47062; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; NILSSON T, 1993, FEBS LETT, V330, P1, DOI 10.1016/0014-5793(93)80906-B; Pagny S, 2003, PLANT J, V33, P189, DOI 10.1046/j.0960-7412.2002.01604.x; Paschinger K, 2006, J BIOL CHEM, V281, P28265, DOI 10.1074/jbc.M602878200; Raju TS, 2014, CURR OPIN BIOTECH, V30, P147, DOI 10.1016/j.copbio.2014.06.014; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Saint-Jore-Dupas C, 2006, PLANT CELL, V18, P3182, DOI 10.1105/tpc.105.036400; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; Spiro RG, 2004, CELL MOL LIFE SCI, V61, P1025, DOI 10.1007/s00018-004-4037-8; Strasser R, 1999, GLYCOCONJUGATE J, V16, P787, DOI 10.1023/A:1007127815012; Strasser R, 2006, PLANT J, V45, P789, DOI 10.1111/j.1365-313X.2005.02648.x; Strasser R, 2004, FEBS LETT, V561, P132, DOI 10.1016/S0014-5793(04)00150-4; van Ree R, 2000, J BIOL CHEM, V275, P11451, DOI 10.1074/jbc.275.15.11451; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; VONSCHAEWEN A, 1993, PLANT PHYSIOL, V102, P1109, DOI 10.1104/pp.102.4.1109; Wilson IBH, 1998, GLYCOBIOLOGY, V8, P651, DOI 10.1093/glycob/8.7.651; Wilson IBH, 2002, CURR OPIN STRUC BIOL, V12, P569, DOI 10.1016/S0959-440X(02)00367-6; Wilson IBH, 1998, GLYCOCONJUGATE J, V15, P1055, DOI 10.1023/A:1006960401562; Yip B, 1997, BIOCHEM J, V321, P465, DOI 10.1042/bj3210465; Yoo JY, 2014, PLANT BIOTECHNOL REP, V8, P357, DOI 10.1007/s11816-014-0328-1	45	14	14	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16560	16572		10.1074/jbc.M115.653162	http://dx.doi.org/10.1074/jbc.M115.653162			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	26001781	Green Published, hybrid			2022-12-28	WOS:000357572800009
J	Loughney, JW; Rustandi, RR; Wang, D; Troutman, MC; Dick, LW; Li, GH; Liu, Z; Li, FS; Freed, DC; Price, CE; Hoang, VM; Culp, TD; DePhillips, PA; Fu, TM; Ha, S				Loughney, John W.; Rustandi, Richard R.; Wang, Dai; Troutman, Matthew C.; Dick, Lawrence W., Jr.; Li, Guanghua; Liu, Zhong; Li, Fengsheng; Freed, Daniel C.; Price, Colleen E.; Hoang, Van M.; Culp, Timothy D.; DePhillips, Pete A.; Fu, Tong-Ming; Ha, Sha			Soluble Human Cytomegalovirus gH/gL/pUL128-131 Pentameric Complex, but Not gH/gL, Inhibits Viral Entry to Epithelial Cells and Presents Dominant Native Neutralizing Epitopes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycoprotein; protein complex; protein purification; vaccine; virus entry; HCMV; gH; gL; pUL128-131; neutralizing epitope; pentameric complex	ENDOTHELIAL-CELLS; ANTIBODY-RESPONSE; RHESUS MACAQUES; VACCINE; TROPISM; GH/GL/UL128-131; INFECTION; GH; GL	Background: HCMV gH/gL/pUL128-131 pentameric complex is a main target for potent neutralizing antibody responses. Results: Soluble gH/gL/pUL128-131 inhibits viral entry and presents neutralizing epitopes. Conclusion: The biological activities of gH/gL/pUL128-131 confirm the critical role of the native complex as an immunogen. Significance: The functional differences between gH/gL and gH/gL/pUL128-131 must be considered when designing vaccines and assessing immune responses. Congenital infection of human cytomegalovirus (HCMV) is one of the leading causes of nongenetic birth defects, and development of a prophylactic vaccine against HCMV is of high priority for public health. The gH/gL/pUL128-131 pentameric complex mediates HCMV entry into endothelial and epithelial cells, and it is a major target for neutralizing antibody responses. To better understand the mechanism by which antibodies interact with the epitopes of the gH/gL/pUL128-131 pentameric complex resulting in viral neutralization, we expressed and purified soluble gH/gL/pUL128-131 pentameric complex and gH/gL from Chinese hamster ovary cells to >95% purity. The soluble gH/gL, which exists predominantly as (gH/gL)(2) homodimer with a molecular mass of 220 kDa in solution, has a stoichiometry of 1:1 and a pI of 6.0-6.5. The pentameric complex has a molecular mass of 160 kDa, a stoichiometry of 1:1:1:1:1, and a pI of 7.4-8.1. The soluble pentameric complex, but not gH/gL, adsorbs 76% of neutralizing activities in HCMV human hyperimmune globulin, consistent with earlier reports that the most potent neutralizing epitopes for blocking epithelial infection are unique to the pentameric complex. Functionally, the soluble pentameric complex, but not gH/gL, blocks viral entry to epithelial cells in culture. Our results highlight the importance of the gH/gL/pUL128-131 pentameric complex in HCMV vaccine design and emphasize the necessity to monitor the integrity of the pentameric complex during the vaccine manufacturing process.	[Loughney, John W.; Rustandi, Richard R.; Troutman, Matthew C.; Dick, Lawrence W., Jr.; Price, Colleen E.; Hoang, Van M.; Culp, Timothy D.; DePhillips, Pete A.; Ha, Sha] Merck Res Labs, Vaccine Bioproc Res & Dev, West Point, PA 19486 USA; [Wang, Dai; Li, Fengsheng; Freed, Daniel C.; Fu, Tong-Ming] Merck Res Labs, Vaccine Res, West Point, PA 19486 USA; [Li, Guanghua; Liu, Zhong] Merck Res Labs, Biol Bioproc Dev, West Point, PA 19486 USA	Merck & Company; Merck & Company; Merck & Company	Ha, S (corresponding author), Merck Res Labs, Vaccine Bioproc Res & Dev, West Point, PA 19486 USA.	sha_ha@merck.com	Fu, Tong-Ming/GLU-4070-2022; Fu, Tong-Ming/AAF-7143-2022; LI, feng/HIR-1703-2022; Fu, Tong-Ming/AEV-7504-2022	Fu, Tong-Ming/0000-0003-1420-2271; Wang, Dai/0000-0001-5666-8622				Anderson CL, 2012, ELECTROPHORESIS, V33, P1538, DOI 10.1002/elps.201100611; Arvin AM, 2004, CLIN INFECT DIS, V39, P233, DOI 10.1086/421999; Chowdary TK, 2010, NAT STRUCT MOL BIOL, V17, P882, DOI 10.1038/nsmb.1837; Ciferri C, 2015, P NATL ACAD SCI USA, V112, P1767, DOI 10.1073/pnas.1424818112; Dou P, 2008, J CHROMATOGR A, V1190, P372, DOI 10.1016/j.chroma.2008.03.001; Edward S, 2013, FIELDS VIROLOGY; ELEK SD, 1974, LANCET, V1, P1; Fouts AE, 2014, P NATL ACAD SCI USA, V111, P8209, DOI 10.1073/pnas.1404653111; Fouts AE, 2012, J VIROL, V86, P7444, DOI 10.1128/JVI.00467-12; Freed DC, 2013, P NATL ACAD SCI USA, V110, pE4997, DOI 10.1073/pnas.1316517110; Fu TM, 2012, VACCINE, V30, P7469, DOI 10.1016/j.vaccine.2012.10.053; Hahn G, 2004, J VIROL, V78, P10023, DOI 10.1128/JVI.78.18.10023-10033.2004; Institute of Medicine CtSPfV, 2001, VACC 21 CENT TOOL DE; Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535; Krummenacher C, 2013, ADV EXP MED BIOL, V790, P178, DOI 10.1007/978-1-4614-7651-1_10; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Loomis RJ, 2013, VACCINE, V31, P919, DOI 10.1016/j.vaccine.2012.12.009; Macagno A, 2010, J VIROL, V84, P1005, DOI 10.1128/JVI.01809-09; Michels DA, 2012, ANAL CHEM, V84, P5380, DOI 10.1021/ac3008847; NEFF BJ, 1979, P SOC EXP BIOL MED, V160, P32; Ryckman BJ, 2008, P NATL ACAD SCI USA, V105, P14118, DOI 10.1073/pnas.0804365105; Ryckman BJ, 2008, J VIROL, V82, P60, DOI 10.1128/JVI.01910-07; Ryckman BJ, 2010, J VIROL, V84, P2597, DOI 10.1128/JVI.02256-09; Saccoccio FM, 2011, VACCINE, V29, P2705, DOI 10.1016/j.vaccine.2011.01.079; Shytuhina A, 2014, J CHROMATOGR A, V1364, P192, DOI 10.1016/j.chroma.2014.05.087; Sinzger C, 2008, CURR TOP MICROBIOL, V325, P63; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Stampfer SD, 2013, CURR OPIN VIROL, V3, P13, DOI 10.1016/j.coviro.2012.10.005; Wang D, 2005, P NATL ACAD SCI USA, V102, P18153, DOI 10.1073/pnas.0509201102; Wang D, 2005, J VIROL, V79, P10330, DOI 10.1128/JVI.79.16.10330-10338.2005; Wang D, 2011, VACCINE, V29, P9075, DOI 10.1016/j.vaccine.2011.09.056; Wen YX, 2014, VACCINE, V32, P3796, DOI 10.1016/j.vaccine.2014.05.004; Wussow F, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004524; Wussow F, 2013, J VIROL, V87, P1322, DOI 10.1128/JVI.01669-12; Zhou MM, 2013, J VIROL, V87, P9680, DOI 10.1128/JVI.01167-13	35	34	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					15985	15995		10.1074/jbc.M115.652230	http://dx.doi.org/10.1074/jbc.M115.652230			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25947373	Green Published, hybrid			2022-12-28	WOS:000356930100008
J	Schuepbach-Mallepell, S; Das, D; Willen, L; Vigolo, M; Tardivel, A; Lebon, L; Kowalczyk-Quintas, C; Nys, J; Smulski, C; Zheng, TS; Maskos, K; Lammens, A; Jiang, XL; Hess, H; Tan, SL; Schneider, P				Schuepbach-Mallepell, Sonia; Das, Dolon; Willen, Laure; Vigolo, Michele; Tardivel, Aubry; Lebon, Luc; Kowalczyk-Quintas, Christine; Nys, Josquin; Smulski, Cristian; Zheng, Timothy S.; Maskos, Klaus; Lammens, Alfred; Jiang, Xuliang; Hess, Henry; Tan, Seng-Lai; Schneider, Pascal			Stoichiometry of Heteromeric BAFF and APRIL Cytokines Dictates Their Receptor Binding and Signaling Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytokine; immunology; protein engineering; receptor; signaling; APRIL; BAFF; heteromers	NECROSIS-FACTOR FAMILY; SINGLE-CHAIN TNF; CRYSTAL-STRUCTURE; B-CELLS; LYMPHOTOXIN-BETA; MEMBER; BLYS; ACTIVATION; TACI; SURVIVAL	Background: The B cell survival factors B cell activation factor (BAFF) and a proliferation-inducing ligand (APRIL) can heteromerize. Results: BAFF-APRIL(2) and APRIL-BAFF(2) heteromers have distinct receptor-binding specificities and activities. Conclusion: BAFF-APRIL(2) resembles APRIL, and APRIL-BAFF(2) resembles BAFF but poorly activates the BAFF receptor. Significance: Heteromers should be taken into account when evaluating the physiology or pharmacological inhibition of BAFF and APRIL. The closely related TNF family ligands B cell activation factor (BAFF) and a proliferation-inducing ligand (APRIL) serve in the generation and maintenance of mature B-lymphocytes. Both BAFF and APRIL assemble as homotrimers that bind and activate several receptors that they partially share. However, heteromers of BAFF and APRIL that occur in patients with autoimmune diseases are incompletely characterized. The N and C termini of adjacent BAFF or APRIL monomers are spatially close and can be linked to create single-chain homo- or hetero-ligands of defined stoichiometry. Similar to APRIL, heteromers consisting of one BAFF and two APRILs (BAA) bind to the receptors B cell maturation antigen (BCMA), transmembrane activator and CAML interactor (TACI) but not to the BAFF receptor (BAFFR). Heteromers consisting of one APRIL and two BAFF (ABB) bind to TACI and BCMA and weakly to BAFFR in accordance with the analysis of the receptor interaction sites in the crystallographic structure of ABB. Receptor binding correlated with activity in reporter cell line assays specific for BAFFR, TACI, or BCMA. Single-chain BAFF (BBB) and to a lesser extent single-chain ABB, but not APRIL or single-chain BAA, rescued BAFFR-dependent B cell maturation in BAFF-deficient mice. In conclusion, BAFF-APRIL heteromers of different stoichiometries have distinct receptor-binding properties and activities. Based on the observation that heteromers are less active than BAFF, we speculate that their physiological role might be to down-regulate BAFF activity.	[Schuepbach-Mallepell, Sonia; Das, Dolon; Willen, Laure; Vigolo, Michele; Tardivel, Aubry; Lebon, Luc; Kowalczyk-Quintas, Christine; Nys, Josquin; Smulski, Cristian; Schneider, Pascal] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Zheng, Timothy S.] Biogen, Cambridge, MA 02142 USA; [Maskos, Klaus; Lammens, Alfred] Proteros Biostruct GmbH, D-82152 Martinsried, Germany; [Jiang, Xuliang; Tan, Seng-Lai] EMD Serono Res & Dev Inst, Billerica, MA 01821 USA; [Hess, Henry] Merck KGaA, D-64293 Darmstadt, Germany	University of Lausanne; Biogen; Merck KGaA	Schneider, P (corresponding author), Univ Lausanne, Dept Biochem, Boveresses 155, CH-1066 Epalinges, Switzerland.	pascal.schneider@unil.ch	Tan, Seng-Lai/AAQ-2585-2021	Vigolo, Michele/0000-0002-4765-6598; Smulski, Cristian/0000-0003-4186-8116; Schneider, Pascal/0000-0003-0677-9409	Swiss National Science Foundation; Institute of Arthritis Research; EMD Serono	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Institute of Arthritis Research; EMD Serono	This work was supported by grants from the Swiss National Science Foundation (to P. S.), by the Institute of Arthritis Research, and by project funding from EMD Serono (to P. S.). P. S. is supported by a research grant from EMD Serono, a subsidiary of Merck, KGaA. X. J., H. H., and S. T. are employees of Merck, KGaA. T. Z. is an employee of BiogenIdec. A. L. and M. K. are employees of Proteros Biostructures GmbH. Other authors declare no competing financial interests.	Benson MJ, 2008, J IMMUNOL, V180, P3655, DOI 10.4049/jimmunol.180.6.3655; Blanc E., 2011, BUSTER VERSION 2 11; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Boschert V, 2010, CELL SIGNAL, V22, P1088, DOI 10.1016/j.cellsig.2010.02.011; Bossen C, 2008, BLOOD, V111, P1004, DOI 10.1182/blood-2007-09-110874; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Bossen C, 2006, SEMIN IMMUNOL, V18, P263, DOI 10.1016/j.smim.2006.04.006; Bossen C, 2011, EUR J IMMUNOL, V41, P787, DOI 10.1002/eji.201040591; Browning JL, 1996, J BIOL CHEM, V271, P8618, DOI 10.1074/jbc.271.15.8618; BROWNING JL, 1993, CELL, V72, P847, DOI 10.1016/0092-8674(93)90574-A; Cachero TG, 2006, BIOCHEMISTRY-US, V45, P2006, DOI 10.1021/bi051685o; Chang SK, 2006, BLOOD, V108, P2687, DOI 10.1182/blood-2005-12-017319; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Craxton A, 2003, BLOOD, V101, P4464, DOI 10.1182/blood-2002-10-3123; CROWE PD, 1994, SCIENCE, V264, P707, DOI 10.1126/science.8171323; Dillon SR, 2006, NAT REV DRUG DISCOV, V5, P235, DOI 10.1038/nrd1982; Dillon SR, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2959; ECK MJ, 1989, J BIOL CHEM, V264, P17595; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Figgett WA, 2013, IMMUNITY, V39, P573, DOI 10.1016/j.immuni.2013.05.019; Gordon NC, 2003, BIOCHEMISTRY-US, V42, P5977, DOI 10.1021/bi034017g; Holler N, 2003, MOL CELL BIOL, V23, P1428, DOI 10.1128/MCB.23.4.1428-1440.2003; Huard B, 2008, J CLIN INVEST, V118, P2887, DOI 10.1172/JCI33760; Hymowitz SG, 2005, J BIOL CHEM, V280, P7218, DOI 10.1074/jbc.M411714200; Ingold K, 2005, J EXP MED, V201, P1375, DOI 10.1084/jem.20042309; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karpusas M, 2002, J MOL BIOL, V315, P1145, DOI 10.1006/jmbi.2001.5296; Kim HM, 2003, NAT STRUCT BIOL, V10, P342, DOI 10.1038/nsb925; Kimberley FC, 2012, J BIOL CHEM, V287, P37434, DOI 10.1074/jbc.M112.406090; Krippner-Heidenreich A, 2008, J IMMUNOL, V180, P8176, DOI 10.4049/jimmunol.180.12.8176; Liu YF, 2003, NATURE, V423, P49, DOI 10.1038/nature01543; Liu YF, 2002, CELL, V108, P383, DOI 10.1016/S0092-8674(02)00631-1; Lopez-Fraga M, 2001, EMBO REP, V2, P945, DOI 10.1093/embo-reports/kve198; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; O'Connor BP, 2004, J EXP MED, V199, P91, DOI 10.1084/jem.20031330; Oren DA, 2002, NAT STRUCT BIOL, V9, P288, DOI 10.1038/nsb769; Patke A, 2006, J EXP MED, V203, P2551, DOI 10.1084/jem.20060990; Roschke V, 2002, J IMMUNOL, V169, P4314, DOI 10.4049/jimmunol.169.8.4314; Schneider P, 2000, METHOD ENZYMOL, V322, P325; Schneider P, 2014, METHOD ENZYMOL, V545, P103, DOI 10.1016/B978-0-12-801430-1.00005-6; Schneider P, 2010, CONTEMP IMMUNOL, P1, DOI 10.1007/978-1-60327-013-7_1; Shulga-Morskaya S, 2004, J IMMUNOL, V173, P2331, DOI 10.4049/jimmunol.173.4.2331; Stohl W, 2014, EXPERT OPIN THER TAR, V18, P473, DOI 10.1517/14728222.2014.888415; Sudhamsu J, 2013, P NATL ACAD SCI USA, V110, P19896, DOI 10.1073/pnas.1310838110; Swee LK, 2010, IMMUNOL LETT, V131, P40, DOI 10.1016/j.imlet.2010.03.007; Treml LS, 2007, J IMMUNOL, V178, P7531, DOI 10.4049/jimmunol.178.12.7531; von Bulow GU, 2001, IMMUNITY, V14, P573, DOI 10.1016/S1074-7613(01)00130-3; Yan MH, 2001, NAT IMMUNOL, V2, P638, DOI 10.1038/89790	51	34	36	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16330	16342		10.1074/jbc.M115.661405	http://dx.doi.org/10.1074/jbc.M115.661405			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25953898	Green Published, hybrid			2022-12-28	WOS:000356930100035
J	Dillon, J; Franks, CJ; Murray, C; Edwards, RJ; Calahorro, F; Ishihara, T; Katsura, I; Holden-Dye, L; O'Connor, V				Dillon, James; Franks, Christopher J.; Murray, Caitriona; Edwards, Richard J.; Calahorro, Fernando; Ishihara, Takeshi; Katsura, Isao; Holden-Dye, Lindy; O'Connor, Vincent			Metabotropic Glutamate Receptors MODULATORS OF CONTEXT-DEPENDENT FEEDING BEHAVIOUR IN C. ELEGANS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAENORHABDITIS-ELEGANS; NEURONS; STARVATION; CIRCUIT; PATHWAY; EXCITATION/INHIBITION; GENERATION; EVOLUTION; CURRENTS; PHARYNX	Glutamatergic neurotransmission is evolutionarily conserved across animal phyla. A major class of glutamate receptors consists of the metabotropic glutamate receptors (mGluRs). In C. elegans, three mGluR genes, mgl-1, mgl-2, and mgl-3, are organized into three subgroups, similar to their mammalian counterparts. Cellular reporters identified expression of the mgls in the nervous system of C. elegans and overlapping expression in the pharyngeal microcircuit that controls pharyngeal muscle activity and feeding behavior. The overlapping expression of mgls within this circuit allowed the investigation of receptor signaling per se and in the context of receptor interactions within a neural network that regulates feeding. We utilized the pharmacological manipulation of neuronally regulated pumping of the pharyngeal muscle in the wild-type and mutants to investigate MGL function. This defined a net mgl-1-dependent inhibition of pharyngeal pumping that is modulated by mgl-3 excitation. Optogenetic activation of the pharyngeal glutamatergic inputs combined with electrophysiological recordings from the isolated pharyngeal preparations provided further evidence for a presynaptic mgl-1-dependent regulation of pharyngeal activity. Analysis of mgl-1, mgl-2, and mgl-3 mutant feeding behavior in the intact organism after acute food removal identified a significant role for mgl-1 in the regulation of an adaptive feeding response. Our data describe the molecular and cellular organization of mgl-1, mgl-2, and mgl-3. Pharmacological analysis identified that, in these paradigms, mgl-1 and mgl-3, but not mgl-2, can modulate the pharyngeal microcircuit. Behavioral analysis identified mgl-1 as a significant determinant of the glutamate-dependent modulation of feeding, further highlighting the significance of mGluRs in complex C. elegans behavior.	[Dillon, James; Franks, Christopher J.; Calahorro, Fernando; Holden-Dye, Lindy; O'Connor, Vincent] Univ Southampton, Ctr Biol Sci, Southampton SO17 1BJ, Hants, England; [Murray, Caitriona] Univ New S Wales, Ramaciotti Ctr Genom, Kensington, NSW 2052, Australia; [Edwards, Richard J.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Kensington, NSW 2052, Australia; [Ishihara, Takeshi] Kyushu Univ, Grad Sch Sci, Dept Biol, Higashi Ku, Fukuoka 8128581, Japan; [Katsura, Isao] Natl Inst Genet, Mishima, Shizuoka 4118540, Japan	University of Southampton; University of New South Wales Sydney; University of New South Wales Sydney; Kyushu University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	O'Connor, V (corresponding author), Univ Southampton, Ctr Biol Sci, Univ Rd, Southampton SO17 1BJ, Hants, England.	voconno@soton.ac.uk	Calahorro, Fernando/H-3294-2013; Edwards, Richard/C-8755-2011	Edwards, Richard/0000-0002-3645-5539; Holden-Dye, Lindy/0000-0002-9704-1217; O'Connor, Vincent/0000-0003-3185-5709; Dillon, James/0000-0003-3244-7483; Franks, C/0000-0002-5412-7037	National Institutes of Health Office of Research Infrastructure Programs [P40 OD010440]; Biotechnology and Biological Sciences Research Council [BB/F009208/1] Funding Source: researchfish; BBSRC [BB/F009208/1] Funding Source: UKRI; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health Office of Research Infrastructure Programs; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Some strains were provided by the CGC, which is funded by National Institutes of Health Office of Research Infrastructure Programs (P40 OD010440).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AVERY L, 1990, J EXP ZOOL, V253, P263, DOI 10.1002/jez.1402530305; AVERY L, 1989, NEURON, V3, P473, DOI 10.1016/0896-6273(89)90206-7; Avery Leon, 2012, WormBook, P1, DOI 10.1895/wormbook.1.150.1; Awad H, 2000, J NEUROSCI, V20, P7871; BRENNER S, 1974, GENETICS, V77, P71; Brockie Penelope J, 2006, WormBook, P1; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Conn PJ, 2009, NEUROPSYCHOPHARMACOL, V34, P248, DOI 10.1038/npp.2008.156; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Dalliere N., 2014, NEUR DEV SYN FUNCT B, P66; Dillon J, 2006, BIOCHEM SOC T, V34, P942, DOI 10.1042/BST0340942; Edwards RJ, 2007, NAT CHEM BIOL, V3, P108, DOI 10.1038/nchembio854; Enz R, 2007, BIOESSAYS, V29, P60, DOI 10.1002/bies.20518; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Franks C. J., 2010, EUR C EL NEUR M FOD, P40; Franks CJ, 2009, INVERTEBR NEUROSCI, V9, P43, DOI 10.1007/s10158-009-0088-8; Greer ER, 2008, CELL METAB, V8, P118, DOI 10.1016/j.cmet.2008.06.005; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Heidinger V, 2002, J NEUROSCI, V22, P5452; Herman E J, 2012, Handb Exp Pharmacol, P297, DOI 10.1007/978-3-642-25758-2_11; Ishihara T., 1996, WORM BREEDERS GAZETT, V14, P40; Jorgensen EM, 2004, NAT NEUROSCI, V7, P1019, DOI 10.1038/nn1004-1019; Kang CH, 2009, GENE DEV, V23, P12, DOI 10.1101/gad.1723409; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kehrer C, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02/006.2008; Krenz WD, 2000, J NEUROPHYSIOL, V83, P1188, DOI 10.1152/jn.2000.83.3.1188; Kucharski R., 2007, Invertebrate Neuroscience, V7, P99, DOI 10.1007/s10158-007-0045-3; Lee RYN, 1999, J NEUROSCI, V19, P159, DOI 10.1523/JNEUROSCI.19-01-00159.1999; Mello C, 1995, METHOD CELL BIOL, V48, P451; Mitri C, 2004, J BIOL CHEM, V279, P9313, DOI 10.1074/jbc.M310878200; Nathoo AN, 2001, P NATL ACAD SCI USA, V98, P14000, DOI 10.1073/pnas.241231298; Oberman LM, 2012, EXPERT OPIN INV DRUG, V21, P1819, DOI 10.1517/13543784.2012.729819; Parmentier ML, 1996, J NEUROSCI, V16, P6687; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Rogers CM, 2001, J NEUROBIOL, V49, P235, DOI 10.1002/neu.1078; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Tharmalingam S, 2012, NEUROPHARMACOLOGY, V63, P667, DOI 10.1016/j.neuropharm.2012.05.029; Wakabayashi T, 2004, NEUROSCI RES, V50, P103, DOI 10.1016/j.neures.2004.06.005; Walker DS, 2002, MOL BIOL CELL, V13, P1329, DOI 10.1091/mbc.01-08-0422; Washio H, 2002, ZOOL SCI, V19, P153, DOI 10.2108/zsj.19.153; Watkins J C, 1981, Adv Biochem Psychopharmacol, V27, P263; WEINSHENKER D, 1995, J NEUROSCI, V15, P6975; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; You YJ, 2006, CELL METAB, V3, P237, DOI 10.1016/j.cmet.2006.02.012; Zheng N, 2011, J NEUROSCI, V31, P10283, DOI 10.1523/JNEUROSCI.1834-11.2011	48	18	18	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15052	15065		10.1074/jbc.M114.606608	http://dx.doi.org/10.1074/jbc.M114.606608			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25869139	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000356177300021
J	Jin, NN; Yin, XM; Gu, JL; Zhang, XH; Shi, JH; Qian, W; Ji, YH; Cao, MH; Gu, XS; Ding, F; Iqbal, K; Gong, CX; Liu, F				Jin, Nana; Yin, Xiaomin; Gu, Jianlan; Zhang, Xinhua; Shi, Jianhua; Qian, Wei; Ji, Yuhua; Cao, Maohong; Gu, Xiaosong; Ding, Fei; Iqbal, Khalid; Gong, Cheng-Xin; Liu, Fei			Truncation and Activation of Dual Specificity Tyrosine Phosphorylation-regulated Kinase 1A by Calpain I A MOLECULAR MECHANISM LINKED TO TAU PATHOLOGY IN ALZHEIMER DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; NEUTRAL PROTEINASE CALPAIN; AMYLOID PRECURSOR PROTEIN; DOWN-SYNDROME; HUMAN-BRAIN; FUNCTIONAL-LINK; MESSENGER-RNA; EXON 10; NEUROFIBRILLARY PATHOLOGY; ABNORMAL PHOSPHORYLATION	Hyperphosphorylation and dysregulation of exon 10 splicing of Tau are pivotally involved in pathogenesis of Alzheimer disease (AD) and/or other tauopathies. Alternative splicing of Tau exon 10, which encodes the second microtubule-binding repeat, generates Tau isoforms containing three and four microtubule-binding repeats, termed 3R-Taus and 4R-Taus, respectively. Dual specificity tyrosine-phosphorylation-regulated kinase 1A (Dyrk1A) lies at the Down syndrome critical region of chromosome 21. Overexpression of this kinase may contribute to the early Tau pathology in Down syndrome via phosphorylation of Tau and dysregulation of Tau exon 10. Here, we report that Dyrk1A was truncated at the C terminus and was associated with overactivation of calpain I in AD brain. Calpain I proteolyzed Dyrk1A in vitro first at the C terminus and further at the N terminus and enhanced its kinase activity toward Tau via increased V-max but not K-m. C-terminal truncation of Dyrk1A resulted in stronger activity than its full-length protein in promotion of exon 10 exclusion and phosphorylation of Tau. Dyrk1A was truncated in kainic acid-induced excitotoxic mouse brains and coincided with an increase in 3R-Tau expression and phosphorylation of Tau via calpain activation. Moreover, truncation of Dyrk1A was correlated with an increase in the ratio of 3R-Tau/4R-Tau and Tau hyperphosphorylation in AD brain. Collectively, these findings suggest that truncation/activation of Dyrk1A by Ca2+/calpain I might contribute to Tau pathology via promotion of exon 10 exclusion and hyperphosphorylation of Tau in AD brain.	[Gu, Xiaosong; Ding, Fei; Gong, Cheng-Xin; Liu, Fei] Nantong Univ, Coinnovat Ctr Neuroregenerat, Jiangsu Key Lab Neuroregenerat, Nantong 226001, Jiangsu, Peoples R China; [Jin, Nana; Yin, Xiaomin; Gu, Jianlan; Zhang, Xinhua; Shi, Jianhua; Iqbal, Khalid; Gong, Cheng-Xin; Liu, Fei] New York State Inst Basic Res Dev Disabil, Dept Neurochem, Staten Isl, NY 10314 USA; [Shi, Jianhua; Qian, Wei] Nantong Univ, Sch Med Sci, Dept Biochem & Mol Biol, Nantong 226001, Jiangsu, Peoples R China; [Cao, Maohong] Nantong Univ, Dept Neurol, Nantong 226001, Jiangsu, Peoples R China	Nantong University; Institute for Basic Research in Developmental Disabilities; Nantong University; Nantong University	Liu, F (corresponding author), New York State Inst Basic Res Dev Disabil, Dept Neurochem, 1050 Forest Hill Rd, Staten Isl, NY 10314 USA.	feiliu63@hotmail.com	Regan, Clinton/E-6250-2012; Shi, Jianhua/L-8463-2016	Shi, Jianhua/0000-0002-5351-406X	Nantong University; New York State Office of People with Developmental Disabilities; National Natural Science Foundation of China [81030059]; United States Alzheimer's Association [IIRG-10-173154]; Jiangsu Education Department [10KJA310040]; Priority Academic Program Development of Jiangsu Higher Education Institutions; National Institutes of Health [P30 AG19610]; NATIONAL INSTITUTE ON AGING [R01AG031581, P30AG019610] Funding Source: NIH RePORTER	Nantong University; New York State Office of People with Developmental Disabilities; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); United States Alzheimer's Association; Jiangsu Education Department; Priority Academic Program Development of Jiangsu Higher Education Institutions; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by Nantong University and the New York State Office of People with Developmental Disabilities and by grants from the National Natural Science Foundation of China (Grant 81030059), the United States Alzheimer's Association (Grant IIRG-10-173154), the Basic Research Program of the Jiangsu Education Department (Grant 10KJA310040), and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The Brain Donation Program is supported in part by National Institutes of Health Grant P30 AG19610 (Arizona Alzheimer's Disease Core Center).	Adayev T, 2007, BIOCHEMISTRY-US, V46, P7614, DOI 10.1021/bi700251n; Adayev T, 2006, BIOCHEMISTRY-US, V45, P12011, DOI 10.1021/bi060632j; ALAFUZOFF I, 1987, ACTA NEUROPATHOL, V74, P209, DOI 10.1007/BF00688184; Alonso AD, 2001, J BIOL CHEM, V276, P37967; ALONSO AD, 1994, P NATL ACAD SCI USA, V91, P5562, DOI 10.1073/pnas.91.12.5562; Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Alvarez M, 2007, MOL BIOL CELL, V18, P1167, DOI 10.1091/mbc.E06-08-0668; ANDREADIS A, 1992, BIOCHEMISTRY-US, V31, P10626, DOI 10.1021/bi00158a027; ARRIAGADA PV, 1992, NEUROLOGY, V42, P1681, DOI 10.1212/WNL.42.9.1681; Becker W, 2011, FEBS J, V278, P246, DOI 10.1111/j.1742-4658.2010.07956.x; Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; Bol SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017190; Boutajangout A, 2004, FEBS LETT, V576, P183, DOI 10.1016/j.febslet.2004.09.011; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; Braak H., 1995, NEUROBIOL AGING, V16, P278, DOI DOI 10.1016/0197-4580(95)00021-6; Chambers CB, 1999, ANN NEUROL, V46, P325, DOI 10.1002/1531-8249(199909)46:3<325::AID-ANA8>3.0.CO;2-V; Chevyreva I, 2008, EXP MOL PATHOL, V84, P71, DOI 10.1016/j.yexmp.2007.08.019; Choi DW, 1998, ANNU REV NEUROSCI, V21, P347, DOI 10.1146/annurev.neuro.21.1.347; D'Souza I, 2006, J BIOL CHEM, V281, P2460, DOI 10.1074/jbc.M505809200; Dierssen M, 2006, THESCIENTIFICWORLDJO, V6, P1911, DOI 10.1100/tsw.2006.319; Espinoza M, 2008, J ALZHEIMERS DIS, V14, P1; Fath T, 2002, J NEUROSCI, V22, P9733; Ferrer I, 2005, NEUROBIOL DIS, V20, P392, DOI 10.1016/j.nbd.2005.03.020; Glading A, 2004, MOL CELL BIOL, V24, P2499, DOI 10.1128/MCB.24.6.2499-2512.2004; Glatz DC, 2006, J NEUROCHEM, V96, P635, DOI 10.1111/j.1471-4159.2005.03552.x; Glenner G G, 1984, Appl Pathol, V2, P357; Goedert M, 2005, MOVEMENT DISORD, V20, pS45, DOI 10.1002/mds.20539; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4051, DOI 10.1073/pnas.85.11.4051; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goedert M, 2005, BBA-MOL BASIS DIS, V1739, P240, DOI 10.1016/j.bbadis.2004.08.007; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Goode BL, 2000, J BIOL CHEM, V275, P38182, DOI 10.1074/jbc.M007489200; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Grynspan F, 1997, J NEUROSCI RES, V48, P181; Hanes J, 2009, J NEUROCHEM, V108, P1167, DOI 10.1111/j.1471-4159.2009.05869.x; IQBAL K, 1986, LANCET, V2, P421; Iqbal K, 2009, ACTA NEUROPATHOL, V118, P53, DOI 10.1007/s00401-009-0486-3; Jackson GR, 2002, NEURON, V34, P509, DOI 10.1016/S0896-6273(02)00706-7; Kentrup H, 1996, J BIOL CHEM, V271, P3488; Khachaturian Z S, 1989, Aging (Milano), V1, P17; Kimura R, 2007, HUM MOL GENET, V16, P15, DOI 10.1093/hmg/ddl437; KOPKE E, 1993, J BIOL CHEM, V268, P24374; KOSIK KS, 1989, NEURON, V2, P1389, DOI 10.1016/0896-6273(89)90077-9; KSIEZAKREDING H, 1992, BRAIN RES, V597, P209, DOI 10.1016/0006-8993(92)91476-U; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; Liang ZH, 2007, J NEUROCHEM, V103, P2462, DOI 10.1111/j.1471-4159.2007.04942.x; Liu F, 2005, J BIOL CHEM, V280, P37755, DOI 10.1074/jbc.M507475200; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; Liu F, 2002, FEBS LETT, V530, P209, DOI 10.1016/S0014-5793(02)03487-7; Liu F, 2008, FASEB J, V22, P3224, DOI 10.1096/fj.07-104539; Lu M, 2001, MOL BIOL CELL, V12, P171, DOI 10.1091/mbc.12.1.171; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; MATTSON MP, 1992, NEUROBIOL AGING, V13, P617, DOI 10.1016/0197-4580(92)90068-9; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Moller RS, 2008, AM J HUM GENET, V82, P1165, DOI 10.1016/j.ajhg.2008.03.001; NIXON RA, 1994, ANN NY ACAD SCI, V747, P77; Perez M, 2002, EUR J BIOCHEM, V269, P1484, DOI 10.1046/j.1432-1033.2002.02794.x; Qian W, 2011, NUCLEIC ACIDS RES, V39, P6161, DOI 10.1093/nar/gkr195; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Reisberg B, 2003, NEW ENGL J MED, V348, P1333, DOI 10.1056/NEJMoa013128; Riley KP, 2002, ANN NEUROL, V51, P567, DOI 10.1002/ana.10161; Rodriguez-Martin T, 2013, NEUROBIOL AGING, V34, P2146, DOI 10.1016/j.neurobiolaging.2013.03.015; Ryoo SR, 2008, J NEUROCHEM, V104, P1333, DOI 10.1111/j.1471-4159.2007.05075.x; Ryoo SR, 2007, J BIOL CHEM, V282, P34850, DOI 10.1074/jbc.M707358200; Ryu YS, 2010, J NEUROCHEM, V115, P574, DOI 10.1111/j.1471-4159.2010.06769.x; SAITO KI, 1993, P NATL ACAD SCI USA, V90, P2628, DOI 10.1073/pnas.90.7.2628; Shi JH, 2008, J BIOL CHEM, V283, P28660, DOI 10.1074/jbc.M802645200; Shi JH, 2011, J BIOL CHEM, V286, P14639, DOI 10.1074/jbc.M110.204453; Shukkur EA, 2006, HUM MOL GENET, V15, P2752, DOI 10.1093/hmg/ddl211; Simpkins KL, 2003, J NEUROSCI, V23, P11322; Singh TJ, 1997, MOL CELL BIOCHEM, V168, P141, DOI 10.1023/A:1006807105059; Stan AD, 2006, BRAIN RES, V1123, P1, DOI 10.1016/j.brainres.2006.09.025; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; Veeranna, 2004, AM J PATHOL, V165, P795, DOI 10.1016/S0002-9440(10)63342-1; Wang JZ, 2008, PROG NEUROBIOL, V85, P148, DOI 10.1016/j.pneurobio.2008.03.002; Wegiel J, 2004, BRAIN RES, V1010, P69, DOI 10.1016/j.brainres.2004.03.008; Wiechmann S, 2003, BIOCHEM BIOPH RES CO, V302, P403, DOI 10.1016/S0006-291X(03)00148-7; WISNIEWSKI KE, 1985, ANN NEUROL, V17, P278, DOI 10.1002/ana.410170310; Woods YL, 2001, BIOCHEM J, V355, P597, DOI 10.1042/bj3550597; Wu HY, 2004, J BIOL CHEM, V279, P4929, DOI 10.1074/jbc.M309767200; Xu J, 2009, J NEUROSCI, V29, P9330, DOI 10.1523/JNEUROSCI.2212-09.2009; YANG LS, 1995, EUR J BIOCHEM, V233, P9, DOI 10.1111/j.1432-1033.1995.009_1.x; Yasojima K, 1999, BRAIN RES, V831, P301, DOI 10.1016/S0006-8993(99)01486-9; Yu QM, 2004, J NEUROCHEM, V90, P164, DOI 10.1111/j.1471-4159.2004.02477.x; Zadran S, 2010, J NEUROSCI, V30, P1086, DOI 10.1523/JNEUROSCI.5120-09.2010	89	39	39	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15219	15237		10.1074/jbc.M115.645507	http://dx.doi.org/10.1074/jbc.M115.645507			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25918155	Green Published, hybrid			2022-12-28	WOS:000356177300035
J	Marsango, S; Caltabiano, G; Pou, C; Liste, MJV; Milligan, G				Marsango, Sara; Caltabiano, Gianluigi; Pou, Chantevy; Varela Liste, Mara Jose; Milligan, Graeme			Analysis of Human Dopamine D-3 Receptor Quaternary Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; CRYSTAL-STRUCTURE; OLIGOMERIC ORGANIZATION; OPIOID RECEPTOR; INTERFACE; COMPLEX; GPCR; DIMERIZATION; COOPERATIVITY; EXPRESSION	The dopamine D-3 receptor is a class A, rhodopsin-like G protein-coupled receptor that can form dimers and/or higher order oligomers. However, the molecular basis for production of these complexes is not well defined. Using combinations of molecular modeling, site-directed mutagenesis, and homogenous time-resolved FRET, the interfaces that allow dopamine D-3 receptor monomers to interact were defined and used to describe likely quaternary arrangements of the receptor. These were then compared with published crystal structures of dimeric beta(1)-adrenoreceptor, beta-opioid, and CXCR4 receptors. The data indicate important contributions of residues from within each of transmembrane domains I, II, IV, V, VI, and VII as well as the intracellular helix VIII in the formation of D-3-D-3 receptor interfaces within homo-oligomers and are consistent with the D-3 receptor adopting a beta(1)-adrenoreceptor-like quaternary arrangement. Specifically, results suggest that D-3 protomers can interact with each other via at least two distinct interfaces: the first one comprising residues from transmembrane domains I and II along with those from helix VIII and a second one involving transmembrane domains IV and V. Moreover, rather than existing only as distinct dimeric species, the results are consistent with the D-3 receptor also assuming a quaternary structure in which two transmembrane domain I-II-helix VIII dimers interact to form a "rhombic" tetramer via an interface involving residues from transmembrane domains VI and VII. In addition, the results also provide insights into the potential contribution of molecules of cholesterol to the overall organization and potential stability of the D-3 receptor and possibly other GPCR quaternary structures.	[Marsango, Sara; Pou, Chantevy; Varela Liste, Mara Jose; Milligan, Graeme] Univ Glasgow, Coll Med Vet & Life Sci, Mol Pharmacol Grp, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland; [Caltabiano, Gianluigi] Univ Autonoma Barcelona, Fac Med, Unitat Bioestadist, Lab Med Computac, Bellaterra 08193, Spain	University of Glasgow; Autonomous University of Barcelona	Milligan, G (corresponding author), Univ Glasgow, Wolfson Link Bldg 253, Glasgow G12 8QQ, Lanark, Scotland.	Graeme.Milligan@glasgow.ac.uk	Caltabiano, Gianluigi/F-4654-2010	Caltabiano, Gianluigi/0000-0002-2929-7069	Medical Research Council (United Kingdom) [MR/L023806/1, G0900050]; Istituto Pasteur, Fondazione Cenci-Bolognetti; European Molecular Biology Organization short term fellowship; Fundacion Pedro Barrie de la Maza; MRC [MR/L023806/1, G0900050] Funding Source: UKRI; Medical Research Council [MR/L023806/1, G0900050] Funding Source: researchfish	Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Istituto Pasteur, Fondazione Cenci-Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti); European Molecular Biology Organization short term fellowship; Fundacion Pedro Barrie de la Maza; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Medical Research Council (United Kingdom) Grants MR/L023806/1 and G0900050 (to G. M.).; Supported by the Istituto Pasteur, Fondazione Cenci-Bolognetti.; Recipient of a European Molecular Biology Organization short term fellowship.; Supported by the Fundacion Pedro Barrie de la Maza.	[Anonymous], PYMOL MOL GRAPH SYST; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Borroto-Escuela DO, 2010, BIOCHEM BIOPH RES CO, V402, P801, DOI 10.1016/j.bbrc.2010.10.122; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Dong MQ, 2010, J BIOL CHEM, V285, P9919, DOI 10.1074/jbc.M109.089730; Ferre S, 2014, PHARMACOL REV, V66, P413, DOI 10.1124/pr.113.008052; Franco R, 2010, SYNAPSE, V64, P566, DOI 10.1002/syn.20775; Fung JJ, 2009, EMBO J, V28, P3315, DOI 10.1038/emboj.2009.267; Gonzalez A, 2012, CHEMBIOCHEM, V13, P1393, DOI 10.1002/cbic.201200189; Gorinski N, 2012, MOL PHARMACOL, V82, P448, DOI 10.1124/mol.112.079137; Guo W, 2005, P NATL ACAD SCI USA, V102, P17495, DOI 10.1073/pnas.0508950102; Guo W, 2003, J BIOL CHEM, V278, P4385, DOI 10.1074/jbc.C200679200; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Hasbi A, 2014, FASEB J, V28, P4806, DOI 10.1096/fj.14-254037; Hern JA, 2010, P NATL ACAD SCI USA, V107, P2693, DOI 10.1073/pnas.0907915107; Huang JY, 2013, NAT STRUCT MOL BIOL, V20, P419, DOI 10.1038/nsmb.2504; Johnston JM, 2011, BIOCHEMISTRY-US, V50, P1682, DOI 10.1021/bi101474v; Joyce JN, 2005, DRUG DISCOV TODAY, V10, P917, DOI 10.1016/S1359-6446(05)03491-4; Joyce JN, 2001, SYNAPSE, V40, P137, DOI 10.1002/syn.1035; Kasai RS, 2014, CURR OPIN CELL BIOL, V27, P78, DOI 10.1016/j.ceb.2013.11.008; Kellendonk C, 2006, NEURON, V49, P603, DOI 10.1016/j.neuron.2006.01.023; Le Foll B., 2014, EUR NEUROPSYCHOPHARM, DOI [10.1016/j.euroneuro.2014.08.017, DOI 10.1016/J.EUR0NEURO.2014.08.017]; Liste MJV, 2015, MOL PHARMACOL, V87, P936, DOI 10.1124/mol.114.096925; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; Lohse MJ, 2010, CURR OPIN PHARMACOL, V10, P53, DOI 10.1016/j.coph.2009.10.007; Maggio R, 2010, CURR OPIN PHARMACOL, V10, P100, DOI 10.1016/j.coph.2009.10.001; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Maurel D, 2008, NAT METHODS, V5, P561, DOI [10.1038/nmeth.1213, 10.1038/NMETH.1213]; Millan MJ, 2002, J PHARMACOL EXP THER, V303, P791, DOI 10.1124/jpet.102.039867; Milligan G, 2004, MOL PHARMACOL, V66, P1, DOI 10.1124/mol.104.000497.; Milligan G, 2013, MOL PHARMACOL, V84, P158, DOI 10.1124/mol.113.084780; Milligan G, 2009, BRIT J PHARMACOL, V158, P5, DOI 10.1111/j.1476-5381.2009.00169.x; Nimchinsky EA, 1997, J BIOL CHEM, V272, P29229, DOI 10.1074/jbc.272.46.29229; Oates J, 2012, BBA-BIOMEMBRANES, V1818, P2228, DOI 10.1016/j.bbamem.2012.04.010; Park PSH, 2002, BIOCHEMISTRY-US, V41, P5588, DOI 10.1021/bi011746s; Patowary S, 2013, BIOCHEM J, V452, P303, DOI 10.1042/BJ20121902; Perreault ML, 2011, CNS NEUROSCI THER, V17, P52, DOI 10.1111/j.1755-5949.2010.00228.x; Pou C, 2012, J BIOL CHEM, V287, P8864, DOI 10.1074/jbc.M111.326678; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Redka DS, 2014, J BIOL CHEM, V289, P24347, DOI 10.1074/jbc.M114.559294; Schetz J. A., 2007, HDB CONT NEUROPHARMA, P221; Sunahara RK, 1997, SCIENCE, V278, P1943, DOI 10.1126/science.278.5345.1943; Tsai SJ, 2003, SCHIZOPHR RES, V63, P197, DOI 10.1016/S0920-9964(02)00436-X; Van Eps N, 2011, P NATL ACAD SCI USA, V108, P9420, DOI 10.1073/pnas.1105810108; Wacker D, 2013, SCIENCE, V340, P615, DOI 10.1126/science.1232808; Ward RJ, 2015, J BIOL CHEM, V290, P12844, DOI 10.1074/jbc.M115.644724; Ward RJ, 2011, J BIOL CHEM, V286, P37414, DOI 10.1074/jbc.M111.287649; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Worth CL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-185; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2014, SCIENCE, V344, P58, DOI 10.1126/science.1249489; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Xu JB, 2010, SYNAPSE, V64, P449, DOI 10.1002/syn.20748; Zhang KH, 2014, NATURE, V509, P115, DOI 10.1038/nature13083	55	21	21	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15146	15162		10.1074/jbc.M114.630681	http://dx.doi.org/10.1074/jbc.M114.630681			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25931118	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000356177300029
J	Lee, HK; Ji, S; Park, SJ; Choung, HW; Choi, Y; Lee, HJ; Park, SY; Park, JC				Lee, Hye-Kyung; Ji, Suk; Park, Su-Jin; Choung, Han-Wool; Choi, Youngnim; Lee, Hyo-Jung; Park, Shin-Young; Park, Joo-Cheol			Odontogenic Ameloblast-associated Protein (ODAM) Mediates Junctional Epithelium Attachment to Teeth via Integrin-ODAM-Rho Guanine Nucleotide Exchange Factor 5 (ARHGEF5)-RhoA Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT INCISOR; ALPHA-V-BETA-6 INTEGRIN; ENAMEL MINERALIZATION; PERIODONTAL-DISEASE; TOOTH DEVELOPMENT; CELL-ADHESION; FIBRONECTIN; LAMININ; EXPRESSION; MATURATION	Adhesion of the junctional epithelium (JE) to the tooth surface is crucial for maintaining periodontal health. Although odontogenic ameloblast-associated protein (ODAM) is expressed in the JE, its molecular functions remain unknown. We investigated ODAM function during JE development and regeneration and its functional significance in the initiation and progression of periodontitis and peri-implantitis. ODAM was expressed in the normal JE of healthy teeth but absent in the pathologic pocket epithelium of diseased periodontium. In periodontitis and peri-implantitis, ODAM was extruded from the JE following onset with JE attachment loss and detected in gingival crevicular fluid. ODAM induced RhoA activity and the expression of downstream factors, including ROCK (Rho-associated kinase), by interacting with Rho guanine nucleotide exchange factor 5 (ARHGEF5). ODAM-mediated RhoA signaling resulted in actin filament rearrangement. Reduced ODAM and RhoA expression in integrin beta(3)- and beta(6)-knockout mice revealed that cytoskeleton reorganization in the JE occurred via integrin-ODAM-ARHGEF5-RhoA signaling. Fibronectin and laminin activated RhoA signaling via the integrin-ODAM pathway. Finally, ODAM was re-expressed with RhoA in regenerating JE after gingivectomy in vivo. These results suggest that ODAM expression in the JE reflects a healthy periodontium and that JE adhesion to the tooth surface is regulated via fibronectin/laminin-integrin-ODAM-ARHGEF5-RhoA signaling. We also propose that ODAM could be used as a biomarker of periodontitis and peri-implantitis.	[Lee, Hye-Kyung; Park, Su-Jin; Choung, Han-Wool; Park, Joo-Cheol] Seoul Natl Univ, Sch Dent, Dept Oral Histol Dev Biol, Seoul 110744, South Korea; [Choi, Youngnim] Seoul Natl Univ, Sch Dent, Dept Immunol & Mol Microbiol, Seoul 110744, South Korea; Seoul Natl Univ, Dent Res Inst, Seoul 110744, South Korea; [Ji, Suk] Korea Univ, Anam Hosp, Dept Periodontol, Seoul 136713, South Korea; [Lee, Hyo-Jung; Park, Shin-Young] Seoul Natl Univ, Bundang Hosp, Sect Dent, Dept Periodontol, Songnam 463707, Gyeonggi Do, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Korea University; Korea University Medicine (KU Medicine); Seoul National University (SNU)	Park, JC (corresponding author), Seoul Natl Univ, Sch Dent, Dept Oral Histol Dev Biol, 101 Daehagro, Seoul 110749, South Korea.	jcapark@snu.ac.kr	Park, Joo Cheol/D-6437-2012; Choi, Youngnim/AAL-8140-2020	Park, Joo Cheol/0000-0002-3162-7557; Choi, Youngnim/0000-0002-6496-5560; LEE, HYE KYUNG/0000-0002-7785-5942; Lee, Hyo-Jung/0000-0002-0439-7389	Bio AMP; Medical Technology Development Program of the National Research Foundation - Korean government (MSIP) [NRF-2013M34A9B2076480]	Bio AMP; Medical Technology Development Program of the National Research Foundation - Korean government (MSIP)	This research was supported by Bio & Medical Technology Development Program of the National Research Foundation Grant NRF-2013M34A9B2076480 funded by the Korean government (MSIP).	Atsuta I, 2013, J BIOMED MATER RES A, V101, P2896, DOI 10.1002/jbm.a.34608; Berglundh T, 2002, J CLIN PERIODONTOL, V29, P197, DOI 10.1034/j.1600-051X.29.s3.12.x; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Bhadriraju K, 2007, EXP CELL RES, V313, P3616, DOI 10.1016/j.yexcr.2007.07.002; Bosshardt DD, 2005, J DENT RES, V84, P9, DOI 10.1177/154405910508400102; BREUSS JM, 1993, J HISTOCHEM CYTOCHEM, V41, P1521, DOI 10.1177/41.10.8245410; CAFFESSE RG, 1979, J PERIODONTOL, V50, P1, DOI 10.1902/jop.1979.50.1.1; Casavecchia P, 2004, J PERIODONTOL, V75, P770, DOI 10.1902/jop.2004.75.5.770; Dean JW, 1997, J PERIODONTOL, V68, P750, DOI 10.1902/jop.1997.68.8.750; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; Fukumoto S, 2005, CONNECT TISSUE RES, V46, P220, DOI 10.1080/03008200500344017; Fukumoto S, 2006, J BIOL CHEM, V281, P5008, DOI 10.1074/jbc.M509295200; Ganss B, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00371; Ghannad F, 2008, AM J PATHOL, V172, P1271, DOI 10.2353/ajpath.2008.071068; Hormia M, 2001, J PERIODONTOL, V72, P788, DOI 10.1902/jop.2001.72.6.788; HYNES RO, 1982, J CELL BIOL, V95, P369, DOI 10.1083/jcb.95.2.369; Ikeda H, 2000, J PERIODONTOL, V71, P961, DOI 10.1902/jop.2000.71.6.961; Jue SS, 2014, ANGLE ORTHOD, V84, P534, DOI 10.2319/051613-378.1; Kestler DP, 2008, MOL MED, V14, P318, DOI 10.2119/2008-00010.Kestler; Kestler DP, 2011, BREAST CANCER-BASIC, V5, P73, DOI 10.4137/BCBCR.S6859; Larjava H, 2011, J DENT RES, V90, P1367, DOI 10.1177/0022034511402207; Larjava H, 2014, EXP CELL RES, V325, P104, DOI 10.1016/j.yexcr.2014.03.010; Lee HK, 2012, GENE EXPR PATTERNS, V12, P102, DOI 10.1016/j.gep.2012.02.002; Lee HK, 2012, J CELL BIOCHEM, V113, P1754, DOI 10.1002/jcb.24047; Lee HK, 2010, J CELL BIOCHEM, V111, P755, DOI 10.1002/jcb.22766; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Masaoka T, 2009, J PERIODONTAL RES, V44, P489, DOI 10.1111/j.1600-0765.2008.01142.x; Moffatt P, 2008, J CELL BIOCHEM, V103, P941, DOI 10.1002/jcb.21465; Mohazab L, 2013, J CELL SCI, V126, P732, DOI 10.1242/jcs.112599; Nakaya H, 1989, Nihon Shishubyo Gakkai Kaishi, V31, P462; Narani N, 2007, EUR J ORAL SCI, V115, P288, DOI 10.1111/j.1600-0722.2007.00467.x; Neves JD, 2012, HISTOCHEM CELL BIOL, V137, P329, DOI 10.1007/s00418-011-0901-4; NISHIKAWA S, 1986, DIFFERENTIATION, V30, P237, DOI 10.1111/j.1432-0436.1986.tb00786.x; NISHIKAWA S, 1988, EUR J CELL BIOL, V47, P222; Nishio C, 2010, J PERIODONTAL RES, V45, P709, DOI 10.1111/j.1600-0765.2010.01288.x; Nishio C, 2010, EUR CELLS MATER, V20, P393; Park JC, 2007, EUR J ORAL SCI, V115, P153, DOI 10.1111/j.1600-0722.2007.00435.x; Redlich M, 1999, AM J ORTHOD DENTOFAC, V116, P152, DOI 10.1016/S0889-5406(99)70212-X; SABAG N, 1984, J PERIODONTOL, V55, P135, DOI 10.1902/jop.1984.55.3.135; Sakai T, 1996, ARCH ORAL BIOL, V41, P885, DOI 10.1016/S0003-9969(96)00014-3; Salmivirta K, 1996, DEV DYNAM, V205, P104, DOI 10.1002/(SICI)1097-0177(199602)205:2<104::AID-AJA2>3.0.CO;2-M; SAWADA T, 1995, ARCH ORAL BIOL, V40, P1029, DOI 10.1016/0003-9969(95)00073-X; Schroeder HE, 2003, J DENT RES, V82, P158, DOI 10.1177/154405910308200302; Schroeder HE, 1997, PERIODONTOL 2000, V13, P91, DOI 10.1111/j.1600-0757.1997.tb00097.x; Shimono M, 2003, J ELECTRON MICROSC, V52, P627, DOI 10.1093/jmicro/52.6.627; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; Sorokin LM, 1997, DEV BIOL, V189, P285, DOI 10.1006/dbio.1997.8668; STENMAN S, 1978, J EXP MED, V147, P1054, DOI 10.1084/jem.147.4.1054; Tabata MJ, 2003, J HISTOCHEM CYTOCHEM, V51, P1673, DOI 10.1177/002215540305101211; THESLEFF I, 1987, J DENT RES, V66, P1107, DOI 10.1177/00220345870660060401; THESLEFF I, 1981, DEV BIOL, V81, P182, DOI 10.1016/0012-1606(81)90361-4; Wang ZL, 2009, J BIOL CHEM, V284, P28599, DOI 10.1074/jbc.M109.047282; Xue H, 2013, EUR J ORAL SCI, V121, P293, DOI 10.1111/eos.12059; Yoshida T, 2012, J DENT RES, V91, P1154, DOI 10.1177/0022034512462722; Yoshida T, 2013, J CELL BIOCHEM, V114, P2138, DOI 10.1002/jcb.24564	55	27	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14740	14753		10.1074/jbc.M115.648022	http://dx.doi.org/10.1074/jbc.M115.648022			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25911094	Green Published, hybrid			2022-12-28	WOS:000355754600043
J	Mishra, RK; Wei, CY; Hresko, RC; Bajpai, R; Heitmeier, M; Matulis, SM; Nooka, AK; Rosen, ST; Hruz, PW; Schiltz, GE; Shanmugam, M				Mishra, Rama K.; Wei, Changyong; Hresko, Richard C.; Bajpai, Richa; Heitmeier, Monique; Matulis, Shannon M.; Nooka, Ajay K.; Rosen, Steven T.; Hruz, Paul W.; Schiltz, Gary E.; Shanmugam, Mala			In Silico Modeling-based Identification of Glucose Transporter 4 (GLUT4)-selective Inhibitors for Cancer Therapy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE-TRANSPORTER; MULTIPLE-MYELOMA; STRUCTURE VALIDATION; INSULIN; GLUT4; DAPAGLIFLOZIN; RITONAVIR; RESISTANCE; MOLPROBITY; MECHANISM	Tumor cells rely on elevated glucose consumption and metabolism for survival and proliferation. Glucose transporters mediating glucose entry are key proximal rate-limiting checkpoints. Unlike GLUT1 that is highly expressed in cancer and more ubiquitously expressed in normal tissues, GLUT4 exhibits more limited normal expression profiles. We have previously determined that insulin-responsive GLUT4 is constitutively localized on the plasma membrane of myeloma cells. Consequently, suppression of GLUT4 or inhibition of glucose transport with the HIV protease inhibitor ritonavir elicited growth arrest and/or apoptosis in multiple myeloma. GLUT4 inhibition also caused sensitization to metformin in multiple myeloma and chronic lymphocytic leukemia and a number of solid tumors suggesting the broader therapeutic utility of targeting GLUT4. This study sought to identify selective inhibitors of GLUT4 to develop a more potent cancer chemotherapeutic with fewer potential off-target effects. Recently, the crystal structure of GLUT1 in an inward open conformation was reported. Although this is an important achievement, a full understanding of the structural biology of facilitative glucose transport remains elusive. To date, there is no three-dimensional structure for GLUT4. We have generated a homology model for GLUT4 that we utilized to screen for drug-like compounds from a library of 18 million compounds. Despite 68% homology between GLUT1 and GLUT4, our virtual screen identified two potent compounds that were shown to target GLUT4 preferentially over GLUT1 and block glucose transport. Our results strongly bolster the utility of developing GLUT4-selective inhibitors as anti-cancer therapeutics.	[Mishra, Rama K.; Schiltz, Gary E.] Northwestern Univ, Ctr Mol Innovat & Drug Discovery, Evanston, IL 60208 USA; [Hresko, Richard C.; Heitmeier, Monique; Hruz, Paul W.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Rosen, Steven T.] City Hope Natl Med Ctr, Duarte, CA 91010 USA; [Wei, Changyong; Bajpai, Richa; Matulis, Shannon M.; Nooka, Ajay K.; Shanmugam, Mala] Emory Univ, Dept Hematol & Med Oncol, Sch Med, Atlanta, GA 30322 USA	Northwestern University; Washington University (WUSTL); City of Hope; Emory University	Shanmugam, M (corresponding author), Emory Univ, Winship Canc Inst, 1365C Clifton Rd NE,Ste C4002, Atlanta, GA 30322 USA.	mala.shan@emory.edu	Bajpai, Richa/H-6404-2019; Shanmugam, Mala/M-6491-2019	Shanmugam, Mala/0000-0002-4415-8083; Hruz, Paul/0000-0002-1478-3355; Rosen, Steven/0000-0002-8818-7724	American Cancer Society [RSG-11-254-01-CSM]; Richard Silverman-Center for Molecular Innovation and Drug Discovery; Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; National Institutes of Health from the NCI [P30 CA060553]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Richard Silverman-Center for Molecular Innovation and Drug Discovery; Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by American Cancer Society Research Scholar Grant RSG-11-254-01-CSM (to M. S.) and a research award from the Richard Silverman-Center for Molecular Innovation and Drug Discovery (to M. S.). Part of this work was performed by the Northwestern University Medicinal and Synthetic Chemistry Core (ChemCore) at the Center for Molecular Innovation and Drug Discovery, which is funded by the Chicago Biomedical Consortium with support from The Searle Funds at The Chicago Community Trust. This work was supported in part by National Institutes of Health Grant P30 CA060553 from the NCI (to the Robert H. Lurie Comprehensive Cancer Center).	Adekola KUA, 2015, LEUKEMIA LYMPHOMA, V56, P450, DOI 10.3109/10428194.2014.922180; [Anonymous], 2011, GLID VERS 5 7; Baell JB, 2013, J CHEM INF MODEL, V53, P39, DOI 10.1021/ci300461a; Bartel TB, 2009, BLOOD, V114, P2068, DOI 10.1182/blood-2009-03-213280; BIRNBAUM MJ, 1989, CELL, V57, P305, DOI 10.1016/0092-8674(89)90968-9; Bredella MA, 2005, AM J ROENTGENOL, V184, P1199, DOI 10.2214/ajr.184.4.01841199; Cao XH, 2007, CANCER CHEMOTH PHARM, V59, P495, DOI 10.1007/s00280-006-0291-9; Castellani M, 2010, CLIN NUCL MED, V35, P1, DOI 10.1097/RLU.0b013e3181c3619c; Chan DA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002394; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CORVERA S, 1994, J CELL BIOL, V126, P979, DOI 10.1083/jcb.126.4.979; Dalva-Aydemir S, 2015, CLIN CANCER RES, V21, P1161, DOI 10.1158/1078-0432.CCR-14-1088; Deng D, 2014, NATURE, V510, P121, DOI 10.1038/nature13306; Durie BGM, 2002, J NUCL MED, V43, P1457; Guan L, 2007, P NATL ACAD SCI USA, V104, P15294, DOI 10.1073/pnas.0707688104; Han SP, 2008, DIABETES, V57, P1723, DOI 10.2337/db07-1472; Hann MM, 2004, CURR OPIN CHEM BIOL, V8, P255, DOI 10.1016/j.cbpa.2004.04.003; HEBERT DN, 1992, J BIOL CHEM, V267, P23829; Hertel J, 2004, J BIOL CHEM, V279, P55147, DOI 10.1074/jbc.M410826200; Hresko RC, 2014, J BIOL CHEM, V289, P16100, DOI 10.1074/jbc.M113.528430; Hresko RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025237; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Ji LN, 2014, CLIN THER, V36, P84, DOI 10.1016/j.clinthera.2013.11.002; Kyle RA, 2004, NEW ENGL J MED, V351, P1860, DOI 10.1056/NEJMra041875; Lemieux MJ, 2005, J ELECTRON MICROSC, V54, pI43, DOI 10.1093/jmicro/dfi017; Macheda ML, 2005, J CELL PHYSIOL, V202, P654, DOI 10.1002/jcp.20166; Manolescu AR, 2007, PHYSIOLOGY, V22, P234, DOI 10.1152/physiol.00011.2007; Maratou E, 2007, EUR J CLIN INVEST, V37, P282, DOI 10.1111/j.1365-2362.2007.01786.x; Maschek G, 2004, CANCER RES, V64, P31, DOI 10.1158/0008-5472.CAN-03-3294; McBrayer SK, 2012, BLOOD, V119, P4686, DOI 10.1182/blood-2011-09-377846; Mohanti BK, 1996, INT J RADIAT ONCOL, V35, P103, DOI 10.1016/S0360-3016(96)85017-6; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; Munshi Nikhil C, 2008, Hematology Am Soc Hematol Educ Program, P297, DOI 10.1182/asheducation-2008.1.297; Murata H, 2000, J BIOL CHEM, V275, P20251, DOI 10.1074/jbc.C000228200; OKA Y, 1990, NATURE, V345, P550, DOI 10.1038/345550a0; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; PIPER RC, 1991, AM J PHYSIOL, V260, pC570, DOI 10.1152/ajpcell.1991.260.3.C570; Ptaszynska A, 2014, DRUG SAFETY, V37, P815, DOI 10.1007/s40264-014-0213-4; Richardson PG, 2005, ONCOLOGY-NY, V19, P1781; Rodriguez-Enriquez S, 2009, J CELL PHYSIOL, V221, P552, DOI 10.1002/jcp.21885; Schrodinger, 2013, MAESTR VERS 9 6 PRIM; TORDJMAN KM, 1989, P NATL ACAD SCI USA, V86, P7761, DOI 10.1073/pnas.86.20.7761; Tripos, 2011, SYBYL X VERS 1 3; Vyas AK, 2010, J BIOL CHEM, V285, P36395, DOI 10.1074/jbc.M110.176321; WRIGHT EM, 1994, J EXP BIOL, V196, P197; Wright EM, 2001, AM J PHYSIOL-RENAL, V280, pF10, DOI 10.1152/ajprenal.2001.280.1.F10; Xu RH, 2005, LEUKEMIA, V19, P2153, DOI 10.1038/sj.leu.2403968; Yang XP, 2014, EUR J CLIN PHARMACOL, V70, P1149, DOI 10.1007/s00228-014-1730-x; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629; Zhao FQ, 2007, CURR GENOMICS, V8, P113, DOI 10.2174/138920207780368187	51	48	51	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14441	14453		10.1074/jbc.M114.628826	http://dx.doi.org/10.1074/jbc.M114.628826			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25847249	hybrid, Green Published			2022-12-28	WOS:000355754600015
J	Nakajima, H; Kubo, T; Ihara, H; Hikida, T; Danjo, T; Nakatsuji, M; Shahani, N; Itakura, M; Ono, Y; Azuma, YT; Inui, T; Kamiya, A; Sawa, A; Takeuchi, T				Nakajima, Hidemitsu; Kubo, Takeya; Ihara, Hideshi; Hikida, Takatoshi; Danjo, Teruko; Nakatsuji, Masatoshi; Shahani, Neelam; Itakura, Masanori; Ono, Yoko; Azuma, Yasu-Taka; Inui, Takashi; Kamiya, Atsushi; Sawa, Akira; Takeuchi, Tadayoshi			Nuclear-translocated Glyceraldehyde-3-phosphate Dehydrogenase Promotes Poly(ADP-ribose) Polymerase-1 Activation during Oxidative/Nitrosative Stress in Stroke	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBRAL-ARTERY OCCLUSION; CELL-DEATH; RAT-BRAIN; GAPDH; NEURODEGENERATION; PATHWAYS; ISCHEMIA; MODEL; APOPTOSIS; DELIVERY	In addition to its role in DNA repair, nuclear poly(ADP-ribose) polymerase-1 (PARP-1) mediates brain damage when it is over-activated by oxidative/nitrosative stress. Nonetheless, it remains unclear how PARP-1 is activated in neuropathological contexts. Here we report that PARP-1 interacts with a pool of glyceradehyde-3-phosphate dehydrogenase (GAPDH) that translocates into the nucleus under oxidative/nitrosative stress both in vitro and in vivo. A well conserved amino acid at the N terminus of GAPDH determines its protein binding with PARP-1. Wild-type (WT) but not mutant GAPDH, that lacks the ability to bind PARP-1, can promote PARP-1 activation. Importantly, disrupting this interaction significantly diminishes PARP-1 overactivation and protects against both brain damage and neurological deficits induced by middle cerebral artery occlusion/reperfusion in a rat stroke model. Together, these findings suggest that nuclear GAPDH is a key regulator of PARP-1 activity, and its signaling underlies the pathology of oxidative/nitrosative stress-induced brain damage including stroke.	[Nakajima, Hidemitsu; Kubo, Takeya; Itakura, Masanori; Ono, Yoko; Azuma, Yasu-Taka; Takeuchi, Tadayoshi] Osaka Prefecture Univ, Lab Vet Pharmacol, Grad Sch Life & Environm Sci, Izumisano, Osaka 5988531, Japan; [Ihara, Hideshi] Osaka Prefecture Univ, Dept Sci, Izumisano, Osaka 5988531, Japan; [Hikida, Takatoshi] Kyoto Univ, Grad Sch Med, Med Innovat Ctr, Kyoto 6068501, Japan; [Hikida, Takatoshi] Japan Sci & Technol Agcy, PRESTO, Saitama 3320012, Japan; [Danjo, Teruko] Osaka Biosci Inst, Dept Syst Biol, Osaka 5650874, Japan; [Nakatsuji, Masatoshi; Inui, Takashi] Osaka Prefecture Univ, Lab Biol Macromol, Grad Sch Life & Environm Sci, Izumisano, Osaka 5988531, Japan; [Nakajima, Hidemitsu; Shahani, Neelam; Kamiya, Atsushi; Sawa, Akira] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21287 USA	Osaka Metropolitan University; Osaka Metropolitan University; Kyoto University; Japan Science & Technology Agency (JST); Osaka Metropolitan University; Johns Hopkins University	Takeuchi, T (corresponding author), Osaka Prefecture Univ, Lab Vet Pharmacol, Grad Sch Life & Environm Sci, Izumisano, Osaka 5988531, Japan.	takeuchi@vet.osakafu-u.ac.jp	Hikida, Takatoshi/J-5561-2017; kamiya, atsushi/L-8550-2016; Inui, Takashi/G-1069-2011	Hikida, Takatoshi/0000-0002-8653-311X; kamiya, atsushi/0000-0002-4274-5567; Nakajima, Hidemitsu/0000-0002-0441-1929; Azuma, Yasu-Taka/0000-0002-3515-171X	Japan Society for the Promotion of Science KAKENHI [15605666, 22580339, 25450428, 23120011, 23680034]; Grants-in-Aid for Scientific Research [15H04275] Funding Source: KAKEN; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091230, P50MH094268] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grants 15605666 (to T. T.), 22580339 and 25450428 (to H. N.), and 23120011 and 23680034 (to T. H.).	Abd Elmageed ZY, 2012, CELL SIGNAL, V24, P1, DOI 10.1016/j.cellsig.2011.07.019; Andrabi SA, 2008, ANN NY ACAD SCI, V1147, P233, DOI 10.1196/annals.1427.014; Belayev L, 1996, STROKE, V27, P1616, DOI 10.1161/01.STR.27.9.1616; Burkle A, 2013, MOL ASPECTS MED, V34, P1046, DOI 10.1016/j.mam.2012.12.010; Butterfield DA, 2010, J ALZHEIMERS DIS, V20, P369, DOI 10.3233/JAD-2010-1375; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Eliasson MJL, 1997, NAT MED, V3, P1089, DOI 10.1038/nm1097-1089; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Ha HC, 2000, NEUROBIOL DIS, V7, P225, DOI 10.1006/nbdi.2000.0324; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hikida T, 2010, NEURON, V66, P896, DOI 10.1016/j.neuron.2010.05.011; Kleiger G, 2002, J MOL BIOL, V323, P69, DOI 10.1016/S0022-2836(02)00885-9; Langelier MF, 2012, SCIENCE, V336, P728, DOI 10.1126/science.1216338; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Nakajima H, 2005, J PHARMACOL EXP THER, V312, P472, DOI 10.1124/jpet.104.075465; Nakajima H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M704199200; Nakajima H, 2012, J BIOTECHNOL, V157, P326, DOI 10.1016/j.jbiotec.2011.10.003; Nakajima H, 2009, J BIOL CHEM, V284, P34331, DOI 10.1074/jbc.M109.027698; Nakamura T, 2013, ANTIOXID REDOX SIGN, V18, P239, DOI 10.1089/ars.2012.4703; OGATA N, 1981, J BIOL CHEM, V256, P4135; Sawa A, 1997, P NATL ACAD SCI USA, V94, P11669, DOI 10.1073/pnas.94.21.11669; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sen N, 2008, NAT CELL BIOL, V10, P866, DOI 10.1038/ncb1747; Sirover MA, 2012, J CELL BIOCHEM, V113, P2193, DOI 10.1002/jcb.24113; Sun Y, 2003, GENE THER, V10, P115, DOI 10.1038/sj.gt.3301868; Tanaka R, 2002, J CEREBR BLOOD F MET, V22, P280, DOI 10.1097/00004647-200203000-00005; Tatton WG, 2000, ADV RES NEURODEGENER, V8, P77; Tristan C, 2011, CELL SIGNAL, V23, P317, DOI 10.1016/j.cellsig.2010.08.003; Vanden Berghe T, 2014, NAT REV MOL CELL BIO, V15, P134, DOI 10.1038/nrm3737; Virag L, 2013, MOL ASPECTS MED, V34, P1153, DOI 10.1016/j.mam.2013.01.007; Wang L, 2002, GENE THER, V9, P381, DOI 10.1038/sj.gt.3301682	33	35	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14493	14503		10.1074/jbc.M114.635607	http://dx.doi.org/10.1074/jbc.M114.635607			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25882840	Green Published, hybrid			2022-12-28	WOS:000355754600021
J	Shiomi, Y; Yamauchi, T; Iwabu, M; Okada-Iwabu, M; Nakayama, R; Orikawa, Y; Yoshioka, Y; Tanaka, K; Ueki, K; Kadowaki, T				Shiomi, Yoshihiro; Yamauchi, Toshimasa; Iwabu, Masato; Okada-Iwabu, Miki; Nakayama, Ryo; Orikawa, Yuki; Yoshioka, Yoshichika; Tanaka, Koichiro; Ueki, Kohjiro; Kadowaki, Takashi			A Novel Peroxisome Proliferator-activated Receptor (PPAR)alpha Agonist and PPAR gamma Antagonist, Z-551, Ameliorates High-fat Diet-induced Obesity and Metabolic Disorders in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; NECROSIS-FACTOR-ALPHA; INSULIN-RESISTANCE; ADIPOSE-TISSUE; ADIPOCYTE HYPERTROPHY; TRANSGENIC MICE; M2 MACROPHAGES; LIVER; ADIPONECTIN; SENSITIVITY	A novel peroxisome proliferator-activated receptor (PPAR) modulator, Z-551, having both PPAR alpha agonistic and PPAR alpha antagonistic activities, has been developed for the treatment of obesity and obesity-related metabolic disorders. We examined the effects of Z-551 on obesity and the metabolic disorders in wild-type mice on the high-fat diet (HFD). In mice on the HFD, Z-551 significantly suppressed body weight gain and ameliorated insulin resistance and abnormal glucose and lipid metabolisms. Z-551 inhibited visceral fat mass gain and adipocyte hypertrophy, and reduced molecules involved in fatty acid uptake and synthesis, macrophage infiltration, and inflammation in adipose tissue. Z-551 increased molecules involved in fatty acid combustion, while reduced molecules associated with gluconeogenesis in the liver. Furthermore, Z-551 significantly reduced fasting plasma levels of glucose, triglyceride, free fatty acid, insulin, and leptin. To elucidate the significance of the PPAR combination, we examined the effects of Z-551 in PPAR alpha-deficient mice and those of a synthetic PPAR gamma antagonist in wild-type mice on the HFD. Both drugs showed similar, but weaker effects on body weight, insulin resistance and specific events provoked in adipose tissue compared with those of Z-551 as described above, except for lack of effects on fasting plasma triglyceride and free fatty acid levels. These findings suggest that Z-551 ameliorates HFD-induced obesity, insulin resistance, and impairment of glucose and lipid metabolisms by PPAR alpha agonistic and PPAR gamma antagonistic activities, and therefore, might be clinically useful for preventing or treating obesity	[Shiomi, Yoshihiro; Yamauchi, Toshimasa; Iwabu, Masato; Okada-Iwabu, Miki; Nakayama, Ryo; Ueki, Kohjiro; Kadowaki, Takashi] Univ Tokyo, Dept Diabet & Metab Dis, Grad Sch Med, Tokyo 1138655, Japan; [Yamauchi, Toshimasa] Univ Tokyo, Dept Integrated Mol Sci Metab Dis, 22nd Century Med & Res Ctr, Tokyo 1138655, Japan; [Orikawa, Yuki; Tanaka, Koichiro] Zeria Pharmaceut Co Ltd, Cent Res Labs, Saitama 3600111, Japan; [Yoshioka, Yoshichika] Osaka Univ, Lab Biofunct Imaging, Immunol Frontier Res Ctr, Osaka 5650871, Japan	University of Tokyo; University of Tokyo; Zeria Pharmaceutical Co Ltd; Osaka University	Kadowaki, T (corresponding author), Univ Tokyo, Dept Diabet & Metab Dis, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kadowaki-3im@h.u-tokyo.ac.jp			Zeria Pharmaceutical Co., Ltd.	Zeria Pharmaceutical Co., Ltd.(Zeria Pharmaceutical Co Ltd)	The joint research project was funded by Zeria Pharmaceutical Co., Ltd.	Ahima RS, 2006, OBESITY, V14, P242, DOI 10.1038/oby.2006.317; Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Ali AA, 2005, ENDOCRINOLOGY, V146, P1226, DOI 10.1210/en.2004-0735; Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678; Auwerx J, 1998, LANCET, V351, P737, DOI 10.1016/S0140-6736(97)06348-4; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Cariou B, 2012, TRENDS ENDOCRIN MET, V23, P205, DOI 10.1016/j.tem.2012.03.001; Cock TA, 2004, EMBO REP, V5, P142, DOI 10.1038/sj.embor.7400082; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI21625, 10.1172/JCI20042162S]; Gonzalez FJ, 2008, TOXICOLOGY, V246, P2, DOI 10.1016/j.tox.2007.09.030; Guerre-Millo M, 2000, J BIOL CHEM, V275, P16638, DOI 10.1074/jbc.275.22.16638; Haluzik MM, 2006, PHYSIOL RES, V55, P115, DOI 10.33549/physiolres.930744; Hara K, 2000, BIOCHEM BIOPH RES CO, V271, P212, DOI 10.1006/bbrc.2000.2605; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; IKEMOTO S, 1995, P NATL ACAD SCI USA, V92, P3096, DOI 10.1073/pnas.92.8.3096; Inoue I, 1997, BIOCHEM BIOPH RES CO, V237, P606, DOI 10.1006/bbrc.1997.7196; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Jeong S, 2009, EXP MOL MED, V41, P397, DOI 10.3858/emm.2009.41.6.045; Kadowaki T, 2000, J CLIN INVEST, V106, P459, DOI 10.1172/JCI10830; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Minnich A, 2001, AM J PHYSIOL-ENDOC M, V280, pE270, DOI 10.1152/ajpendo.2001.280.2.E270; Miyake K, 2002, J CLIN INVEST, V110, P1483, DOI 10.1172/JCI200215880; Mori Y, 2014, INT IMMUNOL, V26, P93, DOI 10.1093/intimm/dxt044; Morimura K, 2006, CARCINOGENESIS, V27, P1074, DOI 10.1093/carcin/bgi329; Murakami K, 2007, EUR J PHARMACOL, V561, P206, DOI 10.1016/j.ejphar.2006.12.037; Nakano R, 2006, BIOCHEM PHARMACOL, V72, P42, DOI 10.1016/j.bcp.2006.03.023; Nio Y, 2012, DIABETOLOGIA, V55, P3350, DOI 10.1007/s00125-012-2710-2; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Nonaka Kiichi, 2011, Clin Calcium, V21, P1003, DOI CliCa110710031009; Okuno A, 1998, J CLIN INVEST, V101, P1354, DOI 10.1172/JCI1235; Rieusset J, 2002, MOL ENDOCRINOL, V16, P2628, DOI 10.1210/me.2002-0036; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; Suganami T, 2010, J LEUKOCYTE BIOL, V88, P33, DOI 10.1189/jlb.0210072; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Toyoda T, 2008, OBESITY, V16, P1199, DOI 10.1038/oby.2008.62; Tsuchida A, 2005, DIABETES, V54, P3358, DOI 10.2337/diabetes.54.12.3358; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Watanabe T, 2009, J BIOL CHEM, V284, P1803, DOI 10.1074/jbc.M807120200; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yamauchi T, 2001, J CLIN INVEST, V108, P1001, DOI 10.1172/JCI12864; Yamauchi T, 2001, J BIOL CHEM, V276, P41245, DOI 10.1074/jbc.M103241200; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984	55	37	42	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14567	14581		10.1074/jbc.M114.622191	http://dx.doi.org/10.1074/jbc.M114.622191			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25907553	Green Published, hybrid			2022-12-28	WOS:000355754600028
J	Song, WJ; Cho, Y; Watt, D; Cavalli, V				Song, Wenjun; Cho, Yongcheol; Watt, Dana; Cavalli, Valeria			Tubulin-tyrosine Ligase (TTL)-mediated Increase in Tyrosinated alpha-Tubulin in Injured Axons Is Required for Retrograde Injury Signaling and Axon Regeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE PLUS ENDS; GROWTH CONE; POSTTRANSLATIONAL MODIFICATIONS; PROTEIN-SYNTHESIS; PERIPHERAL-NERVE; MAP KINASE; TRANSPORT; PHOSPHORYLATION; INITIATION; AXOTOMY	Injured peripheral neurons successfully activate a pro-regenerative program to enable axon regeneration and functional recovery. The microtubule-dependent retrograde transport of injury signals from the lesion site in the axon back to the cell soma stimulates the increased growth capacity of injured neurons. However, the mechanisms initiating this retrograde transport remain poorly understood. Here we show that tubulin-tyrosine ligase (TTL) is required to increase the levels of tyrosinated alpha-tubulin at the axon injury site and plays an important role in injury signaling. Preventing the injury-induced increase in tyrosinated alpha-tubulin by knocking down TTL impairs retrograde organelle transport and delays activation of the pro-regenerative transcription factor c-Jun. In the absence of TTL, axon regeneration is reduced severely. We propose a model in which TTL increases the levels of tyrosinated alpha-tubulin locally at the injury site to facilitate the retrograde transport of injury signals that are required to activate a pro-regenerative program.	[Song, Wenjun; Cho, Yongcheol; Watt, Dana; Cavalli, Valeria] Washington Univ, Sch Med, Dept Anat & Neurobiol, Campus Box 8108,660 S Euclid Ave, St Louis, MO 63110 USA	Washington University (WUSTL)	Cavalli, V (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, Campus Box 8108,660 S Euclid Ave, St Louis, MO 63110 USA.	cavalli@pcg.wustl.edu	Song, Wenjun/HGB-4891-2022		NINDS/National Institutes of Health [R01 NS082446]; National Research Foundation of Korea [NRF-2012R1A6A3A03039290]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082446] Funding Source: NIH RePORTER	NINDS/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Research Foundation of Korea(National Research Foundation of Korea); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by NINDS/National Institutes of Health Grant R01 NS082446 (to V. C.). This work was also supported by National Research Foundation of Korea Grant NRF-2012R1A6A3A03039290 (to Y. C.).	Abe N, 2008, CURR OPIN NEUROBIOL, V18, P276, DOI 10.1016/j.conb.2008.06.005; Abe N, 2009, J BIOL CHEM, V284, P34628, DOI 10.1074/jbc.M109.035022; Ambron RT, 1996, MOL NEUROBIOL, V13, P61, DOI 10.1007/BF02740752; BARRA HS, 1988, MOL NEUROBIOL, V2, P133, DOI 10.1007/BF02935343; Ben-Yaakov K, 2012, EMBO J, V31, P1350, DOI 10.1038/emboj.2011.494; Bieling P, 2008, J CELL BIOL, V183, P1223, DOI 10.1083/jcb.200809190; Bradke F, 2012, NAT REV NEUROSCI, V13, P183, DOI 10.1038/nrn3176; Broude E, 1997, EXP NEUROL, V148, P367, DOI 10.1006/exnr.1997.6665; Cavalli V, 2005, J CELL BIOL, V168, P775, DOI 10.1083/jcb.200410136; Cho Y, 2012, EMBO J, V31, P3063, DOI 10.1038/emboj.2012.160; DEANIN GG, 1980, EUR J BIOCHEM, V109, P207, DOI 10.1111/j.1432-1033.1980.tb04786.x; Drerup CM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003303; Duellberg C, 2014, NAT CELL BIOL, V16, P804, DOI 10.1038/ncb2999; Erck C, 2005, P NATL ACAD SCI USA, V102, P7853, DOI 10.1073/pnas.0409626102; ERSFELD K, 1993, J CELL BIOL, V120, P725, DOI 10.1083/jcb.120.3.725; Finelli MJ, 2013, J NEUROSCI, V33, P19664, DOI 10.1523/JNEUROSCI.0589-13.2013; Ghosh-Roy A, 2012, DEV CELL, V23, P716, DOI 10.1016/j.devcel.2012.08.010; Gumy LF, 2013, J NEUROSCI, V33, P11329, DOI 10.1523/JNEUROSCI.5221-12.2013; Gumy LF, 2011, RNA, V17, P85, DOI 10.1261/rna.2386111; Gumy LF, 2010, EXP NEUROL, V223, P28, DOI 10.1016/j.expneurol.2009.06.004; HALL GF, 1991, P NATL ACAD SCI USA, V88, P5016, DOI 10.1073/pnas.88.11.5016; Honnappa S, 2006, MOL CELL, V23, P663, DOI 10.1016/j.molcel.2006.07.013; Idriss HT, 2000, CELL MOTIL CYTOSKEL, V46, P1; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Jeanneteau F, 2010, NAT NEUROSCI, V13, P1373, DOI 10.1038/nn.2655; Kidd G, 1996, J NEUROSCI, V16, P946; Kumar RA, 2010, HUM MOL GENET, V19, P2817, DOI 10.1093/hmg/ddq182; Lalli G, 2002, J CELL BIOL, V156, P233, DOI 10.1083/jcb.200106142; Liu K, 2011, ANNU REV NEUROSCI, V34, P131, DOI 10.1146/annurev-neuro-061010-113723; Lloyd TE, 2012, NEURON, V74, P344, DOI 10.1016/j.neuron.2012.02.026; Lomakin AJ, 2009, DEV CELL, V17, P323, DOI 10.1016/j.devcel.2009.07.010; Lu Y, 2014, CURR OPIN NEUROBIOL, V27, P135, DOI 10.1016/j.conb.2014.03.007; Marcos S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005405; Moughamian AJ, 2013, J NEUROSCI, V33, P13190, DOI 10.1523/JNEUROSCI.0935-13.2013; Moughamian AJ, 2012, NEURON, V74, P331, DOI 10.1016/j.neuron.2012.02.025; MULLINS FH, 1994, J NEUROCHEM, V62, P227; Peris L, 2006, J CELL BIOL, V174, P839, DOI 10.1083/jcb.200512058; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Poirier K, 2013, EUR J HUM GENET, V21, P381, DOI 10.1038/ejhg.2012.195; Prota AE, 2013, J CELL BIOL, V200, P259, DOI 10.1083/jcb.201211017; Puttagunta R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4527; Rishal I, 2014, NAT REV NEUROSCI, V15, P32, DOI 10.1038/nrn3609; SCHRODER HC, 1985, J CELL BIOL, V100, P276, DOI 10.1083/jcb.100.1.276; Shin JE, 2012, P NATL ACAD SCI USA, V109, pE3696, DOI 10.1073/pnas.1216204109; Shin JE, 2012, NEURON, V74, P1015, DOI 10.1016/j.neuron.2012.04.028; Sirajuddin M, 2014, NAT CELL BIOL, V16, P335, DOI 10.1038/ncb2920; Vaughan PS, 2002, J CELL BIOL, V158, P305, DOI 10.1083/jcb.200201029; Verma P, 2005, J NEUROSCI, V25, P331, DOI 10.1523/JNEUROSCI.3073-04.2005; Weisbrich A, 2007, NAT STRUCT MOL BIOL, V14, P959, DOI 10.1038/nsmb1291; Westerlund N, 2011, NAT NEUROSCI, V14, P305, DOI 10.1038/nn.2755; Yan D, 2012, NEURON, V76, P534, DOI 10.1016/j.neuron.2012.08.043	51	30	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14765	14775		10.1074/jbc.M114.622753	http://dx.doi.org/10.1074/jbc.M114.622753			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25911101	Green Published, hybrid			2022-12-28	WOS:000355754600045
J	Zhang, YH; Laumet, G; Chen, SR; Hittelman, WN; Pan, HL				Zhang, Yuhao; Laumet, Geoffroy; Chen, Shao-Rui; Hittelman, Walter N.; Pan, Hui-Lin			Pannexin-1 Up-regulation in the Dorsal Root Ganglion Contributes to Neuropathic Pain Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION PROTEINS; GENE-EXPRESSION; NERVE INJURY; HUMAN GENOME; SPINAL-CORD; HISTONE H3; CHANNELS; ACTIVATION; RECEPTOR; INTERLEUKIN-1-BETA	Pannexin-1 (Panx1) is a large-pore membrane channel involved in the release of ATP and other signaling mediators. Little is known about the expression and functional role of Panx1 in the dorsal root ganglion (DRG) in the development of chronic neuropathic pain. In this study, we determined the epigenetic mechanism involved in increased Panx1 expression in the DRG after nerve injury. Spinal nerve ligation in rats significantly increased the mRNA and protein levels of Panx1 in the DRG but not in the spinal cord. Immunocytochemical labeling showed that Panx1 was primarily expressed in a subset of medium and large DRG neurons in control rats and that nerve injury markedly increased the number of Panx1-immunoreactive DRG neurons. Nerve injury significantly increased the enrichment of two activating histone marks (H3K4me2 and H3K9ac) and decreased the occupancy of two repressive histone marks (H3K9me2 and H3K27me3) around the promoter region of Panx1 in the DRG. However, nerve injury had no effect on the DNA methylation level around the Panx1 promoter in the DRG. Furthermore, intrathecal injection of the Panx1 blockers or Panx1-specific siRNA significantly reduced pain hypersensitivity induced by nerve injury. In addition, siRNA knockdown of Panx1 expression in a DRG cell line significantly reduced caspase-1 release induced by neuronal depolarization. Our findings suggest that nerve injury increases Panx1 expression levels in the DRG through altered histone modifications. Panx1 up-regulation contributes to the development of neuropathic pain and stimulation of inflammasome signaling.	[Zhang, Yuhao; Laumet, Geoffroy; Chen, Shao-Rui; Pan, Hui-Lin] Univ Texas MD Anderson Canc Ctr, Ctr Neurosci & Pain Res, Dept Anesthesiol & Perioperat Med, Houston, TX 77030 USA; [Hittelman, Walter N.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Pan, HL (corresponding author), Univ Texas MD Anderson Canc Ctr, Unit 110, Dept Anesthesiol & Perioperat Med, 1515 Holcombe Blvd, Houston, TX 77030 USA.	huilinpan@mdanderson.org	zhang, yuhao/O-4356-2015; Regan, Clinton/E-6250-2012; Laumet, Geoffroy/O-7480-2019	Pan, Hui-Lin/0000-0001-8444-3770	National Institutes of Health [R01 DE022015]; N. G. and Helen T. Hawkins Endowment; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022015] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); N. G. and Helen T. Hawkins Endowment; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DE022015. This work was also supported by the N. G. and Helen T. Hawkins Endowment (to H. L. P.).	Baranova A, 2004, GENOMICS, V83, P706, DOI 10.1016/j.ygeno.2003.09.025; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bravo D, 2014, PAIN, V155, P2108, DOI 10.1016/j.pain.2014.07.024; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Cai YQ, 2009, J NEUROCHEM, V111, P1000, DOI 10.1111/j.1471-4159.2009.06396.x; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chen MC, 2013, DERMATOL CLIN, V31, P461, DOI 10.1016/j.det.2013.04.002; Chen SR, 2014, J PHARMACOL EXP THER, V350, P301, DOI 10.1124/jpet.114.215855; Chen SR, 2009, J NEUROCHEM, V110, P352, DOI 10.1111/j.1471-4159.2009.06138.x; Cunha TM, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-63; Dansereau MA, 2008, J NEUROCHEM, V106, P757, DOI 10.1111/j.1471-4159.2008.05429.x; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Gupta-Agarwal S, 2012, J NEUROSCI, V32, P5440, DOI 10.1523/JNEUROSCI.0147-12.2012; Hanstein R., 2012, 2012 NEUR M NEW ORL; Huang L. Y., 2012, 2012 NEUR M NEW ORL; Huang LYM, 2013, GLIA, V61, P1571, DOI 10.1002/glia.22541; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Karatas H, 2013, SCIENCE, V339, P1092, DOI 10.1126/science.1231897; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Li Q, 2013, NEUROSCIENCE, V254, P230, DOI 10.1016/j.neuroscience.2013.09.028; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Luo MC, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-29; Ma C, 2005, PAIN, V113, P106, DOI 10.1016/j.pain.2004.10.001; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martucci C, 2008, PAIN, V137, P81, DOI 10.1016/j.pain.2007.08.017; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Pan HL, 1999, J PHARMACOL EXP THER, V288, P1026; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Pasini D, 2008, GENE DEV, V22, P1345, DOI 10.1101/gad.470008; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Penuela S, 2013, BBA-BIOMEMBRANES, V1828, P15, DOI 10.1016/j.bbamem.2012.01.017; Raupach B, 2006, INFECT IMMUN, V74, P4922, DOI 10.1128/IAI.00417-06; Riccio A, 2010, NAT NEUROSCI, V13, P1330, DOI 10.1038/nn.2671; Ronan JL, 2013, NAT REV GENET, V14, P347, DOI 10.1038/nrg3413; Sandilos JK, 2012, J BIOL CHEM, V287, P11303, DOI 10.1074/jbc.M111.323378; Santiago MF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025178; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Shibasaki M, 2010, PAIN, V149, P514, DOI 10.1016/j.pain.2010.03.023; Sosinsky GE, 2011, CHANNELS, V5, P193, DOI 10.4161/chan.5.3.15765; Thompson RJ, 2008, SCIENCE, V322, P1555, DOI 10.1126/science.1165209; Vessey JP, 2004, J NEUROPHYSIOL, V92, P1252, DOI 10.1152/jn.00148.2004; Wang H, 2002, NEUROSCIENCE, V114, P529, DOI 10.1016/S0306-4522(02)00341-X; Weilinger NL, 2012, J NEUROSCI, V32, P12579, DOI 10.1523/JNEUROSCI.1267-12.2012; Wolf G, 2006, PAIN, V120, P315, DOI 10.1016/j.pain.2005.11.011; Xiao HS, 2002, P NATL ACAD SCI USA, V99, P8360, DOI 10.1073/pnas.122231899; Zappala A, 2006, NEUROSCIENCE, V141, P167, DOI 10.1016/j.neuroscience.2006.03.053; Zelenka M, 2005, PAIN, V116, P257, DOI 10.1016/j.pain.2005.04.018	50	60	61	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14647	14655		10.1074/jbc.M115.650218	http://dx.doi.org/10.1074/jbc.M115.650218			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25925949	Green Published, hybrid			2022-12-28	WOS:000355754600035
J	Cai, WL; Goswami, A; Yang, ZY; Liu, XD; Green, KD; Barnard-Britson, S; Baba, S; Funabashi, M; Nonaka, K; Sunkara, M; Morris, AJ; Spork, AP; Ducho, C; Garneau-Tsodikova, S; Thorson, JS; Van Lanen, SG				Cai, Wenlong; Goswami, Anwesha; Yang, Zhaoyong; Liu, Xiaodong; Green, Keith D.; Barnard-Britson, Sandra; Baba, Satoshi; Funabashi, Masanori; Nonaka, Koichi; Sunkara, Manjula; Morris, Andrew J.; Spork, Anatol P.; Ducho, Christian; Garneau-Tsodikova, Sylvie; Thorson, Jon S.; Van Lanen, Steven G.			The Biosynthesis of Capuramycin-type Antibiotics IDENTIFICATION OF THE A-102395 BIOSYNTHETIC GENE CLUSTER, MECHANISM OF SELF-RESISTANCE, AND FORMATION OF URIDINE-5 '-CARBOXAMIDE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL TRANSLOCASE-I; STREPTOMYCES-VENEZUELAE ISP5230; ALPHA-KETOGLUTARATE DIOXYGENASE; GENE-CLUSTER; ANTIMYCOBACTERIAL ACTIVITY; ESCHERICHIA-COLI; IDENTIFICATION; INHIBITORS; A-500359S; POLYKETIDE	A-500359s, A-503083s, and A-102395 are capuramycin-type nucleoside antibiotics that were discovered using a screen to identify inhibitors of bacterial translocase I, an essential enzyme in peptidoglycan cell wall biosynthesis. Like the parent capuramycin, A-500359s and A-503083s consist of three structural components: a uridine-5'-carboxamide (CarU), a rare unsaturated hexuronic acid, and an aminocaprolactam, the last of which is substituted by an unusual arylamine-containing polyamide in A-102395. The biosynthetic gene clusters for A-500359s and A-503083s have been reported, and two genes encoding a putative non-heme Fe(II)-dependent alpha-ketoglutarate: UMP dioxygenase and an L-Thr: uridine-5'-aldehyde transaldolase were uncovered, suggesting that C-C bond formation during assembly of the high carbon (C6) sugar backbone of CarU proceeds from the precursors UMP and L-Thr to form 5'-C-glycyluridine (C7) as a biosynthetic intermediate. Here, isotopic enrichment studies with the producer of A-503083s were used to indeed establish L-Thr as the direct source of the carboxamide of CarU. With this knowledge, the A-102395 gene cluster was subsequently cloned and characterized. A genetic system in the A-102395-producing strain was developed, permitting the inactivation of several genes, including those encoding the dioxygenase (cpr19) and transaldolase (cpr25), which abolished the production of A-102395, thus confirming their role in biosynthesis. Heterologous production of recombinant Cpr19 and CapK, the transaldolase homolog involved in A-503083 biosynthesis, confirmed their expected function. Finally, a phosphotransferase (Cpr17) conferring self-resistance was functionally characterized. The results provide the opportunity to use comparative genomics along with in vivo and in vitro approaches to probe the biosynthetic mechanism of these intriguing structures.	[Cai, Wenlong; Goswami, Anwesha; Liu, Xiaodong; Green, Keith D.; Barnard-Britson, Sandra; Garneau-Tsodikova, Sylvie; Thorson, Jon S.; Van Lanen, Steven G.] Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY 40506 USA; [Yang, Zhaoyong] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 1000050, Peoples R China; [Yang, Zhaoyong] Peking Union Med Coll, Beijing 1000050, Peoples R China; [Baba, Satoshi] Daiichi Sankyo Co Ltd, New Modal Res Labs, R&D Div, Tokyo 1038426, Japan; [Funabashi, Masanori] Daiichi Sankyo RD Novare Co Ltd, Drug Discovery & Biomed Technol Unit, Tokyo, Japan; [Nonaka, Koichi] Daiichi Sankyo Co Ltd, Biol Technol Res Labs, R&D Div, Tokyo 1038426, Japan; [Sunkara, Manjula; Morris, Andrew J.] Univ Kentucky, Div Cardiovasc Med, Lexington, KY 40506 USA; [Sunkara, Manjula; Morris, Andrew J.] Univ Kentucky, Gill Heart Inst, Lexington, KY 40506 USA; [Spork, Anatol P.; Ducho, Christian] Univ Saarland, Dept Pharm Pharmaceut & Med Chem, D-66123 Saarbrucken, Germany	University of Kentucky; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Daiichi Sankyo Company Limited; Daiichi Sankyo Company Limited; Daiichi Sankyo Company Limited; University of Kentucky; University of Kentucky; Saarland University	Van Lanen, SG (corresponding author), Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, 789 S Limestone, Lexington, KY 40506 USA.	svanlanen@uky.edu	sunkara, Manjula/H-7944-2016; Garneau-Tsodikova, Sylvie/ABH-5882-2020; Cai, Wenlong/AAH-7945-2019; Goswami, Anwesha/J-7628-2019; Thorson, Jon S/L-3696-2013; Ducho, Christian/I-4085-2019; Funabashi, Masanori/GQZ-8735-2022	sunkara, Manjula/0000-0001-6151-1929; Garneau-Tsodikova, Sylvie/0000-0002-7961-5555; Goswami, Anwesha/0000-0002-3107-6417; Thorson, Jon S/0000-0002-7148-0721; Ducho, Christian/0000-0002-0629-9993; 	National Institutes of Health, NIAID [AI087849]; National Center for Advancing Translational Sciences [UL1TR000117]; NSF CAREER [MCB-1149427]; Kentucky Science and Education Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000117] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026884, S10RR024598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087849] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); Kentucky Science and Education Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health, NIAID, Grant AI087849 (to S.V. L.). This work was also supported by National Center for Advancing Translational Sciences Grant UL1TR000117, NSF CAREER award MCB-1149427 (to S. G.-T.), and the Kentucky Science and Education Foundation (to S. V. L.).	Barnard-Britson S, 2012, J AM CHEM SOC, V134, P18514, DOI 10.1021/ja308185q; Blanc V, 1997, MOL MICROBIOL, V23, P191, DOI 10.1046/j.1365-2958.1997.2031574.x; Bogatcheva E, 2011, BIOORG MED CHEM LETT, V21, P5353, DOI 10.1016/j.bmcl.2011.07.015; Bollinger JM, 2006, J INORG BIOCHEM, V100, P586, DOI 10.1016/j.jinorgbio.2006.01.022; Boyle DS, 1998, J BACTERIOL, V180, P6429; Brown MP, 1996, MICROBIOL-UK, V142, P1345, DOI 10.1099/13500872-142-6-1345; Caffrey P, 2003, CHEMBIOCHEM, V4, P654, DOI 10.1002/cbic.200300581; Campelo AB, 2002, MICROBIOL-SGM, V148, P51, DOI 10.1099/00221287-148-1-51; Chang ZX, 2004, J NAT PROD, V67, P1356, DOI 10.1021/np0499261; Cheng L, 2011, MOL BIOSYST, V7, P920, DOI 10.1039/c0mb00237b; Chi XL, 2013, MEDCHEMCOMM, V4, P239, DOI 10.1039/c2md20245j; Chi XL, 2011, J AM CHEM SOC, V133, P14452, DOI 10.1021/ja206304k; Cociancich S, 2015, NAT CHEM BIOL, V11, P195, DOI 10.1038/nchembio.1734; Eichhorn E, 1997, J BIOL CHEM, V272, P23031, DOI 10.1074/jbc.272.37.23031; Fortin PD, 2007, NATURE, V448, P824, DOI 10.1038/nature06068; Fujita Y, 2011, J ANTIBIOT, V64, P495, DOI 10.1038/ja.2011.38; Funabashi M, 2013, ANGEW CHEM INT EDIT, V52, P11607, DOI 10.1002/anie.201305546; Funabashi M, 2010, NAT CHEM BIOL, V6, P581, DOI [10.1038/NCHEMBIO.393, 10.1038/nchembio.393]; Funabashi M, 2010, CHEMBIOCHEM, V11, P184, DOI 10.1002/cbic.200900665; Funabashi M, 2009, J ANTIBIOT, V62, P325, DOI 10.1038/ja.2009.38; GOULD SJ, 1980, J AM CHEM SOC, V102, P1707, DOI 10.1021/ja00525a040; GOULD SJ, 1991, J ORG CHEM, V56, P6666, DOI 10.1021/jo00023a036; Grzyska PK, 2005, BIOCHEMISTRY-US, V44, P3845, DOI 10.1021/bi048746n; Gust B, 2004, ADV APPL MICROBIOL, V54, P107, DOI 10.1016/S0065-2164(04)54004-2; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; He J, 2003, CHEM BIOL, V10, P1225, DOI 10.1016/j.chembiol.2003.11.009; He J, 2001, MICROBIOL-SGM, V147, P2817, DOI 10.1099/00221287-147-10-2817; Hiratsuka T, 2014, ANGEW CHEM INT EDIT, V53, P5423, DOI 10.1002/anie.201402623; Hotoda H, 2003, BIOORG MED CHEM LETT, V13, P2829, DOI 10.1016/S0960-894X(03)00596-1; Hotoda H, 2003, BIOORG MED CHEM LETT, V13, P2833, DOI 10.1016/S0960-894X(03)00597-3; IKEDA M, 1991, J BACTERIOL, V173, P1021, DOI 10.1128/jb.173.3.1021-1026.1991; Isono K., 1978, J AM CHEM SOC, DOI 10.1021/ja00480a052; Jackson M, 2013, FUTURE MICROBIOL, V8, P855, DOI 10.2217/fmb.13.52; KANEOKE M, 1993, BIOSCI BIOTECH BIOCH, V57, P814, DOI 10.1271/bbb.57.814; Kaysser L, 2010, CHEMBIOCHEM, V11, P191, DOI 10.1002/cbic.200900637; Kaysser L, 2009, J BIOL CHEM, V284, P14987, DOI 10.1074/jbc.M901258200; Keller U, 2010, J BACTERIOL, V192, P2583, DOI 10.1128/JB.01526-09; Mantri M, 2012, FEBS J, V279, P1563, DOI 10.1111/j.1742-4658.2012.08496.x; Mao YQ, 1999, CHEM BIOL, V6, P251, DOI 10.1016/S1074-5521(99)80040-4; Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001; Miranzo D, 2010, APPL MICROBIOL BIOT, V85, P1809, DOI 10.1007/s00253-009-2195-1; Murakami R, 2007, J ANTIBIOT, V60, P690, DOI 10.1038/ja.2007.88; Muramatsu Y, 2004, J ANTIBIOT, V57, P639, DOI 10.7164/antibiotics.57.639; Muramatsu Y, 2003, J ANTIBIOT, V56, P253, DOI 10.7164/antibiotics.56.253; Nikonenko BV, 2010, INFECT GENET EVOL, V10, P1151, DOI 10.1016/j.meegid.2010.07.014; Nikonenko BV, 2009, ANTIMICROB AGENTS CH, V53, P3138, DOI 10.1128/AAC.00366-09; Ohnuki T, 2003, J ANTIBIOT, V56, P268, DOI 10.7164/antibiotics.56.268; Palaniappan N, 2006, CHEM BIOL, V13, P753, DOI 10.1016/j.chembiol.2006.05.013; Price JC, 2003, BIOCHEMISTRY-US, V42, P7497, DOI 10.1021/bi030011f; Price JC, 2005, BIOCHEMISTRY-US, V44, P8138, DOI 10.1021/bi050227c; Reddy V. M., 2011, DRUG DEL LETT, V1, P150, DOI [10.2174/2210304x11101020150, DOI 10.2174/2210304X11101020150]; Reddy VM, 2008, ANTIMICROB AGENTS CH, V52, P719, DOI 10.1128/AAC.01469-07; Reddy VM, 2012, J ANTIMICROB CHEMOTH, V67, P1163, DOI 10.1093/jac/dkr589; Reddy VM, 2010, ANTIMICROB AGENTS CH, V54, P2840, DOI 10.1128/AAC.01601-09; Reid R, 2003, BIOCHEMISTRY-US, V42, P72, DOI 10.1021/bi0268706; Remminghorst U, 2006, BIOTECHNOL LETT, V28, P1701, DOI 10.1007/s10529-006-9156-x; Seco EM, 2010, APPL MICROBIOL BIOT, V85, P1797, DOI 10.1007/s00253-009-2193-3; SETO H, 1988, TETRAHEDRON LETT, V29, P2343, DOI 10.1016/S0040-4039(00)86055-4; Shah NS, 2007, EMERG INFECT DIS, V13, P380, DOI 10.3201/eid1303.061400; Shen B, 2000, TOP CURR CHEM, V209, P1; Shi K, 2012, J BIOL CHEM, V287, P13094, DOI 10.1074/jbc.M112.349670; Smith CA, 2012, J BIOL CHEM, V287, P12893, DOI 10.1074/jbc.M112.341206; Straganz GD, 2006, CHEMBIOCHEM, V7, P1536, DOI 10.1002/cbic.200600152; TOOMEY RE, 1966, BIOCHIM BIOPHYS ACTA, V116, P189, DOI 10.1016/0005-2760(66)90001-4; Toth M, 2009, J BIOL CHEM, V284, P6690, DOI 10.1074/jbc.M808148200; Wong EB, 2013, TRENDS MICROBIOL, V21, P493, DOI 10.1016/j.tim.2013.05.002; YAMAGUCHI H, 1986, J ANTIBIOT, V39, P1047, DOI 10.7164/antibiotics.39.1047; Yanai K, 2004, NAT BIOTECHNOL, V22, P848, DOI 10.1038/nbt978; Yang ZY, 2011, J BIOL CHEM, V286, P7885, DOI 10.1074/jbc.M110.203562; Yang ZY, 2010, J BIOL CHEM, V285, P12899, DOI 10.1074/jbc.M110.104141; YE QZ, 1990, P NATL ACAD SCI USA, V87, P9391, DOI 10.1073/pnas.87.23.9391; Zhang GY, 2012, APPL ENVIRON MICROB, V78, P2393, DOI 10.1128/AEM.07185-11; Zhang WJ, 2006, APPL ENVIRON MICROB, V72, P2573, DOI 10.1128/AEM.72.4.2573-2580.2006	73	22	22	2	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13710	13724		10.1074/jbc.M115.646414	http://dx.doi.org/10.1074/jbc.M115.646414			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25855790	Green Published, hybrid			2022-12-28	WOS:000355313000008
J	Pisano, A; Ceglia, S; Palmieri, C; Vecchio, E; Fiume, G; de Laurentiis, A; Mimmi, S; Falcone, C; Iaccino, E; Scialdone, A; Pontoriero, M; Masci, FF; Valea, R; Krishnan, S; Gaspari, M; Cuda, G; Scala, G; Quinto, I				Pisano, Antonio; Ceglia, Simona; Palmieri, Camillo; Vecchio, Eleonora; Fiume, Giuseppe; de Laurentiis, Annamaria; Mimmi, Selena; Falcone, Cristina; Iaccino, Enrico; Scialdone, Annarita; Pontoriero, Marilena; Masci, Francesca Fasanella; Valea, Rosanna; Krishnan, Shibu; Gaspari, Marco; Cuda, Giovanni; Scala, Giuseppe; Quinto, Ileana			CRL3(IBTK) Regulates the Tumor Suppressor Pdcd4 through Ubiquitylation Coupled to Proteasomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA TRANSLATION; CUL3-BASED E3 LIGASE; INITIATION-FACTOR 4A; UBIQUITIN LIGASES; EUKARYOTIC TRANSLATION; DOMAIN PROTEINS; TYROSINE KINASE; BINDING-PROTEIN; BTB DOMAIN; CYCLIN-E	The human inhibitor of Bruton's tyrosine kinase isoform alpha (IBtk alpha) is a BTB protein encoded by the IBTK gene, which maps to chromosomal locus 6q14.1, a mutational hot spot in lymphoproliferative disorders. Here, we demonstrate that IBtk alpha forms a CRL3IBTK complex promoting its self-ubiquitylation. We identified the tumor suppressor Pdcd4 as IBtk alpha interactor and ubiquitylation substrate of CRL3(IBTK) for proteasomal degradation. Serum-induced degradation of Pdcd4 required both IBtk alpha and Cul3, indicating that CRL3(IBTK) regulated the Pdcd4 stability in serum signaling. By promoting Pdcd4 degradation, IBtk alpha counteracted the suppressive effect of Pdcd4 on translation of reporter luciferase mRNAs with stem-loop structured or unstructured 5'-UTR. IBtk alpha depletion by RNAi caused Pdcd4 accumulation and decreased the translation of Bcl-xL mRNA, a well known target of Pdcd4 repression. By characterizing CRL3(IBTK) as a novel ubiquitin ligase, this study provides new insights into regulatory mechanisms of cellular pathways, such as the Pdcd4-dependent translation of mRNAs.	[Pisano, Antonio; Ceglia, Simona; Palmieri, Camillo; Vecchio, Eleonora; Fiume, Giuseppe; de Laurentiis, Annamaria; Mimmi, Selena; Falcone, Cristina; Iaccino, Enrico; Scialdone, Annarita; Pontoriero, Marilena; Masci, Francesca Fasanella; Valea, Rosanna; Krishnan, Shibu; Gaspari, Marco; Cuda, Giovanni; Scala, Giuseppe; Quinto, Ileana] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, I-88100 Catanzaro, Italy	Magna Graecia University of Catanzaro	Scala, G (corresponding author), Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, I-88100 Catanzaro, Italy.	scala@unicz.it; quinto@unicz.it	Cuda, Giovanni/AAC-2821-2019; Cuda, Giovanni/F-5359-2012; Falcone, Cristina/AAP-9529-2020; Gaspari, Marco/ABE-1539-2020; Gaspari, Marco/C-2756-2009; Mimmi, Selena/J-7860-2016; Iaccino, Enrico/I-7333-2015; Mimmi, Selena/AAB-9585-2019; Gaspari, Marco/HGB-2399-2022; vecchio, eleonora/AAT-4287-2020; Palmieri, Camillo/A-3195-2009	Cuda, Giovanni/0000-0001-6313-1866; Cuda, Giovanni/0000-0001-6313-1866; Gaspari, Marco/0000-0002-5411-8800; Gaspari, Marco/0000-0002-5411-8800; Mimmi, Selena/0000-0003-2187-9176; Iaccino, Enrico/0000-0002-3565-7817; Mimmi, Selena/0000-0003-2187-9176; QUINTO, Ileana/0000-0001-8212-8515; krishnan, shibu/0000-0002-5727-6046; Palmieri, Camillo/0000-0001-6707-4723; FIUME, Giuseppe/0000-0002-5414-6190	Ministero della Salute [GR-2009-1606801, RF-2010-2306943]; Ministero dell'Istruzione, dell'Universita e della Ricerca; International Agency for Research on Cancer (AIRC) [IG-2009-9411]; COFIN-MIUR; Fondazione Italiana per la Ricerca sul Cancro (FIRC)	Ministero della Salute(Ministry of Health, Italy); Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); International Agency for Research on Cancer (AIRC)(Fondazione AIRC per la ricerca sul cancro); COFIN-MIUR(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Fondazione Italiana per la Ricerca sul Cancro (FIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Ministero della Salute Grants GR-2009-1606801 (to C. P.) and RF-2010-2306943 (to G. S.) and Ministero dell'Istruzione, dell'Universita e della Ricerca Grant POR CALABRIA FSE 2007/2013 (to G. S.), International Agency for Research on Cancer (AIRC) Grant IG-2009-9411 (to G. S.), and COFIN-MIUR (to G. S. and I. Q.).; Supported by Fondazione Italiana per la Ricerca sul Cancro (FIRC) fellowships.	Baird TD, 2014, MOL BIOL CELL, V25, P1686, DOI 10.1091/mbc.E14-02-0704; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Bennett EJ, 2010, CELL, V143, P951, DOI 10.1016/j.cell.2010.11.017; Biyanee A, 2015, ONCOGENE, V34, P1384, DOI 10.1038/onc.2014.83; Bordeleau ME, 2008, J CLIN INVEST, V118, P2651, DOI 10.1172/JCI34753; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; de Laurentiis A, 2006, INT J BIOL MACROMOL, V39, P122, DOI 10.1016/j.ijbiomac.2006.02.020; De Laurentiis A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.007898; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Fiume G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066087; Fiume G, 2009, COMPUT BIOL CHEM, V33, P434, DOI 10.1016/j.compbiolchem.2009.08.001; Furukawa M, 2003, NAT CELL BIOL, V5, P1001, DOI 10.1038/ncb1056; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Genschik P, 2013, EMBO J, V32, P2307, DOI 10.1038/emboj.2013.173; Geyer R, 2003, MOL CELL, V12, P783, DOI 10.1016/S1097-2765(03)00341-1; Guardavaccaro D, 2004, ONCOGENE, V23, P2037, DOI 10.1038/sj.onc.1207413; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Janda E, 2011, BLOOD, V117, P6520, DOI 10.1182/blood-2010-09-308080; Jin LY, 2012, NATURE, V482, P495, DOI 10.1038/nature10822; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Kumar N, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2012.37; Lankat-Buttgereit B, 2009, BIOL CELL, V101, P309, DOI 10.1042/BC20080191; Lindqvist L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001583; Lipkowitz S, 2011, NAT REV CANCER, V11, P629, DOI 10.1038/nrc3120; Liu WM, 2001, NAT IMMUNOL, V2, P939, DOI 10.1038/ni1001-939; Liwak U, 2012, MOL CELL BIOL, V32, P1818, DOI 10.1128/MCB.06317-11; Lu A, 2013, J CELL BIOL, V203, P233, DOI 10.1083/jcb.201305158; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Mathew R, 2012, NATURE, V491, P619, DOI 10.1038/nature11548; Ohta A, 2013, BIOCHEM J, V451, P111, DOI 10.1042/BJ20121903; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Pintard L, 2003, NATURE, V425, P311, DOI 10.1038/nature01959; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Spatuzza C, 2008, NUCLEIC ACIDS RES, V36, P4402, DOI 10.1093/nar/gkn413; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Weissman AM, 2011, NAT REV MOL CELL BIO, V12, P605, DOI 10.1038/nrm3173; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Yang HS, 2003, MOL CELL BIOL, V23, P26, DOI 10.1128/MCB.23.1.26-37.2003; Yang HS, 2004, MOL CELL BIOL, V24, P3894, DOI 10.1128/MCB.24.9.3894-3906.2004; Zhang DD, 2005, J BIOL CHEM, V280, P30091, DOI 10.1074/jbc.M501279200; Zhuang M, 2009, MOL CELL, V36, P39, DOI 10.1016/j.molcel.2009.09.022; ZOLLMAN S, 1994, P NATL ACAD SCI USA, V91, P10717, DOI 10.1073/pnas.91.22.10717	50	17	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13958	13971		10.1074/jbc.M114.634535	http://dx.doi.org/10.1074/jbc.M114.634535			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25882842	Green Published, hybrid			2022-12-28	WOS:000355313000027
J	Salian-Mehta, S; Xu, M; McKinsey, TA; Tobet, S; Wierman, ME				Salian-Mehta, Smita; Xu, Mei; McKinsey, Timothy A.; Tobet, Stuart; Wierman, Margaret E.			Novel Interaction of Class IIb Histone Deacetylase 6 (HDAC6) with Class IIa HDAC9 Controls Gonadotropin Releasing Hormone (GnRH) Neuronal Cell Survival and Movement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEGATIVE REGULATOR; GENE-EXPRESSION; IN-VIVO; MIGRATION; PROTEIN; ACETYLATION; DEATH; AXL; INHIBITION; CLONING	The impact of histone deacetylases (HDACs) in the control of gonadotropin releasing hormone (GnRH) neuronal development is unknown. We identified an increase in many HDACs in GT1-7 (differentiated) compared with NLT (undifferentiated) GnRH neuronal cell lines. Increased HDAC9 mRNA and protein and specific deacetylase activity in GT1-7 cells suggested a functional role. Introduction of HDAC9 in NLT cells protected from serum withdrawal induced apoptosis and impaired basal neuronal cell movement. Conversely, silencing of endogenous HDAC 9 in GT 1-7 cells increased apoptosis and cell movement. Comparison of WT and mutant HDAC9 constructs demonstrated that the HDAC9 pro-survival effects required combined cytoplasmic and nuclear localization, whereas the effects on cell movement required a cytoplasmic site of action. Co-immunoprecipitation demonstrated a novel interaction of HDAC9 selectively with the Class IIb HDAC6. HDAC6 was also up-regulated at the mRNA and protein levels, and HDAC6 catalytic activity was significantly increased in GT1-7 compared with NLT cells. HDAC9 interacted with HDAC6 through its second catalytic domain. Silencing of HDAC6, HDAC9, or both, in GT1-7 cells augmented apoptosis compared with controls. HDAC6 and -9 had additive effects to promote cell survival via modulating the BAX/BCL2 pathway. Silencing of HDAC6 resulted in an activation of movement of GT1-7 cells with induction in acetylation of alpha-tubulin. Inhibition of HDAC6 and HDAC9 together resulted in an additive effect to increase cell movement but did not alter the acetylation of alpha tubulin. Together, these studies identify a novel interaction of Class IIa HDAC9 with Class IIb HDAC6 to modulate cell movement and survival in GnRH neurons.	[Salian-Mehta, Smita; Xu, Mei; Wierman, Margaret E.] Univ Colorado, Sch Med, Div Endocrinol Metab & Diabet, Aurora, CO 80045 USA; [McKinsey, Timothy A.] Univ Colorado, Sch Med, Div Cardiol, Aurora, CO 80045 USA; [Wierman, Margaret E.] Vet Affairs Med Ctr, Res Serv, Denver, CO 80220 USA; [Tobet, Stuart] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; US Department of Veterans Affairs; Veterans Health Administration (VHA); Colorado State University	Wierman, ME (corresponding author), Univ Colorado Denver, Endocrinol MS8106, 12801 East 17th Ave,RC1 South, Aurora, CO 80045 USA.	margaret.wierman@ucdenver.edu	Salian-Mehta, Smita/AAE-4677-2021		National Center for Advancing Translational Sciences, National Institutes of Health Colorado Clinical and Translational Sciences Institute [UL1 TR001082]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R55HD031191, R01HD031191] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116848] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG043822] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences, National Institutes of Health Colorado Clinical and Translational Sciences Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Todd Horn for performing the HDAC catalytic activity assays. Imaging experiments were performed in the University of Colorado Anschutz Medical Campus Advance Light Microscopy Core supported in part by National Center for Advancing Translational Sciences, National Institutes of Health Colorado Clinical and Translational Sciences Institute Grant UL1 TR001082.	Aizawa S, 2012, NEUROSCIENCE, V205, P63, DOI 10.1016/j.neuroscience.2011.12.024; Allen MP, 2002, MOL CELL BIOL, V22, P599, DOI 10.1128/MCB.22.2.599-613.2002; Bardai FH, 2012, J BIOL CHEM, V287, P35444, DOI 10.1074/jbc.M112.394544; Beier U.H., 2012, SCI SIGNAL, V5, pra45; Bertos NR, 2001, BIOCHEM CELL BIOL, V79, P243, DOI 10.1139/bcb-79-3-243; Bhatia U., 2002, U. S. Patent, Patent No. [WO2002030970A2, 2002030970]; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Chatterjee TK, 2011, J BIOL CHEM, V286, P27836, DOI 10.1074/jbc.M111.262964; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Fenic I, 2004, J ANDROL, V25, P811; Gan L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039770; Gao L, 2002, J BIOL CHEM, V277, P25748, DOI 10.1074/jbc.M111871200; Gao YS, 2007, MOL CELL BIOL, V27, P8637, DOI 10.1128/MCB.00393-07; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Herbison AE, 2008, ENDOCRINOLOGY, V149, P597, DOI 10.1210/en.2007-1139; Hideshima T, 2005, P NATL ACAD SCI USA, V102, P8567, DOI 10.1073/pnas.0503221102; Insinga A, 2005, NAT MED, V11, P71, DOI 10.1038/nm1160; Kurian Joseph R, 2013, Front Endocrinol (Lausanne), V4, P61, DOI 10.3389/fendo.2013.00061; Lemon DD, 2011, J MOL CELL CARDIOL, V51, P41, DOI 10.1016/j.yjmcc.2011.04.005; Li Y, 2013, FEBS J, V280, P775, DOI 10.1111/febs.12079; Lim S, 2007, MOL CELL BIOL, V27, P4105, DOI 10.1128/MCB.00248-07; Maggi R, 2000, ENDOCRINOLOGY, V141, P2105, DOI 10.1210/en.141.6.2105; Martin M, 2007, ONCOGENE, V26, P5450, DOI 10.1038/sj.onc.1210613; Mejat A, 2005, NAT NEUROSCI, V8, P313, DOI 10.1038/nn1408; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Morrison BE, 2006, MOL CELL BIOL, V26, P3550, DOI 10.1128/MCB.26.9.3550-3564.2006; Petrie K, 2003, J BIOL CHEM, V278, P16059, DOI 10.1074/jbc.M212935200; Pierce A, 2008, MOL ENDOCRINOL, V22, P2481, DOI 10.1210/me.2008-0169; Pierce A, 2011, MOL CELL ENDOCRINOL, V339, P151, DOI 10.1016/j.mce.2011.04.007; RADOVICK S, 1991, P NATL ACAD SCI USA, V88, P3402, DOI 10.1073/pnas.88.8.3402; Salian-Mehta S, 2014, J CLIN ENDOCR METAB, V99, P1452, DOI 10.1210/jc.2013-3426; Salian-Mehta S, 2013, MOL CELL ENDOCRINOL, V374, P92, DOI 10.1016/j.mce.2013.04.018; Schwarting GA, 2007, SEMIN REPROD MED, V25, P305, DOI 10.1055/s-2007-984736; Sugo N, 2010, EUR J NEUROSCI, V31, P1521, DOI 10.1111/j.1460-9568.2010.07218.x; Terasawa E, 2010, J NEUROENDOCRINOL, V22, P630, DOI 10.1111/j.1365-2826.2010.02027.x; Thangaraju M, 2009, BIOCHEM J, V417, P379, DOI 10.1042/BJ20081132; Tobet SA, 2006, ENDOCRINOLOGY, V147, P1159, DOI 10.1210/en.2005-1275; Valenzuela-Fernandez A, 2008, TRENDS CELL BIOL, V18, P291, DOI 10.1016/j.tcb.2008.04.003; Walkinshaw DR, 2013, J BIOL CHEM, V288, P9345, DOI 10.1074/jbc.M113.456996; Wierman ME, 2011, FRONT NEUROENDOCRIN, V32, P43, DOI 10.1016/j.yfrne.2010.07.005; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Yang MH, 2013, MOL CANCER RES, V11, P1072, DOI 10.1158/1541-7786.MCR-13-0040-T; Yuan ZG, 2010, J BIOL CHEM, V285, P39329, DOI 10.1074/jbc.M110.179333; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zhou XB, 2001, P NATL ACAD SCI USA, V98, P10572, DOI 10.1073/pnas.191375098	47	9	9	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					14045	14056		10.1074/jbc.M115.640482	http://dx.doi.org/10.1074/jbc.M115.640482			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25873389	hybrid, Green Published			2022-12-28	WOS:000355313000034
J	Dhanjal, S; Kajitani, N; Glahder, J; Mossberg, AK; Johansson, C; Schwartz, S				Dhanjal, Soniya; Kajitani, Naoko; Glahder, Jacob; Mossberg, Ann-Kristin; Johansson, Cecilia; Schwartz, Stefan			Heterogeneous Nuclear Ribonucleoprotein C Proteins Interact with the Human Papillomavirus Type 16 (HPV16) Early 3 '-Untranslated Region and Alleviate Suppression of HPV16 Late L1 mRNA Splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LATE GENE-EXPRESSION; HNRNP C; POLYADENYLATION ELEMENT; BINDING PROTEINS; POLYMERASE-II; CODING REGION; HPV-16 L1; TRANSCRIPTS; INHIBITION; IDENTIFICATION	In order to identify cellular factors that regulate human papillomavirus type 16 (HPV16) gene expression, cervical cancer cells permissive for HPV16 late gene expression were identified and characterized. These cells either contained a novel spliced variant of the L1 mRNAs that bypassed the suppressed HPV16 late, 5'-splice site SD3632; produced elevated levels of RNA-binding proteins SRSF1 (ASF/SF2), SRSF9 (SRp30c), and HuR that are known to regulate HPV16 late gene expression; or were shown by a gene expression array analysis to overexpress the RALYLRNA-binding protein of the heterogeneous nuclear ribonucleoprotein C (hnRNP C) family. Overexpression of RALYL or hnRNP C1 induced HPV16 late gene expression from HPV16 subgenomic plasmids and from episomal forms of the full-length HPV16 genome. This induction was dependent on the HPV16 early untranslated region. Binding of hnRNP C1 to the HPV16 early, untranslated region activated HPV16 late 5'-splice site SD3632 and resulted in production of HPV16 L1 mRNAs. Our results suggested that hnRNP C1 controls HPV16 late gene expression.	[Dhanjal, Soniya; Kajitani, Naoko; Glahder, Jacob; Mossberg, Ann-Kristin; Johansson, Cecilia; Schwartz, Stefan] Lund Univ, Dept Lab Med, S-22184 Lund, Sweden	Lund University	Schwartz, S (corresponding author), Lund Univ, Dept Lab Med, BMC-B13,Rm B1314c, S-22362 Lund, Sweden.	Stefan.Schwartz@med.lu.se	Johansson, Cecilia/O-9433-2019; Johansson, Cecilia/B-4751-2019	Johansson, Cecilia/0000-0001-5965-2853; 	Swedish Research Council-Medicine Grant [2012-1933]; Swedish Cancer Society [CAN 2012/542]; Gunnar Nilsson Cancer Research Trust Fund; Hedda and John Forssmans Foundation through the Royal Physiographic Society in Lund; Crafoord Foundation	Swedish Research Council-Medicine Grant; Swedish Cancer Society(Swedish Cancer Society); Gunnar Nilsson Cancer Research Trust Fund; Hedda and John Forssmans Foundation through the Royal Physiographic Society in Lund; Crafoord Foundation	This work was supported by Swedish Research Council-Medicine Grant 2012-1933, Swedish Cancer Society Grant CAN 2012/542, the Gunnar Nilsson Cancer Research Trust Fund, the Hedda and John Forssmans Foundation through the Royal Physiographic Society in Lund, and the Crafoord Foundation (to S. S.).	Baker C., 1997, HUMAN PAPILLOMAVIRUS; Bernard HU, 2013, VIROLOGY, V445, P197, DOI 10.1016/j.virol.2013.04.035; Bodily J, 2011, TRENDS MICROBIOL, V19, P33, DOI 10.1016/j.tim.2010.10.002; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; BOUVARD V, 2009, LANCET ONCOL, V10, P321, DOI [DOI 10.1016/S1470-2045(09)70096-8, 10.1016/s1470-2045(09)70096-8]; Brunner JE, 2010, VIROLOGY, V400, P240, DOI 10.1016/j.virol.2010.01.031; Busch A, 2012, WIRES RNA, V3, P1, DOI 10.1002/wrna.100; Casaca A, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-358; Cheunim T, 2008, VIRUS RES, V131, P189, DOI 10.1016/j.virusres.2007.09.006; Chow LT, 2010, APMIS, V118, P422, DOI 10.1111/j.1600-0463.2010.02625.x; Collier B, 2002, J VIROL, V76, P2739, DOI 10.1128/JVI.76.6.2739-2752.2002; Collier B, 1998, J BIOL CHEM, V273, P22648, DOI 10.1074/jbc.273.35.22648; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Doorbar J, 2005, J CLIN VIROL, V32, pS7, DOI 10.1016/j.jcv.2004.12.006; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Fay J, 2009, J MED VIROL, V81, P897, DOI 10.1002/jmv.21406; Graham SV, 2008, FRONT BIOSCI-LANDMRK, V13, P5646; Howley P. M., 2006, VIROLOGY, P2299; Irimura Sanae, 2009, Kobe J Med Sci, V54, pE227; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Izquierdo JM, 2010, NUCLEIC ACIDS RES, V38, P8001, DOI 10.1093/nar/gkq698; JEON S, 1995, P NATL ACAD SCI USA, V92, P1654, DOI 10.1073/pnas.92.5.1654; Jia R, 2010, INT J BIOL SCI, V6, P806; Jia R, 2009, FRONT BIOSCI-LANDMRK, V14, P1270, DOI 10.2741/3307; Jia R, 2009, J VIROL, V83, P167, DOI 10.1128/JVI.01719-08; Johansson C, 2013, NAT REV MICROBIOL, V11, P239, DOI 10.1038/nrmicro2984; Johansson C, 2012, EMBO J, V31, P3212, DOI 10.1038/emboj.2012.147; KOZAK M, 1992, ANNU REV CELL BIOL, V8, P197, DOI 10.1146/annurev.cb.08.110192.001213; Lee EK, 2010, NAT STRUCT MOL BIOL, V17, P732, DOI 10.1038/nsmb.1815; Lee HH, 2004, J CELL SCI, V117, P5579, DOI 10.1242/jcs.01482; Li XZ, 2013, NUCLEIC ACIDS RES, V41, P10488, DOI 10.1093/nar/gkt803; Li XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072776; McBride AA, 2013, VIROLOGY, V445, P57, DOI 10.1016/j.virol.2013.06.006; McCloskey A, 2012, SCIENCE, V335, P1643, DOI 10.1126/science.1218469; Motta-Mena LB, 2010, MOL CELL, V37, P223, DOI 10.1016/j.molcel.2009.12.027; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Oberg D, 2005, J VIROL, V79, P9254, DOI 10.1128/JVI.79.14.9254-9269.2005; Orru B, 2012, J VIROL METHODS, V183, P106, DOI 10.1016/j.jviromet.2012.03.023; Ozbun MA, 1997, J VIROL, V71, P5161, DOI 10.1128/JVI.71.7.5161-5172.1997; PINOLROMA S, 1993, MOL CELL BIOL, V13, P5762, DOI 10.1128/MCB.13.9.5762; Rosenberger S, 2010, P NATL ACAD SCI USA, V107, P7006, DOI 10.1073/pnas.1002620107; Rush M, 2005, J VIROL, V79, P12002, DOI 10.1128/JVI.79.18.12002-12015.2005; Schwartz S, 2013, VIROLOGY, V445, P187, DOI 10.1016/j.virol.2013.04.034; Shabman RS, 2011, J INFECT DIS, V204, pS904, DOI 10.1093/infdis/jir323; Sokolowski M, 1997, ONCOGENE, V15, P2303, DOI 10.1038/sj.onc.1201415; Sokolowski M, 2001, VIRUS RES, V73, P163, DOI 10.1016/S0168-1702(00)00238-0; Somberg M, 2008, J VIROL, V82, P3665, DOI 10.1128/JVI.02140-07; Somberg M, 2011, J GEN VIROL, V92, P2411, DOI 10.1099/vir.0.033183-0; Somberg M, 2010, J VIROL, V84, P8219, DOI 10.1128/JVI.00462-10; Spangberg K, 2000, VIROLOGY, V274, P378, DOI 10.1006/viro.2000.0461; Tenzer S, 2013, J PROTEOME RES, V12, P2869, DOI 10.1021/pr400193j; Terhune SS, 2001, J VIROL, V75, P8147, DOI 10.1128/JVI.75.17.8147-8157.2001; Thierry F, 2009, VIROLOGY, V384, P375, DOI 10.1016/j.virol.2008.11.014; TOMITA Y, 1993, GENE, V133, P223; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Zarnack K, 2013, CELL, V152, P453, DOI 10.1016/j.cell.2012.12.023; Zhao X, 2008, VIRUS GENES, V36, P45, DOI 10.1007/s11262-007-0174-0; Zhao XM, 2007, VIROLOGY, V369, P351, DOI 10.1016/j.virol.2007.08.002; Zhao XM, 2005, J VIROL, V79, P4270, DOI 10.1128/JVI.79.7.4270-4288.2005; Zhao XM, 2004, J VIROL, V78, P10888, DOI 10.1128/JVI.78.20.10888-10905.2004; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	62	17	17	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13354	13371		10.1074/jbc.M115.638098	http://dx.doi.org/10.1074/jbc.M115.638098			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25878250	hybrid, Green Published			2022-12-28	WOS:000354975700033
J	He, H; Li, S; Hong, Y; Zou, HJ; Chen, HY; Ding, F; Wan, Y; Liu, ZH				He, Huan; Li, Sheng; Hong, Yuan; Zou, Haojing; Chen, Hongyan; Ding, Fang; Wan, Yong; Liu, Zhihua			Kruppel-like Factor 4 Promotes Esophageal Squamous Cell Carcinoma Differentiation by Up-regulating Keratin 13 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; TRANSCRIPTION FACTOR; GENE-EXPRESSION; TERMINAL DIFFERENTIATION; GOBLET CELLS; BETA-CATENIN; COLON-CANCER; STEM-CELLS; KLF4; BUTYRATE	Squamous cell differentiation requires the coordinated activation and repression of genes specific to the differentiation process; disruption of this program accompanies malignant transformation of epithelium. The exploration of genes that control epidermal proliferation and terminal differentiation is vital to better understand esophageal carcinogenesis. KLF4 is a member of the KLF family of transcription factors and is involved in both cellular proliferation and differentiation. This study using immunohistochemistry analysis of KLF4 in clinical specimens of esophageal squamous cell carcinoma (ESCC) demonstrated that decreased KLF4 was substantially associated with poor differentiation. Moreover, we determined that both KLF4 and KRT13levels were undoubtedly augmented upon sodium butyrate-induced ESCC differentiation and G(1) phase arrest. Conversely, silencing of KLF4 and KRT13 abrogated the inhibition of G(1)-S transition induced by sodium butyrate. Molecular investigation demonstrated that KLF4 transcriptionally regulated KRT13 and the expression of the two molecules appreciably correlated in ESCC tissues and cell lines. Collectively, these results suggest that KLF4 transcriptionally regulates KRT13 and is invovled in ESCC cell differentiation.	[He, Huan; Li, Sheng; Hong, Yuan; Zou, Haojing; Chen, Hongyan; Ding, Fang; Liu, Zhihua] Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100021, Peoples R China; [He, Huan; Li, Sheng; Hong, Yuan; Zou, Haojing; Chen, Hongyan; Ding, Fang; Liu, Zhihua] Peking Union Med Coll, Beijing 100021, Peoples R China; [Wan, Yong] Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Dept Cell Biol,Sch Med, Pittsburgh, PA 15213 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Liu, ZH (corresponding author), Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100021, Peoples R China.	liuzh@cicams.ac.cn		Li, Sheng/0000-0001-8080-9712	National Natural Science Foundation of China [81130043, 81302329, 81420108025]; National Basic Research Program of China [2011CB504205, 2013CB911004]; NATIONAL CANCER INSTITUTE [R01CA154695] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by National Natural Science Foundation of China Grants 81130043, 81302329, and 81420108025 and National Basic Research Program of China Grants 2011CB504205 and 2013CB911004.	Abramova MV, 2006, J BIOL CHEM, V281, P21040, DOI 10.1074/jbc.M511059200; Baker H, 2005, ORAL ONCOL, V41, P183, DOI 10.1016/j.oraloncology.2004.08.009; BANKSSCHLEGEL SP, 1986, CANCER RES, V46, P250; Chen HY, 2013, MOL CANCER RES, V11, P1542, DOI 10.1158/1541-7786.MCR-13-0317; Chen TT, 1997, MOL CELL BIOL, V17, P3056, DOI 10.1128/MCB.17.6.3056; Chen XM, 2003, J MOL BIOL, V326, P665, DOI 10.1016/S0022-2836(02)01449-3; Chew YC, 2013, J BIOL CHEM, V288, P17759, DOI 10.1074/jbc.M113.477133; Cittelly DM, 2013, ONCOGENE, V32, P2555, DOI 10.1038/onc.2012.275; Cui JJ, 2013, CURR CANCER DRUG TAR, V13, P986, DOI 10.2174/15680096113136660104; Dackour R, 2005, IN VITRO CELL DEV-AN, V41, P111; Dong JT, 2009, CELL MOL LIFE SCI, V66, P2691, DOI 10.1007/s00018-009-0045-z; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Flandez M, 2008, EXP CELL RES, V314, P3712, DOI 10.1016/j.yexcr.2008.10.004; Hamakawa H, 2000, CANCER LETT, V160, P115, DOI 10.1016/S0304-3835(00)00574-7; He H, 2014, J BIOL CHEM, V289, P9089, DOI 10.1074/jbc.M113.534271; He H, 2012, MOL CANCER RES, V10, P273, DOI 10.1158/1541-7786.MCR-11-0419; HEERDT BG, 1994, CANCER RES, V54, P3288; Hesse M, 2001, J CELL SCI, V114, P2569; Hinnebusch BF, 2004, AM J PHYSIOL-GASTR L, V286, pG23, DOI 10.1152/ajpgi.00203.2003; Huang CC, 2005, CANCER BIOL THER, V4, P1401, DOI 10.4161/cbt.4.12.2355; Katz JP, 2005, GASTROENTEROLOGY, V128, P935, DOI 10.1053/j.gastro.2005.02.022; Katz JP, 2002, DEVELOPMENT, V129, P2619; Kuroda J, 2005, INT J ONCOL, V26, P361; Li S, 2013, J BIOL CHEM, V288, P4076, DOI 10.1074/jbc.M111.317487; Liu R, 2011, MOL ENDOCRINOL, V25, P1137, DOI 10.1210/me.2010-0497; Luo AP, 2004, ONCOGENE, V23, P1291, DOI 10.1038/sj.onc.1207218; Lupton JR, 2004, J NUTR, V134, P479, DOI 10.1093/jn/134.2.479; Lupton JR, 2000, NUTRITION, V16, P558, DOI 10.1016/S0899-9007(00)00350-6; Magin TM, 2007, EXP CELL RES, V313, P2021, DOI 10.1016/j.yexcr.2007.03.005; Mali P, 2010, STEM CELLS, V28, P713, DOI 10.1002/stem.402; Mariette C, 2007, LANCET ONCOL, V8, P545, DOI 10.1016/S1470-2045(07)70172-9; Nishizawa A, 2008, BRIT J DERMATOL, V159, P974, DOI 10.1111/j.1365-2133.2008.08716.x; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Sheng S, 2008, MOL CELL ENDOCRINOL, V296, P1, DOI 10.1016/j.mce.2008.09.022; SHIMADA Y, 1992, CANCER, V69, P277, DOI 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Southgate J, 2007, BJU INT, V99, P1506, DOI 10.1111/j.1464-410X.2007.06795.x; Swamynathan SK, 2007, MOL CELL BIOL, V27, P182, DOI 10.1128/MCB.00846-06; Tetreault MP, 2010, GASTROENTEROLOGY, V139, P171, DOI 10.1053/j.gastro.2010.03.048; Tong T, 2004, CLIN CANCER RES, V10, P7304, DOI 10.1158/1078-0432.CCR-04-0806; TSUTSUMI T, 1994, GASTROENTEROLOGY, V107, P499, DOI 10.1016/0016-5085(94)90177-5; Wanner R, 1996, BIOCHEM BIOPH RES CO, V223, P666, DOI 10.1006/bbrc.1996.0952; Wu R, 2003, MOL MED, V9, P77, DOI 10.2119/2003-00001.Wu; Yu F, 2011, ONCOGENE, V30, P2161, DOI 10.1038/onc.2010.591; Zhang LY, 2006, CLIN CANCER RES, V12, P1639, DOI 10.1158/1078-0432.CCR-05-1858; Zhao WD, 2004, ONCOGENE, V23, P395, DOI 10.1038/sj.onc.1207067	46	36	38	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13567	13577		10.1074/jbc.M114.629717	http://dx.doi.org/10.1074/jbc.M114.629717			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25851906	hybrid, Green Published			2022-12-28	WOS:000354975700050
J	Li, TF; Painter, RG; Ban, B; Blake, RC				Li, Ting-Feng; Painter, Richard G.; Ban, Bhupal; Blake, Robert C., II			The Multicenter Aerobic Iron Respiratory Chain of Acidithiobacillus ferrooxidans Functions as an Ensemble with a Single Macroscopic Rate Constant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TYPE CYTOCHROMES; SHEWANELLA-ONEIDENSIS MR-1; EXTREME ACID STABILITY; BLUE COPPER PROTEIN; THIOBACILLUS-FERROOXIDANS; ELECTRON-TRANSFER; PERIPLASMIC SPACE; ESCHERICHIA-COLI; REDOX PROTEINS; RUSTICYANIN	Electron transfer reactions among three prominent colored proteins in intact cells of Acidithiobacillus ferrooxidans were monitored using an integrating cavity absorption meter that permitted the acquisition of accurate absorbance data in suspensions of cells that scattered light. The concentrations of proteins in the periplasmic space were estimated to be 350 and 25 mg/ml for rusticyanin and cytochrome c, respectively; cytochrome a was present as one molecule for every 91 nm(2) in the cytoplasmic membrane. All three proteins were rapidly reduced to the same relative extent when suspensions of live bacteria were mixed with different concentrations of ferrous ions at pH 1.5. The subsequent molecular oxygen-dependent oxidation of the multicenter respiratory chain occurred with a single macroscopic rate constant, regardless of the proteins' in vitro redox potentials or their putative positions in the aerobic iron respiratory chain. The crowded electron transport proteins in the periplasm of the organism constituted an electron conductive medium where the network of protein interactions functioned in a concerted fashion as a single ensemble with a standard reduction potential of 650 mV. The appearance of product ferric ions was correlated with the reduction levels of the periplasmic electron transfer proteins; the limiting first-order catalytic rate constant for aerobic respiration on iron was 7,400 s(-1). The ability to conduct direct spectrophotometric studies under noninvasive physiological conditions represents a new and powerful approach to examine the extent and rates of biological events in situ without disrupting the complexity of the live cellular environment.	[Li, Ting-Feng; Painter, Richard G.; Ban, Bhupal; Blake, Robert C., II] Xavier Univ Louisiana, Coll Pharm, New Orleans, LA 70125 USA	Xavier University of Louisiana	Blake, RC (corresponding author), Xavier Univ Louisiana, Coll Pharm, 1 Drexel Dr, New Orleans, LA 70125 USA.	rblake@xula.edu			United States Department of Energy [DE-SC0007229]; United States Department of Defense through Army Research Office [W911NF-12-1-0042]; National Institute on Minority Health and Health Disparities [G12MD007595] Funding Source: NIH RePORTER	United States Department of Energy(United States Department of Energy (DOE)); United States Department of Defense through Army Research Office; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by Grant DE-SC0007229 from the United States Department of Energy and Grant W911NF-12-1-0042 from the United States Department of Defense through its Army Research Office. The authors declare that they have no conflicts of interest with the contents of this article.	Appia-Ayme C, 1999, APPL ENVIRON MICROB, V65, P4781; Bashir Q, 2011, FEBS J, V278, P1391, DOI 10.1111/j.1742-4658.2011.08062.x; BLAKE RC, 1994, BIOCHEMISTRY-US, V33, P9220, DOI 10.1021/bi00197a025; BLAKE RC, 1987, J BIOL CHEM, V262, P14983; Blake RC, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00136; Bonnefoy V, 2012, ENVIRON MICROBIOL, V14, P1597, DOI 10.1111/j.1462-2920.2011.02626.x; Botuyan MV, 1996, J MOL BIOL, V263, P752, DOI 10.1006/jmbi.1996.0613; Bouchal P, 2006, PROTEOMICS, V6, P4278, DOI 10.1002/pmic.200500719; Bright H. J., 1975, ENZYMES, P421; Castelle C, 2008, J BIOL CHEM, V283, P25803, DOI 10.1074/jbc.M802496200; Catarino T, 2001, CHEMBIOCHEM, V2, P416, DOI 10.1002/1439-7633(20010601)2:6<416::AID-CBIC416>3.3.CO;2-Q; CAVAZZA C, 1995, FEMS MICROBIOL LETT, V130, P193; Cavazza C, 1996, EUR J BIOCHEM, V242, P308, DOI 10.1111/j.1432-1033.1996.0308r.x; Chance B, 1943, J BIOL CHEM, V151, P553; Chi A, 2007, MOL CELL PROTEOMICS, V6, P2239, DOI 10.1074/mcp.M700042-MCP200; COBLEY JG, 1975, FEBS LETT, V60, P29, DOI 10.1016/0014-5793(75)80411-X; COX JC, 1978, BIOCHEM J, V174, P497, DOI 10.1042/bj1740497; DeSa RJ, 2004, METHOD ENZYMOL, V384, P1; Doster W, 2007, BIOPHYS J, V93, P1360, DOI 10.1529/biophysj.106.097956; ELTERMAN P, 1970, APPL OPTICS, V9, P2140, DOI 10.1364/AO.9.002140; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Fonseca BM, 2013, BIOCHEM J, V449, P101, DOI 10.1042/BJ20121467; Fry ES, 2010, APPL OPTICS, V49, P575, DOI 10.1364/AO.49.000575; FRY ES, 1992, APPL OPTICS, V31, P2055, DOI 10.1364/AO.31.002055; FUKUMORI Y, 1988, FEMS MICROBIOL LETT, V50, P169; Giudici-Orticoni MT, 1999, J BIOL CHEM, V274, P30365, DOI 10.1074/jbc.274.43.30365; Giudici-Orticoni MT, 2000, BIOCHEMISTRY-US, V39, P7205, DOI 10.1021/bi992846p; GRAHAM LL, 1991, TRENDS BIOCHEM SCI, V16, P328, DOI 10.1016/0968-0004(91)90135-I; Hodgkinson J, 2009, APPL OPTICS, V48, P5748, DOI 10.1364/AO.48.005748; INGLEDEW WJ, 1982, BIOCHIM BIOPHYS ACTA, V683, P89, DOI 10.1016/0304-4173(82)90007-6; INGLEDEW WJ, 1980, BIOCHIM BIOPHYS ACTA, V590, P141, DOI 10.1016/0005-2728(80)90020-1; Javorfi T, 2006, J PHOTOCH PHOTOBIO B, V82, P127, DOI 10.1016/j.jphotobiol.2005.10.002; KAI M, 1992, J BIOCHEM-TOKYO, V112, P816; Kucera J, 2013, ANTON LEEUW INT J G, V103, P905, DOI 10.1007/s10482-012-9872-2; KUSANO T, 1992, J BIOL CHEM, V267, P11242; Meschi F, 2011, J AM CHEM SOC, V133, P16861, DOI 10.1021/ja205043f; Myers JM, 2001, APPL ENVIRON MICROB, V67, P260, DOI 10.1128/AEM.67.1.260-269.2001; Paquete CM, 2014, ACCOUNTS CHEM RES, V47, P56, DOI 10.1021/ar4000696; Paquete CM, 2010, J BIOL CHEM, V285, P10370, DOI 10.1074/jbc.M109.078337; Quatrini R, 2006, HYDROMETALLURGY, V83, P263, DOI 10.1016/j.hydromet.2006.03.030; Quatrini R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-394; Roger M, 2012, BIOCHEM SOC T, V40, P1324, DOI 10.1042/BST20120141; SATO A, 1989, BIOCHIM BIOPHYS ACTA, V976, P129, DOI 10.1016/S0005-2728(89)80221-X; Shi L, 2006, J BACTERIOL, V188, P4705, DOI 10.1128/JB.01966-05; STOCK JB, 1977, J BIOL CHEM, V252, P7850; Sugio T, 2010, BIOSCI BIOTECH BIOCH, V74, P2242, DOI 10.1271/bbb.100446; TAMEGAI H, 1994, FEMS MICROBIOL LETT, V119, P147; TUOVINEN OH, 1973, ARCH MIKROBIOL, V88, P285, DOI 10.1007/BF00409941; TURNER RC, 1957, CAN J CHEM, V35, P1002, DOI 10.1139/v57-137; Valdes J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-597; Walter RL, 1996, J MOL BIOL, V263, P730, DOI 10.1006/jmbi.1996.0612; Yarzabal A, 2004, MICROBIOL-SGM, V150, P2113, DOI 10.1099/mic.0.26966-0; Yarzabal A, 2002, J BACTERIOL, V184, P313, DOI 10.1128/JB.184.1.313-317.2002; ZIMMERMAN SB, 1991, J MOL BIOL, V222, P599, DOI 10.1016/0022-2836(91)90499-V	54	15	15	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18293	18303		10.1074/jbc.M115.657551	http://dx.doi.org/10.1074/jbc.M115.657551			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26041781	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000358512100004
J	Le Henaff, C; Mansouri, R; Modrowski, D; Zarka, M; Geoffroy, V; Marty, C; Tarantino, N; Laplantine, E; Marie, PJ				Le Henaff, Carole; Mansouri, Rafik; Modrowski, Dominique; Zarka, Mylene; Geoffroy, Valerie; Marty, Caroline; Tarantino, Nadine; Laplantine, Emmanuel; Marie, Pierre J.			Increased NF-kappa B Activity and Decreased Wnt/beta-Catenin Signaling Mediate Reduced Osteoblast Differentiation and Function in Delta F508 Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-MINERAL DENSITY; OSTEOPENIA; SMURF1; DEGRADATION; INHIBITION; ADULTS; CELLS; PREVALENCE; ACTIVATION; DISEASE	The prevalent human Delta F508 mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) is associated with reduced bone formation and bone loss in mice. The molecular mechanisms by which the Delta F508-CFTR mutation causes alterations in bone formation are poorly known. In this study, we analyzed the osteoblast phenotype in Delta F508-CFTR mice and characterized the signaling mechanisms underlying this phenotype. Ex vivo studies showed that the Delta F508-CFTR mutation negatively impacted the differentiation of bone marrow stromal cells into osteoblasts and the activity of osteoblasts, demonstrating that the Delta F508-CFTR mutation alters both osteoblast differentiation and function. Treatment with a CFTR corrector rescued the abnormal collagen gene expression in Delta F508-CFTR osteoblasts. Mechanistic analysis revealed that NF-kappa B signaling and transcriptional activity were increased in mutant osteoblasts. Functional studies showed that the activation of NF-kappa B transcriptional activity in mutant osteoblasts resulted in increased beta-catenin phosphorylation, reduced osteoblast beta-catenin expression, and altered expression of Wnt/beta-catenin target genes. Pharmacological inhibition of NF-kappa B activity or activation of canonical Wnt signaling rescued Wnt target gene expression and corrected osteoblast differentiation and function in bone marrow stromal cells and osteoblasts from Delta F508-CFTR mice. Overall, the results show that the Delta F508-CFTR mutation impairs osteoblast differentiation and function as a result of overactive NF-kappa B and reduced Wnt/beta-catenin signaling. Moreover, the data indicate that pharmacological inhibition of NF-kappa B or activation of Wnt/beta-catenin signaling can rescue the abnormal osteoblast differentiation and function induced by the prevalent Delta F508-CFTR mutation, suggesting novel therapeutic strategies to correct the osteoblast dysfunctions in cystic fibrosis.	[Le Henaff, Carole; Mansouri, Rafik; Modrowski, Dominique; Zarka, Mylene; Geoffroy, Valerie; Marty, Caroline; Marie, Pierre J.] INSERM, UMR 1132, F-75475 Paris, France; [Le Henaff, Carole; Mansouri, Rafik; Modrowski, Dominique; Zarka, Mylene; Geoffroy, Valerie; Marty, Caroline; Marie, Pierre J.] Univ Paris Diderot, Sorbonne Paris Cite, F-75013 Paris, France; [Tarantino, Nadine; Laplantine, Emmanuel] Inst Pasteur, Lab Signalisat & Pathogenese, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Marie, PJ (corresponding author), Hop Lariboisiere, INSERM, UMR 1132, 2 Rue Ambroise Pare, F-75475 Paris 10, France.	pierre.marie@inserm.fr	Geoffroy, Valerie/P-1521-2014; Modrowski, Dominique/N-6578-2018	Geoffroy, Valerie/0000-0003-3920-7482; Modrowski, Dominique/0000-0003-1103-7127; Zarka, Mylene/0000-0003-3179-4432	Association Prevention and Traitement des Decalcifications, Paris, France; Association Rhumatisme et Travail, Paris, France; Vaincre La Mucoviscidose (VLM) [RF20110600482]	Association Prevention and Traitement des Decalcifications, Paris, France; Association Rhumatisme et Travail, Paris, France; Vaincre La Mucoviscidose (VLM)	This work was supported by grants from the Association Prevention and Traitement des Decalcifications and the Association Rhumatisme et Travail (to P. J. M.), Paris, France, and by Grant RF20110600482 from Vaincre La Mucoviscidose (VLM 2012-2013, to C. L. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Becq F, 2010, DRUGS, V70, P241, DOI 10.2165/11316160-000000000-00000; Bodas M, 2010, DISCOV MED, V9, P346; Borot F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007116; Boyce BF, 2010, ANN NY ACAD SCI, V1192, P367, DOI 10.1111/j.1749-6632.2009.05315.x; Bronckers A, 2010, BONE, V46, P1188, DOI 10.1016/j.bone.2009.12.002; Chang J, 2013, P NATL ACAD SCI USA, V110, P9469, DOI 10.1073/pnas.1300532110; Chang J, 2009, NAT MED, V15, P682, DOI 10.1038/nm.1954; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Conway SP, 2000, THORAX, V55, P798, DOI 10.1136/thorax.55.9.798; Dif F, 2004, BONE, V35, P595, DOI 10.1016/j.bone.2004.05.021; Du Qiang, 2010, For Immunopathol Dis Therap, V1, P155; Edelman A, 2012, ARCH PEDIATRIE, V19, pS13, DOI 10.1016/S0929-693X(12)71101-6; Eferl R, 2004, EMBO J, V23, P2789, DOI 10.1038/sj.emboj.7600282; Guilbault C, 2007, AM J RESP CELL MOL, V36, P1, DOI 10.1165/rcmb.2006-0184TR; Guo R, 2008, J BIOL CHEM, V283, P23084, DOI 10.1074/jbc.M709848200; Haston CK, 2008, AM J RESP CRIT CARE, V177, P309, DOI 10.1164/rccm.200705-659OC; Haworth CS, 1999, THORAX, V54, P961, DOI 10.1136/thx.54.11.961; Hay E, 2005, J BIOL CHEM, V280, P13616, DOI 10.1074/jbc.M411999200; Hunter MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011598; Kaneki H, 2006, J BIOL CHEM, V281, P4326, DOI 10.1074/jbc.M509430200; Krum SA, 2010, NAT REV RHEUMATOL, V6, P607, DOI 10.1038/nrrheum.2010.133; Laplantine E, 2009, EMBO J, V28, P2885, DOI 10.1038/emboj.2009.241; Le Henaff C, 2014, AM J PATHOL, V184, P1132, DOI 10.1016/j.ajpath.2013.12.027; Le Henaff C, 2012, AM J PATHOL, V180, P2068, DOI 10.1016/j.ajpath.2012.01.039; Legroux-Gerot I, 2012, JOINT BONE SPINE, V79, P73, DOI 10.1016/j.jbspin.2011.05.009; Li X, 2002, J BIOL CHEM, V277, P45129, DOI 10.1074/jbc.M205165200; Longo KA, 2002, J BIOL CHEM, V277, P38239, DOI 10.1074/jbc.M206402200; Miraoui H, 2009, J BIOL CHEM, V284, P4897, DOI 10.1074/jbc.M805432200; MODROWSKI D, 1993, CELL TISSUE RES, V271, P499, DOI 10.1007/BF02913733; Novack DV, 2011, CELL RES, V21, P169, DOI 10.1038/cr.2010.159; Paccou J, 2010, CALCIFIED TISSUE INT, V86, P1, DOI 10.1007/s00223-009-9316-9; Pacifici R, 2010, ARCH BIOCHEM BIOPHYS, V503, P41, DOI 10.1016/j.abb.2010.05.027; Paradis J, 2010, J CYST FIBROS, V9, P239, DOI 10.1016/j.jcf.2010.05.001; Park BK, 2007, NAT MED, V13, P62, DOI 10.1038/nm1519; Pashuck TD, 2009, PEDIATR RES, V65, P311, DOI 10.1203/PDR.0b013e3181961e80; Raggatt LJ, 2010, J BIOL CHEM, V285, P25103, DOI 10.1074/jbc.R109.041087; Sermet-Gaudelus I, 2007, AM J RESP CRIT CARE, V175, P951, DOI 10.1164/rccm.200606-776OC; Shead EF, 2007, THORAX, V62, P650, DOI 10.1136/thx.2006.075887; Stalvey MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080098; Tabary O, 2006, CELL SIGNAL, V18, P652, DOI 10.1016/j.cellsig.2005.06.004; Vij N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004664; Weitzmann MN, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/125705; Zhao M, 2004, J BIOL CHEM, V279, P12854, DOI 10.1074/jbc.M313294200; Zhao M, 2003, J BIOL CHEM, V278, P27939, DOI 10.1074/jbc.M304132200	45	28	31	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					18009	18017		10.1074/jbc.M115.646208	http://dx.doi.org/10.1074/jbc.M115.646208			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26060255	hybrid, Green Published			2022-12-28	WOS:000358511700033
J	Liu, S; Nheu, T; Luwor, R; Nicholson, SE; Zhu, HJ				Liu, Sheng; Nheu, Thao; Luwor, Rodney; Nicholson, Sandra E.; Zhu, Hong-Jian			SPSB1, a Novel Negative Regulator of the Transforming Growth Factor-beta Signaling Pathway Targeting the Type II Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASES; E3 UBIQUITIN LIGASE; WILD-TYPE EGFR; TGF-BETA; SOCS BOX; SPRY DOMAIN; IN-VIVO; PSEUDORECEPTOR BAMBI; STRUCTURAL BASIS; CARCINOMA CELLS	Appropriate cellular signaling is essential to control cell proliferation, differentiation, and cell death. Aberrant signaling can have devastating consequences and lead to disease states, including cancer. The transforming growth factor-beta (TGF-beta) signaling pathway is a prominent signaling pathway that has been tightly regulated in normal cells, whereas its deregulation strongly correlates with the progression of human cancers. The regulation of the TGF-beta signaling pathway involves a variety of physiological regulators. Many of these molecules act to alter the activity of Smad proteins. In contrast, the number of molecules known to affect the TGF-beta signaling pathway at the receptor level is relatively low, and there are no known direct modulators for the TGF-beta type II receptor (T beta RII). Here we identify SPSB1 (a Spry domain-containing Socs box protein) as a novel regulator of the TGF-beta signaling pathway. SPSB1 negatively regulates the TGF-beta signaling pathway through its interaction with both endogenous and overexpressed T beta RII (and not T beta RI) via its Spry domain. As such, T beta RII and SPSB1 co-localize on the cell membrane. SPSB1 maintains T beta RII at a low level by enhancing the ubiquitination levels and degradation rates of T beta RII through its Socs box. More importantly, silencing SPSB1 by siRNA results in enhanced TGF-beta signaling and migration and invasion of tumor cells.	[Liu, Sheng; Nheu, Thao; Luwor, Rodney; Zhu, Hong-Jian] Univ Melbourne, Royal Melbourne Hosp, Dept Surg, Parkville, Vic 3050, Australia; [Nicholson, Sandra E.] Univ Melbourne, Royal Melbourne Hosp, Dept Med Biol, Parkville, Vic 3050, Australia; [Liu, Sheng; Nicholson, Sandra E.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia	Royal Melbourne Hospital; University of Melbourne; Royal Melbourne Hospital; University of Melbourne; Walter & Eliza Hall Institute	Zhu, HJ (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Surg RMH, Parkville, Vic 3050, Australia.	hongjian@unimelb.edu.au		Zhu, Hong-Jian/0000-0002-1478-995X; , Sandra/0000-0002-1314-2134; Luwor, Rodney/0000-0002-3020-4245				Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)82259-5; Anders RA, 1998, J BIOL CHEM, V273, P23118, DOI 10.1074/jbc.273.36.23118; Atfi A, 2007, J CELL BIOL, V178, P201, DOI 10.1083/jcb.200612046; Bierie B, 2009, CELL CYCLE, V8, P3319, DOI 10.4161/cc.8.20.9727; Boivin GP, 1996, LAB INVEST, V74, P513; BORDER WA, 1992, NATURE, V360, P361, DOI 10.1038/360361a0; Bottinger EP, 1997, CANCER RES, V57, P5564; Boyle K, 2007, BLOOD, V110, P1466, DOI 10.1182/blood-2007-03-079178; CENTRELLA M, 1995, MOL CELL BIOL, V15, P3273; Centrella M, 1996, J BIOL CHEM, V271, P18616, DOI 10.1074/jbc.271.31.18616; DeBoer WI, 1997, INT J CANCER, V71, P284, DOI 10.1002/(SICI)1097-0215(19970410)71:2<284::AID-IJC25>3.0.CO;2-G; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Filippakopoulos P, 2010, J MOL BIOL, V401, P389, DOI 10.1016/j.jmb.2010.06.017; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Greenhalgh CJ, 2005, J CLIN INVEST, V115, P397, DOI 10.1172/JCI200522710; Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114; Huang HJS, 1997, J BIOL CHEM, V272, P2927, DOI 10.1074/jbc.272.5.2927; Huse M, 1999, CELL, V96, P425, DOI 10.1016/S0092-8674(00)80555-3; Inoue Y, 2008, CANCER SCI, V99, P2107, DOI 10.1111/j.1349-7006.2008.00925.x; Ito T, 2004, J BIOL CHEM, V279, P25326, DOI 10.1074/jbc.M403135200; Jakowlew SB, 2006, CANCER METAST REV, V25, P435, DOI 10.1007/s10555-006-9006-2; Jenkins BJ, 2005, NAT MED, V11, P845, DOI 10.1038/nm1282; Jin W, 2005, P NATL ACAD SCI USA, V102, P16239, DOI 10.1073/pnas.0503137102; Kamato D, 2013, CELL SIGNAL, V25, P2017, DOI 10.1016/j.cellsig.2013.06.001; Kamizono S, 2001, J BIOL CHEM, V276, P12530, DOI 10.1074/jbc.M010074200; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kile BT, 2002, TRENDS BIOCHEM SCI, V27, P235, DOI 10.1016/S0968-0004(02)02085-6; Kleiber ML, 2009, GENOMICS, V93, P358, DOI 10.1016/j.ygeno.2008.11.011; Koli KM, 1997, J BIOL CHEM, V272, P6423, DOI 10.1074/jbc.272.10.6423; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Kuang CZ, 2006, P NATL ACAD SCI USA, V103, P1858, DOI 10.1073/pnas.0508977103; Kuang ZH, 2010, J CELL BIOL, V190, P129, DOI 10.1083/jcb.200912087; Kuang ZH, 2009, J MOL BIOL, V386, P662, DOI 10.1016/j.jmb.2008.12.078; Larsen L, 2002, APMIS, V110, P833, DOI 10.1034/j.1600-0463.2002.1101201.x; Lewis RS, 2011, J IMMUNOL, V187, P3798, DOI 10.4049/jimmunol.1002993; Liu F, 2006, CYTOKINE GROWTH F R, V17, P9, DOI 10.1016/j.cytogfr.2005.09.010; Liu W, 2006, EMBO J, V25, P1646, DOI 10.1038/sj.emboj.7601057; Luwor RB, 2004, ONCOGENE, V23, P6095, DOI 10.1038/sj.onc.1207870; Luwor RB, 2001, CANCER RES, V61, P5355; Luwor RB, 2011, GROWTH FACTORS, V29, P211, DOI 10.3109/08977194.2011.615311; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2000, GENE DEV, V14, P627; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Masters SL, 2006, NAT STRUCT MOL BIOL, V13, P77, DOI 10.1038/nsmb1034; Masters SL, 2005, MOL CELL BIOL, V25, P5639, DOI 10.1128/MCB.25.13.5639-5647.2005; Matsuura I, 2004, NATURE, V430, P226, DOI 10.1038/nature02650; MIYAZONO K, 1988, J BIOL CHEM, V263, P6407; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Nishiya T, 2011, J BIOL CHEM, V286, P9009, DOI 10.1074/jbc.M110.190678; Onichtchouk D, 1999, NATURE, V401, P480, DOI 10.1038/46794; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Ponting C, 1997, TRENDS BIOCHEM SCI, V22, P193, DOI 10.1016/S0968-0004(97)01049-9; Rahimi RA, 2007, J CELL BIOCHEM, V102, P593, DOI 10.1002/jcb.21501; Razani B, 2001, J BIOL CHEM, V276, P6727, DOI 10.1074/jbc.M008340200; Rhodes DA, 2005, IMMUNOLOGY, V116, P411, DOI 10.1111/j.1365-2567.2005.02248.x; Sekiya T, 2004, BIOCHEM BIOPH RES CO, V320, P680, DOI 10.1016/j.bbrc.2004.06.017; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Stenvers KL, 2003, MOL CELL BIOL, V23, P4371, DOI 10.1128/MCB.23.12.4371-4385.2003; Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771; Su Y, 2007, FASEB J, V21, P682, DOI 10.1096/fj.06-6246com; Suzuki C, 2002, J BIOL CHEM, V277, P39919, DOI 10.1074/jbc.M201901200; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; Wakefield LM, 1989, GROWTH FACTORS, V1, P203, DOI 10.3109/08977198908997997; Wang DK, 2005, J BIOL CHEM, V280, P16393, DOI 10.1074/jbc.M413897200; Wang DK, 2004, BIOCHEM BIOPH RES CO, V313, P320, DOI 10.1016/j.bbrc.2003.11.124; Wang DK, 2002, J BIOL CHEM, V277, P36216, DOI 10.1074/jbc.M205111200; Watanabe Y, 2010, MOL CELL, V37, P123, DOI 10.1016/j.molcel.2009.10.028; Wild R, 2006, MOL CANCER THER, V5, P104, DOI 10.1158/1535-7163.MCT-05-0259; Woo JS, 2006, MOL CELL, V24, P967, DOI 10.1016/j.molcel.2006.11.009; Wrana JL, 2000, CELL, V100, P189, DOI 10.1016/S0092-8674(00)81556-1; Xu XL, 2000, ONCOGENE, V19, P1868, DOI 10.1038/sj.onc.1203504; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0; Yan XH, 2009, J BIOL CHEM, V284, P30097, DOI 10.1074/jbc.M109.049304; Zhang JG, 2001, P NATL ACAD SCI USA, V98, P13261, DOI 10.1073/pnas.231486498; Zhu HJ, 2003, GROWTH FACTORS, V21, P15, DOI 10.1080/0897719031000096424; Zhu HJ, 1999, J BIOL CHEM, V274, P11773, DOI 10.1074/jbc.274.17.11773; Zhu HJ, 1999, J BIOL CHEM, V274, P32258, DOI 10.1074/jbc.274.45.32258; Zhu Hong-Jian, 2001, Molecular Cell Biology Research Communications, V4, P321, DOI 10.1006/mcbr.2001.0301; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	81	23	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					17894	17908		10.1074/jbc.M114.607184	http://dx.doi.org/10.1074/jbc.M114.607184			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26032413	Green Published, hybrid			2022-12-28	WOS:000358511700024
J	Wu, Y; Koharudin, LMI; Mehrens, J; DeLucia, M; Byeon, CH; Byeon, IJL; Calero, G; Ahn, J; Gronenborn, AM				Wu, Ying; Koharudin, Leonardus M. I.; Mehrens, Jennifer; DeLucia, Maria; Byeon, Chang-Hyeok; Byeon, In-Ja L.; Calero, Guillermo; Ahn, Jinwoo; Gronenborn, Angela M.			Structural Basis of Clade-specific Engagement of SAMHD1 (Sterile alpha Motif and Histidine/Aspartate-containing Protein 1) Restriction Factors by Lentiviral Viral Protein X (Vpx) Virulence Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 INFECTION; ACCESSORY PROTEINS; IMMUNE EVASION; INHIBITOR; RELEASE; MX2	Sterile alpha motif (SAM) and histidine/aspartate (HD)-containing protein 1 (SAMHD1) restricts human/simian immunodeficiency virus infection in certain cell types and is counteracted by the virulence factor Vpx. Current evidence indicates that Vpx recruits SAMHD1 to the Cullin4-Ring Finger E3 ubiquitin ligase (CRL4) by facilitating an interaction between SAMHD1 and the substrate receptor DDB1- and Cullin4-associated factor 1 (DCAF1), thereby targeting SAMHD1 for proteasome-dependent down-regulation. Host-pathogen co-evolution and positive selection at the interfaces of host-pathogen complexes are associated with sequence divergence and varying functional consequences. Two alternative interaction interfaces are used by SAMHD1 and Vpx: the SAMHD1 N-terminal tail and the adjacent SAM domain or the C-terminal tail proceeding the HD domain are targeted by different Vpx variants in a unique fashion. In contrast, the C-terminal WD40 domain of DCAF1 interfaces similarly with the two above complexes. Comprehensive biochemical and structural biology approaches permitted us to delineate details of clade-specific recognition of SAMHD1 by lentiviral Vpx proteins. We show that not only the SAM domain but also the N-terminal tail engages in the DCAF1-Vpx interaction. Furthermore, we show that changing the single Ser-52 in human SAMHD1 to Phe, the residue found in SAMHD1 of Red-capped monkey and Mandrill, allows it to be recognized by Vpx proteins of simian viruses infecting those primate species, which normally does not target wild type human SAMHD1 for degradation.	[Ahn, Jinwoo] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Med, Pittsburgh Ctr HIV Prot Interact, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ahn, J (corresponding author), Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA.	jia12@pitt.edu; amg100@pitt.edu	Regan, Clinton/E-6250-2012	Gronenborn, Angela M/0000-0001-9072-3525	National Institutes of Health [P50GM082251]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082251] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P50GM082251 (to A. M. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahn J, 2012, J BIOL CHEM, V287, P12550, DOI 10.1074/jbc.M112.340711; Berger A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002425; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blanchet FP, 2012, CURR HIV RES, V10, P307, DOI 10.2174/157016212800792441; Bricogne G, 2011, AUTOBUSTER; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLucia M, 2013, J BIOL CHEM, V288, P19116, DOI 10.1074/jbc.M113.469007; Emerman M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000301; Feng YQ, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00450; Fregoso OI, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003496; Goujon C, 2013, NATURE, V502, P559, DOI 10.1038/nature12542; Harris RS, 2012, J BIOL CHEM, V287, P40875, DOI 10.1074/jbc.R112.416925; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Kane M, 2013, NATURE, V502, P563, DOI 10.1038/nature12653; Kirchhoff F, 2010, CELL HOST MICROBE, V8, P55, DOI 10.1016/j.chom.2010.06.004; Laguette N, 2012, CELL HOST MICROBE, V11, P205, DOI 10.1016/j.chom.2012.01.007; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lim ES, 2012, CELL HOST MICROBE, V11, P194, DOI 10.1016/j.chom.2012.01.004; Liu ZL, 2013, CELL HOST MICROBE, V14, P398, DOI 10.1016/j.chom.2013.08.015; Luban J, 2012, CELL HOST MICROBE, V12, P408, DOI 10.1016/j.chom.2012.10.002; Mashiba M, 2013, VIRUSES-BASEL, V5, P1, DOI 10.3390/v5010001; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Romani B, 2012, CURR OPIN VIROL, V2, P755, DOI 10.1016/j.coviro.2012.09.010; Sawyer SL, 2005, P NATL ACAD SCI USA, V102, P2832, DOI 10.1073/pnas.0409853102; Sawyer SL, 2004, PLOS BIOL, V2, P1278, DOI 10.1371/journal.pbio.0020275; Schwefel D, 2014, NATURE, V505, P234, DOI 10.1038/nature12815; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Strebel K, 2013, CURR OPIN VIROL, V3, P692, DOI 10.1016/j.coviro.2013.08.004; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Wei W, 2014, J VIROL, V88, P583, DOI 10.1128/JVI.02866-13; Zhang CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037477; Zheng YH, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-112	36	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					17935	17945		10.1074/jbc.M115.665513	http://dx.doi.org/10.1074/jbc.M115.665513			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26045556	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000358511700027
J	Jonna, VR; Crona, M; Rofougaran, R; Lundin, D; Johansson, S; Brannstrom, K; Sjoberg, BM; Hofer, A				Jonna, Venkateswara Rao; Crona, Mikael; Rofougaran, Reza; Lundin, Daniel; Johansson, Samuel; Brannstrom, Kristoffer; Sjoberg, Britt-Marie; Hofer, Anders			Diversity in Overall Activity Regulation of Ribonucleotide Reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALLOSTERIC REGULATION; DIPHOSPHATE REDUCTASE; ESCHERICHIA-COLI; INDUCED OLIGOMERIZATION; SUBSTRATE-SPECIFICITY; TRYPANOSOMA-BRUCEI; CATALYTIC ACTIVITY; EFFECTOR-BINDING; LARGE SUBUNIT; CALF THYMUS	Ribonucleotide reductase (RNR) catalyzes the reduction of ribonucleotides to the corresponding deoxyribonucleotides, which are used as building blocks for DNA replication and repair. This process is tightly regulated via two allosteric sites, the specificity site (s-site) and the overall activity site (a-site). The a-site resides in an N-terminal ATP cone domain that binds dATP or ATP and functions as an on/off switch, whereas the composite s-site binds ATP, dATP, dTTP, or dGTP and determines which substrate to reduce. There are three classes of RNRs, and class I RNRs consist of different combinations of alpha and beta subunits. In eukaryotic and Escherichia coli class I RNRs, dATP inhibits enzyme activity through the formation of inactive alpha(6) and alpha(4)beta(4) complexes, respectively. Here we show that the Pseudomonas aeruginosa class IRNR has a duplicated ATP cone domain and represents a third mechanism of overall activity regulation. Each alpha polypeptide binds three dATP molecules, and the N-terminal ATP cone is critical for binding two of the dATPs because a truncated protein lacking this cone could only bind dATP to its s-site. ATP activates the enzyme solely by preventing dATP from binding. The dATP-induced inactive form is an alpha(4) complex, which can interact with beta(2) to form a non-productive alpha(4)beta(2) complex. Other allosteric effectors induce a mixture of alpha(2) and alpha(4) forms, with the former being able to interact with beta(2) to form active alpha(2)beta(2) complexes. The unique features of the P. aeruginosa RNR are interesting both from evolutionary and drug discovery perspectives.	[Jonna, Venkateswara Rao; Rofougaran, Reza; Johansson, Samuel; Brannstrom, Kristoffer; Hofer, Anders] Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden; [Crona, Mikael; Lundin, Daniel; Sjoberg, Britt-Marie] Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden	Umea University; Stockholm University	Hofer, A (corresponding author), Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden.	anders.hofer@medchem.umu.se	Brännström, Kristoffer/AAC-1204-2020	Crona, Mikael/0000-0002-6420-6097; Hofer, Anders/0000-0003-2890-2957; Lundin, Daniel/0000-0002-8779-6464; Sjoberg, Britt-Marie/0000-0001-5953-3360	Kempe Foundation; Carl Trygger's Foundation; Swedish Cancer Foundation; Swedish Research Council; Wenner-Gren Foundations	Kempe Foundation; Carl Trygger's Foundation; Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Wenner-Gren Foundations	This work was supported by grants form the Kempe Foundation (to A. H.), Carl Trygger's Foundation (to A. H. and B. M. S.), the Swedish Cancer Foundation (to B. M. S.), the Swedish Research Council (to A. H. and B. M. S.), and the Wenner-Gren Foundations (to B. M. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Ando N, 2011, P NATL ACAD SCI USA, V108, P21046, DOI 10.1073/pnas.1112715108; Aravind L, 2000, J MOL MICROB BIOTECH, V2, P191; AVERETT DR, 1983, J BIOL CHEM, V258, P9831; Aye Y, 2011, P NATL ACAD SCI USA, V108, P9815, DOI 10.1073/pnas.1013274108; BERGLUND O, 1972, J BIOL CHEM, V247, P7276; BERGLUND O, 1972, EUR J BIOCHEM, V28, P492, DOI 10.1111/j.1432-1033.1972.tb01936.x; BROWN NC, 1969, J MOL BIOL, V46, P25, DOI 10.1016/0022-2836(69)90055-2; BROWN NC, 1969, J MOL BIOL, V46, P39, DOI 10.1016/0022-2836(69)90056-4; Crona M, 2013, J BIOL CHEM, V288, P8198, DOI 10.1074/jbc.M112.442434; Domkin V, 2002, J BIOL CHEM, V277, P18574, DOI 10.1074/jbc.M201553200; Eliasson R, 1999, J BIOL CHEM, V274, P7182, DOI 10.1074/jbc.274.11.7182; ELIASSON R, 1994, J BIOL CHEM, V269, P26052; ERIKSSON S, 1979, BIOCHEMISTRY-US, V18, P2948, DOI 10.1021/bi00581a005; ERIKSSON S, 1981, J BIOL CHEM, V256, P184; Fairman JW, 2011, NAT STRUCT MOL BIOL, V18, P316, DOI 10.1038/nsmb.2007; Hendricks SP, 1998, J BIOL CHEM, V273, P29512, DOI 10.1074/jbc.273.45.29512; Hendricks SP, 1997, J BIOL CHEM, V272, P2861, DOI 10.1074/jbc.272.5.2861; Hofer A, 1997, P NATL ACAD SCI USA, V94, P6959, DOI 10.1073/pnas.94.13.6959; Hofer A, 1998, J BIOL CHEM, V273, P34098, DOI 10.1074/jbc.273.51.34098; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; Kashlan OB, 2002, BIOCHEMISTRY-US, V41, P462, DOI 10.1021/bi011653a; Lundin Daniel, 2015, Life-Basel, V5, P604, DOI 10.3390/life5010604; Lundin D, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-383; Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; ORMO M, 1990, ANAL BIOCHEM, V189, P138, DOI 10.1016/0003-2697(90)90059-I; Reichard P, 2000, J BIOL CHEM, V275, P33021, DOI 10.1074/jbc.M005337200; Riera J, 1997, P NATL ACAD SCI USA, V94, P475, DOI 10.1073/pnas.94.2.475; Rofougaran R, 2006, J BIOL CHEM, V281, P27705, DOI 10.1074/jbc.M605573200; Rofougaran R, 2008, J BIOL CHEM, V283, P35310, DOI 10.1074/jbc.M806738200; Roshick C, 2000, J BIOL CHEM, V275, P38111, DOI 10.1074/jbc.M006367200; THELANDER L, 1980, J BIOL CHEM, V255, P7426; Tholander F, 2012, P NATL ACAD SCI USA, V109, P9798, DOI 10.1073/pnas.1113051109; Torrents E, 2000, J BIOL CHEM, V275, P2463, DOI 10.1074/jbc.275.4.2463; Torrents E, 2006, J BIOL CHEM, V281, P25287, DOI 10.1074/jbc.M601794200; Wang J, 2009, BIOCHEMISTRY-US, V48, P11612, DOI 10.1021/bi901588z; Zimanyi CM, 2012, STRUCTURE, V20, P1374, DOI 10.1016/j.str.2012.05.009	37	29	29	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17339	17348		10.1074/jbc.M115.649624	http://dx.doi.org/10.1074/jbc.M115.649624			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	25971975	Green Published, hybrid			2022-12-28	WOS:000357730900029
J	Li, S; Deng, ZX; Fu, JY; Xu, CY; Xin, GW; Wu, ZG; Luo, J; Wang, G; Zhang, SL; Zhang, BY; Zou, FD; Jiang, Q; Zhang, CM				Li, Si; Deng, Zhaoxuan; Fu, Jingyan; Xu, Caiyue; Xin, Guangwei; Wu, Zhige; Luo, Jia; Wang, Gang; Zhang, Shuli; Zhang, Boyan; Zou, Fangdong; Jiang, Qing; Zhang, Chuanmao			Spatial Compartmentalization Specializes the Function of Aurora A and Aurora B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOTIC SPINDLE; KINASE AURORA; KINESIN EG5; HUMAN-CELLS; PROTEIN; PHOSPHORYLATION; CENTROSOME; ACTIVATION; LOCALIZATION; KINETOCHORE	Aurora kinase A and B share great similarity in sequences, structures, and phosphorylation motif, yet they show different localizations and play distinct crucial roles. The factors that determine such differences are largely unknown. Here we targeted Aurora A to the localization of Aurora B and found that Aurora A phosphorylates the substrate of Aurora B and substitutes its function in spindle checkpoint. In return, the centrosome targeting of Aurora B substitutes the function of Aurora A in the mitotic entry. Expressing the chimera proteins of the Auroras with exchanged N termini in cells indicates that the divergent N termini are also important for their spatiotemporal localizations and functions. Collectively, we demonstrate that functional divergence of Aurora kinases is determined by spatial compartmentalization, and their divergent N termini also contribute to their spatial and functional differentiation.	[Li, Si; Zou, Fangdong] Sichuan Univ, Coll Life Sci, Minist Educ, Key Lab Bioresources & Ecoenvironm, Chengdu 610064, Sichuan, Peoples R China; [Li, Si; Deng, Zhaoxuan; Fu, Jingyan; Xu, Caiyue; Xin, Guangwei; Wu, Zhige; Luo, Jia; Wang, Gang; Zhang, Shuli; Zhang, Boyan; Jiang, Qing; Zhang, Chuanmao] Peking Univ, Coll Life Sci, Minist Educ, Key Lab Cell Proliferat & Differentiat, Beijing 100871, Peoples R China; [Li, Si; Deng, Zhaoxuan; Fu, Jingyan; Xu, Caiyue; Xin, Guangwei; Wu, Zhige; Luo, Jia; Wang, Gang; Zhang, Shuli; Zhang, Boyan; Jiang, Qing; Zhang, Chuanmao] Peking Univ, Coll Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100871, Peoples R China	Sichuan University; Peking University; Peking University	Zou, FD (corresponding author), Sichuan Univ, Coll Life Sci, Minist Educ, Key Lab Bioresources & Ecoenvironm, Chengdu 610064, Sichuan, Peoples R China.	fundzou@scu.edu.cn; jiangqing@pku.edu.cn; zhangcm@pku.edu.cn	Xu, Caiyue/GQZ-4365-2022; Wang, Gang/Q-7267-2019	Zou, Fangdong/0000-0002-2133-4320; Fu, Jingyan/0000-0002-5896-8132; Zhang, Boyan/0000-0001-7112-9870; Xu, Caiyue/0000-0003-4056-5586; Wang, Gang/0000-0002-0297-6467	State Key Basic Research and Development Plan of the Ministry of Science and Technology of China [2010CB833705, 2014CB138402]; National Natural Science Foundation of China [31430051, 31371365, 91313302, 31030044]	State Key Basic Research and Development Plan of the Ministry of Science and Technology of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by State Key Basic Research and Development Plan of the Ministry of Science and Technology of China Grants 2010CB833705 and 2014CB138402 and the National Natural Science Foundation of China Grants 31430051, 31371365, 91313302, and 31030044. The authors declare that they have no conflicts of interest with the contents of this article.	Abe Y, 2010, J CELL SCI, V123, P3978, DOI 10.1242/jcs.076315; Alexander J, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001796; Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Bian ML, 2010, SCI CHINA LIFE SCI, V53, P1322, DOI 10.1007/s11427-010-4086-1; Brown JR, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-39; Capra EJ, 2012, CELL, V150, P222, DOI 10.1016/j.cell.2012.05.033; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; Carmena M, 2009, CURR OPIN CELL BIOL, V21, P796, DOI 10.1016/j.ceb.2009.09.008; DeBonis S, 2004, MOL CANCER THER, V3, P1079; Dutertre S, 2004, J CELL SCI, V117, P2523, DOI 10.1242/jcs.01108; Eyers PA, 2003, CURR BIOL, V13, P691, DOI 10.1016/S0960-9822(03)00166-0; Fu JY, 2007, MOL CANCER RES, V5, P1, DOI 10.1158/1541-7786.MCR-06-0208; Fu JY, 2009, P NATL ACAD SCI USA, V106, P6939, DOI 10.1073/pnas.0900833106; Fu WX, 2013, P NATL ACAD SCI USA, V110, P15295, DOI 10.1073/pnas.1312382110; Fu WX, 2010, J CELL SCI, V123, P3645, DOI 10.1242/jcs.075911; Giet R, 1999, J BIOL CHEM, V274, P15005, DOI 10.1074/jbc.274.21.15005; Giet R, 2001, J CELL SCI, V114, P2095; Glover DM, 2003, MOL CELL, V12, P797, DOI 10.1016/S1097-2765(03)00405-2; Hans F, 2009, MOL BIOL CELL, V20, P3491, DOI 10.1091/mbc.E09-05-0370; Hebras C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045431; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Hochegger H, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120185; Hutterer A, 2006, DEV CELL, V11, P147, DOI 10.1016/j.devcel.2006.06.002; Jang CY, 2009, J CELL SCI, V122, P1334, DOI 10.1242/jcs.044321; Kim Y, 2010, CELL, V142, P444, DOI 10.1016/j.cell.2010.06.039; Knowlton AL, 2009, CURR BIOL, V19, P758, DOI 10.1016/j.cub.2009.03.018; Lampson MA, 2011, TRENDS CELL BIOL, V21, P133, DOI 10.1016/j.tcb.2010.10.007; Li H, 2008, EUKARYOT CELL, V7, P894, DOI 10.1128/EC.00422-07; Li J, 1997, P NATL ACAD SCI USA, V94, P502, DOI 10.1073/pnas.94.2.502; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; Marumoto T, 2003, J BIOL CHEM, V278, P51786, DOI 10.1074/jbc.M306275200; Przewloka MR, 2009, ANNU REV GENET, V43, P439, DOI 10.1146/annurev-genet-102108-134310; Rausell A, 2010, P NATL ACAD SCI USA, V107, P1995, DOI 10.1073/pnas.0908044107; Reboutier D, 2013, J CELL BIOL, V201, P65, DOI 10.1083/jcb.201210060; Santaguida S, 2011, EMBO J, V30, P1508, DOI 10.1038/emboj.2011.70; Saurin AT, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1319; Scrittori L, 2005, MOL BIOL CELL, V16, P292, DOI 10.1091/mbc.E04-06-0447; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031; Skoufias DA, 2006, J BIOL CHEM, V281, P17559, DOI 10.1074/jbc.M511735200; Song SJ, 2009, CANCER RES, V69, P2314, DOI 10.1158/0008-5472.CAN-08-3984; Sonnen KF, 2013, J CELL SCI, V126, P3223, DOI 10.1242/jcs.129502; Stenoien DL, 2003, CELL MOTIL CYTOSKEL, V55, P134, DOI 10.1002/cm.10120; Tanenbaum ME, 2011, CURR BIOL, V21, P1356, DOI 10.1016/j.cub.2011.07.017; Wang EX, 2011, J CELL BIOL, V194, P538, DOI 10.1083/jcb.201103044; Wang G, 2014, J CELL SCI, V127, P4111, DOI 10.1242/jcs.151753; Zhao ZS, 2005, MOL CELL, V20, P237, DOI 10.1016/j.molcel.2005.08.035	48	35	36	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17546	17558		10.1074/jbc.M115.652453	http://dx.doi.org/10.1074/jbc.M115.652453			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	25987563	hybrid, Green Published			2022-12-28	WOS:000357730900045
J	Sekine, Y; Togi, S; Muromoto, R; Kon, S; Kitai, Y; Yoshimura, A; Oritani, K; Matsuda, T				Sekine, Yuichi; Togi, Sumihito; Muromoto, Ryuta; Kon, Shigeyuki; Kitai, Yuichi; Yoshimura, Akihiko; Oritani, Kenji; Matsuda, Tadashi			STAP-2 Protein Expression in B16F10 Melanoma Cells Positively Regulates Protein Levels of Tyrosinase, Which Determines Organs to Infiltrate in the Body	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSDUCING ADAPTER PROTEIN-2; OCULOCUTANEOUS ALBINISM; MELANOGENIC PROTEINS; IMPROVED SURVIVAL; MURINE MELANOMA; PIVOTAL ROLE; IN-VITRO; CHEMOKINE; GENE; ACTIVATION	Melanoma is the most serious type of skin cancer, with a highly metastatic phenotype. In this report, we show that signal transducing adaptor protein 2 (STAP-2) is involved in cell migration, proliferation, and melanogenesis as well as chemokine receptor expression and tumorigenesis in B16F10 melanoma cells. This was evident in mice injected with STAP-2 shRNA (shSTAP-2)-expressing B16F10 cells, which infiltrated organs in a completely different pattern from the original cells, showing massive colonization in the liver, kidney, and neck but not in the lung. The most important finding was that STAP-2 expression determined tyrosinase protein content. STAP-2 colocalized with tyrosinase in lysosomes and protected tyrosinase from protein degradation. It is noteworthy that B16F10 cells with knocked down tyrosinase showed similar cell characteristics as shSTAP-2 cells. These results indicated that tyrosinase contributed to some cellular events beyond melanogenesis. Taken together, one possibility is that STAP-2 positively regulates the protein levels of tyrosinase, which determines tumor invasion via controlling chemokine receptor expression.	[Sekine, Yuichi; Togi, Sumihito; Muromoto, Ryuta; Kon, Shigeyuki; Kitai, Yuichi; Matsuda, Tadashi] Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Immunol, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Yoshimura, Akihiko] Keio Univ, Dept Microbiol & Immunol, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan; [Oritani, Kenji] Osaka Univ, Grad Sch Med, Dept Hematol & Oncol, Suita, Osaka 5650871, Japan	Hokkaido University; Keio University; Osaka University	Matsuda, T (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Immunol, Kita Ku, Kita 12 Nishi 6, Sapporo, Hokkaido 0600812, Japan.	tmatsuda@pharm.hokudai.ac.jp	Yoshimura, Akihiko/K-5515-2013; Matsuda, Tadashi/A-3835-2012; Muromoto, Ryuta/E-4203-2012; Togi, Sumihito/ABH-6734-2020; Sekine, Yuichi/S-8813-2019	Matsuda, Tadashi/0000-0002-3089-3757; Muromoto, Ryuta/0000-0002-7474-493X; Sekine, Yuichi/0000-0002-2861-603X; Togi, Sumihito/0000-0002-3189-8111	Astellas Foundation for Research on Metabolic Disorders; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Astellas Foundation for Research on Metabolic Disorders; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by the Astellas Foundation for Research on Metabolic Disorders and a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Aksan I, 1998, MOL CELL BIOL, V18, P6930, DOI 10.1128/MCB.18.12.6930; Ando H, 1999, J LIPID RES, V40, P1312; Avihingsanon Y, 2006, KIDNEY INT, V69, P747, DOI 10.1038/sj.ki.5000132; Belperio JA, 2000, J LEUKOCYTE BIOL, V68, P1; Benedito E, 1997, BBA-GEN SUBJECTS, V1336, P59, DOI 10.1016/S0304-4165(97)00011-1; Bertolotto C, 1998, ONCOGENE, V16, P1665, DOI 10.1038/sj.onc.1201685; Bertolotto C, 1998, MOL CELL BIOL, V18, P694, DOI 10.1128/MCB.18.2.694; Bertolotto C, 1998, J CELL BIOL, V142, P827, DOI 10.1083/jcb.142.3.827; Boissy RE, 1996, AM J HUM GENET, V58, P1145; Busca R, 2000, EMBO J, V19, P2900, DOI 10.1093/emboj/19.12.2900; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Erhardt A, 2011, J IMMUNOL, V186, P5284, DOI 10.4049/jimmunol.1003750; FIDLER IJ, 1975, CANCER RES, V35, P218; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; HALABAN R, 1988, P NATL ACAD SCI USA, V85, P7241, DOI 10.1073/pnas.85.19.7241; HEARING VJ, 1992, PIGM CELL RES, V5, P264, DOI 10.1111/j.1600-0749.1992.tb00547.x; Hearing VJ, 1999, J INVEST DERM SYMP P, V4, P24, DOI 10.1038/sj.jidsp.5640176; Ikeda O, 2007, BIOCHEM BIOPH RES CO, V358, P931, DOI 10.1016/j.bbrc.2007.05.030; Kang JS, 2003, CANCER IMMUNOL IMMUN, V52, P693, DOI 10.1007/s00262-003-0407-6; Kawada K, 2004, CANCER RES, V64, P4010, DOI 10.1158/0008-5472.CAN-03-1757; King RA, 2003, HUM GENET, V113, P502, DOI 10.1007/s00439-003-0998-1; Kuhnelt-Leddihn L, 2012, ARCH DERMATOL RES, V304, P185, DOI 10.1007/s00403-012-1222-8; Minoguchi M, 2003, J BIOL CHEM, V278, P11182, DOI 10.1074/jbc.M211230200; MISHIMA Y, 1994, PIGM CELL RES, V7, P376, DOI 10.1111/j.1600-0749.1994.tb00065.x; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; Murakami T, 2002, CANCER RES, V62, P7328; Oetting WS, 2000, PIGM CELL RES, V13, P320, DOI 10.1034/j.1600-0749.2000.130503.x; Oetting WS, 1999, HUM MUTAT, V13, P99, DOI 10.1002/(SICI)1098-1004(1999)13:2<99::AID-HUMU2>3.3.CO;2-3; Panzer U, 2007, J AM SOC NEPHROL, V18, P2071, DOI 10.1681/ASN.2006111237; Panzer U, 2006, J AM SOC NEPHROL, V17, P454, DOI 10.1681/ASN.2005040364; Park H. Y., 2012, FITZPATRICKS DERMATO, P765; Riley PA, 2003, PIGM CELL RES, V16, P548, DOI 10.1034/j.1600-0749.2003.00069.x; Romagnani P, 1999, J AM SOC NEPHROL, V10, P2518; Sahin H, 2012, HEPATOLOGY, V55, P1610, DOI 10.1002/hep.25545; Santodomingo-Garzon T, 2009, HEPATOLOGY, V49, P1267, DOI 10.1002/hep.22761; Segerer S, 2004, AM J PATHOL, V164, P635, DOI 10.1016/S0002-9440(10)63152-5; Sekine Y, 2006, J IMMUNOL, V176, P380, DOI 10.4049/jimmunol.176.1.380; Sekine Y, 2005, J BIOL CHEM, V280, P8188, DOI 10.1074/jbc.M411692200; Sekine Y, 2007, J IMMUNOL, V179, P2397, DOI 10.4049/jimmunol.179.4.2397; Sekine Y, 2014, J IMMUNOL, V192, P3488, DOI 10.4049/jimmunol.1300886; Sekine Y, 2012, J IMMUNOL, V188, P6194, DOI 10.4049/jimmunol.1103467; Sekine Y, 2009, J IMMUNOL, V183, P7966, DOI 10.4049/jimmunol.0902096; Shimada Y, 2009, J PERIODONTOL, V80, P317, DOI [10.1902/jop.2009.080409, 10.1902/jop.2009.080409 ]; Tachibana M, 1996, NAT GENET, V14, P50, DOI 10.1038/ng0996-50; TOMITA Y, 1994, ARCH DERMATOL, V130, P355, DOI 10.1001/archderm.130.3.355; Uong A, 2010, J CELL PHYSIOL, V222, P38, DOI 10.1002/jcp.21935; Wiley HE, 2001, J NATL CANCER I, V93, P1638, DOI 10.1093/jnci/93.21.1638; WINDER A, 1994, CELL MOL BIOL RES, V40, P613; WONG G, 1975, NATURE, V255, P644, DOI 10.1038/255644a0; Wu M, 2000, GENE DEV, V14, P301; WULF E, 1979, P NATL ACAD SCI USA, V76, P4498, DOI 10.1073/pnas.76.9.4498; Yamaguchi Y, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a017046; Yamamoto T, 2003, BIOCHEM BIOPH RES CO, V306, P767, DOI 10.1016/S0006-291X(03)01042-8; YOKOYAMA K, 1994, BBA-GENE STRUCT EXPR, V1217, P317, DOI 10.1016/0167-4781(94)90292-5; Zeremski M, 2007, J VIRAL HEPATITIS, V14, P675, DOI 10.1111/j.1365-2893.2006.00838.x	56	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17462	17473		10.1074/jbc.M115.658575	http://dx.doi.org/10.1074/jbc.M115.658575			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26023234	Green Published, hybrid			2022-12-28	WOS:000357730900038
J	Chan, KL; Pillon, NJ; Sivaloganathan, DM; Costford, SR; Liu, Z; Theret, M; Chazaud, B; Klip, A				Chan, Kenny L.; Pillon, Nicolas J.; Sivaloganathan, Darshan M.; Costford, Sheila R.; Liu, Zhi; Theret, Marine; Chazaud, Benedicte; Klip, Amira			Palmitoleate Reverses High Fat-induced Proinflammatory Macrophage Polarization via AMP-activated Protein Kinase (AMPK)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; SKELETAL-MUSCLE; ADIPOSE-TISSUE; INSULIN-RESISTANCE; ACID; INFLAMMATION; OBESITY; PROMOTES; MICE; ACCUMULATION	A rise in tissue-embedded macrophages displaying "M1-like" proinflammatory polarization is a hallmark of metabolic inflammation during a high fat diet or obesity. Here we show that bone marrow-derived macrophages (BMDM) from high fat-fed mice retain a memory of their dietary environment in vivo (displaying the elevated proinflammatory genes Cxcl1, Il6, Tnf, Nos2) despite 7-day differentiation and proliferation ex vivo. Notably, 6-h incubation with palmitoleate (PO) reversed the proinflammatory gene expression and cytokine secretion seen in BMDM from high fat-fed mice. BMDM from low fat-fed mice exposed to palmitate (PA) for 18 h ex vivo also showed elevated expression of proinflammatory genes (Cxcl1, Il6, Tnf, Nos2, and Il12b) associated with M1 polarization. Conversely, PO treatment increased anti-inflammatory genes (Mrc1, Tgfb1, Il10, Mgl2) and oxidative metabolism, characteristic of M2 macrophages. Therefore, saturated and unsaturated fatty acids bring about opposite macrophage polarization states. Coincubation of BMDM with both fatty acids counteracted the PA-induced Nos2 expression in a PO dose-dependent fashion. PO also prevented PA-induced I kappa B alpha degradation, RelA nuclear translocation, NO production, and cytokine secretion. Mechanistically, PO exerted its anti-inflammatory function through AMP-activated protein kinase as AMP kinase knockout or inhibition by Compound C offset the PO-dependent prevention of PA-induced inflammation. These results demonstrate a nutritional memory of BMDM ex vivo, highlight the plasticity of BMDM polarization in response to saturated and unsaturated fatty acids, and identify the potential to reverse diet-and saturated fat-induced M1-like polarization by administering palmitoleate. These findings could have applicability to reverse obesity-linked inflammation in metabolically relevant tissues.	[Chan, Kenny L.; Pillon, Nicolas J.; Sivaloganathan, Darshan M.; Costford, Sheila R.; Liu, Zhi; Klip, Amira] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 0A4, Canada; [Chan, Kenny L.; Klip, Amira] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Theret, Marine; Chazaud, Benedicte] Univ Lyon 1, Ctr Genet & Physiol Mol & Cellulaire, F-69622 Villeurbanne, France	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Klip, A (corresponding author), Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 0A4, Canada.	amira@sickkids.ca	Pillon, Nicolas J/M-4170-2019; Theret, Marine/AAT-2743-2021; Chazaud, Benedicte/N-9291-2017	Pillon, Nicolas J/0000-0003-1107-9490; Theret, Marine/0000-0002-8059-8756; Chazaud, Benedicte/0000-0002-1262-502X; Sivaloganathan, Darshan/0000-0003-3011-2997	Canadian Diabetes Association [OG-3-12-3838-AK]; Canadian Institutes of Health Research [MOP-130493]; Fondation pour la Recherche Medicale Grant Equipe FRM [DEQ20140329495]; Banting and Best Diabetes Centre (BBDC); Research Training Centre from the Hospital for Sick Children; BBDC; SickKids Summer Research Program (SSuRe); French Ministry of Research; Association Francaise contre les Myopathies	Canadian Diabetes Association; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fondation pour la Recherche Medicale Grant Equipe FRM; Banting and Best Diabetes Centre (BBDC); Research Training Centre from the Hospital for Sick Children; BBDC; SickKids Summer Research Program (SSuRe); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	This work was supported by Canadian Diabetes Association Grant OG-3-12-3838-AK and Canadian Institutes of Health Research Grant MOP-130493 (to A. K.), and by Fondation pour la Recherche Medicale Grant Equipe FRM DEQ20140329495 (to B. C.).; Supported by a studentship from the Banting and Best Diabetes Centre (BBDC).; Supported by a fellowship from the Research Training Centre from the Hospital for Sick Children.; Supported by summer studentships from the BBDC and the SickKids Summer Research Program (SSuRe).; Supported by a fellowship from the French Ministry of Research and Association Francaise contre les Myopathies.	Andrade-Vieira R, 2013, CANCER BIOL THER, V14, P1050, DOI 10.4161/cbt.26206; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Choi EY, 2014, BRIT J NUTR, V111, P1221, DOI 10.1017/S0007114513003681; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Dentin R, 2005, J CLIN INVEST, V115, P2843, DOI 10.1172/JCI25256; Dong J, 2014, J LIPID RES, V55, P363, DOI 10.1194/jlr.M038786; Dzamko N, 2010, J BIOL CHEM, V285, P115, DOI 10.1074/jbc.M109.056762; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Fink LN, 2013, DIABETOLOGIA, V56, P1623, DOI 10.1007/s00125-013-2897-x; Fink LN, 2014, OBESITY, V22, P747, DOI 10.1002/oby.20615; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Galic S, 2011, J CLIN INVEST, V121, P4903, DOI 10.1172/JCI58577; Galvan-Pena S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00420; Huang SR, 2012, J LIPID RES, V53, P2002, DOI 10.1194/jlr.D029546; Huang SCC, 2014, NAT IMMUNOL, V15, P846, DOI 10.1038/ni.2956; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kewalramani G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026947; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Kruszynska YT, 2003, METABOLISM, V52, P233, DOI 10.1053/meta.2003.50029; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Macrae K, 2013, J LIPID RES, V54, P2366, DOI 10.1194/jlr.M036996; Morinaga H, 2015, DIABETES, V64, P1120, DOI 10.2337/db14-1238; Mounier R, 2013, CELL METAB, V18, P251, DOI 10.1016/j.cmet.2013.06.017; Mullen A, 2010, J NUTR BIOCHEM, V21, P444, DOI 10.1016/j.jnutbio.2009.02.008; Nakakuki M, 2013, ATHEROSCLEROSIS, V227, P289, DOI 10.1016/j.atherosclerosis.2012.12.036; Noursadeghi M, 2008, J IMMUNOL METHODS, V329, P194, DOI 10.1016/j.jim.2007.10.015; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Oh DY, 2012, DIABETES, V61, P346, DOI 10.2337/db11-0860; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Pal D, 2012, NAT MED, V18, P1279, DOI 10.1038/nm.2851; Piquet MA, 1996, BIOCHEM J, V317, P667, DOI 10.1042/bj3170667; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Salminen A, 2011, J MOL MED, V89, P667, DOI 10.1007/s00109-011-0748-0; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Snodgrass RG, 2013, J IMMUNOL, V191, P4337, DOI 10.4049/jimmunol.1300298; Solanki P, 2013, QUINTESSENCE INT, V44, P392, DOI 10.3290/j.qi.a29502; Souza CO, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/582197; Stanton MC, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-8; Stefan N, 2010, DIABETES CARE, V33, P405, DOI [10.2337/dc10-0002, 10.2337/dc09-0544]; Steinberg GR, 2014, IMMUNOL CELL BIOL, V92, P340, DOI 10.1038/icb.2014.11; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; Talbot NA, 2014, MOL CELL ENDOCRINOL, V393, P129, DOI 10.1016/j.mce.2014.06.010; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Ubhayasekera SJKA, 2013, ANAL BIOANAL CHEM, V405, P1929, DOI 10.1007/s00216-012-6658-3; Wang XD, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0049935, 10.1371/journal.pone.0045036]; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Weldon SM, 2007, J NUTR BIOCHEM, V18, P250, DOI 10.1016/j.jnutbio.2006.04.003; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Witters LA, 2006, TRENDS BIOCHEM SCI, V31, P13, DOI 10.1016/j.tibs.2005.11.009; XIE QW, 1994, J BIOL CHEM, V269, P4705; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xue BZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045990; Yang ZH, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-120	55	121	130	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16979	16988		10.1074/jbc.M115.646992	http://dx.doi.org/10.1074/jbc.M115.646992			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25987561	hybrid, Green Published			2022-12-28	WOS:000357572800041
J	Finkenwirth, F; Sippach, M; Landmesser, H; Kirsch, F; Ogienko, A; Grunzel, M; Kiesler, C; Steinhoff, HJ; Schneider, E; Eitinger, T				Finkenwirth, Friedrich; Sippach, Michael; Landmesser, Heidi; Kirsch, Franziska; Ogienko, Anastasia; Grunzel, Miriam; Kiesler, Cornelia; Steinhoff, Heinz-Juergen; Schneider, Erwin; Eitinger, Thomas			ATP-dependent Conformational Changes Trigger Substrate Capture and Release by an ECF-type Biotin Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING CASSETTE TRANSPORTER; COUPLING FACTOR TRANSPORTER; MALTOSE ABC TRANSPORTER; CRYSTAL-STRUCTURE; CATALYTIC CYCLE; MEMBRANE-PROTEINS; ESCHERICHIA-COLI; P-GLYCOPROTEIN; S COMPONENTS; MALK DIMER	Energy-coupling factor (ECF) transporters for vitamins and metal ions in prokaryotes consist of two ATP-binding cassette-type ATPases, a substrate-specific transmembrane protein (S component) and a transmembrane protein (T component) that physically interacts with the ATPases and the S component. The mechanism of ECF transporters was analyzed upon reconstitution of a bacterial biotin transporter into phospholipid bilayer nanodiscs. ATPase activity was not stimulated by biotin and was only moderately reduced by vanadate. A non-hydrolyzable ATP analog was a competitive inhibitor. As evidenced by cross-linking of monocysteine variants and by site-specific spin labeling of the Q-helix followed by EPR-based interspin distance analyses, closure and reopening of the ATPase dimer (BioM(2)) was a consequence of ATP binding and hydrolysis, respectively. A previously suggested role of a stretch of small hydrophobic amino acid residues within the first transmembrane segment of the S units for S unit/T unit interactions was structurally and functionally confirmed for the biotin transporter. Cross-linking of this segment in BioY (S) using homobifunctional thiol-reactive reagents to a coupling helix of BioN (T) indicated a reorientation rather than a disruption of the BioY/BioN interface during catalysis. Fluorescence emission of BioY labeled with an environmentally sensitive fluorophore was compatible with an ATP-induced reorientation and consistent with a hypothesized toppling mechanism. As demonstrated by [H-3] biotin capture assays, ATP binding stimulated substrate capture by the transporter, and subsequent ATP hydrolysis led to substrate release. Our study represents the first experimental insight into the individual steps during the catalytic cycle of an ECF transporter in a lipid environment.	[Finkenwirth, Friedrich; Kirsch, Franziska; Ogienko, Anastasia; Grunzel, Miriam; Kiesler, Cornelia; Eitinger, Thomas] Humboldt Univ, Inst Biol Mikrobiol, D-10115 Berlin, Germany; [Landmesser, Heidi; Schneider, Erwin] Humboldt Univ, Inst Biol Physiol Mikroorganismen, D-10115 Berlin, Germany; [Sippach, Michael; Steinhoff, Heinz-Juergen] Univ Osnabruck, Fachbereich Phys, D-49076 Osnabruck, Germany	Humboldt University of Berlin; Humboldt University of Berlin; University Osnabruck	Eitinger, T (corresponding author), Humboldt Univ, Inst Biol Mikrobiol, Chausseestr 117, D-10115 Berlin, Germany.	thomas.eitinger@cms.hu-berlin.de	Steinhoff, Heinz-Juergen/H-3791-2014; Eitinger, Thomas/C-3926-2019	Steinhoff, Heinz-Juergen/0000-0002-5888-0157; Eitinger, Thomas/0000-0003-1449-6433	Deutsche Forschungsgemeinschaft through Paketantrag PAK459 [STE640/10, SCHN274/14-2, EI374/4-1, EI374/4-2]	Deutsche Forschungsgemeinschaft through Paketantrag PAK459(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft through Paketantrag PAK459 by Grants STE640/10 (to H. J. S.), SCHN274/14-2 (to E. S.), and EI374/4-1 and EI374/4-2 (to T. E.). The authors declare that they have no conflicts of interest with the contents of this article.	ALTENBACH C, 1989, BIOCHEMISTRY-US, V28, P7806, DOI 10.1021/bi00445a042; Ames GFL, 2001, J BIOENERG BIOMEMBR, V33, P79, DOI 10.1023/A:1010797029183; Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024; Berntsson RPA, 2012, P NATL ACAD SCI USA, V109, P13990, DOI 10.1073/pnas.1203219109; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bohm S, 2013, P NATL ACAD SCI USA, V110, P5492, DOI 10.1073/pnas.1217745110; Chen J, 2001, P NATL ACAD SCI USA, V98, P1525, DOI 10.1073/pnas.041542498; Cymer F, 2015, J MOL BIOL, V427, P999, DOI 10.1016/j.jmb.2014.09.014; Daus ML, 2007, J BIOL CHEM, V282, P22387, DOI 10.1074/jbc.M701979200; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Duurkens RH, 2007, J BIOL CHEM, V282, P10380, DOI 10.1074/jbc.M608583200; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Eitinger T, 2011, FEMS MICROBIOL REV, V35, P3, DOI 10.1111/j.1574-6976.2010.00230.x; Erkens GB, 2011, NAT STRUCT MOL BIOL, V18, P755, DOI 10.1038/nsmb.2073; Erkens GB, 2010, BIOCHEMISTRY-US, V49, P3203, DOI 10.1021/bi100154r; Eudes A, 2008, J BACTERIOL, V190, P7591, DOI 10.1128/JB.01070-08; Finkenwirth F, 2014, BIOENGINEERED, V5, P129, DOI 10.4161/bioe.26887; Finkenwirth F, 2013, J BACTERIOL, V195, P4105, DOI 10.1128/JB.00350-13; Finkenwirth F, 2010, BIOCHEM J, V431, P373, DOI 10.1042/BJ20100813; Fisher DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046052; Grote M, 2008, BIOPHYS J, V95, P2924, DOI 10.1529/biophysj.108.132456; Grote M, 2009, J BIOL CHEM, V284, P17521, DOI 10.1074/jbc.M109.006270; Hebbeln P, 2007, P NATL ACAD SCI USA, V104, P2909, DOI 10.1073/pnas.0609905104; HENDERSON GB, 1979, J BACTERIOL, V137, P1308, DOI 10.1128/JB.137.3.1308-1314.1979; Heuveling J, 2014, BBA-BIOMEMBRANES, V1838, P106, DOI 10.1016/j.bbamem.2013.08.024; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jeschke G, 2012, ANNU REV PHYS CHEM, V63, P419, DOI 10.1146/annurev-physchem-032511-143716; Karpowich NK, 2013, P NATL ACAD SCI USA, V110, P2534, DOI 10.1073/pnas.1217361110; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; Kirsch F, 2014, BIOMETALS, V27, P653, DOI 10.1007/s10534-014-9738-3; Kirsch F, 2012, J BACTERIOL, V194, P4505, DOI 10.1128/JB.00683-12; Klose D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039492; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Loo TW, 2001, J BIOL CHEM, V276, P36877, DOI 10.1074/jbc.C100467200; Majsnerowska M, 2013, STRUCTURE, V21, P861, DOI 10.1016/j.str.2013.03.007; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; Neubauer O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029087; Neubauer O, 2009, J BACTERIOL, V191, P6482, DOI 10.1128/JB.00965-09; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2011, P NATL ACAD SCI USA, V108, P15152, DOI 10.1073/pnas.1108858108; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Orelle C, 2003, J BIOL CHEM, V278, P47002, DOI 10.1074/jbc.M308268200; Orelle C, 2008, P NATL ACAD SCI USA, V105, P12837, DOI 10.1073/pnas.0803799105; Orelle C, 2010, P NATL ACAD SCI USA, V107, P20293, DOI 10.1073/pnas.1006544107; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; Polyhach Y, 2011, PHYS CHEM CHEM PHYS, V13, P2356, DOI 10.1039/c0cp01865a; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Rodionov DA, 2006, J BACTERIOL, V188, P317, DOI 10.1128/JB.188.1.317-327.2006; Rodionov DA, 2009, J BACTERIOL, V191, P42, DOI 10.1128/JB.01208-08; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Siche S, 2010, RES MICROBIOL, V161, P824, DOI 10.1016/j.resmic.2010.09.010; Sippach M, 2014, BBA-BIOMEMBRANES, V1838, P1760, DOI 10.1016/j.bbamem.2014.02.010; Slotboom DJ, 2014, NAT REV MICROBIOL, V12, P79, DOI 10.1038/nrmicro3175; Song JN, 2013, SCI REP-UK, V3, DOI 10.1038/srep03566; ter Beek J, 2014, J GEN PHYSIOL, V143, P419, DOI 10.1085/jgp.201411164; ter Beek J, 2011, J BIOL CHEM, V286, P5471, DOI 10.1074/jbc.M110.199224; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; Wan LX, 2009, ARCH BIOCHEM BIOPHYS, V485, P102, DOI 10.1016/j.abb.2009.03.003; Wang TL, 2013, NATURE, V497, P272, DOI 10.1038/nature12045; WIDDAS WF, 1952, J PHYSIOL-LONDON, V118, P23, DOI 10.1113/jphysiol.1952.sp004770; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Xu K, 2013, NATURE, V497, P268, DOI 10.1038/nature12046; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yu Y, 2014, CELL RES, V24, P267, DOI 10.1038/cr.2013.172; Zhang MH, 2014, P NATL ACAD SCI USA, V111, P18560, DOI 10.1073/pnas.1412246112; Zhang P, 2013, TRENDS MICROBIOL, V21, P652, DOI 10.1016/j.tim.2013.09.009; Zhang P, 2010, NATURE, V468, P717, DOI 10.1038/nature09488	70	17	17	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16929	16942		10.1074/jbc.M115.654343	http://dx.doi.org/10.1074/jbc.M115.654343			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25991724	hybrid, Green Published			2022-12-28	WOS:000357572800037
J	Baeten, JT; Lilly, B				Baeten, Jeremy T.; Lilly, Brenda			Differential Regulation of NOTCH2 and NOTCH3 Contribute to Their Unique Functions in Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; differentiation; mitogen-activated protein kinase (MAPK); Notch receptor; proliferation; vascular smooth muscle cells	SIGNALING PATHWAY; INTRACELLULAR DOMAIN; DEPENDENT PATHWAY; DOWN-REGULATION; LUNG-CANCER; CROSS-TALK; RAS-MAPK; C-FLIP; APOPTOSIS; GROWTH	Background: Notch receptors govern vascular smooth muscle phenotypes, yet their distinct mechanisms are undefined. Results: NOTCH2 and NOTCH3 are differentially regulated and uniquely control smooth muscle cell proliferation and survival. Conclusion: NOTCH2 and NOTCH3 have discrete functions in vascular smooth muscle cells that are linked to their expression. Significance: These findings highlight functional differences between the predominant Notch receptors in vascular smooth muscle cells. Notch signaling is a key regulator of vascular smooth muscle cell (VSMC) phenotypes, including differentiation, proliferation, and cell survival. However, the exact contribution of the individual Notch receptors has not been thoroughly delineated. In this study, we identify unique roles for NOTCH2 and NOTCH3 in regulating proliferation and cell survival in cultured VSMCs. Our results indicate that NOTCH2 inhibits PDGF-B-dependent proliferation and its expression is decreased by PDGF-B. In contrast, NOTCH3 promotes proliferation and receptor expression is increased by PDGF-B. Additionally, data show that NOTCH3, but not NOTCH2 protects VSMCs from apoptosis and apoptosis mediators degrade NOTCH3 protein. We identified three pro-survival genes specifically regulated by NOTCH3 in cultured VSMCs and in mouse aortas. This regulation is mediated through MAP kinase signaling, which we demonstrate can be activated by NOTCH3, but not NOTCH2. Overall, this study highlights discrete roles for NOTCH2 and NOTCH3 in VSMCs and connects these roles to specific upstream regulators that control their expression.	Ohio State Univ, Ctr Cardiovasc & Pulm Res, Columbus, OH 43205 USA; Ohio State Univ, Nationwide Childrens Hosp, Ctr Heart, Columbus, OH 43205 USA; Ohio State Univ, Dept Pediat, Columbus, OH 43205 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University	Lilly, B (corresponding author), Nationwide Childrens Hosp, Res Inst, 700 Childrens Dr, Columbus, OH 43205 USA.	brenda.lilly@nationwidechildrens.org	LILLY, BRENDA/N-6867-2015	LILLY, BRENDA/0000-0002-3125-7496	American Heart Association	American Heart Association(American Heart Association)	This study was supported by Grant-in-aid (to B. L.) from the American Heart Association.	Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Ballif BA, 2001, CELL GROWTH DIFFER, V12, P397; Bianchi S, 2006, J CELL PHYSIOL, V207, P300, DOI 10.1002/jcp.20542; Blokzijl A, 2003, J CELL BIOL, V163, P723, DOI 10.1083/jcb.200305112; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Boucher J, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00081; Boucher JM, 2013, CIRC RES, V113, P975, DOI 10.1161/CIRCRESAHA.113.301272; Boucher MJ, 2000, J CELL BIOCHEM, V79, P355, DOI 10.1002/1097-4644(20001201)79:3<355::AID-JCB20>3.0.CO;2-0; Cao HQ, 2012, APMIS, V120, P441, DOI 10.1111/j.1600-0463.2011.02825.x; Carmena A, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000066; Carvalho FLF, 2014, PROSTATE, V74, P933, DOI 10.1002/pros.22811; Doi H, 2006, J BIOL CHEM, V281, P28555, DOI 10.1074/jbc.M602749200; Domenga V, 2004, GENE DEV, V18, P2730, DOI 10.1101/gad.308904; Egan SE, 1998, CURR TOP MICROBIOL, V228, P273; Fedorov Y, 2006, RNA, V12, P1188, DOI 10.1261/rna.28106; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; Havrda MC, 2006, THROMB HAEMOSTASIS, V96, P361, DOI 10.1160/TH06-04-0224; Hayward P, 2005, DEVELOPMENT, V132, P1819, DOI 10.1242/dev.01724; Henshall TL, 2015, ARTERIOSCL THROM VAS, V35, P409, DOI 10.1161/ATVBAHA.114.304849; High FA, 2008, P NATL ACAD SCI USA, V105, P1955, DOI 10.1073/pnas.0709663105; High FA, 2007, J CLIN INVEST, V117, P353, DOI 10.1172/JCI30070; Hiratochi M, 2007, NUCLEIC ACIDS RES, V35, P912, DOI 10.1093/nar/gkl1128; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Iso T, 2003, ARTERIOSCL THROM VAS, V23, P543, DOI 10.1161/01.ATV.0000060892.81529.8F; Jackson AL, 2004, TRENDS GENET, V20, P521, DOI 10.1016/j.tig.2004.08.006; Jalali S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046808; Jin S, 2008, CIRC RES, V102, P1483, DOI 10.1161/CIRCRESAHA.107.167965; Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018; Konishi J, 2010, ONCOGENE, V29, P589, DOI 10.1038/onc.2009.366; Krebs LT, 2003, GENESIS, V37, P139, DOI 10.1002/gene.10241; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Li XD, 2009, NAT MED, V15, P1289, DOI 10.1038/nm.2021; Li YX, 2009, CIRCULATION, V119, P2686, DOI 10.1161/CIRCULATIONAHA.108.790485; Lin CH, 2014, VASC PHARMACOL, V63, P88, DOI 10.1016/j.vph.2014.09.004; Lin CH, 2014, STEM CELLS DEV, V23, P2581, DOI 10.1089/scd.2014.0163; Lin LP, 2010, CANCER RES, V70, P632, DOI 10.1158/0008-5472.CAN-09-3293; Liu H, 2008, ANGIOGENESIS, V11, P223, DOI 10.1007/s10456-008-9102-8; Liu H, 2010, CIRC RES, V107, P860, DOI 10.1161/CIRCRESAHA.110.218271; Liu H, 2009, CIRC RES, V104, P466, DOI 10.1161/CIRCRESAHA.108.184846; Long XC, 2007, P NATL ACAD SCI USA, V104, P16570, DOI 10.1073/pnas.0708253104; Mann CD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051119; McCright B, 2006, GENESIS, V44, P29, DOI 10.1002/gene.20181; Munoz-Descalzo S, 2011, DEVELOPMENT, V138, P1501, DOI 10.1242/dev.061309; O'Neill CF, 2007, AM J PATHOL, V171, P1023, DOI 10.2353/ajpath.2007.061029; Pancewicz J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-502; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Pursglove SE, 2005, INT J BIOCHEM CELL B, V37, P2472, DOI 10.1016/j.biocel.2005.06.013; Seidelin JB, 2013, J MOL MED, V91, P839, DOI 10.1007/s00109-013-1003-7; Song GS, 2009, J BIOL CHEM, V284, P31921, DOI 10.1074/jbc.M109.046862; Sweeney C, 2004, FASEB J, V18, P1421, DOI 10.1096/fj.04-1700fje; Tang YF, 2010, J BIOL CHEM, V285, P17556, DOI 10.1074/jbc.M109.076414; Truong M, 2011, ANN SURG ONCOL, V18, P1506, DOI 10.1245/s10434-010-1488-z; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Voss OH, 2005, J BIOL CHEM, V280, P17371, DOI 10.1074/jbc.M412449200; Wang Q, 2012, IERI PROC, V3, P2, DOI 10.1016/j.ieri.2012.09.002; Wang T, 2007, CELL SIGNAL, V19, P2458, DOI 10.1016/j.cellsig.2007.07.019; Wang WL, 2002, J BIOL CHEM, V277, P21723, DOI 10.1074/jbc.M202224200; Wang XW, 2015, ONCOL REP, V33, P1402, DOI 10.3892/or.2015.3731; Ye YZ, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0595-7; Zhao XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021980	61	57	58	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16226	16237		10.1074/jbc.M115.655548	http://dx.doi.org/10.1074/jbc.M115.655548			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25957400	Green Published, hybrid			2022-12-28	WOS:000356930100026
J	Fuerst, O; Lin, YB; Granell, M; Leblanc, G; Padros, E; Lorenz-Fonfria, VA; Cladera, J				Fuerst, Oliver; Lin, Yibin; Granell, Meritxell; Leblanc, Gerard; Padros, Esteve; Lorenz-Fonfria, Victor A.; Cladera, Josep			The Melibiose Transporter of Escherichia coli CRITICAL CONTRIBUTION OF LYS-377 TO THE STRUCTURAL ORGANIZATION OF THE INTERACTING SUBSTRATE BINDING SITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						FRET; IR spectroscopy; membrane biophysics; molecular dynamics; sugar transport; secondary transporter; sodium ligands	INDUCED CONFORMATIONAL-CHANGES; MEMBRANE-SPANNING SEGMENTS; MOLECULAR-DYNAMICS; PHYSIOLOGICAL EVIDENCE; CRYSTAL-STRUCTURE; ACIDIC RESIDUES; SUGAR-BINDING; HELIX-XI; PERMEASE; CARRIER	Background: Lys-377 mutants of the E. coli melibiose permease are defective in the cotransport of substrates. Results: Lys-377 mutants do not bind substrates, whereas Ile-22 mutants bind Na+ but not sugars. Both observations are explained by molecular dynamics simulations. Conclusion: Lys-377 is crucial for the organization of the binding site. Ile-22 may participate in sugar binding. Significance: Uncovering the architecture of the substrate binding site is essential for understanding the transport mechanism. We examine the role of Lys-377, the only charged residue in helix XI, on the functional mechanism of the Na+-sugar melibiose symporter from Escherichia coli. Intrinsic fluorescence, FRET, and Fourier transform infrared difference spectroscopy reveal that replacement of Lys-377 with either Cys, Val, Arg, or Asp disables both Na+ and melibiose binding. On the other hand, molecular dynamics simulations extending up to 200-330 ns reveal that Lys-377 (helix XI) interacts with the anionic side chains of two of the three putative ligands for cation binding (Asp-55 and Asp-59 in helix II). When Asp-59 is protonated during the simulations, Lys-377 preferentially interacts with Asp-55. Interestingly, when a Na+ ion is positioned in the Asp-55-Asp-59 environment, Asp-124 in helix IV (a residue essential for melibiose binding) reorients and approximates the Asp-55-Asp-59 pair, and all three acidic side chains act as Na+ ligands. Under these conditions, the side chain of Lys-377 interacts with the carboxylic moiety of these three Asp residues. These data highlight the crucial role of the Lys-377 residue in the spatial organization of the Na+ binding site. Finally, the analysis of the second-site revertants of K377C reveals that mutation of Ile-22 (in helix I) preserves Na+ binding, whereas that of melibiose is largely abolished according to spectroscopic measurements. This amino acid is located in the border of the sugar-binding site and might participate in sugar binding through apolar interactions.	[Fuerst, Oliver; Lin, Yibin; Granell, Meritxell; Padros, Esteve; Lorenz-Fonfria, Victor A.; Cladera, Josep] Univ Autonoma Barcelona, Fac Med, Dept Bioquim & Biol Mol, Unitat Biofis, E-08193 Barcelona, Spain; [Fuerst, Oliver; Lin, Yibin; Granell, Meritxell; Padros, Esteve; Lorenz-Fonfria, Victor A.; Cladera, Josep] Univ Autonoma Barcelona, Ctr Estudis Biofis, E-08193 Barcelona, Spain; [Leblanc, Gerard; Cladera, Josep] CEA Fontenay Aux Roses, Direct Progammes & Valorizat, Direct Sci Vivant, F-92265 Fontenay Aux Roses, France; [Lorenz-Fonfria, Victor A.] Free Univ Berlin, Dept Phys, Expt Mol Biophys, D-14195 Berlin, Germany	Autonomous University of Barcelona; University of Barcelona; Autonomous University of Barcelona; CEA; UDICE-French Research Universities; Universite Paris Saclay; Free University of Berlin	Cladera, J (corresponding author), Univ Autonoma Barcelona, Fac Med, Unitat Biofis, E-08193 Barcelona, Spain.	josep.cladera@uab.cat	Lin, B.Y./AAA-7774-2020; Fonfria, Victor A. Lorenz/AAU-9034-2021; Fonfria, Victor A Lorenz/B-3754-2018; Granell, Mertixell/K-5027-2014; Cladera, Josep/E-6737-2010	Fonfria, Victor A. Lorenz/0000-0002-8859-8347; Fonfria, Victor A Lorenz/0000-0002-8859-8347; Granell, Mertixell/0000-0003-3486-6892; Cladera, Josep/0000-0002-1724-3477	Ministerio de Ciencia e Innovacion; Fondo Europeo de Desarrollo Regional Grant [BFU2012-40137-C02--01]; the Commissariat a l'Energie Atomique (CEA-Saclay); Ministerio de Educacion, Cultura y Deporte Fellowship [3729]; Universitat Autonoma de Barcelona FPI fellowship; Universitat Autonoma de Barcelona Postdoctoral Fellowship [40607]; Marie Curie Reintegration Grant [PIRG03--6A-2008--231063]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fondo Europeo de Desarrollo Regional Grant; the Commissariat a l'Energie Atomique (CEA-Saclay); Ministerio de Educacion, Cultura y Deporte Fellowship; Universitat Autonoma de Barcelona FPI fellowship; Universitat Autonoma de Barcelona Postdoctoral Fellowship; Marie Curie Reintegration Grant(European Commission)	This work was supported by Ministerio de Ciencia e Innovacion and Fondo Europeo de Desarrollo Regional Grant BFU2012-40137-C02--01 and, in part, by a grant from the Commissariat a l'Energie Atomique (CEA-Saclay).; Supported by Ministerio de Educacion, Cultura y Deporte Fellowship 3729. Present address: Agrana Research and Innovation Center, Josef-Reither-Str. 21-23, 3430 Tulln, Austria.; Supported by a Universitat Autonoma de Barcelona FPI fellowship. Present Address: Dept. of Biochemistry and Molecular Biology, Medical School, University of Texas Health Science Center at Houston, 6431 Fannin, Rm. MSB 6.416, Houston, TX 77030.; Supported by Universitat Autonoma de Barcelona Postdoctoral Fellowship 40607 and Marie Curie Reintegration Grant PIRG03--6A-2008--231063.	Abramson J, 2003, FEBS LETT, V555, P96, DOI 10.1016/S0014-5793(03)01087-1; Angers M, 2008, BIOCHEM J, V416, P347, DOI 10.1042/BJ20080165; Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; Barth A, 2000, PROG BIOPHYS MOL BIO, V74, P141, DOI 10.1016/S0079-6107(00)00021-3; BASSILANA M, 1988, J BIOL CHEM, V263, P9663; BOTFIELD MC, 1988, J BIOL CHEM, V263, P12909; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Ding PZ, 2004, BBA-BIOMEMBRANES, V1660, P106, DOI 10.1016/j.bbamem.2003.11.005; Ding PZ, 2000, J MEMBRANE BIOL, V174, P135, DOI 10.1007/s002320001038; Ding PZ, 2000, BIOCHEM BIOPH RES CO, V268, P409, DOI 10.1006/bbrc.2000.2149; Ding PZ, 2001, BIOCHEMISTRY-US, V40, P5506, DOI 10.1021/bi002761k; Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Ethayathulla AS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4009; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Feenstra KA, 1999, J COMPUT CHEM, V20, P786, DOI 10.1002/(SICI)1096-987X(199906)20:8<786::AID-JCC5>3.0.CO;2-B; Feller SE, 2000, J PHYS CHEM B, V104, P7510, DOI 10.1021/jp0007843; Franco PJ, 2001, BBA-BIOMEMBRANES, V1510, P231, DOI 10.1016/S0005-2736(00)00353-9; Goormaghtigh E, 1999, BBA-REV BIOMEMBRANES, V1422, P105, DOI 10.1016/S0304-4157(99)00004-0; Granell M, 2010, P NATL ACAD SCI USA, V107, P22078, DOI 10.1073/pnas.1008649107; Harvey MJ, 2009, J CHEM THEORY COMPUT, V5, P2371, DOI 10.1021/ct900275y; Harvey MJ, 2009, J CHEM THEORY COMPUT, V5, P1632, DOI 10.1021/ct9000685; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jo S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000880; Jo S, 2009, BIOPHYS J, V97, P50, DOI 10.1016/j.bpj.2009.04.013; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaback H. R., 1971, METHOD ENZYMOL, V22, P99, DOI DOI 10.1016/0076-6879(71)22015-2; Khafizov K, 2012, P NATL ACAD SCI USA, V109, pE3035, DOI 10.1073/pnas.1209039109; Law RJ, 2005, J MOL GRAPH MODEL, V24, P157, DOI 10.1016/j.jmgm.2005.05.006; Leon X, 2005, BIOCHEMISTRY-US, V44, P3506, DOI 10.1021/bi048301z; Li C, 2014, ANALYST, V139, P4231, DOI 10.1039/c4an00483c; Lin YB, 2013, BBA-BIOMEMBRANES, V1828, P1690, DOI 10.1016/j.bbamem.2013.03.003; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Lorenz-Fonfria Victor A, 2012, Methods Mol Biol, V914, P107, DOI 10.1007/978-1-62703-023-6_7; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maehrel C, 1998, J BIOL CHEM, V273, P33192, DOI 10.1074/jbc.273.50.33192; Meyer-Lipp K, 2006, J BIOL CHEM, V281, P25882, DOI 10.1074/jbc.M601259200; MUSVETEAU I, 1995, BIOCHEMISTRY-US, V34, P6775, DOI 10.1021/bi00020a024; Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Poolman B, 1996, MOL MICROBIOL, V19, P911, DOI 10.1046/j.1365-2958.1996.397949.x; POURCHER T, 1991, BIOCHEM BIOPH RES CO, V178, P1176, DOI 10.1016/0006-291X(91)91016-6; POURCHER T, 1990, PHILOS T ROY SOC B, V326, P411, DOI 10.1098/rstb.1990.0021; POURCHER T, 1993, J BIOL CHEM, V268, P3209; POURCHER T, 1995, BIOCHEMISTRY-US, V34, P4412, DOI 10.1021/bi00013a033; Radestock S, 2011, J MOL BIOL, V407, P698, DOI 10.1016/j.jmb.2011.02.008; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Rostkowski M, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-6; Weissborn AC, 1997, BBA-BIOMEMBRANES, V1329, P237, DOI 10.1016/S0005-2736(97)00116-8; WILSON DM, 1992, J BACTERIOL, V174, P3083, DOI 10.1128/JB.174.9.3083-3086.1992; Woolf TB, 1996, PROTEINS, V24, P92; Wu EL, 2014, J COMPUT CHEM, V35, P1997, DOI 10.1002/jcc.23702; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yousef MS, 2009, P NATL ACAD SCI USA, V106, P15291, DOI 10.1073/pnas.0905516106; ZANI ML, 1993, J BIOL CHEM, V268, P3216	56	7	7	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16261	16271		10.1074/jbc.M115.642678	http://dx.doi.org/10.1074/jbc.M115.642678			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25971963	Green Published, hybrid			2022-12-28	WOS:000356930100029
J	Kalinowska, M; Chavez, AE; Lutzu, S; Castillo, PE; Bukauskas, FF; Francesconi, A				Kalinowska, Magdalena; Chavez, Andres E.; Lutzu, Stefano; Castillo, Pablo E.; Bukauskas, Feliksas F.; Francesconi, Anna			Actinin-4 Governs Dendritic Spine Dynamics and Promotes Their Remodeling by Metabotropic Glutamate Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Ca2+; calmodulin-dependent protein kinase II (CaMKII); dendritic spine; metabotropic glutamate receptor (mGluR); neuron; synaptic plasticity; actin-binding proteins; actinin; dendritic protrusion dynamics	LONG-TERM DEPRESSION; PROTEIN-KINASE-II; DEPENDENT MORPHOLOGICAL PLASTICITY; FRAGILE-X-SYNDROME; ALPHA-ACTININ; STRUCTURAL PLASTICITY; CYTOSKELETAL PROTEIN; PROTEOMIC ANALYSIS; SYNAPSE FORMATION; F-ACTIN	Background: Group 1 mGluRs induce dendritic spine remodeling, but the underlying molecular mechanisms remain uncharacterized. Results: -Actinin-4 regulates dendritic protrusion dynamics and morphogenesis and is required for the receptor-induced dynamic remodeling of dendritic protrusions. Conclusion: -Actinin-4 is a novel molecular effector of mGluR-dependent spine remodeling. Significance: mGluR signaling via actinins could contribute to synaptic plasticity and spine dysmorphogenesis in neurodevelopmental disorders. Dendritic spines are dynamic, actin-rich protrusions in neurons that undergo remodeling during neuronal development and activity-dependent plasticity within the central nervous system. Although group 1 metabotropic glutamate receptors (mGluRs) are critical for spine remodeling under physiopathological conditions, the molecular components linking receptor activity to structural plasticity remain unknown. Here we identify a Ca2+-sensitive actin-binding protein, -actinin-4, as a novel group 1 mGluR-interacting partner that orchestrates spine dynamics and morphogenesis in primary neurons. Functional silencing of -actinin-4 abolished spine elongation and turnover stimulated by group 1 mGluRs despite intact surface receptor expression and downstream ERK1/2 signaling. This function of -actinin-4 in spine dynamics was underscored by gain-of-function phenotypes in untreated neurons. Here -actinin-4 induced spine head enlargement, a morphological change requiring the C-terminal domain of -actinin-4 that binds to CaMKII, an interaction we showed to be regulated by group 1 mGluR activation. Our data provide mechanistic insights into spine remodeling by metabotropic signaling and identify -actinin-4 as a critical effector of structural plasticity within neurons.	[Kalinowska, Magdalena; Chavez, Andres E.; Lutzu, Stefano; Castillo, Pablo E.; Bukauskas, Feliksas F.; Francesconi, Anna] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Francesconi, A (corresponding author), Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	anna.francesconi@einstein.yu.edu	Regan, Clinton/E-6250-2012	Castillo, Pablo/0000-0002-9834-1801	National Institutes of Health [MH082870, NS072238, MH081935]; NICHD/National Institutes of Health [P30 HD071593]; NARSAD Young Investigator grant from the Brain and Behavior Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD071593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH082870, R01MH081935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072238] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NARSAD Young Investigator grant from the Brain and Behavior Research Foundation(NARSAD); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants MH082870 (to A.F.), NS072238 (to F.F.B.), MH081935 (to P.E.C), and NICHD/National Institutes of Health Grant P30 HD071593. This work was also supported by a NARSAD Young Investigator grant from the Brain and Behavior Research Foundation (to A.E.C.). The authors declare that they have no conflicts of interest with the contents of this article.	ABE T, 1992, J BIOL CHEM, V267, P13361; Ascano M, 2012, NATURE, V492, P382, DOI 10.1038/nature11737; BASARSKY TA, 1994, J NEUROSCI, V14, P6402; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Bellone C, 2008, CELL MOL LIFE SCI, V65, P2913, DOI 10.1007/s00018-008-8263-3; Bhakar AL, 2012, ANNU REV NEUROSCI, V35, P417, DOI 10.1146/annurev-neuro-060909-153138; Bhatt DH, 2009, ANNU REV PHYSIOL, V71, P261, DOI 10.1146/annurev.physiol.010908.163140; Bonhoeffer T, 2002, NEURON, V35, P1019, DOI 10.1016/S0896-6273(02)00906-6; Brunig I, 2004, NEUROPHARMACOLOGY, V47, P669, DOI 10.1016/j.neuropharm.2004.07.038; Caroni P, 2012, NAT REV NEUROSCI, V13, P478, DOI 10.1038/nrn3258; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Cruz-Martin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032446; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Deller T, 2000, J COMP NEUROL, V418, P164, DOI 10.1002/(SICI)1096-9861(20000306)418:2<164::AID-CNE4>3.0.CO;2-0; Deller T, 2000, HIPPOCAMPUS, V10, P569, DOI 10.1002/1098-1063(2000)10:5<569::AID-HIPO7>3.3.CO;2-D; Djinovic-Carugo K, 2002, FEBS LETT, V513, P119, DOI 10.1016/S0014-5793(01)03304-X; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Ethell IM, 2005, PROG NEUROBIOL, V75, P161, DOI 10.1016/j.pneurobio.2005.02.003; Fiala JC, 1998, J NEUROSCI, V18, P8900; Fink CC, 2003, NEURON, V39, P283, DOI 10.1016/S0896-6273(03)00428-8; Foley KS, 2014, BIOCHEM J, V459, P1, DOI 10.1042/BJ20131511; Fraley TS, 2003, J BIOL CHEM, V278, P24039, DOI 10.1074/jbc.M213288200; Francesconi A, 2002, J NEUROSCI, V22, P2196, DOI 10.1523/JNEUROSCI.22-06-02196.2002; Francesconi A, 2009, J NEUROCHEM, V108, P1515, DOI 10.1111/j.1471-4159.2009.05913.x; Gallagher SM, 2004, J NEUROSCI, V24, P4859, DOI 10.1523/JNEUROSCI.5407-03.2004; Hall DD, 2013, NEURON, V78, P483, DOI 10.1016/j.neuron.2013.02.032; Han K, 2013, NATURE, V503, P72, DOI 10.1038/nature12630; Hannan AJ, 2001, NAT NEUROSCI, V4, P282, DOI 10.1038/85132; Hell JW, 2014, NEURON, V81, P249, DOI 10.1016/j.neuron.2013.12.024; Herman E J, 2012, Handb Exp Pharmacol, P297, DOI 10.1007/978-3-642-25758-2_11; Honkura N, 2008, NEURON, V57, P719, DOI 10.1016/j.neuron.2008.01.013; Hunt DL, 2013, NAT NEUROSCI, V16, P1049, DOI 10.1038/nn.3461; Irwin SA, 2001, AM J MED GENET, V98, P161, DOI 10.1002/1096-8628(20010115)98:2<161::AID-AJMG1025>3.0.CO;2-B; Jalan-Sakrikar N, 2012, J BIOL CHEM, V287, P15275, DOI 10.1074/jbc.M112.351817; Jin DZ, 2013, J NEUROSCI, V33, P3402, DOI 10.1523/JNEUROSCI.3192-12.2013; Kano M, 1997, NEURON, V18, P71, DOI 10.1016/S0896-6273(01)80047-7; Kayser MS, 2008, NEURON, V59, P56, DOI 10.1016/j.neuron.2008.05.007; Ko JW, 2006, NEURON, V50, P233, DOI 10.1016/j.neuron.2006.04.005; Korkotian E, 2001, J NEUROSCI, V21, P6115, DOI 10.1523/JNEUROSCI.21-16-06115.2001; Kremerskothen J, 2005, J NEUROCHEM, V92, P597, DOI 10.1111/j.1471-4159.2004.02888.x; Krupp JJ, 1999, J NEUROSCI, V19, P1165; Kwon HB, 2011, NATURE, V474, P100, DOI 10.1038/nature09986; Lin YC, 2002, J NEUROSCI RES, V67, P484, DOI 10.1002/jnr.10077; Lu L, 2009, P NATL ACAD SCI USA, V106, P18402, DOI 10.1073/pnas.0908207106; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; Luscher C, 2010, NEURON, V65, P445, DOI 10.1016/j.neuron.2010.01.016; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Merrill MA, 2007, BIOCHEMISTRY-US, V46, P8485, DOI 10.1021/bi0623025; Michalon A, 2012, NEURON, V74, P49, DOI 10.1016/j.neuron.2012.03.009; Mockett BG, 2011, J NEUROSCI, V31, P7380, DOI 10.1523/JNEUROSCI.6656-10.2011; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Nakagawa T, 2004, NEUROPHARMACOLOGY, V47, P734, DOI 10.1016/j.neuropharm.2004.07.022; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; O'Leary H, 2006, MOL BIOL CELL, V17, P4656, DOI 10.1091/mbc.E06-03-0252; Oh WC, 2013, P NATL ACAD SCI USA, V110, pE305, DOI 10.1073/pnas.1214705110; Okamoto KI, 2007, P NATL ACAD SCI USA, V104, P6418, DOI 10.1073/pnas.0701656104; Okamoto K, 2009, PHYSIOLOGY, V24, P357, DOI 10.1152/physiol.00029.2009; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; PAPA M, 1995, J NEUROSCI, V15, P1; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; Ramiro-Cortes Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071155; Robison AJ, 2005, J BIOL CHEM, V280, P35329, DOI 10.1074/jbc.M502191200; Sakai Y, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002166; Schulz TW, 2004, J NEUROSCI, V24, P8584, DOI 10.1523/JNEUROSCI.2100-04.2004; Shen K, 2010, ANNU REV NEUROSCI, V33, P473, DOI 10.1146/annurev.neuro.051508.135302; Sjoblom B, 2008, CELL MOL LIFE SCI, V65, P2688, DOI 10.1007/s00018-008-8080-8; Uesaka N, 2014, SCIENCE, V344, P1020, DOI 10.1126/science.1252514; Vanderklish PW, 2002, P NATL ACAD SCI USA, V99, P1639, DOI 10.1073/pnas.032681099; Walikonis RS, 2001, J NEUROSCI, V21, P423, DOI 10.1523/JNEUROSCI.21-02-00423.2001; Wijetunge LS, 2008, J NEUROSCI, V28, P13028, DOI 10.1523/JNEUROSCI.2600-08.2008; Won H, 2012, NATURE, V486, P261, DOI 10.1038/nature11208; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0; Wyszynski M, 1998, J NEUROSCI, V18, P1383; Yang YL, 2008, J NEUROSCI, V28, P5740, DOI 10.1523/JNEUROSCI.3998-07.2008; Yun-Hong Y, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.007138; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Zhang XL, 2013, J NEUROSCI, V33, P12510, DOI 10.1523/JNEUROSCI.2983-12.2013; Zhou ZK, 2011, J NEUROSCI, V31, P819, DOI 10.1523/JNEUROSCI.3869-10.2011; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	80	23	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					15909	15920		10.1074/jbc.M115.640136	http://dx.doi.org/10.1074/jbc.M115.640136			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25944910	hybrid, Green Published			2022-12-28	WOS:000356930100002
J	Workman, E; Kalda, C; Patel, A; Battle, DJ				Workman, Eileen; Kalda, Caitlin; Patel, Aalapi; Battle, Daniel J.			Gemin5 Binds to the Survival Motor Neuron mRNA to Regulate SMN Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mRNA; neurodegenerative disease; post-transcriptional regulation; RNA-binding protein; translation; Gemin5; SMA; SMN; spinal muscular atrophy; survival motor neuron	SPINAL MUSCULAR-ATROPHY; DETERMINING GENE; PROTEIN; COMPLEX; IDENTIFICATION; LOCALIZATION; TRANSLATION; RIBONUCLEOPROTEINS; BIOGENESIS; TRANSPORT	Background: Spinal muscular atrophy (SMA), a neurodegenerative disease, is caused by low levels of expression of the survival motor neuron (SMN) protein. Results: Gemin5 binds to and regulates translation of the mature SMN mRNA. Conclusion: Gemin5 functions in the regulation of the SMN mRNA. Significance: Investigation of the regulation of SMN expression is critical for understanding SMA and developing therapeutics. Reduced expression of SMN causes spinal muscular atrophy, a severe neurodegenerative disease. Despite the importance of maintaining SMN levels, relatively little is known about the mechanisms by which SMN levels are regulated. We show here that Gemin5, the snRNA-binding protein of the SMN complex, binds directly to the SMN mRNA and regulates SMN expression. Gemin5 binds with high specificity, both in vitro and in vivo, to sequence and structural elements in the SMN mRNA 3-untranslated region that are reminiscent of the snRNP code to which Gemin5 binds on snRNAs. Reduction of Gemin5 redistributes the SMN mRNA from heavy polysomes to lighter polysomes and monosomes, suggesting that Gemin5 functions as an activator of SMN translation. SMN protein is not stoichiometrically present on the SMN mRNA with Gemin5, but the mRNA-binding activity of Gemin5 is dependent on SMN levels, providing a feedback mechanism for SMN to regulate its own expression via Gemin5. This work both reveals a new autoregulatory pathway governing SMN expression, and identifies a new mechanism through which SMN can modulate specific mRNA expression via Gemin5.	[Workman, Eileen; Kalda, Caitlin; Patel, Aalapi; Battle, Daniel J.] Ohio State Univ, Wexner Med Ctr, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Battle, Daniel J.] Ohio State Univ, Wexner Med Ctr, Dept Neurol, Columbus, OH 43210 USA	Ohio State University; Ohio State University	Battle, DJ (corresponding author), Dept Mol & Cellular Biochem, 383 Hamilton Hall,1645 Neil Ave, Columbus, OH 43210 USA.	battle.59@osu.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [R01NS077010]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077010] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant R01NS077010 (to D. B.).	Achsel T, 2001, P NATL ACAD SCI USA, V98, P3685, DOI 10.1073/pnas.071033998; Arnold WD, 2013, ANN NEUROL, V74, P348, DOI 10.1002/ana.23995; Battle DJ, 2007, J BIOL CHEM, V282, P27953, DOI 10.1074/jbc.M702317200; Battle DJ, 2006, MOL CELL, V23, P273, DOI 10.1016/j.molcel.2006.05.036; Bradrick SS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007030; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Eggert C, 2006, TRENDS MOL MED, V12, P113, DOI 10.1016/j.molmed.2006.01.005; Fallini C, 2011, J NEUROSCI, V31, P3914, DOI 10.1523/JNEUROSCI.3631-10.2011; Feng WQ, 2005, HUM MOL GENET, V14, P1605, DOI 10.1093/hmg/ddi168; Fierro-Monti I, 2006, J PROTEOME RES, V5, P1367, DOI 10.1021/pr0504539; Fischer U, 2011, WIRES RNA, V2, P718, DOI 10.1002/wrna.87; Gabanella F, 2005, HUM MOL GENET, V14, P3629, DOI 10.1093/hmg/ddi390; Golembe TJ, 2005, MOL CELL BIOL, V25, P10989, DOI 10.1128/MCB.25.24.10989-11004.2005; Gubitz AK, 2002, J BIOL CHEM, V277, P5631, DOI 10.1074/jbc.M109448200; Hafner Markus, 2010, J Vis Exp, DOI 10.3791/2034; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hubers L, 2011, HUM MOL GENET, V20, P553, DOI 10.1093/hmg/ddq500; Jablonka S, 2003, AMYOTROPH LATERAL SC, V4, P144, DOI 10.1080/14660820310011296; Kambach C, 1999, CURR OPIN STRUC BIOL, V9, P222, DOI 10.1016/S0959-440X(99)80032-3; Lau CK, 2009, NAT STRUCT MOL BIOL, V16, P486, DOI 10.1038/nsmb.1584; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Meister G, 2002, TRENDS CELL BIOL, V12, P472, DOI 10.1016/S0962-8924(02)02371-1; Mukherjee C, 2012, CELL REP, V2, P674, DOI 10.1016/j.celrep.2012.07.011; Pacheco A, 2009, NUCLEIC ACIDS RES, V37, P582, DOI 10.1093/nar/gkn979; Paushkin S, 2002, CURR OPIN CELL BIOL, V14, P305, DOI 10.1016/S0955-0674(02)00332-0; Peter CJ, 2011, HUM MOL GENET, V20, P1701, DOI 10.1093/hmg/ddr046; Pineiro D, 2013, NUCLEIC ACIDS RES, V41, P1017, DOI 10.1093/nar/gks1212; Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128; Simic G, 2008, ACTA NEUROPATHOL, V116, P223, DOI 10.1007/s00401-008-0411-1; Stark H, 2001, NATURE, V409, P539, DOI 10.1038/35054102; Todd AG, 2013, HUM MOL GENET, V22, P729, DOI 10.1093/hmg/dds480; Todd AG, 2010, BIOCHEM BIOPH RES CO, V397, P479, DOI 10.1016/j.bbrc.2010.05.139; Wan LL, 2005, MOL CELL BIOL, V25, P5543, DOI 10.1128/MCB.25.13.5543-5551.2005; Winkler C, 2005, GENE DEV, V19, P2320, DOI 10.1101/gad.342005; Workman E, 2014, J BIOL CHEM, V289, P3703, DOI 10.1074/jbc.M113.538264; Yong J, 2010, MOL CELL, V38, P551, DOI 10.1016/j.molcel.2010.03.014; Zhang HLL, 2003, J NEUROSCI, V23, P6627; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	39	21	24	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15662	15669		10.1074/jbc.M115.646257	http://dx.doi.org/10.1074/jbc.M115.646257			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25911097	hybrid, Green Published			2022-12-28	WOS:000356527400028
J	Costales, P; Fuentes-Prior, P; Castellano, J; Revuelta-Lopez, E; Corral-Rodriguez, MA; Nasarre, L; Badimon, L; Llorente-Cortes, V				Costales, Paula; Fuentes-Prior, Pablo; Castellano, Jose; Revuelta-Lopez, Elena; Angeles Corral-Rodriguez, Maria; Nasarre, Laura; Badimon, Lina; Llorente-Cortes, Vicenta			K Domain CR9 of Low Density Lipoprotein (LDL) Receptor-related Protein 1 (LRP1) Is Critical for Aggregated LDL-induced Foam Cell Formation from Human Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; LIGAND-BINDING; ALPHA-2-MACROGLOBULIN RECEPTOR; CHOLESTEROL ACCUMULATION; ATHEROSCLEROTIC LESIONS; UROKINASE RECEPTOR; ALPHA(2)-MACROGLOBULIN RECEPTOR; EMBRYONIC FIBROBLASTS; SCAVENGER RECEPTOR; EXPRESSION	Low density lipoprotein receptor-related protein (LRP1) mediates the internalization of aggregated LDL (AgLDL), which in turn increases the expression of LRP1 in human vascular smooth muscle cells (hVSMCs). This positive feedback mechanism is thus highly efficient to promote the formation of hVSMC foam cells, a crucial vascular component determining the susceptibility of atherosclerotic plaque to rupture. Here we have determined the LRP1 domains involved in AgLDL recognition with the aim of specifically blocking AgLDL internalization in hVSMCs. The capacity of fluorescently labeled AgLDL to bind to functional LRP1 clusters was tested in a receptor-ligand fluorometric assay made by immobilizing soluble LRP1 "minireceptors" (sLRP1-II, sLRP1-III, and sLRP1-IV) recombinantly expressed in CHO cells. This assay showed that AgLDL binds to cluster II. We predicted three well exposed and potentially immunogenic peptides in the CR7-CR9 domains of this cluster (termed P1 (Cys(1051)-Glu(1066)), P2 (Asp(1090)-Cys(1104)), and P3 (Gly(1127)-Cys(1140))). AgLDL, but not native LDL, bound specifically and tightly to P3-coated wells. Rabbit polyclonal antibodies raised against P3 prevented AgLDL uptake by hVSMCs and were almost twice as effective as anti-P1 and anti-P2 Abs in reducing intracellular cholesteryl ester accumulation. Moreover, anti-P3 Abs efficiently prevented AgLDL-induced LRP1 up-regulation and counteracted the down-regulatory effect of AgLDL on hVSMC migration. In conclusion, domain CR9 appears to be critical for LRP1-mediated AgLDL binding and internalization in hVSMCs. Our results open new avenues for an innovative anti-VSMC foam cell-based strategy for the treatment of vascular lipid deposition in atherosclerosis.	[Costales, Paula; Castellano, Jose; Revuelta-Lopez, Elena; Nasarre, Laura; Badimon, Lina; Llorente-Cortes, Vicenta] CSIC ICCC, Biomed Res Inst St Pau IIB St Pau, Cardiovasc Res Ctr, Barcelona 08025, Spain; [Fuentes-Prior, Pablo; Angeles Corral-Rodriguez, Maria] Hosp Santa Cruz & San Pau, Biomed Res Inst St Pau IIB St Pau, Mol Bases Dis, Barcelona 08025, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Catala de Ciencies Cardiovasculars (ICCC)	Llorente-Cortes, V (corresponding author), CSIC ICCC, IIB St Pau Hosp Santa Creu & St Pau, Cardiovasc Res Ctr, Barcelona 08025, Spain.	cllorente@csic-iccc.org	López, Elena Revuelta/G-6632-2017; BADIMON, LINA/S-2950-2019; Revuelta-López, Elena/T-6282-2018; Badimon, Lina/O-4711-2014	López, Elena Revuelta/0000-0001-8962-5936; Revuelta-López, Elena/0000-0001-8962-5936; Fuentes-Prior, Pablo/0000-0002-6618-3204; Badimon, Lina/0000-0002-9162-2459	Instituto Salud Carlos III [FIS PI11/00747, FIS PI14/01729]; Red de Investigacion Cardiovascular [RD RD12/0042/0027]; European Fund for Regional Development;  [SAF2010-15668]	Instituto Salud Carlos III(Instituto de Salud Carlos III); Red de Investigacion Cardiovascular; European Fund for Regional Development(European Commission); 	This work was supported by FIS PI11/00747 and FIS PI14/01729 from Instituto Salud Carlos III, co-financed by the European Fund for Regional Development, by SAF2010-15668, and by Red de Investigacion Cardiovascular (RD RD12/0042/0027).	Allahverdian S, 2014, CIRCULATION, V129, P1551, DOI 10.1161/CIRCULATIONAHA.113.005015; Andersen OM, 2000, BIOCHEMISTRY-US, V39, P10627, DOI 10.1021/bi000498h; Andersen OM, 2001, BIOCHEM J, V357, P289, DOI 10.1042/0264-6021:3570289; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boucher P, 2004, TRENDS CARDIOVAS MED, V14, P55, DOI 10.1016/j.tcm.2003.12.001; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Bu GJ, 1996, J BIOL CHEM, V271, P22218, DOI 10.1074/jbc.271.36.22218; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Chait A, 2000, CURR OPIN LIPIDOL, V11, P457, DOI 10.1097/00041433-200010000-00003; Costales P, 2010, ATHEROSCLEROSIS, V213, P458, DOI 10.1016/j.atherosclerosis.2010.09.034; DAVIS CG, 1987, NATURE, V326, P760, DOI 10.1038/326760a0; Dolmer K, 2000, J BIOL CHEM, V275, P3264, DOI 10.1074/jbc.275.5.3264; Emonard H, 2005, BIOCHIMIE, V87, P369, DOI 10.1016/j.biochi.2004.11.013; Guttman M, 2010, J MOL BIOL, V398, P306, DOI 10.1016/j.jmb.2010.03.022; HERZ J, 1990, EMBO J, V9, P1769, DOI 10.1002/j.1460-2075.1990.tb08301.x; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Hiltunen TP, 1998, CIRCULATION, V97, P1079, DOI 10.1161/01.CIR.97.11.1079; HUBER LA, 1991, EUR J IMMUNOL, V21, P2761, DOI 10.1002/eji.1830211117; Hussain MM, 2001, FRONT BIOSCI, V6, pD417, DOI 10.2741/Hussain1; Jensen GA, 2006, J MOL BIOL, V362, P700, DOI 10.1016/j.jmb.2006.07.013; Jensen JK, 2009, J BIOL CHEM, V284, P17989, DOI 10.1074/jbc.M109.009530; Johnson JL, 2011, ARTERIOSCL THROM VAS, V31, pE35, DOI 10.1161/ATVBAHA.111.225623; Khan OM, 2013, CIRCULATION, V127, P782, DOI 10.1161/CIRCULATIONAHA.112.000588; Kuchenhoff A, 1997, AM J PHYSIOL-CELL PH, V272, pC369, DOI 10.1152/ajpcell.1997.272.2.C369; Langlois B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011584; Li YH, 2003, FEBS LETT, V555, P346, DOI 10.1016/S0014-5793(03)01272-9; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Llorente-Cortes V, 2007, J LIPID RES, V48, P2133, DOI 10.1194/jlr.M700039-JLR200; Llorente-Cortes V, 1998, ARTERIOSCL THROM VAS, V18, P738, DOI 10.1161/01.ATV.18.5.738; Llorente-Cortes V, 2006, J MOL BIOL, V359, P950, DOI 10.1016/j.jmb.2006.04.008; Llorente-Cortes V, 2006, ARTERIOSCL THROM VAS, V26, P117, DOI 10.1161/01.ATV.0000193618.32611.8b; Llorente-Cortes V, 2004, CIRCULATION, V110, P452, DOI 10.1161/01.CIR.0000136032.40666.3D; Llorente-Cortes V, 2004, EUR J CLIN INVEST, V34, P182, DOI 10.1111/j.1365-2362.2004.01316.x; Llorente-Cortes V, 2002, CIRCULATION, V106, P3104, DOI 10.1161/01.CIR.0000041434.28573.0B; Llorente-Cortes V, 2002, ARTERIOSCL THROM VAS, V22, P1905, DOI 10.1161/01.ATV.0000035391.46201.9A; Llorente-Cortes V, 2002, ARTERIOSCL THROM VAS, V22, P387, DOI 10.1161/hq0302.105367; Llorente-Cortes V, 2000, ARTERIOSCL THROM VAS, V20, P1572, DOI 10.1161/01.ATV.20.6.1572; LUOMA J, 1994, J CLIN INVEST, V93, P2014, DOI 10.1172/JCI117195; May P, 2004, MOL CELL BIOL, V24, P8872, DOI 10.1128/MCB.24.20.8872-8883.2004; May P, 2007, ANN MED, V39, P219, DOI 10.1080/07853890701214881; Mikhailenko I, 2001, J BIOL CHEM, V276, P39484, DOI 10.1074/jbc.M104382200; MOESTRUP SK, 1992, CELL TISSUE RES, V269, P375, DOI 10.1007/BF00353892; MOESTRUP SK, 1991, J BIOL CHEM, V266, P14011; Neels JG, 1999, J BIOL CHEM, V274, P31305, DOI 10.1074/jbc.274.44.31305; Newby AC, 2007, TRENDS CARDIOVAS MED, V17, P253, DOI 10.1016/j.tcm.2007.09.001; Nielsen KL, 1996, J BIOL CHEM, V271, P12909, DOI 10.1074/jbc.271.22.12909; NYKJAER A, 1994, J BIOL CHEM, V269, P25668; NYKJAER A, 1992, J BIOL CHEM, V267, P14543; Obermoeller-McCormick LM, 2001, J CELL SCI, V114, P899; Oorni K, 2000, J LIPID RES, V41, P1703; ORTH K, 1992, P NATL ACAD SCI USA, V89, P7422, DOI 10.1073/pnas.89.16.7422; Otero-Vinas M, 2007, ATHEROSCLEROSIS, V194, P326, DOI 10.1016/j.atherosclerosis.2006.10.021; Revuelta-Lopez E, 2013, ARTERIOSCL THROM VAS, V33, P2877, DOI 10.1161/ATVBAHA.113.302323; Rohlmann A, 1998, J CLIN INVEST, V101, P689, DOI 10.1172/JCI1240; Rousselle A, 2013, J CLIN INVEST, V123, P1343, DOI 10.1172/JCI66580; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; Sagare A, 2007, NAT MED, V13, P1029, DOI 10.1038/nm1635; Simonovic M, 2001, BIOCHEMISTRY-US, V40, P15127, DOI 10.1021/bi015688m; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; Veniant MM, 1998, J CLIN INVEST, V102, P1559, DOI 10.1172/JCI4164; von Ballmoos MW, 2006, ARTERIOSCL THROM VAS, V26, P359, DOI 10.1161/01.ATV.0000198250.91406.6d; WARSHAWSKY I, 1995, BIOCHEMISTRY-US, V34, P3404, DOI 10.1021/bi00010a032; Weaver AM, 1997, J BIOL CHEM, V272, P14372, DOI 10.1074/jbc.272.22.14372; WILLIAMS SE, 1994, J BIOL CHEM, V269, P8653; Yamamoto K, 2014, J BIOL CHEM, V289, P6462, DOI 10.1074/jbc.M113.545376; Zhao JF, 2012, MOL NUTR FOOD RES, V56, P691, DOI 10.1002/mnfr.201100735	66	31	32	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					14852	14865		10.1074/jbc.M115.638361	http://dx.doi.org/10.1074/jbc.M115.638361			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25918169	Green Published, hybrid			2022-12-28	WOS:000356177300005
J	Chang, CL; Liou, J				Chang, Chi-Lun; Liou, Jen			Phosphatidylinositol 4,5-Bisphosphate Homeostasis Regulated by Nir2 and Nir3 Proteins at Endoplasmic Reticulum-Plasma Membrane Junctions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDIC-ACID; CELL REGULATION; PHOSPHOINOSITIDES; POOLS; GOLGI; PTDINS(4,5)P-2; TRAFFICKING; 4-PHOSPHATE; PI(4,5)P-2; MULTIPLE	Phosphatidylinositol (PI) 4,5-bisphosphate (PIP2) at the plasma membrane (PM) constitutively controls many cellular functions, and its hydrolysis via receptor stimulation governs cell signaling. The PI transfer protein Nir2 is essential for replenishing PM PIP2 following receptor-induced hydrolysis, but key mechanistic aspects of this process remain elusive. Here, we demonstrate that PI at the membrane of the endoplasmic reticulum (ER) is required for the rapid replenishment of PM PIP2 mediated by Nir2. Nir2 detects PIP2 hydrolysis and translocates to ER-PM junctions via binding to phosphatidic acid. With distinct phosphatidic acid binding abilities and PI transfer protein activities, Nir2 and its homolog Nir3 differentially regulate PIP2 homeostasis in cells during intense receptor stimulation and in the resting state, respectively. Our study reveals that Nir2 and Nir3 work in tandem to achieve different levels of feedback based on the consumption of PM PIP2 and function at ER-PM junctions to mediate nonvesicular lipid transport between the ER and the PM.	[Chang, Chi-Lun; Liou, Jen] Univ Texas SW Med Ctr Dallas, Dept Physiol, 6001 Forest Pk Rd, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Liou, J (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	jen.liou@utsouthwestern.edu	Liou, Jen/AAN-1105-2021; Chang, Chi-Lun/Z-1891-2019	Chang, Chi-Lun/0000-0003-0017-2243	Welch Foundation [I-1789]; Howard Hughes Medical Institute Graduate Grant [56006776]	Welch Foundation(The Welch Foundation); Howard Hughes Medical Institute Graduate Grant	This work was supported by Welch Foundation Grant I-1789 and by Howard Hughes Medical Institute Graduate Grant 56006776 (to the Mechanisms of Disease and Translational Science Ph.D. Track).	Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; Barylko B, 2001, J BIOL CHEM, V276, P7705, DOI 10.1074/jbc.C000861200; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Carlisle FA, 2013, NEUROSCIENCE, V248, P620, DOI 10.1016/j.neuroscience.2013.06.045; Chang CL, 2013, CELL REP, V5, P813, DOI 10.1016/j.celrep.2013.09.038; Cockcroft S, 2012, CURR TOP MICROBIOL, V362, P185, DOI 10.1007/978-94-007-5025-8_9; CREBA JA, 1983, BIOCHEM J, V212, P733, DOI 10.1042/bj2120733; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dickson EJ, 2014, P NATL ACAD SCI USA, V111, pE2281, DOI 10.1073/pnas.1407133111; Edelstein A., 2010, CURR PROTOC MOL BIOL, P20, DOI [DOI 10.1002/0471142727.MB1420S92, 10.1002/0471142727.mb1420s92]; Garner K, 2012, J BIOL CHEM, V287, P32263, DOI 10.1074/jbc.M112.375840; Hammond GRV, 2014, J CELL BIOL, V205, P113, DOI 10.1083/jcb.201312072; Hammond GRV, 2012, SCIENCE, V337, P727, DOI 10.1126/science.1222483; Hammond GRV, 2009, BIOCHEM J, V422, P23, DOI 10.1042/BJ20090428; Hilgemann D.W., 2001, SCI STKE SIGNAL TRAN, V2001, pre19; Ile KE, 2006, NAT CHEM BIOL, V2, P576, DOI 10.1038/nchembio835; Kim S, 2013, EMBO REP, V14, P891, DOI 10.1038/embor.2013.113; Kim YJ, 2011, DEV CELL, V21, P813, DOI 10.1016/j.devcel.2011.09.005; Lev S, 1999, MOL CELL BIOL, V19, P2278; Lev S, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013300; Levine T, 2004, TRENDS CELL BIOL, V14, P483, DOI 10.1016/j.tcb.2004.07.017; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Lu C, 2001, NEUROSCIENCE, V107, P35, DOI 10.1016/S0306-4522(01)00337-2; Nakatsu F, 2012, J CELL BIOL, V199, P1003, DOI 10.1083/jcb.201206095; Nasuhoglu C, 2002, AM J PHYSIOL-CELL PH, V283, pC223, DOI 10.1152/ajpcell.00486.2001; Shulga YV, 2011, CHEM REV, V111, P6186, DOI 10.1021/cr1004106; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Szentpetery Z, 2010, P NATL ACAD SCI USA, V107, P8225, DOI 10.1073/pnas.1000157107	30	74	79	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14289	14301		10.1074/jbc.M114.621375	http://dx.doi.org/10.1074/jbc.M114.621375			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25887399	Green Published, hybrid			2022-12-28	WOS:000355754600003
J	Cvetesic, N; Bilus, M; Gruic-Sovulj, I				Cvetesic, Nevena; Bilus, Mirna; Gruic-Sovulj, Ita			The tRNA A76 Hydroxyl Groups Control Partitioning of the tRNA-dependent Pre- and Post-transfer Editing Pathways in Class I tRNA Synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBONUCLEIC-ACID SYNTHETASE; ESCHERICHIA-COLI; AMINO-ACID; PROTEIN-SYNTHESIS; QUALITY-CONTROL; STRUCTURAL BASIS; TRNA SYNTHETASE; SITE; AMINOACYLATION; ISOLEUCYL	Aminoacyl-tRNA synthetases catalyze ATP-dependent covalent coupling of cognate amino acids and tRNAs for ribosomal protein synthesis. Escherichia coli isoleucyl-tRNA synthetase (IleRS) exploits both the tRNA-dependent pre- and post-transfer editing pathways to minimize errors in translation. However, the molecular mechanisms by which tRNA(Ile) organizes the synthetic site to enhance pre-transfer editing, an idiosyncratic feature of IleRS, remains elusive. Here we show that tRNA(Ile) affects both the synthetic and editing reactions localized within the IleRS synthetic site. In a complex with cognate tRNA, IleRS exhibits a 10-fold faster aminoacyl-AMP hydrolysis and a 10-fold drop in amino acid affinity relative to the free enzyme. Remarkably, the specificity against non-cognate valine was not improved by the presence of tRNA in either of these processes. Instead, amino acid specificity is determined by the protein component per se, whereas the tRNA promotes catalytic performance of the synthetic site, bringing about less error-prone and kinetically optimized isoleucyl-tRNA(Ile) synthesis under cellular conditions. Finally, the extent to which tRNA(Ile) modulates activation and pre-transfer editing is independent of the intactness of its 3'-end. This finding decouples aminoacylation and pre-transfer editing within the IleRS synthetic site and further demonstrates that the A76 hydroxyl groups participate in post-transfer editing only. The data are consistent with a model whereby the 3'-end of the tRNA remains free to sample different positions within the IleRS.tRNA complex, whereas the fine-tuning of the synthetic site is attained via conformational rearrangement of the enzyme through the interactions with the remaining parts of the tRNA body.	[Cvetesic, Nevena; Bilus, Mirna; Gruic-Sovulj, Ita] Univ Zagreb, Fac Sci, Dept Chem, Zagreb 10000, Croatia	University of Zagreb	Gruic-Sovulj, I (corresponding author), Univ Zagreb, Fac Sci, Dept Chem, Horvatovac 102a, Zagreb 10000, Croatia.	gruic@chem.pmf.hr		Cvetesic, Nevena/0000-0002-1575-5612	Unity through Knowledge Fund Grant [8/13]; European Community [315997]	Unity through Knowledge Fund Grant; European Community(European Commission)	This work was supported by Unity through Knowledge Fund Grant 8/13 (to I. G. S.) and in part by a grant from the European Community's Seventh Framework Programme (FP7RegPot/IntegraLife, 315997).	Ahel I, 2002, J BIOL CHEM, V277, P34743, DOI 10.1074/jbc.M206928200; ANSELME J, 1991, FEBS LETT, V280, P163, DOI 10.1016/0014-5793(91)80228-U; Augustine J, 1997, BIOCHEMISTRY-US, V36, P3473, DOI 10.1021/bi962395y; BALDWIN AN, 1966, J BIOL CHEM, V241, P839; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; BERGMANN F, 1961, J BIOL CHEM, V236, P1735; Beuning PJ, 2001, J BIOL CHEM, V276, P30779, DOI 10.1074/jbc.M104761200; Bishop AC, 2002, P NATL ACAD SCI USA, V99, P585, DOI 10.1073/pnas.012611299; Bovee ML, 2003, BIOCHEMISTRY-US, V42, P15102, DOI 10.1021/bi0355701; BREVET A, 1995, J BIOL CHEM, V270, P14439, DOI 10.1074/jbc.270.24.14439; BUONOCOR.V, 1972, J BIOL CHEM, V247, P4843; BUONOCORE V, 1972, J BIOL CHEM, V247, P1343; Carter Charles W. Jr., 2015, Life-Basel, V5, P294, DOI 10.3390/life5010294; CRAMER F, 1975, FEBS LETT, V56, P212, DOI 10.1016/0014-5793(75)81093-3; Cvetesic N, 2014, EMBO J, V33, P1639, DOI 10.15252/embj.201488199; Cvetesic N, 2012, J BIOL CHEM, V287, P25381, DOI 10.1074/jbc.M112.372151; Dock-Bregeon AC, 2004, MOL CELL, V16, P375, DOI 10.1016/S1097-2765(04)00591-X; Dulic M, 2014, BIOCHEMISTRY-US, V53, P6189, DOI 10.1021/bi5007699; Dulic M, 2010, J BIOL CHEM, V285, P23799, DOI 10.1074/jbc.M110.133553; ELDRED EW, 1972, J BIOL CHEM, V247, P2961; ERIANI G, 1990, NUCLEIC ACIDS RES, V18, P1475, DOI 10.1093/nar/18.6.1475; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Farrow MA, 1999, BIOCHEMISTRY-US, V38, P16898, DOI 10.1021/bi9920782; Fersht A., 1999, STRUCTURE MECH PROTE, P349; FERSHT AR, 1977, BIOCHEMISTRY-US, V16, P1025, DOI 10.1021/bi00624a034; FERSHT AR, 1979, BIOCHEMISTRY-US, V18, P2627, DOI 10.1021/bi00579a030; FILLEY SJ, 1993, ARCH BIOCHEM BIOPHYS, V307, P46, DOI 10.1006/abbi.1993.1558; Fukai S, 2000, CELL, V103, P793, DOI 10.1016/S0092-8674(00)00182-3; Fukunaga R, 2006, J MOL BIOL, V359, P901, DOI 10.1016/j.jmb.2006.04.025; Gruic-Sovulj I, 2005, J BIOL CHEM, V280, P23978, DOI 10.1074/jbc.M414260200; Gruic-Sovulj I, 2002, EUR J BIOCHEM, V269, P5271, DOI 10.1046/j.1432-1033.2002.03241.x; Gruic-Sovulj I, 2007, FEBS LETT, V581, P5110, DOI 10.1016/j.febslet.2007.09.058; Guo AC, 2013, NUCLEIC ACIDS RES, V41, pD625, DOI 10.1093/nar/gks992; Guth E, 2005, BIOCHEMISTRY-US, V44, P3785, DOI 10.1021/bi047923h; Hale SP, 1997, SCIENCE, V276, P1250, DOI 10.1126/science.276.5316.1250; Hendrickson TL, 2000, BIOCHEMISTRY-US, V39, P8180, DOI 10.1021/bi0004798; IBBA M, 1994, BIOCHEMISTRY-US, V33, P7107, DOI 10.1021/bi00189a013; Johnson K. A, 1992, TRANSIENT STATE KINE, P1; KATZE JR, 1970, J BIOL CHEM, V245, P923; Kiga D, 2002, P NATL ACAD SCI USA, V99, P9715, DOI 10.1073/pnas.142220099; Kiick KL, 2000, ANGEW CHEM INT EDIT, V39, P2148, DOI 10.1002/1521-3773(20000616)39:12<2148::AID-ANIE2148>3.0.CO;2-7; Lin L, 1996, NATURE, V384, P33, DOI 10.1038/384033b0; Lincecum TL, 2003, MOL CELL, V11, P951, DOI 10.1016/S1097-2765(03)00098-4; Ling JQ, 2012, J BIOL CHEM, V287, P28518, DOI 10.1074/jbc.M112.372920; LOFTFIELD RB, 1972, BIOCHEM J, V128, P1353, DOI 10.1042/bj1281353; MADERN D, 1992, FEBS LETT, V299, P85, DOI 10.1016/0014-5793(92)80106-Q; Minajigi A, 2010, J BIOL CHEM, V285, P23810, DOI 10.1074/jbc.M110.105320; Minajigi A, 2008, P NATL ACAD SCI USA, V105, P17748, DOI 10.1073/pnas.0804247105; Nomanbhoy TK, 1999, MOL CELL, V4, P519, DOI 10.1016/S1097-2765(00)80203-8; Nordin BE, 2003, BIOCHEMISTRY-US, V42, P12989, DOI 10.1021/bi035052q; Nordin BE, 2002, J BIOL CHEM, V277, P20510, DOI 10.1074/jbc.M202023200; NUREKI O, 1994, J MOL BIOL, V236, P710, DOI 10.1006/jmbi.1994.1184; Nureki O, 1998, SCIENCE, V280, P578, DOI 10.1126/science.280.5363.578; OSTREM DL, 1974, BIOCHEMISTRY-US, V13, P1338, DOI 10.1021/bi00704a006; Palencia A, 2012, NAT STRUCT MOL BIOL, V19, P677, DOI 10.1038/nsmb.2317; Perona JJ, 2014, TOP CURR CHEM, V344, P1, DOI 10.1007/128_2013_456; Perona JJ, 2012, BIOCHEMISTRY-US, V51, P8705, DOI 10.1021/bi301180x; Reynolds NM, 2010, P NATL ACAD SCI USA, V107, P4063, DOI 10.1073/pnas.0909640107; Rock FL, 2007, SCIENCE, V316, P1759, DOI 10.1126/science.1142189; Ruan BF, 2005, J BIOL CHEM, V280, P571, DOI 10.1074/jbc.M411039200; Sankaranarayanan R, 2000, NAT STRUCT BIOL, V7, P461; SCHMIDT E, 1994, SCIENCE, V264, P265, DOI 10.1126/science.8146659; Silvian LF, 1999, SCIENCE, V285, P1074, DOI 10.1126/science.285.5430.1074; Splan KE, 2008, J BIOL CHEM, V283, P7128, DOI 10.1074/jbc.M709902200; SPRINZL M, 1975, P NATL ACAD SCI USA, V72, P3049, DOI 10.1073/pnas.72.8.3049; Stehlin C, 1997, BIOCHEMISTRY-US, V36, P2932, DOI 10.1021/bi962295s; Tukalo M, 2005, NAT STRUCT MOL BIOL, V12, P923, DOI 10.1038/nsmb986; Uter NT, 2005, J BIOL CHEM, V280, P23966, DOI 10.1074/jbc.M414259200; Wolfson AD, 2002, P NATL ACAD SCI USA, V99, P5965, DOI 10.1073/pnas.092152799; WU MX, 1994, BIOCHEMISTRY-US, V33, P12260, DOI 10.1021/bi00206a032; Yadavalli SS, 2012, ADV PROTEIN CHEM STR, V86, P1, DOI 10.1016/B978-0-12-386497-0.00001-3; YANIV M, 1969, J MOL BIOL, V44, P1, DOI 10.1016/0022-2836(69)90401-X; YARUS M, 1969, J MOL BIOL, V42, P171, DOI 10.1016/0022-2836(69)90037-0; Zhang CM, 2003, J MOL BIOL, V327, P911, DOI 10.1016/S0022-2836(03)00241-9; Zuniga R, 2002, FEBS LETT, V532, P387, DOI 10.1016/S0014-5793(02)03720-1	75	17	17	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13981	13991		10.1074/jbc.M115.648568	http://dx.doi.org/10.1074/jbc.M115.648568			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25873392	Green Published, hybrid			2022-12-28	WOS:000355313000029
J	Liu, YH; Wang, YH; Chen, Y; Li, XH; Yang, J; Liu, Y; Shen, AG				Liu, Yonghua; Wang, Youhua; Chen, Ying; Li, Xiaohong; Yang, Jiao; Liu, Yang; Shen, Aiguo			Spy1 Protein Mediates Phosphorylation and Degradation of SCG10 Protein in Axonal Degeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WALLERIAN DEGENERATION; MICROTUBULE DYNAMICS; ENZYMATIC-ACTIVITY; ACTIVATION; EXPRESSION; APOPTOSIS; PATHWAY; DISEASE; KINASE; FAMILY	Axon loss is a destructive consequence of a wide range of neurological diseases without a clearly defined mechanism. Recent data demonstrate that SCG10 is a novel axonal maintenance factor and that rapid SCG10 loss after injury requires JNK activity; how JNK induces degradation of SCG10 is not well known. Here we showed that SCG10 was a binding partner of Spy1, a Speedy/RINGO family protein, which participated in cellular response to sciatic nerve injury. During the early stage of axonal injury, Spy1 expression was inversely correlated with SCG10. Spy1 mediated SCG10 phosphorylation and degradation partly in a JNK-dependent manner. Inhibition of Spy1 attenuated SCG10 phosphorylation and delayed injury-induced axonal degeneration. Taken together, these data suggest that Spy1 is an important regulator of SCG10 and can be targeted in future axo-protective therapeutics.	[Liu, Yonghua; Wang, Youhua; Chen, Ying; Li, Xiaohong; Yang, Jiao; Liu, Yang; Shen, Aiguo] Nantong Univ, Coll Med, Nantong 226001, Jiangsu, Peoples R China; [Liu, Yonghua; Wang, Youhua; Chen, Ying; Li, Xiaohong; Yang, Jiao; Liu, Yang; Shen, Aiguo] Nantong Univ, Jiangsu Prov Key Lab Inflammat & Mol Drug Target, Nantong 226001, Jiangsu, Peoples R China; [Shen, Aiguo] Nantong Univ, Jiangsu Prov Key Lab Neuroregenerat, Nantong 226001, Jiangsu, Peoples R China; [Shen, Aiguo] Nantong Univ, Coinnovat Ctr Neuroregenerat, Nantong 226001, Jiangsu, Peoples R China	Nantong University; Nantong University; Nantong University; Nantong University	Shen, AG (corresponding author), Nantong Univ, Jiangsu Prov Key Lab Inflammat & Mol Drug Target, 19 Qixiu Rd, Nantong 226001, Jiangsu, Peoples R China.	shen_aiguo@yahoo.com			National Basic Research Program of China (973 Program) [2012CB822104]; National Natural Science Foundation of China [314440037, 31270802, 81171140, 81200828, 31300902, 81200918]; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions; Colleges and Universities in Natural Science Research Project of Jiangsu Province [11KJA310002, 13KJB310009]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions; Colleges and Universities in Natural Science Research Project of Jiangsu Province	This work was supported by National Basic Research Program of China (973 Program, Grant 2012CB822104); the National Natural Science Foundation of China (Grants 314440037, 31270802, 81171140, 81200828, 31300902, and 81200918); a project funded by the Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions; and the Colleges and Universities in Natural Science Research Project of Jiangsu Province (Grants 11KJA310002 and 13KJB310009).	Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Avery MA, 2009, J CELL BIOL, V184, P501, DOI 10.1083/jcb.200808042; Cao JH, 2013, CELL MOL NEUROBIOL, V33, P213, DOI 10.1007/s10571-012-9887-2; Coleman MP, 2002, TRENDS NEUROSCI, V25, P532, DOI 10.1016/S0166-2236(02)02255-5; Conforti L, 2000, P NATL ACAD SCI USA, V97, P11377, DOI 10.1073/pnas.97.21.11377; Conforti L, 2009, J CELL BIOL, V184, P491, DOI 10.1083/jcb.200807175; Davis ST, 2001, SCIENCE, V291, P134, DOI 10.1126/science.291.5501.134; Dinarina A, 2005, BIOCHEM J, V386, P349, DOI 10.1042/BJ20041779; Gastwirt RF, 2006, J BIOL CHEM, V281, P35425, DOI 10.1074/jbc.M604720200; Gerdts J, 2011, J BIOL CHEM, V286, P28011, DOI 10.1074/jbc.M111.250472; Ghosh AS, 2011, J CELL BIOL, V194, P751, DOI 10.1083/jcb.201103153; Gilley J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000300; Golipour A, 2008, CANCER RES, V68, P3591, DOI 10.1158/0008-5472.CAN-07-6453; Huang Y, 2009, CELL MOL NEUROBIOL, V29, P403, DOI 10.1007/s10571-008-9332-8; Huntwork-Rodriguez S, 2013, J CELL BIOL, V202, P747, DOI 10.1083/jcb.201303066; Karaiskou A, 2001, J BIOL CHEM, V276, P36028, DOI 10.1074/jbc.M104722200; Ke Q, 2009, EXP MOL PATHOL, V87, P167, DOI 10.1016/j.yexmp.2009.07.011; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; McAndrew CW, 2007, CELL CYCLE, V6, P1937, DOI 10.4161/cc.6.15.4520; Morii H, 2006, J NEUROBIOL, V66, P1101, DOI 10.1002/neu.20295; Porter LA, 2003, MOL BIOL CELL, V14, P3664, DOI 10.1091/mbc.E02-12-0820; Riederer BM, 1997, P NATL ACAD SCI USA, V94, P741, DOI 10.1073/pnas.94.2.741; Sasaki Y, 2009, J NEUROSCI, V29, P5525, DOI 10.1523/JNEUROSCI.5469-08.2009; Shin JE, 2014, EXP NEUROL, V252, P1, DOI 10.1016/j.expneurol.2013.11.007; Shin JE, 2012, P NATL ACAD SCI USA, V109, pE3696, DOI 10.1073/pnas.1216204109; Tararuk T, 2006, J CELL BIOL, V173, P265, DOI 10.1083/jcb.200511055; Wang JT, 2012, J CELL BIOL, V196, P7, DOI 10.1083/jcb.201108111; Wang JJ, 2013, HUM MOL GENET, V22, P4888, DOI 10.1093/hmg/ddt339; Zhai QW, 2003, NEURON, V39, P217, DOI 10.1016/S0896-6273(03)00429-X; Zhang L, 2012, J MOL NEUROSCI, V47, P485, DOI 10.1007/s12031-012-9709-5	31	8	8	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13888	13894		10.1074/jbc.M114.611574	http://dx.doi.org/10.1074/jbc.M114.611574			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25869138	hybrid, Green Published			2022-12-28	WOS:000355313000021
J	Maeda, A; Ono, M; Holmbeck, K; Li, L; Kilts, TM; Kram, V; Noonan, ML; Yoshioka, Y; McNerny, EMB; Tantillo, MA; Kohn, DH; Lyons, KM; Robey, PG; Young, MF				Maeda, Azusa; Ono, Mitsuaki; Holmbeck, Kenn; Li, Li; Kilts, Tina M.; Kram, Vardit; Noonan, Megan L.; Yoshioka, Yuya; McNerny, Erin M. B.; Tantillo, Margaret A.; Kohn, David H.; Lyons, Karen M.; Robey, Pamela G.; Young, Marian F.			WNT1-induced Secreted Protein-1 (WISP1), a Novel Regulator of Bone Turnover and Wnt Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE GROWTH-FACTOR; CCN FAMILY PROTEINS; OSTEOBLAST DIFFERENTIATION; SKELETAL DEVELOPMENT; CAUSES OSTEOPENIA; MICE; OSTEOGENESIS; EXPRESSION; PATHWAYS; GENES	WISP1/CCN4 (hereafter referred to as WISP1), a member of the CCN family, is found in mineralized tissues and is produced by osteoblasts and their precursors. In this study, Wisp1-deficient (Wisp1(-/-)) mice were generated. Using dual-energy x-ray absorptiometry, we showed that by 3 months, the total bone mineral density of Wisp1(-/-) mice was significantly lower than that of WT mice. Further investigation by micro-computed tomography showed that female Wisp1(-/-) mice had decreased trabecular bone volume/total volume and that both male and female Wisp1(-/-) mice had decreased cortical bone thickness accompanied by diminished biomechanical strength. The molecular basis for decreased bone mass in Wisp1(-/-) mice arises from reduced bone formation likely caused by osteogenic progenitors that differentiate poorly compared with WT cells. Osteoclast precursors from Wisp1(-/-) mice developed more tartrate-resistant acid phosphatase-positive cells in vitro and in transplants, suggesting that WISP1 is also a negative regulator of osteoclast differentiation. When bone turnover (formation and resorption) was induced by ovariectomy, Wisp1(-/-) mice had lower bone mineral density compared WT mice, confirming the potential for multiple roles for WISP1 in controlling bone homeostasis. Wisp1(-/-) bone marrow stromal cells had reduced expression of beta-catenin and its target genes, potentially caused by WISP1 inhibition of SOST binding to LRP6. Taken together, our data suggest that the decreased bone mass found in Wisp1(-/-) mice could potentially be caused by an insufficiency in the osteodifferentiation capacity of bone marrow stromal cells arising from diminished Wnt signaling, ultimately leading to altered bone turnover and weaker biomechanically compromised bones.	[Maeda, Azusa; Ono, Mitsuaki; Holmbeck, Kenn; Li, Li; Kilts, Tina M.; Kram, Vardit; Noonan, Megan L.; Yoshioka, Yuya; Robey, Pamela G.; Young, Marian F.] NIDCR, Craniofacial & Skeletal Dis Branch, NIH, Bethesda, MD 20892 USA; [McNerny, Erin M. B.; Tantillo, Margaret A.; Kohn, David H.] Univ Michigan, Biol & Mat Sci, Ann Arbor, MI 48109 USA; [McNerny, Erin M. B.; Tantillo, Margaret A.; Kohn, David H.] Univ Michigan, Div Prosthodont, Ann Arbor, MI 48109 USA; [Lyons, Karen M.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Orthoped Hosp, Los Angeles, CA 90095 USA; [Lyons, Karen M.] Univ Calif Los Angeles, Orthoped Hosp, Dept Orthoped Surg, Los Angeles, CA 90095 USA; [Maeda, Azusa; Ono, Mitsuaki; Yoshioka, Yuya] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral Rehabil & Regenerat Med, Okayama, Okayama 7008558, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Okayama University	Young, MF (corresponding author), NIDCR, Craniofacial & Skeletal Dis Branch, NIH, Bldg 30,Rm 225, Bethesda, MD 20892 USA.	myoung@dir.nidcr.nih.gov	Robey, Pamela Gehron/H-1429-2011; Kohn, David/AAJ-4131-2020	Robey, Pamela Gehron/0000-0002-5316-5576; Young, Marian F/0000-0003-0929-8854; Noonan, Megan/0000-0002-1763-1867; McNerny, Erin/0000-0002-1825-9657; Holmbeck, Kenn/0000-0002-4472-3257	National Institutes of Health from NIDCR [1 Z01 DE000379-21]; NIAMS [R01 AR056657, AR052686]; NIDCR [T32 DE007057]; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056657, R01AR052686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE007057, ZIADE000380, ZIADE000379, ZIADE000676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000379] Funding Source: NIH RePORTER	National Institutes of Health from NIDCR; NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program Grant 1 Z01 DE000379-21 from NIDCR (to M. O., K. H., L. L., T. M. K., V. K., M. L. N., P. G. R., and M. F. Y.), Award R01 AR056657 from NIAMS and Award T32 DE007057 from NIDCR (to E. M., B. M., M. A. T., and D. H. K.), and Award AR052686 from NIAMS (to K. M. L.). This work was also supported by a fellowship from the Japan Society for the Promotion of Science (to A. M.).	Albers J, 2013, J CELL BIOL, V200, P537, DOI 10.1083/jcb.201207142; Canalis E, 2010, ENDOCRINOLOGY, V151, P3490, DOI 10.1210/en.2010-0145; Canalis E, 2010, ENDOCRINOLOGY, V151, P221, DOI 10.1210/en.2009-0574; Chen XD, 2004, FASEB J, V18, P948, DOI 10.1096/fj.03-0899com; Drake MT, 2014, CURR OPIN RHEUMATOL, V26, P447, DOI 10.1097/BOR.0000000000000073; French DM, 2004, AM J PATHOL, V165, P855, DOI 10.1016/S0002-9440(10)63348-2; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Heath E, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-18; Inkson CA, 2008, J CELL BIOCHEM, V104, P1865, DOI 10.1002/jcb.21754; Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505; Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599; Katsube K, 2009, DEV GROWTH DIFFER, V51, P55, DOI 10.1111/j.1440-169X.2009.01077.x; Kawaki H, 2008, J BONE MINER RES, V23, P1751, DOI 10.1359/JBMR.080615; Kawaki H, 2011, BONE, V49, P975, DOI 10.1016/j.bone.2011.06.033; Krebsbach PH, 1997, TRANSPLANTATION, V63, P1059, DOI 10.1097/00007890-199704270-00003; Matsushita Y, 2013, J BIOL CHEM, V288, P19973, DOI 10.1074/jbc.M113.454652; Minamizato T, 2007, BIOCHEM BIOPH RES CO, V354, P567, DOI 10.1016/j.bbrc.2007.01.029; Ono M, 2011, J BONE MINER RES, V26, P193, DOI 10.1002/jbmr.205; Parisi MS, 2006, BONE, V38, P671, DOI 10.1016/j.bone.2005.10.005; Pennica D, 1998, P NATL ACAD SCI USA, V95, P14717, DOI 10.1073/pnas.95.25.14717; Rydziel S, 2007, J BIOL CHEM, V282, P19762, DOI 10.1074/jbc.M700212200; Si WK, 2006, MOL CELL BIOL, V26, P2955, DOI 10.1128/MCB.26.8.2955-2964.2006; Smerdel-Ramoya' A, 2008, ENDOCRINOLOGY, V149, P4374, DOI 10.1210/en.2008-0254; Takigawa M, 2013, J CELL COMMUN SIGNAL, V7, P191, DOI 10.1007/s12079-013-0204-8; Tan TW, 2012, J CELL PHYSIOL, V227, P2531, DOI 10.1002/jcp.22991; Wallace JM, 2009, J BONE MINER RES, V24, P1002, DOI [10.1359/jbmr.081259, 10.1359/JBMR.081259]; WANG SJ, 2012, J NONPARAMETR STAT, V24, P1	27	54	56	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					14004	14018		10.1074/jbc.M114.628818	http://dx.doi.org/10.1074/jbc.M114.628818			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25864198	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000355313000031
J	Qi, SK; Wang, ZQ; Li, PS; Wu, QH; Shi, TL; Li, JW; Wong, JM				Qi, Shankang; Wang, Zhiqiang; Li, Pishun; Wu, Qihan; Shi, Tieliu; Li, Jiwen; Wong, Jiemin			Non-germ Line Restoration of Genomic Imprinting for a Small Subset of Imprinted Genes in Ubiquitin-like PHD and RING Finger Domain-Containing 1 (Uhrf1) Null Mouse Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DE-NOVO METHYLATION; DNA METHYLATION; CONTROL REGIONS; HISTONE H3; CHROMATIN; DNMT1; EXPRESSION; H19; METHYLTRANSFERASE; TRANSCRIPTION	The underlying mechanism for the establishment and maintenance of differential DNA methylation in imprinted genes is largely unknown. Previous studies using Dnmt1 knock-out embryonic stem (ES) cells demonstrated that, although re-expression of DNMT1 restored DNA methylation in the non-imprinted regions, the methylation patterns of imprinted genes could be restored only through germ line passage. Knock-out of Uhrf1, an accessory factor essential for DNMT1-mediated DNA methylation, in mouse ES cells also led to impaired global DNA methylation and loss of genomic imprinting. Here, we demonstrate that, although re-expression of UHRF1 in Uhrf1(-/-) ES cells restored DNA methylation for the bulk genome but not for most of the imprinted genes, it did rescue DNA methylation for the imprinted H19, Nnat, and Dlk1 genes. Analysis of histone modifications at the differential methylated regions of the imprinted genes by ChIP assays revealed that for the imprinted genes whose DNA methylation could be restored upon re-expression of UHRF1, the active histone markers (especially H3K4me3) were maintained at considerably low levels, and low levels were maintained even in Uhrf1(-/-) ES cells. In contrast, for the imprinted genes whose DNA methylation could not be restored upon UHRF1 re-expression, the active histone markers (especially H3K4me3) were relatively high and became even higher in Uhrf1(-/-) ES cells. Our study thus supports a role for histone modifications in determining the establishment of imprinting-related DNA methylation and demonstrates that mouse ES cells can be a valuable model for mechanistic study of the establishment and maintenance of differential DNA methylation in imprinted genes.	[Qi, Shankang; Wang, Zhiqiang; Li, Pishun; Wu, Qihan; Shi, Tieliu; Li, Jiwen; Wong, Jiemin] E China Normal Univ, Shanghai Key Lab Regulatory Biol, Inst Biomed Sci, Shanghai 200241, Peoples R China; [Qi, Shankang; Wang, Zhiqiang; Li, Pishun; Wu, Qihan; Shi, Tieliu; Li, Jiwen; Wong, Jiemin] E China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China; [Wong, Jiemin] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, Guangzhou 510060, Guangdong, Peoples R China	East China Normal University; East China Normal University; Sun Yat Sen University	Li, JW (corresponding author), E China Normal Univ, Shanghai Key Lab Regulatory Biol, Inst Biomed Sci, Shanghai 200241, Peoples R China.	jwli@bio.ecnu.edu.cn; jmweng@bio.ecnu.edu.cn		Wong, Jiemin/0000-0002-5311-842X	National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program" of China [2014ZX09507002-005]; Science and Technology Commission of Shanghai Municipality [14XD1401700, 11DZ2260300]; National Natural Science Foundation of China [30871381, 91219302, 81272287, 31371504]	National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program" of China; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grant 2014ZX09507002-005 from the National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program" of China; Grants 14XD1401700 and 11DZ2260300 from the Science and Technology Commission of Shanghai Municipality; and Grants 30871381, 91219302, 81272287, and 31371504 from the National Natural Science Foundation of China.	Bartolomei MS, 2009, GENE DEV, V23, P2124, DOI 10.1101/gad.1841409; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Carr MS, 2007, GENOMICS, V89, P280, DOI 10.1016/j.ygeno.2006.10.005; Choo JH, 2006, HUM MOL GENET, V15, P717, DOI 10.1093/hmg/ddi485; Ciccone DN, 2009, NATURE, V461, P415, DOI 10.1038/nature08315; Cleaton MAM, 2014, ANNU REV GENOM HUM G, V15, P93, DOI 10.1146/annurev-genom-091212-153441; Das R, 2009, MAMM GENOME, V20, P563, DOI 10.1007/s00335-009-9229-y; Delaval K, 2007, EMBO J, V26, P720, DOI 10.1038/sj.emboj.7601513; Ferguson-Smith AC, 2011, NAT REV GENET, V12, P565, DOI 10.1038/nrg3032; FERGUSONSMITH AC, 1993, NATURE, V362, P751, DOI 10.1038/362751a0; Ferron SR, 2011, NATURE, V475, P381, DOI 10.1038/nature10229; Fournier C, 2002, EMBO J, V21, P6560, DOI 10.1093/emboj/cdf655; Henckel A, 2012, EMBO J, V31, P606, DOI 10.1038/emboj.2011.425; Hirasawa R, 2008, GENE DEV, V22, P1607, DOI 10.1101/gad.1667008; Holm TM, 2005, CANCER CELL, V8, P275, DOI 10.1016/j.ccr.2005.09.007; Hu JL, 2009, P NATL ACAD SCI USA, V106, P22187, DOI 10.1073/pnas.0905767106; John RM, 2010, BRIEF FUNCT GENOMICS, V9, P294, DOI 10.1093/bfgp/elq010; Joseph RM, 2014, GENOMICS, V103, P183, DOI 10.1016/j.ygeno.2013.12.001; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kaneda M, 2010, GENES CELLS, V15, P169, DOI 10.1111/j.1365-2443.2009.01374.x; Kato Y, 2007, HUM MOL GENET, V16, P2272, DOI 10.1093/hmg/ddm179; Kota SK, 2010, DEV CELL, V19, P675, DOI 10.1016/j.devcel.2010.10.009; LEIGHTON PA, 1995, GENE DEV, V9, P2079, DOI 10.1101/gad.9.17.2079; Li BZ, 2011, CELL RES, V21, P1172, DOI 10.1038/cr.2011.92; Li J, 2012, J BIOL CHEM, V287, P10089, DOI 10.1074/jbc.M111.313965; Li XJ, 2008, DEV CELL, V15, P547, DOI 10.1016/j.devcel.2008.08.014; Li YF, 2011, CELL RES, V21, P466, DOI 10.1038/cr.2011.15; Liu XL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2562; McGraw S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003873; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; Nakamura T, 2012, NATURE, V486, P415, DOI 10.1038/nature11093; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Plasschaert RN, 2014, DEVELOPMENT, V141, P1805, DOI 10.1242/dev.101428; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Quenneville S, 2011, MOL CELL, V44, P361, DOI 10.1016/j.molcel.2011.08.032; Sasaki H, 1995, DEVELOPMENT, V121, P4195; Sasaki H, 2000, J BIOCHEM, V127, P711, DOI 10.1093/oxfordjournals.jbchem.a022661; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Tucker KL, 1996, GENE DEV, V10, P1008, DOI 10.1101/gad.10.8.1008; Unoki M, 2004, ONCOGENE, V23, P7601, DOI 10.1038/sj.onc.1208053; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Zhang JQ, 2011, CELL RES, V21, P1723, DOI 10.1038/cr.2011.176; Zhou YX, 1997, BIOTECHNIQUES, V22, P850	44	5	6	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					14181	14191		10.1074/jbc.M114.626697	http://dx.doi.org/10.1074/jbc.M114.626697			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25900245	Green Published, hybrid			2022-12-28	WOS:000355313000045
J	Rajbhandari, P; Ozers, MS; Solodin, NM; Warren, CL; Alarid, ET				Rajbhandari, Prashant; Ozers, Mary Szatkowski; Solodin, Natalia M.; Warren, Christopher L.; Alarid, Elaine T.			Peptidylprolyl Isomerase Pin1 Directly Enhances the DNA Binding Functions of Estrogen Receptor alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; TRANSCRIPTION FACTORS; PROLYL ISOMERIZATION; INTRINSIC DISORDER; RESPONSE ELEMENTS; STRUCTURAL BASIS; PHOSPHORYLATION SITES; ACTIVATION FUNCTIONS; STEROID-RECEPTOR; GENE-EXPRESSION	The transcriptional activity of estrogen receptor alpha (ER alpha), the key driver of breast cancer proliferation, is enhanced by multiple cellular interactions, including phosphorylation-dependent interaction with Pin1, a proline isomerase, which mediates cis-trans isomerization of the N-terminal Ser(P)(118)-Pro(119) in the intrinsically disordered AF1 (activation function 1) domain of ER alpha. Because both ER alpha and Pin1 have multiple cellular partners, it is unclear how Pin1 assists in the regulation of ER alpha transactivation mechanisms and whether the functional effects of Pin1 on ER alpha signaling are direct or indirect. Here, we tested the specific action of Pin1 on an essential step in ER alpha transactivation, binding to specific DNA sites. DNA binding analysis demonstrates that stable overexpression of Pin1 increases endogenous ER alpha DNA binding activity when activated by estrogen but not by tamoxifen or EGF. Increased DNA binding affinity is a direct effect of Pin1 on ER alpha because it is observed in solution-based assays with purified components. Further, our data indicate that isomerization is required for Pin1-modulation of ER alpha DNA interactions. In an unbiased in vitro DNA binding microarray with hundreds of thousands of permutations of ER alpha-binding elements, Pin1 selectively enhances the binding affinity of ER alpha to consensus DNA elements. These studies reveal that Pin1 isomerization of phosphorylated ER alpha can directly regulate the function of the adjacent DNA binding domain, and this interaction is further modulated by ligand binding in the ligand-binding domain, providing evidence for Pin1-dependent allosteric regulation of ER alpha function.	[Rajbhandari, Prashant; Ozers, Mary Szatkowski; Solodin, Natalia M.; Alarid, Elaine T.] Univ Wisconsin, Dept Oncol, McArdle Labs Canc Res, Madison, WI 53705 USA; [Rajbhandari, Prashant; Ozers, Mary Szatkowski; Solodin, Natalia M.; Alarid, Elaine T.] Univ Wisconsin, Carbone Comprehens Canc Ctr, Madison, WI 53705 USA; [Warren, Christopher L.] Proteovista LLC, Madison, WI 53719 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Alarid, ET (corresponding author), Univ Wisconsin, Carbone Comprehens Canc Ctr, Dept Oncol, Wisconsin Inst Med Res 6151, 1111 Highland Ave, Madison, WI 53705 USA.	alarid@oncology.wisc.edu		Rajbhandari, Prashant/0000-0002-8146-3861; Alarid, Elaine/0000-0002-9426-7974	McArdle Laboratories for Cancer Research; NATIONAL CANCER INSTITUTE [R01CA159578, T32CA009135] Funding Source: NIH RePORTER	McArdle Laboratories for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank McArdle Laboratories for Cancer Research for support of this project. We also thank the University of Wisconsin Carbone Comprehensive Cancer Center for use of its shared services to complete this research. We thank Dr. Kun Ping Lu (Harvard Medical School) for Pin1 reagents and Dr. Yongna Xing (University of Wisconsin, Madison, WI) for purified PP2A holoenzyme.	Atsriku C, 2009, MOL CELL PROTEOMICS, V8, P467, DOI 10.1074/mcp.M800282-MCP200; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Benecke A, 2000, EMBO REP, V1, P151, DOI 10.1093/embo-reports/kvd028; Brondani V, 2005, BIOCHEM BIOPH RES CO, V328, P6, DOI 10.1016/j.bbrc.2004.12.130; Bunone G, 1996, EMBO J, V15, P2174, DOI 10.1002/j.1460-2075.1996.tb00571.x; Carlson CD, 2010, P NATL ACAD SCI USA, V107, P4544, DOI 10.1073/pnas.0914023107; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Chandra V, 2013, NATURE, V495, P394, DOI 10.1038/nature11966; Chen DS, 2000, MOL CELL, V6, P127, DOI 10.1016/S1097-2765(00)00014-9; Cheng JW, 2007, ENDOCRINOLOGY, V148, P4634, DOI 10.1210/en.2007-0148; Das D, 2004, MOL ENDOCRINOL, V18, P2616, DOI 10.1210/me.2004-0125; Dutertre M, 2003, MOL ENDOCRINOL, V17, P1296, DOI 10.1210/me.2001-0316; Eckert B, 2005, NAT STRUCT MOL BIOL, V12, P619, DOI 10.1038/nsmb946; El Marzouk S, 2008, J STEROID BIOCHEM, V110, P186, DOI 10.1016/j.jsbmb.2008.03.034; Ellison-Zelski SJ, 2009, MOL CELL BIOL, V29, P4949, DOI 10.1128/MCB.00383-09; Endoh H, 1999, MOL CELL BIOL, V19, P5363; Farrell AS, 2013, MOL CELL BIOL, V33, P2930, DOI 10.1128/MCB.01455-12; Fujimoto Y, 2010, J BIOL CHEM, V285, P3126, DOI 10.1074/jbc.M109.055095; FURLOW JD, 1990, ENDOCRINOLOGY, V127, P1028, DOI 10.1210/endo-127-3-1028; Gianni M, 2009, CANCER RES, V69, P1016, DOI 10.1158/0008-5472.CAN-08-2603; Handel AE, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-45; He B, 2009, CELL RES, V19, P929, DOI 10.1038/cr.2009.87; Hennig L, 1998, BIOCHEMISTRY-US, V37, P5953, DOI 10.1021/bi973162p; Hilser VJ, 2011, J BIOL CHEM, V286, P39675, DOI 10.1074/jbc.R111.278929; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Khan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021939; Khanal P, 2012, ONCOGENE, V31, P3845, DOI 10.1038/onc.2011.548; KLEINHITPASS L, 1989, MOL CELL BIOL, V9, P43, DOI 10.1128/MCB.9.1.43; KLEINHITPASS L, 1988, NUCLEIC ACIDS RES, V16, P647, DOI 10.1093/nar/16.2.647; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Klinge CM, 2000, STEROIDS, V65, P227, DOI 10.1016/S0039-128X(99)00107-5; Kobayashi Y, 2000, J BIOL CHEM, V275, P15645, DOI 10.1074/jbc.M000042200; Kumar R, 2004, P NATL ACAD SCI USA, V101, P16425, DOI 10.1073/pnas.0407160101; Kumar R, 2013, J BIOL CHEM, V288, P30285, DOI 10.1074/jbc.M113.491787; KUMAR V, 1987, CELL, V51, P941, DOI 10.1016/0092-8674(87)90581-2; La Montagna R, 2012, CELL CYCLE, V11, P3415, DOI 10.4161/cc.21730; Laity JH, 2000, BIOCHEMISTRY-US, V39, P5341, DOI 10.1021/bi9926678; Laity JH, 2000, J MOL BIOL, V295, P719, DOI 10.1006/jmbi.1999.3406; Likhite VS, 2006, MOL ENDOCRINOL, V20, P3120, DOI 10.1210/me.2006-0068; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; Liou YC, 2002, P NATL ACAD SCI USA, V99, P1335, DOI 10.1073/pnas.032404099; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; Lu KP, 1996, NATURE, V380, P544; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu KP, 2006, MOL CARCINOGEN, V45, P397, DOI 10.1002/mc.20216; Lu ZM, 2014, CELL RES, V24, P1033, DOI 10.1038/cr.2014.109; Lucchetti C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055355; Lummis SCR, 2005, NATURE, V438, P248, DOI 10.1038/nature04130; Malovannaya A, 2011, CELL, V145, P787, DOI 10.1016/j.cell.2011.05.006; Medunjanin S, 2005, J BIOL CHEM, V280, P33006, DOI 10.1074/jbc.M506758200; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Metivier R, 2001, MOL ENDOCRINOL, V15, P1953, DOI 10.1210/me.15.11.1953; Ozers MS, 2009, METHODS MOL BIOL, V544, P637, DOI 10.1007/978-1-59745-483-4_41; Ozers MS, 1997, J BIOL CHEM, V272, P30405, DOI 10.1074/jbc.272.48.30405; Poolman TM, 2013, NUCLEIC ACIDS RES, V41, P8515, DOI 10.1093/nar/gkt624; Pufall MA, 2005, SCIENCE, V309, P142, DOI 10.1126/science.1111915; Pursglove SE, 2004, BIOCHEM BIOPH RES CO, V323, P750, DOI 10.1016/j.bbrc.2004.08.166; Rajbhandari P, 2014, ONCOGENE, V33, P1438, DOI 10.1038/onc.2013.78; Rajbhandari P, 2012, MOL CELL BIOL, V32, P445, DOI 10.1128/MCB.06073-11; Rogatsky I, 1999, J BIOL CHEM, V274, P22296, DOI 10.1074/jbc.274.32.22296; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Sarkar P, 2011, NAT CHEM BIOL, V7, P51, DOI 10.1038/NCHEMBIO.494; Schaufele F, 2005, P NATL ACAD SCI USA, V102, P9802, DOI 10.1073/pnas.0408819102; SCHWABE JWR, 1993, CELL, V75, P567, DOI 10.1016/0092-8674(93)90390-C; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Simons SS, 2014, MOL ENDOCRINOL, V28, P173, DOI 10.1210/me.2013-1334; Sommer S, 2001, SEMIN CANCER BIOL, V11, P339, DOI 10.1006/scbi.2001.0389; Stanya KJ, 2008, J CELL BIOL, V183, P49, DOI 10.1083/jcb.200806172; Thomas RS, 2008, J MOL ENDOCRINOL, V40, P173, DOI 10.1677/JME-07-0165; TORA L, 1989, CELL, V59, P477, DOI 10.1016/0092-8674(89)90031-7; Tzeng DZ, 1996, BIOCHEM BIOPH RES CO, V223, P554, DOI 10.1006/bbrc.1996.0933; Valley CC, 2005, MOL CELL BIOL, V25, P5417, DOI 10.1128/MCB.25.13.5417-5428.2005; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P639, DOI 10.1038/77929; Warnmark A, 2001, J BIOL CHEM, V276, P45939, DOI 10.1074/jbc.M107875200; Warren CL, 2006, P NATL ACAD SCI USA, V103, P867, DOI 10.1073/pnas.0509843102; Watanabe M, 2001, EMBO J, V20, P1341, DOI 10.1093/emboj/20.6.1341; Wei G, 2005, J BIOL CHEM, V280, P12271, DOI 10.1074/jbc.M409522200; Wulf G, 2003, BREAST CANCER RES, V5, P76, DOI 10.1186/bcr572; Wulf G, 2005, NAT CELL BIOL, V7, P435, DOI 10.1038/ncb0505-435; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Xu YX, 2007, GENE DEV, V21, P2950, DOI 10.1101/gad.1592807; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yi P, 2005, MOL CELL BIOL, V25, P9687, DOI 10.1128/MCB.25.21.9687-9699.2005	87	16	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13749	13762		10.1074/jbc.M114.621698	http://dx.doi.org/10.1074/jbc.M114.621698			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25866209	Green Published, hybrid			2022-12-28	WOS:000355313000011
J	Wright, FA; Lu, JP; Sliter, DA; Dupre, N; Rouleau, GA; Wojcikiewicz, RJH				Wright, Forrest A.; Lu, Justine P.; Sliter, Danielle A.; Dupre, Nicolas; Rouleau, Guy A.; Wojcikiewicz, Richard J. H.			A Point Mutation in the Ubiquitin Ligase RNF170 That Causes Autosomal Dominant Sensory Ataxia Destabilizes the Protein and Impairs Inositol 1,4,5-Trisphosphate Receptor-mediated Ca2+ Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; ER-ASSOCIATED DEGRADATION; ERLIN2; COMPLEX	RNF170 is an endoplasmic reticulum membrane ubiquitin ligase that contributes to the ubiquitination of activated inositol 1,4,5-trisphosphate (IP3) receptors, and also, when point mutated (arginine to cysteine at position 199), causes autosomal dominant sensory ataxia (ADSA), a disease characterized by neurodegeneration in the posterior columns of the spinal cord. Here we demonstrate that this point mutation inhibits RNF170 expression and signaling via IP3 receptors. Inhibited expression of mutant RNF170 was seen in cells expressing exogenous RNF170 constructs and in ADSA lymphoblasts, and appears to result from enhanced RNF170 autoubiquitination and proteasomal degradation. The basis for these effects was probed via additional point mutations, revealing that ionic interactions between charged residues in the transmembrane domains of RNF170 are required for protein stability. In ADSA lymphoblasts, platelet-activating factor-induced Ca2+ mobilization was significantly impaired, whereas neither Ca2+ store content, IP3 receptor levels, nor IP3 production were altered, indicative of a functional defect at the IP3 receptor locus, which may be the cause of neurodegeneration. CRISPR/Cas9-mediated genetic deletion of RNF170 showed that RNF170 mediates the addition of all of the ubiquitin conjugates known to become attached to activated IP3 receptors (monoubiquitin and Lys(48)-and Lys(63)-linked ubiquitin chains), and that wild-type and mutant RNF170 have apparently identical ubiquitin ligase activities toward IP3 receptors. Thus, the Ca2+ mobilization defect seen in ADSA lymphoblasts is apparently not due to aberrant IP3 receptor ubiquitination. Rather, the defect likely reflects abnormal ubiquitination of other substrates, or adaptation to the chronic reduction in RNF170 levels.	[Wright, Forrest A.; Lu, Justine P.; Wojcikiewicz, Richard J. H.] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA; [Sliter, Danielle A.] NINDS, NIH, Bethesda, MD 20892 USA; [Dupre, Nicolas] Univ Laval, CHU Quebec, Neuromuscular & Neurogenet Dis Clin, Quebec City, PQ G1J 1Z4, Canada; [Rouleau, Guy A.] McGill Univ, Montreal Neurol Inst & Hosp, Montreal, PQ H3A 2B4, Canada; [Rouleau, Guy A.] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Laval University; McGill University; McGill University	Wojcikiewicz, RJH (corresponding author), 750 E Adams St, Syracuse, NY 13210 USA.	wojcikir@upstate.edu	Dupre, Nicolas/Y-1828-2019; Regan, Clinton/E-6250-2012		National Institutes of Health [DK049194]; National Ataxia Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049194, R29DK049194] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Ataxia Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK049194 and the National Ataxia Foundation.	Al-Saif A, 2012, ANN NEUROL, V72, P510, DOI 10.1002/ana.23641; Alazami AM, 2011, NEUROGENETICS, V12, P333, DOI 10.1007/s10048-011-0291-8; Alzayady KJ, 2005, J BIOL CHEM, V280, P34530, DOI 10.1074/jbc.M508890200; Bano-Polo M, 2011, PROTEIN SCI, V20, P179, DOI 10.1002/pro.551; Bezprozvanny I, 2011, NEUROCHEM RES, V36, P1186, DOI 10.1007/s11064-010-0393-y; Brown SA, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00453; Budhidarmo R, 2012, TRENDS BIOCHEM SCI, V37, P58, DOI 10.1016/j.tibs.2011.11.001; Bultynck G, 2004, BIOCHEM J, V381, P87, DOI 10.1042/BJ20040072; Christianson JC, 2014, NAT STRUCT MOL BIOL, V21, P325, DOI 10.1038/nsmb.2793; Cui G, 2008, J MEMBRANE BIOL, V222, P91, DOI 10.1007/s00232-008-9105-9; Cui GY, 2013, J BIOL CHEM, V288, P20758, DOI 10.1074/jbc.M113.476226; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Foskett JK, 2010, PFLUG ARCH EUR J PHY, V460, P481, DOI 10.1007/s00424-010-0826-0; Kleiger G, 2014, TRENDS CELL BIOL, V24, P352, DOI 10.1016/j.tcb.2013.12.003; Lu JP, 2011, J BIOL CHEM, V286, P24426, DOI 10.1074/jbc.M111.251983; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Matilla-Duenas A, 2012, ADV EXP MED BIOL, V724, P351, DOI 10.1007/978-1-4614-0653-2_27; Metzger MB, 2014, BBA-MOL CELL RES, V1843, P47, DOI 10.1016/j.bbamcr.2013.05.026; Moeller JJ, 2008, ACTA NEUROPATHOL, V116, P331, DOI 10.1007/s00401-008-0362-6; Neutzner A, 2011, J BIOL CHEM, V286, P8633, DOI 10.1074/jbc.M110.197459; Partridge AW, 2004, PROTEINS, V54, P648, DOI 10.1002/prot.10611; Paulson HL, 2009, J NEURO-OPHTHALMOL, V29, P227, DOI 10.1097/WNO0b013e3181b416de; Pearce MMP, 2007, J BIOL CHEM, V282, P20104, DOI 10.1074/jbc.M701862200; Pearce MMP, 2009, J BIOL CHEM, V284, P10433, DOI 10.1074/jbc.M809801200; Pietruck F, 1998, DIABETOLOGIA, V41, P94, DOI 10.1007/s001250050872; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rosskopf D, 1998, AM J PHYSIOL-CELL PH, V274, pC1573, DOI 10.1152/ajpcell.1998.274.6.C1573; Ruggiano A, 2014, J CELL BIOL, V204, P868, DOI 10.1083/jcb.201312042; Seo MD, 2012, NATURE, V483, P108, DOI 10.1038/nature10751; Sliter DA, 2011, J BIOL CHEM, V286, P1074, DOI 10.1074/jbc.M110.188383; Sliter DA, 2008, J BIOL CHEM, V283, P35319, DOI 10.1074/jbc.M807288200; Stitham J, 2007, BRIT J PHARMACOL, V152, P513, DOI 10.1038/sj.bjp.0707413; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Valdmanis PN, 2011, BRAIN, V134, P602, DOI 10.1093/brain/awq329; van Geest M, 2000, MICROBIOL MOL BIOL R, V64, P13, DOI 10.1128/MMBR.64.1.13-33.2000; von Heijne G, 2006, NAT REV MOL CELL BIO, V7, P909, DOI 10.1038/nrm2063; Wakil SM, 2013, EUR J MED GENET, V56, P43, DOI 10.1016/j.ejmg.2012.10.003; Webster JM, 2003, J BIOL CHEM, V278, P38238, DOI 10.1074/jbc.M305600200; Weissman AM, 2011, NAT REV MOL CELL BIO, V12, P605, DOI 10.1038/nrm3173; Wojcikiewicz R.J.H., 2012, WILEY INTERDISCIPL R, V1, P126; Wojcikiewicz RJH, 2009, CELL CALCIUM, V46, P147, DOI 10.1016/j.ceca.2009.05.002; WOJCIKIEWICZ RJH, 1994, J NEUROCHEM, V63, P177; WOJCIKIEWICZ RJH, 1995, J BIOL CHEM, V270, P11678, DOI 10.1074/jbc.270.19.11678; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Yildirim Y, 2011, HUM MOL GENET, V20, P1886, DOI 10.1093/hmg/ddr070	47	20	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13948	13957		10.1074/jbc.M115.655043	http://dx.doi.org/10.1074/jbc.M115.655043			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25882839	Green Published, hybrid			2022-12-28	WOS:000355313000026
J	Bell, AJ; Frankel, LK; Bricker, TM				Bell, Adam J.; Frankel, Laurie K.; Bricker, Terry M.			High Yield Non-detergent Isolation of Photosystem I-Lightharvesting Chlorophyll II Membranes from Spinach Thylakoids IMPLICATIONS FOR THE ORGANIZATION OF THE PS I ANTENNAE IN HIGHER PLANTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HARVESTING COMPLEX-II; ARABIDOPSIS-THALIANA; CHLAMYDOMONAS-REINHARDTII; STATE TRANSITIONS; PROTEIN COMPLEXES; ENERGY-TRANSFER; PORE-SIZE; CYANOBACTERIA; SUBUNITS; LIPODISQ	Styrene-maleic acid copolymer was used to effect a non-detergent partial solubilization of thylakoids from spinach. A high density membrane fraction, which was not solubilized by the copolymer, was isolated and was highly enriched in the Photosystem (PS) I-light-harvesting chlorophyll (LHC) II supercomplex and depleted of PS II, the cytochrome b(6)/f complex, and ATP synthase. The LHC II associated with the supercomplex appeared to be energetically coupled to PS I based on 77 K fluorescence, P-700 photooxidation, and PS I electron transport light saturation experiments. The chlorophyll (Chl) a/b ratio of the PS I-LHC II membranes was 3.2 +/- 0.9, indicating that on average, three LHC II trimers may associate with each PS I. The implication of these findings within the context of higher plant PS I antenna organization is discussed.	[Bell, Adam J.; Frankel, Laurie K.; Bricker, Terry M.] Louisiana State Univ, Dept Biol Sci, Biochem & Mol Biol Sect, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Bricker, TM (corresponding author), 202 Life Sci Bldg, Baton Rouge, LA 70803 USA.	btbric@lsu.edu			Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy [DE-FG02-98ER20310]	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE))	This work was supported by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy Grant DE-FG02-98ER20310 (to T. M. B. and L. K. F.). The authors declare that they have no conflicts of interest with the contents of this article.	ALBERTSSON PA, 1994, METHOD ENZYMOL, V228, P469; Amunts A, 2010, J BIOL CHEM, V285, P3478, DOI 10.1074/jbc.M109.072645; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; Bibby TS, 2001, NATURE, V413, P590, DOI 10.1038/35098153; Boekema EJ, 2001, NATURE, V412, P745, DOI 10.1038/35089104; BRUCE BD, 1988, J BIOL CHEM, V263, P7302; BURNAP RL, 1993, PLANT PHYSIOL, V103, P893, DOI 10.1104/pp.103.3.893; Caffarri S, 2004, BIOCHEMISTRY-US, V43, P9467, DOI 10.1021/bi036265i; CALLAHAN FE, 1989, PLANT PHYSIOL, V91, P629, DOI 10.1104/pp.91.2.629; Chitnis PR, 2001, ANNU REV PLANT PHYS, V52, P593, DOI 10.1146/annurev.arplant.52.1.593; Croce R, 2013, PHOTOSYNTH RES, V116, P153, DOI 10.1007/s11120-013-9838-x; Danielsson R, 2004, BBA-BIOENERGETICS, V1608, P53, DOI 10.1016/j.bbabio.2003.10.005; Danielsson R, 2009, BBA-BIOENERGETICS, V1787, P25, DOI 10.1016/j.bbabio.2008.10.002; DELEPELAIRE P, 1979, P NATL ACAD SCI USA, V76, P111, DOI 10.1073/pnas.76.1.111; Drop B, 2014, PLANT J, V78, P181, DOI 10.1111/tpj.12459; Feissner R, 2003, ANAL BIOCHEM, V315, P90, DOI 10.1016/S0003-2697(02)00658-9; Galka P, 2012, PLANT CELL, V24, P2963, DOI 10.1105/tpc.112.100339; Ihalainen JA, 2002, BIOPHYS J, V83, P2190, DOI 10.1016/S0006-3495(02)73979-9; Kirchhoff H, 2013, PLANT PHYSIOL, V161, P497, DOI 10.1104/pp.112.207548; Kouril R, 2005, BIOCHEMISTRY-US, V44, P10935, DOI 10.1021/bi051097a; Liu HJ, 2013, SCIENCE, V342, P1104, DOI 10.1126/science.1242321; Long AR, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-41; METZ JG, 1985, FEBS LETT, V185, P191, DOI 10.1016/0014-5793(85)80768-7; Narayanan J, 2006, J PHYS CONF SER, V28, P83, DOI 10.1088/1742-6596/28/1/017; Orwick MC, 2012, ANGEW CHEM INT EDIT, V51, P4653, DOI 10.1002/anie.201201355; Orwick-Rydmark M, 2012, NANO LETT, V12, P4687, DOI 10.1021/nl3020395; Pernodet N, 1997, ELECTROPHORESIS, V18, P55, DOI 10.1002/elps.1150180111; Qin XC, 2011, PHOTOCHEM PHOTOBIOL, V87, P143, DOI 10.1111/j.1751-1097.2010.00830.x; Raschle T, 2010, CURR OPIN STRUC BIOL, V20, P471, DOI 10.1016/j.sbi.2010.05.006; Ruban AV, 1997, BBA-BIOENERGETICS, V1321, P61, DOI 10.1016/S0005-2728(97)00047-9; Scheidelaar S, 2015, BIOPHYS J, V108, P279, DOI 10.1016/j.bpj.2014.11.3464; Scheller HV, 2001, BBA-BIOENERGETICS, V1507, P41, DOI 10.1016/S0005-2728(01)00196-7; Serebryany E, 2012, BBA-BIOMEMBRANES, V1818, P225, DOI 10.1016/j.bbamem.2011.07.047; Swainsbury DJK, 2014, ANGEW CHEM INT EDIT, V53, P11803, DOI 10.1002/anie.201406412; Takahashi H, 2014, PLANT CELL PHYSIOL, V55, P1437, DOI 10.1093/pcp/pcu071; TJUS SE, 1995, PHOTOSYNTH RES, V45, P41, DOI 10.1007/BF00032234; VALLON O, 1991, P NATL ACAD SCI USA, V88, P8262, DOI 10.1073/pnas.88.18.8262; van Oort B, 2010, BIOPHYS J, V98, P922, DOI 10.1016/j.bpj.2009.11.012; Wientjes E, 2013, BBA-BIOENERGETICS, V1827, P420, DOI 10.1016/j.bbabio.2012.12.009; Zhang SP, 2004, J BIOL CHEM, V279, P3180, DOI 10.1074/jbc.M311640200	40	58	58	3	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18429	18437		10.1074/jbc.M115.663872	http://dx.doi.org/10.1074/jbc.M115.663872			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26055710	hybrid, Green Published			2022-12-28	WOS:000358512100015
J	Kim, IH; Kim, IJ; Wen, Y; Park, NY; Park, J; Lee, KW; Koh, A; Lee, JH; Koo, SH; Kim, KS				Kim, In Hwang; Kim, Ik-Jung; Wen, Yancheng; Park, Na-Young; Park, Jinyoung; Lee, Keun-Woo; Koh, Ara; Lee, Ji-Hyun; Koo, Seung-Hoi; Kim, Kun-Soo			Vibrio vulnificus Secretes an Insulin-degrading Enzyme That Promotes Bacterial Proliferation in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRULENCE FACTORS; PROTEASE-III; EXPRESSION; IDENTIFICATION; GLUCOSE; GENE; INFECTION; SITE; TRANSPORT; INCREASE	We describe a novel insulin-degrading enzyme, SidC, that contributes to the proliferation of the human bacterial pathogen Vibrio vulnificus in a mouse model. SidC is phylogenetically distinct from other known insulin-degrading enzymes and is expressed and secreted specifically during host infection. Purified SidC causes a significant decrease in serum insulin levels and an increase in blood glucose levels in mice. A comparison of mice infected with wild type V. vulnificus or an isogenic sidC-deletion strain showed that wild type bacteria proliferated to higher levels. Additionally, hyperglycemia leads to increased proliferation of V. vulnificus in diabetic mice. Consistent with these observations, the sid operon was up-regulated in response to low glucose levels through binding of the cAMP-receptor protein (CRP) complex to a region upstream of the operon. We conclude that glucose levels are important for the survival of V. vulnificus in the host, and that this pathogen uses SidC to actively manipulate host endocrine signals, making the host environment more favorable for bacterial survival and growth.	[Kim, In Hwang; Kim, Ik-Jung; Wen, Yancheng; Park, Na-Young; Lee, Keun-Woo; Koh, Ara; Kim, Kun-Soo] Sogang Univ, Dept Life Sci, Seoul 121742, South Korea; [Park, Jinyoung; Lee, Ji-Hyun; Koo, Seung-Hoi] Korea Univ, Div Life Sci, Seoul 136701, South Korea	Sogang University; Korea University	Kim, KS (corresponding author), Sogang Univ, Dept Life Sci, Seoul 121742, South Korea.	kskim@sogang.ac.kr		KIM, KUN-SOO/0000-0002-5433-4175; Koh, Ara/0000-0001-7673-034X	National Research Foundation (NRF) of Korea, Korean government [NRF-2011-0018115]	National Research Foundation (NRF) of Korea, Korean government(National Research Foundation of Korea)	This work was supported by the National Research Foundation (NRF) of Korea, Korean government Grant NRF-2011-0018115. The authors declare that they have no conflict of interest with the contents of this article.	ADEN DP, 1979, NATURE, V282, P615, DOI 10.1038/282615a0; ANASTASI A, 1993, BIOCHEM J, V290, P601, DOI 10.1042/bj2900601; Baek CH, 2003, J MICROBIOL BIOTECHN, V13, P872; BECKER AB, 1992, P NATL ACAD SCI USA, V89, P3835, DOI 10.1073/pnas.89.9.3835; BECKER AB, 1993, BIOCHEM J, V292, P137, DOI 10.1042/bj2920137; Bellia F, 2013, J MASS SPECTROM, V48, P135, DOI 10.1002/jms.3060; Bowden SD, 2009, INFECT IMMUN, V77, P3117, DOI 10.1128/IAI.00093-09; Brunton J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003552; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; CHENG YSE, 1979, J BIOL CHEM, V254, P4698; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; DYKSTRA CC, 1985, J BACTERIOL, V163, P1055, DOI 10.1128/JB.163.3.1055-1059.1985; Gan YH, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003794; Glebov K, 2011, J BIOL CHEM, V286, P22711, DOI 10.1074/jbc.C110.217893; Haque R, 2014, CNS NEUROL DISORD-DR, V13, P259, DOI 10.2174/18715273113126660139; HOOPER NM, 1994, FEBS LETT, V354, P1, DOI 10.1016/0014-5793(94)01079-X; Horseman MA, 2011, INT J INFECT DIS, V15, pE157, DOI 10.1016/j.ijid.2010.11.003; HUMMEL KP, 1972, BIOCHEM GENET, V7, P1, DOI 10.1007/BF00487005; Jeong HS, 2001, J BIOL CHEM, V276, P13875, DOI 10.1074/jbc.M010567200; Jones MK, 2009, INFECT IMMUN, V77, P1723, DOI 10.1128/IAI.01046-08; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; Kim IH, 2013, INFECT IMMUN, V81, P2888, DOI 10.1128/IAI.00375-13; Kim IH, 2011, J MICROBIOL BIOTECHN, V21, P1228, DOI 10.4014/jmb.1111.11016; Kim YJ, 2010, FEBS LETT, V584, P4537, DOI 10.1016/j.febslet.2010.10.035; Kimata K, 1997, P NATL ACAD SCI USA, V94, P12914, DOI 10.1073/pnas.94.24.12914; Kingsbury JM, 2006, EUKARYOT CELL, V5, P816, DOI 10.1128/EC.5.5.816-824.2006; KOENIG KL, 1991, WESTERN J MED, V155, P400; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lee HJ, 2012, J MICROBIOL BIOTECHN, V22, P46, DOI 10.4014/jmb.1108.08042; Lee KE, 2007, J MICROBIOL BIOTECHN, V17, P234; Lee KJ, 2011, NAT CHEM BIOL, V7, P434, DOI [10.1038/NCHEMBIO.589, 10.1038/nchembio.589]; MAHAN MJ, 1993, SCIENCE, V259, P686, DOI 10.1126/science.8430319; Maianti JP, 2014, NATURE, V511, P94, DOI 10.1038/nature13297; McArdle J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002502; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; MIRSKY A, 1949, ARCH BIOCHEM, V20, P1; PERLMAN D, 1983, J MOL BIOL, V167, P391, DOI 10.1016/S0022-2836(83)80341-6; Popoff MR, 2009, FUTURE MICROBIOL, V4, P1021, DOI 10.2217/FMB.09.72; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Ribet D, 2010, FEBS LETT, V584, P2748, DOI 10.1016/j.febslet.2010.05.012; Ryu D, 2011, DIABETES, V60, P1072, DOI 10.2337/db10-1046; Ryu Y, 2012, MICROBIOL-SGM, V158, P1294, DOI 10.1099/mic.0.055269-0; Schild S, 2007, CELL HOST MICROBE, V2, P264, DOI 10.1016/j.chom.2007.09.004; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; Sikora AE, 2007, J BACTERIOL, V189, P8484, DOI 10.1128/JB.00583-07; SWAMY KHS, 1982, J BACTERIOL, V149, P1027, DOI 10.1128/JB.149.3.1027-1033.1982; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Terry LJ, 2012, P NATL ACAD SCI USA, V109, P3071, DOI 10.1073/pnas.1200494109; Wen Y, 2012, J BIOL CHEM, V287, P26727, DOI 10.1074/jbc.M112.374165; Wu SG, 1998, P NATL ACAD SCI USA, V95, P14979, DOI 10.1073/pnas.95.25.14979; Xavier MN, 2013, CELL HOST MICROBE, V14, P159, DOI 10.1016/j.chom.2013.07.009	51	5	6	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18708	18720		10.1074/jbc.M115.656306	http://dx.doi.org/10.1074/jbc.M115.656306			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26041774	Green Published, hybrid			2022-12-28	WOS:000358512100039
J	Sharma, A; Solmaz, SR; Blobel, G; Melcak, I				Sharma, Alok; Solmaz, Sozanne R.; Blobel, Guenter; Melcak, Ivo			Ordered Regions of Channel Nucleoporins Nup62, Nup54, and Nup58 Form Dynamic Complexes in Solution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-PORE COMPLEX; SEDIMENTATION EQUILIBRIUM; P62 COMPLEX; ANALYTICAL ULTRACENTRIFUGATION; TRANSPORT; GLYCOPROTEINS; ARCHITECTURE; PREDICTION; BINDING; DOMAIN	Three out of similar to 30 nucleoporins, Nup62, Nup54, and Nup58, line the nuclear pore channel. These "channel" nucleoporins each contain an ordered region of similar to 150-200 residues, which is predicted to be segmented into 3-4 alpha-helical regions of similar to 40-80 residues. Notably, these segmentations are evolutionarily conserved between uni- and multicellular eukaryotes. Strikingly, the boundaries of these segments match our previously reported mapping and crystal data, which collectively identified two "cognate" segments of Nup54, each interacting with cognate segments, one in Nup58 and the other one in Nup62. Because Nup54 and Nup58 cognate segments form crystallographic hetero- or homo-oligomers, we proposed that these oligomers associate into inter-convertible "mid-plane" rings: a single large ring (40-50 nm diameter, consisting of eight heterododecamers) or three small rings (10-20 nm diameter, each comprising eight homo-tetramers). Each "ring cycle" would recapitulate" dilation" and "constriction" of the nuclear pore complex's central transport channel. As for the Nup54.Nup62 interactome, it forms a 1: 2 triple helix ("finger"), multiples of which project alternately up and down from mid-plane ring(s). Collectively, our previous crystal data suggested a copy number of 128, 64, and 32 for Nup62, Nup54, and Nup58, respectively, that is, a 4: 2: 1 stoichiometry. Here, we carried out solution analysis utilizing the entire ordered regions of Nup62, Nup54, and Nup58, and demonstrate that they form a dynamic "triple complex" that is heterogeneously formed from our previously characterized Nup54.Nup58 and Nup54.Nup62 interactomes. These data are consistent both with our crystal structure-deduced copy numbers and stoichiometries and also with our ring cycle model for structure and dynamics of the nuclear pore channel.	[Sharma, Alok; Solmaz, Sozanne R.; Blobel, Guenter; Melcak, Ivo] Rockefeller Univ, Cell Biol Lab, Howard Hughes Med Inst, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	Blobel, G (corresponding author), Rockefeller Univ, Cell Biol Lab, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10065 USA.	blobel@rockefeller.edu; melcaki@rockefeller.edu	Sharma, Alok/AAE-4725-2022	Sharma, Alok/0000-0002-7668-3501; Sharma, Alok/0000-0001-5199-2319; Solmaz, Sozanne R/0000-0002-1703-3701	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Asakawa H, 2014, NUCLEUS-PHILA, V5, P149, DOI 10.4161/nucl.28487; Bailer SM, 2001, MOL CELL BIOL, V21, P7944, DOI 10.1128/MCB.21.23.7944-7955.2001; BUSS F, 1995, J CELL BIOL, V128, P251, DOI 10.1083/jcb.128.3.251; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; FINLAY DR, 1991, J CELL BIOL, V114, P169, DOI 10.1083/jcb.114.1.169; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, DOI DOI 10.1385/1592598900; GRANDI P, 1995, EMBO J, V14, P76, DOI 10.1002/j.1460-2075.1995.tb06977.x; GUAN TL, 1995, MOL BIOL CELL, V6, P1591, DOI 10.1091/mbc.6.11.1591; Hoelz A, 2011, ANNU REV BIOCHEM, V80, P613, DOI 10.1146/annurev-biochem-060109-151030; Hu TH, 1996, J CELL BIOL, V134, P589, DOI 10.1083/jcb.134.3.589; KITA K, 1993, J BIOCHEM-TOKYO, V113, P377, DOI 10.1093/oxfordjournals.jbchem.a124054; Koh J, 2015, CELL, V161, P1361, DOI 10.1016/j.cell.2015.05.013; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Melcak I, 2007, SCIENCE, V315, P1729, DOI 10.1126/science.1135730; Pollard TD, 2010, MOL BIOL CELL, V21, P4061, DOI 10.1091/mbc.E10-08-0683; ROARK DE, 1976, BIOPHYS CHEM, V5, P185, DOI 10.1016/0301-4622(76)80034-8; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Solmaz SR, 2013, P NATL ACAD SCI USA, V110, P5858, DOI 10.1073/pnas.1302655110; Solmaz SR, 2011, CELL, V147, P590, DOI 10.1016/j.cell.2011.09.034; Ulrich A, 2014, MOL BIOL CELL, V25, P1484, DOI 10.1091/mbc.E13-12-0745; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014	24	12	12	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18370	18378		10.1074/jbc.M115.663500	http://dx.doi.org/10.1074/jbc.M115.663500			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26025361	Green Published, hybrid			2022-12-28	WOS:000358512100010
J	Tuvdendorj, D; Borsheim, E; Sharp, CP; Zhang, XJ; Barone, CM; Chinkes, DL; Wolfe, RR				Tuvdendorj, Demidmaa; Borsheim, Elisabet; Sharp, Carwyn P.; Zhang, Xiaojun; Barone, Carrie M.; Chinkes, David L.; Wolfe, Robert R.			Amino Acid Availability Regulates the Effect of Hyperinsulinemia on Skin Protein Metabolism in Pigs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE PROTEIN; NEONATAL PIGS; INSULIN; STIMULATION; NUTRITION	The effects of amino acid supply and insulin infusion on skin protein kinetics (fractional synthesis rate (FSR), fractional breakdown rate (FBR), and net balance (NB)) in pigs were investigated. Four-month-old pigs were divided into four groups as follows: control, insulin (INS), amino acid (AA), and INS + AA groups based on the nutritional and hormonal conditions. L-[ring-C-13(6)] Phenylalanine was infused. FBR was estimated from the enrichment ratio of arterial phenylalanine to intracellular free phenylalanine. Plasma INS was increased (p< 0.05) in the INS and INS + AA groups. Plasma glucose was maintained by infusion of glucose in the groups receiving INS. The interventions did not change the NB of skin protein. However, the interventions affected the FSR and FBR differently. An infusion of INS significantly increased both FSR and FBR, although AA infusion did not. When an AA infusion was added to the infusion of insulin (INS + AA group), FSR and FBR were both lower when compared with the INS group. Our data demonstrate that in anesthetized pigs INS infusion did not exert an anabolic effect, but rather it increased AA cycling into and out of skin protein. Because co-infusion of AAs with INS ameliorated this effect, it is likely that the increased AA cycling during INS infusion was related to AA supply. Although protein kinetics were affected by both INS and AAs, none of the interventions affected the skin protein deposition. Thus, skin protein content is closely regulated under normal circumstances and is not subject to transient changes in AAs or hormonal concentrations.	[Tuvdendorj, Demidmaa] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Sharp, Carwyn P.; Zhang, Xiaojun; Barone, Carrie M.; Chinkes, David L.] Univ Texas Med Branch, Dept Surg, Galveston, TX 77555 USA; [Sharp, Carwyn P.; Zhang, Xiaojun; Barone, Carrie M.; Chinkes, David L.] Shriners Hosp Children, Metab Unit, Galveston, TX 77555 USA; [Borsheim, Elisabet] Univ Arkansas Med Sci, Ctr Translat Res Aging & Longev, Dept Pediat, Little Rock, AR 72205 USA; [Borsheim, Elisabet; Wolfe, Robert R.] Univ Arkansas Med Sci, Ctr Translat Res Aging & Longev, Dept Geriatr, Little Rock, AR 72205 USA; [Borsheim, Elisabet] Arkansas Childrens Nutr Ctr, Little Rock, AR 72205 USA; [Borsheim, Elisabet] Arkansas Childrens Hosp, Res Inst, Little Rock, AR 72205 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; Arkansas Children's Hospital	Tuvdendorj, D (corresponding author), Univ Texas Med Branch, Div Endocrinol, Dept Internal Med, 8-138 Med Res Bldg,301 Univ Blvd, Galveston, TX 77555 USA.	detuvden@utmb.edu	Tuvdendorj, Demidmaa Ravsal/AAC-4196-2019; zhang, jin/GXV-9154-2022; Børsheim, Elisabet/O-4927-2015; Regan, Clinton/E-6250-2012	Tuvdendorj, Demidmaa Ravsal/0000-0002-3324-5552; Børsheim, Elisabet/0000-0002-7842-0625; 	National Institutes of Health [RO1 AR0490380-05, AG028718]; Shriners Grant [84090, 84050]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028718] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Grant; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 AR0490380-05 and AG028718. This work was also supported by Shriners Grant 84090 for Mass Spec Share Facility and Grant 84050 for Lung Lymph Laboratory Special Shared Facility. The authors declare that they have no conflicts of interest with the contents of this article.	BIOLO G, 1994, AM J PHYSIOL, V267, pE467, DOI 10.1152/ajpendo.1994.267.3.E467; Davis TA, 2002, AM J PHYSIOL-ENDOC M, V282, pE880, DOI 10.1152/ajpendo.00517.2001; Davis TA, 2001, AM J PHYSIOL-ENDOC M, V280, pE770, DOI 10.1152/ajpendo.2001.280.5.E770; Graves C, 2009, J BURN CARE RES, V30, P77, DOI 10.1097/BCR.0b013e3181921f0d; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Luiking YC, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-9; Prod'homme M, 2004, CURR OPIN CLIN NUTR, V7, P71, DOI 10.1097/00075197-200401000-00012; Rooyackers OE, 1997, ANNU REV NUTR, V17, P457, DOI 10.1146/annurev.nutr.17.1.457; SAKURAI Y, 1995, ANN SURG, V222, P283, DOI 10.1097/00000658-199509000-00007; Suryawan A, 2009, AMINO ACIDS, V37, P97, DOI 10.1007/s00726-008-0149-z; Tesseraud S, 2007, DOMEST ANIM ENDOCRIN, V33, P123, DOI 10.1016/j.domaniend.2006.06.002; Volpi E., 2001, HDB PHYSL, VII, P735; Wolfe R R, 2000, Curr Opin Clin Nutr Metab Care, V3, P67, DOI 10.1097/00075197-200001000-00011; Wolfe R. R., 2005, ISOTOPE TRACERS META, P363; Zhang XJ, 1998, AM J PHYSIOL-ENDOC M, V274, pE484, DOI 10.1152/ajpendo.1998.274.3.E484; Zhang XJ, 2003, AM J PHYSIOL-ENDOC M, V284, pE1191, DOI 10.1152/ajpendo.00460.2002; Zhang XJ, 2002, AM J PHYSIOL-ENDOC M, V282, pE1308, DOI 10.1152/ajpendo.00361.2001	17	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					17776	17783		10.1074/jbc.M114.636100	http://dx.doi.org/10.1074/jbc.M114.636100			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26032410	hybrid, Green Published			2022-12-28	WOS:000358511700012
J	Kundumani-Sridharan, V; Subramani, J; Das, KC				Kundumani-Sridharan, Venkatesh; Subramani, Jaganathan; Das, Kumuda C.			Thioredoxin Activates MKK4-NF kappa B Pathway in a Redox-dependent Manner to Control Manganese Superoxide Dismutase Gene Expression in Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; ALPHA-INDUCED APOPTOSIS; MEK KINASE 1; PROTEIN-KINASE; SIGNALING PATHWAY; MNSOD GENE; TNF-ALPHA; INDUCTION; STRESS; MECHANISM	The mitogen-activated protein kinase kinase 4 (MKK4) is activated via phosphorylation of Ser-257 and Thr-261 by upstream MAP3Ks and activates JNK and p38 MAPKs in response to cellular stress. We show that thioredoxin (Trx), a cellular redox protein, activates MKK4 via Cys-246 and Cys-266 residues as mutation of these residues renders MKK4 insensitive to phosphorylation by MAP3Ks, TNF alpha, or Trx. MKK4 is activated in vitro by reduced Trx but not oxidized Trx in the absence of an upstream kinase, suggesting that autophosphorylation of this protein occurs due to reduction of Cys-246 and Cys-266 by Trx. Additionally, mutation of Cys-246 and Cys-266 resulted in loss of kinase activity suggesting that the redox state of Cys-246 and Cys-266 is a critical determinant of MKK4 activation. Trx induces manganese superoxide dismutase (MnSOD) gene transcription by activating MKK4 via redox control of Cys246 and Cys-266, as mutation of these residues abrogates MKK4 activation and MnSOD expression. We further show that MKK4 activates NF kappa B for its binding to the MnSOD promoter, which leads to AP-1 dissociation followed by MnSOD transcription. Taken together, our studies show that the redox status of Cys246 and Cys-266 in MKK4 controls its activities independent of MAP3K, demonstrating integration of the endothelial redox environment to MAPK signaling.	Texas Tech Univ, Hlth Sci Ctr, Dept Anesthesiol, Lubbock, TX 79430 USA; Texas Tech Univ, Hlth Sci Ctr, Ctr Excellence Cardiovasc Res, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Das, KC (corresponding author), 3601 4th St MS 6598, Lubbock, TX 79430 USA.	kumuda.das@ttuhsc.edu	Kundumani-Sridharan, Venkatesh/ABD-9613-2021; Regan, Clinton/E-6250-2012; Kundumani-Sridharan, Venkatesh/I-4799-2016; Kundumani-Sridharan, Venkatesh/AAB-4535-2020; Subramani, Jaganathan/I-5155-2016	Kundumani-Sridharan, Venkatesh/0000-0002-6134-4371; Kundumani-Sridharan, Venkatesh/0000-0002-6134-4371; Subramani, Jaganathan/0000-0002-5707-8621	National Institutes of Health [HL 1R01HL107885, 1R01HL109397]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109397, R01HL107885] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL 1R01HL107885 and 1R01HL109397 (to K. C. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Abid MR, 2004, J BIOL CHEM, V279, P44030, DOI 10.1074/jbc.M408285200; Abid MR, 2001, FASEB J, V15, P2548, DOI 10.1096/fj.01-0338fje; Bianchi A, 2002, FREE RADICAL BIO MED, V32, P1132, DOI 10.1016/S0891-5849(02)00834-1; Brandt B, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.1; Bunse L, 2015, J CLIN INVEST, V125, P593, DOI 10.1172/JCI77780; Clerch LB, 1996, PEDIATR RES, V39, P253, DOI 10.1203/00006450-199602000-00011; Cross JV, 2004, BIOCHEM J, V381, P675, DOI 10.1042/BJ20040591; Cuenda A, 2000, INT J BIOCHEM CELL B, V32, P581, DOI 10.1016/S1357-2725(00)00003-0; Darville MI, 2000, ENDOCRINOLOGY, V141, P153, DOI 10.1210/en.141.1.153; Das KC, 1997, AM J RESP CELL MOL, V17, P713, DOI 10.1165/ajrcmb.17.6.2809; Das KC, 1998, J BIOL CHEM, V273, P34639, DOI 10.1074/jbc.273.51.34639; Das KC, 2001, J BIOL CHEM, V276, P4662, DOI 10.1074/jbc.M006206200; DAS KC, 1995, MOL CELL BIOCHEM, V148, P45, DOI 10.1007/BF00929502; DAS KC, 1995, AM J PHYSIOL-LUNG C, V269, pL588, DOI 10.1152/ajplung.1995.269.5.L588; Das KC, 2015, AM J PHYSIOL-LUNG C, V308, pL429, DOI 10.1152/ajplung.00285.2014; Das KC, 2010, MOL CELL BIOCHEM, V337, P53, DOI 10.1007/s11010-009-0285-0; Davidson SM, 2010, CARDIOVASC RES, V88, P58, DOI 10.1093/cvr/cvq195; Davies C, 2012, BIOCHEM SOC T, V40, P85, DOI 10.1042/BST20110641; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Deacon K, 1997, J BIOL CHEM, V272, P14489, DOI 10.1074/jbc.272.22.14489; Delhalle S, 2002, ONCOGENE, V21, P3917, DOI 10.1038/sj.onc.1205489; Haeusgen W, 2011, EUR J CELL BIOL, V90, P536, DOI 10.1016/j.ejcb.2010.11.008; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199; Johnson NL, 1996, J BIOL CHEM, V271, P3229, DOI 10.1074/jbc.271.6.3229; Kaur S, 2005, J BIOL CHEM, V280, P38599, DOI 10.1074/jbc.M505671200; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Kinscherf R, 1997, FASEB J, V11, P1317, DOI 10.1096/fasebj.11.14.9409551; Lee DY, 2013, J BIOL CHEM, V288, P28668, DOI 10.1074/jbc.M113.470971; Lee FS, 1998, P NATL ACAD SCI USA, V95, P9319, DOI 10.1073/pnas.95.16.9319; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Luo JL, 2005, J CLIN INVEST, V115, P2625, DOI 10.1172/JCI26322; Muniyappa H, 2009, J BIOL CHEM, V284, P17069, DOI 10.1074/jbc.M109.008557; Pacchiana R, 2014, HISTOCHEM CELL BIOL, V142, P593, DOI 10.1007/s00418-014-1244-8; Papa S, 2004, NAT CELL BIOL, V6, P146, DOI 10.1038/ncb1093; Papa S, 2004, J CELL SCI, V117, P5197, DOI 10.1242/jcs.01483; Ravi D, 2004, CANCER CHEMOTH PHARM, V54, P449, DOI 10.1007/s00280-004-0833-y; Sanna MG, 2002, MOL CELL BIOL, V22, P1754, DOI 10.1128/MCB.22.6.1754-1766.2002; Stehlik C, 1998, J EXP MED, V188, P211, DOI 10.1084/jem.188.1.211; SUZUKI K, 1993, AM J PHYSIOL, V265, pH1173, DOI 10.1152/ajpheart.1993.265.4.H1173; Tao L, 2006, BRIT J PHARMACOL, V149, P311, DOI 10.1038/sj.bjp.0706853; Tao L, 2004, P NATL ACAD SCI USA, V101, P11471, DOI 10.1073/pnas.0402941101; VISNER GA, 1992, BIOCHEM BIOPH RES CO, V188, P453; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Wang B, 2015, BRAIN RES, V1615, P89, DOI 10.1016/j.brainres.2015.04.033; Wang TH, 1998, J BIOL CHEM, V273, P4928, DOI 10.1074/jbc.273.9.4928; Wang X, 2007, BBA-MOL CELL RES, V1773, P1349, DOI 10.1016/j.bbamcr.2006.10.016; Weibrecht I, 2010, EXPERT REV PROTEOMIC, V7, P401, DOI 10.1586/EPR.10.10; Wen Hairuo, 2012, World J Hypertens, V2, P34; Widmann C, 1997, ONCOGENE, V15, P2439, DOI 10.1038/sj.onc.1201421; Widmann C, 1998, MOL CELL BIOL, V18, P2416, DOI 10.1128/MCB.18.4.2416; WONG GHW, 1988, SCIENCE, V242, P941, DOI 10.1126/science.3263703; WONG GHW, 1989, CELL, V58, P923, DOI 10.1016/0092-8674(89)90944-6; Xia DR, 2007, J BIOL CHEM, V282, P3507, DOI 10.1074/jbc.M610141200; Xu Y, 1999, DNA CELL BIOL, V18, P709, DOI 10.1089/104454999314999	55	14	15	4	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17505	17519		10.1074/jbc.M115.660365	http://dx.doi.org/10.1074/jbc.M115.660365			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26028649	Green Published, hybrid			2022-12-28	WOS:000357730900042
J	Park, S; Kanayama, K; Kaur, K; Tseng, HCH; Banankhah, S; Quje, DT; Sayre, JW; Jewett, A; Nishimura, I				Park, Sil; Kanayama, Keiichi; Kaur, Kawaljit; Tseng, Han-Ching Helen; Banankhah, Sina; Quje, Davood Talebi; Sayre, James W.; Jewett, Anahid; Nishimura, Ichiro			Osteonecrosis of the Jaw Developed in Mice DISEASE VARIANTS REGULATED BY gamma delta T CELLS IN ORAL MUCOSAL BARRIER IMMUNITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BISPHOSPHONATE-RELATED OSTEONECROSIS; SURGEONS POSITION PAPER; BREAST-CANCER PATIENTS; ZOLEDRONIC ACID; AMERICAN ASSOCIATION; INDUCE OSTEONECROSIS; MULTIPLE-MYELOMA; ANTIGEN RECEPTOR; RISK-FACTORS; BONE-MARROW	Osteonecrosis of the jaw (ONJ), an uncommon co-morbidity in patients treated with bisphosphonates (BP), occurs in the segment of jawbone interfacing oral mucosa. This study aimed to investigate a role of oral mucosal barrier gamma delta T cells in the pathogenesis of ONJ. Female C57Bl/6J (B6) mice received a bolus zoledronate intravenous injection (ZOL, 540 mu g/kg), and their maxillary left first molars were extracted 1 week later. ZOL-treated mice (WT ZOL) delayed oral wound healing with patent open wounds 4 weeks after tooth extraction with characteristic oral epithelial hyperplasia. gamma delta T cells appeared within the tooth extraction site and hyperplastic epithelium in WT ZOL mice. In ZOL-treated gamma delta T cell null (Tcrd(-/-) ZOL) mice, the tooth extraction open wound progressively closed; however, histological ONJ-like lesions were identified in 75 and 60% of WT ZOL and Tcrd(-/-) ZOL mice, respectively. Although the bone exposure phenotype of ONJ was predominantly observed in WT ZOL mice, Tcrd(-/-) ZOL mice developed the pustule/fistula disease phenotype. We further addressed the role of gamma delta T cells from human peripheral blood (h-gamma delta T cells). When co-cultured with ZOL-pretreated human osteoclasts in vitro, h-gamma delta T cells exhibited rapid expansion and robust IFN-gamma secretion. When h-gamma delta T cells were injected into ZOL-treated immunodeficient (Rag2(-/-) ZOL) mice, the oral epithelial hyperplasia developed. However, Rag2(-/-) ZOL mice did not develop osteonecrosis. The results indicate that gamma delta T cells are unlikely to influence the core osteonecrosis mechanism; however, they may serve as a critical modifier contributing to the different oral mucosal disease variations of ONJ.	[Park, Sil; Kanayama, Keiichi; Banankhah, Sina; Quje, Davood Talebi; Nishimura, Ichiro] Univ Calif Los Angeles, Sch Dent, Weintraub Ctr Reconstruct Biotechnol, Div Adv Prosthodont, Los Angeles, CA 90095 USA; [Park, Sil; Kaur, Kawaljit; Tseng, Han-Ching Helen; Jewett, Anahid; Nishimura, Ichiro] Univ Calif Los Angeles, Sch Dent, Div Oral Biol & Med, Los Angeles, CA 90095 USA; [Kanayama, Keiichi] Asahi Univ, Dept Periodontol, Sch Dent, Gifu 5010296, Japan; [Sayre, James W.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Asahi University; University of California System; University of California Los Angeles	Nishimura, I (corresponding author), Univ Calif Los Angeles, Sch Dent, Weintraub Ctr Reconstruct Biotechnol, Box 951668,CHS B3-087, Los Angeles, CA 90095 USA.	inishimura@dentistry.ucla.edu			National Institutes of Health from NIDCR [R01 DE022552]; National Institutes of Health from the National Center for Research Resources Research Facilities Improvement Program Grant [C06 RR014529]; Investigator Initiated Study Program Grant from Merck [38519]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR014529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022552] Funding Source: NIH RePORTER	National Institutes of Health from NIDCR; National Institutes of Health from the National Center for Research Resources Research Facilities Improvement Program Grant; Investigator Initiated Study Program Grant from Merck; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DE022552 from NIDCR and was conducted in part in a facility supported by National Institutes of Health Grant C06 RR014529 from the National Center for Research Resources Research Facilities Improvement Program Grant. This work was also supported by Investigator Initiated Study Program Grant 38519 from Merck. The authors declare that they have no conflicts of interest with the contents of this article.	Akilov OE, 2007, ARCH DERMATOL RES, V299, P315, DOI 10.1007/s00403-007-0765-6; Barasch A, 2011, J DENT RES, V90, P439, DOI 10.1177/0022034510397196; Bedogni A, 2008, ORAL SURG ORAL MED O, V105, P358, DOI 10.1016/j.tripleo.2007.08.040; Bi YM, 2010, AM J PATHOL, V177, P280, DOI 10.2353/ajpath.2010.090592; Cetiner S, 2009, J BONE MINER METAB, V27, P435, DOI 10.1007/s00774-009-0047-9; Coleman R, 2011, BREAST CANCER RES TR, V127, P429, DOI 10.1007/s10549-011-1429-y; Coleman RE, 2011, NEW ENGL J MED, V365, P1396, DOI 10.1056/NEJMoa1105195; Eberl M, 2009, TRENDS IMMUNOL, V30, P562, DOI 10.1016/j.it.2009.09.001; Hansen T, 2006, J ORAL PATHOL MED, V35, P155, DOI 10.1111/j.1600-0714.2006.00391.x; Hao ZY, 2001, J EXP MED, V194, P1151, DOI 10.1084/jem.194.8.1151; Havran WL, 2010, J IMMUNOL, V184, P5423, DOI 10.4049/jimmunol.0902733; Havran WL, 2000, IMMUNOL RES, V21, P63, DOI 10.1385/IR:21:2-3:63; Hemingway F, 2011, CALCIFIED TISSUE INT, V89, P389, DOI 10.1007/s00223-011-9530-0; Hokugo A, 2010, J BONE MINER RES, V25, P1337, DOI 10.1002/jbmr.23; Hunter RP, 2008, J ZOO WILDLIFE MED, V39, P517, DOI 10.1638/2008-0041.1; Ibusuki A, 2014, J INVEST DERMATOL, V134, P396, DOI 10.1038/jid.2013.353; Inoue SI, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00258; ITOHARA S, 1993, CELL, V72, P337, DOI 10.1016/0092-8674(93)90112-4; Jewett A, 1997, J IMMUNOL, V158, P5492; Kalyan S, 2013, J BONE MINER RES, V28, P728, DOI 10.1002/jbmr.1769; Kang B, 2013, J BONE MINER RES, V28, P1631, DOI 10.1002/jbmr.1894; Karunakaran MM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00648; Karunakaran MM, 2014, IMMUNOGENETICS, V66, P243, DOI 10.1007/s00251-014-0763-8; Khamaisi M, 2007, J CLIN ENDOCR METAB, V92, P1172, DOI 10.1210/jc.2006-2036; Khosla S, 2007, J BONE MINER RES, V22, P1479, DOI 10.1359/JBMR.0707ONJ; Kikuiri T, 2010, J BONE MINER RES, V25, P1668, DOI 10.1002/jbmr.37; Kobayashi Y, 2010, J BONE MINER METAB, V28, P165, DOI 10.1007/s00774-009-0128-9; Kunzmann V, 2000, BLOOD, V96, P384; Kuroshima S, 2013, BONE, V56, P101, DOI 10.1016/j.bone.2013.05.013; Kyrgidis A, 2008, J CLIN ONCOL, V26, P4634, DOI 10.1200/JCO.2008.16.2768; Mavrokokki T, 2007, J ORAL MAXIL SURG, V65, P415, DOI 10.1016/j.joms.2006.10.061; Miyazaki H, 2012, BJU INT, V110, pE520, DOI 10.1111/j.1464-410X.2012.11205.x; Morag Y, 2009, RADIOGRAPHICS, V29, P1971, DOI 10.1148/rg.297095050; Ngamphaiboon N, 2011, CLIN BREAST CANCER, V11, P252, DOI 10.1016/j.clbc.2011.02.001; Presland Richard B, 2002, J Dent Educ, V66, P564; Prinz I, 2006, NAT IMMUNOL, V7, P995, DOI 10.1038/ni1371; Reid IR, 2012, NAT REV RHEUMATOL, V8, P90, DOI 10.1038/nrrheum.2011.181; Roelofs AJ, 2010, J BONE MINER RES, V25, P606, DOI 10.1359/jbmr.091009; Rossini M, 2012, CALCIFIED TISSUE INT, V91, P395, DOI 10.1007/s00223-012-9647-9; Ruggiero SL, 2014, J ORAL MAXIL SURG, V72, P1938, DOI 10.1016/j.joms.2014.04.031; Ruggiero SL, 2009, J ORAL MAXIL SURG, V67, P2, DOI 10.1016/j.joms.2009.01.009; Ruggiero SL, 2004, J ORAL MAXIL SURG, V62, P527, DOI 10.1016/j.joms.2004.02.004; Saad F, 2012, ANN ONCOL, V23, P1341, DOI 10.1093/annonc/mdr435; Schiodt M, 2014, OR SURG OR MED OR PA, V117, P204, DOI 10.1016/j.oooo.2013.10.010; Smidt-Hansen T, 2013, J ORAL MAXIL SURG, V71, P1532, DOI 10.1016/j.joms.2013.03.019; Ting K, 1999, AM J PATHOL, V155, P1993, DOI 10.1016/S0002-9440(10)65518-6; Wilhelm M, 2003, BLOOD, V102, P200, DOI 10.1182/blood-2002-12-3665; Woo SB, 2006, ANN INTERN MED, V144, P753, DOI 10.7326/0003-4819-144-10-200605160-00009; Yardeni T, 2011, LAB ANIMAL, V40, P155, DOI 10.1038/laban0511-155; Zhang QZ, 2013, CLIN CANCER RES, V19, P3176, DOI 10.1158/1078-0432.CCR-13-0042; Zhao YH, 2012, CALCIFIED TISSUE INT, V91, P400, DOI 10.1007/s00223-012-9649-7	51	31	33	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17349	17366		10.1074/jbc.M115.652305	http://dx.doi.org/10.1074/jbc.M115.652305			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26013832	Green Published, hybrid			2022-12-28	WOS:000357730900030
J	Takala, H; Bjorling, A; Linna, M; Westenhoff, S; Ihalainen, JA				Takala, Heikki; Bjorling, Alexander; Linna, Marko; Westenhoff, Sebastian; Ihalainen, Janne A.			Light-induced Changes in the Dimerization Interface of Bacteriophytochromes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; high performance liquid chromatography (HPLC); histidine kinase; molecular dynamics; mutagenesis; photoreceptor; protein conformation; x-ray scattering; phytochrome; dimerization	CYANOBACTERIAL PHYTOCHROME CPH1; CHROMOPHORE-BINDING DOMAIN; PSEUDOMONAS-AERUGINOSA BACTERIOPHYTOCHROME; HISTIDINE-KINASE; DEINOCOCCUS-RADIODURANS; CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; AGROBACTERIUM-TUMEFACIENS; MUTATIONAL ANALYSIS; PLANT PHYTOCHROME	Background: Bacteriophytochromes are dimeric histidine kinases, but the functional role of their dimerization interfaces is unclear. Results: The phytochrome from Deinococcus radiodurans has two dimerization interfaces, which are critical for thermal back reversion and are altered by illumination. Conclusion: The dimerization interfaces cause strain in the structure. Significance: A functional role for the dimerization interfaces is proposed. Phytochromes are dimeric photoreceptor proteins that sense red light levels in plants, fungi, and bacteria. The proteins are structurally divided into a light-sensing photosensory module consisting of PAS, GAF, and PHY domains and a signaling output module, which in bacteriophytochromes typically is a histidine kinase (HK) domain. Existing structural data suggest that two dimerization interfaces exist between the GAF and HK domains, but their functional roles remain unclear. Using mutational, biochemical, and computational analyses of the Deinococcus radiodurans phytochrome, we demonstrate that two dimerization interfaces between sister GAF and HK domains stabilize the dimer with approximately equal contributions. The existence of both dimerization interfaces is critical for thermal reversion back to the resting state. We also find that a mutant in which the interactions between the GAF domains were removed monomerizes under red light. This implies that the interactions between the HK domains are significantly altered by photoconversion. The results suggest functional importance of the dimerization interfaces in bacteriophytochromes.	[Takala, Heikki; Bjorling, Alexander; Westenhoff, Sebastian] Univ Gothenburg, Dept Chem & Mol Biol, SE-40530 Gothenburg, Sweden; [Takala, Heikki; Linna, Marko; Ihalainen, Janne A.] Univ Jyvaskyla, Dept Biol & Environm Sci, Nanosci Ctr, FI-40014 Jyvaskyla, Finland	University of Gothenburg; University of Jyvaskyla	Westenhoff, S (corresponding author), Univ Gothenburg, POB 465, SE-40530 Gothenburg, Sweden.	westenho@chem.gu.se; janne.ihalainen@jyu.fi	Takala, Heikki/GVT-1834-2022; Takala, Heikki/ABC-9139-2020	Takala, Heikki/0000-0003-2518-8583; Takala, Heikki/0000-0003-2518-8583; Ihalainen, Janne/0000-0002-8741-1587	Academy of Finland [138063]; Finnish Cultural Foundation [0131067]; Foundation of Strategic Research, Sweden; Swedish Research Council [279944]; European Research Council [279944]; Finnish Academy [138063]	Academy of Finland(Academy of Finland); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Foundation of Strategic Research, Sweden; Swedish Research Council(Swedish Research CouncilEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Finnish Academy(Academy of Finland)	This work was supported by Academy of Finland Grant 138063 (to J. A. I.), by a Finnish Cultural Foundation grant (J. A. I.) and Grant 0131067 (to H. T.), Foundation of Strategic Research, Sweden, and the Swedish and European Research Councils, agreement 279944 (to S. W.).; Supported by Finnish Academy Grant 138063. To whom correspondence may be addressed: P. O. Box 35, FI-40014 University of Jyvaskyla, Finland. E-mail: janne.ihalainen@jyu.fi.	Anders K, 2013, J BIOL CHEM, V288, P35714, DOI 10.1074/jbc.M113.510461; Anders K, 2011, PHOTOCHEM PHOTOBIOL, V87, P160, DOI 10.1111/j.1751-1097.2010.00845.x; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Auldridge ME, 2012, J BIOL CHEM, V287, P7000, DOI 10.1074/jbc.M111.295121; Auldridge ME, 2011, CRIT REV BIOCHEM MOL, V46, P67, DOI 10.3109/10409238.2010.546389; Bellini D, 2012, STRUCTURE, V20, P1436, DOI 10.1016/j.str.2012.06.002; Bellini D, 2012, ACTA CRYSTALLOGR D, V68, P1058, DOI 10.1107/S0907444912020537; Bhattacharya S, 2014, J BIOL CHEM, V289, P32144, DOI 10.1074/jbc.M114.589739; Bjelkmar P, 2010, J CHEM THEORY COMPUT, V6, P459, DOI 10.1021/ct900549r; Bornschlogl T, 2009, BIOPHYS J, V96, P1508, DOI 10.1016/j.bpj.2008.11.012; Burgie ES, 2014, PLANT CELL, V26, P4568, DOI 10.1105/tpc.114.131623; Burgie ES, 2014, J BIOL CHEM, V289, P24573, DOI 10.1074/jbc.M114.571661; Burgie ES, 2014, P NATL ACAD SCI USA, V111, P10179, DOI 10.1073/pnas.1403096111; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Casino P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4258; Casino P, 2009, CELL, V139, P325, DOI 10.1016/j.cell.2009.08.032; Clack T, 2009, PLANT CELL, V21, P786, DOI 10.1105/tpc.108.065227; Diensthuber RP, 2013, STRUCTURE, V21, P1127, DOI 10.1016/j.str.2013.04.024; Essen LO, 2008, P NATL ACAD SCI USA, V105, P14709, DOI 10.1073/pnas.0806477105; Esteban B, 2005, BIOCHEMISTRY-US, V44, P450, DOI 10.1021/bi0484365; Evans K, 2006, J MOL BIOL, V364, P655, DOI 10.1016/j.jmb.2006.09.045; Ferris HU, 2014, J STRUCT BIOL, V186, P376, DOI 10.1016/j.jsb.2014.03.014; Hub JS, 2010, J CHEM THEORY COMPUT, V6, P3713, DOI 10.1021/ct100494z; Kaminski S, 2009, J PHYS CHEM B, V113, P945, DOI 10.1021/jp8047532; Karniol B, 2005, BIOCHEM J, V392, P103, DOI 10.1042/BJ20050826; Karniol B, 2003, P NATL ACAD SCI USA, V100, P2807, DOI 10.1073/pnas.0437914100; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krieger A, 2008, J PHOTOCH PHOTOBIO B, V93, P16, DOI 10.1016/j.jphotobiol.2008.07.001; Lehtivuori H, 2013, J PHYS CHEM B, V117, P11049, DOI 10.1021/jp312061b; Li H, 2010, P NATL ACAD SCI USA, V107, P10872, DOI 10.1073/pnas.1001908107; Mailliet J, 2011, J MOL BIOL, V413, P115, DOI 10.1016/j.jmb.2011.08.023; Marina A, 2005, EMBO J, V24, P4247, DOI 10.1038/sj.emboj.7600886; Marina A, 2001, J BIOL CHEM, V276, P41182, DOI 10.1074/jbc.M106080200; Matsushita T, 2003, NATURE, V424, P571, DOI 10.1038/nature01837; Mechaly AE, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001776; Noack S, 2007, BIOCHEMISTRY-US, V46, P4164, DOI 10.1021/bi602419x; Oka Y, 2004, PLANT CELL, V16, P2104, DOI 10.1105/tpc.104.022350; Pathak GP, 2014, ACS SYNTH BIOL, V3, P832, DOI 10.1021/sb500291r; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Quail PH, 2002, NAT REV MOL CELL BIO, V3, P85, DOI 10.1038/nrm728; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Sharrock RA, 2004, P NATL ACAD SCI USA, V101, P11500, DOI 10.1073/pnas.0404286101; Sineshchekov V, 2002, J PHOTOCH PHOTOBIO B, V67, P39, DOI 10.1016/S1011-1344(02)00282-8; Stojkovic EA, 2014, J PHYS CHEM LETT, V5, P2512, DOI 10.1021/jz501189t; Strauss HM, 2005, FEBS LETT, V579, P3970, DOI 10.1016/j.febslet.2005.06.025; Takala H, 2014, BIOCHEMISTRY-US, V53, P7076, DOI 10.1021/bi501180s; Takala H, 2014, NATURE, V509, P245, DOI 10.1038/nature13310; Taslimi A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5925; Tischer D, 2014, NAT REV MOL CELL BIO, V15, P551, DOI 10.1038/nrm3837; Wagner D, 1996, PLANT CELL, V8, P859, DOI 10.1105/tpc.8.5.859; Wagner JR, 2008, J BIOL CHEM, V283, P12212, DOI 10.1074/jbc.M709355200; Wagner JR, 2007, J BIOL CHEM, V282, P12298, DOI 10.1074/jbc.M611824200; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; Wang C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001493; Wilkins MR, 1999, METH MOL B, V112, P531; Yamada S, 2009, STRUCTURE, V17, P1333, DOI 10.1016/j.str.2009.07.016; Yang X, 2008, P NATL ACAD SCI USA, V105, P14715, DOI 10.1073/pnas.0806718105; Yang XJ, 2011, NATURE, V479, P428, DOI 10.1038/nature10506; Yang XJ, 2009, P NATL ACAD SCI USA, V106, P15639, DOI 10.1073/pnas.0902178106; YANG Y, 1991, P NATL ACAD SCI USA, V88, P11057, DOI 10.1073/pnas.88.24.11057; Yoon JM, 2008, BIOCHEM BIOPH RES CO, V369, P1120, DOI 10.1016/j.bbrc.2008.03.001; Zhang BW, 2011, J AM CHEM SOC, V133, P19393, DOI 10.1021/ja2060066; Zhang JR, 2013, PLANT PHYSIOL, V161, P1445, DOI 10.1104/pp.112.208892; Zienicke Benjamin, 2013, J Biol Chem, V288, P31738, DOI 10.1074/jbc.M113.479535	64	38	38	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16383	16392		10.1074/jbc.M115.650127	http://dx.doi.org/10.1074/jbc.M115.650127			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25971964	Green Published, hybrid			2022-12-28	WOS:000356930100039
J	El Hiani, Y; Linsdell, P				El Hiani, Yassine; Linsdell, Paul			Functional Architecture of the Cytoplasmic Entrance to the Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channel Pore	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC transporter; chloride channel; cystic fibrosis transmembrane conductance regulator (CFTR); electrophysiology; ion channel; cytoplasmic portals; electrostatic attraction; substituted cysteine accessibility mutagenesis; surface charge	WILD-TYPE; LOOP 3; DOMAIN; MUTATIONS; REGION; PHOSPHORYLATION; PYROPHOSPHATE; TUNNELS; PORTALS; ACCESS	As an ion channel, the cystic fibrosis transmembrane conductance regulator must form a continuous pathway for the movement of Cl- and other anions between the cytoplasm and the extracellular solution. Both the structure and the function of the membrane-spanning part of this pathway are well defined. In contrast, the structure of the pathway that connects the cytoplasm to the membrane-spanning regions is unknown, and functional roles for different parts of the protein forming this pathway have not been described. We used patch clamp recording and substituted cysteine accessibility mutagenesis to identify positively charged amino acid side chains that attract cytoplasmic Cl- ions to the inner mouth of the pore. Our results indicate that the side chains of Lys-190, Arg-248, Arg-303, Lys-370, Lys-1041, and Arg-1048, located in different intracellular loops of the protein, play important roles in the electrostatic attraction of Cl- ions. Mutation and covalent modification of these residues have charge-dependent effects on the rate of Cl- permeation, demonstrating their functional role in maximization of Cl- flux. Other nearby positively charged side chains were not involved in electrostatic interactions with Cl-. The location of these Cl--attractive residues suggests that cytoplasmic Cl- ions enter the pore via a lateral portal located between the cytoplasmic extensions to the fourth and sixth transmembrane helices; a secondary, functionally less relevant portal might exist between the extensions to the 10th and 12th transmembrane helices. These results define the cytoplasmic mouth of the pore and show how it attracts Cl- ions from the cytoplasm.	[El Hiani, Yassine; Linsdell, Paul] Dalhousie Univ, Dept Physiol & Biophys, Halifax, NS B3H 4R2, Canada	Dalhousie University	Linsdell, P (corresponding author), Dalhousie Univ, Dept Physiol & Biophys, POB 15000, Halifax, NS B3H 4R2, Canada.	paul.linsdell@dal.ca		El Hiani, Yassine/0000-0002-1251-5066; Linsdell, Paul/0000-0001-6257-6273	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research.	Aubin CNS, 2006, J GEN PHYSIOL, V128, P535, DOI 10.1085/jgp.200609516; Billet A, 2013, J CYST FIBROS, V12, P737, DOI 10.1016/j.jcf.2013.02.002; Cant N, 2014, INT J BIOCHEM CELL B, V52, P15, DOI 10.1016/j.biocel.2014.02.004; Carland JE, 2013, J BIOL CHEM, V288, P31592, DOI 10.1074/jbc.M113.503300; CARSON MR, 1995, J BIOL CHEM, V270, P20466, DOI 10.1074/jbc.270.35.20466; Cotten JF, 1996, J BIOL CHEM, V271, P21279, DOI 10.1074/jbc.271.35.21279; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; El Hiani Y, 2014, BIOCHEM CELL BIOL, V92, P481, DOI 10.1139/bcb-2014-0038; El Hiani Y, 2014, J BIOL CHEM, V289, P28149, DOI 10.1074/jbc.M114.593103; El Hiani Y, 2012, BIOCHEMISTRY-US, V51, P3971, DOI 10.1021/bi300065z; El Hiani Y, 2010, J BIOL CHEM, V285, P32126, DOI 10.1074/jbc.M110.113332; Gulbis JM, 2000, SCIENCE, V289, P123, DOI 10.1126/science.289.5476.123; GUNDERSON KL, 1994, J BIOL CHEM, V269, P19349; Holstead RG, 2011, J MEMBRANE BIOL, V243, P15, DOI 10.1007/s00232-011-9388-0; Hwang TC, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009498; Li MS, 2009, BRIT J PHARMACOL, V157, P1065, DOI 10.1111/j.1476-5381.2009.00258.x; Linsdell P, 2014, MOL MEMBR BIOL, V31, P1, DOI 10.3109/09687688.2013.868055; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Miyazawa A, 1999, J MOL BIOL, V288, P765, DOI 10.1006/jmbi.1999.2721; Mornon JP, 2015, CELL MOL LIFE SCI, V72, P1377, DOI 10.1007/s00018-014-1749-2; Mornon JP, 2009, CELL MOL LIFE SCI, V66, P3469, DOI 10.1007/s00018-009-0133-0; Odolczyk N, 2014, INT J BIOCHEM CELL B, V52, P39, DOI 10.1016/j.biocel.2014.04.004; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Qian F, 2011, PFLUG ARCH EUR J PHY, V462, P559, DOI 10.1007/s00424-011-0998-2; Rosenberg MF, 2011, J BIOL CHEM, V286, P42647, DOI 10.1074/jbc.M111.292268; Samways DSK, 2011, P NATL ACAD SCI USA, V108, P13800, DOI 10.1073/pnas.1017550108; Seibert FS, 1996, J BIOL CHEM, V271, P27493, DOI 10.1074/jbc.271.44.27493; Seibert FS, 1996, J BIOL CHEM, V271, P15139, DOI 10.1074/jbc.271.25.15139; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; St Aubin CN, 2007, MOL PHARMACOL, V71, P1360, DOI 10.1124/mol.106.031732; Wang W, 2014, J BIOL CHEM, V289, P30364, DOI 10.1074/jbc.M114.595710; Wang W, 2010, P NATL ACAD SCI USA, V107, P3888, DOI 10.1073/pnas.0913001107; Wang WY, 2014, PFLUG ARCH EUR J PHY, V466, P477, DOI 10.1007/s00424-013-1317-x; Wang WY, 2012, J BIOL CHEM, V287, P10156, DOI 10.1074/jbc.M112.342972; Wang WY, 2012, BBA-BIOMEMBRANES, V1818, P851, DOI 10.1016/j.bbamem.2011.12.025; Wang WY, 2011, J GEN PHYSIOL, V138, P165, DOI 10.1085/jgp.201110605; Wang YT, 2014, INT J BIOCHEM CELL B, V52, P47, DOI 10.1016/j.biocel.2014.04.001; Zhou JJ, 2010, J GEN PHYSIOL, V135, P229, DOI 10.1085/jgp.200910327	39	28	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15855	15865		10.1074/jbc.M115.656181	http://dx.doi.org/10.1074/jbc.M115.656181			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25944907	Green Published, hybrid			2022-12-28	WOS:000356527400044
J	Rispal, D; Eltschinger, S; Stahl, M; Vaga, S; Bodenmiller, B; Abraham, Y; Filipuzzi, I; Movva, NR; Aebersold, R; Helliwell, SB; Loewith, R				Rispal, Delphine; Eltschinger, Sandra; Stahl, Michael; Vaga, Stefania; Bodenmiller, Bernd; Abraham, Yann; Filipuzzi, Ireos; Movva, N. Rao; Aebersold, Ruedi; Helliwell, Stephen B.; Loewith, Robbie			Target of Rapamycin Complex 2 Regulates Actin Polarization and Endocytosis via Multiple Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE PHOSPHOPROTEOME REVEALS; CELL INTEGRITY PATHWAY; SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE; SPHINGOLIPID HOMEOSTASIS; SIGNALING PATHWAY; PLASMA-MEMBRANE; SERINE PALMITOYLTRANSFERASE; MEDIATED ENDOCYTOSIS; GROWTH-CONTROL	Target of rapamycin is a Ser/Thr kinase that operates in two conserved multiprotein complexes, TORC1 and TORC2. Unlike TORC1, TORC2 is insensitive to rapamycin, and its functional characterization is less advanced. Previous genetic studies demonstrated that TORC2 depletion leads to loss of actin polarization and loss of endocytosis. To determine how TORC2 regulates these readouts, we engineered a yeast strain in which TORC2 can be specifically and acutely inhibited by the imidazoquinoline NVP-BHS345. Kinetic analyses following inhibition of TORC2, supported with quantitative phosphoproteomics, revealed that TORC2 regulates these readouts via distinct pathways as follows: rapidly through direct protein phosphorylation cascades and slowly through indirect changes in the tensile properties of the plasma membrane. The rapid signaling events are mediated in large part through the phospholipid flippase kinases Fpk1 and Fpk2, whereas the slow signaling pathway involves increased plasma membrane tension resulting from a gradual depletion of sphingolipids. Additional hits in our phosphoproteomic screens highlight the intricate control TORC2 exerts over diverse aspects of eukaryote cell physiology.	[Rispal, Delphine; Eltschinger, Sandra; Stahl, Michael; Loewith, Robbie] Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland; [Rispal, Delphine; Eltschinger, Sandra; Stahl, Michael; Loewith, Robbie] Univ Geneva, Inst Genet & Genom Geneva iGE3, CH-1211 Geneva, Switzerland; [Vaga, Stefania; Aebersold, Ruedi] ETH, Inst Mol Syst Biol, Dept Biol, CH-8093 Zurich, Switzerland; [Bodenmiller, Bernd] Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland; [Abraham, Yann; Filipuzzi, Ireos; Movva, N. Rao; Helliwell, Stephen B.] Novartis Inst Biomed Res, CH-4056 Basel, Switzerland; [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland; [Loewith, Robbie] Natl Ctr Competence Res Chem Biol, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Novartis; University of Zurich	Helliwell, SB (corresponding author), Novartis Inst Biomed Res, Novartis Campus, CH-4056 Basel, Switzerland.	stephen.helliwell@novartis.com; robbie.loewith@unige.ch	Loewith, Robbie J/S-6289-2016	Loewith, Robbie J/0000-0002-2482-603X; Vaga, Stefania/0000-0002-8912-7715; Abraham, Yann/0000-0001-5600-5896; Stahl, Michael/0000-0002-7171-9691	Swiss National Science Foundation; National Centre for Competence in Research in Chemical Biology; Canton of Geneva; European Research Council; European Molecular Biology Organization; Marie Curie International Outgoing Fellowship	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Centre for Competence in Research in Chemical Biology; Canton of Geneva; European Research Council(European Research Council (ERC)European Commission); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Marie Curie International Outgoing Fellowship(European Commission)	This work was supported in part by the Swiss National Science Foundation, the National Centre for Competence in Research in Chemical Biology, the Canton of Geneva, and the European Research Council (to R. L.). The collection of protein phosphorylation data was supported in part by the PhosphoNetX project of SystemsX.; Supported by Fellowships from the Swiss National Science Foundation, the European Molecular Biology Organization, and the Marie Curie International Outgoing Fellowship.	Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531; Berchtold D, 2012, NAT CELL BIOL, V14, P542, DOI 10.1038/ncb2480; Bodenmiller B, 2010, METHOD ENZYMOL, V470, P317, DOI 10.1016/S0076-6879(10)70013-6; Breslow DK, 2010, MOL CELL, V40, P267, DOI 10.1016/j.molcel.2010.10.005; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; CAFFERKEY R, 1993, MOL CELL BIOL, V13, P6012, DOI 10.1128/MCB.13.10.6012; Clough T, 2009, J PROTEOME RES, V8, P5275, DOI 10.1021/pr900610q; deHart AKA, 2003, MOL BIOL CELL, V14, P4676, DOI 10.1091/mbc.E03-05-0323; deHart AKA, 2002, J CELL BIOL, V156, P241, DOI 10.1083/jcb.200107135; Friant S, 2000, EMBO J, V19, P2834, DOI 10.1093/emboj/19.12.2834; Friant S, 2001, EMBO J, V20, P6783, DOI 10.1093/emboj/20.23.6783; Gable K, 2000, J BIOL CHEM, V275, P7597, DOI 10.1074/jbc.275.11.7597; Han SM, 2010, P NATL ACAD SCI USA, V107, P5851, DOI 10.1073/pnas.0911617107; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Helliwell SB, 1998, GENETICS, V148, P99; Helliwell SB, 1998, CURR BIOL, V8, P1211, DOI 10.1016/S0960-9822(07)00511-8; HELLIWELL SB, 1994, MOL BIOL CELL, V5, P105, DOI 10.1091/mbc.5.1.105; Hoepfner D, 2012, CELL HOST MICROBE, V11, P654, DOI 10.1016/j.chom.2012.04.015; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Hua ZL, 2002, MOL BIOL CELL, V13, P3162, DOI 10.1091/mbc.E02-03-0172; Huber A, 2011, EMBO J, V30, P3052, DOI 10.1038/emboj.2011.221; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Kall L, 2008, J PROTEOME RES, V7, P29, DOI 10.1021/pr700600n; Kamada Y, 2005, MOL CELL BIOL, V25, P7239, DOI 10.1128/MCB.25.16.7239-7248.2005; Kliegman JI, 2013, CELL REP, V5, P1725, DOI 10.1016/j.celrep.2013.11.040; Krause SA, 2002, CURR BIOL, V12, P588, DOI 10.1016/S0960-9822(02)00760-1; KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Lundgren Deborah H, 2009, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1303s28; Mooren OL, 2012, ANNU REV BIOCHEM, V81, P661, DOI 10.1146/annurev-biochem-060910-094416; Mulet JM, 2006, J BIOL CHEM, V281, P33000, DOI 10.1074/jbc.M604244200; MUNN AL, 1994, J CELL BIOL, V127, P373, DOI 10.1083/jcb.127.2.373; NAGIEC MM, 1994, P NATL ACAD SCI USA, V91, P7899, DOI 10.1073/pnas.91.17.7899; Nakano K, 2008, MOL BIOL CELL, V19, P1783, DOI 10.1091/mbc.E07-07-0646; Niles BJ, 2014, MOL BIOL CELL, V25, P3962, DOI 10.1091/mbc.E14-06-1122; Niles BJ, 2014, CELL REP, V6, P541, DOI 10.1016/j.celrep.2013.12.040; Niles BJ, 2012, P NATL ACAD SCI USA, V109, P1536, DOI 10.1073/pnas.1117563109; Nussio MR, 2009, LANGMUIR, V25, P1086, DOI 10.1021/la803288s; Robertson AS, 2009, CELL MOL LIFE SCI, V66, P2049, DOI 10.1007/s00018-009-0001-y; Robitaille AM, 2013, SCIENCE, V339, P1320, DOI 10.1126/science.1228771; Roelants FM, 2011, P NATL ACAD SCI USA, V108, P19222, DOI 10.1073/pnas.1116948108; Roelants FM, 2010, P NATL ACAD SCI USA, V107, P34, DOI 10.1073/pnas.0912497106; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schmelzle T, 2002, MOL CELL BIOL, V22, P1329, DOI 10.1128/MCB.22.5.1329-1339.2002; Schmidt A, 1996, P NATL ACAD SCI USA, V93, P13780, DOI 10.1073/pnas.93.24.13780; Schmidt A, 1997, CELL, V88, P531, DOI 10.1016/S0092-8674(00)81893-0; Sebastian TT, 2012, BBA-MOL CELL BIOL L, V1821, P1068, DOI 10.1016/j.bbalip.2011.12.007; Shertz CA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-510; Shimada K, 2013, MOL CELL, V51, P829, DOI 10.1016/j.molcel.2013.08.019; Skruzny M, 2012, P NATL ACAD SCI USA, V109, pE2533, DOI 10.1073/pnas.1207011109; Smythe E, 2003, EMBO REP, V4, P246, DOI 10.1038/sj.embor.embor776; Soulard A, 2010, MOL BIOL CELL, V21, P3475, DOI 10.1091/mbc.E10-03-0182; Sturm M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-163; Sun YD, 2012, MOL BIOL CELL, V23, P2388, DOI 10.1091/mbc.E12-03-0209; Takeda M, 2014, EUKARYOT CELL, V13, P363, DOI 10.1128/EC.00279-13; Torres J, 2002, J BIOL CHEM, V277, P43495, DOI 10.1074/jbc.M205408200; Toshima J, 2005, NAT CELL BIOL, V7, P246, DOI 10.1038/ncb1229; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wanke V, 2008, MOL MICROBIOL, V69, P277, DOI 10.1111/j.1365-2958.2008.06292.x; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zanolari B, 2000, EMBO J, V19, P2824, DOI 10.1093/emboj/19.12.2824	68	56	57	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					14963	14978		10.1074/jbc.M114.627794	http://dx.doi.org/10.1074/jbc.M114.627794			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25882841	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000356177300014
J	Kesh, K; Subramanian, L; Ghosh, N; Gupta, V; Gupta, A; Bhattacharya, S; Mahapatra, NR; Swarnakar, S				Kesh, Kousik; Subramanian, Lakshmi; Ghosh, Nillu; Gupta, Vinayak; Gupta, Arnab; Bhattacharya, Samir; Mahapatra, Nitish R.; Swarnakar, Snehasikta			Association of MMP7-181A -> G Promoter Polymorphism with Gastric Cancer Risk INFLUENCE OF NICOTINE IN DIFFERENTIAL ALLELE-SPECIFIC TRANSCRIPTION VIA INCREASED PHOSPHORYLATION OF cAMP-RESPONSE ELEMENT-BINDING PROTEIN (CREB)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; SQUAMOUS-CELL CARCINOMA; MATRIX METALLOPROTEINASE-7; EXPRESSION; TOBACCO; SUSCEPTIBILITY; ACTIVATION; MATRILYSIN; INVASION; PROTEIN	Elevated expression of matrix metalloproteinase7 (MMP7) has been demonstrated to play a pivotal role in cancer invasion. The - 181A -> G(rs11568818) polymorphism in the MMP7 promoter modulates gene expression and possibly affects cancer progression. Here, we evaluated the impact of - 181A -> G polymorphism on MMP7 promoter activity and its association with gastric cancer risk in eastern Indian case-control cohorts (n = 520). The GG genotype as compared with the AA genotype was predisposed (p = 0.02; odds ratio = 1.9, 95% confidence interval = 1.1-3.3) to gastric cancer risk. Stratification analysis showed that tobacco addiction enhanced gastric cancer risk in GG subjects when compared with AA subjects (p = 0.03, odds ratio = 2.46, and 95% confidence interval = 1.07-5.68). Meta-analysis revealed that tobacco enhanced the risk for cancer more markedly in AG and GG carriers. Activity and expression of MMP7 were significantly higher in GG than in AA carriers. In support, MMP7 promoter-reporter assays showed greater transcriptional activity toward A to G transition under basal/nicotine-induced/cAMP-response element-binding protein (CREB) overexpressed conditions in gastric adenocarcinoma cells. Moreover, nicotine (a major component of tobacco) treatment significantly up-regulated MMP7 expression due to enhanced CREB phosphorylation followed by its nuclear translocation in gastric adenocarcinoma cells. Furthermore, chromatin immunoprecipitation experiments revealed higher binding of phosphorylated CREB with the -181G than the -181A allele. Altogether, specific binding of phosphorylated CREB to the G allele-carrying promoter enhances MMP7 gene expression that is further augmented by nicotine due to increased CREB phosphorylation and thereby increases the risk for gastric cancer.	[Kesh, Kousik; Ghosh, Nillu; Swarnakar, Snehasikta] Indian Inst Chem Biol, Drug Dev Diagnost & Biotechnol Div, 4 Raja SC Mullick Rd, Kolkata 700032, India; [Subramanian, Lakshmi; Gupta, Vinayak; Mahapatra, Nitish R.] Indian Inst Technol Madras, Dept Biotechnol, Bhupat & Jyoti Mehta Sch Biosci, Madras 600036, Tamil Nadu, India; [Gupta, Arnab; Bhattacharya, Samir] Saroj Gupta Canc Ctr & Res Inst, Kolkata 700104, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Swarnakar, S (corresponding author), Indian Inst Chem Biol, Drug Dev Diagnost & Biotechnol Div, 4 Raja SC Mullick Rd, Kolkata 700032, India.	snehasiktas@hotmail.com	Kesh, Kousik/AAR-9458-2021; Mahapatra, Nitish R/D-4123-2014	Mahapatra, Nitish R/0000-0002-0695-3510; Gupta, Dr. Vinayak/0000-0003-1001-9269	Council of Scientific and Industrial Research, India [BSC 0111, BSC 0119]; Council of Scientific and Industrial Research, India	Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by Grants BSC 0111 and BSC 0119 from Council of Scientific and Industrial Research, India.r Recipients of Senior Research Fellowship from Council of Scientific and Industrial Research, India.	Al-Wadei MH, 2012, CARCINOGENESIS, V33, P1745, DOI 10.1093/carcin/bgs229; Chuang HC, 2008, MODERN PATHOL, V21, P1444, DOI 10.1038/modpathol.2008.99; Dey S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088040; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Elkington P, 2011, J CLIN INVEST, V121, P1827, DOI 10.1172/JCI45666; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ghilardi G, 2003, CLIN CHEM, V49, P1940, DOI 10.1373/clinchem.2003.018911; Gonzalez CA, 2002, INT J CANCER, V100, P249, DOI 10.1002/ijc.10466; Gueorguiev VD, 2006, J BIOL CHEM, V281, P10188, DOI 10.1074/jbc.M513806200; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He ZH, 2011, J BIOL CHEM, V286, P7279, DOI 10.1074/jbc.M110.178780; Honda M, 1996, GUT, V39, P444, DOI 10.1136/gut.39.3.444; Hughes S, 2007, CLIN CANCER RES, V13, P6673, DOI 10.1158/1078-0432.CCR-07-0884; Ii M, 2006, EXP BIOL MED, V231, P20; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jensen Kendal, 2012, Transl Gastrointest Cancer, V1, P81; Jormsjo S, 2001, ARTERIOSCL THROM VAS, V21, P1834, DOI 10.1161/hq1101.098229; Kubben FJJM, 2006, BRIT J CANCER, V95, P744, DOI 10.1038/sj.bjc.6603307; Langers AMJ, 2011, WORLD J GASTRO ONCOL, V3, P79, DOI 10.4251/wjgo.v3.i6.79; Li ZZ, 2015, MOL CELL BIOCHEM, V399, P49, DOI 10.1007/s11010-014-2231-z; Lien YC, 2011, ANN SURG ONCOL, V18, P2671, DOI 10.1245/s10434-011-1598-2; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Malik MA, 2011, SAUDI J GASTROENTERO, V17, P301, DOI 10.4103/1319-3767.84480; Malik MA, 2011, ASIAN PAC J CANCER P, V12, P73; Maurel J, 2007, INT J CANCER, V121, P1066, DOI 10.1002/ijc.22799; Mishra A, 2011, BIOCHIMIE, V93, P854, DOI 10.1016/j.biochi.2011.02.007; Nagini S, 2012, WORLD J GASTRO ONCOL, V4, P156, DOI 10.4251/wjgo.v4.i7.156; Nakayama H, 2001, J NEUROCHEM, V79, P489, DOI 10.1046/j.1471-4159.2001.00602.x; Oh DY, 2009, CANCER RES TREAT, V41, P59, DOI 10.4143/crt.2009.41.2.59; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Perera FP, 1997, SCIENCE, V278, P1068, DOI 10.1126/science.278.5340.1068; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Richards TJ, 2012, AM J PHYSIOL-LUNG C, V302, pL746, DOI 10.1152/ajplung.00319.2011; Roman J, 2005, AM J PHYSIOL-LUNG C, V288, pL975, DOI 10.1152/ajplung.00003.2004; Rudra DS, 2013, J PINEAL RES, V54, P398, DOI 10.1111/jpi.12034; Sarkissian G, 2008, CLIN CHEM, V54, P574, DOI 10.1373/clinchem.2007.090837; Schuller HM, 1999, CANCER RES, V59, P4510; Schuller HM, 1998, BIOCHEM PHARMACOL, V55, P1377, DOI 10.1016/S0006-2952(97)00651-5; Shi M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-269; Shin VY, 2010, CANCER LETT, V292, P237, DOI 10.1016/j.canlet.2009.12.011; Singh H, 2008, GYNECOL ONCOL, V110, P71, DOI 10.1016/j.ygyno.2008.03.007; SOLOMON MJ, 1988, CELL, V53, P937, DOI 10.1016/S0092-8674(88)90469-2; Sonawane PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016661; Srivastava P, 2010, DIS MARKERS, V29, P37, DOI [10.3233/DMA-2010-0724, 10.1155/2010/149651]; Swarnakar S, 2005, J BIOL CHEM, V280, P9409, DOI 10.1074/jbc.M413398200; Szarvas T, 2011, PATHOL ONCOL RES, V17, P325, DOI 10.1007/s12253-010-9320-4; Thomas GAO, 2005, NAT CLIN PRACT GASTR, V2, P536, DOI 10.1038/ncpgasthep0316; Tredaniel J, 1997, INT J CANCER, V72, P565, DOI 10.1002/(SICI)1097-0215(19970807)72:4<565::AID-IJC3>3.0.CO;2-O; Vairaktaris E, 2007, ANTICANCER RES, V27, P2493; Vineis P, 2004, JNCI-J NATL CANCER I, V96, P99, DOI 10.1093/jnci/djh014; Wang FQ, 2006, CANCER LETT, V236, P292, DOI 10.1016/j.canlet.2005.05.042; Wang FQ, 2005, INT J CANCER, V114, P19, DOI 10.1002/ijc.20697; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; Wilson CL, 1997, P NATL ACAD SCI USA, V94, P1402, DOI 10.1073/pnas.94.4.1402; Yeh YC, 2010, DIGEST DIS SCI, V55, P1649, DOI 10.1007/s10620-009-0926-x; Yi YC, 2010, CLIN CHEM LAB MED, V48, P337, DOI 10.1515/CCLM.2010.082; Zhang JH, 2005, CARCINOGENESIS, V26, P1748, DOI 10.1093/carcin/bgi144	57	25	27	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14391	14406		10.1074/jbc.M114.630129	http://dx.doi.org/10.1074/jbc.M114.630129			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25847246	hybrid, Green Published			2022-12-28	WOS:000355754600011
J	Zhu, L; Cronan, JE				Zhu, Lei; Cronan, John E.			The Conserved Modular Elements of the Acyl Carrier Proteins of Lipid Synthesis Are Only Partially Interchangeable	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAIN-FLIPPING MECHANISM; FATTY-ACID SYNTHESIS; IN-VIVO; GENES; MUTATIONS	Prior work showed that expression of acyl carrier proteins (ACPs) of a diverse set of bacteria replaced the function of Escherichia coli ACP in lipid biosynthesis. However, the AcpAs of Lactococcus lactis and Enterococcus faecalis were inactive. Both failed to support growth of an E. coli acpP mutant strain. This defect seemed likely because of the helix II sequences of the two AcpAs, which differed markedly from those of the proteins that supported growth. To test this premise, chimeric ACPs were constructed in which L. lactis helix II replaced helix II of E. coli AcpP and vice versa. Expression of the AcpP protein L. lactis AcpA helix II allowed weak growth, whereas the L. lactis AcpA-derived protein that contained E. coli AcpP helix II failed to support growth of the E. coli mutant strain. Replacement of the L. lactis AcpA helix II residues in this protein showed that substitution of valine for the phenylalanine residue four residues downstream of the phosphopanthetheine-modified serine gave robust growth and allowed modification by the endogenous AcpS phosphopantetheinyl transferase (rather than the promiscuous Sfp transferase required to modify the L. lactis AcpA and the chimera of L. lactis AcpA helix II in AcpP). Further chimera constructs showed that the lack of function of the L. lactis AcpA-derived protein containing E. coli AcpP helix II was due to incompatibility of L. lactis AcpA helix I with the downstream elements of AcpP. Therefore, the origins of ACP incompatibility can reside in either helix I or in helix II.	[Zhu, Lei; Cronan, John E.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Cronan, John E.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Cronan, JE (corresponding author), Univ Illinois, Dept Microbiol, Chem & Life Sci Lab B103, 601 S Goodwin Ave, Urbana, IL 61801 USA.	j-cronan@life.uiuc.edu	Regan, Clinton/E-6250-2012; Cronan, John/V-6626-2019	Zhu, Lei/0000-0003-2178-4740	National Institutes of Health [AI15650]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015650, R37AI015650] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI15650.	AMANN E, 1985, GENE, V40, P183, DOI 10.1016/0378-1119(85)90041-1; Beld J, 2014, ANGEW CHEM INT EDIT, V53, P14456, DOI 10.1002/anie.201408576; Beld J, 2014, NAT PROD REP, V31, P61, DOI 10.1039/c3np70054b; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Byers DM, 2007, BIOCHEM CELL BIOL, V85, P649, DOI 10.1139/O07-109; Chan DI, 2010, BIOCHEM J, V430, P1, DOI 10.1042/BJ20100462; Nguyen C, 2014, NATURE, V505, P427, DOI 10.1038/nature12810; CRONAN JE, 1981, P NATL ACAD SCI-BIOL, V78, P5440, DOI 10.1073/pnas.78.9.5440; CRONAN JE, 1980, ANAL BIOCHEM, V103, P377, DOI 10.1016/0003-2697(80)90626-0; CRONAN JE, 1988, GENE, V70, P161, DOI 10.1016/0378-1119(88)90114-X; CRONAN JE, 1980, J BACTERIOL, V141, P1291, DOI 10.1128/JB.141.3.1291-1297.1980; Cronan JE, 2014, BIOCHEM J, V460, P157, DOI 10.1042/BJ20140239; Cronan JE, 2009, METHOD ENZYMOL, V459, P395, DOI 10.1016/S0076-6879(09)04617-5; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Lay NR, 2007, J BIOL CHEM, V282, P20319, DOI 10.1074/jbc.M703789200; De Lay NR, 2006, J BACTERIOL, V188, P287, DOI 10.1128/JB.188.1.287-296.2006; GRANA D, 1988, GENETICS, V120, P319; Parris KD, 2000, STRUCT FOLD DES, V8, P883, DOI 10.1016/S0969-2126(00)00178-7; RAWLINGS M, 1992, J BIOL CHEM, V267, P5751; TAKIFF HE, 1992, J BACTERIOL, V174, P1544, DOI 10.1128/jb.174.5.1544-1553.1992; Volkmann G, 2010, J BIOL CHEM, V285, P8605, DOI 10.1074/jbc.M109.060863; Wang HH, 2004, BIOCHEMISTRY-US, V43, P11782, DOI 10.1021/bi0487600; Wang HH, 2004, J BIOL CHEM, V279, P34489, DOI 10.1074/jbc.M403874200; Yang Z, 2012, J STRUCT BIOL, V179, P269, DOI 10.1016/j.jsb.2011.09.006; Zhou Z, 2008, J AM CHEM SOC, V130, P9925, DOI 10.1021/ja802657n; Zhou Z, 2007, ACS CHEM BIOL, V2, P337, DOI 10.1021/cb700054k; Zhu L, 2013, MBIO, V4, DOI 10.1128/mBio.00613-13	27	9	11	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13791	13799		10.1074/jbc.M115.648402	http://dx.doi.org/10.1074/jbc.M115.648402			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25861991	Green Published, hybrid			2022-12-28	WOS:000355313000014
J	Oh, YT; Lee, KM; Bari, W; Raskin, DM; Yoon, SS				Oh, Young Taek; Lee, Kang-Mu; Bari, Wasimul; Raskin, David M.; Yoon, Sang Sun			(p) ppGpp, a Small Nucleotide Regulator, Directs the Metabolic Fate of Glucose in Vibrio cholerae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EL-TOR BIOTYPE; VIRULENCE ACTIVATOR APHA; TOXIN-COREGULATED PILUS; TRIMETHYLAMINE N-OXIDE; ESCHERICHIA-COLI; STRINGENT RESPONSE; PSEUDOMONAS-AERUGINOSA; MYCOBACTERIUM-TUBERCULOSIS; KLEBSIELLA-TERRIGENA; NUTRIENT LIMITATION	When V. cholerae encounters nutritional stress, it activates (p) ppGpp-mediated stringent response. The genes relA and relV are involved in the production of (p) ppGpp, whereas the spoT gene encodes an enzyme that hydrolyzes it. Herein, we show that the bacterial capability to produce (p) ppGpp plays an essential role in glucose metabolism. The V. cholerae mutants defective in (p) ppGpp production (i.e. Delta relA Delta relV and Delta relA Delta relV Delta spoT mutants) lost their viability because of uncontrolled production of organic acids, when grown with extra glucose. In contrast, the Delta relA Delta spoT mutant, a (p) ppGpp overproducer strain, exhibited better growth in the presence of the same glucose concentration. An RNA sequencing analysis demonstrated that transcriptions of genes consisting of an operon for acetoin biosynthesis were markedly elevated in N16961, a seventh pandemic O1 strain, but not in its (p) ppGpp(0) mutant during glucose-stimulated growth. Transposon insertion in acetoin biosynthesis gene cluster resulted in glucose-induced loss of viability of the Delta relA Delta spoT mutant, further suggesting the crucial role of acetoin production in balanced growth under glucose-rich environments. Additional deletion of the aphA gene, encoding a negative regulator for acetoin production, failed to rescue the (p) ppGpp(0) mutant from the defective glucose-mediated growth, suggesting that (p) ppGpp-mediated acetoin production occurs independent of the presence of AphA. Overall, our results reveal that (p) ppGpp, in addition to its well known role as a stringent response mediator, positively regulates acetoin production that contributes to the successful glucose metabolism and consequently the proliferation of V. cholerae cells under a glucose-rich environment, a condition that may mimic the human intestine.	[Oh, Young Taek; Lee, Kang-Mu; Bari, Wasimul; Yoon, Sang Sun] Yonsei Univ, Coll Med, Dept Microbiol & Immunol, Brain Korea PLUS Project Med Sci 21, Seoul 120752, South Korea; [Yoon, Sang Sun] Yonsei Univ, Coll Med, Inst Immunol & Immunol Dis, Seoul 120752, South Korea; [Raskin, David M.] Marian Univ, Coll Osteopath Med, Indianapolis, IN 46222 USA	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Yoon, SS (corresponding author), Yonsei Univ, Coll Med, Dept Microbiol & Immunol, 250 Seongsanno, Seoul 120752, South Korea.	sangsun_yoon@yuhs.ac	Raskin, David/AAZ-5973-2021	Raskin, David/0000-0001-7421-7809; Yoon, Sang Sun/0000-0003-2979-365X; LEE, Kang-Mu/0000-0001-7414-5921	National Research Foundation of Korea - Korean Government (the Ministry of Science, ICT and Future Planning) [2014R1A2A2A01002861, 2014R1A4A1008625, 2014R1A1A2056139]; Yonsei University College of Medicine, Dongwha Holdings Faculty Research Grant [6-2014-0057]	National Research Foundation of Korea - Korean Government (the Ministry of Science, ICT and Future Planning); Yonsei University College of Medicine, Dongwha Holdings Faculty Research Grant	This work was supported by grants from National Research Foundation of Korea Grants 2014R1A2A2A01002861, 2014R1A4A1008625, and 2014R1A1A2056139 funded by the Korean Government (the Ministry of Science, ICT and Future Planning). This work was also supported by Yonsei University College of Medicine, Dongwha Holdings Faculty Research Grant 6-2014-0057.	Agirrezabala X, 2013, EMBO REP, V14, P811, DOI 10.1038/embor.2013.106; Amato SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093110; Amato SM, 2013, MOL CELL, V50, P475, DOI 10.1016/j.molcel.2013.04.002; Barbier T, 2011, FEBS LETT, V585, P2929, DOI 10.1016/j.febslet.2011.08.011; Bari W, 2012, J MICROBIOL, V50, P631, DOI 10.1007/s12275-012-2116-3; Bari W, 2011, INFECT IMMUN, V79, P3149, DOI 10.1128/IAI.01237-10; Battesti A, 2006, MOL MICROBIOL, V62, P1048, DOI 10.1111/j.1365-2958.2006.05442.x; Beck BJ, 1997, J BACTERIOL, V179, P6504, DOI 10.1128/jb.179.21.6862-6864.1997; Blankschien MD, 2010, METAB ENG, V12, P409, DOI 10.1016/j.ymben.2010.06.002; BLOMQVIST K, 1993, J BACTERIOL, V175, P1392, DOI 10.1128/JB.175.5.1392-1404.1993; Carneiro S, 2012, METABOLITES, V2, P717, DOI 10.3390/metabo2040717; Celinska E, 2009, BIOTECHNOL ADV, V27, P715, DOI 10.1016/j.biotechadv.2009.05.002; Childers BM, 2007, FUTURE MICROBIOL, V2, P335, DOI 10.2217/17460913.2.3.335; CLARK DP, 1988, APPL BIOCHEM BIOTECH, V17, P163, DOI 10.1007/BF02779155; Croucher NJ, 2010, CURR OPIN MICROBIOL, V13, P619, DOI 10.1016/j.mib.2010.09.009; Dalebroux ZD, 2012, NAT REV MICROBIOL, V10, P203, DOI 10.1038/nrmicro2720; Dalebroux ZD, 2010, MICROBIOL MOL BIOL R, V74, P171, DOI 10.1128/MMBR.00046-09; Nguyen D, 2011, SCIENCE, V334, P982, DOI 10.1126/science.1211037; Dziejman M, 2002, P NATL ACAD SCI USA, V99, P1556, DOI 10.1073/pnas.042667999; Eisenreich W, 2010, NAT REV MICROBIOL, V8, P401, DOI 10.1038/nrmicro2351; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; Gaca AO, 2013, MBIO, V4, DOI 10.1128/mBio.00646-13; Gaynor EC, 2005, MOL MICROBIOL, V56, P8, DOI 10.1111/j.1365-2958.2005.04525.x; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; GORDEN J, 1993, INFECT IMMUN, V61, P364, DOI 10.1128/IAI.61.1.364-367.1993; Guerrant RL, 2003, CLIN INFECT DIS, V37, P398, DOI 10.1086/376619; Hahn S, 2001, BMJ-BRIT MED J, V323, P81, DOI 10.1136/bmj.323.7304.81; Hardiman T, 2007, J BIOTECHNOL, V132, P359, DOI 10.1016/j.jbiotec.2007.08.029; HARSHMAN RB, 1971, BIOCHEMISTRY-US, V10, P3980, DOI 10.1021/bi00797a027; Haugen SP, 2008, NAT REV MICROBIOL, V6, P507, DOI 10.1038/nrmicro1912; He HJ, 2012, J BACTERIOL, V194, P2962, DOI 10.1128/JB.00014-12; Henard CA, 2014, MOL MICROBIOL, V91, P790, DOI 10.1111/mmi.12498; Heroven AK, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00146; Klinkenberg LG, 2010, J INFECT DIS, V202, P1397, DOI 10.1086/656524; Kovacikova G, 2005, MOL MICROBIOL, V57, P420, DOI 10.1111/j.1365-2958.2005.04700.x; Kovacikova G, 2003, J BACTERIOL, V185, P4825, DOI 10.1128/JB.185.16.4825-4836.2003; Krebs SJ, 2011, J BACTERIOL, V193, P5260, DOI 10.1128/JB.00378-11; Le Bouguenec C, 2011, INT J MED MICROBIOL, V301, P1, DOI 10.1016/j.ijmm.2010.04.021; Lee KM, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.394932; Lin R, 2011, GASTROENTEROLOGY, V140, P560, DOI 10.1053/j.gastro.2010.10.042; Manske C, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00125; MAYER D, 1995, J BACTERIOL, V177, P5261, DOI 10.1128/jb.177.18.5261-5269.1995; McKenney D, 1997, J ANTIMICROB CHEMOTH, V40, P415, DOI 10.1093/jac/40.3.415; Merrell DS, 1999, MOL MICROBIOL, V34, P836, DOI 10.1046/j.1365-2958.1999.01650.x; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; Min KB, 2014, FEMS MICROBIOL LETT, V360, P157, DOI 10.1111/1574-6968.12600; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakagawa A, 2006, GENES GENET SYST, V81, P299, DOI 10.1266/ggs.81.299; Oh YT, 2014, J BIOL CHEM, V289, P13232, DOI 10.1074/jbc.M113.540088; Okada Y, 2002, APPL ENVIRON MICROB, V68, P1541, DOI 10.1128/AEM.68.4.1541-1547.2002; OMBAKA EA, 1983, REV INFECT DIS, V5, pS880; PATRA FC, 1989, BMJ-BRIT MED J, V298, P1353, DOI 10.1136/bmj.298.6684.1353; Philippe N, 2004, PLASMID, V51, P246, DOI 10.1016/j.plasmid.2004.02.003; Primm TP, 2000, J BACTERIOL, V182, P4889, DOI 10.1128/JB.182.17.4889-4898.2000; Raskin DM, 2007, P NATL ACAD SCI USA, V104, P4636, DOI 10.1073/pnas.0611650104; Sack DA, 2004, LANCET, V363, P223, DOI 10.1016/S0140-6736(03)15328-7; Sircar B K, 1990, Indian J Public Health, V34, P68; Solopova A, 2014, P NATL ACAD SCI USA, V111, P7427, DOI 10.1073/pnas.1320063111; Somerville GA, 2009, MICROBIOL MOL BIOL R, V73, P233, DOI 10.1128/MMBR.00005-09; SPIRA B, 1995, J BACTERIOL, V177, P4053, DOI 10.1128/jb.177.14.4053-4058.1995; Spira B, 1998, MOL GEN GENET, V257, P469, DOI 10.1007/s004380050671; Srivatsan A, 2008, CURR OPIN MICROBIOL, V11, P100, DOI 10.1016/j.mib.2008.02.001; Thelin KH, 1996, INFECT IMMUN, V64, P2853, DOI 10.1128/IAI.64.7.2853-2856.1996; Tojo S, 2010, J BACTERIOL, V192, P1573, DOI 10.1128/JB.01394-09; Vinella D, 2005, MOL MICROBIOL, V56, P958, DOI 10.1111/j.1365-2958.2005.04601.x; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wendrich TM, 2002, MOL CELL, V10, P779, DOI 10.1016/S1097-2765(02)00656-1; Xiao ZJ, 2007, CRIT REV MICROBIOL, V33, P127, DOI 10.1080/10408410701364604; Yoon MY, 2014, J MICROBIOL, V52, P983, DOI 10.1007/s12275-014-4655-2; Yoon SS, 2008, INFECT IMMUN, V76, P1282, DOI 10.1128/IAI.00736-07; Yoon SS, 2006, INFECT IMMUN, V74, P6547, DOI 10.1128/IAI.00695-06; Zaborin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034883	72	12	13	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13178	13190		10.1074/jbc.M115.640466	http://dx.doi.org/10.1074/jbc.M115.640466			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25882848	Green Published, hybrid			2022-12-28	WOS:000354975700020
J	Krumholz, EW; Libourel, IGL				Krumholz, Elias W.; Libourel, Igor G. L.			Sequence-based Network Completion Reveals the Integrality of Missing Reactions in Metabolic Networks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ESSENTIAL GENES; RAST SERVER; RECONSTRUCTION; MODEL; PHENOTYPE; OPTIMIZATION; GENERATION; ENZYMES	Genome-scale metabolic models are central in connecting genotypes to metabolic phenotypes. However, even for well studied organisms, such as Escherichia coli, draft networks do not contain a complete biochemical network. Missing reactions are referred to as gaps. These gaps need to be filled to enable functional analysis, and gap-filling choices influence model predictions. To investigate whether functional networks existed where all gap-filling reactions were supported by sequence similarity to annotated enzymes, four draft networks were supplemented with all reactions from the Model SEED database for which minimal sequence similarity was found in their genomes. Quadratic programming revealed that the number of reactions that could partake in a gap-filling solution was vast: 3,270 in the case of E. coli, where 72% of the metabolites in the draft network could connect a gap-filling solution. Nonetheless, no network could be completed without the inclusion of orphaned enzymes, suggesting that parts of the biochemistry integral to biomass precursor formation are uncharacterized. However, many gap-filling reactions were well determined, and the resulting networks showed improved prediction of gene essentiality compared with networks generated through canonical gap filling. In addition, gene essentiality predictions that were sensitive to poorly determined gap-filling reactions were of poor quality, suggesting that damage to the network structure resulting from the inclusion of erroneous gap-filling reactions may be predictable.	[Krumholz, Elias W.; Libourel, Igor G. L.] Univ Minnesota, Dept Plant Biol, St Paul, MN 55108 USA; [Libourel, Igor G. L.] Univ Minnesota, Inst Biotechnol, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Libourel, IGL (corresponding author), Univ Minnesota, Dept Plant Biol, 1500 Gortner Ave, St Paul, MN 55108 USA.	libourel@umn.edu		Libourel, Igor/0000-0001-9408-3270	National Science Foundation [NSF/MCB-1042335]; Office of Naval Research [N141310552]; University of Minnesota Biotechnology Institute	National Science Foundation(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); University of Minnesota Biotechnology Institute(University of Minnesota System)	Supported by National Science Foundation Grant NSF/MCB-1042335, Office of Naval Research Grant N141310552, and seed funding through the University of Minnesota Biotechnology Institute.	ALTSCHUL SF, 1994, NAT GENET, V6, P119, DOI 10.1038/ng0294-119; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Aziz RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048053; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Benedict MN, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003882; Berestovsky N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003306; Bi HP, 2013, APPL MICROBIOL BIOT, V97, P10339, DOI 10.1007/s00253-013-5262-6; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Caspi R, 2014, NUCLEIC ACIDS RES, V42, pD459, DOI 10.1093/nar/gkt1103; Christian N, 2009, MOL BIOSYST, V5, P1889, DOI [10.1039/b915913b, 10.1039/B915913b]; Dreyfuss JM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003126; Durot M, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-85; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Feist AM, 2010, CURR OPIN MICROBIOL, V13, P344, DOI 10.1016/j.mib.2010.03.003; Feng XY, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-94; Fleming RMT, 2009, BIOPHYS CHEM, V145, P47, DOI 10.1016/j.bpc.2009.08.007; Haase I, 2013, CHEMBIOCHEM, V14, P2272, DOI 10.1002/cbic.201300544; Heavner BD, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-55; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Henry CS, 2011, BBA-GEN SUBJECTS, V1810, P967, DOI 10.1016/j.bbagen.2011.03.010; Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672; Jankowski MD, 2008, BIOPHYS J, V95, P1487, DOI 10.1529/biophysj.107.124784; Joyce AR, 2006, J BACTERIOL, V188, P8259, DOI 10.1128/JB.00740-06; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Karp PD, 2010, BRIEF BIOINFORM, V11, P40, DOI 10.1093/bib/bbp043; Karr JR, 2012, CELL, V150, P389, DOI 10.1016/j.cell.2012.05.044; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Konwar KM, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-202; Krumholz EW, 2012, J EXP BOT, V63, P2353, DOI 10.1093/jxb/err407; Kumar VS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-212; MAZELIS M, 1965, BIOCHIM BIOPHYS ACTA, V105, P106, DOI 10.1016/S0926-6593(65)80179-5; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Orth JD, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-30; Orth JD, 2010, BIOTECHNOL BIOENG, V107, P403, DOI 10.1002/bit.22844; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Reed JL, 2006, P NATL ACAD SCI USA, V103, P17480, DOI 10.1073/pnas.0603364103; Reed JL, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002662; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Reed JL, 2003, J BACTERIOL, V185, P2692, DOI 10.1128/JB.185.9.2692-2699.2003; Rolfsson O, 2013, BIOCHEM J, V449, P427, DOI 10.1042/BJ20120980; Rolfsson O, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-155; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Thanassi JA, 2002, NUCLEIC ACIDS RES, V30, P3152, DOI 10.1093/nar/gkf418; Thiele I, 2013, NAT BIOTECHNOL, V31, P419, DOI 10.1038/nbt.2488; Thiele I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045635; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; Vitkin E, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r111; Yang H, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003848; Zomorrodi AR, 2012, METAB ENG, V14, P672, DOI 10.1016/j.ymben.2012.09.005	51	11	11	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19197	19207		10.1074/jbc.M114.634121	http://dx.doi.org/10.1074/jbc.M114.634121			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26041773	Green Published, hybrid			2022-12-28	WOS:000358781100034
J	Zackular, JP; Chazin, WJ; Skaar, EP				Zackular, Joseph P.; Chazin, Walter J.; Skaar, Eric P.			Nutritional Immunity: S100 Proteins at the Host-Pathogen Interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CALCIUM-BINDING PROTEINS; MYELOID-RELATED PROTEINS; PSORIASIN S100A7; CARDIOVASCULAR-DISEASE; HUMAN CALPROTECTIN; CRYSTAL-STRUCTURES; SERUM-LEVELS; EXPRESSION; INFLAMMATION; ZINC	The S100 family of EF-hand calcium (Ca2+)-binding proteins is essential for a wide range of cellular functions. During infection, certain S100 proteins act as damage-associated molecular patterns (DAMPs) and interact with pattern recognition receptors to modulate inflammatory responses. In addition, these inflammatory S100 proteins have potent antimicrobial properties and are essential components of the immune response to invading pathogens. In this review, we focus on S100 proteins that exhibit antimicrobial properties through the process of metal limitation, termed nutritional immunity, and discuss several recent advances in our understanding of S100 protein-mediated metal sequestration at the site of infection.	[Zackular, Joseph P.; Skaar, Eric P.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Sch Med, Nashville, TN 37232 USA; [Chazin, Walter J.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Chazin, Walter J.] Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA; [Chazin, Walter J.] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Skaar, EP (corresponding author), Vanderbilt Univ, Dept Pathol Microbiol & Immunol, 1161 21st Ave South, Nashville, TN 37232 USA.	Eric.skaar@Vanderbilt.edu		Zackular, Joseph/0000-0002-3228-3055	United States Department of Veterans Affairs [1I01BX002482]; National Institutes of Health [R01 AI101171, T32DK007673]; Vanderbilt Digestive Disease Research Center (VDDRC) [P30DK058404]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101171, F32AI120553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007673, P30DK058404] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002482] Funding Source: NIH RePORTER	United States Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Digestive Disease Research Center (VDDRC); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by Merit Review Award 1I01BX002482 from the United States Department of Veterans Affairs, National Institutes of Health Grant R01 AI101171, and Vanderbilt Digestive Disease Research Center (VDDRC) Grant P30DK058404 (to E. P. S.). This is the seventh article in the Thematic Minireview series "Metals at the Host-Pathogen Interface." The authors declare that they have no conflicts of interest with the contents of this article.; Supported by National Institutes of Health Grant T32DK007673.	Bhattacharya S, 2004, BBA-MOL CELL RES, V1742, P69, DOI 10.1016/j.bbamcr.2004.09.002; Brodersen DE, 1999, BIOCHEMISTRY-US, V38, P1695, DOI 10.1021/bi982483d; Broome AM, 2003, J HISTOCHEM CYTOCHEM, V51, P675, DOI 10.1177/002215540305100513; Brophy MB, 2012, J AM CHEM SOC, V134, P18089, DOI 10.1021/ja307974e; CLOHESSY PA, 1995, SCAND J IMMUNOL, V42, P551, DOI 10.1111/j.1365-3083.1995.tb03695.x; Cole AM, 2001, FEBS LETT, V504, P5, DOI 10.1016/S0014-5793(01)02731-4; Damo SM, 2013, P NATL ACAD SCI USA, V110, P3841, DOI 10.1073/pnas.1220341110; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Eckert RL, 2004, J INVEST DERMATOL, V123, P23, DOI 10.1111/j.0022-202X.2004.22719.x; Emberley ED, 2003, CLIN CANCER RES, V9, P2627; Fessatou S, 2005, J PEDIAT HEMATOL ONC, V27, P477, DOI 10.1097/01.mph.0000179958.19524.9c; Foell D, 2007, J LEUKOCYTE BIOL, V81, P28, DOI 10.1189/jlb.0306170; Frosch M, 2000, ARTHRITIS RHEUM-US, V43, P628, DOI 10.1002/1529-0131(200003)43:3<628::AID-ANR20>3.0.CO;2-X; Gaddy JA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004450; Gagnon DM, 2015, J AM CHEM SOC, V137, P3004, DOI 10.1021/ja512204s; Gebhardt C, 2008, J EXP MED, V205, P275, DOI 10.1084/jem.20070679; Gebhardt C, 2006, BIOCHEM PHARMACOL, V72, P1622, DOI 10.1016/j.bcp.2006.05.017; Ghavami S, 2008, J LEUKOCYTE BIOL, V83, P1484, DOI 10.1189/jlb.0607397; Ghavami S, 2010, CELL RES, V20, P314, DOI 10.1038/cr.2009.129; Glaser R, 2005, NAT IMMUNOL, V6, P57, DOI 10.1038/ni1142; GOEBELER M, 1995, BIOCHEM J, V309, P419, DOI 10.1042/bj3090419; Goyette J, 2011, AMINO ACIDS, V41, P821, DOI 10.1007/s00726-010-0528-0; Grimbaldeston MA, 2003, J INVEST DERMATOL, V121, P1168, DOI 10.1046/j.1523-1747.2003.12561.x; HAGA HJ, 1993, LUPUS, V2, P47, DOI 10.1177/096120339300200108; Hammer HB, 2008, SCAND J RHEUMATOL, V37, P179, DOI 10.1080/03009740701874451; Hayden JA, 2013, J AM CHEM SOC, V135, P775, DOI 10.1021/ja3096416; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; HESSIAN PA, 1993, J LEUKOCYTE BIOL, V53, P197, DOI 10.1002/jlb.53.2.197; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Hood MI, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003068; Hsu Kenneth, 2009, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V8, P290; Hunter MJ, 1998, J BIOL CHEM, V273, P12427, DOI 10.1074/jbc.273.20.12427; Isidor B, 2009, ACTA PAEDIATR, V98, P410, DOI 10.1111/j.1651-2227.2008.01092.x; Kane D, 2003, ARTHRITIS RHEUM, V48, P1676, DOI 10.1002/art.10988; Kehl-Fie TE, 2013, INFECT IMMUN, V81, P3395, DOI 10.1128/IAI.00420-13; Kehl-Fie TE, 2011, CELL HOST MICROBE, V10, P158, DOI 10.1016/j.chom.2011.07.004; Kehl-Fie TE, 2010, CURR OPIN CHEM BIOL, V14, P218, DOI 10.1016/j.cbpa.2009.11.008; Konikoff MR, 2006, INFLAMM BOWEL DIS, V12, P524, DOI 10.1097/00054725-200606000-00013; Korndorfer IP, 2007, J MOL BIOL, V370, P887, DOI 10.1016/j.jmb.2007.04.065; LAGASSE E, 1988, MOL CELL BIOL, V8, P2402, DOI 10.1128/MCB.8.6.2402; Leclerc E, 2009, BBA-MOL CELL RES, V1793, P993, DOI 10.1016/j.bbamcr.2008.11.016; Lee KC, 2007, J INVEST DERMATOL, V127, P945, DOI 10.1038/sj.jid.5700663; Lim SY, 2008, J IMMUNOL, V181, P5627, DOI 10.4049/jimmunol.181.8.5627; Lisher JP, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00091; Liu JZ, 2012, CELL HOST MICROBE, V11, P227, DOI 10.1016/j.chom.2012.01.017; LUGERING N, 1995, DIGESTION, V56, P406, DOI 10.1159/000201267; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V322, P1111, DOI 10.1016/j.bbrc.2004.07.096; Mork G, 2003, BRIT J DERMATOL, V149, P484, DOI 10.1046/j.1365-2133.2003.05536.x; Moroz OV, 2009, J MOL BIOL, V391, P536, DOI 10.1016/j.jmb.2009.06.004; Moroz OV, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-11; Moroz OV, 2003, ACTA CRYSTALLOGR D, V59, P859, DOI 10.1107/S0907444903004700; Nakatani Y, 2005, MEDIAT INFLAMM, P280, DOI 10.1155/MI.2005.280; Nukui T, 2008, J CELL BIOCHEM, V104, P453, DOI 10.1002/jcb.21639; Pedersen L, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-196; POTTS BCM, 1995, NAT STRUCT BIOL, V2, P790, DOI 10.1038/nsb0995-790; Propper C, 1999, J BIOL CHEM, V274, P183, DOI 10.1074/jbc.274.1.183; Rammes A, 1997, J BIOL CHEM, V272, P9496; Ravasi T, 2004, GENOMICS, V84, P10, DOI 10.1016/j.ygeno.2004.02.002; Reid PA, 2015, AM J RESP CRIT CARE, V191, P233, DOI 10.1164/rccm.201407-1365LE; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Saito Y, 2002, J PEDIATR-US, V140, P267, DOI 10.1067/mpd.2002.121699; Salama I, 2008, EJSO-EUR J SURG ONC, V34, P357, DOI 10.1016/j.ejso.2007.04.009; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; Schiopu A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/828354; Shang JF, 2013, TUMOR BIOL, V34, P3785, DOI 10.1007/s13277-013-0962-1; Stoll SW, 1998, J INVEST DERMATOL, V111, P1092, DOI 10.1046/j.1523-1747.1998.00402.x; Stulik J, 1999, ELECTROPHORESIS, V20, P1047, DOI 10.1002/(SICI)1522-2683(19990101)20:4/5<1047::AID-ELPS1047>3.0.CO;2-E; Sunahori K, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1939; Turovskaya O, 2008, CARCINOGENESIS, V29, P2035, DOI 10.1093/carcin/bgn188; Tyden H, 2013, RHEUMATOLOGY, V52, P2048, DOI 10.1093/rheumatology/ket263; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; van Lent PL, 2010, ARTHRITIS RHEUM-US, V62, P3353, DOI 10.1002/art.27654; Vaos G, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/542363; Viemann D, 2007, BLOOD, V109, P2453, DOI 10.1182/blood-2006-08-040444; Voganatsi A, 2001, J LEUKOCYTE BIOL, V70, P130; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Wolf R, 2008, J IMMUNOL, V181, P1499, DOI 10.4049/jimmunol.181.2.1499; Yang Z, 2001, J LEUKOCYTE BIOL, V69, P986; Yang Z, 2007, J ALLERGY CLIN IMMUN, V119, P106, DOI 10.1016/j.jaci.2006.08.021; Zheng Y, 2008, IMMUNOLOGY, V124, P357, DOI 10.1111/j.1365-2567.2007.02782.x	82	142	145	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					18991	18998		10.1074/jbc.R115.645085	http://dx.doi.org/10.1074/jbc.R115.645085			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26055713	Green Published, hybrid			2022-12-28	WOS:000358781100014
J	Pallmann, N; Braig, M; Sievert, H; Preukschas, M; Hermans-Borgmeyer, I; Schweizer, M; Nagel, CH; Neumann, M; Wild, P; Haralambieva, E; Hagel, C; Bokemeyer, C; Hauber, J; Balabanov, S				Paellmann, Nora; Braig, Melanie; Sievert, Henning; Preukschas, Michael; Hermans-Borgmeyer, Irm; Schweizer, Michaela; Nagel, Claus Henning; Neumann, Melanie; Wild, Peter; Haralambieva, Eugenia; Hagel, Christian; Bokemeyer, Carsten; Hauber, Joachim; Balabanov, Stefan			Biological Relevance and Therapeutic Potential of the Hypusine Modification System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INITIATION-FACTOR 5A; PROTEIN-INTERACTION NETWORKS; FACTOR EF-P; TRANSLATION INITIATION; DEOXYHYPUSINE HYDROXYLASE; CELL-PROLIFERATION; HEPATOCELLULAR-CARCINOMA; INDEPENDENT PREDICTOR; EMBRYONIC-DEVELOPMENT; PROMOTES TRANSLATION	Hypusine modification of the eukaryotic initiation factor 5A (eIF-5A) is emerging as a crucial regulator in cancer, infections, and inflammation. Although its contribution in translational regulation of proline repeat-rich proteins has been sufficiently demonstrated, its biological role in higher eukaryotes remains poorly understood. To establish the hypusine modification system as a novel platform for therapeutic strategies, we aimed to investigate its functional relevance in mammals by generating and using a range of new knock-out mouse models for the hypusine-modifying enzymes deoxyhypusine synthase and deoxyhypusine hydroxylase as well as for the cancer-related isoform eIF-5A2. We discovered that homozygous depletion of deoxyhypusine synthase and/or deoxyhypusine hydroxylase causes lethality in adult mice with different penetrance compared with haploinsufficiency. Network-based bioinformatic analysis of proline repeat-rich proteins, which are putative eIF-5A targets, revealed that these proteins are organized in highly connected protein-protein interaction networks. Hypusine-dependent translational control of essential proteins (hubs) and protein complexes inside these networks might explain the lethal phenotype observed after deletion of hypusine-modifying enzymes. Remarkably, our results also demonstrate that the cancer-associated isoform eIF-5A2 is dispensable for normal development and viability. Together, our results provide the first genetic evidence that the hypusine modification in eIF-5A is crucial for homeostasis in mammals. More-over, these findings highlight functional diversity of the hypusine system compared with lower eukaryotes and indicate eIF-5A2 as a valuable and safe target for therapeutic intervention in cancer.	[Paellmann, Nora; Braig, Melanie; Sievert, Henning; Preukschas, Michael; Bokemeyer, Carsten; Balabanov, Stefan] Hubertus Wald Tumor Ctr, Dept Oncol Hematol & Bone Marrow Transplantat, Sect Pneumol, D-20246 Hamburg, Germany; [Hermans-Borgmeyer, Irm; Schweizer, Michaela] Univ Med Ctr Hamburg Eppendorf, Ctr Mol Neurobiol, D-20246 Hamburg, Germany; [Neumann, Melanie; Hagel, Christian] Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, D-20246 Hamburg, Germany; [Paellmann, Nora; Nagel, Claus Henning; Hauber, Joachim] Leibniz Inst Expt Virol, Heinrich Pette Inst, D-20251 Hamburg, Germany; [Braig, Melanie; Balabanov, Stefan] Univ Zurich Hosp, Div Hematol, CH-8091 Zurich, Switzerland; [Wild, Peter; Haralambieva, Eugenia] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland; [Preukschas, Michael] Inst Hematopathol, Dept Mol Pathol, D-22547 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Heinrich Pette Institute; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Balabanov, S (corresponding author), Univ Zurich Hosp, Div Hematol, Ramistr 100, CH-8091 Zurich, Switzerland.	stefan.balabanov@usz.ch	Balabanov, Stefan/E-9765-2014	Wild, Peter Johannes/0000-0002-1017-3744	Deutsche Forschungsgemeinschaft [BA 3506/1-1, HA 2580/4-1]; Eppendorfer Krebs and Leukamiehilfe e.V.; Swiss National Science Foundation [31003 A_150066]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Eppendorfer Krebs and Leukamiehilfe e.V.; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Deutsche Forschungsgemeinschaft Grants BA 3506/1-1 (to S. B.) and HA 2580/4-1 (to J. H.), Eppendorfer Krebs and Leukamiehilfe e.V., and Swiss National Science Foundation Grant 31003 A_150066 (to S. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Arrowsmith J, 2013, NAT REV DRUG DISCOV, V12, P568, DOI 10.1038/nrd4090; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bailly M, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-3; Balabanov S, 2007, BLOOD, V109, P1701, DOI 10.1182/blood-2005-03-037648; Barna M, 2008, NATURE, V456, P971, DOI 10.1038/nature07449; Bevec D, 1996, SCIENCE, V271, P1858, DOI 10.1126/science.271.5257.1858; Brown SDM, 2012, MAMM GENOME, V23, P632, DOI 10.1007/s00335-012-9427-x; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Chen W, 2009, CANCER EPIDEM BIOMAR, V18, P400, DOI 10.1158/1055-9965.EPI-08-0754; Clement PMJ, 2003, EUR J BIOCHEM, V270, P4254, DOI 10.1046/j.1432-1033.2003.03806.x; COOPER HL, 1983, P NATL ACAD SCI-BIOL, V80, P1854, DOI 10.1073/pnas.80.7.1854; COOPER HL, 1982, CELL, V29, P791, DOI 10.1016/0092-8674(82)90441-X; Doerfel LK, 2013, SCIENCE, V339, P85, DOI 10.1126/science.1229017; Doncheva NT, 2012, NAT PROTOC, V7, P670, DOI 10.1038/nprot.2012.004; Dudley AM, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100004; Edgar KA, 2010, CANCER RES, V70, P1164, DOI 10.1158/0008-5472.CAN-09-2525; Epis MR, 2012, J BIOL CHEM, V287, P35251, DOI 10.1074/jbc.M112.374686; Fraser HB, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r252; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gingras MC, 2009, INT J DEV BIOL, V53, P1069, DOI 10.1387/ijdb.082820mg; Goldberg MS, 2012, J EXP MED, V209, P217, DOI 10.1084/jem.20111487; Grzmil M, 2012, CANCER RES, V72, P3891, DOI 10.1158/0008-5472.CAN-12-0026; Guan XY, 2004, CANCER RES, V64, P4197, DOI 10.1158/0008-5472.CAN-03-3747; Gutierrez E, 2013, MOL CELL, V51, P35, DOI 10.1016/j.molcel.2013.04.021; Hanazawa M, 2004, MECH DEVELOP, V121, P213, DOI 10.1016/j.mod.2004.02.001; Hauber I, 2005, J CLIN INVEST, V115, P76, DOI 10.1172/JCI200521949; Hauber J, 2010, J CLIN INVEST, V120, P1806, DOI 10.1172/JCI43237; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; He LR, 2011, INT J CANCER, V129, P143, DOI 10.1002/ijc.25669; Hoehndorf R, 2014, BIOINFORMATICS, V30, P719, DOI 10.1093/bioinformatics/btt613; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Ishfaq M, 2012, FEBS LETT, V586, P3236, DOI 10.1016/j.febslet.2012.06.042; Jenkins ZA, 2001, GENOMICS, V71, P101, DOI 10.1006/geno.2000.6418; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Khosravi S, 2014, BRIT J CANCER, V110, P399, DOI 10.1038/bjc.2013.688; Koleske AJ, 1998, NEURON, V21, P1259, DOI 10.1016/S0896-6273(00)80646-7; Landau G, 2010, J BIOL CHEM, V285, P12474, DOI 10.1074/jbc.M110.106419; Lee GH, 2001, BIOCHEM J, V355, P841, DOI 10.1042/bj3550841; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Lee NP, 2010, INT J CANCER, V127, P968, DOI 10.1002/ijc.25100; Lee SB, 2011, BIOCHEM J, V433, P205, DOI 10.1042/BJ20101322; Lee SB, 2009, BIOCHEM BIOPH RES CO, V383, P497, DOI 10.1016/j.bbrc.2009.04.049; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; Li Y, 2014, GASTROENTEROLOGY, V146, P1701, DOI 10.1053/j.gastro.2014.02.029; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Maier B, 2010, J CLIN INVEST, V120, P2156, DOI 10.1172/JCI38924; Mandal A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111800; Memin E, 2014, CANCER RES, V74, P552, DOI 10.1158/0008-5472.CAN-13-0474; Moore CC, 2008, J INFECT DIS, V198, P1407, DOI 10.1086/592222; Muller FL, 2012, NATURE, V488, P337, DOI 10.1038/nature11331; Nishimura K, 2012, AMINO ACIDS, V42, P703, DOI 10.1007/s00726-011-0986-z; Oike Y, 1999, BLOOD, V93, P2771; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Park JH, 2006, P NATL ACAD SCI USA, V103, P51, DOI 10.1073/pnas.0509348102; Park MH, 2006, J BIOCHEM, V139, P161, DOI 10.1093/jb/mvj034; Park MH, 1997, BIOL SIGNAL, V6, P115; Pederson T, 2009, J CELL BIOL, V184, P771, DOI 10.1083/jcb.200812014; Peil L, 2012, NAT CHEM BIOL, V8, P695, DOI [10.1038/NCHEMBIO.1001, 10.1038/nchembio.1001]; Preukschas M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043468; Pritykin Y, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003243; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Regan CP, 2002, P NATL ACAD SCI USA, V99, P9248, DOI 10.1073/pnas.142293999; Reschke M, 2013, CELL REP, V4, P1276, DOI 10.1016/j.celrep.2013.08.014; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Ruggero D, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012336; Saini P, 2009, NATURE, V459, P118, DOI 10.1038/nature08034; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/NMETH.2212, 10.1038/nmeth.2212]; Schroeder M, 2014, CHEMMEDCHEM, V9, P940, DOI 10.1002/cmdc.201300481; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Scuoppo C, 2012, NATURE, V487, P244, DOI 10.1038/nature11126; Sharpless NE, 2006, NAT REV DRUG DISCOV, V5, P741, DOI 10.1038/nrd2110; Sievert H, 2014, DIS MODEL MECH, V7, P963, DOI 10.1242/dmm.014449; Sievert H, 2012, MOL CELL PROTEOMICS, V11, P1289, DOI 10.1074/mcp.M112.019059; Sun Z, 2010, J CELL PHYSIOL, V223, P798, DOI 10.1002/jcp.22100; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tang DJ, 2010, HEPATOLOGY, V51, P1255, DOI 10.1002/hep.23451; Tang Y, 2015, BIOSYSTEMS, V127, P67, DOI 10.1016/j.biosystems.2014.11.005; Taylor CA, 2012, MOL THER, V20, P1305, DOI 10.1038/mt.2012.94; Templin AT, 2011, CELL CYCLE, V10, P1043, DOI 10.4161/cc.10.7.15206; Thepot D, 2000, DEVELOPMENT, V127, P143; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Ude S, 2013, SCIENCE, V339, P82, DOI 10.1126/science.1228985; Valouev IA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-60; Vazquez-Laslop N, 2014, CELL, V157, P529, DOI 10.1016/j.cell.2014.04.002; von Koschitzky I, 2013, AMINO ACIDS, V45, P1047, DOI 10.1007/s00726-013-1575-0; Walsh D, 2011, NAT REV MICROBIOL, V9, P860, DOI 10.1038/nrmicro2655; Yang GF, 2009, GYNECOL ONCOL, V112, P314, DOI 10.1016/j.ygyno.2008.10.024; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Yoon J, 2006, BIOINFORMATICS, V22, P3106, DOI 10.1093/bioinformatics/btl533; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061; Zhu W, 2012, GUT, V61, P562, DOI 10.1136/gutjnl-2011-300207	95	34	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18343	18360		10.1074/jbc.M115.664490	http://dx.doi.org/10.1074/jbc.M115.664490			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26037925	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000358512100008
J	Lindert, U; Weis, MA; Rai, J; Seeliger, F; Hausser, I; Leeb, T; Eyre, D; Rohrbach, M; Giunta, C				Lindert, Uschi; Weis, Mary Ann; Rai, Jyoti; Seeliger, Frank; Hausser, Ingrid; Leeb, Tosso; Eyre, David; Rohrbach, Marianne; Giunta, Cecilia			Molecular Consequences of the SERPINH1/HSP47 Mutation in the Dachshund Natural Model of Osteogenesis Imperfecta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EHLERS-DANLOS-SYNDROME; ENDOPLASMIC-RETICULUM; CROSS-LINKS; I COLLAGEN; BONE-COLLAGEN; ALPHA-CHAINS; PROCOLLAGEN; CHAPERONE; HSP47; PROTEIN	Osteogenesis imperfecta (OI) is a heritable connective tissue disease characterized by bone fragility and increased risk of fractures. Up to now, mutations in at least 18 genes have been associated with dominant and recessive forms of OI that affect the production or post-translational processing of procollagen or alter bone homeostasis. Among those, SERPINH1 encoding heat shock protein 47 (HSP47), a chaperone exclusive for collagen folding in the ER, was identified to cause a severe form of OI in dachshunds (L326P) as well as in humans (one single case with a L78P mutation). To elucidate the disease mechanism underlying OI in the dog model, we applied a range of biochemical assays to mutant and control skin fibroblasts as well as on bone samples. These experiments revealed that type I collagen synthesized by mutant cells had decreased electrophoretic mobility. Procollagen was retained intracellularly with concomitant dilation of ER cisternae and activation of the ER stress response markers GRP78 and phospho-eIF2 alpha, thus suggesting a defect in procollagen processing. In line with the migration shift detected on SDS-PAGE of cell culture collagen, extracts of bone collagen from the OI dog showed a similar mobility shift, and on tandem mass spectrometry, the chains were post-translationally over-modified. The bone collagen had a higher content of pyridinoline than control dog bone. We conclude that the SERPINH1 mutation in this naturally occurring model of OI impairs how HSP47 acts as a chaperone in the ER. This results in abnormal post-translational modification and cross-linking of the bone collagen.	[Lindert, Uschi; Rohrbach, Marianne; Giunta, Cecilia] Univ Childrens Hosp Zurich, Connect Tissue Unit, Div Metab, Childrens Res Ctr, CH-8032 Zurich, Switzerland; [Weis, Mary Ann; Rai, Jyoti; Eyre, David] Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA; [Seeliger, Frank] AstraZeneca, Drug Safety & Metab, S-43183 Molndal, Sweden; [Hausser, Ingrid] Univ Heidelberg Hosp, Inst Pathol, D-69120 Heidelberg, Germany; [Hausser, Ingrid] Heidelberg Univ, Electron Microscopy Core Facil, D-69120 Heidelberg, Germany; [Leeb, Tosso] Univ Bern, Inst Genet, Vetsuisse Fac, CH-3001 Bern, Switzerland	University Children's Hospital Zurich; University of Washington; University of Washington Seattle; AstraZeneca; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Bern	Giunta, C (corresponding author), Univ Childrens Hosp Zurich, Connect Tissue Unit, Div Metab, Steinwiesstr 75, CH-8032 Zurich, Switzerland.	Cecilia.Giunta@kispi.uzh.ch	Giunta, Cecilia/T-8222-2019; Leeb, Tosso/G-3187-2014	Giunta, Cecilia/0000-0002-9313-8257; Leeb, Tosso/0000-0003-0553-4880; Rohrbach, Marianne/0000-0002-4013-6012	Swiss National Foundation (SNF) [310030_138288]; Gottfried und Julia Bangerter-Rhyner-Stiftung; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR036794, R37AR037318] Funding Source: NIH RePORTER	Swiss National Foundation (SNF)(Swiss National Science Foundation (SNSF)); Gottfried und Julia Bangerter-Rhyner-Stiftung; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The work was supported by the Swiss National Foundation (SNF-Grant 310030_138288) and the Gottfried und Julia Bangerter-Rhyner-Stiftung. The authors declare that they have no conflicts of interest with the contents of this article.	Banse X, 2003, J BONE MINER RES, V18, P1247, DOI 10.1359/jbmr.2003.18.7.1247; Barnes AM, 2006, NEW ENGL J MED, V355, P2757, DOI 10.1056/NEJMoa063804; Cabral WA, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.040493; Cabral WA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004465; Cabral WA, 2012, GENET MED, V14, P543, DOI 10.1038/gim.2011.44; CHESSLER SD, 1993, J BIOL CHEM, V268, P18226; Christiansen HE, 2010, AM J HUM GENET, V86, P389, DOI 10.1016/j.ajhg.2010.01.034; Drogemuller C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000579; ENGEL J, 1991, ANNU REV BIOPHYS BIO, V20, P137, DOI 10.1146/annurev.biophys.20.1.137; Eyre DR, 2013, CALCIFIED TISSUE INT, V93, P338, DOI 10.1007/s00223-013-9723-9; Forlino A, 2007, PROTEOMICS, V7, P1877, DOI 10.1002/pmic.200600919; Garbes L, 2015, AM J HUM GENET, V96, P432, DOI 10.1016/j.ajhg.2015.01.002; Giunta C, 2008, AM J HUM GENET, V82, P1290, DOI 10.1016/j.ajhg.2008.05.001; Hanson DA, 1996, J BIOL CHEM, V271, P26508, DOI 10.1074/jbc.271.43.26508; Ishida Y, 2006, MOL BIOL CELL, V17, P2346, DOI 10.1091/mbc.E05-11-1065; Kraenzlin ME, 2008, CLIN CHEM, V54, P1546, DOI 10.1373/clinchem.2008.105262; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamande SR, 1999, SEMIN CELL DEV BIOL, V10, P455, DOI 10.1006/scdb.1999.0317; Law RHP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-216; Lisse TS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040007; Makareeva E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001029; Makareeva E, 2011, TRENDS CELL BIOL, V21, P168, DOI 10.1016/j.tcb.2010.11.007; Nagai N, 2000, J CELL BIOL, V150, P1499, DOI 10.1083/jcb.150.6.1499; Nagata K, 1996, TRENDS BIOCHEM SCI, V21, P23, DOI 10.1016/0968-0004(96)80881-4; Nagata K, 1998, MATRIX BIOL, V16, P379, DOI 10.1016/S0945-053X(98)90011-7; NAKAI A, 1992, J CELL BIOL, V117, P903, DOI 10.1083/jcb.117.4.903; Rauch F, 2015, AM J HUM GENET, V96, P425, DOI 10.1016/j.ajhg.2014.12.027; Risteli J., 1994, J BONE MINER RES, V9, pS186; Rohrbach M, 2012, AM J MED GENET C, V160C, P175, DOI 10.1002/ajmg.c.31334; Satoh T, 1996, J BIOL CHEM, V271, P27919, DOI 10.1074/jbc.271.44.27919; Schwarze U, 2013, HUM MOL GENET, V22, P1, DOI 10.1093/hmg/dds371; Seeliger F, 2003, VET PATHOL, V40, P530, DOI 10.1354/vp.40-5-530; SMITH T, 1995, J BIOL CHEM, V270, P18323, DOI 10.1074/jbc.270.31.18323; STEINMANN B, 1995, AM J HUM GENET, V57, P1505; Thomson CA, 2000, BIOCHEM J, V349, P877, DOI 10.1042/bj3490877; Van Dijk FS, 2014, AM J MED GENET A, V164, P1470, DOI 10.1002/ajmg.a.36545; Widmer C, 2012, P NATL ACAD SCI USA, V109, P13243, DOI 10.1073/pnas.1208072109; WU JJ, 1992, J BIOL CHEM, V267, P23007	38	34	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					17679	17689		10.1074/jbc.M115.661025	http://dx.doi.org/10.1074/jbc.M115.661025			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26004778	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000358511700004
J	Niu, G; Zhang, H; Liu, D; Chen, L; Belani, C; Wang, HG; Cheng, H				Niu, Ge; Zhang, Huan; Liu, Dan; Chen, Li; Belani, Chandra; Wang, Hong-Gang; Cheng, Hua			Tid1, the Mammalian Homologue of Drosophila Tumor Suppressor Tid56, Mediates Macroautophagy by Interacting with Beclin1-containing Autophagy Protein Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN DNAJ PROTEIN; NF-KAPPA-B; T-LYMPHOCYTES; CELL-SURVIVAL; HTID-1; CANCER; APOPTOSIS; DESTABILIZATION; OVEREXPRESSION; CONTRIBUTES	One of the fundamental functions of molecular chaperone proteins is to selectively conjugate cellular proteins, targeting them directly to lysosome. Some of chaperones, such as the stress-induced Hsp70, also play important roles in autophagosome-forming macroautophagy under various stress conditions. However, the role of their co-chaperones in autophagy regulation has not been well defined. We here show that Tid1, a DnaJ co-chaperone for Hsp70 and the mammalian homologue of the Drosophila tumor suppressor Tid56, is a key mediator of macroautophagy pathway. Ectopic expression of Tid1 induces autophagy by forming LC3+ autophagosome foci, whereas silencing Tid1 leads to drastic impairment of autophagy as induced by nutrient deprivation or rapamycin. In contrast, Hsp70 is dispensable for a role in nutrient deprivation-induced autophagy. The murine Tid1 can be replaced with human Tid1 in murine fibroblast cells for induction of autophagy. We further show that Tid1 increases autophagy flux by interacting with the Beclin1-PI3 kinase class III protein complex in response to autophagy inducing signal and that Tid1 is an essential mediator that connects I kappa B kinases to the Beclin1-containing autophagy protein complex. Together, these results reveal a crucial role of Tid1 as an evolutionarily conserved and essential mediator of canonical macroautophagy.	[Niu, Ge; Zhang, Huan; Liu, Dan; Chen, Li; Cheng, Hua] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Cheng, Hua] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Cheng, Hua] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Cheng, Hua] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Belani, Chandra; Wang, Hong-Gang] Penn State Univ, Coll Med, Penn State Hershey Canc Inst, Hershey, PA 17033 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Cheng, H (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA.	hcheng@ihv.umaryland.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [R01AI090113]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090113] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI090113 (to H. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahn BY, 2010, ONCOGENE, V29, P1155, DOI 10.1038/onc.2009.413; Bae MK, 2005, CANCER RES, V65, P2520, DOI 10.1158/0008-5472.CAN-03-2735; Chen CY, 2013, CANCER RES, V73, P4009, DOI 10.1158/0008-5472.CAN-12-4066; Chen CY, 2009, J PATHOL, V219, P347, DOI 10.1002/path.2604; Cheng H, 2005, MOL CELL BIOL, V25, P44, DOI 10.1128/MCB.25.1.44-59.2005; Cheng H, 2002, J BIOL CHEM, V277, P20605, DOI 10.1074/jbc.M201204200; Cheng H, 2001, CURR BIOL, V11, P1771, DOI 10.1016/S0960-9822(01)00540-1; Copeland E, 2011, ONCOGENE, V30, P2252, DOI 10.1038/onc.2010.601; Criollo A, 2010, EMBO J, V29, P619, DOI 10.1038/emboj.2009.364; Cui JZ, 2013, BBA-REV CANCER, V1836, P15, DOI 10.1016/j.bbcan.2013.02.003; Dhennin-Duthille I, 2011, J BIOL CHEM, V286, P5034, DOI 10.1074/jbc.M110.155903; Guo XL, 2012, CANCER LETT, V320, P171, DOI 10.1016/j.canlet.2012.03.002; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Iosefson O, 2012, CELL STRESS CHAPERON, V17, P57, DOI 10.1007/s12192-011-0285-3; Janku F, 2011, NAT REV CLIN ONCOL, V8, P528, DOI 10.1038/nrclinonc.2011.71; Kim SW, 2005, CANCER RES, V65, P8784, DOI 10.1158/0008-5472.CAN-04-4422; Kim SW, 2004, CANCER RES, V64, P7732, DOI 10.1158/0008-5472.CAN-04-1323; Kimura T, 2013, CANCER RES, V73, P3, DOI 10.1158/0008-5472.CAN-12-2464; Kurzik-Dumke U, 2008, INT J MOL MED, V21, P19; KURZIKDUMKE U, 1995, DEV GENET, V16, P64, DOI 10.1002/dvg.1020160110; Linnoila J, 2008, NEURON, V60, P625, DOI 10.1016/j.neuron.2008.09.025; Liu HY, 2005, J BIOL CHEM, V280, P19461, DOI 10.1074/jbc.M500313200; Lo JF, 2004, MOL CELL BIOL, V24, P2226, DOI 10.1128/MCB.24.6.2226-2236.2004; Lu B, 2006, J BIOL CHEM, V281, P13150, DOI 10.1074/jbc.M509179200; Massey AC, 2006, CURR TOP DEV BIOL, V73, P205, DOI 10.1016/S0070-2153(05)73007-6; Ng ACH, 2014, MOL CELL BIOL, V34, P1427, DOI 10.1128/MCB.01021-13; Qian J, 2010, GASTROENTEROLOGY, V138, P1418, DOI 10.1053/j.gastro.2009.10.044; Ren T., 2015, ONCOGENE, P334; Ren T, 2012, J BIOL CHEM, V287, P34683, DOI 10.1074/jbc.M112.377143; Sarkar S, 2001, J BIOL CHEM, V276, P49034, DOI 10.1074/jbc.M103683200; Schilling B, 1998, VIROLOGY, V247, P74, DOI 10.1006/viro.1998.9220; Shin JY, 2013, LUNG CANCER, V81, P362, DOI 10.1016/j.lungcan.2013.05.009; Sohn SY, 2006, J GEN VIROL, V87, P1883, DOI 10.1099/vir.0.81684-0; Sterrenberg JN, 2011, CANCER LETT, V312, P129, DOI 10.1016/j.canlet.2011.08.019; Syken J, 1999, P NATL ACAD SCI USA, V96, P8499, DOI 10.1073/pnas.96.15.8499; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Tarunina M, 2004, MOL CELL BIOL, V24, P10792, DOI 10.1128/MCB.24.24.10792-10801.2004; Trentin GA, 2001, J BIOL CHEM, V276, P13087, DOI 10.1074/jbc.M009267200; Wang L, 2006, ONCOGENE, V25, P4320, DOI 10.1038/sj.onc.1209458; Wei YJ, 2013, CELL, V154, P1269, DOI 10.1016/j.cell.2013.08.015; Yan G, 2008, J BIOL CHEM, V283, P12489, DOI 10.1074/jbc.M707988200; Yang YH, 2013, P NATL ACAD SCI USA, V110, P6841, DOI 10.1073/pnas.1217692110	42	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					18102	18110		10.1074/jbc.M115.665950	http://dx.doi.org/10.1074/jbc.M115.665950			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26055714	hybrid, Green Published			2022-12-28	WOS:000358511700041
J	Cahoon, RE; Lutke, WK; Cameron, JC; Chen, SX; Lee, SG; Rivard, RS; Rea, PA; Jez, JM				Cahoon, Rebecca E.; Lutke, W. Kevin; Cameron, Jeffrey C.; Chen, Sixue; Lee, Soon Goo; Rivard, Rebecca S.; Rea, Philip A.; Jez, Joseph M.			Adaptive Engineering of Phytochelatin-based Heavy Metal Tolerance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTAMATE-CYSTEINE LIGASE; N-TERMINAL DOMAIN; ARABIDOPSIS-THALIANA; GAMMA-GLUTAMYLCYSTEINE; INDIAN MUSTARD; CADMIUM TOLERANCE; GLUTATHIONE SYNTHETASE; FUNCTIONAL-PROPERTIES; NUCLEOTIDE-BINDING; KINETIC MECHANISM	Metabolic engineering approaches are increasingly employed for environmental applications. Because phytochelatins (PC) protect plants from heavy metal toxicity, strategies directed at manipulating the biosynthesis of these peptides hold promise for the remediation of soils and groundwaters contaminated with heavy metals. Directed evolution of Arabidopsis thaliana phytochelatin synthase (AtPCS1) yields mutants that confer levels of cadmium tolerance and accumulation greater than expression of the wild-type enzyme in Saccharomyces cerevisiae, Arabidopsis, or Brassica juncea. Surprisingly, the AtPCS1 mutants that enhance cadmium tolerance and accumulation are catalytically less efficient than wild-type enzyme. Metabolite analyses indicate that transformation with AtPCS1, but not with the mutant variants, decreases the levels of the PC precursors, glutathione and gamma-glutamylcysteine, upon exposure to cadmium. Selection of AtPCS1 variants with diminished catalytic activity alleviates depletion of these metabolites, which maintains redox homeostasis while supporting PC synthesis during cadmium exposure. These results emphasize the importance of metabolic context for pathway engineering and broaden the range of tools available for environmental remediation.	[Cahoon, Rebecca E.; Cameron, Jeffrey C.; Lee, Soon Goo; Jez, Joseph M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Cahoon, Rebecca E.; Lutke, W. Kevin; Chen, Sixue; Rivard, Rebecca S.; Jez, Joseph M.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA; [Chen, Sixue] Univ Florida, Genet Inst, Dept Biol, Gainesville, FL 32610 USA; [Rea, Philip A.; Jez, Joseph M.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	Washington University (WUSTL); Donald Danforth Plant Science Center; State University System of Florida; University of Florida; University of Pennsylvania	Jez, JM (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	jjez@biology2.wustl.edu	Lutke, Kevin/M-2846-2013; CHEN, SI/GZL-4800-2022		Enivironmental Protection Agency [EPA-X-83220101]; United States Department of Agriculture [NRI-2005-02518]; National Science Foundation [MCB-0904215]; Washington University iCARES	Enivironmental Protection Agency; United States Department of Agriculture(United States Department of Agriculture (USDA)); National Science Foundation(National Science Foundation (NSF)); Washington University iCARES	This work was supported by Enivironmental Protection Agency Grant EPA-X-83220101, United States Department of Agriculture Grant NRI-2005-02518, National Science Foundation Grant MCB-0904215, and Washington University iCARES (to J. M. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Bick JA, 2001, BIOCHEMISTRY-US, V40, P9040, DOI 10.1021/bi010518v; Bizily SP, 2000, NAT BIOTECHNOL, V18, P213, DOI 10.1038/72678; Brunetti P, 2015, J EXP BOT, V66, P3815, DOI 10.1093/jxb/erv185; Cameron JC, 2010, PLANT PHYSIOL, V154, P1672, DOI 10.1104/pp.110.162990; Chia JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082675; Clemens S, 1999, EMBO J, V18, P3325, DOI 10.1093/emboj/18.12.3325; Clemens S, 2013, TRENDS PLANT SCI, V18, P92, DOI 10.1016/j.tplants.2012.08.003; Cobbett C, 2002, ANNU REV PLANT BIOL, V53, P159, DOI 10.1146/annurev.arplant.53.100301.135154; Dhankher OP, 2002, NAT BIOTECHNOL, V20, P1140, DOI 10.1038/nbt747; Gasic K, 2007, PLANT MOL BIOL, V64, P361, DOI 10.1007/s11103-007-9158-7; Gasic K, 2007, PLANTA, V225, P1277, DOI 10.1007/s00425-006-0421-y; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; Gromes R, 2008, PLANT J, V54, P1063, DOI 10.1111/j.1365-313X.2008.03477.x; Ha SB, 1999, PLANT CELL, V11, P1153, DOI 10.1105/tpc.11.6.1153; Hicks LM, 2007, PLANT CELL, V19, P2653, DOI 10.1105/tpc.107.052597; Hothorn M, 2006, J BIOL CHEM, V281, P27557, DOI 10.1074/jbc.M602770200; HOWDEN R, 1995, PLANT PHYSIOL, V107, P1067, DOI 10.1104/pp.107.4.1067; HOWDEN R, 1995, PLANT PHYSIOL, V107, P1059, DOI 10.1104/pp.107.4.1059; Huang J, 2012, PLANT PHYSIOL, V158, P1779, DOI 10.1104/pp.111.192872; Jez JM, 2004, J BIOL CHEM, V279, P42726, DOI 10.1074/jbc.M407961200; Jez JM, 2004, J BIOL CHEM, V279, P33463, DOI 10.1074/jbc.M405127200; Jez JM, 2011, INT J PHYTOREMEDIAT, V13, P77, DOI 10.1080/15226514.2011.568537; Johnson MD, 2003, NAT MED, V9, P1081, DOI 10.1038/nm902; Lassner M, 2001, CURR OPIN PLANT BIOL, V4, P152, DOI 10.1016/S1369-5266(00)00152-7; Lee S, 2003, PLANT PHYSIOL, V131, P656, DOI 10.1104/pp.014118; Li YJ, 2004, PLANT CELL PHYSIOL, V45, P1787, DOI 10.1093/pcp/pch202; Li ZS, 1996, J BIOL CHEM, V271, P6509, DOI 10.1074/jbc.271.11.6509; Li ZS, 1997, P NATL ACAD SCI USA, V94, P42, DOI 10.1073/pnas.94.1.42; LOEFFLER S, 1989, FEBS LETT, V258, P42, DOI 10.1016/0014-5793(89)81611-4; Lu YP, 1997, P NATL ACAD SCI USA, V94, P8243, DOI 10.1073/pnas.94.15.8243; MEISTER A, 1995, METHOD ENZYMOL, V252, P26; Mendoza-Cozatl DG, 2010, J BIOL CHEM, V285, P40416, DOI 10.1074/jbc.M110.155408; Park J, 2012, PLANT J, V69, P278, DOI 10.1111/j.1365-313X.2011.04789.x; Pilon-Smits E, 2002, CRIT REV PLANT SCI, V21, P439, DOI 10.1080/0735-260291044313; Pomponi M, 2006, PLANTA, V223, P180, DOI 10.1007/s00425-005-0073-3; Ravilious GE, 2013, J BIOL CHEM, V288, P6107, DOI 10.1074/jbc.M112.439414; Ravilious GE, 2012, NAT PROD REP, V29, P1138, DOI 10.1039/c2np20009k; Ravilious GE, 2012, J BIOL CHEM, V287, P30385, DOI 10.1074/jbc.M112.387001; Ravilious GE, 2012, P NATL ACAD SCI USA, V109, P309, DOI 10.1073/pnas.1115772108; Rea PA, 2004, PLANT PHYSIOL, V136, P2463, DOI 10.1104/pp.104.048579; Rea PA, 2012, PHYSIOL PLANTARUM, V145, P154, DOI 10.1111/j.1399-3054.2012.01571.x; Romanyuk ND, 2006, PLANT PHYSIOL, V141, P858, DOI 10.1104/pp.106.082131; Rugh CL, 1996, P NATL ACAD SCI USA, V93, P3182, DOI 10.1073/pnas.93.8.3182; Ruotolo R, 2004, J BIOL CHEM, V279, P14686, DOI 10.1074/jbc.M314325200; Salt DE, 1998, ANNU REV PLANT PHYS, V49, P643, DOI 10.1146/annurev.arplant.49.1.643; Song WY, 2010, P NATL ACAD SCI USA, V107, P21187, DOI 10.1073/pnas.1013964107; Song WY, 2003, NAT BIOTECHNOL, V21, P914, DOI 10.1038/nbt850; Vatamaniuk OK, 2005, J BIOL CHEM, V280, P23684, DOI 10.1074/jbc.M503362200; Vatamaniuk OK, 2001, J BIOL CHEM, V276, P20817, DOI 10.1074/jbc.C100152200; Vatamaniuk OK, 2000, J BIOL CHEM, V275, P31451, DOI 10.1074/jbc.M002997200; Vatamaniuk OK, 1999, P NATL ACAD SCI USA, V96, P7110, DOI 10.1073/pnas.96.12.7110; Vatamaniuk OK, 2004, J BIOL CHEM, V279, P22449, DOI 10.1074/jbc.M313142200; Vivares D, 2005, P NATL ACAD SCI USA, V102, P18848, DOI 10.1073/pnas.0505833102; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Yi H, 2010, MOL PLANT, V3, P269, DOI 10.1093/mp/ssp112; Zhang M, 2012, J AM CHEM SOC, V134, P16979, DOI 10.1021/ja3078522; Zhu YL, 1999, PLANT PHYSIOL, V121, P1169, DOI 10.1104/pp.121.4.1169; Zhu YL, 1999, PLANT PHYSIOL, V119, P73, DOI 10.1104/pp.119.1.73	59	18	18	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17321	17330		10.1074/jbc.M115.652123	http://dx.doi.org/10.1074/jbc.M115.652123			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26018077	hybrid, Green Published			2022-12-28	WOS:000357730900027
J	Gu, W; Fukuda, T; Isaji, T; Hang, QL; Lee, HH; Sakai, S; Morise, J; Mitoma, J; Higashi, H; Taniguchi, N; Yawo, H; Oka, S; Gu, JG				Gu, Wei; Fukuda, Tomohiko; Isaji, Tomoya; Hang, Qinglei; Lee, Ho-hsun; Sakai, Seiichiro; Morise, Jyoji; Mitoma, Junya; Higashi, Hideyoshi; Taniguchi, Naoyuki; Yawo, Hiromu; Oka, Shogo; Gu, Jianguo			Loss of alpha 1,6-Fucosyltransferase Decreases Hippocampal Long Term Potentiation IMPLICATIONS FOR CORE FUCOSYLATION IN THE REGULATION OF AMPA RECEPTOR HETEROMERIZATION AND CELLULAR SIGNALING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKOCYTE ADHESION DEFICIENCY; N-LINKED GLYCOSYLATION; CALMODULIN KINASE-II; METHYL-D-ASPARTATE; FC-GAMMA-RIII; SYNAPTIC PLASTICITY; GLUTAMATE RECEPTORS; SCHIZOPHRENIA; FUCOSE; NEURONS	Core fucosylation is catalyzed by alpha 1,6-fucosyltransferase (FUT8), which transfers a fucose residue to the innermost GlcNAc residue via alpha 1,6-linkage on N-glycans in mammals. We previously reported that Fut8-knock-out (Fut8(-/-)) mice showed a schizophrenia-like phenotype and a decrease in working memory. To understand the underlying molecular mechanism, we analyzed early form long term potentiation (E-LTP), which is closely related to learning and memory in the hippocampus. The scale of E-LTP induced by high frequency stimulation was significantly decreased in Fut8(-/-) mice. Tetraethylammonium-induced LTP showed no significant differences, suggesting that the decline in E-LTP was caused by postsynaptic events. Unexpectedly, the phosphorylation levels of calcium/calmodulin-dependent protein kinase II (CaMKII), an important mediator of learning and memory in postsynapses, were greatly increased in Fut8(-/-) mice. The expression levels of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors (AMPARs) in the postsynaptic density were enhanced in Fut8(-/-) mice, although there were no significant differences in the total expression levels, implicating that AMPARs without core fucosylation might exist in an active state. The activation of AMPARs was further confirmed by Fura-2 calcium imaging using primary cultured neurons. Taken together, loss of core fucosylation on AMPARs enhanced their heteromerization, which increase sensitivity for postsynaptic depolarization and persistently activate N-methyl-D-aspartate receptors as well as Ca2+ influx and CaMKII and then impair LTP.	[Gu, Wei; Fukuda, Tomohiko; Isaji, Tomoya; Hang, Qinglei; Lee, Ho-hsun; Gu, Jianguo] Tohoku Pharmaceut Univ, Div Regulatory Glycobiol, Sendai, Miyagi 9818558, Japan; [Mitoma, Junya; Higashi, Hideyoshi] Tohoku Pharmaceut Univ, Div Glycosignal Res, Sendai, Miyagi 9818558, Japan; [Sakai, Seiichiro; Yawo, Hiromu] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 9808577, Japan; [Morise, Jyoji; Oka, Shogo] Kyoto Univ, Grad Sch Med, Dept Biol Chem, Human Hlth Sci, Kyoto 6068507, Japan; [Taniguchi, Naoyuki] RIKEN, Dis Glyc Team, Wako, Saitama 3510198, Japan	Tohoku Medical & Pharmaceutical University; Tohoku Medical & Pharmaceutical University; Tohoku University; Kyoto University; RIKEN	Gu, JG (corresponding author), Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Regulatory Glycobiol, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan.	jgu@tohoku-pharm.ac.jp	Taniguchi, Naoyuki/I-4182-2014; Yawo, Hiromu/I-4871-2015; Gu, Jianguo/ABC-9257-2020; Isaji, Tomoya/ABC-9285-2021; Taniguchi, Naoyuki/A-7086-2016; Hang, Qinglei/GOP-0218-2022	Taniguchi, Naoyuki/0000-0001-5889-5968; Yawo, Hiromu/0000-0002-4299-3288; Hang, Qinglei/0000-0003-0419-6621	Japan Society for the Promotion of Science [21370059, 23651196, 24590087]; Grant for Scientific Research on Innovative Areas [23110002]; Strategic Research Foundation Grant-aided Project for Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [15H01413, 15K14408, 15K15025] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grant for Scientific Research on Innovative Areas; Strategic Research Foundation Grant-aided Project for Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-Aid for Scientific Research 21370059 (to J. G.) and Grants for Challenging Exploratory Research 23651196 (to J. G.) and 24590087 (to T. F.) from the Japan Society for the Promotion of Science. This work was also supported by Grant for Scientific Research on Innovative Areas 23110002 (to J. G.) and the Strategic Research Foundation Grant-aided Project for Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Bengtson CP, 2010, BIOPHYS J, V99, P4066, DOI 10.1016/j.bpj.2010.10.044; Booth A, 2014, MOL ENDOCRINOL, V28, P1999, DOI 10.1210/me.2014-1168; BORRELLI E, 1992, P NATL ACAD SCI USA, V89, P2764, DOI 10.1073/pnas.89.7.2764; Chen BS, 2007, NEUROPHARMACOLOGY, V53, P362, DOI 10.1016/j.neuropharm.2007.05.018; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Dingledine R, 1999, PHARMACOL REV, V51, P7; ETZIONI A, 1992, NEW ENGL J MED, V327, P1789, DOI 10.1056/NEJM199212173272505; Ferrara C, 2011, P NATL ACAD SCI USA, V108, P12669, DOI 10.1073/pnas.1108455108; Frantseva MV, 2008, CEREB CORTEX, V18, P990, DOI 10.1093/cercor/bhm151; Freedman R, 2003, NEW ENGL J MED, V349, P1738, DOI 10.1056/NEJMra035458; Fukuda T, 2011, J BIOL CHEM, V286, P18434, DOI 10.1074/jbc.M110.172536; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Greger IH, 2003, NEURON, V40, P763, DOI 10.1016/S0896-6273(03)00668-8; Gu W, 2013, FASEB J, V27, P3947, DOI 10.1096/fj.12-225805; Guo ZY, 2013, NEUROREPORT, V24, P492, DOI 10.1097/WNR.0b013e32836206b5; Hasan A, 2011, BEHAV BRAIN RES, V224, P15, DOI 10.1016/j.bbr.2011.05.017; Hellbusch CC, 2007, J BIOL CHEM, V282, P10762, DOI 10.1074/jbc.M700314200; HVALBY O, 1994, P NATL ACAD SCI USA, V91, P4761, DOI 10.1073/pnas.91.11.4761; Jiang JX, 2006, NEUROSIGNALS, V15, P266, DOI 10.1159/000105517; Kanatsu Y, 2012, J BIOCHEM, V152, P63, DOI 10.1093/jb/mvs055; Khoury GA, 2011, SCI REP-UK, V1, DOI 10.1038/srep00090; Kizuka Y, 2012, CELL MOL LIFE SCI, V69, P4135, DOI 10.1007/s00018-012-1036-z; Kullmann DM, 2007, NAT REV NEUROSCI, V8, P687, DOI 10.1038/nrn2207; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; LLEDO PM, 1995, P NATL ACAD SCI USA, V92, P11175, DOI 10.1073/pnas.92.24.11175; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MEDINA I, 1995, J PHYSIOL-LONDON, V482, P567, DOI 10.1113/jphysiol.1995.sp020540; Mizushima T, 2011, GENES CELLS, V16, P1071, DOI 10.1111/j.1365-2443.2011.01552.x; Morita I, 2009, J BIOL CHEM, V284, P30209, DOI 10.1074/jbc.M109.024208; Mueller TM, 2014, NEUROPSYCHOPHARMACOL, V39, P528, DOI 10.1038/npp.2013.190; Nakakita S, 2005, J BIOCHEM, V138, P277, DOI 10.1093/jb/mvi125; Ohno M, 2002, CURR BIOL, V12, P654, DOI 10.1016/S0960-9822(02)00767-4; Ohta H, 2013, NEUROSCI LETT, V534, P182, DOI 10.1016/j.neulet.2012.11.058; PADJEN AL, 1983, J PHYSIOL-LONDON, V336, P433, DOI 10.1113/jphysiol.1983.sp014589; Payne HL, 2008, MOL MEMBR BIOL, V25, P353, DOI 10.1080/09687680801986480; PETTIT DL, 1994, SCIENCE, V266, P1881, DOI 10.1126/science.7997883; Pi HJ, 2010, J NEUROSCI, V30, P8704, DOI 10.1523/JNEUROSCI.0133-10.2010; Raymond CR, 2007, TRENDS NEUROSCI, V30, P167, DOI 10.1016/j.tins.2007.01.007; Raymond CR, 2000, J NEUROSCI, V20, P969, DOI 10.1523/JNEUROSCI.20-03-00969.2000; Rossmann M, 2011, EMBO J, V30, P959, DOI 10.1038/emboj.2011.16; Sanderson TM, 2012, NEUROPHARMACOLOGY, V62, P1349, DOI 10.1016/j.neuropharm.2011.08.005; Sans N, 2003, J NEUROSCI, V23, P9367; Sans N, 2001, J NEUROSCI, V21, P7506, DOI 10.1523/JNEUROSCI.21-19-07506.2001; Savanthrapadian S, 2013, HIPPOCAMPUS, V23, P1395, DOI 10.1002/hipo.22193; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Stanta JL, 2010, J PROTEOME RES, V9, P4476, DOI 10.1021/pr1002356; Sturla L, 2001, PEDIATR RES, V49, P537, DOI 10.1203/00006450-200104000-00016; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Tanaka H, 2012, CELL REPORTS, V1, P291, DOI 10.1016/j.celrep.2012.02.004; Tucholski J, 2013, NEUROREPORT, V24, P688, DOI 10.1097/WNR.0b013e328363bd8a; Tucholski J, 2013, SCHIZOPHR RES, V146, P177, DOI 10.1016/j.schres.2013.01.031; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Wang YT, 1996, P NATL ACAD SCI USA, V93, P1721, DOI 10.1073/pnas.93.4.1721; Weeber EJ, 2003, J NEUROSCI, V23, P2634; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360	61	26	27	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17566	17575		10.1074/jbc.M114.579938	http://dx.doi.org/10.1074/jbc.M114.579938			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	25979332	Green Published, hybrid			2022-12-28	WOS:000357730900047
J	Steinke, KV; Gorinski, N; Wojciechowski, D; Todorov, V; Guseva, D; Ponimaskin, E; Fahlke, C; Fischer, M				Steinke, Kim Vanessa; Gorinski, Nataliya; Wojciechowski, Daniel; Todorov, Vladimir; Guseva, Daria; Ponimaskin, Evgeni; Fahlke, Christoph; Fischer, Martin			Human CLC-K Channels Require Palmitoylation of Their Accessory Subunit Barttin to Be Functional	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNDROME TYPE-IV; CHLORIDE CHANNELS; SENSORINEURAL DEAFNESS; BETA-SUBUNIT; SURFACE EXPRESSION; SODIUM-CHANNELS; BSND GENE; KIDNEY; TRAFFICKING; RECEPTOR	CLC-K/barttin chloride channels are essential for NaCl re-absorption in Henle's loop and for potassium secretion by the stria vascularis in the inner ear. Here, we studied the posttranslational modification of such channels by palmitoylation of their accessory subunit barttin. We found that barttin is palmitoylated in vivo and in vitro and identified two conserved cysteine residues at positions 54 and 56 as palmitoylation sites. Point mutations at these two residues reduce the macroscopic current amplitudes in cells expressing CLC-K/barttin channels proportionally to the relative reduction in palmitoylated barttin. CLCK/barttin expression, plasma membrane insertion, and single channel properties remain unaffected, indicating that these mutations decrease the number of active channels. R8W and G47R, two naturally occurring barttin mutations identified in patients with Bartter syndrome type IV, reduce barttin palmitoylation and CLC-K/barttin channel activity. Palmitoylation of the accessory subunit barttin might thus play a role in chloride channel dysfunction in certain variants of Bartter syndrome. We did not observe pronounced alteration of barttin palmitoylation upon increased salt and water intake or water deprivation, indicating that this posttranslational modification does not contribute to long term adaptation to variable water intake. Our results identify barttin palmitoylation as a novel posttranslational modification of CLC-K/barttin chloride channels.	[Steinke, Kim Vanessa; Gorinski, Nataliya; Wojciechowski, Daniel; Guseva, Daria; Ponimaskin, Evgeni; Fischer, Martin] Hannover Med Sch, Inst Neurophysiol, D-30625 Hannover, Germany; [Wojciechowski, Daniel; Fahlke, Christoph] FZ Julich, Inst Complex Syst, Zellulare Biophys ICS 4, D-52428 Julich, Germany; [Todorov, Vladimir] Univ Hosp Dresden, Div Nephrol, Lab Expt Nephrol, D-01307 Dresden, Germany	Hannover Medical School; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Fahlke, C (corresponding author), FZ Julich, Inst Complex Syst, Zellulare Biophys ICS 4, Leo Brandt Str, D-52428 Julich, Germany.	c.fahlke@fz-juelich.de; fischer.martin@mh-hannover.de	Guseva, Daria/AAW-2546-2021; Fahlke, Christoph/G-3635-2013; Guseva, Daria/S-8582-2018	Fahlke, Christoph/0000-0001-8602-9952; Todorov, Vladimir/0000-0002-7011-8130; Ponimaskin, evgeni/0000-0002-4570-5130; Guseva, PD, PhD, Daria/0000-0002-8844-572X	Deutsche Forschungsgemeinschaft [FA301/10, PO732]; Cluster of Excellence REBIRTH	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence REBIRTH	This work was supported by Deutsche Forschungsgemeinschaft Grants FA301/10 (to Ch. F.) and PO732 (to E. P.) and by Cluster of Excellence REBIRTH. (A preliminary account was presented at the 91st Annual Meeting of the Deutsche Physiologische Gesellschaft (DPG), March 22-25, 2012, Dresden, Germany (Steinke, K. V., Gorinski, N., Wojciechowski, D., Ponimaskin, E., Fischer, M., and Fahlke, Ch. (2012) Acta Physiol. 204, Suppl. 689 (Abstr. P262)). The authors declare that they have no conflicts of interest with the contents of this article.	Alekov AK, 2009, J GEN PHYSIOL, V133, P485, DOI 10.1085/jgp.200810155; Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Baekkeskov S, 2009, MOL MEMBR BIOL, V26, P42, DOI 10.1080/09687680802680108; Birkenhager R, 2001, NAT GENET, V29, P310, DOI 10.1038/ng752; Bosmans F, 2011, P NATL ACAD SCI USA, V108, P20213, DOI 10.1073/pnas.1108497108; Brum S, 2007, NEPHROL DIAL TRANSPL, V22, P288, DOI 10.1093/ndt/gfl493; Chamberlain LH, 2013, BIOCHEM SOC T, V41, P62, DOI 10.1042/BST20120243; Charollais J, 2009, MOL MEMBR BIOL, V26, P55, DOI 10.1080/09687680802620369; Chien AJ, 1996, J BIOL CHEM, V271, P26465, DOI 10.1074/jbc.271.43.26465; Davda D, 2013, ACS CHEM BIOL, V8, P1912, DOI 10.1021/cb400380s; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Estevez R, 2001, NATURE, V414, P558, DOI 10.1038/35107099; Fahlke C, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00155; Fischer M, 2010, J AM SOC NEPHROL, V21, P1281, DOI 10.1681/ASN.2009121274; Garcia-Nieto V, 2006, PEDIATR NEPHROL, V21, P643, DOI 10.1007/s00467-006-0062-1; Hanwell D, 2002, J BIOL CHEM, V277, P9772, DOI 10.1074/jbc.M110904200; Hautmann M, 2007, J AM SOC NEPHROL, V18, P1150, DOI 10.1681/ASN.2006060633; Hayama A, 2003, HISTOCHEM CELL BIOL, V119, P485, DOI 10.1007/s00418-003-0535-2; Hayashi T, 2005, NEURON, V47, P709, DOI 10.1016/j.neuron.2005.06.035; Hayashi T, 2009, NEURON, V64, P213, DOI 10.1016/j.neuron.2009.08.017; Hebeisen S, 2005, BIOPHYS J, V89, P1710, DOI 10.1529/biophysj.104.056093; Ho GPH, 2011, NEURON, V71, P131, DOI 10.1016/j.neuron.2011.05.033; Imbrici P, 2014, BBA-BIOMEMBRANES, V1838, P2484, DOI 10.1016/j.bbamem.2014.05.017; Janssen AGH, 2009, J AM SOC NEPHROL, V20, P145, DOI 10.1681/ASN.2008010102; Jeck N, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.1.e5; Jeffries O, 2010, J BIOL CHEM, V285, P33307, DOI 10.1074/jbc.M110.153940; Jentsch TJ, 2008, CRIT REV BIOCHEM MOL, V43, P3, DOI [10.1080/10409230701829110, 10.1080/10409230701829110 ]; Kandasamy SK, 2006, BIOPHYS J, V90, P2326, DOI 10.1529/biophysj.105.073395; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; KIEFERLE S, 1994, P NATL ACAD SCI USA, V91, P6943, DOI 10.1073/pnas.91.15.6943; LANDAU D, 1995, AM J MED GENET, V59, P454, DOI 10.1002/ajmg.1320590411; Matsumura Y, 1999, NAT GENET, V21, P95, DOI 10.1038/5036; Miyamura N, 2003, J CLIN ENDOCR METAB, V88, P781, DOI 10.1210/jc.2002-021398; Nothmann D, 2011, J BIOL CHEM, V286, P3935, DOI 10.1074/jbc.M110.187492; Park CW, 2011, CLIN NEPHROL, V75, pS69, DOI 10.2379/CN106509; Ponimaskin EG, 2002, J BIOL CHEM, V277, P2534, DOI 10.1074/jbc.M106529200; Qin N, 1998, P NATL ACAD SCI USA, V95, P4690, DOI 10.1073/pnas.95.8.4690; Renner U, 2007, MOL PHARMACOL, V72, P502, DOI 10.1124/mol.107.037085; Riazuddin S, 2009, AM J HUM GENET, V85, P273, DOI 10.1016/j.ajhg.2009.07.003; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; Schlingmann KP, 2004, NEW ENGL J MED, V350, P1314, DOI 10.1056/NEJMoa032843; Scholl U, 2006, P NATL ACAD SCI USA, V103, P11411, DOI 10.1073/pnas.0601631103; Sesti F, 1998, J GEN PHYSIOL, V112, P651, DOI 10.1085/jgp.112.6.651; Shipston MJ, 2011, J BIOL CHEM, V286, P8709, DOI 10.1074/jbc.R110.210005; SIGWORTH FJ, 1977, NATURE, V270, P265, DOI 10.1038/270265a0; Simon DB, 1997, NAT GENET, V17, P171, DOI 10.1038/ng1097-171; Tajima M, 2007, BIOCHEM BIOPH RES CO, V362, P858, DOI 10.1016/j.bbrc.2007.08.097; TAUBER R, 1986, EMBO J, V5, P2109, DOI 10.1002/j.1460-2075.1986.tb04473.x; Tian LJ, 2008, P NATL ACAD SCI USA, V105, P21006, DOI 10.1073/pnas.0806700106; Uchida S, 2005, ANNU REV PHYSIOL, V67, P759, DOI 10.1146/annurev.physiol.67.032003.153547; Vandewalle A, 1997, AM J PHYSIOL-RENAL, V272, pF678, DOI 10.1152/ajprenal.1997.272.5.F678; Waldegger S, 2002, PFLUG ARCH EUR J PHY, V444, P411, DOI 10.1007/s00424-002-0819-8; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Wolfe JT, 2003, NATURE, V424, P209, DOI 10.1038/nature01772	54	15	16	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17390	17400		10.1074/jbc.M114.631705	http://dx.doi.org/10.1074/jbc.M114.631705			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26013830	Green Published, hybrid			2022-12-28	WOS:000357730900033
J	Ahmed, S; Bott, D; Gomez, A; Tamblyn, L; Rasheed, A; Cho, T; MacPherson, L; Sugamori, KS; Yang, Y; Grant, DM; Cummins, CL; Matthews, J				Ahmed, Shaimaa; Bott, Debbie; Gomez, Alvin; Tamblyn, Laura; Rasheed, Adil; Cho, Tiffany; MacPherson, Laura; Sugamori, Kim S.; Yang, Yang; Grant, Denis M.; Cummins, Carolyn L.; Matthews, Jason			Loss of the Mono-ADP-ribosyltransferase, Tiparp, Increases Sensitivity to Dioxin-induced Steatohepatitis and Lethality	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARYL-HYDROCARBON RECEPTOR; HEAT-SHOCK-PROTEIN; AH RECEPTOR; POLY(ADP-RIBOSE) POLYMERASE; DEFICIENT MICE; NONALCOHOLIC STEATOHEPATITIS; GLUCOCORTICOID-RECEPTOR; LIVER DEVELOPMENT; GENE-EXPRESSION; DOSE-RESPONSE	The aryl hydrocarbon receptor (AHR) mediates the toxic effects of the environmental contaminant dioxin (2,3,7,8-tetrachlorodibenzo-p-dioxin; TCDD). Dioxin causes a range of toxic responses, including hepatic damage, steatohepatitis, and a lethal wasting syndrome; however, the mechanisms are still unknown. Here, we show that the loss of TCDD-inducible poly(ADP-ribose) polymerase (Tiparp), an ADP-ribosyltransferase and AHR repressor, increases sensitivity to dioxin-induced toxicity, steatohepatitis, and lethality. Tiparp(-/-) mice given a single injection of 100 mu g/kg dioxin did not survive beyond day 5; all Tiparp(+/+) mice survived the 30-day treatment. Dioxin-treated Tiparp(-/-) mice exhibited increased liver steatosis and hepatotoxicity. Tiparp ADP-ribosylated AHR but not its dimerization partner, the AHR nuclear translocator, and the repressive effects of TIPARP on AHR were reversed by the macro-domain containing mono-ADP-ribosylase MACROD1 but not MACROD2. These results reveal previously unidentified roles for Tiparp, MacroD1, and ADP-ribosylation in AHR-mediated steatohepatitis and lethality in response to dioxin.	[Ahmed, Shaimaa; Bott, Debbie; Gomez, Alvin; Tamblyn, Laura; Cho, Tiffany; MacPherson, Laura; Sugamori, Kim S.; Yang, Yang; Grant, Denis M.; Matthews, Jason] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON M5S 1A8, Canada; [Rasheed, Adil; Grant, Denis M.; Cummins, Carolyn L.] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto	Matthews, J (corresponding author), Univ Toronto, Dept Pharmacol & Toxicol, 1 Kings Coll Circle,Med Sci Bldg,Rm 4336, Toronto, ON M5S 1A8, Canada.	jason.matthews@utoronto.ca		Cummins, Carolyn/0000-0001-7603-6577; Rasheed, Adil/0000-0002-3204-6674; MacPherson, Laura/0000-0003-3422-4478; Matthews, Jason/0000-0002-9815-8636; Yang, Sunny/0000-0001-9579-8462	Canadian Institutes of Health Research Operating Grant [MOP-125919]; DOW Chemical; Early Researcher Award from the Ontario Ministry of Innovation; Ontario Graduate Scholarship	Canadian Institutes of Health Research Operating Grant(Canadian Institutes of Health Research (CIHR)); DOW Chemical; Early Researcher Award from the Ontario Ministry of Innovation; Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This work was supported by Canadian Institutes of Health Research Operating Grant MOP-125919, an unrestricted research grant from DOW Chemical, an Early Researcher Award from the Ontario Ministry of Innovation (to J. M.), and an Ontario Graduate Scholarship (to L. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Atasheva S, 2012, J VIROL, V86, P8147, DOI 10.1128/JVI.00733-12; Bai P, 2012, CELL METAB, V16, P290, DOI 10.1016/j.cmet.2012.06.016; Bernshausen T, 2006, ARCH TOXICOL, V80, P206, DOI 10.1007/s00204-005-0025-5; Birnbaum LS, 1995, TOXICOL LETT, V82-3, P743, DOI 10.1016/0378-4274(95)03592-3; BIRNBAUM LS, 1994, ENVIRON HEALTH PERSP, V102, P676, DOI 10.2307/3432197; Bunger MK, 2003, J BIOL CHEM, V278, P17767, DOI 10.1074/jbc.M209594200; Carver LA, 1997, J BIOL CHEM, V272, P11452; Casado FL, 2011, MOL PHARMACOL, V80, P673, DOI 10.1124/mol.111.071381; CHANG CY, 1993, PHARMACOGENETICS, V3, P312, DOI 10.1097/00008571-199312000-00005; Chen WSV, 2004, NAT GENET, V36, P304, DOI 10.1038/ng1306; DENIS M, 1988, BIOCHEM BIOPH RES CO, V155, P801, DOI 10.1016/S0006-291X(88)80566-7; Diani-Moore S, 2010, J BIOL CHEM, V285, P38801, DOI 10.1074/jbc.M110.131573; Esser C, 2009, TRENDS IMMUNOL, V30, P447, DOI 10.1016/j.it.2009.06.005; Feijs KLH, 2013, NAT REV MOL CELL BIO, V14, P443, DOI 10.1038/nrm3601; FernandezSalguero PM, 1996, TOXICOL APPL PHARM, V140, P173, DOI 10.1006/taap.1996.0210; Forgacs AL, 2013, TOXICOL SCI, V133, P54, DOI 10.1093/toxsci/kft028; Goode LL, 2010, NAT GENET, V42, P874, DOI 10.1038/ng.668; Hahn ME, 2009, BIOCHEM PHARMACOL, V77, P485, DOI 10.1016/j.bcp.2008.09.016; HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pharmtox.35.1.307; He JH, 2013, MOL CELL BIOL, V33, P2047, DOI 10.1128/MCB.01658-12; Hosoya T, 2008, BIOCHEM BIOPH RES CO, V365, P562, DOI 10.1016/j.bbrc.2007.11.016; Hottiger MO, 2010, TRENDS BIOCHEM SCI, V35, P208, DOI 10.1016/j.tibs.2009.12.003; Karchner SI, 2009, MOL CELL BIOL, V29, P3465, DOI 10.1128/MCB.00206-09; Kraus WL, 2013, MOL ASPECTS MED, V34, P1109, DOI 10.1016/j.mam.2013.01.005; Krishnakumar R, 2010, MOL CELL, V39, P736, DOI 10.1016/j.molcel.2010.08.014; Lee C, 2013, DRUG METAB DISPOS, V41, P457, DOI 10.1124/dmd.112.048835; Lee JH, 2010, GASTROENTEROLOGY, V139, P653, DOI 10.1053/j.gastro.2010.03.033; Lu H, 2011, TOXICOL APPL PHARM, V256, P122, DOI 10.1016/j.taap.2011.07.019; Ma Q, 2001, BIOCHEM BIOPH RES CO, V289, P499, DOI 10.1006/bbrc.2001.5987; MacPherson L, 2013, NUCLEIC ACIDS RES, V41, P1604, DOI 10.1093/nar/gks1337; Marra F, 2008, TRENDS MOL MED, V14, P72, DOI 10.1016/j.molmed.2007.12.003; Matsubara T, 2012, CELL METAB, V16, P634, DOI 10.1016/j.cmet.2012.10.006; Mimura J, 1999, GENE DEV, V13, P20, DOI 10.1101/gad.13.1.20; Moura-Alves P, 2014, NATURE, V512, P387, DOI 10.1038/nature13684; NEBERT DW, 1993, ANN NY ACAD SCI, V685, P624, DOI 10.1111/j.1749-6632.1993.tb35928.x; Neuvonen M, 2009, J MOL BIOL, V385, P212, DOI 10.1016/j.jmb.2008.10.045; PARK SS, 1982, CANCER RES, V42, P1798; Patel R, 2011, J CLIN INVEST, V121, P431, DOI 10.1172/JCI41681; PERDEW GH, 1988, J BIOL CHEM, V263, P13802; POHJANVIRTA R, 1990, PHARMACOL TOXICOL, V66, P399, DOI 10.1111/j.1600-0773.1990.tb00769.x; POHJANVIRTA R, 1994, PHARMACOL REV, V46, P483; POLAND A, 1982, ANNU REV PHARMACOL, V22, P517, DOI 10.1146/annurev.pa.22.040182.002505; POLAND A, 1990, MOL PHARMACOL, V38, P306; POLAND A, 1994, MOL PHARMACOL, V46, P915; Pollenz RS, 2002, CHEM-BIOL INTERACT, V141, P41, DOI 10.1016/S0009-2797(02)00065-0; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Roper SJ, 2014, NUCLEIC ACIDS RES, V42, P8914, DOI 10.1093/nar/gku591; Rosenthal F, 2013, NAT STRUCT MOL BIOL, V20, P502, DOI 10.1038/nsmb.2521; Santostefano MJ, 1997, BIOCHEM BIOPH RES CO, V233, P20, DOI 10.1006/bbrc.1997.6389; Sasse SK, 2013, MOL CELL BIOL, V33, P2104, DOI 10.1128/MCB.01474-12; Schmahl J, 2007, NAT GENET, V39, P52, DOI 10.1038/ng1922; Schmahl J, 2008, GENE DEV, V22, P3255, DOI 10.1101/gad.1723908; Stevens EA, 2009, IMMUNOLOGY, V127, P299, DOI 10.1111/j.1365-2567.2009.03054.x; Tigges J, 2013, J INVEST DERMATOL, V133, P87, DOI 10.1038/jid.2012.259; Uno S, 2004, TOXICOL APPL PHARM, V196, P410, DOI 10.1016/j.taap.2004.01.014; Vyas S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5426; Walisser JA, 2005, P NATL ACAD SCI USA, V102, P17858, DOI 10.1073/pnas.0504757102; Walker NJ, 1999, TOXICOL APPL PHARM, V154, P279, DOI 10.1006/taap.1998.8595; Yang J, 2009, ENDOCR-RELAT CANCER, V16, P139, DOI 10.1677/ERC-08-0150; Yu Z, 2006, CANCER RES, V66, P755, DOI 10.1158/0008-5472.CAN-05-3390	60	40	41	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16824	16840		10.1074/jbc.M115.660100	http://dx.doi.org/10.1074/jbc.M115.660100			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25975270	Green Published, hybrid			2022-12-28	WOS:000357572800028
J	Nomme, J; Antanasijevic, A; Caffrey, M; Van Itallie, CM; Anderson, JM; Fanning, AS; Lavie, A				Nomme, Julian; Antanasijevic, Aleksandar; Caffrey, Michael; Van Itallie, Christina M.; Anderson, James M.; Fanning, Alan S.; Lavie, Arnon			Structural Basis of a Key Factor Regulating the Affinity between the Zonula Occludens First PDZ Domain and Claudins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIGHT-JUNCTION; EXTRACELLULAR DOMAINS; EPITHELIAL-CELLS; PROTEIN ZO-1; RECOGNITION; SPECIFICITY; PHOSPHORYLATION; DETERMINANTS; DIMERIZATION; BARRIER	The molecular seal between epithelial cells, called the tight junction (TJ), is built by several membrane proteins, with claudins playing the most prominent role. The scaffold proteins of the zonula occludens family are required for the correct localization of claudins and hence formation of the TJ. The intracellular C terminus of claudins binds to the N-terminal PDZ domain of zonula occludens proteins (PDZ1). Of the 23 identified human claudin proteins, nine possess a tyrosine at the -6 position. Here we show that the claudin affinity for PDZ1 is dependent on the presence or absence of this tyrosine and that the affinity is reduced if the tyrosine is modified by phosphorylation. The PDZ1 beta 2-beta 3 loop undergoes a significant conformational change to accommodate this tyrosine. Cell culture experiments support a regulatory role for this tyrosine. Plasticity has been recognized as a critical property of TJs that allow cell remodeling and migration. Our work provides a molecular framework for how TJ plasticity may be regulated.	[Nomme, Julian; Antanasijevic, Aleksandar; Caffrey, Michael; Lavie, Arnon] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Van Itallie, Christina M.; Anderson, James M.] NHLBI, Lab Tight Junct Struct & Funct, NIH, Bethesda, MD 20892 USA; [Fanning, Alan S.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of North Carolina; University of North Carolina Chapel Hill	Lavie, A (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA.	lavie@uic.edu	Regan, Clinton/E-6250-2012	Lavie, Arnon/0000-0001-5591-8722; Anderson, James/0000-0003-2765-7996	National Institutes of Health [DK61397, AI101676]; Division of Intramural Research, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061397, R56DK061397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Intramural Research, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK61397 (to A. S. F. and A. L.) and AI101676 (to M. C.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Division of Intramural Research, National Institutes of Health.	Amasheh S, 2002, J CELL SCI, V115, P4969, DOI 10.1242/jcs.00165; Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Antanasijevic A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076363; Appleton BA, 2006, J BIOL CHEM, V281, P22312, DOI 10.1074/jbc.M602901200; Birrane G, 2003, J BIOL CHEM, V278, P1399, DOI 10.1074/jbc.C200571200; Chen J, 2008, EMBO J, V27, P2113, DOI 10.1038/emboj.2008.138; Colegio OR, 2003, AM J PHYSIOL-CELL PH, V284, pC1346, DOI 10.1152/ajpcell.00547.2002; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fanning AS, 2007, J BIOL CHEM, V282, P37710, DOI 10.1074/jbc.M707255200; Findley MK, 2009, IUBMB LIFE, V61, P431, DOI 10.1002/iub.175; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; Ikari A, 2010, BBA-BIOMEMBRANES, V1798, P415, DOI 10.1016/j.bbamem.2009.11.005; Im YJ, 2010, J MOL BIOL, V397, P457, DOI 10.1016/j.jmb.2010.01.048; Itoh M, 1999, J CELL BIOL, V147, P1351, DOI 10.1083/jcb.147.6.1351; Jeansonne B, 2003, CELL MOL BIOL, V49, P13; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karthikeyan S, 2002, J BIOL CHEM, V277, P18973, DOI 10.1074/jbc.M201507200; Luck K, 2012, FEBS LETT, V586, P2648, DOI 10.1016/j.febslet.2012.03.056; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niethammer M, 1998, NEURON, V20, P693, DOI 10.1016/S0896-6273(00)81009-0; Nomme J, 2011, J BIOL CHEM, V286, P43352, DOI 10.1074/jbc.M111.304089; Poliak S, 2002, J CELL BIOL, V159, P361, DOI 10.1083/jcb.200207050; Rodgers LS, 2013, J CELL SCI, V126, P1565, DOI 10.1242/jcs.113399; Twiss F, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.27425; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Van Itallie CM, 2012, J CELL SCI, V125, P4902, DOI 10.1242/jcs.111237; Van Itallie CM, 2011, J BIOL CHEM, V286, P3442, DOI 10.1074/jbc.M110.195578; Van Itallie CM, 2009, MOL BIOL CELL, V20, P3930, DOI 10.1091/mbc.E09-04-0320; Van Itallie CM, 2009, ANN NY ACAD SCI, V1165, P82, DOI 10.1111/j.1749-6632.2009.04052.x; Wang CK, 2010, PROTEIN CELL, V1, P737, DOI 10.1007/s13238-010-0099-6; Ye F, 2013, BIOCHEM J, V455, P1, DOI 10.1042/BJ20130783; Zhang JX, 2008, J MOL BIOL, V384, P255, DOI 10.1016/j.jmb.2008.09.034; Zhang YN, 2006, J BIOL CHEM, V281, P22299, DOI 10.1074/jbc.M602902200	35	33	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16595	16606		10.1074/jbc.M115.646695	http://dx.doi.org/10.1074/jbc.M115.646695			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	26023235	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000357572800012
J	Dai, X; Chen, X; Chen, Q; Shi, L; Liang, HW; Zhou, Z; Liu, Q; Pang, WJ; Hou, DX; Wang, C; Zen, K; Yuan, YZ; Zhang, CY; Xia, L				Dai, Xin; Chen, Xi; Chen, Qun; Shi, Lei; Liang, Hongwei; Zhou, Zhen; Liu, Qian; Pang, Wenjing; Hou, Dongxia; Wang, Cheng; Zen, Ke; Yuan, Yaozong; Zhang, Chen-Yu; Xia, Lu			MicroRNA-193a-3p Reduces Intestinal Inflammation in Response to Microbiota via Down-regulation of Colonic PepT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene regulation; inflammatory bowel disease (IBD); microRNA (miRNA); mucosal immunology; peptide transport	NF-KAPPA-B; OLIGOPEPTIDE TRANSPORTER PEPT-1; INDUCED COLITIS; BOWEL-DISEASE; EXPRESSION; FMLP; MICRORNAS; CELLS; ACTIVATION; APOPTOSIS	Background: The involvement of miRNAs in the host mucosal immune response to gut microbes in colitis is still unclear. Results: miR-193a-3p down-regulates PepT1, and intracolonic-delivery of miR-193a-3p ameliorated the severity of colitis. Conclusion: miRNA-193a-3p can target colonic PepT1 and reduce intestinal inflammation. Significance: Our study illustrates the new role of miRNAs in regulating the host immune response to microbes during colitis. Intestinal inflammation is characterized by epithelial disruption, leading to the loss of barrier function, recruitment of immune cells, and host immune responses to gut microbiota. PepT1, a di/tripeptide transporter that uptakes bacterial products, is up-regulated in inflamed colon tissue, which implies its role in bacterium-associated intestinal inflammation. Although microRNA (miRNA)-mediated gene regulation has been found to be involved in various processes of inflammatory bowel disease (IBD), the biological function of miRNAs in the pathogenesis of IBD remains to be explored. In this study we detected miRNA expression patterns in colon tissues during colitis and investigated the mechanism underlying the regulation of colonic PepT1 by miRNAs. We observed an inverse correlation between PepT1 and miR-193a-3p in inflamed colon tissues with active ulcerative colitis, and we further demonstrated that miR-193a-3p reduced PepT1 expression and activity as a target gene and subsequently suppressed the NF-B pathway. Intracolonic delivery of miR-193a-3p significantly ameliorated dextran sodium sulfate-induced colitis, whereas the overexpression of colonic PepT1 via PepT1 3-untranslated region mutant lentivirus vector abolished the anti-inflammatory effect of miR-193a-3p. Furthermore, antibiotic treatment eliminated the difference in the dextran sodium sulfate-induced inflammation between the presence and absence of miR-193a-3p. These findings suggest that miR-193a-3p regulation of PepT1 mediates the uptake of bacterial products and is a potent mechanism during the colonic inflammation process. Overall, we believe miR-193a-3p may be a potent regulator of colonic PepT1 for maintaining intestinal homeostasis.	[Dai, Xin; Liu, Qian; Pang, Wenjing; Yuan, Yaozong; Xia, Lu] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Gastroenterol, Shanghai 200025, Peoples R China; [Chen, Xi; Chen, Qun; Shi, Lei; Liang, Hongwei; Zhou, Zhen; Hou, Dongxia; Wang, Cheng; Zen, Ke; Zhang, Chen-Yu] Nanjing Univ, Sch Life Sci, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Jiangsu, Peoples R China	Shanghai Jiao Tong University; Nanjing University	Yuan, YZ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Gastroenterol, 197 Ruijin Second Rd, Shanghai 200025, Peoples R China.	yyz28@medmail.com.cn; cyzhang@nju.edu.cn; xialu@medmail.com.cn	Wang, Cheng/O-7206-2016; Zhou, Zhen/L-7152-2019; Shi, Lei/AAJ-1586-2020	Wang, Cheng/0000-0002-1834-2119; Shi, Lei/0000-0002-6631-6732	National Natural Science Foundation of China [81200281, 81101330, 31271378, 81250044, J1103512]; Natural Science Foundation of Jiangsu Province [BK2011013, BK2012014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by National Natural Science Foundation of China Grants 81200281, 81101330, 31271378, 81250044, and J1103512 and Natural Science Foundation of Jiangsu Province Grants BK2011013 and BK2012014. The authors declare that they have no conflicts of interest with the contents of this article.	Adibi SA, 2003, AM J PHYSIOL-GASTR L, V285, pG779, DOI 10.1152/ajpgi.00056.2003; Adibi SA, 1997, GASTROENTEROLOGY, V113, P332, DOI 10.1016/S0016-5085(97)70112-4; Andersen V, 2011, WORLD J GASTROENTERO, V17, P197, DOI 10.3748/wjg.v17.i2.197; Ando Y, 2012, HEPATOLOGY, V56, P1418, DOI 10.1002/hep.25803; Araki Y, 2010, ONCOL REP, V24, P869, DOI 10.3892/or_00000932; Atreya I, 2008, J INTERN MED, V263, P591, DOI 10.1111/j.1365-2796.2008.01953.x; Ayyadurai S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087614; Ayyadurai S, 2013, LAB INVEST, V93, P888, DOI 10.1038/labinvest.2013.77; Bantel H, 2000, AM J GASTROENTEROL, V95, P1845; Bian Z, 2011, J PATHOL, V225, P544, DOI 10.1002/path.2907; Burns KA, 2004, CURR BIOL, V14, pR1040, DOI 10.1016/j.cub.2004.11.040; Buyse M, 2002, AM J PHYSIOL-CELL PH, V283, pC1795, DOI 10.1152/ajpcell.00186.2002; Carlson RM, 2007, AM J PHYSIOL-GASTR L, V292, pG1070, DOI 10.1152/ajpgi.00417.2006; Chen LY, 2009, J IMMUNOL, V182, P2518, DOI 10.4049/jimmunol.0713933; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chen Y, 2013, BIOCHEM BIOPH RES CO, V438, P133, DOI 10.1016/j.bbrc.2013.07.040; Dai R, 2011, TRANSL RES, V157, P163, DOI 10.1016/j.trsl.2011.01.007; Dalal SR, 2014, J CLIN INVEST, V124, P4190, DOI 10.1172/JCI72330; Dalmasso G, 2008, GASTROENTEROLOGY, V134, P166, DOI 10.1053/j.gastro.2007.10.026; Dalmasso G, 2011, GASTROENTEROLOGY, V141, P1334, DOI 10.1053/j.gastro.2011.06.080; Dalmasso G, 2011, AM J PHYSIOL-GASTR L, V300, pG52, DOI 10.1152/ajpgi.00394.2010; Dalmasso G, 2010, AM J PHYSIOL-GASTR L, V299, pG687, DOI 10.1152/ajpgi.00527.2009; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Hindlet P, 2007, J PHARMACOL EXP THER, V323, P192, DOI 10.1124/jpet.107.125799; Hindlet P, 2009, J BIOL CHEM, V284, P6801, DOI 10.1074/jbc.M805564200; Huang Z, 2014, GUT, V63, P1247, DOI 10.1136/gutjnl-2012-304213; Iborra M, 2012, AUTOIMMUN REV, V11, P305, DOI 10.1016/j.autrev.2010.07.002; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Koukos G, 2013, GASTROENTEROLOGY, V145, P842, DOI 10.1053/j.gastro.2013.07.001; Kwon JE, 2013, APOPTOSIS, V18, P896, DOI 10.1007/s10495-013-0841-7; Li LM, 2011, J IMMUNOL, V186, P2552, DOI 10.4049/jimmunol.1001633; Merlin D, 2001, GASTROENTEROLOGY, V120, P1666, DOI 10.1053/gast.2001.24845; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Saleh M, 2011, IMMUNITY, V34, P293, DOI 10.1016/j.immuni.2011.03.008; Salvi A, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-162; Shi B, 2006, J SURG RES, V136, P38, DOI 10.1016/j.jss.2006.05.025; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Wu W, 2015, GUT, V64, P1755, DOI 10.1136/gutjnl-2014-307980; Xue XC, 2014, EUR J IMMUNOL, V44, P673, DOI 10.1002/eji.201343717; Xue XC, 2011, J IMMUNOL, V187, P5879, DOI 10.4049/jimmunol.1100535; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010	43	59	65	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16099	16115		10.1074/jbc.M115.659318	http://dx.doi.org/10.1074/jbc.M115.659318			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25931122	hybrid, Green Published			2022-12-28	WOS:000356930100016
J	Su, Y; Patra, A; Harp, JM; Egli, M; Guengerich, FP				Su, Yan; Patra, Amritraj; Harp, Joel M.; Egli, Martin; Guengerich, F. Peter			Roles of Residues Arg-61 and Gln-38 of Human DNA Polymerase in Bypass of Deoxyguanosine and 7,8-Dihydro-8-oxo-2-deoxyguanosine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA damage; DNA polymerase; kinetics; mutagenesis mechanism; pre-steady-state kinetics; site-directed mutagenesis; x-ray crystallography	IMMUNOGLOBULIN GENE HYPERMUTATION; Y-FAMILY; SOMATIC HYPERMUTATION; TRANSLESION SYNTHESIS; STRUCTURAL BASIS; ETA; REPLICATION; MECHANISM; MUTATIONS; RECOMBINATION	Background: Arg-61 and Gln-38 of human DNA polymerase (hpol) play important roles in the catalytic reaction. Results: Mutations R61M or Q38A/R61A dramatically disrupt the activity of hpol . Conclusion: Polarized water molecules can mimic and partially compensate for the missing side chains of Arg-61 and Gln-38 in the Q38A/R61A mutant. Significance: The positioning and positive charge of Arg-61 synergistically contribute to the activity of hpol , with additional effects of Gln-38. Like the other Y-family DNA polymerases, human DNA polymerase (hpol ) has relatively low fidelity and is able to tolerate damage during DNA synthesis, including 7,8-dihydro-8-oxo-2-deoxyguanosine (8-oxoG), one of the most abundant DNA lesions in the genome. Crystal structures show that Arg-61 and Gln-38 are located near the active site and may play important roles in the fidelity and efficiency of hpol . Site-directed mutagenesis was used to replace these side chains either alone or together, and the wild type or mutant proteins were purified and tested by replicating DNA past deoxyguanosine (G) or 8-oxoG. The catalytic activity of hpol was dramatically disrupted by the R61M and Q38A/R61A mutations, as opposed to the R61A and Q38A single mutants. Crystal structures of hpol mutant ternary complexes reveal that polarized water molecules can mimic and partially compensate for the missing side chains of Arg-61 and Gln-38 in the Q38A/R61A mutant. The combined data indicate that the positioning and positive charge of Arg-61 synergistically contribute to the nucleotidyl transfer reaction, with additional influence exerted by Gln-38. In addition, gel filtration chromatography separated multimeric and monomeric forms of wild type and mutant hpol , indicating the possibility that hpol forms multimers in vivo.	[Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu			United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [P01CA160032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010375] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank P. S. Pallan for advice on some of the crystallography work and K. Trisler for assistance in preparation of the manuscript. Vanderbilt University is a member institution of the Life Sciences Collaborative Access Team at Sector 21 of the Advanced Photon Source (Argonne, IL). Use of the Advanced Photon Source at Argonne National Laboratory was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albertella MR, 2005, CANCER RES, V65, P9799, DOI 10.1158/0008-5472.CAN-05-1095; Bassett E, 2004, CANCER RES, V64, P6469, DOI 10.1158/0008-5472.CAN-04-1328; Biertumpfel C, 2010, NATURE, V465, P1044, DOI 10.1038/nature09196; Bugreev DV, 2007, NAT STRUCT MOL BIOL, V14, P746, DOI 10.1038/nsmb1268; Chen YW, 2006, MOL CANCER RES, V4, P257, DOI 10.1158/1541-7786.MCR-05-0118; Delbos F, 2005, J EXP MED, V201, P1191, DOI 10.1084/jem.20050292; Delbos F, 2007, J EXP MED, V204, P17, DOI 10.1084/jem.20062131; Egli M, 2007, ACCOUNTS CHEM RES, V40, P197, DOI 10.1021/ar068174u; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eoff RL, 2007, J BIOL CHEM, V282, P19831, DOI 10.1074/jbc.M702290200; Furge LL, 1999, BIOCHEMISTRY-US, V38, P4818, DOI 10.1021/bi982163u; Gregory MT, 2014, P NATL ACAD SCI USA, V111, P9133, DOI 10.1073/pnas.1405739111; Guengerich FP, 2006, CHEM REV, V106, P420, DOI 10.1021/cr0404693; Haracska L, 2000, NAT GENET, V25, P458, DOI 10.1038/78169; Hicks JK, 2010, MOL CELL BIOL, V30, P1217, DOI 10.1128/MCB.00993-09; Inui H, 2008, J INVEST DERMATOL, V128, P2055, DOI 10.1038/jid.2008.48; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Kawamoto T, 2005, MOL CELL, V20, P793, DOI 10.1016/j.molcel.2005.10.016; Kent T, 2015, NAT STRUCT MOL BIOL, V22, P230, DOI 10.1038/nsmb.2961; Langer GG, 2013, ACTA CRYSTALLOGR D, V69, P635, DOI 10.1107/S0907444913000565; Lin HK, 2012, BIOCHEMISTRY-US, V51, P7367, DOI 10.1021/bi300956t; Maga G, 2007, NATURE, V447, P606, DOI 10.1038/nature05843; Masutani C, 2000, EMBO J, V19, P3100, DOI 10.1093/emboj/19.12.3100; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McIlwraith MJ, 2005, MOL CELL, V20, P783, DOI 10.1016/j.molcel.2005.10.001; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakamura T, 2012, NATURE, V487, P196, DOI 10.1038/nature11181; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patra A, 2015, J BIOL CHEM, V290, P8028, DOI 10.1074/jbc.M115.637561; Patra A, 2014, J BIOL CHEM, V289, P16867, DOI 10.1074/jbc.M114.551820; Pavlov YI, 2002, P NATL ACAD SCI USA, V99, P9954, DOI 10.1073/pnas.152126799; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reha-Krantz LJ, 2010, BBA-PROTEINS PROTEOM, V1804, P1049, DOI 10.1016/j.bbapap.2009.06.012; Rogozin IB, 2003, MUTAT RES-REV MUTAT, V544, P65, DOI 10.1016/S1383-5742(03)00032-2; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Sassa A, 2013, JOVE-J VIS EXP, DOI 10.3791/50695; Schorr S, 2010, P NATL ACAD SCI USA, V107, P20720, DOI 10.1073/pnas.1008894107; Silverstein TD, 2010, STRUCTURE, V18, P1463, DOI 10.1016/j.str.2010.08.019; Silverstein TD, 2010, NATURE, V465, P1039, DOI 10.1038/nature09104; Suarez SC, 2013, MUTAT RES-FUND MOL M, V745, P46, DOI 10.1016/j.mrfmmm.2013.03.001; Tang KH, 2008, J CELL PHYSIOL, V216, P315, DOI 10.1002/jcp.21458; Tang KH, 2008, NUCLEIC ACIDS RES, V36, P849, DOI 10.1093/nar/gkm1101; Tereshko V, 2001, NUCLEIC ACIDS RES, V29, P1208, DOI 10.1093/nar/29.5.1208; Ummat A, 2012, J MOL BIOL, V415, P627, DOI 10.1016/j.jmb.2011.11.038; Vaisman A, 2000, BIOCHEMISTRY-US, V39, P4575, DOI 10.1021/bi000130k; van Loon B, 2010, DNA REPAIR, V9, P604, DOI 10.1016/j.dnarep.2010.03.004; Wilson TM, 2005, J EXP MED, V201, P637, DOI 10.1084/jem.20042066; Wouters J, 1998, PROTEIN SCI, V7, P2472, DOI 10.1002/pro.5560071127; Yang W, 2007, P NATL ACAD SCI USA, V104, P15591, DOI 10.1073/pnas.0704219104; Yang W, 2014, BIOCHEMISTRY-US, V53, P2793, DOI 10.1021/bi500019s; Zahn KE, 2011, CURR OPIN STRUC BIOL, V21, P358, DOI 10.1016/j.sbi.2011.03.008; Zeng XM, 2001, NAT IMMUNOL, V2, P537, DOI 10.1038/88740; Zhao Y, 2013, P NATL ACAD SCI USA, V110, P8146, DOI 10.1073/pnas.1303126110; Zhao Y, 2012, P NATL ACAD SCI USA, V109, P7269, DOI 10.1073/pnas.1202681109	57	29	29	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					15921	15933		10.1074/jbc.M115.653691	http://dx.doi.org/10.1074/jbc.M115.653691			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25947374	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000356930100003
J	Hossain, ST; Malhotra, A; Deutscher, MP				Hossain, Sk Tofajjen; Malhotra, Arun; Deutscher, Murray P.			The Helicase Activity of Ribonuclease R Is Essential for Efficient Nuclease Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP; Escherichia coli (E; coli); ribonuclease; RNA degradation; RNA helicase	MESSENGER-RNA DECAY; ESCHERICHIA-COLI; POLYNUCLEOTIDE PHOSPHORYLASE; STRUCTURED RNA; RIBOSOMAL-RNA; BINDING; DEGRADOSOME; COMPLEX; ATP; DEGRADATION	Background:Escherichia coli RNase R contains an intrinsic RNA helicase activity. Results: Walker A and Walker B motifs located in the C- and N-terminal regions, respectively, are required for helicase activity. Conclusion: RNase R helicase activity utilizes the nuclease catalytic channel and stimulates the nuclease activity. Significance: These findings help to explain how RNase R efficiently degrades structured RNA. RNase R, which belongs to the RNB family of enzymes, is a 3 to 5 hydrolytic exoribonuclease able to digest highly structured RNA. It was previously reported that RNase R possesses an intrinsic helicase activity that is independent of its ribonuclease activity. However, the properties of this helicase activity and its relationship to the ribonuclease activity were not clear. Here, we show that helicase activity is dependent on ATP and have identified ATP-binding Walker A and Walker B motifs that are present in Escherichia coli RNase R and in 88% of mesophilic bacterial genera analyzed, but absent from thermophilic bacteria. We also show by mutational analysis that both of these motifs are required for helicase activity. Interestingly, the Walker A motif is located in the C-terminal region of RNase R, whereas the Walker B motif is in its N-terminal region implying that the two parts of the protein must come together to generate a functional ATP-binding site. Direct measurement of ATP binding confirmed that ATP binds only when double-stranded RNA is present. Detailed analysis of the helicase activity revealed that ATP hydrolysis is not required because both adenosine 5-O-(thiotriphosphate) and adenosine 5-(,-imino)triphosphate can stimulate helicase activity, as can other nucleoside triphosphates. Although the nuclease activity of RNase R is not needed for its helicase activity, the helicase activity is important for effective nuclease activity against a dsRNA substrate, particularly at lower temperatures and with more stable duplexes. Moreover, competition experiments and mutational analysis revealed that the helicase activity utilizes the same catalytic channel as the nuclease activity. These findings indicate that the helicase activity plays an essential role in the catalytic efficiency of RNase R.	[Hossain, Sk Tofajjen; Malhotra, Arun; Deutscher, Murray P.] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33101 USA	University of Miami	Deutscher, MP (corresponding author), POB 016129, Miami, FL 33101 USA.	m.deutscher@med.miami.edu	Malhotra, Arun/Z-5140-2019; Regan, Clinton/E-6250-2012	Malhotra, Arun/0000-0001-6656-7841; Hossain, Sk Tofajjen/0000-0002-1448-1015	National Institutes of Health [GM 16317]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM016317, R01GM016317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 16317 (to M. P. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Awano N, 2007, J BACTERIOL, V189, P5808, DOI 10.1128/JB.00655-07; Awano N, 2010, J BACTERIOL, V192, P1344, DOI 10.1128/JB.01368-09; Carpousis AJ, 2002, BIOCHEM SOC T, V30, P150, DOI 10.1042/bst0300150; Chen YF, 2008, P NATL ACAD SCI USA, V105, P20203, DOI 10.1073/pnas.0811075106; Cheng ZF, 2005, MOL CELL, V17, P313, DOI 10.1016/j.molcel.2004.11.048; Cheng ZF, 2003, P NATL ACAD SCI USA, V100, P6388, DOI 10.1073/pnas.1231041100; Frazao C, 2006, NATURE, V443, P110, DOI 10.1038/nature05080; Jankowsky E, 2011, TRENDS BIOCHEM SCI, V36, P19, DOI 10.1016/j.tibs.2010.07.008; Khemici V, 2004, MOL MICROBIOL, V51, P777, DOI 10.1046/j.1365-2958.2003.03862.x; Liang WX, 2012, J BIOL CHEM, V287, P33472, DOI 10.1074/jbc.M112.375287; Liang WX, 2011, MOL CELL, V44, P160, DOI 10.1016/j.molcel.2011.06.037; Liang WX, 2010, J BIOL CHEM, V285, P29054, DOI 10.1074/jbc.C110.168641; Lin PH, 2005, P NATL ACAD SCI USA, V102, P16590, DOI 10.1073/pnas.0500994102; Liou GG, 2002, J BIOL CHEM, V277, P41157, DOI 10.1074/jbc.M206618200; Lorentzen E, 2008, MOL CELL, V29, P717, DOI 10.1016/j.molcel.2008.02.018; Makino DL, 2013, NATURE, V495, P70, DOI 10.1038/nature11870; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Sulthana S, 2013, J BIOL CHEM, V288, P12574, DOI 10.1074/jbc.C113.459172; Tanaka N, 2005, BIOCHEMISTRY-US, V44, P9795, DOI 10.1021/bi050407m; Vincent HA, 2006, J BIOL CHEM, V281, P29769, DOI 10.1074/jbc.M606744200; Vincent HA, 2009, J MOL BIOL, V387, P570, DOI 10.1016/j.jmb.2009.01.068; Vincent HA, 2009, J BIOL CHEM, V284, P486, DOI 10.1074/jbc.M806468200; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; Zuo YH, 2006, MOL CELL, V24, P149, DOI 10.1016/j.molcel.2006.09.004	26	16	16	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15697	15706		10.1074/jbc.M115.650176	http://dx.doi.org/10.1074/jbc.M115.650176			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25931119	Green Published, hybrid			2022-12-28	WOS:000356527400032
J	Singh, A; Kett, WC; Severin, IC; Agyekum, I; Duan, JN; Amster, IJ; Proudfoot, AEI; Coombe, DR; Woods, RJ				Singh, Arunima; Kett, Warren C.; Severin, India C.; Agyekum, Isaac; Duan, Jiana; Amster, I. Jonathan; Proudfoot, Amanda E. I.; Coombe, Deirdre R.; Woods, Robert J.			The Interaction of Heparin Tetrasaccharides with Chemokine CCL5 Is Modulated by Sulfation Pattern and pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CCL5; RANTES; CCL5-CCR1 binding; chemokine; heparin; heparan sulfate; CCL5-GAG interaction; pH dependence; molecular modeling; heparin sulfation pattern	GLYCOSAMINOGLYCAN-PROTEIN INTERACTIONS; GENERALIZED BORN MODEL; MOLECULAR-DYNAMICS; BINDING-SITES; PK(A) VALUES; MASS-SPECTROMETRY; DOCKING; RANTES; OLIGOMERIZATION; RATIONALIZATION	Background: Chemokine-glycosaminoglycan (GAG) binding regulates leukocyte migration. Results: Heparin tetrasaccharides are examined for their ability to inhibit CCL5-CCR1 binding, and key interactions between the heparin fragments and CCL5 are identified. Conclusion: Binding modes and inhibitory capabilities depend on the extent and pattern of sulfation of the heparin fragments. Significance: Inhibition of CCL5-CCR1 binding requires heparin to interact with specific residues on the CCL5 surface. Interactions between chemokines such as CCL5 and glycosaminoglycans (GAGs) are essential for creating haptotactic gradients to guide the migration of leukocytes into inflammatory sites, and the GAGs that interact with CCL5 with the highest affinity are heparan sulfates/heparin. The interaction between CCL5 and its receptor on monocytes, CCR1, is mediated through residues Arg-17 and -47 in CCL5, which overlap with the GAG-binding (RKNR47)-R-44 BBXB motifs. Here we report that heparin and tetrasaccharide fragments of heparin are able to inhibit CCL5-CCR1 binding, with IC50 values showing strong dependence on the pattern and extent of sulfation. Modeling of the CCL5-tetrasaccharide complexes suggested that interactions between specific sulfate and carboxylate groups of heparin and residues Arg-17 and -47 of the protein are essential for strong inhibition; tetrasaccharides lacking the specific sulfation pattern were found to preferentially bind CCL5 in positions less favorable for inhibition of the interaction with CCR1. Simulations of a 12-mer heparin fragment bound to CCL5 indicated that the oligosaccharide preferred to interact simultaneously with both (RKNR47)-R-44 motifs in the CCL5 homodimer and engaged residues Arg-47 and -17 from both chains. Direct engagement of these residues by the longer heparin oligosaccharide provides a rationalization for its effectiveness as an inhibitor of CCL5-CCR1 interaction. In this mode, histidine (His-23) may contribute to CCL5-GAG interactions when the pH drops just below neutral, as occurs during inflammation. Additionally, an examination of the contribution of pH to modulating CCL5-heparin interactions suggested a need for careful interpretation of experimental results when experiments are performed under non-physiological conditions.	[Singh, Arunima; Woods, Robert J.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Agyekum, Isaac; Duan, Jiana; Amster, I. Jonathan] Univ Georgia, Dept Chem, Athens, GA 30602 USA; [Kett, Warren C.; Coombe, Deirdre R.] Curtin Univ, Fac Hlth Sci, CHIRI Biosci Res Precinct, Sch Biomed Sci,Mol Immunol, Perth, WA 6102, Australia; [Severin, India C.; Proudfoot, Amanda E. I.] Merck Serono Geneva Res Ctr, CH-1202 Geneva, Switzerland	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Curtin University; Merck KGaA; EMD Serono Inc.	Coombe, DR (corresponding author), Curtin Univ, Fac Hlth Sci, CHIRI Biosci Res Precinct, Sch Biomed Sci,Mol Immunol, Perth, WA 6102, Australia.	d.coombe@curtin.edu.au; rwoods@ccrc.uga.edu	Regan, Clinton/E-6250-2012; Amster, Jon/D-6957-2011; Severin, India/J-1558-2017	Amster, Jon/0000-0001-7523-5144; Singh, Arunima/0000-0001-5885-7478; Coombe, Deirdre/0000-0001-9729-7549; Woods, Robert/0000-0002-2400-6293	National Institutes of Health [R01 GM094919, P41 GM103390]; Science Foundation of Ireland [08/IN.1/B2070]; European Union [LSHB-CT-2005-518167]; European Research Development Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094919, P41GM103390] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Science Foundation of Ireland(Science Foundation Ireland); European Union(European Commission); European Research Development Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM094919 (EUREKA) and P41 GM103390. This work was also supported by Science Foundation of Ireland Grant 08/IN.1/B2070, European Union FP6 INNOCHEM award LSHB-CT-2005-518167, and the European Research Development Fund.	Aldinucci D, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/292376; Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; [Anonymous], 1929, KLIN WOCHENSCHR; Atkovska K, 2014, INT J MOL SCI, V15, P2622, DOI 10.3390/ijms15022622; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Ballut L, 2013, J MOL RECOGNIT, V26, P76, DOI 10.1002/jmr.2250; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Blundell CD, 2007, J BIOL CHEM, V282, P12976, DOI 10.1074/jbc.M611713200; Brandner B, 2009, PROTEIN ENG DES SEL, V22, P367, DOI 10.1093/protein/gzp013; BRUNDEN KR, 1993, J NEUROCHEM, V61, P2147, DOI 10.1111/j.1471-4159.1993.tb07453.x; Carpentier M, 2014, GLYCOCONJUGATE J, V31, P161, DOI 10.1007/s10719-013-9512-8; Case D. A., 2012, AMBER 12; CHAI WG, 1995, CARBOHYD RES, V269, P139, DOI 10.1016/0008-6215(94)00349-K; CHUNG CW, 1995, BIOCHEMISTRY-US, V34, P9307, DOI 10.1021/bi00029a005; Coombe DR, 2008, IMMUNOL CELL BIOL, V86, P598, DOI 10.1038/icb.2008.49; Coombe DR, 2005, CELL MOL LIFE SCI, V62, P410, DOI 10.1007/s00018-004-4293-7; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Forster M, 2006, BIOCHEM SOC T, V34, P431, DOI 10.1042/BST0340431; Frank M, 2014, TOP MED CHEM SER, V12, P53, DOI 10.1007/7355_2014_42; Gandhi NS, 2009, GLYCOBIOLOGY, V19, P1103, DOI 10.1093/glycob/cwp101; Ge XN, 2014, GLYCOBIOLOGY, V24, P715, DOI 10.1093/glycob/cwu035; Genheden S, 2012, J CHEM INF MODEL, V52, P2079, DOI 10.1021/ci3001919; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; Hallgren J, 2004, J IMMUNOL, V173, P1868, DOI 10.4049/jimmunol.173.3.1868; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Hubbard S. J., 1993, NACCESS; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Imberty A, 2007, CARBOHYD RES, V342, P430, DOI 10.1016/j.carres.2006.12.019; JACOBUS WE, 1977, NATURE, V265, P756, DOI 10.1038/265756a0; Johnson Z, 2004, J IMMUNOL, V173, P5776, DOI 10.4049/jimmunol.173.9.5776; Jones AL, 2005, IMMUNOL CELL BIOL, V83, P106, DOI 10.1111/j.1440-1711.2005.01320.x; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Valle-Delgado JJ, 2010, FASEB J, V24, P4250, DOI 10.1096/fj.09-153551; Kailemia MJ, 2013, MOL CELL PROTEOMICS, V12, P979, DOI 10.1074/mcp.M112.026880; Kailemia MJ, 2012, ANAL CHEM, V84, P5475, DOI 10.1021/ac3015824; Kett WC, 2004, SPECTROSC-INT J, V18, P185, DOI 10.1155/2004/392536; Kim JK, 2005, J LEUKOCYTE BIOL, V78, P442, DOI 10.1189/jlb.0305161; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kuschert GSV, 1999, BIOCHEMISTRY-US, V38, P12959, DOI 10.1021/bi990711d; Lazennec G, 2010, TRENDS MOL MED, V16, P133, DOI 10.1016/j.molmed.2010.01.003; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Lindahl U, 2013, J INTERN MED, V273, P555, DOI 10.1111/joim.12061; Lortat-Jacob H, 2002, P NATL ACAD SCI USA, V99, P1229, DOI 10.1073/pnas.032497699; Marques RE, 2013, EXPERT OPIN THER TAR, V17, P1439, DOI 10.1517/14728222.2013.837886; Martin L, 2001, BIOCHEMISTRY-US, V40, P6303, DOI 10.1021/bi002670n; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; Mishra SK, 2012, J CHEM INF MODEL, V52, P1250, DOI 10.1021/ci200529n; Mottarella SE, 2014, J CHEM INF MODEL, V54, P2068, DOI 10.1021/ci500115j; Mourier PAJ, 2004, ANAL BIOCHEM, V332, P299, DOI 10.1016/j.ab.2004.06.020; Nivedha AK, 2014, J COMPUT CHEM, V35, P526, DOI 10.1002/jcc.23517; Nonaka M, 2014, P NATL ACAD SCI USA, V111, P8173, DOI 10.1073/pnas.1319870111; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Onufriev A, 2000, J PHYS CHEM B, V104, P3712, DOI 10.1021/jp994072s; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Pakianathan DR, 1997, BIOCHEMISTRY-US, V36, P9642, DOI 10.1021/bi970593z; Peer L. A., 1955, TRANSPLANTATION TISS, V1I; Proudfoot AEI, 1996, J BIOL CHEM, V271, P2599, DOI 10.1074/jbc.271.5.2599; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Proudfoot AEI, 2002, NAT REV IMMUNOL, V2, P106, DOI 10.1038/nri722; Proudfoot AEI, 2001, J BIOL CHEM, V276, P10620, DOI 10.1074/jbc.M010867200; R Development Core Team, 2012, R LANG ENV STAT COMP; Remko M, 2013, CHEM PHYS LETT, V590, P187, DOI 10.1016/j.cplett.2013.10.062; Revici E., 1949, B I APPL BIOL, V1, P21; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; ROT A, 1992, IMMUNOL TODAY, V13, P291, DOI 10.1016/0167-5699(92)90039-A; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Salmivirta M, 1996, FASEB J, V10, P1270, DOI 10.1096/fasebj.10.11.8836040; Samsonov SA, 2014, J CHEM INF MODEL, V54, P582, DOI 10.1021/ci4006047; Samsonov SA, 2011, J COMPUT AID MOL DES, V25, P477, DOI 10.1007/s10822-011-9433-1; Severin IC, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00293; Shaw JP, 2004, STRUCTURE, V12, P2081, DOI 10.1016/j.str.2004.08.014; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Srinivasan J, 1998, J BIOMOL STRUCT DYN, V16, P671, DOI 10.1080/07391102.1998.10508279; TANAKA Y, 1993, IMMUNOL TODAY, V14, P111, DOI 10.1016/0167-5699(93)90209-4; Tanino Y, 2010, J IMMUNOL, V184, P2677, DOI 10.4049/jimmunol.0903274; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Turnbull J, 2001, TRENDS CELL BIOL, V11, P75, DOI 10.1016/S0962-8924(00)01897-3; Vielhauer V, 2004, KIDNEY INT, V66, P2264, DOI 10.1111/j.1523-1755.2004.66038.x; Vives RR, 2002, BIOCHEMISTRY-US, V41, P14779, DOI 10.1021/bi026459i; WANG HM, 1991, BIOCHEM J, V278, P689, DOI 10.1042/bj2780689; Wang X, 2011, STRUCTURE, V19, P1138, DOI 10.1016/j.str.2011.06.001; Weber M, 2013, SCIENCE, V339, P328, DOI 10.1126/science.1228456; Wolff JJ, 2007, J AM SOC MASS SPECTR, V18, P234, DOI 10.1016/j.jasms.2006.09.020; Wood E.J., 1987, BIOCHEM EDUC, V15, P97, DOI [10.1016/0307-4412(87)90110-5, DOI 10.1016/0307-4412(87)90110-5]	91	45	45	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15421	15436		10.1074/jbc.M115.655845	http://dx.doi.org/10.1074/jbc.M115.655845			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25907556	Green Published, hybrid			2022-12-28	WOS:000356527400010
J	Hori, Y; Hashimoto, T; Nomoto, H; Hyman, BT; Iwatsubo, T				Hori, Yukiko; Hashimoto, Tadafumi; Nomoto, Hidetoshi; Hyman, Bradley T.; Iwatsubo, Takeshi			Role of Apolipoprotein E in beta-Amyloidogenesis ISOFORM-SPECIFIC EFFECTS ON PROTOFIBRIL TO FIBRIL CONVERSION OF A beta IN VITRO AND BRAIN A beta DEPOSITION IN VIVO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL ALZHEIMER-DISEASE; CENTRAL-NERVOUS-SYSTEM; AMYLOID-BETA; MOUSE MODEL; PROTEIN FIBRILLOGENESIS; STABLE COMPLEXES; TRANSGENIC MICE; TYPE-4 ALLELE; PEPTIDE; PATHOGENESIS	Human APOE beta 4 allele is a strong genetic risk factor of Alzheimer disease. Neuropathological and genetic studies suggested that apolipoprotein E4 (apoE4) protein facilitates deposition of amyloid beta peptide (A beta) in the brain, although the mechanism whereby apoE4 increases amyloid aggregates remains elusive. Here we show that injection of A beta protofibrils induced A beta deposition in the brain of APP transgenic mice, suggesting that A beta protofibrils acted as a seed for aggregation and deposition of A beta in vivo. Injection of A beta protofibrils together with apoE3 significantly attenuated A beta deposition, whereas apoE4 did not have this effect. In vitro assays revealed that the conversion of A beta protofibrils to fibrils progressed more slowly upon coincubation with apoE2 or apoE3 compared with that with apoE4. A beta protofibrils complexed with apoE4 were less stable than those with apoE2 or apoE3. These data suggest that the suppression effect of apoE2 or apoE3 on the structural conversion of A beta protofibrils to fibrils is stronger than those of apoE4, thereby impeding beta-amyloid deposition.	[Hori, Yukiko; Hashimoto, Tadafumi; Nomoto, Hidetoshi; Iwatsubo, Takeshi] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Neuropathol & Neurosci, Tokyo 1130033, Japan; [Hashimoto, Tadafumi; Iwatsubo, Takeshi] Univ Tokyo, Grad Sch Med, Dept Neuropathol, Tokyo 1130033, Japan; [Hyman, Bradley T.] Massachusetts Gen Hosp, Dept Neurol, Alzheimers Dis Res Unit, Charlestown, MA 02129 USA	University of Tokyo; University of Tokyo; Harvard University; Massachusetts General Hospital	Iwatsubo, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Neuropathol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	iwatsubo@m.u-tokyo.ac.jp		Hashimoto, Tadafumi/0000-0001-5442-4800	Core Research for Evolutional Science and Technology of Japan Science and Technology Agency; Strategic Research Program for Brain Science from MEXT; Health Labor Sciences Research Grant on Amyloidosis; NATIONAL INSTITUTE ON AGING [P50AG005134] Funding Source: NIH RePORTER	Core Research for Evolutional Science and Technology of Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Strategic Research Program for Brain Science from MEXT; Health Labor Sciences Research Grant on Amyloidosis; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Core Research for Evolutional Science and Technology of Japan Science and Technology Agency, the Strategic Research Program for Brain Science from MEXT, and the Health Labor Sciences Research Grant on Amyloidosis.	Aleshkov S, 1997, BIOCHEMISTRY-US, V36, P10571, DOI 10.1021/bi9626362; Bales KR, 1997, NAT GENET, V17, P263, DOI 10.1038/ng1197-263; Bentley NM, 2002, BIOCHEM J, V366, P273, DOI 10.1042/BJ20020207; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; BOYLES JK, 1985, J CLIN INVEST, V76, P1501, DOI 10.1172/JCI112130; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Cheng IH, 2004, NAT MED, V10, P1190, DOI 10.1038/nm1123; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DeMattos RB, 2004, NEURON, V41, P193, DOI 10.1016/S0896-6273(03)00850-X; Dickson DW, 1997, J NEUROPATH EXP NEUR, V56, P321, DOI 10.1097/00005072-199704000-00001; DONG LM, 1994, J BIOL CHEM, V269, P22358; Dong LM, 1996, J BIOL CHEM, V271, P19053, DOI 10.1074/jbc.271.32.19053; Englund H, 2007, J NEUROCHEM, V103, P334, DOI 10.1111/j.1471-4159.2007.04759.x; EVANS KC, 1995, P NATL ACAD SCI USA, V92, P763, DOI 10.1073/pnas.92.3.763; Fagan AM, 2002, NEUROBIOL DIS, V9, P305, DOI 10.1006/nbdi.2002.0483; GomezIsla T, 1996, ANN NEUROL, V39, P62, DOI 10.1002/ana.410390110; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Hashimoto T, 2002, EMBO J, V21, P1524, DOI 10.1093/emboj/21.7.1524; Hashimoto T, 2012, J NEUROSCI, V32, P15181, DOI 10.1523/JNEUROSCI.1542-12.2012; Holtzman DM, 2000, P NATL ACAD SCI USA, V97, P2892, DOI 10.1073/pnas.050004797; Hori Y, 2007, J BIOL CHEM, V282, P4916, DOI 10.1074/jbc.M608220200; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Kane MD, 2000, J NEUROSCI, V20, P3606, DOI 10.1523/JNEUROSCI.20-10-03606.2000; LADU MJ, 1994, J BIOL CHEM, V269, P23403; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lomakin A, 1997, P NATL ACAD SCI USA, V94, P7942, DOI 10.1073/pnas.94.15.7942; Lord A, 2009, FEBS J, V276, P995, DOI 10.1111/j.1742-4658.2008.06836.x; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Morikawa M, 2005, NEUROBIOL DIS, V19, P66, DOI 10.1016/j.nbd.2004.11.005; Naiki H, 1997, BIOCHEMISTRY-US, V36, P6243, DOI 10.1021/bi9624705; Nakai M, 1996, NEUROSCI LETT, V211, P41, DOI 10.1016/0304-3940(96)12716-6; NAMBA Y, 1991, BRAIN RES, V541, P163, DOI 10.1016/0006-8993(91)91092-F; NASLUND J, 1995, NEURON, V15, P219, DOI 10.1016/0896-6273(95)90079-9; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; PITAS RE, 1987, BIOCHIM BIOPHYS ACTA, V917, P148, DOI 10.1016/0005-2760(87)90295-5; REBECK GW, 1993, NEURON, V11, P575; Ribalta J, 2003, CURR OPIN CLIN NUTR, V6, P177, DOI 10.1097/00075197-200303000-00006; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Tai LM, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-2; Tai LM, 2013, J BIOL CHEM, V288, P5914, DOI 10.1074/jbc.M112.442103; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Yamada K, 2009, J NEUROSCI, V29, P11393, DOI 10.1523/JNEUROSCI.2021-09.2009; Yang DS, 1997, J NEUROCHEM, V68, P721	47	35	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15163	15174		10.1074/jbc.M114.622209	http://dx.doi.org/10.1074/jbc.M114.622209			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25918154	hybrid, Green Published			2022-12-28	WOS:000356177300030
J	Kaushansky, N; Eisenstein, M; Boura-Halfon, S; Hansen, BE; Nielsen, CH; Milo, R; Zeilig, G; Lassmann, H; Altmann, DM; Ben-Nun, A				Kaushansky, Nathali; Eisenstein, Miriam; Boura-Halfon, Sigalit; Hansen, Bjarke Endel; Nielsen, Claus Henrik; Milo, Ron; Zeilig, Gabriel; Lassmann, Hans; Altmann, Daniel M.; Ben-Nun, Avraham			Role of a Novel Human Leukocyte Antigen-DQA1*01:02; DRB1*15:01 Mixed Isotype Heterodimer in the Pathogenesis of "Humanized" Multiple Sclerosis-like Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLIGODENDROCYTE-SPECIFIC PROTEIN; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MYELIN BASIC-PROTEIN; II TRANSGENIC MICE; T-CELL RESPONSES; SJL/J MICE; OSP/CLAUDIN-11-INDUCED EAE; MOLECULAR EVIDENCE; GENE CONVERSION; HLA-DR	Gene-wide association and candidate gene studies indicate that the greatest effect on multiple sclerosis (MS) risk is driven by the HLA-DRB1*15:01 allele within the HLA-DR15 haplotype (HLA-DRB1*15:01-DQA1*01:02-DQB1*0602-DRB5*01:01). Nevertheless, linkage disequilibrium makes it difficult to define, without functional studies, whether the functionally relevant effect derives from DRB1*15:01 only, from its neighboring DQA1*01:02-DQB1*06:02 or DRB5*01:01 genes of HLA-DR15 haplotype, or from their combinations or epistatic interactions. Here, we analyzed the impact of the different HLA-DR15 haplotype alleles on disease susceptibility in a new "humanized" model of MS induced in HLA-transgenic (Tg) mice by human oligodendrocyte-specific protein (OSP)/claudin-11 (hOSP), one of the bona fide potential primary target antigens in MS. We show that the hOSP-associated MS-like disease is dominated by the DRB1*15: 01 allele not only as the DRA1*01:01; DRB1*15: 01 isotypic heterodimer but also, unexpectedly, as a functional DQA1*01: 02; DRB1*15: 01 mixed isotype heterodimer. The contribution of HLA-DQA1/DRB1 mixed isotype heterodimer to OSP pathogenesis was revealed in (DRB1*1501xDQB1*0602)F1 double-Tg mice immunized with hOSP(142-161) peptide, where the encephalitogenic potential of prevalent DRB1*1501/hOSP(142-161)-reactive Th1/Th17 cells is hindered due to a single amino acid difference in the OSP(142-161) region between humans and mice; this impedes binding of DRB1*1501 to the mouse OSP(142-161) epitope in the mouse CNS while exposing functional binding of mouse OSP(142-161) to DQA1*01: 02; DRB1*15: 01 mixed isotype heterodimer. This study, which shows for the first time a functional HLA-DQA1/DRB1 mixed isotype heterodimer and its potential association with disease susceptibility, provides a rationale for a potential effect on MS risk from DQA1*01: 02 through functional DQA1*01: 02; DRB1*15: 01 antigen presentation. Furthermore, it highlights a potential contribution to MS risk also from interisotypic combination between products of neighboring HLA-DR15 haplotype alleles, in this case the DQA1/DRB1 combination.	[Kaushansky, Nathali; Boura-Halfon, Sigalit; Ben-Nun, Avraham] Weizmann Inst Sci, Dept Immunol, IL-7610001 Rehovot, Israel; [Eisenstein, Miriam] Weizmann Inst Sci, Dept Chem Res Support, IL-7610001 Rehovot, Israel; [Hansen, Bjarke Endel; Nielsen, Claus Henrik] Copenhagen Univ Hosp, Rigshosp, Dept Infect Dis & Rheumatol, Inst Inflammat Res, DK-2100 Copenhagen, Denmark; [Milo, Ron] Ben Gurion Univ Negev, Fac Hlth Sci, Barzilai Med Ctr, Dept Neurol, IL-78278 Ashqelon, Israel; [Zeilig, Gabriel] Chaim Sheba Med Ctr, Dept Neurol Rehabil, IL-52621 Tel Hashomer, Israel; [Zeilig, Gabriel] Tel Aviv Univ, Sackler Fac Med, IL-6997801 Tel Aviv, Israel; [Lassmann, Hans] Med Univ Vienna, Dept Neuroimmunol, Ctr Brain Res, A-1090 Vienna, Austria; [Altmann, Daniel M.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Hammersmith Hosp, London W12 0HS, England	Weizmann Institute of Science; Weizmann Institute of Science; Rigshospitalet; University of Copenhagen; Ben Gurion University; Barzilai Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Medical University of Vienna; Imperial College London	Ben-Nun, A (corresponding author), Weizmann Inst Sci, Dept Immunol, 234 Herzl St, IL-7610001 Rehovot, Israel.	avi.ben-nun@weizmann.ac.il	Milo, Ron/AAH-7504-2020; Lassmann, Hans/Z-2269-2019; Hansen, Bjarke/D-3663-2018	Lassmann, Hans/0000-0001-8617-5052; Hansen, Bjarke/0000-0002-8167-8459; Nielsen, Claus Henrik/0000-0001-7543-9016; Altmann, Daniel/0000-0002-2436-6192	Israel Science Foundation; National Multiple Sclerosis Society of New York [RG 3195B8/2]; Israel Ministry of Health; Estate of the Late Florence Blau; William Sahm Foundation; Adiel Eleanor foundation; Nella and Leon Benoziyo Center for Neurological Diseases; Wellcome Trust [WT087999MA]	Israel Science Foundation(Israel Science Foundation); National Multiple Sclerosis Society of New York(National Multiple Sclerosis Society); Israel Ministry of Health; Estate of the Late Florence Blau; William Sahm Foundation; Adiel Eleanor foundation; Nella and Leon Benoziyo Center for Neurological Diseases; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported in part by the Israel Science Foundation, National Multiple Sclerosis Society of New York Grant RG 3195B8/2, the Israel Ministry of Health, the Estate of the Late Florence Blau, the William Sahm Foundation, the Adiel Eleanor foundation, and the Nella and Leon Benoziyo Center for Neurological Diseases. The work in the laboratory of D. M. A. was supported by Wellcome Trust award WT087999MA.	ALTMANN DM, 1995, J EXP MED, V181, P867, DOI 10.1084/jem.181.3.867; Bajramovic JJ, 2008, EUR J IMMUNOL, V38, P1452, DOI 10.1002/eji.200737164; Ben-Nun A, 2006, EUR J IMMUNOL, V36, P478, DOI 10.1002/eji.200535363; Ben-Shimon A, 2010, J MOL BIOL, V402, P259, DOI 10.1016/j.jmb.2010.07.021; BENNUN A, 1983, J IMMUNOL, V130, P1205; BENNUN A, 1981, NATURE, V292, P60, DOI 10.1038/292060a0; Bronstein JM, 1996, NEUROLOGY, V47, P772, DOI 10.1212/WNL.47.3.772; Bronstein JM, 1997, J NEUROSCI RES, V50, P713, DOI 10.1002/(SICI)1097-4547(19971201)50:5<713::AID-JNR8>3.3.CO;2-Q; Bronstein JM, 1999, NEUROLOGY, V53, P154, DOI 10.1212/WNL.53.1.154; CHARRON DJ, 1984, NATURE, V312, P157, DOI 10.1038/312157a0; de Rosbo NK, 1998, J AUTOIMMUN, V11, P287, DOI 10.1006/jaut.1998.0202; de Rosbo NK, 2004, J IMMUNOL, V173, P1426, DOI 10.4049/jimmunol.173.2.1426; FOGDELL A, 1995, TISSUE ANTIGENS, V46, P333, DOI 10.1111/j.1399-0039.1995.tb02503.x; GILES RC, 1985, P NATL ACAD SCI USA, V82, P1776, DOI 10.1073/pnas.82.6.1776; Gregersen JW, 2006, NATURE, V443, P574, DOI 10.1038/nature05133; Hafler DA, 2005, IMMUNOL REV, V204, P208, DOI 10.1111/j.0105-2896.2005.00240.x; Hauser SL, 2006, NEURON, V52, P61, DOI 10.1016/j.neuron.2006.09.011; HOCHMAN PS, 1984, J EXP MED, V160, P1925, DOI 10.1084/jem.160.6.1925; Hohlfeid R, 2004, P NATL ACAD SCI USA, V101, P14599, DOI 10.1073/pnas.0404874101; Kalandadze A, 1996, J BIOL CHEM, V271, P20156, DOI 10.1074/jbc.271.33.20156; Kaushansky N, 2008, INT IMMUNOL, V20, P1439, DOI 10.1093/intimm/dxn099; Kaushansky N, 2007, EUR J IMMUNOL, V37, P2018, DOI 10.1002/eji.200636965; Kaushansky N, 2006, J IMMUNOL, V177, P7364, DOI 10.4049/jimmunol.177.10.7364; Kaushansky N, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-29; Kaushansky N, 2009, J IMMUNOL, V183, P3531, DOI 10.4049/jimmunol.0900784; Khare M, 2005, J NEUROIMMUNOL, V169, P1, DOI 10.1016/j.jneuroim.2005.07.023; Khare M, 2003, INT IMMUNOL, V15, P535, DOI 10.1093/intimm/dxg053; Lincoln MR, 2009, P NATL ACAD SCI USA, V106, P7542, DOI 10.1073/pnas.0812664106; LOCK CB, 1988, IMMUNOGENETICS, V27, P449, DOI 10.1007/BF00364432; LOTTEAU V, 1989, J EXP MED, V169, P351, DOI 10.1084/jem.169.1.351; LOTTEAU V, 1987, NATURE, V329, P339, DOI 10.1038/329339a0; MALISSEN B, 1986, P NATL ACAD SCI USA, V83, P3958, DOI 10.1073/pnas.83.11.3958; Mangalam A, 2008, J IMMUNOL, V180, P7747, DOI 10.4049/jimmunol.180.11.7747; MARSH SGE, 1992, HUM IMMUNOL, V35, P1, DOI 10.1016/0198-8859(92)90090-A; MENGLEGAW L, 1984, J EXP MED, V160, P1184, DOI 10.1084/jem.160.4.1184; Morris-Downes MM, 2002, J NEUROIMMUNOL, V122, P20, DOI 10.1016/S0165-5728(01)00460-X; Morse K, 2012, IMMUNOGENETICS, V64, P507, DOI 10.1007/s00251-012-0606-4; Oksenberg JR, 2010, NAT REV NEUROL, V6, P429, DOI 10.1038/nrneurol.2010.91; OLERUP O, 1991, TISSUE ANTIGENS, V38, P1, DOI 10.1111/j.1399-0039.1991.tb02029.x; OTA K, 1990, NATURE, V346, P183, DOI 10.1038/346183a0; Patsopoulos NA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003926; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rich C, 2004, EUR J IMMUNOL, V34, P1251, DOI 10.1002/eji.200324354; Sawcer S, 2014, LANCET NEUROL, V13, P700, DOI 10.1016/S1474-4422(14)70041-9; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Smith KJ, 1998, J EXP MED, V188, P1511, DOI 10.1084/jem.188.8.1511; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vu T, 2001, J NEUROSCI RES, V66, P506, DOI 10.1002/jnr.1241; ZAMVIL SS, 1985, J EXP MED, V162, P2107, DOI 10.1084/jem.162.6.2107; Zhong MC, 2000, J NEUROIMMUNOL, V105, P39, DOI 10.1016/S0165-5728(00)00186-7	51	5	5	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15260	15278		10.1074/jbc.M115.641209	http://dx.doi.org/10.1074/jbc.M115.641209			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25911099	hybrid, Green Published			2022-12-28	WOS:000356177300038
J	Pronker, MF; Bos, TGAA; Sharp, TH; Thies-Weesie, DME; Janssen, BJC				Pronker, Matti F.; Bos, Trusanne G. A. A.; Sharp, Thomas H.; Thies-Weesie, Dominique M. E.; Janssen, Bert J. C.			Olfactomedin-1 Has a V-shaped Disulfide-linked Tetrameric Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR COMPLEX; NA+ CHANNELS; GLYCOPROTEIN; GLIOMEDIN; PROTEINS; RANVIER; ULTRACENTRIFUGATION; VISUALIZATION; REFINEMENT; SCATTERING	Olfactomedin-1 (Olfm1; also known as noelin and pancortin) is a member of the olfactomedin domain-containing superfamily and a highly expressed neuronal glycoprotein important for nervous system development. It binds a number of secreted proteins and cell surface-bound receptors to induce cell signaling processes. Using a combined approach of x-ray crystallography, solution scattering, analytical ultracentrifugation, and electron microscopy we determined that full-length Olfm1 forms disulfide-linked tetramers with a distinctive V-shaped architecture. The base of the "V" is formed by two disulfide-linked dimeric N-terminal domains. Each of the two V legs consists of a parallel dimeric disulfide-linked coiled coil with a C-terminal beta-propeller dimer at the tips. This agrees with our crystal structure of a C-terminal coiled-coil segment and beta-propeller combination (Olfm1(coil-Olf)) that reveals a disulfide-linked dimeric arrangement with the beta-propeller top faces in an outward exposed orientation. Similar to its family member myocilin, Olfm1 is stabilized by calcium. The dimer-of-dimers architecture suggests a role for Olfm1 in clustering receptors to regulate signaling and sheds light on the conformation of several other olfactomedin domain family members.	[Pronker, Matti F.; Bos, Trusanne G. A. A.; Janssen, Bert J. C.] Univ Utrecht, Fac Sci, Dept Chem, Crystal & Struct Chem,Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; [Thies-Weesie, Dominique M. E.] Univ Utrecht, Fac Sci, Dept Chem, Vant Hoff Lab Phys & Colloid Chem,Debye Inst Nano, NL-3584 CH Utrecht, Netherlands; [Sharp, Thomas H.] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Sect Elect Microscopy, NL-2300 RC Leiden, Netherlands	Utrecht University; Utrecht University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Janssen, BJC (corresponding author), Univ Utrecht, Fac Sci, Dept Chem, Crystal & Struct Chem,Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands.	b.j.c.janssen@uu.nl	Pronker, Matti/AAB-1821-2020; Janssen, Bert/I-3338-2016	Pronker, Matti/0000-0001-5268-7690; Janssen, Bert/0000-0002-8101-8370; Sharp, Thomas/0000-0002-1990-2333	Netherlands Organization for Scientific Research (NWO) VIDI Grant [723.012.002]	Netherlands Organization for Scientific Research (NWO) VIDI Grant(Netherlands Organization for Scientific Research (NWO))	This work was supported by Netherlands Organization for Scientific Research (NWO) VIDI Grant 723.012.002.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Amor V, 2014, J NEUROSCI, V34, P5089, DOI 10.1523/JNEUROSCI.4752-13.2014; Ando K, 2005, NEUROSCIENCE, V133, P947, DOI 10.1016/j.neuroscience.2005.03.009; Anholt RRH, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00006; Barembaum M, 2000, NAT CELL BIOL, V2, P219, DOI 10.1038/35008643; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bernado P, 2012, MOL BIOSYST, V8, P151, DOI 10.1039/c1mb05275f; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Celniker G, 2013, ISR J CHEM, V53, P199, DOI 10.1002/ijch.201200096; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Donegan RK, 2015, HUM MOL GENET, V24, P2111, DOI 10.1093/hmg/ddu730; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Feinberg K, 2010, NEURON, V65, P490, DOI 10.1016/j.neuron.2010.02.004; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Han HJ, 2015, J BIOL CHEM, V290, P3612, DOI 10.1074/jbc.M114.627547; Jackson VA, 2015, STRUCTURE, V23, P774, DOI 10.1016/j.str.2015.01.013; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Liu J, 2006, NATURE, V442, P208, DOI 10.1038/nature04719; Maertens B, 2007, J BIOL CHEM, V282, P10647, DOI 10.1074/jbc.M611339200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moreno TA, 2005, DEV BIOL, V288, P434, DOI 10.1016/j.ydbio.2005.09.050; Moreno TA, 2001, DEV BIOL, V240, P340, DOI 10.1006/dbio.2001.0472; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakaya N, 2008, J NEUROSCI, V28, P7900, DOI 10.1523/JNEUROSCI.0617-08.2008; Nakaya N, 2013, EXP NEUROL, V250, P205, DOI 10.1016/j.expneurol.2013.09.019; Nakaya N, 2012, J BIOL CHEM, V287, P37171, DOI 10.1074/jbc.M112.389916; Nguyen TD, 1998, J BIOL CHEM, V273, P6341, DOI 10.1074/jbc.273.11.6341; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rice HC, 2012, DEVELOPMENT, V139, P3986, DOI 10.1242/dev.082909; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SNYDER DA, 1991, BIOCHEMISTRY-US, V30, P9143, DOI 10.1021/bi00102a004; Sultana A, 2014, EXP NEUROL, V261, P802, DOI 10.1016/j.expneurol.2014.09.002; Sultana A, 2011, INVEST OPHTH VIS SCI, V52, P2584, DOI 10.1167/iovs.10-6356; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tomarev SI, 2009, MOL NEUROBIOL, V40, P122, DOI 10.1007/s12035-009-8076-x; YOKOE H, 1993, P NATL ACAD SCI USA, V90, P4655, DOI 10.1073/pnas.90.10.4655	41	14	15	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15092	15101		10.1074/jbc.M115.653485	http://dx.doi.org/10.1074/jbc.M115.653485			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25903135	Green Published, hybrid			2022-12-28	WOS:000356177300024
J	Sengupta, S; Lingnurkar, R; Carey, TS; Pomaville, M; Kar, P; Feig, M; Wilson, CA; Knott, JG; Arnosti, DN; Henry, RW				Sengupta, Satyaki; Lingnurkar, Raj; Carey, Timothy S.; Pomaville, Monica; Kar, Parimal; Feig, Michael; Wilson, Catherine A.; Knott, Jason G.; Arnosti, David N.; Henry, R. William			The Evolutionarily Conserved C-terminal Domains in the Mammalian Retinoblastoma Tumor Suppressor Family Serve as Dual Regulators of Protein Stability and Transcriptional Potency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; CYCLIN-CDK COMPLEXES; RB FAMILY; KINASE-ACTIVITY; IN-VIVO; GENE; E2F; EXPRESSION; PRB; GROWTH	The retinoblastoma (RB) tumor suppressor and related family of proteins play critical roles in development through their regulation of genes involved in cell fate. Multiple regulatory pathways impact RB function, including the ubiquitin-proteasome system with deregulated RB destruction frequently associated with pathogenesis. With the current study we explored the mechanisms connecting proteasome-mediated turnover of the RB family to the regulation of repressor activity. We find that steady state levels of all RB family members, RB, p107, and p130, were diminished during embryonic stem cell differentiation concomitant with their target gene acquisition. Proteasome-dependent turnover of the RB family is mediated by distinct and autonomously acting instability elements (IE) located in their C-terminal regulatory domains in a process that is sensitive to cyclin-dependent kinase (CDK4) perturbation. The IE regions include motifs that contribute to E2F-DP transcription factor interaction, and consistently, p107 and p130 repressor potency was reduced by IE deletion. The juxtaposition of degron sequences and E2F interaction motifs appears to be a conserved feature across the RB family, suggesting the potential for repressor ubiquitination and specific target gene regulation. These findings establish a mechanistic link between regulation of RB family repressor potency and the ubiquitin-proteasome system.	[Sengupta, Satyaki; Lingnurkar, Raj; Carey, Timothy S.; Pomaville, Monica; Kar, Parimal; Feig, Michael; Knott, Jason G.; Arnosti, David N.; Henry, R. William] Michigan State Univ, Dept Biochem & Mol Biol, 603 Wilson Rd, E Lansing, MI 48824 USA; [Sengupta, Satyaki] Michigan State Univ, Grad Program Physiol, E Lansing, MI 48824 USA; [Wilson, Catherine A.; Knott, Jason G.] Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University	Arnosti, DN (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, 603 Wilson Rd, E Lansing, MI 48824 USA.	arnosti@msu.edu; henryrw@msu.edu	Sengupta, Satyaki/AAD-6065-2022; Feig, Michael/AAI-9540-2021; Regan, Clinton/E-6250-2012	Kar, Parimal/0000-0001-8451-9739	National Institutes of Health [R01GM095347, R01GM079098]; College of Natural Science at Michigan State University; Lyman Briggs College at Michigan State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095347, R01GM079098] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); College of Natural Science at Michigan State University; Lyman Briggs College at Michigan State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM095347 (to J. G. K.) and R01GM079098 (to D. N. A. and R. W. H.).r Supported in part by fellowships from the College of Natural Science at Michigan State University.r Supported in part by an undergraduate research award from the Lyman Briggs College at Michigan State University.	Acharya P, 2012, G3-GENES GENOM GENET, V2, P1459, DOI 10.1534/g3.112.004424; Acharya P, 2010, MOL BIOL CELL, V21, P3890, DOI 10.1091/mbc.E10-06-0520; Ajioka I, 2007, CELL, V131, P378, DOI 10.1016/j.cell.2007.09.036; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BEIJERSBERGEN RL, 1995, GENE DEV, V9, P1340, DOI 10.1101/gad.9.11.1340; Bhattacharya S, 2003, ONCOGENE, V22, P2443, DOI 10.1038/sj.onc.1206339; Black EP, 2003, CANCER RES, V63, P3716; BUCHKOVICH K, 1989, CELL, V58, P1097, DOI 10.1016/0092-8674(89)90508-4; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Cam H, 2004, MOL CELL, V16, P399, DOI 10.1016/j.molcel.2004.09.037; Cecchini MJ, 2011, BIOCHEM J, V434, P297, DOI 10.1042/BJ20101210; CHELLAPPAN SP, 1991, CELL, V65, P1053, DOI 10.1016/0092-8674(91)90557-F; CHEN PL, 1989, CELL, V58, P1193, DOI 10.1016/0092-8674(89)90517-5; Chestukhin A, 2002, MOL CELL BIOL, V22, P453, DOI 10.1128/MCB.22.2.453-468.2002; Chicas A, 2010, CANCER CELL, V17, P376, DOI 10.1016/j.ccr.2010.01.023; Classon M, 2002, NAT REV CANCER, V2, P910, DOI 10.1038/nrc950; Claudio PP, 2000, CANCER RES, V60, P372; Conklin JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2254; DECAPRIO JA, 1989, CELL, V58, P1085, DOI 10.1016/0092-8674(89)90507-2; Dick FA, 2013, NAT REV MOL CELL BIO, V14, P297, DOI 10.1038/nrm3567; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Elenbaas JS, 2015, CELL CYCLE, V14, P589, DOI 10.4161/15384101.2014.991182; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Hilgendorf KI, 2013, GENE DEV, V27, P1003, DOI 10.1101/gad.211326.112; HINDS PW, 1992, CELL, V70, P993, DOI 10.1016/0092-8674(92)90249-C; Hirsch HA, 2004, MOL CELL BIOL, V24, P5989, DOI 10.1128/MCB.24.13.5989-5999.2004; Hurford RK, 1997, GENE DEV, V11, P1447, DOI 10.1101/gad.11.11.1447; Ianari A, 2009, CANCER CELL, V15, P184, DOI 10.1016/j.ccr.2009.01.026; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Ji P, 2004, MOL CELL, V16, P47, DOI 10.1016/j.molcel.2004.09.029; Julian LM, 2008, ONCOGENE, V27, P1572, DOI 10.1038/sj.onc.1210803; Kim Y, 2009, J BIOL CHEM, V284, P23405, DOI 10.1074/jbc.M109.026088; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; MacPherson D, 2007, EMBO J, V26, P784, DOI 10.1038/sj.emboj.7601515; McConnell BB, 1999, MOL CELL BIOL, V19, P1981; Narasimha AM, 2014, ELIFE, V3, DOI 10.7554/eLife.02872; Philips A, 1998, ONCOGENE, V16, P1373, DOI 10.1038/sj.onc.1201655; Raj N, 2012, J BIOL CHEM, V287, P41835, DOI 10.1074/jbc.M112.422428; Raj N, 2012, CELL CYCLE, V11, P3731, DOI 10.4161/cc.21665; Rivadeneira DB, 2010, GASTROENTEROLOGY, V138, P1920, DOI 10.1053/j.gastro.2010.01.007; Rubin SM, 2005, CELL, V123, P1093, DOI 10.1016/j.cell.2005.09.044; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Sage J, 2012, GENE DEV, V26, P1409, DOI 10.1101/gad.193730.112; Salghetti SE, 2000, P NATL ACAD SCI USA, V97, P3118, DOI 10.1073/pnas.050007597; SAVATIER P, 1994, ONCOGENE, V9, P809; Schaffer BE, 2010, CANCER RES, V70, P3877, DOI 10.1158/0008-5472.CAN-09-4228; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.2005.10.017; Sdek P, 2004, J BIOL CHEM, V279, P53317, DOI 10.1074/jbc.M406062200; Stead E, 2002, ONCOGENE, V21, P8320, DOI 10.1038/sj.onc.1206015; Stengel KR, 2009, J BIOL CHEM, V284, P19265, DOI 10.1074/jbc.M808740200; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Takahashi Y, 2000, GENE DEV, V14, P804; Tedesco D, 2002, GENE DEV, V16, P2946, DOI 10.1101/gad.1011202; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Uchida CH, 2005, EMBO J, V24, P160, DOI 10.1038/sj.emboj.7600486; Ullah Z, 2007, MOL BIOL CELL, V18, P1179, DOI 10.1091/mbc.E06-09-0790; Wang K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010622; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; White J, 2005, MOL BIOL CELL, V16, P2018, DOI 10.1091/mbc.e04-12-1056; White J, 2005, STEM CELL REV, V1, P131, DOI 10.1385/SCR:1:2:131; Wirbelauer C, 2000, EMBO J, V19, P5362, DOI 10.1093/emboj/19.20.5362; Wirt SE, 2010, J CELL BIOL, V191, P809, DOI 10.1083/jcb.201003048; ZHANG H, 1995, CELL, V82, P915, DOI 10.1016/0092-8674(95)90271-6; Zhang L, 2014, J BIOL CHEM, V289, P24863, DOI 10.1074/jbc.M114.586818; ZHU L, 1995, EMBO J, V14, P1904, DOI 10.1002/j.1460-2075.1995.tb07182.x	67	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14462	14475		10.1074/jbc.M114.599993	http://dx.doi.org/10.1074/jbc.M114.599993			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25903125	hybrid, Green Published			2022-12-28	WOS:000355754600017
J	Casey, CS; Atagi, Y; Yamazaki, Y; Shinohara, M; Tachibana, M; Fu, Y; Bu, GJ; Kanekiyo, T				Casey, Caroline S.; Atagi, Yuka; Yamazaki, Yu; Shinohara, Mitsuru; Tachibana, Masaya; Fu, Yuan; Bu, Guojun; Kanekiyo, Takahisa			Apolipoprotein E Inhibits Cerebrovascular Pericyte Mobility through a RhoA Protein-mediated Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN-1; ALZHEIMERS-DISEASE; CELL MIGRATION; APOE; EXPRESSION; BETA; LIPOPROTEINS; ASTROCYTES; TISSUE; CLEARANCE	Pericytes play a critical role in the cerebrovasculature within the CNS. These small contractile cells produce large quantities of apolipoprotein E (apoE) whose isoforms influence cerebrovascular functions and determine the genetic risk for Alzheimer disease. Despite extensive studies on astrocyte-secreted apoE, which supports synapses by transporting cholesterol to neurons, the biochemical properties and function of apoE secreted by pericytes are not clear. Because pericytes mediate important functions in the CNS, including the initiation of glial scar formation, angiogenesis, and maintenance of the blood-brain barrier, we investigated the potential role of apoE in pericyte mobility. We found that knockdown of apoE expression significantly accelerates pericyte migration, an effect that can be rescued by exogenous apoE3, but not apoE4, a risk factor for Alzheimer disease. ApoE-regulated migration of pericytes also requires the function of the low-density lipoprotein receptor-related protein 1 (LRP1), a major apoE receptor in the brain that is abundantly expressed in pericytes. Because apoE-knockdown also leads to enhanced cell adhesion, we investigated the role of apoE in the regulation of the actin cytoskeleton. Interestingly, we found that the levels of active RhoA are increased significantly in apoE knockdown pericytes and that RhoA inhibitors blocked pericyte migration. Taken together, our results suggest that apoE has an intrinsic role in pericyte mobility, which is vital in maintaining cerebrovascular function. These findings provide novel insights into the role of apoE in the cerebrovascular system.	[Casey, Caroline S.; Atagi, Yuka; Yamazaki, Yu; Shinohara, Mitsuru; Tachibana, Masaya; Fu, Yuan; Bu, Guojun; Kanekiyo, Takahisa] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA	Mayo Clinic	Bu, GJ (corresponding author), Mayo Clin, Dept Neurosci, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.	bu.guojun@mayo.edu; kanekiyo.takahisa@mayo.edu	Tachibana, Masaya/AAW-3526-2020; Regan, Clinton/E-6250-2012; Fu, Yuan/AAO-6040-2020	Tachibana, Masaya/0000-0002-6761-7158; Fu, Yuan/0000-0003-2293-814X; Yamazaki, Yu/0000-0002-0806-4960	National Institutes of Health [P50AG016574, R01AG027924, R01AG035355, R01AG046205, P01 NS074969]; Alzheimer's Association; Cure Alzheimer's Fund; Alex Lemonade Stand Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS074969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG046205, P50AG016574, P01AG030128, R01AG046205, R01AG035355, R01AG027924] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); Cure Alzheimer's Fund; Alex Lemonade Stand Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants P50AG016574, R01AG027924, R01AG035355, R01AG046205, and P01 NS074969 (to G. B.). This work was also supported by a grant from the Alzheimer's Association and a grant from the Cure Alzheimer's Fund (to G. B.) and a Young Investigator Grant from the Alex Lemonade Stand Foundation (to T. K.).	Bales KR, 2009, J NEUROSCI, V29, P6771, DOI 10.1523/JNEUROSCI.0887-09.2009; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Bu GJ, 2000, TRENDS CARDIOVAS MED, V10, P148, DOI 10.1016/S1050-1738(00)00045-1; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Castoreno AB, 2010, NAT CHEM BIOL, V6, P457, DOI 10.1038/nchembio.363; de la Torre JC, 2002, STROKE, V33, P1152, DOI 10.1161/01.STR.0000014421.15948.67; Dore-Duffy P, 2000, MICROVASC RES, V60, P55, DOI 10.1006/mvre.2000.2244; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fagan AM, 1999, J BIOL CHEM, V274, P30001, DOI 10.1074/jbc.274.42.30001; Fagan AM, 2000, ANN NEUROL, V48, P201, DOI 10.1002/1531-8249(200008)48:2<201::AID-ANA10>3.0.CO;2-X; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Fernandez-Lopez D, 2012, J NEUROSCI, V32, P9588, DOI 10.1523/JNEUROSCI.5977-11.2012; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; HUI DY, 1980, J BIOL CHEM, V255, P1775; Iadecola C, 2013, NEURON, V80, P844, DOI 10.1016/j.neuron.2013.10.008; Ishigami M, 1998, J BIOL CHEM, V273, P20156, DOI 10.1074/jbc.273.32.20156; Jha A, 2008, J SPINAL CORD MED, V31, P171, DOI 10.1080/10790268.2008.11760708; Kanekiyo T, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00093; Kanekiyo T, 2014, NEURON, V81, P740, DOI 10.1016/j.neuron.2014.01.045; Kovac A, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-139; KRUL ES, 1988, J LIPID RES, V29, P1309; Li YH, 2003, FEBS LETT, V555, P346, DOI 10.1016/S0014-5793(03)01272-9; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Morikawa M, 2005, NEUROBIOL DIS, V19, P66, DOI 10.1016/j.nbd.2004.11.005; Nishitsuji K, 2011, J BIOL CHEM, V286, P17536, DOI 10.1074/jbc.M111.225532; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Pencheva N, 2012, CELL, V151, P1068, DOI 10.1016/j.cell.2012.10.028; Reiman EM, 2009, P NATL ACAD SCI USA, V106, P6820, DOI 10.1073/pnas.0900345106; Ridley AJ, 2001, J CELL SCI, V114, P2713; SCHACHTER F, 1994, NAT GENET, V6, P29, DOI 10.1038/ng0194-29; Seitz A, 2003, J NEUROSCI RES, V71, P417, DOI 10.1002/jnr.10482; Senger DR, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005090; Shinohara M, 2013, ACTA NEUROPATHOL, V125, P535, DOI 10.1007/s00401-013-1086-9; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Song H, 2009, CANCER RES, V69, P879, DOI 10.1158/0008-5472.CAN-08-3379; Stratman AN, 2009, BLOOD, V114, P5091, DOI 10.1182/blood-2009-05-222364; Swertfeger DK, 2002, J BIOL CHEM, V277, P4141, DOI 10.1074/jbc.M109124200; WARSHAWSKY I, 1993, J CLIN INVEST, V92, P937, DOI 10.1172/JCI116669; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Wilhelmus MMM, 2005, J NEUROSCI, V25, P3621, DOI 10.1523/JNEUROSCI.4213-04.2005; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946; Xu Q, 2006, J NEUROSCI, V26, P4985, DOI 10.1523/JNEUROSCI.5476-05.2006; Zhao J, 2014, J BIOL CHEM, V289, P11282, DOI 10.1074/jbc.M113.526095; Zlokovic BV, 2013, JAMA NEUROL, V70, P440, DOI 10.1001/jamaneurol.2013.2152; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	51	39	40	1	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					14208	14217		10.1074/jbc.M114.625251	http://dx.doi.org/10.1074/jbc.M114.625251			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25903128	Green Published, hybrid			2022-12-28	WOS:000355313000047
J	Garcia-Fernandez, R; Perbandt, M; Rehders, D; Ziegelmuller, P; Piganeau, N; Hahn, U; Betzel, C; Chavez, MD; Redecke, L				Garcia-Fernandez, Rossana; Perbandt, Markus; Rehders, Dirk; Ziegelmueller, Patrick; Piganeau, Nicolas; Hahn, Ulrich; Betzel, Christian; de los Angeles Chavez, Maria; Redecke, Lars			Three-dimensional Structure of a Kunitz-type Inhibitor in Complex with an Elastase-like Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORCINE PANCREATIC ELASTASE; HUMAN-LEUKOCYTE ELASTASE; NEUTROPHIL ELASTASE; TRYPSIN-INHIBITOR; CRYSTAL-STRUCTURE; CATHEPSIN-G; CHYMOTRYPSIN ELASTASE; PROTEINASE-INHIBITOR; ACTIVE-SITE; SUBSTRATE	Elastase-like enzymes are involved in important diseases such as acute pancreatitis, chronic inflammatory lung diseases, and cancer. Structural insights into their interaction with specific inhibitors will contribute to the development of novel anti-elastase compounds that resist rapid oxidation and proteolysis. Proteinaceous Kunitz-type inhibitors homologous to the bovine pancreatic trypsin inhibitor (BPTI) provide a suitable scaffold, but the structural aspects of their interaction with elastase-like enzymes have not been elucidated. Here, we increased the selectivity of ShPI-1, a versatile serine protease inhibitor from the sea anemone Stichodactyla helianthus with high biomedical and biotechnological potential, toward elastase-like enzymes by substitution of the P1 residue (Lys(13)) with leucine. The variant (rShPI-1/K13L) exhibits a novel anti-porcine pancreatic elastase (PPE) activity together with a significantly improved inhibition of human neuthrophil elastase and chymotrypsin. The crystal structure of the PPE.rShPI-1/K13L complex determined at 2.0 angstrom resolution provided the first details of the canonical interaction between a BPTI-Kunitz-type domain and elastase-like enzymes. In addition to the essential impact of the variant P1 residue for complex stability, the interface is improved by increased contributions of the primary and secondary binding loop as compared with similar trypsin and chymotrypsin complexes. A comparison of the interaction network with elastase complexes of canonical inhibitors from the chelonian in family supports a key role of the P3 site in ShPI-1 in directing its selectivity against pancreatic and neutrophil elastases. Our results provide the structural basis for site-specific mutagenesis to further improve the binding affinity and/or direct the selectivity of BPTI-Kunitz-type inhibitors toward elastase-like enzymes.	[Garcia-Fernandez, Rossana; de los Angeles Chavez, Maria] Univ La Habana, Ctr Estudio Prot, Fac Biol, Havana 20146, Cuba; [Perbandt, Markus; Ziegelmueller, Patrick; Piganeau, Nicolas; Hahn, Ulrich; Betzel, Christian] Univ Hamburg, Inst Biochem & Mol Biol, Dept Chem, D-22761 Hamburg, Germany; [Perbandt, Markus] Hamburg Ctr Ultrafast Imaging, D-22761 Hamburg, Germany; [Rehders, Dirk; Redecke, Lars] Univ Hamburg, Inst Biochem & Mol Biol, Joint Lab Struct Biol Infect & Inflammat, D-20146 Hamburg, Germany; [Rehders, Dirk; Redecke, Lars] Med Univ Lubeck, Inst Biochem, Deutsch Elektronen Synchrotron DESY, D-22603 Hamburg, Germany	Universidad de la Habana; University of Hamburg; University of Hamburg; University of Hamburg; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Lubeck	Redecke, L (corresponding author), Univ Hamburg, Joint Lab Struct Biol Infect & Inflammat, Inst Biochem & Mol Biol, Bldg 22a,Notkestr 85, D-22603 Hamburg, Germany.	redecke@biochem.uni-luebeck.de	Betzel, Christian/G-8105-2018; García-Fernández, Rossana/A-8920-2011; Hahn, Ulrich/E-8069-2010; Perbandt, Markus/K-7603-2018	Betzel, Christian/0000-0002-3879-5019; Hahn, Ulrich/0000-0002-6526-0693; 	International Foundation for Science, Sweden [F4086-1, F4086-2]; German Academic Exchange Service (DAAD); excellence cluster (The Hamburg Centre for Ultrafast Imaging-Structure, Dynamics, and Control of Matter at the Atomic Scale) of the Deutsche Forschungsgemeinschaft; German Federal Ministry of Education and Research [01DN13028]	International Foundation for Science, Sweden(International Foundation for Science); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); excellence cluster (The Hamburg Centre for Ultrafast Imaging-Structure, Dynamics, and Control of Matter at the Atomic Scale) of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by Grants F4086-1 and F4086-2 from the International Foundation for Science, Sweden; the German Academic Exchange Service (DAAD); the excellence cluster (The Hamburg Centre for Ultrafast Imaging-Structure, Dynamics, and Control of Matter at the Atomic Scale) of the Deutsche Forschungsgemeinschaft; and Grant 01DN13028 from the German Federal Ministry of Education and Research.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ANTUCH W, 1993, EUR J BIOCHEM, V212, P675, DOI 10.1111/j.1432-1033.1993.tb17705.x; Apostoluk W, 1998, PROTEINS, V32, P459, DOI 10.1002/(SICI)1097-0134(19980901)32:4<459::AID-PROT5>3.0.CO;2-B; Ascenzi P, 2003, CURR PROTEIN PEPT SC, V4, P231, DOI 10.2174/1389203033487180; Ay J, 2003, ACTA CRYSTALLOGR D, V59, P247, DOI 10.1107/S0907444902020887; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BIETH JG, 1995, METHOD ENZYMOL, V248, P59; BODE W, 1986, EMBO J, V5, P2453, DOI 10.1002/j.1460-2075.1986.tb04521.x; BODE W, 1989, BIOCHEMISTRY-US, V28, P1951, DOI 10.1021/bi00431a001; Buchler M., 1987, ELASTASE ACUTE PANCR, P110; CHASE T, 1967, BIOCHEM BIOPH RES CO, V29, P508, DOI 10.1016/0006-291X(67)90513-X; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chughtai B, 2004, J AEROSOL MED, V17, P289, DOI 10.1089/jam.2004.17.289; COPELAND RA, 1995, BIOORG MED CHEM LETT, V5, P1947, DOI 10.1016/0960-894X(95)00330-V; Debelle L, 1999, INT J BIOCHEM CELL B, V31, P261, DOI 10.1016/S1357-2725(98)00098-3; DeLano W.L, PYMOL MOL GRAPHICS S; Delfin J, 1996, TOXICON, V34, P1367, DOI 10.1016/S0041-0101(96)00114-6; DELMAR EG, 1979, ANAL BIOCHEM, V99, P316, DOI 10.1016/S0003-2697(79)80013-5; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ERLANGER BF, 1961, ARCH BIOCHEM BIOPHYS, V95, P271, DOI 10.1016/0003-9861(61)90145-X; ESTELL DA, 1986, SCIENCE, V233, P659, DOI 10.1126/science.233.4764.659; Eyal E, 2005, J MOL BIOL, V351, P431, DOI 10.1016/j.jmb.2005.05.066; Garcia-Fernandez R, 2012, ACTA CRYSTALLOGR F, V68, P1289, DOI 10.1107/S1744309112039085; Garcia-Fernandez R, 2012, J STRUCT BIOL, V180, P271, DOI 10.1016/j.jsb.2012.08.009; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gil DF, 2011, FEMS YEAST RES, V11, P575, DOI 10.1111/j.1567-1364.2011.00749.x; Gonzalez Y, 2007, BIOL CHEM, V388, P1183, DOI 10.1515/BC.2007.129; Helland R, 1998, EUR J BIOCHEM, V256, P317, DOI 10.1046/j.1432-1327.1998.2560317.x; HUANG K, 1994, STRUCTURE, V2, P679, DOI 10.1016/S0969-2126(00)00068-X; Kiczak L, 2001, BBA-PROTEIN STRUCT M, V1550, P153, DOI 10.1016/S0167-4838(01)00282-5; Kjeldsen T, 1996, GENE, V170, P107, DOI 10.1016/0378-1119(95)00822-5; Koizumi M, 2008, J SYNCHROTRON RADIAT, V15, P308, DOI 10.1107/S0909049507060670; Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733; Kraunsoe JAE, 1996, BIOCHEMISTRY-US, V35, P9090, DOI 10.1021/bi953013b; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krowarsch D, 2003, CELL MOL LIFE SCI, V60, P2427, DOI 10.1007/s00018-003-3120-x; Krowarsch D, 1999, J MOL BIOL, V289, P175, DOI 10.1006/jmbi.1999.2757; Kunitz M, 1936, J GEN PHYSIOL, V19, P991, DOI 10.1085/jgp.19.6.991; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lane AA, 2003, CELL, V115, P305, DOI 10.1016/S0092-8674(03)00852-3; Leatherbarrow R.J., 2009, GRAFIT VERSION 7; Ley AC, 2003, US patent, Patent No. [003/0175919 A1, 0030175919]; Li W, 2009, CANCER RES, V69, P8395, DOI 10.1158/0008-5472.CAN-09-1995; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; McBride JD, 1999, EUR J BIOCHEM, V266, P403, DOI 10.1046/j.1432-1327.1999.00867.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCWHERTER CA, 1989, BIOCHEMISTRY-US, V28, P5708, DOI 10.1021/bi00440a002; Moroy G, 2012, ANTI-CANCER AGENT ME, V12, P565, DOI 10.2174/187152012800617696; NAKAJIMA K, 1979, J BIOL CHEM, V254, P4027; Ooyama T, 1995, CIBA F SYMP, V192, P307; PEANASKY RJ, 1984, ARCH BIOCHEM BIOPHYS, V232, P127, DOI 10.1016/0003-9861(84)90528-9; Salameh MA, 2011, BIOCHEM J, V440, P95, DOI 10.1042/BJ20110788; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Scheidig AJ, 1997, PROTEIN SCI, V6, P1806, DOI 10.1002/pro.5560060902; Schmidt AE, 2005, J BIOL CHEM, V280, P27832, DOI 10.1074/jbc.M504105200; Shapiro SD, 1995, P ASSOC AM PHYSICIAN, V107, P346; SINHA S, 1987, P NATL ACAD SCI USA, V84, P2228, DOI 10.1073/pnas.84.8.2228; Sun ZF, 2004, LANCET ONCOL, V5, P182, DOI 10.1016/S1470-2045(04)01414-7; TSCHESCHE H, 1987, BIOCHIM BIOPHYS ACTA, V913, P97, DOI 10.1016/0167-4838(87)90238-X; Tsunemi M, 1996, BIOCHEMISTRY-US, V35, P11570, DOI 10.1021/bi960900l; VEDVICK T, 1991, J IND MICROBIOL, V7, P197, DOI 10.1007/BF01575883; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wurtele M, 2000, ACTA CRYSTALLOGR D, V56, P520, DOI 10.1107/S0907444900000299; Yanes O, 2007, NAT PROTOC, V2, P119, DOI 10.1038/nprot.2006.487; Zani ML, 2004, EUR J BIOCHEM, V271, P2370, DOI 10.1111/j.1432-1033.2004.04156.x	65	13	13	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					14154	14165		10.1074/jbc.M115.647586	http://dx.doi.org/10.1074/jbc.M115.647586			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25878249	hybrid, Green Published			2022-12-28	WOS:000355313000043
J	Reimund, M; Larsson, M; Kovrov, O; Kasvandik, S; Olivecrona, G; Lookene, A				Reimund, Mart; Larsson, Mikael; Kovrov, Oleg; Kasvandik, Sergo; Olivecrona, Gunilla; Lookene, Aivar			Evidence for Two Distinct Binding Sites for Lipoprotein Lipase on Glycosylphosphatidylinositol-anchored High Density Lipoprotein-binding Protein 1 (GPIHBP1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGLYCERIDE-RICH LIPOPROTEINS; ENDOTHELIAL-CELL TRANSPORTER; HEPARIN-BINDING; TERMINAL DOMAIN; DIRECTED MUTAGENESIS; PANCREATIC LIPASE; IDENTIFICATION; CHYLOMICRONEMIA; CAPILLARIES; PEPTIDES	GPIHBP1 is an endothelial membrane protein that transports lipoprotein lipase (LPL) from the subendothelial space to the luminal side of the capillary endothelium. Here, we provide evidence that two regions of GPIHBP1, the acidic N-terminal domain and the central Ly6 domain, interact with LPL as two distinct binding sites. This conclusion is based on comparative binding studies performed with a peptide corresponding to the N-terminal domain of GPIHBP1, the Ly6 domain of GPIHBP1, wild type GPIHBP1, and the Ly6 domain mutant GPIHBP1 Q114P. Although LPL and the N-terminal domain formed a tight but short lived complex, characterized by fast on-and off-rates, the complex between LPL and the Ly6 domain formed more slowly and persisted for a longer time. Unlike the interaction of LPL with the Ly6 domain, the interaction of LPL with the N-terminal domain was significantly weakened by salt. The Q114P mutant bound LPL similarly to the N-terminal domain of GPIHBP1. Heparin dissociated LPL from the N-terminal domain, and partially from wild type GPIHBP1, but was unable to elute the enzyme from the Ly6 domain. When LPL was in complex with the acidic peptide corresponding to the N-terminal domain of GPIHBP1, the enzyme retained its affinity for the Ly6 domain. Furthermore, LPL that was bound to the N-terminal domain interacted with lipoproteins, whereas LPL bound to the Ly6 domain did not. In summary, our data suggest that the two domains of GPIHBP1 interact independently with LPL and that the functionality of LPL depends on its localization on GPIHBP1.	[Reimund, Mart; Lookene, Aivar] Tallinn Univ Technol, Dept Chem, EE-12618 Tallinn, Estonia; [Larsson, Mikael; Kovrov, Oleg; Olivecrona, Gunilla] Umea Univ, Dept Med Biosci, SE-90187 Umea, Sweden; [Kasvandik, Sergo] Univ Tartu, Inst Technol, EE-50411 Tartu, Estonia	Tallinn University of Technology; Umea University; University of Tartu	Lookene, A (corresponding author), Akad Tee 15, EE-12618 Tallinn, Estonia.	aivar.lookene@ttu.ee	Reimund, Mart/A-2426-2019; Olivecrona, Gunilla/D-2127-2018	Reimund, Mart/0000-0002-9280-5409; Olivecrona, Gunilla/0000-0002-8876-6048; Kasvandik, Sergo/0000-0003-0218-2410	Estonian Ministry of Education and Research [IUT 19-9]; Swedish Science Council [12203]	Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); Swedish Science Council	This work was supported by Estonian Ministry of Education and Research Grant IUT 19-9 and Swedish Science Council Grant 12203.	Beigneux AP, 2007, CELL METAB, V5, P279, DOI 10.1016/j.cmet.2007.02.002; Beigneux AP, 2011, J BIOL CHEM, V286, P19735, DOI 10.1074/jbc.M111.242024; Beigneux AP, 2009, J BIOL CHEM, V284, P30240, DOI 10.1074/jbc.M109.046391; Beigneux AP, 2009, ARTERIOSCL THROM VAS, V29, P956, DOI 10.1161/ATVBAHA.109.186577; Beigneux AP, 2009, J LIPID RES, V50, pS57, DOI 10.1194/jlr.R800030-JLR200; BENGTSSON G, 1980, BIOCHEM J, V189, P625, DOI 10.1042/bj1890625; BENGTSSONOLIVECRONA G, 1991, METHOD ENZYMOL, V197, P345; BERRYMAN DE, 1993, J BIOL CHEM, V268, P3272; Boren J, 2001, J BIOL CHEM, V276, P26916, DOI 10.1074/jbc.M011090200; BOURNE Y, 1994, J MOL BIOL, V238, P709, DOI 10.1006/jmbi.1994.1331; Charriere S, 2011, J CLIN ENDOCR METAB, V96, pE1675, DOI 10.1210/jc.2011-1444; Coca-Prieto I, 2011, J INTERN MED, V270, P224, DOI 10.1111/j.1365-2796.2011.02361.x; Davies BSJ, 2010, CELL METAB, V12, P42, DOI 10.1016/j.cmet.2010.04.016; Franssen R, 2010, CIRC-CARDIOVASC GENE, V3, P169, DOI 10.1161/CIRCGENETICS.109.908905; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gin P, 2008, J BIOL CHEM, V283, P29554, DOI 10.1074/jbc.M802579200; Gin P, 2011, ARTERIOSCL THROM VAS, V31, P176, DOI 10.1161/ATVBAHA.110.214718; Goulbourne CN, 2014, CELL METAB, V19, P849, DOI 10.1016/j.cmet.2014.01.017; HATA A, 1993, J BIOL CHEM, V268, P8447; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; HIDE WA, 1992, J LIPID RES, V33, P167; Holmes RS, 2012, 3 BIOTECH, V2, P37, DOI 10.1007/s13205-011-0026-4; Holmes RS, 2011, COMP BIOCHEM PHYS D, V6, P224, DOI 10.1016/j.cbd.2011.04.003; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kinoshita T, 2008, J BIOCHEM, V144, P287, DOI 10.1093/jb/mvn090; Lookene A, 2000, BIOCHEM BIOPH RES CO, V271, P15, DOI 10.1006/bbrc.2000.2530; Lookene A, 1997, BIOCHEMISTRY-US, V36, P5267, DOI 10.1021/bi962699k; Lookene A, 1996, BIOCHEMISTRY-US, V35, P12155, DOI 10.1021/bi960008e; Lu H, 2010, CURR OPIN CHEM BIOL, V14, P467, DOI 10.1016/j.cbpa.2010.06.176; MA YH, 1994, J LIPID RES, V35, P2049; Nyren Rakel, 2012, BMC Physiology, V12, P14, DOI 10.1186/1472-6793-12-14; Olivecrona G, 1997, METHOD ENZYMOL, V286, P102; Olivecrona G, 2010, J LIPID RES, V51, P1535, DOI 10.1194/jlr.M002717; Olivecrona T, 1999, LIPOPROTEINS IN HEALTH AND DISEASE, P223; Olivecrona T, 2009, CELLULAR LIPID METABOLISM, P315, DOI 10.1007/978-3-642-00300-4_13; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plengpanich W, 2014, J BIOL CHEM, V289, P19491, DOI 10.1074/jbc.M114.558528; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rios JJ, 2012, J INHERIT METAB DIS, V35, P531, DOI 10.1007/s10545-011-9406-5; Robal T, 2012, J BIOL CHEM, V287, P29739, DOI 10.1074/jbc.M111.303529; Sendak RA, 1998, J LIPID RES, V39, P1310; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sonnenburg WK, 2009, J LIPID RES, V50, P2421, DOI 10.1194/jlr.M900145-JLR200; VANTILBEURGH H, 1994, J BIOL CHEM, V269, P4626; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Voss CV, 2011, P NATL ACAD SCI USA, V108, P7980, DOI 10.1073/pnas.1100992108; Xiang SQ, 1999, J LIPID RES, V40, P1655; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099; Young SG, 2013, GENE DEV, V27, P459, DOI 10.1101/gad.209296.112; Young SG, 2011, J LIPID RES, V52, P1869, DOI 10.1194/jlr.R018689; Zhou HX, 2013, CURR OPIN STRUC BIOL, V23, P887, DOI 10.1016/j.sbi.2013.06.014	51	10	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13919	13934		10.1074/jbc.M114.634626	http://dx.doi.org/10.1074/jbc.M114.634626			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25873395	Green Published, hybrid			2022-12-28	WOS:000355313000024
J	Jang, WG; Jeong, BC; Kim, EJ; Choi, H; Oh, SH; Kim, DK; Koo, SH; Choi, HS; Koh, JT				Jang, Won-Gu; Jeong, Byung-Chul; Kim, Eun-Jung; Choi, Hyuck; Oh, Sin-Hye; Kim, Don-Kyu; Koo, Seung-Hoi; Choi, Hueng-Sik; Koh, Jeong-Tae			Cyclic AMP Response Element-binding Protein H (CREBH) Mediates the Inhibitory Actions of Tumor Necrosis Factor alpha in Osteoblast Differentiation by Stimulating Smad1 Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN-2; STRESS TRANSDUCER OASIS; NUCLEAR RECEPTOR SHP; NF-KAPPA-B; ENDOPLASMIC-RETICULUM; TNF-ALPHA; INFLAMMATORY RESPONSE; TRANSCRIPTION FACTOR; CELLS; MECHANISMS	Endoplasmic reticulum (ER) stress transducers, such as old astrocyte specifically induced substance (OASIS) and activating transcription factor 6 (ATF6), which are induced by bone morphogenetic protein 2 (BMP2), regulate bone formation and osteoblast differentiation. Here, we examined the role of cAMP response element-binding protein H(CREBH), a member of the same family of ER membrane-bound basic leucine zipper (bZIP) transcription factors as OASIS and ATF6, in osteoblast differentiation and bone formation. Proinflammatory cytokine TNF alpha increased CREBH expression by up-regulating the nuclear factor-kappa B (NF-kappa B) signaling pathway in osteoblasts, increased the level of N-terminal fragment of CREBH in the nucleus, and inhibited BMP2 induction of osteoblast specific gene expression. Overexpression of CREBH suppressed BMP2-induced up-regulation of the osteogenic markers runt-related transcription factor 2 (Runx2), alkaline phosphatase (ALP), and osteocalcin (OC) in MC3T3-E1 cells and primary osteoblasts, as well as BMP2-induced ALP activity and OC protein production. In contrast, knockdown of CREBH attenuated the inhibitory effect of TNF alpha on BMP2-induced osteoblast differentiation. Mechanistic studies revealed that CREBH increased the expression of Smad ubiquitination regulatory factor 1 (Smurf1), leading to ubiquitin-dependent degradation of Smad1, whereas knock-down of CREBH inhibited TNF alpha-mediated degradation of Smad1 by Smurf1. Consistent with these in vitro findings, administration of Ad-CREBH inhibited BMP2-induced ectopic and orthotopic bone formation in vivo. Taken together, these results suggest that CREBH is a novel negative regulator of osteoblast differentiation and bone formation.	[Jang, Won-Gu; Jeong, Byung-Chul; Kim, Eun-Jung; Choi, Hyuck; Oh, Sin-Hye; Koh, Jeong-Tae] Chonnam Natl Univ, Sch Dent, Dept Pharmacol & Dent Therapeut, Res Ctr Biomineralizat Disorders, Gwangju 500757, South Korea; [Kim, Don-Kyu; Choi, Hueng-Sik] Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Natl Creat Res Initiat Ctr Nucl Receptor Signals, Gwangju 500757, South Korea; [Jang, Won-Gu] Daegu Univ, Sch Engn, Dept Biotechnol, Gyongsan 712714, South Korea; [Koo, Seung-Hoi] Korea Univ, Coll Life Sci & Biotechnol, Div Life Sci, Seoul 136701, South Korea	Chonnam National University; Chonnam National University; Daegu University; Korea University	Choi, HS (corresponding author), Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Natl Creat Res Initiat Ctr Nucl Receptor Signals, Gwangju 500757, South Korea.	hsc@chonnam.ac.kr; jtkoh@chonnam.ac.kr			National Research Foundation of Korea (NRF) - Korea government [MSIP 2011-0030121]; National Creative Research Initiatives from the NRF - Ministry of Science, ICT & Future Planning of the Korean government [20110018305]; NRF - Ministry of Education, Science and Technology [2014R1A1A2055844]	National Research Foundation of Korea (NRF) - Korea government(National Research Foundation of Korea); National Creative Research Initiatives from the NRF - Ministry of Science, ICT & Future Planning of the Korean government; NRF - Ministry of Education, Science and Technology	This work was supported in part by grants from the National Research Foundation of Korea (NRF) funded by Korea government Grant MSIP 2011-0030121 (to J. T. K.) and National Creative Research Initiatives Grant 20110018305 from the NRF (funded by Ministry of Science, ICT & Future Planning of the Korean government) (to H. S. C.).; Supported by the Basic Science Research Program through the NRF funded by Ministry of Education, Science and Technology Grant 2014R1A1A2055844.	Asada R, 2011, J BIOCHEM, V149, P507, DOI 10.1093/jb/mvr041; Beklen A, 2007, J DENT RES, V86, P347, DOI 10.1177/154405910708600409; Chanda D, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.377978; Choy EHS, 2001, NEW ENGL J MED, V344, P907, DOI 10.1056/NEJM200103223441207; Gentile CL, 2010, MOL CELL BIOCHEM, V344, P99, DOI 10.1007/s11010-010-0533-3; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Gilbert L, 2000, ENDOCRINOLOGY, V141, P3956, DOI 10.1210/en.141.11.3956; Gilbert L, 2002, J BIOL CHEM, V277, P2695, DOI 10.1074/jbc.M106339200; Guo R, 2008, J BIOL CHEM, V283, P23084, DOI 10.1074/jbc.M709848200; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Hess K, 2009, BONE, V45, P367, DOI 10.1016/j.bone.2009.04.252; Huang RL, 2014, STEM CELLS DEV, V23, P277, DOI 10.1089/scd.2013.0345; Jang WG, 2011, BMB REP, V44, P735, DOI 10.5483/BMBRep.2011.44.11.735; Jang WG, 2011, BIOCHEM BIOPH RES CO, V404, P1004, DOI 10.1016/j.bbrc.2010.12.099; Jang WG, 2012, J BIOL CHEM, V287, P905, DOI 10.1074/jbc.M111.253187; Jeong BC, 2010, J BONE MINER RES, V25, P262, DOI 10.1359/jbmr.090718; Kaneki H, 2006, J BIOL CHEM, V281, P4326, DOI 10.1074/jbc.M509430200; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Kusumoto K, 2002, J INT MED RES, V30, P251, DOI 10.1177/147323000203000305; Lee AH, 2012, CURR OPIN LIPIDOL, V23, P141, DOI 10.1097/MOL.0b013e3283508fed; Lee HL, 2010, EXP MOL MED, V42, P437, DOI 10.3858/emm.2010.42.6.045; Lee KB, 2011, SPINE J, V11, P568, DOI 10.1016/j.spinee.2011.02.001; Lee MW, 2010, CELL METAB, V11, P331, DOI 10.1016/j.cmet.2010.02.016; Lee YS, 2008, BIOCHEM J, V413, P559, DOI 10.1042/BJ20071637; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Matsumoto Y, 2010, MOL CELL ENDOCRINOL, V325, P118, DOI 10.1016/j.mce.2010.05.004; Mukai T, 2007, BIOCHEM BIOPH RES CO, V356, P1004, DOI 10.1016/j.bbrc.2007.03.099; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Nanes MS, 2003, GENE, V321, P1, DOI 10.1016/S0378-1119(03)00841-2; Okada T, 2002, BIOCHEM J, V366, P585, DOI 10.1042/BJ20020391; Ratanavaraporn J, 2012, BIOMATERIALS, V33, P304, DOI 10.1016/j.biomaterials.2011.09.050; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Saito A, 2014, ANAT SCI INT, V89, P11, DOI 10.1007/s12565-013-0214-x; Saito A, 2011, J BIOL CHEM, V286, P4809, DOI 10.1074/jbc.M110.152900; Upton PD, 2008, MOL PHARMACOL, V73, P539, DOI 10.1124/mol.107.041673; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Wang YG, 2009, NATURE, V460, P534, DOI 10.1038/nature08111; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Yamashita M, 2008, J ENDOCRINOL, V196, P601, DOI 10.1677/JOE-07-0532; Yamazaki M, 2009, J BIOL CHEM, V284, P35987, DOI 10.1074/jbc.M109.070540; Yan XH, 2011, BIOCHEM J, V434, P1, DOI 10.1042/BJ20101827; Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040; Zhao M, 2003, J BIOL CHEM, V278, P27939, DOI 10.1074/jbc.M304132200; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	45	18	18	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13556	13566		10.1074/jbc.M114.587923	http://dx.doi.org/10.1074/jbc.M114.587923			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25873397	hybrid, Green Published			2022-12-28	WOS:000354975700049
J	Pallan, PS; Wang, CX; Lei, L; Yoshimoto, FK; Auchus, RJ; Waterman, MR; Guengerich, FP; Egli, M				Pallan, Pradeep S.; Wang, Chunxue; Lei, Li; Yoshimoto, Francis K.; Auchus, Richard J.; Waterman, Michael R.; Guengerich, F. Peter; Egli, Martin			Human Cytochrome P450 21A2, the Major Steroid 21-Hydroxylase STRUCTURE OF THE ENZYME.PROGESTERONE SUBSTRATE COMPLEX AND RATE-LIMITING C-H BOND CLEAVAGE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYP21A2 MUTATIONS; PROGESTERONE; PURIFICATION; EXPRESSION; P450C17; DEFICIENCY; MICROSOMES; DEUTERIUM; SEQUENCE; SYSTEM	Cytochrome P450 (P450) 21A2 is the major steroid 21-hydroxylase, and deficiency of this enzyme is involved in similar to 95% of cases of human congenital adrenal hyperplasia, a disorder of adrenal steroidogenesis. A structure of the bovine enzyme that we published previously (Zhao, B., Lei, L., Kagawa, N., Sundaramoorthy, M., Banerjee, S., Nagy, L. D., Guengerich, F. P., and Waterman, M. R. (2012) Three-dimensional structure of steroid 21-hydroxylase (cytochrome P450 21A2) with two substrates reveals locations of disease-associated variants. J. Biol. Chem. 287, 10613-10622), containing two molecules of the substrate 17 alpha-hydroxyprogesterone, has been used as a template for understanding genetic deficiencies. We have now obtained a crystal structure of human P450 21A2 in complex with progesterone, a substrate in adrenal 21-hydroxylation. Substrate binding and release were fast for human P450 21A2 with both substrates, and pre-steady-state kinetics showed a partial burst but only with progesterone as substrate and not 17 alpha-hydroxyprogesterone. High intermolecular non-competitive kinetic deuterium isotope effects on both k(cat) and k(cat)/K-m, from 5 to 11, were observed with both substrates, indicative of rate-limiting C-H bond cleavage and suggesting that the juxtaposition of the C21 carbon in the active site is critical for efficient oxidation. The estimated rate of binding of the substrate progesterone (k(on) 2.4 x 10(7) M-1 s(-1)) is only similar to 2-fold greater than the catalytic efficiency (k(cat)/K-m = 1.3 x 10(7) M-1 s(-1)) with this substrate, sug-gesting that the rate of substrate binding may also be partially rate-limiting. The structure of the human P450 21A2-substrate complex provides direct insight into mechanistic effects of genetic variants.	[Pallan, Pradeep S.; Wang, Chunxue; Lei, Li; Yoshimoto, Francis K.; Waterman, Michael R.; Guengerich, F. Peter; Egli, Martin] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA; [Auchus, Richard J.] Univ Michigan, Sch Med, Dept Internal Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA	Vanderbilt University; University of Michigan System; University of Michigan	Guengerich, FP (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, 638 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu; martin.egli@vanderbilt.edu	Wang, Chunxue/E-1840-2018	Wang, Chunxue/0000-0002-7462-9077; Yoshimoto, Francis/0000-0002-2308-2999	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086596, R01GM103937] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Trisler for assistance in the preparation of the manuscript. Vanderbilt University is a member institution of the Life Sciences Collaborative Access Team at Sector 21 of the Advanced Photon Source (Argonne, IL). Use of the Advanced Photon Source at Argonne National Laboratory was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357.	Arase M, 2006, BIOCHEM BIOPH RES CO, V344, P400, DOI 10.1016/j.bbrc.2006.03.067; Auchus RJ, 2003, ARCH BIOCHEM BIOPHYS, V409, P134, DOI 10.1016/S0003-9861(02)00491-5; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Billerbeck AEC, 1999, J CLIN ENDOCR METAB, V84, P2870, DOI 10.1210/jc.84.8.2870; Bratland E, 2009, J AUTOIMMUN, V33, P58, DOI 10.1016/j.jaut.2009.02.018; Daniels F., 1966, PHYS CHEM, P330; DIETER HH, 1982, BIOCHEM BIOPH RES CO, V105, P515, DOI 10.1016/0006-291X(82)91465-6; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fersht A., 1999, STRUCTURE MECH PROTE, P164; Furge LL, 1999, BIOCHEMISTRY-US, V38, P4818, DOI 10.1021/bi982163u; Guengerich F.P., 2015, CYTOCHROME P450 STRU, P523, DOI [10.1007/978-3-319-12108-6, DOI 10.1007/978-3-319-12108-6]; Guengerich FP, 2014, HAYES' PRINCIPLES AND METHODS OF TOXICOLOGY, 6TH EDITION, P1905; Guengerich FP, 2004, BIOCHEMISTRY-US, V43, P10775, DOI 10.1021/bi0491393; Haider S, 2013, P NATL ACAD SCI USA, V110, P2605, DOI 10.1073/pnas.1221133110; Hanna IH, 1998, ARCH BIOCHEM BIOPHYS, V350, P324, DOI 10.1006/abbi.1997.0534; HIGASHI Y, 1986, P NATL ACAD SCI USA, V83, P2841, DOI 10.1073/pnas.83.9.2841; Johnson EF, 2013, J BIOL CHEM, V288, P17082, DOI 10.1074/jbc.R113.452805; Kishimoto W, 2004, ENDOCRINOLOGY, V145, P699, DOI 10.1210/en.2003-1109; KOMINAMI S, 1980, J BIOL CHEM, V255, P3386; Kominami S, 2001, J BIOL CHEM, V276, P10753, DOI 10.1074/jbc.M006043200; Krissinel EB, 2004, ACTA CRYSTALLOGR D, V60, P2250, DOI 10.1107/S0907444904027167; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Mizrachi D, 2011, BIOCHEMISTRY-US, V50, P3968, DOI 10.1021/bi102078e; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; NORTHROP DB, 1982, METHOD ENZYMOL, V87, P607; Nunez BS, 1999, BIOCHEM BIOPH RES CO, V262, P635, DOI 10.1006/bbrc.1999.1271; Ohlsson G, 1999, HUM MUTAT, V13, P482, DOI 10.1002/(SICI)1098-1004(1999)13:6<482::AID-HUMU8>3.0.CO;2-0; OMURA T, 1964, J BIOL CHEM, V239, P2370; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RICHARDSON TH, 1995, ARCH BIOCHEM BIOPHYS, V323, P87, DOI 10.1006/abbi.1995.0013; RODRIGUES NR, 1987, EMBO J, V6, P1653, DOI 10.1002/j.1460-2075.1987.tb02414.x; SANDHU P, 1994, ARCH BIOCHEM BIOPHYS, V309, P168, DOI 10.1006/abbi.1994.1099; Shinkyo R, 2011, J BIOL CHEM, V286, P4632, DOI 10.1074/jbc.M110.193409; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Soardi FC, 2008, J CLIN ENDOCR METAB, V93, P2416, DOI 10.1210/jc.2007-2594; Tardy V, 2010, J CLIN ENDOCR METAB, V95, P1288, DOI 10.1210/jc.2009-1202; Therrell BL, 1998, PEDIATRICS, V101, P583, DOI 10.1542/peds.101.4.583; White PC, 2000, ENDOCR REV, V21, P245, DOI 10.1210/er.21.3.245; WHITE PC, 1985, P NATL ACAD SCI USA, V82, P1089, DOI 10.1073/pnas.82.4.1089; Yoshimoto FK, 2014, BIOCHEMISTRY-US, V53, P7531, DOI 10.1021/bi5011865; Yoshimoto FK, 2012, BIOCHEMISTRY-US, V51, P7064, DOI 10.1021/bi300895w; Yu YG, 2011, GENET TEST MOL BIOMA, V15, P137, DOI 10.1089/gtmb.2010.0131; Zhang HD, 2009, J BIOL CHEM, V284, P3563, DOI 10.1074/jbc.M807778200; Zhao B, 2012, J BIOL CHEM, V287, P10613, DOI 10.1074/jbc.M111.323501	46	54	55	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13128	13143		10.1074/jbc.M115.646307	http://dx.doi.org/10.1074/jbc.M115.646307			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25855791	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000354975700016
J	Djoko, KY; Ong, CLY; Walker, MJ; McEwan, AG				Djoko, Karrera Y.; Ong, Cheryl-Lynn Y.; Walker, Mark J.; McEwan, Alastair G.			The Role of Copper and Zinc Toxicity in Innate Immune Defense against Bacterial Pathogens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ESCHERICHIA-COLI; PERITONEAL-MACROPHAGES; TRANSCRIPTIONAL REGULATOR; ATPASE REDUCE; OXIDASE CUEO; DEFICIENCY; RESISTANCE; SALMONELLA; INFECTION; VIRULENCE	Zinc (Zn) and copper (Cu) are essential for optimal innate immune function, and nutritional deficiency in either metal leads to increased susceptibility to bacterial infection. Recently, the decreased survival of bacterial pathogens with impaired Cu and/or Zn detoxification systems in phagocytes and animal models of infection has been reported. Consequently, a model has emerged in which the host utilizes Cu and/or Zn intoxication to reduce the intracellular survival of pathogens. This review describes and assesses the potential role for Cu and Zn intoxication in innate immune function and their direct bactericidal function.	[McEwan, Alastair G.] Univ Queensland, Sch Chem & Biosci, St Lucia, Qld 4072, Australia; Univ Queensland, Australian Infect Dis Res Ctr, St Lucia, Qld 4072, Australia	University of Queensland; University of Queensland	McEwan, AG (corresponding author), Univ Queensland, Sch Chem & Biosci, Cooper Rd, St Lucia, Qld 4072, Australia.	mcewan@uq.edu.au	Ong, Cheryl-lynn Y/C-5238-2014	Ong, Cheryl-lynn Y/0000-0001-6036-6889; Walker, Mark/0000-0001-7423-2769; McEwan, Alastair/0000-0002-2419-1003; Djoko, Karrera/0000-0001-9814-6515	National Health and Medical Research Council (Australia) [565526]	National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council (Australia) Program Grant 565526. This is the second article in the Thematic Minireview series "Metals at the Host-Pathogen Interface." The authors declare that they have no conflicts of interest with the contents of this article.	Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Achard MES, 2012, BIOCHEM J, V444, P51, DOI 10.1042/BJ20112180; Achard MES, 2010, INFECT IMMUN, V78, P2312, DOI 10.1128/IAI.01208-09; ANDERSON CJ, 1995, J NUCL MED, V36, P850; Andreini C, 2006, J PROTEOME RES, V5, P196, DOI 10.1021/pr050361j; BABU U, 1990, J NUTR, V120, P1692, DOI 10.1093/jn/120.12.1692; Black RE, 2003, J NUTR, V133, p1485S, DOI 10.1093/jn/133.5.1485S; Botella H, 2011, CELL HOST MICROBE, V10, P248, DOI 10.1016/j.chom.2011.08.006; BRIGGS WA, 1982, KIDNEY INT, V21, P827, DOI 10.1038/ki.1982.106; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brocklehurst KR, 1999, MOL MICROBIOL, V31, P893, DOI 10.1046/j.1365-2958.1999.01229.x; Brophy MB, 2012, J AM CHEM SOC, V134, P18089, DOI 10.1021/ja307974e; CARLOMAGNO MA, 1986, MED MICROBIOL IMMUN, V175, P271, DOI 10.1007/BF02126048; Chillappagari S, 2010, J BACTERIOL, V192, P2512, DOI 10.1128/JB.00058-10; CHVAPIL M, 1977, INFECT IMMUN, V16, P367, DOI 10.1128/IAI.16.1.367-373.1977; Coles CL, 2008, J NUTR, V138, P2462, DOI 10.3945/jn.108.095422; CONFORTI A, 1982, AGENTS ACTIONS, V12, P303, DOI 10.1007/BF01965394; CONFORTI A, 1983, BRIT J PHARMACOL, V79, P45, DOI 10.1111/j.1476-5381.1983.tb10493.x; Corbett D, 2011, MOL MICROBIOL, V81, P457, DOI 10.1111/j.1365-2958.2011.07705.x; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; COUSINS RJ, 1988, FASEB J, V2, P2884, DOI 10.1096/fasebj.2.13.2458983; CROCKER A, 1992, J NATL MED ASSOC, V84, P697; De Domenico I, 2007, EMBO J, V26, P2823, DOI 10.1038/sj.emboj.7601735; Dineley KE, 2003, J NEUROCHEM, V85, P563, DOI 10.1046/j.1471-4159.2003.01678.x; Djoko KY, 2013, ACS CHEM BIOL, V8, P2217, DOI 10.1021/cb4002443; Djoko KY, 2012, INFECT IMMUN, V80, P1065, DOI 10.1128/IAI.06163-11; DUNLAP WM, 1974, ANN INTERN MED, V80, P470, DOI 10.7326/0003-4819-80-4-470; Eijkelkamp BA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089427; ERCAN MT, 1991, NUCL MED BIOL, V18, P765, DOI 10.1016/0883-2897(91)90015-D; Espariz M, 2007, MICROBIOL-SGM, V153, P2989, DOI 10.1099/mic.0.2007/006536-0; Festa RA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002887; Festa RA, 2011, MOL MICROBIOL, V79, P133, DOI 10.1111/j.1365-2958.2010.07431.x; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Francis MS, 1997, MICROB PATHOGENESIS, V22, P67, DOI 10.1006/mpat.1996.0092; Franke S, 2003, J BACTERIOL, V185, P3804, DOI 10.1128/JB.185.13.3804-3812.2003; Fukada T, 2011, J BIOL INORG CHEM, V16, P1123, DOI 10.1007/s00775-011-0797-4; Fung DKC, 2013, J BACTERIOL, V195, P4556, DOI 10.1128/JB.00543-13; German N, 2013, FUTURE MICROBIOL, V8, P1257, DOI 10.2217/fmb.13.100; Gold B, 2008, NAT CHEM BIOL, V4, P609, DOI 10.1038/nchembio.109; Haase H, 2008, J IMMUNOL, V181, P6491, DOI 10.4049/jimmunol.181.9.6491; Haase H, 2009, ANNU REV NUTR, V29, P133, DOI 10.1146/annurev-nutr-080508-141119; HERESI G, 1985, NUTR RES, V5, P1327, DOI 10.1016/S0271-5317(85)80043-9; Hodgkinson V, 2012, J BIOL CHEM, V287, P13549, DOI 10.1074/jbc.R111.316406; JAMES SJ, 1987, J NUTR, V117, P1982, DOI 10.1093/jn/117.11.1982; Johnson MDL, 2015, INFECT IMMUN, V83, P1684, DOI 10.1128/IAI.03015-14; JONES DG, 1983, J COMP PATHOL, V93, P143, DOI 10.1016/0021-9975(83)90052-X; KARL L, 1973, P SOC EXP BIOL MED, V142, P1123; Kehl-Fie TE, 2010, CURR OPIN CHEM BIOL, V14, P218, DOI 10.1016/j.cbpa.2009.11.008; Kloosterman TG, 2007, MOL MICROBIOL, V65, P1049, DOI 10.1111/j.1365-2958.2007.05849.x; KREINDLER TG, 1977, J INVEST DERMATOL, V68, P240; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Linder Maria C., 1996, American Journal of Clinical Nutrition, V63, p797S; Liu MJ, 2013, CELL REP, V3, P386, DOI 10.1016/j.celrep.2013.01.009; Liu T, 2007, NAT CHEM BIOL, V3, P60, DOI 10.1038/nchembio844; Liuzzi JP, 2005, P NATL ACAD SCI USA, V102, P6843, DOI 10.1073/pnas.0502257102; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; Maret W, 2013, BIOMETALS, V26, P197, DOI 10.1007/s10534-013-9613-7; Maret W, 2013, ADV NUTR, V4, P82, DOI 10.3945/an.112.003038; Maret W, 2011, BIOMETALS, V24, P411, DOI 10.1007/s10534-010-9406-1; Marrero K, 2012, MICROBIOL-SGM, V158, P2005, DOI 10.1099/mic.0.059345-0; McDevitt CA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002357; MCMURRAY DN, 1990, ANN NY ACAD SCI, V587, P59, DOI 10.1111/j.1749-6632.1990.tb00134.x; McQuade P, 2005, NUCL MED BIOL, V32, P147, DOI 10.1016/j.nucmedbio.2004.10.004; NEWBERNE PM, 1968, BRIT J EXP PATHOL, V49, P448; Ong CLY, 2015, SCI REP-UK, V5, DOI 10.1038/srep10799; Ong CLY, 2014, J INFECT DIS, V209, P1500, DOI 10.1093/infdis/jiu053; Osman D, 2010, J BIOL CHEM, V285, P25259, DOI 10.1074/jbc.M110.145953; Outten FW, 2001, J BIOL CHEM, V276, P30670, DOI 10.1074/jbc.M104122200; PERCIVAL SS, 1995, NUTR REV, V53, P59, DOI 10.1111/j.1753-4887.1995.tb01503.x; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Rensing C, 1997, P NATL ACAD SCI USA, V94, P14326, DOI 10.1073/pnas.94.26.14326; SCHEIE AA, 1994, CARIES RES, V28, P329, DOI 10.1159/000261997; Schwan WR, 2005, INT J MED MICROBIOL, V295, P237, DOI 10.1016/j.ijmm.2005.05.005; Shafeeq S, 2011, MOL MICROBIOL, V81, P1255, DOI 10.1111/j.1365-2958.2011.07758.x; Stahler FN, 2006, INFECT IMMUN, V74, P3845, DOI 10.1128/IAI.02025-05; Subashchandrabose S, 2014, P NATL ACAD SCI USA, V111, P18327, DOI 10.1073/pnas.1415959112; Talaat AM, 2004, P NATL ACAD SCI USA, V101, P4602, DOI 10.1073/pnas.0306023101; Tottey S, 2012, P NATL ACAD SCI USA, V109, P95, DOI 10.1073/pnas.1117515109; Tree JJ, 2008, J BACTERIOL, V190, P6909, DOI 10.1128/JB.00451-08; Tree JJ, 2007, ENVIRON MICROBIOL, V9, P2110, DOI 10.1111/j.1462-2920.2007.01320.x; Tree JJ, 2005, BIOCHEM BIOPH RES CO, V328, P1205, DOI 10.1016/j.bbrc.2005.01.084; Tumer Z, 2010, EUR J HUM GENET, V18, P511, DOI 10.1038/ejhg.2009.187; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Vazquez-Torres A, 2000, J EXP MED, V192, P227, DOI 10.1084/jem.192.2.227; Vignesh KS, 2013, IMMUNITY, V39, P697, DOI 10.1016/j.immuni.2013.09.006; Wagner D, 2005, J IMMUNOL, V174, P1491, DOI 10.4049/jimmunol.174.3.1491; Walker CF, 2004, ANNU REV NUTR, V24, P255, DOI 10.1146/annurev.nutr.23.011702.073054; Ward SK, 2010, MOL MICROBIOL, V77, P1096, DOI 10.1111/j.1365-2958.2010.07273.x; WESTON WL, 1977, ARCH DERMATOL, V113, P422, DOI 10.1001/archderm.113.4.422; WHEELER EM, 1976, ARCH DIS CHILD, V51, P269, DOI 10.1136/adc.51.4.269; White C, 2009, J BIOL CHEM, V284, P33949, DOI 10.1074/jbc.M109.070201; Williams DLH, 1999, ACCOUNTS CHEM RES, V32, P869, DOI 10.1021/ar9800439; WIRTH JJ, 1989, IMMUNOLOGY, V68, P114; WIRTH JJ, 1984, J NUTR, V114, P1826, DOI 10.1093/jn/114.10.1826; Wolschendorf F, 2011, P NATL ACAD SCI USA, V108, P1621, DOI 10.1073/pnas.1009261108; XIN Z, 1991, J DAIRY SCI, V74, P3078, DOI 10.3168/jds.S0022-0302(91)78493-2; ZIDAR BL, 1977, AM J HEMATOL, V3, P177, DOI 10.1002/ajh.2830030209	99	208	213	5	50	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					18954	18961		10.1074/jbc.R115.647099	http://dx.doi.org/10.1074/jbc.R115.647099			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26055706	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000358781100009
J	O'Day, E; Le, MTN; Imai, S; Tan, SM; Kirchner, R; Arthanari, H; Hofmann, O; Wagner, G; Lieberman, J				O'Day, Elizabeth; Le, Minh T. N.; Imai, Shunsuke; Tan, Shen Mynn; Kirchner, Rory; Arthanari, Haribabu; Hofmann, Oliver; Wagner, Gerhard; Lieberman, Judy			An RNA-binding Protein, Lin28, Recognizes and Remodels G-quartets in the MicroRNAs (miRNAs) and mRNAs It Regulates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							G-QUADRUPLEX STRUCTURE; NMR-SPECTROSCOPY; PROMOTER REGION; DNA; TRANSLATION; EXPRESSION; LIN-28; INHIBITION; MYC; TELOMERASE	Lin28 is an evolutionarily conserved RNA-binding protein that inhibits processing of pre-let-7 microRNAs (miRNAs) and regulates translation of mRNAs that control developmental timing, pluripotency, metabolism, and tumorigenesis. The RNA features that mediate Lin28 binding to the terminal loops of let-7 pre-miRNAs and to Lin28-responsive elements (LREs) in mRNAs are not well defined. Here we show that Lin28 target datasets are enriched for RNA sequences predicted to contain stable planar structures of 4 guanines known as G-quartets (G4s). The imino NMR spectra of pre-let-7 loops and LREs contain resonances characteristic of G4 hydrogen bonds. These sequences bind to a G4-binding fluorescent dye, N-methyl-mesoporphyrin IX (NMM). Mutations and truncations in the RNA sequence that prevent G4 formation also prevent Lin28 binding. The addition of Lin28 to a pre-let-7 loop or an LRE reduces G4 resonance intensity and NMM binding, suggesting that Lin28 may function to remodel G4s. Further, we show that NMM inhibits Lin28 binding. Incubation of a human embryonal carcinoma cell line with NMM reduces its stem cell traits. In particular it increases mature let-7 levels, decreases OCT4, HMGA1, CCNB1, CDK4, and Lin28A protein, decreases sphere formation, and inhibits colony formation. Our results suggest a previously unknown structural feature of Lin28 targets and a new strategy for manipulating Lin28 function.	[O'Day, Elizabeth; Imai, Shunsuke; Arthanari, Haribabu; Wagner, Gerhard] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [O'Day, Elizabeth; Le, Minh T. N.; Tan, Shen Mynn; Lieberman, Judy] Boston Childrens Hosp, Cellular & Mol Med Program, Boston, MA 02115 USA; [Kirchner, Rory; Hofmann, Oliver] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Wagner, G (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	Gerhard_wagner@hms.harvard.edu; Judy.Lieberman@childrens.harvard.edu	Regan, Clinton/E-6250-2012; Lieberman, Judy/A-2717-2015; Hofmann, Oliver/F-1800-2013	LE, Thi Nguyet Minh/0000-0002-6077-1566; Imai, Shunsuke/0000-0001-9346-2359; Arthanari, Haribabu/0000-0002-7281-1289; Kirchner, Rory/0000-0003-4814-5885; Wagner, Gerhard/0000-0002-2063-4401; Hofmann, Oliver/0000-0002-7738-1513	Department of Defense Breast Cancer Research Program [W81 XWH-09-1-0058]; National Institutes of Health [GM047467]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM047467] Funding Source: NIH RePORTER	Department of Defense Breast Cancer Research Program(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Department of Defense Breast Cancer Research Program Grant W81 XWH-09-1-0058 (to J. L.) and National Institutes of Health Grant GM047467 (to G. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Adrian M, 2012, METHODS, V57, P11, DOI 10.1016/j.ymeth.2012.05.003; AMBROS V, 1989, CELL, V57, P49, DOI 10.1016/0092-8674(89)90171-2; AMBROS V, 1984, SCIENCE, V226, P409, DOI 10.1126/science.6494891; Arthanari H, 1998, NUCLEIC ACIDS RES, V26, P3724, DOI 10.1093/nar/26.16.3724; Bole M, 2008, MOL BIOSYST, V4, P1212, DOI 10.1039/b812537f; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Bugaut A, 2010, ORG BIOMOL CHEM, V8, P2771, DOI 10.1039/c002418j; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Cho J, 2012, CELL, V151, P765, DOI 10.1016/j.cell.2012.10.019; Cogoi S, 2006, NUCLEIC ACIDS RES, V34, P2536, DOI 10.1093/nar/gkl286; da Silva MW, 2007, METHODS, V43, P264, DOI 10.1016/j.ymeth.2007.05.007; Dai JX, 2006, J AM CHEM SOC, V128, P1096, DOI 10.1021/ja055636a; Dangi-Garimella S, 2009, EMBO J, V28, P347, DOI 10.1038/emboj.2008.294; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; De Armond R, 2005, BIOCHEMISTRY-US, V44, P16341, DOI 10.1021/bi051618u; Drygin D, 2009, CANCER RES, V69, P7653, DOI 10.1158/0008-5472.CAN-09-1304; Furtig B, 2003, CHEMBIOCHEM, V4, P936, DOI 10.1002/cbic.200300700; Grand CL, 2002, MOL CANCER THER, V1, P565; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; HENDERSON E, 1987, CELL, V51, P899, DOI 10.1016/0092-8674(87)90577-0; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Ivanov P, 2014, P NATL ACAD SCI USA, V111, P18201, DOI 10.1073/pnas.1407361111; Jin JY, 2011, NUCLEIC ACIDS RES, V39, P3724, DOI 10.1093/nar/gkq1350; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kikin O, 2006, NUCLEIC ACIDS RES, V34, pW676, DOI 10.1093/nar/gkl253; King CE, 2011, CANCER RES, V71, P4260, DOI 10.1158/0008-5472.CAN-10-4637; Krishnan-Ghosh Y, 2004, J AM CHEM SOC, V126, P11009, DOI 10.1021/ja049259y; Lane AN, 2008, NUCLEIC ACIDS RES, V36, P5482, DOI 10.1093/nar/gkn517; Lehrbach NJ, 2009, NAT STRUCT MOL BIOL, V16, P1016, DOI 10.1038/nsmb.1675; Lightfoot HL, 2011, BIOCHEMISTRY-US, V50, P7514, DOI 10.1021/bi200851d; LIU ZC, 1989, GENE DEV, V3, P2039, DOI 10.1101/gad.3.12b.2039; Loughlin FE, 2012, NAT STRUCT MOL BIOL, V19, P84, DOI 10.1038/nsmb.2202; Maizels N, 2006, NAT STRUCT MOL BIOL, V13, P1055, DOI 10.1038/nsmb1171; MARSH TC, 1994, BIOCHEMISTRY-US, V33, P10718, DOI 10.1021/bi00201a020; Mayr F, 2012, NUCLEIC ACIDS RES, V40, P7492, DOI 10.1093/nar/gks355; Meirelles K, 2012, P NATL ACAD SCI USA, V109, P2358, DOI 10.1073/pnas.1120733109; Mikami-Terao Y, 2008, CANCER LETT, V261, P226, DOI 10.1016/j.canlet.2007.11.017; Moss EG, 2003, DEV BIOL, V258, P432, DOI 10.1016/S0012-1606(03)00126-X; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Mukherjee N, 2011, MOL CELL, V43, P327, DOI 10.1016/j.molcel.2011.06.007; Nam Y, 2011, CELL, V147, P1080, DOI 10.1016/j.cell.2011.10.020; Nicoludis JM, 2012, J AM CHEM SOC, V134, P20446, DOI 10.1021/ja3088746; Palumbo SL, 2008, NUCLEIC ACIDS RES, V36, P1755, DOI 10.1093/nar/gkm1069; Palumbo SL, 2009, J AM CHEM SOC, V131, P10878, DOI 10.1021/ja902281d; Patel DJ, 2007, NUCLEIC ACIDS RES, V35, P7429, DOI 10.1093/nar/gkm711; Peng SP, 2011, STEM CELLS, V29, P496, DOI 10.1002/stem.591; Phan AT, 2005, NAT CHEM BIOL, V1, P167, DOI 10.1038/nchembio723; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Qiu CH, 2010, NUCLEIC ACIDS RES, V38, P1240, DOI 10.1093/nar/gkp1071; Ren JS, 1999, BIOCHEMISTRY-US, V38, P16067, DOI 10.1021/bi992070s; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; Simonsson T, 1998, NUCLEIC ACIDS RES, V26, P1167, DOI 10.1093/nar/26.5.1167; Sun DY, 2005, NUCLEIC ACIDS RES, V33, P6070, DOI 10.1093/nar/gki917; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; West JA, 2009, NATURE, V460, P909, DOI 10.1038/nature08210; Wilbert ML, 2012, MOL CELL, V48, P195, DOI 10.1016/j.molcel.2012.08.004; Xu BS, 2009, RNA, V15, P357, DOI 10.1261/rna.1368009; Xu Y, 2006, NUCLEIC ACIDS RES, V34, P949, DOI 10.1093/nar/gkj485; Xue DB, 2011, HISTOPATHOLOGY, V59, P452, DOI 10.1111/j.1365-2559.2011.03949.x; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zheng K, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-38; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033; Zhu H, 2010, NAT GENET, V42, P626, DOI 10.1038/ng.593	70	25	26	4	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					17909	17922		10.1074/jbc.M115.665521	http://dx.doi.org/10.1074/jbc.M115.665521			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26045559	hybrid, Green Published			2022-12-28	WOS:000358511700025
J	Alfaro-Aco, R; Petry, S				Alfaro-Aco, Ray; Petry, Sabine			Building the Microtubule Cytoskeleton Piece by Piece	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PLUS-END TRACKING; ALPHA-BETA-TUBULIN; DYNAMIC INSTABILITY; SPINDLE LENGTH; INDIVIDUAL MICROTUBULES; DEPOLYMERIZING ACTIVITY; CHROMOSOME SEGREGATION; CYTOPLASMIC VOLUME; SELF-ORGANIZATION; MINUS ENDS	The microtubule (MT) cytoskeleton gives cells their shape, organizes the cellular interior, and segregates chromosomes. These functions rely on the precise arrangement of MTs, which is achieved by the coordinated action of MT-associated proteins (MAPs). We highlight the first and most important examples of how different MAP activities are combined in vitro to create an ensemble function that exceeds the simple addition of their individual activities, and how the Xenopus laevis egg extract system has been utilized as a powerful intermediate between cellular and purified systems to uncover the design principles of self-organized MT networks in the cell.	[Alfaro-Aco, Ray; Petry, Sabine] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Petry, S (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	spetry@princeton.edu			National Institutes of Health/NIGMS [4R00GM100013]; Pew Scholars Program in the Biomedical Sciences; Sidney Kimmel Foundation; David and Lucile Packard Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM100013, T32GM007388] Funding Source: NIH RePORTER	National Institutes of Health/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Pew Scholars Program in the Biomedical Sciences; Sidney Kimmel Foundation; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health/NIGMS Grant 4R00GM100013, the Pew Scholars Program in the Biomedical Sciences, the Sidney Kimmel Foundation, and the David and Lucile Packard Foundation (all to S. P.). This is the third article in the Thematic Minireview series "The State of the Cytoskeleton in 2015." The authors declare that they have no conflicts of interest with the contents of this article.	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Allan VJ, 2011, BIOCHEM SOC T, V39, P1169, DOI 10.1042/BST0391169; Alushin GM, 2014, CELL, V157, P1117, DOI 10.1016/j.cell.2014.03.053; Ayaz P, 2014, ELIFE, V3, DOI 10.7554/eLife.03069; Bieling P, 2008, J CELL BIOL, V183, P1223, DOI 10.1083/jcb.200809190; Brouhard GJ, 2008, CELL, V132, P79, DOI 10.1016/j.cell.2007.11.043; Brouhard GJ, 2014, J CELL BIOL, V207, P323, DOI 10.1083/jcb.201407095; Brown KS, 2007, J CELL BIOL, V176, P765, DOI 10.1083/jcb.200610043; Brugues J, 2012, CELL, V149, P554, DOI 10.1016/j.cell.2012.03.027; Burbank KS, 2007, CURR BIOL, V17, P1373, DOI 10.1016/j.cub.2007.07.058; CASSIMERIS L, 1988, J CELL BIOL, V107, P2223, DOI 10.1083/jcb.107.6.2223; Choi YK, 2010, J CELL BIOL, V191, P1089, DOI 10.1083/jcb.201007030; Cooper JR, 2010, NAT STRUCT MOL BIOL, V17, P77, DOI 10.1038/nsmb.1728; Derr ND, 2012, SCIENCE, V338, P662, DOI 10.1126/science.1226734; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Dixit R, 2009, P NATL ACAD SCI USA, V106, P492, DOI 10.1073/pnas.0807614106; Dogterom M, 2013, CURR OPIN CELL BIOL, V25, P23, DOI 10.1016/j.ceb.2012.12.002; Domnitz SB, 2012, J CELL BIOL, V197, P231, DOI 10.1083/jcb.201108147; Duellberg C, 2014, NAT CELL BIOL, V16, P804, DOI 10.1038/ncb2999; EVANS L, 1985, J CELL BIOL, V100, P1185, DOI 10.1083/jcb.100.4.1185; Gardner MK, 2011, CELL, V147, P1092, DOI 10.1016/j.cell.2011.10.037; Gennerich A, 2009, CURR OPIN CELL BIOL, V21, P59, DOI 10.1016/j.ceb.2008.12.002; Good MC, 2013, SCIENCE, V342, P856, DOI 10.1126/science.1243147; Goodwin SS, 2010, CELL, V143, P263, DOI 10.1016/j.cell.2010.09.022; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Gouveia SM, 2010, INT REV CEL MOL BIO, V285, P1, DOI 10.1016/S1937-6448(10)85001-4; Gouveia SM, 2010, CURR BIOL, V20, P1717, DOI 10.1016/j.cub.2010.08.020; Halpin D, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001225; Hara Y, 2013, MOL BIOL CELL, V24, P1411, DOI 10.1091/mbc.E12-07-0528; Hazel J, 2013, SCIENCE, V342, P853, DOI 10.1126/science.1243110; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Helmke KJ, 2014, J CELL BIOL, V206, P385, DOI 10.1083/jcb.201401014; Hendershott MC, 2014, P NATL ACAD SCI USA, V111, P5860, DOI 10.1073/pnas.1404133111; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; HORIO T, 1986, NATURE, V321, P605, DOI 10.1038/321605a0; Howard J, 2007, CURR OPIN CELL BIOL, V19, P31, DOI 10.1016/j.ceb.2006.12.009; Hughes JR, 2008, PLOS BIOL, V6, P785, DOI 10.1371/journal.pbio.0060098; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Ishihara K, 2014, P NATL ACAD SCI USA, V111, P17715, DOI 10.1073/pnas.1418796111; Jiang K, 2014, DEV CELL, V28, P295, DOI 10.1016/j.devcel.2014.01.001; Jiang K, 2009, EMBO REP, V10, P857, DOI 10.1038/embor.2009.94; Kinoshita K, 2001, SCIENCE, V294, P1340, DOI 10.1126/science.1064629; Kline-Smith SL, 2002, MOL BIOL CELL, V13, P2718, DOI 10.1091/mbc.E01-12-0143; Kollman JM, 2011, NAT REV MOL CELL BIO, V12, P709, DOI 10.1038/nrm3209; Kronja I, 2009, MOL BIOL CELL, V20, P2684, DOI 10.1091/mbc.E08-10-1051; Kumar P, 2012, TRENDS CELL BIOL, V22, P418, DOI 10.1016/j.tcb.2012.05.005; Lecland N, 2014, NAT CELL BIOL, V16, P770, DOI 10.1038/ncb2996; Levy DL, 2012, ANNU REV CELL DEV BI, V28, P113, DOI 10.1146/annurev-cellbio-092910-154158; Li WJ, 2012, J CELL BIOL, V199, P849, DOI 10.1083/jcb.201206101; Liu PF, 2014, MOL BIOL CELL, V25, P2017, DOI 10.1091/mbc.E13-06-0339; Loughlin R, 2011, CELL, V147, P1397, DOI 10.1016/j.cell.2011.11.014; Loughlin R, 2010, J CELL BIOL, V191, P1239, DOI 10.1083/jcb.201006076; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Maney T, 2001, J BIOL CHEM, V276, P34753, DOI 10.1074/jbc.M106626200; Markus SM, 2009, CURR BIOL, V19, P196, DOI 10.1016/j.cub.2008.12.047; Maurer SP, 2014, CURR BIOL, V24, P372, DOI 10.1016/j.cub.2013.12.042; McKenney RJ, 2014, SCIENCE, V345, P337, DOI 10.1126/science.1254198; Mennella V, 2005, NAT CELL BIOL, V7, P235, DOI 10.1038/ncb1222; Meunier S, 2011, NAT CELL BIOL, V13, P1406, DOI 10.1038/ncb2372; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Moores CA, 2002, MOL CELL, V9, P903, DOI 10.1016/S1097-2765(02)00503-8; Nedelec F, 2003, CURR OPIN CELL BIOL, V15, P118, DOI 10.1016/S0955-0674(02)00014-5; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Niethammer P, 2007, PLOS BIOL, V5, P190, DOI 10.1371/journal.pbio.0050029; Nogales E, 2006, CURR OPIN STRUC BIOL, V16, P221, DOI 10.1016/j.sbi.2006.03.005; Ohi R, 2003, DEV CELL, V5, P309, DOI 10.1016/S1534-5807(03)00229-6; Ohi R, 2004, MOL BIOL CELL, V15, P2895, DOI 10.1091/mbc.E04-02-0082; Petry S, 2013, CELL, V152, P768, DOI 10.1016/j.cell.2012.12.044; Reber SB, 2013, NAT CELL BIOL, V15, P1116, DOI 10.1038/ncb2834; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Roberts AJ, 2014, ELIFE, V3, DOI 10.7554/eLife.02641; Rogers GC, 2004, NATURE, V427, P364, DOI 10.1038/nature02256; Rogers SL, 2002, J CELL BIOL, V158, P873, DOI 10.1083/jcb.200202032; Rusan NM, 2001, MOL BIOL CELL, V12, P971, DOI 10.1091/mbc.12.4.971; Schlager MA, 2014, EMBO J, V33, P1855, DOI 10.15252/embj.201488792; Slep KC, 2010, CURR OPIN CELL BIOL, V22, P88, DOI 10.1016/j.ceb.2009.10.009; Stout JR, 2011, MOL BIOL CELL, V22, P3070, DOI 10.1091/mbc.E11-04-0363; Subramanian R, 2012, DEV CELL, V23, P874, DOI 10.1016/j.devcel.2012.10.011; Tanenbaum ME, 2011, CURR BIOL, V21, P1356, DOI 10.1016/j.cub.2011.07.017; Teixido-Travesa N, 2010, MOL BIOL CELL, V21, P3963, DOI 10.1091/mbc.E10-05-0408; Tirnauer JS, 1999, J CELL BIOL, V145, P993, DOI 10.1083/jcb.145.5.993; Trokter M, 2012, P NATL ACAD SCI USA, V109, P20895, DOI 10.1073/pnas.1210573110; van der Vaart B, 2012, J NEUROSCI, V32, P14722, DOI 10.1523/JNEUROSCI.1240-12.2012; VERDE F, 1992, J CELL BIOL, V118, P1097, DOI 10.1083/jcb.118.5.1097; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; Welburn JPI, 2013, CYTOSKELETON, V70, P476, DOI 10.1002/cm.21135; Widlund PO, 2011, P NATL ACAD SCI USA, V108, P2741, DOI 10.1073/pnas.1016498108; Wilbur JD, 2013, ELIFE, V2, DOI 10.7554/eLife.00290; Wollman R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.23; Wordeman L, 2005, CURR OPIN CELL BIOL, V17, P82, DOI 10.1016/j.ceb.2004.12.003; Yamada M, 2008, EMBO J, V27, P2471, DOI 10.1038/emboj.2008.182; Young S, 2014, BIOL OPEN, V3, P1217, DOI 10.1242/bio.201410363; Zanic M, 2013, NAT CELL BIOL, V15, P688, DOI 10.1038/ncb2744	97	31	31	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17154	17162		10.1074/jbc.R115.638452	http://dx.doi.org/10.1074/jbc.R115.638452			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	25957410	hybrid, Green Published			2022-12-28	WOS:000357730900012
J	Musrap, N; Tuccitto, A; Karagiannis, GS; Saraon, P; Batruch, I; Diamandis, EP				Musrap, Natasha; Tuccitto, Alessandra; Karagiannis, George S.; Saraon, Punit; Batruch, Ihor; Diamandis, Eleftherios P.			Comparative Proteomics of Ovarian Cancer Aggregate Formation Reveals an Increased Expression of Calcium-activated Chloride Channel Regulator 1 (CLCA1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO MODEL; GENE-EXPRESSION; PROTEIN EXPRESSION; SPHEROID FORMATION; CELLS REVEALS; ASCITES; COMPONENTS; ADHESION; INVASION; CULTURE	Ovarian cancer is a lethal gynecological disease that is characterized by peritoneal metastasis and increased resistance to conventional chemotherapies. This increased resistance and the ability to spread is often attributed to the formation of multicellular aggregates or spheroids in the peritoneal cavity, which seed abdominal surfaces and organs. Given that the presence of metastatic implants is a predictor of poor survival, a better understanding of how spheroids form is critical to improving patient outcome, and may result in the identification of novel therapeutic targets. Thus, we attempted to gain insight into the proteomic changes that occur during anchorage-independent cancer cell aggregation. As such, an ovarian cancer cell line, OV-90, was cultured in adherent and non-adherent conditions using stable isotope labeling with amino acids in cell culture (SILAC). Anchorage-dependent cells (OV-90AD) were grown in tissue culture flasks, whereas anchorage-independent cells (OV-90AI) were grown in suspension using the hanging-drop method. Cellular proteins from both conditions were then identified using LC-MS/MS, which resulted in the quantification of 1533 proteins. Of these, 13 and 6 proteins were up-regulated and downregulated, respectively, in aggregate-forming cells compared with cells grown as monolayers. Relative gene expression and protein expression of candidates were examined in other cell line models of aggregate formation (TOV-112D and ES-2), which revealed an increased expression of calcium-activated chloride channel regulator 1 (CLCA1). Moreover, inhibitor and siRNA transfection studies demonstrated an apparent effect of CLCA1 on cancer cell aggregation. Further elucidation of the role of CLCA1 in the pathogenesis of ovarian cancer is warranted.	[Musrap, Natasha; Tuccitto, Alessandra; Karagiannis, George S.; Saraon, Punit; Diamandis, Eleftherios P.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [Musrap, Natasha; Tuccitto, Alessandra; Karagiannis, George S.; Saraon, Punit; Batruch, Ihor; Diamandis, Eleftherios P.] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5T 3L9, Canada; [Diamandis, Eleftherios P.] Univ Hlth Network, Dept Clin Biochem, Toronto, ON M5G 2C4, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Diamandis, EP (corresponding author), Mt Sinai Hosp, Joseph & Wolf Lebov Ctr, 60 Murray St,Box 32,6th Floor,Rm L6-201, Toronto, ON M5T 3L9, Canada.	ediamandis@mtsinai.on.ca	Saraon, Punit/K-2639-2019	Diamandis, Eleftherios/0000-0002-1589-820X	Canadian Institutes of Health Research (CIHR) Doctoral Research Award	Canadian Institutes of Health Research (CIHR) Doctoral Research Award(Canadian Institutes of Health Research (CIHR))	Recipient of the Canadian Institutes of Health Research (CIHR) Doctoral Research Award.	Bendall SC, 2008, MOL CELL PROTEOMICS, V7, P1587, DOI 10.1074/mcp.M800113-MCP200; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Burleson KM, 2004, CLIN EXP METASTAS, V21, P685, DOI 10.1007/s10585-004-5768-5; Burleson KM, 2004, GYNECOL ONCOL, V93, P170, DOI 10.1016/j.ygyno.2003.12.034; Casey RC, 2001, AM J PATHOL, V159, P2071, DOI 10.1016/S0002-9440(10)63058-1; Condello S, 2015, ONCOGENE, V34, P2297, DOI 10.1038/onc.2014.178; Elschenbroich S, 2011, J PROTEOME RES, V10, P2286, DOI 10.1021/pr1011087; Faca VM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002425; Francia G, 2004, MOL CELL BIOL, V24, P6837, DOI 10.1128/mcb.24.15.6837-6849.2004; Frede J, 2013, EUR J CANCER, V49, P2331, DOI 10.1016/j.ejca.2013.03.016; Gortzak-Uzan L, 2008, J PROTEOME RES, V7, P339, DOI 10.1021/pr0703223; Gruber AD, 1998, GENOMICS, V54, P200, DOI 10.1006/geno.1998.5562; Hegab AE, 2007, CHEST, V131, P1149, DOI 10.1378/chest.06-2031; Iwanicki MP, 2011, CANCER DISCOV, V1, P144, DOI 10.1158/2159-8274.CD-11-0010; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Lee JM, 2013, LAB INVEST, V93, P528, DOI 10.1038/labinvest.2013.41; Leung F, 2013, TRANS PROTEOMICS, V1, P74, DOI DOI 10.1016/J.TRPR0T.2013.08.001; Li M, 2009, INT J GYNECOL CANCER, V19, P526, DOI 10.1111/IGC.0b013e3181a3d6d2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loewen ME, 2005, PHYSIOL REV, V85, P1061, DOI 10.1152/physrev.00016.2004; Musrap N, 2014, J PROTEOMICS, V103, P204, DOI 10.1016/j.jprot.2014.03.042; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Patel AC, 2009, ANNU REV PHYSIOL, V71, P425, DOI 10.1146/annurev.physiol.010908.163253; Pignata S, 2011, CANCER LETT, V303, P73, DOI 10.1016/j.canlet.2011.01.026; Poland J, 2002, ELECTROPHORESIS, V23, P1174, DOI 10.1002/1522-2683(200204)23:7/8<1174::AID-ELPS1174>3.0.CO;2-O; Puiffe ML, 2007, NEOPLASIA, V9, P820, DOI 10.1593/neo.07472; Shender VO, 2014, MOL CELL PROTEOMICS, V13, P3558, DOI 10.1074/mcp.M114.041194; Shield Kristy, 2007, J Carcinog, V6, P11, DOI 10.1186/1477-3163-6-11; Shield K, 2009, GYNECOL ONCOL, V113, P143, DOI 10.1016/j.ygyno.2008.11.032; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sodek KL, 2009, INT J CANCER, V124, P2060, DOI 10.1002/ijc.24188; Usui A, 2014, MOL CANCER RES, V12, P504, DOI 10.1158/1541-7786.MCR-13-0489; Vaughan S, 2011, NAT REV CANCER, V11, P719, DOI 10.1038/nrc3144; Yang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060861; Zhou YH, 2002, NOVART FDN SYMP, V248, P150; Zietarska M, 2007, MOL CARCINOGEN, V46, P872, DOI 10.1002/mc.20315	36	18	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17218	17227		10.1074/jbc.M115.639773	http://dx.doi.org/10.1074/jbc.M115.639773			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26004777	Green Published, hybrid			2022-12-28	WOS:000357730900018
J	Choi, Y; Kwon, MJ; Lim, Y; Yun, JH; Lee, W; Oh, ES				Choi, Youngsil; Kwon, Mi-Jung; Lim, Yangmi; Yun, Ji-Hye; Lee, Weontae; Oh, Eok-Soo			Trans-regulation of Syndecan Functions by Hetero-oligomerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLON-CARCINOMA CELLS; PROTEIN-KINASE-C; GROWTH-FACTOR; TRANSMEMBRANE DOMAINS; CYTOPLASMIC DOMAIN; RECEPTOR; ADHESION; HIERARCHY; FAMILY; HETERODIMERIZATION	Syndecans, a family of transmembrane heparansulfate proteoglycans, are known to interact through their transmembrane domains to form non-covalently linked homodimers, a process essential for their individual functions. Because all syndecan transmembrane domains are highly conserved and thus might mediate interactions between different members of the syndecan family, we investigated syndecan interactions in detail. All recombinant syndecan-2 and -4 protein variants containing the transmembrane domain formed not only sodium dodecyl sulfate (SDS)-resistant homodimers but also SDS-resistant heterodimers. Biochemical and structural data revealed that recombinant syndecan-2 and -4 formed intermolecular interactions in vitro, and the GXXXG motif in transmembrane domain mediated this interaction. When exogenously expressed in rat embryonic fibroblasts, syndecan-2 interacted with syndecan-4 and vice versa. Furthermore, bimolecular fluorescence complementation-based assay demonstrated specific hetero-molecular interactions between syndecan-2 and -4, supporting hetero-oligomer formation of syndecans in vivo. Interestingly, hetero-oligomerization significantly reduced syndecan-4-mediated cellular processes such as protein kinase C alpha activation and protein kinase C alpha-mediated cell adhesion as well as syndecan-2-mediated tumorigenic activities in colon cancer cells such as migration and anchorage-independent growth. Taken together, these data provide evidence that hetero-oligomerization produces distinct syndecan functions and offer insights into the underlying signaling mechanisms of syndecans.	[Choi, Youngsil; Kwon, Mi-Jung; Lim, Yangmi; Oh, Eok-Soo] Ewha Womans Univ, Dept Life Sci, Res Ctr Cellular Homeostasis, Seoul 120750, South Korea; [Yun, Ji-Hye; Lee, Weontae] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 120749, South Korea	Ewha Womans University; Yonsei University	Oh, ES (corresponding author), Ewha Womans Univ, Dept Life Sci, Seoul 120750, South Korea.	OhES@ewha.ac.kr	LEE, WEON TAE/AAQ-9088-2021	Lee, Weontae/0000-0003-2347-1262	National Research Foundation of Korea - Korea government (MSIP) [2012R1A5A1048236, 2013R1A2A2A01013565]	National Research Foundation of Korea - Korea government (MSIP)	This work was supported by the National Research Foundation of Korea, funded by Korea government (MSIP) Grants 2012R1A5A1048236 and 2013R1A2A2A01013565. The authors declare that they have no conflicts of interest with the contents of this article.	ASUNDI VK, 1995, J BIOL CHEM, V270, P26404, DOI 10.1074/jbc.270.44.26404; Carey DJ, 1997, BIOCHEM J, V327, P1; Choi S, 2005, J BIOL CHEM, V280, P42573, DOI 10.1074/jbc.M509238200; Choi Y, 2012, CELL SIGNAL, V24, P1522, DOI 10.1016/j.cellsig.2012.03.020; Choi Y, 2010, BIOCHEM BIOPH RES CO, V391, P921, DOI 10.1016/j.bbrc.2009.11.165; CizmeciSmith G, 1997, ARTERIOSCL THROM VAS, V17, P172, DOI 10.1161/01.ATV.17.1.172; Cohen BM, 1996, J BIOL CHEM, V271, P4813; DeMali KA, 1999, J BIOL CHEM, V274, P19551, DOI 10.1074/jbc.274.28.19551; Dews IC, 2007, P NATL ACAD SCI USA, V104, P20782, DOI 10.1073/pnas.0708909105; Dovas A, 2010, J BIOL CHEM, V285, P23294, DOI 10.1074/jbc.M109.098129; Duneau JP, 2007, BIOCHEMISTRY-US, V46, P2010, DOI 10.1021/bi061436f; Fears CY, 2006, MATRIX BIOL, V25, P443, DOI 10.1016/j.matbio.2006.07.003; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; Han I, 2004, J MOL HISTOL, V35, P319; Hecker TP, 2002, CANCER RES, V62, P2699; Horowitz A, 1998, J BIOL CHEM, V273, P10914, DOI 10.1074/jbc.273.18.10914; KIM CW, 1994, MOL BIOL CELL, V5, P797, DOI 10.1091/mbc.5.7.797; Lambaerts K, 2009, CURR OPIN CELL BIOL, V21, P662, DOI 10.1016/j.ceb.2009.05.002; Lee H, 2011, BIOCHEM BIOPH RES CO, V409, P148, DOI 10.1016/j.bbrc.2011.04.135; Oh ES, 1997, J BIOL CHEM, V272, P11805, DOI 10.1074/jbc.272.18.11805; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Park H, 2002, J BIOL CHEM, V277, P29730, DOI 10.1074/jbc.M202435200; Rapraeger AC, 1998, CURR OPIN CELL BIOL, V10, P620, DOI 10.1016/S0955-0674(98)80038-0; Rapraeger AC, 2000, J CELL BIOL, V149, P995, DOI 10.1083/jcb.149.5.995; Saoncella S, 1999, P NATL ACAD SCI USA, V96, P2805, DOI 10.1073/pnas.96.6.2805; Schlesinger TK, 1999, BIOCHEM J, V344, P519, DOI 10.1042/0264-6021:3440519; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8; Woods A, 2001, CURR OPIN CELL BIOL, V13, P578, DOI 10.1016/S0955-0674(00)00254-4	30	16	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16943	16953		10.1074/jbc.M114.611798	http://dx.doi.org/10.1074/jbc.M114.611798			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25979339	Green Published, hybrid			2022-12-28	WOS:000357572800038
J	Kim, SW; Hasanuzzaman, M; Cho, M; Heo, YR; Ryu, MJ; Ha, NY; Park, HJ; Park, HY; Shin, JG				Kim, So Won; Hasanuzzaman, Md.; Cho, Munju; Heo, Ye Rang; Ryu, Min-Jung; Ha, Na-Young; Park, Hyun June; Park, Hyung-Yeon; Shin, Jae-Gook			Casein Kinase 2 (CK2)-mediated Phosphorylation of Hsp90 beta as a Novel Mechanism of Rifampin-induced MDR1 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-GLYCOPROTEIN; NUCLEAR RECEPTORS; GENE-EXPRESSION; PROTEIN; CK2; CANCER; RESISTANCE; PXR; LOCALIZATION; APOPTOSIS	The P-glycoprotein (P-gp) encoded by the MDR1 gene is a drug-exporting transporter located in the cellular membrane. P-gp induction is regarded as one of the main mechanisms underlying drug-induced resistance. Although there is great interest in the regulation of P-gp expression, little is known about its underlying regulatory mechanisms. In this study, we demonstrate that casein kinase 2 (CK2)-mediated phosphorylation of heat shock protein 90 beta (Hsp90 beta) and subsequent stabilization of PXR is a key mechanism in the regulation of MDR1 expression. Furthermore, we show that CK2 is directly activated by rifampin. Upon exposure to rifampin, CK2 catalyzes the phosphorylation of Hsp90 beta at the Ser-225/254 residues. Phosphorylated Hsp90 beta then interacts with PXR, causing a subsequent increase in its stability, leading to the induction of P-gp expression. In addition, inhibition of CK2 and Hsp90 beta enhances the down-regulation of PXR and P-gp expression. The results of this study may facilitate the development of new strategies to prevent multidrug resistance and provide a plausible mechanism for acquired drug resistance by CK2-mediated regulation of P-gp expression.	[Kim, So Won] Catholic Kwandong Univ, Dept Pharmacol, Coll Med, Kangnung 210701, South Korea; [Kim, So Won] Catholic Kwandong Univ, Inst Clin & Translat Res, Coll Med, Kangnung 210701, South Korea; [Kim, So Won; Hasanuzzaman, Md.; Cho, Munju; Heo, Ye Rang; Ryu, Min-Jung; Ha, Na-Young; Shin, Jae-Gook] Inje Univ, Coll Med, Dept Pharmacol, Busan 614735, South Korea; [Kim, So Won; Hasanuzzaman, Md.; Cho, Munju; Heo, Ye Rang; Ryu, Min-Jung; Ha, Na-Young; Shin, Jae-Gook] Inje Univ, Coll Med, PharmacoGen Res Ctr, Busan 614735, South Korea; [Kim, So Won; Shin, Jae-Gook] Inje Univ, Busan Paik Hosp, Dept Clin Pharmacol, Busan 614735, South Korea; [Park, Hyun June] Seoul Natl Univ, BioMAX Inst, Seoul 151742, South Korea; [Park, Hyung-Yeon] Noroo Holdings Co Ltd, Agr & Biotechnol Dept, Seoul 135983, South Korea	Catholic Kwandong University; Catholic Kwandong University; Inje University; Inje University; Inje University; Seoul National University (SNU)	Shin, JG (corresponding author), Inje Univ, Busan Paik Hosp, Pharmacogen Res Ctr, Coll Med,Clin Trial Ctr, Busan 633165, South Korea.	phshinjg@gmail.com			National Research Foundation of Korea (NRF) - Korean government (MSIP) [R13-2007-023-00000-0]; Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [HI14C0067]	National Research Foundation of Korea (NRF) - Korean government (MSIP); Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This work was supported by National Research Foundation of Korea (NRF) Grant R13-2007-023-00000-0 funded by the Korean government (MSIP) and Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea, Grant HI14C0067. The authors declare that they have no conflicts of interest with the contents of this article.	Ahmed K, 2002, TRENDS CELL BIOL, V12, P226, DOI 10.1016/S0962-8924(02)02279-1; Akten B, 2009, J NEUROSCI, V29, P466, DOI 10.1523/JNEUROSCI.4034-08.2009; Baciewicz AM, 2013, CURR MED RES OPIN, V29, P1, DOI 10.1185/03007995.2012.747952; Battistutta R, 2000, J BIOL CHEM, V275, P29618, DOI 10.1074/jbc.M004257200; Baysarowich J, 2008, P NATL ACAD SCI USA, V105, P4886, DOI 10.1073/pnas.0711939105; Blumberg B, 1998, GENE DEV, V12, P3195, DOI 10.1101/gad.12.20.3195; Cowen LE, 2006, EUKARYOT CELL, V5, P2184, DOI 10.1128/EC.00274-06; Enkvist E, 2012, ORG BIOMOL CHEM, V10, P8645, DOI 10.1039/c2ob26022k; Feng S, 2007, PROTEOMICS, V7, P351, DOI 10.1002/pmic.200600045; GANT TW, 1992, NUCLEIC ACIDS RES, V20, P2841, DOI 10.1093/nar/20.11.2841; Geick A, 2001, J BIOL CHEM, V276, P14581, DOI 10.1074/jbc.M010173200; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Greiner B, 1999, J CLIN INVEST, V104, P147, DOI 10.1172/JCI6663; Guo CH, 2001, J BIOL CHEM, V276, P5992, DOI 10.1074/jbc.M004862200; Heriche JK, 1998, ONCOGENE, V17, P13, DOI 10.1038/sj.onc.1201900; Huang H, 2007, ONCOGENE, V26, P258, DOI 10.1038/sj.onc.1209788; Kakizaki S, 2011, FRONT BIOSCI-LANDMRK, V16, P2988, DOI 10.2741/3893; Labialle S, 2002, BIOCHEM PHARMACOL, V64, P943, DOI 10.1016/S0006-2952(02)01156-5; Landesman-Bollag E, 2001, ONCOGENE, V20, P3247, DOI 10.1038/sj.onc.1204411; Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703; Lu XY, 2012, BIOCHEM PHARMACOL, V83, P995, DOI 10.1016/j.bcp.2011.11.011; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Miyata Y, 2009, CELL MOL LIFE SCI, V66, P1840, DOI 10.1007/s00018-009-9152-0; MIYATA Y, 1992, J BIOL CHEM, V267, P7042; Niemi M, 2003, CLIN PHARMACOKINET, V42, P819, DOI 10.2165/00003088-200342090-00003; Persidis A, 1999, NAT BIOTECHNOL, V17, P94, DOI 10.1038/5289; Pinna L A, 1997, Prog Cell Cycle Res, V3, P77; Pinna LA, 2002, J CELL SCI, V115, P3873, DOI 10.1242/jcs.00074; Pinna LA, 2012, PROTEIN KINASE CK2; Proia DA, 2012, INVEST NEW DRUG, V30, P2201, DOI 10.1007/s10637-011-9790-6; Schuetz EG, 1996, MOL PHARMACOL, V49, P311; Scotto KW, 2003, ONCOGENE, V22, P7496, DOI 10.1038/sj.onc.1206950; SELDIN DC, 1995, SCIENCE, V267, P894, DOI 10.1126/science.7846532; Squires EJ, 2004, J BIOL CHEM, V279, P49307, DOI 10.1074/jbc.M407281200; Stolarczyk EI, 2012, MOL PHARMACOL, V82, P488, DOI 10.1124/mol.112.078295; Watkins RE, 2001, SCIENCE, V292, P2329, DOI 10.1126/science.1060762; Yamane K, 2005, CANCER RES, V65, P4362, DOI 10.1158/0008-5472.CAN-04-3941	37	21	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					17029	17040		10.1074/jbc.M114.624106	http://dx.doi.org/10.1074/jbc.M114.624106			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25995454	hybrid, Green Published			2022-12-28	WOS:000357572800045
J	Reuven, N; Adler, J; Porat, Z; Polonio-Vallon, T; Hofmann, TG; Shaul, Y				Reuven, Nina; Adler, Julia; Porat, Ziv; Polonio-Vallon, Tilman; Hofmann, Thomas G.; Shaul, Yosef			The Tyrosine Kinase c-Abl Promotes Homeodomain-interacting Protein Kinase 2 (HIPK2) Accumulation and Activation in Response to DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOTIC RESPONSE; REGULATES P73; TISSUE-GROWTH; P53 ACTIVITY; DEGRADATION; PATHWAY; PHOSPHORYLATION; PROTEIN-KINASE-2; PML; ATM	The non-receptor tyrosine kinase c-Abl is activated in response to DNA damage and induces p73-dependent apoptosis. Here, we investigated c-Abl regulation of the homeodomain-interacting protein kinase 2 (HIPK2), an important regulator of p53-dependent apoptosis. c-Abl phosphorylated HIPK2 at several sites, and phosphorylation by c-Abl protected HIPK2 from degradation mediated by the ubiquitin E3 ligase Siah-1. c-Abl and HIPK2 synergized in activating p53 on apoptotic promoters in a reporter assay, and c-Abl was required for endogenous HIPK2 accumulation and phosphorylation of p53 at Ser(46) in response to DNA damage by gamma-and UV radiation. Accumulation of HIPK2 in nuclear speckles and association with promyelocytic leukemia protein (PML) in response to DNA damage were also dependent on c-Abl activity. At high cell density, the Hippo pathway inhibits DNA damage-induced c-Abl activation. Under this condition, DNA damage-induced HIPK2 accumulation, phosphorylation of p53 at Ser(46), and apoptosis were attenuated. These data demonstrate a new mechanism for the induction of DNA damage-induced apoptosis by c-Abl and illustrate network interactions between serine/threonine and tyrosine kinases that dictate cell fate.	[Reuven, Nina; Adler, Julia; Shaul, Yosef] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Porat, Ziv] Weizmann Inst Sci, Biol Serv Unit, IL-76100 Rehovot, Israel; [Polonio-Vallon, Tilman; Hofmann, Thomas G.] DKFZ ZMBH Alliance, Deutsch Krebsforschungszentrum DKFZ, Cell & Tumor Biol Program, Cellular Senescence Grp, D-69120 Heidelberg, Germany	Weizmann Institute of Science; Weizmann Institute of Science; Helmholtz Association; German Cancer Research Center (DKFZ)	Shaul, Y (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	yosef.shaul@weizmann.ac.il	Porat, Ziv/K-1672-2012; Reuven, Nina/AAM-8711-2020	Porat, Ziv/0000-0003-3059-181X; Reuven, Nina/0000-0003-1569-3818	Israel Science Foundation [551/11]; Israel Cancer Research Fund; Cooperation Program in Cancer Research of the Deutsches Krebsforschungszentrum (DKFZ); Israel's Ministry of Science and Technology (MOST); Minerva Foundation; Federal German Ministry for Education and Research; Deutsche Forschungsgemeinschaft (DFG) [SFB 1036]	Israel Science Foundation(Israel Science Foundation); Israel Cancer Research Fund; Cooperation Program in Cancer Research of the Deutsches Krebsforschungszentrum (DKFZ); Israel's Ministry of Science and Technology (MOST); Minerva Foundation; Federal German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by grants from the Israel Science Foundation (Grant 551/11), the Israel Cancer Research Fund, the Cooperation Program in Cancer Research of the Deutsches Krebsforschungszentrum (DKFZ) and Israel's Ministry of Science and Technology (MOST), and the Minerva Foundation with funding from the Federal German Ministry for Education and Research. This work was also supported by the SFB 1036 from the Deutsche Forschungsgemeinschaft (DFG) (to T.G.H.).	Agami R, 1999, NATURE, V399, P809; Bar J, 2004, ONCOGENE, V23, P2128, DOI 10.1038/sj.onc.1207325; Ben-Yehoyada M, 2003, J BIOL CHEM, V278, P34475, DOI 10.1074/jbc.M301051200; Buchdunger E, 2000, J PHARMACOL EXP THER, V295, P139; Calzado MA, 2009, NAT CELL BIOL, V11, P85, DOI 10.1038/ncb1816; Chen J, 2012, CURR BIOL, V22, P1582, DOI 10.1016/j.cub.2012.06.074; Choi DW, 2008, J BIOL CHEM, V283, P4682, DOI 10.1074/jbc.M708873200; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Dauth I, 2007, CANCER RES, V67, P2274, DOI 10.1158/0008-5472.CAN-06-2884; Feng LJ, 2006, CELL CYCLE, V5, P2812, DOI 10.4161/cc.5.23.3526; Gong JG, 1999, NATURE, V399, P806; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hobbs S, 1998, BIOCHEM BIOPH RES CO, V252, P368, DOI 10.1006/bbrc.1998.9646; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Kharbanda S, 1998, ONCOGENE, V17, P3309, DOI 10.1038/sj.onc.1202571; Levy D, 2007, CELL DEATH DIFFER, V14, P743, DOI 10.1038/sj.cdd.4402063; Levy D, 2008, J BIOL CHEM, V283, P27462, DOI 10.1074/jbc.M803941200; Levy D, 2008, MOL CELL, V29, P350, DOI 10.1016/j.molcel.2007.12.022; Mancini F, 2009, EMBO J, V28, P1926, DOI 10.1038/emboj.2009.154; Mantovani F, 2007, NAT STRUCT MOL BIOL, V14, P912, DOI 10.1038/nsmb1306; Moller A, 2003, CANCER RES, V63, P4310; Okada N, 2011, J CELL SCI, V124, P57, DOI 10.1242/jcs.072918; Ortyn WE, 2007, CYTOM PART A, V71A, P215, DOI 10.1002/cyto.a.20370; Poon CLC, 2012, CURR BIOL, V22, P1587, DOI 10.1016/j.cub.2012.06.075; Puca R, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-85; Raina D, 2008, CANCER BIOL THER, V7, P1959, DOI 10.4161/cbt.7.12.6956; Reuven N, 2013, CELL DEATH DIFFER, V20, P1330, DOI 10.1038/cdd.2013.83; Rinaldo C, 2007, MOL CELL, V25, P739, DOI 10.1016/j.molcel.2007.02.008; Saul VV, 2013, J MOL CELL BIOL, V5, P27, DOI 10.1093/jmcb/mjs053; Shima Y, 2008, MOL CELL BIOL, V28, P7126, DOI 10.1128/MCB.00897-08; Smeenk L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017574; Sorrentino G, 2013, CELL DEATH DIFFER, V20, P198, DOI 10.1038/cdd.2012.112; Wang X, 2011, CELL DEATH DIFFER, V18, P5, DOI 10.1038/cdd.2010.106; Weidtkamp-Peters S, 2008, J CELL SCI, V121, P2731, DOI 10.1242/jcs.031922; Winter M, 2008, NAT CELL BIOL, V10, P812, DOI 10.1038/ncb1743; Yuan ZM, 1999, NATURE, V399, P814, DOI 10.1038/21704; Zuckerman V, 2009, J BIOL CHEM, V284, P4031, DOI 10.1074/jbc.M809211200	37	18	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16478	16488		10.1074/jbc.M114.628982	http://dx.doi.org/10.1074/jbc.M114.628982			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25944899	Green Published, hybrid			2022-12-28	WOS:000357572800002
J	Chatterjee, D; Kudlinzki, D; Linhard, V; Saxena, K; Schieborr, U; Gande, SL; Wurm, JP; Wohnert, J; Abele, R; Rogov, VV; Dotsch, V; Osiewacz, HD; Sreeramulu, S; Schwalbe, H				Chatterjee, Deep; Kudlinzki, Denis; Linhard, Verena; Saxena, Krishna; Schieborr, Ulrich; Gande, Santosh L.; Wurm, Jan Philip; Woehnert, Jens; Abele, Rupert; Rogov, Vladimir V.; Doetsch, Volker; Osiewacz, Heinz D.; Sreeramulu, Sridhar; Schwalbe, Harald			Structure and Biophysical Characterization of the S-Adenosylmethionine-dependent O-Methyltransferase PaMTH1, a Putative Enzyme Accumulating during Senescence of Podospora anserina	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aging; cancer; nuclear magnetic resonance (NMR); reactive oxygen species (ROS); x-ray crystallography; PaMTH1; Podospora anserina; methyltransferase; myricetin	STRUCTURE REFINEMENT; FLAVONOIDS; MECHANISMS; INHIBITION; ANTIOXIDANT; PHENIX; 5-LIPOXYGENASE; PEROXIDATION; METHYLATION; SENSITIVITY	Background: PaMTH1, a putative O-methyltransferase protects Podospora anserina from oxidative stress during senescence and acts as a longevity assurance factor. Results: Crystal structures of PaMTH1/PaMTH1-SAM/SAH co-complexes and NMR-based characterization of enzymatic methylation of its substrate were obtained. Conclusion: PaMTH1 catalyzes methyl group transfer from the co-factor to the substrate in a cation-dependent manner. Significance: This work facilitates the identification of endogenous polyphenolic compounds directly involved in metal-induced oxidative stress. Low levels of reactive oxygen species (ROS) act as important signaling molecules, but in excess they can damage biomolecules. ROS regulation is therefore of key importance. Several polyphenols in general and flavonoids in particular have the potential to generate hydroxyl radicals, the most hazardous among all ROS. However, the generation of a hydroxyl radical and subsequent ROS formation can be prevented by methylation of the hydroxyl group of the flavonoids. O-Methylation is performed by O-methyltransferases, members of the S-adenosyl-l-methionine (SAM)-dependent O-methyltransferase superfamily involved in the secondary metabolism of many species across all kingdoms. In the filamentous fungus Podospora anserina, a well established aging model, the O-methyltransferase (PaMTH1) was reported to accumulate in total and mitochondrial protein extracts during aging. In vitro functional studies revealed flavonoids and in particular myricetin as its potential substrate. The molecular architecture of PaMTH1 and the mechanism of the methyl transfer reaction remain unknown. Here, we report the crystal structures of PaMTH1 apoenzyme, PaMTH1-SAM (co-factor), and PaMTH1-S-adenosyl homocysteine (by-product) co-complexes refined to 2.0, 1.9, and 1.9 angstrom, respectively. PaMTH1 forms a tight dimer through swapping of the N termini. Each monomer adopts the Rossmann fold typical for many SAM-binding methyltransferases. Structural comparisons between different O-methyltransferases reveal a strikingly similar co-factor binding pocket but differences in the substrate binding pocket, indicating specific molecular determinants required for substrate selection. Furthermore, using NMR, mass spectrometry, and site-directed active site mutagenesis, we show that PaMTH1 catalyzes the transfer of the methyl group from SAM to one hydroxyl group of the myricetin in a cation-dependent manner.	[Chatterjee, Deep; Kudlinzki, Denis; Linhard, Verena; Saxena, Krishna; Schieborr, Ulrich; Gande, Santosh L.; Sreeramulu, Sridhar; Schwalbe, Harald] Goethe Univ Frankfurt, Inst Organ Chem & Chem Biol, D-60438 Frankfurt, Germany; [Chatterjee, Deep; Kudlinzki, Denis; Linhard, Verena; Saxena, Krishna; Schieborr, Ulrich; Gande, Santosh L.; Wurm, Jan Philip; Woehnert, Jens; Rogov, Vladimir V.; Doetsch, Volker; Sreeramulu, Sridhar; Schwalbe, Harald] Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance BMRZ, D-60438 Frankfurt, Germany; [Wurm, Jan Philip; Woehnert, Jens; Osiewacz, Heinz D.] Goethe Univ Frankfurt, Inst Mol Biosci, D-60438 Frankfurt, Germany; [Abele, Rupert] Goethe Univ Frankfurt, Bioctr, Inst Biochem, D-60438 Frankfurt, Germany; [Rogov, Vladimir V.; Doetsch, Volker] Goethe Univ Frankfurt, Inst Biophys Chem, D-60438 Frankfurt, Germany; [Kudlinzki, Denis; Saxena, Krishna; Schieborr, Ulrich; Gande, Santosh L.; Schwalbe, Harald] German Canc Consortium DKTK, D-69210 Heidelberg, Germany; [Kudlinzki, Denis; Saxena, Krishna; Schieborr, Ulrich; Gande, Santosh L.; Schwalbe, Harald] German Canc Res Ctr, D-69210 Heidelberg, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Sreeramulu, S (corresponding author), Goethe Univ Frankfurt, Inst Organ Chem & Chem Biol, Ctr Biomol Magnet Resonance BMRZ, Max von Laue Str 7, D-60438 Frankfurt, Germany.	sridhar@nmr.uni-frankfurt.de	Schwalbe, Harald/AAB-3143-2020; Schwalbe, Harald J/F-9023-2010	Schwalbe, Harald/0000-0001-5693-7909; Schwalbe, Harald J/0000-0001-5693-7909; Dotsch, Volker/0000-0001-5720-212X; Linhard, Verena/0000-0002-0278-9792; Osiewacz, Heinz D./0000-0002-0360-6994	Deutsche Forschungsgemeinschaft (DFG) in Collaborative Research Center 807; Cluster of Excellence: Macromolecular Complexes (Deutsche Forschungsgemeinschaft); state of Hesse	Deutsche Forschungsgemeinschaft (DFG) in Collaborative Research Center 807(German Research Foundation (DFG)); Cluster of Excellence: Macromolecular Complexes (Deutsche Forschungsgemeinschaft); state of Hesse	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) in Collaborative Research Center 807 and by the Cluster of Excellence: Macromolecular Complexes (Deutsche Forschungsgemeinschaft). The center for Biomolecular magnetic resonance (BMRZ) is supported by the state of Hesse. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Agullo G, 1997, BIOCHEM PHARMACOL, V53, P1649, DOI 10.1016/S0006-2952(97)82453-7; Averbeck NB, 2000, CURR GENET, V37, P200, DOI 10.1007/s002940050520; Bakir T, 2014, INT J FOOD SCI NUTR, V65, P226, DOI 10.3109/09637486.2013.845654; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Cao GH, 1997, FREE RADICAL BIO MED, V22, P749, DOI 10.1016/S0891-5849(96)00351-6; Cho JH, 2008, J MOL BIOL, V382, P987, DOI 10.1016/j.jmb.2008.07.080; Cook CI, 1998, MECH AGEING DEV, V102, P1, DOI 10.1016/S0047-6374(98)00005-0; de Magalhaes JP, 2013, NAT REV CANCER, V13, P357, DOI 10.1038/nrc3497; Decker H, 2011, OXYGEN AND THE EVOLUTION OF LIFE, P43, DOI 10.1007/978-3-642-13179-0_3; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Ehler A, 2014, ACTA CRYSTALLOGR D, V70, P2163, DOI 10.1107/S1399004714012917; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferrer JL, 2005, PLANT PHYSIOL, V137, P1009, DOI 10.1104/pp.104.048751; Garibotto G, 2009, KIDNEY INT, V76, P293, DOI 10.1038/ki.2009.117; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hou XW, 2007, J STRUCT BIOL, V159, P523, DOI 10.1016/j.jsb.2007.04.007; HOULT JRS, 1994, METHOD ENZYMOL, V234, P443; Jungbluth G, 2000, J CHEM SOC PERK T 2, P1946, DOI 10.1039/b002323j; Knab B, 2010, CELL CYCLE, V9, P3387, DOI 10.4161/cc.9.17.13016; Kopycki JG, 2008, J MOL BIOL, V378, P154, DOI 10.1016/j.jmb.2008.02.019; Kopycki JG, 2008, J BIOL CHEM, V283, P20888, DOI 10.1074/jbc.M801943200; Kozbial PZ, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-19; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krug M, 2012, J APPL CRYSTALLOGR, V45, P568, DOI 10.1107/S0021889812011715; Kunstmann B, 2008, AGING CELL, V7, P651, DOI 10.1111/j.1474-9726.2008.00412.x; Kunstmann B, 2009, AGING-US, V1, P328, DOI 10.18632/aging.100029; LAUGHTON MJ, 1991, BIOCHEM PHARMACOL, V42, P1673, DOI 10.1016/0006-2952(91)90501-U; Lee JH, 2010, P NATL ACAD SCI USA, V107, P17557, DOI 10.1073/pnas.1006848107; Liscombe DK, 2012, NAT PROD REP, V29, P1238, DOI 10.1039/c2np20029e; Lolli G, 2012, BIOCHEMISTRY-US, V51, P6097, DOI 10.1021/bi300531c; Martin JL, 2002, CURR OPIN STRUC BIOL, V12, P783, DOI 10.1016/S0959-440X(02)00391-3; MCCORD JM, 1985, NEW ENGL J MED, V312, P159; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; MORONEY MA, 1988, J PHARM PHARMACOL, V40, P787, DOI 10.1111/j.2042-7158.1988.tb05173.x; Mueller U, 2012, J SYNCHROTRON RADIAT, V19, P442, DOI 10.1107/S0909049512006395; Orhan H, 2006, TOXICOL IN VITRO, V20, P1005, DOI 10.1016/j.tiv.2005.12.012; Ottink OM, 2010, ANAL BIOCHEM, V396, P280, DOI 10.1016/j.ab.2009.09.013; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; Rietjens IMCM, 2005, MUTAT RES-FUND MOL M, V574, P124, DOI 10.1016/j.mrfmmm.2005.01.028; Scheckhuber CQ, 2008, MOL GENET GENOMICS, V280, P365, DOI 10.1007/s00438-008-0378-6; Schmalhausen EV, 2007, FOOD CHEM TOXICOL, V45, P1988, DOI 10.1016/j.fct.2007.04.015; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Serrano M, 2007, NAT REV MOL CELL BIO, V8, P715, DOI 10.1038/nrm2242; Singh S, 2008, J BIOL CHEM, V283, P22628, DOI 10.1074/jbc.M800503200; SLATER TF, 1984, BIOCHEM J, V222, P1; Stadtman ER, 2004, CURR MED CHEM, V11, P1105, DOI 10.2174/0929867043365341; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; WILLKER W, 1993, MAGN RESON CHEM, V31, P287, DOI 10.1002/mrc.1260310315; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zatta P, 2008, J CHEM NEUROANAT, V36, P1, DOI 10.1016/j.jchemneu.2008.02.008; ZHU BT, 1994, J BIOL CHEM, V269, P292; Zubieta C, 2001, NAT STRUCT BIOL, V8, P271, DOI 10.1038/85029	64	14	16	1	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16415	16430		10.1074/jbc.M115.660829	http://dx.doi.org/10.1074/jbc.M115.660829			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25979334	Green Published, hybrid			2022-12-28	WOS:000356930100042
J	Fonseca, BD; Zakaria, C; Jia, JJ; Graber, TE; Svitkin, Y; Tahmasebi, S; Healy, D; Hoang, HD; Jensen, JM; Diao, IT; Lussier, A; Dajadian, C; Padmanabhan, N; Wang, W; Matta-Camacho, E; Hearnden, J; Smith, EM; Tsukumo, Y; Yanagiya, A; Morita, M; Petroulakis, E; Gonzalez, JL; Hernandez, G; Alain, T; Damgaard, CK				Fonseca, Bruno D.; Zakaria, Chadi; Jia, Jian-Jun; Graber, Tyson E.; Svitkin, Yuri; Tahmasebi, Soroush; Healy, Danielle; Hoang, Huy-Dung; Jensen, Jacob M.; Diao, Ilo T.; Lussier, Alexandre; Dajadian, Christopher; Padmanabhan, Niranjan; Wang, Walter; Matta-Camacho, Edna; Hearnden, Jaclyn; Smith, Ewan M.; Tsukumo, Yoshinori; Yanagiya, Akiko; Morita, Masahiro; Petroulakis, Emmanuel; Gonzalez, Jose L.; Hernandez, Greco; Alain, Tommy; Damgaard, Christian K.			La-related Protein 1 (LARP1) Represses Terminal Oligopyrimidine (TOP) mRNA Translation Downstream of mTOR Complex 1 (mTORC1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene expression; mammalian target of rapamycin (mTOR); protein synthesis; repressor protein; translation; 5'-terminal oligopyrimidine (5'TOP) motif; La-related protein 1 (LARP1); TOP mRNA translation; mTOR complex 1 (mTORC1); ribosome biogenesis	SENSITIVE PHOSPHOPROTEOME REVEALS; NUTRIENT-SENSING MECHANISMS; RICH AKT SUBSTRATE; 40 KDA PRAS40; MAMMALIAN TARGET; BINDING-PROTEIN; PYRIMIDINE SYNTHESIS; S6 KINASE; 5 UTR; RAPAMYCIN	Background: mTORC1 plays an important role in the regulation of TOP mRNA translation. Results: LARP1 is a target of mTORC1 that associates with TOP mRNAs via their 5TOP motif to repress their translation. Conclusion: LARP1 represses TOP mRNA translation downstream of mTORC1. Significance: We elucidate an important novel signaling pathway downstream of mTORC1 that controls the production of ribosomes and translation factors in eukaryotic cells. The mammalian target of rapamycin complex 1 (mTORC1) is a critical regulator of protein synthesis. The best studied targets of mTORC1 in translation are the eukaryotic initiation factor-binding protein 1 (4E-BP1) and ribosomal protein S6 kinase 1 (S6K1). In this study, we identify the La-related protein 1 (LARP1) as a key novel target of mTORC1 with a fundamental role in terminal oligopyrimidine (TOP) mRNA translation. Recent genome-wide studies indicate that TOP and TOP-like mRNAs compose a large portion of the mTORC1 translatome, but the mechanism by which mTORC1 controls TOP mRNA translation is incompletely understood. Here, we report that LARP1 functions as a key repressor of TOP mRNA translation downstream of mTORC1. Our data show the following: (i) LARP1 associates with mTORC1 via RAPTOR; (ii) LARP1 interacts with TOP mRNAs in an mTORC1-dependent manner; (iii) LARP1 binds the 5TOP motif to repress TOP mRNA translation; and (iv) LARP1 competes with the eukaryotic initiation factor (eIF) 4G for TOP mRNA binding. Importantly, from a drug resistance standpoint, our data also show that reducing LARP1 protein levels by RNA interference attenuates the inhibitory effect of rapamycin, Torin1, and amino acid deprivation on TOP mRNA translation. Collectively, our findings demonstrate that LARP1 functions as an important repressor of TOP mRNA translation downstream of mTORC1.	[Fonseca, Bruno D.; Jia, Jian-Jun; Graber, Tyson E.; Healy, Danielle; Hoang, Huy-Dung; Alain, Tommy] Univ Ottawa, Childrens Hosp Eastern Ontario Res Inst, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8L1, Canada; [Zakaria, Chadi; Graber, Tyson E.; Svitkin, Yuri; Tahmasebi, Soroush; Lussier, Alexandre; Dajadian, Christopher; Padmanabhan, Niranjan; Wang, Walter; Matta-Camacho, Edna; Hearnden, Jaclyn; Tsukumo, Yoshinori; Yanagiya, Akiko; Morita, Masahiro; Petroulakis, Emmanuel] McGill Univ, Dept Biochem, Rosalind & Morris Goodman Canc Ctr, Montreal, PQ H3A 1A3, Canada; [Jensen, Jacob M.; Diao, Ilo T.; Damgaard, Christian K.] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark; [Smith, Ewan M.] MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England; [Petroulakis, Emmanuel] Pfizer Canada Inc, Kirkland, PQ H9J 2M5, Canada; [Gonzalez, Jose L.; Hernandez, Greco] Natl Canc Inst, Div Basic Sci, Mexico City 14080, DF, Mexico	University of Ottawa; Children's Hospital of Eastern Ontario; McGill University; Aarhus University; University of Leicester; Pfizer	Fonseca, BD (corresponding author), Univ Ottawa, Childrens Hosp Eastern Ontario Res Inst, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8L1, Canada.	brunodfonseca@gmail.com; tommy@arc.cheo.ca; ckd@mbg.au.dk	Damgaard, Christian/AAR-4075-2020; Hoang, Huy-Dung/HDO-6126-2022; Graber, Tyson/K-9385-2019; Morita, Masahiro/ABC-1150-2020; Damgaard, Christian/AAP-3147-2021; Damgaard, Christian K/G-7360-2015	Graber, Tyson/0000-0002-5337-3404; Damgaard, Christian/0000-0003-4940-0868; Lussier, Alexandre/0000-0002-1179-0621; Hoang, Huy-Dung/0000-0001-8793-1673; Gonzalez Montoya, Jose Luis/0000-0002-1807-9410; Smith, Ewan/0000-0002-3992-3748; Yanagiya, Akiko/0000-0002-5553-0311; Svitkin, Yuri/0000-0003-3819-2143; Morita, Masahiro/0000-0002-8627-084X	United States Department of Defense prostate cancer research fellow grant award; Novo Nordisk Fonden [NNF13OC0007719] Funding Source: researchfish	United States Department of Defense prostate cancer research fellow grant award(United States Department of Defense); Novo Nordisk Fonden(Novo Nordisk Foundation)	Supported by a United States Department of Defense prostate cancer research fellow grant award. To whom correspondence may be addressed. E-mail: brunodfonseca@gmail.com.	Aitken CE, 2012, NAT STRUCT MOL BIOL, V19, P568, DOI 10.1038/nsmb.2303; Anderson P, 2009, CURR BIOL, V19, pR397, DOI 10.1016/j.cub.2009.03.013; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Aoki K, 2013, FEBS LETT, V587, P2173, DOI 10.1016/j.febslet.2013.05.035; Ben-Sahra I, 2013, SCIENCE, V339, P1323, DOI 10.1126/science.1228792; Bertram PG, 1998, CURR BIOL, V8, P1259, DOI 10.1016/S0960-9822(07)00535-0; Biberman Y, 1999, FEBS LETT, V456, P357, DOI 10.1016/S0014-5793(99)00983-7; Biberman Y, 1997, FEBS LETT, V405, P333, DOI 10.1016/S0014-5793(97)00234-2; Blagden SP, 2009, DEV BIOL, V334, P186, DOI 10.1016/j.ydbio.2009.07.016; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Burrows C, 2010, NUCLEIC ACIDS RES, V38, P5542, DOI 10.1093/nar/gkq294; Cardinali B, 2003, J BIOL CHEM, V278, P35145, DOI 10.1074/jbc.M300722200; Chantranupong L, 2015, CELL, V161, P67, DOI 10.1016/j.cell.2015.02.041; Chen EJ, 2003, J CELL BIOL, V161, P333, DOI 10.1083/jcb.200210141; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Coffman K, 2014, J BIOL CHEM, V289, P4723, DOI 10.1074/jbc.M113.482067; Crosio C, 2000, NUCLEIC ACIDS RES, V28, P2927, DOI 10.1093/nar/28.15.2927; Damgaard CK, 2011, GENE DEV, V25, P2057, DOI 10.1101/gad.17355911; Demirkan G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021729; Dennis MD, 2012, J BIOL CHEM, V287, P42890, DOI 10.1074/jbc.M112.404822; Deragon JM, 2015, WIRES RNA, V6, P399, DOI 10.1002/wrna.1282; Efeyan A, 2015, NATURE, V517, P302, DOI 10.1038/nature14190; Fonseca BD, 2008, BIOCHEM J, V411, P141, DOI 10.1042/BJ20071001; Fonseca BD, 2007, J BIOL CHEM, V282, P24514, DOI 10.1074/jbc.M704406200; Fonseca BD, 2014, SEMIN CELL DEV BIOL, V36, P102, DOI 10.1016/j.semcdb.2014.09.014; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Ginalski K, 2004, TRENDS BIOCHEM SCI, V29, P522, DOI 10.1016/j.tibs.2004.08.006; Gingras AC, 2001, GENE DEV, V15, P2852; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Harthill JE, 2002, BIOCHEM J, V368, P565, DOI 10.1042/BJ20020838; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Hornstein E, 1999, FEBS LETT, V457, P209, DOI 10.1016/S0014-5793(99)01039-X; Hornstein E, 1999, J BIOL CHEM, V274, P1708, DOI 10.1074/jbc.274.3.1708; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Intine RV, 2003, MOL CELL, V12, P1301, DOI 10.1016/S1097-2765(03)00429-5; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; JEFFERIES HBJ, 1994, P NATL ACAD SCI USA, V91, P4441, DOI 10.1073/pnas.91.10.4441; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kakegawa T, 2007, ARCH BIOCHEM BIOPHYS, V465, P274, DOI 10.1016/j.abb.2007.06.001; Kang SA, 2013, SCIENCE, V341, P364, DOI 10.1126/science.1236566; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim SG, 2013, MOL CELL, V49, P172, DOI 10.1016/j.molcel.2012.10.003; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lee VHY, 2008, FEBS J, V275, P2185, DOI 10.1111/j.1742-4658.2008.06372.x; LEVY S, 1991, P NATL ACAD SCI USA, V88, P3319, DOI 10.1073/pnas.88.8.3319; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Merret R, 2013, RNA, V19, P36, DOI 10.1261/rna.035469.112; Meyuhas O, 2000, EUR J BIOCHEM, V267, P6321, DOI 10.1046/j.1432-1327.2000.01719.x; Meyuhas O, 2014, BIOCHIM BIOPHYS ACTA, DOI [DOI 10.1016/J.BBAGRM.2014.08.015, 10.1016/j.bbagrm.2014.08.015]; Meyuhas O, 2009, PROG MOL BIOL TRANSL, V90, P109, DOI 10.1016/S1877-1173(09)90003-5; Miloslavski R, 2014, J MOL CELL BIOL, V6, P255, DOI 10.1093/jmcb/mju008; Mori H, 2000, FEBS LETT, V467, P61, DOI 10.1016/S0014-5793(00)01126-1; Mura M, 2015, ONCOGENE, V34, P5025, DOI 10.1038/onc.2014.428; Nakashima A, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-24; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; NOLAN RD, 1969, EUR J BIOCHEM, V9, P445, DOI 10.1111/j.1432-1033.1969.tb00629.x; Oshiro N, 2007, J BIOL CHEM, V282, P20329, DOI 10.1074/jbc.M702636200; Patursky-Polischuk I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109410; Patursky-Polischuk I, 2009, MOL CELL BIOL, V29, P640, DOI 10.1128/MCB.00980-08; Pearce LR, 2007, BIOCHEM J, V405, P513, DOI 10.1042/BJ20070540; Pellizzoni L, 1996, J MOL BIOL, V259, P904, DOI 10.1006/jmbi.1996.0368; Pellizzoni L, 1997, J MOL BIOL, V267, P264, DOI 10.1006/jmbi.1996.0888; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Rapley J, 2011, J BIOL CHEM, V286, P38043, DOI 10.1074/jbc.M111.245449; Raught B, 2004, EMBO J, V23, P1761, DOI 10.1038/sj.emboj.7600193; Redpath NT, 1996, EMBO J, V15, P2291, DOI 10.1002/j.1460-2075.1996.tb00582.x; Robitaille AM, 2013, SCIENCE, V339, P1320, DOI 10.1126/science.1228771; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Schultze FC, 2010, CELL PROLIFERAT, V43, P396, DOI 10.1111/j.1365-2184.2010.00690.x; Schwartz EI, 2004, MOL CELL BIOL, V24, P9580, DOI 10.1128/MCB.24.21.9580-9591.2004; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; Soulard A, 2010, MOL BIOL CELL, V21, P3475, DOI 10.1091/mbc.E10-03-0182; Stolovich M, 2002, MOL CELL BIOL, V22, P8101, DOI 10.1128/MCB.22.23.8101-8113.2002; Tang H, 2001, MOL CELL BIOL, V21, P8671, DOI 10.1128/MCB.21.24.8671-8683.2001; Tcherkezian J, 2014, GENE DEV, V28, P357, DOI 10.1101/gad.231407.113; TERADA N, 1994, P NATL ACAD SCI USA, V91, P11477, DOI 10.1073/pnas.91.24.11477; Thedieck K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001217; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Topisirovic I, 2011, WIRES RNA, V2, P277, DOI 10.1002/wrna.52; van Gorp AGM, 2009, ONCOGENE, V28, P95, DOI 10.1038/onc.2008.367; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wang L, 2008, J BIOL CHEM, V283, P15619, DOI 10.1074/jbc.M800723200; Wang LF, 2007, J BIOL CHEM, V282, P20036, DOI 10.1074/jbc.M702376200; Wang XM, 2001, EMBO J, V20, P4370, DOI 10.1093/emboj/20.16.4370; Wedaman KP, 2003, MOL BIOL CELL, V14, P1204, DOI 10.1091/mbc.E02-09-0609; Woo SY, 2007, J BIOL CHEM, V282, P25604, DOI 10.1074/jbc.M704343200; Xie JW, 2014, BBA-GENE REGUL MECH, V1839, P1062, DOI 10.1016/j.bbagrm.2014.08.001; Yang RQ, 2011, MOL CELL BIOL, V31, P542, DOI 10.1128/MCB.01162-10; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484	100	139	142	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					15996	16020		10.1074/jbc.M114.621730	http://dx.doi.org/10.1074/jbc.M114.621730			25	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25940091	Green Published, hybrid			2022-12-28	WOS:000356930100009
J	Gerlits, O; Tian, JH; Das, A; Langan, P; Heller, WT; Kovalevsky, A				Gerlits, Oksana; Tian, Jianhui; Das, Amit; Langan, Paul; Heller, William T.; Kovalevsky, Andrey			Phosphoryl Transfer Reaction Snapshots in Crystals: INSIGHTS INTO THE MECHANISM OF PROTEIN KINASE A CATALYTIC SUBUNIT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; enzyme mechanism; molecular dynamics; phosphoryl transfer; protein kinase	ACTIVE-SITE; MAGNETIC-RESONANCE; COMPLEXES; ADENOSINE; DYNAMICS; ANGSTROM; FEATURES; MUTANT	Background: PKAc (catalytic subunit) catalyzes phosphorylation of protein substrates thereby regulating a myriad of cellular processes. Results: X-ray structures of PKAc complexes along the phosphoryl transfer reaction have been obtained. Conclusion: The phosphotransfer follows a multistep mechanism, including conformational changes of the substrate and product groups, a loose transition state, and metal movement. Significance: Mechanistic knowledge about the phosphorylation by PKAc will contribute to understanding of the kinase function and regulation. To study the catalytic mechanism of phosphorylation catalyzed by cAMP-dependent protein kinase (PKA) a structure of the enzyme-substrate complex representing the Michaelis complex is of specific interest as it can shed light on the structure of the transition state. However, all previous crystal structures of the Michaelis complex mimics of the PKA catalytic subunit (PKAc) were obtained with either peptide inhibitors or ATP analogs. Here we utilized Ca2+ ions and sulfur in place of the nucleophilic oxygen in a 20-residue pseudo-substrate peptide (CP20) and ATP to produce a close mimic of the Michaelis complex. In the ternary reactant complex, the thiol group of Cys-21 of the peptide is facing Asp-166 and the sulfur atom is positioned for an in-line phosphoryl transfer. Replacement of Ca2+ cations with Mg2+ ions resulted in a complex with trapped products of ATP hydrolysis: phosphate ion and ADP. The present structural results in combination with the previously reported structures of the transition state mimic and phosphorylated product complexes complete the snapshots of the phosphoryl transfer reaction by PKAc, providing us with the most thorough picture of the catalytic mechanism to date.	[Gerlits, Oksana; Tian, Jianhui; Das, Amit; Langan, Paul; Heller, William T.; Kovalevsky, Andrey] Oak Ridge Natl Lab, Biol & Soft Matter Div, Oak Ridge, TN 37831 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory	Heller, WT (corresponding author), Oak Ridge Natl Lab, Biol & Soft Matter Div, Oak Ridge, TN 37831 USA.	hellerwt@ornl.gov; kovalevskyay@ornl.gov	Heller, William/ABE-1104-2020; Langan, Paul/N-5237-2015	Heller, William/0000-0001-6456-2975; Langan, Paul/0000-0002-0247-3122; Kovalevsky, Andrey/0000-0003-4459-9142	National Institutes of Health from the NIGMS [1R01GM071939-01]; Laboratory Directed Research and Development grant from Oak Ridge National Laboratory; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071939] Funding Source: NIH RePORTER	National Institutes of Health from the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Laboratory Directed Research and Development grant from Oak Ridge National Laboratory; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01GM071939-01 from the NIGMS (to P. L.) and a Laboratory Directed Research and Development grant from Oak Ridge National Laboratory (to A. D., J. T., W. T. H., O. G., and P. L.).	ADAMS JA, 1993, PROTEIN SCI, V2, P2177, DOI 10.1002/pro.5560021217; Adams JA, 2001, CHEM REV, V101, P2271, DOI 10.1021/cr000230w; Akamine P, 2003, J MOL BIOL, V327, P159, DOI 10.1016/S0022-2836(02)01446-8; ARMSTRONG RN, 1979, BIOCHEMISTRY-US, V18, P1230, DOI 10.1021/bi00574a018; Bastidas AC, 2013, J AM CHEM SOC, V135, P4788, DOI 10.1021/ja312237q; Bastidas AC, 2012, J MOL BIOL, V422, P215, DOI 10.1016/j.jmb.2012.05.021; BHATNAGAR D, 1983, BIOCHEMISTRY-US, V22, P6310, DOI 10.1021/bi00295a042; BOSSEMEYER D, 1993, EMBO J, V12, P849, DOI 10.1002/j.1460-2075.1993.tb05725.x; Bruice TC, 2002, ACCOUNTS CHEM RES, V35, P139, DOI 10.1021/ar0001665; Bruice TC, 2000, BIOCHEMISTRY-US, V39, P6267, DOI 10.1021/bi0003689; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gerlits O, 2014, BIOCHEMISTRY-US, V53, P3179, DOI 10.1021/bi5000965; Gerlits O, 2013, BIOCHEMISTRY-US, V52, P3721, DOI 10.1021/bi400066a; GIBBS CS, 1991, J BIOL CHEM, V266, P8923; GRANOT J, 1980, BIOCHEMISTRY-US, V19, P3537, DOI 10.1021/bi00556a019; Grant BD, 1996, BIOCHEMISTRY-US, V35, P2022, DOI 10.1021/bi952144+; HO MF, 1988, J AM CHEM SOC, V110, P2680, DOI 10.1021/ja00216a068; Jin Y, 2012, ANGEW CHEM INT EDIT, V51, P12242, DOI 10.1002/anie.201204266; Johnson DA, 2001, CHEM REV, V101, P2243, DOI 10.1021/cr000226k; Khavrutskii IV, 2009, BIOCHEMISTRY-US, V48, P11532, DOI 10.1021/bi901475g; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; KNIGHT WB, 1989, BIOCHEMISTRY-US, V28, P5728, DOI 10.1021/bi00440a005; Kovalevsky AY, 2012, ACTA CRYSTALLOGR D, V68, P854, DOI 10.1107/S0907444912014886; Li DW, 2010, ANGEW CHEM INT EDIT, V49, P6778, DOI 10.1002/anie.201001898; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; MADHUSUDAN, 1994, PROTEIN SCI, V3, P176; Madhusudan, 2002, NAT STRUCT BIOL, V9, P273, DOI 10.1038/nsb780; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Masterson LR, 2011, P NATL ACAD SCI USA, V108, P6969, DOI 10.1073/pnas.1102701108; Masterson LR, 2010, NAT CHEM BIOL, V6, P821, DOI 10.1038/NCHEMBIO.452; MENDELOW M, 1993, J BIOL CHEM, V268, P12289; Mildvan AS, 1997, PROTEINS, V29, P401, DOI 10.1002/(SICI)1097-0134(199712)29:4<401::AID-PROT1>3.3.CO;2-#; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; MOLL GW, 1976, J BIOL CHEM, V251, P3993; Narayana N, 1997, STRUCTURE, V5, P921, DOI 10.1016/S0969-2126(97)00246-3; Perez-Gallegos A, 2015, PHYS CHEM CHEM PHYS, V17, P3497, DOI 10.1039/c4cp03579h; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Shaffer J, 1999, BIOCHEMISTRY-US, V38, P12072, DOI 10.1021/bi991109q; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sims PC, 2013, J AM CHEM SOC, V135, P7861, DOI 10.1021/ja311604j; Smith M. B, 2007, MARCHS ADV ORGANIC C; Srivastava AK, 2014, STRUCTURE, V22, P1735, DOI 10.1016/j.str.2014.09.010; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; Valiev M, 2007, J PHYS CHEM B, V111, P13455, DOI 10.1021/jp074853q; Yang J, 2004, J MOL BIOL, V336, P473, DOI 10.1016/j.jmb.2003.11.044; YOON MY, 1987, BIOCHEMISTRY-US, V26, P4118, DOI 10.1021/bi00387a056; Zhang P, 2012, SCIENCE, V335, P712, DOI 10.1126/science.1213979; ZHENG JH, 1993, ACTA CRYSTALLOGR D, V49, P362, DOI 10.1107/S0907444993000423; ZHENG JH, 1993, BIOCHEMISTRY-US, V32, P2154, DOI 10.1021/bi00060a005; Zhou J, 1997, BIOCHEMISTRY-US, V36, P2977, DOI 10.1021/bi9619132	52	18	18	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15538	15548		10.1074/jbc.M115.643213	http://dx.doi.org/10.1074/jbc.M115.643213			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25925954	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000356527400019
J	Holder, PG; Jones, LC; Drake, PM; Barfield, RM; Banas, S; de Hart, GW; Baker, J; Rabuka, D				Holder, Patrick G.; Jones, Lesley C.; Drake, Penelope M.; Barfield, Robyn M.; Banas, Stefanie; de Hart, Gregory W.; Baker, Jeanne; Rabuka, David			Reconstitution of Formylglycine-generating Enzyme with Copper(II) for Aldehyde Tag Conversion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						catalysis; enzyme kinetics; metalloenzyme; monoclonal antibody; post-translational modification (PTM); aldehyde tag; antibody drug conjugation	MULTIPLE SULFATASE DEFICIENCY; COUPLED ELECTRON-TRANSFER; INTEGRATED RATE-EQUATIONS; PICTET-SPENGLER LIGATION; ENDOPLASMIC-RETICULUM; CHEMICAL-MODIFICATION; PROTEIN MODIFICATION; CATALYZED 1ST-ORDER; 2ND-ORDER REACTIONS; GALACTOSE-OXIDASE	Background: Aerobic formylglycine-generating enzyme (FGE) converts cysteine to formylglycine in vivo. Results: Purified FGE requires preactivation with copper to convert cysteine to formylglycine in vitro. Conclusion: FGE is a metalloenzyme. It is also a useful biocatalyst for the production of proteins that contain aldehyde tags. Significance: Understanding FGE biochemistry informs research on sulfatases and enables expanded biotechnology applications of the aldehyde tag. To further our aim of synthesizing aldehyde-tagged proteins for research and biotechnology applications, we developed methods for recombinant production of aerobic formylglycine-generating enzyme (FGE) in good yield. We then optimized the FGE biocatalytic reaction conditions for conversion of cysteine to formylglycine in aldehyde tags on intact monoclonal antibodies. During the development of these conditions, we discovered that pretreating FGE with copper(II) is required for high turnover rates and yields. After further investigation, we confirmed that both aerobic prokaryotic (Streptomyces coelicolor) and eukaryotic (Homo sapiens) FGEs contain a copper cofactor. The complete kinetic parameters for both forms of FGE are described, along with a proposed mechanism for FGE catalysis that accounts for the copper-dependent activity.	[Holder, Patrick G.; Jones, Lesley C.; Drake, Penelope M.; Barfield, Robyn M.; Banas, Stefanie; de Hart, Gregory W.; Baker, Jeanne; Rabuka, David] Catalent Pharma Solut, Emeryville, CA 94608 USA		Rabuka, D (corresponding author), 5703 Hollis St, Emeryville, CA 94608 USA.	david.rabuka@catalent.com	Holder, Patrick/O-4876-2016	Holder, Patrick/0000-0003-0971-191X				Agarwal P, 2013, BIOCONJUGATE CHEM, V24, P846, DOI 10.1021/bc400042a; Agarwal P, 2013, P NATL ACAD SCI USA, V110, P46, DOI 10.1073/pnas.1213186110; Appel MJ, 2015, ACS CHEM BIOL, V10, P72, DOI 10.1021/cb500897w; Bertolotti-Ciarlet A, 2009, MOL IMMUNOL, V46, P1878, DOI 10.1016/j.molimm.2009.02.002; BLACKBURN NJ, 1984, BIOCHEM J, V220, P447, DOI 10.1042/bj2200447; Bleck G. T., 2006, BIOPROCESS J, V5, P36; BOEKER EA, 1985, BIOCHEM J, V226, P29, DOI 10.1042/bj2260029; BOEKER EA, 1984, BIOCHEM J, V223, P15, DOI 10.1042/bj2230015; Capozzi G., 1974, THIOL GROUP, P785; Carlson BL, 2008, J BIOL CHEM, V283, P20117, DOI 10.1074/jbc.M800217200; Carrico IS, 2007, NAT CHEM BIOL, V3, P321, DOI 10.1038/nchembio878; Dierks T, 1997, P NATL ACAD SCI USA, V94, P11963, DOI 10.1073/pnas.94.22.11963; Dierks T, 2005, CELL, V121, P541, DOI 10.1016/j.cell.2005.03.001; Dierks T, 1999, EMBO J, V18, P2084, DOI 10.1093/emboj/18.8.2084; Dierks T, 2003, CELL, V113, P435, DOI 10.1016/S0092-8674(03)00347-7; Ennemann EC, 2013, J BIOL CHEM, V288, P5828, DOI 10.1074/jbc.M112.405159; Farver O, 2011, COORDIN CHEM REV, V255, P757, DOI 10.1016/j.ccr.2010.08.005; Finney J, 2014, ARCH BIOCHEM BIOPHYS, V546, P19, DOI 10.1016/j.abb.2013.12.022; Gande SL, 2008, FEBS J, V275, P1118, DOI 10.1111/j.1742-4658.2008.06271.x; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Hammes-Schiffer S, 2012, ENERG ENVIRON SCI, V5, P7696, DOI 10.1039/c2ee03361e; ITO N, 1991, NATURE, V350, P87, DOI 10.1038/350087a0; Kishishita S, 2003, J AM CHEM SOC, V125, P1041, DOI 10.1021/ja017899k; Klinman JP, 2006, J BIOL CHEM, V281, P3013, DOI 10.1074/jbc.R500011200; Kudirka R, 2015, CHEM BIOL, V22, P293, DOI 10.1016/j.chembiol.2014.11.019; Landgrebe J, 2003, GENE, V316, P47, DOI 10.1016/S0378-1119(03)00746-7; Lang K, 2014, CHEM REV, V114, P4764, DOI 10.1021/cr400355w; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Mariappan M, 2008, J BIOL CHEM, V283, P11556, DOI 10.1074/jbc.M707858200; Mariappan M, 2008, J BIOL CHEM, V283, P6375, DOI 10.1074/jbc.M709171200; McGuirl MA, 1997, J BIOL INORG CHEM, V2, P336, DOI 10.1007/s007750050140; Montoya LA, 2012, CHEM COMMUN, V48, P4767, DOI 10.1039/c2cc30730h; Patterson DM, 2014, ACS CHEM BIOL, V9, P592, DOI 10.1021/cb400828a; Peng HJ, 2011, ANGEW CHEM INT EDIT, V50, P9672, DOI 10.1002/anie.201104236; Preusser-Kunze A, 2005, J BIOL CHEM, V280, P14900, DOI 10.1074/jbc.M413383200; Rabuka D, 2012, NAT PROTOC, V7, P1052, DOI 10.1038/nprot.2012.045; Roeser D, 2006, P NATL ACAD SCI USA, V103, P81, DOI 10.1073/pnas.0507592102; Roeser D, 2005, ACTA CRYSTALLOGR D, V61, P1057, DOI 10.1107/S0907444905013831; Roeser D, 2007, ACTA CRYSTALLOGR D, V63, P621, DOI 10.1107/S0907444907009961; Saaranen MJ, 2010, ANTIOXID REDOX SIGN, V12, P15, DOI 10.1089/ars.2009.2674; Sasaki T, 2008, BIOORG MED CHEM LETT, V18, P4550, DOI 10.1016/j.bmcl.2008.07.033; Solomon EI, 2014, CHEM REV, V114, P3659, DOI 10.1021/cr400327t; Sun MMC, 2005, BIOCONJUGATE CHEM, V16, P1282, DOI 10.1021/bc050201y; SZAJEWSKI RP, 1980, J AM CHEM SOC, V102, P2011, DOI 10.1021/ja00526a042; Tipton K. F., 2014, PERSPECT SCI, V1, P131, DOI [10.1016/j.pisc.2014.02.012, DOI 10.1016/J.PISC.2014.02.012]; von Figura K, 1998, BIOESSAYS, V20, P505, DOI 10.1002/(SICI)1521-1878(199806)20:6<505::AID-BIES9>3.0.CO;2-K; Wang WR, 2011, MOL IMMUNOL, V48, P860, DOI 10.1016/j.molimm.2010.12.009; Weinberg DR, 2012, CHEM REV, V112, P4016, DOI 10.1021/cr200177j; WHITTAKER MM, 1993, BIOPHYS J, V64, P762, DOI 10.1016/S0006-3495(93)81437-1; Wu P, 2009, P NATL ACAD SCI USA, V106, P3000, DOI 10.1073/pnas.0807820106; Zhou Q, 2014, BIOCONJUGATE CHEM, V25, P510, DOI 10.1021/bc400505q	51	47	54	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15730	15745		10.1074/jbc.M115.652669	http://dx.doi.org/10.1074/jbc.M115.652669			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25931126	Green Published, hybrid			2022-12-28	WOS:000356527400035
J	Merrill, AH; Carman, GM				Merrill, Alfred H., Jr.; Carman, George M.			Introduction to Thematic Minireview Series: Novel Bioactive Sphingolipids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material						apoptosis; autophagy; cancer; cell signaling; ceramide; diabetes; glycolipid; immunology; sphingolipid; neuropathy	BIOPHYSICAL PROPERTIES; BINDING PROTEINS; ACCUMULATION; BIOSYNTHESIS; INHIBITION; NEUROPATHY; CERAMIDES; AUTOPHAGY; DISEASES; STRESS	Sphingosine was named by J. L. W. Thudichum for its enigmatic properties. This descriptor has applied to sphingolipids for over a century because new enigmas continue to surface. This JBC minireview series presents articles about three novel subspecies of sphingolipids, -galactosylceramides, 4,5-dihydroceramides, and 1-deoxysphingolipids, that have important activities but, until recently, remained undetected (or at least understudied) in the shadow of very closely related compounds. They also serve as a reminder that important metabolites still lie off the radar screen in reports of global and comprehensive metabolomic profiling.	[Merrill, Alfred H., Jr.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Merrill, Alfred H., Jr.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Merrill, Alfred H., Jr.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Carman, George M.] Rutgers State Univ, Rutgers Ctr Lipid Res, Dept Food Sci, New Brunswick, NJ 08901 USA; [Carman, George M.] Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, New Brunswick, NJ 08901 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Merrill, AH (corresponding author), Georgia Inst Technol, Sch Biol, 315 Ferst Dr, Atlanta, GA 30332 USA.	al.merrill@biology.gatech.edu		Merrill, Alfred/0000-0002-6673-968X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028140] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM028140] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Astudillo L, 2015, J INHERIT METAB DIS, V38, P65, DOI 10.1007/s10545-014-9736-1; Birkholz AM, 2015, J BIOL CHEM, V290, P15365, DOI 10.1074/jbc.R115.647057; Bjorkholm P, 2014, BBA-BIOMEMBRANES, V1838, P2066, DOI 10.1016/j.bbamem.2014.04.026; Brown LCW, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001610; Carreira AC, 2015, BIOL CHEM, V396, P597, DOI 10.1515/hsz-2014-0283; CARTER HE, 1947, J BIOL CHEM, V169, P77; Coskun U, 2011, P NATL ACAD SCI USA, V108, P9044, DOI 10.1073/pnas.1105666108; Cuadros R, 2000, CANCER LETT, V152, P23, DOI 10.1016/S0304-3835(99)00428-0; Dohrn MF, 2015, EUR J NEUROL, V22, P806, DOI 10.1111/ene.12663; Duan JJ, 2015, J BIOL CHEM, V290, P15380, DOI 10.1074/jbc.R115.658823; Eichler FS, 2009, J NEUROSCI, V29, P14646, DOI 10.1523/JNEUROSCI.2536-09.2009; Esaki K, 2015, J BIOL CHEM, V290, P14595, DOI 10.1074/jbc.M114.603860; Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200; Gagliostro V, 2012, INT J BIOCHEM CELL B, V44, P2135, DOI 10.1016/j.biocel.2012.08.025; Goni FM, 2014, BIOCHEM SOC T, V42, P1401, DOI 10.1042/BST20140159; Gorden DL, 2015, J LIPID RES, V56, P722, DOI 10.1194/jlr.P056002; Lopez PHH, 2009, CURR OPIN STRUC BIOL, V19, P549, DOI 10.1016/j.sbi.2009.06.001; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Merrill AH, 2011, CHEM REV, V111, P6387, DOI 10.1021/cr2002917; Penno A, 2010, J BIOL CHEM, V285, P11178, DOI 10.1074/jbc.M109.092973; Pruett ST, 2008, J LIPID RES, V49, P1621, DOI 10.1194/jlr.R800012-JLR200; Schnaar RL, 2015, J ALLERGY CLIN IMMUN, V135, P609, DOI 10.1016/j.jaci.2014.10.057; Schulze H, 2014, BBA-MOL CELL BIOL L, V1841, P799, DOI 10.1016/j.bbalip.2013.10.015; Siddique MM, 2013, MOL CELL BIOL, V33, P2353, DOI 10.1128/MCB.00226-13; Siddique MM, 2015, J BIOL CHEM, V290, P15371, DOI 10.1074/jbc.R115.653204; Snook CF, 2006, BBA-MOL CELL BIOL L, V1761, P927, DOI 10.1016/j.bbalip.2006.06.004; Taniguchi N., 2014, HDB GLYCOSYLTRANSFER; Thudichum J.L.W., 1884, TREATISE CHEM CONSTI; Tyznik AJ, 2011, CHEM BIOL, V18, P1620, DOI 10.1016/j.chembiol.2011.10.015; WANG E, 1991, J BIOL CHEM, V266, P14486; Yu R. K., 2007, COMPREHENSIVE GLYCOS, P73, DOI 10.1016/B978-044451967-2/00003-9; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009; Zitomer NC, 2009, J BIOL CHEM, V284, P4786, DOI 10.1074/jbc.M808798200	33	6	6	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15362	15364		10.1074/jbc.R115.663708	http://dx.doi.org/10.1074/jbc.R115.663708			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25947376	hybrid, Green Published			2022-12-28	WOS:000356527400001
J	Migocka, M; Posyniak, E; Maciaszczyk-Dziubinska, E; Papierniak, A; Kosieradzaka, A				Migocka, Magdalena; Posyniak, Ewelina; Maciaszczyk-Dziubinska, Ewa; Papierniak, Anna; Kosieradzaka, Anna			RETRACTED: Functional and Biochemical Characterization of Cucumber Genes Encoding Two Copper ATPases CsHMA5.1 and CsHMA5.2 (Retracted article. See vol. 294, pg. 13200, 2019)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication						copper transport; gene expression; membrane transport; metal homeostasis; vacuolar ATPase; P1B-ATPases	P-TYPE ATPASE; N-TERMINAL DOMAIN; ESCHERICHIA-COLI; METAL TRANSPORTERS; SUPEROXIDE-DISMUTASE; CHLOROPLAST ENVELOPE; CATALYTIC-ACTIVITY; DISTINCT ROLES; BINDING SITE; PROTEIN	Background: Plant copper HMA5-like ATPases have not been biochemically characterized yet. Results: Cucumber copper ATPases CsHMA5.1 and CsHMA5.2 are tonoplast monovalent copper transporters differentially regulated by copper availability. Conclusion: HMA5-like ATPases may contribute to vacuolar sequestration of copper excess in plant cells. Significance: Orthologous transporters are differently displayed to achieve organismal copper homeostasis. Plant copper P-1B-type ATPases appear to be crucial for maintaining copper homeostasis within plant cells, but until now they have been studied mostly in model plant systems. Here, we present the molecular and biochemical characterization of two cucumber copper ATPases, CsHMA5.1 and CsHMA5.2, indicating a different function for HMA5-like proteins in different plants. When expressed in yeast, CsHMA5.1 and CsHMA5.2 localize to the vacuolar membrane and are activated by monovalent copper or silver ions and cysteine, showing different affinities to Cu+ (K-m approximate to 1 or 0.5 m, respectively) and similar affinity to Ag+ (K-m approximate to 2.5 m). Both proteins restore the growth of yeast mutants sensitive to copper excess and silver through intracellular copper sequestration, indicating that they contribute to copper and silver detoxification. Immunoblotting with specific antibodies revealed the presence of CsHMA5.1 and CsHMA5.2 in the tonoplast of cucumber cells. Interestingly, the root-specific CsHMA5.1 was not affected by copper stress, whereas the widely expressed CsHMA5.2 was up-regulated or down-regulated in roots upon copper excess or deficiency, respectively. The copper-induced increase in tonoplast CsHMA5.2 is consistent with the increased activity of ATP-dependent copper transport into tonoplast vesicles isolated from roots of plants grown under copper excess. These data identify CsHMA5.1 and CsHMA5.2 as high affinity Cu+ transporters and suggest that CsHMA5.2 is responsible for the increased sequestration of copper in vacuoles of cucumber root cells under copper excess.	[Migocka, Magdalena; Posyniak, Ewelina; Papierniak, Anna; Kosieradzaka, Anna] Univ Wroclaw, Dept Plant Mol Physiol, Inst Expt Biol, PL-50328 Wroclaw, Poland; [Maciaszczyk-Dziubinska, Ewa] Univ Wroclaw, Inst Expt Biol, Dept Genet & Cell Physiol, PL-50328 Wroclaw, Poland	University of Wroclaw; University of Wroclaw	Migocka, M (corresponding author), Univ Wroclaw, Dept Plant Mol Physiol, Inst Expt Biol, Kanonia 6-8, PL-50328 Wroclaw, Poland.	mmigocka@biol.uni.wroc.pl			Polish Ministry of Science and Higher Education [IP2011 035871]; Wroclaw University [1227/M/IBR/11]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Wroclaw University	This work was supported by Polish Ministry of Science and Higher Education Grant IP2011 035871 and Wroclaw University Grant 1227/M/IBR/11. The authors declare that they have no conflicts of interest with the contents of this article.	Abdel-Ghany SE, 2005, PLANT CELL, V17, P1233, DOI 10.1105/tpc.104.030452; Ames B.N., 1966, METHOD ENZYMOL, V8, P115, DOI [10.1016/0076-6879(66)08014-5, DOI 10.1016/0076-6879(66)08014-5]; Andres-Colas N, 2006, PLANT J, V45, P225, DOI 10.1111/j.1365-313X.2005.02601.x; Arguello JM, 2003, J MEMBRANE BIOL, V195, P93, DOI 10.1007/s00232-003-2048-2; Axelsen KB, 2001, PLANT PHYSIOL, V126, P696, DOI 10.1104/pp.126.2.696; Banci L, 2003, J BIOL CHEM, V278, P50506, DOI 10.1074/jbc.M307389200; Barnes N, 2005, J BIOL CHEM, V280, P9640, DOI 10.1074/jbc.M413840200; Barry AN, 2010, J BIOL INORG CHEM, V15, P47, DOI 10.1007/s00775-009-0595-4; Bissig KD, 2001, FEBS LETT, V507, P367, DOI 10.1016/S0014-5793(01)03009-5; Brachmann CB, 1998, YEAST, V14, P115; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Catty P, 2011, J BIOL CHEM, V286, P36188, DOI 10.1074/jbc.M111.241034; Cobbett CS, 2003, NEW PHYTOL, V159, P315, DOI 10.1046/j.1469-8137.2003.00785.x; CULOTTA VC, 1995, J BIOL CHEM, V270, P29991; Deng FL, 2013, PLANT PHYSIOL, V163, P1353, DOI 10.1104/pp.113.226225; Eren E, 2004, PLANT PHYSIOL, V136, P3712, DOI 10.1104/pp.104.046292; Fan B, 2002, J BIOL CHEM, V277, P46987, DOI 10.1074/jbc.M208490200; GRALLA EB, 1991, P NATL ACAD SCI USA, V88, P8558, DOI 10.1073/pnas.88.19.8558; Hall JL, 2003, J EXP BOT, V54, P2601, DOI 10.1093/jxb/erg303; Hirayama T, 1999, CELL, V97, P383, DOI 10.1016/S0092-8674(00)80747-3; Hung YH, 2007, BIOCHEM J, V401, P569, DOI 10.1042/BJ20060924; Huster D, 2003, J BIOL CHEM, V278, P32212, DOI 10.1074/jbc.M305408200; Kobayashi Y, 2008, PLANT PHYSIOL, V148, P969, DOI 10.1104/pp.108.119933; Koch KA, 1997, CHEM BIOL, V4, P549, DOI 10.1016/S1074-5521(97)90241-6; Lee AM, 2004, J INORG BIOCHEM, V98, P1981, DOI 10.1016/j.jinorgbio.2004.08.018; Maciaszczyk-Dziubinska E, 2010, FEBS LETT, V584, P726, DOI 10.1016/j.febslet.2009.12.027; Mana-Capelli S, 2003, J BIOL CHEM, V278, P40534, DOI 10.1074/jbc.M306907200; Mandal AK, 2004, J BIOL CHEM, V279, P54802, DOI 10.1074/jbc.M410854200; Mandal AK, 2002, J BIOL CHEM, V277, P7201, DOI 10.1074/jbc.M109964200; Migeon A, 2010, CELL MOL LIFE SCI, V67, P3763, DOI 10.1007/s00018-010-0445-0; Migocka M, 2012, PLANT GROWTH REGUL, V67, P171, DOI 10.1007/s10725-012-9674-6; Migocka M, 2015, PLANT CELL ENVIRON, V38, P1127, DOI 10.1111/pce.12447; Migocka Magdalena, 2011, J Exp Bot, V62, P4903, DOI 10.1093/jxb/err180; Mikkelsen MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049027; Mitra B, 2001, BIOCHEMISTRY-US, V40, P7694, DOI 10.1021/bi010576g; Moreno I, 2008, J BIOL CHEM, V283, P9633, DOI 10.1074/jbc.M800736200; Nakanishi Y, 2001, J BIOL CHEM, V276, P7654, DOI 10.1074/jbc.M009743200; Niedenthal RK, 1996, YEAST, V12, P773, DOI 10.1002/(SICI)1097-0061(19960630)12:8<773::AID-YEA972>3.3.CO;2-C; Norling B, 2000, METH BIOTEC, V11, P177; PHUNG LT, 1994, P NATL ACAD SCI USA, V91, P9651, DOI 10.1073/pnas.91.20.9651; Portnoy ME, 2001, MOL GENET GENOMICS, V265, P873, DOI 10.1007/s004380100482; Rensing C, 2000, P NATL ACAD SCI USA, V97, P652, DOI 10.1073/pnas.97.2.652; Seigneurin-Berny D, 2006, J BIOL CHEM, V281, P2882, DOI 10.1074/jbc.M508333200; Sharma R, 2000, J BIOL CHEM, V275, P3873, DOI 10.1074/jbc.275.6.3873; Shikanai T, 2003, PLANT CELL, V15, P1333, DOI 10.1105/tpc.011817; Su YC, 2012, J AM CHEM SOC, V134, P8693, DOI 10.1021/ja3026328; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THIELE DJ, 1988, MOL CELL BIOL, V8, P2745, DOI 10.1128/MCB.8.7.2745; Thorsen M, 2006, MOL BIOL CELL, V17, P4400, DOI 10.1091/mbc.E06-04-0315; Tottey S, 2001, J BIOL CHEM, V276, P19999, DOI 10.1074/jbc.M011243200; Tsivkovskii R, 2001, J BIOL CHEM, V276, P2234, DOI 10.1074/jbc.M003238200; Voskoboinik I, 1998, FEBS LETT, V435, P178, DOI 10.1016/S0014-5793(98)01059-X; Voskoboinik I, 2001, J BIOL CHEM, V276, P28620, DOI 10.1074/jbc.M103532200; Warzybok A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072887; Williams LE, 2005, TRENDS PLANT SCI, V10, P491, DOI 10.1016/j.tplants.2005.08.008; Woeste KE, 2000, PLANT CELL, V12, P443, DOI 10.1105/tpc.12.3.443; Yruela Inmaculada, 2005, Braz. J. Plant Physiol., V17, P145, DOI 10.1590/S1677-04202005000100012	57	16	16	0	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15717	15729		10.1074/jbc.M114.618355	http://dx.doi.org/10.1074/jbc.M114.618355			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25963145	Green Published, hybrid			2022-12-28	WOS:000356527400034
J	Surmeli, NB; Muskens, FM; Marletta, MA				Suermeli, Nur Basak; Muskens, Frederike M.; Marletta, Michael A.			The Influence of Nitric Oxide on Soluble Guanylate Cyclase Regulation by Nucleotides: ROLE OF THE PSEUDOSYMMETRIC SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nitric oxide; guanylate cyclase (guanylyl cyclase); cyclic GMP (cGMP); ATP; signal transduction; heme	CATALYTIC DOMAINS; ADENYLYL-CYCLASE; ACTIVATION; MECHANISM; RECEPTOR; BINDING; HEME; NO; ATP; DIMERIZATION	Background: ATP regulates soluble guanylate cyclase (sGC), which mediates NO signaling. Results: ATP inhibition of sGC is dependent on NO levels; the pseudosymmetric site is involved in ATP regulation. Conclusion: A new kinetic model for sGC activity in the presence of excess NO is proposed. Significance: Cooperativity between the pseudosymmetric and catalytic site results in a more specific cyclase in vivo. Activation of soluble guanylate cyclase (sGC) by the signaling molecule nitric oxide (NO) leads to formation of the second messenger cGMP, which mediates numerous physiological processes. NO activates sGC by binding to the ferrous heme cofactor; the relative amount of NO with respect to sGC heme affects the enzyme activity. ATP can also influence the activity by binding to an allosteric site, most likely the pseudosymmetric site located in the catalytic domain. Here, the role of the pseudosymmetric site on nucleotide regulation was investigated by point mutations at this site. ATP inhibition kinetics of wild type and a pseudosymmetric site (1-C594A/1-D477A) variant of sGC was determined at various levels of NO. Results obtained show that in the presence of less than 1 eq of NO, there appears to be less than complete activation and little change in the nucleotide binding parameters. The most dramatic effects are observed for the addition of excess NO, which results in an increase in the affinity of GTP at the catalytic site and full activation of sGC. The pseudosymmetric site mutation only affected nucleotide affinities in the presence of excess NO; there was a decrease in the affinity for ATP in both the allosteric and catalytic sites. These observations led to a new kinetic model for sGC activity in the presence of excess NO. This model revealed that the active and allosteric sites show cooperativity. This new comprehensive model gives a more accurate description of sGC regulation by NO and nucleotides in vivo.	[Suermeli, Nur Basak; Marletta, Michael A.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Muskens, Frederike M.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Dept Med Chem & Chem Biol, NL-3584 CG Utrecht, Netherlands	Scripps Research Institute; Utrecht University	Marletta, MA (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	marletta@scripps.edu	Surmeli, Nur/K-1717-2015; Surmeli, Nur/AAE-2315-2022	Surmeli, Nur/0000-0002-1841-4004; Surmeli, Nur/0000-0002-1841-4004	American Heart Association [11POST7150020]; Jo Kolk Foundation; Dutch Heart Association; Nora Baart Foundation; K. F. Hein Fund	American Heart Association(American Heart Association); Jo Kolk Foundation; Dutch Heart Association; Nora Baart Foundation; K. F. Hein Fund	Supported by American Heart Association Grant 11POST7150020.; Present address: School of Chemistry, Joseph Black Bldg., University of Glasgow, University Ave., Glasgow G12 8QQ, United Kingdom. Supported by the Jo Kolk Foundation, Dutch Heart Association, Nora Baart Foundation, and K. F. Hein Fund.	Allerston CK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057644; Bellamy TC, 2000, P NATL ACAD SCI USA, V97, P2928, DOI 10.1073/pnas.97.6.2928; Bellamy TC, 2001, J BIOL CHEM, V276, P4287, DOI 10.1074/jbc.M006677200; Beste KY, 2012, BIOCHEMISTRY-US, V51, P194, DOI 10.1021/bi201259y; Brandish PE, 1998, BIOCHEMISTRY-US, V37, P16898, DOI 10.1021/bi9814989; Bredt DS, 2003, J CELL SCI, V116, P9, DOI 10.1242/jcs.00183; Buvinic S, 2001, EUR J PHARMACOL, V424, P221, DOI 10.1016/S0014-2999(01)01165-7; Buys ES, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00038; Cals-Grierson MM, 2004, NITRIC OXIDE-BIOL CH, V10, P179, DOI 10.1016/j.niox.2004.04.005; Cary SPL, 2006, TRENDS BIOCHEM SCI, V31, P231, DOI 10.1016/j.tibs.2006.02.003; Cary SPL, 2005, P NATL ACAD SCI USA, V102, P13064, DOI 10.1073/pnas.0506289102; Chang FJ, 2005, J BIOL CHEM, V280, P11513, DOI 10.1074/jbc.M412203200; Denninger JW, 1999, BBA-BIOENERGETICS, V1411, P334, DOI 10.1016/S0005-2728(99)00024-9; Derbyshire ER, 2009, BIOCHEMISTRY-US, V48, P7519, DOI 10.1021/bi900696x; Fernhoff NB, 2009, P NATL ACAD SCI USA, V106, P21602, DOI 10.1073/pnas.0911083106; Follmann M, 2013, ANGEW CHEM INT EDIT, V52, P9442, DOI 10.1002/anie.201302588; Friebe A, 2009, NITRIC OXIDE-BIOL CH, V21, P149, DOI 10.1016/j.niox.2009.07.004; GARBERS DL, 1994, J BIOL CHEM, V269, P30741; Garthwaite J, 2008, EUR J NEUROSCI, V27, P2783, DOI 10.1111/j.1460-9568.2008.06285.x; Ghofrani HA, 2013, NEW ENGL J MED, V369, P319, DOI 10.1056/NEJMoa1209657; Greene S., 2013, PROBL POST-COMMUNISM, V60, P2; Herzik MA, 2014, P NATL ACAD SCI USA, V111, pE4156, DOI 10.1073/pnas.1416936111; Hill BG, 2010, J BIOL CHEM, V285, P19699, DOI 10.1074/jbc.R110.101618; Karow DS, 2005, BIOCHEMISTRY-US, V44, P16266, DOI 10.1021/bi051601b; Kurtz A, 1998, AM J PHYSIOL-RENAL, V275, pF849, DOI 10.1152/ajprenal.1998.275.6.F849; Liu Y, 1997, P NATL ACAD SCI USA, V94, P13414, DOI 10.1073/pnas.94.25.13414; Ma XL, 2008, J BIOL CHEM, V283, P1167, DOI 10.1074/jbc.M706218200; Martin E, 2012, BIOCHEMISTRY-US, V51, P2737, DOI 10.1021/bi300105s; MARTIN W, 1986, J PHARMACOL EXP THER, V237, P529; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Robinson JW, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003253; Roelofs J, 2002, MOL BIOL EVOL, V19, P2239, DOI 10.1093/oxfordjournals.molbev.a004047; Rothkegel C, 2007, MOL PHARMACOL, V72, P1181, DOI 10.1124/mol.107.036368; Roy B, 2008, J BIOL CHEM, V283, P18841, DOI 10.1074/jbc.M801712200; Ruiz-Stewart I, 2004, P NATL ACAD SCI USA, V101, P37, DOI 10.1073/pnas.0305080101; Ruiz-Stewart I, 2002, EUR J BIOCHEM, V269, P2186, DOI 10.1046/j.1432-1033.2002.02874.x; Russwurm M, 2004, EMBO J, V23, P4443, DOI 10.1038/sj.emboj.7600422; Seeger F, 2014, BIOCHEMISTRY-US, V53, P2153, DOI 10.1021/bi500129k; Segel IH., 1993, ENZYME KINETICS BEHA; Shah AM, 2000, PHARMACOL THERAPEUT, V86, P49, DOI 10.1016/S0163-7258(99)00072-8; Shenoy AR, 2004, FEBS LETT, V561, P11, DOI 10.1016/S0014-5793(04)00128-0; Stone JR, 1996, BIOCHEMISTRY-US, V35, P1093, DOI 10.1021/bi9519718; Sunahara RK, 1998, J BIOL CHEM, V273, P16332, DOI 10.1074/jbc.273.26.16332; Suzuki T, 2001, FEBS LETT, V507, P49, DOI 10.1016/S0014-5793(01)02943-X; TANG WJ, 1992, CELL, V70, P869, DOI 10.1016/0092-8674(92)90236-6; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Tesmer JJG, 1999, SCIENCE, V285, P756, DOI 10.1126/science.285.5428.756; Tesmer JJG, 1998, CURR OPIN STRUC BIOL, V8, P713, DOI 10.1016/S0959-440X(98)80090-0; Toda N, 2003, PHARMACOL REV, V55, P271, DOI 10.1124/pr.55.2.3; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Tsai AL, 2011, J BIOL CHEM, V286, P43182, DOI 10.1074/jbc.M111.290304; Tucker CL, 1998, P NATL ACAD SCI USA, V95, P5993, DOI 10.1073/pnas.95.11.5993; Underbakke ES, 2014, STRUCTURE, V22, P602, DOI 10.1016/j.str.2014.01.008; Underbakke ES, 2013, P NATL ACAD SCI USA, V110, P6777, DOI 10.1073/pnas.1301934110; WALDMAN SA, 1987, PHARMACOL REV, V39, P163; Winger JA, 2005, BIOCHEMISTRY-US, V44, P4083, DOI 10.1021/bi047601d; Yazawa S, 2006, J BIOL CHEM, V281, P21763, DOI 10.1074/jbc.M508983200; Zhao Y, 1999, P NATL ACAD SCI USA, V96, P14753, DOI 10.1073/pnas.96.26.14753	58	13	14	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15570	15580		10.1074/jbc.M115.641431	http://dx.doi.org/10.1074/jbc.M115.641431			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25907555	Green Published, hybrid			2022-12-28	WOS:000356527400022
J	Teng, Y; Radde, BN; Litchfield, LM; Ivanova, MM; Prough, RA; Clark, BJ; Doll, MA; Hein, DW; Klinge, CM				Teng, Yun; Radde, Brandie N.; Litchfield, Lacey M.; Ivanova, Margarita M.; Prough, Russell A.; Clark, Barbara J.; Doll, Mark A.; Hein, David W.; Klinge, Carolyn M.			Dehydroepiandrosterone Activation of G-protein-coupled Estrogen Receptor Rapidly Stimulates MicroRNA-21 Transcription in Human Hepatocellular Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						estrogen receptor; G-protein-coupled receptor (GPCR); gene transcription; microRNA (miRNA); microRNA biogenesis; hormones	BREAST-CANCER CELLS; METHYL-BETA-CYCLODEXTRIN; EPIDERMAL-GROWTH-FACTOR; GENE-EXPRESSION; VARIANT ER-ALPHA-36; PROSTATE-CANCER; UP-REGULATION; GPR30; MIGRATION; PROLIFERATION	Background: MicroRNA-21 (miR-21) is an oncomiR in human hepatocellular carcinoma and is highly expressed in liver, but its regulation is uncharacterized. Results: Dehydroepiandrosterone (DHEA) rapidly increases miR-21 transcription in HepG2 cells by activating G-protein-coupled estrogen receptor (GPER). Conclusion: miR-21 transcription is regulated by DHEA through GPER. Significance: GPER may be among the activators of miR-21 expression in human hepatocellular carcinoma. Little is known about the regulation of the oncomiR miR-21 in liver. Dehydroepiandrosterone (DHEA) regulates gene expression as a ligand for a G-protein-coupled receptor and as a precursor for steroids that activate nuclear receptor signaling. We report that 10 nm DHEA increases primary miR-21 (pri-miR-21) transcription and mature miR-21 expression in HepG2 cells in a biphasic manner with an initial peak at 1 h followed by a second, sustained response from 3-12 h. DHEA also increased miR-21 in primary human hepatocytes and Hep3B cells. siRNA, antibody, and inhibitor studies suggest that the rapid DHEA-mediated increase in miR-21 involves a G-protein-coupled estrogen receptor (GPER/GPR30), estrogen receptor -36 (ER36), epidermal growth factor receptor-dependent, pertussis toxin-sensitive pathway requiring activation of c-Src, ERK1/2, and PI3K. GPER antagonist G-15 attenuated DHEA- and BSA-conjugated DHEA-stimulated pri-miR-21 transcription. Like DHEA, GPER agonists G-1 and fulvestrant increased pri-miR-21 in a GPER- and ER36-dependent manner. DHEA, like G-1, increased GPER and ER36 mRNA and protein levels. DHEA increased ERK1/2 and c-Src phosphorylation in a GPER-responsive manner. DHEA increased c-Jun, but not c-Fos, protein expression after 2 h. DHEA increased androgen receptor, c-Fos, and c-Jun recruitment to the miR-21 promoter. These results suggest that physiological concentrations of DHEA activate a GPER intracellular signaling cascade that increases pri-miR-21 transcription mediated at least in part by AP-1 and androgen receptor miR-21 promoter interaction.	[Teng, Yun; Radde, Brandie N.; Litchfield, Lacey M.; Ivanova, Margarita M.; Prough, Russell A.; Clark, Barbara J.; Klinge, Carolyn M.] Univ Louisville, Sch Med, Ctr Genet & Mol Med, Dept Biochem & Mol Genet, Louisville, KY 40292 USA; [Doll, Mark A.; Hein, David W.] Univ Louisville, Sch Med, Ctr Genet & Mol Med, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA	University of Louisville; University of Louisville	Klinge, CM (corresponding author), Univ Louisville, Sch Med, Ctr Genet & Mol Med, Dept Biochem & Mol Genet, Louisville, KY 40292 USA.	carolyn.klinge@louisville.edu	Regan, Clinton/E-6250-2012; Ivanova, Margarita/AAM-4510-2021; Russell A, Prough/AAH-5907-2020; Hein, David W/A-9707-2008	Ivanova, Margarita/0000-0002-6197-8606; Prough, Russell/0000-0001-8901-8490; Clark, Barbara/0000-0003-1558-1904; Hein, David/0000-0003-3261-9775	National Institutes of Health [R01 CA138410]; NIEHS, National Institutes of Health [T32 ES011564]; NATIONAL CANCER INSTITUTE [R01CA138410] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES011564] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA138410 (to C. M. K.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by NIEHS, National Institutes of Health Grant T32 ES011564.	Anagnostopoulou V, 2013, ENDOCRINOLOGY, V154, P2446, DOI 10.1210/en.2012-2249; Androsavich JR, 2012, RNA, V18, P1510, DOI 10.1261/rna.033308.112; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Borel F, 2012, J HEPATOL, V56, P1371, DOI 10.1016/j.jhep.2011.11.026; Bourdeau V, 2008, NUCLEIC ACIDS RES, V36, P76, DOI 10.1093/nar/gkm945; Cermelli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023937; Chan QKY, 2010, CELL DEATH DIFFER, V17, P1511, DOI 10.1038/cdd.2010.20; Charalampopoulos I, 2006, FASEB J, V20, P577, DOI 10.1096/fj.05-5078fje; Chaudhri RA, 2012, J BIOL CHEM, V287, P7169, DOI 10.1074/jbc.M111.292946; Chen JL, 2009, ENDOCRINOLOGY, V150, P4583, DOI 10.1210/en.2009-0455; Deng H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088034; Dennis MK, 2009, NAT CHEM BIOL, V5, P421, DOI 10.1038/nchembio.168; Dey P, 2013, J MOL ENDOCRINOL, V51, pT61, DOI 10.1530/JME-13-0150; Dinneen JL, 2004, TRAFFIC, V5, P606, DOI 10.1111/j.1398-9219.2004.00204.x; Dong B, 2011, BBA-GEN SUBJECTS, V1810, P427, DOI 10.1016/j.bbagen.2010.11.007; Dorak M. Tevfik, 2012, Frontiers in Genetics, V3, P268, DOI 10.3389/fgene.2012.00268; Dowman JK, 2013, ENDOCRINOLOGY, V154, P4536, DOI 10.1210/en.2013-1592; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Filardo EJ, 2012, ENDOCRINOLOGY, V153, P2953, DOI 10.1210/en.2012-1061; Fox EM, 2008, MOL ENDOCRINOL, V22, P1781, DOI 10.1210/me.2007-0419; Francis H, 2014, J BIOL CHEM, V289, P27526, DOI 10.1074/jbc.M114.602383; Fujita S, 2008, J MOL BIOL, V378, P492, DOI 10.1016/j.jmb.2008.03.015; Girgert R, 2012, BREAST CANCER RES TR, V134, P199, DOI 10.1007/s10549-012-1968-x; Ho HY, 2008, INT J ONCOL, V33, P969, DOI 10.3892/ijo_00000084; Huang YH, 2013, CANCER RES, V73, P2505, DOI 10.1158/0008-5472.CAN-12-2218; Ikeda Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040465; Jiang RQ, 2011, CLIN CANCER RES, V17, P5593, DOI 10.1158/1078-0432.CCR-10-1734; Jin SH, 2008, ARCH DERMATOL RES, V300, P451, DOI 10.1007/s00403-008-0864-z; Joel PB, 1998, J BIOL CHEM, V273, P13317, DOI 10.1074/jbc.273.21.13317; Kang LG, 2010, MOL ENDOCRINOL, V24, P709, DOI 10.1210/me.2009-0317; Labrie F, 1997, J CLIN ENDOCR METAB, V82, P2396, DOI 10.1210/jc.82.8.2396; Li Z, 2012, CELL, V148, P72, DOI 10.1016/j.cell.2011.11.026; Lin F, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-58; Liu DM, 2004, STEROIDS, V69, P279, DOI 10.1016/j.steroids.2004.02.004; Lobenhofer EK, 2000, CELL GROWTH DIFFER, V11, P99; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Madeo A, 2010, CANCER RES, V70, P6036, DOI 10.1158/0008-5472.CAN-10-0408; Mattingly KA, 2008, MOL ENDOCRINOL, V22, P609, DOI 10.1210/me.2007-0029; Mayer D, 2004, INT J ONCOL, V25, P1021; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Miceli V, 2011, OMICS, V15, P313, DOI 10.1089/omi.2010.0108; Moriguchi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060863; Mudduluru G, 2011, BIOSCIENCE REP, V31, P185, DOI 10.1042/BSR20100065; Nie HZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061678; Niro S, 2012, STEROIDS, V77, P542, DOI 10.1016/j.steroids.2012.01.019; Notas G, 2012, STEROIDS, V77, P943, DOI 10.1016/j.steroids.2011.11.005; Pinthus JH, 2007, NEOPLASIA, V9, P68, DOI 10.1593/neo.06739; Prossnitz ER, 2014, MOL CELL ENDOCRINOL, V389, P71, DOI 10.1016/j.mce.2014.02.002; Prossnitz ER, 2011, NAT REV ENDOCRINOL, V7, P715, DOI 10.1038/nrendo.2011.122; Prossnitz ER, 2009, MOL CELL ENDOCRINOL, V308, P32, DOI 10.1016/j.mce.2009.03.026; Qu KZ, 2011, J CLIN GASTROENTEROL, V45, P355, DOI 10.1097/MCG.0b013e3181f18ac2; Rege J, 2013, J CLIN ENDOCR METAB, V98, P1182, DOI 10.1210/jc.2012-2912; Riggs KA, 2006, CANCER RES, V66, P10188, DOI 10.1158/0008-5472.CAN-05-3937; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Samaras N, 2013, REJUV RES, V16, P285, DOI 10.1089/rej.2013.1425; Santolla MF, 2012, J BIOL CHEM, V287, P43234, DOI 10.1074/jbc.M112.417303; Simoncini T, 2006, MOL ENDOCRINOL, V20, P1756, DOI 10.1210/me.2005-0259; Teng Y, 2014, MOL CELL ENDOCRINOL, V392, P23, DOI 10.1016/j.mce.2014.05.007; Terao M, 2011, J BIOL CHEM, V286, P4027, DOI 10.1074/jbc.M110.184994; Tiwary R, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3063; Traish AM, 2011, J SEX MED, V8, P2960, DOI 10.1111/j.1743-6109.2011.02523.x; Turato C, 2014, LIFE SCI, V100, P9, DOI 10.1016/j.lfs.2014.01.073; Vivar OI, 2010, J BIOL CHEM, V285, P22059, DOI 10.1074/jbc.M110.114116; Wallacides A, 2012, MOL CELL ENDOCRINOL, V350, P61, DOI 10.1016/j.mce.2011.11.021; Wang YP, 1999, HEPATOLOGY, V30, P682, DOI 10.1002/hep.510300318; Webb SJ, 2006, DRUG METAB REV, V38, P89, DOI 10.1080/03602530600569877; Wu MH, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001143; Yang WW, 2012, J BIOL CHEM, V287, P40140, DOI 10.1074/jbc.M112.348763; Zhang H, 2006, ONCOGENE, V25, P6101, DOI 10.1038/sj.onc.1209634; Zhu Q, 2012, ONCOL REP, V27, P1660, DOI 10.3892/or.2012.1682; Zou Y, 2009, FEBS LETT, V583, P1368, DOI 10.1016/j.febslet.2009.03.047	71	40	41	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15799	15811		10.1074/jbc.M115.641167	http://dx.doi.org/10.1074/jbc.M115.641167			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25969534	hybrid, Green Published			2022-12-28	WOS:000356527400040
J	Ishino, S; Kawata, Y; Taguchi, H; Kajimura, N; Matsuzaki, K; Hoshino, M				Ishino, So; Kawata, Yasushi; Taguchi, Hideki; Kajimura, Naoko; Matsuzaki, Katsumi; Hoshino, Masaru			Effects of C-terminal Truncation of Chaperonin GroEL on the Yield of In-cage Folding of the Green Fluorescent Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; HYDROPHILIC RESIDUES; STRUCTURAL FEATURES; SUBSTRATE PROTEIN; FUNCTIONAL FORM; REACTION CYCLE; COMPLEX; INTERMEDIATE; POLYPEPTIDE	Chaperonin GroEL from Escherichia coli consists of two heptameric rings stacked back-to-back to form a cagelike structure. It assists in the folding of substrate proteins in concert with the co-chaperonin GroES by incorporating them into its large cavity. The mechanism underlying the incorporation of substrate proteins currently remains unclear. The flexible C-terminal residues of GroEL, which are invisible in the x-ray crystal structure, have recently been suggested to play a key role in the efficient encapsulation of substrates. These C-terminal regions have also been suggested to separate the double rings of GroEL at the bottom of the cavity. To elucidate the role of the C-terminal regions of GroEL on the efficient encapsulation of substrate proteins, we herein investigated the effects of C-terminal truncation on GroE-mediated folding using the green fluorescent protein (GFP) as a substrate. We demonstrated that the yield of in-cage folding mediated by a single ring GroEL (SR1) was markedly decreased by truncation, whereas that mediated by a double ring football-shaped complex was not affected. These results suggest that the C-terminal region of GroEL functions as a barrier between rings, preventing the leakage of GFP through the bottom space of the cage. We also found that once GFP folded into its native conformation within the cavity of SR1 it never escaped even in the absence of the C-terminal tails. This suggests that GFP molecules escaped through the pore only when they adopted a denatured conformation. Therefore, the folding and escape of GFP from C-terminally truncated SR1 center dot GroES appeared to be competing with each other.	[Ishino, So; Matsuzaki, Katsumi; Hoshino, Masaru] Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan; [Kawata, Yasushi] Tottori Univ, Grad Sch Engn, Dept Biotechnol, Tottori 6808552, Japan; [Taguchi, Hideki] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Kajimura, Naoko] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan	Kyoto University; Tottori University; Tokyo Institute of Technology; Osaka University	Hoshino, M (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, 46-29 Yoshida Shimoadachi, Kyoto 6068501, Japan.	hoshi@pharm.kyoto-u.ac.jp	Kawata, Yasushi/ABA-9608-2021; taguchi, hideki/AAM-2663-2021; Taguchi, Hideki/B-6946-2009; Kajimura, Naoko/R-9267-2019	taguchi, hideki/0000-0002-6612-9339; Taguchi, Hideki/0000-0002-6612-9339; Kawata, Yasushi/0000-0002-2744-1506	Japan Society for the Promotion of Science [23570192]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Japan Society for the Promotion of Science Grant-in-aid for Scientific Research (C) 23570192.	Apetri AC, 2008, P NATL ACAD SCI USA, V105, P17351, DOI 10.1073/pnas.0809794105; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; BURNETT BP, 1994, J BACTERIOL, V176, P6980, DOI 10.1128/JB.176.22.6980-6985.1994; Chen DH, 2013, CELL, V153, P1354, DOI 10.1016/j.cell.2013.04.052; CHEN S, 1994, NATURE, V371, P261, DOI 10.1038/371261a0; Doering DS, 1996, BIOCHEMISTRY-US, V35, P12677, DOI 10.1021/bi9615699; Farr GW, 2007, P NATL ACAD SCI USA, V104, P5342, DOI 10.1073/pnas.0700820104; Fei X, 2014, P NATL ACAD SCI USA, V111, P12775, DOI 10.1073/pnas.1412922111; Fujiwara K, 2010, EMBO J, V29, P1552, DOI 10.1038/emboj.2010.52; Gupta AJ, 2014, J MOL BIOL, V426, P2739, DOI 10.1016/j.jmb.2014.04.018; HORWICH AL, 1993, CELL, V74, P909, DOI 10.1016/0092-8674(93)90470-B; Horwich AL, 2009, FEBS LETT, V583, P2654, DOI 10.1016/j.febslet.2009.06.049; Hunt JF, 1996, NATURE, V379, P37, DOI 10.1038/379037a0; Ishino S, 2014, J BIOCHEM, V155, P295, DOI 10.1093/jb/mvu009; Kawata Y, 1999, BIOCHEMISTRY-US, V38, P15731, DOI 10.1021/bi9909750; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Koike-Takeshita A, 2008, J BIOL CHEM, V283, P23774, DOI 10.1074/jbc.M802542200; Koike-Takeshita A, 2014, J BIOL CHEM, V289, P30005, DOI 10.1074/jbc.M114.593822; Koike-Takeshita A, 2014, J MOL BIOL, V426, P3634, DOI 10.1016/j.jmb.2014.08.017; Machida K, 2008, J BIOL CHEM, V283, P6886, DOI 10.1074/jbc.M708002200; MCLENNAN NF, 1994, MOL MICROBIOL, V14, P309, DOI 10.1111/j.1365-2958.1994.tb01292.x; MCLENNAN NF, 1993, MOL MICROBIOL, V7, P49, DOI 10.1111/j.1365-2958.1993.tb01096.x; Motojima F, 2003, J BIOL CHEM, V278, P26648, DOI 10.1074/jbc.M300806200; Motojima F, 2000, BIOCHEM BIOPH RES CO, V267, P842, DOI 10.1006/bbrc.1999.2020; Motojima F, 2010, EMBO J, V29, P4008, DOI 10.1038/emboj.2010.262; Nojima T, 2008, J BIOL CHEM, V283, P18385, DOI 10.1074/jbc.M709825200; Sameshima T, 2008, J BIOL CHEM, V283, P23765, DOI 10.1074/jbc.M802541200; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; Suzuki M, 2008, J BIOL CHEM, V283, P23931, DOI 10.1074/jbc.M804090200; Taguchi H, 2004, J BIOL CHEM, V279, P45737, DOI 10.1074/jbc.M406795200; Tanaka S, 2010, BBA-PROTEINS PROTEOM, V1804, P866, DOI 10.1016/j.bbapap.2009.12.016; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; Thiyagarajan P, 1996, STRUCTURE, V4, P79, DOI 10.1016/S0969-2126(96)00011-1; Ueno T, 2004, MOL CELL, V14, P423, DOI 10.1016/S1097-2765(04)00261-8; Weaver J, 2014, J BIOL CHEM, V289, P23219, DOI 10.1074/jbc.M114.577205; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; Yang D, 2013, P NATL ACAD SCI USA, V110, pE4298, DOI 10.1073/pnas.1318862110	38	10	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15042	15051		10.1074/jbc.M114.633636	http://dx.doi.org/10.1074/jbc.M114.633636			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25887400	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000356177300020
J	Brand, OJ; Somanath, S; Moermans, C; Yanagisawa, H; Hashimoto, M; Cambier, S; Markovics, J; Bondesson, AJ; Hill, A; Jablons, D; Wolters, P; Lou, JL; Marks, JD; Baron, JL; Nishimura, SL				Brand, Oliver J.; Somanath, Sangeeta; Moermans, Catherine; Yanagisawa, Haruhiko; Hashimoto, Mitsuo; Cambier, Stephanie; Markovics, Jennifer; Bondesson, Andrew J.; Hill, Arthur; Jablons, David; Wolters, Paul; Lou, Jianlong; Marks, James D.; Baron, Jody L.; Nishimura, Stephen L.			Transforming Growth Factor-beta and Interleukin-1 beta Signaling Pathways Converge on the Chemokine CCL20 Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ACTIVATES LATENT TGF-BETA-1; AIRWAY EPITHELIAL-CELLS; NF-KAPPA-B; DENDRITIC CELLS; TGF-BETA; EXTRACELLULAR-MATRIX; LUNG INJURY; INTEGRIN; INFLAMMATION	CCL20 is the only chemokine ligand for the chemokine receptor CCR6, which is expressed by the critical antigen presenting cells, dendritic cells. Increased expression of CCL20 is likely involved in the increased recruitment of dendritic cells observed in fibroinflammatory diseases such as chronic obstructive pulmonary disease (COPD). CCL20 expression is increased by the proinflammatory cytokine IL-1 beta. We have determined that IL-1 beta-dependent CCL20 expression is also dependent on the multifunctional cytokine TGF-beta. TGF-beta is expressed in a latent form that must be activated to function, and activation is achieved through binding to the integrin alpha v beta 8 (itgb8). Here we confirm correlative increases in alpha v beta 8 and IL-1 beta with CCL20 protein in lung parenchymal lysates of a large cohort of COPD patients. How IL-1 beta- and alpha v beta 8-mediated TGF-beta activation conspire to increase fibroblast CCL20 expression remains unknown, because these pathways have not been shown to directly interact. We evaluate the 5'-flanking region of CCL20 to determine that IL-1 beta -driven CCL20 expression is dependent on alpha v beta 8-mediated activation of TGF-beta. We identify a TGF-beta-responsive element (i. e. SMAD) located on an upstream enhancer of the human CCL20 promoter required for efficient IL-1 beta-dependent CCL20 expression. By chromatin immunoprecipitation, this upstream enhancer complexes with the p50 subunit of NF-kappa B-on a NF-kappa B-binding element close to the transcriptional start site of CCL20. These interactions are confirmed by electromobility shift assays in nuclear extracts from human lung fibroblasts. These data define a mechanism by which alpha v beta 8-dependent activation of TGF-beta regulates IL-1 beta-dependent CCL20 expression in COPD.	[Brand, Oliver J.; Somanath, Sangeeta; Moermans, Catherine; Yanagisawa, Haruhiko; Hashimoto, Mitsuo; Cambier, Stephanie; Markovics, Jennifer; Bondesson, Andrew J.; Nishimura, Stephen L.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94110 USA; [Lou, Jianlong; Marks, James D.] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94110 USA; [Wolters, Paul; Baron, Jody L.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94110 USA; [Hill, Arthur; Jablons, David] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94110 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Nishimura, SL (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Bldg 3,Rm 211,1001 Potrero Ave, San Francisco, CA 94110 USA.	stephen.nishimura@ucsf.edu	Regan, Clinton/E-6250-2012	Moermans, Catherine/0000-0002-9558-5878	National Institutes of Health [HL113032, HL063993, HL090662, NS044155]; University of California-Center for Accelerated Innovation [U54HL119893]; University of California; University of California San Francisco Liver Center [P30DK026743]; University of California Tobacco Related Disease Research Program; University of California San Francisco Academic Senate; Nina Ireland Lung Disease Program; Leon Fredericq Foundation; Belgian Respiratory Society; University of Liege; European Union; regional, national, and international programmes (COFUND)-BeIPD Project; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL119893, R01HL090662, R01HL113032, R01HL063993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS044155] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California-Center for Accelerated Innovation; University of California(University of California System); University of California San Francisco Liver Center(University of California System); University of California Tobacco Related Disease Research Program(University of California System); University of California San Francisco Academic Senate(University of California System); Nina Ireland Lung Disease Program; Leon Fredericq Foundation; Belgian Respiratory Society; University of Liege(University of Liege); European Union(European Commission); regional, national, and international programmes (COFUND)-BeIPD Project; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL113032, HL063993, HL090662, and NS044155; University of California-Center for Accelerated Innovation Grant U54HL119893; University of California Proof of Concept Award; University of California San Francisco Liver Center Grant P30DK026743 (to S. L. N. and J. L. B.); and by funds from the University of California Tobacco Related Disease Research Program, the University of California San Francisco Academic Senate, the Nina Ireland Lung Disease Program (to P. W.), the Leon Fredericq Foundation, the Belgian Respiratory Society, the University of Liege, and the European Union Seventh Framework Programme for Research (FP7), Co-funding of regional, national, and international programmes (COFUND)-BeIPD Project (to C. M.). J. L., J. D. M., J. L. B., and S. N. have received royalty payments from the Regents of the University of California for beta 8 neutralizing antibodies used in this work.	Aluwihare P, 2009, J CELL SCI, V122, P227, DOI 10.1242/jcs.035246; Alverdi V, 2014, P NATL ACAD SCI USA, V111, P225, DOI 10.1073/pnas.1318115111; Araya J, 2007, J CLIN INVEST, V117, P3551, DOI 10.1172/JCI32526; Araya J, 2006, AM J PATHOL, V169, P405, DOI 10.2353/ajpath.2006.060049; Bosisio D, 2006, EMBO J, V25, P798, DOI 10.1038/sj.emboj.7600977; Caramori G, 2014, INT J CHRONIC OBSTR, V9, P397, DOI 10.2147/COPD.S42544; CHOMARAT P, 1995, J IMMUNOL, V154, P1432; Churg A, 2009, AM J RESP CELL MOL, V40, P482, DOI 10.1165/rcmb.2008-0038OC; Demedts IK, 2007, AM J RESP CRIT CARE, V175, P998, DOI 10.1164/rccm.200608-1113OC; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Doz E, 2008, J IMMUNOL, V180, P1169, DOI 10.4049/jimmunol.180.2.1169; Flanders KC, 2004, INT J EXP PATHOL, V85, P47, DOI 10.1111/j.0959-9673.2004.00377.x; Geraghty P, 2011, J BIOL CHEM, V286, P30211, DOI 10.1074/jbc.M111.238824; Gessner C, 2005, RESP MED, V99, P1229, DOI 10.1016/j.rmed.2005.02.041; Greaves DR, 1997, J EXP MED, V186, P837, DOI 10.1084/jem.186.6.837; Hashimoto M, 2015, J IMMUNOL, V194, P3962, DOI 10.4049/jimmunol.1403043; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; Jeffery Peter K, 2004, Proc Am Thorac Soc, V1, P176, DOI 10.1513/pats.200402-009MS; Kang MJ, 2008, J CLIN INVEST, V118, P2771, DOI 10.1172/JCI32709; Kitamura H, 2011, J CLIN INVEST, V121, P2863, DOI 10.1172/JCI45589; Kolb M, 2001, J CLIN INVEST, V107, P1529, DOI 10.1172/JCI12568; Kudo M, 2012, NAT MED, V18, P547, DOI 10.1038/nm.2684; Lambrecht BN, 2009, IMMUNITY, V31, P412, DOI 10.1016/j.immuni.2009.08.008; Lappalainen U, 2005, AM J RESP CELL MOL, V32, P311, DOI 10.1165/rcmb.2004-0309OC; Larrivee B, 2012, DEV CELL, V22, P489, DOI 10.1016/j.devcel.2012.02.005; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Lucattelli M, 2011, AM J RESP CELL MOL, V44, P423, DOI 10.1165/rcmb.2010-0038OC; Markovics JA, 2011, J BIOL CHEM, V286, P36864, DOI 10.1074/jbc.M111.276790; Melton AC, 2010, J CLIN INVEST, V120, P4436, DOI 10.1172/JCI43786; Mertens M, 2009, J RHEUMATOL, V36, P1118, DOI 10.3899/jrheum.090074; Minagawa S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008074; Minino Arialdi M, 2010, Natl Vital Stat Rep, V59, P1; Mu DZ, 2002, J CELL BIOL, V157, P493, DOI 10.1083/jcb.200109100; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Munger JS, 1998, MOL BIOL CELL, V9, P2627, DOI 10.1091/mbc.9.9.2627; Munoz-Felix JM, 2014, BBA-MOL CELL RES, V1843, P1111, DOI 10.1016/j.bbamcr.2014.02.017; Papi A, 2006, AM J RESP CRIT CARE, V173, P1114, DOI 10.1164/rccm.200506-859OC; Pauwels NS, 2011, EUR RESPIR J, V38, P1019, DOI 10.1183/09031936.00158110; Podowski M, 2012, J CLIN INVEST, V122, P229, DOI 10.1172/JCI46215; Postma Dirkje S, 2006, Proc Am Thorac Soc, V3, P434, DOI 10.1513/pats.200601-006AW; Reibman J, 2003, AM J RESP CELL MOL, V28, P648, DOI 10.1165/rcmb.2002-0095OC; Rumbo M, 2004, GASTROENTEROLOGY, V127, P213, DOI 10.1053/j.gastro.2004.04.018; Saika S, 2004, AM J PATHOL, V164, P651, DOI 10.1016/S0002-9440(10)63153-7; Sapey E, 2009, J CLIN IMMUNOL, V29, P508, DOI 10.1007/s10875-009-9286-8; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Siegel R, 2011, J IMMUNOL, V187, P5636, DOI 10.4049/jimmunol.1003988; Singh B., 2010, SECONDO ATENEO, V73, P86; Sirard C, 2000, J BIOL CHEM, V275, P2063, DOI 10.1074/jbc.275.3.2063; Takizawa H, 2001, AM J RESP CRIT CARE, V163, P1476, DOI 10.1164/ajrccm.163.6.9908135; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; Varona R, 1998, FEBS LETT, V440, P188, DOI 10.1016/S0014-5793(98)01450-1; Vitsky A, 2009, AM J PATHOL, V174, P2137, DOI 10.2353/ajpath.2009.080723; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Wu SH, 2011, CURR OPIN INFECT DIS, V24, P235, DOI 10.1097/QCO.0b013e328344c0e3	54	18	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14717	14728		10.1074/jbc.M114.630368	http://dx.doi.org/10.1074/jbc.M114.630368			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25918170	Green Published, hybrid			2022-12-28	WOS:000355754600041
J	Yoshida, K; Hara, S; Hisabori, T				Yoshida, Keisuke; Hara, Satoshi; Hisabori, Toru			Thioredoxin Selectivity for Thiol-based Redox Regulation of Target Proteins in Chloroplasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADP-MALATE-DEHYDROGENASE; LIGHT ACTIVATION; ATP SYNTHASE; PLASTIDIAL THIOREDOXINS; ARABIDOPSIS-THALIANA; MAGNESIUM CHELATASE; INVERSE REGULATION; STRUCTURAL BASIS; GAMMA-SUBUNIT; REDUCTION	Redox regulation based on the thioredoxin (Trx) system is believed to ensure light-responsive control of various functions in chloroplasts. Five Trx subtypes have been reported to reside in chloroplasts, but their functional diversity in the redox regulation of Trx target proteins remains poorly clarified. To directly address this issue, we studied the Trx-dependent redox shifts of several chloroplast thiol-modulated enzymes in vitro and in vivo. In vitro assays using a series of Arabidopsis recombinant proteins provided new insights into Trx selectivity for the redox regulation as well as the underpinning for previous suggestions. Most notably, by combining the discrimination of thiol status with mass spectrometry and activity measurement, we identified an uncharacterized aspect of the reductive activation of NADP-malate dehydrogenase; two redox-active Cys pairs harbored in this enzyme were reduced via distinct utilization of Trxs even within a single polypeptide. In our in vitro assays, Trx-f was effective in reducing all thiol-modulated enzymes analyzed here. We then investigated the in vivo physiological relevance of these in vitro findings, using Arabidopsis wild-type and Trx-f-deficient plants. Photoreduction of fructose-1,6-bis-phosphatase was partially impaired in Trx-f-deficient plants, but the global impact of Trx-f deficiency on the redox behaviors of thiol-modulated enzymes was not as striking as expected from the in vitro data. Our results provide support for the in vivo functionality of the Trx system and also highlight the complexity and plasticity of the chloroplast redox network.	[Yoshida, Keisuke; Hara, Satoshi; Hisabori, Toru] Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Nagatsuta 4259-R1-8, Yokohama, Kanagawa 2268503, Japan; [Yoshida, Keisuke; Hisabori, Toru] Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol, Tokyo 1020075, Japan	Tokyo Institute of Technology; Japan Science & Technology Agency (JST)	Hisabori, T (corresponding author), Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Nagatsuta 4259-R1-8, Yokohama, Kanagawa 2268503, Japan.	thisabor@res.titech.ac.jp	Hisabori, Toru/E-5205-2014; Yoshida, Keisuke/E-5231-2014; Hara, Satoshi/C-1341-2015	Hisabori, Toru/0000-0003-2046-0277; Yoshida, Keisuke/0000-0001-6542-6254; Hara, Satoshi/0000-0001-6275-6469	Core Research of Evolutional Science and Technology program (CREST) from the Japan Science and Technology Agency (JST); Japan Society for the Promotion of Science [26840090]; Grants-in-Aid for Scientific Research [15H04384] Funding Source: KAKEN	Core Research of Evolutional Science and Technology program (CREST) from the Japan Science and Technology Agency (JST); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Core Research of Evolutional Science and Technology program (CREST) from the Japan Science and Technology Agency (JST) and Grant-in-aid for Scientific Research 26840090 (to K. Y.) from the Japan Society for the Promotion of Science.	Arsova B, 2010, PLANT CELL, V22, P1498, DOI 10.1105/tpc.109.071001; BUCHANAN BB, 1980, ANNU REV PLANT PHYS, V31, P341, DOI 10.1146/annurev.pp.31.060180.002013; Carr PD, 1999, STRUCTURE, V7, P461, DOI 10.1016/S0969-2126(99)80058-6; Chiadmi M, 1999, EMBO J, V18, P6809, DOI 10.1093/emboj/18.23.6809; Chibani K, 2011, FEBS LETT, V585, P1077, DOI 10.1016/j.febslet.2011.03.006; Collin V, 2004, PLANT PHYSIOL, V136, P4088, DOI 10.1104/pp.104.052233; Collin V, 2003, J BIOL CHEM, V278, P23747, DOI 10.1074/jbc.M302077200; Dietz KJ, 2006, J EXP BOT, V57, P1697, DOI 10.1093/jxb/erj160; Dunford RP, 1998, PHOTOSYNTH RES, V58, P221, DOI 10.1023/A:1006178826976; Geck RK, 1996, J BIOL CHEM, V271, P24736, DOI 10.1074/jbc.271.40.24736; Goyer A, 2001, FEBS LETT, V505, P405, DOI 10.1016/S0014-5793(01)02860-5; Hara S, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00508; Hara S, 2013, BBA-GEN SUBJECTS, V1830, P3077, DOI 10.1016/j.bbagen.2013.01.012; Hirasawa M, 2000, BIOCHEMISTRY-US, V39, P3344, DOI 10.1021/bi9916731; Hisabori T, 2007, PHOTOCHEM PHOTOBIOL, V83, P145, DOI 10.1562/2006-02-27-IR-816; HODGES M, 1994, PLANT MOL BIOL, V26, P225, DOI 10.1007/BF00039534; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Hutchison RS, 2000, BIOCHEMISTRY-US, V39, P6679, DOI 10.1021/bi0001978; Ikegami A, 2007, J BIOL CHEM, V282, P19282, DOI 10.1074/jbc.M703324200; ISSAKIDIS E, 1994, J BIOL CHEM, V269, P3511; Issakidis E, 1996, FEBS LETT, V392, P121, DOI 10.1016/0014-5793(96)00801-0; ISSAKIDIS E, 1992, J BIOL CHEM, V267, P21577; Jacquot JP, 1997, FEBS LETT, V401, P143, DOI 10.1016/S0014-5793(96)01459-7; Johansson K, 1999, BIOCHEMISTRY-US, V38, P4319, DOI 10.1021/bi982876c; Kohzuma K, 2013, J BIOL CHEM, V288, P13156, DOI 10.1074/jbc.M113.453225; Konno H, 2000, BIOCHEM J, V352, P783, DOI 10.1042/0264-6021:3520783; Laugier E, 2013, PLANT CELL ENVIRON, V36, P670, DOI 10.1111/pce.12005; Luo T, 2012, PLANT PHYSIOL, V159, P118, DOI 10.1104/pp.112.195446; Marri L, 2009, MOL PLANT, V2, P259, DOI 10.1093/mp/ssn061; Michalska J, 2009, P NATL ACAD SCI USA, V106, P9908, DOI 10.1073/pnas.0903559106; Michelet L, 2005, P NATL ACAD SCI USA, V102, P16478, DOI 10.1073/pnas.0507498102; Michelet L, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00470; Miginiac-Maslow M, 2002, PHOTOSYNTH RES, V72, P1, DOI 10.1023/A:1016099228450; Montrichard F, 2009, J PROTEOMICS, V72, P452, DOI 10.1016/j.jprot.2008.12.002; Motohashi K, 2001, P NATL ACAD SCI USA, V98, P11224, DOI 10.1073/pnas.191282098; Motohashi K, 2006, J BIOL CHEM, V281, P35039, DOI 10.1074/jbc.M605938200; Perez-Ruiz JM, 2006, PLANT CELL, V18, P2356, DOI 10.1105/tpc.106.041541; Richter AS, 2013, PLANT PHYSIOL, V162, P63, DOI 10.1104/pp.113.217141; Rouhier N, 2005, ANTIOXID REDOX SIGN, V7, P919, DOI 10.1089/ars.2005.7.919; Ruelland E, 1998, J BIOL CHEM, V273, P33482, DOI 10.1074/jbc.273.50.33482; Ruelland E, 1997, J BIOL CHEM, V272, P19851, DOI 10.1074/jbc.272.32.19851; Scheibe R, 2004, PHYSIOL PLANTARUM, V120, P21, DOI 10.1111/j.0031-9317.2004.0222.x; SCHURMANN P, 1981, EUR J BIOCHEM, V116, P37, DOI 10.1111/j.1432-1033.1981.tb05297.x; Schwarz O, 1997, J BIOL CHEM, V272, P16924, DOI 10.1074/jbc.272.27.16924; Serrato AJ, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00463; Thormahlen I, 2013, PLANT CELL ENVIRON, V36, P16, DOI 10.1111/j.1365-3040.2012.02549.x; Ueoka-Nakanishi H, 2004, J BIOL CHEM, V279, P16272, DOI 10.1074/jbc.M400607200; WOLOSIUK RA, 1979, J BIOL CHEM, V254, P1627; Yano H, 2001, P NATL ACAD SCI USA, V98, P4794, DOI 10.1073/pnas.071041998; Yoshida K, 2014, PLANT CELL PHYSIOL, V55, P1415, DOI 10.1093/pcp/pcu066; Yoshida K, 2013, PLANT CELL PHYSIOL, V54, P875, DOI 10.1093/pcp/pct037; Yoshida K, 2009, PLANT CELL PHYSIOL, V50, P1449, DOI 10.1093/pcp/pcp090	52	63	65	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14278	14288		10.1074/jbc.M115.647545	http://dx.doi.org/10.1074/jbc.M115.647545			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25878252	hybrid, Green Published			2022-12-28	WOS:000355754600002
J	Palomba, L; Silvestri, C; Imperatore, R; Morello, G; Piscitelli, F; Martella, A; Cristino, L; Di Marzo, V				Palomba, Letizia; Silvestri, Cristoforo; Imperatore, Roberta; Morello, Giovanna; Piscitelli, Fabiana; Martella, Andrea; Cristino, Luigia; Di Marzo, Vincenzo			Negative Regulation of Leptin-induced Reactive Oxygen Species (ROS) Formation by Cannabinoid CB1 Receptor Activation in Hypothalamic Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOCANNABINOID 2-ARACHIDONOYLGLYCEROL; GENE-EXPRESSION; PPAR-GAMMA; IDENTIFICATION; GLUCOSE; OBESITY; CELLS; BETA; TONE	The adipocyte-derived, anorectic hormone leptin was recently shown to owe part of its regulatory effects on appetite-regulating hypothalamic neuropeptides to the elevation of reactive oxygen species (ROS) levels in arcuate nucleus (ARC) neurons. Leptin is also known to exert a negative regulation on hypothalamic endocannabinoid levels and hence on cannabinoid CB1 receptor activity. Here we investigated the possibility of a negative regulation by CB1 receptors of leptin-mediated ROS formation in the ARC. Through pharmacological and molecular biology experiments we report data showing that leptin-induced ROS accumulation is 1) blunted by arachidonyl-2'-chloroethylamide (ACEA) in a CB1-dependent manner in both the mouse hypothalamic cell line mHypoE-N41 and ARC neuron primary cultures, 2) likewise blocked by a peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist, troglitazone, in a manner inhibited by T0070907, a PPAR-gamma antagonist that also inhibited the ACEA effect on leptin, 3) blunted under conditions of increased endocannabinoid tone due to either pharmacological or genetic inhibition of endocannabinoid degradation in mHypoE-N41 and primary ARC neuronal cultures from MAGL(-/-) mice, respectively, and 4) associated with reduction of both PPAR-gamma and catalase activity, which are reversed by both ACEA and troglitazone. We conclude that CB1 activation reverses leptin-induced ROS formation and hence possibly some of the ROS-mediated effects of the hormone by preventing PPAR-gamma inhibition by leptin, with subsequent increase of catalase activity. This mechanism might underlie in part CB1 orexigenic actions under physiopathological conditions accompanied by elevated hypothalamic endocannabinoid levels.	[Palomba, Letizia] Univ Urbino Carlo Bo, Dept Biomol Sci, I-61029 Urbino, Italy; [Palomba, Letizia; Silvestri, Cristoforo; Imperatore, Roberta; Morello, Giovanna; Piscitelli, Fabiana; Martella, Andrea; Cristino, Luigia; Di Marzo, Vincenzo] CNR, Endocannabinoid Res Grp, I-80078 Pozzuoli, NA, Italy; [Silvestri, Cristoforo; Imperatore, Roberta; Morello, Giovanna; Piscitelli, Fabiana; Martella, Andrea; Cristino, Luigia; Di Marzo, Vincenzo] CNR, Ist Chim Biomol, I-80078 Pozzuoli, NA, Italy	University of Urbino; Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica Biomolecolare (ICB-CNR)	Di Marzo, V (corresponding author), CNR, Ist Chim Biomol, Via Campi Flegrei 34, I-80078 Pozzuoli, NA, Italy.	vdimarzo@icb.cnr.it	Silvestri, Cristoforo/Y-2504-2019; Cristino, Luigia/AAE-3934-2020; Di Marzo, Vincenzo/AAD-7742-2019; Piscitelli, Fabiana/A-7100-2014	Silvestri, Cristoforo/0000-0001-5635-1545; Cristino, Luigia/0000-0002-0182-4699; Di Marzo, Vincenzo/0000-0002-1490-3070; Martella, Andrea/0000-0002-4680-7702; Piscitelli, Fabiana/0000-0001-9343-4622; IMPERATORE, Roberta/0000-0003-3609-2771				Bisogno T, 2013, BRIT J PHARMACOL, V169, P784, DOI 10.1111/bph.12013; Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; Chanda PK, 2010, MOL PHARMACOL, V78, P996, DOI 10.1124/mol.110.068304; Chen T, 2012, FREE RADICAL BIO MED, V53, P208, DOI 10.1016/j.freeradbiomed.2012.05.014; Chen X, 2011, NEUROSCIENCE, V178, P159, DOI 10.1016/j.neuroscience.2011.01.024; Cristino L, 2013, P NATL ACAD SCI USA, V110, pE2229, DOI 10.1073/pnas.1219485110; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Diano S, 2011, NAT MED, V17, P1121, DOI 10.1038/nm.2421; Ding GL, 2007, CARDIOVASC RES, V76, P269, DOI 10.1016/j.cardiores.2007.06.027; Du HZ, 2011, BRIT J PHARMACOL, V163, P1533, DOI 10.1111/j.1476-5381.2011.01444.x; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; Garretson JT, 2015, J NEUROSCI, V35, P4571, DOI 10.1523/JNEUROSCI.2129-14.2015; Girnun GD, 2002, MOL ENDOCRINOL, V16, P2793, DOI 10.1210/me.2002-0020; Gray E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-63; Hillard CJ, 1999, J PHARMACOL EXP THER, V289, P1427; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Igaz P, 2006, ENDOCRINOLOGY, V147, P1037, DOI 10.1210/en.2005-0729; Jordan SD, 2010, CELL MOL LIFE SCI, V67, P3255, DOI 10.1007/s00018-010-0414-7; Kirkham TC, 2002, BRIT J PHARMACOL, V136, P550, DOI 10.1038/sj.bjp.0704767; Matarese G, 2010, NAT REV NEUROL, V6, P455, DOI 10.1038/nrneurol.2010.89; Mates J M, 1999, Front Biosci, V4, pD339; Matias I, 2006, J CLIN ENDOCR METAB, V91, P3171, DOI 10.1210/jc.2005-2679; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; O'Sullivan SE, 2007, BRIT J PHARMACOL, V152, P576, DOI 10.1038/sj.bjp.0707423; O'Sullivan SE, 2010, IMMUNOBIOLOGY, V215, P611, DOI 10.1016/j.imbio.2009.09.007; Pagano C, 2007, J CLIN ENDOCR METAB, V92, P4810, DOI 10.1210/jc.2007-0768; Panikashvili D, 2006, NEUROBIOL DIS, V22, P257, DOI 10.1016/j.nbd.2005.11.004; Panikashvili D, 2005, J CEREBR BLOOD F MET, V25, P477, DOI 10.1038/sj.jcbfm.9600047; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Park BH, 2004, MOL CELL BIOL, V24, P8671, DOI 10.1128/MCB.24.19.8671-8680.2004; Petrosino S, 2016, BRIT J PHARMACOL, V173, P1154, DOI 10.1111/bph.13084; Rockwell CE, 2006, MOL PHARMACOL, V70, P101, DOI 10.1124/mol.105.019117; Schlosburg JE, 2010, NAT NEUROSCI, V13, P1113, DOI 10.1038/nn.2616; Schwartz MW, 1996, NAT MED, V2, P589, DOI 10.1038/nm0596-589; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; van Horssen J, 2011, BBA-MOL BASIS DIS, V1812, P141, DOI 10.1016/j.bbadis.2010.06.011; Zhang J, 2008, J BIOL CHEM, V283, P22601, DOI 10.1074/jbc.M800524200	38	38	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13669	13677		10.1074/jbc.M115.646885	http://dx.doi.org/10.1074/jbc.M115.646885			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25869131	Green Published, hybrid			2022-12-28	WOS:000355313000005
J	Tietz, S; Puthiyaveetil, S; Enlow, HM; Yarbrough, R; Wood, M; Semchonok, DA; Lowry, T; Li, Z; Jahns, P; Boekema, EJ; Lenhert, S; Niyogi, KK; Kirchhoff, H				Tietz, Stefanie; Puthiyaveetil, Sujith; Enlow, Heather M.; Yarbrough, Robert; Wood, Magnus; Semchonok, Dmitry A.; Lowry, Troy; Li, Zhirong; Jahns, Peter; Boekema, Egbert J.; Lenhert, Steven; Niyogi, Krishna K.; Kirchhoff, Helmut			Functional Implications of Photosystem II Crystal Formation in Photosynthetic Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING COMPLEX; ELECTRON-TRANSPORT; GRANA MEMBRANES; THYLAKOID MEMBRANES; PROTEIN-PHOSPHORYLATION; ARABIDOPSIS DEFICIENT; XANTHOPHYLL-CYCLE; SPINACH-CHLOROPLASTS; ANTENNA PROTEINS; QUALITY-CONTROL	The structural organization of proteins in biological membranes can affect their function. Photosynthetic thylakoid membranes in chloroplasts have the remarkable ability to change their supramolecular organization between disordered and semicrystalline states. Although the change to the semicrystalline state is known to be triggered by abiotic factors, the functional significance of this protein organization has not yet been understood. Taking advantage of an Arabidopsis thaliana fatty acid desaturase mutant (fad5) that constitutively forms semicrystalline arrays, we systematically test the functional implications of protein crystals in photosynthetic membranes. Here, we show that the change into an ordered state facilitates molecular diffusion of photosynthetic components in crowded thylakoid membranes. The increased mobility of small lipophilic molecules like plastoquinone and xanthophylls has implications for diffusion-dependent electron transport and photoprotective energy-dependent quenching. The mobility of the large photosystem II supercomplexes, however, is impaired, leading to retarded repair of damaged proteins. Our results demonstrate that supramolecular changes into more ordered states have differing impacts on photosynthesis that favor either diffusion-dependent electron transport and photoprotection or protein repair processes, thus fine-tuning the photosynthetic energy conversion.	[Tietz, Stefanie; Puthiyaveetil, Sujith; Enlow, Heather M.; Yarbrough, Robert; Wood, Magnus; Kirchhoff, Helmut] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; [Semchonok, Dmitry A.; Boekema, Egbert J.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Electron Microscopy Grp, NL-9747 AG Groningen, Netherlands; [Lowry, Troy; Lenhert, Steven] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Li, Zhirong; Niyogi, Krishna K.] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Li, Zhirong; Niyogi, Krishna K.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Jahns, Peter] Univ Dusseldorf, Inst Biochem Pflanzen, D-40225 Dusseldorf, Germany	Washington State University; University of Groningen; State University System of Florida; Florida State University; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Heinrich Heine University Dusseldorf	Kirchhoff, H (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.	kirchhh@wsu.edu	Semchonok, Dmitry/E-1461-2017; Puthiyaveetil, Sujith/S-3098-2016; Kirchhoff, Helmut/AAN-6695-2020	Puthiyaveetil, Sujith/0000-0001-7505-4511; Kirchhoff, Helmut/0000-0001-5874-3681; Tietz, Stefanie/0000-0003-1293-1163; Semchonok, Dmitry A./0000-0003-1622-9443	National Science Foundation [MCB115871]; United States-Israel Binational Agricultural Research and Development Fund [US-4334-10]; United States Department of Agriculture ARC [WNP00775]; Washington State University; Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Science, United States Department of Energy, FWP [SISGRKN]	National Science Foundation(National Science Foundation (NSF)); United States-Israel Binational Agricultural Research and Development Fund(US-Israel Binational Science Foundation); United States Department of Agriculture ARC; Washington State University; Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Science, United States Department of Energy, FWP(United States Department of Energy (DOE))	This work was supported by National Science Foundation Grant MCB115871 (to H. K.), United States-Israel Binational Agricultural Research and Development Fund US-4334-10, United States Department of Agriculture ARC Grant WNP00775, and Washington State University. The immunoblot experiments were supported by a grant from the Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Science, United States Department of Energy, FWP number SISGRKN (to K. K. N.)	ALLEN JF, 1992, BIOCHIM BIOPHYS ACTA, V1098, P275, DOI 10.1016/S0005-2728(09)91014-3; Arnoux P, 2009, PLANT CELL, V21, P2036, DOI 10.1105/tpc.109.068007; Betterle N, 2009, J BIOL CHEM, V284, P15255, DOI 10.1074/jbc.M808625200; BILGER W, 1988, Z NATURFORSCH C, V43, P877; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cramer WA, 1996, ANNU REV PLANT PHYS, V47, P477, DOI 10.1146/annurev.arplant.47.1.477; Daum B, 2010, PLANT CELL, V22, P1299, DOI 10.1105/tpc.109.071431; de Bianchi S, 2008, PLANT CELL, V20, P1012, DOI 10.1105/tpc.107.055749; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; Demmig-Adams B, 2012, PHOTOSYNTH RES, V113, P75, DOI 10.1007/s11120-012-9761-6; Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394; Farber A, 1997, PLANT PHYSIOL, V115, P1609, DOI 10.1104/pp.115.4.1609; Frommolt R, 2001, PLANTA, V213, P446, DOI 10.1007/s004250100589; Goral TK, 2012, PLANT J, V69, P289, DOI 10.1111/j.1365-313X.2011.04790.x; Goral TK, 2010, PLANT J, V62, P948, DOI [10.1111/j.1365-313X.2010.04207.x, 10.1111/j.0960-7412.2010.04207.x]; Goss R, 2005, BIOCHEMISTRY-US, V44, P4028, DOI 10.1021/bi047464k; Goss R, 2015, J PLANT PHYSIOL, V172, P13, DOI 10.1016/j.jplph.2014.03.004; HAEHNEL W, 1984, ANNU REV PLANT PHYS, V35, P659, DOI 10.1146/annurev.pp.35.060184.003303; Haferkamp S, 2010, J BIOL CHEM, V285, P17020, DOI 10.1074/jbc.M109.077750; Heilmann I, 2004, PLANT PHYSIOL, V136, P4237, DOI 10.1104/pp.104.052951; Herbstova M, 2012, P NATL ACAD SCI USA, V109, P20130, DOI 10.1073/pnas.1214265109; IZAWA S, 1978, BIOCHEM BIOPH RES CO, V83, P1171, DOI 10.1016/0006-291X(78)91518-8; Jahns P, 2009, BBA-BIOENERGETICS, V1787, P3, DOI 10.1016/j.bbabio.2008.09.013; Jahns P, 2012, BBA-BIOENERGETICS, V1817, P182, DOI 10.1016/j.bbabio.2011.04.012; Johnson MP, 2011, PLANT CELL, V23, P1468, DOI 10.1105/tpc.110.081646; Kereiche S, 2010, FEBS LETT, V584, P759, DOI 10.1016/j.febslet.2009.12.031; Kirchhoff H, 2002, BIOCHEMISTRY-US, V41, P4872, DOI 10.1021/bi011650y; Kirchhoff H, 2000, BBA-BIOENERGETICS, V1459, P148, DOI 10.1016/S0005-2728(00)00143-2; Kirchhoff H, 2004, BBA-BIOENERGETICS, V1659, P63, DOI 10.1016/j.bbabio.2004.08.004; Kirchhoff H, 2008, TRENDS PLANT SCI, V13, P201, DOI 10.1016/j.tplants.2008.03.001; Kirchhoff H, 2008, PLANT PHYSIOL, V146, P1571, DOI 10.1104/pp.107.115170; Kirchhoff H, 2008, BIOCHEMISTRY-US, V47, P431, DOI 10.1021/bi7017877; Kirchhoff H, 2014, BBA-BIOENERGETICS, V1837, P495, DOI 10.1016/j.bbabio.2013.11.003; Kirchhoff H, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23634; Kirchhoff H, 2013, PLANT PHYSIOL, V161, P497, DOI 10.1104/pp.112.207548; Klughammer C, 1998, PHOTOSYNTH RES, V56, P117, DOI 10.1023/A:1005998729041; Kouril R, 2013, BBA-BIOENERGETICS, V1827, P411, DOI 10.1016/j.bbabio.2012.12.003; Kovacs L, 2006, PLANT CELL, V18, P3106, DOI 10.1105/tpc.106.045641; Kramer DM, 2004, PHOTOSYNTH RES, V79, P209, DOI 10.1023/B:PRES.0000015391.99477.0d; Krause G. H., 2003, LIGHT HARVESTING ANT, V13, P373; KUNST L, 1989, PLANT PHYSIOL, V90, P943, DOI 10.1104/pp.90.3.943; KUNST L, 1989, PLANT PHYSIOL, V91, P401, DOI 10.1104/pp.91.1.401; KYLE DJ, 1984, P NATL ACAD SCI-BIOL, V81, P4070, DOI 10.1073/pnas.81.13.4070; Li XP, 2002, FUNCT PLANT BIOL, V29, P1131, DOI 10.1071/FP02065; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Li ZR, 2009, ANNU REV PLANT BIOL, V60, P239, DOI 10.1146/annurev.arplant.58.032806.103844; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Melis A, 1999, TRENDS PLANT SCI, V4, P130, DOI 10.1016/S1360-1385(99)01387-4; Morosinotto T, 2006, FEBS J, V273, P4616, DOI 10.1111/j.1742-4658.2006.05465.x; Mulo P, 2008, PHOTOSYNTH RES, V98, P489, DOI 10.1007/s11120-008-9320-3; Nelson N, 2004, NAT REV MOL CELL BIO, V5, P971, DOI 10.1038/nrm1525; Nield J, 2006, BBA-BIOENERGETICS, V1757, P353, DOI 10.1016/j.bbabio.2006.03.019; OHAD I, 1984, J CELL BIOL, V99, P481, DOI 10.1083/jcb.99.2.481; Oostergetel GT, 1998, ULTRAMICROSCOPY, V74, P47, DOI 10.1016/S0304-3991(98)00022-9; PARK RB, 1964, SCIENCE, V144, P1009, DOI 10.1126/science.144.3621.1009; Pesaresi P, 2011, BBA-BIOENERGETICS, V1807, P887, DOI 10.1016/j.bbabio.2010.08.002; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Puthiyaveetil S, 2014, P NATL ACAD SCI USA, V111, P15839, DOI 10.1073/pnas.1413739111; Rappaport F, 2007, BBA-BIOENERGETICS, V1767, P56, DOI 10.1016/j.bbabio.2006.10.002; Ruban AV, 2015, J EXP BOT, V66, P7, DOI 10.1093/jxb/eru400; Ruban AV, 2012, BBA-BIOENERGETICS, V1817, P167, DOI 10.1016/j.bbabio.2011.04.007; Schuhmann H, 2012, PHYSIOL PLANTARUM, V145, P224, DOI 10.1111/j.1399-3054.2011.01533.x; SEMENOVA GA, 1995, CAN J BOT, V73, P1676, DOI 10.1139/b95-181; Sznee K, 2011, J BIOL CHEM, V286, P39164, DOI 10.1074/jbc.M111.284844; Tikkanen M, 2012, BBA-BIOENERGETICS, V1817, P232, DOI 10.1016/j.bbabio.2011.05.005; Tremmel IG, 2003, BBA-BIOENERGETICS, V1607, P97, DOI 10.1016/j.bbabio.2003.09.004; TSVETKOVA NM, 1994, BBA-BIOMEMBRANES, V1192, P263, DOI 10.1016/0005-2736(94)90127-9; Tyystjarvi E, 1996, P NATL ACAD SCI USA, V93, P2213, DOI 10.1073/pnas.93.5.2213; Vijayan P, 2002, PLANT PHYSIOL, V129, P876, DOI 10.1104/pp.004341; Wagner R, 2012, PHYSIOL PLANTARUM, V145, P203, DOI 10.1111/j.1399-3054.2011.01548.x; WEBB MS, 1991, BIOCHIM BIOPHYS ACTA, V1060, P133, DOI 10.1016/S0005-2728(09)91002-7; Wu W, 2013, BBA-BIOENERGETICS, V1827, P709, DOI 10.1016/j.bbabio.2013.02.013; YAMAMOTO HY, 1985, METHOD ENZYMOL, V110, P303; Yoshioka-Nishimura M, 2014, PLANT CELL PHYSIOL, V55, P1255, DOI 10.1093/pcp/pcu079; Zhang R, 2011, PHOTOSYNTH RES, V108, P171, DOI 10.1007/s11120-011-9672-y	75	38	38	0	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					14091	14106		10.1074/jbc.M114.619841	http://dx.doi.org/10.1074/jbc.M114.619841			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25897076	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000355313000038
J	Andrikopoulos, P; Kieswich, J; Harwood, SM; Baba, A; Matsuda, T; Barbeau, O; Jones, K; Eccles, SA; Yaqoob, MM				Andrikopoulos, Petros; Kieswich, Julius; Harwood, Steven M.; Baba, Akemichi; Matsuda, Toshio; Barbeau, Olivier; Jones, Keith; Eccles, Suzanne A.; Yaqoob, Muhammad M.			Endothelial Angiogenesis and Barrier Function in Response to Thrombin Require Ca2+ Influx through the Na+/Ca2+ Exchanger	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; SPHINGOSINE 1-PHOSPHATE; ACTIVATED RECEPTORS; NA+-CA2+ EXCHANGER; TUMOR-GROWTH; IN-VITRO; CALCIUM; PERMEABILITY; ENTRY; CHANNELS	Thrombin acts on the endothelium by activating protease-activated receptors (PARs). The endothelial thrombin-PAR system becomes deregulated during pathological conditions resulting in loss of barrier function and a pro-inflammatory and pro-angiogenic endothelial phenotype. We reported recently that the ion transporter Na+/Ca2+ exchanger (NCX) operating in the Ca2+-influx (reverse) mode promoted ERK1/2 activation and angiogenesis in vascular endothelial growth factor-stimulated primary human vascular endothelial cells. Here, we investigated whether Ca2+ influx through NCX was involved in ERK1/2 activation, angiogenesis, and endothelial barrier dysfunction in response to thrombin. Reverse-mode NCX inhibitors and RNAi-mediated NCX1 knockdown attenuated ERK1/2 phosphorylation in response to thrombin or an agonist of PAR-1, the main endothelial thrombin receptor. Conversely, promoting reverse-mode NCX by suppressing Na+-K+-ATPase activity enhanced ERK1/2 activation. Reverse-mode NCX inhibitors and NCX1 siRNA suppressed thrombin-induced primary human vascular endothelial cell angiogenesis, quantified as proliferation and tubular differentiation. Reverse-mode NCX inhibitors or NCX1 knockdown preserved barrier integrity upon thrombin stimulation in vitro. Moreover, the reverse-mode NCX inhibitor SEA0400 suppressed Evans' blue albumin extravasation to the lung and kidneys and attenuated edema formation and ERK1/2 activation in the lungs of mice challenged with a peptide activator of PAR-1. Mechanistically, thrombin-induced ERK1/2 activation required NADPH oxidase 2-mediated reactive oxygen species (ROS) production, and reverse-mode NCX inhibitors and NCX1 siRNA suppressed thrombin-induced ROS production. We propose that reverse-mode NCX is a novel mechanism contributing to thrombin-induced angiogenesis and hyperpermeability by mediating ERK1/2 activation in a ROS-dependent manner. Targeting reverse-mode NCX could be beneficial in pathological conditions involving unregulated thrombin signaling.	[Andrikopoulos, Petros; Kieswich, Julius; Harwood, Steven M.; Yaqoob, Muhammad M.] Queen Marys Univ London, Translat Med & Therapeut, William Harvey Res Inst, Barts & London Sch Med, London EC1M 6BQ, England; [Baba, Akemichi] Hyogo Univ Hlth Sci, Chuo Ku, Kobe, Hyogo 6508530, Japan; [Matsuda, Toshio] Osaka Univ, Lab Med Pharmacol, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; [Barbeau, Olivier; Jones, Keith; Eccles, Suzanne A.] Inst Canc Res, Div Canc Therapeut, London SW7 3RP, England	University of London; Queen Mary University London; Osaka University; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Andrikopoulos, P (corresponding author), Queen Marys Univ London, Translat Med & Therapeut, William Harvey Res Inst, Barts & London Sch Med, London EC1M 6BQ, England.	p.andrikopoulos@qmul.ac.uk	Andrikopoulos, Petros/N-7724-2019; Jones, Keith/R-7629-2016	Andrikopoulos, Petros/0000-0002-1555-3498; Jones, Keith/0000-0002-9440-4094	Barts and London Charity [578/1128]; National Health Service; National Institute of Health Research; Institute for Cancer Research; Cancer Research United Kingdom [C309/A8274]; Cancer Research UK [11566] Funding Source: researchfish	Barts and London Charity; National Health Service; National Institute of Health Research(National Institute for Health Research (NIHR)); Institute for Cancer Research; Cancer Research United Kingdom(Cancer Research UK); Cancer Research UK(Cancer Research UK)	This work was supported by Barts and London Charity Grant 578/1128 (to M. M. Y.) and National Health Service funding to the National Institute of Health Research Biomedical Research Centre. This work forms part of the research themes contributing to the translational research portfolio of Barts and the London Cardiovascular Biomedical Research Unit, which is supported and funded by the National Institute of Health Research. The authors declare that they have no conflicts of interest with the contents of this article.; Recipients of funding from the Institute for Cancer Research and Cancer Research United Kingdom Grant C309/A8274.	Andrikopoulos P, 2011, J BIOL CHEM, V286, P37919, DOI 10.1074/jbc.M111.251777; Andrikopoulos P, 2011, J BIOL CHEM, V286, P16846, DOI 10.1074/jbc.M110.187559; Borbiev T, 2003, AM J PHYSIOL-LUNG C, V285, pL43, DOI 10.1152/ajplung.00460.2001; Borissoff JI, 2011, NEW ENGL J MED, V364, P1746, DOI 10.1056/NEJMra1011670; Byrne CJ, 2012, CIRCULATION, V125, P1256, DOI 10.1161/CIRCULATIONAHA.111.055392; Caunt M, 2006, CANCER RES, V66, P4125, DOI 10.1158/0008-5472.CAN-05-2570; Caunt M, 2003, J THROMB HAEMOST, V1, P2097, DOI 10.1046/j.1538-7836.2003.00426.x; Chattopadhyay R, 2014, J BIOL CHEM, V289, P3148, DOI 10.1074/jbc.M113.528190; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; David-Dufilho M, 2005, J BIOL CHEM, V280, P35999, DOI 10.1074/jbc.M506374200; Diebold I, 2009, CIRC RES, V104, P1169, DOI 10.1161/CIRCRESAHA.109.196592; Eccles Suzanne A., 2009, V467, P159, DOI 10.1007/978-1-59745-241-0_9; Eder P, 2007, CARDIOVASC RES, V73, P111, DOI 10.1016/j.cardiores.2006.10.016; Finigan JH, 2009, MICROVASC RES, V77, P35, DOI 10.1016/j.mvr.2008.09.002; Foley CJ, 2014, ONCOGENE, V33, P2264, DOI 10.1038/onc.2013.157; Gandhirajan RK, 2013, J CLIN INVEST, V123, P887, DOI 10.1172/JCI65647; Goel S, 2011, PHYSIOL REV, V91, P1071, DOI 10.1152/physrev.00038.2010; Goldenberg NM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002011; Harper MT, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003701; Hatziapostolou M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002006; Hirano K, 2007, ARTERIOSCL THROM VAS, V27, P27, DOI 10.1161/01.ATV.0000251995.73307.2d; Imahashi K, 2005, CIRC RES, V97, P916, DOI 10.1161/01.RES.0000187456.06162.cb; Itagaki K, 2007, J PHARMACOL EXP THER, V323, P186, DOI 10.1124/jpet.107.121210; Iwamoto T, 2004, NAT MED, V10, P1193, DOI 10.1038/nm1118; Iwamoto T, 2004, MOL PHARMACOL, V66, P45, DOI 10.1124/mol.66.1.45; Iwamoto Takahiro, 2007, Cardiovascular & Hematological Disorders - Drug Targets, V7, P188, DOI 10.2174/187152907781745288; Jin BY, 2012, P NATL ACAD SCI USA, V109, P14864, DOI 10.1073/pnas.1204974109; Kamimura D, 2012, EUR HEART J, V33, P1408, DOI 10.1093/eurheartj/ehr106; Kataoka H, 2003, BLOOD, V102, P3224, DOI 10.1182/blood-2003-04-1130; Keogh RJ, 2002, BIOCHEM BIOPH RES CO, V294, P1001, DOI 10.1016/S0006-291X(02)00568-5; Kevil CG, 2000, AM J PHYSIOL-CELL PH, V279, pC21, DOI 10.1152/ajpcell.2000.279.1.C21; Khananshvili D, 2013, MOL ASPECTS MED, V34, P220, DOI 10.1016/j.mam.2012.07.003; Kimura C, 2000, AM J PHYSIOL-HEART C, V279, pH2310, DOI 10.1152/ajpheart.2000.279.5.H2310; Knezevic N, 2009, J EXP MED, V206, P2761, DOI 10.1084/jem.20090652; Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833; LI L, 1995, CIRC RES, V76, P396, DOI 10.1161/01.RES.76.3.396; Liang GH, 2008, PFLUG ARCH EUR J PHY, V457, P67, DOI 10.1007/s00424-008-0490-9; Matsuda T, 2001, J PHARMACOL EXP THER, V298, P249; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Montezano AC, 2010, CIRC RES, V106, P1363, DOI 10.1161/CIRCRESAHA.109.216036; Nashida T, 2011, NEUROCHEM INT, V59, P51, DOI 10.1016/j.neuint.2011.03.026; Nierodzik ML, 2006, CANCER CELL, V10, P355, DOI 10.1016/j.ccr.2006.10.002; Parekh AB, 2008, J PHYSIOL-LONDON, V586, P3043, DOI 10.1113/jphysiol.2008.153460; Peng XQ, 2004, AM J RESP CRIT CARE, V169, P1245, DOI 10.1164/rccm.200309-1258OC; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Poburko D, 2007, CIRC RES, V101, P1030, DOI 10.1161/CIRCRESAHA.107.155531; Reuter H, 2002, CIRC RES, V91, P90, DOI 10.1161/01.RES.0000027529.37429.38; Schuh K, 2009, BIOCHEM PHARMACOL, V77, P1827, DOI 10.1016/j.bcp.2009.03.012; Sedova M, 1999, CELL CALCIUM, V25, P333, DOI 10.1054/ceca.1999.0036; Singh I, 2007, J BIOL CHEM, V282, P7833, DOI 10.1074/jbc.M608288200; St Amant EV, 2012, CIRC RES, V111, P739, DOI 10.1161/CIRCRESAHA.112.269654; Svensson KJ, 2011, P NATL ACAD SCI USA, V108, P13147, DOI 10.1073/pnas.1104261108; Szewczyk MM, 2007, J CELL MOL MED, V11, P129, DOI 10.1111/j.1582-4934.2007.00010.x; Tauseef M, 2012, J EXP MED, V209, P1953, DOI 10.1084/jem.20111355; Tressel SL, 2011, EMBO MOL MED, V3, P370, DOI 10.1002/emmm.201100145; Vogel SM, 2000, PHYSIOL GENOMICS, V4, P137, DOI 10.1152/physiolgenomics.2000.4.2.137; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Wang Z, 2010, J BIOL CHEM, V285, P21303, DOI 10.1074/jbc.M110.120790; Weissmann N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1660; Zania P, 2008, AM J PHYSIOL-CELL PH, V294, pC1215, DOI 10.1152/ajpcell.00452.2007	60	30	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18412	18428		10.1074/jbc.M114.628156	http://dx.doi.org/10.1074/jbc.M114.628156			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	25979335	Green Published, hybrid			2022-12-28	WOS:000358512100014
J	Zanetti, A; Affatato, R; Centritto, F; Fratelli, M; Kurosaki, M; Barzago, MM; Bolis, M; Terao, M; Garattini, E; Paroni, G				Zanetti, Adriana; Affatato, Roberta; Centritto, Floriana; Fratelli, Maddalena; Kurosaki, Mami; Barzago, Maria Monica; Bolis, Marco; Terao, Mineko; Garattini, Enrico; Paroni, Gabriela			All-trans-retinoic Acid Modulates the Plasticity and Inhibits the Motility of Breast Cancer Cells ROLE OF NOTCH1 AND TRANSFORMING GROWTH FACTOR (TGF beta)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GENE-EXPRESSION; UP-REGULATION; E-CADHERIN; IN-VIVO; ACTIVATION; METASTASIS; REPRESSION; MIGRATION; INVASION	All-trans-retinoic acid (ATRA) is a natural compound proposed for the treatment/chemoprevention of breast cancer. Increasing evidence indicates that aberrant regulation of epithelial-to-mesenchymal transition (EMT) is a determinant of the cancer cell invasive and metastatic behavior. The effects of ATRA on EMT are largely unknown. In HER2-positive SKBR3 and UACC812 cells, showing co-amplification of the ERBB2 and RARA genes, ATRA activates a RAR alpha-dependent epithelial differentiation program. In SKBR3 cells, this causes the formation/reorganization of adherens and tight junctions. Epithelial differentiation and augmented cell-cell contacts underlie the antimigratory action exerted by the retinoid in cells exposed to the EMT-inducing factors EGF and heregulin-beta 1. Down-regulation of NOTCH1, an emerging EMT modulator, is involved in the inhibition of motility by ATRA. Indeed, the retinoid blocks NOTCH1 up-regulation by EGF and/or heregulin-beta 1. Pharmacological inhibition of gamma-secretase and NOTCH1 processing also abrogates SKBR3 cell migration. Stimulation of TGF beta contributes to the anti-migratory effect of ATRA. The retinoid switches TGF beta from an EMT-inducing and pro-migratory determinant to an anti-migratory mediator. Inhibition of the NOTCH1 pathway not only plays a role in the anti-migratory action of ATRA; it is relevant also for the anti-proliferative activity of the retinoid in HCC1599 breast cancer cells, which are addicted to NOTCH1 for growth/viability. This effect is enhanced by the combination of ATRA and the gamma-secretase inhibitor N-(N-(3,5-difluorophenacetyl)-L-alanyl)-S-phenylglycine t-butyl ester, supporting the concept that the two compounds act at the transcriptional and post-translational levels along the NOTCH1 pathway.	[Zanetti, Adriana; Affatato, Roberta; Centritto, Floriana; Fratelli, Maddalena; Kurosaki, Mami; Barzago, Maria Monica; Bolis, Marco; Terao, Mineko; Garattini, Enrico; Paroni, Gabriela] Ist Ric Farmacol Mario Negri, Mol Biol Lab, I-20156 Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Paroni, G (corresponding author), Ist Ric Farmacol Mario Negri, Mol Biol Lab, Via La Masa 19, I-20156 Milan, Italy.	gabriela.paroni@marionegri.it	terao, mineko/AAU-8089-2020; Fratelli, Maddalena/AAA-6446-2020; adriana, zanetti/ABA-1189-2020; Garattini, Enrico/AAI-1998-2019; Terao, Mineko/AAA-6415-2020; Paroni, Gabriela/J-4848-2018; Bolis, Marco/AAC-2379-2019; Barzago, Maria Monica/AAA-6402-2020; KUROSAKI, Mami/ABG-2224-2020; Affatato, Roberta/AHD-9757-2022	Fratelli, Maddalena/0000-0002-1769-3427; adriana, zanetti/0000-0002-5825-9707; Terao, Mineko/0000-0002-9976-9869; Paroni, Gabriela/0000-0003-0132-0869; Bolis, Marco/0000-0003-4377-5079; Barzago, Maria Monica/0000-0002-6952-0069; KUROSAKI, Mami/0000-0001-8231-713X; Affatato, Roberta/0000-0002-2235-039X; Garattini, Enrico/0000-0001-8983-886X	Associazione Italiana per la Ricerca sul il Cancro (MFAG) [12100]; Fondazione "Italo Monzino"	Associazione Italiana per la Ricerca sul il Cancro (MFAG)(Fondazione AIRC per la ricerca sul cancro); Fondazione "Italo Monzino"	This work was supported by a grant from the Associazione Italiana per la Ricerca sul il Cancro (MFAG 2011 Grant 12100) (to G. P.). This work was also supported by the Fondazione "Italo Monzino."	Nieto MA, 2013, SCIENCE, V342, P708, DOI 10.1126/science.1234850; Barroga EF, 2000, RES VET SCI, V68, P79, DOI 10.1053/rvsc.1999.0360; Blick T, 2008, CLIN EXP METASTAS, V25, P629, DOI 10.1007/s10585-008-9170-6; Bolos V, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3447; Brabletz T, 2012, NAT REV CANCER, V12, P425, DOI 10.1038/nrc3265; Centritto F., 2015, EMBO MOL MED, DOI 10.15252/emmm.201404670; Cheng LS, 2009, CANCER LETT, V280, P50, DOI 10.1016/j.canlet.2009.02.007; Cho KW, 2012, DEV BIOL, V365, P259, DOI 10.1016/j.ydbio.2012.02.020; Corada M, 2001, BLOOD, V97, P1679, DOI 10.1182/blood.V97.6.1679; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Doi A, 2015, MOL ONCOL, V9, P355, DOI 10.1016/j.molonc.2014.09.005; Friedl P, 2012, NAT CELL BIOL, V14, P777, DOI 10.1038/ncb2548; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Garattini E, 2014, CANCER TREAT REV, V40, P739, DOI 10.1016/j.ctrv.2014.01.001; GIANNI M, 1993, BIOCHEM BIOPH RES CO, V196, P252, DOI 10.1006/bbrc.1993.2242; Guruharsha KG, 2012, NAT REV GENET, V13, P654, DOI 10.1038/nrg3272; Hardy KM, 2010, J MAMMARY GLAND BIOL, V15, P191, DOI 10.1007/s10911-010-9172-2; Heldin CH, 2012, FEBS LETT, V586, P1959, DOI 10.1016/j.febslet.2012.02.037; Hollestelle A, 2013, BREAST CANCER RES TR, V138, P47, DOI 10.1007/s10549-013-2415-3; Hugo HJ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-235; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Leong KG, 2007, J EXP MED, V204, P2935, DOI 10.1084/jem.20071082; Liu H, 2003, BREAST CANCER RES TR, V79, P63, DOI 10.1023/A:1023366117157; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; Lo-Coco F, 2008, SEMIN ONCOL, V35, P401, DOI 10.1053/j.seminoncol.2008.04.010; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Micchelli CA, 2002, FASEB J, V16, P79, DOI 10.1096/fj.02-0394fje; Nam DH, 2008, CLIN CANCER RES, V14, P4059, DOI 10.1158/1078-0432.CCR-07-4039; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Ocana OH, 2012, CANCER CELL, V22, P709, DOI 10.1016/j.ccr.2012.10.012; Paroni G, 2012, ONCOGENE, V31, P3431, DOI 10.1038/onc.2011.506; Paroni G, 2001, J BIOL CHEM, V276, P21907, DOI 10.1074/jbc.M011565200; Parr C, 2004, INT J MOL MED, V14, P779; Robinson DR, 2011, NAT MED, V17, P1646, DOI 10.1038/nm.2580; Rochette-Egly Cecile, 2009, Nucl Recept Signal, V7, pe005, DOI 10.1621/nrs.07005; Rustighi A, 2009, NAT CELL BIOL, V11, P133, DOI 10.1038/ncb1822; Sahlgren C, 2008, P NATL ACAD SCI USA, V105, P6392, DOI 10.1073/pnas.0802047105; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Sekimoto G, 2007, CANCER RES, V67, P5090, DOI 10.1158/0008-5472.CAN-06-4629; Shah S, 2002, J BIOL CHEM, V277, P25313, DOI 10.1074/jbc.M203158200; Shao S, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0295-3; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Trimboli AJ, 2008, CANCER RES, V68, P937, DOI 10.1158/0008-5472.CAN-07-2148; Vogelmann R, 2005, J CELL SCI, V118, P4901, DOI 10.1242/jcs.02594; Voigt W, 2005, METH MOLEC MED, V110, P39; Voura EB, 1998, MICROSC RES TECHNIQ, V43, P265, DOI 10.1002/(SICI)1097-0029(19981101)43:3<265::AID-JEMT9>3.0.CO;2-Z; Wang SE, 2008, MOL CELL BIOL, V28, P5605, DOI 10.1128/MCB.00787-08; Wang YA, 2005, DEV DYNAM, V234, P892, DOI 10.1002/dvdy.20570; Wolbach SB, 1925, J EXP MED, V42, P753, DOI 10.1084/jem.42.6.753; Wolbach SB, 1933, J EXP MED, V57, P511, DOI 10.1084/jem.57.3.511; Wu Q, 2002, ACTA PHARMACOL SIN, V23, P835; Yugawa T, 2007, MOL CELL BIOL, V27, P3732, DOI 10.1128/MCB.02119-06; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069; Zhang CC, 2012, CLIN CANCER RES, V18, P5008, DOI 10.1158/1078-0432.CCR-12-1379	59	38	41	1	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					17690	17709		10.1074/jbc.M115.638510	http://dx.doi.org/10.1074/jbc.M115.638510			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26018078	hybrid, Green Published			2022-12-28	WOS:000358511700005
J	Alontaga, AY; Ambaye, ND; Li, YJ; Vega, R; Chen, CH; Bzymek, KP; Williams, JC; Hu, WD; Chen, Y				Alontaga, Aileen Y.; Ambaye, Nigus D.; Li, Yi-Jia; Vega, Ramir; Chen, Chih-Hong; Bzymek, Krzysztof P.; Williams, John C.; Hu, Weidong; Chen, Yuan			RWD Domain as an E2 (Ubc9)-Interaction Module	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-LIKE MODIFICATIONS; E1-E2 INTERACTION; CYS DOMAIN; UBC9; PROTEIN; SUMO; BINDING; E1; IDENTIFICATION; CONJUGATION	An RWD domain is a well conserved domain found through bioinformatic analysis of the human proteome sequence; however, its function has been unknown. Ubiquitin-like modifications require the catalysis of three enzymes generally known as E1, E2, and E3. We solved the crystal structure of the E2 for the small ubiquitin-like modifiers (SUMO) in complex with an RWD domain and confirmed the structure using solution NMR analysis. The binding surface of RWD on Ubc9 is located near the N terminus of Ubc9 that is known to be involved in non-covalent binding of the proteins in the conjugation machinery, including a domain of E1, SUMO, and an E3 ligase. NMR data indicate that the RWD domain does not bind to SUMO and E1. The interaction between RWD and Ubc9 has a K-d of 32 +/- 4 mu M. Consistent with the structure and binding affinity and in contrast to a previous report, the RWD domain and RWDD3 have minimal effects on global SUMOylation. The structural and biochemical information presented here forms the basis for further investigation of the functions of RWD-containing proteins.	[Alontaga, Aileen Y.; Ambaye, Nigus D.; Li, Yi-Jia; Vega, Ramir; Chen, Chih-Hong; Bzymek, Krzysztof P.; Williams, John C.; Chen, Yuan] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Med, Duarte, CA 91010 USA; [Hu, Weidong] City Hope Natl Med Ctr, Beckman Res Inst, NMR Core Facil, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Chen, Y (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Med, 1450 East Duarte Rd, Duarte, CA 91010 USA.	ychen@coh.org	Regan, Clinton/E-6250-2012	Li, Yi-Jia/0000-0002-8791-8097; Ambaye, Nigus/0000-0001-5026-6542	National Institutes of Health [GM102538, GM086171]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086171, R01GM102538] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM102538 and GM086171. The authors declare that they have no conflicts of interest with the contents of this article.	Carbia-Nagashima A, 2007, CELL, V131, P309, DOI 10.1016/j.cell.2007.07.044; Chen YA, 2007, BIOSCI TRENDS, V1, P16; Doerks T, 2002, GENOME RES, V12, P47, DOI 10.1101/gr.203201; DOHMEN RJ, 1995, J BIOL CHEM, V270, P18099, DOI 10.1074/jbc.270.30.18099; Dye BT, 2007, ANNU REV BIOPH BIOM, V36, P131, DOI 10.1146/annurev.biophys.36.040306.132820; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garciade la Torre J. G., 1981, Q REV BIOPHYS, V14, P81; Gerez J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057795; Huang DT, 2007, NATURE, V445, P394, DOI 10.1038/nature05490; Huang DT, 2005, MOL CELL, V17, P341, DOI 10.1016/j.molcel.2004.12.020; Truong K, 2012, J BIOL CHEM, V287, P15154, DOI 10.1074/jbc.M112.353789; Knipscheer P, 2007, EMBO J, V26, P2797, DOI 10.1038/sj.emboj.7601711; Lin DH, 2002, J BIOL CHEM, V277, P21740, DOI 10.1074/jbc.M108418200; Liu Q, 1999, BIOCHEMISTRY-US, V38, P1415, DOI 10.1021/bi981840h; Liu Q, 1999, J BIOL CHEM, V274, P16979, DOI 10.1074/jbc.274.24.16979; Nameki N, 2004, PROTEIN SCI, V13, P2089, DOI 10.1110/ps.04751804; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Tatham MH, 2005, NAT STRUCT MOL BIOL, V12, P67, DOI 10.1038/nsmb878; Tatham MH, 2003, BIOCHEMISTRY-US, V42, P9959, DOI 10.1021/bi0345283; Ulrich Helle D., 2009, V497, P3, DOI 10.1007/978-1-59745-566-4_1; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; Walden H, 2003, MOL CELL, V12, P1427, DOI 10.1016/S1097-2765(03)00452-0; Wang JH, 2007, MOL CELL, V27, P228, DOI 10.1016/j.molcel.2007.05.023; Wang JH, 2010, J BIOL CHEM, V285, P33457, DOI 10.1074/jbc.M110.135582; Wang JH, 2009, J BIOL CHEM, V284, P20340, DOI 10.1074/jbc.M109.000257; Yasugi T, 1996, NUCLEIC ACIDS RES, V24, P2005, DOI 10.1093/nar/24.11.2005; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200	27	16	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16550	16559		10.1074/jbc.M115.644047	http://dx.doi.org/10.1074/jbc.M115.644047			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25918163	Green Published, hybrid			2022-12-28	WOS:000357572800008
J	Mei, ZC; Zhang, DW; Hu, B; Wang, J; Shen, X; Xiao, WH				Mei, Zhichao; Zhang, Dawei; Hu, Bo; Wang, Jing; Shen, Xian; Xiao, Wuhan			FBXO32 Targets c-Myc for Proteasomal Degradation and Inhibits c-Myc Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell proliferation; muscle atrophy; Myc (c-Myc); oncogene; ubiquitylation (ubiquitination); FBXO32; proteasomal degradation	TRANSCRIPTIONAL ACTIVITY; DEPENDENT DEGRADATION; UBIQUITIN LIGASES; TUMOR-SUPPRESSOR; PROTEIN; EXPRESSION; GENE; PHOSPHORYLATION; IDENTIFICATION; ATROPHY	Background: FBXO32 is an E3 ubiquitin ligase that plays important roles in tumorigenesis and muscle atrophy. Results: c-Myc was found to be a target of FBXO32 for proteasomal degradation. Conclusion: FBXO32 targets Lys-326 of c-Myc to form polyubiquitin chains, resulting in inhibition of cell proliferation. Significance: FBXO32 may mediate c-Myc proteasomal degradation. FBXO32 (MAFbx/Atrogin-1) is an E3 ubiquitin ligase that is markedly up-regulated in muscle atrophy. Although some data indicate that FBXO32 may play an important role in tumorigenesis, the molecular mechanism of FBXO32 in tumorigenesis has been poorly understood. Here, we present evidence that FBXO32 targets the oncogenic protein c-Myc for ubiquitination and degradation through the proteasome pathway. Phosphorylation of c-Myc at Thr-58 and Ser-62 is dispensable for FBXO32 to induce c-Myc degradation. Mutation of the lysine 326 in c-Myc reduces c-Myc ubiquitination and prevents the c-Myc degradation induced by FBXO32. Furthermore, overexpression of FBXO32 suppresses c-Myc activity and inhibits cell growth, but knockdown of FBXO32 enhances c-Myc activity and promotes cell growth. Finally, we show that FBXO32 is a direct downstream target of c-Myc, highlighting a negative feedback regulation loop between c-Myc and FBXO32. Thus, FBXO32 may function by targeting c-Myc. This work explains the function of FBXO32 and highlights its mechanisms in tumorigenesis.	[Mei, Zhichao; Zhang, Dawei; Hu, Bo; Wang, Jing; Xiao, Wuhan] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan 430072, Peoples R China; [Xiao, Wuhan] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan 430072, Peoples R China; [Shen, Xian] Wenzhou Med Univ, Hosp 1, Wenzhou 325000, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Wenzhou Medical University	Xiao, WH (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Wuhan 430072, Peoples R China.	w-xiao@ihb.ac.cn	Xiao, Wuhan/GLU-7352-2022; hu, bo/ABC-3810-2021	hu, bo/0000-0001-5656-9632	CAS Major Scientific and Technological Project [XDA08010208]; NSFC [31461163003, 31071212, 91019008]; Natural Science Foundation of Zhejiang Province [2012C37080]	CAS Major Scientific and Technological Project; NSFC(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This work was supported by CAS Major Scientific and Technological Project XDA08010208; NSFC Grants 31461163003, 31071212, and 91019008 (to W. X.); and the Natural Science Foundation of Zhejiang Province Grant 2012C37080 (to X. S.). The authors declare that they have no conflicts of interest with the contents of this article.	AMATI B, 1993, CELL, V72, P233, DOI 10.1016/0092-8674(93)90663-B; Baltgalvis KA, 2009, PFLUG ARCH EUR J PHY, V457, P989, DOI 10.1007/s00424-008-0574-6; Barsyte-Lovejoy D, 2004, ONCOGENE, V23, P3481, DOI 10.1038/sj.onc.1207487; Bartholomeusz G, 2007, CANCER RES, V67, P3912, DOI 10.1158/0008-5472.CAN-06-4464; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bretones G, 2011, J BIOL CHEM, V286, P9815, DOI 10.1074/jbc.M110.165977; Chen Z, 2014, MOL CELL BIOL, V34, P1085, DOI 10.1128/MCB.00718-13; Chou JL, 2010, LAB INVEST, V90, P414, DOI 10.1038/labinvest.2009.138; Ciarapica R, 2014, ONCOGENE, V33, P4173, DOI 10.1038/onc.2013.471; DEAN M, 1986, J BIOL CHEM, V261, P9161; Delpuech O, 2007, MOL CELL BIOL, V27, P4917, DOI 10.1128/MCB.01789-06; Farrell AS, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014365; Feng X, 2011, EMBO J, V30, P3397, DOI 10.1038/emboj.2011.248; Ferber EC, 2012, CELL DEATH DIFFER, V19, P968, DOI 10.1038/cdd.2011.179; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Guo W, 2014, CANCER-AM CANCER SOC, V120, P2412, DOI 10.1002/cncr.28764; Harrison SC, 1996, CELL, V86, P341, DOI 10.1016/S0092-8674(00)80105-1; HOANG AT, 1995, MOL CELL BIOL, V15, P4031; Huang ZD, 2004, MOL CELL BIOL, V24, P1582, DOI 10.1128/MCB.24.4.1582-1594.2004; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Julie LC, 2012, FEBS LETT, V586, P362, DOI 10.1016/j.febslet.2011.12.031; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Kulathu Y, 2012, NAT REV MOL CELL BIO, V13, P508, DOI 10.1038/nrm3394; Lagirand-Cantaloube J, 2008, EMBO J, V27, P1266, DOI 10.1038/emboj.2008.52; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Leone G, 2001, MOL CELL, V8, P105, DOI 10.1016/S1097-2765(01)00275-1; Lobo VJSA, 2013, ONCOGENE, V32, P5261, DOI 10.1038/onc.2012.621; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Noguchi K, 1999, J BIOL CHEM, V274, P32580, DOI 10.1074/jbc.274.46.32580; PERSSON H, 1986, MOL CELL BIOL, V6, P942, DOI 10.1128/MCB.6.3.942; Ponting CP, 1997, BIOESSAYS, V19, P469, DOI 10.1002/bies.950190606; Popov N, 2010, NAT CELL BIOL, V12, P973, DOI 10.1038/ncb2104; RABBITTS PH, 1985, EMBO J, V4, P2009, DOI 10.1002/j.1460-2075.1985.tb03885.x; Reed SA, 2012, FASEB J, V26, P987, DOI 10.1096/fj.11-189977; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sears R, 1997, MOL CELL BIOL, V17, P5227, DOI 10.1128/MCB.17.9.5227; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Tansey W.P., 2014, NEW J SCI, V2014, P1; Tintignac LA, 2005, J BIOL CHEM, V280, P2847, DOI 10.1074/jbc.M411346200; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Wang J, 2014, MOL ENDOCRINOL, V28, P239, DOI 10.1210/me.2013-1258; WATERS CM, 1991, ONCOGENE, V6, P797; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Xie P, 2009, J BIOL CHEM, V284, P5488, DOI 10.1074/jbc.M806487200; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Zhang GH, 2011, EMBO J, V30, P4323, DOI 10.1038/emboj.2011.292	48	39	47	0	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16202	16214		10.1074/jbc.M115.645978	http://dx.doi.org/10.1074/jbc.M115.645978			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25944903	Green Published, hybrid			2022-12-28	WOS:000356930100024
J	Samant, SA; Pillai, VB; Sundaresan, NR; Shroff, SG; Gupta, MP				Samant, Sadhana A.; Pillai, Vinodkumar B.; Sundaresan, Nagalingam R.; Shroff, Sanjeev G.; Gupta, Mahesh P.			Histone Deacetylase 3 (HDAC3)-dependent Reversible Lysine Acetylation of Cardiac Myosin Heavy Chain Isoforms Modulates Their Enzymatic and Motor Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiac hypertrophy; molecular cell biology; molecular motor; myosin; signal transduction	MUSCLE-CONTRACTION; ATPASE ACTIVITY; HEART-FAILURE; ACTIN; PURIFICATION; EXPRESSION; PROTEINS; HYPOXIA; COMPLEX; FAMILY	Background: Reversible lysine acetylation has emerged as an important post-translational modification regulating activity of the target protein. Results: Upon lysine acetylation, enzymatic activity of both cardiac myosin heavy chain (MHC) isoforms is up-regulated. Conclusion: As an early response to stress, cardiac MHCs are acetylated. Significance: Contractile performance of the heart can be improved by regulating MHC acetylation without isoform switch. Reversible lysine acetylation is a widespread post-translational modification controlling the activity of proteins in different subcellular compartments. We previously demonstrated that a class II histone deacetylase (HDAC), HDAC4, and a histone acetyltransferase, p300/CREB-binding protein-associated factor, associate with cardiac sarcomeres and that a class I and II HDAC inhibitor, trichostatin A, enhances contractile activity of myofilaments. In this study we show that a class I HDAC, HDAC3, is also present at cardiac sarcomeres. By immunohistochemical and electron microscopic analyses, we found that HDAC3 was localized to A-band of sarcomeres and capable of deacetylating myosin heavy chain (MHC) isoforms. The motor domains of both cardiac - and -MHC isoforms were found to be reversibly acetylated. Biomechanical studies revealed that lysine acetylation significantly decreased the K-m for the actin-activated ATPase activity of MHC isoforms. By in vitro motility assay, we found that lysine acetylation increased the actin-sliding velocity of -myosin by 20% and -myosin by 36% compared with their respective non-acetylated isoforms. Moreover, myosin acetylation was found to be sensitive to cardiac stress. During induction of hypertrophy, myosin isoform acetylation increased progressively with duration of stress stimuli independently of isoform shift, suggesting that lysine acetylation of myosin could be an early response of myofilaments to increase contractile performance of the heart. These studies provide the first evidence for localization of HDAC3 at myofilaments and uncover a novel mechanism modulating the motor activity of cardiac MHC isoforms.	[Samant, Sadhana A.; Pillai, Vinodkumar B.; Sundaresan, Nagalingam R.; Gupta, Mahesh P.] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Shroff, Sanjeev G.] Univ Pittsburg, Dept Bioengn, Pittsburgh, PA 15261 USA	University of Chicago; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gupta, MP (corresponding author), Univ Chicago, Dept Surg, MC 5040,5841 South Maryland Ave, Chicago, IL 60637 USA.	mgupta@surgery.bsd.uchicago.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [RO1-HL83423, RO1-HL117041, RO1-HL111455]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117041, R01HL083423, R01HL111455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-HL83423, RO1-HL117041, and RO1-HL111455.	Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Chen Y, 2009, P NATL ACAD SCI USA, V106, P761, DOI 10.1073/pnas.0811739106; CLARK WA, 1982, J BIOL CHEM, V257, P5449; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Fischle W, 2001, J BIOL CHEM, V276, P35826, DOI 10.1074/jbc.M104935200; Fiske CH, 1925, J BIOL CHEM, V66, P375; Geeves MA, 1999, ANNU REV BIOCHEM, V68, P687, DOI 10.1146/annurev.biochem.68.1.687; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Gupta MP, 2008, J BIOL CHEM, V283, P10135, DOI 10.1074/jbc.M710277200; Gupta MP, 2007, J MOL CELL CARDIOL, V43, P388, DOI 10.1016/j.yjmcc.2007.07.045; Jacques AM, 2008, CARDIOVASC RES, V79, P481, DOI 10.1093/cvr/cvn094; Kamitomo M, 2002, J SOC GYNECOL INVEST, V9, P335, DOI 10.1016/S1071-5576(02)00180-6; Khochbin S, 2001, CURR OPIN GENET DEV, V11, P162, DOI 10.1016/S0959-437X(00)00174-X; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Krenz M, 2007, J BIOL CHEM, V282, P24057, DOI 10.1074/jbc.M704574200; Lahm A, 2007, P NATL ACAD SCI USA, V104, P17335, DOI 10.1073/pnas.0706487104; Longworth MS, 2006, ONCOGENE, V25, P4495, DOI 10.1038/sj.onc.1209473; McKinsey TA, 2002, CURR OPIN CELL BIOL, V14, P763, DOI 10.1016/S0955-0674(02)00389-7; Nagy S, 2008, P NATL ACAD SCI USA, V105, P9616, DOI 10.1073/pnas.0802592105; Nakao K, 1997, J CLIN INVEST, V100, P2362, DOI 10.1172/JCI119776; Pillai JB, 2008, AM J PHYSIOL-HEART C, V294, pH1388, DOI 10.1152/ajpheart.01339.2007; POLLARD TD, 1982, METHOD CELL BIOL, V24, P333; Rajamohan SB, 2009, MOL CELL BIOL, V29, P4116, DOI 10.1128/MCB.00121-09; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; Roels B, 2008, AM J PHYSIOL-REG I, V294, pR1911, DOI 10.1152/ajpregu.00210.2006; Ruppel KM, 1996, ANNU REV CELL DEV BI, V12, P543, DOI 10.1146/annurev.cellbio.12.1.543; SCHLUTER JM, 1994, AM J PHYSIOL, V266, pC1699, DOI 10.1152/ajpcell.1994.266.6.C1699; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; UCHIDA K, 1977, J BIOCHEM, V82, P469; Waltregny D, 2005, FASEB J, V19, P966, DOI 10.1096/fj.04-2303fje; Yang WM, 2002, J BIOL CHEM, V277, P9447, DOI 10.1074/jbc.M105993200; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002	33	27	29	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15559	15569		10.1074/jbc.M115.653048	http://dx.doi.org/10.1074/jbc.M115.653048			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25911107	Green Published, hybrid			2022-12-28	WOS:000356527400021
J	Hemmasi, S; Czulkies, BA; Schorch, B; Veit, A; Aktories, K; Papatheodorou, P				Hemmasi, Sarah; Czulkies, Bernd A.; Schorch, Bjoern; Veit, Antonia; Aktories, Klaus; Papatheodorou, Panagiotis			Interaction of the Clostridium difficile Binary Toxin CDT and Its Host Cell Receptor, Lipolysis-stimulated Lipoprotein Receptor (LSR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFRINGENS IOTA-TOXIN; BOTULINUM C2 TOXIN; ANTHRAX TOXIN; BINDING; IDENTIFICATION; EPIDEMIOLOGY; MECHANISM; INFECTION; PROTEIN; STRAIN	CDT(Clostridium difficile transferase) is a binary, actin ADP-ribosylating toxin frequently associated with hypervirulent strains of the human enteric pathogen C. difficile, the most serious cause of antibiotic-associated diarrhea and pseudomembranous colitis. CDT leads to the collapse of the actin cytoskeleton and, eventually, to cell death. Low doses of CDT result in the formation of microtubule-based protrusions on the cell surface that increase the adherence and colonization of C. difficile. The lipolysis-stimulated lipoprotein receptor (LSR) is the host cell receptor for CDT, and our aim was to gain a deeper insight into the interplay between both proteins. We show that CDT interacts with the extracellular, Ig-like domain of LSR with an affinity in the nanomolar range. We identified LSR splice variants in the colon carcinoma cell line HCT116 and disrupted the LSR gene in these cells by applying the CRISPR-Cas9 technology. LSR truncations ectopically expressed in LSR knock-out cells indicated that intracellular parts of LSR are not essential for plasma membrane targeting of the receptor and cellular uptake of CDT. By generating a series of N-and C-terminal truncations of the binding component of CDT (CDTb), we found that amino acids 757-866 of CDTb are sufficient for binding to LSR. With a transposon-based, random mutagenesis approach, we identified potential LSR-interacting epitopes in CDTb. This study increases our understanding about the interaction between CDT and its receptor LSR, which is key to the development of anti-toxin strategies for preventing cell entry of the toxin.	[Hemmasi, Sarah; Czulkies, Bernd A.; Schorch, Bjoern; Veit, Antonia; Aktories, Klaus; Papatheodorou, Panagiotis] Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, D-79104 Freiburg, Germany; [Hemmasi, Sarah; Schorch, Bjoern] Univ Freiburg, Fak Biol, D-79104 Freiburg, Germany; [Czulkies, Bernd A.] Univ Freiburg, Hermann Staudinger Grad Sch, D-79104 Freiburg, Germany; [Schorch, Bjoern] Univ Freiburg, Spemann Grad Sch Biol & Med, D-79104 Freiburg, Germany; [Aktories, Klaus] Univ Freiburg, Ctr Biol Signalling Studies BIOSS, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg	Papatheodorou, P (corresponding author), Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, Albertstr 25, D-79104 Freiburg, Germany.	panagiotis.papatheodorou@pharmakol.uni-freiburg.de	Aktories, Klaus/CAJ-5682-2022; Papatheodorou, Panagiotis/N-7509-2015	Aktories, Klaus/0000-0002-5397-0436; Papatheodorou, Panagiotis/0000-0003-3571-695X; Schorch, Bjorn/0000-0001-8311-0210	Deutsche Forschungsgemeinschaft [AK6/23-1]; Centre for Biological Signalling Studies (Freiburg, Germany)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Centre for Biological Signalling Studies (Freiburg, Germany)	This work was supported by Deutsche Forschungsgemeinschaft Grant AK6/23-1 and the Centre for Biological Signalling Studies (Freiburg, Germany).	Aktories K, 2004, INT J MED MICROBIOL, V293, P557, DOI 10.1078/1438-4221-00305; AKTORIES K, 1986, NATURE, V322, P390, DOI 10.1038/322390a0; Barth H, 2005, REV PHYSIOL BIOCH P, V152, P165, DOI 10.1007/s10254-004-0029-1; Barth H, 2000, J BIOL CHEM, V275, P18704, DOI 10.1074/jbc.M000596200; Barth H, 2004, MICROBIOL MOL BIOL R, V68, P373, DOI 10.1128/MMBR.68.3.373-402.2004; Bihain BE, 1998, CURR OPIN LIPIDOL, V9, P221, DOI 10.1097/00041433-199806000-00006; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Furuse M, 2014, TISSUE BARRIERS, V2, DOI 10.4161/tisb.28960; Furuse M, 2012, ANN NY ACAD SCI, V1257, P54, DOI 10.1111/j.1749-6632.2012.06486.x; Gerding DN, 2014, GUT MICROBES, V5, P15, DOI 10.4161/gmic.26854; Higashi T, 2013, J CELL SCI, V126, P966, DOI 10.1242/jcs.116442; Kaiser E, 2011, INFECT IMMUN, V79, P3913, DOI 10.1128/IAI.05372-11; Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500; Kelly CP, 1998, ANNU REV MED, V49, P375; Kyne L, 2010, NEW ENGL J MED, V362, P264, DOI 10.1056/NEJMe0910055; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marvaud JC, 2001, INFECT IMMUN, V69, P2435, DOI 10.1128/IAI.69.4.2435-2441.2001; Masuda S, 2011, J CELL SCI, V124, P548, DOI 10.1242/jcs.072058; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; Mesli S, 2004, EUR J BIOCHEM, V271, P3103, DOI 10.1111/j.1432-1033.2004.04223.x; O'Connor JR, 2009, GASTROENTEROLOGY, V136, P1913, DOI 10.1053/j.gastro.2009.02.073; Papatheodorou P, 2013, MBIO, V4, DOI 10.1128/mBio.00244-13; Papatheodorou P, 2012, INFECT IMMUN, V80, P1418, DOI 10.1128/IAI.06378-11; Papatheodorou P, 2011, P NATL ACAD SCI USA, V108, P16422, DOI 10.1073/pnas.1109772108; Perelle S, 1997, INFECT IMMUN, V65, P1402, DOI 10.1128/IAI.65.4.1402-1407.1997; Pilpa RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002354; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Santelli E, 2004, NATURE, V430, P905, DOI 10.1038/nature02763; Schmidt G, 2015, CURR OPIN MICROBIOL, V23, P55, DOI 10.1016/j.mib.2014.11.003; Schwan C, 2011, J BIOL CHEM, V286, P29356, DOI 10.1074/jbc.M111.261925; Schwan C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000626; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Sterthoff C, 2010, INFECT IMMUN, V78, P1468, DOI 10.1128/IAI.01351-09; Stiles BG, 2002, BIOCHEM J, V367, P801, DOI 10.1042/BJ20020566; Stiles BG, 2014, TOXINS, V6, P2626, DOI 10.3390/toxins6092626; Stiles BG, 2011, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00011; Sun JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010553; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Wigelsworth DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051356; Wigelsworth DJ, 2004, J BIOL CHEM, V279, P23349, DOI 10.1074/jbc.M401292200; Yen FT, 2008, J BIOL CHEM, V283, P25650, DOI 10.1074/jbc.M801027200; Yen FT, 1999, J BIOL CHEM, V274, P13390, DOI 10.1074/jbc.274.19.13390; YEN FT, 1994, BIOCHEMISTRY-US, V33, P1172, DOI 10.1021/bi00171a017; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728	44	24	24	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					14031	14044		10.1074/jbc.M115.650523	http://dx.doi.org/10.1074/jbc.M115.650523			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25882847	hybrid, Green Published			2022-12-28	WOS:000355313000033
J	Kissing, S; Hermsen, C; Repnik, U; Nesset, CK; von Bargen, K; Griffiths, G; Ichihara, A; Lee, BS; Schwake, M; De Brabander, J; Haas, A; Saftig, P				Kissing, Sandra; Hermsen, Christina; Repnik, Urska; Nesset, Cecilie Kasi; von Bargen, Kristine; Griffiths, Gareth; Ichihara, Atsuhiro; Lee, Beth S.; Schwake, Michael; De Brabander, Jef; Haas, Albert; Saftig, Paul			Vacuolar ATPase in Phagosome-Lysosome Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT MEMBRANE-FUSION; V-ATPASE; H+-ATPASE; A3 ISOFORM; NEUROTRANSMITTER RELEASE; PRORENIN RECEPTOR; IN-VIVO; SUBUNIT; ACIDIFICATION; MICE	The vacuolar H+ -ATPase (v-ATPase) complex is instrumental in establishing and maintaining acidification of some cellular compartments, thereby ensuring their functionality. Recently it has been proposed that the transmembrane V-0 sector of v-ATPase and its a-subunits promote membrane fusion in the endocytic and exocytic pathways independent of their acidification functions. Here, we tested if such a proton-pumping independent role of v-ATPase also applies to phagosome-lysosome fusion. Surprisingly, endo(lyso)somes in mouse embryonic fibroblasts lacking the V-0 a3 subunit of the v-ATPase acidified normally, and endosome and lysosome marker proteins were recruited to phagosomes with similar kinetics in the presence or absence of the a3 subunit. Further experiments used macrophages with a knockdown of v-ATPase accessory protein 2 (ATP6AP2) expression, resulting in a strongly reduced level of the V-0 sector of the v-ATPase. However, acidification appeared undisturbed, and fusion between latex bead-containing phagosomes and lysosomes, as analyzed by electron microscopy, was even slightly enhanced, as was killing of non-pathogenic bacteria by V-0 mutant macrophages. Pharmacologically neutralized lysosome pH did not affect maturation of phagosomes in mouse embryonic cells or macrophages. Finally, locking the two large parts of the v-ATPase complex together by the drug saliphenylhalamide A did not inhibit in vitro and in cellulo fusion of phagosomes with lysosomes. Hence, our data do not suggest a fusion-promoting role of the v-ATPase in the formation of phagolysosomes.	[Kissing, Sandra; Saftig, Paul] Univ Kiel, Inst Biochem, D-24098 Kiel, Germany; [Hermsen, Christina; von Bargen, Kristine; Haas, Albert] Univ Bonn, Inst Cell Biol, D-53121 Bonn, Germany; [Repnik, Urska; Nesset, Cecilie Kasi; Griffiths, Gareth] Univ Oslo, Dept Biosci, N-0316 Oslo, Norway; [Ichihara, Atsuhiro] Tokyo Womens Med Univ, Dept Med 2, Tokyo 162866, Japan; [Lee, Beth S.] Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Schwake, Michael] Univ Bielefeld, Dept Chem, Biochem 3, D-33615 Bielefeld, Germany; [De Brabander, Jef] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Kiel; University of Bonn; University of Oslo; Tokyo Women's Medical University; University System of Ohio; Ohio State University; University of Bielefeld; University of Texas System; University of Texas Southwestern Medical Center Dallas	Haas, A (corresponding author), Univ Bonn, Inst Cell Biol, D-53121 Bonn, Germany.	albert.haas@uni-bonn.de; psaftig@biochem.uni-kiel.de	Saftig, Paul/A-7966-2010; Lee, Beth S/E-9578-2010	Lee, Beth S/0000-0002-1468-6387; Schwake, Michael/0000-0002-4173-2166	Deutsche Forschungsgemeinschaft [GRK1459, SPP1580]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants GRK1459 (to P.S. and S.K.) and SPP1580 (to A.H., G.G., and P.S).	Baars TL, 2007, MOL BIOL CELL, V18, P3873, DOI 10.1091/mbc.E07-03-0205; Bayer MJ, 2003, J CELL BIOL, V162, P211, DOI 10.1083/jcb.200212004; Becken U, 2010, P NATL ACAD SCI USA, V107, P20726, DOI 10.1073/pnas.1007295107; CLAGUE MJ, 1994, J BIOL CHEM, V269, P21; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Coonrod EM, 2013, DEV CELL, V27, P462, DOI 10.1016/j.devcel.2013.10.014; Del Fattore A, 2006, J MED GENET, V43, P315, DOI 10.1136/jmg.2005.036673; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; Di Giovanni J, 2010, NEURON, V67, P268, DOI 10.1016/j.neuron.2010.06.024; DIMENT S, 1987, J LEUKOCYTE BIOL, V42, P485, DOI 10.1002/jlb.42.5.485; El Far O, 2011, J NEUROCHEM, V117, P603, DOI 10.1111/j.1471-4159.2011.07234.x; Fairn GD, 2012, TRENDS IMMUNOL, V33, P397, DOI 10.1016/j.it.2012.03.003; Fernandez-Mora E, 2005, TRAFFIC, V6, P635, DOI 10.1111/j.1600-0854.2005.00304.x; Forgac M, 1999, J BIOL CHEM, V274, P12951, DOI 10.1074/jbc.274.19.12951; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Grimm C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5699; Haas A, 2007, TRAFFIC, V8, P311, DOI 10.1111/j.1600-0854.2006.00531.x; Hiesinger PR, 2005, CELL, V121, P607, DOI 10.1016/j.cell.2005.03.012; Hinton A, 2009, PFLUG ARCH EUR J PHY, V457, P589, DOI 10.1007/s00424-007-0382-4; Ichihara A, 2011, J RENIN-ANGIO-ALDO S, V12, P638, DOI 10.1177/1470320311429227; Jeyaraj S, 2005, J BIOL CHEM, V280, P37957, DOI 10.1074/jbc.M502883200; Kinouchi K, 2010, CIRC RES, V107, P30, DOI 10.1161/CIRCRESAHA.110.224667; Kluge C, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-29; Korfali N, 2012, NUCLEUS-PHILA, V3, P552, DOI 10.4161/nucl.22257; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Liegeois S, 2006, J CELL BIOL, V173, P949, DOI 10.1083/jcb.200511072; Manolson MF, 2003, J BIOL CHEM, V278, P49271, DOI 10.1074/jbc.M309914200; MARKS SC, 1985, J HERED, V76, P171, DOI 10.1093/oxfordjournals.jhered.a110059; NEZU J, 1992, J BIOCHEM, V112, P212, DOI 10.1093/oxfordjournals.jbchem.a123879; Nyman JKE, 2010, CALCIFIED TISSUE INT, V87, P273, DOI 10.1007/s00223-010-9395-7; Ohya T, 2009, NATURE, V459, P1091, DOI 10.1038/nature08107; Oshima Y, 2011, J AM SOC NEPHROL, V22, P2203, DOI 10.1681/ASN.2011020202; Peri F, 2008, CELL, V133, P916, DOI 10.1016/j.cell.2008.04.037; Riediger F, 2011, J AM SOC NEPHROL, V22, P2193, DOI 10.1681/ASN.2011020200; Roth W, 2000, FASEB J, V14, P2075, DOI 10.1096/fj.99-0970com; SAFTIG P, 1995, EMBO J, V14, P3599, DOI 10.1002/j.1460-2075.1995.tb00029.x; Sato K, 2006, MOL IMMUNOL, V43, P1443, DOI 10.1016/j.molimm.2005.07.035; Scimeca JC, 2000, BONE, V26, P207, DOI 10.1016/S8756-3282(99)00278-1; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; Steinberg BE, 2010, J CELL BIOL, V189, P1171, DOI 10.1083/jcb.200911083; Strasser B, 2011, EMBO J, V30, P4126, DOI 10.1038/emboj.2011.335; Stroupe C, 2009, P NATL ACAD SCI USA, V106, P17626, DOI 10.1073/pnas.0903801106; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; Sun-Wada GH, 2009, J CELL SCI, V122, P2504, DOI 10.1242/jcs.050443; Sun-Wada GH, 2000, DEV BIOL, V228, P315, DOI 10.1006/dbio.2000.9963; Toei M, 2010, BIOCHEMISTRY-US, V49, P4715, DOI 10.1021/bi100397s; Toyomura T, 2003, J BIOL CHEM, V278, P22023, DOI 10.1074/jbc.M302436200; Wang D, 2014, J CELL BIOL, V205, P21, DOI 10.1083/jcb.201312109; Wilkens S, 1999, J BIOL CHEM, V274, P31804, DOI 10.1074/jbc.274.45.31804; Xie XS, 2004, J BIOL CHEM, V279, P19755, DOI 10.1074/jbc.M313796200; Zhang ZY, 2008, J BIOL CHEM, V283, P35983, DOI 10.1074/jbc.M805345200	52	55	55	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					14166	14180		10.1074/jbc.M114.628891	http://dx.doi.org/10.1074/jbc.M114.628891			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25903133	hybrid, Green Published			2022-12-28	WOS:000355313000044
J	Koban, F; El-Kasaby, A; Hausler, C; Stockner, T; Simbrunner, BM; Sitte, HH; Freissmuth, M; Sucic, S				Koban, Florian; El-Kasaby, Ali; Haeusler, Cornelia; Stockner, Thomas; Simbrunner, Benedikt M.; Sitte, Harald H.; Freissmuth, Michael; Sucic, Sonja			A Salt Bridge Linking the First Intracellular Loop with the C Terminus Facilitates the Folding of the Serotonin Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOPAMINE TRANSPORTER; ENDOPLASMIC-RETICULUM; ADENOSINE RECEPTOR; STARTLE DISEASE; QUALITY-CONTROL; PROTEIN; MUTATIONS; EFFICIENT; COMPONENT; MECHANISM	The folding trajectory of solute carrier 6 (SLC6) family members is of interest because point mutations result in misfolding and thus cause clinically relevant phenotypes in people. Here we examined the contribution of the C terminus in supporting folding of the serotonin transporter (SERT; SLC6A4). Our working hypothesis posited that the amphipathic nature of the C-terminal alpha-helix (Thr(603)-Thr(613)) was important for folding of SERT. Accordingly, we disrupted the hydrophobic moment of the alpha-helix by replacing Phe(604), Ile(608), or Ile(612) by Gln. The bulk of the resulting mutants SERT-F604Q, SERT-I608Q, and SERT-I612Q were retained in the endoplasmic reticulum, but their residual delivery to the cell surface still depended on SEC24C. This indicates that the amphipathic nature of the C-terminal alpha-helix was dispensable to endoplasmic reticulum export. The folding trajectory of SERT is thought to proceed through the inward facing conformation. Consistent with this conjecture, cell surface expression of the misfolded mutants was restored by (i) introducing second site suppressor mutations, which trap SERT in the inward facing state, or (ii) by the pharmacochaperone noribogaine, which binds to the inward facing conformation. Finally, mutation of Glu(615) at the end of the C-terminal alpha-helix to Lys reduced surface expression of SERT-E615K. A charge reversal mutation in intracellular loop 1 restored surface expression of SERT-R152E/E615K to wild type levels. These observations support a mechanistic model where the C-terminal amphipathic helix is stabilized by an intramolecular salt bridge between residues Glu(615) and Arg(152). This interaction acts as a pivot in the conformational search associated with folding of SERT.	[Koban, Florian; El-Kasaby, Ali; Haeusler, Cornelia; Stockner, Thomas; Simbrunner, Benedikt M.; Sitte, Harald H.; Freissmuth, Michael; Sucic, Sonja] Med Univ Vienna, Inst Pharmacol, Ctr Physiol & Pharmacol, A-1090 Vienna, Austria; [El-Kasaby, Ali] Mansoura Univ, Dept Pharmacol, Fac Vet Med, Mansoura 35516, Egypt	Medical University of Vienna; Egyptian Knowledge Bank (EKB); Mansoura University	Sucic, S (corresponding author), Med Univ Vienna, Inst Pharmacol, Ctr Physiol & Pharmacol, Waehringer Str 13A, A-1090 Vienna, Austria.	sonja.sucic@meduniwien.ac.at	Sitte, Harald/O-7025-2019; Sitte, Harald/N-2681-2013; Stockner, Thomas/A-9509-2014	Sitte, Harald/0000-0002-1339-7444; Sitte, Harald/0000-0002-1339-7444; Stockner, Thomas/0000-0002-7071-8283; Koban, Florian/0000-0003-0912-3114; Sucic, Sonja/0000-0001-5136-8022; Freissmuth, Michael/0000-0001-9398-1765	Fonds zur Forderung der Wissenschaflichen Forschung (FWF) [SFB35-10]; Austrian Science Fund/FWF [P27518-B27]; doctoral program Cell Communication in Health and Disease - Austrian Science Fund/FWF [W1205]; Medical University of Vienna	Fonds zur Forderung der Wissenschaflichen Forschung (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund/FWF(Austrian Science Fund (FWF)); doctoral program Cell Communication in Health and Disease - Austrian Science Fund/FWF(Austrian Science Fund (FWF)); Medical University of Vienna	This work was supported by Fonds zur Forderung der Wissenschaflichen Forschung (FWF) Project Program Grant SFB35-10 (to M. F.), Austrian Science Fund/FWF Grant P27518-B27 (to S. S.), and the doctoral program Cell Communication in Health and Disease, which was jointly funded by grants from the Austrian Science Fund/FWF (W1205) and the Medical University of Vienna.	Arribas-Gonzalez E, 2015, J BIOL CHEM, V290, P2150, DOI 10.1074/jbc.M114.587055; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bergmayr C, 2013, J BIOL CHEM, V288, P28831, DOI 10.1074/jbc.M113.464776; Bulling S, 2012, J BIOL CHEM, V287, P18524, DOI 10.1074/jbc.M112.343681; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Carta E, 2012, J BIOL CHEM, V287, P28975, DOI 10.1074/jbc.M112.372094; CHAKRABARTTY A, 1994, PROTEIN SCI, V3, P843; Chiba P, 2014, PHARMACOL RES, V83, P63, DOI 10.1016/j.phrs.2013.11.009; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; El-Kasaby A, 2014, J BIOL CHEM, V289, P28987, DOI 10.1074/jbc.M114.595090; El-Kasaby A, 2010, J BIOL CHEM, V285, P39201, DOI 10.1074/jbc.M110.118000; Farhan H, 2007, J BIOL CHEM, V282, P7679, DOI 10.1074/jbc.M609720200; Fenollar-Ferrer C, 2014, BIOCHEMISTRY-US, V53, P5444, DOI 10.1021/bi500637f; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hohenegger M, 1996, MOL PHARMACOL, V49, P73; Houck SA, 2012, BBA-BIOMEMBRANES, V1818, P1108, DOI 10.1016/j.bbamem.2011.11.007; Jacobs MT, 2007, J BIOL CHEM, V282, P29441, DOI 10.1074/jbc.M704456200; Jahn TR, 2005, FEBS J, V272, P5962, DOI 10.1111/j.1742-4658.2005.05021.x; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Korkhov VM, 2006, J BIOL CHEM, V281, P13439, DOI 10.1074/jbc.M511382200; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Kurian MA, 2011, LANCET NEUROL, V10, P54, DOI 10.1016/S1474-4422(10)70269-6; Kurian MA, 2009, J CLIN INVEST, V119, P1595, DOI 10.1172/JCI39060; Kusek J, 2015, MOL PHARMACOL, V87, P39, DOI 10.1124/mol.114.094045; Larsen MB, 2006, BIOCHEMISTRY-US, V45, P1331, DOI 10.1021/bi0508688; Malaga-Dieguez L, 2010, MOL PHARMACOL, V77, P940, DOI 10.1124/mol.110.063511; Montgomery TR, 2014, J NEUROSCI, V34, P6344, DOI 10.1523/JNEUROSCI.2991-13.2014; Ng J, 2014, BRAIN, V137, P1107, DOI 10.1093/brain/awu022; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Pankevych H, 2003, J BIOL CHEM, V278, P30283, DOI 10.1074/jbc.M212918200; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Qi YP, 1997, J NEUROSCI, V17, P1217; Rees MI, 2006, NAT GENET, V38, P801, DOI 10.1038/ng1814; Reiterer V, 2008, J NEUROSCI, V28, P12453, DOI 10.1523/JNEUROSCI.3451-08.2008; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Stockner T, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002909; Sucic S, 2013, J BIOL CHEM, V288, P5330, DOI 10.1074/jbc.M112.408237; Sucic S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230037; Sucic S, 2010, J BIOL CHEM, V285, P10924, DOI 10.1074/jbc.M109.083154; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Wolf MG, 2010, J COMPUT CHEM, V31, P2169, DOI 10.1002/jcc.21507; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978	45	31	31	3	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13263	13278		10.1074/jbc.M115.641357	http://dx.doi.org/10.1074/jbc.M115.641357			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25869136	Green Published, hybrid			2022-12-28	WOS:000354975700027
J	Wood, ER; Bledsoe, R; Chai, J; Daka, P; Deng, HF; Ding, Y; Harris-Gurley, S; Kryn, LH; Nartey, E; Nichols, J; Nolte, RT; Prabhu, N; Rise, C; Sheahan, T; Shotwell, JB; Smith, D; Tai, V; Taylor, JD; Tomberlin, G; Wang, LP; Wisely, B; You, SY; Xia, B; Dickson, H				Wood, Edgar R.; Bledsoe, Randy; Chai, Jing; Daka, Philias; Deng, Hongfeng; Ding, Yun; Harris-Gurley, Sarah; Kryn, Luz Helena; Nartey, Eldridge; Nichols, James; Nolte, Robert T.; Prabhu, Ninad; Rise, Cecil; Sheahan, Timothy; Shotwell, J. Brad; Smith, Danielle; Tai, Vince; Taylor, J. David; Tomberlin, Ginger; Wang, Liping; Wisely, Bruce; You, Shihyun; Xia, Bing; Dickson, Hamilton			The Role of Phosphodiesterase 12 (PDE12) as a Negative Regulator of the Innate Immune Response and the Discovery of Antiviral Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNASE-L; 2-5A SYSTEM; L PATHWAY; INTERFERON; PROTEIN; APOPTOSIS; BINDING; PURIFICATION; MITOCHONDRIA; REPLICATION	2',5'-Oligoadenylate synthetase (OAS) enzymes and RNase-L constitute a major effector arm of interferon (IFN)-mediated antiviral defense. OAS produces a unique oligonucleotide second messenger, 2',5'-oligoadenylate (2-5A), that binds and activates RNase-L. This pathway is down-regulated by virus- and host-encoded enzymes that degrade 2-5A. Phosphodiesterase 12 (PDE12) was the first cellular 2-5A-degrading enzyme to be purified and described at a molecular level. Inhibition of PDE12 may up-regulate the OAS/RNase-L pathway in response to viral infection resulting in increased resistance to a variety of viral pathogens. We generated a PDE12-null cell line, HeLa Delta PDE12, using transcription activator-like effector nuclease-mediated gene inactivation. This cell line has increased 2-5A levels in response to IFN and poly(I-C), a double-stranded RNA mimic compared with the parental cell line. Moreover, HeLa Delta PDE12 cells were resistant to viral pathogens, including encephalomyocarditis virus, human rhinovirus, and respiratory syncytial virus. Based on these results, we used DNA-encoded chemical library screening to identify starting points for inhibitor lead optimization. Compounds derived from this effort raise 2-5A levels and exhibit antiviral activity comparable with the effects observed with PDE12 gene inactivation. The crystal structure of PDE12 complexed with an inhibitor was solved providing insights into the structure-activity relationships of inhibitor potency and selectivity.	[Wood, Edgar R.; Bledsoe, Randy; Harris-Gurley, Sarah; Kryn, Luz Helena; Nartey, Eldridge; Nichols, James; Smith, Danielle; Taylor, J. David; Tomberlin, Ginger; Wisely, Bruce] GlaxoSmithKline, Dept Biol Sci, Res Triangle Pk, NC 27709 USA; [Nolte, Robert T.; Wang, Liping] GlaxoSmithKline, Dept Chem Sci, Res Triangle Pk, NC 27709 USA; [Daka, Philias; Sheahan, Timothy; Shotwell, J. Brad; Tai, Vince; You, Shihyun; Dickson, Hamilton] GlaxoSmithKline, Antiviral Discovery Performance Unit, Res Triangle Pk, NC 27709 USA; [Chai, Jing; Deng, Hongfeng; Ding, Yun; Prabhu, Ninad; Rise, Cecil; Xia, Bing] GlaxoSmithKline, ELT Boston, Waltham, MA 02451 USA	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Wood, ER (corresponding author), GlaxoSmithKline, Biol Sci, 5 Moore Dr, Res Triangle Pk, NC 27709 USA.	edgar.r.wood@mindspring.com	Sheahan, Timothy/J-8201-2019	Sheahan, Timothy/0000-0001-9181-2183; Taylor, J. David/0000-0001-6113-465X				Clark MA, 2009, NAT CHEM BIOL, V5, P647, DOI 10.1038/nchembio.211; Copeland R. A., 2004, ENZYMES PRACTICAL IN; Deng HF, 2012, J MED CHEM, V55, P7061, DOI 10.1021/jm300449x; Disch JS, 2013, J MED CHEM, V56, P3666, DOI 10.1021/jm400204k; Domingo-Gil E, 2006, APOPTOSIS, V11, P725, DOI 10.1007/s10495-006-5541-0; Drappier M, 2014, VIROLOGIE, V18, P264, DOI 10.1684/vir.2014.0578; Einhauer A, 2001, J BIOCHEM BIOPH METH, V49, P455, DOI 10.1016/S0165-022X(01)00213-5; Elbahesh H, 2011, VIROLOGY, V409, P262, DOI 10.1016/j.virol.2010.10.016; Ezelle Heather J, 2012, Front Biosci (Schol Ed), V4, P767; Flodstrom-Tullberg M, 2005, J IMMUNOL, V174, P1171, DOI 10.4049/jimmunol.174.3.1171; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Goldstrohm AC, 2008, NAT REV MOL CELL BIO, V9, P337, DOI 10.1038/nrm2370; Gusho E, 2014, MBIO, V5, DOI 10.1128/mBio.01312-14; Han JQ, 2007, J VIROL, V81, P5561, DOI 10.1128/JVI.01857-06; Kay Brian K., 2009, V498, P185, DOI 10.1007/978-1-59745-196-3_13; Kjaer KH, 2014, BMC CELL BIOL, V15, DOI 10.1186/1471-2121-15-33; Kubota K, 2004, J BIOL CHEM, V279, P37832, DOI 10.1074/jbc.M400089200; Le Roy F, 2007, CELL DEATH DIFFER, V14, P1406, DOI 10.1038/sj.cdd.4402130; Li XL, 2011, WIRES RNA, V2, P58, DOI 10.1002/wrna.32; Lin RJ, 2009, J IMMUNOL, V183, P8035, DOI 10.4049/jimmunol.0902728; Lou ZY, 2014, TRENDS PHARMACOL SCI, V35, P86, DOI 10.1016/j.tips.2013.11.006; Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003; Mazumder R, 2002, NUCLEIC ACIDS RES, V30, P5229, DOI 10.1093/nar/gkf645; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Min JY, 2006, P NATL ACAD SCI USA, V103, P7100, DOI 10.1073/pnas.0602184103; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; Morin B, 2010, ANTIVIR RES, V87, P345, DOI 10.1016/j.antiviral.2010.06.003; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARKS TD, 1994, ANAL BIOCHEM, V216, P413, DOI 10.1006/abio.1994.1060; Poulsen JB, 2011, NUCLEIC ACIDS RES, V39, P3754, DOI 10.1093/nar/gkq1282; Reema KT, 2013, BIOORG MED CHEM LETT, V23, P3584, DOI 10.1016/j.bmcl.2013.04.019; Rorbach J, 2011, NUCLEIC ACIDS RES, V39, P7750, DOI 10.1093/nar/gkr470; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Samuel MA, 2006, J VIROL, V80, P7009, DOI 10.1128/JVI.00489-06; Scherbik SV, 2006, J VIROL, V80, P2987, DOI 10.1128/JVI.80.6.2987-2999.2006; Silverman RH, 2007, J VIROL, V81, P12720, DOI 10.1128/JVI.01471-07; Silverman RH, 2014, J INTERF CYTOK RES, V34, P455, DOI 10.1089/jir.2014.0007; Sorgeloos F, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003474; TORRENCE PF, 1983, ANAL BIOCHEM, V129, P103, DOI 10.1016/0003-2697(83)90058-1; Wang H, 2010, EMBO J, V29, P2566, DOI 10.1038/emboj.2010.152; WILLIAMS BRG, 1978, EUR J BIOCHEM, V92, P455, DOI 10.1111/j.1432-1033.1978.tb12767.x; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang R, 2013, P NATL ACAD SCI USA, V110, P13114, DOI 10.1073/pnas.1306917110; Zhang W, 2012, J BIOL CHEM, V287, P11981, DOI 10.1074/jbc.M111.338525; Zhao L, 2012, CELL HOST MICROBE, V11, P607, DOI 10.1016/j.chom.2012.04.011; Zhou AM, 1997, EMBO J, V16, P6355, DOI 10.1093/emboj/16.21.6355	47	46	47	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19681	19696		10.1074/jbc.M115.653113	http://dx.doi.org/10.1074/jbc.M115.653113			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26055709	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000359364600028
J	Hofer, P; Boeszoermenyi, A; Jaeger, D; Feiler, U; Arthanari, H; Mayer, N; Zehender, F; Rechberger, G; Oberer, M; Zimmermann, R; Lass, A; Haemmerle, G; Breinbauer, R; Zechner, R; Preiss-Landl, K				Hofer, Peter; Boeszoermenyi, Andras; Jaeger, Doris; Feiler, Ursula; Arthanari, Haribabu; Mayer, Nicole; Zehender, Fabian; Rechberger, Gerald; Oberer, Monika; Zimmermann, Robert; Lass, Achim; Haemmerle, Guenter; Breinbauer, Rolf; Zechner, Rudolf; Preiss-Landl, Karina			Fatty Acid-binding Proteins Interact with Comparative Gene Identification-58 Linking Lipolysis with Lipid Ligand Shuttling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; ADIPOSE TRIGLYCERIDE LIPASE; PROLIFERATOR-ACTIVATED RECEPTORS; NMR-SPECTROSCOPY; STRUCTURAL BASIS; PPAR-GAMMA; CGI-58; ALPHA; ATGL; RECONSTRUCTION	The coordinated breakdown of intracellular triglyceride (TG) stores requires the exquisitely regulated interaction of lipolytic enzymes with regulatory, accessory, and scaffolding proteins. Together they form a dynamic multiprotein network designated as the "lipolysome." Adipose triglyceride lipase (Atgl) catalyzes the initiating step of TG hydrolysis and requires comparative gene identification-58 (Cgi-58) as a potent activator of enzyme activity. Here, we identify adipocyte-type fatty acid-binding protein (A-Fabp) and other members of the fatty acid-binding protein (Fabp) family as interaction partners of Cgi-58. Co-immunoprecipitation, microscale thermophoresis, and solid phase assays proved direct protein/protein interaction between A-Fabp and Cgi-58. Using nuclear magnetic resonance titration experiments and site-directed mutagenesis, we located a potential contact region on A-Fabp. In functional terms, A-Fabp stimulates Atgl-catalyzed TG hydrolysis in a Cgi-58-dependent manner. Additionally, transcriptional transactivation assays with a luciferase reporter system revealed that Fabps enhance the ability of Atgl/Cgi-58-mediated lipolysis to induce the activity of peroxisome proliferator-activated receptors. Our studies identify Fabps as crucial structural and functional components of the lipolysome.	[Hofer, Peter; Boeszoermenyi, Andras; Jaeger, Doris; Feiler, Ursula; Rechberger, Gerald; Oberer, Monika; Zimmermann, Robert; Lass, Achim; Haemmerle, Guenter; Zechner, Rudolf; Preiss-Landl, Karina] Graz Univ, Inst Mol Biosci, NAWI Graz, A-8010 Graz, Austria; [Arthanari, Haribabu] Harvard Univ, Dept Biol Chem & Mol Pharmacol, Sch Med, Boston, MA 02115 USA; [Mayer, Nicole; Breinbauer, Rolf] Graz Univ Technol, Inst Organ Chem, A-8010 Graz, Austria; [Zehender, Fabian] NanoTemper Technol GmbH, D-81369 Munich, Germany	University of Graz; Harvard University; Harvard Medical School; Graz University of Technology	Zechner, R (corresponding author), Graz Univ, Inst Mol Biosci, Heinrichstr 31-2, A-8010 Graz, Austria.	rudolf.zechner@uni-graz.at; karina.landl@uni-graz.at	Lass, Achim/C-3332-2008; Breinbauer, Rolf/AAK-1750-2020; Boeszoermenyi, Andras/AAD-9808-2020	Lass, Achim/0000-0002-8190-7151; Breinbauer, Rolf/0000-0001-6009-7359; Boeszoermenyi, Andras/0000-0001-9810-7241; Hofer, Peter/0000-0002-0788-7519; Arthanari, Haribabu/0000-0002-7281-1289; Haemmerle, Guenter/0000-0001-9900-5896; Oberer, Monika/0000-0003-2525-9513; Zimmermann, Robert/0000-0002-7354-870X; Rechberger, Gerald N./0000-0002-0071-317X; Zechner, Rudolf/0000-0001-5483-1182	Austrian Fonds zur Forderung der Wissenschaftlichen Forschung [SFB LIPOTOX F30, P22170]; DK Molecular Enzymology [W09]; Wittgenstein Award - Austrian Fonds zur Forderung der Wissenschaftlichen Forschung [Z136]; Foundation Leduq [TNT 12CVD04]; Austrian Science Fund (FWF) [P 22170, Z 136, W 901, F 3002] Funding Source: researchfish	Austrian Fonds zur Forderung der Wissenschaftlichen Forschung(Austrian Science Fund (FWF)); DK Molecular Enzymology(Austrian Science Fund (FWF)); Wittgenstein Award - Austrian Fonds zur Forderung der Wissenschaftlichen Forschung(Austrian Science Fund (FWF)); Foundation Leduq; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Fonds zur Forderung der Wissenschaftlichen Forschung Grants SFB LIPOTOX F30 and P22170, DK Molecular Enzymology W09, Wittgenstein Award Z136 funded by the Austrian Fonds zur Forderung der Wissenschaftlichen Forschung, and Foundation Leduq TNT 12CVD04. The authors declare that they have no conflicts of interest with the contents of this article.	Adida A, 2006, BBA-MOL CELL BIOL L, V1761, P172, DOI 10.1016/j.bbalip.2006.02.006; Armstrong EH, 2014, J BIOL CHEM, V289, P14941, DOI 10.1074/jbc.M113.514646; Ayers SD, 2007, BIOCHEMISTRY-US, V46, P6744, DOI 10.1021/bi700047a; Birner-Gruenberger R, 2005, MOL CELL PROTEOMICS, V4, P1710, DOI 10.1074/mcp.M500062-MCP200; Borg ML, 2011, DIABETES, V60, P1458, DOI 10.2337/db10-0845; Cao HM, 2013, CELL METAB, V17, P768, DOI 10.1016/j.cmet.2013.04.012; Cerk IK, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.602599; Chung C, 2008, J HEPATOL, V48, P471, DOI 10.1016/j.jhep.2007.10.012; Coe NR, 1999, J LIPID RES, V40, P967; Dai ZY, 2013, INT J BIOCHEM CELL B, V45, P2076, DOI 10.1016/j.biocel.2013.07.008; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; EGLOFF MP, 1995, PROTEIN SCI, V4, P44; Ellong EN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021889; Ferentz AE, 2000, Q REV BIOPHYS, V33, P29, DOI 10.1017/S0033583500003589; Filleur S, 2009, J CELL BIOCHEM, V106, P769, DOI 10.1002/jcb.22072; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Garin-Shkolnik T, 2014, DIABETES, V63, P900, DOI 10.2337/db13-0436; Gillilan RE, 2007, J MOL BIOL, V372, P1246, DOI 10.1016/j.jmb.2007.07.040; Goeritzer M, 2014, J LIPID RES, V55, P2562, DOI 10.1194/jlr.M052613; Granneman JG, 2011, J BIOL CHEM, V286, P5126, DOI 10.1074/jbc.M110.180711; Granneman JG, 2009, J BIOL CHEM, V284, P3049, DOI 10.1074/jbc.M808251200; Gruber A, 2010, J BIOL CHEM, V285, P12289, DOI 10.1074/jbc.M109.064469; Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439; Haunerland NH, 2004, PROG LIPID RES, V43, P328, DOI 10.1016/j.plipres.2004.05.001; Heckmann BL, 2013, BBA-MOL CELL BIOL L, V1831, P276, DOI 10.1016/j.bbalip.2012.09.016; Hostetler HA, 2009, J LIPID RES, V50, P1663, DOI 10.1194/jlr.M900058-JLR200; Hyberts SG, 2012, J BIOMOL NMR, V52, P315, DOI 10.1007/s10858-012-9611-z; Hyberts SG, 2010, J AM CHEM SOC, V132, P2145, DOI 10.1021/ja908004w; Jenkins-Kruchten AE, 2003, J BIOL CHEM, V278, P47636, DOI 10.1074/jbc.M307680200; Kioka H, 2014, P NATL ACAD SCI USA, V111, P273, DOI 10.1073/pnas.1318547111; Lass A, 2011, PROG LIPID RES, V50, P14, DOI 10.1016/j.plipres.2010.10.004; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Lefevre C, 2001, AM J HUM GENET, V69, P1002, DOI 10.1086/324121; MacPhee CE, 2000, BIOCHEMISTRY-US, V39, P3433, DOI 10.1021/bi992523t; MacPherson REK, 2013, AM J PHYSIOL-REG I, V304, pR644, DOI 10.1152/ajpregu.00418.2012; Marcelino AMC, 2006, PROTEINS, V63, P373, DOI 10.1002/prot.20860; Mayer N, 2013, NAT CHEM BIOL, V9, P785, DOI [10.1038/NCHEMBIO.1359, 10.1038/nchembio.1359]; Nagy HM, 2014, BBA-MOL CELL BIOL L, V1841, P588, DOI 10.1016/j.bbalip.2014.01.005; Nooren IMA, 2003, EMBO J, V22, P3486, DOI 10.1093/emboj/cdg359; Oberer M, 2011, CURR OPIN LIPIDOL, V22, P149, DOI 10.1097/MOL.0b013e328346230e; Olzmann JA, 2013, P NATL ACAD SCI USA, V110, P1345, DOI 10.1073/pnas.1213738110; Ozbabacan SEA, 2011, PROTEIN ENG DES SEL, V24, P635, DOI 10.1093/protein/gzr025; Park S, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.27723; Sahu-Osen A, 2015, J LIPID RES, V56, P109, DOI 10.1194/jlr.M055004; Schupp M, 2010, J BIOL CHEM, V285, P40409, DOI 10.1074/jbc.R110.182451; Schweiger M, 2012, J LIPID RES, V53, P2307, DOI 10.1194/jlr.M027409; Schweiger M, 2009, AM J PHYSIOL-ENDOC M, V297, pE289, DOI 10.1152/ajpendo.00099.2009; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Shen WJ, 1999, P NATL ACAD SCI USA, V96, P5528, DOI 10.1073/pnas.96.10.5528; Shen WJ, 2001, J BIOL CHEM, V276, P49443, DOI 10.1074/jbc.M104095200; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Smith AJ, 2004, J BIOL CHEM, V279, P52399, DOI 10.1074/jbc.M410301200; Smith AJ, 2007, J BIOL CHEM, V282, P32424, DOI 10.1074/jbc.M703730200; Smith AJ, 2008, J BIOL CHEM, V283, P33536, DOI 10.1074/jbc.M806732200; Storch J, 2008, ANNU REV NUTR, V28, P73, DOI 10.1146/annurev.nutr.27.061406.093710; Sulsky R, 2007, BIOORG MED CHEM LETT, V17, P3511, DOI 10.1016/j.bmcl.2006.12.044; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; Velkov T, 2013, PPAR RES, V2013, DOI 10.1155/2013/938401; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wolfrum C, 2001, P NATL ACAD SCI USA, V98, P2323, DOI 10.1073/pnas.051619898; Yamaguchi T, 2007, J LIPID RES, V48, P1078, DOI 10.1194/jlr.M600493-JLR200; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; Zechner R, 2009, J LIPID RES, V50, P3, DOI 10.1194/jlr.R800031-JLR200; Zhang J, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.573857; Zierler KA, 2014, CURR OPIN LIPIDOL, V25, P102, DOI 10.1097/MOL.0000000000000058	65	36	37	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18438	18453		10.1074/jbc.M114.628958	http://dx.doi.org/10.1074/jbc.M114.628958			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	25953897	Green Published, hybrid			2022-12-28	WOS:000358512100016
J	Lontay, B; Bodoor, K; Sipos, A; Weitzel, DH; Loiselle, D; Safi, R; Zheng, DH; Devente, J; Hickner, RC; McDonnell, DP; Ribar, T; Haystead, TA				Lontay, Beata; Bodoor, Khaldon; Sipos, Adrienn; Weitzel, Douglas H.; Loiselle, David; Safi, Rachid; Zheng, Donghai; Devente, James; Hickner, Robert C.; McDonnell, Donald P.; Ribar, Thomas; Haystead, Timothy A.			Pregnancy and Smoothelin-like Protein 1 (SMTNL1) Deletion Promote the Switching of Skeletal Muscle to a Glycolytic Phenotype in Human and Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GESTATIONAL DIABETES-MELLITUS; HORMONE REPLACEMENT THERAPY; INSULIN-RESISTANCE; PROGESTERONE-RECEPTOR; POSTMENOPAUSAL WOMEN; ADDUCTOR POLLICIS; ESTROGEN; EXERCISE; ADAPTATION; EXPRESSION	Pregnancy promotes physiological adaptations throughout the body, mediated by the female sex hormones progesterone and estrogen. Changes in the metabolic properties of skeletal muscle enable the female body to cope with the physiological challenges of pregnancy and may also be linked to the development of insulin resistance. We conducted global microarray, proteomic, and metabolic analyses to study the role of the progesterone receptor and its transcriptional regulator, smoothelin-like protein 1 (SMTNL1) in the adaptation of skeletal muscle to pregnancy. We demonstrate that pregnancy promotes fiber-type changes from an oxidative to glycolytic isoform in skeletal muscle. This phenomenon is regulated through an interaction between SMTNL1 and progesterone receptor, which alters the expression of contractile and metabolic proteins. smtnl1(-/-) mice are metabolically less efficient and show impaired glucose tolerance. Pregnancy antagonizes these effects by inducing metabolic activity and increasing glucose tolerance. Our results suggest that SMTNL1 has a role in mediating the actions of steroid hormones to promote fiber switching in skeletal muscle during pregnancy. Our findings also bear on the management of gestational diabetes that develops as a complication of pregnancy in similar to 4% of women.	[Lontay, Beata; Bodoor, Khaldon; Weitzel, Douglas H.; Loiselle, David; Safi, Rachid; McDonnell, Donald P.; Haystead, Timothy A.] Duke Univ, Med Ctr, Dept Pharmacol, Durham, NC 27710 USA; [Lontay, Beata; Sipos, Adrienn] Univ Debrecen, Fac Med, Dept Med Chem, H-4032 Debrecen, Hungary; [Zheng, Donghai; Hickner, Robert C.] E Carolina Univ, Dept Kinesiol, Greenville, NC 27858 USA; [Devente, James] E Carolina Univ, Dept Obstet & Gynecol, Greenville, NC 27834 USA; [Hickner, Robert C.] Univ KwaZulu Natal, Dept Biokinet Exercise & Leisure Sci, ZA-4000 Durban, South Africa; [Ribar, Thomas] Duke Univ, Med Ctr, Duke iPSC Shared Resource Facil, Durham, NC 27710 USA	Duke University; University of Debrecen; University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; University of Kwazulu Natal; Duke University	Haystead, TA (corresponding author), Duke Univ, Sch Med, C118 LSRC Box 3813, Durham, NC 27710 USA.	timothy.haystead@duke.edu	Regan, Clinton/E-6250-2012; Safi, Rachid/A-5909-2010	hickner, Robert/0000-0002-2683-1617	National Institutes of Health [R01DK065954-05]; University of Debrecen [RH/751/2015]; King Hussein fellowship;  [OTKA PD107898];  [TAMOP-4.2.2.A-11/1/KONV-2012-0025];  [TAMOP 4.2.4.A/2-11-1-2012-0001]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065954] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Debrecen; King Hussein fellowship; ; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK065954-05 (to T. A. H.). This work was also supported by Grants OTKA PD107898, TAMOP-4.2.2.A-11/1/KONV-2012-0025, and TAMOP 4.2.4.A/2-11-1-2012-0001, the University of Debrecen (RH/751/2015) (to B. L.), and by The King Hussein fellowship (to K. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Akimoto T, 2004, AM J PHYSIOL-CELL PH, V287, pC1311, DOI 10.1152/ajpcell.00248.2004; Bodoor K, 2011, J BIOL CHEM, V286, P31839, DOI 10.1074/jbc.M111.270397; BOOTH FW, 1991, PHYSIOL REV, V71, P541, DOI 10.1152/physrev.1991.71.2.541; Borman MA, 2004, FEBS LETT, V573, P207, DOI 10.1016/j.febslet.2004.08.002; BRADSHAW MS, 1991, J BIOL CHEM, V266, P16684; Branisteanu DD, 2003, TRENDS ENDOCRIN MET, V14, P54, DOI 10.1016/S1043-2760(03)00003-1; Bryzgalova G, 2006, DIABETOLOGIA, V49, P588, DOI 10.1007/s00125-005-0105-3; Carey AL, 2009, DIABETOLOGIA, V52, P2015, DOI 10.1007/s00125-009-1420-x; Catalano PM, 2010, REPRODUCTION, V140, P365, DOI 10.1530/REP-10-0088; Coleman KM, 2003, J BIOL CHEM, V278, P12834, DOI 10.1074/jbc.M212312200; Barros RPD, 2008, MOL CELL ENDOCRINOL, V295, P24, DOI 10.1016/j.mce.2008.07.008; Edwards DP, 2005, ANNU REV PHYSIOL, V67, P335, DOI 10.1146/annurev.physiol.67.040403.120151; Fitts RH, 2003, AM J PHYS MED REHAB, V82, P320, DOI 10.1097/01.PHM.0000059336.40487.9C; Halayko AJ, 2001, J APPL PHYSIOL, V90, P358, DOI 10.1152/jappl.2001.90.1.358; Hamilton MT, 2000, J APPL PHYSIOL, V88, P327, DOI 10.1152/jappl.2000.88.1.327; Kirwan JP, 2004, J CLIN ENDOCR METAB, V89, P4678, DOI 10.1210/jc.2004-0749; Lontay B, 2004, J COMP NEUROL, V478, P72, DOI 10.1002/cne.20273; Lontay B, 2010, J BIOL CHEM, V285, P29357, DOI 10.1074/jbc.M110.143966; Onambele NGL, 2001, CLIN SCI, V100, P421, DOI 10.1042/CS20000264; Rowan BG, 2000, MOL CELL BIOL, V20, P8720, DOI 10.1128/MCB.20.23.8720-8730.2000; Schmidt Carla, 2009, Methods Mol Biol, V564, P207, DOI 10.1007/978-1-60761-157-8_12; Shadforth IP, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-145; Shao JH, 2002, DIABETES, V51, P19, DOI 10.2337/diabetes.51.1.19; Skelton DA, 1999, CLIN SCI, V96, P357, DOI 10.1042/CS19980318; Solomon CG, 2001, HYPERTENSION, V37, P232, DOI 10.1161/01.HYP.37.2.232; Sugaya A, 2000, LIFE SCI, V66, P641, DOI 10.1016/S0024-3205(99)00636-0; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Ulke-Lemee A, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-10; Wooldridge AA, 2008, J BIOL CHEM, V283, P11850, DOI 10.1074/jbc.M708628200	29	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					17985	17998		10.1074/jbc.M115.658120	http://dx.doi.org/10.1074/jbc.M115.658120			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26048986	hybrid, Green Published			2022-12-28	WOS:000358511700031
J	Hao, W; Tashiro, S; Hasegawa, T; Sato, Y; Kobayashi, T; Tando, T; Katsuyama, E; Fujie, A; Watanabe, R; Morita, M; Miyamoto, K; Morioka, H; Nakamura, M; Matsumoto, M; Amizuka, N; Toyama, Y; Miyamoto, T				Hao, Wu; Tashiro, Syoichi; Hasegawa, Tomoka; Sato, Yuiko; Kobayashi, Tami; Tando, Toshimi; Katsuyama, Eri; Fujie, Atsuhiro; Watanabe, Ryuichi; Morita, Mayu; Miyamoto, Kana; Morioka, Hideo; Nakamura, Masaya; Matsumoto, Morio; Amizuka, Norio; Toyama, Yoshiaki; Miyamoto, Takeshi			Hyperglycemia Promotes Schwann Cell De-differentiation and De-myelination via Sorbitol Accumulation and Igf1 Protein Down-regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIABETIC PERIPHERAL NEUROPATHY; POLYOL PATHWAY; VITAMIN-D; HIGH GLUCOSE; CALCIUM-ABSORPTION; ENDOTHELIAL-CELLS; IN-VITRO; COMPLICATIONS; PROLIFERATION; ACTIVATION	Diabetes mellitus (DM) is frequently accompanied by complications, such as peripheral nerve neuropathy. Schwann cells play a pivotal role in regulating peripheral nerve function and conduction velocity; however, changes in Schwann cell differentiation status in DM are not fully understood. Here, we report that Schwann cells de-differentiate into immature cells under hyperglycemic conditions as a result of sorbitol accumulation and decreased Igf1 expression in those cells. We found that dedifferentiated Schwann cells could be re-differentiated in vitro into mature cells by treatment with an aldose reductase inhibitor, to reduce sorbitol levels, or with vitamin D-3, to elevate Igf1 expression. In vivo DM models exhibited significantly reduced nerve function and conduction, Schwann cell de-differentiation, peripheralnervede-myelination, and all conditions were significantly rescued by aldose reductase inhibitor or vitamin D-3 administration. These findings reveal mechanisms underlying pathological changes in Schwann cells seen in DM and suggest ways to treat neurological conditions associated with this condition.	[Hao, Wu; Sato, Yuiko; Kobayashi, Tami; Tando, Toshimi; Katsuyama, Eri; Fujie, Atsuhiro; Watanabe, Ryuichi; Miyamoto, Kana; Morioka, Hideo; Nakamura, Masaya; Matsumoto, Morio; Toyama, Yoshiaki; Miyamoto, Takeshi] Keio Univ, Sch Med, Dept Orthoped Surg, Shinjuku Ku, Tokyo 1608582, Japan; [Tashiro, Syoichi] Keio Univ, Sch Med, Dept Rehabil Med, Shinjuku Ku, Tokyo 1608582, Japan; [Sato, Yuiko] Keio Univ, Sch Med, Dept Musculoskeletal Reconstruct & Regenerat Surg, Shinjuku Ku, Tokyo 1608582, Japan; [Kobayashi, Tami; Miyamoto, Takeshi] Keio Univ, Sch Med, Dept Integrated Bone Metab & Immunol, Shinjuku Ku, Tokyo 1608582, Japan; [Morita, Mayu] Keio Univ, Sch Med, Dept Dent & Oral Surg, Shinjuku Ku, Tokyo 1608582, Japan; [Hasegawa, Tomoka; Amizuka, Norio] Hokkaido Univ, Grad Sch Dent Med, Dept Dev Biol Hard Tissue, Kita Ku, Sapporo, Hokkaido 0608586, Japan	Keio University; Keio University; Keio University; Keio University; Keio University; Hokkaido University	Miyamoto, T (corresponding author), Keio Univ, Sch Med, Dept Orthoped Surg, Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan.	miyamoto@z5.keio.jp	Nakamura, Masaya/K-4111-2013; Tashiro, Syoichi/I-5119-2019; hao, wu/HDM-1705-2022	Tashiro, Syoichi/0000-0002-1430-0552; 				Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Ameri P, 2013, EUR J ENDOCRINOL, V169, P767, DOI 10.1530/EJE-13-0510; Berrone E, 2006, J BIOL CHEM, V281, P9307, DOI 10.1074/jbc.M600418200; Bischoff-Ferrari HA, 2004, JAMA-J AM MED ASSOC, V291, P1999, DOI 10.1001/jama.291.16.1999; Boulton AJM, 1998, DIABETIC MED, V15, P508, DOI 10.1002/(SICI)1096-9136(199806)15:6<508::AID-DIA613>3.0.CO;2-L; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Busik JV, 2008, DIABETES, V57, P1952, DOI 10.2337/db07-1520; CHAPUY MC, 1992, NEW ENGL J MED, V327, P1637, DOI 10.1056/NEJM199212033272305; Christakos S, 2011, MOL CELL ENDOCRINOL, V347, P25, DOI 10.1016/j.mce.2011.05.038; CHRISTIANSEN C, 1981, EUR J CLIN INVEST, V11, P305, DOI 10.1111/j.1365-2362.1981.tb02121.x; Chung SSM, 2003, J AM SOC NEPHROL, V14, pS233, DOI 10.1097/01.ASN.0000077408.15865.06; CLEMENTS RS, 1979, DIABETES, V28, P604, DOI 10.2337/diab.28.6.604; da Silva TF, 2014, J CLIN INVEST, V124, P2560, DOI 10.1172/JCI72063; DAWSONHUGHES B, 1995, J CLIN ENDOCR METAB, V80, P3657, DOI 10.1210/jc.80.12.3657; Felitsyn N, 2007, J NEUROCHEM, V100, P429, DOI 10.1111/j.1471-4159.2006.04248.x; Fowler MJ, 2008, CLIN DIABETES, V26, P77, DOI [DOI 10.2337/DIACLIN.26.2.77, 10.2337/diaclin.26.2.77]; Frostick SP, 1998, MICROSURG, V18, P397, DOI 10.1002/(SICI)1098-2752(1998)18:7<397::AID-MICR2>3.0.CO;2-F; Galuppo M, 2014, MOLECULES, V19, P2877, DOI 10.3390/molecules19032877; GREENE DA, 1992, DIABETES CARE, V15, P1902, DOI 10.2337/diacare.15.12.1902; Ho ECM, 2006, DIABETES, V55, P1946, DOI 10.2337/db05-1497; Kachroo Sumesh, 2015, J Manag Care Spec Pharm, V21, P243; KAHN SE, 1994, DIABETES, V43, P587, DOI 10.2337/diabetes.43.4.587; KIKKAWA R, 1987, DIABETES, V36, P240, DOI 10.2337/diabetes.36.2.240; Krajewski KM, 2000, BRAIN, V123, P1516, DOI 10.1093/brain/123.7.1516; Lee HK, 2009, GLIA, V57, P1825, DOI 10.1002/glia.20894; LeRoith D, 1997, NEW ENGL J MED, V336, P633, DOI 10.1056/NEJM199702273360907; Liu GS, 2009, HUM GENE THER, V20, P715, DOI 10.1089/hum.2009.002; NIDDK, 2011, NIH PUBL; Peppa Melpomeni, 2005, Hormones (Athens), V4, P28; Porrello E, 2014, J EXP MED, V211, P29, DOI 10.1084/jem.20130720; Rambhade S., 2010, J CHEM PHARM RES, V2, P7; Said G, 2007, NAT CLIN PRACT NEURO, V3, P331, DOI 10.1038/ncpneuro0504; Sakuma M, 2011, J ORTHOP SCI, V16, P418, DOI 10.1007/s00776-011-0089-4; Sango K, 2006, J NEUROCHEM, V98, P446, DOI 10.1111/j.1471-4159.2006.03885.x; SATO A, 1985, NEUROSCI LETT, V53, P15, DOI 10.1016/0304-3940(85)90090-4; Sharp LL, 2005, NAT IMMUNOL, V6, P73, DOI 10.1038/ni1152; Takamura Y, 2008, INVEST OPHTH VIS SCI, V49, P3216, DOI 10.1167/iovs.07-1643; Tashiro S., 2014, NEUROREHAB NEURAL RE; VINIK AI, 1992, DIABETES CARE, V15, P1926, DOI 10.2337/diacare.15.12.1926	39	39	41	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17106	17115		10.1074/jbc.M114.631291	http://dx.doi.org/10.1074/jbc.M114.631291			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	25998127	Green Published, hybrid			2022-12-28	WOS:000357730900006
J	Cameron, K; Weinstein, JY; Zhivin, O; Bule, P; Fleishman, SJ; Alves, VD; Gilbert, HJ; Ferreira, LMA; Fontes, CMGA; Bayer, EA; Najmudin, S				Cameron, Kate; Weinstein, Jonathan Y.; Zhivin, Olga; Bule, Pedro; Fleishman, Sarel J.; Alves, Victor D.; Gilbert, Harry J.; Ferreira, Luis M. A.; Fontes, Carlos M. G. A.; Bayer, Edward A.; Najmudin, Shabir			Combined Crystal Structure of a Type I Cohesin MUTATION AND AFFINITY BINDING STUDIES REVEAL STRUCTURAL DETERMINANTS OF COHESIN-DOCKERIN SPECIFICITIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cellulase; cellulose; cellulosome; computational biology; computer modeling; protein-protein interaction	BACTEROIDES-CELLULOSOLVENS CELLULOSOME; CLOSTRIDIUM-THERMOCELLUM; DOCKERIN COMPLEX; PROTEIN; MODULES; SURFACE; RECOGNITION; SCAFFOLDIN; CELLULASE; FAMILIES	Background: Cellulosomal cohesin-dockerin types are reversed in Bacteroides cellulosolvens. Results: Combined crystallographic and computational approaches of a lone cohesin yielded a structural model of the cohesin-dockerin complex that was verified experimentally. Conclusion: The dockerin dual-binding mode is not exclusive to enzyme integration into cellulosomes; it also characterizes cell-surface attachment. Significance: This combined approach provides a platform for generating testable hypotheses of the high affinity cohesin-dockerin interaction. Cohesin-dockerin interactions orchestrate the assembly of one of nature's most elaborate multienzyme complexes, the cellulosome. Cellulosomes are produced exclusively by anaerobic microbes and mediate highly efficient hydrolysis of plant structural polysaccharides, such as cellulose and hemicellulose. In the canonical model of cellulosome assembly, type I dockerin modules of the enzymes bind to reiterated type I cohesin modules of a primary scaffoldin. Each type I dockerin contains two highly conserved cohesin-binding sites, which confer quaternary flexibility to the multienzyme complex. The scaffoldin also bears a type II dockerin that anchors the entire complex to the cell surface by binding type II cohesins of anchoring scaffoldins. In Bacteroides cellulosolvens, however, the organization of the cohesin-dockerin types is reversed, whereby type II cohesin-dockerin pairs integrate the enzymes into the primary scaffoldin, and type I modules mediate cellulosome attachment to an anchoring scaffoldin. Here, we report the crystal structure of a type I cohesin from B. cellulosolvens anchoring scaffoldin ScaB to 1.84-angstrom resolution. The structure resembles other type I cohesins, and the putative dockerin-binding site, centered at -strands 3, 5, and 6, is likely to be conserved in other B. cellulosolvens type I cohesins. Combined computational modeling, mutagenesis, and affinity-based binding studies revealed similar hydrogen-bonding networks between putative Ser/Asp recognition residues in the dockerin at positions 11/12 and 45/46, suggesting that a dual-binding mode is not exclusive to the integration of enzymes into primary cellulosomes but can also characterize polycellulosome assembly and cell-surface attachment. This general approach may provide valuable structural information of the cohesin-dockerin interface, in lieu of a definitive crystal structure.	[Cameron, Kate; Bule, Pedro; Alves, Victor D.; Ferreira, Luis M. A.; Fontes, Carlos M. G. A.; Najmudin, Shabir] Univ Lisbon, Fac Med Vet, CIISA, P-1300477 Lisbon, Portugal; [Weinstein, Jonathan Y.; Zhivin, Olga; Fleishman, Sarel J.; Bayer, Edward A.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Gilbert, Harry J.] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Universidade de Lisboa; Weizmann Institute of Science; Newcastle University - UK	Bayer, EA (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	Ed.Bayer@weizmann.ac.il	Bule, Pedro/W-6838-2019	Bule, Pedro/0000-0003-2531-9926; Najmudin, Shabir/0000-0002-0429-5454; Fontes, Carlos/0000-0002-1219-9753; Alves, Victor Diogo/0000-0002-8430-4380; Fleishman, Sarel/0000-0003-3177-7560	Fundacao para a Ciencia e a Tecnologia (Lisbon, Portugal) [PTDC/BIA-PRO/103980/2008, EXPL/BIA-MIC/1176/2012]; European Union Seventh Framework Programme FP7 under the WallTraC Project [263916]; European Union Seventh Framework Programme FP7 under BioStruct-X [283570]; Israel Science Foundation [1349/13]; European Research Council Starter's Grant; European Union [NMP.2013.1.1-2, 604530]; ERA-IB Consortium [EIB.12.022]	Fundacao para a Ciencia e a Tecnologia (Lisbon, Portugal)(Portuguese Foundation for Science and Technology); European Union Seventh Framework Programme FP7 under the WallTraC Project; European Union Seventh Framework Programme FP7 under BioStruct-X; Israel Science Foundation(Israel Science Foundation); European Research Council Starter's Grant; European Union(European Commission); ERA-IB Consortium	This work was supported in part by Fundacao para a Ciencia e a Tecnologia (Lisbon, Portugal) Grants PTDC/BIA-PRO/103980/2008 and EXPL/BIA-MIC/1176/2012, European Union Seventh Framework Programme FP7 2007-2013 under the WallTraC Project Grant 263916 and under BioStruct-X Grant 283570; Israel Science Foundation and a European Research Council Starter's Grant (to the Fleishman laboratory); Israel Science Foundation Grant 1349/13, European Union, Area NMP.2013.1.1-2 "Self-assembly of Naturally Occuring Nanosystems," CellulosomePlus Project 604530, and an ERA-IB Consortium Grant EIB.12.022 (acronym FiberFuel) (to the Bayer laboratory). The authors declare that they have no conflicts of interest with the contents of this article.	Adams JJ, 2006, P NATL ACAD SCI USA, V103, P305, DOI 10.1073/pnas.0507109103; Alber O, 2009, PROTEINS, V77, P699, DOI 10.1002/prot.22483; Artzi L, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-100; Barak Y, 2005, J MOL RECOGNIT, V18, P491, DOI 10.1002/jmr.749; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Carvalho AL, 2005, J MOL BIOL, V349, P909, DOI 10.1016/j.jmb.2005.04.037; Carvalho AL, 2003, P NATL ACAD SCI USA, V100, P13809, DOI 10.1073/pnas.1936124100; Carvalho AL, 2007, P NATL ACAD SCI USA, V104, P3089, DOI 10.1073/pnas.0611173104; DeLano W.L, PYMOL MOL GRAPHICS S; Ding SY, 2000, J BACTERIOL, V182, P4915, DOI 10.1128/JB.182.17.4915-4925.2000; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Fleishman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020161; Fontes CMGA, 2010, ANNU REV BIOCHEM, V79, P655, DOI 10.1146/annurev-biochem-091208-085603; Gilbert HJ, 2010, PLANT PHYSIOL, V153, P444, DOI 10.1104/pp.110.156646; GIULIANO C, 1984, APPL ENVIRON MICROB, V48, P446, DOI 10.1128/AEM.48.2.446-448.1984; Haimovitz R, 2008, PROTEOMICS, V8, P968, DOI 10.1002/pmic.200700486; Horino H, 2014, INT J SYST EVOL MICR, V64, P1296, DOI 10.1099/ijs.0.059378-0; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Leibovitz E, 1996, J BACTERIOL, V178, P3077, DOI 10.1128/jb.178.11.3077-3084.1996; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MURRAY WD, 1984, INT J SYST BACTERIOL, V34, P185, DOI 10.1099/00207713-34-2-185; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Najmudin S, 2010, J STRUCT BIOL, V172, P353, DOI 10.1016/j.jsb.2010.07.009; Nakar D, 2004, J BIOL CHEM, V279, P42881, DOI 10.1074/jbc.M407350200; Noach I, 2005, J MOL BIOL, V348, P1, DOI 10.1016/j.jmb.2005.02.024; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinheiro BA, 2008, J BIOL CHEM, V283, P18422, DOI 10.1074/jbc.M801533200; Pinheiro BA, 2012, BIOCATAL BIOTRANSFOR, V30, P309, DOI 10.3109/10242422.2012.681854; Shimon LJW, 1997, STRUCTURE, V5, P381, DOI 10.1016/S0969-2126(97)00195-0; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu Q, 2004, J BACTERIOL, V186, P968, DOI 10.1128/JB.186.4.968-977.2004; Xu Q, 2003, J BACTERIOL, V185, P4548, DOI 10.1128/JB.185.15.4548-4557.2003	39	10	10	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16215	16225		10.1074/jbc.M115.653303	http://dx.doi.org/10.1074/jbc.M115.653303			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25934389	Green Published, hybrid			2022-12-28	WOS:000356930100025
J	Fleetwood, AJ; O'Brien-Simpson, NM; Veith, PD; Lam, RS; Achuthan, A; Cook, AD; Singleton, W; Lund, IK; Reynolds, EC; Hamilton, JA				Fleetwood, Andrew J.; O'Brien-Simpson, Neil M.; Veith, Paul D.; Lam, Roselind S.; Achuthan, Adrian; Cook, Andrew D.; Singleton, William; Lund, Ida K.; Reynolds, Eric C.; Hamilton, John A.			Porphyromonas gingivalis-derived RgpA-Kgp Complex Activates the Macrophage Urokinase Plasminogen Activator System IMPLICATIONS FOR PERIODONTITIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						extracellular matrix; macrophage; periodontal disease; plasmin; plasminogen	PROTEINASE-ADHESIN COMPLEXES; PLG-R-KT; MATRIX METALLOPROTEINASES; RHEUMATOID-ARTHRITIS; TREPONEMA-DENTICOLA; RECEPTOR; DISEASE; PATHOGENESIS; DEGRADATION; VIRULENCE	Background: We recently found that uPA(-/-) mice are resistant to experimental periodontitis following oral infection with P. gingivalis.Results:P. gingivalis-derived RgpA-Kgp complex activates the macrophage urokinase plasminogen activator. Conclusion:P. gingivalis activates a critical host proteolytic pathway to promote tissue destruction. Significance: A new host-pathogen interaction may promote tissues destruction and pathogen virulence in periodontitis. Urokinase plasminogen activator (uPA) converts plasminogen to plasmin, resulting in a proteolytic cascade that has been implicated in tissue destruction during inflammation. Periodontitis is a highly prevalent chronic inflammatory disease characterized by destruction of the tissue and bone that support the teeth. We demonstrate that stimulation of macrophages with the arginine- and lysine-specific cysteine protease complex (RgpA-Kgp complex), produced by the keystone pathogen Porphyromonas gingivalis, dramatically increased their ability to degrade matrix in a uPA-dependent manner. We show that the RgpA-Kgp complex cleaves the inactive zymogens, pro-uPA (at consensus sites Lys(158)-Ile(159) and Lys(135)-Lys(136)) and plasminogen, yielding active uPA and plasmin, respectively. These findings are consistent with activation of the uPA proteolytic cascade by P. gingivalis being required for the pathogen to induce alveolar bone loss in a model of periodontitis and reveal a new host-pathogen interaction in which P. gingivalis activates a critical host proteolytic pathway to promote tissue destruction and pathogen virulence.	[Fleetwood, Andrew J.; Achuthan, Adrian; Cook, Andrew D.; Hamilton, John A.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic 3050, Australia; [O'Brien-Simpson, Neil M.; Veith, Paul D.; Lam, Roselind S.; Singleton, William; Reynolds, Eric C.] Univ Melbourne, Melbourne Dent Sch, Oral Hlth Cooperat Res Ctr, Melbourne, Vic 3010, Australia; [Lund, Ida K.] Rigshosp, Finsen Lab, DK-1165 Copenhagen, Denmark; [Lund, Ida K.] Univ Copenhagen, Biotech Res & Innovat Ctr, DK-1165 Copenhagen, Denmark	Royal Melbourne Hospital; University of Melbourne; University of Melbourne; Rigshospitalet; University of Copenhagen; University of Copenhagen	Fleetwood, AJ (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic 3050, Australia.	andrew.fleetwood@unimelb.edu.au	O'Brien-Simpson, Neil/B-2901-2009; Achuthan, Adrian/S-3931-2019; Achuthan, Adrian/K-7281-2015; Fleetwood, Andrew/AAB-4743-2019	O'Brien-Simpson, Neil/0000-0001-8462-5603; Achuthan, Adrian/0000-0003-3640-2338; Achuthan, Adrian/0000-0003-3640-2338; Fleetwood, Andrew/0000-0002-6803-3533; Veith, Paul/0000-0002-7344-1662; Cook, Andrew/0000-0002-7314-924X	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the National Health and Medical Research Council of Australia (to J. A. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Abe T, 2012, J IMMUNOL, V189, P5442, DOI 10.4049/jimmunol.1202339; Amara U, 2008, ADV EXP MED BIOL, V632, P71, DOI 10.1007/978-0-387-78952-1_6; Anaraki PK, 2015, J BONE MINER RES, V30, P379, DOI 10.1002/jbmr.2350; Andreasen PA, 2000, CELL MOL LIFE SCI, V57, P25, DOI 10.1007/s000180050497; Andronicos NM, 2010, BLOOD, V115, P1319, DOI 10.1182/blood-2008-11-188938; Bamford CV, 2007, INFECT IMMUN, V75, P4364, DOI 10.1128/IAI.00258-07; BELIN D, 1985, EUR J BIOCHEM, V148, P225, DOI 10.1111/j.1432-1033.1985.tb08829.x; Bharadwaj A, 2013, INT J MOL SCI, V14, P6259, DOI 10.3390/ijms14036259; BIRKEDALHANSEN H, 1993, J PERIODONTOL, V64, P474, DOI 10.1902/jop.1993.64.5s.474; Bostanci N, 2012, FEMS MICROBIOL LETT, V333, P1, DOI 10.1111/j.1574-6968.2012.02579.x; BROWN JM, 1995, ARCH ORAL BIOL, V40, P839, DOI 10.1016/0003-9969(95)00049-U; Busso N, 1997, ANN RHEUM DIS, V56, P550, DOI 10.1136/ard.56.9.550; Busso N, 2002, ARTHRITIS RHEUM, V46, P2268, DOI 10.1002/art.10498; Carmeliet P, 1997, NAT GENET, V17, P439, DOI 10.1038/ng1297-439; Castellino FJ, 2005, THROMB HAEMOSTASIS, V93, P647, DOI 10.1160/TH04-12-0842; Chapple CC, 1998, J PATHOL, V186, P281; Chen YY, 2011, MOL MICROBIOL, V79, P1380, DOI 10.1111/j.1365-2958.2010.07530.x; Cook AD, 2002, AM J PATHOL, V160, P917, DOI 10.1016/S0002-9440(10)64914-0; Cook AD, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2946; Daci E, 2003, J BONE MINER RES, V18, P1167, DOI 10.1359/jbmr.2003.18.7.1167; Dano K, 2005, THROMB HAEMOSTASIS, V93, P676, DOI 10.1160/TH05-01-0054; DANO K, 1985, ADV CANCER RES, V44, P139, DOI 10.1016/S0065-230X(08)60028-7; Darveau RP, 2012, J DENT RES, V91, P816, DOI 10.1177/0022034512453589; DeCarlo AA, 2007, J PERIODONTAL RES, V42, P305, DOI 10.1111/j.1600-0765.2006.00949.x; ELLIS V, 1989, J BIOL CHEM, V264, P2185; Falcone DJ, 2001, BLOOD, V97, P777, DOI 10.1182/blood.V97.3.777; Felez J, 1996, THROMB HAEMOSTASIS, V76, P577; Fleetwood AJ, 2007, J IMMUNOL, V178, P5245, DOI 10.4049/jimmunol.178.8.5245; Fleetwood AJ, 2014, J IMMUNOL, V192, P3540, DOI 10.4049/jimmunol.1302864; Gaffen SL, 2008, J DENT RES, V87, P817, DOI 10.1177/154405910808700908; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; HAMILTON JA, 1992, ANN NY ACAD SCI, V667, P87; HAMILTON JA, 1991, BLOOD, V77, P616; Imamura T, 2003, J PERIODONTOL, V74, P111, DOI 10.1902/jop.2003.74.1.111; Kinnby B, 2008, MICROBIOL-SGM, V154, P924, DOI 10.1099/mic.0.2007/013235-0; Koziel J, 2014, CURR RHEUMATOL REP, V16, DOI 10.1007/s11926-014-0408-9; Lacey DC, 2012, J IMMUNOL, V188, P5752, DOI 10.4049/jimmunol.1103426; Lam RS, 2015, IMMUNOL CELL BIOL, V93, P705, DOI 10.1038/icb.2015.25; Lam RS, 2014, J IMMUNOL, V193, P2349, DOI 10.4049/jimmunol.1400853; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244, DOI 10.1128/MMBR.62.4.1244-1263.1998; LOESCHE WJ, 1990, J CLIN MICROBIOL, V28, P1551, DOI 10.1128/JCM.28.7.1551-1559.1990; Lund IK, 2008, J BIOL CHEM, V283, P32506, DOI 10.1074/jbc.M801924200; McAlister AD, 2009, J PERIODONTAL RES, V44, P348, DOI 10.1111/j.1600-0765.2008.01128.x; MCKEE AS, 1986, INFECT IMMUN, V52, P349, DOI 10.1128/IAI.52.2.349-355.1986; Miles LA, 2014, INT REV CEL MOL BIO, V309, P259, DOI 10.1016/B978-0-12-800255-1.00005-3; NUSRAT AR, 1991, J CLIN INVEST, V87, P1091, DOI 10.1172/JCI115070; O'Brien-Simpson NM, 2005, J IMMUNOL, V175, P3980, DOI 10.4049/jimmunol.175.6.3980; O'Brien-Simpson NM, 2000, INFECT IMMUN, V68, P2704, DOI 10.1128/IAI.68.5.2704-2712.2000; Orth RKH, 2011, MOL ORAL MICROBIOL, V26, P229, DOI 10.1111/j.2041-1014.2011.00612.x; PAGE RC, 1991, J PERIODONTAL RES, V26, P230, DOI 10.1111/j.1600-0765.1991.tb01649.x; Pathirana RD, 2007, INFECT IMMUN, V75, P1436, DOI 10.1128/IAI.01627-06; Pathirana RD, 2006, MICROBIOL-SGM, V152, P2381, DOI 10.1099/mic.0.28787-0; Petersen HH, 2001, EUR J BIOCHEM, V268, P4430, DOI 10.1046/j.1432-1327.2001.02365.x; Pinchback JS, 1996, J PATHOL, V179, P326; PLOW EF, 1986, J CELL BIOL, V103, P2411, DOI 10.1083/jcb.103.6.2411; Rajapakse PS, 2002, INFECT IMMUN, V70, P2480, DOI 10.1128/IAI.70.5.2480-2486.2002; Robbins K C, 1976, Methods Enzymol, V45, P257; Schuliga M, 2013, CURR OPIN PHARMACOL, V13, P386, DOI 10.1016/j.coph.2013.05.014; Singh B, 2010, MOL MICROBIOL, V78, P545, DOI 10.1111/j.1365-2958.2010.07373.x; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Socransky SS, 2005, PERIODONTOL 2000, V38, P135, DOI 10.1111/j.1600-0757.2005.00107.x; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; STOPPELLI MP, 1985, P NATL ACAD SCI USA, V82, P4939, DOI 10.1073/pnas.82.15.4939; Wells JM, 2005, METHOD ENZYMOL, V402, P148, DOI 10.1016/S0076-6879(05)02005-7	64	16	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16031	16042		10.1074/jbc.M115.645572	http://dx.doi.org/10.1074/jbc.M115.645572			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25979345	Green Published, hybrid			2022-12-28	WOS:000356930100011
J	Gowda, ASP; Moldovan, GL; Spratt, TE				Gowda, A. S. Prakasha; Moldovan, George-Lucian; Spratt, Thomas E.			Human DNA Polymerase Catalyzes Correct and Incorrect DNA Synthesis with High Catalytic Efficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA polymerase; DNA repair; DNA replication; enzyme kinetics; enzyme mechanism	I KLENOW FRAGMENT; UNIQUE ERROR SIGNATURE; KINETIC MECHANISM; NUCLEOTIDE INCORPORATION; REPLICATION FIDELITY; ESCHERICHIA-COLI; INCORPORATION OPPOSITE; PRIMER TERMINUS; MINOR-GROOVE; CROSS-LINKS	Background: DNA polymerase is a low fidelity polymerase with an unknown function. Results: The kinetic mechanism of correct and incorrect base pair formation was determined. Conclusion: Phosphodiester bond formation is rapid for both correct and mispair formation. Significance: The presence of a mispair does not induce the polymerase to adopt a low catalytic conformation. DNA polymerase (pol ) is a low fidelity A-family polymerase with a putative role in interstrand cross-link repair and homologous recombination. We carried out pre-steady-state kinetic analysis to elucidate the kinetic mechanism of this enzyme. We found that the mechanism consists of seven steps, similar that of other A-family polymerases. pol binds to DNA with a K-d for DNA of 9.2 nm, with an off-rate constant of 0.013 s(-1)and an on-rate constant of 14 m(-1) s(-1). dNTP binding is rapid with K-d values of 20 and 476 m for the correct and incorrect dNTP, respectively. Pyrophosphorylation occurs with a K-d value for PPi of 3.7 mm and a maximal rate constant of 11 s(-1). Pre-steady-state kinetics, examination of the elemental effect using dNTPS, and pulse-chase experiments indicate that a rapid phosphodiester bond formation step is flanked by slow conformational changes for both correct and incorrect base pair formation. These experiments in combination with computer simulations indicate that the first conformational change occurs with rate constants of 75 and 20 s(-1); rapid phosphodiester bond formation occurs with a K-eq of 2.2 and 1.7, and the second conformational change occurs with rate constants of 2.1 and 0.5 s(-1), for correct and incorrect base pair formation, respectively. The presence of a mispair does not induce the polymerase to adopt a low catalytic conformation. pol catalyzes both correct and mispair formation with high catalytic efficiency.	[Gowda, A. S. Prakasha; Moldovan, George-Lucian; Spratt, Thomas E.] Penn State Univ, Milton S Hershey Med Ctr, Dept Biochem & Mol Biol, Coll Med, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Spratt, TE (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, H171,500 Univ Dr, Hershey, PA 17033 USA.	tes13@psu.edu		George-Lucian, Moldovan/0000-0003-3825-149X; Spratt, Thomas/0000-0002-6805-3729	Pennsylvania Department of Health using Tobacco Settlement Funds; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021762] Funding Source: NIH RePORTER	Pennsylvania Department of Health using Tobacco Settlement Funds; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The oligodeoxynucleotide synthesis and MS analysis were performed in the Macromolecular Core facility at the Pennsylvania State University College of Medicine. Core Facility services and instruments used in this project were funded, in part, under a grant with the Pennsylvania Department of Health using Tobacco Settlement Funds.	Arana ME, 2007, DNA REPAIR, V6, P213, DOI 10.1016/j.dnarep.2006.09.012; Arana ME, 2011, BIOCHEMISTRY-US, V50, P10126, DOI 10.1021/bi201197p; Beckman JW, 2008, J BIOL CHEM, V283, P36711, DOI 10.1074/jbc.M806785200; Bevington P. R., 1969, DATA REDUCTION ERROR, P56; BOYD JB, 1990, GENETICS, V125, P813; Carlson KD, 2006, P NATL ACAD SCI USA, V103, P15776, DOI 10.1073/pnas.0605785103; Carlson KD, 2005, MOL CELL BIOL, V25, P2169, DOI 10.1128/MCB.25.6.2169-2176.2005; CARROLL SS, 1991, BIOCHEMISTRY-US, V30, P804, DOI 10.1021/bi00217a034; DAHLBERG ME, 1991, BIOCHEMISTRY-US, V30, P4835, DOI 10.1021/bi00234a002; DONLIN MJ, 1994, BIOCHEMISTRY-US, V33, P14908, DOI 10.1021/bi00253a030; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Dunn D. B., 1986, HDB BIOCH MOL BIOL, P65; ECHOLS H, 1991, ANNU REV BIOCHEM, V60, P477, DOI 10.1146/annurev.biochem.60.1.477; EGER BT, 1992, BIOCHEMISTRY-US, V31, P9227, DOI 10.1021/bi00153a016; EGER BT, 1991, BIOCHEMISTRY-US, V30, P1441, DOI 10.1021/bi00219a039; Furge LL, 1999, BIOCHEMISTRY-US, V38, P4818, DOI 10.1021/bi982163u; Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d; Hobza P, 1999, CHEM REV, V99, P3247, DOI 10.1021/cr9800255; Hubscher U, 2002, ANNU REV BIOCHEM, V71, P133, DOI 10.1146/annurev.biochem.71.090501.150041; Irimia A, 2009, J BIOL CHEM, V284, P22467, DOI 10.1074/jbc.M109.003905; Johnson AA, 2001, J BIOL CHEM, V276, P38090; Johnson SJ, 2004, CELL, V116, P803, DOI 10.1016/S0092-8674(04)00252-1; Joyce CM, 2004, BIOCHEMISTRY-US, V43, P14317, DOI 10.1021/bi048422z; Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693; Kool ET, 2002, ANNU REV BIOCHEM, V71, P191, DOI 10.1146/annurev.biochem.71.110601.135453; KUCHTA RD, 1987, BIOCHEMISTRY-US, V26, P8410, DOI 10.1021/bi00399a057; KUCHTA RD, 1988, BIOCHEMISTRY-US, V27, P6716, DOI 10.1021/bi00418a012; Kunkel TA, 2004, J BIOL CHEM, V279, P16895, DOI 10.1074/jbc.R400006200; Kuzmic P, 2009, METHOD ENZYMOL, V467, P247, DOI 10.1016/S0076-6879(09)67010-5; Lee YS, 2015, NAT STRUCT MOL BIOL, V22, P298, DOI 10.1038/nsmb.2985; Lee YS, 2010, J BIOL CHEM, V285, P28105, DOI 10.1074/jbc.M110.122283; Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200; Marini F, 2003, J BIOL CHEM, V278, P32014, DOI 10.1074/jbc.M305646200; McCain MD, 2005, BIOCHEMISTRY-US, V44, P5647, DOI 10.1021/bi047460f; Meyer AS, 2004, J BIOL CHEM, V279, P33043, DOI 10.1074/jbc.C400232200; MIZRAHI V, 1985, BIOCHEMISTRY-US, V24, P4010, DOI 10.1021/bi00336a031; Moldovan GL, 2010, MOL CELL BIOL, V30, P1088, DOI 10.1128/MCB.01124-09; Pang M, 2005, DNA REPAIR, V4, P971, DOI 10.1016/j.dnarep.2005.04.020; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Patra A, 2015, J BIOL CHEM, V290, P8028, DOI 10.1074/jbc.M115.637561; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Rothwell PJ, 2005, MOL CELL, V19, P345, DOI 10.1016/j.molcel.2005.06.032; Sherrer SM, 2012, CHEM RES TOXICOL, V25, P730, DOI 10.1021/tx200531y; Spratt TE, 1997, BIOCHEMISTRY-US, V36, P13292, DOI 10.1021/bi971253g; Spratt TE, 2001, BIOCHEMISTRY-US, V40, P2647, DOI 10.1021/bi002641c; Spratt TE, 1997, NUCLEIC ACIDS RES, V25, P3354, DOI 10.1093/nar/25.16.3354; Takata K, 2006, J BIOL CHEM, V281, P23445, DOI 10.1074/jbc.M604317200; Takata K, 2010, NUCLEIC ACIDS RES, V38, P3233, DOI 10.1093/nar/gkq048; Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z; Wang WJ, 2011, APPL CATAL B-ENVIRON, V108, P108, DOI 10.1016/j.apcatb.2011.08.015; Washington MT, 2003, MOL CELL BIOL, V23, P8316, DOI 10.1128/MCB.23.22.8316-8322.2003; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; WONG I, 1991, BIOCHEMISTRY-US, V30, P526, DOI 10.1021/bi00216a030; Woodside AM, 2002, BIOCHEMISTRY-US, V41, P1039, DOI 10.1021/bi011496f; Wu EY, 2011, J BIOL CHEM, V286, P19758, DOI 10.1074/jbc.M110.191130; Xia SL, 2013, J AM CHEM SOC, V135, P193, DOI 10.1021/ja3079048; Yamanaka K, 2010, CHEM RES TOXICOL, V23, P689, DOI 10.1021/tx900449u; Zhao LL, 2014, FEBS J, V281, P4394, DOI 10.1111/febs.12947; Zietlow L, 2009, BIOCHEMISTRY-US, V48, P11817, DOI 10.1021/bi9015346	59	8	8	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16292	16303		10.1074/jbc.M115.653287	http://dx.doi.org/10.1074/jbc.M115.653287			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25963146	Green Published, hybrid			2022-12-28	WOS:000356930100032
J	Hayashida, A; Amano, S; Gallo, RL; Linhardt, RJ; Liu, J; Park, PW				Hayashida, Atsuko; Amano, Shiro; Gallo, Richard L.; Linhardt, Robert J.; Liu, Jian; Park, Pyong Woo			2-O-Sulfated Domains in Syndecan-1 Heparan Sulfate Inhibit Neutrophil Cathelicidin and Promote Staphylococcus aureus Corneal Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antimicrobial peptide (AMP); heparan sulfate; host defense; neutrophil; proteoglycan; syndecan; cathelicidin; keratitis	ANTIMICROBIAL PEPTIDE; BACTERIAL KERATITIS; ALPHA-TOXIN; BETA-TOXIN; PROTECTS; MICE; SUSCEPTIBILITY; CHAINS; 2-O-SULFOTRANSFERASE; PROTEOGLYCANS	Background: Syndecan-1 promotes bacterial infections, but how this is accomplished remains unclear. Results: Syndecan-1 and 2-O-sulfated heparan compounds specifically enhanced S. aureus corneal virulence and inhibited bacterial killing by CRAMP secreted from degranulated neutrophils. Conclusion: Specific structural motifs in syndecan-1 HS promote S. aureus corneal infection by inhibiting neutrophil CRAMP. Significance: This study uncovers a new pathogenic role for syndecan-1 in bacterial infection. Ablation of syndecan-1 in mice is a gain of function mutation that enables mice to significantly resist infection by several bacterial pathogens. Syndecan-1 shedding is induced by bacterial virulence factors, and inhibition of shedding attenuates bacterial virulence, whereas administration of purified syndecan-1 ectodomain enhances virulence, suggesting that bacteria subvert syndecan-1 ectodomains released by shedding for their pathogenesis. However, the pro-pathogenic functions of syndecan-1 ectodomain have yet to be clearly defined. Here, we examined how syndecan-1 ectodomain enhances Staphylococcus aureus virulence in injured mouse corneas. We found that syndecan-1 ectodomain promotes S. aureus corneal infection in an HS-dependent manner. Surprisingly, we found that this pro-pathogenic activity is dependent on 2-O-sulfated domains in HS, indicating that the effects of syndecan-1 ectodomain are structure-based. Our results also showed that purified syndecan-1 ectodomain and heparan compounds containing 2-O-sulfate motifs inhibit S. aureus killing by antimicrobial factors secreted by degranulated neutrophils, but does not affect intracellular phagocytic killing by neutrophils. Immunodepletion of antimicrobial factors with staphylocidal activities demonstrated that CRAMP, a cationic antimicrobial peptide, is primarily responsible for S. aureus killing among other factors secreted by degranulated neutrophils. Furthermore, we found that purified syndecan-1 ectodomain and heparan compounds containing 2-O-sulfate units potently and specifically inhibit S. aureus killing by synthetic CRAMP. These results provide compelling evidence that a specific subclass of sulfate groups, and not the overall charge of HS, permits syndecan-1 ectodomains to promote S. aureus corneal infection by inhibiting a key arm of neutrophil host defense.	[Hayashida, Atsuko; Amano, Shiro; Park, Pyong Woo] Harvard Univ, Sch Med, Childrens Hosp, Div Resp Dis, Boston, MA 02115 USA; [Park, Pyong Woo] Harvard Univ, Sch Med, Childrens Hosp, Div Newborn Med, Boston, MA 02115 USA; [Gallo, Richard L.] Univ Calif San Diego, Div Dermatol, La Jolla, CA 92093 USA; [Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem & Chem Biol, Troy, NY 12180 USA; [Liu, Jian] Univ N Carolina, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; University of California System; University of California San Diego; Rensselaer Polytechnic Institute; University of North Carolina; University of North Carolina Chapel Hill	Park, PW (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, 320 Longwood Ave,Enders 461, Boston, MA 02115 USA.	pyong.park@childrens.harvard.edu	Gallo, Richard L/A-8931-2009; Regan, Clinton/E-6250-2012	Gallo, Richard L/0000-0002-1401-7861; Park, Pyong Woo/0000-0002-7979-4979	National Institutes of Health [R01 EY021765, R01 HL107472]; NATIONAL EYE INSTITUTE [R01EY021765] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107472, R01HL094463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI052453, R01AI052453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM102137] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants R01 EY021765 and R01 HL107472.	Baranska-Rybak W, 2006, J ANTIMICROB CHEMOTH, V57, P260, DOI 10.1093/jac/dki460; Bartlett AH, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001367; Bergsson G, 2009, J IMMUNOL, V183, P543, DOI 10.4049/jimmunol.0803959; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Bourcier T, 2003, BRIT J OPHTHALMOL, V87, P834, DOI 10.1136/bjo.87.7.834; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Bullock SL, 1998, GENE DEV, V12, P1894, DOI 10.1101/gad.12.12.1894; Cadwalader EL, 2012, DEVELOPMENT, V139, P1296, DOI 10.1242/dev.078238; CASU B, 1990, HAEMOSTASIS, V20, P62; Chen J, 2007, CHEM BIOL, V14, P986, DOI 10.1016/j.chembiol.2007.07.015; Chen Y, 2007, J BIOL CHEM, V282, P159, DOI 10.1074/jbc.M608542200; Chromek M, 2006, NAT MED, V12, P636, DOI 10.1038/nm1407; Echtermeyer F, 2001, J CLIN INVEST, V107, pR9, DOI 10.1172/JCI10559; EISENHAUER PB, 1992, INFECT IMMUN, V60, P3446, DOI 10.1128/IAI.60.8.3446-3447.1992; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Fechtner T, 2013, J BACTERIOL, V195, P5323, DOI 10.1128/JB.00780-13; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Garner OB, 2011, DEV BIOL, V355, P394, DOI 10.1016/j.ydbio.2011.04.035; Genestier AL, 2005, J CLIN INVEST, V115, P3117, DOI 10.1172/JCI22684; Girgis DO, 2004, CURR EYE RES, V29, P269, DOI 10.1080/02713680490516783; Green M, 2008, CORNEA, V27, P22, DOI 10.1097/ICO.0b013e318156caf2; Gronert K, 2010, EXP EYE RES, V91, P478, DOI 10.1016/j.exer.2010.07.004; Hayashida A, 2011, J BIOL CHEM, V286, P3288, DOI 10.1074/jbc.M110.185165; Hayashida A, 2009, AM J PATHOL, V174, P509, DOI 10.2353/ajpath.2009.080394; Hayashida K, 2008, J BIOL CHEM, V283, P19895, DOI 10.1074/jbc.M801614200; Hayashida K, 2009, BLOOD, V114, P3033, DOI 10.1182/blood-2009-02-204966; Huang LC, 2007, INVEST OPHTH VIS SCI, V48, P4498, DOI 10.1167/iovs.07-0274; Hume EBH, 2000, INFECT IMMUN, V68, P6052, DOI 10.1128/IAI.68.10.6052-6055.2000; Iimura M, 2005, J IMMUNOL, V174, P4901, DOI 10.4049/jimmunol.174.8.4901; Kobayashi F, 2012, GLYCOCONJUGATE J, V29, P211, DOI 10.1007/s10719-012-9388-z; Kobayashi T, 2007, J BIOL CHEM, V282, P19589, DOI 10.1074/jbc.M610707200; Kovach MA, 2012, J IMMUNOL, V189, P304, DOI 10.4049/jimmunol.1103196; KOVENSKY J, 1993, CARBOHYD RES, V245, P361, DOI 10.1016/0008-6215(93)80085-S; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Kumar A, 2010, MICROBES INFECT, V12, P978, DOI 10.1016/j.micinf.2010.06.007; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; LIMBERG M B, 1991, American Journal of Ophthalmology, V112, p2S; LINDAHL B, 1995, BIOCHEM J, V306, P177, DOI 10.1042/bj3060177; Ly CN, 2006, CLIN EXP OPHTHALMOL, V34, P44, DOI 10.1111/j.1442-9071.2006.01143.x; Merres J, 2014, J INNATE IMMUN, V6, P205, DOI 10.1159/000353645; Miller LG, 2005, NEW ENGL J MED, V352, P1445, DOI 10.1056/NEJMoa042683; MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; OCallaghan RJ, 1997, INFECT IMMUN, V65, P1571, DOI 10.1128/IAI.65.5.1571-1578.1997; Park PW, 2000, J BIOL CHEM, V275, P29923, DOI 10.1074/jbc.R000008200; Park PW, 2004, J BIOL CHEM, V279, P251, DOI 10.1074/jbc.M308537200; PARK PW, 1991, J BIOL CHEM, V266, P23399; Park PW, 2001, NATURE, V411, P98, DOI 10.1038/35075100; Park PW, 2000, J BIOL CHEM, V275, P3057, DOI 10.1074/jbc.275.5.3057; Rong JH, 2001, BIOCHEMISTRY-US, V40, P5548, DOI 10.1021/bi002926p; Schaefer F, 2001, BRIT J OPHTHALMOL, V85, P842, DOI 10.1136/bjo.85.7.842; SENGELOV H, 1995, J IMMUNOL, V154, P4157; SHERERTZ RJ, 1993, J INFECT DIS, V167, P98, DOI 10.1093/infdis/167.1.98; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; Stanford KI, 2010, J BIOL CHEM, V285, P286, DOI 10.1074/jbc.M109.063701; Stepp MA, 2002, J CELL SCI, V115, P4517, DOI 10.1242/jcs.00128; Surewaard BGJ, 2013, CELL MICROBIOL, V15, P1427, DOI 10.1111/cmi.12130; Teng YHF, 2012, MATRIX BIOL, V31, P3, DOI 10.1016/j.matbio.2011.10.001; Travis SM, 2000, INFECT IMMUN, V68, P2748, DOI 10.1128/IAI.68.5.2748-2755.2000; Tumova S, 2000, J BIOL CHEM, V275, P9410, DOI 10.1074/jbc.275.13.9410; Wang GS, 2012, ANTIMICROB AGENTS CH, V56, P845, DOI 10.1128/AAC.05637-11; Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214; Whitelock JM, 2005, CHEM REV, V105, P2745, DOI 10.1021/cr010213m; Wilhelmus KR, 2002, OPHTHALMOLOGY, V109, P835, DOI 10.1016/S0161-6420(02)00963-6; Zako M, 2003, J BIOL CHEM, V278, P13561, DOI 10.1074/jbc.M209658200; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147	68	17	17	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16157	16167		10.1074/jbc.M115.660852	http://dx.doi.org/10.1074/jbc.M115.660852			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25931123	Green Published, hybrid			2022-12-28	WOS:000356930100020
J	Pontejo, SM; Alejo, A; Alcami, A				Pontejo, Sergio M.; Alejo, Ali; Alcami, Antonio			Comparative Biochemical and Functional Analysis of Viral and Human Secreted Tumor Necrosis Factor (TNF) Decoy Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inflammation; poxvirus; receptor; tumor necrosis factor (TNF); virus; TNF ligand superfamily; etanercept; immune evasion; vTNFR	SHOPE FIBROMA VIRUS; ECTROMELIA VIRUS; LYMPHOTOXIN-BETA; VACCINIA VIRUS; CELL-SURFACE; SIGNALING PATHWAYS; CD30 HOMOLOG; DNA-SEQUENCE; POXVIRUSES; ENCODES	Background: Poxvirus encodes up to four TNF decoy receptors (vTNFRs) that mimic etanercept, an anti-TNF drug used in the clinic. Results: vTNFRs display differences in ligand specificity and inhibitory potency. Conclusion: Some vTNFRs are more specific and potent TNF inhibitors than etanercept. Significance: This study may help to understand the role of vTNFRs in pathogenesis and improve the anti-TNF treatments. The blockade of tumor necrosis factor (TNF) by etanercept, a soluble version of the human TNF receptor 2 (hTNFR2), is a well established strategy to inhibit adverse TNF-mediated inflammatory responses in the clinic. A similar strategy is employed by poxviruses, encoding four viral TNF decoy receptor homologues (vTNFRs) named cytokine response modifier B (CrmB), CrmC, CrmD, and CrmE. These vTNFRs are differentially expressed by poxviral species, suggesting distinct immunomodulatory properties. Whereas the human variola virus and mouse ectromelia virus encode one vTNFR, the broad host range cowpox virus encodes all vTNFRs. We report the first comprehensive study of the functional and binding properties of these four vTNFRs, providing an explanation for their expression profile among different poxviruses. In addition, the vTNFRs activities were compared with the hTNFR2 used in the clinic. Interestingly, CrmB from variola virus, the causative agent of smallpox, is the most potent TNFR of those tested here including hTNFR2. Furthermore, we demonstrate a new immunomodulatory activity of vTNFRs, showing that CrmB and CrmD also inhibit the activity of lymphotoxin . Similarly, we report for the first time that the hTNFR2 blocks the biological activity of lymphotoxin . The characterization of vTNFRs optimized during virus-host evolution to modulate the host immune response provides relevant information about their potential role in pathogenesis and may be used to improve anti-inflammatory therapies based on soluble decoy TNFRs.	[Pontejo, Sergio M.; Alcami, Antonio] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; [Alejo, Ali] Inst Nacl Invest & Tecnol Agr & Alimentaria, Ctr Invest Sanidad Anim, Madrid 28130, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA)	Alcami, A (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Nicolas Cabrera 1,Campus Cantoblanco, E-28049 Madrid, Spain.	aalcami@cbm.csic.es	Pontejo, Sergio M./AAN-6403-2020; Alejo, Ali/AAF-1477-2020; Alcami, Antonio/F-8512-2015	Pontejo, Sergio M./0000-0002-7756-9831; Alejo, Ali/0000-0002-1613-6063; Alcami, Antonio/0000-0002-3333-6016	Spanish Ministry of Economy and Competitiveness [SAF2009-07857, SAF2012-38957]; Junta para la Ampliacion de Estudios Ph.D. studentship from Consejo Superior de Investigaciones Cientificas; Fundacion Severo Ochoa	Spanish Ministry of Economy and Competitiveness(Spanish Government); Junta para la Ampliacion de Estudios Ph.D. studentship from Consejo Superior de Investigaciones Cientificas; Fundacion Severo Ochoa	This work was supported by Spanish Ministry of Economy and Competitiveness Grants SAF2009-07857 and SAF2012-38957. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Junta para la Ampliacion de Estudios Ph.D. studentship from Consejo Superior de Investigaciones Cientificas and a studentship from Fundacion Severo Ochoa. Present address: Laboratory of Molecular Immunology, NIAID, National Institutes of Health, Bethesda, MD 20892.	Afonso CL, 2005, J VIROL, V79, P966, DOI 10.1128/JVI.79.2.966-977.2005; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Alcami A, 1999, J GEN VIROL, V80, P949, DOI 10.1099/0022-1317-80-4-949; Alejo A, 2006, P NATL ACAD SCI USA, V103, P5995, DOI 10.1073/pnas.0510462103; Alejo A, 2011, ADV EXP MED BIOL, V691, P203, DOI 10.1007/978-1-4419-6612-4_21; Alejo A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005175; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; BROWNING JL, 1993, CELL, V72, P847, DOI 10.1016/0092-8674(93)90574-A; Browning JL, 1996, J EXP MED, V183, P867, DOI 10.1084/jem.183.3.867; Brunetti CR, 2003, P NATL ACAD SCI USA, V100, P4831, DOI 10.1073/pnas.0737244100; Chen NH, 2003, VIROLOGY, V317, P165, DOI 10.1016/S0042-6822(03)00520-8; CROWE PD, 1994, SCIENCE, V264, P707, DOI 10.1126/science.8171323; FENNER F, 1993, HIST PHIL LIFE SCI, V15, P397; Gileva IP, 2006, BBA-PROTEINS PROTEOM, V1764, P1710, DOI 10.1016/j.bbapap.2006.09.006; GOEBEL SJ, 1990, VIROLOGY, V179, P247, DOI 10.1016/0042-6822(90)90294-2; Graham SC, 2007, J MOL BIOL, V372, P660, DOI 10.1016/j.jmb.2007.06.082; Hehlgans T, 2003, EUR CYTOKINE NETW, V14, P103; HOWARD ST, 1991, VIROLOGY, V180, P633, DOI 10.1016/0042-6822(91)90077-O; HU FQ, 1994, VIROLOGY, V204, P343, DOI 10.1006/viro.1994.1539; Kerensky TA, 2012, EXPERT OPIN DRUG SAF, V11, P121, DOI 10.1517/14740338.2012.633509; Kruglov AA, 2013, SCIENCE, V342, P1243, DOI 10.1126/science.1243364; Lin XQ, 2003, INT IMMUNOL, V15, P955, DOI 10.1093/intimm/mcg094; Loparev VN, 1998, P NATL ACAD SCI USA, V95, P3786, DOI 10.1073/pnas.95.7.3786; Mavian C, 2014, VIROLOGY, V462, P218, DOI 10.1016/j.virol.2014.06.010; Montanuy I, 2011, FASEB J, V25, P1960, DOI 10.1096/fj.10-177188; Mukai Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000954; PALUMBO GJ, 1994, J VIROL, V68, P1737, DOI 10.1128/JVI.68.3.1737-1749.1994; Panus JF, 2002, P NATL ACAD SCI USA, V99, P8348, DOI 10.1073/pnas.122238599; Rahman Masmudur M, 2006, PLoS Pathog, V2, pe4; Reading PC, 2002, VIROLOGY, V292, P285, DOI 10.1006/viro.2001.1236; Ribas G, 2003, J VIROL, V77, P10139, DOI 10.1128/JVI.77.18.10139-10146.2003; Ruiz-Arguello MB, 2005, SYMP SOC GEN MICROBI, V64, P269; Saraiva M, 2002, J EXP MED, V196, P829, DOI 10.1084/jem.20020319; Saraiva M, 2001, J VIROL, V75, P226, DOI 10.1128/JVI.75.1.226-233.2001; Schneider K, 2004, IMMUNOL REV, V202, P49, DOI 10.1111/j.0105-2896.2004.00206.x; Smith CA, 1996, VIROLOGY, V223, P132, DOI 10.1006/viro.1996.0462; Tracey D, 2008, PHARMACOL THERAPEUT, V117, P244, DOI 10.1016/j.pharmthera.2007.10.001; Upadhyay V, 2013, NAT REV IMMUNOL, V13, P270, DOI 10.1038/nri3406; UPTON C, 1991, VIROLOGY, V183, P773, DOI 10.1016/0042-6822(91)91009-6; Vanlangenakker N, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.111; Vogel S, 2012, ACTA DERM-VENEREOL, V92, P126, DOI 10.2340/00015555-1227; Xue XG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002162; Yang ZR, 2009, NAT STRUCT MOL BIOL, V16, P1189, DOI 10.1038/nsmb.1683	43	25	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					15973	15984		10.1074/jbc.M115.650119	http://dx.doi.org/10.1074/jbc.M115.650119			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25940088	Green Published, hybrid			2022-12-28	WOS:000356930100007
J	Tsuboi, T; Yamazaki, R; Nobuta, R; Ikeuchi, K; Makino, S; Ohtaki, A; Suzuki, Y; Yoshihisa, T; Trotta, C; Inada, T				Tsuboi, Tatsuhisa; Yamazaki, Reina; Nobuta, Risa; Ikeuchi, Ken; Makino, Shiho; Ohtaki, Ayumi; Suzuki, Yutaka; Yoshihisa, Tohru; Trotta, Christopher; Inada, Toshifumi			The tRNA Splicing Endonuclease Complex Cleaves the Mitochondria-localized CBP1 mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endonuclease; mitochondria; mRNA decay; transfer RNA (tRNA); translation; mRNA decay; endonuclease; mRNA localization; quality control; tRNA splicing	DEPENDENT TRANSLATION ARREST; SACCHAROMYCES-CEREVISIAE; TERMINATION CODON; ACTIVE-SITE; 3' END; YEAST; LACKING; DEGRADATION; RIBOSOME; REVEALS	Background: The yeast tRNA splicing endonuclease (Sen) complex is located on the mitochondrial outer membrane and splices precursor tRNAs. Results: The Sen complex cleaves the mitochondria-localized CBP1 mRNA in vivo and in vitro. Conclusion: Mitochondrial localization of the Sen complex is required for the cleavage of the CBP1 mRNA. Significance: This study shows a novel role of the tRNA splicing endonuclease complex in the cleavage of mitochondria-localized mRNA. The tRNA splicing endonuclease (Sen) complex is located on the mitochondrial outer membrane and splices precursor tRNAs in Saccharomyces cerevisiae. Here, we demonstrate that the Sen complex cleaves the mitochondria-localized mRNA encoding Cbp1 (cytochrome b mRNA processing 1). Endonucleolytic cleavage of this mRNA required two cis-elements: the mitochondrial targeting signal and the stem-loop 652-726-nt region. Mitochondrial localization of the Sen complex was required for cleavage of the CBP1 mRNA, and the Sen complex cleaved this mRNA directly in vitro. We propose that the Sen complex cleaves the CBP1 mRNA, which is co-translationally localized to mitochondria via its mitochondrial targeting signal.	[Tsuboi, Tatsuhisa; Yamazaki, Reina; Nobuta, Risa; Ikeuchi, Ken; Makino, Shiho; Ohtaki, Ayumi; Inada, Toshifumi] Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Suzuki, Yutaka] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba 2778562, Japan; [Yoshihisa, Tohru] Univ Hyogo, Grad Sch Life Sci, Kamigori, Hyogo 6781297, Japan; [Trotta, Christopher] PTC Therapeut, South Plainfield, NJ 07080 USA	Tohoku University; University of Tokyo; University of Hyogo	Inada, T (corresponding author), Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan.	tinada@m.tohoku.ac.jp	Tsuboi, Tatsuhisa/AAA-1926-2022; Tsuboi, Tatsuhisa/AAL-5360-2020; Inada, Toshifumi/AAE-1517-2019	Tsuboi, Tatsuhisa/0000-0003-3249-030X; Makino, Shiho/0000-0001-6147-737X; Ikeuchi, Ken/0000-0002-9578-7920	Japan Society for the Promotion of Science [20112006, 26291002]; Research Grants in the Natural Sciences from the Sumitomo Foundation; Japan Society for the Promotion of Science Research Fellowship; Grants-in-Aid for Scientific Research [15H01542] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Research Grants in the Natural Sciences from the Sumitomo Foundation; Japan Society for the Promotion of Science Research Fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (KAKENHI) from the Japan Society for the Promotion of Science 20112006 and 26291002 and by Research Grants in the Natural Sciences from the Sumitomo Foundation (to TI). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Japan Society for the Promotion of Science Research Fellowship. Present address: Dept. of Developmental and Cell Biology, University of California Irvine, Irvine, CA 92697.	Abe Y, 2000, CELL, V100, P551, DOI 10.1016/S0092-8674(00)80691-1; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; Dhungel N, 2012, GENE DEV, V26, P503, DOI 10.1101/gad.183004.111; Dimitrova LN, 2009, J BIOL CHEM, V284, P10343, DOI 10.1074/jbc.M808840200; Doma MK, 2006, NATURE, V440, P561, DOI 10.1038/nature04530; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Inada T, 2005, EMBO J, V24, P1584, DOI 10.1038/sj.emboj.7600636; Islas-Osuna MA, 2002, J BIOL CHEM, V277, P37987, DOI 10.1074/jbc.M206132200; Kuroha K, 2010, EMBO REP, V11, P956, DOI 10.1038/embor.2010.169; Lyumkis D, 2013, P NATL ACAD SCI USA, V110, P1702, DOI 10.1073/pnas.1210041110; Marc P, 2002, EMBO REP, V3, P159, DOI 10.1093/embo-reports/kvf025; Matsuda R, 2014, GENES CELLS, V19, P1, DOI 10.1111/gtc.12106; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Paushkin SV, 2004, CELL, V117, P311, DOI 10.1016/S0092-8674(04)00342-3; Saint-Georges Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002293; Sambrook Joseph, 2006, CSH Protoc, V2006, DOI [10.1101/pdb.prot3966, 10.1101/pdb.prot4044, 10.1101/pdb.prot4085, 10.1101/pdb.prot4056, 10.1101/pdb.prot4027, 10.1101/pdb.prot4453, 10.1101/pdb.prot3825, 10.1101/pdb.prot4050, 10.1101/pdb.prot4022, 10.1101/pdb.prot3871, 10.1101/pdb.prot4455, 10.1101/pdb.prot3972, 10.1101/pdb.prot3723]; Shao S, 2013, MOL CELL, V50, P637, DOI 10.1016/j.molcel.2013.04.015; Shoemaker CJ, 2011, P NATL ACAD SCI USA, V108, pE1392, DOI 10.1073/pnas.1113956108; Sparks KA, 1997, MOL CELL BIOL, V17, P4199, DOI 10.1128/MCB.17.8.4199; Sparks KA, 1998, NUCLEIC ACIDS RES, V26, P4676, DOI 10.1093/nar/26.20.4676; Trotta CR, 2006, NATURE, V441, P375, DOI 10.1038/nature04741; Trotta CR, 1997, CELL, V89, P849, DOI 10.1016/S0092-8674(00)80270-6; Tsuboi T, 2012, MOL CELL, V46, P518, DOI 10.1016/j.molcel.2012.03.013; Tsuboi T, 2010, J BIOL CHEM, V285, P33589, DOI 10.1074/jbc.M110.117150; van den Elzen AMG, 2010, NAT STRUCT MOL BIOL, V17, P1446, DOI 10.1038/nsmb.1963; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Yoshihisa T, 2003, MOL BIOL CELL, V14, P3266, DOI 10.1091/mbc.E02-11-0757; Yoshihisa T, 2007, GENES CELLS, V12, P285, DOI 10.1111/j.1365-2443.2007.01056.x; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	32	17	17	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16021	16030		10.1074/jbc.M114.634592	http://dx.doi.org/10.1074/jbc.M114.634592			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25971974	Green Published, hybrid			2022-12-28	WOS:000356930100010
J	Wielandt, AG; Pedersen, JT; Falhof, J; Kemmer, GC; Lund, A; Ekberg, K; Fuglsang, AT; Pomorski, TG; Buch-Pedersen, MJ; Palmgren, M				Wielandt, Alex Green; Pedersen, Jesper Torbol; Falhof, Janus; Kemmer, Gerdi Christine; Lund, Anette; Ekberg, Kira; Fuglsang, Anja Thoe; Pomorski, Thomas Gunther; Buch-Pedersen, Morten Jeppe; Palmgren, Michael			Specific Activation of the Plant P-type Plasma Membrane H+-ATPase by Lysophospholipids Depends on the Autoinhibitory N- and C-terminal Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						H+-ATPase; lysophospholipid; plasma membrane; post-transcriptional regulation; proton pump	CALCIUM-PUMP; FATTY-ACIDS; FUNCTIONAL COMPLEMENTATION; CRYSTAL-STRUCTURES; 14-3-3 PROTEIN; BINDING-SITE; YEAST; PHOSPHORYLATION; CA2+; TRANSPORT	Background: Lysophospholipids activate P-type plasma membrane H+-ATPase proton pump by an unknown mechanism. Results: In contrast to fungal plasma membrane H+-ATPase, plant H+-ATPase is activated by lysophospholipids directly via a mechanism involving both terminal domains of the pump. Conclusion: Plant plasma membrane H+-ATPase responds specifically to lysophospholipids. Significance: Lysophospholipids may function in plant signaling. Eukaryotic P-type plasma membrane H+-ATPases are primary active transport systems that are regulated at the post-translation level by cis-acting autoinhibitory domains, which can be relieved by protein kinase-mediated phosphorylation or binding of specific lipid species. Here we show that lysophospholipids specifically activate a plant plasma membrane H+-ATPase (Arabidopsis thaliana AHA2) by a mechanism that involves both cytoplasmic terminal domains of AHA2, whereas they have no effect on the fungal counterpart (Saccharomyces cerevisiae Pma1p). The activation was dependent on the glycerol backbone of the lysophospholipid and increased with acyl chain length, whereas the headgroup had little effect on activation. Activation of the plant pump by lysophospholipids did not involve the penultimate residue, Thr-947, which is known to be phosphorylated as part of a binding site for activating 14-3-3 protein, but was critically dependent on a single autoinhibitory residue (Leu-919) upstream of the C-terminal cytoplasmic domain in AHA2. A corresponding residue is absent in the fungal counterpart. These data indicate that plant plasma membrane H+-ATPases evolved as specific receptors for lysophospholipids and support the hypothesis that lysophospholipids are important plant signaling molecules.	[Wielandt, Alex Green; Pedersen, Jesper Torbol; Falhof, Janus; Kemmer, Gerdi Christine; Lund, Anette; Ekberg, Kira; Fuglsang, Anja Thoe; Pomorski, Thomas Gunther; Buch-Pedersen, Morten Jeppe; Palmgren, Michael] Univ Copenhagen, Ctr Membrane Pumps Cells & Disease PUMPKIN, Danish Natl Res Fdn, Dept Plant & Environm, DK-1871 Frederiksberg, Denmark	Danmarks Grundforskningsfond; University of Copenhagen	Palmgren, M (corresponding author), Univ Copenhagen, Ctr Membrane Pumps Cells & Disease PUMPKIN, Danish Natl Res Fdn, Dept Plant & Environm, DK-1871 Frederiksberg, Denmark.	palmgren@plen.ku.dk	fuglsang, anja thoe t/E-1683-2012; Pomorski, Thomas Günther/G-4804-2014; Palmgren, Michael/A-9808-2013; Pedersen, Jesper Torbøl/AAX-5500-2020; Fuglsang, Anja Thoe/A-6733-2015	fuglsang, anja thoe t/0000-0003-1153-8394; Pomorski, Thomas Günther/0000-0002-4889-0829; Palmgren, Michael/0000-0002-9982-6114; Pedersen, Jesper Torbøl/0000-0003-3094-1461; Fuglsang, Anja Thoe/0000-0003-1153-8394	Danish Strategic Research Council (Fungal-Fight); Danish National Research Foundation (Pumpkin)	Danish Strategic Research Council (Fungal-Fight); Danish National Research Foundation (Pumpkin)(Danmarks Grundforskningsfond)	This work was supported by the Danish Strategic Research Council (Fungal-Fight) and the Danish National Research Foundation (Pumpkin). The authors declare that they have no conflicts of interest with the contents of this article.	Axelsen KB, 1999, BIOCHEMISTRY-US, V38, P7227, DOI 10.1021/bi982482l; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Baldridge RD, 2013, J BIOL CHEM, V288, P19516, DOI 10.1074/jbc.M113.476911; Baunsgaard L, 1996, PLANT J, V10, P451, DOI 10.1046/j.1365-313X.1996.10030451.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brini M, 2013, FEBS J, V280, P5385, DOI 10.1111/febs.12193; Brini M, 2010, J BIOL CHEM, V285, P30779, DOI 10.1074/jbc.M110.140475; BRODIN P, 1992, EUR J BIOCHEM, V204, P939, DOI 10.1111/j.1432-1033.1992.tb16715.x; CID A, 1987, CURR GENET, V12, P105, DOI 10.1007/BF00434664; DEXAERDE AD, 1995, J BIOL CHEM, V270, P23828, DOI 10.1074/jbc.270.40.23828; Drachmann ND, 2014, FEBS J, V281, P4249, DOI 10.1111/febs.12957; Drissner D, 2007, SCIENCE, V318, P265, DOI 10.1126/science.1146487; Ekberg K, 2010, J BIOL CHEM, V285, P7344, DOI 10.1074/jbc.M109.096123; Elmore JM, 2011, MOL PLANT, V4, P416, DOI 10.1093/mp/ssq083; Fuglsang AT, 1999, J BIOL CHEM, V274, P36774, DOI 10.1074/jbc.274.51.36774; Fuglsang AT, 2003, J BIOL CHEM, V278, P42266, DOI 10.1074/jbc.M306707200; Geisler M, 2000, BBA-BIOMEMBRANES, V1465, P52, DOI 10.1016/S0005-2736(00)00131-0; Jahn T, 1997, PLANT CELL, V9, P1805, DOI 10.1105/tpc.9.10.1805; Jahn TP, 2002, J BIOL CHEM, V277, P6353, DOI 10.1074/jbc.M109637200; JAIN MK, 1980, NATURE, V284, P486, DOI 10.1038/284486a0; Kinoshita T, 1999, EMBO J, V18, P5548, DOI 10.1093/emboj/18.20.5548; Laxalt AM, 2002, CURR OPIN PLANT BIOL, V5, P332, DOI 10.1016/S1369-5266(02)00268-6; Lecchi S, 2007, J BIOL CHEM, V282, P35471, DOI 10.1074/jbc.M706094200; MARRE E, 1979, ANNU REV PLANT PHYS, V30, P273, DOI 10.1146/annurev.pp.30.060179.001421; Maudoux O, 2000, J BIOL CHEM, V275, P17762, DOI 10.1074/jbc.M909690199; Meneghelli S, 2008, MOL MEMBR BIOL, V25, P539, DOI 10.1080/09687680802508747; Mlodzinska E, 2015, PHYSIOL PLANTARUM, V154, P270, DOI 10.1111/ppl.12305; NIGGLI V, 1981, J BIOL CHEM, V256, P8588; Niittylae T, 2007, MOL CELL PROTEOMICS, V6, P1711, DOI 10.1074/mcp.M700164-MCP200; Obara K, 2005, P NATL ACAD SCI USA, V102, P14489, DOI 10.1073/pnas.0506222102; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Ottmann C, 2007, MOL CELL, V25, P427, DOI 10.1016/j.molcel.2006.12.017; PALMGREN MG, 1988, PHYSIOL PLANTARUM, V74, P11, DOI 10.1111/j.1399-3054.1988.tb04934.x; PALMGREN MG, 1989, PLANT PHYSIOL, V90, P1009, DOI 10.1104/pp.90.3.1009; PALMGREN MG, 1991, J BIOL CHEM, V266, P20470; Palmgren MG, 2001, ANNU REV PLANT PHYS, V52, P817, DOI 10.1146/annurev.arplant.52.1.817; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; Pedersen BP, 2007, NATURE, V450, P1111, DOI 10.1038/nature06417; Penniston JT, 1998, J MEMBRANE BIOL, V165, P101, DOI 10.1007/s002329900424; REGENBERG B, 1995, PLANT CELL, V7, P1655, DOI 10.1105/tpc.7.10.1655; Rietz S, 2010, MOL PLANT, V3, P524, DOI 10.1093/mp/ssp109; Rudashevskaya EL, 2012, J BIOL CHEM, V287, P4904, DOI 10.1074/jbc.M111.307264; Sahoo SK, 2013, J BIOL CHEM, V288, P6881, DOI 10.1074/jbc.M112.436915; Seo J, 2008, J EXP BOT, V59, P3587, DOI 10.1093/jxb/ern208; SERRANO R, 1983, FEBS LETT, V156, P11, DOI 10.1016/0014-5793(83)80237-3; Speth C, 2010, EUR J CELL BIOL, V89, P145, DOI 10.1016/j.ejcb.2009.10.015; Tidow H, 2012, NATURE, V491, P468, DOI 10.1038/nature11539; Toyoshima C, 2013, NATURE, V495, P260, DOI 10.1038/nature11899; Traaseth NJ, 2009, P NATL ACAD SCI USA, V106, P10165, DOI 10.1073/pnas.0904290106; VENEMA K, 1995, J BIOL CHEM, V270, P19659, DOI 10.1074/jbc.270.33.19659; Viehweger K, 2002, PLANT CELL, V14, P1509, DOI 10.1105/tpc.002329; WELTZIEN HU, 1979, BIOCHIM BIOPHYS ACTA, V559, P259, DOI 10.1016/0304-4157(79)90004-2; Winther AML, 2013, NATURE, V495, P265, DOI 10.1038/nature11900; Zhao J, 2013, NEW PHYTOL, V199, P228, DOI 10.1111/nph.12256	54	20	21	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16281	16291		10.1074/jbc.M114.617746	http://dx.doi.org/10.1074/jbc.M114.617746			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25971968	hybrid, Green Published			2022-12-28	WOS:000356930100031
J	Wang, W; Runkle, KB; Terkowski, SM; Ekaireb, RI; Witze, ES				Wang, Wei; Runkle, Kristin B.; Terkowski, Samantha M.; Ekaireb, Rachel I.; Witze, Eric S.			Protein Depalmitoylation Is Induced by Wnt5a and Promotes Polarized Cell Behavior	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell invasion; cell polarity; cell signaling; protein palmitoylation; Wnt signaling	NITRIC-OXIDE SYNTHASE; RAS LOCALIZATION; PALMITOYLATION; MELANOMA; MIGRATION; INVASION; REVEALS; GROWTH; EXPRESSION; PATHWAY	Background: Wnt5a signaling induces asymmetric localization of the melanoma cell adhesion molecules (MCAM). Results: Wnt5a promotes MCAM depalmitoylation and point mutations in MCAM that block palmitoylation are sufficient to cause asymmetric MCAM localization. Conclusion: Wnt5a induces polarized MCAM localization by promoting MCAM depalmitoylation. Significance: These results reveal a mechanism for Wnt5a-induced polarized cell behavior. Wnt5a signaling regulates polarized cell behavior, but the downstream signaling events that promote cell polarity are not well understood. Our results show that Wnt5a promotes depalmitoylation of the melanoma cell adhesion molecule (MCAM) at cysteine 590. Mutation of Cys-590 to glycine is sufficient to polarize MCAM localization, similar to what is observed with Wnt5a stimulation. Inhibition of the depalmitoylating enzyme APT1 blocks Wnt5a-induced depalmitoylation, asymmetric MCAM localization, and cell invasion. Directly altering expression of the basal protein palmitoylation machinery is sufficient to promote cell invasion. Additionally, cancer mutations in palmitoyltransferases decrease MCAM palmitoylation and have impaired ability to suppress cell invasion. Our results provide evidence that Wnt5a induces protein depalmitoylation, which promotes polarized protein localization and cell invasion.	[Wang, Wei; Runkle, Kristin B.; Terkowski, Samantha M.; Ekaireb, Rachel I.; Witze, Eric S.] Univ Penn, Perelman Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA; [Witze, Eric S.] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Witze, ES (corresponding author), Univ Penn, Perelman Sch Med, Dept Canc Biol, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.	ewitze@exchange.upenn.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [R01-CA-181633-01A1, 2-T32-CA-557726-07]; Melanoma Research Foundation; NATIONAL CANCER INSTITUTE [T32CA115299, R01CA181633] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-CA-181633-01A1 and the Melanoma Research Foundation. The authors declare that they have no conflicts of interest with the contents of this article.; Supported in part by National Institutes of Health Grant 2-T32-CA-557726-07.	Abrami L, 2008, P NATL ACAD SCI USA, V105, P5384, DOI 10.1073/pnas.0710389105; Bakker ERM, 2013, CARCINOGENESIS, V34, P2629, DOI 10.1093/carcin/bgt215; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Conibear E, 2010, J CELL SCI, V123, P4007, DOI 10.1242/jcs.059287; Dekker FJ, 2010, NAT CHEM BIOL, V6, P449, DOI 10.1038/nchembio.362; Draper JM, 2010, MOL MEMBR BIOL, V27, P123, DOI 10.3109/09687681003616854; Eisenberg S, 2013, BIOCHEM SOC T, V41, P79, DOI 10.1042/BST20120268; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; GUO YJ, 1994, INT IMMUNOL, V6, P213, DOI 10.1093/intimm/6.2.213; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; Ho HYH, 2012, P NATL ACAD SCI USA, V109, P4044, DOI 10.1073/pnas.1200421109; Hundt M, 2006, IMMUNITY, V24, P513, DOI 10.1016/j.immuni.2006.03.011; Jennings BC, 2012, J BIOL CHEM, V287, P7236, DOI 10.1074/jbc.M111.337246; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Kong E, 2013, J BIOL CHEM, V288, P9112, DOI 10.1074/jbc.M112.421073; Kurayoshi M, 2006, CANCER RES, V66, P10439, DOI 10.1158/0008-5472.CAN-06-2359; Levental I, 2010, BIOCHEMISTRY-US, V49, P6305, DOI 10.1021/bi100882y; Lin SD, 2010, J CELL BIOL, V190, P263, DOI 10.1083/jcb.200912128; Mitchell DA, 2010, J BIOL CHEM, V285, P38104, DOI 10.1074/jbc.M110.169102; Nomachi A, 2008, J BIOL CHEM, V283, P27973, DOI 10.1074/jbc.M802325200; Noritake J, 2009, J CELL BIOL, V186, P147, DOI 10.1083/jcb.200903101; O'Connell MP, 2010, ONCOGENE, V29, P34, DOI 10.1038/onc.2009.305; Ohno Y., 2006, BIOCHIM BIOPHYS ACTA, V176, P1474; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Saitoh T, 2002, INT J MOL MED, V9, P515; Satyamoorthy K, 2001, ONCOGENE, V20, P4676, DOI 10.1038/sj.onc.1204616; Shaul PW, 1996, J BIOL CHEM, V271, P6518, DOI 10.1074/jbc.271.11.6518; Smalley KSM, 2006, MOL CANCER THER, V5, P1136, DOI 10.1158/1535-7163.MCT-06-0084; Stark MS, 2012, NAT GENET, V44, P165, DOI 10.1038/ng.1041; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Witze ES, 2008, SCIENCE, V320, P365, DOI 10.1126/science.1151250; Witze ES, 2013, DEV CELL, V26, P645, DOI 10.1016/j.devcel.2013.08.019; Yang XW, 2004, J CELL BIOL, V167, P1231, DOI 10.1083/jcb.200404100; Yeh DC, 1999, J BIOL CHEM, V274, P33148, DOI 10.1074/jbc.274.46.33148; Young FB, 2012, PROG NEUROBIOL, V97, P220, DOI 10.1016/j.pneurobio.2011.11.002	42	24	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15707	15716		10.1074/jbc.M115.639609	http://dx.doi.org/10.1074/jbc.M115.639609			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25944911	hybrid, Green Published			2022-12-28	WOS:000356527400033
J	Naito, T; Takatsu, H; Miyano, R; Takada, N; Nakayama, K; Shin, HW				Naito, Tomoki; Takatsu, Hiroyuki; Miyano, Rie; Takada, Naoto; Nakayama, Kazuhisa; Shin, Hye-Won			Phospholipid Flippase ATP10A Translocates Phosphatidylcholine and Is Involved in Plasma Membrane Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASES; AMINOPHOSPHOLIPID TRANSLOCASE; SUBCELLULAR-LOCALIZATION; RECYCLING ENDOSOMES; CDC50 PROTEINS; PHOSPHATIDYLSERINE; TRANSPORT; YEAST; DEFICIENCY; ASYMMETRY	We showed previously that ATP11A and ATP11C have flippase activity toward aminophospholipids (phosphatidylserine (PS) and phosphatidylethanolamine (PE)) and ATP8B1 and that ATP8B2 have flippase activity toward phosphatidylcholine (PC) (Takatsu, H., Tanaka, G., Segawa, K., Suzuki, J., Nagata, S., Nakayama, K., and Shin, H. W. (2014) J. Biol. Chem. 289, 33543-33556). Here, we show that the localization of class 5 P4-ATPases to the plasma membrane (ATP10A and ATP10D) and late endosomes (ATP10B) requires an interaction with CDC50A. Moreover, exogenous expression of ATP10A, but not its ATPase-deficient mutant ATP10A(E203Q), dramatically increased PC flipping but not flipping of PS or PE. Depletion of CDC50A caused ATP10A to be retained at the endoplasmic reticulum instead of being delivered to the plasma membrane and abrogated the increased PC flipping activity observed by expression of ATP10A. These results demonstrate that ATP10A is delivered to the plasma membrane via its interaction with CDC50A and, specifically, flips PC at the plasma membrane. Importantly, expression of ATP10A, but not ATP10A(E203Q), dramatically altered the cell shape and decreased cell size. In addition, expression of ATP10A, but not ATP10A(E203Q), delayed cell adhesion and cell spreading onto the extracellular matrix. These results suggest that enhanced PC flipping activity due to exogenous ATP10A expression alters the lipid composition at the plasma membrane, which may in turn cause a delay in cell spreading and a change in cell morphology.	[Naito, Tomoki; Takatsu, Hiroyuki; Miyano, Rie; Nakayama, Kazuhisa; Shin, Hye-Won] Kyoto Univ, Grad Sch, Sakyo Ku, Kyoto 6068501, Japan; [Takada, Naoto] Kyoto Univ, Fac Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University; Kyoto University	Shin, HW (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan.	shin@pharm.kyoto-u.ac.jp	Shin, Hye-Won/P-5398-2018; Nakayama, Kazuhisa/ABF-2924-2020	Shin, Hye-Won/0000-0002-9138-9554; Naito, Tomoki/0000-0002-8393-3601; Nakayama, Kazuhisa/0000-0001-7701-7183	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Takeda Science Foundation; Grants-in-Aid for Scientific Research [15K14456, 15H01320, 15H04370] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by the Takeda Science Foundation.	Anthonisen AN, 2006, J BIOL CHEM, V281, P31572, DOI 10.1074/jbc.M605194200; Baldridge RD, 2013, P NATL ACAD SCI USA, V110, pE358, DOI 10.1073/pnas.1216948110; Baldridge RD, 2012, P NATL ACAD SCI USA, V109, pE290, DOI 10.1073/pnas.1115725109; Bryde S, 2010, J BIOL CHEM, V285, P40562, DOI 10.1074/jbc.M110.139543; Coleman JA, 2011, J BIOL CHEM, V286, P17205, DOI 10.1074/jbc.M111.229419; Daleke DL, 2003, J LIPID RES, V44, P233, DOI 10.1194/jlr.R200019-JLR200; Das A, 2012, NAT CELL BIOL, V14, P304, DOI 10.1038/ncb2444; Dhar MS, 2006, J NUTR BIOCHEM, V17, P811, DOI 10.1016/j.jnutbio.2006.01.002; Dhar MS, 2004, J NUTR, V134, P799, DOI 10.1093/jn/134.4.799; Fairn GD, 2011, NAT CELL BIOL, V13, P1424, DOI 10.1038/ncb2351; Folmer DE, 2009, HEPATOLOGY, V50, P1597, DOI 10.1002/hep.23158; Folmer DE, 2009, BBA-MOL CELL BIOL L, V1791, P628, DOI 10.1016/j.bbalip.2009.02.008; Furuta N, 2007, MOL BIOL CELL, V18, P295, DOI 10.1091/mbc.E06-05-0461; Hurst SE, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/152902; Kato U, 2002, J BIOL CHEM, V277, P37855, DOI 10.1074/jbc.M205564200; Klomp LWJ, 2004, HEPATOLOGY, V40, P27, DOI 10.1002/hep.20285; Lee S, 2015, EMBO J, V34, P669, DOI 10.15252/embj.201489703; Levano K, 2012, J NEUROCHEM, V120, P302, DOI 10.1111/j.1471-4159.2011.07543.x; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Morita S, 2007, HEPATOLOGY, V46, P188, DOI 10.1002/hep.21591; Nakano K, 2008, MOL BIOL CELL, V19, P1783, DOI 10.1091/mbc.E07-07-0646; Natarajan P, 2004, P NATL ACAD SCI USA, V101, P10614, DOI 10.1073/pnas.0404146101; Natarajan P, 2009, NAT CELL BIOL, V11, P1421, DOI 10.1038/ncb1989; OPDENKAMP JAF, 1979, ANNU REV BIOCHEM, V48, P47, DOI 10.1146/annurev.bi.48.070179.000403; Paulusma CC, 2008, HEPATOLOGY, V47, P268, DOI 10.1002/hep.21950; Paulusma CC, 2006, HEPATOLOGY, V44, P195, DOI 10.1002/hep.21212; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; Riekhof WR, 2009, BBA-MOL CELL BIOL L, V1791, P620, DOI 10.1016/j.bbalip.2009.02.013; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; SCHRIER SL, 1992, BLOOD, V79, P782; Segawa K, 2014, SCIENCE, V344, P1164, DOI 10.1126/science.1252809; SEIGNEURET M, 1984, P NATL ACAD SCI-BIOL, V81, P3751, DOI 10.1073/pnas.81.12.3751; Shin HW, 2005, J CELL SCI, V118, P4039, DOI 10.1242/jcs.02524; Shin HW, 2004, MOL BIOL CELL, V15, P5283, DOI 10.1091/mbc.E04-05-0388; Takatsu H, 2014, J BIOL CHEM, V289, P33543, DOI 10.1074/jbc.M114.593012; Takatsu H, 2011, J BIOL CHEM, V286, P38159, DOI 10.1074/jbc.M111.281006; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; van der Velden LM, 2010, J BIOL CHEM, V285, P40088, DOI 10.1074/jbc.M110.139006; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Yabas M, 2014, J BIOL CHEM, V289, P19531, DOI 10.1074/jbc.C114.570267; Yabas M, 2011, NAT IMMUNOL, V12, P441, DOI 10.1038/ni.2011; Yamamoto H, 2010, MOL BIOL CELL, V21, P2746, DOI 10.1091/mbc.E10-01-0074; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P16586, DOI 10.1073/pnas.0904293106; Zwaal RFA, 1997, BLOOD, V89, P1121, DOI 10.1182/blood.V89.4.1121	44	46	47	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15004	15017		10.1074/jbc.M115.655191	http://dx.doi.org/10.1074/jbc.M115.655191			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25947375	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000356177300017
J	Kim, MS; Jang, J; Rahman, NBAB; Pethe, K; Berry, EA; Huang, LS				Kim, Mi-Sun; Jang, Jichan; Rahman, Nurlilah Binte A. B.; Pethe, Kevin; Berry, Edward A.; Huang, Li-Shar			Isolation and Characterization of a Hybrid Respiratory Supercomplex Consisting of Mycobacterium tuberculosis Cytochrome bcc and Mycobacterium smegmatis Cytochrome aa(3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORYNEBACTERIUM-GLUTAMICUM; BC(1)-AA(3) BRANCH; OXIDASE ACTIVITY; ATP HOMEOSTASIS; C(1); PURIFICATION; MITOCHONDRIA; FLEXIBILITY; COMPLEXES; REDUCTASE	Recently, energy production pathways have been shown to be viable antitubercular drug targets to combat multidrug-resistant tuberculosis and eliminate pathogen in the dormant state. One family of drugs currently under development, the imidazo[1,2-a]pyridine derivatives, is believed to target the pathogen's homolog of the mitochondrial bc(1) complex. This complex, denoted cytochrome bcc, is highly divergent from mitochondrial Complex III both in subunit structure and inhibitor sensitivity, making it a good target for drug development. There is no soluble cytochrome c in mycobacteria to transport electrons from the bcc complex to cytochrome oxidase. Instead, the bcc complex exists in a "supercomplex" with a cytochrome aa(3)-type cytochrome oxidase, presumably allowing direct electron transfer. We describe here purification and initial characterization of the mycobacterial cytochrome bcc-aa(3) supercomplex using a strain of M. smegmatis that has been engineered to express the M. tuberculosis cytochrome bcc. The resulting hybrid super-complex is stable during extraction and purification in the presence of dodecyl maltoside detergent. It is hoped that this purification procedure will potentiate functional studies of the complex as well as crystallographic studies of drug binding and provide structural insight into a third class of the bc complex superfamily.	[Kim, Mi-Sun; Berry, Edward A.; Huang, Li-Shar] SUNY Upstate Med Univ, Syracuse, NY 13210 USA; [Jang, Jichan; Pethe, Kevin] Inst Pasteur Korea, Songnam 463400, Gyeonggi Do, South Korea; [Rahman, Nurlilah Binte A. B.; Pethe, Kevin] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore; [Rahman, Nurlilah Binte A. B.; Pethe, Kevin] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Institut Pasteur Korea; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Berry, EA (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, 750 E Adams St, Syracuse, NY 13210 USA.	berrye@upstate.edu; berryl@upstate.edu	Berry, Edward A./D-5640-2013; Pethe, Kevin/F-9495-2015	Berry, Edward A./0000-0001-8929-0259; Huang, Li-Shar/0000-0003-1427-2544; Pethe, Kevin/0000-0003-0916-8873	National Research Foundation of Korea [NRF-2013R1A6A3A03026543, 2014R1A1A1007464]; National Research foundation of Korea (NRF) - Korean government (MSIP) [2007-00559]; Gyeonggi-do; KISTI; NRF - Korean government (MSIP) [2007-00559]; Lee Kong Chian School of Medicine, Nanyang Technological University Start-Up Grant; State University of New York	National Research Foundation of Korea(National Research Foundation of Korea); National Research foundation of Korea (NRF) - Korean government (MSIP); Gyeonggi-do; KISTI(Korea Institute of Science & Technology Information (KISTI)); NRF - Korean government (MSIP); Lee Kong Chian School of Medicine, Nanyang Technological University Start-Up Grant(Nanyang Technological University); State University of New York	Supported by National Research Foundation of Korea Grant NRF-2013R1A6A3A03026543. Present address: College of Pharmacy, Division of Life and Pharmaceutical Sciences, Ewha Womans University, Seoul, Republic of Korea 120-750.r Supported by a National Research foundation of Korea (NRF) grant funded by the Korean government (MSIP) 2007-00559, Gyeonggi-do, KISTI, and National Research Foundation of Korea Grant 2014R1A1A1007464.r Supported by an NRF grant funded by the Korean government (MSIP) 2007-00559, Gyeonggi-do, KISTI, and a Lee Kong Chian School of Medicine, Nanyang Technological University Start-Up Grant.r Supported by the State University of New York.	Abrahams KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052951; Arora K, 2014, ANTIMICROB AGENTS CH, V58, P6962, DOI 10.1128/AAC.03486-14; Berney M., 2014, ADV PHOTOSYNTHESIS R, P277; Berney M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008614; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Berry EA, 2000, ANNU REV BIOCHEM, V69, P1005, DOI 10.1146/annurev.biochem.69.1.1005; Borisov VB, 2011, BBA-BIOENERGETICS, V1807, P1398, DOI 10.1016/j.bbabio.2011.06.016; Cheng Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087483; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Hagerhall C, 1997, BBA-BIOENERGETICS, V1320, P107, DOI 10.1016/S0005-2728(97)00019-4; Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689; Hasan SS, 2011, J MOL BIOL, V414, P145, DOI 10.1016/j.jmb.2011.09.023; Horvath A, 2000, SCIENCE, V287, P1639, DOI 10.1126/science.287.5458.1639; Kakkar AK, 2014, TUBERCULOSIS, V94, P357, DOI 10.1016/j.tube.2014.04.001; Kusumoto K, 2000, ARCH MICROBIOL, V173, P390, DOI 10.1007/s002030000161; Lechartier B, 2014, EMBO MOL MED, V6, P158, DOI 10.1002/emmm.201201772; Mak PA, 2012, ACS CHEM BIOL, V7, P1190, DOI 10.1021/cb2004884; MARRES CAM, 1977, BIOCHIM BIOPHYS ACTA, V462, P531, DOI 10.1016/0005-2728(77)90099-8; Matsoso LG, 2005, J BACTERIOL, V187, P6300, DOI 10.1128/JB.187.18.6300-6308.2005; Megehee JA, 2006, MICROBIOL-SGM, V152, P823, DOI 10.1099/mic.0.28723-0; Moraski GC, 2011, ACS MED CHEM LETT, V2, P466, DOI 10.1021/ml200036r; Niebisch A, 2003, J BIOL CHEM, V278, P4339, DOI 10.1074/jbc.M210499200; Niebisch A, 2001, ARCH MICROBIOL, V175, P282, DOI 10.1007/s002030100262; Pecsi I, 2014, MBIO, V5, DOI 10.1128/mBio.01093-14; Pethe K, 2013, NAT MED, V19, P1157, DOI 10.1038/nm.3262; Rao SPS, 2008, P NATL ACAD SCI USA, V105, P11945, DOI 10.1073/pnas.0711697105; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Sone N, 2001, BBA-BIOENERGETICS, V1503, P279, DOI 10.1016/S0005-2728(00)00205-X; Sone N, 1996, J BIOL CHEM, V271, P12457, DOI 10.1074/jbc.271.21.12457; THOMAS PE, 1976, ANAL BIOCHEM, V75, P168, DOI 10.1016/0003-2697(76)90067-1; YAMANAKA T, 1981, J BIOCHEM, V89, P265, DOI 10.1093/oxfordjournals.jbchem.a133190; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612	32	31	31	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14350	14360		10.1074/jbc.M114.624312	http://dx.doi.org/10.1074/jbc.M114.624312			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25861988	Green Published, hybrid			2022-12-28	WOS:000355754600008
J	Zhang, WJ; Qian, PX; Zhang, X; Zhang, M; Wang, H; Wu, MM; Kong, XJ; Tan, S; Ding, KS; Perry, JK; Wu, ZS; Cao, Y; Lobie, PE; Zhu, T				Zhang, Weijie; Qian, Pengxu; Zhang, Xiao; Zhang, Min; Wang, Hong; Wu, Mingming; Kong, Xiangjun; Tan, Sheng; Ding, Keshuo; Perry, Jo K.; Wu, Zhengsheng; Cao, Yuan; Lobie, Peter E.; Zhu, Tao			Autocrine/Paracrine Human Growth Hormone-stimulated MicroRNA 96-182-183 Cluster Promotes Epithelial-Mesenchymal Transition and Invasion in Breast Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOMETRIAL CARCINOMA-CELLS; GENE-EXPRESSION; MAMMARY-GLAND; PHENOTYPIC CONVERSION; TRANSCRIPTION FACTOR; METASTASIS; IDENTIFICATION; RECEPTOR; TARGET; STAT5	Human growth hormone (hGH) plays critical roles in pubertal mammary gland growth, development, and sexual maturation. Accumulated studies have reported that autocrine/paracrine hGH is an orthotopically expressed oncoprotein that promotes normal mammary epithelial cell oncogenic transformation. Autocrine/paracrine hGH has also been reported to promote mammary epithelial cell epithelial-mesenchymal transition (EMT) and invasion. However, the underlying mechanism remains largely obscure. MicroRNAs (miRNAs) are reported to be involved in regulation of multiple cellular functions of cancer. To determine whether autocrine/paracrine hGH promotes EMT and invasion through modulation of miRNA expression, we performed microarray profiling using MCF-7 cells stably expressing wild type or a translation-deficient hGH gene and identified miR-96-182-183 as an autocrine/paracrine hGH-regulated miRNA cluster. Forced expression of miR-96-182-183 conferred on epithelioid MCF-7 cells a mesenchymal phenotype and promoted invasive behavior in vitro and dissemination in vivo. Moreover, we observed that miR-96-182-183 promoted EMT and invasion by directly and simultaneously suppressing BRMS1L (breast cancer metastasis suppressor 1-like) gene expression. miR-96 and miR-182 also targeted GHR, providing a potential negative feedback loop in the hGH-GHR signaling pathway. We further demonstrated that autocrine/paracrine hGH stimulated miR-96-182-183 expression and facilitated EMT and invasion via STAT3 and STAT5 signaling. Consistent with elevated expression of autocrine/paracrine hGH in metastatic breast cancer tissue, miR-96-182-183 expression was also remarkably enhanced. Hence, we delineate the roles of the miRNA-96-182-183 cluster and elucidate a novel hGH-GHR-STAT3/STAT5-miR-96-182-183-BRMS1L-ZEB1/E47-EMT/ invasion axis, which provides further understanding of the mechanism of autocrine/paracrine hGH-stimulated EMT and invasion in breast cancer.	[Zhang, Weijie; Qian, Pengxu; Zhang, Xiao; Zhang, Min; Wang, Hong; Wu, Mingming; Kong, Xiangjun; Tan, Sheng; Ding, Keshuo; Wu, Zhengsheng; Zhu, Tao] Univ Sci & Technol China, Sch Life Sci, CAS Key Lab Innate Immun & Chron Dis, Hefei 230027, Anhui, Peoples R China; [Zhang, Weijie; Qian, Pengxu; Zhang, Xiao; Zhang, Min; Wang, Hong; Wu, Mingming; Kong, Xiangjun; Tan, Sheng; Ding, Keshuo; Wu, Zhengsheng; Zhu, Tao] Univ Sci & Technol China, Med Ctr, Hefei 230027, Anhui, Peoples R China; [Zhang, Weijie; Zhang, Min; Zhu, Tao] Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China; [Perry, Jo K.] Univ Auckland, Liggins Inst, Auckland 1023, New Zealand; [Perry, Jo K.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1023, New Zealand; [Wu, Zhengsheng; Cao, Yuan] Anhui Med Univ, Dept Pathol, Hefei 230027, Anhui, Peoples R China; [Lobie, Peter E.] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117599, Singapore; [Lobie, Peter E.] Natl Univ Singapore, Dept Pharmacol, Singapore 117599, Singapore	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Auckland; University of Auckland; Anhui Medical University; National University of Singapore; National University of Singapore	Lobie, PE (corresponding author), Natl Univ Singapore, Canc Sci Inst Singapore, Ctr Translat Med MD6, 11-01K,14 Med Dr, Singapore 117599, Singapore.	csipel@nus.edu.sg; zhut@ustc.edu.cn	Zhu, Tao/H-3495-2018; wu, mingming/GXN-1864-2022; tan, sheng/GSN-2599-2022; Zhang, Xiao/H-2702-2018; cao, yuan/GRR-9461-2022; Qian, Pengxu/B-9376-2016	Perry, Jo/0000-0002-4418-947X; Qian, Pengxu/0000-0001-5636-6704; Mingming, Wu/0000-0001-8420-3750; Zhang, Weijie/0000-0002-6462-6067; Zhang, Xiao/0000-0003-1706-2868	National Key Scientific Program of China [2012CB934002]; Chinese Academy of Science [XDA01040410]; National Natural Science Foundation of China [81272925, 81472494, 81302322, 81402191]; CAS President's International Fellowship Initiative [2015VBA031]; Cancer Science Institute of Singapore from the ministry of education; National Research Foundation of Singapore	National Key Scientific Program of China; Chinese Academy of Science(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS President's International Fellowship Initiative; Cancer Science Institute of Singapore from the ministry of education(Ministry of Education, Singapore); National Research Foundation of Singapore(National Research Foundation, Singapore)	This work was supported by the National Key Scientific Program of China (2012CB934002), the Chinese Academy of Science (XDA01040410), National Natural Science Foundation of China (81272925, 81472494, 81302322, 81402191), CAS President's International Fellowship Initiative (2015VBA031) and the Cancer Science Institute of Singapore through grants from the ministry of education and the National Research Foundation of Singapore.	Barash I, 2006, J CELL PHYSIOL, V209, P305, DOI 10.1002/jcp.20771; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brooks AJ, 2010, NAT REV ENDOCRINOL, V6, P515, DOI 10.1038/nrendo.2010.123; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cascio S, 2010, J CELL PHYSIOL, V224, P242, DOI 10.1002/jcp.22126; Chhabra Y, 2011, EXPERT REV ENDOCRINO, V6, P71, DOI [10.1586/eem.10.73, 10.1586/EEM.10.73]; Ding J, 2010, NAT CELL BIOL, V12, P390, DOI 10.1038/ncb2039; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Emerald BS, 2007, J BIOL CHEM, V282, P680, DOI 10.1074/jbc.M600224200; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Gong C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6406; Hannafon BN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2839; Harding PA, 1996, J BIOL CHEM, V271, P6708, DOI 10.1074/jbc.271.12.6708; Hirata H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055502; Hosui A, 2009, J EXP MED, V206, P819, DOI 10.1084/jem.20080003; Hurst DR, 2011, FEBS LETT, V585, P3185, DOI 10.1016/j.febslet.2011.07.045; Huynh C, 2011, ONCOGENE, V30, P1481, DOI 10.1038/onc.2010.523; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kaulsay KK, 1999, EXP CELL RES, V250, P35, DOI 10.1006/excr.1999.4492; Kaulsay KK, 2001, ENDOCRINOLOGY, V142, P767, DOI 10.1210/en.142.2.767; Kleinberg DL, 1997, J MAMMARY GLAND BIOL, V2, P49, DOI 10.1023/A:1026373513521; Kong XB, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041523, 10.1371/journal.pone.0033381]; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krell J, 2012, MOL DIAGN THER, V16, P167, DOI 10.2165/11632740-000000000-00000; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Liang L, 2013, GASTROENTEROLOGY, V144, P624, DOI 10.1053/j.gastro.2012.11.033; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Meehan WJ, 2003, CLIN EXP METASTAS, V20, P45, DOI 10.1023/A:1022542519586; Mertani HC, 2001, J BIOL CHEM, V276, P21464, DOI 10.1074/jbc.M100437200; Mukhina S, 2004, P NATL ACAD SCI USA, V101, P15166, DOI 10.1073/pnas.0405881101; Nikolaev AY, 2004, BIOCHEM BIOPH RES CO, V323, P1216, DOI 10.1016/j.bbrc.2004.08.227; Oberley C. C., 2014, MOL CARCINOG, DOI [10.1002/mc.22165, DOI 10.1002/MC.22165]; Pandey V, 2008, ENDOCRINOLOGY, V149, P3909, DOI 10.1210/en.2008-0286; Perry JK, 2008, J MAMMARY GLAND BIOL, V13, P131, DOI 10.1007/s10911-008-9070-z; Perry JK, 2013, CURR OPIN ENDOCRINOL, V20, P307, DOI 10.1097/MED.0b013e328363183a; Piao HL, 2012, J MAMMARY GLAND BIOL, V17, P33, DOI 10.1007/s10911-012-9245-5; Qian PX, 2012, CANCER RES, V72, P6036, DOI 10.1158/0008-5472.CAN-12-1507; Qian PX, 2011, CANCER RES, V71, P6463, DOI 10.1158/0008-5472.CAN-11-1322; Raccurt M, 2002, J ENDOCRINOL, V175, P307, DOI 10.1677/joe.0.1750307; Rijnkels M, 2010, J MAMMARY GLAND BIOL, V15, P85, DOI 10.1007/s10911-010-9170-4; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Shafiei F, 2008, ONCOGENE, V27, P2602, DOI 10.1038/sj.onc.1210917; Silverstein RA, 2005, CURR GENET, V47, P1, DOI 10.1007/s00294-004-0541-5; Tang JZ, 2010, ENDOCRINOLOGY, V151, P4133, DOI 10.1210/en.2010-0273; Tang JZ, 2010, ENDOCRINOLOGY, V151, P43, DOI 10.1210/en.2009-0651; Tavassoeli FA, 2003, PATHOLOGY GENETICS T; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Walden PD, 1998, ENDOCRINOLOGY, V139, P659, DOI 10.1210/en.139.2.659; Waters MJ, 1999, CLIN EXP PHARMACOL P, V26, P760, DOI 10.1046/j.1440-1681.1999.03129.x; Weston MD, 2006, BRAIN RES, V1111, P95, DOI 10.1016/j.brainres.2006.07.006; Wu ZS, 2011, J CLIN ENDOCR METAB, V96, pE1619, DOI 10.1210/jc.2011-1245; Xu J, 2011, MOL ENDOCRINOL, V25, P597, DOI 10.1210/me.2010-0255; Zhang L, 2012, NEOPLASMA, V59, P302, DOI 10.4149/neo_2012_039; Zhu T, 2005, CANCER RES, V65, P317; Zhu T, 2001, CELL SIGNAL, V13, P599, DOI 10.1016/S0898-6568(01)00186-3	56	66	70	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13812	13829		10.1074/jbc.M115.653261	http://dx.doi.org/10.1074/jbc.M115.653261			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25873390	Green Published, hybrid			2022-12-28	WOS:000355313000016
J	Singer, K; Maley, N; Mergian, T; DelProposto, J; Cho, KW; Zamarron, BF; Martinez-Santibanez, G; Geletka, L; Muir, L; Wachowiak, P; Demirjian, C; Lumeng, CN				Singer, Kanakadurga; Maley, Nidhi; Mergian, Taleen; DelProposto, Jennifer; Cho, Kae Won; Zamarron, Brian F.; Martinez-Santibanez, Gabriel; Geletka, Lynn; Muir, Lindsey; Wachowiak, Phillip; Demirjian, Chaghig; Lumeng, Carey N.			Differences in Hematopoietic Stem Cells Contribute to Sexually Dimorphic Inflammatory Responses to High Fat Diet-induced Obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE-TISSUE MACROPHAGES; CARDIOVASCULAR-DISEASE; PROMOTES MYELOPOIESIS; EXPRESSION; GENDER; SEX; TRAFFICKING; ADIPONECTIN; SENSITIVITY; DEFICIENCY	Women of reproductive age are protected from metabolic disease relative to postmenopausal women and men. Most preclinical rodent studies are skewed toward the use of male mice to study obesity-induced metabolic dysfunction because of a similar protection observed in female mice. How sex differences in obesity-induced inflammatory responses contribute to these observations is unknown. We have compared and contrasted the effects of high fat diet-induced obesity on glucose metabolism and leukocyte activation in multiple depots in male and female C57Bl/6 mice. With both short term and long term high fat diet, male mice demonstrated increased weight gain and CD11c(+) adipose tissue macrophage content compared with female mice despite similar degrees of adipocyte hypertrophy. Competitive bone marrow transplant studies demonstrated that obesity induced a preferential contribution of male hematopoietic cells to circulating leukocytes and adipose tissue macrophages compared with female cells independent of the sex of the recipient. Sex differences in macrophage and hematopoietic cell in vitro activation in response to obesogenic cues were observed to explain these results. In summary, this report demonstrates that male and female leukocytes and hematopoietic stem cells have cell-autonomous differences in their response to obesity that contribute to an amplified response in males compared with females.	[Singer, Kanakadurga; Maley, Nidhi; Mergian, Taleen; DelProposto, Jennifer; Zamarron, Brian F.; Geletka, Lynn; Muir, Lindsey; Lumeng, Carey N.] Univ Michigan, Sch Med, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Zamarron, Brian F.; Lumeng, Carey N.] Univ Michigan, Sch Med, Grad Program Immunol, Ann Arbor, MI 48109 USA; [Martinez-Santibanez, Gabriel; Lumeng, Carey N.] Univ Michigan, Sch Med, Grad Program Cellular & Mol Biol, Ann Arbor, MI 48109 USA; [Cho, Kae Won] Soonchunhyang Univ, Soonchunhyang Inst Medi Bio Sci SIMS, Cheonan Si 330930, Chungcheongnam, South Korea; [Wachowiak, Phillip; Demirjian, Chaghig] Univ Michigan, Coll Literature Sci & Arts, Ann Arbor, MI 48103 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Soonchunhyang University; University of Michigan System; University of Michigan	Singer, K (corresponding author), Dept Pediat & Communicable Dis, Div Pediat Endocrinol, D1205 MPB,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	ksinger@umich.edu	Regan, Clinton/E-6250-2012; Muir, Lindsey/AAJ-9256-2021	Singer, Kanakadurga/0000-0001-8278-3800; Muir, Lindsey/0000-0002-1756-0325	National Institutes of Health [DK089503]; National Institutes of Health, NIDDK [2P30-DK20572]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089503, T32DK094775, F31DK103524, R01DK090262, P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008322, T32GM007315] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work utilized Core Services from the Michigan Nutrition and Obesity Research Center (supported by National Institutes of Health Grant DK089503 to the University of Michigan). This work also utilized the Microscopy Core of the Michigan Diabetes Research Center (supported by National Institutes of Health, NIDDK, Grant 2P30-DK20572).	Abdgawad M, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032439, 10.1371/journal.pone.0046057]; Barrett-Connor E, 2009, J CARDIOVASC TRANSL, V2, P256, DOI 10.1007/s12265-009-9110-0; Bolego C, 2013, ARTERIOSCL THROM VAS, V33, P1127, DOI 10.1161/ATVBAHA.113.301328; Calippe B, 2010, J IMMUNOL, V185, P1169, DOI 10.4049/jimmunol.0902383; Clayton JA, 2014, NATURE, V509, P282, DOI 10.1038/509282a; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; Estrany ME, 2013, CELL BIOCHEM FUNCT, V31, P504, DOI 10.1002/cbf.2927; Finkelstein JS, 2013, NEW ENGL J MED, V369, P1011, DOI 10.1056/NEJMoa1206168; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Grove KL, 2010, INT J OBESITY, V34, P989, DOI 10.1038/ijo.2010.12; Gui YT, 2004, OBES RES, V12, P1481, DOI 10.1038/oby.2004.185; Imahara SD, 2005, SURGERY, V138, P275, DOI 10.1016/j.surg.2005.03.020; Iwasa T, 2014, ENDOCR J, V61, P891, DOI 10.1507/endocrj.EJ14-0042; Iwasa T, 2014, CYTOKINE, V65, P65, DOI 10.1016/j.cyto.2013.10.004; Karastergiou K, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-13; Kim WK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072108; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Marriott I, 2006, J REPROD IMMUNOL, V71, P12, DOI 10.1016/j.jri.2006.01.004; Marriott I, 2006, IMMUNOL RES, V34, P177, DOI 10.1385/IR:34:3:177; Medrikova D, 2012, INT J OBESITY, V36, P262, DOI 10.1038/ijo.2011.87; Megias J, 2012, STEM CELLS, V30, P1486, DOI 10.1002/stem.1110; Meyer MR, 2006, HYPERTENSION, V47, P1019, DOI 10.1161/01.HYP.0000223064.62762.0b; Morris DL, 2012, OBESITY, V20, P1189, DOI 10.1038/oby.2012.7; Mukundan L, 2009, NAT MED, V15, P1266, DOI 10.1038/nm.2048; Nagareddy PR, 2014, CELL METAB, V19, P821, DOI 10.1016/j.cmet.2014.03.029; Nagareddy PR, 2013, CELL METAB, V17, P695, DOI 10.1016/j.cmet.2013.04.001; Nteeba J, 2013, MOL REPROD DEV, V80, P948, DOI 10.1002/mrd.22231; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Orr JS, 2012, DIABETES, V61, P2718, DOI 10.2337/db11-1595; Pennell LM, 2012, J AUTOIMMUN, V38, pJ282, DOI 10.1016/j.jaut.2011.11.013; Pratt GM, 2009, SURG ENDOSC, V23, P795, DOI 10.1007/s00464-008-0077-8; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Riant E, 2009, ENDOCRINOLOGY, V150, P2109, DOI 10.1210/en.2008-0971; Ribas V, 2011, P NATL ACAD SCI USA, V108, P16457, DOI 10.1073/pnas.1104533108; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Singer K, 2014, MOL METAB, V3, P664, DOI 10.1016/j.molmet.2014.06.005; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Vander Lugt B, 2013, J IMMUNOL, V191, P3119, DOI 10.4049/jimmunol.1200938; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Westcott DJ, 2009, J EXP MED, V206, P3143, DOI 10.1084/jem.20091333; Whitacre CC, 1999, SCIENCE, V283, P1277, DOI 10.1126/science.283.5406.1277	43	65	65	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13250	13262		10.1074/jbc.M114.634568	http://dx.doi.org/10.1074/jbc.M114.634568			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25869128	Green Published, hybrid			2022-12-28	WOS:000354975700026
J	Mizutani, T; Ishizaka, A; Furuichi, Y				Mizutani, Taketoshi; Ishizaka, Aya; Furuichi, Yasuhiro			The Werner Protein Acts as a Coactivator of Nuclear Factor kappa B (NF-kappa B) on HIV-1 and Interleukin-8 (IL-8) Promoters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENESCENCE; INFLAMMATION; MECHANISMS; EXPRESSION; CANCER; FIBROBLASTS	The Werner syndrome helicase (WRN) plays a role in maintaining genomic stability. The lack of WRN results in Werner syndrome, a rare autosomal recessive genetic disorder, which causes premature aging accompanied by many complications such as rare forms of cancer and type 2 diabetes. However, the underlying mechanisms of these complications, arising due to the loss of WRN, are poorly understood. In this study, we demonstrated the function of WRN in transcriptional regulation of NF-kappa B targets. WRN physically interacts via its RecQ C-terminal (RQC) domain with the Rel homology domain of both the RelA (p65) and the p50 subunits of NF-kappa B. In the steady state, WRN is recruited to HIV-1 long terminal repeat (LTR), a typical NF-kappa B-responsive promoter, as well as the p50/p50 homodimer, in an NF-kappa B site-dependent manner. The amount of WRN on LTR increased along with the transactivating RelA/p50 heterodimer in response to TNF-alpha stimulation. Further, a knockdown of WRN reduced the transactivation of LTR in exogenous RelA/p50-introduced or TNF-alpha-stimulated cells. Additionally, knockdown of WRN reduced TNF-alpha stimulation-induced activation of the endogenous promoter of IL-8, an NF-kappa B-responsive gene, and WRN increased its association with the IL-8 promoter region together with RelA/p50 after TNF-alpha stimulation. In conjunction with studies that have shown NF-kappa B to be a key regulator of aging and inflammation, our results indicate a novel role of WRN in transcriptional regulation. Along with NF-kappa B, the loss of WRN is expected to result in incorrect regulation of downstream targets and leads to immune abnormalities and homeostatic disruption.	[Mizutani, Taketoshi; Ishizaka, Aya] Microbial Chem Res Fdn BIKAKEN, Virol Lab, Inst Microbial Chem, Shinagawa Ku, Tokyo 1410021, Japan; [Furuichi, Yasuhiro] GeneCare Res Inst Co Ltd, Kamakura, Kanagawa 2470063, Japan		Mizutani, T (corresponding author), Microbial Chem Res Fdn BIKAKEN, Virol Lab, Inst Microbial Chem, Shinagawa Ku, 3-14-23 Kamiosaki, Tokyo 1410021, Japan.	mizutanit@bikaken.or.jp		Ishizaka, Aya/0000-0003-2800-2430; Mizutani, Taketoshi/0000-0002-1329-6512	Japan Science and Technology Agency (JST); Japan Society for the Promotion of Science (JSPS) KAKENHI [25670221]; Astellas Foundation for Research on Metabolic Disorders Foundation	Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Astellas Foundation for Research on Metabolic Disorders Foundation	This research was supported by a grant from the Strategic Basic Research Programs of Japan Science and Technology Agency (JST) (to T. M.), Japan Society for the Promotion of Science (JSPS) KAKENHI Grant 25670221 (to T. M.), and a grant from the Astellas Foundation for Research on Metabolic Disorders Foundation (to A. I.). The authors declare that they have no conflicts of interest with the contents of this article.	Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784; Adler AS, 2007, GENE DEV, V21, P3244, DOI 10.1101/gad.1588507; Balajee AS, 1999, MOL BIOL CELL, V10, P2655, DOI 10.1091/mbc.10.8.2655; EPSTEIN CJ, 1966, MEDICINE, V45, P177, DOI 10.1097/00005792-196605000-00001; Futami K, 2007, BIOL PHARM BULL, V30, P1958, DOI 10.1248/bpb.30.1958; Futami K, 2015, FRONT GENET, V5, DOI 10.3389/fgene.2014.00441; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Goto M, 1996, CANCER EPIDEM BIOMAR, V5, P239; Goto M, 2008, BIOSCI TRENDS, V2, P218; HENKEL T, 1992, CELL, V68, P1121, DOI 10.1016/0092-8674(92)90083-O; Ishizaka A, 2012, J BIOL CHEM, V287, P11924, DOI 10.1074/jbc.M111.322792; Jurk D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5172; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Krueger BJ, 2008, NUCLEIC ACIDS RES, V36, P2219, DOI 10.1093/nar/gkn061; Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560; Kyng KJ, 2003, P NATL ACAD SCI USA, V100, P12259, DOI 10.1073/pnas.2130723100; Martin GM, 2005, CELL, V120, P523, DOI 10.1016/j.cell.2005.01.031; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; Natoli G, 2012, IMMUNOL REV, V246, P183, DOI 10.1111/j.1600-065X.2012.01103.x; Ogura H, 2008, IMMUNITY, V29, P628, DOI 10.1016/j.immuni.2008.07.018; Orjalo AV, 2009, P NATL ACAD SCI USA, V106, P17031, DOI 10.1073/pnas.0905299106; Pazolli E, 2012, CANCER RES, V72, P2251, DOI 10.1158/0008-5472.CAN-11-3386; Perez-Mancera PA, 2014, NAT REV CANCER, V14, P547, DOI 10.1038/nrc3773; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Sharma A, 2007, J BIOL CHEM, V282, P12048, DOI 10.1074/jbc.M608104200; Shimamoto Akira, 2004, Int J Clin Oncol, V9, P288, DOI 10.1007/s10147-004-0426-0; Smale ST, 2012, IMMUNOL REV, V246, P193, DOI 10.1111/j.1600-065X.2011.01091.x; Smith SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050867; Taube R, 2013, VIRUSES-BASEL, V5, P902, DOI 10.3390/v5030902; Turaga RVN, 2009, CELL CYCLE, V8, P2080, DOI 10.4161/cc.8.13.8925; Wang JX, 2009, EMBO REP, V10, P1272, DOI 10.1038/embor.2009.197; Williams SA, 2006, EMBO J, V25, P139, DOI 10.1038/sj.emboj.7600900; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	35	11	13	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18391	18399		10.1074/jbc.M115.657155	http://dx.doi.org/10.1074/jbc.M115.657155			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26037922	Green Published, hybrid			2022-12-28	WOS:000358512100012
J	Yu, YJ; Prassas, I; Dimitromanolakis, A; Diamandis, EP				Yu, Yijing; Prassas, Ioannis; Dimitromanolakis, Apostolos; Diamandis, Eleftherios P.			Novel Biological Substrates of Human Kallikrein 7 Identified through Degradomics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN TISSUE KALLIKREINS; PROTEINASE-ACTIVATED RECEPTORS; GROWTH-FACTOR MIDKINE; SERINE-PROTEASE; SPECIFICITY; EXPRESSION; SKIN; MODEL; OVEREXPRESSION; ASSOCIATION	Kallikrein-related peptidases (KLKs) are a group of serine proteases widely expressed in various tissues and involved in a wide range of physiological and pathological processes. Although our understanding of the pathophysiological roles of most KLKs has blossomed in recent years, identification of the direct endogenous substrates of human KLKs remains an unmet objective. In this study we employed a degradomics approach to systemically investigate the endogenous substrates of KLK7 in an effort to understand the molecular pathways underlying KLK7 action in skin. We identified several previously known as well as novel protein substrates. Our most promising candidates were further validated with the use of targeted quantitative proteomics (selected reaction monitoring methods) and in vitro recombinant protein digestion assays. Our study revealed midkine, CYR61, and tenascin-C as endogenous substrates for KLK7. Interestingly, some of these substrates (e.g. midkine) were prone to proteolytic cleavage only by KLK7 (and not by other skin-associated KLKs), whereas others (e.g. CYR61 and tenascin-C) could be digested by several KLKs. Furthermore, using melanoma cell line, we show that KLK7-mediated cleavage of midkine results in an overall reduction in the pro-proliferative and pro-migratory effect of midkine. An inverse relation between KLK7 and midkine is also observed in human melanoma tissues. In summary, our degradomics approach revealed three novel endogenous substrates for KLK7, which may shed more light on the pathobiological roles of KLK7 in human skin. Similar substrate screening approaches could be applied for the discovery of biological substrates of other protease.	[Yu, Yijing; Diamandis, Eleftherios P.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [Yu, Yijing; Prassas, Ioannis; Dimitromanolakis, Apostolos; Diamandis, Eleftherios P.] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5T 3L9, Canada; [Diamandis, Eleftherios P.] Univ Hlth Network, Dept Clin Biochem, Toronto, ON M5G 2C4, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Diamandis, EP (corresponding author), Mt Sinai Hosp, Dept Pathol & Lab Med, Suite 6-201,60 Murray St, Toronto, ON M5T 3L9, Canada.	ediamandis@mtsinai.on.ca		Diamandis, Eleftherios/0000-0002-1589-820X				Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Becker-Pauly C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009233; Borgono CA, 2004, NAT REV CANCER, V4, P876, DOI 10.1038/nrc1474; Borgono CA, 2007, BIOL CHEM, V388, P1215, DOI 10.1515/BC.2007.124; Brattsand M, 2005, J INVEST DERMATOL, V124, P198, DOI 10.1111/j.0022-202X.2004.23547.x; Britland S, 2012, BIOTECHNOL PROGR, V28, P485, DOI 10.1002/btpr.736; Cloutier SM, 2002, EUR J BIOCHEM, V269, P2747, DOI 10.1046/j.1432-1033.2002.02960.x; Cohen S, 2012, J IMMUNOL, V188, P259, DOI 10.4049/jimmunol.1101468; Debela M, 2007, P NATL ACAD SCI USA, V104, P16086, DOI 10.1073/pnas.0707811104; Debela M, 2006, J BIOL CHEM, V281, P25678, DOI 10.1074/jbc.M602372200; Descargues P, 2005, NAT GENET, V37, P56, DOI 10.1038/ng1493; Drabovich AP, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006260; Eissa A, 2008, BIOL CHEM, V389, P669, DOI 10.1515/BC.2008.079; Eissa A, 2011, J BIOL CHEM, V286, P687, DOI 10.1074/jbc.M110.125310; Frick IM, 2011, J IMMUNOL, V187, P4300, DOI 10.4049/jimmunol.1004179; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Guillon-Munos A, 2011, J BIOL CHEM, V286, P25505, DOI 10.1074/jbc.M110.213231; Hansson L, 2002, J INVEST DERMATOL, V118, P444, DOI 10.1046/j.0022-202x.2001.01684.x; Iwasaki W, 1997, EMBO J, V16, P6936, DOI 10.1093/emboj/16.23.6936; Jham BC, 2012, J ORAL PATHOL MED, V41, P21, DOI 10.1111/j.1600-0714.2011.01049.x; Kadomatsu K, 2013, J BIOCHEM, V153, P511, DOI 10.1093/jb/mvt035; Kempkes C, 2012, J INVEST DERMATOL, V132, P375, DOI 10.1038/jid.2011.314; Krastel P., 2009, Cyclic Depsipeptides, Patent No. [US 2009/0156472 A1, 20090156472, 2009/0156472A1]; Krenzer S, 2011, J INVEST DERMATOL, V131, P2281, DOI 10.1038/jid.2011.190; Li HX, 2008, PROTEIN SCI, V17, P664, DOI 10.1110/ps.073333208; Martins WK, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-76; Matsumura M, 2005, PROSTATE, V62, P1, DOI 10.1002/pros.20101; Monma F, 2013, J DERMATOL, V40, P980, DOI 10.1111/1346-8138.12333; Nordin SL, 2012, J ANTIMICROB CHEMOTH, V67, P1927, DOI 10.1093/jac/dks136; Oikonomopoulou K, 2006, J BIOL CHEM, V281, P32095, DOI 10.1074/jbc.M513138200; Pope SN, 2005, J STEROID BIOCHEM, V94, P203, DOI 10.1016/j.jsbmb.2005.01.007; Rezze GG, 2011, HUM PATHOL, V42, P409, DOI 10.1016/j.humpath.2010.09.004; Rodriguez D, 2010, BBA-MOL CELL RES, V1803, P39, DOI 10.1016/j.bbamcr.2009.09.015; Sanchez WY, 2012, ENDOCRINOLOGY, V153, P3179, DOI 10.1210/en.2012-1011; Schilling O, 2007, CURR OPIN CHEM BIOL, V11, P36, DOI 10.1016/j.cbpa.2006.11.037; Schlage P, 2014, MOL CELL PROTEOMICS, V13, P580, DOI 10.1074/mcp.M113.035139; Shaw JLV, 2007, CLIN CHEM, V53, P1423, DOI 10.1373/clinchem.2007.088104; Sotiropoulou G, 2012, TRENDS PHARMACOL SCI, V33, P623, DOI 10.1016/j.tips.2012.09.005; Svensson SL, 2010, J BIOL CHEM, V285, P16105, DOI 10.1074/jbc.M109.081232; Tong Y, 2007, J NEUROCHEM, V100, P1097, DOI 10.1111/j.1471-4159.2006.04276.x; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yamasaki K, 2006, FASEB J, V20, P2068, DOI 10.1096/fj.06-6075com; Yoshida S, 2010, BIOL CHEM, V391, P375, DOI 10.1515/BC.2010.034; Yousef GM, 2001, ENDOCR REV, V22, P184, DOI 10.1210/er.22.2.184; Yu YJ, 2014, BIOL CHEM, V395, P931, DOI 10.1515/hsz-2014-0129	45	25	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					17762	17775		10.1074/jbc.M115.643551	http://dx.doi.org/10.1074/jbc.M115.643551			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26032414	hybrid, Green Published			2022-12-28	WOS:000358511700011
J	Sainz-Polo, MA; Gonzalez, B; Menendez, M; Pastor, FIJ; Sanz-Aparicio, J				Angela Sainz-Polo, M.; Gonzalez, Beatriz; Menendez, Margarita; Javier Pastor, F. I.; Sanz-Aparicio, Julia			Exploring Multimodularity in Plant Cell Wall Deconstruction STRUCTURAL AND FUNCTIONAL ANALYSIS OF Xyn10C CONTAINING THE CBM22-1-CBM22-2 TANDEM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING MODULES; THERMOSTABILIZING DOMAINS; MOLECULAR-BASIS; XYLANASE; SPECIFICITY; CELLULOSOMES; BIOCHEMISTRY; RECOGNITION; INSIGHTS; COMPLEX	Elucidating the molecular mechanisms regulating multi-modularity is a challenging task. Paenibacillus barcinonensis Xyn10C is a 120-kDa modular enzyme that presents the CBM22/GH10/CBM9 architecture found in a subset of large xylanases. We report here the three-dimensional structure of the Xyn10C N-terminal region, containing the xylan-binding CBM22-1-CBM22-2 tandem (Xyn10C-XBD), which represents the first solved crystal structure of two contiguous CBM22 modules. Xyn10C-XBD is folded into two separate CBM22 modules linked by a flexible segment that endows the tandem with extraordinary plasticity. Each isolated domain has been expressed and crystallized, and their binding abilities have been investigated. Both domains contain the R(W/Y)YYE motif required for xylan binding. However, crystallographic analysis of CBM22-2 complexes shows Trp-308 as an additional binding determinant. The long loop containing Trp-308 creates a platform that possibly contributes to the recognition of precise decorations at subsite S2. CBM22-2 may thus define a subset of xylan-binding CBM22 modules directed to particular regions of the polysaccharide. Affinity electrophoresis reveals that Xyn10C-XBD binds arabinoxylans more tightly, which is more apparent when CBM22-2 is tested against highly substituted xylan. The crystal structure of the catalytic domain, also reported, shows the capacity of the active site to accommodate xylan substitutions at almost all subsites. The structural differences found at both Xyn10C-XBD domains are consistent with the isothermal titration calorimetry experiments showing two sites with different affinities in the tandem. On the basis of the distinct characteristics of CBM22, a delivery strategy of Xyn10C mediated by Xyn10C-XBD is proposed.	[Angela Sainz-Polo, M.; Gonzalez, Beatriz; Sanz-Aparicio, Julia] CSIC, Inst Quim Fis Rocasolano, Dept Cristalog & Biol Estruct, E-28006 Madrid, Spain; [Menendez, Margarita] CSIC, Inst Quim Fis Rocasolano, Dept Quim Fis Biol, E-28006 Madrid, Spain; [Javier Pastor, F. I.] Univ Barcelona, Fac Biol, Dept Microbiol, E-08028 Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of Barcelona	Sanz-Aparicio, J (corresponding author), CSIC, Inst Quim Fis Rocasolano, Dept Cristalog & Biol Estruct, Serrano 119, E-28006 Madrid, Spain.	xjulia@iqfr.csic.es	Menendez, Margarita/M-1795-2014; Gonzalez, Beatriz/M-1219-2014; Sanz-Aparicio, Julia/F-6201-2013; saso, luciano/F-6306-2012; Sainz-Polo, Maria-Angela/F-3947-2016	Menendez, Margarita/0000-0002-3267-4443; Gonzalez, Beatriz/0000-0002-0710-0202; Sanz-Aparicio, Julia/0000-0002-6849-8621; saso, luciano/0000-0003-4530-8706; Sainz-Polo, Maria-Angela/0000-0002-6269-4330	Spanish Ministry of Science and Innovation [BIO2010-20508-C04-03, BIO2013-48779-C4-2-R, CTQ2013-48995-C2-2-R, BFU2012-36825]; Junta de Ampliacion de Estudios predoctoral fellowship from the Spanish National Research Council	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Ampliacion de Estudios predoctoral fellowship from the Spanish National Research Council	This work was supported by Grants BIO2010-20508-C04-03, BIO2013-48779-C4-2-R, CTQ2013-48995-C2-2-R, and BFU2012-36825 from the Spanish Ministry of Science and Innovation. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Junta de Ampliacion de Estudios predoctoral fellowship from the Spanish National Research Council.	Abbott DW, 2008, MOL BIOL EVOL, V25, P155, DOI 10.1093/molbev/msm243; Abbott DW, 2014, CURR OPIN STRUC BIOL, V28, P32, DOI 10.1016/j.sbi.2014.07.004; Andrews SR, 2004, J BIOL CHEM, V279, P54369, DOI 10.1074/jbc.M409044200; Sainz-Polo MA, 2014, J BIOL CHEM, V289, P31088, DOI 10.1074/jbc.M114.597732; Sainz-Polo MA, 2015, ACTA CRYSTALLOGR F, V71, P136, DOI 10.1107/S2053230X14027496; ATKINS EDT, 1992, PROGR BIOTECHNOL, V7, P39; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Blanco A, 1999, MICROBIOL-SGM, V145, P2163, DOI 10.1099/13500872-145-8-2163; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Charnock SJ, 2000, BIOCHEMISTRY-US, V39, P5013, DOI 10.1021/bi992821q; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Correia MAS, 2010, BIOCHEMISTRY-US, V49, P6193, DOI 10.1021/bi1006139; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fontes CMGA, 2010, ANNU REV BIOCHEM, V79, P655, DOI 10.1146/annurev-biochem-091208-085603; FONTES CMGA, 1995, BIOCHEM J, V307, P151, DOI 10.1042/bj3070151; Gallardo O, 2010, J BIOL CHEM, V285, P2721, DOI 10.1074/jbc.M109.064394; Gilbert HJ, 2013, CURR OPIN STRUC BIOL, V23, P669, DOI 10.1016/j.sbi.2013.05.005; Gilbert HJ, 2010, PLANT PHYSIOL, V153, P444, DOI 10.1104/pp.110.156646; Herve C, 2010, P NATL ACAD SCI USA, V107, P15293, DOI 10.1073/pnas.1005732107; Hogg D, 2003, BIOCHEM J, V371, P1027, DOI 10.1042/BJ20021860; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; McCartney L, 2006, P NATL ACAD SCI USA, V103, P4765, DOI 10.1073/pnas.0508887103; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meissner K, 2000, MOL MICROBIOL, V36, P898, DOI 10.1046/j.1365-2958.2000.01909.x; Montanier C, 2009, P NATL ACAD SCI USA, V106, P3065, DOI 10.1073/pnas.0808972106; Monterroso B, 2008, J BIOL CHEM, V283, P28618, DOI 10.1074/jbc.M802808200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Najmudin S, 2010, J STRUCT BIOL, V172, P353, DOI 10.1016/j.jsb.2010.07.009; Pell G, 2004, J BIOL CHEM, V279, P11777, DOI 10.1074/jbc.M311947200; Pell G, 2004, J BIOL CHEM, V279, P9597, DOI 10.1074/jbc.M312278200; Sanchez MM, 2005, INT J SYST EVOL MICR, V55, P935, DOI 10.1099/ijs.0.63383-0; Shoseyov O, 2006, MICROBIOL MOL BIOL R, V70, P283, DOI 10.1128/MMBR.00028-05; Simpson PJ, 1999, STRUCTURE, V7, P853, DOI 10.1016/S0969-2126(99)80108-7; Sunna A, 2000, BIOCHEM J, V346, P583, DOI 10.1042/0264-6021:3460583; Szabo L, 2001, J BIOL CHEM, V276, P49061, DOI 10.1074/jbc.M109558200; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P28492, DOI 10.1074/jbc.M504468200; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Valenzuela SV, 2014, APPL MICROBIOL BIOT, V98, P5949, DOI 10.1007/s00253-014-5565-2; Valenzuela SV, 2010, J AGR FOOD CHEM, V58, P4814, DOI 10.1021/jf9045792; Vardakou M, 2005, J MOL BIOL, V352, P1060, DOI 10.1016/j.jmb.2005.07.051; Vazana Y, 2012, METHOD ENZYMOL, V510, P429, DOI 10.1016/B978-0-12-415931-0.00023-9; Xie HF, 2001, BIOCHEMISTRY-US, V40, P9167, DOI 10.1021/bi0106742	47	14	16	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17116	17130		10.1074/jbc.M115.659300	http://dx.doi.org/10.1074/jbc.M115.659300			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26001782	hybrid, Green Published			2022-12-28	WOS:000357730900007
J	Yang, YM; Blair, HC; Shapiro, IM; Wang, B				Yang, Yanmei; Blair, Harry C.; Shapiro, Irving M.; Wang, Bin			The Proteasome Inhibitor Carfilzomib Suppresses Parathyroid Hormone-induced Osteoclastogenesis through a RANKL-mediated Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B LIGAND; MULTIPLE-MYELOMA; RECEPTOR ACTIVATOR; GENE-EXPRESSION; BONE-FORMATION; BETA-CATENIN; OSTEOBLASTS; DIFFERENTIATION; DEGRADATION; CELLS	Parathyroid hormone (PTH) induces osteoclast formation and activity by increasing the ratio of RANKL/OPG in osteoblasts. The proteasome inhibitor carfilzomib (CFZ) has been used as an effective therapy for multiple myeloma via the inhibition of pathologic bone destruction. However, the effect of combination of PTH and CFZ on osteoclastogenesis is unknown. We now report that CFZ inhibits PTH-induced RANKL expression and secretion without affecting PTH inhibition of OPG expression, and it does so by blocking HDAC4 proteasomal degradation in osteoblasts. Furthermore, we used different types of culture systems, including co-culture, indirect co-culture, and transactivation, to assess the effect of CFZ on PTH action to induce osteoclastogenesis. Our results demonstrated that CFZ blocks PTH-induced osteoclast formation and bone resorption by its additional effect to inhibit RANKL-mediated I kappa B degradation and NF-kappa B activation in osteoclasts. This study showed for the first time that CFZ targets both osteoblasts and osteoclasts to suppress PTH-induced osteoclast differentiation and bone resorption. These findings warrant further investigation of this novel combination in animal models of osteoporosis and in patients.	[Yang, Yanmei; Wang, Bin] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Ctr Translat Med, Dept Med, Philadelphia, PA 19107 USA; [Shapiro, Irving M.] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Ctr Translat Med, Dept Orthopaed Surg, Philadelphia, PA 19107 USA; [Blair, Harry C.] Dept Vet Affairs Med Ctr, Pittsburgh, PA 15240 USA; [Blair, Harry C.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA; [Blair, Harry C.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15261 USA	Jefferson University; Jefferson University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wang, B (corresponding author), Ctr Translat Med, Dept Med, Locust St, Philadelphia, PA 19107 USA.	bin.wang@jefferson.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [AR062705, AR063289]; Department of Veterans Affairs; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR063289, R03AR062705] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR062705 and AR063289 (to B. W.). This work was also supported by funds from the Department of Veterans Affairs (to H. C. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Ang E, 2009, J CELL PHYSIOL, V220, P450, DOI 10.1002/jcp.21787; Backs J, 2011, J CELL BIOL, V195, P403, DOI 10.1083/jcb.201105063; Bellido T, 2003, J BIOL CHEM, V278, P50259, DOI 10.1074/jbc.M307444200; Berenson JR, 2014, LEUKEMIA, V28, P1529, DOI 10.1038/leu.2014.27; Blair HC, 2007, ANN NY ACAD SCI, V1116, P165, DOI 10.1196/annals.1402.029; Boissy P, 2008, LEUKEMIA RES, V32, P1661, DOI 10.1016/j.leukres.2008.02.019; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Cernotta N, 2011, MOL BIOL CELL, V22, P278, DOI 10.1091/mbc.E10-07-0616; Datta NS, 2009, CELL SIGNAL, V21, P1245, DOI 10.1016/j.cellsig.2009.02.012; Eda H, 2014, LEUKEMIA, V28, P1892, DOI 10.1038/leu.2014.69; Fu Q, 2002, J BIOL CHEM, V277, P48868, DOI 10.1074/jbc.M208494200; Fu Q, 2006, MOL CELL BIOL, V26, P6453, DOI 10.1128/MCB.00356-06; Hodsman AB, 2005, ENDOCR REV, V26, P688, DOI 10.1210/er.2004-0006; Hu B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074191; Huang JC, 2004, J BONE MINER RES, V19, P235, DOI 10.1359/JBMR.0301226; Hurchla MA, 2013, LEUKEMIA, V27, P430, DOI 10.1038/leu.2012.183; Karatoprak C, 2012, INDIAN J PHARMACOL, V44, P270, DOI 10.4103/0253-7613.93869; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kulkarni NH, 2005, J CELL BIOCHEM, V95, P1178, DOI 10.1002/jcb.20506; Marino Silvia, 2014, Bonekey Rep, V3, P570, DOI 10.1038/bonekey.2014.65; Mori K, 2006, J CELL BIOCHEM, V98, P1629, DOI 10.1002/jcb.20891; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; O'Brien CA, 2002, BONE, V30, P453, DOI 10.1016/S8756-3282(01)00692-5; Obri A, 2014, J CELL BIOL, V205, P771, DOI 10.1083/jcb.201403138; Pennisi A, 2009, AM J HEMATOL, V84, P6, DOI 10.1002/ajh.21310; Poole KES, 2005, CURR OPIN PHARMACOL, V5, P612, DOI 10.1016/j.coph.2005.07.004; Qiang YW, 2010, BRIT J HAEMATOL, V148, P726, DOI 10.1111/j.1365-2141.2009.08009.x; Romero G, 2010, J BIOL CHEM, V285, P14756, DOI 10.1074/jbc.M110.102970; Shinoda Y, 2010, J CELL BIOCHEM, V109, P755, DOI 10.1002/jcb.22454; Takahashi Naoyuki, 2007, V135, P285; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Wang B, 2004, ARTHRITIS RHEUM-US, V50, P2995, DOI 10.1002/art.20459; Wang B, 2013, BONE, V52, P268, DOI 10.1016/j.bone.2012.10.001; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Zavrski I, 2005, BIOCHEM BIOPH RES CO, V333, P200, DOI 10.1016/j.bbrc.2005.05.098; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhao L, 2010, J BONE MINER RES, V25, P1246, DOI 10.1002/jbmr.28; Zhu Q, 2007, ONCOGENE, V26, P4199, DOI 10.1038/sj.onc.1210191	39	17	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16918	16928		10.1074/jbc.M115.663963	http://dx.doi.org/10.1074/jbc.M115.663963			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25979341	Green Published, hybrid			2022-12-28	WOS:000357572800036
J	Zehnpfennig, B; Wiriyasermkul, P; Carlson, DA; Quick, M				Zehnpfennig, Britta; Wiriyasermkul, Pattama; Carlson, David A.; Quick, Matthias			Interaction of -Lipoic Acid with the Human Na+/Multivitamin Transporter (hSMVT)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						kinetics; membrane transport; stereoselectivity; Xenopus; yeast; SLC5; scintillation proximity assay; lipoamide; lipoic acid; solute; sodium symporter	DEPENDENT MULTIVITAMIN TRANSPORTER; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; EPITHELIAL-CELLS; NA+/I-SYMPORTER; THIOCTIC ACID; BINDING-SITE; SODIUM; MECHANISM; SUBSTRATE	Background: Transport of -lipoate by hSMVT and its stereospecificity have been elusive. Results: Using hSMVT expressed in oocytes and in Pichia pastoris yielded detailed information about the stereospecificity of hSMVT-mediated lipoate transport and binding. Conclusion: hSMVT can bind two molecules of R-(+)--lipoate, its physiological substrate. Significance: In addition to biotin, pantothenate, and iodide, hSMVT mediates the transport of lipoate. The human Na+/multivitamin transporter (hSMVT) has been suggested to transport -lipoic acid (LA), a potent antioxidant and anti-inflammatory agent used in therapeutic applications, e.g. in the treatment of diabetic neuropathy and Alzheimer disease. However, the molecular basis of the cellular delivery of LA and in particular the stereospecificity of the transport process are not well understood. Here, we expressed recombinant hSMVT in Pichia pastoris and used affinity chromatography to purify the detergent-solubilized protein followed by reconstitution of hSMVT in lipid bilayers. Using a combined approach encompassing radiolabeled LA transport and equilibrium binding studies in conjunction with the stabilized R-(+)- and S-(-)-enantiomers and the R,S-(+/-) racemic mixture of LA or lipoamide, we identified the biologically active form of LA, R-LA, to be the physiological substrate of hSMVT. Interaction of R-LA with hSMVT is strictly dependent on Na+. Under equilibrium conditions, hSMVT can simultaneously bind approximate to 2 molecules of R-LA in a biphasic binding isotherm with dissociation constants (K-d) of 0.9 and 7.4 m. Transport of R-LA in the oocyte and reconstituted system is exclusively dependent on Na+ and exhibits an affinity of approximate to 3 m. Measuring transport with known amounts of protein in proteoliposomes containing hSMVT in outside-out orientation yielded a catalytic turnover number (k(cat)) of about 1 s(-1), a value that is well in agreement with other Na+-coupled transporters. Our data suggest that hSMVT-mediated transport is highly specific for R-LA at our tested concentration range, a finding with wide ramifications for the use of LA in therapeutic applications.	[Zehnpfennig, Britta; Quick, Matthias] Columbia Univ Coll Phys & Surg, Ctr Mol Recognit, New York, NY 10032 USA; [Wiriyasermkul, Pattama; Quick, Matthias] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Carlson, David A.] GeroNova Res Inc, Richmond, CA 94806 USA; [Quick, Matthias] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA	Columbia University; Columbia University; New York State Psychiatry Institute	Carlson, DA (corresponding author), GeroNova Res Inc, 2600 Hilltop Dr,Bldg B,Suite C120, Richmond, CA 94806 USA.	david@geronova.com; mq2102@cumc.columbia.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [DA017293]; National Science Foundation [MCB130730]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017293] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant DA017293 (to M. Q.). This work was also supported by National Science Foundation Grant MCB130730 (to M. Q.). The authors declare that they have no conflicts of interest with the contents of this article.	Abramson J, 2009, CURR OPIN STRUC BIOL, V19, P425, DOI 10.1016/j.sbi.2009.06.002; Balamurugan K, 2003, AM J PHYSIOL-GASTR L, V285, pG73, DOI 10.1152/ajpgi.00059.2003; Bast A, 2003, BIOFACTORS, V17, P207, DOI 10.1002/biof.5520170120; BERKSON BM, 1979, NEW ENGL J MED, V300, P371; Bharath S, 2002, NEUROTOXICOLOGY, V23, P479, DOI 10.1016/S0161-813X(02)00035-9; Breithaupt-Grogler K, 1999, EUR J PHARM SCI, V8, P57, DOI 10.1016/S0928-0987(98)00061-X; Bustamante J, 1998, FREE RADICAL BIO MED, V24, P1023, DOI 10.1016/S0891-5849(97)00371-7; Carlson D. A., 2008, VALIDATED NORMAL PHA; Carlson DA, 2007, ALTERN MED REV, V12, P343; Carreau J P, 1979, Methods Enzymol, V62, P152, DOI 10.1016/0076-6879(79)62212-7; de Carvalho FD, 2011, J BIOL CHEM, V286, P131, DOI 10.1074/jbc.M110.167197; Eskandari S, 1997, J BIOL CHEM, V272, P27230, DOI 10.1074/jbc.272.43.27230; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Foster TS, 2007, DIABETES EDUCATOR, V33, P111, DOI 10.1177/0145721706297450; HARRISON EH, 1974, ARCH BIOCHEM BIOPHYS, V160, P514, DOI 10.1016/0003-9861(74)90428-7; Hediger MA, 2004, PFLUG ARCH EUR J PHY, V447, P465, DOI 10.1007/s00424-003-1192-y; Hermann R, 1996, EUR J PHARM SCI, V4, P167, DOI 10.1016/0928-0987(95)00045-3; HORNBERGER CS, 1953, J AM CHEM SOC, V75, P1273, DOI 10.1021/ja01102a003; Jung H, 1998, BIOCHEMISTRY-US, V37, P11083, DOI 10.1021/bi980684b; Korotchkina LG, 2004, FREE RADICAL RES, V38, P1083, DOI 10.1080/10715760400004168; Li Z, 2015, J BIOL CHEM, V290, P127, DOI 10.1074/jbc.M114.584383; Licata L, 2006, PROTEIN EXPRES PURIF, V47, P171, DOI 10.1016/j.pep.2005.10.010; Maczurek A, 2008, ADV DRUG DELIVER REV, V60, P1463, DOI 10.1016/j.addr.2008.04.015; Malinauskaite L, 2014, NAT STRUCT MOL BIOL, V21, P1006, DOI 10.1038/nsmb.2894; Milne JLS, 2006, J BIOL CHEM, V281, P4364, DOI 10.1074/jbc.M504363200; Nasr ML, 2014, BIOCHEMISTRY-US, V53, P4, DOI 10.1021/bi401412e; PACKER L, 1995, FREE RADICAL BIO MED, V19, P227, DOI 10.1016/0891-5849(95)00017-R; Packer L, 1997, FREE RADICAL BIO MED, V22, P359, DOI 10.1016/S0891-5849(96)00269-9; PATLAK CLIFFORD S., 1957, BULL MATH BIOPHYS, V19, P209, DOI 10.1007/BF02477764; Portulano C, 2014, ENDOCR REV, V35, P106, DOI 10.1210/er.2012-1036; Quick M, 2002, P NATL ACAD SCI USA, V99, P8597, DOI 10.1073/pnas.132266599; Quick M, 2001, J BIOL CHEM, V276, P1728, DOI 10.1074/jbc.M005521200; Quick M, 2007, P NATL ACAD SCI USA, V104, P3603, DOI 10.1073/pnas.0609573104; Reed LJ, 2001, J BIOL CHEM, V276, P38329, DOI 10.1074/jbc.R100026200; ROSENBERG HR, 1959, ARCH BIOCHEM BIOPHYS, V80, P86, DOI 10.1016/0003-9861(59)90345-5; Saier MH, 2000, MICROBIOL MOL BIOL R, V64, P354, DOI 10.1128/MMBR.64.2.354-411.2000; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Schmidt U., 1966, U. S. Patent, Patent No. [US3288797 A, 3288797]; Schreibelt G, 2006, J IMMUNOL, V177, P2630, DOI 10.4049/jimmunol.177.4.2630; Shay KP, 2009, BBA-GEN SUBJECTS, V1790, P1149, DOI 10.1016/j.bbagen.2009.07.026; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Smith AR, 2004, CURR MED CHEM, V11, P1135, DOI 10.2174/0929867043365387; Sonders MS, 1997, J NEUROSCI, V17, P960; Subramanian VS, 2009, AM J PHYSIOL-CELL PH, V296, pC663, DOI 10.1152/ajpcell.00396.2008; Takaishi N, 2007, J AGR FOOD CHEM, V55, P5253, DOI 10.1021/jf063624i; Tang J, 2007, NEUROLOGIST, V13, P164, DOI 10.1097/01.nrl.0000263703.78318.2b; Vincent HK, 2007, J ALTERN COMPLEM MED, V13, P577, DOI 10.1089/acm.2007.6177; Wang HP, 1999, J BIOL CHEM, V274, P14875, DOI 10.1074/jbc.274.21.14875; Watanabe A, 2010, NATURE, V468, P988, DOI 10.1038/nature09580; Wright EM, 2011, PHYSIOL REV, V91, P733, DOI 10.1152/physrev.00055.2009; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zehnpfennig B, 2009, BIOCHEMISTRY-US, V48, P4423, DOI 10.1021/bi9001908; Zhao X, 2003, CHEM BIOL, V10, P1293, DOI 10.1016/j.chembiol.2003.11.016; Zhao YF, 2011, NATURE, V474, P109, DOI 10.1038/nature09971; ZIMMER G, 1995, J MOL CELL CARDIOL, V27, P1895, DOI 10.1016/0022-2828(95)90012-8	55	18	18	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16372	16382		10.1074/jbc.M114.622555	http://dx.doi.org/10.1074/jbc.M114.622555			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25971966	Green Published, hybrid			2022-12-28	WOS:000356930100038
J	Efremov, AK; Qu, YY; Maruyama, H; Lim, CJ; Takeyasu, K; Yan, J				Efremov, Artem K.; Qu, Yuanyuan; Maruyama, Hugo; Lim, Ci J.; Takeyasu, Kunio; Yan, Jie			Transcriptional Repressor TrmBL2 from Thermococcus kodakarensis Forms Filamentous Nucleoprotein Structures and Competes with Histones for DNA Binding in a Salt- and DNA Supercoiling-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						archaea; atomic force microscopy (AFM); DNA-binding protein; extreme thermophile; gene regulation; protein-DNA interaction; single-molecule biophysics; DNA supercoiling; magnetic tweezers	NUCLEOID-ASSOCIATED PROTEIN; ESCHERICHIA-COLI; H-NS; (H3-H4)(2) TETRAMER; IN-VIVO; SINGLE; MOLECULES; ORGANIZATION; COMPARTMENTS; ARCHITECTURE	Background: TrmBL2 and histones maintain the genome functioning in hyperthermophilic euryarchaeal cells. Results: TrmBL2 forms filaments on DNA through cooperative binding and competes with histones in a salt- and DNA supercoiling-dependent manner. Conclusion: TrmBL2-histone collective behavior dynamically controls DNA organization. Significance: The discovered mechanisms provide insights into the regulation of the genome structure and global transcription profile by TrmBL2 and histones. Architectural DNA proteins play important roles in the chromosomal DNA organization and global gene regulation in living cells. However, physiological functions of some DNA-binding proteins from archaea remain unclear. Recently, several abundant DNA-architectural proteins including histones, Alba, and TrmBL2 have been identified in model euryarchaeon Thermococcus kodakarensis. Although histones and Alba proteins have been previously characterized, the DNA binding properties of TrmBL2 and its interplay with the other major architectural proteins in the chromosomal DNA organization and gene transcription regulation remain largely unexplored. Here, we report single-DNA studies showing that at low ionic strength (<300 mm KCl), TrmBL2 binds to DNA largely in non-sequence-specific manner with positive cooperativity, resulting in formation of stiff nucleoprotein filamentous patches, whereas at high ionic strength (>300 mm KCl) TrmBL2 switches to more sequence-specific interaction, suggesting the presence of high affinity TrmBL2-filament nucleation sites. Furthermore, in vitro assays indicate the existence of DNA binding competition between TrmBL2 and archaeal histones B from T. kodakarensis, which can be strongly modulated by DNA supercoiling and ionic strength of surrounding solution. Overall, these results advance our understanding of TrmBL2 DNA binding properties and provide important insights into potential functions of architectural proteins in nucleoid organization and gene regulation in T. kodakarensis.	[Efremov, Artem K.; Lim, Ci J.; Yan, Jie] Natl Univ Singapore, Mechanobiol Inst, Singapore 117411, Singapore; [Efremov, Artem K.; Qu, Yuanyuan; Lim, Ci J.; Yan, Jie] Natl Univ Singapore, Ctr Bioimaging Sci, Singapore 117546, Singapore; [Qu, Yuanyuan; Yan, Jie] Natl Univ Singapore, Dept Phys, Singapore 117542, Singapore; [Qu, Yuanyuan] Shandong Univ, Sch Phys, Jinan 250100, Peoples R China; [Maruyama, Hugo] Osaka Dent Univ, Dept Bacteriol, Hirakata, Osaka 5731121, Japan; [Lim, Ci J.; Yan, Jie] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 119077, Singapore; [Takeyasu, Kunio] Kyoto Univ, Grad Sch Biostudies, Lab Plasma Membrane & Nucl Signaling, Kyoto 6068501, Japan	National University of Singapore; National University of Singapore; National University of Singapore; Shandong University; National University of Singapore; Kyoto University	Takeyasu, K (corresponding author), Kyoto Univ, Grad Sch Biostudies, Lab Plasma Membrane & Nucl Signaling, Kyoto 6068501, Japan.	takeyasu@lif.kyoto-u.ac.jp; phyyj@nus.edu.sg	Qu, Yuanyuan/AAI-8849-2021; Yan, Jie/G-2725-2012; Maruyama, Hugo/E-4141-2010; Maruyama, Hugo/AAS-3342-2020	Qu, Yuanyuan/0000-0001-9134-3567; Yan, Jie/0000-0002-8555-7291; Maruyama, Hugo/0000-0002-2190-7109; Efremov, Artem/0000-0002-1603-610X	Singapore Ministry of Education [MOE2012-T3-1-001, MOE2013-T2-1-154]; Mechanobiology Institute at National University of Singapore; JSPS KAKENHI [26850057]; Grants-in-Aid for Scientific Research [24115003] Funding Source: KAKEN	Singapore Ministry of Education(Ministry of Education, Singapore); Mechanobiology Institute at National University of Singapore(National University of Singapore); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Singapore Ministry of Education Academic Research Fund Tier 3 Grant MOE2012-T3-1-001) and Tier 2 Grant MOE2013-T2-1-154) and the Mechanobiology Institute at National University of Singapore (to J. Y.) and by JSPS KAKENHI Grant 26850057 (to H. M.).	Amit R, 2003, BIOPHYS J, V84, P2467, DOI 10.1016/S0006-3495(03)75051-6; Atomi Haruyuki, 2004, Archaea, V1, P263, DOI 10.1155/2004/204953; Azam TA, 1999, J BIOL CHEM, V274, P33105, DOI 10.1074/jbc.274.46.33105; Azam TA, 1999, J BACTERIOL, V181, P6361, DOI 10.1128/JB.181.20.6361-6370.1999; Bouffartigues E, 2007, NAT STRUCT MOL BIOL, V14, P441, DOI 10.1038/nsmb1233; Bryant Z, 2003, NATURE, V424, P338, DOI 10.1038/nature01810; Cabrera JE, 2003, MOL MICROBIOL, V50, P1493, DOI 10.1046/j.1365-2958.2003.03805.x; CHARBONNIER F, 1994, J BACTERIOL, V176, P1251, DOI 10.1128/jb.176.5.1251-1259.1994; Cunha S, 2001, J STRUCT BIOL, V136, P53, DOI 10.1006/jsbi.2001.4420; Dame RT, 2010, BACTERIAL CHROMATIN, P3, DOI 10.1007/978-90-481-3473-1_1; Dillon SC, 2010, NAT REV MICROBIOL, V8, P185, DOI 10.1038/nrmicro2261; Fishman DM, 1996, BIOPOLYMERS, V38, P535, DOI 10.1002/(SICI)1097-0282(199604)38:4<535::AID-BIP9>3.3.CO;2-H; Forth S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.148301; Fu HX, 2011, CHROMOSOMA, V120, P245, DOI 10.1007/s00412-010-0307-4; Fu HX, 2010, NUCLEIC ACIDS RES, V38, P5594, DOI 10.1093/nar/gkq309; Gosse C, 2002, BIOPHYS J, V82, P3314, DOI 10.1016/S0006-3495(02)75672-5; Grainger DC, 2006, NUCLEIC ACIDS RES, V34, P4642, DOI 10.1093/nar/gkl542; Grummt I, 1999, PROG NUCLEIC ACID RE, V62, P109; Hamiche A, 1998, J BIOL CHEM, V273, P9261, DOI 10.1074/jbc.273.15.9261; Hamiche A, 1996, P NATL ACAD SCI USA, V93, P7588, DOI 10.1073/pnas.93.15.7588; Hancock R, 2004, J STRUCT BIOL, V146, P281, DOI 10.1016/j.jsb.2003.12.008; Hancock R, 2004, BIOL CELL, V96, P595, DOI 10.1016/j.biolcel.2004.05.003; HARRISON SC, 1990, ANNU REV BIOCHEM, V59, P933, DOI 10.1146/annurev.bi.59.070190.004441; HENSEL R, 1988, FEMS MICROBIOL LETT, V49, P75, DOI 10.1111/j.1574-6968.1988.tb02685.x; Ishihama A, 2014, J BACTERIOL, V196, P2718, DOI 10.1128/JB.01579-14; Laurens N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2330; LEIRMO S, 1987, BIOCHEMISTRY-US, V26, P2095, DOI 10.1021/bi00382a006; Lim CJ, 2013, NUCLEIC ACIDS RES, V41, P746, DOI 10.1093/nar/gks1126; Lim CJ, 2012, NUCLEIC ACIDS RES, V40, P3316, DOI 10.1093/nar/gkr1247; Liu YJ, 2010, GENE DEV, V24, P339, DOI 10.1101/gad.1883510; LopezGarcia P, 1997, MOL MICROBIOL, V23, P1267, DOI 10.1046/j.1365-2958.1997.3051668.x; Luger K, 1998, CURR OPIN STRUC BIOL, V8, P33, DOI 10.1016/S0959-440X(98)80007-9; Luijsterburg MS, 2008, CRIT REV BIOCHEM MOL, V43, P393, DOI [10.1080/10409230802528488, 10.1080/10409230802528488 ]; LURZ R, 1986, EMBO J, V5, P3715, DOI 10.1002/j.1460-2075.1986.tb04705.x; Ma J, 2013, SCIENCE, V340, P1580, DOI 10.1126/science.1235441; Marc F, 2002, J BIOL CHEM, V277, P30879, DOI 10.1074/jbc.M203674200; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; Marko JF, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.021926; Maruyama H, 2011, MOL BIOL CELL, V22, P386, DOI 10.1091/mbc.E10-08-0668; Maruyama H, 2013, EMBO REP, V14, P711, DOI 10.1038/embor.2013.94; Morikawa K, 2006, GENES CELLS, V11, P409, DOI 10.1111/j.1365-2443.2006.00949.x; Murphy LD, 1997, J STRUCT BIOL, V119, P336, DOI 10.1006/jsbi.1997.3884; Musgrave D, 2000, MOL MICROBIOL, V35, P341, DOI 10.1046/j.1365-2958.2000.01689.x; Nalabothula N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-391; Noom MC, 2007, CURR BIOL, V17, pR913, DOI 10.1016/j.cub.2007.09.005; Odijk T, 2002, COLLOID SURFACE A, V210, P191, DOI 10.1016/S0927-7757(02)00374-6; Oshima T, 2006, DNA RES, V13, P141, DOI 10.1093/dnares/dsl009; Qu Y, 2013, NUCLEIC ACIDS RES, V41, P5263, DOI 10.1093/nar/gkt249; Sandman K, 2005, CURR OPIN MICROBIOL, V8, P656, DOI 10.1016/j.mib.2005.10.007; Sarkar A, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.051903; Schlingman DJ, 2011, COLLOID SURFACE B, V83, P91, DOI 10.1016/j.colsurfb.2010.11.002; Schnurr Bernhard, 2006, Biophysical Reviews and Letters, V1, P29, DOI 10.1142/S1793048006000021; Sheinin MY, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.108102; Starich MR, 1996, J MOL BIOL, V255, P187, DOI 10.1006/jmbi.1996.0016; Strick TR, 1998, BIOPHYS J, V74, P2016, DOI 10.1016/S0006-3495(98)77908-1; Strick TR, 1996, SCIENCE, V271, P1835, DOI 10.1126/science.271.5257.1835; van Noort J, 2004, P NATL ACAD SCI USA, V101, P6969, DOI 10.1073/pnas.0308230101; Vlijm R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046306; Wang HD, 2002, BIOPHYS J, V83, P3619, DOI 10.1016/S0006-3495(02)75362-9; Wiggins PA, 2006, NAT NANOTECHNOL, V1, P137, DOI 10.1038/nnano.2006.63; Winardhi RS, 2014, J BIOL CHEM, V289, P13739, DOI 10.1074/jbc.M113.545954; Winardhi RS, 2012, NUCLEIC ACIDS RES, V40, P8942, DOI 10.1093/nar/gks669; Wintjens R, 1996, J MOL BIOL, V262, P294, DOI 10.1006/jmbi.1996.0514; Yan J, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.011905; Yan J, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.011905	65	18	18	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15770	15784		10.1074/jbc.M114.626705	http://dx.doi.org/10.1074/jbc.M114.626705			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25931116	Green Published, hybrid			2022-12-28	WOS:000356527400038
J	Jain, A; Rusten, TE; Katheder, N; Elvenes, J; Bruun, JA; Sjottem, E; Lamark, T; Johansen, T				Jain, Ashish; Rusten, Tor Erik; Katheder, Nadja; Elvenes, Julianne; Bruun, Jack-Ansgar; Sjottem, Eva; Lamark, Trond; Johansen, Terje			p62/Sequestosome-1, Autophagy-related Gene 8, and Autophagy in Drosophila Are Regulated by Nuclear Factor Erythroid 2-related Factor 2 (NRF2), Independent of Transcription Factor TFEB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KEAP1-NRF2 PATHWAY; SIGNALING PATHWAY; STRESS-RESPONSE; PB1 DOMAIN; IN-VIVO; PROTEIN; ACTIVATION; P62; DEGRADATION; P62/SQSTM1	The selective autophagy receptor p62/sequestosome 1 (SQSTM1) interacts directly with LC3 and is involved in oxidative stress signaling in two ways in mammals. First, p62 is transcriptionally induced upon oxidative stress by the NF-E2-related factor 2 (NRF2) by direct binding to an antioxidant response element in the p62 promoter. Second, p62 accumulation, occurring when autophagy is impaired, leads to increased p62 binding to the NRF2 inhibitor KEAP1, resulting in reduced proteasomal turnover of NRF2. This gives chronic oxidative stress signaling through a feed forward loop. Here, we show that the Drosophila p62/SQSTM1 orthologue, Ref(2)P, interacts directly with DmAtg8a via an LC3-interacting region motif, supporting a role for Ref(2) P in selective autophagy. The ref(2)P promoter also contains a functional antioxidant response element that is directly bound by the NRF2 orthologue, CncC, which can induce ref(2) P expression along with the oxidative stress-associated gene gstD1. However, distinct from the situation in mammals, Ref(2) P does not interact directly with DmKeap1 via a KEAP1-interacting region motif; nor does ectopically expressed Ref(2) P or autophagy deficiency activate the oxidative stress response. Instead, DmAtg8a interacts directly with DmKeap1, and DmKeap1 is removed upon programmed autophagy in Drosophila gut cells. Strikingly, CncC induced increased Atg8a levels and autophagy independent of TFEB/MitF in fat body and larval gut tissues. Thus, these results extend the intimate relationship between oxidative stress-sensing NRF2/CncC transcription factors and autophagy and suggest that NRF2/CncC may regulate autophagic activity in other organisms too.	[Jain, Ashish; Elvenes, Julianne; Bruun, Jack-Ansgar; Sjottem, Eva; Lamark, Trond; Johansen, Terje] Univ Tromso, Inst Med Biol, Mol Canc Res Grp, N-9037 Tromso, Norway; [Rusten, Tor Erik; Katheder, Nadja] Univ Oslo, Oslo Univ Hosp, Inst Canc Res, Dept Mol Cell Biol, N-0379 Oslo, Norway; [Katheder, Nadja] Univ Oslo, Ctr Canc Biomed, N-0379 Oslo, Norway	UiT The Arctic University of Tromso; University of Oslo; University of Oslo	Rusten, TE (corresponding author), Univ Oslo, Oslo Univ Hosp, Inst Canc Res, Dept Mol Cell Biol,Ctr Canc Biomed, N-0379 Oslo, Norway.	tor.erik.rusten@rr-research.no; terje.johansen@uit.no	Jain, Ashish/H-7356-2017; Johansen, Terje/N-2971-2015; Johansen, Terje/AAY-1753-2021	Jain, Ashish/0000-0001-6549-2788; Johansen, Terje/0000-0003-1451-9578; Johansen, Terje/0000-0003-1451-9578; Rusten, Tor Erik/0000-0002-9150-2676; Katheder, Nadja/0000-0003-0460-0938; Sjottem, Eva/0000-0003-2668-1708; Lamark, Trond/0000-0001-6338-3342; Bruun, Jack-Ansgar/0000-0003-0614-2790	Norwegian Research Council [196898, 214448]; Norwegian Cancer Society [71043-PR-2006-0320]; Research Council of Norway through its Centres of Excellence funding scheme [179571]; Norwegian Cancer Society	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway through its Centres of Excellence funding scheme; Norwegian Cancer Society(Norwegian Cancer Society)	This work was supported by grants from the FRIBIO and FRIBIOMED programs of the Norwegian Research Council (Grants 196898 and 214448) and Norwegian Cancer Society Grant 71043-PR-2006-0320 (to T.J.); partly supported by the Research Council of Norway through its Centres of Excellence funding scheme, project number 179571 (to T. E. R., awarded to Harald Stenmark); and supported by The Norwegian Cancer Society (T. E. R. and N. K.).	An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Avila A, 2002, MOL CELL BIOL, V22, P8787, DOI 10.1128/MCB.22.24.8787-8795.2002; Bartlett BJ, 2011, AUTOPHAGY, V7, P572, DOI 10.4161/auto.7.6.14943; Birgisdottir AB, 2013, J CELL SCI, V126, P3237, DOI 10.1242/jcs.126128; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boehm AK, 2003, MOL CELL BIOL, V23, P7628, DOI 10.1128/MCB.23.21.7628-7637.2003; Carre-Mouka A, 2007, GENETICS, V176, P409, DOI 10.1534/genetics.106.063826; Cazanave SC, 2014, CELL DEATH DIFFER, V21, P1303, DOI 10.1038/cdd.2014.49; Chang TK, 2013, NAT CELL BIOL, V15, P1067, DOI 10.1038/ncb2804; Chang YY, 2009, MOL BIOL CELL, V20, P2004, DOI 10.1091/mbc.E08-12-1250; Chatterjee N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034063; Clausen TH, 2010, AUTOPHAGY, V6, P330, DOI 10.4161/auto.6.3.11226; CONTAMINE D, 1989, GENETICS, V123, P525; de Castro P, 2012, CELL DEATH DIFFER, V19, P1308, DOI 10.1038/cdd.2012.5; Denton D, 2012, CELL DEATH DIFFER, V19, P1299, DOI 10.1038/cdd.2012.43; DEZELEE S, 1989, EMBO J, V8, P3437, DOI 10.1002/j.1460-2075.1989.tb08508.x; Dhakshinamoorthy S, 2001, ONCOGENE, V20, P3906, DOI 10.1038/sj.onc.1204506; Fan WL, 2010, AUTOPHAGY, V6, P614, DOI 10.4161/auto.6.5.12189; Galluzzi L, 2015, EMBO J, V34, P856, DOI 10.15252/embj.201490784; Genau HM, 2015, MOL CELL, V57, P995, DOI 10.1016/j.molcel.2014.12.040; Grimberg KB, 2011, MOL CELL BIOL, V31, P897, DOI 10.1128/MCB.00799-10; Hallsson JH, 2004, GENETICS, V167, P233, DOI 10.1534/genetics.167.1.233; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Hegedus K, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/470482; Ichimura Y, 2013, MOL CELL, V51, P618, DOI 10.1016/j.molcel.2013.08.003; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Ishii T, 1997, BIOCHEM BIOPH RES CO, V232, P33, DOI 10.1006/bbrc.1997.6221; Ishimura R, 2014, FEBS LETT, V588, P822, DOI 10.1016/j.febslet.2014.01.045; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Jaiswal AK, 2004, METHOD ENZYMOL, V378, P221; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kalvari I, 2014, AUTOPHAGY, V10, P913, DOI 10.4161/auto.28260; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Kobayashi M, 2002, GENES CELLS, V7, P807, DOI 10.1046/j.1365-2443.2002.00561.x; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; Lau A, 2010, MOL CELL BIOL, V30, P3275, DOI 10.1128/MCB.00248-10; Lee OH, 2007, J BIOL CHEM, V282, P36412, DOI 10.1074/jbc.M706517200; Ling JH, 2012, CANCER CELL, V21, P105, DOI 10.1016/j.ccr.2011.12.006; Mathers J, 2004, BIOCHEM SOC SYMP, V71, P157, DOI 10.1042/bss0710157; McGinnis N, 1998, DEVELOPMENT, V125, P4553; McMahon M, 2001, CANCER RES, V61, P3299; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; Misra JR, 2013, INSECT BIOCHEM MOLEC, V43, P1116, DOI 10.1016/j.ibmb.2013.09.005; Misra JR, 2011, GENE DEV, V25, P1796, DOI 10.1101/gad.17280911; MOHLER J, 1991, MECH DEVELOP, V34, P3, DOI 10.1016/0925-4773(91)90086-L; MOHLER J, 1995, DEVELOPMENT, V121, P237; Moscat J, 2007, TRENDS BIOCHEM SCI, V32, P95, DOI 10.1016/j.tibs.2006.12.002; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Motohashi H, 2002, GENE, V294, P1, DOI 10.1016/S0378-1119(02)00788-6; Mueller TD, 2002, J MOL BIOL, V319, P1243, DOI 10.1016/S0022-2836(02)00302-9; Mulakkal NC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/273473; Nagy P, 2014, FEBS LETT, V588, P408, DOI 10.1016/j.febslet.2013.12.012; Nagy P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003664; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Nezis IP, 2008, J CELL BIOL, V180, P1065, DOI 10.1083/jcb.200711108; Nezis Ioannis P, 2012, Int J Cell Biol, V2012, P146767, DOI 10.1155/2012/146767; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Noda NN, 2008, GENES CELLS, V13, P1211, DOI 10.1111/j.1365-2443.2008.01238.x; Ohtsubo T, 1999, CELL DEATH DIFFER, V6, P865, DOI 10.1038/sj.cdd.4400566; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pircs K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044214; Sawicki R, 2003, BIOCHEM J, V370, P661, DOI 10.1042/BJ20021287; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shravage BV, 2013, DEVELOPMENT, V140, P1321, DOI 10.1242/dev.089490; Shvets E, 2008, J CELL SCI, V121, P2685, DOI 10.1242/jcs.026005; Sjottem E, 2007, NUCLEIC ACIDS RES, V35, P6648, DOI 10.1093/nar/gkm739; Svenning S, 2011, AUTOPHAGY, V7, P993, DOI 10.4161/auto.7.9.16389; Sykiotis GP, 2008, DEV CELL, V14, P76, DOI 10.1016/j.devcel.2007.12.002; Sykiotis GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112re3; Taguchi K, 2012, P NATL ACAD SCI USA, V109, P13561, DOI 10.1073/pnas.1121572109; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Tang HW, 2013, DEV CELL, V27, P489, DOI 10.1016/j.devcel.2013.10.017; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Wang WP, 2007, J BIOL CHEM, V282, P24670, DOI 10.1074/jbc.M700159200; Wilson MI, 2003, MOL CELL, V12, P39, DOI 10.1016/S1097-2765(03)00246-6; Wu H, 2009, MECH DEVELOP, V126, P624, DOI 10.1016/j.mod.2009.06.1082; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014	81	45	48	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					14945	14962		10.1074/jbc.M115.656116	http://dx.doi.org/10.1074/jbc.M115.656116			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25931115	hybrid, Green Published			2022-12-28	WOS:000356177300013
J	Brenig, J; de Boor, S; Knyphausen, P; Kuhlmann, N; Wroblowski, S; Baldus, L; Scislowski, L; Artz, O; Trauschies, P; Baumann, U; Neundorf, I; Lammers, M				Brenig, Julian; de Boor, Susanne; Knyphausen, Philipp; Kuhlmann, Nora; Wroblowski, Sarah; Baldus, Linda; Scislowski, Lukas; Artz, Oliver; Trauschies, Philip; Baumann, Ulrich; Neundorf, Ines; Lammers, Michael			Structural and Biochemical Basis for the Inhibitory Effect of Liprin-alpha 3 on Mouse Diaphanous 1 (mDia1) Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORMIN HOMOLOGY-2 DOMAIN; ACTIN-FILAMENT ELONGATION; LIPRIN-ALPHA PROTEINS; AUTOREGULATORY DOMAIN; STRUCTURE VALIDATION; INDUCED NUCLEATION; CRYSTAL-STRUCTURES; COILED COILS; FH1 DOMAIN; BINDING	Diaphanous-related formins are eukaryotic actin nucleation factors regulated by an autoinhibitory interaction between the N-terminal RhoGTPase-binding domain (mDia(N)) and the C-terminal Diaphanous-autoregulatory domain (DAD). Although the activation of formins by Rho proteins is well characterized, its inactivation is only marginally understood. Recently, liprin-alpha 3 was shown to interact with mDia1. Overexpression of liprin-alpha 3 resulted in a reduction of the cellular actin filament content. The molecular mechanisms of how liprin-alpha 3 exerts this effect and counteracts mDia1 activation by RhoA are unknown. Here, we functionally and structurally define a minimal liprin-alpha 3 core region, sufficient to recapitulate the liprin-alpha 3 determined mDia1-respective cellular functions. We show that liprin-alpha 3 alters the interaction kinetics and thermodynamics of mDia(N) with RhoA center dot GTP and DAD. RhoA displaces liprin-alpha 3 allosterically, whereas DAD competes with liprin-alpha 3 for a highly overlapping binding site on mDia(N). Liprin-alpha 3 regulates actin polymerization by lowering the regulatory potency of RhoA and DAD on mDia(N). We present a model of a mechanistically unexplored and new aspect of mDia(N) regulation by liprin-alpha 3.	[Brenig, Julian; de Boor, Susanne; Knyphausen, Philipp; Kuhlmann, Nora; Wroblowski, Sarah; Baldus, Linda; Scislowski, Lukas; Artz, Oliver; Trauschies, Philip; Lammers, Michael] Univ Cologne, Inst Genet, Joseph Stelzmann Str 26, D-50931 Cologne, Germany; [Brenig, Julian; de Boor, Susanne; Knyphausen, Philipp; Kuhlmann, Nora; Wroblowski, Sarah; Baldus, Linda; Scislowski, Lukas; Artz, Oliver; Trauschies, Philip; Lammers, Michael] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Baumann, Ulrich; Neundorf, Ines] Univ Cologne, Inst Biochem, D-50674 Cologne, Germany	University of Cologne; University of Cologne; University of Cologne	Lammers, M (corresponding author), Univ Cologne, Inst Genet, Joseph Stelzmann Str 26, D-50931 Cologne, Germany.	michael.lammers@uni-koeln.de	Artz, Oliver/AAZ-8384-2021; Baumann, Ulrich/B-1220-2013; Lammers, Michael/AAX-1164-2020	Artz, Oliver/0000-0002-5708-1281; Lammers, Michael/0000-0003-4168-4640; Neundorf, Ines/0000-0001-6450-3991	European BIOSTRUCTX_5870	European BIOSTRUCTX_5870	We thank the beamline groups at the SLS Villingen/Switzerland, whose outstanding efforts have made these experiments possible. Support by the European BIOSTRUCTX_5870 is gratefully acknowledged. We thank the ESRF/Grenoble for being able to perform and support the first BioSAXS measurements at beamline BM29 ( BAG: MX-1479). We thank Anncharlott Berglar for the design of the graphical abstract and Astrid Schauss and Nikolay Kladt (CECAD Imaging Facility) for critical discussions of the cell biological experiments. Wealso thank Prof. Dr. A. Wittinghofer for providing the RhoA and mDia constructs.	Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Astigarraga S, 2010, J NEUROSCI, V30, P15358, DOI 10.1523/JNEUROSCI.1862-10.2010; Astro V, 2011, ONCOGENE, V30, P1841, DOI 10.1038/onc.2010.562; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bogdan Sven, 2013, Commun Integr Biol, V6, pe27634, DOI 10.4161/cib.27634; Brandt DT, 2007, J CELL BIOL, V178, P193, DOI 10.1083/jcb.200612071; Breitsprecher D, 2012, SCIENCE, V336, P1164, DOI 10.1126/science.1218062; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Courtemanche N, 2012, J BIOL CHEM, V287, P7812, DOI 10.1074/jbc.M111.322958; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Graham DL, 1999, BIOCHEMISTRY-US, V38, P985, DOI 10.1021/bi9821770; Higgs HN, 2005, MOL BIOL CELL, V16, P1, DOI 10.1091/mbc.E04-07-0565; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Kovar DR, 2004, NAT CELL BIOL, V6, P1158, DOI 10.1038/ncb1204-1158; Kuhn Sonja, 2014, Small GTPases, V5, pe29513, DOI 10.4161/sgtp.29513; Lammers M, 2005, EMBO J, V24, P4176, DOI 10.1038/sj.emboj.7600879; Lammers M, 2008, J BIOL CHEM, V283, P35236, DOI 10.1074/jbc.M805634200; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Li F, 2005, J BIOL CHEM, V280, P6986, DOI 10.1074/jbc.M411605200; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Machaidze G, 2010, J MOL BIOL, V403, P529, DOI 10.1016/j.jmb.2010.09.017; Maiti S, 2012, CYTOSKELETON, V69, P393, DOI 10.1002/cm.21033; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nachat R, 2009, J CELL SCI, V122, P4035, DOI 10.1242/jcs.047266; Neidt EM, 2009, J BIOL CHEM, V284, P673, DOI 10.1074/jbc.M804201200; Nezami A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012992; Nomura H, 2011, IMMUNOL LETT, V139, P110, DOI 10.1016/j.imlet.2011.05.010; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Paul A, 2008, CURR BIOL, V18, P9, DOI 10.1016/j.cub.2007.11.062; Pring M, 2003, BIOCHEMISTRY-US, V42, P486, DOI 10.1021/bi026520j; PULIDO R, 1995, P NATL ACAD SCI USA, V92, P11686, DOI 10.1073/pnas.92.25.11686; Ramalingam N, 2010, EUR J CELL BIOL, V89, P723, DOI 10.1016/j.ejcb.2010.06.001; Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604; Sakamoto Satoko, 2012, Bioarchitecture, V2, P43; Sakamoto S, 2012, J CELL SCI, V125, P108, DOI 10.1242/jcs.087411; Schonichen A, 2010, BBA-MOL CELL RES, V1803, P152, DOI 10.1016/j.bbamcr.2010.01.014; Schulte A, 2008, STRUCTURE, V16, P1313, DOI 10.1016/j.str.2008.06.008; Serra-Pages C, 1998, J BIOL CHEM, V273, P15611, DOI 10.1074/jbc.273.25.15611; Seth A, 2006, J CELL BIOL, V174, P701, DOI 10.1083/jcb.200605006; Shannon Katie B, 2012, Int J Cell Biol, V2012, P894817, DOI 10.1155/2012/894817; Shimada A, 2004, MOL CELL, V13, P511, DOI 10.1016/S1097-2765(04)00059-0; Sigurskjold BW, 2000, ANAL BIOCHEM, V277, P260, DOI 10.1006/abio.1999.4402; Spangler SA, 2007, BIOCHEM SOC T, V35, P1278, DOI 10.1042/BST0351278; Spangler SA, 2011, J COMP NEUROL, V519, P3040, DOI 10.1002/cne.22665; Steller I, 1997, J APPL CRYSTALLOGR, V30, P1036, DOI 10.1107/S0021889897008777; Sydor JR, 1998, BIOCHEMISTRY-US, V37, P14292, DOI 10.1021/bi980764f; Taru H, 2011, J NEUROSCI, V31, P16261, DOI 10.1523/JNEUROSCI.0002-11.2011; Vijayakumar M, 1998, J MOL BIOL, V278, P1015, DOI 10.1006/jmbi.1998.1747; Wallar BJ, 2006, J BIOL CHEM, V281, P4300, DOI 10.1074/jbc.M510277200; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Wei ZY, 2011, MOL CELL, V43, P586, DOI 10.1016/j.molcel.2011.07.021; Westendorf JJ, 1999, GENE, V232, P173, DOI 10.1016/S0378-1119(99)00127-4; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886; Zigmond SH, 2003, CURR BIOL, V13, P1820, DOI 10.1016/j.cub.2003.09.057; Zigmond SH, 2004, CURR OPIN CELL BIOL, V16, P99, DOI 10.1016/j.ceb.2003.10.019; Zurner M, 2011, J COMP NEUROL, V519, P3019, DOI 10.1002/cne.22664	65	6	6	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14314	14327		10.1074/jbc.M114.621946	http://dx.doi.org/10.1074/jbc.M114.621946			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25911102	Green Published, hybrid			2022-12-28	WOS:000355754600005
J	Kahn, TB; Fernandez, JM; Perez-Jimenez, R				Kahn, Thomas B.; Fernandez, Julio M.; Perez-Jimenez, Raul			Monitoring Oxidative Folding of a Single Protein Catalyzed by the Disulfide Oxidoreductase DsbA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORMATION IN-VIVO; ESCHERICHIA-COLI; BOND FORMATION; THIOREDOXIN CATALYSIS; SUBSTRATE-SPECIFICITY; SHIGELLA-FLEXNERI; VIRULENCE FACTORS; CRYSTAL-STRUCTURE; OUTER-MEMBRANE; SECRETION	Oxidative folding, the process by which proteins fold and acquire disulfide bonds concurrently, is of critical importance for a wide range of biological processes. Generally, this process is catalyzed by oxidoreductase enzymes that facilitate oxidation and also bear chaperone functionality. Although this process has been well described qualitatively, fine yet important details remain obscured by a limited quantitative perspective, arising from the limitations in the application of bulk biochemical methods to the study of oxidative folding. In this work, we have applied single molecule force spectroscopy techniques to monitor in real time the process of oxidative folding as catalyzed by DsbA, the enzyme solely responsible for the catalysis of oxidative folding in the bacterial periplasm. We provide a quantitative and detailed description of the catalytic mechanism utilized by DsbA that offers insight into the entire sequence of events that occurs in the periplasm from the unfolded-reduced state to the folded-oxidized protein. We have compared our results with those of protein disulfide-isomerase, the eukaryotic counterpart of DsbA, allowing us to devise a general mechanism for oxidative folding that also reflects upon the physiological functions and demands of these enzymes in vivo.	[Kahn, Thomas B.] Columbia Univ, Med Ctr, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Fernandez, Julio M.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Perez-Jimenez, Raul] Ctr Invest Cooperat CIC NanoGUNE, Donostia San Sebastian 20018, Spain; [Perez-Jimenez, Raul] Basque Fdn Sci, Ikerbasque, Bilbao 48013, Spain	Columbia University; Columbia University; Basque Foundation for Science	Perez-Jimenez, R (corresponding author), CIC NanoGUNE, Tolosa Hiribidea 76, San Sebastian 20018, Spain.	r.perezjimenez@nanogune.eu	Perez-Jimenez, Raul/C-3085-2017; Regan, Clinton/E-6250-2012	Perez-Jimenez, Raul/0000-0001-7094-6799; nanoGUNE, CIC/0000-0001-7874-5254	National Institutes of Health [T32GM008281, HL061228]; National Science Foundation [DBI-1252857]; Spanish Ministry of Economy and Competitiveness [BIO2013-46163-R]; European Commission Marie Curie Actions Grant [CIG 631704]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008281] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Spanish Ministry of Economy and Competitiveness(Spanish Government); European Commission Marie Curie Actions Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants T32GM008281 (to T. B. K.) and HL061228 (to J. M. F.). This work was also supported by National Science Foundation Grant DBI-1252857 (to J. M. F.), Spanish Ministry of Economy and Competitiveness Grant BIO2013-46163-R (to R. P.-J.), and European Commission Marie Curie Actions Grant CIG 631704 (to R. P.-J.).	Ainavarapu RK, 2007, BIOPHYS J, V92, P225, DOI 10.1529/biophysj.106.091561; Alegre-Cebollada J, 2011, NAT CHEM, V3, P882, DOI [10.1038/NCHEM.1155, 10.1038/nchem.1155]; Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Berkmen M, 2012, PROTEIN EXPRES PURIF, V82, P240, DOI 10.1016/j.pep.2011.10.009; Bringer MA, 2007, J BACTERIOL, V189, P4860, DOI 10.1128/JB.00233-07; CAMACHO CJ, 1995, PROTEINS, V22, P27, DOI 10.1002/prot.340220105; Coulthurst SJ, 2008, J BIOL CHEM, V283, P23739, DOI 10.1074/jbc.M801829200; Crespo MD, 2012, NAT CHEM BIOL, V8, P707, DOI [10.1038/NCHEMBIO.1019, 10.1038/nchembio.1019]; DAILEY FE, 1993, P NATL ACAD SCI USA, V90, P1043, DOI 10.1073/pnas.90.3.1043; Dutton RJ, 2008, P NATL ACAD SCI USA, V105, P11933, DOI 10.1073/pnas.0804621105; FLORIN EL, 1995, BIOSENS BIOELECTRON, V10, P895, DOI 10.1016/0956-5663(95)99227-C; Grandbois M, 1999, SCIENCE, V283, P1727, DOI 10.1126/science.283.5408.1727; Guddat LW, 1998, STRUCT FOLD DES, V6, P757, DOI 10.1016/S0969-2126(98)00077-X; Ha UH, 2003, INFECT IMMUN, V71, P1590, DOI 10.1128/IAI.71.3.1590-1595.2003; Heras B, 2009, NAT REV MICROBIOL, V7, P215, DOI 10.1038/nrmicro2087; Hiniker A, 2004, J BIOL CHEM, V279, P12967, DOI 10.1074/jbc.M311391200; Jackson MW, 1999, J BACTERIOL, V181, P5126, DOI 10.1128/JB.181.16.5126-5130.1999; JACOBDUBUISSON F, 1994, P NATL ACAD SCI USA, V91, P11552, DOI 10.1073/pnas.91.24.11552; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; KOSHLAND D, 1980, CELL, V20, P749, DOI 10.1016/0092-8674(80)90321-9; Kosuri P, 2012, CELL, V151, P794, DOI 10.1016/j.cell.2012.09.036; Kurth F, 2014, J BIOL CHEM, V289, P19810, DOI 10.1074/jbc.M114.552380; LUNDSTROM J, 1993, BIOCHEMISTRY-US, V32, P6649, DOI 10.1021/bi00077a018; LUNDSTROM J, 1990, J BIOL CHEM, V265, P9114; Manting EH, 2000, MOL MICROBIOL, V37, P226, DOI 10.1046/j.1365-2958.2000.01980.x; MARTIN JL, 1993, NATURE, V365, P464, DOI 10.1038/365464a0; Paxman JJ, 2009, J BIOL CHEM, V284, P17835, DOI 10.1074/jbc.M109.011502; Perez-Jimenez R, 2009, NAT STRUCT MOL BIOL, V16, P890, DOI 10.1038/nsmb.1627; Rietsch A, 1996, P NATL ACAD SCI USA, V93, P13048, DOI 10.1073/pnas.93.23.13048; Sezonov G, 2007, J BACTERIOL, V189, P8746, DOI 10.1128/JB.01368-07; Stenson TH, 2002, INFECT IMMUN, V70, P2297, DOI 10.1128/IAI.70.5.2297-2303.2002; Thanassi DG, 2000, CURR OPIN CELL BIOL, V12, P420, DOI 10.1016/S0955-0674(00)00111-3; WATARAI M, 1995, P NATL ACAD SCI USA, V92, P4927, DOI 10.1073/pnas.92.11.4927; Watson WH, 2003, J BIOL CHEM, V278, P33408, DOI 10.1074/jbc.M211107200; Wedemeyer WJ, 2000, BIOCHEMISTRY-US, V39, P4207, DOI 10.1021/bi992922o; Welker E, 2001, BIOCHEMISTRY-US, V40, P9059, DOI 10.1021/bi010409g; Wiita AP, 2007, NATURE, V450, P124, DOI 10.1038/nature06231; Wiita AP, 2006, P NATL ACAD SCI USA, V103, P7222, DOI 10.1073/pnas.0511035103; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; WUNDERLICH M, 1993, PROTEIN SCI, V2, P717, DOI 10.1002/pro.5560020503; Yu J, 1998, INFECT IMMUN, V66, P3909, DOI 10.1128/IAI.66.8.3909-3917.1998	43	19	19	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14518	14527		10.1074/jbc.M115.646000	http://dx.doi.org/10.1074/jbc.M115.646000			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25897077	Green Published, hybrid			2022-12-28	WOS:000355754600023
J	Dong, Q; Ernst, SE; Ostedgaard, LS; Shah, VS; Heul, ARV; Welsh, MJ; Randak, CO				Dong, Qian; Ernst, Sarah E.; Ostedgaard, Lynda S.; Shah, Viral S.; Heul, Amanda R. Ver; Welsh, Michael J.; Randak, Christoph O.			Mutating the Conserved Q-loop Glutamine 1291 Selectively Disrupts Adenylate Kinase-dependent Channel Gating of the ATP-binding Cassette (ABC) Adenylate Kinase Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and Reduces Channel Function in Primary Human Airway Epithelia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CL-CHANNEL; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; CHLORIDE CHANNEL; IN-VITRO; SUBSTRATE-SPECIFICITY; CATALYTIC CYCLE; MOLECULAR-BASIS; P-GLYCOPROTEIN; REQUIRES ATP	The ATP-binding cassette (ABC) transporter cystic fibrosis transmembrane conductance regulator (CFTR) and two other non-membrane-bound ABC proteins, Rad50 and a structural maintenance of chromosome (SMC) protein, exhibit adenylate kinase activity in the presence of physiologic concentrations of ATP and AMP or ADP (ATP + AMP reversible arrow 2 ADP). The crystal structure of the nucleotide-binding domain of an SMC protein in complex with the adenylate kinase bisubstrate inhibitor P-1, P-5-di(adenosine-5') pentaphosphate (Ap(5)A) suggests that AMP binds to the conserved Q-loop glutamine during the adenylate kinase reaction. Therefore, we hypothesized that mutating the corresponding residue in CFTR, Gln-1291, selectively disrupts adenylate kinase-dependent channel gating at physiologic nucleotide concentrations. We found that substituting Gln-1291 with bulky side-chain amino acids abolished the effects of Ap(5)A, AMP, and adenosine 5'-monophosphoramidate on CFTR channel function. 8-Azidoadenosine 5'-monophosphate photolabeling of the AMP-binding site and adenylate kinase activity were disrupted in Q1291F CFTR. The Gln-1291 mutations did not alter the potency of ATP at stimulating current or ATP-dependent gating when ATP was the only nucleotide present. However, when physiologic concentrations of ADP and AMP were added, adenylate kinase-deficient Q1291F channels opened significantly less than wild type. Consistent with this result, we found that Q1291F CFTR displayed significantly reduced Cl- channel function in well differentiated primary human airway epithelia. These results indicate that a highly conserved residue of an ABC transporter plays an important role in adenylate kinase-dependent CFTR gating. Furthermore, the results suggest that adenylate kinase activity is important for normal CFTR channel function in airway epithelia.	[Dong, Qian; Heul, Amanda R. Ver; Randak, Christoph O.] Univ Iowa, Stead Family Dept Pediat, Iowa City, IA 52242 USA; [Ernst, Sarah E.; Ostedgaard, Lynda S.; Welsh, Michael J.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Shah, Viral S.; Welsh, Michael J.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Shah, Viral S.] Univ Iowa, Med Scientist Training Program, Iowa City, IA 52242 USA; [Ernst, Sarah E.; Welsh, Michael J.] Howard Hughes Med Inst, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; Howard Hughes Medical Institute	Randak, CO (corresponding author), Univ Iowa, Stead Family Dept Pediat, 6336 PBDB, Iowa City, IA 52242 USA.	chris-toph-randak@uiowa.edu	Regan, Clinton/E-6250-2012	Welsh, Michael/0000-0002-1646-6206; Ostedgaard, Lynda/0000-0001-7717-3442; Randak, Christoph/0000-0003-3264-4137	National Institutes of Health [K08HL097071, HL51670, HL091842]; Cystic Fibrosis Foundation [RANDAK09Q0]; Harry Shwachman Cystic Fibrosis Clinical Investigator Award; Parker B. Francis Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL097071, P01HL091842, P01HL051670] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Harry Shwachman Cystic Fibrosis Clinical Investigator Award; Parker B. Francis Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants K08HL097071 (to C. O. R.) and HL51670 and HL091842 (to M. J. W.). This work was also supported by Cystic Fibrosis Foundation Grant RANDAK09Q0.; Recipient of a Harry Shwachman Cystic Fibrosis Clinical Investigator Award and of a Parker B. Francis Fellowship. To whom correspondence should be addressed: Stead Family Dept. of Pediatrics, University of Iowa, 6336 PBDB, Iowa City, IA 52242. Tel.: 319-335-6540; Fax: 319-335-7623; E-mail: christoph-randak@uiowa.edu.	Aleksandrov AA, 2007, PFLUG ARCH EUR J PHY, V453, P693, DOI 10.1007/s00424-006-0140-z; AMES GF, 1992, ADV ENZYMOL RAMB, V65, P1; ANDERSON MP, 1992, SCIENCE, V257, P1701, DOI 10.1126/science.1382316; ANDERSON MP, 1991, CELL, V67, P775, DOI 10.1016/0092-8674(91)90072-7; Baker MD, 2006, BIOCHEMISTRY-US, V45, P416, DOI 10.1021/bi0518592; Berger AL, 2005, P NATL ACAD SCI USA, V102, P455, DOI 10.1073/pnas.0408575102; Berger AL, 2002, J BIOL CHEM, V277, P2125, DOI 10.1074/jbc.M109539200; BERRY MB, 1994, PROTEINS, V19, P183, DOI 10.1002/prot.340190304; Bhaskara V, 2007, MOL CELL, V25, P647, DOI 10.1016/j.molcel.2007.01.028; Bianchet MA, 1997, J BIOENERG BIOMEMBR, V29, P503, DOI 10.1023/A:1022443209010; Bompadre SG, 2005, J GEN PHYSIOL, V125, P361, DOI 10.1085/jgp.200409227; Boyer P.D, 1973, ENZYMES, P279; BOZZI A, 1994, BIOCHEM MOL BIOL INT, V32, P95; Cant N, 2014, INT J BIOCHEM CELL B, V52, P15, DOI 10.1016/j.biocel.2014.02.004; CARSON MR, 1995, J BIOL CHEM, V270, P1711, DOI 10.1074/jbc.270.4.1711; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Chen JH, 2010, CELL, V143, P911, DOI 10.1016/j.cell.2010.11.029; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Cheung JC, 2008, ARCH BIOCHEM BIOPHYS, V476, P95, DOI 10.1016/j.abb.2008.03.033; Cotten JF, 1998, J BIOL CHEM, V273, P31873, DOI 10.1074/jbc.273.48.31873; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Dong Q, 2008, BIOPHYS J, V95, P5178, DOI 10.1529/biophysj.108.140897; Dong Q, 2012, P NATL ACAD SCI USA, V109, P917, DOI 10.1073/pnas.1120065109; DORK T, 1994, HUM GENET, V94, P533; Drakou CE, 2012, PROTEINS, V80, P206, DOI 10.1002/prot.23186; Frederich M, 2002, J BIOL CHEM, V277, P1928, DOI 10.1074/jbc.M107128200; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; GREGORY RJ, 1990, NATURE, V347, P382, DOI 10.1038/347382a0; GUNDERSON KL, 1995, CELL, V82, P231, DOI 10.1016/0092-8674(95)90310-0; GUNDERSON KL, 1994, J BIOL CHEM, V269, P19349; Hanrahan JW, 2003, ABC PROTEINS BACTERI, P589; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; HWANG TC, 1994, P NATL ACAD SCI USA, V91, P4698, DOI 10.1073/pnas.91.11.4698; Hwang TC, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009498; Hwang TC, 2009, J PHYSIOL-LONDON, V587, P2151, DOI 10.1113/jphysiol.2009.171595; Janas E, 2003, J BIOL CHEM, V278, P26862, DOI 10.1074/jbc.M301227200; Karp Philip H, 2002, Methods Mol Biol, V188, P115; Karpowich N, 2001, STRUCTURE, V9, P571, DOI 10.1016/S0969-2126(01)00617-7; KARTNER N, 1992, NAT GENET, V1, P321, DOI 10.1038/ng0892-321; Kennedy HJ, 1999, J BIOL CHEM, V274, P13281, DOI 10.1074/jbc.274.19.13281; Kumar K, 2003, BIOCHEM BIOPH RES CO, V300, P81, DOI 10.1016/S0006-291X(02)02800-0; Lammens A, 2004, CURR BIOL, V14, P1778, DOI 10.1016/j.cub.2004.09.044; Lammens A, 2010, J MOL BIOL, V401, P265, DOI 10.1016/j.jmb.2010.06.029; LIENHARD GE, 1973, J BIOL CHEM, V248, P1121; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Lowe J, 2001, J MOL BIOL, V306, P25, DOI 10.1006/jmbi.2000.4379; LUKACS GL, 1994, EMBO J, V13, P6076, DOI 10.1002/j.1460-2075.1994.tb06954.x; MALAISSE WJ, 1987, BIOCHIM BIOPHYS ACTA, V927, P190, DOI 10.1016/0167-4889(87)90134-0; Mall M, 2004, GASTROENTEROLOGY, V126, P32, DOI 10.1053/j.gastro.2003.10.049; Mathews CJ, 1998, J MEMBRANE BIOL, V163, P55, DOI 10.1007/s002329900370; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; Muanprasat C, 2004, J GEN PHYSIOL, V124, P125, DOI 10.1085/jgp.200409059; MULLER CW, 1992, J MOL BIOL, V224, P159, DOI 10.1016/0022-2836(92)90582-5; MULLERDIECKMANN HJ, 1995, J MOL BIOL, V246, P522; Oldham ML, 2011, P NATL ACAD SCI USA, V108, P15152, DOI 10.1073/pnas.1108858108; Olson LK, 1996, J BIOL CHEM, V271, P16544, DOI 10.1074/jbc.271.28.16544; OSTEDGAARD LS, 1992, J BIOL CHEM, V267, P26142; Ostedgaard LS, 2002, P NATL ACAD SCI USA, V99, P3093, DOI 10.1073/pnas.261714599; Ostedgaard LS, 2007, P NATL ACAD SCI USA, V104, P15370, DOI 10.1073/pnas.0706974104; Polshakov D, 2005, BIOCHEMISTRY-US, V44, P11241, DOI 10.1021/bi050859z; POTTER RL, 1983, METHOD ENZYMOL, V91, P613; Pucar D, 2002, AM J PHYSIOL-HEART C, V283, pH776, DOI 10.1152/ajpheart.00116.2002; Randak C, 2003, CELL, V115, P837, DOI 10.1016/S0092-8674(03)00983-8; Randak CO, 2007, J BIOENERG BIOMEMBR, V39, P473, DOI 10.1007/s10863-007-9119-5; Randak CO, 2013, J BIOL CHEM, V288, P27692, DOI 10.1074/jbc.M113.479675; Randak CO, 2012, J BIOL CHEM, V287, P36105, DOI 10.1074/jbc.M112.408450; Randak CO, 2005, P NATL ACAD SCI USA, V102, P2216, DOI 10.1073/pnas.0409787102; Ren H, 2005, P NATL ACAD SCI USA, V102, P303, DOI 10.1073/pnas.0407459102; Scheffzek K, 1996, BIOCHEMISTRY-US, V35, P9716, DOI 10.1021/bi960642s; SCHULTZ BD, 1995, J GEN PHYSIOL, V105, P329, DOI 10.1085/jgp.105.3.329; SCHULZ GE, 1992, FARADAY DISCUSS, V93, P85, DOI 10.1039/fd9929300085; SHEPPARD DN, 1994, CELL, V76, P1091, DOI 10.1016/0092-8674(94)90385-9; SHYAMALA V, 1991, J BIOL CHEM, V266, P18714; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Urbatsch IL, 2000, BIOCHEMISTRY-US, V39, P11921, DOI 10.1021/bi001220s; Urbatsch IL, 2000, BIOCHEMISTRY-US, V39, P14138, DOI 10.1021/bi001128w; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WARD CL, 1994, J BIOL CHEM, V269, P25710; Weinreich F, 1999, J GEN PHYSIOL, V114, P55, DOI 10.1085/jgp.114.1.55; Yan HG, 1999, ADV ENZYMOL RAMB, V73, P103, DOI 10.1002/9780470123195.ch4; Yang RY, 2011, BBA-BIOMEMBRANES, V1808, P1790, DOI 10.1016/j.bbamem.2011.02.004; Zabner J, 1998, MOL CELL, V2, P397, DOI 10.1016/S1097-2765(00)80284-1; ZELEZNIKAR RJ, 1995, J BIOL CHEM, V270, P7311, DOI 10.1074/jbc.270.13.7311; Zolnerciks JK, 2014, FASEB J, V28, P4335, DOI 10.1096/fj.13-245639	87	10	10	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					14140	14153		10.1074/jbc.M114.611616	http://dx.doi.org/10.1074/jbc.M114.611616			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25887396	hybrid, Green Published			2022-12-28	WOS:000355313000042
J	Ha, BH; Morse, EM; Turk, BE; Boggon, TJ				Ha, Byung Hak; Morse, Elizabeth M.; Turk, Benjamin E.; Boggon, Titus J.			Signaling, Regulation, and Specificity of the Type II p21-activated Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							P-21 ACTIVATED KINASE; PROTEIN-KINASE; PROSTATE-CANCER; CELL-MIGRATION; SERINE/THREONINE KINASE; COLORECTAL-CANCER; PAK4 KINASE; INTEGRIN ALPHA-V-BETA-5; TARGETED DISRUPTION; ANDROGEN RECEPTOR	The p21-activated kinases (PAKs) are a family of six serine/threonine kinases that act as key effectors of RHO family GTPases in mammalian cells. PAKs are subdivided into two groups: type I PAKs (PAK1, PAK2, and PAK3) and type II PAKs (PAK4, PAK5, and PAK6). Although these groups are involved in common signaling pathways, recent work indicates that the two groups have distinct modes of regulation and have both unique and common substrates. Here, we review recent insights into the molecular level details that govern regulation of type II PAK signaling. We also consider mechanisms by which signal transduction is regulated at the level of substrate specificity. Finally, we discuss the implications of these studies for clinical targeting of these kinases.	[Ha, Byung Hak; Turk, Benjamin E.; Boggon, Titus J.] Yale Univ, Dept Pharmacol, Sch Med, New Haven, CT 06520 USA; [Morse, Elizabeth M.] Yale Univ, Dept Cell Biol, Sch Med, New Haven, CT 06520 USA	Yale University; Yale University	Boggon, TJ (corresponding author), Yale Univ, Dept Pharmacol, Sch Med, SHM B-316A,333 Cedar St, New Haven, CT 06520 USA.	titus.boggon@yale.edu		Luoma, Elizabeth/0000-0001-9371-5715	National Institutes of Health [R01GM102262]; Gilead Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223, R01GM102262] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gilead Sciences(Gilead Sciences); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partially supported by National Institutes of Health Grant R01GM102262 (to B. E. T. and T. J. B.) and by a grant from Gilead Sciences.	Abo A, 1998, EMBO J, V17, P6527, DOI 10.1093/emboj/17.22.6527; Ahmed T, 2008, CELL SIGNAL, V20, P1320, DOI 10.1016/j.cellsig.2008.02.021; Arias-Romero LE, 2008, BIOL CELL, V100, P97, DOI 10.1042/BC20070109; Baldassa S, 2010, J CELL PHYSIOL, V224, P722, DOI 10.1002/jcp.22172; Barac A, 2004, J BIOL CHEM, V279, P6182, DOI 10.1074/jbc.M309579200; Baskaran Y, 2012, EMBO REP, V13, P653, DOI 10.1038/embor.2012.75; Begum A, 2009, CANCER SCI, V100, P1908, DOI 10.1111/j.1349-7006.2009.01252.x; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Bompard G, 2010, J CELL BIOL, V190, P807, DOI 10.1083/jcb.200912056; Bradshaw-Pierce EL, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00022; Callow MG, 2005, J CELL SCI, V118, P1861, DOI 10.1242/jcs.02313; Callow MG, 2002, J BIOL CHEM, V277, P550, DOI 10.1074/jbc.M105732200; Cammarano MS, 2005, MOL CELL BIOL, V25, P9532, DOI 10.1128/MCB.25.21.9532-9542.2005; Chen C, 2014, MOL CELL, V53, P140, DOI 10.1016/j.molcel.2013.11.013; Chen SL, 2008, CANCER BIOL THER, V7, P1793, DOI 10.4161/cbt.7.11.6840; Ching YP, 2003, J BIOL CHEM, V278, P33621, DOI 10.1074/jbc.C300234200; Chong C, 2001, J BIOL CHEM, V276, P17347, DOI 10.1074/jbc.M009316200; Cotteret S, 2003, MOL CELL BIOL, V23, P5526, DOI 10.1128/MCB.23.16.5526-5539.2003; Dan C, 2002, MOL CELL BIOL, V22, P567, DOI 10.1128/MCB.22.2.567-577.2002; Dan C, 2001, J BIOL CHEM, V276, P32115, DOI 10.1074/jbc.M100871200; Dart AE, 2013, EUR J CELL BIOL, V92, P129, DOI 10.1016/j.ejcb.2013.03.002; Dummler B, 2009, CANCER METAST REV, V28, P51, DOI 10.1007/s10555-008-9168-1; Eswaran J, 2008, TRENDS BIOCHEM SCI, V33, P394, DOI 10.1016/j.tibs.2008.06.002; Eswaran J, 2007, STRUCTURE, V15, P201, DOI 10.1016/j.str.2007.01.001; Eswaran J, 2009, CANCER METAST REV, V28, P209, DOI 10.1007/s10555-008-9181-4; Fawdar S, 2013, P NATL ACAD SCI USA, V110, P12426, DOI 10.1073/pnas.1305207110; Fram S, 2014, CELL MOL LIFE SCI, V71, P2759, DOI 10.1007/s00018-013-1528-5; Gao J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077818; Gizachew D, 2000, BIOCHEMISTRY-US, V39, P3963, DOI 10.1021/bi992646d; Gnesutta N, 2003, MOL CELL BIOL, V23, P7838, DOI 10.1128/MCB.23.21.7838-7848.2003; Gnesutta N, 2001, J BIOL CHEM, V276, P14414, DOI 10.1074/jbc.M011046200; Gong W, 2009, INT J CANCER, V125, P548, DOI 10.1002/ijc.24428; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Guo Q, 2014, ONCOGENE, V33, P3277, DOI 10.1038/onc.2013.296; Ha BH, 2012, P NATL ACAD SCI USA, V109, P16107, DOI 10.1073/pnas.1214447109; Hofmann C, 2004, J CELL SCI, V117, P4343, DOI 10.1242/jcs.01392; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Jaffer ZM, 2002, INT J BIOCHEM CELL B, V34, P713, DOI 10.1016/S1357-2725(01)00158-3; Jin D, 2015, BIOCHEM J, V467, P293, DOI 10.1042/BJ20141352; Kang SA, 2013, SCIENCE, V341, P364, DOI 10.1126/science.1236566; Kaur R, 2008, PROSTATE, V68, P1510, DOI 10.1002/pros.20787; Kim SY, 2007, CELL, V128, P1133, DOI 10.1016/j.cell.2007.01.039; Kimmelman AC, 2008, P NATL ACAD SCI USA, V105, P19372, DOI 10.1073/pnas.0809966105; King H, 2014, INT REV CEL MOL BIO, V309, P347, DOI 10.1016/B978-0-12-800255-1.00007-7; Knapp S, 2013, ELSEV INSIGHT, P137, DOI 10.1016/B978-0-12-407198-8.00008-4; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Lee SR, 2002, MOL ENDOCRINOL, V16, P85, DOI 10.1210/me.16.1.85; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Levinson NM, 2006, PLOS BIOL, V4, P753, DOI 10.1371/journal.pbio.0040144; Li XF, 2003, MOL CELL BIOL, V23, P7134, DOI 10.1128/MCB.23.20.7134-7142.2003; Li Y, 2012, BBA-MOL CELL RES, V1823, P465, DOI 10.1016/j.bbamcr.2011.11.013; Li ZL, 2010, MOL BIOL CELL, V21, P3317, DOI 10.1091/mbc.E10-03-0245; Li ZL, 2010, J BIOL CHEM, V285, P23699, DOI 10.1074/jbc.M110.123497; Liu T, 2013, J BIOL CHEM, V288, P3359, DOI 10.1074/jbc.M112.384289; Mak GWY, 2011, CANCER RES, V71, P2949, DOI 10.1158/0008-5472.CAN-10-4046; McClendon CL, 2014, P NATL ACAD SCI USA, V111, pE4623, DOI 10.1073/pnas.1418402111; Morreale A, 2000, NAT STRUCT BIOL, V7, P384; Murray BW, 2010, P NATL ACAD SCI USA, V107, P9446, DOI 10.1073/pnas.0911863107; Nekrasova T, 2008, DEV BIOL, V322, P95, DOI 10.1016/j.ydbio.2008.07.006; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Paliouras GN, 2009, MOL CELL BIOL, V29, P3018, DOI 10.1128/MCB.01286-08; Pandey A, 2002, ONCOGENE, V21, P3939, DOI 10.1038/sj.onc.1205478; Parrini MC, 2002, MOL CELL, V9, P73, DOI 10.1016/S1097-2765(01)00428-2; Parsons DW, 2005, NATURE, V436, P792, DOI 10.1038/436792a; Qu J, 2003, MOL CELL BIOL, V23, P7122, DOI 10.1128/MCB.23.20.7122-7133.2003; Radu M, 2014, NAT REV CANCER, V14, P13, DOI 10.1038/nrc3645; Rane Chetan K, 2014, Small GTPases, V5, DOI 10.4161/sgtp.28003; Rennefahrt UEE, 2007, J BIOL CHEM, V282, P15667, DOI 10.1074/jbc.M700253200; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Rudolph J, 2015, J MED CHEM, V58, P111, DOI 10.1021/jm501613q; Shepelev MV, 2012, BIOCHEMISTRY-MOSCOW+, V77, P26, DOI 10.1134/S0006297912010038; Siu MKY, 2010, P NATL ACAD SCI USA, V107, P18622, DOI 10.1073/pnas.0907481107; Soosairajah J, 2005, EMBO J, V24, P473, DOI 10.1038/sj.emboj.7600543; Staben ST, 2014, J MED CHEM, V57, P1033, DOI 10.1021/jm401768t; Strochlic TI, 2012, P NATL ACAD SCI USA, V109, P4116, DOI 10.1073/pnas.1116560109; Tabusa H, 2013, MOL CANCER RES, V11, P109, DOI 10.1158/1541-7786.MCR-12-0466; Tian YM, 2009, MECH DEVELOP, V126, P710, DOI 10.1016/j.mod.2009.05.002; Tuazon PT, 1997, BIOCHEMISTRY-US, V36, P16059, DOI 10.1021/bi9717845; Tyagi N, 2014, ONCOTARGET, V5, P8778, DOI 10.18632/oncotarget.2398; Wang W, 2013, BIOCHEM BIOPH RES CO, V438, P169, DOI 10.1016/j.bbrc.2013.07.047; Wang X, 2010, TUMOR BIOL, V31, P575, DOI 10.1007/s13277-010-0071-3; Wells CM, 2010, J CELL SCI, V123, P1663, DOI 10.1242/jcs.055707; Wells CM, 2010, BIOCHEM J, V425, P465, DOI 10.1042/BJ20091173; Wells CM, 2002, J CELL SCI, V115, P3947, DOI 10.1242/jcs.00080; Whale AD, 2013, ONCOGENE, V32, P2114, DOI 10.1038/onc.2012.233; Wong LE, 2010, J CELL BIOCHEM, V110, P1244, DOI 10.1002/jcb.22639; Workman CT, 2005, NUCLEIC ACIDS RES, V33, pW389, DOI 10.1093/nar/gki439; Wu XC, 2008, J CELL BIOCHEM, V105, P167, DOI 10.1002/jcb.21809; Wu XC, 2006, BIOCHEM BIOPH RES CO, V351, P328, DOI 10.1016/j.bbrc.2006.09.172; Yang F, 2001, J BIOL CHEM, V276, P15345, DOI 10.1074/jbc.M010311200; Zhang HQ, 2002, J CELL BIOL, V158, P1287, DOI 10.1083/jcb.200207008; Zhang J, 2012, CANCER LETT, V317, P24, DOI 10.1016/j.canlet.2011.11.007; Zhang M, 2010, PROSTATE, V70, P807, DOI 10.1002/pros.21114; Zhao Z, 2014, ACS CHEM BIOL, V9, P1230, DOI 10.1021/cb500129t; Zhu GZ, 2005, J BIOL CHEM, V280, P36372, DOI 10.1074/jbc.M505031200	98	43	45	4	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					12975	12983		10.1074/jbc.R115.650416	http://dx.doi.org/10.1074/jbc.R115.650416			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25855792	hybrid, Green Published			2022-12-28	WOS:000354975700001
J	O'Brien, R; DeGiacomo, F; Holcomb, J; Bonner, A; Ring, KL; Zhang, NZ; Zafar, K; Weiss, A; Lager, B; Schilling, B; Gibson, BW; Chen, S; Kwak, S; Ellerby, LM				O'Brien, Robert; DeGiacomo, Francesco; Holcomb, Jennifer; Bonner, Akilah; Ring, Karen L.; Zhang, Ningzhe; Zafar, Khan; Weiss, Andreas; Lager, Brenda; Schilling, Birgit; Gibson, Bradford W.; Chen, Sylvia; Kwak, Seung; Ellerby, Lisa M.			Integration-independent Transgenic Huntington Disease Fragment Mouse Models Reveal Distinct Phenotypes and Life Span in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL MUTANT HUNTINGTIN; WILD-TYPE HUNTINGTIN; CASPASE CLEAVAGE; INTRANUCLEAR INCLUSIONS; REDUCES TOXICITY; RAN TRANSLATION; CAG REPEAT; PROTEIN; PHOSPHORYLATION; AGGREGATION	The cascade of events that lead to cognitive decline, motor deficits, and psychiatric symptoms in patients with Huntington disease (HD) is triggered by a polyglutamine expansion in the N-terminal region of the huntingtin (HTT) protein. A significant mechanism in HD is the generation of mutant HTT fragments, which are generally more toxic than the full-length HTT. The protein fragments observed in human HD tissue and mouse models of HD are formed by proteolysis or aberrant splicing of HTT. To systematically investigate the relative contribution of the various HTT protein proteolysis events observed in vivo, we generated transgenic mouse models of HD representing five distinct proteolysis fragments ending at amino acids 171, 463, 536, 552, and 586 with a polyglutamine length of 148. All lines contain a single integration at the ROSA26 locus, with expression of the fragments driven by the chicken beta-actin promoter at nearly identical levels. The transgenic mice N171-Q148 and N552-Q148 display significantly accelerated phenotypes and a shortened life span when compared with N463-Q148, N536-Q148, and N586-Q148 transgenic mice. We hypothesized that the accelerated phenotype was due to altered HTT protein interactions/complexes that accumulate with age. We found evidence for altered HTT complexes in caspase-2 fragment transgenic mice (N552-Q148) and a stronger interaction with the endogenous HTT protein. These findings correlate with an altered HTT molecular complex and distinct proteins in the HTT interactome set identified by mass spectrometry. In particular, we identified HSP90AA1 (HSP86) as a potential modulator of the distinct neurotoxicity of the caspase-2 fragment mice (N552-Q148) when compared with the caspase-6 transgenic mice (N586-Q148).	[O'Brien, Robert; DeGiacomo, Francesco; Holcomb, Jennifer; Bonner, Akilah; Ring, Karen L.; Zhang, Ningzhe; Zafar, Khan; Schilling, Birgit; Gibson, Bradford W.; Chen, Sylvia; Ellerby, Lisa M.] Buck Inst Res Aging, Novato, CA 94945 USA; [Weiss, Andreas] Evotec AG, D-22419 Hamburg, Germany; [Lager, Brenda; Kwak, Seung] CHDI Management CHDI Fdn Inc, Princeton, NJ 08540 USA	Buck Institute for Research on Aging; Evotec	Ellerby, LM (corresponding author), Buck Inst Res Aging, 8001 Redwood Blvd, Novato, CA 94945 USA.	lellerby@buckinstitute.org	Regan, Clinton/E-6250-2012		National Institutes of Health [T32 AG000266, F32 NS080551]; CHDI; NCRR [1S10 OD016281]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS080551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000266] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016281] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CHDI; NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant T32 AG000266 (to L.M.E., R.O., and K.L.R.), Training Grant F32 NS080551 (to R.O.), and NCRR Shared Instrumentation Program Grant 1S10 OD016281 for TripleTOF 5600 (to B.W.G.). This work was also supported by CHDI (to L.M.E.). The authors declare that they have no conflicts of interest with the contents of this article.	Anne SL, 2007, J NEUROSCI, V27, P7318, DOI 10.1523/JNEUROSCI.1831-07.2007; Atwal RS, 2011, NAT CHEM BIOL, V7, P453, DOI [10.1038/NCHEMBIO.582, 10.1038/nchembio.582]; Baldo B, 2012, J BIOL CHEM, V287, P1406, DOI 10.1074/jbc.M111.294801; Bates GP, 1997, HUM MOL GENET, V6, P1633, DOI 10.1093/hmg/6.10.1633; Bhat KP, 2014, P NATL ACAD SCI USA, V111, P5706, DOI 10.1073/pnas.1402215111; Brown TB, 2008, HUM MOL GENET, V17, P3095, DOI 10.1093/hmg/ddn206; Cardoso F, 2014, NEURODEGENER DIS MAN, V4, P67, DOI [10.2217/nmt.13.78, 10.2217/NMT.13.78]; Carroll JB, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-59; Cleary JD, 2013, HUM MOL GENET, V22, pR45, DOI 10.1093/hmg/ddt371; Cong X, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009829; Culver BP, 2012, J BIOL CHEM, V287, P21599, DOI 10.1074/jbc.M112.359307; Daturpalli S, 2013, J MOL BIOL, V425, P4614, DOI 10.1016/j.jmb.2013.08.006; Di Pardo A, 2012, P NATL ACAD SCI USA, V109, P3528, DOI 10.1073/pnas.1114502109; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Gafni J, 2004, J BIOL CHEM, V279, P20211, DOI 10.1074/jbc.M401267200; Gafni J, 2002, J NEUROSCI, V22, P4842, DOI 10.1523/JNEUROSCI.22-12-04842.2002; Gafni J, 2012, J NEUROSCI, V32, P7454, DOI 10.1523/JNEUROSCI.6379-11.2012; Gipson TA, 2013, RNA BIOL, V10, P1647, DOI 10.4161/rna.26706; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Graham RK, 2010, J NEUROSCI, V30, P15019, DOI 10.1523/JNEUROSCI.2071-10.2010; Gu XF, 2009, NEURON, V64, P828, DOI 10.1016/j.neuron.2009.11.020; Harrison D.E., 2008, BASELINE LIFE SPAN D; Havel LS, 2011, HUM MOL GENET, V20, P1424, DOI 10.1093/hmg/ddr023; HEDREEN JC, 1991, NEUROSCI LETT, V133, P257, DOI 10.1016/0304-3940(91)90583-F; Heikkinen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050717; Hermel E, 2004, CELL DEATH DIFFER, V11, P424, DOI 10.1038/sj.cdd.4401358; Hickey MA, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-12; Hockly E, 2003, BRAIN RES BULL, V61, P469, DOI 10.1016/S0361-9230(03)00185-0; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Iuchi S, 2003, P NATL ACAD SCI USA, V100, P2409, DOI 10.1073/pnas.0437660100; Jeong H, 2009, CELL, V137, P60, DOI 10.1016/j.cell.2009.03.018; Jia HQ, 2012, NEUROBIOL DIS, V46, P351, DOI 10.1016/j.nbd.2012.01.016; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; KIYAMA H, 1990, BRAIN RES, V525, P209, DOI 10.1016/0006-8993(90)90866-A; Labbadia J, 2011, J CLIN INVEST, V121, P3306, DOI 10.1172/JCI57413; Landles C, 2010, J BIOL CHEM, V285, P8808, DOI 10.1074/jbc.M109.075028; Lunkes A, 2002, MOL CELL, V10, P259, DOI 10.1016/S1097-2765(02)00602-0; Luo SQ, 2005, J CELL BIOL, V169, P647, DOI 10.1083/jcb.200412071; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Maiuri T, 2013, HUM MOL GENET, V22, P1383, DOI 10.1093/hmg/dds554; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Marcellin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044457; Menalled LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049838; Mende-Mueller LM, 2001, J NEUROSCI, V21, P1830, DOI 10.1523/JNEUROSCI.21-06-01830.2001; Mielcarek M, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001717; Miller JP, 2010, NEURON, V67, P199, DOI 10.1016/j.neuron.2010.06.021; Pouladi MA, 2012, HUM MOL GENET, V21, P2219, DOI 10.1093/hmg/dds037; Pouladi MA, 2010, HUM MOL GENET, V19, P1528, DOI 10.1093/hmg/ddq026; Pratt WB, 2014, EXP BIOL MED, V239, P1405, DOI 10.1177/1535370214539444; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Ratovitski T, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.185348; Ratovitski T, 2009, J BIOL CHEM, V284, P10855, DOI 10.1074/jbc.M804813200; Reddy K, 2013, NEURON, V78, P405, DOI 10.1016/j.neuron.2013.04.034; Rigamonti D, 2001, J BIOL CHEM, V276, P14545, DOI 10.1074/jbc.C100044200; Rigamonti D, 2000, J NEUROSCI, V20, P3705, DOI 10.1523/JNEUROSCI.20-10-03705.2000; Sathasivam K, 2013, P NATL ACAD SCI USA, V110, P2366, DOI 10.1073/pnas.1221891110; Schilling B, 2006, J BIOL CHEM, V281, P23686, DOI 10.1074/jbc.M513507200; Schilling B, 2012, MOL CELL PROTEOMICS, V11, P202, DOI 10.1074/mcp.M112.017707; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Shirasaki DI, 2012, NEURON, V75, P41, DOI 10.1016/j.neuron.2012.05.024; Stanek LM, 2013, J HUNTINGTONS DIS, V2, P217, DOI 10.3233/JHD-130057; Tebbenkamp ATN, 2011, HUM MOL GENET, V20, P2770, DOI 10.1093/hmg/ddr176; Thompson LM, 2009, J CELL BIOL, V187, P1083, DOI 10.1083/jcb.200909067; Toneff T, 2002, J NEUROCHEM, V82, P84, DOI 10.1046/j.1471-4159.2002.00940.x; Tourette C, 2014, J BIOL CHEM, V289, P6709, DOI 10.1074/jbc.M113.523696; Waldron-Roby E, 2012, J NEUROSCI, V32, P183, DOI 10.1523/JNEUROSCI.1305-11.2012; Wang CE, 2008, HUM MOL GENET, V17, P2738, DOI 10.1093/hmg/ddn175; Warby SC, 2008, HUM MOL GENET, V17, P2390, DOI 10.1093/hmg/ddn139; Weiss A, 2009, ANAL BIOCHEM, V395, P8, DOI 10.1016/j.ab.2009.08.001; Wellington CL, 2002, J NEUROSCI, V22, P7862; Wellington CL, 2000, J BIOL CHEM, V275, P19831, DOI 10.1074/jbc.M001475200; Wellington CL, 1998, J BIOL CHEM, V273, P9158, DOI 10.1074/jbc.273.15.9158; Wheeler VC, 1999, HUM MOL GENET, V8, P115, DOI 10.1093/hmg/8.1.115; Wilkins MR, 1999, METH MOL B, V112, P531; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Xia JR, 2003, HUM MOL GENET, V12, P1393, DOI 10.1093/hmg/ddg156; Yang XL, 2011, NEUROSURGERY, V68, P932, DOI 10.1227/NEU.0b013e3182098c30; Young D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075108; Zhang Y, 2006, EMBO J, V25, P5896, DOI 10.1038/sj.emboj.7601445; Zhang YU, 2003, J NEUROCHEM, V87, P101, DOI 10.1046/j.1471-4159.2003.01980.x; Zheng ZQ, 2013, J BIOL CHEM, V288, P6063, DOI 10.1074/jbc.M112.413575	82	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19287	19306		10.1074/jbc.M114.623561	http://dx.doi.org/10.1074/jbc.M114.623561			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26025364	hybrid, Green Published			2022-12-28	WOS:000358781100041
J	Blackmore, NJ; Nazmi, AR; Hutton, RD; Webby, MN; Baker, EN; Jameson, GB; Parker, EJ				Blackmore, Nicola J.; Nazmi, Ali Reza; Hutton, Richard D.; Webby, Melissa N.; Baker, Edward N.; Jameson, Geoffrey B.; Parker, Emily J.			Complex Formation between Two Biosynthetic Enzymes Modifies the Allosteric Regulatory Properties of Both AN EXAMPLE OF MOLECULAR SYMBIOSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-DEOXY-D-ARABINO-HEPTULOSONATE 7-PHOSPHATE SYNTHASE; AMINO-ACID BIOSYNTHESIS; MYCOBACTERIUM-TUBERCULOSIS H37RV; CHORISMATE MUTASE; SYNERGISTIC ALLOSTERY; PROTEIN INTERACTIONS; DAHP SYNTHASE; ULTRACENTRIFUGATION; NETWORK; PATHWAY	Allostery, where remote ligand binding alters protein function, is essential for the control of metabolism. Here, we have identified a highly sophisticated allosteric response that allows complex control of the pathway for aromatic amino acid biosynthesis in the pathogen Mycobacterium tuberculosis. This response is mediated by an enzyme complex formed by two pathway enzymes: chorismate mutase (CM) and 3-deoxy-D-arabino-heptulosonate 7-phosphate synthase (DAH7PS). Whereas both enzymes are active in isolation, the catalytic activity of both enzymes is enhanced, and in particular that of the much smaller CM is greatly enhanced (by 120-fold), by formation of a heterooctameric complex between CM and DAH7PS. Moreover, on complex formation M. tuberculosis CM, which has no allosteric response on its own, acquires allosteric behavior to facilitate its own regulatory needs by directly appropriating and partly reconfiguring the allosteric machinery that provides a synergistic allosteric response in DAH7PS. Kinetic and analytical ultracentrifugation experiments demonstrate that allosteric binding of phenylalanine specifically promotes hetero-octameric complex dissociation, with concomitant reduction of CM activity. Together, DAH7PS and CM from M. tuberculosis provide exquisite control of aromatic amino acid biosynthesis, not only controlling flux into the start of the pathway, but also directing the pathway intermediate chorismate into either Phe/Tyr or Trp biosynthesis.	[Blackmore, Nicola J.; Nazmi, Ali Reza; Hutton, Richard D.; Webby, Melissa N.; Parker, Emily J.] Univ Canterbury, Dept Chem, Maurice Wilkins Ctr, Christchurch 8140, New Zealand; [Blackmore, Nicola J.; Nazmi, Ali Reza; Hutton, Richard D.; Webby, Melissa N.; Parker, Emily J.] Univ Canterbury, Dept Chem, Biomol Interact Ctr, Christchurch 8140, New Zealand; [Baker, Edward N.] Univ Auckland, Maurice Wilkins Ctr, Auckland 1142, New Zealand; [Baker, Edward N.] Univ Auckland, Sch Biol Sci, Auckland 1142, New Zealand; [Jameson, Geoffrey B.] Massey Univ, Inst Fundamental Sci, Palmerston North 4442, New Zealand	University of Canterbury; University of Canterbury; University of Auckland; University of Auckland; Massey University	Jameson, GB (corresponding author), Massey Univ, Inst Fundamental Sci, Palmerston North 4442, New Zealand.	G.B.Jameson@massey.ac.nz; emily.parker@canterbury.ac.nz		Jameson, Geoffrey/0000-0003-4839-0784; Parker, Emily/0000-0002-9571-9987; Baker, Edward/0000-0003-2456-7661; Webby, Melissa/0000-0001-5721-0381; Nazmi, Ali Reza/0000-0003-1262-5078	Maurice Wilkins Centre for Biomolecular Discovery; New Zealand Marsden Fund [UOC1105]; Maurice Wilkins Centre; University of Canterbury	Maurice Wilkins Centre for Biomolecular Discovery; New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Maurice Wilkins Centre; University of Canterbury	This work was supported in part by the Maurice Wilkins Centre for Biomolecular Discovery, by New Zealand Marsden Fund Grant UOC1105, and by a scholarship from the Maurice Wilkins Centre and the University of Canterbury (to N. J. B.). The authors declare that they have no conflicts of interest with the contents of this article.	An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; Blackmore NJ, 2013, J MOL BIOL, V425, P1582, DOI 10.1016/j.jmb.2012.12.019; EUVERINK GJW, 1995, APPL ENVIRON MICROB, V61, P3796, DOI 10.1128/AEM.61.11.3796-3803.1995; Gabizon R, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00009; Helmstaedt K, 2001, MICROBIOL MOL BIOL R, V65, P404, DOI 10.1128/MMBR.65.3.404-421.2001; Herrmann KM, 1999, ANNU REV PLANT PHYS, V50, P473, DOI 10.1146/annurev.arplant.50.1.473; Jez JM, 2013, CURR OPIN STRUC BIOL, V23, P302, DOI 10.1016/j.sbi.2013.02.011; Jiao WT, 2012, J MOL BIOL, V415, P716, DOI 10.1016/j.jmb.2011.11.037; Kim SK, 2008, FEBS J, V275, P4824, DOI 10.1111/j.1742-4658.2008.06621.x; Kim SK, 2006, J BACTERIOL, V188, P8638, DOI 10.1128/JB.00441-06; Kloosterman H, 2003, MICROBIOL-SGM, V149, P3321, DOI 10.1099/mic.0.26494-0; Laursen T, 2015, TRENDS PLANT SCI, V20, P20, DOI 10.1016/j.tplants.2014.11.002; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Li PP, 2013, APPL MICROBIOL BIOT, V97, P10373, DOI 10.1007/s00253-013-4806-0; Light SH, 2013, PROTEIN SCI, V22, P395, DOI 10.1002/pro.2233; Lin SL, 1998, PROTEINS, V31, P445, DOI 10.1002/(SICI)1097-0134(19980601)31:4<445::AID-PROT10>3.0.CO;2-F; McConkey GA, 2004, TRENDS PARASITOL, V20, P60, DOI 10.1016/j.pt.2003.11.001; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Nussinov R, 2014, PROG BIOPHYS MOL BIO, V116, P158, DOI 10.1016/j.pbiomolbio.2014.07.002; Ouchi T, 2013, NAT CHEM BIOL, V9, P277, DOI [10.1038/NCHEMBIO.1200, 10.1038/nchembio.1200]; Parish T, 2002, MICROBIOL-SGM, V148, P3069, DOI 10.1099/00221287-148-10-3069; Perica T, 2012, BIOCHEM SOC T, V40, P475, DOI 10.1042/BST20120056; Perkins JR, 2010, STRUCTURE, V18, P1233, DOI 10.1016/j.str.2010.08.007; Roderer K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116234; Sasso S, 2009, EMBO J, V28, P2128, DOI 10.1038/emboj.2009.165; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SUGIMOTO SI, 1980, J BIOCHEM-TOKYO, V88, P167; TAIRA K, 1988, J MED CHEM, V31, P129, DOI 10.1021/jm00396a019; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Webby CJ, 2010, J BIOL CHEM, V285, P30567, DOI 10.1074/jbc.M110.111856; Webby CJ, 2005, J MOL BIOL, V354, P927, DOI 10.1016/j.jmb.2005.09.093; Webby CJ, 2005, ACTA CRYSTALLOGR F, V61, P403, DOI 10.1107/S1744309105007931; Westfall CS, 2014, J BIOL CHEM, V289, P28619, DOI 10.1074/jbc.M114.591123; Wu J, 2006, J BIOL CHEM, V281, P4042, DOI 10.1074/jbc.M512223200	34	19	19	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					18187	18198		10.1074/jbc.M115.638700	http://dx.doi.org/10.1074/jbc.M115.638700			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26032422	Green Published, hybrid			2022-12-28	WOS:000358511700048
J	Szabo, A; Ludwig, M; Hegyi, E; Szepeova, R; Witt, H; Sahin-Toth, M				Szabo, Andras; Ludwig, Maren; Hegyi, Eszter; Szepeova, Renata; Witt, Heiko; Sahin-Toth, Miklos			Mesotrypsin Signature Mutation in a Chymotrypsin C (CTRC) Variant Associated with Chronic Pancreatitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CATIONIC TRYPSINOGEN; SUBSTRATE RECOGNITION; INHIBITOR RESISTANCE; PROTEASE INHIBITORS; ESCHERICHIA-COLI; SPECIFICITY; DEGRADATION; AFFINITY; SECRETION; CALDECRIN	Human chymotrypsin C (CTRC) protects against pancreatitis by degrading trypsinogen and thereby curtailing harmful intra-pancreatic trypsinogen activation. Loss-of-function mutations in CTRC increase the risk for chronic pancreatitis. Here we describe functional analysis of eight previously uncharacterized natural CTRC variants tested for potential defects in secretion, proteolytic stability, and catalytic activity. We found that all variants were secreted from transfected cells normally, and none suffered proteolytic degradation by trypsin. Five variants had normal enzymatic activity, whereas variant p.R29Q was catalytically inactive due to loss of activation by trypsin and variant p.S239C exhibited impaired activity possibly caused by disulfide mispairing. Surprisingly, variant p.G214R had increased activity on a small chromogenic peptide substrate but was markedly defective in cleaving bovine beta-casein or the natural CTRC substrates human cationic trypsinogen and procarboxypeptidase A1. Mutation p.G214R is analogous to the evolutionary mutation in human mesotrypsin, which rendered this trypsin isoform resistant to proteinaceous inhibitors and conferred its ability to cleave these inhibitors. Similarly to the mesotrypsin phenotype, CTRC variant p.G214R was inhibited poorly by eglin C, ecotin, or a CTRC-specific variant of SGPI-2, and it readily cleaved the reactive-site peptide bonds in eglin C and ecotin. We conclude that CTRC variants p.R29Q, p.G214R, and p.S239C are risk factors for chronic pancreatitis. Furthermore, the mesotrypsin-like CTRC variant highlights how the same natural mutation in homologous pancreatic serine proteases can evolve a new physiological role or lead to pathology, determined by the biological context of protease function.	[Szabo, Andras; Ludwig, Maren; Sahin-Toth, Miklos] Boston Univ, Henry M Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02118 USA; [Ludwig, Maren; Witt, Heiko] Tech Univ Munich, Pediat Nutr Med, D-85350 Munich, Germany; [Ludwig, Maren; Witt, Heiko] Tech Univ Munich, Else Kroner Fresenius Zentrum EKFZ Ernahrungsmed, D-85350 Munich, Germany; [Hegyi, Eszter] Comenius Univ, Fac Med Bratislava, Univ Childrens Hosp Bratislava, Dept Pediat 2, Bratislava 83340, Slovakia; [Szepeova, Renata] Comenius Univ, Jessenius Fac Med Martin, Martin Univ Hosp, Clin Children & Adolescents, Martin 03601, Slovakia	Boston University; Technical University of Munich; Technical University of Munich; Comenius University Bratislava; Comenius University Bratislava	Sahin-Toth, M (corresponding author), 72 East Concord St,Evans 433, Boston, MA 02118 USA.	miklos@bu.edu	Regan, Clinton/E-6250-2012	Sahin-Toth, Miklos/0000-0003-4513-9922; Ewers, Maren/0000-0002-9029-2240; Szabo, Andras/0000-0001-8687-470X	National Institutes of Health [R01DK082412, R01DK058088, R01DK095753]; Comenius University, Bratislava [573/2013]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058088, R01DK095753, R01DK082412] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Comenius University, Bratislava; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01DK082412, R01DK058088, and R01DK095753 (to M. S.-T.) and by Grant 573/2013 from the Comenius University, Bratislava (to E. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Batra J, 2013, J BIOL CHEM, V288, P9848, DOI 10.1074/jbc.M113.457382; Beer S, 2013, GUT, V62, P1616, DOI 10.1136/gutjnl-2012-303090; CHUNG CH, 1983, J BIOL CHEM, V258, P1032; Eggers CT, 2001, J MOL BIOL, V308, P975, DOI 10.1006/jmbi.2001.4754; FOLK JE, 1965, J BIOL CHEM, V240, P193; FOLK JE, 1965, J BIOL CHEM, V240, P181; Geisz A, 2013, FEBS J, V280, P2888, DOI 10.1111/febs.12292; IIOAKAMA K, 1985, BIOCHIM BIOPHYS ACTA, V831, P249, DOI 10.1016/0167-4838(85)90042-1; Katona G, 2002, J MOL BIOL, V315, P1209, DOI 10.1006/jmbi.2001.5305; KNECHT R, 1983, ANAL BIOCHEM, V130, P65, DOI 10.1016/0003-2697(83)90650-4; Komiyama T, 2000, BIOCHEMISTRY-US, V39, P15156, DOI 10.1021/bi001907c; Lengyel Z, 1998, PROTEIN EXPRES PURIF, V12, P291, DOI 10.1006/prep.1997.0837; Masamune A, 2013, GUT, V62, P653, DOI 10.1136/gutjnl-2012-303860; Masson E, 2008, HUM GENET, V123, P83, DOI 10.1007/s00439-007-0459-3; MCGRATH ME, 1991, J BIOL CHEM, V266, P6620; Mock WL, 1996, ANAL BIOCHEM, V239, P218, DOI 10.1006/abio.1996.0318; Nemoda Z, 2006, J BIOL CHEM, V281, P11879, DOI 10.1074/jbc.M600124200; Nyaruhucha CNM, 1997, J BIOL CHEM, V272, P10573; Paliwal S, 2013, GUT, V62, P1602, DOI 10.1136/gutjnl-2012-302448; Pendlebury D, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.609560; RINDERKNECHT H, 1979, GUT, V20, P886, DOI 10.1136/gut.20.10.886; RINDERKNECHT H, 1984, GASTROENTEROLOGY, V86, P681; RINDERKNECHT H, 1985, DIGEST DIS SCI, V30, P65, DOI 10.1007/BF01318373; Rosendahl J, 2008, NAT GENET, V40, P78, DOI 10.1038/ng.2007.44; Rosendahl J, 2013, GUT, V62, P582, DOI 10.1136/gutjnl-2011-300645; Salameh MA, 2008, J BIOL CHEM, V283, P4115, DOI 10.1074/jbc.M708268200; Salameh MA, 2012, PROTEIN SCI, V21, P1103, DOI 10.1002/pro.2097; Salameh MA, 2011, BIOCHEM J, V440, P95, DOI 10.1042/BJ20110788; Salameh MA, 2010, J BIOL CHEM, V285, P36884, DOI 10.1074/jbc.M110.171348; Salameh MA, 2010, J BIOL CHEM, V285, P1939, DOI 10.1074/jbc.M109.057216; Szabo A, 2014, J BIOL CHEM, V289, P4753, DOI 10.1074/jbc.M113.538884; Szabo A, 2012, FEBS J, V279, P4283, DOI 10.1111/febs.12018; Szabo A, 2011, J BIOL CHEM, V286, P22535, DOI 10.1074/jbc.M111.235754; Szmola R, 2003, J BIOL CHEM, V278, P48580, DOI 10.1074/jbc.M310301200; Szmola R, 2007, P NATL ACAD SCI USA, V104, P11227, DOI 10.1073/pnas.0703714104; Szmola R, 2011, J BIOL CHEM, V286, P1819, DOI 10.1074/jbc.M110.187369; Szmola R, 2010, GUT, V59, P365, DOI 10.1136/gut.2009.198903; Tomomura A, 1996, FEBS LETT, V386, P26, DOI 10.1016/0014-5793(96)00377-8	38	13	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17282	17292		10.1074/jbc.M114.618439	http://dx.doi.org/10.1074/jbc.M114.618439			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26013824	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000357730900024
J	Xu, XB; Tan, XY; Tampe, B; Sanchez, E; Zeisberg, M; Zeisberg, EM				Xu, Xingbo; Tan, Xiaoying; Tampe, Bjoern; Sanchez, Elisa; Zeisberg, Michael; Zeisberg, Elisabeth M.			Snail Is a Direct Target of Hypoxia-inducible Factor 1 alpha (HIF1 alpha) in Hypoxia-induced Endothelial to Mesenchymal Transition of Human Coronary Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; CARDIAC FIBROSIS; KIDNEY FIBROSIS; EXPRESSION; CONTRIBUTES; FIBROBLASTS; ACTIVATION; CARCINOMA; PROTEIN; SLUG	Endothelial to mesenchymal transition (EndMT) was originally described in heart development where the endocardial endothelial cells that line the atrioventricular canal undergo an EndMT to form the endocardial mesenchymal cushion that later gives rise to the septum and mitral and tricuspid valves. In the postnatal heart specifically, endothelial cells that originate from the endocardium maintain increased susceptibility to undergo EndMT as remnants from their embryonic origin. Such EndMT involving adult coronary endothelial cells contributes to microvascular rarefaction and subsequent chronification of hypoxia in the injured heart, ultimately leading to cardiac fibrosis. Although in most endothelial beds hypoxia induces tip cell formation and sprouting angiogenesis, here we demonstrate that hypoxia is a stimulus for human coronary endothelial cells to undergo phenotypic changes reminiscent of EndMT via a mechanism involving hypoxia-inducible factor 1 alpha-induced activation of the EndMT master regulatory transcription factor SNAIL. Our study adds further evidence for the unique susceptibility of endocardium-derived endothelial cells to undergo EndMT and provides novel insights into how hypoxia contributes to progression of cardiac fibrosis. Additional studies may be required to discriminate between distinct sprouting angiogenesis and EndMT responses of different endothelial cells populations.	[Xu, Xingbo; Tan, Xiaoying; Sanchez, Elisa; Zeisberg, Elisabeth M.] Univ Gottingen, Univ Med Ctr Gottingen, Dept Cardiol & Pneumol, D-37075 Gottingen, Germany; [Tampe, Bjoern; Zeisberg, Michael] Univ Gottingen, Univ Med Ctr Gottingen, Dept Nephrol & Rheumatol, D-37075 Gottingen, Germany; [Zeisberg, Elisabeth M.] DZHK German Ctr Cardiovasc Res Partner Site, D-37075 Gottingen, Germany	University of Gottingen; University of Gottingen; German Centre for Cardiovascular Research	Zeisberg, EM (corresponding author), Univ Gottingen, Univ Med Ctr Gottingen, Dept Cardiol & Pneumol, Robert Koch Str 40, D-37075 Gottingen, Germany.	elisabeth.zeisberg@med.uni-goettingen.de	Zeisberg, Elisabeth/ABG-4970-2021; Tampe, Björn/ABA-6091-2021	Tampe, Björn/0000-0002-4357-9863; Xu, Xingbo/0000-0002-8249-5507	University Medical Center of Gottingen; Deutsche Forschungsgemeinschaft (DFG) [SFB1002/C01]; Seed Funding Research Program of the Faculty of Medicine, Georg August University Gottingen; DFG [ZE523/2-1, ZE523/3-1]; Else Kroner Memorial Stipend [2005/59]	University Medical Center of Gottingen; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Seed Funding Research Program of the Faculty of Medicine, Georg August University Gottingen; DFG(German Research Foundation (DFG)); Else Kroner Memorial Stipend	This work was supported in part by funds of the University Medical Center of Gottingen and Deutsche Forschungsgemeinschaft (DFG) Grant SFB1002/C01 (to E. Z.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Seed Funding Research Program of the Faculty of Medicine, Georg August University Gottingen.; Supported by DFG Grants ZE523/2-1 and ZE523/3-1 and Else Kroner Memorial Stipend 2005/59.	Bar EE, 2010, AM J PATHOL, V177, P1491, DOI 10.2353/ajpath.2010.091021; Barbera MJ, 2004, ONCOGENE, V23, P7345, DOI 10.1038/sj.onc.1207990; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Dave JM, 2014, MICROCIRCULATION, V21, P333, DOI 10.1111/micc.12111; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; Du R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030771; EISENBERG LM, 1995, CIRC RES, V77, P1, DOI 10.1161/01.RES.77.1.1; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Ford CE, 2007, BRIT J CANCER, V96, P808, DOI 10.1038/sj.bjc.6603614; Hashimoto N, 2010, AM J RESP CELL MOL, V43, P161, DOI 10.1165/rcmb.2009-0031OC; Ho VT, 1996, BIOCHEM BIOPH RES CO, V223, P175, DOI 10.1006/bbrc.1996.0865; Huang CH, 2009, NEOPLASIA, V11, P1371, DOI 10.1593/neo.91326; Kiran MS, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-6; Kokudo T, 2008, J CELL SCI, V121, P3317, DOI 10.1242/jcs.028282; Kovacic JC, 2012, CIRCULATION, V125, P1795, DOI 10.1161/CIRCULATIONAHA.111.040352; Lee SW, 2013, MOL THER, V21, P1767, DOI 10.1038/mt.2013.146; Lei L, 2008, MOL CELL BIOL, V28, P3790, DOI 10.1128/MCB.01580-07; Lin F, 2012, IUBMB LIFE, V64, P717, DOI 10.1002/iub.1059; Luo DC, 2011, MOL CANCER RES, V9, P234, DOI 10.1158/1541-7786.MCR-10-0214; Luo Y., 2014, BIOMED RES INT, V2014; Maddaluno L, 2013, NATURE, V498, P492, DOI 10.1038/nature12207; Mihira H, 2012, J BIOCHEM, V151, P145, DOI 10.1093/jb/mvr121; Naber HPH, 2013, BIOCHEM BIOPH RES CO, V435, P58, DOI 10.1016/j.bbrc.2013.04.037; Nakano Y, 2008, INVEST OPHTH VIS SCI, V49, P93, DOI 10.1167/iovs.07-0255; Noseda M, 2004, CIRC RES, V94, P910, DOI 10.1161/01.RES.0000124300.76171.C9; Piera-Velazquez S, 2011, AM J PATHOL, V179, P1074, DOI 10.1016/j.ajpath.2011.06.001; Rieder F, 2011, AM J PATHOL, V179, P2660, DOI 10.1016/j.ajpath.2011.07.042; Rivera-Feliciano J, 2006, DEVELOPMENT, V133, P3607, DOI 10.1242/dev.02519; Tampe B, 2014, J AM SOC NEPHROL, V25, P905, DOI 10.1681/ASN.2013070723; Thornhill BA, 2007, KIDNEY INT, V72, P1103, DOI 10.1038/sj.ki.5002512; van Meeteren LA, 2012, CELL TISSUE RES, V347, P177, DOI 10.1007/s00441-011-1222-6; Watson CJ, 2014, HUM MOL GENET, V23, P2176, DOI 10.1093/hmg/ddt614; Welch-Reardon KM, 2014, J CELL SCI, V127, P2017, DOI 10.1242/jcs.143420; Wu BR, 2012, CELL, V151, P1083, DOI 10.1016/j.cell.2012.10.023; Xu XB, 2013, BBA-GENE REGUL MECH, V1829, P425, DOI 10.1016/j.bbagrm.2012.12.010; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Zeisberg EM, 2007, CANCER RES, V67, P10123, DOI 10.1158/0008-5472.CAN-07-3127; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513; Zhang HF, 2008, P NATL ACAD SCI USA, V105, P19579, DOI 10.1073/pnas.0809763105; Zhang L, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-108	41	111	119	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16653	16664		10.1074/jbc.M115.636944	http://dx.doi.org/10.1074/jbc.M115.636944			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25971970	Green Published, hybrid			2022-12-28	WOS:000357572800016
J	Liu, MY; Chen, YL; Zhang, L; Wang, QX; Ma, XZ; Li, XJ; Xiang, R; Zhu, Y; Qin, SC; Yu, Y; Jiang, XC; Duan, YJ; Han, JH				Liu, Mengyang; Chen, Yuanli; Zhang, Ling; Wang, Qixue; Ma, Xingzhe; Li, Xiaoju; Xiang, Rong; Zhu, Yan; Qin, Shucun; Yu, Yang; Jiang, Xian-cheng; Duan, Yajun; Han, Jihong			Regulation of Hepatic Cholesteryl Ester Transfer Protein Expression and Reverse Cholesterol Transport by Inhibition of DNA Topoisomerase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; MACROPHAGE ABCA1 EXPRESSION; APOLIPOPROTEIN-A-I; LIVER-X-RECEPTORS; CETP EXPRESSION; ATHEROSCLEROTIC LESIONS; ETOPOSIDE TREATMENT; SCAVENGER RECEPTOR; UP-REGULATION; ACTIVATION	Cholesteryl ester transfer protein (CETP) transfers cholesteryl esters from high density lipoprotein to triglyceride-rich lipoproteins. CETP expression can be transcriptionally activated by liver X receptor (LXR). Etoposide and teniposide are DNA topoisomerase II (Topo II) inhibitors. Etoposide has been reported to inhibit atherosclerosis in rabbits with unfully elucidated mechanisms. In this study we determined if Topo II activity can influence cholesterol metabolism by regulating hepatic CETP expression. Inhibition of Topo II by etoposide, teniposide, or Topo II siRNA increased CETP expression in human hepatic cell line, HepG2 cells, which was associated with increased CETP secretion and mRNA expression. Meanwhile, inhibition of LXR expression by LXR siRNA attenuated induction of CETP expression by etoposide and teniposide. Etoposide and teniposide induced LXR alpha expression and LXR alpha/beta nuclear translocation while inhibiting expression of receptor interacting protein 140 (RIP140), an LXR co-repressor. In vivo, administration of teniposide moderately reduced serum lipid profiles, induced CETP expression in the liver, and activated reverse cholesterol transport in CETP transgenic mice. Our study demonstrates a novel function of Topo II inhibitors in cholesterol metabolism by activating hepatic CETP expression and reverse cholesterol transport.	[Liu, Mengyang; Chen, Yuanli; Duan, Yajun; Han, Jihong] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Liu, Mengyang; Zhang, Ling; Wang, Qixue; Ma, Xingzhe; Li, Xiaoju; Duan, Yajun; Han, Jihong] Nankai Univ, Coll Life Sci, 94 Weijin Rd, Tianjin 300071, Peoples R China; [Chen, Yuanli; Xiang, Rong] Nankai Univ, Coll Med, Tianjin 300071, Peoples R China; [Chen, Yuanli; Xiang, Rong; Duan, Yajun; Han, Jihong] Nankai Univ, Collaborat Innovat Ctr Biotherapy, Tianjin 300071, Peoples R China; [Zhu, Yan] Tianjin Univ Tradit Chinese Med, Tianjin 300193, Peoples R China; [Qin, Shucun; Yu, Yang] Taishan Med Univ, Tai An 271000, Shandong, Peoples R China; [Jiang, Xian-cheng] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA	Nankai University; Nankai University; Nankai University; Nankai University; Tianjin University of Traditional Chinese Medicine; Shandong First Medical University & Shandong Academy of Medical Sciences; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Duan, YJ (corresponding author), Nankai Univ, Coll Life Sci, 94 Weijin Rd, Tianjin 300071, Peoples R China.	yajundun@nankai.edu.cn; jihonghan2008@nankai.edu.cn	Liu, Mengyang/AAA-6289-2019; Zhu, Yan/A-1548-2017	Liu, Mengyang/0000-0002-3790-923X; Zhu, Yan/0000-0002-3197-7936	Ministry of Science and Technology of China [2010CB945003]; Program for Changjiang Scholars and Innovative Research Team in University [IRT13023]; 111 Project [B08011]; National Science Foundation of China (NSFC) [81272460, 81473204, 31400694]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); 111 Project(Ministry of Education, China - 111 Project); National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by Ministry of Science and Technology of China Grant 2010CB945003, the Program for Changjiang Scholars and Innovative Research Team in University (no. IRT13023), and 111 Project B08011 (to J. H.) and National Science Foundation of China (NSFC) Grants 81272460 and 81473204 (to J. H.) and 31400694 (to Y. C.).	Bell TA, 2013, J LIPID RES, V54, P2647, DOI 10.1194/jlr.M036509; Blaschke F, 2004, CIRC RES, V95, pE110, DOI 10.1161/01.RES.0000150368.56660.4f; Brousseau ME, 2005, ARTERIOSCL THROM VAS, V25, P1057, DOI 10.1161/01.ATV.0000161928.16334.dd; Casquero AC, 2006, J LIPID RES, V47, P1526, DOI 10.1194/jlr.M600135-JLR200; Cazita PM, 2003, J LIPID RES, V44, P33, DOI 10.1194/jlr.M100440-JLR200; Chikamori K, 2010, CURR CANCER DRUG TAR, V10, P758, DOI 10.2174/156800910793605785; ConnellCrowley L, 1997, MOL BIOL CELL, V8, P287, DOI 10.1091/mbc.8.2.287; DELALLERAMOYA M, 1992, ARTERIOSCLER THROMB, V12, P1363, DOI 10.1161/01.ATV.12.11.1363; Docquier A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035839; Duan YJ, 2012, J BIOL CHEM, V287, P23667, DOI 10.1074/jbc.M112.350181; Favari E, 2004, J BIOL CHEM, V279, P9930, DOI 10.1074/jbc.M312476200; Gauthier A, 2005, ARTERIOSCL THROM VAS, V25, P2177, DOI 10.1161/01.ATV.0000183613.13929.13; Gautier T, 2013, J LIPID RES, V54, P2195, DOI 10.1194/jlr.M038141; HAYEK T, 1995, J CLIN INVEST, V96, P2071, DOI 10.1172/JCI118255; Heisig P, 2009, MUTAGENESIS, V24, P465, DOI 10.1093/mutage/gep035; IKEWAKI K, 1993, J CLIN INVEST, V92, P1650, DOI 10.1172/JCI116750; Ishimaru C, 2008, LIPIDS, V43, P373, DOI 10.1007/s11745-007-3149-y; Jakobsson T, 2007, BIOCHEM J, V405, P31, DOI 10.1042/BJ20070004; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Kim JH, 2011, BRIT J PHARMACOL, V162, P773, DOI 10.1111/j.1476-5381.2010.01089.x; Luo Y, 2000, J CLIN INVEST, V105, P513, DOI 10.1172/JCI8573; Naik SU, 2006, CIRCULATION, V113, P90, DOI 10.1161/CIRCULATIONAHA.105.560177; Park SH, 2011, CANCER LETT, V310, P232, DOI 10.1016/j.canlet.2011.07.009; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Rader DJ, 2014, ANNU REV MED, V65, P385, DOI 10.1146/annurev-med-050311-163305; Ratni H, 2010, CURR OPIN DRUG DISC, V13, P403; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Rye KA, 2004, ARTERIOSCL THROM VAS, V24, P421, DOI 10.1161/01.ATV.0000104029.74961.f5; Rye KA, 1997, J BIOL CHEM, V272, P3953, DOI 10.1074/jbc.272.7.3953; Shah PK, 2007, EUR HEART J, V28, P5, DOI 10.1093/eurheartj/ehl392; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Tanigawa H, 2007, CIRCULATION, V116, P1267, DOI 10.1161/CIRCULATIONAHA.107.704254; Tavares ER, 2011, INT J NANOMED, V6, P2297, DOI 10.2147/IJN.S24048; Terasaka N, 2003, FEBS LETT, V536, P6, DOI 10.1016/S0014-5793(02)03578-0; Viennois E, 2011, EXPERT OPIN THER TAR, V15, P219, DOI 10.1517/14728222.2011.547853; Villard EF, 2012, ARTERIOSCL THROM VAS, V32, P2341, DOI 10.1161/ATVBAHA.112.252841; Wang Q, 2014, BIOCHEM J, V459, P345, DOI 10.1042/BJ20131442; Zhang L, 2013, BBA-MOL CELL BIOL L, V1831, P1134, DOI 10.1016/j.bbalip.2013.02.007; Zhong SB, 1996, J CLIN INVEST, V97, P2917, DOI 10.1172/JCI118751; Zhou HW, 2006, BBA-MOL CELL BIOL L, V1761, P1482, DOI 10.1016/j.bbalip.2006.09.008; Zhou XY, 2010, J BIOL CHEM, V285, P6316, DOI 10.1074/jbc.M109.073601	41	4	4	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14418	14429		10.1074/jbc.M115.643015	http://dx.doi.org/10.1074/jbc.M115.643015			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25914138	Green Published, hybrid			2022-12-28	WOS:000355754600013
J	Rannversson, H; Wilson, P; Kristensen, KB; Sinning, S; Kristensen, AS; Stromgaard, K; Andersen, J				Rannversson, Hafsteinn; Wilson, Pamela; Kristensen, Kristina Birch; Sinning, Steffen; Kristensen, Anders Skov; Stromgaard, Kristian; Andersen, Jacob			Importance of the Extracellular Loop 4 in the Human Serotonin Transporter for Inhibitor Binding and Substrate Translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE DOMAIN-I; CYSTEINE-SCANNING MUTAGENESIS; HIGH-AFFINITY RECOGNITION; NEUROTRANSMITTER TRANSPORTERS; NOREPINEPHRINE TRANSPORTERS; BACTERIAL HOMOLOG; CONFORMATIONAL DYNAMICS; SELECTIVE RECOGNITION; ALLOSTERIC MECHANISM; PERMEATION PATHWAY	The serotonin transporter (SERT) terminates serotonergic neurotransmission by performing reuptake of released serotonin, and SERT is the primary target for antidepressants. SERT mediates the reuptake of serotonin through an alternating access mechanism, implying that a central substrate site is connected to both sides of the membrane by permeation pathways, of which only one is accessible at a time. The coordinated conformational changes in SERT associated with substrate translocation are not fully understood. Here, we have identified a Leu to Glu mutation at position 406 (L406E) in the extracellular loop 4 (EL4) of human SERT, which induced a remarkable gain-of-potency (up to >40-fold) for a range of SERT inhibitors. The effects were highly specific for L406E relative to six other mutations in the same position, including the closely related L406D mutation, showing that the effects induced by L406E are not simply charge-related effects. Leu(406) is located >10 angstrom from the central inhibitor binding in an indirect manner. We found that L406E decreased accessibility to a residue in the cytoplasmic pathway. The shift in equilibrium to favor a more outward-facing conformation of SERT can explain the reduced turnover rate and increased association rate of inhibitor binding we found for L406E. Together, our findings show that EL4 allosterically can modulate inhibitor binding within the central binding site, and substantiates that EL4 has an important role in controlling the conformational equilibrium of human SERT.	[Rannversson, Hafsteinn; Wilson, Pamela; Kristensen, Anders Skov; Stromgaard, Kristian; Andersen, Jacob] Univ Copenhagen, Dept Drug Design & Pharmacol, DK-2100 Copenhagen, Denmark; [Kristensen, Kristina Birch; Sinning, Steffen] Aarhus Univ, Translat Neuropsychiat Unit, Dept Clin Med, DK-8240 Risskov, Denmark	University of Copenhagen; Aarhus University	Andersen, J (corresponding author), Univ Copenhagen, Jagtvej 162, DK-2100 Copenhagen, Denmark.	jaa@sund.ku.dk	Kristensen, Anders Skov/B-4414-2009; Andersen, Jacob/B-7768-2016	Kristensen, Anders Skov/0000-0001-8955-6790; Andersen, Jacob/0000-0002-8067-3074; Sinning, Steffen/0000-0001-6971-6929; Stromgaard, Kristian/0000-0003-2206-4737	Lundbeck Foundation; Lundbeck Foundation [R126-2012-12453, R34-2011-3868, R126-2012-12576] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation(Lundbeckfonden)	This work was supported by the Lundbeck Foundation.	Andersen J, 2014, MOL PHARMACOL, V85, P703, DOI 10.1124/mol.113.091249; Andersen J, 2011, P NATL ACAD SCI USA, V108, P12137, DOI 10.1073/pnas.1103060108; Andersen J, 2010, J BIOL CHEM, V285, P2051, DOI 10.1074/jbc.M109.072587; Andersen J, 2009, CHEM COMMUN, P3677, DOI 10.1039/b903035m; Andersen J, 2009, J BIOL CHEM, V284, P10276, DOI 10.1074/jbc.M806907200; Apparsundaram S, 2008, J PHARMACOL EXP THER, V327, P982, DOI 10.1124/jpet.108.142315; Barker EL, 1999, J NEUROSCI, V19, P4705; Barker EL, 1998, J BIOL CHEM, V273, P19459, DOI 10.1074/jbc.273.31.19459; Beuming T, 2008, NAT NEUROSCI, V11, P780, DOI 10.1038/nn.2146; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Celik L, 2008, J AM CHEM SOC, V130, P3853, DOI 10.1021/ja076403h; Chen FH, 2005, EUR NEUROPSYCHOPHARM, V15, P193, DOI 10.1016/j.euroneuro.2004.08.008; Chen JG, 1997, BIOCHEMISTRY-US, V36, P1479, DOI 10.1021/bi962256g; Claxton DP, 2010, NAT STRUCT MOL BIOL, V17, P822, DOI 10.1038/nsmb.1854; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Forrest LR, 2009, PHYSIOLOGY, V24, P377, DOI 10.1152/physiol.00030.2009; GRAHAM D, 1989, BIOCHEM PHARMACOL, V38, P3819, DOI 10.1016/0006-2952(89)90591-1; Henry LK, 2006, J BIOL CHEM, V281, P2012, DOI 10.1074/jbc.M505055200; Henry LK, 2003, J BIOL CHEM, V278, P37052, DOI 10.1074/jbc.M305514200; Hilwi M, 2014, J BIOL CHEM, V289, P34258, DOI 10.1074/jbc.M114.593061; Jacobs MT, 2007, J BIOL CHEM, V282, P29441, DOI 10.1074/jbc.M704456200; Kazmier K, 2014, NAT STRUCT MOL BIOL, V21, P472, DOI 10.1038/nsmb.2816; KOE BK, 1990, PSYCHOPHARMACOLOGY, V100, P470, DOI 10.1007/BF02243998; Koldso H, 2010, J AM CHEM SOC, V132, P1311, DOI 10.1021/ja906923j; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Malinauskaite L, 2014, NAT STRUCT MOL BIOL, V21, P1006, DOI 10.1038/nsmb.2894; Mitchell SM, 2004, J BIOL CHEM, V279, P24089, DOI 10.1074/jbc.M311173200; Neubauer HA, 2006, MOL PHARMACOL, V69, P1242, DOI 10.1124/mol.105.018507; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Plenge P, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.371765; Raba M, 2014, STRUCTURE, V22, P769, DOI 10.1016/j.str.2014.03.011; Rudnick G, 1998, J BIOENERG BIOMEMBR, V30, P173, DOI 10.1023/A:1020573325823; Sato Y, 2004, J BIOL CHEM, V279, P22926, DOI 10.1074/jbc.M312194200; Severinsen K, 2014, MOL PHARMACOL, V85, P208, DOI 10.1124/mol.113.088922; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Sinning S, 2010, J BIOL CHEM, V285, P8363, DOI 10.1074/jbc.M109.045401; Smicun Y, 1999, J BIOL CHEM, V274, P36058, DOI 10.1074/jbc.274.51.36058; Sorensen L, 2012, J BIOL CHEM, V287, P43694, DOI 10.1074/jbc.M112.342212; Stephan MM, 1997, BIOCHEMISTRY-US, V36, P1322, DOI 10.1021/bi962150l; Tao Z, 2009, J BIOL CHEM, V284, P33807, DOI 10.1074/jbc.M109.071977; Torres-Altoro MI, 2010, J BIOL CHEM, V285, P15369, DOI 10.1074/jbc.M109.088138; Tsuruda PR, 2010, J PHARMACOL TOXICOL, V61, P192, DOI 10.1016/j.vascn.2009.12.003; Wang H, 2013, NATURE, V503, P141, DOI 10.1038/nature12648; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhang YW, 2006, J BIOL CHEM, V281, P36213, DOI 10.1074/jbc.M605468200; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zhou Z, 2009, NAT STRUCT MOL BIOL, V16, P652, DOI 10.1038/nsmb.1602; Zhu CB, 2004, MOL PHARMACOL, V65, P1462, DOI 10.1124/mol.65.6.1462; Zomot E, 2003, J BIOL CHEM, V278, P42950, DOI 10.1074/jbc.M209307200	51	7	7	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14582	14594		10.1074/jbc.M114.629071	http://dx.doi.org/10.1074/jbc.M114.629071			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25903124	hybrid, Green Published			2022-12-28	WOS:000355754600029
J	Rosler, KS; Mercier, E; Andrews, IC; Wieden, HJ				Rosler, Kirsten S.; Mercier, Evan; Andrews, Ian C.; Wieden, Hans-Joachim			Histidine 114 Is Critical for ATP Hydrolysis by the Universally Conserved ATPase YchF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS-RESPONSE; ASSEMBLY GTPASE RBGA; OBG-LIKE ATPASE; MOLECULAR-DYNAMICS; CATALYTIC MACHINERY; CRYSTAL-STRUCTURE; SWISS-MODEL; RIBOSOME; OLA1; MECHANISM	GTPases perform a wide range of functions, ranging from protein synthesis to cell signaling. Of all known GTPases, only eight are conserved across all three domains of life. YchF is one of these eight universally conserved GTPases; however, its cellular function and enzymatic properties are poorly understood. YchF differs from the classical GTPases in that it has a higher affinity for ATP than for GTP and is a functional ATPase. As a hydrophobic amino acid-substituted ATPase, YchF does not possess the canonical catalytic Gln required for nucleotide hydrolysis. To elucidate the catalytic mechanism of ATP hydrolysis by YchF, we have taken a two-pronged approach combining classical biochemical and in silico techniques. The use of molecular dynamics simulations allowed us to complement our biochemical findings with information about the structural dynamics of YchF. We have thereby identified the highly conserved His-114 as critical for the ATPase activity of YchF from Escherichia coli. His-114 is located in a flexible loop of the G-domain, which undergoes nucleotide-dependent conformational changes. The use of a catalytic His is also observed in the hydrophobic amino acid-substituted GTPase RbgA and is an identifier of the translational GTPase family.	[Rosler, Kirsten S.; Mercier, Evan; Andrews, Ian C.; Wieden, Hans-Joachim] Univ Lethbridge, Dept Chem & Biochem, Alberta RNA Res & Training Inst, Lethbridge, AB T1K 3M4, Canada	University of Lethbridge	Wieden, HJ (corresponding author), Univ Lethbridge, Dept Chem & Biochem, Univ Dr, Lethbridge, AB T1K 3M4, Canada.	hj.wieden@uleth.ca		Wieden, Hans-Joachim/0000-0001-5181-6059	Canadian Institutes of Health Research (CIHR) [MOP 114938, 103033, 89353, 84917]; Canada Foundation for Innovation (CFI) [202588]; Alberta Innovates Technology Futures	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Alberta Innovates Technology Futures	This work was supported by Canadian Institutes of Health Research (CIHR) Operating Grants MOP 114938, 103033, 89353, and 84917 and Canada Foundation for Innovation (CFI) Grant 202588 (to H.-J. W.), Alberta Innovates Technology Futures New Investigator Award, iCORE Strategic Chair Program (to H.-J. W.) and postgraduate scholarships (to E. M. and K. S. R.), and resource allocations from Compute Canada and WestGrid. The authors declare that they have no conflicts of interest with the contents of this article.	Achila D, 2012, J BIOL CHEM, V287, P8417, DOI 10.1074/jbc.M111.331322; Anand B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009944; Anand B, 2009, BIOCHEM BIOPH RES CO, V386, P602, DOI 10.1016/j.bbrc.2009.06.078; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Ash MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023355; Becker M, 2012, RNA BIOL, V9, P1288, DOI 10.4161/rna.22131; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Caldon CE, 2003, CURR OPIN MICROBIOL, V6, P135, DOI 10.1016/S1369-5274(03)00037-7; Chen YC, 2011, INT J MED MICROBIOL, V301, P469, DOI 10.1016/j.ijmm.2011.02.002; Cheung MY, 2010, J BIOL CHEM, V285, P37359, DOI 10.1074/jbc.M110.172080; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Danese I, 2004, INFECT IMMUN, V72, P5783, DOI 10.1128/IAI.72.10.5783-5790.2004; Daviter T, 2003, J MOL BIOL, V332, P689, DOI 10.1016/S0022-2836(03)00947-1; Fernebro J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-65; Foucher AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046795; Glykos NM, 2006, J COMPUT CHEM, V27, P1765, DOI 10.1002/jcc.20482; Gradia DF, 2009, INT J PARASITOL, V39, P49, DOI 10.1016/j.ijpara.2008.05.019; Guerrero C, 2006, MOL CELL PROTEOMICS, V5, P366, DOI 10.1074/mcp.M500303-MCP200; Gulati M, 2013, NUCLEIC ACIDS RES, V41, P3217, DOI 10.1093/nar/gks1475; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Koller-Eichhorn R, 2007, J BIOL CHEM, V282, P19928, DOI 10.1074/jbc.M700541200; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Marlovits TC, 2002, P NATL ACAD SCI USA, V99, P16243, DOI 10.1073/pnas.242338299; Matsuzawa A, 2014, MOL CELL, V53, P101, DOI 10.1016/j.molcel.2013.10.028; Mishra R, 2005, PROTEINS, V59, P332, DOI 10.1002/prot.20413; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Scrima A, 2006, EMBO J, V25, P2940, DOI 10.1038/sj.emboj.7601171; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Sprang SR, 1997, CURR OPIN STRUC BIOL, V7, P849, DOI 10.1016/S0959-440X(97)80157-1; Teplyakov A, 2003, J BACTERIOL, V185, P4031, DOI 10.1128/JB.185.14.4031-4037.2003; Tomar SK, 2011, BIOCHEM BIOPH RES CO, V408, P459, DOI 10.1016/j.bbrc.2011.04.052; Verstraeten N, 2011, MICROBIOL MOL BIOL R, V75, P507, DOI 10.1128/MMBR.00009-11; Voet D., 2005, BIOCHEMISTRY-US; Wenk M, 2012, J BIOL CHEM, V287, P43585, DOI 10.1074/jbc.M112.413070; Zhang JW, 2009, J ZHEJIANG UNIV-SC B, V10, P796, DOI 10.1631/jzus.B0910009; Zhang J, 2009, P NATL ACAD SCI USA, V106, P15356, DOI 10.1073/pnas.0907213106	41	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18650	18661		10.1074/jbc.M114.598227	http://dx.doi.org/10.1074/jbc.M114.598227			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26018081	hybrid, Green Published			2022-12-28	WOS:000358512100034
J	Huang, YQ; Hamana, T; Liu, JC; Wang, C; An, L; You, P; Chang, JYF; Xu, JM; Jin, CL; Zhang, ZY; McKeehan, WL; Wang, F				Huang, Yanqing; Hamana, Tomoaki; Liu, Junchen; Wang, Cong; An, Lei; You, Pan; Chang, Julia Y. F.; Xu, Jianming; Jin, Chengliu; Zhang, Zhongying; McKeehan, Wallace L.; Wang, Fen			Type 2 Fibroblast Growth Factor Receptor Signaling Preserves Stemness and Prevents Differentiation of Prostate Stem Cells from the Basal Compartment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANDROGEN-INDUCED REGENERATION; EPITHELIAL-CELLS; PROGENITOR CELLS; SELF-RENEWAL; CANCER; MURINE; FGF; PROLIFERATION; EXPRESSION; ORIGIN	Prostate stem cells (P-SCs) are capable of giving rise to all three lineages of prostate epithelial cells, which include basal, luminal, and neuroendocrine cells. Two types of P-SCs have been identified in both human and mouse adult prostates based on prostasphere or organoid cultures, cell lineage tracing, renal capsule implantation, and expression of luminal-and basal-specific proteins. The sphere-forming P-SCs are from the basal cell compartment that express P63, and are therefore designated as basal P-SCs (P-bSCs). Luminal P-SCs (P-lSCs) express luminal cytokeratins and Nkx3.1. Herein, we report that the type 2 FGF receptor (FGFR2) signaling axis is crucial for preserving stemness and preventing differentiation of P-bSCs. FGFR2 signaling mediated by FGFR substrate 2 alpha (FRS2 alpha) is indispensable for formation and maintenance of prostaspheres derived from P63(+) P-bSCs. Ablation of Fgfr2 in P63(+) cells in vitro causes the disintegration of prostaspheres. Ablation of Fgfr2 in vivo reduces the number of P63-expressing basal cells and enriches luminal cells. This suggests a basal stem cell-to-luminal cell differentiation. In addition, ablation of Fgfr2 in P63(+) cells causes defective postnatal development of the prostate. Therefore, the data indicate that FGFR2 signaling is critical for preserving stemness and preventing differentiation of P-bSCs.	[Huang, Yanqing; Hamana, Tomoaki; Liu, Junchen; An, Lei; You, Pan; Chang, Julia Y. F.; Jin, Chengliu; McKeehan, Wallace L.; Wang, Fen] Texas A&M Hlth Sci Ctr, Ctr Canc & Stem Cell Biol, Inst Biosci & Technol, Houston, TX 77030 USA; [Wang, Cong; Wang, Fen] Wenzhou Med Coll, Wenzhou 325030, Zhejiang, Peoples R China; [You, Pan; Zhang, Zhongying] Xiamen Zhongshan Hosp, Xiamen 361004, Fujian, Peoples R China; [Xu, Jianming] Baylor Coll Med, Houston, TX 77030 USA; [Wang, Fen] Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, Coll Med, College Stn, TX 77807 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Wenzhou Medical University; Baylor College of Medicine; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Wang, F (corresponding author), Texas A&M Hlth Sci Ctr, Ctr Canc & Stem Cell Biol, Inst Biosci & Technol, Houston, TX 77030 USA.	fwang@ibt.tamhsc.edu	An, Lei/GQB-0039-2022; Regan, Clinton/E-6250-2012	Huang, Yanqing/0000-0001-7275-3333; Liu, Junchen/0000-0003-2765-9780	National Institutes of Health [CA96824, DE023106, CA140388]; Cancer Prevention and Research Institution of Texas [CPRIT110555, TAMU1400302]; Natural Science Foundation of Zhejiang Province of China [Y2110492]; National Natural Science Foundation of China [s81101712, 31371470, 81270761]; NATIONAL CANCER INSTITUTE [R01CA193455, R01CA112403, R56CA096824, P50CA140388, R01CA096824] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R56DE023106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK059820] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institution of Texas; Natural Science Foundation of Zhejiang Province of China(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants CA96824 and DE023106 (to F. W.), CA140388 (to W. L. M., and F. W.), Cancer Prevention and Research Institution of Texas Grants CPRIT110555 (to F. W. and W. L. M.) and TAMU1400302 (to F. W.), Natural Science Foundation of Zhejiang Province of China Grant Y2110492, and National Natural Science Foundation of China Grants s81101712, 31371470, and 81270761 (to C. W.). The authors declare that they have no conflicts of interest with the contents of this article.	[Anonymous], NATURE, V461, P495; Cervenka I, 2011, MOL CELL BIOL, V31, P179, DOI 10.1128/MCB.00550-10; Chang JLYF, 2013, J BIOL CHEM, V288, P28952, DOI 10.1074/jbc.M113.506873; Choi N, 2012, CANCER CELL, V21, P253, DOI 10.1016/j.ccr.2012.01.005; Chua CW, 2014, NAT CELL BIOL, V16, P951, DOI 10.1038/ncb3047; Clevers H, 2014, SCIENCE, V346, P54, DOI 10.1126/science.1248012; Corn PG, 2013, CLIN CANCER RES, V19, P5856, DOI 10.1158/1078-0432.CCR-13-1550; Dvorak P, 2005, STEM CELLS, V23, P1200, DOI 10.1634/stemcells.2004-0303; ENGLISH HF, 1987, PROSTATE, V11, P229, DOI 10.1002/pros.2990110304; Eom YW, 2014, BIOCHEM BIOPH RES CO, V445, P16, DOI 10.1016/j.bbrc.2014.01.084; EVANS GS, 1987, PROSTATE, V11, P339, DOI 10.1002/pros.2990110406; Garraway IP, 2010, PROSTATE, V70, P491, DOI 10.1002/pros.21083; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; Goldstein AS, 2008, P NATL ACAD SCI USA, V105, P20882, DOI 10.1073/pnas.0811411106; Heer R, 2006, J CELL SCI, V119, P1416, DOI 10.1242/jcs.02802; Huang YQ, 2015, J BIOL CHEM, V290, P17745, DOI 10.1074/jbc.M115.661033; Itkin T, 2012, BLOOD, V120, P1843, DOI 10.1182/blood-2011-11-394692; Kan MK, 2001, IN VITRO CELL DEV-AN, V37, P575; Karthaus WR, 2014, CELL, V159, P163, DOI 10.1016/j.cell.2014.08.017; Kwon OJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5416; Lee DK, 2014, INT J BIOL SCI, V10, P1007, DOI 10.7150/ijbs.9997; Leong KG, 2008, NATURE, V456, P804, DOI 10.1038/nature07427; Lin YS, 2007, GENESIS, V45, P554, DOI 10.1002/dvg.20327; Lin YS, 2007, DEVELOPMENT, V134, P723, DOI 10.1242/dev.02765; Liu J, 2011, MOL ENDOCRINOL, V25, P1849, DOI 10.1210/me.2011-1081; Lu TL, 2013, AM J PATHOL, V182, P975, DOI 10.1016/j.ajpath.2012.11.025; Lu WQ, 1999, J BIOL CHEM, V274, P12827, DOI 10.1074/jbc.274.18.12827; McKeehan WL, 1998, PROG NUCLEIC ACID RE, V59, P135; Memarzadeh S, 2007, CANCER CELL, V12, P572, DOI 10.1016/j.ccr.2007.11.002; Minor PJ, 2013, DEVELOPMENT, V140, P3882, DOI 10.1242/dev.095687; Ousset M, 2012, NAT CELL BIOL, V14, P1130, DOI 10.1038/ncb2600; Pignon JC, 2013, P NATL ACAD SCI USA, V110, P8105, DOI 10.1073/pnas.1221216110; Rybak AP, 2011, BBA-MOL CELL RES, V1813, P683, DOI 10.1016/j.bbamcr.2011.01.018; Shahi P, 2011, STEM CELLS, V29, P678, DOI 10.1002/stem.606; Stulberg MJ, 2012, DEV BIOL, V369, P298, DOI 10.1016/j.ydbio.2012.07.003; SUGIMURA Y, 1986, BIOL REPROD, V34, P973, DOI 10.1095/biolreprod34.5.973; Trokovic R, 2003, EMBO J, V22, P1811, DOI 10.1093/emboj/cdg169; Wang BE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002186; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Wang ZA, 2013, NAT CELL BIOL, V15, P274, DOI 10.1038/ncb2697; Xin L, 2007, STEM CELLS, V25, P2760, DOI 10.1634/stemcells.2007-0355; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Yang F, 2013, CANCER RES, V73, P3716, DOI 10.1158/0008-5472.CAN-12-3274; Yin Y, 2008, DEV BIOL, V319, P426, DOI 10.1016/j.ydbio.2008.04.009; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491; Zhang J, 2012, AUTOPHAGY, V8, P690, DOI 10.4161/auto.19290; Zheng W, 2004, DEV NEUROSCI-BASEL, V26, P181, DOI 10.1159/000082136	47	18	18	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					17753	17761		10.1074/jbc.M115.661066	http://dx.doi.org/10.1074/jbc.M115.661066			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26032417	hybrid, Green Published			2022-12-28	WOS:000358511700010
J	Lee, SM; Riley, EM; Meyer, MB; Benkusky, NA; Plum, LA; DeLuca, HF; Pike, JW				Lee, Seong Min; Riley, Erin M.; Meyer, Mark B.; Benkusky, Nancy A.; Plum, Lori A.; DeLuca, Hector F.; Pike, J. Wesley			1,25-Dihydroxyvitamin D-3 Controls a Cohort of Vitamin D Receptor Target Genes in the Proximal Intestine That Is Enriched for Calcium-regulating Components	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTENTIAL VANILLOID TYPE-6; MINERAL ION HOMEOSTASIS; 25-HYDROXYVITAMIN-D 1-ALPHA-HYDROXYLASE; ZINC TRANSPORTER-1; CA2+ ABSORPTION; DOWN-REGULATION; MESSENGER-RNA; KNOCKOUT MICE; ANIMAL-MODEL; DIETARY ZINC	1,25-Dihydroxyvitamin D3 (1,25(OH)(2)D-3) plays an integral role in calcium homeostasis in higher organisms through its actions in the intestine, kidney, and skeleton. Interestingly, although several intestinal genes are known to play a contributory role in calcium homeostasis, the entire caste of key components remains to be identified. To examine this issue, Cyp27b1 null mice on either a normal or a high calcium/phosphate-containing rescue diet were treated with vehicle or 1,25(OH)(2)D-3 and evaluated 6 h later. RNA samples from the duodena were then subjected to RNA sequence analysis, and the data were analyzed bioinformatically. 1,25(OH)(2)D-3 altered expression of large collections of genes in animals under either dietary condition. 45 genes were found common to both 1,25(OH)(2)D-3-treated groups and were composed of genes previously linked to intestinal calcium uptake, including S100g, Trpv6, Atp2b1, and Cldn2 as well as others. An additional distinct network of 56 genes was regulated exclusively by diet. We then conducted a ChIP sequence analysis of binding sites for the vitamin D receptor (VDR) across the proximal intestine in vitamin D-sufficient normal mice treated with vehicle or 1,25(OH)(2)D-3. The residual VDR cistrome was composed of 4617 sites, which was increased almost 4-fold following hormone treatment. Interestingly, the majority of the genes regulated by 1,25(OH)(2)D-3 in each diet group as well as those found in common in both groups contained frequent VDR sites that likely regulated their expression. This study revealed a global network of genes in the intestine that both represent direct targets of vitamin D action in mice and are involved in calcium absorption.	[Lee, Seong Min; Riley, Erin M.; Meyer, Mark B.; Benkusky, Nancy A.; Plum, Lori A.; DeLuca, Hector F.; Pike, J. Wesley] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Pike, JW (corresponding author), Univ Wisconsin, Dept Biochem, Hector F Deluca Labs, Rm 543D,433 Babcock Dr, Madison, WI 53706 USA.	pike@biochem.wisc.edu			National Institutes of Health from NIDDK [DK-073995, DK-072281]; Wisconsin Alumni Research Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073995, R01DK072281] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; Wisconsin Alumni Research Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-073995 and DK-072281 from NIDDK (to J. W. P.). This work was also supported by funds from the Wisconsin Alumni Research Foundation (to H. F. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Airaksinen MS, 1997, P NATL ACAD SCI USA, V94, P1488, DOI 10.1073/pnas.94.4.1488; Akhter S, 2007, ARCH BIOCHEM BIOPHYS, V460, P227, DOI 10.1016/j.abb.2006.12.005; Alderton A, 2007, J NEUROCHEM, V103, P312, DOI 10.1111/j.1471-1471-4159.2007.04751.x; ARMBRECHT HJ, 1994, BBA-BIOMEMBRANES, V1195, P110, DOI 10.1016/0005-2736(94)90016-7; Baker JE, 2001, MOL CELL BIOL, V21, P2393, DOI 10.1128/MCB.21.7.2393-2403.2001; Benn BS, 2008, ENDOCRINOLOGY, V149, P3196, DOI 10.1210/en.2007-1655; Bertolo RFP, 2001, J NUTR BIOCHEM, V12, P66, DOI 10.1016/S0955-2863(00)00125-X; Bianco SDC, 2007, J BONE MINER RES, V22, P274, DOI 10.1359/JBMR.061110; Braun AP, 2010, CHANNELS, V4, P249, DOI 10.4161/chan.4.4.13330; Bronner F, 2003, J NUTR, V133, P1426, DOI 10.1093/jn/133.5.1426; CARAFOLI E, 1991, PHYSIOL REV, V71, P129, DOI 10.1152/physrev.1991.71.1.129; Christakos S, 2012, ARCH BIOCHEM BIOPHYS, V523, P73, DOI 10.1016/j.abb.2011.12.020; Cragg RA, 2005, GUT, V54, P469, DOI 10.1136/gut.2004.041962; Dardenne O, 2003, BONE, V32, P332, DOI 10.1016/S8756-3282(03)00023-1; Dardenne O, 2001, ENDOCRINOLOGY, V142, P3135, DOI 10.1210/en.142.7.3135; Dhawan P, 2012, J BONE MINER RES, pS34; Dufner-Beattie J, 2003, J BIOL CHEM, V278, P33474, DOI 10.1074/jbc.M305000200; DURSUN N, 1994, JPN J PHYSIOL, V44, P157, DOI 10.2170/jjphysiol.44.157; Erben RG, 2002, MOL ENDOCRINOL, V16, P1524, DOI 10.1210/me.16.7.1524; FEHER JJ, 1983, AM J PHYSIOL, V244, pC303, DOI 10.1152/ajpcell.1983.244.3.C303; Feldman David, 2014, Bonekey Rep, V3, P510, DOI 10.1038/bonekey.2014.5; FLEET JC, 1993, AM J PHYSIOL, V264, pG1037, DOI 10.1152/ajpgi.1993.264.6.G1037; Fu GK, 1997, MOL ENDOCRINOL, V11, P1961, DOI 10.1210/me.11.13.1961; Fujita H, 2008, MOL BIOL CELL, V19, P1912, DOI 10.1091/mbc.E07-09-0973; Fullmer CS, 1996, HISTOCHEM CELL BIOL, V106, P215; Funabashi K, 2010, AM J PHYSIOL-CELL PH, V298, pC786, DOI 10.1152/ajpcell.00469.2009; Glendenning P, 2000, BIOCHEM BIOPH RES CO, V277, P722, DOI 10.1006/bbrc.2000.3745; Glorieux Francis H, 2014, Bonekey Rep, V3, P524, DOI 10.1038/bonekey.2014.19; Inoue K, 2002, HUM MOL GENET, V11, P1775, DOI 10.1093/hmg/11.15.1775; Jones G, 1998, PHYSIOL REV, V78, P1193, DOI 10.1152/physrev.1998.78.4.1193; KOLLENKIRCHEN U, 1991, J BONE MINER RES, V6, P273; Kutuzova GD, 2008, P NATL ACAD SCI USA, V105, P19655, DOI 10.1073/pnas.0810761105; Leyva-Illades D, 2014, J NEUROSCI, V34, P14079, DOI 10.1523/JNEUROSCI.2329-14.2014; Li YC, 1997, P NATL ACAD SCI USA, V94, P9831, DOI 10.1073/pnas.94.18.9831; Li YC, 1998, ENDOCRINOLOGY, V139, P4391, DOI 10.1210/en.139.10.4391; Liuzzi JP, 2003, J NUTR, V133, P342, DOI 10.1093/jn/133.2.342; Liuzzi JP, 2001, J NUTR, V131, P46, DOI 10.1093/jn/131.1.46; Lonard DM, 2012, NAT REV ENDOCRINOL, V8, P598, DOI 10.1038/nrendo.2012.100; Loughran G, 2005, MOL BIOL CELL, V16, P1811, DOI 10.1091/mbc.E04-12-1052; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Marks HD, 2007, J STEROID BIOCHEM, V103, P513, DOI 10.1016/j.jsbmb.2006.11.014; McCormick CC, 2002, J NUTR, V132, P3428, DOI 10.1093/jn/132.11.3428; McMahon RJ, 1998, P NATL ACAD SCI USA, V95, P4841, DOI 10.1073/pnas.95.9.4841; Meyer MB, 2007, J BIOL CHEM, V282, P22344, DOI 10.1074/jbc.M703475200; Meyer MB, 2006, MOL ENDOCRINOL, V20, P1447, DOI 10.1210/me.2006-0031; Meyer MB, 2014, J BIOL CHEM, V289, P16016, DOI 10.1074/jbc.M114.552216; Meyer MB, 2014, J STEROID BIOCHEM, V144, P19, DOI 10.1016/j.jsbmb.2013.09.005; Meyer MB, 2013, J STEROID BIOCHEM, V136, P120, DOI 10.1016/j.jsbmb.2012.08.006; Meyer MB, 2012, MOL ENDOCRINOL, V26, P37, DOI 10.1210/me.2011-1109; Meyer MB, 2010, J STEROID BIOCHEM, V121, P136, DOI 10.1016/j.jsbmb.2010.02.011; Min KS, 2008, TOXICOL LETT, V176, P85, DOI 10.1016/j.toxlet.2007.10.011; Murayama A, 1999, ENDOCRINOLOGY, V140, P2224, DOI 10.1210/en.140.5.2224; Nijenhuis T, 2003, PFLUG ARCH EUR J PHY, V446, P401, DOI 10.1007/s00424-003-1038-7; OHYAMA Y, 1994, J BIOL CHEM, V269, P10545; Okunande GW, 2004, J BIOL CHEM, V279, P33742, DOI 10.1074/jbc.M404628200; Panda DK, 2004, J BIOL CHEM, V279, P16754, DOI 10.1074/jbc.M310271200; Panda DK, 2001, P NATL ACAD SCI USA, V98, P7498, DOI 10.1073/pnas.131029498; PANNABECKER TL, 1995, BIOCHEM BIOPH RES CO, V213, P499, DOI 10.1006/bbrc.1995.2159; PARTHASARATHY L, 1994, LIFE SCI, V54, P1127, DOI 10.1016/0024-3205(94)00835-3; Pike JW, 2015, BONE, V81, P757, DOI 10.1016/j.bone.2015.03.012; Pike JW, 2014, J STEROID BIOCHEM, V144, P5, DOI 10.1016/j.jsbmb.2013.11.004; Pike J Wesley, 2014, Bonekey Rep, V3, P482, DOI 10.1038/bonekey.2013.216; Pike JW, 2012, ARCH BIOCHEM BIOPHYS, V523, P2, DOI 10.1016/j.abb.2011.12.003; Romagnolo B, 1996, J BIOL CHEM, V271, P16820, DOI 10.1074/jbc.271.28.16820; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Shimada T, 2004, J BONE MINER RES, V19, P429, DOI 10.1359/JBMR.0301264; Shimada T, 2005, AM J PHYSIOL-RENAL, V289, pF1088, DOI 10.1152/ajprenal.00474.2004; Shin OH, 2005, J BIOL CHEM, V280, P1641, DOI 10.1074/jbc.M407305200; Smith CL, 2004, ENDOCR REV, V25, P45, DOI 10.1210/er.2003-0023; Song YR, 2003, J NUTR, V133, P374, DOI 10.1093/jn/133.2.374; St John HC, 2014, MOL ENDOCRINOL, V28, P1150, DOI 10.1210/me.2014-1091; THEOFAN G, 1986, J BIOL CHEM, V261, P6943; Van Cromphaut SJ, 2001, P NATL ACAD SCI USA, V98, P13324, DOI 10.1073/pnas.231474698; Vanhooke JL, 2006, P NATL ACAD SCI USA, V103, P75, DOI 10.1073/pnas.0509734103; Wasserman R. H., 1997, Vitamin D., P259; Wasserman R.H., 1969, MINERAL METABOLISM A, VVolume 3, P321; Wasserman RH, 2004, J NUTR, V134, P3137, DOI 10.1093/jn/134.11.3137; YANG SL, 1993, ARCH BIOCHEM BIOPHYS, V303, P98, DOI 10.1006/abbi.1993.1260; Yoshizawa T, 1997, NAT GENET, V16, P391, DOI 10.1038/ng0897-391; Yu YY, 2007, J HISTOCHEM CYTOCHEM, V55, P223, DOI 10.1369/jhc.6A7032.2006; ZELINSKI JM, 1991, BIOCHEM BIOPH RES CO, V179, P749, DOI 10.1016/0006-291X(91)91880-L; Zella LA, 2007, ARCH BIOCHEM BIOPHYS, V460, P206, DOI 10.1016/j.abb.2006.12.016; ZIEROLD C, 1994, P NATL ACAD SCI USA, V91, P900, DOI 10.1073/pnas.91.3.900	84	58	59	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					18199	18215		10.1074/jbc.M115.665794	http://dx.doi.org/10.1074/jbc.M115.665794			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26041780	hybrid, Green Published			2022-12-28	WOS:000358511700049
J	VanSchouwen, B; Akimoto, M; Sayadi, M; Fogolari, F; Melacini, G				VanSchouwen, Bryan; Akimoto, Madoka; Sayadi, Maryam; Fogolari, Federico; Melacini, Giuseppe			Role of Dynamics in the Autoinhibition and Activation of the Hyperpolarization-activated Cyclic Nucleotide-modulated (HCN) Ion Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; CAMP-DEPENDENT ACTIVATION; EMPIRICAL FORCE-FIELD; NMR CHEMICAL-SHIFTS; MOLECULAR-DYNAMICS; PACEMAKER CHANNELS; STRUCTURAL BASIS; COVARIANCE ANALYSIS; REGULATORY SUBUNIT; TERMINAL REGION	The hyperpolarization-activated cyclic nucleotide-modulated (HCN) ion channels control rhythmicity in neurons and cardiomyocytes. Cyclic AMP allosterically modulates HCN through the cAMP-dependent formation of a tetrameric gating ring spanning the intracellular region (IR) of HCN, to which cAMP binds. Although the apo versus holo conformational changes of the cAMP-binding domain (CBD) have been previously mapped, only limited information is currently available on the HCN IR dynamics, which have been hypothesized to play a critical role in the cAMP-dependent gating of HCN. Here, using molecular dynamics simulations validated and complemented by experimental NMR and CD data, we comparatively analyze HCN IR dynamics in the four states of the thermodynamic cycle arising from the coupling between cAMP binding and tetramerization equilibria. This extensive set of molecular dynamics trajectories captures the active-to-inactive transition that had remained elusive for other CBDs, and it provides unprecedented insight on the role of IR dynamics in HCN autoinhibition and its release by cAMP. Specifically, the IR tetramerization domain becomes more flexible in the monomeric states, removing steric clashes that the apo-CDB structure would otherwise impose. Furthermore, the simulations reveal that the active/inactive structural transition for the apo-monomeric CBD occurs through a manifold of pathways that are more divergent than previously anticipated. Upon cAMP binding, these pathways become disallowed, pre-confining the CBD conformational ensemble to a tetramer-compatible state. This conformational confinement primes the IR for tetramerization and thus provides a model of how cAMP controls HCN channel gating.	[VanSchouwen, Bryan; Akimoto, Madoka; Sayadi, Maryam; Melacini, Giuseppe] McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON L8S 4M1, Canada; [Melacini, Giuseppe] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4M1, Canada; [Fogolari, Federico] Univ Udine, Dept Biomed Sci & Technol, I-33100 Udine, Italy	McMaster University; McMaster University; University of Udine	Melacini, G (corresponding author), McMaster Univ, Dept Chem & Chem Biol, 1280 Main St West, Hamilton, ON L8S 4M1, Canada.	melacin@mcmaster.ca		Fogolari, Federico/0000-0001-9862-250X	Canadian Institutes of Health Research [MOP-68897]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Grant (MOP-68897) from the Canadian Institutes of Health Research (to G. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Abu-Abed M, 2007, PROTEINS, V69, P112, DOI 10.1002/prot.21446; Akimoto M, 2014, J BIOL CHEM, V289, P22205, DOI 10.1074/jbc.M114.572164; Akimoto M, 2014, BIOCHEM SOC T, V42, P139, DOI 10.1042/BST20130257; Akimoto M, 2013, P NATL ACAD SCI USA, V110, P14231, DOI 10.1073/pnas.1312644110; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Berrera M, 2006, BIOPHYS J, V90, P3428, DOI 10.1529/biophysj.105.071621; Biel M, 2002, TRENDS CARDIOVAS MED, V12, P206, DOI 10.1016/S1050-1738(02)00162-7; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Blyuss KB, 2012, J THEOR BIOL, V308, P45, DOI 10.1016/j.jtbi.2012.05.019; Bois P, 2011, ION CHANNELS AND THEIR INHIBITORS, P33, DOI 10.1007/978-3-642-19922-6_2; Boulton S, 2014, SCI REP-UK, V4, DOI 10.1038/srep07306; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Cembran A, 2012, BIOCHEMISTRY-US, V51, P10186, DOI 10.1021/bi301279f; Chow SS, 2012, J BIOL CHEM, V287, P600, DOI 10.1074/jbc.M111.269563; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; Craven KB, 2004, J GEN PHYSIOL, V124, P663, DOI 10.1085/jgp.200409178; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Das R, 2007, P NATL ACAD SCI USA, V104, P93, DOI 10.1073/pnas.0609033103; Das R, 2007, J BIOL CHEM, V282, P581, DOI 10.1074/jbc.M607706200; de la Torre JG, 2000, J MAGN RESON, V147, P138, DOI 10.1006/jmre.2000.2170; De S, 2012, BIOCHEMISTRY-US, V51, P8583, DOI 10.1021/bi3008214; Foloppe N, 2000, J COMPUT CHEM, V21, P86, DOI 10.1002/(SICI)1096-987X(20000130)21:2<86::AID-JCC2>3.0.CO;2-G; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hegle AP, 2010, AM J PHYSIOL-CELL PH, V298, pC1066, DOI 10.1152/ajpcell.00389.2009; Huang GY, 2014, STRUCTURE, V22, P116, DOI 10.1016/j.str.2013.09.021; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ishiyama N, 2010, CELL, V141, P117, DOI 10.1016/j.cell.2010.01.017; Izaguirre JA, 2001, J CHEM PHYS, V114, P2090, DOI 10.1063/1.1332996; Jayaraman B, 2007, BIOCHEMISTRY-US, V46, P12174, DOI 10.1021/bi701281e; Johnson JP, 2005, P NATL ACAD SCI USA, V102, P2742, DOI 10.1073/pnas.0408323102; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kusch J, 2010, NEURON, V67, P75, DOI 10.1016/j.neuron.2010.05.022; Lolicato M, 2011, J BIOL CHEM, V286, P44811, DOI 10.1074/jbc.M111.297606; MacKerell AD, 2000, J COMPUT CHEM, V21, P105, DOI 10.1002/(SICI)1096-987X(20000130)21:2<105::AID-JCC3>3.0.CO;2-P; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; McNicholl ET, 2010, J BIOL CHEM, V285, P15523, DOI 10.1074/jbc.M110.105783; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Nussinov R, 2014, J AM CHEM SOC, V136, P17692, DOI 10.1021/ja510028c; Nussinov R, 2014, TRENDS PHARMACOL SCI, V35, P256, DOI 10.1016/j.tips.2014.03.006; Nussinov R, 2014, BIOPHYS CHEM, V186, P22, DOI 10.1016/j.bpc.2013.10.002; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Puljung MC, 2014, P NATL ACAD SCI USA, V111, P9816, DOI 10.1073/pnas.1405371111; Qu Y, 2008, J PHYSIOL-LONDON, V586, P701, DOI 10.1113/jphysiol.2007.144329; Rehmann H, 2007, NAT REV MOL CELL BIO, V8, P63, DOI 10.1038/nrm2082; Rosenbaum T, 2004, NEURON, V42, P193, DOI 10.1016/S0896-6273(04)00199-0; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Saponaro A, 2014, P NATL ACAD SCI USA, V111, P14577, DOI 10.1073/pnas.1410389111; Selvaratnam R, 2012, BIOPHYS J, V102, P630, DOI 10.1016/j.bpj.2011.12.030; Selvaratnam R, 2011, P NATL ACAD SCI USA, V108, P6133, DOI 10.1073/pnas.1017311108; Smith MJ, 2014, NAT CHEM BIOL, V10, P223, DOI [10.1038/NCHEMBIO.1435, 10.1038/nchembio.1435]; Srivastava AK, 2014, STRUCTURE, V22, P1735, DOI 10.1016/j.str.2014.09.010; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; Taraska JW, 2009, NAT METHODS, V6, P532, DOI 10.1038/nmeth.1341; Tsai CJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003394; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; VanSchouwen B, 2011, J BIOL CHEM, V286, P42655, DOI 10.1074/jbc.M111.277723; Veglia G, 2013, FEBS J, V280, P5608, DOI 10.1111/febs.12462; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Wang J, 2002, NEURON, V36, P451, DOI 10.1016/S0896-6273(02)00968-6; Xu XP, 2010, J BIOL CHEM, V285, P37082, DOI 10.1074/jbc.M110.152033; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922	62	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					17642	17654		10.1074/jbc.M115.651877	http://dx.doi.org/10.1074/jbc.M115.651877			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	25944904	hybrid, Green Published			2022-12-28	WOS:000358511700001
J	Kim, H; Youn, SJ; Kim, SO; Ko, J; Lee, JO; Choi, BS				Kim, Henna; Youn, Suk-Jun; Kim, Seong Ok; Ko, Junsang; Lee, Jie-Oh; Choi, Byong-Seok			Structural Studies of Potassium Transport Protein KtrA Regulator of Conductance of K+ (RCK) C Domain in Complex with Cyclic Diadenosine Monophosphate (c-di-AMP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial signal transduction; crystal structure; cyclic diadenosine monophosphate (c-di-AMP); isothermal titration calorimetry (ITC); potassium transport; Staphylococcus aureus (S; aureus)	BACILLUS-SUBTILIS; SIGNAL-TRANSDUCTION; DNA INTEGRITY; GMP; REVEALS; BINDING; SYSTEM; IDENTIFICATION; RECOGNITION; RESISTANCE	Background: Cyclic di-AMP inactivates the potassium transport activity of KtrA. Results: Cyclic di-AMP binding to KrtA induced conformational changes. Conclusion: Cyclic di-AMP selectively binds to the KtrA RCK_C domain and signals the inactivation of potassium transport. Significance: The molecular basis for the role of cyclic di-AMP in potassium channel activity was investigated. Although it was only recently identified as a second messenger, c-di-AMP was found to have fundamental importance in numerous bacterial functions such as ion transport. The potassium transporter protein, KtrA, was identified as a c-di-AMP receptor. However, the co-crystallization of c-di-AMP with the protein has not been studied. Here, we determined the crystal structure of the KtrA RCK_C domain in complex with c-di-AMP. The c-di-AMP nucleotide, which adopts a U-shaped conformation, is bound at the dimer interface of RCK_C close to helices 3 and 4. c-di-AMP interacts with KtrA RCK_C mainly by forming hydrogen bonds and hydrophobic interactions. c-di-AMP binding induces the contraction of the dimer, bringing the two monomers of KtrA RCK_C into close proximity. The KtrA RCK_C was able to interact with only c-di-AMP, but not with c-di-GMP, 3,3-cGAMP, ATP, and ADP. The structure of the KtrA RCK_C domain and c-di-AMP complex would expand our understanding about the mechanism of inactivation in Ktr transporters governed by c-di-AMP.	[Kim, Henna; Youn, Suk-Jun; Kim, Seong Ok; Ko, Junsang; Lee, Jie-Oh; Choi, Byong-Seok] Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST)	Lee, JO (corresponding author), Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea.	jieoh@kaist.ac.kr; byongseok.choi@kaist.ac.kr	Choi, Byong-Seok/C-1937-2011; Lee, Jie-Oh/AAG-4302-2020	Lee, Jie-Oh/0000-0001-6519-6049	National Research Foundation of Korea [2011-0020322]; High Risk High Return project by KAIST; Intelligent Synthetic Biology Center of Global Frontier Project - Ministry of Science, ICT and Future Planning Grant [20110031955]	National Research Foundation of Korea(National Research Foundation of Korea); High Risk High Return project by KAIST; Intelligent Synthetic Biology Center of Global Frontier Project - Ministry of Science, ICT and Future Planning Grant	This work was supported by the National Research Foundation of Korea Grant 2011-0020322 and High Risk High Return project by KAIST (to B-S. C.) and the Intelligent Synthetic Biology Center of Global Frontier Project funded by the Ministry of Science, ICT and Future Planning Grant 20110031955 (to J. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Albright RA, 2006, CELL, V126, P1147, DOI 10.1016/j.cell.2006.08.028; Bai YL, 2014, J BACTERIOL, V196, P614, DOI 10.1128/JB.01041-13; Barker JR, 2013, MBIO, V4, DOI 10.1128/mBio.00018-13; Benach J, 2007, EMBO J, V26, P5153, DOI 10.1038/sj.emboj.7601918; Berry S, 2003, FEBS LETT, V548, P53, DOI 10.1016/S0014-5793(03)00729-4; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Campeotto I, 2015, J BIOL CHEM, V290, P2888, DOI 10.1074/jbc.M114.621789; Campos SS, 2014, J BACTERIOL, V196, P568, DOI 10.1128/JB.01259-13; Corrigan RM, 2013, NAT REV MICROBIOL, V11, P513, DOI 10.1038/nrmicro3069; Corrigan RM, 2013, P NATL ACAD SCI USA, V110, P9084, DOI 10.1073/pnas.1300595110; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; Davies BW, 2012, CELL, V149, P358, DOI 10.1016/j.cell.2012.01.053; Dvir H, 2010, J STRUCT BIOL, V171, P231, DOI 10.1016/j.jsb.2010.03.020; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gundlach J, 2015, J BIOL CHEM, V290, P3069, DOI 10.1074/jbc.M114.619619; Hanelt I, 2011, EUR J CELL BIOL, V90, P696, DOI 10.1016/j.ejcb.2011.04.010; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Holtmann G, 2003, J BACTERIOL, V185, P1289, DOI 10.1128/JB.185.4.1289-1298.2003; Horrigan FT, 2005, J GEN PHYSIOL, V126, P7, DOI 10.1085/jgp.200509262; Huang YH, 2012, NAT STRUCT MOL BIOL, V19, P728, DOI 10.1038/nsmb.2333; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Luo Y, 2012, MOL MICROBIOL, V83, P623, DOI 10.1111/j.1365-2958.2011.07953.x; Matsuda N, 2004, J BIOL CHEM, V279, P54952, DOI 10.1074/jbc.M407268200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mehne FMP, 2013, J BIOL CHEM, V288, P2004, DOI 10.1074/jbc.M112.395491; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Oppenheimer-Shaanan Y, 2011, EMBO REP, V12, P594, DOI 10.1038/embor.2011.77; Ouyang SY, 2012, IMMUNITY, V36, P1073, DOI 10.1016/j.immuni.2012.03.019; Parvatiyar K, 2012, NAT IMMUNOL, V13, P1155, DOI 10.1038/ni.2460; Pozzi C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002626; Rao F, 2010, J BIOL CHEM, V285, P473, DOI 10.1074/jbc.M109.040238; Shang GJ, 2012, NAT STRUCT MOL BIOL, V19, P725, DOI 10.1038/nsmb.2332; Shu C, 2012, NAT STRUCT MOL BIOL, V19, P722, DOI 10.1038/nsmb.2331; Smith FJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3621; Smith WM, 2012, APPL ENVIRON MICROB, V78, P7753, DOI 10.1128/AEM.02316-12; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sureka K, 2014, CELL, V158, P1389, DOI 10.1016/j.cell.2014.07.046; Terwilliger TC, 2006, ACTA CRYSTALLOGR D, V62, P915, DOI 10.1107/S0907444906017161; Vieira-Pires RS, 2013, NATURE, V496, P323, DOI 10.1038/nature12055; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Yang J, 2014, MOL MICROBIOL, V93, P65, DOI 10.1111/mmi.12641; Yin Q, 2012, MOL CELL, V46, P735, DOI 10.1016/j.molcel.2012.05.029; Zhang L, 2013, J BIOL CHEM, V288, P3085, DOI 10.1074/jbc.M112.428110	48	54	58	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16393	16402		10.1074/jbc.M115.641340	http://dx.doi.org/10.1074/jbc.M115.641340			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25957408	Green Published, hybrid			2022-12-28	WOS:000356930100040
J	Crawford, RR; Prescott, ET; Sylvester, CF; Higdon, AN; Shan, JX; Kilberg, MS; Mungrue, IN				Crawford, Rebecca R.; Prescott, Eugenia T.; Sylvester, Charity F.; Higdon, Ashlee N.; Shan, Jixiu; Kilberg, Michael S.; Mungrue, Imran N.			Human CHAC1 Protein Degrades Glutathione, and mRNA Induction Is Regulated by the Transcription Factors ATF4 and ATF3 and a Bipartite ATF/CRE Regulatory Element	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; DNA transcription; DNA-protein interaction; endoplasmic reticulum stress (ER stress); oxidative stress; unfolded protein response (UPR); ATF3; ATF4; CEBP; CHAC1	ENDOPLASMIC-RETICULUM STRESS; ASPARAGINE SYNTHETASE GENE; ER-STRESS; ENDOTHELIAL-CELLS; INDUCIBLE GENE; EXPRESSION; APOPTOSIS; CHOP; ANTIOXIDANT; ACTIVATION	Using an unbiased systems genetics approach, we previously predicted a role for CHAC1 in the endoplasmic reticulum stress pathway, linked functionally to activating transcription factor 4 (ATF4) following treatment with oxidized phospholipids, a model for atherosclerosis. Mouse and yeast CHAC1 homologs have been shown to degrade glutathione in yeast and a cell-free system. In this report, we further defined the ATF4-CHAC1 interaction by cloning the human CHAC1 promoter upstream of a luciferase reporter system for in vitro assays in HEK293 and U2OS cells. Mutation and deletion analyses defined two major cis DNA elements necessary and sufficient for CHAC1 promoter-driven luciferase transcription under conditions of ER stress or ATF4 coexpression: the -267 ATF/cAMP response element (CRE) site and a novel -248 ATF/CRE modifier (ACM) element. We also examined the ability of the CHAC1 ATF/CRE and ACM sequences to bind ATF4 and ATF3 using immunoblot-EMSA and confirmed ATF4, ATF3, and CCAAT/enhancer-binding protein binding at the human CHAC1 promoter in the proximity of the ATF/CRE and ACM using ChIP. To further validate the function of CHAC1 in a human cell model, we measured glutathione levels in HEK293 cells with enhanced CHAC1 expression. Overexpression of CHAC1 led to a robust depletion of glutathione, which was alleviated in a CHAC1 catalytic mutant. These results suggest an important role for CHAC1 in oxidative stress and apoptosis with implications for human health and disease.	[Crawford, Rebecca R.; Prescott, Eugenia T.; Sylvester, Charity F.; Higdon, Ashlee N.; Mungrue, Imran N.] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA 70112 USA; [Shan, Jixiu; Kilberg, Michael S.] Univ Florida, Coll Med, Shands Canc Ctr, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Shan, Jixiu; Kilberg, Michael S.] Univ Florida, Coll Med, Ctr Nutr Sci, Gainesville, FL 32610 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Mungrue, IN (corresponding author), 1901 Perdido St,MEB 5259, New Orleans, LA 70112 USA.	imungr@lsuhsc.edu	Regan, Clinton/E-6250-2012	Mungrue, Imran/0000-0002-0870-7161	National Institutes of Health [HL094709, DK92062, DK94729]; NSF-REU [1359140]; Louisiana Board of Regents [LESQSF(2012-17)-GF-08]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL094709, K99HL094709] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094729, R01DK092062] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF-REU(National Science Foundation (NSF)NSF - Office of the Director (OD)); Louisiana Board of Regents; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant HL094709 (to I. N. M.). This work was also supported by NSF-REU Site (Grant 1359140) studentship (to C. F. S.) and Louisiana Board of Regents Fellowship LESQSF(2012-17)-GF-08 (to R. R. C.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by National Institutes of Health Grants DK92062 and DK94729.	Aquilano K, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00196; Balasubramanian MN, 2013, AM J PHYSIOL-ENDOC M, V304, pE789, DOI 10.1152/ajpendo.00015.2013; Berisha SZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065003; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Chen GK, 2004, MOL PHARMACOL, V65, P906, DOI 10.1124/mol.65.4.906; Cherasse Y, 2007, NUCLEIC ACIDS RES, V35, P5954, DOI 10.1093/nar/gkm642; Chi ZK, 2014, CELL REP, V7, P681, DOI 10.1016/j.celrep.2014.03.048; Chi ZK, 2012, DEV CELL, V22, P707, DOI 10.1016/j.devcel.2012.02.011; Creech CC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015416; Fu LC, 2013, PHYSIOL GENOMICS, V45, P127, DOI 10.1152/physiolgenomics.00160.2012; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Galluzzi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043249; Gargalovic PS, 2006, ARTERIOSCL THROM VAS, V26, P2490, DOI 10.1161/01.ATV.0000242903.41158.a1; Gargalovic PS, 2006, P NATL ACAD SCI USA, V103, P12741, DOI 10.1073/pnas.0605457103; Goebel G, 2012, BRIT J CANCER, V106, P189, DOI 10.1038/bjc.2011.510; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Joo NE, 2012, CANCER MED-US, V1, P295, DOI 10.1002/cam4.35; Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008; Kumar A, 2012, EMBO REP, V13, P1095, DOI 10.1038/embor.2012.156; Li Y, 2008, J BIOL CHEM, V283, P22443, DOI 10.1074/jbc.M801046200; Magne L, 2011, J HEPATOL, V54, P729, DOI 10.1016/j.jhep.2010.07.023; Mungrue IN, 2009, J IMMUNOL, V182, P466, DOI 10.4049/jimmunol.182.1.466; Oh-hashi K, 2013, MOL CELL BIOCHEM, V380, P97, DOI 10.1007/s11010-013-1663-1; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/bj20020508; Romanoski CE, 2011, CIRC RES, V109, pE27, DOI 10.1161/CIRCRESAHA.111.241869; Romanoski CE, 2010, AM J HUM GENET, V86, P399, DOI 10.1016/j.ajhg.2010.02.002; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Selvik LKM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-429; Shan JX, 2012, J BIOL CHEM, V287, P36393, DOI 10.1074/jbc.M112.399600; Siu F, 2002, J BIOL CHEM, V277, P24120, DOI 10.1074/jbc.M201959200; Su N, 2008, J BIOL CHEM, V283, P35106, DOI 10.1074/jbc.M806874200; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tang CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061093; Teske BF, 2013, MOL BIOL CELL, V24, P2477, DOI 10.1091/mbc.E13-01-0067; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Tsunoda S, 2014, ELIFE, V3, DOI 10.7554/eLife.03421; Wolfgang CD, 2000, J BIOL CHEM, V275, P16865, DOI 10.1074/jbc.M909637199; Xiao GZ, 2013, J BIOL CHEM, V288, P25350, DOI 10.1074/jbc.M113.470526; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Yang XL, 2004, J BIOL CHEM, V279, P47109, DOI 10.1074/jbc.M410010200; Yasuda M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093258; Yoshizawa T, 2009, J CLIN INVEST, V119, P2807, DOI 10.1172/JCI39366; Zhang WP, 2008, RES VET SCI, V84, P374, DOI 10.1016/j.rvsc.2007.05.015	45	98	99	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15878	15891		10.1074/jbc.M114.635144	http://dx.doi.org/10.1074/jbc.M114.635144			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25931127	hybrid, Green Published			2022-12-28	WOS:000356527400046
J	Puto, LA; Brognard, J; Hunter, T				Puto, Lorena A.; Brognard, John; Hunter, Tony			Transcriptional Repressor DAXX Promotes Prostate Cancer Tumorigenicity via Suppression of Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; biomarker; cell death; prostate cancer; tumor cell biology; tumor promoter; tumor suppressor gene; DAXX	DOMAIN-ASSOCIATED PROTEIN; CELL-LINES; TUMOR SUPPRESSION; LUNG-TUMORS; BECLIN 1; CARCINOMA; APOPTOSIS; PROGRESSION; INHIBITION; EXPRESSION	Background: Transcriptional repressor DAXX suppresses several tumor suppressor genes and is up-regulated in many cancers. Results: We demonstrate that DAXX has potent growth-enhancing effects on primary prostatic malignancy through inhibition of autophagy. Conclusion: In the early stages of tumorigenesis, autophagy suppresses prostate tumor formation. Significance: This is the first study to link prostate cancer development to autophagy suppression by DAXX. The DAXX transcriptional repressor was originally associated with apoptotic cell death. However, recent evidence that DAXX represses several tumor suppressor genes, including the DAPK1 and DAPK3 protein kinases, and is up-regulated in many cancers argues that a pro-survival role may predominate in a cancer context. Here, we report that DAXX has potent growth-enhancing effects on primary prostatic malignancy through inhibition of autophagy. Through stable gene knockdown and mouse subcutaneous xenograft studies, we demonstrate that DAXX promotes tumorigenicity of human ALVA-31 and PC3 prostate cancer (PCa) cells in vivo. Importantly, DAXX represses expression of essential autophagy modulators DAPK3 and ULK1 in vivo, revealing autophagy suppression as a mechanism through which DAXX promotes PCa tumorigenicity. Furthermore, DAXX knockdown increases autophagic flux in cultured PCa cells. Finally, interrogation of the Oncomine(TM) database suggests that DAXX overexpression is associated with malignant transformation in several human cancers, including prostate and pancreatic cancers. Thus, DAXX may represent a new cancer biomarker for the detection of aggressive disease, whose tissue-specific down-regulation can serve as an improved therapeutic modality. Our results establish DAXX as a pro-survival protein in PCa and reveal that, in the early stages of tumorigenesis, autophagy suppresses prostate tumor formation.	[Puto, Lorena A.; Hunter, Tony] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; [Brognard, John] Univ Manchester, Canc Res UK Manchester Inst, Manchester M20 4BX, Lancs, England	Salk Institute; Cancer Research UK; University of Manchester	Hunter, T (corresponding author), 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	hunter@salk.edu	PUTO, LORENA A./ABB-6941-2021; Brognard, John/T-5099-2019	Brognard, John/0000-0002-9243-6615	National Institutes of Health, NCI [CA14195, CA082683, 5T32CA009523-28]; Department of Defense [DoD-W81XWH-08-1-0209]; Cancer Research UK Manchester Institute; Cancer Research UK [12936] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA014195, T32CA009523, R01CA082683] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); Cancer Research UK Manchester Institute; Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grants CA14195 and CA082683 (to T. H.) and Fellowship 5T32CA009523-28 (to L. A. P.). This work was also supported by Department of Defense Prostate Cancer Research Program Fellowship DoD-W81XWH-08-1-0209 (to L. A. P.) and a grant from the Cancer Research UK Manchester Institute (to J. B.).	Chang MA, 2014, PROSTATE, V74, P149, DOI 10.1002/pros.22737; Clegg NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017449; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; Dong JT, 2006, J CELL BIOCHEM, V97, P433, DOI 10.1002/jcb.20696; Elgendy M, 2011, MOL CELL, V42, P23, DOI 10.1016/j.molcel.2011.02.009; Fernandez-Medarde Alberto, 2011, Genes Cancer, V2, P344, DOI 10.1177/1947601911411084; Festuccia C, 2005, ENDOCR-RELAT CANCER, V12, P983, DOI 10.1677/erc.1.00986; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Guo JY, 2013, GENE DEV, V27, P1447, DOI 10.1101/gad.219642.113; Guo Jinjin, 2010, Genes Cancer, V1, P836, DOI 10.1177/1947601910381645; Heaphy CM, 2011, AM J PATHOL, V179, P1608, DOI 10.1016/j.ajpath.2011.06.018; Hollander MC, 2011, NAT REV CANCER, V11, P289, DOI 10.1038/nrc3037; Horvilleur E, 2014, LEUKEMIA, V28, P1092, DOI 10.1038/leu.2013.295; Hostanska K, 2005, ANTICANCER RES, V25, P139; Jenkins RB, 1997, CANCER RES, V57, P524; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; KAIGHN ME, 1979, INVEST UROL, V17, P16; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Kitanaka C, 2002, J NATL CANCER I, V94, P358; Kohli L, 2013, AUTOPHAGY, V9, P1438, DOI 10.4161/auto.25837; Kwan PS, 2013, CARCINOGENESIS, V34, P750, DOI 10.1093/carcin/bgs391; Lee EJ, 2011, AUTOPHAGY, V7, P689, DOI 10.4161/auto.7.7.15450; Lewis PW, 2010, P NATL ACAD SCI USA, V107, P14075, DOI 10.1073/pnas.1008850107; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liu XD, 2015, ONCOGENE, V34, P2450, DOI 10.1038/onc.2014.199; Liu ZZ, 2014, CANCER CELL, V26, P106, DOI 10.1016/j.ccr.2014.05.015; LOOP SM, 1993, PROSTATE, V22, P93, DOI 10.1002/pros.2990220202; LOWE BA, 1988, J UROLOGY, V140, P1340, DOI 10.1016/S0022-5347(17)42039-8; Magee JA, 2001, CANCER RES, V61, P5692; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Michaelson JS, 1999, GENE DEV, V13, P1918, DOI 10.1101/gad.13.15.1918; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; MOUL JW, 1992, PROSTATE, V20, P327, DOI 10.1002/pros.2990200407; Ouyang DY, 2013, AUTOPHAGY, V9, P20, DOI 10.4161/auto.22397; Pan WW, 2013, J BIOL CHEM, V288, P13620, DOI 10.1074/jbc.M112.446369; Phin S, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00240; Puissant A, 2012, AM J CANCER RES, V2, P397; Puto LA, 2008, GENE DEV, V22, P998, DOI 10.1101/gad.1632208; Puto Lorena A, 2015, Oncoscience, V2, P362; Ramakrishnan S, 2007, AUTOPHAGY, V3, P512; Roach PJ, 2011, MOL CELL BIOL, V31, P3082, DOI 10.1128/MCB.05565-11; Rosenfeldt MT, 2013, NATURE, V504, P296, DOI 10.1038/nature12865; Russell RC, 2013, NAT CELL BIOL, V15, P741, DOI 10.1038/ncb2757; Sakurai T, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0701-x; Strohecker AM, 2013, CANCER DISCOV, V3, P1272, DOI 10.1158/2159-8290.CD-13-0397; Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211; Tang HW, 2011, EMBO J, V30, P636, DOI 10.1038/emboj.2010.338; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Tsourlakis MC, 2013, HUM PATHOL, V44, P1789, DOI 10.1016/j.humpath.2013.01.022; Tsuji T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009885; Ueno T, 2008, AUTOPHAGY, V4, P692, DOI 10.4161/auto.6085; van Bokhoven A, 2001, PROSTATE, V47, P36; Wang RC, 2012, SCIENCE, V338, P956, DOI 10.1126/science.1225967; Wang XD, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r255; Welsh JB, 2001, CANCER RES, V61, P5974; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Yang XL, 1997, CELL, V89, P1067, DOI 10.1016/S0092-8674(00)80294-9; Zalckvar E, 2009, AUTOPHAGY, V5, P720, DOI 10.4161/auto.5.5.8625; Zizzi A, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-111	60	27	29	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15406	15420		10.1074/jbc.M115.658765	http://dx.doi.org/10.1074/jbc.M115.658765			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25903140	Green Published, hybrid			2022-12-28	WOS:000356527400009
J	Chojnacka, M; Gornicka, A; Oeljeklaus, S; Warscheid, B; Chacinska, A				Chojnacka, Magdalena; Gornicka, Agnieszka; Oeljeklaus, Silke; Warscheid, Bettina; Chacinska, Agnieszka			Cox17 Protein Is an Auxiliary Factor Involved in the Control of the Mitochondrial Contact Site and Cristae Organizing System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERMEMBRANE SPACE PROTEINS; CYTOCHROME-C-OXIDASE; INNER-MEMBRANE; MITOFILIN COMPLEXES; OUTER-MEMBRANE; YEAST; BIOGENESIS; ORGANIZATION; ARCHITECTURE; MORPHOLOGY	The mitochondrial contact site and cristae organizing system (MICOS) is a recently discovered protein complex that is crucial for establishing and maintaining the proper inner membrane architecture and contacts with the outer membrane of mitochondria. The ways in which the MICOS complex is assembled and its integrity is regulated remain elusive. Here, we report a direct link between Cox17, a protein involved in the assembly of cytochrome c oxidase, and the MICOS complex. Cox17 interacts with Mic60, thereby modulating MICOS complex integrity. This interaction does not involve Sco1, a partner of Cox17 in transferring copper ions to cytochrome c oxidase. However, the Cox17-MICOS interaction is regulated by copper ions. We propose that Cox17 is a newly identified factor involved in maintaining the architecture of the MICOS complex.	[Chojnacka, Magdalena; Gornicka, Agnieszka; Chacinska, Agnieszka] Int Inst Mol & Cell Biol, PL-02109 Warsaw, Poland; [Oeljeklaus, Silke; Warscheid, Bettina] Univ Freiburg, Dept Biochem & Funct Prote, Inst Biol 2, Fac Biol, D-79104 Freiburg, Germany; [Oeljeklaus, Silke; Warscheid, Bettina] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany	Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; University of Freiburg; University of Freiburg	Chacinska, A (corresponding author), Int Inst Mol & Cell Biol, Lab Mitochondrial Biogenesis, Ks Trojdena 4, PL-02109 Warsaw, Poland.	achacinska@iimcb.gov.pl		Warscheid, Bettina/0000-0001-5096-1975	National Science Centre (NCN) [2011/02/B/NZ2/01402]; Foundation for Polish Science - Welcome Programme; European Union (EU) within the European Regional Development Fund; Welcome Programme; Deutsche Forschungsgemeinschaft (DFG); Excellence Initiative of the German Federal Government Centre for Biological Signalling Studies (EXC 294) [EXC 294 BIOSS]; Excellence Initiative of the German State Government Centre for Biological Signalling Studies (EXC 294) [EXC 294 BIOSS]	National Science Centre (NCN); Foundation for Polish Science - Welcome Programme; European Union (EU) within the European Regional Development Fund; Welcome Programme; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Excellence Initiative of the German Federal Government Centre for Biological Signalling Studies (EXC 294); Excellence Initiative of the German State Government Centre for Biological Signalling Studies (EXC 294)	This work was supported by a National Science Centre (NCN) grant (2011/02/B/NZ2/01402) and the Foundation for Polish Science - Welcome Programme co-financed by the European Union (EU) within the European Regional Development Fund. This work was also supported by stipends within the Welcome Programme (to M. C. and A. G.) and the Deutsche Forschungsgemeinschaft (DFG) and Excellence Initiative of the German Federal and State Governments Grant EXC 294 BIOSS Centre for Biological Signalling Studies (EXC 294) (to B. W.).	Alkhaja AK, 2012, MOL BIOL CELL, V23, P247, DOI 10.1091/mbc.E11-09-0774; Beers J, 1997, J BIOL CHEM, V272, P33191, DOI 10.1074/jbc.272.52.33191; Bottinger L, 2012, MOL BIOL CELL, V23, P3957, DOI 10.1091/mbc.E12-05-0358; Bohnert M, 2012, MOL BIOL CELL, V23, P3948, DOI 10.1091/mbc.E12-04-0295; Bragoszewski P, 2013, MOL CELL BIOL, V33, P2136, DOI 10.1128/MCB.01579-12; Chacinska A, 2004, EMBO J, V23, P3735, DOI 10.1038/sj.emboj.7600389; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Davies KM, 2012, P NATL ACAD SCI USA, V109, P13602, DOI 10.1073/pnas.1204593109; Davies KM, 2011, P NATL ACAD SCI USA, V108, P14121, DOI 10.1073/pnas.1103621108; Frey TG, 2000, TRENDS BIOCHEM SCI, V25, P319, DOI 10.1016/S0968-0004(00)01609-1; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Glerum DM, 1996, J BIOL CHEM, V271, P14504, DOI 10.1074/jbc.271.24.14504; Harner M, 2011, EMBO J, V30, P4356, DOI 10.1038/emboj.2011.379; Harner ME, 2014, ELIFE, V3, DOI 10.7554/eLife.01684; Heaton D, 2000, J BIOL CHEM, V275, P37582, DOI 10.1074/jbc.M006639200; Hoppins S, 2011, J CELL BIOL, V195, P323, DOI 10.1083/jcb.201107053; Horng YC, 2004, J BIOL CHEM, V279, P35334, DOI 10.1074/jbc.M404747200; John GB, 2005, MOL BIOL CELL, V16, P1543, DOI 10.1091/mbc.e04-08-0697; Korner C, 2012, MOL BIOL CELL, V23, P2143, DOI 10.1091/mbc.E11-10-0831; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Mannella CA, 2006, BBA-MOL CELL RES, V1763, P542, DOI 10.1016/j.bbamcr.2006.04.006; Meeusen S, 2006, CELL, V127, P383, DOI 10.1016/j.cell.2006.09.021; Meisinger Chris, 2006, Methods Mol Biol, V313, P33; Merkwirth C, 2009, BBA-MOL CELL RES, V1793, P27, DOI 10.1016/j.bbamcr.2008.05.013; Nittis T, 2001, J BIOL CHEM, V276, P42520, DOI 10.1074/jbc.M107077200; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Ott C, 2012, MOL CELL BIOL, V32, P1173, DOI 10.1128/MCB.06388-11; Pellegrini L, 2007, CELL DEATH DIFFER, V14, P1275, DOI 10.1038/sj.cdd.4402145; Pfanner N, 2014, J CELL BIOL, V204, P1083, DOI 10.1083/jcb.201401006; Rabl R, 2009, J CELL BIOL, V185, P1047, DOI 10.1083/jcb.200811099; Reichert AS, 2002, BBA-MOL CELL RES, V1592, P41, DOI 10.1016/S0167-4889(02)00263-X; Rigby K, 2008, J BIOL CHEM, V283, P15015, DOI 10.1074/jbc.M710072200; SIKORSKI RS, 1989, GENETICS, V122, P19; Stojanovski D, 2012, BBA-MOL CELL RES, V1823, P1142, DOI 10.1016/j.bbamcr.2012.04.014; Toulmay A, 2011, CURR OPIN CELL BIOL, V23, P458, DOI 10.1016/j.ceb.2011.04.006; van der Laan M, 2012, TRENDS CELL BIOL, V22, P185, DOI 10.1016/j.tcb.2012.01.004; Vogel F, 2006, J CELL BIOL, V175, P237, DOI 10.1083/jcb.200605138; von der Malsburg K, 2011, DEV CELL, V21, P694, DOI 10.1016/j.devcel.2011.08.026; Wurm CA, 2006, FEBS LETT, V580, P5628, DOI 10.1016/j.febslet.2006.09.012; Zerbes RM, 2012, BIOL CHEM, V393, P1247, DOI 10.1515/hsz-2012-0239; Zerbes RM, 2012, J MOL BIOL, V422, P183, DOI 10.1016/j.jmb.2012.05.004; Zick M, 2009, BBA-MOL CELL RES, V1793, P5, DOI 10.1016/j.bbamcr.2008.06.013	43	25	26	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15304	15312		10.1074/jbc.M115.645069	http://dx.doi.org/10.1074/jbc.M115.645069			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25918166	Green Published, hybrid			2022-12-28	WOS:000356177300041
J	Hennon, SW; Soman, R; Zhu, L; Dalbey, RE				Hennon, Seth W.; Soman, Raunak; Zhu, Lu; Dalbey, Ross E.			YidC/Alb3/Oxa1 Family of Insertases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							MEMBRANE-PROTEIN INSERTION; ESCHERICHIA-COLI YIDC; SIGNAL RECOGNITION PARTICLE; CYTOCHROME-C-OXIDASE; INDEPENDENT GENE DUPLICATIONS; RESPIRATORY-CHAIN COMPLEXES; F1F0 ATP SYNTHASE; PF3 COAT PROTEIN; INNER-MEMBRANE; CRYSTAL-STRUCTURE	The YidC/Alb3/Oxa1 family functions in the insertion and folding of proteins in the bacterial cytoplasmic membrane, the chloroplast thylakoid membrane, and the mitochondrial inner membrane. All members share a conserved region composed of five transmembrane regions. These proteins mediate membrane insertion of an assorted group of proteins, ranging from respiratory subunits in the mitochondria and light-harvesting chlorophyll-binding proteins in chloroplasts to ATP synthase subunits in bacteria. This review discusses the YidC/Alb3/Oxa1 protein family as well as their function in membrane insertion and two new structures of the bacterial YidC, which suggest a mechanism for membrane insertion by this family of insertases.	[Hennon, Seth W.; Soman, Raunak; Zhu, Lu; Dalbey, Ross E.] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Dalbey, RE (corresponding author), Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA.	dalbey@chemistry.ohio-state.edu			National Science Foundation [MCB-1052033]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB-1052033 (to R. E. D.)	Altamura N, 1996, FEBS LETT, V382, P111, DOI 10.1016/0014-5793(96)00165-2; [Anonymous], J BIOL CHEM, V281, P10002; Aschtgen MS, 2012, MICROBIOLOGYOPEN, V1, P71, DOI 10.1002/mbo3.9; BAUER M, 1994, MOL GEN GENET, V245, P272, DOI 10.1007/BF00290106; Beck K, 2001, EMBO REP, V2, P709, DOI 10.1093/embo-reports/kve154; Bellafiore S, 2002, PLANT CELL, V14, P2303, DOI 10.1105/tpc.003442; Benz M, 2009, MOL PLANT, V2, P1410, DOI 10.1093/mp/ssp095; Bohnert M, 2010, CURR BIOL, V20, P1227, DOI 10.1016/j.cub.2010.05.058; BONNEFOY N, 1994, J MOL BIOL, V239, P201, DOI 10.1006/jmbi.1994.1363; Bonnefoy N, 2009, BBA-MOL CELL RES, V1793, P60, DOI 10.1016/j.bbamcr.2008.05.004; Celebi N, 2006, J MOL BIOL, V357, P1428, DOI 10.1016/j.jmb.2006.01.030; Chen MY, 2002, J BIOL CHEM, V277, P7670, DOI 10.1074/jbc.M110644200; Chen YY, 2014, J BIOL CHEM, V289, P35656, DOI 10.1074/jbc.M114.595082; Chiba S, 2012, MOL CELL, V47, P863, DOI 10.1016/j.molcel.2012.06.034; Chiba S, 2009, EMBO J, V28, P3461, DOI 10.1038/emboj.2009.280; Denks K, 2014, MOL MEMBR BIOL, V31, P58, DOI 10.3109/09687688.2014.907455; Dong Y, 2008, J BACTERIOL, V190, P2458, DOI 10.1128/JB.01366-07; Dunschede B, 2011, J BIOL CHEM, V286, P35187, DOI 10.1074/jbc.M111.250746; Falk S, 2010, J BIOL CHEM, V285, P5954, DOI 10.1074/jbc.M109.084996; Fiumera HL, 2007, MOL CELL BIOL, V27, P4664, DOI 10.1128/MCB.01955-06; Fiumera HL, 2009, GENETICS, V182, P519, DOI 10.1534/genetics.109.101196; Frobel J, 2012, PHILOS T R SOC B, V367, P1029, DOI 10.1098/rstb.2011.0202; Funes S, 2004, MOL BIOL CELL, V15, P1853, DOI 10.1091/mbc.e03-11-0789; Funes S, 2011, BIOL CHEM, V392, P13, DOI 10.1515/BC.2011.013; Funes S, 2009, P NATL ACAD SCI USA, V106, P6656, DOI 10.1073/pnas.0809951106; Gerdes L, 2006, J BIOL CHEM, V281, P16632, DOI 10.1074/jbc.M513623200; Gohre V, 2006, PLANT CELL, V18, P1454, DOI 10.1105/tpc.105.038695; Gotzke H, 2014, J BIOL CHEM, V289, P19089, DOI 10.1074/jbc.M113.541672; Gray AN, 2011, MBIO, V2, DOI 10.1128/mBio.00238-11; Hasona A, 2005, P NATL ACAD SCI USA, V102, P17466, DOI 10.1073/pnas.0508778102; He SC, 1997, MOL BIOL CELL, V8, P1449, DOI 10.1091/mbc.8.8.1449; Hegde RS, 2011, NAT REV MOL CELL BIO, V12, P787, DOI 10.1038/nrm3226; Hell K, 1998, P NATL ACAD SCI USA, V95, P2250, DOI 10.1073/pnas.95.5.2250; Hell K, 1997, FEBS LETT, V418, P367, DOI 10.1016/S0014-5793(97)01412-9; Hell K, 2001, EMBO J, V20, P1281, DOI 10.1093/emboj/20.6.1281; Hennon SW, 2014, BIOCHEMISTRY-US, V53, P3278, DOI 10.1021/bi500257u; Herrmann JM, 2004, J BIOL CHEM, V279, P2507, DOI 10.1074/jbc.M310468200; Jaru-Ampornpan P, 2007, MOL BIOL CELL, V18, P2636, DOI 10.1091/mbc.E07-01-0037; Jia LX, 2009, EUKARYOT CELL, V8, P1792, DOI 10.1128/EC.00219-09; Jia LX, 2003, EMBO J, V22, P6438, DOI 10.1093/emboj/cdg624; Jiang FL, 2003, J BIOL CHEM, V278, P48965, DOI 10.1074/jbc.M307362200; Jiang FL, 2002, J BIOL CHEM, V277, P19281, DOI 10.1074/jbc.M110857200; Kaur J, 2011, EMBO REP, V12, P950, DOI 10.1038/embor.2011.133; Kedrov A, 2013, J MOL BIOL, V425, P4112, DOI 10.1016/j.jmb.2013.07.042; Keil M, 2012, J BIOL CHEM, V287, P34484, DOI 10.1074/jbc.M112.382630; Klenner C, 2012, J BIOL CHEM, V287, P3769, DOI 10.1074/jbc.M111.307223; Klostermann E, 2002, BIOCHEM J, V368, P777, DOI 10.1042/BJ20021291; Kohler R, 2009, MOL CELL, V34, P344, DOI 10.1016/j.molcel.2009.04.019; Kol S, 2009, J MOL BIOL, V390, P893, DOI 10.1016/j.jmb.2009.05.074; Koppen M, 2007, CRIT REV BIOCHEM MOL, V42, P221, DOI 10.1080/10409230701380452; Kumazaki K, 2014, SCI REP-UK, V4, DOI 10.1038/srep07299; Kumazaki K, 2014, NATURE, V509, P516, DOI 10.1038/nature13167; Lemaire C, 2004, J BIOL CHEM, V279, P47464, DOI 10.1074/jbc.M404861200; Li ZP, 2014, J BACTERIOL, V196, P367, DOI 10.1128/JB.01095-13; Linhartova M, 2014, MOL MICROBIOL, V93, P1207, DOI 10.1111/mmi.12730; Luirink J, 2001, FEBS LETT, V501, P1, DOI 10.1016/S0014-5793(01)02616-3; Moore M, 2003, J CELL BIOL, V162, P1245, DOI 10.1083/jcb.200307067; Moore M, 2000, J BIOL CHEM, V275, P1529, DOI 10.1074/jbc.275.3.1529; Mori H, 1999, J CELL BIOL, V146, P45, DOI 10.1083/jcb.146.1.45; Nagamori S, 2004, J CELL BIOL, V165, P53, DOI 10.1083/jcb.200402067; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Nouwen N, 2002, MOL MICROBIOL, V44, P1397, DOI 10.1046/j.1365-2958.2002.02972.x; Oliver DC, 2008, J BIOL CHEM, V283, P5208, DOI 10.1074/jbc.M708936200; Ossenbuhl F, 2004, PLANT CELL, V16, P1790, DOI 10.1105/tpc.023226; Palmer T, 2012, NAT REV MICROBIOL, V10, P483, DOI 10.1038/nrmicro2814; Pasch JC, 2005, APPL MICROBIOL BIOT, V69, P440, DOI 10.1007/s00253-005-0029-3; Preuss M, 2005, J BIOL CHEM, V280, P13004, DOI 10.1074/jbc.M414093200; Price CE, 2010, J BIOL CHEM, V285, P3575, DOI 10.1074/jbc.M109.051128; Ravaud S, 2008, J BIOL CHEM, V283, P9350, DOI 10.1074/jbc.M710493200; Saaf A, 1998, J BIOL CHEM, V273, P30415, DOI 10.1074/jbc.273.46.30415; Sachelaru I, 2013, J BIOL CHEM, V288, P16295, DOI 10.1074/jbc.M112.446583; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Samuelson JC, 2001, J BIOL CHEM, V276, P34847, DOI 10.1074/jbc.M105793200; Saracco SA, 2002, MOL BIOL CELL, V13, P1122, DOI 10.1091/mbc.01-12-0580; Schuenemann D, 1998, P NATL ACAD SCI USA, V95, P10312, DOI 10.1073/pnas.95.17.10312; Schulze RJ, 2014, P NATL ACAD SCI USA, V111, P4844, DOI 10.1073/pnas.1315901111; Scotti PA, 2000, EMBO J, V19, P542, DOI 10.1093/emboj/19.4.542; Seitl I, 2014, MOL MICROBIOL, V91, P408, DOI 10.1111/mmi.12465; Soman R, 2014, J BIOL CHEM, V289, P1023, DOI 10.1074/jbc.M113.522250; Spence E, 2004, J BIOL CHEM, V279, P55792, DOI 10.1074/jbc.M411041200; Sundberg E, 1997, PLANT CELL, V9, P717, DOI 10.1105/tpc.9.5.717; Szyrach G, 2003, EMBO J, V22, P6448, DOI 10.1093/emboj/cdg623; Tjalsma H, 2003, J BIOL CHEM, V278, P15622, DOI 10.1074/jbc.M301205200; Trager C, 2012, PLANT CELL, V24, P4819, DOI 10.1105/tpc.112.102996; Urbanus ML, 2001, EMBO REP, V2, P524, DOI 10.1093/embo-reports/kve108; van Bloois E, 2005, J BIOL CHEM, V280, P12996, DOI 10.1074/jbc.M414094200; van Bloois E, 2004, FEBS LETT, V576, P97, DOI 10.1016/j.febslet.2004.08.069; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; van der Laan M, 2005, CURR OPIN MICROBIOL, V8, P182, DOI 10.1016/j.mib.2005.02.004; van der Laan M, 2003, P NATL ACAD SCI USA, V100, P5801, DOI 10.1073/pnas.0636761100; Wagner S, 2008, J BIOL CHEM, V283, P17881, DOI 10.1074/jbc.M801481200; Wickles S, 2014, ELIFE, V3, DOI 10.7554/eLife.03035; Yen MR, 2001, FEMS MICROBIOL LETT, V204, P223, DOI 10.1111/j.1574-6968.2001.tb10889.x; Yi L, 2003, BIOCHEMISTRY-US, V42, P10537, DOI 10.1021/bi034309h; Yi L, 2004, J BIOL CHEM, V279, P39260, DOI 10.1074/jbc.M405490200; Yu Z, 2008, J BIOL CHEM, V283, P34635, DOI 10.1074/jbc.M804344200; Zhu L, 2013, J BIOL CHEM, V288, P28180, DOI 10.1074/jbc.M113.491613; Zhu L, 2013, J BIOL CHEM, V288, P7704, DOI 10.1074/jbc.M112.429431; Zhu L, 2012, J MOL BIOL, V424, P354, DOI 10.1016/j.jmb.2012.09.026	99	63	64	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					14866	14874		10.1074/jbc.R115.638171	http://dx.doi.org/10.1074/jbc.R115.638171			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25947384	Green Published, hybrid			2022-12-28	WOS:000356177300006
J	Ingold, I; Aichler, M; Yefremova, E; Roveri, A; Buday, K; Doll, S; Tasdemir, A; Hoffard, N; Wurst, W; Walch, A; Ursini, F; Angeli, JPF; Conrad, M				Ingold, Irina; Aichler, Michaela; Yefremova, Elena; Roveri, Antonella; Buday, Katalin; Doll, Sebastian; Tasdemir, Adrianne; Hoffard, Nils; Wurst, Wolfgang; Walch, Axel; Ursini, Fulvio; Angeli, Jose Pedro Friedmann; Conrad, Marcus			Expression of a Catalytically Inactive Mutant Form of Glutathione Peroxidase 4 (Gpx4) Confers a Dominant-negative Effect in Male Fertility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; EMBRYONIC LETHALITY; SELENIUM DEFICIENCY; SPERM MATURATION; NUCLEAR FORM; VITAMIN-E; PROTEIN; MICE; SELENOENZYME; DISRUPTION	The selenoenzyme Gpx4 is essential for early embryogenesis and cell viability for its unique function to prevent phospholipid oxidation. Recently, the cytosolic form of Gpx4 was identified as an upstream regulator of a novel form of non-apoptotic cell death, called ferroptosis, whereas the mitochondrial isoform of Gpx4 was previously shown to be crucial for male fertility. Here, we generated and analyzed mice with a targeted mutation of the active site selenocysteine of Gpx4 (Gpx4_U46S). Mice homozygous for Gpx4_U46S died at the same embryonic stage (E7.5) as Gpx4(-/-) embryos as expected. Surprisingly, male mice heterozygous for Gpx4_U46S presented subfertility. Subfertility was manifested in a reduced number of litters from heterozygous breeding and an impairment of spermatozoa to fertilize oocytes in vitro. Morphologically, sperm isolated from heterozygous Gpx4_U46S mice revealed many structural abnormalities particularly in the spermatozoa midpiece due to improper oxidation and polymerization of sperm capsular proteins and malformation of the mitochondrial capsule surrounding and stabilizing sperm mitochondria. These findings are reminiscent of sperm isolated from selenium-deprived rodents or from mice specifically lacking mitochondrial Gpx4. Due to a strongly facilitated incorporation of Ser in the polypeptide chain as compared with selenocysteine at the UGA codon, expression of the catalytically inactive Gpx4_U46S was found to be strongly increased. Because the stability of the mitochondrial capsule of mature spermatozoa depends on the moonlighting function of Gpx4 both as an enzyme oxidizing capsular protein thiols and as a structural protein, tightly controlled expression of functional Gpx4 emerges as a key for full male fertility.	[Ingold, Irina; Yefremova, Elena; Buday, Katalin; Doll, Sebastian; Tasdemir, Adrianne; Hoffard, Nils; Wurst, Wolfgang; Angeli, Jose Pedro Friedmann; Conrad, Marcus] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Dev Genet, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany; [Aichler, Michaela; Walch, Axel] Helmholtz Zentrum Munchen, Res Unit Analyt Pathol, D-85764 Neuherberg, Germany; [Roveri, Antonella; Ursini, Fulvio] Univ Padua, Dept Mol Med, I-35121 Padua, Italy; [Wurst, Wolfgang] Deutsch Zentrum Neurodegenerat Erkrankungen eV DZ, D-80336 Munich, Germany; [Wurst, Wolfgang] Univ Munich, Munich Cluster Syst Neurol SyNergy, Adolf Butenandt Inst, D-80336 Munich, Germany; [Wurst, Wolfgang] Tech Univ Munchen Weihenstephan, Lehrstuhl Entwicklungsgenet, Helmholtz Zentrum Munchen, D-85764 Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Padua; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Conrad, M (corresponding author), Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Dev Genet, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.	marcus.conrad@helmholtz-muenchen.de	Roveri, Antonella/AAF-3669-2019; Walch, Axel/B-4554-2012; Friedmann Angeli, Jose/C-9038-2014; Conrad, Marcus/E-8792-2015; Angeli, J Pedro Friedmann/ABG-6270-2020; Aichler, Michaela/B-5356-2014	Roveri, Antonella/0000-0002-3252-0559; Walch, Axel/0000-0001-5578-4023; Conrad, Marcus/0000-0003-1140-5612; Angeli, J Pedro Friedmann/0000-0001-7706-1379; Wurst, Wolfgang/0000-0003-4422-7410; Doll, Sebastian/0000-0002-8933-5362	Deutsche Forschungsgemeinschaft (DFG) [CO 291/2-3, CO 291/5-1]; Human Frontier Science Programme (HFSP) [RGP13/2014]; Humboldt Research Fellowship; Helmholtz Portfolio Theme "Supercomputing and Modeling for the Human Brain" (SMHB); German Federal Ministry of Education and Research (BMBF) through the Integrated Network Alcoholism (Alcohol Addiction: systems-oriented approach), under e:Med Programme [01ZX1311G]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Human Frontier Science Programme (HFSP)(Human Frontier Science Program); Humboldt Research Fellowship(Alexander von Humboldt Foundation); Helmholtz Portfolio Theme "Supercomputing and Modeling for the Human Brain" (SMHB); German Federal Ministry of Education and Research (BMBF) through the Integrated Network Alcoholism (Alcohol Addiction: systems-oriented approach), under e:Med Programme(Federal Ministry of Education & Research (BMBF))	This work was supported in part by Deutsche Forschungsgemeinschaft (DFG) Grants CO 291/2-3 and CO 291/5-1 (to M. C.), Human Frontier Science Programme (HFSP) Grant RGP13/2014 (to M. C. and F. U.), and by a Humboldt Research Fellowship (to J. P. F. A.). This work was also funded in part by the Helmholtz Portfolio Theme "Supercomputing and Modeling for the Human Brain" (SMHB) and by the German Federal Ministry of Education and Research (BMBF) through the Integrated Network Alcoholism (Alcohol Addiction: systems-oriented approach), under the auspices of the e:Med Programme (Grant 01ZX1311G (to W. W.)).	Angeli JPF, 2014, NAT CELL BIOL, V16, P1180, DOI 10.1038/ncb3064; Bosl MR, 1997, P NATL ACAD SCI USA, V94, P5531, DOI 10.1073/pnas.94.11.5531; Brigelius-Flohe R, 2013, BBA-GEN SUBJECTS, V1830, P3289, DOI 10.1016/j.bbagen.2012.11.020; Brutsch SH, 2015, ANTIOXID REDOX SIGN, V22, P281, DOI 10.1089/ars.2014.5967; Conrad M, 2005, MOL CELL BIOL, V25, P7637, DOI 10.1128/MCB.25.17.7637-7644.2005; Conrad M, 2004, MOL CELL BIOL, V24, P9414, DOI 10.1128/MCB.24.21.9414-9423.2004; Conrad M, 2007, BIOL CHEM, V388, P1019, DOI 10.1515/BC.2007.130; Conrad M, 2015, BBA-GEN SUBJECTS, V1850, P1566, DOI 10.1016/j.bbagen.2014.10.020; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Hatfield DL, 2014, TRENDS BIOCHEM SCI, V39, P112, DOI 10.1016/j.tibs.2013.12.007; Imai H, 2009, J BIOL CHEM, V284, P32522, DOI 10.1074/jbc.M109.016139; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Maiorino M, 2005, J BIOL CHEM, V280, P38395, DOI 10.1074/jbc.M505983200; Mannes AM, 2011, FASEB J, V25, P2135, DOI 10.1096/fj.10-177147; Nomura K, 1999, J BIOL CHEM, V274, P29294, DOI 10.1074/jbc.274.41.29294; Pfeifer H, 2001, FASEB J, V15, P1236, DOI 10.1096/fj.00-0655fje; Puglisi R, 2007, ENDOCRINOLOGY, V148, P4302, DOI 10.1210/en.2007-0348; Puglisi R, 2012, J CELL PHYSIOL, V227, P1420, DOI 10.1002/jcp.22857; ROVERI A, 1994, METHOD ENZYMOL, V233, P202; Schneider M, 2009, FASEB J, V23, P3233, DOI 10.1096/fj.09-132795; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; SHALGI R, 1989, BIOL REPROD, V40, P1037, DOI 10.1095/biolreprod40.5.1037; Suppmann S, 1999, EMBO J, V18, P2284, DOI 10.1093/emboj/18.8.2284; Ueta T, 2012, J BIOL CHEM, V287, P7675, DOI 10.1074/jbc.M111.335174; Ursini F, 1999, SCIENCE, V285, P1393, DOI 10.1126/science.285.5432.1393; URSINI F, 1982, BIOCHIM BIOPHYS ACTA, V710, P197, DOI 10.1016/0005-2760(82)90150-3; WALLACE E, 1983, GAMETE RES, V7, P377, DOI 10.1002/mrd.1120070409; WALLACE E, 1983, GAMETE RES, V7, P389, DOI 10.1002/mrd.1120070410; Wortmann M, 2013, CIRC RES, V113, P408, DOI 10.1161/CIRCRESAHA.113.279984; WU SH, 1973, BIOL REPROD, V8, P625, DOI 10.1093/biolreprod/8.5.625; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Yant LJ, 2003, FREE RADICAL BIO MED, V34, P496, DOI 10.1016/S0891-5849(02)01360-6	32	46	51	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14668	14678		10.1074/jbc.M115.656363	http://dx.doi.org/10.1074/jbc.M115.656363			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25922076	hybrid, Green Published			2022-12-28	WOS:000355754600037
J	Vashisht, AA; Yu, CC; Sharma, T; Ro, K; Wohlschlegel, JA				Vashisht, Ajay A.; Yu, Clarissa C.; Sharma, Tanu; Ro, Kevin; Wohlschlegel, James A.			The Association of the Xeroderma Pigmentosum Group D DNA Helicase (XPD) with Transcription Factor IIH Is Regulated by the Cytosolic Iron-Sulfur Cluster Assembly Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN IDENTIFICATION TECHNOLOGY; REPAIR; GENE; HOMEOSTASIS; METABOLISM; CANCER; CELLS	Xeroderma pigmentosum groupD(XPD) helicase is a component of the transcription factor IIH (TFIIH) transcription complex and plays essential roles in transcription and nucleotide excision repair. Although iron-sulfur (Fe-S) cluster binding by XPD is required for activity, the process mediating Fe-S cluster assembly remains poorly understood. We recently identified a cytoplasmic Fe-S cluster assembly (CIA) targeting complex composed of MMS19, CIAO1, and FAM96B that is required for the biogenesis of extramitochondrial Fe-S proteins including XPD. Here, we use XPD as a prototypical Fe-S protein to further characterize how Fe-S assembly is facilitated by the CIA targeting complex. Multiple lines of evidence indicate that this process occurs in a stepwise fashion in which XPD acquires a Fe-S cluster from the CIA targeting complex before assembling into TFIIH. First, XPD was found to associate in a mutually exclusive fashion with either TFIIH or the CIA targeting complex. Second, disrupting Fe-S cluster assembly on XPD by either 1) depleting cellular iron levels or 2) utilizing XPD mutants defective in either Fe-S cluster or CIA targeting complex binding blocks Fe-S cluster assembly and prevents XPD incorporation into TFIIH. Finally, subcellular fractionation studies indicate that the association of XPD with the CIA targeting complex occurs in the cytoplasm, whereas its association with TFIIH occurs largely in the nucleus where TFIIH functions. Together, these data establish a sequential assembly process for Fe-S assembly on XPD and highlight the existence of quality control mechanisms that prevent the incorporation of immature apoproteins into their cellular complexes.	[Vashisht, Ajay A.; Yu, Clarissa C.; Sharma, Tanu; Ro, Kevin; Wohlschlegel, James A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Wohlschlegel, JA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA.	jwohl@mednet.ucla.edu	Regan, Clinton/E-6250-2012; Ro, Clarissa/M-7638-2017		National Institutes of Health [GM089778]; University of California Cancer Research Coordinating Committee; Jonsson Cancer Center at UCLA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089778] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Cancer Research Coordinating Committee(University of California System); Jonsson Cancer Center at UCLA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM089778 (to J.A.W.). This work was also supported by the University of California Cancer Research Coordinating Committee (to J.A.W.) and the Jonsson Cancer Center at UCLA (to J.A.W.).	Dubaele S, 2003, MOL CELL, V11, P1635, DOI 10.1016/S1097-2765(03)00182-5; Fan L, 2008, CELL, V133, P789, DOI 10.1016/j.cell.2008.04.030; Friedberg EC, 2001, NAT REV CANCER, V1, P22, DOI 10.1038/35094000; Gari K, 2012, SCIENCE, V337, P243, DOI 10.1126/science.1219664; GOZUKARA EM, 1994, CANCER RES, V54, P3837; GUO B, 1995, J BIOL CHEM, V270, P16529, DOI 10.1074/jbc.270.28.16529; Lamond, 2006, CELL BIOL LAB HDB, P103, DOI [10.1016/b978-012164730-8/50087-3, DOI 10.1016/B978-012164730-8/50087-3]; Lehmann AR, 2001, GENE DEV, V15, P15, DOI 10.1101/gad.859501; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Liu H, 2008, CELL, V133, P801, DOI 10.1016/j.cell.2008.04.029; Maio N, 2014, CELL METAB, V19, P445, DOI 10.1016/j.cmet.2014.01.015; Netz DJA, 2014, TRENDS CELL BIOL, V24, P303, DOI 10.1016/j.tcb.2013.11.005; PROTICSABLJIC M, 1986, PHOTOCHEM PHOTOBIOL, V43, P509, DOI 10.1111/j.1751-1097.1986.tb09528.x; Pugh RA, 2008, J BIOL CHEM, V283, P1732, DOI 10.1074/jbc.M707064200; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Stehling O, 2012, SCIENCE, V337, P195, DOI 10.1126/science.1219723; Vashisht AA, 2009, SCIENCE, V326, P718, DOI 10.1126/science.1176333; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wohlschlegel James A., 2009, V497, P33, DOI 10.1007/978-1-59745-566-4_3; Wolski SC, 2008, PLOS BIOL, V6, P1332, DOI 10.1371/journal.pbio.0060149; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; Ye H., 2010, ADV HEMATOL, V2010, DOI DOI 10.1155/2010/329394; Ye H, 2010, BIOCHEMISTRY-US, V49, P4945, DOI 10.1021/bi1004798	23	29	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					14218	14225		10.1074/jbc.M115.650762	http://dx.doi.org/10.1074/jbc.M115.650762			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25897079	hybrid, Green Published			2022-12-28	WOS:000355313000048
J	Lee, S; Hennigar, SR; Alam, S; Nishida, K; Kelleher, SL				Lee, Sooyeon; Hennigar, Stephen R.; Alam, Samina; Nishida, Keigo; Kelleher, Shannon L.			Essential Role for Zinc Transporter 2 (ZnT2)-mediated Zinc Transport in Mammary Gland Development and Function during Lactation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECRETORY ACTIVATION; SIGNAL TRANSDUCER; IN-VITRO; MACROPHAGES; ZNT2; PROLACTIN; BREAST; TISSUE; PROLIFERATION; DEFICIENCY	The zinc transporter ZnT2 (SLC30A2) imports zinc into vesicles in secreting mammary epithelial cells (MECs) and is critical for zinc efflux into milk during lactation. Recent studies show that ZnT2 also imports zinc into mitochondria and is expressed in the non-lactating mammary gland and non-secreting MECs, highlighting the importance of ZnT2 in general mammary gland biology. In this study we used nulliparous and lactating ZnT2-null mice and characterized the consequences on mammary gland development, function during lactation, and milk composition. We found that ZnT2 was primarily expressed in MECs and to a limited extent in macrophages in the nulliparous mammary gland and loss of ZnT2 impaired mammary expansion during development. Secondly, we found that lactating ZnT2-null mice had substantial defects in mammary gland architecture and MEC function during secretion, including fewer, condensed and disorganized alveoli, impaired Stat5 activation, and unpolarized MECs. Loss of ZnT2 led to reduced milk volume and milk containing less protein, fat, and lactose compared with wild-type littermates, implicating ZnT2 in the regulation of mammary differentiation and optimal milk production during lactation. Together, these results demonstrate that ZnT2-mediated zinc transport is critical for mammary gland function, suggesting that defects in ZnT2 not only reduce milk zinc concentration but may compromise breast health and increase the risk for lactation insufficiency in lactating women.	[Lee, Sooyeon; Kelleher, Shannon L.] Penn State Univ, Interdisciplinary Grad Physiol Program, University Pk, PA 16802 USA; [Lee, Sooyeon; Hennigar, Stephen R.; Kelleher, Shannon L.] Penn State Univ, Dept Nutr Sci, University Pk, PA 16802 USA; [Lee, Sooyeon; Alam, Samina; Kelleher, Shannon L.] Penn State Hershey Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Kelleher, Shannon L.] Penn State Hershey Coll Med, Dept Pharmacol, Hershey, PA 17033 USA; [Alam, Samina; Kelleher, Shannon L.] Penn State Hershey Coll Med, Dept Surg, Hershey, PA 17033 USA; [Nishida, Keigo] RIKEN Ctr Integrat Med Sci IMS RCAI, RCAI, Lab Homeostat Network, Yokohama, Kanagawa 2300045, Japan; [Nishida, Keigo] Suzuka Univ Med Sci, Fac Pharmaceut Sci, Lab Immune Regulat, Suzuka 5138670, Japan	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; RIKEN	Kelleher, SL (corresponding author), 500 Univ Dr, Hershey, PA USA.	slk39@psu.edu	Regan, Clinton/E-6250-2012; alam, samina/V-1599-2018	Lee, Sooyeon/0000-0002-1076-3314	National Institutes of Health [R01HD058614]; Penn State Hershey College of Medicine Department of Surgery; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058614] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Penn State Hershey College of Medicine Department of Surgery; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HD058614 (to S. L. K.). This work was also supported by the Penn State Hershey College of Medicine Department of Surgery.	Arbour MW, 2013, J MIDWIFERY WOM HEAL, V58, P457, DOI 10.1111/jmwh.12070; Bachiller PR, 2013, AM J PHYSIOL-LUNG C, V305, pL569, DOI 10.1152/ajplung.00401.2012; Ballard O, 2013, PEDIATR CLIN N AM, V60, P49, DOI 10.1016/j.pcl.2012.10.002; Bhardwaj P, 2013, CANCER PREV RES, V6, P282, DOI 10.1158/1940-6207.CAPR-12-0467; Bostanci Z, 2015, REPROD TOXICOL, V54, P84, DOI 10.1016/j.reprotox.2014.07.076; Bostanci Z, 2014, EXP CELL RES, V321, P190, DOI 10.1016/j.yexcr.2013.12.005; Brisken C, 2006, J MAMMARY GLAND BIOL, V11, P239, DOI 10.1007/s10911-006-9026-0; Campbell JJ, 2009, ORGANOGENESIS, V5, P43, DOI 10.4161/org.5.2.8321; Chapman RS, 2000, ADV EXP MED BIOL, V480, P129; Chen CC, 2012, GENE DEV, V26, P2154, DOI 10.1101/gad.197343.112; Chen Y, 2003, J BIOL CHEM, V278, P16520, DOI 10.1074/jbc.M210572200; Chowanadisai W, 2006, J BIOL CHEM, V281, P39699, DOI 10.1074/jbc.M605821200; Chua ACL, 2010, DEVELOPMENT, V137, P4229, DOI 10.1242/dev.059261; CLEGG MS, 1981, BIOL TRACE ELEM RES, V3, P107, DOI 10.1007/BF02990451; Colitti M, 2009, TISSUE CELL, V41, P326, DOI 10.1016/j.tice.2009.02.004; COULSTON L, 1980, DIABETES, V29, P665, DOI 10.2337/diabetes.29.8.665; Cui Y, 2004, MOL CELL BIOL, V24, P8037, DOI 10.1128/MCB.24.18.8037-8047.2004; Dempsey C, 2012, J NUTR, V142, P655, DOI 10.3945/jn.111.150623; Dorea JG, 2002, J AM COLL NUTR, V21, P84, DOI 10.1080/07315724.2002.10719198; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; Fata JE, 1999, DEV BIOL, V211, P238, DOI 10.1006/dbio.1999.9313; Feuermann Y, 2009, INT J ENDOCRINOL, V2009, DOI 10.1155/2009/427260; Fleming JM, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3215; Gouon-Evans V, 2000, DEVELOPMENT, V127, P2269; GRIGOR MR, 1986, J NUTR, V116, P1789, DOI 10.1093/jn/116.9.1789; Guo L, 2010, P NATL ACAD SCI USA, V107, P2818, DOI 10.1073/pnas.0914941107; Hanania R, 2012, J BIOL CHEM, V287, P8468, DOI 10.1074/jbc.M111.290676; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Hovey RC, 2010, J MAMMARY GLAND BIOL, V15, P279, DOI 10.1007/s10911-010-9187-8; Humphreys RC, 1996, DEVELOPMENT, V122, P4013; Iavnilovitch E, 2002, MOL CANCER RES, V1, P32; Itsumura N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064045; Jevitt C, 2007, J MIDWIFERY WOM HEAL, V52, P606, DOI 10.1016/j.jmwh.2007.04.006; Jiang DM, 2001, J BIOL CHEM, V276, P47524, DOI 10.1074/jbc.M108834200; Kambe T, 2004, CELL MOL LIFE SCI, V61, P49, DOI 10.1007/s00018-003-3148-y; Kambe T, 2014, CELL MOL LIFE SCI, V71, P3281, DOI 10.1007/s00018-014-1617-0; Kamikawa A, 2009, DEV DYNAM, V238, P1092, DOI 10.1002/dvdy.21947; Kelleher SL, 2011, ADV NUTR, V2, P101, DOI 10.3945/an.110.000232; Kelleher SL, 2012, J CELL PHYSIOL, V227, P1761, DOI 10.1002/jcp.22900; Kelleher SL, 2003, J NUTR, V133, P3378, DOI 10.1093/jn/133.11.3378; Khokha R, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004333; Landskroner-Eiger S, 2010, DEV BIOL, V344, P968, DOI 10.1016/j.ydbio.2010.06.019; Lasry I, 2014, J BIOL CHEM, V289, P7275, DOI 10.1074/jbc.M113.533786; Lopez V, 2011, CANCER LETT, V304, P41, DOI 10.1016/j.canlet.2011.01.027; Lopez V, 2009, BIOCHEM J, V422, P43, DOI 10.1042/BJ20081189; McCormick N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011078; McCormick NH, 2012, AM J PHYSIOL-CELL PH, V303, pC291, DOI 10.1152/ajpcell.00443.2011; McManaman JL, 2003, ADV DRUG DELIVER REV, V55, P629, DOI 10.1016/S0169-409X(03)00033-4; Michalczyk AA, 2002, BIOCHEM J, V364, P105, DOI 10.1042/bj3640105; Miletta MC, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/259189; Miyoshi K, 2001, J CELL BIOL, V155, P531, DOI 10.1083/jcb.200107065; Moynihan AT, 2006, AM J OBSTET GYNECOL, V195, P504, DOI 10.1016/j.ajog.2006.01.106; MUTCH PB, 1980, AM J PHYSIOL, V238, pE26, DOI 10.1152/ajpendo.1980.238.1.E26; Neville MC, 2007, J MAMMARY GLAND BIOL, V12, P205, DOI 10.1007/s10911-007-9060-6; Neville MC, 2009, J MAMMARY GLAND BIOL, V14, P269, DOI 10.1007/s10911-009-9150-8; O'Brien J, 2012, DEVELOPMENT, V139, P269, DOI 10.1242/dev.071696; Palmiter RD, 2004, PFLUG ARCH EUR J PHY, V447, P744, DOI 10.1007/s00424-003-1070-7; Palmiter RD, 1996, EMBO J, V15, P1784, DOI 10.1002/j.1460-2075.1996.tb00527.x; Piela Z, 1998, CUTIS, V61, P197; Qian LX, 2009, AM J PHYSIOL-CELL PH, V297, pC369, DOI 10.1152/ajpcell.00589.2008; Reed JR, 2010, J MAMMARY GLAND BIOL, V15, P329, DOI 10.1007/s10911-010-9188-7; Roberts R, 2009, DIABETOLOGIA, V52, P882, DOI 10.1007/s00125-009-1300-4; Sbai O, 2008, MOL CELL NEUROSCI, V39, P549, DOI 10.1016/j.mcn.2008.08.004; Schwertfeger KL, 2006, J MAMMARY GLAND BIOL, V11, P229, DOI 10.1007/s10911-006-9028-y; Seo YA, 2014, J BIOL CHEM, V289, P23653, DOI 10.1074/jbc.M113.531145; Seo YA, 2011, AM J PHYSIOL-CELL PH, V300, pC1479, DOI 10.1152/ajpcell.00420.2010; Shankar AH, 1998, AM J CLIN NUTR, V68, p447S, DOI 10.1093/ajcn/68.2.447S; SHISHEVA A, 1992, DIABETES, V41, P982, DOI 10.2337/diabetes.41.8.982; Stelwagen K, 1999, MOL CELL ENDOCRINOL, V156, P55, DOI 10.1016/S0303-7207(99)00145-8; Taraboletti G, 2002, AM J PATHOL, V160, P673, DOI 10.1016/S0002-9440(10)64887-0; Thorn SR, 2010, ENDOCRINOLOGY, V151, P3985, DOI 10.1210/en.2010-0029; Trujillo ME, 2006, ENDOCR REV, V27, P798, DOI 10.1210/er.2006-0033; Ucar A, 2010, NAT GENET, V42, P1101, DOI 10.1038/ng.709; Watson C J, 1996, Rev Reprod, V1, P1; Watson CJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1401; Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431; Wiseman BS, 2003, J CELL BIOL, V162, P1123, DOI 10.1083/jcb.200302090; Zhang LJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028432, 10.1371/journal.pone.0020963, 10.1371/journal.pone.0026129, 10.1371/journal.pone.0028953]	78	50	50	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13064	13078		10.1074/jbc.M115.637439	http://dx.doi.org/10.1074/jbc.M115.637439			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25851903	hybrid, Green Published			2022-12-28	WOS:000354975700011
J	Burmeister, WP; Tarbouriech, N; Fender, P; Contesto-Richefeu, C; Peyrefitte, CN; Iseni, F				Burmeister, Wim P.; Tarbouriech, Nicolas; Fender, Pascal; Contesto-Richefeu, Celine; Peyrefitte, Christophe N.; Iseni, Frederic			Crystal Structure of the Vaccinia Virus Uracil-DNA Glycosylase in Complex with DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; INHIBITOR PROTEIN; ESCHERICHIA-COLI; REPAIR ENZYME; REPLICATION; SUBSTRATE; MIMICRY; CELLS; A20; TRANSLOCATION	Vaccinia virus polymerase holoenzyme is composed of the DNA polymerase catalytic subunit E9 associated with its heterodimeric co-factor A20.D4 required for processive genome synthesis. Although A20 has no known enzymatic activity, D4 is an active uracil-DNA glycosylase (UNG). The presence of a repair enzyme as a component of the viral replication machinery suggests that, for poxviruses, DNA synthesis and base excision repair is coupled. We present the 2.7 A crystal structure of the complex formed by D4 and the first 50 amino acids of A20 (D4.A20(1-50)) bound to a 10-mer DNA duplex containing an abasic site resulting from the cleavage of a uracil base. Comparison of the viral complex with its human counterpart revealed major divergences in the contacts between protein and DNA and in the enzyme orientation on the DNA. However, the conformation of the dsDNA within both structures is very similar, suggesting a dominant role of the DNA conformation for UNG function. In contrast to human UNG, D4 appears rigid, and we do not observe a conformational change upon DNA binding. We also studied the interaction of D4.A20(1-50) with different DNA oligomers by surface plasmon resonance. D4 binds weakly to nonspecific DNA and to uracil-containing substrates but binds abasic sites with a K-d of <1.4 mu M. This second DNA complex structure of a family I UNG gives new insight into the role of D4 as a co-factor of vaccinia virus DNA polymerase and allows a better understanding of the structural determinants required for UNG action.	[Burmeister, Wim P.; Tarbouriech, Nicolas; Fender, Pascal] Univ Grenoble Alpes, UVHCI, F-38000 Grenoble, France; [Burmeister, Wim P.; Tarbouriech, Nicolas; Fender, Pascal] CNRS, UVHCI, F-38000 Grenoble, France; [Contesto-Richefeu, Celine; Peyrefitte, Christophe N.; Iseni, Frederic] Inst Rech Biomed Armees, Unite Virol, F-91223 Bretigny Sur Orge, France; [Peyrefitte, Christophe N.] Fdn Merieux, Emerging Pathogens Lab, F-69007 Lyon, France	Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS)	Burmeister, WP (corresponding author), Unit Virus Host Cell Interact, 71 Ave Martyrs, F-38042 Grenoble 9, France.	wim.burmeister@ujf-grenoble.fr; fredericiseni@gmail.com		Burmeister, Wim/0000-0003-0876-6118; tarbouriech, nicolas/0000-0002-0206-3959; Fender, Pascal/0000-0002-6698-3367	ANR [ANR-13-BSV8-0014]; Service de Sante des Armees; Delegation Generale pour l'Armement	ANR(French National Research Agency (ANR)); Service de Sante des Armees; Delegation Generale pour l'Armement	This work was supported by ANR Grant ANR-13-BSV8-0014 (REPLIPOX) and by research grants from the Service de Sante des Armees and the Delegation Generale pour l'Armement. The authors declare that they have no conflicts of interest with the contents of this article.	Barrett TE, 1998, CELL, V92, P117, DOI 10.1016/S0092-8674(00)80904-6; Boyle KA, 2011, J BIOL CHEM, V286, P24702, DOI 10.1074/jbc.M111.222216; Chen RX, 2002, J GEN VIROL, V83, P2339, DOI 10.1099/0022-1317-83-10-2339; Contesto-Richefeu C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003978; De Silva FS, 2003, J VIROL, V77, P159, DOI 10.1128/JVI.77.1.159-166.2003; Dimasi N, 2007, ACTA CRYSTALLOGR F, V63, P204, DOI 10.1107/S1744309107004903; Ellison KS, 1996, J VIROL, V70, P7965, DOI 10.1128/JVI.70.11.7965-7973.1996; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Geoui T, 2007, J MOL BIOL, V366, P117, DOI 10.1016/j.jmb.2006.11.007; Handa P, 2001, J BIOL CHEM, V276, P17324, DOI 10.1074/jbc.M011166200; Holzer GW, 1997, J VIROL, V71, P4997, DOI 10.1128/JVI.71.7.4997-5002.1997; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kavli B, 2002, J BIOL CHEM, V277, P39926, DOI 10.1074/jbc.M207107200; Kim Yun-Jeong, 2012, Curr Mol Pharmacol, V5, P3; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krusong K, 2006, J BIOL CHEM, V281, P4983, DOI 10.1074/jbc.M509137200; LINDAHL T, 1974, P NATL ACAD SCI USA, V71, P3649, DOI 10.1073/pnas.71.9.3649; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MILLNS AK, 1994, VIROLOGY, V198, P504, DOI 10.1006/viro.1994.1061; MOL CD, 1995, CELL, V82, P701, DOI 10.1016/0092-8674(95)90467-0; MULLANEY J, 1989, J GEN VIROL, V70, P449, DOI 10.1099/0022-1317-70-2-449; Panayotou G, 1998, J BIOL CHEM, V273, P45, DOI 10.1074/jbc.273.1.45; Parikh SS, 2000, P NATL ACAD SCI USA, V97, P5083, DOI 10.1073/pnas.97.10.5083; Parikh SS, 1998, EMBO J, V17, P5214, DOI 10.1093/emboj/17.17.5214; Parker JB, 2007, NATURE, V449, P433, DOI 10.1038/nature06131; Porecha RH, 2008, P NATL ACAD SCI USA, V105, P10791, DOI 10.1073/pnas.0801612105; Prichard MN, 1996, J VIROL, V70, P3018, DOI 10.1128/JVI.70.5.3018-3025.1996; Putnam CD, 1999, J MOL BIOL, V287, P331, DOI 10.1006/jmbi.1999.2605; Reddy SM, 1998, VIROLOGY, V251, P393, DOI 10.1006/viro.1998.9428; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; SAVVA R, 1995, NAT STRUCT BIOL, V2, P752, DOI 10.1038/nsb0995-752; Scaramozzino N, 2003, NUCLEIC ACIDS RES, V31, P4950, DOI 10.1093/nar/gkg672; Schonhoft JD, 2013, BIOCHEMISTRY-US, V52, P2536, DOI 10.1021/bi301562n; Schonhoft JD, 2013, BIOCHEMISTRY-US, V52, P2526, DOI 10.1021/bi301561d; Schormann N, 2014, PROTEIN SCI, V23, P1667, DOI 10.1002/pro.2554; Schormann N, 2013, ACTA CRYSTALLOGR F, V69, P1328, DOI 10.1107/S1744309113030613; Schormann N, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-45; Sele C, 2013, J VIROL, V87, P1679, DOI 10.1128/JVI.01533-12; Shudofsky AMD, 2010, J VIROL, V84, P12325, DOI 10.1128/JVI.01435-10; Slupphaug G, 1996, NATURE, V384, P87, DOI 10.1038/384087a0; Stanitsa ES, 2006, J BIOL CHEM, V281, P3439, DOI 10.1074/jbc.M511239200; Ward TM, 2009, VIRUS RES, V142, P78, DOI 10.1016/j.virusres.2009.01.013; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zharkov DO, 2010, MUTAT RES-FUND MOL M, V685, P11, DOI 10.1016/j.mrfmmm.2009.10.017	45	16	17	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					17923	17934		10.1074/jbc.M115.648352	http://dx.doi.org/10.1074/jbc.M115.648352			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26045555	Green Published, hybrid			2022-12-28	WOS:000358511700026
J	Callaway, JB; Smith, SA; McKinnon, KP; de Silva, AM; Crowe, JE; Ting, JPY				Callaway, Justin B.; Smith, Scott A.; McKinnon, Karen P.; de Silva, Aravinda M.; Crowe, James E., Jr.; Ting, Jenny P. -Y.			Spleen Tyrosine Kinase (Syk) Mediates IL-1 beta Induction by Primary Human Monocytes during Antibody-enhanced Dengue Virus Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD MONONUCLEAR-CELLS; FC-GAMMA-RI; INDUCED INFLAMMASOME ACTIVATION; MEMORY B-CELLS; HEMORRHAGIC-FEVER; IFN-GAMMA; SIGNAL-TRANSDUCTION; NLRP3 INFLAMMASOME; IMMUNE-RESPONSES; TNF-ALPHA	Approximately 500,000 people are hospitalized with severe dengue illness annually. Antibody-dependent enhancement (ADE) of dengue virus (DENV) infection is believed to contribute to the pathogenic cytokine storm described in severe dengue patients, but the precise signaling pathways contributing to elevated cytokine production are not elucidated. IL-1 beta is a potent inflammatory cytokine that is frequently elevated during severe dengue, and the unique dual regulation of IL-1 beta provides an informative model to study ADE-induced cytokines. This work utilizes patient-derived anti-DENV mAbs and primary human monocytes to study ADE-induced IL-1 beta and other cytokines. ADE of DENV serotype 2 (DENV-2) elevates mature IL-1 beta secretion by monocytes independent of DENV replication by 4 h postinoculation (hpi). Prior to this, DENV immune complexes activate spleen tyrosine kinase (Syk) within 1 hpi. Syk induces elevated IL1B, TNF, and IL6 mRNA by 2 hpi. Syk mediates elevated IL-1 beta secretion by activating ERK1/2, and both Syk and ERK1/2 inhibitors ablated ADE-induced IL-1 beta secretion. Maturation of pro-IL-1 beta during ADE requires caspase-1 and NLRP3, but caspase-1 is suboptimally increased by ADE and can be significantly enhanced by a typical inflammasome agonist, ATP. Importantly, this inflammatory Syk-ERK signaling axis requires DENV immune complexes, because DENV-2 in the presence of serotype-matched anti-DENV-2 mAb, but not anti-DENV-1 mAb, activates Syk, ERK, and IL-1 beta secretion. This study provides evidence that DENV-2 immune complexes activate Syk to mediate elevated expression of inflammatory cytokines. Syk and ERK may serve as new therapeutic targets for interfering with ADE-induced cytokine expression during severe dengue.	[Callaway, Justin B.; McKinnon, Karen P.; de Silva, Aravinda M.; Ting, Jenny P. -Y.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Callaway, Justin B.; Ting, Jenny P. -Y.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Ting, Jenny P. -Y.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Ting, Jenny P. -Y.] Univ N Carolina, Inst Inflammatory Dis, Chapel Hill, NC 27599 USA; [Smith, Scott A.; Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Vanderbilt Vaccine Ctr, Nashville, TN 37232 USA; [Smith, Scott A.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA; [Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Ting, JPY (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, CB 7295, Chapel Hill, NC 27599 USA.	jenny_ting@med.unc.edu	, UNC Flow Cytometry Core/AGU-9839-2022; Crowe, James/B-5549-2009; , PEP-MX Core/AGV-4051-2022; desilva, Aravinda/ABE-6260-2020	Crowe, James/0000-0002-0049-1079; desilva, Aravinda/0000-0003-3317-5950	National Institutes of Health, NIAID [U54-AI057157, U19-AI109965, U19-AI109784, 5T32AI007273-29]; National Institutes of Health, NCI [2P50CA058223-19A1]; Susan G. Komen Breast Cancer Foundation [KG100307]; University Cancer Research Fund; National Institutes of Health, NCI, Center Core Support Grant [P30CA06086]; NATIONAL CANCER INSTITUTE [P50CA058223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007273, U54AI057157, U19AI109965, K08AI103038, U19AI109784] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); University Cancer Research Fund; National Institutes of Health, NCI, Center Core Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health, NIAID, Grants U54-AI057157 (to J. B. C., S. A. S., A. M. D., J. E. C., and J. P. T.), U19-AI109965 (to J. B. C. and J. P. T.), U19-AI109784 (to A. M. D. and J. P. T.), and 5T32AI007273-29 (to J. B. C.) and by National Institutes of Health, NCI, Grant 2P50CA058223-19A1 (to K. P. M.). This work was also supported in part by Susan G. Komen Breast Cancer Foundation Grant KG100307 (to K. P. M.) and by the University Cancer Research Fund (to K. P. M.). The University of North Carolina Flow Cytometry Core Facility is supported in part by National Institutes of Health, NCI, Center Core Support Grant P30CA06086 to the University of North Carolina Lineberger Comprehensive Cancer Center. The authors declare that they have no conflicts of interest with the contents of this article.	AGARWAL A, 1993, J BIOL CHEM, V268, P15900; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Batliner J, 2011, MOL IMMUNOL, V48, P714, DOI 10.1016/j.molimm.2010.10.016; Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007; BHAMARAPRAVATI N, 1989, REV INFECT DIS, V11, pS826; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bohlin K, 1999, SCAND J CLIN LAB INV, V59, P259; Bozza FA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-86; Bradshaw JM, 2010, CELL SIGNAL, V22, P1175, DOI 10.1016/j.cellsig.2010.03.001; Chan KR, 2014, P NATL ACAD SCI USA, V111, P2722, DOI 10.1073/pnas.1317454111; CHANG DM, 1994, J INFECT DIS, V170, P811, DOI 10.1093/infdis/170.4.811; Chen HC, 2004, J MED VIROL, V73, P419, DOI 10.1002/jmv.20108; Chen HC, 2007, J VIROL, V81, P5518, DOI 10.1128/JVI.02575-06; CHIN J, 1993, J IMMUNOL, V151, P5574; Costa VV, 2013, AM J PATHOL, V182, P1950, DOI 10.1016/j.ajpath.2013.02.027; Dai XL, 2009, BLOOD, V114, P318, DOI 10.1182/blood-2008-10-184457; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Diamond MS, 2000, J VIROL, V74, P7814, DOI 10.1128/JVI.74.17.7814-7823.2000; DINARELLO CA, 1984, REV INFECT DIS, V6, P51, DOI 10.1016/S1359-6101(97)00023-3; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Durbin AP, 2008, VIROLOGY, V376, P429, DOI 10.1016/j.virol.2008.03.028; DURDEN DL, 1995, J IMMUNOL, V154, P4039; Trinidad AG, 2006, J LEUKOCYTE BIOL, V79, P1073, DOI 10.1189/jlb.1205701; Grahames CBA, 1999, BRIT J PHARMACOL, V127, P1915, DOI 10.1038/sj.bjp.0702732; Green S, 2006, CURR OPIN INFECT DIS, V19, P429, DOI 10.1097/01.qco.0000244047.31135.fa; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268; HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201; Hara H, 2013, NAT IMMUNOL, V14, P1247, DOI 10.1038/ni.2749; HAZUDA DJ, 1988, J BIOL CHEM, V263, P8473; HOGQUIST KA, 1991, J IMMUNOL, V147, P2181; Hottz ED, 2013, BLOOD, V122, P3405, DOI 10.1182/blood-2013-05-504449; Huang ZY, 2006, J LEUKOCYTE BIOL, V80, P1553, DOI 10.1189/jlb.0106019; Jaiyen Y, 2009, MICROBIOL IMMUNOL, V53, P442, DOI 10.1111/j.1348-0421.2009.00148.x; Janczy JR, 2014, J IMMUNOL, V193, P5190, DOI 10.4049/jimmunol.1400628; Kahlenberg JM, 2004, J LEUKOCYTE BIOL, V76, P676, DOI 10.1189/jlb.0404221; Kerkar S, 2006, J SURG RES, V132, P40, DOI 10.1016/j.jss.2005.06.033; KOSTURA MJ, 1989, P NATL ACAD SCI USA, V86, P5227, DOI 10.1073/pnas.86.14.5227; Kou Z, 2008, J MED VIROL, V80, P134, DOI 10.1002/jmv.21051; Kou ZH, 2011, VIROLOGY, V410, P240, DOI 10.1016/j.virol.2010.11.007; Lien TS, 2015, THROMB HAEMOSTASIS, V113, P1060, DOI 10.1160/TH14-07-0637; Lin YC, 2010, MOL IMMUNOL, V47, P1569, DOI 10.1016/j.molimm.2010.01.008; LITTAUA R, 1990, J IMMUNOL, V144, P3183; Lupher ML, 1998, J BIOL CHEM, V273, P35273, DOI 10.1074/jbc.273.52.35273; MARCH CJ, 1985, NATURE, V315, P641, DOI 10.1038/315641a0; MARTIN S, 1988, IMMUNOLOGY, V64, P301; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Milella M, 1997, J IMMUNOL, V158, P3148; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Orozco S, 2012, J GEN VIROL, V93, P2152, DOI 10.1099/vir.0.045088-0; Pang T, 2007, IMMUNOL CELL BIOL, V85, P43, DOI 10.1038/sj.icb.7100008; Perregaux DG, 1996, J BIOL CHEM, V271, P29830, DOI 10.1074/jbc.271.47.29830; Pierson TC, 2008, CELL HOST MICROBE, V4, P229, DOI 10.1016/j.chom.2008.08.004; Pierson TC, 2013, CURR OPIN VIROL, V3, P3, DOI 10.1016/j.coviro.2012.12.001; Poeck H, 2010, J MOL MED, V88, P745, DOI 10.1007/s00109-010-0631-4; Prestwood TR, 2012, J VIROL, V86, P12561, DOI 10.1128/JVI.06743-11; Rao N, 2001, EMBO J, V20, P7085, DOI 10.1093/emboj/20.24.7085; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Ritter M, 2010, P NATL ACAD SCI USA, V107, P20459, DOI 10.1073/pnas.1010337107; Sada K, 2000, J IMMUNOL, V164, P338, DOI 10.4049/jimmunol.164.1.338; Sada K, 2001, J BIOCHEM-TOKYO, V130, P177, DOI 10.1093/oxfordjournals.jbchem.a002970; Said-Sadier N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010008; Sanchez-Mejorada G, 1998, J BIOL CHEM, V273, P27610, DOI 10.1074/jbc.273.42.27610; Schumann RR, 1998, BLOOD, V91, P577, DOI 10.1182/blood.V91.2.577.577_577_584; Shio MT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000559; Shresta S, 2005, J IMMUNOL, V175, P3946, DOI 10.4049/jimmunol.175.6.3946; Shresta S, 2004, J VIROL, V78, P2701, DOI 10.1128/JVI.78.6.2701-2710.2004; Smith SA, 2014, J VIROL, V88, P12233, DOI 10.1128/JVI.00247-14; Smith SA, 2013, J INFECT DIS, V207, P1898, DOI 10.1093/infdis/jit119; Smith SA, 2012, J VIROL, V86, P2665, DOI 10.1128/JVI.06335-11; Sohn HW, 2003, J EXP MED, V197, P1511, DOI 10.1084/jem.20021686; Song XY, 2004, J LEUKOCYTE BIOL, V75, P1147, DOI 10.1189/jlb.0403128; Srikiatkhachorn A, 2010, CURR TOP MICROBIOL, V338, P67, DOI 10.1007/978-3-642-02215-9_6; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Tan TY, 2013, J GEN VIROL, V94, P2215, DOI 10.1099/vir.0.055277-0; Trotta R, 1996, J EXP MED, V184, P1027, DOI 10.1084/jem.184.3.1027; Ubol S, 2008, J INFECT DIS, V197, P1459, DOI 10.1086/587699; van de Veerdonk FL, 2009, J INFECT DIS, V199, P1087, DOI 10.1086/597274; van der Poel CE, 2011, J IMMUNOL, V186, P2699, DOI 10.4049/jimmunol.1003526; von Sydow FFO, 2000, MEM I OSWALDO CRUZ, V95, P483, DOI 10.1590/S0074-02762000000400007; Wen HT, 2013, IMMUNITY, V39, P432, DOI 10.1016/j.immuni.2013.08.037; Widman DG, 2008, VACCINE, V26, P2762, DOI 10.1016/j.vaccine.2008.03.009; World Health Organization, 2019, DENG SEV DENG; Wu MF, 2013, BLOOD, V121, P95, DOI 10.1182/blood-2012-05-430090; Yamamoto N, 2003, J PHARMACOL EXP THER, V306, P1174, DOI 10.1124/jpet.103.052316; Zellweger RM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00151; Zellweger RM, 2010, CELL HOST MICROBE, V7, P128, DOI 10.1016/j.chom.2010.01.004; Zompi S, 2012, VIRUSES-BASEL, V4, P62, DOI 10.3390/v4010062	90	30	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17306	17320		10.1074/jbc.M115.664136	http://dx.doi.org/10.1074/jbc.M115.664136			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26032420	Green Published, hybrid			2022-12-28	WOS:000357730900026
J	Darrow, MC; Sergeeva, OA; Isas, JM; Galaz-Montoya, JG; King, JA; Langen, R; Schmid, MF; Chiu, W				Darrow, Michele C.; Sergeeva, Oksana A.; Isas, Jose M.; Galaz-Montoya, Jesus G.; King, Jonathan A.; Langen, Ralf; Schmid, Michael F.; Chiu, Wah			Structural Mechanisms of Mutant Huntingtin Aggregation Suppression by the Synthetic Chaperonin-like CCT5 Complex Explained by Cryoelectron Tomography	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; ELECTRON-MICROSCOPY; IN-VIVO; POLYGLUTAMINE AGGREGATION; MOLECULAR CHAPERONES; PROTEIN; DISEASE; OLIGOMERS; IMAGE; VISUALIZATION	Huntington disease, a neurodegenerative disorder characterized by functional deficits and loss of striatal neurons, is linked to an expanded and unstable CAG trinucleotide repeat in the huntingtin gene (HTT). This DNA sequence translates to a polyglutamine repeat in the protein product, leading to mutant huntingtin (mHTT) protein aggregation. The aggregation of mHTT is inhibited in vitro and in vivo by the TCP-1 ring complex (TRiC) chaperonin. Recently, a novel complex comprised of a single type of TRiC subunit has been reported to inhibit mHTT aggregation. Specifically, the purified CCT5 homo-oligomer complex, when compared with TRiC, has a similar structure, ATP use, and substrate refolding activity, and, importantly, it also inhibits mHTT aggregation. Using an aggregation suppression assay and cryoelectron tomography coupled with a novel computational classification method, we uncover the interactions between the synthetic CCT5 complex (similar to 1 MDa) and aggregates of mutant huntingtin exon 1 containing 46 glutamines (mHTTQ46-Ex1). We find that, in a similar fashion to TRiC, synthetic CCT5 complex caps mHTT fibrils at their tips and encapsulates mHTT oligomers, providing a structural description of the inhibition of mHTTQ46-Ex1 by CCT5 complex and a shared mechanism of mHTT inhibition between TRiC chaperonin and the CCT5 complex: cap and contain.	[Darrow, Michele C.; Galaz-Montoya, Jesus G.; Schmid, Michael F.; Chiu, Wah] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Natl Ctr Macromol Imaging, Houston, TX 77030 USA; [Sergeeva, Oksana A.; King, Jonathan A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Isas, Jose M.; Langen, Ralf] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA	Baylor College of Medicine; Massachusetts Institute of Technology (MIT); University of Southern California	Chiu, W (corresponding author), Baylor Coll Med, Dept Biochem & Mol Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	wah@bcm.edu	Galaz-Montoya, Jesus G/A-8091-2017; Regan, Clinton/E-6250-2012; Galaz-Montoya, Jesus G./Q-7245-2019	Galaz-Montoya, Jesus G./0000-0002-0113-9325; Schmid, Michael/0000-0003-1077-5750; Sergeeva, Oksana/0000-0002-4830-0518; Darrow, Michele/0000-0001-6259-1684	National Institutes of Health [PN2EY016525, P41GM103832, R01NS084345, R01GM080139]; National Institutes of Health training grant NIBIB through the Keck Center of the Gulf Coast Consortia [T32EB009270]; NATIONAL EYE INSTITUTE [PN2EY016525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103832, R01GM080139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS084345] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health training grant NIBIB through the Keck Center of the Gulf Coast Consortia; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research has been supported, in whole or in part, by National Institutes of Health Grants PN2EY016525, P41GM103832, R01NS084345, and R01GM080139.; Supported by National Institutes of Health training grant NIBIB T32EB009270 through the Keck Center of the Gulf Coast Consortia.	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Arrasate M, 2012, EXP NEUROL, V238, P1, DOI 10.1016/j.expneurol.2011.12.013; Barbaro BA, 2015, HUM MOL GENET, V24, P913, DOI 10.1093/hmg/ddu504; Bates GP, 2005, NAT REV GENET, V6, P766, DOI 10.1038/nrg1686; Behrends C, 2006, MOL CELL, V23, P887, DOI 10.1016/j.molcel.2006.08.017; Bennett MJ, 2002, P NATL ACAD SCI USA, V99, P11634, DOI 10.1073/pnas.182393899; Bhardwaj V, 2014, BIOCHEMISTRY-US, V53, P3621, DOI 10.1021/bi500383h; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Caron NS, 2014, HUM MOL GENET, V23, P2324, DOI 10.1093/hmg/ddt625; Clabough Erin B. D., 2013, Yale Journal of Biology and Medicine, V86, P217; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Fodale V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112262; FRYDMAN J, 1992, EMBO J, V11, P4767, DOI 10.1002/j.1460-2075.1992.tb05582.x; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Galaz-Montoya JG, 2015, J STRUCT BIOL, V190, P279, DOI 10.1016/j.jsb.2015.04.016; Gipson TA, 2013, RNA BIOL, V10, P1647, DOI 10.4161/rna.26706; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Gronenborn AM, 1999, PROTEIN SCI, V8, P426; HARPAZ Y, 1994, STRUCTURE, V2, P641, DOI 10.1016/S0969-2126(00)00065-4; Hatters DM, 2012, CURR TOP MED CHEM, V12, P2611; Hendrick JP, 1995, FASEB J, V9, P1559, DOI 10.1096/fasebj.9.15.8529835; Horwich AL, 2007, ANNU REV CELL DEV BI, V23, P115, DOI 10.1146/annurev.cellbio.23.090506.123555; Kitamura A, 2006, NAT CELL BIOL, V8, P1163, DOI 10.1038/ncb1478; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Legleiter J, 2010, J BIOL CHEM, V285, P14777, DOI 10.1074/jbc.M109.093708; LEPAULT J, 1983, J MICROSC-OXFORD, V129, P89, DOI 10.1111/j.1365-2818.1983.tb04163.x; Margulis BA, 2013, FEBS LETT, V587, P1997, DOI 10.1016/j.febslet.2013.05.022; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Myers Richard H, 2004, NeuroRx, V1, P255, DOI 10.1602/neurorx.1.2.255; Pruggnaller S, 2008, J STRUCT BIOL, V164, P161, DOI 10.1016/j.jsb.2008.05.003; Russmann F, 2012, P NATL ACAD SCI USA, V109, P21208, DOI 10.1073/pnas.1218836109; Sathasivam K, 2013, P NATL ACAD SCI USA, V110, P2366, DOI 10.1073/pnas.1221891110; Schmid MF, 2008, J STRUCT BIOL, V161, P243, DOI 10.1016/j.jsb.2007.09.018; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sergeeva OA, 2014, J BIOL CHEM, V289, P27470, DOI 10.1074/jbc.M114.576033; Sergeeva OA, 2013, J BIOL CHEM, V288, P17734, DOI 10.1074/jbc.M112.443929; Shahmoradian SH, 2013, ELIFE, V2, DOI 10.7554/eLife.00710; Sontag EM, 2013, P NATL ACAD SCI USA, V110, P3077, DOI 10.1073/pnas.1222663110; Tam S, 2006, NAT CELL BIOL, V8, P1155, DOI 10.1038/ncb1477; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Thulasiraman V, 1999, EMBO J, V18, P85, DOI 10.1093/emboj/18.1.85; van der Putten H, 2013, NEUROTHERAPEUTICS, V10, P416, DOI 10.1007/s13311-013-0186-5; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Wetzel R, 2012, J MOL BIOL, V421, P466, DOI 10.1016/j.jmb.2012.01.030; Yang W, 2002, HUM MOL GENET, V11, P2905, DOI 10.1093/hmg/11.23.2905; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492	47	23	25	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17451	17461		10.1074/jbc.M115.655373	http://dx.doi.org/10.1074/jbc.M115.655373			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	25995452	hybrid, Green Published			2022-12-28	WOS:000357730900037
J	De La Cruz, EM; Gardel, ML				De La Cruz, Enrique M.; Gardel, Margaret L.			Actin Mechanics and Fragmentation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							COFILIN-LINKED CHANGES; F-ACTIN; CYTOSKELETAL NETWORKS; FILAMENT INTERACTIONS; THIN-FILAMENTS; ALPHA-ACTININ; CELL; DYNAMICS; KINETICS; FLEXIBILITY	Cell physiological processes require the regulation and coordination of both mechanical and dynamical properties of the actin cytoskeleton. Here we review recent advances in understanding the mechanical properties and stability of actin filaments and how these properties are manifested at larger (network) length scales. We discuss how forces can influence local biochemical interactions, resulting in the formation of mechanically sensitive dynamic steady states. Understanding the regulation of such force-activated chemistries and dynamic steady states reflects an important challenge for future work that will provide valuable insights as to how the actin cytoskeleton engenders mechanoresponsiveness of living cells.	[De La Cruz, Enrique M.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06511 USA; [Gardel, Margaret L.] Univ Chicago, James Franck Inst, Inst Biophys Dynam, Chicago, IL 60637 USA; [Gardel, Margaret L.] Univ Chicago, Dept Phys, Chicago, IL 60637 USA	Yale University; University of Chicago; University of Chicago	De La Cruz, EM (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06511 USA.	enrique.delacruz@yale.edu; gardel@uchicago.edu			National Institutes of Health [GM097348]; Burroughs Wellcome Career Award; University of Chicago Materials Research Science and Engineering Center (MRSEC) [DMR-1420709]; Army Research Office sponsored Multidisciplinary University Research Initiative (ARO MURI) [W911NF-14-1-0403]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097348] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Career Award(Burroughs Wellcome Fund); University of Chicago Materials Research Science and Engineering Center (MRSEC); Army Research Office sponsored Multidisciplinary University Research Initiative (ARO MURI); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM097348 (to E. M. D. L. C), Burroughs Wellcome Career Award and University of Chicago Materials Research Science and Engineering Center (MRSEC) Grant DMR-1420709 (to M. L. G.), and Army Research Office sponsored Multidisciplinary University Research Initiative (ARO MURI) W911NF-14-1-0403 (to E. M. D. L. C and M. L. G.). This is the first article in the Thematic Minireview series "The State of the Cytoskeleton in 2015." The authors declare that they have no conflicts of interest with the contents of this article.	Abu Shah E, 2014, ELIFE, V3, DOI 10.7554/eLife.01433; Bathe M, 2008, BIOPHYS J, V94, P2955, DOI 10.1529/biophysj.107.119743; BENAVRAHAM D, 1995, BIOPHYS J, V68, P1231, DOI 10.1016/S0006-3495(95)80299-7; Bischofs IB, 2008, BIOPHYS J, V95, P3488, DOI 10.1529/biophysj.108.134296; Blanchoin L, 1999, J BIOL CHEM, V274, P15538, DOI 10.1074/jbc.274.22.15538; Blanchoin L, 2014, PHYSIOL REV, V94, P235, DOI 10.1152/physrev.00018.2013; Bobkov AA, 2006, J MOL BIOL, V356, P325, DOI 10.1016/j.jmb.2005.11.072; Brangwynne CP, 2006, J CELL BIOL, V173, P733, DOI 10.1083/jcb.200601060; Broedersz CP, 2014, REV MOD PHYS, V86, P995, DOI 10.1103/RevModPhys.86.995; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Cao WX, 2006, J MOL BIOL, V361, P257, DOI 10.1016/j.jmb.2006.06.019; Chaudhry F, 2013, MOL BIOL CELL, V24, P31, DOI 10.1091/mbc.E12-08-0589; Chen CK, 2013, BIOCHEMISTRY-US, V52, P5503, DOI 10.1021/bi400715z; Chen Q, 2015, J BIOL CHEM, V290, P2289, DOI 10.1074/jbc.M114.612978; Chu JW, 2006, BIOPHYS J, V90, P1572, DOI 10.1529/biophysj.105.073924; Clark MG, 2006, MOL BIOL CELL, V17, P1971, DOI 10.1091/mbc.E05-10-0956; De La Cruz EM, 2005, J MOL BIOL, V346, P557, DOI 10.1016/j.jmb.2004.11.065; De La Cruz EM, 2004, CURR OPIN CELL BIOL, V16, P61, DOI 10.1016/j.ceb.2003.11.011; De la Cruz EM, 2015, BIOPHYS J, V108, P2270, DOI 10.1016/j.bpj.2015.03.058; De La Cruz EM, 2010, BIOPHYS J, V99, P1852, DOI 10.1016/j.bpj.2010.07.009; De La Cruz EM, 2010, BIOPHYS J, V98, P1893, DOI 10.1016/j.bpj.2010.01.023; De La Cruz Enrique M, 2009, Biophys Rev, V1, P51, DOI 10.1007/s12551-009-0008-5; Elam WA, 2013, BIOCHEM BIOPH RES CO, V438, P728, DOI 10.1016/j.bbrc.2013.07.109; Falzone TT, 2013, BIOPHYS J, V104, P1709, DOI 10.1016/j.bpj.2013.01.017; Falzone TT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1862; Fan J, 2013, J MOL BIOL, V425, P1225, DOI 10.1016/j.jmb.2013.01.020; Fujii T, 2010, NATURE, V467, P724, DOI 10.1038/nature09372; Galkin VE, 2011, P NATL ACAD SCI USA, V108, P20568, DOI 10.1073/pnas.1110109108; Galkin VE, 2010, NAT STRUCT MOL BIOL, V17, P1318, DOI 10.1038/nsmb.1930; Gardel ML, 2008, METHOD CELL BIOL, V89, P487, DOI 10.1016/S0091-679X(08)00619-5; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; Graham JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094766; Gurel PS, 2014, CURR BIOL, V24, P156, DOI 10.1016/j.cub.2013.12.018; Haviv L, 2008, J MOL BIOL, V375, P325, DOI 10.1016/j.jmb.2007.09.066; Hayakawa K, 2014, P NATL ACAD SCI USA, V111, P9810, DOI 10.1073/pnas.1321451111; Heussinger C, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.031906; HIGUCHI H, 1995, BIOPHYS J, V69, P1000, DOI 10.1016/S0006-3495(95)79975-1; Howard J., 2001, MECH MOTOR PROTEINS; Kang HR, 2014, P NATL ACAD SCI USA, V111, P17821, DOI 10.1073/pnas.1413397111; Kang H, 2013, BIOPHYS J, V105, P2621, DOI 10.1016/j.bpj.2013.10.032; Kang HR, 2012, P NATL ACAD SCI USA, V109, P16923, DOI 10.1073/pnas.1211078109; Kim T, 2014, BIOPHYS J, V106, P526, DOI 10.1016/j.bpj.2013.12.031; Koenderink GH, 2009, P NATL ACAD SCI USA, V106, P15192, DOI 10.1073/pnas.0903974106; KOJIMA H, 1994, P NATL ACAD SCI USA, V91, P12962, DOI 10.1073/pnas.91.26.12962; Lieleg O, 2011, NAT MATER, V10, P236, DOI [10.1038/nmat2939, 10.1038/NMAT2939]; Liu J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.118104; Marchetti MC, 2013, REV MOD PHYS, V85, DOI 10.1103/RevModPhys.85.1143; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; Matsushita S, 2011, J BIOMECH, V44, P1776, DOI 10.1016/j.jbiomech.2011.04.012; McCullough BR, 2008, J MOL BIOL, V381, P550, DOI 10.1016/j.jmb.2008.05.055; McCullough BR, 2011, BIOPHYS J, V101, P151, DOI 10.1016/j.bpj.2011.05.049; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; MOORE PB, 1970, J MOL BIOL, V50, P279, DOI 10.1016/0022-2836(70)90192-0; Murrell MP, 2012, P NATL ACAD SCI USA, V109, P20820, DOI 10.1073/pnas.1214753109; Nadkarni AV, 2014, CURR BIOL, V24, P2749, DOI 10.1016/j.cub.2014.09.048; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; ORLOVA A, 1993, J MOL BIOL, V232, P334, DOI 10.1006/jmbi.1993.1393; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Pavlov D, 2007, J MOL BIOL, V365, P1350, DOI 10.1016/j.jmb.2006.10.102; Pfaendtner J, 2010, J MOL BIOL, V396, P252, DOI 10.1016/j.jmb.2009.11.034; Phillips R., 2008, PHYS BIOL CELL; Pollard T.D., 2017, CELL BIOL, P543; Prochniewicz E, 2005, J MOL BIOL, V353, P990, DOI 10.1016/j.jmb.2005.09.021; Risca VI, 2012, P NATL ACAD SCI USA, V109, P2913, DOI 10.1073/pnas.1114292109; Rodal AA, 1999, J CELL BIOL, V145, P1251, DOI 10.1083/jcb.145.6.1251; Schwarz US, 2012, J CELL SCI, V125, P3051, DOI 10.1242/jcs.093716; Sept D, 2001, BIOPHYS J, V81, P667, DOI 10.1016/S0006-3495(01)75731-1; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Strehle D, 2011, EUR BIOPHYS J BIOPHY, V40, P93, DOI 10.1007/s00249-010-0621-z; Suarez C, 2011, CURR BIOL, V21, P862, DOI 10.1016/j.cub.2011.03.064; TIRION MM, 1993, J MOL BIOL, V230, P186, DOI 10.1006/jmbi.1993.1135; Tsuda Y, 1996, P NATL ACAD SCI USA, V93, P12937, DOI 10.1073/pnas.93.23.12937; Vogel SK, 2013, ELIFE, V2, DOI 10.7554/eLife.00116; WACHSSTOCK DH, 1993, BIOPHYS J, V65, P205, DOI 10.1016/S0006-3495(93)81059-2; Ward A, 2015, NAT MATER, V14, P583, DOI [10.1038/NMAT4222, 10.1038/nmat4222]; Wilson CA, 2010, NATURE, V465, P373, DOI 10.1038/nature08994; Xu JY, 1998, BIOPHYS J, V74, P2731, DOI 10.1016/S0006-3495(98)77979-2; Yeoh S, 2002, J MOL BIOL, V315, P911, DOI 10.1006/jmbi.2001.5280; Yogurtcu ON, 2012, BIOPHYS J, V103, P719, DOI 10.1016/j.bpj.2012.07.020	81	56	56	1	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17137	17144		10.1074/jbc.R115.636472	http://dx.doi.org/10.1074/jbc.R115.636472			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	25957404	hybrid, Green Published			2022-12-28	WOS:000357730900010
J	Sasaki, Y; Margolin, Z; Borgo, B; Havranek, JJ; Milbrandt, J				Sasaki, Yo; Margolin, Zachary; Borgo, Benjamin; Havranek, James J.; Milbrandt, Jeffrey			Characterization of Leber Congenital Amaurosis-associated NMNAT1 Mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DELAYS AXONAL DEGENERATION; MUTATIONS; STRESS; MITOCHONDRIAL; SPECIFICITY; ACTIVATION; SUBSTRATE	Leber congenital amaurosis 9 (LCA9) is an autosomal recessive retinal degeneration condition caused by mutations in the NAD(+) biosynthetic enzyme NMNAT1. This condition leads to early blindness but no other consistent deficits have been reported in patients with NMNAT1 mutations despite its central role in metabolism and ubiquitous expression. To study how these mutations affect NMNAT1 function and ultimately lead to the retinal degeneration phenotype, we performed detailed analysis of LCA-associated NMNAT1 mutants, including the expression, nuclear localization, enzymatic activity, secondary structure, oligomerization, and promotion of axonal and cellular integrity in response to injury. In many assays, most mutants produced results similar to wild type NMNAT1. Indeed, NAD(+) synthetic activity is unlikely to be a primary mechanism underlying retinal degeneration as most LCA-associated NMNAT1 mutants had normal enzymatic activity. In contrast, the secondary structure of many NMNAT1 mutants was relatively less stable as they lost enzymatic activity after heat shock, whereas wild type NMNAT1 retains significant activity after this stress. These results suggest that LCA-associated NMNAT1 mutants are more vulnerable to stressful conditions that lead to protein unfolding, a potential contributor to the retinal degeneration observed in this syndrome.	[Sasaki, Yo; Margolin, Zachary; Borgo, Benjamin; Havranek, James J.; Milbrandt, Jeffrey] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL)	Sasaki, Y (corresponding author), Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA.	ysasaki@genetics.wustl.edu	Regan, Clinton/E-6250-2012	Milbrandt, Jeffrey/0000-0002-5477-7689	National Institutes of Health [R01AG013730, R01NS065053, RO1NS078007, R01NS087632, R01GM101602]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101602] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065053, R01NS078007, R01NS087632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013730] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health Grants R01AG013730 (to J. M.), R01NS065053 (to J. M. and A. D.), RO1NS078007 (to J. M. and A. D.), R01NS087632 (to J. M.), and R01GM101602 (to J. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Athanasiou D, 2013, FEBS LETT, V587, P2008, DOI 10.1016/j.febslet.2013.05.020; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Borgo B, 2012, P NATL ACAD SCI USA, V109, P1494, DOI 10.1073/pnas.1115172109; Chiang PW, 2012, NAT GENET, V44, P972, DOI 10.1038/ng.2370; Conforti L, 2011, FEBS J, V278, P2666, DOI 10.1111/j.1742-4658.2011.08193.x; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; Falk MJ, 2012, NAT GENET, V44, P1040, DOI 10.1038/ng.2361; Greenfield NJ, 2004, METHOD ENZYMOL, V383, P282; Keen TJ, 2003, EUR J HUM GENET, V11, P420, DOI 10.1038/sj.ejhg.5200981; Koenekoop RK, 2012, NAT GENET, V44, P1035, DOI 10.1038/ng.2356; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; NGUYEN VT, 1989, J BIOL CHEM, V264, P10487; Perrault I, 2012, NAT GENET, V44, P975, DOI 10.1038/ng.2357; Press C, 2008, J NEUROSCI, V28, P4861, DOI 10.1523/JNEUROSCI.0525-08.2008; Rallis A, 2013, J CELL SCI, V126, P838, DOI 10.1242/jcs.117259; Rozanowska M, 2005, PHOTOCHEM PHOTOBIOL, V81, P1305, DOI 10.1562/2004-11-13-IR-371; Sasaki Y, 2006, J NEUROSCI, V26, P8484, DOI 10.1523/JNEUROSCI.2320-06.2006; Sasaki Y, 2009, J NEUROSCI, V29, P6526, DOI 10.1523/JNEUROSCI.1429-09.2009; Sasaki Y, 2009, J NEUROSCI, V29, P5525, DOI 10.1523/JNEUROSCI.5469-08.2009; Siemiatkowska AM, 2014, JAMA OPHTHALMOL, V132, P1002, DOI 10.1001/jamaophthalmol.2014.983; Sorci L, 2007, BIOCHEMISTRY-US, V46, P4912, DOI 10.1021/bi6023379; Sparrow JR, 2005, EXP EYE RES, V80, P595, DOI 10.1016/j.exer.2005.01.007; Summers DW, 2014, J NEUROSCI, V34, P9338, DOI 10.1523/JNEUROSCI.0877-14.2014; Zhai RG, 2006, PLOS BIOL, V4, P2336, DOI 10.1371/journal.pbio.0040416; Zhou TJ, 2002, J BIOL CHEM, V277, P13148, DOI 10.1074/jbc.M111469200	26	26	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17228	17238		10.1074/jbc.M115.637850	http://dx.doi.org/10.1074/jbc.M115.637850			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26018082	Green Published, hybrid			2022-12-28	WOS:000357730900019
J	Sun, GN; Hu, ZR; Min, ZY; Yan, XH; Guan, ZP; Su, HX; Fu, Y; Ma, XP; Chen, YG; Zhang, MQ; Tao, QH; Wu, W				Sun, Guanni; Hu, Zhirui; Min, Zheying; Yan, Xiaohua; Guan, Zhenpo; Su, Hanxia; Fu, Yu; Ma, Xiaopeng; Chen, Ye-Guang; Zhang, Michael Q.; Tao, Qinghua; Wu, Wei			Small C-terminal Domain Phosphatase 3 Dephosphorylates the Linker Sites of Receptor-regulated Smads (R-Smads) to Ensure Transforming Growth Factor beta (TGF beta)-mediated Germ Layer Induction in Xenopus Embryos	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN; TGF-BETA; SIGNALING PATHWAYS; MESENDODERM FORMATION; MATERNAL VEGT; IN-VIVO; BMP; MESODERM; PHOSPHORYLATION; IDENTIFICATION	Germ layer induction is one of the earliest events shortly after fertilization that initiates body formation of vertebrate embryos. In Xenopus, the maternally deposited transcriptional factor VegT promotes the expression of zygotic Nodal/Activin ligands that further form a morphogen gradient along the vegetal-animal axis and trigger the induction of the three germ layers. Here we found that SCP3 (small C-terminal domain phosphatase 3) is maternally expressed and vegetally enriched in Xenopus embryos and is essential for the timely induction of germ layers. SCP3 is required for the full activation of Nodal/Activin and bone morphogenetic protein signals and functions via dephosphorylation in the linker regions of receptor-regulated Smads. Consistently, the linker regions of receptor-regulated Smads are heavily phosphorylated in fertilized eggs, and this phosphorylation is gradually removed when embryos approach the midblastula transition. Knockdown of maternal SCP3 attenuates these dephosphorylation events and the activation of Nodal/Activin and bone morphogenetic protein signals after midblastula transition. This study thus suggested that the maternal SCP3 serves as a vegetally enriched, intrinsic factor to ensure a prepared status of Smads for their activation by the upcoming ligands during germ layer induction of Xenopus embryos.	[Sun, Guanni; Guan, Zhenpo; Su, Hanxia; Fu, Yu; Wu, Wei] Tsinghua Univ, Sch Life Sci, MOE Key Lab Prot Sci, Beijing 100084, Peoples R China; [Hu, Zhirui; Ma, Xiaopeng; Zhang, Michael Q.] Tsinghua Univ, TNLIST, Ctr Synthet & Syst Biol, Bioinformat Div, Beijing 100084, Peoples R China; [Min, Zheying; Tao, Qinghua] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Yan, Xiaohua; Chen, Ye-Guang] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Zhang, Michael Q.] Univ Texas Dallas, Ctr Syst Biol, Dept Biol Sci, Richardson, TX 75080 USA	Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University; University of Texas System; University of Texas Dallas	Zhang, MQ (corresponding author), Tsinghua Univ, TNLIST, Ctr Synthet & Syst Biol, Bioinformat Div, Beijing 100084, Peoples R China.	michael.zhang@utdallas.edu; qhtaolab@mail.tsinghua.edu.cn; wwu@mail.tsinghua.edu.cn	Chen, Ye-Guang/L-6998-2019; Yan, Xiaohua/J-4922-2015	Yan, Xiaohua/0000-0002-7528-5771	MOST [2011CB943803, 2011CB943800]; National Natural Science Foundation of China (NSFC) [31221064]; NSFC [91019016]; National Basic Research Foundation of China (NBRPC) [2012CB316503]	MOST; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC(National Natural Science Foundation of China (NSFC)); National Basic Research Foundation of China (NBRPC)(National Basic Research Program of China)	This work was supported by MOST Grant 2011CB943803 and National Natural Science Foundation of China (NSFC) Grant 31221064 (to W. W.), MOST Grant 2011CB943800 (to Q. T.), and NSFC Grant 91019016 and National Basic Research Foundation of China (NBRPC) Grant 2012CB316503 (to M. Q. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Archambault J, 1998, J BIOL CHEM, V273, P27593, DOI 10.1074/jbc.273.42.27593; Bandyopadhyay A, 2013, BIOCHEM PHARMACOL, V85, P857, DOI 10.1016/j.bcp.2013.01.004; Bruce DL, 2012, FEBS LETT, V586, P1897, DOI 10.1016/j.febslet.2012.02.001; Claussen M, 2004, DEVELOPMENT, V131, P4263, DOI 10.1242/dev.01283; Clements D, 1999, DEVELOPMENT, V126, P4903; Dale L, 1999, BIOESSAYS, V21, P751, DOI 10.1002/(SICI)1521-1878(199909)21:9<751::AID-BIES6>3.0.CO;2-I; Engel ME, 1999, J BIOL CHEM, V274, P37413, DOI 10.1074/jbc.274.52.37413; Faure S, 2000, DEVELOPMENT, V127, P2917; Fritz BR, 2001, DEV BIOL, V236, P230, DOI 10.1006/dbio.2001.0324; Fuentealba LC, 2007, CELL, V131, P980, DOI 10.1016/j.cell.2007.09.027; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Hata A, 2000, CELL, V100, P229, DOI 10.1016/S0092-8674(00)81561-5; HEASMAN J, 1991, METHOD CELL BIOL, V36, P213; Heasman J, 2006, SEMIN CELL DEV BIOL, V17, P93, DOI 10.1016/j.semcdb.2005.11.005; Hill CS, 2001, CURR OPIN GENET DEV, V11, P533, DOI 10.1016/S0959-437X(00)00229-X; HUANG HC, 1995, EMBO J, V14, P5965, DOI 10.1002/j.1460-2075.1995.tb00285.x; JONES EA, 1987, DEVELOPMENT, V101, P557; Kamaraju SK, 2005, J BIOL CHEM, V280, P1024, DOI 10.1074/jbc.M403960200; Kamato D, 2013, CELL SIGNAL, V25, P2017, DOI 10.1016/j.cellsig.2013.06.001; Kaneko K, 2008, J EXP ZOOL PART B, V310B, P492, DOI 10.1002/jez.b.21222; Kataoka K, 2005, DEV GROWTH DIFFER, V47, P511; Knockaert M, 2006, P NATL ACAD SCI USA, V103, P11940, DOI 10.1073/pnas.0605133103; Kofron M, 1999, DEVELOPMENT, V126, P5759; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; Kurata T, 2001, DIFFERENTIATION, V67, P33, DOI 10.1046/j.1432-0436.2001.067001033.x; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liu T, 2010, BIOCHEM J, V430, P191, DOI 10.1042/BJ20100427; Loose M, 2004, DEV BIOL, V271, P467, DOI 10.1016/j.ydbio.2004.04.014; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Matsuura I, 2004, NATURE, V430, P226, DOI 10.1038/nature02650; Mori S, 2004, ONCOGENE, V23, P7416, DOI 10.1038/sj.onc.1207981; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; Olson David J, 2012, Methods Mol Biol, V917, P167, DOI 10.1007/978-1-61779-992-1_10; Pera EM, 2003, GENE DEV, V17, P3023, DOI 10.1101/gad.1153603; Rana AA, 2006, PLOS GENET, V2, P1751, DOI 10.1371/journal.pgen.0020193; Saka Y, 2007, DEVELOPMENT, V134, P4209, DOI 10.1242/dev.010645; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; Sapkota G, 2006, J BIOL CHEM, V281, P40412, DOI 10.1074/jbc.M610172200; Schohl A, 2002, DEVELOPMENT, V129, P37; Sudou N, 2012, DEVELOPMENT, V139, P1651, DOI 10.1242/dev.068395; Taverner NV, 2005, MECH DEVELOP, V122, P333, DOI 10.1016/j.mod.2004.10.010; Wang Y, 2010, J BIOL CHEM, V285, P10890, DOI 10.1074/jbc.M109.058347; Wardle FC, 2006, SEMIN CELL DEV BIOL, V17, P99, DOI 10.1016/j.semcdb.2005.11.008; Wrighton KH, 2006, J BIOL CHEM, V281, P38365, DOI 10.1074/jbc.M607246200; Wylie C, 1996, DEVELOPMENT, V122, P2987; Yan XH, 2009, J BIOL CHEM, V284, P30097, DOI 10.1074/jbc.M109.049304; Yeo M, 2003, J BIOL CHEM, V278, P26078, DOI 10.1074/jbc.M301791200; Zhang J, 1998, CELL, V94, P515, DOI 10.1016/S0092-8674(00)81592-5; Zhao YL, 2014, J BIOL CHEM, V289, P26441, DOI 10.1074/jbc.M114.568964	53	3	4	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17239	17249		10.1074/jbc.M115.655605	http://dx.doi.org/10.1074/jbc.M115.655605			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26013826	hybrid, Green Published			2022-12-28	WOS:000357730900020
J	Duselder, A; Fridman, V; Thiede, C; Wiesbaum, A; Goldstein, A; Klopfenstein, DR; Zaitseva, O; Janson, ME; Gheber, L; Schmidt, CF				Dueselder, Andre; Fridman, Vladimir; Thiede, Christina; Wiesbaum, Alice; Goldstein, Alina; Klopfenstein, Dieter R.; Zaitseva, Olga; Janson, Marcel E.; Gheber, Larisa; Schmidt, Christoph F.			Deletion of the Tail Domain of the Kinesin-5 Cin8 Affects Its Directionality	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; OVERLAPPING MICROTUBULES; SPINDLE ELONGATION; FISSION YEAST; CROSS-LINKS; IN-VIVO; MOTOR; MOTILITY; MIDZONE; KINETOCHORES	The bipolar kinesin-5 motors are one of the major players that govern mitotic spindle dynamics. Their bipolar structure enables them to cross-link and slide apart antiparallel microtubules (MTs) emanating from the opposing spindle poles. The budding yeast kinesin-5 Cin8 was shown to switch from fast minus-end-to slow plus-end-directed motility upon binding between antiparallel MTs. This unexpected finding revealed a new dimension of cellular control of transport, the mechanism of which is unknown. Here we have examined the role of the C-terminal tail domain of Cin8 in regulating directionality. We first constructed a stable dimeric Cin8/kinesin-1 chimera (Cin8Kin), consisting of head and neck linker of Cin8 fused to the stalk of kinesin-1. As a single dimeric motor, Cin8Kin switched frequently between plus and minus directionality along single MTs, demonstrating that the Cin8 head domains are inherently bidirectional, but control over directionality was lost. We next examined the activity of a tetrameric Cin8 lacking only the tail domains (Cin8 Delta tail). In contrast to wild-type Cin8, the motility of single molecules of Cin8 Delta tail in high ionic strength was slow and bidirectional, with almost no directionality switches. Cin8 Delta tail showed only a weak ability to cross-link MTs in vitro. In vivo, Cin8 Delta tail exhibited bias toward the plus-end of the MTs and was unable to support viability of cells as the sole kinesin-5 motor. We conclude that the tail of Cin8 is not necessary for bidirectional processive motion, but is controlling the switch between plus-and minus-end-directed motility.	[Dueselder, Andre; Thiede, Christina; Wiesbaum, Alice; Klopfenstein, Dieter R.; Schmidt, Christoph F.] Univ Gottingen, Drittes Phys Inst, D-37077 Gottingen, Germany; [Fridman, Vladimir; Goldstein, Alina; Gheber, Larisa] Ben Gurion Univ Negev, Dept Chem, IL-84105 Beer Sheva, Israel; [Gheber, Larisa] Ben Gurion Univ Negev, Ilse Katz Inst Nanoscale Sci & Technol, IL-84105 Beer Sheva, Israel; [Zaitseva, Olga; Janson, Marcel E.] Wageningen Univ, Cell Biol Lab, NL-6708 PB Wageningen, Netherlands	University of Gottingen; Ben Gurion University; Ben Gurion University; Wageningen University & Research	Gheber, L (corresponding author), Ben Gurion Univ Negev, Dept Chem, IL-84105 Beer Sheva, Israel.	lgheber@bgu.ac.il; christoph.schmidt@phys.uni-goettingen.de	Schmidt, Christoph F/G-3787-2011	Schmidt, Christoph F/0000-0003-2864-6973; Fridman, Vladimir/0000-0002-0299-6935; Gheber, Larisa/0000-0003-3759-4001	Lower Saxony Grant [11-76251-99-26/08 (ZN2440)]; Deutsche Forschungsgemeinschaft (DFG) [SFB 937]; Center for Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB) - DFG; Israel Science Foundation (ISF) [165/13]	Lower Saxony Grant; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Center for Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB) - DFG(German Research Foundation (DFG)); Israel Science Foundation (ISF)(Israel Science Foundation)	This work was supported in part by the Lower Saxony Grant 11-76251-99-26/08 (ZN2440) (to L. G. and C. F. S.) and in part by the Deutsche Forschungsgemeinschaft (DFG) through SFB 937 Project A2 as well as by the Center for Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB) funded by the DFG. The authors declare that they have no conflicts of interest with the contents of this article.; Supported in part by the Israel Science Foundation (ISF) Grant 165/13.	Acar S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2348; Avunie-Masala R, 2011, J CELL SCI, V124, P873, DOI 10.1242/jcs.077396; Braun M, 2011, NAT CELL BIOL, V13, P1259, DOI 10.1038/ncb2323; de Gramont A, 2007, CELL CYCLE, V6, P1231, DOI 10.4161/cc.6.10.4181; Duselder A, 2012, J MOL BIOL, V423, P159, DOI 10.1016/j.jmb.2012.06.043; Edamatsu M, 2014, BIOCHEM BIOPH RES CO, V446, P231, DOI 10.1016/j.bbrc.2014.02.106; Fakhri N, 2014, ELIFE, V3, DOI 10.7554/eLife.02715; Fridman V, 2013, J CELL SCI, V126, P4147, DOI 10.1242/jcs.125153; Fridman V, 2009, EMBO REP, V10, P387, DOI 10.1038/embor.2009.7; Gerson-Gurwitz A, 2009, CELL MOL LIFE SCI, V66, P301, DOI 10.1007/s00018-008-8479-2; Gerson-Gurwitz A, 2011, EMBO J, V30, P4942, DOI 10.1038/emboj.2011.403; Gheber L, 1999, J BIOL CHEM, V274, P9564, DOI 10.1074/jbc.274.14.9564; Gordon DM, 2001, P NATL ACAD SCI USA, V98, P12515, DOI 10.1073/pnas.231212498; Gupta ML, 2006, NAT CELL BIOL, V8, P913, DOI 10.1038/ncb1457; HACKNEY DD, 1995, NATURE, V377, P448, DOI 10.1038/377448a0; Hildebrandt ER, 2006, J BIOL CHEM, V281, P26004, DOI 10.1074/jbc.M604817200; HOVLAND P, 1989, GENE, V83, P57, DOI 10.1016/0378-1119(89)90403-4; Janson ME, 2007, CELL, V128, P357, DOI 10.1016/j.cell.2006.12.030; Kaan HYK, 2011, SCIENCE, V333, P883, DOI 10.1126/science.1204824; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Kapitein LC, 2008, CURR BIOL, V18, P1713, DOI 10.1016/j.cub.2008.09.046; Kapitein LC, 2008, J CELL BIOL, V182, P421, DOI 10.1083/jcb.200801145; Kashina AS, 1997, BBA-MOL CELL RES, V1357, P257, DOI 10.1016/S0167-4889(97)00037-2; Khmelinskii A, 2008, CELL CYCLE, V7, P283, DOI 10.4161/cc.7.3.5349; Lakamper S, 2010, J MOL BIOL, V399, P1, DOI 10.1016/j.jmb.2010.03.009; MICKEY B, 1995, J CELL BIOL, V130, P909, DOI 10.1083/jcb.130.4.909; Movshovich N, 2008, J CELL SCI, V121, P2529, DOI 10.1242/jcs.022996; PELLMAN D, 1995, J CELL BIOL, V130, P1373, DOI 10.1083/jcb.130.6.1373; Roostalu J, 2011, SCIENCE, V332, P94, DOI 10.1126/science.1199945; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SAUNDERS WS, 1995, J CELL BIOL, V128, P617, DOI 10.1083/jcb.128.4.617; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; Scholey JE, 2014, ELIFE, V3, DOI 10.7554/eLife.02217; Sharp DJ, 2000, NATURE, V407, P41, DOI 10.1038/35024000; Sharp DJ, 1999, J CELL BIOL, V144, P125, DOI 10.1083/jcb.144.1.125; Sherman F., 1986, METHODS YEAST GENETI; Su XL, 2011, MOL CELL, V43, P751, DOI 10.1016/j.molcel.2011.06.027; Thiede Christina, 2012, Bioarchitecture, V2, P70; Thiede C, 2013, BIOPHYS J, V104, P432, DOI 10.1016/j.bpj.2012.11.3810; Tytell JD, 2006, J CELL BIOL, V172, P861, DOI 10.1083/jcb.200509101; Varga V, 2009, CELL, V138, P1174, DOI 10.1016/j.cell.2009.07.032; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Wargacki MM, 2010, CELL CYCLE, V9, P2581, DOI 10.4161/cc.9.13.12076; Weinger JS, 2011, CURR BIOL, V21, P154, DOI 10.1016/j.cub.2010.12.038	45	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16841	16850		10.1074/jbc.M114.620799	http://dx.doi.org/10.1074/jbc.M114.620799			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25991727	Green Published, hybrid			2022-12-28	WOS:000357572800029
J	Burgardt, NI; Schmidt, A; Manns, A; Schutkowski, A; Jahreis, G; Lin, YJ; Schulze, B; Masch, A; Lucke, C; Weiwad, M				Ines Burgardt, Noelia; Schmidt, Andreas; Manns, Annika; Schutkowski, Alexandra; Jahreis, Guenther; Lin, Yi-Jan; Schulze, Bianca; Masch, Antonia; Luecke, Christian; Weiwad, Matthias			Parvulin 17-catalyzed Tubulin Polymerization Is Regulated by Calmodulin in a Calcium-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLYL CIS/TRANS ISOMERASE; MICROTUBULE-ASSOCIATED PROTEIN-2; STABLE MICROTUBULES; TARGET RECOGNITION; BINDING-SITE; STOP PROTEIN; AMINO-ACIDS; DOMAIN; PIN1; PHOSPHORYLATION	Recently we have shown that the peptidyl-prolyl cis/trans isomerase parvulin 17 (Par17) interacts with tubulin in a GTP-dependent manner, thereby promoting the formation of microtubules. Microtubule assembly is regulated by Ca2+-loaded calmodulin (Ca2+/CaM) both in the intact cell and under in vitro conditions via direct interaction with microtubule-associated proteins. Here we provide the first evidence that Ca2+/CaM interacts also with Par17 in a physiologically relevant way, thus preventing Par17-promoted microtubule assembly. In contrast, parvulin 14 (Par14), which lacks only the first 25 N-terminal residues of the Par17 sequence, does not interact with Ca2+/CaM, indicating that this interaction is exclusive for Par17. Pull-down experiments and chemical shift perturbation analysis with N-15-labeled Par17 furthermore confirmed that calmodulin (CaM) interacts in a Ca2+-dependent manner with the Par17 N terminus. The reverse experiment with N-15-labeled Ca2+/CaM demonstrated that the N-terminal Par17 segment binds to both CaM lobes simultaneously, indicating that Ca2+/CaM undergoes a conformational change to form a binding channel between its two lobes, apparently similar to the structure of the CaM-smMLCK(796-815) complex. In vitro tubulin polymerization assays furthermore showed that Ca2+/CaM completely suppresses Par17-promoted microtubule assembly. The results imply that Ca2+/CaM binding to the N-terminal segment of Par17 causes steric hindrance of the Par17 active site, thus interfering with the Par17/tubulin interaction. This Ca2+/CaM-mediated control of Par17-assisted microtubule assembly may provide a mechanism that couples Ca2+ signaling with microtubule function.	[Ines Burgardt, Noelia] Univ Buenos Aires, Sch Pharm & Biochem, Inst Biochem & Biophys IQUIFIB, Buenos Aires, DF, Argentina; [Ines Burgardt, Noelia; Schmidt, Andreas; Manns, Annika; Schutkowski, Alexandra; Jahreis, Guenther; Schulze, Bianca; Luecke, Christian; Weiwad, Matthias] Max Planck Res Unit Enzymol Prot Folding, D-06120 Halle, Saale, Germany; [Lin, Yi-Jan] Kaohsiung Med Univ, Ctr Infect Dis & Canc Res, Ctr Excellence Environm Med, Grad Inst Nat Prod, Kaohsiung 807, Taiwan; [Masch, Antonia; Weiwad, Matthias] Univ Halle Wittenberg, Inst Biochem & Biotechnol, Dept Enzymol, D-06099 Halle, Saale, Germany	University of Buenos Aires; Max Planck Society; Kaohsiung Medical University; Martin Luther University Halle Wittenberg	Burgardt, NI (corresponding author), Inst Quim & Fis Quim Biol Prof Alejandro C Paladi, Junin 956,C1113AAD, Buenos Aires, DF, Argentina.	burgardt@qb.ffyb.uba.ar		Schutkowski, Alexandra/0000-0002-9387-7869	Consejo Nacional de Investigaciones Cientificas y Tecnicas (Argentina)	Consejo Nacional de Investigaciones Cientificas y Tecnicas (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	Recipient of the Partial Funding Program for Short Stays Abroad of Consejo Nacional de Investigaciones Cientificas y Tecnicas (Argentina).	BABU YS, 1985, NATURE, V315, P37, DOI 10.1038/315037a0; BAGCHI IC, 1992, J BIOL CHEM, V267, P3024; BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; BARTON JS, 1980, BIOCHIM BIOPHYS ACTA, V630, P392, DOI 10.1016/0304-4165(80)90288-3; Burgardt NI, 2012, BIOMOL NMR ASSIGN, V6, P185, DOI 10.1007/s12104-011-9352-z; Cohen P, 1988, CALMODULIN; COX JA, 1985, J BIOL CHEM, V260, P2527; Denarier E, 1998, P NATL ACAD SCI USA, V95, P6055, DOI 10.1073/pnas.95.11.6055; Downing KH, 1998, CURR OPIN CELL BIOL, V10, P16, DOI 10.1016/S0955-0674(98)80082-3; DURSO NA, 1994, PLANT CELL, V6, P893, DOI 10.1105/tpc.6.6.893; Edlich F, 2005, EMBO J, V24, P2688, DOI 10.1038/sj.emboj.7600739; Edlich F, 2007, J BIOL CHEM, V282, P36496, DOI 10.1074/jbc.M705061200; EISENBERG D, 1982, NATURE, V299, P371, DOI 10.1038/299371a0; Fanghanel J, 2004, FRONT BIOSCI-LANDMRK, V9, P3453, DOI 10.2741/1494; GALAT A, 1995, PROG BIOPHYS MOL BIO, V63, P67, DOI 10.1016/0079-6107(94)00009-X; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Gilli R, 1998, BIOCHEMISTRY-US, V37, P5450, DOI 10.1021/bi972083a; Hasezawa S, 1997, PROTOPLASMA, V198, P202, DOI 10.1007/BF01287569; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; Jaremko L, 2011, J BIOL CHEM, V286, P6554, DOI 10.1074/jbc.M110.160713; JOB D, 1981, P NATL ACAD SCI-BIOL, V78, P4679, DOI 10.1073/pnas.78.8.4679; JOHNSON GVW, 1992, J NEUROSCI RES, V33, P505, DOI 10.1002/jnr.490330402; Jurado LA, 1999, PHYSIOL REV, V79, P661, DOI 10.1152/physrev.1999.79.3.661; Kessler D, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-37; KINDLER S, 1990, J BIOL CHEM, V265, P19679; Kurek I, 2002, PLANT MOL BIOL, V48, P369, DOI 10.1023/A:1014023329807; Kurokawa H, 2001, J MOL BIOL, V312, P59, DOI 10.1006/jmbi.2001.4822; LEE YC, 1984, J BIOL CHEM, V259, P1226; Lefevre J, 2013, J BIOL CHEM, V288, P24910, DOI 10.1074/jbc.M113.457267; Lin YJ, 2013, BIOMOL NMR ASSIGN, V7, P325, DOI 10.1007/s12104-012-9438-2; Lu KP, 2003, CANCER CELL, V4, P175, DOI 10.1016/S1535-6108(03)00218-6; Lu PJ, 1999, NATURE, V399, P784; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; MACCIONI RB, 1995, PHYSIOL REV, V75, P835, DOI 10.1152/physrev.1995.75.4.835; Maestre-Martinez M, 2010, BIOL CHEM, V391, P1157, DOI 10.1515/BC.2010.122; MARGOLIS RL, 1990, EMBO J, V9, P4095, DOI 10.1002/j.1460-2075.1990.tb07631.x; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Mueller JW, 2011, J AM CHEM SOC, V133, P20096, DOI 10.1021/ja2086195; Mueller JW, 2008, PERSPECT MED CHEM, V2, P11; Mueller JW, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-9; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; PADILLA R, 1990, MOL CELL BIOCHEM, V97, P35; Pemberton TJ, 2005, COMP FUNCT GENOM, V6, P277, DOI 10.1002/cfg.482; PIROLLET F, 1992, BIOCHEMISTRY-US, V31, P8849, DOI 10.1021/bi00152a022; POTTER JD, 1983, METHOD ENZYMOL, V102, P135; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; Reimer T, 2003, J MOL BIOL, V330, P955, DOI 10.1016/S0022-2836(03)00713-7; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Sekerina E, 2000, J MOL BIOL, V301, P1003, DOI 10.1006/jmbi.2000.4013; SHIN RW, 1991, LAB INVEST, V64, P693; SOBUE K, 1981, FEBS LETT, V132, P137, DOI 10.1016/0014-5793(81)80447-4; Surmacz TA, 2002, J MOL BIOL, V321, P235, DOI 10.1016/S0022-2836(02)00615-0; Terada T, 2001, J MOL BIOL, V305, P917, DOI 10.1006/jmbi.2000.4293; Thiele A, 2011, J MOL BIOL, V411, P896, DOI 10.1016/j.jmb.2011.06.040; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TUCKER RP, 1990, BRAIN RES REV, V15, P101, DOI 10.1016/0165-0173(90)90013-E; Uchida T, 1999, FEBS LETT, V446, P278, DOI 10.1016/S0014-5793(99)00239-2; Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x; Wall ME, 1997, STRUCTURE, V5, P1599, DOI 10.1016/S0969-2126(97)00308-0; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Zhang RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065266; Zoldak G, 2009, BIOCHEMISTRY-US, V48, P10423, DOI 10.1021/bi9014242	65	5	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16708	16722		10.1074/jbc.M114.593228	http://dx.doi.org/10.1074/jbc.M114.593228			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25940090	Green Published, hybrid			2022-12-28	WOS:000357572800020
J	Kacirova, M; Kosek, D; Kadek, A; Man, P; Vecer, J; Herman, P; Obsilova, V; Obsil, T				Kacirova, Miroslava; Kosek, Dalibor; Kadek, Alan; Man, Petr; Vecer, Jaroslav; Herman, Petr; Obsilova, Veronika; Obsil, Tomas			Structural Characterization of Phosducin and Its Complex with the 14-3-3 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						14-3-3 protein; fluorescence; hydrogen-deuterium exchange; protein complex; protein phosphorylation; small-angle x-ray scattering (SAXS); phosducin	NEUTRAL TREHALASE NTH1; X-RAY-SCATTERING; TRANSDUCIN BETA-GAMMA; TRYPTOPHAN FLUORESCENCE; CRYSTAL-STRUCTURE; PLASMA-MEMBRANE; LIGAND-BINDING; PHOSPHORYLATION; REGULATOR; DISORDER	Background: Phosducin is a conserved regulatory phosphoprotein involved in phototransduction whose function is regulated in a 14-3-3-dependent manner. Results: The 14-3-3 protein binding affects the structure and the accessibility of several regions within both domains of phosphorylated phosducin. Conclusion: The 14-3-3 protein sterically occludes the whole G(t) binding interface of phosducin. Significance: Mechanistic explanation is given for the 14-3-3-dependent inhibition of phosducin function. Phosducin (Pdc), a highly conserved phosphoprotein involved in the regulation of retinal phototransduction cascade, transcriptional control, and modulation of blood pressure, is controlled in a phosphorylation-dependent manner, including the binding to the 14-3-3 protein. However, the molecular mechanism of this regulation is largely unknown. Here, the solution structure of Pdc and its interaction with the 14-3-3 protein were investigated using small angle x-ray scattering, time-resolved fluorescence spectroscopy, and hydrogen-deuterium exchange coupled to mass spectrometry. The 14-3-3 protein dimer interacts with Pdc using surfaces both inside and outside its central channel. The N-terminal domain of Pdc, where both phosphorylation sites and the 14-3-3-binding motifs are located, is an intrinsically disordered protein that reduces its flexibility in several regions without undergoing dramatic disorder-to-order transition upon binding to 14-3-3. Our data also indicate that the C-terminal domain of Pdc interacts with the outside surface of the 14-3-3 dimer through the region involved in G(t) binding. In conclusion, we show that the 14-3-3 protein interacts with and sterically occludes both the N- and C-terminal G(t) binding interfaces of phosphorylated Pdc, thus providing a mechanistic explanation for the 14-3-3-dependent inhibition of Pdc function.	[Kacirova, Miroslava; Kosek, Dalibor; Obsil, Tomas] Charles Univ Prague, Fac Sci, Dept Phys & Macromol Chem, Prague 12843, Czech Republic; [Kadek, Alan; Man, Petr] Charles Univ Prague, Fac Sci, Dept Biochem, Prague 12843, Czech Republic; [Kacirova, Miroslava; Kosek, Dalibor; Obsilova, Veronika; Obsil, Tomas] Acad Sci Czech Republic, Inst Physiol, CR-14220 Prague, Czech Republic; [Kadek, Alan; Man, Petr] Acad Sci Czech Republic, Inst Microbiol, CR-14220 Prague, Czech Republic; [Vecer, Jaroslav; Herman, Petr] Charles Univ Prague, Fac Math & Phys, Inst Phys, CR-12116 Prague, Czech Republic	Charles University Prague; Charles University Prague; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Charles University Prague	Obsilova, V (corresponding author), Acad Sci Czech Republic, Inst Physiol, Videnska 1083, CR-14220 Prague, Czech Republic.	veronika.obsilova@fgu.cas.cz; obsil@natur.cuni.cz	Obsil, Tomas/B-7142-2012; Herman, Petr/A-2626-2008; Košek, Dalibor/AAD-4715-2021; Kádek, Alan/J-6159-2014; Man, Petr/H-2451-2014; Obsilova, Veronika/B-7116-2012	Obsil, Tomas/0000-0003-4602-1272; Herman, Petr/0000-0001-6918-2576; Kádek, Alan/0000-0002-7953-5870; Man, Petr/0000-0002-1485-2197; Obsilova, Veronika/0000-0003-4887-0323	 [CZ.2.16/3.1.00/24023]		The mass spectrometry facility was supported by Project CZ.2.16/3.1.00/24023. We acknowledge the use of analytical ultracentrifuge in Central European Institute of Technology in Brno, Czech Republic.	BAJZER Z, 1993, BIOPHYS J, V65, P2313, DOI 10.1016/S0006-3495(93)81325-0; BAUER PH, 1992, NATURE, V358, P73, DOI 10.1038/358073a0; Beetz N, 2009, J CLIN INVEST, V119, P3597, DOI 10.1172/JCI38433; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bernado P, 2012, MOL BIOSYST, V8, P151, DOI 10.1039/c1mb05275f; Bernado P, 2010, EUR BIOPHYS J BIOPHY, V39, P769, DOI 10.1007/s00249-009-0549-3; Bustos DM, 2012, MOL BIOSYST, V8, P178, DOI 10.1039/c1mb05216k; Chen Y, 1998, BIOCHEMISTRY-US, V37, P9976, DOI 10.1021/bi980274n; Collins MO, 2008, MOL CELL PROTEOMICS, V7, P1331, DOI 10.1074/mcp.M700564-MCP200; CROSS AJ, 1984, BIOPHYS J, V46, P45, DOI 10.1016/S0006-3495(84)83997-1; Dam J, 2005, BIOPHYS J, V89, P619, DOI 10.1529/biophysj.105.059568; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; EFTINK MR, 1976, BIOCHEMISTRY-US, V15, P672, DOI 10.1021/bi00648a035; EFTINK MR, 1976, J PHYS CHEM-US, V80, P486, DOI 10.1021/j100546a014; Engen JR, 2003, ANALYST, V128, P623, DOI 10.1039/b212800b; Footer MJ, 2008, J BIOL CHEM, V283, P23852, DOI 10.1074/jbc.M803448200; Gaudet R, 1996, CELL, V87, P577, DOI 10.1016/S0092-8674(00)81376-8; Gaudet R, 1999, MOL CELL, V3, P649, DOI 10.1016/S1097-2765(00)80358-5; Gilbert C. W., 1983, TIME RESOLVED FLUORE, P605; Guinier A., 1939, ANN PHYS-NEW YORK, V11, P161, DOI DOI 10.1051/ANPHYS/193911120161; Herrmann R, 2010, J NEUROSCI, V30, P3239, DOI 10.1523/JNEUROSCI.4775-09.2010; Hotta K, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003532; Kopecka M, 2014, J BIOL CHEM, V289, P13948, DOI 10.1074/jbc.M113.544551; Kosek D, 2014, J BIOL CHEM, V289, P24463, DOI 10.1074/jbc.M114.583807; Lakowicz J. R., 1999, PRINCIPLES FLUORESCE, P53; Lee BY, 2004, J BIOL CHEM, V279, P54008, DOI 10.1074/jbc.M405669200; LEE RH, 1992, J BIOL CHEM, V267, P24776; LEE RH, 1987, BIOCHEMISTRY-US, V26, P3983, DOI 10.1021/bi00387a036; Loew A, 1998, STRUCT FOLD DES, V6, P1007, DOI 10.1016/S0969-2126(98)00102-6; Macakova E, 2013, BBA-GEN SUBJECTS, V1830, P4491, DOI 10.1016/j.bbagen.2013.05.025; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; Murray CL, 2008, J VIROL, V82, P1294, DOI 10.1128/JVI.01815-07; Nakano K, 2001, P NATL ACAD SCI USA, V98, P4693, DOI 10.1073/pnas.071067198; Obradovic Z, 2003, PROTEINS, V53, P566, DOI 10.1002/prot.10532; Obsil T, 2003, BIOCHEMISTRY-US, V42, P15264, DOI 10.1021/bi0352724; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Obsil T, 2011, SEMIN CELL DEV BIOL, V22, P663, DOI 10.1016/j.semcdb.2011.09.001; Obsilova V, 2004, J BIOL CHEM, V279, P4531, DOI 10.1074/jbc.M306939200; Obsilova V, 2008, BIOCHEMISTRY-US, V47, P1768, DOI 10.1021/bi7019468; Ottmann C, 2007, MOL CELL, V25, P427, DOI 10.1016/j.molcel.2006.12.017; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Rezabkova L, 2012, BIOPHYS J, V103, P1960, DOI 10.1016/j.bpj.2012.09.021; Rezabkova L, 2011, J BIOL CHEM, V286, P43527, DOI 10.1074/jbc.M111.273573; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Silhan J, 2004, J BIOL CHEM, V279, P49113, DOI 10.1074/jbc.M408671200; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Thulin CD, 2001, J BIOL CHEM, V276, P23805, DOI 10.1074/jbc.M101482200; Trcka F, 2014, J BIOL CHEM, V289, P9887, DOI 10.1074/jbc.M113.526046; Truong AB, 2002, PROTEINS, V49, P321, DOI 10.1002/prot.10210; Uversky VN, 1996, BIOPHYS CHEM, V60, P79, DOI 10.1016/0301-4622(96)00009-9; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Vecer J, 2014, FEBS LETT, V588, P443, DOI 10.1016/j.febslet.2013.11.038; Vecer J, 2011, J FLUORESC, V21, P873, DOI 10.1007/s10895-009-0589-1; Veisova D, 2012, BIOCHEM J, V443, P663, DOI 10.1042/BJ20111615; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Willardson BM, 2007, CELL SIGNAL, V19, P2417, DOI 10.1016/j.cellsig.2007.06.013; Woody R.W., 2010, INSTRUMENTAL ANAL IN, P303, DOI [10.1002/9780470602614.ch10, DOI 10.1002/9780470602614.CH10]; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; YOSHIDA T, 1994, J BIOL CHEM, V269, P24050; Zhu X, 1998, Mol Vis, V4, P13; Zhu XM, 2000, MOL CELL BIOL, V20, P5216, DOI 10.1128/MCB.20.14.5216-5226.2000	65	20	20	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16246	16260		10.1074/jbc.M115.636563	http://dx.doi.org/10.1074/jbc.M115.636563			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25971962	hybrid, Green Published			2022-12-28	WOS:000356930100028
J	Cabana, J; Holleran, B; Leduc, R; Escher, E; Guillemette, G; Lavigne, P				Cabana, Jerome; Holleran, Brian; Leduc, Richard; Escher, Emanuel; Guillemette, Gaetan; Lavigne, Pierre			Identification of Distinct Conformations of the Angiotensin-II Type 1 Receptor Associated with the G(q/11) Protein Pathway and the -Arrestin Pathway Using Molecular Dynamics Simulations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						angiotensin II; G protein-coupled receptor (GPCR); molecular dynamics; protein conformation; receptor structure-function; AT1 receptor; AT1R; activation mechanism; biased signaling; functional selectivity	SIGNAL-REGULATED KINASE-1; AMYLOID BETA-PEPTIDE; CONSERVED DRY MOTIF; AT(1) RECEPTOR; CRYSTAL-STRUCTURE; COUPLED-RECEPTOR; FUNCTIONAL SELECTIVITY; ACTIVATION MECHANISM; LIPID-BILAYER; BETA(2)-ADRENERGIC RECEPTOR	Biased signaling represents the ability of G protein-coupled receptors to engage distinct pathways with various efficacies depending on the ligand used or on mutations in the receptor. The angiotensin-II type 1 (AT(1)) receptor, a prototypical class A G protein-coupled receptor, can activate various effectors upon stimulation with the endogenous ligand angiotensin-II (AngII), including the G(q/11) protein and -arrestins. It is believed that the activation of those two pathways can be associated with distinct conformations of the AT(1) receptor. To verify this hypothesis, microseconds of molecular dynamics simulations were computed to explore the conformational landscape sampled by the WT-AT(1) receptor, the N111G-AT(1) receptor (constitutively active and biased for the G(q/11) pathway), and the D74N-AT(1) receptor (biased for the -arrestin1 and -2 pathways) in their apo-forms and in complex with AngII. The molecular dynamics simulations of the AngII-WT-AT(1), N111G-AT(1), and AngII-N111G-AT(1) receptors revealed specific structural rearrangements compared with the initial and ground state of the receptor. Simulations of the D74N-AT(1) receptor revealed that the mutation stabilizes the receptor in the initial ground state. The presence of AngII further stabilized the ground state of the D74N-AT(1) receptor. The biased agonist [Sar(1),Ile(8)]AngII also showed a preference for the ground state of the WT-AT(1) receptor compared with AngII. These results suggest that activation of the G(q/11) pathway is associated with a specific conformational transition stabilized by the agonist, whereas the activation of the -arrestin pathway is linked to the stabilization of the ground state of the receptor.	[Cabana, Jerome; Holleran, Brian; Leduc, Richard; Escher, Emanuel; Guillemette, Gaetan] Univ Sherbrooke, Inst Pharmacol Sherbrooke, Fac Med & Hlth Sci, Dept Pharmacol, Sherbrooke, PQ J1H 5N4, Canada; [Lavigne, Pierre] Univ Sherbrooke, Inst Pharmacol Sherbrooke, Fac Med & Hlth Sci, Dept Biochem, Sherbrooke, PQ J1H 5N4, Canada; [Cabana, Jerome; Lavigne, Pierre] Univ Laval, PROTEO Quebec Network Prot Struct Funct & Engn, Quebec City, PQ G1V 0A6, Canada	University of Sherbrooke; University of Sherbrooke; Laval University	Lavigne, P (corresponding author), Univ Sherbrooke, Inst Pharmacol Sherbrooke, Fac Med & Hlth Sci, Dept Biochem, 3001 12th Ave North, Sherbrooke, PQ J1H 5N4, Canada.	Pierre.Lavigne@USherbrooke.ca		Escher, Emanuel/0000-0001-6601-987X	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research.	Ahuja S, 2009, TRENDS PHARMACOL SCI, V30, P494, DOI 10.1016/j.tips.2009.06.003; Anezo C, 2003, J PHYS CHEM B, V107, P9424, DOI 10.1021/jp0348981; Aplin M, 2009, J MOL CELL CARDIOL, V46, P15, DOI 10.1016/j.yjmcc.2008.09.123; Arsenault J, 2010, BIOCHEM PHARMACOL, V80, P990, DOI 10.1016/j.bcp.2010.06.004; AUMELAS A, 1985, P NATL ACAD SCI USA, V82, P1881, DOI 10.1073/pnas.82.7.1881; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Benigni A, 2010, EMBO MOL MED, V2, P247, DOI 10.1002/emmm.201000080; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; BERWEGER CD, 1995, CHEM PHYS LETT, V232, P429, DOI 10.1016/0009-2614(94)01391-8; Bonde MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014135; BOSSE R, 1990, J CARDIOVASC PHARM, V16, pS50, DOI 10.1097/00005344-199016004-00011; Cabana J, 2013, J BIOL CHEM, V288, P2593, DOI 10.1074/jbc.M112.395939; Clement M, 2005, J BIOL CHEM, V280, P27121, DOI 10.1074/jbc.M413653200; Clement M, 2006, J RECEPT SIG TRANSD, V26, P417, DOI 10.1080/10799890600923195; Clement M, 2009, J BIOL CHEM, V284, P26603, DOI 10.1074/jbc.M109.012922; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; de Gasparo M, 2000, PHARMACOL REV, V52, P415; de Vries AH, 2004, J PHYS CHEM B, V108, P2454, DOI 10.1021/jp0366926; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Deupi X, 2012, P NATL ACAD SCI USA, V109, P119, DOI 10.1073/pnas.1114089108; Domazet I, 2015, MOL PHARMACOL, V87, P982, DOI 10.1124/mol.114.097337; Dror RO, 2011, P NATL ACAD SCI USA, V108, P18684, DOI 10.1073/pnas.1110499108; Ehrhardt C., 2006, SIGNAL TRANSDUCT BAN, V6, P179, DOI [10.1002/sita.200500073, DOI 10.1002/SITA.200500073]; FENG YH, 1995, J BIOL CHEM, V270, P12846, DOI 10.1074/jbc.270.21.12846; Fillion D, 2013, J BIOL CHEM, V288, P8187, DOI 10.1074/jbc.M112.442053; Gaborik Z, 2003, ENDOCRINOLOGY, V144, P2220, DOI 10.1210/en.2002-0135; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOLCK M, 1989, BIOCHEM BIOPH RES CO, V160, P1350, DOI 10.1016/S0006-291X(89)80152-4; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hunyady L, 1999, J AM SOC NEPHROL, V10, pS47; HUNYADY L, 1995, J BIOL CHEM, V270, P16602, DOI 10.1074/jbc.270.28.16602; Hunyady L, 2000, REGUL PEPTIDES, V91, P29, DOI 10.1016/S0167-0115(00)00137-3; Inoue Y, 1997, J HYPERTENS, V15, P703, DOI 10.1097/00004872-199715070-00001; Kandt C, 2007, METHODS, V41, P475, DOI 10.1016/j.ymeth.2006.08.006; Katritch V, 2014, TRENDS BIOCHEM SCI, V39, P233, DOI 10.1016/j.tibs.2014.03.002; KHOSLA MC, 1973, J MED CHEM, V16, P829, DOI 10.1021/jm00265a018; KHOSLA MC, 1972, J MED CHEM, V15, P792, DOI 10.1021/jm00278a003; Lange OF, 2010, BIOPHYS J, V99, P647, DOI 10.1016/j.bpj.2010.04.062; Laporte SA, 1996, MOL PHARMACOL, V49, P89; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee CW, 2008, J BIOL CHEM, V283, P21612, DOI 10.1074/jbc.M803062200; Lee C, 2007, FEBS LETT, V581, P2517, DOI 10.1016/j.febslet.2007.04.069; Lemkul JA, 2008, ARCH BIOCHEM BIOPHYS, V470, P54, DOI 10.1016/j.abb.2007.11.004; Lemkul JA, 2009, FEBS J, V276, P3060, DOI 10.1111/j.1742-4658.2009.07024.x; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; MacCallum JL, 2006, J AM CHEM SOC, V128, P125, DOI 10.1021/ja0535099; Matsoukas MT, 2013, J CHEM INF MODEL, V53, P2798, DOI 10.1021/ci4003014; Miura S, 1999, J BIOL CHEM, V274, P7103, DOI 10.1074/jbc.274.11.7103; Nikiforovich GV, 2006, CHEM BIOL DRUG DES, V68, P239, DOI 10.1111/j.1747-0285.2006.00444.x; NODA K, 1995, J BIOL CHEM, V270, P28511, DOI 10.1074/jbc.270.48.28511; Noda K, 1996, BIOCHEMISTRY-US, V35, P16435, DOI 10.1021/bi961593m; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Ohyama K, 2002, BIOCHEM BIOPH RES CO, V292, P362, DOI 10.1006/bbrc.2002.6670; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2013, ANGEW CHEM INT EDIT, V52, P11021, DOI 10.1002/anie.201302374; Perodin J, 2002, BIOCHEMISTRY-US, V41, P14348, DOI 10.1021/bi0258602; Qian HW, 2001, MOL ENDOCRINOL, V15, P1706, DOI 10.1210/me.15.10.1706; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rosenkilde MM, 2010, TRENDS PHARMACOL SCI, V31, P567, DOI 10.1016/j.tips.2010.08.006; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Shukla AK, 2014, NATURE, V512, P218, DOI 10.1038/nature13430; Szczepek M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5801; Thomas WG, 2003, TRENDS ENDOCRIN MET, V14, P130, DOI 10.1016/S1043-2760(03)00023-7; Thomas WG, 2000, J BIOL CHEM, V275, P2893, DOI 10.1074/jbc.275.4.2893; Tieleman D. Peter, 2004, BMC Biochemistry, V5, P10, DOI 10.1186/1471-2091-5-10; Tieleman DP, 2003, J AM CHEM SOC, V125, P6382, DOI 10.1021/ja029504i; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van der Spoel D, 2011, WIRES COMPUT MOL SCI, V1, P710, DOI 10.1002/wcms.50; Vauquelin G, 2001, J RENIN-ANGIO-ALDO S, V2, pS32, DOI 10.1177/14703203010020010501; Wacker D, 2013, SCIENCE, V340, P615, DOI 10.1126/science.1232808; Wei HJ, 2004, J BIOL CHEM, V279, P48255, DOI 10.1074/jbc.M406205200; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Werner T, 2012, ADV DRUG DELIVER REV, V64, P323, DOI 10.1016/j.addr.2011.11.011; Wilson PC, 2013, J BIOL CHEM, V288, P18872, DOI 10.1074/jbc.M113.472381; Worth CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007011; YAMANO Y, 1995, J BIOL CHEM, V270, P14024, DOI 10.1074/jbc.270.23.14024; Zhang XJC, 2013, PROTEIN CELL, V4, P747, DOI 10.1007/s13238-013-3073-2; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702	84	26	27	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15835	15854		10.1074/jbc.M114.627356	http://dx.doi.org/10.1074/jbc.M114.627356			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25934394	Green Published, hybrid			2022-12-28	WOS:000356527400043
J	Pan, CC; Kumar, S; Shah, N; Bloodworth, JC; Hawinkels, LJAC; Mythreye, K; Hoyt, DG; Lee, NY				Pan, Christopher C.; Kumar, Sanjay; Shah, Nirav; Bloodworth, Jeffrey C.; Hawinkels, Lukas J. A. C.; Mythreye, Karthikeyan; Hoyt, Dale G.; Lee, Nam Y.			Endoglin Regulation of Smad2 Function Mediates Beclin1 Expression and Endothelial Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; CELL PROLIFERATION; RECEPTOR; PROTEIN; ALK1; ANGIOGENESIS; ACTIVATION; APOPTOSIS; RESPONSES; PATHWAYS	Autophagy is the targeted degradation of proteins and organelles critical for homeostasis and cell survival. Transforming growth factor beta (TGF-beta) differentially regulates autophagy in a context-specific manner, although the precise intracellular mechanisms remain less clear. Importantly, how TGF-beta controls autophagic responses in endothelial cells (EC) during angiogenesis is unknown. Here we identified endoglin, an EC-specific TGF-beta co-receptor essential for angiogenesis, as a key determinant of autophagy. Among the two opposing TGF-beta Smad pathways in the EC system (Smad1/5/8 and Smad2/3), we found Smad2 as the major transcriptional regulator of autophagy that targets beclin1 (BECN1) gene expression. Smad2, but not Smad3, acts as a repressor upstream of the BECN1 promoter region. Overall, endoglin promotes autophagy by impeding Smad2 transcriptional repressor activity. Notably, increased beclin1 levels upon Smad2 knockdown directly correlated with enhanced autophagy during angiogenesis. Taken together, these results establish endoglin as a critical mediator of autophagy and demonstrate a new transcriptional mechanism by which Smad2 inhibits angiogenesis.	[Pan, Christopher C.; Kumar, Sanjay; Shah, Nirav; Hoyt, Dale G.; Lee, Nam Y.] Ohio State Univ, Div Pharmacol, Coll Pharm, Columbus, OH 43210 USA; [Lee, Nam Y.] Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Lee, Nam Y.] Ohio State Univ, James Comprehens Canc Ctr, Columbus, OH 43210 USA; [Hawinkels, Lukas J. A. C.] Leiden Univ, Dept Mol Cell Biol, Med Ctr, Leiden, Netherlands; [Bloodworth, Jeffrey C.] Loyola Univ, Med Ctr, Maywood, IL 60153 USA; [Mythreye, Karthikeyan] Univ S Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Loyola University Chicago; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Lee, NY (corresponding author), Ohio State Univ, Div Pharmacol, Coll Pharm, 500 West 12th Ave, Columbus, OH 43210 USA.	lee.5064@osu.edu	Hawinkels, Lukas/Q-5098-2019; Regan, Clinton/E-6250-2012; Karthikeyan, Mythreye/ABC-7345-2020; Lee, Nam/H-3073-2016	Hawinkels, Lukas/0000-0002-2274-9325; Karthikeyan, Mythreye/0000-0001-5478-0098; 	National Institutes of Health [CA178443]; Dutch Cancer Society/Alp d'huZes-Bas Mulder Award [UL2011-5051]; NATIONAL CANCER INSTITUTE [R01CA178443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM109091] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dutch Cancer Society/Alp d'huZes-Bas Mulder Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant CA178443 (awarded to N. Y. L.), and the Dutch Cancer Society/Alp d'huZes-Bas Mulder Award (UL2011-5051) (to L. H.).	Barbara NP, 1999, J BIOL CHEM, V274, P584, DOI 10.1074/jbc.274.2.584; Bohensky J, 2007, AUTOPHAGY, V3, P207, DOI 10.4161/auto.3708; Bourdeau A, 1999, J CLIN INVEST, V104, P1343, DOI 10.1172/JCI8088; Chen G, 2013, CARDIOVASC RES, V98, P437, DOI 10.1093/cvr/cvt035; Choi AMK, 2013, NEW ENGL J MED, V368, P1845, DOI 10.1056/NEJMc1303158; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Du JH, 2012, AM J PHYSIOL-CELL PH, V302, pC383, DOI 10.1152/ajpcell.00164.2011; Fonsatti E, 2003, ONCOGENE, V22, P6557, DOI 10.1038/sj.onc.1206813; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Huang D, 2009, J MOL CELL CARDIOL, V46, P25, DOI 10.1016/j.yjmcc.2008.10.019; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kiyono K, 2009, CANCER RES, V69, P8844, DOI 10.1158/0008-5472.CAN-08-4401; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Kumar S, 2014, ONCOGENE, V33, P3970, DOI 10.1038/onc.2013.386; Kumar S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.399; Lastres P, 1996, J CELL BIOL, V133, P1109, DOI 10.1083/jcb.133.5.1109; Lebrin F, 2005, CARDIOVASC RES, V65, P599, DOI 10.1016/j.cardiores.2004.10.036; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Lee NY, 2007, J BIOL CHEM, V282, P21507, DOI 10.1074/jbc.M700176200; Li DD, 2009, ONCOGENE, V28, P886, DOI 10.1038/onc.2008.441; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; Lien SC, 2013, BBA-MOL CELL RES, V1833, P3124, DOI 10.1016/j.bbamcr.2013.08.023; Ota T, 2002, J CELL PHYSIOL, V193, P299, DOI 10.1002/jcp.10170; Patel AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041394; Pece-Barbara N, 2005, J BIOL CHEM, V280, P27800, DOI 10.1074/jbc.M503471200; Phanish MK, 2006, BIOCHEM J, V393, P601, DOI 10.1042/BJ20051106; Poluzzi C, 2014, J BIOL CHEM, V289, P16114, DOI 10.1074/jbc.M114.556530; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Suzuki HI, 2010, AUTOPHAGY, V6, P645, DOI 10.4161/auto.6.5.12046; Weinmann AS, 2001, MOL CELL BIOL, V21, P6820, DOI 10.1128/MCB.21.20.6820-6832.2001; Wirawan E, 2012, AUTOPHAGY, V8, P6, DOI 10.4161/auto.8.1.16645; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	35	21	27	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					14884	14892		10.1074/jbc.M114.630178	http://dx.doi.org/10.1074/jbc.M114.630178			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25931117	hybrid, Green Published			2022-12-28	WOS:000356177300008
J	Saha, K; Eckert, RL				Saha, Kamalika; Eckert, Richard L.			Methylosome Protein 50 and PKC delta/p38 delta Protein Signaling Control Keratinocyte Proliferation via Opposing Effects on p21(Cip1) Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN INVOLUCRIN PROMOTER; ARGININE METHYLTRANSFERASE 5; KINASE-C-DELTA; HUMAN EPIDERMAL-KERATINOCYTES; DISTAL REGULATORY REGION; TARGET GENES; LUNG-CANCER; DIFFERENTIATION; TRANSCRIPTION; METHYLATION	Protein arginine methyltransferase 5 (PRMT5) is a key epigenetic regulator that symmetrically dimethylates arginine residues on histones H3 and H4 to silence gene expression. PRMT5 is frequently observed in a complex with the cofactor methylosome protein 50 (MEP50), which is required for PRMT5 activity. PKC delta/p38 delta signaling, a key controller of keratinocyte proliferation and differentiation, increases p21(Cip1) expression to suppress keratinocyte proliferation. We now show that MEP50 enhances keratinocyte proliferation and survival via mechanisms that include silencing of p21(Cip1) expression. This is associated with enhanced PRMT5-MEP50 interaction at the p21(Cip1) promoter and enhanced arginine dimethylation of the promoter-associated histones H3 and H4. It is also associated with a MEP50-dependent reduction in the level of p53, a key controller of p21(Cip1) gene expression. We confirm an important biological role for MEP50 and PRMT5 in regulating keratinocyte proliferation using a stratified epidermal equivalent model that mimics in vivo epidermal keratinocyte differentiation. In this model, PRMT5 or MEP50 knockdown results in reduced keratinocyte proliferation. We further show that PKC delta/p38 delta signaling suppresses MEP50 expression, leading to reduced H3/H4 arginine dimethylation at the p21(Cip1) promoter, and that this is associated with enhanced p21(Cip1) expression and reduced cell proliferation. These findings describe an opposing action between PKC delta/p38 delta MAPK signaling and PRMT5/MEP50 epigenetic silencing mechanisms in regulating cell proliferation.	[Saha, Kamalika; Eckert, Richard L.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Eckert, Richard L.] Univ Maryland, Sch Med, Dept Dermatol, Baltimore, MD 21201 USA; [Eckert, Richard L.] Univ Maryland, Sch Med, Dept Obstet & Gynecol, Baltimore, MD 21201 USA; [Eckert, Richard L.] Univ Maryland, Sch Med, Greenebaum Canc Ctr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Eckert, RL (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, 108 N Greene St, Baltimore, MD 21201 USA.	reckert@umaryland.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [R21AR065266, RO1CA131064]; Greenebaum Cancer Center; NATIONAL CANCER INSTITUTE [R01CA131064, R01CA131074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR065266] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Greenebaum Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R21AR065266 and RO1CA131064 (to R. L. E.). This work was also supported by a pilot award from the Greenebaum Cancer Center.	Adhikary G, 2010, J INVEST DERMATOL, V130, P2017, DOI 10.1038/jid.2010.108; Aggarwal P, 2010, CANCER CELL, V18, P329, DOI 10.1016/j.ccr.2010.08.012; Antonysamy S, 2012, P NATL ACAD SCI USA, V109, P17960, DOI 10.1073/pnas.1209814109; Banks EB, 1999, BIOCHEM J, V337, P507, DOI 10.1042/0264-6021:3370507; Banks EB, 1998, BIOCHEM J, V331, P61, DOI 10.1042/bj3310061; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Chew YC, 2013, J BIOL CHEM, V288, P17759, DOI 10.1074/jbc.M113.477133; Chew YC, 2012, J BIOL CHEM, V287, P16168, DOI 10.1074/jbc.M111.305292; Chew YC, 2011, J BIOL CHEM, V286, P28772, DOI 10.1074/jbc.M110.205245; Crish JF, 2008, J INVEST DERMATOL, V128, P530, DOI 10.1038/sj.jid.5701049; Crish JF, 2006, J INVEST DERMATOL, V126, P305, DOI 10.1038/sj.jid.5700019; Crish JF, 1998, J BIOL CHEM, V273, P30460, DOI 10.1074/jbc.273.46.30460; Crish JF, 2002, ONCOGENE, V21, P738, DOI 10.1038/sj.onc.1205038; Eckert RL, 2004, J INVEST DERMATOL, V123, P13, DOI 10.1111/j.0022-202X.2004.22723.x; Eckert RL, 2003, J INVEST DERMATOL, V120, P823, DOI 10.1046/j.1523-1747.2003.12120.x; Eckert RL, 1997, PHYSIOL REV, V77, P397, DOI 10.1152/physrev.1997.77.2.397; Efimova T, 2004, MOL CELL BIOL, V24, P8167, DOI 10.1128/MCB.24.18.8167-8183.2004; Efimova T, 2003, J BIOL CHEM, V278, P34277, DOI 10.1074/jbc.M302759200; Efimova T, 1998, J BIOL CHEM, V273, P24387, DOI 10.1074/jbc.273.38.24387; Efimova T, 2000, J BIOL CHEM, V275, P1601, DOI 10.1074/jbc.275.3.1601; Eftmova T, 2002, J BIOL CHEM, V277, P31753, DOI 10.1074/jbc.M205098200; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fabbrizio E, 2002, EMBO REP, V3, P641, DOI 10.1093/embo-reports/kvf136; GERDES J, 1984, J IMMUNOL, V133, P1710; Gu Z, 2013, ONCOGENE, V32, P1888, DOI 10.1038/onc.2012.207; Gu ZP, 2012, BIOCHEM J, V446, P235, DOI 10.1042/BJ20120768; Han BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036941; Ho MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057008; Kanade SR, 2012, J BIOL CHEM, V287, P7313, DOI 10.1074/jbc.M111.331660; Karkhanis V, 2011, TRENDS BIOCHEM SCI, V36, P633, DOI 10.1016/j.tibs.2011.09.001; Krause CD, 2007, PHARMACOL THERAPEUT, V113, P50, DOI 10.1016/j.pharmthera.2006.06.007; Li JJ, 2000, MOL CARCINOGEN, V29, P159, DOI 10.1002/1098-2744(200011)29:3<159::AID-MC5>3.0.CO;2-W; Ligr M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026250; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; Molina-Serrano D, 2013, BIOCHEM SOC T, V41, P751, DOI 10.1042/BST20130003; Nicholas C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074710; Pal S, 2007, EMBO J, V26, P3558, DOI 10.1038/sj.emboj.7601794; Peng Y, 2008, P NATL ACAD SCI USA, V105, P5236, DOI 10.1073/pnas.0712262105; Peng Y, 2010, J CELL MOL MED, V14, P2780, DOI 10.1111/j.1582-4934.2009.00936.x; Poumay Y, 2004, ARCH DERMATOL RES, V296, P203, DOI 10.1007/s00403-004-0507-y; Rorke EA, 2010, ONCOGENE, V29, P5873, DOI 10.1038/onc.2010.315; Rorke EA, 2015, J INVEST DERMATOL, V135, P170, DOI 10.1038/jid.2014.310; Saha K, 2014, J BIOL CHEM, V289, P11443, DOI 10.1074/jbc.M113.543165; Tae S, 2011, NUCLEIC ACIDS RES, V39, P5424, DOI 10.1093/nar/gkr170; Wei TYW, 2012, CANCER SCI, V103, P1640, DOI 10.1111/j.1349-7006.2012.02367.x; Wei TYW, 2014, CELL SIGNAL, V26, P2940, DOI 10.1016/j.cellsig.2014.09.014; Welter JF, 1995, ONCOGENE, V11, P2681; WELTER JF, 1995, J BIOL CHEM, V270, P12614, DOI 10.1074/jbc.270.21.12614; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409	50	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13521	13530		10.1074/jbc.M115.642868	http://dx.doi.org/10.1074/jbc.M115.642868			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25851901	hybrid, Green Published			2022-12-28	WOS:000354975700046
J	Tomar, S; Johnston, ML; John, SES; Osswald, HL; Nyalapatla, PR; Paul, LN; Ghosh, AK; Denison, MR; Mesecar, AD				Tomar, Sakshi; Johnston, Melanie L.; John, Sarah E. St.; Osswald, Heather L.; Nyalapatla, Prasanth R.; Paul, Lake N.; Ghosh, Arun K.; Denison, Mark R.; Mesecar, Andrew D.			Ligand-induced Dimerization of Middle East Respiratory Syndrome (MERS) Coronavirus nsp5 Protease (3CL(pro)) IMPLICATIONS FOR nsp5 REGULATION AND THE DEVELOPMENT OF ANTIVIRALS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARS-CORONAVIRUS; MAIN PROTEASE; 3C-LIKE PROTEASE; BIOLOGICAL EVALUATION; CATALYTIC-ACTIVITY; DIFFRACTION DATA; DIMER INTERFACE; DESIGN; INHIBITORS; MECHANISM	All coronaviruses, including the recently emerged Middle East respiratory syndrome coronavirus (MERS-CoV) from the beta-CoV subgroup, require the proteolytic activity of the nsp5 protease (also known as 3C-like protease, 3CL(pro)) during virus replication, making it a high value target for the development of anti-coronavirus therapeutics. Kinetic studies indicate that in contrast to 3CL(pro) from other beta-CoV 2c members, including HKU4 and HKU5, MERS-CoV 3CL(pro) is less efficient at processing a peptide substrate due to MERS-CoV 3CL(pro) being a weakly associated dimer. Conversely, HKU4, HKU5, and SARS-CoV 3CL(pro) enzymes are tightly associated dimers. Analytical ultracentrifugation studies support that MERS-CoV 3CL(pro) is a weakly associated dimer (K-d similar to 52 mu M) with a slow off-rate. Peptidomimetic inhibitors of MERS-CoV 3CL(pro) were synthesized and utilized in analytical ultracentrifugation experiments and demonstrate that MERS-CoV 3CL(pro) undergoes significant ligand-induced dimerization. Kinetic studies also revealed that designed reversible inhibitors act as activators at a low compound concentration as a result of induced dimerization. Primary sequence comparisons and x-ray structural analyses of two MERS-CoV 3CL(pro) and inhibitor complexes, determined to 1.6 angstrom, reveal remarkable structural similarity of the dimer interface with 3CL(pro) from HKU4-CoV and HKU5-CoV. Despite this structural similarity, substantial differences in the dimerization ability suggest that long range interactions by the nonconserved amino acids distant from the dimer interface may control MERS-CoV 3CL(pro) dimerization. Activation of MERS-CoV 3CL(pro) through ligand-induced dimerization appears to be unique within the genogroup 2c and may potentially increase the complexity in the development of MERS-CoV 3CL(pro) inhibitors as antiviral agents.	[Tomar, Sakshi; John, Sarah E. St.; Mesecar, Andrew D.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Johnston, Melanie L.; Osswald, Heather L.; Nyalapatla, Prasanth R.; Ghosh, Arun K.; Mesecar, Andrew D.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Paul, Lake N.] Purdue Univ, Bindley Biosci Ctr, W Lafayette, IN 47907 USA; [Denison, Mark R.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Denison, Mark R.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Vanderbilt University; Vanderbilt University	Mesecar, AD (corresponding author), Purdue Univ, Dept Biol Sci, 915 W State St, W Lafayette, IN 47907 USA.	amesecar@purdue.edu	Tomar, Sakshi/H-3283-2018; Tomar, Sakshi/AAL-6766-2020; Nyalapatla, Prasanth Reddy/Q-1111-2019; Regan, Clinton/E-6250-2012; Denison, Mark R/O-7258-2018	Tomar, Sakshi/0000-0001-5994-4178; Tomar, Sakshi/0000-0001-5994-4178; Denison, Mark R/0000-0003-2655-0900; Mesecar, Andrew/0000-0002-1241-2577; St. John, Sarah/0000-0001-6564-7081; Nyalapatla, Prasanth Reddy/0000-0003-1048-5841	National Institutes of Health [P30 CA023168]; United States Department of Energy [DE-AC02-06CH11357]; Michigan Technology Tri-Corridor Grant [085P1000817]; NATIONAL CANCER INSTITUTE [P30CA023168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI026603, R01AI026603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM053386] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy(United States Department of Energy (DOE)); Michigan Technology Tri-Corridor Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Crystallization and DNA sequencing were partially supported by the Purdue Center for Cancer Research Macromolecular Crystallography and DNA Sequencing Shared Resources, which are partially supported by National Institutes of Health Grant P30 CA023168. We acknowledge the LS-CAT and LRL-CAT beam line staff for their help in acquiring x-ray data. Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy Office of Science by Argonne National Laboratory, was supported by the United States Department of Energy under Contract DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corp. and the Michigan Technology Tri-Corridor Grant 085P1000817. Use of the Lilly Research Laboratories Collaborative Access Team (LRL-CAT) beamline at Sector 31 of the Advanced Photon Source was provided by Eli Lilly Co., which operates the facility. We thank Yahira Baez-Santos, Dia Beachboard and Sergey Savinov for their helpful suggestions during manuscript preparation.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agnihothram S, 2014, MBIO, V5, DOI 10.1128/mBio.00047-14; ALENIUS S, 1991, ACTA VET SCAND, V32, P163; Anand K, 2003, SCIENCE, V300, P1763, DOI 10.1126/science.1085658; Annan A, 2013, EMERG INFECT DIS, V19, P456, DOI 10.3201/eid1903.121503; Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742; Baez-Santos YM, 2014, J MED CHEM, V57, P2393, DOI 10.1021/jm401712t; BARBER DML, 1985, VET REC, V117, P459, DOI 10.1136/vr.117.18.459; Barrila J, 2006, BIOCHEMISTRY-US, V45, P14908, DOI 10.1021/bi0616302; Blanchard JE, 2004, CHEM BIOL, V11, P1445, DOI 10.1016/j.chembiol.2004.08.011; Breban R, 2013, LANCET, V382, P694, DOI 10.1016/S0140-6736(13)61492-0; Brown Patrick H, 2008, Curr Protoc Immunol, VChapter 18, DOI 10.1002/0471142735.im1815s81; Butler D, 2012, NATURE, V492, P166, DOI 10.1038/492166a; Cauchemez S, 2013, EUROSURVEILLANCE, V18, P18; CAVALLARO JJ, 1970, J INFECT DIS, V122, P272, DOI 10.1093/infdis/122.4.272; Centers for Disease Control, 2014, MERS IN THE US; Chan JFW, 2012, J INFECTION, V65, P477, DOI 10.1016/j.jinf.2012.10.002; Chen S, 2008, J BIOCHEM, V143, P525, DOI 10.1093/jb/mvm246; Chen S, 2010, PROTEIN CELL, V1, P59, DOI 10.1007/s13238-010-0011-4; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng SC, 2010, BIOPHYS J, V98, P1327, DOI 10.1016/j.bpj.2009.12.4272; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Cotten M, 2013, LANCET, V382, P1993, DOI 10.1016/S0140-6736(13)61887-5; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cui LJ, 2011, ADV VIROL, V2011, DOI 10.1155/2011/129134; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI 10.1038/hr.2014.17; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fan KQ, 2004, J BIOL CHEM, V279, P1637, DOI 10.1074/jbc.M310875200; Ghosh AK, 2005, J MED CHEM, V48, P6767, DOI 10.1021/JM050548m; Ghosh AK, 2008, BIOORG MED CHEM LETT, V18, P5684, DOI 10.1016/j.bmcl.2008.08.082; Ghosh AK, 2007, BIOORG MED CHEM LETT, V17, P5876, DOI 10.1016/j.bmcl.2007.08.031; Grum-Tokars V, 2008, VIRUS RES, V133, P63, DOI 10.1016/j.virusres.2007.02.015; HAMRE D, 1966, P SOC EXP BIOL MED, V121, P190, DOI 10.3181/00379727-121-30734; Hsu MF, 2005, J BIOL CHEM, V280, P31257, DOI 10.1074/jbc.M502577200; Jacobs J, 2013, J MED CHEM, V56, P534, DOI 10.1021/jm301580n; Kaeppler U, 2005, J MED CHEM, V48, P6832, DOI 10.1021/jm0501782; Lai LH, 2006, CURR PHARM DESIGN, V12, P4555, DOI 10.2174/138161206779010396; Lai MMC, 1997, ADV VIRUS RES, V48, P1, DOI 10.1016/S0065-3527(08)60286-9; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Li CM, 2010, J BIOL CHEM, V285, P28134, DOI 10.1074/jbc.M109.095851; Lim LZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101941; LU YQ, 1995, J VIROL, V69, P3554, DOI 10.1128/JVI.69.6.3554-3559.1995; MCINTOSH K, 1967, P NATL ACAD SCI USA, V58, P2268, DOI 10.1073/pnas.58.6.2268; Memish ZA, 2013, EMERG INFECT DIS, V19, P1819, DOI 10.3201/eid1911.131172; Myers DP, 2001, BIOCHEMISTRY-US, V40, P13230, DOI 10.1021/bi0155908; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perera RA, 2013, EUROSURVEILLANCE, V18, P8, DOI 10.2807/1560-7917.ES2013.18.36.20574; Perlman S, 2009, NAT REV MICROBIOL, V7, P439, DOI 10.1038/nrmicro2147; Reusken CBEM, 2013, LANCET INFECT DIS, V13, P859, DOI 10.1016/S1473-3099(13)70164-6; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Shen Y, 2006, MOL CELL, V22, P807, DOI 10.1016/j.molcel.2006.04.026; Shi JH, 2004, J BIOL CHEM, V279, P24765, DOI 10.1074/jbc.M311744200; Shi JH, 2008, J VIROL, V82, P4620, DOI 10.1128/JVI.02680-07; Shi JH, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001084; Stobart CC, 2012, J VIROL, V86, P4801, DOI 10.1128/JVI.06754-11; Turlington M, 2013, BIOORG MED CHEM LETT, V23, P6172, DOI 10.1016/j.bmcl.2013.08.112; van Boheemen S, 2012, MBIO, V3, DOI 10.1128/mBio.00473-12; van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024; Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005; World Health Organization, 2014, MIDDL E RESP SYNDR C; Wu CG, 2013, ACTA CRYSTALLOGR D, V69, P747, DOI 10.1107/S0907444913001315; Yang HT, 2006, CURR PHARM DESIGN, V12, P4573, DOI 10.2174/138161206779010369; Yang HT, 2003, P NATL ACAD SCI USA, V100, P13190, DOI 10.1073/pnas.1835675100; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Ziebuhr J, 2000, J GEN VIROL, V81, P853, DOI 10.1099/0022-1317-81-4-853	65	88	94	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19403	19422		10.1074/jbc.M115.651463	http://dx.doi.org/10.1074/jbc.M115.651463			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26055715	hybrid, Green Published			2022-12-28	WOS:000359364600002
J	Hanelt, I; Jensen, S; Wunnicke, D; Slotboom, DJ				Hanelt, Inga; Jensen, Sonja; Wunnicke, Dorith; Slotboom, Dirk Jan			Low Affinity and Slow Na+ Binding Precedes High Affinity Aspartate Binding in the Secondary-active Transporter Glt(Ph)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fluorescence; membrane protein; membrane transport; pre-steady-state kinetics; transporter; glutamate transport; Sodium-coupled transport; tryptophan fluorescence; binding kinetics; secondary transport	NEURONAL GLUTAMATE TRANSPORTER; HOMOLOG GLT(PH); PYROCOCCUS-HORIKOSHII; EXTRACELLULAR GATE; SUBSTRATE-BINDING; CRYSTAL-STRUCTURE; SODIUM; EAAC1; MECHANISM; DYNAMICS	Background: Glt(Ph) couples uptake of one aspartate to the cotransport of three Na+. Results: Slow binding of Na+ takes place before aspartate binding and has high activation energy. Conclusion: Binding of Na+ is accompanied by a large conformational change enabling subsequent high affinity binding of aspartate. Significance: Insight into the binding kinetics of coupling ions is essential to deduce a mechanism of transport. Glt(Ph) from Pyrococcus horikoshii is a homotrimeric Na+-coupled aspartate transporter. It belongs to the widespread family of glutamate transporters, which also includes the mammalian excitatory amino acid transporters that take up the neurotransmitter glutamate. Each protomer in Glt(Ph) consists of a trimerization domain involved in subunit interactions and a transport domain containing the substrate binding site. Here, we have studied the dynamics of Na+ and aspartate binding to Glt(Ph). Tryptophan fluorescence measurements on the fully active single tryptophan mutant F273W revealed that Na+ binds with low affinity to the apoprotein (K-d 120 mm), with a particularly low k(on) value (5.1 m(-1)s(-1)). At least two sodium ions bind before aspartate. The binding of Na+ requires a very high activation energy (E-a 106.8 kJ mol(-1)) and consequently has a large Q(10) value of 4.5, indicative of substantial conformational changes before or after the initial binding event. The apparent affinity for aspartate binding depended on the Na+ concentration present. Binding of aspartate was not observed in the absence of Na+, whereas in the presence of high Na+ concentrations (above the K-d for Na+) the dissociation constants for aspartate were in the nanomolar range, and the aspartate binding was fast (k(on) of 1.4 x 10(5) m(-1)s(-1)), with low E-a and Q(10) values (42.6 kJ mol(-1) and 1.8, respectively). We conclude that Na+ binding is most likely the rate-limiting step for substrate binding.	[Hanelt, Inga; Jensen, Sonja; Wunnicke, Dorith; Slotboom, Dirk Jan] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Biochem, NL-9747 AG Groningen, Netherlands	University of Groningen	Slotboom, DJ (corresponding author), Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Biochem, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	d.j.slotboom@rug.nl	Hänelt, Inga/N-2982-2016	Hänelt, Inga/0000-0003-1495-3163	Deutsche Forschungsgemeinschaft [HA 6322/1-1]; NWO (Netherlands Organisation for Scientific Research; a NWO vici grant); European Union (European Drug Initiative on Channels and Transporters program and a European Research Council starting grant)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NWO (Netherlands Organisation for Scientific Research; a NWO vici grant); European Union (European Drug Initiative on Channels and Transporters program and a European Research Council starting grant)	This work was supported by the Deutsche Forschungsgemeinschaft (HA 6322/1-1; to I. H.), the NWO (Netherlands Organisation for Scientific Research; a NWO vici grant; to D. J. S.), and by the European Union (European Drug Initiative on Channels and Transporters program and a European Research Council starting grant (to D. J. S.).	Akyuz N, 2013, NATURE, V502, P114, DOI 10.1038/nature12265; Bastug T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033058; Bergles DE, 2002, J NEUROSCI, V22, P10153; Borre L, 2001, J BIOL CHEM, V276, P40396, DOI 10.1074/jbc.M104926200; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; DeChancie J, 2011, MOL BIOSYST, V7, P832, DOI 10.1039/c0mb00175a; Erkens GB, 2013, NATURE, V502, P119, DOI 10.1038/nature12538; Erkens GB, 2010, BIOCHEMISTRY-US, V49, P3203, DOI 10.1021/bi100154r; Ewers D, 2013, P NATL ACAD SCI USA, V110, P12486, DOI 10.1073/pnas.1300772110; Gameiro A, 2011, BIOPHYS J, V100, P2623, DOI 10.1016/j.bpj.2011.04.034; Georgieva ER, 2013, NAT STRUCT MOL BIOL, V20, P215, DOI 10.1038/nsmb.2494; Grazioso G, 2012, J AM CHEM SOC, V134, P453, DOI 10.1021/ja208485w; Groeneveld M, 2010, BIOCHEMISTRY-US, V49, P3511, DOI 10.1021/bi100430s; Hanelt I, 2013, NAT STRUCT MOL BIOL, V20, P210, DOI 10.1038/nsmb.2471; Holley DC, 2009, PHILOS T R SOC B, V364, P155, DOI 10.1098/rstb.2008.0246; Huang ZJ, 2008, BIOPHYS J, V95, P2292, DOI 10.1529/biophysj.108.133421; Huang ZJ, 2010, BIOPHYS J, V99, P1416, DOI 10.1016/j.bpj.2010.06.052; Jensen S, 2013, NAT STRUCT MOL BIOL, V20, P1224, DOI 10.1038/nsmb.2663; KANAI Y, 1995, J BIOL CHEM, V270, P16561, DOI 10.1074/jbc.270.28.16561; KANNER BI, 1982, BIOCHEMISTRY-US, V21, P6327, DOI 10.1021/bi00267a044; Larsson HP, 2010, P NATL ACAD SCI USA, V107, P13912, DOI 10.1073/pnas.1006289107; Larsson HP, 2004, P NATL ACAD SCI USA, V101, P3951, DOI 10.1073/pnas.0306737101; Reyes N, 2013, NAT STRUCT MOL BIOL, V20, P634, DOI 10.1038/nsmb.2548; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Rosental N, 2006, J BIOL CHEM, V281, P27905, DOI 10.1074/jbc.M600331200; Ryan RM, 2009, J BIOL CHEM, V284, P17540, DOI 10.1074/jbc.M109.005926; Tao Z, 2006, J BIOL CHEM, V281, P10263, DOI 10.1074/jbc.M510739200; Tao Z, 2010, J BIOL CHEM, V285, P17725, DOI 10.1074/jbc.M110.121798; Teichman S, 2012, J BIOL CHEM, V287, P17198, DOI 10.1074/jbc.M112.355040; Tzingounis AV, 2007, NAT REV NEUROSCI, V8, P935, DOI 10.1038/nrn2274; Verdon G, 2014, ELIFE, V3, DOI 10.7554/eLife.02283; Verdon G, 2012, NAT STRUCT MOL BIOL, V19, P355, DOI 10.1038/nsmb.2233; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Watzke N, 2001, J GEN PHYSIOL, V117, P547, DOI 10.1085/jgp.117.6.547; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0	38	36	36	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					15962	15972		10.1074/jbc.M115.656876	http://dx.doi.org/10.1074/jbc.M115.656876			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25922069	Green Published, hybrid			2022-12-28	WOS:000356930100006
J	Maszczak-Seneczko, D; Sosicka, P; Kaczmarek, B; Majkowski, M; Luzarowski, M; Olczak, T; Olczak, M				Maszczak-Seneczko, Dorota; Sosicka, Paulina; Kaczmarek, Beata; Majkowski, Michal; Luzarowski, Marcin; Olczak, Teresa; Olczak, Mariusz			UDP-galactose (SLC35A2) and UDP-N-acetylglucosamine (SLC35A3) Transporters Form Glycosylation-related Complexes with Mannoside Acetylglucosaminyltransferases (Mgats)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fluorescence resonance energy transfer (FRET); glycosylation; glycosyltransferase; Golgi; protein complex; sugar transport; UDP-N-acetylglucosamine transporter; UDP-galactose transporter; mannoside acetylglucosaminyltransferase; proximity ligation assay	NUCLEOTIDE SUGAR TRANSPORTERS; MEDIAL GOLGI ENZYMES; CELL-LINE; GLYCOSYLTRANSFERASE COMPLEXES; SUBCELLULAR-LOCALIZATION; ENDOPLASMIC-RETICULUM; MOLECULAR-CLONING; KIN RECOGNITION; GAL TRANSPORTER; HELA-CELLS	Background: UDP-galactose (UGT) and UDP-N-acetylglucosamine (NGT) transporters and mannoside acetylglucosaminyltransferases (Mgats) are important mediators of N-linked protein glycosylation. Results: UGT and NGT are in close proximity to Mgats. Conclusion: UGT, NGT and Mgats may form multiprotein complexes mediating biosynthesis of N-glycans. Significance: Protein-protein interactions between Golgi-resident nucleotide sugar transporters and glycosyltransferases appears to be an inherent feature of N-linked glycosylation. UDP-galactose transporter (UGT; SLC35A2) and UDP-N-acetylglucosamine transporter (NGT; SLC35A3) form heterologous complexes in the Golgi membrane. NGT occurs in close proximity to mannosyl (-1,6-)-glycoprotein -1,6-N-acetylglucosaminyltransferase (Mgat5). In this study we analyzed whether NGT and both splice variants of UGT (UGT1 and UGT2) are able to interact with four different mannoside acetylglucosaminyltransferases (Mgat1, Mgat2, Mgat4B, and Mgat5). Using an in situ proximity ligation assay, we found that all examined glycosyltransferases are in the vicinity of these UDP-sugar transporters both at the endogenous level and upon overexpression. This observation was confirmed via the FLIM-FRET approach for both NGT and UGT1 complexes with Mgats. This study reports for the first time close proximity between endogenous nucleotide sugar transporters and glycosyltransferases. We also observed that among all analyzed Mgats, only Mgat4B occurs in close proximity to UGT2, whereas the other three Mgats are more distant from UGT2, and it was only possible to visualize their vicinity using proximity ligation assay. This strongly suggests that the distance between these protein pairs is longer than 10 nm but at the same time shorter than 40 nm. This study adds to the understanding of glycosylation, one of the most important post-translational modifications, which affects the majority of macromolecules. Our research shows that complex formation between nucleotide sugar transporters and glycosyltransferases might be a more common phenomenon than previously thought.	[Maszczak-Seneczko, Dorota; Sosicka, Paulina; Kaczmarek, Beata; Luzarowski, Marcin; Olczak, Teresa; Olczak, Mariusz] Univ Wroclaw, Fac Biotechnol, Biochem Lab, PL-50383 Wroclaw, Poland; [Majkowski, Michal] Univ Wroclaw, Fac Biotechnol, Lab Cytobiochem, PL-50383 Wroclaw, Poland	University of Wroclaw; University of Wroclaw	Olczak, M (corresponding author), Univ Wroclaw, Fac Biotechnol, Biochem Lab, 14A F Joliot Curie St, PL-50383 Wroclaw, Poland.	Mariusz.Olczak@biotech.uni.wroc.pl			National Science Center (Krakow, Poland) [2011/03/B/NZ1/02084]; Wroclaw Center of Biotechnology program of the Leading National Research Center (KNOW)	National Science Center (Krakow, Poland); Wroclaw Center of Biotechnology program of the Leading National Research Center (KNOW)	This work was supported by Grant 2011/03/B/NZ1/02084 from the National Science Center (Krakow, Poland). Publication costs were supported by Wroclaw Center of Biotechnology program of the Leading National Research Center (KNOW) for 2014-2018.	Abe M, 1999, FEBS LETT, V458, P309, DOI 10.1016/S0014-5793(99)01177-1; BRANDLI AW, 1988, J BIOL CHEM, V263, P16283; Caffaro CE, 2006, ACCOUNTS CHEM RES, V39, P805, DOI 10.1021/ar0400239; CAPASSO JM, 1984, P NATL ACAD SCI-BIOL, V81, P7051, DOI 10.1073/pnas.81.22.7051; COATES SW, 1980, J BIOL CHEM, V255, P9225; CUMMINGS RD, 1982, J BIOL CHEM, V257, P13421; Eckhardt M, 1999, J BIOL CHEM, V274, P8779, DOI 10.1074/jbc.274.13.8779; Ferrari ML, 2012, NEUROCHEM RES, V37, P1325, DOI 10.1007/s11064-012-0741-1; FIELD MC, 1995, GLYCOBIOLOGY, V5, P463, DOI 10.1093/glycob/5.5.463; Gao XD, 2000, J BIOL CHEM, V275, P17718, DOI 10.1074/jbc.M909946199; Gerardy-Schahn R, 2001, BIOCHIMIE, V83, P775, DOI 10.1016/S0300-9084(01)01322-0; Hadley B, 2014, COMPUT STRUCT BIOTEC, V10, P23, DOI 10.1016/j.csbj.2014.05.003; HARA T, 1989, J BIOCHEM-TOKYO, V106, P236, DOI 10.1093/oxfordjournals.jbchem.a122838; Hassinen A, 2011, J BIOL CHEM, V286, P38329, DOI 10.1074/jbc.M111.277681; Hassinen A, 2010, J BIOL CHEM, V285, P17771, DOI 10.1074/jbc.M110.103184; Hong KJ, 2000, BIOCHEMISTRY-US, V39, P2013, DOI 10.1021/bi992363l; Ishida N, 1996, J BIOCHEM, V120, P1074; Lau KS, 2008, GLYCOBIOLOGY, V18, P750, DOI 10.1093/glycob/cwn071; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Maszczak-Seneczko D, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.460543; Maszczak-Seneczko D, 2012, FEBS LETT, V586, P4082, DOI 10.1016/j.febslet.2012.10.016; Maszczak-Seneczko D, 2011, ACTA BIOCHIM POL, V58, P413; Maszczak-Seneczko D, 2011, GLYCOCONJUGATE J, V28, P481, DOI 10.1007/s10719-011-9348-z; Maszczak-Seneczko D, 2011, FEBS LETT, V585, P3090, DOI 10.1016/j.febslet.2011.08.038; Miera N, 1996, J BIOCHEM-TOKYO, V120, P236; Munster AK, 1998, P NATL ACAD SCI USA, V95, P9140, DOI 10.1073/pnas.95.16.9140; NILSSON T, 1994, EMBO J, V13, P562, DOI 10.1002/j.1460-2075.1994.tb06294.x; Nilsson T, 1996, J CELL SCI, V109, P1975; Oelmann S, 2001, J BIOL CHEM, V276, P26291, DOI 10.1074/jbc.M011124200; Oguri S, 1997, J BIOL CHEM, V272, P22721, DOI 10.1074/jbc.272.36.22721; Oguri S, 2006, GLYCOCONJUGATE J, V23, P473, DOI 10.1007/s10719-006-6216-3; Oikawa A, 2013, TRENDS PLANT SCI, V18, P49, DOI 10.1016/j.tplants.2012.07.002; Olczak M, 2006, BBA-MOL CELL RES, V1763, P82, DOI 10.1016/j.bbamcr.2005.12.006; Olczak M, 2013, BIOCHEM BIOPH RES CO, V434, P473, DOI 10.1016/j.bbrc.2013.03.098; Opat AS, 2000, J BIOL CHEM, V275, P11836, DOI 10.1074/jbc.275.16.11836; Puglielli L, 1999, J BIOL CHEM, V274, P35596, DOI 10.1074/jbc.274.50.35596; Puglielli L, 1999, J BIOL CHEM, V274, P4474, DOI 10.1074/jbc.274.7.4474; RABOUILLE C, 1995, J CELL SCI, V108, P1617; Sasai K, 2001, J BIOL CHEM, V276, P759, DOI 10.1074/jbc.M004972200; SCHACHTER H, 1994, MOL GLYCOBIOLOGY, P88; Schoberer J, 2013, PLANT PHYSIOL, V161, P1737, DOI 10.1104/pp.112.210757; SLUSAREWICZ P, 1994, J CELL BIOL, V124, P405, DOI 10.1083/jcb.124.4.405; Sosicka P, 2014, BIOCHEM BIOPH RES CO, V454, P486, DOI 10.1016/j.bbrc.2014.10.098; Spessott W, 2012, FEBS LETT, V586, P2346, DOI 10.1016/j.febslet.2012.05.041; Sprong H, 2003, MOL BIOL CELL, V14, DOI 10.1091/mbc.E03-03-0130; STANLEY P, 1983, SOMAT CELL GENET, V9, P593, DOI 10.1007/BF01574260; Takamatsu S, 2010, GLYCOBIOLOGY, V20, P485, DOI 10.1093/glycob/cwp200; VANDENEIJNDEN DH, 1993, CURR OPIN STRUC BIOL, V3, P711, DOI 10.1016/0959-440X(93)90054-O; Yoshioka S, 1997, J BIOCHEM, V122, P691	49	30	30	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15475	15486		10.1074/jbc.M115.636670	http://dx.doi.org/10.1074/jbc.M115.636670			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25944901	hybrid, Green Published			2022-12-28	WOS:000356527400014
J	DiStefano, MT; Danai, LV; Flach, RJR; Chawla, A; Pedersen, DJ; Guilherme, A; Czech, MP				DiStefano, Marina T.; Danai, Laura V.; Flach, Rachel J. Roth; Chawla, Anil; Pedersen, David J.; Guilherme, Adilson; Czech, Michael P.			The Lipid Droplet Protein Hypoxia-inducible Gene 2 Promotes Hepatic Triglyceride Deposition by Inhibiting Lipolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY LIVER-DISEASE; DIET-INDUCED OBESITY; INSULIN-RESISTANCE; DEFICIENT MICE; ACID OXIDATION; METABOLISM; STEATOSIS; LIPASE; EXPRESSION; STORAGE	The liver is a major site of glucose, fatty acid, and triglyceride (TG) synthesis and serves as a major regulator of whole body nutrient homeostasis. Chronic exposure of humans or rodents to high-calorie diets promotes non-alcoholic fatty liver disease, characterized by neutral lipid accumulation in lipid droplets (LD) of hepatocytes. Here we show that the LD protein hypoxia-inducible gene 2 (Hig2/Hilpda) functions to enhance lipid accumulation in hepatocytes by attenuating TG hydrolysis. Hig2 expression increased in livers of mice on a high-fat diet and during fasting, two states associated with enhanced hepatic TG content. Hig2 expressed in primary mouse hepatocytes localized to LDs and promoted LD TG deposition in the presence of oleate. Conversely, tamoxifen-inducible Hig2 deletion reduced both TG content and LD size in primary hepatocytes from mice harboring floxed alleles of Hig2 and a cre/ERT2 transgene controlled by the ubiquitin C promoter. Hepatic TG was also decreased by liver-specific deletion of Hig2 in mice with floxed Hig2 expressing cre controlled by the albumin promoter. Importantly, we demonstrate that Hig2-deficient hepatocytes exhibit increased TG lipolysis, TG turnover, and fatty acid oxidation as compared with controls. Interestingly, mice with liver-specific Hig2 deletion also display improved glucose tolerance. Taken together, these data indicate that Hig2 plays a major role in promoting lipid sequestration within LDs in mouse hepatocytes through a mechanism that impairs TG degradation.	[DiStefano, Marina T.; Danai, Laura V.; Flach, Rachel J. Roth; Chawla, Anil; Pedersen, David J.; Guilherme, Adilson; Czech, Michael P.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Czech, MP (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantation St, Worcester, MA 01605 USA.	Michael.Czech@umassmed.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [R37-DK030898]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK030898] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant R37-DK030898 (to M. P. C.).	Aibara D, 2013, BIOL PHARM BULL, V36, P1766; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Bechmann LP, 2012, J HEPATOL, V56, P952, DOI 10.1016/j.jhep.2011.08.025; Beylot M, 2012, METABOLISM, V61, P415, DOI 10.1016/j.metabol.2011.07.019; Birkenfeld AL, 2014, HEPATOLOGY, V59, P713, DOI 10.1002/hep.26672; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 2000, J BIOL CHEM, V275, P38486, DOI 10.1074/jbc.M007322200; Charlton M, 2004, CLIN GASTROENTEROL H, V2, P1048, DOI 10.1016/S1542-3565(04)00440-9; Denko N, 2000, CLIN CANCER RES, V6, P480; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gandotra S, 2011, J BIOL CHEM, V286, P34998, DOI 10.1074/jbc.M111.278853; Greenberg AS, 2011, J CLIN INVEST, V121, P2102, DOI 10.1172/JCI46069; Lass A, 2011, PROG LIPID RES, V50, P14, DOI 10.1016/j.plipres.2010.10.004; Leavens KF, 2011, CRIT REV BIOCHEM MOL, V46, P200, DOI 10.3109/10409238.2011.562481; Li JZ, 2007, DIABETES, V56, P2523, DOI 10.2337/db07-0040; Matsusue K, 2008, CELL METAB, V7, P302, DOI 10.1016/j.cmet.2008.03.003; Mattijssen F, 2014, J BIOL CHEM, V289, P19279, DOI 10.1074/jbc.M114.570044; McManaman JL, 2013, J LIPID RES, V54, P1346, DOI 10.1194/jlr.M035063; Nguyen P, 2008, J ANIM PHYSIOL AN N, V92, P272, DOI 10.1111/j.1439-0396.2007.00752.x; Nishimura S, 2011, EUR J GYNAECOL ONCOL, V32, P146; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Ong KT, 2011, HEPATOLOGY, V53, P116, DOI 10.1002/hep.24006; Patel S, 2014, P NATL ACAD SCI USA, V111, P9163, DOI 10.1073/pnas.1318791111; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; Quiroga AD, 2012, BBA-MOL CELL BIOL L, V1821, P762, DOI 10.1016/j.bbalip.2011.09.007; Reid BN, 2008, J BIOL CHEM, V283, P13087, DOI 10.1074/jbc.M800533200; Rubio-Cabezas O, 2009, EMBO MOL MED, V1, P280, DOI 10.1002/emmm.200900037; Sun Z, 2013, TRENDS ENDOCRIN MET, V24, P4, DOI 10.1016/j.tem.2012.09.005; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Thiam AR, 2013, NAT REV MOL CELL BIO, V14, P775, DOI 10.1038/nrm3699; Togashi A, 2005, CANCER RES, V65, P4817, DOI 10.1158/0008-5472.CAN-05-0120; TOVE SB, 1956, J BIOL CHEM, V218, P275; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; Wang H, 2011, J LIPID RES, V52, P2159, DOI 10.1194/jlr.M017939; Wu JW, 2011, HEPATOLOGY, V54, P122, DOI 10.1002/hep.24338; Xu L, 2012, ARTERIOSCL THROM VAS, V32, P1094, DOI 10.1161/ATVBAHA.111.241489; Yang L, 2012, J LIPID RES, V53, P1245, DOI 10.1194/jlr.R024117; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; Ye J, 2009, CELL METAB, V9, P177, DOI 10.1016/j.cmet.2008.12.013; Zhou LK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6949; Zhou LK, 2012, HEPATOLOGY, V56, P95, DOI 10.1002/hep.25611; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225	42	32	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15175	15184		10.1074/jbc.M115.650184	http://dx.doi.org/10.1074/jbc.M115.650184			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25922078	Green Published, hybrid			2022-12-28	WOS:000356177300031
J	Gutmann, S; Hinniger, A; Fendrich, G; Druckes, P; Antz, S; Mattes, H; Mobitz, H; Ofner, S; Schmiedeberg, N; Stojanovic, A; Rieffel, S; Strauss, A; Troxler, T; Glatthar, R; Sparrer, H				Gutmann, Sascha; Hinniger, Alexandra; Fendrich, Gabriele; Drueckes, Peter; Antz, Sylvie; Mattes, Henri; Moebitz, Henrik; Ofner, Silvio; Schmiedeberg, Niko; Stojanovic, Aleksandar; Rieffel, Sebastien; Strauss, Andre; Troxler, Thomas; Glatthar, Ralf; Sparrer, Helmut			The Crystal Structure of Cancer Osaka Thyroid Kinase Reveals an Unexpected Kinase Domain Fold	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TNF-ALPHA PRODUCTION; TUMOR PROGRESSION LOCUS-2; SIGNAL-REGULATED KINASE; PROTEIN-KINASE; TPL2 KINASE; LIPOPOLYSACCHARIDE ACTIVATION; TP12 KINASE; INHIBITION; INFLAMMATION; PHOSPHORYLATION	Macrophages are important cellular effectors in innate immune responses and play a major role in autoimmune diseases such as rheumatoid arthritis. Cancer Osaka thyroid (COT) kinase, also known as mitogen-activated protein kinase kinase kinase 8 (MAP3K8) and tumor progression locus 2 (Tpl-2), is a serine-threonine (ST) kinase and is a key regulator in the production of pro-inflammatory cytokines in macrophages. Due to its pivotal role in immune biology, COT kinase has been identified as an attractive target for pharmaceutical research that is directed at the discovery of orally available, selective, and potent inhibitors for the treatment of autoimmune disorders and cancer. The production of monomeric, recombinant COT kinase has proven to be very difficult, and issues with solubility and stability of the enzyme have hampered the discovery and optimization of potent and selective inhibitors. We developed a protocol for the production of recombinant human COT kinase that yields pure and highly active enzyme in sufficient yields for biochemical and structural studies. The quality of the enzyme allowed us to establish a robust in vitro phosphorylation assay for the efficient biochemical characterization of COT kinase inhibitors and to determine the x-ray co-crystal structures of the COT kinase domain in complex with two ATP-binding site inhibitors. The structures presented in this study reveal two distinct ligand binding modes and a unique kinase domain architecture that has not been observed previously. The structurally versatile active site significantly impacts the design of potent, low molecular weight COT kinase inhibitors.	[Gutmann, Sascha; Hinniger, Alexandra; Fendrich, Gabriele; Drueckes, Peter; Antz, Sylvie; Rieffel, Sebastien; Strauss, Andre] Novartis Pharma AG, Novartis Inst BioMed Res, Ctr Prote Chem, CH-4002 Basel, Switzerland; [Mattes, Henri; Moebitz, Henrik; Ofner, Silvio; Schmiedeberg, Niko; Stojanovic, Aleksandar; Troxler, Thomas; Glatthar, Ralf] Novartis Pharma AG, Novartis Inst BioMed Res, Global Discovery Chem, CH-4002 Basel, Switzerland; [Sparrer, Helmut] Novartis Pharma AG, Novartis Inst BioMed Res, Autoimmun Transplantat Inflammat, CH-4002 Basel, Switzerland	Novartis; Novartis; Novartis	Gutmann, S (corresponding author), Novartis Pharma AG, Novartis Inst BioMed Res, Ctr Prote Chem, CH-4002 Basel, Switzerland.	sascha.gutmann@novartis.com		Gutmann, Sascha/0000-0002-4242-8510; Moebitz, Henrik/0000-0002-8398-6121				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Beinke S, 2004, MOL CELL BIOL, V24, P9658, DOI 10.1128/MCB.24.21.9658-9667.2004; Ben-Addi A, 2014, P NATL ACAD SCI USA, V111, pE2394, DOI 10.1073/pnas.1320440111; Bricogne G., 2011, BUSTER VERSION 1 11; Cho JH, 2005, P NATL ACAD SCI USA, V102, P2350, DOI 10.1073/pnas.0409856102; Cusack K, 2009, BIOORG MED CHEM LETT, V19, P1722, DOI 10.1016/j.bmcl.2009.01.088; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gavrin LK, 2005, BIOORG MED CHEM LETT, V15, P5288, DOI 10.1016/j.bmcl.2005.08.029; George D, 2009, CURR TOP MED CHEM, V9, P611, DOI 10.2174/156802609789007345; Gkirtzimanaki K, 2013, P NATL ACAD SCI USA, V110, pE1470, DOI 10.1073/pnas.1215938110; Green N, 2007, J MED CHEM, V50, P4728, DOI 10.1021/jm070436q; Hu YH, 2006, BIOORG MED CHEM LETT, V16, P6067, DOI 10.1016/j.bmcl.2006.08.102; Hu YH, 2011, BIOORG MED CHEM LETT, V21, P4758, DOI 10.1016/j.bmcl.2011.06.065; Jia Y, 2005, ARCH BIOCHEM BIOPHYS, V441, P64, DOI 10.1016/j.abb.2005.06.020; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaila N, 2007, BIOORGAN MED CHEM, V15, P6425, DOI 10.1016/j.bmc.2007.06.054; Kim JY, 2015, ONCOGENE, V34, P4928, DOI 10.1038/onc.2014.418; Lee HW, 2015, INT J CANCER, V136, P2065, DOI 10.1002/ijc.29248; Liu JS, 2012, J BIOL CHEM, V287, P27326, DOI 10.1074/jbc.M112.366658; Matsumoto T, 2010, BIOCHEM BIOPH RES CO, V400, P369, DOI 10.1016/j.bbrc.2010.08.071; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Min XS, 2009, STRUCTURE, V17, P96, DOI 10.1016/j.str.2008.11.007; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; PATRIOTIS C, 1993, P NATL ACAD SCI USA, V90, P2251, DOI 10.1073/pnas.90.6.2251; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Robinson MJ, 2007, MOL CELL BIOL, V27, P7355, DOI 10.1128/MCB.00301-07; Roget K, 2012, MOL CELL BIOL, V32, P4684, DOI 10.1128/MCB.01065-12; Sriskantharajah S, 2014, J IMMUNOL, V192, P3518, DOI 10.4049/jimmunol.1300172; Strauss A, 2007, PROTEIN EXPRES PURIF, V56, P167, DOI 10.1016/j.pep.2007.06.008; Van Acker GJD, 2007, J BIOL CHEM, V282, P22140, DOI 10.1074/jbc.M702225200; Vougioukalaki M, 2011, CANCER LETT, V304, P80, DOI 10.1016/j.canlet.2011.02.004; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xiao YC, 2014, J EXP MED, V211, P1689, DOI 10.1084/jem.20132640; Yang HT, 2012, MOL CELL BIOL, V32, P3438, DOI 10.1128/MCB.00564-12; ZHENG JH, 1993, ACTA CRYSTALLOGR D, V49, P362, DOI 10.1107/S0907444993000423	38	16	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15210	15218		10.1074/jbc.M115.648097	http://dx.doi.org/10.1074/jbc.M115.648097			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25918157	Green Published, hybrid			2022-12-28	WOS:000356177300034
J	Hernandez-Guillamon, M; Mawhirt, S; Blais, S; Montaner, J; Neubert, TA; Rostagno, A; Ghiso, J				Hernandez-Guillamon, Mar; Mawhirt, Stephanie; Blais, Steven; Montaner, Joan; Neubert, Thomas A.; Rostagno, Agueda; Ghiso, Jorge			Sequential Amyloid-beta Degradation by the Matrix Metalloproteases MMP-2 and MMP-9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-BRAIN-BARRIER; SPONTANEOUS INTRACEREBRAL HEMORRHAGE; ALZHEIMERS-DISEASE; A-BETA; DEGRADING ENZYMES; MASS-SPECTROMETRY; FIBRIL FORMATION; COMPACT PLAQUES; MATRIX-METALLOPROTEINASE-9; PEPTIDE	Matrix metalloproteases (MMPs) MMP-2 and MMP-9 have been implicated in the physiological catabolism of Alzheimer's amyloid-beta (A beta). Conversely, their association with vascular amyloid deposits, blood-brain barrier disruption, and hemorrhagic transformations after ischemic stroke also highlights their involvement in pathological processes. To better understand this dichotomy, recombinant human (rh) MMP-2 and MMP-9 were incubated with A beta 40 and A beta 42, and the resulting proteolytic fragments were assessed via immunoprecipitation and quantitative mass spectrometry. Both MMPs generated A beta fragments truncated only at the C terminus, ending at positions 34, 30, and 16. Using deuterated homologues as internal standards, we observed limited and relatively slow degradation of A beta 42 by rhMMP-2, although the enzyme cleaved >80% of A beta 40 during the 1st h of incubation. rhMMP-9 was significantly less effective, particularly in degrading A beta(1-42), although the targeted peptide bonds were identical. Using A beta(1-34) and A beta(1-30), we demonstrated that these peptides are also substrates for both MMPs, cleaving A beta(1-34) to produce A beta(1-30) first and A beta(1-16) subsequently. Consistent with the kinetics observed with full-length A beta, rhMMP-9 degraded only a minute fraction of A beta(1-34) and was even less effective in producing A beta(1-16). Further degradation of A beta(1-16) by either MMP-2 or MMP-9 was not observed even after prolonged incubation times. Notably, all MMP-generated C-terminally truncated A beta fragments were highly soluble and did not exhibit fibrillogenic properties or induce cytotoxicity in human cerebral microvascular endothelial or neuronal cells supporting the notion that these truncated A beta species are associated with clearance mechanisms rather than being key elements in the fibrillogenesis process.	[Hernandez-Guillamon, Mar; Mawhirt, Stephanie; Rostagno, Agueda; Ghiso, Jorge] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Ghiso, Jorge] NYU, Sch Med, Dept Psychiat, New York, NY 10016 USA; [Blais, Steven; Neubert, Thomas A.] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA; [Hernandez-Guillamon, Mar; Montaner, Joan] Inst Recerca, Neurovasc Res Lab, Barcelona 08035, Spain; [Blais, Steven; Neubert, Thomas A.] NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY 10016 USA; [Montaner, Joan] Univ Autonoma Barcelona, Vall dHebron Hosp, Neurol & Med Dept, Neurovasc Unit, Barcelona 08035, Spain	New York University; New York University; New York University; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); New York University; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron	Ghiso, J (corresponding author), NYU, Sch Med, 550 First Ave,MSB 556, New York, NY 10016 USA.	jorge.ghiso@nyumc.org	Regan, Clinton/E-6250-2012; Montaner, Joan/D-3063-2015	Montaner, Joan/0000-0003-4845-2279; Rostagno, Agueda/0000-0002-6817-2074; Hernandez Guillamon, Maria Mar/0000-0001-8844-0091; neubert, Thomas/0000-0001-7049-2088	National Institutes of Health [AG030539, NS051715, P30 NS050276, U24 CA126485]; Alzheimer's Association; NATIONAL CANCER INSTITUTE [U24CA126485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS050276, R01NS051715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030539] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG030539, NS051715, P30 NS050276, and U24 CA126485. This work was also supported by the Alzheimer's Association.	Abilleira S, 2003, J NEUROSURG, V99, P65, DOI 10.3171/jns.2003.99.1.0065; Alvarez-Sabin J, 2004, STROKE, V35, P1316, DOI 10.1161/01.STR.0000126827.69286.90; Aureli L, 2008, CURR MED CHEM, V15, P2192, DOI 10.2174/092986708785747490; Backstrom JR, 1996, J NEUROSCI, V16, P7910; Randall JB, 2006, NAT MED, V12, P856, DOI 10.1038/nm1438; Calero M, 2012, METHODS MOL BIOL, V849, P213, DOI 10.1007/978-1-61779-551-0_15; Chen EI, 2002, J BIOL CHEM, V277, P4485, DOI 10.1074/jbc.M109469200; Crouch PJ, 2009, J NEUROCHEM, V108, P1198, DOI 10.1111/j.1471-4159.2009.05870.x; De Strooper B, 2010, PHYSIOL REV, V90, P465, DOI 10.1152/physrev.00023.2009; Deb S, 2003, BRAIN RES, V970, P205, DOI 10.1016/S0006-8993(03)02344-8; Deb S, 1996, J NEUROCHEM, V66, P1641; Endres K, 2012, EXP BRAIN RES, V217, P343, DOI 10.1007/s00221-011-2885-7; Fossati S, 2010, FASEB J, V24, P229, DOI 10.1096/fj.09-139584; Fossati S, 2013, BIOCHEM J, V456, P347, DOI 10.1042/BJ20130652; Ghiso J, 2002, ADV DRUG DELIVER REV, V54, P1539, DOI 10.1016/S0169-409X(02)00149-7; Ghiso JA, 2001, J BIOL CHEM, V276, P43909, DOI 10.1074/jbc.M105956200; Gorbenko GP, 2006, CHEM PHYS LIPIDS, V141, P72, DOI 10.1016/j.chemphyslip.2006.02.006; Hampel H, 2010, EXP NEUROL, V223, P334, DOI 10.1016/j.expneurol.2009.09.024; Hernandez-Guillamon M, 2012, BRAIN PATHOL, V22, P133, DOI 10.1111/j.1750-3639.2011.00512.x; Hernandez-Guillamon M, 2010, J BIOL CHEM, V285, P27144, DOI 10.1074/jbc.M110.135228; Kheterpal I, 2006, J MOL BIOL, V361, P785, DOI 10.1016/j.jmb.2006.06.066; KNIGHT CG, 1992, FEBS LETT, V296, P263, DOI 10.1016/0014-5793(92)80300-6; Kridel SJ, 2001, J BIOL CHEM, V276, P20572, DOI 10.1074/jbc.M100900200; Lee JM, 2005, J NEUROL SCI, V229, P249, DOI 10.1016/j.jns.2004.11.041; Liu J, 2012, J NEUROSCI, V32, P3044, DOI 10.1523/JNEUROSCI.6409-11.2012; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; McLaurin J, 2000, J STRUCT BIOL, V130, P259, DOI 10.1006/jsbi.2000.4289; Miners JS, 2008, BRAIN PATHOL, V18, P240, DOI 10.1111/j.1750-3639.2008.00132.x; Miners JS, 2011, J NEUROPATH EXP NEUR, V70, P944, DOI 10.1097/NEN.0b013e3182345e46; Montaner J, 2003, CIRCULATION, V107, P598, DOI 10.1161/01.CIR.0000046451.38849.90; Morelli L, 2002, NEUROCHEM RES, V27, P1387, DOI 10.1023/A:1021679817756; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Obici L, 2005, ANN NEUROL, V58, P639, DOI 10.1002/ana.20571; Portelius E, 2006, J PROTEOME RES, V5, P1010, DOI 10.1021/pr050475v; Portelius E, 2008, EXPERT REV PROTEOMIC, V5, P225, DOI 10.1586/14789450.5.2.225; ROHER AE, 1994, BIOCHEM BIOPH RES CO, V205, P1755, DOI 10.1006/bbrc.1994.2872; ROSENBERG GA, 1993, NEUROSCI LETT, V160, P117, DOI 10.1016/0304-3940(93)90927-D; ROSENBERG GA, 1990, STROKE, V21, P801, DOI 10.1161/01.STR.21.5.801; ROSENBERG GA, 1992, BRAIN RES, V576, P203, DOI 10.1016/0006-8993(92)90681-X; Rosenberg GA, 1995, BRAIN RES, V703, P151, DOI 10.1016/0006-8993(95)01089-0; Rosenberg GA, 2009, LANCET NEUROL, V8, P205, DOI 10.1016/S1474-4422(09)70016-X; Rostagno A, 2010, CELL MOL LIFE SCI, V67, P581, DOI 10.1007/s00018-009-0182-4; Rostagno A., 2009, CURR PROTOC CELL BIO, V3; Sbardella D, 2012, MOL ASPECTS MED, V33, P119, DOI 10.1016/j.mam.2011.10.015; Sekhon BS, 2010, RES REP BIOL, V1, P1, DOI 10.2147/RRB.S12043; Tomidokoro Y, 2005, J BIOL CHEM, V280, P36883, DOI 10.1074/jbc.M504038200; Tomidokoro Y, 2010, AM J PATHOL, V176, P1841, DOI 10.2353/ajpath.2010.090636; Vardy ERLC, 2005, TRENDS MOL MED, V11, P464, DOI 10.1016/j.molmed.2005.08.004; Wang YJ, 2006, DRUG DISCOV TODAY, V11, P931, DOI 10.1016/j.drudis.2006.08.004; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Yan P, 2006, J BIOL CHEM, V281, P24566, DOI 10.1074/jbc.M602440200; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Yin KJ, 2006, J NEUROSCI, V26, P10939, DOI 10.1523/JNEUROSCI.2085-06.2006	53	74	76	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15078	15091		10.1074/jbc.M114.610931	http://dx.doi.org/10.1074/jbc.M114.610931			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25897080	hybrid, Green Published			2022-12-28	WOS:000356177300023
J	Raychaudhuri, S; Espenshade, PJ				Raychaudhuri, Sumana; Espenshade, Peter J.			Endoplasmic Reticulum Exit of Golgi-resident Defective for SREBP Cleavage (Dsc) E3 Ligase Complex Requires Its Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN; UBIQUITIN-CONJUGATING ENZYMES; FISSION YEAST; SECRETORY PATHWAY; DOMAIN; DEGRADATION; TRANSPORT; ER; SUBUNIT; CDC48	Layers of quality control ensure proper protein folding and complex formation prior to exit from the endoplasmic reticulum. The fission yeast Dsc E3 ligase is a Golgi-localized complex required for sterol regulatory element-binding protein (SREBP) transcription factor activation that shows architectural similarity to endoplasmic reticulum-associated degradation E3 ligases. The Dsc E3 ligase consists of five integral membrane proteins (Dsc1-Dsc5) and functionally interacts with the conserved AAA-ATPase Cdc48. Utilizing an in vitro ubiquitination assay, we demonstrated that Dsc1 has ubiquitin E3 ligase activity that requires the E2 ubiquitin-conjugating enzyme Ubc4. Mutations that specifically block Dsc1-Ubc4 interaction prevent SREBP cleavage, indicating that SREBP activation requires Dsc E3 ligase activity. Surprisingly, Golgi localization of the Dsc E3 ligase complex also requires Dsc1 E3 ligase activity. Analysis of Dsc E3 ligase complex formation, glycosylation, and localization indicated that Dsc1 E3 ligase activity is specifically required for endoplasmic reticulum exit of the complex. These results define enzyme activity-dependent sorting as an autoregulatory mechanism for protein trafficking.	[Raychaudhuri, Sumana; Espenshade, Peter J.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, 725 N Wolfe St,Physiol Rm 107B, Baltimore, MD 21205 USA	Johns Hopkins University	Espenshade, PJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, 725 N Wolfe St,Physiol Rm 107B, Baltimore, MD 21205 USA.	peter.espenshade@jhmi.edu	Regan, Clinton/E-6250-2012	Raychaudhuri, Sumana/0000-0002-3164-0057; Espenshade, Peter/0000-0002-6433-0178	National Institutes of Health [HL077588]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Grant HL077588 from the National Institutes of Health (to P. J. E.).	Amemiya Y, 2008, MOL CANCER RES, V6, P1385, DOI 10.1158/1541-7786.MCR-08-0094; Barlowe C, 2002, CURR OPIN CELL BIOL, V14, P417, DOI 10.1016/S0955-0674(02)00348-4; Bien CM, 2010, EUKARYOT CELL, V9, P352, DOI 10.1128/EC.00358-09; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; Borden KLB, 1996, CURR OPIN STRUC BIOL, V6, P395, DOI 10.1016/S0959-440X(96)80060-1; Bourgeois-Daigneault MC, 2013, J CELL SCI, V126, P989, DOI 10.1242/jcs.117804; Braun MA, 2007, MOL CELL BIOL, V27, P2800, DOI 10.1128/MCB.01947-06; Chen ZL, 2012, CURR PROTEIN PEPT SC, V13, P414, DOI 10.2174/138920312802430590; Cheung R, 2013, J BIOL CHEM, V288, P20351, DOI 10.1074/jbc.M113.482224; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; D'Arcangelo JG, 2013, BBA-MOL CELL RES, V1833, P2464, DOI 10.1016/j.bbamcr.2013.02.003; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Hughes AL, 2005, CELL, V120, P831, DOI 10.1016/j.cell.2005.01.012; Hughes BT, 2009, J BIOL CHEM, V284, P20512, DOI 10.1074/jbc.M109.002436; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; Janoo RTK, 2001, GENETICS, V157, P1205; Jin LY, 2012, NATURE, V482, P495, DOI 10.1038/nature10822; KAISER CA, 1990, CELL, V61, P723, DOI 10.1016/0092-8674(90)90483-U; Le Fourn V, 2013, CELL MOL LIFE SCI, V70, P1985, DOI 10.1007/s00018-012-1236-6; Lloyd SJA, 2013, J BIOL CHEM, V288, P21043, DOI 10.1074/jbc.M113.468215; Ma D, 2002, CURR OPIN NEUROBIOL, V12, P287, DOI 10.1016/S0959-4388(02)00319-7; Matynia A, 2002, J CELL SCI, V115, P421; Ossareh-Nazari B, 2010, EXP CELL RES, V316, P3351, DOI 10.1016/j.yexcr.2010.09.005; Rankin CA, 2014, BIOCHEMISTRY-US, V53, P225, DOI 10.1021/bi401378p; Reggiori F, 2002, NAT CELL BIOL, V4, P117, DOI 10.1038/ncb743; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Seino H, 2003, MOL CELL BIOL, V23, P3497, DOI 10.1128/MCB.23.10.3497-3505.2003; Shao W, 2014, J BIOL CHEM, V289, P7547, DOI 10.1074/jbc.M113.545699; Shao W, 2012, CELL METAB, V16, P414, DOI 10.1016/j.cmet.2012.09.002; Stanley Pamela, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a005199; Stewart EV, 2012, J BIOL CHEM, V287, P672, DOI 10.1074/jbc.M111.317370; Stewart EV, 2011, MOL CELL, V42, P160, DOI 10.1016/j.molcel.2011.02.035; Todd BL, 2006, MOL CELL BIOL, V26, P2817, DOI 10.1128/MCB.26.7.2817-2831.2006; Vjestica A, 2008, MOL BIOL CELL, V19, P1125, DOI 10.1091/mbc.E07-07-0663; Wu XL, 2004, MOL CELL BIOL, V24, P7748, DOI 10.1128/MCB.24.17.7748-7757.2004; Xu Z, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-26; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X; Zielinska DF, 2012, MOL CELL, V46, P542, DOI 10.1016/j.molcel.2012.04.031	39	8	8	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14430	14440		10.1074/jbc.M114.630863	http://dx.doi.org/10.1074/jbc.M114.630863			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25918164	Green Published, hybrid			2022-12-28	WOS:000355754600014
J	Thomson, SJ; Hansen, A; Sanguinetti, MC				Thomson, Steven J.; Hansen, Angela; Sanguinetti, Michael C.			Identification of the Intracellular Na+ Sensor in Slo2.1 Potassium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED K+ CHANNELS; KIR CHANNELS; SODIUM; SENSITIVITY; ISCHEMIA	Slo2 potassium channels have a very low open probability under normal physiological conditions, but are readily activated in response to an elevated [Na+](i) (e.g. during ischemia). An intracellular Na+ coordination motif ( DX(R/K)XXH) was previously identified in Kir3.2, Kir3.4, Kir5.1, and Slo2.2 channel subunits. Based loosely on this sequence, we identified five potential Na+ coordination motifs in the C terminus of the Slo2.1 subunit. The Asp residue in each sequence was substituted with Arg, and single mutant channels were heterologously expressed in Xenopus oocytes. The Na+ sensitivity of each of the mutant channels was assessed by voltage clamp of oocytes using micropipettes filled with 2 M NaCl. Wild-type channels and four of the mutant Slo2.1 channels were rapidly activated by leakage of NaCl solution into the cytoplasm. D757R Slo2.1 channels were not activated by NaCl, but were activated by the fenamate niflumic acid, confirming their functional expression. In whole cell voltage clamp recordings of HEK293 cells, wild-type but not D757R Slo2.1 channels were activated by a [NaCl](i) of 70 mM. Thus, a single Asp residue can account for the sensitivity of Slo2.1 channels to intracellular Na+. In excised inside-out macropatches of HEK293 cells, activation of wild-type Slo2.1 currents by 3 mM niflumic acid was 14-fold greater than activation achieved by increasing [NaCl](i) from 3 to 100 mM. Thus, relative to fenamates, intracellular Na+ is a poor activator of Slo2.1.	[Thomson, Steven J.; Hansen, Angela; Sanguinetti, Michael C.] Univ Utah, Nora Eccles Harrison Cardiovasc Res & Training In, 95 South 2000 East, Salt Lake City, UT 84112 USA; [Sanguinetti, Michael C.] Univ Utah, Dept Internal Med, Div Cardiovasc Med, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Sanguinetti, MC (corresponding author), Univ Utah, Nora Eccles Harrison Cardiovasc Res & Training In, 95 South 2000 East, Salt Lake City, UT 84112 USA.	sanguinetti@cvrti.utah.edu		Sanguinetti, Michael/0000-0001-8974-0969	National Institutes of Health NHLBI [R01 HL103877]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103877] Funding Source: NIH RePORTER	National Institutes of Health NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health NHLBI Grant R01 HL103877 (to M. C. S.).	Anderson SE, 1996, AM J PHYSIOL-CELL PH, V270, pC608, DOI 10.1152/ajpcell.1996.270.2.C608; BADER CR, 1985, NATURE, V317, P540, DOI 10.1038/317540a0; Bhattacharjee A, 2003, J NEUROSCI, V23, P11681; Budelli G, 2009, NAT NEUROSCI, V12, P745, DOI 10.1038/nn.2313; Dai L, 2010, J GEN PHYSIOL, V135, P275, DOI 10.1085/jgp.200910316; DRYER SE, 1994, TRENDS NEUROSCI, V17, P155, DOI 10.1016/0166-2236(94)90093-0; EGAN TM, 1992, J NEUROSCI, V12, P1964; Garg P, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12118; Garg P, 2013, J GEN PHYSIOL, V142, P523, DOI 10.1085/jgp.201311064; Garg P, 2012, MOL PHARMACOL, V82, P795, DOI 10.1124/mol.112.079194; Ho IHM, 1999, J BIOL CHEM, V274, P8639, DOI 10.1074/jbc.274.13.8639; KAMEYAMA M, 1984, NATURE, V309, P354, DOI 10.1038/309354a0; Leonetti MD, 2012, P NATL ACAD SCI USA, V109, P19274, DOI 10.1073/pnas.1215078109; Murphy E, 2009, CIRC RES, V104, P292, DOI 10.1161/CIRCRESAHA.108.189050; PIKE MM, 1990, AM J PHYSIOL, V259, pH1767, DOI 10.1152/ajpheart.1990.259.6.H1767; Rosenhouse-Dantsker A, 2008, NAT CHEM BIOL, V4, P624, DOI 10.1038/nchembio.112; SCHREIBMAYER W, 1994, PFLUG ARCH EUR J PHY, V426, P453, DOI 10.1007/BF00388310; STUHMER W, 1992, METHOD ENZYMOL, V207, P319; Tejada MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110833; Thomson SJ, 2014, J BIOL CHEM, V289, P23428, DOI 10.1074/jbc.M114.582437; WENDTGALLITELLI MF, 1993, J PHYSIOL-LONDON, V472, P33, DOI 10.1113/jphysiol.1993.sp019934; Yan YY, 2012, J MEMBRANE BIOL, V245, P667, DOI 10.1007/s00232-012-9425-7; Yuan A, 2003, NEURON, V37, P765, DOI 10.1016/S0896-6273(03)00096-5; Yuan A, 2000, NAT NEUROSCI, V3, P771, DOI 10.1038/77670; Yuan P, 2010, SCIENCE, V329, P182, DOI 10.1126/science.1190414; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103; Zhang Z, 2010, J NEUROSCI, V30, P7554, DOI 10.1523/JNEUROSCI.0525-10.2010	27	16	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14528	14535		10.1074/jbc.M115.653089	http://dx.doi.org/10.1074/jbc.M115.653089			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25903137	Green Published, hybrid			2022-12-28	WOS:000355754600024
J	Zhao, Q; Ahmed, M; Guo, HF; Cheung, IY; Cheung, NKV				Zhao, Qi; Ahmed, Mahiuddin; Guo, Hong-fen; Cheung, Irene Y.; Cheung, Nai-Kong V.			Alteration of Electrostatic Surface Potential Enhances Affinity and Tumor Killing Properties of Anti-ganglioside GD2 Monoclonal Antibody hu3F8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; CANCER-IMMUNOTHERAPY; NEUROBLASTOMA; MATURATION; DISPLAY; GANGLIOSIDES; GLYCOLIPIDS; SPECIFICITY; THERAPY; TARGETS	Ganglioside GD2 is highly expressed on neuroectodermal tumors and an attractive therapeutic target for antibodies that have already shown some clinical efficacy. To further improve the current antibodies, which have modest affinity, we sought to improve affinity by using a combined method of random mutagenesis and in silico assisted design to affinity-mature the anti-GD2 monoclonal antibody hu3F8. Using yeast display, mutants in the Fv with enhanced binding over the parental clone were FACS-sorted and cloned. In silico modeling identified the minimal key interacting residues involved in the important charged interactions with the sialic acid groups of GD2. Two mutations, D32H (L-CDR1) and E1K (L-FR1) altered the electrostatic surface potential of the antigen binding site, allowing for an increase in positive charge to enhance the interaction with the negatively charged GD2-pentasaccharide headgroup. Purified scFv and IgG mutant forms were then tested for antigen specificity by ELISA, for tissue specificity by immunohistochemistry, for affinity by BIACORE, for antibody-dependent cell-mediated cytotoxicity (ADCC) and complement-mediated cytotoxicity in vitro, and for anti-tumor efficacy in xenografted humanized mice. The nearly 7-fold improvement in affinity of hu3F8 with a single D32H (L-CDR1) mutation translated into a similar to 12-fold improvement in NK92MI-transfected CD16-mediated ADCC, a 6-fold improvement in CD32-mediated ADCC, and a 2.5-fold improvement in complement-mediated cytotoxicity while maintaining restricted normal tissue cross-reactivity and achieving substantial improvement in tumor ablation in vivo. Despite increasing GD2 affinity, the double mutation D32H (L-CDR1) and E1K (L-FR1) did not further improve antitumor efficacy.	[Zhao, Qi; Ahmed, Mahiuddin; Guo, Hong-fen; Cheung, Irene Y.; Cheung, Nai-Kong V.] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Cheung, NKV (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave, New York, NY 10065 USA.	cheungn@mskcc.org		Zhao, Qi/0000-0002-5969-6407	National Institutes of Health Cancer Center Core Support Grant [P30 CA008748-48]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	National Institutes of Health Cancer Center Core Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr. Mamoru Ito (Central Institute for Experimental Animals, Kawasaki, Japan) for providing the DKO mice and the MSK Small-Animal Imaging Core Facility and Molecular Cytology Core Facility for providing technical services. Technical services provided by the MSK Small-Animal Imaging Core Facility and Molecular Cytology Core Facility were supported in part by National Institutes of Health Cancer Center Core Support Grant P30 CA008748-48. We thank the Consortium for Functional Genomics, Emory University (Atlanta, GA), and Dr. Steven Robert of the Scripps Research Institute (La Jolla, CA) for providing biotin-GD2. We thank Yi Feng and Hoa Tran for excellent technical support and Drs. Ming Cheng and Hong Xu for reviewing the manuscript.	Ahmed M, 2014, FEBS LETT, V588, P288, DOI 10.1016/j.febslet.2013.11.030; Ahmed M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063359; Barderas R, 2008, P NATL ACAD SCI USA, V105, P9029, DOI 10.1073/pnas.0801221105; Boder ET, 2012, ARCH BIOCHEM BIOPHYS, V526, P99, DOI 10.1016/j.abb.2012.03.009; Bradbury ARM, 2011, NAT BIOTECHNOL, V29, P245, DOI 10.1038/nbt.1791; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chester MA, 1998, EUR J BIOCHEM, V257, P293; Cheung IY, 2012, J CLIN ONCOL, V30, P426, DOI 10.1200/JCO.2011.37.6236; Cheung NKV, 2013, NAT REV CANCER, V13, P397, DOI 10.1038/nrc3526; Cheung NKV, 2012, ONCOIMMUNOLOGY, V1, DOI 10.4161/onci.19864; Cheung NKV, 2012, J CLIN ONCOL, V30, P3264, DOI 10.1200/JCO.2011.41.3807; CHEUNG NKV, 1987, J CLIN ONCOL, V5, P1430, DOI 10.1200/JCO.1987.5.9.1430; Durrant LG, 2012, CLIN EXP IMMUNOL, V167, P206, DOI 10.1111/j.1365-2249.2011.04516.x; FOOTE J, 1994, P NATL ACAD SCI USA, V91, P10370, DOI 10.1073/pnas.91.22.10370; Fredman P, 2003, BIODRUGS, V17, P155, DOI 10.2165/00063030-200317030-00002; Garcia-Rodriguez C, 2007, NAT BIOTECHNOL, V25, P107, DOI 10.1038/nbt1269; Heimburg-Molinaro Jamie, 2009, V534, P341, DOI 10.1007/978-1-59745-022-5_24; Hu J, 2009, J IMMUNOL, V183, P5748, DOI 10.4049/jimmunol.0901409; Inoue H, 2013, J BIOCHEM, V154, P325, DOI 10.1093/jb/mvt058; Kushner BH, 2001, J CLIN ONCOL, V19, P4189, DOI 10.1200/JCO.2001.19.22.4189; Leyland-Jones B, 2001, ANTI-CANCER DRUG, V12, pS11, DOI 10.1097/00001813-200112004-00003; Magnani John L, 2009, Discov Med, V8, P247; Nakanishi T, 2013, PROTEIN ENG DES SEL, V26, P113, DOI 10.1093/protein/gzs088; Navid F, 2010, CURR CANCER DRUG TAR, V10, P200, DOI 10.2174/156800910791054167; Shusterman S, 2010, J CLIN ONCOL, V28, P4969, DOI 10.1200/JCO.2009.27.8861; Tarek N, 2012, J CLIN INVEST, V122, P3260, DOI 10.1172/JCI62749; Thomas R, 2002, J BIOL CHEM, V277, P2059, DOI 10.1074/jbc.M104364200; Valjakka J, 2002, J BIOL CHEM, V277, P44021, DOI 10.1074/jbc.M208392200; Votsmeier C, 2012, MABS-AUSTIN, V4, P341, DOI 10.4161/mabs.19981; Wang LL, 2014, GLYCOBIOLOGY, V24, P507, DOI 10.1093/glycob/cwu019; Wang Y, 2011, J BIOL CHEM, V286, P44218, DOI 10.1074/jbc.M111.290783; Wittrup KD, 2012, METHOD ENZYMOL, V503, P255, DOI 10.1016/B978-0-12-396962-0.00010-0; Yu RK, 2011, J OLEO SCI, V60, P537, DOI 10.5650/jos.60.537; Zhao Qi, 2012, Methods Mol Biol, V899, P73, DOI 10.1007/978-1-61779-921-1_5; Zhao Q, 2011, MOL CANCER THER, V10, P1677, DOI 10.1158/1535-7163.MCT-11-0281; Zhao Q, 2009, PROTEIN EXPRES PURIF, V68, P190, DOI 10.1016/j.pep.2009.08.004	36	22	24	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13017	13027		10.1074/jbc.M115.650903	http://dx.doi.org/10.1074/jbc.M115.650903			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25851904	hybrid, Green Published			2022-12-28	WOS:000354975700004
J	Dong, J; Zhang, Y; Chen, YT; Niu, XD; Zhang, Y; Li, R; Yang, C; Wang, Q; Li, XM; Deng, XM				Dong, Jing; Zhang, Yong; Chen, Yutao; Niu, Xiaodi; Zhang, Yu; Li, Rui; Yang, Cheng; Wang, Quan; Li, Xuemei; Deng, Xuming			Baicalin Inhibits the Lethality of Ricin in Mice by Inducing Protein Oligomerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOME-INACTIVATING PROTEINS; SMALL-MOLECULE INHIBITORS; SHIGA TOXIN; ENDOPLASMIC-RETICULUM; RETROGRADE TRANSPORT; BIOLOGICAL-ACTIVITY; ALPHA-HEMOLYSIN; ANTIBODIES; CELLS; IDENTIFICATION	Toxic ribosome-inactivating proteins abolish cell viability by inhibiting protein synthesis. Ricin, a member of these lethal proteins, is a potential bioterrorism agent. Despite the grave challenge posed by these toxins to public health, post-exposure treatment for intoxication caused by these agents currently is unavailable. In this study, we report the identification of baicalin extracted from Chinese herbal medicine as a compound capable of inhibiting the activity of ricin. More importantly, post-exposure treatment with baicalin significantly increased the survival of mice poisoned by ricin. We determined the mechanism of action of baicalin by solving the crystal structure of its complex with the A chain of ricin (RTA) at 2.2 angstrom resolution, which revealed that baicalin interacts with two RTA molecules at a novel binding site by hydrogen bond networks and electrostatic force interactions, suggesting its role as molecular glue of the RTA. Further biochemical and biophysical analyses validated the amino acids directly involved in binding the inhibitor, which is consistent with the hypothesis that baicalin exerts its inhibitory effects by inducing RTA to form oligomers in solution, a mechanism that is distinctly different from previously reported inhibitors. This work offers promising leads for the development of therapeutics against ricin and probably other ribosome-inactivating proteins.	[Dong, Jing; Zhang, Yong; Zhang, Yu; Li, Rui; Deng, Xuming] Jilin Univ, Coll Vet Med, Inst Zoonosis, Key Lab Zoonosis,Minist Educ, Changchun 130062, Peoples R China; [Dong, Jing] Chinese Acad Fishery Sci, Yangtze River Fisheries Res Inst, Wuhan 430223, Peoples R China; [Chen, Yutao; Wang, Quan; Li, Xuemei] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Niu, Xiaodi] Jilin Univ, Dept Food Qual & Safety, Changchun 130062, Peoples R China; [Yang, Cheng] Nankai Univ, Coll Pharm, Tianjin 300071, Peoples R China	Jilin University; Chinese Academy of Fishery Sciences; Yangtze River Fisheries Research Institute, CAFS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Jilin University; Nankai University	Li, XM (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.	lixm@sun5.ibp.ac.cn; dengxm@jlu.edu.cn	dong, jing/ABE-3368-2021	dong, jing/0000-0002-4589-1471	National Basic Research Program of China [2013CB127205]; National Nature Science Foundation of China [31130053]; National 863 Program of China [2012AA020303]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K22AA020303] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 863 Program of China(National High Technology Research and Development Program of China); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Basic Research Program of China Grant 2013CB127205 (to X. M. D.), National Nature Science Foundation of China Grant 31130053 (to X. M. D.), and National 863 Program of China Grant 2012AA020303 (to X. M. D.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bitzan M, 2009, ANTIMICROB AGENTS CH, V53, P3081, DOI 10.1128/AAC.01661-08; Dowling TC, 2005, ANTIMICROB AGENTS CH, V49, P1808, DOI 10.1128/AAC.49.5.1808-1812.2005; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENDO Y, 1988, J BIOL CHEM, V263, P7917; Food and Drug Administration, 2005, GUID FOR IND, P25; Hale ML, 2001, PHARMACOL TOXICOL, V88, P255, DOI 10.1034/j.1600-0773.2001.d01-113.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mantis NJ, 2006, INFECT IMMUN, V74, P3455, DOI 10.1128/IAI.02088-05; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller DJ, 2002, J MED CHEM, V45, P90, DOI 10.1021/jm010186s; MLSNA D, 1993, PROTEIN SCI, V2, P429; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neal LM, 2010, INFECT IMMUN, V78, P552, DOI 10.1128/IAI.00796-09; NICOLSON GL, 1972, BIOCHIM BIOPHYS ACTA, V266, P543, DOI 10.1016/0005-2736(72)90109-5; Niu XD, 2013, EUR J MED CHEM, V62, P320, DOI 10.1016/j.ejmech.2013.01.008; O'Hara JM, 2012, CURR TOP MICROBIOL, V357, P209, DOI 10.1007/82_2011_193; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pruet JM, 2011, EUR J MED CHEM, V46, P3608, DOI 10.1016/j.ejmech.2011.05.025; Qiu JZ, 2012, J INFECT DIS, V206, P292, DOI 10.1093/infdis/jis336; Rapak A, 1997, P NATL ACAD SCI USA, V94, P3783, DOI 10.1073/pnas.94.8.3783; Rasooly R, 2012, J BIOL CHEM, V287, P27924, DOI 10.1074/jbc.M112.362988; Roche JK, 2008, LAB INVEST, V88, P1178, DOI 10.1038/labinvest.2008.83; Saenz JB, 2007, INFECT IMMUN, V75, P4552, DOI 10.1128/IAI.00442-07; Smith MJ, 2009, INFECT IMMUN, V77, P2730, DOI 10.1128/IAI.00005-09; Spooner RA, 2012, CURR TOP MICROBIOL, V357, P19, DOI 10.1007/82_2011_154; Stechmann B, 2010, CELL, V141, P231, DOI 10.1016/j.cell.2010.01.043; Stirpe F, 2006, CELL MOL LIFE SCI, V63, P1850, DOI 10.1007/s00018-006-6078-7; Takahashi H, 2011, BBA-MOL CELL RES, V1813, P1465, DOI 10.1016/j.bbamcr.2011.05.003; Tzipori S, 2004, CLIN MICROBIOL REV, V17, P926, DOI 10.1128/CMR.17.4.926-941.2004; Vance DJ, 2013, J BIOL CHEM, V288, P36538, DOI 10.1074/jbc.M113.519207; Wahome PG, 2012, CURR TOP MICROBIOL, V357, P179, DOI 10.1007/82_2011_177; Wahome PG, 2010, TOXICON, V56, P313, DOI 10.1016/j.toxicon.2010.03.016; Zhang J, 1999, ACTA BIOCH BIOPH SIN, V31, P472; Zhang X., 2006, J MED RES, V7, P16; Zhu YW, 2013, J BIOL CHEM, V288, P28311, DOI 10.1074/jbc.A113.480830	36	8	10	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12899	12907		10.1074/jbc.M114.632828	http://dx.doi.org/10.1074/jbc.M114.632828			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25847243	Green Published, hybrid			2022-12-28	WOS:000354569000039
J	Balchand, SK; Mann, BJ; Titus, J; Ross, JL; Wadsworth, P				Balchand, Sai K.; Mann, Barbara J.; Titus, Janel; Ross, Jennifer L.; Wadsworth, Patricia			TPX2 Inhibits Eg5 by Interactions with Both Motor and Microtubule	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AURORA-A ACTIVATION; MITOTIC SPINDLE; KINESIN MOTOR; DIRECTIONAL MOTILITY; MAMMALIAN-CELLS; CROSS-LINKS; PROTEIN; DYNEIN; PROMOTES; LOCALIZATION	The microtubule-associated protein, TPX2, regulates the activity of the mitotic kinesin, Eg5, but the mechanism of regulation is not established. Using total internal reflection fluorescence microscopy, we observed that Eg5, in extracts of mammalian cells expressing Eg5-EGFP, moved processively toward the microtubule plus-end at an average velocity of 14 nm/s. TPX2 bound to microtubules with an apparent dissociation constant of similar to 200 nM, and microtubule binding was not dependent on the C-terminal tails of tubulin. Using single molecule assays, we found that full-length TPX2 dramatically reduced Eg5 velocity, whereas truncated TPX2, which lacks the domain that is required for the interaction with Eg5, was a less effective inhibitor at the same concentration. To determine the region(s) of Eg5 that is required for interaction with TPX2, we performed microtubule gliding assays. Dimeric, but not monomeric, Eg5 was differentially inhibited by full-length and truncated TPX2, demonstrating that dimerization or residues in the neck region are important for the interaction of TPX2 with Eg5. These results show that both microtubule binding and interaction with Eg5 contribute to motor inhibition by TPX2 and demonstrate the utility of mammalian cell extracts for biophysical assays.	[Balchand, Sai K.; Mann, Barbara J.; Titus, Janel; Ross, Jennifer L.; Wadsworth, Patricia] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; [Ross, Jennifer L.] Univ Massachusetts, Dept Phys, Amherst, MA 01003 USA; [Wadsworth, Patricia] Univ Massachusetts, Program Mol & Cellular Biol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Wadsworth, P (corresponding author), Univ Massachusetts, Dept Biol, 221 Morrill South,611 N Pleasant St, Amherst, MA 01003 USA.		Ross, Jennifer L/D-7208-2012	Ross, Jennifer L/0000-0002-4838-3798	National Science Foundation Major Research Instrumentation [DBI-0923318]; National Science Foundation [DMR-1207783]	National Science Foundation Major Research Instrumentation(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF))	The multicolor TIRF microscopy was performed on a user-supported instrument funded by National Science Foundation Major Research Instrumentation Grant DBI-0923318 (to J. L. R. and P. W.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by National Science Foundation Grant DMR-1207783.	Barlan K, 2013, CURR BIOL, V23, P317, DOI 10.1016/j.cub.2013.01.008; Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Brouhard GJ, 2008, CELL, V132, P79, DOI 10.1016/j.cell.2007.11.043; Cai DW, 2007, BIOPHYS J, V92, P4137, DOI 10.1529/biophysj.106.100206; Cai DW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000216; Cheeseman Iain M, 2005, Sci STKE, V2005, ppl1, DOI 10.1126/stke.2662005pl1; Day RN, 2009, CHEM SOC REV, V38, P2887, DOI 10.1039/b901966a; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Drechsler H, 2014, ELIFE, V3, DOI 10.7554/eLife.01724; Eckerdt F, 2008, CURR BIOL, V18, P519, DOI 10.1016/j.cub.2008.02.077; Eyers PA, 2004, J BIOL CHEM, V279, P9008, DOI 10.1074/jbc.M312424200; Gable A, 2012, MOL BIOL CELL, V23, P1254, DOI 10.1091/mbc.E11-09-0820; Garrett S, 2002, CURR BIOL, V12, P2055, DOI 10.1016/S0960-9822(02)01277-0; Gerson-Gurwitz A, 2011, EMBO J, V30, P4942, DOI 10.1038/emboj.2011.403; Groen AC, 2008, J CELL SCI, V121, P2293, DOI 10.1242/jcs.024018; Gruss OJ, 2002, NAT CELL BIOL, V4, P871, DOI 10.1038/ncb870; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Hinrichs MH, 2012, J BIOL CHEM, V287, P38559, DOI 10.1074/jbc.M112.369785; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; Illenberger S, 1996, J BIOL CHEM, V271, P10834, DOI 10.1074/jbc.271.18.10834; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Kapitein LC, 2008, J CELL BIOL, V182, P421, DOI 10.1083/jcb.200801145; Korneev MJ, 2007, EUR BIOPHYS J BIOPHY, V36, P675, DOI 10.1007/s00249-007-0134-6; Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155; Kwok BH, 2006, NAT CHEM BIOL, V2, P480, DOI 10.1038/nchembio812; Larson AG, 2010, BIOPHYS J, V98, P2619, DOI 10.1016/j.bpj.2010.03.014; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma N, 2011, J CELL BIOL, V195, P87, DOI 10.1083/jcb.201106149; Ma N, 2010, MOL BIOL CELL, V21, P979, DOI 10.1091/mbc.E09-07-0601; Markus SM, 2012, CURR BIOL, V22, P2221, DOI 10.1016/j.cub.2012.10.017; PASCHAL BM, 1989, NATURE, V342, P569, DOI 10.1038/342569a0; Petry S, 2013, CELL, V152, P768, DOI 10.1016/j.cell.2012.12.044; Roostalu J, 2011, SCIENCE, V332, P94, DOI 10.1126/science.1199945; Skoufias DA, 2006, J BIOL CHEM, V281, P17559, DOI 10.1074/jbc.M511735200; Sung HH, 2008, DEV CELL, V15, P866, DOI 10.1016/j.devcel.2008.10.006; Thorn KS, 2000, J CELL BIOL, V151, P1093, DOI 10.1083/jcb.151.5.1093; Tulu US, 2006, CURR BIOL, V16, P536, DOI 10.1016/j.cub.2006.01.060; Valentine MT, 2006, NAT CELL BIOL, V8, P470, DOI 10.1038/ncb1394; van den Wildenberg SMJL, 2008, CURR BIOL, V18, P1860, DOI 10.1016/j.cub.2008.10.026; Walczak CE, 2008, INT REV CYTOL, V265, P111, DOI 10.1016/S0074-7696(07)65003-7; Wang Z., 2000, BIOPHYS J, V78, P1955; Welburn JPI, 2012, MOL BIOL CELL, V23, P4786, DOI 10.1091/mbc.E12-03-0214; Wittmann T, 1998, J CELL BIOL, V143, P673, DOI 10.1083/jcb.143.3.673; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405	44	22	24	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17367	17379		10.1074/jbc.M114.612903	http://dx.doi.org/10.1074/jbc.M114.612903			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26018074	Green Published, hybrid			2022-12-28	WOS:000357730900031
J	Yu, I; Garnham, CP; Roll-Mecak, A				Yu, Ian; Garnham, Christopher P.; Roll-Mecak, Antonina			Writing and Reading the Tubulin Code	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							MAJOR ALPHA-TUBULIN; BETA-TUBULIN; POSTTRANSLATIONAL MODIFICATION; IN-VITRO; MICROTUBULE DYNAMICS; TYROSINE-LIGASE; RAT-BRAIN; AXONEMAL TUBULIN; C-TERMINUS; PROTEIN	Microtubules give rise to intracellular structures with diverse morphologies and dynamics that are crucial for cell division, motility, and differentiation. They are decorated with abundant and chemically diverse posttranslational modifications that modulate their stability and interactions with cellular regulators. These modifications are important for the biogenesis and maintenance of complex microtubule arrays such as those found in spindles, cilia, neuronal processes, and platelets. Here we discuss the nature and subcellular distribution of these posttranslational marks whose patterns have been proposed to constitute a tubulin code that is interpreted by cellular effectors. We review the enzymes responsible for writing the tubulin code, explore their functional consequences, and identify outstanding challenges in deciphering the tubulin code.	[Yu, Ian; Garnham, Christopher P.; Roll-Mecak, Antonina] NINDS, Cell Biol & Biophys Unit, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA; [Roll-Mecak, Antonina] NHLBI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Roll-Mecak, A (corresponding author), NIH, Cell Biol & Biophys Unit, Porter Neurosci Res Ctr, Bldg 35,Rm 3B-203,35 Convent Dr,MSC 3700, Bethesda, MD 20892 USA.	Antonina@mail.nih.gov		Roll-Mecak, Antonina/0000-0003-2621-7307	National Institutes of Health [1ZIANS003122-05]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003122] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1ZIANS003122-05 (to A. R. M.). This is the fourth article in the Thematic Minireview series "The State of the Cytoskeleton in 2015." The authors declare that they have no conflicts of interest with the contents of this article.	AHMAD FJ, 1993, J NEUROSCI, V13, P856; Akella JS, 2010, NATURE, V467, P218, DOI 10.1038/nature09324; Akhmanova A, 2010, J CELL SCI, V123, P3415, DOI 10.1242/jcs.062414; AUDEBERT S, 1993, MOL BIOL CELL, V4, P615, DOI 10.1091/mbc.4.6.615; BAAS PW, 1990, J CELL BIOL, V111, P495, DOI 10.1083/jcb.111.2.495; BARRA HS, 1973, J NEUROCHEM, V20, P97, DOI 10.1111/j.1471-4159.1973.tb12108.x; Basso M, 2012, J NEUROSCI, V32, P6561, DOI 10.1523/JNEUROSCI.3353-11.2012; BHATTACHARYYA B, 1985, J BIOL CHEM, V260, P208; Bieling P, 2008, J CELL BIOL, V183, P1223, DOI 10.1083/jcb.200809190; Bobinnec Y, 1998, CELL MOTIL CYTOSKEL, V39, P223, DOI 10.1002/(SICI)1097-0169(1998)39:3<223::AID-CM5>3.3.CO;2-3; Bonnet C, 2001, J BIOL CHEM, V276, P12839, DOI 10.1074/jbc.M011380200; BOUCHER D, 1994, BIOCHEMISTRY-US, V33, P12471, DOI 10.1021/bi00207a014; BRADY ST, 1984, J CELL BIOL, V99, P1716, DOI 10.1083/jcb.99.5.1716; Brants J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051258; Bre MH, 1996, J CELL SCI, V109, P727; Bre MH, 1998, MOL BIOL CELL, V9, P2655, DOI 10.1091/mbc.9.9.2655; BULINSKI JC, 1988, J CELL BIOL, V106, P1213, DOI 10.1083/jcb.106.4.1213; Cai DW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000216; Caron JM, 1997, MOL BIOL CELL, V8, P621, DOI 10.1091/mbc.8.4.621; Caron JM, 2001, MOL BIOL CELL, V12, P2672, DOI 10.1091/mbc.12.9.2672; Chu CW, 2011, MOL BIOL CELL, V22, P448, DOI 10.1091/mbc.E10-03-0203; Cueva JG, 2012, CURR BIOL, V22, P1066, DOI 10.1016/j.cub.2012.05.012; Dossou SJY, 2007, CELL MOTIL CYTOSKEL, V64, P847, DOI 10.1002/cm.20229; Drummond DR, 2011, METHODS MOL BIOL, V777, P29, DOI 10.1007/978-1-61779-252-6_3; Duan JM, 2002, CURR BIOL, V12, P313, DOI 10.1016/S0960-9822(02)00651-6; EDDE B, 1990, SCIENCE, V247, P83, DOI 10.1126/science.1967194; EIPPER BA, 1972, P NATL ACAD SCI USA, V69, P2283, DOI 10.1073/pnas.69.8.2283; Erck C, 2005, P NATL ACAD SCI USA, V102, P7853, DOI 10.1073/pnas.0409626102; ERSFELD K, 1993, J CELL BIOL, V120, P725, DOI 10.1083/jcb.120.3.725; Fourest-Lieuvin A, 2006, MOL BIOL CELL, V17, P1041, DOI 10.1091/mbc.E05-07-0621; Garnham CP, 2012, CYTOSKELETON, V69, P442, DOI 10.1002/cm.21027; Gell C, 2010, METHOD CELL BIOL, V95, P221, DOI 10.1016/S0091-679X(10)95013-9; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Grau MB, 2013, J CELL BIOL, V202, P441, DOI 10.1083/jcb.201305041; Ikegami K, 2007, P NATL ACAD SCI USA, V104, P3213, DOI 10.1073/pnas.0611547104; Ikegami K, 2006, J BIOL CHEM, V281, P30707, DOI 10.1074/jbc.M603984200; Ikegami K, 2009, FEBS LETT, V583, P1957, DOI 10.1016/j.febslet.2009.05.003; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Janke C, 2005, SCIENCE, V308, P1758, DOI 10.1126/science.1113010; Johnson V, 2011, BIOCHEMISTRY-US, V50, P8636, DOI 10.1021/bi2005174; Kalinina E, 2007, FASEB J, V21, P836, DOI 10.1096/fj.06-7329com; Kimura Y, 2010, J BIOL CHEM, V285, P22934, DOI 10.1074/jbc.C110.128280; Konishi Y, 2009, NAT NEUROSCI, V12, P559, DOI 10.1038/nn.2314; Kubo T, 2014, MOL BIOL CELL, V25, P107, DOI 10.1091/mbc.E13-07-0424; Kubo T, 2010, CURR BIOL, V20, P441, DOI 10.1016/j.cub.2009.12.058; Laan L, 2010, METHOD CELL BIOL, V95, P617, DOI 10.1016/S0091-679X(10)95031-0; LEDIZET M, 1987, P NATL ACAD SCI USA, V84, P5720, DOI 10.1073/pnas.84.16.5720; LEVILLIERS N, 1995, J CELL SCI, V108, P3013; LHERNAULT SW, 1985, BIOCHEMISTRY-US, V24, P473, DOI 10.1021/bi00323a034; Liao GJ, 1998, J BIOL CHEM, V273, P9797, DOI 10.1074/jbc.273.16.9797; Marcos S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005405; MARUTA H, 1986, J CELL BIOL, V103, P571, DOI 10.1083/jcb.103.2.571; Mary J, 1996, J BIOL CHEM, V271, P9928, DOI 10.1074/jbc.271.17.9928; Mary J, 1997, J PROTEIN CHEM, V16, P403, DOI 10.1023/A:1026336722124; MCNALLY FJ, 1993, CELL, V75, P419, DOI 10.1016/0092-8674(93)90377-3; Mialhe A, 2001, CANCER RES, V61, P5024; Minoura I, 2013, FEBS LETT, V587, P3450, DOI 10.1016/j.febslet.2013.08.032; MITCHISON T, 1984, NATURE, V312, P232, DOI 10.1038/312232a0; Mukai M, 2009, BIOCHEMISTRY-US, V48, P1084, DOI 10.1021/bi802047y; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Pathak N, 2011, J BIOL CHEM, V286, P11685, DOI 10.1074/jbc.M110.209817; PATURLELAFANECHERE L, 1994, J CELL SCI, V107, P1529; Peris L, 2009, J CELL BIOL, V185, P1159, DOI 10.1083/jcb.200902142; Peters JD, 1996, J BIOL CHEM, V271, P4755; Prota AE, 2013, J CELL BIOL, V200, P259, DOI 10.1083/jcb.201211017; REDEKER V, 1991, J BIOL CHEM, V266, P23461; REDEKER V, 1992, FEBS LETT, V313, P185, DOI 10.1016/0014-5793(92)81441-N; Redeker V, 1998, BIOCHEMISTRY-US, V37, P14838, DOI 10.1021/bi981335k; REDEKER V, 1994, SCIENCE, V266, P1688, DOI 10.1126/science.7992051; Rocha C, 2014, EMBO J, V33, P2247, DOI 10.15252/embj.201488466; Rogowski K, 2010, CELL, V143, P564, DOI 10.1016/j.cell.2010.10.014; Roll-Mecak A, 2005, CURR BIOL, V15, P650, DOI 10.1016/j.cub.2005.02.029; Roll-Mecak A, 2015, SEMIN CELL DEV BIOL, V37, P11, DOI 10.1016/j.semcdb.2014.09.026; Rosas-Acosta G, 2005, MOL CELL PROTEOMICS, V4, P56, DOI 10.1074/mcp.M400149-MCP200; Schneider A, 1997, J CELL SCI, V110, P431; Shida T, 2010, P NATL ACAD SCI USA, V107, P21517, DOI 10.1073/pnas.1013728107; Sirajuddin M, 2014, NAT CELL BIOL, V16, P335, DOI 10.1038/ncb2920; Song YY, 2013, NEURON, V78, P109, DOI 10.1016/j.neuron.2013.01.036; Soppina V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048204; Suryavanshi S, 2010, CURR BIOL, V20, P435, DOI 10.1016/j.cub.2009.12.062; Szyk A, 2014, CELL, V157, P1405, DOI 10.1016/j.cell.2014.03.061; Szyk A, 2013, J MOL BIOL, V425, P2412, DOI 10.1016/j.jmb.2013.04.017; Szyk A, 2011, NAT STRUCT MOL BIOL, V18, P1250, DOI 10.1038/nsmb.2148; Thazhath R, 2002, NAT CELL BIOL, V4, P256, DOI 10.1038/ncb764; Tischfield MA, 2011, CURR OPIN GENET DEV, V21, P286, DOI 10.1016/j.gde.2011.01.003; Topalidou I, 2012, CURR BIOL, V22, P1057, DOI 10.1016/j.cub.2012.03.066; Tort O, 2014, MOL BIOL CELL, V25, P3017, DOI 10.1091/mbc.E14-06-1072; van Dijk J, 2007, MOL CELL, V26, P437, DOI 10.1016/j.molcel.2007.04.012; Vemu A, 2014, METHOD ENZYMOL, V540, P149, DOI 10.1016/B978-0-12-397924-7.00009-1; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; Vinh J, 1997, ANAL CHEM, V69, P3979, DOI 10.1021/ac970449j; Wang ZH, 2000, BIOPHYS J, V78, P1955, DOI 10.1016/S0006-3495(00)76743-9; WEBSTER DR, 1987, P NATL ACAD SCI USA, V84, P9040, DOI 10.1073/pnas.84.24.9040; WEBSTER DR, 1990, J CELL BIOL, V111, P113, DOI 10.1083/jcb.111.1.113; Widlund PO, 2012, MOL BIOL CELL, V23, P4393, DOI 10.1091/mbc.E12-06-0444; Wloga D, 2010, EUKARYOT CELL, V9, P184, DOI 10.1128/EC.00176-09; Wloga D, 2009, DEV CELL, V16, P867, DOI 10.1016/j.devcel.2009.04.008; WOLFF A, 1982, NEUROSCI LETT, V31, P323, DOI 10.1016/0304-3940(82)90041-6	98	121	122	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17163	17172		10.1074/jbc.R115.637447	http://dx.doi.org/10.1074/jbc.R115.637447			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	25957412	hybrid, Green Published			2022-12-28	WOS:000357730900013
J	Hadjikyriacou, A; Yang, YZ; Espejo, A; Bedford, MT; Clarke, SG				Hadjikyriacou, Andrea; Yang, Yanzhong; Espejo, Alexsandra; Bedford, Mark T.; Clarke, Steven G.			Unique Features of Human Protein Arginine Methyltransferase 9 (PRMT9) and Its Substrate RNA Splicing Factor SF3B2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYLATION; SPECIFICITY; OLIGOMERIZATION; CATALYZES; RESIDUES; COMPLEX; MEMBERS	Human protein arginine methyltransferase (PRMT) 9 symmetrically dimethylates arginine residues on splicing factor SF3B2 (SAP145) and has been functionally linked to the regulation of alternative splicing of pre-mRNA. Site-directed mutagenesis studies on this enzyme and its substrate had revealed essential unique residues in the double E loop and the importance of the C-terminal duplicated methyltransferase domain. In contrast to what had been observed with other PRMTs and their physiological substrates, a peptide containing the methylatable Arg-508 of SF3B2 was not recognized by PRMT9 in vitro. Although amino acid substitutions of residues surrounding Arg-508 had no great effect on PRMT9 recognition of SF3B2, moving the arginine residue within this sequence abolished methylation. PRMT9 and PRMT5 are the only known mammalian enzymes capable of forming symmetric dimethylarginine (SDMA) residues as type II PRMTs. We demonstrate here that the specificity of these enzymes for their substrates is distinct and not redundant. The loss of PRMT5 activity in mouse embryo fibroblasts results in almost complete loss of SDMA, suggesting that PRMT5 is the primary SDMA-forming enzyme in these cells. PRMT9, with its duplicated methyltransferase domain and conserved sequence in the double E loop, appears to have a unique structure and specificity among PRMTs for methylating SF3B2 and potentially other polypeptides.	[Hadjikyriacou, Andrea; Clarke, Steven G.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Hadjikyriacou, Andrea; Clarke, Steven G.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Yang, Yanzhong; Espejo, Alexsandra; Bedford, Mark T.] Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Smithville, TX 78957 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Texas System; UTMD Anderson Cancer Center	Clarke, SG (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr E, Los Angeles, CA 90095 USA.	clarke@mbi.ucla.edu	Regan, Clinton/E-6250-2012; yang, yanzhong/AAH-6132-2019	Espejo, Alexsandra/0000-0002-8841-7219; bedford, mark/0000-0002-8899-1050; Clarke, Steven/0000-0002-7303-6632	National Institutes of Health [GM026020, DK062248, GM007185]; Ruth L. Kirschstein National Research Service Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK062248, R01DK062248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026020, T32GM007185, R37GM026020] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM026020 (to S. G. C.), DK062248 (to M. T. B.), and GM007185, a Ruth L. Kirschstein National Research Service Award (to A. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Antonysamy S, 2012, P NATL ACAD SCI USA, V109, P17960, DOI 10.1073/pnas.1209814109; Bachand F, 2007, EUKARYOT CELL, V6, P889, DOI 10.1128/EC.00099-07; Baldwin R Mitchell, 2014, World J Biol Chem, V5, P115, DOI 10.4331/wjbc.v5.i2.115; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bezzi M, 2013, GENE DEV, V27, P1903, DOI 10.1101/gad.219899.113; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Branscombe TL, 2001, J BIOL CHEM, V276, P32971, DOI 10.1074/jbc.M105412200; CHAMPIONARNAUD P, 1994, GENE DEV, V8, P1974, DOI 10.1101/gad.8.16.1974; Cura V, 2014, ACTA CRYSTALLOGR D, V70, P2401, DOI 10.1107/S1399004714014278; Dacwag CS, 2009, MOL CELL BIOL, V29, P1909, DOI 10.1128/MCB.00742-08; Dhar S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01311; Duan S., 2012, FBXO11 TARGETS BCL6; Feng Y, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.609271; Feng Y, 2013, J BIOL CHEM, V288, P37010, DOI 10.1074/jbc.M113.525345; Fuhrmann J, 2015, CHEM REV, V115, P5413, DOI 10.1021/acs.chemrev.5b00003; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; GOTTSCHLING H, 1962, NATURE, V196, P829, DOI 10.1038/196829a0; Gui SY, 2013, BIOCHEMISTRY-US, V52, P199, DOI 10.1021/bi301283t; Hasegawa M, 2014, FEBS LETT, V588, P1942, DOI 10.1016/j.febslet.2014.03.053; Herrmann F, 2009, J CELL SCI, V122, P667, DOI 10.1242/jcs.039933; Katz JE, 2003, MOL CELL PROTEOMICS, V2, P525, DOI 10.1074/mcp.M300037-MCP200; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Lee DY, 2007, MOL ENDOCRINOL, V21, P1381, DOI 10.1210/me.2006-0389; Lee YH, 2009, MOL ENDOCRINOL, V23, P425, DOI 10.1210/me.2008-0380; Lott K, 2014, MICROBIOLOGYOPEN, V3, P595, DOI 10.1002/mbo3.191; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Meister G, 2001, CURR BIOL, V11, P1990, DOI 10.1016/S0960-9822(01)00592-9; Miranda TB, 2004, J BIOL CHEM, V279, P22902, DOI 10.1074/jbc.M312904200; Molina-Serrano D, 2013, BIOCHEM SOC T, V41, P751, DOI 10.1042/BST20130003; Petryszak R, 2014, NUCLEIC ACIDS RES, V42, pD926, DOI 10.1093/nar/gkt1270; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Takahashi Y, 2011, J RECEPT SIG TRANSD, V31, P168, DOI 10.3109/10799893.2011.555768; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang J, 1998, J BIOL CHEM, V273, P16935, DOI 10.1074/jbc.273.27.16935; Tee WW, 2010, GENE DEV, V24, P2772, DOI 10.1101/gad.606110; Terada Y, 2006, MOL CELL BIOL, V26, P8149, DOI 10.1128/MCB.01170-06; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wang M, 2014, BIOCHEMISTRY-US, V53, P7884, DOI 10.1021/bi501279g; Wang M, 2013, BIOCHEMISTRY-US, V52, P5430, DOI 10.1021/bi4005123; Wang YC, 2015, MOL PHYLOGENET EVOL, V84, P101, DOI 10.1016/j.ympev.2014.12.002; Wang YC, 2012, FEBS J, V279, P932, DOI 10.1111/j.1742-4658.2012.08490.x; Yang YZ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7428; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Yoshimatsu M, 2011, INT J CANCER, V128, P562, DOI 10.1002/ijc.25366; Zurita-Lopez CI, 2012, J BIOL CHEM, V287, P7859, DOI 10.1074/jbc.M111.336271	45	59	63	4	26	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16723	16743		10.1074/jbc.M115.659433	http://dx.doi.org/10.1074/jbc.M115.659433			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25979344	hybrid, Green Published			2022-12-28	WOS:000357572800021
J	Risse, E; Nicoll, AJ; Taylor, WA; Wright, D; Badoni, M; Yang, XF; Farrow, MA; Collinge, J				Risse, Emmanuel; Nicoll, Andrew J.; Taylor, William A.; Wright, Daniel; Badoni, Mayank; Yang, Xiaofan; Farrow, Mark A.; Collinge, John			Identification of a Compound That Disrupts Binding of Amyloid-beta to the Prion Protein Using a Novel Fluorescence-based Assay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; A-BETA; IN-VIVO; NEURODEGENERATIVE DISEASES; MONOCLONAL-ANTIBODIES; SYNAPTIC PLASTICITY; MEMORY IMPAIRMENT; OLIGOMERS; SCRAPIE; PRP	The prion protein (PrP) has been implicated both in prion diseases such as Creutzfeldt-Jakob disease, where its monomeric cellular isoform (PrPC) is recruited into pathogenic self-propagating polymers of misfolded protein, and in Alzheimer disease, where PrPC may act as a receptor for synaptotoxic oligomeric forms of amyloid-beta (A beta). There has been considerable interest in identification of compounds that bind to PrPC, stabilizing its native fold and thereby acting as pharmacological chaperones to block prion propagation and pathogenesis. However, compounds binding PrPC could also inhibit the binding of toxic A beta species and may have a role in treating Alzheimer disease, a highly prevalent dementia for which there are currently no disease-modifying treatments. However, the absence of a unitary, readily measurable, physiological function of PrP makes screening for ligands challenging, and the highly heterogeneous nature of A beta oligomer preparations makes conventional competition binding assays difficult to interpret. We have therefore developed a high-throughput screen that utilizes site-specifically fluorescently labeled protein to identify compounds that bind to PrP and inhibit both A beta binding and prion propagation. Following a screen of 1,200 approved drugs, we identified Chicago Sky Blue 6B as the first small molecule PrP ligand capable of inhibiting A beta binding, demonstrating the feasibility of development of drugs to block this interaction. The interaction of Chicago Sky Blue 6B was characterized by isothermal titration calorimetry, and its ability to inhibit A beta binding and reduce prion levels was established in cell-based assays.	[Farrow, Mark A.] Univ Coll London UCL Inst Neurol, Med Res Council MRC Prion Unit, London WC1N 3BG, England; Univ Coll London UCL Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England	University of London; University College London; University of London; University College London	Farrow, MA (corresponding author), Univ Coll London UCL Inst Neurol, Med Res Council MRC Prion Unit, London WC1N 3BG, England.	m.farrow@prion.ucl.ac.uk; j.collinge@prion.ucl.ac.uk			Medical Research Council; Department of Health (England); MRC [MC_EX_MR/L023180/1, MC_U123192748] Funding Source: UKRI; Medical Research Council [MC_U123192748, MC_EX_MR/L023180/1, 1272604] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health (England); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council and Department of Health (England). J. C. is a director and shareholder of D-Gen Limited, an academic spin-out company in the field of prion diagnosis, decontamination, and therapeutics.	Antonyuk SV, 2009, P NATL ACAD SCI USA, V106, P2554, DOI 10.1073/pnas.0809170106; Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Barry AE, 2011, J NEUROSCI, V31, P7259, DOI 10.1523/JNEUROSCI.6500-10.2011; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Berry DB, 2013, P NATL ACAD SCI USA, V110, pE4160, DOI 10.1073/pnas.1317164110; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516; Chung E, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-130; Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; Fluharty BR, 2013, J BIOL CHEM, V288, P7857, DOI 10.1074/jbc.M112.423954; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; Griffiths HH, 2011, J BIOL CHEM, V286, P33489, DOI 10.1074/jbc.M111.278556; Hosszu LLP, 1999, NAT STRUCT BIOL, V6, P740, DOI 10.1038/11507; Hu NW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4374; Jackson GS, 1999, BBA-PROTEIN STRUCT M, V1431, P1, DOI 10.1016/S0167-4838(99)00038-2; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Kam TI, 2013, J CLIN INVEST, V123, P2791, DOI 10.1172/JCI66827; Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217; Khalill-Shirazi A, 2007, BBA-PROTEINS PROTEOM, V1774, P1438, DOI 10.1016/j.bbapap.2007.08.028; Kim T, 2013, SCIENCE, V341, P1399, DOI 10.1126/science.1242077; Klohn PC, 2012, SCIENCE, V335, P52, DOI 10.1126/science.1215579; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Klyubin I, 2014, J NEUROSCI, V34, P6140, DOI 10.1523/JNEUROSCI.3526-13.2014; Larson M, 2012, J NEUROSCI, V32, P16857, DOI 10.1523/JNEUROSCI.1858-12.2012; Lauren J, 2014, J ALZHEIMERS DIS, V38, P227, DOI 10.3233/JAD-130950; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Nicoll AJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3416; Nicoll AJ, 2010, P NATL ACAD SCI USA, V107, P17610, DOI 10.1073/pnas.1009062107; Nicoll Andrew J., 2009, Infectious Disorders - Drug Targets, V9, P48; Normand A, 2014, BIOCHEM PHARMACOL, V91, P293, DOI 10.1016/j.bcp.2014.07.033; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; ROSETH S, 1995, J NEUROCHEM, V65, P96; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; Sandberg MK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5347; Sandberg MK, 2011, NATURE, V470, P540, DOI 10.1038/nature09768; Selkoe DJ, 2012, SCIENCE, V337, P1488, DOI 10.1126/science.1228541; Trevitt CR, 2006, BRAIN, V129, P2241, DOI 10.1093/brain/awl150; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; Wagner J, 2013, ACTA NEUROPATHOL, V125, P795, DOI 10.1007/s00401-013-1114-9; White AR, 2003, NATURE, V422, P80, DOI 10.1038/nature01457; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zahn R, 1997, FEBS LETT, V417, P400, DOI 10.1016/S0014-5793(97)01330-6	49	30	30	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					17020	17028		10.1074/jbc.M115.637124	http://dx.doi.org/10.1074/jbc.M115.637124			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25995455	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000357572800044
J	Ohkawa, Y; Momota, H; Kato, A; Hashimoto, N; Tsuda, Y; Kotani, N; Honke, K; Suzumura, A; Furukawa, K; Ohmi, Y; Natsume, A; Wakabayashi, T; Furukawa, K				Ohkawa, Yuki; Momota, Hiroyuki; Kato, Akira; Hashimoto, Noboru; Tsuda, Yusuke; Kotani, Norihiro; Honke, Koichi; Suzumura, Akio; Furukawa, Keiko; Ohmi, Yuhsuke; Natsume, Atsushi; Wakabayashi, Toshihiko; Furukawa, Koichi			Ganglioside GD3 Enhances Invasiveness of Gliomas by Forming a Complex with Platelet-derived Growth Factor Receptor and Yes Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						animal model; cell invasion; ganglioside; glioblastoma; invasion; lipid raft	NF-KAPPA-B; SYNTHASE GENE; MALIGNANT PROPERTIES; REACTIVE ASTROCYTES; NEURAL PROGENITORS; ANTITUMOR-ACTIVITY; GENOMIC ANALYSIS; CELL-MIGRATION; MELANOMA-CELLS; T-CELLS	Background: Roles of GD3 in gliomas are not well understood. Results: PDGF receptor was identified as a GD3-associated molecule by enzyme-mediated activation of radical sources and mass spectrometry, and its association with GD3 and Yes leads to increased invasiveness. Conclusion: GD3 enhances invasiveness by forming a molecular complex. Significance: GD3/PDGF receptor <bold>Yes complex is a potential target for glioma therapy</bold>. There have been a few studies on the ganglioside expression in human glioma tissues. However, the role of these gangliosides such as GD3 and GD2 has not been well understood. In this study we employed a genetically engineered mouse model of glioma to clarify the functions of GD3 in gliomas. Forced expression of platelet-derived growth factor B in cultured astrocytes derived from p53-deficient mice resulted in the expression of GD3 and GD2. GD3-positive astrocytes exhibited increased cell growth and invasion activities along with elevated phosphorylation of Akt and Yes kinase. By enzyme-mediated activation of radical sources reaction and mass spectrometry, we identified PDGF receptor (PDGFR) as a GD3-associated molecule. GD3-positive astrocytes showed a significant amount of PDGFR in glycolipid-enriched microdomains/rafts compared with GD3-negative cells. Src kinase family Yes was co-precipitated with PDGFR, and its pivotal role in the increased cell invasion of GD3-positive astrocytes was demonstrated by silencing with anti-Yes siRNA. Direct association between PDGFR and GD3 was also shown, suggesting that GD3 forms ternary complex with PDGFR and Yes. The fact that GD3, PDGFR, and activated Yes were colocalized in lamellipodia and the edge of tumors in cultured cells and glioma tissues, respectively, suggests that GD3 induced by platelet-derived growth factor B enhances PDGF signals in glycolipid-enriched microdomain/rafts, leading to the promotion of malignant phenotypes such as cell proliferation and invasion in gliomas.	[Ohkawa, Yuki; Hashimoto, Noboru; Tsuda, Yusuke; Furukawa, Keiko; Ohmi, Yuhsuke; Furukawa, Koichi] Nagoya Univ, Grad Sch Med, Dept Biochem 2, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4660065, Japan; [Ohkawa, Yuki; Momota, Hiroyuki; Kato, Akira; Natsume, Atsushi; Wakabayashi, Toshihiko] Nagoya Univ, Grad Sch Med, Dept Neurosurg, Showa Ku, Nagoya, Aichi 4660065, Japan; [Kotani, Norihiro] Saitama Med Univ, Dept Biochem, Fac Med, Moroyama, Saitama 3500495, Japan; [Honke, Koichi] Kochi Univ, Sch Med, Dept Biochem, Nankoku, Kochi 7838505, Japan; [Suzumura, Akio] Nagoya Univ, Environm Med Res Inst, Dept Neuroimmunol, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Ohkawa, Yuki; Furukawa, Keiko; Furukawa, Koichi] Chubu Univ, Dept Biomed Sci, Coll Life & Hlth Sci, Kasugai, Aichi 4878501, Japan	Nagoya University; Nagoya University; Saitama Medical University; Kochi University; Nagoya University; Chubu University	Furukawa, K (corresponding author), Nagoya Univ, Grad Sch Med, Dept Biochem 2, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4660065, Japan.	koichi@med.nagoya-u.ac.jp	Natsume, Atsushi/I-7364-2014; Wakabayashi, Toshihiko/I-3526-2012; OHMI, Yuhsuke/I-7302-2014	Natsume, Atsushi/0000-0002-9113-0470; Wakabayashi, Toshihiko/0000-0001-5254-2088; Kotani, Norihiro/0000-0003-3739-6478	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) [22117511, 23590371, 24390078];  [24.8954]	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This work was supported by Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) Grants 22117511, 23590371, and 24390078 and Grant-in-aid for Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellows 24.8954.	Battula VL, 2012, J CLIN INVEST, V122, P2066, DOI 10.1172/JCI59735; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dai C, 2001, GENE DEV, V15, P1913, DOI 10.1101/gad.903001; Daniotti JL, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00306; Deakin NO, 2011, MOL BIOL CELL, V22, P327, DOI 10.1091/mbc.E10-09-0790; Deakin Nicholas O, 2012, Genes Cancer, V3, P362, DOI 10.1177/1947601912458582; Demuth T, 2004, J NEURO-ONCOL, V70, P217, DOI 10.1007/s11060-004-2751-6; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Furukawa K, 2014, CANCER SCI, V105, P52, DOI 10.1111/cas.12310; Furukawa K, 2012, GLYCOCONJUGATE J, V29, P579, DOI 10.1007/s10719-012-9423-0; Furukawa K, 2012, J BIOCHEM, V151, P573, DOI 10.1093/jb/mvs043; Furukawa K, 2011, NEUROCHEM RES, V36, P1578, DOI 10.1007/s11064-011-0494-2; Hakomori S, 2004, AN ACAD BRAS CIENC, V76, P553, DOI 10.1590/S0001-37652004000300010; Hamamura K, 2005, P NATL ACAD SCI USA, V102, P11041, DOI 10.1073/pnas.0503658102; Hamamura K, 2011, J BIOL CHEM, V286, P18526, DOI 10.1074/jbc.M110.164798; Hambardzumyan D, 2009, TRANSL ONCOL, V2, P89, DOI 10.1593/tlo.09100; Hashimoto N, 2012, PROTEOMICS, V12, P3154, DOI 10.1002/pmic.201200279; Heimburg-Molinaro J, 2011, VACCINE, V29, P8802, DOI 10.1016/j.vaccine.2011.09.009; Heyer J, 2010, NAT REV CANCER, V10, P470, DOI 10.1038/nrc2877; Holland EC, 1998, P NATL ACAD SCI USA, V95, P1218, DOI 10.1073/pnas.95.3.1218; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Holland EC, 1998, GENE DEV, V12, P3675, DOI 10.1101/gad.12.23.3675; Jung J, 2011, CELL CYCLE, V10, P1502, DOI 10.4161/cc.10.9.15495; Kang NY, 2007, BBA-GENE STRUCT EXPR, V1769, P622, DOI 10.1016/j.bbaexp.2007.08.001; KAWAI K, 1994, NEUROSCI LETT, V174, P225, DOI 10.1016/0304-3940(94)90027-2; Kawai K, 1999, PSYCHIAT CLIN NEUROS, V53, P79, DOI 10.1046/j.1440-1819.1999.00475.x; Kleber S, 2008, CANCER CELL, V13, P235, DOI 10.1016/j.ccr.2008.02.003; Kotani N, 2008, P NATL ACAD SCI USA, V105, P7405, DOI 10.1073/pnas.0710346105; Lee DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057489; Louis CU, 2011, BLOOD, V118, P6050, DOI 10.1182/blood-2011-05-354449; MacDonald TJ, 2001, NAT GENET, V29, P143, DOI 10.1038/ng731; Miyata M, 2014, BIOCHEM BIOPH RES CO, V445, P504, DOI 10.1016/j.bbrc.2014.02.038; Momota H, 2010, BRAIN TUMOR PATHOL, V27, P95, DOI 10.1007/s10014-010-0272-x; Ohkawa Y, 2010, J BIOL CHEM, V285, P27213, DOI 10.1074/jbc.M109.087791; Ohmi Y, 2011, J NEUROCHEM, V116, P926, DOI 10.1111/j.1471-4159.2010.07067.x; Okada M, 1996, CANCER RES, V56, P2844; Park S, 2009, CANCER RES, V69, P2809, DOI 10.1158/0008-5472.CAN-08-4079; Pule MA, 2008, NAT MED, V14, P1264, DOI 10.1038/nm.1882; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; Sato A, 2012, ONCOL REP, V28, P1889, DOI 10.3892/or.2012.2010; SCHALLER MD, 1995, MOL CELL BIOL, V15, P2635; Shih AH, 2006, CANCER LETT, V232, P139, DOI 10.1016/j.canlet.2005.02.002; Suzumura A, 1996, BRAIN RES, V713, P192, DOI 10.1016/0006-8993(95)01535-3; SUZUMURA A, 1987, J NEUROIMMUNOL, V15, P263, DOI 10.1016/0165-5728(87)90121-4; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Vajn K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075720; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vukelic Z, 2007, GLYCOBIOLOGY, V17, P504, DOI 10.1093/glycob/cwm012; Wagener R, 1999, ACTA NEUROCHIR, V141, P1339, DOI 10.1007/s007010050439; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; YAMASHIRO S, 1995, GLYCOCONJUGATE J, V12, P894, DOI 10.1007/BF00731251; Yang RK, 2010, DRUG FUTURE, V35, P665, DOI 10.1358/dof.2010.035.08.1513490; Yu RK, 2009, J LIPID RES, V50, pS440, DOI 10.1194/jlr.R800028-JLR200; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zhao JM, 1999, J BIOL CHEM, V274, P13744, DOI 10.1074/jbc.274.20.13744; Zhu H, 2009, P NATL ACAD SCI USA, V106, P2712, DOI 10.1073/pnas.0813314106	58	48	48	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16043	16058		10.1074/jbc.M114.635755	http://dx.doi.org/10.1074/jbc.M114.635755			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25940087	Green Published, hybrid			2022-12-28	WOS:000356930100012
J	Duan, JJ; Merrill, AH				Duan, Jingjing; Merrill, Alfred H., Jr.			1-Deoxysphingolipids Encountered Exogenously and Made de Novo: Dangerous Mysteries inside an Enigma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						cancer; ceramide; diabetes; serine; serine palmitoyltransferase; sphingolipid; 1-deoxysphingolipid; alanine; neuropathy; fumonisin	SPONGE RHIZOCHALINA-INCRUSTATA; AUTONOMIC NEUROPATHY TYPE-1; NEURAL-TUBE DEFECTS; SERINE PALMITOYLTRANSFERASE; SPHINGOLIPID BIOSYNTHESIS; MAMMALIAN-CELLS; FUSARIUM-MONILIFORME; CERAMIDE SYNTHASE; ENDOPLASMIC-RETICULUM; DIABETES-MELLITUS	The traditional backbones of mammalian sphingolipids are 2-amino, 1,3-diols made by serine palmitoyltransferase (SPT). Many organisms additionally produce non-traditional, cytotoxic 1-deoxysphingoid bases and, surprisingly, mammalian SPT biosynthesizes some of them, too (e.g. 1-deoxysphinganine from l-alanine). These are rapidly N-acylated to 1-deoxy-ceramides with very uncommon biophysical properties. The functions of 1-deoxysphingolipids are not known, but they are certainly dangerous as contributors to sensory and autonomic neuropathies when elevated by inherited SPT mutations, and they are noticeable in diabetes, non-alcoholic steatohepatitis, serine deficiencies, and other diseases. As components of food as well as endogenously produced, these substances are mysteries within an enigma.	[Merrill, Alfred H., Jr.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Merrill, AH (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	al.merrill@biology.gatech.edu		Merrill, Alfred/0000-0002-6673-968X; Duan, Jingjing/0000-0003-2716-2627	National Institutes of Health [GM076217]; Smithgall Institute Endowed Chair in Molecular Cell Biology at Georgia Tech; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Smithgall Institute Endowed Chair in Molecular Cell Biology at Georgia Tech; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM076217 (to A. H. M.) and the Smithgall Institute Endowed Chair in Molecular Cell Biology at Georgia Tech. This is the third article in the Thematic Minireview series "Novel Bioactive Sphingolipids." The authors declare that they have no conflicts of interest with the contents of this article.	Abbas HK, 1998, PHYTOCHEMISTRY, V47, P1509, DOI 10.1016/S0031-9422(97)00781-4; Astudillo L, 2015, J INHERIT METAB DIS, V38, P65, DOI 10.1007/s10545-014-9736-1; Auer-Grumbach M, 2013, EUR J MED GENET, V56, P266, DOI 10.1016/j.ejmg.2013.02.002; Beattie AE, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/194371; Beattie AE, 2013, CHEM COMMUN, V49, P7058, DOI 10.1039/c3cc43001d; Begagne E, 2014, J CLIN INVEST, V124, P5368, DOI 10.1172/JCI74188; Berkey R, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00068; Bertea M, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-84; Byun HS, 2013, MEDCHEMCOMM, V4, P1394, DOI [10.1039/c3md00201b, 10.1039/C3MD00201B]; CARTER HE, 1947, J BIOL CHEM, V170, P285; CARTER HE, 1947, J BIOL CHEM, V169, P77; Chen BS, 2011, EUR J MED CHEM, V46, P5480, DOI 10.1016/j.ejmech.2011.09.010; Chen YJ, 2014, NEUROSCIENCE, V279, P113, DOI 10.1016/j.neuroscience.2014.08.011; Coward J, 2009, AUTOPHAGY, V5, P184, DOI 10.4161/auto.5.2.7361; Crews P, 2003, J NAT PROD, V66, P177, DOI 10.1021/np020371o; Cuadros R, 2000, CANCER LETT, V152, P23, DOI 10.1016/S0304-3835(99)00428-0; Dickson MA, 2011, CLIN CANCER RES, V17, P2484, DOI 10.1158/1078-0432.CCR-10-2323; Dohrn MF, 2015, EUR J NEUROL, V22, P806, DOI 10.1111/ene.12663; Donatelli M, 1992, Diabetes Res, V20, P121; Eichler FS, 2009, J NEUROSCI, V29, P14646, DOI 10.1523/JNEUROSCI.2536-09.2009; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; Ernst D, 2015, NEUROMOL MED, V17, P47, DOI 10.1007/s12017-014-8339-1; Esaki K, 2015, J BIOL CHEM, V290, P14595, DOI 10.1074/jbc.M114.603860; Fox EM, 2008, CURR OPIN MICROBIOL, V11, P481, DOI 10.1016/j.mib.2008.10.007; Fox TE, 2006, CELL MOL LIFE SCI, V63, P1017, DOI 10.1007/s00018-005-5543-z; FUKAGAWA NK, 1995, METABOLISM, V44, P630, DOI 10.1016/0026-0495(95)90121-3; Gable K, 2010, J BIOL CHEM, V285, P22844, DOI 10.1074/jbc.M110.122259; Garnier-Amblard EC, 2011, ACS MED CHEM LETT, V2, P438, DOI 10.1021/ml2000164; Garofalo K, 2011, J CLIN INVEST, V121, P4735, DOI 10.1172/JCI57549; Gelineau-van Waes J, 2009, ADV FOOD NUTR RES, V56, P145, DOI 10.1016/S1043-4526(08)00605-0; Gilchrist DG, 1997, CELL DEATH DIFFER, V4, P689, DOI 10.1038/sj.cdd.4400312; Gorden DL, 2015, J LIPID RES, V56, P722, DOI 10.1194/jlr.P056002; Gupta SD, 2015, J BIOL CHEM, V290, P90, DOI 10.1074/jbc.M114.588236; Han G, 2009, P NATL ACAD SCI USA, V106, P8186, DOI 10.1073/pnas.0811269106; Harrer H, 2015, MYCOTOXIN RES, V31, P33, DOI 10.1007/s12550-014-0211-5; Hornemann T, 2009, J BIOL CHEM, V284, P26322, DOI 10.1074/jbc.M109.023192; Huang SX, 2011, P NATL ACAD SCI USA, V108, P19335, DOI 10.1073/pnas.1112969108; Humpf HU, 1998, J BIOL CHEM, V273, P19060, DOI 10.1074/jbc.273.30.19060; Inuzuka M, 2005, J BIOL CHEM, V280, P35776, DOI 10.1074/jbc.M505712200; Jimenez-Rojo N, 2014, BIOPHYS J, V107, P2850, DOI 10.1016/j.bpj.2014.10.010; Kiefer K, 2015, J BIOL CHEM, V290, P2822, DOI 10.1074/jbc.M114.595116; Kok JW, 1997, J BIOL CHEM, V272, P21128, DOI 10.1074/jbc.272.34.21128; Lowther J, 2012, BIOCHEM SOC T, V40, P547, DOI 10.1042/BST20110769; Abad JL, 2013, J ORG CHEM, V78, P5858, DOI 10.1021/jo400440z; Makarieva TN, 2007, J NAT PROD, V70, P1991, DOI 10.1021/np0704811; Makarieva TN, 2005, J NAT PROD, V68, P255, DOI 10.1021/np049710z; Marasas WFO, 2004, J NUTR, V134, P711, DOI 10.1093/jn/134.4.711; Marasas WFO, 2001, ENVIRON HEALTH PERSP, V109, P239, DOI 10.2307/3435014; Mardinoglu A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4083; Martinez TN, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-45; Massard C, 2012, INVEST NEW DRUG, V30, P2318, DOI 10.1007/s10637-011-9772-8; McQuiston TJ, 2006, MINI-REV MED CHEM, V6, P671, DOI 10.2174/138955706777435634; Menaldino DS, 2003, PHARMACOL RES, V47, P373, DOI 10.1016/S1043-6618(03)00054-9; Merrill AH, 2001, ENVIRON HEALTH PERSP, V109, P283, DOI 10.2307/3435020; Merrill AH, 2011, CHEM REV, V111, P6387, DOI 10.1021/cr2002917; Momin AA, 2009, LIPIDS, V44, P725, DOI 10.1007/s11745-009-3316-4; Montefusco DJ, 2012, J BIOL CHEM, V287, P9280, DOI 10.1074/jbc.M111.313445; Morales PR, 2007, DRUG CHEM TOXICOL, V30, P197, DOI 10.1080/01480540701375018; Murphy SM, 2013, NEUROLOGY, V80, P2106, DOI 10.1212/WNL.0b013e318295d789; Myers SJ, 2014, DNA CELL BIOL, V33, P399, DOI 10.1089/dna.2013.2182; Nicholas GM, 2002, BIOORG MED CHEM LETT, V12, P2159, DOI 10.1016/S0960-894X(02)00367-0; Nicholas GM, 2000, J AM CHEM SOC, V122, P4011, DOI 10.1021/ja994215o; Othman A, 2012, DIABETOLOGIA, V55, P421, DOI 10.1007/s00125-011-2384-1; Othman A, 2015, DIABETES, V64, P1035, DOI 10.2337/db14-1325; Oyeniran C, 2015, J ALLERGY CLIN IMMUN, V136, P1035, DOI 10.1016/j.jaci.2015.02.031; PAGANO RE, 1990, BIOCHEM SOC T, V18, P361, DOI 10.1042/bst0180361; Penno A, 2010, J BIOL CHEM, V285, P11178, DOI 10.1074/jbc.M109.092973; Pruett ST, 2008, J LIPID RES, V49, P1621, DOI 10.1194/jlr.R800012-JLR200; PUTZ U, 1995, EUR J CELL BIOL, V68, P113; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Quesney S, 2003, CYTOTECHNOLOGY, V42, P1, DOI 10.1023/A:1026185615650; Raman MCC, 2009, J BIOL CHEM, V284, P17328, DOI 10.1074/jbc.M109.008680; Riley RT, 2001, ENVIRON HEALTH PERSP, V109, P301, DOI 10.2307/3435022; Riley RT, 1998, REV MED VET-TOULOUSE, V149, P617; Sakagami H, 2009, ANTICANCER RES, V29, P343; Salcedo M, 2007, APOPTOSIS, V12, P395, DOI 10.1007/s10495-006-0573-z; Sanchez AM, 2008, EUR J PHARMACOL, V584, P237, DOI 10.1016/j.ejphar.2008.02.011; Schoffski P, 2011, CANCER CHEMOTH PHARM, V68, P1397, DOI 10.1007/s00280-011-1612-1; SCHROEDER JJ, 1994, J BIOL CHEM, V269, P3475; Siow Deanna, 2015, Adv Biol Regul, V57, P42, DOI 10.1016/j.jbior.2014.09.002; Sorensen JL, 2009, J AGR FOOD CHEM, V57, P1632, DOI 10.1021/jf802926u; Suarez L, 2012, BIRTH DEFECTS RES A, V94, P882, DOI 10.1002/bdra.23070; Sugawara T, 2004, BIOSCI BIOTECH BIOCH, V68, P2541, DOI 10.1271/bbb.68.2541; Symolon H, 2011, MOL CANCER THER, V10, P648, DOI 10.1158/1535-7163.MCT-10-0754; Thevissen K, 2005, CURR DRUG TARGETS, V6, P923, DOI 10.2174/138945005774912771; Thudichum J. L. W., 1881, ANN CHEM MED LONDON, V2, P1; Tidhar R, 2013, BBA-MOL CELL RES, V1833, P2511, DOI 10.1016/j.bbamcr.2013.04.010; Uhlig S, 2005, TOXICON, V46, P513, DOI 10.1016/j.toxicon.2005.06.016; Venkataraman K, 2002, J BIOL CHEM, V277, P35642, DOI 10.1074/jbc.M205211200; Vesper H, 1999, J NUTR, V129, P1239, DOI 10.1093/jn/129.7.1239; Voss KA, 2001, ENVIRON HEALTH PERSP, V109, P259, DOI 10.2307/3435017; WANG E, 1991, J BIOL CHEM, V266, P14486; Wei N, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-161; Willis RH, 1997, TOXICON, V35, P1125, DOI 10.1016/S0041-0101(96)00218-8; Wu F, 2014, ANNU REV FOOD SCI T, V5, P351, DOI 10.1146/annurev-food-030713-092431; Yard BA, 2007, J MOL BIOL, V370, P870, DOI 10.1016/j.jmb.2007.04.086; Zeidan YH, 2007, TRENDS MOL MED, V13, P327, DOI 10.1016/j.molmed.2007.06.002; Zhou BN, 2001, TETRAHEDRON, V57, P9549, DOI 10.1016/S0040-4020(01)00958-9; Zitomer NC, 2009, J BIOL CHEM, V284, P4786, DOI 10.1074/jbc.M808798200; Zuellig RA, 2014, DIABETES, V63, P1326, DOI 10.2337/db13-1042	100	53	53	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15380	15389		10.1074/jbc.R115.658823	http://dx.doi.org/10.1074/jbc.R115.658823			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25947379	Green Published, hybrid			2022-12-28	WOS:000356527400004
J	Nakhaei-Rad, S; Nakhaeizadeh, H; Kordes, C; Cirstea, IC; Schmick, M; Dvorsky, R; Bastiaens, PIH; Haussinger, D; Ahmadian, MR				Nakhaei-Rad, Saeideh; Nakhaeizadeh, Hossein; Kordes, Claus; Cirstea, Ion C.; Schmick, Malte; Dvorsky, Radovan; Bastiaens, Philippe I. H.; Haeussinger, Dieter; Ahmadian, Mohammad Reza			The Function of Embryonic Stem Cell-expressed RAS (E-RAS), a Unique RAS Family Member, Correlates with Its Additional Motifs and Its Structural Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphatidylinositide 3-kinase (PI 3-kinase); phosphatidylinositol kinase (PI kinase); Raf kinase; RAS protein; small GTPase; E-RAS; effector selection; H-RAS; embryonic stem cell-expressed RAS; specificity determining residues	PHOSPHOLIPASE-C; H-RAS; K-RAS; PLASMA-MEMBRANE; GOLGI-COMPLEX; LIPID RAFTS; PROTEINS; ACTIVATION; EFFECTOR; ERAS	E-RAS is a member of the RAS family specifically expressed in embryonic stem cells, gastric tumors, and hepatic stellate cells. Unlike classical RAS isoforms (H-, N-, and K-RAS4B), E-RAS has, in addition to striking and remarkable sequence deviations, an extended 38-amino acid-long unique N-terminal region with still unknown functions. We investigated the molecular mechanism of E-RAS regulation and function with respect to its sequence and structural features. We found that N-terminal extension of E-RAS is important for E-RAS signaling activity. E-RAS protein most remarkably revealed a different mode of effector interaction as compared with H-RAS, which correlates with deviations in the effector-binding site of E-RAS. Of all these residues, tryptophan 79 (arginine 41 in H-RAS), in the interswitch region, modulates the effector selectivity of RAS proteins from H-RAS to E-RAS features.	[Nakhaei-Rad, Saeideh; Nakhaeizadeh, Hossein; Cirstea, Ion C.; Dvorsky, Radovan; Ahmadian, Mohammad Reza] Univ Dusseldorf, Fak Med, Inst Biochem & Mol Biol 2, D-40255 Dusseldorf, Germany; [Kordes, Claus; Haeussinger, Dieter] Univ Dusseldorf, Fak Med, Clin Gastroenterol Hepatol & Infect Dis, D-40255 Dusseldorf, Germany; [Cirstea, Ion C.] Fritz Lipmann Inst, Leibniz Inst Age Res, D-07745 Jena, Germany; [Schmick, Malte; Bastiaens, Philippe I. H.] Max Planck Inst Mol Physiol, Dept Syst Cell Biol, D-44227 Dortmund, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Max Planck Society	Ahmadian, MR (corresponding author), Univ Dusseldorf, Fak Med, Inst Biochem & Mol Biol 2, Univ Str 1,Gebaude 22-03-03, D-40255 Dusseldorf, Germany.	reza.ahmadian@uni-duesseldorf.de	Nakhaeirad, Saeideh/AAV-1771-2020; Dvorsky, Radovan/ABE-3042-2020; Kordes, Claus/AFM-1775-2022; Cirstea, Ion Cristian/AAQ-7670-2020	Nakhaeirad, Saeideh/0000-0001-8966-8960; Kordes, Claus/0000-0003-0782-1998; Cirstea, Ion Cristian/0000-0003-3204-1598	German Research Foundation through Collaborative Research Center 974 [SFB 974]	German Research Foundation through Collaborative Research Center 974	This work was supported in part by the German Research Foundation through Collaborative Research Center 974 (Grant SFB 974), Communication and Systems Relevance during Liver Injury and Regeneration. The authors declare that they have no conflicts of interest with the contents of this article.	Ahearn IM, 2012, NAT REV MOL CELL BIO, V13, P39, DOI 10.1038/nrm3255; Ahmadian Mohammad Reza, 2002, EMBO Reports, V3, P214, DOI 10.1093/embo-reports/kvf057; Ahmadian MR, 1997, BIOCHEMISTRY-US, V36, P4535, DOI 10.1021/bi962556y; Ahmadian MR, 1997, NAT STRUCT BIOL, V4, P686, DOI 10.1038/nsb0997-686; Aoyama M, 2010, INT J ONCOL, V37, P1011, DOI 10.3892/ijo_00000752; Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BOS JL, 1989, CANCER RES, V49, P4682; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Buday L, 2008, BBA-REV CANCER, V1786, P178, DOI 10.1016/j.bbcan.2008.05.001; Bunney TD, 2006, MOL CELL, V21, P495, DOI 10.1016/j.molcel.2006.01.008; Bunney TD, 2006, TRENDS CELL BIOL, V16, P640, DOI 10.1016/j.tcb.2006.10.007; Castellano Esther, 2011, Genes Cancer, V2, P261, DOI 10.1177/1947601911408079; Castellano Esther, 2011, Genes Cancer, V2, P216, DOI 10.1177/1947601911408081; Cirstea IC, 2013, HUM MOL GENET, V22, P262, DOI 10.1093/hmg/dds426; Cirstea IC, 2010, NAT GENET, V42, P27, DOI 10.1038/ng.497; Cordeddu V, 2009, NAT GENET, V41, P1022, DOI 10.1038/ng.425; Dillon L. M., 2014, ONCOGENE, V6, P328; Ferro E, 2010, CELL SIGNAL, V22, P1804, DOI 10.1016/j.cellsig.2010.05.010; Filchtinski D, 2010, J MOL BIOL, V399, P422, DOI 10.1016/j.jmb.2010.03.046; Flex E, 2014, HUM MOL GENET, V23, P4315, DOI 10.1093/hmg/ddu148; Gonzalez-Garcia A, 2005, CANCER CELL, V7, P219, DOI 10.1016/j.ccr.2005.01.029; Goodwin JS, 2005, J CELL BIOL, V170, P261, DOI 10.1083/jcb.200502063; Gremer L, 2011, HUM MUTAT, V32, P33, DOI 10.1002/humu.21377; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; Herrmann C, 2003, CURR OPIN STRUC BIOL, V13, P122, DOI 10.1016/S0959-440X(02)00007-6; Holly SP, 2005, MOL BIOL CELL, V16, P2458, DOI 10.1091/mbc.E03-12-0917; Huang L, 1998, NAT STRUCT BIOL, V5, P422, DOI 10.1038/nsb0698-422; Ichise T, 2010, DEVELOPMENT, V137, P1003, DOI 10.1242/dev.043489; Inabe K, 2002, J EXP MED, V195, P189, DOI 10.1084/jem.20011571; Innocenti M, 2003, J CELL BIOL, V160, P17, DOI 10.1083/jcb.200206079; Iwabuchi K, 1998, J BIOL CHEM, V273, P33766, DOI 10.1074/jbc.273.50.33766; Jaiswal M, 2013, J BIOL CHEM, V288, P4486, DOI 10.1074/jbc.M112.429746; Jaumot M, 2002, J BIOL CHEM, V277, P272, DOI 10.1074/jbc.M108423200; Johnson L, 1997, GENE DEV, V11, P2468, DOI 10.1101/gad.11.19.2468; Kaizaki R, 2009, ANTICANCER RES, V29, P2189; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kubota E, 2010, AM J PATHOL, V177, P955, DOI 10.2353/ajpath.2010.091056; Kuriyama M, 1996, J BIOL CHEM, V271, P607, DOI 10.1074/jbc.271.2.607; Lambert JM, 2002, NAT CELL BIOL, V4, P621, DOI 10.1038/ncb833; Lau KS, 2009, MOL CELLS, V28, P315, DOI 10.1007/s10059-009-0143-7; Lenzen C, 1998, BIOCHEMISTRY-US, V37, P7420, DOI 10.1021/bi972621j; LEON J, 1987, MOL CELL BIOL, V7, P1535, DOI 10.1128/MCB.7.4.1535; LERNER EC, 1995, J BIOL CHEM, V270, P26802, DOI 10.1074/jbc.270.45.26802; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; Matallanas D, 2006, MOL CELL BIOL, V26, P100, DOI 10.1128/MCB.26.1.100-116.2006; Matsunaga-Udagawa R, 2010, J BIOL CHEM, V285, P7818, DOI 10.1074/jbc.M109.053975; Nakamura K, 2008, ONCOGENE, V27, P2961, DOI 10.1038/sj.onc.1210956; Nassar N, 1996, NAT STRUCT BIOL, V3, P723, DOI 10.1038/nsb0896-723; Omerovic J, 2007, CELL MOL LIFE SCI, V64, P2575, DOI 10.1007/s00018-007-7133-8; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Potenza N, 2005, EMBO REP, V6, P432, DOI 10.1038/sj.embor.7400397; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Prior IA, 2001, J CELL SCI, V114, P1603; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Qamra R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072473; Riou P, 2013, CELL, V153, P640, DOI 10.1016/j.cell.2013.03.044; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Rodriguez-Viciana P, 2006, MOL CELL, V22, P217, DOI 10.1016/j.molcel.2006.03.027; Rotblat B, 2004, MOL CELL BIOL, V24, P6799, DOI 10.1128/MCB.24.15.6799-6810.2004; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Scheffzek K, 2001, STRUCTURE, V9, P1043, DOI 10.1016/S0969-2126(01)00674-8; Schmick M, 2014, CELL, V157, P459, DOI 10.1016/j.cell.2014.02.051; Schmidt G, 1996, ONCOGENE, V12, P87; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Song C, 2001, J BIOL CHEM, V276, P2752, DOI 10.1074/jbc.M008324200; Stieglitz B, 2008, EMBO J, V27, P1995, DOI 10.1038/emboj.2008.125; Takahashi K, 2005, J BIOL CHEM, V280, P32768, DOI 10.1074/jbc.M506280200; Takahashi K, 2005, BIOCHEM SOC T, V33, P1522, DOI 10.1042/BST0331522; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Tanaka Y, 2009, CELL TRANSPLANT, V18, P381, DOI 10.3727/096368909788809794; Tidyman WE, 2009, CURR OPIN GENET DEV, V19, P230, DOI 10.1016/j.gde.2009.04.001; TUCKER J, 1986, EMBO J, V5, P1351, DOI 10.1002/j.1460-2075.1986.tb04366.x; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Vavvas D, 1998, J BIOL CHEM, V273, P5439, DOI 10.1074/jbc.273.10.5439; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; WILLUMSEN BM, 1984, NATURE, V310, P583, DOI 10.1038/310583a0; Wittinghofer A, 2011, ANNU REV BIOCHEM, V80, P943, DOI 10.1146/annurev-biochem-062708-134043; Yan J, 1998, J BIOL CHEM, V273, P24052, DOI 10.1074/jbc.273.37.24052; Yu Y, 2014, STEM CELLS, V32, P349, DOI 10.1002/stem.1447	82	12	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15892	15903		10.1074/jbc.M115.640607	http://dx.doi.org/10.1074/jbc.M115.640607			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25940089	Green Published, hybrid			2022-12-28	WOS:000356527400047
J	Yang, Y; Wu, SF; Wang, Y; Pan, S; Lan, B; Liu, YH; Zhang, LM; Leng, QL; Chen, D; Zhang, CZ; He, B; Cao, YJ				Yang, Yin; Wu, Songfang; Wang, Yu; Pan, Shuang; Lan, Bei; Liu, Yaohui; Zhang, Liming; Leng, Qianli; Chen, Da; Zhang, Cuizhu; He, Bin; Cao, Youjia			The Us3 Protein of Herpes Simplex Virus 1 Inhibits T Cell Signaling by Confining Linker for Activation of T Cells (LAT) Activation via TRAF6 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						HSV-1; TCR; LAT; signaling; Us3; TRAF6; ubiquitination; interleukin	GAMMA(1)34.5 PROTEIN; ANTIGEN RECEPTOR; RING FINGER; KINASE; TYPE-1; U(S)3; GENE; TRANSLATION; ICP0; HERPES-SIMPLEX-VIRUS-1	Background: HSV-1 inhibits T cell functions, but the underlying mechanism is unclear. Results: The HSV-1 Us3 protein disrupts T cell signal transduction by inhibiting the ubiquitination of LAT. Conclusion: The Us3 protein is a crucial factor to suppress T cell activation in HSV-1 infection. Significance: Inhibition of T cell immunity may promote HSV-1 replication or persistence. Herpes simplex virus 1 (HSV-1) is the most prevalent human virus and causes global morbidity because the virus is able to infect multiple cell types. Remarkably, HSV infection switches between lytic and latent cycles, where T cells play a critical role. However, the precise way of virus-host interactions is incompletely understood. Here we report that HSV-1 productively infected Jurkat T-cells and inhibited antigen-induced T cell receptor activation. We discovered that HSV-1-encoded Us3 protein interrupted TCR signaling and interleukin-2 production by inactivation of the linker for activation of T cells. This study unveils a mechanism by which HSV-1 intrudes into early events of TCR-mediated cell signaling and may provide novel insights into HSV infection, during which the virus escapes from host immune surveillance.	[Yang, Yin; Wu, Songfang; Wang, Yu; Pan, Shuang; Lan, Bei; Liu, Yaohui; Zhang, Liming; Leng, Qianli; Chen, Da; Zhang, Cuizhu; Cao, Youjia] Nankai Univ, Coll Life Sci, Minist Educ, Key Lab Microbial Funct Genom, Tianjin 300071, Peoples R China; [He, Bin] Univ Illinois, Dept Microbiol & Immunol, Coll Med, Chicago, IL 60612 USA	Nankai University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Zhang, CZ (corresponding author), Nankai Univ, Inst Mol Biol, Rm 224,94 Weijin Rd, Tianjin 300071, Peoples R China.	czz912@aliyun.com; tshuo@uic.edu; caoyj@nankai.edu.cn	Zhang, Li/GWM-7501-2022		National Natural Science Foundation of China [81171556, 31370862]; Ministry of Science and Technology of China [2012CB917204]; Program of Introducing Talents of Discipline to Universities [B08011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Program of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project)	This work was supported by National Natural Science Foundation of China Grants 81171556 and 31370862 (to Y. C.) and Ministry of Science and Technology of China Grant 2012CB917204 (to Y. C.). This work was also supported by Program of Introducing Talents of Discipline to Universities B08011.	Aubert M, 2009, J VIROL, V83, P6171, DOI 10.1128/JVI.02163-08; Barcy S, 2001, J IMMUNOL, V166, P6242, DOI 10.4049/jimmunol.166.10.6242; BRAUN RW, 1984, J IMMUNOL, V132, P914; CHAN AC, 1995, EMBO J, V14, P2499, DOI 10.1002/j.1460-2075.1995.tb07247.x; Chuluunbaatar U, 2010, GENE DEV, V24, P2627, DOI 10.1101/gad.1978310; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; HAMMER SM, 1982, INFECT IMMUN, V38, P795, DOI 10.1128/IAI.38.2.795-797.1982; Hata S, 1999, MICROBES INFECT, V1, P601, DOI 10.1016/S1286-4579(99)80059-8; He B, 1997, P NATL ACAD SCI USA, V94, P843, DOI 10.1073/pnas.94.3.843; He B, 1998, J BIOL CHEM, V273, P20737, DOI 10.1074/jbc.273.33.20737; HILL A, 1995, NATURE, V375, P411, DOI 10.1038/375411a0; Huang YP, 2004, J BIOL CHEM, V279, P28827, DOI 10.1074/jbc.R400012200; Imai T, 2011, J VIROL, V85, P5003, DOI 10.1128/JVI.02314-10; Jerome KR, 1999, J VIROL, V73, P8950, DOI 10.1128/JVI.73.11.8950-8957.1999; Jin HL, 2011, J VIROL, V85, P3397, DOI 10.1128/JVI.02373-10; Jin HL, 2009, J VIROL, V83, P4984, DOI 10.1128/JVI.02535-08; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Leopardi R, 1997, P NATL ACAD SCI USA, V94, P7891, DOI 10.1073/pnas.94.15.7891; Li YP, 2011, J BIOL CHEM, V286, P24785, DOI 10.1074/jbc.M111.232439; Lin RT, 2004, J VIROL, V78, P1675, DOI 10.1128/JVI.78.4.1675-1684.2004; Ma YJ, 2012, J VIROL, V86, P2188, DOI 10.1128/JVI.05376-11; Melroe GT, 2004, J VIROL, V78, P8411, DOI 10.1128/JVI.78.16.8411-8420.2004; Nel AE, 2002, J ALLERGY CLIN IMMUN, V109, P758, DOI 10.1067/mai.2002.124259; Neumann J, 2003, J IMMUNOL, V171, P3075, DOI 10.4049/jimmunol.171.6.3075; Ogg PD, 2004, VIROLOGY, V319, P212, DOI 10.1016/j.virol.2003.10.019; Piroozmand A, 2004, INT J MOL MED, V14, P641; Poon APW, 2006, P NATL ACAD SCI USA, V103, P9993, DOI 10.1073/pnas.0604142103; Poppers J, 2000, J VIROL, V74, P11215, DOI 10.1128/JVI.74.23.11215-11221.2000; POSAVAD CM, 1994, J VIROL, V68, P4072, DOI 10.1128/JVI.68.6.4072-4074.1994; POSAVAD CM, 1992, J VIROL, V66, P6264, DOI 10.1128/JVI.66.11.6264-6272.1992; POSAVAD CM, 1993, J IMMUNOL, V151, P4865; Reynolds AE, 2002, J VIROL, V76, P8939, DOI 10.1128/JVI.76.17.8939-8952.2002; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Sen J, 2013, VIROLOGY, V439, P65, DOI 10.1016/j.virol.2013.01.026; Sloan DD, 2006, J IMMUNOL, V176, P1825, DOI 10.4049/jimmunol.176.3.1825; Sloan DD, 2003, J IMMUNOL, V171, P6733, DOI 10.4049/jimmunol.171.12.6733; Taylor KE, 2014, J VIROL, V88, P8091, DOI 10.1128/JVI.00944-14; Verpooten D, 2009, J BIOL CHEM, V284, P1097, DOI 10.1074/jbc.M805905200; Walters MS, 2010, J VIROL, V84, P9666, DOI 10.1128/JVI.00981-10; Wang KZ, 2014, J VIROL, V88, P7941, DOI 10.1128/JVI.03394-13; Wang SM, 2013, J SPECTROSC, V2013, P1, DOI 10.1155/2013/646050; Wang Y, 2014, J BIOL CHEM, V289, P35795, DOI 10.1074/jbc.M114.603845; Whitley RJ, 2001, LANCET, V357, P1513, DOI 10.1016/S0140-6736(00)04638-9; Xie JJ, 2013, J IMMUNOL, V190, P4027, DOI 10.4049/jimmunol.1202742; YORK IA, 1994, CELL, V77, P525, DOI 10.1016/0092-8674(94)90215-1; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	47	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15670	15678		10.1074/jbc.M115.646422	http://dx.doi.org/10.1074/jbc.M115.646422			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25907557	Green Published, hybrid			2022-12-28	WOS:000356527400029
J	Lai, KO; Liang, ZY; Fei, EK; Huang, HQ; Ip, NY				Lai, Kwok-On; Liang, Zhuoyi; Fei, Erkang; Huang, Huiqian; Ip, Nancy Y.			Cyclin-dependent Kinase 5 (Cdk5)-dependent Phosphorylation of p70 Ribosomal S6 Kinase 1 (S6K) Is Required for Dendritic Spine Morphogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIPPOCAMPAL-NEURONS; SYNAPTIC PLASTICITY; TRKB PHOSPHORYLATION; PROTEIN-SYNTHESIS; MAMMALIAN TARGET; RAPAMYCIN; ACTIVATION; CDK5; MORPHOLOGY; MEMORY	The maturation and maintenance of dendritic spines depends on neuronal activity and protein synthesis. One potential mechanism involves mammalian target of rapamycin, which promotes protein synthesis through phosphorylation of eIF4E-binding protein and p70 ribosomal S6 kinase 1 (S6K). Upon extracellular stimulation, mammalian target of rapamycin phosphorylates S6K at Thr-389. S6K also undergoes phosphorylation at other sites, including four serine residues in the autoinhibitory domain. Despite extensive biochemical studies, the importance of phosphorylation in the autoinhibitory domain in S6K function remains unresolved, and its role has not been explored in the cellular context. Here we demonstrated that S6K in neuron was phosphorylated at Ser-411 within the autoinhibitory domain by cyclin-dependent kinase 5. Ser-411 phosphorylation was regulated by neuronal activity and brain-derived neurotrophic factor (BDNF). Knockdown of S6K in hippocampal neurons by RNAi led to loss of dendritic spines, an effect that mimics neuronal activity blockade by tetrodotoxin. Notably, coexpression of wild type S6K, but not the phospho-deficient S411A mutant, could rescue the spine defects. These findings reveal the importance of cyclin-dependent kinase 5-mediated phosphorylation of S6K at Ser-411 in spine morphogenesis driven by BDNF and neuronal activity.	Hong Kong Univ Sci & Technol, Mol Neurosci Ctr, Div Life Sci, Hong Kong, Hong Kong, Peoples R China; Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Hong Kong, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Lai, KO (corresponding author), Univ Hong Kong, Dept Physiol, State Key Lab Brain & Cognit Sci, 21 Sassoon Rd, Hong Kong, Hong Kong, Peoples R China.	laiko@hku.hk; boip@ust.hk	FEI, Erkang/AAI-9825-2021; Lai, Kwok-On/L-7468-2019; Lai, Kwok On/ABC-8046-2021	Lai, Kwok-On/0000-0002-4069-054X; Ip, Nancy Yuk-Yu/0000-0002-2763-8907; Liang, Zhuoyi/0000-0003-1622-524X; FEI, Erkang/0000-0002-3581-9521	Research Grants Council of Hong Kong (Hong Kong University of Science and Technology) [660810, 660110, 661010, 661111]; National Key Basic Research Program of China [2013CB530900]; Theme-based Research Scheme [T13-607/12R]; S. H. Ho Foundation	Research Grants Council of Hong Kong (Hong Kong University of Science and Technology); National Key Basic Research Program of China(National Basic Research Program of China); Theme-based Research Scheme; S. H. Ho Foundation	This study was supported in part by the Research Grants Council of Hong Kong (Hong Kong University of Science and Technology Grants 660810, 660110, 661010, and 661111), the National Key Basic Research Program of China (Grant 2013CB530900), Theme-based Research Scheme (Grant T13-607/12R), and the S. H. Ho Foundation.	Antion MD, 2008, LEARN MEMORY, V15, P29, DOI 10.1101/lm.661908; Antion MD, 2008, MOL CELL BIOL, V28, P2996, DOI 10.1128/MCB.00201-08; Bhattacharya A, 2012, NEURON, V76, P325, DOI 10.1016/j.neuron.2012.07.022; Bramham CR, 2008, CURR OPIN NEUROBIOL, V18, P524, DOI 10.1016/j.conb.2008.09.013; Buchsbaum RJ, 2003, J BIOL CHEM, V278, P18833, DOI 10.1074/jbc.M207876200; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P8351, DOI 10.1073/pnas.95.14.8351; Chen YL, 2014, NEURON, V83, P431, DOI 10.1016/j.neuron.2014.05.027; Cheung ZH, 2007, PLOS BIOL, V5, P865, DOI 10.1371/journal.pbio.0050063; Dennis PB, 1998, J BIOL CHEM, V273, P14845, DOI 10.1074/jbc.273.24.14845; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; HAN JW, 1995, J BIOL CHEM, V270, P21396, DOI 10.1074/jbc.270.36.21396; Hou ZB, 2007, J BIOL CHEM, V282, P6922, DOI 10.1074/jbc.M607836200; Isotani S, 1999, J BIOL CHEM, V274, P34493, DOI 10.1074/jbc.274.48.34493; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Ji YY, 2005, NAT NEUROSCI, V8, P164, DOI 10.1038/nn1381; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; Kim Y, 2006, NATURE, V442, P814, DOI 10.1038/nature04976; Lai KO, 2012, NAT NEUROSCI, V15, P1506, DOI 10.1038/nn.3237; Lai KO, 2009, BBA-MOL BASIS DIS, V1792, P741, DOI 10.1016/j.bbadis.2009.05.001; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Mahalingam M, 1996, MOL CELL BIOL, V16, P405; Papa M, 1996, NEUROSCIENCE, V71, P1005, DOI 10.1016/0306-4522(95)00490-4; Richter JD, 2009, GENE DEV, V23, P1, DOI 10.1101/gad.1735809; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Shah OJ, 2003, J BIOL CHEM, V278, P16433, DOI 10.1074/jbc.M300435200; Takei N, 2004, J NEUROSCI, V24, P9760, DOI 10.1523/JNEUROSCI.1427-04.2004; Tavazoie SF, 2005, NAT NEUROSCI, V8, P1727, DOI 10.1038/nn1566; Verpelli C, 2010, J NEUROSCI, V30, P5830, DOI 10.1523/JNEUROSCI.0119-10.2010; Weng QP, 1998, J BIOL CHEM, V273, P16621, DOI 10.1074/jbc.273.26.16621; Yamashita N, 2007, J NEUROSCI, V27, P12546, DOI 10.1523/JNEUROSCI.3463-07.2007; Yuste R, 2011, NEURON, V71, P772, DOI 10.1016/j.neuron.2011.07.024	31	14	15	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14637	14646		10.1074/jbc.M114.627117	http://dx.doi.org/10.1074/jbc.M114.627117			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25903132	Green Published, hybrid			2022-12-28	WOS:000355754600034
J	Hosokawa, H; Kato, M; Tohyama, H; Tamaki, Y; Endo, Y; Kimura, MY; Tumes, DJ; Motohashi, S; Matsumoto, M; Nakayama, KI; Tanaka, T; Nakayama, T				Hosokawa, Hiroyuki; Kato, Miki; Tohyama, Hiroyuki; Tamaki, Yuuki; Endo, Yusuke; Kimura, Motoko Y.; Tumes, Damon John; Motohashi, Shinichiro; Matsumoto, Masaki; Nakayama, Keiichi I.; Tanaka, Tomoaki; Nakayama, Toshinori			Methylation of Gata3 Protein at Arg-261 Regulates Transactivation of the Il5 Gene in T Helper 2 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-3; ARGININE METHYLATION; INTERLEUKIN-5 GENE; TH2 CELLS; HISTONE HYPERACETYLATION; RNA-POLYMERASE; T-CELLS; DIFFERENTIATION; EXPRESSION; LOCUS	Gata3 acts as a master regulator for T helper 2 (Th2) cell differentiation by inducing chromatin remodeling of the Th2 cytokine loci, accelerating Th2 cell proliferation, and repressing Th1 cell differentiation. Gata3 also directly transactivates the interleukin-5 (Il5) gene via additional mechanisms that have not been fully elucidated. We herein identified a mechanism whereby the methylation of Gata3 at Arg-261 regulates the transcriptional activation of the Il5 gene in Th2 cells. Although the methylation-mimicking Gata3 mutant retained the ability to induce IL-4 and repress IFN gamma production, the IL-5 production was selectively impaired. We also demonstrated that heat shock protein (Hsp) 60 strongly associates with the methylation- mimicking Gata3 mutant and negatively regulates elongation of the Il5 transcript by RNA polymerase II. Thus, arginine methylation appears to play a pivotal role in the organization of Gata3 complexes and the target gene specificity of Gata3.	[Hosokawa, Hiroyuki; Kato, Miki; Tohyama, Hiroyuki; Tamaki, Yuuki; Endo, Yusuke; Kimura, Motoko Y.; Tumes, Damon John; Nakayama, Toshinori] Chiba Univ, Grad Sch Med, Dept Immunol, Chuo Ku, Chiba 2608670, Japan; [Motohashi, Shinichiro] Chiba Univ, Grad Sch Med, Dept Med Immunol, Chuo Ku, Chiba 2608670, Japan; [Tanaka, Tomoaki] Chiba Univ, Grad Sch Med, Dept Clin Cell Biol, Chuo Ku, Chiba 2608670, Japan; [Nakayama, Toshinori] Chiba Univ, Grad Sch Med, Div Endocrinol & Metab, Chuo Ku, Chiba 2608670, Japan; [Matsumoto, Masaki; Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, Fukuoka 8128582, Japan; [Tanaka, Tomoaki; Nakayama, Toshinori] Japan Sci & Technol Agcy, CREST, Chuo Ku, Chiba 2608670, Japan	Chiba University; Chiba University; Chiba University; Chiba University; Kyushu University; Japan Science & Technology Agency (JST)	Nakayama, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Immunol, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	tnakayama@faculty.chiba-u.jp	Nakayama, Toshinori/E-1067-2017; Tumes, Damon J/B-9917-2009	Nakayama, Toshinori/0000-0002-1434-2007; Tumes, Damon J/0000-0001-5709-857X; Hosokawa, Hiroyuki/0000-0002-9592-2889	Takeda Science Foundation; Astellas Foundation for Research on Metabolic Disorders; Uehara Memorial Foundation; Manpei Suzuki Diabetes Foundation; Kanae Foundation for the Promotion of Medical Science;  [26221305];  [24592083];  [26460569];  [24790461];  [23790522]; Grants-in-Aid for Scientific Research [24390239, 15K08524] Funding Source: KAKEN	Takeda Science Foundation(Takeda Science Foundation (TSF)); Astellas Foundation for Research on Metabolic Disorders; Uehara Memorial Foundation(Uehara Memorial Foundation); Manpei Suzuki Diabetes Foundation; Kanae Foundation for the Promotion of Medical Science; ; ; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research S 26221305, C 24592083, and 26460569 and Exploratory Research and Young Scientists B Grants 24790461 and 23790522; the Takeda Science Foundation; the Astellas Foundation for Research on Metabolic Disorders; the Uehara Memorial Foundation; the Manpei Suzuki Diabetes Foundation; and the Kanae Foundation for the Promotion of Medical Science.	Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bresnick EH, 2005, J CELL PHYSIOL, V205, P1, DOI 10.1002/jcp.20393; Campbell M, 2012, J BIOL CHEM, V287, P5806, DOI 10.1074/jbc.M111.289496; Chen YH, 2012, CELL REP, V2, P1197, DOI 10.1016/j.celrep.2012.10.012; Endo Y, 2014, TRENDS IMMUNOL, V35, P69, DOI 10.1016/j.it.2013.11.003; Endo Y, 2011, IMMUNITY, V35, P733, DOI 10.1016/j.immuni.2011.08.017; Filtz TM, 2014, TRENDS PHARMACOL SCI, V35, P76, DOI 10.1016/j.tips.2013.11.005; Heidemann M, 2013, BBA-GENE REGUL MECH, V1829, P55, DOI 10.1016/j.bbagrm.2012.08.013; Ho IC, 2009, NAT REV IMMUNOL, V9, P125, DOI 10.1038/nri2476; Hosokawa H, 2006, J IMMUNOL, V177, P7656, DOI 10.4049/jimmunol.177.11.7656; Hosokawa H, 2013, P NATL ACAD SCI USA, V110, P18626, DOI 10.1073/pnas.1311100110; Hosokawa H, 2013, P NATL ACAD SCI USA, V110, P4691, DOI 10.1073/pnas.1220865110; Hosoya T, 2010, IMMUNOL REV, V238, P110, DOI 10.1111/j.1600-065X.2010.00954.x; Inami M, 2004, J BIOL CHEM, V279, P23123, DOI 10.1074/jbc.M401248200; Jansson M, 2008, NAT CELL BIOL, V10, P1431, DOI 10.1038/ncb1802; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; Karlen S, 1996, BLOOD, V88, P211; Kimura M, 2001, IMMUNITY, V15, P275, DOI 10.1016/S1074-7613(01)00182-0; Kurata H, 1999, IMMUNITY, V11, P677, DOI 10.1016/S1074-7613(00)80142-9; Maneechotesuwan K, 2007, J IMMUNOL, V178, P2491, DOI 10.4049/jimmunol.178.4.2491; Mowen KA, 2004, MOL CELL, V15, P559, DOI 10.1016/j.molcel.2004.06.042; Mowen KA, 2001, CELL, V104, P731, DOI 10.1016/S0092-8674(02)08085-6; Nakamura A, 2011, ENDOCR J, V58, P123, DOI 10.1507/endocrj.K10E-246; Nakayama T, 2008, CURR OPIN IMMUNOL, V20, P265, DOI 10.1016/j.coi.2008.03.011; Omori M, 2003, IMMUNITY, V19, P281, DOI 10.1016/S1074-7613(03)00210-3; Onodera A, 2010, J EXP MED, V207, P2493, DOI 10.1084/jem.20100760; Ortega HG, 2014, NEW ENGL J MED, V371, P1198, DOI 10.1056/NEJMoa1403290; Reiner SL, 2007, CELL, V129, P33, DOI 10.1016/j.cell.2007.03.019; Rosenberg HF, 2013, NAT REV IMMUNOL, V13, P9, DOI 10.1038/nri3341; Rothenberg EV, 2008, SEMIN IMMUNOL, V20, P236, DOI 10.1016/j.smim.2008.07.006; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Sawarkar R, 2012, CELL, V149, P807, DOI 10.1016/j.cell.2012.02.061; Shinnakasu R, 2008, J BIOL CHEM, V283, P28216, DOI 10.1074/jbc.M804174200; SIEGEL MD, 1995, J BIOL CHEM, V270, P24548, DOI 10.1074/jbc.270.41.24548; Takatsu K, 2008, CURR OPIN IMMUNOL, V20, P288, DOI 10.1016/j.coi.2008.04.001; Van Esch H, 2000, NATURE, V406, P419, DOI 10.1038/35019088; Wang J, 2006, INT IMMUNOL, V18, P313, DOI 10.1093/intimm/dxh370; Yamashita M, 2005, J BIOL CHEM, V280, P29409, DOI 10.1074/jbc.M502333200; Yamashita M, 2002, J BIOL CHEM, V277, P42399, DOI 10.1074/jbc.M205876200; Yamashita M, 2006, IMMUNITY, V24, P611, DOI 10.1016/j.immuni.2006.03.017; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	45	23	23	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13095	13103		10.1074/jbc.M114.621524	http://dx.doi.org/10.1074/jbc.M114.621524			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25861992	Green Published, hybrid			2022-12-28	WOS:000354975700013
J	Trubitsyna, M; Grey, H; Houston, DR; Finnegan, DJ; Richardson, JM				Trubitsyna, Maryia; Grey, Heather; Houston, Douglas R.; Finnegan, David J.; Richardson, Julia M.			Structural Basis for the Inverted Repeat Preferences of mariner Transposases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SLEEPING-BEAUTY; TERMINAL REPEATS; DNA TRANSPOSONS; BINDING DOMAIN; GENE-TRANSFER; COMPLEX; CELLS; CONSERVATION; INVOLVEMENT; EVOLUTION	The inverted repeat (IR) sequences delimiting the left and right ends of many naturally active mariner DNA transposons are non-identical and have different affinities for their transposase. We have compared the preferences of two active mariner transposases, Mos1 and Mboumar-9, for their imperfect transposon IRs in each step of transposition: DNA binding, DNA cleavage, and DNA strand transfer. A 3.1 angstrom resolution crystal structure of the Mos1 paired-end complex containing the pre-cleaved left IR sequences reveals the molecular basis for the reduced affinity of the Mos1 transposase DNA-binding domain for the left IR as compared with the right IR. For both Mos1 and Mboumar-9, in vitro DNA transposition is most efficient when the preferred IR sequence is present at both transposon ends. We find that this is due to the higher efficiency of cleavage and strand transfer of the preferred transposon end. We show that the efficiency of Mboumar-9 transposition is improved almost 4-fold by changing the 3' base of the preferred Mboumar-9 IR from guanine to adenine. This preference for adenine at the reactive 3' end for both Mos1 and Mboumar-9 may be a general feature of mariner transposition.	[Trubitsyna, Maryia; Finnegan, David J.] Univ Edinburgh, Sch Biol Sci, Inst Cell Biol, Edinburgh EH9 3BF, Midlothian, Scotland; [Grey, Heather; Houston, Douglas R.; Richardson, Julia M.] Univ Edinburgh, Sch Biol Sci, Inst Struct & Mol Biol, Edinburgh EH9 3BF, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Richardson, JM (corresponding author), Univ Edinburgh, Sch Biol Sci, Inst Cell Biol, Kings Bldg, Edinburgh EH9 3BF, Midlothian, Scotland.	Julia.Richardson@ed.ac.uk	Richardson, Julia/D-1808-2013	Richardson, Julia/0000-0002-1547-3009; Trubitsyna, Maryia/0000-0002-1347-6134; Houston, Douglas/0000-0002-3469-1546	Wellcome Trust [085176/Z/08/Z]; Darwin Trust of Edinburgh Ph.D. Scholarship	Wellcome Trust(Wellcome TrustEuropean Commission); Darwin Trust of Edinburgh Ph.D. Scholarship	This work was supported by Wellcome Trust Grant 085176/Z/08/Z (to J. M. R.) and a Darwin Trust of Edinburgh Ph.D. Scholarship (to M. T.).	Ammar Ismahen, 2012, Methods Mol Biol, V859, P229, DOI 10.1007/978-1-61779-603-6_13; Auge-Gouillou C, 2001, MOL GENET GENOMICS, V265, P58, DOI 10.1007/s004380000386; Auge-Gouillou C, 2001, MOL GENET GENOMICS, V265, P51, DOI 10.1007/s004380000385; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bigot Y, 2005, J MOL BIOL, V351, P108, DOI 10.1016/j.jmb.2005.05.006; Bouuaert CC, 2014, NUCLEIC ACIDS RES, V42, P5799, DOI 10.1093/nar/gku172; Bouuaert CC, 2013, ELIFE, V2, DOI 10.7554/eLife.00668; Bouuaert CC, 2011, MOL CELL BIOL, V31, P317, DOI 10.1128/MCB.01066-10; Clark KJ, 2009, NUCLEIC ACIDS RES, V37, P1239, DOI 10.1093/nar/gkn1025; Cuypers MG, 2013, NUCLEIC ACIDS RES, V41, P2020, DOI 10.1093/nar/gks1295; Damasceno JD, 2010, GENETICA, V138, P301, DOI 10.1007/s10709-009-9406-7; Delauriere L, 2009, GENETICA, V137, P9, DOI 10.1007/s10709-009-9370-2; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Dornan J, 2015, NUCLEIC ACIDS RES, V43, P2424, DOI 10.1093/nar/gkv096; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Hancock SP, 2013, NUCLEIC ACIDS RES, V41, P6750, DOI 10.1093/nar/gkt357; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Huth JR, 1997, NAT STRUCT BIOL, V4, P657, DOI 10.1038/nsb0897-657; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Izsvak Z, 2002, J BIOL CHEM, V277, P34581, DOI 10.1074/jbc.M204001200; Jaillet J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043365; Lampe DJ, 2010, GENETICA, V138, P499, DOI 10.1007/s10709-009-9401-z; Lampe DJ, 1999, P NATL ACAD SCI USA, V96, P11428, DOI 10.1073/pnas.96.20.11428; Lee I, 2003, NUCLEIC ACIDS RES, V31, P4531, DOI 10.1093/nar/gkg499; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Liu DX, 2014, NUCLEIC ACIDS RES, V42, P2637, DOI 10.1093/nar/gkt1218; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; Munoz-Lopez M, 2010, CURR GENOMICS, V11, P115, DOI 10.2174/138920210790886871; Palomeque T, 2006, GENE, V371, P194, DOI 10.1016/j.gene.2005.11.032; Richardson JM, 2004, ACTA CRYSTALLOGR D, V60, P962, DOI 10.1107/S0907444904003798; Richardson JM, 2007, ACTA CRYSTALLOGR F, V63, P434, DOI 10.1107/S1744309107019045; Richardson JM, 2009, CELL, V138, P1096, DOI 10.1016/j.cell.2009.07.012; Rostovskaya M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks643; Sherman A, 1998, NAT BIOTECHNOL, V16, P1050, DOI 10.1038/3497; Sheu SY, 2003, P NATL ACAD SCI USA, V100, P12683, DOI 10.1073/pnas.2133366100; Trubitsyna M, 2014, BIOCHEMISTRY-US, V53, P682, DOI 10.1021/bi401193w; Wolkowicz UM, 2014, ACS CHEM BIOL, V9, P743, DOI 10.1021/cb400791u; Zhang L, 2001, NUCLEIC ACIDS RES, V29, P3566, DOI 10.1093/nar/29.17.3566	38	4	5	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13531	13540		10.1074/jbc.M115.636704	http://dx.doi.org/10.1074/jbc.M115.636704			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25869132	Green Published, hybrid			2022-12-28	WOS:000354975700047
J	Madry, C; Attwell, D				Madry, Christian; Attwell, David			Receptors, Ion Channels, and Signaling Mechanisms Underlying Microglial Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							NEURONAL NMDA RECEPTORS; ATP RELEASE; HIPPOCAMPAL NEUROGENESIS; RETINAL MICROGLIA; PROCESS EXTENSION; BRAIN-SLICES; TNF-ALPHA; IN-VIVO; ACTIVATION; CHEMOTAXIS	Microglia, the innate immune cells of the CNS, play a pivotal role in brain injury and disease. Microglia are extremely motile; their highly ramified processes constantly survey the brain parenchyma, and they respond promptly to brain damage with targeted process movement toward the injury site. Microglia play a key role in brain development and function by pruning synapses during development, phagocytosing apoptotic newborn neurons, and regulating neuronal activity by direct microglia-neuron or indirect microglia-astrocyte-neuron interactions, which all depend on their process motility. This review highlights recent discoveries about microglial dynamics, focusing on the receptors, ion channels, and signaling pathways involved.	[Madry, Christian; Attwell, David] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England	University of London; University College London	Madry, C (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, Gower St, London WC1E 6BT, England.	c.madry@ucl.ac.uk	Attwell, David/ABE-6750-2020; Madry, Christian/ABA-8050-2021	Madry, Christian/0000-0002-0522-7197	Wellcome Trust; European Research Council	Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission)	This work was supported by the Wellcome Trust and the European Research Council.	Anderson CM, 2004, J NEUROCHEM, V88, P246, DOI 10.1046/j.1471-4159.2003.02204.x; Arnoux I, 2013, GLIA, V61, P1582, DOI 10.1002/glia.22503; Avignone E, 2008, J NEUROSCI, V28, P9133, DOI 10.1523/JNEUROSCI.1820-08.2008; Bachstetter AD, 2011, NEUROBIOL AGING, V32, P2030, DOI 10.1016/j.neurobiolaging.2009.11.022; Boucsein C, 2003, EUR J NEUROSCI, V17, P2267, DOI 10.1046/j.1460-9568.2003.02663.x; Braun N, 2000, EUR J NEUROSCI, V12, P4357, DOI 10.1046/j.1460-9568.2000.01342.x; Capani F, 2001, BRAIN RES, V923, P1, DOI 10.1016/S0006-8993(01)03189-4; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Coco S, 2003, J BIOL CHEM, V278, P1354, DOI 10.1074/jbc.M209454200; Corriden R, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3104re1; Cotrina ML, 2000, J NEUROSCI, V20, P2835; Cross AK, 1999, J NEUROSCI RES, V55, P17, DOI 10.1002/(SICI)1097-4547(19990101)55:1<17::AID-JNR3>3.0.CO;2-J; Dahl G, 2013, NEUROPHARMACOLOGY, V75, P583, DOI 10.1016/j.neuropharm.2013.02.019; Damani MR, 2011, AGING CELL, V10, P263, DOI 10.1111/j.1474-9726.2010.00660.x; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Davalos D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2230; De Simoni A, 2008, EUR J NEUROSCI, V28, P1146, DOI 10.1111/j.1460-9568.2008.06417.x; Dibaj P, 2010, GLIA, V58, P1133, DOI 10.1002/glia.20993; Dissing-Olesen L, 2014, J NEUROSCI, V34, P10511, DOI 10.1523/JNEUROSCI.0405-14.2014; Dunwiddie TV, 1997, J NEUROSCI, V17, P7673; Eyo UB, 2014, J NEUROSCI, V34, P10528, DOI 10.1523/JNEUROSCI.0416-14.2014; Farber K, 2008, GLIA, V56, P331, DOI 10.1002/glia.20606; Fontainhas AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015973; Forstreuter F, 2002, J NEUROIMMUNOL, V132, P93, DOI 10.1016/S0165-5728(02)00315-6; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gyoneva S, 2014, GLIA, V62, P1345, DOI 10.1002/glia.22686; Gyoneva S, 2013, J BIOL CHEM, V288, P15291, DOI 10.1074/jbc.M113.458901; Hamilton NB, 2010, NAT REV NEUROSCI, V11, P227, DOI 10.1038/nrn2803; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Hellwig S, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00071; Hines DJ, 2009, GLIA, V57, P1610, DOI 10.1002/glia.20874; Honda S, 2001, J NEUROSCI, V21, P1975, DOI 10.1523/JNEUROSCI.21-06-01975.2001; Hoshiko M, 2012, J NEUROSCI, V32, P15106, DOI 10.1523/JNEUROSCI.1167-12.2012; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Irino Y, 2008, J NEUROSCI RES, V86, P1511, DOI 10.1002/jnr.21610; Isfort K, 2011, J BIOL CHEM, V286, P44776, DOI 10.1074/jbc.M111.289793; Koizumi S, 2007, NATURE, V446, P1091, DOI 10.1038/nature05704; Kolsch V, 2008, J CELL SCI, V121, P551, DOI 10.1242/jcs.023333; Kurpius D, 2007, GLIA, V55, P873, DOI 10.1002/glia.20509; Lambrechts A, 2004, INT J BIOCHEM CELL B, V36, P1890, DOI 10.1016/j.biocel.2004.01.024; Lauro C, 2008, J IMMUNOL, V180, P7590, DOI 10.4049/jimmunol.180.11.7590; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; Lee JE, 2008, INVEST OPHTH VIS SCI, V49, P4169, DOI 10.1167/iovs.08-2076; Li Y, 2012, DEV CELL, V23, P1189, DOI 10.1016/j.devcel.2012.10.027; Liang KJ, 2009, INVEST OPHTH VIS SCI, V50, P4444, DOI 10.1167/iovs.08-3357; Marin-Teva JL, 2004, NEURON, V41, P535, DOI 10.1016/S0896-6273(04)00069-8; McIlvain HB, 2010, EUR J PHARMACOL, V643, P202, DOI 10.1016/j.ejphar.2010.06.046; Mitchell CH, 1998, P NATL ACAD SCI USA, V95, P7174, DOI 10.1073/pnas.95.12.7174; Murali A, 2014, CELL MOL LIFE SCI, V71, P1703, DOI 10.1007/s00018-013-1519-6; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Noda M, 2000, J NEUROSCI, V20, P251, DOI 10.1523/JNEUROSCI.20-01-00251.2000; Noda M, 1999, NEUROSCIENCE, V92, P1465, DOI 10.1016/S0306-4522(99)00036-6; Nolte C, 1996, NEUROSCIENCE, V73, P1091, DOI 10.1016/0306-4522(96)00106-6; Ohsawa K, 2007, GLIA, V55, P604, DOI 10.1002/glia.20489; Ohsawa K, 2012, J NEUROCHEM, V121, P217, DOI 10.1111/j.1471-4159.2012.07693.x; Ohsawa K, 2010, GLIA, V58, P790, DOI 10.1002/glia.20963; Orr AG, 2009, NAT NEUROSCI, V12, P872, DOI 10.1038/nn.2341; Pankratov Y, 2006, PFLUG ARCH EUR J PHY, V452, P589, DOI 10.1007/s00424-006-0061-x; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Pascual O, 2012, P NATL ACAD SCI USA, V109, pE197, DOI 10.1073/pnas.1111098109; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Rogers JT, 2011, J NEUROSCI, V31, P16241, DOI 10.1523/JNEUROSCI.3667-11.2011; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Schipke CG, 2001, FASEB J, V15, P255, DOI 10.1096/fj.01-0514fje; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; Tremblay ME, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000527; Ulmann L, 2013, GLIA, V61, P1306, DOI 10.1002/glia.22516; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Wu LJ, 2008, J NEUROPHYSIOL, V99, P2026, DOI 10.1152/jn.01210.2007; Wu LJ, 2007, GLIA, V55, P810, DOI 10.1002/glia.20500; Zhan Y, 2014, NAT NEUROSCI, V17, P400, DOI 10.1038/nn.3641; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zujovic V, 2000, GLIA, V29, P305, DOI 10.1002/(SICI)1098-1136(20000215)29:4<305::AID-GLIA2>3.0.CO;2-V; Zujovic V, 2001, J NEUROIMMUNOL, V115, P135, DOI 10.1016/S0165-5728(01)00259-4	75	52	54	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12443	12450		10.1074/jbc.R115.637157	http://dx.doi.org/10.1074/jbc.R115.637157			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25855789	Green Published, hybrid			2022-12-28	WOS:000354569000001
J	Lall, P; Lindsay, AJ; Hanscom, S; Kecman, T; Taglauer, ES; McVeigh, UM; Franklin, E; McCaffrey, MW; Khan, AR				Lall, Patrick; Lindsay, Andrew J.; Hanscom, Sara; Kecman, Tea; Taglauer, Elizabeth S.; McVeigh, Una M.; Franklin, Edward; McCaffrey, Mary W.; Khan, Amir R.			Structure-Function Analyses of the Interactions between Rab11 and Rab14 Small GTPases with Their Shared Effector Rab Coupling Protein (RCP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECYCLING ENDOSOMES; BINDING; FAMILY; COMPLEX; TRAFFICKING; MYOSIN; IDENTIFICATION; SUPERFAMILY; RECRUITMENT; SPECIFICITY	Rab GTPases recruit effector proteins, via their GTP-dependent switch regions, to distinct subcellular compartments. Rab11 and Rab25 are closely related small GTPases that bind to common effectors termed the Rab11 family of interacting proteins (FIPs). The FIPs are organized into two subclasses (class I and class II) based on sequence and domain organization, and both subclasses contain a highly conserved Rab-binding domain at their C termini. Yeast two-hybrid and biochemical studies have revealed that the more distantly related Rab14 also interacts with class I FIPs. Here, we perform detailed structural, thermodynamic, and cellular analyses of the interactions between Rab14 and one of the class I FIPs, the Rab-coupling protein (RCP), to clarify the molecular aspects of the interaction. We find that Rab14 indeed binds to RCP, albeit with reduced affinity relative to conventional Rab11-FIP and Rab25-FIP complexes. However, in vivo, Rab11 recruits RCP onto biological membranes. Furthermore, biophysical analyses reveal a noncanonical 1: 2 stoichiometry between Rab14-RCP in dilute solutions, in contrast to Rab11/25 complexes. The structure of Rab14-RCP reveals that Rab14 interacts with the canonical Rab-binding domain and also provides insight into the unusual properties of the complex. Finally, we show that both the Rab coupling protein and Rab14 function in neuritogenesis.	[Lall, Patrick; Kecman, Tea; Taglauer, Elizabeth S.; McVeigh, Una M.; Franklin, Edward; Khan, Amir R.] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland; [Lindsay, Andrew J.; Hanscom, Sara; McCaffrey, Mary W.] Univ Coll Cork, Biosci Inst, Sch Biochem & Cell Biol, Mol Cell Biol Lab, Cork, Ireland	Trinity College Dublin; University College Cork	McCaffrey, MW (corresponding author), Univ Coll Cork, Biosci Inst, Sch Biochem & Cell Biol, Mol Cell Biol Lab, Cork, Ireland.	m.mccaffrey@ucc.ie; amirrafk@tcd.ie	Lindsay, Andrew J/P-9778-2017	Lindsay, Andrew J/0000-0001-9693-7022; Khan, Amir/0000-0003-1176-6952	DOE Office of Science [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER	DOE Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research used resources of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract Number DE-AC02-06CH11357.	ANDRES DA, 1993, CELL, V73, P1091, DOI 10.1016/0092-8674(93)90639-8; Bergbrede T, 2009, J BIOL CHEM, V284, P2628, DOI 10.1074/jbc.M806003200; Bernards A, 2003, BBA-REV CANCER, V1603, P47, DOI 10.1016/S0304-419X(02)00082-3; Burguete AS, 2008, CELL, V132, P286, DOI 10.1016/j.cell.2007.11.048; Cheng JM, 2006, INT J CANCER, V118, P2957, DOI 10.1002/ijc.21739; Chia WJ, 2009, BBA-REV CANCER, V1795, P110, DOI 10.1016/j.bbcan.2008.10.001; Chiang MC, 2014, MITOCHONDRION, V14, P7, DOI 10.1016/j.mito.2013.12.003; Eathiraj S, 2005, NATURE, V436, P415, DOI 10.1038/nature03798; Eathiraj S, 2006, J MOL BIOL, V364, P121, DOI 10.1016/j.jmb.2006.08.064; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eva R, 2010, J NEUROSCI, V30, P11654, DOI 10.1523/JNEUROSCI.2425-10.2010; Fukuda M, 2006, BIOCHEM BIOPH RES CO, V343, P666, DOI 10.1016/j.bbrc.2006.03.001; Fukuda M, 2008, MOL CELL PROTEOMICS, V7, P1031, DOI 10.1074/mcp.M700569-MCP200; GOLDENRING JR, 1993, J BIOL CHEM, V268, P18419; Goody RS, 2005, CELL MOL LIFE SCI, V62, P1657, DOI 10.1007/s00018-005-4486-8; Hagemann Nina, 2012, Small GTPases, V3, P107, DOI 10.4161/sgtp.19380; Hou XM, 2011, EMBO J, V30, P1659, DOI 10.1038/emboj.2011.60; Jagoe WN, 2006, STRUCTURE, V14, P1273, DOI 10.1016/j.str.2006.06.010; Jagoe WN, 2006, ACTA CRYSTALLOGR F, V62, P692, DOI 10.1107/S1744309106023074; Jin Y, 2011, DEV CELL, V21, P1156, DOI 10.1016/j.devcel.2011.10.009; Jing JA, 2010, MOL BIOL CELL, V21, P3041, DOI 10.1091/mbc.E10-04-0313; Junutula JR, 2004, MOL BIOL CELL, V15, P2218, DOI 10.1091/mbc.E03-10-0777; Junutula JR, 2004, J BIOL CHEM, V279, P33430, DOI 10.1074/jbc.M404633200; Kelly EE, 2010, BIOL CELL, V102, P51, DOI 10.1042/BC20090068; Lall P, 2013, BBA-PROTEINS PROTEOM, V1834, P2679, DOI 10.1016/j.bbapap.2013.09.005; Lindsay Andrew J, 2015, Methods Mol Biol, V1298, P161, DOI 10.1007/978-1-4939-2569-8_13; Lindsay AJ, 2013, MOL BIOL CELL, V24, P3420, DOI 10.1091/mbc.E13-05-0236; Miserey-Lenkei S, 2007, TRAFFIC, V8, P1385, DOI 10.1111/j.1600-0854.2007.00612.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pereira-Leal JB, 2000, J MOL BIOL, V301, P1077, DOI 10.1006/jmbi.2000.4010; Pusapati GV, 2012, J BIOL CHEM, V287, P42129, DOI 10.1074/jbc.M112.414565; Qi ML, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003278; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Shiba T, 2006, P NATL ACAD SCI USA, V103, P15416, DOI 10.1073/pnas.0605357103; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Westlake CJ, 2011, P NATL ACAD SCI USA, V108, P2759, DOI 10.1073/pnas.1018823108; Yamamoto H, 2010, MOL BIOL CELL, V21, P2746, DOI 10.1091/mbc.E10-01-0074; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhu YQ, 2010, P NATL ACAD SCI USA, V107, P4699, DOI 10.1073/pnas.0914231107	41	16	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18817	18832		10.1074/jbc.M114.612366	http://dx.doi.org/10.1074/jbc.M114.612366			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26032412	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000358512100048
J	Wang, WY; Shen, T; Guerois, R; Zhang, FM; Kuerban, H; Lv, YC; Gigant, B; Knossow, M; Wang, CG				Wang, Weiyi; Shen, Ting; Guerois, Raphael; Zhang, Fuming; Kuerban, Hureshitanmu; Lv, Yuncong; Gigant, Benoit; Knossow, Marcel; Wang, Chunguang			New Insights into the Coupling between Microtubule Depolymerization and ATP Hydrolysis by Kinesin-13 Protein Kif2C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTROMERE-ASSOCIATED KINESIN; TUBULIN; COMPLEX; MODEL; MCAK; MECHANISM; SOFTWARE; MOTILITY; BINDING; DOMAIN	Kinesin-13 proteins depolymerize microtubules in an ATP hydrolysis-dependent manner. The coupling between these two activities remains unclear. Here, we first studied the role of the kinesin-13 subfamily-specific loop 2 and of the KVD motif at the tip of this loop. Shortening the loop, the lysine/glutamate interchange and the additional Val to Ser substitution all led to Kif2C mutants with decreased microtubule-stimulated ATPase and impaired depolymerization capability. We rationalized these results based on a structural model of the Kif2C-ATP-tubulin complex derived from the recently determined structures of kinesin-1 bound to tubulin. In this model, upon microtubule binding Kif2C undergoes a conformational change governed in part by the interaction of the KVD motif with the tubulin inter-dimer interface. Second, we mutated to an alanine the conserved glutamate residue of the switch 2 nucleotide binding motif. This mutation blocks motile kinesins in a post-conformational change state and inhibits ATP hydrolysis. This Kif2C mutant still depolymerized microtubules and yielded complexes of one Kif2C with two tubulin heterodimers. These results demonstrate that the structural change of Kif2C-ATP upon binding to microtubule ends is sufficient for tubulin release, whereas ATP hydrolysis is not required. Overall, our data suggest that the conformation reached by kinesin-13s upon tubulin binding is similar to that of tubulin-bound, ATP-bound, motile kinesins but that this conformation is adapted to microtubule depolymerization.	[Wang, Weiyi; Shen, Ting; Zhang, Fuming; Kuerban, Hureshitanmu; Lv, Yuncong; Wang, Chunguang] Tongji Univ, Inst Prot Res, Shanghai 200092, Peoples R China; [Wang, Weiyi; Guerois, Raphael; Gigant, Benoit; Knossow, Marcel] Univ Paris Sud, CNRS, CEA, Inst Integrat Biol Cell, F-91198 Gif Sur Yvette, France; [Guerois, Raphael] Inst Biol & Technol Saclay iBiTecS, CEA, F-91191 Gif Sur Yvette, France	Tongji University; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay	Wang, CG (corresponding author), Tongji Univ, Inst Prot Res, Shanghai 200092, Peoples R China.	chunguangwang@tongji.edu.cn	, raph/AAF-4380-2019; Wang, Weiyi/GZN-0408-2022	Gigant, Benoit/0000-0002-5946-6759	National Science Foundation of China [30700125, 31370771]; Ministry of Education of China [20130072110031]; Agence Nationale de la Recherche [ANR-12-BSV8-0002-01]; Fondation ARC pour la Recherche sur le Cancer	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation ARC pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by National Science Foundation of China Grants 30700125 and 31370771 and Specialized Research Fund for the Doctoral Program of Ministry of Education of China Grant 20130072110031 (to C. W.) and by Agence Nationale de la Recherche Grant ANR-12-BSV8-0002-01 (to B. G.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Fondation ARC pour la Recherche sur le Cancer postdoctoral fellowship.	AIZAWA H, 1992, J CELL BIOL, V119, P1287, DOI 10.1083/jcb.119.5.1287; Asenjo AB, 2013, CELL REP, V3, P759, DOI 10.1016/j.celrep.2013.01.030; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bricogne G., 2011, BUSTER; Cao LY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6364; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Cross RA, 2004, TRENDS BIOCHEM SCI, V29, P301, DOI 10.1016/j.tibs.2004.04.010; Dagenbach EM, 2004, J CELL SCI, V117, P3, DOI 10.1242/jcs.00875; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Friel CT, 2011, EMBO J, V30, P3928, DOI 10.1038/emboj.2011.290; Gigant B, 2005, NATURE, V435, P519, DOI 10.1038/nature03566; Gigant B, 2013, NAT STRUCT MOL BIOL, V20, P1001, DOI 10.1038/nsmb.2624; Homma N, 2003, CELL, V114, P229, DOI 10.1016/S0092-8674(03)00522-1; Hunter AW, 2003, MOL CELL, V11, P445, DOI 10.1016/S1097-2765(03)00049-2; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kline-Smith SL, 2004, MOL BIOL CELL, V15, P1146, DOI 10.1091/mbc.E03-08-0581; Kobayashi T, 2011, CELL, V145, P914, DOI 10.1016/j.cell.2011.04.028; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Maney T, 2001, J BIOL CHEM, V276, P34753, DOI 10.1074/jbc.M106626200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moores CA, 2002, MOL CELL, V9, P903, DOI 10.1016/S1097-2765(02)00503-8; Moores CA, 2006, CELL CYCLE, V5, P1812, DOI 10.4161/cc.5.16.3134; Mulder AM, 2009, J CELL BIOL, V185, P51, DOI 10.1083/jcb.200812052; Nawrotek A, 2011, J MOL BIOL, V412, P35, DOI 10.1016/j.jmb.2011.07.029; Ogawa T, 2004, CELL, V116, P591, DOI 10.1016/S0092-8674(04)00129-1; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Sanhaji M, 2011, ONCOTARGET, V2, P935; Shipley K, 2004, EMBO J, V23, P1422, DOI 10.1038/sj.emboj.7600165; Steinmetz MO, 2000, EMBO J, V19, P572, DOI 10.1093/emboj/19.4.572; Tan DY, 2008, STRUCTURE, V16, P1732, DOI 10.1016/j.str.2008.08.017; Tan DY, 2006, J CELL BIOL, V175, P25, DOI 10.1083/jcb.200605194; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Wagenbach M, 2008, J CELL BIOL, V183, P617, DOI 10.1083/jcb.200805145; Walczak CE, 2013, ANNU REV CELL DEV BI, V29, P417, DOI 10.1146/annurev-cellbio-101512-122345; Wang WY, 2012, J BIOL CHEM, V287, P15143, DOI 10.1074/jbc.M111.317859; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	39	12	13	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18721	18731		10.1074/jbc.M115.646919	http://dx.doi.org/10.1074/jbc.M115.646919			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26055718	hybrid, Green Published			2022-12-28	WOS:000358512100040
J	Cesca, F; Satapathy, A; Ferrea, E; Nieus, T; Benfenati, F; Scholz-Starke, J				Cesca, Fabrizia; Satapathy, Annyesha; Ferrea, Enrico; Nieus, Thierry; Benfenati, Fabio; Scholz-Starke, Joachim			Functional Interaction between the Scaffold Protein Kidins220/ARMS and Neuronal Voltage-Gated Na+ Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CHANNEL; NEUROTROPHIC FACTOR; HIPPOCAMPAL-NEURONS; NA(V)1.2 CHANNELS; MODULATION; TRKB; ACTIVATION; MECHANISMS; SUBSTRATE; PATHWAYS	Kidins220 (kinase D-interacting substrate of 220 kDa)/ankyrin repeat-rich membrane spanning (ARMS) acts as a signaling platform at the plasma membrane and is implicated in a multitude of neuronal functions, including the control of neuronal activity. Here, we used the Kidins220-/- mouse model to study the effects of Kidins220 ablation on neuronal excitability. Multielectrode array recordings showed reduced evoked spiking activity in Kidins220-/- hippocampal networks, which was compatible with the increased excitability of GABAergic neurons determined by current-clamp recordings. Spike waveform analysis further indicated an increased sodium conductance in this neuronal subpopulation. Kidins220 association with brain voltage-gated sodium channels was shown by co-immunoprecipitation experiments and Na+ current recordings in transfected HEK293 cells, which revealed dramatic alterations of kinetics and voltage dependence. Finally, an in silico interneuronal model incorporating the Kidins220-induced Na+ current alterations reproduced the firing phenotype observed in Kidins220-/- neurons. These results identify Kidins220 as a novel modulator of Na-v channel activity, broadening our understanding of the molecular mechanisms regulating network excitability.	[Cesca, Fabrizia; Satapathy, Annyesha; Ferrea, Enrico; Benfenati, Fabio; Scholz-Starke, Joachim] Ist Italiano Tecnol, Ctr Synapt Neurosci, I-16163 Genoa, Italy; [Satapathy, Annyesha; Benfenati, Fabio] Univ Genoa, Dept Expt Med, I-16132 Genoa, Italy; [Ferrea, Enrico] German Primate Ctr, Sensorimotor Grp, D-37077 Gottingen, Germany; [Nieus, Thierry] Ist Italiano Tecnol, Neuro Technol Dept, I-16163 Genoa, Italy; [Scholz-Starke, Joachim] CNR, Inst Biophys, I-16149 Genoa, Italy	Istituto Italiano di Tecnologia - IIT; University of Genoa; Deutsches Primatenzentrum (DPZ); Istituto Italiano di Tecnologia - IIT; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR)	Cesca, F (corresponding author), Ist Italiano Tecnol, Via Morego 30, I-16163 Genoa, Italy.	fabrizia.cesca@iit.it; scholz@ge.ibf.cnr.it	Ferrea, Enrico/AAI-7622-2020; Scholz-Starke, Joachim/A-2944-2014	Scholz-Starke, Joachim/0000-0002-7376-6635; Cesca, Fabrizia/0000-0003-2190-6314; Nieus, Thierry/0000-0001-8708-1015	Compagnia di San Paolo; Istituto Italiano di Tecnologia; European Union FP7 Integrating Project "Desire" [602531]	Compagnia di San Paolo(Compagnia di San Paolo); Istituto Italiano di Tecnologia(Istituto Italiano di Tecnologia - IIT); European Union FP7 Integrating Project "Desire"	This work was supported by grants from the Compagnia di San Paolo (to F. C.), Istituto Italiano di Tecnologia (to F. B.), and European Union FP7 Integrating Project "Desire" Grant 602531 (to F. B. and F. C.). The authors declare that they have no conflict of interest with the contents of this article.	Ahn M, 2007, J NEUROSCI, V27, P11533, DOI 10.1523/JNEUROSCI.5005-06.2007; Arevalo JC, 2004, EMBO J, V23, P2358, DOI 10.1038/sj.emboj.7600253; Beacham D, 2007, J NEUROSCI, V27, P11543, DOI 10.1523/JNEUROSCI.1743-07.2007; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Blum R, 2002, NATURE, V419, P687, DOI 10.1038/nature01085; Bologna LL, 2010, NEURAL NETWORKS, V23, P685, DOI 10.1016/j.neunet.2010.05.002; Bouzidi M, 2002, J BIOL CHEM, V277, P28996, DOI 10.1074/jbc.M201760200; Brown DA, 2009, BRIT J PHARMACOL, V156, P1185, DOI 10.1111/j.1476-5381.2009.00111.x; Arevalo JC, 2010, MOL CELL NEUROSCI, V45, P92, DOI 10.1016/j.mcn.2010.06.002; Catterall WA, 2010, NEURON, V67, P915, DOI 10.1016/j.neuron.2010.08.021; Cesca F, 2012, CELL DEATH DIFFER, V19, P194, DOI 10.1038/cdd.2011.141; Chang MS, 2004, J NEUROSCI RES, V78, P186, DOI 10.1002/jnr.20262; Cortes RY, 2007, DEV NEUROBIOL, V67, P1687, DOI 10.1002/dneu.20542; Debanne D, 2011, PHYSIOL REV, V91, P555, DOI 10.1152/physrev.00048.2009; Desai NS, 1999, LEARN MEMORY, V6, P284; Goldin AL, 2003, CURR OPIN NEUROBIOL, V13, P284, DOI 10.1016/S0959-4388(03)00065-5; Herve JC, 2014, BBA-BIOMEMBRANES, V1838, P595, DOI 10.1016/j.bbamem.2013.07.006; Iglesias T, 2000, J BIOL CHEM, V275, P40048, DOI 10.1074/jbc.M005261200; Kong HY, 2001, J NEUROSCI, V21, P176, DOI 10.1523/JNEUROSCI.21-01-00176.2001; Lai HC, 2006, NAT REV NEUROSCI, V7, P548, DOI 10.1038/nrn1938; LEVINE ES, 1995, P NATL ACAD SCI USA, V92, P8074, DOI 10.1073/pnas.92.17.8074; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; LI M, 1992, NEURON, V8, P1151, DOI 10.1016/0896-6273(92)90135-Z; Li T, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001944; Lopez-Menendez C, 2009, J CELL SCI, V122, P3554, DOI 10.1242/jcs.056473; Mantegazza M, 2012, JASPERS BASIC MECH E; Minichiello L, 2009, NAT REV NEUROSCI, V10, P850, DOI 10.1038/nrn2738; Minneci F, 2007, HIPPOCAMPUS, V17, P538, DOI 10.1002/hipo.20291; Neubrand VE, 2012, J CELL SCI, V125, P1845, DOI 10.1242/jcs.102764; Nieto-Gonzalez JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067318; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Ratcliffe CF, 2000, NAT NEUROSCI, V3, P437, DOI 10.1038/74805; Rogalski SL, 2000, J BIOL CHEM, V275, P25082, DOI 10.1074/jbc.M000183200; Scholz-Starke J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035785; Shin HW, 2000, J NEUROSCI, V20, P3580, DOI 10.1523/JNEUROSCI.20-10-03580.2000; Sutachan JJ, 2010, J NEUROSCI RES, V88, P3447, DOI 10.1002/jnr.22513; Tucker K, 2002, J PHYSIOL-LONDON, V542, P413, DOI 10.1113/jphysiol.2002.017376; Wu SH, 2010, J BIOL CHEM, V285, P40472, DOI 10.1074/jbc.M110.171371	39	11	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					18045	18055		10.1074/jbc.M115.654699	http://dx.doi.org/10.1074/jbc.M115.654699			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26037926	Green Published, hybrid			2022-12-28	WOS:000358511700036
J	Hampe, L; Radjainia, M; Xu, C; Harris, PWR; Bashiri, G; Goldstone, DC; Brimble, MA; Wang, Y; Mitra, AK				Hampe, Lutz; Radjainia, Mazdak; Xu, Cheng; Harris, Paul W. R.; Bashiri, Ghader; Goldstone, David C.; Brimble, Margaret A.; Wang, Yu; Mitra, Alok K.			Regulation and Quality Control of Adiponectin Assembly by Endoplasmic Reticulum Chaperone ERp44	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-WEIGHT ADIPONECTIN; PHASE PEPTIDE-SYNTHESIS; TUMOR-NECROSIS-FACTOR; ADIPOSE-TISSUE; CRYSTAL-STRUCTURE; VARIABLE DOMAIN; DISULFIDE-BOND; DSBA-L; PROTEIN; SECRETION	Adiponectin, a collagenous hormone secreted abundantly from adipocytes, possesses potent antidiabetic and anti-inflammatory properties. Mediated by the conserved Cys(39) located in the variable region of the N terminus, the trimeric (low molecular weight (LMW)) adiponectin subunit assembles into different higher order complexes, e.g. hexamers (middle molecular weight (MMW)) and 12-18-mers (high molecular weight (HMW)), the latter being mostly responsible for the insulin-sensitizing activity of adiponectin. The endoplasmic reticulum (ER) chaperone ERp44 retains adiponectin in the early secretory compartment and tightly controls the oxidative state of Cys39 and the oligomerization of adiponectin. Using cellular and in vitro assays, we show that ERp44 specifically recognizes the LMW and MMW forms but not the HMW form. Our binding assays with short peptide mimetics of adiponectin suggest that ERp44 intercepts and converts the pool of fully oxidized LMW and MMW adiponectin, but not the HMW form, into reduced trimeric precursors. These ERp44-bound precursors in the cis-Golgi may be transported back to the ER and released to enhance the population of adiponectin intermediates with appropriate oxidative state for HMW assembly, thereby underpinning the process of ERp44 quality control.	[Hampe, Lutz; Radjainia, Mazdak; Bashiri, Ghader; Goldstone, David C.; Mitra, Alok K.] Univ Auckland, Sch Biol Sci, Auckland 1010, New Zealand; [Harris, Paul W. R.; Brimble, Margaret A.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1010, New Zealand; [Xu, Cheng; Wang, Yu] Univ Hong Kong, State Key Lab Pharmaceut Biotechnol, Hong Kong 999007, Hong Kong, Peoples R China; [Xu, Cheng; Wang, Yu] Univ Hong Kong, Dept Pharmacol & Pharm, Hong Kong 999007, Hong Kong, Peoples R China; [Harris, Paul W. R.; Brimble, Margaret A.] Univ Auckland, Sch Chem Sci, Auckland 1010, New Zealand; [Harris, Paul W. R.; Brimble, Margaret A.] Univ Auckland, Inst Innovat Biotechnol, Auckland 1010, New Zealand	University of Auckland; University of Auckland; University of Hong Kong; University of Hong Kong; University of Auckland; University of Auckland	Mitra, AK (corresponding author), Univ Auckland, Sch Biol Sci, Private Bag 92019, Auckland 1010, New Zealand.	a.mitra@auckland.ac.nz	; Mitra, Alok/P-7800-2016; Bashiri, Ghader/R-4957-2017	Brimble, Margaret/0000-0002-7086-4096; wang, yu/0000-0001-8697-2940; Mitra, Alok/0000-0003-0891-5697; Goldstone, David/0000-0003-0069-9408; Bashiri, Ghader/0000-0002-5092-3749	University of Auckland; German Academic Exchange Service (DAAD) (Germany); Maurice Wilkins Centre for Molecular Biodiscovery; New Zealand Health Research Council; Rutherford Discovery Fellowship (New Zealand)	University of Auckland; German Academic Exchange Service (DAAD) (Germany)(Deutscher Akademischer Austausch Dienst (DAAD)); Maurice Wilkins Centre for Molecular Biodiscovery; New Zealand Health Research Council(Health Research Council of New Zealand); Rutherford Discovery Fellowship (New Zealand)(Royal Society of New Zealand)	This work was supported in part by a University of Auckland doctoral scholarship and the German Academic Exchange Service (DAAD) (Germany) (to L. H.), research funding from the Maurice Wilkins Centre for Molecular Biodiscovery (to A. K. M. and P. W. R. H.), and a New Zealand Health Research Council grant (to A. K. M.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Rutherford Discovery Fellowship (New Zealand).	ALBERICIO F, 1985, INT J PEPT PROT RES, V26, P92; Amblard M, 2006, MOL BIOTECHNOL, V33, P239, DOI 10.1385/MB:33:3:239; Anelli T, 2002, EMBO J, V21, P835, DOI 10.1093/emboj/21.4.835; Anelli T, 2007, EMBO J, V26, P4177, DOI 10.1038/sj.emboj.7601844; Anelli Tiziana, 2013, Int J Cell Biol, V2013, P606703, DOI 10.1155/2013/606703; Anelli T, 2015, FREE RADICAL BIO MED, V83, P323, DOI 10.1016/j.freeradbiomed.2015.02.020; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Berg AH, 2002, TRENDS ENDOCRIN MET, V13, P84, DOI 10.1016/S1043-2760(01)00524-0; Berner HS, 2004, BONE, V35, P842, DOI 10.1016/j.bone.2004.06.008; Briggs DB, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-24; Briggs DB, 2009, BIOCHEMISTRY-US, V48, P12345, DOI 10.1021/bi9015555; Garaulet M, 2007, PUBLIC HEALTH NUTR, V10, P1145, DOI 10.1017/S1368980007000638; Gilchrist A, 2006, CELL, V127, P1265, DOI 10.1016/j.cell.2006.10.036; Goldstein BJ, 2004, J CLIN ENDOCR METAB, V89, P2563, DOI 10.1210/jc.2004-0518; Hara K, 2006, DIABETES CARE, V29, P1357, DOI 10.2337/dc05-1801; Harris PWR, 2014, BIOPOLYMERS, V102, P313, DOI 10.1002/bip.22501; Harris PWR, 2011, TETRAHEDRON LETT, V52, P6024, DOI 10.1016/j.tetlet.2011.09.010; Kelesidis I, 2006, BRIT J CANCER, V94, P1221, DOI 10.1038/sj.bjc.6603051; Kim JA, 2012, BIOSCIENCE REP, V32, P641, DOI 10.1042/BSR20120067; Kishore U, 2004, TRENDS IMMUNOL, V25, P551, DOI 10.1016/j.it.2004.08.006; Korner A, 2007, J CLIN ENDOCR METAB, V92, P1041, DOI 10.1210/jc.2006-1858; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE, P277, DOI [10.1007/978-0-387-46312-4, DOI 10.1007/978-0-387-46312-4_8]; Liu M, 2008, P NATL ACAD SCI USA, V105, P18302, DOI 10.1073/pnas.0806341105; Otsu M, 2006, ANTIOXID REDOX SIGN, V8, P274, DOI 10.1089/ars.2006.8.274; Pajvani UB, 2003, J BIOL CHEM, V278, P9073, DOI 10.1074/jbc.M207198200; Pan CY, 2011, PROTEIN CELL, V2, P990, DOI 10.1007/s13238-011-1116-0; Peake PW, 2008, BIOCHEM BIOPH RES CO, V367, P560, DOI 10.1016/j.bbrc.2007.12.161; Qiang L, 2007, MOL CELL BIOL, V27, P4698, DOI 10.1128/MCB.02279-06; Radjainia M, 2008, J MOL BIOL, V381, P419, DOI 10.1016/j.jmb.2008.06.015; Radjainia M, 2012, FEBS J, V279, P2495, DOI 10.1111/j.1742-4658.2012.08630.x; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Schraw T, 2008, ENDOCRINOLOGY, V149, P2270, DOI 10.1210/en.2007-1561; Shapiro L, 1998, CURR BIOL, V8, P335, DOI 10.1016/S0960-9822(98)70133-2; Shinoda Y, 2006, J CELL BIOCHEM, V99, P196, DOI 10.1002/jcb.20890; Simpson F, 2010, INT J BIOCHEM CELL B, V42, P785, DOI 10.1016/j.biocel.2009.12.021; Suzuki S, 2007, FEBS LETT, V581, P809, DOI 10.1016/j.febslet.2007.01.046; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Tsao TS, 2002, J BIOL CHEM, V277, P29359, DOI 10.1074/jbc.C200312200; Tsao TS, 2003, J BIOL CHEM, V278, P50810, DOI 10.1074/jbc.M309469200; Vavassori S, 2013, MOL CELL, V50, P783, DOI 10.1016/j.molcel.2013.04.016; Wang LK, 2008, EMBO REP, V9, P642, DOI 10.1038/embor.2008.88; Wang Y, 2002, J BIOL CHEM, V277, P19521, DOI 10.1074/jbc.M200601200; Wang Y, 2008, BIOCHEM J, V409, P623, DOI 10.1042/BJ20071492; Wang Y, 2007, CELL RES, V17, P280, DOI 10.1038/cr.2007.14; Wang ZV, 2007, MOL CELL BIOL, V27, P3716, DOI 10.1128/MCB.00931-06; Wang ZV, 2008, P NATL ACAD SCI USA, V105, P18077, DOI 10.1073/pnas.0810027105; Xu AM, 2005, J BIOL CHEM, V280, P18073, DOI 10.1074/jbc.M414231200; Yamauchi T, 2008, INT J OBESITY, V32, pS13, DOI 10.1038/ijo.2008.233	48	30	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					18111	18123		10.1074/jbc.M115.663088	http://dx.doi.org/10.1074/jbc.M115.663088			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26060250	hybrid, Green Published			2022-12-28	WOS:000358511700042
J	Han, S; Lear, TB; Jerome, JA; Rajbhandari, S; Snavely, CA; Gulick, DL; Gibson, KF; Zou, CB; Chen, BB; Mallampalli, RK				Han, SeungHye; Lear, Travis B.; Jerome, Jacob A.; Rajbhandari, Shristi; Snavely, Courtney A.; Gulick, Dexter L.; Gibson, Kevin F.; Zou, Chunbin; Chen, Bill B.; Mallampalli, Rama K.			Lipopolysaccharide Primes the NALP3 Inflammasome by Inhibiting Its Ubiquitination and Degradation Mediated by the SCFFBXL2 E3 Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NLRP3 INFLAMMASOME; ACTIVATION; DEUBIQUITINATION; MOTIF	The inflammasome is a multiprotein complex that augments the proinflammatory response by increasing the generation and cellular release of key cytokines. Specifically, the NALP3 inflammasome requires two-step signaling, priming and activation, to be functional to release the proinflammatory cytokines IL-1 beta and IL-18. The priming process, through unknown mechanisms, increases the protein levels of NALP3 and pro-IL-1 beta in cells. Here we show that LPS increases the NALP3 protein life-span without significantly altering steady-state mRNA in human cells. LPS exposure reduces the ubiquitin-mediated proteasomal processing of NALP3 by inducing levels of an E3 ligase component, FBXO3, which targets FBXL2. The latter is an endogenous mediator of NALP3 degradation. FBXL2 recognizes Trp-73 within NALP3 for interaction and targets Lys-689 within NALP3 for ubiquitin ligation and degradation. A unique small molecule inhibitor of FBXO3 restores FBXL2 levels, resulting in decreased NALP3 protein levels in cells and, thereby, reducing the release of IL-1 beta and IL-18 in human inflammatory cells after NALP3 activation. Our findings uncover NALP3 as a molecular target for FBXL2 and suggest that therapeutic targeting of the inflammasome may serve as a platform for preclinical intervention.	[Han, SeungHye; Lear, Travis B.; Jerome, Jacob A.; Rajbhandari, Shristi; Snavely, Courtney A.; Gulick, Dexter L.; Gibson, Kevin F.; Zou, Chunbin; Chen, Bill B.; Mallampalli, Rama K.] Univ Pittsburgh, Acute Lung Injury Ctr Excellence, Dept Med, Pittsburgh, PA 15213 USA; [Mallampalli, Rama K.] Univ Pittsburgh, Dept Cell Biol Physiol & Bioengn, Pittsburgh, PA 15213 USA; [Mallampalli, Rama K.] Vet Affairs Pittsburgh Healthcare Syst, Med Specialty Serv Line, Pittsburgh, PA 15240 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Mallampalli, RK (corresponding author), Univ Pittsburgh, UPMC Montefiore, Pulm Allergy & Crit Care Med, Dept Med, NW 628, Pittsburgh, PA 15213 USA.	mallampallirk@upmc.edu	Zou, Chunbin/L-7488-2019	Zou, Chunbin/0000-0003-1355-4726; Lear, Travis/0000-0001-9156-0844; Han, SeungHye/0000-0001-5625-6337	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development; National Institutes of Health R01 [HL096376, HL097376, HL098174, HL081784, 1UH2HL123502, P01HL114453, HL116472]; Department of Veterans Affairs; Flight Attendant Medical Research Institute; American Heart Association [12SDG12040330]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UH2HL123502, R01HL097376, R01HL096376, R01HL116472, R01HL098174, R01HL081784, P01HL114453] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002200] Funding Source: NIH RePORTER	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development(US Department of Veterans Affairs); National Institutes of Health R01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Flight Attendant Medical Research Institute; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was performed on the basis of work supported, in part, by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development. This work was supported, in whole or in part, by National Institutes of Health R01 Grants HL096376, HL097376, HL098174, HL081784, 1UH2HL123502, P01HL114453 (to R. K. M.), and HL116472 (to B. B. C.). This work was also supported by a merit review award from the Department of Veterans Affairs, the Flight Attendant Medical Research Institute, and American Heart Association Award 12SDG12040330 (to C. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Chen BB, 2013, NAT IMMUNOL, V14, P470, DOI 10.1038/ni.2565; Chen BB, 2009, MOL CELL BIOL, V29, P3062, DOI 10.1128/MCB.01824-08; Davies John Q, 2005, Methods Mol Biol, V290, P105; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dolinay T, 2012, AM J RESP CRIT CARE, V185, P1225, DOI 10.1164/rccm.201201-0003OC; Fernandes-Alnemri T, 2013, J IMMUNOL, V191, P3995, DOI 10.4049/jimmunol.1301681; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Ghonime MG, 2014, J IMMUNOL, V192, P3881, DOI 10.4049/jimmunol.1301974; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hu Y, 2005, BIOCHEM BIOPH RES CO, V333, P253, DOI 10.1016/j.bbrc.2005.05.102; Juliana C, 2012, J BIOL CHEM, V287, P36617, DOI 10.1074/jbc.M112.407130; Lopez-Castejon G, 2013, J BIOL CHEM, V288, P2721, DOI 10.1074/jbc.M112.422238; Makabe H, 2012, J ANESTH, V26, P658, DOI 10.1007/s00540-012-1409-3; Mallampalli RK, 2013, J IMMUNOL, V191, P5247, DOI 10.4049/jimmunol.1300456; Mayor A, 2007, NAT IMMUNOL, V8, P497, DOI 10.1038/ni1459; Niebler M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003536; Py BF, 2013, MOL CELL, V49, P331, DOI 10.1016/j.molcel.2012.11.009; Radivojac P, 2010, PROTEINS, V78, P365, DOI 10.1002/prot.22555; Rodgers MA, 2014, J EXP MED, V211, P1331, DOI 10.1084/jem.20132486; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Weng LY, 2014, J IMMUNOL, V193, P3676, DOI 10.4049/jimmunol.1401448; Yan YQ, 2015, CELL, V160, P62, DOI 10.1016/j.cell.2014.11.047; Zhu LJ, 2010, CYTOKINE, V49, P201, DOI 10.1016/j.cyto.2009.10.004	25	113	116	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					18124	18133		10.1074/jbc.M115.645549	http://dx.doi.org/10.1074/jbc.M115.645549			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26037928	Green Published, hybrid			2022-12-28	WOS:000358511700043
J	Pan, X; Chen, GQ; Kazachkov, M; Greer, MS; Caldo, KMP; Zou, JT; Weselake, RJ				Pan, Xue; Chen, Guanqun; Kazachkov, Michael; Greer, Michael S.; Caldo, Kristian Mark P.; Zou, Jitao; Weselake, Randall J.			In Vivo and in Vitro Evidence for Biochemical Coupling of Reactions Catalyzed by Lysophosphatidylcholine Acyltransferase and Diacylglycerol Acyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID ACCUMULATION; SACCHAROMYCES-CEREVISIAE; TRANSGENIC ARABIDOPSIS; LANDS CYCLE; YEAST; COA; METABOLISM; PLANTS; GLYCEROLIPIDS; EXPRESSION	Seed oils of flax (Linum usitatissimum L.) and many other plant species contain substantial amounts of polyunsaturated fatty acids (PUFAs). Phosphatidylcholine (PC) is the major site for PUFA synthesis. The exact mechanisms of how these PUFAs are channeled from PC into triacylglycerol (TAG) needs to be further explored. By using in vivo and in vitro approaches, we demonstrated that the PC deacylation reaction catalyzed by the reverse action of acyl-CoA:lysophosphatidylcholine acyltransferase (LPCAT) can transfer PUFAs on PC directly into the acylCoA pool, making these PUFAs available for the diacylglycerol acyltransferase (DGAT)-catalyzed reaction for TAG production. Two types of yeast mutants were generated for in vivo and in vitro experiments, respectively. Both mutants provide a null background with no endogenous TAG forming capacity and an extremely low LPCAT activity. In vivo experiments showed that co-expressing flax DGAT1-1 and LPCAT1 in the yeast quintuple mutant significantly increased 18-carbon PUFAs in TAG with a concomitant decrease of 18-carbon PUFAs in phospholipid. We further showed that after incubation of sn-2-[C-14]acyl-PC, formation of [C-14] TAG was only possible with yeast microsomes containing both LPCAT1 and DGAT1-1. Moreover, the specific activity of overall LPCAT1 and DGAT1-1 coupling process exhibited a preference for transferring C-14-labeled linoleoyl or linolenoyl than oleoyl moieties from the sn-2 position of PC to TAG. Together, our data support the hypothesis of biochemical coupling of the LPCAT1-catalyzed reverse reaction with the DGAT1-1-catalyzed reaction for incorporating PUFAs into TAG. This process represents a potential route for enriching TAG in PUFA content during seed development in flax.	[Pan, Xue; Chen, Guanqun; Greer, Michael S.; Caldo, Kristian Mark P.; Weselake, Randall J.] Univ Alberta, Dept Agr Food & Nutr Sci, Alberta Innovates Phytola Ctr, Edmonton, AB T6G 2P5, Canada; [Kazachkov, Michael; Zou, Jitao] Natl Res Council Canada, Saskatoon, SK S7N 0W9, Canada	Alberta Innovates; University of Alberta; National Research Council Canada	Weselake, RJ (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Alberta Innovates Phytola Ctr, Edmonton, AB T6G 2P5, Canada.	randall.weselake@ualberta.ca	Caldo, Kristian/AAM-8663-2020; pan, xue/AAE-3374-2019; Chen, Guanqun/K-7009-2012	pan, xue/0000-0001-9415-8316; Chen, Guanqun/0000-0001-5790-3903	Genome Alberta/Genome Canada; Canada Research Chairs Program; Canada Foundation for Innovation; Research Capacity Program of Alberta Enterprise and Advanced Education; AVAC Ltd.; Alberta Innovates Bio Solutions; Natural Sciences and Engineering Research Council of Canada; Alberta Innovates Doctoral Award	Genome Alberta/Genome Canada(Genome Canada); Canada Research Chairs Program(Canada Research Chairs); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Research Capacity Program of Alberta Enterprise and Advanced Education; AVAC Ltd.; Alberta Innovates Bio Solutions; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Innovates Doctoral Award	Supported by Genome Alberta/Genome Canada, the Canada Research Chairs Program, the Canada Foundation for Innovation, the Research Capacity Program of Alberta Enterprise and Advanced Education, AVAC Ltd., Alberta Innovates Bio Solutions, and the Natural Sciences and Engineering Research Council of Canada. To whom correspondence should be addressed. Tel.: 780-492-4401; E-mail: randall.weselake@ualberta.ca.; Recipient of an Alberta Innovates Doctoral Award.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bates PD, 2012, PLANT PHYSIOL, V160, P1530, DOI 10.1104/pp.112.204438; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Burgal J, 2008, PLANT BIOTECHNOL J, V6, P819, DOI 10.1111/j.1467-7652.2008.00361.x; Byers SD, 1999, LIPIDS, V34, P1143, DOI 10.1007/s11745-999-0465-6; Carlsson AS, 2011, EUR J LIPID SCI TECH, V113, P812, DOI 10.1002/ejlt.201100032; Chen QL, 2007, FEBS LETT, V581, P5511, DOI 10.1016/j.febslet.2007.10.061; Covello PS, 1996, PLANT PHYSIOL, V111, P223, DOI 10.1104/pp.111.1.223; Dahlqvist A, 2000, P NATL ACAD SCI USA, V97, P6487, DOI 10.1073/pnas.120067297; Dyer JM, 2001, BIOCHEM BIOPH RES CO, V282, P1019, DOI 10.1006/bbrc.2001.4667; Gibson DG, 2011, METHOD ENZYMOL, V498, P349, DOI 10.1016/B978-0-12-385120-8.00015-2; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Hegemann JH, 2011, METHODS MOL BIOL, V765, P189, DOI 10.1007/978-1-61779-197-0_12; Hu ZH, 2012, PLANT PHYSIOL, V158, P1944, DOI 10.1104/pp.111.192153; Kim HU, 2011, PLANT CELL PHYSIOL, V52, P983, DOI 10.1093/pcp/pcr051; Lager I, 2013, J BIOL CHEM, V288, P36902, DOI 10.1074/jbc.M113.521815; LANDS WEM, 1958, J BIOL CHEM, V231, P883; LANDS WEM, 1960, J BIOL CHEM, V235, P2233; Nei M., 2000, MOL EVOLUTION PHYLOG, P352; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; Pan X, 2013, J BIOL CHEM, V288, P24173, DOI 10.1074/jbc.M113.475699; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Siloto RMP, 2009, LIPIDS, V44, P963, DOI 10.1007/s11745-009-3336-0; Sorensen BM, 2005, LIPIDS, V40, P1043, DOI 10.1007/s11745-005-1467-0; SPERLING P, 1993, J BIOL CHEM, V268, P26935; STYMNE S, 1984, BIOCHEM J, V223, P305, DOI 10.1042/bj2230305; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tang GQ, 2005, PLANT J, V44, P433, DOI 10.1111/j.1365-313X.2005.02535.x; TAYLOR DC, 1990, ANAL BIOCHEM, V184, P311, DOI 10.1016/0003-2697(90)90686-4; van Erp H, 2011, PLANT PHYSIOL, V155, P683, DOI 10.1104/pp.110.167239; Venglat P, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-74; Wang LP, 2012, PLANT CELL, V24, P4652, DOI 10.1105/tpc.112.104604; Wang ZW, 2012, PLANT J, V72, P461, DOI 10.1111/j.1365-313X.2012.05093.x; WEISS SB, 1960, J BIOL CHEM, V235, P40; Wickramarathna A. D., 2015, BMC BIOTECH IN PRESS	38	24	26	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					18068	18078		10.1074/jbc.M115.654798	http://dx.doi.org/10.1074/jbc.M115.654798			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26055703	Green Published, hybrid			2022-12-28	WOS:000358511700038
J	Stegehake, D; Kurosinski, MA; Schurmann, S; Daniel, J; Luersen, K; Liebau, E				Stegehake, Dirk; Kurosinski, Marc-Andre; Schuermann, Sabine; Daniel, Jens; Lueersen, Kai; Liebau, Eva			Polyamine-independent Expression of Caenorhabditis elegans Antizyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORNITHINE-DECARBOXYLASE ANTIZYME; TRANSCRIPTIONAL PROFILE; CELLULAR POLYAMINES; OXIDATIVE STRESS; TISSUE-CULTURE; C-ELEGANS; TOR; DEGRADATION; INHIBITOR; GENE	Degradation of ornithine decarboxylase, the rate-limiting enzyme of polyamine biosynthesis, is promoted by the protein antizyme. Expression of antizyme is positively regulated by rising polyamine concentrations that induce a +1 translational frameshift required for production of the full-length protein. Antizyme itself is negatively regulated by the antizyme inhibitor. In our study, the regulation of Caenorhabditis elegans antizyme was investigated, and the antizyme inhibitor was identified. By applying a novel GFP-based method to monitor antizyme frameshifting in vivo, we show that the induction of translational frameshifting also occurs under stressful conditions. Interestingly, during starvation, the initiation of frameshifting was independent of polyamine concentrations. Because frameshifting was also prevalent in a polyamine auxotroph double mutant, a polyamine-independent regulation of antizyme frameshifting is suggested. Polyamine-independent induction of antizyme expression was found to be negatively regulated by the peptide transporter PEPT-1, as well as the target of rapamycin, but not by the daf-2 insulin signaling pathway. Stress-dependent expression of C. elegans antizyme occurred morely slowly than expression in response to increased polyamine levels, pointing to a more general reaction to unfavorable conditions and a diversion away from proliferation and reproduction toward conservation of energy. Interestingly, antizyme expression was found to drastically increase in aging individuals in a postreproductive manner. Although knockdown of antizyme did not affect the lifespan of C. elegans, knockdown of the antizyme inhibitor led to a significant reduction in lifespan. This is most likely caused by an increase in antizyme-mediated degradation of ornithine decarboxylase-1 and a resulting reduction in cellular polyamine levels.	[Stegehake, Dirk; Kurosinski, Marc-Andre; Schuermann, Sabine; Daniel, Jens; Lueersen, Kai; Liebau, Eva] Univ Munster, Inst Anim Physiol, Dept Mol Physiol, D-48143 Munster, Germany	University of Munster	Liebau, E (corresponding author), Inst Anim Physiol, Dept Mol Physiol, Schlosspl 8, D-48143 Munster, Germany.	liebaue@uni-muenster.de			Deutsche Forschungsgemeinschaft [LI793/5-1, LU733/6]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants LI793/5-1 and LU733/6. The authors declare that they have no conflicts of interest with the contents of this article.	Alcazar R, 2010, PLANTA, V231, P1237, DOI 10.1007/s00425-010-1130-0; An JH, 2005, P NATL ACAD SCI USA, V102, P16275, DOI 10.1073/pnas.0508105102; Bercovich Z, 2011, J BIOL CHEM, V286, P33778, DOI 10.1074/jbc.M111.270637; Casero RA, 2007, NAT REV DRUG DISCOV, V6, P373, DOI 10.1038/nrd2243; Childs AC, 2003, CELL MOL LIFE SCI, V60, P1394, DOI 10.1007/s00018-003-2332-4; Coffino P, 2001, NAT REV MOL CELL BIO, V2, P188, DOI 10.1038/35056508; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Evans DS, 2011, AGEING RES REV, V10, P225, DOI 10.1016/j.arr.2010.04.001; Geillinger KE, 2014, J PROTEOME RES, V13, P3685, DOI 10.1021/pr5002669; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gruendler C, 2001, J BIOL CHEM, V276, P46533, DOI 10.1074/jbc.M105500200; Heinick A, 2010, FASEB J, V24, P206, DOI 10.1096/fj.09-135889; Ivanov IP, 2000, NUCLEIC ACIDS RES, V28, P3185, DOI 10.1093/nar/28.17.3185; Ivanov IP, 2000, EMBO J, V19, P1907, DOI 10.1093/emboj/19.8.1907; Ivanov IP, 2008, P NATL ACAD SCI USA, V105, P10079, DOI 10.1073/pnas.0801590105; Ivanov IP, 2010, J MOL EVOL, V70, P289, DOI 10.1007/s00239-010-9331-5; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Kahana C, 2009, CELL MOL LIFE SCI, V66, P2479, DOI 10.1007/s00018-009-0033-3; Kanerva K, 2008, BIOCHEM J, V409, P187, DOI 10.1042/BJ20071004; Kanerva K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006858; Keren-Paz A, 2006, ONCOGENE, V25, P5163, DOI 10.1038/sj.onc.1209521; KIMBLE J, 1979, DEV BIOL, V70, P396, DOI 10.1016/0012-1606(79)90035-6; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kurosinski MA, 2013, ACTA TROP, V126, P167, DOI 10.1016/j.actatropica.2013.02.010; Lewis J. A., 1995, CAENORHABDITIS ELEGA, P3; LI XQ, 1993, MOL CELL BIOL, V13, P2377, DOI 10.1128/MCB.13.4.2377; Lim SK, 2007, ONCOGENE, V26, P6593, DOI 10.1038/sj.onc.1210482; Long XM, 2002, CURR BIOL, V12, P1448, DOI 10.1016/S0960-9822(02)01091-6; Luersen K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060731; Lund J, 2002, CURR BIOL, V12, P1566, DOI 10.1016/S0960-9822(02)01146-6; Macrae M, 1998, BIOCHEM J, V333, P309, DOI 10.1042/bj3330309; MACRAE M, 1995, GENETICS, V140, P517; Mangold U, 2006, CELL MOL LIFE SCI, V63, P2095, DOI 10.1007/s00018-005-5583-4; MATSUFUJI S, 1995, CELL, V80, P51, DOI 10.1016/0092-8674(95)90450-6; McCarroll SA, 2004, NAT GENET, V36, P197, DOI 10.1038/ng1291; Meissner B, 2004, J BIOL CHEM, V279, P36739, DOI 10.1074/jbc.M403415200; MITCHELL JLA, 1994, BIOCHEM J, V299, P19, DOI 10.1042/bj2990019; Mitchell JLA, 2004, BIOCHEM J, V384, P271, DOI 10.1042/BJ20040972; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Newman RM, 2004, J BIOL CHEM, V279, P41504, DOI 10.1074/jbc.M407349200; Nishimura K, 2002, GENES CELLS, V7, P41, DOI 10.1046/j.1356-9597.2001.00494.x; Park SK, 2009, AGING CELL, V8, P258, DOI 10.1111/j.1474-9726.2009.00473.x; Pendeville H, 2001, MOL CELL BIOL, V21, P6549, DOI 10.1128/MCB.21.19.6549-6558.2001; Ramos-Molina B, 2014, FEBS OPEN BIO, V4, P510, DOI 10.1016/j.fob.2014.05.004; Ramos-Molina B, 2012, AMINO ACIDS, V42, P539, DOI 10.1007/s00726-011-1031-y; Ray RM, 2014, AMINO ACIDS, V46, P2005, DOI 10.1007/s00726-014-1757-4; Ray RM, 2014, AMINO ACIDS, V46, P565, DOI 10.1007/s00726-013-1565-2; Ray RM, 2012, J BIOL CHEM, V287, P3674, DOI 10.1074/jbc.M111.232561; Rhee HJ, 2007, J CELL MOL MED, V11, P685, DOI 10.1111/j.1582-4934.2007.00077.x; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Seiler N, 2005, J CELL MOL MED, V9, P623, DOI 10.1111/j.1582-4934.2005.tb00493.x; Soda K, 2009, EXP GERONTOL, V44, P727, DOI 10.1016/j.exger.2009.08.013; SUZUKI T, 1994, P NATL ACAD SCI USA, V91, P8930, DOI 10.1073/pnas.91.19.8930; Wang LH, 2003, P NATL ACAD SCI USA, V100, P11249, DOI 10.1073/pnas.1534805100	54	2	4	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					18090	18101		10.1074/jbc.M115.644385	http://dx.doi.org/10.1074/jbc.M115.644385			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26032421	hybrid, Green Published			2022-12-28	WOS:000358511700040
J	Fischer, RS; Fowler, VM				Fischer, Robert S.; Fowler, Velia M.			Thematic Minireview Series: The State of the Cytoskeleton in 2015	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							SKELETAL-MUSCLE; ACTIN; FILAMENTS; MECHANICS; PROTEINS; MOTILITY; HOMOLOG; BINDING; RING; FTSZ	The study of cytoskeletal polymers has been an active area of research for more than 70 years. However, despite decades of pioneering work by some of the brightest scientists in biochemistry, cell biology, and physiology, many central questions regarding the polymers themselves are only now starting to be answered. For example, although it has long been appreciated that the actin cytoskeleton provides contractility and couples biochemical responses with mechanical stresses in cells, only recently have we begun to understand how the actin polymer itself responds to mechanical loads. Likewise, although it has long been appreciated that the microtubule cytoskeleton can be post-translationally modified, only recently have the enzymes responsible for these modifications been characterized, so that we can now begin to understand how these modifications alter the polymerization and regulation of microtubule structures. Even the septins in eukaryotes and the cytoskeletal polymers of prokaryotes have yielded new insights due to recent advances in microscopy techniques. In this thematic series of minireviews, these topics are covered by some of the very same scientists who generated these recent insights, thereby providing us with an overview of the State of the Cytoskeleton in 2015.	[Fischer, Robert S.] NHLBI, NIH, Bethesda, MD 20892 USA; [Fowler, Velia M.] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Scripps Research Institute	Fischer, RS (corresponding author), NHLBI, NIH, Bldg 10, Bethesda, MD 20892 USA.	fischerr2@nhlbi.nih.gov; vfowler@asbmb.org		Fowler, Velia/0000-0002-3161-8802; Fischer, Robert/0000-0003-0650-2696	NHLBI NIH HHS [R01 HL083464] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083464] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; BORISY GG, 1967, J CELL BIOL, V34, P525, DOI 10.1083/jcb.34.2.525; BYERS B, 1976, J CELL BIOL, V69, P717, DOI 10.1083/jcb.69.3.717; Cabeen MT, 2010, ANNU REV GENET, V44, P365, DOI 10.1146/annurev-genet-102108-134845; Calligaris D, 2010, CELL MOL LIFE SCI, V67, P1089, DOI 10.1007/s00018-009-0245-6; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Dobbelaere J, 2004, SCIENCE, V305, P393, DOI 10.1126/science.1099892; DuFort CC, 2011, NAT REV MOL CELL BIO, V12, P308, DOI 10.1038/nrm3112; Erickson HP, 2007, BIOESSAYS, V29, P668, DOI 10.1002/bies.20601; ERICKSON HP, 1995, CELL, V80, P367, DOI 10.1016/0092-8674(95)90486-7; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; Goehring NW, 2011, SCIENCE, V334, P1137, DOI 10.1126/science.1208619; Guo M, 2013, BIOPHYS J, V105, P1562, DOI 10.1016/j.bpj.2013.08.037; Hoffman LM, 2012, MOL BIOL CELL, V23, P1846, DOI 10.1091/mbc.E11-12-1057; HUNEEUS FC, 1970, J MOL BIOL, V52, P415, DOI 10.1016/0022-2836(70)90410-9; ISHIKAWA H, 1968, J CELL BIOL, V38, P538, DOI 10.1083/jcb.38.3.538; Jensen Mikkel H, 2014, Bioarchitecture, V4, P138, DOI 10.4161/19490992.2014.989035; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Kim TJ, 2015, CURR BIOL, V25, P218, DOI 10.1016/j.cub.2014.11.017; Klemke RL, 2013, METHODS MOL BIOL, V1046, P203, DOI 10.1007/978-1-62703-538-5_12; KORN ED, 1978, P NATL ACAD SCI USA, V75, P588, DOI 10.1073/pnas.75.2.588; Ma LL, 1999, J BIOL CHEM, V274, P19145, DOI 10.1074/jbc.274.27.19145; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Radulovic M, 2011, EXPERT REV PROTEOMIC, V8, P117, DOI [10.1586/epr.10.91, 10.1586/EPR.10.91]; Sobczyk GJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4319; Straub F.B., 1942, STUDIES I MED CHEM U, P3; SUCK D, 1981, P NATL ACAD SCI-BIOL, V78, P4319, DOI 10.1073/pnas.78.7.4319; Waterman C. M., 2015, ANN REV BIO IN PRESS, V44; WITKE W, 1995, CELL, V81, P41, DOI 10.1016/0092-8674(95)90369-0	30	16	16	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17133	17136		10.1074/jbc.R115.663716	http://dx.doi.org/10.1074/jbc.R115.663716			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	25957399	hybrid, Green Published			2022-12-28	WOS:000357730900009
J	Geng, YP; Kedrov, A; Caumanns, JJ; Crevenna, AH; Lamb, DC; Beckmann, R; Driessen, AJM				Geng, Yanping; Kedrov, Alexej; Caumanns, Joseph J.; Crevenna, Alvaro H.; Lamb, Don C.; Beckmann, Roland; Driessen, Arnold J. M.			Role of the Cytosolic Loop C2 and the C Terminus of YidC in Ribosome Binding and Insertion Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEIN INSERTION; FLUORESCENCE CORRELATION SPECTROSCOPY; PHOSPHOLIPID-BILAYER NANODISCS; ESCHERICHIA-COLI YIDC; F1F0 ATP SYNTHASE; SUBUNIT-C; SECYEG TRANSLOCON; COMPLEX; OXA1; RECONSTITUTION	Members of the YidC/Oxa1/Alb3 protein family mediate membrane protein insertion, and this process is initiated by the assembly of YidC.ribosome nascent chain complexes at the inner leaflet of the lipid bilayer. The positively charged C terminus of Escherichia coli YidC plays a significant role in ribosome binding but is not the sole determinant because deletion does not completely abrogate ribosome binding. The positively charged cytosolic loops C1 and C2 of YidC may provide additional docking sites. We performed systematic sequential deletions within these cytosolic domains and studied their effect on the YidC insertase activity and interaction with translation-stalled (programmed) ribosome. Deletions within loop C1 strongly affected the activity of YidC in vivo but did not influence ribosome binding or substrate insertion, whereas loop C2 appeared to be involved in ribosome binding. Combining the latter deletion with the removal of the C terminus of YidC abolished YidC-mediated insertion. We propose that these two regions play an crucial role in the formation and stabilization of an active YidC.ribosome nascent chain complex, allowing for co-translational membrane insertion, whereas loop C1 may be involved in the downstream chaperone activity of YidC or in other protein-protein interactions.	[Geng, Yanping; Caumanns, Joseph J.; Driessen, Arnold J. M.] Univ Groningen, Biomol Sci & Biotechnol Inst, Mol Microbiol, NL-9747 AG Groningen, Netherlands; [Geng, Yanping; Caumanns, Joseph J.; Driessen, Arnold J. M.] Univ Groningen, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands; [Kedrov, Alexej; Beckmann, Roland] Univ Munich, Gene Ctr Munich, D-81377 Munich, Germany; [Crevenna, Alvaro H.; Lamb, Don C.] Univ Munich, NanoSyst Initiat Munich, Ctr Nanosci, Dept Chem,Phys Chem, D-81377 Munich, Germany; [Crevenna, Alvaro H.; Lamb, Don C.] Univ Munich, Ctr Integrated Prot Sci Munich, D-81377 Munich, Germany	University of Groningen; University of Groningen; University of Munich; University of Munich; University of Munich	Driessen, AJM (corresponding author), Univ Groningen, Biomol Sci & Biotechnol Inst, Mol Microbiol, Nijenborgh 7, NL-9747 AG Groningen, Netherlands.	a.j.m.driessen@rug.nl	Crevenna, Alvaro/Q-4476-2019; Lamb, Don C/G-9501-2014; Crevenna, Alvaro/E-9125-2016; Institute, Zernike/W-7033-2019; Driessen, Arnold J.M./D-1876-2012	Crevenna, Alvaro/0000-0002-5580-3711; Lamb, Don C/0000-0002-0232-1903; Crevenna, Alvaro/0000-0002-5580-3711; Kedrov, Alexej/0000-0001-9117-752X; Driessen, Arnold J.M./0000-0001-9258-9104	Netherlands Foundation for Scientific Research; Chinese Scholarship Council; European Research Council Advanced Grant; Deutsche Forschungsgemeinschaft [SFB 646 B11]; Excellent Clusters Nanosystems Initative Munich; Center for Integrated Protein Science Munich; Ludwig-Maximilians-Universitat Munchen via the LMUInnovativ BioImaging Network; Center for NanoScience	Netherlands Foundation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Chinese Scholarship Council(China Scholarship Council); European Research Council Advanced Grant(European Research Council (ERC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellent Clusters Nanosystems Initative Munich; Center for Integrated Protein Science Munich; Ludwig-Maximilians-Universitat Munchen via the LMUInnovativ BioImaging Network; Center for NanoScience	This work was supported by Chemical Sciences and Earth and Life Sciences that are both subsidized by the Netherlands Foundation for Scientific Research and by the Chinese Scholarship Council. This work was also supported by a European Research Council Advanced Grant (to R. B.), Deutsche Forschungsgemeinschaft Grant SFB 646 B11 (to D. C. L.), and funds from the Excellent Clusters Nanosystems Initative Munich, the Center for Integrated Protein Science Munich, the Ludwig-Maximilians-Universitat Munchen via the LMUInnovativ BioImaging Network, and the Center for NanoScience (to D. C. L.).	Aschtgen MS, 2012, MICROBIOLOGYOPEN, V1, P71, DOI 10.1002/mbo3.9; BANEYX F, 1990, J BACTERIOL, V172, P491, DOI 10.1128/JB.172.1.491-494.1990; Bischoff L, 2014, CELL REP, V9, P469, DOI 10.1016/j.celrep.2014.09.011; Chen MY, 2002, J BIOL CHEM, V277, P7670, DOI 10.1074/jbc.M110644200; Chen YY, 2014, J BIOL CHEM, V289, P35656, DOI 10.1074/jbc.M114.595082; Crevenna AH, 2013, J BIOL CHEM, V288, P12102, DOI 10.1074/jbc.M113.456327; Dalbey RE, 2014, BBA-MOL CELL RES, V1843, P1489, DOI 10.1016/j.bbamcr.2013.12.022; de Keyzer J, 2002, FEBS LETT, V510, P17, DOI 10.1016/S0014-5793(01)03213-6; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Du Plessis DJF, 2011, BBA-BIOMEMBRANES, V1808, P851, DOI 10.1016/j.bbamem.2010.08.016; du Plessis DJF, 2006, J BIOL CHEM, V281, P12248, DOI 10.1074/jbc.M600048200; Funes S, 2011, BIOL CHEM, V392, P13, DOI 10.1515/BC.2011.013; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hatzixanthis K, 2003, MOL MICROBIOL, V49, P1377, DOI 10.1046/j.1365-2958.2003.03642.x; Jia LX, 2003, EMBO J, V22, P6438, DOI 10.1093/emboj/cdg624; Jiang FL, 2003, J BIOL CHEM, V278, P48965, DOI 10.1074/jbc.M307362200; Kedrov A, 2013, J MOL BIOL, V425, P4112, DOI 10.1016/j.jmb.2013.07.042; Kedrov A, 2011, EMBO J, V30, P4387, DOI 10.1038/emboj.2011.314; Kohler R, 2009, MOL CELL, V34, P344, DOI 10.1016/j.molcel.2009.04.019; Kol S, 2008, J BIOL CHEM, V283, P9871, DOI 10.1074/jbc.M709408200; Krichevsky O, 2002, REP PROG PHYS, V65, P251, DOI 10.1088/0034-4885/65/2/203; Kumazaki K, 2014, SCI REP-UK, V4, DOI 10.1038/srep07299; Kumazaki K, 2014, NATURE, V509, P516, DOI 10.1038/nature13167; Muller CB, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/46001; Neugebauer SA, 2012, J MOL BIOL, V417, P375, DOI 10.1016/j.jmb.2012.01.046; Pop OI, 2009, FEBS J, V276, P4891, DOI 10.1111/j.1742-4658.2009.07188.x; Price CE, 2011, FEBS LETT, V585, P249, DOI 10.1016/j.febslet.2010.11.057; Price CE, 2010, PROTEOMICS, V10, P3235, DOI 10.1002/pmic.201000284; Price CE, 2010, J BIOL CHEM, V285, P3575, DOI 10.1074/jbc.M109.051128; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Saaf A, 1998, J BIOL CHEM, V273, P30415, DOI 10.1074/jbc.273.46.30415; Sachelaru I, 2013, J BIOL CHEM, V288, P16295, DOI 10.1074/jbc.M112.446583; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Samuelson JC, 2001, J BIOL CHEM, V276, P34847, DOI 10.1074/jbc.M105793200; Seitl I, 2014, MOL MICROBIOL, V91, P408, DOI 10.1111/mmi.12465; Szyrach G, 2003, EMBO J, V22, P6448, DOI 10.1093/emboj/cdg623; van Bloois E, 2006, J BIOL CHEM, V281, P10002, DOI 10.1074/jbc.M511357200; van der Laan M, 2004, J CELL BIOL, V165, P213, DOI 10.1083/jcb.200402100; van der Laan M, 2001, EMBO REP, V2, P519, DOI 10.1093/embo-reports/kve106; Wagner S, 2008, J BIOL CHEM, V283, P17881, DOI 10.1074/jbc.M801481200; Wang P, 2011, BBA-BIOMEMBRANES, V1808, P866, DOI 10.1016/j.bbamem.2010.08.014; Wickles S, 2014, ELIFE, V3, DOI 10.7554/eLife.03035; Wu ZC, 2013, J BACTERIOL, V195, P4545, DOI 10.1128/JB.00792-13; Wu ZC, 2012, J BIOL CHEM, V287, P7885, DOI 10.1074/jbc.M111.297911; Yi L, 2004, J BIOL CHEM, V279, P39260, DOI 10.1074/jbc.M405490200; Zhu L, 2013, J BIOL CHEM, V288, P28180, DOI 10.1074/jbc.M113.491613; Zhu L, 2013, J BIOL CHEM, V288, P7704, DOI 10.1074/jbc.M112.429431	47	19	19	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17250	17261		10.1074/jbc.M115.650309	http://dx.doi.org/10.1074/jbc.M115.650309			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26023232	Green Published, hybrid			2022-12-28	WOS:000357730900021
J	Lopez-Pastrana, J; Ferrer, LM; Li, YF; Xiong, XY; Xi, H; Cueto, R; Nelson, J; Sha, XJ; Li, XY; Cannella, AL; Imoukhuede, PI; Qin, XB; Choi, ET; Wang, H; Yang, XF				Lopez-Pastrana, Jahaira; Ferrer, Lucas M.; Li, Ya-Feng; Xiong, Xinyu; Xi, Hang; Cueto, Ramon; Nelson, Jun; Sha, Xiaojin; Li, Xinyuan; Cannella, Ann L.; Imoukhuede, Princess I.; Qin, Xuebin; Choi, Eric T.; Wang, Hong; Yang, Xiao-Feng			Inhibition of Caspase-1 Activation in Endothelial Cells Improves Angiogenesis A NOVEL THERAPEUTIC POTENTIAL FOR ISCHEMIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATHEROSCLEROSIS; GROWTH; PROLIFERATION; INFLAMMASOMES; INJURY; VEGF; REVASCULARIZATION; VASCULOGENESIS; MECHANISMS; EXPRESSION	Deficient angiogenesis may contribute to worsen the prognosis of myocardial ischemia, peripheral arterial disease, ischemic stroke, etc. Dyslipidemic and inflammatory environments attenuate endothelial cell (EC) proliferation and angiogenesis, worsening the prognosis of ischemia. Under these dyslipidemic and inflammatory environments, EC-caspase-1 becomes activated and induces inflammatory cell death that is defined as pyroptosis. However, the underlying mechanism that correlates caspase-1 activation with angiogenic impairment and the prognosis of ischemia remains poorly defined. By using flow cytometric analysis, enzyme and receptor inhibitors, and hind limb ischemia model in caspase-1 knock-out (KO) mice, we examined our novel hypothesis, i.e. inhibition of caspase-1 in ECs under dyslipidemic and inflammatory environments attenuates EC pyroptosis, improves EC survival mediated by vascular endothelial growth factor receptor 2 (VEGFR-2), angiogenesis, and the prognosis of ischemia. We have made the following findings. Proatherogenic lipids induce higher caspase-1 activation in larger sizes of human aortic endothelial cells (HAECs) than in smaller sizes of HAECs. Proatherogenic lipids increase pyroptosis significantly more in smaller sizes of HAECs than in larger sizes of the cells. VEGFR-2 inhibition increases caspase-1 activation in HAECs induced by lysophosphatidylcholine treatment. Caspase-1 activation inhibits VEGFR-2 expression. Caspase-1 inhibition improves the tube formation of lysophosphatidylcholine-treated HAECs. Finally, caspase-1 depletion improves angiogenesis and blood flow in mouse hind limb ischemic tissues. Our results have demonstrated for the first time that inhibition of proatherogenic caspase-1 activation in ECs improves angiogenesis and the prognosis of ischemia.	[Lopez-Pastrana, Jahaira; Ferrer, Lucas M.; Li, Ya-Feng; Xiong, Xinyu; Xi, Hang; Cueto, Ramon; Nelson, Jun; Sha, Xiaojin; Li, Xinyuan; Cannella, Ann L.; Choi, Eric T.; Wang, Hong; Yang, Xiao-Feng] Temple Univ, Sch Med, Ctr Metab Dis Res, Philadelphia, PA 19140 USA; [Lopez-Pastrana, Jahaira; Ferrer, Lucas M.; Li, Ya-Feng; Xiong, Xinyu; Xi, Hang; Cueto, Ramon; Nelson, Jun; Sha, Xiaojin; Li, Xinyuan; Cannella, Ann L.; Choi, Eric T.; Wang, Hong; Yang, Xiao-Feng] Temple Univ, Sch Med, Cardiovasc Res Ctr, Philadelphia, PA 19140 USA; [Lopez-Pastrana, Jahaira; Ferrer, Lucas M.; Li, Ya-Feng; Xiong, Xinyu; Xi, Hang; Cueto, Ramon; Nelson, Jun; Sha, Xiaojin; Cannella, Ann L.; Choi, Eric T.; Wang, Hong; Yang, Xiao-Feng] Temple Univ, Sch Med, Ctr Thrombosis Res, Philadelphia, PA 19140 USA; [Xiong, Xinyu; Xi, Hang; Cueto, Ramon; Li, Xinyuan; Cannella, Ann L.; Wang, Hong; Yang, Xiao-Feng] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA; [Qin, Xuebin] Temple Univ, Sch Med, Dept Neurosci, Philadelphia, PA 19140 USA; [Choi, Eric T.] Temple Univ, Sch Med, Dept Surg, Philadelphia, PA 19140 USA; [Ferrer, Lucas M.; Imoukhuede, Princess I.] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Illinois System; University of Illinois Urbana-Champaign	Yang, XF (corresponding author), Temple Univ, Sch Med, Ctr Metab Dis Res, MERB 1059,3500 North Broad St, Philadelphia, PA 19140 USA.	xfyang@temple.edu	Li, YaFeng/J-6247-2013; Li, Xinyuan/B-1139-2015; Xiong, Xinyu/I-6674-2015; Regan, Clinton/E-6250-2012; Li, Xinyuan/Z-6299-2019; Imoukhuede, P I/T-7580-2017	Li, YaFeng/0000-0002-7500-0959; Li, Xinyuan/0000-0002-6746-8367; Xiong, Xinyu/0000-0002-9803-8503; Li, Xinyuan/0000-0002-6746-8367; Imoukhuede, P I/0000-0002-4257-1085	National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077288, R01HL110764, R01HL117654] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health grants (to X. F. Y. and H. W.). The authors declare that they have no conflicts of interest with the contents of this article.	ADAMSON RH, 1993, MICROVASC RES, V46, P77, DOI 10.1006/mvre.1993.1036; Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Andries LJ, 1998, CIRC RES, V82, P195; Annex BH, 2013, NAT REV CARDIOL, V10, P387, DOI 10.1038/nrcardio.2013.70; Baffert F, 2006, AM J PHYSIOL-HEART C, V290, pH547, DOI 10.1152/ajpheart.00616.2005; Blacher Silvia, 2001, Angiogenesis, V4, P133, DOI 10.1023/A:1012251229631; Chen CH, 2000, CIRCULATION, V101, P171, DOI 10.1161/01.CIR.101.2.171; CHOWIENCZYK PJ, 1992, LANCET, V340, P1430, DOI 10.1016/0140-6736(92)92621-L; Combadiere C, 2008, CIRCULATION, V117, P1649, DOI 10.1161/CIRCULATIONAHA.107.745091; DeCicco-Skinner KL, 2014, JOVE-J VIS EXP, DOI 10.3791/51312; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Elhage R, 2003, CARDIOVASC RES, V59, P234, DOI 10.1016/S0008-6363(03)00343-2; Gage J, 2012, CAN J CARDIOL, V28, P222, DOI 10.1016/j.cjca.2011.10.013; Goranov AI, 2013, CURR BIOL, V23, P1269, DOI 10.1016/j.cub.2013.05.035; Haas TL, 1997, MICROVASC RES, V53, P113, DOI 10.1006/mvre.1996.1999; Jiang XH, 2005, ARTERIOSCL THROM VAS, V25, P2515, DOI 10.1161/01.ATV.0000189559.87328.e4; Kessler K, 2014, CARDIOVASC RES, V104, P147, DOI 10.1093/cvr/cvu196; Kirii H, 2003, ARTERIOSCL THROM VAS, V23, P656, DOI 10.1161/01.ATV.0000064374.15232.C3; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185; Liu J, 2010, J IMMUNOL, V185, P1215, DOI 10.4049/jimmunol.0903660; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; Mayhew TM, 2002, PLACENTA, V23, P742, DOI 10.1053/plac.2002.0865; Menu P, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.18; Mestas J, 2008, TRENDS CARDIOVAS MED, V18, P228, DOI 10.1016/j.tcm.2008.11.004; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; Muneer PMA, 2012, ARTERIOSCL THROM VAS, V32, P1167, DOI 10.1161/ATVBAHA.112.247668; Munshi N, 2002, J IMMUNOL, V168, P5860, DOI 10.4049/jimmunol.168.11.5860; Natori S, 1999, TRANSPLANTATION, V68, P89, DOI 10.1097/00007890-199907150-00018; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Schielke GP, 1998, J CEREBR BLOOD F MET, V18, P180, DOI 10.1097/00004647-199802000-00009; Schmitz G, 2010, ATHEROSCLEROSIS, V208, P10, DOI 10.1016/j.atherosclerosis.2009.05.029; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Silvestre JS, 2013, PHYSIOL REV, V93, P1743, DOI 10.1152/physrev.00006.2013; Stillman IE, 2012, J AM SOC NEPHROL, V23, P8, DOI 10.1681/ASN.2011111116; Usui F, 2012, BIOCHEM BIOPH RES CO, V425, P162, DOI 10.1016/j.bbrc.2012.07.058; VanBelle E, 1997, CIRCULATION, V96, P2667, DOI 10.1161/01.CIR.96.8.2667; Xiong ZY, 2009, ATHEROSCLEROSIS, V203, P401, DOI 10.1016/j.atherosclerosis.2008.07.041; Yang Xiao-Feng, 2008, Drug Discov Today Ther Strateg, V5, P125, DOI 10.1016/j.ddstr.2008.11.003; Yaoita H, 1998, CIRCULATION, V97, P276, DOI 10.1161/01.CIR.97.3.276; Yin Y, 2009, INT J IMMUNOPATH PH, V22, P311, DOI 10.1177/039463200902200208; Yin Y, 2015, ARTERIOSCL THROM VAS, V35, P804, DOI 10.1161/ATVBAHA.115.305282; Yin Y, 2013, FRONT BIOSCI-LANDMRK, V18, P638, DOI 10.2741/4127; Zechariah A, 2013, ARTERIOSCL THROM VAS, V33, P1561, DOI 10.1161/ATVBAHA.112.300749; Zhang DQ, 2009, CIRCULATION, V120, P1893, DOI 10.1161/CIRCULATIONAHA.109.866889; Zhou Z, 2011, CELL METAB, V13, P592, DOI 10.1016/j.cmet.2011.02.016	47	71	74	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17485	17494		10.1074/jbc.M115.641191	http://dx.doi.org/10.1074/jbc.M115.641191			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26037927	Green Published, hybrid			2022-12-28	WOS:000357730900040
J	Schroter, G; Mann, D; Kotting, C; Gerwert, K				Schroeter, Grit; Mann, Daniel; Koetting, Carsten; Gerwert, Klaus			Integration of Fourier Transform Infrared Spectroscopy, Fluorescence Spectroscopy, Steady-state Kinetics and Molecular Dynamics Simulations of G alpha(i1) Distinguishes between the GTP Hydrolysis and GDP Release Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE-BINDING; HETEROTRIMERIC G-PROTEINS; RATE-LIMITING-STEP; ALPHA-SUBUNIT; PHARAONIS HALORHODOPSIN; ADRENERGIC-RECEPTOR; ACTIVATING PROTEINS; ADENYLATE-CYCLASE; WATER-MOLECULES; GAMMA-S	G alpha subunits are central molecular switches in cells. They are activated by Gprotein-coupled receptors that exchange GDP for GTP, similar to small GTPase activation mechanisms. G alpha subunits are turned off by GTP hydrolysis. For the first time we employed time-resolved FTIR difference spectroscopy to investigate the molecular reaction mechanisms of G alpha(i1). FTIR spectroscopy is a powerful tool that monitors reactions label free with high spatio-temporal resolution. In contrast to common multiple turnover assays, FTIR spectroscopy depicts the single turnover GTPase reaction without nucleotide exchange/Mg2+ binding bias. Global fit analysis resulted in one apparent rate constant of 0.02 s(-1) at 15 degrees C. Isotopic labeling was applied to assign the individual phosphate vibrations for alpha-, beta-, and gamma-GTP (1243, 1224, and 1156 cm(-1), respectively), alpha- and beta-GDP (1214 and 1134/1103 cm(-1), respectively), and free phosphate (1078/991 cm(-1)). In contrast to Ras.GAP catalysis, the bond breakage of the beta-gamma-phosphate but not the Pi release is rate-limiting in the GTPase reaction. Complementary common GTPase assays were used. Reversed phase HPLC provided multiple turnover rates and tryptophan fluorescence provided nucleotide exchange rates. Experiments were complemented by molecular dynamics simulations. This broad approach provided detailed insights at atomic resolution and allows now to identify key residues of G alpha(i1) inGTPhydrolysis and nucleotide exchange. Mutants of the intrinsic arginine finger (G alpha(i1)-R178S) affected exclusively the hydrolysis reaction. The effect of nucleotide binding (G alpha(i1)-D272N) and Ras-like/all-alpha interface coordination (G alpha (i1)-D229N/G alpha(i1)-D231N) on the nucleotide exchange reaction was furthermore elucidated.	[Schroeter, Grit; Mann, Daniel; Koetting, Carsten; Gerwert, Klaus] Ruhr Univ Bochum, Dept Biophys, D-44801 Bochum, Germany	Ruhr University Bochum	Kotting, C (corresponding author), Univ Str 150, D-44801 Bochum, Germany.	carsten.koetting@rub.de; klaus.gerwert@bph.rub.de	Gerwert, Klaus/G-7311-2015; Kötting, Carsten/A-8266-2008	Kötting, Carsten/0000-0002-3599-9657; Mann, Daniel/0000-0002-9106-9358	Deutsche Forschungsgemeinschaft [SFB 642, TP A1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 642, TP A1. The authors declare that they have no conflicts of interest with the contents of this article.	Baltoumas FA, 2013, J STRUCT BIOL, V182, P209, DOI 10.1016/j.jsb.2013.03.004; Barth A, 1998, BIOPHYS J, V75, P538, DOI 10.1016/S0006-3495(98)77543-5; Barth A, 2000, PROG BIOPHYS MOL BIO, V74, P141, DOI 10.1016/S0079-6107(00)00021-3; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; BIRNBAUMER L, 1980, J BIOL CHEM, V255, P3542; BOKOCH GM, 1984, J BIOL CHEM, V259, P3560; BRANDT DR, 1986, J BIOL CHEM, V261, P1656; BURNS DL, 1988, MICROBIOL SCI, V5, P285; Case D.A., 2022, AMBER; Cepus V, 1998, BIOCHEMISTRY-US, V37, P10263, DOI 10.1021/bi973183j; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; FAUROBERT E, 1993, EMBO J, V12, P4191, DOI 10.1002/j.1460-2075.1993.tb06103.x; FERGUSON KM, 1986, J BIOL CHEM, V261, P7393; Freier E, 2011, P NATL ACAD SCI USA, V108, P11435, DOI 10.1073/pnas.1104735108; Furutani Y, 2012, J PHYS CHEM LETT, V3, P2964, DOI 10.1021/jz301287n; Garcia-Marcos M, 2009, P NATL ACAD SCI USA, V106, P3178, DOI 10.1073/pnas.0900294106; Gavriljuk K, 2014, J AM CHEM SOC, V136, P9338, DOI 10.1021/ja501496d; Gavriljuk K, 2012, P NATL ACAD SCI USA, V109, P21348, DOI 10.1073/pnas.1214431110; Gerwert K, 2002, HDB VIBRATIONAL SPEC, V1, P3536; Gerwert K, 2014, BBA-BIOENERGETICS, V1837, P606, DOI 10.1016/j.bbabio.2013.09.006; Gille A, 2003, N-S ARCH PHARMACOL, V368, P210, DOI 10.1007/s00210-003-0783-7; GOODY RS, 1982, ANAL BIOCHEM, V119, P322, DOI 10.1016/0003-2697(82)90592-9; Hamm HE, 2009, PROTEIN SCI, V18, P2326, DOI 10.1002/pro.243; Hardie DG., 1999, PROTEIN PHOSPHORYLAT; HECHT SM, 1973, BIOCHIM BIOPHYS ACTA, V331, P307, DOI 10.1016/0005-2787(73)90015-4; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P762; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P757; Hohenfeld IP, 1999, FEBS LETT, V442, P198, DOI 10.1016/S0014-5793(98)01659-7; Howeler U, 2007, MAXIMOBY, P907; Isom DG, 2013, MOL CELL, V51, P531, DOI 10.1016/j.molcel.2013.07.012; JANERT PK, 2009, GNUPLOT ACTION UNDER; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; KAPLAN JH, 1978, BIOCHEMISTRY-US, V17, P1929, DOI 10.1021/bi00603a020; Kaya AI, 2014, J BIOL CHEM, V289, P24475, DOI 10.1074/jbc.M114.572875; Klasen K, 2012, PFLUG ARCH EUR J PHY, V463, P779, DOI 10.1007/s00424-012-1098-7; Kotting C, 2006, P NATL ACAD SCI USA, V103, P13911, DOI 10.1073/pnas.0604128103; Kotting C, 2015, BIOL CHEM, V396, P131, DOI 10.1515/hsz-2014-0219; Kotting C, 2013, FEBS LETT, V587, P2025, DOI 10.1016/j.febslet.2013.05.021; Kuhne J, 2015, ANGEW CHEM INT EDIT, V54, P4953, DOI 10.1002/anie.201410180; LEVITZKI A, 1980, FEBS LETT, V115, P9, DOI 10.1016/0014-5793(80)80714-9; Leyme A, 2014, J BIOL CHEM, V289, P21818, DOI 10.1074/jbc.M114.549790; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Louet M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002595; MAZZONI MR, 1993, J PROTEIN CHEM, V12, P215, DOI 10.1007/BF01026043; Milligan G, 2006, BRIT J PHARMACOL, V147, pS46, DOI 10.1038/sj.bjp.0706405; Monroy CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062247; Mukhopadhyay S, 1999, P NATL ACAD SCI USA, V96, P9539, DOI 10.1073/pnas.96.17.9539; Park CH, 1997, J AM CHEM SOC, V119, P2453, DOI 10.1021/ja9635589; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rudack T, 2012, P NATL ACAD SCI USA, V109, P15295, DOI 10.1073/pnas.1204333109; Rudack T, 2012, BIOPHYS J, V103, P293, DOI 10.1016/j.bpj.2012.06.015; Sato M, 2006, ANNU REV PHARMACOL, V46, P151, DOI 10.1146/annurev.pharmtox.46.120604.141115; Syberg F, 2012, J BIOL CHEM, V287, P23923, DOI 10.1074/jbc.M112.359208; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Thomas CJ, 2004, P NATL ACAD SCI USA, V101, P7560, DOI 10.1073/pnas.0304091101; Troullier A, 1996, BIOPHYS J, V71, P2970, DOI 10.1016/S0006-3495(96)79537-1; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VEDANI A, 1991, J AM CHEM SOC, V113, P5860, DOI 10.1021/ja00015a049; Vollmecke C, 2009, FEBS J, V276, P6172, DOI 10.1111/j.1742-4658.2009.07320.x; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Xia F, 2011, PHYS CHEM CHEM PHYS, V13, P21451, DOI 10.1039/c1cp22741f; Zielinski T, 2009, J BIOMOL SCREEN, V14, P1195, DOI 10.1177/1087057109347473	66	13	13	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17085	17095		10.1074/jbc.M115.651190	http://dx.doi.org/10.1074/jbc.M115.651190			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	25979337	Green Published, hybrid			2022-12-28	WOS:000357730900004
J	Woodier, J; Rainbow, RD; Stewart, AJ; Pitt, SJ				Woodier, Jason; Rainbow, Richard D.; Stewart, Alan J.; Pitt, Samantha J.			Intracellular Zinc Modulates Cardiac Ryanodine Receptor-mediated Calcium Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM; SINGLE-CHANNEL; MEMBRANE-POTENTIALS; CA2+ RELEASE; ZN2+; HEART; METALLOTHIONEIN; INHIBITION; CELL; CONTRACTILITY	Aberrant Zn2+ homeostasis is a hallmark of certain cardiomyopathies associated with altered contractile force. In this study, we addressed whether Zn2+ modulates cardiac ryanodine receptor gating and Ca2+ dynamics in isolated cardiomyocytes. We reveal that Zn2+ is a high affinity regulator of RyR2 displaying three modes of operation. Picomolar free Zn2+ concentrations potentiate RyR2 responses, but channel activation is still dependent on the presence of cytosolic Ca2+. At concentrations of free Zn2+ > 1 nM, Zn2+ is the main activating ligand, and the dependence on Ca2+ is removed. Zn2+ is therefore a higher affinity activator of RyR2 than Ca2+. Millimolar levels of free Zn2+ were found to inhibit channel openings. In cardiomyocytes, consistent with our single channel results, we show that Zn2+ modulates both the frequency and amplitude of Ca2+ waves in a concentration-dependent manner and that physiological levels of Zn2+ elicit Ca2+ release in the absence of activating levels of cytosolic Ca2+. This highlights a new role for intracellular Zn2+ in shaping Ca2+ dynamics in cardiomyocytes through modulation of RyR2 gating.	[Woodier, Jason; Stewart, Alan J.; Pitt, Samantha J.] Univ St Andrews, Sch Med, St Andrews KY16 9TF, Fife, Scotland; [Rainbow, Richard D.] Univ Leicester, Glenfield Gen Hosp, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England	University of St Andrews; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital	Pitt, SJ (corresponding author), Univ St Andrews, Sch Med, Med & Biol Sci Bldg,North Haugh, St Andrews KY6 9TF, Fife, Scotland.	sjp24@st-andrews.ac.uk	Stewart, Alan J/B-6569-2008	Stewart, Alan J/0000-0003-4580-1840; Rainbow, Richard/0000-0002-0532-1992; Pitt, Samantha/0000-0003-2257-1595	University of St. Andrews; Tenovus Scotland [T14/35]; British Heart Foundation [FS/14/69/31001]; John and Lucille van Geest Cardiovascular Diseases Research Fund; Biotechnology and Biological Sciences Research Council [BB/J006467/1]; Royal Society of Edinburgh Biomedical Research Fellowship; BBSRC [BB/J006467/1] Funding Source: UKRI	University of St. Andrews; Tenovus Scotland; British Heart Foundation(British Heart Foundation); John and Lucille van Geest Cardiovascular Diseases Research Fund; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society of Edinburgh Biomedical Research Fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by University of St. Andrews, Tenovus Scotland Grant T14/35 (to S. J. P.), British Heart Foundation Grant FS/14/69/31001 (to S. J. P.), a grant from the John and Lucille van Geest Cardiovascular Diseases Research Fund (to the University of Leicester and R. D. R.), and Biotechnology and Biological Sciences Research Council Grant BB/J006467/1 (to A. J. S.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Royal Society of Edinburgh Biomedical Research Fellowship.	Aizenman E, 2000, J NEUROCHEM, V75, P1878, DOI 10.1046/j.1471-4159.2000.0751878.x; Alexanian I, 2014, CLIN RES CARDIOL, V103, P938, DOI 10.1007/s00392-014-0735-x; Alvarez-Collazo J, 2012, PFLUG ARCH EUR J PHY, V464, P459, DOI 10.1007/s00424-012-1162-3; ASHLEY RH, 1990, J GEN PHYSIOL, V95, P981, DOI 10.1085/jgp.95.5.981; ATAR D, 1995, J BIOL CHEM, V270, P2473, DOI 10.1074/jbc.270.6.2473; Ayaz M, 2006, AM J PHYSIOL-HEART C, V290, pH1071, DOI 10.1152/ajpheart.00754.2005; Belevych AE, 2013, CARDIOVASC RES, V98, P240, DOI 10.1093/cvr/cvt024; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Bozym R, 2008, METHOD ENZYMOL, V450, P287, DOI 10.1016/S0076-6879(08)03414-9; Carter S, 2011, J MEMBRANE BIOL, V240, P21, DOI 10.1007/s00232-011-9339-9; Chabosseau P, 2014, ACS CHEM BIOL, V9, P2111, DOI 10.1021/cb5004064; CIOFALO FR, 1965, J GEN PHYSIOL, V48, P825, DOI 10.1085/jgp.48.5.825; Colquhoun D, 1983, SINGLE CHANNEL RECOR, P191; Colvin RA, 2010, METALLOMICS, V2, P306, DOI 10.1039/b926662c; CRAWFORD AJ, 1987, EXP NEUROL, V95, P265, DOI 10.1016/0014-4886(87)90137-3; Diaz-Sylvester PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026693; Eisner D, 2013, J MOL CELL CARDIOL, V58, P110, DOI 10.1016/j.yjmcc.2012.11.017; Fukada T, 2011, J BIOL INORG CHEM, V16, P1123, DOI 10.1007/s00775-011-0797-4; Galfre E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031956; Giacconi R, 2008, MOL GENET METAB, V94, P98, DOI 10.1016/j.ymgme.2007.12.006; KALFAKAKOU VP, 1993, BIOL TRACE ELEM RES, V38, P289, DOI 10.1007/BF02785312; KLEINFELD M, 1968, AM J PHYSIOL, V215, P593, DOI 10.1152/ajplegacy.1968.215.3.593; Kranias E. G., 2007, V45, P523; Krezel A, 2006, J BIOL INORG CHEM, V11, P1049, DOI 10.1007/s00775-006-0150-5; Laver DR, 1997, J MEMBRANE BIOL, V156, P213, DOI 10.1007/s002329900202; Li Y, 2009, EXP CELL RES, V315, P2463, DOI 10.1016/j.yexcr.2009.05.016; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Little PJ, 2010, NUTRITION, V26, P1050, DOI 10.1016/j.nut.2010.03.007; MARET W, 1995, NEUROCHEM INT, V27, P111, DOI 10.1016/0197-0186(94)00173-R; MARET W, 1994, P NATL ACAD SCI USA, V91, P237, DOI 10.1073/pnas.91.1.237; Maret W, 2001, P NATL ACAD SCI USA, V98, P12325, DOI 10.1073/pnas.231481398; Mocchegiani E, 2008, TRENDS MOL MED, V14, P419, DOI 10.1016/j.molmed.2008.08.002; Reuter H, 2008, MOL CELL BIOCHEM, V308, P141, DOI 10.1007/s11010-007-9622-3; ROUSSEAU E, 1986, BIOPHYS J, V50, P1009, DOI 10.1016/S0006-3495(86)83543-3; SANDSTEAD HH, 1995, AM J CLIN NUTR, V61, p621S, DOI 10.1093/ajcn/61.3.621S; Sensi SL, 2009, NAT REV NEUROSCI, V10, P780, DOI 10.1038/nrn2734; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; Sims MW, 2014, AM J PHYSIOL-HEART C, V307, pH587, DOI 10.1152/ajpheart.00894.2013; SITSAPESAN R, 1991, J PHYSIOL-LONDON, V434, P469, DOI 10.1113/jphysiol.1991.sp018481; SITSAPESAN R, 1990, J PHYSIOL-LONDON, V423, P425, DOI 10.1113/jphysiol.1990.sp018031; SOMLYO AV, 1981, J CELL BIOL, V90, P577, DOI 10.1083/jcb.90.3.577; Stewart R, 2008, J MEMBRANE BIOL, V222, P65, DOI 10.1007/s00232-008-9102-z; Tuncay E, 2011, CARDIOVASC RES, V89, P634, DOI 10.1093/cvr/cvq352; Turan B, 1997, AM J PHYSIOL-HEART C, V272, pH2095, DOI 10.1152/ajpheart.1997.272.5.H2095; Vinkenborg JL, 2009, NAT METHODS, V6, P737, DOI [10.1038/nmeth.1368, 10.1038/NMETH.1368]; Wang H, 2001, CELL PHYSIOL BIOCHEM, V11, P83, DOI 10.1159/000047795; Xie H, 2004, ACTA PHARMACOL SIN, V25, P1647; Xu L, 1996, CIRC RES, V79, P1100, DOI 10.1161/01.RES.79.6.1100; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081; Yi T, 2013, AM J PHYSIOL-HEART C, V305, pH706, DOI 10.1152/ajpheart.00025.2013	51	48	48	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17599	17610		10.1074/jbc.M115.661280	http://dx.doi.org/10.1074/jbc.M115.661280			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26041778	Green Published, hybrid			2022-12-28	WOS:000357730900050
J	Aro, E; Salo, AM; Khatri, R; Finnila, M; Miinalainen, I; Sormunen, R; Pakkanen, O; Holster, T; Soininen, R; Prein, C; Clausen-Schaumann, H; Aszodi, A; Tuukkanen, J; Kivirikko, KI; Schipani, E; Myllyharju, J				Aro, Ellinoora; Salo, Antti M.; Khatri, Richa; Finnila, Mikko; Miinalainen, Ilkka; Sormunen, Raija; Pakkanen, Outi; Holster, Tiina; Soininen, Raija; Prein, Carina; Clausen-Schaumann, Hauke; Aszodi, Attila; Tuukkanen, Juha; Kivirikko, Kari I.; Schipani, Ernestina; Myllyharju, Johanna			Severe Extracellular Matrix Abnormalities and Chondrodysplasia in Mice Lacking Collagen Prolyl 4-Hydroxylase Isoenzyme II in Combination with a Reduced Amount of Isoenzyme I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-PLATE CHONDROCYTES; ATOMIC-FORCE MICROSCOPY; ALPHA-SUBUNIT ISOFORM; TRANSGENIC MICE; KEY ENZYMES; CARTILAGE; EXPRESSION; CLONING; HYPOXIA; BONE	Collagen prolyl 4-hydroxylases (C-P4H-I, C-P4H-II, and C-P4H-III) catalyze formation of 4-hydroxyproline residues required to form triple-helical collagen molecules. Vertebrate C-P4Hs are alpha(2)beta(2) tetramers differing in their catalytic alpha subunits. C-P4H-I is the major isoenzyme in most cells, and inactivation of its catalytic subunit (P4ha1(-/-)) leads to embryonic lethality in mouse, whereas P4ha1(+/-) mice have no abnormalities. To study the role of C-P4H-II, which predominates in chondrocytes, we generated P4ha2(-/-) mice. Surprisingly, they had no apparent phenotypic abnormalities. To assess possible functional complementarity, we established P4ha1(+/-); P4ha2(-/-) mice. They were smaller than their littermates, had moderate chondrodysplasia, and developed kyphosis. A transient inner cell death phenotype was detected in their developing growth plates. The columnar arrangement of proliferative chondrocytes was impaired, the amount of 4-hydroxyproline and the T-m of collagen II were reduced, and the extracellular matrix was softer in the growth plates of newborn P4ha1(+/-); P4ha2(-/-) mice. No signs of uncompensated ER stress were detected in the mutant growth plate chondrocytes. Some of these defects were also found in P4ha2(-/-) mice, although in a much milder form. Our data show that C-P4H-I can to a large extent compensate for the lack of C-P4H-II in proper endochondral bone development, but their combined partial and complete inactivation, respectively, leads to biomechanically impaired extracellular matrix, moderate chondrodysplasia, and kyphosis. Our mouse data suggest that inactivating mutations in human P4HA2 are not likely to lead to skeletal disorders, and a simultaneous decrease in P4HA1 function would most probably be required to generate such a disease phenotype.	[Aro, Ellinoora; Salo, Antti M.; Pakkanen, Outi; Holster, Tiina; Soininen, Raija; Kivirikko, Kari I.; Myllyharju, Johanna] Univ Oulu, Oulu Ctr Cell Matrix Res, FIN-90014 Oulu, Finland; [Aro, Ellinoora; Salo, Antti M.; Miinalainen, Ilkka; Sormunen, Raija; Pakkanen, Outi; Holster, Tiina; Soininen, Raija; Kivirikko, Kari I.; Myllyharju, Johanna] Univ Oulu, Bioctr Oulu, FIN-90014 Oulu, Finland; [Aro, Ellinoora; Salo, Antti M.; Pakkanen, Outi; Holster, Tiina; Soininen, Raija; Kivirikko, Kari I.; Myllyharju, Johanna] Univ Oulu, Fac Biochem & Mol Med, FIN-90014 Oulu, Finland; [Finnila, Mikko; Tuukkanen, Juha] Univ Oulu, Dept Anat & Cell Biol, FIN-90014 Oulu, Finland; [Sormunen, Raija] Univ Oulu, Dept Pathol, FIN-90014 Oulu, Finland; [Khatri, Richa; Schipani, Ernestina] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Prein, Carina; Clausen-Schaumann, Hauke] Munich Univ Appl Sci, Dept Appl Sci & Mechatron, D-80335 Munich, Germany; [Prein, Carina; Clausen-Schaumann, Hauke; Aszodi, Attila] Munich Univ Appl Sci, Ctr Appl Tissue Engn & Regenerat Med, D-80335 Munich, Germany; [Clausen-Schaumann, Hauke] Univ Munich, Ctr NanoSci, D-80539 Munich, Germany; [Aszodi, Attila] Univ Munich, Ctr Clin, Dept Surg, Lab Expt Surg & Regenerat Med, D-80336 Munich, Germany	University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; Indiana University System; Indiana University Bloomington; University of Munich; University of Munich; University of Munich; University of Munich	Myllyharju, J (corresponding author), Univ Oulu, Bioctr Oulu, Oulu Ctr Cell Matrix Res, Aapistie 7,POB 5000, FIN-90014 Oulu, Finland.	johanna.myllyharju@oulu.fi	Finnila, Mikko/X-6492-2019; Clausen-Schaumann, Hauke/W-1830-2017; Tuukkanen, Juha/R-3728-2018	Clausen-Schaumann, Hauke/0000-0002-9413-0310; Tuukkanen, Juha/0000-0002-1723-6461; Miinalainen, Ilkka/0000-0002-3922-3442; Finnila, Mikko/0000-0002-3348-5759	University of Oulu; Biocenter Finland; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR065403] Funding Source: NIH RePORTER	University of Oulu; Biocenter Finland; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Minna Siurua, Liisa Aijala, and Anu Myllymaki and the personnel of the Biocenter Oulu Transgenic and EM Core Facilities cofunded by the University of Oulu and Biocenter Finland, and the University of Oulu Laboratory Animal Centre for excellent technical assistance.	Allen JL, 2012, MOL BIOL CELL, V23, P3731, DOI 10.1091/mbc.E12-03-0172; Annunen P, 1997, J BIOL CHEM, V272, P17342, DOI 10.1074/jbc.272.28.17342; Annunen P, 1998, J BIOL CHEM, V273, P5989, DOI 10.1074/jbc.273.11.5989; Aro E, 2012, J BIOL CHEM, V287, P37134, DOI 10.1074/jbc.M112.352872; Aszodi A, 2003, GENE DEV, V17, P2465, DOI 10.1101/gad.277003; Barbieri O, 2003, AM J PHYSIOL-CELL PH, V285, pC1504, DOI 10.1152/ajpcell.00579.2002; Bateman JF, 2009, NAT REV GENET, V10, P173, DOI 10.1038/nrg2520; Bengtsson T, 2005, J CELL SCI, V118, P929, DOI 10.1242/jcs.01678; Bentovim L, 2012, DEVELOPMENT, V139, P4473, DOI 10.1242/dev.083881; BUTT HJ, 1995, NANOTECHNOLOGY, V6, P1, DOI 10.1088/0957-4484/6/1/001; Domke J, 1998, LANGMUIR, V14, P3320, DOI 10.1021/la9713006; Dreier R, 2008, MATRIX BIOL, V27, P319, DOI 10.1016/j.matbio.2008.01.006; FASSLER R, 1994, P NATL ACAD SCI USA, V91, P5070, DOI 10.1073/pnas.91.11.5070; Heino J, 2014, ADV EXP MED BIOL, V819, P143, DOI 10.1007/978-94-017-9153-3_10; HELAAKOSKI T, 1989, P NATL ACAD SCI USA, V86, P4392, DOI 10.1073/pnas.86.12.4392; HELAAKOSKI T, 1995, P NATL ACAD SCI USA, V92, P4427, DOI 10.1073/pnas.92.10.4427; Holster T, 2007, J BIOL CHEM, V282, P2512, DOI 10.1074/jbc.M606608200; Humphrey JD, 2014, NAT REV MOL CELL BIO, V15, P802, DOI 10.1038/nrm3896; KIVIRIKKO KI, 1982, METHOD ENZYMOL, V82, P245; Kukkola L, 2003, J BIOL CHEM, V278, P47685, DOI 10.1074/jbc.M306806200; Lamberg A, 1996, J BIOL CHEM, V271, P11988, DOI 10.1074/jbc.271.20.11988; Laws N, 2004, J APPL PHYSIOL, V97, P1970, DOI 10.1152/japplphysiol.01357.2003; Leighton MP, 2007, HUM MOL GENET, V16, P1728, DOI 10.1093/hmg/ddm121; LI SW, 1995, GENE DEV, V9, P2821, DOI 10.1101/gad.9.22.2821; Loparic M, 2010, BIOPHYS J, V98, P2731, DOI 10.1016/j.bpj.2010.02.013; Maes C, 2012, J BONE MINER RES, V27, P596, DOI 10.1002/jbmr.1487; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; Myllyharju J, 2003, MATRIX BIOL, V22, P15, DOI 10.1016/S0945-053X(03)00006-4; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Myllyharju J, 2008, ANN MED, V40, P402, DOI 10.1080/07853890801986594; Nissi R, 2001, J HISTOCHEM CYTOCHEM, V49, P1143, DOI 10.1177/002215540104900908; Nokelainen M, 2001, EUR J BIOCHEM, V268, P5300, DOI 10.1046/j.0014-2956.2001.02464.x; Rajpar MH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000691; Ricard-Blum S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004978; Schipani E, 2001, GENE DEV, V15, P2865; Van den Diepstraten C, 2003, CIRCULATION, V108, P508, DOI 10.1161/01.CIR.0000080883.53863.5C; Warman ML, 2011, AM J MED GENET A, V155A, P943, DOI 10.1002/ajmg.a.33909; Yang CL, 1997, EXP CELL RES, V235, P370, DOI 10.1006/excr.1997.3692	39	30	31	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16964	16978		10.1074/jbc.M115.662635	http://dx.doi.org/10.1074/jbc.M115.662635			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	26001784	hybrid, Green Published			2022-12-28	WOS:000357572800040
J	Casellas, A; Mallol, C; Salavert, A; Jimenez, V; Garcia, M; Agudo, J; Obach, M; Haurigot, V; Vila, L; Molas, M; Lage, R; Morro, M; Casana, E; Ruberte, J; Bosch, F				Casellas, Alba; Mallol, Cristina; Salavert, Ariana; Jimenez, Veronica; Garcia, Miquel; Agudo, Judith; Obach, Merce; Haurigot, Virginia; Vila, Laia; Molas, Maria; Lage, Ricardo; Morro, Meritxell; Casana, Estefania; Ruberte, Jesus; Bosch, Fatima			Insulin-like Growth Factor 2 Overexpression Induces beta-Cell Dysfunction and Increases Beta-cell Susceptibility to Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; TYPE-2 DIABETES-MELLITUS; GOTO-KAKIZAKI RATS; PANCREATIC-ISLETS; TRANSGENIC MICE; FACTOR-II; IGF-II; FAILURE; REPLICATION	The human insulin-like growth factor 2 (IGF2) and insulin genes are located within the same genomic region. Although human genomic studies have demonstrated associations between diabetes and the insulin/IGF2 locus or the IGF2 mRNA-binding protein 2 (IGF2BP2), the role of IGF2 in diabetes pathogenesis is not fully understood. We previously described that transgenic mice overexpressing IGF2 specifically in beta-cells (Tg-IGF2) develop a pre-diabetic state. Here, we characterized the effects of IGF2 on beta-cell functionality. Overexpression of IGF2 led to beta-cell dedifferentiation and endoplasmic reticulum stress causing islet dysfunction in vivo. Both adenovirus-mediated overexpression of IGF2 and treatment of adult wild-type islets with recombinant IGF2 in vitro further confirmed the direct implication of IGF2 on beta-cell dysfunction. Treatment of Tg-IGF2 mice with subdiabetogenic doses of streptozotocin or crossing these mice with a transgenic model of islet lymphocytic infiltration promoted the development of overt diabetes, suggesting that IGF2 makes islets more susceptible to beta-cell damage and immune attack. These results indicate that increased local levels of IGF2 in pancreatic islets may predispose to the onset of diabetes. This study unravels an unprecedented role of IGF2 on beta-cells function.	[Casellas, Alba; Mallol, Cristina; Salavert, Ariana; Jimenez, Veronica; Garcia, Miquel; Agudo, Judith; Obach, Merce; Haurigot, Virginia; Vila, Laia; Molas, Maria; Lage, Ricardo; Morro, Meritxell; Casana, Estefania; Ruberte, Jesus; Bosch, Fatima] Univ Autonoma Barcelona, Ctr Anim Biotechnol & Gene Therapy, E-08193 Bellaterra, Spain; [Casellas, Alba; Mallol, Cristina; Jimenez, Veronica; Garcia, Miquel; Agudo, Judith; Haurigot, Virginia; Vila, Laia; Molas, Maria; Lage, Ricardo; Morro, Meritxell; Casana, Estefania; Bosch, Fatima] Univ Autonoma Barcelona, Sch Vet Med, Dept Biochem & Mol Biol, E-08193 Bellaterra, Spain; [Ruberte, Jesus] Univ Autonoma Barcelona, Sch Vet Med, Dept Anim Hlth & Anat, E-08193 Bellaterra, Spain; [Casellas, Alba; Mallol, Cristina; Jimenez, Veronica; Garcia, Miquel; Agudo, Judith; Obach, Merce; Haurigot, Virginia; Vila, Laia; Molas, Maria; Lage, Ricardo; Morro, Meritxell; Casana, Estefania; Ruberte, Jesus; Bosch, Fatima] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Barcelona 08036, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM	Bosch, F (corresponding author), Univ Autonoma Barcelona, Ctr Anim Biotechnol & Gene Therapy, Edifici H, E-08193 Bellaterra, Spain.	fatima.bosch@uab.es	Morró Larrubia, Meritxell/L-3345-2017; Vilà, Laia/ABG-8595-2020; CASELLAS, ALBA/AAG-6719-2020; Ruberte, Jesus/AAS-9240-2021; JIMENEZ, VERONICA/AAL-2626-2021	Morró Larrubia, Meritxell/0000-0003-1725-9599; JIMENEZ, VERONICA/0000-0001-9145-9877; Mallol, Cristina/0000-0002-2920-9612; RUBERTE, JESUS/0000-0003-1540-1432; Obach, Merce/0000-0002-2756-6181; BOSCH, FATIMA/0000-0002-7705-5515; Molas, Maria/0000-0002-3215-515X; Vila, Laia/0000-0001-7232-2250; Garcia, Miguel/0000-0002-1602-4993; Haurigot, Virginia A./0000-0002-9772-2565; CASELLAS, ALBA/0000-0003-0203-4733; Casana Lorente, Estefania/0000-0002-1353-5018; Lage Fernandez, Ricardo/0000-0002-8779-7723	Ministerio de Economia y Competitividad, Plan Nacional I+D+I [SAF2008-00962, SAF2011-24698]; Generalitat de Catalunya [2009 SGR-224]; ICREA Academia, Spain; Ministerio de Ciencia e Innovacion [SAF2008-00962]; Ministerio de Ciencia e Innovacion, Spain. [JCI-2010-06388]	Ministerio de Economia y Competitividad, Plan Nacional I+D+I(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); ICREA Academia, Spain(ICREA); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Ciencia e Innovacion, Spain.(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported in part by Ministerio de Economia y Competitividad, Plan Nacional I+D+I, Grants SAF2008-00962 and SAF2011-24698, and Generalitat de Catalunya Grants 2009 SGR-224 and ICREA Academia, Spain. The authors declare that they have no conflicts of interest with the contents of this article.; Recipients of predoctoral fellowship from Ministerio de Ciencia e Innovacion.; Recipient of Postdoctoral Fellowship JCI-2010-06388 from Ministerio de Ciencia e Innovacion, Spain.; Recipient of Predoctoral Fellowship SAF2008-00962 from Ministerio de Ciencia e Innovacion.	Allagnat F, 2010, DIABETOLOGIA, V53, P1120, DOI 10.1007/s00125-010-1699-7; Awata T, 2007, J CLIN ENDOCR METAB, V92, P1791, DOI 10.1210/jc.2006-2242; Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Benrahma H, 2014, BIOCHEM GENET, V52, P430, DOI 10.1007/s10528-014-9658-5; Bruning JC, 1997, CELL, V88, P561, DOI 10.1016/S0092-8674(00)81896-6; Butler PC, 2007, NAT CLIN PRACT ENDOC, V3, P758, DOI 10.1038/ncpendmet0647; Casellas A, 2006, DIABETES, V55, P3246, DOI 10.2337/db06-0328; Chan JY, 2013, DIABETES, V62, P1557, DOI 10.2337/db12-0701; Chang-Chen KJ, 2008, REV ENDOCR METAB DIS, V9, P329, DOI 10.1007/s11154-008-9101-5; Chon SJ, 2013, YONSEI MED J, V54, P352, DOI 10.3349/ymj.2013.54.2.352; Cornu M, 2009, DIABETES, V58, P1816, DOI 10.2337/db09-0063; Dai N, 2011, GENE DEV, V25, P1159, DOI 10.1101/gad.2042311; Devedjian JC, 2000, J CLIN INVEST, V105, P731, DOI 10.1172/JCI5656; Djiogue S, 2013, ENDOCR-RELAT CANCER, V20, pR1, DOI 10.1530/ERC-12-0324; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Engin F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006534; FOREJT J, 1992, CELL, V70, P443, DOI 10.1016/0092-8674(92)90168-C; Friedrichsen BN, 2006, J ENDOCRINOL, V188, P481, DOI 10.1677/joe.1.06160; Gerich JE, 2002, DIABETES, V51, pS117, DOI 10.2337/diabetes.51.2007.S117; Guo SL, 2013, J CLIN INVEST, V123, P3305, DOI 10.1172/JCI65390; Hoog A, 1996, ENDOCRINOLOGY, V137, P2415, DOI 10.1210/en.137.6.2415; Huxtable SJ, 2000, DIABETES, V49, P126, DOI 10.2337/diabetes.49.1.126; Inaba W, 2012, EUR J PHARMACOL, V691, P297, DOI 10.1016/j.ejphar.2012.07.030; Iwawaki T, 2013, SEMIN IMMUNOPATHOL, V35, P333, DOI 10.1007/s00281-013-0369-5; Jonas JC, 1999, J BIOL CHEM, V274, P14112, DOI 10.1074/jbc.274.20.14112; Kitamura T, 2013, NAT REV ENDOCRINOL, V9, P615, DOI 10.1038/nrendo.2013.157; Kulkarni RN, 2003, DIABETES, V52, P1528, DOI 10.2337/diabetes.52.6.1528; Kulkarni RN, 2002, BIOCHEM SOC T, V30, P317, DOI 10.1042/bst0300317; LeRoith D, 2003, CANCER LETT, V195, P127, DOI 10.1016/S0304-3835(03)00159-9; Martino L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036188; Monk D, 2006, HUM MOL GENET, V15, P1259, DOI 10.1093/hmg/ddl041; Morcavallo A, 2011, MOL ENDOCRINOL, V25, P1456, DOI 10.1210/me.2010-0484; Nica AC, 2013, GENOME RES, V23, P1554, DOI 10.1101/gr.150706.112; Nielsen Finn Cilius, 1992, Progress in Growth Factor Research, V4, P257, DOI 10.1016/0955-2235(92)90023-B; OHNEDA M, 1993, DIABETES, V42, P1065, DOI 10.2337/diabetes.42.7.1065; OKABAYASHI Y, 1989, DIABETES, V38, P182, DOI 10.2337/diabetes.38.2.182; Pelegrin M, 1998, J BIOL CHEM, V273, P12332, DOI 10.1074/jbc.273.20.12332; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pugliese A, 2002, DIABETES-METAB RES, V18, P13, DOI 10.1002/dmrr.261; Puri S, 2013, GENE DEV, V27, P2563, DOI 10.1101/gad.227785.113; Sachdeva MM, 2009, P NATL ACAD SCI USA, V106, P19090, DOI 10.1073/pnas.0904849106; SWENNE I, 1984, DIABETOLOGIA, V27, P464, DOI 10.1007/BF00273912; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Tersey SA, 2012, DIABETES, V61, P818, DOI 10.2337/db11-1293; Tuusa JT, 2007, J MOL BIOL, V371, P622, DOI 10.1016/j.jmb.2007.02.108; Vangheluwe P, 2005, CELL CALCIUM, V38, P291, DOI 10.1016/j.ceca.2005.06.033; Wajchenberg BL, 2007, ENDOCR REV, V28, P187, DOI 10.1210/er.2006-0038; Wang ZY, 2014, CELL METAB, V19, P872, DOI 10.1016/j.cmet.2014.03.010; Weir GC, 2009, DIABETES OBES METAB, V11, P82, DOI 10.1111/j.1463-1326.2009.01113.x; Weir GC, 2013, ISLETS, V5, P233, DOI 10.4161/isl.27494; Wirawan E, 2012, CELL RES, V22, P43, DOI 10.1038/cr.2011.152; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	53	39	43	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16772	16785		10.1074/jbc.M115.642041	http://dx.doi.org/10.1074/jbc.M115.642041			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25971976	Green Published, hybrid			2022-12-28	WOS:000357572800024
J	Lindow, JC; Dohrmann, PR; McHenry, CS				Lindow, Janet C.; Dohrmann, Paul R.; McHenry, Charles S.			DNA Polymerase alpha Subunit Residues and Interactions Required for Efficient Initiation Complex Formation Identified by a Genetic Selection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI REPLICATION PROTEINS; TERMINAL DOMAIN-III; ESCHERICHIA-COLI; DISTINCT DOMAINS; TAU-BINDS; CLAMP LOADER; BETA-SUBUNIT; PROCESSIVE ELONGATION; DELTA'-SUBUNIT; SLIDING CLAMP	Biophysical and structural studies have defined many of the interactions that occur between individual components or subassemblies of the bacterial replicase, DNA polymerase III holoenzyme (Pol III HE). Here, we extended our knowledge of residues and interactions that are important for the first step of the replicase reaction: the ATP-dependent formation of an initiation complex between the Pol III HE and primed DNA. We exploited a genetic selection using a dominant negative variant of the polymerase catalytic subunit that can effectively compete with wild-type Pol III alpha and form initiation complexes, but cannot elongate. Suppression of the dominant negative phenotype was achieved by secondary mutations that were ineffective in initiation complex formation. The corresponding proteins were purified and characterized. One class of mutant mapped to the PHP domain of Pol III alpha, ablating interaction with the epsilon proofreading subunit and distorting the polymerase active site in the adjacent polymerase domain. Another class of mutation, found near the C terminus, interfered with tau binding. A third class mapped within the known beta-binding domain, decreasing interaction with the beta(2) processivity factor. Surprisingly, mutations within the beta binding domain also ablated interaction with tau, suggesting a larger tau binding site than previously recognized.	[Lindow, Janet C.; Dohrmann, Paul R.; McHenry, Charles S.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80303 USA	University of Colorado System; University of Colorado Boulder	McHenry, CS (corresponding author), 3415 Colorado Ave,UCB596, Boulder, CO 80303 USA.	janet.lindow@yale.edu; charles.mchenry@colorado.edu	Regan, Clinton/E-6250-2012	Lindow, Janet/0000-0003-3235-3698	National Institutes of Health [NRSA F32 GM074532]; National Science Foundation [MCB-1329285]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM074532] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1329285] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported, in whole or in part, by National Institutes of Health Postdoctoral Fellowship Grant NRSA F32 GM074532 (to J. C. L.) and National Science Foundation Grant MCB-1329285. The authors declare that they have no conflicts of interest with the contents of this article.	Bailey S, 2006, CELL, V126, P893, DOI 10.1016/j.cell.2006.07.027; CRUTE JJ, 1983, J BIOL CHEM, V258, P1344; Dalrymple BP, 2001, P NATL ACAD SCI USA, V98, P11627, DOI 10.1073/pnas.191384398; Dohrmann PR, 2005, J MOL BIOL, V350, P228, DOI 10.1016/j.jmb.2005.04.065; Downey CD, 2011, J MOL BIOL, V412, P340, DOI 10.1016/j.jmb.2011.07.051; Downey CD, 2010, MOL CELL, V37, P481, DOI 10.1016/j.molcel.2010.01.013; FAY PJ, 1981, J BIOL CHEM, V256, P976; Gao DX, 2001, J BIOL CHEM, V276, P4447, DOI 10.1074/jbc.M009827200; Gao DX, 2001, J BIOL CHEM, V276, P4441, DOI 10.1074/jbc.M009830200; Gao DX, 2001, J BIOL CHEM, V276, P4433, DOI 10.1074/jbc.M009828200; Glover BP, 2000, J BIOL CHEM, V275, P3017, DOI 10.1074/jbc.275.5.3017; Glover BP, 2001, J BIOL CHEM, V276, P35842, DOI 10.1074/jbc.M103719200; Glover BP, 1998, J BIOL CHEM, V273, P23476, DOI 10.1074/jbc.273.36.23476; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Jergic S, 2013, EMBO J, V32, P1322, DOI 10.1038/emboj.2012.347; Jeruzalmi D, 2001, CELL, V106, P429, DOI 10.1016/S0092-8674(01)00463-9; Jeruzalmi D, 2001, CELL, V106, P417, DOI 10.1016/S0092-8674(01)00462-7; JOHANSON KO, 1982, J BIOL CHEM, V257, P2310; Kelman Z, 1998, EMBO J, V17, P2436, DOI 10.1093/emboj/17.8.2436; Keniry MA, 2006, J BACTERIOL, V188, P4464, DOI 10.1128/JB.01992-05; Kim DR, 1996, J BIOL CHEM, V271, P20681, DOI 10.1074/jbc.271.34.20681; Kim DR, 1996, J BIOL CHEM, V271, P20690, DOI 10.1074/jbc.271.34.20690; Kim DR, 1996, J BIOL CHEM, V271, P20699, DOI 10.1074/jbc.271.34.20699; Kim S, 1996, J BIOL CHEM, V271, P4315; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; Liu B, 2013, STRUCTURE, V21, P658, DOI 10.1016/j.str.2013.02.002; Marceau AH, 2011, EMBO J, V30, P4236, DOI 10.1038/emboj.2011.305; McHenry CS, 2011, ANNU REV BIOCHEM, V80, P403, DOI 10.1146/annurev-biochem-061208-091655; MCHENRY CS, 1979, J BIOL CHEM, V254, P1748; MOK M, 1987, J BIOL CHEM, V262, P16644; MOK M, 1987, J BIOL CHEM, V262, P2304; Ozawa K, 2013, NUCLEIC ACIDS RES, V41, P5354, DOI 10.1093/nar/gkt162; Pritchard AE, 1999, J MOL BIOL, V285, P1067, DOI 10.1006/jmbi.1998.2352; Rego AT, 2013, EMBO J, V32, P1334, DOI 10.1038/emboj.2013.68; Song MS, 2001, J BIOL CHEM, V276, P48709, DOI 10.1074/jbc.M107936200; Song MS, 2001, J BIOL CHEM, V276, P40668, DOI 10.1074/jbc.M106373200; Song MS, 2001, J BIOL CHEM, V276, P35165, DOI 10.1074/jbc.M100389200; Su XC, 2007, NUCLEIC ACIDS RES, V35, P2825, DOI 10.1093/nar/gkm080; Wieczorek A, 2006, J BIOL CHEM, V281, P12561, DOI 10.1074/jbc.M513844200; Wing RA, 2008, J MOL BIOL, V382, P859, DOI 10.1016/j.jmb.2008.07.058; Witte G, 2003, NUCLEIC ACIDS RES, V31, P4434, DOI 10.1093/nar/gkg498; Yuan Q, 2009, J BIOL CHEM, V284, P31672, DOI 10.1074/jbc.M109.050740	42	0	0	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16851	16860		10.1074/jbc.M115.661090	http://dx.doi.org/10.1074/jbc.M115.661090			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25987558	hybrid, Green Published			2022-12-28	WOS:000357572800030
J	Asghar, MY; Magnusson, M; Kemppainen, K; Sukumaran, P; Lof, C; Pulli, I; Kalhori, V; Tornquist, K				Asghar, Muhammad Yasir; Magnusson, Melissa; Kemppainen, Kati; Sukumaran, Pramod; Lof, Christoffer; Pulli, Ilari; Kalhori, Veronica; Tornquist, Kid			Transient Receptor Potential Canonical 1 (TRPC1) Channels as Regulators of Sphingolipid and VEGF Receptor Expression: IMPLICATIONS FOR THYROID CANCER CELL MIGRATION AND PROLIFERATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer; receptor; sphingosine-1-phosphate (S1P); thyroid; transient receptor potential channels (TRP channels); vascular endothelial growth factor (VEGF)	SPHINGOSINE 1-PHOSPHATE; MATRIX METALLOPROTEINASES; MAJOR REGULATOR; ION CHANNELS; CALCIUM; SPHINGOSINE-1-PHOSPHATE; PATHWAYS; ENTRY; ROLES	Background: The identity of calcium channels in the thyroid is undefined. Results: TRPC1 functions as a major regulator of S1P and VEGF receptors via a calcium-dependent mechanism. This is important for cell migration. Conclusion: We have defined a novel physiological role for the TRPC1 channel. Significance: This study explains how TRPC1 regulates receptor expression and migration in thyroid cancer cells. The identity of calcium channels in the thyroid is unclear. In human follicular thyroid ML-1 cancer cells, sphingolipid sphingosine 1-phosphate (S1P), through S1P receptors 1 and 3 (S1P(1)/S1P(3)), and VEGF receptor 2 (VEGFR2) stimulates migration. We show that human thyroid cells express several forms of transient receptor potential canonical (TRPC) channels, including TRPC1. In TRPC1 knockdown (TRPC1-KD) ML-1 cells, the basal and S1P-evoked invasion and migration was attenuated. Furthermore, the expression of S1P(3) and VEGFR2 was significantly down-regulated. Transfecting wild-type ML-1 cells with a nonconducting TRPC1 mutant decreased S1P(3) and VEGFR2 expression. In TRPC1-KD cells, receptor-operated calcium entry was decreased. To investigate whether the decreased receptor expression was due to attenuated calcium entry, cells were incubated with the calcium chelator BAPTA-AM (1,2-bis(o-aminophenoxy)ethane-N,N,N,N-tetraacetic acid). In these cells, and in cells where calmodulin and calmodulin-dependent kinase were blocked pharmacologically, S1P(3) and VEGFR2 expression was decreased. In TRPC1-KD cells, both hypoxia-inducible factor 1 expression and the secretion and activity of MMP2 and MMP9 were attenuated, and proliferation was decreased in TRPC1-KD cells. This was due to a prolonged G(1) phase of the cell cycle, a significant increase in the expression of the cyclin-dependent kinase inhibitors p21 and p27, and a decrease in the expression of cyclin D2, cyclin D3, and CDK6. Transfecting TRPC1 to TRPC1-KD cells rescued receptor expression, migration, and proliferation. Thus, the expression of S1P(3) and VEGFR2 is mediated by a calcium-dependent mechanism. TRPC1 has a crucial role in this process. This regulation is important for the invasion, migration, and proliferation of thyroid cancer cells.	[Pulli, Ilari; Kalhori, Veronica; Tornquist, Kid] Abo Akad Univ, Dept Biosci, FIN-20520 Turku, Finland; [Sukumaran, Pramod] Univ N Dakota, Sch Med & Hlth Sci, Dept Biochem & Mol Biol, Grand Forks, ND 58201 USA; [Lof, Christoffer] Univ Turku, Dept Physiol, Inst Biomed, FIN-20520 Turku, Finland; [Kalhori, Veronica; Tornquist, Kid] Minerva Fdn, Biomedicum Helsinki, Helsinki 00270, Finland	Abo Akademi University; University of North Dakota Grand Forks; University of Turku; University of Helsinki	Tornquist, K (corresponding author), Abo Akad Univ, Dept Biosci, Tykistokatu 6A, FIN-20520 Turku, Finland.	ktornqvi@abo.fi	Asghar, Muhammad Yasir/AAX-4895-2020	Lof, Christoffer/0000-0002-7149-5528; Sukumaran, Pramod/0000-0002-4781-3389; Kemppainen, Kati/0000-0003-3785-2269; Asghar, Muhammad Yasir/0000-0002-1935-8462; Pulli, Ilari/0000-0002-4785-8253	Sigrid Juselius Foundation; Center of Excellence in Cell Stress and Molecular Ageing of Abo Akademi University	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Center of Excellence in Cell Stress and Molecular Ageing of Abo Akademi University	This work was supported by the Sigrid Juselius Foundation and the Center of Excellence in Cell Stress and Molecular Ageing of Abo Akademi University. The authors declare that they have no conflicts of interest with the contents of this article.	Abramowitz J, 2009, FASEB J, V23, P297, DOI 10.1096/fj.08-119495; Ambudkar IS, 2007, BIOCHEM SOC T, V35, P96, DOI 10.1042/BST0350096; Ambudkar IS, 2007, CELL CALCIUM, V42, P213, DOI 10.1016/j.ceca.2007.01.013; Ariano P, 2011, CELL CALCIUM, V49, P387, DOI 10.1016/j.ceca.2011.03.007; Asghar MY, 2012, ENDOCR-RELAT CANCER, V19, P667, DOI 10.1530/ERC-12-0092; Baldini E, 2004, THYROID, V14, P881, DOI 10.1089/thy.2004.14.881; Balthasar S, 2008, ENDOCR-RELAT CANCER, V15, P521, DOI 10.1677/ERC-07-0253; Balthasar S, 2006, BIOCHEM J, V398, P547, DOI 10.1042/BJ20060299; Bergelin N, 2009, ENDOCRINOLOGY, V150, P2055, DOI 10.1210/en.2008-0625; Bergelin N, 2010, ENDOCRINOLOGY, V151, P2994, DOI [10.1210/en.2009-1387, 10.1210//en.2009-1387]; Birnbaumer L, 2009, ANNU REV PHARMACOL, V49, P395, DOI 10.1146/annurev.pharmtox.48.113006.094928; Blaho VA, 2014, J LIPID RES, V55, P1596, DOI 10.1194/jlr.R046300; Blom T, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-45; Cheng HP, 2006, ACTA PHARMACOL SIN, V27, P767, DOI 10.1111/j.1745-7254.2006.00399.x; Cheng KT, 2013, CURR TOP MEMBR, V71, P149, DOI 10.1016/B978-0-12-407870-3.00007-X; Crousillac S, 2009, J NEUROPHYSIOL, V102, P3295, DOI 10.1152/jn.00119.2009; Fabian A, 2011, PFLUG ARCH EUR J PHY, V461, P295, DOI 10.1007/s00424-010-0901-6; Formigli L, 2009, J CELL SCI, V122, P1322, DOI 10.1242/jcs.035402; Gratschev D, 2009, ENDOCRINOLOGY, V150, P5125, DOI 10.1210/en.2009-0288; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; JOENSUU H, 1986, AM J PATHOL, V124, P373; Kalhori V, 2015, MOL CELL ENDOCRINOL, V404, P113, DOI 10.1016/j.mce.2015.01.037; Kalhori V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066189; Kuang CY, 2012, STEM CELLS DEV, V21, P487, DOI 10.1089/scd.2011.0027; Li MQ, 2012, CELL CALCIUM, V51, P486, DOI 10.1016/j.ceca.2012.04.014; Lof C, 2012, MOL ENDOCRINOL, V26, P2046, DOI 10.1210/me.2012-1171; Louis M, 2008, J CELL SCI, V121, P3951, DOI 10.1242/jcs.037218; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Nesin V, 2014, HANDB EXP PHARMACOL, V222, P15, DOI 10.1007/978-3-642-54215-2_2; Nikiforova MN, 2003, J CLIN ENDOCR METAB, V88, P2318, DOI 10.1210/jc.2002-021907; Ong HL, 2014, HANDB EXP PHARMACOL, V223, P1005, DOI 10.1007/978-3-319-05161-1_12; Prevarskaya N, 2011, NAT REV CANCER, V11, P609, DOI 10.1038/nrc3105; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Pyne Susan, 2013, Handb Exp Pharmacol, P55, DOI 10.1007/978-3-7091-1511-4_3; Riccio A, 2002, MOL BRAIN RES, V109, P95, DOI 10.1016/S0169-328X(02)00527-2; Schwab A, 2012, PHYSIOL REV, V92, P1865, DOI 10.1152/physrev.00018.2011; Shi YF, 2004, CANC TREAT, V122, P179; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Storch U, 2012, J BIOL CHEM, V287, P3530, DOI 10.1074/jbc.M111.283218; Suchyna TM, 2004, NATURE, V430, P235, DOI 10.1038/nature02743; Suchyna TM, 2000, J GEN PHYSIOL, V115, P583, DOI 10.1085/jgp.115.5.583; Sukumaran P, 2013, MOL CELL ENDOCRINOL, V374, P10, DOI 10.1016/j.mce.2013.03.026; Sukumaran P, 2012, J BIOL CHEM, V287, P44345, DOI 10.1074/jbc.M112.374348; Tajeddine N, 2012, J BIOL CHEM, V287, P16146, DOI 10.1074/jbc.M112.340034; Tornquist K, 1997, ENDOCRINOLOGY, V138, P4049, DOI 10.1210/en.138.10.4049; Tornquist K, 2014, PFLUG ARCH EUR J PHY, V466, P2025, DOI 10.1007/s00424-014-1509-z; Viitanen TM, 2013, J CELL PHYSIOL, V228, P814, DOI 10.1002/jcp.24230; WES PD, 1995, P NATL ACAD SCI USA, V92, P9652, DOI 10.1073/pnas.92.21.9652; Woo JS, 2010, EXP MOL MED, V42, P614, DOI 10.3858/emm.2010.42.9.061; Xu SZ, 2006, CIRC RES, V98, P1381, DOI 10.1161/01.RES.0000225284.36490.a2	51	34	36	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16116	16131		10.1074/jbc.M115.643668	http://dx.doi.org/10.1074/jbc.M115.643668			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25971967	hybrid, Green Published			2022-12-28	WOS:000356930100017
J	Wei, AC; Liu, T; O'Rourke, B				Wei, An-Chi; Liu, Ting; O'Rourke, Brian			Dual Effect of Phosphate Transport on Mitochondrial Ca2+ Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP; bioenergetics; calcium; metabolism; mitochondrial transport; calcium buffer; calcium uniporter; phosphate carrier	RAT-KIDNEY MITOCHONDRIA; LIVER-MITOCHONDRIA; CALCIUM UNIPORTER; PERMEABILITY TRANSITION; ADENINE-NUCLEOTIDES; INORGANIC-PHOSPHATE; ESSENTIAL COMPONENT; INNER MEMBRANE; P-31 NMR; CARRIER	Background: Inorganic phosphate (P-i) buffers matrix Ca2+, but its impact on mitochondrial Ca2+ handling is often overlooked. Results: Mitochondrial Ca2+ uptake and buffering strictly depend on anion transport rates; ATP accelerates P-i-independent Ca2+ uptake. Conclusion: Maximal Ca2+ uniporter rate and Ca2+ buffering are anion transport limited; ATP alters influx without being hydrolyzed. Significance: P-i transport is fundamentally important in controlling mitochondrial Ca2+ signals. The large inner membrane electrochemical driving force and restricted volume of the matrix confer unique constraints on mitochondrial ion transport. Cation uptake along with anion and water movement induces swelling if not compensated by other processes. For mitochondrial Ca2+ uptake, these include activation of countertransporters (Na+/Ca2+ exchanger and Na+/H+ exchanger) coupled to the proton gradient, ultimately maintained by the proton pumps of the respiratory chain, and Ca2+ binding to matrix buffers. Inorganic phosphate (P-i) is known to affect both the Ca2+ uptake rate and the buffering reaction, but the role of anion transport in determining mitochondrial Ca2+ dynamics is poorly understood. Here we simultaneously monitor extra- and intra-mitochondrial Ca2+ and mitochondrial membrane potential ((m)) to examine the effects of anion transport on mitochondrial Ca2+ flux and buffering in P-i-depleted guinea pig cardiac mitochondria. Mitochondrial Ca2+ uptake proceeded slowly in the absence of P-i but matrix free Ca2+ ([Ca2+](mito)) still rose to approximate to 50 m. P-i (0.001-1 mm) accelerated Ca2+ uptake but decreased [Ca2+](mito) by almost 50% while restoring (m). P-i-dependent effects on Ca2+ were blocked by inhibiting the phosphate carrier. Mitochondrial Ca2+ uptake rate was also increased by vanadate (V-i), acetate, ATP, or a non-hydrolyzable ATP analog (AMP-PNP), with differential effects on matrix Ca2+ buffering and (m) recovery. Interestingly, ATP or AMP-PNP prevented the effects of P-i on Ca2+ uptake. The results show that anion transport imposes an upper limit on mitochondrial Ca2+ uptake and modifies the [Ca2+](mito) response in a complex manner.	[Wei, An-Chi; Liu, Ting; O'Rourke, Brian] Johns Hopkins Univ, Div Cardiol, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University	O'Rourke, B (corresponding author), Johns Hopkins Univ, Div Cardiol, Dept Med, 720 Rutland Ave,1060 Ross Bldg, Baltimore, MD 21205 USA.	bor@jhmi.edu	Regan, Clinton/E-6250-2012	Liu, Ting/0000-0002-8304-5751; Wei, An-Chi/0000-0001-7927-1636; O'Rourke, Brian/0000-0002-5548-4853	National Institutes of Health [R01HL101235, R01HL108917]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL101235, R01HL108917] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants R01HL101235 and R01HL108917. The authors declare that they have no conflicts of interest with the contents of this article.	Balaban RS, 2003, AM J PHYSIOL-CELL PH, V284, pC285, DOI 10.1152/ajpcell.00129.2002; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Buntinas L, 2001, BBA-BIOENERGETICS, V1504, P248, DOI 10.1016/S0005-2728(00)00254-1; CARAFOLI E, 1965, J BIOL CHEM, V240, P2254; Carafoli E, 2010, BBA-BIOENERGETICS, V1797, P595, DOI 10.1016/j.bbabio.2010.03.024; Chalmers S, 2003, J BIOL CHEM, V278, P19062, DOI 10.1074/jbc.M212661200; CHANCE B, 1965, J BIOL CHEM, V240, P2729; Chaudhuri D, 2013, ELIFE, V2, DOI 10.7554/eLife.00704; Csordas G, 2013, CELL METAB, V17, P976, DOI 10.1016/j.cmet.2013.04.020; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; DELUCA HF, 1961, P NATL ACAD SCI USA, V47, P1744, DOI 10.1073/pnas.47.11.1744; DEMASTER EG, 1973, BIOCHEMISTRY-US, V12, P3616, DOI 10.1021/bi00743a007; Fiermonte G, 2004, J BIOL CHEM, V279, P30722, DOI 10.1074/jbc.M400445200; GARLICK PB, 1983, J MOL CELL CARDIOL, V15, P855, DOI 10.1016/0022-2828(83)90347-4; GARLICK PB, 1992, NMR BIOMED, V5, P29, DOI 10.1002/nbm.1940050106; HARRIS EJ, 1977, FEBS LETT, V79, P284, DOI 10.1016/0014-5793(77)80804-1; Hoffman NE, 2014, MOL BIOL CELL, V25, P936, DOI 10.1091/mbc.E13-08-0502; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Kramer R, 1996, KIDNEY INT, V49, P947, DOI 10.1038/ki.1996.133; Kwong JQ, 2014, CELL DEATH DIFFER, V21, P1209, DOI 10.1038/cdd.2014.36; LANGER GA, 1980, AM J PHYSIOL, V239, pH769, DOI 10.1152/ajpheart.1980.239.6.H769; LEHNINGER AL, 1974, P NATL ACAD SCI USA, V71, P1520, DOI 10.1073/pnas.71.4.1520; Leung AWC, 2008, J BIOL CHEM, V283, P26312, DOI 10.1074/jbc.M805235200; Litsky ML, 1997, BIOCHEMISTRY-US, V36, P7071, DOI 10.1021/bi970180y; Liu T, 2009, J BIOENERG BIOMEMBR, V41, P127, DOI 10.1007/s10863-009-9216-8; Mallilankaraman K, 2012, NAT CELL BIOL, V14, P1336, DOI 10.1038/ncb2622; Nicholls DG, 2004, J BIOENERG BIOMEMBR, V36, P277, DOI 10.1023/B:JOBB.0000041753.52832.f3; NICHOLLS DG, 2013, BIOENERGETICS; PAPA S, 1973, FEBS LETT, V36, P9, DOI 10.1016/0014-5793(73)80325-4; PARADIES G, 1991, ARCH BIOCHEM BIOPHYS, V284, P332, DOI 10.1016/0003-9861(91)90304-2; Patron M, 2014, MOL CELL, V53, P726, DOI 10.1016/j.molcel.2014.01.013; Plovanich M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055785; Raffaello A, 2013, EMBO J, V32, P2362, DOI 10.1038/emboj.2013.157; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Sancak Y, 2013, SCIENCE, V342, P1379, DOI 10.1126/science.1242993; SPARAGNA GC, 1995, J BIOL CHEM, V270, P27510, DOI 10.1074/jbc.270.46.27510; TYLER DD, 1969, BIOCHEM J, V111, P665, DOI 10.1042/bj1110665; VASINGTON FD, 1962, J BIOL CHEM, V237, P2670; Wei AC, 2012, J GEN PHYSIOL, V139, P465, DOI 10.1085/jgp.201210784; Wei AC, 2011, BIOPHYS J, V100, P2894, DOI 10.1016/j.bpj.2011.05.027; Wei AC, 2011, BBA-MOL CELL RES, V1813, P1373, DOI 10.1016/j.bbamcr.2011.02.012; WEINBACH EC, 1967, BIOCHIM BIOPHYS ACTA, V148, P256, DOI 10.1016/0304-4165(67)90301-7; WOHLRAB H, 1986, BIOCHIM BIOPHYS ACTA, V853, P115, DOI 10.1016/0304-4173(86)90007-8; ZOCCARATO F, 1982, EUR J BIOCHEM, V127, P333, DOI 10.1111/j.1432-1033.1982.tb06875.x	44	16	16	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16088	16098		10.1074/jbc.M114.628446	http://dx.doi.org/10.1074/jbc.M114.628446			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25963147	hybrid, Green Published			2022-12-28	WOS:000356930100015
J	Hendriks, IA; Schimmel, J; Eifler, K; Olsen, JV; Vertegaal, ACO				Hendriks, Ivo A.; Schimmel, Joost; Eifler, Karolin; Olsen, Jesper V.; Vertegaal, Alfred C. O.			Ubiquitin-specific Protease 11 (USP11) Deubiquitinates Hybrid Small Ubiquitin-like Modifier (SUMO)-Ubiquitin Chains to Counteract RING Finger Protein 4 (RNF4)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						deubiquitylation (deubiquitination); DNA damage response; proteasome; RING finger protein 4 (RNF4); small ubiquitin-like modifier (SUMO); sumoylation; ubiquitin; ubiquitin-dependent protease; ubiquitylation (ubiquitination); USP11	PML NUCLEAR-BODIES; DNA-DAMAGE; IN-VIVO; E3 LIGASE; SUMO; SUMOYLATION; IDENTIFICATION; TARGETS; CELLS; MOTIF	Background: RNF4 is a ubiquitin ligase targeted to SUMOylated proteins. Results: USP11 co-purified with RNF4 and can remove ubiquitin polymers attached to SUMO chains. Conclusion: USP11 is a ubiquitin protease with the ability to counteract RNF4 in the DNA damage response. Significance: Identification of a ubiquitin protease to balance the activity of a SUMO-targeted ubiquitin ligase. Ring finger protein 4 (RNF4) is a SUMO-targeted ubiquitin E3 ligase with a pivotal function in the DNA damage response (DDR). SUMO interaction motifs (SIMs) in the N-terminal part of RNF4 tightly bind to SUMO polymers, and RNF4 can ubiquitinate these polymers in vitro. Using a proteomic approach, we identified the deubiquitinating enzyme ubiquitin-specific protease 11 (USP11), a known DDR-component, as a functional interactor of RNF4. USP11 can deubiquitinate hybrid SUMO-ubiquitin chains to counteract RNF4. SUMO-enriched nuclear bodies are stabilized by USP11, which functions downstream of RNF4 as a counterbalancing factor. In response to DNA damage induced by methyl methanesulfonate, USP11 could counteract RNF4 to inhibit the dissolution of nuclear bodies. Thus, we provide novel insight into cross-talk between ubiquitin and SUMO and uncover USP11 and RNF4 as a balanced SUMO-targeted ubiquitin ligase/protease pair with a role in the DDR.	[Hendriks, Ivo A.; Schimmel, Joost; Eifler, Karolin; Vertegaal, Alfred C. O.] Leiden Univ, Med Ctr, Dept Mol Cell Biol, NL-2333 ZA Leiden, Netherlands; [Olsen, Jesper V.] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Prot Res, DK-2200 Copenhagen, Denmark	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Copenhagen	Vertegaal, ACO (corresponding author), Leiden Univ, Med Ctr, Dept Mol Cell Biol, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands.	vertegaal@lumc.nl	Vertegaal, Alfred/ABG-8141-2021; Vertegaal, Alfred CO/Y-3875-2018; Olsen, Jesper/ABH-4638-2020	Vertegaal, Alfred/0000-0002-7989-0493; Vertegaal, Alfred CO/0000-0002-7989-0493; Olsen, Jesper/0000-0002-4747-4938; Hendriks, Ivo/0000-0002-1439-3701; Schimmel, Joost/0000-0002-2620-4349	Netherlands Organization for Scientific Research (NWO); ZonMW; European Research Council; Danish Research Council	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); ZonMW(Netherlands Organization for Health Research and Development); European Research Council(European Research Council (ERC)European Commission); Danish Research Council(Det Frie Forskningsrad (DFF))	This work was supported by the Netherlands Organization for Scientific Research (NWO) (to A. C. O. V.), ZonMW (to A. C. O. V.), the European Research Council (to A. C. O. V.), and the research career program FSS Sapere Aude (to J. V. O.) from the Danish Research Council. The authors declare that they have no conflicts of interest with the contents of this article.	Becker J, 2013, NAT STRUCT MOL BIOL, V20, P525, DOI 10.1038/nsmb.2526; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Brouwer AK, 2009, MOL BIOL CELL, V20, P4804, DOI 10.1091/mbc.E09-04-0309; Bruderer R, 2011, EMBO REP, V12, P142, DOI 10.1038/embor.2010.206; Burkhart RA, 2013, MOL CANCER RES, V11, P901, DOI 10.1158/1541-7786.MCR-12-0699; Conlan LA, 2004, ONCOGENE, V23, P307, DOI 10.1038/sj.onc.1207119; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Danielsen JR, 2012, J CELL BIOL, V197, P179, DOI 10.1083/jcb.201106152; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Galanty Y, 2012, GENE DEV, V26, P1179, DOI 10.1101/gad.188284.112; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Guo A, 2000, NAT CELL BIOL, V2, P730, DOI 10.1038/35036365; Hay RT, 2007, TRENDS CELL BIOL, V17, P370, DOI 10.1016/j.tcb.2007.08.002; Heideker J, 2009, DNA REPAIR, V8, P517, DOI 10.1016/j.dnarep.2009.01.010; Hendriks IA, 2015, CELL REP, V10, P1778, DOI 10.1016/j.celrep.2015.02.033; Hendriks IA, 2014, NAT STRUCT MOL BIOL, V21, P927, DOI 10.1038/nsmb.2890; Hickey CM, 2012, NAT REV MOL CELL BIO, V13, P755, DOI 10.1038/nrm3478; Hu XYV, 2010, P NATL ACAD SCI USA, V107, P15087, DOI 10.1073/pnas.1009025107; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Hunter T, 2009, ERNST SCHERING FOUND, V1, P1, DOI 10.1007/2789_2008_098; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Luo KT, 2012, EMBO J, V31, P3008, DOI 10.1038/emboj.2012.158; Matic I, 2008, MOL CELL PROTEOMICS, V7, P132, DOI 10.1074/mcp.M700173-MCP200; Matic I, 2010, MOL CELL, V39, P641, DOI 10.1016/j.molcel.2010.07.026; Nacerddine K, 2005, DEV CELL, V9, P769, DOI 10.1016/j.devcel.2005.10.007; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Poulsen SL, 2013, J CELL BIOL, V201, P797, DOI 10.1083/jcb.201212075; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Schimmel J, 2008, MOL CELL PROTEOMICS, V7, P2107, DOI 10.1074/mcp.M800025-MCP200; Schimmel J, 2014, MOL CELL, V53, P1053, DOI 10.1016/j.molcel.2014.02.001; Schimmel J, 2010, J PROTEOMICS, V73, P1523, DOI 10.1016/j.jprot.2010.03.008; Schoenfeld AR, 2004, MOL CELL BIOL, V24, P7444, DOI 10.1128/MCB.24.17.7444-7455.2004; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Smeenk G, 2010, J CELL BIOL, V190, P741, DOI 10.1083/jcb.201001048; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; STUURMAN N, 1992, J CELL SCI, V101, P773; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Sun HY, 2012, J BIOL CHEM, V287, P42071, DOI 10.1074/jbc.M112.410985; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Tatham MH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001484; Ulrich HD, 2005, TRENDS CELL BIOL, V15, P525, DOI 10.1016/j.tcb.2005.08.002; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; van Hagen M, 2010, NUCLEIC ACIDS RES, V38, P1922, DOI 10.1093/nar/gkp1157; Vertegaal ACO, 2007, BIOCHEM SOC T, V35, P1422, DOI 10.1042/BST0351422; Vertegaal ACO, 2004, J BIOL CHEM, V279, P33791, DOI 10.1074/jbc.M404201200; Vertegaal ACO, 2006, MOL CELL PROTEOMICS, V5, P2298, DOI 10.1074/mcp.M600212-MCP200; Vertegaal ACO, 2011, CHEM REV, V111, P7923, DOI 10.1021/cr200187e; Vertegaal ACO, 2010, BIOCHEM SOC T, V38, P46, DOI 10.1042/BST0380046; Vyas R, 2013, CELL DEATH DIFFER, V20, P490, DOI 10.1038/cdd.2012.145; Wang ZG, 1998, NAT GENET, V20, P266, DOI 10.1038/3073; Weisshaar SR, 2008, FEBS LETT, V582, P3174, DOI 10.1016/j.febslet.2008.08.008; Wiltshire TD, 2010, J BIOL CHEM, V285, P14565, DOI 10.1074/jbc.M110.104745; Wu HC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4214; Yin YL, 2012, GENE DEV, V26, P1196, DOI 10.1101/gad.189274.112	63	29	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15526	15537		10.1074/jbc.M114.618132	http://dx.doi.org/10.1074/jbc.M114.618132			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25969536	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000356527400018
J	Sechler, M; Borowicz, S; Van Scoyk, M; Avasarala, S; Zerayesus, S; Edwards, MG; Rathinam, MKK; Zhao, XM; Wu, PY; Tang, K; Bikkavilli, RK; Winn, RA				Sechler, Marybeth; Borowicz, Stanley; Van Scoyk, Michelle; Avasarala, Sreedevi; Zerayesus, Sereke; Edwards, Michael G.; Rathinam, Manoj Kumar Karuppusamy; Zhao, Xiangmin; Wu, Pei-Ying; Tang, Ke; Bikkavilli, Rama Kamesh; Winn, Robert A.			Novel Role for -Catenin in the Regulation of Cancer Cell Migration via the Induction of Hepatocyte Growth Factor Activator Inhibitor Type 1 (HAI-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-CATENIN; BETA-CATENIN; LUNG-CANCER; E-CADHERIN; FACTOR/SCATTER FACTOR; SIGNALING PATHWAY; CARCINOMA-CELLS; HGF-ACTIVATOR; N-CADHERIN; PLAKOGLOBIN	Background: -Catenin is a tumor suppressor in lung cancer. Results: -Catenin is a novel regulator of HAI-1 and cell migration. Conclusion: -Catenin and HAI-1 regulate cell migration and sensitize NSCLC cells to c-MET inhibitor. Significance: Targeting -catenin-mediated HAI-1 expression might be a new strategy to treat lung cancer. -catenin (Plakoglobin), a well-described structural protein functioning at the adherens junctions and desmosomes, was shown to be either lost or weakly expressed in non-small cell lung cancer (NSCLC) cells and tumor tissues. However, the tumor suppressive affects of -catenin were not fully understood. In this study, we have identified a novel role for the affects of -catenin on non-small cell lung cancer (NSCLC) cell migration. Expression of -catenin in NSCLC cells resulted in reduced cell migration as determined by both scratch assays and trans-well cell migration assays. Moreover, the affects of -catenin on cell migration were observed to be p53-dependent. Mechanistically, the anti-migratory effects seen via -catenin were driven by the expression of hepatocyte growth factor activator inhibitor Type I (HAI-1 or SPINT-1), an upstream inhibitor of the c-MET signaling pathway. Furthermore, the re-expression of -catenin sensitized NSCLC cells to c-MET inhibitor-mediated growth inhibition. Taken together, we identify -catenin as a novel regulator of HAI-1, which is a critical regulator of HGF/c-MET signaling. Therefore, targeting -catenin-mediated HAI-1 expression might be a useful strategy to sensitize NSCLC to c-MET inhibitors.	[Sechler, Marybeth] Univ Colorado, Canc Biol Program, Aurora, CO 80045 USA; [Edwards, Michael G.] Univ Colorado, Div Pulm Sci & Crit Care Med, Sch Med, Aurora, CO 80045 USA; [Borowicz, Stanley] Univ Illinois, Dept Med, Div Hematol & Oncol, Chicago, IL 60612 USA; [Van Scoyk, Michelle; Avasarala, Sreedevi; Zerayesus, Sereke; Rathinam, Manoj Kumar Karuppusamy; Zhao, Xiangmin; Wu, Pei-Ying; Tang, Ke; Bikkavilli, Rama Kamesh; Winn, Robert A.] Univ Illinois, Dept Med, Div Pulm Crit Care Sleep & Allergy, Chicago, IL 60612 USA; [Winn, Robert A.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Winn, RA (corresponding author), Univ Illinois, Coll Med, Dept Med, Div Pulm Crit Care Sleep & Allergy, Rm 5160,Res Bldg,909 S Wolcott Ave, Chicago, IL 60612 USA.	rwinn@uic.edu	Regan, Clinton/E-6250-2012	Tang, Ke/0000-0002-1804-5093	United States Dept. of Veterans Affairs; National Institutes of Health [R01CA138528]; NATIONAL CANCER INSTITUTE [R01CA138528, P50CA058187] Funding Source: NIH RePORTER	United States Dept. of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by a Merit Award from the United States Dept. of Veterans Affairs, and National Institutes of Health Grant R01CA138528 (to R. W.).	Aktary Z, 2013, J CELL SCI, V126, P3031, DOI 10.1242/jcs.120642; Breault JE, 2005, CLIN CANCER RES, V11, P557; Bren-Mattison Y, 2005, ONCOGENE, V24, P1412, DOI 10.1038/sj.onc.1208333; Eigenbrot C, 2010, FEBS J, V277, P2215, DOI 10.1111/j.1742-4658.2010.07638.x; Feng Y, 2012, J THORAC ONCOL, V7, P459, DOI 10.1097/JTO.0b013e3182417e44; Hoshiko S., CANC RES, V73, P2659; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Karahoca M, 2013, CLIN EPIGENETICS, V5, DOI 10.1186/1868-7083-5-3; Kataoka H, 2000, CANCER RES, V60, P6148; Kataoka H, 2000, J BIOL CHEM, V275, P40453, DOI 10.1074/jbc.M006412200; Kataoka H, 2003, CANCER METAST REV, V22, P223, DOI 10.1023/A:1023051500010; KNUDSEN KA, 1992, J CELL BIOL, V118, P671, DOI 10.1083/jcb.118.3.671; Kohler BA, 2011, JNCI-J NATL CANCER I, V103, P714, DOI 10.1093/jnci/djr077; Maeda O, 2004, ONCOGENE, V23, P964, DOI 10.1038/sj.onc.1207254; MCCREA PD, 1991, SCIENCE, V254, P1359, DOI 10.1126/science.1962194; Momparler RL, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00188; Mukhina S, 2004, P NATL ACAD SCI USA, V101, P15166, DOI 10.1073/pnas.0405881101; Nagaike K, 2008, AM J PATHOL, V173, P1464, DOI 10.2353/ajpath.2008.071142; Nagashima H, 1997, HEART VESSELS, P110; Nakamura K, 2010, INT J ONCOL, V37, P605, DOI 10.3892/ijo_00000709; Organ Shawna Leslie, 2011, Ther Adv Med Oncol, V3, pS7, DOI 10.1177/1758834011422556; Pantel K, 1998, J CLIN ONCOL, V16, P1407, DOI 10.1200/JCO.1998.16.4.1407; Parker HR, 1998, CELL MOTIL CYTOSKEL, V40, P87, DOI 10.1002/(SICI)1097-0169(1998)40:1<87::AID-CM8>3.0.CO;2-C; Parr C, 2001, INT J ONCOL, V19, P857; Peruzzi B, 2006, CLIN CANCER RES, V12, P3657, DOI 10.1158/1078-0432.CCR-06-0818; Pigors M, 2011, HUM MOL GENET, V20, P1811, DOI 10.1093/hmg/ddr064; Rieger-Christ KM, 2005, BRIT J CANCER, V92, P2153, DOI 10.1038/sj.bjc.6602651; Sadiq AA, 2013, J CLIN ONCOL, V31, P1089, DOI 10.1200/JCO.2012.43.9422; Sattler Martin, 2009, Update Cancer Ther, V3, P109, DOI 10.1016/j.uct.2009.01.001; Sechler M, 2013, PHARMACOGN PERS MED, V6, P25, DOI 10.2147/PGPM.S26058; Shiina H, 2005, CANCER RES, V65, P2130, DOI 10.1158/0008-5472.CAN-04-3398; Shimizu M, 2008, MOL CELL BIOL, V28, P825, DOI 10.1128/MCB.02375-06; SONNENBERG E, 1993, J CELL BIOL, V123, P223, DOI 10.1083/jcb.123.1.223; Tjin EPM, 2004, BLOOD, V104, P2172, DOI 10.1182/blood-2003-12-4386; Winn RA, 2002, ONCOGENE, V21, P7497, DOI 10.1038/sj.onc.1205963; Yin TF, 2005, J BIOL CHEM, V280, P40355, DOI 10.1074/jbc.M506692200; Zhurinsky J, 2000, J CELL SCI, V113, P3127	37	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15610	15620		10.1074/jbc.M114.631820	http://dx.doi.org/10.1074/jbc.M114.631820			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25925948	Green Published, hybrid			2022-12-28	WOS:000356527400025
J	Pamir, N; Liu, NC; Irwin, A; Becker, L; Peng, YF; Ronsein, GE; Bornfeldt, KE; Duffield, JS; Heinecke, JW				Pamir, Nathalie; Liu, Ning-Chun; Irwin, Angela; Becker, Lev; Peng, YuFeng; Ronsein, Graziella E.; Bornfeldt, Karin E.; Duffield, Jeremy S.; Heinecke, Jay W.			Granulocyte/Macrophage Colony-stimulating Factor-dependent Dendritic Cells Restrain Lean Adipose Tissue Expansion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PREADIPOCYTE FACTOR-I; MOUSE BONE-MARROW; ADIPOCYTE DIFFERENTIATION; GM-CSF; GENE-EXPRESSION; ENERGY-BALANCE; OBESITY; MICE; ADIPOGENESIS; HETEROGENEITY	The physiological roles of macrophages and dendritic cells (DCs) in lean white adipose tissue homeostasis have received little attention. Because DCs are generated from bone marrow progenitors in the presence of granulocyte/macrophage colony-stimulating factor (GM-CSF), we used GM-CSF-deficient (Csf2(-/-)) mice fed a low fat diet to test the hypothesis that adipose tissue DCs regulate the development of adipose tissue. At 4 weeks of age, Csf2(-/-) mice had 75% fewer CD45(+)Cd11b(+) Cd11c(+)MHCII(+) F4/80(-) DCs in white adipose tissue than did wild-type controls. Furthermore, the Csf2(-/-) mice showed a 30% increase in whole body adiposity, which persisted to adulthood. Adipocytes from Csf2(-/-) mice were 50% larger by volume and contained higher levels of adipogenesis gene transcripts, indicating enhanced adipocyte differentiation. In contrast, adipogenesis/adipocyte lipid accumulation was inhibited when preadipocytes were co-cultured with CD45(+)Cd11b(+)Cd11c(+) MHCII(+)F4/80(-) DCs. Medium conditioned by DCs, but not by macrophages, also inhibited adipocyte lipid accumulation. Proteomic analysis revealed that matrix metalloproteinase 12 and fibronectin 1 were greatly enriched in the medium conditioned by DCs compared with that conditioned by macrophages. Silencing fibronectin or genetic deletion of matrix metalloproteinase 12 in DCs partially reversed the inhibition of adipocyte lipid accumulation. Our observations indicate that DCs residing in adipose tissue play a critical role in suppressing normal adipose tissue expansion.	[Pamir, Nathalie; Liu, Ning-Chun; Irwin, Angela; Ronsein, Graziella E.; Bornfeldt, Karin E.; Heinecke, Jay W.] Univ Washington, Dept Med, Seattle, WA 98109 USA; [Peng, YuFeng] Univ Washington, Dept Rheumatol, Seattle, WA 98109 USA; [Bornfeldt, Karin E.] Univ Washington, Dept Pathol, Seattle, WA 98109 USA; [Duffield, Jeremy S.] Univ Washington, Div Nephrol & Lung Biol, Seattle, WA 98109 USA; [Becker, Lev] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Chicago	Pamir, N (corresponding author), Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	pamir@ohsu.edu	Regan, Clinton/E-6250-2012; Bornfeldt, Karin/AAI-2241-2019; Ronsein, Graziella E/H-8676-2014; peng, yu/GXW-2071-2022	Bornfeldt, Karin/0000-0001-9208-6523; Ronsein, Graziella E/0000-0002-2340-6770; Pamir, Nathalie/0000-0002-2074-888X	National Institutes of Health [HL092969, HL097365, HL062887, P30 DK035816, P30 DK017047, HL108897, HL112625]; Quantitative and Functional Proteomics Core of the Diabetes Research Center (University of Washington); NORC Energy Balance and Glucose Metabolism Core; American Heart Association [11POST7390072]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108897, R01HL097365, R01HL062887, R01HL112625, P01HL092969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093493, P30DK035816, P30DK017047] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Quantitative and Functional Proteomics Core of the Diabetes Research Center (University of Washington); NORC Energy Balance and Glucose Metabolism Core; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL092969, HL097365, HL062887, P30 DK035816, P30 DK017047, HL108897, and HL112625. This work was also supported in part by the Quantitative and Functional Proteomics Core of the Diabetes Research Center (University of Washington), the NORC Energy Balance and Glucose Metabolism Core, and American Heart Association Grant 11POST7390072.	AILHAUD G, 1992, ANNU REV NUTR, V12, P207, DOI 10.1146/annurev.nu.12.070192.001231; AOTA S, 1991, BIOCHEM SOC T, V19, P830, DOI 10.1042/bst0190830; Averill MM, 2012, ARTERIOSCL THROM VAS, V32, P223, DOI 10.1161/ATVBAHA.111.236927; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Becker L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033297; Bilkovski R, 2011, INT J OBESITY, V35, P1450, DOI 10.1038/ijo.2011.6; Cawthorn WP, 2007, CELL DEATH DIFFER, V14, P1361, DOI 10.1038/sj.cdd.4402127; Cheong C, 2010, CELL, V143, P416, DOI 10.1016/j.cell.2010.09.039; de Jong EC, 2005, SPRINGER SEMIN IMMUN, V26, P289, DOI 10.1007/s00281-004-0167-1; Gagnon A, 2012, LIPIDS, V47, P873, DOI 10.1007/s11745-012-3696-8; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Guyenet SJ, 2012, J CLIN ENDOCR METAB, V97, P745, DOI 10.1210/jc.2011-2525; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Hamilton JA, 2012, CYTOKINE, V57, P30, DOI 10.1016/j.cyto.2011.10.021; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; Helft J, 2010, IMMUNOL REV, V234, P55, DOI 10.1111/j.0105-2896.2009.00885.x; Hume DA, 2008, MUCOSAL IMMUNOL, V1, P432, DOI 10.1038/mi.2008.36; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Ingraham CA, 2011, J BIOL CHEM, V286, P17649, DOI 10.1074/jbc.M111.229427; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kim DH, 2008, AM J PHYSIOL-ENDOC M, V295, pE1038, DOI 10.1152/ajpendo.00061.2008; Kim KA, 2007, MOL CELL BIOL, V27, P2294, DOI 10.1128/MCB.02207-06; Lee JT, 2014, ENDOCRINOLOGY, V155, P3409, DOI 10.1210/en.2014-1037; Lee K, 2003, J CLIN INVEST, V111, P453, DOI 10.1172/JCI15924; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu CX, 2010, ENDOCRINOLOGY, V151, P2189, DOI 10.1210/en.2009-1194; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Mabbott NA, 2010, IMMUNOBIOLOGY, V215, P724, DOI 10.1016/j.imbio.2010.05.012; McLean J. A., 1987, HUMAN ANIMAL CALORIM, P52; Mei BS, 2002, BIOCHEM J, V364, P137, DOI 10.1042/bj3640137; Merad M, 2009, BLOOD, V113, P3418, DOI 10.1182/blood-2008-12-180646; Moon YS, 2002, MOL CELL BIOL, V22, P5585, DOI 10.1128/MCB.22.15.5585-5592.2002; Morrison RF, 2000, J NUTR, V130, p3116S, DOI 10.1093/jn/130.12.3116S; Mystkowski P, 2000, INT J OBESITY, V24, P719, DOI 10.1038/sj.ijo.0801231; Nishimura S, 2007, DIABETES, V56, P1517, DOI 10.2337/db06-1749; O'Connell J, 2011, J CLIN ENDOCR METAB, V96, pE680, DOI 10.1210/jc.2010-2026; Pamir N, 2012, AM J PHYSIOL-ENDOC M, V302, pE961, DOI 10.1152/ajpendo.00447.2011; Pamir N, 2009, ENDOCRINOLOGY, V150, P4124, DOI 10.1210/en.2009-0137; Peng YF, 2011, J CLIN INVEST, V121, P2221, DOI 10.1172/JCI43254; Plenz G, 2003, FASEB J, V17, P1451, DOI 10.1096/fj.02-1035com; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosenson RS, 2011, CLIN CHEM, V57, P392, DOI 10.1373/clinchem.2010.155333; Schreyer SA, 1996, J BIOL CHEM, V271, P26174, DOI 10.1074/jbc.271.42.26174; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Soukas A, 2001, J BIOL CHEM, V276, P34167, DOI 10.1074/jbc.M104421200; SPIEGELMAN BM, 1983, CELL, V35, P657, DOI 10.1016/0092-8674(83)90098-3; Sul HS, 2009, MOL ENDOCRINOL, V23, P1717, DOI 10.1210/me.2009-0160; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; van de Laar L, 2012, BLOOD, V119, P3383, DOI 10.1182/blood-2011-11-370130; Virtue S, 2008, PLOS BIOL, V6, P1819, DOI 10.1371/journal.pbio.0060237; Wang YH, 2010, CLIN LIPIDOL, V5, P109, DOI 10.2217/CLP.09.80; Zhu SN, 2009, J EXP MED, V206, P2141, DOI 10.1084/jem.20090866	53	24	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14656	14667		10.1074/jbc.M115.645820	http://dx.doi.org/10.1074/jbc.M115.645820			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25931125	hybrid, Green Published			2022-12-28	WOS:000355754600036
J	Cameron, K; Najmudin, S; Alves, VD; Bayer, EA; Smith, SP; Bule, P; Waller, H; Ferreira, LMA; Gilbert, HJ; Fontes, CMGA				Cameron, Kate; Najmudin, Shabir; Alves, Victor D.; Bayer, Edward A.; Smith, Steven P.; Bule, Pedro; Waller, Helen; Ferreira, Luis M. A.; Gilbert, Harry J.; Fontes, Carlos M. G. A.			Cell-surface Attachment of Bacterial Multienzyme Complexes Involves Highly Dynamic Protein-Protein Anchors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUAL BINDING MODE; ACETIVIBRIO-CELLULOLYTICUS; COHESIN DOMAIN; DOCKERIN; CELLULOSOME; SCAFFOLDIN; NANOMACHINES; CONTAINS; SYSTEM; GENOME	Protein-protein interactions play a pivotal role in the assembly of the cellulosome, one of nature's most intricate nanomachines dedicated to the depolymerization of complex carbohydrates. The integration of cellulosomal components usually occurs through the binding of type I dockerin modules located at the C terminus of the enzymes to cohesin modules located in the primary scaffoldin subunit. Cellulosomes are typically recruited to the cell surface via type II cohesin-dockerin interactions established between primary and cell-surface anchoring scaffoldin subunits. In contrast with type II interactions, type I dockerins usually display a dual binding mode that may allow increased conformational flexibility during cellulosome assembly. Acetivibrio cellulolyticus produces a highly complex cellulosome comprising an unusual adaptor scaffoldin, ScaB, which mediates the interaction between the primary scaffoldin, ScaA, through type II cohesin-dockerin interactions and the anchoring scaffoldin, ScaC, via type I cohesin-dockerin interactions. Here, we report the crystal structure of the type I ScaB dockerin in complex with a type I ScaC cohesin in two distinct orientations. The data show that the ScaB dockerin displays structural symmetry, reflected by the presence of two essentially identical binding surfaces. The complex interface is more extensive than those observed in other type I complexes, which results in an ultra-high affinity interaction (K-a similar to 10(12) M). A subset of ScaB dockerin residues was also identified as modulating the specificity of type I cohesin-dockerin interactions in A. cellulolyticus. This report reveals that recruitment of cellulosomes onto the cell surface may involve dockerins presenting a dual binding mode to incorporate additional flexibility into the quaternary structure of highly populated multienzyme complexes.	[Cameron, Kate; Najmudin, Shabir; Alves, Victor D.; Bule, Pedro; Ferreira, Luis M. A.; Fontes, Carlos M. G. A.] ULisboa, CIISA, Fac Med Vet, Polo Univ Alto da Ajuda, P-1300477 Lisbon, Portugal; [Bayer, Edward A.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Smith, Steven P.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada; [Waller, Helen; Gilbert, Harry J.] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Universidade de Lisboa; Weizmann Institute of Science; Queens University - Canada; Newcastle University - UK	Najmudin, S (corresponding author), ULisboa, CIISA, Fac Med Vet, Polo Univ Alto da Ajuda, Ave Univ Tecn, P-1300477 Lisbon, Portugal.	shabir@fmv.ulisboa.pt	Bule, Pedro/W-6838-2019	Bule, Pedro/0000-0003-2531-9926; Alves, Victor Diogo/0000-0002-8430-4380; Fontes, Carlos/0000-0002-1219-9753; Najmudin, Shabir/0000-0002-0429-5454; Smith, Steven/0000-0003-2710-4400	Fundacao para a Ciencia e a Tecnologia (Lisbon, Portugal) [PTDC/BIA-PRO/103980/2008, EXPL/BIA-MIC/1176/2012]; European Union [263916, 283570]	Fundacao para a Ciencia e a Tecnologia (Lisbon, Portugal)(Portuguese Foundation for Science and Technology); European Union(European Commission)	This work was supported in part by Fundacao para a Ciencia e a Tecnologia (Lisbon, Portugal) Grants PTDC/BIA-PRO/103980/2008 and EXPL/BIA-MIC/1176/2012, European Union Seventh Framework Programme FP7 2007-2013 under the WallTraC Project Grant 263916, and BioStruct-X Grant 283570.	Artzi L, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-100; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; Cameron K, 2012, ACTA CRYSTALLOGR F, V68, P1030, DOI 10.1107/S1744309112031922; Carvalho AL, 2003, P NATL ACAD SCI USA, V100, P13809, DOI 10.1073/pnas.1936124100; Carvalho AL, 2007, P NATL ACAD SCI USA, V104, P3089, DOI 10.1073/pnas.0611173104; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dassa B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-210; Ding SY, 2000, J BACTERIOL, V182, P4915, DOI 10.1128/JB.182.17.4915-4925.2000; Ding SY, 1999, J BACTERIOL, V181, P6720, DOI 10.1128/JB.181.21.6720-6729.1999; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fontes CMGA, 2010, ANNU REV BIOCHEM, V79, P655, DOI 10.1146/annurev-biochem-091208-085603; Gilbert HJ, 2007, MOL MICROBIOL, V63, P1568, DOI 10.1111/j.1365-2958.2007.05640.x; Haimovitz R, 2008, PROTEOMICS, V8, P968, DOI 10.1002/pmic.200700486; Hamberg Y, 2014, PEERJ, V2, DOI 10.7717/peerj.636; KHAN AW, 1980, J GEN MICROBIOL, V121, P499; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LAMED R, 1987, J BACTERIOL, V169, P3792, DOI 10.1128/jb.169.8.3792-3800.1987; Leibovitz E, 1996, J BACTERIOL, V178, P3077, DOI 10.1128/jb.178.11.3077-3084.1996; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller MEB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006650; Miras I, 2002, BIOCHEMISTRY-US, V41, P2115, DOI 10.1021/bi011854e; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nagy T, 2007, J MOL BIOL, V373, P612, DOI 10.1016/j.jmb.2007.08.007; Pinheiro BA, 2008, J BIOL CHEM, V283, P18422, DOI 10.1074/jbc.M801533200; Schaeffer F, 2002, BIOCHEMISTRY-US, V41, P2106, DOI 10.1021/bi011853m; Xu Q, 2004, J BACTERIOL, V186, P5782, DOI 10.1128/JB.186.17.5782-5789.2004; Xu Q, 2003, J BACTERIOL, V185, P4548, DOI 10.1128/JB.185.15.4548-4557.2003	28	16	16	0	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13578	13590		10.1074/jbc.M114.633339	http://dx.doi.org/10.1074/jbc.M114.633339			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25855788	hybrid, Green Published			2022-12-28	WOS:000354975700051
J	Majumder, A; Syed, KM; Joseph, S; Scambler, PJ; Dutta, D				Majumder, Aditi; Syed, Khaja Mohieddin; Joseph, Sunu; Scambler, Peter J.; Dutta, Debasree			Histone Chaperone HIRA in Regulation of Transcription Factor RUNX1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC STEM-CELLS; DEFINITIVE HEMATOPOIESIS; HEMOGENIC ENDOTHELIUM; AORTIC ENDOTHELIUM; YOLK-SAC; C-MYB; GENE; EXPRESSION; LEUKEMIA; COMPLEX	RUNX1 (Runt-related transcription factor 1) is indispensable for the generation of hemogenic endothelium. However, the regulation of RUNX1 during this developmental process is poorly understood. We investigated the role of the histone chaperone HIRA (histone cell cycle regulation-defective homolog A) from this perspective and report that HIRA significantly contributes toward the regulation of RUNX1 in the transition of differentiating mouse embryonic stem cells from hemogenic to hematopoietic stage. Direct interaction of HIRA and RUNX1 activates the downstream targets of RUNX1 implicated in generation of hematopoietic stem cells. At the molecular level, HIRA-mediated incorporation of histone H3.3 variant within the Runx1 + 24 mouse conserved noncoding element is essential for the expression of Runx1 during endothelial to hematopoietic transition. An inactive chromatin at the intronic enhancer of Runx1 in absence of HIRA significantly repressed the transition of cells from hemogenic to hematopoietic fate. We expect that the HIRA-RUNX1 axis might open up a novel approach in understanding leukemogenesis in future.	[Majumder, Aditi; Syed, Khaja Mohieddin; Joseph, Sunu; Dutta, Debasree] Rajiv Gandhi Ctr Biotechnol, Canc Res Program, Thiruvananthapuram 695014, Kerala, India; [Scambler, Peter J.] UCL, Inst Child Hlth, London WC1E 6BT, England	Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB); University of London; University College London	Dutta, D (corresponding author), Rajiv Gandhi Ctr Biotechnol, Canc Res Program, Thycaud PO, Thiruvananthapuram 695014, Kerala, India.	debasreedutta@rgcb.res.in	Scambler, Peter/AAZ-6026-2020	Scambler, Peter/0000-0002-1487-4628	Department of Science & Technology, India [SB/FT/LS-158/2012]; Department of Biotechnology, India; Department of Biotechnology (DBT), India [DBT/JRF/13/AL/452]; DBT [BT/PR5754/MED/31/167/2012]; British Heart Foundation [RG/15/13/28570]; British Heart Foundation [RG/10/13/28570, PG/15/6/31211] Funding Source: researchfish	Department of Science & Technology, India(Department of Science & Technology (India)); Department of Biotechnology, India(Department of Biotechnology (DBT) India); Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India); DBT(Department of Biotechnology (DBT) India); British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This work was supported by Grant SB/FT/LS-158/2012 from the Department of Science & Technology, India, and by intramural funding from the Department of Biotechnology, India.; Supported by Fellowship DBT/JRF/13/AL/452 from the Department of Biotechnology (DBT), India.; Supported by DBT Fellowship BT/PR5754/MED/31/167/2012.; Supported by British Heart Foundation Grant RG/15/13/28570.	Bakshi R, 2010, J CELL PHYSIOL, V225, P569, DOI 10.1002/jcp.22240; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Burgess RJ, 2013, NAT STRUCT MOL BIOL, V20, P14, DOI 10.1038/nsmb.2461; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Chiang PM, 2011, DEVELOPMENT, V138, P2833, DOI 10.1242/dev.061440; Clarke RL, 2013, NAT CELL BIOL, V15, P502, DOI 10.1038/ncb2724; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; Dutta D, 2011, STEM CELLS, V29, P618, DOI 10.1002/stem.605; Dutta D, 2010, J BIOL CHEM, V285, P41567, DOI 10.1074/jbc.M110.190025; Elagib KE, 2003, BLOOD, V101, P4333, DOI 10.1182/blood-2002-09-2708; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Green EM, 2005, CURR BIOL, V15, P2044, DOI 10.1016/j.cub.2005.10.053; HERNANDEZMUNAIN C, 1994, MOL CELL BIOL, V14, P473, DOI 10.1128/MCB.14.1.473; Hoogenkamp M, 2007, MOL CELL BIOL, V27, P7425, DOI 10.1128/MCB.00905-07; Jin H, 2012, BLOOD, V119, P5239, DOI 10.1182/blood-2011-12-398362; Koh CP, 2013, LEUKEMIA, V27, P1793, DOI 10.1038/leu.2013.200; Lancrin C, 2012, BLOOD, V120, P314, DOI 10.1182/blood-2011-10-386094; Lichtinger M, 2012, EMBO J, V31, P4318, DOI 10.1038/emboj.2012.275; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Ng CEL, 2010, STEM CELLS, V28, P1869, DOI 10.1002/stem.507; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Osato M, 2004, ONCOGENE, V23, P4284, DOI 10.1038/sj.onc.1207779; Palis J, 1999, DEVELOPMENT, V126, P5073; Pchelintsev NA, 2013, CELL REP, V3, P1012, DOI 10.1016/j.celrep.2013.03.026; Ray S, 2009, J BIOL CHEM, V284, P4978, DOI 10.1074/jbc.M807329200; Roberts C, 2002, MOL CELL BIOL, V22, P2318, DOI 10.1128/MCB.22.7.2318-2328.2002; Samokhvalov IM, 2007, NATURE, V446, P1056, DOI 10.1038/nature05725; Soni S, 2014, P NATL ACAD SCI USA, V111, P13337, DOI 10.1073/pnas.1405422111; Soza-Ried C, 2010, P NATL ACAD SCI USA, V107, P17304, DOI 10.1073/pnas.1004640107; Staibano S, 2009, HISTOPATHOLOGY, V54, P580, DOI 10.1111/j.1365-2559.2009.03266.x; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zaidi SK, 2009, CANCER RES, V69, P8249, DOI 10.1158/0008-5472.CAN-09-1567	34	18	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13053	13063		10.1074/jbc.M114.615492	http://dx.doi.org/10.1074/jbc.M114.615492			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25847244	Green Published, hybrid			2022-12-28	WOS:000354975700010
J	Ali, A; Bhatti, MZ; Shah, AS; Duong, HQ; Alkreathy, HM; Mohammad, SF; Khan, RA; Ahmad, A				Ali, Amjad; Bhatti, Muhammad Zeeshan; Shah, Abdus Saboor; Hong-Quan Duong; Alkreathy, Huda Mohammad; Mohammad, Shah Faisal; Khan, Rahmat Ali; Ahmad, Ayaz			Tumor-suppressive p53 Signaling Empowers Metastatic Inhibitor KLF17-dependent Transcription to Overcome Tumorigenesis in Non-small Cell Lung Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Metastasis; KLF17; tumor suppressor p53; lung cancer; chemotherapy	EPITHELIAL-MESENCHYMAL TRANSITIONS; KLF17 EXPRESSION; POOR-PROGNOSIS; MUTANT P53; GROWTH; GENE; PATHWAY; RESTORATION; ACETYLATION; ACTIVATION	Background: How Kruppel-like factor 17 (KLF17) controls metastasis and epithelial-mesenchymal transition (EMT) during cancer progression remains unknown. Results: Tumor-suppressive p53 signaling is critical for KLF17 to inhibit cancer metastasis in NSCLC. Conclusion: These results indicate novel insights into the anti-EMT effect of KLF17 via p53-dependent pathway. Significance: Targeting KLF17 for cancer therapy may be applicable to NSCLC tumors with TP53 status, which may improve the prognosis of NSCLC patients. Metastasis, which is controlled by concerted action of multiple genes, is a complex process and is an important cause of cancer death. Kruppel-like factor 17 (KLF17) is a negative regulator of metastasis and epithelial-mesenchymal transition (EMT) during cancer progression. However, the underlying molecular mechanism and biological relevance of KLF17 in cancer cells are poorly understood. Here, we show that tumor suppressor protein p53 plays an integral role to induce KLF17 expression in non-small cell lung cancer (NSCLC). p53 is recruited to the KLF17 promoter and results in the formation of p53-DNA complex. p53 enhances binding of p300 and favors histone acetylation on the KLF17 promoter. Mechanistically, p53 physically interacts with KLF17 and thereby enhances the anti-metastatic function of KLF17. p53 empowers KLF17-mediated EMT genes transcription via enhancing physical association of KLF17 with target gene promoters. Nutlin-3 recruits KLF17 to EMT target gene promoters and results in the formation of KLF17-DNA complex via a p53-dependent pathway. p53 depletion abrogates DNA binding affinity of KLF17 to EMT target gene promoters. KLF17 is critical for p53 cellular activities in NSCLC. Importantly, KLF17 enhances p53 transcription to generate a novel positive feedback loop. KLF17 depletion accelerates lung cancer cell growth in response to chemotherapy. Mechanistically, we found that KLF17 increases the expression of tumor suppressor genes p53, p21, and pRB. Functionally, KLF17 required p53 to suppress cancer cell invasion and migration in NSCLC. In conclusion, our study highlights a novel insight into the anti-EMT effect of KLF17 via a p53-dependent pathway in NSCLC, and KLF17 may be a new therapeutic target in NSCLC with p53 status.	[Ali, Amjad; Bhatti, Muhammad Zeeshan; Shah, Abdus Saboor] E China Normal Univ, Sch Life Sci, Inst Biomed Sci, Shanghai 200241, Peoples R China; [Hong-Quan Duong] Duy Tan Univ, Inst Res & Dev, Danang 59000, Vietnam; [Alkreathy, Huda Mohammad] King Abdulaziz Univ, Fac Med, Dept Pharmacol, Jeddah 21413, Saudi Arabia; [Mohammad, Shah Faisal] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Microbial Metab, Lab Enzymol & Mol Evolut, Shanghai 200240, Peoples R China; [Mohammad, Shah Faisal; Khan, Rahmat Ali] Univ Sci & Technol Bannu, Fac Biol Sci, Dept Biotechnol, Khyber Pakhtunkhwa, Pakistan; [Ahmad, Ayaz] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing 100101, Peoples R China; [Ali, Amjad; Bhatti, Muhammad Zeeshan; Ahmad, Ayaz] Abdul Wali Khan Univ, Dept Biotechnol, Mardan 23200, Pakistan	East China Normal University; Duy Tan University; King Abdulaziz University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Abdul Wali Khan University	Ali, A (corresponding author), E China Normal Univ, Inst Biomed Sci, 500 Dongchuan Rd, Shanghai 200241, Peoples R China.	amjad_486@yahoo.com; ahdayazb5@awkum.edu.pk	ALKREATHY, HUDA/AAF-1939-2019; Bhatti, Muhammad Zeeshan/ACS-5136-2022; Khan, Rahmat Ali/AAD-7790-2020; Ahmad, Ayaz/GVT-1025-2022	ALKREATHY, HUDA/0000-0002-7824-8802; Ahmad, Ayaz/0000-0003-3555-4735; Bhatti, Muhammad Zeeshan/0000-0003-0532-0532	Higher Education Commission; Ministry of Education of Pakistan	Higher Education Commission(Ministry of Higher Education & Scientific Research (MHESR)); Ministry of Education of Pakistan	This work was supported by the Higher Education Commission and the Ministry of Education of Pakistan.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Ali A, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.48; Ali A, 2014, CANCER LETT, V354, P87, DOI 10.1016/j.canlet.2014.07.045; Ali A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3667; Nieto MA, 2009, INT J DEV BIOL, V53, P1541, DOI 10.1387/ijdb.072410mn; Arva Nicoleta C, 2008, Ethn Dis, V18, pS2; Avantaggiati ML, 1997, CELL, V89, P1175, DOI 10.1016/S0092-8674(00)80304-9; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Cai XD, 2012, BIOCHEM BIOPH RES CO, V418, P67, DOI 10.1016/j.bbrc.2011.12.129; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Dong PX, 2014, CARCINOGENESIS, V35, P760, DOI 10.1093/carcin/bgt369; Ettinger DS, 2010, J NATL COMPR CANC NE, V8, P740, DOI 10.6004/jnccn.2010.0056; Goodrich DW, 2006, ONCOGENE, V25, P5233, DOI 10.1038/sj.onc.1209616; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Gumireddy K, 2009, NAT CELL BIOL, V11, P1297, DOI 10.1038/ncb1974; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Iwanicki MP, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-244; Iyer NG, 2004, P NATL ACAD SCI USA, V101, P7386, DOI 10.1073/pnas.0401002101; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Kunkele A, 2012, NEURO-ONCOLOGY, V14, P859, DOI 10.1093/neuonc/nos115; Lazar V, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-53; Lee ER, 2007, STEM CELLS, V25, P2191, DOI 10.1634/stemcells.2007-0203; Lee JH, 2010, ONCOGENE, V29, P1431, DOI 10.1038/onc.2009.438; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Liu FY, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0425-3; Lu WJ, 2009, NAT REV CANCER, V9, P758, DOI 10.1038/nrc2732; Manning AL, 2011, TRENDS CELL BIOL, V21, P433, DOI 10.1016/j.tcb.2011.05.003; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Matsuoka M, 2003, ENVIRON HEALTH PERSP, V111, P509, DOI 10.1289/ehp.5945; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Mirza A, 2002, ONCOGENE, V21, P2613, DOI 10.1038/sj.onc.1205353; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Poole AJ, 2004, ONCOGENE, V23, P8128, DOI 10.1038/sj.onc.1207994; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sun Z, 2013, MOL ONCOL, V7, P884, DOI 10.1016/j.molonc.2013.04.007; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Szak ST, 2001, MOL CELL BIOL, V21, P3375, DOI 10.1128/MCB.21.10.3375-3386.2001; Tang HR, 2009, ACTA BIOCH BIOPH SIN, V41, P588, DOI 10.1093/abbs/gmp046; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; van Vliet J, 2006, GENOMICS, V87, P474, DOI 10.1016/j.ygeno.2005.12.011; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Yee KS, 2005, CARCINOGENESIS, V26, P1317, DOI 10.1093/carcin/bgi122	49	16	17	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21336	21351		10.1074/jbc.M114.635730	http://dx.doi.org/10.1074/jbc.M114.635730			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	25911104	Green Published, hybrid			2022-12-28	WOS:000360637600012
J	Tuz, K; Mezic, KG; Xu, TH; Barquera, B; Juarez, O				Tuz, Karina; Mezic, Katherine G.; Xu, Tianhao; Barquera, Blanca; Juarez, Oscar			The Kinetic Reaction Mechanism of the Vibrio cholerae Sodium-dependent NADH Dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+-TRANSLOCATING NADH; PUMPING NADHQUINONE OXIDOREDUCTASE; QUINONE OXIDOREDUCTASE; BINDING-SITE; UBIQUINONE OXIDOREDUCTASE; SUBUNIT-B; NADHUBIQUINONE OXIDOREDUCTASE; CONFORMATIONAL-CHANGES; CHARGE TRANSLOCATION; PROSTHETIC GROUPS	The sodium-dependent NADH dehydrogenase (Na+-NQR) is the main ion transporter in Vibrio cholerae. Its activity is linked to the operation of the respiratory chain and is essential for the development of the pathogenic phenotype. Previous studies have described different aspects of the enzyme, including the electron transfer pathways, sodium pumping structures, cofactor and subunit composition, among others. However, the mechanism of the enzyme remains to be completely elucidated. In this work, we have studied the kinetic mechanism of Na+-NQR with the use of steady state kinetics and stopped flow analysis. Na+-NQR follows a hexa-uni ping-pong mechanism, in which NADH acts as the first substrate, reacts with the enzyme, and the oxidized NAD leaves the catalytic site. In this conformation, the enzyme is able to capture two sodium ions and transport them to the external side of the membrane. In the last step, ubiquinone is bound and reduced, and ubiquinol is released. Our data also demonstrate that the catalytic cycle involves two redox states, the three-and five-electron reduced forms. A model that gathers all available information is proposed to explain the kinetic mechanism of Na+-NQR. This model provides a background to understand the current structural and functional information.	[Tuz, Karina; Xu, Tianhao; Juarez, Oscar] IIT, Dept Biol Sci, Chicago, IL 60616 USA; [Mezic, Katherine G.; Barquera, Blanca] Rensselaer Polytech Inst, Dept Biol Sci, Troy, NY 12180 USA	Illinois Institute of Technology; Rensselaer Polytechnic Institute	Juarez, O (corresponding author), Life Sci Bldg,3101 S Dearborn St, Chicago, IL 60616 USA.	ojuarez@iit.edu		Xu, Tianhao/0000-0003-2935-6353; Juarez, Oscar/0000-0002-2915-8413; Tuz, Karina/0000-0002-1669-4612	Illinois Institute of Technology startup funds; National Science Foundation [MCB-1052234]	Illinois Institute of Technology startup funds; National Science Foundation(National Science Foundation (NSF))	This work was supported by Illinois Institute of Technology startup funds (to O. J.) and National Science Foundation Grant MCB-1052234 (to B. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Barquera B, 2002, P NATL ACAD SCI USA, V99, P10322, DOI 10.1073/pnas.162361299; Barquera B, 2004, BIOCHEMISTRY-US, V43, P12322, DOI 10.1021/bi048689y; Barquera B, 2002, BIOCHEMISTRY-US, V41, P3781, DOI 10.1021/bi011873o; Barquera B, 2003, J AM CHEM SOC, V125, P265, DOI 10.1021/ja0207201; Barquera B, 2006, J BIOL CHEM, V281, P36482, DOI 10.1074/jbc.M605765200; Bogachev AV, 2009, BIOCHEMISTRY-US, V48, P6291, DOI 10.1021/bi900524m; Bogachev AV, 2009, BIOCHEMISTRY-US, V48, P6299, DOI 10.1021/bi900525v; Bogachev AV, 2009, J BIOL CHEM, V284, P5533, DOI 10.1074/jbc.M808984200; BUHLER R, 1991, J MEMBRANE BIOL, V121, P141, DOI 10.1007/BF01870529; Casutt MS, 2011, J BIOL CHEM, V286, P40075, DOI 10.1074/jbc.M111.224980; Casutt MS, 2010, J BIOL CHEM, V285, P27088, DOI 10.1074/jbc.M109.071126; Clarke RJ, 1998, BIOPHYS J, V75, P1340, DOI 10.1016/S0006-3495(98)74052-4; Duffy EB, 2006, J BACTERIOL, V188, P8343, DOI 10.1128/JB.01383-06; Fadeeva MS, 2008, BIOCHEMISTRY-MOSCOW+, V73, P123, DOI 10.1134/S0006297908020028; Hase CC, 2001, MICROBIOL MOL BIOL R, V65, P353, DOI 10.1128/MMBR.65.3.353-370.2001; Hase CC, 2001, BBA-BIOENERGETICS, V1505, P169, DOI 10.1016/S0005-2728(00)00286-3; Hayashi M, 2001, BBA-BIOENERGETICS, V1505, P37, DOI 10.1016/S0005-2728(00)00275-9; Hayashi M, 2001, FEBS LETT, V488, P5, DOI 10.1016/S0014-5793(00)02404-2; Juarez O, 2008, J BIOL CHEM, V283, P33162, DOI 10.1074/jbc.M806913200; Juarez O, 2012, BBA-BIOENERGETICS, V1817, P1823, DOI 10.1016/j.bbabio.2012.03.017; Juarez O, 2012, J BIOL CHEM, V287, P25678, DOI 10.1074/jbc.M112.366088; Juarez O, 2011, J BIOL CHEM, V286, P26383, DOI 10.1074/jbc.M111.257873; Juarez O, 2010, P NATL ACAD SCI USA, V107, P12505, DOI 10.1073/pnas.1002866107; Juarez O, 2009, BIOCHEMISTRY-US, V48, P9516, DOI 10.1021/bi900845y; Juarez O, 2009, J BIOL CHEM, V284, P8963, DOI 10.1074/jbc.M809395200; KUBOTA T, 1992, J BIOCHEM-TOKYO, V111, P91, DOI 10.1093/oxfordjournals.jbchem.a123725; Marvig RL, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-155; MCMINN CL, 1977, BIOCHEM J, V161, P569, DOI 10.1042/bj1610569; Meibom KL, 2005, SCIENCE, V310, P1824, DOI 10.1126/science.1120096; Nakayama Y, 1999, BIOL PHARM BULL, V22, P1064; Nedielkov R, 2013, J BIOL CHEM, V288, P30597, DOI 10.1074/jbc.M112.435750; Neehaubl Y, 2013, BIOCHEMISTRY-US, V52, P3085, DOI 10.1021/bi4000386; Neehaul Y, 2012, BIOCHEMISTRY-US, V51, P4072, DOI 10.1021/bi300343u; NGO TT, 1978, J NEUROCHEM, V31, P69, DOI 10.1111/j.1471-4159.1978.tb12434.x; PfenningerLi XD, 1996, BIOCHEMISTRY-US, V35, P6233, DOI 10.1021/bi953032l; PRATAP PR, 1991, BIOCHIM BIOPHYS ACTA, V1069, P288, DOI 10.1016/0005-2736(91)90137-W; PRATAP PR, 1993, BIOCHIM BIOPHYS ACTA, V1151, P89, DOI 10.1016/0005-2736(93)90075-B; Reyes-Prieto A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096696; Segel IH, 1993, ENZYME KINETICS, P506; Shea ME, 2015, BIOCHEMISTRY-US, V54, P490, DOI 10.1021/bi501266e; Shea ME, 2013, J BIOL CHEM, V288, P31241, DOI 10.1074/jbc.M113.510776; SKULACHEV VP, 1989, J BIOENERG BIOMEMBR, V21, P635, DOI 10.1007/BF00762683; Steuber J, 2014, NATURE, V516, P62, DOI 10.1038/nature14003; Steuber J, 2014, BIOL CHEM, V395, P1389, DOI 10.1515/hsz-2014-0204; Strickland M, 2014, J BIOL CHEM, V289, P23723, DOI 10.1074/jbc.M114.574640; STURMER W, 1991, J MEMBRANE BIOL, V121, P163, DOI 10.1007/BF01870530; TRUMPOWER BL, 1979, J BIOL CHEM, V254, P8697; Turk K, 2004, J BIOL CHEM, V279, P21349, DOI 10.1074/jbc.M311692200; Verkhovsky MI, 2010, BBA-BIOENERGETICS, V1797, P738, DOI 10.1016/j.bbabio.2009.12.020; YAGI T, 1991, J BIOENERG BIOMEMBR, V23, P211, DOI 10.1007/BF00762218; Zhou WD, 1999, BIOCHEMISTRY-US, V38, P16246, DOI 10.1021/bi991664s	51	18	18	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20009	20021		10.1074/jbc.M115.658773	http://dx.doi.org/10.1074/jbc.M115.658773			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26004776	Green Published, hybrid			2022-12-28	WOS:000359608900001
J	Volante, A; Alonso, JC				Volante, Andrea; Alonso, Juan C.			Molecular Anatomy of ParA-ParA and ParA-ParB Interactions during Plasmid Partitioning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA; PROTEIN; PSM19035; ATP; TRANSPORT; GENES; RECOGNITION; BINDING; REGION	Firmicutes multidrug resistance inc18 plasmids encode parS sites and two small homodimeric ParA-like (delta(2)) and ParB-like (omega(2)) proteins to ensure faithful segregation. Protein omega(2) binds to parS DNA, forming a short left-handed helix wrapped around the full parS, and interacts with delta(2). Protein delta(2) interacts with delta(2) and, in the ATP-bound form, binds to nonspecific DNA (nsDNA), forming small clusters. Here, we have mapped the omega(2).delta(2) and delta(2).delta(2) interacting domains in the delta(2) that are adjacent to but distinct from each other. The delta(2) nsDNA binding domain is essential for stimulation of omega(2).parS-mediated ATP hydrolysis. From the data presented here, we propose that delta(2) interacts with ATP, nsDNA, and with omega(2) bound to parS at near equimolar concentrations, facilitating a delta(2) structural transition. This delta(2) "activated" state overcomes its impediment in ATP hydrolysis, with the subsequent release of both of the proteins from nsDNA (plasmid unpairing).	[Volante, Andrea; Alonso, Juan C.] CNB CSIC, Ctr Nacl Biotecnol, Dept Microbial Biotechnol, Madrid 28049, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Alonso, JC (corresponding author), CNB CSIC, Ctr Nacl Biotecnol, Dept Microbial Biotechnol, Darwin Str 3, Madrid 28049, Spain.	jcalonso@cnb.csic.es	Alonso, Juan Carlos/D-2595-2009	Alonso, Juan Carlos/0000-0002-5178-7179; Volante, Andrea/0000-0002-3290-0148	Ministerio de Economia y Competitividad, Direccion General de Investigacion [BFU2012-39879-C02-01]; Comunidad de Madrid [S2009MAT-1507]; Consejeria de Educacion de la Comunidad de Madrid-European Social Fund Fellowship [CPI/0266/2008]	Ministerio de Economia y Competitividad, Direccion General de Investigacion; Comunidad de Madrid(Comunidad de Madrid); Consejeria de Educacion de la Comunidad de Madrid-European Social Fund Fellowship	This work was supported in part by Ministerio de Economia y Competitividad, Direccion General de Investigacion, Grant BFU2012-39879-C02-01 and by Comunidad de Madrid Grant S2009MAT-1507 (to J. C. A.). The authors declare that they have no conflict of interest.; Recipient of Consejeria de Educacion de la Comunidad de Madrid-European Social Fund Fellowship CPI/0266/2008.	Barilla D, 2005, EMBO J, V24, P1453, DOI 10.1038/sj.emboj.7600619; Bartosik AA, 2014, MICROBIOL-SGM, V160, P2406, DOI 10.1099/mic.0.081216-0; Baxter JC, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.PLAS-0023-2014; Bloom K, 2010, NATURE, V463, P446, DOI 10.1038/nature08912; BRENNER SL, 1988, J MOL BIOL, V204, P959, DOI 10.1016/0022-2836(88)90055-1; Canas C, 2008, NUCLEIC ACIDS RES, V36, P5242, DOI 10.1093/nar/gkn500; Castaing JP, 2008, MOL MICROBIOL, V70, P1000, DOI 10.1111/j.1365-2958.2008.06465.x; CEGLOWSKI P, 1993, MOL GEN GENET, V241, P579, DOI 10.1007/BF00279900; DAVEY MJ, 1994, J BIOL CHEM, V269, P29908; de la Hoz AB, 2000, P NATL ACAD SCI USA, V97, P728, DOI 10.1073/pnas.97.2.728; de la Hoz AB, 2004, NUCLEIC ACIDS RES, V32, P3136, DOI 10.1093/nar/gkh633; Dmowski M, 2006, J BACTERIOL, V188, P4362, DOI 10.1128/JB.01922-05; Dmowski M, 2011, MICROBIOL-SGM, V157, P1009, DOI 10.1099/mic.0.045369-0; Graham TGW, 2014, GENE DEV, V28, P1228, DOI 10.1101/gad.242206.114; Hatano T, 2010, MOL MICROBIOL, V78, P1182, DOI 10.1111/j.1365-2958.2010.07398.x; Hester CM, 2007, P NATL ACAD SCI USA, V104, P20326, DOI 10.1073/pnas.0705196105; Hwang LC, 2013, EMBO J, V32, P1238, DOI 10.1038/emboj.2013.34; Lim HC, 2014, ELIFE, V3, DOI 10.7554/eLife.02758; Lioy VS, 2010, PLASMID, V64, P1, DOI 10.1016/j.plasmid.2010.04.002; LYNCH AS, 1995, P NATL ACAD SCI USA, V92, P1896, DOI 10.1073/pnas.92.6.1896; McIntosh JR, 2012, Q REV BIOPHYS, V45, P147, DOI 10.1017/S0033583512000017; Murayama K, 2001, J MOL BIOL, V314, P789, DOI 10.1006/jmbi.2001.5157; Murray H, 2006, MOL MICROBIOL, V61, P1352, DOI 10.1111/j.1365-2958.2006.05316.x; Pratto F, 2008, NUCLEIC ACIDS RES, V36, P3676, DOI 10.1093/nar/gkn170; Pratto F, 2009, J BIOL CHEM, V284, P30298, DOI 10.1074/jbc.M109.035410; Ptacin JL, 2010, NAT CELL BIOL, V12, P791, DOI 10.1038/ncb2083; Ravin NV, 2003, J MOL BIOL, V329, P875, DOI 10.1016/S0022-2836(03)00525-4; Ringgaard S, 2009, P NATL ACAD SCI USA, V106, P19369, DOI 10.1073/pnas.0908347106; Rodionov O, 1999, SCIENCE, V283, P546, DOI 10.1126/science.283.5401.546; Schumacher MA, 2012, J BIOL CHEM, V287, P26146, DOI 10.1074/jbc.M112.373696; Sengupta M, 2010, J BACTERIOL, V192, P1175, DOI 10.1128/JB.01245-09; Sherratt D, 2013, EMBO J, V32, P1208, DOI 10.1038/emboj.2013.84; Soberon NE, 2011, NUCLEIC ACIDS RES, V39, P2624, DOI 10.1093/nar/gkq1245; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Szardenings F, 2011, CURR OPIN MICROBIOL, V14, P712, DOI 10.1016/j.mib.2011.09.008; Taylor JA, 2015, NUCLEIC ACIDS RES, V43, P719, DOI 10.1093/nar/gku1295; Vecchiarelli AG, 2014, P NATL ACAD SCI USA, V111, P4880, DOI 10.1073/pnas.1401025111; Vecchiarelli AG, 2013, P NATL ACAD SCI USA, V110, pE1390, DOI 10.1073/pnas.1302745110; Vecchiarelli AG, 2012, MOL MICROBIOL, V86, P513, DOI 10.1111/mmi.12017; Vecchiarelli AG, 2010, MOL MICROBIOL, V78, P78, DOI 10.1111/j.1365-2958.2010.07314.x; Volante A, 2014, THESIS U AUTONOMA MA; Weihofen WA, 2006, NUCLEIC ACIDS RES, V34, P1450, DOI 10.1093/nar/gkl015; Welfle K, 2005, BIOL CHEM, V386, P881, DOI 10.1515/BC.2005.103	43	18	18	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18782	18795		10.1074/jbc.M115.649632	http://dx.doi.org/10.1074/jbc.M115.649632			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26055701	Green Published, hybrid			2022-12-28	WOS:000358512100045
J	Al-Dossary, AA; Bathala, P; Caplan, JL; Martin-DeLeon, PA				Al-Dossary, Amal A.; Bathala, Pradeepthi; Caplan, Jeffrey L.; Martin-DeLeon, Patricia A.			Oviductosome-Sperm Membrane Interaction in Cargo Delivery DETECTION OF FUSION AND UNDERLYING MOLECULAR PLAYERS USING THREE-DIMENSIONAL SUPER-RESOLUTION STRUCTURED ILLUMINATION MICROSCOPY (SR-SIM)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE SPERM; ALPHA-V-BETA-3 INTEGRIN; MAMMALIAN SPERM; LIPID RAFTS; HYPERACTIVATED MOTILITY; MALE-FERTILITY; SPAM1; CA2+; EXPRESSION; FUSION	Oviductosomes ((OVS), exosomes/microvesicles), which deliver the Ca2(+) efflux pump, plasma membrane Ca2(+) ATPase 4 (PMCA4), to sperm are likely to play an important role in sperm fertilizing ability (Al-Dossary, A. A., Strehler, E. E., and Martin-DeLeon, P. A. (2013) PloS one 8, e80181). It is unknown how exosomes/microvesicles deliver transmembrane proteins such as PMCA4 to sperm. Here we define a novel experimental approach for the assessment of the interaction of OVS with sperm at a nanoscale level, using a lipophilic dye (FM4-64FX) and three-dimensional SR/SIM, which has an 8-fold increase in volumetric resolution, compared with conventional confocal microscopy. Coincubation assays detected fusion of prelabeled OVS with sperm, primarily over the head and midpiece. Immunofluorescence revealed oviductosomal delivery of PMCA4a to WT and Pmca4 KO sperm, and also endogenous PMCA4a on the inner acrosomal membrane. Fusion was confirmed by transmission immunoelectron microscopy, showing immunogold particles in OVS, and fusion stalks on sperm membrane. Immunofluorescence colocalized OVS with the alpha v integrin subunit which, along with CD9, resides primarily on the sperm head and midpiece. In capacitated and acrosome reacted sperm, fusion was significantly (p < 0.001) inhibited by blocking integrin/ligand interactions via antibodies, exogenous ligands (vitronectin and fibronectin), and their RGD recognition motif. Our results provide evidence that receptor/ligand interactions, involving alpha v beta 3 and alpha 5 beta 1integrins on sperm and OVS, facilitate fusion of OVS in the delivery of transmembrane proteins to sperm. The mechanism uncovered is likely to be also involved in cargo delivery of prostasomes, epididymosomes, and uterosomes.	[Al-Dossary, Amal A.; Bathala, Pradeepthi; Caplan, Jeffrey L.; Martin-DeLeon, Patricia A.] Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA; [Caplan, Jeffrey L.] Delaware Biotechnol Inst, Newark, DE 19711 USA	University of Delaware	Martin-DeLeon, PA (corresponding author), Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA.	pdeleon@udel.edu	Regan, Clinton/E-6250-2012	Al-Dossary, Amal/0000-0002-4634-6483; Caplan, Jeffrey/0000-0002-3991-0912	National Institutes of Health [RO3HD073523, 5P20RR015588]; INBRE Core Access Award; Saudi Arabian Cultural Mission to USA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R03HD073523] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103446] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); INBRE Core Access Award; Saudi Arabian Cultural Mission to USA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant RO3HD073523, National Institutes of Health Grant 5P20RR015588 (to P. A. D.), INBRE Core Access Award (to P. A. D.), and the Saudi Arabian Cultural Mission to USA (to A. A. A.). The authors declare that they have no conflicts of interest with the contents of this article.	Al-Dossary AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080181; Aravindan RG, 2012, J CELL PHYSIOL, V227, P3138, DOI 10.1002/jcp.24000; Asano A, 2009, J CELL PHYSIOL, V218, P537, DOI 10.1002/jcp.21623; Boissonnas CC, 2010, DEV DYNAM, V239, P773, DOI 10.1002/dvdy.22206; Brandenburger T, 2011, J BIOL CHEM, V286, P7938, DOI 10.1074/jbc.M110.142836; Bronson RA, 1996, MOL HUM REPROD, V2, P153, DOI 10.1093/molehr/2.3.153; Caballero Julieta, 2010, Vet Med Int, V2011, P757194, DOI 10.4061/2011/757194; Chen H, 2006, BIOL REPROD, V74, P923, DOI 10.1095/biolreprod.105.048587; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Costello S, 2009, REPRODUCTION, V138, P425, DOI 10.1530/REP-09-0134; Coy P, 2012, REPRODUCTION, V144, P649, DOI 10.1530/REP-12-0279; Cross NL, 2004, BIOL REPROD, V71, P1367, DOI 10.1095/biolreprod.104.030502; DANEN EHJ, 1994, HISTOPATHOLOGY, V24, P249, DOI 10.1111/j.1365-2559.1994.tb00517.x; Deng XN, 1999, MOL REPROD DEV, V52, P196, DOI 10.1002/(SICI)1098-2795(199902)52:2&lt;196::AID-MRD11&gt;3.0.CO;2-A; Filoteo AG, 1997, J BIOL CHEM, V272, P23741, DOI 10.1074/jbc.272.38.23741; Fusi FM, 1996, MOL HUM REPROD, V2, P169, DOI 10.1093/molehr/2.3.169; FUSI FM, 1992, J ANDROL, V13, P488; Gadella BM, 2014, THERIOGENOLOGY, V81, P74, DOI 10.1016/j.theriogenology.2013.09.005; Geho DH, 2003, BIOCONJUGATE CHEM, V14, P703, DOI 10.1021/bc034037v; Gille J, 1996, ANN NY ACAD SCI, V797, P93, DOI 10.1111/j.1749-6632.1996.tb52952.x; Griffiths GS, 2008, MOL REPROD DEV, V75, P1627, DOI 10.1002/mrd.20907; Griffiths GS, 2009, BIOL REPROD, V81, P562, DOI 10.1095/biolreprod.108.075739; Hemler ME, 1998, CURR OPIN CELL BIOL, V10, P578, DOI 10.1016/S0955-0674(98)80032-X; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Ho HC, 2003, BIOL REPROD, V68, P1590, DOI 10.1095/biolreprod.102.011320; Ho HC, 2002, DEV BIOL, V250, P208, DOI 10.1006/dbio.2002.0797; Hong XM, 2008, ENDOCRINOLOGY, V149, P6207, DOI 10.1210/en.2008-0294; Ito C, 2010, CELL TISSUE RES, V340, P583, DOI 10.1007/s00441-010-0967-7; KOZLOV MM, 1989, EUR BIOPHYS J BIOPHY, V17, P121; LEIKIN SL, 1987, J THEOR BIOL, V129, P411, DOI 10.1016/S0022-5193(87)80021-8; Maecker HT, 1997, FASEB J, V11, P428, DOI 10.1096/fasebj.11.6.9194523; Modelski MJ, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.113.115857; Okunande GW, 2004, J BIOL CHEM, V279, P33742, DOI 10.1074/jbc.M404628200; Patel R, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.108712; Peddibhotla SSD, 2013, MOL BIOL CELL, V24, P933, DOI 10.1091/mbc.E12-06-0481; Pencer J, 2008, EUR BIOPHYS J BIOPHY, V37, P665, DOI 10.1007/s00249-008-0304-1; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Reese KL, 2010, MOL REPROD DEV, V77, P759, DOI 10.1002/mrd.21217; Schuh K, 2004, J BIOL CHEM, V279, P28220, DOI 10.1074/jbc.M312599200; Schwarz A, 2013, CELL TISSUE RES, V353, P549, DOI 10.1007/s00441-013-1633-7; SEFTOR REB, 1992, P NATL ACAD SCI USA, V89, P1557, DOI 10.1073/pnas.89.5.1557; Sepulveda MR, 2006, J BIOL CHEM, V281, P447, DOI 10.1074/jbc.M506950200; Sleight SB, 2005, BIOL REPROD, V73, P721, DOI 10.1095/biolreprod.105.041533; Strehler EE, 2007, BIOCHEM SOC T, V35, P919, DOI 10.1042/BST0350919; Strehler EE, 2001, PHYSIOL REV, V81, P21, DOI 10.1152/physrev.2001.81.1.21; Suarez SS, 2003, CELL MOL BIOL, V49, P351; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thys M., 2012, BIRDS EYE VIEW VET M, DOI [10.5772/37408., DOI 10.5772/37408]; Travis AJ, 2001, DEV BIOL, V240, P599, DOI 10.1006/dbio.2001.0475; Wennemuth G, 2003, J GEN PHYSIOL, V122, P115, DOI 10.1085/jgp.200308839; Yeung C.-H., 2002, EPIDIDYMIS MOL CLIN, P417, DOI DOI 10.1007/978-1-4615-0679-9_24	52	61	64	2	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					17710	17723		10.1074/jbc.M114.633156	http://dx.doi.org/10.1074/jbc.M114.633156			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26023236	Green Published, hybrid			2022-12-28	WOS:000358511700006
J	Jiang, QQ; Greenberg, RA				Jiang, Qinqin; Greenberg, Roger A.			Deciphering the BRCA1 Tumor Suppressor Network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							DNA-DAMAGE RESPONSE; HOMOLOGOUS-RECOMBINATION; FANCONI-ANEMIA; GENOMIC STABILITY; BREAST-CANCER; SYNTHETICALLY LETHAL; RAD52 INACTIVATION; SCREENING REVEALS; REPAIR PATHWAY; OVARIAN-CANCER	The BRCA1 tumor suppressor protein is a central constituent of several distinct macromolecular protein complexes that execute homology-directed DNA damage repair and cell cycle checkpoints. Recent years have borne witness to an exciting phase of discovery at the basic molecular level for how this network of DNA repair proteins acts to maintain genome stability and suppress cancer. The clinical dividends of this investment are now being realized with the approval of first-in-class BRCA-targeted therapies for ovarian cancer and identification of molecular events that determine responsiveness to these agents. Further delineation of the basic science underlying BRCA network function holds promise to maximally exploit genome instability for hereditary and sporadic cancer therapy.	[Greenberg, Roger A.] Univ Penn, Dept Canc Biol, Abramson Family Canc Res Inst, Perelman Sch Med, Philadelphia, PA 19104 USA; Univ Penn, Dept Pathol, Abramson Family Canc Res Inst, Perelman Sch Med, Philadelphia, PA 19104 USA; Univ Penn, Perelman Sch Med, Basser Res Ctr BRCA, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Greenberg, RA (corresponding author), Univ Penn, Dept Canc Biol, Abramson Family Canc Res Inst, Perelman Sch Med, Philadelphia, PA 19104 USA.	rogergr@mail.med.upenn.edu			National Institutes of Health [CA138835, CA17494]; Abramson Family Cancer Research Institute; Basser Research Center for BRCA; NATIONAL CANCER INSTITUTE [R01CA138835] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abramson Family Cancer Research Institute; Basser Research Center for BRCA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA138835 and CA17494 (to R. A. G.). This work was also supported by the Abramson Family Cancer Research Institute and the Basser Research Center for BRCA (to R. A. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Al-Ahmadie H, 2014, CANCER DISCOV, V4, P1014, DOI 10.1158/2159-8290.CD-14-0380; Antoniou AC, 2014, NEW ENGL J MED, V371, P497, DOI [10.1056/NEJMoa1400382, 10.1056/NEJMc1410673]; Audeh MW, 2010, LANCET, V376, P245, DOI 10.1016/S0140-6736(10)60893-8; Aymard F, 2014, NAT STRUCT MOL BIOL, V21, P366, DOI 10.1038/nsmb.2796; Bhatia V, 2014, NATURE, V511, P362, DOI 10.1038/nature13374; Boersma V, 2015, NATURE, V521, P537, DOI 10.1038/nature14216; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Bridge WL, 2005, NAT GENET, V37, P953, DOI 10.1038/ng1627; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Castillo A, 2014, CELL REP, V8, P807, DOI 10.1016/j.celrep.2014.06.050; Ceccaldi R, 2015, NATURE, V518, P258, DOI 10.1038/nature14184; Cheung I, 2002, NAT GENET, V31, P405, DOI [10.1038/ng928, 10.1038/417405a]; Coleman KA, 2011, J BIOL CHEM, V286, P13669, DOI 10.1074/jbc.M110.213728; Cruz-Garcia A, 2014, CELL REP, V9, P451, DOI 10.1016/j.celrep.2014.08.076; Domchek SM, 2013, CANCER DISCOV, V3, P399, DOI 10.1158/2159-8290.CD-12-0421; Drost R., 2011, CANCER CELL, V20, P797; Edwards SL, 2008, NATURE, V451, P1111, DOI 10.1038/nature06548; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Feng ZH, 2011, P NATL ACAD SCI USA, V108, P686, DOI 10.1073/pnas.1010959107; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Fradet-Turcotte A, 2013, NATURE, V499, P50, DOI 10.1038/nature12318; Gardini A, 2014, EMBO J, V33, P890, DOI 10.1002/embj.201385567; Gatti M, 2015, CELL REP, V10, P226, DOI 10.1016/j.celrep.2014.12.021; Gelmon KA, 2011, LANCET ONCOL, V12, P852, DOI 10.1016/S1470-2045(11)70214-5; Goldstein M, 2015, CANCER RES, V75, P2699, DOI 10.1158/0008-5472.CAN-15-0400; Greenberg RA, 2006, GENE DEV, V20, P34, DOI 10.1101/gad.1381306; Guzzo CM, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003485; Hatchi E, 2015, MOL CELL, V57, P636, DOI 10.1016/j.molcel.2015.01.011; Hill SJ, 2014, GENE DEV, V28, P1957, DOI 10.1101/gad.241620.114; Hsiao KY, 2013, J MOL CELL BIOL, V5, P157, DOI 10.1093/jmcb/mjs066; Hu YD, 2011, GENE DEV, V25, P685, DOI 10.1101/gad.2011011; Huntoon CJ, 2013, CANCER RES, V73, P3683, DOI 10.1158/0008-5472.CAN-13-0110; Jasin M, 2002, ONCOGENE, V21, P8981, DOI 10.1038/sj.onc.1206176; Jaspers JE, 2013, CANCER DISCOV, V3, P68, DOI 10.1158/2159-8290.CD-12-0049; Joukov V, 2001, P NATL ACAD SCI USA, V98, P12078, DOI 10.1073/pnas.211427098; Kalb R, 2014, CELL REP, V8, P999, DOI 10.1016/j.celrep.2014.07.025; Kent T, 2015, NAT STRUCT MOL BIOL, V22, P230, DOI 10.1038/nsmb.2961; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kottemann MC, 2013, NATURE, V493, P356, DOI 10.1038/nature11863; Li M, 2013, CANCER CELL, V23, P693, DOI 10.1016/j.ccr.2013.03.025; Litman R, 2005, CANCER CELL, V8, P255, DOI 10.1016/j.ccr.2005.08.004; Lok BH, 2013, ONCOGENE, V32, P3552, DOI 10.1038/onc.2012.391; Lok BH, 2012, CLIN CANCER RES, V18, P6400, DOI 10.1158/1078-0432.CCR-11-3150; London TBC, 2008, J BIOL CHEM, V283, P36132, DOI 10.1074/jbc.M808152200; Long DT, 2014, MOL CELL, V56, P174, DOI 10.1016/j.molcel.2014.08.012; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Mateos-Gomez PA, 2015, NATURE, V518, P254, DOI 10.1038/nature14157; Mattiroli F, 2012, CELL, V150, P1182, DOI 10.1016/j.cell.2012.08.005; Murai J, 2012, CANCER RES, V72, P5588, DOI 10.1158/0008-5472.CAN-12-2753; Nikkila J, 2009, ONCOGENE, V28, P1843, DOI 10.1038/onc.2009.33; Nikkila J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3578; Panier S, 2014, NAT REV MOL CELL BIO, V15, P7, DOI 10.1038/nrm3719; Pathania S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6496; Peng M, 2007, EMBO J, V26, P3238, DOI 10.1038/sj.emboj.7601754; Perets R, 2013, CANCER CELL, V24, P751, DOI 10.1016/j.ccr.2013.10.013; Polato F, 2014, J EXP MED, V211, P1027, DOI 10.1084/jem.20131939; Reczek CR, 2013, J CELL BIOL, V201, P693, DOI 10.1083/jcb.201302145; Rozenova K, 2015, BLOOD, V125, P1730, DOI 10.1182/blood-2014-07-588145; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Savage KI, 2014, MOL CELL, V54, P445, DOI 10.1016/j.molcel.2014.03.021; Sawyer SL, 2015, CANCER DISCOV, V5, P135, DOI 10.1158/2159-8290.CD-14-1156; Schlacher K, 2012, CANCER CELL, V22, P106, DOI 10.1016/j.ccr.2012.05.015; Schlacher K, 2011, CELL, V145, P529, DOI 10.1016/j.cell.2011.03.041; Shakya R, 2008, P NATL ACAD SCI USA, V105, P7040, DOI 10.1073/pnas.0711032105; Shakya R, 2011, SCIENCE, V334, P525, DOI 10.1126/science.1209909; Simhadri S, 2014, J BIOL CHEM, V289, P24617, DOI 10.1074/jbc.M114.566141; Skoulidis F, 2010, CANCER CELL, V18, P499, DOI 10.1016/j.ccr.2010.10.015; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Solyom S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003223; Strom CE, 2011, NUCLEIC ACIDS RES, V39, P3166, DOI 10.1093/nar/gkq1241; Tang JB, 2013, NAT STRUCT MOL BIOL, V20, P317, DOI 10.1038/nsmb.2499; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang JD, 2014, GENE DEV, V28, P2693, DOI 10.1101/gad.252478.114; Willis NA, 2014, NATURE, V510, P556, DOI 10.1038/nature13295; Wu JX, 2012, J BIOL CHEM, V287, P22919, DOI 10.1074/jbc.M112.351007; Wu LJC, 1996, NAT GENET, V14, P430, DOI 10.1038/ng1296-430; Wu WW, 2015, CANCER RES, V75, P1311, DOI 10.1158/0008-5472.CAN-14-2796; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Xu GT, 2015, NATURE, V521, P541, DOI 10.1038/nature14328; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743; Yang HJ, 2005, NATURE, V433, P653, DOI 10.1038/nature03234; Yin ZY, 2012, CANCER RES, V72, P5080, DOI 10.1158/0008-5472.CAN-12-1484; Ying SM, 2012, CANCER RES, V72, P2814, DOI 10.1158/0008-5472.CAN-11-3417; Yousefzadeh MJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004654; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Yun MH, 2009, NATURE, V459, P460, DOI 10.1038/nature07955	90	58	60	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					17724	17732		10.1074/jbc.R115.667931	http://dx.doi.org/10.1074/jbc.R115.667931			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26048987	hybrid, Green Published			2022-12-28	WOS:000358511700007
J	Kostylev, MA; Kaufman, AC; Nygaard, HB; Patel, P; Haas, LT; Gunther, EC; Vortmeyer, A; Strittmatter, SM				Kostylev, Mikhail A.; Kaufman, Adam C.; Nygaard, Haakon B.; Patel, Pujan; Haas, Laura T.; Gunther, Erik C.; Vortmeyer, Alexander; Strittmatter, Stephen M.			Prion-Protein-interacting Amyloid-beta Oligomers of High Molecular Weight Are Tightly Correlated with Memory Impairment in Multiple Alzheimer Mouse Models	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SECRETASE INHIBITION; GLUTAMATE-RECEPTOR 5; LONG-TERM-MEMORY; A-BETA; IN-VIVO; NEUROPATHOLOGIC ASSESSMENT; NATIONAL INSTITUTE; TRANSGENIC MICE; ASSOCIATION GUIDELINES; COGNITIVE DYSFUNCTION	Alzheimer disease (AD) is characterized by amyloid-beta accumulation, with soluble oligomers (A beta o) being the most synaptotoxic. However, the multivalent and unstable nature of A beta o limits molecular characterization and hinders research reproducibility. Here, we characterized multiple A beta o forms throughout the life span of various AD mice and in post-mortem human brain. A beta o exists in several populations, where prion protein (PrPC)-interacting A beta o is a high molecular weight A beta assembly present in multiple mice and humans with AD. Levels of PrPC-interacting A beta o match closely with mouse memory and are equal or superior to other A beta measures in predicting behavioral impairment. However, A beta o metrics vary considerably between mouse strains. Deleting PrPC expression in mice with relatively low PrPC-interacting A beta o (Tg2576) results in partial rescue of cognitive performance as opposed to complete recovery in animals with a high percentage of PrPC-interacting A beta o (APP/PSEN1). These findings highlight the relative contributions and interplay of A beta o forms in AD.	[Kostylev, Mikhail A.; Kaufman, Adam C.; Nygaard, Haakon B.; Patel, Pujan; Haas, Laura T.; Gunther, Erik C.; Strittmatter, Stephen M.] Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06536 USA; [Vortmeyer, Alexander] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06536 USA; [Nygaard, Haakon B.; Gunther, Erik C.; Strittmatter, Stephen M.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Strittmatter, SM (corresponding author), Yale Univ, Sch Med, CNNR Program, BCMM 436,295 Congress Ave, New Haven, CT 06536 USA.	stephen.strittmatter@yale.edu	Regan, Clinton/E-6250-2012; Strittmatter, Stephen/F-5739-2011	Kostylev, Mikhail/0000-0003-0435-8141; Strittmatter, Stephen/0000-0001-8188-3092	National Institutes of Health; BrightFocus Foundation; Alzheimer's Association; Falk Medical Research Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034924, P50AG047270] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BrightFocus Foundation(BrightFocus Foundation); Alzheimer's Association(Alzheimer's Association); Falk Medical Research Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by a National Institutes of Health grant. This work was also supported by the BrightFocus Foundation, Alzheimer's Association, and Falk Medical Research Trust (to S. M. S.). S. M. S. is a co-founder of Axerion Therapeutics seeking to develop PrP-based therapeutics for Alzheimer disease.	Abramowski D, 2008, J PHARMACOL EXP THER, V327, P411, DOI 10.1124/jpet.108.140327; Arendt T, 2009, ACTA NEUROPATHOL, V118, P167, DOI 10.1007/s00401-009-0536-x; Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Ball M, 1997, NEUROBIOL AGING, V18, pS1, DOI 10.1016/s0197-4580(97)00057-2; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Barry AE, 2011, J NEUROSCI, V31, P7259, DOI 10.1523/JNEUROSCI.6500-10.2011; Bate C, 2011, J BIOL CHEM, V286, P37955, DOI 10.1074/jbc.M111.248724; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Best JD, 2007, J PHARMACOL EXP THER, V320, P552, DOI 10.1124/jpet.106.114330; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Bouter Y, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00075; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Bruggink KA, 2013, ANAL BIOCHEM, V433, P112, DOI 10.1016/j.ab.2012.09.014; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; Chang WP, 2011, FASEB J, V25, P775, DOI 10.1096/fj.10-167213; Chen RQ, 2012, CELL REP, V2, P1329, DOI 10.1016/j.celrep.2012.09.030; Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516; Chung E, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-130; Cirrito JR, 2003, J NEUROSCI, V23, P8844; Cisse M, 2011, J NEUROSCI, V31, P10427, DOI 10.1523/JNEUROSCI.1459-11.2011; Comery TA, 2005, J NEUROSCI, V25, P8898, DOI 10.1523/JNEUROSCI.2693-05.2005; CZECH C, 2013, DRUG DISCOV TODAY, V10, pE73; Dash PK, 2005, BIOCHEM BIOPH RES CO, V338, P777, DOI 10.1016/j.bbrc.2005.10.006; Dohler F, 2014, BRAIN, V137, P873, DOI 10.1093/brain/awt375; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Esparza TJ, 2013, ANN NEUROL, V73, P104, DOI 10.1002/ana.23748; Fluharty BR, 2013, J BIOL CHEM, V288, P7857, DOI 10.1074/jbc.M112.423954; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Ganzinger KA, 2014, CHEMBIOCHEM, V15, P2515, DOI 10.1002/cbic.201402377; Garcia-Alloza M, 2006, NEUROBIOL DIS, V24, P516, DOI 10.1016/j.nbd.2006.08.017; Garcia-Alloza M, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-19; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Haas LT, 2014, J BIOL CHEM, V289, P28460, DOI 10.1074/jbc.M114.584342; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hall AM, 2012, BRAIN RES BULL, V88, P3, DOI 10.1016/j.brainresbull.2011.11.017; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hu NW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4374; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Hyde LA, 2005, BEHAV BRAIN RES, V160, P344, DOI 10.1016/j.bbr.2004.12.017; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Hyman BT, 1997, J NEUROPATH EXP NEUR, V56, P1095, DOI 10.1097/00005072-199710000-00002; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kayed R, 2013, J ALZHEIMERS DIS, V33, pS67, DOI 10.3233/JAD-2012-129001; Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217; Klaver AC, 2011, J NEUROSCI METH, V195, P249, DOI 10.1016/j.jneumeth.2010.12.001; Klyubin I, 2014, J NEUROSCI, V34, P6140, DOI 10.1523/JNEUROSCI.3526-13.2014; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; Kudo W, 2012, HUM MOL GENET, V21, P1138, DOI 10.1093/hmg/ddr542; Lalonde R, 2005, NEUROSCI LETT, V390, P87, DOI 10.1016/j.neulet.2005.08.028; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Larson M, 2012, J NEUROSCI, V32, P16857, DOI 10.1523/JNEUROSCI.1858-12.2012; Larson ME, 2012, J NEUROCHEM, V120, P125, DOI 10.1111/j.1471-4159.2011.07478.x; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Loong TW, 2003, BMJ-BRIT MED J, V327, P716, DOI 10.1136/bmj.327.7417.716; Mayeux R, 2003, ANNU REV NEUROSCI, V26, P81, DOI 10.1146/annurev.neuro.26.043002.094919; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nicoll AJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3416; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Ostapchenko VG, 2013, J NEUROSCI, V33, P16552, DOI 10.1523/JNEUROSCI.3214-13.2013; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Reiman EM, 2009, P NATL ACAD SCI USA, V106, P6820, DOI 10.1073/pnas.0900345106; Resenberger UK, 2011, EMBO J, V30, P2057, DOI 10.1038/emboj.2011.86; Rushworth JV, 2013, J BIOL CHEM, V288, P8935, DOI 10.1074/jbc.M112.400358; Savage MJ, 2014, J NEUROSCI, V34, P2884, DOI 10.1523/JNEUROSCI.1675-13.2014; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2011, METHODS MOL BIOL, V670, P33, DOI 10.1007/978-1-60761-744-0_3; Takeda S, 2013, FASEB J, V27, P3239, DOI 10.1096/fj.13-229666; Tomic JL, 2009, NEUROBIOL DIS, V35, P352, DOI 10.1016/j.nbd.2009.05.024; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; Vonsattel JPG, 2008, ACTA NEUROPATHOL, V115, P509, DOI 10.1007/s00401-007-0311-9; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh KP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095995; Yang T, 2013, ALZHEIMERS DEMENT, V9, P99, DOI 10.1016/j.jalz.2012.11.005; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zou WQ, 2011, J BIOL CHEM, V286, P15095, DOI 10.1074/jbc.M110.199356	87	83	84	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17415	17438		10.1074/jbc.M115.643577	http://dx.doi.org/10.1074/jbc.M115.643577			24	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26018073	Green Published, hybrid			2022-12-28	WOS:000357730900035
J	Tomas, A; Lery, L; Regueiro, V; Perez-Gutierrez, C; Martinez, V; Moranta, D; Llobet, E; Gonzalez-Nicolau, M; Insua, JL; Tomas, JM; Sansonetti, PJ; Tournebize, R; Bengoechea, JA				Tomas, Anna; Lery, Leticia; Regueiro, Veronica; Perez-Gutierrez, Camino; Martinez, Veronica; Moranta, David; Llobet, Enrique; Gonzalez-Nicolau, Mar; Insua, Jose L.; Tomas, Juan M.; Sansonetti, Philippe J.; Tournebize, Regis; Bengoechea, Jose A.			Functional Genomic Screen Identifies Klebsiella pneumoniae Factors Implicated in Blocking Nuclear Factor kappa B (NF-kappa B) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; PROTECTIVE INNATE IMMUNITY; HOST-DEFENSE; O-ANTIGEN; STREPTOCOCCAL VIRULENCE; CAPSULE POLYSACCHARIDE; BACTERIAL CLEARANCE; GENETIC-ANALYSIS; OUTER-CORE; LIPOPOLYSACCHARIDE	Klebsiella pneumoniae is an etiologic agent of community-acquired and nosocomial pneumonia. It has been shown that K. pneumoniae infections are characterized by reduced early inflammatory response. Recently our group has shown that K. pneumoniae dampens the activation of inflammatory responses by antagonizing the activation of the NF-kappa B canonical pathway. Our results revealed that K. pneumoniae capsule polysaccharide (CPS) was necessary but not sufficient to attenuate inflammation. To identify additional Klebsiella factors required to dampen inflammation, we standardized and applied a high-throughput gain-of-function screen to examine a Klebsiella transposon mutant library. We identified 114 mutants that triggered the activation of NF-kappa B. Two gene ontology categories accounted for half of the loci identified in the screening: metabolism and transport genes (32% of the mutants) and envelope-related genes (17%). Characterization of the mutants revealed that the lack of the enterobactin siderophore was linked to a reduced CPS expression, which in turn underlined the NF-kappa B activation induced by the mutant. The lipopolysaccharide (LPS) O-polysaccharide and the pullulanase (PulA) type 2 secretion system (T2SS) are required for full effectiveness of the immune evasion. Importantly, these factors do not play a redundant role. The fact that LPS O-polysaccharide and T2SS mutant-induced responses were dependent on TLR2-TLR4-MyD88 activation suggested that LPS O-polysaccharide and PulA perturbed Toll-like receptor (TLR)-dependent recognition of K. pneumoniae. Finally, we demonstrate that LPS O-polysaccharide and pulA mutants are attenuated in the pneumonia mouse model. We propose that LPS O-polysaccharide and PulA T2SS could be new targets for the design of new antimicrobials. Increasing TLR-governed defense responses might provide also selective alternatives for the management of K. pneumoniae pneumonia.	[Tomas, Anna; Regueiro, Veronica; Perez-Gutierrez, Camino; Martinez, Veronica; Moranta, David; Llobet, Enrique; Gonzalez-Nicolau, Mar] FISIB, Infect & Immun Program, Mallorca 07110, Spain; [Tomas, Anna; Regueiro, Veronica; Perez-Gutierrez, Camino; Martinez, Veronica; Moranta, David; Llobet, Enrique; Gonzalez-Nicolau, Mar] Inst Invest Sanitaria Palma IdisPa, Mallorca 07120, Spain; [Tomas, Anna; Regueiro, Veronica; Perez-Gutierrez, Camino; Martinez, Veronica; Moranta, David; Llobet, Enrique; Gonzalez-Nicolau, Mar] Ctr Invest Biomed Red Enfermedades Resp CIBERES, Madrid 28029, Spain; [Lery, Leticia; Sansonetti, Philippe J.; Tournebize, Regis] Inst Pasteur, Unite Pathogenie Microbienne Mol, F-75724 Paris, France; [Lery, Leticia; Sansonetti, Philippe J.; Tournebize, Regis] INSERM U786, F-75724 Paris, France; [Insua, Jose L.; Bengoechea, Jose A.] Queens Univ Belfast, Ctr Infect & Immun, Belfast BT9 7AE, Antrim, North Ireland; [Tomas, Juan M.] Univ Barcelona, Fac Biol, Dept Microbiol, E-08028 Barcelona, Spain; [Sansonetti, Philippe J.] Coll France, Chaire Microbiol & Malad Infect, F-75231 Paris, France; [Tournebize, Regis] Inst Pasteur, Plateforme Imagerie Dynam, Imagopole, F-75724 Paris, France; [Bengoechea, Jose A.] CSIC, Madrid 28008, Spain	Institut Investigacio Sanitaria Illes Balears (IdISBa); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Queens University Belfast; University of Barcelona; UDICE-French Research Universities; PSL Research University Paris; College de France; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Consejo Superior de Investigaciones Cientificas (CSIC)	Bengoechea, JA (corresponding author), Queens Univ Belfast, Ctr Infect & Immun, Hlth Sci Bldg,97 Lisburn Rd, Belfast BT9 7AE, Antrim, North Ireland.	j.bengoechea@qub.ac.uk	Tournebize, Regis/K-7847-2018; Mesquida, David Moranta/H-4958-2012; Tomas, Juan M/L-1398-2015	Tournebize, Regis/0000-0003-3718-3130; Mesquida, David Moranta/0000-0001-9528-4920; Tomas, Juan M/0000-0002-3575-7113; Lery, Leticia/0000-0002-5733-8294; Bengoechea, Jose/0000-0002-9677-8751	ERA-Net Pathogenomic; Marie Curie Career Integration Grant (U-KARE) [PCIG13-GA-2013-618162]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/L007223/1]; Queen's University Belfast start-up funds; Programa Nacional de Proyectos de Investigacion Fundamental del Ministerio de Ciencia e Innovacion [SAF2012-39841]; Biotechnology and Biological Sciences Research Council [BB/L007223/1] Funding Source: researchfish; BBSRC [BB/L007223/1] Funding Source: UKRI	ERA-Net Pathogenomic; Marie Curie Career Integration Grant (U-KARE); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Queen's University Belfast start-up funds; Programa Nacional de Proyectos de Investigacion Fundamental del Ministerio de Ciencia e Innovacion; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a grant from ERA-Net Pathogenomic 2008 (to P. J. S. and J. A. B.), Marie Curie Career Integration Grant (U-KARE) PCIG13-GA-2013-618162, Biotechnology and Biological Sciences Research Council (BBSRC) Grant BB/L007223/1, and Queen's University Belfast start-up funds (to J. A. B.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a predoctoral fellowship from the Programa Nacional de Proyectos de Investigacion Fundamental (SAF2012-39841) del Ministerio de Ciencia e Innovacion.	Alexeyev MF, 1999, BIOTECHNIQUES, V26, P824, DOI 10.2144/99265bm05; AUTENRIETH I, 1991, MED MICROBIOL IMMUN, V180, P135; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Boyle EC, 2003, CURR OPIN CELL BIOL, V15, P633, DOI 10.1016/S0955-0674(03)00099-1; CAMPRUBI S, 1993, FEMS MICROBIOL LETT, V111, P9; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Conde-Alvarez R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002675; Cortes G, 2002, INFECT IMMUN, V70, P2583, DOI 10.1128/IAI.70.5.2583-2590.2002; Cortes G, 2002, INFECT IMMUN, V70, P1075, DOI 10.1128/IAI.70.3.1075-1080.2002; Crepin S, 2012, APPL ENVIRON MICROB, V78, P6001, DOI 10.1128/AEM.00986-12; Deng JC, 2004, J IMMUNOL, V173, P5148, DOI 10.4049/jimmunol.173.8.5148; Dennis JJ, 1998, APPL ENVIRON MICROB, V64, P2710; Frank CG, 2013, CELL MICROBIOL, V15, P1212, DOI 10.1111/cmi.12110; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Greenberger MJ, 1996, J INFECT DIS, V173, P159, DOI 10.1093/infdis/173.1.159; Greenberger MJ, 1996, J IMMUNOL, V157, P3006; Hansen DS, 1999, J CLIN MICROBIOL, V37, P56, DOI 10.1128/JCM.37.1.56-62.1999; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; Happel KI, 2003, J IMMUNOL, V170, P4432, DOI 10.4049/jimmunol.170.9.4432; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Izquierdo L, 2003, J BACTERIOL, V185, P7213, DOI 10.1128/JB.185.24.7213-7221.2003; Karaolis DKR, 2007, INFECT IMMUN, V75, P4942, DOI 10.1128/IAI.01762-06; Kenny EF, 2008, CYTOKINE, V43, P342, DOI 10.1016/j.cyto.2008.07.010; Koplin R, 1997, J BIOL CHEM, V272, P4121, DOI 10.1074/jbc.272.7.4121; Korotkov KV, 2012, NAT REV MICROBIOL, V10, P336, DOI 10.1038/nrmicro2762; Laichalk LL, 1998, INFECT IMMUN, V66, P2822, DOI 10.1128/IAI.66.6.2822-2826.1998; Larsen RA, 2002, ARCH MICROBIOL, V178, P193, DOI 10.1007/s00203-002-0442-2; Lawlor MS, 2007, INFECT IMMUN, V75, P1463, DOI 10.1128/IAI.00372-06; Lawlor MS, 2006, INFECT IMMUN, V74, P5402, DOI 10.1128/IAI.00244-06; Lawlor MS, 2005, MOL MICROBIOL, V58, P1054, DOI 10.1111/j.1365-2958.2005.04918.x; Lery LMS, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-41; Lin CT, 2011, MICROBIOL-SGM, V157, P419, DOI 10.1099/mic.0.044065-0; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Liu ZM, 2014, J EXP MED, V211, P1197, DOI 10.1084/jem.20132629; Llobet E, 2008, MICROBIOL-SGM, V154, P3877, DOI 10.1099/mic.0.2008/022301-0; Llobet E, 2011, INFECT IMMUN, V79, P3718, DOI 10.1128/IAI.05226-11; Llobet E, 2009, ANTIMICROB AGENTS CH, V53, P298, DOI 10.1128/AAC.00657-08; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; March C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056847; March C, 2011, J BIOL CHEM, V286, P9956, DOI 10.1074/jbc.M110.181008; Marolda Cristina L., 2006, V347, P237; Maroncle N, 2002, INFECT IMMUN, V70, P4729, DOI 10.1128/IAI.70.8.4729-4734.2002; Miller WG, 2000, MOL PLANT MICROBE IN, V13, P1243, DOI 10.1094/MPMI.2000.13.11.1243; Moranta D, 2010, INFECT IMMUN, V78, P1135, DOI 10.1128/IAI.00940-09; Murphy CN, 2013, INFECT IMMUN, V81, P3009, DOI 10.1128/IAI.00348-13; NASSIF X, 1989, INFECT IMMUN, V57, P546, DOI 10.1128/IAI.57.2.546-552.1989; Nigro G, 2008, CELL MICROBIOL, V10, P682, DOI 10.1111/j.1462-5822.2007.01075.x; Perez-Gutierrez C, 2010, INFECT IMMUN, V78, P2768, DOI 10.1128/IAI.01417-09; Pugsley AP, 1997, FOLIA MICROBIOL, V42, P184, DOI 10.1007/BF02818976; Rahn A, 2003, MOL MICROBIOL, V47, P1045, DOI 10.1046/j.1365-2958.2003.03354.x; Raymond KN, 2003, P NATL ACAD SCI USA, V100, P3584, DOI 10.1073/pnas.0630018100; Regue M, 2005, J BACTERIOL, V187, P4198, DOI 10.1128/JB.187.12.4198-4206.2005; Regueiro V, 2006, MICROBIOL-SGM, V152, P555, DOI 10.1099/mic.0.28285-0; Regueiro V, 2011, CELL MICROBIOL, V13, P135, DOI 10.1111/j.1462-5822.2010.01526.x; Regueiro V, 2009, INFECT IMMUN, V77, P714, DOI 10.1128/IAI.00852-08; Reines M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002978; Reines M, 2012, J BACTERIOL, V194, P3173, DOI 10.1128/JB.00308-12; Rubires X, 1997, J BACTERIOL, V179, P7581, DOI 10.1128/jb.179.23.7581-7586.1997; Sahly H, 1997, CLIN DIAGN LAB IMMUN, V4, P393, DOI 10.1128/CDLI.4.4.393-399.1997; Sharma RC, 1996, BIOTECHNIQUES, V20, P42; Shelburne SA, 2011, MOL MICROBIOL, V81, P500, DOI 10.1111/j.1365-2958.2011.07708.x; Skurnik M, 1999, MOL MICROBIOL, V31, P1443, DOI 10.1046/j.1365-2958.1999.01285.x; Standiford TJ, 1999, HUM GENE THER, V10, P899, DOI 10.1089/10430349950018300; Sun SC, 2008, NAT REV IMMUNOL, V8, P501, DOI 10.1038/nri2337; Tsai WC, 1998, J IMMUNOL, V161, P2435; Tu YC, 2009, INFECT IMMUN, V77, P2657, DOI 10.1128/IAI.01523-08; van Bueren AL, 2007, NAT STRUCT MOL BIOL, V14, P76, DOI 10.1038/nsmb1187; Wieland CW, 2011, EUR RESPIR J, V37, P848, DOI 10.1183/09031936.00076510	68	36	37	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16678	16697		10.1074/jbc.M114.621292	http://dx.doi.org/10.1074/jbc.M114.621292			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25971969	Green Published, hybrid			2022-12-28	WOS:000357572800018
J	Wei, L; Gao, JX; Zhang, SM; Wu, SJ; Xie, ZP; Ling, GY; Kuang, YQ; Yang, YL; Yu, HN; Wang, YP				Wei, Lin; Gao, Jiuxiang; Zhang, Shumin; Wu, Sijin; Xie, Zeping; Ling, Guiying; Kuang, Yi-Qun; Yang, Yongliang; Yu, Haining; Wang, Yipeng			Identification and Characterization of the First Cathelicidin from Sea Snakes with Potent Antimicrobial and Anti-inflammatory Activity and Special Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNITY; PEPTIDES; ANTIBIOTICS; INFECTIONS; FAMILY; VENOM; LIPOPOLYSACCHARIDE; HYDROPHIINAE; STABILITY; MOLECULES	Cathelicidins are a family of gene-encoded peptide effectors of innate immunity found exclusively in vertebrates. They play pivotal roles in host immune defense against microbial invasions. Dozens of cathelicidins have been identified from several vertebrate species. However, no cathelicidin from marine reptiles has been characterized previously. Here we report the identification and characterization of a novel cathelicidin (Hc-CATH) from the sea snake Hydrophis cyanocinctus. Hc-CATH is composed of 30 amino acids, and the sequence is KFFKRLLKSVRRAVKKFRKKPRLIGLSTLL. Circular dichroism spectroscopy and structure modeling analysis indicated that Hc-CATH mainly assumes an amphipathic alpha-helical conformation in bacterial membrane-mimetic solutions. It possesses potent broad-spectrum and rapid antimicrobial activity. Meanwhile, it is highly stable and shows low cytotoxicity toward mammalian cells. The microbial killing activity of Hc-CATH is executed through the disruption of cell membrane and lysis of bacterial cells. In addition, Hc-CATH exhibited potent anti-inflammatory activity by inhibiting the LPS-induced production of nitric oxide (NO) and pro-inflammatory cytokines such as TNF-alpha, IL-1 beta, and IL-6. Hc-CATH directly binds with LPS to neutralize its toxicity, and it also binds to Toll-like receptor 4 (TLR4/MD2 complex), which therefore inhibits the binding of LPS to TLR4/MD2 complex and the subsequent activation of LPS-induced inflammatory response pathways. Taken together, our study demonstrates that Hc-CATH, the first cathelicidin from sea snake discovered to have both antimicrobial and anti-inflammatory activity, is a potent candidate for the development of peptide antibiotics.	[Wang, Yipeng] Soochow Univ, Coll Pharmaceut Sci, Dept Pharmaceut Sci, Suzhou 215123, Jiangsu, Peoples R China; [Gao, Jiuxiang; Wu, Sijin; Yang, Yongliang; Yu, Haining] Dalian Univ Technol, Dept Biosci & Biotechnol, Dalian 116023, Liaoning, Peoples R China; [Zhang, Shumin; Xie, Zeping] Binzhou Med Univ, Pharmaceut Coll, Yantai 264003, Shandong, Peoples R China; [Wei, Lin] Soochow Univ, Inst Biol, Jiangsu Key Lab Infect & Immun, Suzhou 215123, Jiangsu, Peoples R China; [Wei, Lin] Soochow Univ, Inst Med Sci, Jiangsu Key Lab Infect & Immun, Suzhou 215123, Jiangsu, Peoples R China; [Ling, Guiying] Guiyang Med Coll, Affiliated Hosp, Canc Immunol & Immunotherapy Ctr, Guiyang 550004, Guizhou, Peoples R China; [Kuang, Yi-Qun] Henan Univ, Huaihe Clin Inst, Ctr Translat Med, Kaifeng 475000, Henan, Peoples R China	Soochow University - China; Dalian University of Technology; Binzhou Medical University; Soochow University - China; Soochow University - China; Guizhou Medical University; Henan University	Yu, HN (corresponding author), Dalian Univ Technol, Dept Biosci & Biotechnol, Dalian 116023, Liaoning, Peoples R China.	yuhaining@dlut.edu.cn; yipengwang@suda.edu.cn	Wu, Sijin/AAB-2006-2020; Wang, Yipeng/AAA-1499-2020; Wu, Sijin/AAL-3482-2020; Wei, Lin/AAE-3043-2022; Kuang, Yi-Qun/AAW-4884-2021	Wang, Yipeng/0000-0003-1385-4470; Wei, Lin/0000-0003-3359-2471; Kuang, Yi-Qun/0000-0002-1452-4388	Chinese National Natural Science Foundation [41206153, 81402830]; Suzhou Science and Technology Development Project [SYN201407]; Jiangsu Province Natural Science Foundation [BK20140362, 14KJD350003]; Growth Project for Liaoning Distinguished Young Scientists of Colleges and Universities [LJQ2013010]; Dalian Distinguished Young Scientists Funding [2013J21DW013]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Suzhou Science and Technology Development Project; Jiangsu Province Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Growth Project for Liaoning Distinguished Young Scientists of Colleges and Universities; Dalian Distinguished Young Scientists Funding	This work was supported by Grants 41206153 and 81402830 from the Chinese National Natural Science Foundation, SYN201407 from the Suzhou Science and Technology Development Project, BK20140362 and 14KJD350003 from the Jiangsu Province Natural Science Foundation, LJQ2013010 from the Growth Project for Liaoning Distinguished Young Scientists of Colleges and Universities, and 2013J21DW013 from the Dalian Distinguished Young Scientists Funding. The authors declare that they have no conflicts of interest with the contents of this article.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bals R, 2003, CELL MOL LIFE SCI, V60, P711, DOI 10.1007/s00018-003-2186-9; Berendsen BJA, 2011, FOOD ADDIT CONTAM A, V28, P1657, DOI 10.1080/19440049.2011.604045; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Chow JYC, 2013, WORLD J GASTROENTERO, V19, P2731, DOI 10.3748/wjg.v19.i18.2731; Falcao CB, 2014, AMINO ACIDS, V46, P2561, DOI 10.1007/s00726-014-1801-4; Finlay BB, 2004, NAT REV MICROBIOL, V2, P497, DOI 10.1038/nrmicro908; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; Hancock REW, 2012, NAT REV MICROBIOL, V10, P243, DOI 10.1038/nrmicro2745; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Li SA, 2012, ANTIMICROB AGENTS CH, V56, P3309, DOI 10.1128/AAC.06304-11; Ling GY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093216; Lu ZK, 2010, FEBS J, V277, P2329, DOI 10.1111/j.1742-4658.2010.07648.x; Mookherjee N, 2007, CELL MOL LIFE SCI, V64, P922, DOI 10.1007/s00018-007-6475-6; Mookherjee N, 2007, EXPERT OPIN THER TAR, V11, P993, DOI 10.1517/14728222.11.8.993; Nair DG, 2007, BIOCHEM J, V402, P93, DOI 10.1042/BJ20060318; Nakatsuji T, 2012, J INVEST DERMATOL, V132, P887, DOI 10.1038/jid.2011.387; Oguiura N, 2005, TOXICON, V46, P363, DOI 10.1016/j.toxicon.2005.06.009; Okerman L, 2007, ANAL CHIM ACTA, V586, P284, DOI 10.1016/j.aca.2006.10.034; Pasupuleti M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005285; Radek K, 2007, SEMIN IMMUNOPATHOL, V29, P27, DOI 10.1007/s00281-007-0064-5; Ramanathan B, 2002, MICROBES INFECT, V4, P361, DOI 10.1016/S1286-4579(02)01549-6; Sanders KL, 2008, J EVOLUTION BIOL, V21, P682, DOI 10.1111/j.1420-9101.2008.01525.x; Sanders KL, 2010, J EVOLUTION BIOL, V23, P2685, DOI 10.1111/j.1420-9101.2010.02131.x; Scott MG, 2007, NAT BIOTECHNOL, V25, P465, DOI 10.1038/nbt1288; Spellberg B, 2004, CLIN INFECT DIS, V38, P1279, DOI 10.1086/420937; Steinstraesser L, 2011, IMMUNOBIOLOGY, V216, P322, DOI 10.1016/j.imbio.2010.07.003; Theuretzbacher U, 2006, CURR OPIN INVEST DR, V7, P158; Tosi MF, 2005, J ALLERGY CLIN IMMUN, V116, P241, DOI 10.1016/j.jaci.2005.05.036; Travis SM, 2000, INFECT IMMUN, V68, P2748, DOI 10.1128/IAI.68.5.2748-2755.2000; van Hoek ML, 2014, PHARMACEUTICALS, V7, P723, DOI 10.3390/ph7060723; Viriyakosol S, 2001, J BIOL CHEM, V276, P38044; Wang YP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022120; Wang YP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003217; Wei L, 2013, J MED CHEM, V56, P3546, DOI 10.1021/jm4004158; Xiao YJ, 2009, J INNATE IMMUN, V1, P268, DOI 10.1159/000174822; Xiao YJ, 2006, J BIOL CHEM, V281, P2858, DOI 10.1074/jbc.M507180200; Zaiou M, 2002, J MOL MED, V80, P549, DOI 10.1007/s00109-002-0350-6; Zaiou M, 2007, J MOL MED, V85, P317, DOI 10.1007/s00109-006-0143-4; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83; Zhao H, 2008, PEPTIDES, V29, P1685, DOI 10.1016/j.peptides.2008.06.008	45	73	78	7	58	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16633	16652		10.1074/jbc.M115.642645	http://dx.doi.org/10.1074/jbc.M115.642645			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	26013823	Green Published, hybrid			2022-12-28	WOS:000357572800015
J	Herchenhan, A; Uhlenbrock, F; Eliasson, P; Weis, M; Eyre, D; Kadler, KE; Magnusson, SP; Kjaer, M				Herchenhan, Andreas; Uhlenbrock, Franziska; Eliasson, Pernilla; Weis, MaryAnn; Eyre, David; Kadler, Karl E.; Magnusson, S. Peter; Kjaer, Michael			Lysyl Oxidase Activity Is Required for Ordered Collagen Fibrillogenesis by Tendon Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						collagen; electron microscopy (EM); fibril; lysyl oxidase; tendon; Ehlers-Danlos Syndrome; collagen cross-linking; tendon construct; -aminoproprionitrile (BAPN)	EHLERS-DANLOS-SYNDROME; CROSS-LINKING; BETA-AMINOPROPIONITRILE; V COLLAGEN; I COLLAGEN; TENASCIN-X; 3-DIMENSIONAL ORGANIZATION; EXPERIMENTAL LATHYRISM; ELECTRON-MICROSCOPY; CORE PROTEIN	Background: Lysyl oxidase catalyzes collagen cross-link formation, which is essential for mechanically strong collagen fibrils. Results: LOX inhibition stops early mechanical development of tendon constructs and leads to irregularly shaped collagen fibrils. Conclusion: Collagen cross-linking is essential for successful fibrillogenesis and regulates fibril shape. Significance: LOX activity is required in the control of collagen fibril architecture by a mechanism that remains to be explained. Lysyl oxidases (LOXs) are a family of copper-dependent oxido-deaminases that can modify the side chain of lysyl residues in collagen and elastin, thereby leading to the spontaneous formation of non-reducible aldehyde-derived interpolypeptide chain cross-links. The consequences of LOX inhibition in producing lathyrism are well documented, but the consequences on collagen fibril formation are less clear. Here we used -aminoproprionitrile (BAPN) to inhibit LOX in tendon-like constructs (prepared from human tenocytes), which are an experimental model of cell-mediated collagen fibril formation. The improvement in structure and strength seen with time in control constructs was absent in constructs treated with BAPN. As expected, BAPN inhibited the formation of aldimine-derived cross-links in collagen, and the constructs were mechanically weak. However, an unexpected finding was that BAPN treatment led to structurally abnormal collagen fibrils with irregular profiles and widely dispersed diameters. Of special interest, the abnormal fibril profiles resembled those seen in some Ehlers-Danlos Syndrome phenotypes. Importantly, the total collagen content developed normally, and there was no difference in COL1A1 gene expression. Collagen type V, decorin, fibromodulin, and tenascin-X proteins were unaffected by the cross-link inhibition, suggesting that LOX regulates fibrillogenesis independently of these molecules. Collectively, the data show the importance of LOX for the mechanical development of early collagenous tissues and that LOX is essential for correct collagen fibril shape formation.	[Herchenhan, Andreas; Eliasson, Pernilla; Magnusson, S. Peter; Kjaer, Michael] Univ Copenhagen, Inst Sports Med Copenhagen, DK-2400 Copenhagen, Denmark; [Herchenhan, Andreas; Eliasson, Pernilla; Magnusson, S. Peter; Kjaer, Michael] Univ Copenhagen, Ctr Hlth Ageing, DK-2400 Copenhagen, Denmark; [Uhlenbrock, Franziska] Univ Copenhagen, Fac Hlth & Med Sci, Sect Expt Anim Models, Immunol Lab, DK-1870 Frederiksberg, Denmark; [Weis, MaryAnn; Eyre, David] Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA; [Kadler, Karl E.] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Washington; University of Washington Seattle; University of Manchester	Herchenhan, A (corresponding author), Bispebjerg Hosp, Inst Sports Med Copenhagen, Bispebjerg Bakke 23, DK-2400 Copenhagen, Denmark.	andreas.herchenhan@gmail.com	KADLER, KARL/ABI-2403-2020; Magnusson, S. Peter/AAD-5903-2022; Eliasson, Pernilla/AAY-2126-2020; Kjaer, Michael/W-6842-2019; Magnusson, Peter/AAN-1631-2020; Regan, Clinton/E-6250-2012	KADLER, KARL/0000-0003-4977-4683; Magnusson, S. Peter/0000-0002-4308-5484; Eliasson, Pernilla/0000-0001-6718-034X; Kjaer, Michael/0000-0002-4582-8755; 	National Institutes of Health [AR037318]; Wellcome Trust; Nordea Foundation; University of Copenhagen, Department of Health Sciences, Academy of Muscle Biology, Exercise, and Health Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR037318, R01AR036794, R01AR037318] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Nordea Foundation; University of Copenhagen, Department of Health Sciences, Academy of Muscle Biology, Exercise, and Health Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR037318 (NIAMS; to D. E.). This work was also supported by the Wellcome Trust (to K. E. K) and, in whole or in part, by the Nordea Foundation (a Healthy Aging grant) and the University of Copenhagen, Department of Health Sciences, Academy of Muscle Biology, Exercise, and Health Research. The authors declare that they have no conflicts of interest with the contents of this article.	Baker AM, 2013, ONCOGENE, V32, P1863, DOI 10.1038/onc.2012.202; Bayer ML, 2010, BIOMATERIALS, V31, P4889, DOI 10.1016/j.biomaterials.2010.02.062; Beighton P, 1998, AM J MED GENET, V77, P31, DOI 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.3.CO;2-P; BIRK DE, 1988, J CELL BIOL, V106, P999, DOI 10.1083/jcb.106.3.999; BIRK DE, 1984, J CELL BIOL, V99, P2024, DOI 10.1083/jcb.99.6.2024; Birk DE, 2001, MICRON, V32, P223, DOI 10.1016/S0968-4328(00)00043-3; Bristow J, 2005, AM J MED GENET C, V139C, P24, DOI 10.1002/ajmg.c.30071; BROWN IA, 1972, J ANAT, V113, P159; Canty EG, 2004, J CELL BIOL, V165, P553, DOI 10.1083/jcb.200312071; CHVAPIL M, 1981, J SURG RES, V31, P151, DOI 10.1016/0022-4804(81)90043-3; Cox TR, 2013, CANCER RES, V73, P1721, DOI 10.1158/0008-5472.CAN-12-2233; CRONLUND AL, 1985, CONNECT TISSUE RES, V14, P109, DOI 10.3109/03008208509015017; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; DEYL Z, 1981, BIOCHEM BIOPH RES CO, V101, P1026, DOI 10.1016/0006-291X(81)91851-9; EYRE DR, 1984, ANNU REV BIOCHEM, V53, P717, DOI 10.1146/annurev.bi.53.070184.003441; FLEISCHMAJER R, 1991, J STRUCT BIOL, V106, P82, DOI 10.1016/1047-8477(91)90065-5; HEDBOM E, 1993, J BIOL CHEM, V268, P27307; Herchenhan A, 2013, DEV DYNAM, V242, P2, DOI 10.1002/dvdy.23896; Kadler KE, 1996, BIOCHEM J, V316, P1; Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413; Kalamajski S, 2014, J BIOL CHEM, V289, P18873, DOI 10.1074/jbc.M114.572941; Kapacce Z, 2008, MATRIX BIOL, V27, P371, DOI 10.1016/j.matbio.2007.11.006; KASTELIC J, 1978, CONNECT TISSUE RES, V6, P11, DOI 10.3109/03008207809152283; KOMAI Y, 1991, INVEST OPHTH VIS SCI, V32, P2244; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVENE CI, 1959, J EXP MED, V110, P771, DOI 10.1084/jem.110.5.771; Maki JM, 2005, AM J PATHOL, V167, P927, DOI 10.1016/S0002-9440(10)61183-2; Maki JM, 2002, CIRCULATION, V106, P2503, DOI 10.1161/01.CIR.0000038109.84500.1E; Mao JR, 2002, NAT GENET, V30, P421, DOI 10.1038/ng850; Marturano JE, 2014, ACTA BIOMATER, V10, P1370, DOI 10.1016/j.actbio.2013.11.024; Marturano JE, 2013, P NATL ACAD SCI USA, V110, P6370, DOI 10.1073/pnas.1300135110; Molnar J, 2003, BBA-PROTEINS PROTEOM, V1647, P220, DOI 10.1016/S1570-9639(03)00053-0; Nielsen RH, 2014, FASEB J, V28, P4668, DOI 10.1096/fj.14-249656; NIYIBIZI C, 1994, EUR J BIOCHEM, V224, P943, DOI 10.1111/j.1432-1033.1994.00943.x; Orgel JPRO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007028; ORLOFF SD, 1963, J EXP MED, V117, P1009, DOI 10.1084/jem.117.6.1009; PARRY DAD, 1978, PROC R SOC SER B-BIO, V203, P305, DOI 10.1098/rspb.1978.0107; PIERARD GE, 1988, COLLAGEN REL RES, V8, P453; Pingel J, 2014, J ANAT, V224, P548, DOI 10.1111/joa.12164; PINNELL SR, 1968, P NATL ACAD SCI USA, V61, P708, DOI 10.1073/pnas.61.2.708; PRINGLE GA, 1990, J HISTOCHEM CYTOCHEM, V38, P1405, DOI 10.1177/38.10.1698203; Schalkwijk J, 2001, NEW ENGL J MED, V345, P1167, DOI 10.1056/NEJMoa002939; SIEGEL RC, 1974, P NATL ACAD SCI USA, V71, P4826, DOI 10.1073/pnas.71.12.4826; Silver FH, 2001, SKIN RES TECHNOL, V7, P18, DOI 10.1034/j.1600-0846.2001.007001018.x; SMITH LT, 1982, J INVEST DERMATOL, V79, pS93, DOI 10.1111/1523-1747.ep12545877; Starborg T, 2013, NAT PROTOC, V8, P1433, DOI 10.1038/nprot.2013.086; Svensson L, 1999, J BIOL CHEM, V274, P9636, DOI 10.1074/jbc.274.14.9636; Symoens S, 2012, HUM MUTAT, V33, P1485, DOI 10.1002/humu.22137; TANG SS, 1983, J BIOL CHEM, V258, P4331; TANZER ML, 1964, J CELL BIOL, V22, P623, DOI 10.1083/jcb.22.3.623; Wang L, 2014, J BIOL CHEM, V289, P921, DOI 10.1074/jbc.M113.496364; Wang RY, 2013, J BIOMECH, V46, P2726, DOI 10.1016/j.jbiomech.2013.08.001; WEINER S, 1992, FASEB J, V6, P879, DOI 10.1096/fasebj.6.3.1740237; Wenstrup RJ, 2006, J BIOL CHEM, V281, P12888, DOI 10.1074/jbc.M511528200; Wenstrup RJ, 2004, J BIOL CHEM, V279, P53331, DOI 10.1074/jbc.M409622200; WILMARTH KR, 1992, J TOXICOL ENV HEALTH, V37, P411, DOI 10.1080/15287399209531680; Wu JJ, 2010, J BIOL CHEM, V285, P18537, DOI 10.1074/jbc.M110.112904; Young RD, 2014, P NATL ACAD SCI USA, V111, P687, DOI 10.1073/pnas.1313561110; Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776; Zhu JX, 2012, ANAT REC, V295, P1430, DOI 10.1002/ar.22527	61	88	89	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16440	16450		10.1074/jbc.M115.641670	http://dx.doi.org/10.1074/jbc.M115.641670			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25979340	Green Published, hybrid			2022-12-28	WOS:000356930100044
J	Tan, B; Dong, SC; Shepard, RL; Kays, L; Roth, KD; Geeganage, S; Kuo, MS; Zhao, GS				Tan, Bo; Dong, Sucai; Shepard, Robert L.; Kays, Lisa; Roth, Kenneth D.; Geeganage, Sandaruwan; Kuo, Ming-Shang; Zhao, Genshi			Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT), an Enzyme Essential for NAD(+) Biosynthesis, Leads to Altered Carbohydrate Metabolism in Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate metabolism; glucose metabolism; glycolysis; nicotinamide adenine dinucleotide (NAD); pharmacology	PHARMACOLOGICAL INHIBITION; COLORECTAL-CANCER; GASTRIC-CANCER; ALDOLASE-B; CARCINOMA; APOPTOSIS; STRESS; DEATH; OVEREXPRESSION; KETOHEXOKINASE	Nicotinamide phosphoribosyltransferase (NAMPT) has been extensively studied due to its essential role in NAD(+) biosynthesis in cancer cells and the prospect of developing novel therapeutics. To understand how NAMPT regulates cellular metabolism, we have shown that the treatment with FK866, a specific NAMPT inhibitor, leads to attenuation of glycolysis by blocking the glyceraldehyde 3-phosphate dehydrogenase step (Tan, B., Young, D. A., Lu, Z. H., Wang, T., Meier, T. I., Shepard, R. L., Roth, K., Zhai, Y., Huss, K., Kuo, M. S., Gillig, J., Parthasarathy, S., Burkholder, T. P., Smith, M. C., Geeganage, S., and Zhao, G. (2013) Pharmacological inhibition of nicotinamide phosphoribosyltransferase (NAMPT), an enzyme essential for NAD(+) biosynthesis, in human cancer cells: metabolic basis and potential clinical implications. J. Biol. Chem. 288, 3500-3511). Due to technical limitations, we failed to separate isotopomers of phosphorylated sugars. In this study, we developed an enabling LC-MS methodology. Using this, we confirmed the previous findings and also showed that NAMPT inhibition led to accumulation of fructose 1-phosphate and sedoheptulose 1-phosphate but not glucose 6-phosphate, fructose 6-phosphate, and sedoheptulose 7-phosphate as previously thought. To investigate the metabolic basis of the metabolite formation, we carried out biochemical and cellular studies and established the following. First, glucose-labeling studies indicated that fructose 1-phosphate was derived from dihydroxyacetone phosphate and glyceraldehyde, and sedoheptulose 1-phosphate was derived from dihydroxyacetone phosphate and erythrose via an aldolase reaction. Second, biochemical studies showed that aldolase indeed catalyzed these reactions. Third, glyceraldehyde- and erythrose-labeling studies showed increased incorporation of corresponding labels into fructose 1-phosphate and sedoheptulose 1-phosphate in FK866-treated cells. Fourth, NAMPT inhibition led to increased glyceraldehyde and erythrose levels in the cell. Finally, glucose-labeling studies showed accumulated fructose 1,6-bisphosphate in FK866-treated cells mainly derived from dihydroxyacetone phosphate and glyceraldehyde 3-phosphate. Taken together, this study shows that NAMPT inhibition leads to attenuation of glycolysis, resulting in further perturbation of carbohydrate metabolism in cancer cells. The potential clinical implications of these findings are also discussed.	[Dong, Sucai; Shepard, Robert L.; Kays, Lisa; Geeganage, Sandaruwan; Kuo, Ming-Shang; Zhao, Genshi] Eli Lilly & Co, Lilly Res Labs, Canc Res, Indianapolis, IN 46285 USA; [Tan, Bo; Roth, Kenneth D.; Kuo, Ming-Shang] Eli Lilly & Co, Lilly Res Labs, Discovery Chem, Indianapolis, IN 46285 USA	Eli Lilly; Eli Lilly	Kuo, MS (corresponding author), Eli Lilly & Co, Lilly Res Labs, Canc Res, DC0434, Indianapolis, IN 46285 USA.	Kuo_Ming-Shang@Lilly.com; Zhao_Genshi@Lilly.com			Eli Lilly and Co.	Eli Lilly and Co.(Eli Lilly)	This work was supported by Eli Lilly and Co. The authors declare that they have no conflicts of interest with the contents of this article.	ALBERY WJ, 1976, BIOCHEMISTRY-US, V15, P5631, DOI 10.1021/bi00670a032; BAIS R, 1985, BIOCHEM J, V230, P53, DOI 10.1042/bj2300053; Beck T, 2013, BIOCHEMISTRY-US, V52, P6232, DOI 10.1021/bi400838t; Bi TQ, 2011, ONCOL REP, V26, P1251, DOI 10.3892/or.2011.1378; Busso N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002267; Catchpole G, 2011, J CELL MOL MED, V15, P109, DOI 10.1111/j.1582-4934.2009.00939.x; Clasquin MF, 2011, CELL, V145, P969, DOI 10.1016/j.cell.2011.05.022; Drevs J, 2003, ANTICANCER RES, V23, P4853; Du LN, 2003, J BIOL CHEM, V278, P18426, DOI 10.1074/jbc.M301295200; Garten A, 2009, TRENDS ENDOCRIN MET, V20, P130, DOI 10.1016/j.tem.2008.10.004; Giannetti AM, 2014, J MED CHEM, V57, P770, DOI 10.1021/jm4015108; Hasmann M, 2003, CANCER RES, V63, P7436; Hufton SE, 1999, FEBS LETT, V463, P77, DOI 10.1016/S0014-5793(99)01578-1; Hwa JS, 2006, PROTEOMICS, V6, P1077, DOI 10.1002/pmic.200401345; Imai S, 2009, CURR PHARM DESIGN, V15, P20, DOI 10.2174/138161209787185814; Kardon T, 2008, FEBS LETT, V582, P3330, DOI 10.1016/j.febslet.2008.08.024; Khan JA, 2007, EXPERT OPIN THER TAR, V11, P695, DOI 10.1517/14728222.11.5.695; Kirkland JB, 2009, CURR PHARM DESIGN, V15, P3, DOI 10.2174/138161209787185823; KITAJIMA Y, 1990, J BIOL CHEM, V265, P17493; KUSAKABE T, 1994, J BIOCHEM-TOKYO, V115, P1172, DOI 10.1093/oxfordjournals.jbchem.a124475; Luk T, 2008, J LEUKOCYTE BIOL, V83, P804, DOI 10.1189/jlb.0807581; Magni G, 2004, CELL MOL LIFE SCI, V61, P19, DOI 10.1007/s00018-003-3161-1; Muruganandham M, 2005, CLIN CANCER RES, V11, P3503, DOI 10.1158/1078-0432.CCR-04-1399; Nakajima TE, 2009, J GASTROENTEROL, V44, P685, DOI 10.1007/s00535-009-0063-5; Olesen UH, 2008, BIOCHEM BIOPH RES CO, V367, P799, DOI 10.1016/j.bbrc.2008.01.019; Olesen UH, 2010, MOL CANCER THER, V9, P1609, DOI 10.1158/1535-7163.MCT-09-1130; Pillai JB, 2005, J BIOL CHEM, V280, P43121, DOI 10.1074/jbc.M506162200; Rellos P, 2000, J BIOL CHEM, V275, P1145, DOI 10.1074/jbc.275.2.1145; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Rongvaux A, 2008, J IMMUNOL, V181, P4685, DOI 10.4049/jimmunol.181.7.4685; Sauve AA, 2008, J PHARMACOL EXP THER, V324, P883, DOI 10.1124/jpet.107.120758; Tan B, 2013, J BIOL CHEM, V288, P3500, DOI 10.1074/jbc.M112.394510; van Beijnum JR, 2002, INT J CANCER, V101, P118, DOI 10.1002/ijc.10584; Wang B, 2011, ONCOGENE, V30, P907, DOI 10.1038/onc.2010.468; Watson M, 2009, MOL CELL BIOL, V29, P5872, DOI 10.1128/MCB.00112-09; Wierenga RK, 2010, CELL MOL LIFE SCI, V67, P3961, DOI 10.1007/s00018-010-0473-9; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zheng XZ, 2013, J MED CHEM, V56, P6413, DOI 10.1021/jm4008664	39	32	34	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15812	15824		10.1074/jbc.M114.632141	http://dx.doi.org/10.1074/jbc.M114.632141			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25944913	Green Published, hybrid			2022-12-28	WOS:000356527400041
J	Zhang, RS; Wright, JD; Pless, SA; Nunez, JJ; Kim, RY; Li, JBW; Yang, RY; Ahern, CA; Kurata, HT				Zhang, Roger S.; Wright, Jordan D.; Pless, Stephan A.; Nunez, John-Jose; Kim, Robin Y.; Li, Jenny B. W.; Yang, Runying; Ahern, Christopher A.; Kurata, Harley T.			A Conserved Residue Cluster That Governs Kinetics of ATP-dependent Gating of Kir6.2 Potassium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						diabetes; gating; ion channel; kinetics; potassium channel; KATP channel; PIP2; ligand-dependent gating	CATION-PI INTERACTIONS; ACTIVATING MUTATIONS; CRYSTAL-STRUCTURE; AMINO-ACIDS; K+ CHANNEL; INHIBITION; MECHANISM; TRYPTOPHAN; STOICHIOMETRY; DETERMINANTS	Background: Kir6.2 potassium channels are regulated by ATP. Results: We measured Kir6.2 gating kinetics in response to rapid ATP concentration jumps. Mutations to Trp-68 and Lys-170 dramatically decelerate gating. Conclusion: Trp-68 and Lys-170 interact to form a cluster that enables rapid gating transitions. Significance: The Trp-68/Lys-170 cluster is highly conserved and may play a similar role in other Kir channels. ATP-sensitive potassium (K-ATP) channels are heteromultimeric complexes of an inwardly rectifying Kir channel (Kir6.x) and sulfonylurea receptors. Their regulation by intracellular ATP and ADP generates electrical signals in response to changes in cellular metabolism. We investigated channel elements that control the kinetics of ATP-dependent regulation of K-ATP (Kir6.2 + SUR1) channels using rapid concentration jumps. WT Kir6.2 channels re-open after rapid washout of ATP with a time constant of approximate to 60 ms. Extending similar kinetic measurements to numerous mutants revealed fairly modest effects on gating kinetics despite significant changes in ATP sensitivity and open probability. However, we identified a pair of highly conserved neighboring amino acids (Trp-68 and Lys-170) that control the rate of channel opening and inhibition in response to ATP. Paradoxically, mutations of Trp-68 or Lys-170 markedly slow the kinetics of channel opening (500 and 700 ms for W68L and K170N, respectively), while increasing channel open probability. Examining the functional effects of these residues using phi value analysis revealed a steep negative slope. This finding implies that these residues play a role in lowering the transition state energy barrier between open and closed channel states. Using unnatural amino acid incorporation, we demonstrate the requirement for a planar amino acid at Kir6.2 position 68 for normal channel gating, which is potentially necessary to localize the E-amine of Lys-170 in the phosphatidylinositol 4,5-bisphosphate-binding site. Overall, our findings identify a discrete pair of highly conserved residues with an essential role for controlling gating kinetics of Kir channels.	[Zhang, Roger S.; Wright, Jordan D.; Nunez, John-Jose; Kim, Robin Y.; Li, Jenny B. W.; Yang, Runying; Kurata, Harley T.] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V6T 1Z3, Canada; [Pless, Stephan A.] Univ Copenhagen, Dept Drug Design & Pharmacol, DK-2100 Copenhagen, Denmark; [Ahern, Christopher A.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52246 USA	University of British Columbia; University of Copenhagen; University of Iowa	Kurata, HT (corresponding author), Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V6T 1Z3, Canada.	harley.kurata@ubc.ca		Ahern, Christopher/0000-0002-7975-2744; Pless, Stephan/0000-0001-6654-114X; Kurata, Harley/0000-0003-4357-4189	National Institutes of Health from NIGMS [GM106569, GM087519]; Canadian Institutes of Health Research [MOP-97988]; Human Frontiers in Science Program Young Investigator award; University of British Columbia Work Study; Canadian Institutes of Health Research Banting; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research CGS-M award; Michael Smith Foundation; Canadian Institutes of Health Research; Michael Smith Foundation for Health Research awards; Faculty of Medicine; Novo Nordisk Fonden [NNF14OC0011767] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106569, U54GM087519] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Human Frontiers in Science Program Young Investigator award; University of British Columbia Work Study; Canadian Institutes of Health Research Banting(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research CGS-M award(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation(Michael Smith Foundation for Health Research); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research awards; Faculty of Medicine; Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM106569 from NIGMS (to C. A. A.). This work was also supported by Canadian Institutes of Health Research MOP-97988 and a Human Frontiers in Science Program Young Investigator award (to H. T. K.).; Recipient of summer student research awards from the University of British Columbia Work Study and Faculty of Medicine.; Recipient of Canadian Institutes of Health Research Banting and Michael Smith Foundation for Health Research awards.; Supported by Natural Sciences and Engineering Research Council of Canada undergraduate research award.; Supported by a Canadian Institutes of Health Research CGS-M award.; Member of the Membrane Protein Structural Dynamics Consortium, which is funded by National Institutes of Health Grant GM087519 from NIGMS.; Received salary support as a Michael Smith Foundation for Health Research Scholar and a Canadian Institutes of Health Research New Investigator. To whom correspondence should be addressed. Tel.: 604-827-3634; E-mail: harley.kurata@ubc.ca.	Antcliff JF, 2005, EMBO J, V24, P229, DOI 10.1038/sj.emboj.7600487; Baukrowitz T, 1998, SCIENCE, V282, P1141, DOI 10.1126/science.282.5391.1141; Beene DL, 2003, CURR OPIN NEUROBIOL, V13, P264, DOI 10.1016/S0959-4388(03)00068-0; Belokon YN, 2004, ARKIVOC, P132, DOI 10.3998/ark.5550190.0005.313; CANNELL MB, 1991, BIOPHYS J, V60, P1156, DOI 10.1016/S0006-3495(91)82151-8; Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Dougherty DA, 2014, CHEMBIOCHEM, V15, P1710, DOI 10.1002/cbic.201402080; Drain P, 2004, BIOPHYS J, V86, P2101, DOI 10.1016/S0006-3495(04)74269-1; Enkvetchakul D, 2000, BIOPHYS J, V78, P2334, DOI 10.1016/S0006-3495(00)76779-8; Enkvetchakul D, 2003, J GEN PHYSIOL, V122, P471, DOI 10.1085/jgp.200308878; FERSHT AR, 1991, PHILOS T ROY SOC B, V332, P171, DOI 10.1098/rstb.1991.0046; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Gloyn AL, 2004, NEW ENGL J MED, V350, P1838, DOI 10.1056/NEJMoa032922; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; Haider S, 2007, EMBO J, V26, P3749, DOI 10.1038/sj.emboj.7601809; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Kim MS, 2007, J KOREAN MED SCI, V22, P616, DOI 10.3346/jkms.2007.22.4.616; Koeppe RE, 2007, J GEN PHYSIOL, V130, P223, DOI 10.1085/jgp.200709829; Koster JC, 2008, BIOPHYS J, V95, P4689, DOI 10.1529/biophysj.108.138685; Kurata HT, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000315; Lacroix JJ, 2012, J GEN PHYSIOL, V140, P635, DOI 10.1085/jgp.201210827; Li JBW, 2013, J BIOL CHEM, V288, P23038, DOI 10.1074/jbc.M113.485789; Li LH, 2002, J GEN PHYSIOL, V119, P105, DOI 10.1085/jgp.119.1.105; Lin YW, 2003, J GEN PHYSIOL, V122, P225, DOI 10.1085/jgp.200308822; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Mannikko R, 2011, J PHYSIOL-LONDON, V589, P3071, DOI 10.1113/jphysiol.2011.209700; Massa O, 2005, HUM MUTAT, V25, P22, DOI 10.1002/humu.20124; McTaggart JS, 2010, J PHYSIOL-LONDON, V588, P3201, DOI 10.1113/jphysiol.2010.191767; NEHER E, 1977, ANNU REV BIOPHYS BIO, V6, P345, DOI 10.1146/annurev.bb.06.060177.002021; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Ozkan SB, 2001, NAT STRUCT BIOL, V8, P765, DOI 10.1038/nsb0901-765; Pegan S, 2006, BIOCHEMISTRY-US, V45, P8599, DOI 10.1021/bi060653d; Phillips LR, 2003, J GEN PHYSIOL, V122, P795, DOI 10.1085/jgp.200308953; Phillips LR, 2003, NEURON, V37, P953, DOI 10.1016/S0896-6273(03)00155-7; Pless SA, 2013, ELIFE, V2, DOI 10.7554/eLife.01289; Pless SA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2761; Pless SA, 2011, NAT CHEM BIOL, V7, P617, DOI [10.1038/nchembio.622, 10.1038/NCHEMBIO.622]; Proks P, 2009, PROG BIOPHYS MOL BIO, V99, P7, DOI 10.1016/j.pbiomolbio.2008.10.002; Purohit P, 2007, NATURE, V446, P930, DOI 10.1038/nature05721; Rohacs T, 1999, J BIOL CHEM, V274, P36065, DOI 10.1074/jbc.274.51.36065; Shimomura K, 2007, NEUROLOGY, V69, P1342, DOI 10.1212/01.wnl.0000268488.51776.53; Shyng SL, 2000, J GEN PHYSIOL, V116, P599, DOI 10.1085/jgp.116.5.599; Shyng SL, 1997, J GEN PHYSIOL, V110, P655, DOI 10.1085/jgp.110.6.655; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; Suchyna TM, 2009, BIOPHYS J, V97, P738, DOI 10.1016/j.bpj.2009.05.018; Tao X, 2010, SCIENCE, V328, P67, DOI 10.1126/science.1185954; Trapp S, 1998, J GEN PHYSIOL, V112, P333, DOI 10.1085/jgp.112.3.333; van der Wel PCA, 2007, BIOCHEMISTRY-US, V46, P7514, DOI 10.1021/bi700082v; Wang DT, 2011, NAT STRUCT MOL BIOL, V18, P35, DOI 10.1038/nsmb.1966; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046	54	6	6	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15450	15461		10.1074/jbc.M114.631960	http://dx.doi.org/10.1074/jbc.M114.631960			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25934393	Green Published, hybrid			2022-12-28	WOS:000356527400012
J	O'Callaghan, P; Li, JP; Lannfelt, L; Lindahl, U; Zhang, X				O'Callaghan, Paul; Li, Jin-Ping; Lannfelt, Lars; Lindahl, Ulf; Zhang, Xiao			Microglial Heparan Sulfate Proteoglycans Facilitate the Cluster-of-Differentiation 14 (CD14)/Toll-like Receptor 4 (TLR4)-Dependent Inflammatory Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; CD14; LIPOPOLYSACCHARIDE; ASTROCYTES; EXPRESSION; ACTIVATION; BETA; LPS; GLYCOSAMINOGLYCAN; INDUCTION	Microglia rapidly mount an inflammatory response to pathogens in the central nervous system (CNS). Heparan sulfate proteoglycans (HSPGs) have been attributed various roles in inflammation. To elucidate the relevance of microglial HSPGs in a pro-inflammatory response we isolated microglia from mice over-expressing heparanase (Hpa-tg), the HS-degrading endoglucuronidase, and challenged them with lipopolysaccharide (LPS), a bacterial endotoxin. Prior to LPS-stimulation, the LPS-receptor cluster-of-differentiation 14 (CD14) and Toll-like receptor 4 (TLR4; essential for the LPS response) were similarly expressed in Ctrl and Hpa-tg microglia. However, compared with Ctrl microglia, Hpa-tg cells released significantly less tumor necrosis factor-alpha (TNF alpha), essentially failed to up-regulate interleukin-1 beta (IL1 beta) and did not initiate synthesis of proCD14. Isolated primary astroyctes expressed TLR4, but notably lacked CD14 and in contrast to microglia, LPS challenge induced a similar TNF alpha response in Ctrl and Hpa-tg astrocytes, while neither released IL1 beta. The astrocyte TNF alpha-induction was thus attributed to CD14-independent TLR4 activation and was unaffected by the cells HS status. Equally, the suppressed LPS-response in Hpa-tg microglia indicated a loss of CD14-dependent TLR4 activation, suggesting that microglial HSPGs facilitate this process. Indeed, confocal microscopy confirmed interactions between microglial HS and CD14 in LPS-stimulated microglia and a potential HS-binding motif in CD14 was identified. We conclude that microglial HSPGs facilitate CD14-dependent TLR4 activation and that heparanase can modulate this mechanism.	[O'Callaghan, Paul] Uppsala Univ, Dept Med Cell Biol, Biomed Ctr, S-75123 Uppsala, Sweden; [O'Callaghan, Paul; Li, Jin-Ping; Lindahl, Ulf] Uppsala Univ, Dept Med Biochem & Microbiol, Biomed Ctr, Sci Life Lab, S-75123 Uppsala, Sweden; [Zhang, Xiao] Uppsala Univ, Dept Neurosci, Biomed Ctr, S-75123 Uppsala, Sweden; [Lannfelt, Lars] Uppsala Univ, Dept Publ Hlth & Caring Sci, Rudbeck Lab C11, Mol Geriatr, S-75185 Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University; Uppsala University	O'Callaghan, P (corresponding author), Uppsala Univ, Dept Med Cell Biol, Biomed Ctr, Husargatan 3, S-75123 Uppsala, Sweden.	paul.ocallaghan@mcb.uu.se; xiao.zhang@neuro.uu.se	O'Callaghan, Paul/T-5308-2018	O'Callaghan, Paul/0000-0003-3117-5367	Swedish Research Council [2003-5546]; Vetenskapradet grant [K2012-67X-21128-04-4]; Landstinget i Uppsala lan; Polysackaridforskning AB Uppsala; Alzheimerfonden; Demensforbundet; Stohnes Stiftelse; Swedish Brain Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Vetenskapradet grant; Landstinget i Uppsala lan; Polysackaridforskning AB Uppsala; Alzheimerfonden; Demensforbundet; Stohnes Stiftelse; Swedish Brain Foundation	This work was supported by The Swedish Research Council Grant number 2003-5546, Vetenskapradet grant number K2012-67X-21128-04-4, Landstinget i Uppsala lan, Polysackaridforskning AB Uppsala, Alzheimerfonden, Demensforbundet, Stohnes Stiftelse, and The Swedish Brain Foundation.	Abboud-Jarrous G, 2008, J BIOL CHEM, V283, P18167, DOI 10.1074/jbc.M801327200; Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; BAZIL V, 1989, MOL IMMUNOL, V26, P657, DOI 10.1016/0161-5890(89)90048-5; Blich M, 2013, ARTERIOSCL THROM VAS, V33, pE56, DOI 10.1161/ATVBAHA.112.254961; Brennan TV, 2012, BLOOD, V120, P2899, DOI 10.1182/blood-2011-07-368720; Brunn GJ, 2005, FASEB J, V19, P872, DOI 10.1096/fj.04-3211fje; Cauwels A, 1999, J IMMUNOL, V162, P4762; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Correia JD, 2001, J BIOL CHEM, V276, P21129, DOI 10.1074/jbc.M009164200; Davis DAS, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00470; Deininger MH, 2003, ACTA NEUROPATHOL, V106, P271, DOI 10.1007/s00401-003-0727-9; Doviner V, 2006, MODERN PATHOL, V19, P878, DOI 10.1038/modpathol.3800603; El Khoury J, 2010, NAT MED, V16, P1369, DOI 10.1038/nm1210-1369; Fairbanks MB, 1999, J BIOL CHEM, V274, P29587, DOI 10.1074/jbc.274.42.29587; Farina C, 2005, J NEUROIMMUNOL, V159, P12, DOI 10.1016/j.jneuroim.2004.09.009; GIULIAN D, 1986, J NEUROSCI, V6, P2163; Godowski PJ, 2005, NAT IMMUNOL, V6, P544, DOI 10.1038/ni0605-544; Goldshmidt O, 2002, P NATL ACAD SCI USA, V99, P10031, DOI 10.1073/pnas.152070599; Goode KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109596; Hailey KL, 2009, J BIOL CHEM, V284, P26137, DOI 10.1074/jbc.M109.027375; Hayashida K, 2009, BLOOD, V114, P3033, DOI 10.1182/blood-2009-02-204966; HAZIOT A, 1988, J IMMUNOL, V141, P547; Heneka MT, 2010, BRAIN RES REV, V63, P189, DOI 10.1016/j.brainresrev.2009.11.004; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Hirshoren N, 2014, J CELL MOL MED, V18, P181, DOI 10.1111/jcmm.12179; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Johnstone M, 1999, J NEUROIMMUNOL, V93, P182, DOI 10.1016/S0165-5728(98)00226-4; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kim JI, 2005, J BIOL CHEM, V280, P11347, DOI 10.1074/jbc.M414607200; LABETA MO, 1993, EUR J IMMUNOL, V23, P2144, DOI 10.1002/eji.1830230915; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; LEE SC, 1993, J IMMUNOL, V150, P2659; Lehnardt S, 2002, J NEUROSCI, V22, P2478, DOI 10.1523/JNEUROSCI.22-07-02478.2002; Lerner I, 2011, J CLIN INVEST, V121, P1709, DOI 10.1172/JCI43792; LIEBERMAN AP, 1989, P NATL ACAD SCI USA, V86, P6348, DOI 10.1073/pnas.86.16.6348; Lindahl U, 2009, INT REV CEL MOL BIO, V276, P105, DOI 10.1016/S1937-6448(09)76003-4; Low PC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4450; Lull ME, 2010, NEUROTHERAPEUTICS, V7, P354, DOI 10.1016/j.nurt.2010.05.014; LYNN WA, 1993, INFECT IMMUN, V61, P4452, DOI 10.1128/IAI.61.10.4452-4461.1993; Massena S, 2010, BLOOD, V116, P1924, DOI 10.1182/blood-2010-01-266072; Nadeau S, 2000, J NEUROSCI, V20, P3456, DOI 10.1523/JNEUROSCI.20-09-03456.2000; Nielsen HM, 2009, GLIA, V57, P978, DOI 10.1002/glia.20822; O'Callaghan P, 2008, BRAIN PATHOL, V18, P548, DOI 10.1111/j.1750-3639.2008.00152.x; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Parish CR, 2006, NAT REV IMMUNOL, V6, P633, DOI 10.1038/nri1918; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Ryu Keun-Young, 2012, Exp Neurobiol, V21, P151, DOI 10.5607/en.2012.21.4.151; Tarassishin L, 2014, GLIA, V62, P999, DOI 10.1002/glia.22657; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Zhang D, 2010, MOL NEUROBIOL, V41, P232, DOI 10.1007/s12035-010-8098-4; Zhang X, 2012, ACTA NEUROPATHOL, V124, P465, DOI 10.1007/s00401-012-0997-1	55	35	36	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					14904	14914		10.1074/jbc.M114.634337	http://dx.doi.org/10.1074/jbc.M114.634337			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25869127	hybrid, Green Published			2022-12-28	WOS:000356177300010
J	Than, A; He, HL; Chua, SH; Xu, D; Sun, L; Leow, MKS; Chen, P				Than, Aung; He, Hui Ling; Chua, Si Hui; Xu, Dan; Sun, Lei; Leow, Melvin Khee-Shing; Chen, Peng			Apelin Enhances Brown Adipogenesis and Browning of White Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE-TISSUE; UNCOUPLING PROTEIN; INSULIN-RESISTANCE; TRANSCRIPTIONAL CONTROL; GLUCOSE-HOMEOSTASIS; PPAR-GAMMA; FAT; EXPRESSION; RECEPTOR; DIFFERENTIATION	Brown adipose tissue expends energy in the form of heat via the mitochondrial uncoupling protein UCP1. Recent studies showed that brown adipose tissue is present in adult humans and may be exploited for its anti-obesity and anti-diabetes actions. Apelin is an adipocyte-derived hormone that plays important roles in energy metabolism. Here, we report that apelin-APJ signaling promotes brown adipocyte differentiation by increasing the expressions of brown adipogenic and thermogenic transcriptional factors via the PI3K/Akt and AMPK signaling pathways. It is also found that apelin relieves the TNF alpha inhibition on brown adipogenesis. In addition, apelin increases the basal activity of brown adipocytes, as evidenced by the increased PGC1 alpha and UCP1 expressions, mitochondrial biogenesis, and oxygen consumption. Finally, we provide both in vitro and in vivo evidence that apelin is able to increase the brown-like characteristics in white adipocytes. This study, for the first time, reveals the brown adipogenic and browning effects of apelin and suggests a potential therapeutic route to combat obesity and related metabolic disorders.	[Than, Aung; He, Hui Ling; Chua, Si Hui; Chen, Peng] Nanyang Technol Univ, Sch Chem & Biomed Engn, Bioengn Program, 70 Nanyang Dr, Singapore 637457, Singapore; [Xu, Dan; Sun, Lei] Duke NUS Grad Med Sch, Singapore 169857, Singapore; [Leow, Melvin Khee-Shing] Tan Tock Seng Hosp, Endocrine & Diabet Clin, Singapore 308433, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; Tan Tock Seng Hospital	Chen, P (corresponding author), Nanyang Technol Univ, Sch Chem & Biomed Engn, Bioengn Program, 70 Nanyang Dr, Singapore 637457, Singapore.	chenpeng@ntu.edu.sg	Leow, Melvin/H-3129-2019; Chen, Peng/G-6202-2010; Leow, Melvin/AAJ-1168-2020	Leow, Melvin/0000-0002-2837-5889; Chen, Peng/0000-0003-3730-1846; aung, than/0000-0003-1558-7310	Singapore National Research Foundation under CBRG [NMRC/CBRG/0070/2014]; Singapore Ministry of Education under AcRF [RGT7/13]	Singapore National Research Foundation under CBRG(National Research Foundation, Singapore); Singapore Ministry of Education under AcRF(Ministry of Education, Singapore)	This research is supported by the Singapore National Research Foundation under CBRG Grant (NMRC/CBRG/0070/2014) administrated by the Singapore Ministry of Health's National Medical Research Council. This work is also supported by the Singapore Ministry of Education under AcRF Tier 1 Grant RGT7/13.	Ahfeldt T, 2012, NAT CELL BIOL, V14, P209, DOI 10.1038/ncb2411; Attane C, 2012, DIABETES, V61, P310, DOI 10.2337/db11-0100; Than A, 2014, J BIOL CHEM, V289, P3763, DOI 10.1074/jbc.M113.526210; Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Besse-Patin A, 2014, INT J OBESITY, V38, P707, DOI 10.1038/ijo.2013.158; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Boucher J, 2005, ENDOCRINOLOGY, V146, P1764, DOI 10.1210/en.2004-1427; Buravkov SV, 2014, B EXP BIOL MED+, V157, P654, DOI 10.1007/s10517-014-2637-3; Butruille L, 2013, PEPTIDES, V46, P94, DOI 10.1016/j.peptides.2013.05.013; Cancello R, 1998, ENDOCRINOLOGY, V139, P4747, DOI 10.1210/en.139.11.4747; Carey AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091997; Castan-Laurell I, 2011, ENDOCRINE, V40, P1, DOI 10.1007/s12020-011-9507-9; Chechi K, 2013, TRENDS ENDOCRIN MET, V24, P408, DOI 10.1016/j.tem.2013.04.002; Chondronikola M, 2014, DIABETES, V63, P4089, DOI 10.2337/db14-0746; Cinti S, 1997, ENDOCRINOLOGY, V138, P797, DOI 10.1210/en.138.2.797; Commins SP, 1999, ENDOCRINOLOGY, V140, P292, DOI 10.1210/en.140.1.292; Cypess AM, 2010, CURR OPIN ENDOCRINOL, V17, P143, DOI 10.1097/MED.0b013e328337a81f; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Festuccia WT, 2009, AM J PHYSIOL-REG I, V296, pR1327, DOI 10.1152/ajpregu.91012.2008; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Graves JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037699; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Grundy SM, 2004, J CLIN ENDOCR METAB, V89, P2595, DOI 10.1210/jc.2004-0372; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Heilbronn LK, 2008, CURR PHARM DESIGN, V14, P1225, DOI 10.2174/138161208784246153; Higuchi K, 2007, ENDOCRINOLOGY, V148, P2690, DOI 10.1210/en.2006-1270; Hinoi E, 2014, BIOCHEM BIOPH RES CO, V450, P255, DOI 10.1016/j.bbrc.2014.05.108; Johnson I., 2010, MOL PROBES HDB GUIDE, V11th; Kadoglou NPE, 2012, MED SCI MONITOR, V18, pCR290, DOI 10.12659/MSM.882734; Kajimura S, 2008, GENE DEV, V22, P1397, DOI 10.1101/gad.1666108; Karastergiou K, 2010, MOL CELL ENDOCRINOL, V318, P69, DOI 10.1016/j.mce.2009.11.011; Kelly LJ, 1998, ENDOCRINOLOGY, V139, P4920, DOI 10.1210/en.139.12.4920; Kim HJ, 2014, DIABETES, V63, P4045, DOI 10.2337/db14-0466; Knudsen JG, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0084910, 10.1371/journal.pone.0086457]; Lee P, 2014, CELL METAB, V19, P302, DOI 10.1016/j.cmet.2013.12.017; Lehr L, 2009, INT J OBESITY, V33, P680, DOI 10.1038/ijo.2009.46; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lidell ME, 2010, NAT REV ENDOCRINOL, V6, P319, DOI 10.1038/nrendo.2010.64; Liu X, 2011, CELL DEATH DIFFER, V18, P1561, DOI 10.1038/cdd.2011.13; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Masaki T, 2003, DIABETES, V52, P2266, DOI 10.2337/diabetes.52.9.2266; Masri B, 2006, J BIOL CHEM, V281, P18317, DOI 10.1074/jbc.M600606200; Matsuo K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016446; Mazzucotelli A, 2008, REGUL PEPTIDES, V150, P33, DOI 10.1016/j.regpep.2008.04.003; Nedergaard J, 2005, BBA-MOL BASIS DIS, V1740, P293, DOI 10.1016/j.bbadis.2005.02.003; Nisoli E, 2000, P NATL ACAD SCI USA, V97, P8033, DOI 10.1073/pnas.97.14.8033; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; Pitkin SL, 2010, PHARMACOL REV, V62, P331, DOI 10.1124/pr.110.002949; Sakamoto T, 2013, AM J PHYSIOL-CELL PH, V304, pC729, DOI 10.1152/ajpcell.00312.2012; Scott MA, 2011, STEM CELLS DEV, V20, P1793, DOI 10.1089/scd.2011.0040; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Seale P, 2009, GENE DEV, V23, P788, DOI 10.1101/gad.1779209; Stanford KI, 2013, J CLIN INVEST, V123, P215, DOI 10.1172/JCI62308; Than A, 2013, J BIOL CHEM, V288, P15520, DOI 10.1074/jbc.M113.459792; Than A, 2012, MOL CELL ENDOCRINOL, V362, P227, DOI 10.1016/j.mce.2012.07.002; Than A, 2012, MOL CELL ENDOCRINOL, V351, P296, DOI 10.1016/j.mce.2012.01.005; Than A, 2011, MOL CELL ENDOCRINOL, V332, P261, DOI 10.1016/j.mce.2010.11.002; Trayhurn P, 2006, J NUTR, V136, p1935S, DOI 10.1093/jn/136.7.1935S; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Valladares A, 2001, FEBS LETT, V493, P6, DOI 10.1016/S0014-5793(01)02264-5; van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993; Vijgen GHEJ, 2012, J CLIN ENDOCR METAB, V97, pE1229, DOI 10.1210/jc.2012-1289; Vila-Bedmar R, 2010, ENDOCRINOLOGY, V151, P980, DOI 10.1210/en.2009-0810; Wikstrom JD, 2014, EMBO J, V33, P418, DOI 10.1002/embj.201385014; Yang XL, 2003, OBES RES, V11, P1182, DOI 10.1038/oby.2003.163; Ye F, 2010, J ENDOCRINOL, V206, P27, DOI 10.1677/JOE-10-0090; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803; Yue P, 2011, ENDOCRINOLOGY, V152, P59, DOI 10.1210/en.2010-0576; Yue P, 2010, AM J PHYSIOL-ENDOC M, V298, pE59, DOI 10.1152/ajpendo.00385.2009; Zhang J, 2006, LIFE SCI, V79, P1153, DOI 10.1016/j.lfs.2006.03.040; Zhen EY, 2013, ANAL BIOCHEM, V442, P1, DOI 10.1016/j.ab.2013.07.006; Zhu SM, 2011, MOL CELL BIOCHEM, V353, P305, DOI 10.1007/s11010-011-0799-0	74	65	67	0	24	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14679	14691		10.1074/jbc.M115.643817	http://dx.doi.org/10.1074/jbc.M115.643817			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25931124	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000355754600038
J	Komolov, KE; Bhardwaj, A; Benovic, JL				Komolov, Konstantin E.; Bhardwaj, Anshul; Benovic, Jeffrey L.			Atomic Structure of GRK5 Reveals Distinct Structural Features Novel for G Protein-coupled Receptor Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE LOCALIZATION; G-BETA-GAMMA; CALMODULIN-BINDING; CATALYTIC SUBUNIT; RHODOPSIN KINASE; TERMINAL TAIL; DOMAIN; PKA; ACTIVATION; REGULATOR	G protein-coupled receptor kinases (GRKs) are members of the protein kinase A, G, and C families (AGC) and play a central role in mediating G protein-coupled receptor phosphorylation and desensitization. One member of the family, GRK5, has been implicated in several human pathologies, including heart failure, hypertension, cancer, diabetes, and Alzheimer disease. To gain mechanistic insight into GRK5 function, we determined a crystal structure of full-length human GRK5 at 1.8 angstrom resolution. GRK5 in complex with the ATP analog 5'-adenylyl beta,gamma-imidodiphosphate or the nucleoside sangivamycin crystallized as a monomer. The C-terminal tail (C-tail) of AGC kinase domains is a highly conserved feature that is divided into three segments as follows: the C-lobe tether, the active-site tether (AST), and the N-lobe tether (NLT). This domain is fully resolved in GRK5 and reveals novel interactions with the nucleotide and N-lobe. Similar to other AGC kinases, the GRK5 AST is an integral part of the nucleotide-binding pocket, a feature not observed in other GRKs. The AST also mediates contact between the kinase N- and C-lobes facilitating closure of the kinase domain. The GRK5 NLT is largely displaced from its previously observed position in other GRKs. Moreover, although the autophosphorylation sites in the NLT are > 20 angstrom away from the catalytic cleft, they are capable of rapid cis-autophosphorylation suggesting high mobility of this region. In summary, we provide a snapshot of GRK5 in a partially closed state, where structural elements of the kinase domain C-tail are aligned to form novel interactions to the nucleotide and N-lobe not previously observed in other GRKs.	[Komolov, Konstantin E.; Bhardwaj, Anshul; Benovic, Jeffrey L.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA	Jefferson University	Bhardwaj, A (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA.	anshul.bhardwaj@jefferson.edu; jeffrey.benovic@jefferson.edu	Komolov, Konstantin/ABC-5194-2021	Bhardwaj, Anshul/0000-0002-0897-979X	National Institutes of Health from NIGMS [GM-0080]; United States Department of Energy [DE-AC02-98CH10886]; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL114471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044944] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. Gino Cingolani and John Tesmer for helpful comments on the manuscript and Hsin-Yao Tang for mass spectrometry analysis and discussion. We are thankful to Vivian Stojanoff and the scientific staff at NSLS beamline X6A for assistance and help in data collection. Crystallographic data were collected at the X6A beamline of National Synchrotron Light Source, Brookhaven National Laboratory, which is funded by National Institutes of Health under agreement GM-0080 from NIGMS and the United States Department of Energy under Contract DE-AC02-98CH10886.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Akamine P, 2003, J MOL BIOL, V327, P159, DOI 10.1016/S0022-2836(02)01446-8; Arawaka S, 2006, J NEUROSCI, V26, P9227, DOI 10.1523/JNEUROSCI.0341-06.2006; ARNDT UW, 1968, J PHYS E SCI INSTRUM, V1, P510, DOI 10.1088/0022-3735/1/5/303; Bastidas AC, 2015, BIOCHEMISTRY-US, V54, P2, DOI 10.1021/bi500684c; Bastidas AC, 2012, J MOL BIOL, V422, P215, DOI 10.1016/j.jmb.2012.05.021; Batkin M, 2000, BIOCHEMISTRY-US, V39, P5366, DOI 10.1021/bi000153z; Blundell T. L., 1976, PROTEIN CRYSTALLOGRA, P375; Boguth CA, 2010, EMBO J, V29, P3249, DOI 10.1038/emboj.2010.206; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; BUCZYLKO J, 1991, P NATL ACAD SCI USA, V88, P2568, DOI 10.1073/pnas.88.6.2568; Bychkov ER, 2008, NEUROBIOL AGING, V29, P379, DOI 10.1016/j.neurobiolaging.2006.10.012; Carman CV, 2000, J BIOL CHEM, V275, P10443, DOI 10.1074/jbc.275.14.10443; Chakraborty PK, 2014, CANCER RES, V74, P3489, DOI 10.1158/0008-5472.CAN-13-2708; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen YJ, 2011, J CELL BIOL, V194, P905, DOI 10.1083/jcb.201104114; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gold JI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057324; Gold JI, 2012, CIRC RES, V111, P1048, DOI 10.1161/CIRCRESAHA.112.273367; Gros R, 1997, J CLIN INVEST, V99, P2087, DOI 10.1172/JCI119381; Gurevich EV, 2012, PHARMACOL THERAPEUT, V133, P40, DOI 10.1016/j.pharmthera.2011.08.001; Harris DM, 2008, CLIN SCI, V115, P79, DOI 10.1042/CS20070442; Hayward S, 1997, PROTEINS, V27, P425, DOI 10.1002/(SICI)1097-0134(199703)27:3<425::AID-PROT10>3.0.CO;2-N; Hemmer W, 1997, J BIOL CHEM, V272, P16946, DOI 10.1074/jbc.272.27.16946; Homan K. T., 2015, J BIOL CHEM, V290; Huang CC, 2011, BIOCHEMISTRY-US, V50, P1940, DOI 10.1021/bi101606e; Huang ZM, 2011, FRONT BIOSCI-LANDMRK, V16, P3047, DOI 10.2741/3898; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Jiang XS, 2007, MOL BIOL CELL, V18, P2960, DOI 10.1091/mbc.E07-01-0013; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kim JI, 2012, J UROLOGY, V187, P322, DOI 10.1016/j.juro.2011.09.049; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; KUNAPULI P, 1994, J BIOL CHEM, V269, P10209; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Levay K, 1998, BIOCHEMISTRY-US, V37, P13650, DOI 10.1021/bi980998z; Li HX, 2013, DIABETES, V62, P291, DOI 10.2337/db12-0454; Liggett SB, 2008, NAT MED, V14, P510, DOI 10.1038/nm1750; Lodowski DT, 2006, J BIOL CHEM, V281, P16785, DOI 10.1074/jbc.M601327200; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Lodowski DT, 2005, BIOCHEMISTRY-US, V44, P6958, DOI 10.1021/bi050119q; LOOMIS CR, 1988, J BIOL CHEM, V263, P1682; Martini JS, 2008, P NATL ACAD SCI USA, V105, P12457, DOI 10.1073/pnas.0803153105; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Narayana N, 1997, STRUCTURE, V5, P921, DOI 10.1016/S0969-2126(97)00246-3; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pao CS, 2009, BIOCHEMISTRY-US, V48, P7325, DOI 10.1021/bi900408g; Pitcher JA, 1996, J BIOL CHEM, V271, P24907, DOI 10.1074/jbc.271.40.24907; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Pronin AN, 1998, J BIOL CHEM, V273, P31510, DOI 10.1074/jbc.273.47.31510; Pronin AN, 2002, METHOD ENZYMOL, V343, P547; Pronin AN, 1997, J BIOL CHEM, V272, P18273, DOI 10.1074/jbc.272.29.18273; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shaltiel S, 1998, P NATL ACAD SCI USA, V95, P484, DOI 10.1073/pnas.95.2.484; Sterne-Marr R, 2003, J BIOL CHEM, V278, P6050, DOI 10.1074/jbc.M208787200; Suo Z, 2007, NEUROBIOL AGING, V28, P1873, DOI 10.1016/j.neurobiolaging.2006.08.013; Taylor SS, 2004, BBA-PROTEINS PROTEOM, V1697, P259, DOI 10.1016/j.bbapap.2003.11.029; Tesmer JJG, 2012, ACTA CRYSTALLOGR F, V68, P622, DOI 10.1107/S1744309112017435; Tesmer JJG, 2009, PROG MOL BIOL TRANSL, V86, P75, DOI 10.1016/S1877-1173(09)86004-3; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; Thal DM, 2012, ACS CHEM BIOL, V7, P1830, DOI 10.1021/cb3003013; Thiyagarajan MM, 2004, J BIOL CHEM, V279, P17989, DOI 10.1074/jbc.M310738200; Tidow H, 2013, FEBS J, V280, P5551, DOI 10.1111/febs.12296; UNGERER M, 1993, CIRCULATION, V87, P454, DOI 10.1161/01.CIR.87.2.454; Wang WCH, 2008, PHARMACOGENET GENOM, V18, P729, DOI 10.1097/FPC.0b013e32830967e9; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Xu H, 2014, MOL BIOL CELL, V25, P2105, DOI 10.1091/mbc.E13-09-0547; Yang J, 2004, J MOL BIOL, V336, P473, DOI 10.1016/j.jmb.2003.11.044; Yang J, 2009, J BIOL CHEM, V284, P6241, DOI 10.1074/jbc.M805862200; Zhang P, 2012, SCIENCE, V335, P712, DOI 10.1126/science.1213979; Zhou J, 1997, BIOCHEMISTRY-US, V36, P15733, DOI 10.1021/bi971438n	79	25	25	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20629	20647		10.1074/jbc.M115.647297	http://dx.doi.org/10.1074/jbc.M115.647297			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26032409	hybrid, Green Published			2022-12-28	WOS:000360011800001
J	Farrand, AJ; Hotze, EM; Sato, TK; Wade, KR; Wimley, WC; Johnson, AE; Tweten, RK				Farrand, Allison J.; Hotze, Eileen M.; Sato, Takehiro K.; Wade, Kristin R.; Wimley, William C.; Johnson, Arthur E.; Tweten, Rodney K.			The Cholesterol-dependent Cytolysin Membrane-binding Interface Discriminates Lipid Environments of Cholesterol to Support beta-Barrel Pore Insertion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIBRIO-CHOLERAE CYTOLYSIN; MEDIATED GAS-GANGRENE; STREPTOLYSIN-O; PERFRINGOLYSIN-O; ALPHA-TOXIN; PREPORE COMPLEX; THETA-TOXIN; HUMAN CD59; MECHANISM; TRANSLOCATION	The majority of cholesterol-dependent cytolysins (CDCs) utilize cholesterol as a membrane receptor, whereas a small number are restricted to the GPI-anchored protein CD59 for initial membrane recognition. Two cholesterol-binding CDCs, perfringolysin O (PFO) and streptolysin O (SLO), were found to exhibit strikingly different binding properties to cholesterol-rich natural and synthetic membranes. The structural basis for this difference was mapped to one of the loops (L3) in the membrane binding interface that help anchor the toxin monomers to the membrane after receptor (cholesterol) binding by the membrane insertion of its amino acid side chains. A single point mutation in this loop conferred the binding properties of SLO to PFO and vice versa. Our studies strongly suggest that changing the side chain structure of this loop alters its equilibrium between membrane-inserted and uninserted states, thereby affecting the overall binding affinity and total bound toxin. Previous studies have shown that the lipid environment of cholesterol has a dramatic effect on binding and activity. Combining this data with the results of our current studies on L3 suggests that the structure of this loop has evolved in the different CDCs to preferentially direct binding to cholesterol in different lipid environments. Finally, the efficiency of beta-barrel pore formation was inversely correlated with the increased binding and affinity of the PFO L3 mutant, suggesting that selection of a compatible lipid environment impacts the efficiency of membrane insertion of the beta-barrel pore.	[Farrand, Allison J.; Hotze, Eileen M.; Wade, Kristin R.; Tweten, Rodney K.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA; [Sato, Takehiro K.; Johnson, Arthur E.] Texas A&M Univ, Dept Mol & Cellular Med, College Stn, TX 77843 USA; [Johnson, Arthur E.] Texas A&M Univ, Dept Chem & Biochem & Biophys, College Stn, TX 77843 USA; [Wimley, William C.] Tulane Univ, Sch Med, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Tulane University	Tweten, RK (corresponding author), BMSB-1053, Oklahoma City, OK 73104 USA.	Rod-Tweten@ouhsc.edu	Johnson, Arthur E/G-3457-2012		National Institutes of Health from the NIAID [AI037657]; Robert A. Welch Foundation Chair [BE-0017]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037657] Funding Source: NIH RePORTER	National Institutes of Health from the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Robert A. Welch Foundation Chair(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI037657 from the NIAID and Robert A. Welch Foundation Chair Grant BE-0017. The authors declare that they have no conflicts of interest with the contents of this article.	AWAD MM, 1995, MOL MICROBIOL, V15, P191, DOI 10.1111/j.1365-2958.1995.tb02234.x; Awad MM, 2001, INFECT IMMUN, V69, P7904, DOI 10.1128/IAI.69.12.7904-7910.2001; Bentley CC, 2005, CELL MICROBIOL, V7, P945, DOI 10.1111/j.1462-5822.2005.00525.x; BERNHEIM.AW, 1965, SCIENCE, V148, P1229, DOI 10.1126/science.148.3674.1229; BERNHEIMER AW, 1966, J BACTERIOL, V91, P1677, DOI 10.1128/JB.91.5.1677-1680.1966; COWELL JL, 1978, ARCH BIOCHEM BIOPHYS, V190, P603, DOI 10.1016/0003-9861(78)90316-8; CROWLEY KS, 1993, CELL, V73, P1101, DOI 10.1016/0092-8674(93)90640-C; Dowd KJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002787; DUNCAN JL, 1975, J CELL BIOL, V67, P160, DOI 10.1083/jcb.67.1.160; Ellemor DM, 1999, INFECT IMMUN, V67, P4902, DOI 10.1128/IAI.67.9.4902-4907.1999; Farrand AJ, 2010, P NATL ACAD SCI USA, V107, P4341, DOI 10.1073/pnas.0911581107; Feil SC, 2014, J MOL BIOL, V426, P785, DOI 10.1016/j.jmb.2013.11.020; Flanagan JJ, 2009, BIOCHEMISTRY-US, V48, P3977, DOI 10.1021/bi9002309; Gelber SE, 2008, J BACTERIOL, V190, P3896, DOI 10.1128/JB.01965-07; Giddings KS, 2004, NAT STRUCT MOL BIOL, V11, P1173, DOI 10.1038/nsmb862; Giddings KS, 2003, P NATL ACAD SCI USA, V100, P11315, DOI 10.1073/pnas.2033520100; Heuck AP, 2000, MOL CELL, V6, P1233, DOI 10.1016/S1097-2765(00)00119-2; Heuck AP, 2003, J BIOL CHEM, V278, P31218, DOI 10.1074/jbc.M303151200; Hickey MJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000045; Hotze EM, 2013, INFECT IMMUN, V81, P216, DOI 10.1128/IAI.00927-12; Hotze EM, 2012, J BIOL CHEM, V287, P24534, DOI 10.1074/jbc.M112.380139; Hotze EM, 2002, J BIOL CHEM, V277, P11597, DOI 10.1074/jbc.M111039200; Hotze EM, 2001, J BIOL CHEM, V276, P8261, DOI 10.1074/jbc.M009865200; HOWARD JG, 1953, BRIT J EXP PATHOL, V34, P174; Idone V, 2008, J CELL BIOL, V180, P905, DOI 10.1083/jcb.200708010; Johnson BB, 2012, BIOCHEMISTRY-US, V51, P3373, DOI 10.1021/bi3003132; LaChapelle S, 2009, J BIOL CHEM, V284, P12719, DOI 10.1074/jbc.M900772200; Lin PJ, 2011, J CELL BIOL, V195, P41, DOI 10.1083/jcb.201103117; Madden JC, 2001, CELL, V104, P143, DOI 10.1016/S0092-8674(01)00198-2; Magassa N, 2010, EMBO REP, V11, P400, DOI 10.1038/embor.2010.37; Meehl MA, 2004, MOL MICROBIOL, V52, P1665, DOI 10.1111/j.1365-2958.2004.04082.x; Nelson LD, 2008, J BIOL CHEM, V283, P4632, DOI 10.1074/jbc.M709483200; Nelson LD, 2010, BIOPHYS J, V99, P3255, DOI 10.1016/j.bpj.2010.09.028; Nilsson M, 2006, THROMB HAEMOSTASIS, V95, P982, DOI 10.1160/TH05-08-0572; OHNOIWASHITA Y, 1992, BIOCHIM BIOPHYS ACTA, V1109, P81, DOI 10.1016/0005-2736(92)90190-W; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PRIGENT D, 1976, BIOCHIM BIOPHYS ACTA, V443, P288, DOI 10.1016/0005-2736(76)90511-3; Ramachandran R, 2002, NAT STRUCT BIOL, V9, P823, DOI 10.1038/nsb855; Reinhart G D, 1991, J Fluoresc, V1, P153, DOI 10.1007/BF00865362; Rossjohn J, 1997, CELL, V89, P685, DOI 10.1016/S0092-8674(00)80251-2; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shatursky O, 1999, CELL, V99, P293, DOI 10.1016/S0092-8674(00)81660-8; Shepard LA, 2000, BIOCHEMISTRY-US, V39, P10284, DOI 10.1021/bi000436r; Shepard LA, 1998, BIOCHEMISTRY-US, V37, P14563, DOI 10.1021/bi981452f; Soltani CE, 2007, P NATL ACAD SCI USA, V104, P20226, DOI 10.1073/pnas.0708104105; Soltani CE, 2007, J BIOL CHEM, V282, P15709, DOI 10.1074/jbc.M701173200; Stevens DL, 1997, J INFECT DIS, V176, P189, DOI 10.1086/514022; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Usmani SM, 2012, CELL MICROBIOL, V14, P299, DOI 10.1111/j.1462-5822.2011.01724.x; Wade KR, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004353; WATSON KC, 1974, BIOCHEM J, V140, P95, DOI 10.1042/bj1400095; Wickham SE, 2011, J BIOL CHEM, V286, P20952, DOI 10.1074/jbc.M111.237446; Wimley WC, 1996, BIOCHEMISTRY-US, V35, P5109, DOI 10.1021/bi9600153; Zitzer A, 2003, FEBS LETT, V553, P229, DOI 10.1016/S0014-5793(03)01023-8; Zitzer A, 2001, J BIOL CHEM, V276, P14628, DOI 10.1074/jbc.M100241200	55	28	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					17733	17744		10.1074/jbc.M115.656769	http://dx.doi.org/10.1074/jbc.M115.656769			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26032415	hybrid, Green Published			2022-12-28	WOS:000358511700008
J	Zhang, M; Zhang, FL; Fang, Y; Chen, XM; Chen, YH; Zhang, WX; Dai, HE; Lin, RC; Liu, L				Zhang, Min; Zhang, Feilong; Fang, Ying; Chen, Xuemin; Chen, Yuhong; Zhang, Wenxia; Dai, Huai-En; Lin, Rongcheng; Liu, Lin			The Non-canonical Tetratricopeptide Repeat (TPR) Domain of Fluorescent (FLU) Mediates Complex Formation with Glutamyl-tRNA Reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							5-AMINOLEVULINIC ACID SYNTHESIS; TETRAPYRROLE BIOSYNTHESIS; SINGLET OXYGEN; CHLOROPHYLL BIOSYNTHESIS; ARABIDOPSIS-THALIANA; NEGATIVE REGULATOR; PROTEIN; BARLEY; PLANTS; HEME	The tetratricopeptide repeat (TPR)-containing protein FLU is a negative regulator of chlorophyll biosynthesis in plants. It directly interacts through its TPR domain with glutamyl-tRNA reductase (GluTR), the rate-limiting enzyme in the formation of delta-aminolevulinic acid (ALA). Delineation of how FLU binds to GluTR is important for understanding the molecular basis for FLU-mediated repression of synthesis of ALA, the universal tetrapyrrole precursor. Here, we characterize the FLU-GluTR interaction by solving the crystal structures of the uncomplexed TPR domain of FLU (FLUTPR) at 1.45-angstrom resolution and the complex of the dimeric domain of GluTR bound to FLUTPR at 2.4-angstrom resolution. Three non-canonical TPR motifs of each FLUTPR form a concave surface and clamp the helix bundle in the C-terminal dimeric domain of GluTR. We demonstrate that a 2: 2 FLUTPR-GluTR complex is the functional unit for FLU-mediated GluTR regulation and suggest that the formation of the FLU-GluTR complex prevents glutamyl-tRNA, the GluTR substrate, from binding with this enzyme. These results also provide insights into the spatial regulation of ALA synthesis by the membrane-located FLU protein.	[Zhang, Min; Zhang, Feilong] Anhui Univ, Sch Life Sci, Hefei 230601, Anhui, Peoples R China; [Fang, Ying; Chen, Xuemin; Chen, Yuhong; Zhang, Wenxia; Dai, Huai-En; Lin, Rongcheng; Liu, Lin] Chinese Acad Sci, Inst Bot, Key Lab Photobiol, Photosynthesis Res Ctr, Beijing 100093, Peoples R China; [Fang, Ying; Chen, Xuemin] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Anhui University; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, L (corresponding author), Chinese Acad Sci, Inst Bot, Key Lab Photobiol, Photosynthesis Res Ctr, Beijing 100093, Peoples R China.	liulin@ibcas.ac.cn	Chen, Xuemin/AAW-6728-2020	Chen, Xuemin/0000-0002-1818-9206	National Natural Science Foundation of China [31370759]; National Basic Research Program of China [2011CBA00901]; Hundred Talents Program of the Chinese Academy of Sciences;  [KGZD-EW-T05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Hundred Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); 	This work was supported by the National Natural Science Foundation of China Grant 31370759, the National Basic Research Program of China Grant 2011CBA00901, the Key Research Program (KGZD-EW-T05), and the Hundred Talents Program of the Chinese Academy of Sciences. The authors declare that they have no conflicts of interest with the contents of this article.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Czarnecki O, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23124; Czarnecki O, 2011, PLANT CELL, V23, P4476, DOI 10.1105/tpc.111.086421; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Falciatore A, 2005, GENE DEV, V19, P176, DOI 10.1101/gad.321305; Goslings D, 2004, PLANT J, V40, P957, DOI 10.1111/j.1365-313X.2004.02262.x; Grove TZ, 2008, CURR OPIN STRUC BIOL, V18, P507, DOI 10.1016/j.sbi.2008.05.008; Kauss D, 2012, FEBS LETT, V586, P211, DOI 10.1016/j.febslet.2011.12.029; Khandal D, 2009, P NATL ACAD SCI USA, V106, P13112, DOI 10.1073/pnas.0903522106; Kim CH, 2013, PHOTOSYNTH RES, V116, P455, DOI 10.1007/s11120-013-9876-4; Kumar AM, 2000, PLANT PHYSIOL, V122, P49, DOI 10.1104/pp.122.1.49; Lee KP, 2003, FEBS LETT, V553, P119, DOI 10.1016/S0014-5793(03)00983-9; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meskauskiene R, 2002, FEBS LETT, V532, P27, DOI 10.1016/S0014-5793(02)03617-7; Meskauskiene R, 2001, P NATL ACAD SCI USA, V98, P12826, DOI 10.1073/pnas.221252798; Mochizuki N, 2010, TRENDS PLANT SCI, V15, P488, DOI 10.1016/j.tplants.2010.05.012; Moser J, 2001, EMBO J, V20, P6583, DOI 10.1093/emboj/20.23.6583; op den Camp RGL, 2003, PLANT CELL, V15, P2320, DOI 10.1105/tpc.014662; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Richter A, 2010, PLANT CELL PHYSIOL, V51, P670, DOI 10.1093/pcp/pcq047; Tanaka R, 2007, ANNU REV PLANT BIOL, V58, P321, DOI 10.1146/annurev.arplant.57.032905.105448; VONWETTSTEIN D, 1974, SCIENCE, V184, P800, DOI 10.1126/science.184.4138.800; Vothknecht UC, 1998, PHYTOCHEMISTRY, V47, P513, DOI 10.1016/S0031-9422(97)00538-4; Zeytuni N, 2012, STRUCTURE, V20, P397, DOI 10.1016/j.str.2012.01.006; Zhao AG, 2014, P NATL ACAD SCI USA, V111, P6630, DOI 10.1073/pnas.1400166111; Zhu JW, 2011, MOL CELL, V43, P418, DOI 10.1016/j.molcel.2011.07.011	31	26	26	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17559	17565		10.1074/jbc.M115.662981	http://dx.doi.org/10.1074/jbc.M115.662981			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26037924	Green Published, hybrid			2022-12-28	WOS:000357730900046
J	Cline, K				Cline, Kenneth			Mechanistic Aspects of Folded Protein Transport by the Twin Arginine Translocase (Tat)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SIGNAL PEPTIDE BINDING; CYSTEINE-SCANNING MUTAGENESIS; PRECURSOR PROTEINS; SUBSTRATE-BINDING; COMPONENT; PATHWAY; SYSTEM; THA4; SUBUNIT; SITE	The twin arginine translocase (Tat) transports folded proteins of widely varying size across ionically tight membranes with only 2-3 components of machinery and the proton motive force. Tat operates by a cycle in which the receptor complex combines with the pore-forming component to assemble a new translocase for each substrate. Recent data on component and substrate organization in the receptor complex and on the structure of the pore complex inform models for translocase assembly and translocation. A translocation mechanism involving local transient bilayer rupture is discussed.	Univ Florida, Plant Mol & Cellular Biol, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Cline, K (corresponding author), Univ Florida, Plant Mol & Cellular Biol, Gainesville, FL 32611 USA.	kcline@ufl.edu						Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Alcock F, 2013, P NATL ACAD SCI USA, V110, pE3650, DOI 10.1073/pnas.1306738110; Aldridge C, 2014, J CELL BIOL, V205, P51, DOI 10.1083/jcb.201311057; Aldridge C, 2012, J BIOL CHEM, V287, P34752, DOI 10.1074/jbc.M112.385666; Bageshwar UK, 2007, J CELL BIOL, V179, P87, DOI 10.1083/jcb.200702082; Bageshwar UK, 2009, MOL MICROBIOL, V74, P209, DOI 10.1111/j.1365-2958.2009.06862.x; Berks BC, 2000, MOL MICROBIOL, V35, P260, DOI 10.1046/j.1365-2958.2000.01719.x; Berks BC, 2003, ADV MICROB PHYSIOL, V47, P187, DOI 10.1016/S0065-2911(03)47004-5; Berks BC, 2015, ANNU REV BIOCHEM, V84, P843, DOI 10.1146/annurev-biochem-060614-034251; Blummel AS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8234; Bolhuis A, 2001, J BIOL CHEM, V276, P20213, DOI 10.1074/jbc.M100682200; Bowman L, 2013, FEBS LETT, V587, P3365, DOI 10.1016/j.febslet.2013.09.005; Bruser T, 2003, MICROBIOL RES, V158, P7, DOI 10.1078/0944-5013-00176; Buchanan G, 2002, MOL MICROBIOL, V43, P1457, DOI 10.1046/j.1365-2958.2002.02853.x; Celedon J., 2012, J CELL BIOL, V197, P1; Celedon JM, 2013, BBA-MOL CELL RES, V1833, P341, DOI 10.1016/j.bbamcr.2012.06.028; CHADDOCK AM, 1995, EMBO J, V14, P2715, DOI 10.1002/j.1460-2075.1995.tb07272.x; CLINE K, 1993, EMBO J, V12, P4105, DOI 10.1002/j.1460-2075.1993.tb06094.x; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; Cline K, 2007, EMBO J, V26, P3039, DOI 10.1038/sj.emboj.7601759; Cline K, 2007, ENZYMES, V25, P463, DOI 10.1016/S1874-6047(07)25018-8; Dabney-Smith C, 2006, J BIOL CHEM, V281, P5476, DOI 10.1074/jbc.M512453200; Dabney-Smith C, 2003, J BIOL CHEM, V278, P43027, DOI 10.1074/jbc.M307923200; Dabney-Smith C, 2009, MOL BIOL CELL, V20, P2060, DOI 10.1091/mbc.E08-12-1189; De Buck E, 2008, TRENDS MICROBIOL, V16, P442, DOI 10.1016/j.tim.2008.06.004; de Keyzer J, 2002, J BIOL CHEM, V277, P46059, DOI 10.1074/jbc.M208449200; de Leeuw E, 2002, J MOL BIOL, V322, P1135, DOI 10.1016/S0022-2836(02)00820-3; De Leeuw E, 2001, FEBS LETT, V506, P143, DOI 10.1016/S0014-5793(01)02904-0; Fincher V, 1998, FEBS LETT, V423, P66, DOI 10.1016/S0014-5793(98)00066-0; Fincher V, 2003, EUR J BIOCHEM, V270, P4930, DOI 10.1046/j.1432-1033.2003.03894.x; Frobel J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2308; Frobel J, 2012, PHILOS T R SOC B, V367, P1029, DOI 10.1098/rstb.2011.0202; Frobel J, 2011, J BIOL CHEM, V286, P43679, DOI 10.1074/jbc.M111.292565; Gerard F, 2006, J BIOL CHEM, V281, P6130, DOI 10.1074/jbc.M512733200; Gerard F, 2007, J BIOL CHEM, V282, P5263, DOI 10.1074/jbc.M610337200; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Goosens VJ, 2014, BBA-MOL CELL RES, V1843, P1698, DOI 10.1016/j.bbamcr.2013.10.008; HENRY R, 1994, J BIOL CHEM, V269, P10189; Henry R, 1997, J CELL BIOL, V136, P823, DOI 10.1083/jcb.136.4.823; Holzapfel E, 2007, BIOCHEMISTRY-US, V46, P2892, DOI 10.1021/bi062205b; Hou B, 2006, J MOL BIOL, V355, P957, DOI 10.1016/j.jmb.2005.11.029; Hu YF, 2010, J AM CHEM SOC, V132, P15942, DOI 10.1021/ja1053785; Huang HW, 2006, BBA-BIOMEMBRANES, V1758, P1292, DOI 10.1016/j.bbamem.2006.02.001; Kneuper H, 2012, MOL MICROBIOL, V85, P945, DOI 10.1111/j.1365-2958.2012.08151.x; Koch S, 2012, J BIOL CHEM, V287, P14420, DOI 10.1074/jbc.M112.354555; Kreutzenbeck P, 2007, J BIOL CHEM, V282, P7903, DOI 10.1074/jbc.M610126200; Kwan D, 2010, FEMS MICROBIOL LETT, V308, P138, DOI 10.1111/j.1574-6968.2010.02001.x; Lausberg F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039867; Leake MC, 2008, P NATL ACAD SCI USA, V105, P15376, DOI 10.1073/pnas.0806338105; Lee PA, 2002, J BACTERIOL, V184, P5871, DOI 10.1128/JB.184.21.5871-5879.2002; Lee PA, 2006, J BIOL CHEM, V281, P34072, DOI 10.1074/jbc.M607295200; Ma XY, 2013, PLANT CELL, V25, P999, DOI 10.1105/tpc.112.107409; Ma XY, 2000, J BIOL CHEM, V275, P10016, DOI 10.1074/jbc.275.14.10016; Maldonado B, 2011, J MOL MICROB BIOTECH, V20, P168, DOI 10.1159/000329076; Maurer C, 2010, MOL BIOL CELL, V21, P4151, DOI 10.1091/mbc.E10-07-0585; McDevitt CA, 2006, FEBS J, V273, P5656, DOI 10.1111/j.1742-4658.2006.05554.x; Meloni S, 2003, MOL MICROBIOL, V48, P1195, DOI 10.1046/j.1365-2958.2003.03510.x; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; NIVIERE V, 1992, J GEN MICROBIOL, V138, P2173, DOI 10.1099/00221287-138-10-2173; Pal D, 2013, PLANT PHYSIOL, V161, P990, DOI 10.1104/pp.112.207522; Palmer T, 2012, NAT REV MICROBIOL, V10, P483, DOI 10.1038/nrmicro2814; Panahandeh S, 2008, J BIOL CHEM, V283, P33267, DOI 10.1074/jbc.M804225200; Peltier JB, 2002, PLANT CELL, V14, P211, DOI 10.1105/tpc.010304; Punginelli C, 2007, J BACTERIOL, V189, P5482, DOI 10.1128/JB.00647-07; Ramasamy S, 2013, STRUCTURE, V21, P777, DOI 10.1016/j.str.2013.03.004; Richter S, 2007, J BIOL CHEM, V282, P33257, DOI 10.1074/jbc.M703303200; Rodrigue A, 1999, J BIOL CHEM, V274, P13223, DOI 10.1074/jbc.274.19.13223; Rodriguez F, 2013, P NATL ACAD SCI USA, V110, pE1092, DOI 10.1073/pnas.1219486110; Rollauer SE, 2012, NATURE, V492, P210, DOI 10.1038/nature11683; Rose P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069488; Sargent F, 2006, FEMS MICROBIOL LETT, V254, P198, DOI 10.1111/j.1574-6968.2005.00049.x; Shanmugham A, 2006, BIOCHEMISTRY-US, V45, P2243, DOI 10.1021/bi052188a; Stanley NR, 2000, J BIOL CHEM, V275, P11591, DOI 10.1074/jbc.275.16.11591; Stoddart D, 2014, P NATL ACAD SCI USA, V111, P2425, DOI 10.1073/pnas.1312976111; Tarry MJ, 2009, P NATL ACAD SCI USA, V106, P13284, DOI 10.1073/pnas.0901566106; VOELKER R, 1995, EMBO J, V14, P3905, DOI 10.1002/j.1460-2075.1995.tb00062.x; Walther TH, 2013, CELL, V152, P316, DOI 10.1016/j.cell.2012.12.017; Walther TH, 2010, J AM CHEM SOC, V132, P15945, DOI 10.1021/ja106963s; Whitaker N, 2012, J BIOL CHEM, V287, P11252, DOI 10.1074/jbc.M111.324525; Zhang Y, 2014, BBA-BIOMEMBRANES, V1838, P1881, DOI 10.1016/j.bbamem.2014.03.015; Zoufaly S, 2012, J BIOL CHEM, V287, P13430, DOI 10.1074/jbc.M112.343798	81	48	48	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16530	16538		10.1074/jbc.R114.626820	http://dx.doi.org/10.1074/jbc.R114.626820			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25975269	hybrid, Green Published			2022-12-28	WOS:000357572800006
J	Hsu, HE; Liu, TN; Yeh, CS; Chang, TH; Lo, YC; Kao, CF				Hsu, Hsiang-En; Liu, Tzu-Ning; Yeh, Chung-Shu; Chang, Tien-Hsien; Lo, Yi-Chen; Kao, Cheng-Fu			Feedback Control of Snf1 Protein and Its Phosphorylation Is Necessary for Adaptation to Environmental Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATION-LOOP PHOSPHORYLATION; SACCHAROMYCES-CEREVISIAE; GLUCOSE REPRESSION; GLOBAL ANALYSIS; HISTONE H2B; BUDDING YEAST; KINASE; UBIQUITYLATION; PHOSPHATASE; GROWTH	Snf1, a member of the AMP-activated protein kinase family, plays a critical role in metabolic energy control in yeast cells. Snf1 activity is activated by phosphorylation of Thr-210 on the activation loop of its catalytic subunit; following activation, Snf1 regulates stress-responsive transcription factors. Here, we report that the level of Snf1 protein is dramatically decreased in a UBP8-and UBP10-deleted yeast mutant (ubp8 Delta ubp10 Delta), and this is independent of transcriptional regulation and proteasome-mediated degradation. Surprisingly, most Snf1-mediated functions, including glucose limitation regulation, utilization of alternative carbon sources, stress responses, and aging, are unaffected in this strain. Snf1 phosphorylation in ubp8 Delta ubp10 Delta cells is hyperactivated upon stress, which may compensate for the loss of the Snf1 protein and protect cells against stress and aging. Furthermore, artificial elevation of Snf1 phosphorylation (accomplished through deletion of REG1, which encodes a protein that regulates Snf1 dephosphorylation) restored Snf1 protein levels and the regulation of Snf1 activity in ubp8 Delta ubp10 Delta cells. Our results reveal the existence of a feedback loop that controls Snf1 protein level and its phosphorylation, which is masked by Ubp8 and Ubp10 through an unknown mechanism. We propose that this dynamic modulation of Snf1 phosphorylation and its protein level may be important for adaptation to environmental stress.	[Hsu, Hsiang-En; Kao, Cheng-Fu] Natl Def Med Ctr, Grad Inst Life Sci, Taipei 11490, Taiwan; [Liu, Tzu-Ning; Lo, Yi-Chen] Natl Taiwan Univ, Coll Bioresources & Agr, Inst Food Sci & Technol, Taipei 10617, Taiwan; [Yeh, Chung-Shu; Chang, Tien-Hsien] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 11221, Taiwan; [Yeh, Chung-Shu; Chang, Tien-Hsien] Acad Sinica, Genom Res Ctr, Taipei 11529, Taiwan; [Hsu, Hsiang-En; Kao, Cheng-Fu] Acad Sinica, Inst Cellular & Organism Biol, Taipei 11529, Taiwan	National Defense Medical Center; National Taiwan University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; Academia Sinica - Taiwan	Lo, YC (corresponding author), Inst Food Sci & Technol, Roosevelt Rd,Sect 4, Taipei, Taiwan.	loyichen@ntu.edu.tw; ckao@gate.sinica.edu.tw	Kao, Cheng-Fu/AAE-8400-2022	Kao, Cheng-Fu/0000-0002-8875-8152	Ministry of Science and Technology, Taiwan [101-2311-B-001-005, 102-2311-B-001-029, 102-2313-B-002-057-MY3, 103-2320-B-001-015, 102-2320-B-001-020]; Thematic Projects (Academia Sinica) [AS-99-TP-B20, AS-103-TP-B12, AS-103-TP-B02]; Academia Sinica; College of Bioresources and Agriculture, National Taiwan University	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Thematic Projects (Academia Sinica); Academia Sinica(Academia Sinica - Taiwan); College of Bioresources and Agriculture, National Taiwan University	Supported by the Ministry of Science and Technology, Taiwan, Grants 101-2311-B-001-005 and 102-2311-B-001-029, Thematic Projects (Academia Sinica) Grants AS-99-TP-B20 and AS-103-TP-B12, and Academia Sinica.; Supported by Ministry of Science and Technology, Taiwan, Grant 102-2313-B-002-057-MY3 and the College of Bioresources and Agriculture, National Taiwan University.; Supported by the Ministry of Science and Technology, Taiwan, Grants 103-2320-B-001-015 and 102-2320-B-001-020, Thematic Projects (Academia Sinica) Grants AS-99-TP-B20 and AS-103-TP-B02, and Academia Sinica.	Ashrafi K, 2000, GENE DEV, V14, P1872; BALZI E, 1994, J BIOL CHEM, V269, P2206; Braun KA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005000; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Carlson M, 1999, CURR OPIN MICROBIOL, V2, P202, DOI 10.1016/S1369-5274(99)80035-6; Chen C, 1999, NAT GENET, V23, P81, DOI 10.1038/12687; Emre NCT, 2005, MOL CELL, V17, P585, DOI 10.1016/j.molcel.2005.01.007; Freeberg MA, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r13; Gallego-Sanchez A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002826; Gardner RG, 2005, MOL CELL BIOL, V25, P6123, DOI 10.1128/MCB.25.14.6123-6139.2005; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hedbacker K, 2008, FRONT BIOSCI-LANDMRK, V13, P2408, DOI 10.2741/2854; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; HIRSCHHORN JN, 1995, MOL CELL BIOL, V15, P1999; Hong SP, 2007, J BIOL CHEM, V282, P16838, DOI 10.1074/jbc.M700146200; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jiang R, 1996, GENE DEV, V10, P3105, DOI 10.1101/gad.10.24.3105; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Lee WC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-440; Madia F, 2008, J CELL BIOL, V180, P67, DOI 10.1083/jcb.200707154; McCartney RR, 2001, J BIOL CHEM, V276, P36460, DOI 10.1074/jbc.M104418200; Mitchell SF, 2013, NAT STRUCT MOL BIOL, V20, P127, DOI 10.1038/nsmb.2468; Momcilovic M, 2011, J BIOL CHEM, V286, P23544, DOI 10.1074/jbc.M111.244111; Nath N, 2003, MOL CELL BIOL, V23, P3909, DOI 10.1128/MCB.23.11.3909-3917.2003; Pemberton LF, 1998, CURR OPIN CELL BIOL, V10, P392, DOI 10.1016/S0955-0674(98)80016-1; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Rhie BH, 2013, BIOCHEM BIOPH RES CO, V439, P570, DOI 10.1016/j.bbrc.2013.09.017; Richardson LA, 2012, CELL REP, V2, P372, DOI 10.1016/j.celrep.2012.07.009; Rubenstein EM, 2008, J BIOL CHEM, V283, P222, DOI 10.1074/jbc.M707957200; Ruiz A, 2013, J BIOL CHEM, V288, P31052, DOI 10.1074/jbc.M113.503763; Ruiz A, 2012, P NATL ACAD SCI USA, V109, P8652, DOI 10.1073/pnas.1206280109; Ruiz A, 2011, P NATL ACAD SCI USA, V108, P6349, DOI 10.1073/pnas.1102758108; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schulze JM, 2011, GENE DEV, V25, P2242, DOI 10.1101/gad.177220.111; Simpson-Lavy KJ, 2013, P NATL ACAD SCI USA, V110, P17432, DOI 10.1073/pnas.1304839110; Smith DL, 2007, AGING CELL, V6, P649, DOI 10.1111/j.1474-9726.2007.00326.x; Steffen Kristan K, 2009, J Vis Exp, DOI 10.3791/1209; Sutherland CM, 2003, CURR BIOL, V13, P1299, DOI 10.1016/S0960-9822(03)00459-7; TU JL, 1994, MOL CELL BIOL, V14, P6789, DOI 10.1128/MCB.14.10.6789; TU JL, 1995, EMBO J, V14, P5939, DOI 10.1002/j.1460-2075.1995.tb00282.x; Vincent O, 2001, GENE DEV, V15, P1104, DOI 10.1101/gad.879301; Weinberger M, 2010, AGING-US, V2, P709, DOI 10.18632/aging.100215; Wilson M, 2011, J PETROL, V52, P1, DOI 10.1093/petrology/egq092; Woods R. A., 2001, METH MOL B, V177, P85; Wright DE, 2012, FRONT BIOSCI-LANDMRK, V17, P1051, DOI 10.2741/3973	48	16	16	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16786	16796		10.1074/jbc.M115.639443	http://dx.doi.org/10.1074/jbc.M115.639443			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25947383	Green Published, hybrid			2022-12-28	WOS:000357572800025
J	Spatz, JM; Wein, MN; Gooi, JH; Qu, YL; Garr, JL; Liu, S; Barry, KJ; Uda, Y; Lai, F; Dedic, C; Balcells-Camps, M; Kronenberg, HM; Babij, P; Pajevic, PD				Spatz, Jordan M.; Wein, Marc N.; Gooi, Jonathan H.; Qu, Yili; Garr, Jenna L.; Liu, Shawn; Barry, Kevin J.; Uda, Yuhei; Lai, Forest; Dedic, Christopher; Balcells-Camps, Mercedes; Kronenberg, Henry M.; Babij, Philip; Pajevic, Paola Divieti			The Wnt Inhibitor Sclerostin Is Up-regulated by Mechanical Unloading in Osteocytes in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOST DOWN-REGULATION; SPINAL-CORD-INJURY; PARATHYROID-HORMONE; BONE-FORMATION; BED REST; TARGETED ABLATION; SERUM SCLEROSTIN; RANKL EXPRESSION; GENE-EXPRESSION; SPACE-FLIGHT	Although bone responds to its mechanical environment, the cellular and molecular mechanisms underlying the response of the skeleton to mechanical unloading are not completely understood. Osteocytes are the most abundant but least understood cells in bones and are thought to be responsible for sensing stresses and strains in bone. Sclerostin, a product of the SOST gene, is produced postnatally primarily by osteocytes and is a negative regulator of bone formation. Recent studies show that SOST is mechanically regulated at both the mRNA and protein levels. During prolonged bed rest and immobilization, circulating sclerostin increases both in humans and in animal models, and its increase is associated with a decrease in parathyroid hormone. To investigate whether SOST/sclerostin up-regulation in mechanical unloading is a cell-autonomous response or a hormonal response to decreased parathyroid hormone levels, we subjected osteocytes to an in vitro unloading environment achieved by the NASA rotating wall vessel system. To perform these studies, we generated a novel osteocytic cell line (Ocy454) that produces high levels of SOST/sclerostin at early time points and in the absence of differentiation factors. Importantly, these osteocytes recapitulated the in vivo response to mechanical unloading with increased expression of SOST (3.4 +/- 1.9-fold, p< 0.001), sclerostin (4.7 +/- 0.1-fold, p< 0.001), and the receptor activator of nuclear factor kappa B ligand (RANKL)/osteoprotegerin (OPG) (2.5 +/- 0.7-fold, p < 0.001) ratio. These data demonstrate for the first time a cell-autonomous increase in SOST/sclerostin and RANKL/OPG ratio in the setting of unloading. Thus, targeted osteocyte therapies could hold promise as novel osteoporosis and disuse-induced bone loss treatments by directly modulating the mechanosensing cells in bone.	[Spatz, Jordan M.; Wein, Marc N.; Qu, Yili; Garr, Jenna L.; Liu, Shawn; Barry, Kevin J.; Uda, Yuhei; Lai, Forest; Dedic, Christopher; Kronenberg, Henry M.; Pajevic, Paola Divieti] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Spatz, Jordan M.; Wein, Marc N.; Qu, Yili; Garr, Jenna L.; Liu, Shawn; Barry, Kevin J.; Uda, Yuhei; Lai, Forest; Dedic, Christopher; Kronenberg, Henry M.; Pajevic, Paola Divieti] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Spatz, Jordan M.; Balcells-Camps, Mercedes] MIT, Harvard MIT Inst Med Engn & Sci, Cambridge, MA 02139 USA; [Balcells-Camps, Mercedes] Ramon Llull Univ, Inst Quim Sarria, Bioengn Dept, Barcelona 08017, Spain; [Gooi, Jonathan H.] Univ Melbourne, NorthWest Acad Ctr, St Albans, Vic 3065, Australia; [Babij, Philip] Amgen Inc, Thousand Oaks, CA 91320 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Universitat Ramon Llull; Institut Quimic de Sarria; University of Melbourne; Amgen	Pajevic, PD (corresponding author), Boston Univ, Goldman Sch Dent Med, Mol & Cell Biol, 700 Albany St, Boston, MA 02118 USA.	pdivieti@bu.edu	Uda, Yuhei/AAZ-4978-2021; Pajevic, Paola Divieti/M-3236-2019; Gooi, Jonathan/AAS-7982-2020; Gooi, Jonathan/M-2407-2016	Uda, Yuhei/0000-0003-4705-6215; Gooi, Jonathan/0000-0002-8839-1602; Divieti Pajevic, Paola/0000-0001-9853-9837; Aronson, Jenna/0000-0002-7376-8622; Spatz, Jordan/0000-0002-6732-7353	National Institutes of Health from the NIAMS [AR059655]; National Institutes of Health from NIDDK [DK011794, DK100215]; Northrop Grumman Aerospace Systems Ph.D. training fellowship; Massachusetts Institute of Technology Hugh Hampton Young fellowship; National Space Biomedical Research Institute through NASA [NCC 9-58]; United States Army Institute for Environmental Medicine Oak Ridge Science Institute for Science and Education fellowship program; Spain's Ministerio de Economia e Innovacion [SAF2013-43302-R]; Posimat; Fundacio Empreses Institut Quimic de Sarria; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060221, UH2AR059655, UH3AR059655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK011794, F32DK100215] Funding Source: NIH RePORTER	National Institutes of Health from the NIAMS; National Institutes of Health from NIDDK; Northrop Grumman Aerospace Systems Ph.D. training fellowship; Massachusetts Institute of Technology Hugh Hampton Young fellowship; National Space Biomedical Research Institute through NASA; United States Army Institute for Environmental Medicine Oak Ridge Science Institute for Science and Education fellowship program; Spain's Ministerio de Economia e Innovacion; Posimat; Fundacio Empreses Institut Quimic de Sarria; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants AR059655 from the NIAMS (to P. D. P.) and DK011794 (to H. M. K.) and DK100215 (to M. N. W.) from the NIDDK. P. Babij was employed by Amgen Inc. and received Amgen stock.; Supported by a Northrop Grumman Aerospace Systems Ph.D. training fellowship, a Massachusetts Institute of Technology Hugh Hampton Young fellowship, the National Space Biomedical Research Institute through NASA Grant NCC 9-58, and the United States Army Institute for Environmental Medicine Oak Ridge Science Institute for Science and Education fellowship program.; Supported by Spain's Ministerio de Economia e Innovacion (Grant SAF2013-43302-R), Posimat, and Fundacio Empreses Institut Quimic de Sarria.	Armamento-Villareal R, 2012, J BONE MINER RES, V27, P1215, DOI 10.1002/jbmr.1560; Arnold MA, 2007, DEV CELL, V12, P377, DOI 10.1016/j.devcel.2007.02.004; Bellido T, 2005, ENDOCRINOLOGY, V146, P4577, DOI 10.1210/en.2005-0239; Bishop KA, 2011, J BIOL CHEM, V286, P20880, DOI 10.1074/jbc.M111.231548; Bonewald LF, 1999, J BONE MINER METAB, V17, P61, DOI 10.1007/s007740050066; Bonnet N, 2012, P NATL ACAD SCI USA, V109, P15048, DOI 10.1073/pnas.1203085109; Bonnet N, 2009, J BIOL CHEM, V284, P35939, DOI 10.1074/jbc.M109.060335; Boukhechba F, 2009, J BONE MINER RES, V24, P1927, DOI [10.1359/JBMR.090517, 10.1359/jbmr.090517]; Capulli M, 2009, J CELL BIOCHEM, V107, P240, DOI 10.1002/jcb.22120; Chen JH, 2010, J BIOMECH, V43, P108, DOI 10.1016/j.jbiomech.2009.09.016; Cherian PP, 2003, J BIOL CHEM, V278, P43146, DOI 10.1074/jbc.M302993200; Cohen-Kfir E, 2011, ENDOCRINOLOGY, V152, P4514, DOI 10.1210/en.2011-1128; Costa AG, 2011, J CLIN ENDOCR METAB, V96, P3804, DOI 10.1210/jc.2011-0566; Fulzele K, 2013, BLOOD, V121, P930, DOI 10.1182/blood-2012-06-437160; Galea GL, 2011, FEBS LETT, V585, P2450, DOI 10.1016/j.febslet.2011.06.019; Gaudio A, 2010, J CLIN ENDOCR METAB, V95, P2248, DOI 10.1210/jc.2010-0067; Genetos DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017772; Hammond TG, 2001, AM J PHYSIOL-RENAL, V281, pF12, DOI 10.1152/ajprenal.2001.281.1.F12; Holdsworth G, 2012, J BIOL CHEM, V287, P26464, DOI 10.1074/jbc.M112.350108; Honma M, 2015, J BONE MINER METAB, V33, P73, DOI 10.1007/s00774-013-0555-5; Hughes JM, 2010, J MUSCULOSKEL NEURON, V10, P128; Hughes-Fulford M, 2001, J Gravit Physiol, V8, pP1; Igwe JC, 2011, CONNECT TISSUE RES, V52, P401, DOI 10.3109/03008207.2010.546536; Inniss AM, 2009, AVIAT SPACE ENVIR MD, V80, pA9, DOI 10.3357/ASEM.BR04.2009; Ito Takayasu, 1996, Environmental Medicine (Nagoya), V40, P43; Jami A, 2013, MOL CELLS, V35, P305, DOI 10.1007/s10059-013-2310-0; Kalajzic I, 2004, BONE, V35, P74, DOI 10.1016/j.bone.2004.03.006; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kramer I, 2010, J BONE MINER RES, V25, P178, DOI 10.1359/jbmr.090730; LeBlanc A. D., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P33; Leupin O, 2007, J BONE MINER RES, V22, P1957, DOI 10.1359/JBMR.070804; Li J, 2012, J BIOMECH, V45, P247, DOI 10.1016/j.jbiomech.2011.10.037; Lin CW, 2009, J BONE MINER RES, V24, P1651, DOI [10.1359/JBMR.090411, 10.1359/jbmr.090411]; Loots GG, 2012, BONE, V50, P663, DOI 10.1016/j.bone.2011.11.016; Macias BR, 2013, BONE, V53, P515, DOI 10.1016/j.bone.2013.01.018; Massagli TL, 1999, ARCH PHYS MED REHAB, V80, P998, DOI 10.1016/S0003-9993(99)90050-3; Morse LR, 2012, J BONE MINER RES, V27, P352, DOI 10.1002/jbmr.546; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Nguyen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053813; O'Brien CA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002942; Paic F, 2009, BONE, V45, P682, DOI 10.1016/j.bone.2009.06.010; Papanicolaou SE, 2009, BIORHEOLOGY, V46, P389, DOI 10.3233/BIR-2009-0550; Paszty C, 2010, J BONE MINER RES, V25, P1897, DOI 10.1002/jbmr.161; Powell WF, 2011, J ENDOCRINOL, V209, P21, DOI 10.1530/JOE-10-0308; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Rodionova NV, 2002, ADV SPACE RES, V30, P765, DOI 10.1016/S0273-1177(02)00393-9; Santos A, 2009, J ORTHOP RES, V27, P1280, DOI 10.1002/jor.20888; Semenov M., 2005, J BIOL CHEM, V280, P26770; Sevetson B, 2004, J BIOL CHEM, V279, P13849, DOI 10.1074/jbc.M306249200; Sinha NN, 2011, PHYS WORLD, V24, P25; Smith SM, 2012, NUTRIENTS, V4, P2047, DOI 10.3390/nu4122047; Song KD, 2013, CELL STRESS CHAPERON, V18, P193, DOI 10.1007/s12192-012-0370-2; Spatz JM, 2012, J CLIN ENDOCR METAB, V97, pE1736, DOI 10.1210/jc.2012-1579; Spatz JM, 2013, J BONE MINER RES, V28, P865, DOI 10.1002/jbmr.1807; Spector ER, 2009, AVIAT SPACE ENVIR MD, V80, pA23, DOI 10.3357/ASEM.BR02.2009; Stein EM, 2013, J CLIN ENDOCR METAB, V98, P541, DOI 10.1210/jc.2012-2394; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Tu XL, 2012, BONE, V50, P209, DOI 10.1016/j.bone.2011.10.025; Vilarrasa N, 2011, OBES SURG, V21, P465, DOI 10.1007/s11695-010-0338-1; Wein Marc N, 2015, J Bone Miner Res, V30, P400, DOI 10.1002/jbmr.2381; Woo SM, 2011, J BONE MINER RES, V26, P2634, DOI 10.1002/jbmr.465; Wu JY, 2011, J CLIN INVEST, V121, P3492, DOI 10.1172/JCI46406; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yang F, 2010, BIOCHEM BIOPH RES CO, V400, P684, DOI 10.1016/j.bbrc.2010.08.128; Yu EW, 2011, J CLIN ENDOCR METAB, V96, P2011; Yu LC, 2011, BONE, V49, P1131, DOI 10.1016/j.bone.2011.08.016; Zhang KQ, 2006, MOL CELL BIOL, V26, P4539, DOI 10.1128/MCB.02120-05; Zhu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050099	68	172	180	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16744	16758		10.1074/jbc.M114.628313	http://dx.doi.org/10.1074/jbc.M114.628313			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25953900	Green Published, hybrid			2022-12-28	WOS:000357572800022
J	Zhang, GW; Niu, GD; Franca, CM; Dong, YM; Wang, XH; Butler, NS; Dimopoulos, G; Li, J				Zhang, Genwei; Niu, Guodong; Franca, Caio M.; Dong, Yuemei; Wang, Xiaohong; Butler, Noah S.; Dimopoulos, George; Li, Jun			Anopheles Midgut FREP1 Mediates Plasmodium Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRINOGEN-RELATED PROTEINS; PERITROPHIC MATRIX; MOSQUITO MIDGUT; SPOROGONIC DEVELOPMENT; HEMATOPHAGOUS INSECTS; OOKINETE INVASION; GENE-EXPRESSION; INNATE IMMUNITY; HORSESHOE-CRAB; MALARIA VECTOR	Malaria transmission depends on sexual stage Plasmodium parasites successfully invading Anopheline mosquito midguts following a blood meal. However, the molecular mechanisms of Plasmodium invasion of mosquito midguts have not been fully elucidated. Previously, we showed that genetic polymorphisms in the fibrinogen-related protein 1 (FREP1) gene are significantly associated with Plasmodium falciparum infection in Anopheles gambiae, and FREP1 is important for Plasmodium berghei infection of mosquitoes. Here we identify that the FREP1 protein is secreted from the mosquito midgut epithelium and integrated as tetramers into the peritrophic matrix, a chitinous matrix formed inside the midgut lumen after a blood meal feeding. Moreover, we show that the FREP1 can directly bind Plasmodia sexual stage gametocytes and ookinetes. Notably, ablating FREP1 expression or targeting FREP1 with antibodies significantly decreases P. falciparum infection in mosquito midguts. Our data support that the mosquito-expressed FREP1 mediates mosquito midgut invasion by multiple species of Plasmodium parasites via anchoring ookinetes to the peritrophic matrix and enabling parasites to penetrate the peritrophic matrix and the epithelium. Thus, targeting FREP1 can limit malaria transmission.	[Zhang, Genwei; Niu, Guodong; Franca, Caio M.; Wang, Xiaohong; Li, Jun] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA; [Dong, Yuemei; Dimopoulos, George] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Butler, Noah S.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma - Norman; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Oklahoma System; University of Oklahoma Health Sciences Center	Li, J (corresponding author), Univ Oklahoma, 101 Stephenson Pkwy, Norman, OK 73019 USA.	junli@ou.edu	wang, xiao/HGB-7081-2022; Regan, Clinton/E-6250-2012; Zhang, Genwei/AAB-3853-2022	wang, xiao/0000-0002-4088-3341; Zhang, Genwei/0000-0002-5737-8413; Butler, Noah/0000-0002-1429-0796; Dong, Yuemei/0000-0002-7902-2899; Barbalho de Franca, Caio Martinelle/0000-0002-5056-7983	National Institutes of Health [1R21AI115178-01A1, GM103447]; Oklahoma Center for the Advancement of Science and Technology Grant [HR13-055]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI115178] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103447] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oklahoma Center for the Advancement of Science and Technology Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R21AI115178-01A1 and GM103447 and Oklahoma Center for the Advancement of Science and Technology Grant HR13-055. The authors declare that they have no conflicts of interest with the contents of this article.	Abraham EG, 2004, INSECT BIOCHEM MOLEC, V34, P667, DOI 10.1016/j.ibmb.2004.03.019; Angrisano F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032188; Baker DA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-296; Beetsma AL, 1998, EXP PARASITOL, V88, P69, DOI 10.1006/expr.1998.4203; BILLINGSLEY PF, 1990, ANNU REV ENTOMOL, V35, P219, DOI 10.1146/annurev.en.35.010190.001251; Christophides GK, 2013, PATHOG GLOB HEALTH, V107, P385, DOI 10.1179/2047772413Z.000000000162; Christophides GK, 2004, IMMUNOL REV, V198, P127, DOI 10.1111/j.0105-2896.2004.0127.x; Dinglasan RR, 2009, INSECT BIOCHEM MOLEC, V39, P125, DOI 10.1016/j.ibmb.2008.10.010; Dong YM, 2009, J BIOL CHEM, V284, P9835, DOI 10.1074/jbc.M807084200; Duong-Ly KC, 2014, METHOD ENZYMOL, V541, P105, DOI 10.1016/B978-0-12-420119-4.00009-4; Fan CX, 2008, MOL IMMUNOL, V45, P3338, DOI 10.1016/j.molimm.2008.04.019; Garlatti V, 2007, EMBO J, V26, P623, DOI 10.1038/sj.emboj.7601500; Ghosh AK, 2011, P NATL ACAD SCI USA, V108, P17153, DOI 10.1073/pnas.1103657108; Gokudan S, 1999, P NATL ACAD SCI USA, V96, P10086, DOI 10.1073/pnas.96.18.10086; Gonzalez-Ceron L, 2003, J MED ENTOMOL, V40, P371, DOI 10.1603/0022-2585-40.3.371; Goodman AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029428; Han YS, 2000, EMBO J, V19, P6030, DOI 10.1093/emboj/19.22.6030; Hanington PC, 2011, J INNATE IMMUN, V3, P17, DOI 10.1159/000321882; HUBER M, 1991, P NATL ACAD SCI USA, V88, P2807, DOI 10.1073/pnas.88.7.2807; Invitrogen, 2008, INSECTSELECT BSD SYS, P1; JENSEN JB, 1977, J PARASITOL, V63, P883, DOI 10.2307/3279900; Kawabata S, 1999, DEV COMP IMMUNOL, V23, P391, DOI 10.1016/S0145-305X(99)00019-1; Korochkina S, 2006, CELL MICROBIOL, V8, P163, DOI 10.1111/j.1462-5822.2005.00611.x; Li J, 2013, P NATL ACAD SCI USA, V110, P20675, DOI 10.1073/pnas.1321024110; Li J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010699; Marinotti O, 2006, INSECT MOL BIOL, V15, P1, DOI 10.1111/j.1365-2583.2006.00610.x; Mead EA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-366; Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x; Ploplis VA, 2000, METHODS, V21, P103, DOI 10.1006/meth.2000.0981; Povelones M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003623; Povelones M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002023; Pumpuni CB, 1996, AM J TROP MED HYG, V54, P214, DOI 10.4269/ajtmh.1996.54.214; Qiagen, 2003, QIAEXPRESSIONIST HDB, P1; Qiu JJ, 2011, ONCOGENE, V30, P967, DOI 10.1038/onc.2010.473; Shao L, 2001, ARCH INSECT BIOCHEM, V47, P119, DOI 10.1002/arch.1042; Sinden RE, 2001, TRENDS PARASITOL, V17, P209, DOI 10.1016/S1471-4922(01)01928-6; Sugimoto R, 1998, J BIOL CHEM, V273, P20721, DOI 10.1074/jbc.273.33.20721; Syguda A, 2012, FEBS J, V279, P2544, DOI 10.1111/j.1742-4658.2012.08637.x; Toprak U, 2010, INSECT MOL BIOL, V19, P163, DOI 10.1111/j.1365-2583.2009.00966.x; Vega-Rodriguez J, 2014, P NATL ACAD SCI USA, V111, pE492, DOI 10.1073/pnas.1315517111; Wang XG, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-114; WICKHAM TJ, 1992, BIOTECHNOL PROGR, V8, P391, DOI 10.1021/bp00017a003; Zhang H, 2009, FISH SHELLFISH IMMUN, V26, P56, DOI 10.1016/j.fsi.2008.07.019; Zhao B, 2014, INSECT BIOCHEM MOLEC, V54, P1, DOI 10.1016/j.ibmb.2014.08.001	44	39	39	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16490	16501		10.1074/jbc.M114.623165	http://dx.doi.org/10.1074/jbc.M114.623165			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25991725	Green Published, hybrid			2022-12-28	WOS:000357572800003
J	Holmes, K; Shepherd, DA; Ashcroft, AE; Whelan, M; Rowlands, DJ; Stonehouse, NJ				Holmes, Kris; Shepherd, Dale A.; Ashcroft, Alison E.; Whelan, Mike; Rowlands, David J.; Stonehouse, Nicola J.			Assembly Pathway of Hepatitis B Core Virus-like Particles from Genetically Fused Dimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hepatitis virus; mass spectrometry (MS); protein assembly; protein self-assembly; virus assembly; capsid; fused dimer; tandem core	SPECTROMETRY-MASS SPECTROMETRY; CAPSID PROTEIN; C-TERMINUS; RNA; STABILITY; INTERMEDIATE	Background: We studied assembly of HBV capsids using a genetically-fused dimer. Results: Assembly intermediates composed of two, three and five copies of a fused dimer have been isolated. Conclusion: Capsid assembly could progress using dimeric, trimeric, and pentameric intermediates. Significance: The low abundance and transient nature of assembly intermediates make analysis challenging, however, the stability of the intermediates described here has overcome this. Macromolecular complexes are responsible for many key biological processes. However, in most cases details of the assembly/disassembly of such complexes are unknown at the molecular level, as the low abundance and transient nature of assembly intermediates make analysis challenging. The assembly of virus capsids is an example of such a process. The hepatitis B virus capsid (core) can be composed of either 90 or 120 dimers of coat protein. Previous studies have proposed a trimer of dimers as an important intermediate species in assembly, acting to nucleate further assembly by dimer addition. Using novel genetically-fused coat protein dimers, we have been able to trap higher-order assembly intermediates and to demonstrate for the first time that both dimeric and trimeric complexes are on pathway to virus-like particle (capsid) formation.	[Holmes, Kris; Shepherd, Dale A.; Ashcroft, Alison E.; Rowlands, David J.; Stonehouse, Nicola J.] Univ Leeds, Sch Mol & Cellular Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England; [Holmes, Kris; Shepherd, Dale A.; Ashcroft, Alison E.; Rowlands, David J.; Stonehouse, Nicola J.] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; [Whelan, Mike] IQur Ltd, London Biosci Innovat Ctr, London NW1 0NH, England	University of Leeds; University of Leeds; University of London; University of London Royal Veterinary College	Stonehouse, NJ (corresponding author), Univ Leeds, Sch Mol & Cellular Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England.	n.j.stonehouse@leeds.ac.uk		Stonehouse, Nicola/0000-0003-1146-5519; Cooper-Shepherd, Dale/0000-0001-9301-1777	Biotechnology and Biological Sciences Research Council through its Research Equipment Initiative scheme [BB/E012558/1]	Biotechnology and Biological Sciences Research Council through its Research Equipment Initiative scheme(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank all members of the Ashcroft and Stonehouse groups (especially Sam Stephen and Joe Ward) for helpful discussions and colleagues at the University of Leeds for useful suggestions on the manuscript. The Synapt HDMS mass spectrometer was purchased with funds from the Biotechnology and Biological Sciences Research Council through its Research Equipment Initiative scheme (BB/E012558/1).	BIRNBAUM F, 1990, J VIROL, V64, P3319, DOI 10.1128/JVI.64.7.3319-3330.1990; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; Bourne CR, 2009, BIOCHEMISTRY-US, V48, P1736, DOI 10.1021/bi801814y; Ceres P, 2004, J VIROL, V78, P9538, DOI 10.1128/JVI.78.17.9538-9543.2004; Ceres P, 2002, BIOCHEMISTRY-US, V41, P11525, DOI 10.1021/bi0261645; Hernandez H, 2007, NAT PROTOC, V2, P715, DOI 10.1038/nprot.2007.73; Hilton GR, 2012, J R SOC INTERFACE, V9, P801, DOI 10.1098/rsif.2011.0823; Knapman TW, 2010, RAPID COMMUN MASS SP, V24, P3033, DOI 10.1002/rcm.4732; Packianathan C, 2010, J VIROL, V84, P1607, DOI 10.1128/JVI.02033-09; Peng T, 2012, BIOMACROMOLECULES, V13, P699, DOI 10.1021/bm201587q; Peyret H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120751; Pierson EE, 2014, J AM CHEM SOC, V136, P3536, DOI 10.1021/ja411460w; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; Selzer L, 2014, BIOCHEMISTRY-US, V53, P5496, DOI 10.1021/bi500732b; Shepherd DA, 2013, BIOPHYS J, V105, P1258, DOI 10.1016/j.bpj.2013.07.028; Singh S, 2003, J BIOL CHEM, V278, P18249, DOI 10.1074/jbc.M211408200; Stockley PG, 2007, J MOL BIOL, V369, P541, DOI 10.1016/j.jmb.2007.03.020; STONEHOUSE NJ, 1993, FEBS LETT, V334, P355, DOI 10.1016/0014-5793(93)80711-3; Stray SJ, 2004, BIOCHEMISTRY-US, V43, P9989, DOI 10.1021/bi049571k; SUMMERS J, 1982, CELL, V29, P403, DOI 10.1016/0092-8674(82)90157-X; Tsiang M, 2012, BIOCHEMISTRY-US, V51, P4416, DOI 10.1021/bi300052h; Uetrecht C, 2008, P NATL ACAD SCI USA, V105, P9216, DOI 10.1073/pnas.0800406105; Uetrecht C, 2011, NAT CHEM, V3, P126, DOI 10.1038/NCHEM.947; WINGFIELD PT, 1995, BIOCHEMISTRY-US, V34, P4919, DOI 10.1021/bi00015a003; Wynne SA, 1999, MOL CELL, V3, P771, DOI 10.1016/S1097-2765(01)80009-5; Zlotnick A, 1997, P NATL ACAD SCI USA, V94, P9556, DOI 10.1073/pnas.94.18.9556; Zlotnick A, 1999, BIOCHEMISTRY-US, V38, P14644, DOI 10.1021/bi991611a; Zlotnick A, 1996, BIOCHEMISTRY-US, V35, P7412, DOI 10.1021/bi9604800; Zlotnick A, 2007, NAT PROTOC, V2, P490, DOI 10.1038/nprot.2007.60	29	20	21	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16238	16245		10.1074/jbc.M114.622035	http://dx.doi.org/10.1074/jbc.M114.622035			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25953902	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000356930100027
J	Wei, JJ; Gibbs, JS; Hickman, HD; Cush, SS; Bennink, JR; Yewdell, JW				Wei, Jiajie; Gibbs, James S.; Hickman, Heather D.; Cush, Stephanie S.; Bennink, Jack R.; Yewdell, Jonathan W.			Ubiquitous Autofragmentation of Fluorescent Proteins Creates Abundant Defective Ribosomal Products (DRiPs) for Immunosurveillance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antigen processing; immunology; protein misfolding; protein processing; protein synthesis; DRiPs; fluorescent protein; fragmentation; immunosurveillance	NEWLY SYNTHESIZED PROTEINS; CLASS-I MOLECULES; QUALITY-CONTROL; ANTIGENIC PEPTIDES; MAMMALIAN-CELLS; MAJOR SOURCE; DEGRADATION; TRANSLATION; CHROMOPHORE; VIRUS	Background: Fragments are rapidly generated from GFP. Results: Fragmentation occurs in all fluorescent proteins examined, requires chromophore rearrangement, and is a major source of MHC-I ligands. Conclusion: Fragmentation, a by-product of chromophore rearrangement, creates DRiPs. Significance: Fluorescent protein fragments are generated at high levels, likely influencing experimental outcomes. GFP fragments are the first natural DRiPs biochemically characterized relevant for immunosurveillance. Green fluorescent protein (GFP) and other fluorescent proteins are essential tools for biological research. When fused to peptides or proteins as a reporter, GFP enables localization and quantitation of gene products in otherwise unmanipulated live cells or organisms. We previously reported that a sizable fraction of nascent GFP is post-translationally converted into a 20-kDa Triton X-100-insoluble proteasome substrate (Qian, S. B., Princiotta, M. F., Bennink, J. R., and Yewdell, J. W. (2006) J. Biol. Chem. 281, 392-400; Dolan, B. P., Li, L., Veltri, C. A., Ireland, C. M., Bennink, J. R., and Yewdell, J. W. (2011) J. Immunol. 186, 2065-2072). Here, we show that a similarly sized fragment is generated by all GFP and red fluorescent protein family members we examined. We demonstrate that fragmentation is a by-product of GFP chromophore rearrangement. A non-rearranging GFP mutant fails to fragment and generates diminished levels of K-b-SIINFEKL complexes when SIINFEKL is genetically fused to either the C- or N-terminal domains of GFP fusion proteins. Instructively, another fragmenting GFP mutant that cannot create the functional chromophore but still generates fragments also demonstrates diminished K-b-SIINFEKL generation. However, the mutant and wild-type fragments differ fundamentally in that wild-type fragments are rapidly liberated from the intact molecule and degraded quickly, accounting for increased K-b-SIINFEKL generation. In the fragmenting mutant, the fragments are generated slowly and remain associated, likely in a native conformation based on their original structural description (Barondeau, D. P., Kassmann, C. J., Tainer, J. A., and Getzoff, E. D. (2006) J. Am. Chem. Soc. 128, 4685-4693). The wild-type GFP fragments represent the first biochemically defined natural defective ribosomal products to contribute peptides for immunosurveillance, enabling quantitation of peptide generation efficiency from this source of defective ribosomal products. More broadly, given the wide use of fluorescent proteins, their ubiquitous and abundant fragmentation must be considered when interpreting experiments using these extremely useful probes.	[Wei, Jiajie; Gibbs, James S.; Hickman, Heather D.; Cush, Stephanie S.; Bennink, Jack R.; Yewdell, Jonathan W.] NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Yewdell, JW (corresponding author), NIAID, Viral Dis Lab, 33 North Dr, Bethesda, MD 20892 USA.	JYEWDELL@niaid.nih.gov	yewdell, jyewdell@nih.gov jonathan/A-1702-2012	Hickman, Heather/0000-0003-4168-4894	National Institutes of Health grants from NIAID, Division of Intramural Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000653, ZIAAI000542, ZIAAI001210] Funding Source: NIH RePORTER	National Institutes of Health grants from NIAID, Division of Intramural Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health grants from NIAID, Division of Intramural Research. The authors declare that they have no conflicts of interest with the contents of this article.	Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Anton LC, 1999, J CELL BIOL, V146, P113, DOI 10.1083/jcb.146.1.113; Anton LC, 2014, J LEUKOCYTE BIOL, V95, P551, DOI 10.1189/jlb.1113599; Apcher S, 2013, P NATL ACAD SCI USA, V110, P17951, DOI 10.1073/pnas.1309956110; Barondeau DP, 2006, J AM CHEM SOC, V128, P4685, DOI 10.1021/ja056635l; BLASCO R, 1991, J VIROL, V65, P5910, DOI 10.1128/JVI.65.11.5910-5920.1991; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; CHAKRABARTI S, 1985, MOL CELL BIOL, V5, P3403, DOI 10.1128/MCB.5.12.3403; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Croft NP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003129; David A, 2012, J CELL BIOL, V197, P45, DOI 10.1083/jcb.201112145; Dolan BP, 2012, P NATL ACAD SCI USA, V109, P7025, DOI 10.1073/pnas.1112387109; Dolan BP, 2011, J IMMUNOL, V186, P2065, DOI 10.4049/jimmunol.1003096; Dolan BP, 2010, J IMMUNOL, V184, P1419, DOI 10.4049/jimmunol.0901907; Duttler S, 2013, MOL CELL, V50, P379, DOI 10.1016/j.molcel.2013.03.010; Farfan-Arribas DJ, 2012, P NATL ACAD SCI USA, V109, P16998, DOI 10.1073/pnas.1210271109; Geiler-Samerotte KA, 2011, P NATL ACAD SCI USA, V108, P680, DOI 10.1073/pnas.1017570108; Gross LA, 2000, P NATL ACAD SCI USA, V97, P11990, DOI 10.1073/pnas.97.22.11990; HOSAKA Y, 1988, J IMMUNOL, V140, P606; Iizuka R, 2011, ANAL BIOCHEM, V414, P173, DOI 10.1016/j.ab.2011.03.036; Kelkar DA, 2012, J BIOL CHEM, V287, P2568, DOI 10.1074/jbc.M111.318766; Martynov VI, 2001, J BIOL CHEM, V276, P21012, DOI 10.1074/jbc.M100500200; POOLE B, 1973, J BIOL CHEM, V248, P6221; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; Qian SB, 2006, J BIOL CHEM, V281, P392, DOI 10.1074/jbc.M509126200; Qian SB, 2002, J BIOL CHEM, V277, P38818, DOI 10.1074/jbc.M205547200; Qian SB, 2006, J IMMUNOL, V177, P227, DOI 10.4049/jimmunol.177.1.227; Qian Shu-Bing, 2005, V301, P271; Reits EAJ, 2000, NATURE, V404, P774, DOI 10.1038/35008103; Remington SJ, 2006, CURR OPIN STRUC BIOL, V16, P714, DOI 10.1016/j.sbi.2006.10.001; Remington SJ, 2005, BIOCHEMISTRY-US, V44, P202, DOI 10.1021/bi048383r; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Sawasaki T, 2002, FEBS LETT, V514, P102, DOI 10.1016/S0014-5793(02)02329-3; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Vabulas RM, 2005, SCIENCE, V310, P1960, DOI 10.1126/science.1121925; WHEATLEY DN, 1980, CELL BIOL INT REP, V4, P1081, DOI 10.1016/0309-1651(80)90045-4; Yewdell JW, 2011, CELL BIOL INT, V35, P457, DOI 10.1042/CBI20110055; Yewdell JW, 1996, J IMMUNOL, V157, P1823; Yewdell JW, 2003, NAT REV IMMUNOL, V3, P952, DOI 10.1038/nri1250	40	11	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16431	16439		10.1074/jbc.M115.658062	http://dx.doi.org/10.1074/jbc.M115.658062			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25971973	Green Published, hybrid			2022-12-28	WOS:000356930100043
J	Collins, PE; Grassia, G; Colleran, A; Kiely, PA; Ialenti, A; Maffia, P; Carmody, RJ				Collins, Patricia E.; Grassia, Gianluca; Colleran, Amy; Kiely, Patrick A.; Ialenti, Armando; Maffia, Pasquale; Carmody, Ruaidhri J.			Mapping the Interaction of B Cell Leukemia 3 (BCL-3) and Nuclear Factor B (NF-B) p50 Identifies a BCL-3-mimetic Anti-inflammatory Peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inflammation; NF-B; peptide array; peptides; transcription; BCL-3	FACTOR-KAPPA-B; GENE-EXPRESSION; ANKYRIN REPEAT; PROTEIN; DOMAIN; MICE; TRANSCRIPTION; MEMBRANE; SURVIVAL; ROLES	The NF-B transcriptional response is tightly regulated by a number of processes including the phosphorylation, ubiquitination, and subsequent proteasomal degradation of NF-B subunits. The IB family protein BCL-3 stabilizes a NF-B p50 homodimer.DNA complex through inhibition of p50 ubiquitination. This complex inhibits the binding of the transcriptionally active NF-B subunits p65 and c-Rel on the promoters of NF-B target genes and functions to suppress inflammatory gene expression. We have previously shown that the direct interaction between p50 and BCL-3 is required for BCL-3-mediated inhibition of pro-inflammatory gene expression. In this study we have used immobilized peptide array technology to define regions of BCl-3 that mediate interaction with p50 homodimers. Our data show that BCL-3 makes extensive contacts with p50 homodimers and in particular with ankyrin repeats (ANK) 1, 6, and 7, and the N-terminal region of Bcl-3. Using these data we have designed a BCL-3 mimetic peptide based on a region of the ANK1 of BCL-3 that interacts with p50 and shares low sequence similarity with other IB proteins. When fused to a cargo carrying peptide sequence this BCL-3-derived peptide, but not a mutated peptide, inhibited Toll-like receptor-induced cytokine expression in vitro. The BCL-3 mimetic peptide was also effective in preventing inflammation in vivo in the carrageenan-induced paw edema mouse model. This study demonstrates that therapeutic strategies aimed at mimicking the functional activity of BCL-3 may be effective in the treatment of inflammatory disease.	[Collins, Patricia E.; Grassia, Gianluca; Maffia, Pasquale; Carmody, Ruaidhri J.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Ctr Immunobiol, Glasgow G12 8TA, Lanark, Scotland; [Kiely, Patrick A.] Univ Limerick, Dept Life Sci, Limerick, Ireland; [Kiely, Patrick A.] Univ Limerick, Mat & Surface Sci Inst, Limerick, Ireland; [Colleran, Amy] Natl Univ Ireland Univ Coll Cork, Dept Biochem, Cork, Ireland; [Ialenti, Armando] Univ Naples Federico II, Dept Pharm, I-80131 Naples, Italy	University of Glasgow; University of Limerick; University of Limerick; University College Cork; University of Naples Federico II	Carmody, RJ (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Ctr Immunobiol, Glasgow G12 8TA, Lanark, Scotland.	ruaidhri.carmody@glasgow.ac.uk	Carmody, Ruaidhri/H-5396-2019; Grassia, Gianluca/H-7677-2019	Grassia, Gianluca/0000-0001-7846-5594; Collins, Patricia/0000-0002-0218-7847	Science Foundation Ireland [08/IN.1/B1843]; Biotechnology and Biological Sciences Research Council [BB/M003671/1]; Institute of Infection, Immunity and Inflammation at the University of Glasgow; Engineering and Physical Sciences Research Council [EP/L014165/1]; BBSRC [BB/M003671/1] Funding Source: UKRI; EPSRC [EP/L014165/1] Funding Source: UKRI; MRC [MR/M010694/1] Funding Source: UKRI; Medical Research Council [MR/M010694/1] Funding Source: researchfish	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Institute of Infection, Immunity and Inflammation at the University of Glasgow; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by Science Foundation Ireland Grant 08/IN.1/B1843, Biotechnology and Biological Sciences Research Council Grant BB/M003671/1 and the Institute of Infection, Immunity and Inflammation at the University of Glasgow. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Engineering and Physical Sciences Research Council Research Grant EP/L014165/1.	Bosisio D, 2006, EMBO J, V25, P798, DOI 10.1038/sj.emboj.7600977; Carmody RJ, 2007, CELL MOL IMMUNOL, V4, P31; Carmody RJ, 2007, SCIENCE, V317, P675, DOI 10.1126/science.1142953; Carmody RJ, 2007, J IMMUNOL, V178, P186, DOI 10.4049/jimmunol.178.1.186; Colleran A, 2013, P NATL ACAD SCI USA, V110, P618, DOI 10.1073/pnas.1208446110; Collins PE, 2014, J BIOL CHEM, V289, P7059, DOI 10.1074/jbc.M114.551986; Dyer BW, 2000, ANAL BIOCHEM, V282, P158, DOI 10.1006/abio.2000.4605; Gerondakis S, 1999, ONCOGENE, V18, P6888, DOI 10.1038/sj.onc.1203236; Gilmore TD, 2006, ONCOGENE, V25, P6887, DOI 10.1038/sj.onc.1209982; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Huxford T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000075; Ialenti A, 2005, MOL PHARMACOL, V67, P1620, DOI 10.1124/mol.104.004895; Kramer A, 1998, METH MOL B, V87, P25; Kreisel D, 2011, J CLIN INVEST, V121, P265, DOI 10.1172/JCI42596; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; Manavalan B., 2010, PLOS ONE, V5; Michel F, 2001, EMBO J, V20, P6180, DOI 10.1093/emboj/20.22.6180; Mitchell TC, 2002, ANN NY ACAD SCI, V975, P132, DOI 10.1111/j.1749-6632.2002.tb05947.x; Mitchell TC, 2002, ANN NY ACAD SCI, V975, P114, DOI 10.1111/j.1749-6632.2002.tb05946.x; Muhlbauer M, 2008, J BIOL CHEM, V283, P14182, DOI 10.1074/jbc.M709029200; Natoli G, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.11pe1; Pene F, 2011, J IMMUNOL, V186, P2412, DOI 10.4049/jimmunol.1001331; Posadas I, 2004, BRIT J PHARMACOL, V142, P331, DOI 10.1038/sj.bjp.0705650; Ruan QG, 2010, DIABETES, V59, P2549, DOI 10.2337/db10-0480; Tang WH, 2014, IMMUNITY, V41, P555, DOI 10.1016/j.immuni.2014.09.017; Tassi I, 2014, J IMMUNOL, V193, P4303, DOI 10.4049/jimmunol.1401505; Tunnemann G, 2006, FASEB J, V20, P1775, DOI 10.1096/fj.05-5523com; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; ZHANG Q, 1994, MOL CELL BIOL, V14, P3915, DOI 10.1128/MCB.14.6.3915	29	21	21	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15687	15696		10.1074/jbc.M115.643700	http://dx.doi.org/10.1074/jbc.M115.643700			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25922067	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000356527400031
J	Gao, F; Kight, AD; Henderson, R; Jayanthi, S; Patel, P; Murchison, M; Sharma, P; Goforth, RL; Kumar, TKS; Henry, RL; Heyes, CD				Gao, Feng; Kight, Alicia D.; Henderson, Rory; Jayanthi, Srinivas; Patel, Parth; Murchison, Marissa; Sharma, Priyanka; Goforth, Robyn L.; Kumar, Thallapuranam Krishnaswamy Suresh; Henry, Ralph L.; Heyes, Colin D.			Regulation of Structural Dynamics within a Signal Recognition Particle Promotes Binding of Protein Targeting Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chloroplast; isothermal titration calorimetry (ITC); membrane transport; molecular dynamics; protein dynamic; protein targeting; signal recognition particle (SRP); single molecule biophysics	SINGLE-MOLECULE FLUORESCENCE; TRANSFER CONFOCAL MICROSCOPY; THYLAKOID MEMBRANE-PROTEIN; RESONANCE ENERGY-TRANSFER; CHLOROPLAST HOMOLOG; CPSRP43; SUBUNIT; CHROMODOMAINS; INTEGRATION; COMPONENTS	Background: Targeting of proteins requires a signal recognition particle (SRP) and multiple protein interactions. Results: We observed a decrease in the structural dynamics of cpSRP43 and an increase in substrate affinity upon its binding to cpSRP54. Conclusion: Changes in domain dynamics induced by cpSRP subunit interactions mediate substrate affinity. Significance: Relating structure and dynamics of SRP proteins allows for a better understanding of vectorial targeting within cells. Protein targeting is critical in all living organisms and involves a signal recognition particle (SRP), an SRP receptor, and a translocase. In co-translational targeting, interactions among these proteins are mediated by the ribosome. In chloroplasts, the light-harvesting chlorophyll-binding protein (LHCP) in the thylakoid membrane is targeted post-translationally without a ribosome. A multidomain chloroplast-specific subunit of the SRP, cpSRP43, is proposed to take on the role of coordinating the sequence of targeting events. Here, we demonstrate that cpSRP43 exhibits significant interdomain dynamics that are reduced upon binding its SRP binding partner, cpSRP54. We showed that the affinity of cpSRP43 for the binding motif of LHCP (L18) increases when cpSRP43 is complexed to the binding motif of cpSRP54 (cpSRP54(pep)). These results support the conclusion that substrate binding to the chloroplast SRP is modulated by protein structural dynamics in which a major role of cpSRP54 is to improve substrate binding efficiency to the cpSRP.	[Gao, Feng; Henderson, Rory; Jayanthi, Srinivas; Patel, Parth; Murchison, Marissa; Kumar, Thallapuranam Krishnaswamy Suresh; Heyes, Colin D.] Univ Arkansas, Dept Chem & Biochem, Fayetteville, AR 72701 USA; [Kight, Alicia D.; Sharma, Priyanka; Goforth, Robyn L.; Henry, Ralph L.] Univ Arkansas, Dept Biol Sci, Fayetteville, AR 72701 USA	University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas System; University of Arkansas Fayetteville	Kumar, TKS (corresponding author), Univ Arkansas, Dept Chem & Biochem, 345 N Campus Dr, Fayetteville, AR 72701 USA.	sthalla@uark.edu; rahenry@uark.edu; cheyes@uark.edu	Kumar, Dr Suresh/HHZ-2615-2022; KUMAR, P. SURESH/AAT-8951-2020; Kumar, Suresh Thallapuranam/R-5606-2016; Jayanthi, Srinivas/AAD-2808-2019	Kumar, Dr Suresh/0000-0002-2539-6553; KUMAR, P. SURESH/0000-0003-3222-2604; Kumar, Suresh Thallapuranam/0000-0001-7262-1373; Henderson, Rory/0000-0002-4301-6382; Heyes, Colin/0000-0003-1124-9947; Jayanthi, Srinivas/0000-0001-7357-760X	National Institutes of Health through the Centers of Biomedical Research Excellence program [P30 GM103450]; U.S. Department of Energy, Office of Science, Basic Energy Sciences [DE-FG02-01ER15161]; Arkansas Biosciences Institute; National Center for Research Resources, a component of the NIH [1P30RR031154]; National Science Foundation [MRI 0722625, MRI-R2 0959124, ARI 0963249, 0918970]; Arkansas Science and Technology Authority; NATIONAL CENTER FOR RESEARCH RESOURCES [P30RR031154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103450] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1263119] Funding Source: National Science Foundation	National Institutes of Health through the Centers of Biomedical Research Excellence program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy, Office of Science, Basic Energy Sciences(United States Department of Energy (DOE)); Arkansas Biosciences Institute; National Center for Research Resources, a component of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Science Foundation(National Science Foundation (NSF)); Arkansas Science and Technology Authority; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported in part by National Institutes of Health Grant P30 GM103450 through the Centers of Biomedical Research Excellence program. This work was also supported by the U.S. Department of Energy, Office of Science, Basic Energy Sciences, under Award #DE-FG02-01ER15161 (to R. L. H. and T. K. S. K.: cloning and recombinant protein production, molecular dynamics simulations, and thylakoid insertion), and the Arkansas Biosciences Institute. We thank the Arkansas Statewide Mass Spectrometry Facility for analytical support and the mass spectral data (Grant Number 1P30RR031154 from the National Center for Research Resources, a component of the NIH). MD simulations were supported in part by National Science Foundation Grants MRI 0722625 (Star of Arkansas), MRI-R2 0959124 (Razor), and ARI 0963249 and 0918970 (Cyberinfrastructure for Transformational Scientific Discovery, CI-TRAIN) and a grant from the Arkansas Science and Technology Authority with resources managed by the Arkansas High Performance Computing Center.	Arkhipov A, 2006, STRUCTURE, V14, P1767, DOI 10.1016/j.str.2006.10.003; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Cain P, 2011, BIOCHEM J, V437, P149, DOI 10.1042/BJ20110270; Chen P, 2010, NAT PROD REP, V27, P757, DOI 10.1039/b906691h; Cline K., 2003, LIGHT HARVESTING ANT, P353; Cline K, 2008, CURR OPIN PLANT BIOL, V11, P585, DOI 10.1016/j.pbi.2008.10.008; Cui BX, 2007, P NATL ACAD SCI USA, V104, P13666, DOI 10.1073/pnas.0706192104; DeLille J, 2000, P NATL ACAD SCI USA, V97, P1926, DOI 10.1073/pnas.030395197; Dickson RM, 1997, NATURE, V388, P355, DOI 10.1038/41048; Dunschede B, 2011, J BIOL CHEM, V286, P35187, DOI 10.1074/jbc.M111.250746; Falk S, 2010, J BIOL CHEM, V285, P21655, DOI 10.1074/jbc.C110.132746; Falk S, 2010, J BIOL CHEM, V285, P5954, DOI 10.1074/jbc.M109.084996; FRANKLIN AE, 1993, J BIOL CHEM, V268, P22175; Gao F, 2006, J AM CHEM SOC, V128, P4814, DOI 10.1021/ja058098a; Gao F, 2013, ANAL CHEM, V85, P4414, DOI 10.1021/ac3036926; Goforth RL, 2004, J BIOL CHEM, V279, P43077, DOI 10.1074/jbc.M401600200; GREEN BR, 1996, MOL GENETICS PHOTOSY, P75; Groves MR, 2001, J BIOL CHEM, V276, P27778, DOI 10.1074/jbc.M103470200; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Henry R, 2007, ENZYMES, V25, P493, DOI 10.1016/S1874-6047(07)25019-X; Henry RL, 2010, NAT STRUCT MOL BIOL, V17, P676, DOI 10.1038/nsmb0610-676; Holdermann I, 2012, NAT STRUCT MOL BIOL, V19, P260, DOI 10.1038/nsmb.2196; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jaru-Ampornpan P, 2010, NAT STRUCT MOL BIOL, V17, P696, DOI 10.1038/nsmb.1836; Jia YW, 1999, CHEM PHYS, V247, P69, DOI 10.1016/S0301-0104(99)00127-5; Kathir KM, 2008, J MOL BIOL, V381, P49, DOI 10.1016/j.jmb.2008.05.065; Kuzmenkina EV, 2005, P NATL ACAD SCI USA, V102, P15471, DOI 10.1073/pnas.0507728102; Lewis NE, 2010, J BIOL CHEM, V285, P34220, DOI 10.1074/jbc.M110.160093; LI XX, 1995, P NATL ACAD SCI USA, V92, P3789, DOI 10.1073/pnas.92.9.3789; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; Marty NJ, 2009, J BIOL CHEM, V284, P14891, DOI 10.1074/jbc.M900775200; Nishimura SY, 2006, J PHYS CHEM B, V110, P8151, DOI 10.1021/jp0574145; PAYAN LA, 1991, J CELL BIOL, V112, P603, DOI 10.1083/jcb.112.4.603; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Schuenemann D, 1998, P NATL ACAD SCI USA, V95, P10312, DOI 10.1073/pnas.95.17.10312; Schuler B, 2005, P NATL ACAD SCI USA, V102, P2754, DOI 10.1073/pnas.0408164102; Schuler B, 2002, NATURE, V419, P743, DOI 10.1038/nature01060; SCOPES RK, 1974, ANAL BIOCHEM, V59, P277, DOI 10.1016/0003-2697(74)90034-7; Sharonov A, 2006, P NATL ACAD SCI USA, V103, P18911, DOI 10.1073/pnas.0609643104; Sivaraja V, 2005, J BIOL CHEM, V280, P41465, DOI 10.1074/jbc.M507077200; Stengel KF, 2008, SCIENCE, V321, P253, DOI 10.1126/science.1158640; Talaga DS, 2000, P NATL ACAD SCI USA, V97, P13021, DOI 10.1073/pnas.97.24.13021; Tu CJ, 2000, J BIOL CHEM, V275, P13187, DOI 10.1074/jbc.C000108200; Tzvetkova-Chevolleau T, 2007, PLANT CELL, V19, P1635, DOI 10.1105/tpc.106.048959; Wriggers Willy, 2010, Biophys Rev, V2, P21, DOI 10.1007/s12551-009-0026-3; Yang H, 2003, SCIENCE, V302, P262, DOI 10.1126/science.1086911; YOUNG ME, 1980, BIOTECHNOL BIOENG, V22, P947, DOI 10.1002/bit.260220504; YUAN JG, 1993, P NATL ACAD SCI USA, V90, P8552, DOI 10.1073/pnas.90.18.8552; Zhuang XW, 2000, SCIENCE, V288, P2048, DOI 10.1126/science.288.5473.2048	51	15	15	2	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15462	15474		10.1074/jbc.M114.624346	http://dx.doi.org/10.1074/jbc.M114.624346			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25918165	Green Published, hybrid			2022-12-28	WOS:000356527400013
J	Srivastava, J; Robertson, CL; Gredler, R; Siddiq, A; Rajasekaran, D; Akiel, MA; Emdad, L; Mas, V; Mukhopadhyay, ND; Fisher, PB; Sarkar, D				Srivastava, Jyoti; Robertson, Chadia L.; Gredler, Rachel; Siddiq, Ayesha; Rajasekaran, Devaraja; Akiel, Maaged A.; Emdad, Luni; Mas, Valeria; Mukhopadhyay, Nitai D.; Fisher, Paul B.; Sarkar, Devanand			Astrocyte Elevated Gene-1 (AEG-1) Contributes to Non-thyroidal Illness Syndrome (NTIS) Associated with Hepatocellular Carcinoma (HCC)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hepatocellular carcinoma; liver; NF-kappa B; thyroid hormone; transcriptional coactivator; AEG-1; non-thyroidal illness syndrome	THYROID-HORMONE ACTIONS; RETINOID-X-RECEPTOR; NF-KAPPA-B; LIVER-CANCER; HEPATOCARCINOGENESIS; INFLAMMATION; PROGRESSION; METASTASIS; ACTIVATION; RESISTANCE	Background: Astrocyte elevated gene-1 (AEG-1) inhibits retinoid X receptor (RXR) function and is overexpressed in human hepatocellular carcinoma (HCC), which is associated with non-thyroidal illness syndrome (NTIS). Results: AEG-1 inhibits thyroid hormone (T-3) function by down-regulating type I 5-deiodinase (DIO1) thus contributing to NTIS. Conclusion: A novel role of AEG-1 is identified regulating cancer-associated NTIS. Significance: AEG-1 inhibition might alleviate cancer-associated debilitating disorders. Non-thyroidal illness syndrome (NTIS), characterized by low serum 3,5,3-triiodothyronine (T-3) with normal l-thyroxine (T-4) levels, is associated with malignancy. Decreased activity of type I 5-deiodinase (DIO1), which converts T-4 to T-3, contributes to NTIS. T-3 binds to thyroid hormone receptor, which heterodimerizes with retinoid X receptor (RXR) and regulates transcription of target genes, such as DIO1. NF-B activation by inflammatory cytokines inhibits DIO1 expression. The oncogene astrocyte elevated gene-1 (AEG-1) inhibits RXR-dependent transcription and activates NF-B. Here, we interrogated the role of AEG-1 in NTIS in the context of hepatocellular carcinoma (HCC). T-3-mediated gene regulation was analyzed in human HCC cells, with overexpression or knockdown of AEG-1, and primary hepatocytes from AEG-1 transgenic (Alb/AEG-1) and AEG-1 knock-out (AEG-1KO) mice. Serum T-3 and T-4 levels were checked in Alb/AEG-1 mice and human HCC patients. AEG-1 and DIO1 levels in human HCC samples were analyzed by immunohistochemistry. AEG-1 inhibited T-3-mediated gene regulation in human HCC cells and mouse hepatocytes. AEG-1 overexpression repressed and AEG-1 knockdown induced DIO1 expression. An inverse correlation was observed between AEG-1 and DIO1 levels in human HCC patients. Low T-3 with normal T-4 was observed in the sera of HCC patients and Alb/AEG-1 mice. Inhibition of co-activator recruitment to RXR and activation of NF-B were identified to play a role in AEG-1-mediated down-regulation of DIO1. AEG-1 thus might play a role in NTIS associated with HCC and other cancers.	[Srivastava, Jyoti; Robertson, Chadia L.; Gredler, Rachel; Siddiq, Ayesha; Rajasekaran, Devaraja; Akiel, Maaged A.; Emdad, Luni; Fisher, Paul B.; Sarkar, Devanand] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23298 USA; [Mukhopadhyay, Nitai D.] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA 23298 USA; [Fisher, Paul B.; Sarkar, Devanand] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23298 USA; [Fisher, Paul B.; Sarkar, Devanand] Virginia Commonwealth Univ, VCU Inst Mol Med, Richmond, VA 23298 USA; [Mas, Valeria] Univ Virginia, Dept Surg, Charlottesville, VA 22908 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; University of Virginia	Sarkar, D (corresponding author), Virginia Commonwealth Univ, Dept Human & Mol Genet, 1220 East Broad St,POB 980035, Richmond, VA 23298 USA.	dsarkar@vcu.edu	Srivastava, Jyoti/AAD-7610-2022; Regan, Clinton/E-6250-2012; Akiel, Maaged/B-5109-2014	Akiel, Maaged/0000-0002-0211-2837	National Institutes of Health from NCI [R01 CA138540, R21 CA183954]; National Institutes of Health [R01 CA134721]; James S. McDonnell Foundation; National Institutes of Health from NIDDK [T32DK007150]; NATIONAL CANCER INSTITUTE [R01CA134721, R21CA183954, R01CA138540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007150] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James S. McDonnell Foundation; National Institutes of Health from NIDDK; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA138540 and R21 CA183954 from NCI (to D. S.) and National Institutes of Health Grant R01 CA134721 (to P. B. F.). This work was also supported by the James S. McDonnell Foundation. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by National Institutes of Health Grant T32DK007150 from NIDDK.	Alexia C, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004496; Arnaldi LAT, 2005, THYROID, V15, P210, DOI 10.1089/thy.2005.15.210; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Boguslawska J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024541; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; Darras VM, 2012, J ENDOCRINOL, V215, P189, DOI 10.1530/JOE-12-0204; Emdad L, 2006, CANCER RES, V66, P1509, DOI 10.1158/0008-5472.CAN-05-3029; Frau C, 2015, HEPATOLOGY, V61, P249, DOI 10.1002/hep.27399; Galton VA, 2009, ENDOCRINOLOGY, V150, P2957, DOI 10.1210/en.2008-1572; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Kang DC, 2005, GENE, V353, P8, DOI [10.1016/j.gene.2005.04.006, 10.1016/j.gene.2005.04.005]; Lee SG, 2011, CANCER RES, V71, P6514, DOI 10.1158/0008-5472.CAN-11-0782; Lefebvre P, 2010, TRENDS ENDOCRIN MET, V21, P676, DOI 10.1016/j.tem.2010.06.009; Nagaya T, 2000, J CLIN INVEST, V106, P393, DOI 10.1172/JCI7771; Ortiga-Carvalho TM, 2014, NAT REV ENDOCRINOL, V10, P582, DOI 10.1038/nrendo.2014.143; Robertson CL, 2014, CANCER RES, V74, P6184, DOI 10.1158/0008-5472.CAN-14-1357; Sarkar D, 2004, CANCER RES, V64, P7473, DOI 10.1158/0008-5472.CAN-04-1772; Sarkar D, 2000, ENDOCR J, V47, P63, DOI 10.1507/endocrj.47.63; Sarkar D, 2008, CANCER RES, V68, P1478, DOI 10.1158/0008-5472.CAN-07-6164; Sarkar D, 2013, ADV CANCER RES, V120, P193, DOI 10.1016/B978-0-12-401676-7.00007-3; Sarkar D, 2013, ADV CANCER RES, V120, P39, DOI 10.1016/B978-0-12-401676-7.00002-4; Srivastava J, 2015, HEPATOLOGY, V61, P915, DOI 10.1002/hep.27339; Srivastava J, 2014, CANCER RES, V74, P4364, DOI 10.1158/0008-5472.CAN-14-0421; Srivastava J, 2012, HEPATOLOGY, V56, P1782, DOI 10.1002/hep.25868; St Germain DL, 2009, ENDOCRINOLOGY, V150, P1097, DOI 10.1210/en.2008-1588; TOYODA N, 1995, MOL CELL BIOL, V15, P5100; Warner MH, 2010, J ENDOCRINOL, V205, P1, DOI 10.1677/JOE-09-0412; Wu SM, 2013, CELL MOL LIFE SCI, V70, P1915, DOI 10.1007/s00018-012-1146-7; Yoo BK, 2011, HEPATOLOGY, V53, P1538, DOI 10.1002/hep.24216; Yoo BK, 2010, CANCER RES, V70, P3249, DOI 10.1158/0008-5472.CAN-09-4009; Yoo BK, 2009, P NATL ACAD SCI USA, V106, P12938, DOI 10.1073/pnas.0901451106; Yoo BK, 2009, J CLIN INVEST, V119, P465, DOI 10.1172/JCI36460; Zhu K, 2011, CLIN CANCER RES, V17, P7294, DOI 10.1158/1078-0432.CCR-11-1327	33	19	19	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15549	15558		10.1074/jbc.M115.649707	http://dx.doi.org/10.1074/jbc.M115.649707			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25944909	Green Published, hybrid			2022-12-28	WOS:000356527400020
J	Zhong, L; Chen, XF; Zhang, ZL; Wang, Z; Shi, XZ; Xu, K; Zhang, YW; Xu, HX; Bu, GJ				Zhong, Li; Chen, Xiao-Fen; Zhang, Zhen-Lian; Wang, Zhe; Shi, Xin-Zhen; Xu, Kai; Zhang, Yun-Wu; Xu, Huaxi; Bu, Guojun			DAP12 Stabilizes the C-terminal Fragment of the Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) and Protects against LPS-induced Pro-inflammatory Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; cytokine; inflammation; lipopolysaccharide (LPS); microglia; -secretase; DAP12; TREM-CTF; TREM2	AMYLOID PRECURSOR PROTEIN; GENOME-WIDE ASSOCIATION; CUTTING EDGE; AMPLIFIES INFLAMMATION; RISK-FACTOR; DISEASE; TRAFFICKING; VARIANTS; PHAGOCYTOSIS; ACTIVATION	Triggering receptor expressed on myeloid cells 2 (TREM2) is a DAP12-associated receptor expressed in microglia, macrophages, and other myeloid-derived cells. Previous studies have suggested that TREM2/DAP12 signaling pathway reduces inflammatory responses and promotes phagocytosis of apoptotic neurons. Recently, TREM2 has been identified as a risk gene for Alzheimer disease (AD). Here, we show that DAP12 stabilizes the C-terminal fragment of TREM2 (TREM2-CTF), a substrate for -secretase. Co-expression of DAP12 with TREM2 selectively increased the level of TREM2-CTF with little effects on that of full-length TREM2. The interaction between DAP12 and TREM2 is essential for TREM2-CTF stabilization as a mutant form of DAP12 with disrupted interaction with TREM2 failed to exhibit such an effect. Silencing of either Trem2 or Dap12 gene significantly exacerbated pro-inflammatory responses induced by lipopolysaccharides (LPS). Importantly, overexpression of either full-length TREM2 or TREM2-CTF reduced LPS-induced inflammatory responses. Taken together, our results support a role of DAP12 in stabilizing TREM2-CTF, thereby protecting against excessive pro-inflammatory responses.	[Zhong, Li; Chen, Xiao-Fen; Zhang, Zhen-Lian; Wang, Zhe; Shi, Xin-Zhen; Xu, Kai; Zhang, Yun-Wu; Xu, Huaxi; Bu, Guojun] Xiamen Univ, Coll Med, Inst Neurosci, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Xiamen 361102, Peoples R China; [Xu, Huaxi] Sanford Burnham Med Res Inst, Ctr Neurosci Aging & Stem Cell Res, Degenerat Dis Res Program, La Jolla, CA 92037 USA; [Bu, Guojun] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA	Xiamen University; Sanford Burnham Prebys Medical Discovery Institute; Mayo Clinic	Chen, XF (corresponding author), Xiamen Univ, Coll Med, Inst Neurosci, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Xiamen 361102, Peoples R China.	chenxf@xmu.edu.cn; bu.guojun@mayo.edu	Regan, Clinton/E-6250-2012; Xu, Huaxi/AAV-7177-2021	Zhong, Li/0000-0003-3815-6484; Zhang, Yun-wu/0000-0002-7152-7630	National Institutes of Health [R01AG027924, R01AG035355, R01AG046205]; National Natural Science Foundation of China [81370459, 31400914]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS074969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027924, P50AG016574, R01AG046205, P01AG030128, RF1AG046205, R01AG035355] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants R01AG027924, R01AG035355, R01AG046205 (to G. B.) and Grants (81370459, 31400914) from the National Natural Science Foundation of China (to X. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Benitez BA, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.12.018; Bertram L, 2008, AM J HUM GENET, V83, P623, DOI 10.1016/j.ajhg.2008.10.008; BOCCHINI V, 1992, J NEUROSCI RES, V31, P616, DOI 10.1002/jnr.490310405; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; BUXBAUM JD, 1990, P NATL ACAD SCI USA, V87, P6003, DOI 10.1073/pnas.87.15.6003; Cady J, 2014, JAMA NEUROL, V71, P449, DOI 10.1001/jamaneurol.2013.6237; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; Cuyvers E, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.09.009; Eikelenboom P, 2010, NEURODEGENER DIS, V7, P38, DOI 10.1159/000283480; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Hamerman JA, 2005, NAT IMMUNOL, V6, P579, DOI 10.1038/ni1204; Hamerman JA, 2006, J IMMUNOL, V177, P2051, DOI 10.4049/jimmunol.177.4.2051; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Hsieh CL, 2009, J NEUROCHEM, V109, P1144, DOI 10.1111/j.1471-4159.2009.06042.x; Ito H, 2012, EUR J IMMUNOL, V42, P176, DOI 10.1002/eji.201141679; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kleinberger G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009093; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Landel V, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-33; Lanier LL, 2009, IMMUNOL REV, V227, P150, DOI 10.1111/j.1600-065X.2008.00720.x; Lanier LL, 2000, IMMUNOL TODAY, V21, P611, DOI 10.1016/S0167-5699(00)01745-X; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; Lemere CA, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-36; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; Lucin KM, 2013, NEURON, V79, P873, DOI 10.1016/j.neuron.2013.06.046; Muller T, 2008, PROG NEUROBIOL, V85, P393, DOI 10.1016/j.pneurobio.2008.05.002; Nakayama K, 2011, CELL MOL NEUROBIOL, V31, P887, DOI 10.1007/s10571-011-9688-z; Paloneva J, 2002, AM J HUM GENET, V71, P656, DOI 10.1086/342259; Paloneva J, 2001, NEUROLOGY, V56, P1552, DOI 10.1212/WNL.56.11.1552; Pottier C, 2013, J ALZHEIMERS DIS, V35, P45, DOI 10.3233/JAD-122311; Prada I, 2006, NEUROSCIENCE, V140, P1139, DOI 10.1016/j.neuroscience.2006.03.058; Rayaprolu S, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-19; Schmid CD, 2002, J NEUROCHEM, V83, P1309, DOI 10.1046/j.1471-4159.2002.01243.x; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Sessa G, 2004, EUR J NEUROSCI, V20, P2617, DOI 10.1111/j.1460-9568.2004.03729.x; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Takahashi K, 2007, PLOS MED, V4, P675, DOI 10.1371/journal.pmed.0040124; Turnbull IR, 2005, J EXP MED, V202, P363, DOI 10.1084/jem.20050986; Turnbull IR, 2006, J IMMUNOL, V177, P3520, DOI 10.4049/jimmunol.177.6.3520; Wang H, 2004, J BIOL CHEM, V279, P40560, DOI 10.1074/jbc.M404345200; Wunderlich P, 2013, J BIOL CHEM, V288, P33027, DOI 10.1074/jbc.M113.517540; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; Zhang YW, 2007, P NATL ACAD SCI USA, V104, P10613, DOI 10.1073/pnas.0703903104	45	83	84	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15866	15877		10.1074/jbc.M115.645986	http://dx.doi.org/10.1074/jbc.M115.645986			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25957402	Green Published, hybrid			2022-12-28	WOS:000356527400045
J	Gong, C; Liu, BD; Yao, YD; Qu, SH; Luo, W; Tan, WG; Liu, Q; Yao, HR; Zou, L; Su, FX; Song, EW				Gong, Chang; Liu, Bodu; Yao, Yandan; Qu, Shaohua; Luo, Wei; Tan, Weige; Liu, Qiang; Yao, Herui; Zou, Lee; Su, Fengxi; Song, Erwei			Potentiated DNA Damage Response in Circulating Breast Tumor Cells Confers Resistance to Chemotherapy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TRIPLE-NEGATIVE BREAST; CANCER-PATIENTS; SURVIVAL; REPAIR; COMBINATION; METASTASIS; MECHANISMS; EXPRESSION; INHIBITORS	Circulating tumor cells (CTCs) are seeds for cancer metastasis and are predictive of poor prognosis in breast cancer patients. Whether CTCs and primary tumor cells (PTCs) respond to chemotherapy differently is not known. Here, we show that CTCs of breast cancer are more resistant to chemotherapy than PTCs because of potentiated DNA repair. Surprisingly, the chemoresistance of CTCs was recapitulated in PTCs when they were detached from the extracellular matrix. Detachment of PTCs increased the levels of reactive oxygen species and partially activated the DNA damage checkpoint, converting PTCs to a CTC-like state. Inhibition of checkpoint kinases Chk1 and Chk2 in CTCs reduces the basal checkpoint response and sensitizes CTCs to DNA damage in vitro and in mouse xenografts. Our results suggest that DNA damage checkpoint inhibitors may benefit the chemotherapy of breast cancer patients by sup-pressing the chemoresistance of CTCs and reducing the risk of cancer metastasis.	[Gong, Chang; Liu, Bodu; Yao, Yandan; Qu, Shaohua; Luo, Wei; Tan, Weige; Liu, Qiang; Song, Erwei] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou 510120, Guangdong, Peoples R China; [Gong, Chang; Liu, Bodu; Yao, Yandan; Qu, Shaohua; Luo, Wei; Tan, Weige; Liu, Qiang; Su, Fengxi; Song, Erwei] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Breast Tumor Ctr, Guangzhou 510120, Guangdong, Peoples R China; [Yao, Herui] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Med Oncol, Guangzhou 510120, Guangdong, Peoples R China; [Zou, Lee] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Harvard University; Massachusetts General Hospital	Su, FX (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Breast Tumor Ctr, 107 Yanjiang West Rd, Guangzhou 510120, Guangdong, Peoples R China.	fengxisu@vip.163.com; songerwei02@aliyun.com	Liu, Bodu/G-5222-2016; Liu, Qiang/HHZ-3181-2022; Liu, Bodu/AAR-9402-2021	Liu, Bodu/0000-0003-2097-725X; Liu, Bodu/0000-0003-2097-725X; Liu, Qiang/0000-0002-5451-4862	Ministry of Science and Technology of China [2011CB504203]; Natural Science Foundation of China [81172524, 81230060, 81261140373, 81272893, 81102023, 81372819, 81372817, 81272894, 81272897, 81472466, 81490751, 81442009]; Specialized Research Fund for the Doctoral Program of Higher Education Grant [20120171110075]; Program for New Century Excellent Talents in University [NCET-12-0565]; National Science Foundation of Guangdong Province [2011A080300002, 2014A03036003, S2012030006287, 2014A030310378]; Guangdong Department of Science and Technology Translational Medicine Center [2011A080300002]; Guangzhou Science and Technology Bureau [2012J2200092, 2014J4100170]; Sun Yat-sen University Training Project [12ykpy32, 13ykzd14]; Special Project on New Drug Innovation of Sun Yat-sen University; Elite Young Scholars Program of Sun Yat-sen Memorial Hospital [Y201401]; Yat-Sen Scholarship for Young Scientist and Translational Medicine Public Platform of Guangdong Province [4202037]; Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes [KLB09001]; Sun Yat-Sen University; Key Laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology [(2013)163]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education Grant; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Guangdong Department of Science and Technology Translational Medicine Center; Guangzhou Science and Technology Bureau; Sun Yat-sen University Training Project; Special Project on New Drug Innovation of Sun Yat-sen University; Elite Young Scholars Program of Sun Yat-sen Memorial Hospital; Yat-Sen Scholarship for Young Scientist and Translational Medicine Public Platform of Guangdong Province; Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes; Sun Yat-Sen University; Key Laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology	This work was supported by 973 Grant 2011CB504203 from Projects from Ministry of Science and Technology of China; Natural Science Foundation of China Grants 81172524, 81230060, 81261140373, 81272893, 81102023, 81372819, 81372817, 81272894, 81272897, 81472466, 81490751, and 81442009; Specialized Research Fund for the Doctoral Program of Higher Education Grant 20120171110075; Program for New Century Excellent Talents in University Grant NCET-12-0565; National Science Foundation of Guangdong Province Grants 2011A080300002, 2014A03036003, S2012030006287, and 2014A030310378; Guangdong Department of Science and Technology Translational Medicine Center Grant 2011A080300002; Guangzhou Science and Technology Bureau Grants 2012J2200092 and 2014J4100170; Sun Yat-sen University Training Project Grants 12ykpy32 and 13ykzd14; Special Project on New Drug Innovation of Sun Yat-sen University; Elite Young Scholars Program of Sun Yat-sen Memorial Hospital Grant Y201401; Yat-Sen Scholarship for Young Scientist and Translational Medicine Public Platform of Guangdong Province Grant 4202037; Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes Grant KLB09001; Sun Yat-Sen University; and Key Laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology Grant (2013)163.	Al-Ejeh F, 2010, ONCOGENE, V29, P6085, DOI 10.1038/onc.2010.407; Alagoz M, 2012, CURR MED CHEM, V19, P3874, DOI 10.2174/092986712802002590; Alix-Panabieres C, 2008, CLIN CANCER RES, V14, P5013, DOI 10.1158/1078-0432.CCR-07-5125; Ashwell S, 2008, EXPERT OPIN INV DRUG, V17, P1331, DOI [10.1517/13543784.17.9.1331, 10.1517/13543784.17.9.1331 ]; Avivar-Valderas A, 2011, MOL CELL BIOL, V31, P3616, DOI 10.1128/MCB.05164-11; Barbazan J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040476; Bi HS, 2013, BBA-GEN SUBJECTS, V1830, P4899, DOI 10.1016/j.bbagen.2013.06.026; Boldin MP, 2012, IMMUNOL REV, V246, P205, DOI 10.1111/j.1600-065X.2011.01089.x; Bryant C, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-570; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Dai Y, 2010, CLIN CANCER RES, V16, P376, DOI 10.1158/1078-0432.CCR-09-1029; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; De Giorgi U, 2009, J CLIN ONCOL, V27, P3303, DOI 10.1200/JCO.2008.19.4423; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Gingery A, 2003, J CELL BIOCHEM, V89, P165, DOI 10.1002/jcb.10503; Hayashi N, 2012, INT J CLIN ONCOL, V17, P96, DOI 10.1007/s10147-011-0260-0; Helleday T, 2010, CARCINOGENESIS, V31, P955, DOI 10.1093/carcin/bgq064; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Hong JP, 2013, ANN PLAS SURG, V71, P380, DOI 10.1097/SAP.0b013e3182503ac5; Howard EW, 2008, CLIN EXP METASTAS, V25, P497, DOI 10.1007/s10585-008-9157-3; Iwatsuki M, 2013, BRIT J CANCER, V109, P2829, DOI 10.1038/bjc.2013.680; Kasimir-Bauer S, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3099; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Krebs MG, 2011, J CLIN ONCOL, V29, P1556, DOI 10.1200/JCO.2010.28.7045; Ksiazkiewicz M, 2012, PATHOBIOLOGY, V79, P195, DOI 10.1159/000337106; Ma CX, 2013, BREAST CANCER RES TR, V137, P483, DOI 10.1007/s10549-012-2378-9; Maheswaran S, 2010, CURR OPIN GENET DEV, V20, P96, DOI 10.1016/j.gde.2009.12.002; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Negin BP, 2010, CURR TREAT OPTION ON, V11, P1, DOI 10.1007/s11864-010-0115-3; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Ozkumur E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005616; Park YY, 2012, CARCINOGENESIS, V33, P1843, DOI 10.1093/carcin/bgs167; Pilati P, 2012, ANN SURG ONCOL, V19, P402, DOI 10.1245/s10434-011-2132-2; Poehlmann A, 2010, PATHOL RES PRACT, V206, P591, DOI 10.1016/j.prp.2010.06.006; Rack B, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju066; Rai P, 2010, MUTAT RES-GEN TOX EN, V703, P71, DOI 10.1016/j.mrgentox.2010.07.010; Ravid A, 1999, CANCER RES, V59, P862; Rossi E, 2012, BRIT J CANCER, V107, P1286, DOI 10.1038/bjc.2012.388; Sausville E, 2014, CANCER CHEMOTH PHARM, V73, P539, DOI 10.1007/s00280-014-2380-5; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Sherman MH, 2011, TRENDS CELL BIOL, V21, P312, DOI 10.1016/j.tcb.2011.01.004; Tobin LA, 2012, MOL CANCER RES, V10, P96, DOI 10.1158/1541-7786.MCR-11-0255; Wan Y, 2010, CELL CYCLE, V9, P3391, DOI 10.4161/cc.9.17.13122; Wang MW, 2013, APOPTOSIS, V18, P238, DOI 10.1007/s10495-012-0788-0; Xu Y, 2011, CELL CYCLE, V10, P261, DOI 10.4161/cc.10.2.14543; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yu M, 2014, SCIENCE, V345, P216, DOI 10.1126/science.1253533; Zhong XL, 2012, CELL SIGNAL, V24, P393, DOI 10.1016/j.cellsig.2011.10.005	48	28	29	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					14811	14825		10.1074/jbc.M115.652628	http://dx.doi.org/10.1074/jbc.M115.652628			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25897074	Green Published, hybrid			2022-12-28	WOS:000356177300002
J	Aslanoglou, D; Alvarez-Curto, E; Marsango, S; Milligan, G				Aslanoglou, Despoina; Alvarez-Curto, Elisa; Marsango, Sara; Milligan, Graeme			Distinct Agonist Regulation of Muscarinic Acetylcholine M-2-M-3 Heteromers and Their Corresponding Homomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; FLUORESCENCE CORRELATION SPECTROSCOPY; SNAP-TAG TECHNOLOGY; CRYSTAL-STRUCTURE; DIMER; DIMERIZATION; COMPLEXES; SEROTONIN; DYNAMICS; MONOMERS	Each subtype of the muscarinic receptor family of G protein-coupled receptors is activated by similar concentrations of the neurotransmitter acetylcholine or closely related synthetic analogs such as carbachol. However, pharmacological selectivity can be generated by the introduction of a pair of mutations to produce Receptor Activated Solely by Synthetic Ligand (RASSL) forms of muscarinic receptors. These display loss of potency for acetylcholine/carbachol alongside a concurrent gain in potency for the ligand clozapine N-oxide. Co-expression of a form of wild type human M-2 and a RASSL variant of the human M-3 receptor resulted in concurrent detection of each of M-2-M-2 and M-3-M-3 homomers alongside M-2-M-3 heteromers at the surface of stably transfected Flp-In (TM) T-REx (TM) 293 cells. In this setting occupancy of the receptors with a muscarinic antagonist was without detectable effect on any of the muscarinic oligomers. However, selective agonist occupancy of the M2 receptor resulted in enhanced M-2-M-2 homomer interactions but decreased M-2-M-3 heteromer interactions. By contrast, selective activation of the M-3 RASSL receptor did not significantly alter either M-3-M-3 homomer or M-2-M-3 heteromer interactions. Selectively targeting closely related receptor oligomers may provide novel therapeutic opportunities.	[Aslanoglou, Despoina; Alvarez-Curto, Elisa; Marsango, Sara; Milligan, Graeme] Univ Glasgow, Coll Med Vet & Life Sci, Mol Pharmacol Grp, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow	Milligan, G (corresponding author), Univ Glasgow, Wolfson Link Bldg 253, Glasgow G12 8QQ, Lanark, Scotland.	Graeme.Milligan@glasgow.ac.uk		Aslanoglou, Despoina/0000-0002-8444-1385	Medical Research Council (UK) [MR/L023806/1, G0900050]; Medical Research Council (UK); Medical Research Council [G0900050, 1097074, MR/L023806/1] Funding Source: researchfish; MRC [G0900050, MR/L023806/1] Funding Source: UKRI	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by The Medical Research Council (UK) Grants (MR/L023806/1 and G0900050).r Recipient of studentship support from the Medical Research Council (UK).	Alvarez-Curto E, 2011, MOL PHARMACOL, V80, P1033, DOI 10.1124/mol.111.074674; Alvarez-Curto E, 2010, J BIOL CHEM, V285, P23316, DOI 10.1074/jbc.M110.122184; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Borroto-Escuela DO, 2010, BBA-MOL CELL RES, V1803, P813, DOI 10.1016/j.bbamcr.2010.04.002; Calebiro D, 2013, P NATL ACAD SCI USA, V110, P743, DOI 10.1073/pnas.1205798110; Damian M, 2008, J BIOL CHEM, V283, P21084, DOI 10.1074/jbc.M710419200; Ferre S, 2014, PHARMACOL REV, V66, P413, DOI 10.1124/pr.113.008052; Gavalas A, 2013, MOL PHARMACOL, V84, P346, DOI 10.1124/mol.113.086868; Goin JC, 2006, J BIOL CHEM, V281, P5416, DOI 10.1074/jbc.M507476200; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Hamamura M, 2006, MOL CELL ENDOCRINOL, V247, P192, DOI 10.1016/j.mce.2006.01.004; Heinrich JN, 2009, EUR J PHARMACOL, V605, P53, DOI 10.1016/j.ejphar.2008.12.044; Hern JA, 2010, P NATL ACAD SCI USA, V107, P2693, DOI 10.1073/pnas.0907915107; Herrick-Davis K, 2013, MOL PHARMACOL, V84, P630, DOI 10.1124/mol.113.087072; Herrick-Davis K, 2012, J BIOL CHEM, V287, P23604, DOI 10.1074/jbc.M112.350249; Hu JX, 2012, FASEB J, V26, P604, DOI 10.1096/fj.11-191510; Huang JY, 2013, NAT STRUCT MOL BIOL, V20, P419, DOI 10.1038/nsmb.2504; Hussain AF, 2013, CURR PHARM DESIGN, V19, P5437, DOI 10.2174/1381612811319300014; Ilien B, 2009, J BIOL CHEM, V284, P19533, DOI 10.1074/jbc.M109.017145; Kasai RS, 2011, J CELL BIOL, V192, P463, DOI 10.1083/jcb.201009128; Kolberg K, 2013, CURR PHARM DESIGN, V19, P5406, DOI 10.2174/13816128113199990514; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; Kuszak AJ, 2009, J BIOL CHEM, V284, P26732, DOI 10.1074/jbc.M109.026922; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Marquer C, 2011, J BIOL CHEM, V286, P31661, DOI 10.1074/jbc.M111.261404; Marquer C, 2010, BIOL CELL, V102, P409, DOI 10.1042/BC20090171; McMillin SM, 2011, J BIOL CHEM, V286, P28584, DOI 10.1074/jbc.M111.259788; Milligan G, 2013, MOL PHARMACOL, V84, P158, DOI 10.1124/mol.113.084780; Nenasheva TA, 2013, J MOL CELL CARDIOL, V57, P129, DOI 10.1016/j.yjmcc.2013.01.009; Patowary S, 2013, BIOCHEM J, V452, P303, DOI 10.1042/BJ20121902; Pin JP, 2007, PHARMACOL REV, V59, P5, DOI 10.1124/pr.59.1.5; Pisterzi LF, 2010, J BIOL CHEM, V285, P16723, DOI 10.1074/jbc.M109.069443; Pou C, 2012, J BIOL CHEM, V287, P8864, DOI 10.1074/jbc.M111.326678; Redka DS, 2014, J BIOL CHEM, V289, P24347, DOI 10.1074/jbc.M114.559294; Sartania N, 2007, CELL SIGNAL, V19, P1928, DOI 10.1016/j.cellsig.2007.05.002; Struckmann N, 2003, MOL PHARMACOL, V64, P1444, DOI 10.1124/mol.64.6.1444; Urban DJ, 2015, ANNU REV PHARMACOL, V55, P399, DOI 10.1146/annurev-pharmtox-010814-124803; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Zhang KH, 2014, NATURE, V509, P115, DOI 10.1038/nature13083	39	8	8	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14785	14796		10.1074/jbc.M115.649079	http://dx.doi.org/10.1074/jbc.M115.649079			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25918156	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000355754600047
J	Lapkouski, M; Chuenchor, W; Kim, MS; Gellert, M; Yang, W				Lapkouski, Mikalai; Chuenchor, Watchalee; Kim, Min-Sung; Gellert, Martin; Yang, Wei			Assembly Pathway and Characterization of the RAG1/2-DNA Paired and Signal-end Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							V(D)J RECOMBINATION; SYNAPTIC COMPLEX; SOMATIC RECOMBINATION; ACTIVE-SITE; CHAIN GENES; RAG1; CLEAVAGE; DNA; PROTEINS; SYNAPSIS	Mammalian immune receptor diversity is established via a unique restricted set of site-specific DNA rearrangements in lymphoid cells, known as V(D)J recombination. The lymphoid-specific RAG1-RAG2 protein complex (RAG1/2) initiates this process by binding to two types of recombination signal sequences (RSS), 12RSS and 23RSS, and cleaving at the boundaries of RSS and V, D, or J gene segments, which are to be assembled into immunoglobulins and T-cell receptors. Here we dissect the ordered assembly of the RAG1/2 heterotetramer with 12RSS and 23RSS DNAs. We find that RAG1/2 binds only a single 12RSS or 23RSS and reserves the second DNA-binding site specifically for the complementary RSS, to form a paired complex that reflects the known 12/23 rule of V(D)J recombination. The assembled RAG1/2 paired complex is active in the presence of Mg2+, the physiologically relevant metal ion, in nicking and double-strand cleavage of both RSS DNAs to produce a signal-end complex. We report here the purification and initial crystallization of the RAG1/2 signal-end complex for atomic-resolution structure elucidation. Strict pairing of the 12RSS and 23RSS at the binding step, together with information from the crystal structure of RAG1/2, leads to a molecular explanation of the 12/23 rule.	[Lapkouski, Mikalai; Chuenchor, Watchalee; Kim, Min-Sung; Gellert, Martin; Yang, Wei] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Yang, W (corresponding author), NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	wei.yang@nih.gov	Yang, Wei/D-4926-2011	Yang, Wei/0000-0002-3591-2195; Chuenchor, Watchalee/0000-0002-4366-9914	NIDDK, National Institutes of Health [DK036147, DK036167]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK036167, Z01DK036147, ZIADK036167] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported, in whole or in part, by the intramural research program of the NIDDK, National Institutes of Health (DK036147 and DK036167).	Agrawal A, 1997, CELL, V89, P43, DOI 10.1016/S0092-8674(00)80181-6; Akamatsu Y, 1998, MOL CELL BIOL, V18, P4670, DOI 10.1128/MCB.18.8.4670; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Boboila C, 2012, ADV IMMUNOL, V116, P1, DOI 10.1016/B978-0-12-394300-2.00001-6; CUOMO CA, 1994, NUCLEIC ACIDS RES, V22, P1810, DOI 10.1093/nar/22.10.1810; Curry JD, 2005, NAT IMMUNOL, V6, P1272, DOI 10.1038/ni1270; Deriano L, 2013, ANNU REV GENET, V47, P433, DOI 10.1146/annurev-genet-110711-155540; Fugmann SD, 2000, MOL CELL, V5, P97, DOI 10.1016/S1097-2765(00)80406-2; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; Grundy GJ, 2009, MOL CELL, V35, P217, DOI 10.1016/j.molcel.2009.06.022; HESSE JE, 1989, GENE DEV, V3, P1053, DOI 10.1101/gad.3.7.1053; Hiom K, 1997, CELL, V88, P65, DOI 10.1016/S0092-8674(00)81859-0; Jones JM, 2002, EMBO J, V21, P4162, DOI 10.1093/emboj/cdf394; Jones JM, 2001, P NATL ACAD SCI USA, V98, P12926, DOI 10.1073/pnas.221471198; Kim DR, 1999, GENE DEV, V13, P3070, DOI 10.1101/gad.13.23.3070; Kim MS, 2015, NATURE, V518, P507, DOI 10.1038/nature14174; Kwon J, 2000, MOL CELL, V6, P1037, DOI 10.1016/S1097-2765(00)00102-7; Landree MA, 1999, GENE DEV, V13, P3059, DOI 10.1101/gad.13.23.3059; LEWIS SM, 1994, ADV IMMUNOL, V56, P27, DOI 10.1016/S0065-2776(08)60450-2; Li WH, 1997, MOL CELL BIOL, V17, P6932, DOI 10.1128/MCB.17.12.6932; MCBLANE JF, 1995, CELL, V83, P387, DOI 10.1016/0092-8674(95)90116-7; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; SADOFSKY MJ, 1994, NUCLEIC ACIDS RES, V22, P1805, DOI 10.1093/nar/22.10.1805; SADOFSKY MJ, 1993, NUCLEIC ACIDS RES, V21, P5644, DOI 10.1093/nar/21.24.5644; SAKANO H, 1979, NATURE, V280, P288, DOI 10.1038/280288a0; SAKANO H, 1980, NATURE, V286, P676, DOI 10.1038/286676a0; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; Shlyakhtenko LS, 2009, J BIOL CHEM, V284, P20956, DOI 10.1074/jbc.M109.028977; SILVER DP, 1993, P NATL ACAD SCI USA, V90, P6100, DOI 10.1073/pnas.90.13.6100; Swanson PC, 2004, IMMUNOL REV, V200, P90, DOI 10.1111/j.0105-2896.2004.00159.x; Swanson PC, 2002, MOL CELL BIOL, V22, P7790, DOI 10.1128/MCB.22.22.7790-7801.2002; vanGent DC, 1997, EMBO J, V16, P2665, DOI 10.1093/emboj/16.10.2665; VANGENT DC, 1995, CELL, V81, P925, DOI 10.1016/0092-8674(95)90012-8; Yin FF, 2009, NAT STRUCT MOL BIOL, V16, P499, DOI 10.1038/nsmb.1593	34	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14618	14625		10.1074/jbc.M115.641787	http://dx.doi.org/10.1074/jbc.M115.641787			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25903130	Green Published, hybrid			2022-12-28	WOS:000355754600032
J	Zhou, QJ; Lavorgna, A; Bowman, M; Hiscott, J; Harhaj, EW				Zhou, Qinjie; Lavorgna, Alfonso; Bowman, Melissa; Hiscott, John; Harhaj, Edward W.			Aryl Hydrocarbon Receptor Interacting Protein Targets IRF7 to Suppress Antiviral Signaling and the Induction of Type I Interferon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; RIG-I; REGULATORY FACTOR-7; NEGATIVE REGULATION; UBIQUITIN LIGASE; MEDIATED DEGRADATION; TRANSCRIPTION FACTOR; AH RECEPTOR; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; SUBCELLULAR-LOCALIZATION	The transcription factor IRF7 (interferon regulatory factor 7) is a key regulator of type I interferon and plays essential roles in restricting virus infection and spread. IRF7 activation is tightly regulated to prevent excessive inflammation and autoimmunity; however, how IRF7 is suppressed by negative regulators remains poorly understood. Here, we have identified AIP (aryl hydrocarbon receptor interacting protein) as a new binding partner of IRF7. The interaction between AIP and IRF7 is enhanced upon virus infection, and AIP potently inhibits IRF7-induced type I IFN (IFN alpha/beta) production. Overexpression of AIP blocks virus-induced activation of IFN, whereas knockdown of AIP by siRNA potentiates virally activated IFN production. Consistently, AIP-deficient murine embryonic fibroblasts are highly resistant to virus infection because of increased production of IFN alpha/beta. AIP inhibits IRF7 function by antagonizing the nuclear localization of IRF7. Together, our study identifies AIP as a novel inhibitor of IRF7 and a negative regulator of innate antiviral signaling.	[Zhou, Qinjie] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA; [Lavorgna, Alfonso; Bowman, Melissa; Harhaj, Edward W.] Johns Hopkins Sch Med, Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, 1650 Orleans St, Baltimore, MD 21287 USA; [Bowman, Melissa] Johns Hopkins Sch Med, Grad Program Cellular & Mol Med, Baltimore, MD 21205 USA; [Hiscott, John] Vaccine & Gene Therapy Inst Florida, Div Infect Dis, Port St Lucie, FL 34987 USA	University of Miami; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Vaccine & Gene Therapy Institute of Florida	Harhaj, EW (corresponding author), Johns Hopkins Sch Med, Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, 1650 Orleans St, Baltimore, MD 21287 USA.	eharhaj1@jhmi.edu	Zhou, Qinjie/B-3300-2018; Regan, Clinton/E-6250-2012	Zhou, Qinjie/0000-0002-1321-7490; 	National Institutes of Health [PO1CA128115, RO1CA135362]; NATIONAL CANCER INSTITUTE [R01CA135362, P01CA128115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1CA128115 and RO1CA135362 (to E. W. H.).	Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Balachandran S, 2004, CANCER CELL, V5, P51, DOI 10.1016/S1535-6108(03)00330-1; Basagoudanavar SH, 2011, J VIROL, V85, P2599, DOI 10.1128/JVI.02213-10; Bonjardim CA, 2009, IMMUNOL LETT, V122, P1, DOI 10.1016/j.imlet.2008.11.002; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Burleson GR, 1996, FUND APPL TOXICOL, V29, P40, DOI 10.1006/faat.1996.0004; Carver LA, 1997, J BIOL CHEM, V272, P11452; Carver LA, 1998, J BIOL CHEM, V273, P33580, DOI 10.1074/jbc.273.50.33580; Chahal HS, 2010, TRENDS ENDOCRIN MET, V21, P419, DOI 10.1016/j.tem.2010.02.007; Chang TH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000493; Charoenthongtrakul S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053717; Charoenthongtrakul S, 2011, J VIROL, V85, P6955, DOI 10.1128/JVI.00007-11; Cui J, 2012, NAT IMMUNOL, V13, P387, DOI 10.1038/ni.2239; Fan YH, 2014, J EXP MED, V211, P313, DOI 10.1084/jem.20122844; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gao LL, 2011, J BIOL CHEM, V286, P36592, DOI 10.1074/jbc.M111.283762; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Hahn AM, 2005, J VIROL, V79, P10040, DOI 10.1128/JVI.79.15.10040-10052.2005; Higgs R, 2008, J IMMUNOL, V181, P1780, DOI 10.4049/jimmunol.181.3.1780; Hiscott J, 1999, J INTERF CYTOK RES, V19, P1, DOI 10.1089/107999099314360; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Hu Y, 2011, J IMMUNOL, V187, P6456, DOI 10.4049/jimmunol.1003691; Igreja S, 2010, HUM MUTAT, V31, P950, DOI 10.1002/humu.21292; Joo CH, 2007, J VIROL, V81, P8282, DOI 10.1128/JVI.00235-07; Kashuba E, 2000, ONCOGENE, V19, P1801, DOI 10.1038/sj.onc.1203501; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kazlauskas A, 2000, J BIOL CHEM, V275, P41317, DOI 10.1074/jbc.M007765200; Kuzhandaivelu N, 1996, NUCLEIC ACIDS RES, V24, P4741, DOI 10.1093/nar/24.23.4741; Lavorgna A, 2012, J VIROL, V86, P3357, DOI 10.1128/JVI.06456-11; Lawrence BP, 2006, J IMMUNOL, V177, P5819, DOI 10.4049/jimmunol.177.9.5819; Li ST, 2011, IMMUNITY, V35, P426, DOI 10.1016/j.immuni.2011.06.014; Lin BC, 2007, J BIOL CHEM, V282, P35924, DOI 10.1074/jbc.M705471200; Lin RT, 2000, J BIOL CHEM, V275, P34320, DOI 10.1074/jbc.M002814200; Lin RT, 2006, J BIOL CHEM, V281, P2095, DOI 10.1074/jbc.M510326200; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Litvak V, 2012, NATURE, V490, P421, DOI 10.1038/nature11428; Liu SQ, 2013, ELIFE, V2, DOI 10.7554/eLife.00785; Lu RQ, 2000, J BIOL CHEM, V275, P31805, DOI 10.1074/jbc.M005288200; Ma Q, 1997, J BIOL CHEM, V272, P8878; Marie I, 2000, MOL CELL BIOL, V20, P8803, DOI 10.1128/MCB.20.23.8803-8814.2000; Meyer BK, 1999, BIOCHEMISTRY-US, V38, P8907, DOI 10.1021/bi982223w; Mimura J, 1997, GENES CELLS, V2, P645, DOI 10.1046/j.1365-2443.1997.1490345.x; Morgan RML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053339; Nakhaei P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000650; Ning SB, 2008, MOL CELL BIOL, V28, P6536, DOI 10.1128/MCB.00785-08; Parvatiyar K, 2010, J BIOL CHEM, V285, P14999, DOI 10.1074/jbc.M110.109819; Petrulis JR, 2000, J BIOL CHEM, V275, P37448, DOI 10.1074/jbc.M006873200; Petrulis JR, 2003, J BIOL CHEM, V278, P2677, DOI 10.1074/jbc.M209331200; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Raitila A, 2010, AM J PATHOL, V177, P1969, DOI 10.2353/ajpath.2010.100138; Saitoh T, 2006, NAT IMMUNOL, V7, P598, DOI 10.1038/ni1347; Sathish N, 2011, J BIOL CHEM, V286, P746, DOI 10.1074/jbc.M110.150920; Schimmack G, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/s12964-014-0049-7; Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shembade N, 2008, NAT IMMUNOL, V9, P254, DOI 10.1038/ni1563; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Vierimaa O, 2006, SCIENCE, V312, P1228, DOI 10.1126/science.1126100; Wang J, 2013, J IMMUNOL, V191, P3393, DOI 10.4049/jimmunol.1300740; Wu L, 2009, J VIROL, V83, P1140, DOI 10.1128/JVI.00602-08; Yang HM, 2003, J BIOL CHEM, V278, P15495, DOI 10.1074/jbc.M212940200; You FP, 2009, NAT IMMUNOL, V10, P1300, DOI 10.1038/ni.1815; Yu YX, 2010, IMMUNITY, V33, P863, DOI 10.1016/j.immuni.2010.11.027; Yu YX, 2005, IMMUNITY, V22, P59, DOI 10.1016/j.immuni.2004.11.011; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465; Zhu FX, 2002, P NATL ACAD SCI USA, V99, P5573, DOI 10.1073/pnas.082420599	73	16	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14729	14739		10.1074/jbc.M114.633065	http://dx.doi.org/10.1074/jbc.M114.633065			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25911105	Green Published, hybrid			2022-12-28	WOS:000355754600042
J	Wang, YJ; Thorin, E; Luo, HY; Tremblay, J; Lavoie, JL; Wu, ZH; Peng, JZ; Qi, SJ; Wu, JP				Wang, Yujia; Thorin, Eric; Luo, Hongyu; Tremblay, Johanne; Lavoie, Julie L.; Wu, Zenghui; Peng, Junzheng; Qi, Shijie; Wu, Jiangping			EPHB4 Protein Expression in Vascular Smooth Muscle Cells Regulates Their Contractility, and EPHB4 Deletion Leads to Hypotension in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-PRESSURE; SIGNAL-TRANSDUCTION; TRANSGENIC MICE; EPHRINB LIGANDS; CROSS-LINKING; RECEPTORS; NEOVASCULARIZATION; PHOSPHORYLATION; COSTIMULATION; ANGIOGENESIS	EPH kinases are the largest family of receptor tyrosine kinases, and their ligands, ephrins (EFNs), are also cell surface molecules. This work presents evidence that EPHB4 on vascular smooth muscle cells (VSMCs) is involved in blood pressure regulation. We generated gene KO mice with smooth muscle cell-specific deletion of EPHB4. Male KO mice, but not female KO mice, were hypotensive. VSMCs from male KO mice showed reduced contractility when compared with their WT counterparts. Signaling both from EFNBs to EPHB4 (forward signaling) and from EPHB4 to EFNB2 (reverse signaling) modulated VSMC contractility. At the molecular level, the absence of EPHB4 in VSMCs resulted in compromised signaling from Ca2+/calmodulin-dependent protein kinase II (CaMKII) to myosin light chain kinase (MLCK) to myosin light chain, the last of which controls the contraction force of motor molecule myosin. Near the cell membrane, an adaptor protein GRIP1, which can associate with EFNB2, was found to be essential in mediating EPHB4-to-EFNB reverse signaling, which regulated VSMC contractility, based on siRNA gene knockdown studies. Our research indicates that EPHB4 plays an essential role in regulating small artery contractility and blood pressure.	[Wang, Yujia; Luo, Hongyu; Tremblay, Johanne; Lavoie, Julie L.; Wu, Zenghui; Peng, Junzheng; Qi, Shijie; Wu, Jiangping] Ctr Hosp Univ Montreal CRCHUM, Res Ctr, Montreal, PQ H2X 0A9, Canada; [Thorin, Eric] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Lavoie, Julie L.] Univ Montreal, Dept Kinesiol, Montreal, PQ H3T 1J4, Canada; [Wu, Jiangping] CHUM, Serv Nephrol, Montreal, PQ H2L 4M1, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Wu, JP (corresponding author), CRCHUM, 900 Rue St Denis,Rm R12-428, Montreal, PQ H2X 0A9, Canada.	jianping.wu@umontreal.ca	Cossette, Suzanne/I-8008-2016; Thorin, Eric/K-3978-2013; Lavoie, Julie/F-2288-2013	Thorin, Eric/0000-0001-5827-8935; Lavoie, Julie/0000-0001-6316-2769	Canadian Institutes of Health Research [MOP57697, MOP69089, MOP123389, MOP97829, MOP14496, ISO106797]; Heart and Stroke Foundation of Quebec; Natural Sciences and Engineering Research Council of Canada [203906-2012]; Juvenile Diabetes Research Foundation [17-2013-440]; J.-Louis Levesque Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Quebec; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); J.-Louis Levesque Foundation	This work was supported by Canadian Institutes of Health Research Grants MOP57697, MOP69089, and MOP123389 (to J. W.), MOP97829 (to H. L.), MOP14496, (to E. T.) and ISO106797 (to J. T.). This work was also funded by grants from the Heart and Stroke Foundation of Quebec, the Natural Sciences and Engineering Research Council of Canada (203906-2012), the Juvenile Diabetes Research Foundation (17-2013-440), and the J.-Louis Levesque Foundation (to J. W.).	Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Bruckner K, 1999, NEURON, V22, P511, DOI 10.1016/S0896-6273(00)80706-0; Cheng N, 2002, CYTOKINE GROWTH F R, V13, P75, DOI 10.1016/S1359-6101(01)00031-4; Dravis C, 2007, HEARING RES, V223, P93, DOI 10.1016/j.heares.2006.10.007; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Flanagan JG, 1997, CELL, V90, P403; Foo SS, 2006, CELL, V124, P161, DOI 10.1016/j.cell.2005.10.034; Gale NW, 2001, DEV BIOL, V230, P151, DOI 10.1006/dbio.2000.0112; Golovina VA, 2006, NAT PROTOC, V1, P2681, DOI 10.1038/nprot.2006.425; Hashimoto T, 2007, KIDNEY INT, V72, P954, DOI 10.1038/sj.ki.5002454; Konstantinova I, 2007, CELL, V129, P359, DOI 10.1016/j.cell.2007.02.044; Lavoie JL, 2004, AM J PHYSIOL-RENAL, V286, pF965, DOI 10.1152/ajprenal.00402.2003; Luo HY, 2012, J BIOL CHEM, V287, P6819, DOI 10.1074/jbc.M111.293365; Luo HY, 2011, J BIOL CHEM, V286, P44976, DOI 10.1074/jbc.M111.316414; Luo HY, 2011, J BIOL CHEM, V286, P41135, DOI 10.1074/jbc.M111.302596; Luo HY, 2001, J IMMUNOL, V167, P1362, DOI 10.4049/jimmunol.167.3.1362; Luo HY, 2002, J CLIN INVEST, V110, P1141, DOI 10.1172/JCI200215883; Luo HY, 2004, J CLIN INVEST, V114, P1762, DOI 10.1172/JCI200421846; Martiny-Baron G, 2010, ANGIOGENESIS, V13, P259, DOI 10.1007/s10456-010-9183-z; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pfitzer G, 2001, J APPL PHYSIOL, V91, P497, DOI 10.1152/jappl.2001.91.1.497; Rogatsky I, 2003, P NATL ACAD SCI USA, V100, P13845, DOI 10.1073/pnas.2336092100; Sallstrom J, 2013, AM J PHYSIOL-RENAL, V305, pF71, DOI 10.1152/ajprenal.00694.2012; Salvucci O, 2006, BLOOD, V108, P2914, DOI 10.1182/blood-2006-05-023341; Salvucci O, 2012, ADV CANCER RES, V114, P21, DOI 10.1016/B978-0-12-386503-8.00002-8; Shin D, 2001, DEV BIOL, V230, P139, DOI 10.1006/dbio.2000.9957; TANSEY MG, 1992, J BIOL CHEM, V267, P12511; Wnuk M, 2012, KIDNEY INT, V81, P1212, DOI 10.1038/ki.2012.17; Wu J., 2014, European Patent Office, application, Patent No. [EP14183830, 14183830]; Wu Jiangping, 2005, Curr Opin Hematol, V12, P292, DOI 10.1097/01.moh.0000166497.26397.9f; Wu ZH, 2012, J BIOL CHEM, V287, P15557, DOI 10.1074/jbc.M112.340869; Xin HB, 2002, PHYSIOL GENOMICS, V10, P211, DOI 10.1152/physiolgenomics.00054.2002; Yu G, 2006, J BIOL CHEM, V281, P10222, DOI 10.1074/jbc.M510320200; Yu G, 2003, J IMMUNOL, V171, P106, DOI 10.4049/jimmunol.171.1.106; Yu G, 2004, J BIOL CHEM, V279, P55531, DOI 10.1074/jbc.M410814200; Yu G, 2003, J BIOL CHEM, V278, P47209, DOI 10.1074/jbc.M306659200	36	25	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					14235	14244		10.1074/jbc.M114.621615	http://dx.doi.org/10.1074/jbc.M114.621615			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25903126	Green Published, hybrid			2022-12-28	WOS:000355313000050
J	Wessling-Resnick, M				Wessling-Resnick, Marianne			Nramp1 and Other Transporters Involved in Metal Withholding during Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							DIVALENT-CATION TRANSPORT; SLC11A1 FORMERLY NRAMP1; NATURAL-RESISTANCE; IRON TRANSPORT; MACROPHAGE PROTEIN-1; INTRACELLULAR INFECTIONS; MANGANESE TRANSPORTER; HYDROGEN-PEROXIDE; IN-VITRO; FERROPORTIN	During the course of infection, many natural defenses are set up along the boundaries of the host-pathogen interface. Key among these is the host response to withhold metals to restrict the growth of invading microbes. This simple act of nutritional warfare, starving the invader of an essential element, is an effective means of limiting infection. The physiology of metal withholding is often referred to as "nutritional immunity," and the mechanisms of metal transport that contribute to this host response are the focus of this review.	Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Wessling-Resnick, M (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA.	wessling@hsph.harvard.edu			National Institutes of Health [R01ES0146380, R01DK064570]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014638] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grants R01ES0146380 and R01DK064570 (to M.W.R.). This is the sixth article in the Thematic Minireview series "Metals at the Host-Pathogen Interface." The author declares that she has no conflicts of interest with the contents of this article.	Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Aguirre JD, 2013, J BIOL CHEM, V288, P8468, DOI 10.1074/jbc.M112.433540; Aguirre JD, 2012, J BIOL CHEM, V287, P13541, DOI 10.1074/jbc.R111.312181; Anjem A, 2009, MOL MICROBIOL, V72, P844, DOI 10.1111/j.1365-2958.2009.06699.x; Arredondo M, 2014, BIOMETALS, V27, P115, DOI 10.1007/s10534-013-9691-6; Atkinson PGP, 1999, IMMUNOLOGY, V96, P656; Barton CH, 1999, J LEUKOCYTE BIOL, V66, P757, DOI 10.1002/jlb.66.5.757; Barton JC, 2009, J CLIN GASTROENTEROL, V43, P890, DOI 10.1097/MCG.0b013e31819069c1; Ben-Othman R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003901; Biggs TE, 2001, EUR J IMMUNOL, V31, P2060, DOI 10.1002/1521-4141(200107)31:7<2060::AID-IMMU2060>3.0.CO;2-L; Blackwell JM, 2003, IMMUNOL LETT, V85, P197, DOI 10.1016/S0165-2478(02)00231-6; Blackwell JM, 2001, CELL MICROBIOL, V3, P773, DOI 10.1046/j.1462-5822.2001.00150.x; Brasse-Lagnel C, 2011, GASTROENTEROLOGY, V140, P1261, DOI 10.1053/j.gastro.2010.12.037; Cellier MFM, 2012, CURR TOP MEMBR, V69, P249, DOI 10.1016/B978-0-12-394390-3.00010-0; Champion OL, 2011, MICROBIOL-SGM, V157, P1115, DOI 10.1099/mic.0.045807-0; Chlosta S, 2006, INFECT IMMUN, V74, P3065, DOI 10.1128/IAI.74.5.3065-3067.2006; Chua ACG, 1997, J COMP PHYSIOL B, V167, P361, DOI 10.1007/s003600050085; Culotta VC, 2013, ANTIOXID REDOX SIGN, V19, P933, DOI 10.1089/ars.2012.5093; Denic S, 2007, NUTRITION, V23, P603, DOI 10.1016/j.nut.2007.05.002; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Fleming MD, 1997, NAT GENET, V16, P383, DOI 10.1038/ng0897-383; Fleming MD, 1998, P NATL ACAD SCI USA, V95, P1148, DOI 10.1073/pnas.95.3.1148; Forbes JR, 2003, BLOOD, V102, P1884, DOI 10.1182/blood-2003-02-0425; Forbes JR, 2001, TRENDS MICROBIOL, V9, P397, DOI 10.1016/S0966-842X(01)02098-4; Friis T, 2003, JAIDS-J ACQ IMM DEF, V33, P74, DOI 10.1097/00126334-200305010-00011; Fritsche G, 2007, IMMUNOBIOLOGY, V212, P751, DOI 10.1016/j.imbio.2007.09.014; Galan SR, 2011, Z GASTROENTEROL, V49, P832, DOI 10.1055/s-0029-1245969; Gangaidzo IT, 2001, J INFECT DIS, V184, P936, DOI 10.1086/323203; Gao J, 2008, J BIOL CHEM, V283, P21462, DOI 10.1074/jbc.M803150200; Garrick MD, 2006, BIOL RES, V39, P79, DOI 10.4067/S0716-97602006000100009; GARRICK MD, 1993, J BIOL CHEM, V268, P14867; Gerhard GS, 2001, ARCH PATHOL LAB MED, V125, P1107; Gomez MA, 2007, J BIOL CHEM, V282, P36190, DOI 10.1074/jbc.M703140200; Gordeuk VR, 2006, HAEMATOLOGICA, V91, P739; Goswami T, 2001, BIOCHEM J, V354, P511, DOI 10.1042/0264-6021:3540511; Govoni G, 1997, J LEUKOCYTE BIOL, V62, P277, DOI 10.1002/jlb.62.2.277; Gruenheid S, 1999, J EXP MED, V189, P831, DOI 10.1084/jem.189.5.831; Gruenheid S, 1997, J EXP MED, V185, P717, DOI 10.1084/jem.185.4.717; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Hedges JF, 2013, J IMMUNOL, V190, P4263, DOI 10.4049/jimmunol.1200732; HOLLAND R, 1975, J BACTERIOL, V121, P777, DOI 10.1128/JB.121.3.777-784.1975; Hopfner M, 2001, SCAND J GASTROENTERO, V36, P220, DOI 10.1080/003655201750066004; Illing AC, 2012, J BIOL CHEM, V287, P30485, DOI 10.1074/jbc.M112.364208; Jabado N, 2000, J EXP MED, V192, P1237, DOI 10.1084/jem.192.9.1237; Jenkitkasemwong S, 2012, BIOMETALS, V25, P643, DOI 10.1007/s10534-012-9526-x; Jiang LL, 2013, J NUTR, V143, P1927, DOI 10.3945/jn.113.181867; Johnson EE, 2007, NUTR REV, V65, P341, DOI [10.1301/nr.2007.jul.341-345, 10.1111/j.1753-4887.2007.tb00312.x]; Johnson EE, 2012, MICROBES INFECT, V14, P207, DOI 10.1016/j.micinf.2011.10.001; Johnson EE, 2010, INFECT IMMUN, V78, P5099, DOI 10.1128/IAI.00498-10; Kehl-Fie TE, 2010, CURR OPIN CHEM BIOL, V14, P218, DOI 10.1016/j.cbpa.2009.11.008; Kim J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064944; Kuhn DE, 1999, J LEUKOCYTE BIOL, V66, P113, DOI 10.1002/jlb.66.1.113; Lisher JP, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00091; Liuzzi JP, 2006, P NATL ACAD SCI USA, V103, P13612, DOI 10.1073/pnas.0606424103; Lounis N, 2001, J CLIN VIROL, V20, P123, DOI 10.1016/S1386-6532(00)00136-0; Madejczyk MS, 2012, BBA-BIOMEMBRANES, V1818, P651, DOI 10.1016/j.bbamem.2011.12.002; McDermid JM, 2007, JAIDS-J ACQ IMM DEF, V46, P498, DOI 10.1097/QAI.0b013e31815b2d4b; McDermid JM, 2006, CLIN SCI, V110, P503, DOI 10.1042/CS20050273; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; Min KS, 2013, TOXICOL LETT, V218, P91, DOI 10.1016/j.toxlet.2013.01.010; Moalem S, 2004, BIOMETALS, V17, P135, DOI 10.1023/B:BIOM.0000018375.20026.b3; Moyo V. M., 1997, Central African Journal of Medicine, V43, P334; Nairz M, 2008, EUR J IMMUNOL, V38, P1923, DOI 10.1002/eji.200738056; Nairz M, 2007, CELL MICROBIOL, V9, P2126, DOI 10.1111/j.1462-5822.2007.00942.x; ONWUBALILI JK, 1983, J INFECTION, V7, P2, DOI 10.1016/S0163-4453(83)90863-0; Paradkar PN, 2008, BLOOD, V112, P866, DOI 10.1182/blood-2007-12-126854; Picard V, 2000, J BIOL CHEM, V275, P35738, DOI 10.1074/jbc.M005387200; Pietrangelo A, 2004, BLOOD CELL MOL DIS, V32, P131, DOI 10.1016/j.bcmd.2003.08.003; Pinilla-Tenas JJ, 2011, AM J PHYSIOL-CELL PH, V301, pC862, DOI 10.1152/ajpcell.00479.2010; Posey JE, 2000, SCIENCE, V288, P1651, DOI 10.1126/science.288.5471.1651; Quadri M, 2012, AM J HUM GENET, V90, P467, DOI 10.1016/j.ajhg.2012.01.017; Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2; Searle S, 1998, J CELL SCI, V111, P2855; Sobota JM, 2011, P NATL ACAD SCI USA, V108, P5402, DOI 10.1073/pnas.1100410108; Soe-Lin S, 2009, P NATL ACAD SCI USA, V106, P5960, DOI 10.1073/pnas.0900808106; Soofi S, 2013, LANCET, V382, P29, DOI 10.1016/S0140-6736(13)60437-7; STETTER KO, 1973, FEBS LETT, V36, P5, DOI 10.1016/0014-5793(73)80324-2; Su MA, 1998, BLOOD, V92, P2157, DOI 10.1182/blood.V92.6.2157.418k16_2157_2163; Tabuchi M, 2000, J BIOL CHEM, V275, P22220, DOI 10.1074/jbc.M001478200; Taylor KM, 2005, FEBS LETT, V579, P427, DOI 10.1016/j.febslet.2004.12.006; Techau ME, 2007, J BIOL CHEM, V282, P35646, DOI 10.1074/jbc.M707057200; Thompson K, 2007, FASEB J, V21, P223, DOI 10.1096/fj.06-6710com; Troxell B, 2013, INFECT IMMUN, V81, P2743, DOI 10.1128/IAI.00507-13; Tuschl K, 2012, AM J HUM GENET, V90, P457, DOI 10.1016/j.ajhg.2012.01.018; Valdez Y, 2009, CELL MICROBIOL, V11, P351, DOI 10.1111/j.1462-5822.2008.01258.x; Van Zandt KE, 2008, J LEUKOCYTE BIOL, V84, P689, DOI 10.1189/jlb.1107781; Vidal SM, 1996, J IMMUNOL, V157, P3559; VIDAL SM, 1993, CELL, V73, P469, DOI 10.1016/0092-8674(93)90135-D; Wanachiwanawin W, 2000, J PEDIAT HEMATOL ONC, V22, P581, DOI 10.1097/00043426-200011000-00027; Wang LJ, 2008, J IMMUNOL, V181, P2723, DOI 10.4049/jimmunol.181.4.2723; Weinberg ED, 2010, METALLOMICS, V2, P732, DOI 10.1039/c0mt00023j; Wessling-Resnick M, 2010, ANNU REV NUTR, V30, P105, DOI 10.1146/annurev.nutr.012809.104804; Wyllie S, 2002, MICROBES INFECT, V4, P351, DOI 10.1016/S1286-4579(02)01548-4; Xu M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-104; Yin ZB, 2010, J NEUROCHEM, V112, P1190, DOI 10.1111/j.1471-4159.2009.06534.x; Zaharik ML, 2004, INFECT IMMUN, V72, P5522, DOI 10.1128/IAI.72.9.5522-5525.2004; Zaharik ML, 2004, FRONT BIOSCI-LANDMRK, V9, P1035, DOI 10.2741/1317; Zhao NN, 2010, J BIOL CHEM, V285, P32141, DOI 10.1074/jbc.M110.143248; Zohn IE, 2007, BLOOD, V109, P4174, DOI 10.1182/blood-2007-01-066068; Zwilling BS, 1999, INFECT IMMUN, V67, P1386, DOI 10.1128/IAI.67.3.1386-1392.1999	100	78	79	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					18984	18990		10.1074/jbc.R115.643973	http://dx.doi.org/10.1074/jbc.R115.643973			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26055722	hybrid, Green Published			2022-12-28	WOS:000358781100013
J	Subramanian, D; Bunjobpol, W; Sabapathy, K				Subramanian, Deepa; Bunjobpol, Wilawan; Sabapathy, Kanaga			Interplay between TAp73 Protein and Selected Activator Protein-1 (AP-1) Family Members Promotes AP-1 Target Gene Activation and Cellular Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-JUN; TRANSCRIPTIONAL ACTIVATION; TUMOR-SUPPRESSOR; DNA-DAMAGE; MATRIX METALLOPROTEINASE-1; P53-RELATED PROTEIN; MOUSE DEVELOPMENT; P73; P53; EXPRESSION	Unlike p53, which is mutated at a high rate in human cancers, its homologue p73 is not mutated but is often overexpressed, suggesting a possible context-dependent role in growth promotion. Previously, we have shown that co-expression of TAp73 with the proto-oncogene c-Jun can augment cellular growth and potentiate transactivation of activator protein (AP)-1 target genes such as cyclin D1. Here, we provide further mechanistic insights into the cooperative activity between these two transcription factors. Our data show that TAp73-mediated AP-1 target gene transactivation relies on c-Jun dimerization and requires the canonical AP-1 sites on target gene promoters. Interestingly, only selected members of the Fos family of proteins such as c-Fos and Fra1 were found to cooperate with TAp73 in a c-Jun-dependent manner to transactivate AP-1 target promoters. Inducible expression of TAp73 led to the recruitment of these Fos family members to the AP-1 target promoters on which TAp73 was found to be bound near the AP-1 site. Consistent with the binding of TAp73 and AP-1 members on the target promoters in a c-Jun-dependent manner, TAp73 was observed to physically interact with c-Jun specifically at the chromatin via its carboxyl-terminal region. Furthermore, co-expression of c-Fos or Fra1 was able to cooperate with TAp73 in potentiating cellular growth, similarly to c-Jun. These data together suggest that TAp73 plays a vital role in activation of AP-1 target genes via direct binding to c-Jun at the target promoters, leading to enhanced loading of other AP-1 family members, thereby leading to cellular growth.	[Subramanian, Deepa; Bunjobpol, Wilawan; Sabapathy, Kanaga] Natl Canc Ctr, Humphrey Oei Inst Canc Res, Div Cellular & Mol Res, Singapore 169610, Singapore; [Sabapathy, Kanaga] Duke NUS Grad Med Sch, Canc & Stem Cell Biol Program, Singapore 169857, Singapore; [Sabapathy, Kanaga] Natl Univ Singapore, Dept Biochem, Singapore 117597, Singapore	National Cancer Centre Singapore (NCCS); National University of Singapore; National University of Singapore	Sabapathy, K (corresponding author), Natl Canc Ctr, Humphrey Oei Inst Canc Res, Div Cellular & Mol Res, Mol Carcinogenesis Lab, 11 Hosp Dr, Singapore 169610, Singapore.	cmrksb@nccs.com.sg			National Medical Research Council	National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the National Medical Research Council (to K. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Bakiri L, 2002, MOL CELL BIOL, V22, P4952, DOI 10.1128/MCB.22.13.4952-4964.2002; Brown PH, 1996, CELL GROWTH DIFFER, V7, P1013; Bunjobpo W, 2014, CELL DEATH DIFFER, V21, P1240, DOI 10.1038/cdd.2014.41; Chen XB, 2001, ONCOGENE, V20, P769, DOI 10.1038/sj.onc.1204149; Conforti F, 2012, AGING-US, V4, P202, DOI 10.18632/aging.100441; Dotsch V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004887; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Du WJ, 2013, NAT CELL BIOL, V15, P991, DOI 10.1038/ncb2789; Dulloo I, 2005, J BIOL CHEM, V280, P28203, DOI 10.1074/jbc.M501702200; ESTUS S, 1994, J CELL BIOL, V127, P1717, DOI 10.1083/jcb.127.6.1717; Gong JG, 1999, NATURE, V399, P806; GRIGORIADIS AE, 1993, J CELL BIOL, V122, P685, DOI 10.1083/jcb.122.3.685; Hasenfuss SC, 2014, CELL METAB, V19, P84, DOI 10.1016/j.cmet.2013.11.018; HERBER B, 1994, ONCOGENE, V9, P1295; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Ishimoto O, 2002, CANCER RES, V62, P636; Ji ZL, 2012, MOL CELL BIOL, V32, P385, DOI 10.1128/MCB.05504-11; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Koeppel M, 2011, NUCLEIC ACIDS RES, V39, P6069, DOI 10.1093/nar/gkr028; Lee CW, 1999, ONCOGENE, V18, P4171, DOI 10.1038/sj.onc.1202793; Lefkimmiatis K, 2009, CANCER RES, V69, P8563, DOI 10.1158/0008-5472.CAN-09-0259; Levrero M, 2000, J CELL SCI, V113, P1661; Lin KW, 2004, NEOPLASIA, V6, P546, DOI 10.1593/neo.04205; Melino G, 2002, NAT REV CANCER, V2, P605, DOI 10.1038/nrc861; Moll UM, 2004, MOL CANCER RES, V2, P371; Novak U, 2001, ANN ONCOL, V12, P981, DOI 10.1023/A:1011153206003; Passegue E, 2000, EMBO J, V19, P2969, DOI 10.1093/emboj/19.12.2969; Passegue E, 2002, NAT GENET, V30, P158, DOI 10.1038/ng790; SAEZ E, 1995, CELL, V82, P721, DOI 10.1016/0092-8674(95)90469-7; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Shaulian E, 2000, CELL, V103, P897, DOI 10.1016/S0092-8674(00)00193-8; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shikama N, 1997, TRENDS CELL BIOL, V7, P230, DOI 10.1016/S0962-8924(97)01048-9; Shiozawa T, 2004, ONCOGENE, V23, P8603, DOI 10.1038/sj.onc.1207849; Sprowles A, 2003, ONCOGENE, V22, P498, DOI 10.1038/sj.onc.1206165; Stiewe T, 2002, CELL DEATH DIFFER, V9, P237, DOI 10.1038/sj.cdd.4400995; Sun YB, 2002, J BIOL CHEM, V277, P1544, DOI 10.1074/jbc.M100567200; Talotta F, 2010, ONCOGENE, V29, P4732, DOI 10.1038/onc.2010.211; Toh WH, 2008, NUCLEIC ACIDS RES, V36, P4498, DOI 10.1093/nar/gkn414; Toh WH, 2005, J BIOL CHEM, V280, P17329, DOI 10.1074/jbc.M500044200; Toh WH, 2004, J BIOL CHEM, V279, P44713, DOI 10.1074/jbc.M407672200; Tomasini R, 2008, GENE DEV, V22, P2677, DOI 10.1101/gad.1695308; Verde P, 2007, CELL CYCLE, V6, P2633, DOI 10.4161/cc.6.21.4850; Vikhanskaya F, 2007, NAT CELL BIOL, V9, P698, DOI 10.1038/ncb1598; White LA, 1995, MATRIX BIOL, V14, P715, DOI 10.1016/S0945-053X(05)80014-9; Wilhelm MT, 2010, GENE DEV, V24, P549, DOI 10.1101/gad.1873910; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Zaika A, 2001, J BIOL CHEM, V276, P11310, DOI 10.1074/jbc.M005737200; Zaika AI, 2002, J EXP MED, V196, P765, DOI 10.1084/jem.20020179; Zeng XY, 2000, MOL CELL BIOL, V20, P1299, DOI 10.1128/MCB.20.4.1299-1310.2000; Zhu JH, 1998, CANCER RES, V58, P5061; Zwahlen D, 2000, INT J CANCER, V88, P66	55	21	22	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18636	18649		10.1074/jbc.M115.636548	http://dx.doi.org/10.1074/jbc.M115.636548			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26018080	Green Published, hybrid			2022-12-28	WOS:000358512100033
J	Ishibashi, Y; Hirabayashi, Y				Ishibashi, Yohei; Hirabayashi, Yoshio			AMP-activated Protein Kinase Suppresses Biosynthesis of Glucosylceramide by Reducing Intracellular Sugar Nucleotides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENZYME REPLACEMENT THERAPY; POLYCYSTIC KIDNEY-DISEASE; GLYCOSPHINGOLIPID SYNTHESIS; CERAMIDE GLYCOSYLATION; GAUCHER-DISEASE; INSULIN SENSITIVITY; DRUG-RESISTANCE; CELL-GROWTH; IN-VIVO; SYNTHASE	The membrane glycolipid glucosylceramide (GlcCer) plays a critical role in cellular homeostasis. Its intracellular levels are thought to be tightly regulated. How cells regulate GlcCer levels remains to be clarified. AMP-activated protein kinase (AMPK), which is a crucial cellular energy sensor, regulates glucose and lipid metabolism to maintain energy homeostasis. Here, we investigated whether AMPK affects GlcCer metabolism. AMPK activators (5-aminoimidazole-4-carboxamide 1-beta-D-ribofuranoside and metformin) decreased intracellular GlcCer levels and synthase activity in mouse fibroblasts. AMPK inhibitors or AMPK siRNA reversed these effects, suggesting that GlcCer synthesis is negatively regulated by an AMPK-dependent mechanism. Although AMPK did not affect the phosphorylation or expression of GlcCer synthase, the amount of UDP-glucose, an activated form of glucose required for GlcCer synthesis, decreased under AMPK-activating conditions. Importantly, the UDP-glucose pyrophosphatase Nudt14, which degrades UDP-glucose, generating UMP and glucose 1-phosphate, was phosphorylated and activated by AMPK. On the other hand, suppression of Nudt14 by siRNA had little effect on UDP-glucose levels, indicating that mammalian cells have an alternative UDPglucose pyrophosphatase that mainly contributes to the reduction of UDP-glucose under AMPK-activating conditions. Because AMPK activators are capable of reducing GlcCer levels in cells from Gaucher disease patients, our findings suggest that reducing GlcCer through AMPK activation may lead to a new strategy for treating diseases caused by abnormal accumulation of GlcCer.	[Ishibashi, Yohei; Hirabayashi, Yoshio] RIKEN Brain Sci Inst, Lab Mol Membrane Neurosci, Wako, Saitama 3510198, Japan	RIKEN	Hirabayashi, Y (corresponding author), RIKEN Brain Sci Inst, Lab Mol Membrane Neurosci, Wako, Saitama 3510198, Japan.	hirabaya@riken.jp		Hirabayashi, Yoshio/0000-0002-5774-7354	RIKEN Brain Science Institute; Ministry of Education, Culture, Sports, Science, and Technology of Japan	RIKEN Brain Science Institute; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants from the RIKEN Brain Science Institute (to Y. H.) and RIKEN Special Postdoctoral Researchers Program (to Y. I.), a Grant-in-Aid for Young Scientists (B) (to Y. I.), the Research Activity Start-up (to Y. I.), and "Deciphering sugar chain-based signals regulating integrative neuronal functions" (to Y. H.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Aerts JM, 2007, DIABETES, V56, P1341, DOI 10.2337/db06-1619; Banko MR, 2011, MOL CELL, V44, P878, DOI 10.1016/j.molcel.2011.11.005; Boot RG, 2007, J BIOL CHEM, V282, P1305, DOI 10.1074/jbc.M610544200; Cox TM, 2015, LANCET, V385, P2355, DOI 10.1016/S0140-6736(14)61841-9; Desnick RJ, 2012, ANNU REV GENOM HUM G, V13, P307, DOI 10.1146/annurev-genom-090711-163739; Duggleby RG, 1996, EUR J BIOCHEM, V235, P173, DOI 10.1111/j.1432-1033.1996.00173.x; Eguchi S, 2009, GENES CELLS, V14, P179, DOI 10.1111/j.1365-2443.2008.01260.x; Fuller M, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-113; Grabowski GA, 2008, LANCET, V372, P1263, DOI 10.1016/S0140-6736(08)61522-6; Gupta V, 2012, J BIOL CHEM, V287, P37195, DOI 10.1074/jbc.M112.396390; Gupta V, 2010, J LIPID RES, V51, P866, DOI 10.1194/jlr.D002949; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hanada K, 2005, JPN J INFECT DIS, V58, P131; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Heyen CA, 2009, BIOCHEM BIOPH RES CO, V390, P1414, DOI 10.1016/j.bbrc.2009.11.007; Ichikawa S, 1996, P NATL ACAD SCI USA, V93, P4638, DOI 10.1073/pnas.93.10.4638; Ishibashi Y, 2013, BBA-MOL CELL BIOL L, V1831, P1475, DOI 10.1016/j.bbalip.2013.06.001; Ito M, 2014, BBA-MOL CELL BIOL L, V1841, P682, DOI 10.1016/j.bbalip.2013.09.008; Jennemann R, 2013, PROG LIPID RES, V52, P231, DOI 10.1016/j.plipres.2013.02.001; Korschen HG, 2013, J BIOL CHEM, V288, P3381, DOI 10.1074/jbc.M112.414714; Kohyama-Koganeya A, 2004, J BIOL CHEM, V279, P35995, DOI 10.1074/jbc.M400444200; Kohyama-Koganeya A, 2011, J LIPID RES, V52, P1392, DOI 10.1194/jlr.M014266; Liu YY, 2013, ADV CANCER RES, V117, P59, DOI 10.1016/B978-0-12-394274-6.00003-0; Liu YY, 2011, INT J ONCOL, V39, P425, DOI 10.3892/ijo.2011.1052; Lukina E, 2010, BLOOD, V116, P893, DOI 10.1182/blood-2010-03-273151; MANGOOKARIM R, 1989, P NATL ACAD SCI USA, V86, P6007, DOI 10.1073/pnas.86.15.6007; Marks DL, 1999, J BIOL CHEM, V274, P451, DOI 10.1074/jbc.274.1.451; MARTIN OC, 1994, J CELL BIOL, V125, P769, DOI 10.1083/jcb.125.4.769; Marza E, 2009, J CELL SCI, V122, P822, DOI 10.1242/jcs.042754; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Morad SAF, 2013, NAT REV CANCER, V13, P51, DOI 10.1038/nrc3398; Nakajima K, 2013, MOL CELL PROTEOMICS, V12, P2468, DOI 10.1074/mcp.M112.027151; Nakajima K, 2010, GLYCOBIOLOGY, V20, P865, DOI 10.1093/glycob/cwq044; Natoli TA, 2010, NAT MED, V16, P788, DOI 10.1038/nm.2171; Nguyen HB, 2013, ONCOGENE, V32, P4100, DOI 10.1038/onc.2012.431; Nomura KH, 2011, GLYCOBIOLOGY, V21, P834, DOI 10.1093/glycob/cwr019; Nordstrom V, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001506; Rena G, 2013, DIABETOLOGIA, V56, P1898, DOI 10.1007/s00125-013-2991-0; Schulze H, 2009, BBA-MOL CELL RES, V1793, P674, DOI 10.1016/j.bbamcr.2008.09.020; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; Sidransky E, 2012, LANCET NEUROL, V11, P986, DOI 10.1016/S1474-4422(12)70190-4; Takiar V, 2011, P NATL ACAD SCI USA, V108, P2462, DOI 10.1073/pnas.1011498108; Tsuang D, 2012, NEUROLOGY, V79, P1944, DOI 10.1212/WNL.0b013e3182735e9a; Watanabe S, 2010, GLIA, V58, P1197, DOI 10.1002/glia.20999; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161; Woods A, 2000, MOL CELL BIOL, V20, P6704, DOI 10.1128/MCB.20.18.6704-6711.2000; Yamashita T, 2002, BBA-GEN SUBJECTS, V1573, P236, DOI 10.1016/S0304-4165(02)00389-6; Yamashita T, 1999, P NATL ACAD SCI USA, V96, P9142, DOI 10.1073/pnas.96.16.9142; Yildiz Y, 2006, J CLIN INVEST, V116, P2985, DOI 10.1172/JCI29224; Zhao HM, 2007, DIABETES, V56, P1210, DOI 10.2337/db06-0719	53	12	13	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					18245	18260		10.1074/jbc.M115.658948	http://dx.doi.org/10.1074/jbc.M115.658948			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26048992	Green Published, hybrid			2022-12-28	WOS:000358511700053
J	Drozak, J; Piecuch, M; Poleszak, O; Kozlowski, P; Chrobok, L; Baelde, HJ; de Heer, E				Drozak, Jakub; Piecuch, Maria; Poleszak, Olga; Kozlowski, Piotr; Chrobok, Lukasz; Baelde, Hans J.; de Heer, Emile			UPF0586 Protein C9orf41 Homolog Is Anserine-producing Methyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHYLOGENETIC ANALYSIS; CARNOSINE; HUMANS; METHYLATION; EXPRESSION; MUSCLE; GENE; LOCALIZATION; PREDICTION; DATABASE	Anserine (beta-alanyl-N(P-i)-methyl-L-histidine), a methylated derivative of carnosine (beta-alanyl-L-histidine), is an abundant constituent of vertebrate skeletal muscles. Although it has been suggested to serve as a proton buffer and radical scavenger, its physiological function remains mysterious. The formation of anserine is catalyzed by carnosine N-methyltransferase, recently identified in chicken as histamine N-methyltransferaselike (HNMT-like) protein. Although the HNMT-like gene is absent in mammalian genomes, the activity of carnosine N-methyltransferase was reported in most mammalian species. In the present investigation, we purified carnosineN-methyltransferase from rat muscles about 2600-fold. Three polypeptides of similar to 45, 50, and 70 kDa coeluting with the enzyme activity were identified in the preparation. Mass spectrometry analysis of these polypeptides resulted in the identification of UPF0586 protein C9orf41 homolog as the only meaningful candidate. Rat UPF0586 and its yeast, chicken, and human orthologs were expressed in COS-7 cells and purified to homogeneity. Although all recombinant proteins catalyzed the formation of anserine, as confirmed by chromatographic and mass spectrometry analysis, rat UPF0586 was more active on carnosine than other orthologs. Confocal microscopy of HeLa cells expressing recombinant UPF5086 proteins revealed their presence in both cytosol and nucleus. Carnosine and Gly-His were the best substrates for all UPF0586 orthologs studied, although the enzymes also methylated other L-histidine-containing di- and tripeptides. Finally, cotransfection of COS-7 cells with rat or human UPF0586 and carnosine synthase transformed the cells into efficient anserine producers. We conclude that UPF0586 is mammalian carnosine N-methyl-transferase and hypothesize that it may also serve as a peptide or protein methyltransferase in eukaryotes.	[Drozak, Jakub; Piecuch, Maria; Poleszak, Olga; Chrobok, Lukasz] Univ Warsaw, Fac Biol, Inst Biochem, Dept Metab Regulat, PL-02096 Warsaw, Poland; [Kozlowski, Piotr] Univ Warsaw, Fac Biol, Inst Biochem, Dept Mol Biol, PL-02096 Warsaw, Poland; [Baelde, Hans J.; de Heer, Emile] Leiden Univ, Med Ctr, Dept Pathol, NL-2300 RC Leiden, Netherlands	University of Warsaw; University of Warsaw; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Drozak, J (corresponding author), Univ Warsaw, Fac Biol, Inst Biochem, Dept Metab Regulat, Miecznikowa 1, PL-02096 Warsaw, Poland.	jdrozak@biol.uw.edu.pl		baelde, Hans/0000-0002-1214-500X; Drozak, Jakub/0000-0002-3601-3845; Krupska, Olga/0000-0003-3218-7108	Opus-6 Grant from the Polish National Science Center [DEC-2013/11/B/NZ1/00078]; European Union European Regional Development Fund within the Operational Program "Innovative Economy"	Opus-6 Grant from the Polish National Science Center; European Union European Regional Development Fund within the Operational Program "Innovative Economy"	This work was supported by Opus-6 Grant DEC-2013/11/B/NZ1/00078 from the Polish National Science Center. It was carried out with the use of the CePT infrastructure financed by the European Union European Regional Development Fund within the Operational Program "Innovative Economy" for 2007-2013. The authors declare that they have no conflicts of interest with the contents of this article.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Bae ON, 2013, STROKE, V44, P205, DOI 10.1161/STROKEAHA.112.673954; Baglietto MG, 2014, EUR J MED GENET, V57, P44, DOI 10.1016/j.ejmg.2013.12.001; Banko MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074885; Boldyrev A. A, 2007, CARNOSINE OXIDATIVE, P37; Boldyrev AA, 2013, PHYSIOL REV, V93, P1803, DOI 10.1152/physrev.00039.2012; Boudry-Labis E, 2013, EUR J MED GENET, V56, P163, DOI 10.1016/j.ejmg.2012.12.006; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; CHRISTMAN AA, 1976, INT J BIOCHEM, V7, P519, DOI 10.1016/0020-711X(76)90055-0; Clarke S, 2001, HOMOCYSTEINE IN HEALTH AND DISEASE, P63; CRUSH KG, 1970, COMP BIOCHEM PHYSIOL, V34, P3, DOI 10.1016/0010-406X(70)90049-6; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Drozak J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064805; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; HARMS WS, 1954, BIOCHIM BIOPHYS ACTA, V15, P480, DOI 10.1016/0006-3002(54)90005-0; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Khersonsky O, 2006, CURR OPIN CHEM BIOL, V10, P498, DOI 10.1016/j.cbpa.2006.08.011; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Kubomura D, 2010, NUTR NEUROSCI, V13, P183, DOI 10.1179/147683010X12611460764363; Li DL, 2009, NUCLEIC ACIDS RES, V37, P7059, DOI 10.1093/nar/gkp773; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MADSHUS IH, 1988, BIOCHEM J, V250, P1, DOI 10.1042/bj2500001; MANNION AF, 1992, EUR J APPL PHYSIOL O, V64, P47, DOI 10.1007/BF00376439; Martins MLL, 2002, J BIOCHEM MOL BIOL, V35, P220; MCMANUS IR, 1962, J BIOL CHEM, V237, P1207; Miller BG, 2005, BIOCHEMISTRY-US, V44, P10776, DOI 10.1021/bi0506268; Mora L, 2007, J AGR FOOD CHEM, V55, P4664, DOI 10.1021/jf0703809; Osborne TC, 2007, BIOCHEMISTRY-US, V46, P13370, DOI 10.1021/bi701558t; Peters V, 2012, AMINO ACIDS, V42, P2411, DOI 10.1007/s00726-011-1046-4; Petryszak R, 2014, NUCLEIC ACIDS RES, V42, pD926, DOI 10.1093/nar/gkt1270; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Smyk A, 2006, FEBS J, V273, P4728, DOI 10.1111/j.1742-4658.2006.05477.x; STOCK A, 1987, FEBS LETT, V220, P8, DOI 10.1016/0014-5793(87)80866-9; Szwergold BS, 2005, BIOCHEM BIOPH RES CO, V336, P36, DOI 10.1016/j.bbrc.2005.08.033; Thapar N, 2001, PLANT PHYSIOL, V125, P1023, DOI 10.1104/pp.125.2.1023; Tomonaga S, 2007, NUTR NEUROSCI, V10, P181, DOI 10.1080/10284150701587338; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Veiga-da-Cunha M, 2014, J BIOL CHEM, V289, P19726, DOI 10.1074/jbc.M114.576579; Webb KJ, 2010, J BIOL CHEM, V285, P37598, DOI 10.1074/jbc.M110.170787; Webb KJ, 2010, BIOCHEMISTRY-US, V49, P5225, DOI 10.1021/bi100428x; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wirth VJ, 1998, J ATHL TRAINING, V33, P211; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018	48	23	27	3	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17190	17205		10.1074/jbc.M115.640037	http://dx.doi.org/10.1074/jbc.M115.640037			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26001783	hybrid, Green Published			2022-12-28	WOS:000357730900016
J	Sakai, T; Jung, HS; Sato, O; Yamada, MD; You, DJ; Ikebe, R; Ikebe, M				Sakai, Tsuyoshi; Jung, Hyun Suk; Sato, Osamu; Yamada, Masafumi D.; You, Dong-Ju; Ikebe, Reiko; Ikebe, Mitsuo			Structure and Regulation of the Movement of Human Myosin VIIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; POLYMERASE-CHAIN-REACTION; USHER-SYNDROME PROTEINS; GLOBULAR TAIL DOMAIN; MOTOR-ACTIVITY; CELLS; CARGO; EXPRESSION; BINDING; HEAD	Human myosin VIIA (HM7A) is responsible for human Usher syndrome type 1B, which causes hearing and visual loss in humans. Here we studied the regulation of HM7A. The actin-activated ATPase activity of full-length HM7A (HM7AFull) was lower than that of tail-truncated HM7A(HM7A Delta Tail). Deletion of the C-terminal 40 amino acids and mutation of the basic residues in this region (R2176A or K2179A) abolished the inhibition. Electron microscopy revealed that HM7AFull is a monomer in which the tail domain bends back toward the head-neck domain to form a compact structure. This compact structure is extended at high ionic strength or in the presence of Ca2+. Although myosin VIIA has five isoleucine-glutamine (IQ) motifs, the neck length seems to be shorter than the expected length of five bound calmodulins. Supporting this observation, the IQ domain bound only three calmodulins in Ca2+, and the first IQ motif failed to bind calmodulin in EGTA. These results suggest that the unique IQ domain of HM7A is important for the tail-neck interaction and, therefore, regulation. Cellular studies revealed that dimer formation of HM7A is critical for its translocation to filopodial tips and that the tail domain (HM7ATail) markedly reduced the filopodial tip localization of the HM7A Delta Tail dimer, suggesting that the tail-inhibition mechanism is operating in vivo. The translocation of the HM7AFull dimer was significantly less than that of the HM7A Delta Tail dimer, and R2176A/R2179A mutation rescued the filopodial tip translocation. These results suggest that HM7A can transport its cargo molecules, such as USH1 proteins, upon release of the tail-dependent inhibition.	[Sakai, Tsuyoshi; Sato, Osamu; Yamada, Masafumi D.; Ikebe, Reiko; Ikebe, Mitsuo] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA 01605 USA; [Sakai, Tsuyoshi; Sato, Osamu; Ikebe, Reiko; Ikebe, Mitsuo] Univ Texas Hlth Ctr Tyler, Dept Cellular & Mol Biol, Tyler, TX 75708 USA; [Jung, Hyun Suk; You, Dong-Ju] Korea Basic Sci Inst, Div Electron Microscop Res, Taejon 305333, South Korea; [Jung, Hyun Suk] Kangwon Natl Univ, Dept Biochem, Coll Nat Sci, Chuncheon Si 200701, Gangwon Do, South Korea	University of Massachusetts System; University of Massachusetts Worcester; University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT); Korea Basic Science Institute (KBSI); Kangwon National University	Ikebe, M (corresponding author), Univ Texas Hlth Ctr Tyler, Dept Cellular & Mol Biol, Tyler, TX 75708 USA.	Mitsuo.Ikebe@uthct.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [DC610063]; Korea Basic Science Institute [T34415]; Global Frontier Research Grant [NRF-M1AXA002-2011-0031424]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Basic Science Institute; Global Frontier Research Grant	This work was supported, in whole or in part, by National Institutes of Health found that Drosophila myosin VIIA is a high duty ratio motor grant DC610063 (to M. I.). This work was also supported by Korea Basic Science Institute Grant T34415 (to M. I. and H. S. J) and Global Frontier Research Grant NRF-M1AXA002-2011-0031424 (to H. S. J.).	Adato A, 2005, HUM MOL GENET, V14, P347, DOI 10.1093/hmg/ddi031; Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; Bird JE, 2014, P NATL ACAD SCI USA, V111, P12390, DOI 10.1073/pnas.1409459111; Blumenschein TMA, 2000, BIOCHEMISTRY-US, V39, P3603, DOI 10.1021/bi9924718; Burgess SA, 2004, J STRUCT BIOL, V147, P247, DOI 10.1016/j.jsb.2004.04.004; Chen ZY, 1996, GENOMICS, V36, P440, DOI 10.1006/geno.1996.0489; CHENEY R E, 1992, Current Opinion in Cell Biology, V4, P27, DOI 10.1016/0955-0674(92)90055-H; CHIEN YH, 1984, MOL CELL BIOL, V4, P507, DOI 10.1128/MCB.4.3.507; CHIFFLET S, 1988, ANAL BIOCHEM, V168, P1, DOI 10.1016/0003-2697(88)90002-4; Coudrier E, 2007, PIGM CELL RES, V20, P153, DOI 10.1111/j.1600-0749.2007.00376.x; Futter CE, 2004, MOL BIOL CELL, V15, P2264, DOI 10.1091/mbc.E03-10-0772; Gourinath S, 2003, STRUCTURE, V11, P1621, DOI 10.1016/j.str.2003.10.013; Grati M, 2011, P NATL ACAD SCI USA, V108, P11476, DOI 10.1073/pnas.1104161108; Guzik-Lendrum S, 2013, J BIOL CHEM, V288, P9532, DOI 10.1074/jbc.M112.441238; HASSON T, 1995, P NATL ACAD SCI USA, V92, P9815, DOI 10.1073/pnas.92.21.9815; Hasson T, 1997, J CELL BIOL, V137, P1287, DOI 10.1083/jcb.137.6.1287; HEMSLEY A, 1989, NUCLEIC ACIDS RES, V17, P6545, DOI 10.1093/nar/17.16.6545; Inoue A, 2003, J BIOL CHEM, V278, P5478, DOI 10.1074/jbc.M210489200; Jones I, 1996, CURR OPIN BIOTECH, V7, P512, DOI 10.1016/S0958-1669(96)80054-1; Jung HS, 2008, MOL BIOL CELL, V19, P3234, DOI 10.1091/mbc.E08-02-0206; Knight PJ, 2005, J BIOL CHEM, V280, P34702, DOI 10.1074/jbc.M504887200; Lefevre G, 2008, DEVELOPMENT, V135, P1427, DOI 10.1242/dev.012922; Li XD, 2005, J BIOL CHEM, V280, P17815, DOI 10.1074/jbc.M413295200; Li XD, 2008, P NATL ACAD SCI USA, V105, P1140, DOI 10.1073/pnas.0709741105; Li XD, 2006, J BIOL CHEM, V281, P21789, DOI 10.1074/jbc.M602957200; Liu J, 2006, NATURE, V442, P208, DOI 10.1038/nature04719; Liu XR, 1999, J NEUROSCI, V19, P6267; Maruta S, 1998, EUR J BIOCHEM, V256, P229, DOI 10.1046/j.1432-1327.1998.2560229.x; Mukherjea M, 2009, MOL CELL, V35, P305, DOI 10.1016/j.molcel.2009.07.010; O'Reilly D R, 1997, Methods Mol Biol, V62, P235; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phichith D, 2009, P NATL ACAD SCI USA, V106, P17320, DOI 10.1073/pnas.0909748106; Reiners J, 2006, EXP EYE RES, V83, P97, DOI 10.1016/j.exer.2005.11.010; REYNARD AM, 1961, J BIOL CHEM, V236, P2277; Richardson GP, 2011, ANNU REV PHYSIOL, V73, P311, DOI 10.1146/annurev-physiol-012110-142228; Sakai T, 2011, P NATL ACAD SCI USA, V108, P7028, DOI 10.1073/pnas.1009188108; Sellers JR, 2007, J MUSCLE RES CELL M, V28, P363, DOI 10.1007/s10974-008-9134-0; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; Senften M, 2006, J NEUROSCI, V26, P2060, DOI 10.1523/JNEUROSCI.4251-05.2006; Siemens J, 2002, P NATL ACAD SCI USA, V99, P14946, DOI 10.1073/pnas.232579599; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; SUMMERS MD, 1972, J VIROL, V9, P710, DOI 10.1128/JVI.9.4.710-713.1972; TAN JL, 1992, ANNU REV BIOCHEM, V61, P721, DOI 10.1146/annurev.bi.61.070192.003445; Thirumurugan K, 2006, NATURE, V442, P212, DOI 10.1038/nature04865; Udovichenko IP, 2002, J CELL SCI, V115, P445; Umeki N, 2011, NAT STRUCT MOL BIOL, V18, P783, DOI 10.1038/nsmb.2065; Umeki N, 2009, P NATL ACAD SCI USA, V106, P8483, DOI 10.1073/pnas.0812930106; Watanabe S, 2006, J BIOL CHEM, V281, P7151, DOI 10.1074/jbc.M511592200; Weil D, 1997, NAT GENET, V16, P191, DOI 10.1038/ng0697-191; WEINER MP, 1994, GENE, V151, P119, DOI 10.1016/0378-1119(94)90641-6; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Wu L, 2011, SCIENCE, V331, P757, DOI 10.1126/science.1198848; Yang Y, 2006, P NATL ACAD SCI USA, V103, P5746, DOI 10.1073/pnas.0509935103; Yang Y, 2009, P NATL ACAD SCI USA, V106, P4189, DOI 10.1073/pnas.0808682106; Yu C, 2009, CELL, V138, P537, DOI 10.1016/j.cell.2009.05.030; Zhu T, 1996, BIOCHEMISTRY-US, V35, P513, DOI 10.1021/bi952053c	56	28	29	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17587	17598		10.1074/jbc.M114.599365	http://dx.doi.org/10.1074/jbc.M114.599365			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26001786	hybrid, Green Published			2022-12-28	WOS:000357730900049
J	Tassin, TC; Benavides, DR; Plattner, F; Nishi, A; Bibb, JA				Tassin, Tara C.; Benavides, David R.; Plattner, Florian; Nishi, Akinori; Bibb, James A.			Regulation of ERK Kinase by MEK1 Kinase Inhibition in the Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclin-dependent kinase (CDK); depression; dopamine; ERK; MAPK; NMDA receptor (NMDAR); phosphorylation; Cdk5; MEK1; striatum	ACTIVATED PROTEIN-KINASE; NMDA RECEPTOR ACTIVATION; DEPRESSIVE-LIKE BEHAVIOR; NERVE GROWTH-FACTOR; FORCED SWIM STRESS; MAP KINASE; SYNAPTIC PLASTICITY; TYROSINE PHOSPHORYLATION; MEMORY CONSOLIDATION; NEOSTRIATAL NEURONS	Background: ERK/MAPK signaling is important in brain function. Results: MEK1 is inhibited by phosphorylation at Thr-292/286 by Cdk5, ERK, and Cdk1. These mechanisms are regulated by striatal glutamate and dopamine neurotransmission and acute stress in vivo. Conclusion: Excitatory and metabotropic neurotransmission converge on MEK1 regulation. Significance: A greater understanding of MEK1/ERK signaling provides insights into brain function, disease, and potential treatment strategies. Metabotropic (slow) and ionotropic (fast) neurotransmission are integrated by intracellular signal transduction mechanisms involving protein phosphorylation/dephosphorylation to achieve experience-dependent alterations in brain circuitry. ERK is an important effector of both slow and fast forms of neurotransmission and has been implicated in normal brain function and CNS diseases. Here we characterize phosphorylation of the ERK-activating protein kinase MEK1 by Cdk5, ERK, and Cdk1 in vitro in intact mouse brain tissue and in the context of an animal behavioral paradigm of stress. Cdk5 only phosphorylates Thr-292, whereas ERK and Cdk1 phosphorylate both Thr-292 and Thr-286 MEK1. These sites interact in a kinase-specific manner and inhibit the ability of MEK1 to activate ERK. Thr-292 and Thr-286 MEK1 are phosphorylated in most mouse brain regions to stoichiometries of approximate to 5% or less. Phosphorylation of Thr-292 MEK1 is regulated by cAMP-dependent signaling in mouse striatum in a manner consistent with negative feedback inhibition in response to ERK activation. Protein phosphatase 1 and 2A contribute to the maintenance of the basal phosphorylation state of both Thr-292 and Thr-286 MEK1 and that of ERK. Activation of the NMDA class of ionotropic glutamate receptors reduces inhibitory MEK1 phosphorylation, whereas forced swim, a paradigm of acute stress, attenuates Thr-292 MEK1 phosphorylation. Together, the data indicate that these inhibitory MEK1 sites phosphorylated by Cdk5 and ERK1 serve as mechanistic points of convergence for the regulation of ERK signaling by both slow and fast neurotransmission.	[Tassin, Tara C.; Plattner, Florian; Bibb, James A.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Bibb, James A.] Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Bibb, James A.] Univ Texas SW Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Benavides, David R.] Johns Hopkins Univ Hosp, Dept Neurol, Baltimore, MD 21287 USA; [Nishi, Akinori] Kurume Univ, Dept Pharmacol, Sch Med, Kurume, Fukuoka 8300011, Japan	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Johns Hopkins University; Johns Hopkins Medicine; Kurume University	Bibb, JA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Psychiat, 5323 Harry Hines Blvd,NC5-410, Dallas, TX 75390 USA.	james.bibb@utsouthwestern.edu	Regan, Clinton/E-6250-2012	Plattner, Florian/0000-0002-3150-1866	National Institutes of Health Training Fellowship [T32DA007290]; National Institutes of Health [MH79710, MH083711, DA016672, DA033485, NS073855]; American Cancer Society; Friends of Alzheimer's young investigator award; Darrell K. Royal Research Fund; Texas Institute for Brain Injury and Repair; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079710, R01MH083711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007290, R01DA016672, R01DA033485] Funding Source: NIH RePORTER	National Institutes of Health Training Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Friends of Alzheimer's young investigator award; Darrell K. Royal Research Fund; Texas Institute for Brain Injury and Repair; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Training Fellowship T32DA007290 (to T. C. T.) and National Institutes of Health Grants MH79710, MH083711, DA016672, DA033485, and NS073855 (to J. A. B.). This research was also supported in part through funding from the American Cancer Society (to J. A. B.), a Friends of Alzheimer's young investigator award, and the Darrell K. Royal Research Fund (to F. P.). We also acknowledge the support of the Texas Institute for Brain Injury and Repair.	Atwal JK, 2000, NEURON, V27, P265, DOI 10.1016/S0896-6273(00)00035-0; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; Bertran-Gonzalez J, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00136; Bibb JA, 2010, J NEUROSCI, V30, P14987, DOI 10.1523/JNEUROSCI.4419-10.2010; BRUNET A, 1994, FEBS LETT, V346, P299, DOI 10.1016/0014-5793(94)00475-7; Catalanotti F, 2009, NAT STRUCT MOL BIOL, V16, P294, DOI 10.1038/nsmb.1564; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; Duman CH, 2007, BIOL PSYCHIAT, V61, P661, DOI 10.1016/j.biopsych.2006.05.047; Dwivedi Y, 2001, J NEUROCHEM, V77, P916, DOI 10.1046/j.1471-4159.2001.00300.x; Eblen ST, 2004, MOL CELL BIOL, V24, P2308, DOI 10.1128/MCB.24.6.2308-2317.2004; Eblen ST, 2002, MOL CELL BIOL, V22, P6023, DOI 10.1128/MCB.22.17.6023-6033.2002; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Einat H, 2003, J NEUROSCI, V23, P7311; English JD, 1996, J BIOL CHEM, V271, P24329, DOI 10.1074/jbc.271.40.24329; Fersht A., 1985, ENZYME STRUCTURE MEC; Frost JA, 1997, EMBO J, V16, P6426, DOI 10.1093/emboj/16.21.6426; GARDNER AM, 1994, MOL BIOL CELL, V5, P193, DOI 10.1091/mbc.5.2.193; Girault JA, 2007, CURR OPIN PHARMACOL, V7, P77, DOI 10.1016/j.coph.2006.08.012; Gopalbhai K, 2003, J BIOL CHEM, V278, P8118, DOI 10.1074/jbc.M211870200; Hamada M, 2005, J PHARMACOL EXP THER, V315, P872, DOI 10.1124/jpet.105.090852; Hawasli AH, 2007, NAT NEUROSCI, V10, P880, DOI 10.1038/nn1914; Hayashi K, 2006, J NEUROCHEM, V99, P237, DOI 10.1111/j.1471-4159.2006.04113.x; Huang TY, 2006, BEHAV BRAIN RES, V173, P104, DOI 10.1016/j.bbr.2006.06.009; Kameyama K, 1998, NEURON, V21, P1163, DOI 10.1016/S0896-6273(00)80633-9; Kelly A, 2003, J NEUROSCI, V23, P5354; Kim SH, 2008, P NATL ACAD SCI USA, V105, P4429, DOI 10.1073/pnas.0800257105; Komiyama NH, 2002, J NEUROSCI, V22, P9721; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Kyosseva SV, 1999, BIOL PSYCHIAT, V46, P689, DOI 10.1016/S0006-3223(99)00104-3; Kyosseva SV, 2000, ARCH GEN PSYCHIAT, V57, P685, DOI 10.1001/archpsyc.57.7.685; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Li R, 2014, J NEUROCHEM, V128, P315, DOI 10.1111/jnc.12463; Lu L, 2006, TRENDS NEUROSCI, V29, P695, DOI 10.1016/j.tins.2006.10.005; Martin KC, 1997, NEURON, V18, P899, DOI 10.1016/S0896-6273(00)80330-X; Min XS, 2009, STRUCTURE, V17, P96, DOI 10.1016/j.str.2008.11.007; Mitsuhashi S, 2003, J BIOL CHEM, V278, P82, DOI 10.1074/jbc.M208888200; Nishi A, 1999, J NEUROCHEM, V72, P2015, DOI 10.1046/j.1471-4159.1999.0722015.x; Nishi A, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00043; Paul S, 2003, NAT NEUROSCI, V6, P34, DOI 10.1038/nn989; Philibin SD, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00060; Plattner F, 2014, NEURON, V81, P1070, DOI 10.1016/j.neuron.2014.01.022; PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8; Qi XL, 2008, NEUROBIOL DIS, V31, P278, DOI 10.1016/j.nbd.2008.05.003; Qi XL, 2006, BEHAV BRAIN RES, V175, P233, DOI 10.1016/j.bbr.2006.08.035; Qi XL, 2009, BEHAV BRAIN RES, V199, P203, DOI 10.1016/j.bbr.2008.11.051; Qin Y, 2005, GENE DEV, V19, P2000, DOI 10.1101/gad.342205; Reus GZ, 2014, J PSYCHIATR RES, V55, P15, DOI 10.1016/j.jpsychires.2014.04.010; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; ROSSOMANDO AJ, 1994, MOL CELL BIOL, V14, P1594, DOI 10.1128/MCB.14.3.1594; Sahin B, 2006, J BIOL CHEM, V281, P24322, DOI 10.1074/jbc.M603282200; Sava A, 2012, NEUROPHARMACOLOGY, V62, P925, DOI 10.1016/j.neuropharm.2011.09.025; Schafe GE, 2000, J NEUROSCI, V20, P8177; Schafe GE, 1999, LEARN MEMORY, V6, P97; Seese RR, 2014, NEUROPSYCHOPHARMACOL, V39, P1664, DOI 10.1038/npp.2014.13; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; Selcher JC, 1999, LEARN MEMORY, V6, P478, DOI 10.1101/lm.6.5.478; Sharma M, 2007, BIOCHEM BIOPH RES CO, V358, P379, DOI 10.1016/j.bbrc.2007.04.149; Sharma P, 2002, J BIOL CHEM, V277, P528, DOI 10.1074/jbc.M109324200; SHORS TJ, 1995, NEUROREPORT, V6, P677, DOI 10.1097/00001756-199503000-00023; Shors TJ, 1998, LEARN MEMORY, V5, P220; Slack-Davis JK, 2003, J CELL BIOL, V162, P281, DOI 10.1083/jcb.200212141; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; Subramaniam S, 2004, J CELL BIOL, V165, P357, DOI 10.1083/jcb.200403028; Takahashi S, 2005, P NATL ACAD SCI USA, V102, P1737, DOI 10.1073/pnas.0409456102; Todorova VK, 2003, NEUROPSYCHOPHARMACOL, V28, P1506, DOI 10.1038/sj.npp.1300211; Todorovic C, 2009, NEUROPSYCHOPHARMACOL, V34, P1416, DOI 10.1038/npp.2008.178; Tronson NC, 2008, NEUROPSYCHOPHARMACOL, V33, P1570, DOI 10.1038/sj.npp.1301550; Valjent E, 2000, J NEUROSCI, V20, P8701; Valjent E, 2005, P NATL ACAD SCI USA, V102, P491, DOI 10.1073/pnas.0408305102; VanScyoc WS, 2008, BIOCHEMISTRY-US, V47, P5017, DOI 10.1021/bi701811x; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Wang XH, 2011, BBA-MOL CELL RES, V1813, P827, DOI 10.1016/j.bbamcr.2011.01.027; Wang Z, 2013, PHARMACOL BIOCHEM BE, V112, P104, DOI 10.1016/j.pbb.2013.10.007; Xifro X, 2014, J BIOL CHEM, V289, P8462, DOI 10.1074/jbc.M113.536375; Yao H, 1998, J BIOL CHEM, V273, P8240, DOI 10.1074/jbc.273.14.8240; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; Yu LG, 2004, J BIOL CHEM, V279, P41377, DOI 10.1074/jbc.M400017200; Yuan LL, 2002, J NEUROSCI, V22, P4860, DOI 10.1523/JNEUROSCI.22-12-04860.2002; Yuen EY, 2011, MOL PSYCHIATR, V16, P156, DOI 10.1038/mp.2010.50	79	16	16	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16319	16329		10.1074/jbc.M115.654897	http://dx.doi.org/10.1074/jbc.M115.654897			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25971971	Green Published, hybrid			2022-12-28	WOS:000356930100034
J	Olsan, EE; Matsushita, T; Rezaei, M; Weimbs, T				Olsan, Erin E.; Matsushita, Tamami; Rezaei, Mina; Weimbs, Thomas			Exploitation of the Polymeric Immunoglobulin Receptor for Antibody Targeting to Renal Cyst Lumens in Polycystic Kidney Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody; drug development; genetic disease; IgA; STAT transcription factor; STAT6; dimeric IgA; drug targeting; polycystic kidney disease; polymeric immunoglobulin receptor	EPITHELIAL-CELLS; IG RECEPTOR; IN-VIVO; IMMUNE-RESPONSES; GROWTH-FACTOR; EXPRESSION; STAT6; TRANSCYTOSIS; INFLAMMATION; STIMULATION	Background: Mitogenic cyst fluid in polycystic kidney disease is not accessible to therapeutic IgG antibodies. Results: STAT6 drives expression of the polymeric immunoglobulin receptor, which can transcytose dimeric IgA from the circulation into cyst fluid. Conclusion: Dimeric IgA antibodies target to renal cyst lumens. Significance: Therapeutic antibodies, reformatted to dIgA, could be evaluated for the treatment of polycystic kidney disease. Autosomal-dominant polycystic kidney disease (ADPKD) is a common life-threatening genetic disease that leads to renal failure. No treatment is available yet to effectively slow disease progression. Renal cyst growth is, at least in part, driven by the presence of growth factors in the lumens of renal cysts, which are enclosed spaces lacking connections to the tubular system. We have shown previously shown that IL13 in cyst fluid leads to aberrant activation of STAT6 via the IL4/13 receptor. Although antagonistic antibodies against many of the growth factors implicated in ADPKD are already available, they are IgG isotype antibodies that are not expected to gain access to renal cyst lumens. Here we demonstrate that targeting antibodies to renal cyst lumens is possible with the use of dimeric IgA (dIgA) antibodies. Using human ADPKD tissues and polycystic kidney disease mouse models, we show that the polymeric immunoglobulin receptor (pIgR) is highly expressed by renal cyst-lining cells. pIgR expression is, in part, driven by aberrant STAT6 pathway activation. pIgR actively transports dIgA from the circulation across the cyst epithelium and releases it into the cyst lumen as secretory IgA. dIgA administered by intraperitoneal injection is preferentially targeted to polycystic kidneys whereas injected IgG is not. Our results suggest that pIgR-mediated transcytosis of antagonistic antibodies in dIgA format can be exploited for targeted therapy in ADPKD.	[Weimbs, Thomas] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Weimbs, Thomas] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Weimbs, T (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	weimbs@lifesci.ucsb.edu	Regan, Clinton/E-6250-2012	Weimbs, Thomas/0000-0001-9423-5561	National Institutes of Health [R01 DK62338]; Swiss National Science Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK62338 and a gift from the Lillian Goldman Charitable Trust (to T. W.). This work was also supported by a Swiss National Science Foundation early postdoctoral mobility grant (to M. R). The authors declare that they have no conflicts of interest with the contents of this article.	ABRAMOWSKY CR, 1986, AM J PATHOL, V125, P571; Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; Asano M, 2004, SCAND J IMMUNOL, V60, P267, DOI 10.1111/j.0300-9475.2004.01456.x; Barlucchi L, 2001, CIRC RES, V88, P298, DOI 10.1161/01.RES.88.3.298; Boross P, 2013, EMBO MOL MED, V5, P1213, DOI 10.1002/emmm.201201929; Braathen R, 2006, J BIOL CHEM, V281, P7075, DOI 10.1074/jbc.M508509200; Chapin HC, 2010, J CELL BIOL, V191, P701, DOI 10.1083/jcb.201006173; DAVIDSON LA, 1987, ACTA PAEDIATR SCAND, V76, P733, DOI 10.1111/j.1651-2227.1987.tb10557.x; Dell KM, 2001, KIDNEY INT, V60, P1240, DOI 10.1046/j.1523-1755.2001.00963.x; DU J, 1995, AM J PHYSIOL-CELL PH, V269, pC487, DOI 10.1152/ajpcell.1995.269.2.C487; EVERSON GT, 1990, HEPATOLOGY, V11, P557, DOI 10.1002/hep.1840110406; Gallagher AR, 2010, ADV CHRONIC KIDNEY D, V17, P118, DOI 10.1053/j.ackd.2010.01.002; GARDNER KD, 1991, KIDNEY INT, V39, P718, DOI 10.1038/ki.1991.87; Giffroy D, 1998, INT IMMUNOL, V10, P347, DOI 10.1093/intimm/10.3.347; Goenka S, 2011, IMMUNOL RES, V50, P87, DOI 10.1007/s12026-011-8205-2; Hassane S, 2010, J PATHOL, V222, P21, DOI 10.1002/path.2734; HORIE S, 1994, LANCET, V344, P789, DOI 10.1016/S0140-6736(94)92344-2; Jansson K, 2012, AM J PHYSIOL-RENAL, V303, pF982, DOI 10.1152/ajprenal.00677.2011; Johansen FE, 2011, MUCOSAL IMMUNOL, V4, P598, DOI 10.1038/mi.2011.37; Johansen FE, 2004, TRENDS IMMUNOL, V25, P150, DOI 10.1016/j.it.2004.01.001; Kaetzel CS, 2005, IMMUNOL REV, V206, P83, DOI 10.1111/j.0105-2896.2005.00278.x; Kopf M, 2010, NAT REV DRUG DISCOV, V9, P703, DOI 10.1038/nrd2805; Li XG, 2008, NAT MED, V14, P863, DOI 10.1038/nm1783; Lohse S, 2012, J BIOL CHEM, V287, P25139, DOI 10.1074/jbc.M112.353060; Lohse S, 2011, J IMMUNOL, V186, P3770, DOI 10.4049/jimmunol.1003082; Loman S, 1999, IMMUNOLOGY, V96, P537; Low SH, 2006, DEV CELL, V10, P57, DOI 10.1016/j.devcel.2005.12.005; Monteiro RC, 2010, J CLIN IMMUNOL, V30, P1, DOI 10.1007/s10875-009-9338-0; Mostov KE, 1995, COLD SPRING HARB SYM, V60, P775, DOI 10.1101/SQB.1995.060.01.083; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Olsan EE, 2011, P NATL ACAD SCI USA, V108, P18067, DOI 10.1073/pnas.1111966108; Rice JC, 1999, AM J PHYSIOL-RENAL, V276, pF666, DOI 10.1152/ajprenal.1999.276.5.F666; Rice JC, 1998, AM J PHYSIOL-RENAL, V274, pF966, DOI 10.1152/ajprenal.1998.274.5.F966; Schjerven H, 2000, J IMMUNOL, V165, P3898, DOI 10.4049/jimmunol.165.7.3898; Sliwkowski MX, 2013, SCIENCE, V341, P1192, DOI 10.1126/science.1241145; SOLARI R, 1985, J BIOL CHEM, V260, P1141; Torres VE, 2012, NAT REV NEPHROL, V8, P66, DOI 10.1038/nrneph.2011.196; White KD, 2002, J EXP MED, V196, P551, DOI 10.1084/jem.20020581	38	13	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15679	15686		10.1074/jbc.M114.607929	http://dx.doi.org/10.1074/jbc.M114.607929			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25922073	hybrid, Green Published			2022-12-28	WOS:000356527400030
J	Oskarsson, ME; Singh, K; Wang, J; Vlodavsky, I; Li, JP; Westermark, GT				Oskarsson, Marie E.; Singh, Kailash; Wang, Jian; Vlodavsky, Israel; Li, Jin-ping; Westermark, Gunilla T.			Heparan Sulfate Proteoglycans Are Important for Islet Amyloid Formation and Islet Amyloid Polypeptide-induced Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CELL APOPTOSIS; AMYLIN; BINDING; IAPP; OVEREXPRESSION; ACTIVATION; EXPRESSION; MECHANISM; INTERNALIZATION; IDENTIFICATION	Deposition of beta cell toxic islet amyloid is a cardinal finding in type 2 diabetes. In addition to the main amyloid component islet amyloid polypeptide (IAPP), heparan sulfate proteoglycan is constantly present in the amyloid deposit. Heparan sulfate (HS) side chains bind to IAPP, inducing conformational changes of the IAPP structure and an acceleration of fibril formation. We generated a double-transgenic mouse strain (hpa-hIAPP) that overexpresses human heparanase and human IAPP but is deficient of endogenous mouse IAPP. Culture of hpa-hIAPP islets in 20 mM glucose resulted in less amyloid formation compared with the amyloid load developed in cultured islets isolated from littermates expressing human IAPP only. A similar reduction of amyloid was achieved when human islets were cultured in the presence of heparin fragments. Furthermore, we used CHO cells and the mutant CHO pgsD-677 cell line (deficient in HS synthesis) to explore the effect of cellular HS on IAPP-induced cytotoxicity. Seeding of IAPP aggregation on CHO cells resulted in caspase-3 activation and apoptosis that could be prevented by inhibition of caspase-8. No IAPP-induced apoptosis was seen in HS-deficient CHO pgsD-677 cells. These results suggest that beta cell death caused by extracellular IAPP requires membrane-bound HS. The interaction between HS and IAPP or the subsequent effects represent a possible therapeutic target whose blockage can lead to a prolonged survival of beta cells.	[Oskarsson, Marie E.; Singh, Kailash; Westermark, Gunilla T.] Uppsala Univ, Dept Med Cell Biol, S-75123 Uppsala, Sweden; [Wang, Jian; Li, Jin-ping] Uppsala Univ, Dept Med Biochem & Microbiol, S-75123 Uppsala, Sweden; [Wang, Jian] Ningxia Peoples Hosp, Yinchuan 750021, Peoples R China; [Vlodavsky, Israel] Technion Israel Inst Technol, Canc & Vasc Biol Res Ctr, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel	Uppsala University; Uppsala University; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Li, JP (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Box 571, S-75123 Uppsala, Sweden.	Jin-ping.Li@imbim.uu.se; Westermark@mcb.uu.se		Singh, Kailash/0000-0002-6771-7757	Family Ernfors Research Fund; Swedish Diabetes Foundation; Novo Nordisk Research Fund [VR K2012-67X-21128-04-4]; Cancerfonden Grant [120762];  [VR K2013-55x-20326-07-3]; Novo Nordisk Fonden [NNF15OC0016502] Funding Source: researchfish	Family Ernfors Research Fund; Swedish Diabetes Foundation; Novo Nordisk Research Fund; Cancerfonden Grant; ; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by Grant VR K2013-55x-20326-07-3 (to G. T. W.), the Family Ernfors Research Fund, the Swedish Diabetes Foundation, the Novo Nordisk Research Fund, Grant VR K2012-67X-21128-04-4 (to J. P. L.), and Cancerfonden Grant 120762.	Abedini A, 2005, BIOCHEMISTRY-US, V44, P16284, DOI 10.1021/bi051432v; Abedini A, 2006, BIOCHEMISTRY-US, V45, P9228, DOI 10.1021/bi0510936; ANDERSSO.A, 1972, DIABETES, V21, P546, DOI 10.2337/diab.21.2.S546; Anguiano M, 2002, BIOCHEMISTRY-US, V41, P11338, DOI 10.1021/bi020314u; Bag N, 2013, CHEM COMMUN, V49, P9155, DOI 10.1039/c3cc44880k; Bennet W, 1999, DIABETES, V48, P1907, DOI 10.2337/diabetes.48.10.1907; Buchanan LE, 2013, P NATL ACAD SCI USA, V110, P19285, DOI 10.1073/pnas.1314481110; Butler AE, 2004, DIABETES, V53, P1509, DOI 10.2337/diabetes.53.6.1509; Cabric S, 2007, DIABETES, V56, P2008, DOI 10.2337/db07-0358; Castillo GM, 1998, DIABETES, V47, P612, DOI 10.2337/diabetes.47.4.612; De Carufel CA, 2013, BIOPOLYMERS, V100, P645, DOI 10.1002/bip.22243; Galvis MLE, 2007, NAT CHEM BIOL, V3, P773, DOI 10.1038/nchembio.2007.41; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; Hass G, 1942, ARCH PATHOL, V34, P92; HOOK M, 1982, ANAL BIOCHEM, V119, P236, DOI 10.1016/0003-2697(82)90580-2; Hull RL, 2007, AM J PHYSIOL-CELL PH, V293, pC1586, DOI 10.1152/ajpcell.00208.2007; Janson J, 1999, DIABETES, V48, P491, DOI 10.2337/diabetes.48.3.491; Jendresen CB, 2015, J BIOL CHEM, V290, P5053, DOI 10.1074/jbc.M114.600569; Kajava AV, 2005, J MOL BIOL, V348, P247, DOI 10.1016/j.jmb.2005.02.029; Knight JD, 2004, J MOL BIOL, V341, P1175, DOI 10.1016/j.jmb.2004.06.086; Kohler M, 2003, DIABETES, V52, P2943, DOI 10.2337/diabetes.52.12.2943; Li JP, 2005, P NATL ACAD SCI USA, V102, P6473, DOI 10.1073/pnas.0502287102; Liang GZ, 2013, BIOCHEMISTRY-US, V52, P1089, DOI 10.1021/bi301525e; LIDHOLT K, 1992, P NATL ACAD SCI USA, V89, P2267, DOI 10.1073/pnas.89.6.2267; LORENZO A, 1994, NATURE, V368, P756, DOI 10.1038/368756a0; Luca S, 2007, BIOCHEMISTRY-US, V46, P13505, DOI 10.1021/bi701427q; Ma LJ, 2014, J INORG BIOCHEM, V140, P143, DOI 10.1016/j.jinorgbio.2014.07.002; Mirzabekov TA, 1996, J BIOL CHEM, V271, P1988, DOI 10.1074/jbc.271.4.1988; Noborn F, 2011, P NATL ACAD SCI USA, V108, P5584, DOI 10.1073/pnas.1101194108; Nobuhisa T, 2005, BIOCHEM BIOPH RES CO, V331, P175, DOI 10.1016/j.bbrc.2005.03.129; NORLING B, 1988, CLIN EXP IMMUNOL, V73, P333; Park K, 2001, J BIOL CHEM, V276, P16611, DOI 10.1074/jbc.M008423200; Park YJ, 2012, DIABETOLOGIA, V55, P1035, DOI 10.1007/s00125-012-2451-2; Park YJ, 2014, DIABETOLOGIA, V57, P765, DOI 10.1007/s00125-013-3152-1; Paulsson JF, 2006, DIABETOLOGIA, V49, P1237, DOI 10.1007/s00125-006-0206-7; Paulsson JF, 2005, DIABETES, V54, P2117, DOI 10.2337/diabetes.54.7.2117; Paulsson JF, 2008, EXP DIABETES RES, DOI 10.1155/2008/865850; Pikas DS, 1998, J BIOL CHEM, V273, P18770, DOI 10.1074/jbc.273.30.18770; Potter-Perigo S, 2003, ARCH BIOCHEM BIOPHYS, V413, P182, DOI 10.1016/S0003-9861(03)00116-4; Radhakrishnan P, 2008, INT J BIOCHEM CELL B, V40, P1944, DOI 10.1016/j.biocel.2008.02.014; Sandwall E, 2010, GLYCOBIOLOGY, V20, P533, DOI 10.1093/glycob/cwp205; Sarrazin S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004952; Shin JT, 2012, AMYLOID, V19, P191, DOI 10.3109/13506129.2012.733741; Sipe JD, 2014, AMYLOID, V21, P221, DOI 10.3109/13506129.2014.964858; SNOW AD, 1989, NEUROBIOL AGING, V10, P481, DOI 10.1016/0197-4580(89)90108-5; SNOW AD, 1991, J HISTOCHEM CYTOCHEM, V39, P1321, DOI 10.1177/39.10.1940305; Takahashi I, 2009, BIOCHEM BIOPH RES CO, V383, P113, DOI 10.1016/j.bbrc.2009.03.140; Trikha S, 2011, J BIOL CHEM, V286, P36086, DOI 10.1074/jbc.M111.240762; Watson DJ, 1997, J BIOL CHEM, V272, P31617, DOI 10.1074/jbc.272.50.31617; Westermark GT, 2000, MOL MED, V6, P998, DOI 10.1007/BF03402051; Westermark GT, 2008, NEW ENGL J MED, V359, P977, DOI 10.1056/NEJMc0802893; WESTERMARK P, 1995, DIABETOLOGIA, V38, P543, DOI 10.1007/BF00400722; Westermark P, 2011, PHYSIOL REV, V91, P795, DOI 10.1152/physrev.00042.2009; Wiltzius JJW, 2008, PROTEIN SCI, V17, P1467, DOI 10.1110/ps.036509.108; YOUNG ID, 1992, ARCH PATHOL LAB MED, V116, P951; Zetser A, 2004, J CELL SCI, V117, P2249, DOI 10.1242/jcs.01068; Zhang SP, 2003, J BIOL CHEM, V278, P52810, DOI 10.1074/jbc.M308244200; Zhang SP, 1999, FEBS LETT, V455, P315, DOI 10.1016/S0014-5793(99)00894-7; Ziolkowski AF, 2012, J CLIN INVEST, V122, P132, DOI 10.1172/JCI46177	60	35	35	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15121	15132		10.1074/jbc.M114.631697	http://dx.doi.org/10.1074/jbc.M114.631697			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25922077	hybrid, Green Published			2022-12-28	WOS:000356177300027
J	Sahoo, SK; Shaikh, SA; Sopariwala, DH; Bal, NC; Bruhn, DS; Kopec, W; Khandelia, H; Periasamy, M				Sahoo, Sanjaya K.; Shaikh, Sana A.; Sopariwala, Danesh H.; Bal, Naresh C.; Bruhn, Dennis Skjoth; Kopec, Wojciech; Khandelia, Himanshu; Periasamy, Muthu			The N Terminus of Sarcolipin Plays an Important Role in Uncoupling Sarco-endoplasmic Reticulum Ca2+-ATPase (SERCA) ATP Hydrolysis from Ca2+ Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC SARCOPLASMIC-RETICULUM; CALCIUM-PUMP; FUNCTIONAL ASSOCIATION; CRYSTAL-STRUCTURES; HEAT-PRODUCTION; AMINO-ACIDS; PHOSPHOLAMBAN INHIBITION; CYTOPLASMIC DOMAIN; STRUCTURAL BASIS; PROTEIN	The sarcoendoplasmic reticulum Ca2+-ATPase (SERCA) is responsible for intracellular Ca2+ homeostasis. SERCA activity in muscle can be regulated by phospholamban (PLB), an affinity modulator, and sarcolipin (SLN), an uncoupler. Although PLB gets dislodged from Ca2+-bound SERCA, SLN continues to bind SERCA throughout its kinetic cycle and promotes uncoupling of Ca2+ transport from ATP hydrolysis. To determine the structural regions of SLN that mediate uncoupling of SERCA, we employed mutagenesis and generated chimeras of PLB and SLN. In this study we demonstrate that deletion of SLN N-terminal residues (2)ERSTQ leads to loss of the uncoupling function even though the truncated peptide can target and constitutively bind SERCA. Furthermore, molecular dynamics simulations of SLN and SERCA interaction showed a rearrangement of SERCA residues that is altered when the SLN N terminus is deleted. Interestingly, transfer of the PLB cytosolic domain to the SLN transmembrane (TM) and luminal tail causes the chimeric protein to lose SLN-like function. Further introduction of the PLB TM region into this chimera resulted in conversion to full PLB-like function. We also found that swapping PLB N and C termini with those from SLN caused the resulting chimera to acquire SLN-like function. Swapping the C terminus alone was not sufficient for this conversion. These results suggest that domains can be switched between SLN and PLB without losing the ability to regulate SERCA activity; however, the resulting chimeras acquire functions different from the parent molecules. Importantly, our studies highlight that the N termini of SLN and PLB influence their respective unique functions.	[Shaikh, Sana A.; Sopariwala, Danesh H.; Bal, Naresh C.; Periasamy, Muthu] Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Bruhn, Dennis Skjoth; Kopec, Wojciech; Khandelia, Himanshu] Univ Southern Denmark, Ctr Biomembrane Phys, MEMPHYS, DK-5230 Odense M, Denmark; [Sahoo, Sanjaya K.; Periasamy, Muthu] Sanford Burnham Med Res Inst Lake Nona, Orlando, FL 32827 USA	University System of Ohio; Ohio State University; University of Southern Denmark; Sanford Burnham Prebys Medical Discovery Institute	Periasamy, M (corresponding author), 013 Hamilton Hall,1645 Neil Ave, Columbus, OH 43210 USA.	periasamy.1@osu.edu	Regan, Clinton/E-6250-2012	Bruhn, Dennis Skjoth/0000-0003-1362-4747; Khandelia, Himanshu/0000-0001-9913-6394	National Institutes of Health [RO1-HL088555, RO1-DK098240-01]; American Heart Association [14POST20380847, 13PRE17000059]; Lundbeckfonden Young Investigator Grant; Lundbeck Foundation [R82-2011-7280] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098240] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Lundbeckfonden Young Investigator Grant; Lundbeck Foundation(Lundbeckfonden); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-HL088555 and RO1-DK098240-01 (to M. P.).; Supported by Postdoctoral Fellowship 14POST20380847 from the American Heart Association.; Supported by Pre-doctoral Fellowship 13PRE17000059 from the American Heart Association.; Supported by a Lundbeckfonden Young Investigator Grant.	Akin BL, 2013, J BIOL CHEM, V288, P30181, DOI 10.1074/jbc.M113.501585; ANDERSEN JP, 1995, J BIOL CHEM, V270, P908, DOI 10.1074/jbc.270.2.908; Asahi M, 2003, P NATL ACAD SCI USA, V100, P5040, DOI 10.1073/pnas.0330962100; Babu GJ, 2007, J MOL CELL CARDIOL, V43, P215, DOI 10.1016/j.yjmcc.2007.05.009; Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; Bhupathy P, 2007, J MOL CELL CARDIOL, V42, P903, DOI 10.1016/j.yjmcc.2007.03.738; Brittsan AG, 2000, J BIOL CHEM, V275, P12129, DOI 10.1074/jbc.275.16.12129; Butler J, 2007, CARDIOVASC RES, V74, P114, DOI 10.1016/j.cardiores.2007.01.006; Chen Z., 2005, J BIOL CHEM, V280, P10530; Chen Z, 2007, J BIOL CHEM, V282, P20968, DOI 10.1074/jbc.M703516200; Chen ZH, 2010, J BIOL CHEM, V285, P3253, DOI 10.1074/jbc.M109.080820; Chu GX, 2000, J BIOL CHEM, V275, P38938, DOI 10.1074/jbc.M004079200; CLARKE DM, 1989, J BIOL CHEM, V264, P11246; Daiho T, 2007, J BIOL CHEM, V282, P34429, DOI 10.1074/jbc.M707665200; Daiho T, 2014, J BIOL CHEM, V289, P31241, DOI 10.1074/jbc.M114.584086; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Meis L, 2002, J MEMBRANE BIOL, V188, P1, DOI 10.1007/s00232-001-0171-5; de Meis L, 2001, J BIOL CHEM, V276, P25078, DOI 10.1074/jbc.M103318200; Espinoza-Fonseca LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095979; Gorski PA, 2013, J BIOL CHEM, V288, P8456, DOI 10.1074/jbc.M112.446161; Gramolini AO, 2004, P NATL ACAD SCI USA, V101, P16807, DOI 10.1073/pnas.0407815101; Hellstern S, 2001, J BIOL CHEM, V276, P30845, DOI 10.1074/jbc.M102495200; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Inesi G, 2008, J BIOL CHEM, V283, P1189, DOI 10.1074/jbc.M707189200; Ji Y, 1999, ANAL BIOCHEM, V269, P236, DOI 10.1006/abio.1999.4059; Jones LR, 2002, J BIOL CHEM, V277, P28319, DOI 10.1074/jbc.M204085200; KISS E, 1995, CIRC RES, V77, P759, DOI 10.1161/01.RES.77.4.759; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Loubet B, 2014, J CHEM THEORY COMPUT, V10, P5690, DOI 10.1021/ct500100f; LUO WS, 1994, CIRC RES, V75, P401, DOI 10.1161/01.RES.75.3.401; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Magny EG, 2013, SCIENCE, V341, P1116, DOI 10.1126/science.1238802; Mall S, 2006, J BIOL CHEM, V281, P36597, DOI 10.1074/jbc.M606869200; Mascioni A, 2002, BIOCHEMISTRY-US, V41, P475, DOI 10.1021/bi011243m; Maurya SK, 2015, J BIOL CHEM, V290, P10840, DOI 10.1074/jbc.M115.636878; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; Odermatt A, 1997, GENOMICS, V45, P541, DOI 10.1006/geno.1997.4967; Odermatt A, 1998, J BIOL CHEM, V273, P12360, DOI 10.1074/jbc.273.20.12360; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Reddy LG, 1999, J BIOL CHEM, V274, P7649, DOI 10.1074/jbc.274.12.7649; Rowland LA, 2015, J BIOL CHEM, V290, P12282, DOI 10.1074/jbc.M115.637603; Sahoo SK, 2013, J BIOL CHEM, V288, P6881, DOI 10.1074/jbc.M112.436915; Smith WS, 2002, BIOCHEM J, V361, P277, DOI 10.1042/0264-6021:3610277; Sopariwala DH, 2015, J APPL PHYSIOL, V118, P1050, DOI 10.1152/japplphysiol.01066.2014; Takahashi M, 2007, P NATL ACAD SCI USA, V104, P5800, DOI 10.1073/pnas.0700979104; TOYOFUKU T, 1994, J BIOL CHEM, V269, P3088; TOYOFUKU T, 1993, J BIOL CHEM, V268, P2809; TOYOFUKU T, 1994, J BIOL CHEM, V269, P22929; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Toyoshima C, 2013, NATURE, V495, P260, DOI 10.1038/nature11899; Traaseth NJ, 2008, BIOCHEMISTRY-US, V47, P3, DOI 10.1021/bi701668v; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Winther AML, 2013, NATURE, V495, P265, DOI 10.1038/nature11900; Wolf MG, 2010, J COMPUT CHEM, V31, P2169, DOI 10.1002/jcc.21507; Yamasaki K, 2004, J BIOL CHEM, V279, P2202, DOI 10.1074/jbc.M309398200; Zheng JY, 2014, CIRC-HEART FAIL, V7, P194, DOI 10.1161/CIRCHEARTFAILURE.113.000519	60	42	43	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					14057	14067		10.1074/jbc.M115.636738	http://dx.doi.org/10.1074/jbc.M115.636738			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25882845	Green Published, hybrid			2022-12-28	WOS:000355313000035
J	Levefaudes, M; Patin, D; de Sousa-d'Auria, C; Chami, M; Blanot, D; Herve, M; Arthur, M; Houssin, C; Mengin-Lecreulx, D				Levefaudes, Marjorie; Patin, Delphine; de Sousa-d'Auria, Celia; Chami, Mohamed; Blanot, Didier; Herve, Mireille; Arthur, Michel; Houssin, Christine; Mengin-Lecreulx, Dominique			Diaminopimelic Acid Amidation in Corynebacteriales NEW INSIGHTS INTO THE ROLE OF LtsA IN PEPTIDOGLYCAN MODIFICATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UDP-N-ACETYLGLUCOSAMINE; ASPARAGINE SYNTHETASE-B; BACILLUS-SUBTILIS 168; ESCHERICHIA-COLI; CELL-WALL; OUTER-MEMBRANE; MYCOBACTERIUM-SMEGMATIS; LYSOZYME RESISTANCE; CYTOPLASMIC STEPS; GENE	A gene named ltsA was earlier identified in Rhodococcus and Corynebacterium species while screening for mutations leading to increased cell susceptibility to lysozyme. The encoded protein belonged to a huge family of glutamine amidotransferases whose members catalyze amide nitrogen transfer from glutamine to various specific acceptor substrates. We here describe detailed physiological and biochemical investigations demonstrating the specific role of LtsA protein from Corynebacterium glutamicum (LtsA(Cg)) in the modification by amidation of cell wall peptidoglycan diaminopimelic acid (DAP) residues. A morphologically altered but viable Delta ltsA mutant was generated, which displays a high susceptibility to lysozyme and beta-lactam antibiotics. Analysis of its peptidoglycan structure revealed a total loss of DAP amidation, a modification that was found in 80% of DAP residues in the wild-type polymer. The cell peptidoglycan content and cross-linking were otherwise not modified in the mutant. Heterologous expression of LtsA(Cg) in Escherichia coli yielded a massive and toxic incorporation of amidated DAP into the peptidoglycan that ultimately led to cell lysis. In vitro assays confirmed the amidotransferase activity of LtsA(Cg) and showed that this enzyme used the peptidoglycan lipid intermediates I and II but not, or only marginally, the UDP-MurNAc pentapeptide nucleotide precursor as acceptor substrates. As is generally the case for glutamine amidotransferases, either glutamine or NH4+ could serve as the donor substrate for LtsA(Cg). The enzyme did not amidate tripeptide-and tetrapeptide-truncated versions of lipid I, indicating a strict specificity for a pentapeptide chain length.	[Levefaudes, Marjorie; Patin, Delphine; de Sousa-d'Auria, Celia; Blanot, Didier; Herve, Mireille; Houssin, Christine; Mengin-Lecreulx, Dominique] Univ Paris 11, CNRS, CEA, Inst Integrat Biol Cell I2BC, F-91198 Gif Sur Yvette, France; [Chami, Mohamed] Univ Basel, Biozentrum, Ctr Cellular Imaging & NanoAnalyt C CINA, CH-4058 Basel, Switzerland; [Arthur, Michel] INSERM, UMR S1138, Ctr Rech Cordeliers, Equipe 12, F-75006 Paris, France; [Arthur, Michel] Univ Paris 06, Sorbonne Univ, UMR S1138, Ctr Rech Cordeliers, F-75006 Paris, France; [Arthur, Michel] Univ Paris 05, Sorbonne Paris Cite, UMR S1138, Ctr Rech Cordeliers, F-75006 Paris, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Basel; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Houssin, C (corresponding author), Univ Paris 11, Lab Biol Mol Corynebacteries & Mycobacteries, Bat 409, F-91405 Orsay, France.	christine.houssin@u-psud.fr; dominique.mengin-lecreulx@u-psud.fr	Arthur, Michel/G-3680-2013	Arthur, Michel/0000-0003-1007-636X; Sousa, Celia R/0000-0001-8988-3724; MENGIN-LECREULX, Dominique/0000-0003-3205-0275	CNRS [UMR 8619, UMR 8621]; University of Paris-Sud; Agence Nationale de la Recherche (Bactoprenyl Project) [ANR-11-BSV3-002]	CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Paris-Sud; Agence Nationale de la Recherche (Bactoprenyl Project)(French National Research Agency (ANR))	This work was supported by grants from CNRS (UMR 8619 and UMR 8621), the University of Paris-Sud, and the Agence Nationale de la Recherche (Bactoprenyl Project ANR-11-BSV3-002).	Ammam F, 2013, MOL MICROBIOL, V89, P612, DOI 10.1111/mmi.12299; Arbeloa A, 2004, J BIOL CHEM, V279, P41546, DOI 10.1074/jbc.M407149200; Atrih A, 1999, J BACTERIOL, V181, P3956, DOI 10.1128/JB.181.13.3956-3966.1999; Atrih A, 1998, J BACTERIOL, V180, P4603, DOI 10.1128/JB.180.17.4603-4612.1998; Barreteau H, 2009, J BACTERIOL, V191, P3657, DOI 10.1128/JB.01824-08; Bera A, 2005, MOL MICROBIOL, V55, P778, DOI 10.1111/j.1365-2958.2004.04446.x; Bera A, 2007, J BACTERIOL, V189, P280, DOI 10.1128/JB.01221-06; Bernard E, 2011, J BACTERIOL, V193, P6323, DOI 10.1128/JB.05060-11; BOEHLEIN SK, 1994, J BIOL CHEM, V269, P7450; BONAMY C, 1990, FEMS MICROBIOL LETT, V66, P263, DOI 10.1016/0378-1097(90)90294-Z; Bouhss A, 2004, J BIOL CHEM, V279, P29974, DOI 10.1074/jbc.M314165200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Crick DC, 2001, GLYCOBIOLOGY, V11, p107R, DOI 10.1093/glycob/11.9.107R; DAGERT M, 1979, GENE, V6, P23, DOI 10.1016/0378-1119(79)90082-9; Desmarais SM, 2013, MOL MICROBIOL, V89, P1, DOI 10.1111/mmi.12266; Dusch N, 1999, APPL ENVIRON MICROB, V65, P1530; El Ghachi M, 2006, J BIOL CHEM, V281, P22761, DOI 10.1074/jbc.M602834200; Figueiredo TA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002508; GEIS A, 1978, BIOCHIM BIOPHYS ACTA, V527, P414, DOI 10.1016/0005-2744(78)90355-8; Girardin SE, 2003, J BIOL CHEM, V278, P41702, DOI 10.1074/jbc.M307198200; GLAUNER B, 1988, ANAL BIOCHEM, V172, P451, DOI 10.1016/0003-2697(88)90468-X; Gupta R, 2010, NAT MED, V16, P466, DOI 10.1038/nm.2120; Hirasawa T, 2000, J BACTERIOL, V182, P2696, DOI 10.1128/JB.182.10.2696-2701.2000; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; HUMBERT R, 1980, J BACTERIOL, V142, P212, DOI 10.1128/JB.142.1.212-220.1980; JAYATISSA PM, 1976, J GEN MICROBIOL, V96, P165, DOI 10.1099/00221287-96-1-165; Kumar P, 2012, MOL MICROBIOL, V86, P367, DOI 10.1111/j.1365-2958.2012.08199.x; LAEMMLI UK, 1973, J MOL BIOL, V80, P575, DOI 10.1016/0022-2836(73)90198-8; Larsen TM, 1999, BIOCHEMISTRY-US, V38, P16146, DOI 10.1021/bi9915768; Lavollay M, 2011, J BACTERIOL, V193, P778, DOI 10.1128/JB.00606-10; Lavollay M, 2009, MOL MICROBIOL, V74, P650, DOI 10.1111/j.1365-2958.2009.06887.x; Mahapatra S, 2005, J BACTERIOL, V187, P2747, DOI 10.1128/JB.187.8.2747-2757.2005; Mahapatra S, 2005, J BACTERIOL, V187, P2341, DOI 10.1128/JB.187.7.2341-2347.2005; Mahapatra S, 2008, J BACTERIOL, V190, P655, DOI 10.1128/JB.00982-07; Marchand CH, 2012, J BACTERIOL, V194, P587, DOI 10.1128/JB.06138-11; MAUCK J, 1972, J BIOL CHEM, V247, P1180; MCNEIL M, 1990, J BIOL CHEM, V265, P18200; MENGINLECREULX D, 1982, J BACTERIOL, V151, P1109, DOI 10.1128/JB.151.3.1109-1117.1982; MENGINLECREULX D, 1983, J BACTERIOL, V154, P1284, DOI 10.1128/JB.154.3.1284-1290.1983; MENGINLECREULX D, 1991, J BACTERIOL, V173, P4625, DOI 10.1128/jb.173.15.4625-4636.1991; MENGINLECREULX D, 1985, J BACTERIOL, V163, P208, DOI 10.1128/JB.163.1.208-212.1985; Miller J. H., 1972, EXPT MOL GENETICS, P431; Mitani Y, 2005, J BACTERIOL, V187, P2582, DOI 10.1128/JB.187.8.2582-2591.2005; Munch D, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002509; PETIT JF, 1969, BIOCHEM BIOPH RES CO, V35, P478, DOI 10.1016/0006-291X(69)90371-4; Portevin D, 2004, P NATL ACAD SCI USA, V101, P314, DOI 10.1073/pnas.0305439101; Puech V, 2001, MICROBIOL-SGM, V147, P1365, DOI 10.1099/00221287-147-5-1365; Ren H, 2006, ANTIMICROB AGENTS CH, V50, P250, DOI 10.1128/AAC.50.1.250-255.2006; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Slamti L, 2011, J BACTERIOL, V193, P6266, DOI 10.1128/JB.05695-11; Veiga P, 2009, J BACTERIOL, V191, P3752, DOI 10.1128/JB.00126-09; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P287, DOI 10.1111/j.1574-6976.2007.00088.x; ZIPPERLE GF, 1984, CAN J MICROBIOL, V30, P553, DOI 10.1139/m84-083; Zuber B, 2008, J BACTERIOL, V190, P5672, DOI 10.1128/JB.01919-07	56	24	24	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13079	13094		10.1074/jbc.M115.642843	http://dx.doi.org/10.1074/jbc.M115.642843			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25847251	Green Published, hybrid			2022-12-28	WOS:000354975700012
J	McAtee, CO; Berkebile, AR; Elowsky, CG; Fangman, T; Barycki, JJ; Wahl, JK; Khalimonchuk, O; Naslavsky, N; Caplan, S; Simpson, MA				McAtee, Caitlin O.; Berkebile, Abigail R.; Elowsky, Christian G.; Fangman, Teresa; Barycki, Joseph J.; Wahl, James K., III; Khalimonchuk, Oleh; Naslavsky, Naava; Caplan, Steve; Simpson, Melanie A.			Hyaluronidase Hyal1 Increases Tumor Cell Proliferation and Motility through Accelerated Vesicle Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER; EXPRESSION; INTEGRIN; ACID; METASTASIS; MIGRATION; CD44	Hyaluronan (HA) turnover accelerates metastatic progression of prostate cancer in part by increasing rates of tumor cell proliferation and motility. To determine the mechanism, we overexpressed hyaluronidase 1 (Hyal1) as a fluorescent fusion protein and examined its impact on endocytosis and vesicular trafficking. Overexpression of Hyal1 led to increased rates of internalization of HA and the endocytic recycling marker transferrin. Live imaging of Hyal1, sucrose gradient centrifugation, and specific colocalization of Rab GTPases defined the subcellular distribution of Hyal1 as early and late endosomes, lysosomes, and recycling vesicles. Manipulation of vesicular trafficking by chemical inhibitors or with constitutively active and dominant negative Rab expression constructs caused atypical localization of Hyal1. Using the catalytically inactive point mutant Hyal1-E131Q, we found that enzymatic activity of Hyal1 was necessary for normal localization within the cell as Hyal1-E131Q was mainly detected within the endoplasmic reticulum. Expression of a HA-binding point mutant, Hyal1-Y202F, revealed that secretion of Hyal1 and concurrent reuptake from the extracellular space are critical for rapid HA internalization and cell proliferation. Overall, excess Hyal1 secretion accelerates endocytic vesicle trafficking in a substrate-dependent manner, promoting aggressive tumor cell behavior.	[McAtee, Caitlin O.; Berkebile, Abigail R.; Barycki, Joseph J.; Khalimonchuk, Oleh; Simpson, Melanie A.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Elowsky, Christian G.; Fangman, Teresa] Univ Nebraska, Morrison Microscopy Facil, Lincoln, NE 68588 USA; [Wahl, James K., III] Univ Nebraska Med Ctr, Dept Oral Biol, Coll Dent, Lincoln, NE 68503 USA; [Naslavsky, Naava; Caplan, Steve] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Caplan, Steve; Simpson, Melanie A.] Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Simpson, MA (corresponding author), Univ Nebraska, Dept Biochem, Beadle Ctr N246, 1901 Vine St, Lincoln, NE 68588 USA.	msimpson2@unl.edu	Regan, Clinton/E-6250-2012; Khalimonchuk, Oleh/AAM-1194-2021	Khalimonchuk, Oleh/0000-0002-3972-8678	National Institutes of Health [R01 CA165574, R01 GM087455, R01 GM074876]; Institutional Development Award from the NIGMS [5P30GM106397]; Nebraska Research Initiative; NATIONAL CANCER INSTITUTE [R01CA165574] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103335, P30GM106397, R01GM087455, R01GM074876] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institutional Development Award from the NIGMS; Nebraska Research Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA165574 (to M. A. S.), R01 GM087455 and R01 GM074876 (to S. C.) and by Institutional Development Award 5P30GM106397 from the NIGMS (to M. A. S. and S. C.). This work was also supported by a Nebraska Research Initiative grant (to M. A. S. and S. C.).	Aaltomaa S, 2002, UROL INT, V69, P266, DOI 10.1159/000066123; Anttila MA, 2000, CANCER RES, V60, P150; Auvinen P, 2000, AM J PATHOL, V156, P529, DOI 10.1016/S0002-9440(10)64757-8; Bharadwaj AG, 2007, J BIOL CHEM, V282, P20561, DOI 10.1074/jbc.M702964200; Bharadwaj AG, 2011, EXP CELL RES, V317, P1214, DOI 10.1016/j.yexcr.2011.01.026; Bharadwaj AG, 2009, AM J PATHOL, V174, P1027, DOI 10.2353/ajpath.2009.080501; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Bullen JW, 2014, J BIOL CHEM, V289, P10592, DOI 10.1074/jbc.M113.523068; Caswell P, 2008, TRENDS CELL BIOL, V18, P257, DOI 10.1016/j.tcb.2008.03.004; Caswell PT, 2007, DEV CELL, V13, P496, DOI 10.1016/j.devcel.2007.08.012; CLAGUE MJ, 1994, J BIOL CHEM, V269, P21; Eyster CA, 2009, TRAFFIC, V10, P590, DOI 10.1111/j.1600-0854.2009.00894.x; Franzmann EJ, 2003, INT J CANCER, V106, P438, DOI 10.1002/ijc.11252; Gilcrease MZ, 2007, CANCER LETT, V247, P1, DOI 10.1016/j.canlet.2006.03.031; Gomez CS, 2009, J UROLOGY, V182, P1350, DOI 10.1016/j.juro.2009.06.070; Harada H, 2007, J BIOL CHEM, V282, P5597, DOI 10.1074/jbc.M608358200; Hascall VC, 2014, MATRIX BIOL, V35, P14, DOI 10.1016/j.matbio.2014.01.014; HELMS JB, 1992, NATURE, V360, P352, DOI 10.1038/360352a0; Koshkaryev A, 2012, CANCER BIOL THER, V13, P50, DOI 10.4161/cbt.13.1.18871; Kothapalli D, 2007, J CELL BIOL, V176, P535, DOI 10.1083/jcb.200611058; Kramer MW, 2011, CANCER-AM CANCER SOC, V117, P1197, DOI 10.1002/cncr.25565; KROGSTAD DJ, 1987, AM J TROP MED HYG, V36, P213, DOI 10.4269/ajtmh.1987.36.213; McAtee CO, 2014, ADV CANCER RES, V123, P1, DOI 10.1016/B978-0-12-800092-2.00001-0; Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Puissant E, 2014, TRAFFIC, V15, P500, DOI 10.1111/tra.12162; Ramsay AG, 2007, CANCER METAST REV, V26, P567, DOI 10.1007/s10555-007-9078-7; Richardson DR, 2005, CURR MED CHEM, V12, P2711, DOI 10.2174/092986705774462996; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Slomiany MG, 2009, CANCER RES, V69, P4992, DOI 10.1158/0008-5472.CAN-09-0143; Slomiany MG, 2009, CANCER RES, V69, P1293, DOI 10.1158/0008-5472.CAN-08-2491; Tammi R, 2001, J BIOL CHEM, V276, P35111, DOI 10.1074/jbc.M103481200; Vigetti D, 2014, FEBS J, V281, P4980, DOI 10.1111/febs.12938; Zhang L, 2009, J BIOL CHEM, V284, P9433, DOI 10.1074/jbc.M900210200	35	18	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13144	13156		10.1074/jbc.M115.647446	http://dx.doi.org/10.1074/jbc.M115.647446			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25855794	Green Published, hybrid			2022-12-28	WOS:000354975700017
J	Ranninger, C; Rurik, M; Limonciel, A; Ruzek, S; Reischl, R; Wilmes, A; Jennings, P; Hewitt, P; Dekant, W; Kohlbacher, O; Huber, CG				Ranninger, Christina; Rurik, Marc; Limonciel, Alice; Ruzek, Silke; Reischl, Roland; Wilmes, Anja; Jennings, Paul; Hewitt, Philip; Dekant, Wolfgang; Kohlbacher, Oliver; Huber, Christian G.			Nephron Toxicity Profiling via Untargeted Metabolome Analysis Employing a High Performance Liquid Chromatography-Mass Spectrometry-based Experimental and Computational Pipeline	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPECTRAL DATA; PROTEOMICS; DATABASE; CELLS; ACID; DELINEATION; STRATEGIES; WORKFLOW; STRESS; SYSTEM	Untargeted metabolomics has the potential to improve the predictivity of in vitro toxicity models and therefore may aid the replacement of expensive and laborious animal models. Here we describe a long term repeat dose nephrotoxicity study conducted on the human renal proximal tubular epithelial cell line, RPTEC/TERT1, treated with 10 and 35 mu mol.liter(-1) of chloroacetaldehyde, a metabolite of the anti-cancer drug ifosfamide. Our study outlines the establishment of an automated and easy to use untargeted metabolomics workflow for HPLC-high resolution mass spectrometry data. Automated data analysis work-flows based on open source software (OpenMS, KNIME) enabled a comprehensive and reproducible analysis of the complex and voluminous metabolomics data produced by the profiling approach. Time-and concentration-dependent responses were clearly evident in the metabolomic profiles. To obtain a more comprehensive picture of the mode of action, transcriptomics and proteomics data were also integrated. For toxicity profiling of chloroacetaldehyde, 428 and 317 metabolite features were detectable in positive and negative modes, respectively, after stringent removal of chemical noise and unstable signals. Changes upon treatment were explored using principal component analysis, and statistically significant differences were identified using linear models for microarray assays. The analysis revealed toxic effects only for the treatment with 35 mmol.liter(-1) for 3 and 14 days. The most regulated metabolites were glutathione and metabolites related to the oxidative stress response of the cells. These findings are corroborated by proteomics and transcriptomics data, which show, among other things, an activation of the Nrf2 and ATF4 pathways.	[Ranninger, Christina; Ruzek, Silke; Reischl, Roland; Huber, Christian G.] Salzburg Univ, Dept Mol Biol, Div Chem & Bioanalyt, A-5020 Salzburg, Austria; [Rurik, Marc; Kohlbacher, Oliver] Univ Tubingen, Appl Bioinformat Grp, Ctr Bioinformat, Quantitat Biol Ctr, D-72076 Tubingen, Germany; [Rurik, Marc; Kohlbacher, Oliver] Univ Tubingen, Dept Comp Sci, D-72076 Tubingen, Germany; [Limonciel, Alice; Wilmes, Anja; Jennings, Paul] Med Univ Innsbruck, Div Physiol, Dept Physiol & Med Phys, A-6020 Innsbruck, Austria; [Hewitt, Philip] Nonclin Safety, Merck KGaA, Merck Serono, D-64293 Darmstadt, Germany; [Dekant, Wolfgang] Univ Wurzburg, Dept Toxicol, D-97078 Wurzburg, Germany	Salzburg University; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Medical University of Innsbruck; Merck KGaA; EMD Serono Inc.; University of Wurzburg	Huber, CG (corresponding author), Salzburg Univ, Dept Mol Biol, Div Chem & Bioanalyt, Hellbrunner Str 34, A-5020 Salzburg, Austria.	c.huber@sbg.ac.at	Reischl, Roland/AAP-7190-2020; Huber, Christian G./E-5445-2011; Reischl, Roland J/I-4046-2012; Kohlbacher, Oliver/AAF-3297-2021	Huber, Christian G./0000-0001-8358-1880; Reischl, Roland J/0000-0003-3331-6565; Kohlbacher, Oliver/0000-0003-1739-4598; Jennings, Paul/0000-0002-6860-2898; Wilmes, Anja/0000-0001-9485-4565; Limonciel, Alice/0000-0001-6588-5944	European Union [202222]; Austrian Society for Analytical Chemistry	European Union(European Commission); Austrian Society for Analytical Chemistry	This work was supported by the European Union's 7th Framework Programme FP7/2007-2013 under Grant Agreement 202222, Predict-IV. Part of this work was presented by C. R. at Metabolomics 2013 in Glasgow, for which she received a travel grant awarded by the Austrian Society for Analytical Chemistry. The authors declare no other competing financial interest.	Aschauer L., 2014, TOXICOL IN IN PRESS; Aschauer L, 2013, MOL CELL BIOL, V33, P2535, DOI 10.1128/MCB.01435-12; Berthold M. R., 2008, KNIME KONSTANZ INFOR; Bijlsma S, 2006, ANAL CHEM, V78, P567, DOI 10.1021/ac051495j; Bloomfield V.A., 2014, USING R NUMERICAL AN; BRASSFIELD HA, 1975, J AM CHEM SOC, V97, P4143, DOI 10.1021/ja00847a053; Breitwieser FP, 2011, J PROTEOME RES, V10, P2758, DOI 10.1021/pr1012784; Brown M, 2005, METABOLOMICS, V1, P39, DOI 10.1007/s11306-005-1106-4; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; Cuperlovic-Culf M, 2010, DRUG DISCOV TODAY, V15, P610, DOI 10.1016/j.drudis.2010.06.012; Dickinson DA, 2004, FREE RADICAL BIO MED, V37, P1152, DOI 10.1016/j.freeradbiomed.2004.06.011; Ellis JK, 2011, MOL BIOSYST, V7, P247, DOI 10.1039/c0mb00146e; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Horai H, 2010, J MASS SPECTROM, V45, P703, DOI 10.1002/jms.1777; Huang N, 1999, J AM SOC MASS SPECTR, V10, P1166, DOI 10.1016/S1044-0305(99)00089-6; Jeanmougin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012336; Jenkins S, 2013, METABOLITES, V3, P1102, DOI 10.3390/metabo3041102; Junker J, 2012, J PROTEOME RES, V11, P3914, DOI 10.1021/pr300187f; Kenar E, 2014, MOL CELL PROTEOMICS, V13, P348, DOI 10.1074/mcp.M113.031278; Kleinstreuer NC, 2011, TOXICOL APPL PHARM, V257, P111, DOI 10.1016/j.taap.2011.08.025; Kohlbacher O, 2007, BIOINFORMATICS, V23, pE191, DOI 10.1093/bioinformatics/btl299; Kumar A, 2012, CURR SCI INDIA, V102, P288; Lommen A, 2009, ANAL CHEM, V81, P3079, DOI 10.1021/ac900036d; Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314; Patti GJ, 2011, J SEP SCI, V34, P3460, DOI 10.1002/jssc.201100532; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Ramautar R, 2013, CURR OPIN CHEM BIOL, V17, P841, DOI 10.1016/j.cbpa.2013.06.015; Roux A, 2011, CLIN BIOCHEM, V44, P119, DOI 10.1016/j.clinbiochem.2010.08.016; Ruiz-Aracama A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-251; Savitha S, 2005, CLIN CHIM ACTA, V355, P173, DOI 10.1016/j.cccn.2004.12.005; Scheltema RA, 2011, ANAL CHEM, V83, P2786, DOI 10.1021/ac2000994; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Sturm M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-163; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Tautenhahn R, 2012, NAT BIOTECHNOL, V30, P826, DOI 10.1038/nbt.2348; West PR, 2010, TOXICOL APPL PHARM, V247, P18, DOI 10.1016/j.taap.2010.05.007; Wieser M, 2008, AM J PHYSIOL-RENAL, V295, pF1365, DOI 10.1152/ajprenal.90405.2008; Wilmes A, 2015, TOXICOL IN VITRO, V30, P117, DOI 10.1016/j.tiv.2014.10.006; Wilmes A, 2013, J PROTEOMICS, V79, P180, DOI 10.1016/j.jprot.2012.11.022; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Wojtczak L, 2003, BIOFACTORS, V17, P61, DOI 10.1002/biof.5520170107; Yapar K, 2007, EXP TOXICOL PATHOL, V59, P121, DOI 10.1016/j.etp.2007.02.009	45	9	10	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19121	19132		10.1074/jbc.M115.644146	http://dx.doi.org/10.1074/jbc.M115.644146			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26055719	hybrid, Green Published			2022-12-28	WOS:000358781100028
J	Krokowski, D; Jobava, R; Guan, BJ; Farabaugh, K; Wu, J; Majumder, M; Bianchi, MG; Snider, MD; Bussolati, O; Hatzoglou, M				Krokowski, Dawid; Jobava, Raul; Guan, Bo-Jhih; Farabaugh, Kenneth; Wu, Jing; Majumder, Mithu; Bianchi, Massimiliano G.; Snider, Martin D.; Bussolati, Ovidio; Hatzoglou, Maria			Coordinated Regulation of the Neutral Amino Acid Transporter SNAT2 and the Protein Phosphatase Subunit GADD34 Promotes Adaptation to Increased Extracellular Osmolarity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; MESSENGER-RNA TRANSLATION; GENE-EXPRESSION; CELL-DEATH; ER-STRESS; MAMMALIAN-CELLS; ALPHA-SUBUNIT; SYSTEM-A; PHOSPHORYLATION; INHIBITION	Cells respond to shrinkage induced by increased extracellular osmolarity via programmed changes in gene transcription and mRNA translation. The immediate response to this stress includes the induction of expression of the neutral amino acid transporter SNAT2. Increased SNAT2-mediated uptake of neutral amino acids is an essential adaptive mechanism for restoring cell volume. In contrast, stress-induced phosphorylation of the alpha subunit of the translation initiation factor eIF2 (eIF2 alpha) can promote apoptosis. Here we show that the response to mild hyperosmotic stress involves regulation of the phosphorylation of eIF2 alpha by increased levels of GADD34, a regulatory subunit of protein phosphatase 1 (PP1). The induction of GADD34 was dependent on transcriptional control by the c-Jun-binding cAMP response element in the GADD34 gene promoter and posttranscriptional stabilization of its mRNA. This mechanism differs from the regulation of GADD34 expression by other stresses that involve activating transcription factor 4 (ATF4). ATF4 was not translated during hyperosmotic stress despite an increase in eIF2 alpha phosphorylation. The SNAT2-mediated increase in amino acid uptake was enhanced by increased GADD34 levels in a manner involving decreased eIF2 alpha phosphorylation. It is proposed that the induction of the SNAT2/GADD34 axis enhances cell survival by promoting the immediate adaptive response to stress.	[Krokowski, Dawid; Jobava, Raul; Guan, Bo-Jhih; Farabaugh, Kenneth; Wu, Jing; Majumder, Mithu; Hatzoglou, Maria] Case Western Reserve Univ, Dept Pharmacol, Sch Med, Cleveland, OH 44106 USA; [Snider, Martin D.] Case Western Reserve Univ, Dept Biochem, Sch Med, Cleveland, OH 44106 USA; [Bianchi, Massimiliano G.; Bussolati, Ovidio] Univ Parma, Dept Biomed Biotechnol & Translat Sci, I-43100 Parma, Italy	Case Western Reserve University; Case Western Reserve University; University of Parma	Krokowski, D (corresponding author), Case Western Reserve Univ, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	dawid.krokowski@case.edu; mxh8@case.edu	Bussolati, Ovidio/B-7589-2013; Regan, Clinton/E-6250-2012	Bussolati, Ovidio/0000-0002-4301-2939; BIANCHI, Massimiliano/0000-0002-4179-6573	National Institutes of Health [R37-DK60596, R01-DK53307]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK060596, R01DK053307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008056] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R37-DK60596 and R01-DK53307 (to M. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Bevilacqua E, 2005, FEBS LETT, V579, P3376, DOI 10.1016/j.febslet.2005.05.002; Bevilacqua E, 2010, J BIOL CHEM, V285, P17098, DOI 10.1074/jbc.M110.109439; Bror S, 2014, PFLUG ARCH EUR J PHY, V466, P155, DOI 10.1007/s00424-013-1393-y; Brush MH, 2003, MOL CELL BIOL, V23, P1292, DOI 10.1128/MCB.23.4.1292-1303.2003; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Dey S, 2010, J BIOL CHEM, V285, P33165, DOI 10.1074/jbc.M110.167213; Eisner V, 2006, FEBS LETT, V580, P3469, DOI 10.1016/j.febslet.2006.05.023; Farook JM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.280; Franchi-Gazzola R, 2006, ACTA PHYSIOL, V187, P273, DOI 10.1111/j.1748-1716.2006.01552.x; Franchi-Gazzola R, 2004, BBA-BIOMEMBRANES, V1667, P157, DOI 10.1016/j.bbamem.2004.09.012; Fransson L, 2014, CELL BIOCHEM FUNCT, V32, P445, DOI 10.1002/cbf.3036; Gaccioli F, 2006, J BIOL CHEM, V281, P17929, DOI 10.1074/jbc.M600341200; Guan BJ, 2014, J BIOL CHEM, V289, P12593, DOI 10.1074/jbc.M113.543215; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Haneda M, 2004, GENE, V336, P139, DOI 10.1016/j.gene.2004.04.008; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Jeon US, 2006, ACTA PHYSIOL, V187, P241, DOI 10.1111/j.1748-1716.2006.01551.x; Jiang HY, 2005, J BIOL CHEM, V280, P14189, DOI 10.1074/jbc.M413660200; Jousse C, 2003, J CELL BIOL, V163, P767, DOI 10.1083/jcb.200308075; Kloft N, 2012, J BIOL CHEM, V287, P35299, DOI 10.1074/jbc.M112.379883; Kojima E, 2003, FASEB J, V17, P1573, DOI 10.1096/fj.02-1184fje; Krokowski D, 2013, J BIOL CHEM, V288, P17202, DOI 10.1074/jbc.M113.466920; Krokowski D, 2011, CELL CYCLE, V10, P2691, DOI 10.4161/cc.10.16.16844; Lee JH, 2008, INVEST OPHTH VIS SCI, V49, P1827, DOI 10.1167/iovs.07-1142; Lee YY, 2009, J BIOL CHEM, V284, P6661, DOI 10.1074/jbc.M806735200; Lewerenz J, 2009, J BIOL CHEM, V284, P1106, DOI 10.1074/jbc.M807325200; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Maallem S, 2008, J NEUROCHEM, V105, P1198, DOI 10.1111/j.1471-4159.2008.05222.x; Majumder M, 2012, MOL CELL BIOL, V32, P992, DOI 10.1128/MCB.06665-11; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Nardi F, 2015, J BIOL CHEM, V290, P8173, DOI 10.1074/jbc.M114.625137; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Reid DW, 2014, CELL, V158, P1362, DOI 10.1016/j.cell.2014.08.012; Rutkowski DT, 2007, TRENDS BIOCHEM SCI, V32, P469, DOI 10.1016/j.tibs.2007.09.003; Saikia M, 2012, J BIOL CHEM, V287, P42708, DOI 10.1074/jbc.M112.371799; Seo J, 2009, DIABETES, V58, P2565, DOI 10.2337/db09-0335; Spriggs KA, 2008, BIOL CELL, V100, P27, DOI 10.1042/BC20070098; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec; Zhou W, 2013, J BIOL CHEM, V288, P33146, DOI 10.1074/jbc.M113.504407	43	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					17822	17837		10.1074/jbc.M114.636217	http://dx.doi.org/10.1074/jbc.M114.636217			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26041779	Green Published, hybrid			2022-12-28	WOS:000358511700019
J	Birkholz, A; Nemcovic, M; Yu, ED; Girardi, E; Wang, J; Khurana, A; Pauwels, N; Farber, E; Chitale, S; Franck, RW; Tsuji, M; Howell, A; Van Calenbergh, S; Kronenberg, M; Zajonc, DM				Birkholz, Alysia; Nemcovic, Marek; Yu, Esther Dawen; Girardi, Enrico; Wang, Jing; Khurana, Archana; Pauwels, Nora; Farber, Elisa; Chitale, Sampada; Franck, Richard W.; Tsuji, Moriya; Howell, Amy; Van Calenbergh, Serge; Kronenberg, Mitchell; Zajonc, Dirk M.			Lipid and Carbohydrate Modifications of alpha-Galactosylcer-amide Differently Influence Mouse and Human Type I Natural Killer T Cell Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIGEN PRESENTATION; MOLECULAR-BASIS; HUMAN CD1D; NKT CELLS; RECOGNITION; TCR; GLYCOLIPIDS; LIGAND; BINDING; STIMULATION	The ability of different glycosphingolipids (GSLs) to activate type I natural killer T cells (NKT cells) has been known for 2 decades. The possible therapeutic use of these GSLs has been studied in many ways; however, studies are needed in which the efficacy of promising GSLs is compared under identical conditions. Here, we compare five unique GSLs structurally derived from alpha-galactosylceramide. We employed biophysical and biological assays, as well as x-ray crystallography to study the impact of the chemical modifications of the antigen on type I NKT cell activation. Although all glycolipids are bound by the T cell receptor of type I NKT cells in real time binding assays with high affinity, only a few activate type INKT cells in in vivo or in vitro experiments. The differences in biological responses are likely a result of different pharmacokinetic properties of each lipid, which carry modifications at different parts of the molecule. Our results indicate a need to perform a variety of assays to ascertain the therapeutic potential of type I NKT cell GSL activators.	[Birkholz, Alysia; Nemcovic, Marek; Yu, Esther Dawen; Girardi, Enrico; Wang, Jing; Zajonc, Dirk M.] La Jolla Inst Allergy & Immunol, Div Cell Biol, La Jolla, CA 92037 USA; [Birkholz, Alysia; Khurana, Archana; Kronenberg, Mitchell] La Jolla Inst Allergy & Immunol, Div Dev Immunol, La Jolla, CA 92037 USA; [Birkholz, Alysia; Kronenberg, Mitchell] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92037 USA; [Pauwels, Nora; Van Calenbergh, Serge] Univ Ghent, Dept Pharmaceut, Med Chem Lab, B-9000 Ghent, Belgium; [Franck, Richard W.] CUNY Hunter Coll, Dept Chem, New York, NY 10021 USA; [Tsuji, Moriya] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA; [Farber, Elisa; Chitale, Sampada; Howell, Amy] Univ Connecticut, Dept Chem, Storrs, CT 06269 USA; [Zajonc, Dirk M.] Univ Ghent, Fac Med & Hlth Sci, Dept Internal Med, B-9000 Ghent, Belgium	La Jolla Institute for Immunology; La Jolla Institute for Immunology; University of California System; University of California San Diego; Ghent University; City University of New York (CUNY) System; Hunter College (CUNY); Rockefeller University; University of Connecticut; Ghent University	Zajonc, DM (corresponding author), La Jolla Inst Allergy & Immunol, Div Cell Biol, 9420 Athena Circle, La Jolla, CA 92037 USA.	dzajonc@lji.org	Girardi, Enrico/AAD-2260-2020; Van Calenbergh, Serge/A-3167-2008; Kronenberg, Mitchell/AAT-6078-2021; Yu, Dawen/AAE-6444-2019; Girardi, Enrico/L-4033-2014	Girardi, Enrico/0000-0003-3508-2723; Van Calenbergh, Serge/0000-0002-4201-1264; Yu, Dawen/0000-0002-3970-3753; Girardi, Enrico/0000-0003-3508-2723; Tsuji, Moriya/0000-0001-8587-277X; Howell, Amy/0000-0003-1958-6411; Birkholz, Alysia/0000-0002-3794-5636	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; Department of Energy Office of Biological and Environmental Research; National Institutes of Health from NIGMS [P41GM103393]; Office of Science, Office of Basic Energy Sciences, United States Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071922, R37AI071922, R21AI107318, R01AI070258, R01AI045053, R01AI074952] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087136, P41GM103393] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Office of Science, Office of Basic Energy Sciences, United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Stanford Synchrotron Radiation Lightsource and the Advanced Light Source for access to remote data collection. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research, and by National Institutes of Health Grant P41GM103393 from NIGMS. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, United States Department of Energy under Contract No. DE-AC02-05CH11231.	Anderson BL, 2013, MOLECULES, V18, P15662, DOI 10.3390/molecules181215662; Aspeslagh S, 2013, J IMMUNOL, V191, P2916, DOI 10.4049/jimmunol.1203134; Aspeslagh S, 2011, EMBO J, V30, P2294, DOI 10.1038/emboj.2011.145; Banchet-Cadeddu A, 2011, ORG BIOMOL CHEM, V9, P3080, DOI 10.1039/c0ob00975j; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; Brennan PJ, 2013, NAT REV IMMUNOL, V13, P101, DOI 10.1038/nri3369; Brossay L, 1998, J IMMUNOL, V160, P3681; CALABI F, 1986, NATURE, V323, P540, DOI 10.1038/323540a0; Costantino V, 1997, J AM CHEM SOC, V119, P12465, DOI 10.1021/ja9727225; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Girardi E, 2012, IMMUNOL REV, V250, P167, DOI 10.1111/j.1600-065X.2012.01166.x; Huang J, 2010, NATURE, V464, P932, DOI 10.1038/nature08944; Joyce S, 2011, J IMMUNOL, V187, P1081, DOI 10.4049/jimmunol.1001910; Kakuta S, 2002, IMMUNOLOGY, V105, P92, DOI 10.1046/j.0019-2805.2001.01342.x; Koch M, 2005, NAT IMMUNOL, V6, P819, DOI 10.1038/ni1225; Lawton AP, 2005, J IMMUNOL, V174, P3179, DOI 10.4049/jimmunol.174.6.3179; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li XM, 2010, P NATL ACAD SCI USA, V107, P13010, DOI 10.1073/pnas.1006662107; Li XM, 2009, J IMMUNOL, V183, P4415, DOI 10.4049/jimmunol.0901021; Li YL, 2010, J EXP MED, V207, P2383, DOI 10.1084/jem.20101335; Liu BY, 2014, CELL, V157, P357, DOI 10.1016/j.cell.2014.02.053; Mallevaey T, 2011, IMMUNITY, V34, P315, DOI 10.1016/j.immuni.2011.01.013; MORITA M, 1995, J MED CHEM, V38, P2176, DOI 10.1021/jm00012a018; Naidenko OV, 1999, J EXP MED, V190, P1069, DOI 10.1084/jem.190.8.1069; Padte NN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078407; Padte NN, 2011, CLIN IMMUNOL, V140, P142, DOI 10.1016/j.clim.2010.11.009; Patel O, 2011, J IMMUNOL, V187, P4705, DOI 10.4049/jimmunol.1100794; Pellicci DG, 2009, IMMUNITY, V31, P47, DOI 10.1016/j.immuni.2009.04.018; Petrovsky N, 2004, IMMUNOL CELL BIOL, V82, P488, DOI 10.1111/j.0818-9641.2004.01272.x; Robertson FC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00543; Rogers PR, 2004, J IMMUNOL METHODS, V285, P197, DOI 10.1016/j.jim.2003.12.003; Roozbeh M, 2014, IMMUNOPHARM IMMUNOT, V36, P105, DOI 10.3109/08923973.2014.897726; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Rossjohn J, 2012, NAT REV IMMUNOL, V12, P845, DOI 10.1038/nri3328; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Schmieg J, 2003, J EXP MED, V198, P1631, DOI 10.1084/jem.20031192; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Tyznik AJ, 2011, CHEM BIOL, V18, P1620, DOI 10.1016/j.chembiol.2011.10.015; Venkataswamy MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108383; Wang J, 2010, P NATL ACAD SCI USA, V107, P1535, DOI 10.1073/pnas.0909479107; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wun KS, 2012, J BIOL CHEM, V287, P39139, DOI 10.1074/jbc.M112.412320; Wun KS, 2011, IMMUNITY, V34, P327, DOI 10.1016/j.immuni.2011.02.001; Xu X, 2014, CANCER RES, V74, P6260, DOI 10.1158/0008-5472.CAN-14-1169; Yu KOA, 2005, IMMUNOL LETT, V100, P42, DOI 10.1016/j.imlet.2005.06.010; Zajonc DM, 2007, CURR TOP MICROBIOL, V314, P27; Zajonc DM, 2005, J EXP MED, V202, P1517, DOI 10.1084/jem.20051625	48	13	14	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17206	17217		10.1074/jbc.M115.654814	http://dx.doi.org/10.1074/jbc.M115.654814			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26018083	hybrid, Green Published			2022-12-28	WOS:000357730900017
J	Tremblay, MG; Herdman, C; Guillou, F; Mishra, PK; Baril, J; Bellenfant, S; Moss, T				Tremblay, Michel G.; Herdman, Chelsea; Guillou, Francois; Mishra, Prakash K.; Baril, Joelle; Bellenfant, Sabrina; Moss, Tom			Extended Synaptotagmin Interaction with the Fibroblast Growth Factor Receptor Depends on Receptor Conformation, Not Catalytic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dimerization; fibroblast growth factor receptor (FGFR); receptor endocytosis; receptor modification; receptor structure-function; receptor tyrosine kinase; ESyt-FGFR complex; Extended-Synaptotagmin (ESyt1; 2; 3); FGFR activity; FGFR conformation	POINT MUTATION; BINDING-SITE; SH2 DOMAIN; IN-VIVO; KINASE; PROTEINS; AUTOPHOSPHORYLATION; ENDOCYTOSIS; CELLS; POLYETHYLENIMINE	Background: Extended Synaptotagmins selectively bind the active FGF receptor but the mechanism is unknown. Results: ESyt2 and 3 but not ESyt1 recognize the active conformation of the FGF receptor independently of catalytic activity. Conclusion: ESyt2 and probably ESyt3 access the active cleft of the FGFR1 kinase domain. Significance: How ESyts recognize FGFRs is essential to understanding how they modulate receptor signaling. We previously demonstrated that ESyt2 interacts specifically with the activated FGF receptor and is required for a rapid phase of receptor internalization and for functional signaling via the ERK pathway in early Xenopus embryos. ESyt2 is one of the three-member family of Extended Synaptotagmins that were recently shown to be implicated in the formation of endoplasmic reticulum (ER)-plasma membrane (PM) junctions and in the Ca2+ dependent regulation of these junctions. Here we show that ESyt2 is directed to the ER by its putative transmembrane domain, that the ESyts hetero- and homodimerize, and that ESyt2 homodimerization in vivo requires a TM adjacent sequence but not the SMP domain. ESyt2 and ESyt3, but not ESyt1, selectively interact in vivo with activated FGFR1. In the case of ESyt2, this interaction requires a short TM adjacent sequence and is independent of receptor autophosphorylation, but dependent on receptor conformation. The data show that ESyt2 recognizes a site in the upper kinase lobe of FGFR1 that is revealed by displacement of the kinase domain activation loop during receptor activation.	[Moss, Tom] Quebec Univ Hosp Res Ctr, Canc Div, St Patrick Res Grp Basic Oncol, Lab Growth & Dev, Quebec City, PQ G1R 3S3, Canada; Univ Laval, Fac Med, Dept Mol Biol Med Biochem & Pathol, Quebec City, PQ G1R 3S3, Canada	Laval University	Moss, T (corresponding author), Quebec Univ Hosp Res Ctr, Canc Div, St Patrick Res Grp Basic Oncol, Lab Growth & Dev, Edifice St Patrick,9 Rue McMahon, Quebec City, PQ G1R 3S3, Canada.	Tom.Moss@crhdq.ulaval.ca		Moss, Thomas (Tom)/0000-0003-2047-4783	Cancer Research Society (CRS/SRC); FRSQ (Quebec)	Cancer Research Society (CRS/SRC); FRSQ (Quebec)(Fonds de la Recherche en Sante du Quebec)	This work was supported by a Cancer Research Society (CRS/SRC) grant (to T. M.). The Quebec University Hospital Research Centre (CR-CHU de Quebec) is supported by a grant from the FRSQ (Quebec). The authors declare that they have no conflicts of interest with the contents of this article.	Andersen CBF, 2014, TRENDS BIOCHEM SCI, V39, P82, DOI 10.1016/j.tibs.2013.12.003; Bae JH, 2010, MOL CELLS, V29, P443, DOI 10.1007/s10059-010-0080-5; Bae JH, 2010, P NATL ACAD SCI USA, V107, P2866, DOI 10.1073/pnas.0914157107; Bae JH, 2009, CELL, V138, P514, DOI 10.1016/j.cell.2009.05.028; BELLOT F, 1991, EMBO J, V10, P2849, DOI 10.1002/j.1460-2075.1991.tb07834.x; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Chang CL, 2013, CELL REP, V5, P813, DOI 10.1016/j.celrep.2013.09.038; Creutz CE, 2004, CELL MOL LIFE SCI, V61, P1208, DOI 10.1007/s00018-004-4029-8; Furdui CM, 2006, MOL CELL, V21, P711, DOI 10.1016/j.molcel.2006.01.022; Giordano F, 2013, CELL, V153, P1494, DOI 10.1016/j.cell.2013.05.026; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Herdman C, 2014, CELL CYCLE, V13, P2616, DOI 10.4161/15384101.2014.943573; Jean S, 2012, BIOL OPEN, V1, P731, DOI 10.1242/bio.2012968; Jean S, 2010, DEV CELL, V19, P426, DOI 10.1016/j.devcel.2010.08.007; Lee I, 2006, FASEB J, V20, P202, DOI 10.1096/fj.05-4581hyp; Manford AG, 2012, DEV CELL, V23, P1129, DOI 10.1016/j.devcel.2012.11.004; Min SW, 2007, P NATL ACAD SCI USA, V104, P3823, DOI 10.1073/pnas.0611725104; Moghadam Paanteha K, 2013, Front Endocrinol (Lausanne), V4, P124, DOI 10.3389/fendo.2013.00124; MOHAMMADI M, 1991, MOL CELL BIOL, V11, P5068, DOI 10.1128/MCB.11.10.5068; MOHAMMADI M, 1992, NATURE, V358, P681, DOI 10.1038/358681a0; Mohammadi M, 1996, CELL, V86, P577, DOI 10.1016/S0092-8674(00)80131-2; Morris NJ, 1999, BBA-PROTEIN STRUCT M, V1431, P525, DOI 10.1016/S0167-4838(99)00068-0; Ong SH, 2000, MOL CELL BIOL, V20, P979, DOI 10.1128/MCB.20.3.979-989.2000; Persaud A, 2011, EMBO J, V30, P3259, DOI 10.1038/emboj.2011.234; PETERS KG, 1992, NATURE, V358, P678, DOI 10.1038/358678a0; Reed SE, 2006, J VIROL METHODS, V138, P85, DOI 10.1016/j.jviromet.2006.07.024; Schauder CM, 2014, NATURE, V510, P552, DOI 10.1038/nature13269; Scott RP, 2005, J BIOL CHEM, V280, P13442, DOI 10.1074/jbc.M500507200; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Thisse B, 2005, DEV BIOL, V287, P390, DOI 10.1016/j.ydbio.2005.09.011; Yamashita T, 2012, NEUROSCI RES, V73, P1, DOI 10.1016/j.neures.2012.02.012	31	11	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16142	16156		10.1074/jbc.M115.656918	http://dx.doi.org/10.1074/jbc.M115.656918			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25922075	Green Published, hybrid			2022-12-28	WOS:000356930100019
J	Escobedo-Hinojosa, WI; Vences-Guzman, MA; Schubotz, F; Sandoval-Calderon, M; Summons, RE; Lopez-Lara, IM; Geiger, O; Sohlenkamp, C				Escobedo-Hinojosa, Wendy Itzel; Vences-Guzman, Miguel Angel; Schubotz, Florence; Sandoval-Calderon, Mario; Summons, Roger E.; Lopez-Lara, Isabel Maria; Geiger, Otto; Sohlenkamp, Christian			OlsG (Sinac_1600) Is an Ornithine Lipid N-Methyltransferase from the Planctomycete Singulisphaera acidiphila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-LIPIDS; PHOSPHATIDYLCHOLINE BIOSYNTHESIS; SINORHIZOBIUM-MELILOTI; GENE; IDENTIFICATION; ACCUMULATION; EXPRESSION; SYMBIOSIS; ENZYMES	Ornithine lipids (OLs) are phosphorus-free membrane lipids widespread in bacteria but absent from archaea and eukaryotes. In addition to the unmodified OLs, a variety of OL derivatives hydroxylated in different structural positions has been reported. Recently, methylated derivatives of OLs were described in several planctomycetes isolated from a peat bog in Northern Russia, although the gene/enzyme responsible for the N-methylation of OL remained obscure. Here we identify and characterize the OL N-methyltransferase OlsG (Sinac_1600) from the planctomycete Singulisphaera acidiphila. When OlsG is co-expressed with the OL synthase OlsF in Escherichia coli, methylated OL derivatives are formed. An in vitro characterization shows that OlsG is responsible for the 3-fold methylation of the terminal delta-nitrogen of OL. Methylation is dependent on the presence of the detergent Triton X-100 and the methyldonor S-adenosylmethionine.	[Escobedo-Hinojosa, Wendy Itzel; Vences-Guzman, Miguel Angel; Sandoval-Calderon, Mario; Lopez-Lara, Isabel Maria; Geiger, Otto; Sohlenkamp, Christian] Univ Nacl Autonoma Mexico, Ctr Ciencias Genom, Cuernavaca 62210, Morelos, Mexico; [Schubotz, Florence; Summons, Roger E.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02144 USA	Universidad Nacional Autonoma de Mexico; Massachusetts Institute of Technology (MIT)	Sohlenkamp, C (corresponding author), Univ Nacl Autonoma Mexico, Ctr Ciencias Genom, Ave Univ S-N,Apdo Postal 565-A, Cuernavaca 62210, Morelos, Mexico.	chsohlen@ccg.unam.mx	Summons, Roger Everett/AAL-3789-2020; Lopez-Lara, Isabel/E-3153-2016; Geiger, Otto/F-6356-2019; Sohlenkamp, Christian/C-6219-2018	Lopez-Lara, Isabel/0000-0002-5066-3158; Geiger, Otto/0000-0002-7794-1568; Sohlenkamp, Christian/0000-0002-9962-2859; Sandoval-Calderon, Mario/0000-0001-7888-4334	CONACyT (Consejo Nacional de Ciencia y Tecnologia) [153200]; PAPIIT-UNAM (Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica-Universidad Nacional Autonoma de Mexico) [IN202413]; University of California-Mexus/CONACyT [CN-12-552]; Massachusetts Institute of Technology Mexico Seed Fund; NASA (National Aeronautics and Space Administration) Astrobiology Grant [NNA13AA90A]; University of Bremen; DGAPA (Direccion General de Asuntos del Personal Academico)-UNAM (Universidad Nacional Autonoma de Mexico)	CONACyT (Consejo Nacional de Ciencia y Tecnologia)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PAPIIT-UNAM (Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica-Universidad Nacional Autonoma de Mexico); University of California-Mexus/CONACyT; Massachusetts Institute of Technology Mexico Seed Fund; NASA (National Aeronautics and Space Administration) Astrobiology Grant; University of Bremen; DGAPA (Direccion General de Asuntos del Personal Academico)-UNAM (Universidad Nacional Autonoma de Mexico)	This work has been supported by CONACyT (Consejo Nacional de Ciencia y Tecnologia) Grant 153200, PAPIIT-UNAM (Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica-Universidad Nacional Autonoma de Mexico) Grant IN202413, University of California-Mexus/CONACyT Grant CN-12-552, the Massachusetts Institute of Technology Mexico Seed Fund, NASA (National Aeronautics and Space Administration) Astrobiology Grant NNA13AA90A, the University of Bremen, and a postdoctoral fellowship from the DGAPA (Direccion General de Asuntos del Personal Academico)-UNAM (Universidad Nacional Autonoma de Mexico) (to W.I. E.-H.).	Vences-Guzman MA, 2015, ENVIRON MICROBIOL, V17, P1487, DOI 10.1111/1462-2920.12562; Vences-Guzman MA, 2013, ENVIRON MICROBIOL, V15, P895, DOI 10.1111/j.1462-2920.2012.02867.x; ARONDEL V, 1993, J BIOL CHEM, V268, P16002; BENNING C, 1995, ARCH BIOCHEM BIOPHYS, V317, P103, DOI 10.1006/abbi.1995.1141; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; COHENBAZIRE G, 1957, J CELL COMPAR PHYSL, V49, P25, DOI 10.1002/jcp.1030490104; de Rudder KEE, 1999, J BIOL CHEM, V274, P20011, DOI 10.1074/jbc.274.28.20011; de Rudder KEE, 2000, MOL MICROBIOL, V37, P763, DOI 10.1046/j.1365-2958.2000.02032.x; deRudder KEE, 1997, J BACTERIOL, V179, P6921, DOI 10.1128/jb.179.22.6921-6928.1997; Diercks H, 2015, J BACTERIOL, V197, P497, DOI 10.1128/JB.02004-14; DULLEY JR, 1975, ANAL BIOCHEM, V64, P136, DOI 10.1016/0003-2697(75)90415-7; Gao JL, 2004, MOL MICROBIOL, V53, P1757, DOI 10.1111/j.1365-2958.2004.04240.x; Geiger O, 1999, MOL MICROBIOL, V32, P63, DOI 10.1046/j.1365-2958.1999.01325.x; Geiger O, 2013, BBA-MOL CELL BIOL L, V1831, P503, DOI 10.1016/j.bbalip.2012.08.009; Geiger O, 2010, PROG LIPID RES, V49, P46, DOI 10.1016/j.plipres.2009.08.002; Gonzalez-Silva N, 2011, BIOCHEMISTRY-US, V50, P6396, DOI 10.1021/bi200706v; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hacker S, 2008, J BACTERIOL, V190, P571, DOI 10.1128/JB.01423-07; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kotsyurbenko OR, 2004, ENVIRON MICROBIOL, V6, P1159, DOI 10.1111/j.1462-2920.2004.00634.x; Kulichevskaya IS, 2008, INT J SYST EVOL MICR, V58, P1186, DOI 10.1099/ijs.0.65593-0; Lopez-Lara IM, 2005, MOL PLANT MICROBE IN, V18, P973, DOI 10.1094/MPMI-18-0973; Martinez-Morales F, 2003, MICROBIOL-SGM, V149, P3461, DOI 10.1099/mic.0.26522-0; Minder AC, 2001, MOL MICROBIOL, V39, P1186, DOI 10.1111/j.1365-2958.2001.02325.x; Moore EK, 2013, APPL ENVIRON MICROB, V79, P6874, DOI 10.1128/AEM.02169-13; Riekhof WR, 2014, EUKARYOT CELL, V13, P749, DOI 10.1128/EC.00004-14; Riekhof WR, 2005, ARCH BIOCHEM BIOPHYS, V441, P96, DOI 10.1016/j.abb.2005.07.001; Riekhof WR, 2005, EUKARYOT CELL, V4, P242, DOI 10.1128/EC.4.2.242-252.2005; Ritchie RJ, 1996, BIOCHEM EDUC, V24, P196, DOI 10.1016/S0307-4412(96)00089-1; Rojas-Jimenez K, 2005, MOL PLANT MICROBE IN, V18, P1175, DOI 10.1094/MPMI-18-1175; Sohlenkamp C, 2000, J BIOL CHEM, V275, P27500; Sohlenkamp C, 2003, PROG LIPID RES, V42, P115, DOI 10.1016/S0163-7827(02)00050-4; Sohlenkamp C., 2015, FEMS MICROB IN PRESS; STUDIER FW, 1991, J MOL BIOL, V219, P37, DOI 10.1016/0022-2836(91)90855-Z; Vences-Guzman MA, 2012, FEMS MICROBIOL LETT, V335, P1, DOI 10.1111/j.1574-6968.2012.02623.x; Vences-Guzman MA, 2011, MOL MICROBIOL, V79, P1496, DOI 10.1111/j.1365-2958.2011.07535.x; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weissenmayer B, 2002, MOL MICROBIOL, V45, P721, DOI 10.1046/j.1365-2958.2002.03043.x; Wilderman PJ, 2002, J BACTERIOL, V184, P4792, DOI 10.1128/JB.184.17.4792-4799.2002; Wormer L, 2013, ORG GEOCHEM, V59, P10, DOI 10.1016/j.orggeochem.2013.03.004	41	11	11	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15102	15111		10.1074/jbc.M115.639575	http://dx.doi.org/10.1074/jbc.M115.639575			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25925947	hybrid, Green Published			2022-12-28	WOS:000356177300025
J	Masia-Balague, M; Izquierdo, I; Garrido, G; Cordomi, A; Perez-Benito, L; Miller, NLG; Schlaepfer, DD; Gigoux, V; Aragay, AM				Masia-Balague, Miriam; Izquierdo, Ismael; Garrido, Georgina; Cordomi, Arnau; Perez-Benito, Laura; Miller, Nichol L. G.; Schlaepfer, David D.; Gigoux, Veronique; Aragay, Anna M.			Gastrin-stimulated G alpha(13) Activation of Rgnef Protein (ArhGEF28) in DLD-1 Colon Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; HETEROTRIMERIC G-PROTEINS; FOCAL ADHESION KINASE; RHO-GTPASES; BINDING PROTEIN; G12 FAMILY; P190RHOGEF; CHOLECYSTOKININ; DOMAIN; RAC1	The guanine nucleotide exchange factor Rgnef (also known as ArhGEF28 or p190RhoGEF) promotes colon carcinoma cell motility and tumor progression via interaction with focal adhesion kinase (FAK). Mechanisms of Rgnef activation downstream of integrin or G protein-coupled receptors remain undefined. In the absence of a recognized G protein signaling homology domain in Rgnef, no proximal linkage to G proteins was known. Utilizing multiple methods, we have identified Rgnef as a new effector for G alpha(13) downstream of gastrin and the type 2 cholecystokinin receptor. In DLD-1 colon carcinoma cells depleted of G alpha(13), gastrin-induced FAK Tyr(P)-397 and paxillin Tyr(P)-31 phosphorylation were reduced. RhoA GTP binding and promoter activity were increased by Rgnef in combination with active G alpha(13). Rgnef co-immunoprecipitated with activated G alpha(13)Q226L but not G alpha(12)Q229L. The Rgnef C-terminal (CT, 1279 - 1582) region was sufficient for co-immunoprecipitation, and Rgnef-CT exogenous expression prevented G alpha(13)-stimulated SRE activity. A domain at the C terminus of the protein close to the FAK binding domain is necessary to bind to G alpha(13). Point mutations of Rgnef-CT residues disrupt association with active G alpha(13) but not G alpha(q). These results show that Rgnef functions as an effector of G alpha(13) signaling and that this linkage may mediate FAK activation in DLD-1 colon carcinoma cells.	[Masia-Balague, Miriam; Izquierdo, Ismael; Garrido, Georgina; Aragay, Anna M.] CSIC, Mol Biol Inst Barcelona, Barcelona 08028, Spain; [Cordomi, Arnau; Perez-Benito, Laura] Univ Autonoma Barcelona, Unitat Bioestadist, Dept Pediat, E-08193 Barcelona, Spain; [Miller, Nichol L. G.; Schlaepfer, David D.] Univ Toulouse 3, INSERM, Receptol & Ciblage Therapeut Cancerol, F-31062 Toulouse, France; [Miller, Nichol L. G.; Schlaepfer, David D.] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92093 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Autonomous University of Barcelona; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of California System; University of California San Diego	Aragay, AM (corresponding author), CSIC, Inst Biol Mol Barcelona, Parc Sci Baldiri Reixac 15, E-08028 Barcelona, Spain.	aarbmc@ibmb.csic.es	Aragay, Anna M/K-3813-2014; Regan, Clinton/E-6250-2012; Gigoux, Véronique/AAE-6090-2020; Garrido Antequera, Georgina/H-3469-2015; Cordomi, Arnau/A-1686-2009	Aragay, Anna M/0000-0002-8240-4126; Gigoux, Véronique/0000-0003-1408-5335; Garrido Antequera, Georgina/0000-0001-7702-7998; Cordomi, Arnau/0000-0002-3848-2928; Izquierdo Villalba, Ismael/0000-0001-6142-0250; Perez Benito, Laura/0000-0001-9607-9048	National Institutes of Health [CA180769]; Spanish Ministerio de Economia y Competitividad [BFU2011-30080]; Agencia de Gestio d'Ajuts Universitaris i de Recerca; NATIONAL CANCER INSTITUTE [R01CA102310, R01CA087038, R01CA180769] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministerio de Economia y Competitividad(Spanish Government); Agencia de Gestio d'Ajuts Universitaris i de Recerca(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA180769 (to D. S.). This work was also supported by Spanish Ministerio de Economia y Competitividad Grant BFU2011-30080.; Supported by a Fellowship for Young Research Fellows from Agencia de Gestio d'Ajuts Universitaris i de Recerca. Present address: Center for Biosciences, Dept. of Biosciences and Nutrition, Karolinska Institute, Stockholm SE-171 77, Sweden.	Aittaleb M, 2010, MOL PHARMACOL, V77, P111, DOI 10.1124/mol.109.061234; ARAGAY AM, 1995, J BIOL CHEM, V270, P20073, DOI 10.1074/jbc.270.34.20073; Ardawatia VV, 2011, EXP CELL RES, V317, P293, DOI 10.1016/j.yexcr.2010.10.017; Baisamy L, 2005, J BIOL CHEM, V280, P15405, DOI 10.1074/jbc.M414440200; Beninca C, 2014, CELL SIGNAL, V26, P1135, DOI 10.1016/j.cellsig.2014.01.009; Booden MA, 2002, MOL CELL BIOL, V22, P4053, DOI 10.1128/MCB.22.12.4053-4061.2002; Chen Z, 2008, STRUCTURE, V16, P1532, DOI 10.1016/j.str.2008.07.009; Chen Z, 2012, J BIOL CHEM, V287, P25490, DOI 10.1074/jbc.M111.333716; Chu SJ, 2013, CURR OPIN GASTROEN, V29, P636, DOI 10.1097/MOG.0b013e328365efc7; Diviani D, 2001, J BIOL CHEM, V276, P44247, DOI 10.1074/jbc.M106629200; Dufresne M, 2006, PHYSIOL REV, V86, P805, DOI 10.1152/physrev.00014.2005; Dutt P, 2002, FEBS LETT, V531, P565, DOI 10.1016/S0014-5793(02)03625-6; Escrieut C, 2002, J BIOL CHEM, V277, P7546, DOI 10.1074/jbc.M108563200; Fourmy D, 2011, GASTROENTEROLOGY, V141, P814, DOI 10.1053/j.gastro.2011.07.006; Garcia-Mata R, 2006, METHOD ENZYMOL, V406, P425, DOI 10.1016/S0076-6879(06)06031-9; Gardner JA, 2013, PANCREAS, V42, P819, DOI 10.1097/MPA.0b013e318279c577; Gebbink MFBG, 1997, J CELL BIOL, V137, P1603, DOI 10.1083/jcb.137.7.1603; Gong HX, 2010, SCIENCE, V327, P340, DOI 10.1126/science.1174779; Grabocka E, 2007, MOL PHARMACOL, V72, P993, DOI 10.1124/mol.107.035162; Hajicek N, 2011, J BIOL CHEM, V286, P20625, DOI 10.1074/jbc.M110.201392; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; JIANG HP, 1993, FEBS LETT, V330, P319, DOI 10.1016/0014-5793(93)80896-3; Johansson BB, 2005, FEBS J, V272, P5365, DOI 10.1111/j.1742-4658.2005.04934.x; Jones TLZ, 1998, BIOCHEMISTRY-US, V37, P3196, DOI 10.1021/bi972253j; Juneja J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026085; Kelly P, 2007, BIOCHEMISTRY-US, V46, P6677, DOI 10.1021/bi700235f; Kelly P, 2006, J BIOL CHEM, V281, P26483, DOI 10.1074/jbc.M604376200; Kelly P, 2006, P NATL ACAD SCI USA, V103, P8173, DOI 10.1073/pnas.0510254103; Kim H, 2008, BIOCHEM BIOPH RES CO, V377, P636, DOI 10.1016/j.bbrc.2008.10.030; Kim JS, 2006, BIOCHEM BIOPH RES CO, V351, P903, DOI 10.1016/j.bbrc.2006.10.135; Koh TJ, 2000, REGUL PEPTIDES, V93, P37, DOI 10.1016/S0167-0115(00)00176-2; Krakstad BF, 2004, P NATL ACAD SCI USA, V101, P10314, DOI 10.1073/pnas.0401366101; Kumar RN, 2006, ONCOGENE, V25, P899, DOI 10.1038/sj.onc.1209132; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leve F, 2012, J CELL BIOCHEM, V113, P2549, DOI 10.1002/jcb.24153; Lim Y, 2008, J CELL BIOL, V180, P187, DOI 10.1083/jcb.200708194; Lin H, 2005, HUM MOL GENET, V14, P3643, DOI 10.1093/hmg/ddi392; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lutz S, 2005, J BIOL CHEM, V280, P11134, DOI 10.1074/jbc.M411322200; Lutz S, 2007, SCIENCE, V318, P1923, DOI 10.1126/science.1147554; Meigs TE, 2002, J BIOL CHEM, V277, P24594, DOI 10.1074/jbc.M201984200; Miller NLG, 2013, J CELL SCI, V126, P5074, DOI 10.1242/jcs.135509; Miller NLG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037830; Niu JX, 2003, CIRC RES, V93, P848, DOI 10.1161/01.RES.0000097607.14733.0C; Rasheed SAK, 2013, J BIOL CHEM, V288, P7986, DOI 10.1074/jbc.M112.437749; Rico B, 2004, NAT NEUROSCI, V7, P1059, DOI 10.1038/nn1317; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sabbatini ME, 2010, AM J PHYSIOL-CELL PH, V298, pC592, DOI 10.1152/ajpcell.00448.2009; Sagi SA, 2001, J BIOL CHEM, V276, P15445, DOI 10.1074/jbc.M008961200; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; SALI A, 1995, MOL MED TODAY, V1, P270, DOI 10.1016/s1357-4310(95)91170-7; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Siehler S, 2009, BRIT J PHARMACOL, V158, P41, DOI 10.1111/j.1476-5381.2009.00121.x; Sprang SR, 2007, ADV PROTEIN CHEM, V74, P1, DOI 10.1016/S0065-3233(07)74001-9; Sternweis PC, 2007, ADV PROTEIN CHEM, V74, P189, DOI 10.1016/S0065-3233(07)74006-8; Suzuki N, 2003, P NATL ACAD SCI USA, V100, P733, DOI 10.1073/pnas.0234057100; Suzuki N, 2009, J BIOL CHEM, V284, P5000, DOI 10.1074/jbc.M804073200; Taniguchi T, 1996, ONCOGENE, V12, P1357; van Horck FPG, 2001, J BIOL CHEM, V276, P4948, DOI 10.1074/jbc.M003839200; Wells CD, 2002, J BIOL CHEM, V277, P1174, DOI 10.1074/jbc.M105274200; Wu JH, 2003, MOL BRAIN RES, V117, P27, DOI 10.1016/S0169-328X(03)00263-8; Yu HG, 2011, CANCER RES, V71, P360, DOI 10.1158/0008-5472.CAN-10-2894; Zhai JB, 2003, J BIOL CHEM, V278, P24865, DOI 10.1074/jbc.M302381200	64	18	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15197	15209		10.1074/jbc.M114.628164	http://dx.doi.org/10.1074/jbc.M114.628164			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25922072	Green Published, hybrid			2022-12-28	WOS:000356177300033
J	Zhang, YL; Nguyen, T; Tang, P; Kennedy, NJ; Jiao, HP; Zhang, ML; Reynolds, JM; Jaeschke, A; Martin-Orozco, N; Chung, YS; He, WM; Wang, C; Jia, WP; Ge, BX; Davis, RJ; Fiavell, RA; Dong, C				Zhang, Yongliang; Thang Nguyen; Tang, Peng; Kennedy, Norman J.; Jiao, Huipeng; Zhang, Mingliang; Reynolds, Joseph M.; Jaeschke, Anja; Martin-Orozco, Natalia; Chung, Yeonseok; He, Wei-min; Wang, Chen; Jia, Weiping; Ge, Baoxue; Davis, Roger J.; Fiavell, Richard A.; Dong, Chen			Regulation of Adipose Tissue Inflammation and Insulin Resistance by MAPK Phosphatase 5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROPHAGE POLARIZATION; GLUCOSE-HOMEOSTASIS; VISCERAL ADIPOSITY; IMMUNE-RESPONSES; IKK-BETA; OBESITY; MICE; FAT; SENSITIVITY; MECHANISMS	Obesity and metabolic disorders such as insulin resistance and type 2 diabetes have become a major threat to public health globally. The mechanisms that lead to insulin resistance in type 2 diabetes have not been well understood. In this study, we show that mice deficient in MAPK phosphatase 5 (MKP5) develop insulin resistance spontaneously at an early stage of life and glucose intolerance at a later age. Increased macrophage infiltration in white adipose tissue of young MKP5-deficient mice correlates with the development of insulin resistance. Glucose intolerance in MKP5-deficient mice is accompanied by significantly increased visceral adipose weight, reduced AKT activation, enhanced p38 activity, and increased inflammation in visceral adipose tissue when compared with wild-type (WT) mice. Deficiency of MKP5 resulted in increased inflammatory activation in macrophages. These findings thus demonstrate that MKP5 critically controls inflammation in white adipose tissue and the development of metabolic disorders.	[Zhang, Yongliang; Tang, Peng; Jiao, Huipeng] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117597, Singapore; [Zhang, Yongliang; Tang, Peng; Jiao, Huipeng] Natl Univ Singapore, Inst Life Sci, Immunol Programme, Singapore 117597, Singapore; [Thang Nguyen] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Kennedy, Norman J.; Davis, Roger J.] Univ Massachusetts, Howard Hughes Med Inst, Worcester, MA 01606 USA; [Zhang, Mingliang; Wang, Chen; Jia, Weiping] Shanghai Jiao Tong Univ, Dept Endocrinol & Metab, Affiliated Peoples Hosp 6, Shanghai Diabet Inst,Shanghai Clin Ctr Diabet, Shanghai 200233, Peoples R China; [Reynolds, Joseph M.; Martin-Orozco, Natalia; Chung, Yeonseok] MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77054 USA; [Jaeschke, Anja] Univ Cincinnati, Pathobiol & Mol Med Grad Program, Cincinnati, OH 45215 USA; [He, Wei-min] Texas A&M Univ, Syst Hlth Sci Ctr, Ctr Environm & Genet Med, Inst Biosci & Technol, Houston, TX 77030 USA; [Ge, Baoxue] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Lab Signal Transduct, Shanghai 200025, Peoples R China; [Ge, Baoxue] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200025, Peoples R China; [Fiavell, Richard A.] Yale Univ, Howard Hughes Med Inst, Dept Immunol, New Haven, CT 06520 USA; [Dong, Chen] Tsinghua Univ, Inst Immunol, Beijing 100084, Peoples R China	National University of Singapore; National University of Singapore; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Shanghai Jiao Tong University; University of Texas System; UTMD Anderson Cancer Center; University System of Ohio; University of Cincinnati; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Howard Hughes Medical Institute; Yale University; Tsinghua University	Fiavell, RA (corresponding author), Yale Univ, Howard Hughes Med Inst, Dept Immunol, New Haven, CT 06520 USA.	Richard.flavell@yale.edu; chendong@tsinghua.edu.cn	dong, chen/B-3181-2009	dong, chen/0000-0002-0084-9130; Chung, Yeonseok/0000-0001-5780-4841; Jiao, Huipeng/0000-0001-9632-6176; Davis, Roger/0000-0002-0130-1652	Office of Deputy President, National University of Singapore; National Medical Research Council of Singapore [IRG10nov091, CBRG11nov101]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735] Funding Source: NIH RePORTER	Office of Deputy President, National University of Singapore(National University of Singapore); National Medical Research Council of Singapore(National Medical Research Council, Singapore); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Office of Deputy President, National University of Singapore and the National Medical Research Council (IRG10nov091 and CBRG11nov101) of Singapore (to Y. Z.).	Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Bachmanov AA, 2001, PHYSIOL BEHAV, V72, P603, DOI 10.1016/S0031-9384(01)00412-7; Barzilai N, 1999, DIABETES, V48, P94, DOI 10.2337/diabetes.48.1.94; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Bluhre M, 2009, EXP CLIN ENDOCR DIAB, V117, P241, DOI 10.1055/s-0029-1192044; Bost F, 2005, DIABETES, V54, P402, DOI 10.2337/diabetes.54.2.402; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Christodoulides C, 2009, TRENDS ENDOCRIN MET, V20, P16, DOI 10.1016/j.tem.2008.09.002; Furuhashi M, 2008, J CLIN INVEST, V118, P2640, DOI 10.1172/JCI34750; Gabriely I, 2002, DIABETES, V51, P2951, DOI 10.2337/diabetes.51.10.2951; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Han MS, 2013, SCIENCE, V339, P218, DOI 10.1126/science.1227568; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Koistinen HA, 2003, DIABETOLOGIA, V46, P1324, DOI 10.1007/s00125-003-1196-3; Lim JH, 2009, CELL SIGNAL, V21, P169, DOI 10.1016/j.cellsig.2008.10.004; LONCAR D, 1988, J ULTRA MOL STRUCT R, V101, P109, DOI 10.1016/0889-1605(88)90001-8; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Montagne CT, 2000, DIABETES, V49, P883, DOI 10.2337/diabetes.49.6.883; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Park KW, 2008, CELL METAB, V8, P454, DOI 10.1016/j.cmet.2008.11.001; Pettus LH, 2008, CURR TOP MED CHEM, V8, P1452, DOI 10.2174/156802608786264245; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Stolarczyk E, 2013, CELL METAB, V17, P520, DOI 10.1016/j.cmet.2013.02.019; Sumara G, 2009, CELL, V136, P235, DOI 10.1016/j.cell.2008.11.018; Tanoue T, 1999, J BIOL CHEM, V274, P19949, DOI 10.1074/jbc.274.28.19949; Theodosiou A, 1999, ONCOGENE, V18, P6981, DOI 10.1038/sj.onc.1203185; Tilg H, 2008, MOL MED, V14, P222, DOI 10.2119/2007-00119.Tilg; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xu JF, 2012, J IMMUNOL, V189, P1992, DOI 10.4049/jimmunol.1103207; Zhang Y, 2007, CELL MOL LIFE SCI, V64, P2771, DOI 10.1007/s00018-007-7012-3; Zhang YL, 2004, NATURE, V430, P793, DOI 10.1038/nature02764	40	16	18	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					14875	14883		10.1074/jbc.M115.660969	http://dx.doi.org/10.1074/jbc.M115.660969			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25922079	Green Published, hybrid			2022-12-28	WOS:000356177300007
J	Talhaoui, I; Shafirovich, V; Liu, Z; Saint-Pierre, C; Akishev, Z; Matkarimov, BT; Gasparutto, D; Geacintov, NE; Saparbaev, M				Talhaoui, Ibtissam; Shafirovich, Vladimir; Liu, Zhi; Saint-Pierre, Christine; Akishev, Zhiger; Matkarimov, Bakhyt T.; Gasparutto, Didier; Geacintov, Nicholas E.; Saparbaev, Murat			Oxidatively Generated Guanine(C8)-Thymine(N3) Intrastrand Cross-links in Double-stranded DNA Are Repaired by Base Excision Repair Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RADICAL-INDUCED FORMATION; ESCHERICHIA-COLI; HUMAN-CELLS; MAMMALIAN-CELLS; UVRABC NUCLEASE; IN-VIVO; LESIONS; GUANINE; DAMAGE; INCISION	Oxidatively generated guanine radical cations in DNA can undergo various nucleophilic reactions including the formation of C8-guanine cross-links with adjacent or nearby N3-thymines in DNA in the presence of O-2. The G*[C8-N3]T* lesions have been identified in the DNA of human cells exposed to oxidative stress, and are most likely genotoxic if not removed by cellular defense mechanisms. It has been shown that the G*[C8-N3]T* lesions are substrates of nucleotide excision repair in human cell extracts. Cleavage at the sites of the lesions was also observed but not further investigated (Ding et al. (2012) Nucleic Acids Res. 40, 2506-2517). Using a panel of eukaryotic and prokaryotic bifunctional DNA glycosylases/lyases (NEIL1, Nei, Fpg, Nth, and NTH1) and apurinic/apyrimidinic (AP) endonucleases (Apn1, APE1, and Nfo), the analysis of cleavage fragments by PAGE and MALDI-TOF/MS show that the G*[C8-N3]T* lesions in 17-mer duplexes are incised on either side of G*, that none of the recovered cleavage fragments contain G*, and that T* is converted to a normal T in the 3'-fragment cleavage products. The abilities of the DNA glycosylases to incise the DNA strand adjacent to G*, while this base is initially cross-linked with T*, is a surprising observation and an indication of the versatility of these base excision repair proteins.	[Talhaoui, Ibtissam; Saparbaev, Murat] Univ Paris 11, Grp Reparat ADN, CNRS UMR8200, Inst Cancerol Gustave Roussy, F-94805 Villejuif, France; [Saint-Pierre, Christine; Gasparutto, Didier] Univ Grenoble Alpes, CEA, INAC, SCIB,UMR E3,LAN, F-38000 Grenoble, France; [Akishev, Zhiger] Al Farabi Kazakh Natl Univ, Dept Mol Biol & Genet, Fac Biol, Alma Ata 530038, Kazakhstan; [Matkarimov, Bakhyt T.] Nazarbayev Univ Res & Innovat Syst, Astana 010000, Kazakhstan; [Shafirovich, Vladimir; Liu, Zhi; Geacintov, Nicholas E.] NYU, Dept Chem, 31 Washington Pl, New York, NY 10003 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; CEA; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Al-Farabi Kazakh National University; Nazarbayev University; New York University	Shafirovich, V (corresponding author), NYU, Dept Chem, 31 Washington Pl, New York, NY 10003 USA.	vs5@nyu.edu; ng1@nyu.edu; smurat@igr.fr	Matkarimov, Bakhyt T/J-6201-2012; Saparbaev, Murat/AAC-5478-2020; Akishev, Zhiger D/N-6206-2017; Saparbaev, Murat K/N-3225-2015	Matkarimov, Bakhyt T/0000-0003-0775-7324; Saparbaev, Murat/0000-0002-4630-1074; Akishev, Zhiger D/0000-0001-9943-1625; Saparbaev, Murat K/0000-0002-4630-1074; Shafirovich, Vladimir/0000-0001-8225-6509	Research Facilities Improvement Grant from the National Center for Research Resources, National Institutes of Health [C06 RR-16572]; National Science Foundation [CHE-0958457]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR016572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011589] Funding Source: NIH RePORTER	Research Facilities Improvement Grant from the National Center for Research Resources, National Institutes of Health; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Components of this work were conducted in the Shared Instrumentation Facility at NYU that was constructed with support from a Research Facilities Improvement Grant (C06 RR-16572) from the National Center for Research Resources, National Institutes of Health. The acquisition of the MALDI-TOF mass spectrometer at NYU was supported by the National Science Foundation (CHE-0958457).	Bourdat AG, 1999, NUCLEIC ACIDS RES, V27, P1015, DOI 10.1093/nar/27.4.1015; Box HC, 2001, FREE RADICAL BIO MED, V31, P856, DOI 10.1016/S0891-5849(01)00653-0; Box HC, 1996, RADIAT RES, V145, P641, DOI 10.2307/3579285; Brooks PJ, 2008, DNA REPAIR, V7, P1168, DOI 10.1016/j.dnarep.2008.03.016; Brooks PJ, 2000, J BIOL CHEM, V275, P22355, DOI 10.1074/jbc.M002259200; Cadet J, 2008, ACCOUNTS CHEM RES, V41, P1075, DOI 10.1021/ar700245e; Cadet J, 2012, CANCER LETT, V327, P5, DOI 10.1016/j.canlet.2012.04.005; Clauson C, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012732; Crean C, 2008, CHEMBIOCHEM, V9, P1985, DOI 10.1002/cbic.200800105; Crean C, 2008, NUCLEIC ACIDS RES, V36, P742, DOI 10.1093/nar/gkm1092; Darwanto A, 2009, ANAL BIOCHEM, V394, P13, DOI 10.1016/j.ab.2009.07.015; Ding S, 2012, NUCLEIC ACIDS RES, V40, P2506, DOI 10.1093/nar/gkr1087; DIRKSEN ML, 1988, INT J RADIAT BIOL, V54, P195, DOI 10.1080/09553008814551631; DIZDAROGLU M, 1986, BIOCHEM J, V238, P247, DOI 10.1042/bj2380247; Faure V, 2005, BIOCHEM BIOPH RES CO, V328, P1188, DOI 10.1016/j.bbrc.2005.01.082; Friedberg EC, 2003, NATURE, V421, P436, DOI 10.1038/nature01408; Gu CN, 2006, BIOCHEMISTRY-US, V45, P10739, DOI 10.1021/bi060423z; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Hong HZ, 2007, NUCLEIC ACIDS RES, V35, P7118, DOI 10.1093/nar/gkm851; Ischenko AA, 2002, NATURE, V415, P183, DOI 10.1038/415183a; Ishchenko AA, 2006, P NATL ACAD SCI USA, V103, P2564, DOI 10.1073/pnas.0508582103; Ishchenko AA, 2004, BIOCHEMISTRY-US, V43, P15210, DOI 10.1021/bi049214+; Jaruga P, 2008, DNA REPAIR, V7, P1413, DOI 10.1016/j.dnarep.2008.06.005; Jasti VP, 2011, BIOCHEMISTRY-US, V50, P3862, DOI 10.1021/bi2004944; Jiang Y, 2007, BIOCHEMISTRY-US, V46, P12757, DOI 10.1021/bi7012195; Jung YW, 2007, CHEM REV, V107, P1387, DOI 10.1021/cr068207j; Katafuchi A, 2004, J BIOL CHEM, V279, P14464, DOI 10.1074/jbc.M400393200; Krokan HE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012583; Kropachev K, 2014, NUCLEIC ACIDS RES, V42, P5020, DOI 10.1093/nar/gku162; Kuraoka I, 2000, P NATL ACAD SCI USA, V97, P3832, DOI 10.1073/pnas.070471597; Madugundu GS, 2013, CHEM RES TOXICOL, V26, P1031, DOI 10.1021/tx400158g; Mazouzi A, 2013, P NATL ACAD SCI USA, V110, pE3071, DOI 10.1073/pnas.1305281110; Pande P, 2012, DNA REPAIR, V11, P926, DOI 10.1016/j.dnarep.2012.09.002; Prorok P, 2013, P NATL ACAD SCI USA, V110, pE3695, DOI 10.1073/pnas.1305624110; Scott TL, 2014, ANTIOXID REDOX SIGN, V20, P708, DOI 10.1089/ars.2013.5529; Steenken S, 1997, J AM CHEM SOC, V119, P617, DOI 10.1021/ja962255b; Wallace SS, 2012, CANCER LETT, V327, P73, DOI 10.1016/j.canlet.2011.12.038; Wang J, 2012, NUCLEIC ACIDS RES, V40, P7368, DOI 10.1093/nar/gks357; Wang J, 2012, AGING CELL, V11, P714, DOI 10.1111/j.1474-9726.2012.00828.x; Wang YS, 2008, CHEM RES TOXICOL, V21, P276, DOI 10.1021/tx700411g; Wong D, 2003, J BIOL CHEM, V278, P36242, DOI 10.1074/jbc.M306065200; Yang ZG, 2005, CHEM RES TOXICOL, V18, P1339, DOI 10.1021/tx050147+; You CJ, 2012, NAT CHEM BIOL, V8, P817, DOI 10.1038/NCHEMBIO.1046; Zhang QB, 2003, J AM CHEM SOC, V125, P12795, DOI 10.1021/ja034866r; Zharkov DO, 2002, EMBO J, V21, P789, DOI 10.1093/emboj/21.4.789	45	15	15	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14610	14617		10.1074/jbc.M115.647487	http://dx.doi.org/10.1074/jbc.M115.647487			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25903131	hybrid, Green Published			2022-12-28	WOS:000355754600031
J	Samse, K; Emathinger, J; Hariharan, N; Quijada, P; Ilves, K; Volkers, M; Ormachea, L; De La Torre, A; Orogo, AM; Alvarez, R; Din, S; Mohsin, S; Monsanto, M; Fischer, KM; Dembitsky, WP; Gustafsson, AB; Sussman, MA				Samse, Kaitlen; Emathinger, Jacqueline; Hariharan, Nirmala; Quijada, Pearl; Ilves, Kelli; Voelkers, Mirko; Ormachea, Lucia; De La Torre, Andrea; Orogo, Amabel M.; Alvarez, Roberto; Din, Shabana; Mohsin, Sadia; Monsanto, Megan; Fischer, Kimberlee M.; Dembitsky, Walter P.; Gustafsson, Asa B.; Sussman, Mark A.			Functional Effect of Pim1 Depends upon Intracellular Localization in Human Cardiac Progenitor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELLS; CELLULAR SENESCENCE; NUCLEOSTEMIN; ACTIVATION; PROLIFERATION; REGENERATION; MULTIPOTENT; MAINTAINS; MECHANISM; SURVIVAL	Human cardiac progenitor cells (hCPC) improve heart function after autologous transfer in heart failure patients. Regenerative potential of hCPCs is severely limited with age, requiring genetic modification to enhance therapeutic potential. A legacy of work from our laboratory with Pim1 kinase reveals effects on proliferation, survival, metabolism, and rejuvenation of hCPCs in vitro and in vivo. We demonstrate that subcellular targeting of Pim1 bolsters the distinct cardioprotective effects of this kinase in hCPCs to increase proliferation and survival, and antagonize cellular senescence. Adult hCPCs isolated from patients undergoing left ventricular assist device implantation were engineered to overexpress Pim1 throughout the cell (PimWT) or targeted to either mitochondrial (Mito-Pim1) or nuclear (Nuc-Pim1) compartments. Nuc-Pim1 enhances stem cell youthfulness associated with decreased senescence-associated beta-galactosidase activity, preserved telomere length, reduced expression of p16 and p53, and up-regulation of nucleo-stemin relative to PimWT hCPCs. Alternately, Mito-Pim1 enhances survival by increasing expression of Bcl-2 and Bcl-XL and decreasing cell death after H2O2 treatment, thereby preserving mitochondrial integrity superior to PimWT. Mito-Pim1 increases the proliferation rate by up-regulation of cell cycle modulators Cyclin D, CDK4, and phospho-Rb. Optimal stem cell traits such as proliferation, survival, and increased youthful properties of aged hCPCs are enhanced after targeted Pim1 localization to mitochondrial or nuclear compartments. Targeted Pim1 overexpression in hCPCs allows for selection of the desired phenotypic properties to overcome patient variability and improve specific stem cell characteristics.	[Samse, Kaitlen; Emathinger, Jacqueline; Hariharan, Nirmala; Quijada, Pearl; Ilves, Kelli; Voelkers, Mirko; Ormachea, Lucia; De La Torre, Andrea; Alvarez, Roberto; Din, Shabana; Mohsin, Sadia; Monsanto, Megan; Fischer, Kimberlee M.; Sussman, Mark A.] San Diego State Univ, San Diego Heart Res Inst, San Diego, CA 92182 USA; [Orogo, Amabel M.; Gustafsson, Asa B.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Dembitsky, Walter P.] Sharp Mem Hosp & Rehabil Ctr, San Diego, CA 92123 USA	California State University System; San Diego State University; University of California System; University of California San Diego; Sharp Memorial Hospital Rehabilitation & Physical Therapy	Sussman, MA (corresponding author), 5500 Campanile Dr, San Diego, CA 92182 USA.	heartman4ever@icloud.com	Regan, Clinton/E-6250-2012; Völkers, Mirko/E-7947-2010; Sussman, Mark/H-2284-2014	Völkers, Mirko/0000-0003-2344-1856; Sussman, Mark/0000-0002-0104-4799	National Institutes of Health [R01HL067245, R37HL091102, R01HL105759, R01 HL113656, R01 HL117163, R01 HL113647, R01HL087023, R01HL101217, P01HL085577]; Fondation Leducq; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117163, R01HL113647, R01HL087023, R01HL105759, R37HL091102, R01HL067245, R01HL113656, R01HL101217, P01HL085577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Leducq(Leducq Foundation); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL067245, R37HL091102, R01HL105759, R01 HL113656, R01 HL117163, and R01 HL113647, and an award from Fondation Leducq (to M. A. S.).; Supported National Institutes of Health Grants R01HL087023, R01HL101217, and P01HL085577 and an American Heart Association Established Investigator Award.	Ahuja P, 2010, J CLIN INVEST, V120, P1494, DOI 10.1172/JCI38331; Bailey B, 2009, REGEN MED, V4, P823, DOI [10.2217/rme.09.51, 10.2217/RME.09.51]; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Borillo GA, 2010, CIRC RES, V106, P1265, DOI 10.1161/CIRCRESAHA.109.212035; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Chang BD, 1999, ONCOGENE, V18, P4808, DOI 10.1038/sj.onc.1203078; Cottage CT, 2012, STEM CELLS, V30, P2512, DOI 10.1002/stem.1211; Cottage CT, 2010, CIRC RES, V106, P891, DOI 10.1161/CIRCRESAHA.109.208629; Del Re DP, 2012, CIRC RES, V110, P1154, DOI 10.1161/CIRCRESAHA.112.269183; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Din S, 2014, CIRC RES, V115, P376, DOI 10.1161/CIRCRESAHA.115.304441; Ellison GM, 2011, J AM COLL CARDIOL, V58, P977, DOI 10.1016/j.jacc.2011.05.013; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Fischer KM, 2009, CIRCULATION, V120, P2077, DOI 10.1161/CIRCULATIONAHA.109.884403; Fransioli J, 2008, STEM CELLS, V26, P1315, DOI 10.1634/stemcells.2007-0751; Gonzalez A, 2008, CIRC RES, V102, P597, DOI 10.1161/CIRCRESAHA.107.165464; Hariharan N, 2015, J AM COLL CARDIOL, V65, P133, DOI 10.1016/j.jacc.2014.09.086; Hsu JK, 2012, J CELL BIOL, V197, P613, DOI 10.1083/jcb.201109038; Jesty SA, 2012, P NATL ACAD SCI USA, V109, P13380, DOI 10.1073/pnas.1208114109; Kim JH, 2003, BIOCHEM J, V373, P523, DOI 10.1042/BJ20030363; Kimura W, 2014, ANTIOXID REDOX SIGN, V21, P1660, DOI 10.1089/ars.2014.6029; Leri A, 2003, J MOL CELL CARDIOL, V35, P595, DOI 10.1016/S0022-2828(03)00116-0; Liu ZH, 2013, CELL CYCLE, V12, P2210, DOI 10.4161/cc.25265; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Meng LJ, 2013, P NATL ACAD SCI USA, V110, P11415, DOI 10.1073/pnas.1301672110; Mohsin S, 2012, J AM COLL CARDIOL, V60, P1278, DOI 10.1016/j.jacc.2012.04.047; Muraski JA, 2007, NAT MED, V13, P1467, DOI 10.1038/nm1671; Pereira SL, 2014, HUM REPROD UPDATE, V20, P924, DOI 10.1093/humupd/dmu034; Qu J, 2012, J CELL BIOL, V197, P731, DOI 10.1083/jcb.201103071; Reinecke H, 2008, CIRC RES, V103, P1058, DOI 10.1161/CIRCRESAHA.108.180588; Rota M, 2008, CIRC RES, V103, P107, DOI 10.1161/CIRCRESAHA.108.178525; Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800; Shugo H, 2012, STEM CELLS DEV, V21, P3044, DOI 10.1089/scd.2011.0725; Tsai RYL, 2002, GENE DEV, V16, P2991, DOI 10.1101/gad.55671; Urbanek K, 2005, P NATL ACAD SCI USA, V102, P8692, DOI 10.1073/pnas.0500169102; van Berlo JH, 2014, NATURE, V509, P337, DOI 10.1038/nature13309; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Zhang F, 2009, CANCER BIOL THER, V8, P846, DOI 10.4161/cbt.8.9.8210; Zhang Y, 2008, ONCOGENE, V27, P4809, DOI 10.1038/onc.2008.123; Zhu QB, 2006, MOL CELL BIOL, V26, P9279, DOI 10.1128/MCB.00724-06	41	23	24	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13935	13947		10.1074/jbc.M114.617431	http://dx.doi.org/10.1074/jbc.M114.617431			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25882843	hybrid, Green Published			2022-12-28	WOS:000355313000025
J	Fontaine, SN; Rauch, JN; Nordhues, BA; Assimon, VA; Stothert, AR; Jinwal, UK; Sabbagh, JJ; Chang, L; Stevens, SM; Zuiderweg, ERP; Gestwicki, JE; Dickey, CA				Fontaine, Sarah N.; Rauch, Jennifer N.; Nordhues, Bryce A.; Assimon, Victoria A.; Stothert, Andrew R.; Jinwal, Umesh K.; Sabbagh, Jonathan J.; Chang, Lyra; Stevens, Stanley M., Jr.; Zuiderweg, Erik R. P.; Gestwicki, Jason E.; Dickey, Chad A.			Isoform-selective Genetic Inhibition of Constitutive Cytosolic Hsp70 Activity Promotes Client Tau Degradation Using an Altered Co-chaperone Complement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; RESPONSE REGULATOR GRP78/BIP; NUCLEOTIDE-BINDING DOMAIN; ATP HYDROLYTIC ACTIVITY; HIGH-THROUGHPUT SCREEN; FAST AXONAL-TRANSPORT; MOLECULAR CHAPERONES; COGNATE PROTEIN; HEAT-SHOCK-PROTEIN-70 HSP70; MICROTUBULE DYNAMICS	The constitutively expressed heat shock protein 70 kDa (Hsc70) is a major chaperone protein responsible for maintaining proteostasis, yet how its structure translates into functional decisions regarding client fate is still unclear. We previously showed that Hsc70 preserved aberrant Tau, but it remained unknown if selective inhibition of the activity of this Hsp70 isoform could facilitate Tau clearance. Using single point mutations in the nucleotide binding domain, we assessed the effect of several mutations on the functions of human Hsc70. Biochemical characterization revealed that one mutation abolished both Hsc70 ATPase and refolding activities. This variant resembled the ADP-bound conformer at all times yet remained able to interact with cofactors, nucleotides, and substrates appropriately, resembling a dominant negative Hsc70 (DN-Hsc70). We then assessed the effects of this DN-Hsc70 on its client Tau. DN-Hsc70 potently facilitated Tau clearance via the proteasome in cells and brain tissue, in contrast to wild type Hsc70 that stabilized Tau. Thus, DN-Hsc70 mimics the action of small molecule pan Hsp70 inhibitors with regard to Tau metabolism. This shift in Hsc70 function by a single point mutation was the result of a change in the chaperome associated with Hsc70 such that DN-Hsc70 associated more with Hsp90 and DnaJ proteins, whereas wild type Hsc70 was more associated with other Hsp70 isoforms. Thus, isoform-selective targeting of Hsc70 could be a viable therapeutic strategy for tauopathies and possibly lead to new insights in chaperone complex biology.	[Fontaine, Sarah N.; Nordhues, Bryce A.; Stothert, Andrew R.; Sabbagh, Jonathan J.; Dickey, Chad A.] Univ S Florida, USF Hlth Byrd Alzheimers Inst, Dept Mol Med, Coll Med, Tampa, FL 33613 USA; [Fontaine, Sarah N.; Nordhues, Bryce A.; Sabbagh, Jonathan J.; Dickey, Chad A.] James A Haley Vet Hosp, Tampa, FL 33612 USA; [Jinwal, Umesh K.] Univ S Florida, USF Hlth Byrd Alzheimers Inst, Dept Pharmaceut Sci, Coll Pharm, Tampa, FL 33613 USA; [Rauch, Jennifer N.; Stevens, Stanley M., Jr.] Univ S Florida, Deparment Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA; [Rauch, Jennifer N.; Assimon, Victoria A.; Chang, Lyra; Gestwicki, Jason E.] Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94158 USA; [Zuiderweg, Erik R. P.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	State University System of Florida; University of South Florida; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; University of California System; University of California San Francisco; University of Michigan System; University of Michigan	Dickey, CA (corresponding author), Dept Mol Med, 4001 E Fletcher Ave MDC 36, Tampa, FL 33613 USA.	cdickey@health.usf.edu	Regan, Clinton/E-6250-2012; Rauch, Jennifer/AGI-2683-2022; Fontaine, Sarah/P-6536-2016	Rauch, Jennifer/0000-0001-6853-5915; Chang, Chia Yin/0000-0002-9608-4952; Stevens, Stanley/0000-0002-1399-0256	National Institutes of Health [NS073899, 2R01NS059690, AG042813]; Veterans Health Administration (VHA) [BX001637]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059690, R01NS073899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG042813] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Health Administration (VHA)(US Department of Veterans Affairs); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants NS073899 (to C. A. D.), 2R01NS059690 (to E. R. P. Z. and J. E. G.), and AG042813 (to J. E. G.) and Veterans Health Administration (VHA) Grant BX001637 (to C. A. D.).	Abisambra J, 2013, BIOL PSYCHIAT, V74, P367, DOI 10.1016/j.biopsych.2013.02.027; Agueli C, 2001, BIOCHEM J, V360, P413, DOI 10.1042/0264-6021:3600413; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; Bhattacharya A, 2009, J MOL BIOL, V388, P475, DOI 10.1016/j.jmb.2009.01.062; Brocchieri L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-19; Bunker JM, 2004, MOL BIOL CELL, V15, P2720, DOI 10.1091/mbc.E04-01-0062; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P679, DOI 10.1016/B978-012164491-8/50010-5; Chamberlain LH, 1997, BIOCHEM J, V322, P853, DOI 10.1042/bj3220853; Chang L, 2008, ANAL BIOCHEM, V372, P167, DOI 10.1016/j.ab.2007.08.020; CHAPPELL TG, 1986, CELL, V45, P3, DOI 10.1016/0092-8674(86)90532-5; CHEETHAM ME, 1994, EUR J BIOCHEM, V226, P99, DOI 10.1111/j.1432-1033.1994.tb20030.x; Choi MC, 2009, BIOPHYS J, V97, P519, DOI 10.1016/j.bpj.2009.04.047; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Dou F, 2003, P NATL ACAD SCI USA, V100, P721, DOI 10.1073/pnas.242720499; DWORNICZAK B, 1987, NUCLEIC ACIDS RES, V15, P5181, DOI 10.1093/nar/15.13.5181; FLAHERTY KM, 1994, J BIOL CHEM, V269, P12899; General IJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003624; Gogolla N, 2006, NAT PROTOC, V1, P2452, DOI 10.1038/nprot.2006.180; Howe MK, 2014, CHEM BIOL, V21, P1648, DOI 10.1016/j.chembiol.2014.10.016; Jinwal UK, 2013, FASEB J, V27, P1450, DOI 10.1096/fj.12-220889; Jinwal UK, 2010, J BIOL CHEM, V285, P16798, DOI 10.1074/jbc.M110.113753; Joglekar AP, 2005, EUR J CELL BIOL, V84, P529, DOI 10.1016/j.ejcb.2004.12.028; Johnson ER, 1999, BIOCHEMISTRY-US, V38, P10823, DOI 10.1021/bi990816g; Kang YL, 2014, J MED CHEM, V57, P1188, DOI 10.1021/jm401551n; Kityk R, 2012, MOL CELL, V48, P863, DOI 10.1016/j.molcel.2012.09.023; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; Li J, 2008, CELL DEATH DIFFER, V15, P1460, DOI 10.1038/cdd.2008.81; LIBEREK K, 1991, J BIOL CHEM, V266, P14491; Liu Y, 2005, MOL CELL BIOCHEM, V268, P45, DOI 10.1007/s11010-005-2996-1; Mayer MP, 2010, MOL CELL, V39, P321, DOI 10.1016/j.molcel.2010.07.012; MCKAY DB, 1993, ADV PROTEIN CHEM, V44, P67, DOI 10.1016/S0065-3233(08)60564-1; Miyata Y, 2013, ACS CHEM NEUROSCI, V4, P930, DOI 10.1021/cn300210g; Miyata Y, 2010, J BIOMOL SCREEN, V15, P1211, DOI 10.1177/1087057110380571; OBRIEN MC, 1993, J BIOL CHEM, V268, P24323; PALLEROS DR, 1993, NATURE, V365, P664, DOI 10.1038/365664a0; Panda D, 2003, P NATL ACAD SCI USA, V100, P9548, DOI 10.1073/pnas.1633508100; Panjwani N, 1999, J IMMUNOL, V163, P1936; QUENOUILLE MH, 1956, BIOMETRIKA, V43, P353; Rajapandi T, 2000, J BIOL CHEM, V275, P22597, DOI 10.1074/jbc.M002035200; Rauch JN, 2014, J BIOL CHEM, V289, P1402, DOI 10.1074/jbc.M113.521997; Rodina A, 2013, CHEM BIOL, V20, P1469, DOI 10.1016/j.chembiol.2013.10.008; Rosso SM, 2002, ANN NEUROL, V51, P373, DOI 10.1002/ana.10140; Rousaki A, 2011, J MOL BIOL, V411, P614, DOI 10.1016/j.jmb.2011.06.003; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Sarkar M, 2008, J NEUROSCI RES, V86, P2763, DOI 10.1002/jnr.21721; Schlecht R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078443; SCHMID SL, 1985, J BIOL CHEM, V260, P57; Shiber A, 2013, MOL BIOL CELL, V24, P2076, DOI 10.1091/mbc.E13-01-0010; Stankiewicz M, 2010, FEBS J, V277, P3353, DOI 10.1111/j.1742-4658.2010.07737.x; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; Taldone T, 2014, J MED CHEM, V57, P1208, DOI 10.1021/jm401552y; Tavaria M, 1996, CELL STRESS CHAPERON, V1, P23, DOI 10.1379/1466-1268(1996)001<0023:AHSGTT>2.3.CO;2; Terada S, 2010, EMBO J, V29, P843, DOI 10.1038/emboj.2009.389; Thompson AD, 2012, ACS CHEM BIOL, V7, P1677, DOI 10.1021/cb3002599; Tsai MY, 2000, MOL BIOL CELL, V11, P2161, DOI 10.1091/mbc.11.6.2161; Turturici G, 2008, J MOL HISTOL, V39, P571, DOI 10.1007/s10735-008-9197-7; Wang YP, 2012, BIOCHEM SOC T, V40, P644, DOI 10.1042/BST20120071; WILBANKS SM, 1994, J BIOL CHEM, V269, P12893; Wisen S, 2008, BIOORG MED CHEM LETT, V18, P60, DOI 10.1016/j.bmcl.2007.11.027; Wisen S, 2008, ANAL BIOCHEM, V374, P371, DOI 10.1016/j.ab.2007.12.009; Wittung-Stafshede P, 2003, BIOCHEMISTRY-US, V42, P4937, DOI 10.1021/bi027333o; Yuan AD, 2000, CELL MOL NEUROBIOL, V20, P623, DOI 10.1023/A:1007090422866; Zhang YB, 2004, P NATL ACAD SCI USA, V101, P10272, DOI 10.1073/pnas.0401313101; Zhang Y, 2010, J BIOL CHEM, V285, P15065, DOI 10.1074/jbc.M109.087445; Zhuravleva A, 2012, CELL, V151, P1296, DOI 10.1016/j.cell.2012.11.002; Zhuravleva A, 2011, P NATL ACAD SCI USA, V108, P6987, DOI 10.1073/pnas.1014448108; Zylicz M, 2001, IUBMB LIFE, V51, P283	68	35	35	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13115	13127		10.1074/jbc.M115.637595	http://dx.doi.org/10.1074/jbc.M115.637595			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25864199	Green Published, hybrid			2022-12-28	WOS:000354975700015
J	Miller, MB; Vishwanatha, KS; Mains, RE; Eipper, BA				Miller, Megan B.; Vishwanatha, Kurutihalli S.; Mains, Richard E.; Eipper, Betty A.			An N-terminal Amphipathic Helix Binds Phosphoinositides and Enhances Kalirin Sec14 Domain-mediated Membrane Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPID-BINDING; SECRETORY GRANULES; NMDA RECEPTOR; PROTEIN; PEPTIDES; LOCALIZATION; INHIBITION; COMPLEXES; DEFECTS; ISOFORM	Previous studies revealed an essential role for the lipid-binding Sec14 domain of kalirin (KalSec14), but its mechanism of action is not well understood. Because alternative promoter usage appends unique N-terminal peptides to the KalSec14 domain, we used biophysical, biochemical, and cell biological approaches to examine the two major products, bKalSec14 and cKalSec14. Promoter B encodes a charged, unstructured peptide, whereas promoter C encodes an amphipathic helix (Kal-Chelix). Both bKalSec14 and cKalSec14 interacted with lipids in PIP strip and liposome flotation assays, with significantly greater binding by cKalSec14 in both assays. Disruption of the hydrophobic face of the Kal-C-helix in cKalSec14(KKED) eliminated its increased liposome binding. Although cKalSec14 showed significantly reduced binding to liposomes lacking phosphatidylinositol phosphates or cholesterol, liposome binding by bKalSec14 and cKalSec14(KKED) was not affected. When expressed in AtT-20 cells, bKalSec14-GFP was diffusely localized, whereas cKalSec14-GFP localized to the trans-Golgi network and secretory granules. The amphipathic C-helix was sufficient for this localization. When AtT-20 cells were treated with a cell-permeant derivative of the Kal-C-helix (Kal-C-helixArg(9)), we observed increased secretion of a product stored in mature secretory granules, with no effect on basal secretion; a cell-permeant control peptide (Kal-C-helix(KKED)-Arg(9)) did not have this effect. Through its ability to control expression of a novel, phosphoinositide-binding amphipathic helix, Kalrn promoter usage is expected to affect function.	[Miller, Megan B.; Vishwanatha, Kurutihalli S.; Mains, Richard E.; Eipper, Betty A.] Univ Connecticut, Dept Neurosci, Ctr Hlth, Farmington, CT 06030 USA; [Eipper, Betty A.] Univ Connecticut, Dept Mol Biol & Biophys, Ctr Hlth, Farmington, CT 06030 USA	University of Connecticut; University of Connecticut	Eipper, BA (corresponding author), Univ Connecticut, Dept Neurosci, Ctr Hlth, 263 Farmington Ave,MC 3401, Farmington, CT 06030 USA.	eipper@uchc.edu	Regan, Clinton/E-6250-2012	Rao, Vishwanatha/0000-0001-9471-807X	National Institutes of Health [DK-032948]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK032948, R56DK032948, R37DK032948] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK-032948.	Antonny B, 1997, BIOCHEMISTRY-US, V36, P4675, DOI 10.1021/bi962252b; Back N, 2010, TRAFFIC, V11, P972, DOI 10.1111/j.1600-0854.2010.01066.x; Bhatia VK, 2009, EMBO J, V28, P3303, DOI 10.1038/emboj.2009.261; Bonnemaison M, 2014, TRAFFIC, V15, P1099, DOI 10.1111/tra.12194; Cunningham CC, 2001, J BIOL CHEM, V276, P43390, DOI 10.1074/jbc.M105289200; Curwin AJ, 2009, J BIOL CHEM, V284, P7364, DOI 10.1074/jbc.M808732200; D'Angelo I, 2006, EMBO REP, V7, P174, DOI 10.1038/sj.embor.7400602; Di Paolo G, 2004, NATURE, V431, P415, DOI 10.1038/nature02896; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Drin G, 2010, FEBS LETT, V584, P1840, DOI 10.1016/j.febslet.2009.10.022; EBERHARD DA, 1990, BIOCHEM J, V268, P15, DOI 10.1042/bj2680015; Faust JE, 2015, J BIOL CHEM, V290, P4772, DOI 10.1074/jbc.M114.601823; Gong LW, 2005, P NATL ACAD SCI USA, V102, P5204, DOI 10.1073/pnas.0501412102; Gupta AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033863; Hama H, 1999, J BIOL CHEM, V274, P34294, DOI 10.1074/jbc.274.48.34294; HAY JC, 1995, NATURE, V374, P173, DOI 10.1038/374173a0; He XQ, 2009, P NATL ACAD SCI USA, V106, P18545, DOI 10.1073/pnas.0907454106; Hille B, 2015, BBA-MOL CELL BIOL L, V1851, P844, DOI 10.1016/j.bbalip.2014.09.010; Huang S, 2014, BONE, V60, P235, DOI 10.1016/j.bone.2013.12.023; JANMEY PA, 1992, J BIOL CHEM, V267, P11818; Kiraly DD, 2011, J NEUROSCI, V31, P12554, DOI 10.1523/JNEUROSCI.3143-11.2011; Kiraly DD, 2010, ACS CHEM NEUROSCI, V1, P348, DOI 10.1021/cn100012x; Kono N, 2013, SCIENCE, V340, P1106, DOI 10.1126/science.1233508; Lemtiri-Chlieh F, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-126; Ma XM, 2008, J NEUROSCI, V28, P711, DOI 10.1523/JNEUROSCI.5283-07.2008; Ma XM, 2014, MOL BIOL CELL, V25, P1458, DOI 10.1091/mbc.E13-04-0215; Ma XM, 2008, J NEUROSCI, V28, P12368, DOI 10.1523/JNEUROSCI.4269-08.2008; Mains RE, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-20; Mandela P, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-136; Manneville JB, 2012, METHOD CELL BIOL, V108, P47, DOI 10.1016/B978-0-12-386487-1.00003-1; Martin TFJ, 2015, BBA-MOL CELL BIOL L, V1851, P785, DOI 10.1016/j.bbalip.2014.09.017; Milgram SL, 1997, J CELL SCI, V110, P695; MILGRAM SL, 1994, J CELL SCI, V107, P737; Miller MB, 2013, NEUROSCIENTIST, V19, P255, DOI 10.1177/1073858413475486; Milletti F, 2012, DRUG DISCOV TODAY, V17, P850, DOI 10.1016/j.drudis.2012.03.002; Milosevic I, 2005, J NEUROSCI, V25, P2557, DOI 10.1523/JNEUROSCI.3761-04.2005; Nile AH, 2010, CLIN LIPIDOL, V5, P867, DOI 10.2217/CLP.10.67; Niu Y, 2013, NAT CELL BIOL, V15, P417, DOI 10.1038/ncb2710; ORCI L, 1981, P NATL ACAD SCI-BIOL, V78, P293, DOI 10.1073/pnas.78.1.293; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Penzes P, 2000, J BIOL CHEM, V275, P6395, DOI 10.1074/jbc.275.9.6395; Prosser DC, 2010, TRAFFIC, V11, P1347, DOI 10.1111/j.1600-0854.2010.01100.x; Rothbard JB, 2000, NAT MED, V6, P1253, DOI 10.1038/81359; Saito K, 2007, BBA-MOL CELL BIOL L, V1771, P719, DOI 10.1016/j.bbalip.2007.02.010; Schaaf G, 2008, MOL CELL, V29, P191, DOI 10.1016/j.molcel.2007.11.026; Schiller MR, 2008, EXP CELL RES, V314, P2674, DOI 10.1016/j.yexcr.2008.05.011; Sha BD, 1998, NATURE, V391, P506, DOI 10.1038/35179; Sirokmany G, 2006, J BIOL CHEM, V281, P6096, DOI 10.1074/jbc.M510619200; Sobota JA, 2006, MOL BIOL CELL, V17, P5038, DOI 10.1091/mbc.E06-07-0626; Spijker S, 1999, FASEB J, V13, P735, DOI 10.1096/fasebj.13.6.735; Steveson TC, 2001, J BIOL CHEM, V276, P40326, DOI 10.1074/jbc.M011460200; Ueda S, 2004, CELL SIGNAL, V16, P899, DOI 10.1016/j.cellsig.2004.01.007; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vanni S, 2013, BIOPHYS J, V104, P575, DOI 10.1016/j.bpj.2012.11.3837; Vishwanatha KS, 2012, BIOCHEMISTRY-US, V51, P5663, DOI 10.1021/bi300583s; Wang YJ, 2003, CELL, V114, P299, DOI 10.1016/S0092-8674(03)00603-2; Wenk MR, 2004, P NATL ACAD SCI USA, V101, P8262, DOI 10.1073/pnas.0401874101; Wu JH, 2013, ARTERIOSCL THROM VAS, V33, P702, DOI 10.1161/ATVBAHA.112.300234; Xie Z, 2007, NEURON, V56, P640, DOI 10.1016/j.neuron.2007.10.005; Yan Y, 2015, CEREB CORTEX, V25, P3487, DOI 10.1093/cercor/bhu182; ZHOU A, 1995, J BIOL CHEM, V270, P21509, DOI 10.1074/jbc.270.37.21509	61	11	11	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13541	13555		10.1074/jbc.M115.636746	http://dx.doi.org/10.1074/jbc.M115.636746			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25861993	hybrid, Green Published			2022-12-28	WOS:000354975700048
J	Wang, W; Huang, X; Xin, HB; Fu, MG; Xue, AM; Wu, ZH				Wang, Wei; Huang, Xuan; Xin, Hong-Bo; Fu, Mingui; Xue, Aimin; Wu, Zhao-Hui			TRAF Family Member-associated NF-kappa B Activator (TANK) Inhibits Genotoxic Nuclear Factor kappa B Activation by Facilitating Deubiquitinase USP10-dependent Deubiquitination of TRAF6 Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERFERON ANTIVIRAL RESPONSE; DNA-DAMAGE; LINEAR UBIQUITINATION; NEGATIVE REGULATOR; CELL-SURVIVAL; UP-REGULATION; PROTEIN TANK; CROSS-TALK; KINASE; STRESS	DNA damage-induced NF-kappa B activation plays a critical role in regulating cellular response to genotoxic stress. However, the molecular mechanisms controlling the magnitude and duration of this genotoxic NF-kappa B signaling cascade are poorly understood. We recently demonstrated that genotoxic NF-kappa B activation is regulated by reversible ubiquitination of several essential mediators involved in this signaling pathway. Here we show that TRAF family member-associated NF-kappa B activator (TANK) negatively regulates NF-kappa B activation by DNA damage via inhibiting ubiquitination of TRAF6. Despite the lack of a deubiquitination enzyme domain, TANK has been shown to negatively regulate the ubiquitination of TRAF proteins. We found TANK formed a complex with MCPIP1 (also known as ZC3H12A) and a deubiquitinase, USP10, which was essential for the USP10-dependent deubiquitination of TRAF6 and the resolution of genotoxic NF-kappa B activation upon DNA damage. Clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9-mediated deletion of TANK in human cells significantly enhanced NF-kappa B activation by genotoxic treatment, resulting in enhanced cell survival and increased inflammatory cytokine production. Furthermore, we found that the TANK-MCPIP1-USP10 complex also decreased TRAF6 ubiquitination in cells treated with IL-1 beta or LPS. In accordance, depletion of USP10 enhanced NF-kappa B activation induced by IL-1 beta or LPS. Collectively, our data demonstrate that TANK serves as an important negative regulator of NF-kappa B signaling cascades induced by genotoxic stress and IL-1R/Toll-like receptor stimulation in a manner dependent on MCPIP1/USP10-mediated TRAF6 deubiquitination.	[Wang, Wei; Wu, Zhao-Hui] Univ Tennessee, Dept Pathol & Lab Med, Hlth Sci Ctr, Memphis, TN 38163 USA; [Wang, Wei; Wu, Zhao-Hui] Univ Tennessee, Ctr Canc Res, Hlth Sci Ctr, Memphis, TN 38163 USA; [Huang, Xuan; Xin, Hong-Bo] Nanchang Univ, Inst Translat Med, Nanchang 330031, Peoples R China; [Fu, Mingui] Univ Missouri, Dept Basic Med Sci, Kansas City, MO 64108 USA; [Xue, Aimin] Fudan Univ, Shanghai Med Coll, Dept Forens Med, Shanghai 200032, Peoples R China	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Nanchang University; University of Missouri System; University of Missouri Kansas City; Fudan University	Wu, ZH (corresponding author), Univ Tennessee, Dept Pathol & Lab Med, Hlth Sci Ctr, 19 S Manassas St, Memphis, TN 38163 USA.	zwu6@uthsc.edu			NCI/National Institutes of Health [R01CA149251]; American Cancer Society [RSG-13-186-01-CSM]; National Institute of Health [R21AI103618]; NATIONAL CANCER INSTITUTE [R01CA149251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI103618] Funding Source: NIH RePORTER	NCI/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by NCI/National Institutes of Health grant R01CA149251 (to Z. W.). This work was also supported by American Cancer Society Grant RSG-13-186-01-CSM (to Z. W.).; Supported by National Institute of Health Grant R21AI103618.	Baldwin AS, 2012, IMMUNOL REV, V246, P327, DOI 10.1111/j.1600-065X.2012.01095.x; Chariot A, 2002, J BIOL CHEM, V277, P37029, DOI 10.1074/jbc.M205069200; Cheng GH, 1996, GENE DEV, V10, P963, DOI 10.1101/gad.10.8.963; Clark K, 2011, P NATL ACAD SCI USA, V108, P17093, DOI 10.1073/pnas.1114194108; Clark K, 2011, BIOCHEM J, V434, P93, DOI 10.1042/BJ20101701; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Guo BC, 2007, J BIOL CHEM, V282, P11817, DOI 10.1074/jbc.M700017200; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hinz M, 2014, EMBO REP, V15, P46, DOI 10.1002/embr.201337983; Hinz M, 2010, MOL CELL, V40, P63, DOI 10.1016/j.molcel.2010.09.008; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Jin HS, 2009, CANCER RES, V69, P1782, DOI 10.1158/0008-5472.CAN-08-2256; Kawagoe T, 2009, NAT IMMUNOL, V10, P965, DOI 10.1038/ni.1771; Keusekotten K, 2013, CELL, V153, P1312, DOI 10.1016/j.cell.2013.05.014; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Lee MH, 2011, MOL CELL, V43, P180, DOI 10.1016/j.molcel.2011.06.017; Liang JA, 2010, J EXP MED, V207, P2959, DOI 10.1084/jem.20092641; Lin ZH, 2013, CELL REP, V5, P1639, DOI 10.1016/j.celrep.2013.11.029; Liu JL, 2011, CELL, V147, P223, DOI 10.1016/j.cell.2011.08.037; Mabb AM, 2006, NAT CELL BIOL, V8, P986, DOI 10.1038/ncb1458; Maruyama K, 2012, J BIOL CHEM, V287, P29114, DOI 10.1074/jbc.M112.347799; McCool KW, 2012, IMMUNOL REV, V246, P311, DOI 10.1111/j.1600-065X.2012.01101.x; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; Niu JX, 2013, EMBO J, V32, P3206, DOI 10.1038/emboj.2013.247; Niu JX, 2012, J BIOL CHEM, V287, P21783, DOI 10.1074/jbc.M112.355495; Niu JX, 2011, EMBO J, V30, P3741, DOI 10.1038/emboj.2011.264; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rivkin E, 2013, NATURE, V498, P318, DOI 10.1038/nature12296; Rothe M, 1996, P NATL ACAD SCI USA, V93, P8241, DOI 10.1073/pnas.93.16.8241; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Ruland J, 2011, NAT IMMUNOL, V12, P709, DOI 10.1038/ni.2055; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Stilmann M, 2009, MOL CELL, V36, P365, DOI 10.1016/j.molcel.2009.09.032; Takiuchi T, 2014, GENES CELLS, V19, P254, DOI 10.1111/gtc.12128; Tan GY, 2012, J BIOL CHEM, V287, P33036, DOI 10.1074/jbc.M112.383273; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Wu ZH, 2008, EMBO J, V27, P1963, DOI 10.1038/emboj.2008.127; Wu ZH, 2013, CURR PHARM DESIGN, V19, P3263, DOI 10.2174/1381612811319180010; Wu ZH, 2010, MOL CELL, V40, P75, DOI 10.1016/j.molcel.2010.09.010; Yang YB, 2011, MOL CELL BIOL, V31, P2774, DOI 10.1128/MCB.01139-10; Yuan J, 2010, CELL, V140, P384, DOI 10.1016/j.cell.2009.12.032	46	55	59	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13372	13385		10.1074/jbc.M115.643767	http://dx.doi.org/10.1074/jbc.M115.643767			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25861989	hybrid, Green Published			2022-12-28	WOS:000354975700034
J	Xu, Y; Wu, XL; Her, CT				Xu, Yang; Wu, Xiling; Her, Chengtao			hMSH5 Facilitates the Repair of Camptothecin-induced Double-strand Breaks through an Interaction with FANCJ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; MUTS HOMOLOG HMSH5; ANEMIA GROUP J; MMS22L-NFKBIL2 COMPLEX; MMS22L-TONSL COMPLEX; MISMATCH REPAIR; PROTEIN; REPLICATION; HELICASE; RECOMBINATION	Replication stress from stalled or collapsed replication forks is a major challenge to genomic integrity. The anticancer agent camptothecin (CPT) is a DNA topoisomerase I inhibitor that causes fork collapse and double-strand breaks amid DNA replication. Here we report that hMSH5 promotes cell survival in response to CPT-induced DNA damage. Cells deficient in hMSH5 show elevated CPT-induced gamma-H2AX and RPA2 foci with concomitant reduction of Rad51 foci, indicative of impaired homologous recombination. In addition, CPT-treated hMSH5-deficient cells exhibit aberrant activation of Chk1 and Chk2 kinases and therefore abnormal cell cycle progression. Furthermore, the hMSH5-FANCJ chromatin recruitment underlies the effects of hMSH5on homologous recombination and Chk1 activation. Intriguingly, FANCJ depletion desensitizes hMSH5-deficient cells to CPT-elicited cell killing. Collectively, our data point to the existence of a functional interplay between hMSH5 and FANCJ in double-strand break repair induced by replication stress.	[Xu, Yang; Wu, Xiling; Her, Chengtao] Washington State Univ, Sch Mol Biosci, Coll Vet Med, Pullman, WA 99164 USA	Washington State University	Her, CT (corresponding author), Washington State Univ, Sch Mol Biosci, Coll Vet Med, Mail Drop 64-7520, Pullman, WA 99164 USA.	cher@wsu.edu			National Institutes of Health from the Public Health Service [GM084353]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084353] Funding Source: NIH RePORTER	National Institutes of Health from the Public Health Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM084353 from the Public Health Service (to C. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Bridge WL, 2005, NAT GENET, V37, P953, DOI 10.1038/ng1627; Britton S, 2013, J CELL BIOL, V202, P579, DOI 10.1083/jcb.201303073; Cantor S, 2004, P NATL ACAD SCI USA, V101, P2357, DOI 10.1073/pnas.0308717101; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Chaudhuri AR, 2012, NAT STRUCT MOL BIOL, V19, P417, DOI 10.1038/nsmb.2258; Chowdhury D, 2005, MOL CELL, V20, P801, DOI 10.1016/j.molcel.2005.10.003; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Clark N, 2013, CURR GENOMICS, V14, P81, DOI 10.2174/1389202911314020002; Cloud V, 2012, SCIENCE, V337, P1222, DOI 10.1126/science.1219379; Costantino L, 2014, SCIENCE, V343, P88, DOI 10.1126/science.1243211; Curtin NJ, 2012, NAT REV CANCER, V12, P801, DOI 10.1038/nrc3399; de Vries SS, 1999, GENE DEV, V13, P523, DOI 10.1101/gad.13.5.523; Dohrn L, 2012, BIOCHEM J, V441, P919, DOI 10.1042/BJ20110314; Duro E, 2010, MOL CELL, V40, P632, DOI 10.1016/j.molcel.2010.10.023; Edelmann W, 1999, NAT GENET, V21, P123, DOI 10.1038/5075; Gong ZH, 2010, MOL CELL, V37, P438, DOI 10.1016/j.molcel.2010.01.002; Greenberg RA, 2006, GENE DEV, V20, P34, DOI 10.1101/gad.1381306; Guillemette S, 2014, CANCER RES, V74, P932, DOI 10.1158/0008-5472.CAN-13-2474; Gupta R, 2005, J BIOL CHEM, V280, P25450, DOI 10.1074/jbc.M501995200; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Hiom K, 2010, DNA REPAIR, V9, P250, DOI 10.1016/j.dnarep.2010.01.005; Hirokawa T, 2014, CANCER RES, V74, P3880, DOI 10.1158/0008-5472.CAN-13-3604; HOLLINGSWORTH NM, 1995, GENE DEV, V9, P1728, DOI 10.1101/gad.9.14.1728; Kato T, 2007, CANCER RES, V67, P8544, DOI 10.1158/0008-5472.CAN-07-1307; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Litman R, 2005, CANCER CELL, V8, P255, DOI 10.1016/j.ccr.2005.08.004; Liu SZ, 2011, MOL CELL, V43, P192, DOI 10.1016/j.molcel.2011.06.019; Majka J, 2012, J BIOL CHEM, V287, P2328, DOI 10.1074/jbc.M111.307041; Meerang M, 2011, NAT CELL BIOL, V13, P1376, DOI 10.1038/ncb2367; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; O'Connell BC, 2010, MOL CELL, V40, P645, DOI 10.1016/j.molcel.2010.10.022; O'Donnell L, 2010, MOL CELL, V40, P619, DOI 10.1016/j.molcel.2010.10.024; Peng M, 2006, ONCOGENE, V25, P2245, DOI 10.1038/sj.onc.1209257; Peng M, 2007, EMBO J, V26, P3238, DOI 10.1038/sj.emboj.7601754; Peng M, 2014, EMBO J, V33, P1698, DOI 10.15252/embj.201387530; Piwko W, 2010, EMBO J, V29, P4210, DOI 10.1038/emboj.2010.304; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Schwab RA, 2013, J CELL BIOL, V201, P33, DOI 10.1083/jcb.201208009; Shinohara M, 2008, NAT GENET, V40, P299, DOI 10.1038/ng.83; Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040; Suhasini AN, 2013, MOL CELL BIOL, V33, P2212, DOI 10.1128/MCB.01256-12; Suhasini AN, 2012, TRENDS GENET, V28, P7, DOI 10.1016/j.tig.2011.09.003; Suhasini AN, 2011, EMBO J, V30, P692, DOI 10.1038/emboj.2010.362; Tompkins JD, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-10; Vo AT, 2005, EMBO REP, V6, P438, DOI 10.1038/sj.embor.7400392; Wu XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073284; Xie J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002786; Xu KQ, 2012, J BIOL CHEM, V287, P29543, DOI 10.1074/jbc.M112.352302; Yi W, 2006, CANCER RES, V66, P151, DOI 10.1158/0008-5472.CAN-05-3019; Yi W, 2005, BIOCHEM BIOPH RES CO, V332, P524, DOI 10.1016/j.bbrc.2005.04.154; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004; Zellweger R, 2015, J CELL BIOL, V208, P563, DOI 10.1083/jcb.201406099; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302	58	12	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18545	18558		10.1074/jbc.M115.642884	http://dx.doi.org/10.1074/jbc.M115.642884			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26055704	Green Published, hybrid			2022-12-28	WOS:000358512100026
J	Itoh, Y; Sanosaka, M; Fuchino, H; Yahara, Y; Kumagai, A; Takemoto, D; Kagawa, M; Doi, J; Ohta, M; Tsumaki, N; Kawahara, N; Takemori, H				Itoh, Yumi; Sanosaka, Masato; Fuchino, Hiroyuki; Yahara, Yasuhito; Kumagai, Ayako; Takemoto, Daisaku; Kagawa, Mai; Doi, Junko; Ohta, Miho; Tsumaki, Noriyuki; Kawahara, Nobuo; Takemori, Hiroshi			Salt-inducible Kinase 3 Signaling Is Important for the Gluconeogenic Programs in Mouse Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; GLYCOGEN-STORAGE DISEASE; CREB COACTIVATOR TORC2; PHOSPHORYLASE-KINASE; GENE-EXPRESSION; INSULIN HYPERSENSITIVITY; LIVER GLYCOGENOSIS; KEY REGULATOR; IN-VIVO; METFORMIN	Salt-inducible kinases (SIKs), members of the 5'-AMP-activated protein kinase (AMPK) family, are proposed to be important suppressors of gluconeogenic programs in the liver via the phosphorylation-dependent inactivation of the CREB-specific coactivator CRTC2. Although a dramatic phenotype for glucose metabolism has been found in SIK3-KO mice, additional complex phenotypes, dysregulation of bile acids, cholesterol, and fat homeostasis can render it difficult to discuss the hepatic functions of SIK3. The aim of this study was to examine the cell autonomous actions of SIK3 in hepatocytes. To eliminate systemic effects, we prepared primary hepatocytes and screened the small compounds suppressing SIK3 signaling cascades. SIK3-KO primary hepatocytes produced glucose more quickly after treatment with the cAMP agonist forskolin than the WT hepatocytes, which was accompanied by enhanced gluconeogenic gene expression and CRTC2 dephosphorylation. Reporter-based screening identified pterosin B as a SIK3 signalingspecific inhibitor. Pterosin B suppressed SIK3 downstream cascades by up-regulating the phosphorylation levels in the SIK3 C-terminal regulatory domain. When pterosin B promoted glucose production by up-regulating gluconeogenic gene expression in mouse hepatoma AML-12 cells, it decreased the glycogen content and stimulated an association between the glycogen phosphorylase kinase gamma subunit (PHKG2) and SIK3. PHKG2 phosphorylated the peptides with sequences of the C-terminal domain of SIK3. Here we found that the levels of active AMPK were higher both in the SIK3-KO hepatocytes and in pterosin B-treated AML-12 cells than in their controls. These results suggest that SIK3, rather than SIK1, SIK2, or AMPKs, acts as the predominant suppressor in gluconeogenic gene expression in the hepatocytes.	[Itoh, Yumi; Sanosaka, Masato; Kumagai, Ayako; Takemoto, Daisaku; Kagawa, Mai; Takemori, Hiroshi] Natl Inst Biomed Innovat, Lab Cell Signaling & Metab, Osaka 5670085, Japan; [Fuchino, Hiroyuki; Kawahara, Nobuo] Tsukuba Div, Res Ctr Med Plant Resources, Ibaraki 3050843, Japan; [Yahara, Yasuhito; Tsumaki, Noriyuki] Kyoto Univ, Dept Cell Growth & Differentiat, Ctr iPS Cell Res & Applicat, Kyoto 6068507, Japan; [Takemoto, Daisaku] Kansai Univ, Dept Life Sci & Biotechnol, Osaka 5648680, Japan; [Doi, Junko] Senri Kinran Univ, Dept Food & Nutr, Osaka 5650873, Japan; [Ohta, Miho] Soai Univ, Fac Human Dev, Dept Nutr & Hlth, Osaka 5590033, Japan	National Institute of Health Sciences - Japan; Kyoto University; Kansai University	Takemori, H (corresponding author), Natl Inst Biomed Innovat, Lab Cell Signaling & Metab, 7-6-8 Asagi, Osaka 5670085, Japan.	takemori@nibiohn.go.jp	Takemoto, Daisaku/AAE-1365-2019; Fuchino, Hiroyuki/ABD-5560-2020; Yahara, Yasuhito/AAO-7487-2020	Takemoto, Daisaku/0000-0001-7110-6302; Fuchino, Hiroyuki/0000-0002-6302-4507; Tsumaki, Noriyuki/0000-0002-0520-3654	A-STEP (Adaptable & Seamless Technology Transfer Program through Target-driven RD); Ministry of Health, Labor, and Welfare; MEXT; Uehara Memorial Foundation	A-STEP (Adaptable & Seamless Technology Transfer Program through Target-driven RD); Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation)	This study was supported by Grants-in-Aid for Scientific Research from the A-STEP (Adaptable & Seamless Technology Transfer Program through Target-driven R & D); a grant from the Ministry of Health, Labor, and Welfare (2013-2017 and 2014-2016); funds from Scientific Research on Innovative Areas, a MEXT Grant-in-Aid Project 2012-2013; and a grant from the Uehara Memorial Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; Bertorello AM, 2015, CIRC RES, V116, P642, DOI 10.1161/CIRCRESAHA.116.304529; Blattmann P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003338; Burwinkel B, 2003, PEDIATR RES, V54, P834, DOI 10.1203/01.PDR.0000088069.09275.10; CHAN KFJ, 1982, J BIOL CHEM, V257, P3655; CHRISMAN TD, 1980, J BIOL CHEM, V255, P3270; Clark K, 2012, P NATL ACAD SCI USA, V109, P16986, DOI 10.1073/pnas.1215450109; Doi J, 2002, J BIOL CHEM, V277, P15629, DOI 10.1074/jbc.M109365200; DUNGER DB, 1982, ARCH DIS CHILD, V57, P384, DOI 10.1136/adc.57.5.384; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Gan RY, 2014, INT J MOL SCI, V15, P16698, DOI 10.3390/ijms150916698; Guigas B, 2006, DIABETES, V55, P865, DOI 10.2337/diabetes.55.04.06.db05-1178; HANKS SK, 1987, P NATL ACAD SCI USA, V84, P388, DOI 10.1073/pnas.84.2.388; Hardie DG, 2014, CELL METAB, V20, P939, DOI 10.1016/j.cmet.2014.09.013; Hashimoto YK, 2008, J CELL BIOCHEM, V104, P1724, DOI 10.1002/jcb.21737; HAWORTH JC, 1981, J INHERIT METAB DIS, V4, P57, DOI 10.1007/BF02263589; Horike N, 2003, J BIOL CHEM, V278, P18440, DOI 10.1074/jbc.M211770200; Horike N, 2010, PIGM CELL MELANOMA R, V23, P809, DOI 10.1111/j.1755-148X.2010.00760.x; Hsu FL, 2013, DIABETES, V62, P628, DOI 10.2337/db12-0585; Hurov JB, 2007, P NATL ACAD SCI USA, V104, P5680, DOI 10.1073/pnas.0701179104; IMAI E, 1993, J BIOL CHEM, V268, P5353; Jansson D, 2008, P NATL ACAD SCI USA, V105, P10161, DOI 10.1073/pnas.0800796105; Katoh Y, 2004, EUR J BIOCHEM, V271, P4307, DOI 10.1111/j.1432-1033.2004.04372.x; Katoh Y, 2006, FEBS J, V273, P2730, DOI 10.1111/j.1742-4658.2006.05291.x; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Kumagai A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026148; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Maichele AJ, 1996, NAT GENET, V14, P337, DOI 10.1038/ng1196-337; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Milan D, 2000, SCIENCE, V288, P1248, DOI 10.1126/science.288.5469.1248; Miller RA, 2011, J CLIN INVEST, V121, P2518, DOI 10.1172/JCI45942; Muraoka M, 2009, AM J PHYSIOL-ENDOC M, V296, pE1430, DOI 10.1152/ajpendo.00024.2009; OEI TL, 1962, CLIN CHIM ACTA, V7, P193, DOI 10.1016/0009-8981(62)90009-8; Ota S, 2009, BIOCHEM BIOPH RES CO, V388, P311, DOI 10.1016/j.bbrc.2009.07.164; Park J, 2014, DIABETES, V63, P3659, DOI 10.2337/db13-1423; Patel K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5535; Ratnoglik SL, 2014, MICROBIOL IMMUNOL, V58, P188, DOI 10.1111/1348-0421.12133; Sakamaki JI, 2014, NAT CELL BIOL, V16, P234, DOI 10.1038/ncb2919; Sasagawa S, 2012, DEVELOPMENT, V139, P1153, DOI 10.1242/dev.072652; Sasaki T, 2011, NEURON, V69, P106, DOI 10.1016/j.neuron.2010.12.004; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; SULLIVAN JE, 1994, FEBS LETT, V353, P33, DOI 10.1016/0014-5793(94)01006-4; Sun C, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.388934; Takemori H, 2002, J BIOL CHEM, V277, P42334, DOI 10.1074/jbc.M204602200; Takemori H, 2008, J STEROID BIOCHEM, V108, P287, DOI 10.1016/j.jsbmb.2007.09.006; Takemori H, 2009, ENDOCR J, V56, P121, DOI 10.1507/endocrj.K08E-173; Uebi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037803; Uebi T, 2010, AM J PHYSIOL-ENDOC M, V299, pE413, DOI 10.1152/ajpendo.00525.2009; Viollet B, 2009, FRONT BIOSCI-LANDMRK, V14, P19, DOI 10.2741/3229; Walkinshaw DR, 2013, J BIOL CHEM, V288, P9345, DOI 10.1074/jbc.M113.456996; Wang ZN, 1999, FEBS LETT, V453, P135, DOI 10.1016/S0014-5793(99)00708-5; Zhang S, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-10; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	54	33	34	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					17879	17893		10.1074/jbc.M115.640821	http://dx.doi.org/10.1074/jbc.M115.640821			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26048985	hybrid, Green Published			2022-12-28	WOS:000358511700023
J	Plattner, S; Gruber, C; Stadlmann, J; Widmann, S; Gruber, CW; Altmann, F; Bohlmann, H				Plattner, Stephan; Gruber, Clemens; Stadlmann, Johannes; Widmann, Stefan; Gruber, Christian W.; Altmann, Friedrich; Bohlmann, Holger			Isolation and Characterization of a Thionin Proprotein-processing Enzyme from Barley	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEAF-SPECIFIC THIONINS; SERINE-PROTEASE; SUBSTRATE-SPECIFICITY; ARABIDOPSIS; EXPRESSION; PROTEINS; SEQUENCE; PURIFICATION; PRECURSORS; MECHANISM	Thionins are plant-specific antimicrobial peptides that have been isolated from the endosperm and leaves of cereals, from the leaves of mistletoes, and from several other plant species. They are generally basic peptides with three or four disulfide bridges and a molecular mass of similar to 5 kDa. Thionins are produced as preproproteins consisting of a signal peptide, the thionin domain, and an acidic domain. Previously, only mature thionin peptides have been isolated from plants, and in addition to removal of the signal peptide, at least one cleavage processing step between the thionin and the acidic domain is necessary to release the mature thionin. In this work, we identified a thionin proprotein-processing enzyme (TPPE) from barley. Purification of the enzyme was guided by an assay that used a quenched fluorogenic peptide comprising the amino acid sequence between the thionin and the acidic domain of barley leaf-specific thionin. The barley TPPE was identified as a serine protease (BAJ93208) and expressed in Escherichia coli as a strep tag-labeled protein. The barley BTH6 thionin proprotein was produced in E. coli using the vector pETtrx1a and used as a substrate. We isolated and sequenced the BTH6 thionin from barley to confirm the N and C terminus of the peptide in planta. Using an in vitro enzymatic assay, the recombinant TPPE was able to process the quenched fluorogenic peptide and to cleave the acidic domain at least at six sites releasing the mature thionin from the proprotein. Moreover, it was found that the intrinsic three-dimensional structure of the BTH6 thionin domain prevents cleavage of the mature BTH6 thionin by the TPPE.	[Plattner, Stephan; Widmann, Stefan; Bohlmann, Holger] Univ Nat Resources & Life Sci, Dept Crop Sci, Div Plant Protect, A-1190 Vienna, Austria; [Gruber, Clemens; Stadlmann, Johannes; Altmann, Friedrich] Univ Nat Resources & Life Sci, Dept Chem, A-1190 Vienna, Austria; [Gruber, Christian W.] Med Univ Vienna, Ctr Physiol & Pharmacol, A-1090 Vienna, Austria	University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna; Medical University of Vienna	Bohlmann, H (corresponding author), Univ Nat Resources & Life Sci Vienna, UFT Tulln, Div Plant Protect, Dept Crop Sci, Konrad Lorenz Str 24, A-3430 Tulln, Austria.	holger.bohlmann@boku.ac.at	Stadlmann, Johannes/AAC-3157-2021	Stadlmann, Johannes/0000-0001-5693-6690; Altmann, Friedrich/0000-0002-0112-7877; Gruber, Christian/0000-0001-6060-7048; Grunwald-Gruber, Clemens/0000-0002-6097-8348	Austrian Science Fund [P21896-B16]; Austrian Science Fund (FWF) [P 21896] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Grant P21896-B16 from the Austrian Science Fund. The authors declare that they have no conflicts of interest with the contents of this article.	Abbas A, 2013, BIOTECHNOL LETT, V35, P1085, DOI 10.1007/s10529-013-1180-z; Balls A. K., 1942, CEREAL CHEM, V19, P279; Basak S, 2004, BIOCHEM J, V380, P505, DOI 10.1042/BJ20031405; Benko-Iseppon AM, 2010, CURR PROTEIN PEPT SC, V11, P181, DOI 10.2174/138920310791112075; Berger D, 2000, GENE DEV, V14, P1119; Bogomolovas J, 2009, PROTEIN EXPRES PURIF, V64, P16, DOI 10.1016/j.pep.2008.10.003; BOHLMANN H, 1988, EMBO J, V7, P1559, DOI 10.1002/j.1460-2075.1988.tb02980.x; BOHLMANN H, 1991, ANNU REV PLANT PHYS, V42, P227, DOI 10.1146/annurev.pp.42.060191.001303; BOHLMANN H, 1987, MOL GEN GENET, V207, P446, DOI 10.1007/BF00331614; BOHLMANN H, 1994, CRIT REV PLANT SCI, V13, P1, DOI 10.1080/713608052; Cedzich A, 2009, J BIOL CHEM, V284, P14068, DOI 10.1074/jbc.M900370200; Epple P, 1997, PLANT CELL, V9, P509, DOI 10.1105/tpc.9.4.509; FISHER N, 1968, CEREAL CHEM, V45, P48; Fontanini D, 2002, PLANTA, V215, P885, DOI 10.1007/s00425-002-0823-4; HOLTORF S, 1995, PLANT SCI, V111, P27, DOI 10.1016/0168-9452(95)04214-F; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kraft M, 2007, PROTEIN EXPRES PURIF, V52, P478, DOI 10.1016/j.pep.2006.10.019; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lay FT, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-41; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Liu JX, 2007, PLANT CELL, V19, P4111, DOI 10.1105/tpc.106.050021; Liu JX, 2009, PLANTA, V230, P687, DOI 10.1007/s00425-009-0976-5; Lobstein J, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-56; MATAYOSHI ED, 1990, SCIENCE, V247, P954, DOI 10.1126/science.2106161; Matsumoto T, 2011, PLANT PHYSIOL, V156, P20, DOI 10.1104/pp.110.171579; Oard SV, 2011, BBA-BIOMEMBRANES, V1808, P1737, DOI 10.1016/j.bbamem.2011.02.003; Ottmann C, 2009, P NATL ACAD SCI USA, V106, P17223, DOI 10.1073/pnas.0907587106; Padovan L, 2010, CURR PROTEIN PEPT SC, V11, P210, DOI 10.2174/138920310791112093; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Plattner S, 2014, PROTEIN EXPRES PURIF, V101, P76, DOI 10.1016/j.pep.2014.05.014; PONZ F, 1983, EMBO J, V2, P1035, DOI 10.1002/j.1460-2075.1983.tb01542.x; PONZ F, 1986, EUR J BIOCHEM, V156, P131, DOI 10.1111/j.1432-1033.1986.tb09557.x; Rautengarten C, 2005, PLOS COMPUT BIOL, V1, P297, DOI 10.1371/journal.pcbi.0010040; Rautengarten C, 2008, PLANT J, V54, P466, DOI 10.1111/j.1365-313X.2008.03437.x; Rawlings ND, 2006, NUCLEIC ACIDS RES, V34, pD270, DOI 10.1093/nar/gkj089; REIMANNPHILIPP U, 1989, EUR J BIOCHEM, V182, P283, DOI 10.1111/j.1432-1033.1989.tb14828.x; REIMANNPHILIPP U, 1989, J BIOL CHEM, V264, P8978; Romero A, 1997, EUR J BIOCHEM, V243, P202, DOI 10.1111/j.1432-1033.1997.0202a.x; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHRADER G, 1991, EUR J BIOCHEM, V198, P549, DOI 10.1111/j.1432-1033.1991.tb16049.x; Siezen RJ, 1997, PROTEIN SCI, V6, P501; SMITH EL, 1966, J BIOL CHEM, V241, P5974; Srivastava R, 2008, PLANT J, V56, P219, DOI 10.1111/j.1365-313X.2008.03598.x; Srivastava R, 2009, PLANT J, V59, P930, DOI 10.1111/j.1365-313X.2009.03926.x; Stec B, 2006, CELL MOL LIFE SCI, V63, P1370, DOI 10.1007/s00018-005-5574-5; Stec B, 2004, J PEPT RES, V64, P210, DOI 10.1111/j.1399-3011.2004.00187.x; Tan-Wilson A, 2012, PLANT PHYSIOL BIOCH, V53, P27, DOI 10.1016/j.plaphy.2012.01.005; Terp N, 2000, J PLANT PHYSIOL, V156, P468, DOI 10.1016/S0176-1617(00)80161-3; Tripathi LP, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-200; van den Berg S, 2006, J BIOTECHNOL, V121, P291, DOI 10.1016/j.jbiotec.2005.08.006; Wolf S, 2009, PLANT J, V58, P361, DOI 10.1111/j.1365-313X.2009.03784.x; Yonezawa H, 2000, BIOSCI BIOTECH BIOCH, V64, P2104, DOI 10.1271/bbb.64.2104	52	18	18	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					18056	18067		10.1074/jbc.M115.647859	http://dx.doi.org/10.1074/jbc.M115.647859			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26013828	hybrid, Green Published			2022-12-28	WOS:000358511700037
J	Lim, MS; Chang, MY; Kim, SM; Yi, SH; Suh-Kim, H; Jung, SJ; Kim, MJ; Kim, JH; Lee, YS; Lee, SY; Kim, DW; Lee, SH; Park, CH				Lim, Mi-Sun; Chang, Mi-Yoon; Kim, Sang-Mi; Yi, Sang-Hoon; Suh-Kim, Haeyoung; Jung, Sung Jun; Kim, Min Jung; Kim, Jin Hyuk; Lee, Yong-Sung; Lee, Soo Young; Kim, Dong-Wook; Lee, Sang-Hun; Park, Chang-Hwan			Generation of Dopamine Neurons from Rodent Fibroblasts through the Expandable Neural Precursor Cell Stage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; IN-VITRO; MOUSE FIBROBLASTS; DIRECT CONVERSION; MICROGLIAL ACTIVATION; GENE-EXPRESSION; DEFINED FACTORS; SOMATIC-CELLS; DIFFERENTIATION; ISCHEMIA	Recent groundbreaking work has demonstrated that combined expression of the transcription factors Brn2, Ascl1, and Myt1L (BAM; also known as Wernig factors) convert mouse fibroblasts into postmitotic neuronal cells. However, questions remain regarding whether trans-conversion is achieved directly or involves an intermediary precursor stage. Trans-conversion toward expandable neural precursor cells (NPCs) is more useful than direct one-step neuron formation with respect to yielding a sufficient number of cells and the feasibility of manipulating NPC differentiation toward certain neuron subtypes. Here, we show that co-expression of Wernig factors and Bcl-xL induces fibroblast conversion into NPCs (induced NPCs (iNPCs)) that are highly expandable for > 100 passages. Gene expression analyses showed that the iNPCs exhibited high expression of common NPC genes but not genes specific to defined embryonic brain regions. This finding indicated that a regional identity of iNPCs was not established. Upon induction, iNPCs predominantly differentiated into astrocytes. However, the differentiation potential was not fixed and could be efficiently manipulated into general or specific subtypes of neurons by expression of additional genes. Specifically, overexpression of Nurr1 and Foxa2, transcription factors specific for midbrain dopamine neuron development, drove iNPCs to yield mature midbrain dopamine neurons equipped with presynaptic DA neuronal functions. We further assessed the therapeutic potential of iNPCs in Parkinson disease model rats.	[Lim, Mi-Sun; Kim, Jin Hyuk; Lee, Yong-Sung; Park, Chang-Hwan] Hanyang Univ, Coll Med, Grad Sch Biomed Sci & Engn, Seoul 133791, South Korea; [Lim, Mi-Sun; Chang, Mi-Yoon; Yi, Sang-Hoon; Jung, Sung Jun; Kim, Min Jung; Kim, Jin Hyuk; Lee, Yong-Sung; Lee, Sang-Hun; Park, Chang-Hwan] Hanyang Univ, Coll Med, Hanyang Biomed Res Inst, Seoul 133791, South Korea; [Kim, Sang-Mi] Hanyang Univ, Coll Med, Grad Sch, Dept Biomed Sci, Seoul 133791, South Korea; [Lim, Mi-Sun; Lee, Soo Young; Park, Chang-Hwan] Hanyang Univ, Coll Med, Dept Microbiol, Seoul 133791, South Korea; [Jung, Sung Jun; Kim, Min Jung; Kim, Jin Hyuk] Hanyang Univ, Coll Med, Dept Physiol, Seoul 133791, South Korea; [Chang, Mi-Yoon; Yi, Sang-Hoon; Lee, Yong-Sung; Lee, Sang-Hun] Hanyang Univ, Coll Med, Dept Biochem & Mol Biol, Seoul 133791, South Korea; [Suh-Kim, Haeyoung] Ajou Univ, Coll Med, Dept Anat, Suwon 443749, South Korea; [Suh-Kim, Haeyoung] Ajou Univ, Coll Med, Brain Dis Res Ctr, Suwon 443749, South Korea; [Kim, Dong-Wook] Yonsei Univ, Coll Med, Dept Physiol, Seoul 120752, South Korea; [Kim, Dong-Wook] Yonsei Univ, Coll Med, Cell Therapy Ctr, Seoul 120752, South Korea	Hanyang University; Hanyang University; Hanyang University; Hanyang University; Hanyang University; Hanyang University; Ajou University; Ajou University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Lee, SH (corresponding author), Hanyang Univ, Coll Med, Dept Biochem & Mol Biol, 222 Wang Simni Ro, Seoul 133791, South Korea.	leesh@hanyang.ac.kr; chshpark@hanyang.ac.kr	lee, sang hun/Q-4650-2019	lee, sang hun/0000-0002-9005-5966; Dong-Wook, Kim/0000-0002-5025-1532; Suh-Kim, Haeyoung/0000-0001-8175-1209	Medical Research Center [2008-0062190]; Basic Science Research Program [2011-0008952]; Medical Technology Development Program [2010-0020232, 2012 M3A9C7050126]; Korea National Research Council of Science and Technology Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning [NAP-09-04]	Medical Research Center; Basic Science Research Program; Medical Technology Development Program; Korea National Research Council of Science and Technology Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning	This work was supported by Medical Research Center Grant 2008-0062190; Basic Science Research Program Grant 2011-0008952; Bio & Medical Technology Development Program Grants 2010-0020232 and 2012 M3A9C7050126; and Korea National Research Council of Science and Technology Program Grant NAP-09-04 through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT, and Future Planning.	Akamatsu W, 2009, J NEUROSCI, V29, P2113, DOI 10.1523/JNEUROSCI.4527-08.2009; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; Chang MY, 2007, MOL CELL BIOL, V27, P4293, DOI 10.1128/MCB.00031-07; Chang MY, 2014, STEM CELL REP, V3, P353, DOI 10.1016/j.stemcr.2014.06.013; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; GURDON JB, 1958, NATURE, V182, P64, DOI 10.1038/182064a0; Hamaguchi I, 2000, J VIROL, V74, P10778, DOI 10.1128/JVI.74.22.10778-10784.2000; Han DW, 2012, CELL STEM CELL, V10, P465, DOI 10.1016/j.stem.2012.02.021; He XB, 2011, STEM CELLS, V29, P1861, DOI 10.1002/stem.739; Jantzie LL, 2005, J CEREBR BLOOD F MET, V25, P314, DOI 10.1038/sj.jcbfm.9600025; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Kim J, 2011, CELL STEM CELL, V9, P413, DOI 10.1016/j.stem.2011.09.011; Kim SM, 2014, NAT PROTOC, V9, P871, DOI 10.1038/nprot.2014.056; Laker C, 1998, J VIROL, V72, P339, DOI 10.1128/JVI.72.1.339-348.1998; Lee HS, 2010, STEM CELLS, V28, P501, DOI 10.1002/stem.294; Liu XJ, 2012, CELL RES, V22, P321, DOI 10.1038/cr.2011.181; Lujan E, 2012, CURR OPIN GENET DEV, V22, P517, DOI 10.1016/j.gde.2012.07.002; Lujan E, 2012, P NATL ACAD SCI USA, V109, P2527, DOI 10.1073/pnas.1121003109; Matsui T, 2012, STEM CELLS, V30, P1109, DOI 10.1002/stem.1091; Maucksch C, 2013, STEM CELL TRANSL MED, V2, P579, DOI 10.5966/sctm.2012-0179; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; Park CH, 2008, FEBS LETT, V582, P537, DOI 10.1016/j.febslet.2008.01.018; Park CH, 2006, FASEB J, V20, P2553, DOI 10.1096/fj.06-6159fje; Rhee YH, 2011, J CLIN INVEST, V121, P2326, DOI 10.1172/JCI45794; Ring KL, 2012, CELL STEM CELL, V11, P100, DOI 10.1016/j.stem.2012.05.018; Shim JW, 2004, J NEUROSCI, V24, P843, DOI 10.1523/JNEUROSCI.3977-03.2004; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thier M, 2012, CELL STEM CELL, V10, P473, DOI 10.1016/j.stem.2012.03.003; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Vroemen M, 2005, EXP NEUROL, V195, P127, DOI 10.1016/j.expneurol.2005.04.012; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769	35	25	28	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17401	17414		10.1074/jbc.M114.629808	http://dx.doi.org/10.1074/jbc.M114.629808			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26023233	Green Published, hybrid			2022-12-28	WOS:000357730900034
J	Saenz, A; Presto, J; Lara, P; Akinyi-Oloo, L; Garcia-Fojeda, B; Nilsson, I; Johansson, J; Casals, C				Saenz, Alejandra; Presto, Jenny; Lara, Patricia; Akinyi-Oloo, Laura; Garcia-Fojeda, Belen; Nilsson, IngMarie; Johansson, Jan; Casals, Cristina			Folding and Intramembraneous BRICHOS Binding of the Prosurfactant Protein C Transmembrane Segment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; INTERSTITIAL LUNG-DISEASE; AMYLOID BETA-PEPTIDE; REACTIVE PROTEIN; PHYSICAL-PROPERTIES; SURFACE-ACTIVITY; FIBRIL FORMATION; DOMAIN; MUTATION; TRANSLOCATION	Surfactant protein C (SP-C) is a novel amyloid protein found in the lung tissue of patients suffering from interstitial lung disease (ILD) due to mutations in the gene of the precursor protein pro-SP-C. SP-C is a small alpha-helical hydrophobic protein with an unusually high content of valine residues. SP-C is prone to convert into beta-sheet aggregates, forming amyloid fibrils. Nature's way of solving this folding problem is to include a BRICHOS domain in pro-SP-C, which functions as a chaperone for SP-C during biosynthesis. Mutations in the pro-SP-C BRICHOS domain or linker region lead to amyloid formation of the SP-C protein and ILD. In this study, we used an in vitro transcription/translation system to study translocon-mediated folding of the WT pro-SP-C poly-Val and a designed poly-Leu transmembrane (TM) segment in the endoplasmic reticulum (ER) membrane. Furthermore, to understand how the pro-SP-C BRICHOS domain present in the ER lumen can interact with the TM segment of pro-SP-C, we studied the membrane insertion properties of the recombinant form of the pro-SP-C BRICHOS domain and two ILD-associated mutants. The results show that the co-translational folding of the WT pro-SP-C TM segment is inefficient, that the BRICHOS domain inserts into superficial parts of fluid membranes, and that BRICHOS membrane insertion is promoted by poly-Val peptides present in the membrane. In contrast, one BRICHOS and one non-BRICHOS ILD-associated mutant could not insert into membranes. These findings support a chaperone function of the BRICHOS domain, possibly together with the linker region, during pro-SP-C biosynthesis in the ER.	[Saenz, Alejandra; Casals, Cristina] Univ Complutense Madrid, Dept Biochem & Mol Biol 1, E-28040 Madrid, Spain; [Saenz, Alejandra; Garcia-Fojeda, Belen; Casals, Cristina] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Resp CIBERES, Madrid 28029, Spain; [Presto, Jenny; Johansson, Jan] Karolinska Inst, Ctr Alzheimer Res, NVS Neurobiol Care Sci & Soc Dept, S-14157 Huddinge, Sweden; [Lara, Patricia; Akinyi-Oloo, Laura; Nilsson, IngMarie] Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, S-10691 Stockholm, Sweden	Complutense University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Karolinska Institutet; Stockholm University	Johansson, J (corresponding author), Karolinska Inst, Ctr Alzheimer Res, NVS Neurobiol Care Sci & Soc Dept, S-14157 Huddinge, Sweden.	janne.johansson@ki.se; ccasalsc@ucm.es	García-Fojeda, Belén/G-4214-2015; Casals, Cristina/H-4658-2015; Saenz, Alejandra/G-7275-2015	García-Fojeda, Belén/0000-0002-9558-3020; Casals, Cristina/0000-0003-2696-0918; Johansson, Jan/0000-0002-8719-4703; Saenz, Alejandra/0000-0001-8439-2985; Presto, Jenny/0000-0001-5102-6815	Spanish Ministry of Economy and Competitiveness [SAF2012-32728]; Institute of Health Carlos III (ISCiii) (Spanish Research Center of Respiratory Diseases) [CIBERES CB06/06/0002]; Swedish Research Council; Henrik Granholms Stiftelse [SU 33-1013-09]; Swedish Cancer Society [13624]; Swedish Foundation for International Cooperation in Research and Higher Education (STINT) [210/083(12), KU 2003-4674]; Swedish Foundation for Strategic Research [A305:200]; Swedish Alzheimer foundation; Ake Wibergs foundation; Magn Bergvalls foundation; Foundation of Gamla tjanarinnor; Loo and Hans Ostermans foundation for geriatric research	Spanish Ministry of Economy and Competitiveness(Spanish Government); Institute of Health Carlos III (ISCiii) (Spanish Research Center of Respiratory Diseases); Swedish Research Council(Swedish Research CouncilEuropean Commission); Henrik Granholms Stiftelse; Swedish Cancer Society(Swedish Cancer Society); Swedish Foundation for International Cooperation in Research and Higher Education (STINT); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Alzheimer foundation; Ake Wibergs foundation; Magn Bergvalls foundation; Foundation of Gamla tjanarinnor; Loo and Hans Ostermans foundation for geriatric research	This work was supported by Spanish Ministry of Economy and Competitiveness Grant SAF2012-32728 and Institute of Health Carlos III (ISCiii) (Spanish Research Center of Respiratory Diseases) Grant CIBERES CB06/06/0002, the Swedish Research Council, Henrik Granholms Stiftelse Grant SU 33-1013-09 (to I. M. N.), Swedish Cancer Society Grant 13624 (to I. M. N.), Swedish Foundation for International Cooperation in Research and Higher Education (STINT) Grants 210/083(12) and KU 2003-4674 (to I. M. N.), Swedish Foundation for Strategic Research Grant A305:200 (to I. M. N.), The Swedish Alzheimer foundation, The Ake Wibergs foundation, The Magn Bergvalls foundation, Foundation of Gamla tjanarinnor, and The Loo and Hans Ostermans foundation for geriatric research. The authors declare that they have no conflicts of interest with the contents of this article.	Adu-Gyamfi E, 2013, J BIOL CHEM, V288, P5779, DOI 10.1074/jbc.M112.443960; Beers MF, 2005, ANNU REV PHYSIOL, V67, P663, DOI 10.1146/annurev.physiol.67.040403.101937; Beers MF, 2011, TRAFFIC, V12, P1196, DOI 10.1111/j.1600-0854.2011.01223.x; Biverstal H, 2015, BBA-PROTEINS PROTEOM, V1854, P835, DOI 10.1016/j.bbapap.2015.04.005; Bridges JP, 2003, J BIOL CHEM, V278, P52739, DOI 10.1074/jbc.M309599200; Calvez P, 2009, BIOCHIMIE, V91, P718, DOI 10.1016/j.biochi.2009.03.018; Canadas O, 2008, BIOPHYS J, V95, P3287, DOI 10.1529/biophysj.108.137323; Canadas Olga, 2013, Methods Mol Biol, V974, P55, DOI 10.1007/978-1-62703-275-9_4; CASALS C, 1990, BIOCHIM BIOPHYS ACTA, V1023, P290, DOI 10.1016/0005-2736(90)90425-N; Casals C, 2008, FEBS J, V275, P536, DOI 10.1111/j.1742-4658.2007.06220.x; Casals C, 2012, BBA-BIOMEMBRANES, V1818, P2550, DOI 10.1016/j.bbamem.2012.05.024; Cohen SIA, 2015, NAT STRUCT MOL BIOL, V22, P207, DOI 10.1038/nsmb.2971; Dluhy RA, 2003, BIOPHYS J, V85, P2417, DOI 10.1016/S0006-3495(03)74665-7; Engel MFM, 2006, J MOL BIOL, V356, P783, DOI 10.1016/j.jmb.2005.12.020; Fitzen M, 2009, RAPID COMMUN MASS SP, V23, P3591, DOI 10.1002/rcm.4282; Garcia-Verdugo I, 2007, BIOPHYS J, V93, P3529, DOI 10.1529/biophysj.107.109793; Gustafsson M, 1999, FEBS LETT, V464, P138, DOI 10.1016/S0014-5793(99)01692-0; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Hedlund Joel, 2009, BMC Res Notes, V2, P180, DOI 10.1186/1756-0500-2-180; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Ji SR, 2007, FASEB J, V21, P284, DOI 10.1096/fj.06-6722com; Johansson H, 2009, J MOL BIOL, V389, P227, DOI 10.1016/j.jmb.2009.04.021; Johansson H, 2006, J BIOL CHEM, V281, P21032, DOI 10.1074/jbc.M603001200; Johansson J, 2003, J APPL PHYSIOL, V95, P2055, DOI 10.1152/japplphysiol.00153.2003; Kallberg Y, 2001, J BIOL CHEM, V276, P12945, DOI 10.1074/jbc.M010402200; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; KELLER A, 1991, BIOCHEM J, V277, P493, DOI 10.1042/bj2770493; Kota J, 2005, J CELL BIOL, V168, P79, DOI 10.1083/jcb.200408106; KOZAK M, 1989, MOL CELL BIOL, V9, P5134, DOI 10.1128/MCB.9.11.5134; Lundin C, 2006, FEBS LETT, V580, P2281, DOI 10.1016/j.febslet.2006.03.040; Lundin C, 2008, P NATL ACAD SCI USA, V105, P15702, DOI 10.1073/pnas.0804842105; Marsh D, 1996, BBA-REV BIOMEMBRANES, V1286, P183, DOI 10.1016/S0304-4157(96)00009-3; Nerelius C, 2009, BIOCHEMISTRY-US, V48, P3778, DOI 10.1021/bi900135c; NILSSON I, 1993, J BIOL CHEM, V268, P5798; Nogee LM, 2001, NEW ENGL J MED, V344, P573, DOI 10.1056/NEJM200102223440805; Nyathi Y, 2013, BBA-MOL CELL RES, V1833, P2392, DOI 10.1016/j.bbamcr.2013.02.021; PERCZEL A, 1992, PROTEINS, V13, P57, DOI 10.1002/prot.340130106; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Saenz A, 2007, BIOPHYS J, V92, P482, DOI 10.1529/biophysj.106.090217; Saenz A, 2006, FEBS J, V273, P2515, DOI 10.1111/j.1742-4658.2006.05258.x; Saenz A, 2010, FASEB J, V24, P3662, DOI 10.1096/fj.09-142646; Schamel WWA, 2003, P NATL ACAD SCI USA, V100, P9861, DOI 10.1073/pnas.1633363100; Shao SC, 2011, ANNU REV CELL DEV BI, V27, P25, DOI 10.1146/annurev-cellbio-092910-154125; Sipe JD, 2012, AMYLOID, V19, P167, DOI 10.3109/13506129.2012.734345; Stefansson A, 2004, J BIOL CHEM, V279, P21200, DOI 10.1074/jbc.M400771200; Stewart GA, 2012, AM J RESP CELL MOL, V47, P324, DOI 10.1165/rcmb.2012-0003OC; Szyperski T, 1998, PROTEIN SCI, V7, P2533, DOI 10.1002/pro.5560071206; Thiele JR, 2014, CIRCULATION, V130, P35, DOI 10.1161/CIRCULATIONAHA.113.007124; Thomas AQ, 2002, AM J RESP CRIT CARE, V165, P1322, DOI 10.1164/rccm.200112-123OC; WALTER P, 1983, METHOD ENZYMOL, V96, P84; Whitley P, 1996, J BIOL CHEM, V271, P6241, DOI 10.1074/jbc.271.11.6241; Whitsett JA, 2002, NEW ENGL J MED, V347, P2141, DOI 10.1056/NEJMra022387; Willander H, 2012, J BIOL CHEM, V287, P31608, DOI 10.1074/jbc.M112.393157; Willander H, 2012, P NATL ACAD SCI USA, V109, P2325, DOI 10.1073/pnas.1114740109; Woischnik M, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-88; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; Zavialov AV, 2007, MOL MICROBIOL, V64, P153, DOI 10.1111/j.1365-2958.2007.05644.x	57	6	6	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17628	17641		10.1074/jbc.M114.630343	http://dx.doi.org/10.1074/jbc.M114.630343			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26041777	hybrid, Green Published			2022-12-28	WOS:000357730900052
J	Lim, GGY; Chua, DSK; Basil, AH; Chan, HY; Chai, C; Arumugam, T; Lim, KL				Lim, Grace G. Y.; Chua, Doreen S. K.; Basil, Adeline H.; Chan, Hui-Ying; Chai, Chou; Arumugam, Thiruma; Lim, Kah-Leong			Cytosolic PTEN-induced Putative Kinase 1 Is Stabilized by the NF-kappa B Pathway and Promotes Non-selective Mitophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKIN RECRUITMENT; PINK1; UBIQUITINATION; MITOCHONDRIA; NEURONS; PROTEIN; TRANSLOCATION; LOCALIZATION; CLEAVAGE; IMPORT	The potential cellular function of the 53-kDa cytosolic form of PINK1 (PINK1-53) is often overlooked because of its rapid degradation by the proteasome upon its production. Although a number of recent studies have suggested various roles for PINK1-53, how this labile PINK1 species attains an adequate expression level to fulfil these roles remains unclear. Here we demonstrated that PINK1-53 is stabilized in the presence of enhanced Lys-63-linked ubiquitination and identified TRAF6-related NF-kappa B activation as a novel pathway involved in this. We further showed that a mimetic of PINK1-53 promotes mitophagy but, curiously, in apparently healthy mitochondria. We speculate that this "non-selective" form of mitophagy may potentially help to counteract the build-up of reactive oxygen species in cells undergoing oxidative stress and, as such, represent a cytoprotective response.	[Lim, Grace G. Y.; Chua, Doreen S. K.; Basil, Adeline H.; Chan, Hui-Ying; Chai, Chou; Lim, Kah-Leong] Natl Neurosci Inst, Neurodegenerat Res Lab, Singapore 308433, Singapore; [Lim, Grace G. Y.; Chua, Doreen S. K.; Arumugam, Thiruma; Lim, Kah-Leong] Natl Univ Singapore, Dept Physiol, Singapore 117548, Singapore; [Chua, Doreen S. K.; Lim, Kah-Leong] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Lim, Kah-Leong] Duke Natl Univ Singapore, Grad Sch Med, Singapore, Singapore	National Neuroscience Institute (NNI); National University of Singapore; National University of Singapore; National University of Singapore	Lim, KL (corresponding author), Natl Neurosci Inst, Neurodegenerat Res Lab, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore.	Kah_Leong_Lim@nni.com.sg	Arumugam, Thiruma/AAG-6958-2019; Lim, Kah-Leong/AAY-3308-2020; Lim, Kah/L-5426-2019	Arumugam, Thiruma/0000-0002-3377-0939; Lim, Kah-Leong/0000-0002-5440-2588	National Medical Research Council-TCR; CBRG; A*STAR Biomedical Research Council-TCRP; National University of Singapore; Singapore Millennium Foundation; National University of Singapore Graduate School for Integrative Sciences and Engineering	National Medical Research Council-TCR; CBRG; A*STAR Biomedical Research Council-TCRP; National University of Singapore(National University of Singapore); Singapore Millennium Foundation(Singapore Millennium Foundation); National University of Singapore Graduate School for Integrative Sciences and Engineering(National University of Singapore)	This work was supported by grants from the National Medical Research Council-TCR and CBRG, A*STAR Biomedical Research Council-TCRP, and the National University of Singapore.; Supported by a graduate scholarship award from the Singapore Millennium Foundation.; Supported by a graduate scholarship award from the National University of Singapore Graduate School for Integrative Sciences and Engineering.	Dagda RK, 2014, J NEUROCHEM, V128, P864, DOI 10.1111/jnc.12494; Dagda RK, 2009, J BIOENERG BIOMEMBR, V41, P473, DOI 10.1007/s10863-009-9255-1; Deas E, 2011, HUM MOL GENET, V20, P867, DOI 10.1093/hmg/ddq526; Fedorowicz MA, 2014, EMBO REP, V15, P86, DOI 10.1002/embr.201337294; Gandhi S, 2006, BRAIN, V129, P1720, DOI 10.1093/brain/awl114; Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14; Grenier K, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00100; Haque ME, 2008, P NATL ACAD SCI USA, V105, P1716, DOI 10.1073/pnas.0705363105; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Kane LA, 2014, J CELL BIOL, V205, P143, DOI 10.1083/jcb.201402104; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392; Lee HJ, 2012, CELL MOL LIFE SCI, V69, P3301, DOI 10.1007/s00018-012-1004-7; Lim GGY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073235; Lim KL, 2012, ANTIOXID REDOX SIGN, V16, P935, DOI 10.1089/ars.2011.4105; Lim KL, 2011, NEUROBIOL DIS, V43, P9, DOI 10.1016/j.nbd.2010.08.001; Lim KL, 2006, NEUROBIOL AGING, V27, P524, DOI 10.1016/j.neurobiolaging.2005.07.023; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lin W, 2008, J NEUROCHEM, V106, P464, DOI 10.1111/j.1471-4159.2008.05398.x; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Muqit MMK, 2006, J NEUROCHEM, V98, P156, DOI 10.1111/j.1471-4159.2006.03845.x; Murata H, 2013, MOL BIOL CELL, V24, P2772, DOI 10.1091/mbc.E13-01-0016; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Okatsu K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2016; Petit A, 2005, J BIOL CHEM, V280, P34025, DOI 10.1074/jbc.M505143200; Poole AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010054; Seibler P, 2011, J NEUROSCI, V31, P5970, DOI 10.1523/JNEUROSCI.4441-10.2011; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Tan JMM, 2008, HUM MOL GENET, V17, P431, DOI 10.1093/hmg/ddm320; Todi SV, 2009, EMBO J, V28, P372, DOI 10.1038/emboj.2008.289; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wang C, 2005, J NEUROCHEM, V93, P422, DOI 10.1111/j.1471-4159.2005.03023.x; Wang XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086276; Yamano K, 2013, AUTOPHAGY, V9, P1758, DOI 10.4161/auto.24633; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	38	18	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16882	16893		10.1074/jbc.M114.622399	http://dx.doi.org/10.1074/jbc.M114.622399			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25987559	Green Published, hybrid			2022-12-28	WOS:000357572800033
J	Tang, QY; Larry, T; Hendra, K; Yamamoto, E; Bell, J; Cui, M; Logothetis, DE; Boland, LM				Tang, Qiong-Yao; Larry, Trevor; Hendra, Kalen; Yamamoto, Erica; Bell, Jessica; Cui, Meng; Logothetis, Diomedes E.; Boland, Linda M.			Mutations in Nature Conferred a High Affinity Phosphatidylinositol 4,5-Bisphosphate-binding Site in Vertebrate Inwardly Rectifying Potassium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PIP2 REGULATION; AMPHIMEDON-QUEENSLANDICA; STRUCTURAL DETERMINANTS; KIR CHANNELS; K+ CHANNELS; EVOLUTION; GENOME; MODULATION; SPONGE; GENES	All vertebrate inwardly rectifying potassium (Kir) channels are activated by phosphatidylinositol 4,5-bisphosphate (PIP2) (Logothetis, D. E., Petrou, V. I., Zhang, M., Mahajan, R., Meng, X. Y., Adney, S. K., Cui, M., and Baki, L. (2015) Annu. Rev. Physiol. 77, 81-104; Furst, O., Mondou, B., and D'Avanzo, N. (2014) Front. Physiol. 4, 404-404). Structural components of a PIP2-binding site are conserved in vertebrate Kir channels but not in distantly related animals such as sponges and sea anemones. To expand our understanding of the structure-function relationships of PIP2 regulation of Kir channels, we studied AqKir, which was cloned from the marine sponge Amphimedon queenslandica, an animal that represents the phylogenetically oldest metazoans. A requirement for PIP2 in the maintenance of AqKir activity was examined in intact oocytes by activation of a co-expressed voltage-sensing phosphatase, application of wortmannin (at micromolar concentrations), and activation of a co-expressed muscarinic acetylcholine receptor. All three mechanisms to reduce the availability of PIP2 resulted in inhibition of AqKir current. However, time-dependent rundown of AqKir currents in inside-out patches could not be re-activated by direct application to the inside membrane surface of water-soluble dioctanoyl PIP2, and the current was incompletely re-activated by the more hydrophobic arachidonyl stearyl PIP2. When we introduced mutations to AqKir to restore two positive charges within the vertebrate PIP2-binding site, both forms of PIP2 strongly re-activated the mutant sponge channels in inside-out patches. Molecular dynamics simulations validate the additional hydrogen bonding potential of the sponge channel mutants. Thus, nature's mutations conferred a high affinity activation of vertebrate Kir channels by PIP2, and this is a more recent evolutionary development than the structures that explain ion channel selectivity and inward rectification.	[Tang, Qiong-Yao; Cui, Meng; Logothetis, Diomedes E.] Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Richmond, VA 23298 USA; [Tang, Qiong-Yao; Cui, Meng; Logothetis, Diomedes E.] XuZhou Med Coll, Jiangsu Prov Key Lab Anesthesiol, Xuzhou 221004, Jiangsu, Peoples R China; [Tang, Qiong-Yao; Cui, Meng; Logothetis, Diomedes E.] XuZhou Med Coll, Jiangsu Prov Key Lab Anesthesia & Analgesia Appli, Xuzhou 221004, Jiangsu, Peoples R China; [Bell, Jessica] Univ San Diego, Dept Chem & Biochem, San Diego, CA 92110 USA; [Larry, Trevor; Hendra, Kalen; Yamamoto, Erica; Boland, Linda M.] Univ Richmond, Dept Biol, Richmond, VA 23173 USA	Virginia Commonwealth University; Xuzhou Medical University; Xuzhou Medical University; University of San Diego; University of Richmond	Boland, LM (corresponding author), Univ Richmond, Dept Biol, B-100 Gottwald Sci Ctr, Richmond, VA 23173 USA.	lboland@richmond.edu		Hendra, Kalen/0000-0001-7625-8102; Boland, Linda/0000-0002-6172-1704	National Institutes of Health from NCCR [R15-GM096142, HL059949, HL090882, S10RR027411]; Jiangsu Specially Appointed Professor Program [53051117]; University of Richmond School of Arts and Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027411] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059949, R01HL090882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM096142] Funding Source: NIH RePORTER	National Institutes of Health from NCCR; Jiangsu Specially Appointed Professor Program; University of Richmond School of Arts and Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R15-GM096142 (to L.M. B.), HL059949 and HL090882 (to D. E. L.), and S10RR027411 from NCCR (to M. C.). This work was also supported by Grant 53051117 from the Jiangsu Specially Appointed Professor Program (to Q. Y. T.), undergraduate summer fellowships from the University of Richmond School of Arts and Sciences (to K. H. and E. Y.), and an undergraduate research grant from the University of Richmond School of Arts and Sciences (to E. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Boland LM, 2008, CELL BIOCHEM BIOPHYS, V52, P59, DOI 10.1007/s12013-008-9027-2; D'Avanzo N, 2010, J BIOL CHEM, V285, P37129, DOI 10.1074/jbc.C110.186692; D'Avanzo N, 2010, CHANNELS, V4, P139, DOI 10.4161/chan.4.3.12129; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Du XO, 2004, J BIOL CHEM, V279, P37271, DOI 10.1074/jbc.M403413200; Enkvetchakul D, 2005, J BIOL CHEM, V280, P35785, DOI 10.1074/jbc.C500355200; Falkenburger BH, 2010, J PHYSIOL-LONDON, V588, P3179, DOI 10.1113/jphysiol.2010.192153; Furst O, 2014, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00404; Halaszovich CR, 2009, J BIOL CHEM, V284, P2106, DOI 10.1074/jbc.M803543200; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JEGLA T, 1994, SOC GEN PHY, V49, P213; Jegla TJ, 2009, COMB CHEM HIGH T SCR, V12, P2, DOI 10.2174/138620709787047957; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Knoll AH, 2011, ANNU REV EARTH PL SC, V39, P217, DOI 10.1146/annurev.earth.031208.100209; Koyanagi M, 1998, FEBS LETT, V439, P66, DOI 10.1016/S0014-5793(98)01339-8; Larroux C, 2011, M S-MED SCI, V27, P138, DOI 10.1051/medsci/2011272138; Liu LJ, 2012, NAT STRUCT MOL BIOL, V19, P633, DOI 10.1038/nsmb.2289; Logothetis DE, 2007, PFLUG ARCH EUR J PHY, V455, P83, DOI 10.1007/s00424-007-0276-5; Logothetis DE, 2007, PFLUG ARCH EUR J PHY, V455, P1, DOI 10.1007/s00424-007-0311-6; Logothetis DE, 2007, J PHYSIOL-LONDON, V582, P953, DOI 10.1113/jphysiol.2007.133157; Logothetis DE, 2015, ANNU REV PHYSIOL, V77, P81, DOI 10.1146/annurev-physiol-021113-170358; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Meng XY, 2012, BIOPHYS J, V102, P2049, DOI 10.1016/j.bpj.2012.03.050; Muller WEG, 2001, GENE, V276, P161, DOI 10.1016/S0378-1119(01)00669-2; Murata Y, 2007, J PHYSIOL-LONDON, V583, P875, DOI 10.1113/jphysiol.2007.134775; NAKANISHI S, 1995, P NATL ACAD SCI USA, V92, P5317, DOI 10.1073/pnas.92.12.5317; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Pian P, 2006, J GEN PHYSIOL, V128, P593, DOI 10.1085/jgp.200609648; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Rohacs T, 2002, METHOD ENZYMOL, V345, P71; Rohacs T, 1999, J BIOL CHEM, V274, P36065, DOI 10.1074/jbc.274.51.36065; Sakarya O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000506; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Schulze D, 2003, J BIOL CHEM, V278, P10500, DOI 10.1074/jbc.M208413200; Shyng SL, 2000, J GEN PHYSIOL, V116, P599, DOI 10.1085/jgp.116.5.599; Soom M, 2001, FEBS LETT, V490, P49, DOI 10.1016/S0014-5793(01)02136-6; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Suh BC, 2007, J GEN PHYSIOL, V130, P241, DOI 10.1085/jgp.200709821; Suh BC, 2012, P NATL ACAD SCI USA, V109, P3161, DOI 10.1073/pnas.1121434109; Tang QY, 2014, J BIOL CHEM, V289, P18860, DOI 10.1074/jbc.M113.538033; Tang QY, 2010, J BIOL CHEM, V285, P19259, DOI 10.1074/jbc.M109.100156; Tang QY, 2009, J GEN PHYSIOL, V134, P409, DOI 10.1085/jgp.200910251; Telezhkin V, 2012, J BIOL CHEM, V287, P10001, DOI 10.1074/jbc.M111.322552; Tompkins-MacDonald GJ, 2009, J EXP BIOL, V212, P761, DOI 10.1242/jeb.026971; Wang SZ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1625; Wells GD, 2012, J EXP BIOL, V215, P2435, DOI 10.1242/jeb.066233; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046	52	12	12	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16517	16529		10.1074/jbc.M115.640409	http://dx.doi.org/10.1074/jbc.M115.640409			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25957411	Green Published, hybrid			2022-12-28	WOS:000357572800005
J	Fan, GF; Aleem, S; Yang, M; Miller, WT; Tonks, NK				Fan, Gaofeng; Aleem, Saadat; Yang, Ming; Miller, W. Todd; Tonks, Nicholas K.			Protein-tyrosine Phosphatase and Kinase Specificity in Regulation of SRC and Breast Tumor Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphorylation; phosphotyrosine; Src; tyrosine-protein kinase (tyrosine kinase); tyrosine-protein phosphatase (tyrosine phosphatase); PTP1B; SRC; BRK; CSK; and CBP; PAG	FAMILY KINASE; INSULIN-RECEPTOR; GROWTH-FACTOR; SUBSTRATE RECOGNITION; ADAPTER PROTEIN; LIPID RAFTS; SH3 DOMAIN; 1B; ACTIVATION; BRK	Background: The view that, unlike kinases, phosphatases are nonspecific pervades the field. Results: PTP1B inhibited BRK by dephosphorylating Tyr-342, but activated SRC by antagonizing PAG-dependent inhibition by CSK. Conclusion: Signaling is regulated by combinatorial effects of PTKs and PTPs, with both enzyme classes displaying exquisite specificity. Significance: Defining phosphatase substrate specificity will reveal new, more effective strategies for therapeutic intervention in major human diseases. Despite significant evidence to the contrary, the view that phosphatases are nonspecific still pervades the field. Systems biology approaches to defining how signal transduction pathways are integrated at the level of whole organisms also often downplay the contribution of phosphatases, defining them as erasers that serve merely to restore the system to its basal state. Here, we present a study that counteracts the idea of nonspecific phosphatases. We have characterized two structurally similar and functionally related kinases, BRK and SRC, which are regulated by combinations of activating autophosphorylation and inhibitory C-terminal sites of tyrosine phosphorylation. We demonstrated specificity at the level of the kinases in that SRMS phosphorylated the C terminus of BRK, but not SRC; in contrast, CSK is the kinase responsible for C-terminal phosphorylation of SRC, but not BRK. For the phosphatases, we observed that RNAi-mediated suppression of PTP1B resulted in opposing effects on the activity of BRK and SRC and have defined the mechanisms underlying this specificity. PTP1B inhibited BRK by directly dephosphorylating the Tyr-342 autophosphorylation site. In contrast, PTP1B potentiated SRC activity, but not by dephosphorylating SRC itself directly; instead, PTP1B regulated the interaction between CBP/PAG and CSK. SRC associated with, and phosphorylated, the transmembrane protein CBP/PAG at Tyr-317, resulting in CSK recruitment. We identified PAG as a substrate of PTP1B, and dephosphorylation abolished recruitment of the inhibitory kinase CSK. Overall, these findings illustrate how the combinatorial effects of PTKs and PTPs may be integrated to regulate signaling, with both classes of enzymes displaying exquisite specificity.	[Fan, Gaofeng; Yang, Ming; Tonks, Nicholas K.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Aleem, Saadat; Miller, W. Todd] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Miller, WT (corresponding author), SUNY Stony Brook, Basic Sci Tower,T-5,Rm 133, Stony Brook, NY 11794 USA.	Todd.Miller@stonybrook.edu; tonks@cshl.edu	Regan, Clinton/E-6250-2012; Fan, Gaofeng/H-2996-2013	Fan, Gaofeng/0000-0002-6729-2867	NIH [CA53840, CA58530]; CSHL Cancer Centre Support Grant [CA45508]; Gladowsky Breast Cancer Foundation; Don Monti Memorial Research Foundation; Hansen Memorial Foundation; West Islip Breast Cancer Coalition for Long Island; Glen Cove CARES; Find a Cure Today (FACT); Constance Silveri; Robertson Research Fund; Masthead Cove Yacht Club Carol Marcincuk Fund; NATIONAL CANCER INSTITUTE [R37CA053840, R01CA058530, R01CA053840, P30CA045508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079710, R01MH083711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033485, R01DA016672, T32DA007290] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CSHL Cancer Centre Support Grant; Gladowsky Breast Cancer Foundation; Don Monti Memorial Research Foundation; Hansen Memorial Foundation; West Islip Breast Cancer Coalition for Long Island; Glen Cove CARES; Find a Cure Today (FACT); Constance Silveri; Robertson Research Fund; Masthead Cove Yacht Club Carol Marcincuk Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research by NIH Grants CA53840 (N. K. T.) and CA58530 (W. T. M) and the CSHL Cancer Centre Support Grant CA45508 (N. K. T.). N. K. T. is also grateful for the support from the following foundations: The Gladowsky Breast Cancer Foundation, The Don Monti Memorial Research Foundation, Hansen Memorial Foundation, West Islip Breast Cancer Coalition for Long Island, Glen Cove CARES, Find a Cure Today (FACT), Constance Silveri, Robertson Research Fund and the Masthead Cove Yacht Club Carol Marcincuk Fund.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Andersen JN, 2004, FASEB J, V18, P8, DOI 10.1096/fj.02-1212rev; BARKER SC, 1995, BIOCHEMISTRY-US, V34, P14843, DOI 10.1021/bi00045a027; Bentires-Alj M, 2007, CANCER RES, V67, P2420, DOI 10.1158/0008-5472.CAN-06-4610; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; CASNELLIE JE, 1991, METHOD ENZYMOL, V200, P115; DANFORTH WH, 1962, P NATL ACAD SCI USA, V48, P1191, DOI 10.1073/pnas.48.7.1191; Dube N, 2004, P NATL ACAD SCI USA, V101, P1834, DOI 10.1073/pnas.0304242101; Fan GF, 2013, J BIOL CHEM, V288, P24923, DOI 10.1074/jbc.M113.482737; Garton AJ, 1997, ONCOGENE, V15, P877, DOI 10.1038/sj.onc.1201279; Goel RK, 2013, FEBS J, V280, P4539, DOI 10.1111/febs.12420; Goldstein BJ, 2000, J BIOL CHEM, V275, P4283, DOI 10.1074/jbc.275.6.4283; Hayashi K, 1999, J CELL SCI, V112, P1149; Hrdinka M, 2014, ONCOGENE, V33, P4881, DOI 10.1038/onc.2013.485; Julien SG, 2007, NAT GENET, V39, P338, DOI 10.1038/ng1963; Kamalati T, 1996, J BIOL CHEM, V271, P30956, DOI 10.1074/jbc.271.48.30956; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; KOHMURA N, 1994, MOL CELL BIOL, V14, P6915, DOI 10.1128/MCB.14.10.6915; Krishnan N, 2014, NAT CHEM BIOL, V10, P558, DOI [10.1038/NCHEMBIO.1528, 10.1038/nchembio.1528]; Lantz KA, 2010, OBESITY, V18, P1516, DOI 10.1038/oby.2009.444; Lim WA, 2010, CELL, V142, P661, DOI 10.1016/j.cell.2010.08.023; MITCHELL PJ, 1994, ONCOGENE, V9, P2383; Myers MP, 2001, J BIOL CHEM, V276, P47771, DOI 10.1074/jbc.C100583200; NADA S, 1991, NATURE, V351, P69, DOI 10.1038/351069a0; Okada M, 2012, INT J BIOL SCI, V8, P1385, DOI 10.7150/ijbs.5141; Park SH, 1997, CYTOGENET CELL GENET, V77, P271, DOI 10.1159/000134595; Pellicena P, 1998, J BIOL CHEM, V273, P15325, DOI 10.1074/jbc.273.25.15325; Pulido R, 1998, EMBO J, V17, P7337, DOI 10.1093/emboj/17.24.7337; Qiu HQ, 2005, ONCOGENE, V24, P5656, DOI 10.1038/sj.onc.1208721; Qiu HQ, 2004, ONCOGENE, V23, P2216, DOI 10.1038/sj.onc.1207339; Qiu HQ, 2002, J BIOL CHEM, V277, P34634, DOI 10.1074/jbc.M203877200; Ren LG, 2011, BIOCHEMISTRY-US, V50, P2339, DOI 10.1021/bi1014453; Salmeen A, 2000, MOL CELL, V6, P1401, DOI 10.1016/S1097-2765(00)00137-4; Shima T, 2003, P NATL ACAD SCI USA, V100, P14897, DOI 10.1073/pnas.2432139100; Solheim SA, 2008, J BIOL CHEM, V283, P2773, DOI 10.1074/jbc.M705215200; Sondhi D, 1998, BIOCHEMISTRY-US, V37, P165, DOI 10.1021/bi9722960; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tonks NK, 2013, FEBS J, V280, P346, DOI 10.1111/febs.12077; Wang YM, 2014, MOL CELL, V53, P752, DOI 10.1016/j.molcel.2014.01.020; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4; ZHENG XM, 1992, NATURE, V359, P336, DOI 10.1038/359336a0	46	31	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					15934	15947		10.1074/jbc.M115.651703	http://dx.doi.org/10.1074/jbc.M115.651703			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25897081	Green Published, hybrid			2022-12-28	WOS:000356930100004
J	Shields-Cutler, RR; Crowley, JR; Hung, CS; Stapleton, AE; Aldrich, CC; Marschall, J; Henderson, JP				Shields-Cutler, Robin R.; Crowley, Jan R.; Hung, Chia S.; Stapleton, Ann E.; Aldrich, Courtney C.; Marschall, Jonas; Henderson, Jeffrey P.			Human Urinary Composition Controls Antibacterial Activity of Siderocalin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Escherichia coli (E; coli); host-pathogen interaction; infectious disease; iron; metabolomics; siderophore; NGAL; lipocalin 2; siderocalin; urinary tract infection	ESCHERICHIA-COLI; QUANTITATIVE-ANALYSIS; IRON ACQUISITION; METABOLIC-FATE; SIDEROPHORE; YERSINIABACTIN; ENTEROBACTIN; IDENTIFICATION; EVASION; CELLS	Background: During urinary tract infections, humans secrete the protein siderocalin to block bacterial iron uptake. Results: Human urinary pH and metabolite composition strongly affect siderocalin's antibacterial activity. Conclusion: Siderocalin uses a subset of urinary metabolites as cofactors to withhold iron from E. coli in competition with the bacterial siderophore enterobactin. Significance: Therapeutic control of urinary composition may facilitate an important innate antibacterial defense. During Escherichia coli urinary tract infections, cells in the human urinary tract release the antimicrobial protein siderocalin (SCN; also known as lipocalin 2, neutrophil gelatinase-associated lipocalin/NGAL, or 24p3). SCN can interfere with E. coli iron acquisition by sequestering ferric iron complexes with enterobactin, the conserved E. coli siderophore. Here, we find that human urinary constituents can reverse this relationship, instead making enterobactin critical for overcoming SCN-mediated growth restriction. Urinary control of SCN activity exhibits wide ranging individual differences. We used these differences to identify elevated urinary pH and aryl metabolites as key biochemical host factors controlling urinary SCN activity. These aryl metabolites are well known products of intestinal microbial metabolism. Together, these results identify an innate antibacterial immune interaction that is critically dependent upon individualistic chemical features of human urine.	[Shields-Cutler, Robin R.; Hung, Chia S.; Marschall, Jonas; Henderson, Jeffrey P.] Washington Univ, Sch Med, Div Infect Dis, Dept Med, St Louis, MO 63110 USA; [Shields-Cutler, Robin R.; Hung, Chia S.; Henderson, Jeffrey P.] Washington Univ, Sch Med, Ctr Womens Infect Dis Res, St Louis, MO 63110 USA; [Crowley, Jan R.] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Stapleton, Ann E.] Univ Washington, Div Allergy & Infect Dis, Dept Med, Seattle, WA 98195 USA; [Aldrich, Courtney C.] Univ Minnesota, Dept Med Chem, Minneapolis, MN 55455 USA; [Marschall, Jonas] Univ Hosp Bern, Dept Infect Dis, CH-3010 Bern, Switzerland; [Marschall, Jonas] Univ Bern, CH-3010 Bern, Switzerland	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Washington; University of Washington Seattle; University of Minnesota System; University of Minnesota Twin Cities; University of Bern; University Hospital of Bern; University of Bern	Henderson, JP (corresponding author), Washington Univ, Sch Med, Div Infect Dis, 660 S Euclid Ave, St Louis, MO 63110 USA.	jhenderson@DOM.wustl.edu	Hung, Chia-Suei/G-6167-2010; Henderson, Jeffrey P/D-3337-2015; Marschall, Jonas/AAF-6425-2019; Regan, Clinton/E-6250-2012; Stapleton, Ann E/N-2428-2015	Marschall, Jonas/0000-0002-0052-3210; Stapleton, Ann E/0000-0003-0130-8659; Hung, Chia-Suei/0000-0001-9844-9954	National Institutes of Health from NIDDK [R01DK099534, P50DK064540]; National Center for Advancing Translational Sciences [UL1TR000448]; Longer Life Foundation; United States Public Health Service [P41RR000954, P30DK020579, P30HL101263, P30DK056341]; National Institutes of Health [T32GM007067-37, AI070219, U54CK000162, K12HD001459]; Monsanto Excellence Fund Graduate Fellowship; Barnes-Jewish Hospital Patient Safety and Quality Fellowship Program; Career Award for Medical Scientists from the Burroughs Welcome Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P30HL101263] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579, P50DK064540, R01DK099534, P30DK056341, R01DK088830] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Longer Life Foundation; United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Monsanto Excellence Fund Graduate Fellowship; Barnes-Jewish Hospital Patient Safety and Quality Fellowship Program; Career Award for Medical Scientists from the Burroughs Welcome Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK099534 and P50DK064540 from NIDDK. This work was also supported by National Center for Advancing Translational Sciences Grant UL1TR000448 and the Longer Life Foundation. Mass spectrometry was supported by United States Public Health Service Grants P41RR000954, P30DK020579, P30HL101263 and P30DK056341.; Supported by National Institutes of Health Grant T32GM007067-37 and a Monsanto Excellence Fund Graduate Fellowship.; Supported by National Institutes of Health Grant AI070219.; Supported by National Institutes of Health Grants U54CK000162 and K12HD001459 and the Barnes-Jewish Hospital Patient Safety and Quality Fellowship Program.; Recipient of a Career Award for Medical Scientists from the Burroughs Welcome Fund. To whom correspondence should be addressed: Division of Infectious Diseases, Washington University School of Medicine, 660 S. Euclid Ave., St. Louis, MO 63110. Tel.: 314-747-0240; Fax: 314-454-8294; E-mail: jhenderson@DOM.wustl.edu.	Abergel RJ, 2006, J AM CHEM SOC, V128, P8920, DOI 10.1021/ja062046j; Abergel RJ, 2006, J AM CHEM SOC, V128, P10998, DOI 10.1021/ja062476+; Bachman MA, 2012, MBIO, V3, DOI 10.1128/mBio.00224-11; Bachman MA, 2011, INFECT IMMUN, V79, P3309, DOI 10.1128/IAI.05114-11; Bao GH, 2010, NAT CHEM BIOL, V6, P602, DOI [10.1038/nchembio.402, 10.1038/NCHEMBIO.402]; Barber AE, 2013, CLIN INFECT DIS, V57, P719, DOI 10.1093/cid/cit284; BOOTH AN, 1959, J BIOL CHEM, V234, P3014; Bouatra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073076; BROCK JH, 1991, INFECT IMMUN, V59, P3185, DOI 10.1128/IAI.59.9.3185-3190.1991; CARMELLA SG, 1982, FOOD CHEM TOXICOL, V20, P587, DOI 10.1016/S0278-6915(82)80068-9; Chaturvedi KS, 2014, ACS CHEM BIOL, V9, P551, DOI 10.1021/cb400658k; Chaturvedi KS, 2012, NAT CHEM BIOL, V8, P731, DOI [10.1038/NCHEMBIO.1020, 10.1038/nchembio.1020]; Clayton TA, 2009, P NATL ACAD SCI USA, V106, P14728, DOI 10.1073/pnas.0904489106; Correnti C, 2012, J BIOL CHEM, V287, P13524, DOI 10.1074/jbc.R111.311829; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Fischbach MA, 2006, P NATL ACAD SCI USA, V103, P16502, DOI 10.1073/pnas.0604636103; Foxman B, 2010, NAT REV UROL, V7, P653, DOI 10.1038/nrurol.2010.190; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Gonthier MP, 2003, J NUTR, V133, P461, DOI 10.1093/jn/133.2.461; Henderson JP, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000305; Hoette TM, 2011, ACS CHEM BIOL, V6, P1327, DOI 10.1021/cb200331g; Holmes MA, 2005, STRUCTURE, V13, P29, DOI 10.1016/j.str.2004.10.009; Hooton TM, 2012, NEW ENGL J MED, V366, P1028, DOI 10.1056/NEJMcp1104429; Hung C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086009; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Lang R, 2006, J AGR FOOD CHEM, V54, P5755, DOI 10.1021/jf061118n; Luo MK, 2006, ACS CHEM BIOL, V1, P29, DOI 10.1021/cb0500034; Lv HT, 2014, J PROTEOME RES, V13, P1397, DOI 10.1021/pr4009749; Lv HT, 2011, ANALYST, V136, P4752, DOI 10.1039/c1an15590c; Marschall J, 2012, CLIN INFECT DIS, V54, P1692, DOI 10.1093/cid/cis252; MATZANKE BF, 1986, J BACTERIOL, V167, P674, DOI 10.1128/jb.167.2.674-680.1986; Miethke M, 2006, FEBS J, V273, P409, DOI 10.1111/j.1742-4658.2005.05077.x; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Miller RC, 2004, CLIN CHEM, V50, P924, DOI 10.1373/clinchem.2004.032292; MOBLEY HLT, 1990, INFECT IMMUN, V58, P1281, DOI 10.1128/IAI.58.5.1281-1289.1990; Murphy KC, 2003, BMC MOL BIOL, V4, DOI 10.1186/1471-2199-4-11; Paragas N, 2014, J CLIN INVEST, V124, P2963, DOI 10.1172/JCI71630; Perez-Jimenez J, 2010, AM J CLIN NUTR, V92, P801, DOI 10.3945/ajcn.2010.29924; Perry RD, 1999, MICROBIOL-UK, V145, P1181, DOI 10.1099/13500872-145-5-1181; Raffatellu M, 2009, CELL HOST MICROBE, V5, P476, DOI 10.1016/j.chom.2009.03.011; Reigstad CS, 2007, J BIOL CHEM, V282, P21259, DOI 10.1074/jbc.M611502200; Sieniawska CE, 2012, ANN CLIN BIOCHEM, V49, P341, DOI 10.1258/acb.2011.011179; Sikora AL, 2010, BIOCHEMISTRY-US, V49, P3648, DOI 10.1021/bi100350c; Simerville JA, 2005, AM FAM PHYSICIAN, V71, P1153; Snyder JA, 2004, INFECT IMMUN, V72, P6373, DOI 10.1128/IAI.72.11.6373-6381.2004; Stalmach A, 2009, DRUG METAB DISPOS, V37, P1749, DOI 10.1124/dmd.109.028019; Steigedal M, 2014, J IMMUNOL, V193, P6081, DOI 10.4049/jimmunol.1401528; van Duynhoven J, 2011, P NATL ACAD SCI USA, V108, P4531, DOI 10.1073/pnas.1000098107; Vinayavekhin N, 2010, ACS CHEM BIOL, V5, P91, DOI 10.1021/cb900271r; Wang JH, 2010, SEMIN NEPHROL, V30, P500, DOI 10.1016/j.semnephrol.2010.07.007; Want EJ, 2010, NAT PROTOC, V5, P1005, DOI 10.1038/nprot.2010.50; Wikoff WR, 2011, J PROTEOME RES, V10, P2842, DOI 10.1021/pr200093w; Yi L, 2006, ANAL BIOANAL CHEM, V386, P666, DOI 10.1007/s00216-006-0495-1	53	38	38	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					15949	15960		10.1074/jbc.M115.645812	http://dx.doi.org/10.1074/jbc.M115.645812			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25861985	Green Published, hybrid			2022-12-28	WOS:000356930100005
J	Cheng, YH; Ho, MS; Huang, WT; Chou, YT; King, K				Cheng, Yu-Hong; Ho, Mei-Shang; Huang, Wei-Ting; Chou, Ying-Ting; King, Klim			Modulation of Glucagon-like Peptide-1 (GLP-1) Potency by Endocannabinoid-like Lipids Represents a Novel Mode of Regulating GLP-1 Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTRIC-INHIBITORY POLYPEPTIDE; CENTRAL-NERVOUS-SYSTEM; INSULIN-SECRETION; PARKINSONS-DISEASE; ENERGY-METABOLISM; RAT INSULINOMA; BRAIN-STEM; CELL-LINES; HORMONE; EXENATIDE	Glucagon-like peptide-1 (GLP-1) analogs are approved for treatment of type 2 diabetes and are in clinical trials for disorders including neurodegenerative diseases. GLP-1 receptor (GLP-1R) is expressed in many peripheral and neuronal tissues and is activated by circulating GLP-1. Other than food intake, little is known about factors regulating GLP-1 secretion. Given a normally basal circulating level of GLP-1, knowledge of mechanisms regulating GLP-1R signaling, which has diverse functions in extrapancreatic tissues, remains elusive. In this study, we found that the potency of GLP-1, not exendin 4, is specifically enhanced by the endocannabinoid-like lipids oleoylethanolamide (OEA) and 2-oleoylglycerol but not by stearoylethanolamide (SEA) or palmitoylethanolamide. 9.2 mu M OEA enhances the potency of GLP-1 in stimulating cAMP production by 10-fold but does not affect its receptor binding affinity. OEAand 2-oleoylglycerol, but not SEA, bind to GLP-1 in a dose-dependent and saturable manner. OEA but not SEA promoted GLP1( 7-36) amide to trypsin inactivation in a dose-dependent and saturable manner. Susceptibility of GLP-1(7-36) amide to trypsin inactivation is increased 40-fold upon binding to OEA but not to SEA. Our findings indicate that OEA binds to GLP-1(7-36) amide and enhances the potency that may result from a conformational change of the peptide. In conclusion, modulating potency of GLP-1 by physiologically regulated endocannabinoid- like lipids allows GLP-1R signaling to be regulated spatiotemporally at a constant basal GLP-1 level.	[Cheng, Yu-Hong; Huang, Wei-Ting; King, Klim] Acad Sinica, Genom Res Ctr, Taipei 11529, Taiwan; [Ho, Mei-Shang; Chou, Ying-Ting] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan	King, K (corresponding author), Acad Sinica, Genom Res Ctr, Taipei 11529, Taiwan.	bmkxk@ibms.sinica.edu.tw			Academia Sinica, Taiwan	Academia Sinica, Taiwan(Academia Sinica - Taiwan)	We thank Dr. Ming-Jing Hwang, Dr. Lee-Young Chau, and Dr. Chi-Huy Wong for constructive discussions and Ching-Shu Suen for technical support. The study was supported by Academia Sinica, Taiwan.	ADELHORST K, 1994, J BIOL CHEM, V269, P6275; Aviles-Olmos I, 2014, J PARKINSON DIS, V4, P337, DOI 10.3233/JPD-140364; Aviles-Olmos I, 2013, J CLIN INVEST, V123, P2730, DOI 10.1172/JCI68295; Bacart Johan, 2008, Biotechnol J, V3, P311, DOI 10.1002/biot.200700222; Bagger JI, 2011, J CLIN ENDOCR METAB, V96, P737, DOI 10.1210/jc.2010-2435; Barak LS, 2008, MOL PHARMACOL, V74, P585, DOI 10.1124/mol.108.048884; BHATHENA SJ, 1982, DIABETES, V31, P521, DOI 10.2337/diabetes.31.6.521; Calanna S, 2013, DIABETOLOGIA, V56, P965, DOI 10.1007/s00125-013-2841-0; Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; Chu ZL, 2007, ENDOCRINOLOGY, V148, P2601, DOI 10.1210/en.2006-1608; Ezzili C, 2010, BIOORG MED CHEM LETT, V20, P5959, DOI 10.1016/j.bmcl.2010.08.048; GALLWITZ B, 1993, J MOL ENDOCRINOL, V10, P259, DOI 10.1677/jme.0.0100259; GEFEL D, 1990, ENDOCRINOLOGY, V126, P2164, DOI 10.1210/endo-126-4-2164; Gu GB, 2013, J COMP NEUROL, V521, P2235, DOI 10.1002/cne.23282; Hamilton A, 2009, NEUROREPORT, V20, P1161, DOI 10.1097/WNR.0b013e32832fbf14; Hara T, 2013, REV PHYSIOL BIOCH P, V164, P77, DOI 10.1007/112_2013_13; Hermanson DJ, 2013, NAT NEUROSCI, V16, P1291, DOI 10.1038/nn.3480; Holscher C, 2014, J ENDOCRINOL, V221, pT31, DOI 10.1530/JOE-13-0221; Hsu YY, 2009, BIOTECHNOL BIOENG, V104, P1142, DOI 10.1002/bit.22495; Jiang LI, 2007, J BIOL CHEM, V282, P10576, DOI 10.1074/jbc.M609695200; Kerr BD, 2011, BIOCHEM BIOPH RES CO, V404, P870, DOI 10.1016/j.bbrc.2010.12.077; Kleberg K, 2014, BIOFACTORS, V40, P363, DOI 10.1002/biof.1158; KORMAN LY, 1985, DIABETES, V34, P717, DOI 10.2337/diabetes.34.8.717; Larsen PJ, 1997, NEUROSCIENCE, V77, P257, DOI 10.1016/S0306-4522(96)00434-4; Llewellyn-Smith IJ, 2013, NEUROSCIENCE, V229, P130, DOI 10.1016/j.neuroscience.2012.09.071; Llewellyn-Smith IJ, 2011, NEUROSCIENCE, V180, P111, DOI 10.1016/j.neuroscience.2011.02.023; Lockie SH, 2013, J NEUROENDOCRINOL, V25, P597, DOI 10.1111/jne.12039; Loening AM, 2006, PROTEIN ENG DES SEL, V19, P391, DOI 10.1093/protein/gzl023; Lonborg J, 2012, CIRC-CARDIOVASC INTE, V5, P288, DOI 10.1161/CIRCINTERVENTIONS.112.968388; Mayo KE, 2003, PHARMACOL REV, V55, P167, DOI 10.1124/pr.55.1.6; Meier JJ, 2004, DIABETES, V53, P654, DOI 10.2337/diabetes.53.3.654; Merchenthaler I, 1999, J COMP NEUROL, V403, P261, DOI 10.1002/(SICI)1096-9861(19990111)403:2<261::AID-CNE8>3.0.CO;2-5; Nadkarni P, 2014, PROG MOL BIOL TRANSL, V121, P23, DOI 10.1016/B978-0-12-800101-1.00002-8; Ning Y, 2008, BRIT J PHARMACOL, V155, P1056, DOI 10.1038/bjp.2008.337; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; ORSKOV C, 1992, DIABETOLOGIA, V35, P701; Overton HA, 2006, CELL METAB, V3, P167, DOI 10.1016/j.cmet.2006.02.004; Parthier C, 2009, TRENDS BIOCHEM SCI, V34, P303, DOI 10.1016/j.tibs.2009.02.004; PHILIPPE J, 1987, J CLIN INVEST, V79, P351, DOI 10.1172/JCI112819; Richardson D, 2007, ANAL BIOCHEM, V360, P216, DOI 10.1016/j.ab.2006.10.039; Roberts CJ, 2012, NEUROSCIENCE, V204, P74, DOI 10.1016/j.neuroscience.2011.11.065; ROBINSON RM, 1982, BIOPOLYMERS, V21, P1217, DOI 10.1002/bip.360210615; Salahpour Ali, 2012, Front Endocrinol (Lausanne), V3, P105, DOI 10.3389/fendo.2012.00105; Trapp S, 2013, CURR OPIN PHARMACOL, V13, P964, DOI 10.1016/j.coph.2013.09.006; UNSON CG, 1987, P NATL ACAD SCI USA, V84, P4083, DOI 10.1073/pnas.84.12.4083; Vaughn LK, 2010, BRIT J PHARMACOL, V160, P530, DOI 10.1111/j.1476-5381.2010.00790.x; WIDMANN C, 1994, MOL PHARMACOL, V45, P1029; WIEDENKELLER DE, 1983, ENDOCRINOLOGY, V113, P2311, DOI 10.1210/endo-113-6-2311; Yang Y, 2013, J ALZHEIMERS DIS, V37, P637, DOI 10.3233/JAD-130491	49	26	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14302	14313		10.1074/jbc.M115.655662	http://dx.doi.org/10.1074/jbc.M115.655662			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25903129	Green Published, hybrid			2022-12-28	WOS:000355754600004
J	Kim, WJ; Wittner, BS; Amzallag, A; Brannigan, BW; Ting, DT; Ramaswamy, S; Maheswaran, S; Haber, DA				Kim, Woo Jae; Wittner, Ben S.; Amzallag, Arnaud; Brannigan, Brian W.; Ting, David T.; Ramaswamy, Sridhar; Maheswaran, Shyamala; Haber, Daniel A.			The WTX Tumor Suppressor Interacts with the Transcriptional Corepressor TRIM28	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNAI SCREEN; EXPRESSION; PROTEIN; GENE; INACTIVATION; REGULATOR; TIF1-BETA; PHD	WTX encodes a tumor suppressor implicated in the pediatric kidney cancer Wilms tumor and in mesenchymal differentiation with potentially distinct functions in the cytoplasm, at the plasma membrane, and in the nucleus. Although modulating components of the WNT signaling pathway is a proposed function for cytoplasmic and membrane-bound WTX, its nuclear properties are not well understood. Here we report that the transcriptional corepressor TRIM28 is the major binding partner for nuclear WTX. WTX interacted with the coiled coil domain of TRIM28 required for its binding to Kruppel-associated box domains of transcription factors and for its chromatin recruitment through its own coiled coil and proline-rich domains. Knockdown of endogenous WTX reduced the recruitment of TRIM28 to a chromatinized reporter sequence and its ability to repress a target transcript. In mouse embryonic stem cells where TRIM28 plays a major role in repressing endogenous retroviruses and long interspersed elements, knockdown of either TRIM28 or WTX combined with single molecule RNA sequencing revealed a highly significant shared set of differentially regulated transcripts, including derepression of non-coding repetitive sequences and their neighboring protein encoding genes (p < 1e - 20). In mesenchymal precursor cells, depletion of WTX and TRIM28 resulted in analogous beta-catenin-independent defects in adipogenic and osteogenic differentiation, and knockdown of WTX reduced TRIM28 binding to Ppar gamma promoter. Together, the physical and functional interaction between WTX and TRIM28 suggests that the nuclear fraction of WTX plays a role in epigenetic silencing, an effect that may contribute to its function as a regulator of cellular differentiation and tumorigenesis.	[Ting, David T.; Ramaswamy, Sridhar; Haber, Daniel A.] Massachusetts Gen Hosp, Ctr Canc, Dept Med, Charlestown, MA 02129 USA; [Maheswaran, Shyamala] Massachusetts Gen Hosp, Ctr Canc, Dept Surg, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Haber, Daniel A.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Howard Hughes Medical Institute	Haber, DA (corresponding author), Massachusetts Gen Hosp, Ctr Canc, CNY 7,Bldg 149, Charlestown, MA 02129 USA.	Haber@helix.mgh.harvard.edu	Amzallag, Arnaud/Y-5802-2019; Ting, David/F-4389-2017	Amzallag, Arnaud/0000-0001-7467-1227; Ting, David/0000-0002-3261-2322	Howard Hughes Medical Institute; American Cancer Society	Howard Hughes Medical Institute(Howard Hughes Medical Institute); American Cancer Society(American Cancer Society)	This work was supported by the Howard Hughes Medical Institute (to D. A. H.) and an American Cancer Society institutional research grant (to W. J. K.).	Akhavanfard S, 2014, GENE CHROMOSOME CANC, V53, P67, DOI 10.1002/gcc.22118; Baek SH, 2008, DEV CELL, V14, P459, DOI 10.1016/j.devcel.2008.03.018; Barde I, 2013, SCIENCE, V340, P350, DOI 10.1126/science.1232398; Cammas F, 2000, DEVELOPMENT, V127, P2955; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Filipponi D, 2013, CANCER CELL, V24, P528, DOI 10.1016/j.ccr.2013.08.022; Hohn O, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00246; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; Iyengar S, 2011, J BIOL CHEM, V286, P26267, DOI 10.1074/jbc.R111.252569; Jenkins ZA, 2009, NAT GENET, V41, P95, DOI 10.1038/ng.270; Katoh L, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00234; Kim WJ, 2012, MOL CELL, V45, P587, DOI 10.1016/j.molcel.2011.12.025; Lipson D, 2009, NAT BIOTECHNOL, V27, P652, DOI 10.1038/nbt.1551; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; Moisan A, 2011, DEV CELL, V20, P583, DOI 10.1016/j.devcel.2011.03.013; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Rivera MN, 2007, SCIENCE, V315, P642, DOI 10.1126/science.1137509; Rivera MN, 2009, P NATL ACAD SCI USA, V106, P8338, DOI 10.1073/pnas.0811349106; Rodic N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003402; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Singh K, 2015, GENE DEV, V29, P513, DOI 10.1101/gad.254532.114; Sripathy SP, 2006, MOL CELL BIOL, V26, P8623, DOI 10.1128/MCB.00487-06; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tanneberger K, 2011, EMBO J, V30, P1433, DOI 10.1038/emboj.2011.28; Ting DT, 2011, SCIENCE, V331, P593, DOI 10.1126/science.1200801; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Trosset JY, 2006, PROTEINS, V64, P60, DOI 10.1002/prot.20955; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Weber P, 2002, DEVELOPMENT, V129, P2329; Wegert J, 2009, GENE CHROMOSOME CANC, V48, P1102, DOI 10.1002/gcc.20712; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhu Q, 2011, NATURE, V477, P179, DOI 10.1038/nature10371	35	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14381	14390		10.1074/jbc.M114.631945	http://dx.doi.org/10.1074/jbc.M114.631945			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25882849	Green Published, hybrid			2022-12-28	WOS:000355754600010
J	Tong, D; Ortega, J; Kim, C; Huang, J; Gu, LY; Li, GM				Tong, Dan; Ortega, Janice; Kim, Christine; Huang, Jian; Gu, Liya; Li, Guo-Min			Arsenic Inhibits DNA Mismatch Repair by Promoting EGFR Expression and PCNA Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL LUNG-CANCER; DRINKING-WATER; DAMAGE; MORTALITY; EXPOSURE; ALPHA; CHILE; POLYMERASE; MUTATIONS; ARGENTINA	Both genotoxic and non-genotoxic chemicals can act as carcinogens. However, while genotoxic compounds lead directly to mutations that promote unregulated cell growth, the mechanism by which non-genotoxic carcinogens lead to cellular transformation is poorly understood. Using a model non-genotoxic carcinogen, arsenic, we show here that exposure to arsenic inhibits mismatch repair (MMR) in human cells, possibly through its ability to stimulate epidermal growth factor receptor (EGFR)-dependent tyrosine phosphorylation of proliferating cellular nuclear antigen (PCNA). HeLa cells exposed to exogenous arsenic demonstrate a dose-and time-dependent increase in the levels of EGFR and tyrosine 211-phosphorylated PCNA. Cell extracts derived from arsenic-treated HeLa cells are defective in MMR, and unphosphorylated recombinant PCNA restores normal MMR activity to these extracts. These results suggest a model in which arsenic induces expression of EGFR, which in turn phosphorylates PCNA, and phosphorylated PCNA then inhibits MMR, leading to increased susceptibility to carcinogenesis. This study suggests a putative novel mechanism of action for arsenic and other non-genotoxic carcinogens.	[Tong, Dan; Huang, Jian; Li, Guo-Min] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Tong, Dan; Ortega, Janice; Kim, Christine; Gu, Liya; Li, Guo-Min] Univ Kentucky, Coll Med, Dept Toxicol & Canc Biol, Markey Canc Ctr, Lexington, KY 40536 USA; [Tong, Dan; Li, Guo-Min] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China	Wuhan University; University of Kentucky; Tsinghua University	Li, GM (corresponding author), Univ Kentucky, Coll Med, Dept Toxicol & Canc Biol, 789 South Limestone St, Lexington, KY 40536 USA.	gmli@uky.edu		Kim, Christine/0000-0001-5027-7591; Li, Guo-Min/0000-0002-9842-4578	National Cancer Institute [CA167181, T32 CA165990]; National Institutes of Health, of the United States; National Natural Science Foundation of China [31370766, 31461143005, 30740420548]; Kentucky Lung Cancer Research program; NATIONAL CANCER INSTITUTE [T32CA165990, R01CA167181] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health, of the United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Kentucky Lung Cancer Research program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants from the National Cancer Institute (CA167181), National Institutes of Health, of the United States, the National Natural Science Foundation of China (31370766, 31461143005, and 30740420548), and Kentucky Lung Cancer Research program.r Supported by a National Cancer Institute training grant (T32 CA165990).	Andrew AS, 2006, ENVIRON HEALTH PERSP, V114, P1193, DOI 10.1289/ehp.9008; Andrew AS, 2009, TOXICOL SCI, V109, P350, DOI 10.1093/toxsci/kfp015; Bates MN, 2004, AM J EPIDEMIOL, V159, P381, DOI 10.1093/aje/kwh054; Briggs S, 2013, J PATHOL, V230, P148, DOI 10.1002/path.4185; Chen XQ, 1996, NAT MED, V2, P1033; Church DN, 2013, HUM MOL GENET, V22, P2820, DOI 10.1093/hmg/ddt131; COHN SE, 1992, EPIDEMIOLOGY, V3, P471, DOI 10.1097/00001648-199209000-00016; FANG WH, 1993, J BIOL CHEM, V268, P11838; FIEN K, 1992, MOL CELL BIOL, V12, P155, DOI 10.1128/MCB.12.1.155; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Gu LY, 1998, NUCLEIC ACIDS RES, V26, P1173, DOI 10.1093/nar/26.5.1173; Guo SL, 2004, J BIOL CHEM, V279, P16912, DOI 10.1074/jbc.M313213200; Heck JE, 2009, ENVIRON HEALTH PERSP, V117, P1718, DOI 10.1289/ehp.0900566; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; HOLMES J, 1990, P NATL ACAD SCI USA, V87, P5837, DOI 10.1073/pnas.87.15.5837; Iaccarino I, 1998, EMBO J, V17, P2677, DOI 10.1093/emboj/17.9.2677; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Knobeloch LM, 2006, J HEALTH POPUL NUTR, V24, P206; Li D, 2001, Environ Health Prev Med, V6, P27, DOI 10.1007/BF02897306; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Liaw J, 2008, CANCER EPIDEM BIOMAR, V17, P1982, DOI 10.1158/1055-9965.EPI-07-2816; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; Loeb LA, 2008, CANCER RES, V68, P3551, DOI 10.1158/0008-5472.CAN-07-5835; Marshall G, 2007, JNCI-J NATL CANCER I, V99, P920, DOI 10.1093/jnci/djm004; Martinez VD, 2012, AM J RESP CRIT CARE, V185, P1131, DOI 10.1164/ajrccm.185.10.1131; McCulloch SD, 2008, CELL RES, V18, P148, DOI 10.1038/cr.2008.4; MERLO A, 1994, CANCER RES, V54, P2098; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; OKAJIMA T, 1993, ANAL BIOCHEM, V211, P293, DOI 10.1006/abio.1993.1272; Ortega J, 2015, P NATL ACAD SCI USA, V112, P5667, DOI 10.1073/pnas.1417711112; PAN ZQ, 1995, J BIOL CHEM, V270, P22008, DOI 10.1074/jbc.270.37.22008; PARSONS R, 1993, CELL, V75, P1227, DOI 10.1016/0092-8674(93)90331-J; Pifarre A, 1997, BRIT J CANCER, V75, P184, DOI 10.1038/bjc.1997.31; Putila JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025886; Qin XJ, 2008, TOXICOL APPL PHARM, V232, P41, DOI 10.1016/j.taap.2008.05.019; Qin XJ, 2008, CHEM RES TOXICOL, V21, P1806, DOI 10.1021/tx8001548; Aballay LR, 2012, INT J ENVIRON HEAL R, V22, P220, DOI 10.1080/09603123.2011.628792; Rossman TG, 2003, MUTAT RES-FUND MOL M, V533, P37, DOI 10.1016/j.mrfmmm.2003.07.009; Shi HL, 2004, CHEM RES TOXICOL, V17, P871, DOI 10.1021/tx049939e; Smith KR, 2001, AM J PHYSIOL-LUNG C, V280, pL442, DOI 10.1152/ajplung.2001.280.3.L442; Soto-Reyes E, 2005, BIOMETALS, V18, P493, DOI 10.1007/s10534-005-0858-7; THOMAS DC, 1991, J BIOL CHEM, V266, P3744; Tomer G, 2002, J BIOL CHEM, V277, P21801, DOI 10.1074/jbc.M111342200; Tran HP, 2002, TOXICOL LETT, V133, P59, DOI 10.1016/S0378-4274(02)00088-7; Wang HT, 2012, J BIOL CHEM, V287, P12379, DOI 10.1074/jbc.M111.329623; Wang SC, 2006, NAT CELL BIOL, V8, P1359, DOI 10.1038/ncb1501; Yuan Y, 2010, EPIDEMIOLOGY, V21, P103, DOI 10.1097/EDE.0b013e3181c21e46; Zhang M, 2014, MOL CELL, V55, P31, DOI 10.1016/j.molcel.2014.04.028; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027; Zhou X, 2000, CLIN CANCER RES, V6, P559	50	23	25	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14536	14541		10.1074/jbc.M115.641399	http://dx.doi.org/10.1074/jbc.M115.641399			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25907674	hybrid, Green Published			2022-12-28	WOS:000355754600025
J	Stolzenberg, S; Quick, M; Zhao, CF; Gotfryd, K; Khelashvili, G; Gether, U; Loland, CJ; Javitch, JA; Noskov, S; Weinstein, H; Shi, L				Stolzenberg, Sebastian; Quick, Matthias; Zhao, Chunfeng; Gotfryd, Kamil; Khelashvili, George; Gether, Ulrik; Loland, Claus J.; Javitch, Jonathan A.; Noskov, Sergei; Weinstein, Harel; Shi, Lei			Mechanism of the Association between Na+ Binding and Conformations at the Intracellular Gate in Neurotransmitter: Sodium Symporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOPAMINE TRANSPORTER; MOLECULAR-DYNAMICS; BACTERIAL HOMOLOG; ION SELECTIVITY; OCCLUDED STATE; OUTWARD-OPEN; LEUT; SUBSTRATE; PROTEIN; SITE	Neurotransmitter: sodium symporters (NSSs) terminate neurotransmission by Na+-dependent reuptake of released neurotransmitters. Previous studies suggested that Na+-binding reconfigures dynamically coupled structural elements in an allosteric interaction network (AIN) responsible for function-related conformational changes, but the intramolecular pathway of this mechanism has remained uncharted. We describe a new approach for the modeling and analysis of intramolecular dynamics in the bacterial NSS homolog LeuT. From microsecond-scale molecular dynamics simulations and cognate experimental verifications in both LeuT and human dopamine transporter (hDAT), we apply the novel method to identify the composition and the dynamic properties of their conserved AIN. In LeuT, two different perturbations disrupting Na+ binding and transport (i.e. replacing Na+ with Li+ or the Y268A mutation at the intracellular gate) affect the AIN in strikingly similar ways. In contrast, other mutations that affect the intracellular gate (i.e. R5A and D369A) do not significantly impair Na+ cooperativity and transport. Our analysis shows these perturbations to have much lesser effects on the AIN, underscoring the sensitivity of this novel method to the mechanistic nature of the perturbation. Notably, this set of observations holds as well for hDAT, where the aligned Y335A, R60A, and D436A mutations also produce different impacts on Na+ dependence. Thus, the detailed AIN generated from our method is shown to connect Na+ binding with global conformational changes that are critical for the transport mechanism. That the AIN between the Na+ binding sites and the intracellular gate in bacterial LeuT resembles that in eukaryotic hDAT highlights the conservation of allosteric pathways underlying NSS function.	[Stolzenberg, Sebastian; Khelashvili, George; Weinstein, Harel; Shi, Lei] Cornell Univ, Dept Physiol & Biophys, New York, NY 10065 USA; [Weinstein, Harel; Shi, Lei] Cornell Univ, Weill Med Coll, Inst Computat Biomed, New York, NY 10065 USA; [Stolzenberg, Sebastian] Cornell Univ, Dept Phys, Ithaca, NY 14850 USA; [Quick, Matthias; Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA; [Quick, Matthias; Javitch, Jonathan A.] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA; [Zhao, Chunfeng; Noskov, Sergei] Univ Calgary, Ctr Mol Simulat, Calgary, AB T2N 1N4, Canada; [Zhao, Chunfeng; Noskov, Sergei] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Gotfryd, Kamil; Gether, Ulrik; Loland, Claus J.] Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark; [Shi, Lei] NIDA, Computat Chem & Mol Biophys Unit, Intramural Res Program, NIH, Baltimore, MD 21224 USA	Cornell University; Cornell University; Cornell University; Columbia University; Columbia University; New York State Psychiatry Institute; University of Calgary; University of Calgary; University of Copenhagen; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Weinstein, H (corresponding author), Weill Cornell Med Coll, 1300 York Ave,Box 75, New York, NY 10065 USA.	haw2002@med.cornell.edu; les2007@med.cornell.edu	WEINSTEIN, HAREL/O-8245-2019; Shi, Lei/AAV-1321-2020; Gourdon, Pontus/E-1076-2014; Loland, Claus/E-5975-2014	WEINSTEIN, HAREL/0000-0003-3473-9818; Shi, Lei/0000-0002-4137-096X; Gourdon, Pontus/0000-0002-8631-3539; Gotfryd, Kamil/0000-0002-0299-0779; Gether, Ulrik/0000-0002-0020-3807; Loland, Claus/0000-0002-1773-1446; Noskov, Sergei/0000-0001-7769-335X; Javitch, Jonathan/0000-0001-7395-2967	United States Department of Energy Office of Science User Facility [DE-AC05-00OR22725]; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000606] Funding Source: NIH RePORTER	United States Department of Energy Office of Science User Facility(United States Department of Energy (DOE)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank MiEstrella Miller-Cruz and Trang Nguyen for the preparation of bacterial membrane vesicles and the purification of LeuT variants and Lone Rosenquist for technical assistance in the hDAT experiments. Computations were performed on Ranger at the Texas Advanced Computing Center (TG-MCB090022); the resources of the Oak Ridge Leadership Computing Facility, which is a United States Department of Energy Office of Science User Facility supported under Contract DE-AC05-00OR22725; the West-Grid/Compute Canada facilities; and the local Tielemann, Noskov, and Kusalik cluster supported by the Canadian Foundation for Innovation.	Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Celik L, 2008, BIOPHYS J, V94, P1600, DOI 10.1529/biophysj.107.117580; Cheng MH, 2013, BIOPHYS J, V105, P630, DOI 10.1016/j.bpj.2013.06.032; Claxton DP, 2010, NAT STRUCT MOL BIOL, V17, P822, DOI 10.1038/nsmb.1854; del Sol A, 2009, STRUCTURE, V17, P1042, DOI 10.1016/j.str.2009.06.008; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; Hamilton PJ, 2013, MOL PSYCHIATR, V18, P1315, DOI 10.1038/mp.2013.102; Hamilton PJ, 2014, NAT CHEM BIOL, V10, P582, DOI [10.1038/NCHEMBIO.1545, 10.1038/nchembio.1545]; Hansen FH, 2014, J CLIN INVEST, V124, P3107, DOI 10.1172/JCI73778; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kantcheva AK, 2013, P NATL ACAD SCI USA, V110, P8489, DOI 10.1073/pnas.1221279110; Khelashvili G, 2015, PROTEINS, V83, P952, DOI 10.1002/prot.24792; Kniazeff J, 2008, J BIOL CHEM, V283, P17691, DOI 10.1074/jbc.M800475200; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; LeVine MV, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003603; Loland CJ, 2004, J BIOL CHEM, V279, P3228, DOI 10.1074/jbc.M304755200; Loland CJ, 2002, P NATL ACAD SCI USA, V99, P1683, DOI 10.1073/pnas.032386299; Loland CJ, 2008, MOL PHARMACOL, V73, P813, DOI 10.1124/mol.107.039800; Loland CJ, 2012, BIOL PSYCHIAT, V72, P405, DOI 10.1016/j.biopsych.2012.03.022; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Newman AH, 2009, TOP MED CHEM SER, V4, P95, DOI 10.1007/7355_2008_027; Noskov SY, 2008, J MOL BIOL, V377, P804, DOI 10.1016/j.jmb.2008.01.015; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Quick M, 2007, P NATL ACAD SCI USA, V104, P3603, DOI 10.1073/pnas.0609573104; Quick M, 2006, J BIOL CHEM, V281, P26444, DOI 10.1074/jbc.M602438200; Quick M, 2012, NAT STRUCT MOL BIOL, V19, P207, DOI 10.1038/nsmb.2197; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Schmitt KC, 2010, ANN NY ACAD SCI, V1187, P316, DOI 10.1111/j.1749-6632.2009.05148.x; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yu HB, 2010, P NATL ACAD SCI USA, V107, P20329, DOI 10.1073/pnas.1007150107; Zhao CF, 2012, BIOPHYS J, V103, P878, DOI 10.1016/j.bpj.2012.07.044; Zhao CF, 2011, BIOCHEMISTRY-US, V50, P1848, DOI 10.1021/bi101454f; Zhao YF, 2011, NATURE, V474, P109, DOI 10.1038/nature09971; Zhao YF, 2010, NATURE, V465, P188, DOI 10.1038/nature09057	42	41	41	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13992	14003		10.1074/jbc.M114.625343	http://dx.doi.org/10.1074/jbc.M114.625343			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25869126	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000355313000030
J	Hishiki, A; Hara, K; Ikegaya, Y; Yokoyama, H; Shimizu, T; Sato, M; Hashimoto, H				Hishiki, Asami; Hara, Kodai; Ikegaya, Yuzu; Yokoyama, Hideshi; Shimizu, Toshiyuki; Sato, Mamoru; Hashimoto, Hiroshi			Structure of a Novel DNA-binding Domain of Helicase-like Transcription Factor (HLTF) and Its Functional Implication in DNA Damage Tolerance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIMPLE REPETITIVE SEQUENCES; UBIQUITIN LIGASE; STRANDED-DNA; HUMAN SHPRH; REPLICATION; REPAIR; PCNA; TRANSLOCASE; INSTABILITY; ZRANB3	HLTF (helicase-like transcription factor) is a yeast RAD5 homolog found in mammals. HLTF has E3 ubiquitin ligase and DNA helicase activities, and plays a pivotal role in the template-switching pathway of DNA damage tolerance. HLTF has an N-terminal domain that has been designated the HIRAN (HIP116 and RAD5 N-terminal) domain. The HIRAN domain has been hypothesized to play a role in DNA binding; however, the structural basis of, and functional evidence for, the HIRAN domain in DNA binding has remained unclear. Here we show for the first time the crystal structure of the HIRAN domain of human HLTF in complex with DNA. The HIRAN domain is composed of six beta-strands and two alpha-helices, forming an OB-fold structure frequently found in ssDNA-binding proteins, including in replication factor A(RPA). Interestingly, this study reveals that the HIRAN domain interacts with not only with a single-stranded DNA but also with a duplex DNA. Furthermore, the structure unexpectedly clarifies that the HIRAN domain specifically recognizes the 3'-end of DNA. These results suggest that the HIRAN domain functions as a sensor to the 3'-end of the primer strand at the stalled replication fork and that the domain facilitates fork regression. HLTF is recruited to a damaged site through the HIRAN domain at the stalled replication fork. Furthermore, our results have implications for the mechanism of template switching.	[Hishiki, Asami; Hara, Kodai; Ikegaya, Yuzu; Yokoyama, Hideshi; Hashimoto, Hiroshi] Univ Shizuoka, Sch Pharmaceut Sci, Suruga Ku, Shizuoka 4228002, Japan; [Hishiki, Asami; Sato, Mamoru] Yokohama City Univ, Grad Sch Med Life Sci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Hishiki, Asami] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Shimizu, Toshiyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Hashimoto, Hiroshi] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan	University of Shizuoka; Yokohama City University; Sanford Burnham Prebys Medical Discovery Institute; University of Tokyo; Osaka University	Hashimoto, H (corresponding author), Univ Shizuoka, Sch Pharmaceut Sci, Suruga Ku, 52-1 Yada, Shizuoka 4228002, Japan.	hash@u-shizuoka-ken.ac.jp		Hashimoto, Hiroshi/0000-0003-1503-6789; hara, kodai/0000-0002-1586-6312; Yokoyama, Hideshi/0000-0002-3137-2793	KAKENHI [23770125, 26440034, 25121728, 25291017]; National Project on Protein Structural and Functional Analyses (Protein 3000 Project); Targeted Proteins Research Program (TPRP) from Ministry of Education, Culture, Sports, Science and Technology (MEXT); Takeda Science Foundation; Naito Foundation; Grants-in-Aid for Scientific Research [26440034] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Project on Protein Structural and Functional Analyses (Protein 3000 Project); Targeted Proteins Research Program (TPRP) from Ministry of Education, Culture, Sports, Science and Technology (MEXT); Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKENHI (Grants 23770125, 26440034, 25121728, and 25291017), the National Project on Protein Structural and Functional Analyses (Protein 3000 Project), and the Targeted Proteins Research Program (TPRP) from Ministry of Education, Culture, Sports, Science and Technology (MEXT) (to A. H., T. S., M. S., and H. H.). This work was also supported by grants from the Takeda Science Foundation and the Naito Foundation (to H. H.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arcus V, 2002, CURR OPIN STRUC BIOL, V12, P794, DOI 10.1016/S0959-440X(02)00392-5; Betous R, 2012, GENE DEV, V26, P151, DOI 10.1101/gad.178459.111; Blastyak A, 2010, MOL CELL BIOL, V30, P684, DOI 10.1128/MCB.00863-09; Bochkarev A, 1997, NATURE, V385, P176, DOI 10.1038/385176a0; Boerkoel CF, 2002, NAT GENET, V30, P215, DOI 10.1038/ng821; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burkovics P, 2014, NUCLEIC ACIDS RES, V42, P1711, DOI 10.1093/nar/gkt1040; Ciccia A, 2012, MOL CELL, V47, P396, DOI 10.1016/j.molcel.2012.05.024; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Friedberg EC, 2014, DNA REPAIR MUTAGENES; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Ikegaya Y., 2015, ACTA CRYS F IN PRESS; Iyer LM, 2006, CELL CYCLE, V5, P775, DOI 10.4161/cc.5.7.2629; JOHNSON RE, 1992, MOL CELL BIOL, V12, P3807, DOI 10.1128/MCB.12.9.3807; JOHNSON RE, 1994, J BIOL CHEM, V269, P28259; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Lin JR, 2011, MOL CELL, V42, P237, DOI 10.1016/j.molcel.2011.02.026; MacKay C, 2009, BIOCHEM BIOPH RES CO, V390, P187, DOI 10.1016/j.bbrc.2009.08.151; Masuda Y, 2012, NUCLEIC ACIDS RES, V40, P10394, DOI 10.1093/nar/gks763; Motegi A, 2006, J CELL BIOL, V175, P703, DOI 10.1083/jcb.200606145; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Unk I, 2008, P NATL ACAD SCI USA, V105, P3768, DOI 10.1073/pnas.0800563105; Unk I, 2006, P NATL ACAD SCI USA, V103, P18107, DOI 10.1073/pnas.0608595103; Weston R, 2012, GENE DEV, V26, P1558, DOI 10.1101/gad.193516.112; Yuan JS, 2012, MOL CELL, V47, P410, DOI 10.1016/j.molcel.2012.05.025	33	50	50	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13215	13223		10.1074/jbc.M115.643643	http://dx.doi.org/10.1074/jbc.M115.643643			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25858588	Green Published, hybrid			2022-12-28	WOS:000354975700023
J	Kim, W; Kim, HD; Jung, Y; Kim, J; Chung, J				Kim, Wonho; Kim, Hag Dong; Jung, Youjin; Kim, Joon; Chung, Jongkyeong			Drosophila Low Temperature Viability Protein 1 (LTV1) Is Required for Ribosome Biogenesis and Cell Growth Downstream of Drosophila Myc (dMyc)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR EXPORT; SACCHAROMYCES-CEREVISIAE; C-MYC; CYTOPLASMIC MATURATION; PRE-RIBOSOMES; SUBUNIT; RNA; TRANSCRIPTION; CANCER; GENES	During animal development, various signaling pathways converge to regulate cell growth. In this study, we identified LTV1 as a novel cell growth regulator in Drosophila. LTV1 mutant larvae exhibited developmental delays and lethality at the second larval stage. Using biochemical studies, we discovered that LTV1 interacted with ribosomal protein S3 and co-purified with free 40S ribosome subunits. We further demonstrated that LTV1 is crucial for ribosome biogenesis through 40S ribosome subunit synthesis and preribosomal RNA processing, suggesting that LTV1 is required for cell growth by regulating protein synthesis. We also demonstrated that Drosophila Myc (dMyc) directly regulates LTV1 transcription and requires LTV1 to stimulate ribosome biogenesis. Importantly, the loss of LTV1 blocked the cell growth and endoreplication induced by dMyc. Combined, these results suggest that LTV1 is a key downstream factor of dMyc-induced cell growth by properly maintaining ribosome biogenesis.	[Kim, Wonho] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Kim, Wonho; Chung, Jongkyeong] Seoul Natl Univ, Inst Mol Biol & Genet, Natl Creat Res Initiat Ctr Energy Homeostasis Reg, Seoul 151742, South Korea; [Kim, Wonho; Chung, Jongkyeong] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Kim, Hag Dong; Jung, Youjin; Kim, Joon] Korea Univ, Div Life Sci, Biochem Lab, Seoul 136701, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Seoul National University (SNU); Seoul National University (SNU); Korea University	Kim, J (corresponding author), Korea Univ, Div Life Sci, Biochem Lab, Seoul 136701, South Korea.	joonkim@korea.ac.kr; jkc@snu.ac.kr			National Creative Research Initiatives Program [2010-0018291]; Korean Ministry of Science, ICT and Future Planning [2012R1A2A1A01009027]; BK21 Plus Program	National Creative Research Initiatives Program(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korean Ministry of Science, ICT and Future Planning; BK21 Plus Program	This work was supported by National Creative Research Initiatives Program Grant 2010-0018291, Korean Ministry of Science, ICT and Future Planning Grant 2012R1A2A1A01009027, and BK21 Plus Program.	Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Barna M, 2008, NATURE, V456, P971, DOI 10.1038/nature07449; Boon K, 2001, EMBO J, V20, P1383, DOI 10.1093/emboj/20.6.1383; Budirahardja Y, 2009, DEVELOPMENT, V136, P2861, DOI 10.1242/dev.021931; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Fassio CA, 2010, GENETICS, V185, P199, DOI 10.1534/genetics.110.115584; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Grandi P, 2002, MOL CELL, V10, P105, DOI 10.1016/S1097-2765(02)00579-8; Grewal SS, 2005, NAT CELL BIOL, V7, P295, DOI 10.1038/ncb1223; Hariharan IK, 2006, ANNU REV GENET, V40, P335, DOI 10.1146/annurev.genet.39.073003.100738; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Ho JHN, 2000, J CELL BIOL, V151, P1057, DOI 10.1083/jcb.151.5.1057; Johnson AW, 2002, TRENDS BIOCHEM SCI, V27, P580, DOI 10.1016/S0968-0004(02)02208-9; Karbstein K, 2011, CURR OPIN CHEM BIOL, V15, P657, DOI 10.1016/j.cbpa.2011.07.023; Lempiainen H, 2009, CURR OPIN CELL BIOL, V21, P855, DOI 10.1016/j.ceb.2009.09.002; Loar JW, 2004, GENETICS, V168, P1877, DOI 10.1534/genetics.104.032656; LONG EO, 1980, J MOL BIOL, V138, P873, DOI 10.1016/0022-2836(80)90070-4; Maggi LB, 2008, MOL CELL BIOL, V28, P7050, DOI 10.1128/MCB.01548-07; Merwin JR, 2014, GENETICS, V198, P1071, DOI 10.1534/genetics.114.168294; Meyuhas O, 2000, EUR J BIOCHEM, V267, P6321, DOI 10.1046/j.1432-1327.2000.01719.x; Milkereit P, 2003, J BIOL CHEM, V278, P4072, DOI 10.1074/jbc.M208898200; Mitchell NC, 2010, DEVELOPMENT, V137, P2875, DOI 10.1242/dev.049585; Moy TI, 2002, J CELL SCI, V115, P2985; Moy TI, 1999, GENE DEV, V13, P2118, DOI 10.1101/gad.13.16.2118; Neto-Silva RM, 2009, ANNU REV CELL DEV BI, V25, P197, DOI 10.1146/annurev.cellbio.24.110707.175242; Pierce SB, 2004, DEVELOPMENT, V131, P2317, DOI 10.1242/dev.01108; Pignoni F, 1997, DEVELOPMENT, V124, P271; Poortinga G, 2004, EMBO J, V23, P3325, DOI 10.1038/sj.emboj.7600335; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Schafer T, 2003, EMBO J, V22, P1370, DOI 10.1093/emboj/cdg121; Schafer T, 2006, NATURE, V441, P651, DOI 10.1038/nature04840; Schlosser I, 2003, NUCLEIC ACIDS RES, V31, P6148, DOI 10.1093/nar/gkg794; SEDLAK BJ, 1984, DEV BIOL, V104, P489, DOI 10.1016/0012-1606(84)90106-4; Seiser RM, 2006, GENETICS, V174, P679, DOI 10.1534/genetics.106.062117; Shiue CN, 2009, ONCOGENE, V28, P1833, DOI 10.1038/onc.2009.21; Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Wu CH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000090; XU T, 1993, DEVELOPMENT, V117, P1223; Yang JP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2469; Zeller KI, 2001, J BIOL CHEM, V276, P48285, DOI 10.1074/jbc.M108506200; Zemp I, 2007, FEBS LETT, V581, P2783, DOI 10.1016/j.febslet.2007.05.013; Zemp I, 2009, J CELL BIOL, V185, P1167, DOI 10.1083/jcb.200904048	43	7	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13591	13604		10.1074/jbc.M114.607036	http://dx.doi.org/10.1074/jbc.M114.607036			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25858587	hybrid, Green Published			2022-12-28	WOS:000354975700052
J	Homan, KT; Waldschmidt, HV; Glukhova, A; Cannavo, A; Song, JL; Cheung, JY; Koch, WJ; Larsen, SD; Tesmer, JJG				Homan, Kristoff T.; Waldschmidt, Helen V.; Glukhova, Alisa; Cannavo, Alessandro; Song, Jianliang; Cheung, Joseph Y.; Koch, Walter J.; Larsen, Scott D.; Tesmer, John J. G.			Crystal Structure of G Protein-coupled Receptor Kinase 5 in Complex with a Rationally Designed Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHODOPSIN KINASE; MOLECULAR-BASIS; DESENSITIZATION; LOCALIZATION; SITES; PHOSPHORYLATION; IDENTIFICATION; ACTIVATION; EXPRESSION; POTENT	G protein-coupled receptor kinases (GRKs) regulate cell signaling by initiating the desensitization of active G protein-coupled receptors. The two most widely expressed GRKs (GRK2 and GRK5) play a role in cardiovascular disease and thus represent important targets for the development of novel therapeutic drugs. In the course of a GRK2 structure-based drug design campaign, one inhibitor (CCG215022) exhibited nanomolar IC50 values against both GRK2 and GRK5 and good selectivity against other closely related kinases such as GRK1 and PKA. Treatment of murine cardiomyocytes with CCG215022 resulted in significantly increased contractility at 20-fold lower concentrations than paroxetine, an inhibitor with more modest selectivity for GRK2. A 2.4 angstrom crystal structure of the GRK5.CCG215022 complex was determined and revealed that the inhibitor binds in the active site similarly to its parent compound GSK180736A. As designed, its 2-pyridylmethyl amide side chain occupies the hydrophobic subsite of the active site where it forms three additional hydrogen bonds, including one with the catalytic lysine. The overall conformation of the GRK5 kinase domain is similar to that of a previously determined structure of GRK6 in what is proposed to be its active state, but the C-terminal region of the enzyme adopts a distinct conformation. The kinetic properties of site-directed mutants in this region are consistent with the hypothesis that this novel C-terminal structure is representative of the membrane-bound conformation of the enzyme.	[Homan, Kristoff T.; Glukhova, Alisa; Tesmer, John J. G.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Homan, Kristoff T.; Glukhova, Alisa; Tesmer, John J. G.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Homan, Kristoff T.; Glukhova, Alisa; Tesmer, John J. G.] Univ Michigan, Dept Biol Sci, Ann Arbor, MI 48109 USA; [Waldschmidt, Helen V.; Larsen, Scott D.] Univ Michigan, Vahlteich Med Chem Core, Ann Arbor, MI 48109 USA; [Waldschmidt, Helen V.; Larsen, Scott D.] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA; [Cannavo, Alessandro; Song, Jianliang; Cheung, Joseph Y.; Koch, Walter J.] Temple Univ, Ctr Translat Med, Sch Med, Philadelphia, PA 19140 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Tesmer, JJG (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	tesmerjj@umich.edu	Cannavo, Alessandro/T-1451-2018; Cannavo, Alessandro/K-7380-2016; Cannavo, Alessandro/AGP-2284-2022; Regan, Clinton/E-6250-2012	Cannavo, Alessandro/0000-0001-8948-5961; Cannavo, Alessandro/0000-0001-8948-5961; Cannavo, Alessandro/0000-0001-8948-5961; Glukhova, Alisa/0000-0003-4146-965X; Tesmer, John/0000-0003-1125-3727	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Michigan Economic Development Corp.; Michigan Technology Tri-Corridor Grant [085P1000817]; National Institutes of Health [DK20572]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL108806, R01HL086865, R01HL071818, P01HL075443, P01HL091799, R37HL061690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572, P30DK020572] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Michigan Economic Development Corp.; Michigan Technology Tri-Corridor Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr. Jeffrey L. Benovic and Dr. Konstanin Komolov for reading and providing feedback on the manuscript and for providing their atomic coordinates in advance of publication. We also thank Kelly L. Larimore for technical assistance. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357, and use of LS-CAT Sector 21 was supported by the Michigan Economic Development Corp. and Michigan Technology Tri-Corridor Grant 085P1000817. is research used the DNA Sequencing Core of the Michigan Diabetes Research and Training Center supported by National Institutes of Health Grant DK20572.	Ames JB, 2012, FRONT MOL NEUROSCI, V5, DOI [10.3389/fnmol.2012.00010, 10.1016/j.bbagen.2011.10.003]; Boguth CA, 2010, EMBO J, V29, P3249, DOI 10.1038/emboj.2010.206; Carman CV, 2000, J BIOL CHEM, V275, P10443, DOI 10.1074/jbc.275.14.10443; Chen EP, 2001, ANN THORAC SURG, V71, P1320, DOI 10.1016/S0003-4975(00)01754-9; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DeLano W.L, PYMOL MOL GRAPHICS S; Dorn GW, 2009, J MOL MED, V87, P455, DOI 10.1007/s00109-009-0450-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Fredericks ZL, 1996, J BIOL CHEM, V271, P13796, DOI 10.1074/jbc.271.23.13796; Gaffarogullari EC, 2011, J MOL BIOL, V411, P823, DOI 10.1016/j.jmb.2011.06.034; Gold JI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057324; Gold JI, 2012, CIRC RES, V111, P1048, DOI 10.1161/CIRCRESAHA.112.273367; Goodman KB, 2007, J MED CHEM, V50, P6, DOI 10.1021/jm0609014; Gurevich EV, 2012, PHARMACOL THERAPEUT, V133, P40, DOI 10.1016/j.pharmthera.2011.08.001; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Homan KT, 2013, CURR MED CHEM, V20, P39; Homan KT, 2015, ACS CHEM BIOL, V10, P310, DOI 10.1021/cb5006323; Homan KT, 2015, ACS CHEM BIOL, V10, P246, DOI 10.1021/cb5003976; Huang CC, 2009, J BIOL CHEM, V284, P17206, DOI 10.1074/jbc.M809544200; Johnson LR, 2004, MOL CELL BIOL, V24, P10169, DOI 10.1128/MCB.24.23.10169-10179.2004; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; KOIDE K, 1995, CHEM BIOL, V2, P601, DOI 10.1016/1074-5521(95)90124-8; Komolov KE, 2015, J BIOL CHEM, V290, P20629, DOI 10.1074/jbc.M115.647297; Levay K, 1998, BIOCHEMISTRY-US, V37, P13650, DOI 10.1021/bi980998z; LIGGETT SB, 1992, J BIOL CHEM, V267, P4740; Lodowski DT, 2006, J BIOL CHEM, V281, P16785, DOI 10.1074/jbc.M601327200; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; LOUDON RP, 1994, J BIOL CHEM, V269, P22691; Madhusudan, 2002, NAT STRUCT BIOL, V9, P273, DOI 10.1038/nsb780; Martini JS, 2008, P NATL ACAD SCI USA, V105, P12457, DOI 10.1073/pnas.0803153105; Mushegian A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033806; Narayana N, 1999, BIOCHEMISTRY-US, V38, P2367, DOI 10.1021/bi9820659; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAPERMASTER DS, 1982, METHOD ENZYMOL, V81, P240; Pitcher JA, 1996, J BIOL CHEM, V271, P24907, DOI 10.1074/jbc.271.40.24907; Pronin AN, 1998, J BIOL CHEM, V273, P31510, DOI 10.1074/jbc.273.47.31510; Pronin AN, 1997, J BIOL CHEM, V272, P3806, DOI 10.1074/jbc.272.6.3806; Rockman HA, 1996, P NATL ACAD SCI USA, V93, P9954, DOI 10.1073/pnas.93.18.9954; Singh P, 2008, J BIOL CHEM, V283, P14053, DOI 10.1074/jbc.M708974200; Tesmer JJG, 2012, ACTA CRYSTALLOGR F, V68, P622, DOI 10.1107/S1744309112017435; Tesmer JJG, 2010, J MED CHEM, V53, P1867, DOI 10.1021/jm9017515; Tesmer JJG, 2009, PROG MOL BIOL TRANSL, V86, P75, DOI 10.1016/S1877-1173(09)86004-3; Thal DM, 2012, ACS CHEM BIOL, V7, P1830, DOI 10.1021/cb3003013; Thal DM, 2011, MOL PHARMACOL, V80, P294, DOI 10.1124/mol.111.071522; Thiyagarajan MM, 2004, J BIOL CHEM, V279, P17989, DOI 10.1074/jbc.M310738200; Tran TM, 2007, BIOCHEMISTRY-US, V46, P14438, DOI 10.1021/bi700922h; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082072; Yi XP, 2005, ANAT REC PART A, V282A, P13, DOI 10.1002/ar.a.20143; Yi YP, 2002, HYPERTENSION, V39, P1058, DOI 10.1161/01.HYP0000019130.09167.3B	52	34	35	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20649	20659		10.1074/jbc.M115.647370	http://dx.doi.org/10.1074/jbc.M115.647370			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26032411	hybrid, Green Published			2022-12-28	WOS:000360011800002
J	Darwin, KH				Darwin, K. Heran			Mycobacterium tuberculosis and Copper: A Newly Appreciated Defense against an Old Foe?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							NUTRITIONAL IMMUNITY; MULTICOPPER OXIDASE; ELEMENTAL ANALYSIS; IDENTIFICATION; IRON; METALLOTHIONEIN; SPECIFICITY; RESISTANCE; VIRULENCE; SMEGMATIS	Several independent studies have recently converged upon the conclusion that the human bacterial pathogen Mycobacterium tuberculosis encounters copper during infections. At least three independently regulated pathways respond to excess copper and are required for the full virulence of M. tuberculosis in animals. In this review, I will discuss the functions of the best-characterized copper-responsive proteins in M. tuberculosis, the potential sources of copper during an infection, and remaining questions about the interface between copper and tuberculosis.	NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	New York University	Darwin, KH (corresponding author), NYU, Sch Med, Dept Microbiol, 550 First Ave MSB 236, New York, NY 10016 USA.	heran.darwin@med.nyu.edu		Darwin, K Heran/0000-0002-5043-7548	National Institutes of Health [HL92774]; Investigators in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092774] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Investigators in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant HL92774 (to K. H. D.). This is the third article in the Thematic Minireview series "Metals at the Host-Pathogen Interface." The author declares that she has no conflicts of interest with the contents of this article.; The recipient of an Investigators in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund.	Agranoff DD, 1998, MOL MICROBIOL, V28, P403, DOI 10.1046/j.1365-2958.1998.00790.x; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; Festa RA, 2011, MOL MICROBIOL, V79, P133, DOI 10.1111/j.1365-2958.2010.07431.x; Gold B, 2008, NAT CHEM BIOL, V4, P609, DOI 10.1038/nchembio.109; Graham JE, 1999, P NATL ACAD SCI USA, V96, P11554, DOI 10.1073/pnas.96.20.11554; Hatori Y, 2013, ANTIOXID REDOX SIGN, V19, P945, DOI 10.1089/ars.2012.5086; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Huston WM, 2002, MOL MICROBIOL, V45, P1741, DOI 10.1046/j.1365-2958.2002.03132.x; Jacob C, 1998, BIOCHEM BIOPH RES CO, V248, P569, DOI 10.1006/bbrc.1998.9026; Kono S, 2013, INT REV NEUROBIOL, V110, P125, DOI 10.1016/B978-0-12-410502-7.00007-7; Kosman DJ, 2010, J BIOL INORG CHEM, V15, P15, DOI 10.1007/s00775-009-0590-9; Liu JZ, 2012, CELL HOST MICROBE, V11, P227, DOI 10.1016/j.chom.2012.01.017; Liu T, 2007, NAT CHEM BIOL, V3, P60, DOI 10.1038/nchembio844; Lutsenko S, 2008, BIOCHEM SOC T, V36, P1233, DOI 10.1042/BST0361233; Niederweis M, 1999, MOL MICROBIOL, V33, P933, DOI 10.1046/j.1365-2958.1999.01472.x; Novoa-Aponte L, 2012, BMC STRUCT BIOL, V12, DOI 10.1186/1472-6807-12-25; Robinson NJ, 2010, ANNU REV BIOCHEM, V79, P537, DOI 10.1146/annurev-biochem-030409-143539; Rowland JL, 2013, J BACTERIOL, V195, P3724, DOI 10.1128/JB.00546-13; Shi XS, 2014, MBIO, V5, DOI 10.1128/mBio.00876-13; Shi XL, 2003, J BIOL CHEM, V278, P50309, DOI 10.1074/jbc.M307019200; Speer A, 2013, ANTIMICROB AGENTS CH, V57, P1089, DOI 10.1128/AAC.01781-12; Talaat AM, 2004, P NATL ACAD SCI USA, V101, P4602, DOI 10.1073/pnas.0306023101; Tan BG, 2014, NUCLEIC ACIDS RES, V42, P1326, DOI 10.1093/nar/gkt902; Taylor AB, 2005, P NATL ACAD SCI USA, V102, P15459, DOI 10.1073/pnas.0506227102; Wagner D, 2005, J IMMUNOL, V174, P1491, DOI 10.4049/jimmunol.174.3.1491; Ward SK, 2008, J BACTERIOL, V190, P2939, DOI 10.1128/JB.01847-07; Ward SK, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00063; Ward SK, 2010, MOL MICROBIOL, V77, P1096, DOI 10.1111/j.1365-2958.2010.07273.x; WEINBERG ED, 1975, JAMA-J AM MED ASSOC, V231, P39, DOI 10.1001/jama.231.1.39; White C, 2009, J BIOL CHEM, V284, P33949, DOI 10.1074/jbc.M109.070201; Wolschendorf F, 2011, P NATL ACAD SCI USA, V108, P1621, DOI 10.1073/pnas.1009261108	31	26	26	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					18962	18966		10.1074/jbc.R115.640193	http://dx.doi.org/10.1074/jbc.R115.640193			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26055711	hybrid, Green Published			2022-12-28	WOS:000358781100010
J	Garcia-Santamarina, S; Thiele, DJ				Garcia-Santamarina, Sarela; Thiele, Dennis J.			Copper at the Fungal Pathogen-Host Axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CRYPTOCOCCUS-NEOFORMANS; CANDIDA-ALBICANS; ASPERGILLUS-FUMIGATUS; TRANSCRIPTIONAL REGULATION; SACCHAROMYCES-CEREVISIAE; SUPEROXIDE DISMUTASES; FUNCTIONAL EXPRESSION; INTRACELLULAR COPPER; HUMAN GENE; CELL-WALL	Fungal infections are responsible for millions of human deaths annually. Copper, an essential but toxic trace element, plays an important role at the host-pathogen axis during infection. In this review, we describe how the host uses either Cu compartmentalization within innate immune cells or Cu sequestration in other infected host niches such as in the brain to combat fungal infections. We explore Cu toxicity mechanisms and the Cu homeostasis machinery that fungal pathogens bring into play to succeed in establishing an infection. Finally, we address recent approaches that manipulate Cu-dependent processes at the host-pathogen axis for antifungal drug development.	[Garcia-Santamarina, Sarela; Thiele, Dennis J.] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Thiele, Dennis J.] Duke Univ, Sch Med, Dept Biochem, Durham, NC 27710 USA	Duke University; Duke University	Thiele, DJ (corresponding author), Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Box 3813, Durham, NC 27710 USA.	dennis.thiele@duke.edu	Garcia Santamarina, Sarela/O-4477-2017; Santamarina, Sarela Garcia/AAA-2261-2021	Garcia Santamarina, Sarela/0000-0002-0611-7918; Santamarina, Sarela Garcia/0000-0002-0611-7918	National Institutes of Health [GM041840, DK074192, AI106013]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI106013] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041840] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM041840, DK074192, and AI106013 (to D. J. T.). This is the first article in the Thematic Minireview series "Metals at the Host-Pathogen Interface." The authors declare that they have no conflicts of interest with the contents of this article.	Banci L, 2010, NATURE, V465, P645, DOI 10.1038/nature09018; Boekhout T., 2010, MALASSEZIA SKIN, P6; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Brown GD, 2012, SCIENCE, V336, P647, DOI 10.1126/science.1222236; Burq V., 1867, CHOLERA IMMUNITE ACQ; Butler MJ, 1998, CAN J MICROBIOL, V44, P1115, DOI 10.1139/cjm-44-12-1115; Cabrera A, 2008, BIOMETALS, V21, P525, DOI 10.1007/s10534-008-9139-6; Casey AL, 2010, J HOSP INFECT, V74, P72, DOI 10.1016/j.jhin.2009.08.018; Chaturvedi KS, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00003; Chung RS, 2008, J BIOL CHEM, V283, P15349, DOI 10.1074/jbc.M708446200; Cox GM, 2003, INFECT IMMUN, V71, P173, DOI 10.1128/IAI.71.1.173-180.2003; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; da Silva MB, 2009, MEM I OSWALDO CRUZ, V104, P644, DOI 10.1590/S0074-02762009000400019; DAMERON CT, 1991, P NATL ACAD SCI USA, V88, P6127, DOI 10.1073/pnas.88.14.6127; Dickinson EK, 2000, J BIOL CHEM, V275, P26780; Ding C, 2014, MOL MICROBIOL, V93, P10, DOI 10.1111/mmi.12653; Ding C, 2013, CELL HOST MICROBE, V13, P265, DOI 10.1016/j.chom.2013.02.002; Ding C, 2011, MOL MICROBIOL, V81, P1560, DOI 10.1111/j.1365-2958.2011.07794.x; DIXON DM, 1987, J MED VET MYCOL, V25, P97; DOLLWET HHA, 1985, TRACE ELEM MED, V2, P80; Douglas LM, 2012, MBIO, V3, DOI 10.1128/mBio.00254-11; Dupont CL, 2011, METALLOMICS, V3, P1109, DOI 10.1039/c1mt00107h; Festa RA, 2014, CHEM BIOL, V21, P977, DOI 10.1016/j.chembiol.2014.06.009; Festa RA, 2011, CURR BIOL, V21, pR877, DOI 10.1016/j.cub.2011.09.040; Foster AW, 2014, MOL MICROBIOL, V93, P317, DOI 10.1111/mmi.12661; GITLIN JD, 1988, J BIOL CHEM, V263, P6281; Gleason JE, 2014, P NATL ACAD SCI USA, V111, P5866, DOI 10.1073/pnas.1400137111; Gray KC, 2012, P NATL ACAD SCI USA, V109, P2234, DOI 10.1073/pnas.1117280109; Hodgkinson V, 2012, J BIOL CHEM, V287, P13549, DOI 10.1074/jbc.R111.316406; Homann OR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000783; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Hung IH, 1997, J BIOL CHEM, V272, P21461, DOI 10.1074/jbc.272.34.21461; Hwang CS, 2002, MICROBIOL-SGM, V148, P3705, DOI 10.1099/00221287-148-11-3705; Keller G, 2005, EUKARYOT CELL, V4, P1863, DOI 10.1128/EC.4.11.1863-1871.2005; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Klomp LWJ, 1997, J BIOL CHEM, V272, P9221, DOI 10.1074/jbc.272.14.9221; KWONCHUNG KJ, 1982, J BACTERIOL, V150, P1414, DOI 10.1128/JB.150.3.1414-1421.1982; Ladomersky E, 2015, METALLOMICS, V7, P957, DOI 10.1039/c4mt00327f; Lazary A, 2014, INT J INFECT DIS, V24, P23, DOI 10.1016/j.ijid.2014.01.022; Lin SJ, 1997, J BIOL CHEM, V272, P9215; Linder MC, 2001, MUTAT RES-FUND MOL M, V475, P141, DOI 10.1016/S0027-5107(01)00076-8; Lutsenko S, 2010, CURR OPIN CHEM BIOL, V14, P211, DOI 10.1016/j.cbpa.2010.01.003; Macomber L, 2007, J BACTERIOL, V189, P1616, DOI 10.1128/JB.01357-06; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; Manso Y, 2011, J BIOL INORG CHEM, V16, P1103, DOI 10.1007/s00775-011-0802-y; Martchenko M, 2004, MOL BIOL CELL, V15, P456, DOI 10.1091/mbc.E03-03-0179; MEHRA RK, 1992, GENE, V114, P75, DOI 10.1016/0378-1119(92)90709-X; MEHRA RK, 1989, J BIOL CHEM, V264, P19747; Millardet P. M. A., 1933, DISCOVERY BORDEAUX M; Morris-Jones R, 2003, INFECT IMMUN, V71, P4026, DOI 10.1128/IAI.71.7.4026-4033.2003; Mukherjee PK, 2011, J CHEMOTHERAPY, V23, P319, DOI 10.1179/joc.2011.23.6.319; Nevitt T, 2012, BBA-MOL CELL RES, V1823, P1580, DOI 10.1016/j.bbamcr.2012.02.011; Ngamskulrungroj P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016076; Nosanchuk JD, 2000, LANCET, V355, P2049, DOI 10.1016/S0140-6736(00)02356-4; Nosanchuk JD, 1999, MOL CELL BIOL, V19, P745; O'Brien HE, 2005, APPL ENVIRON MICROB, V71, P5544, DOI 10.1128/AEM.71.9.5544-5550.2005; Ohrvika H, 2013, P NATL ACAD SCI USA, V110, pE4279, DOI 10.1073/pnas.1311749110; Palacios O, 2014, METALLOMICS, V6, P279, DOI 10.1039/c3mt00266g; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Patel BN, 1997, J BIOL CHEM, V272, P20185, DOI 10.1074/jbc.272.32.20185; Pihet M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-177; Potrykus J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003910; Rae TD, 2001, J BIOL CHEM, V276, P5166, DOI 10.1074/jbc.M008005200; Reeder NL, 2011, ANTIMICROB AGENTS CH, V55, P5753, DOI 10.1128/AAC.00724-11; Rees EM, 2004, J BIOL CHEM, V279, P54221, DOI 10.1074/jbc.M411669200; Richardson MD, 2005, J ANTIMICROB CHEMOTH, V56, P5, DOI 10.1093/jac/dki218; Roemer T, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a019703; Salas SD, 1996, J EXP MED, V184, P377, DOI 10.1084/jem.184.2.377; Samanovic MI, 2012, CELL HOST MICROBE, V11, P106, DOI 10.1016/j.chom.2012.01.009; Stehling O, 2012, SCIENCE, V337, P195, DOI 10.1126/science.1219723; Sun TS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6550; THROWER AR, 1988, J BIOL CHEM, V263, P7037; Thywissen A, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00096; Upadhyay S, 2013, EUKARYOT CELL, V12, P1641, DOI 10.1128/EC.00217-13; Vest KE, 2013, J BIOL CHEM, V288, P23884, DOI 10.1074/jbc.M113.470674; Wagner D, 2005, J IMMUNOL, V174, P1491, DOI 10.4049/jimmunol.174.3.1491; Walton FJ, 2005, MOL MICROBIOL, V57, P1381, DOI 10.1111/j.1365-2958.2005.04779.x; WANG YL, 1995, INFECT IMMUN, V63, P3131, DOI 10.1128/IAI.63.8.3131-3136.1995; Waterman SR, 2007, INFECT IMMUN, V75, P714, DOI 10.1128/IAI.01351-06; Weissman Z, 2000, P NATL ACAD SCI USA, V97, P3520, DOI 10.1073/pnas.97.7.3520; White C, 2009, J BIOL CHEM, V284, P33949, DOI 10.1074/jbc.M109.070201; White TC, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a019802; Wolschendorf F, 2011, P NATL ACAD SCI USA, V108, P1621, DOI 10.1073/pnas.1009261108; YamaguchiIwai Y, 1997, J BIOL CHEM, V272, P17711, DOI 10.1074/jbc.272.28.17711; Youseff BH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002713; Zhou B, 1997, P NATL ACAD SCI USA, V94, P7481, DOI 10.1073/pnas.94.14.7481	86	54	55	1	19	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					18945	18953		10.1074/jbc.R115.649129	http://dx.doi.org/10.1074/jbc.R115.649129			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26055724	Green Published, hybrid			2022-12-28	WOS:000358781100008
J	Guengerich, FP				Guengerich, F. Peter			Introduction: Metals in Biology METALS AT THE HOST-PATHOGEN INTERFACE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							MINIREVIEW SERIES METALS	This seventh Metals in Biology Thematic Series deals with the metal-based interactions of mammalian hosts with pathogens. Both pathogens and hosts have complex regulatory systems for metal homeostasis. Understanding these provides strategies for fighting pathogens, either by excluding essential metals from the microbes, by delivery of excess metals to cause toxicity, or by complexing metals in microorganisms. Intervention is possible by delivery of complexing reagents or by targeting the microbial regulatory apparatus.	Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA	Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 638 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu			NCI NIH HHS [R37 CA090426] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA090426] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Darwin KH, 2015, J BIOL CHEM, V290, P18962, DOI 10.1074/jbc.R115.640193; Djoko KY, 2015, J BIOL CHEM, V290, P18954, DOI 10.1074/jbc.R115.647099; Garcia-Santamarina S, 2015, J BIOL CHEM, V290, P18945, DOI 10.1074/jbc.R115.649129; Guengerich FP, 2014, J BIOL CHEM, V289, P28094, DOI 10.1074/jbc.R114.607093; Guengerich FP, 2013, J BIOL CHEM, V288, P13164, DOI 10.1074/jbc.R113.467712; Guengerich FP, 2012, J BIOL CHEM, V287, P13508, DOI 10.1074/jbc.R112.355933; Guengerich FP, 2010, J BIOL CHEM, V285, P26727, DOI 10.1074/jbc.R110.150870; Guengerich FP, 2009, J BIOL CHEM, V284, P18557, DOI 10.1074/jbc.M109.003863; Guengerich FP, 2009, J BIOL CHEM, V284, P709, DOI 10.1074/jbc.R800060200; Koh EI, 2015, J BIOL CHEM, V290, P18967, DOI 10.1074/jbc.R115.644328; Lane RW, 2014, HAYES' PRINCIPLES AND METHODS OF TOXICOLOGY, 6TH EDITION, P3; Schmidt PJ, 2015, J BIOL CHEM, V290, P18975, DOI 10.1074/jbc.R115.650150; Tokar E. J., 2013, CASARETT DOULLS TOXI, P981; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Wareham LK, 2015, J BIOL CHEM, V290, P18999, DOI 10.1074/jbc.R115.642926; Wessling-Resnick M., 2015, J BIOL CHEM, V290, DOI [10.1074/jbc.R115.643973, DOI 10.1074/JBC.R115.643973]; Zackular JP, 2015, J BIOL CHEM, V290, P18991, DOI 10.1074/jbc.R115.645085	17	5	5	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					18943	18944		10.1074/jbc.R115.670265	http://dx.doi.org/10.1074/jbc.R115.670265			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26055725	Green Published, hybrid			2022-12-28	WOS:000358781100007
J	Hong, S; Harris, KA; Fanning, KD; Sarachan, KL; Frohlich, KM; Agris, PF				Hong, Seoyeon; Harris, Kimberly A.; Fanning, Kathryn D.; Sarachan, Kathryn L.; Frohlich, Kyla M.; Agris, Paul F.			Evidence That Antibiotics Bind to Human Mitochondrial Ribosomal RNA Has Implications for Aminoglycoside Toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECYCLING FACTOR; PROTEIN-SYNTHESIS; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; BACTERIAL RIBOSOME; 70S RIBOSOME; BASE-PAIR; GENTAMICIN; 16S; SPECTINOMYCIN	Aminoglycosides are a well known antibiotic family used to treat bacterial infections in humans and animals, but which can be toxic. By binding to the decoding site of helix44 of the small subunit RNA of the bacterial ribosome, the aminoglycoside antibiotics inhibit protein synthesis, cause misreading, or obstruct peptidyl-tRNA translocation. Although aminoglycosides bind helix69 of the bacterial large subunit RNA as well, little is known about their interaction with the homologous human helix69. To probe the role this binding event plays in toxicity, changes to thermal stability, base stacking, and conformation upon aminoglycoside binding to the human cytoplasmic helix69 were compared with those of the human mitochondrial and Escherichia coli helix69. Surprisingly, binding of gentamicin and kanamycin A to the chemically synthesized terminal hairpins of the human cytoplasmic, human mitochondrial, and E. coli helix69 revealed similar dissociation constants (1.3-1.7 and 4.0-5.4 mu M, respectively). In addition, aminoglycoside binding enhanced conformational stability of the human mitochondrial helix69 by increasing base stacking. Proton one-dimensional and two-dimensional NMR suggested significant and specific conformational changes of human mitochondrial and E. coli helix69 upon aminoglycoside binding, as compared with human cytoplasmic helix69. The conformational changes and similar aminoglycoside binding affinities observed for human mitochondrial helix69 and E. coli helix69, as well as the increase in structural stability shown for the former, suggest that this binding event is important to understanding aminoglycoside toxicity.	[Agris, Paul F.] SUNY Albany, RNA Inst, Albany, NY 12222 USA; SUNY Albany, Dept Biol Sci, Albany, NY 12222 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Agris, PF (corresponding author), SUNY Albany, RNA Inst, 1400 Washington Ave, Albany, NY 12222 USA.	pagris@albany.edu		Harris, Kimberly/0000-0003-3028-5863; Sarachan, Kathryn/0000-0003-2511-1404	National Science Foundation [MCB 1101859]; Enhancing STEM Research Experiences for State University of New York (SUNY) Undergraduates	National Science Foundation(National Science Foundation (NSF)); Enhancing STEM Research Experiences for State University of New York (SUNY) Undergraduates	This work was supported by the National Science Foundation (Grant MCB 1101859) (to P. F. A.) and the Enhancing STEM Research Experiences for State University of New York (SUNY) Undergraduates (to S. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Agrawal RK, 2004, P NATL ACAD SCI USA, V101, P8900, DOI 10.1073/pnas.0401904101; Barsanti J. A., 1990, INFECT DIS DOG CAT, P515; Becker B, 2013, ACS CHEM BIOL, V8, P105, DOI 10.1021/cb3005116; BIEHL LG, 1986, VET CLIN N AM-FOOD A, V2, P481, DOI 10.1016/S0749-0720(15)31258-5; Borovinskaya MA, 2007, NAT STRUCT MOL BIOL, V14, P727, DOI 10.1038/nsmb1271; Bottger EC, 2001, EMBO REP, V2, P318, DOI 10.1093/embo-reports/kve062; Brodersen DE, 2000, CELL, V103, P1143, DOI 10.1016/S0092-8674(00)00216-6; Brown A, 2014, SCIENCE, V346, P718, DOI 10.1126/science.1258026; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; Chen AA, 2013, P NATL ACAD SCI USA, V110, P16820, DOI 10.1073/pnas.1309392110; DAVIES J, 1968, J BIOL CHEM, V243, P3312; DAYAL VS, 1979, ANN OTO RHINOL LARYN, V88, P36, DOI 10.1177/000348947908800107; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dibrov SM, 2010, NUCLEIC ACIDS RES, V38, P4458, DOI 10.1093/nar/gkq159; Durant PC, 1999, J MOL BIOL, V285, P115, DOI 10.1006/jmbi.1998.2297; FINEGOLD SM, 1966, ANN NY ACAD SCI, V132, P942, DOI 10.1111/j.1749-6632.1966.tb43018.x; Fox TD, 2012, GENETICS, V192, P1203, DOI 10.1534/genetics.112.141267; Francis SP, 2013, J NEUROSCI, V33, P3079, DOI 10.1523/JNEUROSCI.3430-12.2013; GUTELL RR, 1994, MICROBIOL REV, V58, P10, DOI 10.1128/MMBR.58.1.10-26.1994; Hall AM, 2013, KIDNEY INT, V83, P72, DOI 10.1038/ki.2012.328; HAMDY AH, 1975, LAB ANIM SCI, V25, P570; Hermann T, 2007, BLOOD CELL MOL DIS, V38, P193, DOI 10.1016/j.bcmd.2006.11.006; Hinojosa R, 2001, LARYNGOSCOPE, V111, P1797, DOI 10.1097/00005537-200110000-00025; Hobbie SN, 2005, ANTIMICROB AGENTS CH, V49, P5112, DOI 10.1128/AAC.49.12.5112-5118.2005; Hobbie SN, 2008, P NATL ACAD SCI USA, V105, P3244, DOI 10.1073/pnas.0707265105; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Isefuku S, 2003, J ORTHOP TRAUMA, V17, P212, DOI 10.1097/00005131-200303000-00010; Jackson GL, 2003, PEDIATR NEPHROL, V18, P653, DOI 10.1007/s00467-003-1161-x; Janosi L, 1998, EMBO J, V17, P1141, DOI 10.1093/emboj/17.4.1141; JANOSI L, 1994, P NATL ACAD SCI USA, V91, P4249, DOI 10.1073/pnas.91.10.4249; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; KANE FJ, 1975, SOUTHERN MED J, V68, P1283, DOI 10.1097/00007611-197510000-00025; Kaul M, 2002, BIOCHEMISTRY-US, V41, P7695, DOI 10.1021/bi020130f; KELLEY G. W., 1960, CORNELL VET, V50, P60; KES P, 1990, MAGNESIUM TRACE ELEM, V9, P54; Korostelev A, 2006, CELL, V126, P1065, DOI 10.1016/j.cell.2006.08.032; KOTECHA B, 1994, HEARING RES, V73, P173, DOI 10.1016/0378-5955(94)90232-1; Kurata S, 2010, P NATL ACAD SCI USA, V107, P10854, DOI 10.1073/pnas.1006247107; Lancaster L, 2002, CELL, V111, P129, DOI 10.1016/S0092-8674(02)00938-8; Lynch SR, 2001, J MOL BIOL, V306, P1037, DOI 10.1006/jmbi.2000.4420; Magnet S, 2005, CHEM REV, V105, P477, DOI 10.1021/cr0301088; McDowell JA, 1996, BIOCHEMISTRY-US, V35, P14077, DOI 10.1021/bi9615710; Meroueh M, 2000, NUCLEIC ACIDS RES, V28, P2075, DOI 10.1093/nar/28.10.2075; Mingeot-Leclercq MP, 1999, ANTIMICROB AGENTS CH, V43, P1003, DOI 10.1128/AAC.43.5.1003; MOAZED D, 1987, NATURE, V327, P389, DOI 10.1038/327389a0; Mueller U, 1999, RNA, V5, P670, DOI 10.1017/S1355838299982304; Ogle JM, 2005, ANNU REV BIOCHEM, V74, P129, DOI 10.1146/annurev.biochem.74.061903.155440; PEL HJ, 1994, MOL BIOL REP, V19, P183, DOI 10.1007/BF00986960; Perez-Fernandez D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4112; Pfister P, 2003, ANTIMICROB AGENTS CH, V47, P1496, DOI 10.1128/AAC.47.5.1496-1502.2003; Poirrier AL, 2010, TOXICOL LETT, V193, P41, DOI 10.1016/j.toxlet.2009.12.003; Rodger A., 1997, CIRCULAR DICHROISM L, P25; Rolland N, 1999, P NATL ACAD SCI USA, V96, P5464, DOI 10.1073/pnas.96.10.5464; Sanchez-Perez J, 2001, CONTACT DERMATITIS, V44, P54; Scheunemann AE, 2010, NUCLEIC ACIDS RES, V38, P3094, DOI 10.1093/nar/gkp1253; Schulze S, 2003, ALLERGY, V58, P88, DOI 10.1034/j.1398-9995.2003.23710_5.x; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Shah S, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004496.pub2, DOI 10.1002/14651858.CD004496.PUB2]; SMITH CR, 1980, NEW ENGL J MED, V302, P1106, DOI 10.1056/NEJM198005153022002; Sosnick T R, 2001, Curr Protoc Nucleic Acid Chem, VChapter 11, DOI 10.1002/0471142700.nc1105s04; Sumita M, 2005, RNA, V11, P1420, DOI 10.1261/rna.2320605; Teyssier E, 2003, NUCLEIC ACIDS RES, V31, P4218, DOI 10.1093/nar/gkg449; Thomas JR, 2008, CHEM REV, V108, P1171, DOI 10.1021/cr0681546; TISCH DE, 1958, ANN NY ACAD SCI, V76, P44, DOI 10.1111/j.1749-6632.1958.tb54692.x; Walter P., 2002, MOL BIOL CELL, P819; WALTON JR, 1978, J ANTIMICROB CHEMOTH, V4, P309, DOI 10.1093/jac/4.4.309; Wang LY, 2012, NAT STRUCT MOL BIOL, V19, P957, DOI 10.1038/nsmb.2360; Wang Y, 1997, BIOCHEMISTRY-US, V36, P768, DOI 10.1021/bi962095g; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P8467, DOI 10.1073/pnas.87.21.8467; WOODCOCK J, 1991, EMBO J, V10, P3099, DOI 10.1002/j.1460-2075.1991.tb07863.x; Yarian CS, 1999, NUCLEIC ACIDS RES, V27, P3543, DOI 10.1093/nar/27.17.3543; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	72	21	21	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19273	19286		10.1074/jbc.M115.655092	http://dx.doi.org/10.1074/jbc.M115.655092			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26060252	Green Published, hybrid			2022-12-28	WOS:000358781100040
J	Deng, C; Chen, HD; Yang, N; Feng, Y; Hsueh, AJW				Deng, Cheng; Chen, Haidi; Yang, Na; Feng, Yi; Hsueh, Aaron J. W.			Apela Regulates Fluid Homeostasis by Binding to the APJ Receptor to Activate Gi Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORPHAN RECEPTOR; G-PROTEIN; CARDIOVASCULAR-RESPONSES; KNOCKOUT MICE; FOOD-INTAKE; LIGAND; APELIN-13; RATS; PEPTIDE; BRAIN	Apela ( APJ early endogenous ligand, also known as elabela or toddler) is a recently discovered peptide hormone. Based on genetic studies in zebrafish, apela was found to be important for endoderm differentiation and heart development during embryogenesis. Although common phenotypes of apela and APJ-null zebrafish during embryonic development suggested that apela interacts with the APJ receptor, kinetics of apela binding to APJ and intracellular signaling pathways for apela remain unknown. The role of apela in adults is also uncertain. Using a chimeric apela ligand, we showed direct binding of apela to APJ with high affinity (K-d = 0.51 nM) and the ability of apelin, the known peptide ligand for APJ, to compete for apela binding. Apela, similar to apelin, acts through the inhibitory G protein pathway by inhibiting forskolin-stimulated cAMP production and by inducing ERK1/2 phosphorylation. In adult rats, apela is expressed exclusively in the kidney, unlike the wide tissue distribution of apelin. In vivo studies demonstrated the ability of apela to regulate fluid homeostasis by increasing diuresis and water intake. Dose-response studies further indicated that apela induces 2- and 5-fold higher maximal responses than apelin in ERK1/2 phosphorylation and diuresis/water intake, respectively. After designing an apela antagonist, we further demonstrated the role of endogenous ligand(s) in regulating APJ-mediated fluid homeostasis. Our results identified apela as a potent peptide hormone capable of regulating fluid homeostasis in adult kidney through coupling to the APJ-mediated G(i) signaling pathway.	[Deng, Cheng; Chen, Haidi; Yang, Na] Nanjing Normal Univ, Jiangsu Key Lab Biodivers & Biotechnol, Coll Life Sci, Nanjing 210023, Jiangsu, Peoples R China; [Deng, Cheng; Feng, Yi; Hsueh, Aaron J. W.] Stanford Univ, Program Reprod & Stem Cell Biol, Dept Ob Gyn, Sch Med, Stanford, CA 94305 USA	Nanjing Normal University; Stanford University	Hsueh, AJW (corresponding author), Stanford Univ, Program Reprod & Stem Cell Biol, Dept Ob Gyn, Sch Med, Stanford, CA 94305 USA.	aaron.hsueh@stanford.edu		deng, cheng/0000-0002-5296-8879	National Natural Science Foundation of China [31401207]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); One Hundred Person Project of Nanjing Normal University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); One Hundred Person Project of Nanjing Normal University	This work was supported by the National Natural Science Foundation of China (31401207), the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), and the One Hundred Person Project of Nanjing Normal University. The authors declare that they have no conflicts of interest with the contents of this article.	Bai B, 2008, ACTA BIOCH BIOPH SIN, V40, P311, DOI 10.1111/j.1745-7270.2008.00403.x; Ben-Shlomo I, 2005, MOL ENDOCRINOL, V19, P1097, DOI 10.1210/me.2004-0451; Ben-Shlomo Izhar, 2003, Sci STKE, V2003, pRE9, DOI 10.1126/stke.2003.187.re9; Boucher J, 2005, ENDOCRINOLOGY, V146, P1764, DOI 10.1210/en.2004-1427; Cheng Zhijie, 2010, Curr Chem Genomics, V4, P84, DOI 10.2174/1875397301004010084; Chng SC, 2013, DEV CELL, V27, P672, DOI 10.1016/j.devcel.2013.11.002; FLANAGAN JG, 1990, CELL, V63, P185, DOI 10.1016/0092-8674(90)90299-T; Habata Y, 1999, BBA-MOL CELL RES, V1452, P25, DOI 10.1016/S0167-4889(99)00114-7; Hekmat AS, 2011, REGUL PEPTIDES, V172, P62, DOI 10.1016/j.regpep.2011.08.010; Horiuchi Y, 2003, J NEUROIMMUNOL, V144, P46, DOI 10.1016/j.jneuroim.2003.08.029; Hus-Citharel A, 2008, KIDNEY INT, V74, P486, DOI 10.1038/ki.2008.199; Jung BP, 1997, BIOCHEM BIOPH RES CO, V230, P69, DOI 10.1006/bbrc.1996.5828; Katugampola SD, 2001, BRIT J PHARMACOL, V132, P1255, DOI 10.1038/sj.bjp.0703939; Kuba K, 2007, CIRC RES, V101, pE32, DOI 10.1161/CIRCRESAHA.107.158659; Lee DK, 2000, J NEUROCHEM, V74, P34, DOI 10.1046/j.1471-4159.2000.0740034.x; Lee DK, 2005, ENDOCRINOLOGY, V146, P231, DOI 10.1210/en.2004-0359; Masri B, 2002, BIOCHEM BIOPH RES CO, V290, P539, DOI 10.1006/bbrc.2001.6230; Masri B, 2006, J BIOL CHEM, V281, P18317, DOI 10.1074/jbc.M600606200; McKinley MJ, 2001, JPN J PHYSIOL, V51, P281, DOI 10.2170/jjphysiol.51.281; Metpally RPR, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-106; Mitra A, 2006, PHYSIOL BEHAV, V89, P221, DOI 10.1016/j.physbeh.2006.06.006; Najafipour H, 2012, REGUL PEPTIDES, V178, P43, DOI 10.1016/j.regpep.2012.06.006; Pauli A, 2014, SCIENCE, V343, P746, DOI 10.1126/science.1248636; Reaux A, 2001, J NEUROCHEM, V77, P1085, DOI 10.1046/j.1471-4159.2001.00320.x; Reichman-Fried M, 2014, BIOESSAYS, V36, P741, DOI 10.1002/bies.201400048; Roberts EM, 2010, J NEUROENDOCRINOL, V22, P301, DOI 10.1111/j.1365-2826.2010.01968.x; Roberts EM, 2009, J ENDOCRINOL, V202, P453, DOI 10.1677/JOE-09-0134; Rowland NE, 2003, AM J PHYSIOL-REG I, V284, pR1586, DOI 10.1152/ajpregu.00730.2002; STEIN JH, 1972, J CLIN INVEST, V51, P1709, DOI 10.1172/JCI106972; Sunter D, 2003, NEUROSCI LETT, V353, P1, DOI 10.1016/S0304-3940(03)00351-3; Szokodi I, 2002, CIRC RES, V91, P434, DOI 10.1161/01.RES.0000033522.37861.69; Taheri S, 2002, BIOCHEM BIOPH RES CO, V291, P1208, DOI 10.1006/bbrc.2002.6575; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; Wang GY, 2004, ENDOCRINOLOGY, V145, P1342, DOI 10.1210/en.2003-1116; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8	35	73	77	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18261	18268		10.1074/jbc.M115.648238	http://dx.doi.org/10.1074/jbc.M115.648238			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	25995451	Green Published, hybrid			2022-12-28	WOS:000358512100001
J	De Gois, S; Slama, P; Pietrancosta, N; Erdozain, AM; Louis, F; Bouvrais-Veret, C; Daviet, L; Giros, B				De Gois, Stephanie; Slama, Patrick; Pietrancosta, Nicolas; Erdozain, Amaia M.; Louis, Franck; Bouvrais-Veret, Caroline; Daviet, Laurent; Giros, Bruno			Ctr9, a Protein in the Transcription Complex Paf1, Regulates Dopamine Transporter Activity at the Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; FUNCTIONAL INTERACTION; VESICULAR GLUTAMATE; MUTATIONAL ANALYSIS; POTASSIUM CHANNELS; TRAFFICKING; RECEPTOR; DOMAIN; INTERNALIZATION; BINDING	Dopamine (DA) is a major regulator of sensorimotor and cognitive functions. The DA transporter (DAT) is the key protein that regulates the spatial and temporal activity of DA release into the synaptic cleft via the rapid reuptake of DA into presynaptic termini. Several lines of evidence have suggested that transporter-interacting proteins may play a role in DAT function and regulation. Here, we identified the tetratricopeptide repeat domain-containing protein Ctr9 as a novel DAT binding partner using a yeast two-hybrid system. We showed that Ctr9 is expressed in dopaminergic neurons and forms a stable complex with DAT in vivo via GST pulldown and co-immunoprecipitation assays. In mammalian cells co-expressing both proteins, Ctr9 partially colocalizes with DAT at the plasma membrane. This interaction between DAT and Ctr9 results in a dramatic enhancement of DAT-mediated DA uptake due to an increased number of DAT transporters at the plasma membrane. We determined that the binding of Ctr9 to DAT requires residues YKF in the first half of the DAT C terminus. In addition, we characterized Ctr9, providing new insight into this protein. Using three-dimensional modeling, we identified three novel tetratricopeptide repeat domains in the Ctr9 sequence, and based on deletion mutation experiments, we demonstrated the role of the SH2 domain of Ctr9 in nuclear localization. Our results demonstrate that Ctr9 localization is not restricted to the nucleus, as previously described for the transcription complex Paf1. Taken together, our data provide evidence that Ctr9 modulates DAT function by regulating its trafficking.	[De Gois, Stephanie; Slama, Patrick; Erdozain, Amaia M.; Louis, Franck; Bouvrais-Veret, Caroline; Giros, Bruno] INSERM U952, F-75005 Paris, France; [De Gois, Stephanie; Slama, Patrick; Erdozain, Amaia M.; Louis, Franck; Bouvrais-Veret, Caroline; Giros, Bruno] CNRS UMR 7224, F-75005 Paris, France; [De Gois, Stephanie; Slama, Patrick; Erdozain, Amaia M.; Louis, Franck; Bouvrais-Veret, Caroline; Giros, Bruno] Univ Paris 06, Neurosci Paris Seine, F-75005 Paris, France; [De Gois, Stephanie; Giros, Bruno] McGill Univ, Dept Psychiat, Douglas Hosp Res Ctr, Verdun, PQ H4H 1R3, Canada; [Pietrancosta, Nicolas] Univ Paris 05, Sorbonne Paris Cite, F-75006 Paris, France; [Pietrancosta, Nicolas] CNRS, UMR 8601, F-75006 Paris, France; [Daviet, Laurent] Hybrigenics, F-75014 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; McGill University; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite	Giros, B (corresponding author), McGill Univ, Dept Psychiat, Douglas Hosp Res Ctr, Verdun, PQ H4H 1R3, Canada.	bruno.giros@mcgill.ca	Erdozain, Amaia M/Q-9664-2018; GIROS, Bruno/ABD-5790-2021; Erdozain, Amaia/AAD-1883-2021; pietrancosta, nicolas/AAC-2777-2019; pietrancosta, nicolas/B-5235-2019; Nicolas, PIetrancosta/P-4645-2017	GIROS, Bruno/0000-0001-5876-9822; pietrancosta, nicolas/0000-0002-9934-7818; pietrancosta, nicolas/0000-0002-9934-7818; Nicolas, PIetrancosta/0000-0002-9934-7818; Erdozain, Amaia Maite/0000-0003-0207-9122	Canadian Institutes for Health Research Operating Grant [240843]; INSERM/CNRS/Universite Pierre et Marie Curie funding; Fondation pour la Recherche Medicale; Basque Government; "Schizo'Oui" association; Canadian Institutes for Health Research	Canadian Institutes for Health Research Operating Grant(Canadian Institutes of Health Research (CIHR)); INSERM/CNRS/Universite Pierre et Marie Curie funding; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Basque Government(Basque Government); "Schizo'Oui" association; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes for Health Research Operating Grant 240843 and by INSERM/CNRS/Universite Pierre et Marie Curie funding (to B. G.). Post doctoral support was provided by grants from the Fondation pour la Recherche Medicale and the Basque Government (to A. M. E.), "Schizo'Oui" association, and the Canadian Institutes for Health Research. The authors declare that they have no conflicts of interest with the contents of this article.	An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Bessis AS, 2000, PROTEIN SCI, V9, P2200, DOI 10.1110/ps.9.11.2200; Bjerggaard C, 2004, J NEUROSCI, V24, P7024, DOI 10.1523/JNEUROSCI.1863-04.2004; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Boudanova E, 2008, MOL CELL NEUROSCI, V39, P211, DOI 10.1016/j.mcn.2008.06.011; Caraveo G, 2006, SCIENCE, V314, P122, DOI 10.1126/science.1127815; Carneiro AM, 2002, J NEUROSCI, V22, P7045; Chang MY, 2001, J NEUROCHEM, V77, P754, DOI 10.1046/j.1471-4159.2001.00284.x; Daniels GM, 1999, J BIOL CHEM, V274, P35794, DOI 10.1074/jbc.274.50.35794; De Gois S, 2005, J NEUROSCI, V25, P7121, DOI 10.1523/JNEUROSCI.5221-04.2005; Eddy SR, 2004, NAT BIOTECHNOL, V22, P1035, DOI 10.1038/nbt0804-1035; Egana LA, 2009, J NEUROSCI, V29, P4592, DOI 10.1523/JNEUROSCI.4559-08.2009; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Fon EA, 2001, MUSCLE NERVE, V24, P581, DOI 10.1002/mus.1044; Foreman PK, 1996, GENETICS, V144, P1387; Gainetdinov RR, 1999, SCIENCE, V283, P397, DOI 10.1126/science.283.5400.397; Garcia-Olivares J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059788; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; GIROS B, 1991, FEBS LETT, V295, P149, DOI 10.1016/0014-5793(91)81406-X; GIROS B, 1993, TRENDS PHARMACOL SCI, V14, P43, DOI 10.1016/0165-6147(93)90029-J; GIROS B, 1992, MOL PHARMACOL, V42, P383; Granas C, 2003, J BIOL CHEM, V278, P4990, DOI 10.1074/jbc.M205058200; Herve F, 2008, AAPS J, V10, P455, DOI 10.1208/s12248-008-9055-2; Holton KL, 2005, NAT NEUROSCI, V8, P881, DOI 10.1038/nn1478; Jaehning JA, 2010, BBA-GENE REGUL MECH, V1799, P379, DOI 10.1016/j.bbagrm.2010.01.001; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lee FJS, 2001, FASEB J, V15, P916, DOI 10.1096/fj.00-0334com; Lee FJS, 2007, EMBO J, V26, P2127, DOI 10.1038/sj.emboj.7601656; Lee KH, 2004, NEUROCHEM RES, V29, P1405, DOI 10.1023/B:NERE.0000026404.08779.43; Li L, 2003, PROTEINS, V53, P693, DOI 10.1002/prot.10460; Li LB, 2004, J BIOL CHEM, V279, P21012, DOI 10.1074/jbc.M311972200; Lichtenberg H, 1999, FEBS LETT, V457, P363, DOI 10.1016/S0014-5793(99)01068-6; Lin ZC, 2011, PROG MOL BIOL TRANSL, V98, P1, DOI 10.1016/B978-0-12-385506-0.00001-6; Loland CJ, 2002, P NATL ACAD SCI USA, V99, P1683, DOI 10.1073/pnas.032386299; Malek SN, 1996, J BIOL CHEM, V271, P6952, DOI 10.1074/jbc.271.12.6952; Malherbe P, 2003, J BIOL CHEM, V278, P8340, DOI 10.1074/jbc.M211759200; Marton HA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-4; Masson J, 1999, EUR J NEUROSCI, V11, P1349, DOI 10.1046/j.1460-9568.1999.00540.x; Melikian HE, 1999, J NEUROSCI, V19, P7699; Miranda M, 2004, J BIOL CHEM, V279, P30760, DOI 10.1074/jbc.M312774200; Mortensen OV, 2003, EUR J PHARMACOL, V479, P159, DOI 10.1016/j.ejphar.2003.08.066; Moszczynska A, 2007, J MOL NEUROSCI, V32, P217, DOI 10.1007/s12031-007-0037-0; Mueller CL, 2002, MOL CELL BIOL, V22, P1971, DOI 10.1128/MCB.22.7.1971-1980.2002; Navaroli DM, 2011, J NEUROSCI, V31, P13758, DOI 10.1523/JNEUROSCI.2649-11.2011; Nieoullon A, 2002, PROG NEUROBIOL, V67, P53, DOI 10.1016/S0301-0082(02)00011-4; Pristupa ZB, 1998, SYNAPSE, V30, P79, DOI 10.1002/(SICI)1098-2396(199809)30:1<79::AID-SYN10>3.3.CO;2-I; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Rickhag M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2568; Shibata R, 2003, J BIOL CHEM, V278, P36445, DOI 10.1074/jbc.M306142200; SIKORSKI RS, 1990, CELL, V60, P307, DOI 10.1016/0092-8674(90)90745-Z; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Torres GE, 2001, NEURON, V30, P121, DOI 10.1016/S0896-6273(01)00267-7; Torres GE, 2004, P NATL ACAD SCI USA, V101, P15650, DOI 10.1073/pnas.0308088101; Torres GE, 2003, J BIOL CHEM, V278, P2731, DOI 10.1074/jbc.M201926200; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Vinatier J, 2006, J NEUROCHEM, V97, P1111, DOI 10.1111/j.1471-4159.2006.03821.x; Youn MY, 2007, J BIOL CHEM, V282, P34727, DOI 10.1074/jbc.M705411200	59	9	9	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					17848	17862		10.1074/jbc.M115.646315	http://dx.doi.org/10.1074/jbc.M115.646315			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26048990	hybrid, Green Published			2022-12-28	WOS:000358511700021
J	Kulasekaran, G; Nossova, N; Marat, AL; Lund, I; Cremer, C; Ioannou, MS; McPherson, PS				Kulasekaran, Gopinath; Nossova, Nadya; Marat, Andrea L.; Lund, Ingrid; Cremer, Christopher; Ioannou, Maria S.; McPherson, Peter S.			Phosphorylation-dependent Regulation of Connecdenn/DENND1 Guanine Nucleotide Exchange Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENN DOMAIN; GLUT4 TRANSLOCATION; PROTEIN; RAB; KINASE; FAMILY; PATHWAYS; BINDING; GTPASES; CELLS	Connecdenn 1/2 are DENN (differentially expressed in normal and neoplastic cells) domain-bearing proteins that function as GEFs (guanine nucleotide exchange factors) for the small GTPase Rab35. Disruption of connecdenn/Rab35 function leads to defects in the recycling of multiple cargo proteins from endosomes with altered cell function, yet the regulation of connecdenn GEF activity is unexplored. We now demonstrate that connecdenn 1/2 are autoinhibited such that the purified, fulllength proteins have significantly less Rab35 binding and GEF activity than the isolated DENN domain. Both proteins are phosphorylated with prominent phosphorylation sites between residues 500 and 600 of connecdenn 1. A large scale proteomics screen revealed that connecdenn 1 is phosphorylated at residues Ser-536 and Ser-538 in an Akt-dependent manner in response to insulin stimulation of adipocytes. Interestingly, we find that an Akt inhibitor reduces connecdenn 1 interaction with Rab35 after insulin treatment of adipocytes. Remarkably, a peptide flanking Ser-536/Ser-538 binds the DENN domain of connecdenn 1, whereas a phosphomimetic peptide does not. Moreover, connecdenn 1 interacts with 14-3-3 proteins, and this interaction is also disrupted by Akt inhibition and by mutation of Ser-536/Ser-538. We propose that Akt phosphorylation of connecdenn 1 downstream of insulin activation regulates connecdenn 1 function through an intramolecular interaction.	[Kulasekaran, Gopinath; Nossova, Nadya; Marat, Andrea L.; Lund, Ingrid; Cremer, Christopher; Ioannou, Maria S.; McPherson, Peter S.] McGill Univ, Dept Neurol & Neurosurg, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada	McGill University	McPherson, PS (corresponding author), McGill Univ, Dept Neurol & Neurosurg, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada.	peter.mcpherson@mcgill.ca		Marat, Andrea/0000-0001-8571-4253	Canadian Institutes of Health [MOP15396]; Fonds de Recherche du Quebec-Sante; Jeanne Timmins-Costello fellowship from the Montreal Neurological Institute; Masters Award; Frederick Banting and Charles Best Canada Graduate Scholarship from the Canadian Institutes of Health Research; Max E. Binz Fellowship from McGill University; Jeanne Timmins-Costello Studentship from the Montreal Neurological Institute; Lloyd Carr-Harris Fellowship from McGill University	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec); Jeanne Timmins-Costello fellowship from the Montreal Neurological Institute; Masters Award; Frederick Banting and Charles Best Canada Graduate Scholarship from the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Max E. Binz Fellowship from McGill University; Jeanne Timmins-Costello Studentship from the Montreal Neurological Institute; Lloyd Carr-Harris Fellowship from McGill University	This work was supported by Canadian Institutes of Health Research Grant MOP15396 (to P. S. M.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a fellowship from le Fonds de Recherche du Quebec-Sante and a Jeanne Timmins-Costello fellowship from the Montreal Neurological Institute.; Supported by a Masters Award, Frederick Banting and Charles Best Canada Graduate Scholarship from the Canadian Institutes of Health Research, a Max E. Binz Fellowship from McGill University, and a Jeanne Timmins-Costello Studentship from the Montreal Neurological Institute.; Supported by the Lloyd Carr-Harris Fellowship from McGill University.	Allaire PD, 2006, J NEUROSCI, V26, P13202, DOI 10.1523/JNEUROSCI.4608-06.2006; Allaire PD, 2013, J CELL SCI, V126, P722, DOI 10.1242/jcs.112375; Allaire PD, 2010, MOL CELL, V37, P370, DOI 10.1016/j.molcel.2009.12.037; BRASELMANN S, 1995, EMBO J, V14, P4839, DOI 10.1002/j.1460-2075.1995.tb00165.x; Chahdi A, 2008, MOL CELL BIOL, V28, P1679, DOI 10.1128/MCB.00898-07; Chaineau M, 2013, TRAFFIC, V14, P1109, DOI 10.1111/tra.12096; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Collins BC, 2013, NAT METHODS, V10, P1246, DOI [10.1038/NMETH.2703, 10.1038/nmeth.2703]; Davey JR, 2012, TRAFFIC, V13, P1429, DOI 10.1111/j.1600-0854.2012.01397.x; Dhillon AS, 2009, CELL SIGNAL, V21, P1645, DOI 10.1016/j.cellsig.2009.07.001; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Humphrey SJ, 2013, CELL METAB, V17, P1009, DOI 10.1016/j.cmet.2013.04.010; Hussain NK, 2001, NAT CELL BIOL, V3, P927, DOI 10.1038/ncb1001-927; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Ioannou MS, 2015, J CELL BIOL, V208, P629, DOI 10.1083/jcb.201407068; Levine TP, 2013, BIOINFORMATICS, V29, P499, DOI 10.1093/bioinformatics/bts725; Levivier E, 2001, BIOCHEM BIOPH RES CO, V287, P688, DOI 10.1006/bbrc.2001.5652; Marat AL, 2011, J BIOL CHEM, V286, P13791, DOI 10.1074/jbc.R110.217067; Marat AL, 2010, J BIOL CHEM, V285, P10627, DOI 10.1074/jbc.M109.050930; Miyamoto Y, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003661; O'Toole TE, 2011, J CELL PHYSIOL, V226, P2965, DOI 10.1002/jcp.22644; Ramm G, 2006, J BIOL CHEM, V281, P29174, DOI 10.1074/jbc.M603274200; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; She QB, 2005, CANCER CELL, V8, P287, DOI 10.1016/j.ccr.2005.09.006; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Tzivion G, 1998, NATURE, V394, P88, DOI 10.1038/27938; Xu J, 2015, EMBO REP, V16, P709, DOI 10.15252/embr.201440006; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yohe ME, 2007, J BIOL CHEM, V282, P13813, DOI 10.1074/jbc.M700185200; Yoshimura S, 2010, J CELL BIOL, V191, P367, DOI 10.1083/jcb.201008051; Zhang Dapeng, 2012, Frontiers in Genetics, V3, P283, DOI 10.3389/fgene.2012.00283; Zhang LX, 1997, J BIOL CHEM, V272, P13717, DOI 10.1074/jbc.272.21.13717	32	14	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					17999	18008		10.1074/jbc.M115.636712	http://dx.doi.org/10.1074/jbc.M115.636712			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26055712	Green Published, hybrid			2022-12-28	WOS:000358511700032
J	Kunda, S; Yuan, Y; Balsara, RD; Zajicek, J; Castellino, FJ				Kunda, Shailaja; Yuan, Yue; Balsara, Rashna D.; Zajicek, Jaroslav; Castellino, Francis J.			Hydroxyproline-induced Helical Disruption in Conantokin Rl-B Affects Subunit-selective Antagonistic Activities toward Ion Channels of N-Methyl-D-aspartate Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-CARBOXYGLUTAMATE RESIDUES; NMDA RECEPTORS; MOLECULAR-STRUCTURE; NONCOMPETITIVE INHIBITION; REGIONAL EXPRESSION; BINDING PROPERTIES; CRYSTAL-STRUCTURE; CHEMICAL-SHIFT; XPLOR-NIH; IN-VITRO	Conantokins are similar to 20-amino acid peptides present in predatory marine snail venoms that function as allosteric antagonists of ion channels of the N-methyl-D-aspartate receptor (NMDAR). These peptides possess a high percentage of post-/co-translationally modified amino acids, particularly gamma-carboxyglutamate (Gla). Appropriately spaced Gla residues allow binding of functional divalent cations, which induces end-to-end alpha-helices in many conantokins. A smaller number of these peptides additionally contain 4-hydroxyproline (Hyp). Hyp should prevent adoption of the metal ion-induced full alpha-helix, with unknown functional consequences. To address this disparity, as well as the role of Hyp in conantokins, we have solved the high resolution three-dimensional solution structure of a Gla/Hyp-containing 18-residue conantokin, conRl-B, by high field NMR spectroscopy. We show that Hyp(10) disrupts only a small region of the alpha-helix of the Mn(2+.)peptide complex, which displays cation-induced alpha-helices on each terminus of the peptide. The function of conRl-B was examined by measuring its inhibition of NMDA/Gly-mediated current through NMDAR ion channels in mouse cortical neurons. The conRl-B displays high inhibitory selectivity for subclasses of NMDARs that contain the functionally important GluN2B subunit. Replacement of Hyp10 with N(8)Q results in a Mg2+-complexed end-to-end alpha-helix, accompanied by attenuation of NMDAR inhibitory activity. However, replacement of Hyp(10) with Pro(10) allowed the resulting peptide to retain its inhibitory property but diminished its GluN2B specificity. Thus, these modified amino acids, in specific peptide backbones, play critical roles in their subunit-selective inhibition of NMDAR ion channels, a finding that can be employed to design NMDAR antagonists that function at ion channels of distinct NMDAR subclasses.	[Castellino, Francis J.] Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA; Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame	Castellino, FJ (corresponding author), Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA.	fcastell@nd.edu	Yuan, Yue/S-5884-2017; Regan, Clinton/E-6250-2012	Yuan, Yue/0000-0003-1003-379X; 	National Institutes of Health [HL019982]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL019982] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL019982. The authors declare that they have no conflicts of interest with the contents of this article.	Acker TM, 2011, MOL PHARMACOL, V80, P782, DOI 10.1124/mol.111.073239; Al-Hallaq RA, 2007, J NEUROSCI, V27, P8334, DOI 10.1523/JNEUROSCI.2155-07.2007; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699; Bettini E, 2010, J PHARMACOL EXP THER, V335, P636, DOI 10.1124/jpet.110.172544; Blandl T, 1999, J PEPT RES, V53, P453, DOI 10.1034/j.1399-3011.1999.00042.x; Blandl T, 1997, BIOCHEM J, V328, P777, DOI 10.1042/bj3280777; Blandl T, 1998, FEBS LETT, V435, P257, DOI 10.1016/S0014-5793(98)01077-1; Brothwell SLC, 2008, J PHYSIOL-LONDON, V586, P739, DOI 10.1113/jphysiol.2007.144618; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Buczek O, 2005, CELL MOL LIFE SCI, V62, P3067, DOI 10.1007/s00018-005-5283-0; Case D. A., 2014, AMBER 14 VERSION 4 1; Cerutti DS, 2013, J PHYS CHEM B, V117, P2328, DOI 10.1021/jp311851r; Chandler LJ, 2001, J BIOL CHEM, V276, P2627, DOI 10.1074/jbc.M003390200; Chen ZG, 1998, J BIOL CHEM, V273, P16248, DOI 10.1074/jbc.273.26.16248; Cnudde SE, 2007, J AM CHEM SOC, V129, P1586, DOI 10.1021/ja065722q; COLPITTS TL, 1993, INT J PEPT PROT RES, V41, P567; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Dai QY, 2004, BIOCHEMISTRY-US, V43, P13225, DOI 10.1021/bi048796s; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Gill AC, 2000, EMBO J, V19, P5324, DOI 10.1093/emboj/19.20.5324; Gowd KH, 2010, J PEPT SCI, V16, P375, DOI 10.1002/psc.1249; Gowd KH, 2012, BIOCHEMISTRY-US, V51, P4685, DOI 10.1021/bi300055n; HAACK JA, 1990, J BIOL CHEM, V265, P6025; HAACK JA, 1993, NEUROSCI LETT, V163, P63, DOI 10.1016/0304-3940(93)90229-E; Hansen KB, 2014, NAT CHEM BIOL, V10, P698, DOI 10.1038/nchembio.1614; Hansen KB, 2011, J NEUROSCI, V31, P3650, DOI 10.1523/JNEUROSCI.5565-10.2011; Hardingham GE, 2002, BBA-PROTEINS PROTEOM, V1600, P148, DOI 10.1016/S1570-9639(02)00455-7; Hetman M, 2006, CURR TOP MED CHEM, V6, P787, DOI 10.2174/156802606777057553; HOLLMANN M, 1993, NEURON, V10, P943, DOI 10.1016/0896-6273(93)90209-A; Holmgren SK, 1998, NATURE, V392, P666, DOI 10.1038/33573; Huang LX, 2010, MOL CELL NEUROSCI, V45, P163, DOI 10.1016/j.mcn.2010.06.007; Kar K, 2007, BIOPOLYMERS, V87, P339, DOI 10.1002/bip.20834; Karakas E, 2014, SCIENCE, V344, P992, DOI 10.1126/science.1251915; Karakas E, 2011, NATURE, V475, P249, DOI 10.1038/nature10180; Kunda S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081405; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Levine MS, 1999, J NEUROSCI RES, V58, P515, DOI 10.1002/(SICI)1097-4547(19991115)58:4<515::AID-JNR5>3.0.CO;2-F; Logan SM, 2007, J NEUROPHYSIOL, V98, P2693, DOI 10.1152/jn.00462.2007; Lopez-Vera E, 2008, BIOCHEMISTRY-US, V47, P1741, DOI 10.1021/bi701934m; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Moddel G, 2005, BRAIN RES, V1046, P10, DOI 10.1016/j.brainres.2005.03.042; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Mullasseril P, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1085; Noda Y, 2004, EUR J PHARMACOL, V500, P121, DOI 10.1016/j.ejphar.2004.07.017; Ogden KK, 2011, TRENDS PHARMACOL SCI, V32, P726, DOI 10.1016/j.tips.2011.08.003; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; PASTOR RW, 1988, MOL PHYS, V65, P1409, DOI 10.1080/00268978800101881; Platt RJ, 2012, J BIOL CHEM, V287, P20727, DOI 10.1074/jbc.M112.350462; Prorok M, 1996, BIOCHEMISTRY-US, V35, P16528, DOI 10.1021/bi9621122; Prorok M, 1998, J BIOL CHEM, V273, P19573, DOI 10.1074/jbc.273.31.19573; Prorok M, 2001, CURR DRUG TARGETS, V2, P313, DOI 10.2174/1389450013348542; Prorok M, 2007, CURR DRUG TARGETS, V8, P633, DOI 10.2174/138945007780618481; Qi HH, 2008, NATURE, V455, P421, DOI 10.1038/nature07186; Rauner C, 2011, J BIOL CHEM, V286, P7558, DOI 10.1074/jbc.M110.182600; REID KBM, 1972, BIOCHEM J, V130, P749, DOI 10.1042/bj1300749; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shen Y, 2010, J BIOMOL NMR, V46, P199, DOI 10.1007/s10858-009-9395-y; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Teichert RW, 2007, J BIOL CHEM, V282, P36905, DOI 10.1074/jbc.M706611200; Tichelaar W, 2004, J MOL BIOL, V344, P435, DOI 10.1016/j.jmb.2004.09.048; Tovar KR, 2013, J NEUROSCI, V33, P9150, DOI 10.1523/JNEUROSCI.0829-13.2013; Tovar KR, 2012, J NEUROSCI, V32, P8065, DOI 10.1523/JNEUROSCI.0538-12.2012; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Warder SE, 1998, J BIOL CHEM, V273, P7512, DOI 10.1074/jbc.273.13.7512; Warder SE, 1997, FEBS LETT, V411, P19, DOI 10.1016/S0014-5793(97)00573-5; Wei JJ, 2006, NEUROSCI LETT, V405, P137, DOI 10.1016/j.neulet.2006.06.040; Wenzel A, 1996, J NEUROCHEM, V66, P1240; White HS, 2000, J PHARMACOL EXP THER, V292, P425; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Xiao C, 2008, NEUROPEPTIDES, V42, P601, DOI 10.1016/j.npep.2008.09.003; Yoshii A, 2007, NAT NEUROSCI, V10, P702, DOI 10.1038/nn1903; Zhou X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.82; Zhu D, 2002, AMINO ACIDS, V23, P11, DOI 10.1007/s00726-001-0103-9	79	6	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					18156	18172		10.1074/jbc.M115.650341	http://dx.doi.org/10.1074/jbc.M115.650341			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26048991	Green Published, hybrid			2022-12-28	WOS:000358511700046
J	Meyers, NL; Larsson, M; Olivecrona, G; Small, DM				Meyers, Nathan L.; Larsson, Mikael; Olivecrona, Gunilla; Small, Donald M.			A Pressure-dependent Model for the Regulation of Lipoprotein Lipase by Apolipoprotein C-II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; SITE-DIRECTED MUTAGENESIS; AMPHIPATHIC ALPHA-HELIX; SODIUM DODECYL-SULFATE; ESTER TRANSFER PROTEIN; RECOMBINANT WILD-TYPE; EXCHANGEABLE APOLIPOPROTEINS; PLASMA APOLIPOPROTEINS; LIPID-BINDING; A-I	Apolipoprotein C-II (apoC-II) is the co-factor for lipoprotein lipase (LPL) at the surface of triacylglycerol-rich lipoproteins. LPL hydrolyzes triacylglycerol, which increases local surface pressure as surface area decreases and amphipathic products transiently accumulate at the lipoprotein surface. To understand how apoC-II adapts to these pressure changes, we characterized the behavior of apoC-II at multiple lipid/water interfaces. ApoC-II adsorption to a triacylglycerol/water interface resulted in large increases in surface pressure. ApoC-II was exchangeable at this interface and desorbed on interfacial compressions. These compressions increase surface pressure and mimic the action of LPL. Analysis of gradual compressions showed that apoC-II undergoes a two-step desorption, which indicates that lipid-bound apoC-II can exhibit at least two conformations. We characterized apoC-II at phospholipid/triacylglycerol/water interfaces, which more closely mimic lipoprotein surfaces. ApoC-II had a large exclusion pressure, similar to that of apoC-I and apoC-III. However, apoC-II desorbed at retention pressures higher than those seen with the other apoCs. This suggests that it is unlikely that apoC-I and apoC-III inhibit LPL via displacement of apoC-II from the lipoprotein surface. Upon rapid compressions and re-expansions, re-adsorption of apoC-II increased pressure by lower amounts than its initial adsorption. This indicates that apoC-II removed phospholipid from the interface upon desorption. These results suggest that apoC-II regulates the activity of LPL in a pressure-dependent manner. ApoC-II is provided as a component of triacylglycerol-rich lipoproteins and is the co-factor for LPL as pressure increases. Above its retention pressure, apoC-II desorbs and removes phospholipid. This triggers release of LPL from lipoproteins.	[Meyers, Nathan L.; Small, Donald M.] Boston Univ, Dept Physiol & Biophys, Sch Med, Boston, MA 02118 USA; [Larsson, Mikael; Olivecrona, Gunilla] Umea Univ, Dept Med Biosci Physiol Chem, SE-90187 Umea, Sweden; [Larsson, Mikael] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA	Boston University; Umea University; University of California System; University of California Los Angeles	Small, DM (corresponding author), Boston Univ, Dept Physiol & Biophys, Sch Med, 700 Albany St W302, Boston, MA 02118 USA.	dmsmall@bu.edu	Olivecrona, Gunilla/D-2127-2018	Olivecrona, Gunilla/0000-0002-8876-6048	American Heart Association [12PRE12060584]; Swedish Science Council [12203]	American Heart Association(American Heart Association); Swedish Science Council	This work was supported by American Heart Association Grant 12PRE12060584 and Swedish Science Council Grant 12203. The authors declare that they have no conflicts of interest with the contents of this article.	Amar MJA, 2015, J PHARMACOL EXP THER, V352, P227, DOI 10.1124/jpet.114.220418; Andersson Y, 1997, J LIPID RES, V38, P2111; BENGTSSON G, 1980, EUR J BIOCHEM, V106, P549, DOI 10.1111/j.1432-1033.1980.tb04602.x; Benjamins J, 1996, COLLOID SURFACE A, V114, P245, DOI 10.1016/0927-7757(96)03533-9; BERGMAN EN, 1971, J CLIN INVEST, V50, P1831, DOI 10.1172/JCI106674; Bolanos-Garcia VM, 2008, BIOPHYS J, V94, P1735, DOI 10.1529/biophysj.107.115220; Brahm AJ, 2015, NAT REV ENDOCRINOL, V11, P352, DOI 10.1038/nrendo.2015.26; BROWN WV, 1972, BIOCHEM BIOPH RES CO, V46, P375; CISTOLA DP, 1986, BIOCHEMISTRY-US, V25, P2804, DOI 10.1021/bi00358a011; CISTOLA DP, 1988, BIOCHEMISTRY-US, V27, P1881, DOI 10.1021/bi00406a013; CLARKE AR, 1985, BIOCHIM BIOPHYS ACTA, V827, P358, DOI 10.1016/0167-4838(85)90220-1; Cohen DE, 2013, SEMIN LIVER DIS, V33, P380, DOI 10.1055/s-0033-1358519; Cohn JS, 2004, J CLIN ENDOCR METAB, V89, P3949, DOI 10.1210/jc.2003-032056; ECKEL RH, 1989, NEW ENGL J MED, V320, P1060; EKMAN R, 1975, CLIN CHIM ACTA, V63, P29, DOI 10.1016/0009-8981(75)90374-5; Gangabadage CS, 2008, J BIOL CHEM, V283, P17416, DOI 10.1074/jbc.M800756200; Hatters DM, 2002, EUR BIOPHYS J BIOPHY, V31, P2, DOI 10.1007/s002490100172; Hatters DM, 2000, BIOCHEMISTRY-US, V39, P8276, DOI 10.1021/bi000002w; HAVEL RJ, 1973, BIOCHEMISTRY-US, V12, P1828, DOI 10.1021/bi00733a026; HAVEL RJ, 1973, J CLIN INVEST, V52, P32, DOI 10.1172/JCI107171; HUFF MW, 1988, ARTERIOSCLEROSIS, V8, P471, DOI 10.1161/01.ATV.8.5.471; JACKSON RL, 1986, BIOCHIM BIOPHYS ACTA, V875, P211, DOI 10.1016/0005-2760(86)90170-0; JACKSON RL, 1979, BIOCHIM BIOPHYS ACTA, V556, P369, DOI 10.1016/0005-2736(79)90126-3; Jong MC, 1999, ARTERIOSCL THROM VAS, V19, P472, DOI 10.1161/01.ATV.19.3.472; Kei AA, 2012, METABOLISM, V61, P906, DOI 10.1016/j.metabol.2011.12.002; KINNUNEN PKJ, 1977, P NATL ACAD SCI USA, V74, P4848, DOI 10.1073/pnas.74.11.4848; KREBS KE, 1983, BIOCHIM BIOPHYS ACTA, V751, P470, DOI 10.1016/0005-2760(83)90308-9; Labourdenne S, 1997, METHOD ENZYMOL, V286, P306; LAROSA JC, 1970, BIOCHEM BIOPH RES CO, V41, P57, DOI 10.1016/0006-291X(70)90468-7; Larsson M, 2013, J BIOL CHEM, V288, P33997, DOI 10.1074/jbc.M113.495366; LEE AG, 1987, NATURE, V328, P486, DOI 10.1038/328486b0; Liu HQ, 2000, BIOCHEMISTRY-US, V39, P9201, DOI 10.1021/bi0009441; MacPhee CE, 1999, ANAL BIOCHEM, V275, P22, DOI 10.1006/abio.1999.4283; MacRaild CA, 2004, BIOCHEMISTRY-US, V43, P8084, DOI 10.1021/bi049817l; MacRaild CA, 2001, BIOCHEMISTRY-US, V40, P5414, DOI 10.1021/bi002821m; MCKEONE BJ, 1988, BIOCHEMISTRY-US, V27, P4500, DOI 10.1021/bi00412a042; MCLEAN LR, 1985, BIOCHEMISTRY-US, V24, P4196, DOI 10.1021/bi00336a057; Meyers NL, 2013, J LIPID RES, V54, P1927, DOI 10.1194/jlr.M037531; Meyers NL, 2012, BIOCHEMISTRY-US, V51, P1238, DOI 10.1021/bi2015212; MILLER KW, 1983, J BIOL CHEM, V258, P3772; Mitsche MA, 2014, J BIOL CHEM, V289, P9000, DOI 10.1074/jbc.M113.540955; Mitsche MA, 2013, J LIPID RES, V54, P1578, DOI 10.1194/jlr.M034462; Mitsche MA, 2011, BIOPHYS J, V101, P353, DOI 10.1016/j.bpj.2011.03.055; Mitsche MA, 2010, J PHYS CHEM B, V114, P3276, DOI 10.1021/jp908730t; Mitsche MA, 2009, LANGMUIR, V25, P2322, DOI 10.1021/la802663g; Murdoch SJ, 1996, BBA-LIPID LIPID MET, V1303, P222, DOI 10.1016/0005-2760(96)00105-1; Olivecrona G, 1997, ARTERIOSCL THROM VAS, V17, P1545, DOI 10.1161/01.ATV.17.8.1545; Ooi EMM, 2008, CLIN SCI, V114, P611, DOI 10.1042/CS20070308; SEGREST JP, 1990, PROTEINS, V8, P103, DOI 10.1002/prot.340080202; SEGREST JP, 1994, ADV PROTEIN CHEM, V45, P303; SEGREST JP, 1992, J LIPID RES, V33, P141; SEHAYEK E, 1991, J BIOL CHEM, V266, P18259; Shen Y, 2002, J BIOL CHEM, V277, P4334, DOI 10.1074/jbc.M105421200; Shen Y, 2010, J BIOL CHEM, V285, P7484, DOI 10.1074/jbc.M109.022046; Small DM, 2009, J LIPID RES, V50, pS329, DOI 10.1194/jlr.R800083-JLR200; Sparrow J T, 1980, Ann N Y Acad Sci, V348, P187, DOI 10.1111/j.1749-6632.1980.tb21300.x; Storjohann R, 2000, BBA-MOL CELL BIOL L, V1486, P253, DOI 10.1016/S1388-1981(00)00062-7; Sundaram M, 2010, J LIPID RES, V51, P150, DOI [10.1194/jlr.M900346-JLR200, 10.1194/M900346-JLR200]; VAINIO P, 1983, BIOCHEMISTRY-US, V22, P2270, DOI 10.1021/bi00278a033; VAINIO P, 1983, J BIOL CHEM, V258, P5477; WANG CS, 1985, J CLIN INVEST, V75, P384, DOI 10.1172/JCI111711; WANG CS, 1981, CLIN CHEM, V27, P663; WANG CS, 1991, PROG LIPID RES, V30, P253, DOI 10.1016/0163-7827(91)90022-W; Wang L, 2005, J BIOL CHEM, V280, P4154, DOI 10.1074/bc.M411618200; Wang L, 2007, BIOCHEMISTRY-US, V46, P12140, DOI 10.1021/bi7010114; Wang LB, 2014, J LIPID RES, V55, P478, DOI 10.1194/jlr.M044743; Weers PMM, 2003, BIOPHYS CHEM, V100, P481, DOI 10.1016/S0301-4622(02)00300-9; Weinberg RB, 2002, J BIOL CHEM, V277, P21549, DOI 10.1074/jbc.M202197200; Zdunek J, 2003, BIOCHEMISTRY-US, V42, P1872, DOI 10.1021/bi0267184	69	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					18029	18044		10.1074/jbc.M114.629865	http://dx.doi.org/10.1074/jbc.M114.629865			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26026161	Green Published, hybrid			2022-12-28	WOS:000358511700035
J	Arao, Y; Coons, LA; Zuercher, WJ; Korach, KS				Arao, Yukitomo; Coons, Laurel A.; Zuercher, William J.; Korach, Kenneth S.			Transactivation Function-2 of Estrogen Receptor alpha Contains Transactivation Function-1-regulating Element	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING DOMAIN; ASPARTATE 351; TAMOXIFEN; ACTIVATION; ANTAGONIST; PROMOTER; IDENTIFICATION; ANTIESTROGENS; RALOXIFENE; AGONIST	ER alpha has a ligand-dependent transactivation function in the ligand binding domain of ER alpha C terminus (AF-2) and a ligand-independent activation function in the N terminus (AF-1). It is still not fully understood how AF-1 and AF-2 activities are regulated cooperatively by ligands. To evaluate the AF-1 involvement in the estrogenic activities of various compounds, we analyzed these transactivation functions using AF-1-truncated and AF-2-mutated ER alpha mutants. AF-2 is composed of two domains with flexible and static regions. We used an AF-2 flexible region mutant and an AF-2 static region mutant. Both mutants have been reported as non-E2 responsive due to disruption of E2-mediated coactivator recruitment to the AF-2. The AF-2 mutants were not activated by agonists, but surprisingly antagonists and selective estrogen receptor modulators (SERMs) activated the AF-2 mutants. This antagonist reversal activity was derived from AF-1. Furthermore, we demonstrated that the AF-2 contains an AF-1 suppression function using C-terminal-truncated ER alpha mutants. From these findings we hypothesized that the mutation of AF-2 disrupted its ability to suppress AF-1, causing the antagonist reversal. To assess the AF-2-mediated AF-1 suppression, we analyzed the transcription activity of physically separated AF-1 and AF-2 using a novel hybrid reporter assay. We observed that the AF-1 activity was not suppressed by the physically separated AF-2. Furthermore, SERMs did not induce the AF-1-mediated activity from the separated mutant AF-2, which differed from the intact protein. These results imply that SERM activity is dependent on a conformational change of the full-length ER alpha molecule, which allows for AF-1 activation.	[Arao, Yukitomo; Coons, Laurel A.; Korach, Kenneth S.] NIEHS, Receptor Biol Sect, Reprod & Dev Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Coons, Laurel A.] Duke Univ, Dept Pharmacol & Canc Biol, Med Ctr, Durham, NC 27710 USA; [Zuercher, William J.] GlaxoSmithKline, Dept Biol Chem, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Duke University; GlaxoSmithKline	Korach, KS (corresponding author), 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	korach@niehs.nih.gov	Arao, Yukitomo/AAL-1665-2021	Arao, Yukitomo/0000-0003-1560-351X; Korach, Kenneth/0000-0002-7765-418X; Coons, Laurel/0000-0001-7132-2996	National Institutes of Health (Division of Intramural Research of the NIEHS) [Z01ES70065]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES070065] Funding Source: NIH RePORTER	National Institutes of Health (Division of Intramural Research of the NIEHS); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant Z01ES70065 (Division of Intramural Research of the NIEHS; to K. S. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Anghel SI, 2000, J BIOL CHEM, V275, P20867, DOI 10.1074/jbc.M002098200; Arao Y, 2013, J BIOL CHEM, V288, P21105, DOI 10.1074/jbc.M113.463455; Arao Y, 2012, P NATL ACAD SCI USA, V109, P21140, DOI 10.1073/pnas.1216189110; Arao Y, 2011, P NATL ACAD SCI USA, V108, P14986, DOI 10.1073/pnas.1109180108; Benecke A, 2000, EMBO REP, V1, P151, DOI 10.1093/embo-reports/kvd028; BERRY M, 1990, EMBO J, V9, P2811, DOI 10.1002/j.1460-2075.1990.tb07469.x; Blair RM, 2000, TOXICOL SCI, V54, P138, DOI 10.1093/toxsci/54.1.138; Bourguet W, 2000, TRENDS PHARMACOL SCI, V21, P381, DOI 10.1016/S0165-6147(00)01548-0; Carascossa S, 2010, GENE DEV, V24, P708, DOI 10.1101/gad.568410; Coldham NG, 1997, ENVIRON HEALTH PERSP, V105, P734, DOI 10.1289/ehp.97105734; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; Dayan G, 2006, MOL PHARMACOL, V70, P579, DOI 10.1124/mol.105.021931; Jordan VC, 2003, NAT REV DRUG DISCOV, V2, P205, DOI 10.1038/nrd1031; Jordan VC, 1999, ENDOCR REV, V20, P253, DOI 10.1210/edrv.20.3.0368; Lannigan DA, 2003, STEROIDS, V68, P1, DOI 10.1016/S0039-128X(02)00110-1; Liu H, 2001, CANCER RES, V61, P3632; Mak HY, 1999, MOL CELL BIOL, V19, P3895; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; MCDONNELL DP, 1995, MOL ENDOCRINOL, V9, P659, DOI 10.1210/me.9.6.659; Metivier R, 2002, MOL CELL, V10, P1019, DOI 10.1016/S1097-2765(02)00746-3; Nettles KW, 2005, ANNU REV PHYSIOL, V67, P309, DOI 10.1146/annurev.physiol.66.032802.154710; Norris JD, 1996, MOL ENDOCRINOL, V10, P1605, DOI 10.1210/mend.10.12.8961270; Pike ACW, 1999, EMBO J, V18, P4608, DOI 10.1093/emboj/18.17.4608; Waller CL, 1996, CHEM RES TOXICOL, V9, P1240, DOI 10.1021/tx960054f; Wu YL, 2005, MOL CELL, V18, P413, DOI 10.1016/j.molcel.2005.04.014; Yoon K, 2001, J STEROID BIOCHEM, V78, P25, DOI 10.1016/S0960-0760(01)00070-X; Yoon K, 2000, MOL CELL ENDOCRINOL, V162, P211, DOI 10.1016/S0303-7207(99)00261-0; Zwart W, 2007, EMBO J, V26, P3534, DOI 10.1038/sj.emboj.7601791	28	15	15	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17611	17627		10.1074/jbc.M115.638650	http://dx.doi.org/10.1074/jbc.M115.638650			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26028650	hybrid, Green Published			2022-12-28	WOS:000357730900051
J	Romani, B; Baygloo, NS; Aghasadeghi, MR; Allahbakhshi, E				Romani, Bizhan; Baygloo, Nima Shaykh; Aghasadeghi, Mohammad Reza; Allahbakhshi, Elham			HIV-1 Vpr Protein Enhances Proteasomal Degradation of MCM10 DNA Replication Factor through the Cul4-DDB1[VprBP] E3 Ubiquitin Ligase to Induce G(2)/M Cell Cycle Arrest	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; INHIBITS TELOMERASE; POLYMERASE-ALPHA; COMPLEX; INFECTION; ORIGINS; SAMHD1; ICP0; ADAPTER; MCM2-7	Human immunodeficiency virus type 1 Vpr is an accessory protein that induces G(2)/M cell cycle arrest. It is well documented that interaction of Vpr with the Cul4-DDB1[VprBP] E3 ubiquitin ligase is essential for the induction of G(2)/M arrest. In this study, we show that HIV-1 Vpr indirectly binds MCM10, a eukaryotic DNA replication factor, in a Vpr-binding protein (VprBP) (VprBP)-dependent manner. Binding of Vpr to MCM10 enhanced ubiquitination and proteasomal degradation of MCM10. G(2)/M-defective mutants of Vpr were not able to deplete MCM10, and we show that Vpr-induced depletion of MCM10 is related to the ability of Vpr to induce G(2)/M arrest. Our study demonstrates that MCM10 is the natural substrate of the Cul4-DDB1[VprBP] E3 ubiquitin ligase whose degradation is regulated by VprBP, but Vpr enhances the proteasomal degradation of MCM10 by interacting with VprBP.	[Romani, Bizhan; Baygloo, Nima Shaykh] Univ Isfahan, Fac Sci, Dept Biol, Esfahan 8174673441, Iran; [Romani, Bizhan; Allahbakhshi, Elham] AJUMS, Fac Med, CMRC, Ahvaz 6135715794, Iran; [Aghasadeghi, Mohammad Reza] Pasteur Inst Iran, Hepatitis & AIDS Dept, Tehran 1316943551, Iran	University of Isfahan; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran	Allahbakhshi, E (corresponding author), AJUMS, Fac Med, CMRC, Ahvaz 6135715794, Iran.	abakhshi_e@ajums.ac.ir	aghasadeghi, mohammad reza/K-9497-2017	aghasadeghi, mohammad reza/0000-0003-2186-0774				Banks L, 2003, TRENDS BIOCHEM SCI, V28, P452, DOI 10.1016/S0968-0004(03)00141-5; Belzile JP, 2007, PLOS PATHOG, V3, P882, DOI 10.1371/journal.ppat.0030085; Homesley L, 2000, GENE DEV, V14, P913; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Isaacson MK, 2009, CELL HOST MICROBE, V5, P559, DOI 10.1016/j.chom.2009.05.012; Jung HY, 2013, J BIOL CHEM, V288, P7252, DOI 10.1074/jbc.M112.416792; Kaur M, 2012, NUCLEIC ACIDS RES, V40, P7332, DOI 10.1093/nar/gks366; Klockow LC, 2013, VIROLOGY, V444, P191, DOI 10.1016/j.virol.2013.06.010; Laguette N, 2014, CELL, V156, P134, DOI 10.1016/j.cell.2013.12.011; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Lomonte P, 2001, J BIOL CHEM, V276, P5829, DOI 10.1074/jbc.M008547200; Lomonte P, 2007, FEBS LETT, V581, P658, DOI 10.1016/j.febslet.2007.01.027; Merchant AM, 1997, MOL CELL BIOL, V17, P3261, DOI 10.1128/MCB.17.6.3261; Precious B, 2005, J VIROL, V79, P13434, DOI 10.1128/JVI.79.21.13434-13441.2005; Ricke RM, 2004, MOL CELL, V16, P173, DOI 10.1016/j.molcel.2004.09.017; Ricke RM, 2006, J BIOL CHEM, V281, P18414, DOI 10.1074/jbc.M513551200; Romani B, 2009, ARCH VIROL, V154, P1579, DOI 10.1007/s00705-009-0481-y; Smith MC, 2011, FUTURE VIROL, V6, P421, DOI 10.2217/FVL.11.24; Wang X, 2013, J BIOL CHEM, V288, P15474, DOI 10.1074/jbc.M112.416735; Wen XY, 2007, J BIOL CHEM, V282, P27046, DOI 10.1074/jbc.M703955200; Wen XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030939; Wohlschlegel JA, 2002, MOL CELL, V9, P233, DOI 10.1016/S1097-2765(02)00456-2; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zimmerman ES, 2004, MOL CELL BIOL, V24, P9286, DOI 10.1128/MCB.24.21.9286-9294.2004	26	37	40	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17380	17389		10.1074/jbc.M115.641522	http://dx.doi.org/10.1074/jbc.M115.641522			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26032416	Green Published, hybrid			2022-12-28	WOS:000357730900032
J	Jegouzo, SAF; Feinberg, H; Dungarwalla, T; Drickamer, K; Weis, WI; Taylor, ME				Jegouzo, Sabine A. F.; Feinberg, Hadar; Dungarwalla, Tabassum; Drickamer, Kurt; Weis, William I.; Taylor, Maureen E.			A Novel Mechanism for Binding of Galactose-terminated Glycans by the C-type Carbohydrate Recognition Domain in Blood Dendritic Cell Antigen 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL-BASIS; LIGAND-BINDING; LECTIN; RECEPTORS; BDCA-2; EXPRESSION; PROTEIN	Blood dendritic cell antigen 2 (BDCA-2; also designated CLEC4C or CD303) is uniquely expressed on plasmacytoid dendritic cells. Stimulation of BDCA-2 with antibodies leads to an anti-inflammatory response in these cells, but the natural ligands for the receptor are not known. The C-type carbohydrate recognition domain in the extracellular portion of BDCA-2 contains a signature motif typical of C-type animal lectins that bind mannose, glucose, or GlcNAc, yet it has been reported that BDCA-2 binds selectively to galactose-terminated, biantennary N-linked glycans. A combination of glycan array analysis and binding competition studies with monosaccharides and natural and synthetic oligosaccharides have been used to define the binding epitope for BDCA-2 as the trisaccharide Gal beta 1-3/4GlcNAc beta 1-2Man. X-ray crystallography and mutagenesis studies show that mannose is ligated to the conserved Ca2+ in the primary binding site that is characteristic of C-type carbohydrate recognition domains, and the GlcNAc and galactose residues make additional interactions in a wide, shallow groove adjacent to the primary binding site. As predicted from these studies, BDCA-2 binds to IgG, which bears galactose-terminated glycans that are not commonly found attached to other serum glycoproteins. Thus, BDCA-2 has the potential to serve as a previously unrecognized immunoglobulin Fc receptor.	[Feinberg, Hadar; Weis, William I.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Feinberg, Hadar; Weis, William I.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Jegouzo, Sabine A. F.; Dungarwalla, Tabassum; Drickamer, Kurt; Taylor, Maureen E.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England	Stanford University; Stanford University; Imperial College London	Taylor, ME (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Sir Ernst Chain Bldg, London SW7 2AZ, England.	maureen.taylor@imperial.ac.uk	Weis, William I/G-1437-2011	Weis, William I/0000-0002-5583-6150; Taylor, Maureen/0000-0001-8300-4987; Jegouzo, Sabine/0000-0001-7768-0102	 [NIGMS GM62116];  [GM98791]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116, P41GM103393, R24GM098791] Funding Source: NIH RePORTER	; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Nicola Stambach for providing the initial cDNA clone of BDCA-2, Paul Hitchen for performing mass spectrometry, and the Consortium for Functional Glycomics (funded by Grants NIGMS GM62116 and GM98791) for production of the mammalian glycan microarray by the Glycan Array Synthesis Core of the Scripps Research Institute, La Jolla, CA) and for analysis of samples on the array by David Smith and Jamie Heimburg-Molinaro in the Protein-Glycan Interaction Core of Emory University School of Medicine (Atlanta, GA).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Cao W., 2007, PLOS BIOL, V5, pe248; Chan VSF, 2012, AUTOIMMUN REV, V11, P890, DOI 10.1016/j.autrev.2012.03.004; Cormack B., 2001, CURR PROTOC NEUROSCI, V4, P11, DOI DOI 10.1002/0471142727.MB0805S37; DRICKAMER K, 1992, NATURE, V360, P183, DOI 10.1038/360183a0; Dzionek A, 2000, J IMMUNOL, V165, P6037, DOI 10.4049/jimmunol.165.11.6037; Dzionek A, 2001, J EXP MED, V194, P1823, DOI 10.1084/jem.194.12.1823; EISENBERG SP, 1990, NATURE, V343, P341, DOI 10.1038/343341a0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Feinberg H, 2000, J BIOL CHEM, V275, P21539, DOI 10.1074/jbc.M002366200; Feinberg H, 2000, J BIOL CHEM, V275, P35176, DOI 10.1074/jbc.M005557200; Feinberg H, 2007, J BIOL CHEM, V282, P17250, DOI 10.1074/jbc.M701624200; Feinberg H, 2013, J BIOL CHEM, V288, P28457, DOI 10.1074/jbc.M113.497149; FORNSTEDT N, 1975, FEBS LETT, V57, P187, DOI 10.1016/0014-5793(75)80713-7; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; Jahn PS, 2010, CELL IMMUNOL, V265, P15, DOI 10.1016/j.cellimm.2010.06.005; Jegouzo SAF, 2014, GLYCOBIOLOGY, V24, P1291, DOI 10.1093/glycob/cwu072; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kolatkar AR, 1996, J BIOL CHEM, V271, P6679, DOI 10.1074/jbc.271.12.6679; Lee RT, 2011, GLYCOBIOLOGY, V21, P512, DOI 10.1093/glycob/cwq193; LEE RT, 1991, J BIOL CHEM, V266, P4810; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mizuno H, 1997, NAT STRUCT BIOL, V4, P438, DOI 10.1038/nsb0697-438; Nagae M, 2014, PROTEINS, V82, P1512, DOI 10.1002/prot.24504; Nagae M, 2013, J BIOL CHEM, V288, P33598, DOI 10.1074/jbc.M113.513572; Ng KKS, 2002, J BIOL CHEM, V277, P16088, DOI 10.1074/jbc.M200493200; Plato A, 2013, INT REV IMMUNOL, V32, P134, DOI 10.3109/08830185.2013.777065; Raghavan M, 1996, ANNU REV CELL DEV BI, V12, P181, DOI 10.1146/annurev.cellbio.12.1.181; Reizis B, 2011, ANNU REV IMMUNOL, V29, P163, DOI 10.1146/annurev-immunol-031210-101345; Riboldi E, 2011, J BIOL CHEM, V286, P35329, DOI 10.1074/jbc.C111.290494; Rock J, 2007, EUR J IMMUNOL, V37, P3564, DOI 10.1002/eji.200737711; SCHATZ PJ, 1993, BIO-TECHNOL, V11, P1138, DOI 10.1038/nbt1093-1138; Schraml BU, 2015, CURR OPIN IMMUNOL, V32, P13, DOI 10.1016/j.coi.2014.11.001; Suzuki N, 2004, P NATL ACAD SCI USA, V101, P9023, DOI 10.1073/pnas.0402822101; Varki A., 2001, CURR PROT MOL BIOL, V17, P2021; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; Zou Y, 2012, J CARBOHYD CHEM, V31, P436, DOI 10.1080/07328303.2012.666689	40	24	24	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16759	16771		10.1074/jbc.M115.660613	http://dx.doi.org/10.1074/jbc.M115.660613			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25995448	Green Published, hybrid			2022-12-28	WOS:000357572800023
J	Lhuillier, C; Barjon, C; Niki, T; Gelin, A; Praz, F; Morales, O; Souquere, S; Hirashima, M; Wei, M; Dellis, O; Busson, P				Lhuillier, Claire; Barjon, Clement; Niki, Toshiro; Gelin, Aurore; Praz, Francoise; Morales, Olivier; Souquere, Sylvie; Hirashima, Mitsuomi; Wei, Ming; Dellis, Olivier; Busson, Pierre			Impact of Exogenous Galectin-9 on Human T Cells CONTRIBUTION OF THE T CELL RECEPTOR COMPLEX TO ANTIGEN-INDEPENDENT ACTIVATION BUT NOT TO APOPTOSIS INDUCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING PATHWAY; GLYCAN-BINDING; TIM-3; APOPTOSIS; DEATH; INFLAMMATION; AUTOIMMUNITY; INVOLVEMENT; SUPPRESSES; RESISTANCE	Galectin-9 (gal-9) is a multifunctional beta-galactoside-binding lectin, frequently released in the extracellular medium, where it acts as a pleiotropic immune modulator. Despite its overall immunosuppressive effects, a recent study has reported bimodal action of gal-9 on human resting blood T cells with apoptosis occurring in the majority of them, followed by a wave of activation and expansion of Th1 cells in the surviving population. Our knowledge of the signaling events triggered by exogenous gal-9 in T cells remains limited. One of these events is cytosolic calcium (Ca2+) release reported in some murine and human T cells. The aim of this study was to investigate the contribution of Ca2+ mobilization to apoptotic and nonapoptotic effects of exogenous gal-9 in human T cells. We found that the T cell receptor (TCR)-CD3 complex and the Lck kinase were required for Ca2+ mobilization but not for apoptosis induction in Jurkat cells. These data were confirmed in human CD4(+) T cells from peripheral blood as follows: a specific Lck chemical inhibitor abrogated Ca2+ mobilization but not apoptosis induction. Moreover, Lck activity was also required for the production of Th1-type cytokines, i.e. interleukin-2 and interferon-gamma, which resulted from gal-9 stimulation in peripheral CD4(+) T cells. These findings indicate that gal-9 acts on T cells by two distinct pathways as follows: one mimicking antigen-specific activation of the TCR with a mandatory contribution of proximal elements of the TCR complex, especially Lck, and another resulting in apoptosis that is independent of this complex.	[Lhuillier, Claire; Barjon, Clement; Souquere, Sylvie; Dellis, Olivier; Busson, Pierre] Univ Paris 11, F-91400 Orsay, France; [Lhuillier, Claire; Barjon, Clement; Gelin, Aurore; Busson, Pierre] Inst Gustave Roussy, CNRS, UMR 8126, F-94805 Villejuif, France; [Lhuillier, Claire; Barjon, Clement; Wei, Ming] Ecole Natl Vet Alfort, Cellvax, F-94704 Maisons Alfort, France; [Niki, Toshiro; Hirashima, Mitsuomi] Kagawa Univ, Fac Med, Dept Immunol & Immunopathol, Takamatsu, Kagawa 7610793, Japan; [Niki, Toshiro; Hirashima, Mitsuomi] GalPharma Co Ltd, Takamatsu, Kagawa 7610301, Japan; [Praz, Francoise] Ctr Rech St Antoine, INSERM, UMR S 938, F-75012 Paris, France; [Praz, Francoise] Univ Paris 06, Sorbonne Univ, UMR S 938, Ctr Rech St Antoine, F-75012 Paris, France; [Morales, Olivier] Inst Biol Lille, CNRS, UMR Grp IRCV 8161, F-59021 Lille, France; [Souquere, Sylvie] Inst Gustave Roussy, UMR 8122, F-94805 Villejuif, France; [Dellis, Olivier] INSERM, UMR S 757, F-91405 Orsay, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Ecole Nationale Veterinaire d'Alfort (ENVA); Kagawa University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm)	Busson, P (corresponding author), Univ Paris 11, 15 Rue Georges Clemenceau, F-91400 Orsay, France.	pierre.busson@gustaveroussy.fr	MORALES, Olivier/AAR-5337-2020; Dellis, Olivier/E-8501-2011; PRAZ, Françoise/A-7291-2008; PRAZ, Françoise/AAF-7761-2020	Dellis, Olivier/0000-0003-0377-9163; PRAZ, Françoise/0000-0002-5353-8889; PRAZ, Françoise/0000-0002-5353-8889; Busson, Pierre/0000-0003-1027-3400; MORALES, Olivier/0000-0002-2135-3265	Institut National du Cancer Grant INCa-DHOS; Ligue Nationale Contre le Cancer (Comite du Val de Marne); Association Nationale Recherche-Technologie; Association pour la Recherche Contre le Cancer	Institut National du Cancer Grant INCa-DHOS; Ligue Nationale Contre le Cancer (Comite du Val de Marne)(Ligue nationale contre le cancer); Association Nationale Recherche-Technologie; Association pour la Recherche Contre le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was supported in part by Institut National du Cancer Grant INCa-DHOS 2010 and the Ligue Nationale Contre le Cancer (Comite du Val de Marne). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a fellowship from the Association Nationale Recherche-Technologie.; Supported by a fellowship from Association pour la Recherche Contre le Cancer.	Abraham RT, 2004, NAT REV IMMUNOL, V4, P301, DOI 10.1038/nri1330; ALCOVER A, 1988, EMBO J, V7, P1973, DOI 10.1002/j.1460-2075.1988.tb03035.x; ALCOVER A, 1990, J BIOL CHEM, V265, P4131; Altman A, 1990, Adv Immunol, V48, P227, DOI 10.1016/S0065-2776(08)60756-7; Anderson AC, 2007, SCIENCE, V318, P1141, DOI 10.1126/science.1148536; Bacigalupo ML, 2013, WORLD J GASTROENTERO, V19, P8831, DOI 10.3748/wjg.v19.i47.8831; Barjon C, 2012, INFECT AGENTS CANCER, V7, DOI 10.1186/1750-9378-7-16; Bi S, 2008, J BIOL CHEM, V283, P12248, DOI 10.1074/jbc.M800523200; Bi SG, 2011, P NATL ACAD SCI USA, V108, P10650, DOI 10.1073/pnas.1017954108; Boscher C, 2011, CURR OPIN CELL BIOL, V23, P383, DOI 10.1016/j.ceb.2011.05.001; Brandt B, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.1; Brimmell M, 1998, ONCOGENE, V16, P1803, DOI 10.1038/sj.onc.1201704; Brownlie RJ, 2013, NAT REV IMMUNOL, V13, P257, DOI 10.1038/nri3403; Chen IJ, 2007, J BIOL CHEM, V282, P35361, DOI 10.1074/jbc.M706923200; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Djillani A, 2014, BBA-MOL CELL RES, V1843, P2341, DOI 10.1016/j.bbamcr.2014.03.012; Dong S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015114; Golden-Mason L, 2013, J VIROL, V87, P4835, DOI 10.1128/JVI.01085-12; Gooden MJM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065616; Heusschen R, 2013, BBA-REV CANCER, V1836, P177, DOI 10.1016/j.bbcan.2013.04.006; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Hsu DK, 2009, IMMUNOL REV, V230, P114, DOI 10.1111/j.1600-065X.2009.00798.x; Jayaraman P, 2010, J EXP MED, V207, P2343, DOI 10.1084/jem.20100687; Kared H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003422; Kashio Y, 2003, J IMMUNOL, V170, P3631, DOI 10.4049/jimmunol.170.7.3631; Keryer-Bibens C, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-283; Klibi J, 2009, BLOOD, V113, P1957, DOI 10.1182/blood-2008-02-142596; Lee J, 2011, MOL CELL BIOL, V31, P3963, DOI 10.1128/MCB.05297-11; Leitner J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003253; Lequin D, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-225; Li H, 2012, HEPATOLOGY, V56, P1342, DOI 10.1002/hep.25777; Lu LH, 2007, J BIOCHEM, V141, P157, DOI 10.1093/jb/mvm019; Madireddi S, 2014, J EXP MED, V211, P1425, DOI 10.1084/jem.20132687; Mengshol JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009504; Moritoki M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060807; Mrizak D, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju363; Nika K, 2010, IMMUNITY, V32, P766, DOI 10.1016/j.immuni.2010.05.011; Nishi N, 2005, FEBS LETT, V579, P2058, DOI 10.1016/j.febslet.2005.02.054; Oomizu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048574; Oomizu S, 2012, CLIN IMMUNOL, V143, P51, DOI 10.1016/j.clim.2012.01.004; Pace KE, 1999, J IMMUNOL, V163, P3801; Paster W, 2009, J IMMUNOL, V182, P2160, DOI 10.4049/jimmunol.0802639; Peng W, 2008, CANCER RES, V68, P7228, DOI 10.1158/0008-5472.CAN-08-1245; POPPEMA S, 1991, AM J PATHOL, V138, P1479; Proust R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043200; Rangachari M, 2012, NAT MED, V18, P1394, DOI 10.1038/nm.2871; Reddy PBJ, 2011, J IMMUNOL, V187, P5745, DOI 10.4049/jimmunol.1102105; Seki M, 2008, CLIN IMMUNOL, V127, P78, DOI 10.1016/j.clim.2008.01.006; Sharma S, 2011, P NATL ACAD SCI USA, V108, P19001, DOI 10.1073/pnas.1107087108; Soares H, 2013, J EXP MED, V210, P2415, DOI 10.1084/jem.20130150; Stachlewitz RF, 2005, J PHARMACOL EXP THER, V315, P36, DOI 10.1124/jpet.105.089169; Stillman BN, 2006, J IMMUNOL, V176, P778, DOI 10.4049/jimmunol.176.2.778; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; Su EW, 2011, GLYCOBIOLOGY, V21, P1258, DOI 10.1093/glycob/cwq214; Tanikawa R, 2010, BIOCHEM BIOPH RES CO, V394, P317, DOI 10.1016/j.bbrc.2010.02.175; Tribulatti MV, 2009, J LEUKOCYTE BIOL, V86, P371, DOI 10.1189/jlb.0908529; Walzel H, 2000, GLYCOBIOLOGY, V10, P131, DOI 10.1093/glycob/10.2.131; Wang F, 2007, CELL IMMUNOL, V250, P68, DOI 10.1016/j.cellimm.2008.01.006; Wiersma VR, 2012, J INVEST DERMATOL, V132, P2302, DOI 10.1038/jid.2012.133; Wu C, 2014, IMMUNITY, V41, P270, DOI 10.1016/j.immuni.2014.06.011; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	61	32	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16797	16811		10.1074/jbc.M115.661272	http://dx.doi.org/10.1074/jbc.M115.661272			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25947381	hybrid, Green Published			2022-12-28	WOS:000357572800026
J	Szundi, I; Li, H; Chen, EF; Bogomolni, R; Spudich, JL; Kliger, DS				Szundi, Istvan; Li, Hai; Chen, Eefei; Bogomolni, Roberto; Spudich, John L.; Kliger, David S.			Platymonas subcordiformis Channelrhodopsin-2 Function I. THE PHOTOCHEMICAL REACTION CYCLE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTONATION CHANGES; LIGHT; CHANNEL; PHOTOCYCLE; MECHANISMS	The photocycle kinetics of Platymonas subcordiformis channelrhodopsin-2 (PsChR2), among the most highly efficient light-gated cation channels and the most blue-shifted channelrhodopsin, was studied by time-resolved absorption spectroscopy in the 340-650-nm range and in the 100-ns to 3-s time window. Global exponential fitting of the time dependence of spectral changes revealed six lifetimes: 0.60 mu s, 5.3 mu s, 170 mu s, 1.4 ms, 6.7 ms, and 1.4 s. The sequential intermediates derived for a single unidirectional cycle scheme based on these lifetimes were found to contain mixtures of K, L, M, O, and P molecular states, named in analogy to photointermediates in the bacteriorhodopsin photocycle. The photochemistry is described by the superposition of two independent parallel photocycles. The analysis revealed that 30% of the photoexcited receptor molecules followed Cycle 1 through the K, M, O, and P states, whereas 70% followed Cycle 2 through the K, L, M, and O states. The recovered state, R, is spectrally close, but not identical, to the dark state on the seconds time scale. The two-cycle model of this high efficiency channelrhodopsin-2 (ChR) opens new perspectives in understanding the mechanism of channelrhodopsin function.	[Szundi, Istvan; Chen, Eefei; Bogomolni, Roberto; Kliger, David S.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; [Li, Hai; Spudich, John L.] Univ Texas Med Sch, Dept Biochem & Mol Biol, Ctr Membrane Biol, Houston, TX 77030 USA	University of California System; University of California Santa Cruz; University of Texas System; University of Texas Health Science Center Houston	Spudich, JL (corresponding author), UT Med Sch, Ctr Membrane Biol, 6431 Fannin St,MSB 6-130, Houston, TX 77030 USA.	John.L.Spudich@uth.tmc.edu; kliger@ucsc.edu			National Institutes of Health from the NEI [R01EY000983]; National Institutes of Health from the NIGMS [R01GM027750]; Hermann Eye Fund from the Robert A. Welch Foundation; Endowed Chair from the Robert A. Welch Foundation [AU-0009]; NATIONAL EYE INSTITUTE [R01EY000983] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027750] Funding Source: NIH RePORTER	National Institutes of Health from the NEI; National Institutes of Health from the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Hermann Eye Fund from the Robert A. Welch Foundation; Endowed Chair from the Robert A. Welch Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by National Institutes of Health Grant R01EY000983 from the NEI (to D. S. K.) and by National Institutes of Health Grant R01GM027750 from the NIGMS, the Hermann Eye Fund, and Endowed Chair AU-0009 from the Robert A. Welch Foundation (to J. L. S.) The authors declare that they have no conflicts of interest with the contents of this article.	Bamann C, 2008, J MOL BIOL, V375, P686, DOI 10.1016/j.jmb.2007.10.072; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Chow BY, 2012, PROG BRAIN RES, V196, P49, DOI 10.1016/B978-0-444-59426-6.00003-3; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Ernst OP, 2014, CHEM REV, V114, P126, DOI 10.1021/cr4003769; Govorunova EG, 2013, J BIOL CHEM, V288, P29911, DOI 10.1074/jbc.M113.505495; Hou SY, 2012, PHOTOCHEM PHOTOBIOL, V88, P119, DOI 10.1111/j.1751-1097.2011.01027.x; Lorenz-Fonfria VA, 2014, BBA-BIOENERGETICS, V1837, P626, DOI 10.1016/j.bbabio.2013.10.014; Lorenz-Fonfria VA, 2013, P NATL ACAD SCI USA, V110, pE1273, DOI 10.1073/pnas.1219502110; Mooney VL, 2012, BIOCHEMISTRY-US, V51, P2630, DOI 10.1021/bi300157r; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Ritter E, 2013, J BIOL CHEM, V288, P10451, DOI 10.1074/jbc.M112.446427; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; Stehfest K, 2010, CHEMPHYSCHEM, V11, P1120, DOI 10.1002/cphc.200900980; Szundi I, 1997, BIOPHYS J, V73, P688, DOI 10.1016/S0006-3495(97)78103-7; Szundi I, 2014, BIOCHEMISTRY-US, V53, P5393, DOI 10.1021/bi500567m; Verhoefen MK, 2010, CHEMPHYSCHEM, V11, P3113, DOI 10.1002/cphc.201000181	19	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16573	16584		10.1074/jbc.M114.631614	http://dx.doi.org/10.1074/jbc.M114.631614			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25971972	hybrid, Green Published			2022-12-28	WOS:000357572800010
J	van den Biggelaar, M; Madsen, JJ; Faber, JH; Zuurveld, MG; van der Zwaan, C; Olsen, OH; Stennicke, HR; Mertens, K; Meijer, AB				van den Biggelaar, Maartje; Madsen, Jesper J.; Faber, Johan H.; Zuurveld, Marleen G.; van der Zwaan, Carmen; Olsen, Ole H.; Stennicke, Henning R.; Mertens, Koen; Meijer, Alexander B.			Factor VIII Interacts with the Endocytic Receptor Low-density Lipoprotein Receptor-related Protein 1 via an Extended Surface Comprising "Hot-Spot" Lysine Residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COAGULATION-FACTOR-VIII; PLASMINOGEN-ACTIVATOR INHIBITOR-1; VON-WILLEBRAND-FACTOR; CARBOXYL-TERMINAL DOMAIN; ALPHA-2-MACROGLOBULIN RECEPTOR; BINDING-SITE; C1 DOMAIN; PROTEIN/ALPHA(2)-MACROGLOBULIN RECEPTOR; LIGAND RECOGNITION; MASS-SPECTROMETRY	Lysine residues are implicated in driving the ligand binding to the LDL receptor family. However, it has remained unclear how specificity is regulated. Using coagulation factor VIII as a model ligand, we now study the contribution of individual lysine residues in the interaction with the largest member of the LDL receptor family, low-density lipoprotein receptor-related protein (LRP1). Using hydrogen-deuterium exchange mass spectrometry (HDX-MS) and SPR interaction analysis on a library of lysine replacement variants as two independent approaches, we demonstrate that the interaction between factor VIII (FVIII) and LRP1 occurs over an extended surface containing multiple lysine residues. None of the individual lysine residues account completely for LRP1 binding, suggesting an additive binding model. Together with structural docking studies, our data suggest that FVIII interacts with LRP1 via an extended surface of multiple lysine residues that starts at the bottom of the C1 domain and winds around the FVIII molecule.	[van den Biggelaar, Maartje; Zuurveld, Marleen G.; van der Zwaan, Carmen; Mertens, Koen; Meijer, Alexander B.] Sanquin Blood Supply Fdn, Dept Plasma Prot, NL-1066 CX Amsterdam, Netherlands; [Madsen, Jesper J.; Faber, Johan H.; Olsen, Ole H.; Stennicke, Henning R.] Novo Nordisk AS, Global Res, DK-2760 Malov, Denmark; [Mertens, Koen; Meijer, Alexander B.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Dept Pharmaceut, NL-3508 TC Utrecht, Netherlands	Novo Nordisk; Utrecht University	van den Biggelaar, M (corresponding author), Sanquin Res, Dept Plasma Prot, Plesmanlaan 125, NL-1066 CX Amsterdam, Netherlands.	m.vandenbiggelaar@sanquin.nl	Madsen, Jesper Jonasson/AAU-5858-2020; Madsen, Jesper J/E-7233-2015	Madsen, Jesper Jonasson/0000-0003-1411-9080; Madsen, Jesper J/0000-0003-1411-9080				Andersen MD, 2011, INT J MASS SPECTROM, V302, P139, DOI 10.1016/j.ijms.2010.09.010; Andersen OM, 2000, J BIOL CHEM, V275, P21017, DOI 10.1074/jbc.M000507200; Bloem E, 2013, J BIOL CHEM, V288, P29670, DOI 10.1074/jbc.M113.473116; Bloem E, 2012, J BIOL CHEM, V287, P5775, DOI 10.1074/jbc.M111.308627; Bovenschen N, 2003, J BIOL CHEM, V278, P9370, DOI 10.1074/jbc.M212053200; Brown MS, 1997, NATURE, V388, P629, DOI 10.1038/41672; BU GJ, 1995, EMBO J, V14, P2269, DOI 10.1002/j.1460-2075.1995.tb07221.x; Chivian D, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl480; Dieckmann M, 2010, BIOL CHEM, V391, P1341, DOI 10.1515/BC.2010.129; Dolmer K, 2013, J BIOL CHEM, V288, P24081, DOI 10.1074/jbc.M113.473728; Ebina T, 2009, BIOPOLYMERS, V92, P1, DOI 10.1002/bip.21105; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; Fisher C, 2006, MOL CELL, V22, P277, DOI 10.1016/j.molcel.2006.02.021; Fribourg C, 2006, BIOCHEMISTRY-US, V45, P10777, DOI 10.1021/bi060451h; Gettins PGW, 2012, BIOCHEM J, V443, P65, DOI 10.1042/BJ20111867; Gilbert GE, 2012, BLOOD, V120, P1923, DOI 10.1182/blood-2012-01-408245; Gilbert GE, 2002, J BIOL CHEM, V277, P6374, DOI 10.1074/jbc.M104732200; Herczenik E, 2012, J ALLERGY CLIN IMMUN, V129, P501, DOI 10.1016/j.jaci.2011.08.029; HERZ J, 1991, J BIOL CHEM, V266, P21232; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Herz J, 2009, J LIPID RES, V50, pS287, DOI 10.1194/jlr.R800077-JLR200; Howard GC, 1996, J BIOL CHEM, V271, P14105, DOI 10.1074/jbc.271.24.14105; Jensen GA, 2006, J MOL BIOL, V362, P700, DOI 10.1016/j.jmb.2006.07.013; Jensen JK, 2009, J BIOL CHEM, V284, P17989, DOI 10.1074/jbc.M109.009530; Kavan D, 2011, INT J MASS SPECTROM, V302, P53, DOI 10.1016/j.ijms.2010.07.030; KRIEGER M, 1994, ANNU REV BIOCHEM, V63, P601, DOI 10.1146/annurev.bi.63.070194.003125; LALAZAR A, 1988, J BIOL CHEM, V263, P3542; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lee CJ, 2010, STRUCTURE, V18, P366, DOI 10.1016/j.str.2009.12.013; Lenting PJ, 1999, J BIOL CHEM, V274, P23734, DOI 10.1074/jbc.274.34.23734; LEYTE A, 1989, BIOCHEM J, V263, P187, DOI 10.1042/bj2630187; Lu JH, 2011, BLOOD, V117, P3181, DOI 10.1182/blood-2010-08-301663; Meems H, 2011, INT J BIOCHEM CELL B, V43, P1114, DOI 10.1016/j.biocel.2011.03.014; Meems H, 2009, BLOOD, V114, P3938, DOI 10.1182/blood-2009-01-197707; Migliorini MM, 2003, J BIOL CHEM, V278, P17986, DOI 10.1074/jbc.M212592200; MOESTRUP SK, 1990, J BIOL CHEM, V265, P12623; Nielsen KL, 1996, J BIOL CHEM, V271, P12909, DOI 10.1074/jbc.271.22.12909; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rodenburg KW, 1998, BIOCHEM J, V329, P55; Stefansson S, 1998, J BIOL CHEM, V273, P6358, DOI 10.1074/jbc.273.11.6358; Strickland DK, 2003, J THROMB HAEMOST, V1, P1663, DOI 10.1046/j.1538-7836.2003.00330.x; STRICKLAND DK, 1991, J BIOL CHEM, V266, P13364; Svensson LA, 2013, BIOL CHEM, V394, P761, DOI 10.1515/hsz-2012-0298; Thim L, 2010, HAEMOPHILIA, V16, P349, DOI 10.1111/j.1365-2516.2009.02135.x; Van den Biggelaar M, 2007, J THROMB HAEMOST, V5, P2235, DOI 10.1111/j.1538-7836.2007.02737.x; van den Biggelaar M, 2011, INT J BIOCHEM CELL B, V43, P431, DOI 10.1016/j.biocel.2010.11.017; van den Biggelaar M, 2009, BLOOD, V113, P3102, DOI 10.1182/blood-2008-05-159699; van Helden PMW, 2008, BRIT J HAEMATOL, V142, P644, DOI 10.1111/j.1365-2141.2008.07232.x; WILLIAMS SE, 1994, J BIOL CHEM, V269, P8653; Willnow TE, 1996, EMBO J, V15, P2632, DOI 10.1002/j.1460-2075.1996.tb00623.x; WILLNOW TE, 1995, P NATL ACAD SCI USA, V92, P4537, DOI 10.1073/pnas.92.10.4537; Zaiou M, 2000, J LIPID RES, V41, P1087	52	23	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16463	16476		10.1074/jbc.M115.650911	http://dx.doi.org/10.1074/jbc.M115.650911			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25903134	Green Published, hybrid			2022-12-28	WOS:000357572800001
J	LeMaster, DM; Mustafi, SM; Brecher, M; Zhang, J; Heroux, A; Li, HM; Hernandez, G				LeMaster, David M.; Mustafi, Sourajit M.; Brecher, Matthew; Zhang, Jing; Heroux, Annie; Li, Hongmin; Hernandez, Griselda			Coupling of Conformational Transitions in the N-terminal Domain of the 51-kDa FK506-binding Protein (FKBP51) Near Its Site of Interaction with the Steroid Receptor Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; conformational change; nuclear magnetic resonance (NMR); prolyl isomerase; x-ray crystallography	GLUCOCORTICOID-RECEPTOR; PROGESTERONE-RECEPTOR; CHEMICAL-EXCHANGE; ACTIVE-SITE; GR-ALPHA; DYNAMICS; BINDING; HSP90; RELAXATION; ASSOCIATION	Background: FK506-binding protein 51 (FKBP51) inhibits and FKBP52 stimulates transcription by various steroid receptors. Exchange of a single residue largely reverses this pattern of regulation. Results: Unlike FKBP52, FKBP51 has two distinct coupled conformational transitions surrounding this mutation site. Conclusion: Structural analysis of FKBP51 transient states can inform inhibitor design by conformational selection. Significance: The differential plasticity of the FKBP domains may underlie their differential regulation. Interchanging Leu-119 for Pro-119 at the tip of the (4)-(5) loop in the first FK506 binding domain (FK1) of the FKBP51 and FKBP52 proteins, respectively, has been reported to largely reverse the inhibitory (FKBP51) or stimulatory (FKBP52) effects of these co-chaperones on the transcriptional activity of glucocorticoid and androgen receptor-protein complexes. Previous NMR relaxation studies have identified exchange line broadening, indicative of submillisecond conformational motion, throughout the (4)-(5) loop in the FK1 domain of FKBP51, which are suppressed by the FKBP52-like L119P substitution. This substitution also attenuates exchange line broadening in the underlying (2) and (3a) strands that is centered near a bifurcated main chain hydrogen bond interaction between these two strands. The present study demonstrates that these exchange line broadening effects arise from two distinct coupled conformational transitions, and the transition within the (2) and (3a) strands samples a transient conformation that resembles the crystal structures of the selectively inhibited FK1 domain of FKBP51 recently reported. Although the crystal structures for their series of inhibitors were interpreted as evidence for an induced fit mechanism of association, the presence of a similar conformation being significantly populated in the unliganded FKBP51 domain is more consistent with a conformational selection binding process. The contrastingly reduced conformational plasticity of the corresponding FK1 domain of FKBP52 is consistent with the current model in which FKBP51 binds to both the apo- and hormone-bound forms of the steroid receptor to modulate its affinity for ligand, whereas FKBP52 binds selectively to the latter state.	[LeMaster, David M.; Mustafi, Sourajit M.; Brecher, Matthew; Zhang, Jing; Li, Hongmin; Hernandez, Griselda] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA; [LeMaster, David M.; Li, Hongmin; Hernandez, Griselda] SUNY Albany, Dept Biomed Sci, Sch Publ Hlth, Albany, NY 12201 USA; [Heroux, Annie] Brookhaven Natl Lab, Upton, NY 11973 USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; United States Department of Energy (DOE); Brookhaven National Laboratory	Hernandez, G (corresponding author), Empire State Plaza, Albany, NY 12201 USA.	griselda.hernandez@health.ny.gov	Li, Hongmin/ABI-2439-2020; Regan, Clinton/E-6250-2012	Li, Hongmin/0000-0002-8684-5308; Brecher, Matthew/0000-0003-1151-2290	National Institutes of Health [GM 088214]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088214] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 088214 (to G. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anderson JS, 2014, BIOPHYS CHEM, V192, P41, DOI 10.1016/j.bpc.2014.06.004; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Barent RL, 1998, MOL ENDOCRINOL, V12, P342, DOI 10.1210/me.12.3.342; Baughman G, 1997, BIOCHEM BIOPH RES CO, V232, P437, DOI 10.1006/bbrc.1997.6307; Binder EB, 2004, NAT GENET, V36, P1319, DOI 10.1038/ng1479; Blackburn EA, 2011, CURR OPIN PHARMACOL, V11, P365, DOI 10.1016/j.coph.2011.04.007; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Bracher A, 2013, J MOL BIOL, V425, P4134, DOI 10.1016/j.jmb.2013.07.041; Bracher A, 2011, ACTA CRYSTALLOGR D, V67, P549, DOI 10.1107/S0907444911013862; Brath U, 2006, J AM CHEM SOC, V128, P5718, DOI 10.1021/ja0570279; Brath U, 2009, J MOL BIOL, V387, P233, DOI 10.1016/j.jmb.2009.01.047; Case DA, 1995, J BIOMOL NMR, V6, P341; Chen H, 2014, ACTA CRYSTALLOGR D, V70, P636, DOI 10.1107/S1399004713032112; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; Davies TH, 2002, J BIOL CHEM, V277, P4597, DOI 10.1074/jbc.C100531200; DeLano W.L, PYMOL MOL GRAPHICS S; Denny WB, 2000, ENDOCRINOLOGY, V141, P4107, DOI 10.1210/en.141.11.4107; Egeler EL, 2011, J BIOL CHEM, V286, P31328, DOI 10.1074/jbc.M111.264101; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fabian AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057508; Feng HP, 2001, BLOOD, V97, P3505, DOI 10.1182/blood.V97.11.3505; Gaali S, 2015, NAT CHEM BIOL, V11, P33, DOI 10.1038/nchembio.1699; Galat A, 2008, J CHEM INF MODEL, V48, P1118, DOI 10.1021/ci700429n; Galigniana NM, 2012, J NEUROCHEM, V122, P4, DOI 10.1111/j.1471-4159.2012.07775.x; Gkika D, 2006, AM J PHYSIOL-RENAL, V290, pF1253, DOI 10.1152/ajprenal.00298.2005; HAIGH CW, 1979, PROG NUCL MAG RES SP, V13, P303, DOI 10.1016/0079-6565(79)80010-2; Han B, 2011, J BIOMOL NMR, V50, P43, DOI 10.1007/s10858-011-9478-4; Jiang W, 2008, NEOPLASIA, V10, P235, DOI 10.1593/neo.07929; Kirschke E, 2014, CELL, V157, P1685, DOI 10.1016/j.cell.2014.04.038; Kohlhoff KJ, 2009, J AM CHEM SOC, V131, P13894, DOI 10.1021/ja903772t; Lakomek NA, 2012, J BIOMOL NMR, V53, P209, DOI 10.1007/s10858-012-9626-5; Li PY, 2003, ACTA CRYSTALLOGR D, V59, P16, DOI 10.1107/S0907444902017523; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Mandel AM, 1996, BIOCHEMISTRY-US, V35, P16009, DOI 10.1021/bi962089k; Millet O, 2000, J AM CHEM SOC, V122, P2867, DOI 10.1021/ja993511y; Moon S, 2007, J BIOMOL NMR, V38, P139, DOI 10.1007/s10858-007-9156-8; Mustafi SM, 2014, BIOCHEM J, V461, P115, DOI 10.1042/BJ20140232; Mustafi SM, 2014, BIOCHEM J, V458, P525, DOI 10.1042/BJ20131429; Mustafi SM, 2013, BIOCHEM J, V453, P371, DOI 10.1042/BJ20130276; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palmer AG, 2014, J MAGN RESON, V241, P3, DOI 10.1016/j.jmr.2014.01.008; Pei HD, 2009, CANCER CELL, V16, P259, DOI 10.1016/j.ccr.2009.07.016; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfaff SJ, 2010, J BIOL CHEM, V285, P15256, DOI 10.1074/jbc.M110.108118; Riggs DL, 2007, MOL CELL BIOL, V27, P8658, DOI 10.1128/MCB.00985-07; Riggs DL, 2003, EMBO J, V22, P1158, DOI 10.1093/emboj/cdg108; SANCHEZ ER, 1990, J BIOL CHEM, V265, P22067; Sapienza PJ, 2011, J MOL BIOL, V405, P378, DOI 10.1016/j.jmb.2010.10.037; Sekhar A, 2013, P NATL ACAD SCI USA, V110, P12867, DOI 10.1073/pnas.1305688110; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Shen Y, 2010, J BIOMOL NMR, V48, P13, DOI 10.1007/s10858-010-9433-9; Shim S, 2009, NEURON, V64, P471, DOI 10.1016/j.neuron.2009.09.025; Silverstein AM, 1999, J BIOL CHEM, V274, P36980, DOI 10.1074/jbc.274.52.36980; SMITH DF, 1990, J BIOL CHEM, V265, P3996; Stechschulte LA, 2014, MOL ENDOCRINOL, V28, P1254, DOI 10.1210/me.2014-1023; Stechschulte LA, 2014, MOL ENDOCRINOL, V28, P1265, DOI 10.1210/me.2014-1022; TAI PKK, 1986, BIOCHEMISTRY-US, V25, P5269, DOI 10.1021/bi00366a043; Tang SS, 2011, J BIOMOL NMR, V51, P303, DOI 10.1007/s10858-011-9556-7; Trebble PJ, 2013, J CELL SCI, V126, P3159, DOI 10.1242/jcs.124784; Wochnik GM, 2005, J BIOL CHEM, V280, P4609, DOI 10.1074/jbc.M407498200; Wu BL, 2004, P NATL ACAD SCI USA, V101, P8348, DOI 10.1073/pnas.0305969101; Yang W, 2000, J MED CHEM, V43, P1135, DOI 10.1021/jm9904396	63	11	11	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15746	15757		10.1074/jbc.M115.650655	http://dx.doi.org/10.1074/jbc.M115.650655			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25953903	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000356527400036
J	Liu, FG; Geng, JF; Gumpper, RH; Barman, A; Davis, I; Ozarowski, A; Hamelberg, D; Liu, AM				Liu, Fange; Geng, Jiafeng; Gumpper, Ryan H.; Barman, Arghya; Davis, Ian; Ozarowski, Andrew; Hamelberg, Donald; Liu, Aimin			An Iron Reservoir to the Catalytic Metal: THE RUBREDOXIN IRON IN AN EXTRADIOL DIOXYGENASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						computation; dioxygenase; iron-sulfur protein; metabolism; tryptophan; iron reservoir; kynurenine	DESULFOVIBRIO-VULGARIS; SACCHAROMYCES-CEREVISIAE; DECARBOXYLASE ACMSD; CRYSTAL-STRUCTURES; ELECTRON-TRANSFER; STRUCTURAL BASIS; PROTEIN; 3-HYDROXYANTHRANILATE; ACID; PURIFICATION	Background: An accessory [Fe(Cys)(4)] center of unknown function is present in 3-hydroxyanthranilate 3,4-dioxygenase. Results: An intermolecular iron shuttling from the [Fe(Cys)(4)] site to the catalytic site is observed. Conclusion: The rubredoxin-like domain is an iron reservoir for the catalytic site when the catalytic metal becomes stripped during metabolic events. Significance: An iron shuttling mechanism is proposed for the iron-sulfur center. The rubredoxin motif is present in over 74,000 protein sequences and 2,000 structures, but few have known functions. A secondary, non-catalytic, rubredoxin-like iron site is conserved in 3-hydroxyanthranilate 3,4-dioxygenase (HAO), from single cellular sources but not multicellular sources. Through the population of the two metal binding sites with various metals in bacterial HAO, the structural and functional relationship of the rubredoxin-like site was investigated using kinetic, spectroscopic, crystallographic, and computational approaches. It is shown that the first metal presented preferentially binds to the catalytic site rather than the rubredoxin-like site, which selectively binds iron when the catalytic site is occupied. Furthermore, an iron ion bound to the rubredoxin-like site is readily delivered to an empty catalytic site of metal-free HAO via an intermolecular transfer mechanism. Through the use of metal analysis and catalytic activity measurements, we show that a downstream metabolic intermediate can selectively remove the catalytic iron. As the prokaryotic HAO is often crucial for cell survival, there is a need for ensuring its activity. These results suggest that the rubredoxin-like site is a possible auxiliary iron source to the catalytic center when it is lost during catalysis in a pathway with metabolic intermediates of metal-chelating properties. A spare tire concept is proposed based on this biochemical study, and this concept opens up a potentially new functional paradigm for iron-sulfur centers in iron-dependent enzymes as transient iron binding and shuttling sites to ensure full metal loading of the catalytic site.	[Liu, Fange; Geng, Jiafeng; Gumpper, Ryan H.; Barman, Arghya; Davis, Ian; Hamelberg, Donald; Liu, Aimin] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA; [Liu, Fange; Hamelberg, Donald; Liu, Aimin] Georgia State Univ, Ctr Diagnost & Therapeut, Atlanta, GA 30303 USA; [Geng, Jiafeng; Davis, Ian; Hamelberg, Donald; Liu, Aimin] Georgia State Univ, Mol Basis Dis Program, Atlanta, GA 30303 USA; [Ozarowski, Andrew] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32310 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; State University System of Florida; Florida State University	Liu, AM (corresponding author), Georgia State Univ, 50 Decatur St SE, Atlanta, GA 30303 USA.	Feradical@gsu.edu	Liu, Aimin/C-1572-2017; Geng, Jiafeng/G-4948-2015	Liu, Aimin/0000-0002-4182-8176; Geng, Jiafeng/0000-0001-9488-0974; Davis, Ian/0000-0002-1566-4972; Liu, Fange/0000-0002-3235-9996	NSF [DMR-1157490]; State of Florida; DOE; User Collaboration Grants Program Award [5064 (2007)]; DOE, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; Direct For Biological Sciences [0953061] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107529] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); State of Florida; DOE(United States Department of Energy (DOE)); User Collaboration Grants Program Award; DOE, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Mossbauer spectroscopy data were collected at the National High Magnetic Field Laboratory, which is funded by the NSF through the Cooperative Agreement No. DMR-1157490, the State of Florida, and the DOE. The Mossbauer spectrometer was funded by the User Collaboration Grants Program Award 5064 (2007) (to A. O.). X-ray diffraction data were collected at the South-east Regional Collaborative Access Team (SER-CAT) 22-ID beamline with the Advanced Photon Source at the Argonne National Laboratory. The use of the Advanced Photon Source was supported by DOE, Office of Science, Office of Basic Energy Sciences, under Contract W-31-109-Eng-38.	Adam V, 2004, STRUCTURE, V12, P1729, DOI 10.1016/j.str.2004.07.013; Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; Andrejasic M, 2008, ACTA CRYSTALLOGR D, V64, P1093, DOI 10.1107/S0907444908027388; ARCHER M, 1995, J MOL BIOL, V251, P690, DOI 10.1006/jmbi.1995.0465; ARCIERO DM, 1983, J BIOL CHEM, V258, P4981; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cerutti DS, 2009, J CHEM THEORY COMPUT, V5, P2322, DOI 10.1021/ct9001015; Chakraborty S, 2008, BIOSCI BIOTECH BIOCH, V72, P735, DOI 10.1271/bbb.70606; Coelho AV, 1997, J BIOL INORG CHEM, V2, P680, DOI 10.1007/s007750050184; Colabroy KL, 2005, BIOCHEMISTRY-US, V44, P7623, DOI 10.1021/bi0473455; Coulter ED, 2001, ARCH BIOCHEM BIOPHYS, V394, P76, DOI 10.1006/abbi.2001.2531; Dilovic I, 2009, BIOPOLYMERS, V91, P1189, DOI 10.1002/bip.21167; Dong M, 2014, J AM CHEM SOC, V136, P1754, DOI 10.1021/ja4118957; Dunwell JM, 2001, TRENDS BIOCHEM SCI, V26, P740, DOI 10.1016/S0968-0004(01)01981-8; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans G. W, 1982, LIFE CHEM REPORTS, V1, P57; Farnaud S, 2008, BIOCHEM J, V413, P553, DOI 10.1042/BJ20080406; Franco R., 1999, IRON METABOLISM INOR, P341; Gil M, 2013, FREE RADICAL BIO MED, V65, P150, DOI 10.1016/j.freeradbiomed.2013.06.021; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Hegg EL, 1997, EUR J BIOCHEM, V250, P625, DOI 10.1111/j.1432-1033.1997.t01-1-00625.x; Huo L, 2015, PROTEINS, V83, P178, DOI 10.1002/prot.24722; Huo L, 2013, J BIOL CHEM, V288, P30862, DOI 10.1074/jbc.M113.496869; ICHIYAMA A, 1965, J BIOL CHEM, V240, P740; Iyer RB, 2005, J BIOL INORG CHEM, V10, P407, DOI 10.1007/s00775-005-0650-8; Jin S, 2002, J AM CHEM SOC, V124, P9845, DOI 10.1021/ja026587u; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jordan JB, 2009, J BIOL CHEM, V284, P24155, DOI 10.1074/jbc.M109.017764; JORGENSEN WL, 1982, J CHEM PHYS, V77, P4156, DOI 10.1063/1.444325; Kawasaki S, 2007, FEBS LETT, V581, P2460, DOI 10.1016/j.febslet.2007.04.050; Kim C, 2001, J BACTERIOL, V183, P4866, DOI 10.1128/JB.183.16.4866-4875.2001; KOONTZ WA, 1976, J BIOL CHEM, V251, P368; Kurnasov O, 2003, CHEM BIOL, V10, P1195, DOI 10.1016/j.chembiol.2003.11.011; Lambert AR, 2008, STRUCTURE, V16, P558, DOI 10.1016/j.str.2008.01.017; Larini L, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2464095; Larsson KM, 2001, STRUCTURE, V9, P739, DOI 10.1016/S0969-2126(01)00627-X; LESUISSE E, 1992, J GEN MICROBIOL, V138, P85, DOI 10.1099/00221287-138-1-85; Li TF, 2005, J AM CHEM SOC, V127, P12282, DOI 10.1021/ja0532234; Li TF, 2007, J AM CHEM SOC, V129, P9278, DOI 10.1021/ja073648l; Li TF, 2006, BIOCHEMISTRY-US, V45, P6628, DOI 10.1021/bi060108c; Li X, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-4; Logan DT, 2003, P NATL ACAD SCI USA, V100, P3826, DOI 10.1073/pnas.0736456100; LOVENBERG W, 1965, P NATL ACAD SCI USA, V54, P193, DOI 10.1073/pnas.54.1.193; Luke I, 2008, ARCH MICROBIOL, V190, P685, DOI 10.1007/s00203-008-0420-4; MIKOGAMI T, 1995, BIOCHEM J, V308, P391, DOI 10.1042/bj3080391; Minakata K, 2011, J CLIN BIOCHEM NUTR, V49, P207, DOI 10.3164/jcbn.11-16; MOURA I, 1990, J BIOL CHEM, V265, P21596; Mukhopadhyay A, 2011, J BIOL INORG CHEM, V16, P51, DOI 10.1007/s00775-010-0700-8; Muraki T, 2003, APPL ENVIRON MICROB, V69, P1564, DOI 10.1128/AEM.69.3.1564-1572.2003; Nicolaes V, 2014, J BACTERIOL, V196, P300, DOI 10.1128/JB.00921-13; OGASAWARA N, 1966, J BIOL CHEM, V241, P613; ORMEJOHN.WH, 1973, ANNU REV BIOCHEM, V42, P159, DOI 10.1146/annurev.bi.42.070173.001111; Ozarowski A, 2003, J AM CHEM SOC, V125, P12606, DOI 10.1021/ja030221f; Proudfoot M, 2008, J MOL BIOL, V375, P301, DOI 10.1016/j.jmb.2007.10.060; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Scherr N, 2007, P NATL ACAD SCI USA, V104, P12151, DOI 10.1073/pnas.0702842104; Sheldon RA, 1998, ACCOUNTS CHEM RES, V31, P485, DOI 10.1021/ar9700163; Silaghi-Dumitrescu R, 2003, BIOCHEMISTRY-US, V42, P2806, DOI 10.1021/bi027253k; Sun JP, 2005, BIOCHEMISTRY-US, V44, P8801, DOI 10.1021/bi0504714; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thakur A, 2012, J BIOL CHEM, V287, P13194, DOI 10.1074/jbc.M112.339655; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; van der Donk WA, 2010, CURR OPIN STRUC BIOL, V20, P673, DOI 10.1016/j.sbi.2010.08.005; Varghese S, 2003, J BACTERIOL, V185, P221, DOI 10.1128/JB.185.1.221-230.2003; WATENPAUGH KD, 1980, J MOL BIOL, V138, P615, DOI 10.1016/S0022-2836(80)80020-9; Zhang Y, 2005, BIOCHEMISTRY-US, V44, P7632, DOI 10.1021/bi047353l	67	8	8	2	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15621	15634		10.1074/jbc.M115.650259	http://dx.doi.org/10.1074/jbc.M115.650259			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25918158	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000356527400026
J	Watt, D; Dixit, R; Cavalli, V				Watt, Dana; Dixit, Ram; Cavalli, Valeria			JIP3 Activates Kinesin-1 Motility to Promote Axon Elongation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						axon; kinesin; molecular motor; neurite outgrowth; regeneration; JIP3; KHC; motility	SCAFFOLD PROTEIN; HEAVY-CHAIN; LIGHT-CHAINS; VESICLE TRANSPORT; MOTOR; KINASE; BINDING; DYNEIN; UNC-16; EXPRESSION	Background: Axon growth and regeneration depend on kinesin-1-dependent transport. Results: JIP3 binding to KHC promotes kinesin-1 motility along microtubules and is essential for axon elongation and regeneration. Conclusion: JIP3 regulation of kinesin-1 motility is critical for axon elongation and regeneration. Significance: Regulation of intracellular transport is important for proper neuronal development. Kinesin-1 is a molecular motor responsible for cargo transport along microtubules and plays critical roles in polarized cells, such as neurons. Kinesin-1 can function as a dimer of two kinesin heavy chains (KHC), which harbor the motor domain, or as a tetramer in combination with two accessory light chains (KLC). To ensure proper cargo distribution, kinesin-1 activity is precisely regulated. Both KLC and KHC subunits bind cargoes or regulatory proteins to engage the motor for movement along microtubules. We previously showed that the scaffolding protein JIP3 interacts directly with KHC in addition to its interaction with KLC and positively regulates dimeric KHC motility. Here we determined the stoichiometry of JIP3-KHC complexes and observed approximately four JIP3 molecules binding per KHC dimer. We then determined whether JIP3 activates tetrameric kinesin-1 motility. Using an in vitro motility assay, we show that JIP3 binding to KLC engages kinesin-1 with microtubules and that JIP3 binding to KHC promotes kinesin-1 motility along microtubules. We tested the in vivo relevance of these findings using axon elongation as a model for kinesin-1-dependent cellular function. We demonstrate that JIP3 binding to KHC, but not KLC, is essential for axon elongation in hippocampal neurons as well as axon regeneration in sensory neurons. These findings reveal that JIP3 regulation of kinesin-1 motility is critical for axon elongation and regeneration.	[Watt, Dana; Cavalli, Valeria] Washington Univ, Dept Anat & Neurobiol, Sch Med, St Louis, MO 63110 USA; [Dixit, Ram] Washington Univ, Dept Biol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Cavalli, V (corresponding author), Washington Univ, Dept Anat & Neurobiol, Sch Med, Campus Box 8108,660 S Euclid Ave, St Louis, MO 63110 USA.	cavalli@pcg.wustl.edu			National Institutes of Health, NINDS [R01 NS082446]; National Science Foundation [MCB-1121287]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082446] Funding Source: NIH RePORTER	National Institutes of Health, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health, NINDS, Grant R01 NS082446 (to V. C.). This work was also supported by National Science Foundation Grant MCB-1121287 (to R. D.).	Abe N, 2009, J BIOL CHEM, V284, P34628, DOI 10.1074/jbc.M109.035022; Aoyama T, 2009, J CELL SCI, V122, P4177, DOI 10.1242/jcs.048579; Araki Y, 2007, EMBO J, V26, P1475, DOI 10.1038/sj.emboj.7601609; Arimoto M, 2011, J NEUROSCI, V31, P2216, DOI 10.1523/JNEUROSCI.2653-10.2011; Bilimoria PM, 2010, J NEUROSCI, V30, P16766, DOI 10.1523/JNEUROSCI.1362-10.2010; Blasius TL, 2007, J CELL BIOL, V176, P11, DOI 10.1083/jcb.200605099; Bowman AB, 2000, CELL, V103, P583, DOI 10.1016/S0092-8674(00)00162-8; Broude E, 1997, EXP NEUROL, V148, P367, DOI 10.1006/exnr.1997.6665; Brown HM, 2009, DEV NEUROBIOL, V69, P174, DOI 10.1002/dneu.20690; Byrd DT, 2001, NEURON, V32, P787, DOI 10.1016/S0896-6273(01)00532-3; Cai DW, 2007, J CELL BIOL, V176, P51, DOI 10.1083/jcb.200605097; Cai Q, 2005, J CELL BIOL, V170, P959, DOI 10.1083/jcb.200506042; Campbell PD, 2013, GENE EXPR PATTERNS, V13, P271, DOI 10.1016/j.gep.2013.05.002; Cavalli V, 2005, J CELL BIOL, V168, P775, DOI 10.1083/jcb.200410136; Cherny D, 2010, EMBO J, V29, P2161, DOI 10.1038/emboj.2010.103; Cho Y, 2012, EMBO J, V31, P3063, DOI 10.1038/emboj.2012.160; Coffman VC, 2012, TRENDS BIOCHEM SCI, V37, P499, DOI 10.1016/j.tibs.2012.08.002; Dajas-Ballador F, 2008, CURR BIOL, V18, P221, DOI 10.1016/j.cub.2008.01.025; Dietrich KA, 2008, P NATL ACAD SCI USA, V105, P8938, DOI 10.1073/pnas.0803575105; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Drerup CM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003303; Edwards SL, 2013, GENETICS, V194, P143, DOI 10.1534/genetics.112.147348; Falzone TL, 2010, HUM MOL GENET, V19, P4399, DOI 10.1093/hmg/ddq363; Falzone TL, 2009, J NEUROSCI, V29, P5758, DOI 10.1523/JNEUROSCI.0780-09.2009; Fu MM, 2013, J CELL BIOL, V202, P495, DOI 10.1083/jcb.201302078; Gindhart JG, 1998, J CELL BIOL, V141, P443, DOI 10.1083/jcb.141.2.443; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; GOLDBERG DJ, 1987, DEV BIOL, V124, P35, DOI 10.1016/0012-1606(87)90456-8; Goldstein LSB, 2001, P NATL ACAD SCI USA, V98, P6999, DOI 10.1073/pnas.111145298; Gordon MP, 2004, P NATL ACAD SCI USA, V101, P6462, DOI 10.1073/pnas.0401638101; GRIFFIN JW, 1976, J NEUROBIOL, V7, P355, DOI 10.1002/neu.480070407; Gunawardena S, 2013, HUM MOL GENET, V22, P3828, DOI 10.1093/hmg/ddt237; Ha HY, 2005, DEV BIOL, V277, P184, DOI 10.1016/j.ydbio.2004.09.019; Hammond JW, 2010, MOL BIOL CELL, V21, P572, DOI 10.1091/mbc.E09-01-0044; Hoerndli FJ, 2013, NEURON, V80, P1421, DOI 10.1016/j.neuron.2013.10.050; Ito M, 1999, MOL CELL BIOL, V19, P7539; Ito M, 2000, GENE, V255, P229, DOI 10.1016/S0378-1119(00)00335-8; Iwanaga A, 2007, NEUROSCI LETT, V429, P43, DOI 10.1016/j.neulet.2007.09.057; Jacobson C, 2006, NEURON, V49, P797, DOI 10.1016/j.neuron.2006.02.005; JOHNSON CS, 1990, CELL MOTIL CYTOSKEL, V16, P204, DOI 10.1002/cm.970160307; Kaan HYK, 2011, SCIENCE, V333, P883, DOI 10.1126/science.1204824; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kawano T, 2012, TRAFFIC, V13, P834, DOI 10.1111/j.1600-0854.2012.01350.x; Kelkar N, 2003, P NATL ACAD SCI USA, V100, P9843, DOI 10.1073/pnas.1733944100; Kelkar N, 2000, MOL CELL BIOL, V20, P1030, DOI 10.1128/MCB.20.3.1030-1043.2000; Konecna A, 2006, MOL BIOL CELL, V17, P3651, DOI 10.1091/mbc.E06-02-0112; Kuribayashi J, 2010, BRAIN RES, V1362, P133, DOI 10.1016/j.brainres.2010.09.053; Loiseau P, 2010, DEVELOPMENT, V137, P2763, DOI 10.1242/dev.048108; Mar FM, 2014, J NEUROSCI, V34, P5965, DOI 10.1523/JNEUROSCI.4680-13.2014; Matsuguchi T, 2003, EMBO J, V22, P4455, DOI 10.1093/emboj/cdg438; Matsuura H, 2002, J BIOL CHEM, V277, P40703, DOI 10.1074/jbc.M202004200; Morfini GA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065235; Moua P, 2011, DEVELOPMENT, V138, P1087, DOI 10.1242/dev.048645; Nakata T, 2011, J CELL BIOL, V194, P245, DOI 10.1083/jcb.201104034; Palacios IM, 2002, DEVELOPMENT, V129, P5473, DOI 10.1242/dev.00119; Poirier K, 2013, NAT GENET, V45, P639, DOI 10.1038/ng.2613; Rahman A, 1999, J CELL BIOL, V146, P1277, DOI 10.1083/jcb.146.6.1277; Rishal I, 2012, CELL REP, V1, P608, DOI 10.1016/j.celrep.2012.05.013; Schlager MA, 2014, CELL REP, V8, P1248, DOI 10.1016/j.celrep.2014.07.052; Shin JE, 2014, EXP NEUROL, V252, P1, DOI 10.1016/j.expneurol.2013.11.007; Shin JE, 2012, NEURON, V74, P1015, DOI 10.1016/j.neuron.2012.04.028; SKOUFIAS DA, 1994, J BIOL CHEM, V269, P1477; Su QN, 2004, NAT CELL BIOL, V6, P941, DOI 10.1038/ncb1169; Sun FN, 2011, EMBO J, V30, P3416, DOI 10.1038/emboj.2011.229; Sun T, 2013, J BIOL CHEM, V288, P14531, DOI 10.1074/jbc.M113.464453; Suzuki A, 2010, FEBS LETT, V584, P2801, DOI 10.1016/j.febslet.2010.05.020; Takino T, 2005, J BIOL CHEM, V280, P37772, DOI 10.1074/jbc.M505241200; Terada S, 2010, EMBO J, V29, P843, DOI 10.1038/emboj.2009.389; Watanabe TM, 2010, BIOCHEMISTRY-US, V49, P4654, DOI 10.1021/bi9021582; Willemsen MH, 2014, J MED GENET, V51, P487, DOI 10.1136/jmedgenet-2013-102182; Williams LS, 2014, DEVELOPMENT, V141, P176, DOI 10.1242/dev.097592; Wong YL, 2010, P NATL ACAD SCI USA, V107, P11781, DOI 10.1073/pnas.1005854107; Wozniak MJ, 2006, EMBO J, V25, P5457, DOI 10.1038/sj.emboj.7601427; Xu J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1760; Yamada M, 2010, EMBO J, V29, P517, DOI 10.1038/emboj.2009.378; Zhang H, 2014, METHODS, V67, P169, DOI 10.1016/j.ymeth.2014.01.010; Zheng JQ, 2001, J NEUROSCI, V21, P9291, DOI 10.1523/JNEUROSCI.21-23-09291.2001	78	21	22	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15512	15525		10.1074/jbc.M115.651885	http://dx.doi.org/10.1074/jbc.M115.651885			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25944905	Green Published, hybrid			2022-12-28	WOS:000356527400017
J	Gong, WM; Gohla, RM; Bowlin, KM; Koyano-Nakagawa, N; Garry, DJ; Shi, XZ				Gong, Wuming; Gohla, Rachel M.; Bowlin, Kathy M.; Koyano-Nakagawa, Naoko; Garry, Daniel J.; Shi, Xiaozhong			Kelch Repeat and BTB Domain Containing Protein 5 ( Kbtbd5) Regulates Skeletal Muscle Myogenesis through the E2F1-DP1 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEASOME PATHWAY; NEMALINE MYOPATHY; RETINOBLASTOMA PROTEIN; TRANSCRIPTIONAL ACTIVITY; EMBRYONIC-DEVELOPMENT; NUCLEAR-LOCALIZATION; EXPRESSION ANALYSIS; CELL-FUNCTION; MICE LACKING; RNA-SEQ	We have previously isolated a muscle-specific Kelch gene, Kelch repeat and BTB domain containing protein 5 (Kbtbd5)/Kelch-like protein 40 (Klhl40). In this report, we identified DP1 as a direct interacting factor for Kbtbd5 using a yeast two-hybrid screen and in vitro binding assays. Our studies demonstrate that Kbtbd5 interacts and regulates the cytoplasmic localization of DP1. GST pulldown assays demonstrate that the dimerization domain of DP1 interacts with all three of the Kbtbd5 domains. We further show that Kbtbd5 promotes the ubiquitination and degradation of DP1, thereby inhibiting E2F1-DP1 activity. To investigate the in vivo function of Kbtbd5, we used gene disruption technology and engineered Kbtbd5 null mice. Targeted deletion of Kbtbd5 resulted in postnatal lethality. Histological studies reveal that the Kbtbd5 null mice have smaller muscle fibers, a disorganized sarcomeric structure, increased extracellular matrix, and decreased numbers of mitochondria compared with wild-type controls. RNA sequencing and quantitative PCR analyses demonstrate the up-regulation of E2F1 target apoptotic genes (Bnip3 and p53inp1) in Kbtbd5 null skeletal muscle. Consistent with these observations, the cellular apoptosis in Kbtbd5 null mice was increased. Breeding of Kbtbd5 null mouse into the E2F1 null background rescues the lethal phenotype of the Kbtbd5 null mice but not the growth defect. The expression of Bnip3 and p53inp1 in Kbtbd5 mutant skeletal muscle are also restored to control levels in the E2F1 null background. In summary, our studies demonstrate that Kbtbd5 regulates skeletal muscle myogenesis through the regulation of E2F1-DP1 activity.	[Gong, Wuming; Gohla, Rachel M.; Bowlin, Kathy M.; Koyano-Nakagawa, Naoko; Garry, Daniel J.; Shi, Xiaozhong] Univ Minnesota Twin Cities, Lillehei Heart Inst, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Shi, XZ (corresponding author), Univ Minnesota, Lillehei Heart Inst, 2231 6th St ,SE 4-136 CCRB, Minneapolis, MN 55455 USA.	shixz@umn.edu	Gong, Wuming/GQH-1435-2022; Regan, Clinton/E-6250-2012	Gong, Wuming/0000-0002-3147-4028; 	National Institutes of Health [5R01AR047850, 5R01AR055906]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047850, R01AR055906] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R01AR047850 and 5R01AR055906.	Adams J, 2000, TRENDS CELL BIOL, V10, P17, DOI 10.1016/S0962-8924(99)01673-6; Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Blais A, 2004, CURR OPIN GENET DEV, V14, P527, DOI 10.1016/j.gde.2004.07.003; Bowlin KM, 2013, DIFFERENTIATION, V86, P184, DOI 10.1016/j.diff.2013.08.002; Brackertz M, 2006, NUCLEIC ACIDS RES, V34, P397, DOI 10.1093/nar/gkj437; Campanero MR, 1997, P NATL ACAD SCI USA, V94, P2221, DOI 10.1073/pnas.94.6.2221; Canning P, 2013, J BIOL CHEM, V288, P7803, DOI 10.1074/jbc.M112.437996; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Cirak S, 2010, BRAIN, V133, P2123, DOI 10.1093/brain/awq108; Cummings CM, 2009, J BIOL CHEM, V284, P11663, DOI 10.1074/jbc.M809374200; Datta A, 2002, MOL CELL BIOL, V22, P8398, DOI 10.1128/MCB.22.24.8398-8408.2002; delaLuna S, 1996, J CELL SCI, V109, P2443; Dhanoa BS, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-13; Dhume A, 2006, CELL MOTIL CYTOSKEL, V63, P493, DOI 10.1002/cm.20141; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Frey N, 2000, P NATL ACAD SCI USA, V97, P14632, DOI 10.1073/pnas.260501097; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Garg A, 2014, J CLIN INVEST, V124, P3529, DOI 10.1172/JCI74994; Garry DJ, 2000, P NATL ACAD SCI USA, V97, P5416, DOI 10.1073/pnas.100501197; Geng Y, 1996, ONCOGENE, V12, P1173; Ginsberg D, 2002, FEBS LETT, V529, P122, DOI 10.1016/S0014-5793(02)03270-2; GIRLING R, 1993, NATURE, V362, P83, DOI 10.1038/362083a0; Gupta VA, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-11; Gupta VA, 2013, AM J HUM GENET, V93, P1108, DOI 10.1016/j.ajhg.2013.10.020; Hateboer G, 1996, GENE DEV, V10, P2960, DOI 10.1101/gad.10.23.2960; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Hofmann F, 1996, GENE DEV, V10, P2949, DOI 10.1101/gad.10.23.2949; Hsu SIH, 2001, EMBO J, V20, P2273, DOI 10.1093/emboj/20.9.2273; Kohn MJ, 2004, MOL CELL BIOL, V24, P7197, DOI 10.1128/MCB.24.16.7197-7205.2004; Kohn MJ, 2003, DEVELOPMENT, V130, P1295, DOI 10.1242/dev.00355; Kroll J, 2005, MOL CELL BIOL, V25, P8531, DOI 10.1128/MCB.25.19.8531-8540.2005; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lammens T, 2009, TRENDS CELL BIOL, V19, P111, DOI 10.1016/j.tcb.2009.01.002; Lavia P, 1999, BIOESSAYS, V21, P221; Li J, 2008, DEV CELL, V14, P62, DOI 10.1016/j.devcel.2007.10.017; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Magae J, 1996, J CELL SCI, V109, P1717; Magae J, 1999, ONCOGENE, V18, P593, DOI 10.1038/sj.onc.1202345; Martelli F, 2001, P NATL ACAD SCI USA, V98, P4455, DOI 10.1073/pnas.081061398; Marti A, 1999, NAT CELL BIOL, V1, P14, DOI 10.1038/8984; Masuhiro Y, 2008, J BIOL CHEM, V283, P31575, DOI 10.1074/jbc.M800328200; Meeson AP, 2007, EMBO J, V26, P1902, DOI 10.1038/sj.emboj.7601635; Ohta T, 1999, MOL CELL, V3, P535, DOI 10.1016/S1097-2765(00)80482-7; Ohta T, 2001, CANCER RES, V61, P1347; Perez-Torrado R, 2006, BIOESSAYS, V28, P1194, DOI 10.1002/bies.20500; Pintard L, 2003, NATURE, V425, P311, DOI 10.1038/nature01959; Polager S, 2009, NAT REV CANCER, V9, P738, DOI 10.1038/nrc2718; Prag S, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-42; Ravenscroft G, 2013, AM J HUM GENET, V93, P6, DOI 10.1016/j.ajhg.2013.05.004; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rowland BD, 2006, CELL, V127, P871, DOI 10.1016/j.cell.2006.11.019; Sambuughin N, 2010, AM J HUM GENET, V87, P842, DOI 10.1016/j.ajhg.2010.10.020; Sellers WR, 1998, GENE DEV, V12, P95, DOI 10.1101/gad.12.1.95; Shi XZ, 2014, DEV BIOL, V389, P208, DOI 10.1016/j.ydbio.2014.02.018; Shi XZ, 2010, BIOCHEM J, V428, P213, DOI 10.1042/BJ20091906; Shi XZ, 2010, STEM CELLS, V28, P462, DOI 10.1002/stem.274; Stogios PJ, 2004, TRENDS BIOCHEM SCI, V29, P634, DOI 10.1016/j.tibs.2004.10.003; Sugimoto M, 1999, GENE DEV, V13, P3027, DOI 10.1101/gad.13.22.3027; Tracy K, 2007, MOL CELL BIOL, V27, P6229, DOI 10.1128/MCB.02246-06; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; van den Heuvel S, 2004, CURR BIOL, V14, pR59, DOI 10.1016/j.cub.2003.12.044; Wang J, 1996, J CELL BIOCHEM, V62, P405; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; XUE FY, 1993, CELL, V72, P681, DOI 10.1016/0092-8674(93)90397-9; Yamasaki L, 1996, CELL, V85, P537, DOI 10.1016/S0092-8674(00)81254-4; Yurkova N, 2008, CIRC RES, V102, P472, DOI 10.1161/CIRCRESAHA.107.164731	70	13	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15350	15361		10.1074/jbc.M114.629956	http://dx.doi.org/10.1074/jbc.M114.629956			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25940086	Green Published, hybrid			2022-12-28	WOS:000356177300045
J	Guo, Y; Hu, BF; Huang, H; Tsung, A; Gaikwad, NW; Xu, MS; Jiang, MX; Ren, SR; Fan, J; Billiar, TR; Huang, M; Xie, W				Guo, Yan; Hu, Bingfang; Huang, Hai; Tsung, Allan; Gaikwad, Nilesh W.; Xu, Meishu; Jiang, Mengxi; Ren, Songrong; Fan, Jie; Billiar, Timothy R.; Huang, Min; Xie, Wen			Estrogen Sulfotransferase Is an Oxidative Stress-responsive Gene That Gender-specifically Affects Liver Ischemia/Reperfusion Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIA-REPERFUSION INJURY; REDUCED-SIZE LIVER; NRF2 ACTIVATION; CELL-SURVIVAL; X-RECEPTOR; MICE; 17-BETA-ESTRADIOL; ANTIOXIDANT; MECHANISMS; INHIBITION	Estrogen sulfotransferase (EST) regulates estrogen homeostasis by sulfonating and deactivating estrogens. Liver ischemia and reperfusion (I/R) involves both hypoxia during the ischemic phase and oxidative damage during the reperfusion phase. In this report, we showed that the expression of EST was markedly induced by I/R. Mechanistically, oxidative stress-induced activation of Nrf2 was responsible for the EST induction, which was abolished in Nrf2(-/-) mice. EST is a direct transcriptional target of Nrf2. In female mice, the I/R-responsive induction of EST compromised estrogen activity. EST ablation attenuated I/R injury as a result of decreased estrogen deprivation, whereas this benefit was abolished upon ovariectomy. The effect of EST ablation was sex-specific because the EST-/- males showed heightened I/R injury. Reciprocally, both estrogens and EST regulate the expression and activity of Nrf2. Estrogen deprivation by ovariectomy abolished the I/R-responsive Nrf2 accumulation, whereas the compromised estrogen deprivation in EST-/- mice was associated with increased Nrf2 accumulation. Our results suggested a novel I/R-responsive feedback mechanism to limit the activity of Nrf2 in which Nrf2 induces the expression of EST, which subsequently increases estrogen deactivation and limits the estrogen-responsive activation of Nrf2. Inhibition of EST, at least in females, may represent an effective approach to manage hepatic I/R injury.	[Guo, Yan; Hu, Bingfang; Xu, Meishu; Jiang, Mengxi; Ren, Songrong; Xie, Wen] Univ Pittsburgh, Ctr Pharmacogenet, Pittsburgh, PA 15261 USA; [Guo, Yan; Hu, Bingfang; Xu, Meishu; Jiang, Mengxi; Ren, Songrong; Xie, Wen] Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA; [Huang, Hai; Tsung, Allan; Billiar, Timothy R.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15261 USA; [Xie, Wen] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Guo, Yan] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Pathol, Shanghai 200025, Peoples R China; [Hu, Bingfang; Huang, Min] Sun Yat Sen Univ, Inst Clin Pharmacol, Guangzhou 510275, Guangdong, Peoples R China; [Gaikwad, Nilesh W.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Gaikwad, Nilesh W.] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA; [Fan, Jie] Vet Affairs Pittsburgh Healthcare Syst, Surg Res, Pittsburgh, PA 15240 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Shanghai Jiao Tong University; Sun Yat Sen University; University of California System; University of California Davis; University of California System; University of California Davis; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Huang, M (corresponding author), Sun Yat Sen Univ, Inst Clin Pharmacol, Guangzhou 510006, Guangdong, Peoples R China.	huangmin@mail.sysu.edu.cn; wex6@pitt.edu	Xie, Wen/M-1768-2016; Huang, Huang/AAN-5671-2020; Regan, Clinton/E-6250-2012; Huang, Hai/F-4286-2012	Huang, Hai/0000-0001-7430-0119; Guo, Yan/0000-0002-2344-0944; Jiang, Mengxi/0000-0003-4446-984X	National Institutes of Health [HD073070, DK099232, ES023438]; Joseph Koslow Endowed Professorship; Visiting Scholar Foundation of Shanghai Municipal Education Commission; China Scholarship Council [201206380045]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD073070] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES023438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM053789] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joseph Koslow Endowed Professorship; Visiting Scholar Foundation of Shanghai Municipal Education Commission; China Scholarship Council(China Scholarship Council); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HD073070, DK099232, and ES023438, and by the Joseph Koslow Endowed Professorship (to W. X.).r Supported by the Visiting Scholar Foundation of Shanghai Municipal Education Commission.r Supported by China Scholarship Council Scholarship 201206380045.	Alnouti Y, 2008, J PHARMACOL EXP THER, V324, P612, DOI 10.1124/jpet.107.129650; Dery MAC, 2005, INT J BIOCHEM CELL B, V37, P535, DOI 10.1016/j.biocel.2004.08.012; Eckhoff DE, 2002, SURGERY, V132, P302, DOI 10.1067/msy.2002.125718; Gao J, 2012, DIABETES, V61, P1543, DOI 10.2337/db11-1152; Gong H, 2008, CANCER RES, V68, P7386, DOI 10.1158/0008-5472.CAN-08-1545; Gong HB, 2007, MOL ENDOCRINOL, V21, P1781, DOI 10.1210/me.2007-0187; Gorrini C, 2013, J EXP MED, V210, P1529, DOI 10.1084/jem.20121337; Harada H, 2001, J APPL PHYSIOL, V91, P2816, DOI 10.1152/jappl.2001.91.6.2816; Hybertson BM, 2011, MOL ASPECTS MED, V32, P234, DOI 10.1016/j.mam.2011.10.006; Jaeschke H, 2003, AM J PHYSIOL-GASTR L, V284, pG15, DOI 10.1152/ajpgi.00342.2002; Jain A, 2000, ANN SURG, V232, P490, DOI 10.1097/00000658-200010000-00004; James MO, 2010, ENVIRON INT, V36, P942, DOI 10.1016/j.envint.2009.02.004; Jarrar D, 2000, AM J PHYSIOL-HEART C, V279, pH1015, DOI 10.1152/ajpheart.2000.279.3.H1015; Katsuoka F, 2005, MOL CELL BIOL, V25, P8044, DOI 10.1128/MCB.25.18.8044-8051.2005; Ke BB, 2013, J HEPATOL, V59, P1200, DOI 10.1016/j.jhep.2013.07.016; Klune JR, 2010, SURG CLIN N AM, V90, P665, DOI 10.1016/j.suc.2010.04.003; Kudoh K, 2014, ANN SURG, V260, P118, DOI 10.1097/SLA.0000000000000287; Lee CC, 2000, HEPATO-GASTROENTEROL, V47, P446; Leonard MO, 2006, FASEB J, V20, P2624, DOI 10.1096/fj.06-5097fje; Lin FS, 2012, SHOCK, V37, P183, DOI 10.1097/SHK.0b013e31823f1918; Lin XH, 2011, FREE RADICAL BIO MED, V51, P97, DOI 10.1016/j.freeradbiomed.2011.04.020; Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212; Pasqualini JR, 2009, ANN NY ACAD SCI, V1155, P88, DOI 10.1111/j.1749-6632.2009.04113.x; Penugonda S, 2006, TOXICOL APPL PHARM, V216, P197, DOI 10.1016/j.taap.2006.05.002; Qian YM, 2001, ENDOCRINOLOGY, V142, P5342, DOI 10.1210/en.142.12.5342; Serracino-Inglott F, 2001, AM J SURG, V181, P160, DOI 10.1016/S0002-9610(00)00573-0; Shen SQ, 2007, J SURG RES, V140, P67, DOI 10.1016/j.jss.2006.10.022; Soljancic A, 2013, AM J PHYSIOL-REG I, V304, pR951, DOI 10.1152/ajpregu.00360.2012; Song WC, 2001, ANN NY ACAD SCI, V948, P43; Staren ED, 2004, AM J SURG, V188, P136, DOI 10.1016/j.amjsurg.2003.12.063; Staudinger J, 2001, DRUG METAB DISPOS, V29, P1467; Sueyoshi T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021229; Vilatoba M, 2005, TRANSPL P, V37, P399, DOI 10.1016/j.transproceed.2004.12.053; Wang ZG, 2014, HEPATOLOGY, V59, P1381, DOI 10.1002/hep.26912; Xu JL, 2012, DIABETES, V61, P3208, DOI 10.2337/db11-1716; Zhai Y, 2011, AM J TRANSPLANT, V11, P1563, DOI 10.1111/j.1600-6143.2011.03579.x; Zhang HP, 1998, J BIOL CHEM, V273, P10888, DOI 10.1074/jbc.273.18.10888	37	33	35	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14754	14764		10.1074/jbc.M115.642124	http://dx.doi.org/10.1074/jbc.M115.642124			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25922074	Green Published, hybrid			2022-12-28	WOS:000355754600044
J	Norris, KL; Hao, R; Chen, LF; Lai, CH; Kapur, M; Shaughnessy, PJ; Chou, D; Yan, J; Taylor, JP; Engelender, S; West, AE; Lim, KL; Yao, TP				Norris, Kristi L.; Hao, Rui; Chen, Liang-Fu; Lai, Chun-Hsiang; Kapur, Meghan; Shaughnessy, Peter J.; Chou, Dennis; Yan, Jin; Taylor, J. Paul; Engelender, Simone; West, Anna E.; Lim, Kah-Leong; Yao, Tso-Pang			Convergence of Parkin, PINK1, and alpha-Synuclein on Stress-induced Mitochondrial Morphological Remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEWY-BODY FORMATION; HUMAN-CELLS; DISEASE; MITOPHAGY; FUSION; PROTEIN; SYNPHILIN-1; MEMBRANE; UBIQUITINATION; DEGENERATION	Mutations in PARKIN (PARK2), an ubiquitin ligase, cause early onset Parkinson disease. Parkin was shown to bind, ubiquitinate, and target depolarized mitochondria for destruction by autophagy. This process, mitophagy, is considered crucial for maintaining mitochondrial integrity and suppressing Parkinsonism. Here, we report that under moderate mitochondrial stress, parkin does not translocate to mitochondria to induce mitophagy; rather, it stimulates mitochondrial connectivity. Mitochondrial stress-induced fusion requires PINK1 (PARK6), mitofusins, and parkin ubiquitin ligase activity. Upon exposure to mitochondrial toxins, parkin binds alpha-synuclein (PARK1), and in conjunction with the ubiquitin-conjugating enzyme Ubc13, stimulates K63-linked ubiquitination. Importantly, alpha-synuclein inactivation phenocopies parkin overexpression and suppresses stress-induced mitochondria fission, whereas Ubc13 inactivation abrogates parkin-dependent mitochondrial fusion. The convergence of parkin, PINK1, and alpha-synuclein on mitochondrial dynamics uncovers a common function of these PARK genes in the mitochondrial stress response and provides a potential physiological basis for the prevalence of alpha-synuclein pathology in Parkinson disease.	[Norris, Kristi L.; Hao, Rui; Lai, Chun-Hsiang; Kapur, Meghan; Shaughnessy, Peter J.; Chou, Dennis; Yan, Jin; Yao, Tso-Pang] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Chen, Liang-Fu; West, Anna E.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Taylor, J. Paul] St Jude Childrens Res Hosp, Dept Cell & Mol Biol, Memphis, TN 38105 USA; [Engelender, Simone] Technion Israel Inst Technol, Rappaport Fac Med, Dept Pharmacol, IL-31096 Haifa, Israel; [Engelender, Simone] Technion Israel Inst Technol, Res Inst, IL-31096 Haifa, Israel; [Lim, Kah-Leong] Natl Univ Singapore, Dept Physiol, Singapore 117548, Singapore	Duke University; Duke University; St Jude Children's Research Hospital; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; National University of Singapore	Yao, TP (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	tsopang.yao@dm.duke.edu	Lim, Kah-Leong/AAY-3308-2020; Taylor, J. Paul/N-2482-2018; soler, martha maricel m gomez/L-6025-2014; Lim, Kah/L-5426-2019; Regan, Clinton/E-6250-2012	Taylor, J. Paul/0000-0002-5794-0349; soler, martha maricel m gomez/0000-0002-4412-8108; Engelender, Simone/0000-0001-7401-6855; Lim, Kah-Leong/0000-0002-5440-2588	National Institutes of Health [T32-CA-059365, 1R01DA033610, 2R01-NS054022]; Leukemia and Lymphoma Society [5396-11]; NATIONAL CANCER INSTITUTE [T32CA059365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033610] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants T32-CA-059365 (to K. L. N.), 1R01DA033610 (to A. E. W.), and 2R01-NS054022 (to T. P. Y.) and Leukemia and Lymphoma Society Grant 5396-11 (to K. L. N.).	Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Chan N. C., 2011, HUMAN MOL GENET; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Chen SG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010848; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Dauer W, 2002, P NATL ACAD SCI USA, V99, P14524, DOI 10.1073/pnas.172514599; DEXTER DT, 1994, ANN NEUROL, V35, P38, DOI 10.1002/ana.410350107; Doss-Pepe EW, 2005, J BIOL CHEM, V280, P16619, DOI 10.1074/jbc.M413591200; Ellis CE, 2005, MOL CELL BIOL, V25, P10190, DOI 10.1128/MCB.25.22.10190-10201.2005; Engelender S, 1999, NAT GENET, V22, P110, DOI 10.1038/8820; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Hao R, 2013, MOL CELL, V51, P819, DOI 10.1016/j.molcel.2013.08.016; Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359; Irrcher I, 2010, HUM MOL GENET, V19, P3734, DOI 10.1093/hmg/ddq288; Kamp F, 2010, EMBO J, V29, P3571, DOI 10.1038/emboj.2010.223; Karbowski M, 2006, NATURE, V443, P658, DOI 10.1038/nature05111; Kim KY, 2011, J CLIN INVEST, V121, P3701, DOI 10.1172/JCI44736; Lee JY, 2014, J CELL SCI, V127, P4954, DOI 10.1242/jcs.157321; Lee JY, 2010, J CELL BIOL, V189, P671, DOI 10.1083/jcb.201001039; Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.E02-06-0330; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Miyakawa S, 2013, MOVEMENT DISORD, V28, P388, DOI 10.1002/mds.25346; Mortiboys H, 2008, ANN NEUROL, V64, P555, DOI 10.1002/ana.21492; Musgrove REJ, 2013, NEUROTOX RES, V23, P358, DOI 10.1007/s12640-012-9352-5; Nakada K, 2009, INT J BIOCHEM CELL B, V41, P1907, DOI 10.1016/j.biocel.2009.05.010; Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Pham AH, 2012, HUM MOL GENET, V21, P4817, DOI 10.1093/hmg/dds311; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Rapaport D, 1998, J BIOL CHEM, V273, P20150, DOI 10.1074/jbc.273.32.20150; Smith WW, 2010, HUM MOL GENET, V19, P2087, DOI 10.1093/hmg/ddq086; Tan JMM, 2008, HUM MOL GENET, V17, P431, DOI 10.1093/hmg/ddm320; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Whitworth AJ, 2005, P NATL ACAD SCI USA, V102, P8024, DOI 10.1073/pnas.0501078102; Yang BX, 2006, J BIOL CHEM, V281, P16202, DOI 10.1074/jbc.M601864200; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338	45	55	59	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13862	13874		10.1074/jbc.M114.634063	http://dx.doi.org/10.1074/jbc.M114.634063			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25861987	Green Published, hybrid			2022-12-28	WOS:000355313000019
J	Hwang, B; McCool, K; Wan, J; Wuerzberger-Davis, SM; Young, EWK; Choi, EY; Cingolani, G; Weaver, BA; Miyamoto, S				Hwang, Byounghoon; McCool, Kevin; Wan, Jun; Wuerzberger-Davis, Shelly M.; Young, Edmond W. K.; Choi, Eun Young; Cingolani, Gino; Weaver, Beth A.; Miyamoto, Shigeki			IPO3-mediated Nonclassical Nuclear Import of NF-kappa B Essential Modulator (NEMO) Drives DNA Damage-dependent NF-kappa B Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RISK MYELODYSPLASTIC SYNDROME; LOCALIZATION SIGNAL; NUCLEOCYTOPLASMIC TRANSPORT; ALPHA; PROTEIN; ATM; UBIQUITINATION; INHIBITION; SENESCENCE; PATHWAY	Activation of I kappa B kinase (IKK) and NF-kappa B by genotoxic stresses modulates apoptotic responses and production of inflammatory mediators, thereby contributing to therapy resistance and premature aging. We previously reported that genotoxic agents induce nuclear localization of NF-kappa B essential modulator (NEMO) via an undefined mechanism to arbitrate subsequent DNA damage-dependent IKK/NF-kappa B signaling. Here we show that a nonclassical nuclear import pathway via IPO3 (importin 3, transportin 2) mediates stress-induced NEMO nuclear translocation. We found putative nuclear localization signals in NEMO whose mutations disrupted stress-inducible nuclear translocation of NEMO and IKK/NF-kappa B activation in stably reconstituted NEMO-deficient cells. RNAi screening of both importin alpha and beta family members, as well as co-immunoprecipitation analyses, revealed that a nonclassical importin beta family member, IPO3, was the only importin that was able to associate with NEMO and whose reduced expression prevented genotoxic stress-induced NEMO nuclear translocation, IKK/NF-kappa B activation, and inflammatory cytokine transcription. Recombinant IPO3 interacted with recombinant NEMO but not the nuclear localization signal mutant version and induced nuclear import of NEMO in digitonin-permeabilized cells. We also provide evidence that NEMO is disengaged from IKK complex following genotoxic stress induction. Thus, the IPO3 nuclear import pathway is an early and crucial determinant of the IKK/NF-kappa B signaling arm of the mammalian DNA damage response.	[Hwang, Byounghoon; McCool, Kevin; Wuerzberger-Davis, Shelly M.; Choi, Eun Young; Miyamoto, Shigeki] Univ Wisconsin, Dept Oncol, Madison, WI USA; [McCool, Kevin] Univ Wisconsin, Mol & Cellular Pharmacol Program, Madison, WI USA; [Wan, Jun; Weaver, Beth A.] Univ Wisconsin, Dept Cell & Regenerat Biol, Madison, WI USA; [Wuerzberger-Davis, Shelly M.; Weaver, Beth A.; Miyamoto, Shigeki] Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA; [Young, Edmond W. K.] Univ Toronto, Dept Mech & Ind Engn, Toronto, ON M5S 3G8, Canada; [Young, Edmond W. K.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G8, Canada; [Cingolani, Gino] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Toronto; University of Toronto; Jefferson University	Miyamoto, S (corresponding author), 6159 Wisconsin Inst Med Res, 1111 Highland Ave, Madison, WI 53705 USA.	smiyamot@wisc.edu	Regan, Clinton/E-6250-2012	Young, Edmond/0000-0002-1274-5478	National Institutes of Health [R01 CA77474, GM083681, CA140458]; NATIONAL CANCER INSTITUTE [P30CA056036, R01CA077474, R01CA140458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083681, T32GM008692] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA77474 and GM083681 (to S. M.) and CA140458 (to B. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Blanc V, 2003, J BIOL CHEM, V278, P41198, DOI 10.1074/jbc.M302951200; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; Campbell KJ, 2004, MOL CELL, V13, P853, DOI 10.1016/S1097-2765(04)00131-5; Carvalho G, 2007, ONCOGENE, V26, P2299, DOI 10.1038/sj.onc.1210043; Cassany Aurelia, 2008, V464, P181; Chen JQ, 2013, CURR OPIN IMMUNOL, V25, P4, DOI 10.1016/j.coi.2012.12.005; Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711; Chook YM, 2011, BBA-MOL CELL RES, V1813, P1593, DOI 10.1016/j.bbamcr.2010.10.014; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Dormann D, 2010, EMBO J, V29, P2841, DOI 10.1038/emboj.2010.143; Fagerlund R, 2005, J BIOL CHEM, V280, P15942, DOI 10.1074/jbc.M500814200; Fagerlund R, 2008, CELL SIGNAL, V20, P1442, DOI 10.1016/j.cellsig.2008.03.012; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Gilmore TD, 2011, CURR TOP MICROBIOL, V349, P245, DOI 10.1007/82_2010_105; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Grosjean-Raillard J, 2009, ONCOGENE, V28, P1099, DOI 10.1038/onc.2008.457; Gudleski N, 2010, P NATL ACAD SCI USA, V107, P9358, DOI 10.1073/pnas.1000304107; Guttinger S, 2004, P NATL ACAD SCI USA, V101, P2918, DOI 10.1073/pnas.0400342101; Harte MT, 2014, ONCOGENE, V33, P713, DOI 10.1038/onc.2013.10; Hayden MS, 2011, CELL RES, V21, P223, DOI 10.1038/cr.2011.13; Hinz M, 2010, MOL CELL, V40, P63, DOI 10.1016/j.molcel.2010.09.008; Huang TT, 2000, J BIOL CHEM, V275, P9501, DOI 10.1074/jbc.275.13.9501; Huang TT, 2002, MOL CELL BIOL, V22, P5813, DOI 10.1128/MCB.22.16.5813-5825.2002; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Hwang B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116374; Imasaki T, 2007, MOL CELL, V28, P57, DOI 10.1016/j.molcel.2007.08.006; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Janssens S, 2006, CELL DEATH DIFFER, V13, P773, DOI 10.1038/sj.cdd.4401843; Janssens S, 2005, CELL, V123, P1079, DOI 10.1016/j.cell.2005.09.036; Janssens S, 2012, CELL DEATH DIFFER, V19, P13, DOI 10.1038/cdd.2011.162; Jin HS, 2009, CANCER RES, V69, P1782, DOI 10.1158/0008-5472.CAN-08-2256; Jing H, 2011, GENE DEV, V25, P2137, DOI 10.1101/gad.17620611; Kelley JB, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-63; Kose S, 2012, CELL, V149, P578, DOI 10.1016/j.cell.2012.02.058; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Liang PZ, 2013, TRAFFIC, V14, P1132, DOI 10.1111/tra.12097; Lott K, 2011, J BIOL CHEM, V286, P28160, DOI 10.1074/jbc.M111.228007; Mabb AM, 2006, NAT CELL BIOL, V8, P986, DOI 10.1038/ncb1458; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; McCool KW, 2012, IMMUNOL REV, V246, P311, DOI 10.1111/j.1600-065X.2012.01101.x; Miyamoto S, 1998, MOL CELL BIOL, V18, P19, DOI 10.1128/MCB.18.1.19; Neish AS, 2011, TRENDS MICROBIOL, V19, P596, DOI 10.1016/j.tim.2011.08.004; Niu JX, 2011, EMBO J, V30, P3741, DOI 10.1038/emboj.2011.264; Osorio FG, 2012, GENE DEV, V26, P2311, DOI 10.1101/gad.197954.112; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Plafker SM, 2000, EMBO J, V19, P5502, DOI 10.1093/emboj/19.20.5502; Plafker SM, 2004, J CELL BIOL, V167, P649, DOI 10.1083/jcb.200406001; Plafker SM, 2002, MOL CELL BIOL, V22, P1266, DOI 10.1128/MCB.22.4.1266-1275.2002; Pumroy RA, 2015, BIOCHEM J, V466, P13, DOI 10.1042/BJ20141186; Rebane A, 2004, RNA, V10, P590, DOI 10.1261/rna.5224304; Rosato RR, 2010, J BIOL CHEM, V285, P10064, DOI 10.1074/jbc.M109.095208; Sabatel H, 2011, BIOCHEM PHARMACOL, V82, P1371, DOI 10.1016/j.bcp.2011.07.105; SCHREIBER V, 1992, EMBO J, V11, P3263, DOI 10.1002/j.1460-2075.1992.tb05404.x; Siomi MC, 1997, J CELL BIOL, V138, P1181, DOI 10.1083/jcb.138.6.1181; Sorokin AV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1439, DOI 10.1134/S0006297907130032; Stilmann M, 2009, MOL CELL, V36, P365, DOI 10.1016/j.molcel.2009.09.032; Tilstra JS, 2012, J CLIN INVEST, V122, P2601, DOI 10.1172/JCI45785; Tsuchiya Y, 2010, MOL CELL, V39, P570, DOI 10.1016/j.molcel.2010.07.030; Twyffels L, 2014, FEBS LETT, V588, P1857, DOI 10.1016/j.febslet.2014.04.023; Wan J, 2014, CURR BIOL, V24, P2687, DOI 10.1016/j.cub.2014.09.052; Wang JX, 2009, EMBO REP, V10, P1272, DOI 10.1038/embor.2009.197; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Wittig I, 2009, PROTEOMICS, V9, P5214, DOI 10.1002/pmic.200900151; Wu LX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018447; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Wu ZH, 2008, EMBO J, V27, P1963, DOI 10.1038/emboj.2008.127; Wu ZH, 2010, MOL CELL, V40, P75, DOI 10.1016/j.molcel.2010.09.010; Wuerzberger-Davis SM, 2007, ONCOGENE, V26, P641, DOI 10.1038/sj.onc.1209815; Wuerzberger-Davis SM, 2005, MOL CANCER RES, V3, P345, DOI 10.1158/1541-7786.MCR-05-0028; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Yang YB, 2011, MOL CELL BIOL, V31, P2774, DOI 10.1128/MCB.01139-10; Young DB, 2005, J BIOL CHEM, V280, P27587, DOI 10.1074/jbc.M411689200; Zienkiewicz J, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000386	76	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					17967	17984		10.1074/jbc.M115.645960	http://dx.doi.org/10.1074/jbc.M115.645960			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26060253	hybrid, Green Published			2022-12-28	WOS:000358511700030
J	Li, T; Tian, Y; Li, Q; Chen, HY; Lv, HH; Xie, W; Han, JH				Li, Tao; Tian, Yao; Li, Qian; Chen, Huiying; Lv, Huihui; Xie, Wei; Han, Junhai			The Neurexin/N-Ethylmaleimide-sensitive Factor (NSF) Interaction Regulates Short Term Synaptic Depression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUSION PROTEIN; ALPHA-NEUREXINS; MEMBRANE-FUSION; TRANSSYNAPTIC INTERACTION; NEUROMUSCULAR-JUNCTION; VESICLE DOCKING; BETA-NEUREXINS; CA2+ CHANNELS; DROSOPHILA; DOMAIN	Although Neurexins, which are cell adhesion molecules localized predominantly to the presynaptic terminals, are known to regulate synapse formation and synaptic transmission, their roles in the regulation of synaptic vesicle release during repetitive nerve stimulation are unknown. Here, we show that nrx mutant synapses exhibit rapid short term synaptic depression upon tetanic nerve stimulation. Moreover, we demonstrate that the intracellular region of NRX is essential for synaptic vesicle release upon tetanic nerve stimulation. Using a yeast two-hybrid screen, we find that the intracellular region of NRX interacts with N-ethylmaleimide-sensitive factor (NSF), an enzyme that mediates soluble NSF attachment protein receptor (SNARE) complex disassembly and plays an important role in synaptic vesicle release. We further map the binding sites of each molecule and demonstrate that the NRX/NSF interaction is critical for both the distribution of NSF at the presynaptic terminals and SNARE complex disassembly. Our results reveal a previously unknown role of NRX in the regulation of short term synaptic depression upon tetanic nerve stimulation and provide new mechanistic insights into the role of NRX in synaptic vesicle release.	[Li, Tao; Tian, Yao; Li, Qian; Chen, Huiying; Lv, Huihui; Xie, Wei; Han, Junhai] Southeast Univ, Inst Life Sci, Key Lab Dev Genes & Human Dis, Nanjing 210096, Jiangsu, Peoples R China; [Xie, Wei; Han, Junhai] Nantong Univ, Coinnovat Ctr Neuroregenerat, Nantong 226001, JS, Peoples R China	Southeast University - China; Nantong University	Han, JH (corresponding author), Southeast Univ, Inst Life Sci, 2 Sipailou Rd, Nanjing 210096, Jiangsu, Peoples R China.	junhaihan@seu.edu.cn		Tian, Yao/0000-0002-0367-6239	Ministry of Science and Technology [2014CB942803, 2012CB517903]; Chinese Ministry of Education [113028A]; Excellent Youth Foundation of Jiangsu Province of China [BK20140024]; National Natural Science Foundation of China [30930051]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Chinese Ministry of Education(Ministry of Education, China); Excellent Youth Foundation of Jiangsu Province of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Ministry of Science and Technology Grants 2014CB942803 and 2012CB517903, Research Project of Chinese Ministry of Education Grant 113028A, Excellent Youth Foundation of Jiangsu Province of China Grant BK20140024 (to J. H.), and National Natural Science Foundation of China Key Program 30930051 (to W. X.). The authors declare that they have no conflicts of interest with the contents of this article.	Aoto J, 2013, CELL, V154, P75, DOI 10.1016/j.cell.2013.05.060; Atasoy D, 2007, P NATL ACAD SCI USA, V104, P2525, DOI 10.1073/pnas.0611003104; Biederer T, 2001, J BIOL CHEM, V276, P47869, DOI 10.1074/jbc.M105287200; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Choi YB, 2011, NEURON, V70, P468, DOI 10.1016/j.neuron.2011.03.020; de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019; Delgado R, 2000, NEURON, V28, P941, DOI 10.1016/S0896-6273(00)00165-3; Fairless R, 2008, J NEUROSCI, V28, P12969, DOI 10.1523/JNEUROSCI.5294-07.2008; Fleming KG, 1998, J BIOL CHEM, V273, P15675, DOI 10.1074/jbc.273.25.15675; Gokce O, 2013, J NEUROSCI, V33, P14617, DOI 10.1523/JNEUROSCI.1232-13.2013; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; HATA Y, 1993, NEURON, V10, P307, DOI 10.1016/0896-6273(93)90320-Q; Hata Y, 1996, J NEUROSCI, V16, P2488; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Ho A, 2006, J NEUROSCI, V26, P13089, DOI 10.1523/JNEUROSCI.2855-06.2006; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; JAN LY, 1976, J PHYSIOL-LONDON, V262, P189, DOI 10.1113/jphysiol.1976.sp011592; Kawasaki F, 2009, P NATL ACAD SCI USA, V106, P14658, DOI 10.1073/pnas.0907144106; Ko J, 2009, NEURON, V64, P791, DOI 10.1016/j.neuron.2009.12.012; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; Li J, 2007, NEURON, V55, P741, DOI 10.1016/j.neuron.2007.08.002; Li Y, 2013, J NEUROSCI, V33, P15545, DOI 10.1523/JNEUROSCI.0819-13.2013; Littleton JT, 2001, P NATL ACAD SCI USA, V98, P12233, DOI 10.1073/pnas.221450198; Littleton JT, 1998, NEURON, V21, P401, DOI 10.1016/S0896-6273(00)80549-8; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Missler M, 1998, J NEUROSCI, V18, P3630; Missler M, 1998, TRENDS GENET, V14, P20, DOI 10.1016/S0168-9525(97)01324-3; Missler M, 1998, J BIOL CHEM, V273, P34716, DOI 10.1074/jbc.273.52.34716; NAGIEC EE, 1995, J BIOL CHEM, V270, P29182, DOI 10.1074/jbc.270.49.29182; Owald D, 2012, NAT NEUROSCI, V15, P1219, DOI 10.1038/nn.3183; Petrenko AG, 1996, J NEUROSCI, V16, P4360; Rowen L, 2002, GENOMICS, V79, P587, DOI 10.1006/geno.2002.6734; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Sudhof T. C., 2011, CSH PERSPECT BIOL, V3, P3, DOI DOI 10.1101/CSHPERSPECT.A005637; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; SUMIDA M, 1994, J BIOL CHEM, V269, P20636; Sun MK, 2011, J NEUROSCI, V31, P687, DOI 10.1523/JNEUROSCI.3854-10.2011; TAGAYA M, 1993, J BIOL CHEM, V268, P2662; Tian Y, 2013, NEURON, V77, P311, DOI 10.1016/j.neuron.2012.11.012; Tolar LA, 1998, J NEUROSCI, V18, P10250; Uemura T, 2010, CELL, V141, P1068, DOI 10.1016/j.cell.2010.04.035; VANDEGOOR J, 1995, P NATL ACAD SCI USA, V92, P5739, DOI 10.1073/pnas.92.12.5739; Wang DY, 2006, BBA-GEN SUBJECTS, V1760, P1428, DOI 10.1016/j.bbagen.2006.05.011; WHITEHEART SW, 1994, J CELL BIOL, V126, P945, DOI 10.1083/jcb.126.4.945; Wojcik SM, 2007, NEURON, V55, P11, DOI 10.1016/j.neuron.2007.06.013; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Yu RC, 1998, NAT STRUCT BIOL, V5, P803, DOI 10.1038/1843; Yu WH, 2011, MOL CELL NEUROSCI, V47, P19, DOI 10.1016/j.mcn.2011.02.002; Zeng XK, 2007, FEBS LETT, V581, P2509, DOI 10.1016/j.febslet.2007.04.068; Zhang WQ, 2005, J NEUROSCI, V25, P4330, DOI 10.1523/JNEUROSCI.0497-05.2005	55	16	16	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					17656	17667		10.1074/jbc.M115.644583	http://dx.doi.org/10.1074/jbc.M115.644583			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	25953899	Green Published, hybrid			2022-12-28	WOS:000358511700002
J	Hartmann, M; Parra, LM; Ruschel, A; Lindner, C; Morrison, H; Herrlich, A; Herrlich, P				Hartmann, Monika; Parra, Liseth M.; Ruschel, Anne; Lindner, Christina; Morrison, Helen; Herrlich, Andreas; Herrlich, Peter			Inside-out Regulation of Ectodomain Cleavage of Cluster-of-Differentiation-44 (CD44) and of Neuregulin-1 Requires Substrate Dimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-CONVERTING-ENZYME; GROWTH-FACTOR RECEPTOR; NECROSIS-FACTOR-ALPHA; BREAST-CANCER CELLS; EGF RECEPTOR; TRANSMEMBRANE DOMAIN; SIGNALING PATHWAYS; STRUCTURAL BASIS; CARCINOMA-CELLS; LIGAND RELEASE	Ectodomain shedding of transmembrane precursor proteins generates numerous life-essential molecules, such as epidermal growth factor receptor ligands. This cleavage not only releases the regulatory growth factor, but it is also the required first step for the subsequent processing by gamma-secretase and the release of gene regulatory intracellular fragments. Signaling within the cell modifies the cytoplasmic tails of substrates, a step important in starting the specific and regulated cleavage of a large number of studied substrates. Ectodomain cleavage occurs, however, on the outside of the plasma membrane and is carried out by membrane-bound metalloproteases. How the intracellular domain modification communicates with the ectodomain of the substrate to allow for cleavage to occur is unknown. Here, we show that homodimerization of a cluster-of-differentiation-44 or of pro-neuregulin-1 monomers represents an essential precondition for their regulated ectodomain cleavage. Both substrates are associated with their respective metalloproteases under both basal or cleavage-stimulated conditions. These interactions only turn productive by specific intracellular signal-induced intracellular domain modifications of the substrates, which in turn regulate metalloprotease access to the substrates' ectodomain and cleavage. We propose that substrate intracellular domain modification induces a relative rotation or other positional change of the dimerization partners that allow metalloprotease cleavage in the extracellular space. Our findings fill an important gap in understanding substrate-specific inside-out signal transfer along cleaved transmembrane proteins and suggest that substrate dimerization (homo-or possibly heterodimerization) might represent a general principle in ectodomain shedding.	[Hartmann, Monika; Parra, Liseth M.; Ruschel, Anne; Lindner, Christina; Morrison, Helen; Herrlich, Peter] Fritz Lipmann Inst, Leibniz Inst Age Res, D-07745 Jena, Germany; [Parra, Liseth M.; Herrlich, Andreas] Harvard Univ, Brigham & Womens Hosp, Sch Med, Harvard Inst Med,Renal Div, Boston, MA 02115 USA	Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Harvard University; Brigham & Women's Hospital; Harvard Medical School	Herrlich, P (corresponding author), Leibniz Inst Age Res, Beutenbergstr 11, D-07745 Jena, Germany.	herrlich@fli-leibniz.de	Morrison, Helen/B-3984-2017; Morrison, Helen/F-9748-2014	Morrison, Helen/0000-0003-4938-1409; Morrison, Helen/0000-0003-4938-1409	National Institutes of Health from NIDDK [R00DK077731]; Ernst- Jung Foundation; German Research Foundation [DFGHE551]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK077731] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; Ernst- Jung Foundation; German Research Foundation(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R00DK077731 from NIDDK (to A. H.). This work was also supported by our institutions. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a fellowship from the Ernst- Jung Foundation.; Supported by Grant DFGHE551 from the German Research Foundation.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; Arkhipov A, 2013, CELL, V152, P557, DOI 10.1016/j.cell.2012.12.030; ARRIBAS J, 1995, J CELL BIOL, V128, P433, DOI 10.1083/jcb.128.3.433; BAZIL V, 1992, J IMMUNOL, V149, P747; Blobel CR, 2009, EXP CELL RES, V315, P671, DOI 10.1016/j.yexcr.2008.10.011; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Bozkulak EC, 2009, MOL CELL BIOL, V29, P5679, DOI 10.1128/MCB.00406-09; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; Dang M, 2013, P NATL ACAD SCI USA, V110, P9776, DOI 10.1073/pnas.1307478110; Dang M, 2011, J BIOL CHEM, V286, P17704, DOI 10.1074/jbc.M110.187823; Eggert S, 2009, J BIOL CHEM, V284, P28943, DOI 10.1074/jbc.M109.038646; Endres NF, 2013, CELL, V152, P543, DOI 10.1016/j.cell.2012.12.032; Eto M, 2009, J BIOL CHEM, V284, P35273, DOI 10.1074/jbc.R109.059972; Fan HZ, 1999, EMBO J, V18, P6962, DOI 10.1093/emboj/18.24.6962; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; GADELLA TWJ, 1995, J CELL BIOL, V129, P1543, DOI 10.1083/jcb.129.6.1543; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; Gooz M, 2010, CRIT REV BIOCHEM MOL, V45, P146, DOI 10.3109/10409231003628015; Gordon K, 2010, TISSUE ANTIGENS, V75, P136, DOI 10.1111/j.1399-0039.2009.01416.x; Gordon WR, 2007, NAT STRUCT MOL BIOL, V14, P295, DOI 10.1038/nsmb1227; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; Hartmann M., 2015, MOL CANCER RES, V13, P1; Hartmann M, 2013, TRENDS BIOCHEM SCI, V38, P111, DOI 10.1016/j.tibs.2012.12.002; Herrlich A, 2008, FASEB J, V22, P4281, DOI 10.1096/fj.08-113852; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jin HC, 2006, NATURE, V442, P576, DOI 10.1038/nature04856; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Kaden D, 2008, J BIOL CHEM, V283, P7271, DOI 10.1074/jbc.M708046200; Killock DJ, 2010, BIOCHEM J, V428, P293, DOI 10.1042/BJ20091611; Killock DJ, 2009, J BIOL CHEM, V284, P8824, DOI 10.1074/jbc.M806983200; Klein T, 2011, J PROTEOME RES, V10, P17, DOI 10.1021/pr100556z; Kosel D, 2010, J CELL SCI, V123, P1320, DOI 10.1242/jcs.057919; Koumangoye RB, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-167; Le Gall SM, 2010, J CELL SCI, V123, P3913, DOI 10.1242/jcs.069997; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Liu DC, 1997, J IMMUNOL, V159, P2702; Liu QR, 2004, BIOCHEM J, V377, P171, DOI 10.1042/BJ20030128; Liu XF, 1998, J BIOL CHEM, V273, P34335, DOI 10.1074/jbc.273.51.34335; Maretzky T, 2013, P NATL ACAD SCI USA, V110, P11433, DOI 10.1073/pnas.1302553110; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Melis M, 2003, AM J RESP CRIT CARE, V167, P1131, DOI 10.1164/rccm.200207-654OC; Meloty-Kapella L, 2012, DEV CELL, V22, P1299, DOI 10.1016/j.devcel.2012.04.005; Mendelson K, 2010, J BIOL CHEM, V285, P25024, DOI 10.1074/jbc.M110.102566; Moriki T, 2001, J MOL BIOL, V311, P1011, DOI 10.1006/jmbi.2001.4923; Morrison H, 2001, GENE DEV, V15, P968, DOI 10.1101/gad.189601; Murphy G, 2009, SEMIN CELL DEV BIOL, V20, P138, DOI 10.1016/j.semcdb.2008.09.004; Musse AA, 2012, SEMIN CELL DEV BIOL, V23, P429, DOI 10.1016/j.semcdb.2012.01.011; Nakayama H, 2012, MOL BIOL CELL, V23, P1964, DOI 10.1091/mbc.E11-08-0683; Okimoto T, 2001, MOL THER, V4, P232, DOI 10.1006/mthe.2001.0443; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Pietras A, 2014, CELL STEM CELL, V14, P357, DOI 10.1016/j.stem.2014.01.005; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Schulz A, 2010, J NEUROSCI, V30, P10177, DOI 10.1523/JNEUROSCI.0840-10.2010; Schwarz J, 2013, BBA-MOL CELL RES, V1833, P3355, DOI 10.1016/j.bbamcr.2013.10.005; Sleeman JP, 1997, J BIOL CHEM, V272, P31837, DOI 10.1074/jbc.272.50.31837; Tao RH, 2008, J CELL SCI, V121, P3207, DOI 10.1242/jcs.033399; Tian X, 2013, NATURE, V499, P346, DOI 10.1038/nature12234; Todaro M, 2014, CELL STEM CELL, V14, P342, DOI 10.1016/j.stem.2014.01.009; Tsukamoto H, 2013, INFLAMM BOWEL DIS, V19, P1365, DOI 10.1097/MIB.0b013e318281f43a; van der Vorst EPC, 2012, ATHEROSCLEROSIS, V224, P302, DOI 10.1016/j.atherosclerosis.2012.04.023; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Wild-Bode C, 2006, J BIOL CHEM, V281, P23824, DOI 10.1074/jbc.M601542200; Willems SH, 2010, BIOCHEM J, V428, P439, DOI 10.1042/BJ20100179; Xu PL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002689; Yu Q, 1997, J EXP MED, V186, P1985, DOI 10.1084/jem.186.12.1985; Zeilstra J, 2014, ONCOGENE, V33, P665, DOI 10.1038/onc.2012.611; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	72	32	32	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17041	17054		10.1074/jbc.M114.610204	http://dx.doi.org/10.1074/jbc.M114.610204			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	25925953	hybrid, Green Published			2022-12-28	WOS:000357730900001
J	Bagneris, C; Rogala, KB; Baratchian, M; Zamfir, V; Kunze, MBA; Dagless, S; Pirker, KF; Collins, MK; Hall, BA; Barrett, TE; Kay, CWM				Bagneris, Claire; Rogala, Kacper B.; Baratchian, Mehdi; Zamfir, Vlad; Kunze, Micha B. A.; Dagless, Selina; Pirker, Katharina F.; Collins, Mary K.; Hall, Benjamin A.; Barrett, Tracey E.; Kay, Christopher W. M.			Probing the Solution Structure of I kappa B Kinase (IKK) Subunit gamma and Its Interaction with Kaposi Sarcoma-associated Herpes Virus Flice-interacting Protein and IKK Subunit beta by EPR Spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; GENE-EXPRESSION; COILED COILS; VFLIP; ACTIVATION; RECOGNITION; DOMAIN; MODEL; NEMO	Viral flice-interacting protein (vFLIP), encoded by the oncogenic Kaposi sarcoma-associated herpes virus (KSHV), constitutively activates the canonical nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappa B) pathway. This is achieved through subversion of the I kappa B kinase (IKK) complex (or signalosome), which involves a physical interaction between vFLIP and the modulatory subunit IKK gamma. Although this interaction has been examined both in vivo and in vitro, the mechanism by which vFLIP activates the kinase remains to be determined. Because IKK gamma functions as a scaffold, recruiting both vFLIP and the IKK alpha/beta subunits, it has been proposed that binding of vFLIP could trigger a structural rearrangement in IKK gamma conducive to activation. To investigate this hypothesis we engineered a series of mutants along the length of the IKK gamma molecule that could be individually modified with nitroxide spin labels. Subsequent distance measurements using electron paramagnetic resonance spectroscopy combined with molecular modeling and molecular dynamics simulations revealed that IKK gamma is a parallel coiled-coil whose response to binding of vFLIP or IKK beta is localized twisting/stiffening and not large-scale rearrangements. The coiled-coil comprises N- and C-terminal regions with distinct registers accommodated by a twist: this structural motif is exploited by vFLIP, allowing it to bind and subsequently activate the NF-kappa B pathway. In vivo assays confirm that NF-kappa B activation by vFLIP only requires the N-terminal region up to the transition between the registers, which is located directly C-terminal of the vFLIP binding site.	[Bagneris, Claire; Rogala, Kacper B.; Zamfir, Vlad; Barrett, Tracey E.] Univ London Birkbeck Coll, Inst Struct & Mol Biol, Dept Biol Sci, London WC1E 7HX, England; [Rogala, Kacper B.; Zamfir, Vlad; Kunze, Micha B. A.; Dagless, Selina; Pirker, Katharina F.; Kay, Christopher W. M.] UCL, Inst Struct & Mol Biol, London WC1E 6BT, England; [Baratchian, Mehdi; Collins, Mary K.] UCL Canc Inst, MRC Ctr Med Mol Virol, Potters Bar EN6 3QG, Herts, England; [Baratchian, Mehdi; Collins, Mary K.] Natl Inst Biol Stand & Controls, Potters Bar EN6 3QG, Herts, England; [Hall, Benjamin A.] Univ Cambridge, Hutchison MRC Res Ctr, MRC Canc Unit, Cambridge CB2 0XZ, England; [Kay, Christopher W. M.] UCL, London Ctr Nanotechnol, London WC1H 0AH, England	University of London; Birkbeck University London; University of London; Birkbeck University London; University College London; National Institute for Biological Standards & Control; University of Cambridge; University of London; University College London	Hall, BA (corresponding author), Univ Cambridge, Hutchison MRC Res Ctr, MRC Canc Unit, Box 197,Cambridge Biomed Campus, Cambridge CB2 0XZ, England.	bh418@mrc-cu.cam.ac.uk; t.barrett@mail.cryst.bbk.ac.uk; c.kay@ucl.ac.uk	Hall, Ben/AAA-4981-2020; Kay, Christopher William Michael/C-2467-2008; Rogala, Kacper/B-1279-2012	Hall, Ben/0000-0003-0355-2946; Kay, Christopher William Michael/0000-0002-5200-6004; Rogala, Kacper/0000-0001-5997-7770; Bagneris, Claire/0000-0002-0561-7574	Medical Research Council [ID18218]; Cancer Research UK [A12595]; UCL Cancer Institute; Wellcome Trust; Royal Society; MRC [MC_UU_12022/9] Funding Source: UKRI; Medical Research Council [MC_UU_12022/9] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); UCL Cancer Institute; Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by a Medical Research Council Grant (ID18218) (to T. E. B.), a Cancer Research UK Grant (A12595) and a UCL Cancer Institute grant (to M. K. C.), a Wellcome Trust PhD Studentship (to M. B. A. K.), and a Royal Society Fellowship (to B. A. H.). We declare that no conflict of interest arises from the work presented here.	Bagneris C, 2008, MOL CELL, V30, P620, DOI 10.1016/j.molcel.2008.04.029; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Field N, 2003, J CELL SCI, V116, P3721, DOI 10.1242/jcs.00691; Fujita H, 2014, MOL CELL BIOL, V34, P1322, DOI 10.1128/MCB.01538-13; Hall BA, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002685; Hiscott J, 2006, ONCOGENE, V25, P6844, DOI 10.1038/sj.onc.1209941; Hong S, 2007, J BIOL CHEM, V282, P12119, DOI 10.1074/jbc.M610392200; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Jenner RG, 2001, J VIROL, V75, P891, DOI 10.1128/JVI.75.2.891-902.2001; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Keller SA, 2006, BLOOD, V107, P3295, DOI 10.1182/blood-2005-07-2730; Lo YC, 2009, MOL CELL, V33, P602, DOI 10.1016/j.molcel.2009.01.012; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Marrink SJ, 2004, J PHYS CHEM B, V108, P750, DOI 10.1021/jp036508g; Matta H, 2003, J BIOL CHEM, V278, P52406, DOI 10.1074/jbc.M307308200; Matta H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036601; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; Polley S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001581; Polyhach Y, 2011, PHYS CHEM CHEM PHYS, V13, P2356, DOI 10.1039/c0cp01865a; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Rushe M, 2008, STRUCTURE, V16, P798, DOI 10.1016/j.str.2008.02.012; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Shimizu A, 2011, J VIROL, V85, P7444, DOI 10.1128/JVI.02337-10; Stafford RL, 2011, BIOCHEMISTRY-US, V50, P3807, DOI 10.1021/bi200141e; Stansfeld PJ, 2011, J CHEM THEORY COMPUT, V7, P1157, DOI 10.1021/ct100569y; Tolani B, 2014, J VIROL, V88, P6345, DOI 10.1128/JVI.00028-14; Trigg J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023519; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]	33	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16539	16549		10.1074/jbc.M114.622928	http://dx.doi.org/10.1074/jbc.M114.622928			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25979343	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000357572800007
J	Zhang, WL; Ogando, DG; Bonanno, JA; Obukhov, AG				Zhang, Wenlin; Ogando, Diego G.; Bonanno, Joseph A.; Obukhov, Alexander G.			Human SLC4A11 Is a Novel NH3/H+ Co-transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL DYSTROPHY; CORNEAL ENDOTHELIUM; TRANSPORTER FAMILY; AMMONIA; EXPRESSION; MUTATIONS; GLUTAMINE; PROTEINS; GLYCOPROTEIN; AMT/MEP/RH	SLC4A11 has been proposed to be an electrogenic membrane transporter, permeable to Na+, H+ (OH-), bicarbonate, borate, and NH4+. Recent studies indicate, however, that neither bicarbonate or borate is a substrate. Here, we examined potential NH4+, Na+, and H+ contributions to electrogenic ion transport through SLC4A11 stably expressed in Na+/H+ exchanger-deficient PS120 fibroblasts. Inward currents observed during exposure to NH4Cl were determined by the [NH3](o), not [NH4+](o), and current amplitudes varied with the [H+] gradient. These currents were relatively unaffected by removal of Na+, K+, or Cl- from the bath but could be reduced by inclusion of NH4Cl in the pipette solution. Bath pH changes alone did not generate significant currents through SLC4A11, except immediately following exposure to NH4Cl. Reversal potential shifts in response to changing [NH3](o) and pH(o) suggested an NH3/H4C-coupled transport mode for SLC4A11. Proton flux through SLC4A11 in the absence of ammonia was relatively small, suggesting that ammonia transport is of more physiological relevance. Methylammonia produced currents similar to NH3 but with reduced amplitude. Estimated stoichiometry of SLC4A11 transport was 1: 2 (NH3/H4C). NH3-dependent currents were insensitive to 10 mu M ethyl-isopropyl amiloride or 100 mu M 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid. We propose that SLC4A11 is an NH3/2H(4)C co-transporter exhibiting unique characteristics.	[Zhang, Wenlin; Ogando, Diego G.; Bonanno, Joseph A.] Indiana Univ, Sch Optometry, Bloomington, IN 47405 USA; [Obukhov, Alexander G.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Bonanno, JA (corresponding author), 800 Atwater Ave, Bloomington, IN 47405 USA.	jbonanno@indiana.edu; aobukhov@iu.edu	Obukhov, Alexander G/C-7246-2008; Zhang, Wenlin/AAW-7646-2021; Zhang, Wenlin/B-6955-2013; Regan, Clinton/E-6250-2012	Obukhov, Alexander G/0000-0002-3862-6004; Zhang, Wenlin/0000-0003-3229-9177; Zhang, Wenlin/0000-0003-3229-9177; 	National Institutes of Health [R01EY008834, P30EY019008, R01HL115140]; NATIONAL EYE INSTITUTE [P30EY019008, R01EY008834] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R01EY008834 (to J. A. B.), P30EY019008 (Core Grant of Vision Science), and R01HL115140 (to A. G. O). The authors declare that they have no conflicts of interest with the contents of this article.	Albrecht J, 2006, HEPATOLOGY, V44, P788, DOI 10.1002/hep.21357; Aldave AJ, 2013, CLIN GENET, V84, P109, DOI 10.1111/cge.12191; Beitz E, 2006, P NATL ACAD SCI USA, V103, P269, DOI 10.1073/pnas.0507225103; BORON WF, 1976, J GEN PHYSIOL, V67, P91, DOI 10.1085/jgp.67.1.91; COHEN BN, 1992, J GEN PHYSIOL, V100, P373, DOI 10.1085/jgp.100.3.373; Damkier HH, 2007, AM J PHYSIOL-REG I, V293, pR2136, DOI 10.1152/ajpregu.00356.2007; Gottsch JD, 2003, INVEST OPHTH VIS SCI, V44, P594, DOI 10.1167/iovs.02-0300; Groger N, 2010, J BIOL CHEM, V285, P14467, DOI 10.1074/jbc.M109.094680; Han KH, 2009, AM J PHYSIOL-LUNG C, V297, pL153, DOI 10.1152/ajplung.90524.2008; Han SB, 2013, INVEST OPHTH VIS SCI, V54, P6179, DOI 10.1167/iovs.13-12089; Handlogten ME, 2005, AM J PHYSIOL-GASTR L, V288, pG1036, DOI 10.1152/ajpgi.00418.2004; Houillier P, 2012, AM J PHYSIOL-RENAL, V302, pF293, DOI 10.1152/ajprenal.00307.2011; Jalimarada SS, 2013, INVEST OPHTH VIS SCI, V54, P4330, DOI 10.1167/iovs.13-11929; Kao LY, 2015, AM J PHYSIOL-CELL PH, V308, pC176, DOI 10.1152/ajpcell.00271.2014; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; Lee HW, 2013, REPRODUCTION, V146, P283, DOI 10.1530/REP-13-0154; Lima AS, 2009, SENSORS-BASEL, V9, P6613, DOI 10.3390/s90906613; Litman Thomas, 2009, Handb Exp Pharmacol, P327, DOI 10.1007/978-3-540-79885-9_17; Lopez IA, 2009, J BIOL CHEM, V284, P26882, DOI 10.1074/jbc.M109.008102; Nakhoul NL, 2010, AM J PHYSIOL-CELL PH, V299, pC1386, DOI 10.1152/ajpcell.00211.2010; Nakhoul NL, 2010, AM J PHYSIOL-CELL PH, V299, pC695, DOI 10.1152/ajpcell.00019.2010; Newsholme P, 2003, CELL BIOCHEM FUNCT, V21, P1, DOI 10.1002/cbf.1003; Newsholme P, 2003, BRAZ J MED BIOL RES, V36, P153, DOI 10.1590/S0100-879X2003000200002; Nowak DM, 2013, INVEST OPHTH VIS SCI, V54, P2207, DOI 10.1167/iovs.13-11592; Ogando DG, 2013, AM J PHYSIOL-CELL PH, V305, pC716, DOI 10.1152/ajpcell.00056.2013; PACKER RK, 1991, J AM SOC NEPHROL, V2, P77; Park M, 2004, MOL CELL, V16, P331, DOI 10.1016/j.molcel.2004.09.030; Parker MD, 2001, BIOCHEM BIOPH RES CO, V282, P1103, DOI 10.1006/bbrc.2001.4692; Ramprasad VL, 2007, ONLINE HUM MUTAT, V28, P522, DOI [DOI 10.1002/humu.9487, 10.1002/humu.9487]; Shei W, 2013, MOL VIS, V19, P1096; Siddiqui S, 2014, CORNEA, V33, P247, DOI 10.1097/ICO.0000000000000041; Soria LR, 2013, HEPATOLOGY, V57, P2061, DOI 10.1002/hep.26236; Tanaka M, 2008, PLANT CELL, V20, P2860, DOI 10.1105/tpc.108.058628; ten Hoopen F, 2010, J EXP BOT, V61, P2303, DOI 10.1093/jxb/erq057; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; Vilas GL, 2013, HUM MOL GENET, V22, P4579, DOI 10.1093/hmg/ddt307; Vilas GL, 2011, BIOCHEMISTRY-US, V50, P2157, DOI 10.1021/bi101887z; Virkki LV, 2002, AM J PHYSIOL-CELL PH, V282, pC1278, DOI 10.1152/ajpcell.00589.2001; Vithana EN, 2008, HUM MOL GENET, V17, P656, DOI 10.1093/hmg/ddm337; Weiner ID, 2010, CURR OPIN NEPHROL HY, V19, P471, DOI 10.1097/MNH.0b013e32833bfa4e; Winkler F, 2006, PFLUG ARCH EUR J PHY, V451, P701, DOI 10.1007/s00424-005-1511-6; Yao H, 1999, J CLIN INVEST, V104, P637, DOI 10.1172/JCI6785	42	46	47	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16894	16905		10.1074/jbc.M114.627455	http://dx.doi.org/10.1074/jbc.M114.627455			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	26018076	Green Published, hybrid			2022-12-28	WOS:000357572800034
J	Bradley, EW; Carpio, LR; Newton, AC; Westendorf, JJ				Bradley, Elizabeth W.; Carpio, Lomeli R.; Newton, Alexandra C.; Westendorf, Jennifer J.			Deletion of the PH-domain and Leucine-rich Repeat Protein Phosphatase 1 (Phlpp1) Increases Fibroblast Growth Factor (Fgf) 18 Expression and Promotes Chondrocyte Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt PKB; cartilage; fibroblast growth factor (FGF); fibroblast growth factor receptor (FGFR); FOXO; osteoarthritis	FACTOR RECEPTOR-3; SIGNALING PATHWAYS; MICE LACKING; MURINE CHONDROCYTES; BONE-DEVELOPMENT; TUMOR-GROWTH; RAT MODEL; KINASE B; AKT; CARTILAGE	Background: Phlpp1 is a tumor suppressor that represses Akt2 and other signaling pathways. Results: Chondrocyte proliferation, matrix production, Akt2 phosphorylation, and Fgf18/Erk1/2 signaling were increased in Phlpp1(-/-) mice, but levels of the transcription factor FoxO1 were reduced. Conclusion: Phlpp1 deficiency increases Akt2 activity, which diminishes FoxO1 levels and induces Fgf18 expression to stimulate Erk1/2 activity and chondrocyte proliferation. Significance: Phlpp1 inhibition may promote cartilage regeneration. Endochondral ossification orchestrates formation of the vertebrate skeleton and is often induced during disease and repair processes of the musculoskeletal system. Here we show that the protein phosphatase Phlpp1 regulates endochondral ossification. Phlpp1 null mice exhibit decreased bone mass and notable changes in the growth plate, including increased BrdU incorporation and matrix production. Phosphorylation of known Phlpp1 substrates, Akt2, PKC, and p70 S6 kinase, were enhanced in ex vivo cultured Phlpp1(-/-) chondrocytes. Furthermore, Phlpp1 deficiency diminished FoxO1 levels leading to increased expression of Fgf18, Mek/Erk activity, and chondrocyte metabolic activity. Phlpp inhibitors also increased matrix content, Fgf18 production and Erk1/2 phosphorylation. Chemical inhibition of Fgfr-signaling abrogated elevated Erk1/2 phosphorylation and metabolic activity in Phlpp1-null cultures. These results demonstrate that Phlpp1 controls chondrogenesis via multiple mechanisms and that Phlpp1 inhibition could be a strategy to promote cartilage regeneration and repair.	[Bradley, Elizabeth W.; Westendorf, Jennifer J.] Mayo Clin, Dept Orthoped Surg, Rochester, MN 55905 USA; [Carpio, Lomeli R.] Mayo Clin, Mayo Grad Sch, Rochester, MN 55905 USA; [Westendorf, Jennifer J.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Newton, Alexandra C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; University of California System; University of California San Diego	Westendorf, JJ (corresponding author), Mayo Clin, Dept Orthoped Surg, 200 First St SW, Rochester, MN 55905 USA.	westendorf.jennifer@mayo.edu	Regan, Clinton/E-6250-2012	Bradley, Elizabeth/0000-0002-8814-5524; Shull, Lomeli/0000-0001-7537-8516	National Institutes of Health [AR056950, AR61873, AR65397, AR68103, GM055252, GM067946]; Mayo Clinic; Mayo Graduate School; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR061873, K01AR065397, R01AR068103, T32AR056950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067946, R25GM055252] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic; Mayo Graduate School; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants AR056950, AR61873, AR65397, AR68103, GM055252, and GM067946, the Mayo Clinic, and Mayo Graduate School.	Beier F, 2010, J CELL BIOCHEM, V110, P573, DOI 10.1002/jcb.22604; Bradley EW, 2013, J BIOL CHEM, V288, P9572, DOI 10.1074/jbc.M112.423723; Brognard J, 2008, TRENDS ENDOCRIN MET, V19, P223, DOI 10.1016/j.tem.2008.04.001; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; BROWN JH, 1992, AM FAM PHYSICIAN, V46, P1180; Colvin JS, 1996, NAT GENET, V12, P390, DOI 10.1038/ng0496-390; Davidson D, 2005, J BIOL CHEM, V280, P20509, DOI 10.1074/jbc.M410148200; Ellsworth JL, 2002, OSTEOARTHR CARTILAGE, V10, P308, DOI 10.1053/joca.2002.0514; Ericson K, 2010, P NATL ACAD SCI USA, V107, P2598, DOI 10.1073/pnas.0914018107; Fayard E, 2005, J CELL SCI, V118, P5675, DOI 10.1242/jcs.02724; Fukai A, 2010, ARTHRITIS RHEUM-US, V62, P826, DOI 10.1002/art.27296; Gao T, 2008, J BIOL CHEM, V283, P6300, DOI 10.1074/jbc.M707319200; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Govoni KE, 2007, PHYSIOL GENOMICS, V30, P354, DOI 10.1152/physiolgenomics.00022.2007; Guntur AR, 2011, DEVELOPMENT, V138, P1433, DOI 10.1242/dev.058016; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; Haque T, 2007, HISTOL HISTOPATHOL, V22, P97, DOI 10.14670/HH-22.97; Ikegami D, 2011, DEVELOPMENT, V138, P1507, DOI 10.1242/dev.057802; Iwata T, 2000, HUM MOL GENET, V9, P1603, DOI 10.1093/hmg/9.11.1603; Jin EJ, 2007, J CELL BIOCHEM, V102, P252, DOI 10.1002/jcb.21430; Jones DC, 2010, P NATL ACAD SCI USA, V107, P8254, DOI 10.1073/pnas.1003727107; Kita K, 2008, GENES CELLS, V13, P839, DOI 10.1111/j.1365-2443.2008.01209.x; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lazarus JE, 2007, BONE, V40, P577, DOI 10.1016/j.bone.2006.10.013; Liu ZH, 2002, GENE DEV, V16, P859, DOI 10.1101/gad.965602; Lohmander LS, 2014, ARTHRITIS RHEUMATOL, V66, P1820, DOI 10.1002/art.38614; Masubuchi S, 2010, P NATL ACAD SCI USA, V107, P1642, DOI 10.1073/pnas.0910292107; Mikic B, 2004, J ORTHOPAED RES, V22, P552, DOI 10.1016/j.orthres.2003.09.002; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; Moore EE, 2005, OSTEOARTHR CARTILAGE, V13, P623, DOI 10.1016/j.joca.2005.03.003; Mugniery E, 2012, HUM MOL GENET, V21, P2503, DOI 10.1093/hmg/dds065; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Naski MC, 1998, DEVELOPMENT, V125, P4977; Ohbayashi N, 2002, GENE DEV, V16, P870, DOI 10.1101/gad.965702; Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702; Panda DK, 2012, AM J PHYSIOL-ENDOC M, V303, pE1489, DOI 10.1152/ajpendo.00254.2012; Pardo OE, 2009, CANCER RES, V69, P8645, DOI 10.1158/0008-5472.CAN-09-1576; Power J, 2014, J ORTHOP RES, V32, P669, DOI 10.1002/jor.22580; Price J, 2010, J CELL PHYSIOL, V222, P502, DOI 10.1002/jcp.22001; Priore R, 2006, J CELL PHYSIOL, V207, P800, DOI 10.1002/jcp.20620; Razidlo D. F., PLOS ONE, V5; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Rimoin DL, 2007, ANN NY ACAD SCI, V1117, P302, DOI 10.1196/annals.1402.072; Rokutanda S, 2009, DEV BIOL, V328, P78, DOI 10.1016/j.ydbio.2009.01.009; ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0; Schipani E, 2001, GENE DEV, V15, P2865; Shung CY, 2012, HUM MOL GENET, V21, P4628, DOI 10.1093/hmg/dds305; Sierecki E, 2010, J MED CHEM, V53, P6899, DOI 10.1021/jm100331d; Staines KA, 2013, J ENDOCRINOL, V219, pR1, DOI 10.1530/JOE-13-0276; Ulici V, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-40; Valverde-Franco G, 2006, HUM MOL GENET, V15, P1783, DOI 10.1093/hmg/ddl100; Yamaoka H, 2010, CELL PROLIFERAT, V43, P67, DOI 10.1111/j.1365-2184.2009.00655.x; Zeng GQ, 2014, INT J MOL SCI, V15, P13236, DOI 10.3390/ijms150813236; Zhao HH, 2014, J CELL MOL MED, V18, P283, DOI 10.1111/jcmm.12186	57	32	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16272	16280		10.1074/jbc.M114.612937	http://dx.doi.org/10.1074/jbc.M114.612937			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25953896	Green Published, hybrid			2022-12-28	WOS:000356930100030
J	Petitjean, M; Teste, MA; Francois, JM; Parrou, JL				Petitjean, Marjorie; Teste, Marie-Ange; Francois, Jean M.; Parrou, Jean-Luc			RETRACTED: Yeast Tolerance to Various Stresses Relies on the Trehalose-6P Synthase (Tps1) Protein, Not on Trehalose (Retracted article. See vol. 294, pg. 5812, 2019)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication						ATP; heat shock factor protein 1 (HSF1); heat shock protein (HSP); oxidative stress; Saccharomyces cerevisiae; desiccation; heat shock; viability	SHOCK TRANSCRIPTION FACTOR; SACCHAROMYCES-CEREVISIAE; DESICCATION TOLERANCE; CARBOHYDRATE-METABOLISM; GENETIC-EVIDENCE; HEAT; ACCUMULATION; HSP104; THERMOTOLERANCE; EXPRESSION	Background: Decades of observations strengthened the idea that trehalose is a chemical chaperone. Results: A catalytically inactive variant of the trehalose-6P synthase (Tps1) maintains cell survival and energy homeostasis under stress exposure. Conclusion: The Tps1 protein itself, not trehalose, is crucial for cell integrity. Significance: This work provides unbiased evidence for an alternative function of Tps1, a new moonlighting protein. Trehalose is a stable disaccharide commonly found in nature, from bacteria to fungi and plants. For the model yeast Saccharomyces cerevisiae, claims that trehalose is a stress protectant were based indirectly either on correlation between accumulation of trehalose and high resistance to various stresses or on stress hypersensitivity of mutants deleted for TPS1, which encodes the first enzyme in trehalose biosynthetic pathway. Our goal was to investigate more directly which one, between trehalose and/or the Tps1 protein, may serve yeast cells to withstand exposure to stress. By employing an original strategy that combined the use of mutant strains expressing catalytically inactive variants of Tps1, with MAL(+) yeast strains able to accumulate trehalose from an exogenous supply, we bring for the first time unbiased proof that trehalose does not protect yeast cells from dying and that the stress-protecting role of trehalose in this eukaryotic model was largely overestimated. Conversely, we identified the Tps1 protein as a key player for yeast survival in response to temperature, oxidative, and desiccation stress. We also showed by robust RT-quantitative PCR and genetic interaction analysis that the role of Tps1 in thermotolerance is not dependent upon Hsf1-dependent transcription activity. Finally, our results revealed that the Tps1 protein is essential to maintain ATP levels during heat shock. Altogether, these findings supported the idea that Tps1 is endowed with a regulatory function in energy homeostasis, which is essential to withstand adverse conditions and maintain cellular integrity.	[Petitjean, Marjorie; Teste, Marie-Ange; Francois, Jean M.; Parrou, Jean-Luc] Univ Toulouse, INSA, UPS, INP,LISBP, F-31077 Toulouse, France; [Petitjean, Marjorie; Teste, Marie-Ange; Francois, Jean M.; Parrou, Jean-Luc] INRA, Ingn Syst Biol & Proc UMR792, F-31400 Toulouse, France; [Petitjean, Marjorie; Teste, Marie-Ange; Francois, Jean M.; Parrou, Jean-Luc] CNRS, UMR5504, F-31400 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse	Francois, JM (corresponding author), INSA, LISBP, 135 Ave Rangueil, F-31077 Toulouse 04, France.	fran_jm@insa-toulouse.fr; jean-luc.parrou@insa-toulouse.fr		Francois, Jean marie/0000-0001-9884-5535	Region Midi Pyrenees [10051296]; CNRS PEP2I grant; French Ministry of Education and Research	Region Midi Pyrenees(Region Provence-Alpes-Cote d'AzurRegion Occitanie); CNRS PEP2I grant; French Ministry of Education and Research	This work was supported in part by Grant 10051296 from Region Midi Pyrenees (to J. M. F.), and by a CNRS PEP2I grant (to J.-L. P.), and a doctoral grant from the French Ministry of Education and Research (to M. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Badaruddin M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003604; Benaroudj N, 2001, J BIOL CHEM, V276, P24261, DOI 10.1074/jbc.M101487200; Borodina I, 2014, BIOTECHNOL J, V9, P609, DOI 10.1002/biot.201300445; Boudreau BA, 2013, FUNGAL GENET BIOL, V57, P1, DOI 10.1016/j.fgb.2013.06.001; Bulman AL, 2005, PROTEINS, V58, P826, DOI 10.1002/prot.20371; Calahan D, 2011, GENETICS, V189, P507, DOI 10.1534/genetics.111.130369; Conlin LK, 2007, MOL CELL BIOL, V27, P1505, DOI 10.1128/MCB.01158-06; CROWE JH, 1984, SCIENCE, V223, P701, DOI 10.1126/science.223.4637.701; CROWE JH, 1992, ANNU REV PHYSIOL, V54, P579, DOI 10.1146/annurev.ph.54.030192.003051; DEVIRGILIO C, 1993, EUR J BIOCHEM, V212, P315; DEVIRGILIO C, 1990, FEBS LETT, V273, P107, DOI 10.1016/0014-5793(90)81062-S; DEVIRGILIO C, 1994, EUR J BIOCHEM, V219, P179; Doyle SM, 2009, TRENDS BIOCHEM SCI, V34, P40, DOI 10.1016/j.tibs.2008.09.010; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Elliott B, 1996, GENETICS, V144, P923; Fernandes PMB, 2001, LETT APPL MICROBIOL, V32, P42, DOI 10.1046/j.1472-765x.2001.00853.x; FRANCOIS J, 1991, YEAST, V7, P575, DOI 10.1002/yea.320070605; Francois J, 2001, FEMS MICROBIOL REV, V25, P125, DOI 10.1016/S0168-6445(00)00059-0; Gancedo C, 2004, FEMS YEAST RES, V4, P351, DOI 10.1016/S1567-1356(03)00222-8; Gancedo C, 2008, MICROBIOL MOL BIOL R, V72, P197, DOI 10.1128/MMBR.00036-07; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gibney PA, 2013, P NATL ACAD SCI USA, V110, pE4393, DOI 10.1073/pnas.1318100110; Gonzalez B, 1997, YEAST, V13, P1347, DOI 10.1002/(SICI)1097-0061(199711)13:14<1347::AID-YEA176>3.0.CO;2-O; Hashikawa N, 2004, MOL CELL BIOL, V24, P3648, DOI 10.1128/MCB.24.9.3648-3659.2004; Hattendorf DA, 2002, EMBO J, V21, P12, DOI 10.1093/emboj/21.1.12; Hazell BW, 1995, FEBS LETT, V377, P457, DOI 10.1016/0014-5793(95)01392-X; Hoskins JR, 2009, P NATL ACAD SCI USA, V106, P22233, DOI 10.1073/pnas.0911937106; HOTTIGER T, 1987, J BACTERIOL, V169, P5518, DOI 10.1128/jb.169.12.5518-5522.1987; Hounsa CG, 1998, MICROBIOL-UK, V144, P671, DOI 10.1099/00221287-144-3-671; Jones GM, 2008, NAT METHODS, V5, P239, DOI 10.1038/NMETH.1181; Jules M, 2004, APPL ENVIRON MICROB, V70, P2771, DOI 10.1128/AEM.70.5.2771-2778.2004; Jules M, 2008, APPL ENVIRON MICROB, V74, P605, DOI 10.1128/AEM.00557-07; Kandror O, 2004, MOL CELL, V13, P771, DOI 10.1016/S1097-2765(04)00148-0; KANE SM, 1974, J BACTERIOL, V118, P8, DOI 10.1128/JB.118.1.8-14.1974; Lee JW, 2012, NAT CHEM BIOL, V8, P536, DOI [10.1038/nchembio.970, 10.1038/NCHEMBIO.970]; Lee J, 2013, P NATL ACAD SCI USA, V110, P8513, DOI 10.1073/pnas.1217988110; LILLIE SH, 1980, J BACTERIOL, V143, P1384, DOI 10.1128/JB.143.3.1384-1394.1980; Mahmud SA, 2009, YEAST, V26, P17, DOI 10.1002/yea.1646; MURPHY TA, 1965, J BIOL CHEM, V240, P1500; Ngamskulrungroj P, 2009, INFECT IMMUN, V77, P4584, DOI 10.1128/IAI.00565-09; Parrou JL, 1997, MICROBIOL-UK, V143, P1891, DOI 10.1099/00221287-143-6-1891; Parrou JL, 1997, ANAL BIOCHEM, V248, P186, DOI 10.1006/abio.1997.2138; Paul MJ, 2008, ANNU REV PLANT BIOL, V59, P417, DOI 10.1146/annurev.arplant.59.032607.092945; Pereira M D, 2001, BMC Microbiol, V1, P11, DOI 10.1186/1471-2180-1-11; Piper P, 1998, TRENDS MICROBIOL, V6, P43, DOI 10.1016/S0966-842X(97)01190-6; Plourde-Owobi L, 1999, J BACTERIOL, V181, P3830, DOI 10.1128/JB.181.12.3830-3832.1999; Ratnakumar S, 2006, FEMS YEAST RES, V6, P902, DOI 10.1111/j.1567-1364.2006.00066.x; Sakurai H, 2010, FEBS J, V277, P4140, DOI 10.1111/j.1742-4658.2010.07829.x; Saleh AA, 2014, BBA-MOL CELL RES, V1843, P746, DOI 10.1016/j.bbamcr.2014.01.004; Shi L, 2010, MOL BIOL CELL, V21, P1982, DOI 10.1091/mbc.E10-01-0056; Simola M, 2000, MOL MICROBIOL, V37, P42, DOI 10.1046/j.1365-2958.2000.01970.x; Singer MA, 1998, MOL CELL, V1, P639, DOI 10.1016/S1097-2765(00)80064-7; Tapia H, 2014, CURR BIOL, V24, P2758, DOI 10.1016/j.cub.2014.10.005; Teste MA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-99; THEVELEIN JM, 1995, TRENDS BIOCHEM SCI, V20, P3, DOI 10.1016/S0968-0004(00)88938-0; van Dijken JP, 2000, ENZYME MICROB TECH, V26, P706, DOI 10.1016/S0141-0229(00)00162-9; VANDERCAMMEN A, 1989, EUR J BIOCHEM, V182, P613, DOI 10.1111/j.1432-1033.1989.tb14870.x; VANSCHAFTINGEN E, 1987, ADV ENZYMOL RAMB, V59, P315; Walther T, 2013, BIOCHEM J, V454, P227, DOI 10.1042/BJ20130587; Walther T, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.100; Welch AZ, 2013, MOL BIOL CELL, V24, P115, DOI 10.1091/mbc.E12-07-0524; WIEMKEN A, 1990, ANTON LEEUW INT J G, V58, P209, DOI 10.1007/BF00548935; Wilson RA, 2007, EMBO J, V26, P3673, DOI 10.1038/sj.emboj.7601795; Wilson RA, 2010, P NATL ACAD SCI USA, V107, P21902, DOI 10.1073/pnas.1006839107; Yamamoto A, 2005, J BIOL CHEM, V280, P11911, DOI 10.1074/jbc.M411256200; Yamamoto A, 2007, EUKARYOT CELL, V6, P1373, DOI 10.1128/EC.00098-07; Yamamoto N, 2009, FEBS J, V276, P1962, DOI 10.1111/j.1742-4658.2009.06923.x; Young E, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-24	69	62	69	0	253	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16177	16190		10.1074/jbc.M115.653899	http://dx.doi.org/10.1074/jbc.M115.653899			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25934390	Green Published, hybrid			2022-12-28	WOS:000356930100022
J	Priyamvada, S; Anbazhagan, AN; Gujral, T; Borthakur, A; Saksena, S; Gill, RK; Alrefai, WA; Dudeja, PK				Priyamvada, Shubha; Anbazhagan, Arivarasu N.; Gujral, Tarunmeet; Borthakur, Alip; Saksena, Seema; Gill, Ravinder K.; Alrefai, Waddah A.; Dudeja, Pradeep K.			All-trans-retinoic Acid Increases SLC26A3 DRA (Down-regulated in Adenoma) Expression in Intestinal Epithelial Cells via HNF-1 beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL CHLORIDE DIARRHEA; VITAMIN-A SUPPLEMENTATION; CL-/OH-EXCHANGE; RECEPTOR-BETA; GENE-EXPRESSION; DECREASED EXPRESSION; GUT INTEGRITY; CACO-2 CELLS; CANCER; MECHANISM	All-trans-retinoic acid (ATRA) is an active vitamin A derivative known to modulate a number of physiological processes, including growth and development, differentiation, and gene transcription. The protective effect of ATRA in gut inflammation and diarrheal diseases has been documented. In this regard, down-regulated in adenoma (DRA, a key luminal membrane Cl- transporter involved in NaCl absorption) has been shown to be suppressed in intestinal inflammation. This suppression of DRA is associated with diarrheal phenotype. Therefore, current studies were undertaken to examine the effects of ATRA on DRA expression. DRA mRNA levels were significantly elevated (similar to 4-fold) in response to ATRA with induction starting as early as 8 h of incubation. Similarly, ATRA increased DRA protein expression by similar to 50%. Furthermore, DRA promoter activity was significantly increased in response to ATRA indicating transcriptional activation. ATRA effects on DRA expression appeared to be mediated via the RAR-beta receptor subtype, as ATRA remarkably induced RAR-beta mRNA levels, whereas RAR-beta knockdown substantially attenuated the ability of ATRA to increase DRA expression. Results obtained from agonist (CH-55) and antagonist (LE-135) studies further confirmed that ATRA exerts its effects through RAR-beta. Furthermore, ATRA treatment resulted in a significant increase in HNF-1 beta mRNA levels. The ability of ATRA to induce DRA expression was inhibited in the presence of HNF-1 beta siRNA indicative of its involvement in ATRA-induced effects on DRA expression. In conclusion, ATRA may act as an antidiarrheal agent by increasing DRA expression via the RAR-beta/HNF-1 beta-dependent pathway.	[Alrefai, Waddah A.; Dudeja, Pradeep K.] Univ Illinois, Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA; [Priyamvada, Shubha; Anbazhagan, Arivarasu N.; Gujral, Tarunmeet; Borthakur, Alip; Saksena, Seema; Gill, Ravinder K.; Alrefai, Waddah A.; Dudeja, Pradeep K.] Univ Illinois, Dept Med, Div Gastroenterol & Hepatol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Dudeja, PK (corresponding author), Jesse Brown Vet Affairs Med Ctr, Med Res Serv 600 151, 820 South Damen Ave, Chicago, IL 60612 USA.	pkdudeja@uic.edu		Priyamvada, Shubha/0000-0002-7241-569X	National Institutes of Health from the NIDDK, Department of Veteran Affairs [DK54016, DK81858, DK92441, DK71596, DK96254, RO3 DK 096258, BX002011, BX000152]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054016, R01DK081858, R56DK071596, R01DK092441, R01DK071596, R21DK096254, R03DK096258] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000152, I01BX002011] Funding Source: NIH RePORTER	National Institutes of Health from the NIDDK, Department of Veteran Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants DK54016, DK81858, and DK92441 (to P. K. D.), DK71596 (to W. A. A.), DK96254 (to S. S.), and RO3 DK 096258 (to R. K. G.) from the NIDDK, Department of Veteran Affairs Grants BX002011 and a senior research career scientist award (to P. K. D.) and Grant BX000152 (to W. A. A.).	Alrefai WA, 2007, AM J PHYSIOL-GASTR L, V293, pG923, DOI 10.1152/ajpgi.00029.2007; Altucci L, 2007, NAT REV DRUG DISCOV, V6, P793, DOI 10.1038/nrd2397; Bai AP, 2010, J INTERF CYTOK RES, V30, P399, DOI 10.1089/jir.2009.0028; Bai AP, 2009, J LEUKOCYTE BIOL, V86, P959, DOI 10.1189/jlb.0109006; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Baltes S, 2004, DEV GROWTH DIFFER, V46, P503; BIEBERDO.FA, 1972, J CLIN INVEST, V51, P1958, DOI 10.1172/JCI107002; Borenshtein D, 2009, INFECT IMMUN, V77, P3639, DOI 10.1128/IAI.00225-09; Borthakur A, 2008, J NUTR, V138, P1355, DOI 10.1093/jn/138.7.1355; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen K, 2013, NUTRITION, V29, P1197, DOI 10.1016/j.nut.2013.03.025; DAVIS KD, 1993, ENDOCRINOLOGY, V132, P1469, DOI 10.1210/en.132.4.1469; DUDEJA PK, 2003, COLONIC DIS, P3; Duggan C, 2002, AM J CLIN NUTR, V75, P789, DOI 10.1093/ajcn/75.5.789; Filteau SM, 2001, J PEDIATR GASTR NUTR, V32, P464, DOI 10.1097/00005176-200104000-00014; Geisen C, 1997, CANCER RES, V57, P1460; Germain P, 2006, PHARMACOL REV, V58, P712, DOI 10.1124/pr.58.4.4; Ghana VAST study Team, 1993, LANCET, V342, P7; Gill R. K., 2003, Recent Research Developments in Physiology, Vol. 1, Part II, P643; Gill RK, 2007, J CLIN INVEST, V117, P428, DOI 10.1172/JCI29625; Humphreys EH, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008563; Kiela PR, 2003, J BIOL CHEM, V278, P5659, DOI 10.1074/jbc.M209473200; Lampen A, 2000, J PHARMACOL EXP THER, V295, P979; Lee MO, 2000, BIOCHEM PHARMACOL, V59, P485, DOI 10.1016/S0006-2952(99)00355-X; Lee-Kwon W, 2003, J BIOL CHEM, V278, P16494, DOI 10.1074/jbc.M300580200; Liu Y, 1996, MOL CELL BIOL, V16, P1138; Magee TR, 1998, J BIOL CHEM, V273, P30024, DOI 10.1074/jbc.273.45.30024; Makela S, 2002, HUM MUTAT, V20, P425, DOI 10.1002/humu.10139; McCormack SA, 1996, IN VITRO CELL DEV-AN, V32, P53; Miano JM, 2000, CIRC RES, V87, P355; Mouchel N, 2004, BIOCHEM J, V378, P909, DOI 10.1042/BJ20031157; Ozdemir R, 2013, NEONATOLOGY, V104, P22, DOI 10.1159/000350510; Raheja G, 2010, AM J PHYSIOL-GASTR L, V298, pG395, DOI 10.1152/ajpgi.00465.2009; Saksena S, 2010, AM J PHYSIOL-GASTR L, V298, pG159, DOI 10.1152/ajpgi.00374.2009; Schweinfest CW, 2006, J BIOL CHEM, V281, P37962, DOI 10.1074/jbc.M607527200; Sempertegui F, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.1.e1; Singh V, 2012, AM J PHYSIOL-GASTR L, V303, pG1393, DOI 10.1152/ajpgi.00345.2012; Singla A, 2012, AM J PHYSIOL-GASTR L, V302, pG618, DOI 10.1152/ajpgi.00172.2011; Singla A, 2010, AM J PHYSIOL-GASTR L, V298, pG182, DOI 10.1152/ajpgi.00345.2009; Sporn M. B., 1994, RETINOIDS; Sun SY, 2002, CRIT REV ONCOL HEMAT, V41, P41, DOI 10.1016/S1040-8428(01)00144-5; Talbot C, 2010, AM J PHYSIOL-GASTR L, V299, pG358, DOI 10.1152/ajpgi.00151.2010; Thurnham DI, 2000, J INFECT DIS, V182, pS23, DOI 10.1086/315912; Veldhoen M, 2012, NAT REV IMMUNOL, V12, P696, DOI 10.1038/nri3299; Villamor E, 2000, J INFECT DIS, V182, pS122, DOI 10.1086/315921; Wan Y, 2012, BIOCHEM GENET, V50, P495, DOI 10.1007/s10528-011-9494-9; Wan YJY, 1998, EXP CELL RES, V238, P241, DOI 10.1006/excr.1997.3851; Wang ZH, 2005, AM J PHYSIOL-CELL PH, V288, pC957, DOI 10.1152/ajpcell.00505.2004; Yang HY, 1998, AM J PHYSIOL-GASTR L, V275, pG1445, DOI 10.1152/ajpgi.1998.275.6.G1445	49	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15066	15077		10.1074/jbc.M114.566356	http://dx.doi.org/10.1074/jbc.M114.566356			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25887398	hybrid, Green Published			2022-12-28	WOS:000356177300022
J	Esaki, K; Sayano, T; Sonoda, C; Akagi, T; Suzuki, T; Ogawa, T; Okamoto, M; Yoshikawa, T; Hirabayashi, Y; Furuya, S				Esaki, Kayoko; Sayano, Tomoko; Sonoda, Chiaki; Akagi, Takumi; Suzuki, Takeshi; Ogawa, Takuya; Okamoto, Masahiro; Yoshikawa, Takeo; Hirabayashi, Yoshio; Furuya, Shigeki			L-Serine Deficiency Elicits Intracellular Accumulation of Cytotoxic Deoxysphingolipids and Lipid Body Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-PHOSPHOGLYCERATE DEHYDROGENASE-DEFICIENCY; SPHINGOLIPID METABOLISM; QUANTITATIVE-ANALYSIS; CERAMIDE SYNTHASES; DIABETES-MELLITUS; PYRUVATE-KINASE; AMINO ACIDS; PALMITOYLTRANSFERASE; PLASMA; BIOSYNTHESIS	L-Serine is required to synthesize membrane lipids such as phosphatidylserine and sphingolipids. Nevertheless, it remains largely unknown how a diminished capacity to synthesize L-serine affects lipid homeostasis in cells and tissues. Here, we show that deprivation of external L-serine leads to the generation of 1-deoxysphingolipids (doxSLs), including 1-deoxysphinganine, in mouse embryonicfibroblasts(KO-MEFs)lackingD-3-phosphoglyceratede-hydrogenase (Phgdh), which catalyzes the first step in the de novo synthesis of L-serine. A novel mass spectrometry-based lipidomic approach demonstrated that 1-deoxydihydroceramide was the most abundant species of doxSLs accumulated in L-serine-deprived KO-MEFs. Among normal sphingolipid species in KO-MEFs, levels of sphinganine, dihydroceramide, ceramide, and hexosylceramide were significantly reduced after deprivation of external L-serine, whereas those of sphingomyelin, sphingosine, and sphingosine 1-phosphate were retained. The synthesis of doxSLs was suppressed by supplementing the culture medium with L-serine but was potentiated by increasing the ratio of L-alanine to L-serine in the medium. Unlike with L-serine, depriving cells of external L-leucine did not promote the occurrence of doxSLs. Consistent with results obtained from KO-MEFs, brain-specific deletion of Phgdh in mice also resulted in accumulation of doxSLs in the brain. Furthermore, L-serine-deprived KO-MEFs exhibited increased formation of cytosolic lipid bodies containing doxSLs and other sphingolipids. These in vitro and in vivo studies indicate that doxSLs are generated in the presence of a high ratio of L-alanine to L-serine in cells and tissues lacking Phgdh, and de novo synthesis of L-serine is necessary to maintain normal sphingolipid homeostasis when the external supply of this amino acid is limited.	[Esaki, Kayoko; Sayano, Tomoko; Sonoda, Chiaki; Furuya, Shigeki] Kyushu Univ, Lab Funct Genom & Metab, Grad Sch Bioresource & Bioenvironm Sci, Div Syst Bioengn, Fukuoka 8128581, Japan; [Suzuki, Takeshi; Okamoto, Masahiro] Kyushu Univ, Lab Synthet Biol, Grad Sch Bioresource & Bioenvironm Sci, Div Syst Bioengn, Fukuoka 8128581, Japan; [Okamoto, Masahiro; Furuya, Shigeki] Kyushu Univ, Bioarchitecture Ctr, Fukuoka 8128581, Japan; [Esaki, Kayoko; Yoshikawa, Takeo] RIKEN Brain Sci Inst, Lab Mol Psychiat, Wako, Saitama 3510198, Japan; [Esaki, Kayoko; Sayano, Tomoko; Hirabayashi, Yoshio] RIKEN Brain Sci Inst, Lab Mol Membrane Neurosci, Wako, Saitama 3510198, Japan; [Akagi, Takumi] RIKEN Brain Sci Inst, Support Unit Neuromorphol Anal, Wako, Saitama 3510198, Japan; [Ogawa, Takuya] Int Univ Hlth & Welf, Dept Pharmaceut Sci, Otawara, Tochigi 3248501, Japan	Kyushu University; Kyushu University; Kyushu University; RIKEN; RIKEN; RIKEN; International University of Health & Welfare	Furuya, S (corresponding author), Kyushu Univ, Div Syst Bioengn, Grad Sch Bioresource & Bioenvironm Sci, Fukuoka 8128581, Japan.	shigekifur@brs.kyushu-u.ac.jp	Ogawa, Takuya/ABC-9628-2020; Yoshikawa, Takeo/F-9599-2019	Ogawa, Takuya/0000-0001-9194-3079; Hirabayashi, Yoshio/0000-0002-5774-7354; Furuya, Shigeki/0000-0001-9020-3597	Tojuro Iijima Foundation for Food and Technology; Japan Society for the Promotion of Science KAKENHI [14J05809]; Junior Research Associate of RIKEN; Grants-in-Aid for Scientific Research [24614007] Funding Source: KAKEN	Tojuro Iijima Foundation for Food and Technology; Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Junior Research Associate of RIKEN; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant from The Tojuro Iijima Foundation for Food and Technology (to S. F.) and Japan Society for the Promotion of Science KAKENHI Grant 14J05809 (to K. E.).r Supported by the fellowship of Junior Research Associate of RIKEN.	Baird RD, 2009, MOL CANCER THER, V8, P1430, DOI 10.1158/1535-7163.MCT-08-1167; Bertea M, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-84; Causeret C, 2000, LIPIDS, V35, P1117, DOI 10.1007/s11745-000-0627-6; Chaneton B, 2012, NATURE, V491, P458, DOI 10.1038/nature11540; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Cuadros R, 2000, CANCER LETT, V152, P23, DOI 10.1016/S0304-3835(99)00428-0; de Koning TJ, 1998, ANN NEUROL, V44, P261, DOI 10.1002/ana.410440219; De Luca G, 2001, METABOLISM, V50, P739, DOI 10.1053/meta.2001.24193; Ding YF, 2013, NAT PROTOC, V8, P43, DOI 10.1038/nprot.2012.142; Ehmsen JT, 2013, J NEUROSCI, V33, P12464, DOI 10.1523/JNEUROSCI.4914-12.2013; Eichler FS, 2009, J NEUROSCI, V29, P14646, DOI 10.1523/JNEUROSCI.2536-09.2009; Gable K, 2010, J BIOL CHEM, V285, P22844, DOI 10.1074/jbc.M110.122259; Hanada K, 2000, FEBS LETT, V474, P63, DOI 10.1016/S0014-5793(00)01579-9; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hapala I, 2011, BIOL CELL, V103, P271, DOI 10.1042/BC20100144; Hashemi HF, 2015, CURR OPIN CELL BIOL, V33, P119, DOI 10.1016/j.ceb.2015.02.002; ICHIHARA A, 1955, P NATL ACAD SCI USA, V41, P605, DOI 10.1073/pnas.41.9.605; Kamaura M, 2010, CIRC J, V74, P2434, DOI 10.1253/circj.CJ-10-0150; Kawakami Y, 2009, NEUROSCI RES, V63, P184, DOI 10.1016/j.neures.2008.12.002; Klomp LWJ, 2000, AM J HUM GENET, V67, P1389, DOI 10.1086/316886; Kung C, 2012, CHEM BIOL, V19, P1187, DOI 10.1016/j.chembiol.2012.07.021; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Lowther J, 2012, BIOCHEM SOC T, V40, P547, DOI 10.1042/BST20110769; Marshall Lee L., 2014, Journal of Chemical Biology, V7, P67, DOI 10.1007/s12154-014-0108-y; Massard C, 2012, INVEST NEW DRUG, V30, P2318, DOI 10.1007/s10637-011-9772-8; McCampbell A, 2005, HUM MOL GENET, V14, P3507, DOI 10.1093/hmg/ddi380; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Michel C, 1997, J BIOL CHEM, V272, P22432, DOI 10.1074/jbc.272.36.22432; Mitoma J, 2004, GENE, V334, P15, DOI 10.1016/j.gene.2004.03.015; Mochida T, 2011, MOL GENET METAB, V103, P406, DOI 10.1016/j.ymgme.2011.05.002; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Mullen TD, 2011, J LIPID RES, V52, P68, DOI 10.1194/jlr.M009142; Ogawa T, 2006, J BONE MINER METAB, V24, P373, DOI 10.1007/s00774-006-0705-0; Othman A, 2012, DIABETOLOGIA, V55, P421, DOI 10.1007/s00125-011-2384-1; Othman A, 2015, BMJ OPEN DIAB RES CA, V3, DOI 10.1136/bmjdrc-2014-000073; Penno A, 2010, J BIOL CHEM, V285, P11178, DOI 10.1074/jbc.M109.092973; Pitson SM, 2011, TRENDS BIOCHEM SCI, V36, P97, DOI 10.1016/j.tibs.2010.08.001; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Salcedo M, 2007, APOPTOSIS, V12, P395, DOI 10.1007/s10495-006-0573-z; Sayano T, 2013, FEBS J, V280, P1502, DOI 10.1111/febs.12146; SCHARFF R, 1966, BIOCHEM J, V99, P173, DOI 10.1042/bj0990173; Schoffski P, 2011, CANCER CHEMOTH PHARM, V68, P1397, DOI 10.1007/s00280-011-1612-1; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; SNELL K, 1984, ADV ENZYME REGUL, V22, P325, DOI 10.1016/0065-2571(84)90021-9; Wolosker H, 2008, FEBS J, V275, P3514, DOI 10.1111/j.1742-4658.2008.06515.x; Yang JH, 2010, J BIOL CHEM, V285, P41380, DOI 10.1074/jbc.M110.187443; Yoshida K, 2004, J BIOL CHEM, V279, P3573, DOI 10.1074/jbc.C300507200; Zitomer NC, 2009, J BIOL CHEM, V284, P4786, DOI 10.1074/jbc.M808798200	49	47	47	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14595	14609		10.1074/jbc.M114.603860	http://dx.doi.org/10.1074/jbc.M114.603860			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25903138	Green Published, hybrid			2022-12-28	WOS:000355754600030
J	Zhao, PS; Lieu, T; Barlow, N; Sostegni, S; Haerteis, S; Korbmacher, C; Liedtke, W; Jimenez-Vargas, NN; Vanner, SJ; Bunnett, NW				Zhao, Peishen; Lieu, TinaMarie; Barlow, Nicholas; Sostegni, Silvia; Haerteis, Silke; Korbmacher, Christoph; Liedtke, Wolfgang; Jimenez-Vargas, Nestor N.; Vanner, Stephen J.; Bunnett, Nigel W.			Neutrophil Elastase Activates Protease-activated Receptor-2 (PAR(2)) and Transient Receptor Potential Vanilloid 4 (TRPV4) to Cause Inflammation and Pain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAST-CELL TRYPTASE; ARRESTIN-DEPENDENT ENDOCYTOSIS; SODIUM-CHANNEL ENAC; PROTEOLYTIC ACTIVATION; INDUCE INFLAMMATION; SERINE-PROTEASE; BIASED AGONIST; TRYPSIN-IV; PROTEINASE; KALLIKREIN	Proteases that cleave protease-activated receptor-2 (PAR(2)) at Arg(362) down arrow Ser(37) reveal a tethered ligand that binds to the cleaved receptor. PAR(2) activates transient receptor potential (TRP) channels of nociceptive neurons to induce neurogenic inflammation and pain. Although proteases that cleave PAR(2) at non-canonical sites can trigger distinct signaling cascades, the functional importance of the PAR(2)-biased agonism is uncertain. We investigated whether neutrophil elastase, a biased agonist of PAR(2), causes inflammation and pain by activating PAR(2) and TRP vanilloid 4 (TRPV4). Elastase cleaved human PAR(2) at Ala(662) down arrow Ser(67) and Ser(672) down arrow Val(68). Elastase stimulated PAR(2)-dependent cAMP accumulation and ERK1/2 activation, but not Ca2+ mobilization, in KNRK cells. Elastase induced PAR(2) coupling to G alpha(s) but not G alpha(q) in HEK293 cells. Although elastase did not promote recruitment of G protein-coupled receptor kinase-2 (GRK2) or beta-arrestin to PAR(2), consistent with its inability to promote receptor endocytosis, elastase did stimulate GRK6 recruitment. Elastase caused PAR(2)-dependent sensitization of TRPV4 currents in Xenopus laevis oocytes by adenylyl cyclase-and protein kinase A (PKA)-dependent mechanisms. Elastase stimulated PAR(2)-dependentc AMP formation and ERK1/2 phosphorylation, and a PAR(2)- and TRPV4-mediated influx of extracellular Ca2+ in mouse nociceptors. Adenylyl cyclase and PKA-mediated elastase-induced activation of TRPV4 and hyperexcitability of nociceptors. Intraplantar injection of elastase to mice caused edema and mechanical hyperalgesia by PAR(2)- and TRPV4-mediated mechanisms. Thus, the elastase-biased agonism of PAR(2) causes G alpha(s)-dependent activation of adenylyl cyclase and PKA, which activates TRPV4 and sensitizes nociceptors to cause inflammation and pain. Our results identify a novel mechanism of elastase-induced activation of TRPV4 and expand the role of PAR(2) as a mediator of protease-driven inflammation and pain.	[Zhao, Peishen; Lieu, TinaMarie; Barlow, Nicholas; Bunnett, Nigel W.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Bunnett, Nigel W.] Monash Univ, ARC Ctr Excellence Convergent Bionano Sci & Techn, Parkville, Vic 3052, Australia; [Sostegni, Silvia; Haerteis, Silke; Korbmacher, Christoph] Univ Erlangen Nurnberg, Inst Zellulare & Mol Physiol, D-91054 Erlangen, Germany; [Liedtke, Wolfgang] Duke Univ, Sch Med, Dept Neurol, Durham, NC 27710 USA; [Jimenez-Vargas, Nestor N.; Vanner, Stephen J.] Queens Univ, Div Gastroenterol, Gastrointestinal Dis Res Unit, Kingston, ON N7L 3N6, Canada; [Bunnett, Nigel W.] Univ Melbourne, Dept Pharmacol, Melbourne, Vic 3010, Australia	Monash University; Monash University; University of Erlangen Nuremberg; Duke University; Queens University - Canada; University of Melbourne	Bunnett, NW (corresponding author), Monash Inst Pharmaceut Sci, 381 Royal Parade, Parkville, Vic 3052, Australia.	Nigel.Bunnett@Monash.edu	Zhao, Peishen/AFQ-6840-2022; Barlow, Nicholas/W-8442-2019; Lieu, TinaMarie/AAM-7691-2020; Liedtke, Wolfgang/GNH-1878-2022; Haerteis, Silke/AGS-5314-2022	Jimenez-Vargas, Nestor N/0000-0001-6595-1884; Barlow, Nicholas/0000-0002-5749-3542; Bunnett, Nigel W./0000-0003-3367-0644; Haerteis, Silke/0000-0002-9440-3307	NHMRC [63303, 1049682, 1031886]; ARC Centre of Excellence in Convergent Bio-Nano Science and Technology; Monash University; Bayerische Forschungsstiftung; Else Kroner-Fresenius-Stiftung	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); ARC Centre of Excellence in Convergent Bio-Nano Science and Technology(Australian Research Council); Monash University(Monash University); Bayerische Forschungsstiftung; Else Kroner-Fresenius-Stiftung	This work was supported by NHMRC Grants 63303, 1049682, and 1031886, grants from the ARC Centre of Excellence in Convergent Bio-Nano Science and Technology and Monash University (to N. W. B.), a Ph.D. fellowship from the Bayerische Forschungsstiftung (to S. S.), and the Else Kroner-Fresenius-Stiftung (to S. H.).	Amadesi S, 2004, CURR OPIN PHARMACOL, V4, P551, DOI 10.1016/j.coph.2004.08.004; Amadesi S, 2004, J NEUROSCI, V24, P4300, DOI 10.1523/JNEUROSCI.5679-03.2004; Amadesi S, 2009, J COMP NEUROL, V516, P141, DOI 10.1002/cne.22104; Ayoub Mohammed Akli, 2013, Front Endocrinol (Lausanne), V4, P196, DOI 10.3389/fendo.2013.00196; Bledsoe G, 2008, TOXICOL SCI, V102, P433, DOI 10.1093/toxsci/kfn008; Bohm SK, 1996, J BIOL CHEM, V271, P22003; Caldwell RA, 2005, AM J PHYSIOL-LUNG C, V288, pL813, DOI 10.1152/ajplung.00435.2004; Camerer E, 2000, P NATL ACAD SCI USA, V97, P5255, DOI 10.1073/pnas.97.10.5255; Corvera CU, 1997, J CLIN INVEST, V100, P1383, DOI 10.1172/JCI119658; Cottrell GS, 2004, J BIOL CHEM, V279, P13532, DOI 10.1074/jbc.M312090200; Dai Y, 2007, J CLIN INVEST, V117, P1979, DOI 10.1172/JCI30951; de Garavilla L, 2001, BRIT J PHARMACOL, V133, P975, DOI 10.1038/sj.bjp.0704152; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Dery O, 1999, J BIOL CHEM, V274, P18524, DOI 10.1074/jbc.274.26.18524; Diakov A, 2008, J PHYSIOL-LONDON, V586, P4587, DOI 10.1113/jphysiol.2008.154435; Dulon S, 2005, AM J RESP CELL MOL, V32, P411, DOI 10.1165/rcmb.2004-0274OC; Dulon S, 2003, AM J RESP CELL MOL, V28, P339, DOI 10.1165/rcmb.4908; Eijkelkamp N, 2009, BRAIN BEHAV IMMUN, V23, P18, DOI 10.1016/j.bbi.2008.07.006; Elmariah SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099702; Fan HC, 2009, J BIOL CHEM, V284, P27884, DOI 10.1074/jbc.M109.028803; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Grant AD, 2007, J PHYSIOL-LONDON, V578, P715, DOI 10.1113/jphysiol.2006.121111; Gurevich EV, 2012, PHARMACOL THERAPEUT, V133, P40, DOI 10.1016/j.pharmthera.2011.08.001; Haerteis S, 2012, PFLUG ARCH EUR J PHY, V464, P353, DOI 10.1007/s00424-012-1138-3; Hansen KK, 2005, P NATL ACAD SCI USA, V102, P8363, DOI 10.1073/pnas.0409535102; Henriksen PA, 2014, CURR OPIN HEMATOL, V21, P23, DOI 10.1097/MOH.0000000000000001; Jensen DD, 2013, J BIOL CHEM, V288, P22942, DOI 10.1074/jbc.M113.455774; Kayssi A, 2007, J PHYSIOL-LONDON, V580, P977, DOI 10.1113/jphysiol.2006.126599; Knecht W, 2007, J BIOL CHEM, V282, P26089, DOI 10.1074/jbc.M703840200; Kocan Martina, 2010, Front Endocrinol (Lausanne), V1, P12, DOI 10.3389/fendo.2010.00012; Li JJ, 2011, ENVIRON HEALTH PERSP, V119, P784, DOI 10.1289/ehp.1002807; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Lindner JR, 2000, J IMMUNOL, V165, P6504, DOI 10.4049/jimmunol.165.11.6504; Loew D, 2000, BIOCHEMISTRY-US, V39, P10812, DOI 10.1021/bi0003341; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; Mihara K, 2013, J BIOL CHEM, V288, P32979, DOI 10.1074/jbc.M113.483123; Molino M, 1997, J BIOL CHEM, V272, P4043, DOI 10.1074/jbc.272.7.4043; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; NYSTEDT S, 1995, EUR J BIOCHEM, V232, P84, DOI 10.1111/j.1432-1033.1995.tb20784.x; Oikonomopoulou K, 2006, BIOL CHEM, V387, P817, DOI 10.1515/BC.2006.104; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Poole DP, 2013, J BIOL CHEM, V288, P5790, DOI 10.1074/jbc.M112.438184; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Ramachandran R, 2011, J BIOL CHEM, V286, P24638, DOI 10.1074/jbc.M110.201988; Ramsay AJ, 2008, BIOL CHEM, V389, P653, DOI 10.1515/BC.2008.078; Ramsay AJ, 2008, J BIOL CHEM, V283, P12293, DOI 10.1074/jbc.M709493200; Rauh R, 2010, J PHYSIOL-LONDON, V588, P1211, DOI 10.1113/jphysiol.2009.180224; Reed DE, 2003, J PHYSIOL-LONDON, V547, P531, DOI 10.1113/jphysiol.2002.032011; Sipe WEB, 2008, AM J PHYSIOL-GASTR L, V294, pG1288, DOI 10.1152/ajpgi.00002.2008; Smith R, 2000, FEBS LETT, V484, P285, DOI 10.1016/S0014-5793(00)02146-3; Sostegni S, 2015, PFLUG ARCH EUR J PHY, V467, P687, DOI 10.1007/s00424-014-1539-6; Steinhoff M, 2000, NAT MED, V6, P151, DOI 10.1038/72247; STOFFEL RH, 1994, J BIOL CHEM, V269, P27791; Sun BB, 2013, J MOL HISTOL, V44, P259, DOI 10.1007/s10735-013-9486-7; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Vergnolle N, 2010, BRIT J PHARMACOL, V159, P1161, DOI 10.1111/j.1476-5381.2009.00590.x; Vergnolle N, 2001, NAT MED, V7, P821, DOI 10.1038/89945; Vergnolle N, 2009, PHARMACOL THERAPEUT, V123, P292, DOI 10.1016/j.pharmthera.2009.05.004; Watanabe H, 2003, CELL CALCIUM, V33, P489, DOI 10.1016/S0143-4160(03)00064-2; Willoughby D, 2012, BIOCHEM SOC T, V40, P246, DOI 10.1042/BST20110613; Wilson S, 2005, BIOCHEM J, V388, P967, DOI 10.1042/BJ20041066; Zhao PS, 2014, J BIOL CHEM, V289, P27215, DOI 10.1074/jbc.M114.599712; Zhou Y, 2013, NEUROCHEM RES, V38, P2168, DOI 10.1007/s11064-013-1125-x	64	106	114	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13875	13887		10.1074/jbc.M115.642736	http://dx.doi.org/10.1074/jbc.M115.642736			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25878251	Green Published, hybrid			2022-12-28	WOS:000355313000020
J	Leone, P; Bebeacua, C; Opota, O; Kellenberger, C; Klaholz, B; Orlov, I; Cambillau, C; Lemaitre, B; Roussel, A				Leone, Philippe; Bebeacua, Cecilia; Opota, Onya; Kellenberger, Christine; Klaholz, Bruno; Orlov, Igor; Cambillau, Christian; Lemaitre, Bruno; Roussel, Alain			X-ray and Cryo-electron Microscopy Structures of Monalysin Pore-forming Toxin Reveal Multimerization of the Pro-form	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPTAMERIC TRANSMEMBRANE PORE; CRYSTAL-STRUCTURE; PROTECTIVE ANTIGEN; ELECTRON-MICROSCOPY; CONFORMATIONAL-CHANGES; MAXIMUM-LIKELIHOOD; MEMBRANE-CHANNEL; AEROLYSIN; MECHANISM; HEMOLYSIN	beta-Barrel pore-forming toxins (beta-PFT), a large family of bacterial toxins, are generally secreted as water-soluble monomers and can form oligomeric pores in membranes following proteolytic cleavage and interaction with cell surface receptors. Monalysin has been recently identified as a beta-PFT that contributes to the virulence of Pseudomonas entomophila against Drosophila. It is secreted as a pro-protein that becomes active upon cleavage. Here we report the crystal and cryo-electron microscopy structure of the pro-form of Monalysin as well as the crystal structures of the cleaved form and of an inactive mutant lacking the membrane-spanning region. The overall structure of Monalysin displays an elongated shape, which resembles those of beta-poreforming toxins, such as Aerolysin, but is devoid of a receptorbinding domain. X-ray crystallography, cryo-electron microscopy, and light-scattering studies show that pro-Monalysin forms a stable doughnut-like 18-mer complex composed of two disk-shaped nonamers held together by N-terminal swapping of the pro-peptides. This observation is in contrast with the monomeric pro-form of the other beta-PFTs that are receptor-dependent for membrane interaction. The membrane-spanning region of pro-Monalysin is fully buried in the center of the doughnut, suggesting that upon cleavage of pro-peptides, the two disk-shaped nonamers can, and have to, dissociate to leave the transmembrane segments free to deploy and lead to pore formation. In contrast with other toxins, the delivery of 18 subunits at once, nearby the cell surface, may be used to bypass the requirement of receptor-dependent concentration to reach the threshold for oligomerization into the pore-forming complex.	[Leone, Philippe; Bebeacua, Cecilia; Kellenberger, Christine; Cambillau, Christian; Roussel, Alain] CNRS, AFMB, Unite Mixte Rech UMR 7257, F-13288 Marseille, France; [Leone, Philippe; Bebeacua, Cecilia; Kellenberger, Christine; Cambillau, Christian; Roussel, Alain] Aix Marseille Univ, Architecture & Fonct Macromol Biol, UMR 7257, F-13288 Marseille, France; [Opota, Onya; Lemaitre, Bruno] Ecole Polytech Fed Lausanne, Global Hlth Inst, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Klaholz, Bruno; Orlov, Igor] Univ Strasbourg, IGBMC Inst Genet & Mol & Cellular Biol, Dept Integrated Struct Biol, CNRS,UMR 7104,INSERM,U964,CBI, F-67404 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Roussel, A (corresponding author), CNRS, AFMB, Unite Mixte Rech UMR 7257, F-13288 Marseille, France.	alain.roussel@afmb.univ-mrs.fr	Opota, Onya/K-5851-2017; kellenberger, christine/AAV-9304-2020; Lemaitre, Bruno/T-8146-2019	Opota, Onya/0000-0002-5421-0607; Lemaitre, Bruno/0000-0001-7970-1667	French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-01]; European Strategy Forum on Research Infrastructures (ESFRI)	French Infrastructure for Integrated Structural Biology (FRISBI); European Strategy Forum on Research Infrastructures (ESFRI)	This work was supported by the French Infrastructure for Integrated Structural Biology (FRISBI) Grant ANR-10-INSB-05-01 and by Instruct as part of the European Strategy Forum on Research Infrastructures (ESFRI).	Benson EL, 1998, BIOCHEMISTRY-US, V37, P3941, DOI 10.1021/bi972657b; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Blemont M, 2013, ACTA CRYSTALLOGR F, V69, P930, DOI 10.1107/S174430911301885X; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Cabiaux V, 1997, BIOCHEMISTRY-US, V36, P15224, DOI 10.1021/bi971216p; Cole AR, 2004, NAT STRUCT MOL BIOL, V11, P797, DOI 10.1038/nsmb804; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; De S, 2011, P NATL ACAD SCI USA, V108, P7385, DOI 10.1073/pnas.1017442108; Degiacomi MT, 2013, NAT CHEM BIOL, V9, P623, DOI [10.1038/NCHEMBIO.1312, 10.1038/nchembio.1312]; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gouaux E, 1997, CURR OPIN STRUC BIOL, V7, P566, DOI 10.1016/S0959-440X(97)80123-6; GRUBER HJ, 1994, MOL MICROBIOL, V14, P1093, DOI 10.1111/j.1365-2958.1994.tb01341.x; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Iacovache I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002135; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kitadokoro K, 2011, J BIOL CHEM, V286, P19549, DOI 10.1074/jbc.M111.228478; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lacy DB, 2004, P NATL ACAD SCI USA, V101, P13147, DOI 10.1073/pnas.0405405101; Mancheno JM, 2005, J BIOL CHEM, V280, P17251, DOI 10.1074/jbc.M413933200; Melton JA, 2004, J BIOL CHEM, V279, P14315, DOI 10.1074/jbc.M313758200; MILNE JC, 1994, J BIOL CHEM, V269, P20607; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; Mueller M, 2009, NATURE, V459, P726, DOI 10.1038/nature08026; Olson R, 2005, J MOL BIOL, V350, P997, DOI 10.1016/j.jmb.2005.05.045; Olson R, 1999, NAT STRUCT BIOL, V6, P134; Opota O, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002259; Parker MW, 2005, PROG BIOPHYS MOL BIO, V88, P91, DOI 10.1016/j.pbiomolbio.2004.01.009; PARKER MW, 1994, NATURE, V367, P292, DOI 10.1038/367292a0; Roblin P, 2008, PROTEINS, V71, P485, DOI 10.1002/prot.21900; Roussel A, 1991, SILICON GRAPHICS GEO, P86; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Scheres SHW, 2010, METHOD ENZYMOL, V482, P295, DOI 10.1016/S0076-6879(10)82012-9; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Szczesny P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020349; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; van Heel M, 2005, J STRUCT BIOL, V151, P250, DOI 10.1016/j.jsb.2005.05.009; VANDERGOOT FG, 1994, J BIOL CHEM, V269, P30496; VANDERGOOT FG, 1993, J BIOL CHEM, V268, P18272; VANHEEL M, 1984, ULTRAMICROSCOPY, V13, P165, DOI 10.1016/0304-3991(84)90066-4; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Wallace AJ, 2000, CELL, V100, P265, DOI 10.1016/S0092-8674(00)81564-0; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamashita K, 2011, P NATL ACAD SCI USA, V108, P17314, DOI 10.1073/pnas.1110402108	45	17	18	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13191	13201		10.1074/jbc.M115.646109	http://dx.doi.org/10.1074/jbc.M115.646109			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25847242	Green Published, hybrid			2022-12-28	WOS:000354975700021
J	Li, J; Biss, M; Fu, Y; Xu, X; Moore, SA; Xiao, W				Li, Jia; Biss, Michael; Fu, Yu; Xu, Xin; Moore, Stanley A.; Xiao, Wei			Two Duplicated Genes DDI2 and DDI3 in Budding Yeast Encode a Cyanamide Hydratase and Are Induced by Cyanamide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; HD-DOMAIN; DNTP TRIPHOSPHOHYDROLASE; MYROTHECIUM-VERRUCARIA; NATURAL CYANAMIDE; ESCHERICHIA-COLI; DNA GLYCOSYLASE; EXPRESSION; SPECIFICITY; DISRUPTION	Two DNA damage-inducible genes in Saccharomyces cerevisiae, DDI2 and DDI3, are identical and encode putative HD domain-containing proteins, whose functions are currently unknown. Because Ddi2/3 also shows limited homology to a fungal cyanamide hydratase that converts cyanamide to urea, we tested the enzymatic activity of recombinant Ddi2. To this end, we developed a novel enzymatic assay and determined that the K-m value of the recombinant Ddi2/3 for cyanamide is 17.3 +/- 0.05 mM, and its activity requires conserved residues in the HD domain. Unlike most other DNA damage-inducible genes, DDI2/3 is only induced by a specific set of alkylating agents and surprisingly is strongly induced by cyanamide. To characterize the biological function of DDI2/3, we sequentially deleted both DDI genes and found that the double mutant was unable to metabolize cyanamide and became much more sensitive to growth inhibition by cyanamide, suggesting that the DDI2/3 genes protect host cells from cyanamide toxicity. Despite the physiological relevance of the cyanamide induction, DDI2/3 is not involved in its own transcriptional regulation. The significance of cyanamide hydratase activity and its induced expression is discussed.	[Li, Jia; Biss, Michael; Fu, Yu; Xiao, Wei] Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK S7N 5E5, Canada; [Moore, Stanley A.] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada; [Xu, Xin; Xiao, Wei] Capital Normal Univ, Coll Life Sci, Beijing 100048, Peoples R China	University of Saskatchewan; University of Saskatchewan; Capital Normal University	Xiao, W (corresponding author), Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK S7N 5E5, Canada.	wei.xiao@usask.ca		Xiao, Wei/0000-0001-7568-0782	Natural Sciences and Engineering Research Council of Canada [RGPIN-2014-04580, SAM 262138-2011]; University of Saskatchewan	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Saskatchewan	This work was supported in part by the Natural Sciences and Engineering Research Council of Canada Discovery Grants RGPIN-2014-04580 and SAM 262138-2011 (to W. X.).; Supported by a graduate teaching fellowship from University of Saskatchewan.	Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; BERBEN G, 1991, YEAST, V7, P475, DOI 10.1002/yea.320070506; Briganti F, 1999, J BIOL INORG CHEM, V4, P528, DOI 10.1007/s007750050375; Brown PM, 2006, ACTA CRYSTALLOGR F, V62, P811, DOI 10.1107/S1744309106028144; Brownt PM, 2006, P NATL ACAD SCI USA, V103, P15032, DOI 10.1073/pnas.0605143103; CHEN J, 1989, P NATL ACAD SCI USA, V86, P7961, DOI 10.1073/pnas.86.20.7961; CHEN J, 1990, EMBO J, V9, P4569, DOI 10.1002/j.1460-2075.1990.tb07910.x; Clarke DJ, 2001, MOL CELL BIOL, V21, P1997, DOI 10.1128/MCB.21.6.1997-2007.2001; Coissac E, 1997, MOL BIOL EVOL, V14, P1062, DOI 10.1093/oxfordjournals.molbev.a025712; DeMaster EG, 1998, BIOCHEM PHARMACOL, V55, P2007, DOI 10.1016/S0006-2952(98)00080-X; Fu Y., 2008, THESIS U SASKATCHEWA; Fu Y, 2008, FEMS MICROBIOL REV, V32, P908, DOI 10.1111/j.1574-6976.2008.00126.x; Fu Y, 2008, CELL, V133, P601, DOI 10.1016/j.cell.2008.02.050; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Gotz R, 1999, YEAST, V15, P855, DOI 10.1002/(SICI)1097-0061(199907)15:10A<855::AID-YEA425>3.0.CO;2-C; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; Hulme R, 2008, TETRAHEDRON, V64, P3372, DOI 10.1016/j.tet.2008.01.087; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jia XM, 2002, MUTAT RES-GEN TOX EN, V519, P83, DOI 10.1016/S1383-5718(02)00129-8; Kamo T, 2003, J CHEM ECOL, V29, P275, DOI 10.1023/A:1022621709486; Kamo T, 2008, PHYTOCHEMISTRY, V69, P1166, DOI 10.1016/j.phytochem.2007.11.004; Kamo T, 2006, BIOSCI BIOTECH BIOCH, V70, P2310, DOI 10.1271/bbb.60171; Katla VR, 2013, CHEM PHARM BULL, V61, P25, DOI 10.1248/cpb.c12-00582; Ke SH, 1997, NUCLEIC ACIDS RES, V25, P3371, DOI 10.1093/nar/25.16.3371; Kondo N, 2004, J BIOCHEM, V136, P221, DOI 10.1093/jb/mvh115; Kondo N, 2007, ACTA CRYSTALLOGR D, V63, P230, DOI 10.1107/S0907444906049262; Liu Y, 1997, MOL GEN GENET, V255, P533, DOI 10.1007/s004380050526; MAIERGREINER UH, 1991, P NATL ACAD SCI USA, V88, P4260, DOI 10.1073/pnas.88.10.4260; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; MONDZAC A, 1965, J LAB CLIN MED, V66, P526; MYERS AM, 1986, GENE, V45, P299, DOI 10.1016/0378-1119(86)90028-4; Nagata M, 2008, J BIOL CHEM, V283, P2176, DOI 10.1074/jbc.M705309200; OLSON JA, 1953, J BIOL CHEM, V202, P841; Padilla PA, 1998, J BACTERIOL, V180, P5718, DOI 10.1128/JB.180.21.5718-5726.1998; Pastushok L, 2005, J BIOL CHEM, V280, P17891, DOI 10.1074/jbc.M410469200; Powner MW, 2009, NATURE, V459, P239, DOI 10.1038/nature08013; QUIRK S, 1991, J BACTERIOL, V173, P6665, DOI 10.1128/jb.173.21.6665-6669.1991; Rao F, 2010, BIOCHEM BIOPH RES CO, V398, P500, DOI 10.1016/j.bbrc.2010.06.107; Rodriguez-Navarro S, 2002, YEAST, V19, P1261, DOI 10.1002/yea.916; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Sherman F., 1983, METHODS YEAST GENETI; STELLER WA, 1965, J AGR FOOD CHEM, V13, P329, DOI 10.1021/jf60140a011; STRANSKY H, 1973, Z PFLANZENPHYSIOL, V70, P74, DOI 10.1016/S0044-328X(73)80049-2; Thaller MC, 1998, PROTEIN SCI, V7, P1647, DOI 10.1002/pro.5560070722; Weeks JT, 2000, CROP SCI, V40, P1749, DOI 10.2135/cropsci2000.4061749x; White RE, 2011, FEBS LETT, V585, P139, DOI 10.1016/j.febslet.2010.11.026; Wightman R, 2003, MICROBIOL-SGM, V149, P1447, DOI 10.1099/mic.0.26194-0; Yakunin AF, 2004, J BIOL CHEM, V279, P36819, DOI 10.1074/jbc.M405120200; Zhang XH, 2005, J PLANT PHYSIOL, V162, P1064, DOI 10.1016/j.jplph.2004.11.013; Zhu Y, 2004, NUCLEIC ACIDS RES, V32, P5066, DOI 10.1093/nar/gkh838; Zhu Y, 1998, NUCLEIC ACIDS RES, V26, P5402, DOI 10.1093/nar/26.23.5402; Zimmerman MD, 2008, J MOL BIOL, V378, P215, DOI 10.1016/j.jmb.2008.02.036	52	10	12	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12664	12675		10.1074/jbc.M115.645408	http://dx.doi.org/10.1074/jbc.M115.645408			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25847245	Green Published, hybrid			2022-12-28	WOS:000354569000020
J	Jaijyan, DK; Singh, H; Singh, AP				Jaijyan, Dabbu Kumar; Singh, Himanshu; Singh, Agam Prasad			A Sporozoite- and Liver Stage-expressed Tryptophan-rich Protein Plays an Auxiliary Role in Plasmodium Liver Stage Development and Is a Potential Vaccine Candidate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCUMSPOROZOITE PROTEIN; MALARIA PARASITE; PROTECTIVE IMMUNITY; T-CELLS; IMMUNIZATION; INFECTION; ANTIGEN; BERGHEI; FALCIPARUM; MOSQUITO	The liver stages of the malaria parasite are clinically silent and constitute ideal targets for causal prophylactic drugs and vaccines. Cellular and molecular events responsible for liver stage development are poorly characterized. Here, we show that sporozoite, liver stage tryptophan-rich protein (SLTRiP) forms large multimers. Mice immunized with a purified recombinant SLTRiP protein gave high antibody titers in both inbred and outbred mice. Immunized mice showed highly significant levels of protection upon challenge with sporozoites and exhibited 10,000-fold fewer parasite 18S-rRNA copy numbers in their livers. The protection offered by immunization with SLTRiP came mainly from T-cells, and antibodies had little role to play despite their high titers. Immunofluorescence assays showed that SLTRiP is expressed in the sporozoite and early to late liver stages of malaria parasites. SLTRiP protein is exported to the cytosol of infected host cells during the early hours of parasite infection. Parasites deficient in SLTRiP were moderately defective in liver stage parasite development. A transcriptome profile of SLTRiP-deficient parasite-infected hepatocytes highlighted that SLTRiP interferes with multiple pathways in the host cell. We have demonstrated a role for SLTRiP in sporozoites and the liver stage of malaria parasites.	[Jaijyan, Dabbu Kumar; Singh, Himanshu; Singh, Agam Prasad] Natl Inst Immunol, Infect Dis Lab, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Singh, AP (corresponding author), Natl Inst Immunol, Infect Dis Lab, Aruna Asaf Ali Marg, New Delhi 110067, India.	singhap@nii.res.in	singh, Agam prasad/F-2532-2012; Singh, Agam/AAH-2031-2020	singh, Agam prasad/0000-0003-4262-2556; Singh, Agam/0000-0003-4262-2556	Department of Biotechnology, Government of India [BT/HRD/35/02/13/2008]; NII core grant	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); NII core grant	This work was supported in part by Ramalingaswami Fellowship Grant BT/HRD/35/02/13/2008 from the Department of Biotechnology, Government of India, conferred (to A. P. S.) and generous funding from an NII core grant. The authors declare that they have no conflicts of interest with the contents of this article.	Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Albuquerque SS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-270; Aly ASI, 2009, ANNU REV MICROBIOL, V63, P195, DOI 10.1146/annurev.micro.091208.073403; Amino R, 2006, NAT MED, V12, P220, DOI 10.1038/nm1350; Arndt Claudia, 2012, Methods Mol Biol, V869, P49, DOI 10.1007/978-1-61779-821-4_5; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Broer R, 2006, J VIROL, V80, P1302, DOI 10.1128/JVI.80.3.1302-1310.2006; Burns JM, 1999, INFECT IMMUN, V67, P675, DOI 10.1128/IAI.67.2.675-680.1999; CLYDE DF, 1975, AM J TROP MED HYG, V24, P397, DOI 10.4269/ajtmh.1975.24.397; de Chassey B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003440; Frevert U, 2005, PLOS BIOL, V3, P1034, DOI 10.1371/journal.pbio.0030192; Garg S, 2008, MICROBES INFECT, V10, P1097, DOI 10.1016/j.micinf.2008.05.008; Gruner AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001371; Hill AVS, 2010, HUM VACCINES, V6, P78, DOI 10.4161/hv.6.1.10116; Hoffman SL, 2000, NAT MED, V6, P1218, DOI 10.1038/81315; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; Ingmundson A, 2012, MOL MICROBIOL, V83, P1229, DOI 10.1111/j.1365-2958.2012.08004.x; Ishino T, 2005, CELL MICROBIOL, V7, P199, DOI 10.1111/j.1462-5822.2004.00447.x; Ishino T, 2004, PLOS BIOL, V2, P77, DOI 10.1371/journal.pbio.0020004; Jalah R, 2005, MOL BIOCHEM PARASIT, V142, P158, DOI 10.1016/j.molbiopara.2005.01.020; Jensen KDC, 2013, INFECT IMMUN, V81, P2156, DOI 10.1128/IAI.01185-12; Jobe O, 2007, J INFECT DIS, V196, P599, DOI 10.1086/519743; Kappe SHI, 2011, SCIENCE, V334, P460, DOI 10.1126/science.1213934; KHAN ZM, 1992, INFECT IMMUN, V60, P264, DOI 10.1128/IAI.60.1.264-270.1992; Kitagawa Y, 2011, J VIROL, V85, P4606, DOI 10.1128/JVI.02012-10; Komla-Soukha I, 2006, J VIROL, V80, P4648, DOI 10.1128/JVI.80.10.4648-4655.2006; Kumar KA, 2004, J IMMUNOL METHODS, V292, P157, DOI 10.1016/j.jim.2004.06.017; Kumar KA, 2006, NATURE, V444, P937, DOI 10.1038/nature05361; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; MELLOUK S, 1990, LANCET, V335, P721, DOI 10.1016/0140-6736(90)90832-P; Mikolajczak SA, 2007, INT J PARASITOL, V37, P483, DOI 10.1016/j.ijpara.2007.01.002; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Mota MM, 2001, SCIENCE, V291, P141, DOI 10.1126/science.291.5501.141; Mueller AK, 2005, P NATL ACAD SCI USA, V102, P3022, DOI 10.1073/pnas.0408442102; Olotu A, 2011, LANCET INFECT DIS, V11, P102, DOI 10.1016/S1473-3099(10)70262-0; Orito Y, 2013, MOL MICROBIOL, V87, P66, DOI 10.1111/mmi.12083; Pinzon-Charry A, 2008, EXPERT OPIN BIOL TH, V8, P441, DOI [10.1517/14712598.8.4.441, 10.1517/14712598.8.4.441 ]; Plassmeyer ML, 2009, J BIOL CHEM, V284, P26951, DOI 10.1074/jbc.M109.013706; Prudencio M, 2006, NAT REV MICROBIOL, V4, P849, DOI 10.1038/nrmicro1529; Sacarlal J, 2009, J INFECT DIS, V200, P329, DOI 10.1086/600119; Silvie O, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000086; Singh AP, 2007, CELL, V131, P492, DOI 10.1016/j.cell.2007.09.013; Skariah S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046621; Sturm A, 2006, SCIENCE, V313, P1287, DOI 10.1126/science.1129720; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; Tsuji M, 2003, TRENDS PARASITOL, V19, P88, DOI 10.1016/S1471-4922(02)00053-3; van Dijk MR, 2005, P NATL ACAD SCI USA, V102, P12194, DOI 10.1073/pnas.0500925102; Vaughan AM, 2012, CURR OPIN IMMUNOL, V24, P324, DOI 10.1016/j.coi.2012.03.009; WEISS WR, 1988, P NATL ACAD SCI USA, V85, P573, DOI 10.1073/pnas.85.2.573	51	11	11	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19496	19511		10.1074/jbc.M114.588129	http://dx.doi.org/10.1074/jbc.M114.588129			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	25960542	hybrid, Green Published			2022-12-28	WOS:000359364600011
J	Sun, CC; Li, SJ; Yang, CL; Xue, RL; Xi, YY; Wang, L; Zhao, QL; Li, DJ				Sun, Cheng-Cao; Li, Shu-Jun; Yang, Cui-Li; Xue, Rui-Lin; Xi, Yong-Yong; Wang, Liang; Zhao, Qian-Long; Li, De-Jia			Sulforaphane Attenuates Muscle Inflammation in Dystrophin-deficient mdx Mice via NF-E2-related Factor 2 (Nrf2)-mediated Inhibition of NF-kappa B Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; NRF2 ENHANCES SUSCEPTIBILITY; NRF2-DEFICIENT MICE; SKELETAL-MUSCLE; ORAL TREATMENT; ACTIVATION; APOPTOSIS; MECHANISMS; EXPRESSION; PATHOLOGY	Inflammation is widely distributed in patients with Duchenne muscular dystrophy and ultimately leads to progressive deterioration of muscle function with chronic muscle damage, oxidative stress, and reduced oxidative capacity. NF-E2-related factor 2 (Nrf2) plays a critical role in defending against inflammation in different tissues via activation of phase II enzyme heme oxygenase-1 and inhibition of the NF-kappa B signaling pathway. However, the role of Nrf2 in the inflammation of dystrophic muscle remains unknown. To determine whether Nrf2 may counteract inflammation in dystrophic muscle, we treated 4-week-old male mdx mice with the Nrf2 activator sulforaphane (SFN) by gavage (2 mg/kg of body weight/day) for 4 weeks. The experimental results demonstrated that SFN treatment increased the expression of muscle phase II enzyme heme oxygenase-1 in an Nrf2-dependent manner. Inflammation in mice was reduced by SFN treatment as indicated by decreased infiltration of immune cells and expression of the inflammatory cytokine CD45 and proinflammatory cytokines tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 in the skeletal muscles of mdx mice. In addition, SFN treatment also decreased the expression of NF-kappa B(p65) and phosphorylated I kappa B kinase-alpha as well as increased inhibitor of kappa B-alpha expression in mdx mice in an Nrf2-dependent manner. Collectively, these results show that SFN-induced Nrf2 can alleviate muscle inflammation in mdx mice by inhibiting the NF-kappa B signaling pathway.	[Sun, Cheng-Cao; Li, Shu-Jun; Yang, Cui-Li; Xue, Rui-Lin; Xi, Yong-Yong; Wang, Liang; Li, De-Jia] Wuhan Univ, Dept Occupat & Environm Hlth, Sch Publ Hlth, Wuhan 430071, Peoples R China; [Zhao, Qian-Long] Lanzhou Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, Lanzhou 730000, Peoples R China	Wuhan University; Lanzhou University	Li, DJ (corresponding author), Wuhan Univ, Dept Occupat & Environm Hlth, Sch Publ Hlth, 115N Donghu Rd, Wuhan 430071, Peoples R China.	lodjlwhu@sina.com	Sun, Cheng-Cao/E-9504-2016	Sun, Cheng-Cao/0000-0002-0554-3165	National Natural Science Foundation of China [81271943]; Fundamental Research Funds for the Central Universities [2015305020202]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (Grant 81271943 to D.-J. L.) and Fundamental Research Funds for the Central Universities (Grant 2015305020202). The authors declare that they have no conflicts of interest with the contents of this article.	Aires A, 2009, J APPL MICROBIOL, V106, P2086, DOI 10.1111/j.1365-2672.2009.04180.x; ANDERSON JE, 1987, ANAT REC, V219, P243, DOI 10.1002/ar.1092190305; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Barton ER, 2002, J CELL BIOL, V157, P137, DOI 10.1083/jcb.200108071; Bauer R, 2009, EUR J HEART FAIL, V11, P463, DOI 10.1093/eurjhf/hfp028; Bhatnagar S, 2010, J MOL MED, V88, P155, DOI 10.1007/s00109-009-0550-4; Blaauw B, 2008, HUM MOL GENET, V17, P3686, DOI 10.1093/hmg/ddn264; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008; Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6; CAMPBELL KP, 1995, CELL, V80, P675, DOI 10.1016/0092-8674(95)90344-5; Charan RA, 2012, FASEB J, V26, P587, DOI 10.1096/fj.11-189829; Davies KE, 2006, CELL, V127, P1304, DOI 10.1016/j.cell.2006.12.010; de Souza CG, 2012, J MED FOOD, V15, P795, DOI 10.1089/jmf.2012.0016; Deconinck N, 2007, PEDIATR NEUROL, V36, P1, DOI 10.1016/j.pediatrneurol.2006.09.016; Durham WJ, 2006, MUSCLE NERVE, V34, P298, DOI 10.1002/mus.20579; Evans NP, 2010, CLIN NUTR, V29, P391, DOI 10.1016/j.clnu.2009.10.001; Farkas D, 2014, AM J RESP CELL MOL, V51, P413, DOI 10.1165/rcmb.2013-0355OC; GOROSPE JRM, 1994, NEUROMUSCULAR DISORD, V4, P325, DOI 10.1016/0960-8966(94)90068-X; Govoni A, 2013, CELL MOL LIFE SCI, V70, P4585, DOI 10.1007/s00018-013-1396-z; GRANCHELLI JA, 1995, J NEUROL SCI, V131, P1, DOI 10.1016/0022-510X(95)00089-K; Heier CR, 2013, EMBO MOL MED, V5, P1569, DOI 10.1002/emmm.201302621; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hori YS, 2011, J PHARMACOL EXP THER, V338, P784, DOI 10.1124/jpet.111.183210; Jin W, 2008, ANN CLIN LAB SCI, V38, P221; Jin W, 2009, J NEUROTRAUM, V26, P131, DOI 10.1089/neu.2008.0655; Jorgensen LH, 2011, AM J PATHOL, V178, P273, DOI 10.1016/j.ajpath.2010.11.027; Juge N, 2007, CELL MOL LIFE SCI, V64, P1105, DOI 10.1007/s00018-007-6484-5; Khor TO, 2006, CANCER RES, V66, P11580, DOI 10.1158/0008-5472.CAN-06-3562; Lee JH, 2013, PHARMACOL THERAPEUT, V137, P153, DOI 10.1016/j.pharmthera.2012.09.008; Li YY, 2010, CLIN CANCER RES, V16, P2580, DOI 10.1158/1078-0432.CCR-09-2937; Mao L, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/238321; Moon DO, 2009, CANCER LETT, V274, P132, DOI 10.1016/j.canlet.2008.09.013; Nahirney PC, 1997, ANAT REC, V247, P341; Nakaso K, 2003, FEBS LETT, V546, P181, DOI 10.1016/S0014-5793(03)00517-9; Nallasamy P, 2014, J NUTR BIOCHEM, V25, P824, DOI 10.1016/j.jnutbio.2014.03.011; Nguyen B., 2014, J THORAC CARDIOVASC, V148, P690; Osburn WO, 2007, INT J CANCER, V121, P1883, DOI 10.1002/ijc.22943; Price LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075415; Rangasamy T, 2005, J EXP MED, V202, P47, DOI 10.1084/jem.20050538; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Scaife CL, 2002, CANCER RES, V62, P6870; Souza CG, 2013, FOOD FUNCT, V4, P1271, DOI 10.1039/c3fo60039d; Spencer MJ, 1997, J CLIN INVEST, V99, P2745, DOI 10.1172/JCI119464; Straub V, 1997, J CELL BIOL, V139, P375, DOI 10.1083/jcb.139.2.375; Sun CC, 2015, J APPL PHYSIOL, V118, P224, DOI 10.1152/japplphysiol.00744.2014; Tidball JG, 2005, CURR OPIN RHEUMATOL, V17, P707, DOI 10.1097/01.bor.0000179948.65895.1a; Tidball JG, 2004, PEDIATR RES, V56, P831, DOI 10.1203/01.PDR.0000145578.01985.D0; Trollet C, 2009, EXPERT OPIN BIOL TH, V9, P849, DOI 10.1517/14712590903029164; Villalta SA, 2009, HUM MOL GENET, V18, P482, DOI 10.1093/hmg/ddn376; Wehling M, 2001, J CELL BIOL, V155, P123, DOI 10.1083/jcb.200105110	51	117	123	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					17784	17795		10.1074/jbc.M115.655019	http://dx.doi.org/10.1074/jbc.M115.655019			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26013831	hybrid, Green Published			2022-12-28	WOS:000358511700013
J	Wang, YF; Lavender, P; Watson, J; Arno, M; Lehner, T				Wang, Yufei; Lavender, Paul; Watson, Julie; Arno, Matthew; Lehner, Thomas			Stress-activated Dendritic Cells (DC) Induce Dual Interleukin (IL)-15-and IL1-mediated Pathways, Which May Elicit CD4(+) Memory T Cells and Interferon (IFN)-stimulated Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						immunology; inflammasome; stress; T helper cells; transcription factor	I INTERFERON; IMMUNE-RESPONSES; INFECTION; INFLAMMASOME; EXPRESSION; PHENOTYPE; DIFFERENTIATION; PROLIFERATION; STIMULATION; HOMEOSTASIS	Background: Immunological memory is maintained by antigen-independent tonic stimulation. Results: Stress-treated dendritic cells stimulate IL-15- and IL-1-mediated pathways, required for optimum memory T cell induction. Conclusion: Stress agents may be responsible for the persistence of immunological memory, involving an epigenetic mechanism. Significance: Repetitive stress may account for tonic stimulation, which maintains immunological memory. The prevailing evidence suggests that immunological memory does not require antigenic re-stimulation but is maintained by low level tonic stimulation. We examined the hypothesis that stress agents contribute to tonic cellular activation and maintain immunological memory. Stimulation of monocyte-derived dendritic cells (DC) with stress agents elicits reactive oxygen species and HSP70. NFB is activated, which up-regulates membrane-associated (ma) IL-15, caspase-1 and IL-1. Co-culture of stress-treated DC with mononuclear cells activates IL-15 and IL-1 receptors on CD4(+) T cells, eliciting CD40L, proliferation, and up-regulation of CD45RO(+) memory T cells. The transcription factors Tbet(high) and RORt are up-regulated, whereas FoxP3 is down-regulated, resulting in enhanced Th1 and Th17 expression and the corresponding cytokines. The interaction between maIL-15 expressed by DC and IL-15R on CD4(+) T cells results in one pathway and the corresponding cells expressing IL-1 and IL1R as a second pathway. Importantly, inhibition studies with IL-15 antibodies and IL-1R inhibitor suggest that both pathways may be required for optimum CD4(+) CD45RO(+) memory T cell expression. Type 1 IFN expression in splenic CD11c DC of stress-treated mice demonstrated a significant increase of IFN- in CD11c CD317(+) and CD8(+) DC. Analysis of RNA in human CD4(+) memory T cells showed up-regulation of type 1 IFN-stimulated genes and inhibition with histone methyltransferase inhibitor. We suggest the paradigm that stress-induced tonic stimulation might be responsible for the robust persistence of the immune response in vaccination and that epigenetic changes are involved in maintaining CD4(+) T cell memory.	[Wang, Yufei; Lehner, Thomas] Kings Coll London, Mucosal Immunol Unit, London SE1 1UL, England; [Lavender, Paul; Watson, Julie] Kings Coll London, MRC, London SE1 1UL, England; [Lavender, Paul; Watson, Julie] Kings Coll London, Asthma UK Ctr Allerg Mech Asthma, London SE1 1UL, England; [Arno, Matthew] Kings Coll London, Genom Ctr, London SE1 1UL, England	University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; King's College London	Lehner, T (corresponding author), Guys Hosp, Mucosal Immunol Unit, Room 2-64S,2nd Floor,Hodgkin Bldg, London SE1 1UL, England.	Thomas.lehner@kcl.ac.uk		Lavender, Paul/0000-0001-8710-0263	European Union Network of excellence, Europrise Grant [LSHP-CT-2006-037611C]; Advanced Immunization Technology Grant [280873]; King's Health Partner's Research and Challenge Fund; Department of Health, National Institute for Health Research (NIHR) Biomedical Research Centre; Medical Research Council [G1000758] Funding Source: researchfish	European Union Network of excellence, Europrise Grant; Advanced Immunization Technology Grant; King's Health Partner's Research and Challenge Fund; Department of Health, National Institute for Health Research (NIHR) Biomedical Research Centre(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the European Union Network of excellence, Europrise Grant LSHP-CT-2006-037611C), Advanced Immunization Technology Grant 280873, and King's Health Partner's Research and Challenge Fund.; Supported by the Department of Health, National Institute for Health Research (NIHR) Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust.	Abt MC, 2009, CURR OPIN GASTROEN, V25, P496, DOI 10.1097/MOG.0b013e328331b6b4; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Andris F, 2011, J IMMUNOL, V186, P2245, DOI 10.4049/jimmunol.1002333; Angelini G, 2002, P NATL ACAD SCI USA, V99, P1491, DOI 10.1073/pnas.022630299; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Becker TC, 2002, J EXP MED, V195, P1541, DOI 10.1084/jem.20020369; Berger G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002221; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Chattopadhyay PK, 2005, NAT MED, V11, P1113, DOI 10.1038/nm1293; Corcoran BM, 2008, CURR PHARM DESIGN, V14, P1382, DOI 10.2174/138161208784480225; Devadas S, 2002, J EXP MED, V195, P59, DOI 10.1084/jem.20010659; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Flahaut S, 1996, FEMS MICROBIOL LETT, V138, P49, DOI 10.1016/0378-1097(96)00080-8; Frentsch M, 2005, NAT MED, V11, P1118, DOI 10.1038/nm1292; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Goujon C, 2013, NATURE, V502, P559, DOI 10.1038/nature12542; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Hattori H, 2010, P NATL ACAD SCI USA, V107, P3546, DOI 10.1073/pnas.0914351107; Huang J, 2006, J VIROL, V80, P5740, DOI 10.1128/JVI.00169-06; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Intlekofer AM, 2006, IMMUNOL REV, V211, P203, DOI 10.1111/j.0105-2896.2006.00396.x; Jordan-Williams KL, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-16; Judge AD, 2002, J EXP MED, V196, P935, DOI 10.1084/jem.20020772; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978; Lenz DC, 2004, P NATL ACAD SCI USA, V101, P9357, DOI 10.1073/pnas.0400640101; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; LOS M, 1995, EMBO J, V14, P3731, DOI 10.1002/j.1460-2075.1995.tb00043.x; Malim MH, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006940; Manlapat AK, 2007, EUR J IMMUNOL, V37, P1064, DOI 10.1002/eji.200636690; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Mosca F, 2008, P NATL ACAD SCI USA, V105, P10501, DOI 10.1073/pnas.0804699105; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Nathan C, 2013, NAT REV IMMUNOL, V13, P349, DOI 10.1038/nri3423; Peng G, 2006, J EXP MED, V203, P41, DOI 10.1084/jem.20051512; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Purton JF, 2007, J EXP MED, V204, P951, DOI 10.1084/jem.20061805; Santini SM, 2000, J EXP MED, V191, P1777, DOI 10.1084/jem.191.10.1777; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; Srivastava S, 2014, J EXP MED, V211, P961, DOI 10.1084/jem.20131556; Swain SL, 1999, SCIENCE, V286, P1381, DOI 10.1126/science.286.5443.1381; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; Vendrame D, 2009, J VIROL, V83, P10527, DOI 10.1128/JVI.01235-09; Wang YF, 2012, J BIOL CHEM, V287, P17152, DOI 10.1074/jbc.M112.347179; Wang YF, 2010, EUR J IMMUNOL, V40, P1628, DOI 10.1002/eji.200940251; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Youngblood B, 2013, IMMUNOLOGY, V139, P277, DOI 10.1111/imm.12074; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6; Zhao X, 2008, GENE DEV, V22, P640, DOI 10.1101/gad.1632608; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	58	10	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15595	15609		10.1074/jbc.M115.645754	http://dx.doi.org/10.1074/jbc.M115.645754			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25907558	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000356527400024
J	Zhang, P; Leger, AJ; Baleja, JD; Rana, R; Corlin, T; Nguyen, N; Koukos, G; Bohm, A; Covic, L; Kuliopulos, A				Zhang, Ping; Leger, Andrew J.; Baleja, James D.; Rana, Rajashree; Corlin, Tiffany; Nga Nguyen; Koukos, Georgios; Bohm, Andrew; Covic, Lidija; Kuliopulos, Athan			Allosteric Activation of a G Protein-coupled Receptor with Cell-penetrating Receptor Mimetics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biotechnology; cell surface receptor; cell-penetrating peptide (CPP); chemical biology; drug delivery system; G protein-coupled receptor (GPCR); nuclear magnetic resonance (NMR); receptor structure-function; signal transduction; thrombin	RESOLUTION CRYSTAL-STRUCTURE; PEPDUCIN-BASED INTERVENTION; LIGHT-DEPENDENT CHANGES; THROMBIN-RECEPTOR; AGONIST PEPDUCIN; STRUCTURAL BASIS; CYTOPLASMIC END; PAR1; RHODOPSIN; GPCR	Background: Intracellular parts of GPCRs have yet to be effectively exploited as allosteric modulators. Results: The structure and mechanism of action of a lipidated pepducin agonist is determined. Conclusion: The pepducin requires the H8 helix and TM7 tyrosine propeller to stabilize the on-state and trigger receptor-G protein signaling. Significance: This work provides critical insight into the identification of allosteric modulators to this major drug target class. G protein-coupled receptors (GPCRs) are remarkably versatile signaling systems that are activated by a large number of different agonists on the outside of the cell. However, the inside surface of the receptors that couple to G proteins has not yet been effectively modulated for activity or treatment of diseases. Pepducins are cell-penetrating lipopeptides that have enabled chemical and physical access to the intracellular face of GPCRs. The structure of a third intracellular (i3) loop agonist, pepducin, based on protease-activated receptor-1 (PAR1) was solved by NMR and found to closely resemble the i3 loop structure predicted for the intact receptor in the on-state. Mechanistic studies revealed that the pepducin directly interacts with the intracellular H8 helix region of PAR1 and allosterically activates the receptor through the adjacent (D/N)PXXYYY motif through a dimer-like mechanism. The i3 pepducin enhances PAR1/G subunit interactions and induces a conformational change in fluorescently labeled PAR1 in a very similar manner to that induced by thrombin. As pepducins can potentially be made to target any GPCR, these data provide insight into the identification of allosteric modulators to this major drug target class.	Tufts Univ, Sch Med, Tufts Med Ctr, Ctr Hemostasis & Thrombosis Res,Mol Oncol Res Ins, Boston, MA 02111 USA; Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA; Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA	Tufts Medical Center; Tufts University; Tufts University; Tufts University	Kuliopulos, A (corresponding author), Tufts Med Ctr, Box 7510,800 Washington St, Boston, MA 02111 USA.	athan.kuliopulos@tufts.edu	Koukos, Georgios/B-1544-2009	Koukos, Georgios/0000-0002-9470-0651; Corlin, Tiffany/0000-0002-3971-3492	National Institutes of Health from the NHLBI [P50 HL110789]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL110789] Funding Source: NIH RePORTER	National Institutes of Health from the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P50 HL110789 from the NHLBI (to A. K.).	Altenbach C, 2001, BIOCHEMISTRY-US, V40, P15493, DOI 10.1021/bi011545o; Altenbach C, 2001, BIOCHEMISTRY-US, V40, P15483, DOI 10.1021/bi011546g; Audet M, 2012, CELL, V151, P14, DOI 10.1016/j.cell.2012.09.003; Ayoub MA, 2007, MOL PHARMACOL, V71, P1329, DOI 10.1124/mol.106.030304; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Ballesteros JA, 2001, MOL PHARMACOL, V60, P1, DOI 10.1124/mol.60.1.1; Bock A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2028; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Canto I, 2013, J BIOL CHEM, V288, P15900, DOI 10.1074/jbc.M113.469866; Carr R, 2014, J BIOL CHEM, V289, P35668, DOI 10.1074/jbc.M114.618819; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Cisowski J, 2011, AM J PATHOL, V179, P513, DOI 10.1016/j.ajpath.2011.03.025; Covic L, 2000, BIOCHEMISTRY-US, V39, P5458, DOI 10.1021/bi9927078; Covic L, 2002, P NATL ACAD SCI USA, V99, P643, DOI 10.1073/pnas.022460899; Covic L, 2002, NAT MED, V8, P1161, DOI 10.1038/nm760; Dowal L, 2011, P NATL ACAD SCI USA, V108, P2951, DOI 10.1073/pnas.1014863108; Edwards RJ, 2007, NAT CHEM BIOL, V3, P108, DOI 10.1038/nchembio854; Fontanini KB, 2010, BIOPHYS J, V98, p278A, DOI 10.1016/j.bpj.2009.12.1520; Hu JX, 2010, NAT CHEM BIOL, V6, P541, DOI [10.1038/NCHEMBIO.385, 10.1038/nchembio.385]; Huang JY, 2013, NAT STRUCT MOL BIOL, V20, P419, DOI 10.1038/nsmb.2504; Imamoto Y, 2000, BIOCHEMISTRY-US, V39, P15225, DOI 10.1021/bi0018685; Janz JM, 2011, J AM CHEM SOC, V133, P15878, DOI 10.1021/ja206661w; Kaneider NC, 2005, NAT MED, V11, P661, DOI 10.1038/nm1245; Kaneider NC, 2007, NAT IMMUNOL, V8, P1303, DOI 10.1038/ni1525; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Kimmelstiel C, 2011, CIRC-CARDIOVASC INTE, V4, P171, DOI 10.1161/CIRCINTERVENTIONS.110.959098; Krishna AG, 2002, BIOCHEMISTRY-US, V41, P8298, DOI 10.1021/bi025534m; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Kuliopulos A, 2004, THROMB HAEMOSTASIS, V92, P1387, DOI 10.1160/TH04-03-0187; Kuliopulos A, 2003, LIFE SCI, V74, P255, DOI 10.1016/j.lfs.2003.09.012; Kuliopulos A, 1999, BIOCHEMISTRY-US, V38, P4572, DOI 10.1021/bi9824792; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Leger AJ, 2006, CIRCULATION, V113, P1244, DOI 10.1161/CIRCULATIONAHA.105.587758; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; Liu YQ, 2004, BIOCHEMISTRY-US, V43, P7421, DOI 10.1021/bi049552a; McLaughlin JN, 2007, P NATL ACAD SCI USA, V104, P5662, DOI 10.1073/pnas.0700763104; O'Callaghan K, 2012, J BIOL CHEM, V287, P12787, DOI 10.1074/jbc.R112.355461; O'Callaghan K, 2012, BLOOD, V119, P1717, DOI 10.1182/blood-2011-04-347518; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Quoyer J, 2013, P NATL ACAD SCI USA, V110, pE5088, DOI 10.1073/pnas.1312515110; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Seeley S, 2003, CHEM BIOL, V10, P1033, DOI 10.1016/j.chembiol.2003.10.014; Sevigny LM, 2011, P NATL ACAD SCI USA, V108, P8491, DOI 10.1073/pnas.1017091108; Swift S, 2006, J BIOL CHEM, V281, P4109, DOI 10.1074/jbc.M509525200; Swift S, 2000, J BIOL CHEM, V275, P2627, DOI 10.1074/jbc.275.4.2627; Tchernychev B, 2010, P NATL ACAD SCI USA, V107, P22255, DOI 10.1073/pnas.1009633108; Tressel SL, 2011, EMBO MOL MED, V3, P370, DOI 10.1002/emmm.201100145; Tressel SL, 2011, METHODS MOL BIOL, V683, P259, DOI 10.1007/978-1-60761-919-2_19; Trivedi V, 2009, CELL, V137, P332, DOI 10.1016/j.cell.2009.02.018; Tsuji M, 2013, ORG BIOMOL CHEM, V11, P3030, DOI 10.1039/c3ob27445d; Wielders SJH, 2007, J THROMB HAEMOST, V5, P571, DOI 10.1111/j.1538-7836.2007.02364.x; Wisler JW, 2014, CURR OPIN CELL BIOL, V27, P18, DOI 10.1016/j.ceb.2013.10.008; Wootten D, 2013, NAT REV DRUG DISCOV, V12, P630, DOI 10.1038/nrd4052; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2014, SCIENCE, V344, P58, DOI 10.1126/science.1249489; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Yang E, 2009, CANCER RES, V69, P6223, DOI 10.1158/0008-5472.CAN-09-0187; Yao XJ, 2009, P NATL ACAD SCI USA, V106, P9501, DOI 10.1073/pnas.0811437106; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801; Zhang C, 2012, NATURE, V492, P387, DOI 10.1038/nature11701; Zhang P, 2012, CIRCULATION, V126, P83, DOI 10.1161/CIRCULATIONAHA.112.091918; Zweemer AJM, 2014, MOL PHARMACOL, V86, P358, DOI 10.1124/mol.114.093328	66	27	28	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15785	15798		10.1074/jbc.M115.636316	http://dx.doi.org/10.1074/jbc.M115.636316			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25934391	Green Published, hybrid			2022-12-28	WOS:000356527400039
J	Cha, J; Burnum-Johnson, KE; Bartos, A; Li, YJ; Baker, ES; Tilton, SC; Webb-Robertson, BJM; Piehowski, PD; Monroe, ME; Jegga, AG; Murata, S; Hirota, Y; Dey, SK				Cha, Jeeyeon; Burnum-Johnson, Kristin E.; Bartos, Amanda; Li, Yingju; Baker, Erin S.; Tilton, Susan C.; Webb-Robertson, Bobbie-Jo M.; Piehowski, Paul D.; Monroe, Matthew E.; Jegga, Anil G.; Murata, Shigeo; Hirota, Yasushi; Dey, Sudhansu K.			Muscle Segment Homeobox Genes Direct Embryonic Diapause by Limiting Inflammation in the Uterus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-QUALITY CONTROL; NF-KAPPA-B; UBIQUITIN-PROTEASOME SYSTEM; UTERINE RECEPTIVITY; PROTEOMICS DATA; PEPTIDE IDENTIFICATION; MOLECULAR CHAPERONES; PARKINSONS-DISEASE; SOFTWARE PACKAGE; MOUSE UTERUS	Embryonic diapause is a reproductive strategy widespread in the animal kingdom. This phenomenon is defined by a temporary arrest in blastocyst growth and metabolic activity within a quiescent uterus without implantation until the environmental and maternal milieu become favorable for pregnancy to progress. We found that uterine Msx expression persists during diapause across species; their inactivation in the mouse uterus results in termination of diapause with the development of implantation-like responses ("pseudoimplantation") that ultimately succumbed to resorption. To understand the cause of this failure, we compared proteome profiles between floxed and Msx-deleted uteri. In deleted uteri, several functional networks, including transcription/translation, ubiquitin-proteasome, inflammation, and endoplasmic reticulum stress, were dysregulated. Computational modeling predicted intersection of these pathways on an enhanced inflammatory signature. Further studies showed that this signature was reflected in increased phosphorylated I kappa B levels and nuclear NF kappa B in deleted uteri. This was associated with enhanced proteasome activity and endoplasmic reticulum stress. Interestingly, treatment with anti-inflammatory glucocorticoid (dexamethasone) reduced the inflammatory signature with improvement of the diapause phenotype. These findings highlight an unexpected role of uterine Msx in limiting aberrant inflammatory responses to maintain embryonic diapause.	[Cha, Jeeyeon; Bartos, Amanda; Li, Yingju; Piehowski, Paul D.; Dey, Sudhansu K.] Cincinnati Childrens Hosp, Med Ctr, Div Reprod Sci, Cincinnati, OH 45229 USA; [Jegga, Anil G.] Cincinnati Childrens Hosp, Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA; [Burnum-Johnson, Kristin E.; Baker, Erin S.; Tilton, Susan C.; Webb-Robertson, Bobbie-Jo M.; Monroe, Matthew E.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99354 USA; [Tilton, Susan C.] Oregon State Univ, Environm & Mol Toxicol, Corvallis, OR 97331 USA; [Murata, Shigeo] Univ Tokyo, Lab Prot Metab, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Hirota, Yasushi] Univ Tokyo, Dept Obstet & Gynecol, Grad Sch Med, Bunkyo Ku, Tokyo 1138655, Japan	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Oregon State University; University of Tokyo; University of Tokyo	Dey, SK (corresponding author), Cincinnati Childrens Hosp, Med Ctr, Div Reprod Sci, Cincinnati, OH 45229 USA.	sk.dey@cchmc.org	Monroe, Matthew/L-1157-2019; Regan, Clinton/E-6250-2012; Jegga, Anil/H-6140-2011; Hirota, Yasushi/AAD-8713-2020; Murata, Shigeo/A-1426-2010; Baker, Erin S/K-3979-2017; Piehowski, Paul D/AAH-5497-2019; Baker, Erin/AAS-4038-2021; Webb-Robertson, Bobbie-Jo/K-8230-2019; Burnum, Kristin E/B-1308-2011	Jegga, Anil/0000-0002-4881-7752; Hirota, Yasushi/0000-0003-0241-9780; Murata, Shigeo/0000-0002-3177-3503; Baker, Erin S/0000-0001-5246-2213; Piehowski, Paul D/0000-0001-5108-2227; Burnum, Kristin E/0000-0002-2722-4149; Dewar, Amanda/0000-0003-1579-3202; Webb-Robertson, Bobbie-Jo/0000-0002-4744-2397	National Institutes of Health [R01ES022190, U01CA184783-01, R01HD068524, P01CA77839]; Laboratory Directed Research and Development Program at the Pacific Northwest National Laboratory [DE-AC05-76RL01830]; Japan Society for the Promotion of Science; Astellas Foundation for Research on Metabolic Disorders; Cell Science Research Foundation; Tokyo Biochemical Research Foundation; Nakatomi Foundation; March of Dimes; National Research Service Award Fellowship of the University of Cincinnati Medical Scientist Training Program [F30AG040858]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD068524] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U01CA184783, P01CA077839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES022190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG040858] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [26000014] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Laboratory Directed Research and Development Program at the Pacific Northwest National Laboratory; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Astellas Foundation for Research on Metabolic Disorders; Cell Science Research Foundation(Cell Science Research Foundation, Japan); Tokyo Biochemical Research Foundation; Nakatomi Foundation; March of Dimes(March of Dimes); National Research Service Award Fellowship of the University of Cincinnati Medical Scientist Training Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by National Institutes of Health Grants R01ES022190, U01CA184783-01, R01HD068524, and P01CA77839. This work was also supported in part by the Laboratory Directed Research and Development Program at the Pacific Northwest National Laboratory (operated by Battelle for the Department of Energy under Contract DE-AC05-76RL01830), a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science; grants from the Astellas Foundation for Research on Metabolic Disorders, the Cell Science Research Foundation, the Tokyo Biochemical Research Foundation, and the Nakatomi Foundation (to Y. H.); grants the March of Dimes (to S. K. D.); and National Research Service Award Fellowship F30AG040858 of the University of Cincinnati Medical Scientist Training Program (to J. C.).	Adams J, 2004, CANCER CELL, V5, P417, DOI 10.1016/S1535-6108(04)00120-5; Ahn KS, 2005, ANN NY ACAD SCI, V1056, P218, DOI 10.1196/annals.1352.026; Baker ES, 2007, J AM SOC MASS SPECTR, V18, P1176, DOI 10.1016/j.jasms.2007.03.031; Baker ES, 2014, MOL CELL PROTEOMICS, V13, P1119, DOI 10.1074/mcp.M113.034595; Baker ES, 2010, J PROTEOME RES, V9, P997, DOI 10.1021/pr900888b; Barral JM, 2004, SEMIN CELL DEV BIOL, V15, P17, DOI 10.1016/j.semcdb.2003.12.010; BIGSBY RM, 1993, J STEROID BIOCHEM, V46, P253, DOI 10.1016/0960-0760(93)90301-C; Burnum KE, 2012, ENDOCRINOLOGY, V153, P4568, DOI 10.1210/en.2012-1335; Cha J, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130035; Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; Daikoku T, 2004, MOL ENDOCRINOL, V18, P1238, DOI 10.1210/me.2003-0403; Daikoku T, 2011, DEV CELL, V21, P1014, DOI 10.1016/j.devcel.2011.09.010; Das SK, 2000, J BIOL CHEM, V275, P28834, DOI 10.1074/jbc.M003827200; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; Esser C, 2004, BBA-MOL CELL RES, V1695, P171, DOI 10.1016/j.bbamcr.2004.09.020; Forster F, 2013, STRUCTURE, V21, P1551, DOI 10.1016/j.str.2013.08.010; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hamazaki J, 2006, EMBO J, V25, P4524, DOI 10.1038/sj.emboj.7601338; Horn M, 2014, DEV CELL, V28, P697, DOI 10.1016/j.devcel.2014.01.028; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Jaitly N, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-87; JOHNSON DC, 1980, BIOL REPROD, V22, P1136, DOI 10.1093/biolreprod/22.5.1136; Kastle M, 2012, PROG MOL BIOL TRANSL, V109, P113, DOI 10.1016/B978-0-12-397863-9.00004-3; Kaimal V, 2010, NUCLEIC ACIDS RES, V38, pW96, DOI 10.1093/nar/gkq418; Kaneko T, 2009, CELL, V137, P914, DOI 10.1016/j.cell.2009.05.008; Kawabata T, 2012, J BIOL CHEM, V287, P10289, DOI 10.1074/jbc.M111.319426; Kim S, 2008, J PROTEOME RES, V7, P3354, DOI 10.1021/pr8001244; King AM, 2014, J EXP BIOL, V217, P1719, DOI 10.1242/jeb.100081; Kitamura M, 2011, INT REV IMMUNOL, V30, P4, DOI 10.3109/08830185.2010.522281; Kondratyev M, 2007, EXP CELL RES, V313, P3395, DOI 10.1016/j.yexcr.2007.07.006; Lanigan F, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2621; Livesay EA, 2008, ANAL CHEM, V80, P294, DOI 10.1021/ac701727r; Lopes FL, 2004, REPRODUCTION, V128, P669, DOI 10.1530/rep.1.00444; Ma WG, 2003, P NATL ACAD SCI USA, V100, P2963, DOI 10.1073/pnas.0530162100; Maattanen P, 2010, SEMIN CELL DEV BIOL, V21, P500, DOI 10.1016/j.semcdb.2010.03.006; Matzke MM, 2011, BIOINFORMATICS, V27, P2866, DOI 10.1093/bioinformatics/btr479; MCLAREN A, 1968, J ENDOCRINOL, V42, P453, DOI 10.1677/joe.0.0420453; McNaught KSP, 2001, NAT REV NEUROSCI, V2, P589, DOI 10.1038/35086067; Monroe ME, 2007, BIOINFORMATICS, V23, P2021, DOI 10.1093/bioinformatics/btm281; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Oslowski CM, 2011, METHOD ENZYMOL, V490, P71, DOI 10.1016/B978-0-12-385114-7.00004-0; PARIA BC, 1993, P NATL ACAD SCI USA, V90, P10159, DOI 10.1073/pnas.90.21.10159; Piehowski PD, 2013, PROTEOMICS, V13, P766, DOI 10.1002/pmic.201200096; PSYCHOYOS A, 1973, HDB PHYSL, P187; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Renfree MB, 2000, ANNU REV PHYSIOL, V62, P353, DOI 10.1146/annurev.physiol.62.1.353; Schwartz AL, 1999, ANNU REV MED, V50, P57; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sherman MY, 2011, ONCOTARGET, V2, P356; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Sontag EM, 2014, CURR OPIN CELL BIOL, V26, P139, DOI 10.1016/j.ceb.2013.12.006; Tegeder I, 2001, FASEB J, V15, P2057, DOI 10.1096/fj.01-0390rev; Tranguch S, 2005, P NATL ACAD SCI USA, V102, P14326, DOI 10.1073/pnas.0505775102; Tranguch S, 2007, J CLIN INVEST, V117, P1824, DOI 10.1172/JCI31622; Vane JR, 1998, INFLAMM RES, V47, pS78; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Wang JQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037647; Wang JQ, 2011, DEV CELL, V21, P575, DOI 10.1016/j.devcel.2011.07.003; Webb-Robertson BJM, 2014, MOL CELL PROTEOMICS, V13, P3639, DOI 10.1074/mcp.M113.030932; Webb-Robertson BJM, 2011, PROTEOMICS, V11, P4736, DOI 10.1002/pmic.201100078; Webb-Robertson BJM, 2010, J PROTEOME RES, V9, P5748, DOI 10.1021/pr1005247; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Yamamoto Y, 2001, J CLIN INVEST, V107, P135, DOI 10.1172/JCI11914; Yang F, 2012, CELL STRESS CHAPERON, V17, P577, DOI 10.1007/s12192-012-0333-7; YOSHINAGA K, 1961, J REPROD FERTIL, V2, P35, DOI 10.1530/jrf.0.0020035; Zimmer JSD, 2006, MASS SPECTROM REV, V25, P450, DOI 10.1002/mas.20071	72	11	11	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15337	15349		10.1074/jbc.M115.655001	http://dx.doi.org/10.1074/jbc.M115.655001			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25931120	Green Published, hybrid			2022-12-28	WOS:000356177300044
J	Mirbaha, H; Holmes, BB; Sanders, DW; Bieschke, J; Diamond, MI				Mirbaha, Hilda; Holmes, Brandon B.; Sanders, David W.; Bieschke, Jan; Diamond, Marc I.			Tau Trimers Are the Minimal Propagation Unit Spontaneously Internalized to Seed Intracellular Aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; ALZHEIMERS-DISEASE; PROTEIN; OLIGOMERS; TRANSMISSION; TAUOPATHIES; LUCIFERASE; CELLS; PERMEABILIZATION; DEGENERATION	Tau amyloid assemblies propagate aggregation from the outside to the inside of a cell, which may mediate progression of the tauopathies. The critical size of Tau assemblies, or "seeds," responsible for this activity is currently unknown, but this could be important for the design of effective therapies. We studied recombinant Tau repeat domain (RD) and Tau assemblies purified from Alzheimer disease (AD) brain composed largely of full-length Tau. Large RD fibrils were first sonicated to create a range of assembly sizes. We confirmed our ability to resolve stable assemblies ranging from n = 1 to > 100 units of Tau using size exclusion chromatography, fluorescence correlation spectroscopy, cross-linking followed by Western blot, and mass spectrometry. All recombinant Tau assemblies bound heparan sulfate proteoglycans on the cell surface, which are required for Tau uptake and seeding, because they were equivalently sensitive to inhibition by heparin and chlorate. However, cells only internalized RD assemblies of n >= 3 units. We next analyzed Tau assemblies from AD or control brains. AD brains contained aggregated species, whereas normal brains had predominantly monomer, and no evidence of large assemblies. HEK293 cells and primary neurons spontaneously internalized Tau of n >= 3 units from AD brain in a heparin-and chlorate-sensitive manner. Only n >= 3-unit assemblies from AD brain spontaneously seeded intracellular Tau aggregation in HEK293 cells. These results indicate that a clear minimum size (n = 3) of Tau seed exists for spontaneous propagation of Tau aggregation from the outside to the inside of a cell, whereas many larger sizes of soluble aggregates trigger uptake and seeding.	[Mirbaha, Hilda; Holmes, Brandon B.; Sanders, David W.; Diamond, Marc I.] Univ Texas SW Med Ctr Dallas, Ctr Alzheimers & Neurodegenerat Dis, Dallas, TX 75390 USA; [Bieschke, Jan] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Washington University (WUSTL)	Diamond, MI (corresponding author), Univ Texas SW Med Ctr Dallas, Ctr Alzheimers & Neurodegenerat Dis, 6000 Harry Hines Blvd,NL10-120, Dallas, TX 75390 USA.	Marc.Diamond@UTSouthwestern.edu	Regan, Clinton/E-6250-2012; Bieschke, Jan/AAG-2705-2019	Holmes, Brandon/0000-0002-1153-840X; Sanders, David/0000-0002-1835-6895; Bieschke, Jan/0000-0002-3485-9767	National Institutes of Health [P50AG005681, P01AG003991]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS086251, R01NS071835, F31NS079039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG003991, P50AG005681] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Hong Jiang and David Holtzman for providing the Tau monoclonal antibodies utilized in this study, Kenneth M. Pryse for help in performing FCS, David Piwnica-Worms for plasmids, and Paul Seidler for help with the cross-linking procedure. We are grateful to Nigel Cairns, Erin Householder, the technical support of the Betty Martz Laboratory for Neurodegenerative Research, and the Knight Alzheimer's Disease Research Center at Washington University in St. Louis for brain tissue, supported by the following National Institutes of Health grants: P50AG005681 (Knight Alzheimer's Disease Research Center) and P01AG003991 (Healthy Aging and Senile Dementia). We thank Ning Wang, Larisa Belaygorod, Suzanne Schindler, and Sarah Kaufman for recombinant Tau preparation. We thank Suzanne Schindler, Jennifer Furman, Kristen Funk, and Sarah Kaufman for helpful comments on the manuscript.	Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; BELLINGERKAWAHARA CG, 1988, VIROLOGY, V164, P537, DOI 10.1016/0042-6822(88)90569-7; Bugiani O, 1999, J NEUROPATH EXP NEUR, V58, P667, DOI 10.1097/00005072-199906000-00011; Buschmann V, 2003, BIOCONJUGATE CHEM, V14, P195, DOI 10.1021/bc025600x; Chattopadhyay K, 2002, P NATL ACAD SCI USA, V99, P14171, DOI 10.1073/pnas.172524899; Clavaguera F, 2013, BRAIN PATHOL, V23, P342, DOI 10.1111/bpa.12044; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Fadoulogiou VE, 2008, ANAL BIOCHEM, V373, P404, DOI 10.1016/j.ab.2007.10.027; Flach K, 2012, J BIOL CHEM, V287, P43223, DOI 10.1074/jbc.M112.396176; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Frost B, 2009, J BIOL CHEM, V284, P3546, DOI 10.1074/jbc.M805627200; Funke SA, 2007, BIOCHEM BIOPH RES CO, V364, P902, DOI 10.1016/j.bbrc.2007.10.085; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Guo JL, 2014, NAT MED, V20, P130, DOI 10.1038/nm.3457; Hashimoto T, 2011, J BIOL CHEM, V286, P27081, DOI 10.1074/jbc.M111.257378; Haustein E, 2007, ANNU REV BIOPH BIOM, V36, P151, DOI 10.1146/annurev.biophys.36.040306.132612; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Iba M, 2013, J NEUROSCI, V33, P1024, DOI 10.1523/JNEUROSCI.2642-12.2013; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Lasagna-Reeves CA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00700; Lasagna-Reeves CA, 2012, FASEB J, V26, P1946, DOI 10.1096/fj.11-199851; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Patterson KR, 2011, J BIOL CHEM, V286, P23063, DOI 10.1074/jbc.M111.237974; Relini A, 2004, J MOL BIOL, V338, P943, DOI 10.1016/j.jmb.2004.03.054; Remy I, 2006, NAT METHODS, V3, P977, DOI 10.1038/nmeth979; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; RUBEN GC, 1991, J BIOL CHEM, V266, P22019; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Tian H., 2013, INT J CELL BIOL; Villalobos V, 2010, CHEM BIOL, V17, P1018, DOI 10.1016/j.chembiol.2010.06.018; Wadia JS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003314; WILLE H, 1992, J CELL BIOL, V118, P573, DOI 10.1083/jcb.118.3.573; Wille H, 2009, P NATL ACAD SCI USA, V106, P16990, DOI 10.1073/pnas.0909006106; Wu JW, 2013, J BIOL CHEM, V288, P1856, DOI 10.1074/jbc.M112.394528	36	139	142	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					14893	14903		10.1074/jbc.M115.652693	http://dx.doi.org/10.1074/jbc.M115.652693			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25887395	Green Published, hybrid			2022-12-28	WOS:000356177300009
J	Zhang, HS; Chen, Y; Fan, L; Xi, QL; Wu, GH; Li, XX; Yuan, TL; He, SQ; Yu, Y; Shao, ML; Liu, Y; Bai, CG; Ling, ZQ; Li, M; Liu, Y; Fang, J				Zhang, Hai-Sheng; Chen, Ying; Fan, Li; Xi, Qiu-Lei; Wu, Guo-Hao; Li, Xiu-Xiu; Yuan, Tang-Long; He, Sheng-Qi; Yu, Yue; Shao, Meng-Le; Liu, Yang; Bai, Chen-Guang; Ling, Zhi-Qiang; Li, Min; Liu, Yong; Fang, Jing			The Endoplasmic Reticulum Stress Sensor IRE1 alpha in Intestinal Epithelial Cells Is Essential for Protecting against Colitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE PROTEIN; ER STRESS; LIPOPOLYSACCHARIDE; APOPTOSIS; BARRIER; ACTIVATION; MECHANISMS; INDUCTION; DISEASE; DAMAGE	Intestinal epithelial cells (IECs) have critical roles in maintaining homeostasis of intestinal epithelium. Endoplasmic reticulum (ER) stress is implicated in intestinal epithelium homeostasis and inflammatory bowel disease; however, it remains elusive whether IRE1 alpha, a major sensor of ER stress, is directly involved in these processes. We demonstrate here that genetic ablation of Ire1 alpha in IECs leads to spontaneous colitis in mice. Deletion of IRE1 alpha in IECs results in loss of goblet cells and failure of intestinal epithelial barrier function. IRE1 alpha deficiency induces cell apoptosis through induction of CHOP, the pro-apoptotic protein, and sensitizes cells to lipopolysaccharide, an endotoxin from bacteria. IRE1 alpha deficiency confers upon mice higher susceptibility to chemical-induced colitis. These results suggest that IRE1 alpha functions to maintain the intestinal epithelial homeostasis and plays an important role in defending against inflammation bowel diseases.	[Zhang, Hai-Sheng; Chen, Ying; Fan, Li; Li, Xiu-Xiu; Yuan, Tang-Long; He, Sheng-Qi; Yu, Yue; Shao, Meng-Le; Liu, Yang; Liu, Yong; Fang, Jing] Chinese Acad Sci, Lab Food Safety Res, Lab Nutr & Metab, Inst Nutrit Sci, Shanghai 200031, Peoples R China; [Xi, Qiu-Lei; Wu, Guo-Hao; Fang, Jing] Fudan Univ, Sch Med, Dept Surg, Zhongshan Hosp, Shanghai 200030, Peoples R China; [Bai, Chen-Guang] Second Mil Med Univ, Changhai Hosp, Dept Pathol, Shanghai 200433, Peoples R China; [Ling, Zhi-Qiang] Zhejiang Canc Hosp, Dept Pathol, Zhejiang Canc Res Inst, Hangzhou 310022, Zhejiang, Peoples R China; [Ling, Zhi-Qiang] Zhejiang Canc Ctr, Hangzhou 310022, Zhejiang, Peoples R China; [Fang, Jing] Minist Hlth, Key Lab Food Safety Risk Assessment, Beijing 100021, Peoples R China; [Li, Min] Univ Oklahoma, Hlth Sci Ctr, Dept Surg, Oklahoma City, OK 73104 USA	Chinese Academy of Sciences; Fudan University; Naval Medical University; Zhejiang Cancer Hospital; Zhejiang Cancer Hospital; University of Oklahoma System; University of Oklahoma Health Sciences Center	Liu, Y (corresponding author), Chinese Acad Sci, Lab Food Safety Res, Lab Nutr & Metab, Inst Nutrit Sci, Shanghai 200031, Peoples R China.	liuy@sibs.ac.cn; jfang@sibs.ac.cn	Shao, Mengle/AAH-8392-2019	Shao, Mengle/0000-0002-5488-9904; Wu, Guohao/0000-0001-9490-4200	Natural Science Foundation of China [31270829, 31230036, 81321062, 91213306]; Shanghai Ministry of Science and Technology [13JC1406200]; Shanghai Institutes for Biological Sciences [2012CSP003]; Chinese Academy of Sciences/International Partnership Program for Creative Research Teams International Partnership Program for Creative Research Teams; Ministry of Science and Technology (973 Programs) [2012CB524900]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Ministry of Science and Technology; Shanghai Institutes for Biological Sciences(Chinese Academy of Sciences); Chinese Academy of Sciences/International Partnership Program for Creative Research Teams International Partnership Program for Creative Research Teams; Ministry of Science and Technology (973 Programs)	This work was supported by Natural Science Foundation of China Grant 31270829, Shanghai Ministry of Science and Technology Grant 13JC1406200, Shanghai Institutes for Biological Sciences Grant 2012CSP003, the Chinese Academy of Sciences/International Partnership Program for Creative Research Teams International Partnership Program for Creative Research Teams (to J. F.), and the Ministry of Science and Technology (973 Programs 2012CB524900) and Natural Science Foundation of China Grants 31230036, 81321062, and 91213306 (to Y. L.).	Abraham C, 2011, GASTROENTEROLOGY, V140, P1729, DOI 10.1053/j.gastro.2011.02.012; Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Al-Sadi R, 2011, AM J PHYSIOL-GASTR L, V300, pG1054, DOI 10.1152/ajpgi.00055.2011; Alhusaini S, 2010, BIOCHEM BIOPH RES CO, V397, P472, DOI 10.1016/j.bbrc.2010.05.138; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Bertolotti A, 2001, J CLIN INVEST, V107, P585, DOI 10.1172/JCI11476; Braus NA, 2009, CLIN IMMUNOL, V132, P1, DOI 10.1016/j.clim.2009.02.006; Colgan SP, 2013, INFLAMM BOWEL DIS, V19, P2238, DOI 10.1097/MIB.0b013e31828dcaaf; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cummins EP, 2008, GASTROENTEROLOGY, V134, P156, DOI 10.1053/j.gastro.2007.10.012; Dong ML, 2013, BBA-MOL BASIS DIS, V1832, P848, DOI 10.1016/j.bbadis.2013.02.023; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Endo M, 2006, J IMMUNOL, V176, P6245, DOI 10.4049/jimmunol.176.10.6245; Eri RD, 2011, MUCOSAL IMMUNOL, V4, P354, DOI 10.1038/mi.2010.74; HALL PA, 1994, J CELL SCI, V107, P3569; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Itoh H, 1999, J CLIN INVEST, V104, P1539, DOI 10.1172/JCI6211; Jarry A, 2008, J CLIN INVEST, V118, P1132, DOI 10.1172/JCI32140; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kaser A, 2009, SEMIN IMMUNOL, V21, P156, DOI 10.1016/j.smim.2009.01.001; Laukoetter MG, 2008, WORLD J GASTROENTERO, V14, P401, DOI 10.3748/wjg.14.401; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Malhotra JD, 2008, P NATL ACAD SCI USA, V105, P18525, DOI 10.1073/pnas.0809677105; MORI K, 1993, CELL, V74, P743; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rose WA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00574; Rutgeerts P, 2009, GASTROENTEROLOGY, V136, P1182, DOI 10.1053/j.gastro.2009.02.001; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Schulzke JD, 2009, ANN NY ACAD SCI, V1165, P294, DOI 10.1111/j.1749-6632.2009.04062.x; SETH R, 1991, LANCET, V338, P83, DOI 10.1016/0140-6736(91)90077-3; Shao ML, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4528; Shkoda A, 2007, GASTROENTEROLOGY, V132, P190, DOI 10.1053/j.gastro.2006.10.030; Shore GC, 2011, CURR OPIN CELL BIOL, V23, P143, DOI 10.1016/j.ceb.2010.11.003; SPECIAN RD, 1991, AM J PHYSIOL, V260, pC183, DOI 10.1152/ajpcell.1991.260.2.C183; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Strugala V, 2008, INT J CLIN PRACT, V62, P762, DOI 10.1111/j.1742-1241.2007.01665.x; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tambuwala MM, 2010, GASTROENTEROLOGY, V139, P2093, DOI 10.1053/j.gastro.2010.06.068; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Tsuru A, 2013, P NATL ACAD SCI USA, V110, P2864, DOI 10.1073/pnas.1212484110; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; van Es JH, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1017; Xue J, 2010, GASTROENTEROLOGY, V138, P606, DOI 10.1053/j.gastro.2009.09.049; Yue C, 2013, INFLAMM RES, V62, P407, DOI 10.1007/s00011-013-0593-4	47	45	47	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15327	15336		10.1074/jbc.M114.633560	http://dx.doi.org/10.1074/jbc.M114.633560			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25925952	Green Published, hybrid			2022-12-28	WOS:000356177300043
J	Zhang, LL; Mu, GG; Ding, QS; Li, YX; Shi, YB; Dai, JF; Yu, HG				Zhang, Ling-Li; Mu, Gang-Gang; Ding, Qian-Shan; Li, Yan-Xia; Shi, Yun-Bo; Dai, Jin-Fen; Yu, Hong-Gang			Phosphatase and Tensin Homolog (PTEN) Represses Colon Cancer Progression through Inhibiting Paxillin Transcription via PI3K/AKT/NF-kappa B Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; PROMOTES TUMOR PROGRESSION; FACTOR-KAPPA-B; COLORECTAL-CANCER; CELL-MIGRATION; GASTRIC-CANCER; IN-VIVO; SURVIVAL; SUPPRESSION; EXPRESSION	The tumor suppressor gene phosphatase and tensin homolog (PTEN) is frequently mutated in colon cancer. However, the potential contribution of loss of PTEN to colon cancer progression remains unclear. In this study, we demonstrated that PTEN overexpression or knockdown in Lovo colon cancer cells decreased or increased paxillin expression, respectively. Moreover, paxillin reversed PTEN-mediated inhibition of Lovo cell invasion and migration. Overexpression of PTEN in an orthotropic colon cancer nude mice model inhibited tumor formation and progression. In addition, PTEN protein level was negatively correlated with that of paxillin in human colon cancer tissues. Mechanistically, we identified three NF-kappa B binding sites on paxillin promoter and confirmed that paxillin was a direct transcriptional target of NF-kappa B. Our findings reveal a novel mechanism by which PTEN inhibits the progression of colon cancer by inhibiting paxillin expression downstream of PI3K/AKT/NF kappa B pathway. Thereby, PTEN/PI3K/AKT/NF-kappa B/paxillin signaling cascade is an attractive therapeutic target for colon cancer progression.	[Zhang, Ling-Li; Mu, Gang-Gang; Ding, Qian-Shan; Li, Yan-Xia; Dai, Jin-Fen; Yu, Hong-Gang] Wuhan Univ, Dept Gastroenterol, Renmin Hosp, Wuhan 430060, Peoples R China; [Zhang, Ling-Li] Zhengzhou Univ, Dept Gastroenterol, Affiliated Hosp 1, Zhengzhou 450000, Henan Province, Peoples R China; [Shi, Yun-Bo] Zhengzhou Univ, Dept Neurol, Affiliated Hosp 1, Zhengzhou 450000, Henan Province, Peoples R China	Wuhan University; Zhengzhou University; Zhengzhou University	Yu, HG (corresponding author), Wuhan Univ, Inst Gastroenterol & Hepatol, Renmin Hosp, Dept Gastroenterol, Jiefang Rd 238, Wuhan 430060, Peoples R China.	yhgwhu@gmail.com			National Natural Science Foundation of China and China [81172350]; Fundamental Research Funds for the Chinese Central Universities [201130202020016]	National Natural Science Foundation of China and China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Chinese Central Universities	This work was supported by the National Natural Science Foundation of China (Grant 81172350) and China and the Fundamental Research Funds for the Chinese Central Universities (Grant 201130202020016).	Chatzizacharias NA, 2007, EXPERT OPIN THER TAR, V11, P1315, DOI 10.1517/14728222.11.10.1315; Chen DL, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-277; Chen DL, 2013, CARCINOGENESIS, V34, P803, DOI 10.1093/carcin/bgs400; Chen L, 2008, J BIOL CHEM, V283, P13799, DOI 10.1074/jbc.M800555200; Cordes N, 2006, ONCOGENE, V25, P1378, DOI 10.1038/sj.onc.1209164; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Franca-Koh J, 2007, NAT CELL BIOL, V9, P15, DOI 10.1038/ncb0107-15; Golubovskaya V, 2004, BBA-GENE STRUCT EXPR, V1678, P111, DOI 10.1016/j.bbaexp.2004.03.002; Haier J, 2002, ONCOGENE, V21, P1450, DOI 10.1038/sj.onc.1205213; Herlevsen M, 2007, BIOCHEM BIOPH RES CO, V352, P549, DOI 10.1016/j.bbrc.2006.11.067; Horwitz AR, 1999, SCIENCE, V286, P1102, DOI 10.1126/science.286.5442.1102; Hwang PH, 2001, CANCER LETT, V172, P83, DOI 10.1016/S0304-3835(01)00632-2; Jhawer M, 2008, CANCER RES, V68, P1953, DOI 10.1158/0008-5472.CAN-07-5659; Kim RH, 2006, BRIT J CANCER, V94, P620, DOI 10.1038/sj.bjc.6602994; Ko BS, 2010, LIFE SCI, V86, P199, DOI 10.1016/j.lfs.2009.12.003; Kotelevets L, 2001, J CELL BIOL, V155, P1129, DOI 10.1083/jcb.200105109; Lee M, 2010, ONCOL REP, V23, P757, DOI 10.3892/or_00000695; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Seidler J, 2005, RADIOTHER ONCOL, V76, P129, DOI 10.1016/j.radonc.2005.06.018; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Sun Y, 2014, CLIN INVEST MED, V37, pE131; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Wu DW, 2014, CARCINOGENESIS, V35, P1823, DOI 10.1093/carcin/bgu102; Wu H, 2003, ONCOGENE, V22, P3113, DOI 10.1038/sj.onc.1206451; Xia LM, 2012, J HEPATOL, V57, P600, DOI 10.1016/j.jhep.2012.04.020; Yu HG, 2011, CANCER RES, V71, P360, DOI 10.1158/0008-5472.CAN-10-2894; Yu M, 2014, ONCOGENE, V33, P1538, DOI 10.1038/onc.2013.102; Zhang LL, 2013, MOL MED REP, V7, P1387, DOI 10.3892/mmr.2013.1400; Zhang SY, 2010, CLIN CANCER RES, V16, P4325, DOI 10.1158/1078-0432.CCR-09-2990	32	74	82	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15018	15029		10.1074/jbc.M115.641407	http://dx.doi.org/10.1074/jbc.M115.641407			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25873394	hybrid, Green Published			2022-12-28	WOS:000356177300018
J	Chen, JR; Lazarenko, OP; Blackburn, ML; Mercer, KE; Badger, TM; Ronis, MJJ				Chen, Jin-Ran; Lazarenko, Oxana P.; Blackburn, Michael L.; Mercer, Kelly E.; Badger, Thomas M.; Ronis, Martin J. J.			p47(phox)-Nox2-dependent ROS Signaling Inhibits Early Bone Development in Mice but Protects against Skeletal Aging	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REACTIVE OXYGEN; NADPH OXIDASE; LIFE-SPAN; SENESCENCE PATHWAYS; OXIDATIVE STRESS; DAMAGE THEORY; NOX FAMILY; DIFFERENTIATION; ACTIVATION; CELLS	Bone remodeling is age-dependently regulated and changes dramatically during the course of development. Progressive accumulation of reactive oxygen species (ROS) has been suspected to be the leading cause of many inflammatory and degenerative diseases, as well as an important factor underlying many effects of aging. In contrast, how reduced ROS signaling regulates inflammation and remodeling in bone remains unknown. Here, we utilized a p47(phox) knock-out mouse model, in which an essential cytosolic co-activator of Nox2 is lost, to characterize bone metabolism at 6 weeks and 2 years of age. Compared with their age-matched wild type controls, loss of Nox2 function in p47(phox-/-) mice resulted in age-related switch of bone mass and strength. Differences in bone mass were associated with increased bone formation in 6-week-old p47(phox-/-) mice but decreased in 2-year-old p47(phox-/-) mice. Despite decreases in ROS generation in bone marrow cells and p47(phox)-Nox2 signaling in osteoblastic cells, 2-year-old p47(phox-/-) mice showed increased senescence-associated secretory phenotype in bone compared with their wild type controls. These in vivo findings were mechanistically recapitulated in ex vivo cell culture of primary fetal calvarial cells from p47(phox-/-) mice. These cells showed accelerated cell senescence pathway accompanied by increased inflammation. These data indicate that the observed age-related switch of bone mass in p47(phox)-deficient mice occurs through an increased inflammatory milieu in bone and that p47(phox)-Nox2-dependent physiological ROS signaling suppresses inflammation in aging.	[Chen, Jin-Ran; Lazarenko, Oxana P.; Blackburn, Michael L.; Mercer, Kelly E.; Badger, Thomas M.; Ronis, Martin J. J.] Univ Arkansas Med Sci, Arkansas Childrens Nutr Ctr, Little Rock, AR 72202 USA; [Chen, Jin-Ran; Lazarenko, Oxana P.; Blackburn, Michael L.; Badger, Thomas M.; Ronis, Martin J. J.] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72202 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Chen, JR (corresponding author), Arkansas Childrens Nutr Ctr, Slot 512-20B,15 Childrens Way, Little Rock, AR 72202 USA.	chenjinran@uams.edu	Regan, Clinton/E-6250-2012		United States Department of Agriculture/Agricultural Research Service [6251-51000-003]; National Institutes of Health [RO1 AA18282]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018282] Funding Source: NIH RePORTER	United States Department of Agriculture/Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by United States Department of Agriculture/Agricultural Research Service Grant 6251-51000-003 to the Arkansas Children's Nutrition Center, and in part by National Institutes of Health Grant RO1 AA18282.	Almeida Maria, 2012, Bonekey Rep, V1; Arakaki N, 2013, BIOMED RES-TOKYO, V34, P161, DOI 10.2220/biomedres.34.161; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Campisi J, 2011, CURR OPIN GENET DEV, V21, P107, DOI 10.1016/j.gde.2010.10.005; Cao JJ, 2009, BONE, V44, P1097, DOI 10.1016/j.bone.2009.02.017; Chen JR, 2008, J PHARMACOL EXP THER, V324, P50, DOI 10.1124/jpet.107.130351; Chen JR, 2014, J BONE MINER RES, V29, P1043, DOI 10.1002/jbmr.2034; Chen JR, 2013, FASEB J, V27, P3514, DOI 10.1096/fj.12-226464; Chen JR, 2011, J PHARMACOL EXP THER, V336, P734, DOI 10.1124/jpet.110.175091; Chen JR, 2009, J NUTR, V139, P1839, DOI 10.3945/jn.109.109041; Chen JR, 2009, J BONE MINER RES, V24, P221, DOI 10.1359/JBMR.081011; Geiszt M, 2004, J BIOL CHEM, V279, P51715, DOI 10.1074/jbc.R400024200; Gems D, 2009, CELL CYCLE, V8, P1681, DOI 10.4161/cc.8.11.8595; Gladyshev VN, 2014, ANTIOXID REDOX SIGN, V20, P727, DOI 10.1089/ars.2013.5228; Goettsch C, 2013, J CLIN INVEST, V123, P4731, DOI 10.1172/JCI67603; Groemping Y, 2003, CELL, V113, P343, DOI 10.1016/S0092-8674(03)00314-3; Hagenow K, 2009, J IMMUNOL, V183, P874, DOI 10.4049/jimmunol.0900966; Hole PS, 2013, BLOOD, V122, P3322, DOI 10.1182/blood-2013-04-491944; Howcroft TK, 2013, AGING-US, V5, P84, DOI 10.18632/aging.100531; Kassem M, 2011, AGING CELL, V10, P191, DOI 10.1111/j.1474-9726.2011.00669.x; KEY LL, 1990, BONE, V11, P115, DOI 10.1016/8756-3282(90)90058-7; Koc A, 2004, P NATL ACAD SCI USA, V101, P7999, DOI 10.1073/pnas.0307929101; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P319, DOI 10.1016/j.freeradbiomed.2007.03.028; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lee K, 2011, P NATL ACAD SCI USA, V108, P9548, DOI 10.1073/pnas.1012645108; Lee NK, 2005, BLOOD, V106, P852, DOI 10.1182/blood-2004-09-3662; Maghzal GJ, 2012, FREE RADICAL BIO MED, V53, P1903, DOI 10.1016/j.freeradbiomed.2012.09.002; Marks DJB, 2009, AM J GASTROENTEROL, V104, P117, DOI 10.1038/ajg.2008.72; Murray TVA, 2013, J BIOL CHEM, V288, P15745, DOI 10.1074/jbc.M112.439844; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Ristow M, 2011, FREE RADICAL BIO MED, V51, P327, DOI 10.1016/j.freeradbiomed.2011.05.010; Sareila O, 2011, ANTIOXID REDOX SIGN, V15, P2197, DOI 10.1089/ars.2010.3635; Schrenzel J, 1998, NATURE, V392, P734, DOI 10.1038/33725; Tan CY, 2014, ARTERIOSCL THROM VAS, V34, P768, DOI 10.1161/ATVBAHA.113.302847; Tsukagoshi H, 2010, CELL, V143, P606, DOI 10.1016/j.cell.2010.10.020; Van Raamsdonk JM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000361; Van Raamsdonk JM, 2012, P NATL ACAD SCI USA, V109, P5785, DOI 10.1073/pnas.1116158109; WONG GL, 1975, P NATL ACAD SCI USA, V72, P3167, DOI 10.1073/pnas.72.8.3167; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yang S, 2002, J CELL BIOCHEM, V84, P645, DOI 10.1002/jcb.10074; Yang S, 2001, J BIOL CHEM, V276, P5452, DOI 10.1074/jbc.M001004200; Zhang J, 2014, FASEB J, V28, P3134, DOI 10.1096/fj.13-243659; Zhang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070438	43	20	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14692	14704		10.1074/jbc.M114.633461	http://dx.doi.org/10.1074/jbc.M114.633461			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25922068	Green Published, hybrid			2022-12-28	WOS:000355754600039
J	Clairfeuille, T; Norwood, SJ; Qi, XY; Teasdale, RD; Collins, BM				Clairfeuille, Thomas; Norwood, Suzanne J.; Qi, Xiaying; Teasdale, Rohan D.; Collins, Brett M.			Structure and Membrane Binding Properties of the Endosomal Tetratricopeptide Repeat (TPR) Domain-containing Sorting Nexins SNX20 and SNX21	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOX-HOMOLOGY DOMAIN; MITOCHONDRIAL FISSION; CARGO; ENDOCYTOSIS; COMPLEXES; PROTEINS; REVEALS	Sorting nexins (SNX) orchestrate membrane trafficking and signaling events required for the proper distribution of proteins within the endosomal network. Their phox homology (PX) domain acts as a phosphoinositide (PI) recognition module that targets them to specific endocytic membrane domains. The modularity of SNX proteins confers a wide variety of functions from signaling to membrane deformation and cargo binding, and many SNXs are crucial modulators of endosome dynamics and are involved in a myriad of physiological and pathological processes such as neurodegenerative diseases, cancer, and inflammation. Here, we have studied the poorly characterized SNX20 and its paralogue SNX21, which contain an N-terminal PX domain and a C-terminal PX-associated B (PXB) domain of unknown function. The two proteins share similar PI-binding properties and are recruited to early endosomal compartments by their PX domain. The crystal structure of the SNX21 PXB domain reveals a tetratricopeptide repeat (TPR)-fold, a module that typically binds short peptide motifs, with three TPR alpha-helical repeats. However, the C-terminal capping helix adopts a highly unusual and potentially self-inhibitory topology. SAXS solution structures of SNX20 and SNX21 show that these proteins adopt a compact globular architecture, and membrane interaction analyses indicate the presence of overlapping PI-binding sites that may regulate their intracellular localization. This study provides the first structural analysis of this poorly characterized subfamily of SNX proteins, highlighting a likely role as endosome-associated scaffolds.	[Clairfeuille, Thomas; Norwood, Suzanne J.; Qi, Xiaying; Teasdale, Rohan D.; Collins, Brett M.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia	University of Queensland	Collins, BM (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia.	b.collins@imb.uq.edu.au	Qi, Xiaying/D-2640-2017; Teasdale, Rohan D/B-2538-2009; Teasdale, Rohan/AAD-6698-2019; Collins, Brett/J-1563-2014	Qi, Xiaying/0000-0002-1793-1974; Teasdale, Rohan D/0000-0001-7455-5269; Teasdale, Rohan/0000-0001-7455-5269; Collins, Brett/0000-0002-6070-3774	Australian Research Council ARC [DP0985029]; National Health and Medical Research Council (NHMRC) [APP1042082, APP1058734]; NHMRC [APP1041929, APP1061574]; ARC [FT100100027]	Australian Research Council ARC(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); ARC(Australian Research Council)	This work is supported in part by Australian Research Council ARC Grant DP0985029 and National Health and Medical Research Council (NHMRC) Grants APP1042082 and APP1058734.r Supported by NHMRC Senior Research Fellowship APP1041929.r Supported by NHMRC Career Development Fellowship APP1061574 and previously held ARC Future Fellowship Grant FT100100027.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Allan RK, 2011, CELL STRESS CHAPERON, V16, P353, DOI 10.1007/s12192-010-0248-0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bawono P, 2014, METHODS MOL BIOL, V1079, P245, DOI 10.1007/978-1-62703-646-7_16; Blatner NR, 2007, EMBO J, V26, P3709, DOI 10.1038/sj.emboj.7601800; Carlton J, 2005, TRAFFIC, V6, P75, DOI 10.1111/j.1600-0854.2005.00260.x; Cullen PJ, 2008, NAT REV MOL CELL BIO, V9, P574, DOI 10.1038/nrm2427; Danson C, 2013, J CELL SCI, V126, P4885, DOI 10.1242/jcs.125732; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gallon M, 2014, P NATL ACAD SCI USA, V111, pE3604, DOI 10.1073/pnas.1410552111; Ghai R, 2015, J CELL SCI, V128, P553, DOI 10.1242/jcs.158204; Ghai R, 2013, P NATL ACAD SCI USA, V110, pE643, DOI 10.1073/pnas.1216229110; Ghai R, 2011, P NATL ACAD SCI USA, V108, P7763, DOI 10.1073/pnas.1017110108; Hsu VW, 2012, NAT REV MOL CELL BIO, V13, P1, DOI 10.1038/nrm3332; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Lieu ZZ, 2007, MOL BIOL CELL, V18, P4979, DOI 10.1091/mbc.E07-06-0622; Mozdy AD, 2000, J CELL BIOL, V151, P367, DOI 10.1083/jcb.151.2.367; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Schaff UY, 2008, EUR J IMMUNOL, V38, P550, DOI 10.1002/eji.200737777; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Seet LF, 2006, BBA-MOL CELL BIOL L, V1761, P878, DOI 10.1016/j.bbalip.2006.04.011; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Stahelin RV, 2004, J BIOL CHEM, V279, P54918, DOI 10.1074/jbc.M407798200; Steinberg F, 2013, NAT CELL BIOL, V15, P461, DOI 10.1038/ncb2721; Suzuki M, 2005, J BIOL CHEM, V280, P21444, DOI 10.1074/jbc.M414092200; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teasdale RD, 2012, BIOCHEM J, V441, P39, DOI 10.1042/BJ20111226; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Xing Y, 2004, J BIOL CHEM, V279, P30662, DOI 10.1074/jbc.M404107200; Yu JW, 2001, J BIOL CHEM, V276, P44179, DOI 10.1074/jbc.M108811200; Zeng WQ, 2002, BIOCHEM BIOPH RES CO, V299, P542, DOI 10.1016/S0006-291X(02)02695-5; Zeytuni N, 2012, STRUCTURE, V20, P397, DOI 10.1016/j.str.2012.01.006; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P18526, DOI 10.1073/pnas.0706441104	36	14	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14504	14517		10.1074/jbc.M115.650598	http://dx.doi.org/10.1074/jbc.M115.650598			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25882846	hybrid, Green Published			2022-12-28	WOS:000355754600022
J	Burke, SJ; May, AL; Noland, RC; Lu, DH; Brissova, M; Powers, AC; Sherrill, EM; Karlstad, MD; Campagna, SR; Stephens, JM; Colliera, JJ				Burke, Susan J.; May, Amanda L.; Noland, Robert C.; Lu, Danhong; Brissova, Marcela; Powers, Alvin C.; Sherrill, Elizabeth M.; Karlstad, Michael D.; Campagna, Shawn R.; Stephens, Jacqueline M.; Colliera, J. Jason			Thiobenzothiazole-modified Hydrocortisones Display Anti-inflammatory Activity with Reduced Impact on Islet beta-Cell Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-SECRETION; GLUCOSE; TRANSPLANTATION; EXPRESSION; RAT; DYSFUNCTION; MECHANISMS; CYCLOOXYGENASE-2; GLUCOCORTICOIDS; PREDNISOLONE	Glucocorticoids signal through the glucocorticoid receptor (GR) and are administered clinically for a variety of situations, including inflammatory disorders, specific cancers, rheumatoid arthritis, and organ/tissue transplantation. However, glucocorticoid therapy is also associated with additional complications, including steroid-induced diabetes. We hypothesized that modification of the steroid backbone is one strategy to enhance the therapeutic potential of GR activation. Toward this goal, two commercially unavailable, thiobenzothiazole-containing derivatives of hydrocortisone (termed MS4 and MS6) were examined using 832/13 rat insulinoma cells as well as rodent and human islets. We found that MS4 had transrepression properties but lacked transactivation ability, whereas MS6 retained both transactivation and transrepression activities. In addition, MS4 and MS6 both displayed anti-inflammatory activity. Furthermore, MS4 displayed reduced impact on islet beta-cell function in both rodent and human islets. Similar to dexamethasone, MS6 promoted adipocyte development in vitro, whereas MS4 did not. Moreover, neither MS4 nor MS6 activated the Pck1 (Pepck) gene in primary rat hepatocytes. We conclude that modification of the functional groups attached to the D-ring of the hydrocortisone steroid molecule produces compounds with altered structure-function GR agonist activity with decreased impact on insulin secretion and reduced adipogenic potential but with preservation of anti-inflammatory activity.	[Burke, Susan J.; Colliera, J. Jason] Pennington Biomed Res Ctr, Lab Islet Biol & Inflammat, Baton Rouge, LA 70808 USA; [Noland, Robert C.] Pennington Biomed Res Ctr, Skeletal Muscle Metab Lab, Baton Rouge, LA 70808 USA; [Stephens, Jacqueline M.] Pennington Biomed Res Ctr, Adipocyte Biol Lab, Baton Rouge, LA 70808 USA; [Burke, Susan J.; Sherrill, Elizabeth M.; Colliera, J. Jason] Univ Tennessee, Dept Nutr, Knoxville, TN 37996 USA; [May, Amanda L.; Campagna, Shawn R.] Univ Tennessee, Dept Chem, Knoxville, TN 37996 USA; [Lu, Danhong] Duke Univ, Sarah W Stedman Nutr & Metab Ctr, Sch Med, Durham, NC 27701 USA; [Brissova, Marcela; Powers, Alvin C.] Vanderbilt Univ, Med Ctr, Dept Med, Div Diabet Endocrinol & Metab, Nashville, TN 37232 USA; [Powers, Alvin C.] Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Karlstad, Michael D.; Colliera, J. Jason] Univ Tennessee, Grad Sch Med, Med Ctr, Dept Surg, Knoxville, TN 37920 USA; [Powers, Alvin C.] Tennessee Valley Healthcare Syst, Dept Vet Affairs, Nashville, TN 37212 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; Duke University; Vanderbilt University; Vanderbilt University; University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Colliera, JJ (corresponding author), Pennington Biomed Res Ctr, Lab Islet Biol & Inflammat, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	Jason.collier@pbrc.edu	Karlstad, Michael/V-3212-2019; Stephens, Jacqueline M/R-5217-2018; Collier, Susan J/N-1959-2017; Noland, Robert/N-1982-2017	Karlstad, Michael/0000-0002-3190-8738; Collier, Susan J/0000-0003-2571-4416; Noland, Robert/0000-0001-5543-3450	COBRE [NIH8 P20-GM103528]; NORC center grants from the National Institutes of Health [1P30-DK072476]; Vanderbilt Diabetes Research and Training Center, National Institutes of Health [P30 DK020593]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476, U01DK089572, P30DK020593, R01DK103860, R01DK097829] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R44GM099207, P20GM103528] Funding Source: NIH RePORTER	COBRE; NORC center grants from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Diabetes Research and Training Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project used the PBRC Genomics Core Facilities that are supported in part by COBRE (Grant NIH8 P20-GM103528) and NORC (Grant 1P30-DK072476) center grants from the National Institutes of Health. Islet isolation and insulin secretion studies were performed in collaboration with the Vanderbilt Islet Procurement and Analysis Core (supported by the Vanderbilt Diabetes Research and Training Center, National Institutes of Health Grant P30 DK020593).	Beck IME, 2009, ENDOCR REV, V30, P830, DOI 10.1210/er.2009-0013; Biju P, 2011, BIOORG MED CHEM LETT, V21, P6343, DOI 10.1016/j.bmcl.2011.08.108; Blondeau B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030210; Burke S. J., 2014, IMMUNOME RES, V10, pe002, DOI DOI 10.4172/1745-7580.S2.E002; Burke SJ, 2014, AM J PHYSIOL-ENDOC M, V306, pE131, DOI 10.1152/ajpendo.00347.2013; Burke SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046986; Burke SJ, 2011, CELL IMMUNOL, V271, P379, DOI 10.1016/j.cellimm.2011.08.004; Cardozo AK, 2003, DIABETOLOGIA, V46, P255, DOI 10.1007/s00125-002-1017-0; Chanson P, 2010, NEUROENDOCRINOLOGY, V92, P96, DOI 10.1159/000314272; Clark AR, 2012, PHARMACOL THERAPEUT, V134, P54, DOI 10.1016/j.pharmthera.2011.12.004; Collier JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022485; Collier JJ, 2006, DIABETES, V55, P1398, DOI 10.2337/db05-1000; Collier JJ, 2004, BIOCHEM BIOPH RES CO, V324, P1018, DOI 10.1016/j.bbrc.2004.09.149; Collier JJ, 2004, MOL ENDOCRINOL, V18, P1051, DOI 10.1210/me.2003-0357; Colvin ES, 2013, ENDOCRINOLOGY, V154, P1039, DOI 10.1210/en.2012-1923; CORBETT JA, 1993, AUTOIMMUNITY, V15, P145, DOI 10.3109/08916939309043889; Dai C, 2012, DIABETOLOGIA, V55, P707, DOI 10.1007/s00125-011-2369-0; Delaunay F, 1997, J CLIN INVEST, V100, P2094, DOI 10.1172/JCI119743; Gesina E, 2004, DIABETES, V53, P2322, DOI 10.2337/diabetes.53.9.2322; Harlan DM, 2009, DIABETES, V58, P2175, DOI 10.2337/db09-0476; Heitmeier MR, 2004, J BIOL CHEM, V279, P53145, DOI 10.1074/jbc.M410978200; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Kadmiel M, 2013, TRENDS PHARMACOL SCI, V34, P518, DOI 10.1016/j.tips.2013.07.003; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Lambillotte C, 1997, J CLIN INVEST, V99, P414, DOI 10.1172/JCI119175; Laskewitz AJ, 2010, ENDOCRINOLOGY, V151, P2171, DOI 10.1210/en.2009-1374; Lorenz MA, 2013, J BIOL CHEM, V288, P10923, DOI 10.1074/jbc.M112.414961; Lu DH, 2002, P NATL ACAD SCI USA, V99, P2708, DOI 10.1073/pnas.052005699; Lu WY, 2010, ANAL CHEM, V82, P3212, DOI 10.1021/ac902837x; Martin AP, 2008, DIABETES, V57, P3025, DOI 10.2337/db08-0625; Martin AP, 2008, DIABETES, V57, P387, DOI 10.2337/db07-1309; McCall M, 2012, AM J TRANSPLANT, V12, P322, DOI 10.1111/j.1600-6143.2011.03796.x; Melamud E, 2010, ANAL CHEM, V82, P9818, DOI 10.1021/ac1021166; MITCHELL J, 1994, MOL ENDOCRINOL, V8, P585, DOI 10.1210/me.8.5.585; Miyazaki Y, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-44; Monti P, 2008, J CLIN INVEST, V118, P1806, DOI 10.1172/JCI35197; NEWGARD CB, 1995, ANNU REV BIOCHEM, V64, P689, DOI 10.1146/annurev.biochem.64.1.689; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; OBrien RM, 1995, BBA-GENE STRUCT EXPR, V1264, P284, DOI 10.1016/0167-4781(95)00194-8; Oshima H, 2006, J BIOL CHEM, V281, P29330, DOI 10.1074/jbc.M602424200; Padgett LE, 2013, ANN NY ACAD SCI, V1281, P16, DOI 10.1111/j.1749-6632.2012.06826.x; Petersons CJ, 2013, DIABETES CARE, V36, P2822, DOI 10.2337/dc12-2617; Piemonti L, 2002, DIABETES, V51, P55, DOI 10.2337/diabetes.51.1.55; Prentki M, 2013, CELL METAB, V18, P162, DOI 10.1016/j.cmet.2013.05.018; Richard AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098897; Rosen J, 2005, ENDOCR REV, V26, P452, DOI 10.1210/er.2005-0002; Rother KI, 2004, J CLIN INVEST, V114, P877, DOI 10.1172/JC1200423235; Sarjeant K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008417; Sarkar SA, 2012, DIABETES, V61, P436, DOI 10.2337/db11-0853; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; SCHARP DW, 1990, DIABETES, V39, P515, DOI 10.2337/diabetes.39.4.515; Schroppel B, 2005, J AM SOC NEPHROL, V16, P444, DOI 10.1681/ASN.2004090743; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Shipp LE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013754; Ullrich S, 2005, DIABETES, V54, P1090, DOI 10.2337/diabetes.54.4.1090; van Raalte DH, 2014, NETH J MED, V72, P62; van Raalte DH, 2013, METABOLISM, V62, P568, DOI 10.1016/j.metabol.2012.10.007; Vandevyver S, 2013, ENDOCRINOLOGY, V154, P993, DOI 10.1210/en.2012-2045; Wang YH, 2006, J NUTR, V136, P2953, DOI 10.1093/jn/136.12.2953; Yuan J, 2008, NAT PROTOC, V3, P1328, DOI 10.1038/nprot.2008.131; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005	61	7	7	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13401	13416		10.1074/jbc.M114.632190	http://dx.doi.org/10.1074/jbc.M114.632190			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25851902	Green Published, hybrid			2022-12-28	WOS:000354975700036
J	Harris, KA; Bobay, BG; Sarachan, KL; Sims, AF; Bilbille, Y; Deutsch, C; Iwata-Reuyl, D; Agris, PF				Harris, Kimberly A.; Bobay, Benjamin G.; Sarachan, Kathryn L.; Sims, Alexis F.; Bilbille, Yann; Deutsch, Christopher; Iwata-Reuyl, Dirk; Agris, Paul F.			NMR-based Structural Analysis of Threonylcarbamoyl-AMP Synthase and Its Substrate Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA MODIFICATION; ESCHERICHIA-COLI; PROTEIN STRUCTURES; CRYSTAL-STRUCTURE; MODIFIED NUCLEOSIDES; KEOPS COMPLEX; T(6)A; BIOSYNTHESIS; ANTICODON; REVEALS	The hypermodified nucleoside N-6-threonylcarbamoyladenosine (t(6)A(37)) is present in many distinct tRNA species and has been found in organisms in all domains of life. This post-transcriptional modification enhances translation fidelity by stabilizing the anticodon/codon interaction in the ribosomal decoding site. The biosynthetic pathway of t(6)A(37) is complex and not well understood. In bacteria, the following four proteins have been discovered to be both required and sufficient for t(6)A(37) modification: TsaC, TsaD, TsaB, and TsaE. Of these, TsaC and TsaD are members of universally conserved protein families. Although TsaC has been shown to catalyze the formation of L-threonylcarbamoyl-AMP, a key intermediate in the biosynthesis of t(6)A(37), the details of the enzymatic mechanism remain unsolved. Therefore, the solution structure of Escherichia coli TsaC was characterized by NMR to further study the interactions with ATP and L-threonine, both substrates of TsaC in the biosynthesis of L-threonylcarbamoyl-AMP. Several conserved amino acids were identified that create a hydrophobic binding pocket for the adenine of ATP. Additionally, two residues were found to interact with L-threonine. Both binding sites are located in a deep cavity at the center of the protein. Models derived from the NMR data and molecular modeling reveal several sites with considerable conformational flexibility in TsaC that may be important for L-threonine recognition, ATP activation, and/or protein/protein interactions. These observations further the understanding of the enzymatic reaction catalyzed by TsaC, a threonylcarbamoyl-AMP synthase, and provide structure-based insight into the mechanism of t(6)A(37) biosynthesis.	[Harris, Kimberly A.; Bobay, Benjamin G.; Bilbille, Yann] N Carolina State Univ, Dept Mol & Struct Biochem, Raleigh, NC 27695 USA; [Harris, Kimberly A.; Sarachan, Kathryn L.; Sims, Alexis F.; Agris, Paul F.] SUNY Albany, RNA Inst, Dept Biol Sci, Albany, NY 12222 USA; [Harris, Kimberly A.; Sarachan, Kathryn L.; Sims, Alexis F.; Agris, Paul F.] SUNY Albany, Dept Chem, Albany, NY 12222 USA; [Deutsch, Christopher; Iwata-Reuyl, Dirk] Portland State Univ, Dept Chem, Portland, OR 97207 USA	University of North Carolina; North Carolina State University; State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Portland State University	Agris, PF (corresponding author), SUNY Albany, RNA Inst, 1400 Washington Ave, Albany, NY 12222 USA.	pagris@albany.edu	Regan, Clinton/E-6250-2012; Bobay, Benjamin G/ABF-8860-2021	Bobay, Benjamin/0000-0003-4775-3686; Sarachan, Kathryn/0000-0003-2511-1404; Harris, Kimberly/0000-0003-3028-5863	National Institutes of Health [5R01-GM23037-25]; NIH [R01 GM110588]; National Science Foundation [MCB-0548602, MCB-1101859]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110588, R01GM023037] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01-GM23037-25 (to P. F. A.) and NIH Grant R01 GM110588 (to P. F. A.; Manal Swairjo, P. I.). This work was also supported by National Science Foundation Grants MCB-0548602 and MCB-1101859 (to P. F. A.). The authors declare that they have no conflicts of interest with the contents of this article.	Agari Y, 2008, PROTEINS, V70, P1108, DOI 10.1002/prot.21794; Auffinger P, 1998, MODIFICATION EDITING, P569; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Cantara WA, 2011, NUCLEIC ACIDS RES, V39, pD195, DOI 10.1093/nar/gkq1028; Clore GM, 1999, J AM CHEM SOC, V121, P9008, DOI 10.1021/ja991789k; Daugeron MC, 2011, NUCLEIC ACIDS RES, V39, P6148, DOI 10.1093/nar/gkr178; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Deutsch C, 2012, J BIOL CHEM, V287, P13666, DOI 10.1074/jbc.M112.344028; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Downey M, 2006, CELL, V124, P1155, DOI 10.1016/j.cell.2005.12.044; El Yacoubi B, 2011, EMBO J, V30, P882, DOI 10.1038/emboj.2010.363; El Yacoubi B, 2009, NUCLEIC ACIDS RES, V37, P2894, DOI 10.1093/nar/gkp152; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Ferrage F, 2003, J AM CHEM SOC, V125, P2541, DOI 10.1021/ja0211407; Goddard D., 2008, SPARKY 3; GROSJEAN H, 1995, BIOCHIMIE, V77, P139, DOI 10.1016/0300-9084(96)88117-X; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Harris KA, 2011, RNA, V17, P1678, DOI 10.1261/rna.2592411; Hubbard SJ., 1993, COMPUTER PROGRAM; Jia J, 2002, PROTEINS, V49, P139, DOI 10.1002/prot.10178; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Kisseleva-Romanova E, 2006, EMBO J, V25, P3576, DOI 10.1038/sj.emboj.7601235; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kuratani M, 2011, PROTEINS, V79, P2065, DOI 10.1002/prot.23026; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lauhon CT, 2012, BIOCHEMISTRY-US, V51, P8950, DOI 10.1021/bi301233d; Lin CA, 2010, MOL CELL BIOL, V30, P354, DOI 10.1128/MCB.00754-09; Mao DYL, 2008, MOL CELL, V32, P259, DOI 10.1016/j.molcel.2008.10.002; Martin A. C., 1996, PROFIT VERSION 3 1; MCLACHLAN AD, 1982, ACTA CRYSTALLOGR A, V38, P871, DOI 10.1107/S0567739482001806; MILLER JP, 1976, NUCLEIC ACIDS RES, V3, P1185, DOI 10.1093/nar/3.5.1185; Morin A, 1998, RNA, V4, P24; Murphy FV, 2004, NAT STRUCT MOL BIOL, V11, P1186, DOI 10.1038/nsmb861; Nishimura S, 1972, Prog Nucleic Acid Res Mol Biol, V12, P49; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Perrochia L, 2013, NUCLEIC ACIDS RES, V41, P9484, DOI 10.1093/nar/gkt720; Perrochia L, 2013, NUCLEIC ACIDS RES, V41, P1953, DOI 10.1093/nar/gks1287; Petkun S, 2011, STRUCTURE, V19, P1773, DOI 10.1016/j.str.2011.09.023; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sivashanmugam A, 2009, PROTEIN SCI, V18, P936, DOI 10.1002/pro.102; Srinivasan M, 2011, EMBO J, V30, P873, DOI 10.1038/emboj.2010.343; Teplova M, 2000, PROTEIN SCI, V9, P2557, DOI 10.1110/ps.9.12.2557; Vendeix FAP, 2012, J MOL BIOL, V416, P467, DOI 10.1016/j.jmb.2011.12.048; Wan LCK, 2013, NUCLEIC ACIDS RES, V41, P6332, DOI 10.1093/nar/gkt322; WEISSENBACH J, 1981, EUR J BIOCHEM, V116, P207, DOI 10.1111/j.1432-1033.1981.tb05320.x; Yarian C, 2002, J BIOL CHEM, V277, P16391, DOI 10.1074/jbc.M200253200	50	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20032	20043		10.1074/jbc.M114.631242	http://dx.doi.org/10.1074/jbc.M114.631242			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26060251	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000359608900003
J	Zeng, LL; Hu, C; Zhang, FQ; Xu, DC; Cui, MZ; Xu, XM				Zeng, Linlin; Hu, Chen; Zhang, Fuqiang; Xu, Daniel C.; Cui, Mei-Zhen; Xu, Xuemin			Cellular FLICE-like Inhibitory Protein (c-FLIP) and PS1-associated Protein (PSAP) Mediate Presenilin 1-induced gamma-Secretase-dependent and -independent Apoptosis, Respectively	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; PERTURBED CALCIUM HOMEOSTASIS; ALZHEIMERS-DISEASE; TRANSMEMBRANE DOMAIN; MUTANT PRESENILIN-1; INCREASED SENSITIVITY; CASPASE-8 ACTIVATION; SIGNALING PATHWAY; CANCER CELLS; DEATH	Presenilin 1 (PS1) has been implicated in apoptosis; however, its mechanism remains elusive. We report that PS1-induced apoptosis was associated with cellular FLICE-like inhibitory protein (c-FLIP) turnover and that gamma-secretase inhibitor blocked c-FLIP turnover and also partially blocked PS1-induced apoptosis. A complete inhibition of PS1-induced apoptosis was achieved by knockdown of PS1-associated protein (PSAP), a mitochondrial proapoptotic protein that forms a complex with Bax upon induction of apoptosis, in the presence of gamma-secretase inhibitor. PS1-induced apoptosis was partially inhibited by knockdown of caspase-8, Fas-associated protein with death domain (FADD), or Bid. However, knockdown of Bax or overexpression of Bcl-2 resulted in complete inhibition of PS1-induced apoptosis. These data suggest that PS1 induces apoptosis through two pathways: the gamma-secretase-dependent pathway mediated by turnover of c-FLIP and the gamma-secretase-independent pathway mediated by PSAP-Bax complex formation. These two pathways converge on Bax to activate mitochondria-dependent apoptosis. These findings provide new insight into the mechanisms by which PS1 is involved in apoptosis and the mechanism by which PS1 exerts its pathogenic effects. In addition, our results suggest that PS2 induces apoptosis through a pathway that is different from that of PS1.	[Zeng, Linlin; Hu, Chen; Zhang, Fuqiang; Cui, Mei-Zhen; Xu, Xuemin] Univ Tennessee, Dept Biomed & Diagnost Sci, Coll Vet Med, Knoxville, TN 37996 USA; [Hu, Chen] Univ Tennessee, Dept Comparat & Expt Med, Knoxville, TN 37996 USA; [Xu, Daniel C.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; Princeton University	Xu, XM (corresponding author), Univ Tennessee, Dept Biomed & Diagnost Sci, Coll Vet Med, 2407 River Dr, Knoxville, TN 37996 USA.	xmx@utk.edu	Regan, Clinton/E-6250-2012	Cui, Mei-Zhen/0000-0003-4745-6999; xu, xuemin/0000-0002-7426-272X	National Institutes of Health [R181741110, R21AG039596, 0355339B]; Alzheimer's Association grant; American Health Assistance Foundation; University of Tennessee Center of Excellence in Livestock Diseases and Human Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG039596, R01AG026640] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association grant(Alzheimer's Association); American Health Assistance Foundation(BrightFocus Foundation); University of Tennessee Center of Excellence in Livestock Diseases and Human Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R181741110 and R21AG039596 (to X. X.) and 0355339B (to M.-Z.C.). This work was also supported by an Alzheimer's Association grant and a grant from the American Health Assistance Foundation (to X. X.) and by the University of Tennessee Center of Excellence in Livestock Diseases and Human Health (to X. X.). The authors declare that they have no conflicts of interest with the contents of this article.	Alberici A, 1999, J BIOL CHEM, V274, P30764, DOI 10.1074/jbc.274.43.30764; Berezovska O, 2000, J NEUROCHEM, V75, P583, DOI 10.1046/j.1471-4159.2000.0750583.x; Chan SL, 2002, NEUROBIOL DIS, V11, P2, DOI 10.1006/nbdi.2002.0542; Chandu D, 2006, J NEUROCHEM, V96, P228, DOI 10.1111/j.1471-4159.2005.03547.x; Chui DH, 1999, NAT MED, V5, P560, DOI 10.1038/8438; Coen K, 2010, BIOCHEM SOC T, V38, P1474, DOI 10.1042/BST0381474; Daniel PT, 2001, LEUKEMIA, V15, P1022, DOI 10.1038/sj.leu.2402169; Day TW, 2008, BIOCHEM PHARMACOL, V76, P1694, DOI 10.1016/j.bcp.2008.09.007; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; Deng GM, 1996, FEBS LETT, V397, P50, DOI 10.1016/S0014-5793(96)01142-8; Dickens LS, 2012, EXP CELL RES, V318, P1269, DOI 10.1016/j.yexcr.2012.04.005; Dubrez L, 1996, EMBO J, V15, P5504, DOI 10.1002/j.1460-2075.1996.tb00935.x; Engidawork E, 2001, NEUROSCI LETT, V303, P79, DOI 10.1016/S0304-3940(01)01618-4; Fukumori A, 2010, J NEUROSCI, V30, P7853, DOI 10.1523/JNEUROSCI.1443-10.2010; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; Jost PJ, 2009, NATURE, V460, P1035, DOI 10.1038/nature08229; Kantari C, 2011, BBA-MOL CELL RES, V1813, P558, DOI 10.1016/j.bbamcr.2011.01.026; Katayama T, 1999, NAT CELL BIOL, V1, P479, DOI 10.1038/70265; Kaufmann T, 2012, CELL DEATH DIFFER, V19, P42, DOI 10.1038/cdd.2011.121; Keller JN, 1998, J NEUROSCI, V18, P4439; Kim SH, 2001, J BIOL CHEM, V276, P43343, DOI 10.1074/jbc.M108245200; Kim TW, 1997, SCIENCE, V277, P373, DOI 10.1126/science.277.5324.373; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Krueger A, 2001, J BIOL CHEM, V276, P20633, DOI 10.1074/jbc.M101780200; Lamarca V, 2008, EUR J CELL BIOL, V87, P325, DOI 10.1016/j.ejcb.2008.02.004; Li T, 2013, BBA-MOL BASIS DIS, V1832, P453, DOI 10.1016/j.bbadis.2012.11.016; Loetscher H, 1997, J BIOL CHEM, V272, P20655, DOI 10.1074/jbc.272.33.20655; Mao GZ, 2008, BBA-GEN SUBJECTS, V1780, P696, DOI 10.1016/j.bbagen.2008.01.013; Mattson MP, 2006, NAT REV NEUROSCI, V7, P278, DOI 10.1038/nrn1886; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Mosser DD, 2000, MOL CELL BIOL, V20, P7146, DOI 10.1128/MCB.20.19.7146-7159.2000; Ozturk S, 2012, EXP CELL RES, V318, P1324, DOI 10.1016/j.yexcr.2012.01.019; Ola MS, 2011, MOL CELL BIOCHEM, V351, P41, DOI 10.1007/s11010-010-0709-x; Popescu B. O., 2000, J Cell Mol Med, V4, P249, DOI 10.1111/j.1582-4934.2000.tb00124.x; Robinson AJ, 2012, EXP CELL RES, V318, P1316, DOI 10.1016/j.yexcr.2012.01.026; Selkoe DJ, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004457; Sharp DA, 2005, J BIOL CHEM, V280, P19401, DOI 10.1074/jbc.M413962200; Shirley S, 2013, CANCER LETT, V332, P141, DOI 10.1016/j.canlet.2010.10.009; Soriano S, 2001, J CELL BIOL, V152, P785, DOI 10.1083/jcb.152.4.785; Tanzi RE, 2013, J ALZHEIMERS DIS, V33, pS5, DOI 10.3233/JAD-2012-129044; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Vito P, 1996, SCIENCE, V271, P521, DOI 10.1126/science.271.5248.521; Weihl CC, 1999, J NEUROSCI, V19, P5360; Wilson TR, 2009, ONCOGENE, V28, P63, DOI 10.1038/onc.2008.366; Wilson TR, 2007, CANCER RES, V67, P5754, DOI 10.1158/0008-5472.CAN-06-3585; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wolozin B, 1998, NEUROBIOL AGING, V19, pS23, DOI 10.1016/S0197-4580(98)00041-4; Wolozin B, 1996, SCIENCE, V274, P1710, DOI 10.1126/science.274.5293.1710; Xu XM, 1999, J BIOL CHEM, V274, P32543, DOI 10.1074/jbc.274.46.32543; Xu XM, 2002, J BIOL CHEM, V277, P48913, DOI 10.1074/jbc.M209613200; Xu XM, 2009, J ALZHEIMERS DIS, V16, P211, DOI 10.3233/JAD-2009-0957; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zaltsman Y, 2010, NAT CELL BIOL, V12, P553, DOI 10.1038/ncb2057; Zhao GJ, 2005, J BIOL CHEM, V280, P37689, DOI 10.1074/jbc.M507993200; Zhao M, 2003, NEUROCHEM RES, V28, P307, DOI 10.1023/A:1022337519035	55	12	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18269	18280		10.1074/jbc.M115.640177	http://dx.doi.org/10.1074/jbc.M115.640177			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26025363	hybrid, Green Published			2022-12-28	WOS:000358512100002
J	Bhopale, VM; Yang, M; Yu, K; Thom, SR				Bhopale, Veena M.; Yang, Ming; Yu, Kevin; Thom, Stephen R.			Factors Associated with Nitric Oxide-mediated beta(2) Integrin Inhibition of Neutrophils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATRIAL-NATRIURETIC-PEPTIDE; VASODILATOR-STIMULATED PHOSPHOPROTEIN; FOCAL ADHESION KINASE; ACTIN S-NITROSYLATION; LEUKOCYTE ADHESION; CELL-ADHESION; SYNTHASE; MACROPHAGES; ACTIVATION; NUCLEATION	This investigation explored the mechanism for inhibition of beta(2) integrin adhesion molecules when neutrophils are exposed to nitric oxide ((NO)-N-center dot). Roles for specific proteins were elucidated using chemical inhibitors, depletion with small inhibitory RNA, and cells from knock-out mice. Optimal inhibition occurs with exposures to a (NO)-N-center dot flux of similar to 28 nmol/min for 2 min or more, which sets up an autocatalytic cascade triggered by activating type 2 nitric-oxide synthase (NOS-2) and NADPH oxidase (NOX). Integrin inhibition does not occur with neutrophils exposed to a NOX inhibitor (Nox2ds), a NOS-2 inhibitor (1400W), or with cells from mice lacking NOS-2 or the gp91(phox) component of NOX. Reactive species cause S-nitrosylation of cytosolic actin that enhances actin polymerization. Protein cross-linking and actin filament formation assays indicate that increased polymerization occurs because of associations involving vasodilator-stimulated phosphoprotein, focal adhesion kinase, and protein-disulfide isomerase in proximity to actin filaments. These effects were inhibited in cells exposed to ultraviolet light which photo-reverses S-nitrosylated cysteine residues and by co-incubations with cytochalasin D. The autocatalytic cycle can be arrested by protein kinase G activated with 8-bromo-cyclic GMP and by a high (NO)-N-center dot flux (similar to 112 nmol/min) that inactivates NOX.	[Bhopale, Veena M.; Yang, Ming; Yu, Kevin; Thom, Stephen R.] Univ Maryland, Sch Med, Dept Emergency Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Thom, SR (corresponding author), Univ Maryland, Sch Med, Dept Emergency Med, 655 W Baltimore St,Bressler Res Bldg,Rm 4-013, Baltimore, MD 21201 USA.	sthom@smail.umaryland.edu			Office of Naval Research [N00014-14-10094]	Office of Naval Research(Office of Naval Research)	This work was supported by Grant N00014-14-10094 from the Office of Naval Research.	ARNDT H, 1993, GASTROENTEROLOGY, V105, P675, DOI 10.1016/0016-5085(93)90882-D; Baldini PM, 2003, J LEUKOCYTE BIOL, V73, P502, DOI 10.1189/jlb.0702377; Banick PD, 1997, J CELL PHYSIOL, V172, P12, DOI 10.1002/(SICI)1097-4652(199707)172:1<12::AID-JCP2>3.0.CO;2-G; Blystone SD, 2004, BBA-MOL CELL RES, V1692, P47, DOI 10.1016/j.bbamcr.2004.04.011; Brown EJ, 1996, ANN MED, V28, P201, DOI 10.3109/07853899609033121; Calderwood DA, 2000, J BIOL CHEM, V275, P22607, DOI 10.1074/jbc.R900037199; Cambi A, 2006, MOL BIOL CELL, V17, P4270, DOI 10.1091/mbc.E05-12-1098; Chan AY, 1998, J CELL SCI, V111, P199; Chen HJ, 2008, J BIOL CHEM, V283, P4439, DOI 10.1074/jbc.M709439200; Chen YS, 2002, BIOCHEMISTRY-US, V41, P4618, DOI 10.1021/bi011877t; Daniel KB, 2013, CHEMBIOCHEM, V14, P593, DOI 10.1002/cbic.201200724; Daniliuc S, 2003, J IMMUNOL, V171, P3225, DOI 10.4049/jimmunol.171.6.3225; Endo S, 1996, RES COMMUN MOL PATH, V91, P347; Furst R, 2005, CIRC RES, V96, P43, DOI 10.1161/01.RES.0000151983.01148.06; GABOURY J, 1993, AM J PHYSIOL, V265, pH862, DOI 10.1152/ajpheart.1993.265.3.H862; Hato T, 1998, J CELL BIOL, V141, P1685, DOI 10.1083/jcb.141.7.1685; Hirabayashi N, 2005, DIGEST DIS SCI, V50, P893, DOI 10.1007/s10620-005-2661-2; Huttelmaier S, 1998, CURR BIOL, V8, P479, DOI 10.1016/S0960-9822(98)70199-X; Jiang HB, 2001, PHARMACOLOGY, V62, P10, DOI 10.1159/000056066; JOHNSON G, 1991, CRIT CARE MED, V19, P244, DOI 10.1097/00003246-199102000-00021; Kiemer AK, 2001, ANN RHEUM DIS, V60, pIII68; KLATT P, 1995, EMBO J, V14, P3687, DOI 10.1002/j.1460-2075.1995.tb00038.x; KUBES P, 1991, P NATL ACAD SCI USA, V88, P4651, DOI 10.1073/pnas.88.11.4651; KUBES P, 1994, AM J PHYSIOL, V267, pH931, DOI 10.1152/ajpheart.1994.267.3.H931; KUBES P, 1995, J CLIN INVEST, V95, P2510, DOI 10.1172/JCI117952; Leeuwenburgh C, 1997, J BIOL CHEM, V272, P1433, DOI 10.1074/jbc.272.3.1433; Leite ACRM, 2009, BRIT J PHARMACOL, V156, P818, DOI 10.1111/j.1476-5381.2008.00094.x; LINCOLN TM, 1983, ADV CYCL NUCL RES<D>, V15, P139; LOPEZBELMONTE J, 1993, BRIT J PHARMACOL, V108, P73, DOI 10.1111/j.1476-5381.1993.tb13442.x; MUNZEL T, 1995, J CLIN INVEST, V95, P187, DOI 10.1172/JCI117637; NIU XF, 1994, CIRC RES, V74, P1133, DOI 10.1161/01.RES.74.6.1133; Paes AMD, 2011, J LEUKOCYTE BIOL, V90, P799, DOI 10.1189/jlb.0610324; PIEPER GM, 1994, J PHARMACOL EXP THER, V269, P451; RADOMSKI MW, 1987, LANCET, V2, P1057, DOI 10.1016/S0140-6736(87)91481-4; SCHMIDT HHHW, 1988, EUR J PHARMACOL, V154, P213, DOI 10.1016/0014-2999(88)90101-X; Selemidis S, 2007, CARDIOVASC RES, V75, P349, DOI 10.1016/j.cardiores.2007.03.030; STAMLER JS, 1994, CELL, V78, P931, DOI 10.1016/0092-8674(94)90269-0; Sun CX, 2007, J CELL BIOL, V179, P239, DOI 10.1083/jcb.200705122; Thom SR, 2008, J BIOL CHEM, V283, P10822, DOI 10.1074/jbc.M709200200; Thom SR, 2014, J BIOL CHEM, V289, P18831, DOI 10.1074/jbc.M113.543702; Thom SR, 2013, J APPL PHYSIOL, V114, P550, DOI 10.1152/japplphysiol.01386.2012; Thom SR, 2013, J BIOL CHEM, V288, P4810, DOI 10.1074/jbc.M112.426353; Thom SR, 2012, J BIOL CHEM, V287, P30346, DOI 10.1074/jbc.M112.355875; Thom SR, 2011, J BIOL CHEM, V286, P32854, DOI 10.1074/jbc.M111.255778; TSAO PS, 1992, AM HEART J, V123, P1464, DOI 10.1016/0002-8703(92)90796-X; Vaughn MW, 2000, J BIOL CHEM, V275, P2342, DOI 10.1074/jbc.275.4.2342; Vila-Petroff MG, 1999, CIRC RES, V84, P1020, DOI 10.1161/01.RES.84.9.1020; Vollmar AM, 1997, EUR J PHARMACOL, V319, P279, DOI 10.1016/S0014-2999(96)00859-X; Yoshida M, 2003, J BIOL CHEM, V278, P36953, DOI 10.1074/jbc.M305214200	49	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17474	17484		10.1074/jbc.M115.651620	http://dx.doi.org/10.1074/jbc.M115.651620			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26032418	Green Published, hybrid			2022-12-28	WOS:000357730900039
J	Jamros, MA; Aubol, BE; Keshwani, MM; Zhang, ZY; Stamm, S; Adams, JA				Jamros, Michael A.; Aubol, Brandon E.; Keshwani, Malik M.; Zhang, Zhaiyi; Stamm, Stefan; Adams, Joseph A.			Intra-domain Cross-talk Regulates Serine-arginine Protein Kinase 1-dependent Phosphorylation and Splicing Function of Transformer 2 beta 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; SR PROTEIN; NUCLEAR IMPORT; PROCESSIVE PHOSPHORYLATION; KINETIC-ANALYSIS; FACTOR ASF/SF2; SMN GENE; SRPK1; PHOSPHATASE-1; RECOGNITION	Transformer 2 beta 1 (Tra2 beta 1) is a splicing effector protein composed of a core RNA recognition motif flanked by two arwginine-serine-rich (RS) domains, RS1 and RS2. Although Tra2 beta 1-dependent splicing is regulated by phosphorylation, very little is known about how protein kinases phosphorylate these two RS domains. We now show that the serine-arginine protein kinase-1 (SRPK1) is a regulator of Tra2 beta 1 and promotes exon inclusion in the survival motor neuron gene 2 (SMN2). To understand how SRPK1 phosphorylates this splicing factor, we performed mass spectrometric and kinetic experiments. We found that SRPK1 specifically phosphorylates 21 serines in RS1, a process facilitated by a docking groove in the kinase domain. Although SRPK1 readily phosphorylates RS2 in a splice variant lacking the N-terminal RS domain (Tra2 beta 3), RS1 blocks phosphorylation of these serines in the full-length Tra2 beta 1. Thus, RS2 serves two new functions. First, RS2 positively regulates binding of the central RNA recognition motif to an exonic splicing enhancer sequence, a phenomenon reversed by SRPK1 phosphorylation on RS1. Second, RS2 enhances ligand exchange in the SRPK1 active site allowing highly efficient Tra2 beta 1 phosphorylation. These studies demonstrate that SRPK1 is a regulator of Tra2 beta 1 splicing function and that the individual RS domains engage in considerable cross-talk, assuming novel functions with regard to RNA binding, splicing, and SRPK1 catalysis.	[Jamros, Michael A.; Aubol, Brandon E.; Keshwani, Malik M.; Adams, Joseph A.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Zhang, Zhaiyi; Stamm, Stefan] Univ Kentucky, Mol & Cellular Biochem Dept, Lexington, KY 40536 USA	University of California System; University of California San Diego; University of Kentucky	Adams, JA (corresponding author), Univ Calif San Diego, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	j2adams@ucsd.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [RO1 GM067969, GM067969]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752, R01GM067969] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 GM067969 (to J. A. A.) and a supplement to GM067969. The authors declare that they have no conflicts of interest with the contents of this article.	ADAMS JA, 1992, BIOCHEMISTRY-US, V31, P8516, DOI 10.1021/bi00151a019; Allemand E, 2005, P NATL ACAD SCI USA, V102, P3605, DOI 10.1073/pnas.0409889102; Aubol BE, 2003, P NATL ACAD SCI USA, V100, P12601, DOI 10.1073/pnas.1635129100; Aubol BE, 2014, BIOCHEM J, V462, P143, DOI 10.1042/BJ20140494; Aubol BE, 2014, BIOCHEMISTRY-US, V53, P4625, DOI 10.1021/bi500483m; Aubol BE, 2013, BIOCHEMISTRY-US, V52, P7595, DOI 10.1021/bi4010864; Aubol BE, 2012, BIOCHEMISTRY-US, V51, P6584, DOI 10.1021/bi300876h; Aubol BE, 2011, BIOCHEMISTRY-US, V50, P6888, DOI 10.1021/bi2007993; Chalfant CE, 2002, J BIOL CHEM, V277, P12587, DOI 10.1074/jbc.M112010200; Cho SY, 2011, P NATL ACAD SCI USA, V108, P8233, DOI 10.1073/pnas.1017700108; Clery A, 2011, NAT STRUCT MOL BIOL, V18, P443, DOI 10.1038/nsmb.2001; Cowper AE, 2001, J BIOL CHEM, V276, P48908, DOI 10.1074/jbc.M103967200; Daoud R, 2002, J NEUROSCI, V22, P5889; Glatz DC, 2006, J NEUROCHEM, V96, P635, DOI 10.1111/j.1471-4159.2005.03552.x; Grant BD, 1996, BIOCHEMISTRY-US, V35, P2022, DOI 10.1021/bi952144+; Hagopian JC, 2008, J MOL BIOL, V382, P894, DOI 10.1016/j.jmb.2008.07.055; Haynes C, 2006, NUCLEIC ACIDS RES, V34, P305, DOI 10.1093/nar/gkj424; Hofmann Y, 2000, P NATL ACAD SCI USA, V97, P9618, DOI 10.1073/pnas.160181697; HOSHIJIMA K, 1991, SCIENCE, V252, P833, DOI 10.1126/science.1902987; Jiang ZH, 2003, J BIOL CHEM, V278, P18997, DOI 10.1074/jbc.M301800200; Kataoka N, 1999, J CELL BIOL, V145, P1145, DOI 10.1083/jcb.145.6.1145; Keshwani MM, 2015, BIOCHEM J, V466, P311, DOI 10.1042/BJ20141373; KOHTZ JD, 1994, NATURE, V368, P119, DOI 10.1038/368119a0; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Lai MC, 2001, P NATL ACAD SCI USA, V98, P10154, DOI 10.1073/pnas.181354098; Li SJ, 2013, J BIOL CHEM, V288, P8898, DOI 10.1074/jbc.M113.456715; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; LYNCH KW, 1995, GENE DEV, V9, P284, DOI 10.1101/gad.9.3.284; Ma CT, 2008, J MOL BIOL, V376, P55, DOI 10.1016/j.jmb.2007.08.029; Ma CT, 2009, J MOL BIOL, V390, P618, DOI 10.1016/j.jmb.2009.05.060; MERMOUD JE, 1994, EMBO J, V13, P5679, DOI 10.1002/j.1460-2075.1994.tb06906.x; Ngo JCK, 2008, MOL CELL, V29, P563, DOI 10.1016/j.molcel.2007.12.017; Ngo JCK, 2005, MOL CELL, V20, P77, DOI 10.1016/j.molcel.2005.08.025; Novoyatleva T, 2008, HUM MOL GENET, V17, P52, DOI 10.1093/hmg/ddm284; ROSCIGNO RF, 1995, RNA, V1, P692; Singh NN, 2004, CRIT REV EUKAR GENE, V14, P271, DOI 10.1615/CritRevEukaryotGeneExpr.v14.i4.30; Stoilov P, 2004, HUM MOL GENET, V13, P509, DOI 10.1093/hmg/ddh051; Stojdl DF, 1999, BIOCHEM CELL BIOL, V77, P293, DOI 10.1139/bcb-77-4-293; Stoss O, 1999, BRAIN RES PROTOC, V4, P383, DOI 10.1016/S1385-299X(99)00043-4; Sumanasekera C, 2012, NUCLEIC ACIDS RES, V40, P4025, DOI 10.1093/nar/gkr1289; Tacke R, 1998, CELL, V93, P139, DOI 10.1016/S0092-8674(00)81153-8; TAZI J, 1992, J BIOL CHEM, V267, P4322; Velazquez-Dones A, 2005, J BIOL CHEM, V280, P41761, DOI 10.1074/jbc.M504156200; Ward AJ, 2010, J PATHOL, V220, P152, DOI 10.1002/path.2649; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I; Xiang SQ, 2013, STRUCTURE, V21, P2162, DOI 10.1016/j.str.2013.09.014; Yu FX, 2013, GENE DEV, V27, P1223, DOI 10.1101/gad.219402.113; Yun CY, 2003, J BIOL CHEM, V278, P18050, DOI 10.1074/jbc.M211714200; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837; Zhang ZY, 2011, J BIOL CHEM, V286, P10126, DOI 10.1074/jbc.M110.183970; Zhou J, 1997, BIOCHEMISTRY-US, V36, P15733, DOI 10.1021/bi971438n; Zhou ZH, 2012, MOL CELL, V47, P422, DOI 10.1016/j.molcel.2012.05.014	52	7	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17269	17281		10.1074/jbc.M115.656579	http://dx.doi.org/10.1074/jbc.M115.656579			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26013829	Green Published, hybrid			2022-12-28	WOS:000357730900023
J	Landeta, O; Landajuela, A; Garcia-Saez, A; Basanez, G				Landeta, Olatz; Landajuela, Ane; Garcia-Saez, Ana; Basanez, Gorka			Minimalist Model Systems Reveal Similarities and Differences between Membrane Interaction Modes of MCL1 and BAK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROAPOPTOTIC BAX; LIPID PACKING; MITOCHONDRIA; PERMEABILIZATION; APOPTOSIS; PORE; RETROTRANSLOCATION; LOCALIZATION; SENSITIVITY; CURVATURE	Proteins belonging to the BCL2 family are key modulators of apoptosis that establish a complex network of interactions among themselves and with other cellular factors to regulate cell fate. It is well established that mitochondrial membranes are the main locus of action of all BCL2 family proteins, but it is difficult to obtain a precise view of how BCL2 family members operate at the native mitochondrial membrane environment during apoptosis. Here, we used minimalist model systems and multiple fluorescence-based techniques to examine selected membrane activities of MCL1 and BAK under apoptotic-like conditions. We show that three distinct apoptosis-related factors (i.e. the BCL2 homology 3 ligand cBID, the mitochondrion-specific lipid cardiolipin, and membrane geometrical curvature) all promote membrane association of BCL2-like structural folds belonging to both MCL1 and BAK. However, at the same time, the two proteins exhibited distinguishing features in their membrane association modes under apoptotic-like conditions. In addition, scanning fluorescence cross-correlation spectroscopy and FRET measurements revealed that the BCL2-like structural fold of MCL1, but not that of BAK, forms stable heterodimeric complexes with cBID in a manner adjustable by membrane cardiolipin content and curvature degree. Our results add significantly to a growing body of evidence indicating that the mitochondrial membrane environment plays a complex and active role in the mode of action of BCL2 family proteins.	[Landeta, Olatz; Landajuela, Ane; Basanez, Gorka] Ctr Mixto Ctr Super Invest Cient CSIC EuskalHerri, Unidad Biofis, Leioa 48940, Spain; [Garcia-Saez, Ana] Univ Tubingen, Interfac Inst Biochem, D-72076 Tubingen, Germany; [Garcia-Saez, Ana] Max Planck Inst Intelligent Syst, D-70569 Stuttgart, Germany; [Garcia-Saez, Ana] BioQuant, German Canc Res Ctr, D-69120 Heidelberg, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; Eberhard Karls University of Tubingen; Max Planck Society; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Landeta, O (corresponding author), Ctr Mixto Ctr Super Invest Cient CSIC EuskalHerri, Unidad Biofis, Barrio Sarriena S-N, Leioa 48940, Spain.	olatz.landeta@ehu.eus; gorka_basanez@ehu.eus	Saez, Ana J. Garcia/U-1611-2019	Landeta, Olatz/0000-0002-5494-0271	Ministerio de Economia y Competitividad [BFU2011-28566]; Gobierno Vasco Grant [IT838-13]; UPV/EHU Grant [EHU13-74]; Max Planck Society; German Cancer Research Center; German Ministry of Education and Research (BMBG) [0312040]	Ministerio de Economia y Competitividad(Spanish Government); Gobierno Vasco Grant; UPV/EHU Grant; Max Planck Society(Max Planck SocietyFoundation CELLEX); German Cancer Research Center; German Ministry of Education and Research (BMBG)	This work was supported by Ministerio de Economia y Competitividad Grant BFU2011-28566, Gobierno Vasco Grant IT838-13, and UPV/EHU Grant EHU13-74 (to G. B.) and grants from the Max Planck Society, the German Cancer Research Center, and the German Ministry of Education and Research (BMBG; Grant 0312040) (to A. G.-S.).; Recipient of a postdoctoral fellowship from the UPV/EHU.	Aimon S, 2014, DEV CELL, V28, P212, DOI 10.1016/j.devcel.2013.12.012; Aouacheria A, 2013, TRENDS CELL BIOL, V23, P103, DOI 10.1016/j.tcb.2012.10.010; Basanez G, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001399; Bigay J, 2012, DEV CELL, V23, P886, DOI 10.1016/j.devcel.2012.10.009; Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Bleicken S, 2013, J BIOL CHEM, V288, P33241, DOI 10.1074/jbc.M113.512087; Brouwer JM, 2014, MOL CELL, V55, P938, DOI 10.1016/j.molcel.2014.07.016; Burre J, 2014, P NATL ACAD SCI USA, V111, pE4274, DOI 10.1073/pnas.1416598111; Chu CT, 2013, NAT CELL BIOL, V15, P1197, DOI 10.1038/ncb2837; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Edlich F, 2011, CELL, V145, P104, DOI 10.1016/j.cell.2011.02.034; George NM, 2010, J BIOL CHEM, V285, P1384, DOI 10.1074/jbc.M109.049924; Hardwick JM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008722; He LH, 2003, P NATL ACAD SCI USA, V100, P1022, DOI 10.1073/pnas.0333594100; Hermann E, 2015, METHODS MOL BIOL, V1232, P181, DOI 10.1007/978-1-4939-1752-5_15; Horvath SE, 2013, PROG LIPID RES, V52, P590, DOI 10.1016/j.plipres.2013.07.002; Kim PK, 2004, MOL CELL, V14, P523, DOI 10.1016/S1097-2765(04)00263-1; Kozlov MM, 2014, CURR OPIN CELL BIOL, V29, P53, DOI 10.1016/j.ceb.2014.03.006; Landeta O, 2014, ACS CHEM BIOL, V9, P2852, DOI 10.1021/cb500592e; Landeta O, 2011, J BIOL CHEM, V286, P8213, DOI 10.1074/jbc.M110.165852; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; Moldoveanu T, 2013, NAT STRUCT MOL BIOL, V20, P589, DOI 10.1038/nsmb.2563; Montessuit S, 2010, CELL, V142, P889, DOI 10.1016/j.cell.2010.08.017; Nakajima W, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.6; Nouraini S, 2000, MOL CELL BIOL, V20, P1604, DOI 10.1128/MCB.20.5.1604-1615.2000; Perciavalle RM, 2013, TRENDS CELL BIOL, V23, P22, DOI 10.1016/j.tcb.2012.08.011; Priault M, 2003, CELL DEATH DIFFER, V10, P1068, DOI 10.1038/sj.cdd.4401270; Renault TT, 2015, INT J BIOCHEM CELL B, V64, P136, DOI 10.1016/j.biocel.2015.03.020; Renault TT, 2015, MOL CELL, V57, P69, DOI 10.1016/j.molcel.2014.10.028; Renault TT, 2014, CHEM BIOL, V21, P114, DOI 10.1016/j.chembiol.2013.10.009; Renner LD, 2011, P NATL ACAD SCI USA, V108, P6264, DOI 10.1073/pnas.1015757108; Sano R, 2009, MOL CELL, V36, P500, DOI 10.1016/j.molcel.2009.10.021; Schellenberg B, 2013, MOL CELL, V49, P959, DOI 10.1016/j.molcel.2012.12.022; Shamas-Din A, 2013, J BIOL CHEM, V288, P22111, DOI 10.1074/jbc.M113.482109; Shamas-Din A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008714; Terrones O, 2004, J BIOL CHEM, V279, P30081, DOI 10.1074/jbc.M313420200; Todt F, 2013, CELL DEATH DIFFER, V20, P333, DOI 10.1038/cdd.2012.131; Todt F, 2015, EMBO J, V34, P67, DOI 10.15252/embj.201488806; Turcatti G, 1996, J BIOL CHEM, V271, P19991, DOI 10.1074/jbc.271.33.19991; Tyurina YY, 2014, NAT CHEM, V6, P542, DOI [10.1038/NCHEM.1924, 10.1038/nchem.1924]; Valentijn AJ, 2008, CELL DEATH DIFFER, V15, P1243, DOI 10.1038/cdd.2008.39; Vanni S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5916; Wang Y, 2013, J BIOL CHEM, V288, P35840, DOI 10.1074/jbc.M113.503680; Westphal D, 2014, CELL DEATH DIFFER, V21, P196, DOI 10.1038/cdd.2013.139	46	10	10	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					17004	17019		10.1074/jbc.M114.602193	http://dx.doi.org/10.1074/jbc.M114.602193			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25987560	hybrid, Green Published			2022-12-28	WOS:000357572800043
J	Szundi, I; Bogomolni, R; Kliger, DS				Szundi, Istvan; Bogomolni, Roberto; Kliger, David S.			Platymonas subcordiformis Channelrhodopsin-2 (PsChR2) Function II. RELATIONSHIP OF THE PHOTOCHEMICAL REACTION CYCLE TO CHANNEL CURRENTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT; PHOTOCYCLE; MECHANISM	Channelrhodopsins, such as the algal phototaxis receptor Platymonas subcordiformis channelrhodopsin-2 (PsChR2), are light-gated cation channels used as optogenetic tools for photocontrol of membrane potential in living cells. Channelrhodopsin (ChR)-mediated photocurrent responses are complex and poorly understood, exhibiting alterations in peak current amplitude, extents and kinetics of inactivation, and kinetics of the recovery of the prestimulus dark current that are sensitive to duration and frequency of photostimuli. From the analysis of time-resolved optical absorption data, presented in the accompanying article, we derived a two-cycle model that describes the photocycles of PsChR2. Here, we applied the model to evaluate the transient currents produced by PsChR2 expressed in HEK293 cells under both fast laser excitation and step-like continuous illumination. Interpretation of the photocurrents in terms of the photocycle kinetics indicates that the O states in both cycles are responsible for the channel current and fit the current transients under the different illumination regimes. The peak and plateau currents in response to a single light step, a train of light pulses, and a light step superimposed on a continuous light background observed for ChR2 proteins are explained in terms of contributions from the two parallel photocycles. The analysis shows that the peak current desensitization and recovery phenomena are inherent properties of the photocycles. The light dependence of desensitization is reproduced and explained by the time evolution of the concentration transients in response to step-like illumination. Our data show that photocycle kinetic parameters are sufficient to explain the complex dependence of photocurrent responses to photostimuli.	[Szundi, Istvan; Bogomolni, Roberto; Kliger, David S.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Kliger, DS (corresponding author), Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA.	kliger@ucsc.edu			National Institutes of Health from the NEI [R01EY000983]; NATIONAL EYE INSTITUTE [R01EY000983] Funding Source: NIH RePORTER	National Institutes of Health from the NEI; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grant R01EY000983 from the NEI (to D. S. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Bamann C, 2008, J MOL BIOL, V375, P686, DOI 10.1016/j.jmb.2007.10.072; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Ernst OP, 2014, CHEM REV, V114, P126, DOI 10.1021/cr4003769; Govorunova EG, 2013, J BIOL CHEM, V288, P29911, DOI 10.1074/jbc.M113.505495; Hegemann P, 2005, BIOPHYS J, V89, P3911, DOI 10.1529/biophysj.105.069716; Hou SY, 2012, PHOTOCHEM PHOTOBIOL, V88, P119, DOI 10.1111/j.1751-1097.2011.01027.x; Lorenz-Fonfria VA, 2014, BBA-BIOENERGETICS, V1837, P626, DOI 10.1016/j.bbabio.2013.10.014; Lorenz-Fonfria VA, 2013, P NATL ACAD SCI USA, V110, pE1273, DOI 10.1073/pnas.1219502110; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nikolic K, 2009, PHOTOCHEM PHOTOBIOL, V85, P400, DOI 10.1111/j.1751-1097.2008.00460.x; Ritter E, 2013, J BIOL CHEM, V288, P10451, DOI 10.1074/jbc.M112.446427; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399; Sineshchekov OA, 2013, BIOPHYS J, V104, P807, DOI 10.1016/j.bpj.2013.01.002; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; Stehfest K, 2010, CHEMPHYSCHEM, V11, P1120, DOI 10.1002/cphc.200900980; Szundi I, 2004, BIOCHEMISTRY-US, V43, P15746, DOI 10.1021/bi049408p; Szundi I, 2015, J BIOL CHEM, V290, P16573, DOI 10.1074/jbc.M114.631614; Verhoefen MK, 2010, CHEMPHYSCHEM, V11, P3113, DOI 10.1002/cphc.201000181	20	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16585	16594		10.1074/jbc.M115.653071	http://dx.doi.org/10.1074/jbc.M115.653071			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25971978	hybrid, Green Published			2022-12-28	WOS:000357572800011
J	Verissimo, AF; Shroff, NP; Daldal, F				Verissimo, Andreia F.; Shroff, Namita P.; Daldal, Fevzi			During Cytochrome c Maturation CcmI Chaperones the Class I Apocytochromes until the Formation of Their b-Type Cytochrome Intermediates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHODOBACTER-CAPSULATUS; ESCHERICHIA-COLI; HEME-BINDING; PHOTOSYNTHETIC GROWTH; ELECTRON-TRANSFER; BC(1) COMPLEX; NMR STRUCTURE; TPR DOMAIN; AMINO-ACID; SYSTEM I	The c-type cytochromes are electron transfer proteins involved in energy transduction. They have heme-binding (CXXCH) sites that covalently ligate heme b via thioether bonds and are classified into different classes based on their protein folds and the locations and properties of their cofactors. Rhodobacter capsulatus produces various c-type cytochromes using the cytochrome c maturation (Ccm) System I, formed from the CcmABCDEFGHI proteins. CcmI, a component of the heme ligation complex CcmFHI, interacts with the heme-handling protein CcmE and chaperones apocytochrome c(2) by binding its C-terminal helix. Whether CcmI also chaperones other c-type apocytochromes, and the effects of heme on these interactions were unknown previously. Here, we purified different classes of soluble and membrane-bound c-type apocytochromes (class I, c(2) and c(1), and class II c') and investigated their interactions with CcmI and apoCcmE. We report that, in the absence of heme, CcmI and apoCcmE recognized different classes of c-type apocytochromes with different affinities (nM to mu M K-D values). When present, heme induced conformational changes in class I apocytochromes (e.g. c(2)) and decreased significantly their high affinity for CcmI. Knowing that CcmI does not interact with mature cytochrome c(2) and that heme converts apocytochrome c(2) into its b-type derivative, these findings indicate that CcmI holds the class I apocytochromes (e.g. c(2)) tightly until their noncovalent heme-containing b-type cytochrome-like intermediates are formed. We propose that these intermediates are subsequently converted into mature cytochromes following the covalent ligation of heme via the remaining components of the Ccm complex.	[Verissimo, Andreia F.; Shroff, Namita P.; Daldal, Fevzi] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Daldal, F (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	fdaldal@sas.upenn.edu	Regan, Clinton/E-6250-2012		U.S. Department of Energy from the Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences [DOE DE-FG02-91ER20052]; National Institutes of Health [GM38237]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038237] Funding Source: NIH RePORTER	U.S. Department of Energy from the Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. Department of Energy Grant DOE DE-FG02-91ER20052 from the Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences. This work was also supported by National Institutes of Health Grant GM38237. The authors declare that they have no conflicts of interest with the contents of this article.	Allen JWA, 2005, BIOCHEM J, V389, P587, DOI 10.1042/BJ20041894; AMBLER RP, 1991, BIOCHIM BIOPHYS ACTA, V1058, P42, DOI 10.1016/S0005-2728(05)80266-X; Anderson JLR, 2014, CHEM SCI, V5, P507, DOI [10.1039/c3sc52019f, 10.1039/C3SC52019F]; Aramini JM, 2012, BIOCHEMISTRY-US, V51, P3705, DOI 10.1021/bi300457b; Arnesano F, 2002, BIOCHEMISTRY-US, V41, P13587, DOI 10.1021/bi026362w; Bertini I, 2006, CHEM REV, V106, P90, DOI 10.1021/cr050241v; Bowman SEJ, 2008, NAT PROD REP, V25, P1118, DOI 10.1039/b717196j; Cinege G, 2004, MOL GENET GENOMICS, V271, P171, DOI 10.1007/s00438-003-0968-2; COLLIER GS, 1979, BIOCHEM J, V179, P281, DOI 10.1042/bj1790281; Colon W, 1996, BIOCHEMISTRY-US, V35, P5538, DOI 10.1021/bi960052u; Cortajarena AL, 2010, FEBS J, V277, P1058, DOI 10.1111/j.1742-4658.2009.07549.x; Cross R, 2000, J BACTERIOL, V182, P1442, DOI 10.1128/JB.182.5.1442-1447.2000; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; DALDAL F, 1986, P NATL ACAD SCI USA, V83, P2012, DOI 10.1073/pnas.83.7.2012; DALDAL F, 1987, J MOL BIOL, V195, P1, DOI 10.1016/0022-2836(87)90322-6; Daltrop O, 2003, J BIOL CHEM, V278, P4404, DOI 10.1074/jbc.M211124200; Daltrop O, 2002, P NATL ACAD SCI USA, V99, P7872, DOI 10.1073/pnas.132259099; DELGADO MJ, 1995, J BACTERIOL, V177, P4927, DOI 10.1128/jb.177.17.4927-4934.1995; Deshmukh M, 2000, MOL MICROBIOL, V35, P123, DOI 10.1046/j.1365-2958.2000.01683.x; Di Silvio E, 2013, BBA-PROTEINS PROTEOM, V1834, P1554, DOI 10.1016/j.bbapap.2013.04.027; DUMONT ME, 1994, BIOCHEMISTRY-US, V33, P7368, DOI 10.1021/bi00189a043; Enggist E, 2002, STRUCTURE, V10, P1551, DOI 10.1016/S0969-2126(02)00885-7; Fee JA, 2004, BIOCHEMISTRY-US, V43, P12162, DOI 10.1021/bi048968l; Feissner RE, 2006, MOL MICROBIOL, V61, P219, DOI 10.1111/j.1365-2958.2006.05221.x; FENG YQ, 1991, BIOCHEMISTRY-US, V30, P10150, DOI 10.1021/bi00106a011; Ferguson SJ, 2012, BBA-BIOENERGETICS, V1817, P1754, DOI 10.1016/j.bbabio.2012.05.004; FISHER WR, 1973, J BIOL CHEM, V248, P3188; Fujii S, 2014, BIOSCI BIOTECH BIOCH, V78, P1191, DOI 10.1080/09168451.2014.912120; GRAY KA, 1994, BIOCHEMISTRY-US, V33, P3120, DOI 10.1021/bi00176a047; HAMADA D, 1993, BIOCHEMISTRY-US, V32, P10351, DOI 10.1021/bi00090a010; Han D, 2008, PROTEINS, V70, P900, DOI 10.1002/prot.21597; Harvat EM, 2009, BIOCHEMISTRY-US, V48, P1820, DOI 10.1021/bi801609a; HOCHKOEPPLER A, 1995, J BACTERIOL, V177, P608, DOI 10.1128/jb.177.3.608-613.1995; Inoue H, 2011, FEBS J, V278, P2341, DOI 10.1111/j.1742-4658.2011.08155.x; JENNEY FE, 1993, EMBO J, V12, P1283, DOI 10.1002/j.1460-2075.1993.tb05773.x; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Kellogg JA, 2002, BBA-PROTEINS PROTEOM, V1601, P215, DOI 10.1016/S1570-9639(02)00471-5; Kojima N, 2005, BIOSCI BIOTECH BIOCH, V69, P1418, DOI 10.1271/bbb.69.1418; Kranz RG, 2009, MICROBIOL MOL BIOL R, V73, P510, DOI 10.1128/MMBR.00001-09; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lang SE, 1996, J BACTERIOL, V178, P5279, DOI 10.1128/jb.178.17.5279-5290.1996; Lapouge K, 2000, MOL CELL, V6, P899, DOI 10.1016/S1097-2765(00)00087-3; Lee DH, 2005, J AM CHEM SOC, V127, P3716, DOI 10.1021/ja044658e; McGuirl MA, 2003, BBA-GEN SUBJECTS, V1619, P23, DOI 10.1016/S0304-4165(02)00437-3; Moore G. R., 1990, CYTOCHROMES C EVOLUT; Osyczka A, 2001, BIOCHEMISTRY-US, V40, P14547, DOI 10.1021/bi011630w; PIELAK GJ, 1995, BIOCHEMISTRY-US, V34, P3268, DOI 10.1021/bi00010a017; Robinson, 1982, CYCLOTRONS CYTOCHROM, P263, DOI 10.1016/B978-0-12-397580-5.50026-0; SAMBONGI Y, 1994, FEBS LETT, V344, P207, DOI 10.1016/0014-5793(94)00399-8; San Francisco B, 2014, J MOL BIOL, V426, P570, DOI 10.1016/j.jmb.2013.10.025; Sanders C, 2008, J BIOL CHEM, V283, P29715, DOI 10.1074/jbc.M805413200; Sanders C, 2007, J BACTERIOL, V189, P789, DOI 10.1128/JB.01441-06; Schulz H, 1998, SCIENCE, V281, P1197, DOI 10.1126/science.281.5380.1197; SEERY VL, 1973, J BIOL CHEM, V248, P3796; Shaw AL, 1999, J BIOL CHEM, V274, P9911, DOI 10.1074/jbc.274.15.9911; THOMAS PE, 1976, ANAL BIOCHEM, V75, P168, DOI 10.1016/0003-2697(76)90067-1; Tobias R., 2013, 14 DIV PALL LIF SCI; Tomlinson EJ, 2000, P NATL ACAD SCI USA, V97, P5156, DOI 10.1073/pnas.090089397; Travaglini-Allocatelli C, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/505714; Verissimo AF, 2014, BBA-BIOENERGETICS, V1837, P989, DOI 10.1016/j.bbabio.2014.03.003; Verissimo AF, 2013, J BIOL CHEM, V288, P6272, DOI 10.1074/jbc.M112.440024; Verissimo AF, 2011, J BIOL CHEM, V286, P40452, DOI 10.1074/jbc.M111.277764; Yamanaka M, 2009, BIOSCI BIOTECH BIOCH, V73, P2022, DOI 10.1271/bbb.90220; Zeytuni N, 2012, STRUCTURE, V20, P397, DOI 10.1016/j.str.2012.01.006	64	1	1	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16989	17003		10.1074/jbc.M115.652818	http://dx.doi.org/10.1074/jbc.M115.652818			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25979338	Green Published, hybrid			2022-12-28	WOS:000357572800042
J	Allis, CD				Allis, C. David			"Modifying" My Career toward Chromatin Biology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; epigenetics; histone; histone acetylation; histone modification	PEDIATRIC GLIOBLASTOMA; REPEATING UNIT; YEAST		Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA	Rockefeller University	Allis, CD (corresponding author), Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA.	alliscd@mail.rockefeller.edu			NIMH NIH HHS [P50 MH096890] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH096890] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; KAYNE PS, 1988, CELL, V55, P27, DOI 10.1016/0092-8674(88)90006-2; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Mukhopadhyay R., 2015, ASBMB TODAY IN PRESS, V14; OUDET P, 1975, CELL, V4, P281, DOI 10.1016/0092-8674(75)90149-X; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Wu G, 2014, NAT GENET, V46, P444, DOI 10.1038/ng.2938	9	2	2	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					15904	15908		10.1074/jbc.X115.663229	http://dx.doi.org/10.1074/jbc.X115.663229			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25944906	Green Published, hybrid			2022-12-28	WOS:000356930100001
J	Pollard, RD; Blesso, CN; Zabalawi, M; Fulp, B; Gerelus, M; Zhu, XW; Lyons, EW; Nuradin, N; Francone, OL; Li, XA; Sahoo, D; Thomas, MJ; Sorci-Thomas, MG				Pollard, Ricquita D.; Blesso, Christopher N.; Zabalawi, Manal; Fulp, Brian; Gerelus, Mark; Zhu, Xuewei; Lyons, Erica W.; Nuradin, Nebil; Francone, Omar L.; Li, Xiang-An; Sahoo, Daisy; Thomas, Michael J.; Sorci-Thomas, Mary G.			Procollagen C-endopeptidase Enhancer Protein 2 (PCPE2) Reduces Atherosclerosis in Mice by Enhancing Scavenger Receptor Class B1 (SR-BI)-mediated High-density Lipoprotein (HDL)-Cholesteryl Ester Uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apolipoprotein; atherosclerosis; cholesterol metabolism; extracellular matrix protein; high-density lipoprotein (HDL); scavenger receptor	APOLIPOPROTEIN-A-I; CHOLESTEROL EFFLUX CAPACITY; APOA-I; SR-BI; SELECTIVE UPTAKE; HDL CHOLESTEROL; CELL-SURFACE; WILD-TYPE; LDLR-/; BINDING	Background: Extracellular matrix protein PCPE2 is linked to alterations in HDL size and concentration. Results: PCPE2 protects against diet-induced atherosclerosis by promoting HDL catabolism, reverse cholesterol transport, and SR-BI-mediated uptake of HDL-cholesteryl ester. Conclusion: PCPE2 mediates HDL function by reducing lipid and immune cell accumulation in the artery. Significance: These findings establish a role for the extracellular matrix glycoprotein PCPE2 in SR-BI-mediated HDL function and the prevention of atherosclerosis. Studies in human populations have shown a significant correlation between procollagen C-endopeptidase enhancer protein 2 (PCPE2) single nucleotide polymorphisms and plasma HDL cholesterol concentrations. PCPE2, a 52-kDa glycoprotein located in the extracellular matrix, enhances the cleavage of C-terminal procollagen by bone morphogenetic protein 1 (BMP1). Our studies here focused on investigating the basis for the elevated concentration of enlarged plasma HDL in PCPE2-deficient mice to determine whether they protected against diet-induced atherosclerosis. PCPE2-deficient mice were crossed with LDL receptor-deficient mice to obtain LDLr-/-, PCPE2(-/-) mice, which had elevated HDL levels compared with LDLr-/- mice with similar LDL concentrations. We found that LDLr-/-, PCPE2(-/-) mice had significantly more neutral lipid and CD68+ infiltration in the aortic root than LDLr-/- mice. Surprisingly, in light of their elevated HDL levels, the extent of aortic lipid deposition in LDLr-/-, PCPE2(-/-) mice was similar to that reported for LDLr-/-, apoA-I-/- mice, which lack any apoA-I/HDL. Furthermore, LDLr-/-, PCPE2(-/-) mice had reduced HDL apoA-I fractional clearance and macrophage to fecal reverse cholesterol transport rates compared with LDLr-/- mice, despite a 2-fold increase in liver SR-BI expression. PCPE2 was shown to enhance SR-BI function by increasing the rate of HDL-associated cholesteryl ester uptake, possibly by optimizing SR-BI localization and/or conformation. We conclude that PCPE2 is atheroprotective and an important component of the reverse cholesterol transport HDL system.	[Nuradin, Nebil; Sahoo, Daisy; Thomas, Michael J.; Sorci-Thomas, Mary G.] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA; [Nuradin, Nebil; Sahoo, Daisy; Thomas, Michael J.; Sorci-Thomas, Mary G.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Pollard, Ricquita D.; Zabalawi, Manal; Fulp, Brian; Gerelus, Mark; Zhu, Xuewei; Lyons, Erica W.] Wake Forest Univ, Sch Med, Dept Internal Med, Sect Mol Med, Winston Salem, NC 27101 USA; [Pollard, Ricquita D.; Zabalawi, Manal; Fulp, Brian; Gerelus, Mark; Zhu, Xuewei; Lyons, Erica W.] Wake Forest Univ, Sch Med, Dept Biochem, Winston Salem, NC 27101 USA; [Blesso, Christopher N.] Univ Connecticut, Dept Nutr Sci, Storrs, CT 06268 USA; [Francone, Omar L.] Shire Human Genet Therapies, Lexington, MA 02421 USA; [Li, Xiang-An] Univ Kentucky, Dept Pediat, Lexington, KY 40506 USA	Medical College of Wisconsin; Medical College of Wisconsin; Wake Forest University; Wake Forest University; University of Connecticut; Shire Pharmaceuticals Limited; University of Kentucky	Sorci-Thomas, MG (corresponding author), Med Coll Wisconsin, Dept Med, Div Endocrinol Metab & Clin Nutr, 8701 W Watertown Plank Rd, Milwaukee, WI 53226 USA.	msthomas@mcw.edu	Blesso, Christopher/AAK-3357-2020; Blesso, Christopher/N-9495-2014	Blesso, Christopher/0000-0002-4434-4839; Lyons, Erica/0000-0002-8917-321X; Gerelus, Mark/0000-0001-8986-4523; Sorci-Thomas, Mary/0000-0002-6464-5006	North Carolina Biotechnology [2007-IDG-1021]; National Institutes of Health (NIH) Shared Instrumentation Grant [1S10RR027940]; NIH Shared Instrumentation Grant [1S10RR17846]; NIH from NCI [5P30CA12197]; NATIONAL CANCER INSTITUTE [P30CA012197] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027940, S10RR017846] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL091797, R01HL112270, R01HL127649, R01HL058012, R01HL112276] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113832] Funding Source: NIH RePORTER	North Carolina Biotechnology; National Institutes of Health (NIH) Shared Instrumentation Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Shared Instrumentation Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The mass spectrometers used for these studies were acquired with funds from several agencies: TSQ Discovery Max LC-MS/MS and Advion Nanomate from North Carolina Biotechnology Grant 2007-IDG-1021, TSQ Quantum XLS GC-MS/MS from National Institutes of Health (NIH) Shared Instrumentation Grant 1S10RR027940, and Waters Q-TOF mass spectrometer from NIH Shared Instrumentation Grant 1S10RR17846. The MS analyses were performed in the Mass Spectrometer Facility of the Comprehensive Cancer Center of Wake Forest University School of Medicine, supported in part by NIH Grant 5P30CA12197 from NCI.	Alexander E. T., 2014, ARTERIOSCLER THROMB, V31, P320; Baicu CF, 2012, AM J PHYSIOL-HEART C, V303, pH234, DOI 10.1152/ajpheart.00227.2012; Bally I, 2009, J BIOL CHEM, V284, P19340, DOI 10.1074/jbc.M109.004473; Batta AK, 1999, J LIPID RES, V40, P1148; Bekhouche M, 2010, J BIOL CHEM, V285, P15950, DOI 10.1074/jbc.M109.086447; Berquin IM, 2007, J CLIN INVEST, V117, P1866, DOI 10.1172/JCI31494; Bhat S, 2005, J BIOL CHEM, V280, P33015, DOI 10.1074/jbc.M505081200; Bhat S, 2007, BIOCHEMISTRY-US, V46, P7811, DOI 10.1021/bi700384t; Bhat S, 2010, BIOCHEMISTRY-US, V49, P5213, DOI 10.1021/bi1003734; Blanc G, 2007, J BIOL CHEM, V282, P16924, DOI 10.1074/jbc.M701610200; BODEN WE, 2000, AM J CARDIOL, V86, P19, DOI DOI 10.1016/S0002-9149(00)01464-8; Brier S, 2010, J BIOL CHEM, V285, P32251, DOI 10.1074/jbc.M110.149112; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; CASTELLI WP, 1977, CIRCULATION, V55, P767, DOI 10.1161/01.CIR.55.5.767; Chadwick AC, 2013, CURR OPIN ENDOCRINOL, V20, P124, DOI 10.1097/MED.0b013e32835ed575; Chadwick AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045660; Chau P, 2007, BIOCHEMISTRY-US, V46, P8445, DOI 10.1021/bi700028u; Chau PL, 2006, BIOCHEMISTRY-US, V45, P3981, DOI 10.1021/bi052535g; Connelly MA, 1999, J BIOL CHEM, V274, P41, DOI 10.1074/jbc.274.1.41; Cuchel M, 2010, ARTERIOSCL THROM VAS, V30, P526, DOI 10.1161/ATVBAHA.109.196105; Curtiss LK, 2006, ARTERIOSCL THROM VAS, V26, P12, DOI 10.1161/01.ATV.0000194291.94269.5a; de la Llera-Moya M, 2010, ARTERIOSCL THROM VAS, V30, P796, DOI 10.1161/ATVBAHA.109.199158; Denis M, 2004, J BIOL CHEM, V279, P7384, DOI 10.1074/jbc.M306963200; Francone OL, 2011, J LIPID RES, V52, P1974, DOI 10.1194/jlr.M016527; Gaboriaud C, 2011, BIOCHEM J, V439, P185, DOI 10.1042/BJ20111027; Getz GS, 2011, J LIPID RES, V52, P1861, DOI 10.1194/jlr.R020149; Goldsmith EC, 2013, AM J PHYSIOL-CELL PH, V304, pC393, DOI 10.1152/ajpcell.00347.2012; Harder CJ, 2006, J LIPID RES, V47, P492, DOI 10.1194/jlr.M500444-JLR200; Heinzel K, 2007, EUR J IMMUNOL, V37, P2562, DOI 10.1002/eji.200637474; Hozoji M, 2009, J BIOL CHEM, V284, P11293, DOI 10.1074/jbc.M900580200; Huggins KW, 2001, J LIPID RES, V42, P1457; Iatan I, 2011, J LIPID RES, V52, P2043, DOI 10.1194/jlr.M016196; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; KALUZNY MA, 1985, J LIPID RES, V26, P135; Kartz GA, 2014, BIOCHEMISTRY-US, V53, P6173, DOI 10.1021/bi500706x; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Kocher O, 2009, CURR OPIN LIPIDOL, V20, P236, DOI 10.1097/MOL.0b013e32832aee82; Krieger M, 1999, CURR OPIN LIPIDOL, V10, P491, DOI 10.1097/00041433-199912000-00003; Kronenberg D, 2009, J BIOL CHEM, V284, P33437, DOI 10.1074/jbc.M109.046128; Kwiterovich PO, 1998, AM J CARDIOL, V82, p13Q; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Manavalan APC, 2014, J BIOL CHEM, V289, P4683, DOI 10.1074/jbc.M113.499129; MCFARLANE AS, 1958, NATURE, V182, P53, DOI 10.1038/182053a0; Miles RR, 2013, J BIOL CHEM, V288, P6386, DOI 10.1074/jbc.M112.410092; Moali C, 2005, J BIOL CHEM, V280, P24188, DOI 10.1074/jbc.M501486200; Nagata KO, 2013, P NATL ACAD SCI USA, V110, P5034, DOI 10.1073/pnas.1220703110; Oram JF, 2000, CURR OPIN LIPIDOL, V11, P253, DOI 10.1097/00041433-200006000-00005; Pagler TA, 2006, J BIOL CHEM, V281, P11193, DOI 10.1074/jbc.M510261200; Patel S, 2009, J AM COLL CARDIOL, V53, P962, DOI 10.1016/j.jacc.2008.12.008; PITTMAN RC, 1987, J BIOL CHEM, V262, P2443; Potteaux S, 2011, J CLIN INVEST, V121, P2025, DOI 10.1172/JCI43802; Puppione DL, 2006, BBA-PROTEINS PROTEOM, V1764, P1363, DOI 10.1016/j.bbapap.2006.06.001; Reaven E, 2004, J LIPID RES, V45, P513, DOI 10.1194/jlr.M300370-JLR200; Ricard-Blum S, 2002, J BIOL CHEM, V277, P33864, DOI 10.1074/jbc.M205018200; Rohrl C, 2013, BBA-MOL CELL BIOL L, V1831, P1626, DOI [10.1016/j.bbalip2013.07.014, 10.1016/j.bbalip.2013.07.014]; Rohatgi A, 2014, NEW ENGL J MED, V371, P2383, DOI 10.1056/NEJMoa1409065; Rye KA, 2004, ARTERIOSCL THROM VAS, V24, P421, DOI 10.1161/01.ATV.0000104029.74961.f5; Saddar S, 2010, ARTERIOSCL THROM VAS, V30, P144, DOI 10.1161/ATVBAHA.109.196170; Sahoo D, 2007, BBA-MOL CELL BIOL L, V1771, P818, DOI 10.1016/j.bbalip.2007.04.019; Sahoo D, 2007, BBA-MOL CELL BIOL L, V1771, P807, DOI 10.1016/j.bbalip.2006.03.003; Schwenke DC, 2002, J LIPID RES, V43, P1927, DOI 10.1194/jlr.M200261-JLR200; Silver DL, 2001, J BIOL CHEM, V276, P25287, DOI 10.1074/jbc.M101726200; Sorci-Thomas MG, 2013, J CARDIOVASC PHARM, V62, P239, DOI 10.1097/FJC.0b013e31829d48a5; Sorci-Thomas MG, 2012, ARTERIOSCL THROM VAS, V32, P2561, DOI 10.1161/ATVBAHA.112.300135; Sorci-Thomas MG, 2012, J LIPID RES, V53, P1890, DOI 10.1194/jlr.M026674; Sorci-Thomas MG, 2012, BBA-MOL CELL BIOL L, V1821, P502, DOI 10.1016/j.bbalip.2011.08.019; Sorci-Thomas MG, 2000, J BIOL CHEM, V275, P12156, DOI 10.1074/jbc.275.16.12156; SorciThomas MG, 1996, J LIPID RES, V37, P673; Steiglitz BM, 2001, CYTOGENET CELL GENET, V95, P244, DOI 10.1159/000059356; Steiglitz BM, 2002, J BIOL CHEM, V277, P49820, DOI 10.1074/jbc.M209891200; Sviridov D, 2009, J LIPID RES, V50, P1257, DOI 10.1194/jlr.E900003-JLR200; Tavori H, 2015, J LIPID RES, V56, P635, DOI 10.1194/jlr.M056408; Teillet F, 2008, J BIOL CHEM, V283, P25715, DOI 10.1074/jbc.M803551200; Trigatti B, 1999, P NATL ACAD SCI USA, V96, P9322, DOI 10.1073/pnas.96.16.9322; Tsukamoto K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069725; Vadon-Le Goff S, 2011, J BIOL CHEM, V286, P38932, DOI 10.1074/jbc.M111.274944; Vedhachalam C, 2007, J BIOL CHEM, V282, P25123, DOI 10.1074/jbc.M704590200; Vedhachalam C, 2007, ARTERIOSCL THROM VAS, V27, P1603, DOI 10.1161/ATVBAHA.107.145789; Vergeer M, 2010, J LIPID RES, V51, P2058, DOI 10.1194/jlr.R001610; Wang N, 2000, J BIOL CHEM, V275, P33053, DOI 10.1074/jbc.M005438200; Wang N, 2003, J CLIN INVEST, V111, P99, DOI 10.1172/JCI200316808; Wang SH, 2013, ARTERIOSCL THROM VAS, V33, P1197, DOI 10.1161/ATVBAHA.112.301195; Weiss T, 2010, J BIOL CHEM, V285, P33867, DOI 10.1074/jbc.M110.141366; West M, 2009, J CLIN ENDOCR METAB, V94, P1451, DOI 10.1210/jc.2008-1223; Wilhelm AJ, 2010, J BIOL CHEM, V285, P36158, DOI 10.1074/jbc.M110.134130; Wilhelm AJ, 2009, ARTERIOSCL THROM VAS, V29, P843, DOI 10.1161/ATVBAHA.108.183442; Xu H, 2000, GENOMICS, V66, P264, DOI 10.1006/geno.2000.6229; Zabalawi M, 2003, AM J PATHOL, V163, P1201, DOI 10.1016/S0002-9440(10)63480-3; Zabalawi M, 2007, J LIPID RES, V48, P52, DOI 10.1194/jlr.M600370-JLR200; Zhang YZ, 2005, J CLIN INVEST, V115, P2870, DOI 10.1172/JCI25327; Zhang YZ, 2003, CIRCULATION, V108, P661, DOI 10.1161/01.CIR.0000086981.09834.E0; Zhu J, 2009, J LIPID RES, V50, P1330, DOI 10.1194/jlr.M900034-JLR200	92	23	23	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15496	15511		10.1074/jbc.M115.646240	http://dx.doi.org/10.1074/jbc.M115.646240			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25947382	hybrid, Green Published			2022-12-28	WOS:000356527400016
J	Matsumura, R; Hirakawa, J; Sato, K; Ikeda, T; Nagai, M; Fukuda, M; Imai, Y; Kawashima, H				Matsumura, Ryuji; Hirakawa, Jotaro; Sato, Kaori; Ikeda, Toshiaki; Nagai, Motoe; Fukuda, Minoru; Imai, Yasuyuki; Kawashima, Hiroto			Novel Antibodies Reactive with Sialyl Lewis X in Both Humans and Mice Define Its Critical Role in Leukocyte Trafficking and Contact Hypersensitivity Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH ENDOTHELIAL VENULES; SELECTIN LIGAND BIOSYNTHESIS; LYMPH-NODE ADDRESSIN; P-SELECTIN; VASCULAR ADDRESSIN; O-GLYCANS; EXPRESSION; RECRUITMENT; ADHESION; ANTIGEN	Sialyl Lewis X (sLe(x)) antigen functions as a common carbohydrate determinant recognized by all three members of the selectin family. However, its expression and function in mice remain undefined due to the poor reactivity of conventional anti-sLe(x) monoclonal antibodies (mAbs) with mouse tissues. Here, we developed novel anti-sLe(x) mAbs, termed F1 and F2, which react well with both human and mouse sLe(x), by immunizing fucosyltransferase (FucT)-IV and FucT-VII doubly deficient mice with 6-sulfo-sLe(x)-expressing cells transiently transfected with an expression vector encoding CMP-N-acetylneuraminic acid hydroxylase. F1 and F2 specifically bound both the N-acetyl and the N-glycolyl forms of sLe(x) as well as 6-sulfo-sLe(x), a major ligand for L-selectin expressed in high endothelial venules, and efficiently blocked physiological lymphocyte homing to lymph nodes in mice. Importantly, both of the mAbs inhibited contact hypersensitivity responses not only when administered in the L-selectin-dependent sensitization phase but also when administered in the elicitation phase in mice. When administered in the latter phase, F1 and F2 efficiently blocked rolling of mouse leukocytes along blood vessels expressing P-and E-selectin in the auricular skin in vivo. Consistent with these findings, the mAbs blocked P-and E-selectin-dependent leukocyte rolling in a flow chamber assay. Taken together, these results indicate that novel anti-sLe(x) mAbs reactive with both human and mouse tissues, with the blocking ability against leukocyte trafficking mediated by all three selectins, have been established. These mAbs should be useful in determining the role of sLe(x) antigen under physiological and pathological conditions.	[Matsumura, Ryuji; Hirakawa, Jotaro; Sato, Kaori; Ikeda, Toshiaki; Nagai, Motoe; Imai, Yasuyuki; Kawashima, Hiroto] Univ Shizuoka, Lab Microbiol & Immunol, Sch Pharmaceut Sci, Shizuoka 4228526, Japan; [Hirakawa, Jotaro; Kawashima, Hiroto] Hoshi Univ, Sch Pharm & Pharmaceut Sci, Dept Biochem, Tokyo 1428501, Japan; [Fukuda, Minoru] Sanford Burnham Med Res Inst, Glycobiol Unit, La Jolla, CA 92037 USA	University of Shizuoka; Hoshi University; Sanford Burnham Prebys Medical Discovery Institute	Kawashima, H (corresponding author), Hoshi Univ, Sch Pharm & Pharmaceut Sci, Dept Biochem, Shinagawa Ku, 2-4-41 Ebara, Tokyo 1428501, Japan.	h-kawashima@hoshi.ac.jp	Regan, Clinton/E-6250-2012; Imai, Yasuyuki/E-8701-2010	Imai, Yasuyuki/0000-0002-8937-0221	National Institutes of Health [U54GM62116]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [15K14955] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Drs. Yoko Ishihara (Kurume University, School of Medicine) and Toshio Nishikawa (Tokyo Women's Medical University) for providing the human tonsil tissue sections. We also thank Koichiro Tsuboi and Hiroaki Matsuura (University of Shizuoka, School of Pharmaceutical Sciences) for technical support and Drs. Richard D. Cummings, David F. Smith, and Jamie Heimburg-Molinaro (Emory University School of Medicine) at the Consortium for Functional Glycomics (supported by National Institutes of Health Grant U54GM62116) for performing the glycan array analysis and for providing the FucT-IV and FucT-VII DKO mice.	Arata-Kawai H, 2011, AM J PATHOL, V178, P423, DOI 10.1016/j.ajpath.2010.11.009; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; DUIJVESTIJN AM, 1988, AM J PATHOL, V130, P147; FUKUSHIMA K, 1984, CANCER RES, V44, P5279; GALLATIN WM, 1983, NATURE, V304, P30, DOI 10.1038/304030a0; Hirakawa J, 2010, J BIOL CHEM, V285, P40864, DOI 10.1074/jbc.M110.167296; Hiraoka N, 2004, J BIOL CHEM, V279, P3058, DOI 10.1074/jbc.M311150200; Homeister JW, 2001, IMMUNITY, V15, P115, DOI 10.1016/S1074-7613(01)00166-2; Kannagi R, 2009, GLYCOCONJUGATE J, V26, P923, DOI 10.1007/s10719-008-9122-z; KAWANO T, 1995, J BIOL CHEM, V270, P16458, DOI 10.1074/jbc.270.27.16458; Kawashima H, 2005, NAT IMMUNOL, V6, P1096, DOI 10.1038/ni1259; Kawashima Hiroto, 2013, Methods Mol Biol, V1022, P51, DOI 10.1007/978-1-62703-465-4_5; Kobayashi M, 2004, P NATL ACAD SCI USA, V101, P17807, DOI 10.1073/pnas.0407503101; Lee M, 2014, NAT IMMUNOL, V15, P982, DOI 10.1038/ni.2983; Leppanen A, 1999, J BIOL CHEM, V274, P24838, DOI 10.1074/jbc.274.35.24838; Leppanen A, 2000, J BIOL CHEM, V275, P39569, DOI 10.1074/jbc.M005005200; Ley K, 2004, NAT REV IMMUNOL, V4, P325, DOI 10.1038/nri1351; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; McEver RP, 2002, CURR OPIN CELL BIOL, V14, P581, DOI 10.1016/S0955-0674(02)00367-8; MICHIE SA, 1993, AM J PATHOL, V143, P1688; Mitoma J, 2007, NAT IMMUNOL, V8, P409, DOI 10.1038/ni1442; Mitoma J, 2009, GLYCOCONJUGATE J, V26, P511, DOI 10.1007/s10719-008-9207-8; North SJ, 2010, J BIOL CHEM, V285, P5759, DOI 10.1074/jbc.M109.068353; ROSEN SD, 1994, CURR OPIN CELL BIOL, V6, P663, DOI 10.1016/0955-0674(94)90092-2; SAWADA M, 1993, BIOCHEM BIOPH RES CO, V193, P337, DOI 10.1006/bbrc.1993.1629; SAWADA R, 1993, J BIOL CHEM, V268, P12675; Suzawa K, 2007, AM J GASTROENTEROL, V102, P1499, DOI 10.1111/j.1572-0241.2007.01189.x; TAMATANI T, 1995, AM J PHYSIOL-HEART C, V269, pH1282, DOI 10.1152/ajpheart.1995.269.4.H1282; Uchimura K, 2005, NAT IMMUNOL, V6, P1105, DOI 10.1038/ni1258; Wagers AJ, 1997, J IMMUNOL, V159, P1917; Yeh JC, 2001, CELL, V105, P957, DOI 10.1016/S0092-8674(01)00394-4	31	17	17	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15313	15326		10.1074/jbc.M115.650051	http://dx.doi.org/10.1074/jbc.M115.650051			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25944902	Green Published, hybrid			2022-12-28	WOS:000356177300042
J	Yuan, Z; Guo, WH; Yang, J; Li, L; Wang, ML; Lei, Y; Wan, Y; Zhao, XY; Luo, N; Cheng, P; Liu, XY; Nie, CL; Peng, Y; Tong, AP; Wei, YQ				Yuan, Zhu; Guo, Wenhao; Yang, Jun; Li, Lei; Wang, Meiliang; Lei, Yi; Wan, Yang; Zhao, Xinyu; Luo, Na; Cheng, Ping; Liu, Xinyu; Nie, Chunlai; Peng, Yong; Tong, Aiping; Wei, Yuquan			PNAS-4, an Early DNA Damage Response Gene, Induces S Phase Arrest and Apoptosis by Activating Checkpoint Kinases in Lung Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; THERAPEUTIC-EFFICACY; CYCLE ARREST; HUMAN CDC25A; CHK1; INHIBITOR; EXPRESSION; CLEAVAGE; ATM; DEGRADATION	PNAS-4, a novel pro-apoptotic gene, was activated during the early response to DNA damage. Our previous study has shown that PNAS-4 induces S phase arrest and apoptosis when overexpressed in A549 lung cancer cells. However, the underlying action mechanism remains far from clear. In this work, we found that PNAS-4 expression in lung tumor tissues is significantly lower than that in adjacent lung tissues; its expression is significantly increased in A549 cells after exposure to cisplatin, methyl methane sulfonate, and mitomycin; and its overexpression induces S phase arrest and apoptosis in A549 (p53 WT), NCI-H460 (p53 WT), H526 (p53 mutation), and Calu-1 (p53(-/-)) lung cancer cells, leading to proliferation inhibition irrespective of their p53 status. The S phase arrest is associated with up-regulation of p21Waf1/Cip1 and inhibition of the Cdc25A-CDK2-cyclin E/A pathway. Up-regulation of p21Waf1/Cip1 is p53-independent and correlates with activation of ERK. We further showed that the intra-S phase checkpoint, which occurs via DNA-dependent protein kinase-mediated activation of Chk1 and Chk2, is involved in the S phase arrest and apoptosis. Gene silencing of Chk1/2 rescues, whereas that of ATM or ATR does not affect, S phase arrest and apoptosis. Furthermore, human PNAS-4 induces DNA breaks in comet assays and gamma-H2AX staining. Intriguingly, caspase-dependent cleavage of Chk1 has an additional role in enhancing apoptosis. Taken together, our findings suggest a novel mechanism by which elevated PNAS-4 first causes DNA-dependent protein kinase-mediated Chk1/2 activation and then results in inhibition of the Cdc25A-CDK2-cyclin E/A pathway, ultimately causing S phase arrest and apoptosis in lung cancer cells.	[Yuan, Zhu; Yang, Jun; Li, Lei; Wang, Meiliang; Lei, Yi; Wan, Yang; Zhao, Xinyu; Cheng, Ping; Liu, Xinyu; Nie, Chunlai; Peng, Yong; Tong, Aiping; Wei, Yuquan] Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, State Key Lab Biotherapy, Chengdu 610041, Peoples R China; [Yuan, Zhu; Yang, Jun; Li, Lei; Wang, Meiliang; Lei, Yi; Wan, Yang; Zhao, Xinyu; Cheng, Ping; Liu, Xinyu; Nie, Chunlai; Peng, Yong; Tong, Aiping; Wei, Yuquan] Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, Ctr Canc, Chengdu 610041, Peoples R China; [Guo, Wenhao] Sichuan Univ, West China Med Sch, Dept Abdominal Oncol, Ctr Canc, Chengdu 610041, Sichuan Provinc, Peoples R China; [Guo, Wenhao] Sichuan Univ, West China Med Sch, State Key Lab Biotherapy, Chengdu 610041, Sichuan Provinc, Peoples R China; [Luo, Na] Nankai Univ, Sch Med, Collaborat Innovat Ctr Biotherapy, Tianjin 300071, Peoples R China	Sichuan University; Sichuan University; Sichuan University; Sichuan University; Nankai University	Yuan, Z (corresponding author), Collaborat Innovat Ctr Biotherapy, State Key Lab Biotherapy, Chengdu, Peoples R China.	yuanzhu@scu.edu.cn; aipingtong@scu.edu.cn	li, li/HII-4157-2022; Li, Li/AEM-3636-2022; LI, LI/GVS-5344-2022		National Natural Science Foundation of China [30900744, 81272524]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 30900744 and 81272524.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Ashton AW, 1999, J BIOL CHEM, V274, P20805, DOI 10.1074/jbc.274.30.20805; Baluchamy S, 2010, J BIOL CHEM, V285, P24769, DOI 10.1074/jbc.M110.138099; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Beier F, 1999, J BIOL CHEM, V274, P30273, DOI 10.1074/jbc.274.42.30273; Best CJM, 2005, CLIN CANCER RES, V11, P6823, DOI 10.1158/1078-0432.CCR-05-0585; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Brumbaugh KM, 2004, MOL CELL, V14, P585, DOI 10.1016/j.molcel.2004.05.005; Cai PL, 2012, MOL BIOL REP, V39, P621, DOI 10.1007/s11033-011-0779-1; Choy A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078077; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Clarke CAL, 2005, J BIOL CHEM, V280, P35337, DOI 10.1074/jbc.M506460200; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Eastman A, 2004, J CELL BIOCHEM, V91, P223, DOI 10.1002/jcb.10699; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Filippov V, 2007, CANCER RES, V67, P7621, DOI 10.1158/0008-5472.CAN-07-0145; Forrest MS, 2005, ENVIRON HEALTH PERSP, V113, P801, DOI 10.1289/ehp.7635; Foster SS, 2012, P NATL ACAD SCI USA, V109, P9953, DOI 10.1073/pnas.1120476109; Gartel AL, 2002, MOL CANCER THER, V1, P639; Gehen SC, 2008, ONCOGENE, V27, P4065, DOI 10.1038/onc.2008.48; Germain M, 1999, J BIOL CHEM, V274, P28379, DOI 10.1074/jbc.274.40.28379; Gewandter JS, 2011, CELL CYCLE, V10, P2561, DOI 10.4161/cc.10.15.16347; Han SW, 2010, CURR CANCER DRUG TAR, V10, P566, DOI 10.2174/156800910791859461; HARPER JW, 1993, CELL, V75, P805; Hassepass I, 2003, J BIOL CHEM, V278, P29824, DOI 10.1074/jbc.M302704200; Hou SY, 2009, CELL BIOL INT, V33, P276, DOI 10.1016/j.cellbi.2008.11.014; HUNTER T, 1994, CELL, V79, P573, DOI 10.1016/0092-8674(94)90543-6; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Kang K, 2011, NEOPLASIA, V13, P1043, DOI 10.1593/neo.11972; Kim GY, 2002, J BIOL CHEM, V277, P29792, DOI 10.1074/jbc.M201299200; Lee AYL, 2012, J BIOL CHEM, V287, P2531, DOI 10.1074/jbc.M111.291104; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Li J, 2005, J BIOL CHEM, V280, P12041, DOI 10.1074/jbc.M412445200; Li L, 2013, APOPTOSIS, V18, P467, DOI 10.1007/s10495-012-0797-z; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Masai H, 2010, ANNU REV BIOCHEM, V79, P89, DOI 10.1146/annurev.biochem.052308.103205; Matsuura K, 2008, J BIOL CHEM, V283, P25485, DOI 10.1074/jbc.M803111200; Okita N, 2013, BBA-GEN SUBJECTS, V1830, P2204, DOI 10.1016/j.bbagen.2012.10.009; Pabla N, 2008, J BIOL CHEM, V283, P6572, DOI 10.1074/jbc.M707568200; Park KS, 2002, BRIT J PHARMACOL, V137, P597, DOI 10.1038/sj.bjp.0704909; Ray D, 2007, CELL CYCLE, V6, P3039, DOI 10.4161/cc.6.24.5104; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Santin AD, 2005, VIROLOGY, V331, P269, DOI 10.1016/j.virol.2004.09.045; Shin EJ, 2012, EMBO REP, V13, P339, DOI 10.1038/embor.2012.3; Sinkkonen ST, 2011, SCI REP-UK, V1, DOI 10.1038/srep00026; Solier S, 2014, CELL MOL LIFE SCI, V71, P2289, DOI 10.1007/s00018-013-1555-2; Solier S, 2009, CELL CYCLE, V8, P1853, DOI 10.4161/cc.8.12.8865; Sorensen CS, 2003, CANCER CELL, V3, P247, DOI 10.1016/S1535-6108(03)00048-5; WEI YQ, 1994, CANCER RES, V54, P4952; Xiao Z, 2003, J BIOL CHEM, V278, P21767, DOI 10.1074/jbc.M300229200; Xu XH, 2001, J BIOL CHEM, V276, P43221, DOI 10.1074/jbc.M104446200; Yamashita A, 2001, GENE DEV, V15, P2215, DOI 10.1101/gad.913001; Yan F, 2009, BIOCHIMIE, V91, P502, DOI 10.1016/j.biochi.2008.12.002; Yang D, 2013, CELL DEATH DIFFER, V20, P235, DOI 10.1038/cdd.2012.113; Yeo EJ, 2006, CANCER RES, V66, P6345, DOI 10.1158/0008-5472.CAN-05-4460; Yu J, 2004, CURR OPIN ONCOL, V16, P19, DOI 10.1097/00001622-200401000-00005; Yuan Z, 2009, CANCER CHEMOTH PHARM, V65, P13, DOI 10.1007/s00280-009-0998-5; Yuan Z, 2009, CANCER SCI, V100, P1757, DOI 10.1111/j.1349-7006.2009.01242.x; Zeng H, 2012, INT J RADIAT ONCOL, V84, pE533, DOI 10.1016/j.ijrobp.2012.06.028; Zhang N, 2012, HUM GENE THER, V23, P837, DOI 10.1089/hum.2011.136; Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019; Zhou B, 2012, MOL BIOL REP, V39, P243, DOI 10.1007/s11033-011-0732-3	64	25	25	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					14927	14944		10.1074/jbc.M115.658419	http://dx.doi.org/10.1074/jbc.M115.658419			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25918161	Green Published, hybrid			2022-12-28	WOS:000356177300012
J	Suwa, Y; Gu, JY; Baranovskiy, AG; Babayeva, ND; Pavlov, YI; Tahirov, TH				Suwa, Yoshiaki; Gu, Jianyou; Baranovskiy, Andrey G.; Babayeva, Nigar D.; Pavlov, Youri I.; Tahirov, Tahir H.			Crystal Structure of the Human Pol alpha B Subunit in Complex with the C-terminal Domain of the Catalytic Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-ALPHA; CYCLE-DEPENDENT PHOSPHORYLATION; ACCESSORY SUBUNITS; ZINC-FINGER; PRIMASE; REPLICATION; DELTA; ZETA; EPSILON; HELICASE	In eukaryoticDNAreplication, shortRNA-DNAhybrid primers synthesized by primase-DNA polymerase alpha (Prim-Pol alpha) are needed to start DNA replication by the replicative DNA poly-merases, Pol delta and Pol epsilon. The C terminus of the Pol alpha catalytic subunit (p180(C)) in complex with the B subunit (p70) regulates the RNA priming and DNA polymerizing activities of Prim-Pol alpha. It tethers Pol alpha and primase, facilitating RNA primer handover from primase to Pol alpha. To understand these regulatory mechanisms and to reveal the details of human Pol alpha organization, we determined the crystal structure of p70 in complex with p180(C). The structured portion of p70 includes a phosphodiesterase (PDE) domain and an oligonucleotide/oligosaccharide binding (OB) domain. The N-terminal domain and the linker connecting it to the PDE domain are disordered in the reported crystal structure. The p180(C) adopts an elongated asymmetric saddle shape, with a three-helix bundle in the middle and zinc-binding modules (Zn1 and Zn2) on each side. The extensive p180(C)-p70 interactions involve 20 hydrogen bonds and a number of hydrophobic interactions resulting in an extended buried surface of 4080 angstrom(2). Importantly, in the structure of the p180(C)-p70 complex with full-length p70, the residues from the N-terminal to the OB domain contribute to interactions with p180(C). The comparative structural analysis revealed both the conserved features and the differences between the human and yeast Pol alpha complexes.	[Suwa, Yoshiaki; Gu, Jianyou; Baranovskiy, Andrey G.; Babayeva, Nigar D.; Pavlov, Youri I.; Tahirov, Tahir H.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Pavlov, Youri I.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Pavlov, Youri I.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Tahirov, TH (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.	ttahirov@unmc.edu	Regan, Clinton/E-6250-2012; Pavlov, Youri/T-7532-2017	Pavlov, Youri/0000-0003-1179-5796; Tahirov, Tahir/0000-0002-1238-0069	National Institutes of Health [R01 GM101167, P41 GM103403]; National Cancer Institute Cancer Center [P30 CA036727]; U.S. Department of Energy [DE-AC0206CH11357]; NATIONAL CANCER INSTITUTE [P30CA036727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101167, P41GM103403] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM101167 (to T. H. T.) and P41 GM103403 and National Cancer Institute Cancer Center Support Grant P30 CA036727. This work was also supported in part by U.S. Department of Energy under Contract DE-AC0206CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ARAKI H, 1991, P NATL ACAD SCI USA, V88, P4601, DOI 10.1073/pnas.88.11.4601; Arezi B, 2000, TRENDS BIOCHEM SCI, V25, P572, DOI 10.1016/S0968-0004(00)01680-7; Baranovskiy AG, 2008, CELL CYCLE, V7, P3026, DOI 10.4161/cc.7.19.6720; Baranovskiy AG, 2015, J BIOL CHEM, V290, P5635, DOI 10.1074/jbc.M114.624742; Baranovskiy AG, 2014, NUCLEIC ACIDS RES, V42, P14013, DOI 10.1093/nar/gku1209; Baranovskiy AG, 2012, J BIOL CHEM, V287, P17281, DOI 10.1074/jbc.M112.351122; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DeLano W.L, PYMOL MOL GRAPHICS S; Dua R, 1998, J BIOL CHEM, V273, P30046, DOI 10.1074/jbc.273.45.30046; Dua R, 1999, J BIOL CHEM, V274, P22283, DOI 10.1074/jbc.274.32.22283; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FOIANI M, 1995, MOL CELL BIOL, V15, P883; FOIANI M, 1994, MOL CELL BIOL, V14, P923, DOI 10.1128/MCB.14.2.923; Gan GN, 2008, CELL RES, V18, P174, DOI 10.1038/cr.2007.117; Garcia JS, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-82; Garcia JS, 2004, NUCLEIC ACIDS RES, V32, P3005, DOI 10.1093/nar/gkh623; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; Giot L, 1997, GENETICS, V146, P1239; Grossi S, 2004, GENE DEV, V18, P992, DOI 10.1101/gad.300004; Heitzer E, 2014, CURR OPIN GENET DEV, V24, P107, DOI 10.1016/j.gde.2013.12.005; Huang H, 2010, J BIOL CHEM, V285, P33475, DOI 10.1074/jbc.M110.156240; Huang H, 2010, J BIOL CHEM, V285, P17112, DOI 10.1074/jbc.M110.116830; Johansson E, 2010, TRENDS BIOCHEM SCI, V35, P339, DOI 10.1016/j.tibs.2010.01.004; Johnson RE, 2012, P NATL ACAD SCI USA, V109, P12455, DOI 10.1073/pnas.1206052109; Kilkenny ML, 2012, J BIOL CHEM, V287, P23740, DOI 10.1074/jbc.M112.368951; Kilkenny ML, 2013, P NATL ACAD SCI USA, V110, P15961, DOI 10.1073/pnas.1311185110; Klinge S, 2009, EMBO J, V28, P1978, DOI 10.1038/emboj.2009.150; Kunkel TA, 2014, NAT STRUCT MOL BIOL, V21, P649, DOI 10.1038/nsmb.2852; Langston LD, 2014, P NATL ACAD SCI USA, V111, P15390, DOI 10.1073/pnas.1418334111; Lawrence CW, 2004, ADV PROTEIN CHEM, V69, P167; Lee YS, 2014, P NATL ACAD SCI USA, V111, P2954, DOI 10.1073/pnas.1324001111; Loeb LA, 2008, NAT REV GENET, V9, P594, DOI 10.1038/nrg2345; Makarova AV, 2012, NUCLEIC ACIDS RES, V40, P11618, DOI 10.1093/nar/gks948; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; Mizuno T, 1999, MOL CELL BIOL, V19, P7886; NASHEUER HP, 1991, J BIOL CHEM, V266, P7893; Netz DJA, 2012, NAT CHEM BIOL, V8, P125, DOI 10.1038/nchembio.721; Northam MR, 2014, NUCLEIC ACIDS RES, V42, P290, DOI 10.1093/nar/gkt830; Northam MR, 2010, GENETICS, V184, P27, DOI 10.1534/genetics.109.107482; Nuutinen T, 2008, NUCLEIC ACIDS RES, V36, P5102, DOI 10.1093/nar/gkn497; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pavlov YI, 2006, CURR BIOL, V16, P202, DOI 10.1016/j.cub.2005.12.002; Pavlov YI, 2010, MUTAT RES-FUND MOL M, V685, P45, DOI 10.1016/j.mrfmmm.2009.08.002; Pellegrini Luca, 2012, Subcell Biochem, V62, P157, DOI 10.1007/978-94-007-4572-8_9; Preston BD, 2010, SEMIN CANCER BIOL, V20, P281, DOI 10.1016/j.semcancer.2010.10.009; Reijns MAM, 2015, NATURE, V518, P502, DOI 10.1038/nature14183; Sengupta S, 2013, CURR BIOL, V23, P543, DOI 10.1016/j.cub.2013.02.011; Shevchuk NA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh014; Tahirov TH, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-11; Uchiyama M, 2004, MOL CELL BIOL, V24, P7419, DOI 10.1128/MCB.24.17.7419-7434.2004; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Weeks SD, 2007, PROTEIN EXPRES PURIF, V53, P40, DOI 10.1016/j.pep.2006.12.006; Zhang YB, 2014, J BIOL CHEM, V289, P22021, DOI 10.1074/jbc.M114.570333; Zhou B, 2012, J BIOL CHEM, V287, P26854, DOI 10.1074/jbc.M112.363655; Zhou JQ, 1997, NUCLEIC ACIDS RES, V25, P1094, DOI 10.1093/nar/25.6.1094	57	26	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14328	14337		10.1074/jbc.M115.649954	http://dx.doi.org/10.1074/jbc.M115.649954			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25847248	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000355754600006
J	Koo, J; Wu, XY; Mao, ZX; Khuri, FR; Sun, SY				Koo, Junghui; Wu, Xiaoyun; Mao, Zixu; Khuri, Fadlo R.; Sun, Shi-Yong			Rictor Undergoes Glycogen Synthase Kinase 3 (GSK3)-dependent, FBXW7-mediated Ubiquitination and Proteasomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MTOR COMPLEX 2; LUNG-CANCER CELLS; TUMOR-SUPPRESSOR; C-MYC; DEPENDENT DEGRADATION; PHOSPHORYLATION; FBW7; AKT; APOPTOSIS; DIFFERENTIATION	Rictor, an essential component of mTOR complex 2 (mTORC2), plays a pivotal role in regulating mTOR signaling and other biological functions. Posttranslational regulation of rictor (e.g. via degradation) and its underlying mechanism are largely undefined and thus are the focus of this study. Chemical inhibition of the proteasome increased rictor ubiquitination and levels. Consistently, inhibition of FBXW7 with various genetic means including knockdown, knock-out, and enforced expression of a dominant-negative mutant inhibited rictor ubiquitination and increased rictor levels, whereas enforced expression of FBXW7 decreased rictor stability and levels. Moreover, we detected an interaction between FBXW7 and rictor. Hence, rictor is degraded through an FBXW7-mediated ubiquitination/proteasome mechanism. We show that this process is dependent on glycogen synthase kinase 3 (GSK3): GSK3 was associated with rictor and directly phosphorylated the Thr-1695 site in a putative CDC4 phospho-degron motif of rictor; mutation of this site impaired the interaction between rictor and FBXW7, decreased rictor ubiquitination, and increased rictor stability. Finally, enforced activation of Akt enhanced rictor levels and increasedmTORC2activity as evidenced by increased formation of mTORC2 and elevated phosphorylation of Akt, SGK1, and PKC alpha. Hence we suggest that PI3K/Akt signaling may positively regulate mTORC2 signaling, likely through suppressing GSK3-dependent rictor degradation.	[Koo, Junghui; Wu, Xiaoyun; Khuri, Fadlo R.; Sun, Shi-Yong] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Mao, Zixu] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; [Mao, Zixu] Winship Canc Inst, Atlanta, GA 30322 USA	Emory University; Emory University	Sun, SY (corresponding author), Emory Univ, Sch Med, 1365-C Clifton Rd NE,C3088, Atlanta, GA 30322 USA.	ssun@emory.edu	Khuri, Fadlo R./AAU-4942-2020; Regan, Clinton/E-6250-2012	Khuri, Fadlo R./0000-0002-8638-7618; 	National Institutes of Health [R01 CA118450, R01 CA160522]; NATIONAL CANCER INSTITUTE [R01CA160522, R01CA118450] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant R01 CA118450 ( to S.-Y. S.) and R01 CA160522 ( to S.-Y. S.).	Chen CH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001731; Chen SZ, 2011, CANCER RES, V71, P6270, DOI 10.1158/0008-5472.CAN-11-0838; Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09; Elrod HA, 2007, MOL CANCER THER, V6, P2029, DOI 10.1158/1535-7163.MCT-07-0004; Fu L, 2009, CANCER RES, V69, P8967, DOI 10.1158/0008-5472.CAN-09-2190; Gao DM, 2010, MOL CELL, V39, P797, DOI 10.1016/j.molcel.2010.08.016; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2009, CANCER CELL, V15, P148, DOI 10.1016/j.ccr.2008.12.017; Guo Z, 2012, BIOCHEM BIOPH RES CO, V418, P426, DOI 10.1016/j.bbrc.2012.01.054; Hagan GN, 2008, MOL CELL BIOL, V28, P4215, DOI 10.1128/MCB.00867-07; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Hoeller D, 2009, NATURE, V458, P438, DOI 10.1038/nature07960; Kanei-Ishii C, 2008, J BIOL CHEM, V283, P30540, DOI 10.1074/jbc.M804340200; Kitagawa K, 2009, ONCOGENE, V28, P2393, DOI 10.1038/onc.2009.111; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lee K, 2012, J EXP MED, V209, P713, DOI 10.1084/jem.20111470; Liu XG, 2004, JNCI-J NATL CANCER I, V96, P1769, DOI 10.1093/jnci/djh322; Mao JH, 2004, NATURE, V432, P775, DOI 10.1038/nature03155; Mao JH, 2008, SCIENCE, V321, P1499, DOI 10.1126/science.1162981; McDonald PC, 2008, CANCER RES, V68, P1618, DOI 10.1158/0008-5472.CAN-07-5869; Oh WJ, 2011, CELL CYCLE, V10, P2305, DOI 10.4161/cc.10.14.16586; Roulin D, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-57; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Soucy Teresa A, 2010, Genes Cancer, V1, P708, DOI 10.1177/1947601910382898; Sparks CA, 2010, ONCOGENE, V29, P3733, DOI 10.1038/onc.2010.139; Sun SY, 1999, ONCOGENE, V18, P2357, DOI 10.1038/sj.onc.1202543; Treins C, 2010, ONCOGENE, V29, P1003, DOI 10.1038/onc.2009.401; Wang ZW, 2012, FEBS LETT, V586, P1409, DOI 10.1016/j.febslet.2012.03.017; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217	31	48	49	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					14120	14129		10.1074/jbc.M114.633057	http://dx.doi.org/10.1074/jbc.M114.633057			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25897075	Green Published, hybrid			2022-12-28	WOS:000355313000040
J	Artinian, N; Cloninger, C; Holmes, B; Benavides-Serrato, A; Bashir, T; Gera, J				Artinian, Nicholas; Cloninger, Cheri; Holmes, Brent; Benavides-Serrato, Angelica; Bashir, Tariq; Gera, Joseph			Phosphorylation of the Hippo Pathway Component AMOTL2 by the mTORC2 Kinase Promotes YAP Signaling, Resulting in Enhanced Glioblastoma Growth and Invasiveness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YES-ASSOCIATED PROTEIN-1; TUMOR-SUPPRESSOR; MOLECULAR PATHOLOGY; COMPLEX; GLIOMAS; ONCOPROTEIN; INHIBITION; RESISTANCE; REGULATOR; CANCER	The mechanistic target of rapamycin (mTOR) and Hippo signaling pathways are two major signaling cascades that coordinately regulate cell growth and proliferation. Dysregulation of these pathways plays a critical role in gliomagenesis. Recent reports have provided evidence of cross-talk between the mTOR and Hippo pathways; however, a complete description of the signaling relationships between these pathways remains to be elucidated. Utilizing a gene-trapping strategy in a mouse glioma model, we report the identification of AMOTL2 as a candidate substrate for mTORC2. AMOTL2 is phosphorylated at serine 760 by mTORC2. Mutation of AMOTL2 mimicking constitutive Ser(760) phosphorylation blocks its ability to bind and repress YAP leading to increased relative expression of known YAP gene targets. Moreover, overexpression of AMOTL2 or a non-phosphorylatable AMOTL2-S760A mutant inhibited YAP-induced transcription, foci formation, growth, and metastatic properties, whereas overexpression of a phosphomimetic AMOTL2-S760E mutant negated these repressive effects of AMOTL2 in glioblastoma (GBM) cells in vitro. Similar effects on xenograft growth were observed in GBM cells expressing these AMOTL2 Ser(760) mutants. YAP was also shown to be required for Rictor-mediated GBM growth and survival. Finally, an analysis of mTORC2/AMOTL2/YAP activities in primary GBM samples supported the clinical relevance of this signaling cascade, and we propose that pharmacological agents cotargeting these regulatory circuits may hold therapeutic potential.	[Artinian, Nicholas; Bashir, Tariq; Gera, Joseph] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Gera, Joseph] Univ Calif Los Angeles, Jonnson Comprehens Canc Ctr, Los Angeles, CA 90048 USA; [Gera, Joseph] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90048 USA; [Artinian, Nicholas; Cloninger, Cheri; Holmes, Brent; Benavides-Serrato, Angelica; Bashir, Tariq; Gera, Joseph] Greater Los Angeles Vet Affairs Healthcare Syst, Dept Res & Dev, Los Angeles, CA 91343 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Gera, J (corresponding author), 16111 Plummer St 151 Bldg 1,Rm C111A, Los Angeles, CA 91343 USA.	jgera@mednet.ucla.edu	Regan, Clinton/E-6250-2012	Holmes, Brent/0000-0002-2768-2991; Gera, Joseph/0000-0002-2908-6894	National Institutes of Health [R01CA168700]; Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [R01CA168700] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002665] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA168700. This work was also supported by the Department of Veterans Affairs. The authors declare that they have no conflicts of interest with the contents of this article.	Bashir T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047741; Benavides-Serrato Angelica, 2014, Genes Cancer, V5, P393; Chan SW, 2011, J BIOL CHEM, V286, P7018, DOI 10.1074/jbc.C110.212621; Cloninger C, 2011, MOL CANCER THER, V10, P2244, DOI 10.1158/1535-7163.MCT-11-0478; Cloughesy TF, 2014, ANNU REV PATHOL-MECH, V9, P1, DOI 10.1146/annurev-pathol-011110-130324; Cornu M, 2013, CURR OPIN GENET DEV, V23, P53, DOI 10.1016/j.gde.2012.12.005; Csibi A, 2012, NAT CELL BIOL, V14, P1244, DOI 10.1038/ncb2634; Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004; Dunn GP, 2012, GENE DEV, V26, P756, DOI 10.1101/gad.187922.112; Fernandez A, 2012, ONCOGENE, V31, P1923, DOI 10.1038/onc.2011.379; Grzmil M, 2013, BBA-PROTEINS PROTEOM, V1834, P1371, DOI 10.1016/j.bbapap.2013.01.041; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Holmes B, 2012, CELL SIGNAL, V24, P309, DOI 10.1016/j.cellsig.2011.09.015; Hong WJ, 2012, SEMIN CELL DEV BIOL, V23, P785, DOI 10.1016/j.semcdb.2012.05.004; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Jo OD, 2008, J BIOL CHEM, V283, P23274, DOI 10.1074/jbc.M801185200; Kamnasaran D, 2007, P NATL ACAD SCI USA, V104, P8053, DOI 10.1073/pnas.0611669104; Kim SG, 2013, MOL CELLS, V35, P463, DOI 10.1007/s10059-013-0138-2; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lau YKI, 2008, CANCER RES, V68, P5733, DOI 10.1158/0008-5472.CAN-08-0190; Liang N, 2014, J EXP MED, V211, P2249, DOI 10.1084/jem.20140341; Liu YC, 2015, TUMOR BIOL, V36, P2223, DOI 10.1007/s13277-015-3297-2; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Masri J, 2007, CANCER RES, V67, P11712, DOI 10.1158/0008-5472.CAN-07-2223; Masui K, 2012, NEUROPATH APPL NEURO, V38, P271, DOI 10.1111/j.1365-2990.2011.01238.x; Miller E, 2012, CHEM BIOL, V19, P955, DOI 10.1016/j.chembiol.2012.07.005; Mo JS, 2014, EMBO REP, V15, P642, DOI 10.15252/embr.201438638; Modena P, 2006, J CLIN ONCOL, V24, P5223, DOI 10.1200/JCO.2006.06.3701; Mok J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000482; Orr BA, 2011, J NEUROPATH EXP NEUR, V70, P568, DOI 10.1097/NEN.0b013e31821ff8d8; Paramasivam M, 2011, MOL BIOL CELL, V22, P3725, DOI 10.1091/mbc.E11-04-0300; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Striedinger K, 2008, NEOPLASIA, V10, P1204, DOI 10.1593/neo.08642; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; SUZUMURA A, 1984, BRAIN RES, V324, P379, DOI 10.1016/0006-8993(84)90054-4; Tanaka K, 2011, CANCER DISCOV, V1, P524, DOI 10.1158/2159-8290.CD-11-0124; Tumaneng K, 2012, NAT CELL BIOL, V14, P1322, DOI 10.1038/ncb2615; Urh M, 2009, METHOD ENZYMOL, V463, P417, DOI 10.1016/S0076-6879(09)63026-3; Wang WQ, 2011, J BIOL CHEM, V286, P4364, DOI 10.1074/jbc.C110.205401; Wu Si-Han, 2014, Cancer Biology Medicine, V11, P255, DOI 10.7497/j.issn.2095-3941.2014.04.004; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	46	65	69	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19387	19401		10.1074/jbc.M115.656587	http://dx.doi.org/10.1074/jbc.M115.656587			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	25998128	Green Published, hybrid			2022-12-28	WOS:000359364600001
J	Lichnerova, K; Kaniakova, M; Park, SP; Skrenkova, K; Wang, YX; Petralia, RS; Suh, YH; Horak, M				Lichnerova, Katarina; Kaniakova, Martina; Park, Seung Pyo; Skrenkova, Kristyna; Wang, Ya-Xian; Petralia, Ronald S.; Suh, Young Ho; Horak, Martin			Two N-glycosylation Sites in the GluN1 Subunit Are Essential for Releasing N-methyl-D-aspartate (NMDA) Receptors from the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-TERMINAL DOMAIN; CELL-SURFACE EXPRESSION; ER RETENTION SIGNAL; FUNCTIONAL EXPRESSION; SUBTYPE-DEPENDENCE; NR2 SUBUNITS; TRAFFICKING; BINDING; MODULATION; DELIVERY	NMDA receptors (NMDARs) comprise a subclass of neurotransmitter receptors whose surface expression is regulated at multiple levels, including processing in the endoplasmic reticulum (ER), intracellular trafficking via the Golgi apparatus, internalization, recycling, anddegradation. With respect to early processing, NMDARs are regulated by the availability of GluN subunits within the ER, the presence of ER retention and export signals, and post translational modifications, including phosphorylation and palmitoylation. However, the role of N-glycosylation, one of the most common posttranslational modifications, in regulating NMDAR processing has not been studied in detail. Using biochemistry, confocal and electron microscopy, and electrophysiology in conjunction with a lentivirus-based molecular replacement strategy, we found that NMDARs are released from the ER only when two asparagine residues in the GluN1 subunit (Asn-203 and Asn-368) are N-glycosylated. Although the GluN2A and GluN2B subunits are also N-glycosylated, their N-glycosylation sites do not appear to be essential for surface delivery of NMDARs. Furthermore, we found that removing N-glycans from native NMDAR saltered the receptor affinity for glutamate. Our results suggest a novel mechanism by which neurons ensure that postsynaptic membranes contain sufficient numbers of functional NMDARs.	[Lichnerova, Katarina; Kaniakova, Martina; Skrenkova, Kristyna; Horak, Martin] Acad Sci Czech Republ Vvi, Inst Physiol, Prague 14220 4, Czech Republic; [Lichnerova, Katarina] Charles Univ Prague, Dept Physiol, Fac Sci, Prague 12843 2, Czech Republic; [Park, Seung Pyo; Suh, Young Ho] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Neurosci Res Inst, Seoul 110799, South Korea; [Wang, Ya-Xian; Petralia, Ronald S.] NIDCD, Adv Imaging Core, NIH, Bethesda, MD 20892 USA	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Charles University Prague; Seoul National University (SNU); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Suh, YH (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Sci, 103 Daehak Ro, Seoul 110799, South Korea.	suhyho@snu.ac.kr; mhorak@biomed.cas.cz	Horak, Martin/F-9819-2010; Suh, Young Ho/AAJ-6405-2021; Kaniakova, Martina/C-2593-2012; Skrenkova, Kristyna/Q-1046-2017; Rehakova, Kristyna/AAH-3522-2019	Horak, Martin/0000-0002-4359-051X; Suh, Young Ho/0000-0003-3979-1615; Kaniakova, Martina/0000-0002-7956-3265; Skrenkova, Kristyna/0000-0003-2110-6587; 	Grant Agency of the Czech Republic [14-02219S]; Marie Curie International Reintegration Grant [PIRG-GA-2010-276827]; Grant Agency of Charles University [1520-243-253483]; Research Project of the AS CR [RVO:67985823]; BIOCEV/Biotechnology and Biomedicine Center of Academy of Sciences; Charles University in Vestec; European Regional Development Fund; NIDCD/National Institutes of Health; National Research Foundation of Korea - Ministry of Science, ICT, and Future Planning [2011-0011694]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZICDC000081] Funding Source: NIH RePORTER	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Marie Curie International Reintegration Grant(European Commission); Grant Agency of Charles University; Research Project of the AS CR; BIOCEV/Biotechnology and Biomedicine Center of Academy of Sciences; Charles University in Vestec; European Regional Development Fund(European Commission); NIDCD/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Research Foundation of Korea - Ministry of Science, ICT, and Future Planning; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by project 14-02219S from the Grant Agency of the Czech Republic (to M. H., K. L., M. K., and K. S.), Marie Curie International Reintegration Grant PIRG-GA-2010-276827 (to M. H.), Grant Agency of Charles University Grant 1520-243-253483 (to K. L.), and the Research Project of the AS CR RVO:67985823 and BIOCEV/Biotechnology and Biomedicine Center of Academy of Sciences and Charles University in Vestec (project supported by the European Regional Development Fund (to M. H., K. L., and K. S.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Intramural Research Program of the NIDCD/National Institutes of Health.; Supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Science, ICT, and Future Planning (2011-0011694). To whom correspondence may be addressed: Dept. of Biomedical Sciences, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul 110-799, South Korea. E-mail: suhyho@snu.ac.kr.	Alvarez VA, 2007, J NEUROSCI, V27, P7365, DOI 10.1523/JNEUROSCI.0956-07.2007; Borschel WF, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1512; Chazot PL, 1997, J NEUROCHEM, V68, P507; Chazot PL, 1995, MOL MEMBR BIOL, V12, P331, DOI 10.3109/09687689509072435; Chen NS, 1999, J NEUROSCI, V19, P6844, DOI 10.1523/JNEUROSCI.19-16-06844.1999; Clark RAC, 1998, J NEUROCHEM, V70, P2594; Copits BA, 2014, J PHYSIOL-LONDON, V592, P2079, DOI 10.1113/jphysiol.2013.269597; Everts I, 1997, MOL PHARMACOL, V52, P861, DOI 10.1124/mol.52.5.861; Freeze HH, 2006, NAT REV GENET, V7, P537, DOI 10.1038/nrg1894; Fukaya M, 2003, P NATL ACAD SCI USA, V100, P4855, DOI 10.1073/PNAS.0830996100; Gleichman AJ, 2012, J NEUROSCI, V32, P11082, DOI 10.1523/JNEUROSCI.0064-12.2012; Horak M, 2006, NEUROSCIENCE, V137, P93, DOI 10.1016/j.neuroscience.2005.08.058; Horak M, 2008, J NEUROSCI, V28, P3500, DOI 10.1523/JNEUROSCI.5239-07.2008; Horak M, 2009, J BIOL CHEM, V284, P9683, DOI 10.1074/jbc.M807050200; Huh KH, 1999, J BIOL CHEM, V274, P151, DOI 10.1074/jbc.274.1.151; Kaniakova M, 2012, J NEUROCHEM, V123, P385, DOI 10.1111/jnc.12002; Kaniakova M, 2012, J BIOL CHEM, V287, P26423, DOI 10.1074/jbc.M112.339085; Karakas E, 2014, SCIENCE, V344, P992, DOI 10.1126/science.1251915; Kenny AV, 2009, J BIOL CHEM, V284, P324, DOI 10.1074/jbc.M804023200; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lichnerova K, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00375; Luo JH, 2002, NEUROPHARMACOLOGY, V42, P306, DOI 10.1016/S0028-3908(01)00188-5; McIlhinney RAJ, 1998, NEUROPHARMACOLOGY, V37, P1355, DOI 10.1016/S0028-3908(98)00121-X; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Okabe S, 1999, J NEUROSCI, V19, P7781; Penn AC, 2008, EMBO J, V27, P3056, DOI 10.1038/emboj.2008.222; Petralia RS, 2010, NEUROSCIENCE, V167, P68, DOI 10.1016/j.neuroscience.2010.01.022; Petralia RS, 2009, FRONT NEUROSCI, P149; Petralia RS, 1999, METH MOL B, V128, P73; Prybylowski K, 2005, NEURON, V47, P845, DOI 10.1016/j.neuron.2005.08.016; Prybylowski K, 2002, J NEUROSCI, V22, P8902; Qiu S, 2009, J BIOL CHEM, V284, P20285, DOI 10.1074/jbc.M109.004960; Sanz-Clemente A, 2013, NEUROSCIENTIST, V19, P62, DOI 10.1177/1073858411435129; Schluter OM, 2006, NEURON, V51, P99, DOI 10.1016/j.neuron.2006.05.016; Scott DB, 2001, J NEUROSCI, V21, P3063, DOI 10.1523/JNEUROSCI.21-09-03063.2001; She K, 2012, J BIOL CHEM, V287, P27432, DOI 10.1074/jbc.M112.345108; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Storey GP, 2011, J NEUROSCI, V31, P6311, DOI 10.1523/JNEUROSCI.5553-10.2011; Taylor EW, 2014, J NEUROSCI, V34, P10, DOI 10.1523/JNEUROSCI.4761-12.2014; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Tucholski J, 2013, SCHIZOPHR RES, V146, P177, DOI 10.1016/j.schres.2013.01.031; Vagin O, 2009, AM J PHYSIOL-RENAL, V296, pF459, DOI 10.1152/ajprenal.90340.2008; Yuan HJ, 2009, J NEUROSCI, V29, P12045, DOI 10.1523/JNEUROSCI.1365-09.2009; Zheng CY, 2015, BIOCHEM J, V465, P471, DOI 10.1042/BJ20140806; Zhu SJ, 2013, NAT STRUCT MOL BIOL, V20, P477, DOI 10.1038/nsmb.2522	45	37	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18379	18390		10.1074/jbc.M115.656546	http://dx.doi.org/10.1074/jbc.M115.656546			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26045554	hybrid, Green Published			2022-12-28	WOS:000358512100011
J	Lin, S; Ikegami, M; Moon, C; Naren, AP; Shannon, JM				Lin, Sui; Ikegami, Machiko; Moon, Changsuk; Naren, Anjaparavanda P.; Shannon, John M.			Lysophosphatidylcholine Acyltransferase 1 (LPCAT1) Specifically Interacts with Phospholipid Transfer Protein StarD10 to Facilitate Surfactant Phospholipid Trafficking in Alveolar Type II Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLCHOLINE TRANSFER PROTEIN; LIPID-TRANSFER; CRYSTAL-STRUCTURE; ACYL-COA; MEMBRANE-PROTEIN; LUNG SURFACTANT; TRANSPORT; IDENTIFICATION; METABOLISM; EXPRESSION	Pulmonary surfactant, a mixture of proteins and phospholipids, plays an important role in facilitating gas exchange by maintaining alveolar stability. Saturated phosphatidylcholine (SatPC), the major component of surfactant, is synthesized both de novo and by the remodeling of unsaturated phosphatidylcholine (PC) by lyso-PC acyltransferase 1 (LPCAT1). After synthesis in the endoplasmic reticulum, SatPC is routed to lamellar bodies (LBs) for storage prior to secretion. The mechanism by which SatPC is transported to LB is not understood. The specificity of LPCAT1 for lyso-PC as an acyl acceptor suggests that formation of SatPC via LPCAT1 reacylation is a final step in SatPC synthesis prior to transport. We hypothesized that LPCAT1 forms a transient complex with SatPC and specific phospholipid transport protein(s) to initiate trafficking of SatPC from the endoplasmic reticulum to the LB. Herein we have assessed the ability of different StarD proteins to interact with LPCAT1. We found that LPCAT1 interacts with StarD10, that this interaction is direct, and that amino acids 79-271 of LPCAT1 and the steroidogenic acute regulatory protein-related lipid transfer (START) domain of START domain-containing protein 10 (StarD10) are sufficient for this interaction. The role of StarD10 in trafficking of phospholipid to LB was confirmed by the observation that knockdown of StarD10 significantly reduced transport of phospholipid to LB. LPCAT1 also interacted with one isoform of StarD7 but showed no interaction with StarD2/PC transfer protein.	[Lin, Sui; Ikegami, Machiko; Shannon, John M.] Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Cincinnati, OH 45229 USA; [Moon, Changsuk; Naren, Anjaparavanda P.] Cincinnati Childrens Hosp Med Ctr, Div Pulm Med, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Shannon, JM (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Cincinnati, OH 45229 USA.	john.shannon@cchmc.org	Regan, Clinton/E-6250-2012		National Institutes of Health [HL098319, DK080834, DK093045]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080834, R01DK093045, R01DK058545] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL098319 (to J. M. S.), DK080834 (to A. P. N.), and DK093045 (to A. P. N.). The authors declare no conflicts of interest with the contents of this article.	Agassandian M, 2010, FASEB J, V24, P1271, DOI 10.1096/fj.09-136044; Alpy F, 2005, J CELL SCI, V118, P2791, DOI 10.1242/jcs.02485; Alpy F, 2014, BIOCHIMIE, V96, P85, DOI 10.1016/j.biochi.2013.09.015; Anantharaman V, 2002, GENOME BIOL, V3; AVERY ME, 1959, AMA J DIS CHILD, V97, P517, DOI 10.1001/archpedi.1959.02070010519001; BANKAITIS VA, 1990, NATURE, V347, P561, DOI 10.1038/347561a0; Bankaitis VA, 2010, TRENDS BIOCHEM SCI, V35, P150, DOI 10.1016/j.tibs.2009.10.008; Besnard V, 2010, AM J PHYSIOL-LUNG C, V298, pL646, DOI 10.1152/ajplung.00409.2009; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bridges JP, 2010, J CLIN INVEST, V120, P1736, DOI 10.1172/JCI38061; Butler PL, 2010, J BIOL CHEM, V285, P6246, DOI 10.1074/jbc.M109.017350; CESARONE CF, 1979, ANAL BIOCHEM, V100, P188, DOI 10.1016/0003-2697(79)90131-3; Chen XN, 2006, P NATL ACAD SCI USA, V103, P11724, DOI 10.1073/pnas.0604946103; CHEVALIER G, 1972, ANAT RECORD, V174, P289, DOI 10.1002/ar.1091740303; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Conkright JJ, 2010, AM J RESP CELL MOL, V42, P181, DOI 10.1165/rcmb.2009-0058OC; DENBREEJEN JN, 1989, BIOCHIM BIOPHYS ACTA, V1002, P277, DOI 10.1016/0005-2760(89)90341-X; Ellis Bryon, 2012, World J Biol Chem, V3, P159, DOI 10.4331/wjbc.v3.i7.159; Favale NO, 2010, BBA-MOL CELL BIOL L, V1801, P1184, DOI 10.1016/j.bbalip.2010.07.003; Feng L, 2000, BIOCHEMISTRY-US, V39, P15399, DOI 10.1021/bi001076a; Fisher AB, 2005, J LIPID RES, V46, P1248, DOI 10.1194/jlr.M400499-JLR200; Friedman JS, 2010, P NATL ACAD SCI USA, V107, P15523, DOI 10.1073/pnas.1002897107; Goss V, 2013, BBA-MOL CELL BIOL L, V1831, P448, DOI 10.1016/j.bbalip.2012.11.009; Grupp K, 2013, MOL ONCOL, V7, P1001, DOI 10.1016/j.molonc.2013.07.009; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Harayama T, 2014, CELL METAB, V20, P295, DOI 10.1016/j.cmet.2014.05.019; HAWCO MW, 1981, J APPL PHYSIOL, V51, P509, DOI 10.1152/jappl.1981.51.2.509; Hishikawa D, 2013, FASEB J, V27, P5131, DOI 10.1096/fj.13-237941; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; Horibata Y, 2010, J BIOL CHEM, V285, P7358, DOI 10.1074/jbc.M109.056960; Ito M, 2013, BBA-MOL CELL BIOL L, V1831, P459, DOI 10.1016/j.bbalip.2012.11.008; Kanno K, 2007, J BIOL CHEM, V282, P30728, DOI 10.1074/jbc.M703745200; KAPLAN MR, 1985, J CELL BIOL, V101, P441, DOI 10.1083/jcb.101.2.441; KENNEDY EP, 1961, FED PROC, V20, P934; LANDS WEM, 1958, J BIOL CHEM, V231, P883; Lev S, 2010, NAT REV MOL CELL BIO, V11, P739, DOI 10.1038/nrm2971; Lo B, 2008, J IMMUNOL, V180, P881, DOI 10.4049/jimmunol.180.2.881; Mansilla F, 2009, J MOL MED, V87, P85, DOI 10.1007/s00109-008-0409-0; MASON RJ, 1984, BIOCHIM BIOPHYS ACTA, V794, P392, DOI 10.1016/0005-2760(84)90005-5; MASON RJ, 1976, J LIPID RES, V17, P281; Moessinger C, 2011, J BIOL CHEM, V286, P21330, DOI 10.1074/jbc.M110.202424; Mulugeta S, 2002, J BIOL CHEM, V277, P22147, DOI 10.1074/jbc.M201812200; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; Olayioye MA, 2005, J BIOL CHEM, V280, P27436, DOI 10.1074/jbc.M413330200; Olayioye MA, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M701990200; Osanai K, 2006, RESPIROLOGY, V11, pS70, DOI 10.1111/j.1440-1843.2006.00813.x; Osanai K, 2001, BBA-MOL CELL BIOL L, V1531, P222, DOI 10.1016/S1388-1981(01)00104-4; Osanai K, 1998, AM J RESP CELL MOL, V19, P929, DOI 10.1165/ajrcmb.19.6.3292; Perez-Gil J, 2010, PHYSIOLOGY, V25, P132, DOI 10.1152/physiol.00006.2010; PISON U, 1989, AM REV RESPIR DIS, V140, P1033, DOI 10.1164/ajrccm/140.4.1033; POSSMAYER F, 1984, CAN J BIOCHEM CELL B, V62, P1121, DOI 10.1139/o84-146; Possmayer F, 2004, FETAL NEONATAL PHYSL, V2, P1014, DOI DOI 10.1016/B978-0-7216-9654-6.50104-1; Prinz WA, 2010, CELL, V143, P870, DOI 10.1016/j.cell.2010.11.031; Rice WR, 2002, AM J PHYSIOL-LUNG C, V283, pL256, DOI 10.1152/ajplung.00302.2001; Roderick SL, 2002, NAT STRUCT BIOL, V9, P507, DOI 10.1038/nsb812; Romanowski MJ, 2002, P NATL ACAD SCI USA, V99, P6949, DOI 10.1073/pnas.052140699; ROONEY SA, 1985, AM REV RESPIR DIS, V131, P439; Schmidt R, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-55; Sha BD, 1998, NATURE, V391, P506, DOI 10.1038/35179; SLEIGHT RG, 1984, J CELL BIOL, V99, P742, DOI 10.1083/jcb.99.2.742; Soccio RE, 2003, J BIOL CHEM, V278, P22183, DOI 10.1074/jbc.R300003200; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Soupene E, 2008, P NATL ACAD SCI USA, V105, P88, DOI 10.1073/pnas.0709737104; Soupene E, 2012, BMC BIOCHEM, V13, DOI 10.1186/1471-2091-13-8; Stocker A, 2002, STRUCTURE, V10, P1533, DOI 10.1016/S0969-2126(02)00884-5; Toulmay A, 2011, CURR OPIN CELL BIOL, V23, P458, DOI 10.1016/j.ceb.2011.04.006; Tsujishita Y, 2000, NAT STRUCT BIOL, V7, P408; van Helvoort A, 1999, P NATL ACAD SCI USA, V96, P11501, DOI 10.1073/pnas.96.20.11501; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Veldhuizen R, 2004, SUB CELL BIOCHEM, V37, P359; Voelker DR, 2003, J LIPID RES, V44, P441, DOI 10.1194/jlr.R200020-JLR200; VOORHOUT WF, 1993, MICROSC RES TECHNIQ, V26, P366, DOI 10.1002/jemt.1070260504; Weibrecht I, 2010, EXPERT REV PROTEOMIC, V7, P401, DOI 10.1586/EPR.10.10; WIRTZ KWA, 1991, ANNU REV BIOCHEM, V60, P73, DOI 10.1146/annurev.biochem.60.1.73; Wu MS, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-44; Yamano G, 2001, FEBS LETT, V508, P221, DOI 10.1016/S0014-5793(01)03056-3; Zhang M, 2002, J BIOL CHEM, V277, P33300, DOI 10.1074/jbc.M200003200; Zou CB, 2011, J BIOL CHEM, V286, P28019, DOI 10.1074/jbc.M111.253385	78	16	17	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18559	18574		10.1074/jbc.M115.666701	http://dx.doi.org/10.1074/jbc.M115.666701			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26048993	Green Published, hybrid			2022-12-28	WOS:000358512100027
J	Chattopadhyay, MK; Keembiyehetty, CN; Chen, WP; Tabor, H				Chattopadhyay, Manas K.; Keembiyehetty, Chithra N.; Chen, Weiping; Tabor, Herbert			Polyamines Stimulate the Level of the sigma(38) Subunit (RpoS) of Escherichia coli RNA Polymerase, Resulting in the Induction of the Glutamate Decarboxylase-dependent Acid Response System via the gadE Regulon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STATIONARY-PHASE; GENE-EXPRESSION; SHIGELLA-FLEXNERI; RESISTANCE; STRESS; PROTEIN; GROWTH; IDENTIFICATION; TRANSLATION; MECHANISMS	To study the physiological roles of polyamines, we carried out a global microarray analysis on the effect of adding polyamines to an Escherichia coli mutant that lacks polyamines because of deletions in the genes in the polyamine biosynthetic pathway. Previously, we have reported that the earliest response to polyamine addition is the increased expression of the genes for the glutamate-dependent acid resistance system (GDAR). We also presented preliminary evidence for the involvement of rpoS and gadE regulators. In the current study, further confirmation of the regulatory roles of rpoS and gadE is shown by a comparison of genome-wide expression profiling data from a series of microarrays comparing the genes induced by polyamine addition to polyamine-free rpoS(+)/gadE(+) cells with genes induced by polyamine addition to polyamine-free Delta rpoS/gadE(+) and rpoS6+/Delta gadE cells. The results indicate that most of the genes in the E. coli GDAR system that are induced by polyamines require rpoS and gadE. Our data also show that gadE is the main regulator of GDAR and other acid fitness island genes. Both polyamines and rpoS are necessary for the expression of gadE gene from the three promoters of gadE (P1, P2, and P3). The most important effect of polyamine addition is the very rapid increase in the level of RpoS sigma factor. Our current hypothesis is that polyamines increase the level of RpoS protein and that this increased RpoS level is responsible for the stimulation of gadE expression, which in turn induces the GDAR system in E. coli.	[Chattopadhyay, Manas K.; Tabor, Herbert] NIDDK, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA; [Keembiyehetty, Chithra N.; Chen, Weiping] NIDDK, Genom Core Facil, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Chattopadhyay, MK (corresponding author), NIDDK, NIH, 8 Ctr Dr,Bldg 8,Rm 219, Bethesda, MD 20892 USA.	manasc@intra.niddk.nih.gov	Chen, Weiping/C-9550-2011		National Institutes of Health NIDDK Intramural Research Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK024709] Funding Source: NIH RePORTER	National Institutes of Health NIDDK Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health NIDDK Intramural Research Program. The authors declare that they have no conflicts of interest with the contents of this article.	Atlung T, 2002, MOL GENET GENOMICS, V266, P873, DOI 10.1007/s00438-001-0610-0; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Battesti A, 2011, ANNU REV MICROBIOL, V65, P189, DOI 10.1146/annurev-micro-090110-102946; Bougdour A, 2008, MOL MICROBIOL, V68, P298, DOI 10.1111/j.1365-2958.2008.06146.x; Bougdour A, 2007, P NATL ACAD SCI USA, V104, P12896, DOI 10.1073/pnas.0705561104; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown L, 2002, J BACTERIOL, V184, P4455, DOI 10.1128/JB.184.16.4455-4465.2002; Castanie-Cornet MP, 1999, J BACTERIOL, V181, P3525, DOI 10.1128/JB.181.11.3525-3535.1999; Castanie-Cornet MP, 2001, MICROBIOL-UK, V147, P709, DOI 10.1099/00221287-147-3-709; Chattopadhyay MK, 2006, YEAST, V23, P751, DOI 10.1002/yea.1393; Chattopadhyay MK, 2013, J BIOL CHEM, V288, P33559, DOI 10.1074/jbc.M113.510552; Chattopadhyay MK, 2003, P NATL ACAD SCI USA, V100, P2261, DOI 10.1073/pnas.2627990100; Cohen S.S., 1998, GUIDE POLYAMINES, V1st ed.; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Biase D, 1999, MOL MICROBIOL, V32, P1198, DOI 10.1046/j.1365-2958.1999.01430.x; De Biase D, 2012, MOL MICROBIOL, V86, P770, DOI 10.1111/mmi.12020; Dukan S, 1999, J BIOL CHEM, V274, P26027, DOI 10.1074/jbc.274.37.26027; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; GENTRY DR, 1993, J BACTERIOL, V175, P7982, DOI 10.1128/JB.175.24.7982-7989.1993; GORDEN J, 1993, INFECT IMMUN, V61, P364, DOI 10.1128/IAI.61.1.364-367.1993; Gottesman S, 2004, ANNU REV MICROBIOL, V58, P303, DOI 10.1146/annurev.micro.58.030603.123841; HENGGEARONIS R, 1993, CELL, V72, P165, DOI 10.1016/0092-8674(93)90655-A; Hommais F, 2004, MICROBIOL-SGM, V150, P61, DOI 10.1099/mic.0.26659-0; Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009; Jung IL, 2003, J BIOL CHEM, V278, P22846, DOI 10.1074/jbc.M212055200; Kanjee U, 2013, ANNU REV MICROBIOL, V67, P65, DOI 10.1146/annurev-micro-092412-155708; Kanjee U, 2011, EMBO J, V30, P931, DOI 10.1038/emboj.2011.5; Lacour S, 2004, J BACTERIOL, V186, P7186, DOI 10.1128/JB.186.21.7186-7195.2004; Landini P, 2014, ENV MICROBIOL REP, V6, P1, DOI 10.1111/1758-2229.12112; LANGE R, 1994, GENE DEV, V8, P1600, DOI 10.1101/gad.8.13.1600; LANGE R, 1991, MOL MICROBIOL, V5, P49, DOI 10.1111/j.1365-2958.1991.tb01825.x; Lin JS, 1996, APPL ENVIRON MICROB, V62, P3094, DOI 10.1128/AEM.62.9.3094-3100.1996; LIN JS, 1995, J BACTERIOL, V177, P4097, DOI 10.1128/jb.177.14.4097-4104.1995; Ma Z, 2004, J BACTERIOL, V186, P7378, DOI 10.1128/JB.186.21.7378-7389.2004; Ma Z, 2003, MOL MICROBIOL, V49, P1309, DOI 10.1046/j.1365-2958.2003.03633.x; Masuda N, 2003, MOL MICROBIOL, V48, P699, DOI 10.1046/j.1365-2958.2003.03477.x; Miller J. H., 1992, SHORT COURSE BACTERI, P263; Patten CL, 2004, MOL GENET GENOMICS, V272, P580, DOI 10.1007/s00438-004-1089-2; Pegg AE, 2011, METHODS MOL BIOL, V720, P3, DOI 10.1007/978-1-61779-034-8_1; Richard HT, 2003, ADV APPL MICROBIOL, V52, P167, DOI 10.1016/S0065-2164(03)01007-4; Schellhorn HE, 2014, FUTURE MICROBIOL, V9, P497, DOI 10.2217/fmb.14.9; SMALL P, 1994, J BACTERIOL, V176, P1729, DOI 10.1128/jb.176.6.1729-1737.1994; Soper T, 2010, P NATL ACAD SCI USA, V107, P9602, DOI 10.1073/pnas.1004435107; StimHerndon KP, 1996, MICROBIOL-UK, V142, P1311, DOI 10.1099/13500872-142-5-1311; Subbarayan PR, 2004, MOL GENET GENOMICS, V270, P533, DOI 10.1007/s00438-003-0944-x; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; TABOR H, 1982, P NATL ACAD SCI-BIOL, V79, P7087, DOI 10.1073/pnas.79.23.7087; Tkachenko AG, 2014, FEMS MICROBIOL LETT, V361, P25, DOI 10.1111/1574-6968.12613; Vanaja SK, 2009, J BACTERIOL, V191, P1868, DOI 10.1128/JB.01481-08; Vecerek B, 2010, NUCLEIC ACIDS RES, V38, P1284, DOI 10.1093/nar/gkp1125; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; Wallace HM, 2003, BIOCHEM J, V376, P1, DOI 10.1042/BJ20031327; Williams K, 1997, BIOCHEM J, V325, P289, DOI 10.1042/bj3250289; Yoshida M, 2004, J BIOL CHEM, V279, P46008, DOI 10.1074/jbc.M404393200; Yoshida M, 2002, J BIOL CHEM, V277, P37139, DOI 10.1074/jbc.M206668200	56	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					17809	17821		10.1074/jbc.M115.655688	http://dx.doi.org/10.1074/jbc.M115.655688			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26025365	Green Published, hybrid			2022-12-28	WOS:000358511700018
J	Liu, D; Wen, Y; Tang, TT; Lv, LL; Tang, RN; Liu, H; Ma, KL; Crowley, SD; Liu, BC				Liu, Dan; Wen, Yi; Tang, Tao-Tao; Lv, Lin-Li; Tang, Ri-Ning; Liu, Hong; Ma, Kun-Ling; Crowley, Steve D.; Liu, Bi-Cheng			Megalin/Cubulin-Lysosome-mediated Albumin Reabsorption Is Involved in the Tubular Cell Activation of NLRP3 Inflammasome and Tubulointerstitial Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROXIMAL TUBULE; NALP3 INFLAMMASOME; KAPPA-B; PROTEIN; PROTEOLYSIS; MECHANISM; APOPTOSIS; CUBILIN; TOXINS	Albuminuria contributes to the development and progression of chronic kidney disease by inducing tubulointerstitial inflammation (TI) and fibrosis. However, the exact mechanisms of TI in response to albuminuria are unresolved. We previously demonstrated that NLRP3 and inflammasomes mediate albumin-induced lesions in tubular cells. Here, we further investigated the role of endocytic receptors and lysosome rupture in NLRP3 inflammasome activation. A murine proteinuric nephropathy model was induced by albumin overload as described previously. The priming and activation signals for inflammasome complex formation were evoked simultaneously by albumin excess in tubular epithelial cells. The former signal was dependent on a albumin-triggered NF-kappa B pathway activation. This process is mediated by the endocytic receptor, megalin and cubilin. However, the silencing of megalin or cubilin inhibited the albumin-induced NLRP3 signal. Notably, subsequent lysosome rupture and the corresponding release of lysosomal hydrolases, especially cathepsin B, were observed in tubular epithelial cells exposed to albumin. Cathepsin B release and distribution are essential for NLRP3 signal activation, and inhibitors of cathepsin B suppressed the NLRP3 signal in tubular epithelial cells. Taken together, our findings suggest that megalin/cubilin and lysosome rupture are involved in albumin-triggered tubular injury and TI. This study provides novel insights into albuminuria-induced TI and implicates the active control of albuminuria as a critical strategy to halt the progression of chronic kidney disease.	[Liu, Dan; Wen, Yi; Tang, Tao-Tao; Lv, Lin-Li; Tang, Ri-Ning; Liu, Hong; Ma, Kun-Ling; Liu, Bi-Cheng] Southeast Univ, Sch Med, Zhong Da Hosp, Inst Nephrol, Nanjing 210009, Jiangsu, Peoples R China; [Crowley, Steve D.] Duke Univ, Div Nephrol, Dept Med, Durham, NC 27710 USA; [Crowley, Steve D.] Durham Vet Affairs Med Ctr, Durham, NC 27710 USA	Southeast University - China; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center	Liu, BC (corresponding author), 87 Dingjiaqiao Rd, Nanjing 210009, Jiangsu, Peoples R China.	liubc64@163.com			National Natural Scientific Foundation [81130010]; Major State Basic Research Development Program ("973") Grant [2012CB517706]; Program for Clinical Medical Science of Jiangsu Province Grant [BL2014080]	National Natural Scientific Foundation(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program ("973") Grant; Program for Clinical Medical Science of Jiangsu Province Grant	This work was supported by National Natural Scientific Foundation Grant 81130010, Major State Basic Research Development Program ("973") Grant 2012CB517706, and Program for Clinical Medical Science of Jiangsu Province Grant BL2014080. The authors declare that they have no conflicts of interest with the contents of this article.	Abbate M, 2006, J AM SOC NEPHROL, V17, P2974, DOI 10.1681/ASN.2006040377; Amsellem S, 2010, J AM SOC NEPHROL, V21, P1859, DOI 10.1681/ASN.2010050492; Anders HJ, 2011, J AM SOC NEPHROL, V22, P1007, DOI 10.1681/ASN.2010080798; Birn H, 1997, J BIOL CHEM, V272, P26497, DOI 10.1074/jbc.272.42.26497; Cabezas F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016794; Caruso-Neves C, 2006, P NATL ACAD SCI USA, V103, P18810, DOI 10.1073/pnas.0605029103; Chang A, 2014, CURR OPIN NEPHROL HY, V23, P204, DOI 10.1097/01.mnh.0000444814.49755.90; Christensen EI, 2009, PFLUG ARCH EUR J PHY, V458, P1039, DOI 10.1007/s00424-009-0685-8; Dickson LE, 2014, J AM SOC NEPHROL, V25, P443, DOI 10.1681/ASN.2013090950; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Eddy AA, 2004, NEPHROL DIAL TRANSPL, V19, P277, DOI 10.1093/ndt/gfg533; EDDY AA, 1989, AM J PATHOL, V135, P719; Erkan E, 2007, J AM SOC NEPHROL, V18, P1199, DOI 10.1681/ASN.2006040407; Fang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072344; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Jin CC, 2010, J CLIN IMMUNOL, V30, P628, DOI 10.1007/s10875-010-9440-3; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lee D, 2013, AM J PHYSIOL-RENAL, V304, pF1009, DOI 10.1152/ajprenal.00601.2012; Leheste JR, 2002, FASEB J, V16, P247, DOI 10.1096/fj.02-0578fje; Li XN, 2010, J AM SOC NEPHROL, V21, P1115, DOI 10.1681/ASN.2009070760; Lichtnekert J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026778; Liu BC, 2009, CLIN CHIM ACTA, V403, P23, DOI 10.1016/j.cca.2008.12.015; Liu D, 2014, INT J BIOCHEM CELL B, V57, P7, DOI 10.1016/j.biocel.2014.09.018; Liu WJ, 2015, AM J PHYSIOL-RENAL, V308, pF639, DOI 10.1152/ajprenal.00383.2014; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2012, IMMUNITY, V36, P313, DOI 10.1016/j.immuni.2012.03.005; Mason DR, 2012, J INNATE IMMUN, V4, P16, DOI 10.1159/000334247; Menu P, 2011, CLIN EXP IMMUNOL, V166, P1, DOI 10.1111/j.1365-2249.2011.04440.x; Morigi M, 2002, J AM SOC NEPHROL, V13, P1179; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Nielsen R, 2013, KIDNEY INT, V84, P902, DOI 10.1038/ki.2013.218; Nielsen R, 2010, PEDIATR NEPHROL, V25, P813, DOI 10.1007/s00467-009-1381-9; Nykjaer A, 1999, CELL, V96, P507, DOI 10.1016/S0092-8674(00)80655-8; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Vilaysane A, 2010, J AM SOC NEPHROL, V21, P1732, DOI 10.1681/ASN.2010020143; Wang YP, 1999, J AM SOC NEPHROL, V10, P1204; Yamahara K, 2013, J AM SOC NEPHROL, V24, P1769, DOI 10.1681/ASN.2012111080; Zhai XY, 2000, KIDNEY INT, V58, P1523, DOI 10.1046/j.1523-1755.2000.00314.x; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831; Zoja C, 1998, KIDNEY INT, V53, P1608, DOI 10.1046/j.1523-1755.1998.00905.x; Zoja C, 2015, NEPHROL DIAL TRANSPL, V30, P706, DOI 10.1093/ndt/gfu261	45	71	74	3	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					18018	18028		10.1074/jbc.M115.662064	http://dx.doi.org/10.1074/jbc.M115.662064			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26025362	hybrid, Green Published			2022-12-28	WOS:000358511700034
J	Makinoshima, H; Takita, M; Saruwatari, K; Umemura, S; Obata, Y; Ishii, G; Matsumoto, S; Sugiyama, E; Ochiai, A; Abe, R; Goto, K; Esumi, H; Tsuchihara, K				Makinoshima, Hideki; Takita, Masahiro; Saruwatari, Koichi; Umemura, Shigeki; Obata, Yuuki; Ishii, Genichiro; Matsumoto, Shingo; Sugiyama, Eri; Ochiai, Atsushi; Abe, Ryo; Goto, Koichi; Esumi, Hiroyasu; Tsuchihara, Katsuya			Signaling through the Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Axis Is Responsible for Aerobic Glycolysis mediated by Glucose Transporter in Epidermal Growth Factor Receptor (EGFR)-mutated Lung Adenocarcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOLIC PATHWAYS; CANCER-CELLS; SURVIVAL; KINASE; DEGRADATION; RESISTANCE; ONCOGENES; PROTEINS; GLUT1	Oncogenic epidermal growth factor receptor (EGFR) signaling plays an important role in regulating global metabolic pathways, including aerobic glycolysis, the pentose phosphate pathway (PPP), and pyrimidine biosynthesis. However, the molecular mechanism by which EGFR signaling regulates cancer cell metabolism is still unclear. To elucidate how EGFR signaling is linked to metabolic activity, we investigated the involvement of the RAS/MEK/ERK and PI3K/AKT/mammalian target of rapamycin (mTOR) pathways on metabolic alteration in lung adenocarcinoma (LAD) cell lines with activating EGFR mutations. Although MEK inhibition did not alter lactate production and the extracellular acidification rate, PI3K/mTOR inhibitors significantly suppressed glycolysis in EGFR-mutant LAD cells. Moreover, a comprehensive metabolomics analysis revealed that the levels of glucose 6-phosphate and 6-phosphogluconate as early metabolites in glycolysis and PPP were decreased after inhibition of the PI3K/AKT/mTOR pathway, suggesting a link between PI3K signaling and the proper function of glucose transporters or hexokinases in glycolysis. Indeed, PI3K/mTOR inhibition effectively suppressed membrane localization of facilitative glucose transporter 1 (GLUT1), which, instead, accumulated in the cytoplasm. Finally, aerobic glycolysis and cell proliferation were down-regulated when GLUT1 gene expression was suppressed by RNAi. Taken together, these results suggest that PI3K/AKT/mTOR signaling is indispensable for the regulation of aerobic glycolysis in EGFR-mutated LAD cells.	[Makinoshima, Hideki; Takita, Masahiro; Matsumoto, Shingo; Tsuchihara, Katsuya] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Div Translat Res, Kashiwa, Chiba 2778577, Japan; [Takita, Masahiro; Tsuchihara, Katsuya] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba 2778561, Japan; [Saruwatari, Koichi; Umemura, Shigeki; Matsumoto, Shingo; Sugiyama, Eri; Goto, Koichi] Natl Canc Ctr Hosp East, Res Ctr Innovat Oncol, Thorac Oncol, Kashiwa, Chiba 2778577, Japan; [Ishii, Genichiro; Ochiai, Atsushi] Natl Canc Ctr Hosp East, Res Ctr Innovat Oncol, Div Pathol, Kashiwa, Chiba 2778577, Japan; [Obata, Yuuki; Abe, Ryo] Tokyo Univ Sci, Res Inst Biomed Sci, Div Immunobiol, Noda, Chiba 2780022, Japan; [Esumi, Hiroyasu] Tokyo Univ Sci, Res Inst Biomed Sci, Div Clin Res, Noda, Chiba 2780022, Japan	National Cancer Center - Japan; University of Tokyo; National Cancer Center - Japan; National Cancer Center - Japan; Tokyo University of Science; Tokyo University of Science	Makinoshima, H (corresponding author), Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Div Translat Res, Kashiwa, Chiba 2778577, Japan.	hmakinos@east.ncc.go.jp	将大, 田北/AAK-8626-2020		National Cancer Center Research and Development Fund [25-A-6, 26-A-16]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [26830121]	National Cancer Center Research and Development Fund(National Cancer Center - Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by National Cancer Center Research and Development Fund Grants 25-A-6 and 26-A-16 and KAKENHI Grant-in-Aid for Young Scientists (B) 26830121 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Ben-Sahra I, 2013, SCIENCE, V339, P1323, DOI 10.1126/science.1228792; Bogan JS, 2012, ANNU REV BIOCHEM, V81, P507, DOI 10.1146/annurev-biochem-060109-094246; Boroughs LK, 2015, NAT CELL BIOL, V17, P351, DOI 10.1038/ncb3124; Busaidy NL, 2012, J CLIN ONCOL, V30, P2919, DOI 10.1200/JCO.2011.39.7356; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Camp ER, 2005, CLIN CANCER RES, V11, P397; Chan DA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002394; Chen LQ, 2015, ANNU REV BIOCHEM, V84, P865, DOI 10.1146/annurev-biochem-060614-033904; Cross DAE, 2014, CANCER DISCOV, V4, P1046, DOI 10.1158/2159-8290.CD-14-0337; D'Amato V, 2014, BRIT J CANCER, V110, P2887, DOI 10.1038/bjc.2014.241; Eyster CA, 2009, TRAFFIC, V10, P590, DOI 10.1111/j.1600-0854.2009.00894.x; Filipits M, 2014, CURR OPIN ONCOL, V26, P152, DOI 10.1097/CCO.0000000000000049; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Gainor JF, 2013, ONCOLOGIST, V18, P865, DOI 10.1634/theoncologist.2013-0095; Green DR, 2014, SCIENCE, V345, P1466, DOI 10.1126/science.1250256; Haber DA, 2005, COLD SH Q B, V70, P419, DOI 10.1101/sqb.2005.70.043; Hallberg B, 2013, NAT REV CANCER, V13, P685, DOI 10.1038/nrc3580; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Kaira K, 2014, LUNG CANCER, V83, P197, DOI 10.1016/j.lungcan.2013.11.025; Kami K, 2013, METABOLOMICS, V9, P444, DOI 10.1007/s11306-012-0452-2; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Lee EE, 2015, MOL CELL, V58, P845, DOI 10.1016/j.molcel.2015.04.015; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Lopez-Serra P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4608; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Macheda ML, 2005, J CELL PHYSIOL, V202, P654, DOI 10.1002/jcp.20166; Makinoshima H, 2014, J BIOL CHEM, V289, P20813, DOI 10.1074/jbc.M114.575464; Ohashi Y, 2008, MOL BIOSYST, V4, P135, DOI 10.1039/b714176a; Ooga T, 2011, MOL BIOSYST, V7, P1217, DOI 10.1039/c0mb00141d; Ooi AT, 2015, CLIN CANCER RES, V21, P2440, DOI 10.1158/1078-0432.CCR-14-1209; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Qu YQ, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/1756-9966-33-52; Reed BC, 2005, MOL BIOL CELL, V16, P4183, DOI 10.1091/mbc.e04-11-0978; Sellers K, 2015, J CLIN INVEST, V125, P687, DOI 10.1172/JCI72873; Soga T, 2013, CANCER SCI, V104, P275, DOI 10.1111/cas.12085; Spratlin JL, 2009, CLIN CANCER RES, V15, P431, DOI 10.1158/1078-0432.CCR-08-1059; Stella GM, 2013, LANCET RESP MED, V1, P251, DOI 10.1016/S2213-2600(13)70009-2; Suzuki A, 2014, NUCLEIC ACIDS RES, V42, P13557, DOI 10.1093/nar/gku885; Suzuki A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073484; Szablewski L, 2013, BBA-REV CANCER, V1835, P164, DOI 10.1016/j.bbcan.2012.12.004; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Thurnher M, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005970; Tsuchihara K, 2013, TRANSL LUNG CANCER R, V2, P463, DOI 10.3978/j.issn.2218-6751.2013.11.02; Umemura S, 2015, JPN J CLIN ONCOL, V45, P513, DOI 10.1093/jjco/hyv017; Viale A, 2014, NATURE, V514, P628, DOI 10.1038/nature13611; Wang RN, 2012, NAT IMMUNOL, V13, P907, DOI 10.1038/ni.2386; Watson RT, 2006, TRENDS BIOCHEM SCI, V31, P215, DOI 10.1016/j.tibs.2006.02.007; Weihua Z, 2008, CANCER CELL, V13, P385, DOI 10.1016/j.ccr.2008.03.015; Wong KK, 2010, CURR OPIN GENET DEV, V20, P87, DOI 10.1016/j.gde.2009.11.002; Wu N, 2013, MOL CELL, V49, P1167, DOI 10.1016/j.molcel.2013.01.035; Zhang C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3935	52	118	127	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17495	17504		10.1074/jbc.M115.660498	http://dx.doi.org/10.1074/jbc.M115.660498			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26023239	Green Published, hybrid			2022-12-28	WOS:000357730900041
J	Ibrahim, SA; Crack, JC; Rolfe, MD; Borrero-de Acuna, JM; Thomson, AJ; Le Brun, NE; Schobert, M; Stapleton, MR; Green, J				Ibrahim, Susan A.; Crack, Jason C.; Rolfe, Matthew D.; Borrero-de Acuna, Jose Manuel; Thomson, Andrew J.; Le Brun, Nick E.; Schobert, Max; Stapleton, Melanie R.; Green, Jeffrey			Three Pseudomonas putida FNR Family Proteins with Different Sensitivities to O-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR FNR; IRON-SULFUR CLUSTER; ESCHERICHIA-COLI; ANAEROBIC GROWTH; AEROBIC CONDITIONS; 2FE-2S CONVERSION; REGULATOR FNR; NITRIC-OXIDE; DNA-BINDING; IN-VITRO	The Escherichia coli fumarate-nitrate reduction regulator (FNR) protein is the paradigm for bacterial O-2-sensing transcription factors. However, unlike E. coli, some bacterial species possess multiple FNR proteins that presumably have evolved to fulfill distinct roles. Here, three FNR proteins (ANR, PP_3233, and PP_3287) from a single bacterial species, Pseudomonas putida KT2440, have been analyzed. Under anaerobic conditions, all three proteins had spectral properties resembling those of [4Fe-4S] proteins. The reactivity of the ANR [4Fe-4S] cluster with O-2 was similar to that of E. coli FNR, and during conversion to the apo-protein, via a [2Fe-2S] intermediate, cluster sulfur was retained. Like ANR, reconstituted PP_3233 and PP_3287 were converted to [2Fe-2S] forms when exposed to O-2, but their [4Fe-4S] clusters reacted more slowly. Transcription from an FNR-dependent promoter with a consensus FNR-binding site in P. putida and E. coli strains expressing only one FNR protein was consistent with the in vitro responses to O-2. Taken together, the experimental results suggest that the local environments of the iron-sulfur clusters in the different P. putida FNR proteins influence their reactivity with O-2, such that ANR resembles E. coli FNR and is highly responsive to low concentrations of O-2, whereas PP_3233 and PP_3287 have evolved to be less sensitive to O-2.	[Ibrahim, Susan A.; Rolfe, Matthew D.; Stapleton, Melanie R.; Green, Jeffrey] Univ Sheffield, Mol Biol & Biotechnol, Krebs Inst, Sheffield S10 2TN, S Yorkshire, England; [Crack, Jason C.; Thomson, Andrew J.; Le Brun, Nick E.] Univ E Anglia, Sch Chem, Ctr Mol & Struct Biochem, Norwich NR4 7TJ, Norfolk, England; [Borrero-de Acuna, Jose Manuel; Schobert, Max] Tech Univ Carolo Wilhelmina Braunschweig, Inst Mikrobiol, D-38106 Braunschweig, Germany	University of Sheffield; University of East Anglia; Braunschweig University of Technology	Green, J (corresponding author), Univ Sheffield, Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England.	jeff.green@sheffield.ac.uk	Borrero-de Acuña, José Manuel/AAT-7277-2020	Borrero-de Acuña, José Manuel/0000-0002-6409-8110; Crack, Jason C./0000-0002-4979-1910; Le Brun, Nick/0000-0001-9780-4061; Ibrahim, Susan/0000-0002-5250-0512	Biotechnology and Biological Sciences Research Council UK [BB/G018960/1, BB/G019347/1, BB/L008114/1]; Higher Committee for Education and Development in Iraq; Deutsche Forschungsgemeinschaft [SCHO 888/4-1]; Biotechnology and Biological Sciences Research Council [BB/G019347/1, BB/L007673/1, BB/G018960/1, BB/L008114/1] Funding Source: researchfish; BBSRC [BB/L008114/1, BB/L007673/1, BB/G018960/1, BB/G019347/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Higher Committee for Education and Development in Iraq; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Grants BB/G018960/1, BB/G019347/1, and BB/L008114/1 from the Biotechnology and Biological Sciences Research Council UK, a Ph.D. scholarship from Higher Committee for Education and Development in Iraq (to S. I.), and Deutsche Forschungsgemeinschaft Grant SCHO 888/4-1 (to M. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Bates DM, 2000, J BIOL CHEM, V275, P6234, DOI 10.1074/jbc.275.9.6234; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Constantinidou C, 2006, J BIOL CHEM, V281, P4802, DOI 10.1074/jbc.M512312200; Crack JC, 2008, METHOD ENZYMOL, V437, P191, DOI 10.1016/S0076-6879(07)37011-0; Crack JC, 2007, P NATL ACAD SCI USA, V104, P2092, DOI 10.1073/pnas.0609514104; Crack JC, 2013, J BIOL CHEM, V288, P11492, DOI 10.1074/jbc.M112.439901; Crack JC, 2012, ANTIOXID REDOX SIGN, V17, P1215, DOI 10.1089/ars.2012.4511; Crack JC, 2012, CURR OPIN CHEM BIOL, V16, P35, DOI 10.1016/j.cbpa.2012.02.009; Crack JC, 2011, J AM CHEM SOC, V133, P1112, DOI 10.1021/ja109581t; Dibden DP, 2005, MICROBIOL-SGM, V151, P4063, DOI 10.1099/mic.0.28253-0; ENGEL P, 1991, ARCH MICROBIOL, V156, P463, DOI 10.1007/BF00245393; Gostick DO, 1998, MICROBIOL-SGM, V144, P705, DOI 10.1099/00221287-144-3-705; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HIDALGO E, 1995, J BIOL CHEM, V270, P20908, DOI 10.1074/jbc.270.36.20908; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Jervis AJ, 2009, P NATL ACAD SCI USA, V106, P4659, DOI 10.1073/pnas.0804943106; Kang YS, 2005, J BACTERIOL, V187, P1135, DOI 10.1128/JB.187.3.1135-1160.2005; Khoroshilova N, 1997, P NATL ACAD SCI USA, V94, P6087, DOI 10.1073/pnas.94.12.6087; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; KILEY PJ, 1991, J BACTERIOL, V173, P16, DOI 10.1128/jb.173.1.16-22.1991; Korner H, 2003, FEMS MICROBIOL REV, V27, P559, DOI 10.1016/S0168-6445(03)00066-4; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lazazzera BA, 1996, J BIOL CHEM, V271, P2762, DOI 10.1074/jbc.271.5.2762; Martinez-Garcia E, 2011, ENVIRON MICROBIOL, V13, P2702, DOI 10.1111/j.1462-2920.2011.02538.x; Mettert EL, 2005, J MOL BIOL, V354, P220, DOI 10.1016/j.jmb.2005.09.066; Miller J. H, 1972, EXPT MOL GENETICS; Moore LJ, 2006, J BIOL CHEM, V281, P33268, DOI 10.1074/jbc.M608331200; Myers KS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003565; Partridge JD, 2007, J BIOL CHEM, V282, P11230, DOI 10.1074/jbc.M700728200; Partridge JD, 2006, J BIOL CHEM, V281, P27806, DOI 10.1074/jbc.M603450200; Reinhart F, 2008, J BACTERIOL, V190, P879, DOI 10.1128/JB.01374-07; Rolfe MD, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120091; Sass AM, 2013, ISME J, V7, P1568, DOI 10.1038/ismej.2013.36; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; SHARROCKS AD, 1990, FEBS LETT, V270, P119, DOI 10.1016/0014-5793(90)81248-M; SHARROCKS AD, 1991, P ROY SOC B-BIOL SCI, V245, P219, DOI 10.1098/rspb.1991.0113; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smith LJ, 2010, BIOCHEM J, V432, P417, DOI 10.1042/BJ20101440; Ugidos A, 2008, ENVIRON MICROBIOL, V10, P1690, DOI 10.1111/j.1462-2920.2008.01586.x; WING HJ, 1995, J BACTERIOL, V177, P6704, DOI 10.1128/jb.177.23.6704-6710.1995; Wong SM, 2000, P NATL ACAD SCI USA, V97, P10191, DOI 10.1073/pnas.97.18.10191; Zhang B, 2012, P NATL ACAD SCI USA, V109, P15734, DOI 10.1073/pnas.1208787109; ZIMMERMANN A, 1991, MOL MICROBIOL, V5, P1483, DOI 10.1111/j.1365-2958.1991.tb00794.x	43	18	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16812	16823		10.1074/jbc.M115.654079	http://dx.doi.org/10.1074/jbc.M115.654079			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25971977	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000357572800027
J	Erion, KA; Berdan, CA; Burritt, NE; Corkey, BE; Deeney, JT				Erion, Karel A.; Berdan, Charles A.; Burritt, Nathan E.; Corkey, Barbara E.; Deeney, Jude T.			Chronic Exposure to Excess Nutrients Left-shifts the Concentration Dependence of Glucose-stimulated Insulin Secretion in Pancreatic -Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						beta cell (-cell); calcium imaging; insulin secretion; lipid; metabolism; type 2 diabetes; hyperinsulinemia	LONG-TERM EXPOSURE; BETA-CELL; GENE-EXPRESSION; PROINSULIN BIOSYNTHESIS; AMPLIFYING PATHWAYS; FATTY-ACIDS; HYPERINSULINEMIA; ISLETS; MOUSE; GLUCOKINASE	Background: Fasting insulin secretion is increased in obesity and type 2 diabetes. Results: Culture of -cells in excess nutrients resulted in increased lipid stores and a left-shifted dose-response curve of glucose-stimulated insulin secretion due to an enhanced sensitivity of exocytosis to Ca2+. Conclusion: Intracellular lipid modulates the dose response of glucose-stimulated insulin secretion. Significance: A shift in -cell glucose sensitivity may contribute to hyperinsulinemia. Hyperinsulinemia (HI) is elevated plasma insulin at basal glucose. Impaired glucose tolerance is associated with HI, although the exact cause and effect relationship remains poorly defined. We tested the hypothesis that HI can result from an intrinsic response of the -cell to chronic exposure to excess nutrients, involving a shift in the concentration dependence of glucose-stimulated insulin secretion. INS-1 (832/13) cells were cultured in either a physiological (4 mm) or high (11 mm) glucose concentration with or without concomitant exposure to oleate. Isolated rat islets were also cultured with or without oleate. A clear hypersensitivity to submaximal glucose concentrations was evident in INS-1 cells cultured in excess nutrients such that the 25% of maximal (S-0.25) glucose-stimulated insulin secretion was significantly reduced in cells cultured in 11 mm glucose (S-0.25 = 3.5 mm) and 4 mm glucose with oleate (S-0.25 = 4.5 mm) compared with 4 mm glucose alone (S-0.25 = 5.7 mm). The magnitude of the left shift was linearly correlated with intracellular lipid stores in INS-1 cells (r(2) = 0.97). We observed no significant differences in the dose responses for glucose stimulation of respiration, NAD(P)H autofluorescence, or Ca2+ responses between left- and right-shifted -cells. However, a left shift in the sensitivity of exocytosis to Ca2+ was documented in permeabilized INS-1 cells cultured in 11 versus 4 mm glucose (S-0.25 = 1.1 and 1.7 m, respectively). Our results suggest that the sensitivity of exocytosis to triggering is modulated by a lipid component, the levels of which are influenced by the culture nutrient environment.	[Erion, Karel A.; Berdan, Charles A.; Burritt, Nathan E.; Corkey, Barbara E.; Deeney, Jude T.] Boston Univ, Sch Med, Dept Med, Obes Res Ctr, Boston, MA 02118 USA	Boston University	Deeney, JT (corresponding author), Boston Univ, Sch Med, Dept Med, Obes Res Ctr, 650 Albany St X-810, Boston, MA 02118 USA.	jdeeney@bu.edu	Regan, Clinton/E-6250-2012	Deeney, Jude/0000-0003-0988-9419	National Institutes of Health [R01 DK35914, T32 DK007201]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007201, R01DK035914] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK35914 (to B. E. C.) and T32 DK007201 (to K. A. E.). The authors declare that they have no conflicts of interest with the contents of this article.	Andrikopoulos S, 2005, J ENDOCRINOL, V187, P45, DOI 10.1677/joe.1.06333; Antunes CM, 2000, DIABETES, V49, P2028, DOI 10.2337/diabetes.49.12.2028; Bensellam M, 2012, MOL CELL ENDOCRINOL, V364, P1, DOI 10.1016/j.mce.2012.08.003; Bollheimer LC, 1998, J CLIN INVEST, V101, P1094, DOI 10.1172/JCI420; BYRNE MM, 1995, AM J PHYSIOL-ENDOC M, V268, pE21, DOI 10.1152/ajpendo.1995.268.1.E21; Corkey BE, 2012, DIABETES CARE, V35, P2432, DOI 10.2337/dc12-0825; Corkey BE, 2012, DIABETES, V61, P4, DOI 10.2337/db11-1483; Cunningham BA, 1996, AM J PHYSIOL-ENDOC M, V271, pE702, DOI 10.1152/ajpendo.1996.271.4.E702; Deeney JT, 2000, J BIOL CHEM, V275, P9363, DOI 10.1074/jbc.275.13.9363; Deeney JT, 2001, J BIOL CHEM, V276, P36946, DOI 10.1074/jbc.M105056200; GERMAN MS, 1993, P NATL ACAD SCI USA, V90, P1781, DOI 10.1073/pnas.90.5.1781; Gohring I, 2014, J BIOL CHEM, V289, P3786, DOI 10.1074/jbc.M113.507335; Greaves J, 2010, BIOCHEM SOC T, V38, P163, DOI 10.1042/BST0380163; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Hagman DK, 2008, DIABETES, V57, P424, DOI 10.2337/db07-1285; Heart E, 2006, AM J PHYSIOL-ENDOC M, V290, pE143, DOI 10.1152/ajpendo.00216.2005; Heindel U, 2003, FEBS LETT, V544, P57, DOI 10.1016/S0014-5793(03)00449-6; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Henquin JC, 2006, DIABETES, V55, P441, DOI 10.2337/diabetes.55.02.06.db05-1051; Henquin JC, 2011, DIABETES RES CLIN PR, V93, pS27, DOI 10.1016/S0168-8227(11)70010-9; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Kelpe CL, 2003, J BIOL CHEM, V278, P30015, DOI 10.1074/jbc.M302548200; Kotronen A, 2007, AM J PHYSIOL-ENDOC M, V293, pE1709, DOI 10.1152/ajpendo.00444.2007; Lai AL, 2011, J BIOL CHEM, V286, P25291, DOI 10.1074/jbc.M111.258848; LENZEN S, 1987, ACTA ENDOCRINOL-COP, V115, P21, DOI 10.1530/acta.0.1150021; Ling ZD, 1996, DIABETES, V45, P1774, DOI 10.2337/diabetes.45.12.1774; Matschinsky FM, 1998, DIABETES, V47, P307, DOI 10.2337/diabetes.47.3.307; MEISTAS MT, 1983, AM J PHYSIOL, V245, pE155, DOI 10.1152/ajpendo.1983.245.2.E155; Miles PDG, 1998, J CLIN INVEST, V101, P202, DOI 10.1172/JCI1256; Ning J, 2011, AM J PHYSIOL-ENDOC M, V301, pE391, DOI 10.1152/ajpendo.00164.2011; Nolan CJ, 2006, DIABETES, V55, pS16, DOI 10.2337/db06-S003; OBITABOT ET, 1993, J SURG RES, V55, P575, DOI 10.1006/jsre.1993.1187; Olofsson CS, 2007, DIABETES, V56, P1888, DOI 10.2337/db06-1150; Oprescu AI, 2007, DIABETES, V56, P2927, DOI 10.2337/db07-0075; PAOLISSO G, 1995, DIABETOLOGIA, V38, P1295; Poitout V, 2010, BBA-MOL CELL BIOL L, V1801, P289, DOI 10.1016/j.bbalip.2009.08.006; POLONSKY KS, 1988, J CLIN INVEST, V81, P442, DOI 10.1172/JCI113339; Prentki M, 1996, DIABETES, V45, P273, DOI 10.2337/diabetes.45.3.273; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Prentki M, 2013, CELL METAB, V18, P162, DOI 10.1016/j.cmet.2013.05.018; Reed MA, 2011, J CLIN ENDOCR METAB, V96, P2525, DOI 10.1210/jc.2011-0165; Rituper B, 2012, CELL CALCIUM, V52, P250, DOI 10.1016/j.ceca.2012.05.009; Roche E, 1998, DIABETES, V47, P1086, DOI 10.2337/diabetes.47.7.1086; Roche E, 1997, J BIOL CHEM, V272, P3091, DOI 10.1074/jbc.272.5.3091; Rocheleau JV, 2004, J BIOL CHEM, V279, P31780, DOI 10.1074/jbc.M314005200; RUSSELL DS, 1987, J BIOL CHEM, V262, P11833; Saadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030200; SAKO Y, 1990, DIABETES, V39, P1580, DOI 10.2337/diabetes.39.12.1580; Schuit F, 2002, DIABETES, V51, pS326, DOI 10.2337/diabetes.51.2007.S326; Shanik MH, 2008, DIABETES CARE, V31, pS262, DOI 10.2337/dc08-s264; Skelly RH, 1998, BIOCHEM J, V331, P553, DOI 10.1042/bj3310553; Stein DT, 1997, J CLIN INVEST, V100, P398, DOI 10.1172/JCI119546; Tsuboi T, 2006, DIABETES, V55, P1057, DOI 10.2337/diabetes.55.04.06.db05-1577; Unger RH, 2001, DIABETES, V50, pS118, DOI 10.2337/diabetes.50.2007.S118; Weir GC, 2001, DIABETES, V50, pS154, DOI 10.2337/diabetes.50.2007.S154; Zhao SG, 2014, CELL METAB, V19, P993, DOI 10.1016/j.cmet.2014.04.003; ZHOU YP, 1994, J CLIN INVEST, V93, P870, DOI 10.1172/JCI117042; Zhou YP, 1999, METABOLISM, V48, P857, DOI 10.1016/S0026-0495(99)90219-6	58	38	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16191	16201		10.1074/jbc.M114.620351	http://dx.doi.org/10.1074/jbc.M114.620351			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25934392	hybrid, Green Published			2022-12-28	WOS:000356930100023
J	Sosanya, NM; Cacheaux, LP; Workman, ER; Niere, F; Perrone-Bizzozero, NI; Raab-Graham, KF				Sosanya, Natasha M.; Cacheaux, Luisa P.; Workman, Emily R.; Niere, Farr; Perrone-Bizzozero, Nora I.; Raab-Graham, Kimberly F.			Mammalian Target of Rapamycin (mTOR) Tagging Promotes Dendritic Branch Variability through the Capture of Ca2+/Calmodulin-dependent Protein Kinase II (CaMKII) mRNAs by the RNA-binding Protein HuD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fluorescence; mammalian target of rapamycin (mTOR); mRNA decay; neuron; protein synthesis; RNA-binding protein; dendritic branch; in situ hybridization; synaptic tagging and capture; translational control	LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; HIPPOCAMPAL-NEURONS; SIGNALING PATHWAY; CYTOPLASMIC POLYADENYLATION; UP-REGULATION; POLY(A) TAIL; GAP-43 GENE; MEMORY; TRANSLATION	Background: Memory requires protein synthesis of dendritic CaMKII. Results: HuD directs CaMKII expression in a branch-specific manner. mTOR inhibition reduces HuD binding and promotes deadenylation of CaMKII mRNA. Conclusion: mTOR activity tags synapses, allowing HuD to capture CaMKII in a branch-specific manner. Significance: mTOR and HuD provide a molecular model for the synaptic tagging and capture hypothesis. The fate of a memory, whether stored or forgotten, is determined by the ability of an active or tagged synapse to undergo changes in synaptic efficacy requiring protein synthesis of plasticity-related proteins. A synapse can be tagged, but without the capture of plasticity-related proteins, it will not undergo long lasting forms of plasticity (synaptic tagging and capture hypothesis). What the tag is and how plasticity-related proteins are captured at tagged synapses are unknown. Ca2+/calmodulin-dependent protein kinase II (CaMKII) is critical in learning and memory and is synthesized locally in neuronal dendrites. The mechanistic (mammalian) target of rapamycin (mTOR) is a protein kinase that increases CaMKII protein expression; however, the mechanism and site of dendritic expression are unknown. Herein, we show that mTOR activity mediates the branch-specific expression of CaMKII, favoring one secondary, daughter branch over the other in a single neuron. mTOR inhibition decreased the dendritic levels of CaMKII protein and mRNA by shortening its poly(A) tail. Overexpression of the RNA-stabilizing protein HuD increased CaMKII protein levels and preserved its selective expression in one daughter branch over the other when mTOR was inhibited. Unexpectedly, deleting the third RNA recognition motif of HuD, the domain that binds the poly(A) tail, eliminated the branch-specific expression of CaMKII when mTOR was active. These results provide a model for one molecular mechanism that may underlie the synaptic tagging and capture hypothesis where mTOR is the tag, preventing deadenylation of CaMKII mRNA, whereas HuD captures and promotes its expression in a branch-specific manner.	[Sosanya, Natasha M.; Cacheaux, Luisa P.; Workman, Emily R.; Niere, Farr; Raab-Graham, Kimberly F.] Univ Texas Austin, Ctr Learning & Memory, Dept Neurosci, Austin, TX 78712 USA; [Sosanya, Natasha M.; Raab-Graham, Kimberly F.] Univ Texas Austin, Inst Cell Biol, Austin, TX 78712 USA; [Workman, Emily R.; Raab-Graham, Kimberly F.] Univ Texas Austin, Inst Neurosci, Austin, TX 78712 USA; [Sosanya, Natasha M.] US Army Inst Surg Res, Joint Base San Antonio Ft Sam, Houston, TX 78234 USA; [Perrone-Bizzozero, Nora I.] Univ New Mexico, Hlth Sci Ctr, Dept Neurosci Psychiat & Behav Sci, Albuquerque, NM 87131 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; United States Department of Defense; United States Army; University of New Mexico; University of New Mexico's Health Sciences Center	Raab-Graham, KF (corresponding author), Univ Texas Austin, Ctr Learning & Memory, Dept Neurosci, 1 Univ Stn,C7000, Austin, TX 78712 USA.	Kimberly@mail.clm.utexas.edu	Regan, Clinton/E-6250-2012	Niere, Farr/0000-0003-0287-0889; Raab-Graham, Kimberly/0000-0001-6502-057X	National Science Foundation (NSF) [IOS 1026527, IOS 1355158]; National Institutes of Health [R01 NS30255, DA034897]; NSF Postdoctoral Research Fellowship in Biology [DBI-1103738, DBI-1306528]; Direct For Biological Sciences [1306528] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030255] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Postdoctoral Research Fellowship in Biology(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Science Foundation (NSF) Grants IOS 1026527 and IOS 1355158 (to K. F. R.-G.) and by National Institutes of Health Grants R01 NS30255 and DA034897 (to N. I. P.-B.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by NSF Postdoctoral Research Fellowship in Biology DBI-1103738.; Supported by NSF Postdoctoral Research Fellowship in Biology DBI-1306528.	Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Albig AR, 2001, MOL BIOL CELL, V12, P3428, DOI 10.1091/mbc.12.11.3428; Anderson KD, 2000, J NEUROCHEM, V75, P1103, DOI 10.1046/j.1471-4159.2000.0751103.x; Beckel-Mitchener AC, 2002, J BIOL CHEM, V277, P27996, DOI 10.1074/jbc.M201982200; Blundell J, 2008, NEUROBIOL LEARN MEM, V90, P28, DOI 10.1016/j.nlm.2007.12.004; Bolognani F, 2004, NEUROSCI LETT, V371, P152, DOI 10.1016/j.neulet.2004.08.074; Bolognani F, 2007, NEUROBIOL LEARN MEM, V87, P635, DOI 10.1016/j.nlm.2006.11.004; Bolognani F, 2010, NUCLEIC ACIDS RES, V38, P117, DOI 10.1093/nar/gkp863; Cajigas IJ, 2012, NEURON, V74, P453, DOI 10.1016/j.neuron.2012.02.036; Cammalleri M, 2003, P NATL ACAD SCI USA, V100, P14368, DOI 10.1073/pnas.2336098100; Deschenes-Furry J, 2006, BIOESSAYS, V28, P822, DOI 10.1002/bies.20449; Dictenberg JB, 2008, DEV CELL, V14, P926, DOI 10.1016/j.devcel.2008.04.003; Doyle M, 2011, EMBO J, V30, P3540, DOI 10.1038/emboj.2011.278; Dynes JL, 2007, J COMP NEUROL, V500, P433, DOI 10.1002/cne.21189; Farris S, 2014, J NEUROSCI, V34, P4481, DOI 10.1523/JNEUROSCI.4944-13.2014; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Gong R, 2006, J BIOL CHEM, V281, P18802, DOI 10.1074/jbc.M512524200; Govindarajan A, 2006, NAT REV NEUROSCI, V7, P575, DOI 10.1038/nrn1937; Govindarajan A, 2011, NEURON, V69, P132, DOI 10.1016/j.neuron.2010.12.008; Graber TE, 2013, P NATL ACAD SCI USA, V110, P16205, DOI 10.1073/pnas.1307747110; Harnett MT, 2012, NATURE, V491, P599, DOI 10.1038/nature11554; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kim S, 2015, ELIFE, V4, DOI 10.7554/eLife.04158; Knowles RB, 1996, J NEUROSCI, V16, P7812; Kohrmann M, 1999, MOL BIOL CELL, V10, P2945, DOI 10.1091/mbc.10.9.2945; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Ma WJ, 1997, NUCLEIC ACIDS RES, V25, P3564, DOI 10.1093/nar/25.18.3564; Mahan AL, 2012, J NEUROSCI, V32, P4651, DOI 10.1523/JNEUROSCI.3308-11.2012; Makara JK, 2009, NAT NEUROSCI, V12, P1485, DOI 10.1038/nn.2428; Makino H, 2011, NEURON, V72, P1001, DOI 10.1016/j.neuron.2011.09.036; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Merianda TT, 2013, J NEUROSCI, V33, P13735, DOI 10.1523/JNEUROSCI.0962-13.2013; Miller S, 2002, NEURON, V36, P507, DOI 10.1016/S0896-6273(02)00978-9; Pascale A, 2004, P NATL ACAD SCI USA, V101, P1217, DOI 10.1073/pnas.0307674100; Raab-Graham KF, 2006, SCIENCE, V314, P144, DOI 10.1126/science.1131693; Ratti A, 2008, J BIOL CHEM, V283, P7531, DOI 10.1074/jbc.M706082200; Redondo RL, 2011, NAT REV NEUROSCI, V12, P17, DOI 10.1038/nrn2963; Redondo RL, 2010, J NEUROSCI, V30, P4981, DOI 10.1523/JNEUROSCI.3140-09.2010; Routtenberg A, 2000, P NATL ACAD SCI USA, V97, P7657, DOI 10.1073/pnas.97.13.7657; Sosanya NM, 2015, NEUROBIOL DIS, V73, P96, DOI 10.1016/j.nbd.2014.09.011; Sosanya NM, 2013, J CELL BIOL, V202, P53, DOI 10.1083/jcb.201212089; Sutton MA, 2004, SCIENCE, V304, P1979, DOI 10.1126/science.1096202; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Tiruchinapalli DM, 2008, RNA BIOL, V5, P157, DOI 10.4161/rna.5.3.6782; Udagawa T, 2012, MOL CELL, V47, P253, DOI 10.1016/j.molcel.2012.05.016; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	48	32	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16357	16371		10.1074/jbc.M114.599399	http://dx.doi.org/10.1074/jbc.M114.599399			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25944900	hybrid, Green Published			2022-12-28	WOS:000356930100037
J	Jiao, RB; Postnikoff, S; Harkness, TA; Arnason, TG				Jiao, Rubin; Postnikoff, Spike; Harkness, Troy A.; Arnason, Terra G.			The SNF1 Kinase Ubiquitin-associated Domain Restrains Its Activation, Activity, and the Yeast Life Span	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aging; allosteric regulation; AMP-activated kinase (AMPK); FOXO; oxidative stress; Saccharomyces cerevisiae; SNF1 kinase; UBA domain	AMPK HOMOLOG SNF1; PROTEIN-PROTEIN INTERACTIONS; HUMAN SKELETAL-MUSCLE; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; CELL-CYCLE; CRYSTAL-STRUCTURE; GENE-EXPRESSION; GAMMA-SUBUNIT; PHOSPHORYLATION	Background: The UBA domain in the AMP kinase family is poorly defined. Results: This motif restrains kinase activity, resulting in decreased life span and oxidative stress resistance. Conclusion: This inhibitory domain has defined influences with FOXOs on stress and aging. Significance: The overactive kinase created by UBA mutations has positive stress resistance and aging influences that may translate to human metabolic benefits. The enzyme family of heterotrimeric AMP-dependent protein kinases is activated upon low energy states, conferring a switch toward energy-conserving metabolic pathways through immediate kinase actions on enzyme targets and delayed alterations in gene expression through its nuclear relocalization. This family is evolutionarily conserved, including the presence of a ubiquitin-associated (UBA) motif in most catalytic subunits. The potential for the UBA domain to promote protein associations or direct subcellular location, as seen in other UBA-containing proteins, led us to query whether the UBA domain within the yeast AMP-dependent protein kinase ortholog, SNF1 kinase, was important in these aspects of its regulation. Here, we demonstrate that conserved UBA motif mutations significantly alter SNF1 kinase activation and biological activity, including enhanced allosteric subunit associations and increased oxidative stress resistance and life span. Significantly, the enhanced UBA-dependent longevity and oxidative stress response are at least partially dependent on the Fkh1 and Fkh2 stress response transcription factors, which in turn are shown to influence Snf1 gene expression.	[Jiao, Rubin; Postnikoff, Spike; Harkness, Troy A.; Arnason, Terra G.] Univ Saskatchewan, Dept Anat & Cell Biol, Saskatoon, SK S7N 5E5, Canada; [Arnason, Terra G.] Univ Saskatchewan, Dept Med, Saskatoon, SK S7N 5E5, Canada	University of Saskatchewan; University of Saskatchewan	Arnason, TG (corresponding author), Univ Saskatchewan, Dept Med, Saskatoon, SK S7N 5E5, Canada.	terra.arnason@usask.ca		Harkness, Troy/0000-0002-8271-7229	Natural Sciences and Engineering Research Council; Canadian Institutes of Health Research	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Natural Sciences and Engineering Research Council and Canadian Institutes of Health Research (to T. A.).	Adams CR, 1999, CURR OPIN GENET DEV, V9, P185, DOI 10.1016/S0959-437X(99)80028-8; Adams J, 2004, PROTEIN SCI, V13, P155, DOI 10.1110/ps.03340004; Amodeo GA, 2007, NATURE, V449, P492, DOI 10.1038/nature06127; Amodeo GA, 2010, BIOCHEM BIOPH RES CO, V397, P197, DOI 10.1016/j.bbrc.2010.05.083; Andersson L, 2003, BIOCHEM SOC T, V31, P232, DOI 10.1042/BST0310232; Ashrafi K, 2000, GENE DEV, V14, P1872; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Baskin KK, 2011, CIRC RES, V109, P1153, DOI 10.1161/CIRCRESAHA.111.252742; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; CARLSON M, 1981, GENETICS, V98, P25; CELENZA JL, 1989, MOL CELL BIOL, V9, P5045, DOI 10.1128/MCB.9.11.5045; CELENZA JL, 1986, SCIENCE, V233, P1175, DOI 10.1126/science.3526554; Chen ZP, 2000, AM J PHYSIOL-ENDOC M, V279, pE1202, DOI 10.1152/ajpendo.2000.279.5.E1202; Cheung PCF, 2000, BIOCHEM J, V346, P659, DOI 10.1042/0264-6021:3460659; Chiacchiera F, 2010, CELL CYCLE, V9, P1091, DOI 10.4161/cc.9.6.11035; Dubacq C, 2004, MOL CELL BIOL, V24, P2560, DOI 10.1128/MCB.24.6.2560-2572.2004; Elbing K, 2006, BIOCHEM J, V393, P797, DOI 10.1042/BJ20051213; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Goldstein A, 1975, Methods Enzymol, V42, P504; Greene NP, 2012, AM J PHYSIOL-ENDOC M, V303, pE1212, DOI 10.1152/ajpendo.00309.2012; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Hardie DG, 2006, GASTROENTEROLOGY, V131, P973, DOI 10.1053/j.gastro.2006.07.032; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hardie DG, 1999, BIOCHEM SOC SYMP, P13; Harkness T., 2014, BIOCHEM PHARMACOL, V2, P151; Harkness TAA, 2004, GENETICS, V168, P759, DOI 10.1534/genetics.104.027771; Harkness TAA, 2002, GENETICS, V162, P615; Hollenhorst PC, 2000, GENETICS, V154, P1533; Hong SP, 2007, J BIOL CHEM, V282, P16838, DOI 10.1074/jbc.M700146200; Iniesta AA, 2012, J BACTERIOL, V194, P5875, DOI 10.1128/JB.01110-12; Jaleel M, 2006, BIOCHEM J, V394, P545, DOI 10.1042/BJ20051844; Jiang R, 1996, GENE DEV, V10, P3105, DOI 10.1101/gad.10.24.3105; Jiang R, 1997, MOL CELL BIOL, V17, P2099, DOI 10.1128/MCB.17.4.2099; Rodriguez-Colman MJ, 2013, BBA-MOL CELL RES, V1833, P2004, DOI 10.1016/j.bbamcr.2013.02.015; KENNEDY BK, 1994, J CELL BIOL, V127, P1985, DOI 10.1083/jcb.127.6.1985; Lam YY, 2013, EXP GERONTOL, V48, P1018, DOI 10.1016/j.exger.2013.04.005; Lin SS, 2003, J BIOL CHEM, V278, P13390, DOI 10.1074/jbc.M212818200; Lu JY, 2011, CELL, V146, P968, DOI 10.1016/j.cell.2011.07.044; Ludin K, 1998, P NATL ACAD SCI USA, V95, P6245, DOI 10.1073/pnas.95.11.6245; McGee SL, 2003, DIABETES, V52, P926, DOI 10.2337/diabetes.52.4.926; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Momcilovic M, 2011, J BIOL CHEM, V286, P23544, DOI 10.1074/jbc.M111.244111; Mueller TD, 2004, J BIOL CHEM, V279, P11926, DOI 10.1074/jbc.M312865200; Mueller TD, 2002, J MOL BIOL, V319, P1243, DOI 10.1016/S0022-2836(02)00302-9; Musi N, 2001, DIABETES, V50, P921, DOI 10.2337/diabetes.50.5.921; Ostrow AZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087647; Owen O E, 1979, Adv Exp Med Biol, V111, P169; Postnikoff SDL, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00183; Postnikoff SDL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002583; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Pramila T, 2006, GENE DEV, V20, P2266, DOI 10.1101/gad.1450606; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Rudolph MJ, 2010, ACTA CRYSTALLOGR F, V66, P999, DOI 10.1107/S1744309110028265; Rudolph MJ, 2005, BIOCHEM BIOPH RES CO, V337, P1224, DOI 10.1016/j.bbrc.2005.09.181; Salminen A, 2011, J MOL MED, V89, P667, DOI 10.1007/s00109-011-0748-0; Sanz P, 2000, MOL CELL BIOL, V20, P1321, DOI 10.1128/MCB.20.4.1321-1328.2000; Sanz P, 2000, GENETICS, V154, P99; Schmidt MC, 1999, MOL CELL BIOL, V19, P4561; Simpson-Lavy KJ, 2013, P NATL ACAD SCI USA, V110, P17432, DOI 10.1073/pnas.1304839110; Sproul K, 2009, EUR J ENDOCRINOL, V161, P405, DOI 10.1530/EJE-09-0245; Sutherland CM, 2003, CURR BIOL, V13, P1299, DOI 10.1016/S0960-9822(03)00459-7; Suwa M, 2006, J APPL PHYSIOL, V101, P1685, DOI 10.1152/japplphysiol.00255.2006; Takekoshi K, 2006, METABOLISM, V55, P1122, DOI 10.1016/j.metabol.2006.04.007; Treitel MA, 1998, MOL CELL BIOL, V18, P6273, DOI 10.1128/MCB.18.11.6273; Tullet JMA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004109; Vincent O, 2001, GENE DEV, V15, P1104, DOI 10.1101/gad.879301; Wilson MA, 2011, MOL CELL BIOL, V31, P3126, DOI 10.1128/MCB.01350-10; Woods A, 2003, J BIOL CHEM, V278, P28434, DOI 10.1074/jbc.M303946200; Wu SB, 2012, BBA-MOL BASIS DIS, V1822, P233, DOI 10.1016/j.bbadis.2011.09.014; Yeo WK, 2008, J APPL PHYSIOL, V105, P1519, DOI 10.1152/japplphysiol.90540.2008; Zhang YY, 2012, MOL CELL BIOCHEM, V368, P69, DOI 10.1007/s11010-012-1344-5; Zungu M, 2011, AM J PATHOL, V178, P4, DOI 10.1016/j.ajpath.2010.11.030	74	11	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15393	15404		10.1074/jbc.M115.647032	http://dx.doi.org/10.1074/jbc.M115.647032			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25869125	Green Published, hybrid			2022-12-28	WOS:000356527400008
J	Andersson, DA; Filipovic, MR; Gentry, C; Eberhardt, M; Vastani, N; Leffler, A; Reeh, P; Bevan, S				Andersson, David A.; Filipovic, Milos R.; Gentry, Clive; Eberhardt, Mirjam; Vastani, Nisha; Leffler, Andreas; Reeh, Peter; Bevan, Stuart			Streptozotocin Stimulates the Ion Channel TRPA1 Directly INVOLVEMENT OF PEROXYNITRITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATE TRPA1; NITRIC-OXIDE; SENSORY NEUROPATHY; PANCREATIC-ISLETS; GENERATION; COLD; HYPERALGESIA; CONTRIBUTES; MECHANISMS; RECEPTOR	Streptozotocin (STZ)-induced diabetes is the most commonly used animal model of diabetes. Here, we have demonstrated that intraplantar injections of low dose STZ evoked acute polymodal hypersensitivities in mice. These hypersensitivities were inhibited by a TRPA1 antagonist and were absent in TRPA1-null mice. In wild type mice, systemic STZ treatment (180 mg/kg) evoked a loss of cold and mechanical sensitivity within an hour of injection, which lasted for at least 10 days. In contrast, Trpa1(-/-) mice developed mechanical, cold, and heat hypersensitivity 24 h after STZ. The TRPA1-dependent sensory loss produced by STZ occurs before the onset of diabetes and may thus not be readily distinguished from the similar sensory abnormalities produced by the ensuing diabetic neuropathy. In vitro, STZ activated TRPA1 in isolated sensory neurons, TRPA1 cell lines, and membrane patches. Mass spectrometry studies revealed that STZ oxidizes TRPA1 cysteines to disulfides and sulfenic acids. Furthermore, incubation of tyrosine with STZ resulted in formation of dityrosine, suggesting formation of peroxynitrite. Functional analysis of TRPA1 mutants showed that cysteine residues that were oxidized by STZ were important for TRPA1 responsiveness to STZ. Our results have identified oxidation of TRPA1 cysteine residues, most likely by peroxynitrite, as a novel mechanism of action of STZ. Direct stimulation of TRPA1 complicates the interpretation of results from STZ models of diabetic sensory neuropathy and strongly argues that more refined models of diabetic neuropathy should replace the use of STZ.	[Andersson, David A.; Gentry, Clive; Vastani, Nisha; Bevan, Stuart] Kings Coll London, Wolfson Ctr Agerelated Dis, London SE1 1UL, England; [Filipovic, Milos R.] Univ Erlangen Nurnberg, Dept Chem & Pharm, Bioinorgan Chem Div, D-91058 Erlangen, Germany; [Eberhardt, Mirjam; Leffler, Andreas] Hannover Med Sch, Dept Anesthesiol & Intens Care, D-30625 Hannover, Germany; [Reeh, Peter] Univ Erlangen Nurnberg, Inst Physiol & Pathophysiol, D-91054 Erlangen, Germany	University of London; King's College London; University of Erlangen Nuremberg; Hannover Medical School; University of Erlangen Nuremberg	Andersson, DA (corresponding author), Kings Coll London, Wolfson Ctr Agerelated Dis, Hodgkin Bldg,Guys Campus, London SE1 1UL, England.	david.andersson@kcl.ac.uk	Reeh, Peter W./J-8981-2012; Bevan, Stuart/A-8821-2008; Andersson, David A/C-3435-2008; Filipovic, Milos/D-5482-2014	Reeh, Peter W./0000-0002-4367-094X; Andersson, David A/0000-0001-7451-8548; Filipovic, Milos/0000-0003-0060-0041	Diabetes UK Alec and Beryl Warren Award BDA [13/0004649]; FAU Erlangen-Nuremberg (EFI-MRIC); Diabetes UK [13/0004649] Funding Source: researchfish	Diabetes UK Alec and Beryl Warren Award BDA(Diabetes UK); FAU Erlangen-Nuremberg (EFI-MRIC); Diabetes UK(Diabetes UK)	This work was supported in part by the Diabetes UK Alec and Beryl Warren Award BDA 13/0004649 (to D. A. A. and S. B.).; Supported by FAU Erlangen-Nuremberg (EFI-MRIC).	Alvarez B, 1999, J BIOL CHEM, V274, P842, DOI 10.1074/jbc.274.2.842; Andersson DA, 2008, J NEUROSCI, V28, P2485, DOI 10.1523/JNEUROSCI.5369-07.2008; Andersson DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077986; Andersson DA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1559; Andersson DA, 2009, P NATL ACAD SCI USA, V106, P8374, DOI 10.1073/pnas.0812675106; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Bessac BF, 2008, J CLIN INVEST, V118, P1899, DOI 10.1172/JCI34192; BEVAN S, 1995, J NEUROSCI, V15, P4918; Bierhaus A, 2012, NAT MED, V18, P926, DOI 10.1038/nm.2750; Bishnoi M, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-52; Cao DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038005; Cunha JM, 2009, BRAZ J MED BIOL RES, V42, P197, DOI 10.1590/S0100-879X2009000200008; Dai Y, 2007, J CLIN INVEST, V117, P1979, DOI 10.1172/JCI30951; Day BJ, 1997, ARCH BIOCHEM BIOPHYS, V347, P256, DOI 10.1006/abbi.1997.0341; Drel VR, 2007, EUR J PHARMACOL, V569, P48, DOI 10.1016/j.ejphar.2007.05.055; Dworkin RH, 2007, PAIN, V132, P237, DOI 10.1016/j.pain.2007.08.033; Eberhardt M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5381; Eberhardt MJ, 2012, J BIOL CHEM, V287, P28291, DOI 10.1074/jbc.M111.328674; Edwards JL, 2008, PHARMACOL THERAPEUT, V120, P1, DOI 10.1016/j.pharmthera.2008.05.005; Eid SR, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-48; EIZIRIK DL, 1988, DIABETOLOGIA, V31, P168, DOI 10.1007/BF00276851; Engel MA, 2011, GASTROENTEROLOGY, V141, P1346, DOI 10.1053/j.gastro.2011.07.002; Filipovic MR, 2007, FREE RADICAL RES, V41, P62, DOI 10.1080/10715760600944296; Fleming T, 2012, DIABETOLOGIA, V55, P1151, DOI 10.1007/s00125-012-2452-1; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Friedel FC, 2012, J INORG BIOCHEM, V109, P26, DOI 10.1016/j.jinorgbio.2011.12.008; Gentry C, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-4; Hill K, 2009, CELL CALCIUM, V45, P155, DOI 10.1016/j.ceca.2008.08.001; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Jack MM, 2012, EXP NEUROL, V234, P62, DOI 10.1016/j.expneurol.2011.12.015; JANCSO N, 1967, BRIT J PHARM CHEMOTH, V31, P138, DOI 10.1111/j.1476-5381.1967.tb01984.x; Jeffry JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007021; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kissner R, 1997, CHEM RES TOXICOL, V10, P1285, DOI 10.1021/tx970160x; Koivisto A, 2012, PHARMACOL RES, V65, P149, DOI 10.1016/j.phrs.2011.10.006; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; KWON NS, 1994, FASEB J, V8, P529, DOI 10.1096/fasebj.8.8.8181671; Lancaster JR, 2006, CHEM RES TOXICOL, V19, P1160, DOI 10.1021/tx060061w; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Moparthi L, 2014, P NATL ACAD SCI USA, V111, P16901, DOI 10.1073/pnas.1412689111; Nagai R, 2002, DIABETES, V51, P2833, DOI 10.2337/diabetes.51.9.2833; NUKATSUKA M, 1988, FEBS LETT, V239, P295, DOI 10.1016/0014-5793(88)80938-4; Obata K, 2005, J CLIN INVEST, V115, P2393, DOI 10.1172/JCI23437; Obrosova IG, 2009, NEUROTHERAPEUTICS, V6, P638, DOI 10.1016/j.nurt.2009.07.004; Petrus M, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-40; PIPELEERS D, 1986, P NATL ACAD SCI USA, V83, P5267, DOI 10.1073/pnas.83.14.5267; Raza H, 2012, INT J MOL SCI, V13, P5751, DOI 10.3390/ijms13055751; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Sugimoto K, 2008, CURR PHARM DESIGN, V14, P953, DOI 10.2174/138161208784139774; Szolcsanyi J, 2004, NEUROPEPTIDES, V38, P377, DOI 10.1016/j.npep.2004.07.005; Takahashi N, 2008, CHANNELS, V2, P287, DOI 10.4161/chan.2.4.6745; TAKASU N, 1991, DIABETES, V40, P1141, DOI 10.2337/diabetes.40.9.1141; Tomlinson DR, 2008, NAT REV NEUROSCI, V9, P36, DOI 10.1038/nrn2294; Vincent AM, 2011, NAT REV NEUROL, V7, P573, DOI 10.1038/nrneurol.2011.137; Wang S, 2008, BRAIN, V131, P1241, DOI 10.1093/brain/awn060; Wei H, 2009, ANESTHESIOLOGY, V111, P147, DOI 10.1097/ALN.0b013e3181a1642b; Willis WD, 2006, PROG NEUROBIOL, V78, P189, DOI 10.1016/j.pneurobio.2006.02.007; WINK DA, 1994, CHEM RES TOXICOL, V7, P519, DOI 10.1021/tx00040a007; Wrigglesworth R, 1996, J MED CHEM, V39, P4942, DOI 10.1021/jm960512h; Zygmunt PM, 2014, HANDB EXP PHARMACOL, V222, P583, DOI 10.1007/978-3-642-54215-2_23	62	53	54	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15185	15196		10.1074/jbc.M115.644476	http://dx.doi.org/10.1074/jbc.M115.644476			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25903127	Green Published, hybrid			2022-12-28	WOS:000356177300032
J	Lim, PX; Patel, DR; Poisson, KE; Basuita, M; Tsai, C; Lyndaker, AM; Hwang, BJ; Lu, AL; Weiss, RS				Lim, Pei Xin; Patel, Darshil R.; Poisson, Kelsey E.; Basuita, Manpreet; Tsai, Charlton; Lyndaker, Amy M.; Hwang, Bor-Jang; Lu, A-Lien; Weiss, Robert S.			Genome Protection by the 9-1-1 Complex Subunit HUS1 Requires Clamp Formation, DNA Contacts, and ATR Signaling-independent Effector Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CHECKPOINT SENSOR; CELL NUCLEAR ANTIGEN; DAMAGE RESPONSE; STRUCTURAL BASIS; SLIDING CLAMP; FISSION YEAST; MUTY HOMOLOG; PCNA; RAD9-HUS1-RAD1; RECRUITMENT	The RAD9A-HUS1-RAD1 (9-1-1) complex is a heterotrimeric clamp that promotes checkpoint signaling and repair at DNA damage sites. In this study, we elucidated HUS1 functional residues that drive clamp assembly, DNA interactions, and downstream effector functions. First, we mapped a HUS1-RAD9A interface residue that was critical for 9-1-1 assembly and DNA loading. Next, we identified multiple positively charged residues in the inner ring of HUS1 that were crucial for genotoxin-induced 9-1-1 chromatin localization and ATR signaling. Finally, we found two hydrophobic pockets on the HUS1 outer surface that were important for cell survival after DNA damage. Interestingly, these pockets were not required for 9-1-1 chromatin localization or ATR-mediated CHK1 activation but were necessary for interactions between HUS1 and its binding partner MYH, suggesting that they serve as interaction domains for the recruitment and coordination of downstream effectors at damage sites. Together, these results indicate that, once properly loaded onto damaged DNA, the 9-1-1 complex executes multiple, separable functions that promote genome maintenance.	[Lim, Pei Xin; Patel, Darshil R.; Poisson, Kelsey E.; Basuita, Manpreet; Tsai, Charlton; Lyndaker, Amy M.; Weiss, Robert S.] Cornell Univ, Dept Biomed Sci, Ithaca, NY 14853 USA; [Hwang, Bor-Jang; Lu, A-Lien] Univ Maryland, Dept Biochem & Mol Biol, Sch Med, Baltimore, MD 21201 USA	Cornell University; University System of Maryland; University of Maryland Baltimore	Weiss, RS (corresponding author), Cornell Univ, Dept Biomed Sci, Tower Rd, Ithaca, NY 14853 USA.	rsw26@cornell.edu	Regan, Clinton/E-6250-2012	Tsai, Charlton/0000-0003-0502-7467; Lim, Pei Xin/0000-0001-5742-3539	National Institutes of Health [R01 CA108773, R01 CA78391]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD052471] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA078391, R01CA108773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007273] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA108773 (to R. S. W.) and R01 CA78391 (to A. L.).	Abmayr Susan M, 2006, Curr Protoc Pharmacol, VChapter 12, DOI [10.1002/0471142727.mb1201s75, 10.1002/0471141755.ph1203s35]; Alver RC, 2014, NUCLEIC ACIDS RES, V42, P8389, DOI 10.1093/nar/gku479; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bai HB, 2010, DNA REPAIR, V9, P478, DOI 10.1016/j.dnarep.2010.01.011; Beattie TR, 2012, EMBO J, V31, P1556, DOI 10.1038/emboj.2012.12; Bermudez VP, 2003, P NATL ACAD SCI USA, V100, P1633, DOI 10.1073/pnas.0437927100; Bunting KA, 2003, EMBO J, V22, P5883, DOI 10.1093/emboj/cdg568; Chang DY, 2005, J BIOL CHEM, V280, P408, DOI 10.1074/jbc.M406800200; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Danielsen JMR, 2009, J BIOL CHEM, V284, P4140, DOI 10.1074/jbc.M808174200; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Dionne I, 2003, MOL CELL, V11, P275, DOI 10.1016/S1097-2765(02)00824-9; Dore AS, 2009, MOL CELL, V34, P735, DOI 10.1016/j.molcel.2009.04.027; Eichinger CS, 2011, TRENDS BIOCHEM SCI, V36, P563, DOI 10.1016/j.tibs.2011.08.002; Eichinger CS, 2010, P NATL ACAD SCI USA, V107, P11370, DOI 10.1073/pnas.1004248107; Ellison V, 2003, PLOS BIOL, V1, P231, DOI 10.1371/journal.pbio.0000033; Friedrich-Heineken F, 2005, J MOL BIOL, V353, P980, DOI 10.1016/j.jmb.2005.09.018; Gembka A, 2007, NUCLEIC ACIDS RES, V35, P2596, DOI 10.1093/nar/gkl1139; Georgescu RE, 2008, CELL, V132, P43, DOI 10.1016/j.cell.2007.11.045; Gu YS, 2001, NUCLEIC ACIDS RES, V29, P2666, DOI 10.1093/nar/29.12.2666; Guan X, 2007, NUCLEIC ACIDS RES, V35, P6207, DOI 10.1093/nar/gkm678; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Han L, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-67; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Helt CE, 2005, CELL CYCLE, V4, P529, DOI 10.4161/cc.4.4.1598; HINDS PW, 1990, CELL GROWTH DIFFER, V1, P571; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hopkins KM, 2004, MOL CELL BIOL, V24, P7235, DOI 10.1128/MCB.24.16.7235-7248.2004; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kaur R, 2001, MOL BIOL CELL, V12, P3744, DOI 10.1091/mbc.12.12.3744; Lyndaker AM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003320; Madabushi A., 2011, ADV MED BIOL, P41; Majka J, 2006, J BIOL CHEM, V281, P27855, DOI 10.1074/jbc.M605176200; McNally R, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-3; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Naryzhny SN, 2008, CELL MOL LIFE SCI, V65, P3789, DOI 10.1007/s00018-008-8305-x; Park MJ, 2009, DNA REPAIR, V8, P1190, DOI 10.1016/j.dnarep.2009.06.004; Querol-Audi J, 2012, P NATL ACAD SCI USA, V109, P8528, DOI 10.1073/pnas.1121116109; Sakurai S, 2005, EMBO J, V24, P683, DOI 10.1038/sj.emboj.7600519; Shi GL, 2006, BIOCHEM J, V400, P53, DOI 10.1042/BJ20060774; Smirnova E, 2005, BIOCHEM J, V389, P13, DOI 10.1042/BJ20050211; Sohn SY, 2009, J MOL BIOL, V390, P490, DOI 10.1016/j.jmb.2009.05.028; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vasileva A, 2013, J CELL SCI, V126, P3927, DOI 10.1242/jcs.126763; Weiss RS, 2000, GENE DEV, V14, P1886; Weiss RS, 2002, CURR BIOL, V12, P73, DOI 10.1016/S0960-9822(01)00626-1; Xing GX, 2009, MOL MICROBIOL, V71, P678, DOI 10.1111/j.1365-2958.2008.06553.x; Xu M, 2009, J BIOL CHEM, V284, P20457, DOI 10.1074/jbc.C109.022384; Xu XJ, 2013, NUCLEIC ACIDS RES, V41, P10020, DOI 10.1093/nar/gkt810; Yazinski SA, 2009, P NATL ACAD SCI USA, V106, P21282, DOI 10.1073/pnas.0904965106	52	12	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					14826	14840		10.1074/jbc.M114.630640	http://dx.doi.org/10.1074/jbc.M114.630640			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25911100	hybrid, Green Published			2022-12-28	WOS:000356177300003
J	Rosenthal, AK; Gohr, CM; Mitton-Fitzgerald, E; Grewal, R; Ninomiya, J; Coyne, CB; Jackson, WT				Rosenthal, Ann K.; Gohr, Claudia M.; Mitton-Fitzgerald, Elizabeth; Grewal, Rupinder; Ninomiya, James; Coyne, Carolyn B.; Jackson, William T.			Autophagy Modulates Articular Cartilage Vesicle Formation in Primary Articular Chondrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM PYROPHOSPHATE DIHYDRATE; MATRIX VESICLES; CELL-DEATH; UNCONVENTIONAL SECRETION; OSTEOARTHRITIC CARTILAGE; ACTIVATION; PROTEIN; ELABORATION; MICROVILLI; MECHANISM	Chondrocyte-derived extracellular organelles known as articular cartilage vesicles (ACVs) participate in non-classical protein secretion, intercellular communication, and pathologic calcification. Factors affecting ACV formation and release remain poorly characterized; although in some cell types, the generation of extracellular vesicles is associated with up-regulation of autophagy. We sought to determine the role of autophagy in ACV production by primary articular chondrocytes. Using an innovative dynamic model with a light scatter nanoparticle counting apparatus, we determined the effects of autophagy modulators on ACV number and content in conditioned medium from normal adult porcine and human osteoarthritic chondrocytes. Healthy articular chondrocytes release ACVs into conditioned medium and show significant levels of ongoing autophagy. Rapamycin, which promotes autophagy, increased ACV numbers in a dose- and time-dependent manner associated with increased levels of autophagy markers and autophagosome formation. These effects were suppressed by pharmacologic autophagy inhibitors and short interfering RNA for ATG5. Caspase-3 inhibition and a Rho/ROCK inhibitor prevented rapamycin-induced increases in ACV number. Osteoarthritic chondrocytes, which are deficient in autophagy, did not increase ACV number in response to rapamycin. SMER28, which induces autophagy via an mTOR-independent mechanism, also increased ACV number. ACVs induced under all conditions had similar ecto-enzyme specific activities and types of RNA, and all ACVs contained LC3, an autophagosome-resident protein. These findings identify autophagy as a critical participant in ACV formation, and augment our understanding of ACVs in cartilage disease and repair.	[Rosenthal, Ann K.; Gohr, Claudia M.; Mitton-Fitzgerald, Elizabeth; Grewal, Rupinder] Zablocki VA Med Ctr, Dept Med, Div Rheumatol, Milwaukee, WI 53295 USA; [Ninomiya, James] Med Coll Wisconsin, Dept Orthoped Surg, Milwaukee, WI 53226 USA; [Jackson, William T.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA; [Jackson, William T.] Med Coll Wisconsin, Ctr Infect Dis Res, Milwaukee, WI 53226 USA; [Coyne, Carolyn B.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15219 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Rosenthal, AK (corresponding author), Zablocki VA Med Ctr, Rheumatol Sect, Cc-111W,5000 W Natl Ave, Milwaukee, WI 53295 USA.	ann.rosenthal@va.gov	Regan, Clinton/E-6250-2012		Veteran's Affairs Research Service; Dept. of Veteran's Affairs [101BX000812]; National Institutes of Health [R01-AI104928]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104928] Funding Source: NIH RePORTER; Veterans Affairs [I01CX001143, I01BX000812] Funding Source: NIH RePORTER	Veteran's Affairs Research Service(US Department of Veterans Affairs); Dept. of Veteran's Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the Veteran's Affairs Research Service with a Merit Review Grant from the Dept. of Veteran's Affairs (to A. K. R., 101BX000812) and National Institutes of Health Grant R01-AI104928 (to W. T. J.).	Almonte-Becerril M, 2010, APOPTOSIS, V15, P631, DOI 10.1007/s10495-010-0458-z; Antonyak MA, 2011, P NATL ACAD SCI USA, V108, P4852, DOI 10.1073/pnas.1017667108; ARKESTEIJN CLM, 1976, J CLIN CHEM CLIN BIO, V14, P155; Bovellan M, 2010, FEBS J, V277, P58, DOI 10.1111/j.1742-4658.2009.07412.x; Carames B, 2012, ANN RHEUM DIS, V71, P575, DOI 10.1136/annrheumdis-2011-200557; Carames B, 2010, ARTHRITIS RHEUM-US, V62, P791, DOI 10.1002/art.27305; CHEN J, 1995, P NATL ACAD SCI USA, V92, P4947, DOI 10.1073/pnas.92.11.4947; Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239; Derfus B, 1998, CALCIFIED TISSUE INT, V63, P258, DOI 10.1007/s002239900523; DERFUS BA, 1992, ARTHRITIS RHEUM, V35, P231, DOI 10.1002/art.1780350218; Derfus BA, 1996, CONNECT TISSUE RES, V35, P337, DOI 10.3109/03008209609029209; Derfus BA, 2001, OSTEOARTHR CARTILAGE, V9, P189, DOI 10.1053/joca.2000.0375; Duran JM, 2010, J CELL BIOL, V188, P527, DOI 10.1083/jcb.200911154; Fader CM, 2008, TRAFFIC, V9, P230, DOI 10.1111/j.1600-0854.2007.00677.x; Godin CM, 2010, MOL PHARMACOL, V77, P903, DOI 10.1124/mol.110.063859; Gottlieb RA, 2013, AUTOPHAGY IN HEALTH AND DISEASE, P3, DOI 10.1016/B978-0-12-385101-7.00001-2; HALE JE, 1987, J BIOL CHEM, V262, P1916; Huang KZ, 2014, SEMIN CELL DEV BIOL, V36, P79, DOI 10.1016/j.semcdb.2014.09.011; Jaovisidha K, 2002, OSTEOARTHR CARTILAGE, V10, P646, DOI 10.1053/joca.2002.0722; Kalamida D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102408; Kulich I, 2014, INT J MOL SCI, V15, P7462, DOI 10.3390/ijms15057462; Lee SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019163; de Figueroa PL, 2015, ARTHRITIS RHEUMATOL, V67, P966, DOI 10.1002/art.39025; Manjithaya R, 2010, AUTOPHAGY, V6, P650, DOI 10.4161/auto.6.5.12066; MITCHELL PG, 1992, ARTHRITIS RHEUM, V35, P343, DOI 10.1002/art.1780350314; Mitton E, 2009, BIOCHEM BIOPH RES CO, V388, P533, DOI 10.1016/j.bbrc.2009.08.038; Pallet N, 2013, PROTEOMICS, V13, P1108, DOI 10.1002/pmic.201200531; Pfeiffer ZA, 2004, J LEUKOCYTE BIOL, V75, P1173, DOI 10.1189/jlb.1203648; Roach HI, 2004, APOPTOSIS, V9, P265, DOI 10.1023/B:APPT.0000025803.17498.26; ROSENTHAL AK, 1991, ARTHRITIS RHEUM, V34, P904, DOI 10.1002/art.1780340717; Rosenthal AK, 2011, ARTHRITIS RHEUM-US, V63, P401, DOI 10.1002/art.30120; ROY S, 1968, ANN RHEUM DIS, V27, P544, DOI 10.1136/ard.27.6.544; Sasaki H, 2012, ARTHRITIS RHEUM-US, V64, P1920, DOI 10.1002/art.34323; Shen D, 2011, CELL BIOCHEM BIOPHYS, V60, P173, DOI 10.1007/s12013-010-9138-4; Sirois I, 2012, AUTOPHAGY, V8, P927, DOI 10.4161/auto.19768; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Thouverey C, 2009, J CELL BIOCHEM, V106, P127, DOI 10.1002/jcb.21992; Wang A.L, 2009, PLOS ONE, V4, pe5304, DOI DOI 10.1371/JOURNAL.PONE.0004160; Wang AM, 2009, AUTOPHAGY, V5, P864, DOI 10.4161/auto.9041; Wiley JS, 2011, TISSUE ANTIGENS, V78, P321, DOI 10.1111/j.1399-0039.2011.01780.x; Zhang M, 2013, SCIENCE, V340, P559, DOI 10.1126/science.1234740	41	21	24	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13028	13038		10.1074/jbc.M114.630558	http://dx.doi.org/10.1074/jbc.M114.630558			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25869133	Green Published, hybrid			2022-12-28	WOS:000354975700005
J	Zhang, ZT; Elsayed, AK; Shi, QQ; Zhang, YN; Zuo, QS; Li, D; Lian, C; Tang, BB; Xiao, TR; Xu, Q; Chang, GB; Chen, GH; Zhang, L; Wang, KH; Wang, YJ; Jin, K; Wang, YL; Song, JZ; Cui, HM; Li, BC				Zhang, Zhentao; Elsayed, Ahmed Kamel; Shi, Qingqing; Zhang, Yani; Zuo, Qisheng; Li, Dong; Lian, Chao; Tang, Beibei; Xiao, Tianrong; Xu, Qi; Chang, Guobin; Chen, Guohong; Zhang, Lei; Wang, Kehua; Wang, Yingjie; Jin, Kai; Wang, Yilin; Song, Jiuzhou; Cui, Hengmi; Li, Bichun			Crucial Genes and Pathways in Chicken Germ Stem Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; FUNCTIONAL-CHARACTERIZATION; MOLECULAR EVOLUTION; SIGNAL-TRANSDUCTION; SELF-RENEWAL; EXPRESSION; PROTEIN; MOUSE; IDENTIFICATION; CHROMOSOME	Male germ cell differentiation is a subtle and complex regulatory process. Currently, its regulatory mechanism is still not fully understood. In our experiment, we performed the first comprehensive genome and transcriptome-wide analyses of the crucial genes and signaling pathways in three kinds of crucial cells (embryonic stem cells, primordial germ cell, and spermatogonial stem cells) that are associated with the male germ cell differentiation. We identified thousands of differentially expressed genes in this process, and from these we chose 173 candidate genes, of which 98 genes were involved in cell differentiation, 19 were involved in the metabolic process, and 56 were involved in the differentiation and metabolic processes, like GAL9, AMH, PLK1, and PSMD7 and so on. In addition, we found that 18 key signaling pathways were involved mainly in cell proliferation, differentiation, and signal transduction processes like TGF-beta, Notch, and Jak-STAT. Further exploration found that the candidate gene expression patterns were the same between in vitro induction experiments and transcriptome results. Our results yield clues to the mechanistic basis of male germ cell differentiation and provide an important reference for further studies.	[Zhang, Zhentao; Elsayed, Ahmed Kamel; Shi, Qingqing; Zhang, Yani; Zuo, Qisheng; Li, Dong; Lian, Chao; Tang, Beibei; Xiao, Tianrong; Xu, Qi; Chang, Guobin; Chen, Guohong; Zhang, Lei; Wang, Yingjie; Jin, Kai; Wang, Yilin; Cui, Hengmi; Li, Bichun] Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou 225009, Jiangsu, Peoples R China; [Wang, Kehua] Chinese Acad Agr Sci, Poultry Inst, Yangzhou 225009, Jiangsu, Peoples R China; [Song, Jiuzhou] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20740 USA; [Elsayed, Ahmed Kamel] Suez Canal Univ, Coll Vet Med, Dept Anat & Embryol, Ismailia 41522, Egypt	Yangzhou University; Chinese Academy of Agricultural Sciences; University System of Maryland; University of Maryland College Park; Egyptian Knowledge Bank (EKB); Suez Canal University	Zhang, YN (corresponding author), Yangzhou Univ, Coll Anim Sci & Technol, 48 East Wenhui Rd, Yangzhou 225009, Jiangsu, Peoples R China.	ynzhang@yzu.edu.cn; yubcli@yzu.edu.cn	XU, Qi/AID-2262-2022; Elsayed, Ahmed/AAC-9689-2020; JIN, KAI/AAY-8565-2020; Song, Jiuzhou/AAD-6440-2020	JIN, KAI/0000-0003-2489-2173; Kamel, Ahmed/0000-0002-2519-1531				Aplin AE, 1999, CURR OPIN CELL BIOL, V11, P737, DOI 10.1016/S0955-0674(99)00045-9; Arikawa T, 2009, BONE, V44, P849, DOI 10.1016/j.bone.2009.01.365; Ault BH, 2000, PEDIATR NEPHROL, V14, P1045, DOI 10.1007/s004670050069; Backstrom N, 2005, MOL BIOL EVOL, V22, P1992, DOI 10.1093/molbev/msi198; Beguin P, 2001, NATURE, V411, P701, DOI 10.1038/35079621; BEHRINGER RR, 1994, CURR TOP DEV BIOL, V29, P171, DOI 10.1016/S0070-2153(08)60550-5; Boudreau J, 1999, BIOCHEM J, V339, P481, DOI 10.1042/0264-6021:3390481; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Breau MA, 2013, P NATL ACAD SCI USA, V110, P16892, DOI 10.1073/pnas.1306282110; Briggs MM, 2000, J EXP BIOL, V203, P2485; Butcher JT, 2007, DEV BIOL, V302, P256, DOI 10.1016/j.ydbio.2006.09.048; Camerino GM, 2006, CELL MOL BIOL, V52, P51, DOI 10.1170/T750; Ceplitis H, 2004, MOL BIOL EVOL, V21, P249, DOI 10.1093/molbev/msg239; CHAKRAVARTI S, 1995, MAMM GENOME, V6, P367, DOI 10.1007/BF00364803; Chen CH, 1997, J BIOL CHEM, V272, P8679, DOI 10.1074/jbc.272.13.8679; Chen CMA, 2000, MECH DEVELOP, V90, P293; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Dann CT, 2008, STEM CELLS, V26, P2928, DOI 10.1634/stemcells.2008-0134; Edelmann HML, 1999, BIOL CHEM, V380, P231, DOI 10.1515/BC.1999.031; Edgar AJ, 1996, J ANAT, V189, P451; Ellegren H, 2001, GENETICS, V158, P325; Ewen KA, 2010, MOL CELL ENDOCRINOL, V323, P76, DOI 10.1016/j.mce.2009.12.013; Fan XH, 2003, MOL CELL BIOL, V23, P4637, DOI 10.1128/MCB.23.13.4637-4648.2003; Foley HA, 2002, J BIOL CHEM, V277, P16211, DOI 10.1074/jbc.M106556200; FRANK I, 1989, J VIROL, V63, P4479, DOI 10.1128/JVI.63.11.4479-4488.1989; Garcez RC, 2014, CELL MOL LIFE SCI, V71, P2149, DOI 10.1007/s00018-013-1477-z; Grigoryev SA, 1999, J BIOL CHEM, V274, P5626, DOI 10.1074/jbc.274.9.5626; Grottoli S, 1996, J ENDOCRINOL INVEST, V19, P739, DOI 10.1007/BF03347877; Gupta-Rossi N, 2011, J BIOL CHEM, V286, P18720, DOI 10.1074/jbc.M110.190769; Haddad N, 2011, AM J PHYSIOL-RENAL, V301, pF1057, DOI 10.1152/ajprenal.00497.2010; Handel MA, 2006, MOL CELL ENDOCRINOL, V250, P201, DOI 10.1016/j.mce.2005.12.046; HARWIG SSL, 1994, FEBS LETT, V342, P281, DOI 10.1016/0014-5793(94)80517-2; Hattori S, 1996, YAKUGAKU ZASSHI, V116, P21, DOI 10.1248/yakushi1947.116.1_21; HIGGS DR, 1989, BLOOD, V73, P1081; Hori T, 2000, MOL BIOL CELL, V11, P3645, DOI 10.1091/mbc.11.10.3645; Hu JJ, 2010, J BIOL CHEM, V285, P33113, DOI 10.1074/jbc.M110.117044; Huber TB, 2003, HUM MOL GENET, V12, P3397, DOI 10.1093/hmg/ddg360; Irwin DM, 2003, J MOL EVOL, V56, P234, DOI 10.1007/s00239-002-2396-z; Johnson PA, 2008, BIOL REPROD, V78, P13, DOI 10.1095/biolreprod.107.061879; Kitadate Y, 2010, P NATL ACAD SCI USA, V107, P14241, DOI 10.1073/pnas.1003462107; KullakUblick GA, 1996, J HEPATOL, V25, P985, DOI 10.1016/S0168-8278(96)80307-2; KULLAKUBLICK GA, 1995, GASTROENTEROLOGY, V109, P1274, DOI 10.1016/0016-5085(95)90588-X; Kumar MS, 2003, CIRC RES, V92, P840, DOI 10.1161/01.RES.0000069031.55281.7C; Lee EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063627; LOPEZ FJ, 1991, P NATL ACAD SCI USA, V88, P4508, DOI 10.1073/pnas.88.10.4508; MacLean G, 2001, MECH DEVELOP, V107, P195, DOI 10.1016/S0925-4773(01)00463-4; MAGUIRE J, 1994, SCIENCE, V265, P241, DOI 10.1126/science.7912851; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Miles DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054606; Milona P, 2007, BIOCHEM BIOPH RES CO, V356, P169, DOI 10.1016/j.bbrc.2007.02.098; Mu H, 2003, MECH DEVELOP, V120, P143, DOI 10.1016/S0925-4773(02)00423-9; MURAGAKI Y, 1991, EUR J BIOCHEM, V197, P615, DOI 10.1111/j.1432-1033.1991.tb15951.x; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Pernaute B, 2010, DEV DYNAM, V239, P620, DOI 10.1002/dvdy.22176; Pommereit D, 2001, MECH DEVELOP, V102, P255, DOI 10.1016/S0925-4773(01)00305-7; Rao M, 2004, DEV BIOL, V275, P269, DOI 10.1016/j.ydbio.2004.08.013; Rastegar T, 2013, IRAN J BASIC MED SCI, V16, P134; Revenkova E, 2004, NAT CELL BIOL, V6, P555, DOI 10.1038/ncb1135; Sahlender DA, 2005, J CELL BIOL, V169, P285, DOI 10.1083/jcb.200501162; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Saitou M, 2005, CELL CYCLE, V4, P1736, DOI 10.4161/cc.4.12.2209; SAJJADI FG, 1991, NEW BIOL, V3, P769; Salic AN, 1997, DEVELOPMENT, V124, P4739; Scaal M, 2001, ANAT EMBRYOL, V203, P1, DOI 10.1007/PL00008244; Schwarz K, 2001, J CLIN INVEST, V108, P1621, DOI 10.1172/JCI12849; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Smith CA, 2009, INT J DEV BIOL, V53, P59, DOI 10.1387/ijdb.082742cs; SUMOY L, 1995, DEV BIOL, V170, P230, DOI 10.1006/dbio.1995.1210; SZALA S, 1990, P NATL ACAD SCI USA, V87, P6833, DOI 10.1073/pnas.87.17.6833; TAKESHITA S, 1993, BIOCHEM J, V294, P271, DOI 10.1042/bj2940271; Trbovich AM, 2004, J STEROID BIOCHEM, V92, P199, DOI 10.1016/j.jsbmb.2004.07.002; Tsuneyoshi N, 2008, BIOCHEM BIOPH RES CO, V367, P899, DOI 10.1016/j.bbrc.2007.12.189; Wahlberg K, 2009, BLOOD, V114, P1254, DOI 10.1182/blood-2009-03-210146; Wang B, 2006, NUTR NEUROSCI, V9, P147, DOI 10.1080/10284150600903594; WEISS J, 1987, BLOOD, V69, P652; Western PS, 1999, DEV DYNAM, V216, P411; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Xiao YJ, 2006, J BIOL CHEM, V281, P2858, DOI 10.1074/jbc.M507180200; Yu Z, 2009, J MOL CELL BIOL, V1, P93, DOI 10.1093/jmcb/mjp026; Zhang YG, 2008, J HYPERTENS, V26, P1119, DOI 10.1097/HJH.0b013e3282fa1412; Zhou JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065755; Zhou Q, 2008, BIOL REPROD, V78, P537, DOI 10.1095/biolreprod.107.064337	84	30	32	0	28	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13605	13621		10.1074/jbc.M114.601401	http://dx.doi.org/10.1074/jbc.M114.601401			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25847247	Green Published, hybrid			2022-12-28	WOS:000354975700053
J	Lillehoj, EP; Hyun, SW; Liu, AG; Guang, W; Verceles, AC; Luzina, IG; Atamas, SP; Kim, KC; Goldblum, SE				Lillehoj, Erik P.; Hyun, Sang Won; Liu, Anguo; Guang, Wei; Verceles, Avelino C.; Luzina, Irina G.; Atamas, Sergei P.; Kim, K. Chul; Goldblum, Simeon E.			NEU1 Sialidase Regulates Membrane-tethered Mucin (MUC1) Ectodomain Adhesiveness for Pseudomonas aeruginosa and Decoy Receptor Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; AIRWAY EPITHELIAL-CELLS; C-SRC; ANTIGEN; INTERLEUKIN-8; INFECTION; ADHERENCE; SURFACE; PILI	Airway epithelia express sialylated receptors that recognize exogenous danger signals. Regulation of receptor responsiveness to these signals remains incompletely defined. Here, we explore the mechanisms through which the human sialidase, neuraminidase-1 (NEU1), promotes the interaction between the sialoprotein, mucin 1 (MUC1), and the opportunistic pathogen, Pseudomonas aeruginosa. P. aeruginosa flagellin engaged the MUC1 ectodomain (ED), increasing NEU1 association with MUC1. The flagellin stimulus increased the association of MUC1-ED with both NEU1 and its chaperone/transport protein, protective protein/cathepsin A. Scatchard analysis demonstrated NEU1-dependent increased binding affinity of flagellin to MUC1-expressing epithelia. NEU1-driven MUC1-ED desialylation rapidly increased P. aeruginosa adhesion to and invasion of the airway epithelium. MUC1-ED desialylation also increased its shedding, and the shed MUC1-ED competitively blocked P. aeruginosa adhesion to cell-associated MUC1-ED. Levels of desialylated MUC1-ED were elevated in the bronchoalveolar lavage fluid of mechanically ventilated patients with P. aeruginosa airway colonization. Preincubation of P. aeruginosa with these same ex vivo fluids competitively inhibited bacterial adhesion to airway epithelia, and MUC1-ED immunodepletion completely abrogated their inhibitory activity. These data indicate that a prokaryote, P. aeruginosa, in a ligand-specific manner, mobilizes eukaryotic NEU1 to enhance bacterial pathogenicity, but the host retaliates by releasing MUC1-ED into the airway lumen as a hyperadhesive decoy receptor.	[Lillehoj, Erik P.; Guang, Wei] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA; [Hyun, Sang Won; Liu, Anguo; Verceles, Avelino C.; Luzina, Irina G.; Atamas, Sergei P.; Goldblum, Simeon E.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Goldblum, Simeon E.] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Luzina, Irina G.; Atamas, Sergei P.; Goldblum, Simeon E.] Baltimore Vet Affairs Med Ctr, Baltimore, MD 21201 USA; [Kim, K. Chul] Univ Arizona, Coll Med, Dept Otolaryngol, Tucson, AZ 85724 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center; University of Arizona	Goldblum, SE (corresponding author), Univ Maryland, Sch Med, 20 Penn St,Rm 351, Baltimore, MD 21201 USA.	sgoldblu@mbrc.umaryland.edu	Regan, Clinton/E-6250-2012	Lillehoj, Erik/0000-0002-2710-1704; , Erik/0000-0003-0910-6074	National Institutes of Health [HL084223, HL070155]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047125, R01HL070155, R01HL084223] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002352] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants HL084223 and HL070155 (to S. E. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Adamo R, 2004, AM J RESP CELL MOL, V30, P627, DOI 10.1165/rcmb.2003-0260OC; Ali M, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-4; Amith SR, 2010, CELL SIGNAL, V22, P314, DOI 10.1016/j.cellsig.2009.09.038; [Anonymous], 2010, MANDELL DOUGLAS BENN; Bachert C, 2013, TRAFFIC, V14, P47, DOI 10.1111/tra.12019; BAKER N, 1990, INFECT IMMUN, V58, P2361, DOI 10.1128/IAI.58.7.2361-2366.1990; Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Bonten EJ, 2014, CELL MOL LIFE SCI, V71, P2017, DOI 10.1007/s00018-013-1538-3; Brewer C, 1996, CHEST, V109, P1019; Button B, 2012, SCIENCE, V337, P937, DOI 10.1126/science.1223012; Champigny MJ, 2003, GENE, V319, P177, DOI 10.1016/S0378-1119(03)00808-4; Comolli JC, 1999, INFECT IMMUN, V67, P3207, DOI 10.1128/IAI.67.7.3207-3214.1999; Croce M V, 1999, Pathol Oncol Res, V5, P197, DOI 10.1053/paor.1999.0212; DONNENBERG MS, 1989, J INFECT DIS, V160, P452, DOI 10.1093/infdis/160.3.452; FONTENOT JD, 1995, J BIOMOL STRUCT DYN, V13, P245, DOI 10.1080/07391102.1995.10508837; Hsiao YS, 2009, BIOCHEM BIOPH RES CO, V380, P467, DOI 10.1016/j.bbrc.2009.01.108; Huang FC, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0275-6; Julian J, 2009, J CELL BIOCHEM, V108, P802, DOI 10.1002/jcb.22292; Kato Kosuke, 2010, Front Biosci (Elite Ed), V2, P68, DOI 10.2741/e67; Kitazume S, 2010, J BIOL CHEM, V285, P6515, DOI 10.1074/jbc.M109.073106; Lee C, 2014, J BIOL CHEM, V289, P9121, DOI 10.1074/jbc.M114.555888; Lewis AL, 2012, CELL MICROBIOL, V14, P1174, DOI 10.1111/j.1462-5822.2012.01807.x; Li YQ, 2001, J BIOL CHEM, V276, P35239, DOI 10.1074/jbc.C100359200; Li YQ, 2001, J BIOL CHEM, V276, P6061, DOI 10.1074/jbc.C000754200; Lillehoj EP, 2004, AM J PHYSIOL-LUNG C, V287, pL809, DOI 10.1152/ajplung.00385.2003; Lillehoj EP, 2002, AM J PHYSIOL-LUNG C, V282, pL751, DOI 10.1152/ajplung.00383.2001; Lillehoj EP, 2001, AM J PHYSIOL-LUNG C, V280, pL181, DOI 10.1152/ajplung.2001.280.1.L181; Lillehoj EP, 2013, INT REV CEL MOL BIO, V303, P139, DOI 10.1016/B978-0-12-407697-6.00004-0; Lillehoj EP, 2012, J BIOL CHEM, V287, P8214, DOI 10.1074/jbc.M111.292888; Luzina IG, 2009, ARTHRITIS RHEUM-US, V60, P1530, DOI 10.1002/art.24435; Norum LF, 1998, TUMOR BIOL, V19, P134, DOI 10.1159/000056515; Novosad SA, 2013, CURR OPIN PULM MED, V19, P133, DOI 10.1097/MCP.0b013e32835d8312; PRINCE A, 1992, MICROB PATHOGENESIS, V13, P251, DOI 10.1016/0882-4010(92)90035-M; Pshezhetsky AV, 2013, BIOCHEMISTRY-MOSCOW+, V78, P736, DOI 10.1134/S0006297913070067; Ramos HC, 2004, TRENDS MICROBIOL, V12, P509, DOI 10.1016/j.tim.2004.09.002; Ranke TD, 2012, J CLIN MICROBIOL, V50, P2791, DOI 10.1128/JCM.01338-12; Razawi H, 2013, GLYCOBIOLOGY, V23, P935, DOI 10.1093/glycob/cwt030; ROSTAND KS, 1993, J BIOL CHEM, V268, P24053; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; Schroeder JA, 2001, J BIOL CHEM, V276, P13057, DOI 10.1074/jbc.M011248200; Shanks KK, 2010, CLIN VACCINE IMMUNOL, V17, P1196, DOI 10.1128/CVI.00167-10; Soong G, 2006, J CLIN INVEST, V116, P2297, DOI 10.1172/JCI27920; Stonebraker JR, 2004, J VIROL, V78, P13755, DOI 10.1128/JVI.78.24.13755-13768.2004; Thathiah A, 2004, BIOCHEM J, V382, P363, DOI 10.1042/BJ20040513; Thathiah A, 2003, J BIOL CHEM, V278, P3386, DOI 10.1074/jbc.M208326200; WOODS DE, 1980, INFECT IMMUN, V29, P1146	46	25	25	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18316	18331		10.1074/jbc.M115.657114	http://dx.doi.org/10.1074/jbc.M115.657114			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	25963144	Green Published, hybrid			2022-12-28	WOS:000358512100006
J	Molina, R; Marcaida, MJ; Redondo, P; Marenchino, M; Duchateau, P; D'Abramo, M; Montoya, G; Prieto, J				Molina, Rafael; Jose Marcaida, Maria; Redondo, Pilar; Marenchino, Marco; Duchateau, Phillippe; D'Abramo, Marco; Montoya, Guillermo; Prieto, Jesus			Engineering a Nickase on the Homing Endonuclease I-DmoI Scaffold	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; MOLECULAR-BASIS; RESTRICTION; RECOGNITION; EFFICIENT; VARIANTS; CREI; GENE	Homing endonucleases are useful tools for genome modification because of their capability to recognize and cleave specifically large DNA targets. These endonucleases generate a DNA double strand break that can be repaired by the DNA damage response machinery. The break can be repaired by homologous recombination, an error-free mechanism, or by non-homologous end joining, a process susceptible to introducing errors in the repaired sequence. The type of DNA cleavage might alter the balance between these two alternatives. The use of "nickases" producing a specific single strand break instead of a double strand break could be an approach to reduce the toxicity associated with non-homologous end joining by promoting the use of homologous recombination to repair the cleavage of a single DNA break. Taking advantage of the sequential DNA cleavage mechanism of I-DmoI LAGLIDADG homing endonuclease, we have developed a new variant that is able to cut preferentially the coding DNA strand, generating a nicked DNA target. Our structural and biochemical analysis shows that by decoupling the action of the catalytic residues acting on each strand we can inhibit one of them while keeping the other functional.	[Molina, Rafael; Jose Marcaida, Maria; Redondo, Pilar; Montoya, Guillermo; Prieto, Jesus] Spanish Natl Canc Res Ctr CNIO, Macromol Crystallog Grp, Madrid 28029, Spain; [Marenchino, Marco] Spanish Natl Canc Res Ctr CNIO, NMR Unit, Struct Biol & Biocomp Program, Madrid 28029, Spain; [Duchateau, Phillippe] CELLECTIS SA, F-75013 Paris, France; [D'Abramo, Marco] Univ Roma La Sapienza, Dept Chem, I-00185 Rome, Italy; [Montoya, Guillermo] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, Prot Struct & Funct Program, Fac Hlth & Med Sci, DK-2200 Copenhagen, Denmark	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Sapienza University Rome; University of Copenhagen	Montoya, G (corresponding author), Spanish Natl Canc Res Ctr CNIO, Macromol Crystallog Grp, C Melchor Fernandez Almagro 3, Madrid 28029, Spain.	guillermo.montoya@cpr.ku.dk; jprieto@cnio.es	Molina, Rafael/AAG-6552-2019; Molina, Rafael/L-6203-2016; D'Abramo, Marco/B-7035-2008; Marcaida, Maria Jose/I-1644-2017; Redondo, Pilar/L-7612-2014	Molina, Rafael/0000-0002-6443-4989; Molina, Rafael/0000-0002-6443-4989; D'Abramo, Marco/0000-0001-6020-8581; Marcaida, Maria Jose/0000-0003-0663-5309; Redondo, Pilar/0000-0002-6723-0818	European Community [283570]; Novo Nordisk Foundation [NNF14CC0001]; Novo Nordisk Foundation Center for Protein Research [PI Guillermo Montoya] Funding Source: researchfish	European Community(European Commission); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Foundation Center for Protein Research	We thank the Swiss Light Source and XALOC beamline staff for support. This research received funding from the European Community's FP7 Grant Agreement 283570 (BioStruct-X; providing access to Swiss Light Source and ALBA synchrotrons). The Novo Nordisk Foundation Center for Protein Research, University of Copenhagen is supported financially by the Novo Nordisk Foundation (Grant agreement NNF14CC0001).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Armalyte E, 2005, J BIOL CHEM, V280, P41584, DOI 10.1074/jbc.M506775200; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chevalier B, 2004, BIOCHEMISTRY-US, V43, P14015, DOI 10.1021/bi048970c; Daboussi F, 2012, NUCLEIC ACIDS RES, V40, P6367, DOI 10.1093/nar/gks268; Dapprich S, 1999, J MOL STRUC-THEOCHEM, V461, P1, DOI 10.1016/S0166-1280(98)00475-8; Davis L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023981; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Grizot S, 2009, NUCLEIC ACIDS RES, V37, P5405, DOI 10.1093/nar/gkp548; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Joshi R, 2011, J MOL BIOL, V405, P185, DOI 10.1016/j.jmb.2010.10.029; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Lee GS, 2004, CELL, V117, P171, DOI 10.1016/S0092-8674(04)00301-0; LykkeAndersen J, 1997, EMBO J, V16, P3272, DOI 10.1093/emboj/16.11.3272; Marcaida MJ, 2010, CELL MOL LIFE SCI, V67, P727, DOI 10.1007/s00018-009-0188-y; Marciada MJ, 2008, P NATL ACAD SCI USA, V105, P16888, DOI 10.1073/pnas.0804795105; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Metzger MJ, 2011, NUCLEIC ACIDS RES, V39, P926, DOI 10.1093/nar/gkq826; Mimitou EP, 2009, TRENDS BIOCHEM SCI, V34, P264, DOI 10.1016/j.tibs.2009.01.010; Molina R, 2015, NAT STRUCT MOL BIOL, V22, P65, DOI 10.1038/nsmb.2932; Munoz IG, 2011, NUCLEIC ACIDS RES, V39, P729, DOI 10.1093/nar/gkq801; Niu Y, 2008, J MOL BIOL, V382, P188, DOI 10.1016/j.jmb.2008.07.010; Prieto J, 2008, J BIOL CHEM, V283, P4364, DOI 10.1074/jbc.M706323200; Prieto J, 2007, NUCLEIC ACIDS RES, V35, P3262, DOI 10.1093/nar/gkm183; Redondo P, 2008, NATURE, V456, P107, DOI 10.1038/nature07343; Roberts RJ, 2015, NUCLEIC ACIDS RES, V43, pD298, DOI 10.1093/nar/gku1046; Silva GH, 2004, NUCLEIC ACIDS RES, V32, P3156, DOI 10.1093/nar/gkh618; Smith AM, 2009, P NATL ACAD SCI USA, V106, P5099, DOI 10.1073/pnas.0810588106; van Nierop GP, 2009, NUCLEIC ACIDS RES, V37, P5725, DOI 10.1093/nar/gkp643; Zhang ZQ, 1998, J AM SOC MASS SPECTR, V9, P225, DOI 10.1016/S1044-0305(97)00284-5	32	7	7	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18534	18544		10.1074/jbc.M115.658666	http://dx.doi.org/10.1074/jbc.M115.658666			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26045557	Green Published, hybrid			2022-12-28	WOS:000358512100025
J	Rostovtseva, TK; Gurnev, PA; Protchenko, O; Hoogerheide, DP; Yap, TL; Philpott, CC; Lee, JC; Bezrukov, SM				Rostovtseva, Tatiana K.; Gurnev, Philip A.; Protchenko, Olga; Hoogerheide, David P.; Yap, Thai Leong; Philpott, Caroline C.; Lee, Jennifer C.; Bezrukov, Sergey M.			alpha-Synuclein Shows High Affinity Interaction with Voltage-dependent Anion Channel, Suggesting Mechanisms of Mitochondrial Regulation and Toxicity in Parkinson Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEX-I; ALZHEIMERS-DISEASE; FIBRIL FORMATION; INNER MEMBRANE; VDAC; PROTEIN; TRANSLOCATION; TUBULIN; MUTATION; BINDING	Participation of the small, intrinsically disordered protein alpha-synuclein (alpha-syn) in Parkinson disease (PD) pathogenesis has been well documented. Although recent research demonstrates the involvement of alpha-syn in mitochondrial dysfunction in neurodegeneration and suggests direct interaction of alpha-syn with mitochondria, the molecular mechanism(s) of alpha-syn toxicity and its effect on neuronal mitochondria remain vague. Here we report that at nanomolar concentrations, alpha-syn reversibly blocks the voltage-dependent anion channel (VDAC), the major channel of the mitochondrial outer membrane that controls most of the metabolite fluxes in and out of the mitochondria. Detailed analysis of the blockage kinetics of VDAC reconstituted into planar lipid membranes suggests that alpha-syn is able to translocate through the channel and thus target complexes of the mitochondrial respiratory chain in the inner mitochondrial membrane. Supporting our in vitro experiments, a yeast model of PD shows that alpha-syn toxicity in yeast depends on VDAC. The functional interactions between VDAC and alpha-syn, revealed by the present study, point toward the long sought after physiological and pathophysiological roles for monomeric alpha-syn in PD and in other alpha-synucleinopathies.	[Rostovtseva, Tatiana K.; Gurnev, Philip A.; Hoogerheide, David P.; Bezrukov, Sergey M.] Eunice Kennedy Shriver NICHD, Program Phys Biol, NIH, Bethesda, MD 20892 USA; [Gurnev, Philip A.] Univ Massachusetts, Dept Phys, Amherst, MA 01003 USA; [Protchenko, Olga; Philpott, Caroline C.] NIDDK, Liver Dis Branch, NIH, Bethesda, MD 20892 USA; [Hoogerheide, David P.] NIST, Ctr Neutron Res, Gaithersburg, MD 20899 USA; [Yap, Thai Leong; Lee, Jennifer C.] NHLBI, Lab Mol Biophys, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Massachusetts System; University of Massachusetts Amherst; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institute of Standards & Technology (NIST) - USA; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Rostovtseva, TK (corresponding author), Eunice Kennedy Shriver NICHD, Program Phys Biol, NIH, 9000 Rockville Pike,Bldg 9,Rm 1E-106, Bethesda, MD 20892 USA.	rostovtt@mail.nih.gov	Lee, Jennifer/E-9658-2015; Hoogerheide, David P./AAB-3753-2019; Protchenko, Olga/AAU-9237-2021; Regan, Clinton/E-6250-2012	Lee, Jennifer/0000-0003-0506-8349; Hoogerheide, David P./0000-0003-2918-1469; Protchenko, Olga/0000-0002-4688-4214	National Institutes of Health (NIH); Eunice Kennedy Shriver NICHD; NIDDK; NHLBI; National Science Foundation EAGER [1249199]; National Research Council at the National Institute of Standards and Technology; National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000072] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL001055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK054513] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Science Foundation EAGER; National Research Council at the National Institute of Standards and Technology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the Intramural Research Program of the National Institutes of Health (NIH), Eunice Kennedy Shriver NICHD, NIDDK, and NHLBI. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by National Science Foundation EAGER Award 1249199.; Recipient of a National Research Council Research Associateship Award at the National Institute of Standards and Technology and the National Institutes of Health.	Alavian KN, 2015, MOL PHARMACOL, V87, P1, DOI 10.1124/mol.114.095661; Banerjee K, 2010, FEBS LETT, V584, P1571, DOI 10.1016/j.febslet.2010.03.012; Bezrukov SM, 2004, BIOPHYS J, V87, P3162, DOI 10.1529/biophysj.104.044453; BLAUSTEIN RO, 1990, J GEN PHYSIOL, V96, P921, DOI 10.1085/jgp.96.5.921; Buettner S, 2013, CELL DEATH DIFFER, V20, P465, DOI 10.1038/cdd.2012.142; Buttner S, 2008, J BIOL CHEM, V283, P7554, DOI 10.1074/jbc.M708477200; Buttner S, 2013, EMBO J, V32, P3041, DOI 10.1038/emboj.2013.228; Carneiro CMM, 2003, BBA-BIOMEMBRANES, V1612, P144, DOI 10.1016/S0005-2736(03)00113-5; Ciaccioli G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055848; Cole NB, 2008, EXP CELL RES, V314, P2076, DOI 10.1016/j.yexcr.2008.03.012; COLOMBINI M, 1989, J MEMBRANE BIOL, V111, P103, DOI 10.1007/BF01871775; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Crowther RA, 1998, FEBS LETT, V436, P309, DOI 10.1016/S0014-5793(98)01146-6; DAUM G, 1985, BIOCHIM BIOPHYS ACTA, V822, P1, DOI 10.1016/0304-4157(85)90002-4; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; De Pinto V, 2010, BBA-BIOENERGETICS, V1797, P1268, DOI 10.1016/j.bbabio.2010.01.031; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Elkon H, 2002, J MOL NEUROSCI, V18, P229, DOI 10.1385/JMN:18:3:229; Ellis CE, 2005, MOL CELL BIOL, V25, P10190, DOI 10.1128/MCB.25.22.10190-10201.2005; Federico A, 2012, J NEUROL SCI, V322, P254, DOI 10.1016/j.jns.2012.05.030; Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110; Goedert M, 2001, METH MOLEC MED, V62, P33, DOI 10.1385/1-59259-142-6:33; Gurnev PA, 2014, BIOPHYS J, V106, P556, DOI 10.1016/j.bpj.2013.12.028; Gurnev PA, 2011, FEBS LETT, V585, P2363, DOI 10.1016/j.febslet.2011.06.008; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Junn E, 2002, NEUROSCI LETT, V320, P146, DOI 10.1016/S0304-3940(02)00016-2; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lemasters JJ, 2006, BBA-MOL BASIS DIS, V1762, P181, DOI 10.1016/j.bbadis.2005.10.006; Lemeshko VV, 2006, EUR BIOPHYS J BIOPHY, V36, P57, DOI 10.1007/s00249-006-0101-7; Lemeshko VV, 2014, BBA-BIOMEMBRANES, V1838, P1362, DOI 10.1016/j.bbamem.2014.01.001; Li WW, 2007, NEUROREPORT, V18, P1543, DOI 10.1097/WNR.0b013e3282f03db4; Liu GW, 2009, NEUROSCI LETT, V454, P187, DOI 10.1016/j.neulet.2009.02.056; Lu LL, 2013, ACTA BIOCH BIOPH SIN, V45, P170, DOI 10.1093/abbs/gms114; Luth ES, 2014, J BIOL CHEM, V289, P21490, DOI 10.1074/jbc.M113.545749; Maglia G, 2008, P NATL ACAD SCI USA, V105, P19720, DOI 10.1073/pnas.0808296105; Maldonado EN, 2012, J PHARMACOL EXP THER, V342, P637, DOI 10.1124/jpet.112.192153; Maldonado EN, 2010, CANCER RES, V70, P10192, DOI 10.1158/0008-5472.CAN-10-2429; Martin LJ, 2014, NEUROBIOL AGING, V35, P1132, DOI 10.1016/j.neurobiolaging.2013.11.008; McCommis KS, 2012, BBA-BIOMEMBRANES, V1818, P1444, DOI 10.1016/j.bbamem.2011.10.025; Movileanu L, 2005, BIOPHYS J, V89, P1030, DOI 10.1529/biophysj.104.057406; Murray IVJ, 2003, BIOCHEMISTRY-US, V42, P8530, DOI 10.1021/bi027363r; Nakamura K, 2013, NEUROTHERAPEUTICS, V10, P391, DOI 10.1007/s13311-013-0182-9; Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538; Nakamura K, 2008, J NEUROSCI, V28, P12305, DOI 10.1523/JNEUROSCI.3088-08.2008; Pfefferkorn CM, 2012, BBA-BIOMEMBRANES, V1818, P162, DOI 10.1016/j.bbamem.2011.07.032; Pfefferkorn CM, 2010, J PHYS CHEM B, V114, P4615, DOI 10.1021/jp908092e; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Porcelli AM, 2005, BIOCHEM BIOPH RES CO, V326, P799, DOI 10.1016/j.bbrc.2004.11.105; Proukakis C, 2013, NEUROLOGY, V80, P1062, DOI 10.1212/WNL.0b013e31828727ba; Robotta M, 2014, CHEMBIOCHEM, V15, P2499, DOI 10.1002/cbic.201402281; Rochet JC, 2012, PROG MOL BIOL TRANSL, V107, P125, DOI 10.1016/B978-0-12-385883-2.00011-4; Rostovtseva T, 1996, J BIOL CHEM, V271, P28006, DOI 10.1074/jbc.271.45.28006; Rostovtseva T, 1997, BIOPHYS J, V72, P1954, DOI 10.1016/S0006-3495(97)78841-6; Rostovtseva TK, 2006, J BIOL CHEM, V281, P37496, DOI 10.1074/jbc.M602548200; Rostovtseva TK, 2012, BBA-BIOMEMBRANES, V1818, P1526, DOI 10.1016/j.bbamem.2011.11.004; Rostovtseva TK, 2008, P NATL ACAD SCI USA, V105, P18746, DOI 10.1073/pnas.0806303105; Rostovtseva TK, 2005, J BIOENERG BIOMEMBR, V37, P129, DOI 10.1007/s10863-005-6566-8; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Shen JM, 2014, BRAIN RES, V1591, P14, DOI 10.1016/j.brainres.2014.09.046; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Shoshan-Barmatz V, 2003, CELL BIOCHEM BIOPHYS, V39, P279, DOI 10.1385/CBB:39:3:279; Shoshan-Barmatz V, 2012, MITOCHONDRION, V12, P24, DOI 10.1016/j.mito.2011.04.001; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Su LHJ, 2010, DIS MODEL MECH, V3, P194, DOI 10.1242/dmm.004267; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Vila M, 2008, J NEUROCHEM, V107, P317, DOI 10.1111/j.1471-4159.2008.05604.x; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Wilhelm BG, 2014, SCIENCE, V344, P1023, DOI 10.1126/science.1252884; Wolfe AJ, 2007, J AM CHEM SOC, V129, P14034, DOI 10.1021/ja0749340; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; Zakharov SD, 2007, BIOCHEMISTRY-US, V46, P14369, DOI 10.1021/bi701275p	77	129	131	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18467	18477		10.1074/jbc.M115.641746	http://dx.doi.org/10.1074/jbc.M115.641746			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26055708	hybrid, Green Published			2022-12-28	WOS:000358512100018
J	Antala, S; Ovchinnikov, S; Kamisetty, H; Baker, D; Dempski, RE				Antala, Sagar; Ovchinnikov, Sergey; Kamisetty, Hetunandan; Baker, David; Dempski, Robert E.			Computation and Functional Studies Provide a Model for the Structure of the Zinc Transporter hZIP4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR FACILITATOR SUPERFAMILY; MIX-AND-MATCH; ACRODERMATITIS-ENTEROPATHICA; ESCHERICHIA-COLI; STRUCTURE PREDICTION; PROTEIN STRUCTURES; MFS TRANSPORTERS; ZNT TRANSPORTERS; BINDING; SEQUENCE	Members of the Zrt and Irt protein (ZIP) family are a central participant in transition metal homeostasis as they function to increase the cytosolic concentration of zinc and/or iron. However, the lack of a crystal structure hinders elucidation of the molecular mechanism of ZIP proteins. Here, we employed GREMLIN, a co-evolution-based contact prediction approach in conjunction with the Rosetta structure prediction program to construct a structural model of the human (h) ZIP4 transporter. The predicted contact data are best fit by modeling hZIP4 as a dimer. Mutagenesis of residues that comprise a central putative hZIP4 transmembrane transition metal coordination site in the structural model alter the kinetics and specificity of hZIP4. Comparison of the hZIP4 dimer model to all known membrane protein structures identifies the 12-transmembrane monomeric Piriformospora indica phosphate transporter (PiPT), a member of the major facilitator superfamily (MFS), as a likely structural homolog.	[Dempski, Robert E.] Worcester Polytech Inst, Dept Chem & Biochem, Worcester, MA 01609 USA; [Antala, Sagar; Dempski, Robert E.] Worcester Polytech Inst, Dept Chem & Biochem, Worcester, MA 01609 USA; [Ovchinnikov, Sergey; Kamisetty, Hetunandan; Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Ovchinnikov, Sergey; Kamisetty, Hetunandan; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Ovchinnikov, Sergey] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA	Worcester Polytechnic Institute; Worcester Polytechnic Institute; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Dempski, RE (corresponding author), Worcester Polytech Inst, Dept Chem & Biochem, 100 Inst Rd, Worcester, MA 01609 USA.	rdempski@wpi.edu	Baker, David/K-8941-2012; Regan, Clinton/E-6250-2012	Baker, David/0000-0001-7896-6217; Ovchinnikov, Sergey/0000-0003-2774-2744	Worcester Polytechnic Institute Research Foundation; National Institutes of Health [GM105964, GM092802]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092802, R01GM105964] Funding Source: NIH RePORTER	Worcester Polytechnic Institute Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research described within this manuscript was supported by the Worcester Polytechnic Institute Research Foundation and National Institutes of Health Grants GM105964 (to R. E. D.) and GM092802 (to D. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Antala S, 2012, BIOCHEMISTRY-US, V51, P963, DOI 10.1021/bi201553p; Bafaro EM, 2015, METALLOMICS, V7, P1319, DOI 10.1039/c5mt00066a; Barth P, 2007, P NATL ACAD SCI USA, V104, P15682, DOI 10.1073/pnas.0702515104; Cong Q, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-82; Coudray N, 2013, P NATL ACAD SCI USA, V110, P2140, DOI 10.1073/pnas.1215455110; Dempski RE, 2012, CURR TOP MEMBR, V69, P221, DOI 10.1016/B978-0-12-394390-3.00009-4; DiMaio F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020450; Durr KL, 2009, J BIOL CHEM, V284, P3842, DOI 10.1074/jbc.M808101200; Dufner-Beattie J, 2003, J BIOL CHEM, V278, P33474, DOI 10.1074/jbc.M305000200; Dufner-Beattie J, 2003, J BIOL CHEM, V278, P50142, DOI 10.1074/jbc.M304163200; Eide DJ, 2004, PFLUG ARCH EUR J PHY, V447, P796, DOI 10.1007/s00424-003-1074-3; Franz MC, 2014, J BIOMOL SCREEN, V19, P909, DOI 10.1177/1087057114526781; Gaither LA, 2001, BIOMETALS, V14, P251, DOI 10.1023/A:1012988914300; Hediger MA, 2004, PFLUG ARCH EUR J PHY, V447, P465, DOI 10.1007/s00424-003-1192-y; Hoch E, 2012, P NATL ACAD SCI USA, V109, P7202, DOI 10.1073/pnas.1200362109; Hopf TA, 2012, CELL, V149, P1607, DOI 10.1016/j.cell.2012.04.012; Kambe T, 2012, CURR TOP MEMBR, V69, P199, DOI 10.1016/B978-0-12-394390-3.00008-2; Kamisetty H, 2013, P NATL ACAD SCI USA, V110, P15674, DOI 10.1073/pnas.1314045110; Kozma D, 2013, NUCLEIC ACIDS RES, V41, pD524, DOI 10.1093/nar/gks1169; Kury S, 2002, NAT GENET, V31, P239, DOI 10.1038/ng913; Lange OF, 2012, P NATL ACAD SCI USA, V109, P10873, DOI 10.1073/pnas.1203013109; LAZDUNSKI M, 1971, EUR J BIOCHEM, V20, P124, DOI 10.1111/j.1432-1033.1971.tb01370.x; Lin W, 2010, J BIOL CHEM, V285, P39013, DOI 10.1074/jbc.M110.180620; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; Madej MG, 2013, P NATL ACAD SCI USA, V110, pE4831, DOI 10.1073/pnas.1319754110; Madej MG, 2013, P NATL ACAD SCI USA, V110, P5870, DOI 10.1073/pnas.1303538110; Nugent T, 2012, P NATL ACAD SCI USA, V109, pE1540, DOI 10.1073/pnas.1120036109; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Paulsen IT, 1997, J MEMBRANE BIOL, V156, P99, DOI 10.1007/s002329900192; Pedersen BP, 2013, NATURE, V496, P533, DOI 10.1038/nature12042; Pinilla-Tenas JJ, 2011, AM J PHYSIOL-CELL PH, V301, pC862, DOI 10.1152/ajpcell.00479.2010; Raman S, 2009, PROTEINS, V77, P89, DOI 10.1002/prot.22540; Richards R, 2011, JOVE-J VIS EXP, DOI 10.3791/2627; SANDERS D, 1986, J MEMBRANE BIOL, V90, P67, DOI 10.1007/BF01869687; Simons KT, 1999, PROTEINS, V34, P82, DOI 10.1002/(SICI)1097-0134(19990101)34:1<82::AID-PROT7>3.0.CO;2-A; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Vastermark A, 2014, J MOL MICROB BIOTECH, V24, P82, DOI 10.1159/000358429; Vastermark A, 2014, P NATL ACAD SCI USA, V111, pE1162, DOI 10.1073/pnas.1400016111; Wang K, 2002, AM J HUM GENET, V71, P66, DOI 10.1086/341125; Wei YN, 2006, J BIOL CHEM, V281, P23492, DOI 10.1074/jbc.M602254200; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; Xu JR, 2010, BIOINFORMATICS, V26, P889, DOI 10.1093/bioinformatics/btq066; Yarov-Yarovoy V, 2012, P NATL ACAD SCI USA, V109, pE93, DOI 10.1073/pnas.1118434109; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264	45	49	50	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					17796	17805		10.1074/jbc.M114.617613	http://dx.doi.org/10.1074/jbc.M114.617613			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	25971965	Green Published, hybrid			2022-12-28	WOS:000358511700014
J	Lowery, J; Kuczmarski, ER; Herrmann, H; Goldman, RD				Lowery, Jason; Kuczmarski, Edward R.; Herrmann, Harald; Goldman, Robert D.			Intermediate Filaments Play a Pivotal Role in Regulating Cell Architecture and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							MICE LACKING VIMENTIN; GIANT AXONAL NEUROPATHY; IN-VITRO; POSTTRANSLATIONAL MODIFICATIONS; MECHANICAL-PROPERTIES; SKELETAL MYOPATHY; ALEXANDER-DISEASE; EPITHELIAL-CELLS; DESMIN MUTATIONS; 14-3-3 PROTEINS	Intermediate filaments (IFs) are composed of one or more members of a large family of cytoskeletal proteins, whose expression is cell-and tissue type-specific. Their importance in regulating the physiological properties of cells is becoming widely recognized in functions ranging from cell motility to signal transduction. IF proteins assemble into nanoscale biopolymers with unique strain-hardening properties that are related to their roles in regulating the mechanical integrity of cells. Furthermore, mutations in the genes encoding IF proteins cause a wide range of human diseases. Due to the number of different types of IF proteins, we have limited this short review to cover structure and function topics mainly related to the simpler homopolymeric IF networks composed of vimentin, and specifically for diseases, the related muscle-specific desmin IF networks.	[Lowery, Jason; Kuczmarski, Edward R.; Goldman, Robert D.] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Herrmann, Harald] German Canc Res Ctr, Div Mol Genet B060, D-69120 Heidelberg, Germany	Northwestern University; Feinberg School of Medicine; Helmholtz Association; German Cancer Research Center (DKFZ)	Goldman, RD (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, 303 E Chicago Ave,Ward Bldg 11-145, Chicago, IL 60611 USA.	r-goldman@northwestern.edu			National Institutes of Health from the NIGMS [PO1GM096971]; Hannah's Hope Fund; German Research Foundation (DFG) [HE 1853/9-2 (FOR 1228), HE1853/11-1]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM096971] Funding Source: NIH RePORTER	National Institutes of Health from the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Hannah's Hope Fund; German Research Foundation (DFG)(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant PO1GM096971 from the NIGMS and Hannah's Hope Fund (to R. D. G.). This work was also supported by German Research Foundation (DFG) Grants HE 1853/9-2 (FOR 1228) and HE1853/11-1 (to H. H.). This is the second article in the Thematic Minireview series "The State of the Cytoskeleton in 2015." The authors declare that they have no conflicts of interest with the contents of this article.	Bar H, 2006, J MOL BIOL, V360, P1031, DOI 10.1016/j.jmb.2006.05.068; Bar H, 2010, J MOL BIOL, V397, P1188, DOI 10.1016/j.jmb.2010.02.024; Bar H, 2005, P NATL ACAD SCI USA, V102, P15099, DOI 10.1073/pnas.0504568102; BENZEEV A, 1984, J CELL BIOL, V99, P1424, DOI 10.1083/jcb.99.4.1424; BEUTTENMULLER M, 1994, EXP CELL RES, V213, P128, DOI 10.1006/excr.1994.1182; Bhattacharya R, 2009, J CELL SCI, V122, P1390, DOI 10.1242/jcs.043042; Bomont P, 2000, NAT GENET, V26, P370, DOI 10.1038/81701; Brenner M, 2001, NAT GENET, V27, P117, DOI 10.1038/83679; Chang L, 2004, NAT REV MOL CELL BIO, V5, P601, DOI 10.1038/nrm1438; Chang L, 2009, J CELL SCI, V122, P2914, DOI 10.1242/jcs.046789; Chernoivanenko IS, 2015, FASEB J, V29, P820, DOI 10.1096/fj.14-259903; CHOU YH, 1989, P NATL ACAD SCI USA, V86, P1885, DOI 10.1073/pnas.86.6.1885; Chou YH, 2003, MOL BIOL CELL, V14, P1468, DOI 10.1091/mbc.E02-08-0545; CHOU YH, 1990, CELL, V62, P1063, DOI 10.1016/0092-8674(90)90384-Q; Clemen CS, 2013, ACTA NEUROPATHOL, V125, P47, DOI 10.1007/s00401-012-1057-6; COCHARD P, 1984, J NEUROSCI, V4, P2080; Cohen S, 2012, J CELL BIOL, V198, P575, DOI 10.1083/jcb.201110067; Colucci-Guyon E, 1999, GLIA, V25, P33, DOI 10.1002/(SICI)1098-1136(19990101)25:1<33::AID-GLIA4>3.0.CO;2-J; COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3; Conway DE, 2013, CURR BIOL, V23, P1024, DOI 10.1016/j.cub.2013.04.049; Coulombe PA, 2004, NAT CELL BIOL, V6, P699, DOI 10.1038/ncb0804-699; Dupin I, 2011, J CELL SCI, V124, P865, DOI 10.1242/jcs.076356; Eckes B, 1998, J CELL SCI, V111, P1897; Eckes B, 2000, J CELL SCI, V113, P2455; ENGEL A, 1985, J ULTRA MOL STRUCT R, V90, P323, DOI 10.1016/S0022-5320(85)80010-1; Eriksson JE, 2009, J CLIN INVEST, V119, P1763, DOI 10.1172/JCI38339; FRANKE WW, 1987, CELL, V49, P131, DOI 10.1016/0092-8674(87)90763-X; FUCHS E, 1992, CELL, V69, P899, DOI 10.1016/0092-8674(92)90607-E; Fudge DS, 2003, BIOPHYS J, V85, P2015, DOI 10.1016/S0006-3495(03)74629-3; Gao YS, 2001, J CELL BIOL, V152, P877, DOI 10.1083/jcb.152.5.877; GARD DL, 1980, CELL, V19, P263, DOI 10.1016/0092-8674(80)90408-0; GEISLER N, 1982, EMBO J, V1, P1649, DOI 10.1002/j.1460-2075.1982.tb01368.x; Goldfarb LG, 1998, NAT GENET, V19, P402, DOI 10.1038/1300; Goto H, 1998, J BIOL CHEM, V273, P11728, DOI 10.1074/jbc.273.19.11728; Guo M, 2013, BIOPHYS J, V105, P1562, DOI 10.1016/j.bpj.2013.08.037; Guzman C, 2006, J MOL BIOL, V360, P623, DOI 10.1016/j.jmb.2006.05.030; Haubold KW, 2003, J APPL PHYSIOL, V95, P1617, DOI 10.1152/japplphysiol.00408.2003; Helfand BT, 2011, MOL BIOL CELL, V22, P1274, DOI 10.1091/mbc.E10-08-0699; Helfand BT, 2003, MOL BIOL CELL, V14, P5069, DOI 10.1091/mbc.E03-06-0376; Helmke BP, 2000, CIRC RES, V86, P745, DOI 10.1161/01.RES.86.7.745; Henrion D, 1997, J CLIN INVEST, V100, P2909, DOI 10.1172/JCI119840; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Ho CL, 1998, J CELL SCI, V111, P1767; Hyder CL, 2008, FEBS LETT, V582, P2140, DOI 10.1016/j.febslet.2008.04.064; INAGAKI M, 1987, NATURE, V328, P649, DOI 10.1038/328649a0; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; JANMEY PA, 1991, J CELL BIOL, V113, P155, DOI 10.1083/jcb.113.1.155; Ketema M, 2013, MOL BIOL CELL, V24, P2454, DOI 10.1091/mbc.E13-02-0100; Kokkinos MI, 2007, CELLS TISSUES ORGANS, V185, P191, DOI 10.1159/000101320; Kreplak L, 2005, J MOL BIOL, V354, P569, DOI 10.1016/j.jmb.2005.09.092; Kreplak L, 2009, J MOL BIOL, V385, P1043, DOI 10.1016/j.jmb.2008.10.095; Kreplak L, 2008, BIOPHYS J, V94, P2790, DOI 10.1529/biophysj.107.119826; Ku NO, 1998, EMBO J, V17, P1892, DOI 10.1093/emboj/17.7.1892; Li HH, 2006, J CELL SCI, V119, P4452, DOI 10.1242/jcs.03219; Li ZL, 1996, DEV BIOL, V175, P362, DOI 10.1006/dbio.1996.0122; Liao J, 1996, J CELL BIOL, V133, P345, DOI 10.1083/jcb.133.2.345; Mahammad S, 2013, J CLIN INVEST, V123, P1964, DOI 10.1172/JCI66387; Martin KH, 2012, JOVE-J VIS EXP, DOI 10.3791/4119; Martys JL, 1999, MOL BIOL CELL, V10, P1289, DOI 10.1091/mbc.10.5.1289; Mendez MG, 2014, BIOPHYS J, V107, P314, DOI 10.1016/j.bpj.2014.04.050; Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639; Menko AS, 2014, MOL BIOL CELL, V25, P776, DOI 10.1091/mbc.E12-12-0900; Milner DJ, 1996, J CELL BIOL, V134, P1255, DOI 10.1083/jcb.134.5.1255; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Munoz-Marmol AM, 1998, P NATL ACAD SCI USA, V95, P11312, DOI 10.1073/pnas.95.19.11312; Murray ME, 2014, MOL BIOL CELL, V25, P87, DOI 10.1091/mbc.E13-06-0326; Nekrasova OE, 2011, MOL BIOL CELL, V22, P2282, DOI 10.1091/mbc.E10-09-0766; Nieminen M, 2006, NAT CELL BIOL, V8, P156, DOI 10.1038/ncb1355; Noding B, 2014, BIOPHYS J, V107, P2914, DOI 10.1016/j.bpj.2014.09.050; Ofek G, 2009, BIOPHYS J, V97, P1873, DOI 10.1016/j.bpj.2009.07.050; Omary MB, 2009, J CLIN INVEST, V119, P1756, DOI 10.1172/JCI39894; Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319; Perng MD, 2004, MOL BIOL CELL, V15, P2335, DOI 10.1091/mbc.E03-12-0893; Petrie RJ, 2014, SCIENCE, V345, P1062, DOI 10.1126/science.1256965; Quinlan RA, 2007, EXP CELL RES, V313, P2077, DOI 10.1016/j.yexcr.2007.04.004; Razafsky D, 2009, J CELL BIOL, V186, P461, DOI 10.1083/jcb.200906068; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Robert A, 2014, FASEB J, V28, P2879, DOI 10.1096/fj.14-250019; Rogel MR, 2011, FASEB J, V25, P3873, DOI 10.1096/fj.10-170795; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Schaffeld M, 2001, EUR J CELL BIOL, V80, P692, DOI 10.1078/0171-9335-00206; Schnittler HJ, 1998, HISTOCHEM CELL BIOL, V110, P161, DOI 10.1007/s004180050277; Schoumacher M, 2010, J CELL BIOL, V189, P541, DOI 10.1083/jcb.200909113; SHEA TB, 1993, J NEUROSCI RES, V36, P66, DOI 10.1002/jnr.490360108; Shen WJ, 2012, ENDOCRINOLOGY, V153, P3249, DOI 10.1210/en.2012-1048; Sin WC, 1998, MOL CELL BIOL, V18, P6325, DOI 10.1128/MCB.18.11.6325; Snider NT, 2014, NAT REV MOL CELL BIO, V15, P163, DOI 10.1038/nrm3753; Takai Y, 1996, J CELL BIOL, V133, P141, DOI 10.1083/jcb.133.1.141; Taylor MRG, 2007, CIRCULATION, V115, P1244, DOI 10.1161/CIRCULATIONAHA.106.646778; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tzivion G, 2000, J BIOL CHEM, V275, P29772, DOI 10.1074/jbc.M001207200; Vuoriluoto K, 2011, ONCOGENE, V30, P1436, DOI 10.1038/onc.2010.509; Wei JC, 2008, ANTICANCER RES, V28, P327; Yamaguchi T, 2005, J CELL BIOL, V171, P431, DOI 10.1083/jcb.200504091; Yasui Y, 2001, ONCOGENE, V20, P2868, DOI 10.1038/sj.onc.1204407; Yoon M, 1998, J CELL BIOL, V143, P147, DOI 10.1083/jcb.143.1.147; Zhu QS, 2011, ONCOGENE, V30, P457, DOI 10.1038/onc.2010.421	98	146	149	1	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17145	17153		10.1074/jbc.R115.640359	http://dx.doi.org/10.1074/jbc.R115.640359			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	25957409	Green Published, hybrid			2022-12-28	WOS:000357730900011
J	Terzyan, SS; Burgett, AWG; Heroux, A; Smith, CA; Mooers, BHM; Hanigan, MH				Terzyan, Simon S.; Burgett, Anthony W. G.; Heroux, Annie; Smith, Clyde A.; Mooers, Blaine H. M.; Hanigan, Marie H.			Human gamma-Glutamyl Transpeptidase 1 STRUCTURES OF THE FREE ENZYME, INHIBITOR-BOUND TETRAHEDRAL TRANSITION STATES, AND GLUTAMATE-BOUND ENZYME REVEAL NOVEL MOVEMENT WITHIN THE ACTIVE SITE DURING CATALYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROMOLECULAR STRUCTURES; GLUTATHIONE METABOLISM; SUBSTRATE-SPECIFICITY; ESCHERICHIA-COLI; ACID; IDENTIFICATION; TRANSFERASE; RESISTANCE; MECHANISM; CISPLATIN	gamma-Glutamyl transpeptidase 1 (GGT1) is a cell surface, N-terminal nucleophile hydrolase that cleaves glutathione and other g-glutamyl compounds. GGT1 expression is essential in cysteine homeostasis, and its induction has been implicated in the pathology of asthma, reperfusion injury, and cancer. In this study, we report four new crystal structures of human GGT1 (hGGT1) that show conformational changes within the active site as the enzyme progresses from the free enzyme to inhibitor-bound tetrahedral transition states and finally to the glutamate-bound structure prior to the release of this final product of the reaction. The structure of the apoenzyme shows flexibility within the active site. The serine-borate-bound hGGT1 crystal structure demonstrates that serine-borate occupies the active site of the enzyme, resulting in an enzyme-inhibitor complex that replicates the enzyme's tetrahedral intermediate/transition state. The structure of GGsTop-bound hGGT1 reveals its interactions with the enzyme and why neutral phosphonate diesters are more potent inhibitors than monoanionic phosphonates. These structures are the first structures for any eukaryotic GGT that include a molecule in the active site covalently bound to the catalytic Thr-381. The glutamate-bound structure shows the conformation of the enzyme prior to release of the final product and reveals novel information regarding the displacement of the main chain atoms that form the oxyanion hole and movement of the lid loop region when the active site is occupied. These data provide new insights into the mechanism of hGGT1-catalyzed reactions and will be invaluable in the development of new classes of hGGT1 inhibitors for therapeutic use.	[Terzyan, Simon S.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Macromol Crystallog Lab, Oklahoma City, OK 73104 USA; [Burgett, Anthony W. G.] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA; [Heroux, Annie] Brookhaven Natl Lab, Photon Sci Div, Energy Sci Directorate, Upton, NY 11973 USA; [Smith, Clyde A.] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 94025 USA; [Mooers, Blaine H. M.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA; [Hanigan, Marie H.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Stanton L Young Biomed Res Ctr, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma - Norman; United States Department of Energy (DOE); Brookhaven National Laboratory; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Hanigan, MH (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Stanton L Young Biomed Res Ctr, Rm 264,975 NE 10th St, Oklahoma City, OK 73104 USA.	marie-hanigan@ouhsc.edu	Regan, Clinton/E-6250-2012; Mooers, Blaine/S-4383-2017	Mooers, Blaine/0000-0001-8181-8987	National Institutes of Health (NIH) from the NIGMS [P20GM103640]; National Institutes of Health (NIH) [R01AI088011]; United States Department of Energy Offices of Biological and Environmental Research and Basic Energy Sciences [DE-AC02-98CH10886, E-SC0012704]; NIH [P41RR012408, P41GM103473, P41-GM111244]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; Department of Energy Office of Biological and Environmental Research; NIH, NIGMS [P41GM103393]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103473, P41GM103393, P41GM111244, P20GM103640] Funding Source: NIH RePORTER	National Institutes of Health (NIH) from the NIGMS; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy Offices of Biological and Environmental Research and Basic Energy Sciences; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grants P20GM103640 (an Institutional Development Award (IDeA) from the NIGMS) and R01AI088011 (to B. H. M. M.). X-ray diffraction data were collected at the National Synchrotron Light Source, for which financial support comes principally from the United States Department of Energy Offices of Biological and Environmental Research and Basic Energy Sciences Grants DE-AC02-98CH10886 and E-SC0012704 and from NIH Grants P41RR012408, P41GM103473, and P41-GM111244. X-ray diffraction data were also collected at the Stanford Synchrotron Radiation Light source, the use of which was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract DE-AC02-76SF00515. The Stanford Synchrotron Radiation Lightsource Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research and by NIH, NIGMS, Grant P41GM103393. The authors declare that they have no conflicts of interest with the contents of this article.	AHLUWALIA GS, 1990, PHARMACOL THERAPEUT, V46, P243, DOI 10.1016/0163-7258(90)90094-I; ALLISON RD, 1985, METHOD ENZYMOL, V113, P419; Anders MW, 1998, ANNU REV PHARMACOL, V38, P501, DOI 10.1146/annurev.pharmtox.38.1.501; BEHRMAN EJ, 1970, J ORG CHEM, V35, P3063, DOI 10.1021/jo00834a043; Boanca G, 2007, J BIOL CHEM, V282, P534, DOI 10.1074/jbc.M607694200; Castonguay R, 2007, BIOCHEMISTRY-US, V46, P12253, DOI 10.1021/bi700956c; CURTHOYS NP, 1979, ENZYME, V24, P383, DOI 10.1159/000458694; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Han L, 2007, BIOCHEMISTRY-US, V46, P1432, DOI 10.1021/bi061890j; Han LY, 2006, BIOORGAN MED CHEM, V14, P6043, DOI 10.1016/j.bmc.2006.05.008; Hanigan MH, 1999, CARCINOGENESIS, V20, P553, DOI 10.1093/carcin/20.4.553; Hanigan MH, 1996, J HISTOCHEM CYTOCHEM, V44, P1101, DOI 10.1177/44.10.8813074; Hogg N, 1997, BIOCHEM J, V323, P477, DOI 10.1042/bj3230477; Inoue M, 2000, BIOCHEMISTRY-US, V39, P7764, DOI 10.1021/bi000220p; King JB, 2009, J BIOL CHEM, V284, P9059, DOI 10.1074/jbc.M809608200; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lherbet C, 2004, ORG BIOMOL CHEM, V2, P238, DOI 10.1039/b310767a; Lieberman MW, 1996, P NATL ACAD SCI USA, V93, P7923, DOI 10.1073/pnas.93.15.7923; Morrow AL, 2007, BIOCHEMISTRY-US, V46, P13407, DOI 10.1021/bi701599e; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Okada T, 2006, P NATL ACAD SCI USA, V103, P6471, DOI 10.1073/pnas.0511020103; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pompella A, 2006, BIOCHEM PHARMACOL, V71, P231, DOI 10.1016/j.bcp.2005.10.005; REVEL JP, 1959, J BIOL CHEM, V234, P577; TATE SS, 1978, P NATL ACAD SCI USA, V75, P4806, DOI 10.1073/pnas.75.10.4806; Townsend DM, 2003, J AM SOC NEPHROL, V14, P1, DOI 10.1097/01.ASN.0000042803.28024.92; Tuzova M, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00179; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; West MB, 2013, J BIOL CHEM, V288, P31902, DOI 10.1074/jbc.M113.498139; Wickham S, 2011, ANAL BIOCHEM, V414, P208, DOI 10.1016/j.ab.2011.03.026; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamamoto S, 2011, J PHARMACOL EXP THER, V339, P945, DOI 10.1124/jpet.111.183004	33	38	42	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17576	17586		10.1074/jbc.M115.659680	http://dx.doi.org/10.1074/jbc.M115.659680			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26013825	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000357730900048
J	Najyb, O; Brissette, L; Rassart, E				Najyb, Ouafa; Brissette, Louise; Rassart, Eric			Apolipoprotein D Internalization Is a Basigin-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apolipoprotein D (apoD); basigin; internalization; cyclophilin A; human neuroblastoma	MATRIX-METALLOPROTEINASE INDUCER; LIPOCALIN PROTEIN FAMILY; ARACHIDONIC-ACID; MESSENGER-RNA; GROWTH-FACTOR; IMMUNOGLOBULIN SUPERFAMILY; MOLECULAR CHARACTERIZATION; EXPRESSION PATTERN; CYCLOPHILIN-A; MICE LACKING	Background: ApoD appears to be a protein with multiple functions that could influence inflammatory and oxidative pathways to prevent neurotoxicity. Results: The internalization of apoD is mediated by a specific cell surface receptor. Conclusion: Basigin, a transmembrane glycoprotein, is implicated in the internalization process of apoD. Significance: This is the first evidence that a specific receptor is involved in apoD internalization. Apolipoprotein D (apoD), a member of the lipocalin family, is a 29-kDa secreted glycoprotein that binds and transports small lipophilic molecules. Expressed in several tissues, apoD is up-regulated under different stress stimuli and in a variety of pathologies. Numerous studies have revealed that overexpression of apoD led to neuroprotection in various mouse models of acute stress and neurodegeneration. This multifunctional protein is internalized in several cells types, but the specific internalization mechanism remains unknown. In this study, we demonstrate that the internalization of apoD involves a specific cell surface receptor in 293T cells, identified as the transmembrane glycoprotein basigin (BSG, CD147); more particularly, its low glycosylated form. Our results show that internalized apoD colocalizes with BSG into vesicular compartments. Down-regulation of BSG disrupted the internalization of apoD in cells. In contrast, overexpression of basigin in SH-5YSY cells, which poorly express BSG, restored the uptake of apoD. Cyclophilin A, a known ligand of BSG, competitively reduced apoD internalization, confirming that BSG is a key player in the apoD internalization process. In summary, our results demonstrate that basigin is very likely the apoD receptor and provide additional clues on the mechanisms involved in apoD-mediated functions, including neuroprotection.	[Najyb, Ouafa; Rassart, Eric] Univ Quebec, Ctr Biomed, Dept Sci Biol, Lab Biol Mol, Montreal, PQ H3C 398, Canada; [Brissette, Louise] Univ Quebec, Ctr Biomed, Dept Sci Biol, Lab Metab Lipoprot, Montreal, PQ H3C 398, Canada	University of Quebec; University of Quebec Montreal; University of Quebec; University of Quebec Montreal	Rassart, E (corresponding author), Univ Quebec, Ctr Biomed, Dept Sci Biol, Lab Biol Mol, Succursale Ctr Ville, Montreal, PQ H3C 398, Canada.	rassart.eric@uqam.ca			Canadian Institutes of Health Research [MOP-15677]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant MOP-15677.	Agrawal SM, 2011, J NEUROSCI, V31, P669, DOI 10.1523/JNEUROSCI.3659-10.2011; Allain F, 2002, P NATL ACAD SCI USA, V99, P2714, DOI 10.1073/pnas.052284899; AYRAULTJARRIER M, 1963, B SOC CHIM BIOL, V45, P703; Bajo-Graneras R, 2011, GLIA, V59, P1551, DOI 10.1002/glia.21200; BAJZER Z, 1989, J BIOL CHEM, V264, P13623; Beesley AH, 2008, BRIT J HAEMATOL, V142, P1000, DOI 10.1111/j.1365-2141.2008.07296.x; Bhatia S, 2012, BIOCHEM J, V442, P713, DOI 10.1042/BJ20111166; BISWAS C, 1995, CANCER RES, V55, P434; BLAIS Y, 1994, INT J CANCER, V59, P400, DOI 10.1002/ijc.2910590319; Boulos S, 2007, NEUROBIOL DIS, V25, P54, DOI 10.1016/j.nbd.2006.08.012; Brodeur MR, 2008, J BONE MINER RES, V23, P326, DOI 10.1359/JBMR.071022; CABRAL JHM, 1995, FEBS LETT, V366, P53, DOI 10.1016/0014-5793(95)00484-Q; Campisi J, 2005, SCIENCE, V309, P886, DOI 10.1126/science.1116801; Caudroy S, 2002, CLIN EXP METASTAS, V19, P697, DOI 10.1023/A:1021350718226; Chen HM, 2010, CLIN EXP METASTAS, V27, P557, DOI 10.1007/s10585-010-9345-9; Choi EY, 2002, EXP MOL MED, V34, P391, DOI 10.1038/emm.2002.56; Dai JY, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-337; Do Carmo S, 2002, J BIOL CHEM, V277, P5514, DOI 10.1074/jbc.M105057200; Do Carmo S, 2008, J NEUROSCI, V28, P10330, DOI 10.1523/JNEUROSCI.2644-08.2008; Do Carmo S, 2007, BBA-MOL CELL RES, V1773, P954, DOI 10.1016/j.bbamcr.2007.03.007; DRAYNA D, 1986, J BIOL CHEM, V261, P6535; Eichinger A, 2007, J BIOL CHEM, V282, P31068, DOI 10.1074/jbc.M703552200; Eyster CA, 2009, TRAFFIC, V10, P590, DOI 10.1111/j.1600-0854.2009.00894.x; Fan QW, 1998, NEUROSCI RES, V30, P53, DOI 10.1016/S0168-0102(97)00119-3; Flower DR, 1996, BIOCHEM J, V318, P1; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; Fukamachi K, 2002, J BIOL CHEM, V277, P43549, DOI 10.1074/jbc.C200502200; Ganfornina MD, 2008, AGING CELL, V7, P506, DOI 10.1111/j.1474-9726.2008.00395.x; Ganfornina MD, 2005, DEV DYNAM, V232, P191, DOI 10.1002/dvdy.20193; Gioiosa L, 2008, BEHAV BRAIN RES, V188, P255, DOI 10.1016/j.bbr.2007.11.002; Guo HM, 1997, J BIOL CHEM, V272, P24; Heo S, 2012, NEUROCHEM INT, V61, P702, DOI 10.1016/j.neuint.2012.07.006; Hino M, 2003, SURG TODAY, V33, P486, DOI 10.1007/s10595-002-2538-4; HOPKINS CR, 1983, J CELL BIOL, V97, P508, DOI 10.1083/jcb.97.2.508; Hori K, 2000, INVEST OPHTH VIS SCI, V41, P3128; Huang W, 2013, BIOCHEM J, V449, P437, DOI 10.1042/BJ20120343; Igakura T, 1998, DEV BIOL, V194, P152, DOI 10.1006/dbio.1997.8819; Jia L, 2006, IUBMB LIFE, V58, P209, DOI 10.1080/15216540600719580; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kosugi T, 2015, NEPHROL DIAL TRANSPL, V30, P1097, DOI 10.1093/ndt/gfu302; Kuno N, 1998, FEBS LETT, V425, P191, DOI 10.1016/S0014-5793(98)00213-0; Leung WCY, 2004, CIRC RES, V95, P179, DOI 10.1161/01.RES.0000135482.74178.14; Maldonado-Baez L, 2013, J CELL BIOL, V201, P233, DOI 10.1083/jcb.201208172; Muramatsu T, 2003, HISTOL HISTOPATHOL, V18, P981, DOI 10.14670/HH-18.981; Nahalkova J, 2010, NEUROCHEM INT, V56, P67, DOI 10.1016/j.neuint.2009.09.003; Naruhashi K, 1997, BIOCHEM BIOPH RES CO, V236, P733, DOI 10.1006/bbrc.1997.6993; Niesman IR, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-39; Oakley AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034057; Perdomo G, 2009, AGING-US, V1, P17; PETERS K, 1977, ANNU REV BIOCHEM, V46, P523, DOI 10.1146/annurev.bi.46.070177.002515; PROVOST PR, 1991, FEBS LETT, V290, P139, DOI 10.1016/0014-5793(91)81244-3; PROVOST PR, 1991, J LIPID RES, V32, P1959; Pushkarsky T, 2001, P NATL ACAD SCI USA, V98, P6360, DOI 10.1073/pnas.111583198; Rassart E, 2000, BBA-PROTEIN STRUCT M, V1482, P185, DOI 10.1016/S0167-4838(00)00162-X; Reindl M, 2001, J NEUROIMMUNOL, V119, P327, DOI 10.1016/S0165-5728(01)00378-2; Rickhag M, 2008, J CEREBR BLOOD F MET, V28, P551, DOI 10.1038/sj.jcbfm.9600552; Ruiz M, 2013, FEBS J, V280, P3928, DOI 10.1111/febs.12394; Sanchez D, 2002, MECH DEVELOP, V110, P225, DOI 10.1016/S0925-4773(01)00578-0; Sarjeant JM, 2003, ARTERIOSCL THROM VAS, V23, P2172, DOI 10.1161/01.ATV.0000100404.05459.39; Sasaki Y, 2009, J BIOL CHEM, V284, P872, DOI 10.1074/jbc.M807185200; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SEGUIN D, 1995, MOL BRAIN RES, V30, P242, DOI 10.1016/0169-328X(95)00008-G; SHERRY B, 1992, P NATL ACAD SCI USA, V89, P3511, DOI 10.1073/pnas.89.8.3511; Silva JP, 2010, ADV EXP MED BIOL, V706, P59; Siwik DA, 2008, J MOL CELL CARDIOL, V44, P210, DOI 10.1016/j.yjmcc.2007.07.054; SMITH KM, 1990, J LIPID RES, V31, P995; Soiland H, 2007, CELL ONCOL, V29, P195; Sun JX, 2001, CANCER RES, V61, P2276; Tang W, 2004, MOL BIOL CELL, V15, P4043, DOI 10.1091/mbc.E04-05-0402; Tang W, 2004, J BIOL CHEM, V279, P11112, DOI 10.1074/jbc.M312947200; Terrisse L, 1998, J NEUROCHEM, V71, P1643; Thomas EA, 2003, PROSTAG LEUKOTR ESS, V69, P421, DOI 10.1016/j.plefa.2003.08.014; Thomas EA, 2003, CURR MOL MED, V3, P408, DOI 10.2174/1566524033479681; Toole BP, 2003, CURR TOP DEV BIOL, V54, P371, DOI 10.1016/S0070-2153(03)54015-7; Tribouillard-Tanvier D, 2012, J BIOL CHEM, V287, P4628, DOI 10.1074/jbc.M111.269480; Tsukamoto K, 2013, P NATL ACAD SCI USA, V110, P17023, DOI 10.1073/pnas.1315986110; VIEIRA AV, 1995, MOL REPROD DEV, V42, P443, DOI 10.1002/mrd.1080420411; Vogt M, 2001, J MOL RECOGNIT, V14, P79, DOI 10.1002/1099-1352(200101/02)14:1<79::AID-JMR521>3.0.CO;2-4; Waldow T, 2009, J SURG RES, V152, P198, DOI 10.1016/j.jss.2008.03.014; XU Q, 1992, J BIOL CHEM, V267, P11968; Yoon YW, 2005, ATHEROSCLEROSIS, V180, P37, DOI 10.1016/j.atherosclerosis.2004.11.021; Yuasa J, 2001, ANDROLOGIA, V33, P293, DOI 10.1046/j.1439-0272.2001.00448.x; Yurchenko V, 2006, IMMUNOLOGY, V117, P301, DOI 10.1111/j.1365-2567.2005.02316.x; Yurchenko V, 2002, J BIOL CHEM, V277, P22959, DOI 10.1074/jbc.M201593200; Zucker S, 2001, AM J PATHOL, V158, P1921, DOI 10.1016/S0002-9440(10)64660-3	85	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16077	16087		10.1074/jbc.M115.644302	http://dx.doi.org/10.1074/jbc.M115.644302			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25918162	hybrid, Green Published			2022-12-28	WOS:000356930100014
J	Teran, M; Nugent, MA				Teran, Madelane; Nugent, Matthew A.			Synergistic Binding of Vascular Endothelial Growth Factor-A and Its Receptors to Heparin Selectively Modulates Complex Affinity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						heparan sulfate; heparin; heparin-binding protein; surface plasmon resonance (SPR); vascular endothelial growth factor (VEGF); neuropilin-1; VEGF receptor	VEGF RECEPTOR; PATHOLOGICAL ANGIOGENESIS; EXTRACELLULAR DOMAIN; TUMOR ANGIOGENESIS; MITOGENIC ACTIVITY; TYROSINE KINASE; SEMAPHORIN-III; MICE LACKING; SULFATE; ISOFORMS	Background: Vascular endothelial growth factor (VEGF) requires heparin-like molecules for full activity. Results: VEGF, VEGF receptor-2, and neuropilin-1 complexes bind heparin synergistically. Neuropilin-1 enhances VEGF signaling and is dependent on heparan sulfate. Conclusion: Heparin influences VEGF receptor-1, VEGF receptor-2, and neuropilin-1 through distinct mechanisms and regulates VEGF-induced signaling. Significance: Heparin-like molecules with specific structural features might be used to selectively manipulate the VEGF system to regulate angiogenesis. Angiogenesis is a highly regulated process orchestrated by the VEGF system. Heparin/heparan sulfate proteoglycans and neuropilin-1 (NRP-1) have been identified as co-receptors, yet the mechanisms of action have not been fully defined. In the present study, we characterized molecular interactions between receptors and co-receptors, using surface plasmon resonance and in vitro binding assays. Additionally, we demonstrate that these binding events are relevant to VEGF activity within endothelial cells. We defined interactions and structural requirements for heparin/HS interactions with VEGF receptor (VEGFR)-1, NRP-1, and VEGF(165) in complex with VEGFR-2 and NRP-1. We demonstrate that these structural requirements are distinct for each interaction. We further show that VEGF(165), VEGFR-2, and monomeric NRP-1 bind weakly to heparin alone yet show synergistic binding to heparin when presented together in various combinations. This synergistic binding appears to translate to alterations in VEGF signaling in endothelial cells. We found that soluble NRP-1 increases VEGF binding and activation of VEGFR-2 and ERK1/2 in endothelial cells and that these effects require sulfated HS. These data suggest that the presence of HS/heparin and NRP-1 may dictate the specific receptor type activated by VEGF and ultimately determine the biological output of the system. The ability of co-receptors to fine-tune VEGF responsiveness suggests the possibility that VEGF-mediated angiogenesis can be selectively stimulated or inhibited by targeting HS/heparin and NRP-1.	[Teran, Madelane] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Nugent, Matthew A.] Univ Massachusetts, Dept Biol Sci, Lowell, MA 01854 USA	Boston University; University of Massachusetts System; University of Massachusetts Lowell	Nugent, MA (corresponding author), Univ Massachusetts, Dept Biol Sci, Olsen Hall Rm 414A,198 Riverside St, Lowell, MA 01854 USA.	matthew_nugent@uml.edu	Regan, Clinton/E-6250-2012; Nugent, Matthew/GSI-5872-2022		National Institutes of Health [HL088672, M2012014]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants HL088672 and grant M2012014. The authors declare that they have no conflicts of interest with the contents of this article.	Ashikari- Hada S, 2005, J BIOL CHEM, V280, P31508, DOI 10.1074/jbc.M414581200; Cao YH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.259re1; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Carmeliet P, 1999, NAT MED, V5, P495, DOI 10.1038/8379; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Casu B, 2001, ADV CARBOHYD CHEM BI, V57, P159, DOI 10.1016/S0065-2318(01)57017-1; CHIANG MK, 1995, GROWTH FACTORS, V12, P1, DOI 10.3109/08977199509003208; Chung AS, 2011, ANNU REV CELL DEV BI, V27, P563, DOI 10.1146/annurev-cellbio-092910-154002; COHEN T, 1995, J BIOL CHEM, V270, P11322, DOI 10.1074/jbc.270.19.11322; Day ES, 2013, ANAL BIOCHEM, V440, P96, DOI 10.1016/j.ab.2013.05.012; Dougher AM, 1997, GROWTH FACTORS, V14, P257, DOI 10.3109/08977199709021524; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Forsten KE, 2000, J THEOR BIOL, V205, P215, DOI 10.1006/jtbi.2000.2064; Forsten-Williams K, 2005, J THEOR BIOL, V233, P483, DOI 10.1016/j.jtbi.2004.10.020; GITAYGOREN H, 1992, J BIOL CHEM, V267, P6093; Goerges AL, 2003, J BIOL CHEM, V278, P19518, DOI 10.1074/jbc.M211208200; Grunewald FS, 2010, BBA-PROTEINS PROTEOM, V1804, P567, DOI 10.1016/j.bbapap.2009.09.002; Guo P, 2001, CANCER RES, V61, P8569; Hamma-Kourbali Y, 2001, J BIOL CHEM, V276, P39748, DOI 10.1074/jbc.M101117200; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Ibrahimi OA, 2004, BIOCHEMISTRY-US, V43, P4724, DOI 10.1021/bi0352320; Jakobsson L, 2006, DEV CELL, V10, P625, DOI 10.1016/j.devcel.2006.03.009; Karamysheva AF, 2008, BIOCHEMISTRY-MOSCOW+, V73, P751, DOI 10.1134/S0006297908070031; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kiselyov A, 2007, EXPERT OPIN INV DRUG, V16, P83, DOI 10.1517/13543784.16.1.83; Koch S, 2014, DEV CELL, V28, P633, DOI 10.1016/j.devcel.2014.02.010; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Maes C, 2002, MECH DEVELOP, V111, P61, DOI 10.1016/S0925-4773(01)00601-3; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Nagy JA, 2007, ANNU REV PATHOL-MECH, V2, P251, DOI 10.1146/annurev.pathol.2.010506.134925; Nugent MA, 2013, BIOCHEMISTRY-MOSCOW+, V78, P726, DOI 10.1134/S0006297913070055; Nugent MA, 2000, P NATL ACAD SCI USA, V97, P10301, DOI 10.1073/pnas.97.19.10301; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Ono K, 1999, GLYCOBIOLOGY, V9, P705, DOI 10.1093/glycob/9.7.705; Park M, 1999, BIOCHEM BIOPH RES CO, V264, P730, DOI 10.1006/bbrc.1999.1580; Rahimi N, 2000, J BIOL CHEM, V275, P16986, DOI 10.1074/jbc.M000528200; Robinson CJ, 2001, J CELL SCI, V114, P853; Roy H, 2006, FEBS LETT, V580, P2879, DOI 10.1016/j.febslet.2006.03.087; Singh AJ, 2005, MOL BIOL CELL, V16, P2106, DOI 10.1091/mbc.E04-08-0749; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Stalmans I, 2002, J CLIN INVEST, V109, P327, DOI 10.1172/jci0214362; Takahashi H, 2005, CLIN SCI, V109, P227, DOI 10.1042/CS20040370; Uchimura Kenji, 2006, BMC Biochem, V7, P2, DOI 10.1186/1471-2091-7-2; Vander Kooi CW, 2007, P NATL ACAD SCI USA, V104, P6152, DOI 10.1073/pnas.0700043104; Whitaker GB, 2001, J BIOL CHEM, V276, P25520, DOI 10.1074/jbc.M102315200; Xu D, 2011, J BIOL CHEM, V286, P737, DOI 10.1074/jbc.M110.177006; Zelzer E, 2002, DEVELOPMENT, V129, P1893; Zhao WJ, 2012, BIOSCIENCE REP, V32, P71, DOI 10.1042/BSR20110077	53	50	51	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16451	16462		10.1074/jbc.M114.627372	http://dx.doi.org/10.1074/jbc.M114.627372			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25979342	hybrid, Green Published			2022-12-28	WOS:000356930100045
J	Oganesyan, V; Peng, L; Woods, RM; Wu, HR; Dall'Acqua, WF				Oganesyan, Vaheh; Peng, Li; Woods, Robert M.; Wu, Herren; Dall'Acqua, William F.			Structural Insights into the Neutralization Properties of the Fully Human, Anti-interferon Monoclonal Antibody Sifalimumab	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I INTERFERON-RECEPTOR; ALPHA-RECEPTOR; BINDING-SITE; MUTATIONAL ANALYSIS; LIGAND-BINDING; CYTOKINES; RESIDUES; CHAIN; BETA	We report the three-dimensional structure of human interferon alpha-2A (IFN-alpha 2A) bound to the Fab fragment of a therapeutic monoclonal antibody (sifalimumab; IgG1/kappa). The structure of the corresponding complex was solved at a resolution of 3.0 angstrom using molecular replacement and constitutes the first reported structure of a human type I IFN bound to a therapeutic antibody. This study revealed the major contribution made by the first complementarity-determining region in each of sifalimumab light and heavy chains. These data also provided the molecular basis for sifalimumab mechanism of action. We propose that its interferon-neutralizing properties are the result of direct competition for IFN-alpha 2A binding to the IFN receptor subunit 1 (IFNAR1) and do not involve inhibiting IFN-alpha 2A binding to the IFN receptor subunit 2 (IFNAR2).	[Oganesyan, Vaheh; Peng, Li; Woods, Robert M.; Wu, Herren; Dall'Acqua, William F.] MedImmune LLC, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD 20878 USA	AstraZeneca; Medimmune	Oganesyan, V (corresponding author), MedImmune LLC, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD 20878 USA.	oganesyanv@medimmune.com; dallacquaw@medimmune.com			AstraZeneca	AstraZeneca(AstraZeneca)	This work was supported by AstraZeneca. All authors are full-time employees of MedImmune LLC (Gaithersburg, MD).	Alsharifi M, 2008, IMMUNOL CELL BIOL, V86, P239, DOI 10.1038/sj.icb.7100159; Baccala R, 2005, IMMUNOL REV, V204, P9, DOI 10.1111/j.0105-2896.2005.00252.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Cajean-Feroldi C, 2004, BIOCHEMISTRY-US, V43, P12498, DOI 10.1021/bi049111r; Chill JH, 2002, BIOCHEMISTRY-US, V41, P3575, DOI 10.1021/bi011778f; Chuntharapai A, 1999, J IMMUNOL, V163, P766; Donnelly RP, 2010, J INTERF CYTOK RES, V30, P555, DOI 10.1089/jir.2010.0078; Foster GR, 1998, J VIRAL HEPATITIS, V5, P143, DOI 10.1046/j.1365-2893.1998.00103.x; Gavutis M, 2005, BIOPHYS J, V88, P4289, DOI 10.1529/biophysj.104.055855; Ghasriani H, 2013, J BIOL CHEM, V288, P247, DOI 10.1074/jbc.M112.413252; GRESSER I, 1976, J EXP MED, V144, P1305, DOI 10.1084/jem.144.5.1305; Hill EE, 2002, J MOL BIOL, V322, P205, DOI 10.1016/S0022-2836(02)00653-8; Isaacs A., 1957, J INTERFERON RES, P429; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kabat EA, 1991, SEQUENCES PROTEINS I; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Karpusas M, 1997, P NATL ACAD SCI USA, V94, P11813, DOI 10.1073/pnas.94.22.11813; Klaus W, 1997, J MOL BIOL, V274, P661, DOI 10.1006/jmbi.1997.1396; Kumaran J, 2007, FASEB J, V21, P3288, DOI 10.1096/fj.07-8585com; Lamken P, 2004, J MOL BIOL, V341, P303, DOI 10.1016/j.jmb.2004.05.059; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lewerenz M, 1998, J MOL BIOL, V282, P585, DOI 10.1006/jmbi.1998.2026; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NOVICK D, 1994, CELL, V77, P391, DOI 10.1016/0092-8674(94)90154-6; Oganesyan V, 2009, ACTA CRYSTALLOGR F, V65, P14, DOI 10.1107/S1744309108037925; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ouyang SY, 2012, J MOL MED, V90, P837, DOI 10.1007/s00109-012-0866-3; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pan MJ, 2008, BIOCHEMISTRY-US, V47, P12018, DOI 10.1021/bi801588g; Peng L, 2015, MABS-AUSTIN, V7, P428, DOI 10.1080/19420862.2015.1007810; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Piehler J, 2000, J BIOL CHEM, V275, P40425, DOI 10.1074/jbc.M006854200; Quadt-Akabayov SR, 2006, PROTEIN SCI, V15, P2656, DOI 10.1110/ps.062283006; Radhakrishnan R, 1996, STRUCTURE, V4, P1453, DOI 10.1016/S0969-2126(96)00152-9; Roisman LC, 2005, J MOL BIOL, V353, P271, DOI 10.1016/j.jmb.2005.08.042; Santiago-Raber ML, 2003, J EXP MED, V197, P777, DOI 10.1084/jem.20021996; Selmi C, 2006, CURR OPIN INVEST DR, V7, P451; Stanfield RL, 2006, J MOL BIOL, V357, P1566, DOI 10.1016/j.jmb.2006.01.023; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Thomas C, 2011, CELL, V146, P621, DOI 10.1016/j.cell.2011.06.048; UZE G, 1990, CELL, V60, P225, DOI 10.1016/0092-8674(90)90738-Z; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766	45	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					14979	14985		10.1074/jbc.M115.652156	http://dx.doi.org/10.1074/jbc.M115.652156			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25925951	hybrid, Green Published			2022-12-28	WOS:000356177300015
J	Christensen, MG; Fagerberg, SK; de Bruijn, PI; Bjaelde, RG; Jakobsen, H; Leipziger, J; Skals, M; Praetorius, HA				Christensen, Mette G.; Fagerberg, Steen K.; de Bruijn, Pauline I.; Bjaelde, Randi G.; Jakobsen, Helle; Leipziger, Jens; Skals, Marianne; Praetorius, Helle A.			[Ca2+](i) Oscillations and IL-6 Release Induced by alpha-Hemolysin from Escherichia coli Require P2 Receptor Activation in Renal Epithelia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIGHT JUNCTION INTEGRITY; EXTRACELLULAR ATP; TRANSPORT; P2Y(2); PORE; AMPLIFICATION; ERYTHROCYTES; INHIBITION; EXPRESSION; INFECTION	Urinary tract infections are commonly caused by alpha-hemolysin (HlyA)-producing Escherichia coli. In erythrocytes, the cytotoxic effect of HlyA is strongly amplified by P2X receptors, which are activated by extracellular ATP released from the cytosol of the erythrocytes. In renal epithelia, HlyA causes reversible [Ca2+](i) oscillations, which trigger interleukin-6 (IL-6) and IL-8 release. We speculate that this effect is caused by HlyA-induced ATP release from the epithelial cells and successive P2 receptor activation. Here, we demonstrate that HlyA-induced [Ca2+](i) oscillations in renal epithelia were completely prevented by scavenging extracellular ATP. In accordance, HlyA was unable to inflict any [Ca2+](i) oscillations in 132-1N1 cells, which lack P2R completely. After transfecting these cells with the hP2Y(2) receptor, HlyA readily triggered [Ca2+](i) oscillations, which were abolished by P2 receptor antagonists. Moreover, HlyA-induced [Ca2+](i) oscillations were markedly reduced in medullary thick ascending limbs isolated from P2Y(2) receptor-deficient mice compared with wild type. Interestingly, the following HlyA-induced IL-6 release was absent in P2Y(2) receptor-deficient mice. This suggests that HlyA induces ATP release from renal epithelia, which via P2Y(2) receptors is the main mediator of HlyA-induced [Ca2+](i) oscillations and IL-6 release. This supports the notion that ATP signaling occurs early during bacterial infection and is a key player in the further inflammatory response.	[Christensen, Mette G.; Fagerberg, Steen K.; de Bruijn, Pauline I.; Bjaelde, Randi G.; Jakobsen, Helle; Leipziger, Jens; Skals, Marianne; Praetorius, Helle A.] Aarhus Univ, Dept Biomed, Physiol, DK-8000 Aarhus C, Denmark	Aarhus University	Praetorius, HA (corresponding author), Aarhus Univ, Ole Worms Alle 3,Build 1170, DK-8000 Aarhus C, Denmark.	hp@biomed.au.dk		Leipziger, Jens/0000-0002-6719-7034; Praetorius, Helle/0000-0002-0970-5061; Christensen, Mette G./0000-0001-9249-2070; Fagerberg, Steen/0000-0001-5846-0155	Danish Council for Independent Research, Medical Sciences [DFF-1331-00203A, 12-125828]; Novo Nordisk Fonden [0505892]; Lundbeck Foundation [R100-A9482]	Danish Council for Independent Research, Medical Sciences(Det Frie Forskningsrad (DFF)); Novo Nordisk Fonden(Novo Nordisk Foundation); Lundbeck Foundation(Lundbeckfonden)	The work was supported by The Danish Council for Independent Research, Medical Sciences Grants DFF-1331-00203A and 12-125828, Novo Nordisk Fonden Grant 0505892, and Lundbeck Foundation Grant R100-A9482.	Bailey MA, 2000, KIDNEY INT, V58, P1893, DOI 10.1111/j.1523-1755.2000.00361.x; Baqi Y, 2011, J MED CHEM, V54, P817, DOI 10.1021/jm1012193; Becker MD, 2000, INVEST OPHTH VIS SCI, V41, P1812; Benson M, 1996, J INFECT DIS, V174, P1080, DOI 10.1093/infdis/174.5.1080; BENZ R, 1989, INFECT IMMUN, V57, P887, DOI 10.1128/IAI.57.3.887-895.1989; BHAKDI S, 1986, INFECT IMMUN, V52, P63, DOI 10.1128/IAI.52.1.63-69.1986; BHAKDI S, 1988, EUR J EPIDEMIOL, V4, P135, DOI 10.1007/BF00144740; Bien J, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/681473; Bjaelde RG, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00238; Bucker R, 2011, J INFECT DIS, V204, P1283, DOI 10.1093/infdis/jir504; BULLEN JJ, 1972, BMJ-BRIT MED J, V1, P69, DOI 10.1136/bmj.1.5792.69; CAVALIERI SJ, 1984, MICROBIOL REV, V48, P326, DOI 10.1128/MMBR.48.4.326-343.1984; Chauffier K, 2012, JOINT BONE SPINE, V79, P604, DOI 10.1016/j.jbspin.2011.12.013; Douillet CD, 2006, AM J PHYSIOL-LUNG C, V291, pL734, DOI 10.1152/ajplung.00389.2005; Foxman B, 2010, NAT REV UROL, V7, P653, DOI 10.1038/nrurol.2010.190; Geyti CS, 2008, PFLUG ARCH EUR J PHY, V455, P1105, DOI 10.1007/s00424-007-0366-4; Hanley PJ, 2004, P NATL ACAD SCI USA, V101, P9479, DOI 10.1073/pnas.0400733101; Hejl JL, 2013, PFLUG ARCH EUR J PHY, V465, P529, DOI 10.1007/s00424-012-1174-z; Ihara H, 2005, BIOCHEM BIOPH RES CO, V326, P329, DOI 10.1016/j.bbrc.2004.11.037; Inoue K, 2007, J INVEST DERMATOL, V127, P362, DOI 10.1038/sj.jid.5700526; Jensen MEJ, 2007, J AM SOC NEPHROL, V18, P2062, DOI 10.1681/ASN.2006070700; JOHNSON JR, 1991, CLIN MICROBIOL REV, V4, P80, DOI 10.1128/CMR.4.1.80-128.1991; Khalil A, 2000, CLIN EXP IMMUNOL, V122, P200, DOI 10.1046/j.1365-2249.2000.01377.x; Kishore BK, 1995, AM J PHYSIOL-RENAL, V269, pF863, DOI 10.1152/ajprenal.1995.269.6.F863; Koschinski A, 2006, FASEB J, V20, P973, DOI 10.1096/fj.05-4561fje; Kruse R, 2012, J UROLOGY, V188, P2419, DOI 10.1016/j.juro.2012.07.095; Larsen CK, 2011, J MEMBRANE BIOL, V244, P131, DOI 10.1007/s00232-011-9406-2; LEE J, 1995, J IMMUNOL, V155, P2158; Lehrmann H, 2002, J AM SOC NEPHROL, V13, P10, DOI 10.1681/ASN.V13110; Leipziger J, 2003, AM J PHYSIOL-RENAL, V284, pF419, DOI 10.1152/ajprenal.00075.2002; Marques RD, 2012, AM J PHYSIOL-RENAL, V302, pF487, DOI 10.1152/ajprenal.00570.2011; Masin J, 2013, INFECT IMMUN, V81, P4571, DOI 10.1128/IAI.00711-13; Munksgaard PS, 2012, CELL MICROBIOL, V14, P1904, DOI 10.1111/cmi.12021; Praetorius HA, 2001, J MEMBRANE BIOL, V184, P71, DOI 10.1007/s00232-001-0075-4; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Rochfort KD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101815; ROPELE M, 1989, BIOCHIM BIOPHYS ACTA, V985, P9, DOI 10.1016/0005-2736(89)90096-5; Save S, 2010, INFECT IMMUN, V78, P3609, DOI 10.1128/IAI.00074-10; Sipos A, 2009, J AM SOC NEPHROL, V20, P1724, DOI 10.1681/ASN.2008101099; Skals M, 2013, ACTA PHYSIOL, V209, P95, DOI 10.1111/apha.12156; Skals M, 2014, J BIOL CHEM, V289, P19098, DOI 10.1074/jbc.M114.571414; Skals M, 2011, PFLUG ARCH EUR J PHY, V462, P669, DOI 10.1007/s00424-011-1010-x; Skalsa M, 2009, P NATL ACAD SCI USA, V106, P4030, DOI 10.1073/pnas.0807044106; Suzuki T, 2011, J BIOL CHEM, V286, P31263, DOI 10.1074/jbc.M111.238147; Torres AG, 1997, MOL MICROBIOL, V23, P825, DOI 10.1046/j.1365-2958.1997.2641628.x; Uhlen P, 2000, NATURE, V405, P694, DOI 10.1038/35015091; Unwin RJ, 2003, NEWS PHYSIOL SCI, V18, P237, DOI 10.1152/nips.01436.2003; Wood MW, 2012, J COMP PATHOL, V147, P11, DOI 10.1016/j.jcpa.2011.09.005; Yoshida H, 2006, EUR J PHARMACOL, V540, P1, DOI 10.1016/j.ejphar.2006.04.008	49	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14776	14784		10.1074/jbc.M115.639526	http://dx.doi.org/10.1074/jbc.M115.639526			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25911098	Green Published, hybrid			2022-12-28	WOS:000355754600046
J	Petzold, C; Marceau, AH; Miller, KH; Marqusee, S; Keck, JL				Petzold, Christine; Marceau, Aimee H.; Miller, Katherine H.; Marqusee, Susan; Keck, James L.			Interaction with Single-stranded DNA-binding Protein Stimulates Escherichia coli Ribonuclease HI Enzymatic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							R-LOOP FORMATION; RNA-POLYMERASE BACKTRACKING; GENOME INSTABILITY; EXONUCLEASE-I; TRANSCRIPTION ELONGATION; FACILITATE REPLICATION; UNWINDING PROTEIN; TOPOISOMERASE-I; SSB; COMPLEXES	Single-stranded (ss) DNA-binding proteins (SSBs) bind and protect ssDNA intermediates formed during replication, recombination, and repair reactions. SSBs also directly interact with many different genome maintenance proteins to stimulate their enzymatic activities and/or mediate their proper cellular localization. We have identified an interaction formed between Escherichia coli SSB and ribonuclease HI (RNase HI), an enzyme that hydrolyzes RNA in RNA/DNA hybrids. The RNase HI center dot SSB complex forms by RNase HI binding the intrinsically disordered C terminus of SSB (SSB-Ct), a mode of interaction that is shared among all SSB interaction partners examined to date. Residues that comprise the SSB-Ct binding site are conserved among bacterial RNase HI enzymes, suggesting that RNase HI center dot SSB complexes are present in many bacterial species and that retaining the interaction is important for its cellular function. A steady-state kinetic analysis shows that interaction with SSB stimulates RNase HI activity by lowering the reaction K-m. SSB or RNase HI protein variants that disrupt complex formation nullify this effect. Collectively our findings identify a direct RNase HI/SSB interaction that could play a role in targeting RNase HI activity to RNA/DNA hybrid substrates within the genome.	[Petzold, Christine; Marceau, Aimee H.; Keck, James L.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, 1135 Biochem Sci Bldg,420 Henry Mall, Madison, WI 53706 USA; [Miller, Katherine H.; Marqusee, Susan] Univ Calif Berkeley, Calif Inst Quantitat Biosci, QB3, Berkeley, CA 94720 USA; [Miller, Katherine H.; Marqusee, Susan] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Keck, JL (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, 1135 Biochem Sci Bldg,420 Henry Mall, Madison, WI 53706 USA.	jlkeck@wisc.edu	Regan, Clinton/E-6250-2012	Keck, James/0000-0002-5961-0220	National Institutes of Health [GM098885, GM07215]; National Science Foundation Graduate Research Fellowship Program [DGE-1256259]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098885, T32GM008295, T32GM007215] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM098885 and GM07215 (a training grant in molecular biosciences to A. H. M.). This work was also supported by National Science Foundation Graduate Research Fellowship Program Grant DGE-1256259 (to C. P.). J. L. K. is cofounder of Replisoma, Inc.	Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Baharoglu Z, 2010, MOL MICROBIOL, V77, P324, DOI 10.1111/j.1365-2958.2010.07208.x; Bermejo R, 2012, MOL CELL, V45, P710, DOI 10.1016/j.molcel.2012.03.001; Bhattacharyya B, 2014, P NATL ACAD SCI USA, V111, P1373, DOI 10.1073/pnas.1318001111; Boubakri H, 2010, EMBO J, V29, P145, DOI 10.1038/emboj.2009.308; Broccoli S, 2004, MOL MICROBIOL, V52, P1769, DOI 10.1111/j.1365-2958.2004.04092.x; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Cadman CJ, 2004, NUCLEIC ACIDS RES, V32, P6378, DOI 10.1093/nar/gkh980; Camps M, 2005, FRONT BIOSCI-LANDMRK, V10, P689, DOI 10.2741/1564; Carlini L, 1998, FEBS LETT, V430, P197, DOI 10.1016/S0014-5793(98)00655-3; Celniker G, 2013, ISR J CHEM, V53, P199, DOI 10.1002/ijch.201200096; Costes A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001238; CROUCH R J, 1990, New Biologist, V2, P771; Curth U, 1996, NUCLEIC ACIDS RES, V24, P2706, DOI 10.1093/nar/24.14.2706; Dabora JM, 1996, BIOCHEMISTRY-US, V35, P11951, DOI 10.1021/bi9611671; DASGUPTA S, 1987, CELL, V51, P1113, DOI 10.1016/0092-8674(87)90597-6; DeLano W.L, PYMOL MOL GRAPHICS S; DROLET M, 1995, P NATL ACAD SCI USA, V92, P3526, DOI 10.1073/pnas.92.8.3526; Duch A, 2013, J MOL BIOL, V425, P4745, DOI 10.1016/j.jmb.2013.08.019; Dutta D, 2011, CELL, V146, P533, DOI 10.1016/j.cell.2011.07.034; El Hage A, 2010, GENE DEV, V24, P1546, DOI 10.1101/gad.573310; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Epshtein V, 2014, NATURE, V505, P372, DOI 10.1038/nature12928; Genschel J, 2000, BIOL CHEM, V381, P183, DOI 10.1515/BC.2000.025; George NP, 2012, J BIOL CHEM, V287, P22123, DOI 10.1074/jbc.M112.367573; Ginno PA, 2012, MOL CELL, V45, P814, DOI 10.1016/j.molcel.2012.01.017; Glover BP, 1998, J BIOL CHEM, V273, P23476, DOI 10.1074/jbc.273.36.23476; Hamperl S, 2014, DNA REPAIR, V19, P84, DOI 10.1016/j.dnarep.2014.03.023; Handa P, 2001, J BIOL CHEM, V276, P16992, DOI 10.1074/jbc.M100393200; HAUSEN P, 1970, EUR J BIOCHEM, V14, P278, DOI 10.1111/j.1432-1033.1970.tb00287.x; Helmrich A, 2013, NAT STRUCT MOL BIOL, V20, P412, DOI 10.1038/nsmb.2543; Helmrich A, 2011, MOL CELL, V44, P966, DOI 10.1016/j.molcel.2011.10.013; Herrera-Moyano E, 2014, GENE DEV, V28, P735, DOI 10.1101/gad.234070.113; Hiller B, 2012, J EXP MED, V209, P1419, DOI 10.1084/jem.20120876; Hingorani Manju M., 2005, P193; Hobbs MD, 2007, J BIOL CHEM, V282, P11058, DOI 10.1074/jbc.M611007200; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; ITAYA M, 1990, P NATL ACAD SCI USA, V87, P8587, DOI 10.1073/pnas.87.21.8587; ITOH T, 1980, P NATL ACAD SCI-BIOL, V77, P2450, DOI 10.1073/pnas.77.5.2450; KATAYANAGI K, 1990, NATURE, V347, P306, DOI 10.1038/347306a0; Keck JL, 1997, TECH PROT CHEM, V8, P409, DOI 10.1016/S1080-8914(97)80041-5; Kelman Z, 1998, EMBO J, V17, P2436, DOI 10.1093/emboj/17.8.2436; KITANI T, 1985, J MOL BIOL, V184, P45, DOI 10.1016/0022-2836(85)90042-7; Kogoma T, 1997, MICROBIOL MOL BIOL R, V61, P212, DOI 10.1128/.61.2.212-238.1997; KORNBERG A, 1992, DNA REPLICATION, P275; Lazzaro F, 2012, MOL CELL, V45, P99, DOI 10.1016/j.molcel.2011.12.019; Lecointe F, 2007, EMBO J, V26, P4239, DOI 10.1038/sj.emboj.7601848; Leela JK, 2013, P NATL ACAD SCI USA, V110, P258, DOI 10.1073/pnas.1213123110; Lin YL, 2012, CURR GENOMICS, V13, P65, DOI 10.2174/138920212799034767; Lu D, 2008, P NATL ACAD SCI USA, V105, P9169, DOI 10.1073/pnas.0800741105; Lu D, 2011, NUCLEIC ACIDS RES, V39, P6536, DOI 10.1093/nar/gkr315; Maduike NZ, 2014, MOL MICROBIOL, V91, P39, DOI 10.1111/mmi.12440; Marceau AH, 2011, EMBO J, V30, P4236, DOI 10.1038/emboj.2011.305; Marechal A, 2014, MOL CELL, V53, P235, DOI 10.1016/j.molcel.2013.11.002; Masai H, 1996, BIOCHIMIE, V78, P1109, DOI 10.1016/S0300-9084(97)86737-5; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGlynn P, 2012, MOL MICROBIOL, V85, P12, DOI 10.1111/j.1365-2958.2012.08102.x; Merrikh H, 2012, NAT REV MICROBIOL, V10, P449, DOI 10.1038/nrmicro2800; MEYER RR, 1990, MICROBIOL REV, V54, P342, DOI 10.1128/MMBR.54.4.342-380.1990; MOLINEUX IJ, 1974, P NATL ACAD SCI USA, V71, P3858, DOI 10.1073/pnas.71.10.3858; MOLINEUX IJ, 1975, J MOL BIOL, V98, P811, DOI 10.1016/S0022-2836(75)80012-X; Nudler E, 2012, CELL, V149, P1438, DOI 10.1016/j.cell.2012.06.003; OGAWA T, 1984, MOL GEN GENET, V193, P231, DOI 10.1007/BF00330673; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Poveda AM, 2010, TRANSCR-AUSTIN, V1, P99, DOI 10.4161/trns.1.2.12665; Proshkin S, 2010, SCIENCE, V328, P504, DOI 10.1126/science.1184939; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rizzo J, 2002, MOL CELL PROBE, V16, P277, DOI 10.1006/mcpr.2002.0423; Ryzhikov M, 2011, NUCLEIC ACIDS RES, V39, P6305, DOI 10.1093/nar/gkr199; SAMBROOK J, 2001, MOL CLONING LAB MANU, V2; Sandigursky M, 1996, RADIAT RES, V145, P619, DOI 10.2307/3579281; Schweimer K, 2002, BIOCHEMISTRY-US, V41, P5120, DOI 10.1021/bi015986j; Shereda RD, 2007, J BIOL CHEM, V282, P19247, DOI 10.1074/jbc.M608011200; Shereda RD, 2009, J MOL BIOL, V386, P612, DOI 10.1016/j.jmb.2008.12.065; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; Soultanas P, 2011, TRANSCR-AUSTIN, V2, P140, DOI 10.4161/trns.2.3.15908; Sparks JL, 2012, MOL CELL, V47, P980, DOI 10.1016/j.molcel.2012.06.035; Suski C, 2008, MOL CELL, V30, P779, DOI 10.1016/j.molcel.2008.04.020; Tehranchi AK, 2010, CELL, V141, P595, DOI 10.1016/j.cell.2010.03.036; von Hippel PH, 1998, SCIENCE, V281, P660, DOI 10.1126/science.281.5377.660; Wahba L, 2011, MOL CELL, V44, P978, DOI 10.1016/j.molcel.2011.10.017; Wessel SR, 2013, J BIOL CHEM, V288, P17569, DOI 10.1074/jbc.M113.478156; Wimberly H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3115; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; YANG W, 1990, SCIENCE, V249, P1398, DOI 10.1126/science.2169648; Yu K, 2006, METHOD ENZYMOL, V409, P316, DOI 10.1016/S0076-6879(05)09018-X; Yuzhakov A, 1999, CELL, V96, P153, DOI 10.1016/S0092-8674(00)80968-X	88	45	45	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14626	14636		10.1074/jbc.M115.655134	http://dx.doi.org/10.1074/jbc.M115.655134			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25903123	hybrid, Green Published			2022-12-28	WOS:000355754600033
J	Cook, JR; Langlet, F; Kido, Y; Accili, D				Cook, Joshua R.; Langlet, Fanny; Kido, Yoshiaki; Accili, Domenico			Pathogenesis of Selective Insulin Resistance in Isolated Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR FOXO1; DEPENDENT DIABETES-MELLITUS; HEPATIC LIPID-ACCUMULATION; FATTY LIVER-DISEASE; RAT HEPATOCYTES; GLUCOSE-PRODUCTION; KINASE-ACTIVITY; CIRCULATING MONOCYTES; PRIMARY CULTURES; NATURAL-HISTORY	The development of insulin resistance (IR) in the liver is a key pathophysiologic event in the development of type 2 diabetes. Although insulin loses its ability to suppress glucose production, it largely retains its capacity to drive lipogenesis. This selective IR results in the characteristic hyperglycemia and dyslipidemia of type 2 diabetes. The delineation of two branched pathways of insulin receptor (InsR) signaling to glucose versus triglyceride production, one through FoxO and the other through SREBP-1c, provides a mechanism to account for this pathophysiological abnormality. We tested the complementary hypothesis that selective IR arises due to different intrinsic sensitivities of glucose production versus de novo lipogenesis to insulin as a result of cell-autonomous down-regulation of InsR number in response to chronic hyperinsulinemia. We demonstrate in mouse primary hepatocytes that chronic hyperinsulinemia abrogates insulin's inhibition of glucose production, but not its stimulation of de novo lipogenesis. Using a competitive inhibitor of InsR, we show that there is a 4-fold difference between levels of InsR inhibition required to cause resistance of glucose production versus lipogenesis to the actions of insulin. Our data support a parsimonious model in which differential InsR activation underlies the selective IR of glucose production relative to lipogenesis, but both processes require signaling through Akt1/2.	[Cook, Joshua R.; Langlet, Fanny; Accili, Domenico] Columbia Univ, Dept Med, New York, NY 10032 USA; [Kido, Yoshiaki] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Diabet & Endocrinol, Kobe, Hyogo 6500017, Japan	Columbia University; Kobe University	Accili, D (corresponding author), Dept Med, 1150 St Nicholas Ave,Rm 238, New York, NY 10032 USA.	da230@columbia.edu	Regan, Clinton/E-6250-2012	Cook, Joshua Robert/0000-0001-6004-0504	National Institutes of Health [DK100038, DK57539, DK63608]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL087123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057539, P30DK063608, F30DK100038] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK100038, DK57539 (to D. A.), and DK63608 (to Columbia University Diabetes Research Center).	Accili D, 2004, DIABETES, V53, P1633, DOI 10.2337/diabetes.53.7.1633; Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106; AMATRUDA JM, 1982, DIABETES, V31, P145, DOI 10.2337/diabetes.31.2.145; ARNER P, 1983, J CLIN INVEST, V72, P1729, DOI 10.1172/JCI111132; ARNER P, 1986, J CLIN INVEST, V77, P1716, DOI 10.1172/JCI112492; BAR RS, 1976, J CLIN INVEST, V58, P1123, DOI 10.1172/JCI108565; BLACKARD WG, 1978, ENDOCRINOLOGY, V103, P548, DOI 10.1210/endo-103-2-548; Brassard P, 2008, J CLIN ENDOCR METAB, V93, P837, DOI 10.1210/jc.2007-1670; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; CARO JF, 1986, J CLIN INVEST, V78, P249, DOI 10.1172/JCI112558; CARO JF, 1980, J BIOL CHEM, V255, P52; CARO JF, 1987, J CLIN INVEST, V79, P1330, DOI 10.1172/JCI112958; CARO JF, 1989, DIABETES METAB REV, V5, P665, DOI 10.1002/dmr.5610050804; COMI RJ, 1987, J CLIN INVEST, V79, P453, DOI 10.1172/JCI112833; Diraison F, 2003, DIABETES METAB, V29, P478, DOI 10.1016/S1262-3636(07)70061-7; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; FEHLMANN M, 1982, P NATL ACAD SCI-BIOL, V79, P5921, DOI 10.1073/pnas.79.19.5921; FREIDENBERG GR, 1987, J CLIN INVEST, V79, P240, DOI 10.1172/JCI112789; GAVIN JR, 1974, P NATL ACAD SCI USA, V71, P84, DOI 10.1073/pnas.71.1.84; Gonzalez E, 2011, P NATL ACAD SCI USA, V108, P10162, DOI 10.1073/pnas.1019268108; GOODNER CJ, 1988, DIABETES, V37, P1316, DOI 10.2337/diabetes.37.10.1316; Haeusler RA, 2008, CELL METAB, V8, P7, DOI 10.1016/j.cmet.2008.06.010; Haeusler RA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6190; Haeusler RA, 2012, CELL METAB, V15, P65, DOI 10.1016/j.cmet.2011.11.010; Hegarty BD, 2005, P NATL ACAD SCI USA, V102, P791, DOI 10.1073/pnas.0405067102; HURRELL DG, 1989, ENDOCRINOLOGY, V125, P2454, DOI 10.1210/endo-125-5-2454; KAHN CR, 1972, BIOCHEM BIOPH RES CO, V48, P135, DOI 10.1016/0006-291X(72)90354-3; KATO S, 1982, J BIOCHEM-TOKYO, V92, P699, DOI 10.1093/oxfordjournals.jbchem.a133981; Kido Y, 2000, DIABETES, V49, P589, DOI 10.2337/diabetes.49.4.589; KOLTERMAN OG, 1981, J CLIN INVEST, V68, P957, DOI 10.1172/JCI110350; Laplante M, 2009, CURR BIOL, V19, pR1046, DOI 10.1016/j.cub.2009.09.058; Leavens KF, 2011, CRIT REV BIOCHEM MOL, V46, P200, DOI 10.3109/10409238.2011.562481; Leavens KF, 2009, CELL METAB, V10, P405, DOI 10.1016/j.cmet.2009.10.004; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Lin HV, 2011, CELL METAB, V14, P9, DOI 10.1016/j.cmet.2011.06.003; Lindsley CW, 2005, BIOORG MED CHEM LETT, V15, P761, DOI 10.1016/j.bmcl.2004.11.011; Logie L, 2007, DIABETES, V56, P2218, DOI 10.2337/db07-0343; Lu MJ, 2012, NAT MED, V18, P388, DOI 10.1038/nm.2686; MARBAN SL, 1990, CLIN RES, V38, pA768; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Matsumoto M, 2006, J CLIN INVEST, V116, P2464, DOI 10.1172/JCI27047; Monnier L, 2007, DIABETES CARE, V30, P263, DOI 10.2337/dc06-1612; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; OLEFSKY JM, 1976, J CLIN INVEST, V57, P1165, DOI 10.1172/JCI108384; Owen JL, 2012, P NATL ACAD SCI USA, V109, P16184, DOI 10.1073/pnas.1213343109; Pajvani UB, 2013, NAT MED, V19, P1055, DOI 10.1038/nm.3259; Petersen KF, 1998, DIABETES, V47, P381, DOI 10.2337/diabetes.47.3.381; PONTIROLI AE, 1992, DIABETOLOGIA, V35, P294, DOI 10.1007/BF00400934; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Schaffer L, 2008, BIOCHEM BIOPH RES CO, V376, P380, DOI 10.1016/j.bbrc.2008.08.151; Semple RK, 2009, J CLIN INVEST, V119, P315, DOI 10.1172/JCI37432; Shanik MH, 2008, DIABETES CARE, V31, pS262, DOI 10.2337/dc08-s264; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; TAKAYAMA S, 1988, J CLIN ENDOCR METAB, V66, P992, DOI 10.1210/jcem-66-5-992; Wan M, 2011, CELL METAB, V14, P516, DOI 10.1016/j.cmet.2011.09.001; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002	59	51	54	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13972	13980		10.1074/jbc.M115.638197	http://dx.doi.org/10.1074/jbc.M115.638197			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25873396	Green Published, hybrid			2022-12-28	WOS:000355313000028
J	Li, G; Xu, F; Zhu, J; Krawczyk, M; Zhang, Y; Yuan, J; Patel, S; Wang, YJ; Lin, Y; Zhang, M; Cai, HM; Chen, D; Zhang, MX; Cao, GQ; Yeh, E; Lin, DN; Su, Q; Li, WW; Sen, GL; Afshari, N; Chen, SC; Maas, RL; Fu, XD; Zhang, K; Liu, YZ; Ouyang, H				Li, Gen; Xu, Fan; Zhu, Jie; Krawczyk, Michal; Zhang, Ying; Yuan, Jin; Patel, Sherrinal; Wang, Yujuan; Lin, Ying; Zhang, Ming; Cai, Huimin; Chen, Daniel; Zhang, Meixia; Cao, Guiqun; Yeh, Emily; Lin, Danni; Su, Qiao; Li, Wen-wen; Sen, George L.; Afshari, Natalie; Chen, Shaochen; Maas, Richard L.; Fu, Xiang-Dong; Zhang, Kang; Liu, Yizhi; Ouyang, Hong			Transcription Factor PAX6 (Paired Box 6) Controls Limbal Stem Cell Lineage in Development and Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE GENE LISTS; CORNEAL EPITHELIUM; P63; DIFFERENTIATION; MORPHOGENESIS; HOMEOSTASIS; SOFTWARE; KERATINS; CANCER; TOOLS	PAX6 is a master regulatory gene involved in neuronal cell fate specification. It also plays a critical role in early eye field and subsequent limbal stem cell (LSC) determination during eye development. Defects in Pax6 cause aniridia and LSC deficiency in humans and the Sey (Small eye) phenotype in mice (Masse, K., Bhamra, S., Eason, R., Dale, N., and Jones, E. A. (2007) Nature 449, 1058-1062). However, how PAX6 specifies LSC and corneal fates during eye development is not well understood. Here, we show that PAX6 is expressed in the primitive eye cup and later in corneal tissue progenitors in early embryonic development. In contrast, p63 expression commences after that of PAX6 in ocular adnexal and skin tissue progenitors and later in LSCs. Using an in vitro feeder-free culture system, we show that PAX6 knockdown in LSCs led to up-regulation of skin epidermis-specific keratins concomitant with differentiation to a skin fate. Using gene expression analysis, we identified the involvement of Notch, Wnt, and TGF-beta signaling pathways in LSC fate determination. Thus, loss of PAX6 converts LSCs to epidermal stem cells, as demonstrated by a switch in the keratin gene expression profile and by the appearance of congenital dermoid tissue.	[Li, Gen; Zhang, Ming; Cai, Huimin; Zhang, Meixia; Cao, Guiqun; Zhang, Kang] Sichuan Univ, W China Hosp, Mol Med Res Ctr, Chengdu 610041, Sichuan, Peoples R China; [Xu, Fan; Yuan, Jin; Wang, Yujuan; Lin, Ying; Zhang, Kang; Liu, Yizhi; Ouyang, Hong] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510060, Guangdong, Peoples R China; [Zhu, Jie; Krawczyk, Michal; Patel, Sherrinal; Chen, Daniel; Yeh, Emily; Lin, Danni; Afshari, Natalie; Zhang, Kang; Ouyang, Hong] Univ Calif San Diego, Dept Ophthalmol, Biomat & Tissue Engn Ctr, Inst Engn Med, La Jolla, CA 92093 USA; [Sen, George L.; Fu, Xiang-Dong; Zhang, Kang] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Chen, Shaochen; Zhang, Kang] Univ Calif San Diego, Dept Nanoengn, La Jolla, CA 92093 USA; [Zhang, Ying; Cao, Guiqun; Maas, Richard L.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Zhang, Ying; Cao, Guiqun; Maas, Richard L.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Cai, Huimin] Guangzhou KangRui Biol Pharmaceut Technol Co Ltd, Guangzhou 510005, Guangdong, Peoples R China; [Li, Wen-wen] Sun Yat Sen Univ, Affiliated Hosp 1, Lab Anim Ctr, Guangzhou 510080, Guangdong, Peoples R China; [Zhang, Kang] Vet Adm Healthcare Syst, San Diego, CA 92161 USA	Sichuan University; Sun Yat Sen University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Sun Yat Sen University	Zhang, K (corresponding author), Univ Calif San Diego, Dept Ophthalmol, La Jolla, CA 92093 USA.	kang.zhang@gmail.com	liu, yi/GXE-9662-2022; wang, yujuan/C-8428-2016; Zhu, Jie/AAD-1330-2022; Zhang, Kang/Y-2740-2019	Zhu, Jie/0000-0001-6862-9022; Zhang, Kang/0000-0002-4549-1697; Ouyang, Hong/0000-0002-7622-7733	973 Program [2015CB94600, 2014CB964900]; State Key Laboratory of Ophthalmology [RO1EY025090-A1, RO1EY021374]; NATIONAL EYE INSTITUTE [R01EY021374, R01EY025090, R01EY010123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008666] Funding Source: NIH RePORTER	973 Program(National Basic Research Program of China); State Key Laboratory of Ophthalmology; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by 973 Program Grants 2015CB94600 and 2014CB964900 and by State Key Laboratory of Ophthalmology Grants RO1EY025090-A1 and RO1EY021374. The authors declare that they have no conflicts of interest with the contents of this article.	Arwert EN, 2012, NAT REV CANCER, V12, P170, DOI 10.1038/nrc3217; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Collu GM, 2014, CELL MOL LIFE SCI, V71, P3553, DOI 10.1007/s00018-014-1644-x; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; DAVANGER M, 1971, NATURE, V229, P560, DOI 10.1038/229560a0; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; EICHNER R, 1984, J CELL BIOL, V98, P1388, DOI 10.1083/jcb.98.4.1388; Figueira EC, 2007, INVEST OPHTH VIS SCI, V48, P144, DOI 10.1167/iovs.06-0346; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; KOPAN R, 1989, GENE DEV, V3, P1, DOI 10.1101/gad.3.1.1; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Li W, 2008, J PATHOL, V214, P114, DOI 10.1002/path.2256; Lien WH, 2014, GENE DEV, V28, P1517, DOI 10.1101/gad.244772.114; Masse K, 2007, NATURE, V449, P1058, DOI 10.1038/nature06189; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Mukhopadhyay M, 2006, DEVELOPMENT, V133, P2149, DOI 10.1242/dev.02381; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Ouyang H, 2014, NATURE, V511, P358, DOI 10.1038/nature13465; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Ramaesh T, 2003, INVEST OPHTH VIS SCI, V44, P1871, DOI 10.1167/iovs.02-0576; Rowan S, 2008, DEV BIOL, V321, P111, DOI 10.1016/j.ydbio.2008.06.002; Schlotzer-Schrehardt U, 2005, EXP EYE RES, V81, P247, DOI 10.1016/j.exer.2005.02.016; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Vauclair S, 2007, DEV CELL, V13, P242, DOI 10.1016/j.devcel.2007.06.012; Wu GM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r53; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Zhao B, 2008, INVEST OPHTH VIS SCI, V49, P3395, DOI 10.1167/iovs.07-1263	29	42	44	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20448	20454		10.1074/jbc.M115.662940	http://dx.doi.org/10.1074/jbc.M115.662940			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26045558	hybrid, Green Published			2022-12-28	WOS:000359608900042
J	Adachi, M; So, M; Sakurai, K; Kardos, J; Goto, Y				Adachi, Masayuki; So, Masatomo; Sakurai, Kazumasa; Kardos, Jozsef; Goto, Yuji			Supersaturation-limited and Unlimited Phase Transitions Compete to Produce the Pathway Complexity in Amyloid Fibrillation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; BETA(2)-MICROGLOBULIN; MECHANISM; AGGREGATION; KINETICS; FIBRILS; CRYSTALLIZATION; ACCELERATION; NUCLEATION; MORPHOLOGY	Although amyloid fibrils and amorphous aggregates are two types of aggregates formed by denatured proteins, their relationship currently remains unclear. We used beta(2)-microglobulin (beta 2m), a protein responsible for dialysis-related amyloidosis, to clarify the mechanism by which proteins form either amyloid fibrils or amorphous aggregates. Whenultrasonication was used to accelerate the spontaneous fibrillation of beta 2m at pH 2.0, the effects observed depended on ultrasonic power; although stronger ultrasonic power effectively accelerated fibrillation, excessively strong ultrasonic power decreased the amount of fibrils formed, as monitored by thioflavin T fluorescence. An analysis of the products formed indicated that excessively strong ultrasonic power generated fibrillar aggregates that retained beta-structures but without high efficiency as seeds. On the other hand, when the spontaneous fibrillation of beta 2m was induced at higher concentrations of NaCl at pH 2.0 with stirring, amorphous aggregates became more dominant than amyloid fibrils. These apparent complexities in fibrillation were explained comprehensively by a competitive mechanism in which supersaturation-limited reactions competed with supersaturation-unlimited reactions. We link the kinetics of protein aggregation and a conformational phase diagram, in which supersaturation played important roles.	[Adachi, Masayuki; So, Masatomo; Goto, Yuji] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Sakurai, Kazumasa] Kinki Univ, Inst Adv Technol, High Pressure Prot Res Ctr, Wakayama 6496493, Japan; [Kardos, Jozsef] Eotvos Lorand Univ, Dept Biochem, H-1117 Budapest, Hungary; [Kardos, Jozsef] Eotvos Lorand Univ, MTA ELTE NAP B Neuroimmunol Res Grp, H-1117 Budapest, Hungary	Osaka University; Kindai University (Kinki University); Eotvos Lorand University; Eotvos Lorand University	Goto, Y (corresponding author), Osaka Univ, Inst Prot Res, Yamadaoka 3-2, Suita, Osaka 5650871, Japan.	ygoto@protein.osaka-u.ac.jp	Kardos, József/J-1035-2017	Kardos, József/0000-0002-2135-2932; So, Masatomo/0000-0002-4815-4995	Japanese Ministry of Education, Culture, Sports, Science, and Technology; Hungarian National Research, Development and Innovation Office [KTIA_NAP_13-2-2014-0017]; Grants-in-Aid for Scientific Research [15K14458] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hungarian National Research, Development and Innovation Office; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japanese Ministry of Education, Culture, Sports, Science, and Technology and performed under the International Collaborative Research Program of Institute for Protein Research, Osaka University. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Hungarian National Research, Development and Innovation Office (KTIA_NAP_13-2-2014-0017).	Arosio P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033372; Bemporad F, 2012, CHEM BIOL, V19, P315, DOI 10.1016/j.chembiol.2012.02.003; Bouchard M, 2000, PROTEIN SCI, V9, P1960, DOI 10.1110/ps.9.10.1960; Bramanti E, 2013, J PHYS CHEM B, V117, P13816, DOI 10.1021/jp4079986; Chatani E, 2009, P NATL ACAD SCI USA, V106, P11119, DOI 10.1073/pnas.0901422106; Chiba T, 2003, J BIOL CHEM, V278, P47016, DOI 10.1074/jbc.M304473200; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Ciryam P, 2013, CELL REP, V5, P781, DOI 10.1016/j.celrep.2013.09.043; Dusa A, 2006, BIOCHEMISTRY-US, V45, P2752, DOI 10.1021/bi051426z; EATON WA, 1987, BLOOD, V70, P1245; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Giehm L, 2010, ANAL BIOCHEM, V400, P270, DOI 10.1016/j.ab.2010.02.001; Gosal WS, 2005, J MOL BIOL, V351, P850, DOI 10.1016/j.jmb.2005.06.040; GOTO Y, 1989, BIOCHEMISTRY-US, V28, P945, DOI 10.1021/bi00429a004; Hall D, 2015, FEBS LETT, V589, P672, DOI 10.1016/j.febslet.2015.01.032; HOFRICHTER J, 1976, P NATL ACAD SCI USA, V73, P3035, DOI 10.1073/pnas.73.9.3035; Hong DP, 2006, BIOCHEMISTRY-US, V45, P9342, DOI 10.1021/bi0604936; Ikenoue T, 2014, P NATL ACAD SCI USA, V111, P6654, DOI 10.1073/pnas.1322602111; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Kardos J, 2005, BBA-PROTEINS PROTEOM, V1753, P108, DOI 10.1016/j.bbapap.2005.08.013; Kardos J, 2004, J BIOL CHEM, V279, P55308, DOI 10.1074/jbc.M409677200; Kitayama H, 2013, BBA-PROTEINS PROTEOM, V1834, P2640, DOI 10.1016/j.bbapap.2013.09.016; Korevaar PA, 2012, NATURE, V481, P492, DOI 10.1038/nature10720; Lin YX, 2014, LANGMUIR, V30, P1845, DOI 10.1021/la403100h; Miti T, 2015, BIOMACROMOLECULES, V16, P326, DOI 10.1021/bm501521r; Morris AM, 2009, BBA-PROTEINS PROTEOM, V1794, P375, DOI 10.1016/j.bbapap.2008.10.016; Muta H, 2014, J BIOL CHEM, V289, P18228, DOI 10.1074/jbc.M114.566950; Nymeyer H, 1998, P NATL ACAD SCI USA, V95, P5921, DOI 10.1073/pnas.95.11.5921; Ohhashi Y, 2005, J BIOL CHEM, V280, P32843, DOI 10.1074/jbc.M506501200; Platt GW, 2008, J MOL BIOL, V378, P251, DOI 10.1016/j.jmb.2008.01.092; Raman B, 2005, BIOCHEMISTRY-US, V44, P1288, DOI 10.1021/bi048029t; Sasahara K, 2008, BIOCHEMISTRY-US, V47, P2650, DOI 10.1021/bi701968g; Sasahara K, 2007, J MOL BIOL, V372, P981, DOI 10.1016/j.jmb.2007.06.088; Sipe JD, 2014, AMYLOID, V21, P221, DOI 10.3109/13506129.2014.964858; So M, 2011, J MOL BIOL, V412, P568, DOI 10.1016/j.jmb.2011.07.069; Souillac PO, 2002, J BIOL CHEM, V277, P12666, DOI 10.1074/jbc.M109229200; Tycko R, 2013, ACCOUNTS CHEM RES, V46, P1487, DOI 10.1021/ar300282r; Umemoto A, 2014, J BIOL CHEM, V289, P27290, DOI 10.1074/jbc.M114.569814; Uversky VN, 2009, CURR PROTEIN PEPT SC, V10, P483, DOI 10.2174/138920309789351921; Wetzel R, 2006, ACCOUNTS CHEM RES, V39, P671, DOI 10.1021/ar050069h; Wolynes PG, 2005, PHILOS T R SOC A, V363, P453, DOI 10.1098/rsta.2004.1502; Yagi H, 2015, BBA-PROTEINS PROTEOM, V1854, P209, DOI 10.1016/j.bbapap.2014.12.014; Yagi H, 2013, BBA-PROTEINS PROTEOM, V1834, P2480, DOI 10.1016/j.bbapap.2013.08.013; Yamaguchi K, 2012, PROTEIN SCI, V21, P38, DOI 10.1002/pro.755; Yoshimura Y, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.07HA01; Yoshimura Y, 2012, P NATL ACAD SCI USA, V109, P14446, DOI 10.1073/pnas.1208228109	46	47	47	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					18134	18145		10.1074/jbc.M115.648139	http://dx.doi.org/10.1074/jbc.M115.648139			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26063798	Green Published, hybrid			2022-12-28	WOS:000358511700044
J	Huang, YQ; Hamana, T; Liu, JC; Wang, C; An, L; You, P; Chang, JYF; Xu, JM; McKeehan, WL; Wang, F				Huang, Yanqing; Hamana, Tomoaki; Liu, Junchen; Wang, Cong; An, Lei; You, Pan; Chang, Julia Y. F.; Xu, Jianming; McKeehan, Wallace L.; Wang, Fen			Prostate Sphere-forming Stem Cells Are Derived from the P63-expressing Basal Compartment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANDROGEN-INDUCED REGENERATION; EPITHELIAL-CELLS; CANCER INITIATION; MOUSE PROSTATE; LUMINAL CELLS; ORIGIN; DIFFERENTIATION; IDENTIFICATION; CASTRATION; REVEALS	Prostate stem cells (P-SCs) are capable of giving rise to all three lineages of prostate epithelial cells, including basal, luminal, and neuroendocrine cells. Multiple methods have been used to identify P-SCs in adult prostates. These include in vivo renal capsule implantation of a single epithelial cell with urogenital mesenchymal cells, in vitro prostasphere and organoid cultures, and lineage tracing with castration-resistant Nkx3.1 expression (CARN), in conjunction with expression of cell type-specific markers. Both organoid culture and CARN tracing show the existence of P-SCs in the luminal compartment. Although prostasphere cells predominantly express basal cell-specific cytokeratin and P63, the lineage of prostasphere-forming cells in the P-SC hierarchy remains to be determined. Using lineage tracing with P63(CreERT2), we show here that the sphere-forming P-SCs are P63-expressing cells and reside in the basal compartment. Therefore we designate them as basal P-SCs (P-bSCs). P-bSCs are capable of differentiating into AR(+) and CK18(+) organoid cells, but organoid cells cannot form spheres. We also report that prostaspheres contain quiescent stem cells. Therefore, the results show that P-bSCs represent stem cells that are early in the hierarchy of overall prostate tissue stem cells. Understanding the contribution of the two types of P-SCs to prostate development and prostate cancer stem cells and how to manipulate them may open new avenues for control of prostate cancer progression and relapse.	[Huang, Yanqing; Hamana, Tomoaki; Liu, Junchen; An, Lei; You, Pan; Chang, Julia Y. F.; McKeehan, Wallace L.; Wang, Fen] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Ctr Canc & Stem Cell Biol, Houston, TX 77030 USA; [Wang, Cong; Wang, Fen] Wenzhou Med Coll, Wenzhou 325030, Zhejiang, Peoples R China; [You, Pan] Xiamen Zhongshan Hosp, Xiamen 361004, Fujian, Peoples R China; [Xu, Jianming] Baylor Coll Med, Houston, TX 77030 USA; [Wang, Fen] Texas A&M Hlth Sci Ctr, Coll Med, Dept Mol & Cellular Med, College Stn, TX 77807 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Wenzhou Medical University; Baylor College of Medicine; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Wang, F (corresponding author), Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Ctr Canc & Stem Cell Biol, Houston, TX 77030 USA.	fwang@ibt.tamhsc.edu	An, Lei/GQB-0039-2022; Regan, Clinton/E-6250-2012	Huang, Yanqing/0000-0001-7275-3333; Liu, Junchen/0000-0003-2765-9780	National Institutes of Health [CA96824, DE023106, CA140388]; Cancer Prevention and Research Institution of Texas [CPRIT110555]; Natural Science Foundation of Zhejiang Province of China [Y2110492]; National Natural Science Foundation of China [81101712, 31371470, 81270761]; NATIONAL CANCER INSTITUTE [R01CA193455, R01CA096824, R56CA096824, P50CA140388, R01CA112403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R56DE023106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK059820] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institution of Texas; Natural Science Foundation of Zhejiang Province of China(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants CA96824 and DE023106 (to F. W.), and CA140388 (to W. L. M., and F. W.), and Cancer Prevention and Research Institution of Texas Grant CPRIT110555 (to F. W. and W. L. M.), Natural Science Foundation of Zhejiang Province of China Grant Y2110492, and the National Natural Science Foundation of China Grants 81101712, 31371470, and 81270761 (to C. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bhatia-Gaur R, 1999, GENE DEV, V13, P966, DOI 10.1101/gad.13.8.966; Choi N, 2012, CANCER CELL, V21, P253, DOI 10.1016/j.ccr.2012.01.005; Chua CW, 2014, NAT CELL BIOL, V16, P951, DOI 10.1038/ncb3047; ENGLISH HF, 1987, PROSTATE, V11, P229, DOI 10.1002/pros.2990110304; EVANS GS, 1987, PROSTATE, V11, P339, DOI 10.1002/pros.2990110406; Garraway IP, 2010, PROSTATE, V70, P491, DOI 10.1002/pros.21083; Huang YQ, 2015, J BIOL CHEM, V290, P17753, DOI 10.1074/jbc.M115.661066; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Karthaus WR, 2014, CELL, V159, P163, DOI 10.1016/j.cell.2014.08.017; Lawson DA, 2010, P NATL ACAD SCI USA, V107, P2610, DOI 10.1073/pnas.0913873107; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Lin YS, 2007, GENESIS, V45, P554, DOI 10.1002/dvg.20327; Lin YS, 2007, DEVELOPMENT, V134, P723, DOI 10.1242/dev.02765; Liu J, 2011, MOL ENDOCRINOL, V25, P1849, DOI 10.1210/me.2011-1081; Lu TL, 2013, AM J PATHOL, V182, P975, DOI 10.1016/j.ajpath.2012.11.025; Ousset M, 2012, NAT CELL BIOL, V14, P1130, DOI 10.1038/ncb2600; Pignon JC, 2013, P NATL ACAD SCI USA, V110, P8105, DOI 10.1073/pnas.1221216110; Rybak AP, 2011, BBA-MOL CELL RES, V1813, P683, DOI 10.1016/j.bbamcr.2011.01.018; Shen MM, 2003, DEV DYNAM, V228, P767, DOI 10.1002/dvdy.10397; Signoretti S, 2000, AM J PATHOL, V157, P1769, DOI 10.1016/S0002-9440(10)64814-6; Signoretti S, 2005, P NATL ACAD SCI USA, V102, P11355, DOI 10.1073/pnas.0500165102; SUGIMURA Y, 1986, BIOL REPROD, V34, P973, DOI 10.1095/biolreprod34.5.973; Trokovic R, 2003, EMBO J, V22, P1811, DOI 10.1093/emboj/cdg169; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Wang JJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4415; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Wang ZA, 2014, CELL REP, V8, P1339, DOI 10.1016/j.celrep.2014.08.002; Wang ZA, 2013, NAT CELL BIOL, V15, P274, DOI 10.1038/ncb2697; Xin L, 2007, STEM CELLS, V25, P2760, DOI 10.1634/stemcells.2007-0355; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491	31	19	20	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					17745	17752		10.1074/jbc.M115.661033	http://dx.doi.org/10.1074/jbc.M115.661033			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26032419	hybrid, Green Published			2022-12-28	WOS:000358511700009
J	Jakubauskiene, E; Vilys, L; Makino, Y; Poellinger, L; Kanopka, A				Jakubauskiene, Egle; Vilys, Laurynas; Makino, Yuichi; Poellinger, Lorenz; Kanopka, Arvydas			Increased Serine-Arginine (SR) Protein Phosphorylation Changes Pre-mRNA Splicing in Hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAS DOMAIN PROTEIN; FACTOR ASF/SF2; EXPRESSION; VARIANT; FAMILY; DEPHOSPHORYLATION; TRANSCRIPTION; MACHINERY; CANCER; CYR61	The removal of introns from mRNA precursors (pre-mRNAs) is an essential step in eukaryotic gene expression. The splicing machinery heavily contributes to biological complexity and especially to the ability of cells to adapt to altered cellular conditions. Inhibitory PAS domain protein (IPAS), a dominant negative regulator of hypoxia-inducible gene expression, is generated from hypoxia inducible transcription factor-3 alpha (HIF-3 alpha) pre-mRNA by an alternative splicing mechanism. Inactivation of the IPAS transcript in mice leads to the neo-vascularization of the cornea, suggesting that IPAS is an important regulator of anti-angiogenesis in this tissue. For the first time we demonstrate that serine-arginine (SR) proteins are involved in oxygen tension-dependent changes in pre-mRNA splicing. SR proteins isolated from hypoxic cells differentially interact with RNA (compared with proteins isolated from cells cultured under normoxic conditions). They possess the differential ability to activate hypoxia-dependent splice sites, and they are more phosphorylated than those isolated from normoxic HeLa cells. We also show that expression of SR protein kinases (CLK1, SRPK1, SRPK2) in hypoxic cells is elevated at mRNA and protein levels. Increased expression of CLK1 kinase is regulated by HIFs. Reduction of CLK1 cellular expression levels reduces hypoxia-dependent full-length carbonic anhydrase IX (CAIX) mRNA and CAIX protein formation and changes hypoxia-dependent cysteine-rich angiogenic inducer 61 (Cyr61) mRNA isoform formation profiles.	[Jakubauskiene, Egle; Vilys, Laurynas; Kanopka, Arvydas] Vilnius State Univ, Inst Biotechnol, Dept Immunol & Cell Biol, LT-02241 Vilnius, Lithuania; [Makino, Yuichi] Asahikawa Med Coll, Div Metab & Biosyst Sci, Dept Med, Asahikawa, Hokkaido 0788510, Japan; [Poellinger, Lorenz] Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden; [Poellinger, Lorenz] Natl Univ Singapore, Canc Sci Inst, Singapore 117599, Singapore	Vilnius University; Asahikawa Medical College; Karolinska Institutet; National University of Singapore	Kanopka, A (corresponding author), Vilnius State Univ, Inst Biotechnol, Dept Immunol & Cell Biol, Graiciuno 8, LT-02241 Vilnius, Lithuania.	kanopka@ibt.lt			European Union [222741]	European Union(European Commission)	This work was supported by a European Union grant ("METOXIA" project 222741). The authors declare that they have no conflicts of interest with the contents of this article.	Barathova M, 2008, BRIT J CANCER, V98, P129, DOI 10.1038/sj.bjc.6604111; Cho SY, 2011, P NATL ACAD SCI USA, V108, P8233, DOI 10.1073/pnas.1017700108; Colwill K, 1996, EMBO J, V15, P265, DOI 10.1002/j.1460-2075.1996.tb00357.x; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Gang HY, 2011, CIRC RES, V108, P1084, DOI 10.1161/CIRCRESAHA.110.238709; Gardner LB, 2008, CELL CYCLE, V7, P1916, DOI 10.4161/cc.7.13.6203; Graveley BR, 1999, CURR BIOL, V9, pR6, DOI 10.1016/S0960-9822(99)80032-3; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; Gu YZ, 1998, GENE EXPRESSION, V7, P205; Hang XY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-126; Hastings ML, 2001, CURR OPIN CELL BIOL, V13, P302, DOI 10.1016/S0955-0674(00)00212-X; Huang YQ, 2005, MOL CELL, V17, P613, DOI 10.1016/j.molcel.2005.02.020; Kanopka A, 1998, NATURE, V393, P185, DOI 10.1038/30277; KREIVI JP, 1991, NUCLEIC ACIDS RES, V19, P6956, DOI 10.1093/nar/19.24.6956; Lendahl U, 2009, NAT REV GENET, V10, P821, DOI 10.1038/nrg2665; Makino Y, 2002, J BIOL CHEM, V277, P32405, DOI 10.1074/jbc.C200328200; Makino Y, 2001, NATURE, V414, P550, DOI 10.1038/35107085; McManus CJ, 2011, CURR OPIN GENET DEV, V21, P373, DOI 10.1016/j.gde.2011.04.001; Minchenko OH, 2005, MOL CELL BIOCHEM, V280, P227, DOI 10.1007/s11010-005-8009-6; Muraki M, 2004, J BIOL CHEM, V279, P24246, DOI 10.1074/jbc.M314298200; Naro Chiara, 2013, Int J Cell Biol, V2013, P151839, DOI 10.1155/2013/151839; Ngo JCK, 2008, MOL CELL, V29, P563, DOI 10.1016/j.molcel.2007.12.017; Ngo JCK, 2005, MOL CELL, V20, P77, DOI 10.1016/j.molcel.2005.08.025; Perbal B, 2009, J CELL COMMUN SIGNAL, V3, P153, DOI 10.1007/s12079-009-0051-9; Pilarsky CP, 1998, PROSTATE, V36, P85; Prasad J, 1999, MOL CELL BIOL, V19, P6991; Ratcliffe PJ, 2013, J PHYSIOL-LONDON, V591, P2027, DOI 10.1113/jphysiol.2013.251470; Saltzman AL, 2011, GENE DEV, V25, P373, DOI 10.1101/gad.2004811; Sampath D, 2001, J CLIN ENDOCR METAB, V86, P1707, DOI 10.1210/jc.86.4.1707; Sanford JR, 1999, GENE DEV, V13, P1513, DOI 10.1101/gad.13.12.1513; Semenza GL, 2014, ANNU REV PATHOL-MECH, V9, P47, DOI 10.1146/annurev-pathol-012513-104720; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Sena JA, 2014, MOL CANCER RES, V12, P1233, DOI 10.1158/1541-7786.MCR-14-0149; Shepard PJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-242; Shi Y, 2007, MOL CELL, V28, P79, DOI 10.1016/j.molcel.2007.08.028; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12; Wu SP, 1997, EMBO J, V16, P4421, DOI 10.1093/emboj/16.14.4421; Xiao SH, 1998, EMBO J, V17, P6359, DOI 10.1093/emboj/17.21.6359; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837	40	35	35	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					18079	18089		10.1074/jbc.M115.639690	http://dx.doi.org/10.1074/jbc.M115.639690			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26023237	Green Published, hybrid			2022-12-28	WOS:000358511700039
J	Date, K; Satoh, A; Iida, K; Ogawa, H				Date, Kimie; Satoh, Ayano; Iida, Kaoruko; Ogawa, Haruko			Pancreatic alpha-Amylase Controls Glucose Assimilation by Duodenal Retrieval through N-Glycan-specific Binding, Endocytosis, and Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIABETES-MELLITUS; EXOCRINE FUNCTION; STARCH DIGESTION; ACIDIFICATION; INTERNALIZATION; TRANSCYTOSIS; ABSORPTION; PATHWAYS; RECEPTOR; ENZYMES	alpha-Amylase, a major pancreatic protein and starch hydrolase, is essential for energy acquisition. Mammalian pancreatic alpha-amylase binds specifically to glycoprotein N-glycans in the brush-border membrane to activate starch digestion, whereas it significantly inhibits glucose uptake by Na+/glucose cotransporter 1 (SGLT1) at high concentrations (Asanuma-Date, K., Hirano, Y., Le, N., Sano, K., Kawasaki, N., Hashii, N., Hiruta, Y., Nakayama, K., Umemura, M., Ishikawa, K., Sakagami, H., and Ogawa, H. (2012) Functional regulation of sugar assimilation by N-glycan-specific interaction of pancreatic alpha-amylase with glycoproteins of duodenal brush border membrane. J. Biol. Chem. 287, 23104-23118). However, how the inhibition is stopped was unknown. Here, we show a new mechanism for the regulation of intestinal glucose absorption. Immunohistochemistry revealed that alpha-amylase in the duodena of non-fasted, but not fasted, pigs was internalized from the pancreatic fluid and immunostained. Wedemonstrated that after N-glycan binding, pancreatic alpha-amylase underwent internalization into lysosomes in a process that was inhibited by alpha-mannoside. The internalized alpha-amylase was degraded, showing low enzymatic activity and molecular weight at the basolateral membrane. In a human intestinal Caco-2 cell line, Alexa Fluor 488-labeled pancreatic alpha-amylase bound to the cytomembrane was transported to lysosomes through the endocytic pathway and then disappeared, suggesting degradation. Our findings indicate that N-glycan recognition by alpha-amylase protects enterocytes against a sudden increase in glucose concentration and restores glucose uptake by gradual internalization, which homeostatically controls the postprandial blood glucose level. The internalization of alpha-amylase may also enhance the supply of amino acids required for the high turnover of small intestine epithelial cells. This study provides novel and significant insights into the control of blood sugar during the absorption stage in the intestine.	[Date, Kimie; Iida, Kaoruko; Ogawa, Haruko] Ochanomizu Univ, Grad Sch Humanities & Sci, Bunkyo Ku, Tokyo 1128610, Japan; [Ogawa, Haruko] Ochanomizu Univ, Glycosci Inst, Bunkyo Ku, Tokyo 1128610, Japan; [Satoh, Ayano] Okayama Univ, Grad Sch Nat Sci & Technol, Kita Ku, Okayama 7008530, Japan	Ochanomizu University; Ochanomizu University; Okayama University	Ogawa, H (corresponding author), Ochanomizu Univ, Grad Sch Humanities & Sci, Bunkyo Ku, 2-1-1 Otsuka, Tokyo 1128610, Japan.	ogawa.haruko@ocha.ac.jp	Asanuma, Kimie/AAW-2543-2020; Satoh, Ayano/B-2423-2011	Asanuma, Kimie/0000-0003-4311-0544; Satoh, Ayano/0000-0003-3736-1283	Japan Society for the Promotion of Science [10385, 40058]; Dr. Yoshifumi Jigami Memorial Fund; Society of Yeast Scientists; Ministry of Education, Culture, Sports, Science, and Technology [22570111]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Dr. Yoshifumi Jigami Memorial Fund; Society of Yeast Scientists; Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Japan Society for the Promotion of Science Grants 10385 and 40058 (to K. D.) and the Dr. Yoshifumi Jigami Memorial Fund, the Society of Yeast Scientists (to K. D.), and Grant-in-aid for Scientific Research (C) 22570111 (to H. O.) from the Ministry of Education, Culture, Sports, Science, and Technology. The authors declare that they have no competing interests.	Ait-Slimane T, 2009, MOL BIOL CELL, V20, P3792, DOI 10.1091/mbc.E09-04-0275; Antileo E, 2013, AM J PHYSIOL-GASTR L, V304, pG655, DOI 10.1152/ajpgi.00472.2012; Asanuma-Date K, 2012, J BIOL CHEM, V287, P23104, DOI 10.1074/jbc.M111.314658; Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721; BERNACKI E, 1976, ACTA PHYSIOL POL, V27, P337; BERNFELD P, 1951, ADV ENZYMOL REL S BI, V12, P379; Bose S, 2007, J PHYSIOL-LONDON, V581, P457, DOI 10.1113/jphysiol.2007.129171; Caballero B. E., 2013, ENCY HUMAN NUTR, P139; CAMMISOTTO PG, 2010, INT J CELL BIOL, V2010; Cammisotto PG, 2007, AM J PHYSIOL-GASTR L, V293, pG773, DOI 10.1152/ajpgi.00260.2007; CHAE C, 1995, J VET MED SCI, V57, P883, DOI 10.1292/jvms.57.883; Cloutier M, 2006, J HISTOCHEM CYTOCHEM, V54, P781, DOI 10.1369/jhc.5A6877.2006; GRAY GM, 1992, J NUTR, V122, P172, DOI 10.1093/jn/122.1.172; Guha S, 2008, INDIAN J BIOCHEM BIO, V45, P75; Hardt PD, 2003, PANCREATOLOGY, V3, P395, DOI 10.1159/000073655; HOFLACK B, 1985, J BIOL CHEM, V260, P2008; Howard A, 2004, J NUTR, V134, P2957, DOI 10.1093/jn/134.11.2957; Hubatsch I, 2007, NAT PROTOC, V2, P2111, DOI 10.1038/nprot.2007.303; HUGHSON EJ, 1990, J CELL BIOL, V110, P337, DOI 10.1083/jcb.110.2.337; Jiang RL, 2011, J CELL PHYSIOL, V226, P3022, DOI 10.1002/jcp.22650; KELLER PJ, 1967, J BIOL CHEM, V242, P281; KESSLER M, 1978, BIOCHIM BIOPHYS ACTA, V506, P136, DOI 10.1016/0005-2736(78)90440-6; Khoursandi S, 2004, AM J PHYSIOL-CELL PH, V287, pC1041, DOI 10.1152/ajpcell.00197.2004; Kipp H, 2003, AM J PHYSIOL-CELL PH, V285, pC737, DOI 10.1152/ajpcell.00041.2003; Kitazawa H, 2004, J BIOL CHEM, V279, P42867, DOI 10.1074/jbc.M408047200; KLUMPERMAN J, 1993, J CELL BIOL, V121, P997, DOI 10.1083/jcb.121.5.997; Larger E, 2012, DIABETIC MED, V29, P1047, DOI 10.1111/j.1464-5491.2012.03597.x; Leja-Szpak A, 2004, J PHYSIOL PHARMACOL, V55, P239; Lipschutz Joshua H, 2001, Curr Protoc Cell Biol, VChapter 15, DOI 10.1002/0471143030.cb1505s12; Matsushita H, 2002, J BIOL CHEM, V277, P4680, DOI 10.1074/jbc.M105877200; Mohammad-Panah R, 2003, J BIOL CHEM, V278, P29267, DOI 10.1074/jbc.M304357200; Nichols BL, 2003, P NATL ACAD SCI USA, V100, P1432, DOI 10.1073/pnas.0237170100; Nickavar B, 2013, IRAN J PHARM RES, V12, P57; ORLANDI PA, 1993, J BIOL CHEM, V268, P12010; Yadav R, 2013, J CLIN DIAGN RES, V7, P1291, DOI 10.7860/JCDR/2013/6016.3120; YAMASHIRO DJ, 1987, J CELL BIOL, V105, P2723, DOI 10.1083/jcb.105.6.2723; YAMASHIRO DJ, 1984, J CELL BIOCHEM, V26, P231, DOI 10.1002/jcb.240260404	37	17	19	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17439	17450		10.1074/jbc.M114.594937	http://dx.doi.org/10.1074/jbc.M114.594937			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26023238	hybrid, Green Published			2022-12-28	WOS:000357730900036
J	Eun, YJ; Kapoor, M; Hussain, S; Garner, EC				Eun, Ye-Jin; Kapoor, Mrinal; Hussain, Saman; Garner, Ethan C.			Bacterial Filament Systems: Toward Understanding Their Emergent Behavior and Cellular Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ACTIN-LIKE PROTEINS; ESCHERICHIA-COLI; BACILLUS-SUBTILIS; FTSZ FILAMENTS; PLASMID SEGREGATION; DYNAMIC INSTABILITY; DNA SEGREGATION; MREB FILAMENTS; DIVISION; TUBULIN	Bacteria use homologs of eukaryotic cytoskeletal filaments to conduct many different tasks, controlling cell shape, division, and DNA segregation. These filaments, combined with factors that regulate their polymerization, create emergent self-organizing machines. Here, we summarize the current understanding of the assembly of these polymers and their spatial regulation by accessory factors, framing them in the context of being dynamical systems. We highlight how comparing the in vivo dynamics of the filaments with those measured in vitro has provided insight into the regulation, emergent behavior, and cellular functions of these polymeric systems.	[Eun, Ye-Jin; Kapoor, Mrinal; Hussain, Saman; Garner, Ethan C.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Eun, Ye-Jin; Kapoor, Mrinal; Hussain, Saman; Garner, Ethan C.] Harvard Univ, FAS, Ctr Syst Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University	Garner, EC (corresponding author), FAS Ctr Syst Biol, Dept Mol & Cellular Biol, Northwest Lab Bldg 445-20,52 Oxford St, Cambridge, MA 02138 USA.	egarner@g.harvard.edu	Hussain, Saman/L-8440-2019; Garner, Ethan/J-4025-2014	Hussain, Saman/0000-0001-6687-7591; Kapoor, Mrinal/0000-0002-5309-3832; Garner, Ethan/0000-0003-0141-3555; Eun, Ye Jin/0000-0002-4787-515X	National Institutes of Health [DP2AI117923-01]; Smith Family Award; Searle Scholar Fellowship; Helen Hay Whitney Foundation; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [DP2AI117923] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Smith Family Award; Searle Scholar Fellowship; Helen Hay Whitney Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by National Institutes of Health Grant DP2AI117923-01, a Smith Family Award, and a Searle Scholar Fellowship (to E. C. G.). This is the sixth article in the Thematic Minireview series "The State of the Cytoskeleton in 2015." The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Helen Hay Whitney Foundation.; Supported by the Howard Hughes Medical Institute.	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Addinall SG, 2005, J BACTERIOL, V187, P358, DOI 10.1128/JB.187.1.358-365.2005; Anderson DE, 2004, J BACTERIOL, V186, P5775, DOI 10.1128/JB.186.17.5775-5781.2004; Arumugam S, 2012, ANGEW CHEM INT EDIT, V51, P11858, DOI 10.1002/anie.201204332; Aylett CHS, 2012, P NATL ACAD SCI USA, V109, P16522, DOI 10.1073/pnas.1210899109; Bean GJ, 2008, BIOCHEMISTRY-US, V47, P826, DOI 10.1021/bi701538e; Becker E, 2006, EMBO J, V25, P5919, DOI 10.1038/sj.emboj.7601443; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; Bisicchia P, 2013, MBIO, V4, DOI 10.1128/mBio.00856-13; Cabeen MT, 2010, ANNU REV GENET, V44, P365, DOI 10.1146/annurev-genet-102108-134845; Campbell CS, 2007, J CELL BIOL, V179, P1059, DOI 10.1083/jcb.200708206; Chastanet Arnaud, 2012, Front Biosci (Schol Ed), V4, P1582; Chen YD, 2005, BIOPHYS J, V88, P505, DOI 10.1529/biophysj.104.044149; DAM M, 1994, J MOL BIOL, V236, P1289, DOI 10.1016/0022-2836(94)90058-2; Daniel RA, 2003, CELL, V113, P767, DOI 10.1016/S0092-8674(03)00421-5; Derman AI, 2009, MOL MICROBIOL, V73, P534, DOI 10.1111/j.1365-2958.2009.06771.x; DOI M, 1988, J BACTERIOL, V170, P4619, DOI 10.1128/jb.170.10.4619-4624.1988; Dominguez-Escobar J, 2011, SCIENCE, V333, P225, DOI 10.1126/science.1203466; Duman R, 2013, P NATL ACAD SCI USA, V110, pE4601, DOI 10.1073/pnas.1313978110; Dye NA, 2011, MOL MICROBIOL, V81, P368, DOI 10.1111/j.1365-2958.2011.07698.x; Egan AJF, 2013, ANN NY ACAD SCI, V1277, P8, DOI 10.1111/j.1749-6632.2012.06818.x; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Erickson HP, 1996, P NATL ACAD SCI USA, V93, P519, DOI 10.1073/pnas.93.1.519; ERICKSON HP, 1995, CELL, V80, P367, DOI 10.1016/0092-8674(95)90486-7; Esue O, 2006, J BACTERIOL, V188, P968, DOI 10.1128/JB.188.3.968-976.2006; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; Garner EC, 2011, SCIENCE, V333, P222, DOI 10.1126/science.1203285; Gayathri P, 2012, SCIENCE, V338, P1334, DOI 10.1126/science.1229091; Geissler B, 2007, MICROBIOL-SGM, V153, P814, DOI 10.1099/mic.0.2006/001834-0; Gitai Z, 2005, CELL, V120, P577, DOI 10.1016/j.cell.2005.02.026; Goley ED, 2010, MOL CELL, V39, P975, DOI 10.1016/j.molcel.2010.08.027; Graumann PL, 2004, BIOESSAYS, V26, P1209, DOI 10.1002/bies.20126; Guberman JM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000233; Gundogdu ME, 2011, EMBO J, V30, P617, DOI 10.1038/emboj.2010.345; Guo F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012680; Holden SJ, 2014, P NATL ACAD SCI USA, V111, P4566, DOI 10.1073/pnas.1313368111; Horger I, 2008, BIOPHYS J, V94, pL81, DOI 10.1529/biophysj.107.128363; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Kim SY, 2006, P NATL ACAD SCI USA, V103, P10929, DOI 10.1073/pnas.0604503103; Kirchhausen T, 2012, NAT CELL BIOL, V14, P906, DOI 10.1038/ncb2570; Kraemer JA, 2012, CELL, V149, P1488, DOI 10.1016/j.cell.2012.04.034; Lan GH, 2009, P NATL ACAD SCI USA, V106, P121, DOI 10.1073/pnas.0807963106; Landgraf D, 2012, NAT METHODS, V9, P480, DOI [10.1038/NMETH.1955, 10.1038/nmeth.1955]; Larsen RA, 2007, GENE DEV, V21, P1340, DOI 10.1101/gad.1546107; Li Z, 2007, EMBO J, V26, P4694, DOI 10.1038/sj.emboj.7601895; Loose M, 2008, SCIENCE, V320, P789, DOI 10.1126/science.1154413; Loose M, 2014, NAT CELL BIOL, V16, P38, DOI 10.1038/ncb2885; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Lu CL, 2000, J BACTERIOL, V182, P164, DOI 10.1128/JB.182.1.164-170.2000; Ma XL, 1996, P NATL ACAD SCI USA, V93, P12998, DOI 10.1073/pnas.93.23.12998; Margolin W, 1998, TRENDS MICROBIOL, V6, P233, DOI 10.1016/S0966-842X(98)01280-3; Mayer JA, 2009, CELL MOTIL CYTOSKEL, V66, P109, DOI 10.1002/cm.20332; Meier EL, 2014, CURR OPIN CELL BIOL, V26, P19, DOI 10.1016/j.ceb.2013.08.006; Michie KA, 2006, J BACTERIOL, V188, P1680, DOI 10.1128/JB.188.5.1680-1690.2006; Moller-Jensen J, 2003, MOL CELL, V12, P1477, DOI 10.1016/S1097-2765(03)00451-9; Moller-Jensen J, 2007, EMBO J, V26, P4413, DOI 10.1038/sj.emboj.7601864; Montabana EA, 2014, P NATL ACAD SCI USA, V111, P3407, DOI 10.1073/pnas.1318339111; Muchova K, 2013, ENVIRON MICROBIOL, V15, P3259, DOI 10.1111/1462-2920.12200; MUKHERJEE A, 1994, J BACTERIOL, V176, P2754, DOI 10.1128/JB.176.9.2754-2758.1994; Niu LL, 2008, BIOPHYS J, V95, P2009, DOI 10.1529/biophysj.108.128751; Nurse P, 2013, J BIOL CHEM, V288, P3469, DOI 10.1074/jbc.M112.413708; Orlova A, 2007, NAT STRUCT MOL BIOL, V14, P921, DOI 10.1038/nsmb1300; Osawa M, 2008, SCIENCE, V320, P792, DOI 10.1126/science.1154520; Osawa M, 2011, MOL MICROBIOL, V81, P571, DOI 10.1111/j.1365-2958.2011.07716.x; Osawa M, 2009, EMBO J, V28, P3476, DOI 10.1038/emboj.2009.277; Petek NA, 2014, METHOD ENZYMOL, V540, P19, DOI 10.1016/B978-0-12-397924-7.00002-9; Poggio S, 2010, MOL MICROBIOL, V77, P74, DOI 10.1111/j.1365-2958.2010.07223.x; Polka JK, 2014, P NATL ACAD SCI USA, V111, P2176, DOI 10.1073/pnas.1304127111; Polka JK, 2009, J BACTERIOL, V191, P6219, DOI 10.1128/JB.00676-09; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Reimold C, 2013, MOL BIOL CELL, V24, P2340, DOI 10.1091/mbc.E12-10-0728; Renner LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084143; Romberg L, 2001, J BIOL CHEM, V276, P11743, DOI 10.1074/jbc.M009033200; Rueff AS, 2014, MOL MICROBIOL, V91, P348, DOI 10.1111/mmi.12467; Salje J, 2011, MOL CELL, V43, P478, DOI 10.1016/j.molcel.2011.07.008; Schirner K, 2015, NAT CHEM BIOL, V11, P38, DOI 10.1038/nchembio.1689; Schumacher MA, 2007, NATURE, V450, P1268, DOI 10.1038/nature06392; Shih YL, 2005, MOL MICROBIOL, V58, P917, DOI 10.1111/j.1365-2958.2005.04841.x; Si FW, 2013, BIOPHYS J, V105, P1976, DOI 10.1016/j.bpj.2013.09.030; Soufo HJD, 2004, EMBO REP, V5, P789, DOI 10.1038/sj.embor.7400209; Stachowiak JC, 2012, NAT CELL BIOL, V14, P944, DOI 10.1038/ncb2561; Swulius MT, 2011, BIOCHEM BIOPH RES CO, V407, P650, DOI 10.1016/j.bbrc.2011.03.062; Szwedziak P, 2014, ELIFE, V3, DOI 10.7554/eLife.04601; Szwedziak P, 2012, EMBO J, V31, P2249, DOI 10.1038/emboj.2012.76; Thanbichler M, 2006, CELL, V126, P147, DOI 10.1016/j.cell.2006.05.038; Tinsley E, 2006, J BACTERIOL, V188, P2829, DOI 10.1128/JB.188.8.2829-2835.2006; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; Ursell TS, 2014, P NATL ACAD SCI USA, V111, pE1025, DOI 10.1073/pnas.1317174111; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; van den Ent F, 2014, ELIFE, V3, DOI 10.7554/eLife.02634; van den Ent F, 2010, EMBO J, V29, P1081, DOI 10.1038/emboj.2010.9; van Teeffelen S, 2011, P NATL ACAD SCI USA, V108, P15822, DOI 10.1073/pnas.1108999108; von Olshausen P, 2013, BIOPHYS J, V105, P1171, DOI 10.1016/j.bpj.2013.07.038; Wang SY, 2014, P NATL ACAD SCI USA, V111, P8452, DOI 10.1073/pnas.1406593111; Wu LJ, 2012, NAT REV MICROBIOL, V10, P8, DOI 10.1038/nrmicro2671; Yakhnina AA, 2012, MOL MICROBIOL, V85, P1090, DOI 10.1111/j.1365-2958.2012.08159.x; Zehr EA, 2014, STRUCTURE, V22, P539, DOI 10.1016/j.str.2014.02.006; Zieske K, 2014, ELIFE, V3, DOI 10.7554/eLife.03949	99	24	25	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17181	17189		10.1074/jbc.R115.637876	http://dx.doi.org/10.1074/jbc.R115.637876			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	25957405	hybrid, Green Published			2022-12-28	WOS:000357730900015
J	Guo, YJ; Yang, L; Haught, K; Scarlata, S				Guo, Yuanjian; Yang, Lu; Haught, Katrina; Scarlata, Suzanne			Osmotic Stress Reduces Ca2+ Signals through Deformation of Caveolae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; G-ALPHA(Q); RECEPTOR	Caveolae are membrane invaginations that can sequester various signaling proteins. Caveolae have been shown to provide mechanical strength to cells by flattening to accommodate increased volume when cells are subjected to hypo-osmotic stress. We have previously found that caveolin, the main structural component of caveolae, specifically binds G alpha(q) and stabilizes its activation state resulting in an enhanced Ca2+ signal upon activation. Here, we show that osmotic stress caused by decreasing the osmolarity in half reversibly changes the configuration of caveolae without releasing a significant portion of caveolin molecules. This change in configuration due to flattening leads to a loss in Cav1-G alpha(q) association. This loss in G alpha(q)/Cav1 association due to osmotic stress results in a significant reduction of G alpha(q)/phospholipase C alpha(q)-mediated Ca2+ signals. This reduced Ca2+ response is also seen when caveolae are reduced by treatment with siRNA(Cav1) or by dissolving them by methyl-beta-cyclodextran. No change in Ca2+ release with osmotic swelling can be seen when growth factor pathways are activated. Taken together, these results connect the mechanical deformation of caveolae to G alpha(q)-mediated Ca2+ signals.	[Guo, Yuanjian; Yang, Lu; Haught, Katrina; Scarlata, Suzanne] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Scarlata, S (corresponding author), SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA.	Suzanne.Scarlata@stonybrook.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [GM053132]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072853, R01GM116178, R01GM053132] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM053132. The authors declare that they have no conflicts of interest with the contents of this article.	Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Calizo RC, 2013, ANAL BIOCHEM, V440, P40, DOI 10.1016/j.ab.2013.04.033; Calizo RC, 2012, BIOCHEMISTRY-US, V51, P9513, DOI 10.1021/bi301107p; D'Alessandro M, 2002, J CELL SCI, V115, P4341, DOI 10.1242/jcs.00120; Dowal L, 2006, J BIOL CHEM, V281, P23999, DOI 10.1074/jbc.M512330200; Exton JH, 1996, ANNU REV PHARMACOL, V36, P481, DOI 10.1146/annurev.pa.36.040196.002405; Galbiati F, 2001, TRENDS MOL MED, V7, P435, DOI 10.1016/S1471-4914(01)02105-0; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guo YJ, 2005, J BIOL CHEM, V280, P1438, DOI 10.1074/jbc.M407593200; Guo YJ, 2011, BIOPHYS J, V100, P1599, DOI 10.1016/j.bpj.2011.02.013; Harvey RD, 2012, J MOL CELL CARDIOL, V52, P366, DOI 10.1016/j.yjmcc.2011.07.007; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Marx J, 2001, SCIENCE, V294, P1862, DOI 10.1126/science.294.5548.1862; Parton RG, 2006, J CELL SCI, V119, P787, DOI 10.1242/jcs.02853; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Pelkmans L, 2002, TRAFFIC, V3, P311, DOI 10.1034/j.1600-0854.2002.30501.x; Radel C, 2005, AM J PHYSIOL-HEART C, V288, pH936, DOI 10.1152/ajpheart.00519.2004; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; ROTHBERG KG, 1990, J CELL BIOL, V111, P2931, DOI 10.1083/jcb.111.6.2931; Schwencke C, 2006, CARDIOVASC RES, V70, P42, DOI 10.1016/j.cardiores.2005.11.029; Sengupta P, 2008, J CELL SCI, V121, P1363, DOI 10.1242/jcs.020081; Shvets E, 2014, CURR OPIN CELL BIOL, V29, P99, DOI 10.1016/j.ceb.2014.04.011; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Stary CM, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00393; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Taggart MJ, 2001, NEWS PHYSIOL SCI, V16, P61; Thomsen P, 2002, MOL BIOL CELL, V13, P238, DOI 10.1091/mbc.01-06-0317; Tjondrokoesoemo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025740; Woodman SE, 2002, J BIOL CHEM, V277, P38988, DOI 10.1074/jbc.M205511200	30	13	13	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16698	16707		10.1074/jbc.M115.655126	http://dx.doi.org/10.1074/jbc.M115.655126			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25957403	Green Published, hybrid			2022-12-28	WOS:000357572800019
J	Goitea, VE; Hallak, ME				Goitea, Victor E.; Hallak, Marta E.			Calreticulin and Arginylated Calreticulin Have Different Susceptibilities to Proteasomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						post-translational modification (PTM); proteasome; protein degradation; protein turnover; ubiquitylation (ubiquitination); arginylation; calreticulin; dimer	RNA-PROTEIN TRANSFERASE; POSTTRANSLATIONAL ARGINYLATION; HEAT-SHOCK; STRESS GRANULES; FORMS; ARGINYLTRANSFERASE; DIMERIZATION; INDUCTION; COMPONENT; CALCIUM	Background: Calreticulin (CRT) retrotranslocated from the endoplasmic reticulum to the cytoplasm is post-translationally arginylated. Results: Arginylated CRT (R-CRT) has a longer half-life than non-arginylated CRT and displays different ubiquitin dependence. Conclusion: CRT and R-CRT differ in their susceptibility to proteasomal degradation. Significance: Arginylation is not required for proteasomal degradation of CRT, although R-CRT displays ubiquitin modification. Post-translational arginylation has been suggested to target proteins for proteasomal degradation. The degradation mechanism for arginylated calreticulin (R-CRT) localized in the cytoplasm is unknown. To evaluate the effect of arginylation on CRT stability, we examined the metabolic fates and degradation mechanisms of cytoplasmic CRT and R-CRT in NIH 3T3 and CHO cells. Both CRT isoforms were found to be proteasomal substrates, but the half-life of R-CRT (2 h) was longer than that of cytoplasmic CRT (0.7 h). Arginylation was not required for proteasomal degradation of CRT, although R-CRT displays ubiquitin modification. A CRT mutant incapable of dimerization showed reduced metabolic stability of R-CRT, indicating that R-CRT dimerization may protect it from proteasomal degradation. Our findings, taken together, demonstrate a novel function of arginylation: increasing the half-life of CRT in cytoplasm.	[Hallak, Marta E.] Univ Nacl Cordoba, Ctr Invest Quim Biol Cordoba CIQUIBIC, Consejo Nacl Invest Cient & Tecn, Fac Ciencias Quim, RA-5000 Cordoba, Argentina; Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Biol, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; National University of Cordoba	Hallak, ME (corresponding author), Univ Nacl Cordoba, Ctr Invest Quim Biol Cordoba CIQUIBIC, Consejo Nacl Invest Cient & Tecn, Fac Ciencias Quim, X5000HUA, RA-5000 Cordoba, Argentina.	mhallak@fcq.unc.edu.ar		Goitea, Victor/0000-0002-1564-4111	Agencia Nacional de Promocion Cientifica y Technologica [PICT 2012-1979]; Consejo Nacional de Investigaciones Cientificas y Tecnicas; La Secretaria de Ciencia y Tecnologia, Universidad Nacional de Cordoba	Agencia Nacional de Promocion Cientifica y Technologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); La Secretaria de Ciencia y Tecnologia, Universidad Nacional de Cordoba	This work was supported by grants from the Agencia Nacional de Promocion Cientifica y Technologica (PICT 2012-1979), Consejo Nacional de Investigaciones Cientificas y Tecnicas, and La Secretaria de Ciencia y Tecnologia, Universidad Nacional de Cordoba. The authors declare that they have no conflicts of interest with the contents of this article.	Afshar N, 2005, MOL CELL BIOL, V25, P8844, DOI 10.1128/MCB.25.20.8844-8853.2005; Alvarez-Castelao B, 2009, J BIOL CHEM, V284, P28253, DOI 10.1074/jbc.M109.004101; Bogyo M, 2002, CURR TOP MICROBIOL, V268, P185; Bush KT, 1997, J BIOL CHEM, V272, P9086; Carpio MA, 2013, INT J BIOCHEM CELL B, V45, P1223, DOI 10.1016/j.biocel.2013.03.017; Carpio MA, 2010, BIOCHEM J, V429, P63, DOI 10.1042/BJ20091953; CIECHANOVER A, 1988, J BIOL CHEM, V263, P11155; Castaneda-Patlan MC, 2010, INT J BIOCHEM CELL B, V42, P120, DOI 10.1016/j.biocel.2009.09.019; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; Decca MB, 2007, J BIOL CHEM, V282, P8237, DOI 10.1074/jbc.M608559200; Decca MB, 2006, NEUROCHEM RES, V31, P401, DOI 10.1007/s11064-005-9037-z; Erales J, 2014, BBA-MOL CELL RES, V1843, P216, DOI 10.1016/j.bbamcr.2013.05.008; Gold LI, 2010, FASEB J, V24, P665, DOI 10.1096/fj.09-145482; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Guo N, 2013, ASIA-PAC J CLIN ONCO, V9, P6, DOI 10.1111/j.1743-7563.2012.01535.x; Hallak ME, 1997, NEUROCHEM RES, V22, P467, DOI 10.1023/A:1027315912242; Hamalainen-Laanaya HK, 2012, ANAL BIOCHEM, V429, P32, DOI 10.1016/j.ab.2012.07.006; Hattori T, 2003, ONCOGENE, V22, P1273, DOI 10.1038/sj.onc.1206204; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hu RG, 2006, J BIOL CHEM, V281, P32559, DOI 10.1074/jbc.M604355200; Jariel-Encontre I, 2008, BBA-REV CANCER, V1786, P153, DOI 10.1016/j.bbcan.2008.05.004; Jorgensen CS, 2003, EUR J BIOCHEM, V270, P4140, DOI 10.1046/j.1432-1033.2003.03808.x; Karakozova M, 2006, SCIENCE, V313, P192, DOI 10.1126/science.1129344; Kwon YT, 1999, MOL CELL BIOL, V19, P182; Kwon YT, 2002, SCIENCE, V297, P96, DOI 10.1126/science.1069531; Labriola CA, 2011, MOL BIOCHEM PARASIT, V175, P112, DOI 10.1016/j.molbiopara.2010.10.002; Labriola CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013141; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Sambrooks CL, 2012, J BIOL CHEM, V287, P22043, DOI 10.1074/jbc.M111.338335; Menendez-Benito V, 2005, HUM MOL GENET, V14, P2787, DOI 10.1093/hmg/ddi312; Nguyen TQ, 1996, MOL IMMUNOL, V33, P379, DOI 10.1016/0161-5890(95)00149-2; Petris G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023712; Raghavan M, 2013, TRENDS IMMUNOL, V34, P13, DOI 10.1016/j.it.2012.08.002; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Rechsteiner M, 2005, TRENDS CELL BIOL, V15, P27, DOI 10.1016/j.tcb.2004.11.003; Rizvi SM, 2004, MOL CELL, V15, P913, DOI 10.1016/j.molcel.2004.09.001; Saha S, 2011, DEV BIOL, V358, P1, DOI 10.1016/j.ydbio.2011.06.043; Sriram SM, 2011, NAT REV MOL CELL BIO, V12, P735, DOI 10.1038/nrm3217; Tanahashi N, 2000, J BIOL CHEM, V275, P14336, DOI 10.1074/jbc.275.19.14336; Tasaki T, 2012, ANNU REV BIOCHEM, V81, P261, DOI 10.1146/annurev-biochem-051710-093308; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Walsh CT, 2005, ANGEW CHEM INT EDIT, V44, P7342, DOI 10.1002/anie.200501023; Wang JL, 2011, CHEM BIOL, V18, P121, DOI 10.1016/j.chembiol.2010.10.016; Wang WA, 2012, INT J BIOCHEM CELL B, V44, P842, DOI 10.1016/j.biocel.2012.02.009; Wong CCL, 2007, PLOS BIOL, V5, P2231, DOI 10.1371/journal.pbio.0050258; Xiao GQ, 1999, J NEUROSCI RES, V58, P652, DOI 10.1002/(SICI)1097-4547(19991201)58:5<652::AID-JNR6>3.0.CO;2-H; Zhang FL, 2012, J CELL BIOL, V197, P819, DOI 10.1083/jcb.201112129	47	13	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16403	16414		10.1074/jbc.M114.626127	http://dx.doi.org/10.1074/jbc.M114.626127			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25969538	hybrid, Green Published			2022-12-28	WOS:000356930100041
J	Svensson, K; Schnyder, S; Albert, V; Cardel, B; Quagliata, L; Terracciano, LM; Handschin, C				Svensson, Kristoffer; Schnyder, Svenia; Albert, Verena; Cardel, Bettina; Quagliata, Luca; Terracciano, Luigi M.; Handschin, Christoph			Resveratrol and SRT1720 Elicit Differential Effects in Metabolic Organs and Modulate Systemic Parameters Independently of Skeletal Muscle Peroxisome Proliferator-activated Receptor Co-activator 1 alpha (PGC-1 alpha)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						metabolic disease; metabolism; obesity; peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1a) (PPARGC1A); resveratrol; skeletal muscle	SMALL-MOLECULE ACTIVATORS; ADIPOSE-TISSUE; GLUCOSE-HOMEOSTASIS; SIRT1; MICE; SUPPLEMENTATION; MITOCHONDRIAL; RESTRICTION; FAT; ADIPONECTIN	Background: Resveratrol and SRT1720 elicit beneficial metabolic effects, supposedly through activation of PGC-1 in skeletal muscle. Results: Resveratrol/SRT1720 differentially affect transcriptional regulation in metabolic organs and modulates systemic parameters independently of muscle PGC-1. Conclusion: Skeletal muscle PGC-1 is largely dispensable for the systemic metabolic effects of resveratrol/SRT1720. Significance: Identifying molecular targets of resveratrol and SRT1720 is important to understand their therapeutic effect. Resveratrol (RSV) and SRT1720 (SRT) elicit beneficial metabolic effects and are postulated to ameliorate obesity and related metabolic complications. The co-activator, peroxisome proliferator-activated receptor co-activator 1 (PGC-1), has emerged as a major downstream effector responsible for metabolic remodeling of muscle and other metabolic tissues in response to RSV or SRT treatment. However, the requirement of PGC-1 in skeletal muscle for the systemic metabolic effects of these compounds has so far not been demonstrated. Using muscle-specific PGC-1 knock-out mice, we show that PGC-1 is necessary for transcriptional induction of mitochondrial genes in muscle with both RSV and SRT treatment. Surprisingly, the beneficial effects of SRT on glucose homeostasis and of both compounds on energy expenditure occur even in the absence of muscle PGC-1. Moreover, RSV and SRT treatment elicit differential transcriptional effects on genes involved in lipid metabolism and mitochondrial biogenesis in liver and adipose tissue. These findings indicate that RSV and SRT do not induce analogous metabolic effects in vivo. Our results provide important insights into the mechanism, effects, and organ specificity of the caloric restriction mimetics RSV and SRT. These findings are important for the design of future therapeutic interventions aimed at ameliorating obesity and obesity-related metabolic dysfunction.	[Svensson, Kristoffer; Schnyder, Svenia; Albert, Verena; Cardel, Bettina; Handschin, Christoph] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Quagliata, Luca; Terracciano, Luigi M.] Univ Basel Hosp, Inst Pathol, Dept Mol Pathol, CH-4003 Basel, Switzerland	University of Basel; University of Basel	Handschin, C (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.	christoph.handschin@unibas.ch	Terracciano, Luigi M./AAB-5335-2022; Handschin, Christoph/E-6886-2015; Quagliata, Luca/B-8321-2015	Terracciano, Luigi M./0000-0002-9393-9660; Handschin, Christoph/0000-0003-0603-1097; Quagliata, Luca/0000-0001-8249-9914; Schmid, Svenia/0000-0002-1670-3646	ERC [616830-MUSCLE_NET]; Swiss National Science Foundation; SystemsX.ch; Swiss Society for Research on Muscle Diseases (SSEM); Neuromuscular Research Association Basel (NeRAB); Gebert-Ruf Foundation "Rare Diseases" Program; "Novartis Stiftung fur medizinisch-biologische Forschung"; University of Basel; Biozentrum	ERC(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SystemsX.ch; Swiss Society for Research on Muscle Diseases (SSEM); Neuromuscular Research Association Basel (NeRAB); Gebert-Ruf Foundation "Rare Diseases" Program; "Novartis Stiftung fur medizinisch-biologische Forschung"; University of Basel; Biozentrum	This project was supported by the ERC Consolidator Grant 616830-MUSCLE_NET, the Swiss National Science Foundation, SystemsX.ch, the Swiss Society for Research on Muscle Diseases (SSEM), the Neuromuscular Research Association Basel (NeRAB), the Gebert-Ruf Foundation "Rare Diseases" Program, the "Novartis Stiftung fur medizinisch-biologische Forschung," the University of Basel, and the Biozentrum. The authors declare that they have no conflicts of interest with the contents of this article.	Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Baur JA, 2010, BBA-PROTEINS PROTEOM, V1804, P1626, DOI 10.1016/j.bbapap.2009.10.025; Beaudoin MS, 2013, AM J PHYSIOL-REG I, V305, pR542, DOI 10.1152/ajpregu.00200.2013; Bhatt JK, 2012, NUTR RES, V32, P537, DOI 10.1016/j.nutres.2012.06.003; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Finley LWS, 2012, P NATL ACAD SCI USA, V109, P2931, DOI 10.1073/pnas.1115813109; Gomez-Zorita S, 2012, BRIT J NUTR, V107, P202, DOI 10.1017/S0007114511002753; Gomez-Zorita S, 2013, NUTRITION, V29, P1374, DOI 10.1016/j.nut.2013.04.014; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Handschin C, 2009, TRENDS PHARMACOL SCI, V30, P322, DOI 10.1016/j.tips.2009.03.006; Hector KL, 2012, BIOL LETTERS, V8, P790, DOI 10.1098/rsbl.2012.0316; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Higashida K, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001603; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Ingram DK, 2006, AGING CELL, V5, P97, DOI 10.1111/j.1474-9726.2006.00202.x; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jang MK, 2013, BIOCHEM BIOPH RES CO, V431, P421, DOI 10.1016/j.bbrc.2012.12.154; Jimenez-Gomez Y, 2013, CELL METAB, V18, P533, DOI 10.1016/j.cmet.2013.09.004; Jin SH, 2013, TOXICOL APPL PHARM, V271, P95, DOI 10.1016/j.taap.2013.04.023; Kelly TJ, 2009, J BIOL CHEM, V284, P19945, DOI 10.1074/jbc.M109.015164; Kim HB, 2006, DIABETES, V55, P1342, DOI 10.2337/db05-1507; Konings E, 2014, INT J OBESITY, V38, P470, DOI 10.1038/ijo.2013.155; Kulkarni SS, 2015, BBA-MOL BASIS DIS, V1852, P1114, DOI 10.1016/j.bbadis.2014.10.005; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Martin-Montalvo A, 2013, ANTIOXID REDOX SIGN, V19, P310, DOI 10.1089/ars.2012.4866; Miller RA, 2011, J GERONTOL A-BIOL, V66, P191, DOI 10.1093/gerona/glq178; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Minor RK, 2011, SCI REP-UK, V1, DOI 10.1038/srep00070; Montgomery MK, 2013, J LIPID RES, V54, P3322, DOI 10.1194/jlr.M040451; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011; Perez-Schindler J, 2013, P NATL ACAD SCI USA, V110, P20314, DOI 10.1073/pnas.1312039110; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Qi L, 2009, CELL METAB, V9, P277, DOI 10.1016/j.cmet.2009.01.006; Qiang L, 2011, CELL METAB, V14, P758, DOI 10.1016/j.cmet.2011.10.007; Ringholm S, 2013, EXP GERONTOL, V48, P1311, DOI 10.1016/j.exger.2013.08.012; Rivera L, 2009, BIOCHEM PHARMACOL, V77, P1053, DOI 10.1016/j.bcp.2008.11.027; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Smith JJ, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-31; Speakman JR, 2011, MOL ASPECTS MED, V32, P159, DOI 10.1016/j.mam.2011.07.001; Tilg H, 2005, EXPERT OPIN THER TAR, V9, P245, DOI 10.1517/14728222.9.2.245; Timmers S, 2011, CELL METAB, V14, P612, DOI 10.1016/j.cmet.2011.10.002; Tome-Carneiro J, 2012, MOL NUTR FOOD RES, V56, P810, DOI 10.1002/mnfr.201100673; Townsend KL, 2014, TRENDS ENDOCRIN MET, V25, P168, DOI 10.1016/j.tem.2013.12.004; Turner N, 2009, DIABETES, V58, P2547, DOI 10.2337/db09-0784; Um JH, 2010, DIABETES, V59, P554, DOI 10.2337/db09-0482; Yamazaki Y, 2009, AM J PHYSIOL-ENDOC M, V297, pE1179, DOI 10.1152/ajpendo.90997.2008	48	19	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16059	16076		10.1074/jbc.M114.590653	http://dx.doi.org/10.1074/jbc.M114.590653			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25987562	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000356930100013
J	Williamson, RC; Cowell, CAM; Reville, T; Roper, JA; Rendall, TCS; Bass, MD				Williamson, Rosalind C.; Cowell, Christopher A. M.; Reville, Thomas; Roper, James A.; Rendall, Thomas C. S.; Bass, Mark D.			Coronin-1C Protein and Caveolin Protein Provide Constitutive and Inducible Mechanisms of Rac1 Protein Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						caveolin; endocytosis; fibroblast; fibronectin; migration; Rac (Rac GTPase); trafficking; coronin-1c; syndecan-4	RESONANCE ENERGY-TRANSFER; WOUND REPAIR; DIRECTIONAL MIGRATION; EXTRACELLULAR-MATRIX; CELL-ADHESION; RHO-GTPASES; ACTIVATION; FIBRONECTIN; MEMBRANE; CDC42	Background: Directional migration requires removal of Rac1 from the back of the cell. Results: Coronin-1C and caveolin provide parallel pathways for constitutive recycling or fibronectin-inducible degradation of Rac1. Discussion: Redundant trafficking pathways facilitate polarity while migrating, and responsiveness to chemotactic gradients while stationary. Significance: Maintenance of polarized migration, when the chemotactic gradient has dissipated, is essential for wound healing over a period of days. Sustained directional fibroblast migration requires both polarized activation of the protrusive signal, Rac1, and redistribution of inactive Rac1 from the rear of the cell so that it can be redistributed or degraded. In this work, we determine how alternative endocytic mechanisms dictate the fate of Rac1 in response to the extracellular matrix environment. We discover that both coronin-1C and caveolin retrieve Rac1 from similar locations at the rear and sides of the cell. We find that coronin-1C-mediated extraction, which is responsible for Rac1 recycling, is a constitutive process that maintains Rac1 protein levels within the cell. In the absence of coronin-1C, the effect of caveolin-mediated endocytosis, which targets Rac1 for proteasomal degradation, becomes apparent. Unlike constitutive coronin-1C-mediated trafficking, caveolin-mediated Rac1 endocytosis is induced by engagement of the fibronectin receptor syndecan-4. Such an inducible endocytic/degradation mechanism would predict that, in the presence of fibronectin, caveolin defines regions of the cell that are resistant to Rac1 activation but, in the absence of fibronectin leaves more of the membrane susceptible to Rac1 activation and protrusion. Indeed, we demonstrate that fibronectin-stimulated activation of Rac1 is accelerated in the absence of caveolin and that, when caveolin is knocked down, polarization of active Rac1 is lost in FRET experiments and culminates in shunting migration in a fibrous fibronectin matrix. Although the concept of polarized Rac1 activity in response to chemoattractants has always been apparent, our understanding of the balance between recycling and degradation explains how polarity can be maintained when the chemotactic gradient has faded.	[Williamson, Rosalind C.; Cowell, Christopher A. M.; Reville, Thomas; Roper, James A.; Bass, Mark D.] Univ Bristol, Sch Biochem, Bristol BS8 1TD, Avon, England; [Rendall, Thomas C. S.] Univ Bristol, Dept Engn, Bristol BS8 1TD, Avon, England; [Bass, Mark D.] Univ Sheffield, Dept Biomed Sci, Ctr Membrane Interact & Dynam, Sheffield S10 2TN, S Yorkshire, England	University of Bristol; University of Bristol; University of Sheffield	Bass, MD (corresponding author), Univ Bristol, Sch Biochem, Univ Walk, Bristol BS8 1TD, Avon, England.	mark.bass@sheffield.ac.uk		Roper, James/0000-0002-8910-6033; Bass, Mark/0000-0002-8854-9705; Rendall, Thomas/0000-0001-8930-4307	Wellcome Trust [088419]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Wellcome Trust Grant 088419 (to M. D. B.).	Barrientos S, 2014, WOUND REPAIR REGEN, V22, P569, DOI 10.1111/wrr.12205; Bass MD, 2007, J CELL BIOL, V177, P527, DOI 10.1083/jcb.200610076; Bass MD, 2011, DEV CELL, V21, P681, DOI 10.1016/j.devcel.2011.08.007; Bridgewater RE, 2012, J CELL SCI, V125, P3695, DOI 10.1242/jcs.095810; Castro-Castro A, 2011, EMBO J, V30, P3913, DOI 10.1038/emboj.2011.310; DANEN EHJ, 1995, J BIOL CHEM, V270, P21612, DOI 10.1074/jbc.270.37.21612; de Kreu BJ, 2011, J CELL SCI, V124, P2375, DOI 10.1242/jcs.080630; del Pozo MA, 2000, EMBO J, V19, P2008, DOI 10.1093/emboj/19.9.2008; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Del Pozo MA, 2002, NAT CELL BIOL, V4, P232, DOI 10.1038/ncb759; Echtermeyer F, 2001, J CLIN INVEST, V107, pR9, DOI 10.1172/JCI10559; Elfenbein A, 2009, J CELL BIOL, V186, P75, DOI 10.1083/jcb.200810179; Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563; Goetz JG, 2011, CELL, V146, P148, DOI 10.1016/j.cell.2011.05.040; Grande-Garcia A, 2007, J CELL BIOL, V177, P683, DOI 10.1083/jcb.200701006; Hassanain HH, 2005, SURGERY, V137, P92, DOI 10.1016/j.surg.2004.06.012; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Kwon AH, 2007, EXP BIOL MED, V232, P935; Liu SX, 2009, AM J PATHOL, V174, P1847, DOI 10.2353/ajpath.2009.080779; Lynch EA, 2006, MOL BIOL CELL, V17, P2236, DOI 10.1091/mbc.E05-08-0779; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; MAKAREM R, 1994, J BIOL CHEM, V269, P4005; Nethe M, 2010, J CELL SCI, V123, P1948, DOI 10.1242/jcs.062919; Nomanbhoy TK, 1999, BIOCHEMISTRY-US, V38, P1744, DOI 10.1021/bi982198u; Ojeda V, 2014, MOL CELL BIOL, V34, P3388, DOI 10.1128/MCB.00347-14; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; Prieto-Sanchez RM, 2006, ONCOGENE, V25, P2961, DOI 10.1038/sj.onc.1209333; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Razani B, 2001, J BIOL CHEM, V276, P38121; Rosentreter A, 2007, EXP CELL RES, V313, P878, DOI 10.1016/j.yexcr.2006.12.015; Sharma A, 1999, EMBO J, V18, P1468, DOI 10.1093/emboj/18.6.1468; Shaw TJ, 2009, J CELL SCI, V122, P3209, DOI 10.1242/jcs.031187; Spoerl Z, 2002, J BIOL CHEM, V277, P48858, DOI 10.1074/jbc.M205136200; Visvikis O, 2008, FEBS J, V275, P386, DOI 10.1111/j.1742-4658.2007.06209.x; Wang ZG, 2013, ONCOL REP, V29, P1066, DOI 10.3892/or.2012.2216; Williamson RC, 2014, J CELL SCI, V127, P4292, DOI 10.1242/jcs.154864; Xavier Charks-Paer, 2008, V48, P98, DOI 10.1007/978-0-387-09595-0_9	37	10	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15437	15449		10.1074/jbc.M115.640367	http://dx.doi.org/10.1074/jbc.M115.640367			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25925950	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000356527400011
J	Wu, YB; Span, LM; Nygren, P; Zhu, H; Moore, DT; Cheng, H; Roder, H; DeGrado, WF; Bennett, JS				Wu, Yibing; Span, Lisa M.; Nygren, Patrik; Zhu, Hua; Moore, David T.; Cheng, Hong; Roder, Heinrich; DeGrado, William F.; Bennett, Joel S.			The Tyrosine Kinase c-Src Specifically Binds to the Active Integrin IIb3 to Initiate Outside-in Signaling in Platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						integrin; platelet; signal transduction; Src; Src homology 3 domain (SH3 domain)	FAMILY KINASES; STRUCTURAL BASIS; SH3 DOMAINS; ACTIVATION; MECHANISM; PHOSPHORYLATION; IDENTIFICATION; CYTOSKELETON; RECOGNITION; THROMBIN	It is currently believed that inactive tyrosine kinase c-Src in platelets binds to the cytoplasmic tail of the 3 integrin subunit via its SH3 domain. Although a recent NMR study supports this contention, it is likely that such binding would be precluded in inactive c-Src because an auto-inhibitory linker physically occludes the 3 tail binding site. Accordingly, we have re-examined c-Src binding to 3 by immunoprecipitation as well as NMR spectroscopy. In unstimulated platelets, we detected little to no interaction between c-Src and 3. Following platelet activation, however, c-Src was co-immunoprecipitated with 3 in a time-dependent manner and underwent progressive activation as well. We then measured chemical shift perturbations in the N-15-labeled SH3 domain induced by the C-terminal 3 tail peptide NITYRGT and found that the peptide interacted with the SH3 domain RT-loop and surrounding residues. A control peptide whose last three residues where replaced with those of the 1 cytoplasmic tail induced only small chemical shift perturbations on the opposite face of the SH3 domain. Next, to mimic inactive c-Src, we found that the canonical polyproline peptide RPLPPLP prevented binding of the 3 peptide to the RT- loop. Under these conditions, the 3 peptide induced chemical shift perturbations similar to the negative control. We conclude that the primary interaction of c-Src with the 3 tail occurs in its activated state and at a site that overlaps with PPII binding site in its SH3 domain. Interactions of inactive c-Src with 3 are weak and insensitive to 3 tail mutations.	[Wu, Yibing; DeGrado, William F.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Span, Lisa M.; Nygren, Patrik; Zhu, Hua; Bennett, Joel S.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Moore, David T.; Roder, Heinrich] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Cheng, Hong; Roder, Heinrich] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	University of California System; University of California San Francisco; University of Pennsylvania; University of Pennsylvania; Fox Chase Cancer Center	Bennett, JS (corresponding author), Univ Penn, Sch Med, Dept Med, Hematol Oncol Div, Philadelphia, PA 19104 USA.	bennetts@mail.med.upenn.edu	Regan, Clinton/E-6250-2012; Roder, Heinrich/B-3455-2009; Nygren, Patrik/B-7319-2015	Roder, Heinrich/0000-0003-1860-2491; Nygren, Patrik/0000-0002-9233-2859	National Institutes of Health [P01 HL40387, R01 GM056250, P01 CA06927, GM054616]; NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL040387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM054616, R01GM054616, R01GM056250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by National Institutes of Health Grants P01 HL40387 (to J. S. B. and W. F. D.), R01 GM056250 (to H. R.), P01 CA06927 to the Fox Chase Cancer Center, and GM054616. The Spectroscopy Support Facility at the Fox Chase Cancer Center provided access to NMR instrumentation. The authors declare that they have no conflicts of interest with the contents of this article.	Ablooglu AJ, 2009, BLOOD, V113, P3585, DOI 10.1182/blood-2008-09-180687; Arias-Salgado EG, 2005, J CELL BIOL, V170, P837, DOI 10.1083/jcb.200503125; Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; CLARK EA, 1993, MOL CELL BIOL, V13, P1863, DOI 10.1128/MCB.13.3.1863; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Haling JR, 2011, BLOOD, V117, P1719, DOI 10.1182/blood-2010-09-305433; Ingley E, 2008, BBA-PROTEINS PROTEOM, V1784, P56, DOI 10.1016/j.bbapap.2007.08.012; Katyal P, 2013, PROTEIN SCI, V22, P1358, DOI 10.1002/pro.2323; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Law DA, 1999, NATURE, V401, P808, DOI 10.1038/44599; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Liao ZJ, 2015, BLOOD, V125, P1995, DOI 10.1182/blood-2014-09-603035; Lowell CA, 1996, GENE DEV, V10, P1845, DOI 10.1101/gad.10.15.1845; Metcalf DG, 2010, P NATL ACAD SCI USA, V107, P22481, DOI 10.1073/pnas.1015545107; Moore DT, 2012, P NATL ACAD SCI USA, V109, P793, DOI 10.1073/pnas.1117220108; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; Perez Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep01295; PUMIGLIA KM, 1993, BIOCHEM J, V294, P253, DOI 10.1042/bj2940253; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; RICKLES RJ, 1995, P NATL ACAD SCI USA, V92, P10909, DOI 10.1073/pnas.92.24.10909; Satoh K, 2009, AM J PHYSIOL-GASTR L, V296, pG1382, DOI 10.1152/ajpgi.90536.2008; Schumann FH, 2007, J BIOMOL NMR, V39, P275, DOI 10.1007/s10858-007-9197-z; Senis YA, 2014, BLOOD, V124, P2013, DOI 10.1182/blood-2014-01-453134; Shattil SJ, 1998, BLOOD, V91, P2645, DOI 10.1182/blood.V91.8.2645.2645_2645_2657; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; SPARKS AB, 1994, J BIOL CHEM, V269, P23853; STEHELIN D, 1976, NATURE, V260, P170, DOI 10.1038/260170a0; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Xiao R, 2013, BLOOD, V121, P700, DOI 10.1182/blood-2012-07-440644; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; YU H, 1993, FEBS LETT, V324, P87, DOI 10.1016/0014-5793(93)81538-B; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0	34	20	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15825	15834		10.1074/jbc.M115.648428	http://dx.doi.org/10.1074/jbc.M115.648428			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25947380	hybrid, Green Published			2022-12-28	WOS:000356527400042
J	Hisano, Y; Inoue, A; Okudaira, M; Taimatsu, K; Matsumoto, H; Kotani, H; Ohga, R; Aoki, J; Kawahara, A				Hisano, Yu; Inoue, Asuka; Okudaira, Michiyo; Taimatsu, Kiyohito; Matsumoto, Hirotaka; Kotani, Hirohito; Ohga, Rie; Aoki, Junken; Kawahara, Atsuo			Maternal and Zygotic Sphingosine Kinase 2 Are Indispensable for Cardiac Development in Zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOLOGICAL SAMPLES; 1-PHOSPHATE; SPHINGOSINE-1-PHOSPHATE; MIGRATION; TALEN; FTY720; SPHINGOLIPIDS; METABOLISM; PRECURSORS; RECEPTORS	Sphingosine 1-phosphate (S1P) is synthesized from sphingosine by sphingosine kinases (SPHK1 and SPHK2) in invertebrates and vertebrates, whereas specific receptors for S1P (S1PRs) selectively appear in vertebrates, suggesting that S1P acquires novel functions invertebrates. Because the developmental functions of SPHK1 and SPHK2 remain obscure in vertebrates, we generated sphk1 or sphk2 gene-disrupted zebrafish by introducing premature stop codons in their coding regions using transcription activator-like effector nucleases. Both zygotic sphk1 and sphk2 zebrafish mutants exhibited no obvious developmental defects and grewtoadults. The maternal-zygotic sphk2 mutant(MZsphk2), but not the maternal-zygotic sphk1 mutant and maternal sphk2 mutant, had a defect in the cardiac progenitor migration and a concomitant decrease in S1P level, leading to a two-heart phenotype (cardia bifida). Cardia bifida in MZsphk2, which was rescued by injecting sphk2 mRNA, was a phenotype identical to that of zygotic mutants of the S1P transporter spns2 and S1P receptor s1pr2, indicating that the Sphk2-Spns2-S1pr2 axis regulates the cardiac progenitor migration in zebrafish. The contribution of maternally supplied lipid mediators during vertebrate organogenesis presents as a requirement for maternal-zygotic Sphk2.	[Hisano, Yu] RIKEN, Lab Dev Gene Regulat, Brain Sci Inst, Wako, Saitama 3510198, Japan; [Inoue, Asuka; Okudaira, Michiyo; Matsumoto, Hirotaka; Aoki, Junken] Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Inoue, Asuka] Univ Yamanashi, Grad Sch Med Sci, PRESTO, Chuo 4093898, Japan; [Aoki, Junken] Univ Yamanashi, Grad Sch Med Sci, Japan Sci & Technol Agcy, CREST, Chuo 4093898, Japan; [Taimatsu, Kiyohito; Kotani, Hirohito; Ohga, Rie; Kawahara, Atsuo] Univ Yamanashi, Grad Sch Med Sci, Ctr Med Educ & Sci, Dev Biol Lab, Chuo 4093898, Japan	RIKEN; Tohoku University; Japan Science & Technology Agency (JST); University of Yamanashi; Japan Science & Technology Agency (JST); University of Yamanashi; University of Yamanashi	Hisano, Y (corresponding author), RIKEN, Lab Dev Gene Regulat, Brain Sci Inst, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	y.hisano@riken.jp; akawahara@yamanashi.ac.jp	Okudaira, Michiyo/AGR-2053-2022	Aoki, Junken/0000-0001-9435-1896	Japan Society for the Promotion of Science; Program for Next Generation World-Leading Researchers (NEXT Program); Takeda Science Foundation; Special Postdoctoral Researcher Program from RIKEN; PRESTO (Precursory Research for Embryonic Science and Technology); CREST from Japan Science and Technology Agency (JST)	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Program for Next Generation World-Leading Researchers (NEXT Program); Takeda Science Foundation(Takeda Science Foundation (TSF)); Special Postdoctoral Researcher Program from RIKEN; PRESTO (Precursory Research for Embryonic Science and Technology); CREST from Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This work was supported by the Japan Society for the Promotion of Science and the Program for Next Generation World-Leading Researchers (NEXT Program) and by Takeda Science Foundation. This work was also supported by the Special Postdoctoral Researcher Program (to Y. H.) from RIKEN and by PRESTO (Precursory Research for Embryonic Science and Technology; to A. I.) and CREST (to J. A.), from Japan Science and Technology Agency (JST).	Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Balczerski B, 2012, DEV BIOL, V362, P230, DOI 10.1016/j.ydbio.2011.12.010; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Carvalho L, 2010, TRENDS CELL BIOL, V20, P586, DOI 10.1016/j.tcb.2010.06.009; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hanaoka R, 2006, GENES CELLS, V11, P293, DOI 10.1111/j.1365-2443.2006.00939.x; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hisano Y, 2014, DEV GROWTH DIFFER, V56, P26, DOI 10.1111/dgd.12094; Hisano Y, 2013, BIOL OPEN, V2, P789, DOI 10.1242/bio.20134994; Hisano Y, 2013, BIOL OPEN, V2, P363, DOI 10.1242/bio.20133871; Hisano Y, 2012, J BIOCHEM, V152, P305, DOI 10.1093/jb/mvs090; Hisano Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038941; Hisano Y, 2011, J BIOL CHEM, V286, P1758, DOI 10.1074/jbc.M110.171116; Kawahara A, 2009, SCIENCE, V323, P524, DOI 10.1126/science.1167449; Kihara A, 2008, BBA-MOL CELL BIOL L, V1781, P496, DOI 10.1016/j.bbalip.2008.05.003; Kihara A, 2007, PROG LIPID RES, V46, P126, DOI 10.1016/j.plipres.2007.03.001; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kimura T, 2000, BIOCHEM J, V348, P71, DOI 10.1042/0264-6021:3480071; Kupperman E, 2000, NATURE, V406, P192, DOI 10.1038/35018092; Langdon YG, 2011, ANNU REV GENET, V45, P357, DOI 10.1146/annurev-genet-110410-132517; Li L, 2010, DEVELOPMENT, V137, P859, DOI 10.1242/dev.039487; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Mendelson K, 2013, J BIOL CHEM, V288, P2143, DOI 10.1074/jbc.M112.427344; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; Mizugishi K, 2007, J CLIN INVEST, V117, P2993, DOI 10.1172/JCI30674; Neubauer HA, 2013, FEBS J, V280, P5317, DOI 10.1111/febs.12314; Nishi T, 2014, BBA-MOL CELL BIOL L, V1841, P759, DOI 10.1016/j.bbalip.2013.07.012; Obinata H, 2012, SEMIN IMMUNOPATHOL, V34, P73, DOI 10.1007/s00281-011-0287-3; Okudaira M, 2014, J LIPID RES, V55, P2178, DOI 10.1194/jlr.D048439; Orr Gandy K. A., 2013, BIOCHIM BIOPHYS ACTA, V1831, P157; Osborne N, 2008, CURR BIOL, V18, P1882, DOI 10.1016/j.cub.2008.10.061; Ota S, 2013, GENES CELLS, V18, P450, DOI 10.1111/gtc.12050; Pitson SM, 2002, J BIOL CHEM, V277, P49545, DOI 10.1074/jbc.M206687200; Saigusa D, 2012, ANAL BIOANAL CHEM, V403, P1897, DOI 10.1007/s00216-012-6004-9; Sakuma T, 2013, GENES CELLS, V18, P315, DOI 10.1111/gtc.12037; Spiegel S, 2000, BBA-MOL CELL BIOL L, V1484, P107, DOI 10.1016/S1388-1981(00)00010-X; Strub GM, 2010, ADV EXP MED BIOL, V688, P141; Ye D, 2013, DEVELOPMENT, V140, P789, DOI 10.1242/dev.085340; Yokota S, 2004, FEBS LETT, V578, P106, DOI 10.1016/j.febslet.2004.10.081; Zhang L, 2013, BLOOD, V122, P791, DOI 10.1182/blood-2012-12-473884	43	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					14841	14851		10.1074/jbc.M114.634717	http://dx.doi.org/10.1074/jbc.M114.634717			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25907554	Green Published, hybrid			2022-12-28	WOS:000356177300004
J	Allsopp, RC; Evans, RJ				Allsopp, Rebecca C.; Evans, Richard J.			Contribution of the Juxtatransmembrane Intracellular Regions to the Time Course and Permeation of ATP-gated P2X7 Receptor Ion Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P2X(2) RECEPTOR; XENOPUS OOCYTES; C-TERMINUS; DESENSITIZATION; PORE; ACTIVATION; EXPRESSION; MOTIF; LYMPHOCYTES; SENSITIVITY	P2X7 receptors are ATP-gated ion channels that contribute to inflammation and cell death. They have the novel property of showing marked facilitation to repeated applications of agonist, and the intrinsic channel pore dilates to allow the passage of fluorescent dyes. A 60-s application of ATP to hP2X7 receptors expressed in Xenopus oocytes gave rise to a current that had a biphasic time course with initial and secondary slowly developing components. A second application of ATP evoked a response with a more rapid time to peak. This facilitation was reversed to initial levels following a 10-min agonist-free interval. A chimeric approach showed that replacement of the pre-TM1 amino-terminal region with the corresponding P2X2 receptor section (P2X7-2N beta) gave responses that quickly reached a steady state and did not show facilitation. Subsequent point mutations of variant residues identified Asn-16 and Ser-23 as important contributors to the time course/facilitation. The P2X7 receptor is unique in having an intracellular carboxylterminal cysteine-rich region (Ccys). Deletion of this region removed the secondary slowly developing current, and, when expressed in HEK293 cells, ethidium bromide uptake was only similar to 5% that ofWTlevels, indicating reduced large pore formation. Dye uptake was also reduced for the P2X7-2N beta chimera. Surprisingly, combination of the chimera and the Ccys deletion (P2X7-2N beta delCcys) restored the current rise time and ethidium uptake toWTlevels. These findings suggest that there is a coevolved interaction between the juxtatransmembrane amino and carboxyl termini in the regulation of P2X7 receptor gating.	[Allsopp, Rebecca C.; Evans, Richard J.] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England	University of Leicester	Evans, RJ (corresponding author), Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England.	rje6@le.ac.uk			Wellcome Trust [080487/Z/06/Z]; Medical Research Council [MR/K027018/1]; MRC [MR/K027018/1] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Wellcome Trust Grant 080487/Z/06/Z and Medical Research Council Grant MR/K027018/1.	Adinolfi E, 2010, FASEB J, V24, P3393, DOI 10.1096/fj.09-153601; Allsopp RC, 2011, J BIOL CHEM, V286, P44691, DOI 10.1074/jbc.M111.303917; Boue-Grabot E, 2000, J BIOL CHEM, V275, P10190, DOI 10.1074/jbc.275.14.10190; Brandle U, 1997, FEBS LETT, V404, P294, DOI 10.1016/S0014-5793(97)00128-2; Browne LE, 2013, J NEUROSCI, V33, P3557, DOI 10.1523/JNEUROSCI.2235-12.2013; Chaumont S, 2004, J BIOL CHEM, V279, P29628, DOI 10.1074/jbc.M403940200; Coddou C, 2011, PHARMACOL REV, V63, P641, DOI 10.1124/pr.110.003129; Denlinger LC, 2003, J IMMUNOL, V171, P1304, DOI 10.4049/jimmunol.171.3.1304; Ennion S, 2000, J BIOL CHEM, V275, P29361, DOI 10.1074/jbc.M003637200; Ennion SJ, 2002, BIOCHEM BIOPH RES CO, V291, P611, DOI 10.1006/bbrc.2002.6488; FENWICK EM, 1982, J PHYSIOL-LONDON, V331, P577, DOI 10.1113/jphysiol.1982.sp014393; Fryatt AG, 2014, MOL PHARMACOL, V86, P707, DOI 10.1124/mol.114.095307; Hattori M, 2012, NATURE, V485, P207, DOI 10.1038/nature11010; Hechler B, 2003, J EXP MED, V198, P661, DOI 10.1084/jem.20030144; Jiang LH, 2001, J BIOL CHEM, V276, P14902, DOI 10.1074/jbc.M011327200; Jiang LH, 2005, AM J PHYSIOL-CELL PH, V289, pC1295, DOI 10.1152/ajpcell.00253.2005; Jiang LH, 2009, EUR BIOPHYS J BIOPHY, V38, P339, DOI 10.1007/s00249-008-0315-y; Jiang RT, 2013, TRENDS BIOCHEM SCI, V38, P20, DOI 10.1016/j.tibs.2012.10.006; Jiang YQ, 2013, CHINESE SCI BULL, V58, P2812, DOI 10.1007/s11434-013-5870-7; Kaczmarek-Hajek K, 2012, PURINERG SIGNAL, V8, P375, DOI 10.1007/s11302-012-9314-7; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Khadra A, 2013, BIOPHYS J, V104, P2612, DOI 10.1016/j.bpj.2013.05.006; Khakh BS, 1999, NAT NEUROSCI, V2, P322, DOI 10.1038/7233; Klapperstuck M, 2000, BBA-BIOMEMBRANES, V1467, P444, DOI 10.1016/S0005-2736(00)00245-5; Nicke A, 2009, J BIOL CHEM, V284, P25813, DOI 10.1074/jbc.M109.033134; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Petrou S, 1997, FEBS LETT, V411, P339, DOI 10.1016/S0014-5793(97)00700-X; Rassendren F, 1997, J BIOL CHEM, V272, P5482, DOI 10.1074/jbc.272.9.5482; Rettinger J, 2003, J GEN PHYSIOL, V121, P451, DOI 10.1085/jgp.200208730; Riedel T, 2007, BIOPHYS J, V93, P846, DOI 10.1529/biophysj.106.103614; Robinson LE, 2014, J BIOL CHEM, V289, P31983, DOI 10.1074/jbc.M114.574699; Roger B, 2008, J NEUROSCI, V28, P6393, DOI 10.1523/JNEUROSCI.0696-08.2008; Roger S, 2010, J BIOL CHEM, V285, P17514, DOI 10.1074/jbc.M109.053082; Shemon AN, 2006, J BIOL CHEM, V281, P2079, DOI 10.1074/jbc.M507816200; Simon J, 1997, MOL PHARMACOL, V52, P237, DOI 10.1124/mol.52.2.237; Sorge RE, 2012, NAT MED, V18, P595, DOI 10.1038/nm.2710; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Virginio C, 1999, NAT NEUROSCI, V2, P315, DOI 10.1038/7225; Werner P, 1996, P NATL ACAD SCI USA, V93, P15485, DOI 10.1073/pnas.93.26.15485; WILEY JS, 1992, ARCH BIOCHEM BIOPHYS, V292, P411, DOI 10.1016/0003-9861(92)90010-T; Wilhelm K, 2010, NAT MED, V16, P1434, DOI 10.1038/nm.2242; Wilson HL, 2002, J BIOL CHEM, V277, P34017, DOI 10.1074/jbc.M205120200; Yan D, 2013, P NATL ACAD SCI USA, V110, P2228, DOI 10.1073/pnas.1222285110; Yan ZH, 2010, J NEUROSCI, V30, P14213, DOI 10.1523/JNEUROSCI.2390-10.2010; Yan ZH, 2008, J GEN PHYSIOL, V132, P563, DOI 10.1085/jgp.200810059	46	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14556	14566		10.1074/jbc.M115.642033	http://dx.doi.org/10.1074/jbc.M115.642033			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25903136	Green Published, hybrid			2022-12-28	WOS:000355754600027
J	Habtemichael, EN; Alcazar-Roman, A; Rubin, BR; Grossi, LR; Belman, JP; Julca, O; Loffler, MG; Li, HJ; Chi, NW; Samuel, VT; Bogan, JS				Habtemichael, Estifanos N.; Alcazar-Roman, Abel; Rubin, Bradley R.; Grossi, Laura R.; Belman, Jonathan P.; Julca, Omar; Loeffler, Michael G.; Li, Hongjie; Chi, Nai-Wen; Samuel, Varman T.; Bogan, Jonathan S.			Coordinated Regulation of Vasopressin Inactivation and Glucose Uptake by Action of TUG Protein in Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RESPONSIVE AMINOPEPTIDASE; GLUT4 STORAGE-VESICLES; SKELETAL-MUSCLE; MAMMALIAN-CELLS; GLUT4-CONTAINING VESICLES; TRANSPORTER TRANSLOCATION; 3T3-L1 ADIPOCYTES; DILEUCINE MOTIF; TRAFFICKING; COMPARTMENT	In adipose and muscle cells, insulin stimulates the exocytic translocation of vesicles containing GLUT4, a glucose transporter, and insulin-regulated aminopeptidase (IRAP), a transmembrane aminopeptidase. A substrate of IRAP is vasopressin, which controls water homeostasis. The physiological importance of IRAP translocation to inactivate vasopressin remains uncertain. We previously showed that in skeletal muscle, insulin stimulates proteolytic processing of the GLUT4 retention protein, TUG, to promote GLUT4 translocation and glucose uptake. Here we show that TUG proteolysis also controls IRAP targeting and regulates vasopressin action in vivo. Transgenic mice with constitutive TUG proteolysis in muscle consumed much more water than wild-type control mice. The transgenic mice lost more body weight during water restriction, and the abundance of renal AQP2 water channels was reduced, implying that vasopressin activity is decreased. To compensate for accelerated vasopressin degradation, vasopressin secretion was increased, as assessed by the cosecreted protein copeptin. IRAP abundance was increased in T-tubule fractions of fasting transgenic mice, when compared with controls. Recombinant IRAP bound to TUG, and this interaction was mapped to a short peptide in IRAP that was previously shown to be critical for GLUT4 intracellular retention. In cultured 3T3-L1 adipocytes, IRAP was present in TUG-bound membranes and was released by insulin stimulation. Together with previous results, these data support a model in which TUG controls vesicle translocation by interacting with IRAP as well as GLUT4. Furthermore, the effect of IRAP to reduce vasopressin activity is a physiologically important consequence of vesicle translocation, which is coordinated with the stimulation of glucose uptake.	[Habtemichael, Estifanos N.; Alcazar-Roman, Abel; Rubin, Bradley R.; Grossi, Laura R.; Belman, Jonathan P.; Julca, Omar; Loeffler, Michael G.; Li, Hongjie; Samuel, Varman T.; Bogan, Jonathan S.] Yale Univ, Sch Med, Sect Endocrinol & Metab, Dept Internal Med, POB 208020, New Haven, CT 06520 USA; [Rubin, Bradley R.; Grossi, Laura R.; Belman, Jonathan P.; Julca, Omar; Bogan, Jonathan S.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Chi, Nai-Wen] Univ Calif San Diego, Vet Affairs San Diego Healthcare Syst, La Jolla, CA 92093 USA; [Chi, Nai-Wen] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Samuel, Varman T.] Vet Adm Med Ctr, West Haven, CT 06516 USA	Yale University; Yale University; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Bogan, JS (corresponding author), Yale Univ, Sch Med, Sect Endocrinol & Metab, Dept Internal Med, POB 208020, New Haven, CT 06520 USA.	jonathan.bogan@yale.edu	Regan, Clinton/E-6250-2012; Bogan, Jonathan S/A-1575-2010; Loffler, Michael/F-1748-2013	Bogan, Jonathan S/0000-0001-6463-8466; Alcazar-Roman, Abel R./0000-0003-1668-1886; Belman, Jonathan/0000-0002-1051-6938; Loffler, Michael/0000-0002-6529-9723	National Institutes of Health [P30 DK45735]; Yale Mouse Metabolic Phenotyping Center (National Institutes of Health) [U24 DK059635]; Physiology Core of the George M. O'Brien Kidney Center at Yale (National Institutes of Health) [P30 DK079310]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092661, U24DK059635, P30DK079310, P30DK045735, F30DK093198, T32DK007058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG041383] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000702, I01BX000901] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale Mouse Metabolic Phenotyping Center (National Institutes of Health); Physiology Core of the George M. O'Brien Kidney Center at Yale (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	We thank Dr. Vassily Ogryzko for the BirA construct and Drs. Mark Knepper, Gerald Shulman, and Charisse Orme for helpful discussions and assistance. This work used the Cell Biology Core of the Yale Diabetes Endocrinology Research Center (supported by National Institutes of Health Grant P30 DK45735), the Yale Mouse Metabolic Phenotyping Center (National Institutes of Health Grant U24 DK059635), and the Physiology Core of the George M. O'Brien Kidney Center at Yale (National Institutes of Health Grant P30 DK079310), as well as services provided by the W. M. Keck Foundation Biotechnology Resource Laboratory at Yale University.	Ariga M, 2008, J BIOL CHEM, V283, P10208, DOI 10.1074/jbc.M710604200; Bankir L, 2013, NAT REV NEPHROL, V9, P223, DOI 10.1038/nrneph.2013.22; Belman JP, 2015, J BIOL CHEM, V290, P4447, DOI 10.1074/jbc.M114.603977; Belman JP, 2014, REV ENDOCR METAB DIS, V15, P55, DOI 10.1007/s11154-013-9276-2; Bogan JS, 2012, J BIOL CHEM, V287, P23932, DOI 10.1074/jbc.M112.339457; Bogan JS, 2012, ANNU REV BIOCHEM, V81, P507, DOI 10.1146/annurev-biochem-060109-094246; Bogan JS, 2010, CURR OPIN CELL BIOL, V22, P506, DOI 10.1016/j.ceb.2010.03.012; Bogan JS, 2003, NATURE, V425, P727, DOI 10.1038/nature01989; Cartee G, 2015, DIABETOLOGIA, V58, P19, DOI 10.1007/s00125-014-3395-5; Chi NW, 2000, J BIOL CHEM, V275, P38437, DOI 10.1074/jbc.M007635200; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; Enhorning S, 2011, J CLIN ENDOCR METAB, V96, pE1065, DOI 10.1210/jc.2010-2981; Fraser JA, 2011, J GEN PHYSIOL, V138, P95, DOI 10.1085/jgp.201110617; Garvey WT, 1998, J CLIN INVEST, V101, P2377, DOI 10.1172/JCI1557; Gross DN, 2004, MOL CELL BIOL, V24, P7151, DOI 10.1128/MCB.24.16.7151-7162.2004; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Hofmann SM, 2007, J CLIN INVEST, V117, P3271, DOI 10.1172/JCI31929; Hosaka T, 2005, MOL BIOL CELL, V16, P2882, DOI 10.1091/mbc.E05-01-0072; Hou JC, 2006, J BIOL CHEM, V281, P33457, DOI 10.1074/jbc.M601583200; Jedrychowski MP, 2010, J BIOL CHEM, V285, P104, DOI 10.1074/jbc.M109.040428; Jian OY, 2009, MOL CELL, V34, P145, DOI 10.1016/j.molcel.2009.03.013; Johnson AO, 2001, MOL BIOL CELL, V12, P367, DOI 10.1091/mbc.12.2.367; Jordens I, 2010, MOL BIOL CELL, V21, P2034, DOI 10.1091/mbc.E10-02-0158; Kandror KV, 2011, TRAFFIC, V12, P665, DOI 10.1111/j.1600-0854.2011.01175.x; KANDROR KV, 1994, P NATL ACAD SCI USA, V91, P8017, DOI 10.1073/pnas.91.17.8017; Katagiri H, 2002, MOL ENDOCRINOL, V16, P1049, DOI 10.1210/me.16.5.1049; Keller SR, 2003, FRONT BIOSCI-LANDMRK, V8, pS410, DOI 10.2741/1078; KELLER SR, 1995, J BIOL CHEM, V270, P23612, DOI 10.1074/jbc.270.40.23612; Klip A, 2014, AM J PHYSIOL-CELL PH, V306, pC879, DOI 10.1152/ajpcell.00069.2014; Knepper MA, 2015, NEW ENGL J MED, V372, P1349, DOI 10.1056/NEJMra1404726; Kupriyanova TA, 2002, J BIOL CHEM, V277, P9133, DOI 10.1074/jbc.M106999200; Lin BZ, 1997, J BIOL CHEM, V272, P24145, DOI 10.1074/jbc.272.39.24145; Liu XD, 2000, ANAL BIOCHEM, V280, P20, DOI 10.1006/abio.2000.4478; Loffler MG, 2013, J BIOL CHEM, V288, P20135, DOI 10.1074/jbc.M113.458075; Maianu L, 2001, J CLIN ENDOCR METAB, V86, P5450, DOI 10.1210/jc.86.11.5450; Mechold U, 2005, J BIOTECHNOL, V116, P245, DOI 10.1016/j.jbiotec.2004.12.003; Miranda CA, 2014, AM J PHYSIOL-RENAL, V306, pF359, DOI 10.1152/ajprenal.00330.2013; Mironova E, 2015, AM J PHYSIOL-RENAL, V308, pF237, DOI 10.1152/ajprenal.00246.2014; Mironova E, 2012, P NATL ACAD SCI USA, V109, P10095, DOI 10.1073/pnas.1201978109; Morgenthaler NG, 2006, CLIN CHEM, V52, P112, DOI 10.1373/clinchem.2005.060038; Morgenthaler NG, 2008, TRENDS ENDOCRIN MET, V19, P43, DOI 10.1016/j.tem.2007.11.001; Morris NJ, 1998, J BIOL CHEM, V273, P3582, DOI 10.1074/jbc.273.6.3582; Muniyappa R, 2013, REV ENDOCR METAB DIS, V14, P5, DOI 10.1007/s11154-012-9229-1; Nilsson SK, 2008, J BIOL CHEM, V283, P25920, DOI 10.1074/jbc.M802721200; Pilch PF, 2008, ACTA PHYSIOL, V192, P89, DOI 10.1111/j.1748-1716.2007.01788.x; Richter EA, 2013, PHYSIOL REV, V93, P993, DOI 10.1152/physrev.00038.2012; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Sun HY, 2012, J BIOL CHEM, V287, P42071, DOI 10.1074/jbc.M112.410985; Terrand J, 2009, J BIOL CHEM, V284, P381, DOI 10.1074/jbc.M806538200; Tettamanzi MC, 2006, PROTEIN SCI, V15, P498, DOI 10.1110/ps.051901806; Tsuchiya Y, 2010, J BIOL CHEM, V285, P34371, DOI 10.1074/jbc.M110.128520; Wagenmakers AJM, 2016, J PHYSIOL-LONDON, V594, P2207, DOI 10.1113/jphysiol.2014.284513; Wallis MG, 2007, AM J PHYSIOL-ENDOC M, V293, pE1092, DOI 10.1152/ajpendo.00440.2007; Waters SB, 1997, J BIOL CHEM, V272, P23323, DOI 10.1074/jbc.272.37.23323; Watson RT, 2008, J CELL SCI, V121, P1243, DOI 10.1242/jcs.017517; Willnow TE, 2011, CURR OPIN LIPIDOL, V22, P79, DOI 10.1097/MOL.0b013e3283416f2b; Wilson JLL, 2013, CLIN EXP NEPHROL, V17, P751, DOI 10.1007/s10157-013-0789-5; Xu YK, 2011, J CELL BIOL, V193, P643, DOI 10.1083/jcb.201008135; Xu Z, 2002, J BIOL CHEM, V277, P47972, DOI 10.1074/jbc.C200486200; Yang BX, 2006, AM J PHYSIOL-RENAL, V291, pF465, DOI 10.1152/ajprenal.00494.2005; Yeh TYJ, 2007, BIOCHEM J, V402, P279, DOI 10.1042/BJ20060793; Yu CF, 2007, J BIOL CHEM, V282, P7710, DOI 10.1074/jbc.M610824200; Zorzano Antonio, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0324s31	63	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14454	14461		10.1074/jbc.C115.639203	http://dx.doi.org/10.1074/jbc.C115.639203			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25944897	Green Published, hybrid			2022-12-28	WOS:000355754600016
J	Paul, SS; Sil, P; Haldar, S; Mitra, S; Chattopadhyay, K				Paul, Simanta Sarani; Sil, Pallabi; Haldar, Shubhasis; Mitra, Samaresh; Chattopadhyay, Krishnananda			Subtle Change in the Charge Distribution of Surface Residues May Affect the Secondary Functions of Cytochrome c	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; CARDIOLIPIN INTERACTION; STRUCTURAL TRANSITIONS; MITOCHONDRIAL PATHWAY; PEROXIDASE-ACTIVITY; APOPTOTIC ACTIVITY; HORSE HEART; ACETIC-ACID; PROTEIN; RELEASE	Although the primary function of cytochrome c (cyt c) is electron transfer, the protein caries out an additional secondary function involving its interaction with membrane cardiolipin (CDL), its peroxidase activity, and the initiation of apoptosis. Whereas the primary function of cyt c is essentially conserved, its secondary function varies depending on the source of the protein. We report here a detailed experimental and computational study, which aims to understand, at the molecular level, the difference in the secondary functions of cyt c obtained from horse heart (mammalian) and Saccharomyces cerevisiae (yeast). The conformational landscape of cyt c has been found to be heterogeneous, consisting of an equilibrium between the compact and extended conformers as well as the oligomeric species. Because the determination of relative populations of these conformers is difficult to obtain by ensemble measurements, we used fluorescence correlation spectroscopy (FCS), a method that offers single-molecule resolution. The population of different species is found to depend on multiple factors, including the protein source, the presence of CDL and urea, and their concentrations. The complex interplay between the conformational distribution and oligomerization plays a crucial role in the variation of the pre-apoptotic regulation of cyt c observed from different sources. Finally, computational studies reveal that the variation in the charge distribution at the surface and the charge reversal sites may be the key determinant of the conformational stability of cyt c.	[Paul, Simanta Sarani; Sil, Pallabi; Haldar, Shubhasis; Mitra, Samaresh; Chattopadhyay, Krishnananda] CSIR Indian Inst Chem Biol, Prot Folding & Dynam Lab, Struct Biol & Bioinformat Div, 4 Raja SC Mullick Rd, Kolkata 700032, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Chattopadhyay, K (corresponding author), CSIR Indian Inst Chem Biol, Prot Folding & Dynam Lab, Struct Biol & Bioinformat Div, 4 Raja SC Mullick Rd, Kolkata 700032, India.	krish@iicb.res.in		Haldar, Shubhasis/0000-0002-4304-5570	network project grant (UNSEEN) from the Council of Scientific and Industrial Research (CSIR), India; Indian National Science Academy (INSA)	network project grant (UNSEEN) from the Council of Scientific and Industrial Research (CSIR), India; Indian National Science Academy (INSA)	This study was funded by a network project grant (UNSEEN) from the Council of Scientific and Industrial Research (CSIR), India.r Recipient of a senior scientist award grant from the Indian National Science Academy (INSA).	Ascenzi P, 2011, IUBMB LIFE, V63, P160, DOI 10.1002/iub.440; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Basova LV, 2007, BIOCHEMISTRY-US, V46, P3423, DOI 10.1021/bi061854k; Belikova NA, 2006, BIOCHEMISTRY-US, V45, P4998, DOI 10.1021/bi0525573; Bender CE, 2012, P NATL ACAD SCI USA, V109, P4904, DOI 10.1073/pnas.1120680109; Bergstrom CL, 2013, P NATL ACAD SCI USA, V110, P6269, DOI 10.1073/pnas.1303819110; BLAUER G, 1993, BIOCHEMISTRY-US, V32, P6674, DOI 10.1021/bi00077a021; Brustovetsky N, 1996, BIOCHEMISTRY-US, V35, P8483, DOI 10.1021/bi960833v; Carmona-Gutierrez D, 2010, CELL DEATH DIFFER, V17, P763, DOI 10.1038/cdd.2009.219; Chattopadhyay K, 2005, BIOPHYS J, V88, P1413, DOI 10.1529/biophysj.104.053199; Chattopadhyay K, 2002, P NATL ACAD SCI USA, V99, P14171, DOI 10.1073/pnas.172524899; Diederix REM, 2002, BIOCHEMISTRY-US, V41, P13067, DOI 10.1021/bi0260841; Driscoll WJ, 2007, J BIOL CHEM, V282, P22353, DOI 10.1074/jbc.M610070200; Genova ML, 2008, BBA-BIOENERGETICS, V1777, P740, DOI 10.1016/j.bbabio.2008.04.007; Giannattasio S, 2008, FEBS LETT, V582, P1519, DOI 10.1016/j.febslet.2008.03.048; Godoy LC, 2009, P NATL ACAD SCI USA, V106, P2653, DOI 10.1073/pnas.0809279106; Gogvadze V, 2006, BBA-BIOENERGETICS, V1757, P639, DOI 10.1016/j.bbabio.2006.03.016; Guaragnella N, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00070; Haldar S, 2015, LANGMUIR, V31, P4213, DOI 10.1021/la5029993; Haldar S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031797; Haldar S, 2010, J BIOL CHEM, V285, P25314, DOI 10.1074/jbc.M110.116673; Hanske J, 2012, P NATL ACAD SCI USA, V109, P125, DOI 10.1073/pnas.1112312108; Hirota S, 2010, P NATL ACAD SCI USA, V107, P12854, DOI 10.1073/pnas.1001839107; Hong YN, 2012, J AM CHEM SOC, V134, P18713, DOI 10.1021/ja307426k; Huttemann M, 2011, MITOCHONDRION, V11, P369, DOI 10.1016/j.mito.2011.01.010; Jemmerson R, 1999, BIOCHEMISTRY-US, V38, P3599, DOI 10.1021/bi9809268; Joshi AS, 2009, BBA-MOL CELL RES, V1793, P212, DOI 10.1016/j.bbamcr.2008.07.024; Kagan VE, 2009, FREE RADICAL BIO MED, V46, P1439, DOI 10.1016/j.freeradbiomed.2009.03.004; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kapralov AA, 2007, BIOCHEMISTRY-US, V46, P14232, DOI 10.1021/bi701237b; Kluck RM, 2000, J BIOL CHEM, V275, P16127, DOI 10.1074/jbc.275.21.16127; Liu JH, 2003, MOL CANCER RES, V1, P892; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; LOUIE GV, 1990, J MOL BIOL, V214, P527, DOI 10.1016/0022-2836(90)90197-T; Ludovico P, 2002, MOL BIOL CELL, V13, P2598, DOI 10.1091/mbc.E01-12-0161; Manon S, 1997, FEBS LETT, V415, P29, DOI 10.1016/S0014-5793(97)01087-9; McClelland LJ, 2014, P NATL ACAD SCI USA, V111, P6648, DOI 10.1073/pnas.1323828111; Miyamoto S, 2012, PHOTOCH PHOTOBIO SCI, V11, P1536, DOI 10.1039/c2pp25119a; Mueller GP, 2007, J BIOL CHEM, V282, P22364, DOI 10.1074/jbc.M701801200; Muenzner J, 2014, CHEM PHYS LIPIDS, V179, P57, DOI 10.1016/j.chemphyslip.2013.11.002; Muenzner J, 2013, J PHYS CHEM B, V117, P12878, DOI 10.1021/jp402104r; Nantes IL, 2001, J BIOL CHEM, V276, P153, DOI 10.1074/jbc.M006338200; Nantes IL, 2010, METHODS MOL BIOL, V606, P147, DOI 10.1007/978-1-60761-447-0_12; Oberst A, 2008, CELL DEATH DIFFER, V15, P1139, DOI 10.1038/cdd.2008.65; Olteanu A, 2003, BIOCHEM BIOPH RES CO, V312, P733, DOI 10.1016/j.bbrc.2003.10.182; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; Patriarca A, 2012, ARCH BIOCHEM BIOPHYS, V522, P62, DOI 10.1016/j.abb.2012.03.028; Petrosillo G, 2003, FASEB J, V17, P2202, DOI 10.1096/fj.03-0012com; PINHEIRO TJT, 1994, BIOCHIMIE, V76, P489, DOI 10.1016/0300-9084(94)90173-2; Pitschke M, 1998, NAT MED, V4, P832, DOI 10.1038/nm0798-832; RYTOMAA M, 1995, J BIOL CHEM, V270, P3197, DOI 10.1074/jbc.270.7.3197; Santucci R, 2010, EXPERT REV PROTEOMIC, V7, P507, DOI 10.1586/EPR.10.50; Sarkar S, 2014, BIOCHEMISTRY-US, V53, P1393, DOI 10.1021/bi4014837; Sen Mojumdar S, 2012, J PHYS CHEM B, V116, P12189, DOI 10.1021/jp307297s; Sinibaldi F, 2008, BIOCHEMISTRY-US, V47, P6928, DOI 10.1021/bi800048v; Sinibaldi F, 2013, BIOCHEMISTRY-US, V52, P4578, DOI 10.1021/bi400324c; Sinibaldi F, 2011, J INORG BIOCHEM, V105, P1365, DOI 10.1016/j.jinorgbio.2011.07.022; Sukhotnik I, 2005, EUR J PEDIATR SURG, V15, P229, DOI 10.1055/s-2005-865766; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Tyurin VA, 2007, CELL DEATH DIFFER, V14, P872, DOI 10.1038/sj.cdd.4402068; Wang ZH, 2011, ORG BIOMOL CHEM, V9, P4766, DOI 10.1039/c1ob05552f; Winge DR, 2012, MOL CELL BIOL, V32, P2647, DOI 10.1128/MCB.00573-12; Yu TN, 2001, J BIOL CHEM, V276, P13034, DOI 10.1074/jbc.M009773200	64	20	20	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14476	14490		10.1074/jbc.M114.607010	http://dx.doi.org/10.1074/jbc.M114.607010			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25873393	Green Published, hybrid			2022-12-28	WOS:000355754600018
J	Lee, J; Ding, SJ; Walpole, TB; Holding, AN; Montgomery, MG; Fearnley, IM; Walker, JE				Lee, Jennifer; Ding, ShuJing; Walpole, Thomas B.; Holding, Andrew N.; Montgomery, Martin G.; Fearnley, Ian M.; Walker, John E.			Organization of Subunits in the Membrane Domain of the Bovine F-ATPase Revealed by Covalent Cross-linking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEART-MITOCHONDRIA; YEAST MITOCHONDRIA; MASS-SPECTROMETRY; PERIPHERAL STALK; GXXXG MOTIF; SYNTHASE; PROTEIN; IDENTIFICATION; SEQUENCE; DISRUPTION	The F-ATPase in bovine mitochondria is a membrane-bound complex of about 30 subunits of 18 different kinds. Currently, similar to 85% of its structure is known. The enzyme has a membrane extrinsic catalytic domain, and a membrane intrinsic domain where the turning of the enzyme's rotor is generated from the transmembrane proton-motive force. The domains are linked by central and peripheral stalks. The central stalk and a hydrophobic ring of c-subunits in the membrane domain constitute the enzyme's rotor. The external surface of the catalytic domain and membrane subunit a are linked by the peripheral stalk, holding them static relative to the rotor. The membrane domain contains six additional subunits named ATP8, e, f, g, DAPIT(diabetes-associated protein in insulin-sensitive tissues), and 6.8PL (6.8-kDa proteolipid), each with a single predicted transmembrane alpha-helix, but their orientation and topography are unknown. Mutations in ATP8 uncouple the enzyme and interfere with its assembly, but its roles and the roles of the other five subunits are largely unknown. We have reacted accessible amino groups in the enzyme with bifunctional cross-linking agents and identified the linked residues. Cross-links involving the supernumerary subunits, where the structures are not known, show that the C terminus of ATP8 extends similar to 70 angstrom from the membrance into the peripheral stalk and that the N termini of the other supernumerary subunits are on the same side of the membrane, probably in the mitochondirail matrix. These experiments contribute significantly toward building up a complete structural picture of the F-ATPase.	[Lee, Jennifer; Ding, ShuJing; Walpole, Thomas B.; Montgomery, Martin G.; Fearnley, Ian M.; Walker, John E.] MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England; [Holding, Andrew N.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Walker, JE (corresponding author), MRC, Mitochondrial Biol Unit, Cambridge Biomed Campus,Hills Rd, Cambridge CB2 0XY, England.	walker@mrc-mbu.cam.ac.uk	Holding, Andrew/I-1069-2019	Holding, Andrew/0000-0002-8459-7048; Walker, John/0000-0001-7929-2162; Walpole, Thomas Benjamin/0000-0001-5483-5650	Medical Research Council (MRC) [U105663150]; MRC [MC_U105663150] Funding Source: UKRI; Medical Research Council [MC_U105663150] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the intramural program of the Medical Research Council (MRC Grant U105663150 (to J. E. W.).	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Allegretti M, 2015, NATURE, V521, P237, DOI 10.1038/nature14185; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Arnold I, 1998, EMBO J, V17, P7170, DOI 10.1093/emboj/17.24.7170; Arnold I, 1999, J BIOL CHEM, V274, P36, DOI 10.1074/jbc.274.1.36; Arselin G, 2004, J BIOL CHEM, V279, P40392, DOI 10.1074/jbc.M404316200; Arselin G, 2003, EUR J BIOCHEM, V270, P1875, DOI 10.1046/j.1432-1033.2003.03557.x; Baker LA, 2012, P NATL ACAD SCI USA, V109, P11675, DOI 10.1073/pnas.1204935109; Belogrudov GI, 1996, J BIOL CHEM, V271, P20340, DOI 10.1074/jbc.271.34.20340; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Bustos DM, 2005, J BIOL CHEM, V280, P29004, DOI 10.1074/jbc.M502140200; Carbajo RJ, 2007, J MOL BIOL, V368, P310, DOI 10.1016/j.jmb.2007.02.059; Chen RM, 2007, FEBS LETT, V581, P3145, DOI 10.1016/j.febslet.2007.05.079; Cherepanov DA, 1999, FEBS LETT, V449, P1, DOI 10.1016/S0014-5793(99)00386-5; COLLINSON IR, 1994, J MOL BIOL, V242, P408; COLLINSON IR, 1994, BIOCHEM J, V303, P639, DOI 10.1042/bj3030639; COLLINSON IR, 1994, BIOCHEMISTRY-US, V33, P7971, DOI 10.1021/bi00191a026; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dickson VK, 2006, EMBO J, V25, P2911, DOI 10.1038/sj.emboj.7601177; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FEARNLEY IM, 1986, EMBO J, V5, P2003, DOI 10.1002/j.1460-2075.1986.tb04456.x; Gissi C, 2008, HEREDITY, V101, P301, DOI 10.1038/hdy.2008.62; GRASSO DG, 1991, EUR J BIOCHEM, V199, P203, DOI 10.1111/j.1432-1033.1991.tb16110.x; Holding AN, 2013, J PROTEOME RES, V12, P5923, DOI 10.1021/pr4003867; Jonckheere AI, 2008, J MED GENET, V45, P129, DOI 10.1136/jmg.2007.052084; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu SD, 2015, BIOCHEM J, V468, P167, DOI 10.1042/BJ20150197; MACREADIE IG, 1983, NUCLEIC ACIDS RES, V11, P4435, DOI 10.1093/nar/11.13.4435; Meyer B, 2007, MOL CELL PROTEOMICS, V6, P1690, DOI 10.1074/mcp.M700097-MCP200; Miranda-Astudillo H, 2014, BBA-BIOENERGETICS, V1837, P1, DOI 10.1016/j.bbabio.2013.08.001; NAGLEY P, 1988, P NATL ACAD SCI USA, V85, P2091, DOI 10.1073/pnas.85.7.2091; Ohsakaya S, 2011, J BIOL CHEM, V286, P20292, DOI 10.1074/jbc.M110.198523; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; PULLMAN ME, 1963, J BIOL CHEM, V238, P3762; Rees DM, 2009, P NATL ACAD SCI USA, V106, P21597, DOI 10.1073/pnas.0910365106; Rinner O, 2008, NAT METHODS, V5, P315, DOI [10.1038/nmeth.1192, 10.1038/NMETH.1192]; Roudeau S, 1999, J BIOENERG BIOMEMBR, V31, P85, DOI 10.1023/A:1005407525915; Runswick MJ, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120160; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Seebacher J, 2006, J PROTEOME RES, V5, P2270, DOI 10.1021/pr060154z; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Spannagel C, 1997, EUR J BIOCHEM, V247, P1111, DOI 10.1111/j.1432-1033.1997.01111.x; Stephens AN, 2000, EUR J BIOCHEM, V267, P6443, DOI 10.1046/j.1432-1327.2000.01733.x; Stephens AN, 2003, J BIOL CHEM, V278, P17867, DOI 10.1074/jbc.M300967200; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Vaillier J, 1999, J BIOL CHEM, V274, P543, DOI 10.1074/jbc.274.1.543; van Lis R, 2007, PLANT PHYSIOL, V144, P1190, DOI 10.1104/pp.106.094060; Vazquez-Acevedo M, 2006, J BIOENERG BIOMEMBR, V38, P271, DOI 10.1007/s10863-006-9046-x; Velours J, 1998, BIOCHIMIE, V80, P793, DOI 10.1016/S0300-9084(00)88873-2; VELOURS J, 1984, EMBO J, V3, P207, DOI 10.1002/j.1460-2075.1984.tb01785.x; WALKER JE, 1991, BIOCHEMISTRY-US, V30, P5369, DOI 10.1021/bi00236a007; Walker JE, 2013, BIOCHEM SOC T, V41, P1, DOI 10.1042/BST20110773; Walker JE, 2006, BBA-BIOENERGETICS, V1757, P286, DOI 10.1016/j.bbabio.2006.01.001; Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107	58	31	32	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13308	13320		10.1074/jbc.M115.645283	http://dx.doi.org/10.1074/jbc.M115.645283			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25851905	Green Published, hybrid			2022-12-28	WOS:000354975700030
